##ANALYSISTYPE=GERMLINE_TRIO
##SAMPLE=<ID=genotype,Gender=male,ExternalSampleName=131787,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=affected,SampleName=GS140127_01>
##SAMPLE=<ID=GS140549_01,Gender=female,ExternalSampleName=131752,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=unaffected>
##SAMPLE=<ID=GS140550_01,Gender=male,ExternalSampleName=131751,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=unaffected>
##DESCRIPTION=genotype=Genotype of variant in sample.
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - SNP quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM), genotype, depth and allele frequency for child, mother and father (TRIO).
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon number, HGVS.c, HGVS.p).
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in all populations of 1000g project.
##DESCRIPTION=ExAC=Allele frequency in all populations of ExAC project.
##DESCRIPTION=ExAC_hom=Homoyzgous counts for populations ALL, NFE and AFR of ExAC project.
##DESCRIPTION=ExAC_sub=Sub-population allele frequenciens for populations AFR,AMR,EAS,NFE,SAS of ExAC project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD database.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=MetaLR=MetaLR effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen2=PolyPhen2 (HVAR) effect prediction: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=FATHMM=FATHMM effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 15-20.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=ihdb_allsys_hom=Homozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=ihdb_allsys_het=Heterozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validated=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, ExAC pLI score).
##FILTER=anno_high_impact=Variant annotated to have high impact by SnpEff.
##FILTER=anno_omim=Variant annotated with information from OMIM.
##FILTER=anno_pathogenic_clinvar=Variant annotated to be pathogenic by ClinVar.
##FILTER=anno_pathogenic_hgmd=Variant annotated to be pathogenic by HGMD.
##FILTER=gene_blacklist=The gene(s) are contained on the blacklist of unreliable genes.
##FILTER=low_DP=Depth less than 20.
##FILTER=low_MQM=Mean mapping quality of alternate allele less than Q50.
##FILTER=low_QUAL=Variant quality less than Q30.
##FILTER=pred_pathogenic=Variant predicted to be pathogenic by one or more tools (conservation or effect prediction).
##FILTER=trio_comp_f=Trio analyis:Variant is compound-heteroygous inherited from father.
##FILTER=trio_comp_m=Trio analyis: Variant is compound-heteroygous inherited from mother.
##FILTER=trio_denovo=Trio analyis: Variant is de-novo in child.
##FILTER=trio_hemizygous=Trio analyis: Variant is hemizygous.
##FILTER=trio_recessive=Trio analyis: Variant is recessively inherited from parents.
#chr	start	end	ref	obs	genotype	filter	quality	gene	variant_type	coding_and_splicing	RepeatMasker	dbSNP	1000g	ExAC	ExAC_hom	ExAC_sub	gnomAD	phyloP	Sift	MetaLR	PolyPhen2	FATHMM	CADD	OMIM	ClinVar	HGMD	COSMIC	ihdb_allsys_hom	ihdb_allsys_het	classification	classification_comment	validated	comment	gene_info
chr1	977330	977330	T	C	hom	low_DP;anno_omim	QUAL=1743;DP=13;AF=1.00;MQM=60;TRIO=HOM,13,1.00,HOM,20,1.00,HOM,26,1.00	AGRN	splice_region&intron	AGRN:ENST00000379370:splice_region&intron:LOW:exon6/35:c.1178-6T>C:		rs2799066	0.8852	0.9166	49652,26935,2511	0.7175,0.9541,0.9998,0.9161,0.9544	0.9235							103320 [AGRN (provisional) Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120];	RCV000116254.2 [benign]; 			1713	355	2	[2] auto-classification 14.09.2017  			AGRN (inh=AR pLI=0.17)
chr1	981931	981931	A	G	hom	anno_omim	QUAL=6340;DP=55;AF=0.98;MQM=59;TRIO=HOM,55,0.98,HOM,73,1.00,HOM,96,1.00	AGRN	synonymous	AGRN:ENST00000379370:synonymous:LOW:exon18/36:c.3066A>G:p.Ser1022Ser		rs2465128	0.7977	0.8768	45286,25865,1210	0.5130,0.9312,0.9649,0.9018,0.8890	0.8872							103320 [AGRN (provisional) Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120];	RCV000116259.2 [benign]; 		COSM1126908	1616	436	2	[2] auto-classification 14.09.2017  		GS151035_01: storniert, da VUS4 in SYNGAP1 SBW 2.03.2016	AGRN (inh=AR pLI=0.17)
chr1	982994	982994	T	C	hom	anno_omim	QUAL=15575;DP=143;AF=0.99;MQM=59;TRIO=HOM,143,0.99,HOM,143,1.00,HOM,208,1.00	AGRN	synonymous	AGRN:ENST00000379370:synonymous:LOW:exon21/36:c.3558T>C:p.Phe1186Phe		rs10267	0.8359	0.8989	49550,27787,1439	0.5354,0.9420,0.9995,0.9151,0.9543	0.9089							103320 [AGRN (provisional) Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120];	RCV000116264.2 [benign]; 		COSM4144271	1689	375	2	[2] auto-classification 14.09.2017  			AGRN (inh=AR pLI=0.17)
chr1	984302	984302	T	C	het	low_DP;anno_omim	QUAL=572;DP=10;AF=0.60;MQM=60;TRIO=HET,10,0.60,WT,17,0.00,HOM,19,1.00	AGRN	synonymous	AGRN:ENST00000379370:synonymous:LOW:exon24/36:c.4161T>C:p.Thr1387Thr		rs9442391	0.5457	0.6295	6170,2886,108	0.3853,0.7571,0.8435,0.6388,0.5753	0.5885							103320 [AGRN (provisional) Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120];	RCV000116269.2 [benign]; 			645	994	2	[2] auto-classification 14.09.2017  			AGRN (inh=AR pLI=0.17)
chr1	987200	987200	C	T	hom	anno_omim	QUAL=11199;DP=65;AF=0.98;MQM=60;TRIO=HOM,65,0.98,HOM,144,1.00,HOM,160,0.99	AGRN	splice_region&intron	AGRN:ENST00000379370:splice_region&intron:LOW:exon33/35:c.5651+5C>T:		rs9803031	0.7887	0.8757	47145,27015,1042	0.4520,0.9366,0.9968,0.9055,0.8844	0.8880							103320 [AGRN (provisional) Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120];	RCV000116279.2 [benign]; 			1631	424	2	[2] auto-classification 14.09.2017  			AGRN (inh=AR pLI=0.17)
chr1	990380	990380	C	T	hom	anno_omim	QUAL=12528;DP=170;AF=0.96;MQM=60;TRIO=HOM,170,0.96,HET,332,0.44,HET,435,0.49	AGRN	3'UTR	AGRN:ENST00000379370:3'UTR:MODIFIER:exon36/36:c.*19C>T:		rs3121561	0.3435	0.3334	938,271,224	0.5610,0.2791,0.2212,0.3195,0.3068	0.3626							103320 [AGRN (provisional) Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120];	RCV000252490.1 [benign]; 			179	817					AGRN (inh=AR pLI=0.17)
chr1	990417	990417	T	C	hom	anno_omim	QUAL=16882;DP=198;AF=0.99;MQM=59;TRIO=HOM,198,0.99,HET,389,0.46,HET,507,0.49	AGRN,RP11-54O7.14	3'UTR	AGRN:ENST00000379370:3'UTR:MODIFIER:exon36/36:c.*56T>C:		rs2465136	0.3840	0.0000	0,0,0	0,0,0,0,0	0.3948							103320 [AGRN (provisional) Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120];				185	799					AGRN (inh=AR pLI=0.17), RP11-54O7.14 (inh=n/a pLI=n/a)
chr1	990517	990517	C	T	hom	anno_omim	QUAL=18598;DP=126;AF=0.99;MQM=59;TRIO=HOM,126,0.99,HET,285,0.48,HOM,376,1.00	AGRN,RP11-54O7.14	3'UTR	AGRN:ENST00000379370:3'UTR:MODIFIER:exon36/36:c.*156C>T:		rs2710872	0.9179	0.0000	0,0,0	0,0,0,0,0	0.8780							103320 [AGRN (provisional) Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120];				177	51					AGRN (inh=AR pLI=0.17), RP11-54O7.14 (inh=n/a pLI=n/a)
chr1	990773	990773	C	T	hom	anno_omim	QUAL=22636;DP=190;AF=1.00;MQM=60;TRIO=HOM,190,1.00,HET,297,0.54,HOM,405,1.00	AGRN,RP11-54O7.14	3'UTR	AGRN:ENST00000379370:3'UTR:MODIFIER:exon36/36:c.*412C>T:		rs2799072	0.8460	0.0000	0,0,0	0,0,0,0,0	0.8194							103320 [AGRN (provisional) Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120];				172	52					AGRN (inh=AR pLI=0.17), RP11-54O7.14 (inh=n/a pLI=n/a)
chr1	990806	990806	G	A	hom	anno_omim	QUAL=24719;DP=227;AF=0.98;MQM=59;TRIO=HOM,227,0.98,HET,312,0.54,HOM,451,1.00	AGRN,RP11-54O7.14	3'UTR	AGRN:ENST00000379370:3'UTR:MODIFIER:exon36/36:c.*445G>A:		rs2799073	0.8462	0.0000	0,0,0	0,0,0,0,0	0.8196							103320 [AGRN (provisional) Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120];				172	52					AGRN (inh=AR pLI=0.17), RP11-54O7.14 (inh=n/a pLI=n/a)
chr1	990984	990984	G	A	hom	anno_omim	QUAL=16025;DP=154;AF=0.99;MQM=59;TRIO=HOM,154,0.99,HET,190,0.59,HOM,273,1.00	AGRN,RP11-54O7.14	3'UTR	AGRN:ENST00000379370:3'UTR:MODIFIER:exon36/36:c.*623G>A:		rs8014	0.9223	0.0000	0,0,0	0,0,0,0,0	0.8818							103320 [AGRN (provisional) Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120];				176	50					AGRN (inh=AR pLI=0.17), RP11-54O7.14 (inh=n/a pLI=n/a)
chr1	1957037	1957037	T	C	het	anno_omim	QUAL=6920;DP=173;AF=0.55;MQM=59;TRIO=HET,173,0.55,WT,342,0.00,HET,399,0.49	GABRD	synonymous	GABRD:ENST00000378585:synonymous:LOW:exon4/9:c.330T>C:p.Gly110Gly		rs2229110	0.5613	0.5934	22096,14241,2764	0.7290,0.4569,0.3148,0.6578,0.4732	0.6471							137163 [GABRD (confirmed) Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060|Epilepsy,idiopathic generalized,10,613060|Epilepsy,juvenile myoclonic,susceptibility to,613060];	RCV000254456.1 [benign]; 		COSM424897	908	907	2	[2] auto-classification 14.09.2017  			GABRD (inh=n/a pLI=0.92)
chr1	1960674	1960674	C	T	het	anno_omim	QUAL=4915;DP=126;AF=0.49;MQM=59;TRIO=HET,126,0.49,HET,266,0.56,WT,386,0.01	GABRD	synonymous	GABRD:ENST00000378585:synonymous:LOW:exon7/9:c.816C>T:p.Ser272Ser		rs28408173	0.1983	0.2873	1279,346,4	0.0574,0.4576,0.5830,0.2597,0.2879	0.1923							137163 [GABRD (confirmed) Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060|Epilepsy,idiopathic generalized,10,613060|Epilepsy,juvenile myoclonic,susceptibility to,613060];	RCV000248963.1 [benign]; 			55	440	2	[2] auto-classification 14.09.2017  			GABRD (inh=n/a pLI=0.92)
chr1	2337277	2337277	C	T	het	anno_omim	QUAL=119;DP=22;AF=0.41;MQM=60;TRIO=HET,22,0.41,WT,1,0.00,WT,1,0.00	PEX10	splice_region&intron	PEX10:ENST00000288774:splice_region&intron:LOW:exon5/5:c.973-4G>A:,PEX10:ENST00000447513:splice_region&intron:LOW:exon5/5:c.913-4G>A:,PEX10:ENST00000507596:splice_region&intron:LOW:exon5/5:c.913-10G>A:		rs11586985	0.0809	0.1530	377,256,3	0.0369,0.1009,0.1867,0.1791,0.1262	0.1049							602859 [PEX10 (confirmed) Peroxisome biogenesis disorder 6A (Zellweger),614870|Peroxisome biogenesis disorder 6B,614871];	RCV000251204.1 [benign]; RCV000341363.1 [likely benign]; 			69	736	2	[2] auto-classification 14.09.2017  			PEX10 (inh=AR pLI=0.01)
chr1	5926507	5926507	T	C	het	anno_omim	QUAL=8816;DP=279;AF=0.49;MQM=59;TRIO=HET,279,0.49,WT,156,0.00,HOM,182,0.99	NPHP4	synonymous	NPHP4:ENST00000378156:synonymous:LOW:exon26/30:c.3570A>G:p.Glu1190Glu		rs555164	0.3197	0.4604	7291,4640,147	0.2681,0.4606,0.3327,0.4929,0.4711	0.3935							607215 [NPHP4 (provisional) Nephronophthisis 4,606966|Senior-Loken syndrome 4,606996];	RCV000081716.5 [benign]; RCV000266333.1 [benign]; RCV000324301.1 [benign]; 		COSM1126976	354	994	2	[2] auto-classification 14.09.2017  			NPHP4 (inh=AR pLI=0.00)
chr1	5935162	5935162	A	T	het	anno_high_impact;anno_omim	QUAL=4972;DP=90;AF=0.38;MQM=60;TRIO=HET,90,0.38,HOM,87,1.00,HET,128,0.52	NPHP4	splice_acceptor	NPHP4:ENST00000378156:splice_acceptor:HIGH:exon20/29:c.2818-2T>A:		rs1287637	0.8433	0.8363	35542,19394,3252	0.8949,0.7944,0.8179,0.8304,0.8305	0.8615	0.4520					18.68	607215 [NPHP4 (provisional) Nephronophthisis 4,606966|Senior-Loken syndrome 4,606996];	RCV000153587.2 [benign]; 		COSM3751327	1371	638	1	[1] auto-classification 16.06.2016  [2] Ute Grasshoff 24.11.2015			NPHP4 (inh=AR pLI=0.00)
chr1	6526183	6526183	G	A	het	low_DP;anno_omim	QUAL=378;DP=16;AF=0.44;MQM=59;TRIO=HET,16,0.44,WT,5,0.00,HET,20,0.70	TNFRSF25,PLEKHG5	5'UTR,3'UTR	TNFRSF25:ENST00000377782:5'UTR:MODIFIER:exon1/10:c.-16C>T:,TNFRSF25:ENST00000356876:5'UTR:MODIFIER:exon1/10:c.-16C>T:,TNFRSF25:ENST00000351959:5'UTR:MODIFIER:exon1/9:c.-16C>T:,PLEKHG5:ENST00000400913:3'UTR:MODIFIER:exon21/21:c.*1440C>T:,PLEKHG5:ENST00000340850:3'UTR:MODIFIER:exon21/21:c.*1440C>T:,PLEKHG5:ENST00000377748:3'UTR:MODIFIER:exon22/22:c.*1440C>T:		rs3007417	0.2023	0.1694	440,67,329	0.5832,0.1157,0.0008,0.1465,0.1193	0.1849							611101 [PLEKHG5 (confirmed) Spinal muscular atrophy,distal,autosomal recessive,4,611067|Charcot-Marie-Tooth disease,recessive intermediate C,615376];	RCV000399468.1 [benign]; 			22	321					TNFRSF25 (inh=n/a pLI=0.45), PLEKHG5 (inh=AR pLI=0.00)
chr1	6526203	6526210	CGTGCTCT	-	het	low_DP;anno_omim	QUAL=389;DP=17;AF=0.53;MQM=59;TRIO=HET,17,0.53,WT,6,0.00,HET,21,0.67	TNFRSF25,PLEKHG5	5'UTR,3'UTR	TNFRSF25:ENST00000377782:5'UTR:MODIFIER:exon1/10:c.-43_-36delAGAGCACG:,TNFRSF25:ENST00000356876:5'UTR:MODIFIER:exon1/10:c.-43_-36delAGAGCACG:,TNFRSF25:ENST00000351959:5'UTR:MODIFIER:exon1/9:c.-43_-36delAGAGCACG:,PLEKHG5:ENST00000400913:3'UTR:MODIFIER:exon21/21:c.*1413_*1420delAGAGCACG:,PLEKHG5:ENST00000340850:3'UTR:MODIFIER:exon21/21:c.*1413_*1420delAGAGCACG:,PLEKHG5:ENST00000377748:3'UTR:MODIFIER:exon22/22:c.*1413_*1420delAGAGCACG:		rs45616733	0.2027	0.0954	62,10,43	0.4489,0.0520,0.0000,0.0834,0.0797	0.1845							611101 [PLEKHG5 (confirmed) Spinal muscular atrophy,distal,autosomal recessive,4,611067|Charcot-Marie-Tooth disease,recessive intermediate C,615376];	RCV000302421.1 [benign]; 			20	289					TNFRSF25 (inh=n/a pLI=0.45), PLEKHG5 (inh=AR pLI=0.00)
chr1	6526241	6526244	CGCC	-	het	low_DP;anno_omim	QUAL=326;DP=11;AF=0.73;MQM=59;TRIO=HET,11,0.73,WT,3,0.00,HET,15,0.73	TNFRSF25,PLEKHG5	5'UTR,3'UTR	TNFRSF25:ENST00000356876:5'UTR:MODIFIER:exon1/10:c.-77_-74delGGCG:,PLEKHG5:ENST00000400913:3'UTR:MODIFIER:exon21/21:c.*1379_*1382delGGCG:,PLEKHG5:ENST00000340850:3'UTR:MODIFIER:exon21/21:c.*1379_*1382delGGCG:,PLEKHG5:ENST00000377748:3'UTR:MODIFIER:exon22/22:c.*1379_*1382delGGCG:		rs45542640	0.2025	0.0000	0,0,0	0,0,0,0,0	0.1844							611101 [PLEKHG5 (confirmed) Spinal muscular atrophy,distal,autosomal recessive,4,611067|Charcot-Marie-Tooth disease,recessive intermediate C,615376];	RCV000361894.1 [benign]; 			12	56					TNFRSF25 (inh=n/a pLI=0.45), PLEKHG5 (inh=AR pLI=0.00)
chr1	6526319	6526319	C	T	het	anno_omim	QUAL=293;DP=31;AF=0.35;MQM=60;TRIO=HET,31,0.35,WT,30,0.00,HET,33,0.39	PLEKHG5	3'UTR	PLEKHG5:ENST00000400913:3'UTR:MODIFIER:exon21/21:c.*1304G>A:,PLEKHG5:ENST00000340850:3'UTR:MODIFIER:exon21/21:c.*1304G>A:,PLEKHG5:ENST00000377748:3'UTR:MODIFIER:exon22/22:c.*1304G>A:		rs45604837	0.0863	0.0000	0,0,0	0,0,0,0,0	0.0837							611101 [PLEKHG5 (confirmed) Spinal muscular atrophy,distal,autosomal recessive,4,611067|Charcot-Marie-Tooth disease,recessive intermediate C,615376];	RCV000263899.1 [likely benign]; 			1	27					PLEKHG5 (inh=AR pLI=0.00)
chr1	6526465	6526465	C	G	het	anno_omim	QUAL=3463;DP=85;AF=0.48;MQM=60;TRIO=HET,85,0.48,WT,150,0.00,HET,199,0.54	PLEKHG5	3'UTR	PLEKHG5:ENST00000400913:3'UTR:MODIFIER:exon21/21:c.*1158G>C:,PLEKHG5:ENST00000340850:3'UTR:MODIFIER:exon21/21:c.*1158G>C:,PLEKHG5:ENST00000377748:3'UTR:MODIFIER:exon22/22:c.*1158G>C:	MIR3	rs2986754	0.2043	0.0000	0,0,0	0,0,0,0,0	0.1820							611101 [PLEKHG5 (confirmed) Spinal muscular atrophy,distal,autosomal recessive,4,611067|Charcot-Marie-Tooth disease,recessive intermediate C,615376];	RCV000387093.1 [benign]; 			1	38					PLEKHG5 (inh=AR pLI=0.00)
chr1	6527333	6527333	A	G	het	anno_omim	QUAL=1629;DP=78;AF=0.51;MQM=59;TRIO=HET,78,0.51,WT,53,0.00,HET,59,0.47	PLEKHG5	3'UTR	PLEKHG5:ENST00000400913:3'UTR:MODIFIER:exon21/21:c.*290T>C:,PLEKHG5:ENST00000340850:3'UTR:MODIFIER:exon21/21:c.*290T>C:,PLEKHG5:ENST00000377748:3'UTR:MODIFIER:exon22/22:c.*290T>C:,PLEKHG5:ENST00000377725:3'UTR:MODIFIER:exon22/22:c.*318T>C:,PLEKHG5:ENST00000377728:3'UTR:MODIFIER:exon21/21:c.*290T>C:,PLEKHG5:ENST00000377732:3'UTR:MODIFIER:exon21/21:c.*290T>C:,PLEKHG5:ENST00000400915:3'UTR:MODIFIER:exon22/22:c.*290T>C:,PLEKHG5:ENST00000377740:3'UTR:MODIFIER:exon22/22:c.*290T>C:,PLEKHG5:ENST00000535355:3'UTR:MODIFIER:exon21/21:c.*290T>C:,PLEKHG5:ENST00000377737:3'UTR:MODIFIER:exon22/22:c.*290T>C:		rs14708	0.2670	0.0000	0,0,0	0,0,0,0,0	0.2637							611101 [PLEKHG5 (confirmed) Spinal muscular atrophy,distal,autosomal recessive,4,611067|Charcot-Marie-Tooth disease,recessive intermediate C,615376];	RCV000311319.1 [benign]; 			7	67					PLEKHG5 (inh=AR pLI=0.00)
chr1	6529443	6529443	A	G	het	anno_omim	QUAL=9849;DP=342;AF=0.47;MQM=59;TRIO=HET,342,0.47,WT,392,0.00,HET,488,0.48	PLEKHG5	synonymous	PLEKHG5:ENST00000537245:synonymous:LOW:exon19/22:c.2238T>C:p.Ser746Ser,PLEKHG5:ENST00000400913:synonymous:LOW:exon18/21:c.2001T>C:p.Ser667Ser,PLEKHG5:ENST00000340850:synonymous:LOW:exon18/21:c.2001T>C:p.Ser667Ser,PLEKHG5:ENST00000377748:synonymous:LOW:exon19/22:c.2232T>C:p.Ser744Ser,PLEKHG5:ENST00000377725:synonymous:LOW:exon18/22:c.2001T>C:p.Ser667Ser,PLEKHG5:ENST00000377728:synonymous:LOW:exon18/21:c.2001T>C:p.Ser667Ser,PLEKHG5:ENST00000377732:synonymous:LOW:exon18/21:c.2112T>C:p.Ser704Ser,PLEKHG5:ENST00000400915:synonymous:LOW:exon19/22:c.2169T>C:p.Ser723Ser,PLEKHG5:ENST00000377740:synonymous:LOW:exon19/22:c.2232T>C:p.Ser744Ser,PLEKHG5:ENST00000535355:synonymous:LOW:exon18/21:c.2208T>C:p.Ser736Ser,PLEKHG5:ENST00000377737:synonymous:LOW:exon19/22:c.2001T>C:p.Ser667Ser,PLEKHG5:ENST00000544978:synonymous:LOW:exon19/22:c.2001T>C:p.Ser667Ser		rs730600	0.2696	0.1723	2980,684,1843	0.5910,0.0891,0.0049,0.1425,0.1780	0.2653							611101 [PLEKHG5 (confirmed) Spinal muscular atrophy,distal,autosomal recessive,4,611067|Charcot-Marie-Tooth disease,recessive intermediate C,615376];	RCV000175354.2 [benign]; RCV000288519.1 [benign]; 			79	616	2	[2] auto-classification 14.09.2017  			PLEKHG5 (inh=AR pLI=0.00)
chr1	6531589	6531589	C	T	het	anno_omim	QUAL=1721;DP=39;AF=0.69;MQM=59;TRIO=HET,39,0.69,WT,115,0.00,HET,115,0.44	PLEKHG5	missense	PLEKHG5:ENST00000537245:missense:MODERATE:exon13/22:c.1477G>A:p.Ala493Thr,PLEKHG5:ENST00000400913:missense:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr,PLEKHG5:ENST00000340850:missense:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr,PLEKHG5:ENST00000377748:missense:MODERATE:exon13/22:c.1471G>A:p.Ala491Thr,PLEKHG5:ENST00000377725:missense:MODERATE:exon12/22:c.1240G>A:p.Ala414Thr,PLEKHG5:ENST00000377728:missense:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr,PLEKHG5:ENST00000377732:missense:MODERATE:exon12/21:c.1351G>A:p.Ala451Thr,PLEKHG5:ENST00000400915:missense:MODERATE:exon13/22:c.1408G>A:p.Ala470Thr,PLEKHG5:ENST00000377740:missense:MODERATE:exon13/22:c.1471G>A:p.Ala491Thr,PLEKHG5:ENST00000535355:missense:MODERATE:exon12/21:c.1447G>A:p.Ala483Thr,PLEKHG5:ENST00000377737:missense:MODERATE:exon13/22:c.1240G>A:p.Ala414Thr,PLEKHG5:ENST00000544978:missense:MODERATE:exon13/22:c.1240G>A:p.Ala414Thr		rs74809741	0.0553	0.0629	169,106,28	0.1059,0.0424,0.0000,0.0716,0.0607	0.0573	0.6410	T,T,T,T,T,T,T,T,T,T,T,T,T	T	B,B,B,B,B	T,T,T,T,T,T,T,T,T,T,T,T	12.65	611101 [PLEKHG5 (confirmed) Spinal muscular atrophy,distal,autosomal recessive,4,611067|Charcot-Marie-Tooth disease,recessive intermediate C,615376];	RCV000317056.1 [likely benign]; 		COSM4144152, COSM4144153	14	264	2	[2] auto-classification 14.09.2017  			PLEKHG5 (inh=AR pLI=0.00)
chr1	6533393	6533393	G	C	het	anno_omim	QUAL=407;DP=23;AF=0.35;MQM=60;TRIO=HET,23,0.35,WT,19,0.00,HET,25,0.56	PLEKHG5	missense	PLEKHG5:ENST00000537245:missense:MODERATE:exon9/22:c.950C>G:p.Thr317Ser,PLEKHG5:ENST00000400913:missense:MODERATE:exon8/21:c.713C>G:p.Thr238Ser,PLEKHG5:ENST00000340850:missense:MODERATE:exon8/21:c.713C>G:p.Thr238Ser,PLEKHG5:ENST00000377748:missense:MODERATE:exon9/22:c.944C>G:p.Thr315Ser,PLEKHG5:ENST00000377725:missense:MODERATE:exon8/22:c.713C>G:p.Thr238Ser,PLEKHG5:ENST00000377728:missense:MODERATE:exon8/21:c.713C>G:p.Thr238Ser,PLEKHG5:ENST00000377732:missense:MODERATE:exon8/21:c.824C>G:p.Thr275Ser,PLEKHG5:ENST00000400915:missense:MODERATE:exon9/22:c.881C>G:p.Thr294Ser,PLEKHG5:ENST00000377740:missense:MODERATE:exon9/22:c.944C>G:p.Thr315Ser,PLEKHG5:ENST00000535355:missense:MODERATE:exon8/21:c.920C>G:p.Thr307Ser,PLEKHG5:ENST00000377737:missense:MODERATE:exon9/22:c.713C>G:p.Thr238Ser,PLEKHG5:ENST00000544978:missense:MODERATE:exon9/22:c.713C>G:p.Thr238Ser		rs61741379	0.2857	0.2212	796,120,537	0.6544,0.1535,0.0193,0.1807,0.1647	0.2792	0.8480	T,T,T,T,T,T,T,T,T,T,T,T,T	T	B,B,B,B,B	T,T,T,T,T,T,T,T,T,T,T,T	0.01	611101 [PLEKHG5 (confirmed) Spinal muscular atrophy,distal,autosomal recessive,4,611067|Charcot-Marie-Tooth disease,recessive intermediate C,615376];	RCV000180356.2 [benign]; RCV000346358.1 [benign]; 		COSM3751353, COSM3751354	72	615	2	[2] auto-classification 14.09.2017  			PLEKHG5 (inh=AR pLI=0.00)
chr1	6579521	6579521	G	C	het	anno_omim	QUAL=3471;DP=124;AF=0.53;MQM=59;TRIO=HET,124,0.53,HET,78,0.46,HET,91,0.52	PLEKHG5	missense,5'UTR	PLEKHG5:ENST00000377748:missense:MODERATE:exon1/22:c.51C>G:p.Ser17Arg,PLEKHG5:ENST00000377740:missense:MODERATE:exon1/22:c.51C>G:p.Ser17Arg,PLEKHG5:ENST00000377737:5'UTR:MODIFIER:exon1/22:c.-181C>G:		rs17438786	0.0136	0.0252	51,36,0	0.0058,0.0177,0.0000,0.0334,0.0174	0.0245	0.0870	T,T	T	B,B	T,T	5.81	611101 [PLEKHG5 (confirmed) Spinal muscular atrophy,distal,autosomal recessive,4,611067|Charcot-Marie-Tooth disease,recessive intermediate C,615376];				0	110					PLEKHG5 (inh=AR pLI=0.00)
chr1	6579607	6579607	C	T	hom	anno_omim	QUAL=20275;DP=186;AF=1.00;MQM=59;TRIO=HOM,186,1.00,HOM,206,1.00,HOM,271,1.00	PLEKHG5	5'UTR	PLEKHG5:ENST00000377748:5'UTR:MODIFIER:exon1/22:c.-36G>A:,PLEKHG5:ENST00000377740:5'UTR:MODIFIER:exon1/22:c.-36G>A:,PLEKHG5:ENST00000377737:5'UTR:MODIFIER:exon1/22:c.-267G>A:		rs1556035	0.7460	0.8523	44471,25994,1339	0.5248,0.9344,0.8012,0.8829,0.8650	0.8596							611101 [PLEKHG5 (confirmed) Spinal muscular atrophy,distal,autosomal recessive,4,611067|Charcot-Marie-Tooth disease,recessive intermediate C,615376];				1490	415					PLEKHG5 (inh=AR pLI=0.00)
chr1	6579843	6579843	C	T	hom	anno_omim	QUAL=41968;DP=296;AF=0.99;MQM=59;TRIO=HOM,296,0.99,HOM,454,1.00,HOM,585,1.00	PLEKHG5	5'UTR	PLEKHG5:ENST00000377748:5'UTR:MODIFIER:exon1/22:c.-272G>A:,PLEKHG5:ENST00000377740:5'UTR:MODIFIER:exon1/22:c.-272G>A:,PLEKHG5:ENST00000377737:5'UTR:MODIFIER:exon1/22:c.-503G>A:		rs1010584	0.7354	0.0000	0,0,0	0,0,0,0,0	0.7728							611101 [PLEKHG5 (confirmed) Spinal muscular atrophy,distal,autosomal recessive,4,611067|Charcot-Marie-Tooth disease,recessive intermediate C,615376];				161	68					PLEKHG5 (inh=AR pLI=0.00)
chr1	10435324	10435324	C	A	het	anno_omim	QUAL=7247;DP=299;AF=0.45;MQM=60;TRIO=HET,299,0.45,HET,116,0.57,HET,147,0.52	KIF1B	synonymous	KIF1B:ENST00000377081:synonymous:LOW:exon47/48:c.5301C>A:p.Thr1767Thr,KIF1B:ENST00000263934:synonymous:LOW:exon46/47:c.5163C>A:p.Thr1721Thr,KIF1B:ENST00000377086:synonymous:LOW:exon48/49:c.5301C>A:p.Thr1767Thr		rs11121552	0.2316	0.2717	4770,2846,50	0.0866,0.3536,0.2896,0.2908,0.2351	0.2794							605995 [KIF1B (confirmed) Charcot-Marie-Tooth disease,type 2A1,118210|Pheochromocytoma,171300|Neuroblastoma,susceptibility to,1,256700];	RCV000117408.5 [other]; RCV000262668.1 [benign]; RCV000317736.1 [benign]; RCV000353894.1 [benign]; 		COSM146393	163	785	2	[2] auto-classification 14.09.2017  			KIF1B (inh=AD pLI=1.00)
chr1	10436892	10436892	-	AC	het	anno_omim	QUAL=4808;DP=130;AF=0.44;MQM=59;TRIO=HET,130,0.82,HET,110,0.32,WT,126,0.52	KIF1B	3'UTR,intron	KIF1B:ENST00000263934:3'UTR:MODIFIER:exon47/47:c.*279_*280dupCA:,KIF1B:ENST00000377086:3'UTR:MODIFIER:exon49/49:c.*279_*280dupCA:,KIF1B:ENST00000377081:intron:MODIFIER:exon47/47:c.5409-1473_5409-1472dupCA:		rs146112447;rs769994641	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0586							605995 [KIF1B (confirmed) Charcot-Marie-Tooth disease,type 2A1,118210|Pheochromocytoma,171300|Neuroblastoma,susceptibility to,1,256700];				2	7					KIF1B (inh=AD pLI=1.00)
chr1	10436924	10436924	C	T	het	anno_omim	QUAL=4808;DP=130;AF=0.44;MQM=59;TRIO=HET,130,0.82,WT,110,0.32,HET,126,0.52	KIF1B	3'UTR,intron	KIF1B:ENST00000263934:3'UTR:MODIFIER:exon47/47:c.*279C>T:,KIF1B:ENST00000377086:3'UTR:MODIFIER:exon49/49:c.*279C>T:,KIF1B:ENST00000377081:intron:MODIFIER:exon47/47:c.5409-1473C>T:	(AC)n	rs78490707	0.0403	0.0000	0,0,0	0,0,0,0,0	0.0085							605995 [KIF1B (confirmed) Charcot-Marie-Tooth disease,type 2A1,118210|Pheochromocytoma,171300|Neuroblastoma,susceptibility to,1,256700];	RCV000313395.1 [likely benign]; RCV000334533.1 [likely benign]; RCV000391449.1 [likely benign]; 			0	6					KIF1B (inh=AD pLI=1.00)
chr1	10438006	10438006	A	T	het	anno_omim	QUAL=1434;DP=82;AF=0.45;MQM=59;TRIO=HET,82,0.45,HET,59,0.53,WT,73,0.00	KIF1B	3'UTR,intron	KIF1B:ENST00000377086:3'UTR:MODIFIER:exon49/49:c.*1361A>T:,KIF1B:ENST00000377081:intron:MODIFIER:exon47/47:c.5409-391A>T:	AluSg	rs2847347	0.0182	0.0000	0,0,0	0,0,0,0,0	0.0362							605995 [KIF1B (confirmed) Charcot-Marie-Tooth disease,type 2A1,118210|Pheochromocytoma,171300|Neuroblastoma,susceptibility to,1,256700];	RCV000273631.1 [likely benign]; RCV000313452.1 [likely benign]; RCV000370496.1 [likely benign]; 			1	27					KIF1B (inh=AD pLI=1.00)
chr1	10438687	10438687	C	T	het	anno_omim	QUAL=12161;DP=255;AF=0.56;MQM=59;TRIO=HET,255,0.56,HET,281,0.51,HET,354,0.51	KIF1B	3'UTR	KIF1B:ENST00000377081:3'UTR:MODIFIER:exon48/48:c.*227C>T:,KIF1B:ENST00000377086:3'UTR:MODIFIER:exon49/49:c.*2042C>T:		rs1536262	0.5465	0.0000	0,0,0	0,0,0,0,0	0.5499							605995 [KIF1B (confirmed) Charcot-Marie-Tooth disease,type 2A1,118210|Pheochromocytoma,171300|Neuroblastoma,susceptibility to,1,256700];	RCV000264101.1 [benign]; RCV000321672.1 [benign]; RCV000361157.1 [benign]; 			54	134					KIF1B (inh=AD pLI=1.00)
chr1	10438892	10438892	G	A	het	anno_omim	QUAL=8905;DP=286;AF=0.54;MQM=59;TRIO=HET,286,0.54,HET,160,0.57,HET,193,0.52	KIF1B	3'UTR	KIF1B:ENST00000377081:3'UTR:MODIFIER:exon48/48:c.*432G>A:,KIF1B:ENST00000377086:3'UTR:MODIFIER:exon49/49:c.*2247G>A:		rs1002076	0.3337	0.0000	0,0,0	0,0,0,0,0	0.3305							605995 [KIF1B (confirmed) Charcot-Marie-Tooth disease,type 2A1,118210|Pheochromocytoma,171300|Neuroblastoma,susceptibility to,1,256700];	RCV000263064.1 [benign]; RCV000315959.1 [benign]; RCV000373975.1 [benign]; 			23	103					KIF1B (inh=AD pLI=1.00)
chr1	10440556	10440556	A	G	het	anno_omim	QUAL=8674;DP=321;AF=0.48;MQM=51;TRIO=HET,321,0.48,HET,181,0.49,HET,226,0.48	KIF1B	3'UTR	KIF1B:ENST00000377081:3'UTR:MODIFIER:exon48/48:c.*2096A>G:,KIF1B:ENST00000377086:3'UTR:MODIFIER:exon49/49:c.*3911A>G:	AluSx	rs1138791	0.3488	0.0000	0,0,0	0,0,0,0,0	0.3604							605995 [KIF1B (confirmed) Charcot-Marie-Tooth disease,type 2A1,118210|Pheochromocytoma,171300|Neuroblastoma,susceptibility to,1,256700];	RCV000270484.1 [benign]; RCV000315156.1 [benign]; RCV000369878.1 [benign]; 			26	80					KIF1B (inh=AD pLI=1.00)
chr1	10441664	10441664	T	C	het	anno_omim	QUAL=13528;DP=457;AF=0.52;MQM=60;TRIO=HET,457,0.52,HET,272,0.44,HET,349,0.50	KIF1B,RN7SL721P	intergenic_region	RN7SL721P:ENSG00000054523-ENSG00000265945:intergenic_region:MODIFIER::n.10441664T>C:		rs3748581	0.5270	0.0000	0,0,0	0,0,0,0,0	0.5291							605995 [KIF1B (confirmed) Charcot-Marie-Tooth disease,type 2A1,118210|Pheochromocytoma,171300|Neuroblastoma,susceptibility to,1,256700];	RCV000289173.1 [benign]; RCV000343588.1 [benign]; RCV000394684.1 [benign]; 			47	93					KIF1B (inh=AD pLI=1.00), RN7SL721P (inh=n/a pLI=n/a)
chr1	11085004	11085004	-	TGTTT	het	anno_omim	QUAL=16980;DP=384;AF=0.49;MQM=59;TRIO=HET,384,0.49,HET,258,0.50,HOM,272,0.99	TARDBP				rs3059695;rs5772439	0.9151	0.0000	0,0,0	0,0,0,0,0	0.8780							605078 [TARDBP (confirmed) Amyotrophic lateral sclerosis 10,with or without FTD,612069|Frontotemporal lobar degeneration,TARDBP-related,612069];				159	89					TARDBP (inh=AD pLI=0.98)
chr1	11846092	11846092	-	T	hom	anno_omim	QUAL=4482;DP=109;AF=0.79;MQM=59;TRIO=HOM,109,0.79,HOM,37,0.89,HOM,51,0.90	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3'UTR:MODIFIER:exon12/12:c.*4644dupA:,MTHFR:ENST00000376592:3'UTR:MODIFIER:exon11/11:c.*4644dupA:,C1orf167:ENST00000433342:intron:MODIFIER:exon16/20:c.3639+757dupT:		rs397709443	0.9513	0.0000	0,0,0	0,0,0,0,0	0.9801							607093 [MTHFR (provisional) Homocystinuria due to MTHFR deficiency,236250|Schizophrenia,susceptibility to,181500|Vascular disease,susceptibility to|Neural tube defects,susceptibility to,601634|Thromboembolism,susceptibility to,188050];	RCV000339671.1 [benign]; 			189	33					MTHFR (inh=AR pLI=0.00), C1orf167 (inh=n/a pLI=0.16)
chr1	11846252	11846252	G	A	hom	anno_omim	QUAL=14879;DP=330;AF=1.00;MQM=59;TRIO=HOM,330,1.00,HET,159,0.50,HET,182,0.54	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3'UTR:MODIFIER:exon12/12:c.*4485C>T:,MTHFR:ENST00000376592:3'UTR:MODIFIER:exon11/11:c.*4485C>T:,C1orf167:ENST00000433342:intron:MODIFIER:exon16/20:c.3639+906G>A:	Tigger15a	rs4846048	0.7065	0.0000	0,0,0	0,0,0,0,0	0.6860							607093 [MTHFR (provisional) Homocystinuria due to MTHFR deficiency,236250|Schizophrenia,susceptibility to,181500|Vascular disease,susceptibility to|Neural tube defects,susceptibility to,601634|Thromboembolism,susceptibility to,188050];	RCV000301152.1 [likely benign]; 			114	112					MTHFR (inh=AR pLI=0.00), C1orf167 (inh=n/a pLI=0.16)
chr1	11846447	11846447	G	A	hom	anno_omim	QUAL=25316;DP=383;AF=1.00;MQM=60;TRIO=HOM,383,1.00,HOM,182,1.00,HOM,216,1.00	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3'UTR:MODIFIER:exon12/12:c.*4290C>T:,MTHFR:ENST00000376592:3'UTR:MODIFIER:exon11/11:c.*4290C>T:,C1orf167:ENST00000433342:intron:MODIFIER:exon16/20:c.3640-998G>A:		rs4845884	0.9333	0.0000	0,0,0	0,0,0,0,0	0.9390							607093 [MTHFR (provisional) Homocystinuria due to MTHFR deficiency,236250|Schizophrenia,susceptibility to,181500|Vascular disease,susceptibility to|Neural tube defects,susceptibility to,601634|Thromboembolism,susceptibility to,188050];	RCV000405207.1 [benign]; 			257	0					MTHFR (inh=AR pLI=0.00), C1orf167 (inh=n/a pLI=0.16)
chr1	11846660	11846663	TTTT	-	hom	anno_omim	QUAL=1919;DP=83;AF=0.64;MQM=57;TRIO=HOM,83,0.64,HOM,30,0.43,HOM,38,0.58	MTHFR,C1orf167	splice_region,3'UTR,intron	MTHFR:ENST00000376590:splice_region:LOW:exon12/12:c.*4074_*4077delAAAA:,MTHFR:ENST00000376583:3'UTR:MODIFIER:exon12/12:c.*4074_*4077delAAAA:,MTHFR:ENST00000376592:3'UTR:MODIFIER:exon11/11:c.*4074_*4077delAAAA:,MTHFR:ENST00000376590:3'UTR:MODIFIER:exon12/12:c.*4074_*4077delAAAA:,C1orf167:ENST00000433342:intron:MODIFIER:exon16/20:c.3640-770_3640-767delTTTT:	AluJr	rs55780505;rs796422158	0.7772	0.0000	0,0,0	0,0,0,0,0	0.5158							607093 [MTHFR (provisional) Homocystinuria due to MTHFR deficiency,236250|Schizophrenia,susceptibility to,181500|Vascular disease,susceptibility to|Neural tube defects,susceptibility to,601634|Thromboembolism,susceptibility to,188050];	RCV000308474.1 [likely benign]; 			92	31	2	[2] auto-classification 14.09.2017  			MTHFR (inh=AR pLI=0.00), C1orf167 (inh=n/a pLI=0.16)
chr1	11847334	11847334	-	GAA	hom	anno_omim	QUAL=9728;DP=231;AF=0.98;MQM=59;TRIO=HOM,231,0.98,HET,133,0.58,HET,222,0.41	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3'UTR:MODIFIER:exon12/12:c.*3400_*3402dupTTC:,MTHFR:ENST00000376592:3'UTR:MODIFIER:exon11/11:c.*3400_*3402dupTTC:,MTHFR:ENST00000376590:3'UTR:MODIFIER:exon12/12:c.*3400_*3402dupTTC:,C1orf167:ENST00000433342:intron:MODIFIER:exon16/20:c.3640-108_3640-106dupAGA:		rs113394969;rs70983598	0.5701	0.0000	0,0,0	0,0,0,0,0	0.5694							607093 [MTHFR (provisional) Homocystinuria due to MTHFR deficiency,236250|Schizophrenia,susceptibility to,181500|Vascular disease,susceptibility to|Neural tube defects,susceptibility to,601634|Thromboembolism,susceptibility to,188050];				86	131					MTHFR (inh=AR pLI=0.00), C1orf167 (inh=n/a pLI=0.16)
chr1	11847759	11847759	C	T	hom	anno_omim	QUAL=12117;DP=201;AF=0.98;MQM=59;TRIO=HOM,201,0.98,HET,245,0.50,HET,294,0.52	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3'UTR:MODIFIER:exon12/12:c.*2978G>A:,MTHFR:ENST00000376592:3'UTR:MODIFIER:exon11/11:c.*2978G>A:,MTHFR:ENST00000376590:3'UTR:MODIFIER:exon12/12:c.*2978G>A:,C1orf167:ENST00000433342:intron:MODIFIER:exon17/20:c.3746-171C>T:		rs3737966	0.5585	0.0000	0,0,0	0,0,0,0,0	0.5599							607093 [MTHFR (provisional) Homocystinuria due to MTHFR deficiency,236250|Schizophrenia,susceptibility to,181500|Vascular disease,susceptibility to|Neural tube defects,susceptibility to,601634|Thromboembolism,susceptibility to,188050];	RCV000309373.1 [likely benign]; 			88	132					MTHFR (inh=AR pLI=0.00), C1orf167 (inh=n/a pLI=0.16)
chr1	11848879	11848879	A	G	hom	anno_omim	QUAL=19089;DP=250;AF=1.00;MQM=59;TRIO=HOM,250,1.00,HOM,151,1.00,HOM,217,1.00	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3'UTR:MODIFIER:exon12/12:c.*1858T>C:,MTHFR:ENST00000376592:3'UTR:MODIFIER:exon11/11:c.*1858T>C:,MTHFR:ENST00000376590:3'UTR:MODIFIER:exon12/12:c.*1858T>C:,MTHFR:ENST00000376585:3'UTR:MODIFIER:exon13/13:c.*1858T>C:,C1orf167:ENST00000433342:intron:MODIFIER:exon20/20:c.4245+76A>G:		rs2077360	0.9305	0.0000	0,0,0	0,0,0,0,0	0.9363							607093 [MTHFR (provisional) Homocystinuria due to MTHFR deficiency,236250|Schizophrenia,susceptibility to,181500|Vascular disease,susceptibility to|Neural tube defects,susceptibility to,601634|Thromboembolism,susceptibility to,188050];	RCV000404791.1 [benign]; 			501	3					MTHFR (inh=AR pLI=0.00), C1orf167 (inh=n/a pLI=0.16)
chr1	11849447	11849447	A	G	hom	anno_omim	QUAL=17848;DP=153;AF=1.00;MQM=59;TRIO=HOM,153,1.00,HOM,188,1.00,HOM,227,1.00	C1orf167,MTHFR	missense,3'UTR	C1orf167:ENST00000433342:missense:MODERATE:exon21/21:c.4366A>G:p.Arg1456Gly,MTHFR:ENST00000376583:3'UTR:MODIFIER:exon12/12:c.*1290T>C:,MTHFR:ENST00000376592:3'UTR:MODIFIER:exon11/11:c.*1290T>C:,MTHFR:ENST00000376590:3'UTR:MODIFIER:exon12/12:c.*1290T>C:,MTHFR:ENST00000376585:3'UTR:MODIFIER:exon13/13:c.*1290T>C:		rs868014	0.9329	0.9871	7319,2565,292	0.8024,0.9862,1.0000,0.9988,0.9997	0.9874	-4.9500	.,.,.,T	T,T	.,B	.,T	1.61	607093 [MTHFR (provisional) Homocystinuria due to MTHFR deficiency,236250|Schizophrenia,susceptibility to,181500|Vascular disease,susceptibility to|Neural tube defects,susceptibility to,601634|Thromboembolism,susceptibility to,188050];	RCV000277799.1 [benign]; 		COSM4142235, COSM4142236	1614	18	2	[2] auto-classification 14.09.2017  			C1orf167 (inh=n/a pLI=0.16), MTHFR (inh=AR pLI=0.00)
chr1	11850365	11850365	T	G	hom	anno_omim	QUAL=18960;DP=314;AF=1.00;MQM=59;TRIO=HOM,314,1.00,HET,351,0.49,HET,383,0.48	MTHFR	3'UTR	MTHFR:ENST00000376583:3'UTR:MODIFIER:exon12/12:c.*372A>C:,MTHFR:ENST00000376592:3'UTR:MODIFIER:exon11/11:c.*372A>C:,MTHFR:ENST00000376590:3'UTR:MODIFIER:exon12/12:c.*372A>C:,MTHFR:ENST00000376585:3'UTR:MODIFIER:exon13/13:c.*372A>C:		rs4846049	0.6284	0.0000	0,0,0	0,0,0,0,0	0.6376							607093 [MTHFR (provisional) Homocystinuria due to MTHFR deficiency,236250|Schizophrenia,susceptibility to,181500|Vascular disease,susceptibility to|Neural tube defects,susceptibility to,601634|Thromboembolism,susceptibility to,188050];	RCV000405126.1 [likely benign]; 			103	118					MTHFR (inh=AR pLI=0.00)
chr1	11854457	11854457	G	A	hom	anno_omim	QUAL=18571;DP=121;AF=1.00;MQM=60;TRIO=HOM,121,1.00,HOM,205,1.00,HOM,264,1.00	MTHFR	synonymous	MTHFR:ENST00000376583:synonymous:LOW:exon8/12:c.1428C>T:p.Phe476Phe,MTHFR:ENST00000376592:synonymous:LOW:exon7/11:c.1305C>T:p.Phe435Phe,MTHFR:ENST00000376590:synonymous:LOW:exon8/12:c.1305C>T:p.Phe435Phe,MTHFR:ENST00000376585:synonymous:LOW:exon9/13:c.1428C>T:p.Phe476Phe		rs4846051	0.9030	0.9697	57567,33195,2451	0.6834,0.9845,0.9990,0.9974,0.9992	0.9755							607093 [MTHFR (provisional) Homocystinuria due to MTHFR deficiency,236250|Schizophrenia,susceptibility to,181500|Vascular disease,susceptibility to|Neural tube defects,susceptibility to,601634|Thromboembolism,susceptibility to,188050];	RCV000153514.3 [benign]; RCV000293357.1 [benign]; 			2251	32	2	[2] auto-classification 14.09.2017  			MTHFR (inh=AR pLI=0.00)
chr1	12009955	12009955	C	T	het	anno_omim	QUAL=6861;DP=124;AF=0.46;MQM=59;TRIO=HET,124,0.46,HET,190,0.53,HET,248,0.49	PLOD1	synonymous	PLOD1:ENST00000376369:synonymous:LOW:exon4/20:c.435C>T:p.Phe145Phe,PLOD1:ENST00000196061:synonymous:LOW:exon3/19:c.294C>T:p.Phe98Phe		rs7529452	0.2678	0.3281	7178,3488,33	0.0632,0.3661,0.3730,0.3197,0.4249	0.3312							153454 [PLOD1 (provisional) Ehlers-Danlos syndrome,type VI,225400];	RCV000243254.1 [benign]; RCV000370739.1 [benign]; 		COSM3996779, COSM3996782, COSM3996781, COSM3996780	249	864	2	[2] auto-classification 14.09.2017  			PLOD1 (inh=AR pLI=0.00)
chr1	12024235	12024235	C	T	het	low_DP;anno_omim	QUAL=1188;DP=19;AF=0.58;MQM=59;TRIO=HET,19,0.58,HET,36,0.39,HET,54,0.54	PLOD1	synonymous	PLOD1:ENST00000376369:synonymous:LOW:exon13/20:c.1347C>T:p.Asn449Asn,PLOD1:ENST00000196061:synonymous:LOW:exon12/19:c.1206C>T:p.Asn402Asn		rs1130529	0.3484	0.3631	8340,3773,429	0.2908,0.3748,0.3933,0.3325,0.4434	0.3624							153454 [PLOD1 (provisional) Ehlers-Danlos syndrome,type VI,225400];	RCV000252620.2 [benign]; RCV000350343.1 [benign]; 		COSM3996784, COSM3996785	252	898	2	[2] auto-classification 14.09.2017  			PLOD1 (inh=AR pLI=0.00)
chr1	12040324	12040324	A	G	het	anno_omim	QUAL=4167;DP=34;AF=0.47;MQM=60;TRIO=HET,34,0.47,HOM,101,1.00,HET,123,0.36	MFN2	5'UTR	MFN2:ENST00000444836:5'UTR:MODIFIER:exon1/18:c.-222A>G:		rs2236054	0.5729	0.0000	0,0,0	0,0,0,0,0	0.5264							608507 [MFN2 (confirmed) Charcot-Marie-Tooth disease,axonal,type 2A2A,609260|Hereditary motor and sensory neuropathy VIA,601152|Charcot-Marie-Tooth disease,axonal,type 2A2B,617087];	RCV000293763.1 [benign]; RCV000331244.1 [benign]; RCV000337093.1 [benign]; 			45	115					MFN2 (inh=AR+AD pLI=1.00)
chr1	12040479	12040479	T	C	het	anno_omim	QUAL=5233;DP=57;AF=0.51;MQM=60;TRIO=HET,57,0.51,HOM,112,1.00,HET,130,0.43	MFN2	5'UTR	MFN2:ENST00000235329:5'UTR:MODIFIER:exon1/19:c.-212T>C:,MFN2:ENST00000444836:5'UTR:MODIFIER:exon1/18:c.-67T>C:		rs2180183	0.6100	0.0000	0,0,0	0,0,0,0,0	0.5525							608507 [MFN2 (confirmed) Charcot-Marie-Tooth disease,axonal,type 2A2A,609260|Hereditary motor and sensory neuropathy VIA,601152|Charcot-Marie-Tooth disease,axonal,type 2A2B,617087];	RCV000332649.1 [benign]; RCV000370987.1 [benign]; RCV000387990.1 [benign]; 			47	121					MFN2 (inh=AR+AD pLI=1.00)
chr1	12071680	12071680	A	G	hom	anno_omim	QUAL=29308;DP=257;AF=0.99;MQM=59;TRIO=HOM,257,0.99,HOM,322,0.99,HOM,418,1.00	MFN2	3'UTR	MFN2:ENST00000235329:3'UTR:MODIFIER:exon19/19:c.*58A>G:,MFN2:ENST00000444836:3'UTR:MODIFIER:exon18/18:c.*58A>G:		rs1042842	0.7324	0.0000	0,0,0	0,0,0,0,0	0.7191							608507 [MFN2 (confirmed) Charcot-Marie-Tooth disease,axonal,type 2A2A,609260|Hereditary motor and sensory neuropathy VIA,601152|Charcot-Marie-Tooth disease,axonal,type 2A2B,617087];	RCV000275398.1 [benign]; RCV000330515.1 [benign]; 			1098	1119					MFN2 (inh=AR+AD pLI=1.00)
chr1	12072518	12072518	G	C	hom	anno_omim	QUAL=12885;DP=112;AF=0.98;MQM=59;TRIO=HOM,112,0.98,HOM,143,1.00,HOM,173,1.00	MFN2	3'UTR	MFN2:ENST00000235329:3'UTR:MODIFIER:exon19/19:c.*896G>C:,MFN2:ENST00000444836:3'UTR:MODIFIER:exon18/18:c.*896G>C:		rs3088064	0.5441	0.0000	0,0,0	0,0,0,0,0	0.5700							608507 [MFN2 (confirmed) Charcot-Marie-Tooth disease,axonal,type 2A2A,609260|Hereditary motor and sensory neuropathy VIA,601152|Charcot-Marie-Tooth disease,axonal,type 2A2B,617087];	RCV000321687.1 [benign]; RCV000376417.1 [benign]; 			91	127					MFN2 (inh=AR+AD pLI=1.00)
chr1	16371067	16371067	G	T	het	low_DP;pred_pathogenic;anno_omim	QUAL=234;DP=4;AF=0.75;MQM=60;TRIO=HET,4,0.75,HOM,1,1.00,HOM,5,1.00	CLCNKB	missense	CLCNKB:ENST00000375679:missense:MODERATE:exon2/20:c.80G>T:p.Arg27Leu		rs2015352	0.5555	0.6413	18450,10701,377	0.3297,0.7585,0.6597,0.6565,0.6965	0.6271	-0.4670	D,D	T	B	D	24.00	602023 [CLCNKB (confirmed) Bartter syndrome,type 3,607364|Bartter syndrome,type 4b,digenic,613090];			COSM3750546	876	900	2	[2] auto-classification 14.09.2017  			CLCNKB (inh=AR pLI=0.00)
chr1	16373124	16373124	A	G	hom	anno_omim	QUAL=23237;DP=186;AF=0.98;MQM=59;TRIO=HOM,186,0.98,HOM,249,1.00,HOM,312,1.00	CLCNKB	synonymous	CLCNKB:ENST00000375679:synonymous:LOW:exon4/20:c.324A>G:p.Ser108Ser		rs5257	0.7404	0.8022	40313,21921,836	0.3879,0.9074,0.9898,0.8104,0.8742	0.8123							602023 [CLCNKB (confirmed) Bartter syndrome,type 3,607364|Bartter syndrome,type 4b,digenic,613090];				1408	616	2	[2] auto-classification 14.09.2017  			CLCNKB (inh=AR pLI=0.00)
chr1	16374533	16374533	G	C	hom	low_DP;anno_omim	QUAL=383;DP=5;AF=1.00;MQM=60;TRIO=HOM,5,1.00,HOM,5,1.00,HOM,3,1.00	CLCNKB	synonymous	CLCNKB:ENST00000375679:synonymous:LOW:exon5/20:c.492G>C:p.Gly164Gly		rs2014562	0.8940	0.9298	52555,29576,3019	0.7633,0.9605,0.9997,0.9424,0.9277	0.9317							602023 [CLCNKB (confirmed) Bartter syndrome,type 3,607364|Bartter syndrome,type 4b,digenic,613090];				1818	245	2	[2] auto-classification 14.09.2017  			CLCNKB (inh=AR pLI=0.00)
chr1	16374994	16374994	C	T	hom	low_MQM;anno_omim	QUAL=18061;DP=162;AF=0.99;MQM=46;TRIO=HOM,162,0.99,HOM,204,1.00,HOM,246,1.00	CLCNKB	splice_region&intron	CLCNKB:ENST00000375679:splice_region&intron:LOW:exon6/19:c.577-5C>T:		rs34666902	0.7386	0.8008	40086,21748,810	0.3848,0.9066,0.9897,0.8083,0.8737	0.8106							602023 [CLCNKB (confirmed) Bartter syndrome,type 3,607364|Bartter syndrome,type 4b,digenic,613090];				1400	619	2	[2] auto-classification 14.09.2017  			CLCNKB (inh=AR pLI=0.00)
chr1	16375063	16375063	C	G	hom	pred_pathogenic;anno_omim	QUAL=17380;DP=195;AF=0.99;MQM=52;TRIO=HOM,195,0.99,HOM,174,1.00,HOM,218,1.00	CLCNKB	missense	CLCNKB:ENST00000375679:missense:MODERATE:exon7/20:c.641C>G:p.Ala214Gly		rs45612832	0.8273	0.9006	49725,28393,1668	0.5633,0.9408,0.9993,0.9249,0.9250	0.9074	-0.0370	T	T	B	D	0.36	602023 [CLCNKB (confirmed) Bartter syndrome,type 3,607364|Bartter syndrome,type 4b,digenic,613090];				1788	294	2	[2] auto-classification 14.09.2017  			CLCNKB (inh=AR pLI=0.00)
chr1	16375064	16375064	A	C	hom	anno_omim	QUAL=17380;DP=195;AF=0.99;MQM=52;TRIO=HOM,195,0.99,HOM,174,1.00,HOM,218,1.00	CLCNKB	synonymous	CLCNKB:ENST00000375679:synonymous:LOW:exon7/20:c.642A>C:p.Ala214Ala		rs1889790;rs45575235	0.8273	0.9006	49718,28392,1667	0.5632,0.9410,0.9993,0.9249,0.9250	0.9074							602023 [CLCNKB (confirmed) Bartter syndrome,type 3,607364|Bartter syndrome,type 4b,digenic,613090];				1788	294	2	[2] auto-classification 14.09.2017  			CLCNKB (inh=AR pLI=0.00)
chr1	16375354	16375354	C	T	hom	anno_omim	QUAL=19099;DP=180;AF=1.00;MQM=59;TRIO=HOM,180,1.00,HOM,203,1.00,HOM,238,1.00	CLCNKB	5'UTR,intron	CLCNKB:ENST00000375667:5'UTR:MODIFIER:exon1/13:c.-113C>T:,CLCNKB:ENST00000375679:intron:MODIFIER:exon7/19:c.656-261C>T:	MIR	rs9442227	0.7274	0.0000	0,0,0	0,0,0,0,0	0.6829							602023 [CLCNKB (confirmed) Bartter syndrome,type 3,607364|Bartter syndrome,type 4b,digenic,613090];				150	68					CLCNKB (inh=AR pLI=0.00)
chr1	16376191	16376191	C	T	hom	low_MQM;pred_pathogenic;anno_omim	QUAL=25793;DP=188;AF=0.98;MQM=46;TRIO=HOM,188,0.98,HOM,314,1.00,HOM,406,1.00	CLCNKB	missense	CLCNKB:ENST00000375679:missense:MODERATE:exon9/20:c.860C>T:p.Ala287Val,CLCNKB:ENST00000375667:missense:MODERATE:exon2/13:c.353C>T:p.Ala118Val		rs34188929	0.8299	0.9096	49342,28428,1594	0.5590,0.9525,0.9986,0.9400,0.9253	0.9247	-0.3350	T,T	T	B,B	D,D	0.01	602023 [CLCNKB (confirmed) Bartter syndrome,type 3,607364|Bartter syndrome,type 4b,digenic,613090];			COSM4142953, COSM4142952	1815	261	2	[2] auto-classification 14.09.2017  			CLCNKB (inh=AR pLI=0.00)
chr1	16376319	16376319	T	C	hom	anno_omim	QUAL=33079;DP=194;AF=0.99;MQM=59;TRIO=HOM,194,0.99,HOM,362,1.00,HOM,486,1.00	CLCNKB	synonymous	CLCNKB:ENST00000375679:synonymous:LOW:exon10/20:c.876T>C:p.Cys292Cys,CLCNKB:ENST00000375667:synonymous:LOW:exon3/13:c.369T>C:p.Cys123Cys		rs7368151	0.8301	0.9114	51203,29597,1694	0.5638,0.9532,0.9998,0.9414,0.9267	0.9173							602023 [CLCNKB (confirmed) Bartter syndrome,type 3,607364|Bartter syndrome,type 4b,digenic,613090];			COSM4142955, COSM4142954	1818	265	2	[2] auto-classification 14.09.2017  			CLCNKB (inh=AR pLI=0.00)
chr1	16380196	16380196	T	C	hom	pred_pathogenic;anno_omim	QUAL=28369;DP=304;AF=1.00;MQM=51;TRIO=HOM,304,1.00,HOM,253,1.00,HOM,369,1.00	CLCNKB	missense	CLCNKB:ENST00000375679:missense:MODERATE:exon16/20:c.1685T>C:p.Met562Thr,CLCNKB:ENST00000375667:missense:MODERATE:exon9/13:c.1178T>C:p.Met393Thr		rs5253	0.8383	0.9310	52942,31936,2492	0.6908,0.9539,0.8081,0.9802,0.9302	0.9354	-0.9230	T,T,T,T	T	B,B	D,D,D	0.01	602023 [CLCNKB (confirmed) Bartter syndrome,type 3,607364|Bartter syndrome,type 4b,digenic,613090];				1979	122	2	[2] auto-classification 14.09.2017  			CLCNKB (inh=AR pLI=0.00)
chr1	16380243	16380243	A	G	hom	low_MQM;pred_pathogenic;anno_omim;anno_pathogenic_hgmd	QUAL=15409;DP=132;AF=1.00;MQM=48;TRIO=HOM,132,1.00,HET,233,0.42,HOM,311,0.99	CLCNKB	missense	CLCNKB:ENST00000375679:missense:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu,CLCNKB:ENST00000375667:missense:MODERATE:exon9/13:c.1225A>G:p.Lys409Glu		rs2275166	0.7017	0.6586	26455,14211,3279	0.7960,0.5059,0.7950,0.6569,0.5812	0.7160	0.8530	T,T,T,T	T	B,B	D,D,D	4.33	602023 [CLCNKB (confirmed) Bartter syndrome,type 3,607364|Bartter syndrome,type 4b,digenic,613090];		CM1514575 [CLASS=DM? MUT=ALT PHEN="Migraine without aura" GENE=CLCNKB]; 		882	909	1	[1] swoedl 28.06.2016			CLCNKB (inh=AR pLI=0.00)
chr1	16380252	16380252	C	T	hom	low_MQM;anno_omim	QUAL=14431;DP=124;AF=1.00;MQM=48;TRIO=HOM,124,1.00,HET,219,0.43,HOM,302,1.00	CLCNKB	synonymous	CLCNKB:ENST00000375679:synonymous:LOW:exon16/20:c.1741C>T:p.Leu581Leu,CLCNKB:ENST00000375667:synonymous:LOW:exon9/13:c.1234C>T:p.Leu412Leu		rs2275167	0.6136	0.6210	23581,13624,1758	0.5802,0.4817,0.7899,0.6427,0.5269	0.6412							602023 [CLCNKB (confirmed) Bartter syndrome,type 3,607364|Bartter syndrome,type 4b,digenic,613090];				826	931	2	[2] auto-classification 14.09.2017  			CLCNKB (inh=AR pLI=0.00)
chr1	16383402	16383402	C	T	het	low_MQM;anno_omim	QUAL=650;DP=261;AF=0.26;MQM=34;TRIO=HET,261,0.26,WT,140,0.00,WT,143,0.07	CLCNKB	synonymous	CLCNKB:ENST00000375679:synonymous:LOW:exon20/20:c.2055C>T:p.Ala685Ala,CLCNKB:ENST00000375667:synonymous:LOW:exon13/13:c.1545C>T:p.Ala515Ala		rs6698427	0.0000	0.0010	1,0,1	0.0058,0.0009,0.0008,0.0006,0.0001	0.0849							602023 [CLCNKB (confirmed) Bartter syndrome,type 3,607364|Bartter syndrome,type 4b,digenic,613090];				0	24					CLCNKB (inh=AR pLI=0.00)
chr1	16383448	16383448	A	C	het	low_MQM;anno_omim	QUAL=15861;DP=219;AF=0.69;MQM=40;TRIO=HET,219,0.69,HOM,241,1.00,HOM,290,0.89	CLCNKB	3'UTR	CLCNKB:ENST00000375679:3'UTR:MODIFIER:exon20/20:c.*37A>C:,CLCNKB:ENST00000375667:3'UTR:MODIFIER:exon13/13:c.*37A>C:		rs10803415	0.9010	0.9401	50420,29364,4051	0.9163,0.9577,0.7985,0.9686,0.9141	0.9058							602023 [CLCNKB (confirmed) Bartter syndrome,type 3,607364|Bartter syndrome,type 4b,digenic,613090];				1726	240					CLCNKB (inh=AR pLI=0.00)
chr1	16383574	16383574	A	T	het	low_MQM;anno_omim	QUAL=889;DP=247;AF=0.13;MQM=32;TRIO=HET,247,0.13,WT,381,0.00,HET,616,0.20	CLCNKB	3'UTR	CLCNKB:ENST00000375679:3'UTR:MODIFIER:exon20/20:c.*163A>T:,CLCNKB:ENST00000375667:3'UTR:MODIFIER:exon13/13:c.*163A>T:		rs1057841	0.0000	0.0000	0,0,0	0,0,0,0,0	0.2504							602023 [CLCNKB (confirmed) Bartter syndrome,type 3,607364|Bartter syndrome,type 4b,digenic,613090];				0	68					CLCNKB (inh=AR pLI=0.00)
chr1	16383581	16383581	G	T	het	low_MQM;anno_omim	QUAL=19835;DP=250;AF=0.84;MQM=37;TRIO=HET,250,0.84,HET,383,0.51,HET,618,0.80	CLCNKB	3'UTR	CLCNKB:ENST00000375679:3'UTR:MODIFIER:exon20/20:c.*170G>T:,CLCNKB:ENST00000375667:3'UTR:MODIFIER:exon13/13:c.*170G>T:		rs1057844	0.0000	0.0000	0,0,0	0,0,0,0,0	0.4992							602023 [CLCNKB (confirmed) Bartter syndrome,type 3,607364|Bartter syndrome,type 4b,digenic,613090];				49	211					CLCNKB (inh=AR pLI=0.00)
chr1	16383605	16383605	A	G	het	low_MQM;anno_omim	QUAL=19776;DP=200;AF=0.75;MQM=37;TRIO=HET,200,0.75,HET,403,0.53,HET,647,0.77	CLCNKB	3'UTR	CLCNKB:ENST00000375679:3'UTR:MODIFIER:exon20/20:c.*194A>G:,CLCNKB:ENST00000375667:3'UTR:MODIFIER:exon13/13:c.*194A>G:		rs1057845	0.0000	0.0000	0,0,0	0,0,0,0,0	0.4932							602023 [CLCNKB (confirmed) Bartter syndrome,type 3,607364|Bartter syndrome,type 4b,digenic,613090];				68	415					CLCNKB (inh=AR pLI=0.00)
chr1	16383668	16383668	T	G	hom	low_MQM;anno_omim	QUAL=32767;DP=174;AF=0.99;MQM=41;TRIO=HOM,174,0.99,HOM,360,1.00,HOM,661,1.00	CLCNKB	3'UTR	CLCNKB:ENST00000375679:3'UTR:MODIFIER:exon20/20:c.*257T>G:,CLCNKB:ENST00000375667:3'UTR:MODIFIER:exon13/13:c.*257T>G:		rs6660218	1.0000	0.9999	7654,2609,519	0.9990,1.0000,1.0000,1.0000,1.0000	1.0000							602023 [CLCNKB (confirmed) Bartter syndrome,type 3,607364|Bartter syndrome,type 4b,digenic,613090];				1634	0					CLCNKB (inh=AR pLI=0.00)
chr1	16383682	16383682	G	C	het	low_MQM;pred_pathogenic;anno_omim	QUAL=4435;DP=223;AF=0.20;MQM=41;TRIO=HET,223,0.20,WT,322,0.00,HET,651,0.36	CLCNKB	3'UTR	CLCNKB:ENST00000375679:3'UTR:MODIFIER:exon20/20:c.*271G>C:,CLCNKB:ENST00000375667:3'UTR:MODIFIER:exon13/13:c.*271G>C:		rs1057854	0.0000	0.3197	10,0,8	0.3990,0.2612,0.4272,0.3183,0.2964	0.3304	-3.2740	D	T			0.06	602023 [CLCNKB (confirmed) Bartter syndrome,type 3,607364|Bartter syndrome,type 4b,digenic,613090];				0	1014	1	[1] Ute Grasshoff 13.08.2014			CLCNKB (inh=AR pLI=0.00)
chr1	16383742	16383742	C	G	het	anno_omim	QUAL=18366;DP=357;AF=0.54;MQM=57;TRIO=HET,357,0.54,HOM,224,1.00,HET,519,0.53	CLCNKB	3'UTR	CLCNKB:ENST00000375679:3'UTR:MODIFIER:exon20/20:c.*331C>G:,CLCNKB:ENST00000375667:3'UTR:MODIFIER:exon13/13:c.*331C>G:		rs1057857	0.0000	0.6207	2104,825,99	0.5885,0.6741,0.4944,0.6400,0.6190	0.6426	-0.3020	T,T,T	T		T	4.97	602023 [CLCNKB (confirmed) Bartter syndrome,type 3,607364|Bartter syndrome,type 4b,digenic,613090];			COSM4142956	462	1167					CLCNKB (inh=AR pLI=0.00)
chr1	17312743	17312743	C	T	het	pred_pathogenic;anno_omim	QUAL=772;DP=23;AF=0.43;MQM=59;TRIO=HET,23,0.43,HOM,19,0.95,HET,25,0.44	ATP13A2,RP1-37C10.3	missense,synonymous	ATP13A2:ENST00000341676:missense:MODERATE:exon27/27:c.3214G>A:p.Ala1072Thr,ATP13A2:ENST00000326735:synonymous:LOW:exon29/29:c.3516G>A:p.Pro1172Pro,ATP13A2:ENST00000452699:synonymous:LOW:exon29/29:c.3501G>A:p.Pro1167Pro		rs3170740	0.3313	0.5065	12467,8266,189	0.2451,0.5477,0.3343,0.5549,0.4875	0.4714	-2.5480	T,T	T	B	D,D	10.40	610513 [ATP13A2 (confirmed) Kufor-Rakeb syndrome,606693|Spastic paraplegia 78,autosomal recessive,617225];	RCV000116444.3 [benign]; RCV000336632.1 [benign]; 		COSM3750607, COSM3750606	735	1369	2	[2] auto-classification 14.09.2017  			ATP13A2 (inh=AR pLI=0.00), RP1-37C10.3 (inh=n/a pLI=n/a)
chr1	17313343	17313343	G	A	het	anno_omim	QUAL=10735;DP=99;AF=0.49;MQM=59;TRIO=HET,99,0.49,HOM,200,1.00,HET,283,0.49	ATP13A2,RP1-37C10.3	synonymous	ATP13A2:ENST00000326735:synonymous:LOW:exon27/29:c.3192C>T:p.Ala1064Ala,ATP13A2:ENST00000341676:synonymous:LOW:exon26/27:c.3060C>T:p.Ala1020Ala,ATP13A2:ENST00000452699:synonymous:LOW:exon27/29:c.3177C>T:p.Ala1059Ala		rs9435659	0.3385	0.4648	13360,8833,197	0.1973,0.4806,0.2930,0.5210,0.4700	0.4669							610513 [ATP13A2 (confirmed) Kufor-Rakeb syndrome,606693|Spastic paraplegia 78,autosomal recessive,617225];	RCV000116442.2 [benign]; RCV000309613.1 [benign]; 		COSM3747591, COSM3747592	743	1366	2	[2] auto-classification 14.09.2017  			ATP13A2 (inh=AR pLI=0.00), RP1-37C10.3 (inh=n/a pLI=n/a)
chr1	17313454	17313454	G	A	het	anno_omim	QUAL=2372;DP=64;AF=0.48;MQM=59;TRIO=HET,64,0.48,WT,138,0.00,HET,177,0.44	ATP13A2,RP1-37C10.3	splice_region&intron	ATP13A2:ENST00000326735:splice_region&intron:LOW:exon26/28:c.3084-3C>T:,ATP13A2:ENST00000341676:splice_region&intron:LOW:exon25/26:c.2952-3C>T:,ATP13A2:ENST00000452699:splice_region&intron:LOW:exon26/28:c.3069-3C>T:		rs7531163	0.3065	0.2739	5114,1978,157	0.1725,0.3666,0.5515,0.2424,0.2313	0.2811							610513 [ATP13A2 (confirmed) Kufor-Rakeb syndrome,606693|Spastic paraplegia 78,autosomal recessive,617225];	RCV000116440.2 [benign]; RCV000324328.1 [benign]; 			156	1022	2	[2] auto-classification 14.09.2017  			ATP13A2 (inh=AR pLI=0.00), RP1-37C10.3 (inh=n/a pLI=n/a)
chr1	17313654	17313654	C	T	het	anno_omim	QUAL=10630;DP=71;AF=0.48;MQM=60;TRIO=HET,71,0.48,HOM,245,1.00,HET,280,0.48	ATP13A2,RP1-37C10.3	synonymous	ATP13A2:ENST00000326735:synonymous:LOW:exon26/29:c.2970G>A:p.Val990Val,ATP13A2:ENST00000341676:synonymous:LOW:exon25/27:c.2838G>A:p.Val946Val,ATP13A2:ENST00000452699:synonymous:LOW:exon26/29:c.2955G>A:p.Val985Val		rs761421	0.3462	0.4639	13375,8738,258	0.2236,0.4803,0.2894,0.5174,0.4688	0.4670							610513 [ATP13A2 (confirmed) Kufor-Rakeb syndrome,606693|Spastic paraplegia 78,autosomal recessive,617225];	RCV000116439.2 [benign]; RCV000360410.1 [benign]; 		COSM3750609, COSM3750608	736	1375	2	[2] auto-classification 14.09.2017  			ATP13A2 (inh=AR pLI=0.00), RP1-37C10.3 (inh=n/a pLI=n/a)
chr1	17314702	17314702	C	T	het	anno_omim	QUAL=11025;DP=286;AF=0.48;MQM=60;TRIO=HET,286,0.48,WT,497,0.01,HET,583,0.51	ATP13A2,RP1-37C10.3	synonymous	ATP13A2:ENST00000326735:synonymous:LOW:exon25/29:c.2790G>A:p.Ser930Ser,ATP13A2:ENST00000341676:synonymous:LOW:exon24/27:c.2658G>A:p.Ser886Ser,ATP13A2:ENST00000452699:synonymous:LOW:exon25/29:c.2775G>A:p.Ser925Ser		rs3738815	0.2909	0.2414	4267,1325,125	0.1524,0.3430,0.5525,0.1952,0.2227	0.2488							610513 [ATP13A2 (confirmed) Kufor-Rakeb syndrome,606693|Spastic paraplegia 78,autosomal recessive,617225];	RCV000116437.2 [benign]; RCV000281364.1 [benign]; 		COSM3750611, COSM3750610	117	873	2	[2] auto-classification 14.09.2017  			ATP13A2 (inh=AR pLI=0.00), RP1-37C10.3 (inh=n/a pLI=n/a)
chr1	17314942	17314942	G	A	het	anno_omim	QUAL=14158;DP=313;AF=0.50;MQM=59;TRIO=HET,313,0.50,HOM,263,0.99,HET,322,0.45	ATP13A2,RP1-37C10.3	synonymous	ATP13A2:ENST00000326735:synonymous:LOW:exon24/29:c.2637C>T:p.Gly879Gly,ATP13A2:ENST00000341676:synonymous:LOW:exon23/27:c.2505C>T:p.Gly835Gly,ATP13A2:ENST00000452699:synonymous:LOW:exon24/29:c.2622C>T:p.Gly874Gly		rs9435662	0.3387	0.4590	13485,8859,203	0.1922,0.4754,0.2900,0.5152,0.4681	0.4650							610513 [ATP13A2 (confirmed) Kufor-Rakeb syndrome,606693|Spastic paraplegia 78,autosomal recessive,617225];	RCV000116435.2 [benign]; RCV000331660.1 [benign]; 		COSM3750613, COSM3750612	737	1371	2	[2] auto-classification 14.09.2017  			ATP13A2 (inh=AR pLI=0.00), RP1-37C10.3 (inh=n/a pLI=n/a)
chr1	17319011	17319011	G	A	het	anno_omim	QUAL=6564;DP=83;AF=0.48;MQM=60;TRIO=HET,83,0.48,HOM,126,1.00,HET,152,0.48	ATP13A2,RP1-37C10.3	synonymous	ATP13A2:ENST00000326735:synonymous:LOW:exon17/29:c.1815C>T:p.Pro605Pro,ATP13A2:ENST00000341676:synonymous:LOW:exon17/27:c.1800C>T:p.Pro600Pro,ATP13A2:ENST00000452699:synonymous:LOW:exon17/29:c.1800C>T:p.Pro600Pro		rs2076603	0.4485	0.5540	19279,12838,984	0.4426,0.5381,0.2867,0.6189,0.5165	0.5576							610513 [ATP13A2 (confirmed) Kufor-Rakeb syndrome,606693|Spastic paraplegia 78,autosomal recessive,617225];	RCV000116434.2 [benign]; RCV000299686.1 [benign]; 		COSM3997076, COSM3997075	1032	1292	2	[2] auto-classification 14.09.2017  			ATP13A2 (inh=AR pLI=0.00), RP1-37C10.3 (inh=n/a pLI=n/a)
chr1	19198064	19198064	T	G	het	anno_omim	QUAL=3432;DP=98;AF=0.51;MQM=59;TRIO=HET,98,0.51,WT,149,0.00,HET,185,0.47	ALDH4A1,RP13-279N23.2	3'UTR	ALDH4A1:ENST00000290597:3'UTR:MODIFIER:exon16/16:c.*262A>C:,ALDH4A1:ENST00000538309:3'UTR:MODIFIER:exon15/15:c.*1275A>C:,ALDH4A1:ENST00000538839:3'UTR:MODIFIER:exon14/14:c.*1275A>C:,ALDH4A1:ENST00000375341:3'UTR:MODIFIER:exon15/15:c.*1275A>C:		rs1138333	0.1793	0.0000	0,0,0	0,0,0,0,0	0.2341							606811 [ALDH4A1 (provisional) Hyperprolinemia,type II,239510];	RCV000395442.1 [likely benign]; 			18	98					ALDH4A1 (inh=AR pLI=0.00), RP13-279N23.2 (inh=n/a pLI=n/a)
chr1	19198100	19198100	C	G	het	anno_omim	QUAL=3434;DP=99;AF=0.55;MQM=59;TRIO=HET,99,0.55,WT,144,0.00,HET,166,0.49	ALDH4A1,RP13-279N23.2	3'UTR	ALDH4A1:ENST00000290597:3'UTR:MODIFIER:exon16/16:c.*226G>C:,ALDH4A1:ENST00000538309:3'UTR:MODIFIER:exon15/15:c.*1239G>C:,ALDH4A1:ENST00000538839:3'UTR:MODIFIER:exon14/14:c.*1239G>C:,ALDH4A1:ENST00000375341:3'UTR:MODIFIER:exon15/15:c.*1239G>C:		rs1138328	0.1651	0.0000	0,0,0	0,0,0,0,0	0.2276							606811 [ALDH4A1 (provisional) Hyperprolinemia,type II,239510];	RCV000305397.1 [likely benign]; 			18	96					ALDH4A1 (inh=AR pLI=0.00), RP13-279N23.2 (inh=n/a pLI=n/a)
chr1	19198141	19198141	T	C	het	anno_omim	QUAL=3367;DP=121;AF=0.51;MQM=60;TRIO=HET,121,0.51,WT,139,0.00,HET,146,0.48	ALDH4A1,RP13-279N23.2	3'UTR	ALDH4A1:ENST00000290597:3'UTR:MODIFIER:exon16/16:c.*185A>G:,ALDH4A1:ENST00000538309:3'UTR:MODIFIER:exon15/15:c.*1198A>G:,ALDH4A1:ENST00000538839:3'UTR:MODIFIER:exon14/14:c.*1198A>G:,ALDH4A1:ENST00000375341:3'UTR:MODIFIER:exon15/15:c.*1198A>G:		rs7366541	0.1799	0.0000	0,0,0	0,0,0,0,0	0.2342							606811 [ALDH4A1 (provisional) Hyperprolinemia,type II,239510];	RCV000390012.1 [likely benign]; 			18	93					ALDH4A1 (inh=AR pLI=0.00), RP13-279N23.2 (inh=n/a pLI=n/a)
chr1	19198414	19198414	G	A	het	anno_omim	QUAL=4601;DP=171;AF=0.49;MQM=59;TRIO=HET,171,0.49,WT,168,0.00,HET,195,0.49	ALDH4A1,RP13-279N23.2	3'UTR,intron	ALDH4A1:ENST00000538309:3'UTR:MODIFIER:exon15/15:c.*925C>T:,ALDH4A1:ENST00000538839:3'UTR:MODIFIER:exon14/14:c.*925C>T:,ALDH4A1:ENST00000375341:3'UTR:MODIFIER:exon15/15:c.*925C>T:,ALDH4A1:ENST00000290597:intron:MODIFIER:exon15/15:c.*42-130C>T:		rs1140477	0.1935	0.0000	0,0,0	0,0,0,0,0	0.2423							606811 [ALDH4A1 (provisional) Hyperprolinemia,type II,239510];	RCV000369725.1 [likely benign]; 			13	65					ALDH4A1 (inh=AR pLI=0.00), RP13-279N23.2 (inh=n/a pLI=n/a)
chr1	19198418	19198418	C	T	het	anno_omim	QUAL=4601;DP=171;AF=0.49;MQM=59;TRIO=HET,171,0.49,WT,168,0.00,HET,195,0.49	ALDH4A1,RP13-279N23.2	3'UTR,intron	ALDH4A1:ENST00000538309:3'UTR:MODIFIER:exon15/15:c.*921G>A:,ALDH4A1:ENST00000538839:3'UTR:MODIFIER:exon14/14:c.*921G>A:,ALDH4A1:ENST00000375341:3'UTR:MODIFIER:exon15/15:c.*921G>A:,ALDH4A1:ENST00000290597:intron:MODIFIER:exon15/15:c.*42-134G>A:		rs1138269	0.1933	0.0000	0,0,0	0,0,0,0,0	0.2424							606811 [ALDH4A1 (provisional) Hyperprolinemia,type II,239510];	RCV000273844.1 [likely benign]; 			13	65					ALDH4A1 (inh=AR pLI=0.00), RP13-279N23.2 (inh=n/a pLI=n/a)
chr1	19198576	19198576	A	G	hom	anno_omim	QUAL=29983;DP=378;AF=1.00;MQM=59;TRIO=HOM,378,1.00,HOM,239,1.00,HOM,313,0.99	ALDH4A1,RP13-279N23.2	3'UTR,intron	ALDH4A1:ENST00000538309:3'UTR:MODIFIER:exon15/15:c.*763T>C:,ALDH4A1:ENST00000538839:3'UTR:MODIFIER:exon14/14:c.*763T>C:,ALDH4A1:ENST00000375341:3'UTR:MODIFIER:exon15/15:c.*763T>C:,ALDH4A1:ENST00000290597:intron:MODIFIER:exon15/15:c.*42-292T>C:		rs1138267	0.6751	0.0000	0,0,0	0,0,0,0,0	0.6397							606811 [ALDH4A1 (provisional) Hyperprolinemia,type II,239510];	RCV000369525.1 [likely benign]; 			83	55					ALDH4A1 (inh=AR pLI=0.00), RP13-279N23.2 (inh=n/a pLI=n/a)
chr1	19198627	19198627	G	A	het	anno_omim	QUAL=6409;DP=296;AF=0.49;MQM=60;TRIO=HET,296,0.49,WT,204,0.00,HET,264,0.45	ALDH4A1,RP13-279N23.2	3'UTR,intron	ALDH4A1:ENST00000538309:3'UTR:MODIFIER:exon15/15:c.*712C>T:,ALDH4A1:ENST00000538839:3'UTR:MODIFIER:exon14/14:c.*712C>T:,ALDH4A1:ENST00000375341:3'UTR:MODIFIER:exon15/15:c.*712C>T:,ALDH4A1:ENST00000290597:intron:MODIFIER:exon15/15:c.*42-343C>T:		rs14311	0.1935	0.0000	0,0,0	0,0,0,0,0	0.2425							606811 [ALDH4A1 (provisional) Hyperprolinemia,type II,239510];	RCV000325202.1 [likely benign]; 			13	65					ALDH4A1 (inh=AR pLI=0.00), RP13-279N23.2 (inh=n/a pLI=n/a)
chr1	19198637	19198637	G	A	het	anno_omim	QUAL=12517;DP=243;AF=0.49;MQM=59;TRIO=HET,243,0.49,HOM,206,1.00,HET,259,0.54	ALDH4A1,RP13-279N23.2	3'UTR,intron	ALDH4A1:ENST00000538309:3'UTR:MODIFIER:exon15/15:c.*702C>T:,ALDH4A1:ENST00000538839:3'UTR:MODIFIER:exon14/14:c.*702C>T:,ALDH4A1:ENST00000375341:3'UTR:MODIFIER:exon15/15:c.*702C>T:,ALDH4A1:ENST00000290597:intron:MODIFIER:exon15/15:c.*42-353C>T:		rs3202002	0.4744	0.0000	0,0,0	0,0,0,0,0	0.3870							606811 [ALDH4A1 (provisional) Hyperprolinemia,type II,239510];	RCV000384464.1 [likely benign]; 			29	72					ALDH4A1 (inh=AR pLI=0.00), RP13-279N23.2 (inh=n/a pLI=n/a)
chr1	19198682	19198682	C	-	het	anno_omim	QUAL=7969;DP=114;AF=0.46;MQM=59;TRIO=HET,114,0.46,HOM,176,0.99,HET,196,0.54	ALDH4A1,RP13-279N23.2	3'UTR,intron	ALDH4A1:ENST00000538309:3'UTR:MODIFIER:exon15/15:c.*657delG:,ALDH4A1:ENST00000538839:3'UTR:MODIFIER:exon14/14:c.*657delG:,ALDH4A1:ENST00000375341:3'UTR:MODIFIER:exon15/15:c.*657delG:,ALDH4A1:ENST00000290597:intron:MODIFIER:exon15/15:c.*42-398delG:		rs11311839	0.4677	0.0000	0,0,0	0,0,0,0,0	0.3943							606811 [ALDH4A1 (provisional) Hyperprolinemia,type II,239510];	RCV000321565.1 [likely benign]; 			29	73					ALDH4A1 (inh=AR pLI=0.00), RP13-279N23.2 (inh=n/a pLI=n/a)
chr1	19198895	19198895	A	G	het	anno_omim	QUAL=5086;DP=202;AF=0.48;MQM=59;TRIO=HET,202,0.48,WT,194,0.00,HET,246,0.45	ALDH4A1,RP13-279N23.2	3'UTR,intron	ALDH4A1:ENST00000538309:3'UTR:MODIFIER:exon15/15:c.*444T>C:,ALDH4A1:ENST00000538839:3'UTR:MODIFIER:exon14/14:c.*444T>C:,ALDH4A1:ENST00000375341:3'UTR:MODIFIER:exon15/15:c.*444T>C:,ALDH4A1:ENST00000290597:intron:MODIFIER:exon15/15:c.*41+403T>C:		rs9117	0.1102	0.0000	0,0,0	0,0,0,0,0	0.1787							606811 [ALDH4A1 (provisional) Hyperprolinemia,type II,239510];	RCV000394585.1 [likely benign]; 			12	58					ALDH4A1 (inh=AR pLI=0.00), RP13-279N23.2 (inh=n/a pLI=n/a)
chr1	19199221	19199221	C	T	het	anno_omim	QUAL=20955;DP=220;AF=0.44;MQM=60;TRIO=HET,220,0.44,HOM,404,1.00,HET,488,0.47	ALDH4A1,RP13-279N23.2	3'UTR,intron	ALDH4A1:ENST00000538309:3'UTR:MODIFIER:exon15/15:c.*118G>A:,ALDH4A1:ENST00000538839:3'UTR:MODIFIER:exon14/14:c.*118G>A:,ALDH4A1:ENST00000375341:3'UTR:MODIFIER:exon15/15:c.*118G>A:,ALDH4A1:ENST00000290597:intron:MODIFIER:exon15/15:c.*41+77G>A:		rs11740	0.4714	0.0000	0,0,0	0,0,0,0,0	0.3870							606811 [ALDH4A1 (provisional) Hyperprolinemia,type II,239510];	RCV000402241.1 [likely benign]; 			30	71					ALDH4A1 (inh=AR pLI=0.00), RP13-279N23.2 (inh=n/a pLI=n/a)
chr1	19201956	19201956	A	G	hom	anno_omim	QUAL=18486;DP=322;AF=1.00;MQM=59;TRIO=HOM,322,1.00,HOM,132,1.00,HOM,139,1.00	ALDH4A1,RP13-279N23.2	synonymous	ALDH4A1:ENST00000290597:synonymous:LOW:exon13/16:c.1380T>C:p.Asp460Asp,ALDH4A1:ENST00000538309:synonymous:LOW:exon13/15:c.1200T>C:p.Asp400Asp,ALDH4A1:ENST00000538839:synonymous:LOW:exon12/14:c.1227T>C:p.Asp409Asp,ALDH4A1:ENST00000375341:synonymous:LOW:exon13/15:c.1380T>C:p.Asp460Asp		rs2230708	0.7372	0.7298	32562,17258,2502	0.6895,0.8260,0.7163,0.7175,0.7575	0.7323							606811 [ALDH4A1 (provisional) Hyperprolinemia,type II,239510];	RCV000316598.1 [benign]; 			1138	829	2	[2] auto-classification 14.09.2017  			ALDH4A1 (inh=AR pLI=0.00), RP13-279N23.2 (inh=n/a pLI=n/a)
chr1	19202896	19202896	G	A	hom	anno_omim	QUAL=7483;DP=139;AF=0.97;MQM=59;TRIO=HOM,139,0.97,HET,72,0.33,HOM,97,0.99	ALDH4A1,RP13-279N23.2	synonymous,intron	ALDH4A1:ENST00000290597:synonymous:LOW:exon12/16:c.1251C>T:p.Ala417Ala,ALDH4A1:ENST00000538309:synonymous:LOW:exon12/15:c.1071C>T:p.Ala357Ala,ALDH4A1:ENST00000375341:synonymous:LOW:exon12/15:c.1251C>T:p.Ala417Ala,ALDH4A1:ENST00000538839:intron:MODIFIER:exon11/13:c.1185+806C>T:		rs2230707	0.5160	0.5069	15519,7243,1007	0.4468,0.7109,0.6211,0.4738,0.5007	0.5110							606811 [ALDH4A1 (provisional) Hyperprolinemia,type II,239510];	RCV000295896.1 [likely benign]; 		COSM4143135, COSM4143136	486	1051	2	[2] auto-classification 14.09.2017  			ALDH4A1 (inh=AR pLI=0.00), RP13-279N23.2 (inh=n/a pLI=n/a)
chr1	19202917	19202917	T	C	hom	anno_omim	QUAL=7752;DP=108;AF=0.99;MQM=59;TRIO=HOM,108,0.99,HOM,73,0.97,HOM,87,0.99	ALDH4A1,RP13-279N23.2	synonymous,intron	ALDH4A1:ENST00000290597:synonymous:LOW:exon12/16:c.1230A>G:p.Ser410Ser,ALDH4A1:ENST00000538309:synonymous:LOW:exon12/15:c.1050A>G:p.Ser350Ser,ALDH4A1:ENST00000375341:synonymous:LOW:exon12/15:c.1230A>G:p.Ser410Ser,ALDH4A1:ENST00000538839:intron:MODIFIER:exon11/13:c.1185+785A>G:		rs7550938	0.6609	0.7025	27774,14964,1171	0.5050,0.8091,0.7275,0.7011,0.7487	0.6990							606811 [ALDH4A1 (provisional) Hyperprolinemia,type II,239510];	RCV000350845.1 [benign]; 		COSM1337325, COSM1337326	1049	863	2	[2] auto-classification 14.09.2017  			ALDH4A1 (inh=AR pLI=0.00), RP13-279N23.2 (inh=n/a pLI=n/a)
chr1	19202926	19202926	T	C	hom	anno_omim	QUAL=6368;DP=70;AF=0.99;MQM=59;TRIO=HOM,70,0.99,HOM,73,0.96,HOM,87,0.99	ALDH4A1,RP13-279N23.2	synonymous,intron	ALDH4A1:ENST00000290597:synonymous:LOW:exon12/16:c.1221A>G:p.Ala407Ala,ALDH4A1:ENST00000538309:synonymous:LOW:exon12/15:c.1041A>G:p.Ala347Ala,ALDH4A1:ENST00000375341:synonymous:LOW:exon12/15:c.1221A>G:p.Ala407Ala,ALDH4A1:ENST00000538839:intron:MODIFIER:exon11/13:c.1185+776A>G:		rs2230706	0.6601	0.7061	26738,14365,1117	0.5095,0.8123,0.7310,0.7043,0.7510	0.6985							606811 [ALDH4A1 (provisional) Hyperprolinemia,type II,239510];	RCV000397654.1 [benign]; 		COSM1337327, COSM1337328	1047	862	2	[2] auto-classification 14.09.2017  			ALDH4A1 (inh=AR pLI=0.00), RP13-279N23.2 (inh=n/a pLI=n/a)
chr1	19203997	19203997	C	G	hom	anno_omim	QUAL=7639;DP=87;AF=0.98;MQM=59;TRIO=HOM,87,0.98,HOM,56,1.00,HOM,107,1.00	ALDH4A1,RP13-279N23.2	synonymous	ALDH4A1:ENST00000290597:synonymous:LOW:exon10/16:c.1050G>C:p.Ala350Ala,ALDH4A1:ENST00000538309:synonymous:LOW:exon10/15:c.870G>C:p.Ala290Ala,ALDH4A1:ENST00000538839:synonymous:LOW:exon10/14:c.1050G>C:p.Ala350Ala,ALDH4A1:ENST00000375341:synonymous:LOW:exon10/15:c.1050G>C:p.Ala350Ala		rs2230705	0.6416	0.7072	26078,15560,2381	0.7378,0.7631,0.5004,0.7353,0.6051	0.7198							606811 [ALDH4A1 (provisional) Hyperprolinemia,type II,239510];	RCV000267887.1 [benign]; 		COSM1473186, COSM424869	938	928	2	[2] auto-classification 14.09.2017  			ALDH4A1 (inh=AR pLI=0.00), RP13-279N23.2 (inh=n/a pLI=n/a)
chr1	21889635	21889635	T	C	hom	anno_omim	QUAL=4846;DP=33;AF=0.97;MQM=59;TRIO=HOM,33,0.97,HOM,90,1.00,HET,125,0.52	ALPL	synonymous	ALPL:ENST00000374832:synonymous:LOW:exon5/12:c.330T>C:p.Ser110Ser,ALPL:ENST00000539907:synonymous:LOW:exon3/10:c.99T>C:p.Ser33Ser,ALPL:ENST00000540617:synonymous:LOW:exon4/11:c.165T>C:p.Ser55Ser,ALPL:ENST00000374840:synonymous:LOW:exon5/12:c.330T>C:p.Ser110Ser,ALPL:ENST00000425315:synonymous:LOW:exon4/11:c.330T>C:p.Ser110Ser		rs1780316	0.9295	0.9450	54032,29655,3879	0.8664,0.9735,0.9878,0.9456,0.9542	0.9473							171760 [ALPL (confirmed) Hypophosphatasia,infantile,241500|Hypophosphatasia,childhood,241510|Odontohypophosphatasia,146300|Hypophosphatasia,adult,146300];	RCV000178778.1 [benign]; 		COSM3746801	1907	192	2	[2] auto-classification 14.09.2017  			ALPL (inh=AR+AD pLI=0.00)
chr1	21904263	21904263	C	-	het	anno_omim	QUAL=5373;DP=210;AF=0.50;MQM=59;TRIO=HET,210,0.50,HET,243,0.53,WT,288,0.00	ALPL	3'UTR	ALPL:ENST00000374832:3'UTR:MODIFIER:exon12/12:c.*124delC:,ALPL:ENST00000539907:3'UTR:MODIFIER:exon10/10:c.*124delC:,ALPL:ENST00000540617:3'UTR:MODIFIER:exon11/11:c.*124delC:,ALPL:ENST00000374840:3'UTR:MODIFIER:exon12/12:c.*124delC:,ALPL:ENST00000425315:3'UTR:MODIFIER:exon11/11:c.*124delC:,ALPL:ENST00000374829:3'UTR:MODIFIER:exon4/4:c.*124delC:		rs140511985	0.0228	0.0000	0,0,0	0,0,0,0,0	0.0449							171760 [ALPL (confirmed) Hypophosphatasia,infantile,241500|Hypophosphatasia,childhood,241510|Odontohypophosphatasia,146300|Hypophosphatasia,adult,146300];	RCV000325855.1 [likely benign]; 			1	30					ALPL (inh=AR+AD pLI=0.00)
chr1	21904267	21904267	A	G	hom	anno_omim	QUAL=23868;DP=221;AF=1.00;MQM=59;TRIO=HOM,221,1.00,HOM,245,0.98,HOM,296,1.00	ALPL	3'UTR	ALPL:ENST00000374832:3'UTR:MODIFIER:exon12/12:c.*126A>G:,ALPL:ENST00000539907:3'UTR:MODIFIER:exon10/10:c.*126A>G:,ALPL:ENST00000540617:3'UTR:MODIFIER:exon11/11:c.*126A>G:,ALPL:ENST00000374840:3'UTR:MODIFIER:exon12/12:c.*126A>G:,ALPL:ENST00000425315:3'UTR:MODIFIER:exon11/11:c.*126A>G:,ALPL:ENST00000374829:3'UTR:MODIFIER:exon4/4:c.*126A>G:		rs1697406	0.8682	0.0000	0,0,0	0,0,0,0,0	0.8703							171760 [ALPL (confirmed) Hypophosphatasia,infantile,241500|Hypophosphatasia,childhood,241510|Odontohypophosphatasia,146300|Hypophosphatasia,adult,146300];	RCV000382769.1 [benign]; 			178	48					ALPL (inh=AR+AD pLI=0.00)
chr1	22149183	22149183	G	C	het	anno_omim	QUAL=1423;DP=27;AF=0.56;MQM=60;TRIO=HET,27,0.56,WT,28,0.00,HOM,42,1.00	LDLRAD2,HSPG2	3'UTR,intron	LDLRAD2:ENST00000344642:3'UTR:MODIFIER:exon5/5:c.*475G>C:,HSPG2:ENST00000374695:3'UTR:MODIFIER:exon97/97:c.*626C>G:,LDLRAD2:ENST00000543870:intron:MODIFIER:exon5/5:c.*218+257G>C:		rs1049644	0.3199	0.0000	0,0,0	0,0,0,0,0	0.2999							142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000297630.1 [benign]; RCV000354787.1 [benign]; 			14	59					LDLRAD2 (inh=n/a pLI=0.00), HSPG2 (inh=AR pLI=0.00)
chr1	22149935	22149935	T	C	hom	anno_omim	QUAL=15305;DP=116;AF=1.00;MQM=59;TRIO=HOM,116,1.00,HOM,144,1.00,HOM,233,1.00	HSPG2,LDLRAD2	synonymous,3'UTR,intron	HSPG2:ENST00000374695:synonymous:LOW:exon97/97:c.13050A>G:p.Ser4350Ser,LDLRAD2:ENST00000344642:3'UTR:MODIFIER:exon5/5:c.*1227T>C:,LDLRAD2:ENST00000543870:intron:MODIFIER:exon5/5:c.*219-468T>C:		rs897467	0.7804	0.8204	29345,16802,1769	0.7297,0.7689,0.8206,0.8389,0.8304	0.8082							142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000302221.1 [benign]; RCV000359351.1 [benign]; 		COSM3750884	1499	563	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00), LDLRAD2 (inh=n/a pLI=0.00)
chr1	22150120	22150120	C	T	het	anno_omim	QUAL=5840;DP=155;AF=0.46;MQM=59;TRIO=HET,155,0.46,WT,209,0.01,HET,317,0.55	HSPG2,LDLRAD2	missense,3'UTR,intron	HSPG2:ENST00000374695:missense:MODERATE:exon96/97:c.12992G>A:p.Ser4331Asn,LDLRAD2:ENST00000344642:3'UTR:MODIFIER:exon5/5:c.*1412C>T:,LDLRAD2:ENST00000543870:intron:MODIFIER:exon5/5:c.*219-283C>T:		rs3736360	0.1761	0.1849	2248,1110,30	0.0835,0.1308,0.1612,0.1830,0.2836	0.1826	0.0960	T	T	B	T	13.76	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000278239.1 [benign]; RCV000375072.1 [benign]; 		COSM3750886	63	582	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00), LDLRAD2 (inh=n/a pLI=0.00)
chr1	22150160	22150160	G	T	het	anno_omim	QUAL=8183;DP=304;AF=0.50;MQM=59;TRIO=HET,304,0.50,WT,206,0.01,HET,324,0.55	HSPG2,LDLRAD2	synonymous,3'UTR,intron	HSPG2:ENST00000374695:synonymous:LOW:exon96/97:c.12952C>A:p.Arg4318Arg,LDLRAD2:ENST00000344642:3'UTR:MODIFIER:exon5/5:c.*1452G>T:,LDLRAD2:ENST00000543870:intron:MODIFIER:exon5/5:c.*219-243G>T:		rs3736358	0.0000	0.1808	2228,1111,9	0.0359,0.1302,0.1613,0.1831,0.2838	0.1795							142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000286377.1 [benign]; RCV000339035.1 [benign]; 		COSM3750887	63	579	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00), LDLRAD2 (inh=n/a pLI=0.00)
chr1	22154845	22154845	A	G	het	anno_omim	QUAL=1286;DP=45;AF=0.33;MQM=60;TRIO=HET,45,0.33,WT,38,0.00,HOM,32,0.97	HSPG2	synonymous	HSPG2:ENST00000374695:synonymous:LOW:exon89/97:c.12312T>C:p.Asp4104Asp		rs2228347	0.2572	0.2982	5929,3255,98	0.1360,0.1835,0.1607,0.3143,0.4734	0.2931							142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000319755.1 [benign]; RCV000353544.1 [benign]; 		COSM3746805	215	869	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00)
chr1	22159774	22159774	G	A	het	anno_omim	QUAL=4229;DP=147;AF=0.43;MQM=59;TRIO=HET,147,0.43,WT,207,0.00,HET,238,0.50	HSPG2	synonymous	HSPG2:ENST00000374695:synonymous:LOW:exon80/97:c.11082C>T:p.Pro3694Pro		rs2229486	0.0859	0.0792	484,201,147	0.1712,0.0372,0.0000,0.0772,0.1091	0.0958							142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000304022.1 [likely benign]; RCV000393030.1 [likely benign]; 			17	333	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00)
chr1	22160043	22160043	C	T	het	anno_omim	QUAL=5275;DP=190;AF=0.42;MQM=60;TRIO=HET,190,0.42,WT,225,0.00,HET,287,0.48	HSPG2	missense	HSPG2:ENST00000374695:missense:MODERATE:exon79/97:c.10895G>A:p.Arg3632Gln		rs2229493	0.0859	0.0795	487,202,148	0.1733,0.0372,0.0000,0.0774,0.1091	0.0960	-0.0650	T,T	T	B,B	T,T	4.68	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000276227.1 [likely benign]; RCV000389238.1 [likely benign]; 			17	334	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00)
chr1	22163390	22163390	G	A	het	anno_omim	QUAL=5476;DP=182;AF=0.50;MQM=60;TRIO=HET,182,0.50,WT,227,0.00,HET,353,0.40	HSPG2	synonymous	HSPG2:ENST00000374695:synonymous:LOW:exon75/97:c.10260C>T:p.His3420His		rs35444472	0.0861	0.1274	211,66,72	0.2079,0.1172,0.0000,0.1227,0.1214	0.0952							142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000293149.1 [likely benign]; RCV000352651.1 [likely benign]; 		COSM3750889	16	329	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00)
chr1	22165901	22165901	A	G	het	anno_omim	QUAL=2711;DP=85;AF=0.61;MQM=59;TRIO=HET,85,0.61,WT,39,0.00,HET,88,0.67	HSPG2	synonymous	HSPG2:ENST00000374695:synonymous:LOW:exon73/97:c.9852T>C:p.Ala3284Ala		rs2291826	0.3460	0.2876	5587,2297,1470	0.5338,0.1840,0.1621,0.2616,0.3795	0.3318							142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000336014.1 [benign]; RCV000399444.1 [benign]; 			153	779	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00)
chr1	22167605	22167605	C	T	het	anno_omim	QUAL=2093;DP=53;AF=0.45;MQM=59;TRIO=HET,53,0.45,WT,164,0.00,HET,183,0.42	HSPG2	missense	HSPG2:ENST00000374695:missense:MODERATE:exon71/97:c.9502G>A:p.Ala3168Thr		rs2228349	0.0837	0.1177	377,153,103	0.2266,0.0711,0.0000,0.1144,0.1355	0.0929	0.9110	T	T	B,B	T	13.43	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000259415.1 [likely benign]; RCV000316947.1 [likely benign]; 			17	331	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00)
chr1	22168801	22168801	T	C	het	anno_omim	QUAL=1512;DP=69;AF=0.46;MQM=59;TRIO=HET,69,0.46,WT,76,0.00,HET,87,0.43	HSPG2	missense	HSPG2:ENST00000374695:missense:MODERATE:exon68/97:c.8983A>G:p.Ser2995Gly		rs2229491	0.0887	0.0812	498,194,166	0.1832,0.0383,0.0000,0.0781,0.1111	0.0975	-0.0660	T	T	B,B	T	0.01	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000313160.1 [likely benign]; RCV000370135.1 [likely benign]; 			17	337	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00)
chr1	22168845	22168845	A	T	het	pred_pathogenic;anno_omim	QUAL=1052;DP=50;AF=0.56;MQM=59;TRIO=HET,50,0.56,WT,44,0.00,HET,57,0.39	HSPG2	missense	HSPG2:ENST00000374695:missense:MODERATE:exon68/97:c.8939T>A:p.Leu2980His		rs2229489	0.0343	0.0560	210,96,0	0.0095,0.0258,0.0000,0.0606,0.1160	0.0495	1.8860	T	T	B,B	T	7.97	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000262561.1 [likely benign]; RCV000354940.1 [likely benign]; 		COSM425370	7	264	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00)
chr1	22173990	22173990	A	G	het	anno_omim	QUAL=7236;DP=164;AF=0.55;MQM=59;TRIO=HET,164,0.55,WT,327,0.00,HET,426,0.49	HSPG2	splice_region&intron	HSPG2:ENST00000374695:splice_region&intron:LOW:exon61/96:c.8026-5T>C:,HSPG2:ENST00000430507:splice_region&intron:LOW:exon16/18:c.*1375-5T>C:		rs35917892	0.0347	0.0505	223,104,0	0.0085,0.0221,0.0000,0.0553,0.1049	0.0497							142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000308491.1 [likely benign]; RCV000407500.1 [likely benign]; 			7	262	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00)
chr1	22174518	22174518	G	T	het	anno_omim	QUAL=7681;DP=288;AF=0.44;MQM=59;TRIO=HET,288,0.44,WT,359,0.00,HET,362,0.51	HSPG2	synonymous,3'UTR	HSPG2:ENST00000374695:synonymous:LOW:exon60/97:c.7806C>A:p.Val2602Val,HSPG2:ENST00000430507:3'UTR:MODIFIER:exon15/19:c.*1155C>A:		rs12737091	0.0347	0.0511	220,102,0	0.0086,0.0225,0.0000,0.0558,0.1060	0.0497							142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000318918.1 [likely benign]; RCV000375837.1 [likely benign]; 			7	262	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00)
chr1	22179244	22179244	C	T	het	anno_omim	QUAL=3591;DP=92;AF=0.43;MQM=59;TRIO=HET,92,0.43,WT,152,0.00,HET,204,0.51	HSPG2	missense,3'UTR	HSPG2:ENST00000374695:missense:MODERATE:exon52/97:c.6673G>A:p.Gly2225Ser,HSPG2:ENST00000430507:3'UTR:MODIFIER:exon7/19:c.*22G>A:		rs35669711	0.0347	0.0509	222,103,0	0.0087,0.0222,0.0000,0.0558,0.1050	0.0498	-0.1820	T	T	B,B	T	12.31	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000306325.1 [likely benign]; RCV000398821.1 [likely benign]; 			7	261	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00)
chr1	22179451	22179451	C	T	het	anno_omim	QUAL=5828;DP=86;AF=0.48;MQM=59;TRIO=HET,86,0.48,WT,272,0.00,HET,434,0.46	HSPG2	synonymous	HSPG2:ENST00000374695:synonymous:LOW:exon51/97:c.6552G>A:p.Thr2184Thr,HSPG2:ENST00000430507:synonymous:LOW:exon6/19:c.390G>A:p.Thr130Thr		rs34443576	0.0345	0.0512	219,102,0	0.0087,0.0223,0.0002,0.0561,0.1048	0.0499							142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000263025.1 [likely benign]; RCV000318160.1 [likely benign]; 			7	261	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00)
chr1	22180723	22180723	C	T	het	anno_omim	QUAL=3074;DP=84;AF=0.46;MQM=60;TRIO=HET,84,0.46,WT,144,0.00,HET,197,0.51	HSPG2	splice_region&intron,synonymous	HSPG2:ENST00000430507:splice_region&intron:LOW:exon4/18:c.249+3G>A:,HSPG2:ENST00000374695:synonymous:LOW:exon50/97:c.6402G>A:p.Val2134Val		rs12742444	0.0345	0.0895	149,60,0	0.0125,0.0502,0.0000,0.1021,0.1323	0.0477							142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000289771.1 [benign]; RCV000294008.1 [likely benign]; RCV000330249.1 [likely benign]; 			5	259	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00)
chr1	22181895	22181895	C	T	het	pred_pathogenic;anno_omim	QUAL=5770;DP=168;AF=0.49;MQM=59;TRIO=HET,168,0.49,WT,261,0.00,HET,311,0.53	HSPG2	missense	HSPG2:ENST00000374695:missense:MODERATE:exon47/97:c.5899G>A:p.Val1967Ile		rs2229475	0.0347	0.0536	207,95,0	0.0092,0.0238,0.0000,0.0580,0.1125	0.0492	1.8290	T	T	D	T	24.30	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000339647.1 [likely benign]; RCV000375538.1 [likely benign]; 			6	262	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00)
chr1	22191454	22191454	G	A	het	pred_pathogenic;anno_omim	QUAL=7192;DP=128;AF=0.40;MQM=59;TRIO=HET,128,0.40,HOM,210,1.00,WT,349,0.00	HSPG2	missense	HSPG2:ENST00000374695:missense:MODERATE:exon36/97:c.4508C>T:p.Ala1503Val		rs897471	0.6915	0.7463	25154,14147,1363	0.6525,0.8269,0.9042,0.7582,0.6023	0.7312	2.2600	T	T	D	T	23.30	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000274418.1 [benign]; RCV000299057.1 [benign]; RCV000371265.1 [benign]; 		COSM3750893	1127	809	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00)
chr1	22199245	22199245	C	T	het	anno_omim	QUAL=3097;DP=48;AF=0.58;MQM=60;TRIO=HET,48,0.58,HOM,81,1.00,WT,76,0.01	HSPG2	synonymous	HSPG2:ENST00000374695:synonymous:LOW:exon32/97:c.3897G>A:p.Val1299Val		rs2229482	0.4249	0.6067	17522,12414,386	0.3382,0.5082,0.5028,0.6752,0.5410	0.5578							142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000269271.1 [benign]; RCV000346655.1 [benign]; RCV000366230.1 [benign]; 		COSM425375	779	986	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00)
chr1	22206649	22206649	T	C	hom	anno_omim	QUAL=22322;DP=206;AF=1.00;MQM=60;TRIO=HOM,206,1.00,HOM,239,1.00,HOM,255,1.00	HSPG2	missense	HSPG2:ENST00000374695:missense:MODERATE:exon17/97:c.2294A>G:p.Asn765Ser		rs989994	0.9299	0.9811	58602,33315,3265	0.7916,0.9923,1.0000,0.9996,0.9997	0.9849	0.8030	T	T	B	T	16.97	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000317586.1 [benign]; RCV000372262.1 [benign]; 			2108	12	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00)
chr1	22206942	22206942	G	A	hom	anno_omim	QUAL=8248;DP=135;AF=1.00;MQM=59;TRIO=HOM,135,1.00,HOM,61,1.00,HOM,74,1.00	HSPG2	synonymous	HSPG2:ENST00000374695:synonymous:LOW:exon16/97:c.2109C>T:p.Ala703Ala		rs1874793	0.9299	0.9812	58461,33240,3259	0.7924,0.9923,1.0000,0.9996,0.9998	0.9850							142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000282418.1 [benign]; RCV000318734.1 [benign]; 		COSM4143367	2108	12	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00)
chr1	22207235	22207235	T	C	hom	anno_omim	QUAL=11349;DP=170;AF=0.99;MQM=59;TRIO=HOM,170,0.99,HOM,74,1.00,HOM,132,1.00	HSPG2	missense	HSPG2:ENST00000374695:missense:MODERATE:exon15/97:c.1912A>G:p.Met638Val		rs1874792	0.9736	0.9931	47715,27169,3347	0.9216,0.9971,1.0000,0.9997,1.0000	0.9946	1.5550	T	T	B	T	0.01	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000260399.1 [benign]; RCV000296869.1 [benign]; 			2118	1	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00)
chr1	22214127	22214127	A	G	hom	pred_pathogenic;anno_omim	QUAL=12838;DP=125;AF=1.00;MQM=59;TRIO=HOM,125,1.00,HET,183,0.50,HOM,214,1.00	HSPG2	synonymous	HSPG2:ENST00000374695:synonymous:LOW:exon8/97:c.744T>C:p.Leu248Leu		rs2229478	0.5363	0.4175	11513,3745,2116	0.6406,0.5977,0.6264,0.3354,0.4014	0.4500	-0.2600	D,T	T	B	T,D	0.03	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000267416.1 [benign]; RCV000317902.1 [benign]; 		COSM3750895, COSM3750894	276	947	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00)
chr1	22217108	22217108	G	A	hom	anno_omim	QUAL=25902;DP=224;AF=1.00;MQM=59;TRIO=HOM,224,1.00,HOM,277,1.00,HOM,332,1.00	HSPG2	synonymous	HSPG2:ENST00000374695:synonymous:LOW:exon4/97:c.324C>T:p.Phe108Phe		rs2501260	0.9481	0.9861	59156,33346,3754	0.8475,0.9944,1.0000,0.9996,0.9998	0.9891							142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1,255800|Dyssegmental dysplasia,Silverman-Handmaker type,224410];	RCV000289547.1 [benign]; RCV000406389.1 [benign]; 			2113	7	2	[2] auto-classification 14.09.2017  			HSPG2 (inh=AR pLI=0.00)
chr1	22779159	22779159	T	C	hom		QUAL=28748;DP=268;AF=1.00;MQM=60;TRIO=HOM,268,1.00,HOM,255,1.00,HOM,394,1.00	ZBTB40	5'UTR,intron	ZBTB40:ENST00000404138:5'UTR:MODIFIER:exon2/19:c.-350T>C:,ZBTB40:ENST00000375647:intron:MODIFIER:exon1/17:c.-70+662T>C:,ZBTB40:ENST00000374651:intron:MODIFIER:exon1/15:c.-70+662T>C:	MER58B	rs10737466	0.9698	0.0000	0,0,0	0,0,0,0,0	0.9776											229	0					ZBTB40 (inh=n/a pLI=0.00)
chr1	22832743	22832743	A	T	hom		QUAL=15555;DP=213;AF=1.00;MQM=60;TRIO=HOM,213,1.00,HET,168,0.55,HOM,209,0.99	ZBTB40	splice_region&intron	ZBTB40:ENST00000375647:splice_region&intron:LOW:exon6/17:c.1360+9A>T:,ZBTB40:ENST00000404138:splice_region&intron:LOW:exon7/18:c.1360+9A>T:,ZBTB40:ENST00000374651:splice_region&intron:LOW:exon4/15:c.1024+9A>T:		rs209732	0.7991	0.6929	29845,12471,4048	0.8934,0.8591,0.8964,0.6120,0.7051	0.7103										COSM3746831	913	879	2	[2] auto-classification 14.09.2017  			ZBTB40 (inh=n/a pLI=0.00)
chr1	22835677	22835677	A	G	hom		QUAL=24886;DP=342;AF=1.00;MQM=59;TRIO=HOM,342,1.00,HET,273,0.53,HOM,306,1.00	ZBTB40	missense	ZBTB40:ENST00000375647:missense:MODERATE:exon9/18:c.1784A>G:p.Tyr595Cys,ZBTB40:ENST00000404138:missense:MODERATE:exon10/19:c.1784A>G:p.Tyr595Cys,ZBTB40:ENST00000374651:missense:MODERATE:exon7/16:c.1448A>G:p.Tyr483Cys		rs209729	0.8225	0.7648	35937,17374,4314	0.9102,0.8960,0.8982,0.7209,0.7137	0.7793	0.2230	T,T,T	T	B,B	T,T,T	4.98				COSM3746832	1162	778	2	[2] auto-classification 14.09.2017  			ZBTB40 (inh=n/a pLI=0.00)
chr1	22846709	22846709	G	A	hom	pred_pathogenic	QUAL=12120;DP=169;AF=1.00;MQM=59;TRIO=HOM,169,1.00,HOM,93,1.00,HOM,135,1.00	ZBTB40	missense	ZBTB40:ENST00000375647:missense:MODERATE:exon14/18:c.2989G>A:p.Val997Met,ZBTB40:ENST00000404138:missense:MODERATE:exon15/19:c.2989G>A:p.Val997Met,ZBTB40:ENST00000374651:missense:MODERATE:exon12/16:c.2653G>A:p.Val885Met		rs209720	0.9984	0.9970	60319,33052,5194	0.9992,0.9979,1.0000,0.9955,0.9992	0.9972	2.3000	T,T,T	T	B,B	T,T,T	14.26					2096	10	2	[2] auto-classification 14.09.2017  			ZBTB40 (inh=n/a pLI=0.00)
chr1	22852715	22852715	G	C	hom		QUAL=10923;DP=174;AF=0.99;MQM=60;TRIO=HOM,174,0.99,HET,108,0.46,HOM,140,0.99	ZBTB40	synonymous	ZBTB40:ENST00000375647:synonymous:LOW:exon18/18:c.3546G>C:p.Pro1182Pro,ZBTB40:ENST00000404138:synonymous:LOW:exon19/19:c.3546G>C:p.Pro1182Pro,ZBTB40:ENST00000374651:synonymous:LOW:exon16/16:c.3210G>C:p.Pro1070Pro		rs881646	0.3181	0.3422	7646,4486,132	0.1588,0.1585,0.4547,0.3677,0.4232	0.3392										COSM3746849	302	944	2	[2] auto-classification 14.09.2017  			ZBTB40 (inh=n/a pLI=0.00)
chr1	22853141	22853141	G	A	hom		QUAL=17671;DP=157;AF=1.00;MQM=59;TRIO=HOM,157,1.00,HET,234,0.50,HOM,316,1.00	ZBTB40	3'UTR	ZBTB40:ENST00000375647:3'UTR:MODIFIER:exon18/18:c.*252G>A:,ZBTB40:ENST00000404138:3'UTR:MODIFIER:exon19/19:c.*252G>A:,ZBTB40:ENST00000374651:3'UTR:MODIFIER:exon16/16:c.*252G>A:		rs2281354	0.2378	0.0000	0,0,0	0,0,0,0,0	0.2480											19	106					ZBTB40 (inh=n/a pLI=0.00)
chr1	22855194	22855194	-	T	hom		QUAL=627;DP=49;AF=0.43;MQM=59;TRIO=HOM,49,0.43,WT,39,0.21,HOM,48,0.48	ZBTB40	3'UTR	ZBTB40:ENST00000375647:3'UTR:MODIFIER:exon18/18:c.*2320dupT:,ZBTB40:ENST00000404138:3'UTR:MODIFIER:exon19/19:c.*2320dupT:	AluJo	rs35637563;rs778707681	0.0000	0.0000	0,0,0	0,0,0,0,0	0.3301											23	4					ZBTB40 (inh=n/a pLI=0.00)
chr1	22856601	22856601	T	C	hom		QUAL=19089;DP=229;AF=0.99;MQM=59;TRIO=HOM,229,0.99,HET,218,0.48,HOM,284,1.00	ZBTB40	3'UTR	ZBTB40:ENST00000375647:3'UTR:MODIFIER:exon18/18:c.*3712T>C:,ZBTB40:ENST00000404138:3'UTR:MODIFIER:exon19/19:c.*3712T>C:		rs1062663	0.3295	0.0000	0,0,0	0,0,0,0,0	0.3063											28	107					ZBTB40 (inh=n/a pLI=0.00)
chr1	22965438	22965438	A	G	het	low_DP;anno_omim	QUAL=330;DP=14;AF=0.64;MQM=60;TRIO=HET,14,0.64,HOM,2,1.00,HET,5,0.60	C1QA	synonymous	C1QA:ENST00000374642:synonymous:LOW:exon3/3:c.276A>G:p.Gly92Gly,C1QA:ENST00000402322:synonymous:LOW:exon2/2:c.276A>G:p.Gly92Gly		rs172378	0.6164	0.5387	11213,3757,1982	0.7473,0.6766,0.6170,0.4517,0.6067	0.5073	-0.2960	T	T			0.30	120550 [C1QA (confirmed) C1q deficiency,613652];			COSM3721050	377	946	2	[2] auto-classification 14.09.2017  			C1QA (inh=AR pLI=0.05)
chr1	22974534	22974534	T	-	het	anno_omim	QUAL=525;DP=54;AF=0.43;MQM=59;TRIO=HET,54,0.43,WT,39,0.21,HET,67,0.52	C1QC	3'UTR	C1QC:ENST00000374640:3'UTR:MODIFIER:exon3/3:c.*273delT:,C1QC:ENST00000374639:3'UTR:MODIFIER:exon3/3:c.*273delT:	L2d2	rs71020441	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0880							120575 [C1QC (provisional) C1q deficiency,613652];				3	41					C1QC (inh=AR pLI=0.02)
chr1	22974566	22974566	T	G	het	anno_omim	QUAL=76;DP=53;AF=0.40;MQM=57;TRIO=HET,53,0.40,WT,51,0.10,WT,65,0.11	C1QC	3'UTR	C1QC:ENST00000374640:3'UTR:MODIFIER:exon3/3:c.*290T>G:,C1QC:ENST00000374639:3'UTR:MODIFIER:exon3/3:c.*290T>G:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0017							120575 [C1QC (provisional) C1q deficiency,613652];				0	18					C1QC (inh=AR pLI=0.02)
chr1	22987958	22987958	A	G	hom	anno_omim	QUAL=38139;DP=417;AF=1.00;MQM=59;TRIO=HOM,417,1.00,HOM,349,1.00,HOM,455,1.00	C1QB	3'UTR	C1QB:ENST00000314933:3'UTR:MODIFIER:exon3/3:c.*79A>G:,C1QB:ENST00000509305:3'UTR:MODIFIER:exon3/3:c.*79A>G:		rs10580	0.9914	0.0000	0,0,0	0,0,0,0,0	0.9837							120570 [C1QB (confirmed) C1q deficiency,613652];				217	17					C1QB (inh=AR pLI=0.09)
chr1	24128467	24128467	C	T	hom	anno_omim	QUAL=30088;DP=380;AF=0.99;MQM=59;TRIO=HOM,380,0.99,HET,345,0.50,HOM,430,1.00	HMGCL	3'UTR	HMGCL:ENST00000374490:3'UTR:MODIFIER:exon9/9:c.*486G>A:,HMGCL:ENST00000436439:3'UTR:MODIFIER:exon7/7:c.*486G>A:,HMGCL:ENST00000374483:3'UTR:MODIFIER:exon10/10:c.*486G>A:		rs11714	0.8834	0.0000	0,0,0	0,0,0,0,0	0.9202							613898 [HMGCL (provisional) HMG-CoA lyase deficiency,246450];	RCV000343484.1 [benign]; RCV000345640.1 [benign]; 			195	35					HMGCL (inh=AR pLI=0.00)
chr1	24134721	24134721	T	C	hom	anno_omim	QUAL=21813;DP=293;AF=1.00;MQM=59;TRIO=HOM,293,1.00,HET,226,0.53,HOM,287,1.00	HMGCL	synonymous	HMGCL:ENST00000374490:synonymous:LOW:exon7/9:c.654A>G:p.Leu218Leu,HMGCL:ENST00000436439:synonymous:LOW:exon5/7:c.441A>G:p.Leu147Leu,HMGCL:ENST00000374483:synonymous:LOW:exon8/10:c.579A>G:p.Leu193Leu		rs719400	0.8874	0.9042	49752,27714,4863	0.9669,0.9007,0.7920,0.9114,0.8727	0.9306	0.8730		T			7.75	613898 [HMGCL (provisional) HMG-CoA lyase deficiency,246450];	RCV000078343.6 [benign]; RCV000268428.1 [benign]; 			1725	352	2	[2] auto-classification 14.09.2017  			HMGCL (inh=AR pLI=0.00)
chr1	24180962	24180962	T	C	het	pred_pathogenic;anno_omim	QUAL=9699;DP=254;AF=0.50;MQM=60;TRIO=HET,254,0.50,WT,210,0.00,HOM,202,1.00	FUCA1	missense	FUCA1:ENST00000374479:missense:MODERATE:exon5/8:c.857A>G:p.Gln286Arg		rs13551	0.2113	0.2791	5299,3906,125	0.1450,0.1878,0.2563,0.3386,0.1515	0.2798	0.6520	D,D	T	B	T	12.55	612280 [FUCA1 (confirmed) Fucosidosis,230000];	RCV000000726.2 [benign]; RCV000382814.1 [benign]; 		COSM3746875	174	832	2	[2] auto-classification 14.09.2017  			FUCA1 (inh=AR pLI=0.00)
chr1	24194770	24194770	C	G	het	anno_omim	QUAL=2651;DP=160;AF=0.48;MQM=59;TRIO=HET,160,0.48,HET,107,0.45,WT,114,0.00	FUCA1	missense	FUCA1:ENST00000374479:missense:MODERATE:exon1/8:c.7G>C:p.Ala3Pro		rs61996282	0.0134	0.0161	4,0,0	0.0000,0.0971,0.0000,0.0087,0.0181	0.0155	-2.4990	T	T	B	T	17.53	612280 [FUCA1 (confirmed) Fucosidosis,230000];	RCV000358584.1 [likely benign]; 			0	34					FUCA1 (inh=AR pLI=0.00)
chr1	26131654	26131654	G	A	hom	anno_omim	QUAL=15817;DP=161;AF=0.99;MQM=59;TRIO=HOM,161,0.99,HOM,221,1.00,HET,333,0.52	SEPN1	missense	SEPN1:ENST00000361547:missense:MODERATE:exon4/13:c.425G>A:p.Cys142Tyr,SEPN1:ENST00000354177:missense:MODERATE:exon3/13:c.323G>A:p.Cys108Tyr,SEPN1:ENST00000374315:missense:MODERATE:exon3/12:c.323G>A:p.Cys108Tyr		rs7349185	0.8419	0.8144	40353,20231,2986	0.7804,0.9150,0.9416,0.7777,0.8805	0.8181	0.9620	T,T,T	T	B,B	T,T,T	0.02	606210 [SEPN1 (confirmed) Muscular dystrophy,rigid spine,1,602771|Myopathy,congenital,with fiber-type disproportion,255310];	RCV000082016.8 [benign]; RCV000371932.1 [benign]; 			1412	674	2	[2] auto-classification 14.09.2017  			SELENON (inh=AR+AD pLI=0.00)
chr1	26138262	26138262	T	C	hom	anno_omim	QUAL=25217;DP=235;AF=1.00;MQM=59;TRIO=HOM,235,1.00,HOM,352,1.00,HET,489,0.52	SEPN1,RP1-317E23.6	synonymous	SEPN1:ENST00000361547:synonymous:LOW:exon9/13:c.1173T>C:p.Pro391Pro,SEPN1:ENST00000354177:synonymous:LOW:exon8/13:c.1071T>C:p.Pro357Pro,SEPN1:ENST00000374315:synonymous:LOW:exon8/12:c.1071T>C:p.Pro357Pro		rs760597	0.7919	0.8133	26670,14099,1304	0.6368,0.9016,0.9641,0.7917,0.8825	0.8096							606210 [SEPN1 (confirmed) Muscular dystrophy,rigid spine,1,602771|Myopathy,congenital,with fiber-type disproportion,255310];	RCV000082009.7 [benign]; RCV000358370.1 [benign]; 		COSM1127046	1402	669	2	[2] auto-classification 14.09.2017  			SELENON (inh=AR+AD pLI=0.00), RP1-317E23.6 (inh=n/a pLI=n/a)
chr1	26140573	26140573	C	A	hom	pred_pathogenic;anno_omim	QUAL=22048;DP=218;AF=1.00;MQM=59;TRIO=HOM,218,1.00,HOM,326,1.00,HET,440,0.50	SEPN1,RP1-317E23.6	missense	SEPN1:ENST00000361547:missense:MODERATE:exon12/13:c.1506C>A:p.Asn502Lys,SEPN1:ENST00000354177:missense:MODERATE:exon12/13:c.1404C>A:p.Asn468Lys,SEPN1:ENST00000374315:missense:MODERATE:exon11/12:c.1404C>A:p.Asn468Lys		rs2294228	0.6975	0.7747	37783,20184,467	0.2939,0.8902,0.9643,0.7769,0.8804	0.7861	0.1580	T,T,D	T	B,B	D,D,D	22.10	606210 [SEPN1 (confirmed) Muscular dystrophy,rigid spine,1,602771|Myopathy,congenital,with fiber-type disproportion,255310];	RCV000082012.7 [benign]; RCV000299948.1 [benign]; 		COSM4143697	1377	689	2	[2] auto-classification 14.09.2017  			SELENON (inh=AR+AD pLI=0.00), RP1-317E23.6 (inh=n/a pLI=n/a)
chr1	26143704	26143704	-	TTTTG	hom	anno_omim	QUAL=13450;DP=154;AF=0.95;MQM=58;TRIO=HOM,154,0.95,HOM,192,1.00,HET,230,0.44	SEPN1,RP1-317E23.6,RP1-317E23.3	3'UTR	SEPN1:ENST00000361547:3'UTR:MODIFIER:exon13/13:c.*1511_*1515dupTTTTG:,SEPN1:ENST00000354177:3'UTR:MODIFIER:exon13/13:c.*1511_*1515dupTTTTG:,SEPN1:ENST00000374315:3'UTR:MODIFIER:exon12/12:c.*1511_*1515dupTTTTG:		rs397712756	0.0000	0.0000	0,0,0	0,0,0,0,0	0.7101							606210 [SEPN1 (confirmed) Muscular dystrophy,rigid spine,1,602771|Myopathy,congenital,with fiber-type disproportion,255310];				156	68					SELENON (inh=AR+AD pLI=0.00), RP1-317E23.6 (inh=n/a pLI=n/a), RP1-317E23.3 (inh=n/a pLI=n/a)
chr1	26143821	26143821	T	C	hom	anno_omim	QUAL=16548;DP=249;AF=0.99;MQM=54;TRIO=HOM,249,0.99,HOM,180,0.98,HET,268,0.46	SEPN1,RP1-317E23.6,RP1-317E23.3	3'UTR	SEPN1:ENST00000361547:3'UTR:MODIFIER:exon13/13:c.*1612T>C:,SEPN1:ENST00000354177:3'UTR:MODIFIER:exon13/13:c.*1612T>C:,SEPN1:ENST00000374315:3'UTR:MODIFIER:exon12/12:c.*1612T>C:	AluSx	rs3203750	0.7630	0.0000	0,0,0	0,0,0,0,0	0.7113							606210 [SEPN1 (confirmed) Muscular dystrophy,rigid spine,1,602771|Myopathy,congenital,with fiber-type disproportion,255310];	RCV000365105.1 [benign]; 			155	64					SELENON (inh=AR+AD pLI=0.00), RP1-317E23.6 (inh=n/a pLI=n/a), RP1-317E23.3 (inh=n/a pLI=n/a)
chr1	26143931	26143931	T	C	hom	anno_omim	QUAL=22045;DP=340;AF=0.99;MQM=53;TRIO=HOM,340,0.99,HOM,231,1.00,HET,349,0.45	SEPN1,RP1-317E23.6,RP1-317E23.3	3'UTR	SEPN1:ENST00000361547:3'UTR:MODIFIER:exon13/13:c.*1722T>C:,SEPN1:ENST00000354177:3'UTR:MODIFIER:exon13/13:c.*1722T>C:,SEPN1:ENST00000374315:3'UTR:MODIFIER:exon12/12:c.*1722T>C:	AluSx	rs4659383	0.8622	0.0000	0,0,0	0,0,0,0,0	0.8016							606210 [SEPN1 (confirmed) Muscular dystrophy,rigid spine,1,602771|Myopathy,congenital,with fiber-type disproportion,255310];	RCV000378653.1 [benign]; 			140	57					SELENON (inh=AR+AD pLI=0.00), RP1-317E23.6 (inh=n/a pLI=n/a), RP1-317E23.3 (inh=n/a pLI=n/a)
chr1	26144438	26144438	C	-	hom	anno_omim	QUAL=4305;DP=74;AF=0.99;MQM=59;TRIO=HOM,74,0.99,HOM,80,1.00,HET,108,0.60	SEPN1,RP1-317E23.6,RP1-317E23.3	3'UTR	SEPN1:ENST00000361547:3'UTR:MODIFIER:exon13/13:c.*2236delC:,SEPN1:ENST00000354177:3'UTR:MODIFIER:exon13/13:c.*2236delC:,SEPN1:ENST00000374315:3'UTR:MODIFIER:exon12/12:c.*2236delC:		rs397752421;rs558875165	0.7666	0.0000	0,0,0	0,0,0,0,0	0.7146							606210 [SEPN1 (confirmed) Muscular dystrophy,rigid spine,1,602771|Myopathy,congenital,with fiber-type disproportion,255310];	RCV000351112.1 [uncertain significance]; 			156	68					SELENON (inh=AR+AD pLI=0.00), RP1-317E23.6 (inh=n/a pLI=n/a), RP1-317E23.3 (inh=n/a pLI=n/a)
chr1	33245802	33245802	C	G	het	anno_omim	QUAL=9423;DP=261;AF=0.52;MQM=60;TRIO=HET,261,0.52,HET,187,0.61,HET,252,0.46	YARS	synonymous	YARS:ENST00000373477:synonymous:LOW:exon11/13:c.1218G>C:p.Leu406Leu		rs699005	0.0875	0.0982	815,337,52	0.1029,0.2215,0.0004,0.0948,0.0618	0.1073							603623 [YARS (confirmed) Charcot-Marie-Tooth disease,dominant intermediate C,608323];	RCV000355335.1 [benign]; 			20	320	2	[2] auto-classification 14.09.2017  			YARS (inh=AD pLI=0.00)
chr1	33283528	33283528	G	A	het	low_DP;anno_omim	QUAL=44;DP=9;AF=0.56;MQM=60;TRIO=HET,9,0.56,WT,187,0.61,WT,1,0.00	YARS,S100PBP	5'UTR,intron	YARS:ENST00000373477:5'UTR:MODIFIER:exon1/13:c.-683C>T:,S100PBP:ENST00000373475:intron:MODIFIER:exon1/6:c.-120+238G>A:,S100PBP:ENST00000373476:intron:MODIFIER:exon1/6:c.-120+328G>A:,S100PBP:ENST00000398243:intron:MODIFIER:exon1/6:c.-120+238G>A:		rs72654022	0.0603	0.0000	0,0,0	0,0,0,0,0	0.0834							603623 [YARS (confirmed) Charcot-Marie-Tooth disease,dominant intermediate C,608323];	RCV000377277.1 [benign]; 			4	13					YARS (inh=AD pLI=0.00), S100PBP (inh=n/a pLI=0.95)
chr1	33475639	33475639	G	A	het	low_MQM;anno_omim	QUAL=1234;DP=716;AF=0.14;MQM=33;TRIO=HET,716,0.14,HET,553,0.24,HET,541,0.12	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*791C>T:		rs138902451	0.0000	0.1262	0,0,0	0.0536,0.0000,0.0000,0.1228,0.1337	0.4669							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				0	148					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33475650	33475650	T	C	het	low_MQM;anno_omim	QUAL=1340;DP=668;AF=0.13;MQM=33;TRIO=HET,668,0.13,HET,550,0.24,HET,557,0.13	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*780A>G:		rs141799861	0.0000	0.1567	0,0,0	0.0618,0.0000,0.0000,0.1488,0.1672	0.4693							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				0	149					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33475687	33475687	C	G	het	low_MQM;anno_omim	QUAL=2564;DP=384;AF=0.11;MQM=33;TRIO=HET,384,0.11,HET,606,0.29,HET,581,0.16	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*743G>C:		rs201444233	0.0000	0.1149	0,0,0	0.0709,0.0000,0.0000,0.1053,0.1178	0.4100							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				0	114					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33475721	33475721	G	C	het	low_MQM;anno_omim	QUAL=4116;DP=336;AF=0.11;MQM=34;TRIO=HET,336,0.11,HET,608,0.32,HET,552,0.20	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*709C>G:		rs139591926	0.0000	0.2199	0,0,0	0.0000,0.0000,0.0000,0.2389,0.2106	0.4724							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				0	162					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33475750	33475750	A	G	het	low_MQM;anno_omim	QUAL=4731;DP=438;AF=0.13;MQM=39;TRIO=HET,438,0.13,HET,577,0.32,HET,530,0.22	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*680T>C:		rs142975905	0.0000	0.4931	0,0,0	0.4688,0.0000,0.0000,0.4935,0.4940	0.4963							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				0	211					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33475767	33475767	G	A	het	low_MQM;anno_omim	QUAL=4608;DP=520;AF=0.14;MQM=41;TRIO=HET,520,0.14,HET,548,0.34,HET,514,0.24	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*663C>T:		rs74066436	0.0000	0.4981	0,0,0	0.4773,0.0000,0.0000,0.4980,0.4989	0.4981							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				0	217					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33475791	33475791	A	G	het	low_MQM;anno_omim	QUAL=7358;DP=535;AF=0.21;MQM=42;TRIO=HET,535,0.21,HET,613,0.37,HET,526,0.27	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*639T>C:		rs6884	0.0000	0.5495	554,81,22	0.5691,0.0000,0.0000,0.5271,0.5574	0.5611							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				25	206					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33475879	33475879	C	T	het	anno_omim	QUAL=9315;DP=581;AF=0.28;MQM=54;TRIO=HET,581,0.28,HET,398,0.41,HET,348,0.32	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*551G>A:		rs61800917	0.0000	0.5000	0,0,0	0.5000,0.0000,0.0000,0.5000,0.5000	0.4999							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				0	232					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33475967	33475967	G	A	het	low_MQM;anno_omim	QUAL=2822;DP=417;AF=0.23;MQM=47;TRIO=HET,417,0.23,HET,173,0.29,HET,193,0.24	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*463C>T:		rs74066437	0.0000	0.4888	0,0,0	0.0000,0.0000,0.0000,0.4935,0.4870	0.4963							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				0	220					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33475977	33475977	G	A	het	low_MQM;anno_omim	QUAL=692;DP=328;AF=0.12;MQM=40;TRIO=HET,328,0.12,HET,148,0.25,HET,158,0.17	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*453C>T:		rs115408325	0.0000	0.4714	0,0,0	0.0000,0.0000,0.0000,0.4758,0.4699	0.4939							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				0	170					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33475979	33475979	A	G	het	low_MQM;anno_omim	QUAL=692;DP=328;AF=0.12;MQM=40;TRIO=HET,328,0.12,HET,148,0.25,HET,158,0.17	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*451T>C:		rs4045165	0.0000	0.4669	0,0,0	0.0000,0.0000,0.0000,0.4722,0.4651	0.4922							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				0	170					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33475982	33475982	C	A	het	low_MQM;anno_omim	QUAL=692;DP=328;AF=0.12;MQM=40;TRIO=HET,328,0.12,HET,148,0.25,HET,158,0.17	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*448G>T:		rs114902220	0.0000	0.4632	0,0,0	0.0000,0.0000,0.0000,0.4661,0.4620	0.4910							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				0	169					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33476032	33476032	T	C	het	low_MQM;anno_omim	QUAL=247;DP=231;AF=0.11;MQM=35;TRIO=HET,231,0.11,HET,129,0.22,HET,155,0.15	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*398A>G:		rs77170021	0.0000	0.1585	0,0,0	0.0000,0.0000,0.0000,0.1829,0.1520	0.4901							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				0	138					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33476065	33476065	G	A	het	low_MQM;anno_omim	QUAL=1053;DP=324;AF=0.23;MQM=34;TRIO=HET,324,0.23,HET,114,0.20,HET,150,0.12	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*365C>T:		rs143947377	0.0000	0.4761	0,0,0	0.0000,0.0000,0.0000,0.4843,0.4734	0.4972							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				0	160					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33476074	33476074	A	T	het	low_MQM;anno_omim	QUAL=1142;DP=344;AF=0.23;MQM=34;TRIO=HET,344,0.23,HET,119,0.18,WT,156,0.10	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*356T>A:		rs199780633	0.0000	0.4727	0,0,0	0.0000,0.0000,0.0000,0.4796,0.4702	0.4969							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				0	167					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33476090	33476090	T	C	het	low_MQM;anno_omim	QUAL=1466;DP=395;AF=0.25;MQM=34;TRIO=HET,395,0.25,HET,119,0.16,HET,154,0.12	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*340A>G:,AK2:ENST00000548033:3'UTR:MODIFIER:exon6/6:c.*340A>G:		rs140167370	0.0000	0.4540	0,0,0	0.0000,0.0000,0.0000,0.4658,0.4507	0.4965							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				0	167					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33476143	33476143	G	A	het	low_MQM;anno_omim	QUAL=136;DP=259;AF=0.15;MQM=36;TRIO=HET,259,0.15,HET,86,0.14,HET,111,0.14	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*287C>T:,AK2:ENST00000548033:3'UTR:MODIFIER:exon6/6:c.*287C>T:		rs201412582	0.0000	0.0365	0,0,0	0.0307,0.0000,0.0000,0.0477,0.0328	0.4913							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				0	150					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33476224	33476225	AC	-	het	low_MQM;anno_omim	QUAL=1538;DP=219;AF=0.27;MQM=46;TRIO=HET,219,0.27,HET,71,0.27,HET,74,0.35	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*205_*206delGT:,AK2:ENST00000548033:3'UTR:MODIFIER:exon6/6:c.*205_*206delGT:		rs67829320	0.4665	0.4937	0,0,0	0.4869,0.4793,0.4863,0.4920,0.4973	0.4990							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				0	180					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33476239	33476239	T	C	het	low_MQM;anno_omim	QUAL=2629;DP=269;AF=0.30;MQM=48;TRIO=HET,269,0.30,HET,72,0.32,HET,81,0.38	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*191A>G:,AK2:ENST00000548033:3'UTR:MODIFIER:exon6/6:c.*191A>G:		rs74066438	0.0000	0.4945	0,0,0	0.4869,0.4839,0.4921,0.4931,0.4983	0.4994							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				0	193					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33476292	33476292	A	G	het	anno_omim	QUAL=4626;DP=270;AF=0.30;MQM=50;TRIO=HET,270,0.30,HET,136,0.49,HET,119,0.46	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*138T>C:,AK2:ENST00000548033:3'UTR:MODIFIER:exon6/6:c.*138T>C:		rs74066439	0.0000	0.4912	1,1,0	0.4874,0.4922,0.4931,0.4909,0.4939	0.4994							103020 [AK2 (confirmed) Reticular dysgenesis,267500];			COSN163035	1	204					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33476353	33476353	C	T	het	low_MQM;anno_omim	QUAL=2535;DP=235;AF=0.18;MQM=47;TRIO=HET,235,0.18,HET,155,0.41,HET,144,0.33	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*77G>A:,AK2:ENST00000548033:3'UTR:MODIFIER:exon6/6:c.*77G>A:		rs66599471	0.0000	0.3611	0,0,0	0.3624,0.3301,0.3539,0.3576,0.3918	0.4992							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				7	294					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33476385	33476385	C	G	het	low_MQM;anno_omim	QUAL=1365;DP=228;AF=0.20;MQM=47;TRIO=HET,228,0.20,HET,137,0.36,HET,136,0.26	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*45G>C:,AK2:ENST00000548033:3'UTR:MODIFIER:exon6/6:c.*45G>C:,AK2:ENST00000467905:3'UTR:MODIFIER:exon8/8:c.*94G>C:		rs76881767	0.0000	0.2172	0,0,0	0.2524,0.2010,0.2365,0.2256,0.1489	0.4957							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				8	271					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33476387	33476387	C	T	het	low_MQM;anno_omim	QUAL=1365;DP=228;AF=0.20;MQM=47;TRIO=HET,228,0.20,HET,137,0.36,HET,136,0.26	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*43G>A:,AK2:ENST00000548033:3'UTR:MODIFIER:exon6/6:c.*43G>A:,AK2:ENST00000467905:3'UTR:MODIFIER:exon8/8:c.*92G>A:		rs201842558	0.0000	0.2102	0,0,0	0.2457,0.1922,0.2258,0.2186,0.1455	0.4952							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				8	269					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33476396	33476396	G	A	het	low_MQM;anno_omim	QUAL=1717;DP=234;AF=0.20;MQM=47;TRIO=HET,234,0.20,HET,132,0.35,HET,137,0.23	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*34C>T:,AK2:ENST00000548033:3'UTR:MODIFIER:exon6/6:c.*34C>T:,AK2:ENST00000467905:3'UTR:MODIFIER:exon8/8:c.*83C>T:		rs79824855	0.0000	0.1762	0,0,0	0.2051,0.1644,0.1873,0.1827,0.1197	0.4891							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				7	282					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33476404	33476404	T	G	het	low_MQM;anno_omim	QUAL=1360;DP=221;AF=0.20;MQM=47;TRIO=HET,221,0.20,HET,127,0.31,HET,132,0.23	AK2,RP1-117O3.2	3'UTR	AK2:ENST00000373449:3'UTR:MODIFIER:exon7/7:c.*26A>C:,AK2:ENST00000548033:3'UTR:MODIFIER:exon6/6:c.*26A>C:,AK2:ENST00000467905:3'UTR:MODIFIER:exon8/8:c.*75A>C:		rs76230073	0.0000	0.1717	0,0,0	0.2003,0.1606,0.1852,0.1780,0.1168	0.4786							103020 [AK2 (confirmed) Reticular dysgenesis,267500];				8	260					AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33478931	33478931	G	C	het	low_MQM;pred_pathogenic;anno_omim	QUAL=1074;DP=678;AF=0.19;MQM=37;TRIO=HET,678,0.19,WT,477,0.04,WT,594,0.02	AK2,RP1-117O3.2	missense,3'UTR	AK2:ENST00000354858:missense:MODERATE:exon6/6:c.571C>G:p.His191Asp,AK2:ENST00000373449:missense:MODERATE:exon6/7:c.571C>G:p.His191Asp,AK2:ENST00000548033:missense:MODERATE:exon5/6:c.445C>G:p.His149Asp,AK2:ENST00000467905:missense:MODERATE:exon6/8:c.571C>G:p.His191Asp,AK2:ENST00000480134:3'UTR:MODIFIER:exon5/5:c.*74C>G:		rs80324279	0.0000	0.3397	0,0,0	0.3260,0.3648,0.3593,0.3506,0.2508	0.0366	9.8270	D,D,D,D	T	B,P,P,B	T,T,T,T	26.40	103020 [AK2 (confirmed) Reticular dysgenesis,267500];			COSM4143820, COSM4143819	1	357	2	[2] auto-classification 14.09.2017  			AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	33478959	33478959	C	G	het	low_MQM;pred_pathogenic;anno_omim	QUAL=1182;DP=650;AF=0.19;MQM=38;TRIO=HET,650,0.19,WT,425,0.04,WT,556,0.02	AK2,RP1-117O3.2	missense,3'UTR	AK2:ENST00000354858:missense:MODERATE:exon6/6:c.543G>C:p.Lys181Asn,AK2:ENST00000373449:missense:MODERATE:exon6/7:c.543G>C:p.Lys181Asn,AK2:ENST00000548033:missense:MODERATE:exon5/6:c.417G>C:p.Lys139Asn,AK2:ENST00000467905:missense:MODERATE:exon6/8:c.543G>C:p.Lys181Asn,AK2:ENST00000480134:3'UTR:MODIFIER:exon5/5:c.*46G>C:		rs72884305	0.0000	0.4088	0,0,0	0.3969,0.4487,0.4348,0.4246,0.2839	0.1175	-0.4040	D,D,D,D	T	B,B,B,B	T,T,T,T	23.60	103020 [AK2 (confirmed) Reticular dysgenesis,267500];			COSM4143821, COSM4143822	0	337	2	[2] auto-classification 14.09.2017  			AK2 (inh=AR pLI=0.01), RP1-117O3.2 (inh=n/a pLI=n/a)
chr1	39492080	39492080	G	T	het		QUAL=4687;DP=95;AF=0.52;MQM=60;TRIO=HET,95,0.52,HOM,91,1.00,HET,115,0.48	NDUFS5	splice_region&intron	NDUFS5:ENST00000372967:splice_region&intron:LOW:exon1/2:c.-3+10G>T:,NDUFS5:ENST00000372969:splice_region&intron:LOW:exon1/2:c.-3+6G>T:		rs1122472	0.5377	0.0000	0,0,0	0,0,0,0,0	0.7122											133	82	2	[2] auto-classification 14.09.2017  			NDUFS5 (inh=n/a pLI=0.10)
chr1	40539076	40539076	C	T	hom	anno_omim	QUAL=18386;DP=388;AF=1.00;MQM=59;TRIO=HOM,388,1.00,HET,208,0.39,HET,252,0.50	PPT1	3'UTR	PPT1:ENST00000433473:3'UTR:MODIFIER:exon9/9:c.*657G>A:		rs1126973	0.6673	0.0000	0,0,0	0,0,0,0,0	0.7068							600722 [PPT1 (confirmed) Ceroid lipofuscinosis,neuronal,1,256730];	RCV000407971.1 [benign]; 			122	90					PPT1 (inh=AR pLI=0.00)
chr1	40539203	40539203	-	TGAT	hom	anno_omim	QUAL=21578;DP=351;AF=0.99;MQM=59;TRIO=HOM,351,0.99,HET,365,0.45,HET,460,0.47	PPT1	3'UTR	PPT1:ENST00000433473:3'UTR:MODIFIER:exon9/9:c.*526_*529dupATCA:		rs3841663;rs397730033	0.6140	0.0000	0,0,0	0,0,0,0,0	0.6640							600722 [PPT1 (confirmed) Ceroid lipofuscinosis,neuronal,1,256730];	RCV000404464.1 [benign]; 			120	92					PPT1 (inh=AR pLI=0.00)
chr1	40539228	40539228	G	C	hom	anno_omim	QUAL=29600;DP=535;AF=1.00;MQM=59;TRIO=HOM,535,1.00,HET,425,0.46,HET,539,0.48	PPT1	3'UTR	PPT1:ENST00000433473:3'UTR:MODIFIER:exon9/9:c.*505C>G:		rs1126972	0.6607	0.0000	0,0,0	0,0,0,0,0	0.7023							600722 [PPT1 (confirmed) Ceroid lipofuscinosis,neuronal,1,256730];	RCV000308813.1 [benign]; 			122	90					PPT1 (inh=AR pLI=0.00)
chr1	40539448	40539448	A	C	hom	anno_omim	QUAL=39256;DP=867;AF=1.00;MQM=59;TRIO=HOM,867,1.00,HET,416,0.53,HET,464,0.45	PPT1	3'UTR	PPT1:ENST00000433473:3'UTR:MODIFIER:exon9/9:c.*285T>G:		rs1126970	0.6611	0.0000	0,0,0	0,0,0,0,0	0.7026							600722 [PPT1 (confirmed) Ceroid lipofuscinosis,neuronal,1,256730];	RCV000330027.1 [benign]; 			122	90					PPT1 (inh=AR pLI=0.00)
chr1	40539572	40539572	A	G	het	anno_omim	QUAL=7546;DP=344;AF=0.46;MQM=60;TRIO=HET,344,0.46,WT,237,0.00,HET,267,0.48	PPT1	3'UTR	PPT1:ENST00000433473:3'UTR:MODIFIER:exon9/9:c.*161T>C:,PPT1:ENST00000449045:3'UTR:MODIFIER:exon6/6:c.*161T>C:		rs11552578	0.1514	0.0000	0,0,0	0,0,0,0,0	0.1191							600722 [PPT1 (confirmed) Ceroid lipofuscinosis,neuronal,1,256730];	RCV000261946.1 [likely benign]; 			2	44					PPT1 (inh=AR pLI=0.00)
chr1	40557033	40557033	A	G	het	pred_pathogenic;anno_omim	QUAL=9320;DP=434;AF=0.44;MQM=59;TRIO=HET,434,0.44,WT,345,0.00,HET,350,0.48	PPT1	missense,intron	PPT1:ENST00000433473:missense:MODERATE:exon4/9:c.401T>C:p.Ile134Thr,PPT1:ENST00000449045:intron:MODIFIER:exon1/5:c.125-1849T>C:		rs1800205	0.0739	0.0667	410,111,0	0.0103,0.0375,0.1309,0.0500,0.1247	0.0665	0.5740	T,T,T,T	T	B,B	D,D,D,D	15.55	600722 [PPT1 (confirmed) Ceroid lipofuscinosis,neuronal,1,256730];	RCV000118047.4 [other]; RCV000306615.1 [likely benign]; 		COSM3751190	6	221	2	[2] auto-classification 14.09.2017  			PPT1 (inh=AR pLI=0.00)
chr1	40562993	40562993	T	C	hom	anno_omim	QUAL=5986;DP=36;AF=1.00;MQM=59;TRIO=HOM,36,1.00,HOM,62,1.00,HOM,101,1.00	PPT1	5'UTR	PPT1:ENST00000433473:5'UTR:MODIFIER:exon1/9:c.-83A>G:		rs6600313	0.8327	0.0000	0,0,0	0,0,0,0,0	0.8462							600722 [PPT1 (confirmed) Ceroid lipofuscinosis,neuronal,1,256730];	RCV000354321.1 [benign]; 			177	47					PPT1 (inh=AR pLI=0.00)
chr1	40563019	40563019	G	T	het	anno_omim	QUAL=1556;DP=32;AF=0.59;MQM=60;TRIO=HET,32,0.59,WT,53,0.02,HET,87,0.51	PPT1	5'UTR	PPT1:ENST00000433473:5'UTR:MODIFIER:exon1/9:c.-109C>A:		rs41301070	0.1138	0.0000	0,0,0	0,0,0,0,0	0.0937							600722 [PPT1 (confirmed) Ceroid lipofuscinosis,neuronal,1,256730];	RCV000259483.1 [likely benign]; 			2	21					PPT1 (inh=AR pLI=0.00)
chr1	43199024	43199024	C	T	het	anno_omim	QUAL=6613;DP=220;AF=0.50;MQM=59;TRIO=HET,220,0.50,WT,253,0.00,HET,338,0.51	CLDN19	3'UTR	CLDN19:ENST00000296387:3'UTR:MODIFIER:exon5/5:c.*1733G>A:,CLDN19:ENST00000539749:3'UTR:MODIFIER:exon3/3:c.*2409G>A:	AluSx1	rs112310775	0.1254	0.0000	0,0,0	0,0,0,0,0	0.1278							610036 [CLDN19 (confirmed) Hypomagnesemia 5,renal,with ocular involvement,248190];	RCV000380298.1 [likely benign]; 			5	45					CLDN19 (inh=AR pLI=0.18)
chr1	43199115	43199115	A	G	het	anno_omim	QUAL=10924;DP=412;AF=0.49;MQM=60;TRIO=HET,412,0.49,WT,354,0.00,HET,441,0.50	CLDN19	3'UTR	CLDN19:ENST00000296387:3'UTR:MODIFIER:exon5/5:c.*1642T>C:,CLDN19:ENST00000539749:3'UTR:MODIFIER:exon3/3:c.*2318T>C:		rs56345167	0.1907	0.0000	0,0,0	0,0,0,0,0	0.1888							610036 [CLDN19 (confirmed) Hypomagnesemia 5,renal,with ocular involvement,248190];	RCV000345414.1 [benign]; 			8	59					CLDN19 (inh=AR pLI=0.18)
chr1	43200526	43200526	T	C	het	anno_omim	QUAL=5078;DP=139;AF=0.49;MQM=59;TRIO=HET,139,0.49,HET,127,0.43,HET,142,0.51	CLDN19	3'UTR	CLDN19:ENST00000296387:3'UTR:MODIFIER:exon5/5:c.*231A>G:,CLDN19:ENST00000539749:3'UTR:MODIFIER:exon3/3:c.*907A>G:		rs912075	0.6068	0.0000	0,0,0	0,0,0,0,0	0.5875							610036 [CLDN19 (confirmed) Hypomagnesemia 5,renal,with ocular involvement,248190];	RCV000328599.1 [benign]; 			81	111					CLDN19 (inh=AR pLI=0.18)
chr1	43200855	43200855	G	A	het	anno_omim	QUAL=7353;DP=130;AF=0.53;MQM=59;TRIO=HET,130,0.53,HET,212,0.54,HET,254,0.46	CLDN19	3'UTR,intron	CLDN19:ENST00000539749:3'UTR:MODIFIER:exon3/3:c.*578C>T:,CLDN19:ENST00000372539:3'UTR:MODIFIER:exon4/4:c.*684C>T:,CLDN19:ENST00000296387:intron:MODIFIER:exon4/4:c.627-50C>T:		rs74885359	0.0387	0.0995	677,577,2	0.0257,0.0507,0.0000,0.1424,0.0407	0.1021							610036 [CLDN19 (confirmed) Hypomagnesemia 5,renal,with ocular involvement,248190];				40	418					CLDN19 (inh=AR pLI=0.18)
chr1	43201216	43201216	A	C	het	anno_omim	QUAL=10576;DP=197;AF=0.47;MQM=59;TRIO=HET,197,0.47,HET,286,0.49,HET,353,0.49	CLDN19	3'UTR,intron	CLDN19:ENST00000539749:3'UTR:MODIFIER:exon3/3:c.*217T>G:,CLDN19:ENST00000372539:3'UTR:MODIFIER:exon4/4:c.*323T>G:,CLDN19:ENST00000296387:intron:MODIFIER:exon4/4:c.626+333T>G:	L2b	rs12141833	0.5569	0.0000	0,0,0	0,0,0,0,0	0.5413							610036 [CLDN19 (confirmed) Hypomagnesemia 5,renal,with ocular involvement,248190];				50	74					CLDN19 (inh=AR pLI=0.18)
chr1	43201534	43201534	G	A	het	pred_pathogenic;anno_omim	QUAL=4072;DP=92;AF=0.47;MQM=59;TRIO=HET,92,0.47,WT,175,0.01,HET,243,0.56	CLDN19	missense,splice_region&intron,3'UTR	CLDN19:ENST00000539749:missense:MODERATE:exon3/3:c.556C>T:p.Arg186Cys,CLDN19:ENST00000296387:splice_region&intron:LOW:exon4/4:c.626+15C>T:,CLDN19:ENST00000372539:3'UTR:MODIFIER:exon4/4:c.*5C>T:		rs4660658	0.1905	0.2648	749,338,145	0.3086,0.4433,0.3793,0.2813,0.1476	0.1803	-1.1650	D	T	B	D	4.82	610036 [CLDN19 (confirmed) Hypomagnesemia 5,renal,with ocular involvement,248190];	RCV000401216.1 [benign]; 		COSM3746967	65	538	2	[2] auto-classification 14.09.2017  			CLDN19 (inh=AR pLI=0.18)
chr1	43212111	43212111	C	T	het	anno_omim	QUAL=9137;DP=306;AF=0.48;MQM=59;TRIO=HET,306,0.48,HET,181,0.54,HET,206,0.48	LEPRE1	3'UTR	LEPRE1:ENST00000236040:3'UTR:MODIFIER:exon14/14:c.*472G>A:,LEPRE1:ENST00000397054:3'UTR:MODIFIER:exon15/15:c.*393G>A:,LEPRE1:ENST00000296388:3'UTR:MODIFIER:exon15/15:c.*257G>A:		rs6882	0.6625	0.0000	0,0,0	0,0,0,0,0	0.6421							610339 [LEPRE1 (confirmed) Osteogenesis imperfecta,type VIII,610915];				100	107					P3H1 (inh=AR pLI=0.00)
chr1	43212431	43212431	A	G	hom	anno_omim	QUAL=23826;DP=237;AF=1.00;MQM=59;TRIO=HOM,237,1.00,HOM,214,1.00,HOM,347,1.00	LEPRE1	synonymous,3'UTR	LEPRE1:ENST00000296388:synonymous:LOW:exon15/15:c.2148T>C:p.Gly716Gly,LEPRE1:ENST00000236040:3'UTR:MODIFIER:exon14/14:c.*152T>C:,LEPRE1:ENST00000397054:3'UTR:MODIFIER:exon15/15:c.*73T>C:		rs4660662	1.0000	1.0000	14842,7042,1411	1.0000,1.0000,1.0000,0.9999,1.0000	1.0000							610339 [LEPRE1 (confirmed) Osteogenesis imperfecta,type VIII,610915];	RCV000174947.1 [likely benign]; 			2103	1	2	[2] auto-classification 14.09.2017  			P3H1 (inh=AR pLI=0.00)
chr1	43212869	43212869	A	T	het	pred_pathogenic;anno_omim	QUAL=2982;DP=114;AF=0.47;MQM=60;TRIO=HET,114,0.47,WT,74,0.00,HET,126,0.50	LEPRE1	missense,intron	LEPRE1:ENST00000236040:missense:MODERATE:exon14/14:c.2129T>A:p.Phe710Tyr,LEPRE1:ENST00000397054:intron:MODIFIER:exon14/14:c.2074+55T>A:,LEPRE1:ENST00000296388:intron:MODIFIER:exon14/14:c.2055+74T>A:		rs3738496	0.1210	0.1234	1074,441,34	0.0762,0.2151,0.2476,0.1147,0.0720	0.1300	-0.0100	D	T	B	T	9.96	610339 [LEPRE1 (confirmed) Osteogenesis imperfecta,type VIII,610915];				36	398	2	[2] auto-classification 14.09.2017  			P3H1 (inh=AR pLI=0.00)
chr1	43408966	43408966	G	A	het	anno_omim	QUAL=7602;DP=303;AF=0.46;MQM=60;TRIO=HET,303,0.46,HET,350,0.53,WT,490,0.00	SLC2A1	synonymous	SLC2A1:ENST00000426263:synonymous:LOW:exon2/10:c.45C>T:p.Ala15Ala,SLC2A1:ENST00000415851:synonymous:LOW:exon2/5:c.45C>T:p.Ala15Ala,SLC2A1:ENST00000372500:synonymous:LOW:exon2/4:c.45C>T:p.Ala15Ala		rs1385129	0.2404	0.2446	3400,1609,153	0.1812,0.3088,0.2890,0.2292,0.2699	0.2417							138140 [SLC2A1 (confirmed) GLUT1 deficiency syndrome 1,infantile onset,severe,606777|GLUT1 deficiency syndrome 2,childhood onset,612126|Epilepsy,idiopathic generalized,susceptibility to,12,614847|Dystonia 9,601042|Stomatin-deficient cryohydrocytosis with neurologic defects,608885];	RCV000081435.7 [benign]; RCV000311968.1 [benign]; RCV000366638.1 [benign]; 		COSM3751209, COSM3751207, COSM3751208	188	1187	2	[2] auto-classification 14.09.2017  			SLC2A1 (inh=AR+AD pLI=0.94)
chr1	44290530	44290530	A	G	het	anno_omim	QUAL=7859;DP=266;AF=0.46;MQM=60;TRIO=HET,266,0.46,HET,116,0.41,HOM,112,0.98	ST3GAL3	missense,intron	ST3GAL3:ENST00000262915:missense:MODERATE:exon5/13:c.382A>G:p.Thr128Ala,ST3GAL3:ENST00000351035:missense:MODERATE:exon4/12:c.289A>G:p.Thr97Ala,ST3GAL3:ENST00000372375:missense:MODERATE:exon5/13:c.337A>G:p.Thr113Ala,ST3GAL3:ENST00000361746:missense:MODERATE:exon4/12:c.382A>G:p.Thr128Ala,ST3GAL3:ENST00000372368:missense:MODERATE:exon4/12:c.337A>G:p.Thr113Ala,ST3GAL3:ENST00000372372:missense:MODERATE:exon3/11:c.289A>G:p.Thr97Ala,ST3GAL3:ENST00000330208:intron:MODIFIER:exon4/6:c.209+9925A>G:,ST3GAL3:ENST00000335430:intron:MODIFIER:exon3/9:c.161+9925A>G:,ST3GAL3:ENST00000353126:intron:MODIFIER:exon4/9:c.209+9925A>G:,ST3GAL3:ENST00000372374:intron:MODIFIER:exon4/10:c.209+9925A>G:,ST3GAL3:ENST00000372377:intron:MODIFIER:exon4/8:c.209+9925A>G:,ST3GAL3:ENST00000545417:intron:MODIFIER:exon4/6:c.254+9925A>G:,ST3GAL3:ENST00000361392:intron:MODIFIER:exon4/11:c.209+9925A>G:,ST3GAL3:ENST00000361400:intron:MODIFIER:exon3/10:c.161+9925A>G:,ST3GAL3:ENST00000347631:intron:MODIFIER:exon4/11:c.254+9925A>G:,ST3GAL3:ENST00000361812:intron:MODIFIER:exon3/5:c.254+9925A>G:,ST3GAL3:ENST00000372362:intron:MODIFIER:exon3/5:c.209+9925A>G:,ST3GAL3:ENST00000531451:intron:MODIFIER:exon2/4:c.161+9925A>G:,ST3GAL3:ENST00000332628:intron:MODIFIER:exon3/9:c.209+9925A>G:,ST3GAL3:ENST00000372365:intron:MODIFIER:exon3/7:c.209+9925A>G:,ST3GAL3:ENST00000372366:intron:MODIFIER:exon2/6:c.206+9925A>G:,ST3GAL3:ENST00000372367:intron:MODIFIER:exon2/6:c.206+9925A>G:,ST3GAL3:ENST00000372369:intron:MODIFIER:exon3/10:c.209+9925A>G:,ST3GAL3:ENST00000528371:intron:MODIFIER:exon2/6:c.161+9925A>G:,ST3GAL3:ENST00000531816:intron:MODIFIER:exon2/3:c.161+9925A>G:,ST3GAL3:ENST00000531993:intron:MODIFIER:exon2/7:c.161+9925A>G:,ST3GAL3:ENST00000533933:intron:MODIFIER:exon3/8:c.209+9925A>G:	MER5B	rs37458	0.2364	0.3476	3717,2596,394	0.3706,0.2934,0.1938,0.4137,0.1645	0.3187	-0.1510	T,T,T,T,T,T	T	B,B,B	T,T,T,T,T,T	0.01	606494 [ST3GAL3 (provisional) Mental retardation,autosomal recessive 12,611090|Epileptic encephalopathy,early infantile,15,615006];	RCV000118418.3 [other]; 		COSM3751230	214	905	2	[2] auto-classification 14.09.2017  			ST3GAL3 (inh=AR pLI=0.57)
chr1	44396196	44396196	A	G	het	anno_omim	QUAL=3247;DP=160;AF=0.44;MQM=59;TRIO=HET,160,0.44,WT,78,0.00,HET,120,0.49	ST3GAL3	3'UTR	ST3GAL3:ENST00000262915:3'UTR:MODIFIER:exon13/13:c.*303A>G:,ST3GAL3:ENST00000330208:3'UTR:MODIFIER:exon7/7:c.*322A>G:,ST3GAL3:ENST00000335430:3'UTR:MODIFIER:exon10/10:c.*509A>G:,ST3GAL3:ENST00000351035:3'UTR:MODIFIER:exon12/12:c.*303A>G:,ST3GAL3:ENST00000353126:3'UTR:MODIFIER:exon10/10:c.*303A>G:,ST3GAL3:ENST00000372374:3'UTR:MODIFIER:exon11/11:c.*303A>G:,ST3GAL3:ENST00000372375:3'UTR:MODIFIER:exon13/13:c.*303A>G:,ST3GAL3:ENST00000372377:3'UTR:MODIFIER:exon9/9:c.*628A>G:,ST3GAL3:ENST00000545417:3'UTR:MODIFIER:exon7/7:c.*322A>G:,ST3GAL3:ENST00000361392:3'UTR:MODIFIER:exon12/12:c.*303A>G:,ST3GAL3:ENST00000361400:3'UTR:MODIFIER:exon11/11:c.*303A>G:		rs12561948	0.0507	0.0000	0,0,0	0,0,0,0,0	0.0383							606494 [ST3GAL3 (provisional) Mental retardation,autosomal recessive 12,611090|Epileptic encephalopathy,early infantile,15,615006];				0	22					ST3GAL3 (inh=AR pLI=0.57)
chr1	44396646	44396646	C	G	het	anno_omim	QUAL=13577;DP=234;AF=0.49;MQM=59;TRIO=HET,234,0.49,HOM,222,1.00,HET,264,0.54	ST3GAL3	3'UTR	ST3GAL3:ENST00000262915:3'UTR:MODIFIER:exon13/13:c.*753C>G:,ST3GAL3:ENST00000330208:3'UTR:MODIFIER:exon7/7:c.*772C>G:,ST3GAL3:ENST00000335430:3'UTR:MODIFIER:exon10/10:c.*959C>G:,ST3GAL3:ENST00000351035:3'UTR:MODIFIER:exon12/12:c.*753C>G:,ST3GAL3:ENST00000353126:3'UTR:MODIFIER:exon10/10:c.*753C>G:,ST3GAL3:ENST00000372374:3'UTR:MODIFIER:exon11/11:c.*753C>G:,ST3GAL3:ENST00000372375:3'UTR:MODIFIER:exon13/13:c.*753C>G:,ST3GAL3:ENST00000372377:3'UTR:MODIFIER:exon9/9:c.*1078C>G:,ST3GAL3:ENST00000545417:3'UTR:MODIFIER:exon7/7:c.*772C>G:,ST3GAL3:ENST00000361392:3'UTR:MODIFIER:exon12/12:c.*753C>G:,ST3GAL3:ENST00000361400:3'UTR:MODIFIER:exon11/11:c.*753C>G:		rs6801	0.5188	0.0000	0,0,0	0,0,0,0,0	0.6083							606494 [ST3GAL3 (provisional) Mental retardation,autosomal recessive 12,611090|Epileptic encephalopathy,early infantile,15,615006];				125	97					ST3GAL3 (inh=AR pLI=0.57)
chr1	45285648	45285648	C	T	hom	anno_omim	QUAL=20148;DP=522;AF=0.99;MQM=59;TRIO=HOM,522,0.99,HET,168,0.54,HET,178,0.49	PTCH2,RNU5E-6P	3'UTR,non_coding_transcript_exon	PTCH2:ENST00000447098:3'UTR:MODIFIER:exon23/23:c.*713G>A:,RNU5E-6P:ENST00000365574:non_coding_transcript_exon:MODIFIER:exon1/1:n.22G>A:	U5	rs41269085	0.2290	0.0000	0,0,0	0,0,0,0,0	0.2268							603673 [PTCH2 (provisional) Medulloblastoma,somatic,155255|Basal cell carcinoma,somatic,605462|Basal cell nevus syndrome,109400];				9	41					PTCH2 (inh=AD pLI=0.00), RNU5E-6P (inh=n/a pLI=n/a)
chr1	45292866	45292866	G	A	hom	anno_omim	QUAL=9055;DP=168;AF=0.99;MQM=59;TRIO=HOM,168,0.99,HET,149,0.51,HET,208,0.50	PTCH2	synonymous	PTCH2:ENST00000372192:synonymous:LOW:exon16/22:c.2487C>T:p.Asp829Asp,PTCH2:ENST00000447098:synonymous:LOW:exon16/23:c.2487C>T:p.Asp829Asp		rs2295996	0.1478	0.1608	1683,926,42	0.0850,0.1727,0.2220,0.1651,0.1564	0.1622							603673 [PTCH2 (provisional) Medulloblastoma,somatic,155255|Basal cell carcinoma,somatic,605462|Basal cell nevus syndrome,109400];			COSM3751243	74	664	2	[2] auto-classification 14.09.2017  			PTCH2 (inh=AD pLI=0.00)
chr1	45293518	45293518	A	G	hom	anno_omim	QUAL=13200;DP=202;AF=1.00;MQM=59;TRIO=HOM,202,1.00,HET,269,0.48,HET,323,0.48	PTCH2	synonymous	PTCH2:ENST00000372192:synonymous:LOW:exon14/22:c.2055T>C:p.Ala685Ala,PTCH2:ENST00000447098:synonymous:LOW:exon14/23:c.2055T>C:p.Ala685Ala		rs7525308	0.4455	0.3846	9301,4018,1766	0.5870,0.4236,0.4844,0.3459,0.3498	0.4351							603673 [PTCH2 (provisional) Medulloblastoma,somatic,155255|Basal cell carcinoma,somatic,605462|Basal cell nevus syndrome,109400];			COSM3751244	291	1116	2	[2] auto-classification 14.09.2017  			PTCH2 (inh=AD pLI=0.00)
chr1	45340282	45340282	C	T	hom	anno_omim	QUAL=20673;DP=403;AF=1.00;MQM=60;TRIO=HOM,403,1.00,HET,252,0.48,HET,315,0.48	EIF2B3	3'UTR,intron	EIF2B3:ENST00000372183:3'UTR:MODIFIER:exon10/10:c.*31G>A:,EIF2B3:ENST00000360403:intron:MODIFIER:exon10/11:c.1202+68G>A:	HAL1	rs9988451	0.4517	0.4112	9682,4009,1747	0.5969,0.5668,0.4480,0.3657,0.3710	0.4364							606273 [EIF2B3 (provisional) Leukoencephalopathy with vanishing white matter,603896];				377	1355					EIF2B3 (inh=AR pLI=0.39)
chr1	45452227	45452227	G	C	hom	anno_omim	QUAL=6946;DP=130;AF=1.00;MQM=59;TRIO=HOM,130,1.00,HET,108,0.43,HET,187,0.43	EIF2B3	5'UTR	EIF2B3:ENST00000360403:5'UTR:MODIFIER:exon1/12:c.-72C>G:,EIF2B3:ENST00000372183:5'UTR:MODIFIER:exon1/10:c.-72C>G:		rs489676	0.4806	0.0000	0,0,0	0,0,0,0,0	0.4816							606273 [EIF2B3 (provisional) Leukoencephalopathy with vanishing white matter,603896];	RCV000343867.1 [benign]; 			50	90					EIF2B3 (inh=AR pLI=0.39)
chr1	46164846	46164846	A	T	hom		QUAL=21027;DP=306;AF=0.99;MQM=60;TRIO=HOM,306,0.99,HET,179,0.47,HOM,299,1.00	IPP	3'UTR	IPP:ENST00000396478:3'UTR:MODIFIER:exon9/9:c.*792T>A:		rs10749856	0.3249	0.0000	0,0,0	0,0,0,0,0	0.2857											26	102					IPP (inh=n/a pLI=0.00)
chr1	46195375	46195375	T	C	hom	pred_pathogenic	QUAL=10538;DP=231;AF=1.00;MQM=60;TRIO=HOM,231,1.00,HET,60,0.57,HOM,65,0.97	IPP	missense	IPP:ENST00000396478:missense:MODERATE:exon4/9:c.791A>G:p.Lys264Arg		rs28375469	0.3149	0.3041	5748,2867,309	0.2406,0.3380,0.3433,0.2933,0.3603	0.3038	7.6230	T,T	T	B,B	T,T	16.17				COSM146501, COSM3751253	197	677	2	[2] auto-classification 14.09.2017  			IPP (inh=n/a pLI=0.00)
chr1	46655158	46655158	T	C	hom	pred_pathogenic;anno_omim	QUAL=12742;DP=142;AF=0.99;MQM=59;TRIO=HOM,142,0.99,HOM,142,1.00,HOM,128,1.00	POMGNT1	missense&splice_region,missense,3'UTR	POMGNT1:ENST00000371986:missense&splice_region:MODERATE:exon21/23:c.1867A>G:p.Met623Val,POMGNT1:ENST00000371984:missense:MODERATE:exon21/22:c.1867A>G:p.Met623Val,POMGNT1:ENST00000371992:missense&splice_region:MODERATE:exon21/23:c.1867A>G:p.Met623Val,POMGNT1:ENST00000535522:missense:MODERATE:exon20/22:c.1801A>G:p.Met601Val,POMGNT1:ENST00000396420:3'UTR:MODIFIER:exon18/19:c.*1536A>G:		rs6659553	0.9425	0.9838	58446,33140,3478	0.8219,0.9926,1.0000,0.9997,0.9998	0.9872	5.7560	T,T,T,T	T	B,B,B	D,D,D,D	5.36	606822 [POMGNT1 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,3,253280|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,3,613151|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,3,613157|Retinitis pigmentosa 76,617123];	RCV000153758.3 [benign]; 			2098	2	2	[2] auto-classification 14.09.2017  			POMGNT1 (inh=AR pLI=0.00)
chr1	46660295	46660295	T	C	hom	pred_pathogenic;anno_omim	QUAL=17633;DP=264;AF=1.00;MQM=59;TRIO=HOM,264,1.00,HOM,199,0.99,HET,302,0.44	POMGNT1	missense,synonymous	POMGNT1:ENST00000396420:missense:MODERATE:exon7/19:c.563A>G:p.Asn188Ser,POMGNT1:ENST00000371986:synonymous:LOW:exon8/23:c.681A>G:p.Lys227Lys,POMGNT1:ENST00000371984:synonymous:LOW:exon8/22:c.681A>G:p.Lys227Lys,POMGNT1:ENST00000371992:synonymous:LOW:exon8/23:c.681A>G:p.Lys227Lys,POMGNT1:ENST00000535522:synonymous:LOW:exon7/22:c.615A>G:p.Lys205Lys		rs2292487	0.3335	0.3549	8093,4203,641	0.3476,0.3922,0.1471,0.3521,0.4422	0.3605	0.5750	D	T			6.38	606822 [POMGNT1 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,3,253280|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,3,613151|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,3,613157|Retinitis pigmentosa 76,617123];	RCV000081805.9 [other]; RCV000304915.1 [likely benign]; RCV000343385.1 [likely benign]; 		COSM3751255, COSM3751254	271	940	2	[2] auto-classification 14.09.2017  			POMGNT1 (inh=AR pLI=0.00)
chr1	47716041	47716042	AA	-	het	anno_omim	QUAL=5398;DP=257;AF=0.51;MQM=56;TRIO=HET,257,0.51,HET,175,0.51,WT,176,0.00	STIL	3'UTR	STIL:ENST00000371877:3'UTR:MODIFIER:exon17/17:c.*766_*767delTT:,STIL:ENST00000337817:3'UTR:MODIFIER:exon17/17:c.*766_*767delTT:,STIL:ENST00000360380:3'UTR:MODIFIER:exon18/18:c.*766_*767delTT:		rs398089260	0.3926	0.0000	0,0,0	0,0,0,0,0	0.4363							181590 [STIL (confirmed) Microcephaly 7,primary,autosomal recessive,612703];	RCV000312243.1 [benign]; 			73	118					STIL (inh=AR pLI=0.20)
chr1	47717189	47717189	A	G	het	anno_omim	QUAL=8355;DP=443;AF=0.50;MQM=59;TRIO=HET,443,0.50,HET,230,0.40,WT,306,0.01	STIL	synonymous	STIL:ENST00000371877:synonymous:LOW:exon17/17:c.3486T>C:p.Pro1162Pro,STIL:ENST00000337817:synonymous:LOW:exon17/17:c.3483T>C:p.Pro1161Pro,STIL:ENST00000360380:synonymous:LOW:exon18/18:c.3483T>C:p.Pro1161Pro,STIL:ENST00000243182:synonymous:LOW:exon17/17:c.3483T>C:p.Pro1161Pro,STIL:ENST00000396221:synonymous:LOW:exon17/17:c.3432T>C:p.Pro1144Pro		rs2758735	0.3934	0.4979	15897,9723,152	0.1617,0.4503,0.4494,0.5397,0.5336	0.5038							181590 [STIL (confirmed) Microcephaly 7,primary,autosomal recessive,612703];	RCV000080044.7 [benign]; RCV000265706.1 [benign]; 			590	1049	2	[2] auto-classification 14.09.2017  			STIL (inh=AR pLI=0.20)
chr1	47726087	47726087	T	C	het	anno_omim	QUAL=6435;DP=210;AF=0.51;MQM=60;TRIO=HET,210,0.51,HET,117,0.47,HET,176,0.47	STIL	missense	STIL:ENST00000371877:missense:MODERATE:exon16/17:c.2954A>G:p.His985Arg,STIL:ENST00000337817:missense:MODERATE:exon16/17:c.2951A>G:p.His984Arg,STIL:ENST00000360380:missense:MODERATE:exon17/18:c.2951A>G:p.His984Arg,STIL:ENST00000243182:missense:MODERATE:exon16/17:c.2951A>G:p.His984Arg,STIL:ENST00000396221:missense:MODERATE:exon16/17:c.2900A>G:p.His967Arg		rs13376679	0.1783	0.2421	4067,3002,232	0.2088,0.1315,0.0196,0.2979,0.2331	0.2479	0.0410	T,T,T,T,T	T	B,B,B	T,T,T,T,T	0.01	181590 [STIL (confirmed) Microcephaly 7,primary,autosomal recessive,612703];	RCV000080043.6 [benign]; RCV000279688.1 [likely benign]; 		COSM4144058	175	847	2	[2] auto-classification 14.09.2017  			STIL (inh=AR pLI=0.20)
chr1	47767914	47767914	G	A	het	pred_pathogenic;anno_omim	QUAL=13793;DP=245;AF=0.51;MQM=60;TRIO=HET,245,0.51,HET,186,0.54,HOM,259,0.99	STIL	missense	STIL:ENST00000371877:missense:MODERATE:exon4/17:c.257C>T:p.Ala86Val,STIL:ENST00000337817:missense:MODERATE:exon4/17:c.257C>T:p.Ala86Val,STIL:ENST00000360380:missense:MODERATE:exon5/18:c.257C>T:p.Ala86Val,STIL:ENST00000243182:missense:MODERATE:exon4/17:c.257C>T:p.Ala86Val,STIL:ENST00000396221:missense:MODERATE:exon4/17:c.257C>T:p.Ala86Val		rs3125630	0.6064	0.5035	16139,7072,3680	0.8402,0.5480,0.5500,0.4622,0.4674	0.5630	5.1820	T,T,T,T,T,T,T	T	B,B,B,B	T,T,T,T,T,T,T	9.33	181590 [STIL (confirmed) Microcephaly 7,primary,autosomal recessive,612703];	RCV000020526.1 [benign]; RCV000147687.2 [other]; RCV000262563.1 [benign]; 			469	1041	2	[2] auto-classification 14.09.2017  			STIL (inh=AR pLI=0.20)
chr1	51066088	51066088	T	C	het		QUAL=3510;DP=166;AF=0.43;MQM=60;TRIO=HET,166,0.43,HET,136,0.48,WT,172,0.00	FAF1	intron	FAF1:ENST00000371778:intron:MODIFIER:exon9/19:c.745-4200A>G:,FAF1:ENST00000396153:intron:MODIFIER:exon8/18:c.745-4200A>G:,FAF1:ENST00000545823:intron:MODIFIER:exon1/11:c.19-4200A>G:	Charlie1a	rs6679854	0.1695	0.0000	0,0,0	0,0,0,0,0	0.2071											12	66					FAF1 (inh=n/a pLI=1.00)
chr1	53676448	53676448	G	A	het	pred_pathogenic;anno_omim	QUAL=11045;DP=289;AF=0.53;MQM=59;TRIO=HET,289,0.53,WT,215,0.00,HOM,229,1.00	CPT2,RP5-1024G6.2	missense	CPT2:ENST00000371486:missense:MODERATE:exon4/5:c.1102G>A:p.Val368Ile		rs1799821	0.4131	0.4841	15346,9849,451	0.2836,0.4291,0.7326,0.5438,0.2609	0.4869	-0.0540	T	T	B	D	0.01	600650 [CPT2 (confirmed) CPT II deficiency,myopathic,stress-induced,255110|CPT II deficiency,infantile,600649|CPT II deficiency,lethal neonatal,608836|Encephalopathy,acute,infection-induced,4,susceptibility to,614212];	RCV000023026.3 [other]; RCV000078116.6 [benign]; RCV000202483.2 [benign]; 	CM139511 [CLASS=DP MUT=ALT PHEN="Infuenza infection-associated encephalopathy" GENE=CPT2]; 	COSM3751293	515	969	2	[2] old entry - no details available			CPT2 (inh=AR pLI=0.00), RP5-1024G6.2 (inh=n/a pLI=n/a)
chr1	53679229	53679229	A	G	het	pred_pathogenic;anno_omim	QUAL=6097;DP=270;AF=0.48;MQM=60;TRIO=HET,270,0.48,WT,179,0.00,HET,238,0.46	CPT2,RP5-1024G6.2	missense	CPT2:ENST00000371486:missense:MODERATE:exon5/5:c.1939A>G:p.Met647Val		rs1799822	0.1004	0.1620	1862,1554,9	0.0452,0.1211,0.0854,0.2154,0.1007	0.1638	7.4450	D	T	B	D	23.00	600650 [CPT2 (confirmed) CPT II deficiency,myopathic,stress-induced,255110|CPT II deficiency,infantile,600649|CPT II deficiency,lethal neonatal,608836|Encephalopathy,acute,infection-induced,4,susceptibility to,614212];	RCV000078120.6 [benign]; RCV000202533.2 [other]; 		COSM3751294	83	604	2	[2] auto-classification 14.09.2017  			CPT2 (inh=AR pLI=0.00), RP5-1024G6.2 (inh=n/a pLI=n/a)
chr1	55315351	55315351	T	C	hom	anno_omim	QUAL=17342;DP=256;AF=1.00;MQM=59;TRIO=HOM,256,1.00,HOM,129,1.00,HOM,158,1.00	DHCR24	3'UTR	DHCR24:ENST00000371269:3'UTR:MODIFIER:exon9/9:c.*2555A>G:		rs657688	0.9998	0.0000	0,0,0	0,0,0,0,0	0.9994							606418 [DHCR24 (confirmed) Desmosterolosis,602398];	RCV000322714.1 [benign]; 			232	0					DHCR24 (inh=AR pLI=0.97)
chr1	55315941	55315941	G	T	het	anno_omim	QUAL=10507;DP=447;AF=0.47;MQM=60;TRIO=HET,447,0.47,WT,318,0.00,HET,386,0.50	DHCR24	3'UTR	DHCR24:ENST00000371269:3'UTR:MODIFIER:exon9/9:c.*1965C>A:		rs11555500	0.0102	0.0000	0,0,0	0,0,0,0,0	0.0240							606418 [DHCR24 (confirmed) Desmosterolosis,602398];	RCV000349713.1 [likely benign]; 			0	12					DHCR24 (inh=AR pLI=0.97)
chr1	55316082	55316082	A	C	hom	anno_omim	QUAL=25133;DP=320;AF=1.00;MQM=59;TRIO=HOM,320,1.00,HOM,190,1.00,HOM,258,1.00	DHCR24	3'UTR	DHCR24:ENST00000371269:3'UTR:MODIFIER:exon9/9:c.*1824T>G:		rs654561	0.9832	0.0000	0,0,0	0,0,0,0,0	0.9905							606418 [DHCR24 (confirmed) Desmosterolosis,602398];	RCV000281973.1 [benign]; 			232	1					DHCR24 (inh=AR pLI=0.97)
chr1	55319902	55319902	A	G	hom	low_DP;anno_omim	QUAL=600;DP=7;AF=1.00;MQM=60;TRIO=HOM,7,1.00,HOM,3,1.00,HOM,9,1.00	DHCR24	synonymous	DHCR24:ENST00000371269:synonymous:LOW:exon7/9:c.1026T>C:p.Ile342Ile,DHCR24:ENST00000537443:synonymous:LOW:exon4/6:c.378T>C:p.Ile126Ile,DHCR24:ENST00000535035:synonymous:LOW:exon7/9:c.903T>C:p.Ile301Ile		rs718265	0.6276	0.6651	27364,15776,1954	0.6191,0.5178,0.3970,0.6892,0.8092	0.6710							606418 [DHCR24 (confirmed) Desmosterolosis,602398];	RCV000263910.1 [benign]; 		COSM4144102	956	902	2	[2] auto-classification 14.09.2017  			DHCR24 (inh=AR pLI=0.97)
chr1	55464743	55464743	T	C	hom	anno_omim	QUAL=35603;DP=348;AF=0.99;MQM=59;TRIO=HOM,348,0.99,HOM,531,1.00,HET,648,0.49	BSND	5'UTR	BSND:ENST00000371265:5'UTR:MODIFIER:exon1/4:c.-117T>C:		rs2500340	0.5941	0.0000	0,0,0	0,0,0,0,0	0.6594							606412 [BSND (provisional) Bartter syndrome,type 4a,602522|Sensorineural deafness with mild renal dysfunction,602522];	RCV000268082.1 [benign]; 			132	82					BSND (inh=AR pLI=0.00)
chr1	55464790	55464790	C	G	hom	anno_omim	QUAL=37360;DP=331;AF=0.99;MQM=60;TRIO=HOM,331,0.99,HOM,567,1.00,HET,758,0.48	BSND	5'UTR_premature_start_codon_gain,5'UTR	BSND:ENST00000371265:5'UTR_premature_start_codon_gain:LOW:exon1/4:c.-70C>G:,BSND:ENST00000371265:5'UTR:MODIFIER:exon1/4:c.-70C>G:		rs2500341	0.5950	0.0000	0,0,0	0,0,0,0,0	0.6602							606412 [BSND (provisional) Bartter syndrome,type 4a,602522|Sensorineural deafness with mild renal dysfunction,602522];	RCV000320898.1 [benign]; 			809	538	2	[2] auto-classification 14.09.2017  			BSND (inh=AR pLI=0.00)
chr1	55474325	55474325	A	C	het	anno_omim	QUAL=18420;DP=304;AF=0.54;MQM=59;TRIO=HET,304,0.54,WT,322,0.01,HOM,452,1.00	BSND	3'UTR	BSND:ENST00000371265:3'UTR:MODIFIER:exon4/4:c.*24A>C:		rs6682884	0.3624	0.3755	9028,5896,1215	0.4981,0.1877,0.2970,0.4197,0.2780	0.4333							606412 [BSND (provisional) Bartter syndrome,type 4a,602522|Sensorineural deafness with mild renal dysfunction,602522];	RCV000304051.1 [benign]; 			329	863					BSND (inh=AR pLI=0.00)
chr1	57340727	57340727	C	A	het	anno_omim	QUAL=5784;DP=135;AF=0.44;MQM=60;TRIO=HET,135,0.44,HOM,141,0.99,WT,210,0.00	C8A	missense	C8A:ENST00000361249:missense:MODERATE:exon3/11:c.277C>A:p.Gln93Lys		rs652785	0.3437	0.3684	8692,4750,225	0.2120,0.2106,0.4553,0.3787,0.4968	0.3654	0.1090	T	T	B	T	0.10	120950 [C8A (confirmed) C8 deficiency,type I,613790];	RCV000018567.2 [benign]; 			404	997	2	[2] auto-classification 14.09.2017  			C8A (inh=AR pLI=0.00)
chr1	57395020	57395020	A	G	het	anno_omim	QUAL=14134;DP=543;AF=0.51;MQM=60;TRIO=HET,543,0.51,HET,531,0.49,WT,781,0.00	C8B	3'UTR	C8B:ENST00000371237:3'UTR:MODIFIER:exon12/12:c.*57T>C:,C8B:ENST00000543257:3'UTR:MODIFIER:exon13/13:c.*57T>C:		rs2795	0.3672	0.0000	0,0,0	0,0,0,0,0	0.3182							120960 [C8B (confirmed) C8 deficiency,type II,613789];				250	503					C8B (inh=AR pLI=0.00)
chr1	57422484	57422484	C	T	hom	anno_omim	QUAL=26325;DP=298;AF=1.00;MQM=60;TRIO=HOM,298,1.00,HOM,249,1.00,HOM,266,1.00	C8B	missense	C8B:ENST00000371237:missense:MODERATE:exon3/12:c.349G>A:p.Gly117Arg,C8B:ENST00000543257:missense:MODERATE:exon4/13:c.193G>A:p.Gly65Arg,C8B:ENST00000535057:missense:MODERATE:exon4/13:c.163G>A:p.Gly55Arg		rs1013579	0.9864	0.9773	58006,31300,5137	0.9937,0.9774,0.9999,0.9683,0.9896	0.9785	0.5350	T,T,T	T	B,B	T,T,T	14.76	120960 [C8B (confirmed) C8 deficiency,type II,613789];				1980	119	2	[2] auto-classification 14.09.2017  			C8B (inh=AR pLI=0.00)
chr1	63881552	63881552	C	T	het	pred_pathogenic;anno_omim	QUAL=7428;DP=250;AF=0.57;MQM=60;TRIO=HET,250,0.57,HET,64,0.44,HOM,87,1.00	ALG6	missense	ALG6:ENST00000263440:missense:MODERATE:exon10/14:c.917C>T:p.Ser306Phe,ALG6:ENST00000371108:missense:MODERATE:exon11/15:c.911C>T:p.Ser304Phe		rs4630153	0.8305	0.7514	34408,15616,3808	0.8629,0.8338,0.8596,0.6875,0.8565	0.7527	0.9670	T,T	T	B	D,D	14.01	604566 [ALG6 (provisional) Congenital disorder of glycosylation,type Ic,603147];	RCV000081560.8 [other]; RCV000323730.1 [benign]; 			1785	1217	2	[2] Peter Bauer 25.08.2014			ALG6 (inh=AR pLI=0.06)
chr1	63903452	63903452	T	C	het	anno_omim	QUAL=2117;DP=96;AF=0.53;MQM=60;TRIO=HET,96,0.53,HET,14,0.57,HOM,21,1.00	ALG6	3'UTR	ALG6:ENST00000371108:3'UTR:MODIFIER:exon15/15:c.*761T>C:		rs3009572	0.6847	0.0000	0,0,0	0,0,0,0,0	0.5866							604566 [ALG6 (provisional) Congenital disorder of glycosylation,type Ic,603147];	RCV000401182.1 [benign]; 			68	110					ALG6 (inh=AR pLI=0.06)
chr1	67520060	67520061	CA	-	het	anno_omim	QUAL=458;DP=26;AF=0.46;MQM=59;TRIO=HET,26,0.46,HET,8,0.50,HOM,12,1.00	SLC35D1,C1orf141	intergenic_region	C1orf141:ENSG00000116704-ENSG00000203963:intergenic_region:MODIFIER::n.67520060_67520061delCA:		rs397707349;rs760658879	0.6562	0.0000	0,0,0	0,0,0,0,0	0.6041							610804 [SLC35D1 (confirmed) Schneckenbecken dysplasia,269250];				86	93					SLC35D1 (inh=AR pLI=0.00), C1orf141 (inh=n/a pLI=0.00)
chr1	67520083	67520083	C	T	het	low_DP;anno_omim	QUAL=238;DP=17;AF=0.71;MQM=59;TRIO=HET,17,0.71,HET,6,0.50,WT,7,0.00	SLC35D1,C1orf141	intergenic_region	C1orf141:ENSG00000116704-ENSG00000203963:intergenic_region:MODIFIER::n.67520083C>T:		rs3806321	0.1567	0.0000	0,0,0	0,0,0,0,0	0.1580							610804 [SLC35D1 (confirmed) Schneckenbecken dysplasia,269250];				10	39					SLC35D1 (inh=AR pLI=0.00), C1orf141 (inh=n/a pLI=0.00)
chr1	76190216	76190216	G	A	hom	low_DP;anno_omim	QUAL=2288;DP=17;AF=0.94;MQM=59;TRIO=HOM,17,0.94,HET,77,0.48,HET,108,0.45	ACADM	5'UTR	ACADM:ENST00000370841:5'UTR:MODIFIER:exon1/12:c.-257G>A:		rs17848068	0.2043	0.0000	0,0,0	0,0,0,0,0	0.2659							607008 [ACADM (provisional) Acyl-CoA dehydrogenase,medium chain,deficiency of,201450];	RCV000322244.1 [likely benign]; 			23	97					ACADM (inh=AR pLI=0.00)
chr1	92940411	92940411	C	T	het	anno_omim	QUAL=6192;DP=282;AF=0.55;MQM=60;TRIO=HET,282,0.55,WT,119,0.00,HET,164,0.49	GFI1	3'UTR	GFI1:ENST00000294702:3'UTR:MODIFIER:exon7/7:c.*1175G>A:,GFI1:ENST00000370332:3'UTR:MODIFIER:exon7/7:c.*1175G>A:,GFI1:ENST00000427103:3'UTR:MODIFIER:exon7/7:c.*1175G>A:		rs41313373	0.0673	0.0000	0,0,0	0,0,0,0,0	0.0925							600871 [GFI1 (confirmed) Neutropenia,severe congenital 2,autosomal dominant,613107|Neutropenia,nonimmune chronic idiopathic,of adults,607847];	RCV000343388.1 [benign]; 			1	61					GFI1 (inh=AD pLI=0.03)
chr1	92944315	92944320	AGAGAG	-	hom	anno_omim	QUAL=4081;DP=59;AF=0.73;MQM=59;TRIO=HOM,59,0.73,HOM,98,0.46,HOM,149,0.42	GFI1	splice_region&intron	GFI1:ENST00000294702:splice_region&intron:LOW:exon5/6:c.925-10_925-5delCTCTCT:,GFI1:ENST00000370332:splice_region&intron:LOW:exon5/6:c.925-10_925-5delCTCTCT:,GFI1:ENST00000427103:splice_region&intron:LOW:exon5/6:c.925-10_925-5delCTCTCT:	(AG)n	rs200902533	0.0000	0.1647	369,265,7	0.1057,0.1983,0.0351,0.1914,0.1215	0.1253							600871 [GFI1 (confirmed) Neutropenia,severe congenital 2,autosomal dominant,613107|Neutropenia,nonimmune chronic idiopathic,of adults,607847];	RCV000376604.1 [benign]; 			222	38	2	[2] auto-classification 14.09.2017  			GFI1 (inh=AD pLI=0.03)
chr1	92948938	92948938	C	T	het	pred_pathogenic;anno_omim	QUAL=3369;DP=105;AF=0.50;MQM=60;TRIO=HET,105,0.50,HET,267,0.45,WT,325,0.00	GFI1	missense	GFI1:ENST00000294702:missense:MODERATE:exon2/7:c.107G>A:p.Ser36Asn,GFI1:ENST00000370332:missense:MODERATE:exon2/7:c.107G>A:p.Ser36Asn,GFI1:ENST00000427103:missense:MODERATE:exon2/7:c.107G>A:p.Ser36Asn		rs34631763	0.0194	0.0445	118,99,1	0.0124,0.0277,0.0000,0.0647,0.0088	0.0426	4.3840	T,T,T	T	B	T,T,T	20.70	600871 [GFI1 (confirmed) Neutropenia,severe congenital 2,autosomal dominant,613107|Neutropenia,nonimmune chronic idiopathic,of adults,607847];	RCV000245181.1 [benign]; RCV000334859.1 [benign]; 		COSM3747114	6	154					GFI1 (inh=AD pLI=0.03)
chr1	97543752	97543752	G	A	het	anno_omim	QUAL=15965;DP=471;AF=0.48;MQM=60;TRIO=HET,471,0.48,HET,323,0.50,HET,438,0.48	DPYD	3'UTR	DPYD:ENST00000370192:3'UTR:MODIFIER:exon23/23:c.*780C>T:		rs291593	0.3850	0.0000	0,0,0	0,0,0,0,0	0.3020							612779 [DPYD (confirmed) Dihydropyrimidine dehydrogenase deficiency,274270|5-fluorouracil toxicity,274270];	RCV000086445.1 [not provided]; RCV000320911.1 [likely benign]; 			15	91					DPYD (inh=AR pLI=0.00)
chr1	97543764	97543764	C	T	het	anno_omim	QUAL=15424;DP=403;AF=0.49;MQM=60;TRIO=HET,403,0.49,HET,340,0.50,HET,463,0.47	DPYD	3'UTR	DPYD:ENST00000370192:3'UTR:MODIFIER:exon23/23:c.*768G>A:		rs291592	0.5775	0.0000	0,0,0	0,0,0,0,0	0.4496							612779 [DPYD (confirmed) Dihydropyrimidine dehydrogenase deficiency,274270|5-fluorouracil toxicity,274270];	RCV000086446.1 [not provided]; RCV000384818.1 [benign]; 			40	112					DPYD (inh=AR pLI=0.00)
chr1	97543959	97543959	C	T	het	anno_omim	QUAL=7018;DP=325;AF=0.53;MQM=60;TRIO=HET,325,0.53,HET,214,0.44,WT,287,0.00	DPYD	3'UTR	DPYD:ENST00000370192:3'UTR:MODIFIER:exon23/23:c.*573G>A:		rs1042482	0.0895	0.0000	0,0,0	0,0,0,0,0	0.0662							612779 [DPYD (confirmed) Dihydropyrimidine dehydrogenase deficiency,274270|5-fluorouracil toxicity,274270];	RCV000086448.1 [not provided]; RCV000381756.1 [likely benign]; 			2	25					DPYD (inh=AR pLI=0.00)
chr1	97915624	97915624	A	G	het	anno_omim	QUAL=4765;DP=205;AF=0.44;MQM=60;TRIO=HET,205,0.44,WT,150,0.00,HET,187,0.52	DPYD	synonymous	DPYD:ENST00000370192:synonymous:LOW:exon14/23:c.1896T>C:p.Phe632Phe		rs17376848	0.0521	0.0469	204,58,2	0.0222,0.0809,0.1263,0.0372,0.0360	0.0507							612779 [DPYD (confirmed) Dihydropyrimidine dehydrogenase deficiency,274270|5-fluorouracil toxicity,274270];	RCV000086470.1 [not provided]; RCV000244711.1 [benign]; RCV000270743.1 [likely benign]; 			4	165	2	[2] auto-classification 14.09.2017  			DPYD (inh=AR pLI=0.00)
chr1	98185527	98185527	A	G	hom	anno_omim	QUAL=15775;DP=206;AF=1.00;MQM=60;TRIO=HOM,206,1.00,HOM,123,1.00,HOM,150,1.00	DPYD	3'UTR,intron	DPYD:ENST00000306031:3'UTR:MODIFIER:exon6/6:c.*917T>C:,DPYD:ENST00000370192:intron:MODIFIER:exon5/22:c.483+1539T>C:,DPYD:ENST00000423006:intron:MODIFIER:exon4/6:c.372+1539T>C:		rs2151562	0.9978	0.0000	0,0,0	0,0,0,0,0	0.9951							612779 [DPYD (confirmed) Dihydropyrimidine dehydrogenase deficiency,274270|5-fluorouracil toxicity,274270];				232	0					DPYD (inh=AR pLI=0.00)
chr1	98186077	98186077	T	C	hom	anno_omim	QUAL=20084;DP=282;AF=1.00;MQM=60;TRIO=HOM,282,1.00,HOM,138,1.00,HOM,192,1.00	DPYD	3'UTR,intron	DPYD:ENST00000306031:3'UTR:MODIFIER:exon6/6:c.*367A>G:,DPYD:ENST00000370192:intron:MODIFIER:exon5/22:c.483+989A>G:,DPYD:ENST00000423006:intron:MODIFIER:exon4/6:c.372+989A>G:		rs1333718	0.9978	0.0000	0,0,0	0,0,0,0,0	0.9952							612779 [DPYD (confirmed) Dihydropyrimidine dehydrogenase deficiency,274270|5-fluorouracil toxicity,274270];				232	0					DPYD (inh=AR pLI=0.00)
chr1	98348885	98348885	G	A	hom	pred_pathogenic;anno_omim	QUAL=15099;DP=217;AF=1.00;MQM=60;TRIO=HOM,217,1.00,HOM,163,1.00,HET,217,0.52	DPYD	missense,intron	DPYD:ENST00000370192:missense:MODERATE:exon2/23:c.85C>T:p.Arg29Cys,DPYD:ENST00000306031:missense:MODERATE:exon2/6:c.85C>T:p.Arg29Cys,DPYD:ENST00000423006:intron:MODIFIER:exon1/6:c.39+37555C>T:		rs1801265	0.7398	0.7652	35865,20266,1770	0.5836,0.7928,0.9258,0.7788,0.7456	0.7709	2.2350	T,T	T	P	D,D	23.70	612779 [DPYD (confirmed) Dihydropyrimidine dehydrogenase deficiency,274270|5-fluorouracil toxicity,274270];	RCV000086506.1 [not provided]; 		COSM3735988, COSM3735989	1279	769	2	[2] old entry - no details available			DPYD (inh=AR pLI=0.00)
chr1	98460060	98460060	A	C	het		QUAL=2938;DP=159;AF=0.48;MQM=60;TRIO=HET,159,0.48,WT,63,0.00,HET,88,0.51	MIR137HG			AluSx		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000											0	2					MIR137HG (inh=n/a pLI=n/a)
chr1	98460106	98460106	G	A	hom		QUAL=9176;DP=171;AF=0.99;MQM=59;TRIO=HOM,171,0.99,HOM,87,1.00,HET,125,0.53	MIR137HG			AluSx	rs9440288	0.8552	0.0000	0,0,0	0,0,0,0,0	0.8330											106	44					MIR137HG (inh=n/a pLI=n/a)
chr1	98461132	98461132	G	C	hom		QUAL=22273;DP=266;AF=1.00;MQM=60;TRIO=HOM,266,1.00,HOM,282,1.00,HET,368,0.47	MIR137HG			L2a	rs9324380	0.9267	0.0000	0,0,0	0,0,0,0,0	0.9084											121	31					MIR137HG (inh=n/a pLI=n/a)
chr1	98461257	98461257	-	TTGT	hom		QUAL=16857;DP=239;AF=0.96;MQM=59;TRIO=HOM,239,0.96,HOM,212,0.99,HET,275,0.44	MIR137HG				rs10655213	0.8936	0.0000	0,0,0	0,0,0,0,0	0.8638											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98461443	98461443	C	T	het		QUAL=4939;DP=163;AF=0.52;MQM=60;TRIO=HET,163,0.52,HET,96,0.47,HET,103,0.52	MIR137HG				rs9662365	0.4657	0.0000	0,0,0	0,0,0,0,0	0.4793											32	87					MIR137HG (inh=n/a pLI=n/a)
chr1	98461954	98461954	T	C	hom		QUAL=5952;DP=151;AF=0.99;MQM=60;TRIO=HOM,151,0.99,HOM,26,1.00,HET,33,0.58	MIR137HG				rs1938570	0.8936	0.0000	0,0,0	0,0,0,0,0	0.8560											106	44					MIR137HG (inh=n/a pLI=n/a)
chr1	98462921	98462921	C	A	het		QUAL=5239;DP=253;AF=0.50;MQM=60;TRIO=HET,253,0.50,WT,157,0.00,HET,184,0.48	MIR137HG				rs146033831	0.0176	0.0000	0,0,0	0,0,0,0,0	0.0066											0	3					MIR137HG (inh=n/a pLI=n/a)
chr1	98465528	98465528	G	A	hom		QUAL=22761;DP=310;AF=1.00;MQM=60;TRIO=HOM,310,1.00,HOM,253,1.00,HET,336,0.50	MIR137HG				rs2154403	0.9034	0.0000	0,0,0	0,0,0,0,0	0.8739											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98465840	98465840	G	A	het		QUAL=5673;DP=284;AF=0.48;MQM=60;TRIO=HET,284,0.48,HET,226,0.42,WT,308,0.00	MIR137HG			L2a	rs116319667	0.0046	0.0000	0,0,0	0,0,0,0,0	0.0089											0	7					MIR137HG (inh=n/a pLI=n/a)
chr1	98468539	98468540	TA	-	hom		QUAL=16913;DP=330;AF=0.99;MQM=59;TRIO=HOM,330,0.99,HOM,145,1.00,HET,207,0.54	MIR137HG				rs775004417	0.8920	0.0000	0,0,0	0,0,0,0,0	0.8636											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98469687	98469687	A	-	het		QUAL=6817;DP=227;AF=0.47;MQM=59;TRIO=HET,227,0.47,WT,251,0.00,HET,318,0.50	MIR137HG				rs564190891	0.0036	0.0000	0,0,0	0,0,0,0,0	0.0017											0	2					MIR137HG (inh=n/a pLI=n/a)
chr1	98470051	98470051	-	AT	hom		QUAL=23926;DP=520;AF=0.99;MQM=59;TRIO=HOM,520,0.99,HOM,129,0.99,HET,233,0.48	MIR137HG				rs10655252;rs141251091	0.8636	0.0000	0,0,0	0,0,0,0,0	0.8389											107	43					MIR137HG (inh=n/a pLI=n/a)
chr1	98470605	98470605	A	G	hom		QUAL=6798;DP=179;AF=1.00;MQM=59;TRIO=HOM,179,1.00,HOM,20,1.00,HET,25,0.44	MIR137HG				rs10747495	0.9022	0.0000	0,0,0	0,0,0,0,0	0.8737											108	43					MIR137HG (inh=n/a pLI=n/a)
chr1	98472208	98472208	A	G	het		QUAL=2956;DP=167;AF=0.45;MQM=60;TRIO=HET,167,0.45,WT,75,0.00,HET,97,0.41	MIR137HG			(ATTAC)n	rs78878051	0.0633	0.0000	0,0,0	0,0,0,0,0	0.0176											0	3					MIR137HG (inh=n/a pLI=n/a)
chr1	98472879	98472879	C	T	hom		QUAL=20970;DP=327;AF=1.00;MQM=60;TRIO=HOM,327,1.00,HOM,193,1.00,HET,254,0.56	MIR137HG				rs1938564	0.8137	0.0000	0,0,0	0,0,0,0,0	0.7958											106	44					MIR137HG (inh=n/a pLI=n/a)
chr1	98472958	98472958	T	A	hom		QUAL=15823;DP=223;AF=1.00;MQM=60;TRIO=HOM,223,1.00,HOM,170,1.00,HET,183,0.55	MIR137HG				rs1938563	0.9014	0.0000	0,0,0	0,0,0,0,0	0.8727											108	41					MIR137HG (inh=n/a pLI=n/a)
chr1	98473716	98473716	T	A	hom		QUAL=18931;DP=397;AF=1.00;MQM=59;TRIO=HOM,397,1.00,HOM,117,1.00,HET,129,0.55	MIR137HG				rs1938562	0.9014	0.0000	0,0,0	0,0,0,0,0	0.8728											108	41					MIR137HG (inh=n/a pLI=n/a)
chr1	98474767	98474767	C	T	hom		QUAL=15240;DP=288;AF=1.00;MQM=60;TRIO=HOM,288,1.00,HOM,116,1.00,HET,162,0.49	MIR137HG				rs2391902	0.8247	0.0000	0,0,0	0,0,0,0,0	0.8029											106	44					MIR137HG (inh=n/a pLI=n/a)
chr1	98475522	98475522	T	C	hom		QUAL=16468;DP=309;AF=1.00;MQM=60;TRIO=HOM,309,1.00,HOM,118,1.00,HET,172,0.52	MIR137HG				rs2154402	0.9255	0.0000	0,0,0	0,0,0,0,0	0.9082											121	31					MIR137HG (inh=n/a pLI=n/a)
chr1	98475913	98475913	G	A	hom		QUAL=14309;DP=297;AF=1.00;MQM=60;TRIO=HOM,297,1.00,HOM,88,1.00,HET,127,0.54	MIR137HG				rs9324381	0.8606	0.0000	0,0,0	0,0,0,0,0	0.8381											106	44					MIR137HG (inh=n/a pLI=n/a)
chr1	98476718	98476718	G	A	hom		QUAL=26022;DP=420;AF=1.00;MQM=60;TRIO=HOM,420,1.00,HOM,219,1.00,HET,280,0.59	MIR137HG				rs1938561	0.9022	0.0000	0,0,0	0,0,0,0,0	0.8737											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98476950	98476950	T	C	hom		QUAL=25133;DP=337;AF=1.00;MQM=59;TRIO=HOM,337,1.00,HOM,268,1.00,HET,329,0.55	MIR137HG			L2c	rs9440293	0.9024	0.0000	0,0,0	0,0,0,0,0	0.8700											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98476958	98476958	C	T	hom		QUAL=25465;DP=344;AF=1.00;MQM=59;TRIO=HOM,344,1.00,HOM,269,1.00,HET,338,0.54	MIR137HG			L2c	rs9727941	0.8614	0.0000	0,0,0	0,0,0,0,0	0.8352											106	44					MIR137HG (inh=n/a pLI=n/a)
chr1	98476966	98476966	G	C	hom		QUAL=25209;DP=343;AF=1.00;MQM=59;TRIO=HOM,343,1.00,HOM,265,1.00,HET,342,0.55	MIR137HG			L2c	rs9724773	0.8614	0.0000	0,0,0	0,0,0,0,0	0.8351											106	44					MIR137HG (inh=n/a pLI=n/a)
chr1	98478159	98478159	-	AC	hom		QUAL=10804;DP=248;AF=0.87;MQM=59;TRIO=HOM,248,0.87,HOM,119,0.91,HET,167,0.49	MIR137HG			MIRb	rs112555829;rs397754812;rs58879433	0.7742	0.0000	0,0,0	0,0,0,0,0	0.7620											101	46					MIR137HG (inh=n/a pLI=n/a)
chr1	98478544	98478544	A	T	hom		QUAL=29696;DP=410;AF=1.00;MQM=59;TRIO=HOM,410,1.00,HOM,333,1.00,HET,453,0.48	MIR137HG			L2c	rs1938565	0.9024	0.0000	0,0,0	0,0,0,0,0	0.8737											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98478981	98478981	C	T	hom		QUAL=5344;DP=128;AF=1.00;MQM=60;TRIO=HOM,128,1.00,HOM,22,1.00,HET,28,0.43	MIR137HG				rs1938566	0.8247	0.0000	0,0,0	0,0,0,0,0	0.8032											106	44					MIR137HG (inh=n/a pLI=n/a)
chr1	98480128	98480128	T	C	hom		QUAL=22156;DP=410;AF=0.99;MQM=60;TRIO=HOM,410,0.99,HOM,195,1.00,HET,222,0.49	MIR137HG			MER102b	rs1938567	0.8772	0.0000	0,0,0	0,0,0,0,0	0.8533											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98480212	98480212	C	T	het		QUAL=7964;DP=430;AF=0.53;MQM=59;TRIO=HET,430,0.53,HET,148,0.50,WT,203,0.00	MIR137HG			MER102b	rs11165944	0.3331	0.0000	0,0,0	0,0,0,0,0	0.2968											16	73					MIR137HG (inh=n/a pLI=n/a)
chr1	98480332	98480332	G	A	hom		QUAL=190;DP=171;AF=0.27;MQM=52;TRIO=HOM,171,0.27,HOM,48,0.19,HOM,72,0.14	MIR137HG			A-rich		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0124											0	7					MIR137HG (inh=n/a pLI=n/a)
chr1	98480337	98480337	C	A	het		QUAL=423;DP=214;AF=0.30;MQM=52;TRIO=HET,214,0.30,WT,72,0.06,WT,113,0.10	MIR137HG			A-rich		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0047											0	2					MIR137HG (inh=n/a pLI=n/a)
chr1	98481750	98481750	C	T	het		QUAL=6511;DP=333;AF=0.45;MQM=60;TRIO=HET,333,0.45,HET,216,0.47,WT,299,0.01	MIR137HG				rs6683447	0.3187	0.0000	0,0,0	0,0,0,0,0	0.2736											15	64					MIR137HG (inh=n/a pLI=n/a)
chr1	98482580	98482580	G	A	hom		QUAL=14223;DP=269;AF=1.00;MQM=59;TRIO=HOM,269,1.00,HOM,105,1.00,HET,171,0.50	MIR137HG			L1MB1	rs2391903	0.9259	0.0000	0,0,0	0,0,0,0,0	0.9080											120	32					MIR137HG (inh=n/a pLI=n/a)
chr1	98482693	98482693	A	G	hom		QUAL=16846;DP=242;AF=1.00;MQM=60;TRIO=HOM,242,1.00,HOM,159,1.00,HET,246,0.54	MIR137HG			L1MB1	rs1892549	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8477											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98482828	98482828	A	G	hom		QUAL=15807;DP=302;AF=1.00;MQM=60;TRIO=HOM,302,1.00,HOM,122,1.00,HET,139,0.44	MIR137HG			L1MB1	rs1892550	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8479											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98482961	98482961	C	T	hom		QUAL=14130;DP=281;AF=1.00;MQM=60;TRIO=HOM,281,1.00,HOM,97,0.99,HET,134,0.45	MIR137HG			L1MB1	rs1892551	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8476											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98483035	98483035	G	A	hom		QUAL=9774;DP=215;AF=1.00;MQM=60;TRIO=HOM,215,1.00,HOM,54,1.00,HET,75,0.48	MIR137HG				rs1892552	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8483											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98483150	98483150	A	G	hom		QUAL=6153;DP=147;AF=1.00;MQM=60;TRIO=HOM,147,1.00,HOM,19,1.00,HET,34,0.62	MIR137HG				rs2391904	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8478											108	41					MIR137HG (inh=n/a pLI=n/a)
chr1	98483322	98483322	T	C	hom		QUAL=6597;DP=154;AF=1.00;MQM=60;TRIO=HOM,154,1.00,HOM,33,1.00,HET,49,0.31	MIR137HG				rs9324382	0.8692	0.0000	0,0,0	0,0,0,0,0	0.8468											105	45					MIR137HG (inh=n/a pLI=n/a)
chr1	98484152	98484152	T	C	hom		QUAL=7933;DP=167;AF=1.00;MQM=60;TRIO=HOM,167,1.00,HOM,53,1.00,HET,91,0.35	MIR137HG				rs1938571	0.8157	0.0000	0,0,0	0,0,0,0,0	0.7958											106	44					MIR137HG (inh=n/a pLI=n/a)
chr1	98484291	98484291	G	A	hom		QUAL=11171;DP=210;AF=1.00;MQM=60;TRIO=HOM,210,1.00,HOM,97,1.00,HET,108,0.36	MIR137HG				rs4447033	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8480											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98484474	98484474	T	C	hom		QUAL=3412;DP=60;AF=1.00;MQM=57;TRIO=HOM,60,1.00,HOM,40,1.00,HET,39,0.36	MIR137HG			AluSx1	rs1938572	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8478											108	43					MIR137HG (inh=n/a pLI=n/a)
chr1	98484617	98484617	C	T	hom		QUAL=3227;DP=80;AF=1.00;MQM=59;TRIO=HOM,80,1.00,HOM,12,1.00,HET,27,0.41	MIR137HG			AluSx1	rs1938573	0.8706	0.0000	0,0,0	0,0,0,0,0	0.8506											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98484954	98484954	G	T	hom		QUAL=19123;DP=335;AF=1.00;MQM=60;TRIO=HOM,335,1.00,HOM,157,1.00,HET,223,0.47	MIR137HG				rs1938558	0.8708	0.0000	0,0,0	0,0,0,0,0	0.8476											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98485102	98485102	G	A	hom		QUAL=13942;DP=249;AF=1.00;MQM=60;TRIO=HOM,249,1.00,HOM,128,1.00,HET,154,0.43	MIR137HG			MIR	rs1938559	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8477											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98485192	98485192	C	T	hom		QUAL=22238;DP=509;AF=1.00;MQM=60;TRIO=HOM,509,1.00,HOM,106,1.00,HET,138,0.43	MIR137HG			MIR	rs1938560	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8479											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98485573	98485573	C	T	hom		QUAL=8871;DP=148;AF=1.00;MQM=60;TRIO=HOM,148,1.00,HOM,88,1.00,HET,74,0.64	MIR137HG				rs9324383	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8482											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98485698	98485698	-	TTT	hom		QUAL=470;DP=25;AF=0.40;MQM=58;TRIO=HOM,25,0.40,HOM,1,1.00,WT,2,0.00	MIR137HG				rs10637296;rs10695922;rs34150565	0.8578	0.0000	0,0,0	0,0,0,0,0	0.7896											61	7					MIR137HG (inh=n/a pLI=n/a)
chr1	98485927	98485927	T	C	hom		QUAL=7083;DP=107;AF=1.00;MQM=57;TRIO=HOM,107,1.00,HOM,83,1.00,HET,108,0.44	MIR137HG			AluSx1	rs9725319	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8479											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98485991	98485991	C	T	het		QUAL=2548;DP=111;AF=0.38;MQM=59;TRIO=HET,111,0.38,WT,137,0.00,HET,160,0.44	MIR137HG			AluSx1	rs74829086	0.0527	0.0000	0,0,0	0,0,0,0,0	0.0141											0	3					MIR137HG (inh=n/a pLI=n/a)
chr1	98486162	98486162	T	C	hom		QUAL=7636;DP=152;AF=1.00;MQM=59;TRIO=HOM,152,1.00,HOM,66,1.00,HET,73,0.36	MIR137HG				rs4477335	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8478											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98486242	98486242	-	A	hom		QUAL=4611;DP=129;AF=0.95;MQM=59;TRIO=HOM,129,0.95,HOM,19,0.95,HET,23,0.43	MIR137HG				rs397709296	0.8678	0.0000	0,0,0	0,0,0,0,0	0.8477											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98486370	98486370	G	A	hom		QUAL=4995;DP=101;AF=1.00;MQM=60;TRIO=HOM,101,1.00,HOM,32,1.00,HET,42,0.48	MIR137HG				rs4480407	0.8928	0.0000	0,0,0	0,0,0,0,0	0.8650											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98487333	98487333	A	G	hom		QUAL=20750;DP=273;AF=1.00;MQM=60;TRIO=HOM,273,1.00,HOM,220,1.00,HET,282,0.57	MIR137HG				rs9659624	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8477											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98487510	98487510	C	A	hom		QUAL=20809;DP=390;AF=1.00;MQM=60;TRIO=HOM,390,1.00,HOM,163,1.00,HET,204,0.55	MIR137HG				rs5005705	0.8690	0.0000	0,0,0	0,0,0,0,0	0.8466											106	44					MIR137HG (inh=n/a pLI=n/a)
chr1	98487566	98487566	C	T	hom		QUAL=13847;DP=235;AF=1.00;MQM=60;TRIO=HOM,235,1.00,HOM,130,0.99,HET,144,0.53	MIR137HG				rs9324384	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8478											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98487763	98487763	G	A	hom		QUAL=18171;DP=309;AF=1.00;MQM=59;TRIO=HOM,309,1.00,HOM,165,0.99,HET,182,0.50	MIR137HG				rs4634961	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8480											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98487899	98487899	C	A	hom		QUAL=19922;DP=274;AF=1.00;MQM=60;TRIO=HOM,274,1.00,HOM,232,1.00,HET,262,0.52	MIR137HG				rs9324385	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8480											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98487959	98487959	G	A	hom		QUAL=26008;DP=377;AF=0.99;MQM=60;TRIO=HOM,377,0.99,HOM,265,1.00,HET,326,0.51	MIR137HG				rs9324386	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8481											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98488030	98488030	G	A	hom		QUAL=22558;DP=331;AF=1.00;MQM=60;TRIO=HOM,331,1.00,HOM,214,1.00,HET,332,0.50	MIR137HG				rs9324387	0.8712	0.0000	0,0,0	0,0,0,0,0	0.8476											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98488155	98488155	G	A	hom		QUAL=17795;DP=284;AF=1.00;MQM=60;TRIO=HOM,284,1.00,HOM,169,1.00,HET,197,0.46	MIR137HG				rs9324388	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8479											107	43					MIR137HG (inh=n/a pLI=n/a)
chr1	98488863	98488863	A	G	hom		QUAL=16835;DP=323;AF=1.00;MQM=60;TRIO=HOM,323,1.00,HOM,126,1.00,HET,131,0.64	MIR137HG				rs9659996	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8477											107	43					MIR137HG (inh=n/a pLI=n/a)
chr1	98488895	98488895	C	T	hom		QUAL=10423;DP=172;AF=1.00;MQM=60;TRIO=HOM,172,1.00,HOM,101,1.00,HET,92,0.58	MIR137HG				rs9658841	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8479											107	43					MIR137HG (inh=n/a pLI=n/a)
chr1	98489080	98489080	G	A	hom		QUAL=7306;DP=173;AF=1.00;MQM=60;TRIO=HOM,173,1.00,HOM,26,1.00,HET,38,0.61	MIR137HG				rs9661157	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8479											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98489277	98489277	-	TACTT	het		QUAL=6221;DP=138;AF=0.86;MQM=59;TRIO=HET,138,0.86,HOM,56,0.96,HET,88,0.34	MIR137HG				rs142603792;rs71071680	0.8708	0.0000	0,0,0	0,0,0,0,0	0.8462											100	52					MIR137HG (inh=n/a pLI=n/a)
chr1	98489330	98489330	C	T	hom		QUAL=9465;DP=220;AF=1.00;MQM=59;TRIO=HOM,220,1.00,HOM,52,1.00,HET,81,0.31	MIR137HG				rs10747496	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8481											107	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98489478	98489478	A	G	hom		QUAL=19540;DP=402;AF=1.00;MQM=60;TRIO=HOM,402,1.00,HOM,125,1.00,HET,163,0.42	MIR137HG				rs4584446	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8476											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98489735	98489735	T	C	hom		QUAL=14574;DP=328;AF=1.00;MQM=60;TRIO=HOM,328,1.00,HOM,57,1.00,HET,130,0.51	MIR137HG				rs2391905	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8477											109	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98490012	98490013	TT	-	hom		QUAL=10563;DP=299;AF=0.92;MQM=59;TRIO=HOM,299,0.92,HOM,78,0.95,HET,95,0.54	MIR137HG			L2a	rs55633609;rs58960152	0.8706	0.0000	0,0,0	0,0,0,0,0	0.8392											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98490165	98490165	C	T	hom		QUAL=8589;DP=179;AF=1.00;MQM=60;TRIO=HOM,179,1.00,HOM,46,1.00,HET,73,0.44	MIR137HG				rs4950117	0.8940	0.0000	0,0,0	0,0,0,0,0	0.8657											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98490358	98490358	G	T	hom		QUAL=16004;DP=258;AF=1.00;MQM=60;TRIO=HOM,258,1.00,HOM,155,0.99,HET,168,0.51	MIR137HG				rs4950118	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8473											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98490636	98490636	T	C	hom		QUAL=18224;DP=371;AF=0.99;MQM=59;TRIO=HOM,371,0.99,HOM,121,1.00,HET,172,0.48	MIR137HG				rs10783082	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8478											108	41					MIR137HG (inh=n/a pLI=n/a)
chr1	98490770	98490770	-	TTAAGTAT	hom		QUAL=16756;DP=229;AF=0.98;MQM=59;TRIO=HOM,229,0.98,HOM,155,0.99,HET,151,0.56	MIR137HG				rs397733292	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8429											108	41					MIR137HG (inh=n/a pLI=n/a)
chr1	98491248	98491248	A	C	hom		QUAL=18353;DP=339;AF=0.99;MQM=59;TRIO=HOM,339,0.99,HOM,140,1.00,HET,192,0.45	MIR137HG			MIR3	rs4950119	0.8682	0.0000	0,0,0	0,0,0,0,0	0.8351											98	51					MIR137HG (inh=n/a pLI=n/a)
chr1	98491382	98491382	G	A	hom		QUAL=14533;DP=270;AF=1.00;MQM=60;TRIO=HOM,270,1.00,HOM,105,1.00,HET,175,0.44	MIR137HG			MIRb	rs4950120	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8478											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98491473	98491473	A	C	hom		QUAL=17739;DP=353;AF=1.00;MQM=60;TRIO=HOM,353,1.00,HOM,116,0.99,HET,173,0.50	MIR137HG			MIRb	rs4245673	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8475											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98491732	98491732	T	C	hom		QUAL=18299;DP=251;AF=1.00;MQM=60;TRIO=HOM,251,1.00,HOM,193,1.00,HET,287,0.49	MIR137HG				rs1938568	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8475											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98492462	98492462	C	T	hom		QUAL=22574;DP=421;AF=1.00;MQM=60;TRIO=HOM,421,1.00,HOM,185,0.99,HET,198,0.46	MIR137HG				rs9440393	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8477											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98492580	98492580	A	G	het		QUAL=13352;DP=471;AF=0.49;MQM=60;TRIO=HET,471,0.49,HET,263,0.48,HET,285,0.50	MIR137HG				rs9440302	0.4575	0.0000	0,0,0	0,0,0,0,0	0.4746											32	87					MIR137HG (inh=n/a pLI=n/a)
chr1	98492854	98492854	T	C	hom		QUAL=16862;DP=356;AF=1.00;MQM=60;TRIO=HOM,356,1.00,HOM,95,1.00,HET,113,0.50	MIR137HG				rs9324389	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8479											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98493263	98493263	A	G	hom		QUAL=13426;DP=217;AF=1.00;MQM=60;TRIO=HOM,217,1.00,HOM,124,1.00,HET,187,0.45	MIR137HG				rs1938569	0.8706	0.0000	0,0,0	0,0,0,0,0	0.8476											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98493785	98493785	G	A	hom		QUAL=3173;DP=63;AF=0.98;MQM=60;TRIO=HOM,63,0.98,HOM,11,1.00,HET,14,0.36	MIR137HG				rs2022864	0.8712	0.0000	0,0,0	0,0,0,0,0	0.8483											108	37					MIR137HG (inh=n/a pLI=n/a)
chr1	98493789	98493789	A	G	hom		QUAL=3173;DP=63;AF=0.98;MQM=60;TRIO=HOM,63,0.98,HOM,11,1.00,HET,14,0.36	MIR137HG				rs2022865	0.8712	0.0000	0,0,0	0,0,0,0,0	0.8478											107	38					MIR137HG (inh=n/a pLI=n/a)
chr1	98494185	98494185	G	A	hom		QUAL=12898;DP=217;AF=0.99;MQM=60;TRIO=HOM,217,0.99,HOM,104,0.99,HET,153,0.55	MIR137HG				rs10875124	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8472											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98494200	98494200	A	C	hom		QUAL=12349;DP=218;AF=1.00;MQM=60;TRIO=HOM,218,1.00,HOM,97,0.99,HET,140,0.53	MIR137HG				rs10875125	0.8710	0.0000	0,0,0	0,0,0,0,0	0.8470											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98494388	98494388	-	A	hom		QUAL=7544;DP=186;AF=0.92;MQM=60;TRIO=HOM,186,0.92,HOM,48,1.00,HET,83,0.43	MIR137HG				rs869272703	0.8700	0.0000	0,0,0	0,0,0,0,0	0.8477											105	45					MIR137HG (inh=n/a pLI=n/a)
chr1	98494606	98494606	A	G	hom		QUAL=14526;DP=242;AF=1.00;MQM=60;TRIO=HOM,242,1.00,HOM,132,1.00,HET,151,0.44	MIR137HG				rs1198574	0.8712	0.0000	0,0,0	0,0,0,0,0	0.8475											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98495513	98495513	T	C	hom		QUAL=10041;DP=153;AF=1.00;MQM=60;TRIO=HOM,153,1.00,HOM,95,1.00,HET,129,0.54	MIR137HG				rs1198573	0.8708	0.0000	0,0,0	0,0,0,0,0	0.8477											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98496512	98496512	T	-	het		QUAL=3674;DP=218;AF=0.50;MQM=60;TRIO=HET,218,0.50,HET,105,0.60,WT,145,0.03	MIR137HG				rs377025796	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0117											0	6					MIR137HG (inh=n/a pLI=n/a)
chr1	98497176	98497176	A	C	hom		QUAL=6040;DP=157;AF=1.00;MQM=60;TRIO=HOM,157,1.00,HOM,16,1.00,HET,15,0.67	MIR137HG				rs1198572	0.8441	0.0000	0,0,0	0,0,0,0,0	0.8175											96	51					MIR137HG (inh=n/a pLI=n/a)
chr1	98497355	98497355	A	G	het		QUAL=773;DP=54;AF=0.50;MQM=58;TRIO=HET,54,0.50,HET,14,0.57,WT,10,0.00	MIR137HG				rs188465986	0.0022	0.0000	0,0,0	0,0,0,0,0	0.0075											0	5					MIR137HG (inh=n/a pLI=n/a)
chr1	98497672	98497672	A	G	hom		QUAL=4984;DP=120;AF=1.00;MQM=60;TRIO=HOM,120,1.00,HOM,21,1.00,HET,35,0.37	MIR137HG				rs1198571	0.8706	0.0000	0,0,0	0,0,0,0,0	0.8475											108	41					MIR137HG (inh=n/a pLI=n/a)
chr1	98498898	98498898	C	A	hom		QUAL=24030;DP=426;AF=1.00;MQM=60;TRIO=HOM,426,1.00,HOM,190,1.00,HET,268,0.47	MIR137HG				rs1782815	0.8686	0.0000	0,0,0	0,0,0,0,0	0.8468											106	44					MIR137HG (inh=n/a pLI=n/a)
chr1	98499590	98499590	A	-	het		QUAL=1528;DP=84;AF=0.57;MQM=58;TRIO=HET,84,0.57,WT,30,0.00,HET,34,0.50	MIR137HG			(AGAA)n	rs143336786	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0301											0	8					MIR137HG (inh=n/a pLI=n/a)
chr1	98499647	98499647	G	A	het		QUAL=359;DP=69;AF=0.26;MQM=53;TRIO=HET,69,0.26,HET,17,0.18,HET,14,0.21	MIR137HG			(AGAA)n	rs12405733	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1516											2	78					MIR137HG (inh=n/a pLI=n/a)
chr1	98499651	98499651	G	A	het		QUAL=495;DP=80;AF=0.25;MQM=52;TRIO=HET,80,0.25,HET,18,0.44,HET,14,0.21	MIR137HG			(AGAA)n	rs1782814	0.0000	0.0000	0,0,0	0,0,0,0,0	0.2235											1	55					MIR137HG (inh=n/a pLI=n/a)
chr1	98499659	98499659	G	A	het		QUAL=1926;DP=64;AF=0.80;MQM=55;TRIO=HET,64,0.80,HET,16,0.63,HET,13,0.15	MIR137HG			(AGAA)n	rs58126792	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1114											4	104					MIR137HG (inh=n/a pLI=n/a)
chr1	98499663	98499663	A	G	het		QUAL=1926;DP=64;AF=0.80;MQM=55;TRIO=HET,64,0.80,HET,16,0.63,HET,13,0.15	MIR137HG			(AGAA)n	rs60475427	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0839											7	97					MIR137HG (inh=n/a pLI=n/a)
chr1	98499843	98499843	T	C	hom		QUAL=10102;DP=168;AF=0.99;MQM=60;TRIO=HOM,168,0.99,HOM,95,1.00,HET,159,0.47	MIR137HG				rs1782813	0.8890	0.0000	0,0,0	0,0,0,0,0	0.8588											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98500045	98500045	G	C	het		QUAL=6848;DP=389;AF=0.50;MQM=60;TRIO=HET,389,0.50,HET,133,0.44,WT,168,0.01	MIR137HG			UCON1	rs7554283	0.3195	0.0000	0,0,0	0,0,0,0,0	0.2740											15	64					MIR137HG (inh=n/a pLI=n/a)
chr1	98501011	98501011	T	C	het		QUAL=7047;DP=317;AF=0.49;MQM=60;TRIO=HET,317,0.49,HET,201,0.53,WT,249,0.00	MIR137HG				rs4950101	0.2772	0.0000	0,0,0	0,0,0,0,0	0.2410											13	61					MIR137HG (inh=n/a pLI=n/a)
chr1	98501984	98501984	T	C	hom		QUAL=13773;DP=276;AF=0.99;MQM=60;TRIO=HOM,276,0.99,HOM,84,0.99,HET,106,0.59	MIR137HG				rs1702294	0.8401	0.0000	0,0,0	0,0,0,0,0	0.8111											97	53					MIR137HG (inh=n/a pLI=n/a)
chr1	98502159	98502159	G	C	hom		QUAL=29026;DP=321;AF=1.00;MQM=59;TRIO=HOM,321,1.00,HOM,361,1.00,HET,439,0.51	MIR137HG			Tigger3a	rs1702293	0.9257	0.0000	0,0,0	0,0,0,0,0	0.9081											122	31					MIR137HG (inh=n/a pLI=n/a)
chr1	98502340	98502340	G	A	hom		QUAL=18817;DP=241;AF=1.00;MQM=59;TRIO=HOM,241,1.00,HOM,231,1.00,HET,244,0.48	MIR137HG			Tigger3a	rs1782810	0.7967	0.0000	0,0,0	0,0,0,0,0	0.7716											94	55					MIR137HG (inh=n/a pLI=n/a)
chr1	98502410	98502410	A	C	hom		QUAL=21509;DP=277;AF=1.00;MQM=60;TRIO=HOM,277,1.00,HOM,249,1.00,HET,297,0.51	MIR137HG			Tigger3a	rs1782811	0.9026	0.0000	0,0,0	0,0,0,0,0	0.8734											108	42					MIR137HG (inh=n/a pLI=n/a)
chr1	98502594	98502594	A	C	hom		QUAL=17993;DP=242;AF=1.00;MQM=59;TRIO=HOM,242,1.00,HOM,208,1.00,HET,271,0.49	MIR137HG				rs1628294	0.9257	0.0000	0,0,0	0,0,0,0,0	0.9081											121	31					MIR137HG (inh=n/a pLI=n/a)
chr1	98502934	98502934	G	T	hom		QUAL=10727;DP=213;AF=1.00;MQM=60;TRIO=HOM,213,1.00,HOM,73,1.00,HET,107,0.37	MIR137HG				rs1625579	0.7969	0.0000	0,0,0	0,0,0,0,0	0.7714											96	53					MIR137HG (inh=n/a pLI=n/a)
chr1	98506616	98506616	-	TTCATTCA	hom		QUAL=1348;DP=80;AF=0.45;MQM=59;TRIO=HOM,80,0.45,WT,20,0.60,HET,37,0.49	MIR137HG				rs35835879	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1485											10	17					MIR137HG (inh=n/a pLI=n/a)
chr1	98507696	98507696	A	G	hom		QUAL=6043;DP=154;AF=0.99;MQM=60;TRIO=HOM,154,0.99,HOM,15,1.00,HET,35,0.43	MIR137HG				rs4292998	0.8129	0.0000	0,0,0	0,0,0,0,0	0.7826											96	52					MIR137HG (inh=n/a pLI=n/a)
chr1	98507718	98507718	C	A	hom		QUAL=7191;DP=184;AF=0.99;MQM=60;TRIO=HOM,184,0.99,HOM,18,1.00,HET,38,0.45	MIR137HG				rs4411173	0.8896	0.0000	0,0,0	0,0,0,0,0	0.8586											108	41					MIR137HG (inh=n/a pLI=n/a)
chr1	98508258	98508258	C	T	hom		QUAL=39483;DP=578;AF=1.00;MQM=59;TRIO=HOM,578,1.00,HOM,412,1.00,HET,500,0.52	MIR137HG				rs2802535	0.8097	0.0000	0,0,0	0,0,0,0,0	0.7813											96	53					MIR137HG (inh=n/a pLI=n/a)
chr1	98508488	98508488	G	A	het		QUAL=8642;DP=419;AF=0.50;MQM=60;TRIO=HET,419,0.50,WT,173,0.00,HET,196,0.56	MIR137HG				rs78924727	0.0527	0.0000	0,0,0	0,0,0,0,0	0.0140											0	3					MIR137HG (inh=n/a pLI=n/a)
chr1	98512127	98512127	G	T	hom		QUAL=32994;DP=411;AF=1.00;MQM=59;TRIO=HOM,411,1.00,HOM,412,1.00,HET,497,0.47	MIR137HG				rs2660304	0.8468	0.0000	0,0,0	0,0,0,0,0	0.8166											97	52					MIR137HG (inh=n/a pLI=n/a)
chr1	98513144	98513144	T	A	hom		QUAL=13152;DP=231;AF=1.00;MQM=60;TRIO=HOM,231,1.00,HOM,116,1.00,HET,133,0.53	MIR137HG				rs2660303	0.9259	0.0000	0,0,0	0,0,0,0,0	0.9070											121	31					MIR137HG (inh=n/a pLI=n/a)
chr1	98513676	98513676	-	CGCA	hom		QUAL=3176;DP=48;AF=0.06;MQM=57;TRIO=HOM,48,0.06,HOM,15,0.07,HOM,84,0.01	MIR137HG				rs150117500	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000											1	1					MIR137HG (inh=n/a pLI=n/a)
chr1	98513712	98513712	-	CACACACC	hom		QUAL=3176;DP=48;AF=0.06;MQM=57;TRIO=HOM,48,0.06,HOM,15,0.07,HOM,84,0.01	MIR137HG			(CA)n		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0183											0	0					MIR137HG (inh=n/a pLI=n/a)
chr1	98513845	98513845	G	A	hom		QUAL=13347;DP=150;AF=1.00;MQM=59;TRIO=HOM,150,1.00,HOM,186,0.99,HET,260,0.47	MIR137HG				rs61786696	0.9263	0.0000	0,0,0	0,0,0,0,0	0.9081											121	31					MIR137HG (inh=n/a pLI=n/a)
chr1	98513959	98513959	A	G	hom		QUAL=18117;DP=248;AF=1.00;MQM=59;TRIO=HOM,248,1.00,HOM,210,1.00,HET,277,0.49	MIR137HG				rs61786697	0.9261	0.0000	0,0,0	0,0,0,0,0	0.9080											121	31					MIR137HG (inh=n/a pLI=n/a)
chr1	100327026	100327026	C	T	het	anno_omim	QUAL=12699;DP=436;AF=0.53;MQM=60;TRIO=HET,436,0.53,HET,201,0.48,HET,300,0.46	AGL	5'UTR_premature_start_codon_gain,5'UTR,intron	AGL:ENST00000361522:5'UTR_premature_start_codon_gain:LOW:exon1/32:c.-2C>T:,AGL:ENST00000361522:5'UTR:MODIFIER:exon1/32:c.-2C>T:,AGL:ENST00000294724:intron:MODIFIER:exon2/33:c.83-33C>T:,AGL:ENST00000361915:intron:MODIFIER:exon2/33:c.83-33C>T:,AGL:ENST00000370163:intron:MODIFIER:exon2/33:c.83-33C>T:,AGL:ENST00000370165:intron:MODIFIER:exon2/33:c.83-33C>T:,AGL:ENST00000361302:intron:MODIFIER:exon2/33:c.35-33C>T:,AGL:ENST00000370161:intron:MODIFIER:exon1/32:c.35-33C>T:		rs2307129	0.2272	0.1962	2368,1011,766	0.4009,0.1257,0.1212,0.1863,0.1928	0.2334							610860 [AGL (confirmed) Glycogen storage disease IIIa,232400|Glycogen storage disease IIIb,232400];	RCV000248220.1 [benign]; 			105	668	2	[2] auto-classification 14.09.2017  			AGL (inh=AR pLI=0.00)
chr1	100336361	100336361	C	T	het	anno_omim	QUAL=8597;DP=341;AF=0.43;MQM=60;TRIO=HET,341,0.43,HOM,98,1.00,HET,117,0.51	AGL	synonymous	AGL:ENST00000294724:synonymous:LOW:exon7/34:c.894C>T:p.Leu298Leu,AGL:ENST00000361915:synonymous:LOW:exon7/34:c.894C>T:p.Leu298Leu,AGL:ENST00000370163:synonymous:LOW:exon7/34:c.894C>T:p.Leu298Leu,AGL:ENST00000370165:synonymous:LOW:exon7/34:c.894C>T:p.Leu298Leu,AGL:ENST00000361302:synonymous:LOW:exon7/34:c.846C>T:p.Leu282Leu,AGL:ENST00000370161:synonymous:LOW:exon6/33:c.846C>T:p.Leu282Leu,AGL:ENST00000361522:synonymous:LOW:exon5/32:c.843C>T:p.Leu281Leu		rs2230306	0.7626	0.7214	31587,16316,4105	0.9144,0.6901,0.6811,0.7011,0.7494	0.7554							610860 [AGL (confirmed) Glycogen storage disease IIIa,232400|Glycogen storage disease IIIb,232400];	RCV000179774.2 [benign]; RCV000327447.1 [benign]; 			1086	866	2	[2] auto-classification 14.09.2017  			AGL (inh=AR pLI=0.00)
chr1	100358103	100358103	C	T	het	pred_pathogenic;anno_omim	QUAL=8351;DP=249;AF=0.49;MQM=60;TRIO=HET,249,0.49,HET,182,0.47,HET,223,0.51	AGL	missense	AGL:ENST00000294724:missense:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser,AGL:ENST00000361915:missense:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser,AGL:ENST00000370163:missense:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser,AGL:ENST00000370165:missense:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser,AGL:ENST00000361302:missense:MODERATE:exon24/34:c.3151C>T:p.Pro1051Ser,AGL:ENST00000370161:missense:MODERATE:exon23/33:c.3151C>T:p.Pro1051Ser,AGL:ENST00000361522:missense:MODERATE:exon22/32:c.3148C>T:p.Pro1050Ser		rs3753494	0.1106	0.1361	1249,817,71	0.1216,0.0905,0.0289,0.1539,0.1453	0.1364	7.2300	D,D,D,D,D,D,D	T	B,B,B	T,T,T,T,T,T,T	18.13	610860 [AGL (confirmed) Glycogen storage disease IIIa,232400|Glycogen storage disease IIIb,232400];	RCV000241565.1 [benign]; RCV000363737.1 [likely benign]; 			69	576	2	[2] auto-classification 14.09.2017  			AGL (inh=AR pLI=0.00)
chr1	100387939	100387939	C	T	het	anno_omim	QUAL=4269;DP=172;AF=0.48;MQM=59;TRIO=HET,172,0.48,HOM,41,1.00,HET,53,0.45	AGL	3'UTR	AGL:ENST00000294724:3'UTR:MODIFIER:exon34/34:c.*732C>T:,AGL:ENST00000361915:3'UTR:MODIFIER:exon34/34:c.*732C>T:,AGL:ENST00000370163:3'UTR:MODIFIER:exon34/34:c.*732C>T:,AGL:ENST00000370165:3'UTR:MODIFIER:exon34/34:c.*732C>T:,AGL:ENST00000361302:3'UTR:MODIFIER:exon34/34:c.*732C>T:,AGL:ENST00000370161:3'UTR:MODIFIER:exon33/33:c.*732C>T:,AGL:ENST00000361522:3'UTR:MODIFIER:exon32/32:c.*732C>T:		rs3766600	0.5905	0.0000	0,0,0	0,0,0,0,0	0.6320							610860 [AGL (confirmed) Glycogen storage disease IIIa,232400|Glycogen storage disease IIIb,232400];	RCV000355131.1 [benign]; 			90	110					AGL (inh=AR pLI=0.00)
chr1	100654908	100654908	A	-	het	anno_omim	QUAL=1042;DP=44;AF=0.27;MQM=56;TRIO=HET,44,0.80,WT,7,0.71,HOM,1,1.00	DBT	3'UTR	DBT:ENST00000370132:3'UTR:MODIFIER:exon11/11:c.*6903delT:	AluSz	rs774983659	0.0000	0.0000	0,0,0	0,0,0,0,0	0.7975							248610 [DBT (confirmed) Maple syrup urine disease,type II,248600];	RCV000399929.1 [uncertain significance]; 			20	97					DBT (inh=AR pLI=0.00)
chr1	100654908	100654908	A	T	het	anno_omim	QUAL=1042;DP=44;AF=0.27;MQM=59;TRIO=HET,44,0.80,HOM,7,0.71,WT,1,1.00	DBT	3'UTR	DBT:ENST00000370132:3'UTR:MODIFIER:exon11/11:c.*6903T>A:	AluSz	rs10783125	0.9339	0.0000	0,0,0	0,0,0,0,0	0.1288							248610 [DBT (confirmed) Maple syrup urine disease,type II,248600];	RCV000314460.1 [benign]; 			52	111					DBT (inh=AR pLI=0.00)
chr1	100654909	100654909	A	T	het	anno_omim	QUAL=1042;DP=44;AF=0.27;MQM=56;TRIO=HET,44,0.80,WT,7,0.71,HOM,1,1.00	DBT	3'UTR	DBT:ENST00000370132:3'UTR:MODIFIER:exon11/11:c.*6902T>A:	AluSz	rs200943386	0.0000	0.0000	0,0,0	0,0,0,0,0	0.7634							248610 [DBT (confirmed) Maple syrup urine disease,type II,248600];				20	97					DBT (inh=AR pLI=0.00)
chr1	100655583	100655583	T	A	hom	anno_omim	QUAL=4243;DP=101;AF=1.00;MQM=59;TRIO=HOM,101,1.00,HOM,15,1.00,HOM,13,1.00	DBT	3'UTR	DBT:ENST00000370132:3'UTR:MODIFIER:exon11/11:c.*6228A>T:	MER3	rs4281338	0.7668	0.0000	0,0,0	0,0,0,0,0	0.7571							248610 [DBT (confirmed) Maple syrup urine disease,type II,248600];	RCV000308827.1 [benign]; 			159	49					DBT (inh=AR pLI=0.00)
chr1	100655696	100655697	AA	-	het	anno_omim	QUAL=3391;DP=182;AF=0.48;MQM=59;TRIO=HET,182,0.48,WT,57,0.02,HET,89,0.65	DBT	3'UTR	DBT:ENST00000370132:3'UTR:MODIFIER:exon11/11:c.*6114_*6115delTT:	MLT1J2	rs3081711	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1787							248610 [DBT (confirmed) Maple syrup urine disease,type II,248600];	RCV000365742.1 [uncertain significance]; 			12	71					DBT (inh=AR pLI=0.00)
chr1	100656265	100656265	C	T	hom	anno_omim	QUAL=13997;DP=174;AF=0.99;MQM=60;TRIO=HOM,174,0.99,HOM,106,1.00,HOM,140,1.00	DBT	3'UTR	DBT:ENST00000370132:3'UTR:MODIFIER:exon11/11:c.*5546G>A:		rs11166412	0.8007	0.0000	0,0,0	0,0,0,0,0	0.7965							248610 [DBT (confirmed) Maple syrup urine disease,type II,248600];	RCV000319712.1 [benign]; 			176	52					DBT (inh=AR pLI=0.00)
chr1	100656661	100656661	T	C	hom	anno_omim	QUAL=24018;DP=361;AF=1.00;MQM=60;TRIO=HOM,361,1.00,HOM,156,1.00,HOM,208,1.00	DBT	3'UTR	DBT:ENST00000370132:3'UTR:MODIFIER:exon11/11:c.*5150A>G:		rs6701655	0.7696	0.0000	0,0,0	0,0,0,0,0	0.7585							248610 [DBT (confirmed) Maple syrup urine disease,type II,248600];	RCV000351715.1 [benign]; 			168	59					DBT (inh=AR pLI=0.00)
chr1	100657305	100657305	T	C	hom	low_DP;anno_omim	QUAL=2968;DP=17;AF=0.06;MQM=51;TRIO=HOM,17,0.88,WT,39,0.97,WT,54,1.00	DBT	3'UTR	DBT:ENST00000370132:3'UTR:MODIFIER:exon11/11:c.*4506A>G:		rs112901689	0.7816	0.0000	0,0,0	0,0,0,0,0	0.0000							248610 [DBT (confirmed) Maple syrup urine disease,type II,248600];	RCV000350352.1 [benign]; 			47	42					DBT (inh=AR pLI=0.00)
chr1	100658578	100658578	G	A	hom	anno_omim	QUAL=34963;DP=348;AF=0.98;MQM=59;TRIO=HOM,348,0.98,HOM,323,1.00,HOM,478,1.00	DBT	3'UTR	DBT:ENST00000370132:3'UTR:MODIFIER:exon11/11:c.*3233C>T:		rs2784174	0.7696	0.0000	0,0,0	0,0,0,0,0	0.7586							248610 [DBT (confirmed) Maple syrup urine disease,type II,248600];	RCV000329977.1 [benign]; 			167	60					DBT (inh=AR pLI=0.00)
chr1	100672060	100672060	T	C	hom	pred_pathogenic;anno_omim	QUAL=28958;DP=345;AF=1.00;MQM=60;TRIO=HOM,345,1.00,HOM,246,1.00,HOM,301,1.00	DBT	missense	DBT:ENST00000370132:missense:MODERATE:exon9/11:c.1150A>G:p.Ser384Gly		rs12021720	0.8918	0.9138	50877,27619,3051	0.7642,0.9628,0.9703,0.9096,0.9521	0.9179	1.9050	T,T	T	B	T	1.11	248610 [DBT (confirmed) Maple syrup urine disease,type II,248600];	RCV000116865.5 [other]; 			1732	342	2	[2] old entry - no details available			DBT (inh=AR pLI=0.00)
chr1	109771063	109771063	T	C	hom		QUAL=21662;DP=237;AF=1.00;MQM=60;TRIO=HOM,237,1.00,HOM,203,1.00,HOM,230,1.00	SARS	splice_region&intron	SARS:ENST00000369923:splice_region&intron:LOW:exon3/11:c.288+9T>C:,SARS:ENST00000234677:splice_region&intron:LOW:exon3/10:c.288+9T>C:		rs683182	0.6799	0.7571	35558,21327,1142	0.4650,0.8139,0.8970,0.7986,0.6555	0.7678										COSM3747470, COSM3747471	1022	577	2	[2] auto-classification 14.09.2017  			SARS (inh=n/a pLI=1.00)
chr1	110709719	110709719	T	C	het	anno_omim	QUAL=18596;DP=267;AF=0.44;MQM=59;TRIO=HET,267,0.45,HET,333,0.54,HOM,387,1.00	SLC6A17,RP5-1028L10.1	synonymous	SLC6A17:ENST00000331565:synonymous:LOW:exon2/12:c.168T>C:p.Asp56Asp		rs7527375	0.3930	0.4656	12998,8876,1288	0.5152,0.2551,0.2194,0.5355,0.3717	0.5129							610299 [SLC6A17 (provisional) Mental retardation,autosomal recessive 48,616269];				458	819	2	[2] auto-classification 14.09.2017  			SLC6A17 (inh=AR pLI=0.96), RP5-1028L10.1 (inh=n/a pLI=n/a)
chr1	110709720	110709720	G	A	het	anno_omim	QUAL=18596;DP=267;AF=0.44;MQM=59;TRIO=HET,267,0.45,WT,333,0.54,HOM,387,1.00	SLC6A17,RP5-1028L10.1	missense	SLC6A17:ENST00000331565:missense:MODERATE:exon2/12:c.169G>A:p.Ala57Thr		rs12737742	0.2502	0.3771	8912,6485,50	0.0954,0.2021,0.2177,0.4603,0.3537	0.3744	0.5380	T,T	T	B	T	13.72	610299 [SLC6A17 (provisional) Mental retardation,autosomal recessive 48,616269];				352	809	2	[2] auto-classification 14.09.2017  			SLC6A17 (inh=AR pLI=0.96), RP5-1028L10.1 (inh=n/a pLI=n/a)
chr1	110738296	110738296	G	A	het	anno_omim	QUAL=16245;DP=299;AF=0.50;MQM=59;TRIO=HET,299,0.50,HET,383,0.53,HET,544,0.53	SLC6A17	synonymous	SLC6A17:ENST00000331565:synonymous:LOW:exon10/12:c.1581G>A:p.Ser527Ser		rs2784140	0.2897	0.4141	11537,8339,52	0.0999,0.3124,0.2750,0.4943,0.3924	0.4178							610299 [SLC6A17 (provisional) Mental retardation,autosomal recessive 48,616269];			COSM146574	324	798	2	[2] auto-classification 14.09.2017  			SLC6A17 (inh=AR pLI=0.96)
chr1	110741081	110741081	C	G	het	anno_omim	QUAL=2579;DP=145;AF=0.50;MQM=59;TRIO=HET,145,0.50,HET,120,0.35,WT,160,0.01	SLC6A17	3'UTR	SLC6A17:ENST00000331565:3'UTR:MODIFIER:exon12/12:c.*15C>G:		rs2761446	0.0170	0.0390	108,93,0	0.0073,0.0140,0.0000,0.0545,0.0320	0.0367							610299 [SLC6A17 (provisional) Mental retardation,autosomal recessive 48,616269];				7	146					SLC6A17 (inh=AR pLI=0.96)
chr1	110741349	110741349	G	T	het	anno_omim	QUAL=17284;DP=384;AF=0.47;MQM=59;TRIO=HET,384,0.47,HOM,273,1.00,HET,332,0.57	SLC6A17	3'UTR	SLC6A17:ENST00000331565:3'UTR:MODIFIER:exon12/12:c.*283G>T:		rs2603580	0.5425	0.0000	0,0,0	0,0,0,0,0	0.6453							610299 [SLC6A17 (provisional) Mental retardation,autosomal recessive 48,616269];				73	112					SLC6A17 (inh=AR pLI=0.96)
chr1	110741583	110741583	C	G	het	anno_omim	QUAL=10073;DP=175;AF=0.38;MQM=59;TRIO=HET,175,0.38,HOM,177,1.00,HET,214,0.52	SLC6A17	3'UTR	SLC6A17:ENST00000331565:3'UTR:MODIFIER:exon12/12:c.*517C>G:		rs2784141	0.5447	0.0000	0,0,0	0,0,0,0,0	0.6452							610299 [SLC6A17 (provisional) Mental retardation,autosomal recessive 48,616269];				73	112					SLC6A17 (inh=AR pLI=0.96)
chr1	110742085	110742085	T	C	het	anno_omim	QUAL=27307;DP=287;AF=0.44;MQM=59;TRIO=HET,287,0.44,HOM,500,1.00,HET,681,0.49	SLC6A17	3'UTR	SLC6A17:ENST00000331565:3'UTR:MODIFIER:exon12/12:c.*1019T>C:		rs2603579	0.5449	0.0000	0,0,0	0,0,0,0,0	0.6462							610299 [SLC6A17 (provisional) Mental retardation,autosomal recessive 48,616269];				73	111					SLC6A17 (inh=AR pLI=0.96)
chr1	110742502	110742502	A	G	het	anno_omim	QUAL=1540;DP=177;AF=0.31;MQM=58;TRIO=HET,177,0.31,HET,83,0.24,HET,104,0.26	SLC6A17	3'UTR	SLC6A17:ENST00000331565:3'UTR:MODIFIER:exon12/12:c.*1436A>G:	(GATG)n	rs2361044	0.2883	0.0000	0,0,0	0,0,0,0,0	0.3756							610299 [SLC6A17 (provisional) Mental retardation,autosomal recessive 48,616269];				44	88					SLC6A17 (inh=AR pLI=0.96)
chr1	110742615	110742615	A	G	het	anno_omim	QUAL=2501;DP=127;AF=0.42;MQM=60;TRIO=HET,127,0.42,HET,70,0.34,HET,105,0.44	SLC6A17	3'UTR	SLC6A17:ENST00000331565:3'UTR:MODIFIER:exon12/12:c.*1549A>G:	GA-rich	rs12133992	0.2867	0.0000	0,0,0	0,0,0,0,0	0.3672							610299 [SLC6A17 (provisional) Mental retardation,autosomal recessive 48,616269];				38	93					SLC6A17 (inh=AR pLI=0.96)
chr1	110742992	110742992	T	G	het	anno_omim	QUAL=7256;DP=180;AF=0.51;MQM=59;TRIO=HET,180,0.51,HET,182,0.52,HET,269,0.45	SLC6A17	3'UTR	SLC6A17:ENST00000331565:3'UTR:MODIFIER:exon12/12:c.*1926T>G:		rs2784142	0.3079	0.0000	0,0,0	0,0,0,0,0	0.3952							610299 [SLC6A17 (provisional) Mental retardation,autosomal recessive 48,616269];				44	109					SLC6A17 (inh=AR pLI=0.96)
chr1	110743588	110743588	G	C	het	anno_omim	QUAL=8345;DP=167;AF=0.53;MQM=60;TRIO=HET,167,0.53,WT,389,0.00,HET,473,0.52	SLC6A17	3'UTR	SLC6A17:ENST00000331565:3'UTR:MODIFIER:exon12/12:c.*2522G>C:		rs151008748	0.0132	0.0000	0,0,0	0,0,0,0,0	0.0218							610299 [SLC6A17 (provisional) Mental retardation,autosomal recessive 48,616269];				1	10					SLC6A17 (inh=AR pLI=0.96)
chr1	115259401	115259401	C	T	het	anno_omim	QUAL=3853;DP=190;AF=0.60;MQM=59;TRIO=HET,190,0.60,WT,118,0.00,HET,138,0.38	NRAS	5'UTR	NRAS:ENST00000369535:5'UTR:MODIFIER:exon1/7:c.-140G>A:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							164790 [NRAS (confirmed) RAS-associated autoimmune lymphoproliferative syndrome type IV,somatic,614470|Noonan syndrome 6,613224|Epidermal nevus,somatic,162900|Thyroid carcinoma,follicular,somatic,188470|Colorectal cancer,somatic,114500|Melanocytic nevus syndrome,congenital,somatic,137550|Neurocutaneous melanosis,somatic,249400|Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200];				0	2					NRAS (inh=AD pLI=0.91)
chr1	115576023	115576023	A	G	hom	anno_omim	QUAL=17910;DP=260;AF=1.00;MQM=59;TRIO=HOM,260,1.00,HOM,135,1.00,HOM,149,1.00	TSHB	missense	TSHB:ENST00000256592:missense:MODERATE:exon2/3:c.40A>G:p.Thr14Ala,TSHB:ENST00000369517:missense:MODERATE:exon1/2:c.40A>G:p.Thr14Ala		rs10776792	0.9836	0.9707	57192,31035,5156	0.9955,0.9929,1.0000,0.9645,0.9599	0.9746	0.2240	T,T	T	B	T,T	0.01	188540 [TSHB (confirmed) Hypothryoidism,congenital,nongoitrous 4,275100];	RCV000242832.1 [benign]; RCV000396537.1 [benign]; 			1976	127	2	[2] Peter Bauer 25.08.2014			TSHB (inh=AR pLI=0.01)
chr1	115829313	115829313	G	A	hom	pred_pathogenic;anno_omim	QUAL=20368;DP=190;AF=0.99;MQM=60;TRIO=HOM,190,0.99,HET,277,0.51,HOM,390,0.99	NGF,RP4-663N10.1	missense	NGF:ENST00000369512:missense:MODERATE:exon3/3:c.104C>T:p.Ala35Val		rs6330	0.2474	0.3656	8859,6583,196	0.1881,0.3372,0.1670,0.4453,0.2298	0.3702	2.2980	D	T	B	T	19.04	162030 [NGF (confirmed) Neuropathy,hereditary sensory and autonomic,type V,608654];	RCV000268865.1 [benign]; 		COSM3735921	322	958	2	[2] auto-classification 14.09.2017  			NGF (inh=AR pLI=0.70), RP4-663N10.1 (inh=n/a pLI=n/a)
chr1	119965519	119965519	C	T	het	anno_omim	QUAL=10741;DP=468;AF=0.54;MQM=59;TRIO=HET,468,0.54,WT,297,0.00,HET,354,0.41	HSD3B2	3'UTR	HSD3B2:ENST00000369416:3'UTR:MODIFIER:exon4/4:c.*276C>T:,HSD3B2:ENST00000543831:3'UTR:MODIFIER:exon4/4:c.*276C>T:		rs1819698	0.3101	0.0000	0,0,0	0,0,0,0,0	0.2245							613890 [HSD3B2 (confirmed) Adrenal hyperplasia,congenital,due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency,201810];	RCV000335090.1 [benign]; 			6	53					HSD3B2 (inh=n/a pLI=0.00)
chr1	119965564	119965564	C	G	het	anno_omim	QUAL=10623;DP=436;AF=0.55;MQM=60;TRIO=HET,436,0.55,WT,291,0.00,HET,356,0.42	HSD3B2	3'UTR	HSD3B2:ENST00000369416:3'UTR:MODIFIER:exon4/4:c.*321C>G:,HSD3B2:ENST00000543831:3'UTR:MODIFIER:exon4/4:c.*321C>G:		rs1361530	0.2560	0.0000	0,0,0	0,0,0,0,0	0.1755							613890 [HSD3B2 (confirmed) Adrenal hyperplasia,congenital,due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency,201810];	RCV000379840.1 [likely benign]; 			5	51					HSD3B2 (inh=n/a pLI=0.00)
chr1	147228874	147228874	C	T	het	anno_omim	QUAL=6217;DP=268;AF=0.51;MQM=60;TRIO=HET,268,0.51,HET,193,0.54,WT,301,0.00	GJA5	3'UTR	GJA5:ENST00000271348:3'UTR:MODIFIER:exon2/2:c.*1396G>A:		rs11240121	0.4073	0.0000	0,0,0	0,0,0,0,0	0.3022							121013 [GJA5 (confirmed) Atrial fibrillation,familial,11,614049|Atrial standstill,digenic (GJA5/SCN5A),108770];				19	89					GJA5 (inh=AD pLI=0.10)
chr1	147229299	147229299	G	A	hom	anno_omim	QUAL=12825;DP=219;AF=1.00;MQM=59;TRIO=HOM,219,1.00,HOM,133,1.00,HET,162,0.50	GJA5	3'UTR	GJA5:ENST00000271348:3'UTR:MODIFIER:exon2/2:c.*971C>T:		rs1043806	0.8662	0.0000	0,0,0	0,0,0,0,0	0.8007							121013 [GJA5 (confirmed) Atrial fibrillation,familial,11,614049|Atrial standstill,digenic (GJA5/SCN5A),108770];				152	70					GJA5 (inh=AD pLI=0.10)
chr1	147229382	147229382	G	A	hom	anno_omim	QUAL=22626;DP=255;AF=0.99;MQM=60;TRIO=HOM,255,0.99,HOM,196,1.00,HOM,277,1.00	GJA5	3'UTR	GJA5:ENST00000271348:3'UTR:MODIFIER:exon2/2:c.*888C>T:,GJA5:ENST00000369237:3'UTR:MODIFIER:exon2/2:c.*888C>T:		rs10900395	0.9886	0.0000	0,0,0	0,0,0,0,0	0.9882							121013 [GJA5 (confirmed) Atrial fibrillation,familial,11,614049|Atrial standstill,digenic (GJA5/SCN5A),108770];				232	0					GJA5 (inh=AD pLI=0.10)
chr1	147229563	147229563	G	A	het	anno_omim	QUAL=7586;DP=356;AF=0.43;MQM=60;TRIO=HET,356,0.43,HET,317,0.48,WT,383,0.00	GJA5,RP11-433J22.2	3'UTR	GJA5:ENST00000271348:3'UTR:MODIFIER:exon2/2:c.*707C>T:,GJA5:ENST00000369237:3'UTR:MODIFIER:exon2/2:c.*707C>T:		rs1043802	0.3191	0.0000	0,0,0	0,0,0,0,0	0.2518							121013 [GJA5 (confirmed) Atrial fibrillation,familial,11,614049|Atrial standstill,digenic (GJA5/SCN5A),108770];				16	86					GJA5 (inh=AD pLI=0.10), RP11-433J22.2 (inh=n/a pLI=n/a)
chr1	147229628	147229628	-	GGGCATTTGCCAGAGGTACATACCA	het	anno_omim	QUAL=11474;DP=217;AF=0.27;MQM=59;TRIO=HET,217,0.27,HET,287,0.45,HET,373,0.49	GJA5,RP11-433J22.2	3'UTR	GJA5:ENST00000271348:3'UTR:MODIFIER:exon2/2:c.*617_*641dupTGGTATGTACCTCTGGCAAATGCCC:,GJA5:ENST00000369237:3'UTR:MODIFIER:exon2/2:c.*617_*641dupTGGTATGTACCTCTGGCAAATGCCC:		rs371724095	0.4667	0.0000	0,0,0	0,0,0,0,0	0.0000							121013 [GJA5 (confirmed) Atrial fibrillation,familial,11,614049|Atrial standstill,digenic (GJA5/SCN5A),108770];				74	75					GJA5 (inh=AD pLI=0.10), RP11-433J22.2 (inh=n/a pLI=n/a)
chr1	147230217	147230217	T	C	hom	anno_omim	QUAL=19860;DP=325;AF=1.00;MQM=59;TRIO=HOM,325,1.00,HOM,192,0.99,HET,233,0.54	GJA5,RP11-433J22.2	3'UTR	GJA5:ENST00000271348:3'UTR:MODIFIER:exon2/2:c.*53A>G:,GJA5:ENST00000369237:3'UTR:MODIFIER:exon2/2:c.*53A>G:		rs1692141	0.8804	0.0000	0,0,0	0,0,0,0,0	0.8150							121013 [GJA5 (confirmed) Atrial fibrillation,familial,11,614049|Atrial standstill,digenic (GJA5/SCN5A),108770];				1361	526					GJA5 (inh=AD pLI=0.10), RP11-433J22.2 (inh=n/a pLI=n/a)
chr1	147245474	147245474	G	C	hom	anno_omim	QUAL=20888;DP=217;AF=1.00;MQM=60;TRIO=HOM,217,1.00,HOM,184,1.00,HOM,278,1.00	GJA5	5'UTR	GJA5:ENST00000271348:5'UTR:MODIFIER:exon1/2:c.-152C>G:		rs791286	0.9748	0.0000	0,0,0	0,0,0,0,0	0.9821							121013 [GJA5 (confirmed) Atrial fibrillation,familial,11,614049|Atrial standstill,digenic (GJA5/SCN5A),108770];	RCV000277169.1 [likely benign]; 			231	1					GJA5 (inh=AD pLI=0.10)
chr1	150771703	150771703	T	C	hom	anno_omim	QUAL=35017;DP=355;AF=1.00;MQM=60;TRIO=HOM,355,1.00,HOM,341,1.00,HOM,363,1.00	CTSK	synonymous	CTSK:ENST00000271651:synonymous:LOW:exon7/8:c.831A>G:p.Ala277Ala		rs10788796	0.9633	0.9887	59361,33273,4455	0.9257,0.9940,0.9946,0.9986,0.9771	0.9900							601105 [CTSK (provisional) Pycnodysostosis,265800];				2089	15	2	[2] auto-classification 14.09.2017  			CTSK (inh=AR pLI=0.00)
chr1	151313774	151313774	A	G	het	anno_omim	QUAL=6544;DP=286;AF=0.48;MQM=59;TRIO=HET,286,0.48,HOM,90,1.00,WT,137,0.01	RFX5,RP11-126K1.8	3'UTR	RFX5:ENST00000290524:3'UTR:MODIFIER:exon11/11:c.*888T>C:		rs7552906	0.6280	0.0000	0,0,0	0,0,0,0,0	0.6231							601863 [RFX5 (confirmed) Bare lymphocyte syndrome,type II,complementation group C,209920|Bare lymphocyte syndrome,type II,complementation group E,209920];	RCV000373841.1 [benign]; 			96	116					RFX5 (inh=AR+AD pLI=0.00), RP11-126K1.8 (inh=n/a pLI=n/a)
chr1	151314379	151314379	T	C	het	anno_omim	QUAL=8286;DP=200;AF=0.56;MQM=60;TRIO=HET,200,0.56,HOM,113,1.00,HET,157,0.47	RFX5,RP11-126K1.8	3'UTR	RFX5:ENST00000290524:3'UTR:MODIFIER:exon11/11:c.*283A>G:,RFX5:ENST00000368870:3'UTR:MODIFIER:exon11/11:c.*283A>G:	MLT1K	rs1752387	0.7644	0.0000	0,0,0	0,0,0,0,0	0.7674							601863 [RFX5 (confirmed) Bare lymphocyte syndrome,type II,complementation group C,209920|Bare lymphocyte syndrome,type II,complementation group E,209920];	RCV000352021.1 [benign]; 			131	68					RFX5 (inh=AR+AD pLI=0.00), RP11-126K1.8 (inh=n/a pLI=n/a)
chr1	151315287	151315287	G	C	het	pred_pathogenic;anno_omim	QUAL=3266;DP=123;AF=0.50;MQM=59;TRIO=HET,123,0.50,HET,139,0.50,WT,187,0.00	RFX5	missense	RFX5:ENST00000290524:missense:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg,RFX5:ENST00000368870:missense:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg,RFX5:ENST00000452671:missense:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg,RFX5:ENST00000452513:missense:MODERATE:exon10/10:c.1106C>G:p.Pro369Arg		rs2233854	0.0635	0.1188	1090,898,5	0.0269,0.0659,0.0005,0.1618,0.0980	0.1178	1.7460	D,D,D,D,D	T	B,B	T,T,T,T,T	15.46	601863 [RFX5 (confirmed) Bare lymphocyte syndrome,type II,complementation group C,209920|Bare lymphocyte syndrome,type II,complementation group E,209920];	RCV000268166.1 [likely benign]; 		COSM3750354	55	486	2	[2] auto-classification 14.09.2017  			RFX5 (inh=AR+AD pLI=0.00)
chr1	151316161	151316161	G	A	hom	anno_omim	QUAL=13269;DP=190;AF=1.00;MQM=59;TRIO=HOM,190,1.00,HOM,93,1.00,HOM,132,1.00	RFX5	synonymous	RFX5:ENST00000290524:synonymous:LOW:exon9/11:c.753C>T:p.Leu251Leu,RFX5:ENST00000368870:synonymous:LOW:exon9/11:c.753C>T:p.Leu251Leu,RFX5:ENST00000452671:synonymous:LOW:exon9/11:c.753C>T:p.Leu251Leu,RFX5:ENST00000452513:synonymous:LOW:exon8/10:c.633C>T:p.Leu211Leu		rs1752386	0.9780	0.9934	59713,33243,4434	0.9267,0.9970,1.0000,0.9999,0.9998	0.9947							601863 [RFX5 (confirmed) Bare lymphocyte syndrome,type II,complementation group C,209920|Bare lymphocyte syndrome,type II,complementation group E,209920];				2102	2	2	[2] auto-classification 14.09.2017  			RFX5 (inh=AR+AD pLI=0.00)
chr1	152274685	152274685	T	A	hom	anno_omim	QUAL=8578;DP=95;AF=1.00;MQM=60;TRIO=HOM,95,1.00,HOM,63,1.00,HOM,107,1.00	FLG,FLG-AS1	3'UTR,intron	FLG:ENST00000368799:3'UTR:MODIFIER:exon3/3:c.*491A>T:,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+376T>A:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+376T>A:		rs1933061	0.9994	0.0000	0,0,0	0,0,0,0,0	0.9979							135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];				229	2					FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152276149	152276149	C	T	het	anno_omim	QUAL=45774;DP=518;AF=0.52;MQM=58;TRIO=HET,518,0.52,HET,1333,0.51,HET,1859,0.52	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.11213G>A:p.Arg3738His,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+1840C>T:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+1840C>T:		rs77422831	0.2869	0.2288	4735,817,4	0.0318,0.4477,0.5597,0.1493,0.3703	0.2417	-2.2530	T	T	B	T	10.76	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM3996928	98	551	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152276626	152276626	G	C	het	low_MQM;anno_omim	QUAL=9260;DP=471;AF=0.18;MQM=36;TRIO=HET,471,0.18,HET,823,0.22,HOM,338,0.98	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.10736C>G:p.Thr3579Arg,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+2317G>C:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+2317G>C:		rs3126075	0.4778	0.0523	1683,83,1243	0.3997,0.0581,0.1103,0.0078,0.0227	0.1878	-5.4480	T	T	B	T	0.16	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM4142671	130	110	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152276699	152276699	A	G	het	low_MQM;anno_omim	QUAL=13578;DP=561;AF=0.32;MQM=38;TRIO=HET,561,0.32,HET,979,0.21,HET,623,0.59	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.10663T>C:p.Trp3555Arg,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+2390A>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+2390A>G:		rs12728605	0.0000	0.1929	11,3,0	0.3155,0.3082,0.3857,0.1135,0.2885	0.1255	-1.1810	T	T	B	T	0.01	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM4142674	3	359	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152276772	152276772	C	A	het	pred_pathogenic;anno_omim	QUAL=31885;DP=429;AF=0.43;MQM=56;TRIO=HET,429,0.43,HET,1167,0.44,HET,725,0.80	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.10590G>T:p.Arg3530Ser,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+2463C>A:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+2463C>A:		rs72697000	0.2905	0.2343	5402,1033,6	0.0314,0.4534,0.5649,0.1525,0.3917	0.2456	-5.0060	T	T	D	T	1.14	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM3996929	107	545	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152276871	152276871	A	G	het	anno_omim	QUAL=38354;DP=539;AF=0.40;MQM=58;TRIO=HET,539,0.40,HET,1133,0.47,HOM,643,0.99	FLG,FLG-AS1	synonymous,intron	FLG:ENST00000368799:synonymous:LOW:exon3/3:c.10491T>C:p.Asp3497Asp,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+2562A>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+2562A>G:		rs3126066	0.4471	0.2779	6890,1057,1209	0.4785,0.4699,0.5929,0.1543,0.3944	0.2818							135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM3996930	128	554	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152276889	152276889	A	G	het	anno_omim	QUAL=37876;DP=537;AF=0.40;MQM=58;TRIO=HET,537,0.40,HET,1146,0.46,HOM,633,0.99	FLG,FLG-AS1	synonymous,intron	FLG:ENST00000368799:synonymous:LOW:exon3/3:c.10473T>C:p.Asn3491Asn,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+2580A>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+2580A>G:		rs3126067	0.5226	0.3007	8467,1093,2670	0.7136,0.4828,0.5955,0.1563,0.3950	0.3308							135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM3996931	141	557	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152277055	152277055	C	G	het	anno_omim	QUAL=26512;DP=469;AF=0.40;MQM=53;TRIO=HET,469,0.40,HET,892,0.44,HET,613,0.79	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.10307G>C:p.Gly3436Ala,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+2746C>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+2746C>G:		rs2065955	0.5142	0.2987	8272,1051,2636	0.7095,0.4816,0.5932,0.1556,0.3887	0.3215	-0.5970	T	T	P	T	8.40	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM4142675	120	577	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152277168	152277168	A	G	het	anno_omim	QUAL=46973;DP=514;AF=0.45;MQM=51;TRIO=HET,514,0.45,HET,1099,0.47,HOM,959,0.99	FLG,FLG-AS1	synonymous,intron	FLG:ENST00000368799:synonymous:LOW:exon3/3:c.10194T>C:p.Ser3398Ser,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+2859A>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+2859A>G:		rs3091276	0.4736	0.2896	7123,1067,1406	0.5180,0.4764,0.6037,0.1608,0.4122	0.2908							135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM3996932	130	597	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152277345	152277345	C	T	het	anno_omim	QUAL=47107;DP=556;AF=0.46;MQM=58;TRIO=HET,556,0.46,HET,1341,0.48,HET,1992,0.48	FLG,FLG-AS1	synonymous,intron	FLG:ENST00000368799:synonymous:LOW:exon3/3:c.10017G>A:p.Gln3339Gln,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+3036C>T:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+3036C>T:		rs2065956	0.2875	0.2293	4811,838,4	0.0312,0.4480,0.5600,0.1495,0.3733	0.2422							135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM3996933	102	544	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152277396	152277396	T	C	het	anno_omim	QUAL=80878;DP=522;AF=0.45;MQM=58;TRIO=HET,522,0.45,HET,1289,0.49,HOM,1872,0.99	FLG,FLG-AS1	synonymous,intron	FLG:ENST00000368799:synonymous:LOW:exon3/3:c.9966A>G:p.Gln3322Gln,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+3087T>C:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+3087T>C:		rs6681433	0.3411	0.2611	5728,1092,77	0.1267,0.4638,0.5814,0.1719,0.4299	0.2721							135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];				122	592	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152277717	152277717	C	A	het	low_MQM;anno_omim	QUAL=42828;DP=273;AF=0.31;MQM=48;TRIO=HET,273,0.31,HET,975,0.40,HOM,1117,1.00	FLG,FLG-AS1	synonymous,intron	FLG:ENST00000368799:synonymous:LOW:exon3/3:c.9645G>T:p.Val3215Val,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+3408C>A:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+3408C>A:		rs9436066	0.4696	0.2992	7303,1113,1196	0.4788,0.4776,0.6441,0.1742,0.4321	0.3027							135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];				136	586	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152277822	152277822	T	C	het	low_MQM;anno_omim	QUAL=11953;DP=325;AF=0.17;MQM=38;TRIO=HET,325,0.17,HET,814,0.19,HOM,400,0.98	FLG,FLG-AS1	synonymous,intron	FLG:ENST00000368799:synonymous:LOW:exon3/3:c.9540A>G:p.Ser3180Ser,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+3513T>C:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+3513T>C:		rs3126069	0.2238	0.0917	2823,434,32	0.0207,0.1530,0.2618,0.0397,0.2431	0.1318							135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];				125	179	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152277826	152277826	A	C	het	low_MQM;anno_omim	QUAL=11953;DP=325;AF=0.17;MQM=38;TRIO=HET,325,0.17,HET,814,0.19,HOM,400,0.98	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.9536T>G:p.Val3179Gly,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+3517A>C:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+3517A>C:		rs2065957	0.3936	0.1330	4141,444,1188	0.4244,0.1748,0.2995,0.0412,0.2486	0.2390	-0.6040	T	T	B	T	0.01	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];				141	196	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152278434	152278434	T	G	het	low_MQM;anno_omim	QUAL=2785;DP=449;AF=0.24;MQM=39;TRIO=HET,449,0.24,HET,492,0.25,WT,552,0.00	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.8928A>C:p.Glu2976Asp,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+4125T>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+4125T>G:		rs61816760	0.2873	0.4220	129,24,98	0.4429,0.4032,0.1970,0.4491,0.3843	0.3862	-1.3040	T	T	B	T	0.01	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM3801882	19	928	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152278555	152278555	T	C	het	low_MQM;anno_omim	QUAL=26984;DP=450;AF=0.26;MQM=45;TRIO=HET,450,0.26,HET,1314,0.25,HET,1616,0.50	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.8807A>G:p.Asp2936Gly,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+4246T>C:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+4246T>C:		rs80221306	0.0000	0.2148	4,0,3	0.1073,0.3479,0.4078,0.1546,0.3241	0.2065	-0.3860	T	T	B	T	0.38	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM1317676	1	680	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152278689	152278689	C	A	het	anno_omim	QUAL=144558;DP=681;AF=0.55;MQM=50;TRIO=HET,681,0.55,HET,2485,0.54,HOM,3301,1.00	FLG,FLG-AS1	synonymous,intron	FLG:ENST00000368799:synonymous:LOW:exon3/3:c.8673G>T:p.Val2891Val,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+4380C>A:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+4380C>A:		rs57672167	0.3964	0.2692	6196,1077,556	0.2090,0.4686,0.5836,0.1719,0.4265	0.2781							135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];				132	591	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152278856	152278856	T	G	het	anno_omim	QUAL=16438;DP=845;AF=0.22;MQM=50;TRIO=HET,845,0.22,HET,2636,0.21,HET,3913,0.18	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.8506A>C:p.Ser2836Arg,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+4547T>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+4547T>G:		rs11582087	0.0000	0.1893	0,0,0	0.0347,0.3392,0.3979,0.1367,0.2914	0.1776		T,T	T	B	T	13.01	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];				0	627	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152279019	152279019	G	A	het	low_MQM;anno_omim	QUAL=8430;DP=994;AF=0.16;MQM=35;TRIO=HET,994,0.16,HET,2438,0.19,HET,4119,0.17	FLG,FLG-AS1	synonymous,intron	FLG:ENST00000368799:synonymous:LOW:exon3/3:c.8343C>T:p.Asp2781Asp,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+4710G>A:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+4710G>A:		rs57670307	0.0000	0.1823	0,0,0	0.0277,0.3349,0.3884,0.1293,0.2912	0.1231							135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM1319976	0	557	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152279729	152279729	C	T	het	anno_omim	QUAL=70999;DP=577;AF=0.46;MQM=58;TRIO=HET,577,0.46,HET,1198,0.53,HOM,1550,0.99	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.7633G>A:p.Gly2545Arg,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+5420C>T:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+5420C>T:		rs3126072	0.4748	0.2974	7255,1075,1480	0.5136,0.4781,0.6037,0.1725,0.4277	0.3006	-0.2430	T	T	B	T	1.03	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM3996934	132	612	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152279841	152279841	G	C	het	anno_omim	QUAL=72444;DP=483;AF=0.47;MQM=58;TRIO=HET,483,0.47,HET,1197,0.52,HOM,1580,1.00	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.7521C>G:p.His2507Gln,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+5532G>C:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+5532G>C:		rs3126074	0.4623	0.2943	6970,1076,1209	0.4795,0.4767,0.6041,0.1724,0.4277	0.2981	-7.9550	T	T	B	T	0.01	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];				129	611	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152279920	152279920	A	G	het	anno_omim	QUAL=75412;DP=461;AF=0.49;MQM=59;TRIO=HET,461,0.49,HET,1216,0.53,HOM,1664,1.00	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.7442T>C:p.Leu2481Ser,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+5611A>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+5611A>G:		rs55650366	0.3425	0.2608	5666,1064,88	0.1310,0.4639,0.5822,0.1716,0.4262	0.2715	-1.3450	T	T	B	T	0.01	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM3996935	121	599	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152280032	152280032	T	C	het	anno_omim	QUAL=82464;DP=556;AF=0.47;MQM=58;TRIO=HET,556,0.47,HET,1332,0.51,HOM,1836,1.00	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.7330A>G:p.Lys2444Glu,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+5723T>C:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+5723T>C:		rs71625200	0.3431	0.2608	5660,1063,88	0.1315,0.4640,0.5816,0.1715,0.4260	0.2715	-0.8890	T	T	B	T	0.01	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM3996936	122	598	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152280170	152280170	C	G	het	low_MQM;anno_omim	QUAL=56531;DP=457;AF=0.45;MQM=47;TRIO=HET,457,0.45,HET,1167,0.44,HOM,1442,0.97	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.7192G>C:p.Glu2398Gln,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+5861C>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+5861C>G:		rs71625201	0.3305	0.2585	5456,1036,72	0.1274,0.4613,0.5620,0.1711,0.4243	0.2578	-1.3100	T,T	T	B	T	0.02	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM3996937	107	605	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152280265	152280265	C	G	het	low_MQM;pred_pathogenic;anno_omim	QUAL=35095;DP=506;AF=0.39;MQM=38;TRIO=HET,506,0.39,HET,1102,0.31,HET,1088,0.86	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.7097G>C:p.Ser2366Thr,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+5956C>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+5956C>G:		rs71625202	0.0000	0.2062	197,29,0	0.0341,0.3493,0.4035,0.1531,0.3339	0.2129	0.0300	D,D	T	D	T	14.66	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM3747555	11	630	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152280347	152280347	C	T	het	low_MQM;pred_pathogenic;anno_omim	QUAL=30219;DP=475;AF=0.35;MQM=37;TRIO=HET,475,0.35,HET,1162,0.29,HET,1021,0.79	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.7015G>A:p.Asp2339Asn,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+6038C>T:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+6038C>T:		rs139476473	0.0000	0.1512	30,15,0	0.0271,0.2573,0.3350,0.0984,0.2964	0.1479	1.6910	D,T	T	D	T	24.30	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM146618	3	337	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152280372	152280372	G	A	het	low_MQM;anno_omim	QUAL=41242;DP=518;AF=0.49;MQM=36;TRIO=HET,518,0.49,HET,1128,0.35,HOM,1040,0.99	FLG,FLG-AS1	synonymous,intron	FLG:ENST00000368799:synonymous:LOW:exon3/3:c.6990C>T:p.His2330His,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+6063G>A:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+6063G>A:		rs6664985	0.4535	0.2788	6451,965,1061	0.4261,0.4577,0.5750,0.1618,0.4259	0.2751							135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM3996938	127	508	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152280471	152280471	C	G	het	low_MQM;anno_omim	QUAL=10449;DP=683;AF=0.26;MQM=37;TRIO=HET,683,0.26,HET,1352,0.13,HET,1878,0.29	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.6891G>C:p.Glu2297Asp,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+6162C>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+6162C>G:		rs78179835	0.0000	0.2086	23,0,23	0.0970,0.3476,0.3998,0.1516,0.3306	0.1947	-0.9250	T,T	T	B	T	0.01	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM4142679	2	669	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152280736	152280736	T	C	het	anno_omim	QUAL=22837;DP=802;AF=0.31;MQM=53;TRIO=HET,802,0.31,HET,1509,0.18,HET,2389,0.33	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.6626A>G:p.His2209Arg,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+6427T>C:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+6427T>C:		rs66977240	0.0000	0.2357	1,0,1	0.3596,0.3586,0.4141,0.1557,0.3321	0.2184	-5.2630	T	T	B	T	0.09	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM4142690	0	711	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152280759	152280759	A	G	het	anno_omim	QUAL=35982;DP=882;AF=0.34;MQM=53;TRIO=HET,882,0.34,HET,1570,0.23,HET,2678,0.40	FLG,FLG-AS1	synonymous,intron	FLG:ENST00000368799:synonymous:LOW:exon3/3:c.6603T>C:p.Asp2201Asp,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+6450A>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+6450A>G:		rs2338554	0.3672	0.2416	650,0,643	0.4255,0.3587,0.4183,0.1555,0.3322	0.2416							135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM4142691	1	728	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152280782	152280782	A	G	het	anno_omim	QUAL=131894;DP=889;AF=0.65;MQM=56;TRIO=HET,889,0.65,HET,1662,0.63,HOM,2800,1.00	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.6580T>C:p.Tyr2194His,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+6473A>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+6473A>G:		rs2184953	0.5397	0.3177	8529,1108,2650	0.7120,0.4906,0.6083,0.1746,0.4315	0.3434	-2.7490	T	T	B	T	0.01	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM3927615	144	615	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152280788	152280788	T	G	het	anno_omim	QUAL=71910;DP=898;AF=0.32;MQM=54;TRIO=HET,898,0.32,HET,1669,0.27,HET,2840,0.73	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.6574A>C:p.Lys2192Gln,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.376+6479T>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.462+6479T>G:		rs66954353	0.0000	0.2371	61,14,1	0.3629,0.3590,0.4187,0.1563,0.3342	0.2399	0.2450	T	T	B	T	0.03	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];				1	734	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152280864	152280864	A	G	het	anno_omim	QUAL=112174;DP=520;AF=0.61;MQM=54;TRIO=HET,520,0.61,HET,1525,0.66,HOM,2569,1.00	FLG,FLG-AS1	synonymous,intron	FLG:ENST00000368799:synonymous:LOW:exon3/3:c.6498T>C:p.Ser2166Ser,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-6518A>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-6518A>G:		rs2184954	0.4637	0.2946	6956,1068,1210	0.4806,0.4777,0.6055,0.1724,0.4280	0.2982							135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];				130	608	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152280900	152280900	T	G	het	anno_omim	QUAL=31668;DP=707;AF=0.31;MQM=51;TRIO=HET,707,0.31,HET,1482,0.31,HET,2359,0.35	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.6462A>C:p.Gln2154His,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-6482T>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-6482T>G:		rs74129452	0.3439	0.2366	0,0,0	0.3620,0.3584,0.4189,0.1561,0.3322	0.2375	-3.3340	T	T	B	T	0.01	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];				0	725	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152281007	152281007	A	G	het	anno_omim	QUAL=28960;DP=826;AF=0.28;MQM=59;TRIO=HET,826,0.28,HET,1589,0.30,HET,2308,0.30	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.6355T>C:p.Tyr2119His,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-6375A>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-6375A>G:		rs7512553	0.3277	0.2207	0,0,0	0.3608,0.3523,0.4116,0.1382,0.3001	0.2243	0.1210	T	T	B	T	0.01	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];				0	679	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152281008	152281008	A	G	het	anno_omim	QUAL=28960;DP=826;AF=0.28;MQM=59;TRIO=HET,826,0.28,HET,1589,0.30,HET,2308,0.30	FLG,FLG-AS1	synonymous,intron	FLG:ENST00000368799:synonymous:LOW:exon3/3:c.6354T>C:p.His2118His,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-6374A>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-6374A>G:		rs7512554	0.3277	0.2207	0,0,0	0.3608,0.3522,0.4116,0.1382,0.3001	0.2244							135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];				0	678	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152281039	152281039	G	A	het	anno_omim	QUAL=33474;DP=956;AF=0.30;MQM=59;TRIO=HET,956,0.30,HET,1656,0.33,HET,2398,0.32	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.6323C>T:p.Ala2108Val,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-6343G>A:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-6343G>A:		rs7522925	0.0000	0.2208	0,0,0	0.3621,0.3521,0.4112,0.1382,0.3001	0.2245	-3.7960	T	T	B	T	10.05	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM4142692	1	681	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152281228	152281228	C	G	het	anno_omim	QUAL=38205;DP=742;AF=0.26;MQM=53;TRIO=HET,742,0.26,HET,1969,0.35,HET,2615,0.33	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.6134G>C:p.Ser2045Thr,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-6154C>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-6154C>G:		rs7546186	0.0000	0.2189	1,1,0	0.3512,0.3506,0.4047,0.1379,0.2997	0.2173	1.5140	T	T	P	T	4.80	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];				0	668	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152281290	152281290	A	G	het	anno_omim	QUAL=35643;DP=692;AF=0.23;MQM=50;TRIO=HET,692,0.23,HET,1998,0.34,HET,2597,0.33	FLG,FLG-AS1	synonymous,intron	FLG:ENST00000368799:synonymous:LOW:exon3/3:c.6072T>C:p.His2024His,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-6092A>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-6092A>G:		rs80353812	0.3281	0.2205	0,0,0	0.3594,0.3521,0.4093,0.1383,0.3006	0.2226							135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM4142693	0	669	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152281304	152281304	A	C	het	pred_pathogenic;anno_omim	QUAL=37065;DP=691;AF=0.27;MQM=51;TRIO=HET,691,0.27,HET,1972,0.33,HET,2612,0.33	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.6058T>G:p.Ser2020Ala,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-6078A>C:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-6078A>C:		rs7512857	0.0000	0.2186	0,0,0	0.3407,0.3512,0.4103,0.1380,0.2997	0.2224	0.3910	T	T	D	T	0.82	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM4142694	0	674	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152281479	152281479	G	T	het	anno_omim	QUAL=106048;DP=894;AF=0.59;MQM=56;TRIO=HET,894,0.59,HET,1623,0.68,HOM,2002,1.00	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.5883C>A:p.His1961Gln,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-5903G>T:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-5903G>T:		rs3126079	0.5381	0.3173	8527,1116,2651	0.7122,0.4901,0.6078,0.1748,0.4285	0.3429	-4.7080	T	T	B	T	0.01	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM4142695	144	616	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152281523	152281523	A	C	het	low_MQM;anno_omim	QUAL=20209;DP=835;AF=0.19;MQM=48;TRIO=HET,835,0.19,HET,1559,0.30,HET,1842,0.29	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.5839T>G:p.Trp1947Gly,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-5859A>C:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-5859A>C:		rs80059102	0.0000	0.2197	0,0,0	0.3567,0.3513,0.4090,0.1380,0.2998	0.1992	-0.5530	T	T	B	T	0.45	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];				0	662	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152281534	152281534	A	T	het	low_MQM;anno_omim	QUAL=17162;DP=765;AF=0.18;MQM=48;TRIO=HET,765,0.18,HET,1518,0.28,HET,1786,0.28	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.5828T>A:p.Leu1943His,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-5848A>T:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-5848A>T:		rs113544881	0.3135	0.2157	1,0,0	0.3133,0.3506,0.4072,0.1378,0.3007	0.1822	-2.7300	T	T	B	T	1.98	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];				1	646	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152281690	152281690	C	T	het	anno_omim	QUAL=41373;DP=548;AF=0.48;MQM=59;TRIO=HET,548,0.48,HET,1176,0.51,HET,1373,0.53	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.5672G>A:p.Arg1891Gln,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-5692C>T:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-5692C>T:		rs12407748	0.2875	0.2286	4730,821,4	0.0314,0.4473,0.5600,0.1493,0.3697	0.2416	-4.0060	T,T	T	B	T	11.35	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM3996939	96	557	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152281948	152281948	G	A	het	pred_pathogenic;anno_omim	QUAL=37411;DP=471;AF=0.48;MQM=58;TRIO=HET,471,0.48,HET,1123,0.51,HET,1995,0.38	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.5414C>T:p.Ala1805Val,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-5434G>A:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-5434G>A:		rs12405241	0.2875	0.2288	4747,824,4	0.0312,0.4471,0.5616,0.1493,0.3701	0.2416	-5.6230	T,T	T	D	T	10.19	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM3996940	99	550	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152282267	152282267	G	A	het	pred_pathogenic;anno_omim	QUAL=36513;DP=436;AF=0.46;MQM=59;TRIO=HET,436,0.46,HET,1239,0.48,HET,1533,0.49	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.5095C>T:p.Arg1699Cys,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-5115G>A:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-5115G>A:		rs12405278	0.2877	0.2288	4748,823,4	0.0312,0.4475,0.5619,0.1493,0.3702	0.2416	0.1370	D	T	D	T	23.80	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM3996941	99	551	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152282311	152282311	C	T	het	pred_pathogenic;anno_omim	QUAL=39336;DP=526;AF=0.46;MQM=59;TRIO=HET,526,0.46,HET,1241,0.48,HET,1517,0.51	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.5051G>A:p.Arg1684His,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-5071C>T:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-5071C>T:		rs12407807	0.2967	0.2320	4772,823,25	0.0667,0.4482,0.5622,0.1494,0.3703	0.2440	-2.4830	T	T	D	T	17.66	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];				99	556	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152282917	152282917	G	T	het	pred_pathogenic;anno_omim	QUAL=38140;DP=490;AF=0.50;MQM=59;TRIO=HET,490,0.50,HET,1078,0.49,HET,1524,0.50	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.4445C>A:p.Ser1482Tyr,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-4465G>T:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-4465G>T:		rs11204978	0.2871	0.2287	4739,822,4	0.0312,0.4472,0.5608,0.1493,0.3700	0.2416	0.2470	D	T	B	T	20.70	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM3996942	98	551	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152283236	152283236	T	C	het	anno_omim	QUAL=75862;DP=528;AF=0.48;MQM=55;TRIO=HET,528,0.48,HET,1310,0.49,HOM,1682,0.99	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.4126A>G:p.Arg1376Gly,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-4146T>C:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-4146T>C:		rs11581433	0.3431	0.2614	5670,1074,84	0.1310,0.4693,0.5787,0.1718,0.4262	0.2719	-2.3740	T	T	B	T	0.01	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];				121	600	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152283283	152283283	C	T	het	anno_omim	QUAL=39991;DP=525;AF=0.48;MQM=53;TRIO=HET,525,0.48,HET,1249,0.50,HET,1663,0.49	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.4079G>A:p.Arg1360His,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-4099C>T:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-4099C>T:		rs11586631	0.2877	0.2289	4733,821,5	0.0334,0.4472,0.5593,0.1494,0.3700	0.2417	-6.3060	T	T	B	T	15.37	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM4142696	98	554	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152283862	152283862	G	C	het	anno_omim	QUAL=61859;DP=539;AF=0.49;MQM=54;TRIO=HET,539,0.49,HET,1071,0.48,HOM,1395,0.99	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.3500C>G:p.Ala1167Gly,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-3520G>C:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-3520G>C:		rs58001094	0.5341	0.3040	7080,917,2165	0.6688,0.4726,0.5799,0.1712,0.4075	0.3400		T	T	B	T	0.01	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM1600315	128	627	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152283975	152283975	A	G	het	anno_omim	QUAL=72530;DP=573;AF=0.50;MQM=52;TRIO=HET,573,0.50,HET,1176,0.49,HOM,1637,1.00	FLG,FLG-AS1	synonymous,intron	FLG:ENST00000368799:synonymous:LOW:exon3/3:c.3387T>C:p.Ser1129Ser,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-3407A>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-3407A>G:		rs66831674	0.4631	0.2943	6959,1082,1208	0.4802,0.4764,0.6018,0.1724,0.4276	0.2981							135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM3996943	129	608	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152284377	152284377	G	A	het	anno_omim	QUAL=30395;DP=584;AF=0.53;MQM=55;TRIO=HET,584,0.53,WT,1297,0.00,HET,1614,0.55	FLG,FLG-AS1	synonymous,intron	FLG:ENST00000368799:synonymous:LOW:exon3/3:c.2985C>T:p.His995His,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-3005G>A:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-3005G>A:		rs373872833	0.0000	0.0001	0,0,0	0.0000,0.0004,0.0000,0.0001,0.0000	0.0001							135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];				0	6					FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152284854	152284854	A	G	het	anno_omim	QUAL=57077;DP=488;AF=0.47;MQM=58;TRIO=HET,488,0.47,HET,879,0.51,HOM,1248,0.99	FLG,FLG-AS1	synonymous,intron	FLG:ENST00000368799:synonymous:LOW:exon3/3:c.2508T>C:p.Asp836Asp,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-2528A>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-2528A>G:		rs3120653	0.4732	0.2978	7162,1091,1406	0.5180,0.4778,0.6039,0.1729,0.4261	0.3011							135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];				130	612	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152285099	152285099	C	T	het	pred_pathogenic;anno_omim	QUAL=86468;DP=493;AF=0.53;MQM=59;TRIO=HET,493,0.53,HET,1423,0.50,HOM,1887,1.00	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.2263G>A:p.Glu755Lys,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-2283C>T:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-2283C>T:		rs74129461	0.3277	0.2559	5584,1073,29	0.0766,0.4617,0.5815,0.1716,0.4257	0.2674	-0.3080	T	T	B	T	22.60	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM3996944	118	594	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152285930	152285930	G	A	het	anno_omim	QUAL=70377;DP=522;AF=0.51;MQM=59;TRIO=HET,522,0.51,HET,1181,0.49,HOM,1576,0.99	FLG,FLG-AS1	missense,intron	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.1432C>T:p.Pro478Ser,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-1452G>A:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-1452G>A:		rs11584340	0.3446	0.2613	5646,1060,89	0.1364,0.4642,0.5820,0.1715,0.4261	0.2718	-1.8930	T,T	T	B	T	0.01	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];		CM084968 [CLASS=DP MUT=ALT PHEN="Psoriasis increased risk association with" GENE=FLG]; 		121	598	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152286002	152286002	T	C	het	anno_omim;anno_pathogenic_hgmd	QUAL=68436;DP=457;AF=0.48;MQM=59;TRIO=HET,457,0.48,HET,1157,0.49,HOM,1577,0.99	FLG,FLG-AS1	missense,intron,non_coding_transcript_exon	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.1360A>G:p.Thr454Ala,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-1380T>C:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-1380T>C:,FLG-AS1:ENST00000392688:non_coding_transcript_exon:MODIFIER:exon1/7:n.68T>C:		rs2011331	0.4641	0.2949	6975,1079,1214	0.4821,0.4770,0.6055,0.1728,0.4278	0.2988	-2.8550	T	T	B	T	1.41	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];		CM1611993 [CLASS=DM? MUT=ALT PHEN="Ichthyosis vulgaris" GENE=FLG]; 	COSM4142699	129	610	3	[3] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152286032	152286032	C	T	het	anno_omim	QUAL=40732;DP=577;AF=0.48;MQM=59;TRIO=HET,577,0.48,HET,1214,0.50,HET,1566,0.46	FLG,FLG-AS1	missense,intron,non_coding_transcript_exon	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.1330G>A:p.Gly444Arg,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-1350C>T:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-1350C>T:,FLG-AS1:ENST00000392688:non_coding_transcript_exon:MODIFIER:exon1/7:n.98C>T:		rs11588170	0.2871	0.2287	4727,813,4	0.0312,0.4475,0.5609,0.1492,0.3699	0.2415	-0.6390	T	T	P	T	6.88	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM3996946	98	552	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152286126	152286126	A	G	het	anno_omim	QUAL=20453;DP=473;AF=0.49;MQM=59;TRIO=HET,473,0.49,HET,1206,0.50,WT,1528,0.00	FLG,FLG-AS1	synonymous,intron,non_coding_transcript_exon	FLG:ENST00000368799:synonymous:LOW:exon3/3:c.1236T>C:p.Arg412Arg,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-1256A>G:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-1256A>G:,FLG-AS1:ENST00000392688:non_coding_transcript_exon:MODIFIER:exon1/7:n.192A>G:		rs11582620	0.0861	0.1176	1007,442,1	0.0182,0.0987,0.1015,0.1158,0.2019	0.1164							135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];			COSM146620	27	335	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	152286367	152286367	C	A	het	pred_pathogenic;anno_omim	QUAL=59549;DP=570;AF=0.51;MQM=59;TRIO=HET,570,0.51,HET,915,0.50,HOM,1284,1.00	FLG,FLG-AS1	missense,intron,non_coding_transcript_exon	FLG:ENST00000368799:missense:MODERATE:exon3/3:c.995G>T:p.Gly332Val,FLG-AS1:ENST00000593011:intron:MODIFIER:exon2/3:n.377-1015C>A:,FLG-AS1:ENST00000420707:intron:MODIFIER:exon4/8:n.463-1015C>A:,FLG-AS1:ENST00000392688:non_coding_transcript_exon:MODIFIER:exon1/7:n.433C>A:		rs41267154	0.3407	0.2603	5628,1059,75	0.1265,0.4634,0.5803,0.1715,0.4261	0.2711	-1.0200	T	T	D	T	15.37	135940 [FLG (confirmed) Ichthyosis vulgaris,146700|Dermatitis,atopic,susceptibility to,2,605803];				118	598	2	[2] auto-classification 14.09.2017  			FLG (inh=AD pLI=n/a), FLG-AS1 (inh=n/a pLI=n/a)
chr1	154138283	154138283	G	A	hom	anno_omim	QUAL=446;DP=153;AF=0.25;MQM=53;TRIO=HOM,153,0.25,HOM,30,0.23,HOM,46,0.28	TPM3	intron	TPM3:ENST00000271850:intron:MODIFIER:exon8/8:c.775+4593C>T:,TPM3:ENST00000368533:intron:MODIFIER:exon7/7:c.664+4593C>T:,TPM3:ENST00000330188:intron:MODIFIER:exon7/7:c.664+4593C>T:,TPM3:ENST00000341485:intron:MODIFIER:exon7/7:c.616+4593C>T:,TPM3:ENST00000341372:intron:MODIFIER:exon7/7:c.589+4593C>T:,TPM3:ENST00000328159:intron:MODIFIER:exon8/8:c.743+3498C>T:,TPM3:ENST00000302206:intron:MODIFIER:exon7/7:c.394+4593C>T:,TPM3:ENST00000368531:intron:MODIFIER:exon7/7:c.664+4593C>T:,TPM3:ENST00000323144:intron:MODIFIER:exon7/7:c.664+4593C>T:	AluSq2	rs200411262	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0038							191030 [TPM3 (confirmed) Nemaline myopathy 1,autosomal dominant or recessive,609284|CAP myopathy 1,609284|Myopathy,congenital,with fiber-type disproportion,255310];				6	15					TPM3 (inh=AR+AD pLI=0.19)
chr1	154548721	154548721	T	C	hom	anno_omim	QUAL=8969;DP=115;AF=0.98;MQM=59;TRIO=HOM,115,0.98,HOM,126,1.00,HET,110,0.51	CHRNB2	3'UTR	CHRNB2:ENST00000368476:3'UTR:MODIFIER:exon6/6:c.*313T>C:		rs2072660	0.6927	0.0000	0,0,0	0,0,0,0,0	0.7072							118507 [CHRNB2 (confirmed) Epilepsy,nocturnal frontal lobe,3,605375];				143	77					CHRNB2 (inh=AD pLI=0.72)
chr1	154552010	154552010	C	G	het	anno_omim	QUAL=8476;DP=299;AF=0.56;MQM=59;TRIO=HET,299,0.56,HET,337,0.48,WT,413,0.00	CHRNB2,RP11-61L14.6	3'UTR	CHRNB2:ENST00000368476:3'UTR:MODIFIER:exon6/6:c.*3602C>G:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0001							118507 [CHRNB2 (confirmed) Epilepsy,nocturnal frontal lobe,3,605375];				0	2					CHRNB2 (inh=AD pLI=0.72), RP11-61L14.6 (inh=n/a pLI=n/a)
chr1	156107534	156107534	C	T	het	anno_omim	QUAL=6821;DP=153;AF=0.60;MQM=59;TRIO=HET,153,0.60,WT,263,0.00,HET,353,0.54	LMNA	splice_region&synonymous,synonymous,intron	LMNA:ENST00000368300:splice_region&synonymous:LOW:exon10/12:c.1698C>T:p.His566His,LMNA:ENST00000368299:splice_region&synonymous:LOW:exon10/12:c.1698C>T:p.His566His,LMNA:ENST00000448611:splice_region&synonymous:LOW:exon10/13:c.1362C>T:p.His454His,LMNA:ENST00000473598:splice_region&synonymous:LOW:exon11/13:c.1401C>T:p.His467His,LMNA:ENST00000368301:synonymous:LOW:exon13/13:c.1698C>T:p.His566His,LMNA:ENST00000361308:synonymous:LOW:exon10/10:c.1698C>T:p.His566His,LMNA:ENST00000368297:synonymous:LOW:exon11/11:c.1455C>T:p.His485His,LMNA:ENST00000392353:synonymous:LOW:exon10/10:c.1455C>T:p.His485His,LMNA:ENST00000347559:intron:MODIFIER:exon9/10:c.1608+511C>T:		rs4641	0.2202	0.2655	756,324,16	0.0998,0.3660,0.3081,0.2817,0.2943	0.2634							150330 [LMNA (confirmed) Emery-Dreifuss muscular dystrophy 2,AD,181350|Cardiomyopathy,dilated,1A,115200|Lipodystrophy,familial partial,type 2,151660|Emery-Dreifuss muscular dystrophy 3,AR,616516|Charcot-Marie-Tooth disease,type 2B1,605588|Muscular dystrophy,congenital,613205|Muscular dystrophy,limb-girdle,type 1B,159001|Mandibuloacral dysplasia,248370|Hutchinson-Gilford progeria,176670|Restrictive dermopathy,lethal,275210|Heart-hand syndrome,Slovenian type,610140|Malouf syndrome,212112];	RCV000041327.8 [other]; RCV000057348.2 [not provided]; RCV000225004.1 [benign]; RCV000252567.1 [benign]; RCV000280696.1 [benign]; RCV000307278.1 [benign]; RCV000310337.1 [benign]; RCV000313972.1 [benign]; RCV000335127.1 [benign]; RCV000339153.1 [benign]; RCV000350197.1 [benign]; RCV000375103.1 [benign]; RCV000393593.1 [benign]; RCV000398387.1 [benign]; 	CM003892 [CLASS=DP MUT=ALT PHEN="Metabolic syndrome association with" GENE=LMNA]; 	COSM3750412, COSM3750413	166	775	2	[2] auto-classification 14.09.2017  			LMNA (inh=AR+AD pLI=0.99)
chr1	156785617	156785617	G	A	hom	anno_omim	QUAL=22498;DP=200;AF=1.00;MQM=59;TRIO=HOM,200,1.00,HOM,211,1.00,HOM,301,1.00	NTRK1,SH2D2A	5'UTR,intron	NTRK1:ENST00000392302:5'UTR:MODIFIER:exon1/17:c.-5G>A:,SH2D2A:ENST00000392306:intron:MODIFIER:exon2/8:c.123+181C>T:,SH2D2A:ENST00000368198:intron:MODIFIER:exon2/8:c.69+181C>T:,SH2D2A:ENST00000368199:intron:MODIFIER:exon2/8:c.123+181C>T:		rs1800601	0.6370	0.6674	27406,15332,1316	0.5013,0.6842,0.8219,0.6768,0.6537	0.6737							191315 [NTRK1 (confirmed) Insensitivity to pain,congenital,with anhidrosis,256800|Medullary thyroid carcinoma,familial,155240];				998	939					NTRK1 (inh=AR+AD pLI=0.00), SH2D2A (inh=n/a pLI=0.00)
chr1	156846233	156846233	G	A	het	anno_omim	QUAL=6482;DP=156;AF=0.49;MQM=60;TRIO=HET,156,0.49,HOM,150,1.00,WT,147,0.00	NTRK1	synonymous	NTRK1:ENST00000524377:synonymous:LOW:exon14/17:c.1674G>A:p.Gln558Gln,NTRK1:ENST00000392302:synonymous:LOW:exon14/17:c.1566G>A:p.Gln522Gln,NTRK1:ENST00000368196:synonymous:LOW:exon13/16:c.1656G>A:p.Gln552Gln,NTRK1:ENST00000358660:synonymous:LOW:exon13/16:c.1665G>A:p.Gln555Gln		rs6334	0.2129	0.2203	3033,1498,102	0.1350,0.2174,0.3553,0.2145,0.2327	0.2203							191315 [NTRK1 (confirmed) Insensitivity to pain,congenital,with anhidrosis,256800|Medullary thyroid carcinoma,familial,155240];	RCV000366755.1 [benign]; 		COSM3750439, COSM3750440	112	712	2	[2] auto-classification 14.09.2017  			NTRK1 (inh=AR+AD pLI=0.00)
chr1	156848995	156848995	C	T	het	anno_omim	QUAL=3913;DP=53;AF=0.34;MQM=59;TRIO=HET,53,0.34,WT,104,0.01,HOM,128,0.97	NTRK1	synonymous	NTRK1:ENST00000524377:synonymous:LOW:exon15/17:c.1887C>T:p.Ala629Ala,NTRK1:ENST00000392302:synonymous:LOW:exon15/17:c.1779C>T:p.Ala593Ala,NTRK1:ENST00000368196:synonymous:LOW:exon14/16:c.1869C>T:p.Ala623Ala,NTRK1:ENST00000358660:synonymous:LOW:exon14/16:c.1878C>T:p.Ala626Ala		rs6337	0.3341	0.5724	22665,17445,216	0.2049,0.5699,0.0365,0.7286,0.3894	0.5806							191315 [NTRK1 (confirmed) Insensitivity to pain,congenital,with anhidrosis,256800|Medullary thyroid carcinoma,familial,155240];	RCV000127264.1 [benign]; RCV000287221.1 [benign]; 		COSM4142850, COSM4142851	959	940	2	[2] auto-classification 14.09.2017  			NTRK1 (inh=AR+AD pLI=0.00)
chr1	160009121	160009121	A	C	het	anno_omim	QUAL=3032;DP=174;AF=0.50;MQM=59;TRIO=HET,174,0.50,HET,68,0.46,WT,81,0.00	KCNJ10	3'UTR	KCNJ10:ENST00000368089:3'UTR:MODIFIER:exon2/2:c.*2062T>G:		rs1053074	0.4810	0.0000	0,0,0	0,0,0,0,0	0.4439							602208 [KCNJ10 (confirmed) SESAME syndrome,612780|Enlarged vestibular aqueduct,digenic,600791];	RCV000275599.1 [likely benign]; RCV000328225.1 [likely benign]; RCV000367826.1 [likely benign]; 			37	108					KCNJ10 (inh=AR pLI=0.60)
chr1	160009143	160009143	G	C	hom	anno_omim	QUAL=8499;DP=145;AF=1.00;MQM=59;TRIO=HOM,145,1.00,HOM,59,0.97,HOM,69,1.00	KCNJ10	3'UTR	KCNJ10:ENST00000368089:3'UTR:MODIFIER:exon2/2:c.*2040C>G:		rs2486254	0.9982	0.0000	0,0,0	0,0,0,0,0	0.9972							602208 [KCNJ10 (confirmed) SESAME syndrome,612780|Enlarged vestibular aqueduct,digenic,600791];	RCV000288441.1 [benign]; RCV000326994.1 [benign]; RCV000385122.1 [benign]; 			223	0					KCNJ10 (inh=AR pLI=0.60)
chr1	160009164	160009171	ACACACAC	-	hom	low_DP;anno_omim	QUAL=463;DP=9;AF=0.00;MQM=60;TRIO=HOM,9,0.56,WT,34,0.56,WT,42,0.05	KCNJ10	3'UTR	KCNJ10:ENST00000368089:3'UTR:MODIFIER:exon2/2:c.*2012_*2019delGTGTGTGT:	(AC)n	rs68110005;rs777546653	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1523							602208 [KCNJ10 (confirmed) SESAME syndrome,612780|Enlarged vestibular aqueduct,digenic,600791];	RCV000271458.1 [uncertain significance]; RCV000310224.1 [uncertain significance]; RCV000362624.1 [uncertain significance]; 			17	0					KCNJ10 (inh=AR pLI=0.60)
chr1	160009419	160009419	A	C	hom	anno_omim	QUAL=31957;DP=369;AF=0.99;MQM=59;TRIO=HOM,369,0.99,HOM,263,1.00,HOM,346,1.00	KCNJ10	3'UTR	KCNJ10:ENST00000368089:3'UTR:MODIFIER:exon2/2:c.*1764T>G:		rs2486253	0.8628	0.0000	0,0,0	0,0,0,0,0	0.8136							602208 [KCNJ10 (confirmed) SESAME syndrome,612780|Enlarged vestibular aqueduct,digenic,600791];	RCV000262610.1 [benign]; RCV000302435.1 [benign]; RCV000359621.1 [benign]; 			158	66					KCNJ10 (inh=AR pLI=0.60)
chr1	160246990	160246990	T	-	het	anno_omim	QUAL=216;DP=292;AF=0.18;MQM=59;TRIO=HET,292,0.18,HET,137,0.21,WT,191,0.16	PEX19,DCAF8	3'UTR,intron	PEX19:ENST00000368072:3'UTR:MODIFIER:exon8/8:c.*2351delA:,DCAF8:ENST00000556710:intron:MODIFIER:exon6/17:c.436+931delA:,DCAF8:ENST00000608310:intron:MODIFIER:exon6/17:c.436+931delA:	Charlie10	rs751979135	0.0000	0.2690	0,0,0	0.0000,0.0000,0.0000,0.2753,0.2648	0.2458							615820 [DCAF8 (provisional) Giant axonal neuropathy 2,autosomal dominant,610100]:600279 [PEX19 (confirmed) Peroxisome biogenesis disorder 12A (Zellweger),614886];				0	57					PEX19 (inh=AR pLI=0.04), DCAF8 (inh=AD pLI=1.00)
chr1	160247185	160247185	G	C	het	anno_omim	QUAL=10232;DP=284;AF=0.44;MQM=60;TRIO=HET,284,0.44,WT,167,0.01,HOM,217,1.00	PEX19,DCAF8	3'UTR,intron	PEX19:ENST00000368072:3'UTR:MODIFIER:exon8/8:c.*2156C>G:,DCAF8:ENST00000556710:intron:MODIFIER:exon6/17:c.436+736C>G:,DCAF8:ENST00000608310:intron:MODIFIER:exon6/17:c.436+736C>G:	Charlie10	rs10594	0.4523	0.5642	1766,279,19	0.0000,0.0000,0.0000,0.4481,0.6152	0.4954							615820 [DCAF8 (provisional) Giant axonal neuropathy 2,autosomal dominant,610100]:600279 [PEX19 (confirmed) Peroxisome biogenesis disorder 12A (Zellweger),614886];	RCV000334144.1 [benign]; 			573	939					PEX19 (inh=AR pLI=0.04), DCAF8 (inh=AD pLI=1.00)
chr1	161140278	161140278	A	-	het	anno_high_impact;anno_omim	QUAL=6153;DP=232;AF=0.45;MQM=59;TRIO=HET,232,0.45,WT,330,0.00,HET,376,0.45	PPOX	frameshift,intron	PPOX:ENST00000352210:frameshift:HIGH:exon10/13:c.1067delA:p.Gln356fs,PPOX:ENST00000367999:frameshift:HIGH:exon10/13:c.1067delA:p.Gln356fs,PPOX:ENST00000432542:frameshift:HIGH:exon4/6:c.302delA:p.Gln101fs,PPOX:ENST00000544598:intron:MODIFIER:exon3/5:c.223-132delA:,PPOX:ENST00000535223:intron:MODIFIER:exon2/3:c.88-132delA:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							600923 [PPOX (provisional) Porphyria variegata,176200];				0	2					PPOX (inh=AR+AD pLI=0.33)
chr1	167399868	167399868	-	AG	hom	anno_omim	QUAL=15645;DP=191;AF=0.99;MQM=59;TRIO=HOM,191,0.99,HOM,147,0.99,HOM,177,0.99	POU2F1,CD247	intergenic_region	CD247:ENSG00000143190-ENSG00000198821:intergenic_region:MODIFIER::n.167399868_167399869insAG:		rs397750029	0.9870	0.0000	0,0,0	0,0,0,0,0	0.9884							186780 [CD247 (confirmed) Immunodeficiency 25,610163];				231	1					POU2F1 (inh=n/a pLI=0.91), CD247 (inh=AR pLI=0.66)
chr1	167399962	167399962	T	C	hom	anno_omim	QUAL=39723;DP=389;AF=1.00;MQM=59;TRIO=HOM,389,1.00,HOM,381,1.00,HOM,464,1.00	CD247	3'UTR	CD247:ENST00000362089:3'UTR:MODIFIER:exon8/8:c.*956A>G:,CD247:ENST00000392122:3'UTR:MODIFIER:exon8/8:c.*956A>G:		rs947480	0.9874	0.0000	0,0,0	0,0,0,0,0	0.9884							186780 [CD247 (confirmed) Immunodeficiency 25,610163];				231	1					CD247 (inh=AR pLI=0.66)
chr1	167400074	167400074	T	A	hom	anno_omim	QUAL=45607;DP=406;AF=1.00;MQM=59;TRIO=HOM,406,1.00,HOM,433,1.00,HOM,593,1.00	CD247	3'UTR	CD247:ENST00000362089:3'UTR:MODIFIER:exon8/8:c.*844A>T:,CD247:ENST00000392122:3'UTR:MODIFIER:exon8/8:c.*844A>T:		rs1052231	0.8111	0.0000	0,0,0	0,0,0,0,0	0.8148							186780 [CD247 (confirmed) Immunodeficiency 25,610163];				173	51					CD247 (inh=AR pLI=0.66)
chr1	179519880	179519880	T	C	hom	anno_omim	QUAL=27918;DP=268;AF=1.00;MQM=60;TRIO=HOM,268,1.00,HOM,272,1.00,HOM,330,1.00	NPHS2,AXDND1	3'UTR,intron	NPHS2:ENST00000367615:3'UTR:MODIFIER:exon8/8:c.*428A>G:,NPHS2:ENST00000367616:3'UTR:MODIFIER:exon7/7:c.*428A>G:,AXDND1:ENST00000367618:intron:MODIFIER:exon25/25:c.3032-3767T>C:		rs1060775	0.9018	0.0000	0,0,0	0,0,0,0,0	0.9089							604766 [NPHS2 (confirmed) Nephrotic syndrome,type 2,600995];	RCV000210058.1 [benign]; RCV000263320.1 [benign]; 			193	38					NPHS2 (inh=AR pLI=0.01), AXDND1 (inh=n/a pLI=0.00)
chr1	179520050	179520050	T	C	het	anno_omim	QUAL=7951;DP=330;AF=0.45;MQM=60;TRIO=HET,330,0.45,HOM,121,1.00,WT,177,0.00	NPHS2,AXDND1	3'UTR,intron	NPHS2:ENST00000367615:3'UTR:MODIFIER:exon8/8:c.*258A>G:,NPHS2:ENST00000367616:3'UTR:MODIFIER:exon7/7:c.*258A>G:,AXDND1:ENST00000367618:intron:MODIFIER:exon25/25:c.3032-3597T>C:		rs2274622	0.2831	0.0000	0,0,0	0,0,0,0,0	0.2323							604766 [NPHS2 (confirmed) Nephrotic syndrome,type 2,600995];	RCV000210053.1 [benign]; RCV000354410.1 [likely benign]; 			23	81					NPHS2 (inh=AR pLI=0.01), AXDND1 (inh=n/a pLI=0.00)
chr1	179520151	179520151	C	T	hom	anno_omim	QUAL=24234;DP=290;AF=1.00;MQM=59;TRIO=HOM,290,1.00,HOM,194,1.00,HOM,263,0.99	NPHS2,AXDND1	3'UTR,intron	NPHS2:ENST00000367615:3'UTR:MODIFIER:exon8/8:c.*157G>A:,NPHS2:ENST00000367616:3'UTR:MODIFIER:exon7/7:c.*157G>A:,AXDND1:ENST00000367618:intron:MODIFIER:exon25/25:c.3032-3496C>T:		rs1410590	0.9052	0.0000	0,0,0	0,0,0,0,0	0.9118							604766 [NPHS2 (confirmed) Nephrotic syndrome,type 2,600995];	RCV000210055.1 [benign]; RCV000265258.1 [benign]; 			193	38					NPHS2 (inh=AR pLI=0.01), AXDND1 (inh=n/a pLI=0.00)
chr1	179520254	179520254	C	G	hom	anno_omim	QUAL=22119;DP=393;AF=0.99;MQM=59;TRIO=HOM,393,0.99,HOM,131,0.99,HOM,174,0.99	NPHS2,AXDND1	3'UTR,intron	NPHS2:ENST00000367615:3'UTR:MODIFIER:exon8/8:c.*54G>C:,NPHS2:ENST00000367616:3'UTR:MODIFIER:exon7/7:c.*54G>C:,AXDND1:ENST00000367618:intron:MODIFIER:exon25/25:c.3032-3393C>G:		rs1410591	0.5879	0.0000	0,0,0	0,0,0,0,0	0.6116							604766 [NPHS2 (confirmed) Nephrotic syndrome,type 2,600995];	RCV000320321.1 [likely benign]; 			736	930					NPHS2 (inh=AR pLI=0.01), AXDND1 (inh=n/a pLI=0.00)
chr1	179520506	179520506	G	A	hom	anno_omim	QUAL=20741;DP=346;AF=0.99;MQM=60;TRIO=HOM,346,0.99,HOM,128,0.99,HOM,184,1.00	NPHS2,AXDND1	synonymous,intron	NPHS2:ENST00000367615:synonymous:LOW:exon8/8:c.954C>T:p.Ala318Ala,NPHS2:ENST00000367616:synonymous:LOW:exon7/7:c.750C>T:p.Ala250Ala,AXDND1:ENST00000367618:intron:MODIFIER:exon25/25:c.3032-3141G>A:		rs1410592	0.5877	0.6192	23360,13445,1870	0.5972,0.6658,0.4806,0.6358,0.6042	0.6197							604766 [NPHS2 (confirmed) Nephrotic syndrome,type 2,600995];	RCV000243457.1 [benign]; RCV000289839.1 [likely benign]; 		COSM146700	802	1012	2	[2] auto-classification 14.09.2017  			NPHS2 (inh=AR pLI=0.01), AXDND1 (inh=n/a pLI=0.00)
chr1	179544898	179544898	T	C	hom	low_DP;anno_omim	QUAL=441;DP=1;AF=1.00;MQM=60;TRIO=HOM,1,1.00,HOM,3,1.00,HOM,13,1.00	NPHS2	synonymous	NPHS2:ENST00000367615:synonymous:LOW:exon1/8:c.102A>G:p.Gly34Gly,NPHS2:ENST00000367616:synonymous:LOW:exon1/7:c.102A>G:p.Gly34Gly		rs1079292	0.9309	0.9616	4890,1600,105	0.8323,0.9797,0.9812,0.9923,0.9504	0.9775							604766 [NPHS2 (confirmed) Nephrotic syndrome,type 2,600995];	RCV000247522.1 [benign]; RCV000361602.1 [benign]; 		COSM3749013	1891	88	2	[2] auto-classification 14.09.2017  			NPHS2 (inh=AR pLI=0.01)
chr1	180235728	180235728	C	T	het	anno_omim	QUAL=1870;DP=76;AF=0.51;MQM=59;TRIO=HET,76,0.51,WT,91,0.00,HET,108,0.42	LHX4	splice_region&synonymous	LHX4:ENST00000263726:splice_region&synonymous:LOW:exon3/6:c.450C>T:p.Asn150Asn		rs16855642	0.0427	0.0218	65,3,50	0.1092,0.0102,0.0129,0.0115,0.0191	0.0370							602146 [LHX4 (confirmed) Pituitary hormone deficiency,combined,4,262700];	RCV000246585.1 [benign]; RCV000341510.1 [likely benign]; 			1	55					LHX4 (inh=AR+AD pLI=0.40)
chr1	180240510	180240510	T	C	het	anno_omim	QUAL=1640;DP=69;AF=0.52;MQM=60;TRIO=HET,69,0.52,HET,77,0.47,WT,115,0.00	LHX4,RP5-1180C10.2	splice_region&intron	LHX4:ENST00000263726:splice_region&intron:LOW:exon3/5:c.452-5T>C:		rs2764449	0.0413	0.0665	352,213,2	0.0150,0.0252,0.0128,0.0790,0.0813	0.0664							602146 [LHX4 (confirmed) Pituitary hormone deficiency,combined,4,262700];	RCV000301831.1 [likely benign]; 		COSM3997105	14	288	2	[2] auto-classification 14.09.2017  			LHX4 (inh=AR+AD pLI=0.40), RP5-1180C10.2 (inh=n/a pLI=n/a)
chr1	180243524	180243524	A	G	het	pred_pathogenic;anno_omim	QUAL=7708;DP=211;AF=0.48;MQM=60;TRIO=HET,211,0.48,HET,155,0.48,HET,204,0.57	LHX4,RP5-1180C10.2	missense	LHX4:ENST00000263726:missense:MODERATE:exon6/6:c.983A>G:p.Asn328Ser		rs7536561	0.4263	0.4850	15435,9207,216	0.1875,0.2390,0.5837,0.5253,0.5981	0.4835	2.5290	T	T	B	D	0.46	602146 [LHX4 (confirmed) Pituitary hormone deficiency,combined,4,262700];	RCV000242291.1 [benign]; RCV000313852.1 [benign]; 		COSM3746684	614	972	2	[2] auto-classification 14.09.2017  			LHX4 (inh=AR+AD pLI=0.40), RP5-1180C10.2 (inh=n/a pLI=n/a)
chr1	183155305	183155305	G	A	het	anno_omim	QUAL=20062;DP=281;AF=0.52;MQM=60;TRIO=HET,281,0.52,WT,367,0.00,HOM,522,1.00	LAMC1,LAMC2	intergenic_region	LAMC2:ENSG00000135862-ENSG00000058085:intergenic_region:MODIFIER::n.183155305G>A:		rs2276543	0.2989	0.0000	0,0,0	0,0,0,0,0	0.2733							150292 [LAMC2 (confirmed) Epidermolysis bullosa,junctional,Herlitz type,226700|Epidermolysis bullosa,junctional,non-Herlitz type,226650];	RCV000387645.1 [benign]; 			13	91					LAMC1 (inh=n/a pLI=1.00), LAMC2 (inh=AR pLI=0.00)
chr1	183524855	183524855	C	A	hom	anno_omim	QUAL=44594;DP=476;AF=1.00;MQM=59;TRIO=HOM,476,1.00,HOM,391,0.99,HOM,547,0.99	NCF2,SMG7	3'UTR	NCF2:ENST00000413720:3'UTR:MODIFIER:exon14/14:c.*398G>T:,NCF2:ENST00000418089:3'UTR:MODIFIER:exon13/13:c.*398G>T:,NCF2:ENST00000367536:3'UTR:MODIFIER:exon16/16:c.*398G>T:		rs796860	0.9393	0.0000	0,0,0	0,0,0,0,0	0.9058							608515 [NCF2 (confirmed) Chronic granulomatous disease due to deficiency of NCF-2,233710];	RCV000361687.1 [benign]; 			73	122					NCF2 (inh=AR pLI=0.00), SMG7 (inh=n/a pLI=1.00)
chr1	183542387	183542387	T	C	hom	anno_omim	QUAL=18383;DP=259;AF=0.99;MQM=59;TRIO=HOM,259,0.99,HOM,191,1.00,HET,267,0.54	NCF2,SMG7	missense,intron	NCF2:ENST00000367535:missense:MODERATE:exon5/15:c.542A>G:p.Lys181Arg,NCF2:ENST00000413720:missense:MODERATE:exon4/14:c.407A>G:p.Lys136Arg,NCF2:ENST00000367536:missense:MODERATE:exon6/16:c.542A>G:p.Lys181Arg,NCF2:ENST00000418089:intron:MODIFIER:exon3/12:c.367-2413A>G:		rs2274064	0.4916	0.4895	15075,7092,687	0.3626,0.6573,0.6286,0.4582,0.5122	0.4988	0.5830	T,T,T,T	T	B,B	T,T,T	7.83	608515 [NCF2 (confirmed) Chronic granulomatous disease due to deficiency of NCF-2,233710];	RCV000243467.1 [benign]; RCV000388595.1 [benign]; 		COSM3750690	537	1272	2	[2] auto-classification 14.09.2017  			NCF2 (inh=AR pLI=0.00), SMG7 (inh=n/a pLI=1.00)
chr1	196654324	196654324	A	C	het	anno_omim	QUAL=9439;DP=287;AF=0.49;MQM=60;TRIO=HET,287,0.49,HET,209,0.48,HET,266,0.47	CFH	synonymous	CFH:ENST00000367429:synonymous:LOW:exon7/22:c.921A>C:p.Ala307Ala,CFH:ENST00000439155:synonymous:LOW:exon7/10:c.921A>C:p.Ala307Ala,CFH:ENST00000359637:synonymous:LOW:exon6/9:c.729A>C:p.Ala243Ala		rs1061147	0.7131	0.6666	27692,12666,1709	0.5734,0.8434,0.9510,0.6167,0.7003	0.6753							134370 [CFH (confirmed) Hemolytic uremic syndrome,atypical,susceptibility to,1,235400|Complement factor H deficiency,609814|Macular degeneration,age-related,4,610698|Basal laminar drusen,126700];	RCV000267123.1 [benign]; RCV000305955.1 [benign]; RCV000354801.1 [benign]; RCV000358116.1 [benign]; 		COSM3750723	877	960	2	[2] auto-classification 14.09.2017  			CFH (inh=AR+AD pLI=1.00)
chr1	196659237	196659237	C	T	het	anno_omim	QUAL=5463;DP=191;AF=0.57;MQM=56;TRIO=HET,191,0.57,HET,104,0.41,HET,108,0.49	CFH	missense	CFH:ENST00000367429:missense:MODERATE:exon9/22:c.1204C>T:p.His402Tyr,CFH:ENST00000439155:missense:MODERATE:exon9/10:c.1204C>T:p.His402Tyr,CFH:ENST00000359637:missense:MODERATE:exon8/9:c.1012C>T:p.His338Tyr		rs1061170	0.7334	0.6721	27768,12485,2037	0.6307,0.8458,0.9506,0.6169,0.7008	0.6787	-6.7150	T,T,T,T	T	B,B	T,T,T	0.01	134370 [CFH (confirmed) Hemolytic uremic syndrome,atypical,susceptibility to,1,235400|Complement factor H deficiency,609814|Macular degeneration,age-related,4,610698|Basal laminar drusen,126700];	RCV000296616.1 [benign]; RCV000327040.1 [benign]; RCV000349294.1 [benign]; RCV000388493.1 [benign]; 		COSM424915	880	956	2	[2] old entry - no details available			CFH (inh=AR+AD pLI=1.00)
chr1	196682947	196682947	G	A	het	anno_omim	QUAL=8619;DP=262;AF=0.42;MQM=60;TRIO=HET,262,0.42,HET,192,0.49,HET,257,0.48	CFH	synonymous	CFH:ENST00000367429:synonymous:LOW:exon10/22:c.1419G>A:p.Ala473Ala		rs2274700	0.4790	0.4431	12010,5836,1095	0.4594,0.4518,0.4359,0.4182,0.5481	0.4439							134370 [CFH (confirmed) Hemolytic uremic syndrome,atypical,susceptibility to,1,235400|Complement factor H deficiency,609814|Macular degeneration,age-related,4,610698|Basal laminar drusen,126700];	RCV000281469.1 [benign]; RCV000338900.1 [benign]; RCV000387444.1 [benign]; RCV000404891.1 [benign]; 	CM062504 [CLASS=DP MUT=ALT PHEN="Membranoproliferative glomerulonephritis association" GENE=CFH]; 	COSM3750724	462	1003	2	[2] auto-classification 14.09.2017  			CFH (inh=AR+AD pLI=1.00)
chr1	196709816	196709816	G	T	het	pred_pathogenic;anno_omim;anno_pathogenic_hgmd	QUAL=6969;DP=285;AF=0.53;MQM=59;TRIO=HET,285,0.53,WT,187,0.00,HET,216,0.51	CFH	missense	CFH:ENST00000367429:missense:MODERATE:exon18/22:c.2850G>T:p.Gln950His		rs149474608	0.0016	0.0036	5,5,0	0.0008,0.0010,0.0000,0.0061,0.0002	0.0039	-0.2730	D	T	B	T	21.40	134370 [CFH (confirmed) Hemolytic uremic syndrome,atypical,susceptibility to,1,235400|Complement factor H deficiency,609814|Macular degeneration,age-related,4,610698|Basal laminar drusen,126700];	RCV000273876.1 [likely benign]; RCV000308622.1 [likely benign]; RCV000333684.1 [likely benign]; RCV000367943.1 [likely benign]; 	CM034428 [CLASS=DM MUT=ALT PHEN="Haemolytic uraemic syndrome" GENE=CFH]; 		0	25	2	[2] Ute Grasshoff 30.01.2015 [n/a] comment imported from detected variant: conflicting evidence			CFH (inh=AR+AD pLI=1.00)
chr1	197053373	197053373	G	A	hom	anno_omim	QUAL=19127;DP=241;AF=1.00;MQM=59;TRIO=HOM,241,1.00,HOM,138,1.00,HOM,201,1.00	ASPM	3'UTR	ASPM:ENST00000367409:3'UTR:MODIFIER:exon28/28:c.*81C>T:,ASPM:ENST00000294732:3'UTR:MODIFIER:exon27/27:c.*81C>T:,ASPM:ENST00000367408:3'UTR:MODIFIER:exon23/23:c.*81C>T:		rs12677	0.7823	0.0000	0,0,0	0,0,0,0,0	0.7916							605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive,608716];	RCV000353007.1 [benign]; 			386	73					ASPM (inh=AR pLI=0.00)
chr1	197055925	197055925	T	C	hom	anno_omim	QUAL=13664;DP=170;AF=1.00;MQM=60;TRIO=HOM,170,1.00,HOM,108,1.00,HOM,137,1.00	ASPM	splice_region&intron	ASPM:ENST00000367409:splice_region&intron:LOW:exon27/27:c.10331+8A>G:,ASPM:ENST00000294732:splice_region&intron:LOW:exon26/26:c.5576+8A>G:,ASPM:ENST00000367408:splice_region&intron:LOW:exon22/22:c.3326+8A>G:		rs10754213	0.7827	0.8786	47902,27379,1065	0.4519,0.9429,0.9997,0.9059,0.9006	0.8882							605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive,608716];	RCV000145076.3 [other]; RCV000368400.1 [benign]; 			1678	381	2	[2] auto-classification 14.09.2017  			ASPM (inh=AR pLI=0.00)
chr1	197070776	197070776	C	T	het	anno_omim	QUAL=8716;DP=228;AF=0.55;MQM=59;TRIO=HET,228,0.55,HET,190,0.46,HET,246,0.49	ASPM	synonymous,intron	ASPM:ENST00000367409:synonymous:LOW:exon18/28:c.7605G>A:p.Val2535Val,ASPM:ENST00000294732:intron:MODIFIER:exon17/26:c.4066-5482G>A:,ASPM:ENST00000367408:intron:MODIFIER:exon13/22:c.1816-5482G>A:		rs10922162	0.2949	0.2396	5351,822,16	0.0437,0.4940,0.7019,0.1561,0.2786	0.2562							605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive,608716];	RCV000020793.1 [benign]; RCV000145189.3 [benign]; RCV000261841.1 [benign]; 			87	555	2	[2] auto-classification 14.09.2017  			ASPM (inh=AR pLI=0.00)
chr1	197070815	197070815	T	C	hom	anno_omim	QUAL=19710;DP=238;AF=1.00;MQM=59;TRIO=HOM,238,1.00,HOM,155,1.00,HOM,198,1.00	ASPM	synonymous,intron	ASPM:ENST00000367409:synonymous:LOW:exon18/28:c.7566A>G:p.Leu2522Leu,ASPM:ENST00000294732:intron:MODIFIER:exon17/26:c.4066-5521A>G:,ASPM:ENST00000367408:intron:MODIFIER:exon13/22:c.1816-5521A>G:		rs1412640	0.8159	0.8876	48397,27386,1582	0.5494,0.9477,0.9995,0.9068,0.9012	0.8957							605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive,608716];	RCV000020792.1 [benign]; RCV000145187.6 [other]; RCV000317009.1 [benign]; 			1680	382	2	[2] auto-classification 14.09.2017  			ASPM (inh=AR pLI=0.00)
chr1	197070901	197070901	A	G	hom	pred_pathogenic;anno_omim	QUAL=23221;DP=320;AF=1.00;MQM=60;TRIO=HOM,320,1.00,HOM,168,1.00,HOM,206,1.00	ASPM	missense,intron	ASPM:ENST00000367409:missense:MODERATE:exon18/28:c.7480T>C:p.Tyr2494His,ASPM:ENST00000294732:intron:MODIFIER:exon17/26:c.4066-5607T>C:,ASPM:ENST00000367408:intron:MODIFIER:exon13/22:c.1816-5607T>C:		rs964201	0.9974	0.9956	60051,32876,5182	0.9989,0.9990,1.0000,0.9930,0.9978	0.9963	2.9990	T,T	T	B,B	T	8.34	605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive,608716];	RCV000020789.1 [benign]; RCV000145183.6 [benign]; RCV000332016.1 [benign]; 			2093	10	2	[2] auto-classification 14.09.2017  			ASPM (inh=AR pLI=0.00)
chr1	197091537	197091537	A	T	hom	anno_omim	QUAL=24417;DP=311;AF=1.00;MQM=59;TRIO=HOM,311,1.00,HOM,203,1.00,HOM,251,1.00	ASPM	synonymous	ASPM:ENST00000367409:synonymous:LOW:exon14/28:c.3579T>A:p.Ser1193Ser,ASPM:ENST00000294732:synonymous:LOW:exon14/27:c.3579T>A:p.Ser1193Ser,ASPM:ENST00000367408:synonymous:LOW:exon10/23:c.1329T>A:p.Ser443Ser		rs4915337	0.7825	0.8779	47849,27354,1075	0.4504,0.9430,0.9997,0.9058,0.9008	0.8881							605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive,608716];	RCV000020768.1 [benign]; RCV000145113.2 [other]; RCV000304377.1 [benign]; 			1678	383	2	[2] auto-classification 14.09.2017  			ASPM (inh=AR pLI=0.00)
chr1	197094030	197094030	C	T	het	anno_omim	QUAL=9400;DP=394;AF=0.49;MQM=59;TRIO=HET,394,0.49,HET,152,0.48,HET,185,0.49	ASPM	synonymous	ASPM:ENST00000367409:synonymous:LOW:exon12/28:c.3138G>A:p.Arg1046Arg,ASPM:ENST00000294732:synonymous:LOW:exon12/27:c.3138G>A:p.Arg1046Arg,ASPM:ENST00000367408:synonymous:LOW:exon8/23:c.888G>A:p.Arg296Arg		rs6676084	0.2167	0.2801	5028,3284,147	0.1582,0.2487,0.1120,0.3151,0.3118	0.2802							605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive,608716];	RCV000020763.1 [benign]; RCV000145109.2 [benign]; RCV000259745.1 [likely benign]; 		COSM3750735	215	870	2	[2] auto-classification 14.09.2017  			ASPM (inh=AR pLI=0.00)
chr1	197108946	197108946	A	G	het	anno_omim	QUAL=4087;DP=256;AF=0.41;MQM=60;TRIO=HET,256,0.41,HET,109,0.44,WT,143,0.00	ASPM	synonymous	ASPM:ENST00000367409:synonymous:LOW:exon4/28:c.1977T>C:p.Ile659Ile,ASPM:ENST00000294732:synonymous:LOW:exon4/27:c.1977T>C:p.Ile659Ile		rs17550662	0.0192	0.0454	165,144,0	0.0092,0.0202,0.0000,0.0672,0.0107	0.0449							605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive,608716];	RCV000020751.1 [benign]; RCV000145092.1 [benign]; RCV000353888.1 [likely benign]; 			7	204					ASPM (inh=AR pLI=0.00)
chr1	197112533	197112533	G	A	hom	anno_omim	QUAL=7448;DP=113;AF=1.00;MQM=60;TRIO=HOM,113,1.00,HOM,61,0.98,HOM,52,1.00	ASPM	synonymous	ASPM:ENST00000367409:synonymous:LOW:exon3/28:c.849C>T:p.Ser283Ser,ASPM:ENST00000294732:synonymous:LOW:exon3/27:c.849C>T:p.Ser283Ser		rs6677082	0.7556	0.8698	47376,27349,752	0.3744,0.9388,0.9834,0.9054,0.9006	0.8810							605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive,608716];	RCV000081938.7 [other]; RCV000284938.1 [benign]; 			1663	395	2	[2] auto-classification 14.09.2017  			ASPM (inh=AR pLI=0.00)
chr1	198661668	198661668	G	A	het	anno_omim	QUAL=807;DP=56;AF=0.46;MQM=60;TRIO=HET,56,0.46,HET,7,0.86,WT,5,0.00	PTPRC	3'UTR,intron	PTPRC:ENST00000598951:3'UTR:MODIFIER:exon3/3:c.*155G>A:,PTPRC:ENST00000367364:3'UTR:MODIFIER:exon3/3:c.*155G>A:,PTPRC:ENST00000442510:intron:MODIFIER:exon3/32:c.100+166G>A:,PTPRC:ENST00000352140:intron:MODIFIER:exon3/31:c.94+166G>A:,PTPRC:ENST00000367376:intron:MODIFIER:exon3/32:c.94+166G>A:,PTPRC:ENST00000594404:intron:MODIFIER:exon3/29:c.94+166G>A:,PTPRC:ENST00000348564:intron:MODIFIER:exon3/29:c.100+166G>A:,PTPRC:ENST00000413409:intron:MODIFIER:exon3/3:c.100+166G>A:		rs115067628	0.0040	0.0000	0,0,0	0,0,0,0,0	0.0117							151460 [PTPRC (confirmed) Hepatitic C virus,susceptibility to,609532|Severe combined immunodeficiency,T cell-negative,B-cell/natural killer-cell positive,608971];				0	7					PTPRC (inh=AR pLI=1.00)
chr1	201012597	201012597	G	A	hom	low_DP;anno_omim	QUAL=366;DP=10;AF=1.00;MQM=60;TRIO=HOM,10,1.00,WT,3,0.00,HOM,4,1.00	CACNA1S	synonymous	CACNA1S:ENST00000362061:synonymous:LOW:exon40/44:c.4860C>T:p.Pro1620Pro,CACNA1S:ENST00000367338:synonymous:LOW:exon39/43:c.4803C>T:p.Pro1601Pro		rs41267497	0.0461	0.1065	954,852,5	0.0287,0.0594,0.0015,0.1588,0.0271	0.1056							114208 [CACNA1S (confirmed) Hypokalemic periodic paralysis,type 1,170400|Malignant hyperthermia susceptibility 5,601887|Thyrotoxic periodic paralysis,susceptibility to,1,188580];	RCV000254312.1 [benign]; RCV000335360.1 [benign]; RCV000373693.1 [benign]; 			46	398	2	[2] auto-classification 14.09.2017  			CACNA1S (inh=AD pLI=0.00)
chr1	201038687	201038687	A	G	het	anno_omim	QUAL=8183;DP=223;AF=0.48;MQM=60;TRIO=HET,223,0.48,WT,344,0.00,HET,428,0.51	CACNA1S	synonymous	CACNA1S:ENST00000362061:synonymous:LOW:exon18/44:c.2403T>C:p.Phe801Phe,CACNA1S:ENST00000367338:synonymous:LOW:exon18/43:c.2403T>C:p.Phe801Phe		rs7415038	0.2941	0.4034	3683,2641,749	0.5478,0.2963,0.0181,0.4924,0.1984	0.4083							114208 [CACNA1S (confirmed) Hypokalemic periodic paralysis,type 1,170400|Malignant hyperthermia susceptibility 5,601887|Thyrotoxic periodic paralysis,susceptibility to,1,188580];	RCV000252908.1 [benign]; RCV000276522.1 [benign]; RCV000333904.1 [benign]; 			286	865	2	[2] auto-classification 14.09.2017  			CACNA1S (inh=AD pLI=0.00)
chr1	201044748	201044748	A	G	het	anno_omim	QUAL=10600;DP=155;AF=0.51;MQM=59;TRIO=HET,155,0.51,WT,261,0.00,HOM,280,1.00	CACNA1S	splice_region&intron	CACNA1S:ENST00000362061:splice_region&intron:LOW:exon12/43:c.1828-5T>C:,CACNA1S:ENST00000367338:splice_region&intron:LOW:exon12/42:c.1828-5T>C:		rs1998721	0.7596	0.7814	37595,20198,1541	0.5465,0.7180,0.9570,0.7783,0.8930	0.7820							114208 [CACNA1S (confirmed) Hypokalemic periodic paralysis,type 1,170400|Malignant hyperthermia susceptibility 5,601887|Thyrotoxic periodic paralysis,susceptibility to,1,188580];	RCV000254042.1 [benign]; RCV000345729.1 [benign]; RCV000388676.1 [benign]; 			1300	693	2	[2] auto-classification 14.09.2017  			CACNA1S (inh=AD pLI=0.00)
chr1	201047062	201047062	G	A	hom	anno_omim	QUAL=14951;DP=142;AF=0.98;MQM=59;TRIO=HOM,142,0.98,HOM,261,1.00,HET,263,0.47	CACNA1S	synonymous	CACNA1S:ENST00000362061:synonymous:LOW:exon11/44:c.1564C>T:p.Leu522Leu,CACNA1S:ENST00000367338:synonymous:LOW:exon11/43:c.1564C>T:p.Leu522Leu		rs4915476	0.1909	0.2072	2934,1790,385	0.2627,0.2748,0.0440,0.2304,0.1084	0.2205							114208 [CACNA1S (confirmed) Hypokalemic periodic paralysis,type 1,170400|Malignant hyperthermia susceptibility 5,601887|Thyrotoxic periodic paralysis,susceptibility to,1,188580];	RCV000254329.1 [benign]; RCV000278332.1 [benign]; RCV000335825.1 [benign]; 	CM023570 [CLASS=DP MUT=ALT PHEN="Hypokalaemic periodic paralysis association with" GENE=CACNA1S]; 	COSM3750745	119	711	2	[2] auto-classification 14.09.2017  			CACNA1S (inh=AD pLI=0.00)
chr1	201047075	201047075	A	G	hom	anno_omim	QUAL=17599;DP=190;AF=0.99;MQM=59;TRIO=HOM,190,0.99,HOM,270,1.00,HET,286,0.50	CACNA1S	synonymous	CACNA1S:ENST00000362061:synonymous:LOW:exon11/44:c.1551T>C:p.Gly517Gly,CACNA1S:ENST00000367338:synonymous:LOW:exon11/43:c.1551T>C:p.Gly517Gly		rs4915477	0.5711	0.5839	22620,14306,4198	0.8970,0.5714,0.2245,0.6553,0.3168	0.6651							114208 [CACNA1S (confirmed) Hypokalemic periodic paralysis,type 1,170400|Malignant hyperthermia susceptibility 5,601887|Thyrotoxic periodic paralysis,susceptibility to,1,188580];	RCV000249332.1 [benign]; RCV000305536.1 [benign]; RCV000397592.1 [benign]; 		COSM4143154	807	912	2	[2] auto-classification 14.09.2017  			CACNA1S (inh=AD pLI=0.00)
chr1	209788213	209788213	T	C	hom	anno_omim	QUAL=5589;DP=150;AF=0.99;MQM=60;TRIO=HOM,150,0.99,HET,41,0.59,HET,72,0.46	CAMK1G,LAMB3	intergenic_region	LAMB3:ENSG00000008118-ENSG00000196878:intergenic_region:MODIFIER::n.209788213T>C:		rs926387	0.7748	0.0000	0,0,0	0,0,0,0,0	0.7552							150310 [LAMB3 (provisional) Epidermolysis bullosa,junctional,Herlitz type,226700|Epidermolysis bullosa,junctional,non-Herlitz type,226650|Amelogenesis imperfecta,type IA,104530];	RCV000307061.1 [benign]; 			98	105					CAMK1G (inh=n/a pLI=0.10), LAMB3 (inh=AR+AD pLI=0.00)
chr1	209788514	209788514	G	A	het	anno_omim	QUAL=5399;DP=185;AF=0.52;MQM=60;TRIO=HET,185,0.52,WT,241,0.00,HET,263,0.46	LAMB3	3'UTR	LAMB3:ENST00000356082:3'UTR:MODIFIER:exon23/23:c.*102C>T:,LAMB3:ENST00000391911:3'UTR:MODIFIER:exon22/22:c.*102C>T:,LAMB3:ENST00000367030:3'UTR:MODIFIER:exon23/23:c.*102C>T:		rs2566	0.2951	0.0000	0,0,0	0,0,0,0,0	0.2760							150310 [LAMB3 (provisional) Epidermolysis bullosa,junctional,Herlitz type,226700|Epidermolysis bullosa,junctional,non-Herlitz type,226650|Amelogenesis imperfecta,type IA,104530];	RCV000266238.1 [benign]; 	CR1010233 [CLASS=DP MUT=ALT PHEN="Cervical cancer increased risk association with" GENE=LAMB3]; 		38	162					LAMB3 (inh=AR+AD pLI=0.00)
chr1	209799253	209799253	A	G	het	anno_omim	QUAL=21322;DP=304;AF=0.39;MQM=59;TRIO=HET,304,0.39,HOM,383,1.00,HET,547,0.50	LAMB3	synonymous	LAMB3:ENST00000356082:synonymous:LOW:exon14/23:c.1716T>C:p.Cys572Cys,LAMB3:ENST00000391911:synonymous:LOW:exon13/22:c.1716T>C:p.Cys572Cys,LAMB3:ENST00000367030:synonymous:LOW:exon14/23:c.1716T>C:p.Cys572Cys		rs2179402	0.7650	0.7565	34184,18267,3036	0.7736,0.7755,0.8259,0.7469,0.7425	0.7538							150310 [LAMB3 (provisional) Epidermolysis bullosa,junctional,Herlitz type,226700|Epidermolysis bullosa,junctional,non-Herlitz type,226650|Amelogenesis imperfecta,type IA,104530];	RCV000253193.1 [benign]; RCV000341091.1 [benign]; 		COSM3746765	1232	728	2	[2] auto-classification 14.09.2017  			LAMB3 (inh=AR+AD pLI=0.00)
chr1	209807972	209807972	G	A	hom	anno_omim	QUAL=5431;DP=37;AF=1.00;MQM=60;TRIO=HOM,37,1.00,HOM,58,1.00,HOM,91,1.00	LAMB3	synonymous	LAMB3:ENST00000356082:synonymous:LOW:exon6/23:c.384C>T:p.Pro128Pro,LAMB3:ENST00000391911:synonymous:LOW:exon5/22:c.384C>T:p.Pro128Pro,LAMB3:ENST00000367030:synonymous:LOW:exon6/23:c.384C>T:p.Pro128Pro		rs1130667	0.2454	0.3625	7446,5200,99	0.1504,0.2141,0.2551,0.4234,0.3520	0.3438							150310 [LAMB3 (provisional) Epidermolysis bullosa,junctional,Herlitz type,226700|Epidermolysis bullosa,junctional,non-Herlitz type,226650|Amelogenesis imperfecta,type IA,104530];	RCV000242747.1 [benign]; RCV000339606.1 [benign]; 		COSM3746766	306	1007	2	[2] auto-classification 14.09.2017  			LAMB3 (inh=AR+AD pLI=0.00)
chr1	209811886	209811886	T	G	hom	anno_omim	QUAL=18952;DP=256;AF=1.00;MQM=59;TRIO=HOM,256,1.00,HOM,137,1.00,HOM,211,1.00	LAMB3	synonymous	LAMB3:ENST00000356082:synonymous:LOW:exon4/23:c.291A>C:p.Ser97Ser,LAMB3:ENST00000391911:synonymous:LOW:exon3/22:c.291A>C:p.Ser97Ser,LAMB3:ENST00000367030:synonymous:LOW:exon4/23:c.291A>C:p.Ser97Ser		rs2076356	0.4325	0.5709	20809,14492,881	0.4142,0.4398,0.2927,0.6594,0.4938	0.5704							150310 [LAMB3 (provisional) Epidermolysis bullosa,junctional,Herlitz type,226700|Epidermolysis bullosa,junctional,non-Herlitz type,226650|Amelogenesis imperfecta,type IA,104530];	RCV000250461.1 [benign]; RCV000361905.1 [benign]; 		COSM146753	855	951	2	[2] auto-classification 14.09.2017  			LAMB3 (inh=AR+AD pLI=0.00)
chr1	209959614	209959614	G	T	het	anno_omim	QUAL=6941;DP=339;AF=0.54;MQM=57;TRIO=HET,339,0.54,WT,126,0.00,HET,185,0.50	IRF6	3'UTR	IRF6:ENST00000367021:3'UTR:MODIFIER:exon9/9:c.*2151C>A:		rs1044516	0.3099	0.0000	0,0,0	0,0,0,0,0	0.2170							607199 [IRF6 (confirmed) van der Woude syndrome,119300|Popliteal pterygium syndrome 1,119500|Orofacial cleft 6,608864];	RCV000264919.1 [benign]; RCV000323553.1 [benign]; RCV000378096.1 [benign]; 			7	38					IRF6 (inh=n/a pLI=0.98)
chr1	209959872	209959872	G	A	hom	anno_omim	QUAL=18993;DP=311;AF=1.00;MQM=56;TRIO=HOM,311,1.00,HOM,124,0.99,HOM,150,0.99	IRF6	3'UTR	IRF6:ENST00000367021:3'UTR:MODIFIER:exon9/9:c.*1893C>T:		rs680331	0.8081	0.0000	0,0,0	0,0,0,0,0	0.8034							607199 [IRF6 (confirmed) van der Woude syndrome,119300|Popliteal pterygium syndrome 1,119500|Orofacial cleft 6,608864];	RCV000282539.1 [benign]; RCV000350498.1 [benign]; RCV000401160.1 [benign]; 			100	43					IRF6 (inh=n/a pLI=0.98)
chr1	209960436	209960436	G	A	het	anno_omim	QUAL=6339;DP=256;AF=0.46;MQM=59;TRIO=HET,256,0.46,WT,202,0.00,HET,248,0.50	IRF6,RP3-434O14.8	3'UTR	IRF6:ENST00000367021:3'UTR:MODIFIER:exon9/9:c.*1329C>T:	AluJo	rs2235372	0.2991	0.0000	0,0,0	0,0,0,0,0	0.2102							607199 [IRF6 (confirmed) van der Woude syndrome,119300|Popliteal pterygium syndrome 1,119500|Orofacial cleft 6,608864];	RCV000279720.1 [benign]; RCV000334805.1 [benign]; RCV000374211.1 [benign]; 			7	38					IRF6 (inh=n/a pLI=0.98), RP3-434O14.8 (inh=n/a pLI=n/a)
chr1	209960922	209960922	A	C	het	anno_omim	QUAL=2823;DP=125;AF=0.47;MQM=60;TRIO=HET,125,0.47,HOM,44,1.00,WT,126,0.00	RP3-434O14.8,IRF6	3'UTR	IRF6:ENST00000367021:3'UTR:MODIFIER:exon9/9:c.*843T>G:		rs599021	0.3043	0.0000	0,0,0	0,0,0,0,0	0.3670							607199 [IRF6 (confirmed) van der Woude syndrome,119300|Popliteal pterygium syndrome 1,119500|Orofacial cleft 6,608864];	RCV000263360.1 [benign]; RCV000318759.1 [benign]; RCV000373362.1 [benign]; 			36	84	2	[2] auto-classification 14.09.2017  			RP3-434O14.8 (inh=n/a pLI=n/a), IRF6 (inh=n/a pLI=0.98)
chr1	209960925	209960925	T	C	het	anno_omim	QUAL=3095;DP=128;AF=0.53;MQM=59;TRIO=HET,128,0.53,WT,43,0.00,HET,125,0.46	RP3-434O14.8,IRF6	3'UTR	IRF6:ENST00000367021:3'UTR:MODIFIER:exon9/9:c.*840A>G:		rs742214	0.2971	0.0000	0,0,0	0,0,0,0,0	0.2095							607199 [IRF6 (confirmed) van der Woude syndrome,119300|Popliteal pterygium syndrome 1,119500|Orofacial cleft 6,608864];	RCV000259961.1 [benign]; RCV000324588.1 [benign]; RCV000379305.1 [benign]; 			7	38	2	[2] auto-classification 14.09.2017  			RP3-434O14.8 (inh=n/a pLI=n/a), IRF6 (inh=n/a pLI=0.98)
chr1	209961023	209961023	T	A	het	anno_omim	QUAL=2200;DP=98;AF=0.50;MQM=60;TRIO=HET,98,0.50,WT,51,0.02,HET,82,0.49	IRF6,RP3-434O14.8	3'UTR	IRF6:ENST00000367021:3'UTR:MODIFIER:exon9/9:c.*742A>T:		rs742215	0.3037	0.0000	0,0,0	0,0,0,0,0	0.2156							607199 [IRF6 (confirmed) van der Woude syndrome,119300|Popliteal pterygium syndrome 1,119500|Orofacial cleft 6,608864];	RCV000313232.1 [benign]; RCV000349382.1 [benign]; RCV000406738.1 [benign]; 			7	38					IRF6 (inh=n/a pLI=0.98), RP3-434O14.8 (inh=n/a pLI=n/a)
chr1	209961314	209961314	T	C	het	anno_omim	QUAL=6575;DP=269;AF=0.50;MQM=60;TRIO=HET,269,0.50,WT,189,0.01,HET,241,0.47	IRF6	3'UTR	IRF6:ENST00000367021:3'UTR:MODIFIER:exon9/9:c.*451A>G:		rs17317411	0.0875	0.0000	0,0,0	0,0,0,0,0	0.0997							607199 [IRF6 (confirmed) van der Woude syndrome,119300|Popliteal pterygium syndrome 1,119500|Orofacial cleft 6,608864];	RCV000300766.1 [benign]; RCV000349717.1 [benign]; RCV000400523.1 [benign]; 			6	36					IRF6 (inh=n/a pLI=0.98)
chr1	209968684	209968684	C	A	het	anno_omim	QUAL=18456;DP=339;AF=0.45;MQM=60;TRIO=HET,339,0.45,WT,326,0.00,HOM,458,1.00	IRF6	synonymous	IRF6:ENST00000367021:synonymous:LOW:exon5/9:c.459G>T:p.Ser153Ser,IRF6:ENST00000542854:synonymous:LOW:exon3/7:c.174G>T:p.Ser58Ser		rs2013162	0.4038	0.4020	10291,4614,392	0.2747,0.5631,0.5758,0.3712,0.4178	0.4095							607199 [IRF6 (confirmed) van der Woude syndrome,119300|Popliteal pterygium syndrome 1,119500|Orofacial cleft 6,608864];	RCV000251393.1 [benign]; RCV000288076.1 [benign]; RCV000345570.1 [benign]; RCV000402163.1 [benign]; 		COSM3746770	241	956	2	[2] auto-classification 14.09.2017  			IRF6 (inh=n/a pLI=0.98)
chr1	209969902	209969902	G	C	het	anno_omim	QUAL=4762;DP=210;AF=0.47;MQM=60;TRIO=HET,210,0.47,WT,51,0.02,HOM,86,0.99	IRF6	splice_region&intron	IRF6:ENST00000367021:splice_region&intron:LOW:exon3/8:c.175-5C>G:,IRF6:ENST00000542854:splice_region&intron:LOW:exon1/6:c.-111-5C>G:		rs7552506	0.2710	0.3260	6527,4149,370	0.2702,0.2974,0.1542,0.3569,0.3348	0.3229							607199 [IRF6 (confirmed) van der Woude syndrome,119300|Popliteal pterygium syndrome 1,119500|Orofacial cleft 6,608864];	RCV000243913.1 [benign]; RCV000300705.1 [benign]; 			217	897	2	[2] auto-classification 14.09.2017  			IRF6 (inh=n/a pLI=0.98)
chr1	209975386	209975386	A	G	het	anno_omim	QUAL=11915;DP=286;AF=0.49;MQM=60;TRIO=HET,286,0.49,HOM,263,1.00,WT,353,0.00	IRF6	splice_region,5'UTR,intron	IRF6:ENST00000367021:splice_region:LOW:exon2/9:c.-73T>C:,IRF6:ENST00000367021:5'UTR:MODIFIER:exon2/9:c.-73T>C:,IRF6:ENST00000542854:intron:MODIFIER:exon1/6:c.-112+3906T>C:		rs861019	0.3864	0.0000	0,0,0	0,0,0,0,0	0.4353							607199 [IRF6 (confirmed) van der Woude syndrome,119300|Popliteal pterygium syndrome 1,119500|Orofacial cleft 6,608864];	RCV000294795.1 [benign]; RCV000352053.1 [benign]; RCV000382341.1 [benign]; 			49	121	2	[2] auto-classification 14.09.2017  			IRF6 (inh=n/a pLI=0.98)
chr1	215796350	215796350	T	G	het	gene_blacklist;anno_omim	QUAL=13518;DP=354;AF=0.52;MQM=60;TRIO=HET,354,0.52,WT,178,0.00,HOM,266,1.00	USH2A	3'UTR	USH2A:ENST00000366943:3'UTR:MODIFIER:exon73/73:c.*2773A>C:,USH2A:ENST00000307340:3'UTR:MODIFIER:exon72/72:c.*2773A>C:		rs6667509	0.1030	0.0000	0,0,0	0,0,0,0,0	0.0987							608400 [USH2A (confirmed) Usher syndrome,type 2A,276901|Retinitis pigmentosa 39,613809];				5	40					USH2A (inh=AR pLI=0.00)
chr1	215798014	215798014	G	A	hom	gene_blacklist;anno_omim	QUAL=33490;DP=447;AF=1.00;MQM=60;TRIO=HOM,447,1.00,HOM,227,1.00,HOM,326,1.00	USH2A	3'UTR	USH2A:ENST00000366943:3'UTR:MODIFIER:exon73/73:c.*1109C>T:,USH2A:ENST00000307340:3'UTR:MODIFIER:exon72/72:c.*1109C>T:		rs2797255	0.9912	0.0000	0,0,0	0,0,0,0,0	0.9896							608400 [USH2A (confirmed) Usher syndrome,type 2A,276901|Retinitis pigmentosa 39,613809];				231	0					USH2A (inh=AR pLI=0.00)
chr1	215808007	215808007	G	A	het	gene_blacklist;pred_pathogenic;anno_omim;anno_pathogenic_hgmd	QUAL=3650;DP=177;AF=0.47;MQM=60;TRIO=HET,177,0.47,HET,136,0.50,WT,196,0.00	USH2A	missense	USH2A:ENST00000366943:missense:MODERATE:exon70/73:c.15091C>T:p.Arg5031Trp,USH2A:ENST00000307340:missense:MODERATE:exon70/72:c.15091C>T:p.Arg5031Trp		rs56038610	0.0060	0.0157	24,14,1	0.0034,0.0035,0.0000,0.0191,0.0102	0.0161	3.0690	T,T	T	B	T,T	23.00	608400 [USH2A (confirmed) Usher syndrome,type 2A,276901|Retinitis pigmentosa 39,613809];	RCV000041778.2 [benign]; RCV000087008.3 [not provided]; 	CM165975 [CLASS=DM? MUT=ALT PHEN="Retinitis pigmentosa" GENE=USH2A]; 		0	53	3	[3] auto-classification 14.09.2017  			USH2A (inh=AR pLI=0.00)
chr1	215848062	215848062	C	T	het	gene_blacklist;anno_omim	QUAL=8136;DP=379;AF=0.51;MQM=60;TRIO=HET,379,0.51,HET,246,0.50,WT,314,0.01	USH2A	synonymous	USH2A:ENST00000366943:synonymous:LOW:exon63/73:c.13191G>A:p.Glu4397Glu,USH2A:ENST00000307340:synonymous:LOW:exon63/72:c.13191G>A:p.Glu4397Glu		rs2009923	0.2035	0.1993	2705,1107,12	0.0568,0.1703,0.3530,0.1823,0.2899	0.2029							608400 [USH2A (confirmed) Usher syndrome,type 2A,276901|Retinitis pigmentosa 39,613809];	RCV000041736.5 [benign]; 		COSM3746785, COSM3746784	83	646	2	[2] auto-classification 14.09.2017  			USH2A (inh=AR pLI=0.00)
chr1	215848641	215848641	T	C	het	gene_blacklist;anno_omim	QUAL=20824;DP=390;AF=0.48;MQM=60;TRIO=HET,390,0.48,HET,281,0.50,HOM,377,0.99	USH2A	synonymous	USH2A:ENST00000366943:synonymous:LOW:exon63/73:c.12612A>G:p.Thr4204Thr,USH2A:ENST00000307340:synonymous:LOW:exon63/72:c.12612A>G:p.Thr4204Thr		rs2797235	0.6897	0.7662	35716,21979,2019	0.6324,0.8208,0.6468,0.8137,0.6925	0.7673							608400 [USH2A (confirmed) Usher syndrome,type 2A,276901|Retinitis pigmentosa 39,613809];	RCV000154669.2 [benign]; 		COSM146765	1344	677	2	[2] auto-classification 14.09.2017  			USH2A (inh=AR pLI=0.00)
chr1	215901492	215901492	C	T	hom	gene_blacklist;anno_omim	QUAL=39520;DP=412;AF=0.99;MQM=59;TRIO=HOM,412,0.99,HET,545,0.42,HOM,642,0.99	USH2A	synonymous	USH2A:ENST00000366943:synonymous:LOW:exon61/73:c.11946G>A:p.Leu3982Leu,USH2A:ENST00000307340:synonymous:LOW:exon61/72:c.11946G>A:p.Leu3982Leu		rs2820718	0.1188	0.1560	1676,1148,143	0.1661,0.0722,0.0014,0.1855,0.1423	0.1772							608400 [USH2A (confirmed) Usher syndrome,type 2A,276901|Retinitis pigmentosa 39,613809];	RCV000041709.5 [benign]; 			58	611	2	[2] auto-classification 14.09.2017  			USH2A (inh=AR pLI=0.00)
chr1	215914751	215914751	G	T	het	gene_blacklist;pred_pathogenic;anno_omim;anno_pathogenic_hgmd	QUAL=5400;DP=209;AF=0.54;MQM=60;TRIO=HET,209,0.54,HET,194,0.51,WT,254,0.00	USH2A	missense	USH2A:ENST00000366943:missense:MODERATE:exon60/73:c.11677C>A:p.Pro3893Thr,USH2A:ENST00000307340:missense:MODERATE:exon60/72:c.11677C>A:p.Pro3893Thr		rs41303285	0.0062	0.0173	29,22,0	0.0039,0.0042,0.0000,0.0231,0.0138	0.0159	5.6550	T,T	T	D	T,T	27.70	608400 [USH2A (confirmed) Usher syndrome,type 2A,276901|Retinitis pigmentosa 39,613809];	RCV000041701.3 [benign]; 	CM165987 [CLASS=DM? MUT=ALT PHEN="Usher syndrome 2" GENE=USH2A]; 		1	58	3	[3] auto-classification 14.09.2017  			USH2A (inh=AR pLI=0.00)
chr1	215960153	215960153	A	C	het	gene_blacklist;pred_pathogenic;anno_omim;anno_pathogenic_hgmd	QUAL=76;DP=237;AF=0.37;MQM=59;TRIO=HET,237,0.37,WT,232,0.01,WT,279,0.02	USH2A	missense	USH2A:ENST00000366943:missense:MODERATE:exon52/73:c.10246T>G:p.Cys3416Gly,USH2A:ENST00000307340:missense:MODERATE:exon52/72:c.10246T>G:p.Cys3416Gly		rs527236140	0.0000	0.3805	0,0,0	0.4202,0.4444,0.4413,0.3697,0.2984	0.2227	5.2280	D,D	T	D	T,T	25.20	608400 [USH2A (confirmed) Usher syndrome,type 2A,276901|Retinitis pigmentosa 39,613809];	RCV000132699.1 [likely benign]; 	CM135012 [CLASS=DM MUT=ALT PHEN="Usher syndrome" GENE=USH2A]; 	COSM130095, COSM4143327	0	107	2	[2] old entry - no details available			USH2A (inh=AR pLI=0.00)
chr1	215960167	215960167	T	G	hom	gene_blacklist;pred_pathogenic;anno_omim	QUAL=27367;DP=235;AF=1.00;MQM=59;TRIO=HOM,235,1.00,HOM,288,1.00,HOM,369,1.00	USH2A	missense	USH2A:ENST00000366943:missense:MODERATE:exon52/73:c.10232A>C:p.Glu3411Ala,USH2A:ENST00000307340:missense:MODERATE:exon52/72:c.10232A>C:p.Glu3411Ala		rs10864198	0.5887	0.5469	18352,9040,2437	0.6816,0.5730,0.6404,0.5209,0.4927	0.5802	2.5980	T,T	T	B	T,T	2.89	608400 [USH2A (confirmed) Usher syndrome,type 2A,276901|Retinitis pigmentosa 39,613809];	RCV000041665.8 [benign]; 		COSM3750864, COSM3750863	636	1030	2	[2] auto-classification 14.09.2017  			USH2A (inh=AR pLI=0.00)
chr1	216166454	216166454	T	G	het	gene_blacklist;pred_pathogenic;anno_omim;anno_pathogenic_hgmd	QUAL=2793;DP=128;AF=0.48;MQM=60;TRIO=HET,128,0.48,HET,94,0.57,WT,98,0.00	USH2A	missense	USH2A:ENST00000366943:missense:MODERATE:exon35/73:c.6713A>C:p.Glu2238Ala,USH2A:ENST00000307340:missense:MODERATE:exon35/72:c.6713A>C:p.Glu2238Ala		rs41277212	0.0076	0.0220	42,29,0	0.0041,0.0175,0.0001,0.0282,0.0151	0.0225	4.8840	D,D	T	P	T,T	27.10	608400 [USH2A (confirmed) Usher syndrome,type 2A,276901|Retinitis pigmentosa 39,613809];	RCV000041894.3 [benign]; RCV000087012.3 [not provided]; 	CM140482 [CLASS=DM? MUT=ALT PHEN="Retinitis pigmentosa autosomal recessive" GENE=USH2A]; 	COSM3750866, COSM3750865	2	94	3	[3] auto-classification 14.09.2017  			USH2A (inh=AR pLI=0.00)
chr1	216172380	216172380	A	G	hom	gene_blacklist;pred_pathogenic;anno_omim	QUAL=19062;DP=181;AF=0.99;MQM=60;TRIO=HOM,181,0.99,HOM,189,1.00,HOM,229,1.00	USH2A	missense	USH2A:ENST00000366943:missense:MODERATE:exon34/73:c.6506T>C:p.Ile2169Thr,USH2A:ENST00000307340:missense:MODERATE:exon34/72:c.6506T>C:p.Ile2169Thr		rs10864219	0.5935	0.5567	19463,8401,992	0.4328,0.6918,0.8351,0.5039,0.6011	0.5625	2.3950	T,T	T	B	T,T	16.28	608400 [USH2A (confirmed) Usher syndrome,type 2A,276901|Retinitis pigmentosa 39,613809];	RCV000041888.5 [benign]; 		COSM3750868, COSM3750867	630	968	2	[2] auto-classification 14.09.2017  			USH2A (inh=AR pLI=0.00)
chr1	216219781	216219781	A	G	het	gene_blacklist;anno_omim	QUAL=8795;DP=201;AF=0.49;MQM=60;TRIO=HET,201,0.49,HET,125,0.50,HOM,146,1.00	USH2A	missense	USH2A:ENST00000366943:missense:MODERATE:exon32/73:c.6317T>C:p.Ile2106Thr,USH2A:ENST00000307340:missense:MODERATE:exon32/72:c.6317T>C:p.Ile2106Thr		rs6657250	0.5956	0.6069	23304,15047,3022	0.7653,0.3286,0.4430,0.6715,0.5092	0.6759	0.9880	T,T	T	B	T,T	6.63	608400 [USH2A (confirmed) Usher syndrome,type 2A,276901|Retinitis pigmentosa 39,613809];	RCV000154111.3 [benign]; 		COSM146769	882	933	2	[2] auto-classification 14.09.2017  			USH2A (inh=AR pLI=0.00)
chr1	216258194	216258194	G	T	het	anno_omim	QUAL=5971;DP=156;AF=0.49;MQM=60;TRIO=HET,156,0.49,HET,133,0.51,HET,177,0.51	USH2A,RP11-22M7.2	synonymous	USH2A:ENST00000366943:synonymous:LOW:exon25/73:c.5013C>A:p.Gly1671Gly,USH2A:ENST00000307340:synonymous:LOW:exon25/72:c.5013C>A:p.Gly1671Gly		rs56110889	0.1058	0.1353	1316,977,195	0.1929,0.0778,0.0001,0.1712,0.0754	0.1597							608400 [USH2A (confirmed) Usher syndrome,type 2A,276901|Retinitis pigmentosa 39,613809];	RCV000041853.8 [benign]; 		COSM3746786, COSM3746787	47	509	2	[2] auto-classification 14.09.2017  			USH2A (inh=AR pLI=0.00), RP11-22M7.2 (inh=n/a pLI=n/a)
chr1	216347452	216347452	C	A	het	gene_blacklist;anno_omim	QUAL=3567;DP=218;AF=0.42;MQM=60;TRIO=HET,218,0.42,HET,108,0.45,WT,121,0.00	USH2A	3'UTR,intron	USH2A:ENST00000366942:3'UTR:MODIFIER:exon21/21:c.*1128G>T:,USH2A:ENST00000366943:intron:MODIFIER:exon21/72:c.4627+1142G>T:,USH2A:ENST00000307340:intron:MODIFIER:exon21/71:c.4627+1142G>T:		rs401269	0.1945	0.0000	0,0,0	0,0,0,0,0	0.1987							608400 [USH2A (confirmed) Usher syndrome,type 2A,276901|Retinitis pigmentosa 39,613809];	RCV000292348.1 [likely benign]; RCV000347288.1 [likely benign]; 			9	83					USH2A (inh=AR pLI=0.00)
chr1	216347556	216347556	A	G	het	gene_blacklist;anno_omim	QUAL=3710;DP=224;AF=0.48;MQM=60;TRIO=HET,224,0.48,HET,56,0.54,WT,55,0.00	USH2A	3'UTR,intron	USH2A:ENST00000366942:3'UTR:MODIFIER:exon21/21:c.*1024T>C:,USH2A:ENST00000366943:intron:MODIFIER:exon21/72:c.4627+1038T>C:,USH2A:ENST00000307340:intron:MODIFIER:exon21/71:c.4627+1038T>C:		rs439940	0.1953	0.0000	0,0,0	0,0,0,0,0	0.1998							608400 [USH2A (confirmed) Usher syndrome,type 2A,276901|Retinitis pigmentosa 39,613809];	RCV000343421.1 [likely benign]; RCV000394423.1 [likely benign]; 			9	82					USH2A (inh=AR pLI=0.00)
chr1	216348764	216348764	C	T	het	gene_blacklist;anno_omim	QUAL=29533;DP=481;AF=0.53;MQM=60;TRIO=HET,481,0.53,HET,456,0.49,HOM,507,1.00	USH2A	missense	USH2A:ENST00000366943:missense:MODERATE:exon21/73:c.4457G>A:p.Arg1486Lys,USH2A:ENST00000307340:missense:MODERATE:exon21/72:c.4457G>A:p.Arg1486Lys,USH2A:ENST00000366942:missense:MODERATE:exon21/21:c.4457G>A:p.Arg1486Lys		rs1805049	0.6623	0.6580	26453,12968,1738	0.5771,0.7430,0.7839,0.6247,0.6972	0.6608	-1.6250	T,T,T	T	B,B	T,T,T	6.14	608400 [USH2A (confirmed) Usher syndrome,type 2A,276901|Retinitis pigmentosa 39,613809];	RCV000154668.1 [benign]; 		COSM3746790, COSM3746789, COSM3746788	859	944	2	[2] auto-classification 14.09.2017  			USH2A (inh=AR pLI=0.00)
chr1	216371934	216371934	A	C	het	anno_omim	QUAL=4085;DP=223;AF=0.54;MQM=59;TRIO=HET,223,0.54,HET,82,0.55,WT,90,0.00	USH2A,RP5-1099E6.3	splice_region&intron	USH2A:ENST00000366943:splice_region&intron:LOW:exon17/72:c.3812-8T>G:,USH2A:ENST00000307340:splice_region&intron:LOW:exon17/71:c.3812-8T>G:,USH2A:ENST00000366942:splice_region&intron:LOW:exon17/20:c.3812-8T>G:		rs646094	0.1977	0.2217	2706,1683,130	0.1720,0.1790,0.2145,0.2418,0.2347	0.2128							608400 [USH2A (confirmed) Usher syndrome,type 2A,276901|Retinitis pigmentosa 39,613809];	RCV000041834.4 [benign]; RCV000261033.1 [likely benign]; RCV000316207.1 [likely benign]; 			124	681	2	[2] auto-classification 14.09.2017  			USH2A (inh=AR pLI=0.00), RP5-1099E6.3 (inh=n/a pLI=n/a)
chr1	216592003	216592003	T	C	hom	gene_blacklist;anno_omim	QUAL=18945;DP=160;AF=1.00;MQM=60;TRIO=HOM,160,1.00,HOM,190,0.99,HOM,254,1.00	USH2A	synonymous	USH2A:ENST00000366943:synonymous:LOW:exon3/73:c.504A>G:p.Thr168Thr,USH2A:ENST00000307340:synonymous:LOW:exon3/72:c.504A>G:p.Thr168Thr,USH2A:ENST00000366942:synonymous:LOW:exon3/21:c.504A>G:p.Thr168Thr		rs4253963	0.6328	0.6485	25942,13990,1291	0.4936,0.6990,0.8390,0.6462,0.6039	0.6525							608400 [USH2A (confirmed) Usher syndrome,type 2A,276901|Retinitis pigmentosa 39,613809];	RCV000041854.4 [benign]; RCV000260536.1 [benign]; RCV000332187.1 [benign]; 			825	947	2	[2] auto-classification 14.09.2017  			USH2A (inh=AR pLI=0.00)
chr1	216595306	216595306	C	T	hom	gene_blacklist;anno_omim	QUAL=32981;DP=294;AF=0.99;MQM=60;TRIO=HOM,294,0.99,HOM,279,1.00,HOM,445,1.00	USH2A	missense	USH2A:ENST00000366943:missense:MODERATE:exon2/73:c.373G>A:p.Ala125Thr,USH2A:ENST00000307340:missense:MODERATE:exon2/72:c.373G>A:p.Ala125Thr,USH2A:ENST00000366942:missense:MODERATE:exon2/21:c.373G>A:p.Ala125Thr		rs10779261	0.7612	0.7293	32387,16635,2945	0.7527,0.7321,0.8348,0.7059,0.7349	0.7398	0.3550	T,T,T	T	B,B	T,T,T	2.86	608400 [USH2A (confirmed) Usher syndrome,type 2A,276901|Retinitis pigmentosa 39,613809];	RCV000041833.5 [benign]; RCV000291734.1 [benign]; RCV000344307.1 [benign]; 			1010	855	2	[2] auto-classification 14.09.2017  			USH2A (inh=AR pLI=0.00)
chr1	220323449	220323449	T	-	het	anno_omim	QUAL=51;DP=149;AF=0.28;MQM=59;TRIO=HET,149,0.28,WT,44,0.34,WT,53,0.28	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951:3'UTR:MODIFIER:exon35/35:c.*1144delA:	FLAM_C	rs11316594;rs778873874	0.0000	0.0000	0,0,0	0,0,0,0,0	0.4718							609275 [RAB3GAP2 (provisional) Martsolf syndrome,212720|Warburg micro syndrome 2,614225];	RCV000295570.1 [uncertain significance]; RCV000407502.1 [uncertain significance]; 			48	32					RAB3GAP2 (inh=AR pLI=1.00)
chr1	220324189	220324189	A	G	het	anno_omim	QUAL=9776;DP=417;AF=0.54;MQM=60;TRIO=HET,417,0.54,WT,218,0.00,HET,266,0.53	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951:3'UTR:MODIFIER:exon35/35:c.*404T>C:		rs1059140	0.0627	0.0000	0,0,0	0,0,0,0,0	0.0695							609275 [RAB3GAP2 (provisional) Martsolf syndrome,212720|Warburg micro syndrome 2,614225];	RCV000333488.1 [likely benign]; RCV000387992.1 [likely benign]; 			4	42					RAB3GAP2 (inh=AR pLI=1.00)
chr1	220330672	220330672	C	T	het	anno_omim	QUAL=9349;DP=417;AF=0.54;MQM=60;TRIO=HET,417,0.54,WT,211,0.00,HET,288,0.48	RAB3GAP2	synonymous	RAB3GAP2:ENST00000358951:synonymous:LOW:exon31/35:c.3495G>A:p.Leu1165Leu		rs11547779	0.0605	0.0876	537,319,0	0.0174,0.0448,0.0575,0.0996,0.1334	0.0867							609275 [RAB3GAP2 (provisional) Martsolf syndrome,212720|Warburg micro syndrome 2,614225];	RCV000118107.3 [other]; RCV000276331.1 [likely benign]; RCV000331360.1 [likely benign]; 		COSM3750881	26	433	2	[2] auto-classification 14.09.2017  			RAB3GAP2 (inh=AR pLI=1.00)
chr1	220331205	220331205	C	G	het	pred_pathogenic;anno_omim	QUAL=6485;DP=291;AF=0.45;MQM=60;TRIO=HET,291,0.45,WT,182,0.00,HET,248,0.46	RAB3GAP2	missense	RAB3GAP2:ENST00000358951:missense:MODERATE:exon30/35:c.3275G>C:p.Ser1092Thr		rs2289189	0.0603	0.0895	513,299,0	0.0179,0.0439,0.0584,0.1018,0.1380	0.0860	7.4300	T	T	P,P	T	26.80	609275 [RAB3GAP2 (provisional) Martsolf syndrome,212720|Warburg micro syndrome 2,614225];	RCV000118106.3 [other]; RCV000318653.1 [likely benign]; RCV000373355.1 [likely benign]; 		COSM3750882	26	433	2	[2] auto-classification 14.09.2017  			RAB3GAP2 (inh=AR pLI=1.00)
chr1	223178561	223178561	A	C	hom		QUAL=20411;DP=190;AF=1.00;MQM=60;TRIO=HOM,190,1.00,HOM,287,1.00,HET,374,0.53	DISP1	synonymous	DISP1:ENST00000284476:synonymous:LOW:exon8/8:c.3822A>C:p.Pro1274Pro		rs9441941	0.4980	0.5453	18095,11104,998	0.4482,0.5308,0.5169,0.5783,0.4775	0.5469								RCV000249331.1 [benign]; 		COSM146786	716	1022	2	[2] auto-classification 14.09.2017  			DISP1 (inh=n/a pLI=0.00)
chr1	225589473	225589473	C	T	het	anno_omim	QUAL=8375;DP=323;AF=0.50;MQM=59;TRIO=HET,323,0.50,WT,267,0.00,HET,352,0.44	LBR	3'UTR	LBR:ENST00000272163:3'UTR:MODIFIER:exon14/14:c.*1532G>A:,LBR:ENST00000338179:3'UTR:MODIFIER:exon14/14:c.*1532G>A:		rs7406	0.2726	0.0000	0,0,0	0,0,0,0,0	0.2483							600024 [LBR (confirmed) Pelger-Huet anomaly,169400|Greenberg skeletal dysplasia,215140|Reynolds syndrome,613471];	RCV000353652.1 [benign]; 			3	59					LBR (inh=AR+AD pLI=1.00)
chr1	225590750	225590750	G	C	het	anno_omim	QUAL=4466;DP=313;AF=0.47;MQM=60;TRIO=HET,313,0.47,WT,47,0.00,HET,56,0.50	LBR	3'UTR	LBR:ENST00000272163:3'UTR:MODIFIER:exon14/14:c.*255C>G:,LBR:ENST00000338179:3'UTR:MODIFIER:exon14/14:c.*255C>G:		rs11551874	0.1020	0.0000	0,0,0	0,0,0,0,0	0.0907							600024 [LBR (confirmed) Pelger-Huet anomaly,169400|Greenberg skeletal dysplasia,215140|Reynolds syndrome,613471];	RCV000347591.1 [benign]; 			3	45					LBR (inh=AR+AD pLI=1.00)
chr1	225607144	225607144	C	T	het	pred_pathogenic;anno_omim	QUAL=1826;DP=75;AF=0.40;MQM=60;TRIO=HET,75,0.40,HOM,20,1.00,HET,47,0.45	LBR	missense	LBR:ENST00000272163:missense:MODERATE:exon5/14:c.461G>A:p.Ser154Asn,LBR:ENST00000338179:missense:MODERATE:exon5/14:c.461G>A:p.Ser154Asn		rs2230419	0.7123	0.8009	39850,23754,916	0.4210,0.8750,0.9561,0.8453,0.6965	0.8117	-0.1880	T,T,T	T	B,B	D,D,T	0.01	600024 [LBR (confirmed) Pelger-Huet anomaly,169400|Greenberg skeletal dysplasia,215140|Reynolds syndrome,613471];	RCV000245894.1 [benign]; RCV000287243.1 [benign]; 			1443	577	2	[2] auto-classification 14.09.2017  			LBR (inh=AR+AD pLI=1.00)
chr1	225609884	225609884	A	G	het	anno_omim	QUAL=2398;DP=127;AF=0.57;MQM=59;TRIO=HET,127,0.57,HOM,16,1.00,HET,18,0.61	LBR	synonymous	LBR:ENST00000272163:synonymous:LOW:exon3/14:c.261T>C:p.Pro87Pro,LBR:ENST00000338179:synonymous:LOW:exon3/14:c.261T>C:p.Pro87Pro		rs1056608	0.6709	0.7503	35255,20940,767	0.3824,0.8515,0.8991,0.7914,0.6550	0.7632							600024 [LBR (confirmed) Pelger-Huet anomaly,169400|Greenberg skeletal dysplasia,215140|Reynolds syndrome,613471];	RCV000250536.1 [benign]; RCV000373671.1 [benign]; 			1279	719	2	[2] auto-classification 14.09.2017  			LBR (inh=AR+AD pLI=1.00)
chr1	225611661	225611661	C	T	het	anno_omim	QUAL=17114;DP=367;AF=0.53;MQM=60;TRIO=HET,367,0.53,HET,210,0.49,HOM,283,1.00	LBR	synonymous	LBR:ENST00000272163:synonymous:LOW:exon2/14:c.117G>A:p.Val39Val,LBR:ENST00000338179:synonymous:LOW:exon2/14:c.117G>A:p.Val39Val		rs1056607	0.6571	0.7112	31217,18389,2091	0.6334,0.7876,0.7676,0.7419,0.5212	0.7261							600024 [LBR (confirmed) Pelger-Huet anomaly,169400|Greenberg skeletal dysplasia,215140|Reynolds syndrome,613471];	RCV000245794.1 [benign]; RCV000338935.1 [benign]; 			1116	812	2	[2] auto-classification 14.09.2017  			LBR (inh=AR+AD pLI=1.00)
chr1	226555302	226555302	A	G	het	pred_pathogenic	QUAL=5831;DP=200;AF=0.48;MQM=59;TRIO=HET,200,0.48,WT,220,0.00,HET,303,0.47	PARP1	missense	PARP1:ENST00000366794:missense:MODERATE:exon17/23:c.2285T>C:p.Val762Ala		rs1136410	0.1969	0.2018	3399,997,11	0.0507,0.4470,0.4376,0.1740,0.1018	0.2127	8.9570	T	T	P	T	32.00			CM042761 [CLASS=DFP MUT=ALT PHEN="Prostate cancer susceptibility association with" GENE=PARP1]; 	COSM3997295	63	654	2	[2] auto-classification 14.09.2017  			PARP1 (inh=n/a pLI=0.01)
chr1	226570840	226570840	T	C	het		QUAL=4927;DP=95;AF=0.57;MQM=59;TRIO=HET,95,0.57,HOM,73,1.00,HET,92,0.51	PARP1	synonymous	PARP1:ENST00000366794:synonymous:LOW:exon8/23:c.1056A>G:p.Lys352Lys		rs1805415	0.7893	0.7939	39108,22757,4192	0.8975,0.5514,0.5649,0.8262,0.8983	0.8228										COSM3746819	1585	646	2	[2] auto-classification 14.09.2017  			PARP1 (inh=n/a pLI=0.01)
chr1	226573364	226573364	A	G	het		QUAL=4659;DP=152;AF=0.55;MQM=60;TRIO=HET,152,0.55,WT,208,0.00,HET,248,0.45	PARP1	synonymous	PARP1:ENST00000366794:synonymous:LOW:exon7/23:c.852T>C:p.Ala284Ala		rs1805414	0.5166	0.4228	12034,4017,1535	0.5474,0.5776,0.8053,0.3450,0.3627	0.4306									CM071915 [CLASS=DP MUT=ALT PHEN="Colorectal adenoma association with" GENE=PARP1]; 	COSM4143411	286	1013	2	[2] auto-classification 14.09.2017  			PARP1 (inh=n/a pLI=0.01)
chr1	226589958	226589958	G	A	het		QUAL=9300;DP=303;AF=0.47;MQM=59;TRIO=HET,303,0.47,WT,299,0.00,HET,470,0.49	PARP1	synonymous	PARP1:ENST00000366794:synonymous:LOW:exon2/23:c.243C>T:p.Asp81Asp,PARP1:ENST00000366792:synonymous:LOW:exon2/4:c.243C>T:p.Asp81Asp,PARP1:ENST00000366791:synonymous:LOW:exon2/3:c.243C>T:p.Asp81Asp,PARP1:ENST00000366790:synonymous:LOW:exon2/2:c.243C>T:p.Asp81Asp		rs1805404	0.2183	0.2085	3496,997,92	0.1255,0.4499,0.4375,0.1739,0.1022	0.2178										COSM3997297, COSM3997296	63	658	2	[2] auto-classification 14.09.2017  			PARP1 (inh=n/a pLI=0.01)
chr1	226595647	226595647	C	G	het		QUAL=2447;DP=43;AF=0.56;MQM=59;TRIO=HET,43,0.56,WT,147,0.00,HET,161,0.50	PARP1	5'UTR	PARP1:ENST00000366794:5'UTR:MODIFIER:exon1/23:c.-17G>C:,PARP1:ENST00000366792:5'UTR:MODIFIER:exon1/4:c.-17G>C:,PARP1:ENST00000366791:5'UTR:MODIFIER:exon1/3:c.-17G>C:,PARP1:ENST00000366790:5'UTR:MODIFIER:exon1/2:c.-17G>C:		rs907187	0.1991	0.2035	3026,886,10	0.0515,0.4346,0.4269,0.1768,0.1022	0.2128										COSN392383	62	639					PARP1 (inh=n/a pLI=0.01)
chr1	227172290	227172290	C	T	het	anno_omim	QUAL=15897;DP=342;AF=0.48;MQM=60;TRIO=HET,342,0.48,HOM,382,0.98,WT,506,0.00	ADCK3	synonymous	ADCK3:ENST00000366777:synonymous:LOW:exon12/15:c.1440C>T:p.Phe480Phe,ADCK3:ENST00000366779:synonymous:LOW:exon17/20:c.1440C>T:p.Phe480Phe,ADCK3:ENST00000366778:synonymous:LOW:exon12/15:c.1284C>T:p.Phe428Phe,ADCK3:ENST00000458507:synonymous:LOW:exon9/12:c.603C>T:p.Phe201Phe,ADCK3:ENST00000433743:synonymous:LOW:exon8/11:c.462C>T:p.Phe154Phe		rs12593	0.2386	0.3525	8437,6747,207	0.1979,0.2542,0.1806,0.4508,0.2013	0.3536							606980 [ADCK3 (confirmed) Coenzyme Q10 deficiency,primary,4,612016];	RCV000116235.2 [likely benign]; RCV000330955.1 [benign]; RCV000373810.1 [benign]; 		COSM146801, COSM146800	610	1480	2	[2] auto-classification 14.09.2017  			COQ8A (inh=AR pLI=0.00)
chr1	227174145	227174145	T	C	het	anno_omim	QUAL=4263;DP=115;AF=0.56;MQM=59;TRIO=HET,115,0.56,HOM,88,1.00,WT,169,0.00	ADCK3	splice_region&intron	ADCK3:ENST00000366777:splice_region&intron:LOW:exon14/14:c.1660-9T>C:,ADCK3:ENST00000366779:splice_region&intron:LOW:exon19/19:c.1660-9T>C:,ADCK3:ENST00000366778:splice_region&intron:LOW:exon14/14:c.1504-9T>C:,ADCK3:ENST00000458507:splice_region&intron:LOW:exon11/11:c.823-9T>C:,ADCK3:ENST00000433743:splice_region&intron:LOW:exon10/10:c.682-9T>C:		rs7552783	0.3516	0.4155	11096,8198,896	0.4223,0.2877,0.2249,0.4979,0.2745	0.4382							606980 [ADCK3 (confirmed) Coenzyme Q10 deficiency,primary,4,612016];	RCV000285548.1 [benign]; RCV000406694.1 [benign]; 			783	1550	2	[2] auto-classification 14.09.2017  			COQ8A (inh=AR pLI=0.00)
chr1	227174210	227174210	T	C	het	anno_omim	QUAL=5280;DP=160;AF=0.44;MQM=59;TRIO=HET,160,0.44,HOM,119,1.00,WT,185,0.00	ADCK3	synonymous	ADCK3:ENST00000366777:synonymous:LOW:exon15/15:c.1716T>C:p.Ser572Ser,ADCK3:ENST00000366779:synonymous:LOW:exon20/20:c.1716T>C:p.Ser572Ser,ADCK3:ENST00000366778:synonymous:LOW:exon15/15:c.1560T>C:p.Ser520Ser,ADCK3:ENST00000458507:synonymous:LOW:exon12/12:c.879T>C:p.Ser293Ser,ADCK3:ENST00000433743:synonymous:LOW:exon11/11:c.738T>C:p.Ser246Ser		rs3738725	0.3139	0.4054	10713,8223,489	0.3121,0.2817,0.2270,0.4977,0.2741	0.4085							606980 [ADCK3 (confirmed) Coenzyme Q10 deficiency,primary,4,612016];	RCV000116236.2 [likely benign]; RCV000277497.1 [benign]; RCV000363761.1 [benign]; 		COSM3997300, COSM3997301	769	1554	2	[2] auto-classification 14.09.2017  			COQ8A (inh=AR pLI=0.00)
chr1	227174823	227174823	-	T	het	anno_omim	QUAL=13660;DP=258;AF=0.46;MQM=59;TRIO=HET,258,0.46,HOM,381,0.98,WT,484,0.00	ADCK3	3'UTR	ADCK3:ENST00000366777:3'UTR:MODIFIER:exon15/15:c.*389dupT:,ADCK3:ENST00000366779:3'UTR:MODIFIER:exon20/20:c.*389dupT:,ADCK3:ENST00000366778:3'UTR:MODIFIER:exon15/15:c.*389dupT:,ADCK3:ENST00000458507:3'UTR:MODIFIER:exon12/12:c.*389dupT:		rs11420839	0.2927	0.0000	0,0,0	0,0,0,0,0	0.3979							606980 [ADCK3 (confirmed) Coenzyme Q10 deficiency,primary,4,612016];	RCV000267417.1 [benign]; RCV000324404.1 [benign]; 			46	120					COQ8A (inh=AR pLI=0.00)
chr1	227175245	227175245	-	T	het	anno_omim	QUAL=8168;DP=167;AF=0.44;MQM=59;TRIO=HET,167,0.44,HOM,222,0.98,WT,333,0.00	ADCK3	3'UTR	ADCK3:ENST00000366777:3'UTR:MODIFIER:exon15/15:c.*797_*798insT:,ADCK3:ENST00000366779:3'UTR:MODIFIER:exon20/20:c.*797_*798insT:,ADCK3:ENST00000366778:3'UTR:MODIFIER:exon15/15:c.*797_*798insT:		rs397803535	0.2548	0.0000	0,0,0	0,0,0,0,0	0.3663							606980 [ADCK3 (confirmed) Coenzyme Q10 deficiency,primary,4,612016];	RCV000333606.1 [benign]; RCV000385912.1 [benign]; 			40	106					COQ8A (inh=AR pLI=0.00)
chr1	227175253	227175253	C	T	het	anno_omim	QUAL=8741;DP=167;AF=0.47;MQM=59;TRIO=HET,167,0.47,HOM,218,1.00,WT,326,0.00	ADCK3,CDC42BPA	intergenic_region	CDC42BPA:ENSG00000163050-ENSG00000143776:intergenic_region:MODIFIER::n.227175253C>T:		rs10495274	0.4191	0.0000	0,0,0	0,0,0,0,0	0.5212							606980 [ADCK3 (confirmed) Coenzyme Q10 deficiency,primary,4,612016];	RCV000292165.1 [benign]; RCV000346994.1 [benign]; 			71	102					COQ8A (inh=AR pLI=0.00), CDC42BPA (inh=n/a pLI=1.00)
chr1	228346936	228346936	G	A	het	anno_omim	QUAL=2306;DP=45;AF=0.60;MQM=59;TRIO=HET,45,0.60,WT,92,0.00,HET,131,0.53	GJC2	3'UTR	GJC2:ENST00000366714:3'UTR:MODIFIER:exon2/2:c.*157G>A:		rs45491398	0.0234	0.0000	0,0,0	0,0,0,0,0	0.0596							608803 [GJC2 (confirmed) Leukodystrophy,hypomyelinating,2,608804|Spastic paraplegia 44,autosomal recessive,613206|Lymphedema,hereditary,IC,613480];				2	29					GJC2 (inh=AR+AD pLI=0.48)
chr1	228347352	228347352	A	G	hom	anno_omim	QUAL=1580;DP=33;AF=1.00;MQM=59;TRIO=HOM,33,1.00,HOM,8,1.00,HOM,13,1.00	GJC2	3'UTR	GJC2:ENST00000366714:3'UTR:MODIFIER:exon2/2:c.*573A>G:		rs6668719	0.8043	0.0000	0,0,0	0,0,0,0,0	0.8406							608803 [GJC2 (confirmed) Leukodystrophy,hypomyelinating,2,608804|Spastic paraplegia 44,autosomal recessive,613206|Lymphedema,hereditary,IC,613480];				198	28					GJC2 (inh=AR+AD pLI=0.48)
chr1	228612838	228612838	G	T	het		QUAL=18647;DP=289;AF=0.52;MQM=60;TRIO=HET,289,0.52,HET,287,0.46,HOM,387,1.00	HIST3H3	synonymous	HIST3H3:ENST00000366696:synonymous:LOW:exon1/1:c.189C>A:p.Ile63Ile		rs2230656	0.6903	0.8208	42225,25958,845	0.3981,0.9333,0.6616,0.8819,0.8542	0.8331										COSM4143485	1560	489	2	[2] auto-classification 14.09.2017  			HIST3H3 (inh=n/a pLI=0.00)
chr1	229569803	229569803	A	G	het	anno_omim	QUAL=3138;DP=68;AF=0.57;MQM=59;TRIO=HET,68,0.57,HET,74,0.49,HET,109,0.54	ACTA1	5'UTR	ACTA1:ENST00000366684:5'UTR:MODIFIER:exon1/7:c.-65T>C:,ACTA1:ENST00000366683:5'UTR:MODIFIER:exon1/6:c.-65T>C:		rs605430	0.6302	0.0000	0,0,0	0,0,0,0,0	0.6055							102610 [ACTA1 (confirmed) Nemaline myopathy 3,autosomal dominant or recessive,161800|Myopathy,actin,congenital,with excess of thin myofilaments,161800|Myopathy,actin,congenital,with cores,161800|Myopathy,congenital,with fiber-type disproportion 1,255310|Myopathy,scapulohumeroperoneal,616852];	RCV000290269.1 [likely benign]; RCV000349853.1 [likely benign]; RCV000384487.1 [likely benign]; 			67	128					ACTA1 (inh=AD pLI=0.01)
chr1	229569804	229569804	G	A	het	anno_omim	QUAL=3138;DP=68;AF=0.57;MQM=59;TRIO=HET,68,0.57,HET,74,0.49,HET,109,0.54	ACTA1	5'UTR	ACTA1:ENST00000366684:5'UTR:MODIFIER:exon1/7:c.-66C>T:,ACTA1:ENST00000366683:5'UTR:MODIFIER:exon1/6:c.-66C>T:		rs605428	0.6436	0.0000	0,0,0	0,0,0,0,0	0.6052							102610 [ACTA1 (confirmed) Nemaline myopathy 3,autosomal dominant or recessive,161800|Myopathy,actin,congenital,with excess of thin myofilaments,161800|Myopathy,actin,congenital,with cores,161800|Myopathy,congenital,with fiber-type disproportion 1,255310|Myopathy,scapulohumeroperoneal,616852];	RCV000300855.1 [likely benign]; RCV000355646.1 [likely benign]; RCV000393746.1 [likely benign]; 			67	128					ACTA1 (inh=AD pLI=0.01)
chr1	231377081	231377081	C	T	hom	anno_omim	QUAL=19215;DP=318;AF=0.95;MQM=59;TRIO=HOM,318,0.95,HOM,253,0.99,HET,318,0.55	GNPAT	5'UTR	GNPAT:ENST00000366647:5'UTR:MODIFIER:exon1/16:c.-44C>T:,GNPAT:ENST00000366646:5'UTR:MODIFIER:exon1/15:c.-44C>T:		rs518686	0.5819	0.5490	18565,9146,1688	0.5692,0.6149,0.5936,0.5217,0.6239	0.5532							602744 [GNPAT (provisional) Rhizomelic chondrodysplasia punctata,type 2,222765];	RCV000320754.1 [benign]; 			587	949					GNPAT (inh=AR pLI=0.29)
chr1	231401902	231401902	G	A	hom	anno_omim	QUAL=17575;DP=348;AF=1.00;MQM=60;TRIO=HOM,348,1.00,HET,202,0.49,HET,258,0.50	GNPAT	synonymous	GNPAT:ENST00000366647:synonymous:LOW:exon7/16:c.915G>A:p.Glu305Glu,GNPAT:ENST00000366646:synonymous:LOW:exon6/15:c.732G>A:p.Glu244Glu		rs574553	0.6286	0.5676	19885,9534,2503	0.6928,0.6236,0.5969,0.5338,0.6230	0.5688							602744 [GNPAT (provisional) Rhizomelic chondrodysplasia punctata,type 2,222765];	RCV000245766.1 [benign]; RCV000334462.1 [benign]; 		COSM3750988	649	1011	2	[2] auto-classification 14.09.2017  			GNPAT (inh=AR pLI=0.29)
chr1	231500353	231500353	-	T	hom	anno_omim	QUAL=17746;DP=351;AF=0.96;MQM=59;TRIO=HOM,351,0.96,HET,164,0.44,HOM,185,0.98	EGLN1	3'UTR	EGLN1:ENST00000366641:3'UTR:MODIFIER:exon5/5:c.*1803dupA:		rs3215625;rs541569859	0.0000	0.0000	0,0,0	0,0,0,0,0	0.5882							606425 [EGLN1 (confirmed) Erythrocytosis,familial,3,609820|Hemoglobin,high altitude adaptation,609070];				102	101					EGLN1 (inh=AD pLI=0.93)
chr1	231557255	231557255	C	G	het	low_DP;pred_pathogenic;anno_omim	QUAL=206;DP=3;AF=0.67;MQM=60;TRIO=HET,3,0.67,HOM,9,1.00,WT,3,0.00	EGLN1	missense	EGLN1:ENST00000366641:missense:MODERATE:exon1/5:c.380G>C:p.Cys127Ser	(GCC)n	rs12097901	0.2604	0.0000	11,3,4	0.0000,0.0000,0.0000,0.0000,0.0000	0.1584	-0.0310	T	T	B	D	0.05	606425 [EGLN1 (confirmed) Erythrocytosis,familial,3,609820|Hemoglobin,high altitude adaptation,609070];	RCV000144173.3 [other]; RCV000348869.1 [benign]; 	CM140742 [CLASS=DFP MUT=ALT PHEN="Reduced haemoglobin levels" GENE=EGLN1]; 	COSM4143508	36	316	2	[2] auto-classification 14.09.2017  			EGLN1 (inh=AD pLI=0.93)
chr1	231559226	231559226	A	G	het	anno_omim	QUAL=5115;DP=198;AF=0.52;MQM=60;TRIO=HET,198,0.52,HOM,70,1.00,WT,82,0.02	EGLN1	5'UTR	EGLN1:ENST00000366641:5'UTR:MODIFIER:exon1/5:c.-1592T>C:		rs12406290	0.2915	0.0000	0,0,0	0,0,0,0,0	0.1910							606425 [EGLN1 (confirmed) Erythrocytosis,familial,3,609820|Hemoglobin,high altitude adaptation,609070];	RCV000366629.1 [benign]; 			13	65					EGLN1 (inh=AD pLI=0.93)
chr1	231560220	231560220	A	G	het	anno_omim	QUAL=15577;DP=596;AF=0.54;MQM=60;TRIO=HET,596,0.54,HOM,212,1.00,WT,206,0.00	EGLN1	5'UTR	EGLN1:ENST00000366641:5'UTR:MODIFIER:exon1/5:c.-2586T>C:		rs2153364	0.2939	0.0000	0,0,0	0,0,0,0,0	0.1914							606425 [EGLN1 (confirmed) Erythrocytosis,familial,3,609820|Hemoglobin,high altitude adaptation,609070];	RCV000363746.1 [benign]; 			13	64					EGLN1 (inh=AD pLI=0.93)
chr1	235825643	235825643	G	A	het	anno_omim	QUAL=2726;DP=207;AF=0.46;MQM=60;TRIO=HET,207,0.46,HET,30,0.33,WT,66,0.00	LYST	3'UTR	LYST:ENST00000389793:3'UTR:MODIFIER:exon53/53:c.*597C>T:,LYST:ENST00000389794:3'UTR:MODIFIER:exon53/53:c.*597C>T:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0001							606897 [LYST (confirmed) Chediak-Higashi syndrome,214500];				0	2					LYST (inh=AR pLI=1.00)
chr1	235826383	235826383	A	-	hom	anno_omim	QUAL=14828;DP=234;AF=0.92;MQM=59;TRIO=HOM,234,0.92,HET,194,0.50,HOM,276,0.90	LYST	splice_region&intron	LYST:ENST00000389793:splice_region&intron:LOW:exon52/52:c.11268-5delT:,LYST:ENST00000389794:splice_region&intron:LOW:exon52/52:c.11268-5delT:		rs36014994;rs556428133;rs796277765	0.4227	0.5064	8946,5649,2095	0.7266,0.4167,0.2160,0.5413,0.3895	0.5810							606897 [LYST (confirmed) Chediak-Higashi syndrome,214500];				492	1065	1	[1] old entry - no details available			LYST (inh=AR pLI=1.00)
chr1	235940450	235940450	C	T	hom	anno_omim	QUAL=17710;DP=241;AF=1.00;MQM=60;TRIO=HOM,241,1.00,HET,202,0.43,HOM,237,1.00	LYST	synonymous,3'UTR	LYST:ENST00000389793:synonymous:LOW:exon17/53:c.5373G>A:p.Lys1791Lys,LYST:ENST00000389794:synonymous:LOW:exon17/53:c.5373G>A:p.Lys1791Lys,LYST:ENST00000536965:3'UTR:MODIFIER:exon16/22:c.*797G>A:		rs2273584	0.3009	0.3483	8275,5496,1288	0.4968,0.2727,0.0604,0.4046,0.1993	0.4193							606897 [LYST (confirmed) Chediak-Higashi syndrome,214500];	RCV000246380.1 [benign]; RCV000308180.1 [benign]; 		COSM3746866	314	1015	2	[2] auto-classification 14.09.2017  			LYST (inh=AR pLI=1.00)
chr1	235945294	235945294	T	C	hom	anno_omim	QUAL=15537;DP=184;AF=0.99;MQM=60;TRIO=HOM,184,0.99,HET,151,0.50,HOM,234,1.00	LYST	synonymous,3'UTR	LYST:ENST00000389793:synonymous:LOW:exon15/53:c.4956A>G:p.Leu1652Leu,LYST:ENST00000389794:synonymous:LOW:exon15/53:c.4956A>G:p.Leu1652Leu,LYST:ENST00000536965:3'UTR:MODIFIER:exon14/22:c.*380A>G:		rs6696123	0.3035	0.3501	8327,5510,1294	0.4976,0.2738,0.0605,0.4055,0.2059	0.4200							606897 [LYST (confirmed) Chediak-Higashi syndrome,214500];	RCV000253208.1 [benign]; RCV000398616.1 [benign]; 		COSM3746867	316	1017	2	[2] auto-classification 14.09.2017  			LYST (inh=AR pLI=1.00)
chr1	235971763	235971763	A	G	het	anno_omim	QUAL=8439;DP=203;AF=0.53;MQM=60;TRIO=HET,203,0.53,HET,197,0.51,HET,267,0.51	LYST	synonymous	LYST:ENST00000389793:synonymous:LOW:exon5/53:c.2355T>C:p.Leu785Leu,LYST:ENST00000389794:synonymous:LOW:exon5/53:c.2355T>C:p.Leu785Leu,LYST:ENST00000536965:synonymous:LOW:exon5/22:c.2355T>C:p.Leu785Leu		rs3768066	0.0707	0.1035	758,615,24	0.0713,0.0877,0.0507,0.1348,0.0403	0.1047							606897 [LYST (confirmed) Chediak-Higashi syndrome,214500];	RCV000242666.1 [benign]; RCV000377101.1 [likely benign]; 			48	517	2	[2] auto-classification 14.09.2017  			LYST (inh=AR pLI=1.00)
chr1	235972435	235972435	T	C	hom	anno_omim	QUAL=27834;DP=484;AF=0.99;MQM=60;TRIO=HOM,484,0.99,HET,197,0.51,HOM,286,1.00	LYST	synonymous	LYST:ENST00000389793:synonymous:LOW:exon5/53:c.1683A>G:p.Leu561Leu,LYST:ENST00000389794:synonymous:LOW:exon5/53:c.1683A>G:p.Leu561Leu,LYST:ENST00000536965:synonymous:LOW:exon5/22:c.1683A>G:p.Leu561Leu		rs3820553	0.3027	0.3499	8325,5507,1300	0.4977,0.2742,0.0602,0.4054,0.2054	0.4199							606897 [LYST (confirmed) Chediak-Higashi syndrome,214500];	RCV000243167.1 [benign]; RCV000369958.1 [benign]; 		COSM3746868	318	1017	2	[2] auto-classification 14.09.2017  			LYST (inh=AR pLI=1.00)
chr1	235972867	235972867	T	C	hom	anno_omim	QUAL=27810;DP=456;AF=1.00;MQM=59;TRIO=HOM,456,1.00,HET,191,0.56,HOM,305,0.99	LYST	synonymous	LYST:ENST00000389793:synonymous:LOW:exon5/53:c.1251A>G:p.Gln417Gln,LYST:ENST00000389794:synonymous:LOW:exon5/53:c.1251A>G:p.Gln417Gln,LYST:ENST00000536965:synonymous:LOW:exon5/22:c.1251A>G:p.Gln417Gln		rs1063128	0.3033	0.3500	8312,5503,1292	0.5000,0.2741,0.0601,0.4055,0.2055	0.4197							606897 [LYST (confirmed) Chediak-Higashi syndrome,214500];	RCV000246231.1 [benign]; RCV000271690.1 [benign]; 		COSM3746869	317	1017	2	[2] auto-classification 14.09.2017  			LYST (inh=AR pLI=1.00)
chr1	236557771	236557771	G	A	hom	pred_pathogenic;anno_omim	QUAL=24473;DP=251;AF=1.00;MQM=60;TRIO=HOM,251,1.00,HOM,225,1.00,HOM,289,1.00	EDARADD	missense	EDARADD:ENST00000334232:missense:MODERATE:exon1/6:c.27G>A:p.Met9Ile		rs966365	0.7768	0.8308	42529,23173,1467	0.5333,0.9129,0.9191,0.8328,0.9138	0.8412	-0.0830	D	T	B	T	3.35	606603 [EDARADD (confirmed) Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941|Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940];	RCV000249322.1 [benign]; RCV000262285.1 [benign]; 		COSM3746871	1475	573	2	[2] auto-classification 14.09.2017  			EDARADD (inh=AD pLI=0.10)
chr1	236647511	236647511	T	C	het	anno_omim	QUAL=13119;DP=280;AF=0.54;MQM=59;TRIO=HET,280,0.54,HET,142,0.49,HOM,225,1.00	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000359362:3'UTR:MODIFIER:exon6/6:c.*1562T>C:,ENO1P1:ENST00000366587:non_coding_transcript_exon:MODIFIER:exon1/1:n.1047T>C:		rs7513402	0.2540	0.0000	0,0,0	0,0,0,0,0	0.3102							606603 [EDARADD (confirmed) Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941|Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940];	RCV000300675.1 [likely benign]; 			34	101					EDARADD (inh=AD pLI=0.10), ENO1P1 (inh=n/a pLI=n/a)
chr1	236647550	236647550	C	G	het	anno_omim	QUAL=13992;DP=335;AF=0.55;MQM=59;TRIO=HET,335,0.55,HET,127,0.53,HOM,224,1.00	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000359362:3'UTR:MODIFIER:exon6/6:c.*1601C>G:,ENO1P1:ENST00000366587:non_coding_transcript_exon:MODIFIER:exon1/1:n.1086C>G:		rs3916983	0.2033	0.0000	0,0,0	0,0,0,0,0	0.2232							606603 [EDARADD (confirmed) Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941|Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940];	RCV000313375.1 [likely benign]; 			20	91					EDARADD (inh=AD pLI=0.10), ENO1P1 (inh=n/a pLI=n/a)
chr1	236647736	236647736	C	T	het	anno_omim	QUAL=7352;DP=163;AF=0.54;MQM=59;TRIO=HET,163,0.54,HET,74,0.54,HOM,131,0.99	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000359362:3'UTR:MODIFIER:exon6/6:c.*1787C>T:,ENO1P1:ENST00000366587:non_coding_transcript_exon:MODIFIER:exon1/1:n.1272C>T:		rs6428955	0.1378	0.0000	0,0,0	0,0,0,0,0	0.1736							606603 [EDARADD (confirmed) Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941|Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940];	RCV000268785.1 [likely benign]; 			14	83					EDARADD (inh=AD pLI=0.10), ENO1P1 (inh=n/a pLI=n/a)
chr1	236648008	236648008	G	A	hom	low_DP;anno_omim	QUAL=869;DP=10;AF=0.60;MQM=57;TRIO=HOM,10,0.60,HOM,15,0.33,HOM,27,0.04	EDARADD	3'UTR	EDARADD:ENST00000359362:3'UTR:MODIFIER:exon6/6:c.*2059G>A:	AluSc	rs200288312	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0048							606603 [EDARADD (confirmed) Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941|Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940];				5	14					EDARADD (inh=AD pLI=0.10)
chr1	237054569	237054569	A	G	het	anno_omim	QUAL=7272;DP=103;AF=0.55;MQM=59;TRIO=HET,103,0.55,HET,101,0.50,HOM,145,1.00	MTR	synonymous	MTR:ENST00000366577:synonymous:LOW:exon29/33:c.3144A>G:p.Ala1048Ala,MTR:ENST00000535889:synonymous:LOW:exon28/32:c.2991A>G:p.Ala997Ala		rs2229276	0.3233	0.3833	9367,5488,217	0.1942,0.4496,0.4469,0.4010,0.3247	0.3905							156570 [MTR (confirmed) Homocystinuria-megaloblastic anemia,cblG complementation type,250940|Neural tube defects,folate-sensitive,susceptibility to,601634];	RCV000126869.2 [benign]; RCV000366897.1 [benign]; 		COSM3751028	324	1001	2	[2] auto-classification 14.09.2017  			MTR (inh=AR pLI=0.00)
chr1	237058744	237058744	C	A	het	anno_omim	QUAL=14706;DP=218;AF=0.51;MQM=60;TRIO=HET,218,0.51,HET,223,0.46,HOM,310,1.00	MTR	synonymous	MTR:ENST00000366577:synonymous:LOW:exon31/33:c.3492C>A:p.Arg1164Arg,MTR:ENST00000535889:synonymous:LOW:exon30/32:c.3339C>A:p.Arg1113Arg		rs12070777	0.3215	0.4330	6783,3972,162	0.2409,0.5028,0.4739,0.4576,0.3477	0.3875							156570 [MTR (confirmed) Homocystinuria-megaloblastic anemia,cblG complementation type,250940|Neural tube defects,folate-sensitive,susceptibility to,601634];	RCV000126862.2 [benign]; RCV000316970.1 [benign]; 		COSM3751029	325	987	2	[2] auto-classification 14.09.2017  			MTR (inh=AR pLI=0.00)
chr1	237061056	237061056	A	C	het	anno_omim	QUAL=10754;DP=311;AF=0.55;MQM=59;TRIO=HET,311,0.55,HET,80,0.53,HOM,153,1.00	MTR	3'UTR	MTR:ENST00000366577:3'UTR:MODIFIER:exon33/33:c.*112A>C:,MTR:ENST00000535889:3'UTR:MODIFIER:exon32/32:c.*112A>C:		rs2853522	0.5401	0.0000	0,0,0	0,0,0,0,0	0.5720							156570 [MTR (confirmed) Homocystinuria-megaloblastic anemia,cblG complementation type,250940|Neural tube defects,folate-sensitive,susceptibility to,601634];	RCV000369614.1 [benign]; 			170	215					MTR (inh=AR pLI=0.00)
chr1	237061705	237061705	T	-	het	anno_omim	QUAL=1748;DP=108;AF=0.47;MQM=57;TRIO=HET,108,0.47,HET,32,0.56,HOM,42,0.81	MTR	3'UTR	MTR:ENST00000366577:3'UTR:MODIFIER:exon33/33:c.*773delT:	AluY	rs796166778	0.4605	0.0000	0,0,0	0,0,0,0,0	0.6828							156570 [MTR (confirmed) Homocystinuria-megaloblastic anemia,cblG complementation type,250940|Neural tube defects,folate-sensitive,susceptibility to,601634];	RCV000322819.1 [benign]; 			83	112					MTR (inh=AR pLI=0.00)
chr1	237061849	237061849	G	A	het	anno_omim	QUAL=1239;DP=81;AF=0.43;MQM=51;TRIO=HET,81,0.43,HET,34,0.59,WT,66,0.00	MTR	3'UTR	MTR:ENST00000366577:3'UTR:MODIFIER:exon33/33:c.*905G>A:	AluY	rs1131450	0.2460	0.0000	0,0,0	0,0,0,0,0	0.2744							156570 [MTR (confirmed) Homocystinuria-megaloblastic anemia,cblG complementation type,250940|Neural tube defects,folate-sensitive,susceptibility to,601634];	RCV000328630.1 [benign]; 			24	81					MTR (inh=AR pLI=0.00)
chr1	237062198	237062198	A	C	het	anno_omim	QUAL=16868;DP=267;AF=0.54;MQM=60;TRIO=HET,267,0.54,HET,245,0.47,HOM,296,1.00	MTR	3'UTR	MTR:ENST00000366577:3'UTR:MODIFIER:exon33/33:c.*1254A>C:		rs2853523	0.7646	0.0000	0,0,0	0,0,0,0,0	0.7284							156570 [MTR (confirmed) Homocystinuria-megaloblastic anemia,cblG complementation type,250940|Neural tube defects,folate-sensitive,susceptibility to,601634];	RCV000360926.1 [benign]; 			121	106					MTR (inh=AR pLI=0.00)
chr1	237062305	237062305	A	G	het	anno_omim	QUAL=21941;DP=415;AF=0.52;MQM=60;TRIO=HET,415,0.52,HET,296,0.52,HOM,370,0.99	MTR	3'UTR	MTR:ENST00000366577:3'UTR:MODIFIER:exon33/33:c.*1361A>G:		rs1050993	0.7644	0.0000	0,0,0	0,0,0,0,0	0.7284							156570 [MTR (confirmed) Homocystinuria-megaloblastic anemia,cblG complementation type,250940|Neural tube defects,folate-sensitive,susceptibility to,601634];	RCV000270883.1 [benign]; 			119	106					MTR (inh=AR pLI=0.00)
chr1	237063335	237063335	G	C	het	anno_omim	QUAL=12927;DP=228;AF=0.50;MQM=60;TRIO=HET,228,0.50,HET,207,0.53,HOM,222,1.00	MTR	3'UTR	MTR:ENST00000366577:3'UTR:MODIFIER:exon33/33:c.*2391G>C:	L1ME3F	rs1050996	0.7328	0.0000	0,0,0	0,0,0,0,0	0.6990							156570 [MTR (confirmed) Homocystinuria-megaloblastic anemia,cblG complementation type,250940|Neural tube defects,folate-sensitive,susceptibility to,601634];	RCV000275160.1 [benign]; 			190	222					MTR (inh=AR pLI=0.00)
chr1	237063504	237063504	A	G	het	anno_omim	QUAL=11930;DP=380;AF=0.50;MQM=60;TRIO=HET,380,0.50,HET,106,0.54,HOM,148,1.00	MTR	3'UTR	MTR:ENST00000366577:3'UTR:MODIFIER:exon33/33:c.*2560A>G:	L1ME3F	rs9779	0.3219	0.3793	440,132,8	0.0000,0.0000,0.0000,0.4073,0.3684	0.3701							156570 [MTR (confirmed) Homocystinuria-megaloblastic anemia,cblG complementation type,250940|Neural tube defects,folate-sensitive,susceptibility to,601634];	RCV000369642.1 [benign]; 			250	708					MTR (inh=AR pLI=0.00)
chr1	237063709	237063709	-	A	hom	anno_omim	QUAL=9455;DP=88;AF=0.88;MQM=59;TRIO=HOM,88,0.88,HOM,62,0.94,HOM,184,0.95	MTR	3'UTR	MTR:ENST00000366577:3'UTR:MODIFIER:exon33/33:c.*2774dupA:	L1ME3F	rs537046483;rs757040639;rs796715143	0.6516	0.0000	0,0,0	0,0,0,0,0	0.7257							156570 [MTR (confirmed) Homocystinuria-megaloblastic anemia,cblG complementation type,250940|Neural tube defects,folate-sensitive,susceptibility to,601634];	RCV000316041.1 [benign]; 			183	16					MTR (inh=AR pLI=0.00)
chr1	237064626	237064626	T	G	het	anno_omim	QUAL=33769;DP=424;AF=0.49;MQM=60;TRIO=HET,424,0.49,HET,514,0.48,HOM,672,0.99	MTR	3'UTR	MTR:ENST00000366577:3'UTR:MODIFIER:exon33/33:c.*3682T>G:		rs6676866	0.5397	0.0000	0,0,0	0,0,0,0,0	0.5727							156570 [MTR (confirmed) Homocystinuria-megaloblastic anemia,cblG complementation type,250940|Neural tube defects,folate-sensitive,susceptibility to,601634];	RCV000320905.1 [benign]; 			102	116					MTR (inh=AR pLI=0.00)
chr1	237065326	237065326	C	T	het	anno_omim	QUAL=8093;DP=170;AF=0.55;MQM=60;TRIO=HET,170,0.55,HET,114,0.46,HOM,157,1.00	MTR	3'UTR	MTR:ENST00000366577:3'UTR:MODIFIER:exon33/33:c.*4382C>T:		rs4659746	0.5447	0.0000	0,0,0	0,0,0,0,0	0.5783							156570 [MTR (confirmed) Homocystinuria-megaloblastic anemia,cblG complementation type,250940|Neural tube defects,folate-sensitive,susceptibility to,601634];	RCV000405275.1 [benign]; 			105	112					MTR (inh=AR pLI=0.00)
chr1	237065583	237065583	G	T	het	anno_omim	QUAL=13268;DP=220;AF=0.52;MQM=59;TRIO=HET,220,0.52,HET,176,0.57,HOM,257,1.00	MTR	3'UTR	MTR:ENST00000366577:3'UTR:MODIFIER:exon33/33:c.*4639G>T:		rs10925264	0.7646	0.0000	0,0,0	0,0,0,0,0	0.7282							156570 [MTR (confirmed) Homocystinuria-megaloblastic anemia,cblG complementation type,250940|Neural tube defects,folate-sensitive,susceptibility to,601634];	RCV000363593.1 [benign]; 			119	106					MTR (inh=AR pLI=0.00)
chr1	237065810	237065810	T	G	het	anno_omim	QUAL=4783;DP=177;AF=0.52;MQM=60;TRIO=HET,177,0.52,WT,180,0.00,HET,171,0.55	MTR	3'UTR	MTR:ENST00000366577:3'UTR:MODIFIER:exon33/33:c.*4866T>G:	L2c	rs45563435	0.0076	0.0000	0,0,0	0,0,0,0,0	0.0132							156570 [MTR (confirmed) Homocystinuria-megaloblastic anemia,cblG complementation type,250940|Neural tube defects,folate-sensitive,susceptibility to,601634];	RCV000274054.1 [uncertain significance]; 			0	20					MTR (inh=AR pLI=0.00)
chr1	237066114	237066114	A	G	het	anno_omim	QUAL=3157;DP=158;AF=0.49;MQM=59;TRIO=HET,158,0.49,HET,86,0.59,WT,114,0.00	MTR	3'UTR	MTR:ENST00000366577:3'UTR:MODIFIER:exon33/33:c.*5170A>G:		rs6680753	0.0104	0.0000	0,0,0	0,0,0,0,0	0.0203							156570 [MTR (confirmed) Homocystinuria-megaloblastic anemia,cblG complementation type,250940|Neural tube defects,folate-sensitive,susceptibility to,601634];	RCV000388244.1 [likely benign]; 			0	11					MTR (inh=AR pLI=0.00)
chr1	240939104	240939104	G	A	het		QUAL=9081;DP=345;AF=0.48;MQM=60;TRIO=HET,345,0.48,HOM,146,0.99,WT,165,0.00	RGS7	3'UTR,intron	RGS7:ENST00000348120:3'UTR:MODIFIER:exon15/15:c.*416C>T:,RGS7:ENST00000366563:3'UTR:MODIFIER:exon18/18:c.*416C>T:,RGS7:ENST00000366564:3'UTR:MODIFIER:exon17/17:c.*359C>T:,RGS7:ENST00000366565:3'UTR:MODIFIER:exon18/18:c.*359C>T:,RGS7:ENST00000446183:3'UTR:MODIFIER:exon18/18:c.*416C>T:,RGS7:ENST00000331110:intron:MODIFIER:exon17/17:c.*7-7526C>T:		rs35557904	0.1727	0.0000	0,0,0	0,0,0,0,0	0.1728											2	43					RGS7 (inh=n/a pLI=0.78)
chr1	240939152	240939152	A	G	het		QUAL=9436;DP=319;AF=0.44;MQM=59;TRIO=HET,319,0.44,HOM,181,0.99,WT,209,0.00	RGS7	3'UTR,intron	RGS7:ENST00000348120:3'UTR:MODIFIER:exon15/15:c.*368T>C:,RGS7:ENST00000366563:3'UTR:MODIFIER:exon18/18:c.*368T>C:,RGS7:ENST00000366564:3'UTR:MODIFIER:exon17/17:c.*311T>C:,RGS7:ENST00000366565:3'UTR:MODIFIER:exon18/18:c.*311T>C:,RGS7:ENST00000446183:3'UTR:MODIFIER:exon18/18:c.*368T>C:,RGS7:ENST00000331110:intron:MODIFIER:exon17/17:c.*7-7574T>C:		rs16840577	0.1727	0.0000	0,0,0	0,0,0,0,0	0.1720											2	42					RGS7 (inh=n/a pLI=0.78)
chr1	240939391	240939391	C	T	het		QUAL=12776;DP=503;AF=0.46;MQM=60;TRIO=HET,503,0.46,HET,553,0.47,WT,688,0.00	RGS7	3'UTR,intron	RGS7:ENST00000348120:3'UTR:MODIFIER:exon15/15:c.*129G>A:,RGS7:ENST00000366563:3'UTR:MODIFIER:exon18/18:c.*129G>A:,RGS7:ENST00000366564:3'UTR:MODIFIER:exon17/17:c.*72G>A:,RGS7:ENST00000366565:3'UTR:MODIFIER:exon18/18:c.*72G>A:,RGS7:ENST00000446183:3'UTR:MODIFIER:exon18/18:c.*129G>A:,RGS7:ENST00000331110:intron:MODIFIER:exon17/17:c.*7-7813G>A:		rs12757054	0.0497	0.0000	0,0,0	0,0,0,0,0	0.0595											6	78					RGS7 (inh=n/a pLI=0.78)
chr1	240975213	240975213	T	C	het		QUAL=11065;DP=255;AF=0.55;MQM=60;TRIO=HET,255,0.55,WT,201,0.00,HOM,237,1.00	RGS7	splice_region&intron	RGS7:ENST00000407727:splice_region&intron:LOW:exon13/16:c.1082+5A>G:,RGS7:ENST00000331110:splice_region&intron:LOW:exon14/17:c.1004+5A>G:,RGS7:ENST00000348120:splice_region&intron:LOW:exon11/14:c.923+5A>G:,RGS7:ENST00000366563:splice_region&intron:LOW:exon14/17:c.1082+5A>G:,RGS7:ENST00000366564:splice_region&intron:LOW:exon14/16:c.1082+5A>G:,RGS7:ENST00000366565:splice_region&intron:LOW:exon14/17:c.1082+5A>G:,RGS7:ENST00000446183:splice_region&intron:LOW:exon14/17:c.830+5A>G:,RGS7:ENST00000366562:splice_region&intron:LOW:exon13/15:c.1082+5A>G:,RGS7:ENST00000401882:splice_region&intron:LOW:exon11/13:c.923+5A>G:		rs2275742	0.4046	0.5060	16301,10968,360	0.2596,0.4093,0.4555,0.5720,0.4335	0.5082										COSM146839	652	964	2	[2] auto-classification 14.09.2017  			RGS7 (inh=n/a pLI=0.78)
chr1	241519098	241519098	T	A	hom		QUAL=35182;DP=434;AF=1.00;MQM=60;TRIO=HOM,434,1.00,HOM,287,1.00,HOM,423,1.00	RGS7	5'UTR	RGS7:ENST00000366563:5'UTR:MODIFIER:exon2/18:c.-22A>T:,RGS7:ENST00000366564:5'UTR:MODIFIER:exon2/17:c.-22A>T:,RGS7:ENST00000366565:5'UTR:MODIFIER:exon2/18:c.-22A>T:		rs4659599	0.9483	0.9779	57908,32328,3876	0.8684,0.9896,0.9965,0.9860,0.9882	0.9797											1913	58					RGS7 (inh=n/a pLI=0.78)
chr1	247581560	247581560	A	T	het	anno_omim	QUAL=12620;DP=502;AF=0.50;MQM=59;TRIO=HET,502,0.50,WT,357,0.00,HET,471,0.52	NLRP3	5'UTR	NLRP3:ENST00000336119:5'UTR:MODIFIER:exon1/9:c.-537A>T:,NLRP3:ENST00000366497:5'UTR:MODIFIER:exon2/9:c.-537A>T:,NLRP3:ENST00000391828:5'UTR:MODIFIER:exon2/11:c.-71A>T:,NLRP3:ENST00000348069:5'UTR:MODIFIER:exon1/7:c.-537A>T:,NLRP3:ENST00000366496:5'UTR:MODIFIER:exon1/8:c.-537A>T:		rs116502550	0.0030	0.0000	0,0,0	0,0,0,0,0	0.0111							606416 [NLRP3 (confirmed) Familial cold-induced inflammatory syndrome 1,120100|Muckle-Wells syndrome,191900|CINCA syndrome,607115];	RCV000272392.1 [likely benign]; RCV000307404.1 [likely benign]; RCV000362149.1 [likely benign]; 			0	13					NLRP3 (inh=AD pLI=0.45)
chr1	247581692	247581692	T	C	hom	anno_omim	QUAL=17568;DP=264;AF=0.99;MQM=58;TRIO=HOM,264,0.99,HOM,161,1.00,HOM,169,1.00	NLRP3	5'UTR,intron	NLRP3:ENST00000336119:5'UTR:MODIFIER:exon1/9:c.-405T>C:,NLRP3:ENST00000366497:5'UTR:MODIFIER:exon2/9:c.-405T>C:,NLRP3:ENST00000348069:5'UTR:MODIFIER:exon1/7:c.-405T>C:,NLRP3:ENST00000366496:5'UTR:MODIFIER:exon1/8:c.-405T>C:,NLRP3:ENST00000391828:intron:MODIFIER:exon2/10:c.-39+100T>C:	AluSx1	rs7523422	0.9978	0.0000	0,0,0	0,0,0,0,0	0.9975							606416 [NLRP3 (confirmed) Familial cold-induced inflammatory syndrome 1,120100|Muckle-Wells syndrome,191900|CINCA syndrome,607115];	RCV000307398.1 [benign]; RCV000342282.1 [benign]; RCV000396602.1 [benign]; 			220	0					NLRP3 (inh=AD pLI=0.45)
chr1	247581872	247581872	G	A	het	anno_omim	QUAL=5043;DP=217;AF=0.54;MQM=58;TRIO=HET,217,0.54,HET,67,0.55,HET,85,0.44	NLRP3	5'UTR,intron	NLRP3:ENST00000336119:5'UTR:MODIFIER:exon1/9:c.-225G>A:,NLRP3:ENST00000366497:5'UTR:MODIFIER:exon2/9:c.-225G>A:,NLRP3:ENST00000348069:5'UTR:MODIFIER:exon1/7:c.-225G>A:,NLRP3:ENST00000366496:5'UTR:MODIFIER:exon1/8:c.-225G>A:,NLRP3:ENST00000391828:intron:MODIFIER:exon2/10:c.-38-187G>A:	AluSx1	rs138900557	0.0158	0.0000	0,0,0	0,0,0,0,0	0.0455							606416 [NLRP3 (confirmed) Familial cold-induced inflammatory syndrome 1,120100|Muckle-Wells syndrome,191900|CINCA syndrome,607115];	RCV000313147.1 [likely benign]; RCV000347982.1 [likely benign]; RCV000396614.1 [likely benign]; 			1	28					NLRP3 (inh=AD pLI=0.45)
chr1	247582063	247582063	G	T	het	anno_omim	QUAL=9894;DP=333;AF=0.48;MQM=60;TRIO=HET,333,0.48,HET,232,0.41,HET,287,0.50	NLRP3	5'UTR	NLRP3:ENST00000336119:5'UTR:MODIFIER:exon1/9:c.-34G>T:,NLRP3:ENST00000366497:5'UTR:MODIFIER:exon2/9:c.-34G>T:,NLRP3:ENST00000391828:5'UTR:MODIFIER:exon3/11:c.-34G>T:,NLRP3:ENST00000348069:5'UTR:MODIFIER:exon1/7:c.-34G>T:,NLRP3:ENST00000366496:5'UTR:MODIFIER:exon1/8:c.-34G>T:		rs73136263	0.0270	0.0367	112,64,9	0.0367,0.0108,0.0016,0.0449,0.0217	0.0553							606416 [NLRP3 (confirmed) Familial cold-induced inflammatory syndrome 1,120100|Muckle-Wells syndrome,191900|CINCA syndrome,607115];	RCV000291636.1 [benign]; RCV000348931.1 [benign]; RCV000383741.1 [benign]; 			6	162					NLRP3 (inh=AD pLI=0.45)
chr1	247587477	247587477	G	A	het	anno_omim	QUAL=6296;DP=167;AF=0.47;MQM=60;TRIO=HET,167,0.47,HET,155,0.41,HET,192,0.58	NLRP3	synonymous	NLRP3:ENST00000336119:synonymous:LOW:exon3/9:c.732G>A:p.Ala244Ala,NLRP3:ENST00000366497:synonymous:LOW:exon4/9:c.732G>A:p.Ala244Ala,NLRP3:ENST00000391828:synonymous:LOW:exon5/11:c.732G>A:p.Ala244Ala,NLRP3:ENST00000348069:synonymous:LOW:exon3/7:c.732G>A:p.Ala244Ala,NLRP3:ENST00000366496:synonymous:LOW:exon3/8:c.732G>A:p.Ala244Ala,NLRP3:ENST00000391827:synonymous:LOW:exon3/8:c.732G>A:p.Ala244Ala		rs3806268	0.3874	0.4996	16070,10284,74	0.1056,0.3995,0.5386,0.5569,0.5447	0.5034							606416 [NLRP3 (confirmed) Familial cold-induced inflammatory syndrome 1,120100|Muckle-Wells syndrome,191900|CINCA syndrome,607115];	RCV000245535.1 [benign]; RCV000260400.1 [benign]; RCV000318048.1 [benign]; RCV000371499.1 [benign]; 		COSM146848	674	1029	2	[2] auto-classification 14.09.2017  			NLRP3 (inh=AD pLI=0.45)
chr1	247587531	247587531	A	G	hom	anno_omim	QUAL=14196;DP=158;AF=1.00;MQM=60;TRIO=HOM,158,1.00,HOM,120,1.00,HOM,162,1.00	NLRP3	synonymous	NLRP3:ENST00000336119:synonymous:LOW:exon3/9:c.786A>G:p.Arg262Arg,NLRP3:ENST00000366497:synonymous:LOW:exon4/9:c.786A>G:p.Arg262Arg,NLRP3:ENST00000391828:synonymous:LOW:exon5/11:c.786A>G:p.Arg262Arg,NLRP3:ENST00000348069:synonymous:LOW:exon3/7:c.786A>G:p.Arg262Arg,NLRP3:ENST00000366496:synonymous:LOW:exon3/8:c.786A>G:p.Arg262Arg,NLRP3:ENST00000391827:synonymous:LOW:exon3/8:c.786A>G:p.Arg262Arg		rs4925543	0.9199	0.9426	54053,30707,3740	0.8480,0.9690,0.9986,0.9594,0.8817	0.9462							606416 [NLRP3 (confirmed) Familial cold-induced inflammatory syndrome 1,120100|Muckle-Wells syndrome,191900|CINCA syndrome,607115];				1913	185	2	[2] auto-classification 14.09.2017  			NLRP3 (inh=AD pLI=0.45)
chr1	247612036	247612036	G	C	hom	anno_omim	QUAL=50300;DP=706;AF=1.00;MQM=59;TRIO=HOM,706,1.00,HOM,384,1.00,HOM,505,1.00	NLRP3	3'UTR	NLRP3:ENST00000336119:3'UTR:MODIFIER:exon9/9:c.*230G>C:,NLRP3:ENST00000366497:3'UTR:MODIFIER:exon9/9:c.*230G>C:,NLRP3:ENST00000391828:3'UTR:MODIFIER:exon11/11:c.*230G>C:,NLRP3:ENST00000348069:3'UTR:MODIFIER:exon7/7:c.*230G>C:,NLRP3:ENST00000366496:3'UTR:MODIFIER:exon8/8:c.*230G>C:		rs10754558	0.6536	0.0000	0,0,0	0,0,0,0,0	0.6328							606416 [NLRP3 (confirmed) Familial cold-induced inflammatory syndrome 1,120100|Muckle-Wells syndrome,191900|CINCA syndrome,607115];	RCV000284662.1 [benign]; RCV000339908.1 [benign]; RCV000379007.1 [benign]; 			68	103					NLRP3 (inh=AD pLI=0.45)
chr2	1417244	1417244	A	G	het	anno_omim	QUAL=8243;DP=243;AF=0.54;MQM=60;TRIO=HET,243,0.54,WT,223,0.00,HET,355,0.52	TPO	5'UTR_premature_start_codon_gain,5'UTR	TPO:ENST00000329066:5'UTR_premature_start_codon_gain:LOW:exon1/17:c.-75A>G:,TPO:ENST00000539820:5'UTR_premature_start_codon_gain:LOW:exon1/6:c.-80A>G:,TPO:ENST00000382269:5'UTR_premature_start_codon_gain:LOW:exon1/6:c.-75A>G:,TPO:ENST00000337415:5'UTR_premature_start_codon_gain:LOW:exon1/16:c.-80A>G:,TPO:ENST00000345913:5'UTR_premature_start_codon_gain:LOW:exon1/17:c.-80A>G:,TPO:ENST00000346956:5'UTR_premature_start_codon_gain:LOW:exon1/16:c.-80A>G:,TPO:ENST00000349624:5'UTR_premature_start_codon_gain:LOW:exon1/16:c.-80A>G:,TPO:ENST00000329066:5'UTR:MODIFIER:exon1/17:c.-75A>G:,TPO:ENST00000539820:5'UTR:MODIFIER:exon1/6:c.-80A>G:,TPO:ENST00000382269:5'UTR:MODIFIER:exon1/6:c.-75A>G:,TPO:ENST00000337415:5'UTR:MODIFIER:exon1/16:c.-80A>G:,TPO:ENST00000345913:5'UTR:MODIFIER:exon1/17:c.-80A>G:,TPO:ENST00000346956:5'UTR:MODIFIER:exon1/16:c.-80A>G:,TPO:ENST00000349624:5'UTR:MODIFIER:exon1/16:c.-80A>G:		rs2071403	0.6324	0.0000	0,0,0	0,0,0,0,0	0.5603							606765 [TPO (confirmed) Thyroid dyshormonogenesis 2A,274500];	RCV000326086.1 [likely benign]; 	CR146967 [CLASS=FP MUT=ALT PHEN="Decreased thyroid mRNA expression association with" GENE=TPO]; 		54	122	2	[2] auto-classification 14.09.2017  			TPO (inh=AR pLI=0.00)
chr2	1481155	1481155	G	T	het	low_DP;anno_omim	QUAL=693;DP=10;AF=0.50;MQM=60;TRIO=HET,10,0.50,HOM,22,1.00,WT,21,0.00	TPO	missense,intron	TPO:ENST00000329066:missense:MODERATE:exon8/17:c.1117G>T:p.Ala373Ser,TPO:ENST00000337415:missense:MODERATE:exon8/16:c.1117G>T:p.Ala373Ser,TPO:ENST00000345913:missense:MODERATE:exon8/17:c.1117G>T:p.Ala373Ser,TPO:ENST00000346956:missense:MODERATE:exon8/16:c.1117G>T:p.Ala373Ser,TPO:ENST00000382201:missense:MODERATE:exon8/16:c.1117G>T:p.Ala373Ser,TPO:ENST00000349624:intron:MODIFIER:exon7/15:c.820-7213G>T:,TPO:ENST00000382198:intron:MODIFIER:exon6/14:c.820-7213G>T:		rs2280132	0.4081	0.4578	1258,473,48	0.4678,0.0000,0.5978,0.5326,0.4095	0.4697	0.1730	T,T,T,T,T,T,T	T	B,B,B	T,T,T,T,T,T	0.01	606765 [TPO (confirmed) Thyroid dyshormonogenesis 2A,274500];	RCV000250722.1 [benign]; RCV000407447.1 [likely benign]; 	CM146545 [CLASS=DFP MUT=ALT PHEN="Thyroid dyshormonogenesis" GENE=TPO]; 	COSM3749597, COSM3749598	428	1019	2	[2] auto-classification 14.09.2017  			TPO (inh=AR pLI=0.00)
chr2	1481231	1481231	G	C	hom	low_DP;pred_pathogenic;anno_omim	QUAL=287;DP=4;AF=1.00;MQM=60;TRIO=HOM,4,1.00,HOM,8,1.00,WT,12,0.00	TPO	missense,intron	TPO:ENST00000329066:missense:MODERATE:exon8/17:c.1193G>C:p.Ser398Thr,TPO:ENST00000337415:missense:MODERATE:exon8/16:c.1193G>C:p.Ser398Thr,TPO:ENST00000345913:missense:MODERATE:exon8/17:c.1193G>C:p.Ser398Thr,TPO:ENST00000346956:missense:MODERATE:exon8/16:c.1193G>C:p.Ser398Thr,TPO:ENST00000382201:missense:MODERATE:exon8/16:c.1193G>C:p.Ser398Thr,TPO:ENST00000349624:intron:MODIFIER:exon7/15:c.820-7137G>C:,TPO:ENST00000382198:intron:MODIFIER:exon6/14:c.820-7137G>C:		rs2175977	0.7103	0.6400	2234,500,70	0.7797,0.0000,0.0000,0.5997,0.6457	0.6557	1.2970	T,T,T,T,T,T,T	T,T	.,D,D,D	.,T,T,T,T,T,T	23.50	606765 [TPO (confirmed) Thyroid dyshormonogenesis 2A,274500];	RCV000242879.1 [benign]; RCV000311144.1 [benign]; 		COSM1579950, COSM3749599	782	935	2	[2] auto-classification 14.09.2017  			TPO (inh=AR pLI=0.00)
chr2	1520676	1520676	T	C	het	anno_omim	QUAL=10050;DP=244;AF=0.52;MQM=59;TRIO=HET,244,0.52,WT,219,0.00,HOM,228,1.00	TPO	missense	TPO:ENST00000329066:missense:MODERATE:exon15/17:c.2540T>C:p.Val847Ala,TPO:ENST00000337415:missense:MODERATE:exon15/16:c.2540T>C:p.Val847Ala,TPO:ENST00000345913:missense:MODERATE:exon15/17:c.2540T>C:p.Val847Ala,TPO:ENST00000346956:missense:MODERATE:exon14/16:c.2408T>C:p.Val803Ala,TPO:ENST00000349624:missense:MODERATE:exon14/16:c.2021T>C:p.Val674Ala,TPO:ENST00000382201:missense:MODERATE:exon14/16:c.2369T>C:p.Val790Ala,TPO:ENST00000382198:missense:MODERATE:exon13/15:c.2021T>C:p.Val674Ala		rs1126799	0.6639	0.5898	21459,9540,3194	0.7841,0.6230,0.5874,0.5357,0.6538	0.6240	0.6090	T,T,T,T,T,T,T,T,T,T,.	T,.	B,B,B,B,.	T,T,T,T,T,T,T,T,T,T,.	0.02	606765 [TPO (confirmed) Thyroid dyshormonogenesis 2A,274500];	RCV000253477.1 [benign]; RCV000333699.1 [benign]; 		COSM3927753, COSM148793	609	1035	2	[2] auto-classification 14.09.2017  			TPO (inh=AR pLI=0.00)
chr2	1546327	1546327	C	G	het	anno_omim	QUAL=21208;DP=482;AF=0.45;MQM=60;TRIO=HET,482,0.45,HOM,501,1.00,WT,714,0.00	TPO	missense,3'UTR	TPO:ENST00000337415:missense:MODERATE:exon16/16:c.2753C>G:p.Pro918Arg,TPO:ENST00000329066:3'UTR:MODIFIER:exon17/17:c.*81C>G:,TPO:ENST00000345913:3'UTR:MODIFIER:exon17/17:c.*81C>G:,TPO:ENST00000346956:3'UTR:MODIFIER:exon16/16:c.*81C>G:,TPO:ENST00000349624:3'UTR:MODIFIER:exon16/16:c.*81C>G:,TPO:ENST00000382201:3'UTR:MODIFIER:exon16/16:c.*81C>G:		rs1042589	0.3526	0.4594	7417,4802,237	0.2911,0.4549,0.5173,0.5055,0.3726	0.4150	-1.1970	T,.	T,T		T,.	0.57	606765 [TPO (confirmed) Thyroid dyshormonogenesis 2A,274500];	RCV000309201.1 [likely benign]; 		COSM4001255	367	832	2	[2] auto-classification 14.09.2017  			TPO (inh=AR pLI=0.00)
chr2	11911761	11911761	C	T	het	anno_omim	QUAL=18152;DP=262;AF=0.59;MQM=59;TRIO=HET,262,0.59,HOM,445,1.00,WT,575,0.00	LPIN1	synonymous	LPIN1:ENST00000449576:synonymous:LOW:exon5/22:c.699C>T:p.Ile233Ile,LPIN1:ENST00000396098:synonymous:LOW:exon5/10:c.570C>T:p.Ile190Ile,LPIN1:ENST00000396099:synonymous:LOW:exon5/22:c.570C>T:p.Ile190Ile,LPIN1:ENST00000425416:synonymous:LOW:exon5/21:c.570C>T:p.Ile190Ile,LPIN1:ENST00000256720:synonymous:LOW:exon4/20:c.552C>T:p.Ile184Ile		rs11538448	0.0507	0.1330	610,525,3	0.0311,0.0924,0.0012,0.1838,0.0805	0.0984							605518 [LPIN1 (provisional) Myoglobinuria,acute recurrent,autosomal recessive,268200];	RCV000082649.5 [benign]; RCV000260825.1 [likely benign]; 			49	460	2	[2] auto-classification 14.09.2017  			LPIN1 (inh=AR pLI=0.00)
chr2	26413917	26413917	C	T	hom	anno_omim	QUAL=37578;DP=558;AF=0.99;MQM=59;TRIO=HOM,558,0.99,HOM,258,1.00,HOM,360,1.00	HADHA	3'UTR	HADHA:ENST00000380649:3'UTR:MODIFIER:exon20/20:c.*202G>A:		rs7260	0.7875	0.0000	0,0,0	0,0,0,0,0	0.7666							600890 [HADHA (confirmed) LCHAD deficiency,609016|Trifunctional protein deficiency,609015|HELLP syndrome,maternal,of pregnancy,609016|Fatty liver,acute,of pregnancy,609016];	RCV000269209.1 [benign]; RCV000361491.1 [benign]; 			151	73					HADHA (inh=AR pLI=0.02)
chr2	26467666	26467666	G	A	hom	anno_omim	QUAL=5581;DP=44;AF=1.00;MQM=60;TRIO=HOM,44,1.00,HOM,61,1.00,HOM,98,1.00	HADHB				rs3806516	0.4573	0.0000	0,0,0	0,0,0,0,0	0.6027							143450 [HADHB (confirmed) Trifunctional protein deficiency,609015];	RCV000336882.1 [benign]; RCV000395927.1 [benign]; 			112	96					HADHB (inh=AR pLI=0.00)
chr2	26477125	26477125	-	ACT	hom	anno_omim	QUAL=18752;DP=277;AF=0.97;MQM=59;TRIO=HOM,277,0.97,HOM,115,1.00,HOM,181,1.00	HADHB	disruptive_inframe_insertion,5'UTR	HADHB:ENST00000317799:disruptive_inframe_insertion:MODERATE:exon2/16:c.5_7dupCTA:p.Thr2dup,HADHB:ENST00000405867:disruptive_inframe_insertion:MODERATE:exon2/14:c.5_7dupCTA:p.Thr2dup,HADHB:ENST00000537713:disruptive_inframe_insertion:MODERATE:exon2/15:c.5_7dupCTA:p.Thr2dup,HADHB:ENST00000545822:5'UTR:MODIFIER:exon2/17:c.-145_-143dupCTA:		rs147970487	0.7095	0.8315	44610,29087,3978	0.8789,0.6033,0.1804,0.9339,0.8447	0.8682							143450 [HADHB (confirmed) Trifunctional protein deficiency,609015];				1761	295	2	[2] auto-classification 14.09.2017  			HADHB (inh=AR pLI=0.00)
chr2	26512957	26512957	G	C	hom	anno_omim	QUAL=38065;DP=470;AF=1.00;MQM=59;TRIO=HOM,470,1.00,HOM,300,1.00,HOM,367,1.00	HADHB	3'UTR	HADHB:ENST00000317799:3'UTR:MODIFIER:exon16/16:c.*136G>C:,HADHB:ENST00000405867:3'UTR:MODIFIER:exon14/14:c.*136G>C:,HADHB:ENST00000545822:3'UTR:MODIFIER:exon17/17:c.*136G>C:		rs1056471	0.7111	0.0000	0,0,0	0,0,0,0,0	0.8704							143450 [HADHB (confirmed) Trifunctional protein deficiency,609015];	RCV000395328.1 [benign]; 			182	46					HADHB (inh=AR pLI=0.00)
chr2	27589810	27589810	T	C	het	anno_omim	QUAL=18564;DP=333;AF=0.55;MQM=60;TRIO=HET,333,0.55,WT,300,0.00,HOM,416,1.00	EIF2B4,AC074117.10	splice_region&intron	EIF2B4:ENST00000493344:splice_region&intron:LOW:exon9/11:c.1077-7A>G:,EIF2B4:ENST00000347454:splice_region&intron:LOW:exon10/12:c.1014-7A>G:,EIF2B4:ENST00000445933:splice_region&intron:LOW:exon10/12:c.1011-7A>G:,EIF2B4:ENST00000451130:splice_region&intron:LOW:exon9/11:c.1074-7A>G:		rs2280737	0.3834	0.3986	10318,4965,1266	0.4919,0.5689,0.1561,0.3822,0.4002	0.4155							606687 [EIF2B4 (provisional) Leukoencephaly with vanishing white matter,603896|Ovarioleukodystrophy,603896];	RCV000081778.5 [benign]; RCV000296534.1 [benign]; 			418	1490	2	[2] auto-classification 14.09.2017  			EIF2B4 (inh=AR pLI=0.83), AC074117.10 (inh=n/a pLI=n/a)
chr2	31749714	31749714	C	T	het	anno_omim	QUAL=7042;DP=266;AF=0.49;MQM=60;TRIO=HET,266,0.49,WT,228,0.00,HET,259,0.54	SRD5A2	non_coding_transcript_exon	SRD5A2:ENST00000405650:non_coding_transcript_exon:MODIFIER:exon5/5:n.2483G>A:	UCON44	rs1042578	0.1669	0.0000	0,0,0	0,0,0,0,0	0.1560							607306 [SRD5A2 (confirmed) Pseudovaginal perineoscrotal hypospadias,264600];	RCV000083670.1 [not provided]; RCV000392570.1 [benign]; 			7	64					SRD5A2 (inh=AR pLI=n/a)
chr2	31749910	31749910	T	G	het	anno_omim	QUAL=11043;DP=521;AF=0.53;MQM=59;TRIO=HET,521,0.53,WT,217,0.00,HET,275,0.48	SRD5A2	non_coding_transcript_exon	SRD5A2:ENST00000405650:non_coding_transcript_exon:MODIFIER:exon5/5:n.2287A>C:	UCON44	rs28383087	0.0046	0.0000	0,0,0	0,0,0,0,0	0.0099							607306 [SRD5A2 (confirmed) Pseudovaginal perineoscrotal hypospadias,264600];	RCV000083669.1 [not provided]; RCV000297080.1 [uncertain significance]; 			0	5					SRD5A2 (inh=AR pLI=n/a)
chr2	31751223	31751223	C	T	het	anno_omim	QUAL=5049;DP=262;AF=0.52;MQM=60;TRIO=HET,262,0.52,WT,95,0.00,HET,113,0.48	SRD5A2	non_coding_transcript_exon	SRD5A2:ENST00000405650:non_coding_transcript_exon:MODIFIER:exon5/5:n.974G>A:		rs28383082	0.0034	0.0073	1,1,0	0.0057,0.0027,0.0000,0.0107,0.0010	0.0096							607306 [SRD5A2 (confirmed) Pseudovaginal perineoscrotal hypospadias,264600];				0	27					SRD5A2 (inh=AR pLI=n/a)
chr2	31805706	31805706	G	C	het	anno_omim	QUAL=10914;DP=124;AF=0.52;MQM=59;TRIO=HET,124,0.52,HET,309,0.52,HET,411,0.50	SRD5A2	non_coding_transcript_exon	SRD5A2:ENST00000405650:non_coding_transcript_exon:MODIFIER:exon1/5:n.431C>G:		rs523349	0.6522	0.6999	17653,10654,1699	0.7587,0.6640,0.5397,0.7234,0.6607	0.6998							607306 [SRD5A2 (confirmed) Pseudovaginal perineoscrotal hypospadias,264600];	RCV000083650.1 [not provided]; RCV000250955.1 [benign]; 			1029	904					SRD5A2 (inh=AR pLI=n/a)
chr2	31805880	31805880	-	G	het	anno_omim	QUAL=13380;DP=60;AF=0.77;MQM=59;TRIO=HET,60,0.77,HOM,179,0.97,HOM,254,0.99	SRD5A2	non_coding_transcript_exon	SRD5A2:ENST00000405650:non_coding_transcript_exon:MODIFIER:exon1/5:n.256dupC:		rs142200057	1.0000	1.0000	58283,31916,4520	1.0000,0.9999,1.0000,1.0000,0.9999	1.0000							607306 [SRD5A2 (confirmed) Pseudovaginal perineoscrotal hypospadias,264600];				2133	22	1	[1] auto-classification 16.06.2016  21.04.2016 ahdoeha1: Artefakt ssHC			SRD5A2 (inh=AR pLI=n/a)
chr2	31806031	31806031	C	G	het	anno_omim	QUAL=1678;DP=33;AF=0.48;MQM=59;TRIO=HET,33,0.48,HET,45,0.58,HET,51,0.59	SRD5A2	non_coding_transcript_exon	SRD5A2:ENST00000405650:non_coding_transcript_exon:MODIFIER:exon1/5:n.106G>C:		rs632148	0.6404	0.0000	0,0,0	0,0,0,0,0	0.6781							607306 [SRD5A2 (confirmed) Pseudovaginal perineoscrotal hypospadias,264600];	RCV000083635.1 [not provided]; RCV000359892.1 [benign]; 			716	591					SRD5A2 (inh=AR pLI=n/a)
chr2	32381110	32381110	T	G	het	anno_omim	QUAL=375;DP=37;AF=0.38;MQM=57;TRIO=HET,37,0.38,HOM,2,1.00,HET,9,0.44	SPAST	3'UTR	SPAST:ENST00000315285:3'UTR:MODIFIER:exon17/17:c.*1545T>G:,SPAST:ENST00000345662:3'UTR:MODIFIER:exon16/16:c.*1545T>G:	AluSp	rs9789593	0.3379	0.0000	0,0,0	0,0,0,0,0	0.2813							604277 [SPAST (confirmed) Spastic paraplegia 4,autosomal dominant,182601];	RCV000365577.1 [benign]; 			11	106					SPAST (inh=AD pLI=1.00)
chr2	32381727	32381727	-	AGG	het	anno_omim	QUAL=9988;DP=320;AF=0.47;MQM=60;TRIO=HET,320,0.47,HOM,118,0.99,HET,144,0.56	SPAST	3'UTR	SPAST:ENST00000315285:3'UTR:MODIFIER:exon17/17:c.*2164_*2165insGAG:,SPAST:ENST00000345662:3'UTR:MODIFIER:exon16/16:c.*2164_*2165insGAG:		rs141200833;rs3040810	0.9820	0.0000	0,0,0	0,0,0,0,0	0.9798							604277 [SPAST (confirmed) Spastic paraplegia 4,autosomal dominant,182601];				225	6					SPAST (inh=AD pLI=1.00)
chr2	32381829	32381829	G	A	het	anno_omim	QUAL=6327;DP=233;AF=0.47;MQM=60;TRIO=HET,233,0.47,HET,112,0.52,HET,128,0.53	SPAST	3'UTR	SPAST:ENST00000315285:3'UTR:MODIFIER:exon17/17:c.*2264G>A:,SPAST:ENST00000345662:3'UTR:MODIFIER:exon16/16:c.*2264G>A:		rs3769602	0.4800	0.0000	0,0,0	0,0,0,0,0	0.3871							604277 [SPAST (confirmed) Spastic paraplegia 4,autosomal dominant,182601];	RCV000304584.1 [benign]; 			50	117					SPAST (inh=AD pLI=1.00)
chr2	39209047	39209047	A	G	hom	anno_omim	QUAL=20388;DP=282;AF=1.00;MQM=59;TRIO=HOM,282,1.00,HOM,143,1.00,HOM,191,1.00	SOS1	3'UTR	SOS1:ENST00000402219:3'UTR:MODIFIER:exon23/23:c.*3918T>C:,SOS1:ENST00000426016:3'UTR:MODIFIER:exon24/24:c.*3918T>C:		rs1043793	0.7476	0.0000	0,0,0	0,0,0,0,0	0.8005							182530 [SOS1 (confirmed) Fibromatosis,gingival,1,135300|Noonan syndrome 4,610733];	RCV000278864.1 [likely benign]; RCV000397761.1 [likely benign]; 			189	41					SOS1 (inh=AD pLI=1.00)
chr2	39209426	39209426	A	G	hom	anno_omim	QUAL=29135;DP=462;AF=1.00;MQM=60;TRIO=HOM,462,1.00,HOM,181,1.00,HOM,229,1.00	SOS1	3'UTR	SOS1:ENST00000402219:3'UTR:MODIFIER:exon23/23:c.*3539T>C:,SOS1:ENST00000426016:3'UTR:MODIFIER:exon24/24:c.*3539T>C:		rs1037495	0.7466	0.0000	0,0,0	0,0,0,0,0	0.8008							182530 [SOS1 (confirmed) Fibromatosis,gingival,1,135300|Noonan syndrome 4,610733];	RCV000264420.1 [likely benign]; RCV000319593.1 [likely benign]; 			189	40					SOS1 (inh=AD pLI=1.00)
chr2	39210398	39210398	A	T	hom	anno_omim	QUAL=30095;DP=336;AF=1.00;MQM=60;TRIO=HOM,336,1.00,HOM,255,1.00,HOM,321,1.00	SOS1	3'UTR	SOS1:ENST00000402219:3'UTR:MODIFIER:exon23/23:c.*2567T>A:,SOS1:ENST00000426016:3'UTR:MODIFIER:exon24/24:c.*2567T>A:		rs6704656	0.8996	0.0000	0,0,0	0,0,0,0,0	0.9412							182530 [SOS1 (confirmed) Fibromatosis,gingival,1,135300|Noonan syndrome 4,610733];	RCV000307023.1 [likely benign]; RCV000343245.1 [likely benign]; 			198	33					SOS1 (inh=AD pLI=1.00)
chr2	39210719	39210719	-	TA	hom	anno_omim	QUAL=21435;DP=344;AF=0.98;MQM=59;TRIO=HOM,344,0.98,HOM,139,0.99,HOM,176,0.98	SOS1	3'UTR	SOS1:ENST00000402219:3'UTR:MODIFIER:exon23/23:c.*2244_*2245dupTA:,SOS1:ENST00000426016:3'UTR:MODIFIER:exon24/24:c.*2244_*2245dupTA:		rs35129186;rs397813136;rs55672510	0.7476	0.0000	0,0,0	0,0,0,0,0	0.8016							182530 [SOS1 (confirmed) Fibromatosis,gingival,1,135300|Noonan syndrome 4,610733];	RCV000193464.1 [likely benign]; RCV000260090.1 [likely benign]; RCV000334114.1 [likely benign]; 			186	44					SOS1 (inh=AD pLI=1.00)
chr2	39211121	39211121	T	C	hom	anno_omim	QUAL=32493;DP=443;AF=1.00;MQM=59;TRIO=HOM,443,1.00,HOM,238,1.00,HOM,290,1.00	SOS1	3'UTR	SOS1:ENST00000402219:3'UTR:MODIFIER:exon23/23:c.*1844A>G:,SOS1:ENST00000426016:3'UTR:MODIFIER:exon24/24:c.*1844A>G:		rs10166395	0.7622	0.0000	0,0,0	0,0,0,0,0	0.8163							182530 [SOS1 (confirmed) Fibromatosis,gingival,1,135300|Noonan syndrome 4,610733];	RCV000340008.1 [likely benign]; RCV000395187.1 [likely benign]; 			188	42					SOS1 (inh=AD pLI=1.00)
chr2	39211359	39211359	A	-	hom	anno_omim	QUAL=33377;DP=425;AF=1.00;MQM=59;TRIO=HOM,425,1.00,HOM,295,1.00,HOM,325,0.99	SOS1	3'UTR	SOS1:ENST00000402219:3'UTR:MODIFIER:exon23/23:c.*1606delT:,SOS1:ENST00000426016:3'UTR:MODIFIER:exon24/24:c.*1606delT:		rs398080194	0.8976	0.0000	0,0,0	0,0,0,0,0	0.9396							182530 [SOS1 (confirmed) Fibromatosis,gingival,1,135300|Noonan syndrome 4,610733];	RCV000192447.1 [likely benign]; RCV000271859.1 [likely benign]; RCV000329110.1 [likely benign]; 			197	34					SOS1 (inh=AD pLI=1.00)
chr2	39212565	39212565	-	TG	hom	anno_omim	QUAL=11581;DP=155;AF=0.96;MQM=59;TRIO=HOM,155,0.96,HOM,99,0.98,HOM,126,0.98	SOS1	3'UTR	SOS1:ENST00000402219:3'UTR:MODIFIER:exon23/23:c.*399_*400insCA:,SOS1:ENST00000426016:3'UTR:MODIFIER:exon24/24:c.*399_*400insCA:		rs144104838;rs58580760	0.9026	0.0000	0,0,0	0,0,0,0,0	0.7977							182530 [SOS1 (confirmed) Fibromatosis,gingival,1,135300|Noonan syndrome 4,610733];	RCV000303815.1 [likely benign]; RCV000356097.1 [likely benign]; 			176	54					SOS1 (inh=AD pLI=1.00)
chr2	39212637	39212637	T	C	het	anno_omim	QUAL=11530;DP=498;AF=0.51;MQM=59;TRIO=HET,498,0.51,HOM,145,1.00,WT,178,0.01	SOS1	3'UTR	SOS1:ENST00000402219:3'UTR:MODIFIER:exon23/23:c.*328A>G:,SOS1:ENST00000426016:3'UTR:MODIFIER:exon24/24:c.*328A>G:		rs1059310	0.5234	0.0000	0,0,0	0,0,0,0,0	0.5285							182530 [SOS1 (confirmed) Fibromatosis,gingival,1,135300|Noonan syndrome 4,610733];	RCV000263668.1 [likely benign]; RCV000297792.1 [likely benign]; 			88	120					SOS1 (inh=AD pLI=1.00)
chr2	39262348	39262348	C	G	het	anno_omim	QUAL=3186;DP=161;AF=0.46;MQM=60;TRIO=HET,161,0.46,WT,93,0.00,HET,109,0.47	SOS1	splice_region&intron	SOS1:ENST00000402219:splice_region&intron:LOW:exon8/22:c.1074+5G>C:,SOS1:ENST00000426016:splice_region&intron:LOW:exon9/23:c.1074+5G>C:,SOS1:ENST00000395038:splice_region&intron:LOW:exon8/21:c.1074+5G>C:,SOS1:ENST00000428721:splice_region&intron:LOW:exon8/10:c.903+5G>C:		rs145155424	0.0028	0.0098	4,3,0	0.0017,0.0021,0.0000,0.0164,0.0002	0.0096							182530 [SOS1 (confirmed) Fibromatosis,gingival,1,135300|Noonan syndrome 4,610733];	RCV000038508.8 [benign]; RCV000128195.4 [benign]; RCV000157008.2 [other]; RCV000224268.1 [likely benign]; RCV000296571.1 [likely benign]; 			0	32	2	[2] Stefanie Beck-Woedl 04.03.2015			SOS1 (inh=AD pLI=1.00)
chr2	44114074	44114074	G	A	hom	anno_omim	QUAL=16666;DP=212;AF=1.00;MQM=59;TRIO=HOM,212,1.00,HOM,131,1.00,HOM,188,1.00	LRPPRC	3'UTR	LRPPRC:ENST00000260665:3'UTR:MODIFIER:exon38/38:c.*1665C>T:	AluSz6	rs1139250	0.6006	0.0000	0,0,0	0,0,0,0,0	0.6371							607544 [LRPPRC (confirmed) Leigh syndrome,French-Canadian type,220111];	RCV000375009.1 [benign]; 			87	104					LRPPRC (inh=AR pLI=0.00)
chr2	44115183	44115183	T	A	het	anno_omim	QUAL=2242;DP=116;AF=0.53;MQM=60;TRIO=HET,116,0.53,WT,40,0.00,HET,56,0.48	LRPPRC	3'UTR	LRPPRC:ENST00000260665:3'UTR:MODIFIER:exon38/38:c.*556A>T:		rs1136998	0.0603	0.0000	0,0,0	0,0,0,0,0	0.0757							607544 [LRPPRC (confirmed) Leigh syndrome,French-Canadian type,220111];	RCV000301796.1 [likely benign]; 			2	46					LRPPRC (inh=AR pLI=0.00)
chr2	44209477	44209477	C	T	hom	anno_omim	QUAL=8924;DP=167;AF=1.00;MQM=60;TRIO=HOM,167,1.00,HET,60,0.55,HOM,82,1.00	LRPPRC	synonymous	LRPPRC:ENST00000260665:synonymous:LOW:exon2/38:c.246G>A:p.Gln82Gln,LRPPRC:ENST00000409946:synonymous:LOW:exon2/14:c.246G>A:p.Gln82Gln,LRPPRC:ENST00000409659:synonymous:LOW:exon2/12:c.246G>A:p.Gln82Gln		rs6741066	0.5040	0.6240	25833,17604,2539	0.7041,0.4802,0.0350,0.7259,0.5277	0.6781							607544 [LRPPRC (confirmed) Leigh syndrome,French-Canadian type,220111];	RCV000117556.2 [likely benign]; RCV000311110.1 [benign]; 		COSM1408165	974	875	2	[2] auto-classification 14.09.2017  			LRPPRC (inh=AR pLI=0.00)
chr2	45171842	45171842	A	G	hom	anno_omim	QUAL=10931;DP=44;AF=1.00;MQM=59;TRIO=HOM,44,1.00,HOM,130,1.00,HOM,185,1.00	SIX3	synonymous	SIX3:ENST00000260653:synonymous:LOW:exon2/2:c.942A>G:p.Ala314Ala		rs338074	0.9375	0.9215	39340,21492,3257	0.9717,0.9313,0.9811,0.9178,0.8776	0.9385							603714 [SIX3 (confirmed) Holoprosencephaly 2,157170|Schizencephaly,269160];	RCV000153953.5 [benign]; 			1761	320	2	[2] auto-classification 14.09.2017  			SIX3 (inh=AD pLI=0.35)
chr2	45172447	45172447	G	T	het	low_MQM;anno_omim	QUAL=32;DP=71;AF=0.20;MQM=48;TRIO=HET,71,0.20,WT,22,0.00,WT,36,0.08	SIX3	3'UTR	SIX3:ENST00000260653:3'UTR:MODIFIER:exon2/2:c.*548G>T:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0002							603714 [SIX3 (confirmed) Holoprosencephaly 2,157170|Schizencephaly,269160];				0	10					SIX3 (inh=AD pLI=0.35)
chr2	45172485	45172485	G	A	het	anno_omim	QUAL=595;DP=56;AF=0.45;MQM=53;TRIO=HET,56,0.45,HET,4,0.50,HET,9,0.44	SIX3	3'UTR	SIX3:ENST00000260653:3'UTR:MODIFIER:exon2/2:c.*586G>A:	A-rich	rs60528008	0.0000	0.0000	0,0,0	0,0,0,0,0	0.4373							603714 [SIX3 (confirmed) Holoprosencephaly 2,157170|Schizencephaly,269160];				16	88					SIX3 (inh=AD pLI=0.35)
chr2	45172557	45172557	T	-	het	anno_omim	QUAL=2095;DP=123;AF=0.48;MQM=59;TRIO=HET,123,0.48,HET,18,0.72,HET,26,0.54	SIX3	3'UTR	SIX3:ENST00000260653:3'UTR:MODIFIER:exon2/2:c.*666delT:	(CT)n	rs61475963;rs796089108	0.4643	0.0000	0,0,0	0,0,0,0,0	0.3949							603714 [SIX3 (confirmed) Holoprosencephaly 2,157170|Schizencephaly,269160];				19	88					SIX3 (inh=AD pLI=0.35)
chr2	45172925	45172925	G	A	het	anno_omim	QUAL=8928;DP=294;AF=0.50;MQM=60;TRIO=HET,294,0.50,HET,172,0.53,HET,246,0.50	SIX3	3'UTR	SIX3:ENST00000260653:3'UTR:MODIFIER:exon2/2:c.*1026G>A:	(TC)n	rs13022334	0.2384	0.0000	0,0,0	0,0,0,0,0	0.2124							603714 [SIX3 (confirmed) Holoprosencephaly 2,157170|Schizencephaly,269160];				11	82					SIX3 (inh=AD pLI=0.35)
chr2	46583281	46583281	C	T	het	anno_omim	QUAL=9404;DP=191;AF=0.50;MQM=59;TRIO=HET,191,0.50,HOM,246,1.00,WT,201,0.00	EPAS1	splice_region&intron	EPAS1:ENST00000263734:splice_region&intron:LOW:exon2/15:c.218-9C>T:		rs75984373	0.0663	0.4038	9868,3862,1591	0.5765,0.4056,0.7628,0.3542,0.3301	0.4737							603349 [EPAS1 (confirmed) Erythrocytosis,familial,4,611783];	RCV000298342.1 [benign]; 			46	164	2	[2] auto-classification 14.09.2017  			EPAS1 (inh=AD pLI=1.00)
chr2	46603671	46603671	C	G	het	anno_omim	QUAL=1014;DP=23;AF=0.52;MQM=60;TRIO=HET,23,0.52,WT,15,0.00,HOM,26,1.00	EPAS1	splice_region&intron	EPAS1:ENST00000263734:splice_region&intron:LOW:exon8/15:c.1035-7C>G:		rs7557402	0.3125	0.4104	11112,8162,371	0.2655,0.2172,0.1800,0.4940,0.4040	0.4057							603349 [EPAS1 (confirmed) Erythrocytosis,familial,4,611783];	RCV000329925.1 [benign]; 		COSM4001689	499	1032	2	[2] auto-classification 14.09.2017  			EPAS1 (inh=AD pLI=1.00)
chr2	46612327	46612328	TT	-	het	anno_omim	QUAL=2523;DP=137;AF=0.51;MQM=59;TRIO=HET,137,0.51,WT,42,0.07,HOM,53,0.94	EPAS1	3'UTR	EPAS1:ENST00000263734:3'UTR:MODIFIER:exon16/16:c.*539_*540delTT:		rs397984477;rs759043045	0.8858	0.0000	0,0,0	0,0,0,0,0	0.7539							603349 [EPAS1 (confirmed) Erythrocytosis,familial,4,611783];	RCV000353138.1 [benign]; 			147	75					EPAS1 (inh=AD pLI=1.00)
chr2	46613038	46613038	A	G	het	anno_omim	QUAL=10385;DP=337;AF=0.49;MQM=60;TRIO=HET,337,0.49,WT,345,0.00,HET,476,0.50	EPAS1	3'UTR	EPAS1:ENST00000263734:3'UTR:MODIFIER:exon16/16:c.*1239A>G:		rs11539645	0.0172	0.0000	0,0,0	0,0,0,0,0	0.0421							603349 [EPAS1 (confirmed) Erythrocytosis,familial,4,611783];	RCV000298454.1 [likely benign]; 			3	26					EPAS1 (inh=AD pLI=1.00)
chr2	48914615	48914615	C	G	het	anno_omim	QUAL=3431;DP=214;AF=0.47;MQM=60;TRIO=HET,214,0.47,HET,50,0.56,WT,85,0.00	LHCGR,STON1-GTF2A1L,GTF2A1L	3'UTR,intron	LHCGR:ENST00000294954:3'UTR:MODIFIER:exon11/11:c.*221G>C:,LHCGR:ENST00000344775:3'UTR:MODIFIER:exon10/10:c.*221G>C:,STON1-GTF2A1L:ENST00000402114:intron:MODIFIER:exon10/10:c.3441+15796C>G:	MER5C	rs62137532	0.1627	0.0000	0,0,0	0,0,0,0,0	0.1921							152790 [LHCGR (provisional) Precocious puberty,male,176410|Leydig cell hypoplasia with pseudohermaphroditism,238320|Leydig cell hypoplasia with hypergonadotropic hypogonadism,238320|Luteinizing hormone resistance,female,238320|Leydig cell adenoma,somatic,with precocious puberty,176410];	RCV000269092.1 [benign]; RCV000324261.1 [benign]; RCV000363622.1 [benign]; 			8	58					LHCGR (inh=AR pLI=0.00), STON1-GTF2A1L (inh=n/a pLI=0.00), GTF2A1L (inh=n/a pLI=0.00)
chr2	48925746	48925746	C	T	het	anno_omim	QUAL=8067;DP=103;AF=0.54;MQM=60;TRIO=HET,103,0.54,HOM,121,1.00,HET,218,0.50	LHCGR,STON1-GTF2A1L,GTF2A1L	splice_region&intron,intron	LHCGR:ENST00000294954:splice_region&intron:LOW:exon9/10:c.866+8G>A:,LHCGR:ENST00000405626:splice_region&intron:LOW:exon9/9:c.866+8G>A:,LHCGR:ENST00000401907:splice_region&intron:LOW:exon9/10:c.866+8G>A:,LHCGR:ENST00000403273:splice_region&intron:LOW:exon9/10:c.866+8G>A:,STON1-GTF2A1L:ENST00000402114:intron:MODIFIER:exon10/10:c.3441+26927C>T:,LHCGR:ENST00000344775:intron:MODIFIER:exon8/9:c.681-4303G>A:		rs6755901	0.7374	0.7657	36619,22916,3879	0.8635,0.5197,0.4770,0.8288,0.8028	0.7973							152790 [LHCGR (provisional) Precocious puberty,male,176410|Leydig cell hypoplasia with pseudohermaphroditism,238320|Leydig cell hypoplasia with hypergonadotropic hypogonadism,238320|Luteinizing hormone resistance,female,238320|Leydig cell adenoma,somatic,with precocious puberty,176410];	RCV000243145.1 [benign]; RCV000262221.1 [benign]; RCV000302553.1 [benign]; RCV000357135.1 [benign]; 		COSM4001691	1451	603	2	[2] auto-classification 14.09.2017  			LHCGR (inh=AR pLI=0.00), STON1-GTF2A1L (inh=n/a pLI=0.00), GTF2A1L (inh=n/a pLI=0.00)
chr2	58388696	58388696	A	G	het	anno_omim	QUAL=10427;DP=317;AF=0.46;MQM=60;TRIO=HET,317,0.46,HET,198,0.53,HET,260,0.53	FANCL	synonymous	FANCL:ENST00000402135:synonymous:LOW:exon12/14:c.996T>C:p.Ser332Ser,FANCL:ENST00000403295:synonymous:LOW:exon11/13:c.897T>C:p.Ser299Ser,FANCL:ENST00000233741:synonymous:LOW:exon12/14:c.981T>C:p.Ser327Ser,FANCL:ENST00000403676:synonymous:LOW:exon8/10:c.630T>C:p.Ser210Ser		rs848291	0.7065	0.6487	25916,12325,4274	0.9057,0.6825,0.5640,0.6097,0.6628	0.6976							608111 [FANCL (provisional) Fanconi anemia,complementation group L,614083];	RCV000253562.1 [benign]; RCV000282580.1 [benign]; 		COSM4001713	954	1334	2	[2] auto-classification 14.09.2017  			FANCL (inh=AR pLI=0.00)
chr2	61276263	61276263	G	A	hom	anno_omim	QUAL=13372;DP=233;AF=0.99;MQM=60;TRIO=HOM,233,0.99,HOM,72,1.00,HOM,106,1.00	PEX13	3'UTR	PEX13:ENST00000295030:3'UTR:MODIFIER:exon4/4:c.*358G>A:		rs1177230	0.9952	0.0000	0,0,0	0,0,0,0,0	0.9885							601789 [PEX13 (provisional) Peroxisome biogenesis disorder 11A (Zellweger),614883|Peroxisome biogenesis disorder 11B,614885];	RCV000399354.1 [benign]; 			227	5					PEX13 (inh=AR pLI=0.02)
chr2	61276857	61276857	C	T	het	anno_omim	QUAL=1394;DP=58;AF=0.45;MQM=59;TRIO=HET,58,0.45,HET,62,0.58,WT,51,0.00	PEX13	3'UTR	PEX13:ENST00000295030:3'UTR:MODIFIER:exon4/4:c.*952C>T:	AluSp	rs56739127	0.3039	0.0000	0,0,0	0,0,0,0,0	0.2828							601789 [PEX13 (provisional) Peroxisome biogenesis disorder 11A (Zellweger),614883|Peroxisome biogenesis disorder 11B,614885];	RCV000385469.1 [benign]; 			25	104					PEX13 (inh=AR pLI=0.02)
chr2	61277099	61277099	G	A	het	anno_omim	QUAL=1907;DP=121;AF=0.43;MQM=59;TRIO=HET,121,0.43,HET,46,0.54,WT,81,0.00	PEX13	3'UTR	PEX13:ENST00000295030:3'UTR:MODIFIER:exon4/4:c.*1194G>A:		rs75205376	0.0763	0.0000	0,0,0	0,0,0,0,0	0.1346							601789 [PEX13 (provisional) Peroxisome biogenesis disorder 11A (Zellweger),614883|Peroxisome biogenesis disorder 11B,614885];	RCV000317941.1 [likely benign]; 			8	82					PEX13 (inh=AR pLI=0.02)
chr2	61278052	61278052	A	G	hom	anno_omim	QUAL=5954;DP=98;AF=1.00;MQM=59;TRIO=HOM,98,1.00,HET,71,0.58,HOM,63,0.98	PEX13	3'UTR	PEX13:ENST00000295030:3'UTR:MODIFIER:exon4/4:c.*2147A>G:	AluY	rs2564097	0.6160	0.0000	0,0,0	0,0,0,0,0	0.6370							601789 [PEX13 (provisional) Peroxisome biogenesis disorder 11A (Zellweger),614883|Peroxisome biogenesis disorder 11B,614885];	RCV000368512.1 [benign]; 			91	110					PEX13 (inh=AR pLI=0.02)
chr2	69547236	69547236	G	C	het	anno_omim	QUAL=7606;DP=235;AF=0.50;MQM=55;TRIO=HET,235,0.50,WT,226,0.00,HET,325,0.54	GFPT1	3'UTR	GFPT1:ENST00000357308:3'UTR:MODIFIER:exon20/20:c.*6085C>G:,GFPT1:ENST00000361060:3'UTR:MODIFIER:exon19/19:c.*6085C>G:		rs7642	0.6554	0.0000	0,0,0	0,0,0,0,0	0.6528							138292 [GFPT1 (confirmed) Myasthenia,congenital,12,with tubular aggregates,610542];	RCV000403310.1 [benign]; 			82	102					GFPT1 (inh=AR pLI=0.97)
chr2	69548320	69548320	C	T	het	anno_omim	QUAL=7096;DP=374;AF=0.53;MQM=59;TRIO=HET,374,0.53,WT,111,0.00,HET,152,0.41	GFPT1	3'UTR	GFPT1:ENST00000357308:3'UTR:MODIFIER:exon20/20:c.*5001G>A:,GFPT1:ENST00000361060:3'UTR:MODIFIER:exon19/19:c.*5001G>A:		rs13396883	0.6587	0.0000	0,0,0	0,0,0,0,0	0.6561							138292 [GFPT1 (confirmed) Myasthenia,congenital,12,with tubular aggregates,610542];	RCV000318156.1 [benign]; 			82	102					GFPT1 (inh=AR pLI=0.97)
chr2	69548591	69548591	C	T	het	anno_omim	QUAL=6701;DP=313;AF=0.54;MQM=60;TRIO=HET,313,0.54,WT,112,0.00,HET,132,0.53	GFPT1	3'UTR	GFPT1:ENST00000357308:3'UTR:MODIFIER:exon20/20:c.*4730G>A:,GFPT1:ENST00000361060:3'UTR:MODIFIER:exon19/19:c.*4730G>A:		rs28694003	0.6386	0.0000	0,0,0	0,0,0,0,0	0.6410							138292 [GFPT1 (confirmed) Myasthenia,congenital,12,with tubular aggregates,610542];	RCV000379130.1 [benign]; 			81	103					GFPT1 (inh=AR pLI=0.97)
chr2	69549262	69549262	T	C	het	anno_omim	QUAL=5380;DP=252;AF=0.54;MQM=60;TRIO=HET,252,0.54,WT,107,0.00,HET,144,0.42	GFPT1	3'UTR	GFPT1:ENST00000357308:3'UTR:MODIFIER:exon20/20:c.*4059A>G:,GFPT1:ENST00000361060:3'UTR:MODIFIER:exon19/19:c.*4059A>G:		rs13751	0.6476	0.0000	0,0,0	0,0,0,0,0	0.6478							138292 [GFPT1 (confirmed) Myasthenia,congenital,12,with tubular aggregates,610542];	RCV000396983.1 [benign]; 			80	104					GFPT1 (inh=AR pLI=0.97)
chr2	69550036	69550036	T	C	het	anno_omim	QUAL=15066;DP=572;AF=0.51;MQM=59;TRIO=HET,572,0.51,WT,409,0.00,HET,530,0.50	GFPT1	3'UTR	GFPT1:ENST00000357308:3'UTR:MODIFIER:exon20/20:c.*3285A>G:,GFPT1:ENST00000361060:3'UTR:MODIFIER:exon19/19:c.*3285A>G:		rs7579532	0.6587	0.0000	0,0,0	0,0,0,0,0	0.6563							138292 [GFPT1 (confirmed) Myasthenia,congenital,12,with tubular aggregates,610542];	RCV000376118.1 [benign]; 			83	102					GFPT1 (inh=AR pLI=0.97)
chr2	69550230	69550230	T	G	het	anno_omim	QUAL=7740;DP=293;AF=0.53;MQM=59;TRIO=HET,293,0.53,WT,141,0.00,HET,209,0.61	GFPT1	3'UTR	GFPT1:ENST00000357308:3'UTR:MODIFIER:exon20/20:c.*3091A>C:,GFPT1:ENST00000361060:3'UTR:MODIFIER:exon19/19:c.*3091A>C:		rs7582334	0.6476	0.0000	0,0,0	0,0,0,0,0	0.6467							138292 [GFPT1 (confirmed) Myasthenia,congenital,12,with tubular aggregates,610542];	RCV000384360.1 [benign]; 			81	103					GFPT1 (inh=AR pLI=0.97)
chr2	69550256	69550256	C	T	het	anno_omim	QUAL=8184;DP=302;AF=0.56;MQM=60;TRIO=HET,302,0.56,WT,121,0.00,HET,201,0.61	GFPT1	3'UTR	GFPT1:ENST00000357308:3'UTR:MODIFIER:exon20/20:c.*3065G>A:,GFPT1:ENST00000361060:3'UTR:MODIFIER:exon19/19:c.*3065G>A:		rs7568296	0.6635	0.0000	0,0,0	0,0,0,0,0	0.6601							138292 [GFPT1 (confirmed) Myasthenia,congenital,12,with tubular aggregates,610542];	RCV000345588.1 [benign]; 			82	102					GFPT1 (inh=AR pLI=0.97)
chr2	69550652	69550652	G	A	het	anno_omim	QUAL=7252;DP=313;AF=0.49;MQM=59;TRIO=HET,313,0.49,WT,173,0.00,HET,263,0.49	GFPT1	3'UTR	GFPT1:ENST00000357308:3'UTR:MODIFIER:exon20/20:c.*2669C>T:,GFPT1:ENST00000361060:3'UTR:MODIFIER:exon19/19:c.*2669C>T:	AluJb	rs10185336	0.6384	0.0000	0,0,0	0,0,0,0,0	0.6416							138292 [GFPT1 (confirmed) Myasthenia,congenital,12,with tubular aggregates,610542];	RCV000357113.1 [benign]; 			81	103					GFPT1 (inh=AR pLI=0.97)
chr2	69550811	69550811	T	-	het	anno_omim	QUAL=141;DP=110;AF=0.38;MQM=58;TRIO=HET,110,0.38,WT,15,0.13,WT,17,0.35	GFPT1	3'UTR	GFPT1:ENST00000357308:3'UTR:MODIFIER:exon20/20:c.*2510delA:,GFPT1:ENST00000361060:3'UTR:MODIFIER:exon19/19:c.*2510delA:	AluJb:AluSc	rs370178312	0.0000	0.0000	0,0,0	0,0,0,0,0	0.6025							138292 [GFPT1 (confirmed) Myasthenia,congenital,12,with tubular aggregates,610542];	RCV000395185.1 [uncertain significance]; 			53	32					GFPT1 (inh=AR pLI=0.97)
chr2	69551011	69551011	T	C	het	low_MQM;anno_omim	QUAL=396;DP=36;AF=0.53;MQM=45;TRIO=HET,36,0.53,WT,3,0.00,HET,5,0.20	GFPT1	3'UTR	GFPT1:ENST00000357308:3'UTR:MODIFIER:exon20/20:c.*2310A>G:,GFPT1:ENST00000361060:3'UTR:MODIFIER:exon19/19:c.*2310A>G:	AluSc	rs10198150	0.6384	0.0000	0,0,0	0,0,0,0,0	0.6403							138292 [GFPT1 (confirmed) Myasthenia,congenital,12,with tubular aggregates,610542];	RCV000294511.1 [benign]; 			75	61					GFPT1 (inh=AR pLI=0.97)
chr2	69551052	69551052	T	C	het	anno_omim	QUAL=717;DP=55;AF=0.56;MQM=50;TRIO=HET,55,0.56,WT,2,0.00,HET,8,0.13	GFPT1	3'UTR	GFPT1:ENST00000357308:3'UTR:MODIFIER:exon20/20:c.*2269A>G:,GFPT1:ENST00000361060:3'UTR:MODIFIER:exon19/19:c.*2269A>G:	AluSc	rs10198171	0.6494	0.0000	0,0,0	0,0,0,0,0	0.6520							138292 [GFPT1 (confirmed) Myasthenia,congenital,12,with tubular aggregates,610542];	RCV000333128.1 [benign]; 			78	77					GFPT1 (inh=AR pLI=0.97)
chr2	69552521	69552521	C	A	het	anno_omim	QUAL=9111;DP=470;AF=0.44;MQM=60;TRIO=HET,470,0.44,WT,183,0.00,HET,292,0.47	GFPT1	3'UTR	GFPT1:ENST00000357308:3'UTR:MODIFIER:exon20/20:c.*800G>T:,GFPT1:ENST00000361060:3'UTR:MODIFIER:exon19/19:c.*800G>T:		rs2667	0.6382	0.0000	0,0,0	0,0,0,0,0	0.6412							138292 [GFPT1 (confirmed) Myasthenia,congenital,12,with tubular aggregates,610542];	RCV000260888.1 [benign]; 			82	103					GFPT1 (inh=AR pLI=0.97)
chr2	69553376	69553376	A	-	het	anno_omim	QUAL=860;DP=93;AF=0.42;MQM=59;TRIO=HET,93,0.42,WT,58,0.16,HET,83,0.53	GFPT1	splice_region&intron	GFPT1:ENST00000357308:splice_region&intron:LOW:exon19/19:c.2056-11delT:,GFPT1:ENST00000361060:splice_region&intron:LOW:exon18/18:c.2002-11delT:	(A)n	rs201330278;rs879120371	0.0000	0.5003	4291,2540,705	0.5725,0.4844,0.3357,0.5252,0.4503	0.6260							138292 [GFPT1 (confirmed) Myasthenia,congenital,12,with tubular aggregates,610542];	RCV000276530.1 [uncertain significance]; 			639	850	2	[2] auto-classification 14.09.2017  			GFPT1 (inh=AR pLI=0.97)
chr2	69573029	69573029	T	C	het	anno_omim	QUAL=4686;DP=184;AF=0.51;MQM=60;TRIO=HET,184,0.51,WT,129,0.00,HET,178,0.49	GFPT1	splice_region&intron	GFPT1:ENST00000357308:splice_region&intron:LOW:exon12/19:c.1105+7A>G:,GFPT1:ENST00000361060:splice_region&intron:LOW:exon11/18:c.1051+7A>G:		rs6722492	0.6472	0.5961	22189,11621,3832	0.8569,0.4891,0.4697,0.5895,0.6171	0.6476							138292 [GFPT1 (confirmed) Myasthenia,congenital,12,with tubular aggregates,610542];	RCV000117140.3 [benign]; RCV000324739.1 [benign]; 			787	968	2	[2] auto-classification 14.09.2017  			GFPT1 (inh=AR pLI=0.97)
chr2	71680950	71680950	C	A	het	anno_omim	QUAL=2042;DP=79;AF=0.51;MQM=59;TRIO=HET,79,0.51,HET,107,0.57,WT,127,0.00	DYSF	5'UTR	DYSF:ENST00000409582:5'UTR:MODIFIER:exon1/56:c.-179C>A:,DYSF:ENST00000409762:5'UTR:MODIFIER:exon1/55:c.-179C>A:,DYSF:ENST00000413539:5'UTR:MODIFIER:exon1/56:c.-179C>A:,DYSF:ENST00000429174:5'UTR:MODIFIER:exon1/56:c.-179C>A:,DYSF:ENST00000258104:5'UTR:MODIFIER:exon1/55:c.-179C>A:		rs6741336	0.2049	0.0000	0,0,0	0,0,0,0,0	0.1370							603009 [DYSF (confirmed) Muscular dystrophy,limb-girdle,type 2B,253601|Myopathy,distal,with anterior tibial onset,606768|Miyoshi muscular dystrophy 1,254130];				2	42					DYSF (inh=AR pLI=0.00)
chr2	71780215	71780215	T	C	het	anno_omim	QUAL=21671;DP=298;AF=0.44;MQM=60;TRIO=HET,298,0.44,HOM,372,0.99,HET,545,0.50	DYSF	synonymous	DYSF:ENST00000410020:synonymous:LOW:exon20/56:c.1881T>C:p.Asp627Asp,DYSF:ENST00000409582:synonymous:LOW:exon20/56:c.1878T>C:p.Asp626Asp,DYSF:ENST00000409762:synonymous:LOW:exon20/55:c.1878T>C:p.Asp626Asp,DYSF:ENST00000413539:synonymous:LOW:exon21/56:c.1920T>C:p.Asp640Asp,DYSF:ENST00000429174:synonymous:LOW:exon20/56:c.1827T>C:p.Asp609Asp,DYSF:ENST00000258104:synonymous:LOW:exon20/55:c.1827T>C:p.Asp609Asp,DYSF:ENST00000394120:synonymous:LOW:exon20/55:c.1830T>C:p.Asp610Asp,DYSF:ENST00000409366:synonymous:LOW:exon20/56:c.1830T>C:p.Asp610Asp,DYSF:ENST00000409651:synonymous:LOW:exon21/56:c.1923T>C:p.Asp641Asp,DYSF:ENST00000409744:synonymous:LOW:exon19/55:c.1788T>C:p.Asp596Asp,DYSF:ENST00000410041:synonymous:LOW:exon20/55:c.1881T>C:p.Asp627Asp		rs2303596	0.5755	0.6430	26416,16845,3200	0.7849,0.6082,0.1789,0.7104,0.5348	0.6922							603009 [DYSF (confirmed) Muscular dystrophy,limb-girdle,type 2B,253601|Myopathy,distal,with anterior tibial onset,606768|Miyoshi muscular dystrophy 1,254130];	RCV000080244.9 [other]; RCV000302229.1 [benign]; RCV000357010.1 [benign]; 		COSM4001738, COSM4001739	984	902	2	[2] auto-classification 14.09.2017  			DYSF (inh=AR pLI=0.00)
chr2	71795152	71795152	A	T	het	anno_omim	QUAL=1121;DP=34;AF=0.38;MQM=60;TRIO=HET,34,0.38,HOM,21,1.00,HET,33,0.45	DYSF	synonymous	DYSF:ENST00000410020:synonymous:LOW:exon25/56:c.2637A>T:p.Ser879Ser,DYSF:ENST00000409582:synonymous:LOW:exon25/56:c.2634A>T:p.Ser878Ser,DYSF:ENST00000409762:synonymous:LOW:exon25/55:c.2634A>T:p.Ser878Ser,DYSF:ENST00000413539:synonymous:LOW:exon26/56:c.2676A>T:p.Ser892Ser,DYSF:ENST00000429174:synonymous:LOW:exon25/56:c.2583A>T:p.Ser861Ser,DYSF:ENST00000258104:synonymous:LOW:exon25/55:c.2583A>T:p.Ser861Ser,DYSF:ENST00000394120:synonymous:LOW:exon25/55:c.2586A>T:p.Ser862Ser,DYSF:ENST00000409366:synonymous:LOW:exon25/56:c.2586A>T:p.Ser862Ser,DYSF:ENST00000409651:synonymous:LOW:exon26/56:c.2679A>T:p.Ser893Ser,DYSF:ENST00000409744:synonymous:LOW:exon24/55:c.2544A>T:p.Ser848Ser,DYSF:ENST00000410041:synonymous:LOW:exon25/55:c.2637A>T:p.Ser879Ser		rs2288355	0.5505	0.6042	23766,15206,3432	0.8104,0.5042,0.1531,0.6741,0.4792	0.6825							603009 [DYSF (confirmed) Muscular dystrophy,limb-girdle,type 2B,253601|Myopathy,distal,with anterior tibial onset,606768|Miyoshi muscular dystrophy 1,254130];	RCV000080254.9 [other]; RCV000283608.1 [benign]; RCV000378035.1 [benign]; 		COSM3766590, COSM3766591	859	964	2	[2] auto-classification 14.09.2017  			DYSF (inh=AR pLI=0.00)
chr2	71838597	71838597	C	A	het	anno_omim	QUAL=5805;DP=101;AF=0.50;MQM=60;TRIO=HET,101,0.50,HET,163,0.50,HET,271,0.44	DYSF	splice_region&synonymous	DYSF:ENST00000410020:splice_region&synonymous:LOW:exon38/56:c.4062C>A:p.Ile1354Ile,DYSF:ENST00000409582:splice_region&synonymous:LOW:exon38/56:c.4059C>A:p.Ile1353Ile,DYSF:ENST00000409762:splice_region&synonymous:LOW:exon38/55:c.4059C>A:p.Ile1353Ile,DYSF:ENST00000413539:splice_region&synonymous:LOW:exon39/56:c.4101C>A:p.Ile1367Ile,DYSF:ENST00000429174:splice_region&synonymous:LOW:exon38/56:c.4008C>A:p.Ile1336Ile,DYSF:ENST00000258104:splice_region&synonymous:LOW:exon38/55:c.4008C>A:p.Ile1336Ile,DYSF:ENST00000394120:splice_region&synonymous:LOW:exon38/55:c.4011C>A:p.Ile1337Ile,DYSF:ENST00000409366:splice_region&synonymous:LOW:exon38/56:c.4011C>A:p.Ile1337Ile,DYSF:ENST00000409651:splice_region&synonymous:LOW:exon39/56:c.4104C>A:p.Ile1368Ile,DYSF:ENST00000409744:splice_region&synonymous:LOW:exon37/55:c.3969C>A:p.Ile1323Ile,DYSF:ENST00000410041:splice_region&synonymous:LOW:exon38/55:c.4062C>A:p.Ile1354Ile		rs2303606	0.4495	0.5015	15435,9359,839	0.3984,0.5378,0.4644,0.5308,0.4265	0.5044							603009 [DYSF (confirmed) Muscular dystrophy,limb-girdle,type 2B,253601|Myopathy,distal,with anterior tibial onset,606768|Miyoshi muscular dystrophy 1,254130];	RCV000080282.9 [other]; RCV000288114.1 [benign]; RCV000382443.1 [benign]; 			565	1017	2	[2] auto-classification 14.09.2017  			DYSF (inh=AR pLI=0.00)
chr2	73613031	73613031	-	GGA	hom	low_DP;anno_omim	QUAL=352;DP=1;AF=0.00;MQM=59;TRIO=HOM,1,0.00,HOM,6,0.83,HOM,14,0.64	ALMS1	disruptive_inframe_insertion	ALMS1:ENST00000264448:disruptive_inframe_insertion:MODERATE:exon1/23:c.72_74dupGGA:p.Glu25dup,ALMS1:ENST00000377715:disruptive_inframe_insertion:MODERATE:exon1/10:c.72_74dupGGA:p.Glu25dup,ALMS1:ENST00000409009:disruptive_inframe_insertion:MODERATE:exon1/22:c.72_74dupGGA:p.Glu25dup		rs193922695;rs55889738;rs764804760;rs772724963;rs778948871	0.0000	0.0370	3,2,0	0.0033,0.0000,0.0000,0.0488,0.0307	0.3767							606844 [ALMS1 (confirmed) Alstrom syndrome,203800];	RCV000286389.1,RCV000029331.1 [likely benign,uncertain significance]; RCV000202933.4 [other]; RCV000206303.2 [other]; 			673	107	1	[1] old entry - no details available			ALMS1 (inh=AR pLI=0.00)
chr2	73651967	73651967	C	T	het	anno_omim	QUAL=7802;DP=310;AF=0.45;MQM=60;TRIO=HET,310,0.45,WT,272,0.00,HET,312,0.51	ALMS1	missense	ALMS1:ENST00000264448:missense:MODERATE:exon5/23:c.1174C>T:p.Arg392Cys,ALMS1:ENST00000377715:missense:MODERATE:exon5/10:c.1174C>T:p.Arg392Cys,ALMS1:ENST00000409009:missense:MODERATE:exon4/22:c.1048C>T:p.Arg350Cys		rs3813227	0.3636	0.2712	6226,1811,2992	0.7789,0.4192,0.0079,0.2329,0.1680	0.3806	0.2600	T,T,T	T	B,B	T,T,T	0.09	606844 [ALMS1 (confirmed) Alstrom syndrome,203800];				115	707	2	[2] auto-classification 14.09.2017  			ALMS1 (inh=AR pLI=0.00)
chr2	73675227	73675227	-	CTC	het	anno_omim	QUAL=15046;DP=161;AF=0.46;MQM=59;TRIO=HET,161,0.46,HOM,299,1.00,HET,323,0.48	ALMS1	disruptive_inframe_insertion	ALMS1:ENST00000264448:disruptive_inframe_insertion:MODERATE:exon8/23:c.1571_1573dupCTC:p.Ser524_Leu525insPro,ALMS1:ENST00000377715:disruptive_inframe_insertion:MODERATE:exon8/10:c.1571_1573dupCTC:p.Ser524_Leu525insPro,ALMS1:ENST00000409009:disruptive_inframe_insertion:MODERATE:exon7/22:c.1445_1447dupCTC:p.Ser482_Leu483insPro		rs34628045;rs587621330	0.6004	0.6384	25241,13578,636	0.3575,0.7358,0.7761,0.6375,0.6714	0.6450							606844 [ALMS1 (confirmed) Alstrom syndrome,203800];	RCV000205185.1 [benign]; 			914	974	1	[1] old entry - no details available			ALMS1 (inh=AR pLI=0.00)
chr2	73675669	73675669	T	G	hom	anno_omim	QUAL=29406;DP=300;AF=1.00;MQM=59;TRIO=HOM,300,1.00,HOM,287,1.00,HOM,325,1.00	ALMS1	missense	ALMS1:ENST00000264448:missense:MODERATE:exon8/23:c.2012T>G:p.Val671Gly,ALMS1:ENST00000377715:missense:MODERATE:exon8/10:c.2012T>G:p.Val671Gly,ALMS1:ENST00000409009:missense:MODERATE:exon7/22:c.1886T>G:p.Val629Gly		rs2037814	0.8722	0.8627	45056,24926,3971	0.9006,0.9488,0.7828,0.8639,0.8266	0.8724	-0.5500	T,T,T	T	B,B,B	T,T,T	0.66	606844 [ALMS1 (confirmed) Alstrom syndrome,203800];				1578	535	2	[2] auto-classification 14.09.2017  			ALMS1 (inh=AR pLI=0.00)
chr2	73675844	73675844	C	T	het	anno_omim	QUAL=14783;DP=254;AF=0.49;MQM=60;TRIO=HET,254,0.49,HOM,230,0.99,HET,325,0.50	ALMS1	synonymous	ALMS1:ENST00000264448:synonymous:LOW:exon8/23:c.2187C>T:p.Phe729Phe,ALMS1:ENST00000377715:synonymous:LOW:exon8/10:c.2187C>T:p.Phe729Phe,ALMS1:ENST00000409009:synonymous:LOW:exon7/22:c.2061C>T:p.Phe687Phe		rs7598901	0.5264	0.5991	22804,13264,187	0.1856,0.5333,0.7744,0.6301,0.6670	0.6026							606844 [ALMS1 (confirmed) Alstrom syndrome,203800];				890	976	2	[2] auto-classification 14.09.2017  			ALMS1 (inh=AR pLI=0.00)
chr2	73677833	73677833	A	G	het	anno_omim	QUAL=8805;DP=175;AF=0.49;MQM=59;TRIO=HET,175,0.49,WT,359,0.01,HET,465,0.54	ALMS1	synonymous	ALMS1:ENST00000264448:synonymous:LOW:exon8/23:c.4176A>G:p.Gln1392Gln,ALMS1:ENST00000377715:synonymous:LOW:exon8/10:c.4176A>G:p.Gln1392Gln,ALMS1:ENST00000409009:synonymous:LOW:exon7/22:c.4050A>G:p.Gln1350Gln		rs6546836	0.3383	0.2609	5695,1808,2469	0.7064,0.4140,0.0078,0.2307,0.1588	0.3592							606844 [ALMS1 (confirmed) Alstrom syndrome,203800];			COSM1409404	107	717	2	[2] auto-classification 14.09.2017  			ALMS1 (inh=AR pLI=0.00)
chr2	73677898	73677898	G	C	het	anno_omim	QUAL=9043;DP=215;AF=0.44;MQM=59;TRIO=HET,215,0.44,WT,337,0.00,HET,451,0.55	ALMS1	missense	ALMS1:ENST00000264448:missense:MODERATE:exon8/23:c.4241G>C:p.Gly1414Ala,ALMS1:ENST00000377715:missense:MODERATE:exon8/10:c.4241G>C:p.Gly1414Ala,ALMS1:ENST00000409009:missense:MODERATE:exon7/22:c.4115G>C:p.Gly1372Ala		rs6546837	0.3636	0.2681	6259,1823,2999	0.7790,0.4200,0.0078,0.2320,0.1585	0.3990	-2.3660	T,T,T	T	B,B,B	T,T,T	0.01	606844 [ALMS1 (confirmed) Alstrom syndrome,203800];				115	712	2	[2] auto-classification 14.09.2017  			ALMS1 (inh=AR pLI=0.00)
chr2	73679280	73679280	A	G	het	anno_omim	QUAL=9602;DP=298;AF=0.51;MQM=60;TRIO=HET,298,0.51,WT,291,0.00,HET,380,0.54	ALMS1	missense	ALMS1:ENST00000264448:missense:MODERATE:exon8/23:c.5623A>G:p.Ile1875Val,ALMS1:ENST00000377715:missense:MODERATE:exon8/10:c.5623A>G:p.Ile1875Val,ALMS1:ENST00000409009:missense:MODERATE:exon7/22:c.5497A>G:p.Ile1833Val		rs6546838	0.3588	0.2676	6146,1827,2890	0.7648,0.4179,0.0078,0.2334,0.1591	0.3775	-0.1850	T,T,T	T	B,B,B	T,T,T	0.01	606844 [ALMS1 (confirmed) Alstrom syndrome,203800];				115	712	2	[2] auto-classification 14.09.2017  			ALMS1 (inh=AR pLI=0.00)
chr2	73679866	73679866	T	C	het	anno_omim	QUAL=6784;DP=277;AF=0.51;MQM=60;TRIO=HET,277,0.51,WT,198,0.00,HET,237,0.46	ALMS1	missense	ALMS1:ENST00000264448:missense:MODERATE:exon8/23:c.6209T>C:p.Ile2070Thr,ALMS1:ENST00000377715:missense:MODERATE:exon8/10:c.6209T>C:p.Ile2070Thr,ALMS1:ENST00000409009:missense:MODERATE:exon7/22:c.6083T>C:p.Ile2028Thr		rs10496192	0.1036	0.1432	1355,899,31	0.0815,0.1729,0.0054,0.1661,0.1428	0.1452	-0.1900	T,T,T	T	B,B,B	T,T,T	0.01	606844 [ALMS1 (confirmed) Alstrom syndrome,203800];				55	556	2	[2] auto-classification 14.09.2017  			ALMS1 (inh=AR pLI=0.00)
chr2	73679990	73679990	T	A	het	anno_omim	QUAL=5300;DP=198;AF=0.47;MQM=60;TRIO=HET,198,0.47,WT,186,0.00,HET,220,0.49	ALMS1	missense	ALMS1:ENST00000264448:missense:MODERATE:exon8/23:c.6333T>A:p.Ser2111Arg,ALMS1:ENST00000377715:missense:MODERATE:exon8/10:c.6333T>A:p.Ser2111Arg,ALMS1:ENST00000409009:missense:MODERATE:exon7/22:c.6207T>A:p.Ser2069Arg		rs6724782	0.3638	0.2699	6205,1830,2944	0.7794,0.4203,0.0078,0.2357,0.1593	0.3816	-0.2040	T,T,T	T	B,B,B	T,T,T	0.01	606844 [ALMS1 (confirmed) Alstrom syndrome,203800];			COSM4133927	114	711	2	[2] auto-classification 14.09.2017  			ALMS1 (inh=AR pLI=0.00)
chr2	73680508	73680508	G	C	het	pred_pathogenic;anno_omim	QUAL=9776;DP=418;AF=0.50;MQM=60;TRIO=HET,418,0.50,WT,286,0.00,HET,271,0.55	ALMS1	missense	ALMS1:ENST00000264448:missense:MODERATE:exon8/23:c.6851G>C:p.Arg2284Pro,ALMS1:ENST00000377715:missense:MODERATE:exon8/10:c.6851G>C:p.Arg2284Pro,ALMS1:ENST00000409009:missense:MODERATE:exon7/22:c.6725G>C:p.Arg2242Pro		rs6546839	0.3644	0.2696	6267,1836,2991	0.7791,0.4202,0.0078,0.2344,0.1592	0.3813	2.6600	T,T,T	T	B,B,B	T,T,T	17.18	606844 [ALMS1 (confirmed) Alstrom syndrome,203800];				115	714	2	[2] auto-classification 14.09.2017  			ALMS1 (inh=AR pLI=0.00)
chr2	73717567	73717567	G	T	het	anno_omim	QUAL=5821;DP=240;AF=0.51;MQM=60;TRIO=HET,240,0.51,WT,135,0.01,HET,221,0.50	ALMS1	missense	ALMS1:ENST00000264448:missense:MODERATE:exon10/23:c.8478G>T:p.Arg2826Ser,ALMS1:ENST00000409009:missense:MODERATE:exon9/22:c.8352G>T:p.Arg2784Ser		rs2056486	0.3582	0.2663	6089,1794,2866	0.7646,0.4184,0.0078,0.2312,0.1591	0.3767	-0.0370	T,T	T	B,B,B	T,T	0.29	606844 [ALMS1 (confirmed) Alstrom syndrome,203800];			COSM4133929	115	707	2	[2] auto-classification 14.09.2017  			ALMS1 (inh=AR pLI=0.00)
chr2	73717656	73717656	A	G	het	anno_omim	QUAL=8615;DP=321;AF=0.52;MQM=60;TRIO=HET,321,0.52,WT,235,0.00,HET,314,0.48	ALMS1	missense	ALMS1:ENST00000264448:missense:MODERATE:exon10/23:c.8567A>G:p.Asn2856Ser,ALMS1:ENST00000409009:missense:MODERATE:exon9/22:c.8441A>G:p.Asn2814Ser		rs10193972	0.3582	0.2661	6099,1798,2869	0.7644,0.4183,0.0078,0.2310,0.1592	0.3766	-0.6910	T,T	T	B,B,B	T,T	0.01	606844 [ALMS1 (confirmed) Alstrom syndrome,203800];				115	709	2	[2] auto-classification 14.09.2017  			ALMS1 (inh=AR pLI=0.00)
chr2	73746923	73746923	C	T	het	anno_omim	QUAL=3520;DP=154;AF=0.48;MQM=60;TRIO=HET,154,0.48,WT,67,0.00,HET,101,0.60	ALMS1	synonymous	ALMS1:ENST00000264448:synonymous:LOW:exon11/23:c.9558C>T:p.Thr3186Thr,ALMS1:ENST00000409009:synonymous:LOW:exon10/22:c.9432C>T:p.Thr3144Thr		rs11884776	0.2568	0.2169	3536,1663,1229	0.5029,0.2071,0.0055,0.2207,0.1543	0.2913							606844 [ALMS1 (confirmed) Alstrom syndrome,203800];				99	690	2	[2] auto-classification 14.09.2017  			ALMS1 (inh=AR pLI=0.00)
chr2	73828538	73828538	G	A	het	anno_omim	QUAL=12355;DP=204;AF=0.54;MQM=60;TRIO=HET,204,0.54,HOM,197,1.00,HET,279,0.50	ALMS1	missense	ALMS1:ENST00000264448:missense:MODERATE:exon19/23:c.12086G>A:p.Arg4029Lys,ALMS1:ENST00000409009:missense:MODERATE:exon18/22:c.11960G>A:p.Arg3987Lys		rs1052161	0.5823	0.6334	24870,13499,538	0.3248,0.7337,0.7539,0.6375,0.6694	0.6404	-1.7990	T,T	T	B,B	T,T	0.01	606844 [ALMS1 (confirmed) Alstrom syndrome,203800];			COSM4133930	891	978	2	[2] auto-classification 14.09.2017  			ALMS1 (inh=AR pLI=0.00)
chr2	73829372	73829372	C	T	het	anno_omim	QUAL=8135;DP=395;AF=0.49;MQM=59;TRIO=HET,395,0.49,WT,213,0.00,HET,274,0.50	ALMS1	synonymous	ALMS1:ENST00000264448:synonymous:LOW:exon20/23:c.12172C>T:p.Leu4058Leu,ALMS1:ENST00000409009:synonymous:LOW:exon19/22:c.12046C>T:p.Leu4016Leu		rs1052162	0.3417	0.2636	5895,1786,2706	0.7234,0.4125,0.0074,0.2301,0.1573	0.3631							606844 [ALMS1 (confirmed) Alstrom syndrome,203800];				115	702	2	[2] auto-classification 14.09.2017  			ALMS1 (inh=AR pLI=0.00)
chr2	73837006	73837006	T	A	het	anno_omim	QUAL=9755;DP=211;AF=0.45;MQM=60;TRIO=HET,211,0.45,WT,177,0.00,HOM,229,1.00	ALMS1	3'UTR	ALMS1:ENST00000264448:3'UTR:MODIFIER:exon23/23:c.*267T>A:		rs62149804	0.1052	0.0000	0,0,0	0,0,0,0,0	0.1323							606844 [ALMS1 (confirmed) Alstrom syndrome,203800];	RCV000334312.1 [likely benign]; 			9	60					ALMS1 (inh=AR pLI=0.00)
chr2	74185876	74185876	A	T	hom	anno_omim	QUAL=10459;DP=108;AF=1.00;MQM=60;TRIO=HOM,108,1.00,HET,130,0.54,HOM,165,1.00	DGUOK,DGUOK-AS1	3'UTR,intron	DGUOK:ENST00000264093:3'UTR:MODIFIER:exon7/7:c.*13A>T:,DGUOK:ENST00000348222:3'UTR:MODIFIER:exon5/5:c.*13A>T:,DGUOK:ENST00000356837:3'UTR:MODIFIER:exon7/7:c.*13A>T:,DGUOK-AS1:ENST00000453103:intron:MODIFIER:exon1/1:n.308-10814T>A:,DGUOK-AS1:ENST00000439192:intron:MODIFIER:exon1/1:n.326-542T>A:,DGUOK-AS1:ENST00000413452:intron:MODIFIER:exon1/1:n.228-542T>A:		rs4777	0.5308	0.5858	21034,12311,1303	0.4999,0.5527,0.5268,0.6063,0.5572	0.5968							601465 [DGUOK (provisional) Mitochondrial DNA depletion syndrome 3 (hepatocerebral type),251880|Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal recessive 4,617070|Portal hypertension,noncirrhotic,617068];	RCV000124678.3 [benign]; RCV000351874.1 [benign]; 			685	1011					DGUOK (inh=AR pLI=0.37), DGUOK-AS1 (inh=n/a pLI=n/a)
chr2	84650707	84650707	A	G	hom	anno_omim	QUAL=17133;DP=230;AF=1.00;MQM=60;TRIO=HOM,230,1.00,HOM,160,1.00,HOM,148,1.00	SUCLG1	3'UTR	SUCLG1:ENST00000393868:3'UTR:MODIFIER:exon9/9:c.*163T>C:		rs2832	0.8021	0.0000	0,0,0	0,0,0,0,0	0.8130							611224 [SUCLG1 (provisional) Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria),245400];	RCV000301645.1 [benign]; RCV000399966.1 [benign]; 			199	28					SUCLG1 (inh=AR pLI=0.06)
chr2	85894308	85894308	G	T	het	anno_omim	QUAL=4203;DP=168;AF=0.43;MQM=60;TRIO=HET,168,0.43,WT,115,0.00,HOM,87,1.00	SFTPB	splice_region&intron	SFTPB:ENST00000393822:splice_region&intron:LOW:exon3/11:c.232-8C>A:,SFTPB:ENST00000519937:splice_region&intron:LOW:exon2/10:c.196-8C>A:,SFTPB:ENST00000342375:splice_region&intron:LOW:exon3/11:c.196-8C>A:,SFTPB:ENST00000409383:splice_region&intron:LOW:exon3/11:c.232-8C>A:		rs3024798	0.2969	0.3553	7917,4570,53	0.0932,0.4048,0.3835,0.3760,0.4008	0.3616							178640 [SFTPB (confirmed) Surfactant metabolism dysfunction,pulmonary,1,265120];	RCV000151852.2 [benign]; RCV000318879.1 [benign]; 			330	1007	2	[2] auto-classification 14.09.2017  			SFTPB (inh=AR pLI=0.04)
chr2	85895338	85895338	T	G	het	anno_omim	QUAL=5197;DP=123;AF=0.51;MQM=59;TRIO=HET,123,0.51,WT,105,0.01,HOM,120,1.00	SFTPB	missense,5'UTR	SFTPB:ENST00000393822:missense:MODERATE:exon2/12:c.5A>C:p.His2Pro,SFTPB:ENST00000409383:missense:MODERATE:exon2/12:c.5A>C:p.His2Pro,SFTPB:ENST00000342375:5'UTR:MODIFIER:exon2/12:c.-32A>C:		rs2077079	0.4185	0.4254	1818,709,187	0.3731,0.4162,0.5353,0.4239,0.4369	0.4108	0.8210	T,T	T	B	T,T	0.01	178640 [SFTPB (confirmed) Surfactant metabolism dysfunction,pulmonary,1,265120];	RCV000151854.2 [benign]; RCV000344398.1 [benign]; 	CR077669 [CLASS=FP MUT=ALT PHEN="Increased promoter activity" GENE=SFTPB]; 	COSM3766592	364	1004	2	[2] auto-classification 14.09.2017  			SFTPB (inh=AR pLI=0.04)
chr2	86441303	86441303	A	C	hom	anno_omim	QUAL=24190;DP=399;AF=0.99;MQM=59;TRIO=HOM,399,0.99,HET,367,0.50,HET,500,0.46	REEP1	3'UTR	REEP1:ENST00000538924:3'UTR:MODIFIER:exon7/7:c.*2920T>G:,REEP1:ENST00000165698:3'UTR:MODIFIER:exon7/7:c.*2920T>G:,REEP1:ENST00000535845:3'UTR:MODIFIER:exon6/6:c.*2920T>G:,REEP1:ENST00000541910:3'UTR:MODIFIER:exon5/5:c.*2859T>G:		rs708600	0.3736	0.0000	0,0,0	0,0,0,0,0	0.3125							609139 [REEP1 (provisional) Spastic paraplegia 31,autosomal dominant,610250|Neuronopathy,distal hereditary motor,type VB,614751];	RCV000388753.1 [benign]; 			37	99					REEP1 (inh=AD pLI=0.94)
chr2	86441334	86441334	-	TGTT	hom	anno_omim	QUAL=20520;DP=287;AF=0.98;MQM=59;TRIO=HOM,287,0.98,HET,352,0.51,HET,498,0.47	REEP1	3'UTR	REEP1:ENST00000538924:3'UTR:MODIFIER:exon7/7:c.*2885_*2888dupAACA:,REEP1:ENST00000165698:3'UTR:MODIFIER:exon7/7:c.*2885_*2888dupAACA:,REEP1:ENST00000535845:3'UTR:MODIFIER:exon6/6:c.*2885_*2888dupAACA:,REEP1:ENST00000541910:3'UTR:MODIFIER:exon5/5:c.*2824_*2827dupAACA:		rs397794472	0.3730	0.0000	0,0,0	0,0,0,0,0	0.3102							609139 [REEP1 (provisional) Spastic paraplegia 31,autosomal dominant,610250|Neuronopathy,distal hereditary motor,type VB,614751];	RCV000296783.1 [benign]; 			37	100					REEP1 (inh=AD pLI=0.94)
chr2	86442112	86442112	-	A	het	anno_omim	QUAL=1569;DP=129;AF=0.61;MQM=59;TRIO=HET,129,0.61,HET,32,0.34,HET,69,0.36	REEP1	3'UTR	REEP1:ENST00000538924:3'UTR:MODIFIER:exon7/7:c.*2110dupT:,REEP1:ENST00000165698:3'UTR:MODIFIER:exon7/7:c.*2110dupT:,REEP1:ENST00000535845:3'UTR:MODIFIER:exon6/6:c.*2110dupT:,REEP1:ENST00000541910:3'UTR:MODIFIER:exon5/5:c.*2049dupT:		rs200132323	0.4267	0.0000	0,0,0	0,0,0,0,0	0.5061							609139 [REEP1 (provisional) Spastic paraplegia 31,autosomal dominant,610250|Neuronopathy,distal hereditary motor,type VB,614751];	RCV000332274.1 [benign]; 			29	82					REEP1 (inh=AD pLI=0.94)
chr2	86481835	86481835	C	T	hom	anno_omim	QUAL=11637;DP=221;AF=0.99;MQM=60;TRIO=HOM,221,0.99,HET,159,0.56,HET,205,0.57	REEP1	synonymous,intron	REEP1:ENST00000538924:synonymous:LOW:exon4/7:c.306G>A:p.Thr102Thr,REEP1:ENST00000165698:synonymous:LOW:exon4/7:c.285G>A:p.Thr95Thr,REEP1:ENST00000535845:synonymous:LOW:exon3/6:c.204G>A:p.Thr68Thr,REEP1:ENST00000540790:synonymous:LOW:exon5/8:c.222G>A:p.Thr74Thr,REEP1:ENST00000541910:intron:MODIFIER:exon3/4:c.182+9253G>A:		rs2276625	0.4287	0.4673	13960,6927,274	0.2245,0.6426,0.6133,0.4551,0.4519	0.4755							609139 [REEP1 (provisional) Spastic paraplegia 31,autosomal dominant,610250|Neuronopathy,distal hereditary motor,type VB,614751];	RCV000118136.4 [other]; RCV000386509.1 [benign]; 		COSM3758400	565	1283	2	[2] auto-classification 14.09.2017  			REEP1 (inh=AD pLI=0.94)
chr2	87012073	87012073	A	G	het	anno_omim	QUAL=9929;DP=306;AF=0.54;MQM=59;TRIO=HET,306,0.54,HET,155,0.54,HET,231,0.55	CD8A	3'UTR	CD8A:ENST00000456996:3'UTR:MODIFIER:exon8/8:c.*970T>C:,CD8A:ENST00000352580:3'UTR:MODIFIER:exon5/5:c.*970T>C:,CD8A:ENST00000283635:3'UTR:MODIFIER:exon6/6:c.*970T>C:,CD8A:ENST00000409511:3'UTR:MODIFIER:exon9/9:c.*970T>C:		rs1051386	0.1861	0.1368	115,24,5	0.0000,0.0000,0.0000,0.1369,0.1336	0.1896							186910 [CD8A (confirmed) CD8 deficiency,familial,608957];				14	183					CD8A (inh=AR pLI=0.02)
chr2	87012293	87012293	A	G	het	anno_omim	QUAL=3964;DP=217;AF=0.55;MQM=59;TRIO=HET,217,0.55,HET,31,0.45,HET,41,0.44	CD8A	3'UTR	CD8A:ENST00000456996:3'UTR:MODIFIER:exon8/8:c.*750T>C:,CD8A:ENST00000352580:3'UTR:MODIFIER:exon5/5:c.*750T>C:,CD8A:ENST00000283635:3'UTR:MODIFIER:exon6/6:c.*750T>C:,CD8A:ENST00000409511:3'UTR:MODIFIER:exon9/9:c.*750T>C:		rs3020729	0.1861	0.1368	115,24,5	0.0000,0.0000,0.0000,0.1367,0.1336	0.1894							186910 [CD8A (confirmed) CD8 deficiency,familial,608957];				13	183					CD8A (inh=AR pLI=0.02)
chr2	87012399	87012399	-	AA	het	anno_omim	QUAL=579;DP=98;AF=0.35;MQM=59;TRIO=HET,98,0.35,HET,27,0.48,HET,21,0.24	CD8A	3'UTR	CD8A:ENST00000456996:3'UTR:MODIFIER:exon8/8:c.*642_*643dupTT:,CD8A:ENST00000352580:3'UTR:MODIFIER:exon5/5:c.*642_*643dupTT:,CD8A:ENST00000283635:3'UTR:MODIFIER:exon6/6:c.*642_*643dupTT:,CD8A:ENST00000409511:3'UTR:MODIFIER:exon9/9:c.*642_*643dupTT:		rs10628397;rs538181811	0.1723	0.1533	1,1,0	0.0000,0.0000,0.0000,0.1566,0.1516	0.3022							186910 [CD8A (confirmed) CD8 deficiency,familial,608957];				7	175					CD8A (inh=AR pLI=0.02)
chr2	87016506	87016506	A	G	het	anno_omim	QUAL=7343;DP=125;AF=0.49;MQM=59;TRIO=HET,125,0.49,HET,212,0.45,HET,303,0.46	CD8A	synonymous,intron	CD8A:ENST00000538832:synonymous:LOW:exon5/7:c.688T>C:p.Leu230Leu,CD8A:ENST00000283635:synonymous:LOW:exon4/6:c.565T>C:p.Leu189Leu,CD8A:ENST00000409511:synonymous:LOW:exon7/9:c.565T>C:p.Leu189Leu,CD8A:ENST00000409781:synonymous:LOW:exon3/5:c.454T>C:p.Leu152Leu,CD8A:ENST00000456996:intron:MODIFIER:exon6/7:c.514+257T>C:,CD8A:ENST00000352580:intron:MODIFIER:exon3/4:c.514+257T>C:		rs3020726	0.0821	0.1177	997,852,34	0.0789,0.0624,0.0706,0.1594,0.0519	0.1244							186910 [CD8A (confirmed) CD8 deficiency,familial,608957];			COSM4001774	48	582	2	[2] auto-classification 14.09.2017  			CD8A (inh=AR pLI=0.02)
chr2	87018452	87018452	A	G	hom	anno_omim	QUAL=39501;DP=524;AF=1.00;MQM=59;TRIO=HOM,524,1.00,HOM,316,1.00,HOM,405,1.00	CD8A	5'UTR,intron	CD8A:ENST00000283635:5'UTR:MODIFIER:exon1/6:c.-504T>C:,CD8A:ENST00000538832:intron:MODIFIER:exon1/6:c.-148+181T>C:,CD8A:ENST00000456996:intron:MODIFIER:exon3/7:c.-270-234T>C:,CD8A:ENST00000409511:intron:MODIFIER:exon3/8:c.-270-234T>C:		rs6743139	0.6581	0.0000	0,0,0	0,0,0,0,0	0.7144							186910 [CD8A (confirmed) CD8 deficiency,familial,608957];				125	89					CD8A (inh=AR pLI=0.02)
chr2	87018547	87018547	A	G	het	anno_omim	QUAL=16953;DP=322;AF=0.49;MQM=59;TRIO=HET,322,0.49,HOM,283,1.00,HET,327,0.53	CD8A	5'UTR,intron	CD8A:ENST00000283635:5'UTR:MODIFIER:exon1/6:c.-599T>C:,CD8A:ENST00000538832:intron:MODIFIER:exon1/6:c.-148+86T>C:,CD8A:ENST00000456996:intron:MODIFIER:exon3/7:c.-270-329T>C:,CD8A:ENST00000409511:intron:MODIFIER:exon3/8:c.-270-329T>C:		rs3810831	0.1312	0.0000	0,0,0	0,0,0,0,0	0.2054							186910 [CD8A (confirmed) CD8 deficiency,familial,608957];				6	73					CD8A (inh=AR pLI=0.02)
chr2	88874891	88874891	C	A	hom	pred_pathogenic;anno_omim	QUAL=37058;DP=394;AF=1.00;MQM=60;TRIO=HOM,394,1.00,HOM,327,1.00,HOM,410,1.00	EIF2AK3,AC104134.2	missense	EIF2AK3:ENST00000303236:missense:MODERATE:exon13/17:c.2110G>T:p.Ala704Ser,EIF2AK3:ENST00000419748:missense:MODERATE:exon13/17:c.1657G>T:p.Ala553Ser		rs1805165	0.7206	0.7021	30514,17236,4704	0.9508,0.6730,0.5077,0.7193,0.6180	0.7688	2.4940	T,T,T,T	T	B	T,T,T	15.98	604032 [EIF2AK3 (confirmed) Wolcott-Rallison syndrome,226980];	RCV000116968.2 [likely benign]; RCV000374096.1 [benign]; 			1107	807	2	[2] auto-classification 14.09.2017  			EIF2AK3 (inh=AR pLI=0.01), AC104134.2 (inh=n/a pLI=n/a)
chr2	88879131	88879131	T	C	het	anno_omim	QUAL=5031;DP=276;AF=0.47;MQM=60;TRIO=HET,276,0.47,WT,127,0.00,HET,115,0.50	EIF2AK3	synonymous	EIF2AK3:ENST00000303236:synonymous:LOW:exon11/17:c.1791A>G:p.Gln597Gln,EIF2AK3:ENST00000419748:synonymous:LOW:exon11/17:c.1338A>G:p.Gln446Gln		rs1805164	0.2582	0.2854	5151,3017,242	0.2199,0.3802,0.3068,0.3024,0.1595	0.2914							604032 [EIF2AK3 (confirmed) Wolcott-Rallison syndrome,226980];	RCV000116967.2 [likely benign]; RCV000396340.1 [benign]; 		COSM3746552, COSM3746551	171	766	2	[2] auto-classification 14.09.2017  			EIF2AK3 (inh=AR pLI=0.01)
chr2	88895123	88895123	T	C	hom	pred_pathogenic;anno_omim	QUAL=24629;DP=365;AF=1.00;MQM=60;TRIO=HOM,365,1.00,HOM,171,1.00,HOM,211,1.00	EIF2AK3	missense	EIF2AK3:ENST00000303236:missense:MODERATE:exon3/17:c.497A>G:p.Gln166Arg,EIF2AK3:ENST00000419748:missense:MODERATE:exon3/17:c.44A>G:p.Gln15Arg		rs13045	0.6490	0.6379	25325,14844,3911	0.8677,0.5613,0.4712,0.6669,0.5339	0.7040	5.4970	T,T,T,T	T	B	T,T,T	11.15	604032 [EIF2AK3 (confirmed) Wolcott-Rallison syndrome,226980];	RCV000116970.3 [other]; RCV000283479.1 [benign]; 	CM138802 [CLASS=R MUT=ALT PHEN="Wolcott-Rallison syndrome" GENE=EIF2AK3]; 	COSM4001780, COSM4001781	961	889	2	[2] Peter Bauer 25.08.2014			EIF2AK3 (inh=AR pLI=0.01)
chr2	88926730	88926732	CAG	-	hom	low_DP;anno_omim	QUAL=550;DP=11;AF=0.91;MQM=59;TRIO=HOM,11,0.91,HET,14,0.21,HOM,15,1.00	EIF2AK3	conservative_inframe_deletion	EIF2AK3:ENST00000303236:conservative_inframe_deletion:MODERATE:exon1/17:c.61_63delCTG:p.Leu21del	(CAG)n	rs144052332;rs72416210	0.7965	0.6612	1883,442,59	0.0000,0.0000,0.0000,0.6585,0.6559	0.7771							604032 [EIF2AK3 (confirmed) Wolcott-Rallison syndrome,226980];	RCV000173359.3 [benign]; RCV000344451.1 [benign]; 			962	672	2	[2] auto-classification 14.09.2017  			EIF2AK3 (inh=AR pLI=0.01)
chr2	96778665	96778665	-	A	het	anno_omim	QUAL=1456;DP=130;AF=0.38;MQM=59;TRIO=HET,130,0.38,HOM,95,0.58,WT,115,0.08	GPAT2,ADRA2B	intergenic_region	ADRA2B:ENSG00000186281-ENSG00000222040:intergenic_region:MODIFIER::n.96778665_96778666insA:		rs11464083;rs34790807	0.6280	0.0000	0,0,0	0,0,0,0,0	0.6763							104260 [ADRA2B (confirmed) Epilepsy,myoclonic,familial adult,2,607876];				58	150					GPAT2 (inh=n/a pLI=0.00), ADRA2B (inh=AD pLI=0.00)
chr2	96780122	96780122	G	T	het	anno_omim	QUAL=6477;DP=112;AF=0.51;MQM=59;TRIO=HET,112,0.51,WT,142,0.01,HOM,164,0.99	ADRA2B	3'UTR	ADRA2B:ENST00000409345:3'UTR:MODIFIER:exon1/1:c.*423C>A:		rs4907299	0.3335	0.0000	0,0,0	0,0,0,0,0	0.3436							104260 [ADRA2B (confirmed) Epilepsy,myoclonic,familial adult,2,607876];				19	102					ADRA2B (inh=AD pLI=0.00)
chr2	96780185	96780185	G	T	het	anno_omim	QUAL=3806;DP=188;AF=0.47;MQM=59;TRIO=HET,188,0.47,HET,132,0.52,WT,147,0.00	ADRA2B	3'UTR	ADRA2B:ENST00000409345:3'UTR:MODIFIER:exon1/1:c.*360C>A:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							104260 [ADRA2B (confirmed) Epilepsy,myoclonic,familial adult,2,607876];				0	2					ADRA2B (inh=AD pLI=0.00)
chr2	96780716	96780716	T	G	het	anno_omim	QUAL=14002;DP=369;AF=0.49;MQM=59;TRIO=HET,369,0.49,HOM,305,1.00,WT,452,0.01	ADRA2B	synonymous	ADRA2B:ENST00000409345:synonymous:LOW:exon1/1:c.1173A>C:p.Gly391Gly		rs2229169	0.7053	0.6785	26959,14687,2620	0.7454,0.6575,0.5587,0.6760,0.7774	0.6717							104260 [ADRA2B (confirmed) Epilepsy,myoclonic,familial adult,2,607876];				1155	808	2	[2] auto-classification 14.09.2017  			ADRA2B (inh=AD pLI=0.00)
chr2	96780986	96780986	-	TCCTCCTCT	het	anno_omim	QUAL=7743;DP=173;AF=0.36;MQM=59;TRIO=HET,173,0.36,HOM,152,0.99,HET,234,0.44	ADRA2B	disruptive_inframe_insertion	ADRA2B:ENST00000409345:disruptive_inframe_insertion:MODERATE:exon1/1:c.894_902dupAGAGGAGGA:p.Glu299_Glu301dup	(CTC)n	rs28365031;rs29000568;rs34667759;rs4066772	0.4706	0.6982	7673,3576,1062	0.8460,0.6530,0.5896,0.6653,0.7698	0.6794							104260 [ADRA2B (confirmed) Epilepsy,myoclonic,familial adult,2,607876];			COSM1023814, COSM1023812	1125	795	2	[2] auto-classification 14.09.2017  			ADRA2B (inh=AD pLI=0.00)
chr2	98330052	98330052	C	A	het	anno_omim	QUAL=3455;DP=158;AF=0.49;MQM=60;TRIO=HET,158,0.49,HET,58,0.45,HET,82,0.50	ZAP70	5'UTR	ZAP70:ENST00000264972:5'UTR:MODIFIER:exon1/14:c.-186C>A:		rs2276645	0.1935	0.0000	0,0,0	0,0,0,0,0	0.3523							176947 [ZAP70 (confirmed) Autoimmune disease,multisystem,infantile-onset,2,617006|Immunodeficiency 48,269840];	RCV000357744.1 [benign]; 			41	103					ZAP70 (inh=AR pLI=0.27)
chr2	98354511	98354511	G	A	het	anno_omim	QUAL=13319;DP=289;AF=0.57;MQM=59;TRIO=HET,289,0.57,HET,295,0.53,HET,381,0.51	ZAP70	synonymous	ZAP70:ENST00000264972:synonymous:LOW:exon13/14:c.1677G>A:p.Glu559Glu,ZAP70:ENST00000442208:synonymous:LOW:exon11/12:c.1299G>A:p.Glu433Glu,ZAP70:ENST00000451498:synonymous:LOW:exon5/6:c.756G>A:p.Glu252Glu		rs3192177	0.1484	0.3012	5449,4154,79	0.1427,0.2156,0.0074,0.3847,0.1455	0.2964							176947 [ZAP70 (confirmed) Autoimmune disease,multisystem,infantile-onset,2,617006|Immunodeficiency 48,269840];	RCV000126355.2 [benign]; RCV000356778.1 [benign]; 		COSM4134221	195	826	2	[2] auto-classification 14.09.2017  			ZAP70 (inh=AR pLI=0.27)
chr2	98355990	98355990	G	A	het	anno_omim	QUAL=2107;DP=37;AF=0.54;MQM=59;TRIO=HET,37,0.54,HET,47,0.55,HET,70,0.60	ZAP70	3'UTR	ZAP70:ENST00000264972:3'UTR:MODIFIER:exon14/14:c.*29G>A:,ZAP70:ENST00000442208:3'UTR:MODIFIER:exon12/12:c.*29G>A:		rs11678558	0.1486	0.2916	4892,3746,63	0.1426,0.1857,0.0080,0.3789,0.1443	0.2960							176947 [ZAP70 (confirmed) Autoimmune disease,multisystem,infantile-onset,2,617006|Immunodeficiency 48,269840];	RCV000366961.1 [benign]; 			179	746					ZAP70 (inh=AR pLI=0.27)
chr2	98356250	98356250	G	C	het	anno_omim	QUAL=245;DP=21;AF=0.43;MQM=59;TRIO=HET,21,0.43,HET,17,0.35,WT,21,0.00	ZAP70	3'UTR	ZAP70:ENST00000264972:3'UTR:MODIFIER:exon14/14:c.*289G>C:,ZAP70:ENST00000442208:3'UTR:MODIFIER:exon12/12:c.*289G>C:		rs2278699	0.1488	0.0000	0,0,0	0,0,0,0,0	0.1351							176947 [ZAP70 (confirmed) Autoimmune disease,multisystem,infantile-onset,2,617006|Immunodeficiency 48,269840];	RCV000331946.1 [benign]; 			4	60					ZAP70 (inh=AR pLI=0.27)
chr2	99172243	99172243	C	T	het		QUAL=2986;DP=137;AF=0.46;MQM=60;TRIO=HET,137,0.46,WT,130,0.02,HET,173,0.42	INPP4A	synonymous,intron	INPP4A:ENST00000074304:synonymous:LOW:exon17/26:c.1809C>T:p.Ser603Ser,INPP4A:ENST00000409851:synonymous:LOW:exon16/25:c.1794C>T:p.Ser598Ser,INPP4A:ENST00000523221:synonymous:LOW:exon15/24:c.1809C>T:p.Ser603Ser,INPP4A:ENST00000409016:intron:MODIFIER:exon17/25:c.1720+89C>T:,INPP4A:ENST00000409463:intron:MODIFIER:exon5/10:c.232-9937C>T:,INPP4A:ENST00000545415:intron:MODIFIER:exon17/25:c.1720+89C>T:,INPP4A:ENST00000409540:intron:MODIFIER:exon17/25:c.1720+89C>T:		rs41486345	0.0254	0.0803	202,133,0	0.0083,0.0291,0.0000,0.1083,0.0267	0.0773											14	274	2	[2] auto-classification 14.09.2017  			INPP4A (inh=n/a pLI=0.99)
chr2	105977776	105977776	G	A	het		QUAL=10160;DP=571;AF=0.50;MQM=60;TRIO=HET,571,0.50,HET,215,0.55,WT,339,0.00	FHL2	synonymous,3'UTR	FHL2:ENST00000409177:synonymous:LOW:exon6/6:c.1152C>T:p.Asp384Asp,FHL2:ENST00000344213:synonymous:LOW:exon7/7:c.1134C>T:p.Asp378Asp,FHL2:ENST00000393353:synonymous:LOW:exon6/6:c.804C>T:p.Asp268Asp,FHL2:ENST00000393352:synonymous:LOW:exon6/6:c.804C>T:p.Asp268Asp,FHL2:ENST00000322142:synonymous:LOW:exon7/7:c.804C>T:p.Asp268Asp,FHL2:ENST00000358129:synonymous:LOW:exon8/8:c.804C>T:p.Asp268Asp,FHL2:ENST00000409807:synonymous:LOW:exon6/6:c.804C>T:p.Asp268Asp,FHL2:ENST00000408995:synonymous:LOW:exon6/6:c.804C>T:p.Asp268Asp,FHL2:ENST00000336660:3'UTR:MODIFIER:exon5/5:c.*173C>T:		rs3087523	0.0517	0.0913	588,461,3	0.0222,0.0970,0.0274,0.1184,0.0543	0.0938								RCV000041652.3 [benign]; 		COSM1398595	21	418	2	[2] auto-classification 14.09.2017  			FHL2 (inh=n/a pLI=0.00)
chr2	106510191	106510191	-	AAAG	hom		QUAL=17434;DP=175;AF=0.98;MQM=59;TRIO=HOM,175,0.98,HOM,169,0.99,HOM,208,1.00	NCK2	3'UTR	NCK2:ENST00000233154:3'UTR:MODIFIER:exon5/5:c.*562_*565dupAGAA:,NCK2:ENST00000451463:3'UTR:MODIFIER:exon4/4:c.*731_*734dupAGAA:,NCK2:ENST00000393349:3'UTR:MODIFIER:exon4/4:c.*562_*565dupAGAA:		rs10645562	0.9591	0.0000	0,0,0	0,0,0,0,0	0.9294											200	30					NCK2 (inh=n/a pLI=0.70)
chr2	106510477	106510477	T	A	het		QUAL=142;DP=84;AF=0.15;MQM=56;TRIO=HET,84,0.15,HET,6,0.50,WT,74,0.03	NCK2	3'UTR	NCK2:ENST00000233154:3'UTR:MODIFIER:exon5/5:c.*845T>A:,NCK2:ENST00000451463:3'UTR:MODIFIER:exon4/4:c.*1014T>A:,NCK2:ENST00000393349:3'UTR:MODIFIER:exon4/4:c.*845T>A:	PRIMA4-int	rs73946608	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0003											0	7					NCK2 (inh=n/a pLI=0.70)
chr2	106510478	106510478	A	C	het		QUAL=142;DP=84;AF=0.15;MQM=56;TRIO=HET,84,0.15,HET,6,0.50,WT,74,0.03	NCK2	3'UTR	NCK2:ENST00000233154:3'UTR:MODIFIER:exon5/5:c.*846A>C:,NCK2:ENST00000451463:3'UTR:MODIFIER:exon4/4:c.*1015A>C:,NCK2:ENST00000393349:3'UTR:MODIFIER:exon4/4:c.*846A>C:	PRIMA4-int	rs73946609	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0003											0	9					NCK2 (inh=n/a pLI=0.70)
chr2	109389463	109389463	G	A	hom	anno_omim	QUAL=16314;DP=168;AF=1.00;MQM=60;TRIO=HOM,168,1.00,HOM,173,1.00,HOM,167,1.00	RANBP2	synonymous	RANBP2:ENST00000283195:synonymous:LOW:exon23/29:c.8253G>A:p.Glu2751Glu		rs826580	0.9872	0.9959	59941,33182,4734	0.9545,0.9987,1.0000,0.9999,0.9999	0.9969							601181 [RANBP2 (provisional) Encephalopathy,acute,infection-induced,3,susceptibility to,608033];				2106	2	2	[2] auto-classification 14.09.2017  			RANBP2 (inh=AD pLI=1.00)
chr2	109510933	109510937	TAATG	-	het	anno_omim	QUAL=2911;DP=80;AF=0.68;MQM=59;TRIO=HET,80,1.00,WT,11,1.00,HET,17,1.00	EDAR	splice_region,3'UTR,non_coding_transcript	EDAR:ENST00000376651:splice_region:LOW:exon11/11:c.*2426_*2430delCATTA:,EDAR:ENST00000376651:3'UTR:MODIFIER:exon11/11:c.*2426_*2430delCATTA:,EDAR:ENST00000409271:3'UTR:MODIFIER:exon12/12:c.*2426_*2430delCATTA:,EDAR:ENST00000258443:3'UTR:MODIFIER:exon12/12:c.*2426_*2430delCATTA:,EDAR:ENST00000376651:non_coding_transcript:MODIFIER:exon11/11:c.*2426_*2430delCATTA:		rs555061424	0.0026	0.0000	0,0,0	0,0,0,0,0	0.0043							604095 [EDAR (confirmed) Ectodermal dysplasia 10A,hypohidrotic/hair/nail type,autosomal dominant,129490|Ectodermal dysplasia 10B,hypohidrotic/hair/tooth type,autosomal recessive,224900|Hair morphology 1,hair thickness,612630];	RCV000357958.1 [uncertain significance]; 			0	4					EDAR (inh=AR+AD pLI=0.00)
chr2	109510937	109510937	G	A	het	anno_omim	QUAL=2911;DP=80;AF=0.68;MQM=60;TRIO=HET,80,1.00,HOM,11,1.00,HET,17,1.00	EDAR	3'UTR	EDAR:ENST00000376651:3'UTR:MODIFIER:exon11/11:c.*2426C>T:,EDAR:ENST00000409271:3'UTR:MODIFIER:exon12/12:c.*2426C>T:,EDAR:ENST00000258443:3'UTR:MODIFIER:exon12/12:c.*2426C>T:		rs1478517	0.5317	0.0000	0,0,0	0,0,0,0,0	0.5267							604095 [EDAR (confirmed) Ectodermal dysplasia 10A,hypohidrotic/hair/nail type,autosomal dominant,129490|Ectodermal dysplasia 10B,hypohidrotic/hair/tooth type,autosomal recessive,224900|Hair morphology 1,hair thickness,612630];	RCV000268013.1 [benign]; 			116	82					EDAR (inh=AR+AD pLI=0.00)
chr2	109511765	109511765	A	G	hom	anno_omim	QUAL=23775;DP=409;AF=1.00;MQM=60;TRIO=HOM,409,1.00,HOM,131,0.99,HOM,187,1.00	EDAR	3'UTR	EDAR:ENST00000376651:3'UTR:MODIFIER:exon11/11:c.*1598T>C:,EDAR:ENST00000409271:3'UTR:MODIFIER:exon12/12:c.*1598T>C:,EDAR:ENST00000258443:3'UTR:MODIFIER:exon12/12:c.*1598T>C:		rs10865025	0.6699	0.0000	0,0,0	0,0,0,0,0	0.7246							604095 [EDAR (confirmed) Ectodermal dysplasia 10A,hypohidrotic/hair/nail type,autosomal dominant,129490|Ectodermal dysplasia 10B,hypohidrotic/hair/tooth type,autosomal recessive,224900|Hair morphology 1,hair thickness,612630];	RCV000374162.1 [benign]; 			170	53					EDAR (inh=AR+AD pLI=0.00)
chr2	109512234	109512234	T	C	hom	anno_omim	QUAL=41846;DP=417;AF=1.00;MQM=59;TRIO=HOM,417,1.00,HOM,372,1.00,HOM,504,1.00	EDAR	3'UTR	EDAR:ENST00000376651:3'UTR:MODIFIER:exon11/11:c.*1129A>G:,EDAR:ENST00000409271:3'UTR:MODIFIER:exon12/12:c.*1129A>G:,EDAR:ENST00000258443:3'UTR:MODIFIER:exon12/12:c.*1129A>G:	MIR3	rs13001699	0.7208	0.0000	0,0,0	0,0,0,0,0	0.7405							604095 [EDAR (confirmed) Ectodermal dysplasia 10A,hypohidrotic/hair/nail type,autosomal dominant,129490|Ectodermal dysplasia 10B,hypohidrotic/hair/tooth type,autosomal recessive,224900|Hair morphology 1,hair thickness,612630];	RCV000400545.1 [benign]; 			175	48					EDAR (inh=AR+AD pLI=0.00)
chr2	109513321	109513321	C	A	hom	anno_omim	QUAL=20607;DP=250;AF=0.99;MQM=59;TRIO=HOM,250,0.99,HOM,163,1.00,HOM,240,1.00	EDAR	3'UTR	EDAR:ENST00000376651:3'UTR:MODIFIER:exon11/11:c.*42G>T:,EDAR:ENST00000409271:3'UTR:MODIFIER:exon12/12:c.*42G>T:,EDAR:ENST00000258443:3'UTR:MODIFIER:exon12/12:c.*42G>T:		rs7607563	0.8830	0.9067	34504,18960,2193	0.7734,0.9489,0.9977,0.9047,0.9239	0.9103							604095 [EDAR (confirmed) Ectodermal dysplasia 10A,hypohidrotic/hair/nail type,autosomal dominant,129490|Ectodermal dysplasia 10B,hypohidrotic/hair/tooth type,autosomal recessive,224900|Hair morphology 1,hair thickness,612630];	RCV000143979.1 [not provided]; RCV000367811.1 [benign]; 			1594	311					EDAR (inh=AR+AD pLI=0.00)
chr2	109513654	109513654	G	A	hom	anno_omim	QUAL=23709;DP=250;AF=1.00;MQM=59;TRIO=HOM,250,1.00,HOM,211,1.00,HOM,313,1.00	EDAR	synonymous	EDAR:ENST00000376651:synonymous:LOW:exon11/11:c.1152C>T:p.Cys384Cys,EDAR:ENST00000409271:synonymous:LOW:exon12/12:c.1152C>T:p.Cys384Cys,EDAR:ENST00000258443:synonymous:LOW:exon12/12:c.1056C>T:p.Cys352Cys		rs12623957	0.7119	0.8103	40324,23145,924	0.4325,0.9027,0.9604,0.8382,0.7538	0.8218							604095 [EDAR (confirmed) Ectodermal dysplasia 10A,hypohidrotic/hair/nail type,autosomal dominant,129490|Ectodermal dysplasia 10B,hypohidrotic/hair/tooth type,autosomal recessive,224900|Hair morphology 1,hair thickness,612630];	RCV000143982.1 [uncertain significance]; RCV000150610.3 [benign]; RCV000269800.1 [benign]; 			1426	594	2	[2] auto-classification 14.09.2017  			EDAR (inh=AR+AD pLI=0.00)
chr2	109526969	109526969	G	A	hom	anno_omim	QUAL=24329;DP=247;AF=1.00;MQM=59;TRIO=HOM,247,1.00,HOM,196,1.00,HOM,307,1.00	EDAR	synonymous	EDAR:ENST00000376651:synonymous:LOW:exon8/11:c.846C>T:p.Ser282Ser,EDAR:ENST00000409271:synonymous:LOW:exon9/12:c.846C>T:p.Ser282Ser,EDAR:ENST00000258443:synonymous:LOW:exon9/12:c.750C>T:p.Ser250Ser		rs260632	0.9213	0.9170	50929,27250,4027	0.8828,0.9511,0.9983,0.9052,0.9223	0.9188							604095 [EDAR (confirmed) Ectodermal dysplasia 10A,hypohidrotic/hair/nail type,autosomal dominant,129490|Ectodermal dysplasia 10B,hypohidrotic/hair/tooth type,autosomal recessive,224900|Hair morphology 1,hair thickness,612630];	RCV000143987.1 [uncertain significance]; RCV000150611.2 [benign]; RCV000285005.1 [benign]; 		COSM3766486, COSM3766485	1758	329	2	[2] auto-classification 14.09.2017  			EDAR (inh=AR+AD pLI=0.00)
chr2	110922703	110922703	C	T	hom	anno_omim	QUAL=11612;DP=217;AF=1.00;MQM=60;TRIO=HOM,217,1.00,HET,145,0.52,HET,191,0.52	NPHP1	synonymous	NPHP1:ENST00000316534:synonymous:LOW:exon7/20:c.654G>A:p.Glu218Glu,NPHP1:ENST00000445609:synonymous:LOW:exon7/20:c.654G>A:p.Glu218Glu,NPHP1:ENST00000393272:synonymous:LOW:exon7/20:c.654G>A:p.Glu218Glu,NPHP1:ENST00000355301:synonymous:LOW:exon5/18:c.468G>A:p.Glu156Glu,NPHP1:ENST00000417665:synonymous:LOW:exon7/21:c.654G>A:p.Glu218Glu		rs11675767	0.4744	0.3793	9426,3514,1250	0.4899,0.3489,0.5961,0.3226,0.5047	0.3736							607100 [NPHP1 (confirmed) Nephronophthisis 1,juvenile,256100|Senior-Loken syndrome-1,266900|Joubert syndrome 4,609583];	RCV000078490.9 [other]; RCV000313743.1 [benign]; RCV000367290.1 [benign]; RCV000400518.1 [benign]; 			417	1460	2	[2] auto-classification 14.09.2017  			NPHP1 (inh=AR pLI=0.00)
chr2	113820476	113820476	T	C	het	anno_omim	QUAL=4008;DP=169;AF=0.48;MQM=60;TRIO=HET,169,0.48,HET,78,0.41,HET,120,0.42	IL36RN	3'UTR	IL36RN:ENST00000346807:3'UTR:MODIFIER:exon5/5:c.*222T>C:,IL36RN:ENST00000393200:3'UTR:MODIFIER:exon5/5:c.*222T>C:		rs2515401	0.7153	0.0000	0,0,0	0,0,0,0,0	0.6348							605507 [IL36RN (confirmed) Psoriasis 14,pustular,614204];	RCV000262540.1 [benign]; 			91	110					IL36RN (inh=AR pLI=0.00)
chr2	113820530	113820530	A	G	het	anno_omim	QUAL=4095;DP=174;AF=0.47;MQM=59;TRIO=HET,174,0.47,HET,85,0.32,HET,114,0.47	IL36RN	3'UTR	IL36RN:ENST00000346807:3'UTR:MODIFIER:exon5/5:c.*276A>G:,IL36RN:ENST00000393200:3'UTR:MODIFIER:exon5/5:c.*276A>G:		rs1800930	0.7155	0.0000	0,0,0	0,0,0,0,0	0.6347							605507 [IL36RN (confirmed) Psoriasis 14,pustular,614204];	RCV000317835.1 [benign]; 			90	111					IL36RN (inh=AR pLI=0.00)
chr2	113820580	113820580	C	A	het	anno_omim	QUAL=4316;DP=183;AF=0.40;MQM=60;TRIO=HET,183,0.40,HET,97,0.35,HET,152,0.48	IL36RN	3'UTR	IL36RN:ENST00000346807:3'UTR:MODIFIER:exon5/5:c.*326C>A:,IL36RN:ENST00000393200:3'UTR:MODIFIER:exon5/5:c.*326C>A:		rs2515402	0.7155	0.0000	0,0,0	0,0,0,0,0	0.6345							605507 [IL36RN (confirmed) Psoriasis 14,pustular,614204];	RCV000323693.1 [benign]; 			92	106					IL36RN (inh=AR pLI=0.00)
chr2	113820655	113820655	A	T	het	anno_omim	QUAL=7343;DP=189;AF=0.49;MQM=60;TRIO=HET,189,0.49,HET,163,0.48,HET,249,0.53	IL36RN	3'UTR	IL36RN:ENST00000346807:3'UTR:MODIFIER:exon5/5:c.*401A>T:,IL36RN:ENST00000393200:3'UTR:MODIFIER:exon5/5:c.*401A>T:		rs3180234	0.7151	0.0000	0,0,0	0,0,0,0,0	0.6233							605507 [IL36RN (confirmed) Psoriasis 14,pustular,614204];	RCV000283822.1 [benign]; 			91	108					IL36RN (inh=AR pLI=0.00)
chr2	113820672	113820672	A	G	het	anno_omim	QUAL=8420;DP=218;AF=0.50;MQM=60;TRIO=HET,218,0.50,HET,176,0.48,HET,265,0.51	IL36RN	3'UTR	IL36RN:ENST00000346807:3'UTR:MODIFIER:exon5/5:c.*418A>G:,IL36RN:ENST00000393200:3'UTR:MODIFIER:exon5/5:c.*418A>G:		rs3180235	0.7151	0.0000	0,0,0	0,0,0,0,0	0.6347							605507 [IL36RN (confirmed) Psoriasis 14,pustular,614204];	RCV000348147.1 [benign]; 			91	109					IL36RN (inh=AR pLI=0.00)
chr2	113820732	113820732	T	C	het	anno_omim	QUAL=9904;DP=278;AF=0.43;MQM=59;TRIO=HET,278,0.43,HET,246,0.46,HET,311,0.53	IL36RN	3'UTR	IL36RN:ENST00000346807:3'UTR:MODIFIER:exon5/5:c.*478T>C:,IL36RN:ENST00000393200:3'UTR:MODIFIER:exon5/5:c.*478T>C:		rs2515403	0.7153	0.0000	0,0,0	0,0,0,0,0	0.6344							605507 [IL36RN (confirmed) Psoriasis 14,pustular,614204];	RCV000384030.1 [benign]; 			91	110					IL36RN (inh=AR pLI=0.00)
chr2	113820814	113820814	C	G	het	anno_omim	QUAL=7791;DP=224;AF=0.46;MQM=60;TRIO=HET,224,0.46,HET,203,0.45,HET,232,0.51	IL36RN	3'UTR	IL36RN:ENST00000346807:3'UTR:MODIFIER:exon5/5:c.*560C>G:,IL36RN:ENST00000393200:3'UTR:MODIFIER:exon5/5:c.*560C>G:		rs2472188	0.7153	0.0000	0,0,0	0,0,0,0,0	0.6346							605507 [IL36RN (confirmed) Psoriasis 14,pustular,614204];	RCV000289570.1 [benign]; 			91	110					IL36RN (inh=AR pLI=0.00)
chr2	113821117	113821117	C	T	het	anno_omim	QUAL=6757;DP=330;AF=0.45;MQM=60;TRIO=HET,330,0.45,HET,108,0.43,HET,140,0.51	IL36RN	3'UTR	IL36RN:ENST00000346807:3'UTR:MODIFIER:exon5/5:c.*863C>T:,IL36RN:ENST00000393200:3'UTR:MODIFIER:exon5/5:c.*863C>T:	L1ME4a	rs2515404	0.8698	0.0000	0,0,0	0,0,0,0,0	0.7864							605507 [IL36RN (confirmed) Psoriasis 14,pustular,614204];	RCV000349605.1 [benign]; 			111	85					IL36RN (inh=AR pLI=0.00)
chr2	113821200	113821200	T	C	het	anno_omim	QUAL=5044;DP=163;AF=0.52;MQM=60;TRIO=HET,163,0.52,HET,107,0.40,HET,131,0.49	IL36RN	3'UTR	IL36RN:ENST00000346807:3'UTR:MODIFIER:exon5/5:c.*946T>C:,IL36RN:ENST00000393200:3'UTR:MODIFIER:exon5/5:c.*946T>C:		rs957201	0.7153	0.0000	0,0,0	0,0,0,0,0	0.6349							605507 [IL36RN (confirmed) Psoriasis 14,pustular,614204];	RCV000300576.1 [benign]; 			88	104					IL36RN (inh=AR pLI=0.00)
chr2	113821653	113821653	T	C	het	anno_omim	QUAL=12895;DP=370;AF=0.50;MQM=59;TRIO=HET,370,0.50,HET,276,0.46,HET,408,0.45	IL36RN	3'UTR	IL36RN:ENST00000346807:3'UTR:MODIFIER:exon5/5:c.*1399T>C:,IL36RN:ENST00000393200:3'UTR:MODIFIER:exon5/5:c.*1399T>C:	MLT1C2	rs768627	0.7153	0.0000	0,0,0	0,0,0,0,0	0.6346							605507 [IL36RN (confirmed) Psoriasis 14,pustular,614204];	RCV000361128.1 [benign]; 			84	92					IL36RN (inh=AR pLI=0.00)
chr2	113887207	113887207	T	C	het	anno_omim	QUAL=2257;DP=110;AF=0.48;MQM=60;TRIO=HET,110,0.48,HOM,29,1.00,WT,46,0.00	IL1RN	synonymous	IL1RN:ENST00000259206:synonymous:LOW:exon4/6:c.180T>C:p.Ala60Ala,IL1RN:ENST00000409052:synonymous:LOW:exon6/9:c.69T>C:p.Ala23Ala,IL1RN:ENST00000361779:synonymous:LOW:exon4/6:c.69T>C:p.Ala23Ala,IL1RN:ENST00000354115:synonymous:LOW:exon3/5:c.117T>C:p.Ala39Ala,IL1RN:ENST00000409930:synonymous:LOW:exon2/4:c.171T>C:p.Ala57Ala		rs419598	0.1917	0.2491	4299,2596,27	0.0669,0.3168,0.0703,0.2749,0.2838	0.2575							147679 [IL1RN (confirmed) Gastric cancer risk after H. pylori infection,137215|Microvascular complications of diabetes 4,612628|Interleukin 1 receptor antagonist deficiency,612852];	RCV000389038.1 [benign]; 	CM025329 [CLASS=DP MUT=ALT PHEN="Alopecia areata association with" GENE=IL1RN]; 	COSM3766494, COSM3766495, COSM3766493	147	796	2	[2] auto-classification 14.09.2017  			IL1RN (inh=AR pLI=0.34)
chr2	113891412	113891412	G	A	hom	anno_omim	QUAL=12529;DP=148;AF=0.99;MQM=59;TRIO=HOM,148,0.99,HOM,169,0.99,HET,245,0.47	IL1RN	3'UTR	IL1RN:ENST00000259206:3'UTR:MODIFIER:exon6/6:c.*964G>A:,IL1RN:ENST00000409052:3'UTR:MODIFIER:exon9/9:c.*822G>A:,IL1RN:ENST00000361779:3'UTR:MODIFIER:exon6/6:c.*964G>A:,IL1RN:ENST00000354115:3'UTR:MODIFIER:exon5/5:c.*964G>A:	L2b	rs9005	0.3199	0.0000	0,0,0	0,0,0,0,0	0.2741							147679 [IL1RN (confirmed) Gastric cancer risk after H. pylori infection,137215|Microvascular complications of diabetes 4,612628|Interleukin 1 receptor antagonist deficiency,612852];	RCV000355397.1 [benign]; 			30	105					IL1RN (inh=AR pLI=0.34)
chr2	113975110	113975110	A	G	hom	anno_omim	QUAL=9499;DP=169;AF=1.00;MQM=60;TRIO=HOM,169,1.00,HET,136,0.50,HET,184,0.48	PAX8,PAX8-AS1	3'UTR,intron	PAX8:ENST00000429538:3'UTR:MODIFIER:exon12/12:c.*1000T>C:,PAX8:ENST00000263335:3'UTR:MODIFIER:exon10/10:c.*1077T>C:,PAX8:ENST00000348715:3'UTR:MODIFIER:exon12/12:c.*1077T>C:,PAX8:ENST00000397647:3'UTR:MODIFIER:exon9/9:c.*1077T>C:,PAX8-AS1:ENST00000456685:intron:MODIFIER:exon2/5:n.305+1171A>G:		rs1049137	0.1460	0.0000	0,0,0	0,0,0,0,0	0.1911							167415 [PAX8 (confirmed) Hypothyroidism,congenital,due to thyroid dysgenesis or hypoplasia,218700];	RCV000381833.1 [likely benign]; 			14	98					PAX8 (inh=n/a pLI=0.90), PAX8-AS1 (inh=n/a pLI=n/a)
chr2	114036436	114036436	G	C	hom	anno_omim	QUAL=11806;DP=82;AF=0.98;MQM=60;TRIO=HOM,82,0.98,HOM,137,1.00,HOM,168,1.00	PAX8	5'UTR	PAX8:ENST00000429538:5'UTR:MODIFIER:exon1/12:c.-104C>G:,PAX8:ENST00000263335:5'UTR:MODIFIER:exon1/10:c.-104C>G:,PAX8:ENST00000348715:5'UTR:MODIFIER:exon1/12:c.-104C>G:,PAX8:ENST00000397647:5'UTR:MODIFIER:exon1/9:c.-104C>G:		rs2084163	0.9764	0.0000	0,0,0	0,0,0,0,0	0.9809							167415 [PAX8 (confirmed) Hypothyroidism,congenital,due to thyroid dysgenesis or hypoplasia,218700];				232	0					PAX8 (inh=n/a pLI=0.90)
chr2	121726447	121726447	G	A	hom	anno_omim	QUAL=9532;DP=83;AF=1.00;MQM=60;TRIO=HOM,83,1.00,HOM,108,1.00,HOM,148,1.00	GLI2	synonymous,5'UTR	GLI2:ENST00000361492:synonymous:LOW:exon5/13:c.801G>A:p.Ser267Ser,GLI2:ENST00000452319:synonymous:LOW:exon6/14:c.801G>A:p.Ser267Ser,GLI2:ENST00000314490:5'UTR:MODIFIER:exon5/14:c.-184G>A:		rs2592595	0.8273	0.9401	54822,32314,1206	0.4731,0.9636,0.9997,0.9852,0.9791	0.9498	-5.5090	T,T	T	B		8.35	165230 [GLI2 (confirmed) Holoprosencephaly 9,610829|Culler-Jones syndrome,615849];	RCV000247010.1 [benign]; RCV000346541.1 [benign]; 			1975	118	2	[2] auto-classification 14.09.2017  			GLI2 (inh=AD pLI=1.00)
chr2	121746956	121746956	G	T	hom	anno_omim	QUAL=16964;DP=89;AF=0.98;MQM=59;TRIO=HOM,89,0.98,HOM,178,1.00,HOM,296,1.00	GLI2	missense,intron	GLI2:ENST00000361492:missense:MODERATE:exon13/13:c.3466G>T:p.Ala1156Ser,GLI2:ENST00000452319:missense:MODERATE:exon14/14:c.3466G>T:p.Ala1156Ser,GLI2:ENST00000314490:intron:MODIFIER:exon13/13:c.2460+22G>T:		rs3738880	0.5090	0.6296	23928,16654,739	0.4046,0.5558,0.4746,0.7231,0.5149	0.6323	-0.3680	T,T	T	B,B	T,T	2.06	165230 [GLI2 (confirmed) Holoprosencephaly 9,610829|Culler-Jones syndrome,615849];	RCV000081284.5 [benign]; RCV000273393.1 [benign]; 			974	881	2	[2] auto-classification 14.09.2017  			GLI2 (inh=AD pLI=1.00)
chr2	121747406	121747406	G	A	hom	pred_pathogenic;anno_omim	QUAL=21143;DP=189;AF=0.99;MQM=59;TRIO=HOM,189,0.99,HOM,213,1.00,HOM,270,1.00	GLI2	missense,intron	GLI2:ENST00000361492:missense:MODERATE:exon13/13:c.3916G>A:p.Asp1306Asn,GLI2:ENST00000452319:missense:MODERATE:exon14/14:c.3916G>A:p.Asp1306Asn,GLI2:ENST00000314490:intron:MODIFIER:exon13/13:c.2460+472G>A:		rs12711538	0.5671	0.6464	24934,16738,1632	0.5826,0.5638,0.4738,0.7227,0.5240	0.6592	2.1560	T,T	T	B,B	T,T	0.39	165230 [GLI2 (confirmed) Holoprosencephaly 9,610829|Culler-Jones syndrome,615849];	RCV000081285.5 [benign]; RCV000340352.1 [benign]; 		COSM3757603	994	886	2	[2] auto-classification 14.09.2017  			GLI2 (inh=AD pLI=1.00)
chr2	121747429	121747429	A	G	hom	anno_omim	QUAL=22752;DP=193;AF=0.99;MQM=59;TRIO=HOM,193,0.99,HOM,233,1.00,HOM,307,1.00	GLI2	synonymous,intron	GLI2:ENST00000361492:synonymous:LOW:exon13/13:c.3939A>G:p.Pro1313Pro,GLI2:ENST00000452319:synonymous:LOW:exon14/14:c.3939A>G:p.Pro1313Pro,GLI2:ENST00000314490:intron:MODIFIER:exon13/13:c.2460+495A>G:		rs10167980	0.5124	0.6344	24344,16984,768	0.4062,0.5559,0.4840,0.7275,0.5230	0.6365							165230 [GLI2 (confirmed) Holoprosencephaly 9,610829|Culler-Jones syndrome,615849];	RCV000081286.5 [benign]; RCV000287111.1 [benign]; 		COSM3721935	995	882	2	[2] auto-classification 14.09.2017  			GLI2 (inh=AD pLI=1.00)
chr2	121749067	121749067	G	C	hom	anno_omim	QUAL=20242;DP=247;AF=1.00;MQM=60;TRIO=HOM,247,1.00,HOM,160,1.00,HOM,227,1.00	GLI2	3'UTR	GLI2:ENST00000361492:3'UTR:MODIFIER:exon13/13:c.*816G>C:,GLI2:ENST00000452319:3'UTR:MODIFIER:exon14/14:c.*816G>C:		rs2278741	0.5078	0.0000	0,0,0	0,0,0,0,0	0.6062							165230 [GLI2 (confirmed) Holoprosencephaly 9,610829|Culler-Jones syndrome,615849];	RCV000314058.1 [benign]; 			115	97					GLI2 (inh=AD pLI=1.00)
chr2	121749584	121749589	ACACAC	-	hom	anno_omim	QUAL=1688;DP=57;AF=0.00;MQM=59;TRIO=HOM,57,0.16,WT,28,0.50,HOM,89,0.51	GLI2	3'UTR	GLI2:ENST00000361492:3'UTR:MODIFIER:exon13/13:c.*1371_*1376delACACAC:,GLI2:ENST00000452319:3'UTR:MODIFIER:exon14/14:c.*1371_*1376delACACAC:	(AC)n		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0480							165230 [GLI2 (confirmed) Holoprosencephaly 9,610829|Culler-Jones syndrome,615849];	RCV000384685.1 [uncertain significance]; 			1	0					GLI2 (inh=AD pLI=1.00)
chr2	127819777	127819777	C	T	het	anno_omim	QUAL=5043;DP=161;AF=0.43;MQM=59;TRIO=HET,161,0.43,WT,236,0.00,HET,315,0.47	BIN1	splice_region&intron	BIN1:ENST00000316724:splice_region&intron:LOW:exon9/18:c.775-4G>A:,BIN1:ENST00000376113:splice_region&intron:LOW:exon8/13:c.682-4G>A:,BIN1:ENST00000259238:splice_region&intron:LOW:exon8/15:c.682-4G>A:,BIN1:ENST00000346226:splice_region&intron:LOW:exon8/15:c.682-4G>A:,BIN1:ENST00000348750:splice_region&intron:LOW:exon8/12:c.682-4G>A:,BIN1:ENST00000351659:splice_region&intron:LOW:exon9/15:c.775-4G>A:,BIN1:ENST00000352848:splice_region&intron:LOW:exon8/14:c.682-4G>A:,BIN1:ENST00000357970:splice_region&intron:LOW:exon9/17:c.775-4G>A:,BIN1:ENST00000393040:splice_region&intron:LOW:exon8/14:c.682-4G>A:,BIN1:ENST00000393041:splice_region&intron:LOW:exon8/14:c.682-4G>A:,BIN1:ENST00000409400:splice_region&intron:LOW:exon8/13:c.682-4G>A:		rs61748157	0.0972	0.1580	711,375,15	0.0892,0.0971,0.0231,0.1735,0.2204	0.1136							601248 [BIN1 (provisional) Myopathy,centronuclear,autosomal recessive,255200];	RCV000145347.3 [benign]; RCV000381094.1 [likely benign]; 			31	500	2	[2] auto-classification 14.09.2017  			BIN1 (inh=AR pLI=0.47)
chr2	135677471	135677471	-	GTTT	het		QUAL=5897;DP=220;AF=0.45;MQM=59;TRIO=HET,220,0.45,HET,138,0.44,HET,206,0.46	CCNT2	splice_region&intron	CCNT2:ENST00000264157:splice_region&intron:LOW:exon2/8:c.240+13_240+14insTGTT:,CCNT2:ENST00000537343:splice_region&intron:LOW:exon2/10:c.-373+13_-373+14insTGTT:,CCNT2:ENST00000295238:splice_region&intron:LOW:exon2/9:c.240+13_240+14insTGTT:		rs3841862;rs45507394	0.4173	0.3331	7509,3221,1074	0.4550,0.3467,0.4694,0.2848,0.3805	0.3398											309	771	2	[2] auto-classification 14.09.2017  			CCNT2 (inh=n/a pLI=0.50)
chr2	135711516	135711516	C	T	het		QUAL=15482;DP=361;AF=0.49;MQM=60;TRIO=HET,361,0.49,HET,190,0.54,HOM,250,1.00	CCNT2	synonymous	CCNT2:ENST00000264157:synonymous:LOW:exon9/9:c.1491C>T:p.Asp497Asp,CCNT2:ENST00000537343:synonymous:LOW:exon10/11:c.966C>T:p.Asp322Asp,CCNT2:ENST00000295238:synonymous:LOW:exon9/10:c.1491C>T:p.Asp497Asp		rs3814355	0.7328	0.5894	23022,9042,2736	0.7286,0.6744,0.8755,0.4936,0.7226	0.5907											799	659	2	[2] auto-classification 14.09.2017  			CCNT2 (inh=n/a pLI=0.50)
chr2	135711657	135711657	G	A	het		QUAL=25388;DP=414;AF=0.49;MQM=59;TRIO=HET,414,0.49,HET,365,0.53,HOM,469,1.00	CCNT2	synonymous	CCNT2:ENST00000264157:synonymous:LOW:exon9/9:c.1632G>A:p.Lys544Lys,CCNT2:ENST00000537343:synonymous:LOW:exon10/11:c.1107G>A:p.Lys369Lys,CCNT2:ENST00000295238:synonymous:LOW:exon9/10:c.1632G>A:p.Lys544Lys		rs3814354	0.7021	0.5800	22314,8992,2134	0.6434,0.6666,0.8755,0.4917,0.7200	0.5832										COSM1399489, COSM1179790	781	668	2	[2] auto-classification 14.09.2017  			CCNT2 (inh=n/a pLI=0.50)
chr2	135713386	135713389	AAAA	-	het		QUAL=7607;DP=263;AF=0.50;MQM=59;TRIO=HET,263,0.50,HET,110,0.60,HET,177,0.57	CCNT2	3'UTR	CCNT2:ENST00000264157:3'UTR:MODIFIER:exon9/9:c.*1170_*1173delAAAA:,CCNT2:ENST00000295238:3'UTR:MODIFIER:exon10/10:c.*1270_*1273delAAAA:		rs397897552	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1952											25	101					CCNT2 (inh=n/a pLI=0.50)
chr2	135713703	135713703	G	A	het		QUAL=9297;DP=261;AF=0.52;MQM=60;TRIO=HET,261,0.52,HET,70,0.46,HOM,146,1.00	CCNT2	3'UTR	CCNT2:ENST00000264157:3'UTR:MODIFIER:exon9/9:c.*1485G>A:,CCNT2:ENST00000295238:3'UTR:MODIFIER:exon10/10:c.*1585G>A:		rs3769023	0.7059	0.0000	0,0,0	0,0,0,0,0	0.5527											94	112					CCNT2 (inh=n/a pLI=0.50)
chr2	135715175	135715175	C	-	het		QUAL=13043;DP=325;AF=0.51;MQM=60;TRIO=HET,325,0.51,HET,169,0.50,HOM,208,1.00	CCNT2	3'UTR	CCNT2:ENST00000264157:3'UTR:MODIFIER:exon9/9:c.*2957delC:		rs10709967	0.0000	0.0000	0,0,0	0,0,0,0,0	0.5482											65	72					CCNT2 (inh=n/a pLI=0.50)
chr2	135715466	135715469	TAAT	-	het		QUAL=11143;DP=325;AF=0.51;MQM=59;TRIO=HET,325,0.51,HET,119,0.56,HOM,175,0.99	CCNT2	3'UTR	CCNT2:ENST00000264157:3'UTR:MODIFIER:exon9/9:c.*3252_*3255delTAAT:		rs570752784	0.0000	0.0000	0,0,0	0,0,0,0,0	0.5459											65	72					CCNT2 (inh=n/a pLI=0.50)
chr2	135715957	135715957	A	G	het		QUAL=11406;DP=418;AF=0.44;MQM=59;TRIO=HET,418,0.44,HET,178,0.43,HOM,146,1.00	CCNT2	3'UTR	CCNT2:ENST00000264157:3'UTR:MODIFIER:exon9/9:c.*3739A>G:		rs1947112	0.7055	0.0000	0,0,0	0,0,0,0,0	0.5530											65	72					CCNT2 (inh=n/a pLI=0.50)
chr2	145142173	145142173	T	-	het	anno_omim	QUAL=2205;DP=153;AF=0.50;MQM=59;TRIO=HET,153,0.50,WT,34,0.03,HET,73,0.48	ZEB2	3'UTR	ZEB2:ENST00000558170:3'UTR:MODIFIER:exon10/10:c.*4845delA:		rs201661554	0.0885	0.0000	0,0,0	0,0,0,0,0	0.0392							605802 [ZEB2 (confirmed) Mowat-Wilson syndrome,235730];	RCV000269026.1 [benign]; 			0	14					ZEB2 (inh=AD pLI=1.00)
chr2	145143934	145143934	G	A	het	anno_omim	QUAL=3363;DP=173;AF=0.50;MQM=60;TRIO=HET,173,0.50,HOM,36,0.97,WT,49,0.00	ZEB2	3'UTR	ZEB2:ENST00000558170:3'UTR:MODIFIER:exon10/10:c.*3084C>T:		rs62169201	0.0397	0.0000	0,0,0	0,0,0,0,0	0.0920							605802 [ZEB2 (confirmed) Mowat-Wilson syndrome,235730];	RCV000289693.1 [benign]; 			4	32					ZEB2 (inh=AD pLI=1.00)
chr2	145144612	145144612	-	TA	hom	anno_omim	QUAL=546;DP=30;AF=0.67;MQM=59;TRIO=HOM,30,0.67,HET,28,0.21,HET,42,0.33	ZEB2	3'UTR	ZEB2:ENST00000558170:3'UTR:MODIFIER:exon10/10:c.*2404_*2405dupTA:	(TG)n	rs143648355;rs767117745	0.0000	0.0000	0,0,0	0,0,0,0,0	0.6673							605802 [ZEB2 (confirmed) Mowat-Wilson syndrome,235730];	RCV000294757.1 [uncertain significance]; 			50	45					ZEB2 (inh=AD pLI=1.00)
chr2	145145034	145145034	A	G	hom	anno_omim	QUAL=17099;DP=263;AF=1.00;MQM=60;TRIO=HOM,263,1.00,HOM,113,1.00,HOM,142,0.99	ZEB2	3'UTR	ZEB2:ENST00000558170:3'UTR:MODIFIER:exon10/10:c.*1984T>C:		rs10179925	0.9958	0.0000	0,0,0	0,0,0,0,0	0.9951							605802 [ZEB2 (confirmed) Mowat-Wilson syndrome,235730];	RCV000368446.1 [benign]; 			176	0					ZEB2 (inh=AD pLI=1.00)
chr2	149270710	149270710	A	G	hom	anno_omim	QUAL=15036;DP=329;AF=0.99;MQM=60;TRIO=HOM,329,0.99,HET,157,0.50,HET,167,0.46	MBD5	3'UTR	MBD5:ENST00000404807:3'UTR:MODIFIER:exon10/10:c.*200A>G:,MBD5:ENST00000407073:3'UTR:MODIFIER:exon15/15:c.*200A>G:		rs16828708	0.4491	0.0000	0,0,0	0,0,0,0,0	0.2861							611472 [MBD5 (provisional) Mental retardation,autosomal dominant 1,156200];	RCV000380890.1 [likely benign]; 			22	96					MBD5 (inh=AD pLI=1.00)
chr2	149881076	149881076	A	G	hom	anno_omim	QUAL=4686;DP=95;AF=0.14;MQM=55;TRIO=HOM,95,0.14,HOM,45,0.02,HOM,84,0.07	KIF5C	3'UTR	KIF5C:ENST00000435030:3'UTR:MODIFIER:exon26/26:c.*1492A>G:,KIF5C:ENST00000414838:3'UTR:MODIFIER:exon24/24:c.*1492A>G:,KIF5C:ENST00000397413:3'UTR:MODIFIER:exon19/19:c.*1492A>G:	(GT)n	rs78917133	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0035							604593 [KIF5C (provisional) Cortical dysplasia,complex,with other brain malformations 2,615282];				8	3					KIF5C (inh=AD pLI=1.00)
chr2	152346553	152346553	G	A	het	anno_high_impact;pred_pathogenic;anno_omim;anno_pathogenic_hgmd	QUAL=4950;DP=279;AF=0.44;MQM=60;TRIO=HET,279,0.44,HET,145,0.48,WT,227,0.00	NEB,RIF1	stop_gained	NEB:ENST00000397345:stop_gained:HIGH:exon181/182:c.25336C>T:p.Arg8446*,NEB:ENST00000409198:stop_gained:HIGH:exon149/150:c.19768C>T:p.Arg6590*,NEB:ENST00000427231:stop_gained:HIGH:exon181/182:c.25336C>T:p.Arg8446*,NEB:ENST00000397336:stop_gained:HIGH:exon14/15:c.1261C>T:p.Arg421*,NEB:ENST00000172853:stop_gained:HIGH:exon148/149:c.19768C>T:p.Arg6590*,NEB:ENST00000509223:stop_gained:HIGH:exon12/13:c.1075C>T:p.Arg359*,NEB:ENST00000603639:stop_gained:HIGH:exon179/180:c.25336C>T:p.Arg8446*,NEB:ENST00000604864:stop_gained:HIGH:exon179/180:c.25336C>T:p.Arg8446*		rs200731870	0.0000	0.0001	0,0,0	0.0000,0.0000,0.0000,0.0001,0.0000	0.0001	2.9000					60.00	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];		CM1413908 [CLASS=DM MUT=ALT PHEN="Nemaline myopathy" GENE=NEB]; 	COSM1590777, COSM1007385, COSM1007383	0	2					NEB (inh=AR pLI=0.00), RIF1 (inh=n/a pLI=1.00)
chr2	152346979	152346979	T	C	het	anno_omim	QUAL=10901;DP=291;AF=0.47;MQM=60;TRIO=HET,291,0.47,HET,240,0.49,HET,301,0.55	NEB,RIF1	missense	NEB:ENST00000397345:missense:MODERATE:exon180/182:c.25204A>G:p.Ile8402Val,NEB:ENST00000409198:missense:MODERATE:exon148/150:c.19636A>G:p.Ile6546Val,NEB:ENST00000427231:missense:MODERATE:exon180/182:c.25204A>G:p.Ile8402Val,NEB:ENST00000397336:missense:MODERATE:exon13/15:c.1129A>G:p.Ile377Val,NEB:ENST00000172853:missense:MODERATE:exon147/149:c.19636A>G:p.Ile6546Val,NEB:ENST00000509223:missense:MODERATE:exon11/13:c.943A>G:p.Ile315Val,NEB:ENST00000603639:missense:MODERATE:exon178/180:c.25204A>G:p.Ile8402Val,NEB:ENST00000604864:missense:MODERATE:exon178/180:c.25204A>G:p.Ile8402Val		rs1061305	0.3343	0.4136	7524,4880,826	0.4743,0.4079,0.3032,0.4502,0.2697	0.4068	-0.6960	T,T,T,T,T,T,T,T	T	B,B,B,B	T,T,T,T,T,T,T	12.31	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	RCV000081132.9 [other]; RCV000398581.1 [benign]; 			318	936	2	[2] auto-classification 14.09.2017  			NEB (inh=AR pLI=0.00), RIF1 (inh=n/a pLI=1.00)
chr2	152352843	152352843	C	G	hom	pred_pathogenic;anno_omim	QUAL=34171;DP=329;AF=1.00;MQM=59;TRIO=HOM,329,1.00,HOM,321,1.00,HOM,415,1.00	NEB,RIF1	missense	NEB:ENST00000397345:missense:MODERATE:exon173/182:c.24433G>C:p.Ala8145Pro,NEB:ENST00000409198:missense:MODERATE:exon141/150:c.18865G>C:p.Ala6289Pro,NEB:ENST00000427231:missense:MODERATE:exon173/182:c.24433G>C:p.Ala8145Pro,NEB:ENST00000397336:missense:MODERATE:exon6/15:c.358G>C:p.Ala120Pro,NEB:ENST00000172853:missense:MODERATE:exon140/149:c.18865G>C:p.Ala6289Pro,NEB:ENST00000509223:missense:MODERATE:exon5/13:c.265G>C:p.Ala89Pro,NEB:ENST00000603639:missense:MODERATE:exon171/180:c.24433G>C:p.Ala8145Pro,NEB:ENST00000604864:missense:MODERATE:exon171/180:c.24433G>C:p.Ala8145Pro		rs7575451	0.6278	0.6499	24235,13117,1701	0.5989,0.7603,0.7772,0.6488,0.5238	0.6500	3.0990	T,T,T,T,T,T,T,T,.,.	T,T,.	B,B,B,B,.,.	T,T,T,T,T,T,T,T,.,.	23.20	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	RCV000081126.9 [other]; RCV000266979.1 [benign]; 		COSM4154530, COSM4154529, COSM4154531	863	944	2	[2] auto-classification 14.09.2017  			NEB (inh=AR pLI=0.00), RIF1 (inh=n/a pLI=1.00)
chr2	152354239	152354239	G	A	het	anno_omim	QUAL=4768;DP=187;AF=0.50;MQM=58;TRIO=HET,187,0.50,HET,221,0.43,WT,314,0.00	NEB,RIF1	splice_region&intron,intron	NEB:ENST00000397345:splice_region&intron:LOW:exon170/181:c.24208-7C>T:,NEB:ENST00000427231:splice_region&intron:LOW:exon170/181:c.24208-7C>T:,NEB:ENST00000397336:splice_region&intron:LOW:exon3/14:c.133-7C>T:,NEB:ENST00000603639:splice_region&intron:LOW:exon168/179:c.24208-7C>T:,NEB:ENST00000604864:splice_region&intron:LOW:exon168/179:c.24208-7C>T:,NEB:ENST00000409198:intron:MODIFIER:exon140/149:c.18826-1357C>T:,NEB:ENST00000172853:intron:MODIFIER:exon139/148:c.18826-1357C>T:,NEB:ENST00000509223:intron:MODIFIER:exon4/12:c.226-1357C>T:		rs113048349	0.0050	0.0160	2,1,0	0.0036,0.0070,0.0000,0.0228,0.0135	0.0105							161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	RCV000223141.2 [other]; 			0	44					NEB (inh=AR pLI=0.00), RIF1 (inh=n/a pLI=1.00)
chr2	152387553	152387553	T	C	hom	gene_blacklist;anno_omim	QUAL=36292;DP=376;AF=1.00;MQM=60;TRIO=HOM,376,1.00,HOM,311,0.99,HOM,450,1.00	NEB	synonymous	NEB:ENST00000397345:synonymous:LOW:exon145/182:c.21585A>G:p.Thr7195Thr,NEB:ENST00000409198:synonymous:LOW:exon118/150:c.16482A>G:p.Thr5494Thr,NEB:ENST00000427231:synonymous:LOW:exon145/182:c.21585A>G:p.Thr7195Thr,NEB:ENST00000172853:synonymous:LOW:exon117/149:c.16482A>G:p.Thr5494Thr,NEB:ENST00000603639:synonymous:LOW:exon143/180:c.21585A>G:p.Thr7195Thr,NEB:ENST00000604864:synonymous:LOW:exon143/180:c.21585A>G:p.Thr7195Thr		rs4664475	0.4916	0.5830	20606,12509,761	0.3977,0.7277,0.5825,0.6176,0.4196	0.5888							161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	RCV000081120.9 [other]; RCV000375369.1 [benign]; 			762	986	2	[2] auto-classification 14.09.2017  			NEB (inh=AR pLI=0.00)
chr2	152388416	152388416	T	-	hom	gene_blacklist;anno_omim	QUAL=18751;DP=190;AF=1.00;MQM=59;TRIO=HOM,190,1.00,HOM,153,1.00,HOM,259,1.00	NEB	splice_region&intron	NEB:ENST00000397345:splice_region&intron:LOW:exon143/181:c.21418-6delA:,NEB:ENST00000409198:splice_region&intron:LOW:exon116/149:c.16315-6delA:,NEB:ENST00000427231:splice_region&intron:LOW:exon143/181:c.21418-6delA:,NEB:ENST00000172853:splice_region&intron:LOW:exon115/148:c.16315-6delA:,NEB:ENST00000603639:splice_region&intron:LOW:exon141/179:c.21418-6delA:,NEB:ENST00000604864:splice_region&intron:LOW:exon141/179:c.21418-6delA:		rs398090759	0.4912	0.6045	14652,8850,622	0.4280,0.7502,0.6228,0.6463,0.4319	0.5904							161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	RCV000081118.5 [benign]; RCV000305612.1 [benign]; 			758	983	2	[2] auto-classification 14.09.2017  			NEB (inh=AR pLI=0.00)
chr2	152422076	152422076	C	G	het	gene_blacklist;pred_pathogenic;anno_omim	QUAL=20112;DP=415;AF=0.47;MQM=60;TRIO=HET,415,0.47,HET,275,0.55,HOM,328,1.00	NEB	missense	NEB:ENST00000397345:missense:MODERATE:exon116/182:c.18305G>C:p.Arg6102Thr,NEB:ENST00000409198:missense:MODERATE:exon89/150:c.13202G>C:p.Arg4401Thr,NEB:ENST00000427231:missense:MODERATE:exon116/182:c.18305G>C:p.Arg6102Thr,NEB:ENST00000172853:missense:MODERATE:exon88/149:c.13202G>C:p.Arg4401Thr,NEB:ENST00000603639:missense:MODERATE:exon114/180:c.18305G>C:p.Arg6102Thr,NEB:ENST00000604864:missense:MODERATE:exon114/180:c.18305G>C:p.Arg6102Thr		rs2288210	0.6532	0.6707	24879,13497,1824	0.6339,0.7729,0.8003,0.6676,0.5530	0.6716	5.7170	T,T,T,T,T,T	T	B	T,T,T,T,T	15.63	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	RCV000081115.9 [other]; RCV000293399.1 [benign]; 		COSM4154536, COSM4154537, COSM4154535	901	937	2	[2] auto-classification 14.09.2017  			NEB (inh=AR pLI=0.00)
chr2	152424933	152424933	-	A	het	gene_blacklist;anno_omim	QUAL=2695;DP=139;AF=0.32;MQM=59;TRIO=HET,139,0.32,HET,77,0.44,HOM,84,0.83	NEB	splice_region&intron	NEB:ENST00000397345:splice_region&intron:LOW:exon111/181:c.17635-3dupT:,NEB:ENST00000409198:splice_region&intron:LOW:exon84/149:c.12532-3dupT:,NEB:ENST00000427231:splice_region&intron:LOW:exon111/181:c.17635-3dupT:,NEB:ENST00000172853:splice_region&intron:LOW:exon83/148:c.12532-3dupT:,NEB:ENST00000603639:splice_region&intron:LOW:exon109/179:c.17635-3dupT:,NEB:ENST00000604864:splice_region&intron:LOW:exon109/179:c.17635-3dupT:		rs3214503;rs397772995;rs539518038	0.5066	0.4669	2228,1284,229	0.4626,0.4910,0.5069,0.4703,0.4028	0.6575							161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	RCV000305873.1 [benign]; 		COSM1613493, COSM1613494, COSM1613492	597	983	2	[2] auto-classification 14.09.2017  			NEB (inh=AR pLI=0.00)
chr2	152432311	152432311	T	C	het	gene_blacklist;anno_omim	QUAL=4116;DP=220;AF=0.46;MQM=60;TRIO=HET,220,0.46,HET,117,0.48,WT,160,0.00	NEB	splice_region&synonymous	NEB:ENST00000397345:splice_region&synonymous:LOW:exon107/182:c.16911A>G:p.Pro5637Pro,NEB:ENST00000409198:splice_region&synonymous:LOW:exon80/150:c.11808A>G:p.Pro3936Pro,NEB:ENST00000427231:splice_region&synonymous:LOW:exon107/182:c.16911A>G:p.Pro5637Pro,NEB:ENST00000172853:splice_region&synonymous:LOW:exon79/149:c.11808A>G:p.Pro3936Pro,NEB:ENST00000603639:splice_region&synonymous:LOW:exon105/180:c.16911A>G:p.Pro5637Pro,NEB:ENST00000604864:splice_region&synonymous:LOW:exon105/180:c.16911A>G:p.Pro5637Pro		rs33988153	0.1102	0.1984	2894,2179,12	0.0411,0.0931,0.0010,0.2562,0.2122	0.1971							161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	RCV000081112.9 [other]; RCV000333036.1 [likely benign]; 		COSM3757669, COSM3757668, COSM3757670	137	778	2	[2] auto-classification 14.09.2017  			NEB (inh=AR pLI=0.00)
chr2	152490458	152490458	A	G	hom	gene_blacklist;pred_pathogenic;anno_omim	QUAL=45358;DP=402;AF=1.00;MQM=59;TRIO=HOM,402,1.00,HOM,434,1.00,HOM,605,1.00	NEB	missense,intron	NEB:ENST00000397345:missense:MODERATE:exon65/182:c.9124T>C:p.Cys3042Arg,NEB:ENST00000427231:missense:MODERATE:exon65/182:c.9124T>C:p.Cys3042Arg,NEB:ENST00000603639:missense:MODERATE:exon63/180:c.9124T>C:p.Cys3042Arg,NEB:ENST00000604864:missense:MODERATE:exon63/180:c.9124T>C:p.Cys3042Arg,NEB:ENST00000409198:intron:MODIFIER:exon62/149:c.8854-2766T>C:,NEB:ENST00000172853:intron:MODIFIER:exon62/148:c.8890-3125T>C:		rs6710212	0.9720	0.9928	59546,33349,4133	0.9184,0.9966,1.0000,0.9997,0.9999	0.9943	1.6720	T,T	T		T,T	9.50	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	RCV000215771.2 [benign]; 			2099	5	2	[2] auto-classification 14.09.2017  			NEB (inh=AR pLI=0.00)
chr2	152496526	152496526	A	G	het	gene_blacklist;pred_pathogenic;anno_omim	QUAL=7721;DP=181;AF=0.49;MQM=60;TRIO=HET,181,0.49,HET,204,0.47,HET,288,0.47	NEB	missense	NEB:ENST00000397345:missense:MODERATE:exon62/182:c.8734T>C:p.Ser2912Pro,NEB:ENST00000409198:missense:MODERATE:exon62/150:c.8734T>C:p.Ser2912Pro,NEB:ENST00000427231:missense:MODERATE:exon62/182:c.8734T>C:p.Ser2912Pro,NEB:ENST00000172853:missense:MODERATE:exon62/149:c.8734T>C:p.Ser2912Pro,NEB:ENST00000603639:missense:MODERATE:exon60/180:c.8734T>C:p.Ser2912Pro,NEB:ENST00000604864:missense:MODERATE:exon60/180:c.8734T>C:p.Ser2912Pro		rs6713162	0.4453	0.2540	5615,909,2004	0.6351,0.1377,0.5970,0.1637,0.3469	0.3143	5.5460	T,T,T,T	T	B	T,T,T,T	16.29	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	RCV000117776.4 [other]; RCV000383498.1 [benign]; 		COSM148951, COSM3757671, COSM3757672	124	619	2	[2] auto-classification 14.09.2017  			NEB (inh=AR pLI=0.00)
chr2	152497088	152497088	G	A	het	gene_blacklist;anno_omim	QUAL=13542;DP=439;AF=0.47;MQM=53;TRIO=HET,439,0.47,HET,712,0.47,WT,902,0.00	NEB	synonymous	NEB:ENST00000397345:synonymous:LOW:exon61/182:c.8466C>T:p.His2822His,NEB:ENST00000409198:synonymous:LOW:exon61/150:c.8466C>T:p.His2822His,NEB:ENST00000427231:synonymous:LOW:exon61/182:c.8466C>T:p.His2822His,NEB:ENST00000172853:synonymous:LOW:exon61/149:c.8466C>T:p.His2822His,NEB:ENST00000603639:synonymous:LOW:exon59/180:c.8466C>T:p.His2822His,NEB:ENST00000604864:synonymous:LOW:exon59/180:c.8466C>T:p.His2822His		rs61730771	0.0323	0.0216	35,6,9	0.0468,0.0092,0.0036,0.0177,0.0450	0.0226							161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	RCV000117774.4 [other]; RCV000313699.1 [likely benign]; 		COSM3694907, COSM3694906, COSM3694905	1	93					NEB (inh=AR pLI=0.00)
chr2	152499143	152499143	C	T	het	gene_blacklist;pred_pathogenic;anno_omim	QUAL=7419;DP=245;AF=0.56;MQM=60;TRIO=HET,245,0.56,HET,275,0.50,WT,378,0.00	NEB	missense	NEB:ENST00000397345:missense:MODERATE:exon60/182:c.8318G>A:p.Arg2773Gln,NEB:ENST00000409198:missense:MODERATE:exon60/150:c.8318G>A:p.Arg2773Gln,NEB:ENST00000427231:missense:MODERATE:exon60/182:c.8318G>A:p.Arg2773Gln,NEB:ENST00000172853:missense:MODERATE:exon60/149:c.8318G>A:p.Arg2773Gln,NEB:ENST00000603639:missense:MODERATE:exon58/180:c.8318G>A:p.Arg2773Gln,NEB:ENST00000604864:missense:MODERATE:exon58/180:c.8318G>A:p.Arg2773Gln		rs35974308	0.0206	0.0236	37,16,0	0.0050,0.0083,0.0119,0.0259,0.0460	0.0237	3.9180	T,D,D,T	T	D	T,T,T,T	26.40	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	RCV000117773.4 [other]; RCV000300645.1 [likely benign]; 		COSM3757674, COSM3757673, COSM3757675	2	115					NEB (inh=AR pLI=0.00)
chr2	152511778	152511778	A	C	het	gene_blacklist;anno_omim	QUAL=4466;DP=124;AF=0.58;MQM=60;TRIO=HET,124,0.58,HET,71,0.52,HET,86,0.62	NEB	splice_region&intron	NEB:ENST00000397345:splice_region&intron:LOW:exon51/181:c.6807+6T>G:,NEB:ENST00000409198:splice_region&intron:LOW:exon51/149:c.6807+6T>G:,NEB:ENST00000427231:splice_region&intron:LOW:exon51/181:c.6807+6T>G:,NEB:ENST00000172853:splice_region&intron:LOW:exon51/148:c.6807+6T>G:,NEB:ENST00000603639:splice_region&intron:LOW:exon49/179:c.6807+6T>G:,NEB:ENST00000604864:splice_region&intron:LOW:exon49/179:c.6807+6T>G:		rs10930723	0.4309	0.3411	5084,857,1656	0.6326,0.2144,0.6622,0.2418,0.4015	0.3009							161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	RCV000117771.8 [other]; RCV000335316.1 [benign]; 			119	623	2	[2] auto-classification 14.09.2017  			NEB (inh=AR pLI=0.00)
chr2	152521096	152521096	C	T	het	gene_blacklist;anno_omim	QUAL=3490;DP=169;AF=0.44;MQM=60;TRIO=HET,169,0.44,HET,62,0.40,HET,85,0.46	NEB	synonymous	NEB:ENST00000397345:synonymous:LOW:exon44/182:c.5370G>A:p.Glu1790Glu,NEB:ENST00000409198:synonymous:LOW:exon44/150:c.5370G>A:p.Glu1790Glu,NEB:ENST00000427231:synonymous:LOW:exon44/182:c.5370G>A:p.Glu1790Glu,NEB:ENST00000172853:synonymous:LOW:exon44/149:c.5370G>A:p.Glu1790Glu,NEB:ENST00000603639:synonymous:LOW:exon42/180:c.5370G>A:p.Glu1790Glu,NEB:ENST00000604864:synonymous:LOW:exon42/180:c.5370G>A:p.Glu1790Glu		rs10170273	0.4349	0.3018	4373,710,1512	0.6146,0.1809,0.6052,0.2091,0.3776	0.3056							161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	RCV000117761.4 [other]; RCV000376756.1 [benign]; 		COSM3757676, COSM148953, COSM3757677	120	632	2	[2] auto-classification 14.09.2017  			NEB (inh=AR pLI=0.00)
chr2	152527572	152527572	C	T	het	gene_blacklist;pred_pathogenic;anno_omim	QUAL=14815;DP=303;AF=0.51;MQM=59;TRIO=HET,303,0.51,HET,314,0.54,HET,432,0.56	NEB	missense	NEB:ENST00000397345:missense:MODERATE:exon38/182:c.4471G>A:p.Val1491Met,NEB:ENST00000409198:missense:MODERATE:exon38/150:c.4471G>A:p.Val1491Met,NEB:ENST00000427231:missense:MODERATE:exon38/182:c.4471G>A:p.Val1491Met,NEB:ENST00000172853:missense:MODERATE:exon38/149:c.4471G>A:p.Val1491Met,NEB:ENST00000603639:missense:MODERATE:exon36/180:c.4471G>A:p.Val1491Met,NEB:ENST00000604864:missense:MODERATE:exon36/180:c.4471G>A:p.Val1491Met		rs7426114	0.5331	0.7386	34995,23317,423	0.2824,0.8616,0.4071,0.8357,0.6491	0.7518	2.6960	D,T,T,D	T	B	T,T,T,T	25.80	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	RCV000081137.9 [other]; RCV000348796.1 [benign]; 	CM1414605 [CLASS=DP MUT=ALT PHEN="Stress fracture association with" GENE=NEB]; 	COSM4001231, COSM4001233, COSM4001232	1356	626	2	[2] auto-classification 14.09.2017  			NEB (inh=AR pLI=0.00)
chr2	152527608	152527608	C	T	het	gene_blacklist;anno_omim	QUAL=13856;DP=330;AF=0.49;MQM=60;TRIO=HET,330,0.49,HET,368,0.45,HET,515,0.43	NEB	missense	NEB:ENST00000397345:missense:MODERATE:exon38/182:c.4435G>A:p.Val1479Ile,NEB:ENST00000409198:missense:MODERATE:exon38/150:c.4435G>A:p.Val1479Ile,NEB:ENST00000427231:missense:MODERATE:exon38/182:c.4435G>A:p.Val1479Ile,NEB:ENST00000172853:missense:MODERATE:exon38/149:c.4435G>A:p.Val1479Ile,NEB:ENST00000603639:missense:MODERATE:exon36/180:c.4435G>A:p.Val1479Ile,NEB:ENST00000604864:missense:MODERATE:exon36/180:c.4435G>A:p.Val1479Ile		rs34577613	0.3353	0.1899	3255,393,738	0.3894,0.1048,0.5497,0.1104,0.2944	0.2132	0.0190	T,T,T,T	T	B	T,T,T,T	12.95	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	RCV000117759.4 [other]; RCV000402157.1 [benign]; 		COSM3757679, COSM3757678, COSM148955	65	476	2	[2] auto-classification 14.09.2017  			NEB (inh=AR pLI=0.00)
chr2	152527636	152527636	C	G	het	gene_blacklist;pred_pathogenic;anno_omim	QUAL=10215;DP=424;AF=0.48;MQM=60;TRIO=HET,424,0.48,HET,401,0.47,WT,545,0.00	NEB	missense	NEB:ENST00000397345:missense:MODERATE:exon38/182:c.4407G>C:p.Glu1469Asp,NEB:ENST00000409198:missense:MODERATE:exon38/150:c.4407G>C:p.Glu1469Asp,NEB:ENST00000427231:missense:MODERATE:exon38/182:c.4407G>C:p.Glu1469Asp,NEB:ENST00000172853:missense:MODERATE:exon38/149:c.4407G>C:p.Glu1469Asp,NEB:ENST00000603639:missense:MODERATE:exon36/180:c.4407G>C:p.Glu1469Asp,NEB:ENST00000604864:missense:MODERATE:exon36/180:c.4407G>C:p.Glu1469Asp		rs34800215	0.0272	0.0201	37,6,20	0.0538,0.0087,0.0037,0.0179,0.0290	0.0258	0.3640	T,T,T,T	T	D	T,T,T,T	23.20	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	RCV000117758.4 [other]; RCV000313738.1 [likely benign]; 		COSM3694913, COSM3694911, COSM3694912	0	86					NEB (inh=AR pLI=0.00)
chr2	152531077	152531077	A	G	het	gene_blacklist;anno_omim	QUAL=6951;DP=256;AF=0.49;MQM=60;TRIO=HET,256,0.49,HET,148,0.43,HET,206,0.41	NEB	missense	NEB:ENST00000397345:missense:MODERATE:exon36/182:c.3901T>C:p.Tyr1301His,NEB:ENST00000409198:missense:MODERATE:exon36/150:c.3901T>C:p.Tyr1301His,NEB:ENST00000427231:missense:MODERATE:exon36/182:c.3901T>C:p.Tyr1301His,NEB:ENST00000172853:missense:MODERATE:exon36/149:c.3901T>C:p.Tyr1301His,NEB:ENST00000603639:missense:MODERATE:exon34/180:c.3901T>C:p.Tyr1301His,NEB:ENST00000604864:missense:MODERATE:exon34/180:c.3901T>C:p.Tyr1301His		rs6711382	0.7161	0.8265	41970,26480,2028	0.6398,0.9142,0.5904,0.8911,0.7114	0.8340	1.3400	T,T,T,T	T	B	T,T,T,T	14.24	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	RCV000153548.3 [benign]; 		COSM4001236, COSM4001235, COSM4001234	1589	466	2	[2] auto-classification 14.09.2017  			NEB (inh=AR pLI=0.00)
chr2	152536427	152536427	C	T	het	gene_blacklist;anno_omim	QUAL=8915;DP=293;AF=0.48;MQM=60;TRIO=HET,293,0.48,HET,398,0.52,WT,425,0.00	NEB	splice_region&intron	NEB:ENST00000397345:splice_region&intron:LOW:exon31/181:c.3147+5G>A:,NEB:ENST00000409198:splice_region&intron:LOW:exon31/149:c.3147+5G>A:,NEB:ENST00000427231:splice_region&intron:LOW:exon31/181:c.3147+5G>A:,NEB:ENST00000172853:splice_region&intron:LOW:exon31/148:c.3147+5G>A:,NEB:ENST00000603639:splice_region&intron:LOW:exon29/179:c.3147+5G>A:,NEB:ENST00000604864:splice_region&intron:LOW:exon29/179:c.3147+5G>A:		rs74859201	0.0114	0.0157	17,6,0	0.0035,0.0067,0.0037,0.0179,0.0285	0.0161							161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	RCV000117754.3 [benign]; 			0	80					NEB (inh=AR pLI=0.00)
chr2	152536498	152536498	T	A	het	gene_blacklist;pred_pathogenic;anno_omim	QUAL=23492;DP=396;AF=0.49;MQM=59;TRIO=HET,396,0.49,HET,373,0.48,HOM,420,1.00	NEB	missense	NEB:ENST00000397345:missense:MODERATE:exon31/182:c.3081A>T:p.Lys1027Asn,NEB:ENST00000409198:missense:MODERATE:exon31/150:c.3081A>T:p.Lys1027Asn,NEB:ENST00000427231:missense:MODERATE:exon31/182:c.3081A>T:p.Lys1027Asn,NEB:ENST00000172853:missense:MODERATE:exon31/149:c.3081A>T:p.Lys1027Asn,NEB:ENST00000603639:missense:MODERATE:exon29/180:c.3081A>T:p.Lys1027Asn,NEB:ENST00000604864:missense:MODERATE:exon29/180:c.3081A>T:p.Lys1027Asn		rs6735208	0.5835	0.7499	35419,23029,770	0.3860,0.8796,0.4832,0.8306,0.6387	0.7616	-0.4180	T,T,T,T	T	P	T,T,T,T	23.20	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	RCV000081134.9 [other]; RCV000265121.1 [benign]; 			1348	632	2	[2] auto-classification 14.09.2017  			NEB (inh=AR pLI=0.00)
chr2	152573981	152573981	A	G	het	gene_blacklist;anno_omim	QUAL=14852;DP=354;AF=0.46;MQM=59;TRIO=HET,354,0.46,HET,182,0.48,HOM,252,1.00	NEB	synonymous	NEB:ENST00000397345:synonymous:LOW:exon10/182:c.771T>C:p.Ala257Ala,NEB:ENST00000409198:synonymous:LOW:exon10/150:c.771T>C:p.Ala257Ala,NEB:ENST00000427231:synonymous:LOW:exon10/182:c.771T>C:p.Ala257Ala,NEB:ENST00000172853:synonymous:LOW:exon10/149:c.771T>C:p.Ala257Ala,NEB:ENST00000603639:synonymous:LOW:exon8/180:c.771T>C:p.Ala257Ala,NEB:ENST00000604864:synonymous:LOW:exon8/180:c.771T>C:p.Ala257Ala		rs4611637	0.5693	0.7438	34969,22935,596	0.3416,0.8663,0.4736,0.8293,0.6424	0.7555							161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	RCV000081142.9 [other]; RCV000374203.1 [benign]; 		COSM4001250, COSM4001251, COSM4001249	1347	642	2	[2] auto-classification 14.09.2017  			NEB (inh=AR pLI=0.00)
chr2	152580766	152580766	A	G	het	gene_blacklist;anno_omim	QUAL=4603;DP=153;AF=0.42;MQM=60;TRIO=HET,153,0.42,HET,245,0.50,WT,388,0.00	NEB	splice_region&intron	NEB:ENST00000397345:splice_region&intron:LOW:exon8/181:c.612+8T>C:,NEB:ENST00000409198:splice_region&intron:LOW:exon8/149:c.612+8T>C:,NEB:ENST00000427231:splice_region&intron:LOW:exon8/181:c.612+8T>C:,NEB:ENST00000172853:splice_region&intron:LOW:exon8/148:c.612+8T>C:,NEB:ENST00000603639:splice_region&intron:LOW:exon6/179:c.612+8T>C:,NEB:ENST00000604864:splice_region&intron:LOW:exon6/179:c.612+8T>C:		rs113095802	0.0254	0.0242	26,4,13	0.0489,0.0117,0.0048,0.0232,0.0344	0.0223							161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	RCV000117768.4 [other]; RCV000281896.1 [likely benign]; 			0	90					NEB (inh=AR pLI=0.00)
chr2	152690248	152690248	G	A	hom	anno_omim	QUAL=16516;DP=304;AF=1.00;MQM=60;TRIO=HOM,304,1.00,HOM,82,1.00,HOM,111,1.00	CACNB4	3'UTR	CACNB4:ENST00000539935:3'UTR:MODIFIER:exon14/14:c.*5385C>T:,CACNB4:ENST00000360283:3'UTR:MODIFIER:exon13/13:c.*5385C>T:		rs1568673	0.8784	0.0000	0,0,0	0,0,0,0,0	0.9362							601949 [CACNB4 (confirmed) Epilepsy,juvenile myoclonic,susceptibility to,6,607682|Epilepsy,idiopathic generalized,susceptibility to,9,607682|Episodic ataxia,type 5,613855];	RCV000270694.1 [benign]; RCV000307038.1 [benign]; 			218	13					CACNB4 (inh=AD pLI=0.01)
chr2	152691829	152691829	C	G	het	anno_omim	QUAL=6394;DP=340;AF=0.49;MQM=60;TRIO=HET,340,0.49,HET,123,0.55,WT,187,0.01	CACNB4	3'UTR	CACNB4:ENST00000539935:3'UTR:MODIFIER:exon14/14:c.*3804G>C:,CACNB4:ENST00000360283:3'UTR:MODIFIER:exon13/13:c.*3804G>C:		rs2344734	0.4603	0.0000	0,0,0	0,0,0,0,0	0.3416							601949 [CACNB4 (confirmed) Epilepsy,juvenile myoclonic,susceptibility to,6,607682|Epilepsy,idiopathic generalized,susceptibility to,9,607682|Episodic ataxia,type 5,613855];	RCV000287445.1 [benign]; RCV000342430.1 [benign]; 			10	75					CACNB4 (inh=AD pLI=0.01)
chr2	152693977	152693977	A	G	het	anno_omim	QUAL=5973;DP=311;AF=0.49;MQM=60;TRIO=HET,311,0.49,HET,134,0.50,WT,237,0.00	CACNB4	3'UTR	CACNB4:ENST00000539935:3'UTR:MODIFIER:exon14/14:c.*1656T>C:,CACNB4:ENST00000360283:3'UTR:MODIFIER:exon13/13:c.*1656T>C:		rs62174451	0.0236	0.0000	0,0,0	0,0,0,0,0	0.0266							601949 [CACNB4 (confirmed) Epilepsy,juvenile myoclonic,susceptibility to,6,607682|Epilepsy,idiopathic generalized,susceptibility to,9,607682|Episodic ataxia,type 5,613855];	RCV000274412.1 [likely benign]; RCV000389857.1 [likely benign]; 			0	12					CACNB4 (inh=AD pLI=0.01)
chr2	152695191	152695191	C	T	het	anno_omim	QUAL=2120;DP=135;AF=0.49;MQM=59;TRIO=HET,135,0.49,HET,21,0.48,WT,39,0.05	CACNB4	3'UTR	CACNB4:ENST00000539935:3'UTR:MODIFIER:exon14/14:c.*442G>A:,CACNB4:ENST00000360283:3'UTR:MODIFIER:exon13/13:c.*442G>A:,CACNB4:ENST00000534999:3'UTR:MODIFIER:exon13/13:c.*442G>A:		rs7597215	0.4842	0.0000	0,0,0	0,0,0,0,0	0.4163							601949 [CACNB4 (confirmed) Epilepsy,juvenile myoclonic,susceptibility to,6,607682|Epilepsy,idiopathic generalized,susceptibility to,9,607682|Episodic ataxia,type 5,613855];	RCV000290411.1 [benign]; RCV000347650.1 [benign]; 			7	79					CACNB4 (inh=AD pLI=0.01)
chr2	152717331	152717331	A	T	het	anno_omim	QUAL=4631;DP=227;AF=0.49;MQM=60;TRIO=HET,227,0.49,HET,185,0.52,WT,267,0.00	CACNB4	synonymous	CACNB4:ENST00000539935:synonymous:LOW:exon10/14:c.762T>A:p.Ile254Ile,CACNB4:ENST00000360283:synonymous:LOW:exon9/13:c.663T>A:p.Ile221Ile,CACNB4:ENST00000534999:synonymous:LOW:exon9/13:c.660T>A:p.Ile220Ile,CACNB4:ENST00000397327:synonymous:LOW:exon10/14:c.621T>A:p.Ile207Ile,CACNB4:ENST00000427385:synonymous:LOW:exon10/14:c.708T>A:p.Ile236Ile,CACNB4:ENST00000201943:synonymous:LOW:exon10/13:c.762T>A:p.Ile254Ile		rs61736804	0.0503	0.0330	111,21,74	0.1213,0.0142,0.0034,0.0285,0.0318	0.0523							601949 [CACNB4 (confirmed) Epilepsy,juvenile myoclonic,susceptibility to,6,607682|Epilepsy,idiopathic generalized,susceptibility to,9,607682|Episodic ataxia,type 5,613855];	RCV000116535.2 [likely benign]; RCV000287797.1 [benign]; RCV000384571.1 [benign]; 		COSM3757681, COSM3757680, COSM3757683, COSM3757682	2	168	2	[2] auto-classification 14.09.2017  			CACNB4 (inh=AD pLI=0.01)
chr2	166170127	166170127	T	C	hom	anno_omim	QUAL=20756;DP=189;AF=0.99;MQM=60;TRIO=HOM,189,0.99,HOM,189,1.00,HOM,270,1.00	SCN2A	splice_region&intron	SCN2A:ENST00000283256:splice_region&intron:LOW:exon8/26:c.1035-3T>C:,SCN2A:ENST00000357398:splice_region&intron:LOW:exon8/26:c.1035-3T>C:,SCN2A:ENST00000375437:splice_region&intron:LOW:exon8/26:c.1035-3T>C:,SCN2A:ENST00000375427:splice_region&intron:LOW:exon7/25:c.1035-3T>C:		rs2121371	0.7724	0.8016	39160,23066,3402	0.8086,0.8046,0.7750,0.8314,0.7078	0.8130							182390 [SCN2A (confirmed) Seizures,benign familial infantile,3,607745|Epileptic encephalopathy,early infantile,11,613721];	RCV000118252.2 [benign]; RCV000264306.1 [benign]; RCV000303132.1 [benign]; 			1354	654	2	[2] auto-classification 14.09.2017  			SCN2A (inh=AD pLI=1.00)
chr2	166246710	166246710	A	C	het	anno_omim;trio_denovo	QUAL=660;DP=352;AF=0.50;MQM=59;TRIO=HET,352,0.50,WT,106,0.01,WT,187,0.01	SCN2A	3'UTR	SCN2A:ENST00000283256:3'UTR:MODIFIER:exon27/27:c.*376A>C:,SCN2A:ENST00000357398:3'UTR:MODIFIER:exon27/27:c.*376A>C:,SCN2A:ENST00000375437:3'UTR:MODIFIER:exon27/27:c.*376A>C:		rs376498111	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0084							182390 [SCN2A (confirmed) Seizures,benign familial infantile,3,607745|Epileptic encephalopathy,early infantile,11,613721];				0	16					SCN2A (inh=AD pLI=1.00)
chr2	166248047	166248047	G	A	het	anno_omim	QUAL=8529;DP=360;AF=0.48;MQM=60;TRIO=HET,360,0.48,HET,122,0.44,HET,174,0.55	SCN2A	3'UTR	SCN2A:ENST00000283256:3'UTR:MODIFIER:exon27/27:c.*1713G>A:,SCN2A:ENST00000357398:3'UTR:MODIFIER:exon27/27:c.*1713G>A:,SCN2A:ENST00000375437:3'UTR:MODIFIER:exon27/27:c.*1713G>A:		rs1007722	0.3834	0.0000	0,0,0	0,0,0,0,0	0.3861							182390 [SCN2A (confirmed) Seizures,benign familial infantile,3,607745|Epileptic encephalopathy,early infantile,11,613721];	RCV000306459.1 [benign]; RCV000370498.1 [benign]; 			38	107					SCN2A (inh=AD pLI=1.00)
chr2	166847034	166847034	T	C	hom	anno_omim	QUAL=15770;DP=286;AF=1.00;MQM=60;TRIO=HOM,286,1.00,HOM,76,1.00,HOM,108,1.00	SCN1A,AC010127.3	3'UTR	SCN1A:ENST00000303395:3'UTR:MODIFIER:exon26/26:c.*721A>G:,SCN1A:ENST00000423058:3'UTR:MODIFIER:exon26/26:c.*721A>G:,SCN1A:ENST00000375405:3'UTR:MODIFIER:exon26/26:c.*721A>G:		rs4667859	0.9972	0.0000	0,0,0	0,0,0,0,0	0.9967							182389 [SCN1A (confirmed) Epilepsy,generalized,with febrile seizures plus,type 2,604403|Migraine,familial hemiplegic,3,609634|Febrile seizures,familial,3A,604403|Epileptic encephalopathy,early infantile,6,607208];	RCV000308219.1 [benign]; RCV000398925.1 [benign]; 			232	0					SCN1A (inh=AD pLI=1.00), AC010127.3 (inh=n/a pLI=n/a)
chr2	166892788	166892788	C	T	hom	pred_pathogenic;anno_omim	QUAL=17092;DP=247;AF=1.00;MQM=60;TRIO=HOM,247,1.00,HET,188,0.46,HOM,211,1.00	SCN1A,AC010127.3	missense	SCN1A:ENST00000303395:missense:MODERATE:exon16/26:c.3199G>A:p.Ala1067Thr,SCN1A:ENST00000423058:missense:MODERATE:exon16/26:c.3199G>A:p.Ala1067Thr,SCN1A:ENST00000375405:missense:MODERATE:exon16/26:c.3166G>A:p.Ala1056Thr,SCN1A:ENST00000409050:missense:MODERATE:exon16/26:c.3115G>A:p.Ala1039Thr		rs2298771	0.7885	0.7252	32206,15293,3539	0.8247,0.8208,0.8979,0.6787,0.6864	0.7482	-0.5650	T,T,T,T	T	B,B,B	D,D,D,D	12.04	182389 [SCN1A (confirmed) Epilepsy,generalized,with febrile seizures plus,type 2,604403|Migraine,familial hemiplegic,3,609634|Febrile seizures,familial,3A,604403|Epileptic encephalopathy,early infantile,6,607208];	RCV000030432.1 [benign]; RCV000079572.10 [other]; RCV000338109.1 [benign]; RCV000401331.1 [benign]; 	CM144700 [CLASS=DP MUT=ALT PHEN="Epilepsy symptomatic reduced risk" GENE=SCN1A]; 	COSM3757723, COSM3757724, COSM3757725	887	907	2	[2] auto-classification 14.09.2017  			SCN1A (inh=AD pLI=1.00), AC010127.3 (inh=n/a pLI=n/a)
chr2	166897864	166897864	A	G	hom	anno_omim	QUAL=10229;DP=157;AF=1.00;MQM=59;TRIO=HOM,157,1.00,HET,79,0.62,HOM,119,0.99	SCN1A,AC010127.3	synonymous	SCN1A:ENST00000303395:synonymous:LOW:exon13/26:c.2292T>C:p.Val764Val,SCN1A:ENST00000423058:synonymous:LOW:exon13/26:c.2292T>C:p.Val764Val,SCN1A:ENST00000375405:synonymous:LOW:exon13/26:c.2259T>C:p.Val753Val,SCN1A:ENST00000409050:synonymous:LOW:exon13/26:c.2208T>C:p.Val736Val		rs6432860	0.7889	0.7260	32433,15442,3550	0.8257,0.8211,0.8985,0.6797,0.6863	0.7483							182389 [SCN1A (confirmed) Epilepsy,generalized,with febrile seizures plus,type 2,604403|Migraine,familial hemiplegic,3,609634|Febrile seizures,familial,3A,604403|Epileptic encephalopathy,early infantile,6,607208];	RCV000030431.1 [benign]; RCV000079565.9 [other]; RCV000275349.1 [benign]; RCV000332804.1 [benign]; 		COSM3757728, COSM3757726, COSM3757727	885	910	2	[2] auto-classification 14.09.2017  			SCN1A (inh=AD pLI=1.00), AC010127.3 (inh=n/a pLI=n/a)
chr2	166897989	166897989	-	A	het	anno_omim	QUAL=543;DP=53;AF=0.47;MQM=60;TRIO=HET,53,0.47,HET,12,0.58,HOM,29,0.79	SCN1A,AC010127.3	splice_region&intron	SCN1A:ENST00000303395:splice_region&intron:LOW:exon12/25:c.2177-11dupT:,SCN1A:ENST00000423058:splice_region&intron:LOW:exon12/25:c.2177-11dupT:,SCN1A:ENST00000375405:splice_region&intron:LOW:exon12/25:c.2144-11dupT:,SCN1A:ENST00000409050:splice_region&intron:LOW:exon12/25:c.2093-11dupT:		rs11394960;rs397959165	0.4347	0.4303	1173,588,64	0.3769,0.4568,0.4824,0.4264,0.4289	0.6794							182389 [SCN1A (confirmed) Epilepsy,generalized,with febrile seizures plus,type 2,604403|Migraine,familial hemiplegic,3,609634|Febrile seizures,familial,3A,604403|Epileptic encephalopathy,early infantile,6,607208];	RCV000350738.1 [benign]; RCV000386585.1 [benign]; 			221	291	2	[2] auto-classification 14.09.2017  			SCN1A (inh=AD pLI=1.00), AC010127.3 (inh=n/a pLI=n/a)
chr2	166903445	166903445	T	C	hom	anno_omim	QUAL=11324;DP=135;AF=1.00;MQM=59;TRIO=HOM,135,1.00,HET,144,0.53,HOM,161,0.99	SCN1A,AC010127.3	synonymous	SCN1A:ENST00000303395:synonymous:LOW:exon9/26:c.1212A>G:p.Val404Val,SCN1A:ENST00000423058:synonymous:LOW:exon9/26:c.1212A>G:p.Val404Val,SCN1A:ENST00000375405:synonymous:LOW:exon9/26:c.1212A>G:p.Val404Val,SCN1A:ENST00000409050:synonymous:LOW:exon9/26:c.1212A>G:p.Val404Val		rs7580482	0.7093	0.7034	30492,15443,1727	0.5748,0.8100,0.8987,0.6798,0.6860	0.7074							182389 [SCN1A (confirmed) Epilepsy,generalized,with febrile seizures plus,type 2,604403|Migraine,familial hemiplegic,3,609634|Febrile seizures,familial,3A,604403|Epileptic encephalopathy,early infantile,6,607208];	RCV000030430.1 [benign]; RCV000079554.9 [other]; RCV000290590.1 [benign]; RCV000384881.1 [benign]; 		COSM3757729, COSM3757730, COSM3757731	873	915	2	[2] auto-classification 14.09.2017  			SCN1A (inh=AD pLI=1.00), AC010127.3 (inh=n/a pLI=n/a)
chr2	167054934	167054934	-	AATC	het	anno_omim	QUAL=4887;DP=188;AF=0.49;MQM=59;TRIO=HET,188,0.49,HET,79,0.44,HET,128,0.55	SCN9A,AC010127.3	3'UTR	SCN9A:ENST00000303354:3'UTR:MODIFIER:exon27/27:c.*244_*247dupGATT:,SCN9A:ENST00000409672:3'UTR:MODIFIER:exon27/27:c.*244_*247dupGATT:,SCN9A:ENST00000375387:3'UTR:MODIFIER:exon27/27:c.*244_*247dupGATT:		rs397744175	0.7458	0.0000	0,0,0	0,0,0,0,0	0.7659							603415 [SCN9A (confirmed) Erythermalgia,primary,133020|Paroxysmal extreme pain disorder,167400,|Insensitivity to pain,congenital,243000|Febrile seizures,familial,3B,613863|Epilepsy,generalized,with febrile seizures plus,type 7,613863|Small fiber neuropathy,133020|Dravet syndrome,modifier of,607208|HSAN2D,autosomal recessive,243000];	RCV000283356.1 [benign]; RCV000289285.1 [benign]; RCV000312409.1 [benign]; RCV000347662.1 [benign]; RCV000352131.1 [benign]; RCV000402766.1 [benign]; RCV000406754.1 [benign]; 			137	79					SCN9A (inh=AR+AD pLI=0.00), AC010127.3 (inh=n/a pLI=n/a)
chr2	167060981	167060984	AAAC	-	het	anno_omim	QUAL=4575;DP=81;AF=0.41;MQM=60;TRIO=HET,81,0.41,HET,64,0.56,HOM,100,1.00	SCN9A,AC010127.3	splice_region&intron	SCN9A:ENST00000303354:splice_region&intron:LOW:exon24/26:c.4402-10_4402-7delGTTT:,SCN9A:ENST00000409672:splice_region&intron:LOW:exon24/26:c.4366-10_4366-7delGTTT:,SCN9A:ENST00000375387:splice_region&intron:LOW:exon24/26:c.4402-10_4402-7delGTTT:,SCN9A:ENST00000409435:splice_region&intron:LOW:exon23/25:c.4399-10_4399-7delGTTT:		rs546230376	0.8988	0.8811	46221,24837,4352	0.9399,0.9088,0.9343,0.8711,0.8354	0.8965							603415 [SCN9A (confirmed) Erythermalgia,primary,133020|Paroxysmal extreme pain disorder,167400,|Insensitivity to pain,congenital,243000|Febrile seizures,familial,3B,613863|Epilepsy,generalized,with febrile seizures plus,type 7,613863|Small fiber neuropathy,133020|Dravet syndrome,modifier of,607208|HSAN2D,autosomal recessive,243000];	RCV000153913.4 [benign]; RCV000264835.1 [benign]; RCV000270584.1 [benign]; RCV000300254.1 [benign]; RCV000324833.1 [benign]; RCV000359605.1 [benign]; RCV000360774.1 [benign]; RCV000405665.1 [benign]; 	CD072486 [CLASS=R MUT=ALT PHEN="Congenital indifference to pain" GENE=SCN9A]; 		1320	428	1	[1] old entry - no details available			SCN9A (inh=AR+AD pLI=0.00), AC010127.3 (inh=n/a pLI=n/a)
chr2	167099158	167099158	A	G	het	pred_pathogenic;anno_omim	QUAL=12011;DP=228;AF=0.53;MQM=60;TRIO=HET,228,0.53,HET,177,0.51,HOM,201,1.00	SCN9A,AC010127.3	missense	SCN9A:ENST00000303354:missense:MODERATE:exon19/27:c.3484T>C:p.Trp1162Arg,SCN9A:ENST00000409672:missense:MODERATE:exon19/27:c.3448T>C:p.Trp1150Arg,SCN9A:ENST00000375387:missense:MODERATE:exon19/27:c.3484T>C:p.Trp1162Arg,SCN9A:ENST00000409435:missense:MODERATE:exon18/26:c.3481T>C:p.Trp1161Arg		rs6746030	0.8872	0.8693	9228,4075,1003	0.8944,0.8647,0.9543,0.8730,0.8440	0.8858	0.9510	T,T,T,T	T	B	D,D,D,D	9.09	603415 [SCN9A (confirmed) Erythermalgia,primary,133020|Paroxysmal extreme pain disorder,167400,|Insensitivity to pain,congenital,243000|Febrile seizures,familial,3B,613863|Epilepsy,generalized,with febrile seizures plus,type 7,613863|Small fiber neuropathy,133020|Dravet syndrome,modifier of,607208|HSAN2D,autosomal recessive,243000];				1584	477	2	[2] auto-classification 14.09.2017  			SCN9A (inh=AR+AD pLI=0.00), AC010127.3 (inh=n/a pLI=n/a)
chr2	167144974	167144974	A	T	het	anno_omim	QUAL=1668;DP=106;AF=0.51;MQM=60;TRIO=HET,106,0.51,HET,53,0.36,WT,83,0.00	SCN9A,AC010127.3	synonymous	SCN9A:ENST00000303354:synonymous:LOW:exon10/27:c.1290T>A:p.Arg430Arg,SCN9A:ENST00000409672:synonymous:LOW:exon10/27:c.1287T>A:p.Arg429Arg,SCN9A:ENST00000375387:synonymous:LOW:exon10/27:c.1290T>A:p.Arg430Arg,SCN9A:ENST00000409435:synonymous:LOW:exon9/26:c.1287T>A:p.Arg429Arg		rs6747673	0.5467	0.4944	15287,7551,2822	0.7591,0.5498,0.3871,0.4744,0.4388	0.5661							603415 [SCN9A (confirmed) Erythermalgia,primary,133020|Paroxysmal extreme pain disorder,167400,|Insensitivity to pain,congenital,243000|Febrile seizures,familial,3B,613863|Epilepsy,generalized,with febrile seizures plus,type 7,613863|Small fiber neuropathy,133020|Dravet syndrome,modifier of,607208|HSAN2D,autosomal recessive,243000];	RCV000118293.4 [other]; RCV000267710.1 [benign]; RCV000282544.1 [benign]; RCV000292831.1 [benign]; RCV000317687.1 [benign]; RCV000318943.1 [benign]; RCV000372285.1 [benign]; RCV000387463.1 [benign]; 		COSM4001294, COSM4001293	483	977	2	[2] auto-classification 14.09.2017  			SCN9A (inh=AR+AD pLI=0.00), AC010127.3 (inh=n/a pLI=n/a)
chr2	167144995	167144995	T	C	het	anno_omim	QUAL=2355;DP=158;AF=0.48;MQM=60;TRIO=HET,158,0.48,HET,57,0.35,WT,96,0.01	SCN9A,AC010127.3	synonymous	SCN9A:ENST00000303354:synonymous:LOW:exon10/27:c.1269A>G:p.Glu423Glu,SCN9A:ENST00000409672:synonymous:LOW:exon10/27:c.1266A>G:p.Glu422Glu,SCN9A:ENST00000375387:synonymous:LOW:exon10/27:c.1269A>G:p.Glu423Glu,SCN9A:ENST00000409435:synonymous:LOW:exon9/26:c.1266A>G:p.Glu422Glu		rs13402180	0.3544	0.3730	8581,5243,710	0.3789,0.2689,0.3228,0.3958,0.3568	0.3997							603415 [SCN9A (confirmed) Erythermalgia,primary,133020|Paroxysmal extreme pain disorder,167400,|Insensitivity to pain,congenital,243000|Febrile seizures,familial,3B,613863|Epilepsy,generalized,with febrile seizures plus,type 7,613863|Small fiber neuropathy,133020|Dravet syndrome,modifier of,607208|HSAN2D,autosomal recessive,243000];	RCV000118292.4 [other]; RCV000289711.1 [benign]; RCV000309654.1 [benign]; RCV000344725.1 [benign]; RCV000352364.1 [benign]; RCV000359549.1 [benign]; RCV000397247.1 [benign]; RCV000399562.1 [benign]; 		COSM3757732, COSM3757733	302	929	2	[2] auto-classification 14.09.2017  			SCN9A (inh=AR+AD pLI=0.00), AC010127.3 (inh=n/a pLI=n/a)
chr2	167145142	167145142	A	G	het	anno_omim	QUAL=1915;DP=116;AF=0.52;MQM=60;TRIO=HET,116,0.52,HET,41,0.46,WT,57,0.00	SCN9A,AC010127.3	synonymous	SCN9A:ENST00000303354:synonymous:LOW:exon10/27:c.1122T>C:p.Ala374Ala,SCN9A:ENST00000409672:synonymous:LOW:exon10/27:c.1119T>C:p.Ala373Ala,SCN9A:ENST00000375387:synonymous:LOW:exon10/27:c.1122T>C:p.Ala374Ala,SCN9A:ENST00000409435:synonymous:LOW:exon9/26:c.1119T>C:p.Ala373Ala		rs13414203	0.3544	0.3740	8517,5205,702	0.3810,0.2698,0.3228,0.3965,0.3581	0.3995							603415 [SCN9A (confirmed) Erythermalgia,primary,133020|Paroxysmal extreme pain disorder,167400,|Insensitivity to pain,congenital,243000|Febrile seizures,familial,3B,613863|Epilepsy,generalized,with febrile seizures plus,type 7,613863|Small fiber neuropathy,133020|Dravet syndrome,modifier of,607208|HSAN2D,autosomal recessive,243000];	RCV000118290.4 [other]; RCV000271006.1 [benign]; RCV000286417.1 [benign]; RCV000321452.1 [benign]; RCV000341529.1 [benign]; RCV000372805.1 [benign]; RCV000376267.1 [benign]; RCV000384212.1 [benign]; 			302	926	2	[2] auto-classification 14.09.2017  			SCN9A (inh=AR+AD pLI=0.00), AC010127.3 (inh=n/a pLI=n/a)
chr2	167163043	167163043	T	C	het	anno_omim	QUAL=6253;DP=243;AF=0.36;MQM=60;TRIO=HET,243,0.36,HET,137,0.55,HET,139,0.56	SCN9A	synonymous	SCN9A:ENST00000303354:synonymous:LOW:exon4/27:c.447A>G:p.Pro149Pro,SCN9A:ENST00000409672:synonymous:LOW:exon4/27:c.444A>G:p.Pro148Pro,SCN9A:ENST00000375387:synonymous:LOW:exon4/27:c.447A>G:p.Pro149Pro,SCN9A:ENST00000409435:synonymous:LOW:exon3/26:c.444A>G:p.Pro148Pro		rs9646771	0.6412	0.6841	14286,7626,2360	0.8480,0.6946,0.5441,0.6928,0.6177	0.6964							603415 [SCN9A (confirmed) Erythermalgia,primary,133020|Paroxysmal extreme pain disorder,167400,|Insensitivity to pain,congenital,243000|Febrile seizures,familial,3B,613863|Epilepsy,generalized,with febrile seizures plus,type 7,613863|Small fiber neuropathy,133020|Dravet syndrome,modifier of,607208|HSAN2D,autosomal recessive,243000];	RCV000118307.3 [other]; RCV000283990.1 [benign]; RCV000297056.1 [benign]; RCV000341457.1 [benign]; RCV000354313.1 [benign]; RCV000390493.1 [benign]; RCV000396292.1 [benign]; RCV000400502.1 [benign]; 		COSM3933365, COSM3933366	877	947	2	[2] auto-classification 14.09.2017  			SCN9A (inh=AR+AD pLI=0.00)
chr2	167168093	167168093	C	T	het	anno_omim	QUAL=11464;DP=296;AF=0.56;MQM=60;TRIO=HET,296,0.56,HET,256,0.53,HET,313,0.51	SCN9A	synonymous	SCN9A:ENST00000303354:synonymous:LOW:exon2/27:c.174G>A:p.Gln58Gln,SCN9A:ENST00000409672:synonymous:LOW:exon2/27:c.174G>A:p.Gln58Gln,SCN9A:ENST00000375387:synonymous:LOW:exon2/27:c.174G>A:p.Gln58Gln,SCN9A:ENST00000409435:synonymous:LOW:exon1/26:c.174G>A:p.Gln58Gln		rs6432901	0.5743	0.5874	21462,13126,2784	0.7515,0.4332,0.4391,0.6253,0.5472	0.6397							603415 [SCN9A (confirmed) Erythermalgia,primary,133020|Paroxysmal extreme pain disorder,167400,|Insensitivity to pain,congenital,243000|Febrile seizures,familial,3B,613863|Epilepsy,generalized,with febrile seizures plus,type 7,613863|Small fiber neuropathy,133020|Dravet syndrome,modifier of,607208|HSAN2D,autosomal recessive,243000];	RCV000118295.3 [other]; RCV000265880.1 [benign]; RCV000271887.1 [benign]; RCV000310588.1 [benign]; RCV000323339.1 [benign]; RCV000358311.1 [benign]; RCV000363455.1 [benign]; RCV000380181.1 [benign]; 			773	972	2	[2] auto-classification 14.09.2017  			SCN9A (inh=AR+AD pLI=0.00)
chr2	169828367	169828367	T	G	het	pred_pathogenic;anno_omim	QUAL=69;DP=112;AF=0.47;MQM=60;TRIO=HET,112,0.47,WT,155,0.01,WT,208,0.00	ABCB11	missense	ABCB11:ENST00000263817:missense:MODERATE:exon14/28:c.1628A>C:p.Asp543Ala		rs200687717	0.0000	0.1037	0,0,0	0.1389,0.1541,0.1632,0.0886,0.0311	0.0510	1.8360	T	T	B	D	15.29	603201 [ABCB11 (confirmed) Cholestasis,progressive familial intrahepatic 2,601847|Cholestasis,benign recurrent intrahepatic,2,605479];			COSM3736641, COSM3736640	0	43	2	[2] auto-classification 14.09.2017  			ABCB11 (inh=AR pLI=0.00)
chr2	169830328	169830328	A	G	het	pred_pathogenic;anno_omim	QUAL=19410;DP=454;AF=0.51;MQM=60;TRIO=HET,454,0.51,HET,277,0.47,HOM,305,1.00	ABCB11	missense	ABCB11:ENST00000263817:missense:MODERATE:exon13/28:c.1331T>C:p.Val444Ala		rs2287622	0.5887	0.5794	20582,11827,1670	0.5795,0.4204,0.7293,0.5943,0.5808	0.5706	2.0330	T	T	B	D	15.16	603201 [ABCB11 (confirmed) Cholestasis,progressive familial intrahepatic 2,601847|Cholestasis,benign recurrent intrahepatic,2,605479];	RCV000174528.2 [benign]; RCV000273829.1 [benign]; 	CM071525 [CLASS=DFP MUT=ALT PHEN="Cholestasis drug-induced association with" GENE=ABCB11]; 		771	977	2	[2] auto-classification 14.09.2017  			ABCB11 (inh=AR pLI=0.00)
chr2	169984262	169984262	-	T	hom	anno_omim	QUAL=9749;DP=202;AF=0.81;MQM=59;TRIO=HOM,202,0.81,HOM,120,0.89,HET,169,0.46	LRP2	3'UTR	LRP2:ENST00000263816:3'UTR:MODIFIER:exon79/79:c.*910dupA:		rs11411235;rs397941904	0.6619	0.0000	0,0,0	0,0,0,0,0	0.7029							600073 [LRP2 (confirmed) Donnai-Barrow syndrome,222448];	RCV000296745.1 [benign]; 			95	127					LRP2 (inh=AR pLI=1.00)
chr2	170003432	170003432	T	G	hom	pred_pathogenic;anno_omim	QUAL=18211;DP=186;AF=1.00;MQM=60;TRIO=HOM,186,1.00,HOM,176,1.00,HOM,210,1.00	LRP2	missense	LRP2:ENST00000263816:missense:MODERATE:exon69/79:c.12628A>C:p.Ile4210Leu		rs4667591	0.5559	0.7176	32407,20298,321	0.2376,0.7843,0.4631,0.7851,0.8086	0.7262	6.2840	D	T	D	D	31.00	600073 [LRP2 (confirmed) Donnai-Barrow syndrome,222448];	RCV000117509.3 [other]; RCV000372220.1 [benign]; 		COSM1401028	1331	679	2	[2] auto-classification 14.09.2017  			LRP2 (inh=AR pLI=1.00)
chr2	170010985	170010985	T	C	hom	pred_pathogenic;anno_omim	QUAL=23381;DP=340;AF=1.00;MQM=60;TRIO=HOM,340,1.00,HOM,153,1.00,HOM,211,0.99	LRP2	missense	LRP2:ENST00000263816:missense:MODERATE:exon66/79:c.12280A>G:p.Lys4094Glu		rs2075252	0.7780	0.7621	35867,18792,4168	0.8951,0.8038,0.4841,0.7491,0.8625	0.7846	4.7880	T	T	B	D	16.49	600073 [LRP2 (confirmed) Donnai-Barrow syndrome,222448];	RCV000117508.3 [other]; RCV000310751.1 [benign]; 		COSM4001308	1350	666	2	[2] auto-classification 14.09.2017  			LRP2 (inh=AR pLI=1.00)
chr2	170025083	170025083	A	G	het	pred_pathogenic;anno_omim	QUAL=10280;DP=426;AF=0.50;MQM=59;TRIO=HET,426,0.50,WT,251,0.00,HET,357,0.51	LRP2	synonymous	LRP2:ENST00000263816:synonymous:LOW:exon61/79:c.11601T>C:p.Cys3867Cys		rs2229268	0.1907	0.2026	2904,1434,12	0.0351,0.1004,0.3286,0.2068,0.2909	0.2033	2.0780	T	T			4.95	600073 [LRP2 (confirmed) Donnai-Barrow syndrome,222448];	RCV000117501.3 [other]; RCV000263671.1 [benign]; 		COSM4133221	91	718	2	[2] auto-classification 14.09.2017  			LRP2 (inh=AR pLI=1.00)
chr2	170032989	170032989	C	T	het	anno_omim	QUAL=18613;DP=392;AF=0.46;MQM=59;TRIO=HET,392,0.46,HOM,300,1.00,HET,417,0.45	LRP2	synonymous	LRP2:ENST00000263816:synonymous:LOW:exon54/79:c.10503G>A:p.Gln3501Gln		rs2229265	0.3796	0.4725	14603,8567,539	0.3189,0.6766,0.1026,0.5066,0.4887	0.4826							600073 [LRP2 (confirmed) Donnai-Barrow syndrome,222448];	RCV000117498.3 [other]; RCV000300800.1 [benign]; 		COSM4133222	598	1039	2	[2] auto-classification 14.09.2017  			LRP2 (inh=AR pLI=1.00)
chr2	170092395	170092395	A	G	het	anno_omim	QUAL=8650;DP=161;AF=0.52;MQM=60;TRIO=HET,161,0.52,WT,313,0.00,HET,448,0.55	LRP2	synonymous	LRP2:ENST00000263816:synonymous:LOW:exon29/79:c.4875T>C:p.Cys1625Cys		rs2229267	0.4613	0.3337	7934,2189,2243	0.6555,0.4998,0.4107,0.2497,0.3693	0.3746							600073 [LRP2 (confirmed) Donnai-Barrow syndrome,222448];	RCV000117534.3 [other]; RCV000335299.1 [benign]; 		COSM4133227	184	853	2	[2] auto-classification 14.09.2017  			LRP2 (inh=AR pLI=1.00)
chr2	170099473	170099473	T	C	hom	anno_omim	QUAL=19832;DP=248;AF=0.99;MQM=60;TRIO=HOM,248,0.99,HOM,260,1.00,HET,293,0.51	LRP2	synonymous	LRP2:ENST00000263816:synonymous:LOW:exon24/79:c.3660A>G:p.Ala1220Ala,LRP2:ENST00000443831:synonymous:LOW:exon22/23:c.3249A>G:p.Ala1083Ala		rs831042	0.5819	0.5231	17509,6874,1874	0.6009,0.6833,0.4705,0.4531,0.7297	0.5245							600073 [LRP2 (confirmed) Donnai-Barrow syndrome,222448];	RCV000117527.3 [other]; RCV000282794.1 [benign]; 			571	1012	2	[2] auto-classification 14.09.2017  			LRP2 (inh=AR pLI=1.00)
chr2	170103336	170103336	T	C	hom	anno_omim	QUAL=31117;DP=420;AF=1.00;MQM=60;TRIO=HOM,420,1.00,HOM,366,0.99,HET,515,0.49	LRP2	synonymous	LRP2:ENST00000263816:synonymous:LOW:exon21/79:c.3069A>G:p.Thr1023Thr,LRP2:ENST00000443831:synonymous:LOW:exon19/23:c.2658A>G:p.Thr886Thr		rs831043	0.6186	0.5385	18669,7113,2485	0.6920,0.6899,0.4720,0.4603,0.7500	0.5379							600073 [LRP2 (confirmed) Donnai-Barrow syndrome,222448];	RCV000117524.3 [other]; RCV000314964.1 [benign]; 			607	1009	2	[2] auto-classification 14.09.2017  			LRP2 (inh=AR pLI=1.00)
chr2	170103351	170103351	G	T	hom	anno_omim	QUAL=29733;DP=366;AF=1.00;MQM=60;TRIO=HOM,366,1.00,HOM,385,1.00,HET,517,0.48	LRP2	synonymous	LRP2:ENST00000263816:synonymous:LOW:exon21/79:c.3054C>A:p.Thr1018Thr,LRP2:ENST00000443831:synonymous:LOW:exon19/23:c.2643C>A:p.Thr881Thr		rs2075249	0.4565	0.4921	15497,7144,407	0.2761,0.6593,0.4670,0.4638,0.6682	0.5014							600073 [LRP2 (confirmed) Donnai-Barrow syndrome,222448];	RCV000117523.3 [other]; RCV000369606.1 [benign]; 			502	1019	2	[2] auto-classification 14.09.2017  			LRP2 (inh=AR pLI=1.00)
chr2	170115588	170115588	T	C	hom	anno_omim	QUAL=16616;DP=236;AF=1.00;MQM=60;TRIO=HOM,236,1.00,HOM,177,1.00,HET,241,0.50	LRP2	synonymous	LRP2:ENST00000263816:synonymous:LOW:exon17/79:c.2460A>G:p.Thr820Thr,LRP2:ENST00000443831:synonymous:LOW:exon15/23:c.2049A>G:p.Thr683Thr		rs2241190	0.6224	0.5464	19120,7438,2458	0.6887,0.7043,0.4714,0.4710,0.7553	0.5462							600073 [LRP2 (confirmed) Donnai-Barrow syndrome,222448];	RCV000117518.3 [other]; RCV000288847.1 [benign]; 			629	1012	2	[2] auto-classification 14.09.2017  			LRP2 (inh=AR pLI=1.00)
chr2	170129528	170129528	G	A	het	anno_omim	QUAL=16200;DP=312;AF=0.49;MQM=60;TRIO=HET,312,0.49,WT,295,0.00,HOM,396,1.00	LRP2	synonymous	LRP2:ENST00000263816:synonymous:LOW:exon15/79:c.2025C>T:p.Val675Val,LRP2:ENST00000443831:synonymous:LOW:exon14/23:c.1818C>T:p.Val606Val		rs830994	0.6096	0.6245	24489,14495,1399	0.5137,0.4558,0.9105,0.6596,0.5004	0.6273							600073 [LRP2 (confirmed) Donnai-Barrow syndrome,222448];	RCV000117515.3 [other]; RCV000404343.1 [benign]; 			916	912	2	[2] auto-classification 14.09.2017  			LRP2 (inh=AR pLI=1.00)
chr2	170150671	170150671	G	A	het	anno_omim	QUAL=11236;DP=267;AF=0.57;MQM=60;TRIO=HET,267,0.57,HOM,228,1.00,WT,304,0.00	LRP2	synonymous	LRP2:ENST00000263816:synonymous:LOW:exon6/79:c.639C>T:p.Asp213Asp,LRP2:ENST00000443831:synonymous:LOW:exon6/23:c.639C>T:p.Asp213Asp		rs2229266	0.3702	0.3204	7064,2430,620	0.3374,0.5623,0.4730,0.2659,0.3247	0.3261							600073 [LRP2 (confirmed) Donnai-Barrow syndrome,222448];	RCV000117541.3 [other]; RCV000330283.1 [benign]; 		COSM3757758	185	786	2	[2] auto-classification 14.09.2017  			LRP2 (inh=AR pLI=1.00)
chr2	170218847	170218847	C	G	hom	anno_omim	QUAL=6541;DP=55;AF=1.00;MQM=59;TRIO=HOM,55,1.00,HOM,67,1.00,HOM,108,0.99	LRP2	synonymous	LRP2:ENST00000263816:synonymous:LOW:exon1/79:c.63G>C:p.Ala21Ala,LRP2:ENST00000443831:synonymous:LOW:exon1/23:c.63G>C:p.Ala21Ala		rs1559014	0.9846	0.9971	20105,10407,1277	0.9613,0.9990,1.0000,0.9999,0.9998	0.9977							600073 [LRP2 (confirmed) Donnai-Barrow syndrome,222448];	RCV000117542.3 [other]; RCV000366077.1 [benign]; 		COSM3749605	2094	3	2	[2] auto-classification 14.09.2017  			LRP2 (inh=AR pLI=1.00)
chr2	172291616	172291616	C	T	het	anno_omim	QUAL=8524;DP=295;AF=0.53;MQM=60;TRIO=HET,295,0.53,WT,214,0.00,HET,283,0.57	DCAF17	synonymous	DCAF17:ENST00000375255:synonymous:LOW:exon2/14:c.150C>T:p.Val50Val,DCAF17:ENST00000539783:synonymous:LOW:exon2/12:c.150C>T:p.Val50Val		rs6751956	0.3067	0.2723	4779,1780,705	0.3779,0.4077,0.2513,0.2305,0.3140	0.2758							612515 [DCAF17 (provisional) Woodhouse-Sakati syndrome,241080];	RCV000116869.2 [likely benign]; RCV000280952.1 [benign]; 			113	814	2	[2] auto-classification 14.09.2017  			DCAF17 (inh=AR pLI=0.00)
chr2	172330393	172330393	A	G	het	anno_omim	QUAL=8211;DP=359;AF=0.43;MQM=60;TRIO=HET,359,0.43,WT,208,0.00,HET,310,0.50	DCAF17	synonymous,intron	DCAF17:ENST00000375255:synonymous:LOW:exon10/14:c.999A>G:p.Gln333Gln,DCAF17:ENST00000539783:intron:MODIFIER:exon9/11:c.982-4104A>G:		rs3731983	0.2067	0.2267	3293,1285,171	0.1695,0.3756,0.1857,0.2017,0.2895	0.2304	0.4960		T			0.05	612515 [DCAF17 (provisional) Woodhouse-Sakati syndrome,241080];	RCV000116872.2 [likely benign]; RCV000261719.1 [benign]; 		COSM4001323	90	733	2	[2] auto-classification 14.09.2017  			DCAF17 (inh=AR pLI=0.00)
chr2	172336541	172336541	C	T	het	anno_omim	QUAL=6522;DP=264;AF=0.51;MQM=60;TRIO=HET,264,0.51,WT,151,0.01,HET,243,0.49	DCAF17	splice_region&intron	DCAF17:ENST00000375255:splice_region&intron:LOW:exon12/13:c.1267-7C>T:,DCAF17:ENST00000539783:splice_region&intron:LOW:exon10/11:c.1066-7C>T:		rs3731981	0.2061	0.2243	3337,1318,169	0.1665,0.3721,0.1824,0.1997,0.2867	0.2304							612515 [DCAF17 (provisional) Woodhouse-Sakati syndrome,241080];	RCV000116867.2 [likely benign]; RCV000331955.1 [benign]; 		COSM4001324	91	729	2	[2] auto-classification 14.09.2017  			DCAF17 (inh=AR pLI=0.00)
chr2	172338194	172338194	G	A	het	anno_omim	QUAL=7143;DP=344;AF=0.45;MQM=60;TRIO=HET,344,0.45,WT,132,0.00,HET,217,0.52	DCAF17	3'UTR	DCAF17:ENST00000375255:3'UTR:MODIFIER:exon14/14:c.*570G>A:,DCAF17:ENST00000539783:3'UTR:MODIFIER:exon12/12:c.*570G>A:		rs3795998	0.2065	0.2633	405,80,1	0.0000,0.0000,0.0000,0.2347,0.2781	0.2434							612515 [DCAF17 (provisional) Woodhouse-Sakati syndrome,241080];	RCV000390781.1 [benign]; 			24	227					DCAF17 (inh=AR pLI=0.00)
chr2	172338300	172338300	T	G	het	anno_omim	QUAL=7519;DP=294;AF=0.49;MQM=60;TRIO=HET,294,0.49,WT,150,0.00,HET,231,0.56	DCAF17	3'UTR	DCAF17:ENST00000375255:3'UTR:MODIFIER:exon14/14:c.*676T>G:,DCAF17:ENST00000539783:3'UTR:MODIFIER:exon12/12:c.*676T>G:		rs3821084	0.2061	0.2631	404,80,1	0.0000,0.0000,0.0000,0.2347,0.2779	0.2434							612515 [DCAF17 (provisional) Woodhouse-Sakati syndrome,241080];	RCV000299788.1 [benign]; 			24	227					DCAF17 (inh=AR pLI=0.00)
chr2	172339964	172339964	C	T	hom	anno_omim	QUAL=36717;DP=380;AF=1.00;MQM=59;TRIO=HOM,380,1.00,HOM,334,1.00,HOM,410,1.00	DCAF17	3'UTR	DCAF17:ENST00000375255:3'UTR:MODIFIER:exon14/14:c.*2340C>T:,DCAF17:ENST00000539783:3'UTR:MODIFIER:exon12/12:c.*2340C>T:		rs888428	0.9774	0.9986	5382,1369,88	0.9265,0.0000,0.0000,1.0000,1.0000	0.9960							612515 [DCAF17 (provisional) Woodhouse-Sakati syndrome,241080];	RCV000391394.1 [benign]; 			649	1					DCAF17 (inh=AR pLI=0.00)
chr2	172340049	172340049	T	A	het	anno_omim	QUAL=9869;DP=454;AF=0.53;MQM=60;TRIO=HET,454,0.53,WT,300,0.01,HET,352,0.51	DCAF17	3'UTR	DCAF17:ENST00000375255:3'UTR:MODIFIER:exon14/14:c.*2425T>A:,DCAF17:ENST00000539783:3'UTR:MODIFIER:exon12/12:c.*2425T>A:		rs12151641	0.2065	0.2643	408,80,1	0.0000,0.0000,0.0000,0.2346,0.2798	0.2434							612515 [DCAF17 (provisional) Woodhouse-Sakati syndrome,241080];	RCV000391085.1 [benign]; 			24	227					DCAF17 (inh=AR pLI=0.00)
chr2	172340419	172340419	T	C	het	anno_omim	QUAL=9731;DP=397;AF=0.47;MQM=60;TRIO=HET,397,0.47,WT,238,0.00,HET,320,0.55	DCAF17	3'UTR	DCAF17:ENST00000375255:3'UTR:MODIFIER:exon14/14:c.*2795T>C:,DCAF17:ENST00000539783:3'UTR:MODIFIER:exon12/12:c.*2795T>C:		rs17221346	0.2718	0.2825	465,88,3	0.0000,0.0000,0.0000,0.2509,0.2963	0.2757							612515 [DCAF17 (provisional) Woodhouse-Sakati syndrome,241080];	RCV000269174.1 [benign]; 			28	247					DCAF17 (inh=AR pLI=0.00)
chr2	172340736	172340736	C	G	het	anno_omim	QUAL=5900;DP=242;AF=0.50;MQM=60;TRIO=HET,242,0.50,WT,150,0.00,HET,185,0.54	DCAF17	3'UTR	DCAF17:ENST00000375255:3'UTR:MODIFIER:exon14/14:c.*3112C>G:,DCAF17:ENST00000539783:3'UTR:MODIFIER:exon12/12:c.*3112C>G:		rs17221367	0.2065	0.2648	400,80,1	0.0000,0.0000,0.0000,0.2363,0.2797	0.2361							612515 [DCAF17 (provisional) Woodhouse-Sakati syndrome,241080];	RCV000375173.1 [benign]; 			24	223					DCAF17 (inh=AR pLI=0.00)
chr2	172341327	172341327	A	G	het	anno_omim	QUAL=5046;DP=165;AF=0.52;MQM=60;TRIO=HET,165,0.52,WT,132,0.00,HET,196,0.53	DCAF17	3'UTR	DCAF17:ENST00000375255:3'UTR:MODIFIER:exon14/14:c.*3703A>G:,DCAF17:ENST00000539783:3'UTR:MODIFIER:exon12/12:c.*3703A>G:	L1ME2z	rs9789572	0.2065	0.2634	407,80,1	0.0000,0.0000,0.0000,0.2350,0.2782	0.2448							612515 [DCAF17 (provisional) Woodhouse-Sakati syndrome,241080];	RCV000316959.1 [benign]; 			22	197					DCAF17 (inh=AR pLI=0.00)
chr2	173339808	173339808	G	A	het	pred_pathogenic;anno_omim	QUAL=13435;DP=230;AF=0.52;MQM=59;TRIO=HET,230,0.52,WT,279,0.00,HOM,321,1.00	ITGA6	missense	ITGA6:ENST00000264106:missense:MODERATE:exon8/26:c.1255G>A:p.Ala419Thr,ITGA6:ENST00000409532:missense:MODERATE:exon7/26:c.781G>A:p.Ala261Thr,ITGA6:ENST00000264107:missense:MODERATE:exon7/26:c.1138G>A:p.Ala380Thr,ITGA6:ENST00000343713:missense:MODERATE:exon7/26:c.1123G>A:p.Ala375Thr,ITGA6:ENST00000375221:missense:MODERATE:exon8/27:c.1255G>A:p.Ala419Thr,ITGA6:ENST00000409080:missense:MODERATE:exon7/25:c.1138G>A:p.Ala380Thr		rs11895564	0.2516	0.2810	5014,2867,580	0.3351,0.2593,0.0910,0.2928,0.3156	0.2847	3.1200	T,T,T,T,T,T,T,T	T	B,B,P,P	T,T,T,T,T,T,T,T	22.30	147556 [ITGA6 (provisional) Epidermolysis bullosa,junctional,with pyloric stenosis,226730];	RCV000279397.1 [benign]; 		COSM3757774, COSM3757775, COSM3757773	207	908	2	[2] auto-classification 14.09.2017  			ITGA6 (inh=AR pLI=0.01)
chr2	173344474	173344474	A	G	het	anno_omim	QUAL=12733;DP=351;AF=0.46;MQM=59;TRIO=HET,351,0.46,WT,219,0.00,HOM,290,0.99	ITGA6	splice_region&intron	ITGA6:ENST00000264106:splice_region&intron:LOW:exon11/25:c.1604+7A>G:,ITGA6:ENST00000409532:splice_region&intron:LOW:exon10/25:c.1130+7A>G:,ITGA6:ENST00000264107:splice_region&intron:LOW:exon10/25:c.1487+7A>G:,ITGA6:ENST00000343713:splice_region&intron:LOW:exon10/25:c.1472+7A>G:,ITGA6:ENST00000375221:splice_region&intron:LOW:exon11/26:c.1604+7A>G:,ITGA6:ENST00000409080:splice_region&intron:LOW:exon10/24:c.1487+7A>G:		rs1920979	0.4071	0.3710	8645,3834,1379	0.5178,0.3607,0.3600,0.3389,0.4457	0.3839							147556 [ITGA6 (provisional) Epidermolysis bullosa,junctional,with pyloric stenosis,226730];	RCV000406071.1 [benign]; 		COSM4001327, COSM4001326, COSM4001325	304	975	2	[2] auto-classification 14.09.2017  			ITGA6 (inh=AR pLI=0.01)
chr2	173369231	173369231	A	G	het	anno_omim	QUAL=10124;DP=271;AF=0.45;MQM=59;TRIO=HET,271,0.45,WT,162,0.00,HOM,220,1.00	ITGA6,AC093818.1	3'UTR	ITGA6:ENST00000264106:3'UTR:MODIFIER:exon26/26:c.*251A>G:,ITGA6:ENST00000409532:3'UTR:MODIFIER:exon26/26:c.*435A>G:,ITGA6:ENST00000264107:3'UTR:MODIFIER:exon26/26:c.*435A>G:,ITGA6:ENST00000343713:3'UTR:MODIFIER:exon26/26:c.*435A>G:,ITGA6:ENST00000375221:3'UTR:MODIFIER:exon27/27:c.*435A>G:,ITGA6:ENST00000409080:3'UTR:MODIFIER:exon25/25:c.*251A>G:		rs17664	0.6340	0.0000	0,0,0	0,0,0,0,0	0.5081							147556 [ITGA6 (provisional) Epidermolysis bullosa,junctional,with pyloric stenosis,226730];	RCV000331172.1 [benign]; 			33	121					ITGA6 (inh=AR pLI=0.01), AC093818.1 (inh=n/a pLI=n/a)
chr2	178404735	178404735	-	AAAG	hom	anno_omim	QUAL=1725;DP=48;AF=1.00;MQM=59;TRIO=HOM,48,1.00,HOM,6,1.00,HOM,9,1.00	AGPS	3'UTR	AGPS:ENST00000264167:3'UTR:MODIFIER:exon20/20:c.*1814_*1815insAGAA:		rs139584283	0.8850	0.0000	0,0,0	0,0,0,0,0	0.8636							603051 [AGPS (provisional) Rhizomelic chondrodysplasia punctata,type 3,600121];				173	48					AGPS (inh=AR pLI=1.00)
chr2	178404789	178404789	A	G	hom	anno_omim	QUAL=1364;DP=34;AF=1.00;MQM=59;TRIO=HOM,34,1.00,HOM,3,1.00,HOM,11,1.00	AGPS	3'UTR	AGPS:ENST00000264167:3'UTR:MODIFIER:exon20/20:c.*1866A>G:	(TA)n	rs10930795	0.8944	0.0000	0,0,0	0,0,0,0,0	0.8293							603051 [AGPS (provisional) Rhizomelic chondrodysplasia punctata,type 3,600121];	RCV000377269.1 [benign]; 			181	44					AGPS (inh=AR pLI=1.00)
chr2	178404802	178404805	TATA	-	hom	anno_omim	QUAL=1076;DP=40;AF=0.80;MQM=59;TRIO=HOM,40,0.80,HOM,5,1.00,HOM,14,0.64	AGPS	3'UTR	AGPS:ENST00000264167:3'UTR:MODIFIER:exon20/20:c.*1896_*1899delATAT:	(TA)n	rs144293437;rs72185133;rs773223731	0.9101	0.0000	0,0,0	0,0,0,0,0	0.7312							603051 [AGPS (provisional) Rhizomelic chondrodysplasia punctata,type 3,600121];	RCV000292898.1 [other]; 			173	15					AGPS (inh=AR pLI=1.00)
chr2	178406481	178406481	C	T	hom	anno_omim	QUAL=14530;DP=310;AF=1.00;MQM=60;TRIO=HOM,310,1.00,HET,87,0.51,HOM,102,1.00	AGPS	3'UTR	AGPS:ENST00000264167:3'UTR:MODIFIER:exon20/20:c.*3558C>T:		rs8941	0.6967	0.0000	0,0,0	0,0,0,0,0	0.7216							603051 [AGPS (provisional) Rhizomelic chondrodysplasia punctata,type 3,600121];	RCV000344624.1 [benign]; 			133	86					AGPS (inh=AR pLI=1.00)
chr2	178406769	178406769	-	T	hom	anno_omim	QUAL=11906;DP=205;AF=0.97;MQM=59;TRIO=HOM,205,0.97,HOM,73,0.99,HOM,104,1.00	AGPS	3'UTR	AGPS:ENST00000264167:3'UTR:MODIFIER:exon20/20:c.*3854dupT:		rs397783598	0.8902	0.0000	0,0,0	0,0,0,0,0	0.8544							603051 [AGPS (provisional) Rhizomelic chondrodysplasia punctata,type 3,600121];	RCV000295522.1 [benign]; 			177	50					AGPS (inh=AR pLI=1.00)
chr2	178407176	178407176	C	A	hom	anno_omim	QUAL=15591;DP=267;AF=1.00;MQM=60;TRIO=HOM,267,1.00,HOM,87,1.00,HOM,133,1.00	AGPS	3'UTR	AGPS:ENST00000264167:3'UTR:MODIFIER:exon20/20:c.*4253C>A:		rs10803912	0.8770	0.0000	0,0,0	0,0,0,0,0	0.8434							603051 [AGPS (provisional) Rhizomelic chondrodysplasia punctata,type 3,600121];	RCV000361548.1 [benign]; 			175	52					AGPS (inh=AR pLI=1.00)
chr2	178407897	178407897	T	C	hom	anno_omim	QUAL=22405;DP=266;AF=1.00;MQM=59;TRIO=HOM,266,1.00,HOM,180,1.00,HOM,279,1.00	AGPS	3'UTR	AGPS:ENST00000264167:3'UTR:MODIFIER:exon20/20:c.*4974T>C:		rs2293475	0.8764	0.0000	0,0,0	0,0,0,0,0	0.8428							603051 [AGPS (provisional) Rhizomelic chondrodysplasia punctata,type 3,600121];	RCV000269027.1 [benign]; 			175	52					AGPS (inh=AR pLI=1.00)
chr2	179315444	179315444	T	G	het	anno_omim	QUAL=721;DP=42;AF=0.52;MQM=59;TRIO=HET,42,0.52,HET,16,0.50,HET,16,0.50	PRKRA	5'UTR,intron	PRKRA:ENST00000487082:5'UTR:MODIFIER:exon1/8:c.-166A>C:,PRKRA:ENST00000432031:5'UTR:MODIFIER:exon1/7:c.-274A>C:,PRKRA:ENST00000325748:intron:MODIFIER:exon1/7:c.65+249A>C:,PRKRA:ENST00000438687:intron:MODIFIER:exon1/8:c.-385+249A>C:		rs184658426	0.0088	0.0000	0,0,0	0,0,0,0,0	0.0230							603424 [PRKRA (confirmed) Dystonia 16,612067];				1	12					PRKRA (inh=AR pLI=0.15)
chr2	179395554	179395554	G	A	het	pred_pathogenic;anno_omim	QUAL=4377;DP=312;AF=0.44;MQM=60;TRIO=HET,312,0.44,HET,98,0.43,WT,169,0.00	TTN,TTN-AS1	missense,intron,non_coding_transcript_exon	TTN:ENST00000589042:missense:MODERATE:exon358/363:c.105788C>T:p.Ala35263Val,TTN:ENST00000342992:missense:MODERATE:exon307/312:c.98084C>T:p.Ala32695Val,TTN:ENST00000342175:missense:MODERATE:exon187/192:c.79169C>T:p.Ala26390Val,TTN:ENST00000359218:missense:MODERATE:exon187/192:c.78968C>T:p.Ala26323Val,TTN:ENST00000460472:missense:MODERATE:exon186/191:c.78593C>T:p.Ala26198Val,TTN:ENST00000591111:missense:MODERATE:exon308/313:c.100865C>T:p.Ala33622Val,TTN-AS1:ENST00000419746:intron:MODIFIER:exon2/16:n.220-4905G>A:,TTN-AS1:ENST00000585625:intron:MODIFIER:exon3/3:n.681-487G>A:,TTN-AS1:ENST00000587568:intron:MODIFIER:exon2/2:n.343-487G>A:,TTN-AS1:ENST00000442329:intron:MODIFIER:exon1/2:n.471-487G>A:,TTN-AS1:ENST00000431259:intron:MODIFIER:exon2/4:n.561-487G>A:,TTN-AS1:ENST00000589434:intron:MODIFIER:exon1/2:n.423-6777G>A:,TTN-AS1:ENST00000456053:intron:MODIFIER:exon1/6:n.413+7191G>A:,TTN-AS1:ENST00000588804:intron:MODIFIER:exon2/4:n.435+2014G>A:,TTN-AS1:ENST00000585487:intron:MODIFIER:exon1/3:n.346-4905G>A:,TTN-AS1:ENST00000590040:intron:MODIFIER:exon1/3:n.345+7191G>A:,TTN-AS1:ENST00000586707:intron:MODIFIER:exon1/2:n.345+7191G>A:,TTN-AS1:ENST00000592600:intron:MODIFIER:exon1/1:n.345+7191G>A:,TTN-AS1:ENST00000591332:intron:MODIFIER:exon1/2:n.346-4905G>A:,TTN-AS1:ENST00000592750:intron:MODIFIER:exon1/3:n.345+7191G>A:,TTN-AS1:ENST00000592630:intron:MODIFIER:exon1/3:n.346-6777G>A:,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.198+7191G>A:,TTN-AS1:ENST00000604571:intron:MODIFIER:exon1/1:n.321-487G>A:,TTN-AS1:ENST00000592182:intron:MODIFIER:exon1/3:n.491+2344G>A:,TTN-AS1:ENST00000587944:intron:MODIFIER:exon1/1:n.727-487G>A:,TTN-AS1:ENST00000589842:intron:MODIFIER:exon1/3:n.75-487G>A:,TTN-AS1:ENST00000588257:intron:MODIFIER:exon1/4:n.75-487G>A:,TTN-AS1:ENST00000591867:intron:MODIFIER:exon1/4:n.74+2014G>A:,TTN-AS1:ENST00000591466:intron:MODIFIER:exon1/3:n.74+2014G>A:,TTN-AS1:ENST00000588244:intron:MODIFIER:exon1/5:n.75-487G>A:,TTN-AS1:ENST00000589391:intron:MODIFIER:exon1/5:n.75-487G>A:,TTN-AS1:ENST00000585358:intron:MODIFIER:exon2/4:n.126+1491G>A:,TTN-AS1:ENST00000588716:intron:MODIFIER:exon2/5:n.126+1491G>A:,TTN-AS1:ENST00000592836:intron:MODIFIER:exon1/4:n.74+2014G>A:,TTN-AS1:ENST00000450692:intron:MODIFIER:exon1/3:n.74+2014G>A:,TTN-AS1:ENST00000586831:intron:MODIFIER:exon1/4:n.74+2014G>A:,TTN-AS1:ENST00000592689:intron:MODIFIER:exon1/5:n.74+2014G>A:,TTN-AS1:ENST00000586452:intron:MODIFIER:exon1/6:n.74+2014G>A:,TTN-AS1:ENST00000590807:intron:MODIFIER:exon1/5:n.74+2014G>A:,TTN-AS1:ENST00000589355:non_coding_transcript_exon:MODIFIER:exon1/2:n.13G>A:		rs66961115	0.0052	0.0114	20,18,0	0.0021,0.0042,0.0000,0.0165,0.0014	0.0118	2.3280	T,T,T,T,T	T	B,B,B,B	T,T,T,T	20.80	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000040971.8 [other]; RCV000242301.1 [likely benign]; 			0	55					TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179395555	179395555	C	A	het	pred_pathogenic;anno_omim	QUAL=4377;DP=312;AF=0.44;MQM=60;TRIO=HET,312,0.44,HET,98,0.43,WT,169,0.00	TTN,TTN-AS1	missense,intron,non_coding_transcript_exon	TTN:ENST00000589042:missense:MODERATE:exon358/363:c.105787G>T:p.Ala35263Ser,TTN:ENST00000342992:missense:MODERATE:exon307/312:c.98083G>T:p.Ala32695Ser,TTN:ENST00000342175:missense:MODERATE:exon187/192:c.79168G>T:p.Ala26390Ser,TTN:ENST00000359218:missense:MODERATE:exon187/192:c.78967G>T:p.Ala26323Ser,TTN:ENST00000460472:missense:MODERATE:exon186/191:c.78592G>T:p.Ala26198Ser,TTN:ENST00000591111:missense:MODERATE:exon308/313:c.100864G>T:p.Ala33622Ser,TTN-AS1:ENST00000419746:intron:MODIFIER:exon2/16:n.220-4904C>A:,TTN-AS1:ENST00000585625:intron:MODIFIER:exon3/3:n.681-486C>A:,TTN-AS1:ENST00000587568:intron:MODIFIER:exon2/2:n.343-486C>A:,TTN-AS1:ENST00000442329:intron:MODIFIER:exon1/2:n.471-486C>A:,TTN-AS1:ENST00000431259:intron:MODIFIER:exon2/4:n.561-486C>A:,TTN-AS1:ENST00000589434:intron:MODIFIER:exon1/2:n.423-6776C>A:,TTN-AS1:ENST00000456053:intron:MODIFIER:exon1/6:n.413+7192C>A:,TTN-AS1:ENST00000588804:intron:MODIFIER:exon2/4:n.435+2015C>A:,TTN-AS1:ENST00000585487:intron:MODIFIER:exon1/3:n.346-4904C>A:,TTN-AS1:ENST00000590040:intron:MODIFIER:exon1/3:n.345+7192C>A:,TTN-AS1:ENST00000586707:intron:MODIFIER:exon1/2:n.345+7192C>A:,TTN-AS1:ENST00000592600:intron:MODIFIER:exon1/1:n.345+7192C>A:,TTN-AS1:ENST00000591332:intron:MODIFIER:exon1/2:n.346-4904C>A:,TTN-AS1:ENST00000592750:intron:MODIFIER:exon1/3:n.345+7192C>A:,TTN-AS1:ENST00000592630:intron:MODIFIER:exon1/3:n.346-6776C>A:,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.198+7192C>A:,TTN-AS1:ENST00000604571:intron:MODIFIER:exon1/1:n.321-486C>A:,TTN-AS1:ENST00000592182:intron:MODIFIER:exon1/3:n.491+2345C>A:,TTN-AS1:ENST00000587944:intron:MODIFIER:exon1/1:n.727-486C>A:,TTN-AS1:ENST00000589842:intron:MODIFIER:exon1/3:n.75-486C>A:,TTN-AS1:ENST00000588257:intron:MODIFIER:exon1/4:n.75-486C>A:,TTN-AS1:ENST00000591867:intron:MODIFIER:exon1/4:n.74+2015C>A:,TTN-AS1:ENST00000591466:intron:MODIFIER:exon1/3:n.74+2015C>A:,TTN-AS1:ENST00000588244:intron:MODIFIER:exon1/5:n.75-486C>A:,TTN-AS1:ENST00000589391:intron:MODIFIER:exon1/5:n.75-486C>A:,TTN-AS1:ENST00000585358:intron:MODIFIER:exon2/4:n.126+1492C>A:,TTN-AS1:ENST00000588716:intron:MODIFIER:exon2/5:n.126+1492C>A:,TTN-AS1:ENST00000592836:intron:MODIFIER:exon1/4:n.74+2015C>A:,TTN-AS1:ENST00000450692:intron:MODIFIER:exon1/3:n.74+2015C>A:,TTN-AS1:ENST00000586831:intron:MODIFIER:exon1/4:n.74+2015C>A:,TTN-AS1:ENST00000592689:intron:MODIFIER:exon1/5:n.74+2015C>A:,TTN-AS1:ENST00000586452:intron:MODIFIER:exon1/6:n.74+2015C>A:,TTN-AS1:ENST00000590807:intron:MODIFIER:exon1/5:n.74+2015C>A:,TTN-AS1:ENST00000589355:non_coding_transcript_exon:MODIFIER:exon1/2:n.14C>A:		rs67254537	0.0052	0.0113	20,18,0	0.0021,0.0042,0.0000,0.0165,0.0011	0.0118	2.6440	T,T,T,T,T	T	B,B,B,B	T,T,T,T	18.00	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000040970.8 [other]; RCV000247062.1 [likely benign]; 			0	55					TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179395573	179395573	C	T	het	pred_pathogenic;anno_omim	QUAL=5161;DP=333;AF=0.48;MQM=60;TRIO=HET,333,0.48,HET,95,0.45,WT,174,0.00	TTN,TTN-AS1	missense,intron,non_coding_transcript_exon	TTN:ENST00000589042:missense:MODERATE:exon358/363:c.105769G>A:p.Glu35257Lys,TTN:ENST00000342992:missense:MODERATE:exon307/312:c.98065G>A:p.Glu32689Lys,TTN:ENST00000342175:missense:MODERATE:exon187/192:c.79150G>A:p.Glu26384Lys,TTN:ENST00000359218:missense:MODERATE:exon187/192:c.78949G>A:p.Glu26317Lys,TTN:ENST00000460472:missense:MODERATE:exon186/191:c.78574G>A:p.Glu26192Lys,TTN:ENST00000591111:missense:MODERATE:exon308/313:c.100846G>A:p.Glu33616Lys,TTN-AS1:ENST00000419746:intron:MODIFIER:exon2/16:n.220-4886C>T:,TTN-AS1:ENST00000585625:intron:MODIFIER:exon3/3:n.681-468C>T:,TTN-AS1:ENST00000587568:intron:MODIFIER:exon2/2:n.343-468C>T:,TTN-AS1:ENST00000442329:intron:MODIFIER:exon1/2:n.471-468C>T:,TTN-AS1:ENST00000431259:intron:MODIFIER:exon2/4:n.561-468C>T:,TTN-AS1:ENST00000589434:intron:MODIFIER:exon1/2:n.423-6758C>T:,TTN-AS1:ENST00000456053:intron:MODIFIER:exon1/6:n.413+7210C>T:,TTN-AS1:ENST00000588804:intron:MODIFIER:exon2/4:n.435+2033C>T:,TTN-AS1:ENST00000585487:intron:MODIFIER:exon1/3:n.346-4886C>T:,TTN-AS1:ENST00000590040:intron:MODIFIER:exon1/3:n.345+7210C>T:,TTN-AS1:ENST00000586707:intron:MODIFIER:exon1/2:n.345+7210C>T:,TTN-AS1:ENST00000592600:intron:MODIFIER:exon1/1:n.345+7210C>T:,TTN-AS1:ENST00000591332:intron:MODIFIER:exon1/2:n.346-4886C>T:,TTN-AS1:ENST00000592750:intron:MODIFIER:exon1/3:n.345+7210C>T:,TTN-AS1:ENST00000592630:intron:MODIFIER:exon1/3:n.346-6758C>T:,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.198+7210C>T:,TTN-AS1:ENST00000604571:intron:MODIFIER:exon1/1:n.321-468C>T:,TTN-AS1:ENST00000592182:intron:MODIFIER:exon1/3:n.491+2363C>T:,TTN-AS1:ENST00000587944:intron:MODIFIER:exon1/1:n.727-468C>T:,TTN-AS1:ENST00000589842:intron:MODIFIER:exon1/3:n.75-468C>T:,TTN-AS1:ENST00000588257:intron:MODIFIER:exon1/4:n.75-468C>T:,TTN-AS1:ENST00000591867:intron:MODIFIER:exon1/4:n.74+2033C>T:,TTN-AS1:ENST00000591466:intron:MODIFIER:exon1/3:n.74+2033C>T:,TTN-AS1:ENST00000588244:intron:MODIFIER:exon1/5:n.75-468C>T:,TTN-AS1:ENST00000589391:intron:MODIFIER:exon1/5:n.75-468C>T:,TTN-AS1:ENST00000585358:intron:MODIFIER:exon2/4:n.126+1510C>T:,TTN-AS1:ENST00000588716:intron:MODIFIER:exon2/5:n.126+1510C>T:,TTN-AS1:ENST00000592836:intron:MODIFIER:exon1/4:n.74+2033C>T:,TTN-AS1:ENST00000450692:intron:MODIFIER:exon1/3:n.74+2033C>T:,TTN-AS1:ENST00000586831:intron:MODIFIER:exon1/4:n.74+2033C>T:,TTN-AS1:ENST00000592689:intron:MODIFIER:exon1/5:n.74+2033C>T:,TTN-AS1:ENST00000586452:intron:MODIFIER:exon1/6:n.74+2033C>T:,TTN-AS1:ENST00000590807:intron:MODIFIER:exon1/5:n.74+2033C>T:,TTN-AS1:ENST00000589355:non_coding_transcript_exon:MODIFIER:exon1/2:n.32C>T:		rs56324595	0.0066	0.0139	27,23,0	0.0029,0.0056,0.0001,0.0201,0.0033	0.0139	7.8180	D,D,D,D,D	T	D,D,D,D	T,T,T,T	23.60	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000040968.8 [other]; RCV000232021.1 [benign]; RCV000232021.1 [benign]; RCV000250202.1 [benign]; 			0	75					TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179404498	179404498	G	C	het	pred_pathogenic;anno_omim	QUAL=15914;DP=509;AF=0.51;MQM=60;TRIO=HET,509,0.51,WT,526,0.00,HET,648,0.51	TTN,TTN-AS1	missense,intron,non_coding_transcript_exon	TTN:ENST00000589042:missense:MODERATE:exon352/363:c.98294C>G:p.Ala32765Gly,TTN:ENST00000342992:missense:MODERATE:exon301/312:c.90590C>G:p.Ala30197Gly,TTN:ENST00000342175:missense:MODERATE:exon181/192:c.71675C>G:p.Ala23892Gly,TTN:ENST00000359218:missense:MODERATE:exon181/192:c.71474C>G:p.Ala23825Gly,TTN:ENST00000460472:missense:MODERATE:exon180/191:c.71099C>G:p.Ala23700Gly,TTN:ENST00000591111:missense:MODERATE:exon302/313:c.93371C>G:p.Ala31124Gly,TTN-AS1:ENST00000456053:intron:MODIFIER:exon1/6:n.413+16135G>C:,TTN-AS1:ENST00000590040:intron:MODIFIER:exon1/3:n.346-2451G>C:,TTN-AS1:ENST00000586707:intron:MODIFIER:exon1/2:n.345+16135G>C:,TTN-AS1:ENST00000592600:intron:MODIFIER:exon1/1:n.345+16135G>C:,TTN-AS1:ENST00000591332:intron:MODIFIER:exon2/2:n.442+3943G>C:,TTN-AS1:ENST00000592750:intron:MODIFIER:exon1/3:n.345+16135G>C:,TTN-AS1:ENST00000592630:intron:MODIFIER:exon2/3:n.433+2080G>C:,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.198+16135G>C:,TTN-AS1:ENST00000586831:intron:MODIFIER:exon1/4:n.75-2451G>C:,TTN-AS1:ENST00000592689:intron:MODIFIER:exon3/5:n.260-336G>C:,TTN-AS1:ENST00000586452:intron:MODIFIER:exon1/6:n.74+10958G>C:,TTN-AS1:ENST00000590807:intron:MODIFIER:exon1/5:n.74+10958G>C:,TTN-AS1:ENST00000419746:non_coding_transcript_exon:MODIFIER:exon5/17:n.1721G>C:		rs72648273	0.0010	0.0028	0,0,0	0.0005,0.0010,0.0001,0.0042,0.0009	0.0030	9.8690	D,D,D,D,D	D	D,D,D,D	T,T,T,T	21.70	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000040867.5 [likely benign]; RCV000118794.4 [likely benign]; RCV000248345.1 [likely benign]; RCV000260558.1 [uncertain significance]; RCV000264048.1 [uncertain significance]; RCV000321435.1 [uncertain significance]; RCV000322722.1 [uncertain significance]; RCV000354955.1 [uncertain significance]; RCV000361061.1 [uncertain significance]; 			1	28					TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179432185	179432185	A	G	het	pred_pathogenic;anno_omim	QUAL=20892;DP=503;AF=0.53;MQM=60;TRIO=HET,503,0.53,HOM,416,1.00,WT,543,0.00	TTN,TTN-AS1	missense,intron	TTN:ENST00000589042:missense:MODERATE:exon326/363:c.78674T>C:p.Ile26225Thr,TTN:ENST00000342992:missense:MODERATE:exon275/312:c.70970T>C:p.Ile23657Thr,TTN:ENST00000342175:missense:MODERATE:exon155/192:c.52055T>C:p.Ile17352Thr,TTN:ENST00000359218:missense:MODERATE:exon155/192:c.51854T>C:p.Ile17285Thr,TTN:ENST00000460472:missense:MODERATE:exon154/191:c.51479T>C:p.Ile17160Thr,TTN:ENST00000591111:missense:MODERATE:exon276/313:c.73751T>C:p.Ile24584Thr,TTN-AS1:ENST00000419746:intron:MODIFIER:exon7/16:n.2044-15114A>G:,TTN-AS1:ENST00000456053:intron:MODIFIER:exon1/6:n.414-3842A>G:,TTN-AS1:ENST00000586707:intron:MODIFIER:exon1/2:n.346-16255A>G:,TTN-AS1:ENST00000592600:intron:MODIFIER:exon1/1:n.346-17115A>G:,TTN-AS1:ENST00000591332:intron:MODIFIER:exon2/2:n.443-30138A>G:,TTN-AS1:ENST00000592750:intron:MODIFIER:exon1/3:n.346-30138A>G:,TTN-AS1:ENST00000592630:intron:MODIFIER:exon2/3:n.433+29767A>G:,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.198+43822A>G:,TTN-AS1:ENST00000586831:intron:MODIFIER:exon2/4:n.215-15114A>G:,TTN-AS1:ENST00000592689:intron:MODIFIER:exon5/5:n.462+25097A>G:,TTN-AS1:ENST00000586452:intron:MODIFIER:exon1/6:n.75-3842A>G:,TTN-AS1:ENST00000590807:intron:MODIFIER:exon1/5:n.75-16066A>G:,TTN-AS1:ENST00000438095:intron:MODIFIER:exon2/3:n.195-3842A>G:,TTN-AS1:ENST00000590932:intron:MODIFIER:exon1/1:n.615+25097A>G:		rs12463674	0.1300	0.2368	4109,3069,7	0.0471,0.0980,0.0444,0.3013,0.2201	0.2352	5.9890	T,D,T,T,D	T	B,B,B,B	T,T,T,T	22.90	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000040637.11 [benign]; RCV000252077.1 [benign]; RCV000277833.1 [likely benign]; RCV000299007.1 [likely benign]; RCV000311963.1 [likely benign]; RCV000338511.1 [likely benign]; RCV000369992.1 [likely benign]; RCV000399563.1 [likely benign]; 			181	842	2	[2] auto-classification 14.09.2017  			TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179440029	179440029	G	A	het	anno_omim	QUAL=13316;DP=381;AF=0.51;MQM=59;TRIO=HET,381,0.51,HOM,285,0.99,WT,396,0.00	TTN,TTN-AS1	synonymous,intron	TTN:ENST00000589042:synonymous:LOW:exon326/363:c.70830C>T:p.Ser23610Ser,TTN:ENST00000342992:synonymous:LOW:exon275/312:c.63126C>T:p.Ser21042Ser,TTN:ENST00000342175:synonymous:LOW:exon155/192:c.44211C>T:p.Ser14737Ser,TTN:ENST00000359218:synonymous:LOW:exon155/192:c.44010C>T:p.Ser14670Ser,TTN:ENST00000460472:synonymous:LOW:exon154/191:c.43635C>T:p.Ser14545Ser,TTN:ENST00000591111:synonymous:LOW:exon276/313:c.65907C>T:p.Ser21969Ser,TTN-AS1:ENST00000419746:intron:MODIFIER:exon7/16:n.2044-7270G>A:,TTN-AS1:ENST00000456053:intron:MODIFIER:exon2/6:n.563+3853G>A:,TTN-AS1:ENST00000586707:intron:MODIFIER:exon1/2:n.346-8411G>A:,TTN-AS1:ENST00000592600:intron:MODIFIER:exon1/1:n.346-9271G>A:,TTN-AS1:ENST00000591332:intron:MODIFIER:exon2/2:n.443-22294G>A:,TTN-AS1:ENST00000592750:intron:MODIFIER:exon1/3:n.346-22294G>A:,TTN-AS1:ENST00000592630:intron:MODIFIER:exon2/3:n.434-22294G>A:,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.198+51666G>A:,TTN-AS1:ENST00000586831:intron:MODIFIER:exon2/4:n.215-7270G>A:,TTN-AS1:ENST00000592689:intron:MODIFIER:exon5/5:n.463-22294G>A:,TTN-AS1:ENST00000586452:intron:MODIFIER:exon2/6:n.224+3853G>A:,TTN-AS1:ENST00000590807:intron:MODIFIER:exon1/5:n.75-8222G>A:,TTN-AS1:ENST00000438095:intron:MODIFIER:exon3/3:n.344+3853G>A:,TTN-AS1:ENST00000590932:intron:MODIFIER:exon1/1:n.616-22294G>A:		rs12464787	0.1466	0.2400	4061,2996,58	0.1184,0.0989,0.0445,0.2979,0.2117	0.2523							188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000040563.9 [benign]; RCV000247860.1 [benign]; RCV000266148.1 [likely benign]; RCV000297946.1 [likely benign]; RCV000306054.1 [likely benign]; RCV000355113.1 [likely benign]; RCV000358526.1 [likely benign]; RCV000398179.1 [likely benign]; 		COSM4133286, COSM4133285, COSM4133282, COSM4133284, COSM4133283	182	834	2	[2] auto-classification 14.09.2017  			TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179444768	179444768	C	G	hom	anno_omim	QUAL=59878;DP=523;AF=1.00;MQM=60;TRIO=HOM,523,1.00,HOM,561,1.00,HOM,773,1.00	TTN,TTN-AS1,RP11-171I2.2	missense,intron	TTN:ENST00000589042:missense:MODERATE:exon318/363:c.67246G>C:p.Ala22416Pro,TTN:ENST00000342992:missense:MODERATE:exon267/312:c.59542G>C:p.Ala19848Pro,TTN:ENST00000342175:missense:MODERATE:exon147/192:c.40627G>C:p.Ala13543Pro,TTN:ENST00000359218:missense:MODERATE:exon147/192:c.40426G>C:p.Ala13476Pro,TTN:ENST00000460472:missense:MODERATE:exon146/191:c.40051G>C:p.Ala13351Pro,TTN:ENST00000591111:missense:MODERATE:exon268/313:c.62323G>C:p.Ala20775Pro,TTN-AS1:ENST00000419746:intron:MODIFIER:exon7/16:n.2044-2531C>G:,TTN-AS1:ENST00000456053:intron:MODIFIER:exon2/6:n.563+8592C>G:,TTN-AS1:ENST00000586707:intron:MODIFIER:exon1/2:n.346-3672C>G:,TTN-AS1:ENST00000592600:intron:MODIFIER:exon1/1:n.346-4532C>G:,TTN-AS1:ENST00000591332:intron:MODIFIER:exon2/2:n.443-17555C>G:,TTN-AS1:ENST00000592750:intron:MODIFIER:exon1/3:n.346-17555C>G:,TTN-AS1:ENST00000592630:intron:MODIFIER:exon2/3:n.434-17555C>G:,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.198+56405C>G:,TTN-AS1:ENST00000586831:intron:MODIFIER:exon2/4:n.215-2531C>G:,TTN-AS1:ENST00000592689:intron:MODIFIER:exon5/5:n.463-17555C>G:,TTN-AS1:ENST00000586452:intron:MODIFIER:exon2/6:n.224+8592C>G:,TTN-AS1:ENST00000590807:intron:MODIFIER:exon1/5:n.75-3483C>G:,TTN-AS1:ENST00000438095:intron:MODIFIER:exon3/3:n.345-2531C>G:,TTN-AS1:ENST00000590932:intron:MODIFIER:exon1/1:n.616-17555C>G:		rs4145333	0.9946	0.9986	60192,33352,4769	0.9862,0.9988,1.0000,0.9998,1.0000	0.9987	0.6560	T,T,T,T,T	T	B,B,B	T,T,T,T	2.49	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000040520.7 [benign]; RCV000248869.1 [benign]; RCV000282280.1 [likely benign]; RCV000286185.1 [likely benign]; RCV000317492.1 [likely benign]; RCV000339521.1 [likely benign]; RCV000374422.1 [likely benign]; RCV000407028.1 [likely benign]; 			2206	1	2	[2] auto-classification 14.09.2017  			TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a), RP11-171I2.2 (inh=n/a pLI=n/a)
chr2	179453796	179453796	C	T	het	pred_pathogenic;anno_omim	QUAL=8369;DP=331;AF=0.56;MQM=59;TRIO=HET,331,0.56,WT,259,0.00,HET,298,0.44	TTN,TTN-AS1	missense,intron	TTN:ENST00000589042:missense:MODERATE:exon304/363:c.62656G>A:p.Asp20886Asn,TTN:ENST00000342992:missense:MODERATE:exon253/312:c.54952G>A:p.Asp18318Asn,TTN:ENST00000342175:missense:MODERATE:exon133/192:c.36037G>A:p.Asp12013Asn,TTN:ENST00000359218:missense:MODERATE:exon133/192:c.35836G>A:p.Asp11946Asn,TTN:ENST00000460472:missense:MODERATE:exon132/191:c.35461G>A:p.Asp11821Asn,TTN:ENST00000591111:missense:MODERATE:exon254/313:c.57733G>A:p.Asp19245Asn,TTN-AS1:ENST00000419746:intron:MODIFIER:exon11/16:n.3189-2070C>T:,TTN-AS1:ENST00000456053:intron:MODIFIER:exon2/6:n.564-8527C>T:,TTN-AS1:ENST00000591332:intron:MODIFIER:exon2/2:n.443-8527C>T:,TTN-AS1:ENST00000592750:intron:MODIFIER:exon1/3:n.346-8527C>T:,TTN-AS1:ENST00000592630:intron:MODIFIER:exon2/3:n.434-8527C>T:,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.198+65433C>T:,TTN-AS1:ENST00000592689:intron:MODIFIER:exon5/5:n.463-8527C>T:,TTN-AS1:ENST00000586452:intron:MODIFIER:exon2/6:n.225-2070C>T:,TTN-AS1:ENST00000590807:intron:MODIFIER:exon2/5:n.199+5421C>T:,TTN-AS1:ENST00000590932:intron:MODIFIER:exon1/1:n.616-8527C>T:,TTN-AS1:ENST00000590743:intron:MODIFIER:exon2/2:n.653-2070C>T:,TTN-AS1:ENST00000589907:intron:MODIFIER:exon1/2:n.420+4076C>T:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0001	7.8180	T,D,D,D,D	T	D,D,D,D	T,T,T,T	22.70	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];				0	2					TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179462494	179462494	A	G	het	anno_omim	QUAL=22293;DP=578;AF=0.47;MQM=60;TRIO=HET,578,0.47,HOM,462,0.99,WT,664,0.00	TTN,TTN-AS1	synonymous,intron,non_coding_transcript_exon	TTN:ENST00000589042:synonymous:LOW:exon294/363:c.57315T>C:p.His19105His,TTN:ENST00000342992:synonymous:LOW:exon243/312:c.49611T>C:p.His16537His,TTN:ENST00000342175:synonymous:LOW:exon123/192:c.30696T>C:p.His10232His,TTN:ENST00000359218:synonymous:LOW:exon123/192:c.30495T>C:p.His10165His,TTN:ENST00000460472:synonymous:LOW:exon122/191:c.30120T>C:p.His10040His,TTN:ENST00000591111:synonymous:LOW:exon244/313:c.52392T>C:p.His17464His,TTN-AS1:ENST00000419746:intron:MODIFIER:exon13/16:n.3450+86A>G:,TTN-AS1:ENST00000456053:intron:MODIFIER:exon3/6:n.649+86A>G:,TTN-AS1:ENST00000592750:intron:MODIFIER:exon2/3:n.431+86A>G:,TTN-AS1:ENST00000592630:intron:MODIFIER:exon3/3:n.519+86A>G:,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.198+74131A>G:,TTN-AS1:ENST00000586452:intron:MODIFIER:exon4/6:n.486+86A>G:,TTN-AS1:ENST00000590807:intron:MODIFIER:exon3/5:n.285+86A>G:,TTN-AS1:ENST00000589907:intron:MODIFIER:exon2/2:n.506+86A>G:,TTN-AS1:ENST00000589234:intron:MODIFIER:exon2/4:n.243+86A>G:,TTN-AS1:ENST00000589830:intron:MODIFIER:exon1/2:n.86+86A>G:,TTN-AS1:ENST00000592689:non_coding_transcript_exon:MODIFIER:exon6/6:n.634A>G:		rs35833641	0.1270	0.2349	4069,3055,8	0.0467,0.0968,0.0374,0.3002,0.2132	0.2340							188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000040390.5 [benign]; RCV000251182.1 [benign]; RCV000287439.1 [likely benign]; RCV000295798.1 [likely benign]; RCV000326309.1 [likely benign]; RCV000327457.1 [likely benign]; RCV000384352.1 [likely benign]; RCV000387828.1 [likely benign]; 		COSM4001385, COSM4001388, COSM4001386, COSM4001387, COSM4001389	181	834	2	[2] auto-classification 14.09.2017  			TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179542499	179542499	T	C	het	anno_omim;trio_denovo	QUAL=864;DP=293;AF=0.27;MQM=54;TRIO=HET,293,0.27,WT,658,0.00,WT,744,0.00	TTN,TTN-AS1	synonymous,intron	TTN:ENST00000589042:synonymous:LOW:exon146/363:c.34140A>G:p.Glu11380Glu,TTN:ENST00000342992:synonymous:LOW:exon143/312:c.30408A>G:p.Glu10136Glu,TTN:ENST00000591111:synonymous:LOW:exon144/313:c.33189A>G:p.Glu11063Glu,TTN-AS1:ENST00000592630:intron:MODIFIER:exon3/3:n.520-35982T>C:,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.199-83168T>C:,TTN:ENST00000342175:intron:MODIFIER:exon47/191:c.13859-35455A>G:,TTN:ENST00000359218:intron:MODIFIER:exon47/191:c.13658-35455A>G:,TTN:ENST00000460472:intron:MODIFIER:exon46/190:c.13283-35455A>G:,TTN-AS1:ENST00000589830:intron:MODIFIER:exon2/2:n.212-35982T>C:,TTN-AS1:ENST00000589487:intron:MODIFIER:exon5/6:n.782+98T>C:,TTN-AS1:ENST00000431752:intron:MODIFIER:exon1/1:n.125-35982T>C:		rs147418835	0.0030	0.0001	0,0,0	0.0000,0.0000,0.0000,0.0000,0.0001	0.0000							188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000259807.1 [uncertain significance]; RCV000275254.1 [uncertain significance]; RCV000317393.1 [uncertain significance]; RCV000332773.1 [uncertain significance]; RCV000371038.1 [uncertain significance]; RCV000374409.1 [uncertain significance]; 			0	5					TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179545859	179545859	C	T	het	anno_omim	QUAL=8789;DP=347;AF=0.49;MQM=60;TRIO=HET,347,0.49,HOM,131,0.98,WT,226,0.00	TTN,TTN-AS1	missense,intron	TTN:ENST00000589042:missense:MODERATE:exon138/363:c.33287G>A:p.Arg11096His,TTN:ENST00000342992:missense:MODERATE:exon135/312:c.29555G>A:p.Arg9852His,TTN:ENST00000591111:missense:MODERATE:exon136/313:c.32336G>A:p.Arg10779His,TTN-AS1:ENST00000592630:intron:MODIFIER:exon3/3:n.520-32622C>T:,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.199-79808C>T:,TTN:ENST00000342175:intron:MODIFIER:exon47/191:c.13859-38815G>A:,TTN:ENST00000359218:intron:MODIFIER:exon47/191:c.13658-38815G>A:,TTN:ENST00000460472:intron:MODIFIER:exon46/190:c.13283-38815G>A:,TTN-AS1:ENST00000589830:intron:MODIFIER:exon2/2:n.212-32622C>T:,TTN-AS1:ENST00000589487:intron:MODIFIER:exon6/6:n.939+2553C>T:,TTN-AS1:ENST00000431752:intron:MODIFIER:exon1/1:n.125-32622C>T:		rs36051007	0.1260	0.2347	3963,2974,7	0.0475,0.0979,0.0369,0.3005,0.2134	0.2327	-0.5180	T	T	B	T	18.18	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000040156.7 [benign]; RCV000251495.1 [benign]; RCV000270218.1 [likely benign]; RCV000273725.1 [likely benign]; RCV000327674.1 [likely benign]; RCV000331522.1 [likely benign]; RCV000362564.1 [likely benign]; RCV000384442.1 [likely benign]; 		COSM4001412, COSM4001413	183	821	2	[2] auto-classification 14.09.2017  			TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179554305	179554305	C	T	het	pred_pathogenic;anno_omim	QUAL=11498;DP=436;AF=0.45;MQM=60;TRIO=HET,436,0.45,HOM,199,1.00,WT,261,0.00	TTN,TTN-AS1	missense,intron	TTN:ENST00000589042:missense:MODERATE:exon123/363:c.31864G>A:p.Gly10622Arg,TTN:ENST00000342992:missense:MODERATE:exon120/312:c.28132G>A:p.Gly9378Arg,TTN:ENST00000591111:missense:MODERATE:exon121/313:c.30913G>A:p.Gly10305Arg,TTN-AS1:ENST00000592630:intron:MODIFIER:exon3/3:n.520-24176C>T:,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.199-71362C>T:,TTN:ENST00000342175:intron:MODIFIER:exon47/191:c.13859-47261G>A:,TTN:ENST00000359218:intron:MODIFIER:exon47/191:c.13658-47261G>A:,TTN:ENST00000460472:intron:MODIFIER:exon46/190:c.13283-47261G>A:,TTN-AS1:ENST00000589830:intron:MODIFIER:exon2/2:n.212-24176C>T:,TTN-AS1:ENST00000589487:intron:MODIFIER:exon6/6:n.940-4930C>T:,TTN-AS1:ENST00000431752:intron:MODIFIER:exon1/1:n.125-24176C>T:		rs2244492	0.4133	0.3995	8028,3459,1608	0.6112,0.3622,0.1783,0.3697,0.4653	0.4460	3.2520	T,T	T		T,T	23.70	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000040129.6 [benign]; RCV000245743.1 [benign]; RCV000266150.1 [likely benign]; RCV000269588.1 [likely benign]; RCV000305987.1 [likely benign]; RCV000321271.1 [likely benign]; RCV000360822.1 [likely benign]; RCV000364010.1 [likely benign]; 			292	1005	2	[2] auto-classification 14.09.2017  			TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179569387	179569387	T	A	het	pred_pathogenic;anno_omim	QUAL=7668;DP=324;AF=0.50;MQM=60;TRIO=HET,324,0.50,WT,162,0.00,HET,257,0.48	TTN,TTN-AS1	missense,intron	TTN:ENST00000589042:missense:MODERATE:exon105/363:c.29812A>T:p.Thr9938Ser,TTN:ENST00000342992:missense:MODERATE:exon102/312:c.26080A>T:p.Thr8694Ser,TTN:ENST00000591111:missense:MODERATE:exon103/313:c.28861A>T:p.Thr9621Ser,TTN-AS1:ENST00000592630:intron:MODIFIER:exon3/3:n.520-9094T>A:,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.199-56280T>A:,TTN:ENST00000342175:intron:MODIFIER:exon47/191:c.13858+33422A>T:,TTN:ENST00000359218:intron:MODIFIER:exon47/191:c.13657+33422A>T:,TTN:ENST00000460472:intron:MODIFIER:exon46/190:c.13282+33422A>T:,TTN-AS1:ENST00000589830:intron:MODIFIER:exon2/2:n.212-9094T>A:,TTN-AS1:ENST00000431752:intron:MODIFIER:exon1/1:n.125-9094T>A:		rs72650006	0.0106	0.0199	22,18,0	0.0048,0.0141,0.0003,0.0259,0.0152	0.0193	6.2960	T	T	B	T	19.00	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000040096.6 [benign]; RCV000204308.2 [benign]; RCV000204308.2 [benign]; RCV000252332.1 [benign]; RCV000307512.1 [likely benign]; RCV000308804.1 [likely benign]; RCV000359919.1 [likely benign]; RCV000365787.1 [likely benign]; RCV000395851.1 [likely benign]; RCV000395854.1 [likely benign]; 			2	111					TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179585266	179585266	C	T	hom	anno_omim	QUAL=14818;DP=260;AF=1.00;MQM=60;TRIO=HOM,260,1.00,HOM,81,1.00,HOM,125,1.00	TTN,TTN-AS1	synonymous,intron	TTN:ENST00000589042:synonymous:LOW:exon80/363:c.23223G>A:p.Gln7741Gln,TTN:ENST00000342992:synonymous:LOW:exon77/312:c.19491G>A:p.Gln6497Gln,TTN:ENST00000591111:synonymous:LOW:exon78/313:c.22272G>A:p.Gln7424Gln,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.199-40401C>T:,TTN:ENST00000342175:intron:MODIFIER:exon47/191:c.13858+17543G>A:,TTN:ENST00000359218:intron:MODIFIER:exon47/191:c.13657+17543G>A:,TTN:ENST00000460472:intron:MODIFIER:exon46/190:c.13282+17543G>A:		rs2562831	0.9820	0.9950	59606,33233,4367	0.9435,0.9973,1.0000,0.9997,0.9999	0.9958							188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000039984.9 [benign]; RCV000254037.1 [benign]; RCV000271518.1 [likely benign]; RCV000296181.1 [likely benign]; RCV000325238.1 [likely benign]; RCV000331319.1 [likely benign]; RCV000365884.1 [likely benign]; RCV000385735.1 [likely benign]; 			2205	3	2	[2] auto-classification 14.09.2017  			TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179600563	179600563	G	A	hom	anno_omim	QUAL=21278;DP=287;AF=1.00;MQM=60;TRIO=HOM,287,1.00,HOM,124,1.00,HOM,234,1.00	TTN,TTN-AS1	synonymous,intron,non_coding_transcript_exon	TTN:ENST00000589042:synonymous:LOW:exon50/363:c.14610C>T:p.Ser4870Ser,TTN:ENST00000342992:synonymous:LOW:exon47/312:c.10878C>T:p.Ser3626Ser,TTN:ENST00000591111:synonymous:LOW:exon48/313:c.13659C>T:p.Ser4553Ser,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.199-25104G>A:,TTN:ENST00000342175:intron:MODIFIER:exon47/191:c.13858+2246C>T:,TTN:ENST00000359218:intron:MODIFIER:exon47/191:c.13657+2246C>T:,TTN:ENST00000460472:intron:MODIFIER:exon46/190:c.13282+2246C>T:,TTN-AS1:ENST00000582847:non_coding_transcript_exon:MODIFIER:exon4/6:n.550G>A:		rs2742348	0.9818	0.9949	59643,33284,4359	0.9425,0.9974,1.0000,0.9997,0.9999	0.9957							188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000039860.9 [benign]; RCV000245943.1 [benign]; RCV000266820.1 [likely benign]; RCV000302107.1 [likely benign]; RCV000306880.1 [likely benign]; RCV000345343.1 [likely benign]; RCV000359096.1 [likely benign]; RCV000397599.1 [likely benign]; 			2206	3	2	[2] auto-classification 14.09.2017  			TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179610967	179610967	C	T	het	pred_pathogenic;anno_omim	QUAL=8276;DP=394;AF=0.51;MQM=60;TRIO=HET,394,0.51,WT,172,0.01,HET,207,0.50	TTN,TTN-AS1	missense,intron	TTN:ENST00000360870:missense:MODERATE:exon46/46:c.16160G>A:p.Cys5387Tyr,TTN:ENST00000589042:intron:MODIFIER:exon47/362:c.11312-4319G>A:,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.199-14700C>T:,TTN:ENST00000342992:intron:MODIFIER:exon45/311:c.10360+6884G>A:,TTN:ENST00000342175:intron:MODIFIER:exon45/191:c.10799-4319G>A:,TTN:ENST00000359218:intron:MODIFIER:exon45/191:c.10598-4319G>A:,TTN:ENST00000460472:intron:MODIFIER:exon44/190:c.10223-4319G>A:,TTN:ENST00000591111:intron:MODIFIER:exon45/312:c.10361-4319G>A:,TTN-AS1:ENST00000590773:intron:MODIFIER:exon2/4:n.243+3270C>T:,TTN-AS1:ENST00000578746:intron:MODIFIER:exon1/4:n.64+1398C>T:		rs72648913	0.0012	0.0029	1,1,0	0.0006,0.0011,0.0001,0.0044,0.0006	0.0031	1.6850	D,D	T	B	T	14.66	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000041064.5 [other]; RCV000172706.4 [likely benign]; 			0	27					TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179614952	179614952	A	G	hom	anno_omim	QUAL=49250;DP=587;AF=1.00;MQM=60;TRIO=HOM,587,1.00,HOM,395,1.00,HOM,510,1.00	TTN,TTN-AS1	synonymous,intron	TTN:ENST00000360870:synonymous:LOW:exon46/46:c.12175T>C:p.Leu4059Leu,TTN:ENST00000589042:intron:MODIFIER:exon47/362:c.11311+2899T>C:,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.199-10715A>G:,TTN:ENST00000342992:intron:MODIFIER:exon45/311:c.10360+2899T>C:,TTN:ENST00000342175:intron:MODIFIER:exon45/191:c.10798+2899T>C:,TTN:ENST00000359218:intron:MODIFIER:exon45/191:c.10597+2899T>C:,TTN:ENST00000460472:intron:MODIFIER:exon44/190:c.10222+2899T>C:,TTN:ENST00000591111:intron:MODIFIER:exon45/312:c.10360+2899T>C:,TTN-AS1:ENST00000590773:intron:MODIFIER:exon2/4:n.244-6041A>G:,TTN-AS1:ENST00000578746:intron:MODIFIER:exon1/4:n.64+5383A>G:		rs10803917	0.9750	0.9926	59714,33307,4396	0.9200,0.9970,1.0000,0.9997,0.9998	0.9945							188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000041012.3 [benign]; 			2196	10	2	[2] auto-classification 14.09.2017  			TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179615887	179615887	T	C	hom	pred_pathogenic;anno_omim	QUAL=24534;DP=371;AF=1.00;MQM=60;TRIO=HOM,371,1.00,HOM,159,1.00,HOM,221,1.00	TTN,TTN-AS1	missense,intron	TTN:ENST00000360870:missense:MODERATE:exon46/46:c.11240A>G:p.Asp3747Gly,TTN:ENST00000589042:intron:MODIFIER:exon47/362:c.11311+1964A>G:,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.199-9780T>C:,TTN:ENST00000342992:intron:MODIFIER:exon45/311:c.10360+1964A>G:,TTN:ENST00000342175:intron:MODIFIER:exon45/191:c.10798+1964A>G:,TTN:ENST00000359218:intron:MODIFIER:exon45/191:c.10597+1964A>G:,TTN:ENST00000460472:intron:MODIFIER:exon44/190:c.10222+1964A>G:,TTN:ENST00000591111:intron:MODIFIER:exon45/312:c.10360+1964A>G:,TTN-AS1:ENST00000590773:intron:MODIFIER:exon2/4:n.244-5106T>C:,TTN-AS1:ENST00000578746:intron:MODIFIER:exon1/4:n.65-5106T>C:		rs922984	0.7330	0.8271	42438,28413,1803	0.6001,0.5361,0.7529,0.9252,0.7890	0.8208	1.9380	T	T	B	T	8.53	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000041005.4 [benign]; 			1872	325	2	[2] auto-classification 14.09.2017  			TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179615931	179615931	C	G	hom	anno_omim	QUAL=19566;DP=273;AF=1.00;MQM=60;TRIO=HOM,273,1.00,HOM,136,1.00,HOM,182,1.00	TTN,TTN-AS1	missense,intron	TTN:ENST00000360870:missense:MODERATE:exon46/46:c.11196G>C:p.Leu3732Phe,TTN:ENST00000589042:intron:MODIFIER:exon47/362:c.11311+1920G>C:,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.199-9736C>G:,TTN:ENST00000342992:intron:MODIFIER:exon45/311:c.10360+1920G>C:,TTN:ENST00000342175:intron:MODIFIER:exon45/191:c.10798+1920G>C:,TTN:ENST00000359218:intron:MODIFIER:exon45/191:c.10597+1920G>C:,TTN:ENST00000460472:intron:MODIFIER:exon44/190:c.10222+1920G>C:,TTN:ENST00000591111:intron:MODIFIER:exon45/312:c.10360+1920G>C:,TTN-AS1:ENST00000590773:intron:MODIFIER:exon2/4:n.244-5062C>G:,TTN-AS1:ENST00000578746:intron:MODIFIER:exon1/4:n.65-5062C>G:		rs922985	0.9750	0.9926	59376,33139,4336	0.9195,0.9971,1.0000,0.9997,0.9998	0.9945	-0.1470	T	T	B	T	4.29	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000041004.4 [benign]; 			2194	11	2	[2] auto-classification 14.09.2017  			TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179615994	179615994	T	C	hom	anno_omim	QUAL=16792;DP=223;AF=1.00;MQM=60;TRIO=HOM,223,1.00,HOM,119,0.99,HOM,164,1.00	TTN,TTN-AS1	synonymous,intron	TTN:ENST00000360870:synonymous:LOW:exon46/46:c.11133A>G:p.Thr3711Thr,TTN:ENST00000589042:intron:MODIFIER:exon47/362:c.11311+1857A>G:,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.199-9673T>C:,TTN:ENST00000342992:intron:MODIFIER:exon45/311:c.10360+1857A>G:,TTN:ENST00000342175:intron:MODIFIER:exon45/191:c.10798+1857A>G:,TTN:ENST00000359218:intron:MODIFIER:exon45/191:c.10597+1857A>G:,TTN:ENST00000460472:intron:MODIFIER:exon44/190:c.10222+1857A>G:,TTN:ENST00000591111:intron:MODIFIER:exon45/312:c.10360+1857A>G:,TTN-AS1:ENST00000590773:intron:MODIFIER:exon2/4:n.244-4999T>C:,TTN-AS1:ENST00000578746:intron:MODIFIER:exon1/4:n.65-4999T>C:		rs922986	0.9750	0.9926	59578,33255,4387	0.9200,0.9970,1.0000,0.9997,0.9997	0.9944							188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000041002.3 [benign]; 			2202	11	2	[2] auto-classification 14.09.2017  			TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179616771	179616771	A	-	hom	anno_omim	QUAL=3062;DP=140;AF=0.74;MQM=59;TRIO=HOM,140,0.74,HOM,25,0.64,HOM,44,0.41	TTN,TTN-AS1	splice_region&intron,intron	TTN:ENST00000360870:splice_region&intron:LOW:exon45/45:c.10361-5delT:,TTN:ENST00000589042:intron:MODIFIER:exon47/362:c.11311+1080delT:,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.199-8882delA:,TTN:ENST00000342992:intron:MODIFIER:exon45/311:c.10360+1080delT:,TTN:ENST00000342175:intron:MODIFIER:exon45/191:c.10798+1080delT:,TTN:ENST00000359218:intron:MODIFIER:exon45/191:c.10597+1080delT:,TTN:ENST00000460472:intron:MODIFIER:exon44/190:c.10222+1080delT:,TTN:ENST00000591111:intron:MODIFIER:exon45/312:c.10360+1080delT:,TTN-AS1:ENST00000590773:intron:MODIFIER:exon2/4:n.244-4208delA:,TTN-AS1:ENST00000578746:intron:MODIFIER:exon1/4:n.65-4208delA:		rs397986815;rs577374633;rs58651353;rs770426988	0.5262	0.4728	1119,496,80	0.4880,0.4770,0.5124,0.4633,0.4564	0.6879							188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000040993.2 [likely benign]; RCV000415616.1 [uncertain significance]; RCV000415691.1 [uncertain significance]; 			666	640	1	[1] old entry - no details available			TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179620951	179620951	C	T	hom	pred_pathogenic;anno_omim	QUAL=12423;DP=254;AF=1.00;MQM=59;TRIO=HOM,254,1.00,HOM,67,1.00,HOM,93,1.00	TTN,TTN-AS1	missense&splice_region,intron	TTN:ENST00000589042:missense&splice_region:MODERATE:exon46/363:c.11252G>A:p.Gly3751Asp,TTN:ENST00000342175:missense&splice_region:MODERATE:exon44/192:c.10739G>A:p.Gly3580Asp,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.199-4716C>T:,TTN:ENST00000342992:intron:MODIFIER:exon44/311:c.10303+2760G>A:,TTN:ENST00000359218:intron:MODIFIER:exon44/191:c.10540+1318G>A:,TTN:ENST00000460472:intron:MODIFIER:exon43/190:c.10165+2760G>A:,TTN:ENST00000591111:intron:MODIFIER:exon44/312:c.10303+2760G>A:,TTN-AS1:ENST00000590773:intron:MODIFIER:exon2/4:n.244-42C>T:,TTN:ENST00000360870:intron:MODIFIER:exon44/45:c.10303+2760G>A:,TTN-AS1:ENST00000578746:intron:MODIFIER:exon1/4:n.65-42C>T:		rs7585334	0.8045	0.8508	44227,28583,3438	0.8372,0.5495,0.7527,0.9274,0.7953	0.8805	3.7080	T	T	B	T	22.80	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000041121.4 [benign]; 			1884	305	2	[2] auto-classification 14.09.2017  			TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179621184	179621184	G	A	het	anno_omim	QUAL=10405;DP=475;AF=0.48;MQM=60;TRIO=HET,475,0.48,HET,355,0.50,WT,489,0.00	TTN,TTN-AS1	synonymous,intron	TTN:ENST00000589042:synonymous:LOW:exon46/363:c.11019C>T:p.Cys3673Cys,TTN:ENST00000342175:synonymous:LOW:exon44/192:c.10506C>T:p.Cys3502Cys,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.199-4483G>A:,TTN:ENST00000342992:intron:MODIFIER:exon44/311:c.10303+2527C>T:,TTN:ENST00000359218:intron:MODIFIER:exon44/191:c.10540+1085C>T:,TTN:ENST00000460472:intron:MODIFIER:exon43/190:c.10165+2527C>T:,TTN:ENST00000591111:intron:MODIFIER:exon44/312:c.10303+2527C>T:,TTN-AS1:ENST00000590773:intron:MODIFIER:exon3/4:n.300+135G>A:,TTN:ENST00000360870:intron:MODIFIER:exon44/45:c.10303+2527C>T:,TTN-AS1:ENST00000578746:intron:MODIFIER:exon2/4:n.121+135G>A:		rs72955212	0.0052	0.0114	22,19,0	0.0024,0.0044,0.0000,0.0164,0.0012	0.0120							188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000041119.3 [benign]; RCV000226302.1 [benign]; RCV000226302.1 [benign]; 			0	55					TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179621477	179621477	C	T	hom	pred_pathogenic;anno_omim	QUAL=13190;DP=238;AF=1.00;MQM=59;TRIO=HOM,238,1.00,HOM,83,1.00,HOM,115,1.00	TTN,TTN-AS1	missense,intron	TTN:ENST00000589042:missense:MODERATE:exon46/363:c.10726G>A:p.Ala3576Thr,TTN:ENST00000342175:missense:MODERATE:exon44/192:c.10213G>A:p.Ala3405Thr,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.199-4190C>T:,TTN:ENST00000342992:intron:MODIFIER:exon44/311:c.10303+2234G>A:,TTN:ENST00000359218:intron:MODIFIER:exon44/191:c.10540+792G>A:,TTN:ENST00000460472:intron:MODIFIER:exon43/190:c.10165+2234G>A:,TTN:ENST00000591111:intron:MODIFIER:exon44/312:c.10303+2234G>A:,TTN-AS1:ENST00000590773:intron:MODIFIER:exon3/4:n.300+428C>T:,TTN:ENST00000360870:intron:MODIFIER:exon44/45:c.10303+2234G>A:,TTN-AS1:ENST00000578746:intron:MODIFIER:exon2/4:n.121+428C>T:		rs6433728	0.9990	0.9997	60261,33342,4863	0.9962,0.9999,1.0000,1.0000,1.0000	0.9997	0.2260	T	T	B	T	22.80	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000152471.4 [other]; 			2214	0	2	[2] auto-classification 14.09.2017  			TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179621503	179621503	C	T	het	anno_omim	QUAL=2979;DP=210;AF=0.48;MQM=60;TRIO=HET,210,0.48,HET,67,0.51,WT,102,0.00	TTN,TTN-AS1	missense,intron	TTN:ENST00000589042:missense:MODERATE:exon46/363:c.10700G>A:p.Ser3567Asn,TTN:ENST00000342175:missense:MODERATE:exon44/192:c.10187G>A:p.Ser3396Asn,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.199-4164C>T:,TTN:ENST00000342992:intron:MODIFIER:exon44/311:c.10303+2208G>A:,TTN:ENST00000359218:intron:MODIFIER:exon44/191:c.10540+766G>A:,TTN:ENST00000460472:intron:MODIFIER:exon43/190:c.10165+2208G>A:,TTN:ENST00000591111:intron:MODIFIER:exon44/312:c.10303+2208G>A:,TTN-AS1:ENST00000590773:intron:MODIFIER:exon3/4:n.300+454C>T:,TTN:ENST00000360870:intron:MODIFIER:exon44/45:c.10303+2208G>A:,TTN-AS1:ENST00000578746:intron:MODIFIER:exon2/4:n.121+454C>T:		rs72955213	0.0064	0.0141	24,20,0	0.0031,0.0056,0.0001,0.0201,0.0035	0.0142	1.3030	T	T	B	T	18.73	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000041115.4 [benign]; RCV000227153.1 [benign]; RCV000227153.1 [benign]; 			0	73					TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179623758	179623758	C	T	hom	anno_omim	QUAL=16196;DP=239;AF=1.00;MQM=60;TRIO=HOM,239,1.00,HOM,115,1.00,HOM,136,1.00	TTN,TTN-AS1	missense,intron,non_coding_transcript_exon	TTN:ENST00000589042:missense:MODERATE:exon44/363:c.10256G>A:p.Ser3419Asn,TTN:ENST00000342992:missense:MODERATE:exon44/312:c.10256G>A:p.Ser3419Asn,TTN:ENST00000342175:missense:MODERATE:exon43/192:c.10118G>A:p.Ser3373Asn,TTN:ENST00000359218:missense:MODERATE:exon43/192:c.10118G>A:p.Ser3373Asn,TTN:ENST00000460472:missense:MODERATE:exon43/191:c.10118G>A:p.Ser3373Asn,TTN:ENST00000591111:missense:MODERATE:exon44/313:c.10256G>A:p.Ser3419Asn,TTN:ENST00000360870:missense:MODERATE:exon44/46:c.10256G>A:p.Ser3419Asn,TTN-AS1:ENST00000585451:intron:MODIFIER:exon1/4:n.199-1909C>T:,TTN-AS1:ENST00000590773:non_coding_transcript_exon:MODIFIER:exon4/5:n.341C>T:,TTN-AS1:ENST00000578746:non_coding_transcript_exon:MODIFIER:exon3/5:n.162C>T:,TTN-AS1:ENST00000610005:non_coding_transcript_exon:MODIFIER:exon1/5:n.278C>T:		rs2291310	0.8089	0.8512	44905,28700,3721	0.8450,0.5501,0.7636,0.9274,0.7891	0.8838	0.3980	T,T,T,T,T,T,T	T	B,B,B,B	T,T,T,T,T	15.07	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000039852.10 [benign]; RCV000251067.1 [benign]; RCV000275658.1 [likely benign]; RCV000301488.1 [likely benign]; RCV000333056.1 [likely benign]; RCV000354685.1 [likely benign]; RCV000367878.1 [likely benign]; RCV000400937.1 [likely benign]; 			1891	307	2	[2] auto-classification 14.09.2017  			TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179629363	179629363	T	C	hom	anno_omim	QUAL=44979;DP=501;AF=1.00;MQM=60;TRIO=HOM,501,1.00,HOM,401,1.00,HOM,509,1.00	TTN,TTN-AS1	synonymous,intron	TTN:ENST00000589042:synonymous:LOW:exon42/363:c.9879A>G:p.Glu3293Glu,TTN:ENST00000342992:synonymous:LOW:exon42/312:c.9879A>G:p.Glu3293Glu,TTN:ENST00000342175:synonymous:LOW:exon41/192:c.9741A>G:p.Glu3247Glu,TTN:ENST00000359218:synonymous:LOW:exon41/192:c.9741A>G:p.Glu3247Glu,TTN:ENST00000460472:synonymous:LOW:exon41/191:c.9741A>G:p.Glu3247Glu,TTN:ENST00000591111:synonymous:LOW:exon42/313:c.9879A>G:p.Glu3293Glu,TTN:ENST00000360870:synonymous:LOW:exon42/46:c.9879A>G:p.Glu3293Glu,TTN-AS1:ENST00000585451:intron:MODIFIER:exon3/4:n.456+268T>C:,TTN-AS1:ENST00000610005:intron:MODIFIER:exon3/4:n.561+268T>C:		rs4894043	0.9736	0.9921	59764,33351,4343	0.9141,0.9969,1.0000,0.9997,0.9998	0.9941							188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000040976.9 [benign]; RCV000248023.1 [benign]; RCV000259982.1 [likely benign]; RCV000265831.1 [likely benign]; RCV000300096.1 [likely benign]; RCV000305792.1 [likely benign]; RCV000354969.1 [likely benign]; RCV000360490.1 [likely benign]; 			2205	10	2	[2] auto-classification 14.09.2017  			TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179629461	179629461	C	T	hom	pred_pathogenic;anno_omim	QUAL=45091;DP=435;AF=1.00;MQM=59;TRIO=HOM,435,1.00,HOM,430,1.00,HOM,544,1.00	TTN,TTN-AS1	missense,intron	TTN:ENST00000589042:missense:MODERATE:exon42/363:c.9781G>A:p.Val3261Met,TTN:ENST00000342992:missense:MODERATE:exon42/312:c.9781G>A:p.Val3261Met,TTN:ENST00000342175:missense:MODERATE:exon41/192:c.9643G>A:p.Val3215Met,TTN:ENST00000359218:missense:MODERATE:exon41/192:c.9643G>A:p.Val3215Met,TTN:ENST00000460472:missense:MODERATE:exon41/191:c.9643G>A:p.Val3215Met,TTN:ENST00000591111:missense:MODERATE:exon42/313:c.9781G>A:p.Val3261Met,TTN:ENST00000360870:missense:MODERATE:exon42/46:c.9781G>A:p.Val3261Met,TTN-AS1:ENST00000585451:intron:MODIFIER:exon3/4:n.456+366C>T:,TTN-AS1:ENST00000610005:intron:MODIFIER:exon3/4:n.561+366C>T:		rs2291311	0.8049	0.8500	44778,28694,3593	0.8310,0.5504,0.7642,0.9273,0.7891	0.8800	1.0930	T,T,T,T,T,T	T	P,P,P,P	T,T,T,T,T	21.60	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000040961.10 [benign]; RCV000251159.1 [benign]; RCV000272076.1 [likely benign]; RCV000296790.1 [likely benign]; RCV000320840.1 [likely benign]; RCV000327097.1 [likely benign]; RCV000381817.1 [likely benign]; RCV000384754.1 [likely benign]; 			1895	309	2	[2] auto-classification 14.09.2017  			TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179634421	179634421	T	G	het	pred_pathogenic;anno_omim	QUAL=425;DP=105;AF=0.66;MQM=58;TRIO=HET,105,0.66,WT,104,0.00,WT,137,0.00	TTN,TTN-AS1	missense,intron	TTN:ENST00000589042:missense:MODERATE:exon37/363:c.8887A>C:p.Thr2963Pro,TTN:ENST00000342992:missense:MODERATE:exon37/312:c.8887A>C:p.Thr2963Pro,TTN:ENST00000342175:missense:MODERATE:exon36/192:c.8749A>C:p.Thr2917Pro,TTN:ENST00000359218:missense:MODERATE:exon36/192:c.8749A>C:p.Thr2917Pro,TTN:ENST00000460472:missense:MODERATE:exon36/191:c.8749A>C:p.Thr2917Pro,TTN:ENST00000591111:missense:MODERATE:exon37/313:c.8887A>C:p.Thr2963Pro,TTN:ENST00000360870:missense:MODERATE:exon37/46:c.8887A>C:p.Thr2963Pro,TTN-AS1:ENST00000585451:intron:MODIFIER:exon3/4:n.457-3581T>G:,TTN-AS1:ENST00000610005:intron:MODIFIER:exon3/4:n.562-3581T>G:		rs200875815	0.2155	0.3891	5,5,0	0.4553,0.4827,0.4692,0.3398,0.4119	0.2138	5.9120	T,T,T,T,T,D	D	D,D,D,D,D	T,T,T,T,T	18.25	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000172804.2 [benign]; 		COSM146063, COSM146062, COSM146060, COSM146061	2	117	2	[2] auto-classification 14.09.2017  			TTN (inh=AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179642425	179642425	G	A	het	anno_omim	QUAL=5128;DP=174;AF=0.54;MQM=60;TRIO=HET,174,0.54,HOM,61,1.00,HET,65,0.46	TTN,RP11-88L24.4	splice_region&intron	TTN:ENST00000589042:splice_region&intron:LOW:exon25/362:c.4480+6C>T:,TTN:ENST00000342992:splice_region&intron:LOW:exon25/311:c.4480+6C>T:,TTN:ENST00000342175:splice_region&intron:LOW:exon24/191:c.4342+6C>T:,TTN:ENST00000359218:splice_region&intron:LOW:exon24/191:c.4342+6C>T:,TTN:ENST00000460472:splice_region&intron:LOW:exon24/190:c.4342+6C>T:,TTN:ENST00000591111:splice_region&intron:LOW:exon25/312:c.4480+6C>T:,TTN:ENST00000360870:splice_region&intron:LOW:exon25/45:c.4480+6C>T:		rs719201	0.9115	0.9588	55886,32629,3762	0.8507,0.9308,0.8757,0.9890,0.9583	0.9611							188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000040333.9 [benign]; RCV000266351.1 [likely benign]; RCV000272158.1 [likely benign]; RCV000303750.1 [likely benign]; RCV000323768.1 [likely benign]; RCV000358588.1 [likely benign]; RCV000382980.1 [likely benign]; 			2127	88	2	[2] auto-classification 14.09.2017  			TTN (inh=AD pLI=0.00), RP11-88L24.4 (inh=n/a pLI=n/a)
chr2	179644035	179644035	G	A	het	pred_pathogenic;anno_omim	QUAL=13416;DP=289;AF=0.52;MQM=60;TRIO=HET,289,0.52,HOM,183,1.00,HET,194,0.58	TTN,RP11-88L24.4	missense	TTN:ENST00000589042:missense:MODERATE:exon23/363:c.3884C>T:p.Ser1295Leu,TTN:ENST00000342992:missense:MODERATE:exon23/312:c.3884C>T:p.Ser1295Leu,TTN:ENST00000342175:missense:MODERATE:exon22/192:c.3746C>T:p.Ser1249Leu,TTN:ENST00000359218:missense:MODERATE:exon22/192:c.3746C>T:p.Ser1249Leu,TTN:ENST00000460472:missense:MODERATE:exon22/191:c.3746C>T:p.Ser1249Leu,TTN:ENST00000591111:missense:MODERATE:exon23/313:c.3884C>T:p.Ser1295Leu,TTN:ENST00000360870:missense:MODERATE:exon23/46:c.3884C>T:p.Ser1295Leu		rs1552280	0.9201	0.9606	55941,32580,3872	0.8687,0.9322,0.8766,0.9890,0.9583	0.9623	6.2480	T,T,T,T,T,T	T	B,B,B,B	T,T,T,T,T	19.99	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000040271.10 [benign]; RCV000241712.1 [benign]; RCV000264528.1 [likely benign]; RCV000268224.1 [likely benign]; RCV000299899.1 [likely benign]; RCV000303354.1 [likely benign]; RCV000357032.1 [likely benign]; RCV000360628.1 [likely benign]; 			2121	86	2	[2] auto-classification 14.09.2017  			TTN (inh=AD pLI=0.00), RP11-88L24.4 (inh=n/a pLI=n/a)
chr2	179644855	179644855	T	C	het	pred_pathogenic;anno_omim	QUAL=6197;DP=217;AF=0.50;MQM=60;TRIO=HET,217,0.50,HOM,65,1.00,HET,98,0.43	TTN	missense	TTN:ENST00000589042:missense:MODERATE:exon22/363:c.3601A>G:p.Lys1201Glu,TTN:ENST00000342992:missense:MODERATE:exon22/312:c.3601A>G:p.Lys1201Glu,TTN:ENST00000342175:missense:MODERATE:exon21/192:c.3463A>G:p.Lys1155Glu,TTN:ENST00000359218:missense:MODERATE:exon21/192:c.3463A>G:p.Lys1155Glu,TTN:ENST00000460472:missense:MODERATE:exon21/191:c.3463A>G:p.Lys1155Glu,TTN:ENST00000591111:missense:MODERATE:exon22/313:c.3601A>G:p.Lys1201Glu,TTN:ENST00000360870:missense:MODERATE:exon22/46:c.3601A>G:p.Lys1201Glu		rs10497520	0.5002	0.6944	32542,24959,1082	0.4633,0.3726,0.1991,0.8655,0.5786	0.7025	4.1160	T,T,T,T,T,T	T	B,B,B,B,P	T,T,T,T,T	19.62	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000040243.9 [benign]; RCV000246507.1 [benign]; RCV000270311.1 [likely benign]; RCV000305380.1 [likely benign]; RCV000309003.1 [likely benign]; RCV000340634.1 [likely benign]; RCV000362447.1 [likely benign]; RCV000391742.1 [likely benign]; 		COSM4001424, COSM4001425, COSM4001423, COSM4001421, COSM4001422	1542	563	2	[2] auto-classification 14.09.2017  			TTN (inh=AD pLI=0.00)
chr2	179650701	179650701	C	T	het	anno_omim	QUAL=22536;DP=623;AF=0.56;MQM=60;TRIO=HET,623,0.56,HOM,488,1.00,WT,607,0.00	TTN	synonymous	TTN:ENST00000589042:synonymous:LOW:exon14/363:c.2244G>A:p.Glu748Glu,TTN:ENST00000342992:synonymous:LOW:exon14/312:c.2244G>A:p.Glu748Glu,TTN:ENST00000342175:synonymous:LOW:exon13/192:c.2106G>A:p.Glu702Glu,TTN:ENST00000359218:synonymous:LOW:exon13/192:c.2106G>A:p.Glu702Glu,TTN:ENST00000460472:synonymous:LOW:exon13/191:c.2106G>A:p.Glu702Glu,TTN:ENST00000591111:synonymous:LOW:exon14/313:c.2244G>A:p.Glu748Glu,TTN:ENST00000360870:synonymous:LOW:exon14/46:c.2244G>A:p.Glu748Glu		rs6715406	0.2047	0.3192	7161,5389,191	0.1882,0.1526,0.0707,0.4010,0.2516	0.3392							188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];	RCV000040044.5 [benign]; RCV000243970.1 [benign]; RCV000283289.1 [likely benign]; RCV000286612.1 [likely benign]; RCV000322867.1 [likely benign]; RCV000338218.1 [likely benign]; RCV000377759.1 [likely benign]; RCV000400193.1 [likely benign]; 		COSM4001429, COSM4001431, COSM4001430, COSM4001426, COSM4001428, COSM4001427	336	989	2	[2] auto-classification 14.09.2017  			TTN (inh=AD pLI=0.00)
chr2	190430177	190430177	A	G	hom	anno_omim	QUAL=30890;DP=295;AF=1.00;MQM=59;TRIO=HOM,295,1.00,HOM,276,1.00,HOM,397,1.00	SLC40A1	synonymous	SLC40A1:ENST00000261024:synonymous:LOW:exon6/8:c.663T>C:p.Val221Val		rs2304704	0.5501	0.6143	24088,13127,244	0.2200,0.7601,0.7885,0.6257,0.6405	0.6285							604653 [SLC40A1 (confirmed) Hemochromatosis,type 4,606069];	RCV000247963.1 [benign]; RCV000281104.1 [benign]; 			846	966	2	[2] auto-classification 14.09.2017  			SLC40A1 (inh=n/a pLI=0.98)
chr2	190445495	190445495	-	CCG	hom	low_DP;anno_omim	QUAL=1535;DP=15;AF=0.80;MQM=60;TRIO=HOM,15,0.80,HET,30,0.50,HOM,40,0.95	SLC40A1	5'UTR	SLC40A1:ENST00000261024:5'UTR:MODIFIER:exon1/8:c.-312_-310dupCGG:		rs16836041;rs3833570	0.5335	0.0000	0,0,0	0,0,0,0,0	0.5204							604653 [SLC40A1 (confirmed) Hemochromatosis,type 4,606069];	RCV000259537.1 [benign]; 			74	51					SLC40A1 (inh=n/a pLI=0.98)
chr2	191069434	191069434	G	A	het	anno_omim	QUAL=3249;DP=229;AF=0.45;MQM=60;TRIO=HET,229,0.45,WT,51,0.00,HET,69,0.49	HIBCH	3'UTR	HIBCH:ENST00000359678:3'UTR:MODIFIER:exon14/14:c.*409C>T:,HIBCH:ENST00000392332:3'UTR:MODIFIER:exon13/13:c.*519C>T:		rs1058230	0.3632	0.0000	0,0,0	0,0,0,0,0	0.3058							610690 [HIBCH (provisional) 3-hydroxyisobutryl-CoA hydrolase deficiency,250620];				20	86					HIBCH (inh=AR pLI=0.00)
chr2	191069476	191069476	C	T	het	anno_omim	QUAL=5403;DP=328;AF=0.47;MQM=60;TRIO=HET,328,0.47,WT,96,0.00,HET,126,0.49	HIBCH	3'UTR	HIBCH:ENST00000359678:3'UTR:MODIFIER:exon14/14:c.*367G>A:,HIBCH:ENST00000392332:3'UTR:MODIFIER:exon13/13:c.*477G>A:		rs1058227	0.3636	0.0000	0,0,0	0,0,0,0,0	0.3054							610690 [HIBCH (provisional) 3-hydroxyisobutryl-CoA hydrolase deficiency,250620];				20	87					HIBCH (inh=AR pLI=0.00)
chr2	191069689	191069689	T	A	het	anno_omim	QUAL=8108;DP=293;AF=0.46;MQM=59;TRIO=HET,293,0.46,WT,221,0.00,HET,329,0.51	HIBCH	3'UTR	HIBCH:ENST00000359678:3'UTR:MODIFIER:exon14/14:c.*154A>T:,HIBCH:ENST00000392332:3'UTR:MODIFIER:exon13/13:c.*264A>T:	MER58B	rs11542	0.3480	0.0000	0,0,0	0,0,0,0,0	0.2945							610690 [HIBCH (provisional) 3-hydroxyisobutryl-CoA hydrolase deficiency,250620];				20	76					HIBCH (inh=AR pLI=0.00)
chr2	191110893	191110893	C	T	het	pred_pathogenic;anno_omim	QUAL=3824;DP=217;AF=0.43;MQM=60;TRIO=HET,217,0.43,WT,47,0.00,HET,85,0.58	HIBCH	missense	HIBCH:ENST00000359678:missense:MODERATE:exon10/14:c.796G>A:p.Asp266Asn,HIBCH:ENST00000392332:missense:MODERATE:exon10/13:c.796G>A:p.Asp266Asn,HIBCH:ENST00000410045:missense:MODERATE:exon3/7:c.127G>A:p.Asp43Asn		rs144053672	0.0008	0.0027	1,1,0	0.0014,0.0005,0.0000,0.0045,0.0007	0.0030	2.5220	T,T,T,T,T	T	B,B	T,T	23.30	610690 [HIBCH (provisional) 3-hydroxyisobutryl-CoA hydrolase deficiency,250620];	RCV000224515.1 [uncertain significance]; 			0	14					HIBCH (inh=AR pLI=0.00)
chr2	191161622	191161622	T	C	het	pred_pathogenic;anno_omim	QUAL=14883;DP=313;AF=0.47;MQM=60;TRIO=HET,313,0.47,HOM,229,1.00,HET,278,0.50	HIBCH	missense	HIBCH:ENST00000359678:missense:MODERATE:exon3/14:c.136A>G:p.Thr46Ala,HIBCH:ENST00000392332:missense:MODERATE:exon3/13:c.136A>G:p.Thr46Ala		rs1058180	0.6843	0.7393	33450,18999,2177	0.6445,0.7882,0.5446,0.7549,0.7563	0.7459	2.9820	T,T,T	T	B,B	T,T,T	9.02	610690 [HIBCH (provisional) 3-hydroxyisobutryl-CoA hydrolase deficiency,250620];				1074	848	2	[2] auto-classification 14.09.2017  			HIBCH (inh=AR pLI=0.00)
chr2	191184475	191184475	A	G	het	anno_high_impact;pred_pathogenic;anno_omim	QUAL=5024;DP=134;AF=0.46;MQM=60;TRIO=HET,134,0.46,HOM,86,1.00,HET,143,0.34	HIBCH	start_lost	HIBCH:ENST00000359678:start_lost:HIGH:exon1/14:c.2T>C:p.Met1?,HIBCH:ENST00000392332:start_lost:HIGH:exon1/13:c.2T>C:p.Met1?		rs291466	0.4317	0.5279	16666,11152,971	0.4603,0.2760,0.1523,0.6007,0.6061	0.5310	1.2900	D,D	T	B,B	T,T	15.22	610690 [HIBCH (provisional) 3-hydroxyisobutryl-CoA hydrolase deficiency,250620];		CM1311889 [CLASS=FP MUT=ALT PHEN="Increased methylmalonic acid concentrations" GENE=HIBCH]; 		718	1019	1	[1] auto-classification 16.06.2016  			HIBCH (inh=AR pLI=0.00)
chr2	191184524	191184524	C	T	hom	anno_omim	QUAL=15786;DP=250;AF=0.98;MQM=60;TRIO=HOM,250,0.98,HOM,119,1.00,HOM,190,0.98	HIBCH	5'UTR	HIBCH:ENST00000359678:5'UTR:MODIFIER:exon1/14:c.-48G>A:,HIBCH:ENST00000392332:5'UTR:MODIFIER:exon1/13:c.-48G>A:		rs3749022	0.5487	0.6843	19853,13606,545	0.4077,0.4258,0.4613,0.7786,0.7498	0.6790							610690 [HIBCH (provisional) 3-hydroxyisobutryl-CoA hydrolase deficiency,250620];			COSN166358	1225	610					HIBCH (inh=AR pLI=0.00)
chr2	191841759	191841759	G	A	het	anno_omim	QUAL=4966;DP=231;AF=0.45;MQM=60;TRIO=HET,231,0.45,WT,116,0.00,HET,172,0.53	STAT1	splice_region&intron	STAT1:ENST00000361099:splice_region&intron:LOW:exon21/24:c.1874-8C>T:,STAT1:ENST00000409465:splice_region&intron:LOW:exon20/23:c.1874-8C>T:,STAT1:ENST00000540176:splice_region&intron:LOW:exon19/22:c.*1200-8C>T:,STAT1:ENST00000392322:splice_region&intron:LOW:exon21/22:c.1874-8C>T:,STAT1:ENST00000392323:splice_region&intron:LOW:exon22/23:c.1880-8C>T:		rs2066804	0.2266	0.2260	3440,1838,154	0.1701,0.1042,0.4529,0.2377,0.1774	0.2288							600555 [STAT1 (provisional) Immunodeficiency 31A,mycobacteriosis,autosomal dominant,614892|Immunodeficiency 31B,mycobacterial and viral infections,autosomal recessive,613796|Immunodeficiency 31C,autosomal dominant,614162];	RCV000335899.1 [benign]; 			116	817	2	[2] auto-classification 14.09.2017  			STAT1 (inh=AR+AD pLI=1.00)
chr2	198362018	198362018	T	C	hom	anno_omim	QUAL=32193;DP=445;AF=1.00;MQM=59;TRIO=HOM,445,1.00,HOM,241,1.00,HOM,307,1.00	HSPD1	synonymous	HSPD1:ENST00000345042:synonymous:LOW:exon3/12:c.273A>G:p.Lys91Lys,HSPD1:ENST00000388968:synonymous:LOW:exon3/12:c.273A>G:p.Lys91Lys,HSPD1:ENST00000544407:synonymous:LOW:exon3/3:c.273A>G:p.Lys91Lys		rs8539	0.6546	0.6490	26123,15686,2679	0.7158,0.4642,0.5216,0.6834,0.6898	0.6448							118190 [HSPD1 (confirmed) Spastic paraplegia 13,autosomal dominant,605280|Leukodystrophy,hypomyelinating,4,612233];	RCV000117240.3 [other]; RCV000291547.1 [benign]; 		COSM3757861, COSM3757863, COSM3757862	1397	1038	2	[2] auto-classification 14.09.2017  			HSPD1 (inh=AR+AD pLI=0.99)
chr2	198363504	198363504	A	G	het	anno_omim	QUAL=2917;DP=207;AF=0.46;MQM=56;TRIO=HET,207,0.46,HET,60,0.45,WT,86,0.01	HSPD1	synonymous	HSPD1:ENST00000345042:synonymous:LOW:exon2/12:c.69T>C:p.Thr23Thr,HSPD1:ENST00000388968:synonymous:LOW:exon2/12:c.69T>C:p.Thr23Thr,HSPD1:ENST00000544407:synonymous:LOW:exon2/3:c.69T>C:p.Thr23Thr		rs1050347	0.1581	0.1643	506,311,29	0.1072,0.1792,0.2199,0.1760,0.1093	0.1720							118190 [HSPD1 (confirmed) Spastic paraplegia 13,autosomal dominant,605280|Leukodystrophy,hypomyelinating,4,612233];	RCV000117242.3 [other]; RCV000387107.1 [benign]; 			100	757	2	[2] auto-classification 14.09.2017  			HSPD1 (inh=AR+AD pLI=0.99)
chr2	198364518	198364518	G	A	het	anno_omim	QUAL=1295;DP=23;AF=0.87;MQM=60;TRIO=HET,23,0.87,HET,52,0.71,WT,63,0.00	HSPD1	5'UTR_premature_start_codon_gain,5'UTR,intron	HSPD1:ENST00000388968:5'UTR_premature_start_codon_gain:LOW:exon1/12:c.-15C>T:,HSPD1:ENST00000388968:5'UTR:MODIFIER:exon1/12:c.-15C>T:,HSPD1:ENST00000345042:intron:MODIFIER:exon1/11:c.-3+366C>T:,HSPD1:ENST00000544407:intron:MODIFIER:exon1/2:c.-3+205C>T:		rs13165	0.2332	0.0000	0,0,0	0,0,0,0,0	0.2294							118190 [HSPD1 (confirmed) Spastic paraplegia 13,autosomal dominant,605280|Leukodystrophy,hypomyelinating,4,612233];	RCV000125394.1 [benign]; RCV000349661.1 [benign]; 			11	64	2	[2] auto-classification 14.09.2017  			HSPD1 (inh=AR+AD pLI=0.99)
chr2	200134420	200134420	-	AA	hom	anno_omim	QUAL=2079;DP=99;AF=0.67;MQM=58;TRIO=HOM,99,0.67,HOM,9,0.33,HOM,6,0.50	SATB2	3'UTR	SATB2:ENST00000260926:3'UTR:MODIFIER:exon12/12:c.*2512_*2513dupTT:,SATB2:ENST00000417098:3'UTR:MODIFIER:exon11/11:c.*2512_*2513dupTT:,SATB2:ENST00000443023:3'UTR:MODIFIER:exon10/10:c.*2512_*2513dupTT:		rs386392269;rs58333872	0.0000	0.0000	0,0,0	0,0,0,0,0	0.7336							608148 [SATB2 (confirmed) Glass syndrome,612313];				154	22					SATB2 (inh=AD pLI=1.00)
chr2	200135233	200135233	-	A	hom	anno_omim	QUAL=1948;DP=314;AF=0.42;MQM=59;TRIO=HOM,314,0.42,WT,126,0.26,HOM,169,0.49	SATB2	3'UTR	SATB2:ENST00000260926:3'UTR:MODIFIER:exon12/12:c.*1700dupT:,SATB2:ENST00000417098:3'UTR:MODIFIER:exon11/11:c.*1700dupT:,SATB2:ENST00000443023:3'UTR:MODIFIER:exon10/10:c.*1700dupT:		rs397987298;rs67882050	0.5377	0.0000	0,0,0	0,0,0,0,0	0.7543							608148 [SATB2 (confirmed) Glass syndrome,612313];				44	120					SATB2 (inh=AD pLI=1.00)
chr2	200136284	200136284	A	-	het	anno_omim	QUAL=1798;DP=99;AF=0.47;MQM=59;TRIO=HET,99,0.47,HET,75,0.59,WT,66,0.14	SATB2	3'UTR	SATB2:ENST00000260926:3'UTR:MODIFIER:exon12/12:c.*650delT:,SATB2:ENST00000417098:3'UTR:MODIFIER:exon11/11:c.*650delT:,SATB2:ENST00000443023:3'UTR:MODIFIER:exon10/10:c.*650delT:		rs397987299	0.4403	0.0000	0,0,0	0,0,0,0,0	0.5126							608148 [SATB2 (confirmed) Glass syndrome,612313];				57	122					SATB2 (inh=AD pLI=1.00)
chr2	200136583	200136583	T	A	hom	anno_omim	QUAL=16760;DP=204;AF=1.00;MQM=59;TRIO=HOM,204,1.00,HOM,121,1.00,HOM,199,1.00	SATB2	3'UTR	SATB2:ENST00000260926:3'UTR:MODIFIER:exon12/12:c.*351A>T:,SATB2:ENST00000417098:3'UTR:MODIFIER:exon11/11:c.*351A>T:,SATB2:ENST00000443023:3'UTR:MODIFIER:exon10/10:c.*351A>T:		rs6435006	0.9325	0.0000	0,0,0	0,0,0,0,0	0.9456							608148 [SATB2 (confirmed) Glass syndrome,612313];				231	1					SATB2 (inh=AD pLI=1.00)
chr2	200173684	200173684	T	G	hom	anno_omim	QUAL=20796;DP=127;AF=1.00;MQM=60;TRIO=HOM,127,1.00,HOM,238,1.00,HOM,302,1.00	SATB2	splice_region&intron	SATB2:ENST00000260926:splice_region&intron:LOW:exon10/11:c.1543-4A>C:,SATB2:ENST00000417098:splice_region&intron:LOW:exon9/10:c.1543-4A>C:,SATB2:ENST00000443023:splice_region&intron:LOW:exon8/9:c.1366-4A>C:,SATB2:ENST00000428695:splice_region&intron:LOW:exon5/6:c.1189-4A>C:,SATB2:ENST00000457245:splice_region&intron:LOW:exon10/11:c.1543-4A>C:		rs10153730	0.9309	0.9820	58446,33219,3290	0.8017,0.9914,1.0000,0.9996,0.9995	0.9855							608148 [SATB2 (confirmed) Glass syndrome,612313];				2093	12	2	[2] auto-classification 14.09.2017  			SATB2 (inh=AD pLI=1.00)
chr2	202565570	202565570	C	T	het	anno_omim	QUAL=4513;DP=243;AF=0.47;MQM=60;TRIO=HET,243,0.47,HET,138,0.45,WT,171,0.01	ALS2	3'UTR	ALS2:ENST00000264276:3'UTR:MODIFIER:exon34/34:c.*1004G>A:		rs11300	0.1024	0.0000	0,0,0	0,0,0,0,0	0.0841							606352 [ALS2 (confirmed) Amyotrophic lateral sclerosis 2,juvenile,205100|Primary lateral sclerosis,juvenile,606353|Spastic paralysis,infantile onset ascending,607225];	RCV000305695.1 [likely benign]; RCV000360466.1 [likely benign]; 			2	40					ALS2 (inh=AR pLI=0.00)
chr2	202565681	202565681	G	A	het	anno_omim	QUAL=4559;DP=280;AF=0.48;MQM=60;TRIO=HET,280,0.48,HET,102,0.44,WT,169,0.01	ALS2	3'UTR	ALS2:ENST00000264276:3'UTR:MODIFIER:exon34/34:c.*893C>T:		rs3219174	0.0897	0.0000	0,0,0	0,0,0,0,0	0.0642							606352 [ALS2 (confirmed) Amyotrophic lateral sclerosis 2,juvenile,205100|Primary lateral sclerosis,juvenile,606353|Spastic paralysis,infantile onset ascending,607225];	RCV000326977.1 [likely benign]; RCV000381762.1 [likely benign]; 			1	31					ALS2 (inh=AR pLI=0.00)
chr2	202575821	202575821	G	A	hom	anno_omim	QUAL=16533;DP=255;AF=1.00;MQM=60;TRIO=HOM,255,1.00,HOM,149,1.00,HET,194,0.61	ALS2	synonymous,3'UTR	ALS2:ENST00000264276:synonymous:LOW:exon26/34:c.4015C>T:p.Leu1339Leu,ALS2:ENST00000457679:3'UTR:MODIFIER:exon18/26:c.*363C>T:		rs3219168	0.9054	0.9232	51524,28358,3331	0.8239,0.8948,0.9849,0.9222,0.9603	0.9231							606352 [ALS2 (confirmed) Amyotrophic lateral sclerosis 2,juvenile,205100|Primary lateral sclerosis,juvenile,606353|Spastic paralysis,infantile onset ascending,607225];	RCV000250217.1 [benign]; RCV000283291.1 [benign]; RCV000347093.1 [benign]; 			2300	357	2	[2] auto-classification 14.09.2017  			ALS2 (inh=AR pLI=0.00)
chr2	202593280	202593280	G	A	het	anno_omim	QUAL=7402;DP=337;AF=0.49;MQM=60;TRIO=HET,337,0.49,HET,242,0.50,WT,313,0.00	ALS2	synonymous	ALS2:ENST00000264276:synonymous:LOW:exon15/34:c.2796C>T:p.Ser932Ser,ALS2:ENST00000457679:synonymous:LOW:exon6/26:c.732C>T:p.Ser244Ser		rs3219161	0.1150	0.0979	745,261,26	0.0678,0.0329,0.2434,0.0857,0.1332	0.0955							606352 [ALS2 (confirmed) Amyotrophic lateral sclerosis 2,juvenile,205100|Primary lateral sclerosis,juvenile,606353|Spastic paralysis,infantile onset ascending,607225];	RCV000254279.1 [benign]; RCV000267099.1 [likely benign]; RCV000322182.1 [likely benign]; 		COSM3757885	30	449	2	[2] auto-classification 14.09.2017  			ALS2 (inh=AR pLI=0.00)
chr2	202598113	202598113	C	T	het	anno_omim	QUAL=5337;DP=190;AF=0.51;MQM=60;TRIO=HET,190,0.51,HET,90,0.52,HET,128,0.45	ALS2	synonymous	ALS2:ENST00000264276:synonymous:LOW:exon13/34:c.2466G>A:p.Val822Val,ALS2:ENST00000457679:synonymous:LOW:exon4/26:c.402G>A:p.Val134Val		rs2276615	0.3724	0.5272	18156,12226,133	0.1575,0.6708,0.3467,0.6063,0.4008	0.5394							606352 [ALS2 (confirmed) Amyotrophic lateral sclerosis 2,juvenile,205100|Primary lateral sclerosis,juvenile,606353|Spastic paralysis,infantile onset ascending,607225];	RCV000249292.1 [benign]; RCV000288406.1 [benign]; RCV000352784.1 [benign]; 		COSM149044	931	1243	2	[2] auto-classification 14.09.2017  			ALS2 (inh=AR pLI=0.00)
chr2	202625615	202625615	C	T	hom	anno_omim	QUAL=24039;DP=492;AF=1.00;MQM=59;TRIO=HOM,492,1.00,HOM,165,1.00,HET,252,0.46	ALS2	missense	ALS2:ENST00000264276:missense:MODERATE:exon4/34:c.1102G>A:p.Val368Met,ALS2:ENST00000467448:missense:MODERATE:exon4/4:c.1102G>A:p.Val368Met		rs3219156	0.8966	0.9106	50185,27117,3007	0.7836,0.9351,0.9999,0.9018,0.9519	0.9130	-2.3570	T,T	T	B,B,B,B	T,T	0.03	606352 [ALS2 (confirmed) Amyotrophic lateral sclerosis 2,juvenile,205100|Primary lateral sclerosis,juvenile,606353|Spastic paralysis,infantile onset ascending,607225];	RCV000243956.1 [benign]; RCV000269440.1 [benign]; RCV000326864.1 [benign]; 			2139	509	2	[2] auto-classification 14.09.2017  			ALS2 (inh=AR pLI=0.00)
chr2	206988751	206988751	A	G	het	anno_omim	QUAL=5405;DP=278;AF=0.52;MQM=60;TRIO=HET,278,0.52,HET,98,0.52,WT,131,0.00	NDUFS1	3'UTR	NDUFS1:ENST00000233190:3'UTR:MODIFIER:exon19/19:c.*158T>C:,NDUFS1:ENST00000423725:3'UTR:MODIFIER:exon18/18:c.*158T>C:,NDUFS1:ENST00000457011:3'UTR:MODIFIER:exon15/15:c.*158T>C:,NDUFS1:ENST00000440274:3'UTR:MODIFIER:exon18/18:c.*158T>C:		rs3770989	0.0256	0.0000	0,0,0	0,0,0,0,0	0.0263							157655 [NDUFS1 (provisional) Mitochondrial complex I deficiency,252010];	RCV000260695.1 [uncertain significance]; RCV000318219.1 [uncertain significance]; 			0	21					NDUFS1 (inh=AR pLI=0.00)
chr2	206992537	206992537	A	C	het	pred_pathogenic;anno_omim	QUAL=1524;DP=236;AF=0.53;MQM=60;TRIO=HET,236,0.53,WT,132,0.00,WT,161,0.00	NDUFS1	missense	NDUFS1:ENST00000455934:missense:MODERATE:exon16/19:c.1910T>G:p.Ile637Arg,NDUFS1:ENST00000233190:missense:MODERATE:exon16/19:c.1868T>G:p.Ile623Arg,NDUFS1:ENST00000423725:missense:MODERATE:exon15/18:c.1697T>G:p.Ile566Arg,NDUFS1:ENST00000457011:missense:MODERATE:exon12/15:c.1520T>G:p.Ile507Arg,NDUFS1:ENST00000440274:missense:MODERATE:exon15/18:c.1760T>G:p.Ile587Arg,NDUFS1:ENST00000449699:missense:MODERATE:exon16/19:c.1868T>G:p.Ile623Arg,NDUFS1:ENST00000432169:missense:MODERATE:exon13/16:c.1535T>G:p.Ile512Arg		rs201634181	0.0000	0.0046	0,0,0	0.0079,0.0030,0.0043,0.0057,0.0006	0.0013	9.2840	D,D,D,D,D,D,D	D	D,P,P,P	D,D,D,D,D,D,D	28.90	157655 [NDUFS1 (provisional) Mitochondrial complex I deficiency,252010];			COSM215852	0	78					NDUFS1 (inh=AR pLI=0.00)
chr2	207026131	207026131	G	A	het	pred_pathogenic	QUAL=6049;DP=227;AF=0.45;MQM=55;TRIO=HET,227,0.45,HET,294,0.47,WT,379,0.00	EEF1B2	missense	EEF1B2:ENST00000236957:missense:MODERATE:exon4/7:c.265G>A:p.Gly89Arg,EEF1B2:ENST00000392221:missense:MODERATE:exon4/7:c.265G>A:p.Gly89Arg,EEF1B2:ENST00000392222:missense:MODERATE:exon3/6:c.265G>A:p.Gly89Arg		rs11546386	0.0178	0.0126	25,3,0	0.0012,0.0051,0.0306,0.0076,0.0405	0.0123	5.3110	T,T,T,T	T	B	T,T,T,T	22.00				COSM3695209	3	58					EEF1B2 (inh=n/a pLI=0.33)
chr2	207657706	207657706	G	C	het	anno_omim	QUAL=4824;DP=192;AF=0.52;MQM=59;TRIO=HET,192,0.52,WT,126,0.00,HET,177,0.53	FASTKD2,RP11,95H11.1	intergenic_region	95H11.1:ENSG00000118246-ENSG00000260171:intergenic_region:MODIFIER::n.207657706G>C:	AluSc	rs114333222	0.0016	0.0000	0,0,0	0,0,0,0,0	0.0039							612322 [FASTKD2 (provisional) Mitochondrial complex IV deficiency,220110];	RCV000364221.1 [uncertain significance]; 			0	5					FASTKD2 (inh=AR pLI=0.00), PRPF31 (inh=AD pLI=0.97), 95H11.1 (inh=n/a pLI=n/a)
chr2	211421452	211421452	-	TCT	hom	anno_omim	QUAL=12769;DP=254;AF=0.95;MQM=59;TRIO=HOM,254,0.95,HET,166,0.49,HET,195,0.49	CPS1	conservative_inframe_insertion,5'UTR	CPS1:ENST00000430249:conservative_inframe_insertion:MODERATE:exon2/39:c.15_16insTTC:p.Ile5_Lys6insPhe,CPS1:ENST00000233072:5'UTR:MODIFIER:exon1/38:c.-4_-3insTTC:		rs3835047;rs61509952	0.4770	0.4350	11669,5397,1790	0.5875,0.5215,0.3653,0.4019,0.4558	0.4418							608307 [CPS1 (confirmed) Carbamoylphosphate synthetase I deficiency,237300|Pulmonary hypertension,neonatal,susceptibility to,615371|Venoocclusive disease after bone marrow transplantation];				434	1000	1	[1] old entry - no details available			CPS1 (inh=AR pLI=0.08)
chr2	211456637	211456637	A	G	hom	pred_pathogenic;anno_omim	QUAL=15942;DP=210;AF=1.00;MQM=60;TRIO=HOM,210,1.00,HOM,178,0.99,HET,254,0.51	CPS1	missense	CPS1:ENST00000430249:missense:MODERATE:exon11/39:c.1048A>G:p.Thr350Ala,CPS1:ENST00000233072:missense:MODERATE:exon10/38:c.1030A>G:p.Thr344Ala		rs1047883	0.0000	0.5697	19535,10771,1924	0.6106,0.4533,0.5466,0.5724,0.6009	0.5769	0.2530	T,T,T,T	T	B	D,D	4.19	608307 [CPS1 (confirmed) Carbamoylphosphate synthetase I deficiency,237300|Pulmonary hypertension,neonatal,susceptibility to,615371|Venoocclusive disease after bone marrow transplantation];	RCV000116829.5 [other]; RCV000364698.1 [benign]; 		COSM4133424, COSM4133425	758	983	2	[2] auto-classification 14.09.2017  			CPS1 (inh=AR pLI=0.08)
chr2	211456639	211456639	C	T	hom	anno_omim	QUAL=15942;DP=210;AF=1.00;MQM=60;TRIO=HOM,210,1.00,HOM,178,0.99,HET,254,0.51	CPS1	synonymous	CPS1:ENST00000430249:synonymous:LOW:exon11/39:c.1050C>T:p.Thr350Thr,CPS1:ENST00000233072:synonymous:LOW:exon10/38:c.1032C>T:p.Thr344Thr		rs2229589	0.5913	0.5736	19866,10782,2240	0.6579,0.4541,0.5466,0.5721,0.6009	0.5896							608307 [CPS1 (confirmed) Carbamoylphosphate synthetase I deficiency,237300|Pulmonary hypertension,neonatal,susceptibility to,615371|Venoocclusive disease after bone marrow transplantation];	RCV000116830.5 [other]; RCV000302372.1 [benign]; 			765	976	2	[2] auto-classification 14.09.2017  			CPS1 (inh=AR pLI=0.08)
chr2	211481257	211481257	C	G	hom	anno_omim	QUAL=15598;DP=142;AF=1.00;MQM=60;TRIO=HOM,142,1.00,HOM,254,1.00,HET,292,0.42	CPS1	synonymous	CPS1:ENST00000430249:synonymous:LOW:exon22/39:c.2697C>G:p.Gly899Gly,CPS1:ENST00000233072:synonymous:LOW:exon21/38:c.2679C>G:p.Gly893Gly,CPS1:ENST00000451903:synonymous:LOW:exon11/28:c.1326C>G:p.Gly442Gly		rs2287599	0.6492	0.5861	21467,10811,3868	0.8637,0.4588,0.4966,0.5673,0.6284	0.6316							608307 [CPS1 (confirmed) Carbamoylphosphate synthetase I deficiency,237300|Pulmonary hypertension,neonatal,susceptibility to,615371|Venoocclusive disease after bone marrow transplantation];	RCV000116831.4 [other]; RCV000347604.1 [benign]; 			744	996	2	[2] auto-classification 14.09.2017  			CPS1 (inh=AR pLI=0.08)
chr2	211543147	211543147	T	G	het	anno_omim	QUAL=7846;DP=273;AF=0.51;MQM=59;TRIO=HET,273,0.51,HET,93,0.63,HET,130,0.63	CPS1	3'UTR	CPS1:ENST00000430249:3'UTR:MODIFIER:exon39/39:c.*438T>G:,CPS1:ENST00000233072:3'UTR:MODIFIER:exon38/38:c.*438T>G:,CPS1:ENST00000451903:3'UTR:MODIFIER:exon28/28:c.*438T>G:		rs7684	0.2690	0.0000	0,0,0	0,0,0,0,0	0.3329							608307 [CPS1 (confirmed) Carbamoylphosphate synthetase I deficiency,237300|Pulmonary hypertension,neonatal,susceptibility to,615371|Venoocclusive disease after bone marrow transplantation];	RCV000335404.1 [benign]; 			29	112					CPS1 (inh=AR pLI=0.08)
chr2	215796302	215796302	-	ACAA	het	anno_omim	QUAL=6985;DP=218;AF=0.49;MQM=59;TRIO=HET,218,0.49,HOM,156,0.97,WT,282,0.00	ABCA12,AC072062.1	3'UTR	ABCA12:ENST00000272895:3'UTR:MODIFIER:exon53/53:c.*1052_*1055dupTTGT:		rs57011945	0.3015	0.0000	0,0,0	0,0,0,0,0	0.3368							607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A,601277|Ichthyosis,congenital,autosomal recessive 4B (harlequin),242500];	RCV000285776.1 [benign]; 			40	100					ABCA12 (inh=AR pLI=0.00), AC072062.1 (inh=n/a pLI=n/a)
chr2	215796568	215796568	T	C	hom	anno_omim	QUAL=19207;DP=226;AF=1.00;MQM=59;TRIO=HOM,226,1.00,HOM,159,1.00,HOM,203,1.00	ABCA12,AC072062.1	3'UTR	ABCA12:ENST00000272895:3'UTR:MODIFIER:exon53/53:c.*790A>G:		rs12694349	0.5939	0.0000	0,0,0	0,0,0,0,0	0.5853							607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A,601277|Ichthyosis,congenital,autosomal recessive 4B (harlequin),242500];	RCV000365901.1 [benign]; 			65	105					ABCA12 (inh=AR pLI=0.00), AC072062.1 (inh=n/a pLI=n/a)
chr2	215797332	215797332	C	T	hom	anno_omim	QUAL=15380;DP=321;AF=1.00;MQM=60;TRIO=HOM,321,1.00,HOM,82,1.00,HET,127,0.55	ABCA12,AC072062.1	3'UTR	ABCA12:ENST00000272895:3'UTR:MODIFIER:exon53/53:c.*26G>A:		rs17426207	0.3982	0.4314	10530,5449,641	0.3502,0.4540,0.3561,0.4255,0.5274	0.4221							607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A,601277|Ichthyosis,congenital,autosomal recessive 4B (harlequin),242500];	RCV000267300.1 [benign]; 			335	1013					ABCA12 (inh=AR pLI=0.00), AC072062.1 (inh=n/a pLI=n/a)
chr2	215820013	215820013	G	A	het	anno_omim	QUAL=13130;DP=328;AF=0.41;MQM=60;TRIO=HET,328,0.41,HOM,196,1.00,HET,265,0.49	ABCA12,AC072062.1	synonymous	ABCA12:ENST00000272895:synonymous:LOW:exon43/53:c.6306C>T:p.Tyr2102Tyr,ABCA12:ENST00000389661:synonymous:LOW:exon35/45:c.5352C>T:p.Tyr1784Tyr		rs10498027	0.3500	0.4051	10283,6091,513	0.3127,0.3855,0.2320,0.4250,0.4772	0.4065							607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A,601277|Ichthyosis,congenital,autosomal recessive 4B (harlequin),242500];	RCV000254526.1 [benign]; RCV000300175.1 [benign]; 		COSM3757935	365	1067	2	[2] auto-classification 14.09.2017  			ABCA12 (inh=AR pLI=0.00), AC072062.1 (inh=n/a pLI=n/a)
chr2	215839570	215839570	C	T	het	anno_omim	QUAL=8765;DP=334;AF=0.49;MQM=60;TRIO=HET,334,0.49,WT,246,0.00,HET,339,0.48	ABCA12	synonymous	ABCA12:ENST00000272895:synonymous:LOW:exon35/53:c.5400G>A:p.Thr1800Thr,ABCA12:ENST00000389661:synonymous:LOW:exon27/45:c.4446G>A:p.Thr1482Thr		rs16853022	0.1196	0.0477	495,3,440	0.2869,0.0215,0.0382,0.0145,0.0730	0.0904							607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A,601277|Ichthyosis,congenital,autosomal recessive 4B (harlequin),242500];	RCV000246212.1 [benign]; RCV000271010.1 [benign]; 			10	158	2	[2] auto-classification 14.09.2017  			ABCA12 (inh=AR pLI=0.00)
chr2	215851303	215851303	A	G	hom	anno_omim	QUAL=15522;DP=180;AF=0.99;MQM=60;TRIO=HOM,180,0.99,HET,163,0.52,HOM,248,1.00	ABCA12	synonymous	ABCA12:ENST00000272895:synonymous:LOW:exon28/53:c.4126T>C:p.Leu1376Leu,ABCA12:ENST00000389661:synonymous:LOW:exon20/45:c.3172T>C:p.Leu1058Leu		rs34351934	0.2071	0.1356	1703,316,769	0.3801,0.2486,0.0402,0.0942,0.1600	0.1642							607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A,601277|Ichthyosis,congenital,autosomal recessive 4B (harlequin),242500];	RCV000248405.1 [benign]; RCV000305663.1 [benign]; 			47	471	2	[2] auto-classification 14.09.2017  			ABCA12 (inh=AR pLI=0.00)
chr2	215854156	215854156	C	T	het	anno_omim	QUAL=14250;DP=345;AF=0.49;MQM=60;TRIO=HET,345,0.49,HET,348,0.49,HET,456,0.46	ABCA12	synonymous	ABCA12:ENST00000272895:synonymous:LOW:exon26/53:c.3726G>A:p.Pro1242Pro,ABCA12:ENST00000389661:synonymous:LOW:exon18/45:c.2772G>A:p.Pro924Pro		rs71428357	0.0719	0.0653	427,98,43	0.0998,0.1985,0.0004,0.0534,0.0502	0.0719							607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A,601277|Ichthyosis,congenital,autosomal recessive 4B (harlequin),242500];	RCV000243239.1 [benign]; RCV000331070.1 [likely benign]; 			14	247	2	[2] auto-classification 14.09.2017  			ABCA12 (inh=AR pLI=0.00)
chr2	215876166	215876166	A	T	hom	anno_omim	QUAL=15166;DP=215;AF=1.00;MQM=60;TRIO=HOM,215,1.00,HOM,127,1.00,HOM,162,1.00	ABCA12	missense	ABCA12:ENST00000272895:missense:MODERATE:exon17/53:c.2329T>A:p.Ser777Thr,ABCA12:ENST00000389661:missense:MODERATE:exon9/45:c.1375T>A:p.Ser459Thr		rs7560008	0.9984	0.9994	60286,33210,5059	0.9934,0.9997,1.0000,1.0000,1.0000	0.9995	-1.4110	T,T	T	B,B	T,T	0.08	607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A,601277|Ichthyosis,congenital,autosomal recessive 4B (harlequin),242500];	RCV000248760.1 [benign]; RCV000319091.1 [benign]; 			2102	2	2	[2] auto-classification 14.09.2017  			ABCA12 (inh=AR pLI=0.00)
chr2	215876371	215876371	T	C	hom	anno_omim	QUAL=10498;DP=185;AF=0.99;MQM=60;TRIO=HOM,185,0.99,HET,135,0.51,HET,211,0.51	ABCA12	splice_region&synonymous	ABCA12:ENST00000272895:splice_region&synonymous:LOW:exon17/53:c.2124A>G:p.Ala708Ala,ABCA12:ENST00000389661:splice_region&synonymous:LOW:exon9/45:c.1170A>G:p.Ala390Ala		rs10198064	0.2794	0.1520	2861,266,1963	0.6145,0.2533,0.0442,0.0867,0.1584	0.2294							607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A,601277|Ichthyosis,congenital,autosomal recessive 4B (harlequin),242500];	RCV000243989.1 [benign]; RCV000288434.1 [benign]; 			54	455	2	[2] auto-classification 14.09.2017  			ABCA12 (inh=AR pLI=0.00)
chr2	215901774	215901774	C	T	het	anno_omim	QUAL=7551;DP=320;AF=0.52;MQM=60;TRIO=HET,320,0.52,WT,203,0.00,HET,236,0.52	ABCA12,AC072062.3	synonymous	ABCA12:ENST00000272895:synonymous:LOW:exon8/53:c.888G>A:p.Val296Val		rs17501837	0.2234	0.2057	2859,1304,104	0.1482,0.2959,0.3980,0.1977,0.1289	0.2107							607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A,601277|Ichthyosis,congenital,autosomal recessive 4B (harlequin),242500];	RCV000245963.1 [benign]; RCV000347345.1 [benign]; 		COSM50991	71	569	2	[2] auto-classification 14.09.2017  			ABCA12 (inh=AR pLI=0.00), AC072062.3 (inh=n/a pLI=n/a)
chr2	216176807	216176807	T	G	het	anno_omim	QUAL=2406;DP=41;AF=0.49;MQM=60;TRIO=HET,41,0.49,WT,130,0.00,HET,174,0.51	ATIC	5'UTR	ATIC:ENST00000236959:5'UTR:MODIFIER:exon1/16:c.-59T>G:,ATIC:ENST00000540518:5'UTR:MODIFIER:exon1/16:c.-465T>G:		rs4535042	0.2448	0.0000	0,0,0	0,0,0,0,0	0.2266							601731 [ATIC (provisional) AICA-ribosiduria due to ATIC deficiency,608688];				218	807					ATIC (inh=AR pLI=0.00)
chr2	216214492	216214492	T	G	het	anno_omim	QUAL=10116;DP=210;AF=0.52;MQM=59;TRIO=HET,210,0.52,HOM,164,1.00,HET,206,0.42	ATIC,FN1	intergenic_region	FN1:ENSG00000138363-ENSG00000115414:intergenic_region:MODIFIER::n.216214492T>G:		rs10498036	0.5952	0.0000	0,0,0	0,0,0,0,0	0.6095							601731 [ATIC (provisional) AICA-ribosiduria due to ATIC deficiency,608688];				55	120					ATIC (inh=AR pLI=0.00), FN1 (inh=AD pLI=0.06)
chr2	217277249	217277249	C	T	het	anno_omim	QUAL=8659;DP=114;AF=0.48;MQM=60;TRIO=HET,114,0.48,WT,173,0.00,HOM,254,1.00	SMARCAL1,AC098820.2	5'UTR	SMARCAL1:ENST00000357276:5'UTR:MODIFIER:exon1/18:c.-218C>T:		rs3755141	0.2079	0.0000	0,0,0	0,0,0,0,0	0.2337							606622 [SMARCAL1 (provisional) Schimke immunoosseous dysplasia,242900];	RCV000265625.1 [benign]; 			18	85					SMARCAL1 (inh=AR pLI=0.00), AC098820.2 (inh=n/a pLI=n/a)
chr2	219646547	219646547	-	C	hom	anno_omim	QUAL=4527;DP=52;AF=0.96;MQM=59;TRIO=HOM,52,0.96,HOM,56,0.98,HOM,59,1.00	CYP27A1	5'UTR	CYP27A1:ENST00000258415:5'UTR:MODIFIER:exon1/9:c.-357dupC:		rs397795841	0.9998	0.0000	0,0,0	0,0,0,0,0	1.0000							606530 [CYP27A1 (provisional) Cerebrotendinous xanthomatosis,213700];	RCV000322434.1 [benign]; 			230	2					CYP27A1 (inh=AR pLI=0.00)
chr2	219940484	219940484	C	T	hom	anno_omim	QUAL=16790;DP=291;AF=1.00;MQM=59;TRIO=HOM,291,1.00,HOM,114,1.00,HOM,123,1.00	NHEJ1,SLC23A3	3'UTR	NHEJ1:ENST00000409720:3'UTR:MODIFIER:exon7/7:c.*558G>A:,NHEJ1:ENST00000356853:3'UTR:MODIFIER:exon8/8:c.*619G>A:		rs359960	0.9852	0.0000	0,0,0	0,0,0,0,0	0.9839							611290 [NHEJ1 (provisional) Severe combined immunodeficiency with microcephaly,growth retardation,and sensitivity to ionizing radiation,611291];				224	8					NHEJ1 (inh=n/a pLI=0.03), SLC23A3 (inh=n/a pLI=0.00)
chr2	219941063	219941063	G	A	hom	anno_omim	QUAL=20190;DP=326;AF=1.00;MQM=59;TRIO=HOM,326,1.00,HET,199,0.46,HOM,235,1.00	NHEJ1,SLC23A3	synonymous,3'UTR	NHEJ1:ENST00000409720:synonymous:LOW:exon7/7:c.930C>T:p.Asn310Asn,NHEJ1:ENST00000356853:3'UTR:MODIFIER:exon8/8:c.*40C>T:		rs897477	0.6384	0.7109	31172,19666,2546	0.6984,0.6154,0.4480,0.7684,0.6444	0.7336							611290 [NHEJ1 (provisional) Severe combined immunodeficiency with microcephaly,growth retardation,and sensitivity to ionizing radiation,611291];			COSM4001506	1182	905	2	[2] auto-classification 14.09.2017  			NHEJ1 (inh=n/a pLI=0.03), SLC23A3 (inh=n/a pLI=0.00)
chr2	220283259	220283259	A	G	het	low_DP;anno_omim	QUAL=4879;DP=6;AF=0.83;MQM=60;TRIO=HET,6,0.83,HOM,63,1.00,HOM,104,1.00	DES	synonymous	DES:ENST00000373960:synonymous:LOW:exon1/9:c.75A>G:p.Pro25Pro		rs1318299	0.8862	0.9652	49754,28119,1579	0.6654,0.9818,0.9996,0.9889,0.9748	0.9680							125660 [DES (confirmed) Myopathy,myofibrillar,1,601419|Cardiomyopathy,dilated,1I,604765|Scapuloperoneal syndrome,neurogenic,Kaeser type,181400|Muscular dystrophy,limb-girdle,type 2R,615325];	RCV000029660.1 [benign]; RCV000037251.10 [benign]; RCV000250669.1 [benign]; RCV000299687.1 [benign]; RCV000356753.1 [benign]; RCV000395699.1 [benign]; RCV000395883.1 [benign]; 		COSM3757962	2062	75	2	[2] auto-classification 14.09.2017  			DES (inh=AR+AD pLI=0.00)
chr2	220283277	220283277	T	C	hom	low_DP;anno_omim	QUAL=5311;DP=7;AF=1.00;MQM=60;TRIO=HOM,7,1.00,HOM,67,1.00,HOM,102,1.00	DES	synonymous	DES:ENST00000373960:synonymous:LOW:exon1/9:c.93T>C:p.Ser31Ser		rs2017800	0.8660	0.9611	48951,27937,1280	0.6090,0.9793,0.9998,0.9886,0.9749	0.9641							125660 [DES (confirmed) Myopathy,myofibrillar,1,601419|Cardiomyopathy,dilated,1I,604765|Scapuloperoneal syndrome,neurogenic,Kaeser type,181400|Muscular dystrophy,limb-girdle,type 2R,615325];	RCV000029661.1 [benign]; RCV000037256.10 [benign]; RCV000242424.1 [benign]; RCV000277612.1 [benign]; RCV000312502.1 [benign]; RCV000325693.1 [benign]; RCV000369464.1 [benign]; 		COSM3749630	2074	81	2	[2] auto-classification 14.09.2017  			DES (inh=AR+AD pLI=0.00)
chr2	220285309	220285309	C	T	hom	anno_omim	QUAL=37665;DP=393;AF=0.98;MQM=59;TRIO=HOM,393,0.98,HOM,372,0.99,HOM,451,1.00	DES	synonymous	DES:ENST00000373960:synonymous:LOW:exon4/9:c.828C>T:p.Asp276Asp		rs1058261	0.3375	0.3363	6988,4285,1016	0.4452,0.3020,0.1882,0.3603,0.2988	0.3509							125660 [DES (confirmed) Myopathy,myofibrillar,1,601419|Cardiomyopathy,dilated,1I,604765|Scapuloperoneal syndrome,neurogenic,Kaeser type,181400|Muscular dystrophy,limb-girdle,type 2R,615325];	RCV000037254.8 [benign]; RCV000247557.1 [benign]; RCV000311313.1 [benign]; RCV000338231.1 [benign]; RCV000390698.1 [benign]; RCV000397462.1 [benign]; 			308	989	2	[2] auto-classification 14.09.2017  			DES (inh=AR+AD pLI=0.00)
chr2	220285666	220285666	G	C	hom	anno_omim	QUAL=35360;DP=179;AF=0.99;MQM=59;TRIO=HOM,179,0.99,HOM,419,1.00,HOM,534,1.00	DES	synonymous	DES:ENST00000373960:synonymous:LOW:exon5/9:c.1014G>C:p.Leu338Leu		rs12920	0.3377	0.3414	6724,4097,1020	0.4560,0.3077,0.1923,0.3631,0.3053	0.3524							125660 [DES (confirmed) Myopathy,myofibrillar,1,601419|Cardiomyopathy,dilated,1I,604765|Scapuloperoneal syndrome,neurogenic,Kaeser type,181400|Muscular dystrophy,limb-girdle,type 2R,615325];	RCV000037222.8 [benign]; RCV000250707.1 [benign]; RCV000270208.1 [benign]; RCV000293964.1 [benign]; RCV000325316.1 [benign]; RCV000388336.1 [benign]; 		COSM4133480	309	989	2	[2] auto-classification 14.09.2017  			DES (inh=AR+AD pLI=0.00)
chr2	220286142	220286142	G	A	hom	anno_omim	QUAL=29889;DP=207;AF=1.00;MQM=59;TRIO=HOM,207,1.00,HOM,317,1.00,HOM,467,1.00	DES	synonymous	DES:ENST00000373960:synonymous:LOW:exon6/9:c.1104G>A:p.Ala368Ala		rs1058284	0.3337	0.3362	7020,4314,1009	0.4421,0.3024,0.1887,0.3603,0.2989	0.3510							125660 [DES (confirmed) Myopathy,myofibrillar,1,601419|Cardiomyopathy,dilated,1I,604765|Scapuloperoneal syndrome,neurogenic,Kaeser type,181400|Muscular dystrophy,limb-girdle,type 2R,615325];	RCV000037225.9 [benign]; RCV000242476.1 [benign]; RCV000305879.1 [benign]; RCV000342152.1 [benign]; RCV000403379.1 [benign]; RCV000405738.1 [benign]; 		COSM4001515	308	989	2	[2] auto-classification 14.09.2017  			DES (inh=AR+AD pLI=0.00)
chr2	223158653	223158653	T	-	hom	anno_omim	QUAL=17030;DP=166;AF=0.98;MQM=59;TRIO=HOM,166,0.98,HOM,194,1.00,HOM,235,1.00	PAX3	3'UTR,intron	PAX3:ENST00000409828:3'UTR:MODIFIER:exon4/4:c.*171delA:,PAX3:ENST00000392069:intron:MODIFIER:exon4/9:c.586+233delA:,PAX3:ENST00000344493:intron:MODIFIER:exon4/7:c.586+233delA:,PAX3:ENST00000350526:intron:MODIFIER:exon4/7:c.586+233delA:,PAX3:ENST00000336840:intron:MODIFIER:exon4/8:c.586+233delA:,PAX3:ENST00000392070:intron:MODIFIER:exon4/8:c.586+233delA:,PAX3:ENST00000409551:intron:MODIFIER:exon4/8:c.583+233delA:,PAX3:ENST00000258387:intron:MODIFIER:exon4/4:c.587-177delA:		rs397987956	1.0000	0.0000	0,0,0	0,0,0,0,0	1.0000							606597 [PAX3 (confirmed) Waardenburg syndrome,type 1,193500|Waardenburg syndrome,type 3,148820|Craniofacial-deafness-hand syndrome,122880|Rhabdomyosarcoma 2,alveolar,268220];				152	0					PAX3 (inh=AR+AD pLI=0.90)
chr2	223161889	223161889	A	G	hom	anno_omim	QUAL=8521;DP=55;AF=1.00;MQM=59;TRIO=HOM,55,1.00,HOM,125,1.00,HOM,131,1.00	PAX3	synonymous	PAX3:ENST00000392069:synonymous:LOW:exon2/10:c.129T>C:p.Gly43Gly,PAX3:ENST00000344493:synonymous:LOW:exon2/8:c.129T>C:p.Gly43Gly,PAX3:ENST00000350526:synonymous:LOW:exon2/8:c.129T>C:p.Gly43Gly,PAX3:ENST00000336840:synonymous:LOW:exon2/9:c.129T>C:p.Gly43Gly,PAX3:ENST00000392070:synonymous:LOW:exon2/9:c.129T>C:p.Gly43Gly,PAX3:ENST00000409551:synonymous:LOW:exon2/9:c.129T>C:p.Gly43Gly,PAX3:ENST00000409828:synonymous:LOW:exon2/4:c.129T>C:p.Gly43Gly,PAX3:ENST00000258387:synonymous:LOW:exon2/5:c.129T>C:p.Gly43Gly		rs12623857	0.9044	0.8872	35371,17979,2524	0.8461,0.9401,1.0000,0.8536,0.9549	0.8843							606597 [PAX3 (confirmed) Waardenburg syndrome,type 1,193500|Waardenburg syndrome,type 3,148820|Craniofacial-deafness-hand syndrome,122880|Rhabdomyosarcoma 2,alveolar,268220];	RCV000176002.3 [benign]; RCV000326158.1 [benign]; RCV000362250.1 [benign]; 			1639	432	2	[2] auto-classification 14.09.2017  			PAX3 (inh=AR+AD pLI=0.90)
chr2	227867719	227867719	G	A	het	anno_omim	QUAL=7022;DP=387;AF=0.47;MQM=59;TRIO=HET,387,0.47,HET,151,0.52,WT,199,0.00	COL4A4	3'UTR	COL4A4:ENST00000396625:3'UTR:MODIFIER:exon48/48:c.*4322C>T:		rs1054413	0.5399	0.0000	0,0,0	0,0,0,0,0	0.5063							120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,familial benign];	RCV000346117.1 [benign]; 			34	125					COL4A4 (inh=AR pLI=0.00)
chr2	227868854	227868854	C	T	het	anno_omim	QUAL=5734;DP=285;AF=0.51;MQM=59;TRIO=HET,285,0.51,HET,146,0.53,WT,173,0.00	COL4A4	3'UTR	COL4A4:ENST00000396625:3'UTR:MODIFIER:exon48/48:c.*3187G>A:	L2c	rs56324594	0.4683	0.0000	0,0,0	0,0,0,0,0	0.4444							120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,familial benign];	RCV000351903.1 [benign]; 			33	113					COL4A4 (inh=AR pLI=0.00)
chr2	227869921	227869921	T	-	het	anno_omim	QUAL=4323;DP=316;AF=0.52;MQM=59;TRIO=HET,316,0.52,HET,92,0.39,WT,117,0.08	COL4A4	3'UTR	COL4A4:ENST00000396625:3'UTR:MODIFIER:exon48/48:c.*2120delA:		rs71821803	0.2871	0.0000	0,0,0	0,0,0,0,0	0.3350							120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,familial benign];	RCV000267226.1 [benign]; 			31	123					COL4A4 (inh=AR pLI=0.00)
chr2	227871266	227871266	-	T	het	anno_omim	QUAL=4233;DP=255;AF=0.45;MQM=59;TRIO=HET,255,0.45,HET,180,0.46,WT,234,0.00	COL4A4	3'UTR	COL4A4:ENST00000396625:3'UTR:MODIFIER:exon48/48:c.*774dupA:		rs370368184;rs59918285	0.5154	0.0000	0,0,0	0,0,0,0,0	0.4807							120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,familial benign];	RCV000393839.1 [benign]; 			33	125					COL4A4 (inh=AR pLI=0.00)
chr2	227871475	227871475	T	-	het	anno_omim	QUAL=2965;DP=234;AF=0.48;MQM=59;TRIO=HET,234,0.48,HET,91,0.51,WT,101,0.00	COL4A4	3'UTR	COL4A4:ENST00000396625:3'UTR:MODIFIER:exon48/48:c.*566delA:		rs796331910	0.4806	0.0000	0,0,0	0,0,0,0,0	0.4593							120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,familial benign];	RCV000311172.1 [benign]; 			32	127					COL4A4 (inh=AR pLI=0.00)
chr2	227872182	227872182	G	A	het	anno_omim	QUAL=5371;DP=210;AF=0.55;MQM=60;TRIO=HET,210,0.55,HET,189,0.47,WT,200,0.02	COL4A4	synonymous	COL4A4:ENST00000396625:synonymous:LOW:exon48/48:c.4932C>T:p.Phe1644Phe,COL4A4:ENST00000329662:synonymous:LOW:exon47/47:c.4923C>T:p.Phe1641Phe		rs2228557	0.5144	0.4657	13498,5686,1763	0.5990,0.5413,0.4012,0.4116,0.5826	0.4858							120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,familial benign];	RCV000247000.1 [benign]; RCV000291655.1 [benign]; 		COSM3757991	373	1052	2	[2] auto-classification 14.09.2017  			COL4A4 (inh=AR pLI=0.00)
chr2	227872995	227872995	T	C	het	anno_omim	QUAL=4275;DP=110;AF=0.51;MQM=60;TRIO=HET,110,0.51,HET,230,0.55,WT,225,0.00	COL4A4	synonymous	COL4A4:ENST00000396625:synonymous:LOW:exon47/48:c.4548A>G:p.Val1516Val,COL4A4:ENST00000329662:synonymous:LOW:exon46/47:c.4539A>G:p.Val1513Val		rs2228555	0.6406	0.5602	19250,8400,2574	0.7258,0.5896,0.5621,0.5028,0.6802	0.5804							120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,familial benign];	RCV000250409.1 [benign]; RCV000284418.1 [benign]; 		COSM3757992	562	1069	2	[2] auto-classification 14.09.2017  			COL4A4 (inh=AR pLI=0.00)
chr2	227873028	227873028	A	G	het	anno_omim	QUAL=4395;DP=142;AF=0.56;MQM=59;TRIO=HET,142,0.56,HET,179,0.56,WT,176,0.00	COL4A4	splice_region&intron	COL4A4:ENST00000396625:splice_region&intron:LOW:exon46/47:c.4523-8T>C:,COL4A4:ENST00000329662:splice_region&intron:LOW:exon45/46:c.4514-8T>C:		rs13419076	0.5156	0.4649	13136,5504,1736	0.6010,0.5375,0.3990,0.4105,0.5828	0.4862							120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,familial benign];	RCV000245457.1 [benign]; RCV000339277.1 [benign]; 			376	1050	2	[2] auto-classification 14.09.2017  			COL4A4 (inh=AR pLI=0.00)
chr2	227886773	227886773	A	G	het	pred_pathogenic;anno_omim	QUAL=4776;DP=233;AF=0.49;MQM=60;TRIO=HET,233,0.49,HET,136,0.54,WT,203,0.00	COL4A4	missense	COL4A4:ENST00000396625:missense:MODERATE:exon44/48:c.4207T>C:p.Ser1403Pro,COL4A4:ENST00000329662:missense:MODERATE:exon43/47:c.4198T>C:p.Ser1400Pro		rs3752895	0.5262	0.4763	14088,6128,1982	0.6357,0.5471,0.4040,0.4269,0.5640	0.5001	3.4190	T,T	T	B	D,D	20.60	120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,familial benign];	RCV000249698.1 [benign]; RCV000407614.1 [benign]; 		COSM3757993	401	1059	2	[2] auto-classification 14.09.2017  			COL4A4 (inh=AR pLI=0.00)
chr2	227892619	227892619	C	T	het	anno_omim	QUAL=4996;DP=256;AF=0.57;MQM=60;TRIO=HET,256,0.57,HET,69,0.71,WT,82,0.00	COL4A4	splice_region&synonymous	COL4A4:ENST00000396625:splice_region&synonymous:LOW:exon42/48:c.4080G>A:p.Pro1360Pro,COL4A4:ENST00000329662:splice_region&synonymous:LOW:exon42/47:c.4080G>A:p.Pro1360Pro		rs2228556	0.4918	0.4700	13568,6287,1395	0.5349,0.5431,0.4058,0.4322,0.5568	0.4760							120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,familial benign];	RCV000253144.1 [benign]; RCV000329823.1 [benign]; 		COSM1752390	401	1062	2	[2] auto-classification 14.09.2017  			COL4A4 (inh=AR pLI=0.00)
chr2	227892720	227892720	C	T	het	pred_pathogenic;anno_omim;anno_pathogenic_clinvar	QUAL=4077;DP=161;AF=0.57;MQM=60;TRIO=HET,161,0.57,HET,96,0.66,WT,91,0.00	COL4A4	missense	COL4A4:ENST00000396625:missense:MODERATE:exon42/48:c.3979G>A:p.Val1327Met,COL4A4:ENST00000329662:missense:MODERATE:exon42/47:c.3979G>A:p.Val1327Met		rs2229813	0.4930	0.4879	12092,5508,1240	0.5479,0.5562,0.4240,0.4513,0.5698	0.4747	-0.1400	T,T	T	B	D,D	14.35	120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,familial benign];	RCV000171504.1 [likely pathogenic]; RCV000246048.1 [benign]; RCV000271269.1 [benign]; 		COSM1752392	403	1061	1	[1] harmuth 03.04.2017			COL4A4 (inh=AR pLI=0.00)
chr2	227896652	227896652	C	G	het	anno_omim	QUAL=6928;DP=322;AF=0.50;MQM=60;TRIO=HET,322,0.50,HET,185,0.60,WT,270,0.00	COL4A4	splice_region&intron	COL4A4:ENST00000396625:splice_region&intron:LOW:exon40/47:c.3817+9G>C:,COL4A4:ENST00000329662:splice_region&intron:LOW:exon40/46:c.3817+9G>C:		rs13423714	0.4960	0.4801	13242,6080,1363	0.5380,0.5508,0.4159,0.4402,0.5791	0.4751							120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,familial benign];	RCV000249465.1 [benign]; RCV000326292.1 [benign]; 			406	1057	2	[2] auto-classification 14.09.2017  			COL4A4 (inh=AR pLI=0.00)
chr2	227896886	227896886	C	T	het	anno_omim	QUAL=3595;DP=210;AF=0.45;MQM=60;TRIO=HET,210,0.45,HET,97,0.46,WT,165,0.00	COL4A4	synonymous	COL4A4:ENST00000396625:synonymous:LOW:exon39/48:c.3684G>A:p.Lys1228Lys,COL4A4:ENST00000329662:synonymous:LOW:exon39/47:c.3684G>A:p.Lys1228Lys		rs2229812	0.4956	0.4716	13744,6323,1371	0.5289,0.5441,0.4077,0.4320,0.5717	0.4753							120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,familial benign];	RCV000244180.1 [benign]; RCV000286046.1 [benign]; 		COSM3757994	411	1063	2	[2] auto-classification 14.09.2017  			COL4A4 (inh=AR pLI=0.00)
chr2	227896976	227896976	C	T	het	anno_omim	QUAL=3707;DP=294;AF=0.49;MQM=59;TRIO=HET,294,0.49,HET,42,0.50,WT,72,0.00	COL4A4	synonymous	COL4A4:ENST00000396625:synonymous:LOW:exon39/48:c.3594G>A:p.Gly1198Gly,COL4A4:ENST00000329662:synonymous:LOW:exon39/47:c.3594G>A:p.Gly1198Gly		rs10203363	0.4950	0.4746	13401,6131,1351	0.5311,0.5464,0.4129,0.4345,0.5743	0.4741							120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,familial benign];	RCV000252184.1 [benign]; RCV000322357.1 [benign]; 		COSM3757995	407	1065	2	[2] auto-classification 14.09.2017  			COL4A4 (inh=AR pLI=0.00)
chr2	227915832	227915832	G	A	het	pred_pathogenic;anno_omim	QUAL=8110;DP=316;AF=0.51;MQM=60;TRIO=HET,316,0.51,HET,266,0.55,WT,384,0.01	COL4A4	missense	COL4A4:ENST00000396625:missense:MODERATE:exon33/48:c.3011C>T:p.Pro1004Leu,COL4A4:ENST00000329662:missense:MODERATE:exon33/47:c.3011C>T:p.Pro1004Leu		rs1800517	0.5473	0.5205	16667,7960,1561	0.5643,0.5631,0.4551,0.4862,0.6434	0.5206	4.3580	D,D	T	B	D,D	20.90	120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,familial benign];	RCV000251893.1 [benign]; RCV000389933.1 [benign]; 		COSM4001525	549	1050	2	[2] auto-classification 14.09.2017  			COL4A4 (inh=AR pLI=0.00)
chr2	227954599	227954599	G	A	het	pred_pathogenic;anno_omim	QUAL=2729;DP=140;AF=0.47;MQM=60;TRIO=HET,140,0.47,HET,112,0.44,WT,152,0.01	COL4A4	missense	COL4A4:ENST00000396625:missense:MODERATE:exon21/48:c.1444C>T:p.Pro482Ser,COL4A4:ENST00000329662:missense:MODERATE:exon21/47:c.1444C>T:p.Pro482Ser		rs2229814	0.5485	0.5345	17676,8236,1270	0.5081,0.6808,0.4908,0.4944,0.6342	0.5405	0.6240	T,T	T	B	D,D	1.22	120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,familial benign];	RCV000248568.1 [benign]; RCV000299491.1 [benign]; 		COSM3757996	555	1046	2	[2] auto-classification 14.09.2017  			COL4A4 (inh=AR pLI=0.00)
chr2	228111435	228111435	T	C	het	pred_pathogenic;anno_omim	QUAL=8339;DP=297;AF=0.52;MQM=60;TRIO=HET,297,0.52,HET,124,0.54,HET,180,0.50	COL4A3,AC097662.2	missense	COL4A3:ENST00000396578:missense:MODERATE:exon7/52:c.422T>C:p.Leu141Pro		rs10178458	0.7967	0.8302	41833,23030,1954	0.6316,0.8951,0.9136,0.8308,0.8597	0.8339	0.3960	T,T,T,T,T	T	B,B,B,B	D	0.04	120070 [COL4A3 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,benign familial,141200|Alport syndrome,autosomal dominant,104200];	RCV000245465.1 [benign]; RCV000399711.1 [benign]; 			1452	574	2	[2] auto-classification 14.09.2017  			COL4A3 (inh=AR+AD pLI=0.00), AC097662.2 (inh=n/a pLI=n/a)
chr2	228113175	228113175	A	G	het	pred_pathogenic;anno_omim	QUAL=8519;DP=342;AF=0.49;MQM=59;TRIO=HET,342,0.49,HET,115,0.52,HET,181,0.52	COL4A3,AC097662.2	missense	COL4A3:ENST00000396578:missense:MODERATE:exon9/52:c.485A>G:p.Glu162Gly		rs6436669	0.7963	0.8304	41904,23062,1956	0.6310,0.8949,0.9138,0.8310,0.8600	0.8341	0.2100	T,T,T,T,T	T	B,B,B,B	D	9.66	120070 [COL4A3 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,benign familial,141200|Alport syndrome,autosomal dominant,104200];	RCV000242416.1 [benign]; RCV000295878.1 [benign]; 			1453	574	2	[2] auto-classification 14.09.2017  			COL4A3 (inh=AR+AD pLI=0.00), AC097662.2 (inh=n/a pLI=n/a)
chr2	228128540	228128540	C	T	hom	anno_omim	QUAL=9947;DP=147;AF=0.99;MQM=59;TRIO=HOM,147,0.99,HOM,70,1.00,HOM,102,1.00	COL4A3,AC097662.2	synonymous	COL4A3:ENST00000396578:synonymous:LOW:exon21/52:c.1195C>T:p.Leu399Leu		rs10205042	0.7676	0.7667	35528,17828,2160	0.6715,0.8657,0.8900,0.7336,0.8091	0.7679							120070 [COL4A3 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,benign familial,141200|Alport syndrome,autosomal dominant,104200];	RCV000245175.1 [benign]; RCV000363958.1 [benign]; 			1074	834	2	[2] auto-classification 14.09.2017  			COL4A3 (inh=AR+AD pLI=0.00), AC097662.2 (inh=n/a pLI=n/a)
chr2	228135631	228135631	C	T	hom	pred_pathogenic;anno_omim	QUAL=9723;DP=193;AF=0.99;MQM=59;TRIO=HOM,193,0.99,HOM,76,1.00,HET,103,0.52	COL4A3,AC097662.2	missense	COL4A3:ENST00000396578:missense:MODERATE:exon25/52:c.1721C>T:p.Pro574Leu		rs28381984	0.4000	0.4695	13946,7735,189	0.1902,0.4875,0.4665,0.4785,0.5890	0.4692	2.1930	D,D,D,D,D	T	D,D,D,D	D	26.10	120070 [COL4A3 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,benign familial,141200|Alport syndrome,autosomal dominant,104200];	RCV000247531.1 [benign]; RCV000296144.1 [benign]; 		COSM3758002, COSM3758001	461	1006	2	[2] auto-classification 14.09.2017  			COL4A3 (inh=AR+AD pLI=0.00), AC097662.2 (inh=n/a pLI=n/a)
chr2	228147093	228147093	A	G	het	pred_pathogenic;anno_omim	QUAL=3605;DP=245;AF=0.47;MQM=60;TRIO=HET,245,0.47,WT,71,0.00,HET,77,0.52	COL4A3,AC097662.2	missense	COL4A3:ENST00000396578:missense:MODERATE:exon32/52:c.2501A>G:p.Lys834Arg		rs56226424	0.0056	0.0124	15,13,0	0.0018,0.0068,0.0000,0.0188,0.0040	0.0122	-0.2720	T,T,T,T,T	T	B,B,B,B	D	0.14	120070 [COL4A3 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,benign familial,141200|Alport syndrome,autosomal dominant,104200];	RCV000244722.1 [benign]; 			1	50					COL4A3 (inh=AR+AD pLI=0.00), AC097662.2 (inh=n/a pLI=n/a)
chr2	228176901	228176901	A	C	hom	anno_omim	QUAL=38934;DP=587;AF=1.00;MQM=60;TRIO=HOM,587,1.00,HOM,241,1.00,HOM,346,1.00	COL4A3,AC097662.2	3'UTR	COL4A3:ENST00000396578:3'UTR:MODIFIER:exon52/52:c.*315A>C:		rs2070735	0.7290	0.0000	0,0,0	0,0,0,0,0	0.7722							120070 [COL4A3 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,benign familial,141200|Alport syndrome,autosomal dominant,104200];	RCV000271870.1 [benign]; 			171	54					COL4A3 (inh=AR+AD pLI=0.00), AC097662.2 (inh=n/a pLI=n/a)
chr2	228177479	228177479	C	T	hom	anno_omim	QUAL=27975;DP=416;AF=1.00;MQM=60;TRIO=HOM,416,1.00,HOM,179,1.00,HOM,254,1.00	COL4A3,AC097662.2	3'UTR	COL4A3:ENST00000396578:3'UTR:MODIFIER:exon52/52:c.*893C>T:		rs7587228	0.8476	0.0000	0,0,0	0,0,0,0,0	0.8776							120070 [COL4A3 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,benign familial,141200|Alport syndrome,autosomal dominant,104200];	RCV000318374.1 [benign]; 			185	44					COL4A3 (inh=AR+AD pLI=0.00), AC097662.2 (inh=n/a pLI=n/a)
chr2	228177751	228177751	G	A	hom	anno_omim	QUAL=24343;DP=462;AF=0.99;MQM=60;TRIO=HOM,462,0.99,HOM,195,1.00,HET,253,0.45	COL4A3,AC097662.2	3'UTR	COL4A3:ENST00000396578:3'UTR:MODIFIER:exon52/52:c.*1165G>A:		rs28554165	0.2690	0.0000	0,0,0	0,0,0,0,0	0.2761							120070 [COL4A3 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,benign familial,141200|Alport syndrome,autosomal dominant,104200];	RCV000365583.1 [benign]; 			34	100					COL4A3 (inh=AR+AD pLI=0.00), AC097662.2 (inh=n/a pLI=n/a)
chr2	228177825	228177825	C	G	hom	anno_omim	QUAL=28548;DP=414;AF=1.00;MQM=60;TRIO=HOM,414,1.00,HOM,189,1.00,HOM,253,1.00	COL4A3,AC097662.2	3'UTR	COL4A3:ENST00000396578:3'UTR:MODIFIER:exon52/52:c.*1239C>G:	L2d	rs10188531	0.9161	0.0000	0,0,0	0,0,0,0,0	0.9354							120070 [COL4A3 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,benign familial,141200|Alport syndrome,autosomal dominant,104200];	RCV000392111.1 [benign]; 			193	33					COL4A3 (inh=AR+AD pLI=0.00), AC097662.2 (inh=n/a pLI=n/a)
chr2	228178645	228178645	C	G	hom	anno_omim	QUAL=19235;DP=304;AF=0.99;MQM=59;TRIO=HOM,304,0.99,HOM,118,1.00,HOM,166,1.00	COL4A3,AC097662.2	3'UTR	COL4A3:ENST00000396578:3'UTR:MODIFIER:exon52/52:c.*2059C>G:	MER5A	rs4290648	0.9161	0.0000	0,0,0	0,0,0,0,0	0.9354							120070 [COL4A3 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,benign familial,141200|Alport syndrome,autosomal dominant,104200];	RCV000372136.1 [benign]; 			167	32					COL4A3 (inh=AR+AD pLI=0.00), AC097662.2 (inh=n/a pLI=n/a)
chr2	228178780	228178780	A	C	hom	anno_omim	QUAL=18546;DP=321;AF=1.00;MQM=59;TRIO=HOM,321,1.00,HOM,109,1.00,HOM,126,1.00	COL4A3,AC097662.2	3'UTR	COL4A3:ENST00000396578:3'UTR:MODIFIER:exon52/52:c.*2194A>C:		rs7567291	1.0000	0.0000	0,0,0	0,0,0,0,0	1.0000							120070 [COL4A3 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,benign familial,141200|Alport syndrome,autosomal dominant,104200];	RCV000292828.1 [benign]; 			232	0					COL4A3 (inh=AR+AD pLI=0.00), AC097662.2 (inh=n/a pLI=n/a)
chr2	231050715	231050715	A	G	hom	anno_omim	QUAL=23133;DP=228;AF=1.00;MQM=59;TRIO=HOM,228,1.00,HOM,206,1.00,HOM,294,1.00	SP110	missense	SP110:ENST00000258381:missense:MODERATE:exon11/19:c.1274T>C:p.Leu425Ser,SP110:ENST00000358662:missense:MODERATE:exon11/18:c.1274T>C:p.Leu425Ser,SP110:ENST00000392048:missense:MODERATE:exon11/15:c.1268T>C:p.Leu423Ser,SP110:ENST00000258382:missense:MODERATE:exon11/15:c.1274T>C:p.Leu425Ser,SP110:ENST00000540870:missense:MODERATE:exon12/16:c.1292T>C:p.Leu431Ser,SP110:ENST00000338556:missense:MODERATE:exon10/14:c.380T>C:p.Leu127Ser		rs3948464	0.9040	0.8869	47894,25126,3764	0.8502,0.9278,0.9968,0.8670,0.9161	0.8893	-0.3640	T,T,T,T,T,T	T	B,B,B,B,B	T,T,T,T,T,T	0.01	604457 [SP110 (confirmed) Hepatic venoocclusive disease with immunodeficiency,235550|Mycobacterium tuberculosis,susceptibility to,607948];	RCV000005877.5 [uncertain significance]; 			1641	425	2	[2] auto-classification 14.09.2017  			SP110 (inh=AR pLI=0.00)
chr2	231072709	231072709	C	T	hom	anno_omim	QUAL=20466;DP=315;AF=1.00;MQM=60;TRIO=HOM,315,1.00,HOM,137,0.99,HOM,163,1.00	SP110,SP140	missense	SP110:ENST00000258381:missense:MODERATE:exon8/19:c.895G>A:p.Gly299Arg,SP110:ENST00000358662:missense:MODERATE:exon8/18:c.895G>A:p.Gly299Arg,SP110:ENST00000392048:missense:MODERATE:exon8/15:c.895G>A:p.Gly299Arg,SP110:ENST00000258382:missense:MODERATE:exon8/15:c.895G>A:p.Gly299Arg,SP110:ENST00000540870:missense:MODERATE:exon9/16:c.913G>A:p.Gly305Arg,SP110:ENST00000338556:missense:MODERATE:exon8/14:c.151G>A:p.Gly51Arg		rs1365776	0.8025	0.7087	24440,9224,3778	0.9176,0.8210,0.8933,0.6282,0.7173	0.7055	-0.2260	T,T,T,T,T,T	T	B,B,B,B	T,T,T,T,T,T	18.52	604457 [SP110 (confirmed) Hepatic venoocclusive disease with immunodeficiency,235550|Mycobacterium tuberculosis,susceptibility to,607948];	RCV000335389.1 [benign]; 			902	904	2	[2] auto-classification 14.09.2017  			SP110 (inh=AR pLI=0.00), SP140 (inh=n/a pLI=0.00)
chr2	231077110	231077110	C	T	het	anno_omim	QUAL=7696;DP=295;AF=0.46;MQM=60;TRIO=HET,295,0.46,WT,346,0.00,HET,398,0.42	SP110,SP140	missense,5'UTR	SP110:ENST00000258381:missense:MODERATE:exon5/19:c.619G>A:p.Glu207Lys,SP110:ENST00000358662:missense:MODERATE:exon5/18:c.619G>A:p.Glu207Lys,SP110:ENST00000392048:missense:MODERATE:exon5/15:c.619G>A:p.Glu207Lys,SP110:ENST00000258382:missense:MODERATE:exon5/15:c.619G>A:p.Glu207Lys,SP110:ENST00000540870:missense:MODERATE:exon6/16:c.637G>A:p.Glu213Lys,SP110:ENST00000338556:5'UTR:MODIFIER:exon5/14:c.-126G>A:		rs9061	0.1306	0.1142	1025,327,31	0.0793,0.0414,0.1829,0.0978,0.2402	0.1107	-0.4510	T,T,T,T,T,T	T	B,B,B,B	T,T,T,T,T,T	11.56	604457 [SP110 (confirmed) Hepatic venoocclusive disease with immunodeficiency,235550|Mycobacterium tuberculosis,susceptibility to,607948];	RCV000350537.1 [benign]; 	CM131316 [CLASS=DP MUT=ALT PHEN="Pulmonary tuberculosis association with" GENE=SP110]; 	COSM149088, COSM3927760	47	463	2	[2] auto-classification 14.09.2017  			SP110 (inh=AR pLI=0.00), SP140 (inh=n/a pLI=0.00)
chr2	231077112	231077112	G	A	het	pred_pathogenic;anno_omim	QUAL=14747;DP=288;AF=0.52;MQM=60;TRIO=HET,288,0.52,HOM,344,1.00,WT,399,0.00	SP110,SP140	missense,5'UTR	SP110:ENST00000258381:missense:MODERATE:exon5/19:c.617C>T:p.Ala206Val,SP110:ENST00000358662:missense:MODERATE:exon5/18:c.617C>T:p.Ala206Val,SP110:ENST00000392048:missense:MODERATE:exon5/15:c.617C>T:p.Ala206Val,SP110:ENST00000258382:missense:MODERATE:exon5/15:c.617C>T:p.Ala206Val,SP110:ENST00000540870:missense:MODERATE:exon6/16:c.635C>T:p.Ala212Val,SP110:ENST00000338556:5'UTR:MODIFIER:exon5/14:c.-128C>T:		rs28930679	0.1591	0.2108	2792,1894,113	0.1434,0.2417,0.0867,0.2403,0.1764	0.2141	-0.0850	D,D,T,T,T,D,D	T	B,B,B,B	T,T,T,T,T,T,T	5.33	604457 [SP110 (confirmed) Hepatic venoocclusive disease with immunodeficiency,235550|Mycobacterium tuberculosis,susceptibility to,607948];	RCV000293290.1 [benign]; 			136	774	2	[2] auto-classification 14.09.2017  			SP110 (inh=AR pLI=0.00), SP140 (inh=n/a pLI=0.00)
chr2	231077154	231077154	G	A	het	anno_omim	QUAL=11549;DP=203;AF=0.48;MQM=60;TRIO=HET,203,0.48,HOM,281,1.00,WT,335,0.00	SP110,SP140	splice_region&intron	SP110:ENST00000258381:splice_region&intron:LOW:exon4/18:c.584-9C>T:,SP110:ENST00000358662:splice_region&intron:LOW:exon4/17:c.584-9C>T:,SP110:ENST00000392048:splice_region&intron:LOW:exon4/14:c.584-9C>T:,SP110:ENST00000258382:splice_region&intron:LOW:exon4/14:c.584-9C>T:,SP110:ENST00000540870:splice_region&intron:LOW:exon5/15:c.602-9C>T:,SP110:ENST00000338556:splice_region&intron:LOW:exon4/13:c.-161-9C>T:		rs41309096	0.2288	0.2379	3534,2034,619	0.3389,0.2530,0.0872,0.2498,0.2036	0.2572							604457 [SP110 (confirmed) Hepatic venoocclusive disease with immunodeficiency,235550|Mycobacterium tuberculosis,susceptibility to,607948];	RCV000315466.1 [benign]; 			163	807	2	[2] auto-classification 14.09.2017  			SP110 (inh=AR pLI=0.00), SP140 (inh=n/a pLI=0.00)
chr2	231077676	231077676	G	A	het	pred_pathogenic;anno_omim	QUAL=2165;DP=45;AF=0.51;MQM=60;TRIO=HET,45,0.51,WT,93,0.00,HET,125,0.54	SP110,SP140	missense,5'UTR	SP110:ENST00000258381:missense:MODERATE:exon4/19:c.383C>T:p.Ala128Val,SP110:ENST00000358662:missense:MODERATE:exon4/18:c.383C>T:p.Ala128Val,SP110:ENST00000392048:missense:MODERATE:exon4/15:c.383C>T:p.Ala128Val,SP110:ENST00000258382:missense:MODERATE:exon4/15:c.383C>T:p.Ala128Val,SP110:ENST00000540870:missense:MODERATE:exon5/16:c.401C>T:p.Ala134Val,SP110:ENST00000338556:5'UTR:MODIFIER:exon4/14:c.-362C>T:		rs11556887	0.0966	0.1040	924,350,5	0.0288,0.0390,0.0977,0.0991,0.2377	0.1025	0.1220	T,T,D,D,D,D,D	T	B,B,P,D	T,T,T,T,T,T,T	15.74	604457 [SP110 (confirmed) Hepatic venoocclusive disease with immunodeficiency,235550|Mycobacterium tuberculosis,susceptibility to,607948];	RCV000264680.1 [benign]; 		COSM149089, COSM3927761	48	452	2	[2] auto-classification 14.09.2017  			SP110 (inh=AR pLI=0.00), SP140 (inh=n/a pLI=0.00)
chr2	231077725	231077725	A	G	hom	anno_omim	QUAL=7981;DP=116;AF=1.00;MQM=60;TRIO=HOM,116,1.00,HOM,62,1.00,HOM,85,1.00	SP110,SP140	missense,5'UTR	SP110:ENST00000258381:missense:MODERATE:exon4/19:c.334T>C:p.Trp112Arg,SP110:ENST00000358662:missense:MODERATE:exon4/18:c.334T>C:p.Trp112Arg,SP110:ENST00000392048:missense:MODERATE:exon4/15:c.334T>C:p.Trp112Arg,SP110:ENST00000258382:missense:MODERATE:exon4/15:c.334T>C:p.Trp112Arg,SP110:ENST00000540870:missense:MODERATE:exon5/16:c.352T>C:p.Trp118Arg,SP110:ENST00000338556:5'UTR:MODIFIER:exon4/14:c.-411T>C:		rs1129411	0.9511	0.9091	50293,25799,4991	0.9804,0.9379,0.9977,0.8788,0.9375	0.9136	-0.1940	T,T,T,T,T,T,T	T	B,B,B,B	T,T,T,T,T,T,T	0.07	604457 [SP110 (confirmed) Hepatic venoocclusive disease with immunodeficiency,235550|Mycobacterium tuberculosis,susceptibility to,607948];				1714	356	2	[2] auto-classification 14.09.2017  			SP110 (inh=AR pLI=0.00), SP140 (inh=n/a pLI=0.00)
chr2	233390937	233390937	A	G	hom	low_DP;anno_omim	QUAL=473;DP=4;AF=1.00;MQM=60;TRIO=HOM,4,1.00,HET,6,0.67,HOM,11,0.91	CHRND	synonymous,5'UTR	CHRND:ENST00000258385:synonymous:LOW:exon1/12:c.12A>G:p.Pro4Pro,CHRND:ENST00000543200:synonymous:LOW:exon1/11:c.12A>G:p.Pro4Pro,CHRND:ENST00000536614:synonymous:LOW:exon1/8:c.12A>G:p.Pro4Pro,CHRND:ENST00000457943:5'UTR:MODIFIER:exon1/10:c.-260A>G:		rs2245601	0.4834	0.5010	15364,7802,728	0.3760,0.5654,0.6895,0.4869,0.4896	0.5034							100720 [CHRND (confirmed) Myasthenic syndrome,congenital,3A,slow-channel,616321|Myasthenic syndrome,congenital,3B,fast-channel,616322|Myasthenic syndrome,congenital,3C,associated with acetylcholine receptor deficiency,616323|Multiple pterygium syndrome,lethal type,253290];	RCV000116730.3 [benign]; RCV000306623.1 [benign]; RCV000395212.1 [benign]; 		COSM149097	480	1011	2	[2] auto-classification 14.09.2017  			CHRND (inh=AR pLI=0.00)
chr2	233400074	233400074	A	G	het	anno_omim	QUAL=6324;DP=166;AF=0.44;MQM=60;TRIO=HET,166,0.44,HET,172,0.52,HET,185,0.48	CHRND	splice_region,3'UTR	CHRND:ENST00000457943:splice_region:LOW:exon10/10:c.*52A>G:,CHRND:ENST00000258385:3'UTR:MODIFIER:exon12/12:c.*52A>G:,CHRND:ENST00000543200:3'UTR:MODIFIER:exon11/11:c.*52A>G:,CHRND:ENST00000457943:3'UTR:MODIFIER:exon10/10:c.*52A>G:		rs2767	0.4159	0.4119	10267,4146,388	0.2898,0.6647,0.5654,0.3688,0.4319	0.4156							100720 [CHRND (confirmed) Myasthenic syndrome,congenital,3A,slow-channel,616321|Myasthenic syndrome,congenital,3B,fast-channel,616322|Myasthenic syndrome,congenital,3C,associated with acetylcholine receptor deficiency,616323|Multiple pterygium syndrome,lethal type,253290];	RCV000277975.1 [other]; RCV000319987.1 [benign]; 			291	914	2	[2] auto-classification 14.09.2017  			CHRND (inh=AR pLI=0.00)
chr2	233400907	233400907	T	C	het	anno_omim	QUAL=9011;DP=271;AF=0.48;MQM=59;TRIO=HET,271,0.48,HET,184,0.51,HET,238,0.53	CHRND			MLT1F	rs1004175	0.4159	0.4124	941,173,11	0.0000,0.0000,0.0000,0.3613,0.4303	0.4341							100720 [CHRND (confirmed) Myasthenic syndrome,congenital,3A,slow-channel,616321|Myasthenic syndrome,congenital,3B,fast-channel,616322|Myasthenic syndrome,congenital,3C,associated with acetylcholine receptor deficiency,616323|Multiple pterygium syndrome,lethal type,253290];	RCV000261184.1 [benign]; RCV000329395.1 [other]; 			72	274					CHRND (inh=AR pLI=0.00)
chr2	233411039	233411039	A	T	het	low_QUAL;anno_omim	QUAL=7;DP=158;AF=0.18;MQM=58;TRIO=HET,158,0.18,WT,61,0.07,WT,93,0.06	CHRNG	3'UTR	CHRNG:ENST00000389494:3'UTR:MODIFIER:exon12/12:c.*613A>T:	(T)n		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0469							100730 [CHRNG (confirmed) Escobar syndrome,265000|Multiple pterygium syndrome,lethal type,253290];				0	5					CHRNG (inh=AR pLI=0.00)
chr2	238232752	238232752	C	A	het	anno_omim	QUAL=2699;DP=98;AF=0.48;MQM=59;TRIO=HET,98,0.48,HOM,41,0.85,HET,52,0.42	COL6A3	3'UTR	COL6A3:ENST00000295550:3'UTR:MODIFIER:exon44/44:c.*665G>T:,COL6A3:ENST00000347401:3'UTR:MODIFIER:exon43/43:c.*665G>T:,COL6A3:ENST00000353578:3'UTR:MODIFIER:exon43/43:c.*665G>T:,COL6A3:ENST00000472056:3'UTR:MODIFIER:exon41/41:c.*665G>T:		rs1050785	0.6879	0.0000	0,0,0	0,0,0,0,0	0.6511							120250 [COL6A3 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Dystonia 27,616411];	RCV000329533.1 [benign]; 			70	118					COL6A3 (inh=AR+AD pLI=0.00)
chr2	238232811	238232811	T	A	het	anno_omim	QUAL=4343;DP=273;AF=0.48;MQM=60;TRIO=HET,273,0.48,HET,92,0.41,WT,111,0.00	COL6A3	3'UTR	COL6A3:ENST00000295550:3'UTR:MODIFIER:exon44/44:c.*606A>T:,COL6A3:ENST00000347401:3'UTR:MODIFIER:exon43/43:c.*606A>T:,COL6A3:ENST00000353578:3'UTR:MODIFIER:exon43/43:c.*606A>T:,COL6A3:ENST00000472056:3'UTR:MODIFIER:exon41/41:c.*606A>T:		rs7436	0.1556	0.0000	0,0,0	0,0,0,0,0	0.1034							120250 [COL6A3 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Dystonia 27,616411];	RCV000275535.1 [benign]; 			2	41					COL6A3 (inh=AR+AD pLI=0.00)
chr2	238233410	238233410	C	G	het	anno_omim	QUAL=7207;DP=362;AF=0.46;MQM=60;TRIO=HET,362,0.46,HET,264,0.47,WT,541,0.00	COL6A3	3'UTR	COL6A3:ENST00000295550:3'UTR:MODIFIER:exon44/44:c.*7G>C:,COL6A3:ENST00000347401:3'UTR:MODIFIER:exon43/43:c.*7G>C:,COL6A3:ENST00000353578:3'UTR:MODIFIER:exon43/43:c.*7G>C:,COL6A3:ENST00000472056:3'UTR:MODIFIER:exon41/41:c.*7G>C:		rs4663722	0.2099	0.1415	1487,343,291	0.2368,0.2111,0.2208,0.0985,0.1880	0.1456							120250 [COL6A3 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Dystonia 27,616411];	RCV000080905.6 [benign]; RCV000372374.1 [benign]; 			40	447					COL6A3 (inh=AR+AD pLI=0.00)
chr2	238243285	238243285	G	A	het	anno_omim	QUAL=3491;DP=173;AF=0.53;MQM=60;TRIO=HET,173,0.53,HET,106,0.48,WT,139,0.00	COL6A3	synonymous	COL6A3:ENST00000295550:synonymous:LOW:exon41/44:c.9213C>T:p.His3071His,COL6A3:ENST00000347401:synonymous:LOW:exon40/43:c.8610C>T:p.His2870His,COL6A3:ENST00000353578:synonymous:LOW:exon40/43:c.8595C>T:p.His2865His,COL6A3:ENST00000472056:synonymous:LOW:exon38/41:c.7392C>T:p.His2464His,COL6A3:ENST00000409809:synonymous:LOW:exon39/42:c.8595C>T:p.His2865His,COL6A3:ENST00000346358:synonymous:LOW:exon40/43:c.8613C>T:p.His2871His		rs2270671	0.1004	0.1055	706,372,43	0.0948,0.1248,0.0356,0.1057,0.1311	0.1072							120250 [COL6A3 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Dystonia 27,616411];	RCV000081024.8 [other]; RCV000306390.1 [benign]; 			32	453	2	[2] auto-classification 14.09.2017  			COL6A3 (inh=AR+AD pLI=0.00)
chr2	238243464	238243464	C	G	hom	pred_pathogenic;anno_omim	QUAL=17044;DP=202;AF=1.00;MQM=59;TRIO=HOM,202,1.00,HOM,167,1.00,HOM,189,1.00	COL6A3	missense	COL6A3:ENST00000295550:missense:MODERATE:exon41/44:c.9034G>C:p.Ala3012Pro,COL6A3:ENST00000347401:missense:MODERATE:exon40/43:c.8431G>C:p.Ala2811Pro,COL6A3:ENST00000353578:missense:MODERATE:exon40/43:c.8416G>C:p.Ala2806Pro,COL6A3:ENST00000472056:missense:MODERATE:exon38/41:c.7213G>C:p.Ala2405Pro,COL6A3:ENST00000409809:missense:MODERATE:exon39/42:c.8416G>C:p.Ala2806Pro,COL6A3:ENST00000346358:missense:MODERATE:exon40/43:c.8434G>C:p.Ala2812Pro		rs2270669	0.7923	0.7729	36619,20313,4735	0.9538,0.6511,0.7159,0.7795,0.7338	0.8168	5.5020	T,T,T,T,T,T	T	B,B,B	T,T,T,T,T,T	21.50	120250 [COL6A3 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Dystonia 27,616411];	RCV000081019.6 [benign]; RCV000261014.1 [benign]; 	CM151272 [CLASS=R MUT=ALT PHEN="Neuromuscular disorder" GENE=COL6A3]; 		1301	709	2	[2] Ute Grasshoff 24.11.2015			COL6A3 (inh=AR+AD pLI=0.00)
chr2	238244963	238244963	A	G	het	pred_pathogenic;anno_omim	QUAL=7758;DP=200;AF=0.54;MQM=59;TRIO=HET,200,0.54,HET,185,0.44,HET,257,0.52	COL6A3	missense	COL6A3:ENST00000295550:missense:MODERATE:exon40/44:c.8780T>C:p.Met2927Thr,COL6A3:ENST00000347401:missense:MODERATE:exon39/43:c.8177T>C:p.Met2726Thr,COL6A3:ENST00000353578:missense:MODERATE:exon39/43:c.8162T>C:p.Met2721Thr,COL6A3:ENST00000472056:missense:MODERATE:exon37/41:c.6959T>C:p.Met2320Thr,COL6A3:ENST00000409809:missense:MODERATE:exon38/42:c.8162T>C:p.Met2721Thr,COL6A3:ENST00000346358:missense:MODERATE:exon39/43:c.8180T>C:p.Met2727Thr		rs6728818	0.6366	0.6386	25150,14679,3160	0.7832,0.5222,0.5460,0.6626,0.5528	0.6836	1.7470	T,T,T,T,T,T	T	B,B,B	D,D,D,D,D,D	3.84	120250 [COL6A3 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Dystonia 27,616411];	RCV000081013.7 [benign]; RCV000382239.1 [benign]; 	CM151271 [CLASS=R MUT=ALT PHEN="Neuromuscular disorder" GENE=COL6A3]; 		935	930	2	[2] Ute Grasshoff 24.11.2015			COL6A3 (inh=AR+AD pLI=0.00)
chr2	238247734	238247734	C	G	het	pred_pathogenic;anno_omim	QUAL=2127;DP=166;AF=0.34;MQM=60;TRIO=HET,166,0.34,HET,64,0.27,HET,84,0.32	COL6A3	missense	COL6A3:ENST00000295550:missense:MODERATE:exon39/44:c.8491G>C:p.Asp2831His,COL6A3:ENST00000347401:missense:MODERATE:exon38/43:c.7888G>C:p.Asp2630His,COL6A3:ENST00000353578:missense:MODERATE:exon38/43:c.7873G>C:p.Asp2625His,COL6A3:ENST00000472056:missense:MODERATE:exon36/41:c.6670G>C:p.Asp2224His,COL6A3:ENST00000409809:missense:MODERATE:exon37/42:c.7873G>C:p.Asp2625His,COL6A3:ENST00000346358:missense:MODERATE:exon38/43:c.7891G>C:p.Asp2631His		rs36104025	0.0325	0.0673	354,278,6	0.0161,0.0316,0.0002,0.0893,0.0721	0.0658	5.4160	D,D,D,D,D,D	T	D,D,D	D,D,D,D,D,D	22.90	120250 [COL6A3 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Dystonia 27,616411];	RCV000081011.6 [benign]; RCV000297122.1 [benign]; 			10	322	2	[2] auto-classification 14.09.2017  			COL6A3 (inh=AR+AD pLI=0.00)
chr2	238253065	238253065	C	T	het	anno_omim	QUAL=12004;DP=263;AF=0.48;MQM=60;TRIO=HET,263,0.48,HET,339,0.53,HET,467,0.48	COL6A3	synonymous	COL6A3:ENST00000295550:synonymous:LOW:exon36/44:c.7596G>A:p.Lys2532Lys,COL6A3:ENST00000347401:synonymous:LOW:exon35/43:c.6993G>A:p.Lys2331Lys,COL6A3:ENST00000353578:synonymous:LOW:exon35/43:c.6978G>A:p.Lys2326Lys,COL6A3:ENST00000472056:synonymous:LOW:exon33/41:c.5775G>A:p.Lys1925Lys,COL6A3:ENST00000409809:synonymous:LOW:exon34/42:c.6978G>A:p.Lys2326Lys,COL6A3:ENST00000346358:synonymous:LOW:exon35/43:c.6996G>A:p.Lys2332Lys		rs2291795	0.1548	0.1292	1110,416,144	0.1690,0.1275,0.1691,0.1095,0.1792	0.1277							120250 [COL6A3 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Dystonia 27,616411];	RCV000080995.6 [benign]; RCV000367078.1 [benign]; 		COSM4001576	30	428	2	[2] auto-classification 14.09.2017  			COL6A3 (inh=AR+AD pLI=0.00)
chr2	238253149	238253149	G	A	het	anno_omim	QUAL=10631;DP=450;AF=0.44;MQM=59;TRIO=HET,450,0.44,HET,478,0.47,WT,664,0.00	COL6A3	synonymous	COL6A3:ENST00000295550:synonymous:LOW:exon36/44:c.7512C>T:p.Asn2504Asn,COL6A3:ENST00000347401:synonymous:LOW:exon35/43:c.6909C>T:p.Asn2303Asn,COL6A3:ENST00000353578:synonymous:LOW:exon35/43:c.6894C>T:p.Asn2298Asn,COL6A3:ENST00000472056:synonymous:LOW:exon33/41:c.5691C>T:p.Asn1897Asn,COL6A3:ENST00000409809:synonymous:LOW:exon34/42:c.6894C>T:p.Asn2298Asn,COL6A3:ENST00000346358:synonymous:LOW:exon35/43:c.6912C>T:p.Asn2304Asn		rs2646258	0.1084	0.1085	778,369,44	0.0939,0.1695,0.0427,0.1045,0.1228	0.1129							120250 [COL6A3 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Dystonia 27,616411];	RCV000080994.8 [other]; RCV000274813.1 [benign]; 			30	463	2	[2] auto-classification 14.09.2017  			COL6A3 (inh=AR+AD pLI=0.00)
chr2	238257013	238257013	G	A	het	anno_omim	QUAL=7206;DP=440;AF=0.44;MQM=60;TRIO=HET,440,0.44,HET,166,0.49,WT,201,0.00	COL6A3	synonymous	COL6A3:ENST00000295550:synonymous:LOW:exon30/44:c.6945C>T:p.Phe2315Phe,COL6A3:ENST00000347401:synonymous:LOW:exon29/43:c.6342C>T:p.Phe2114Phe,COL6A3:ENST00000353578:synonymous:LOW:exon29/43:c.6327C>T:p.Phe2109Phe,COL6A3:ENST00000472056:synonymous:LOW:exon27/41:c.5124C>T:p.Phe1708Phe,COL6A3:ENST00000409809:synonymous:LOW:exon28/42:c.6327C>T:p.Phe2109Phe,COL6A3:ENST00000346358:synonymous:LOW:exon29/43:c.6345C>T:p.Phe2115Phe		rs2646265	0.1064	0.1100	800,393,37	0.0892,0.1700,0.0427,0.1075,0.1228	0.1144							120250 [COL6A3 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Dystonia 27,616411];	RCV000080980.8 [other]; RCV000365938.1 [benign]; 			30	480	2	[2] auto-classification 14.09.2017  			COL6A3 (inh=AR+AD pLI=0.00)
chr2	238258814	238258814	C	G	het	anno_omim	QUAL=11478;DP=222;AF=0.47;MQM=60;TRIO=HET,222,0.47,HET,172,0.47,HOM,226,1.00	COL6A3	synonymous	COL6A3:ENST00000295550:synonymous:LOW:exon28/44:c.6855G>C:p.Gly2285Gly,COL6A3:ENST00000347401:synonymous:LOW:exon27/43:c.6252G>C:p.Gly2084Gly,COL6A3:ENST00000353578:synonymous:LOW:exon27/43:c.6237G>C:p.Gly2079Gly,COL6A3:ENST00000472056:synonymous:LOW:exon25/41:c.5034G>C:p.Gly1678Gly,COL6A3:ENST00000409809:synonymous:LOW:exon26/42:c.6237G>C:p.Gly2079Gly,COL6A3:ENST00000346358:synonymous:LOW:exon27/43:c.6255G>C:p.Gly2085Gly		rs3790993	0.5543	0.5489	18509,10030,1764	0.5841,0.4639,0.6668,0.5474,0.5123	0.5655							120250 [COL6A3 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Dystonia 27,616411];	RCV000080973.6 [benign]; RCV000276863.1 [benign]; 			611	1067	2	[2] auto-classification 14.09.2017  			COL6A3 (inh=AR+AD pLI=0.00)
chr2	238267717	238267717	C	T	het	anno_omim	QUAL=10617;DP=489;AF=0.47;MQM=59;TRIO=HET,489,0.47,HET,393,0.48,WT,540,0.00	COL6A3	synonymous	COL6A3:ENST00000295550:synonymous:LOW:exon20/44:c.6369G>A:p.Leu2123Leu,COL6A3:ENST00000347401:synonymous:LOW:exon19/43:c.5766G>A:p.Leu1922Leu,COL6A3:ENST00000353578:synonymous:LOW:exon19/43:c.5751G>A:p.Leu1917Leu,COL6A3:ENST00000472056:synonymous:LOW:exon17/41:c.4548G>A:p.Leu1516Leu,COL6A3:ENST00000409809:synonymous:LOW:exon18/42:c.5751G>A:p.Leu1917Leu,COL6A3:ENST00000346358:synonymous:LOW:exon19/43:c.5769G>A:p.Leu1923Leu		rs2646254	0.3309	0.2129	3532,644,1227	0.4828,0.2833,0.3510,0.1378,0.2595	0.2414							120250 [COL6A3 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Dystonia 27,616411];	RCV000080967.6 [benign]; RCV000376283.1 [benign]; 			65	591	2	[2] auto-classification 14.09.2017  			COL6A3 (inh=AR+AD pLI=0.00)
chr2	238277573	238277573	C	A	het	anno_omim	QUAL=2279;DP=183;AF=0.46;MQM=59;TRIO=HET,183,0.46,HET,82,0.48,WT,98,0.00	COL6A3	synonymous	COL6A3:ENST00000295550:synonymous:LOW:exon10/44:c.4533G>T:p.Gly1511Gly,COL6A3:ENST00000347401:synonymous:LOW:exon9/43:c.3930G>T:p.Gly1310Gly,COL6A3:ENST00000353578:synonymous:LOW:exon9/43:c.3915G>T:p.Gly1305Gly,COL6A3:ENST00000472056:synonymous:LOW:exon7/41:c.2712G>T:p.Gly904Gly,COL6A3:ENST00000409809:synonymous:LOW:exon8/42:c.3915G>T:p.Gly1305Gly,COL6A3:ENST00000346358:synonymous:LOW:exon9/43:c.3933G>T:p.Gly1311Gly		rs2645774	0.2656	0.2355	3441,1524,409	0.2841,0.3181,0.2521,0.2131,0.2456	0.2381							120250 [COL6A3 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Dystonia 27,616411];	RCV000080941.6 [benign]; RCV000311595.1 [benign]; 		COSM3758064	103	698	2	[2] auto-classification 14.09.2017  			COL6A3 (inh=AR+AD pLI=0.00)
chr2	238277795	238277795	A	G	het	low_DP;anno_omim	QUAL=41;DP=12;AF=0.25;MQM=60;TRIO=HET,12,0.25,HOM,1,1.00,WT,1,0.00	COL6A3	synonymous	COL6A3:ENST00000295550:synonymous:LOW:exon10/44:c.4311T>C:p.Ile1437Ile,COL6A3:ENST00000347401:synonymous:LOW:exon9/43:c.3708T>C:p.Ile1236Ile,COL6A3:ENST00000353578:synonymous:LOW:exon9/43:c.3693T>C:p.Ile1231Ile,COL6A3:ENST00000472056:synonymous:LOW:exon7/41:c.2490T>C:p.Ile830Ile,COL6A3:ENST00000409809:synonymous:LOW:exon8/42:c.3693T>C:p.Ile1231Ile,COL6A3:ENST00000346358:synonymous:LOW:exon9/43:c.3711T>C:p.Ile1237Ile		rs2646260	0.3884	0.2889	5612,1830,1780	0.5862,0.3421,0.2928,0.2355,0.3026	0.3364							120250 [COL6A3 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Dystonia 27,616411];	RCV000080938.6 [benign]; RCV000405778.1 [benign]; 		COSM3749639	136	732	2	[2] auto-classification 14.09.2017  			COL6A3 (inh=AR+AD pLI=0.00)
chr2	238283605	238283605	G	A	hom	anno_omim	QUAL=2378;DP=64;AF=1.00;MQM=59;TRIO=HOM,64,1.00,HET,43,0.53,HET,44,0.43	COL6A3	synonymous	COL6A3:ENST00000295550:synonymous:LOW:exon8/44:c.3129C>T:p.Gly1043Gly,COL6A3:ENST00000347401:synonymous:LOW:exon7/43:c.2526C>T:p.Gly842Gly,COL6A3:ENST00000353578:synonymous:LOW:exon7/43:c.2511C>T:p.Gly837Gly,COL6A3:ENST00000472056:synonymous:LOW:exon5/41:c.1308C>T:p.Gly436Gly,COL6A3:ENST00000409809:synonymous:LOW:exon6/42:c.2511C>T:p.Gly837Gly,COL6A3:ENST00000346358:synonymous:LOW:exon7/43:c.2529C>T:p.Gly843Gly,COL6A3:ENST00000392004:synonymous:LOW:exon7/8:c.2511C>T:p.Gly837Gly,COL6A3:ENST00000392003:synonymous:LOW:exon6/7:c.1908C>T:p.Gly636Gly		rs12622093	0.2159	0.2327	3330,1920,92	0.1272,0.2352,0.2858,0.2393,0.2350	0.2342							120250 [COL6A3 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Dystonia 27,616411];	RCV000080926.6 [benign]; RCV000289678.1 [benign]; 		COSM1482931, COSM442555	126	727	2	[2] auto-classification 14.09.2017  			COL6A3 (inh=AR+AD pLI=0.00)
chr2	238289980	238289980	G	C	het	pred_pathogenic;anno_omim	QUAL=8160;DP=270;AF=0.46;MQM=60;TRIO=HET,270,0.46,HET,291,0.52,WT,377,0.00	COL6A3	missense	COL6A3:ENST00000295550:missense:MODERATE:exon5/44:c.1475C>G:p.Thr492Ser,COL6A3:ENST00000347401:missense:MODERATE:exon4/43:c.872C>G:p.Thr291Ser,COL6A3:ENST00000353578:missense:MODERATE:exon4/43:c.857C>G:p.Thr286Ser,COL6A3:ENST00000472056:missense:MODERATE:exon3/41:c.254C>G:p.Thr85Ser,COL6A3:ENST00000409809:missense:MODERATE:exon3/42:c.857C>G:p.Thr286Ser,COL6A3:ENST00000346358:missense:MODERATE:exon5/43:c.1475C>G:p.Thr492Ser,COL6A3:ENST00000392004:missense:MODERATE:exon4/8:c.857C>G:p.Thr286Ser,COL6A3:ENST00000392003:missense:MODERATE:exon3/7:c.254C>G:p.Thr85Ser		rs113897824	0.0036	0.0075	8,3,0	0.0012,0.0023,0.0000,0.0088,0.0116	0.0075	0.2260	T,T,T,T,T,T,T,T,T	T	B,B,B,B,B,B	D,D,D,D,D,D,D,D,D	8.32	120250 [COL6A3 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Dystonia 27,616411];	RCV000080913.6 [other]; RCV000303469.1 [likely benign]; 			1	42					COL6A3 (inh=AR+AD pLI=0.00)
chr2	238289984	238289984	C	G	het	pred_pathogenic;anno_omim	QUAL=8160;DP=270;AF=0.46;MQM=60;TRIO=HET,270,0.46,HET,291,0.52,WT,377,0.00	COL6A3	missense	COL6A3:ENST00000295550:missense:MODERATE:exon5/44:c.1471G>C:p.Asp491His,COL6A3:ENST00000347401:missense:MODERATE:exon4/43:c.868G>C:p.Asp290His,COL6A3:ENST00000353578:missense:MODERATE:exon4/43:c.853G>C:p.Asp285His,COL6A3:ENST00000472056:missense:MODERATE:exon3/41:c.250G>C:p.Asp84His,COL6A3:ENST00000409809:missense:MODERATE:exon3/42:c.853G>C:p.Asp285His,COL6A3:ENST00000346358:missense:MODERATE:exon5/43:c.1471G>C:p.Asp491His,COL6A3:ENST00000392004:missense:MODERATE:exon4/8:c.853G>C:p.Asp285His,COL6A3:ENST00000392003:missense:MODERATE:exon3/7:c.250G>C:p.Asp84His		rs112010940	0.0036	0.0075	8,3,0	0.0012,0.0023,0.0000,0.0088,0.0116	0.0075	0.8220	D,D,D,D,D,D,D,D,D	T	B,P,B,B,P,B	D,D,D,D,D,D,D,D,D	22.80	120250 [COL6A3 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Dystonia 27,616411];	RCV000080912.6 [other]; RCV000358271.1 [likely benign]; 			1	42					COL6A3 (inh=AR+AD pLI=0.00)
chr2	238322712	238322712	C	T	het	anno_omim	QUAL=2579;DP=144;AF=0.48;MQM=60;TRIO=HET,144,0.48,HET,76,0.45,WT,92,0.00	COL6A3	5'UTR	COL6A3:ENST00000295550:5'UTR:MODIFIER:exon1/44:c.-147G>A:,COL6A3:ENST00000347401:5'UTR:MODIFIER:exon1/43:c.-147G>A:,COL6A3:ENST00000353578:5'UTR:MODIFIER:exon1/43:c.-147G>A:,COL6A3:ENST00000472056:5'UTR:MODIFIER:exon1/41:c.-147G>A:,COL6A3:ENST00000346358:5'UTR:MODIFIER:exon1/43:c.-147G>A:,COL6A3:ENST00000392004:5'UTR:MODIFIER:exon1/8:c.-147G>A:,COL6A3:ENST00000392003:5'UTR:MODIFIER:exon1/7:c.-147G>A:		rs113567254	0.0006	0.0000	0,0,0	0,0,0,0,0	0.0013							120250 [COL6A3 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Dystonia 27,616411];	RCV000340388.1 [likely benign]; 			0	2					COL6A3 (inh=AR+AD pLI=0.00)
chr2	239969974	239969974	G	C	hom		QUAL=22615;DP=345;AF=0.99;MQM=59;TRIO=HOM,345,0.99,HET,359,0.53,HET,469,0.55	HDAC4	3'UTR	HDAC4:ENST00000345617:3'UTR:MODIFIER:exon27/27:c.*4819C>G:		rs1055333	0.2346	0.0000	0,0,0	0,0,0,0,0	0.2200											13	76					HDAC4 (inh=AD pLI=1.00)
chr2	239970256	239970256	-	ATAGATAGATAG	hom		QUAL=8060;DP=111;AF=0.50;MQM=59;TRIO=HOM,111,0.90,HET,178,0.95,WT,216,0.98	HDAC4	3'UTR	HDAC4:ENST00000345617:3'UTR:MODIFIER:exon27/27:c.*4525_*4536dupCTATCTATCTAT:		rs3841081	0.0491	0.0000	0,0,0	0,0,0,0,0	0.0980											12	14					HDAC4 (inh=AD pLI=1.00)
chr2	239970360	239970360	A	C	hom		QUAL=15265;DP=276;AF=1.00;MQM=59;TRIO=HOM,276,1.00,HET,207,0.50,HET,289,0.48	HDAC4	3'UTR	HDAC4:ENST00000345617:3'UTR:MODIFIER:exon27/27:c.*4433T>G:		rs895808	0.3343	0.0000	0,0,0	0,0,0,0,0	0.3492											28	100					HDAC4 (inh=AD pLI=1.00)
chr2	239972883	239972883	C	T	het		QUAL=2788;DP=147;AF=0.52;MQM=60;TRIO=HET,147,0.52,HET,83,0.48,WT,143,0.01	HDAC4	3'UTR	HDAC4:ENST00000345617:3'UTR:MODIFIER:exon27/27:c.*1910G>A:		rs4852010	0.3361	0.0000	0,0,0	0,0,0,0,0	0.3060											13	108					HDAC4 (inh=AD pLI=1.00)
chr2	239974241	239974241	-	C	het		QUAL=3109;DP=110;AF=0.46;MQM=59;TRIO=HET,110,0.46,WT,88,0.00,HOM,109,0.87	HDAC4	3'UTR	HDAC4:ENST00000345617:3'UTR:MODIFIER:exon27/27:c.*551dupG:		rs397972964	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1462											5	52					HDAC4 (inh=AD pLI=1.00)
chr2	240003870	240003870	G	A	hom		QUAL=6183;DP=81;AF=0.99;MQM=60;TRIO=HOM,81,0.99,HOM,51,1.00,HOM,73,1.00	HDAC4	synonymous	HDAC4:ENST00000345617:synonymous:LOW:exon21/27:c.2565C>T:p.Pro855Pro,HDAC4:ENST00000543185:synonymous:LOW:exon15/21:c.1317C>T:p.Pro439Pro		rs1063639	0.5952	0.5333	17909,7374,1651	0.5669,0.7047,0.6877,0.4672,0.6068	0.5363										COSM4133597	564	1008	2	[2] auto-classification 14.09.2017  			HDAC4 (inh=AD pLI=1.00)
chr2	240066417	240066417	A	G	hom		QUAL=8190;DP=68;AF=0.99;MQM=60;TRIO=HOM,68,0.99,HOM,93,0.99,HOM,103,1.00	HDAC4	splice_region&intron	HDAC4:ENST00000345617:splice_region&intron:LOW:exon7/26:c.734-7T>C:,HDAC4:ENST00000543185:splice_region&intron:LOW:exon1/20:c.-515-7T>C:,HDAC4:ENST00000541256:splice_region&intron:LOW:exon5/14:c.641-7T>C:		rs2290087	0.8878	0.8616	45478,24708,4858	0.9666,0.6402,0.8436,0.8610,0.9475	0.8949											1624	443	2	[2] auto-classification 14.09.2017  			HDAC4 (inh=AD pLI=1.00)
chr2	241531479	241531479	A	G	het	anno_omim	QUAL=1391;DP=40;AF=0.60;MQM=60;TRIO=HET,40,0.60,WT,27,0.00,HET,50,0.68	CAPN10	synonymous,intron	CAPN10:ENST00000391984:synonymous:LOW:exon4/12:c.600A>G:p.Pro200Pro,CAPN10:ENST00000391982:synonymous:LOW:exon4/8:c.600A>G:p.Pro200Pro,CAPN10:ENST00000404753:synonymous:LOW:exon4/11:c.600A>G:p.Pro200Pro,CAPN10:ENST00000354082:synonymous:LOW:exon4/10:c.600A>G:p.Pro200Pro,CAPN10:ENST00000270364:intron:MODIFIER:exon2/3:c.273+2588A>G:,CAPN10:ENST00000352879:intron:MODIFIER:exon1/3:c.141+5010A>G:		rs3792269	0.1176	0.1823	1333,816,11	0.0571,0.1215,0.1196,0.1975,0.2295	0.1478							605286 [CAPN10 (confirmed) Diabetes mellitus,noninsulin-dependent 1,601283];				63	559	2	[2] auto-classification 14.09.2017  			CAPN10 (inh=n/a pLI=0.00)
chr2	241536126	241536126	A	G	het	pred_pathogenic;anno_omim	QUAL=294;DP=26;AF=0.62;MQM=60;TRIO=HET,26,0.62,WT,6,0.00,HET,7,0.57	CAPN10	missense,intron	CAPN10:ENST00000391984:missense:MODERATE:exon9/12:c.1510A>G:p.Thr504Ala,CAPN10:ENST00000404753:missense:MODERATE:exon9/11:c.1510A>G:p.Thr504Ala,CAPN10:ENST00000270364:intron:MODIFIER:exon2/3:c.273+7235A>G:,CAPN10:ENST00000352879:intron:MODIFIER:exon1/3:c.142-1179A>G:,CAPN10:ENST00000354082:intron:MODIFIER:exon7/9:c.1279-1179A>G:		rs7607759	0.1168	0.1474	1289,853,10	0.0442,0.0734,0.0981,0.1664,0.2195	0.1437	-0.3280	T,T	T	B,B	D,D	0.01	605286 [CAPN10 (confirmed) Diabetes mellitus,noninsulin-dependent 1,601283];		CM043260 [CLASS=DP MUT=ALT PHEN="Diabetes mellitus 2 association with" GENE=CAPN10]; 		64	548	2	[2] auto-classification 14.09.2017  			CAPN10 (inh=n/a pLI=0.00)
chr2	241537421	241537421	G	A	het	anno_omim	QUAL=2861;DP=122;AF=0.52;MQM=60;TRIO=HET,122,0.52,HOM,50,1.00,WT,63,0.00	CAPN10	synonymous,intron	CAPN10:ENST00000391984:synonymous:LOW:exon10/12:c.1860G>A:p.Ala620Ala,CAPN10:ENST00000404753:synonymous:LOW:exon10/11:c.1860G>A:p.Ala620Ala,CAPN10:ENST00000352879:synonymous:LOW:exon2/4:c.258G>A:p.Ala86Ala,CAPN10:ENST00000354082:synonymous:LOW:exon8/10:c.1395G>A:p.Ala465Ala,CAPN10:ENST00000270364:intron:MODIFIER:exon2/3:c.273+8530G>A:		rs3749166	0.5118	0.5811	20691,12428,493	0.3129,0.6065,0.6594,0.6154,0.5643	0.5833							605286 [CAPN10 (confirmed) Diabetes mellitus,noninsulin-dependent 1,601283];			COSM4133667, COSM4133668	709	1033	2	[2] auto-classification 14.09.2017  			CAPN10 (inh=n/a pLI=0.00)
chr2	241538061	241538061	T	C	het	anno_omim	QUAL=2067;DP=83;AF=0.55;MQM=60;TRIO=HET,83,0.55,WT,40,0.00,HET,65,0.57	CAPN10	splice_region&intron,intron	CAPN10:ENST00000391984:splice_region&intron:LOW:exon11/11:c.1990-7T>C:,CAPN10:ENST00000404753:splice_region&intron:LOW:exon10/10:c.1944-7T>C:,CAPN10:ENST00000352879:splice_region&intron:LOW:exon3/3:c.388-7T>C:,CAPN10:ENST00000354082:splice_region&intron:LOW:exon9/9:c.1525-7T>C:,CAPN10:ENST00000270364:intron:MODIFIER:exon2/3:c.273+9170T>C:		rs55878652	0.1204	0.1915	644,369,7	0.0654,0.1363,0.1211,0.2152,0.2193	0.1429							605286 [CAPN10 (confirmed) Diabetes mellitus,noninsulin-dependent 1,601283];			COSM3766550, COSM3766549	63	559	2	[2] auto-classification 14.09.2017  			CAPN10 (inh=n/a pLI=0.00)
chr2	241538074	241538074	A	G	hom	pred_pathogenic;anno_omim	QUAL=5183;DP=86;AF=0.99;MQM=59;TRIO=HOM,86,0.99,HOM,34,1.00,HOM,52,0.96	CAPN10	missense,synonymous,intron	CAPN10:ENST00000391984:missense:MODERATE:exon12/12:c.1996A>G:p.Ile666Val,CAPN10:ENST00000352879:missense:MODERATE:exon4/4:c.394A>G:p.Ile132Val,CAPN10:ENST00000354082:missense:MODERATE:exon10/10:c.1531A>G:p.Ile511Val,CAPN10:ENST00000404753:synonymous:LOW:exon11/11:c.1950A>G:p.Pro650Pro,CAPN10:ENST00000270364:intron:MODIFIER:exon2/3:c.273+9183A>G:		rs2975766	0.9898	0.9799	29606,16386,3095	0.9958,0.9862,0.9996,0.9707,0.9878	0.9822	-0.9330	T,T,T	T	B,B,B	D,T,D	0.01	605286 [CAPN10 (confirmed) Diabetes mellitus,noninsulin-dependent 1,601283];				1960	141	2	[2] auto-classification 14.09.2017  			CAPN10 (inh=n/a pLI=0.00)
chr2	241538229	241538229	A	G	hom	anno_omim	QUAL=4391;DP=60;AF=0.97;MQM=60;TRIO=HOM,60,0.97,HOM,61,1.00,HET,82,0.51	CAPN10	3'UTR,intron	CAPN10:ENST00000391984:3'UTR:MODIFIER:exon12/12:c.*132A>G:,CAPN10:ENST00000404753:3'UTR:MODIFIER:exon11/11:c.*143A>G:,CAPN10:ENST00000352879:3'UTR:MODIFIER:exon4/4:c.*132A>G:,CAPN10:ENST00000354082:3'UTR:MODIFIER:exon10/10:c.*132A>G:,CAPN10:ENST00000270364:intron:MODIFIER:exon2/3:c.273+9338A>G:		rs2975767	0.7264	0.0000	0,0,0	0,0,0,0,0	0.7690							605286 [CAPN10 (confirmed) Diabetes mellitus,noninsulin-dependent 1,601283];				157	66					CAPN10 (inh=n/a pLI=0.00)
chr2	241538531	241538531	T	C	het	anno_omim	QUAL=876;DP=52;AF=0.48;MQM=60;TRIO=HET,52,0.48,WT,41,0.00,HET,54,0.39	CAPN10	intron	CAPN10:ENST00000270364:intron:MODIFIER:exon2/3:c.273+9640T>C:		rs17846983	0.0767	0.0000	0,0,0	0,0,0,0,0	0.0856							605286 [CAPN10 (confirmed) Diabetes mellitus,noninsulin-dependent 1,601283];				3	39					CAPN10 (inh=n/a pLI=0.00)
chr3	3191388	3191388	T	A	hom	anno_omim	QUAL=35180;DP=465;AF=1.00;MQM=59;TRIO=HOM,465,1.00,HOM,265,1.00,HOM,326,1.00	TRNT1,CRBN				rs711628	0.9048	0.0000	0,0,0	0,0,0,0,0	0.9181							612907 [TRNT1 (provisional) Sideroblastic anemia with B-cell immunodeficiency,periodic fevers,and developmental delay,616084|Retinitis pigmentosa and erythrocytic microcytosis,616959]:609262 [CRBN (confirmed) Mental retardation,autosomal recessive 2,607417];				151	1					TRNT1 (inh=n/a pLI=0.00), CRBN (inh=AR pLI=0.04)
chr3	3191426	3191426	T	C	het	anno_omim	QUAL=13420;DP=377;AF=0.51;MQM=60;TRIO=HET,377,0.51,HET,253,0.51,HET,325,0.50	TRNT1,CRBN				rs1045433	0.1292	0.0000	0,0,0	0,0,0,0,0	0.1431							612907 [TRNT1 (provisional) Sideroblastic anemia with B-cell immunodeficiency,periodic fevers,and developmental delay,616084|Retinitis pigmentosa and erythrocytic microcytosis,616959]:609262 [CRBN (confirmed) Mental retardation,autosomal recessive 2,607417];				4	53					TRNT1 (inh=n/a pLI=0.00), CRBN (inh=AR pLI=0.04)
chr3	3191776	3191776	T	C	hom	anno_omim	QUAL=20079;DP=354;AF=0.99;MQM=60;TRIO=HOM,354,0.99,HOM,118,1.00,HOM,132,1.00	CRBN,TRNT1	3'UTR	CRBN:ENST00000231948:3'UTR:MODIFIER:exon11/11:c.*773A>G:,CRBN:ENST00000432408:3'UTR:MODIFIER:exon11/11:c.*773A>G:		rs711627	0.9048	0.0000	0,0,0	0,0,0,0,0	0.9185							612907 [TRNT1 (provisional) Sideroblastic anemia with B-cell immunodeficiency,periodic fevers,and developmental delay,616084|Retinitis pigmentosa and erythrocytic microcytosis,616959]:609262 [CRBN (confirmed) Mental retardation,autosomal recessive 2,607417];				229	3					CRBN (inh=AR pLI=0.04), TRNT1 (inh=n/a pLI=0.00)
chr3	3192524	3192524	-	TAAC	het	anno_omim	QUAL=7124;DP=196;AF=0.41;MQM=59;TRIO=HET,196,0.41,HET,156,0.46,HET,203,0.46	CRBN,TRNT1	3'UTR	CRBN:ENST00000231948:3'UTR:MODIFIER:exon11/11:c.*21_*24dupGTTA:,CRBN:ENST00000432408:3'UTR:MODIFIER:exon11/11:c.*21_*24dupGTTA:		rs3830315;rs397828468;rs4183	0.0000	0.5523	16578,12513,512	0.3466,0.3497,0.2377,0.6713,0.4820	0.5324							612907 [TRNT1 (provisional) Sideroblastic anemia with B-cell immunodeficiency,periodic fevers,and developmental delay,616084|Retinitis pigmentosa and erythrocytic microcytosis,616959]:609262 [CRBN (confirmed) Mental retardation,autosomal recessive 2,607417];				840	804					CRBN (inh=AR pLI=0.04), TRNT1 (inh=n/a pLI=0.00)
chr3	3215954	3215954	A	G	hom	anno_omim	QUAL=21559;DP=332;AF=1.00;MQM=60;TRIO=HOM,332,1.00,HOM,130,1.00,HOM,208,1.00	CRBN	splice_region&intron	CRBN:ENST00000231948:splice_region&intron:LOW:exon2/10:c.175-9T>C:,CRBN:ENST00000432408:splice_region&intron:LOW:exon2/10:c.172-9T>C:		rs1669321	0.8838	0.9673	57252,33213,2185	0.6505,0.9802,1.0000,0.9982,0.9994	0.9732							609262 [CRBN (confirmed) Mental retardation,autosomal recessive 2,607417];	RCV000116835.1 [benign]; 			2069	37	2	[2] auto-classification 14.09.2017  			CRBN (inh=AR pLI=0.04)
chr3	4403357	4403357	A	C	hom	anno_omim	QUAL=16466;DP=254;AF=1.00;MQM=59;TRIO=HOM,254,1.00,HOM,103,1.00,HOM,140,0.99	SUMF1	3'UTR,intron	SUMF1:ENST00000272902:3'UTR:MODIFIER:exon9/9:c.*471T>G:,SUMF1:ENST00000534863:intron:MODIFIER:exon8/9:c.1014+14657T>G:		rs2259818	0.8802	0.0000	0,0,0	0,0,0,0,0	0.9754							607939 [SUMF1 (provisional) Multiple sulfatase deficiency,272200];	RCV000303426.1 [benign]; 			219	12					SUMF1 (inh=AR pLI=0.04)
chr3	4403365	4403368	CTCA	-	hom	anno_omim	QUAL=13824;DP=239;AF=1.00;MQM=59;TRIO=HOM,239,1.00,HOM,90,1.00,HOM,128,1.00	SUMF1	3'UTR,intron	SUMF1:ENST00000272902:3'UTR:MODIFIER:exon9/9:c.*460_*463delTGAG:,SUMF1:ENST00000534863:intron:MODIFIER:exon8/9:c.1014+14646_1014+14649delTGAG:		rs3835161	0.7047	0.0000	0,0,0	0,0,0,0,0	0.5921							607939 [SUMF1 (provisional) Multiple sulfatase deficiency,272200];	RCV000358113.1 [benign]; 			72	116					SUMF1 (inh=AR pLI=0.04)
chr3	4403537	4403537	C	T	hom	anno_omim	QUAL=16273;DP=267;AF=0.99;MQM=59;TRIO=HOM,267,0.99,HOM,111,1.00,HOM,161,0.99	SUMF1	3'UTR,intron	SUMF1:ENST00000272902:3'UTR:MODIFIER:exon9/9:c.*291G>A:,SUMF1:ENST00000383843:3'UTR:MODIFIER:exon8/8:c.*291G>A:,SUMF1:ENST00000458465:3'UTR:MODIFIER:exon5/5:c.*291G>A:,SUMF1:ENST00000534863:intron:MODIFIER:exon8/9:c.1014+14477G>A:	MIR3	rs4685744	0.4281	0.0000	0,0,0	0,0,0,0,0	0.4206							607939 [SUMF1 (provisional) Multiple sulfatase deficiency,272200];	RCV000260015.1 [benign]; 			58	113					SUMF1 (inh=AR pLI=0.04)
chr3	4403767	4403767	A	G	hom	anno_omim	QUAL=19853;DP=292;AF=1.00;MQM=59;TRIO=HOM,292,1.00,HOM,153,1.00,HOM,172,1.00	SUMF1	3'UTR,intron	SUMF1:ENST00000272902:3'UTR:MODIFIER:exon9/9:c.*61T>C:,SUMF1:ENST00000383843:3'UTR:MODIFIER:exon8/8:c.*61T>C:,SUMF1:ENST00000458465:3'UTR:MODIFIER:exon5/5:c.*61T>C:,SUMF1:ENST00000534863:intron:MODIFIER:exon8/9:c.1014+14247T>C:		rs2819561	0.7045	0.0000	0,0,0	0,0,0,0,0	0.5919							607939 [SUMF1 (provisional) Multiple sulfatase deficiency,272200];	RCV000330948.1 [benign]; 			574	695					SUMF1 (inh=AR pLI=0.04)
chr3	4403817	4403817	T	A	hom	anno_omim	QUAL=18277;DP=185;AF=0.97;MQM=59;TRIO=HOM,185,0.97,HOM,196,0.99,HOM,234,0.99	SUMF1	3'UTR,intron	SUMF1:ENST00000272902:3'UTR:MODIFIER:exon9/9:c.*11A>T:,SUMF1:ENST00000383843:3'UTR:MODIFIER:exon8/8:c.*11A>T:,SUMF1:ENST00000458465:3'UTR:MODIFIER:exon5/5:c.*11A>T:,SUMF1:ENST00000405420:3'UTR:MODIFIER:exon8/8:c.*11A>T:,SUMF1:ENST00000534863:intron:MODIFIER:exon8/9:c.1014+14197A>T:		rs2633851	0.7268	0.6334	24987,10216,3098	0.7688,0.7535,0.7672,0.5529,0.7403	0.6336							607939 [SUMF1 (provisional) Multiple sulfatase deficiency,272200];	RCV000082713.5 [benign]; RCV000387786.1 [benign]; 			788	981					SUMF1 (inh=AR pLI=0.04)
chr3	4403818	4403818	T	C	hom	anno_omim	QUAL=18277;DP=185;AF=0.97;MQM=59;TRIO=HOM,185,0.97,HOM,196,0.99,HOM,234,0.99	SUMF1	3'UTR,intron	SUMF1:ENST00000272902:3'UTR:MODIFIER:exon9/9:c.*10A>G:,SUMF1:ENST00000383843:3'UTR:MODIFIER:exon8/8:c.*10A>G:,SUMF1:ENST00000458465:3'UTR:MODIFIER:exon5/5:c.*10A>G:,SUMF1:ENST00000405420:3'UTR:MODIFIER:exon8/8:c.*10A>G:,SUMF1:ENST00000534863:intron:MODIFIER:exon8/9:c.1014+14196A>G:		rs35083095	0.4321	0.4936	15396,8297,295	0.2269,0.6157,0.6264,0.4985,0.4732	0.5037							607939 [SUMF1 (provisional) Multiple sulfatase deficiency,272200];	RCV000082712.5 [benign]; RCV000295742.1 [benign]; 			552	1057					SUMF1 (inh=AR pLI=0.04)
chr3	4403837	4403837	A	G	hom	anno_omim	QUAL=21313;DP=175;AF=0.99;MQM=60;TRIO=HOM,175,0.99,HOM,223,1.00,HOM,269,1.00	SUMF1	synonymous,intron	SUMF1:ENST00000272902:synonymous:LOW:exon9/9:c.1116T>C:p.Thr372Thr,SUMF1:ENST00000383843:synonymous:LOW:exon8/8:c.1041T>C:p.Thr347Thr,SUMF1:ENST00000458465:synonymous:LOW:exon5/5:c.720T>C:p.Thr240Thr,SUMF1:ENST00000405420:synonymous:LOW:exon8/8:c.1056T>C:p.Thr352Thr,SUMF1:ENST00000534863:intron:MODIFIER:exon8/9:c.1014+14177T>C:		rs2633852	0.7604	0.6441	26090,10370,3935	0.8686,0.7590,0.7685,0.5554,0.7404	0.6427							607939 [SUMF1 (provisional) Multiple sulfatase deficiency,272200];	RCV000082714.5 [benign]; RCV000325033.1 [benign]; 		COSM3760098	812	1000	2	[2] auto-classification 14.09.2017  			SUMF1 (inh=AR pLI=0.04)
chr3	4508742	4508742	C	T	het	pred_pathogenic;anno_omim	QUAL=834;DP=41;AF=0.56;MQM=60;TRIO=HET,41,0.56,HET,28,0.64,WT,27,0.00	SUMF1	missense	SUMF1:ENST00000534863:missense:MODERATE:exon1/10:c.188G>A:p.Ser63Asn,SUMF1:ENST00000272902:missense:MODERATE:exon1/9:c.188G>A:p.Ser63Asn,SUMF1:ENST00000383843:missense:MODERATE:exon1/8:c.188G>A:p.Ser63Asn,SUMF1:ENST00000458465:missense:MODERATE:exon1/5:c.188G>A:p.Ser63Asn,SUMF1:ENST00000405420:missense:MODERATE:exon1/8:c.188G>A:p.Ser63Asn		rs2819590	0.1166	0.2851	1161,941,1	0.1104,0.3473,0.0046,0.3761,0.1437	0.2149	0.5130	T,T,T,T,D,T	T	P,P,P,B	D,D,D,D,D	21.10	607939 [SUMF1 (provisional) Multiple sulfatase deficiency,272200];	RCV000244602.1 [benign]; RCV000362882.1 [benign]; 		COSM3760113, COSM3760112	132	744	2	[2] auto-classification 14.09.2017  			SUMF1 (inh=AR pLI=0.04)
chr3	4712413	4712413	G	A	het	anno_omim	QUAL=6286;DP=122;AF=0.48;MQM=60;TRIO=HET,122,0.48,HOM,162,1.00,WT,165,0.01	ITPR1	splice_region&synonymous,intron	ITPR1:ENST00000302640:splice_region&synonymous:LOW:exon19/61:c.1962G>A:p.Lys654Lys,ITPR1:ENST00000354582:splice_region&synonymous:LOW:exon20/61:c.2007G>A:p.Lys669Lys,ITPR1:ENST00000423119:splice_region&synonymous:LOW:exon20/59:c.2007G>A:p.Lys669Lys,ITPR1:ENST00000357086:splice_region&synonymous:LOW:exon20/59:c.2007G>A:p.Lys669Lys,ITPR1:ENST00000456211:splice_region&synonymous:LOW:exon19/58:c.1962G>A:p.Lys654Lys,ITPR1:ENST00000443694:splice_region&synonymous:LOW:exon17/59:c.1962G>A:p.Lys654Lys,ITPR1:ENST00000544951:intron:MODIFIER:exon12/19:c.996+16843G>A:		rs2306875	0.6140	0.6832	14002,7958,1444	0.7075,0.7243,0.4584,0.6998,0.6572	0.6776							147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15,606658|Spinocerebellar ataxia 29,congenital nonprogressive,117360|Gillespie syndrome,206700];	RCV000117299.2 [likely benign]; RCV000369453.1 [benign]; 			1408	1444	2	[2] auto-classification 14.09.2017  			ITPR1 (inh=AD pLI=1.00)
chr3	4716811	4716811	A	C	het	anno_omim	QUAL=4917;DP=221;AF=0.50;MQM=59;TRIO=HET,221,0.50,HET,172,0.45,WT,239,0.00	ITPR1	synonymous,intron	ITPR1:ENST00000302640:synonymous:LOW:exon22/61:c.2613A>C:p.Leu871Leu,ITPR1:ENST00000354582:synonymous:LOW:exon23/61:c.2658A>C:p.Leu886Leu,ITPR1:ENST00000423119:synonymous:LOW:exon23/59:c.2658A>C:p.Leu886Leu,ITPR1:ENST00000357086:synonymous:LOW:exon23/59:c.2658A>C:p.Leu886Leu,ITPR1:ENST00000456211:synonymous:LOW:exon22/58:c.2613A>C:p.Leu871Leu,ITPR1:ENST00000443694:synonymous:LOW:exon20/59:c.2613A>C:p.Leu871Leu,ITPR1:ENST00000544951:intron:MODIFIER:exon12/19:c.996+21241A>C:		rs2306877	0.3329	0.2692	4898,1268,611	0.3685,0.4256,0.2927,0.1937,0.3831	0.2756							147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15,606658|Spinocerebellar ataxia 29,congenital nonprogressive,117360|Gillespie syndrome,206700];	RCV000117300.2 [likely benign]; RCV000323015.1 [benign]; 			158	1026	2	[2] auto-classification 14.09.2017  			ITPR1 (inh=AD pLI=1.00)
chr3	4767262	4767262	T	C	hom	anno_omim	QUAL=21988;DP=319;AF=1.00;MQM=59;TRIO=HOM,319,1.00,HOM,153,0.99,HOM,264,1.00	ITPR1	synonymous,intron	ITPR1:ENST00000302640:synonymous:LOW:exon40/61:c.5124T>C:p.Thr1708Thr,ITPR1:ENST00000354582:synonymous:LOW:exon41/61:c.5169T>C:p.Thr1723Thr,ITPR1:ENST00000443694:synonymous:LOW:exon38/59:c.5124T>C:p.Thr1708Thr,ITPR1:ENST00000423119:intron:MODIFIER:exon39/58:c.5077-7510T>C:,ITPR1:ENST00000357086:intron:MODIFIER:exon39/58:c.5077-7510T>C:,ITPR1:ENST00000456211:intron:MODIFIER:exon38/57:c.5032-7510T>C:,ITPR1:ENST00000544951:intron:MODIFIER:exon12/19:c.996+71692T>C:		rs7613447	0.5122	0.6893	29493,21347,1060	0.4745,0.5988,0.3215,0.8119,0.5594	0.6879							147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15,606658|Spinocerebellar ataxia 29,congenital nonprogressive,117360|Gillespie syndrome,206700];				1917	1082	2	[2] auto-classification 14.09.2017  			ITPR1 (inh=AD pLI=1.00)
chr3	4817057	4817057	T	C	hom	anno_omim	QUAL=19477;DP=259;AF=1.00;MQM=60;TRIO=HOM,259,1.00,HOM,133,1.00,HOM,205,1.00	ITPR1	synonymous,intron	ITPR1:ENST00000302640:synonymous:LOW:exon46/61:c.6066T>C:p.Asn2022Asn,ITPR1:ENST00000354582:synonymous:LOW:exon46/61:c.6066T>C:p.Asn2022Asn,ITPR1:ENST00000423119:synonymous:LOW:exon44/59:c.5967T>C:p.Asn1989Asn,ITPR1:ENST00000357086:synonymous:LOW:exon44/59:c.5967T>C:p.Asn1989Asn,ITPR1:ENST00000456211:synonymous:LOW:exon43/58:c.5922T>C:p.Asn1974Asn,ITPR1:ENST00000443694:synonymous:LOW:exon44/59:c.6066T>C:p.Asn2022Asn,ITPR1:ENST00000544951:intron:MODIFIER:exon12/19:c.997-30730T>C:		rs6442905	0.9627	0.9701	56862,31392,4478	0.9553,0.9769,0.9870,0.9697,0.9589	0.9712							147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15,606658|Spinocerebellar ataxia 29,congenital nonprogressive,117360|Gillespie syndrome,206700];				3030	219	2	[2] auto-classification 14.09.2017  			ITPR1 (inh=AD pLI=1.00)
chr3	4842231	4842231	C	T	het	anno_omim	QUAL=6842;DP=304;AF=0.47;MQM=59;TRIO=HET,304,0.47,WT,188,0.00,HET,265,0.49	ITPR1	synonymous,intron	ITPR1:ENST00000302640:synonymous:LOW:exon53/61:c.7009C>T:p.Leu2337Leu,ITPR1:ENST00000354582:synonymous:LOW:exon53/61:c.7009C>T:p.Leu2337Leu,ITPR1:ENST00000423119:synonymous:LOW:exon51/59:c.6910C>T:p.Leu2304Leu,ITPR1:ENST00000357086:synonymous:LOW:exon51/59:c.6910C>T:p.Leu2304Leu,ITPR1:ENST00000456211:synonymous:LOW:exon50/58:c.6865C>T:p.Leu2289Leu,ITPR1:ENST00000443694:synonymous:LOW:exon51/59:c.7009C>T:p.Leu2337Leu,ITPR1:ENST00000544951:intron:MODIFIER:exon12/19:c.997-5556C>T:		rs2291862	0.2646	0.2868	5218,2657,88	0.1355,0.3827,0.4144,0.2812,0.2876	0.2923							147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15,606658|Spinocerebellar ataxia 29,congenital nonprogressive,117360|Gillespie syndrome,206700];	RCV000117303.2 [likely benign]; RCV000404711.1 [benign]; 		COSM3760145, COSM3760144, COSM3760146	270	1332	2	[2] auto-classification 14.09.2017  			ITPR1 (inh=AD pLI=1.00)
chr3	4856180	4856180	T	C	hom	anno_omim	QUAL=11754;DP=141;AF=0.99;MQM=59;TRIO=HOM,141,0.99,HOM,111,1.00,HOM,121,1.00	ITPR1,AC018816.3	synonymous	ITPR1:ENST00000302640:synonymous:LOW:exon57/61:c.7590T>C:p.Thr2530Thr,ITPR1:ENST00000354582:synonymous:LOW:exon57/61:c.7590T>C:p.Thr2530Thr,ITPR1:ENST00000423119:synonymous:LOW:exon55/59:c.7491T>C:p.Thr2497Thr,ITPR1:ENST00000357086:synonymous:LOW:exon55/59:c.7491T>C:p.Thr2497Thr,ITPR1:ENST00000456211:synonymous:LOW:exon54/58:c.7446T>C:p.Thr2482Thr,ITPR1:ENST00000544951:synonymous:LOW:exon16/20:c.1524T>C:p.Thr508Thr,ITPR1:ENST00000443694:synonymous:LOW:exon55/59:c.7590T>C:p.Thr2530Thr		rs711631	0.7909	0.8244	41384,23153,2400	0.6989,0.8538,0.9664,0.8329,0.7374	0.8292							147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15,606658|Spinocerebellar ataxia 29,congenital nonprogressive,117360|Gillespie syndrome,206700];	RCV000117304.2 [likely benign]; RCV000288234.1 [benign]; 			2174	963	2	[2] auto-classification 14.09.2017  			ITPR1 (inh=AD pLI=1.00), AC018816.3 (inh=n/a pLI=n/a)
chr3	4856234	4856234	G	A	het	anno_omim	QUAL=4181;DP=127;AF=0.45;MQM=60;TRIO=HET,127,0.45,HET,62,0.55,HOM,71,1.00	ITPR1,AC018816.3	synonymous	ITPR1:ENST00000302640:synonymous:LOW:exon57/61:c.7644G>A:p.Lys2548Lys,ITPR1:ENST00000354582:synonymous:LOW:exon57/61:c.7644G>A:p.Lys2548Lys,ITPR1:ENST00000423119:synonymous:LOW:exon55/59:c.7545G>A:p.Lys2515Lys,ITPR1:ENST00000357086:synonymous:LOW:exon55/59:c.7545G>A:p.Lys2515Lys,ITPR1:ENST00000456211:synonymous:LOW:exon54/58:c.7500G>A:p.Lys2500Lys,ITPR1:ENST00000544951:synonymous:LOW:exon16/20:c.1578G>A:p.Lys526Lys,ITPR1:ENST00000443694:synonymous:LOW:exon55/59:c.7644G>A:p.Lys2548Lys		rs901854	0.5875	0.6055	22215,12504,1523	0.5589,0.5272,0.7220,0.6128,0.5849	0.6048							147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15,606658|Spinocerebellar ataxia 29,congenital nonprogressive,117360|Gillespie syndrome,206700];	RCV000117305.2 [likely benign]; RCV000379072.1 [benign]; 			1293	1460	2	[2] auto-classification 14.09.2017  			ITPR1 (inh=AD pLI=1.00), AC018816.3 (inh=n/a pLI=n/a)
chr3	4889079	4889079	-	AA	hom	anno_omim	QUAL=1232;DP=107;AF=0.14;MQM=59;TRIO=HOM,107,0.14,WT,21,0.57,HOM,19,0.11	ITPR1,AC018816.3	3'UTR	ITPR1:ENST00000302640:3'UTR:MODIFIER:exon61/61:c.*1183_*1184dupAA:,ITPR1:ENST00000354582:3'UTR:MODIFIER:exon61/61:c.*1183_*1184dupAA:,ITPR1:ENST00000423119:3'UTR:MODIFIER:exon59/59:c.*1183_*1184dupAA:,ITPR1:ENST00000357086:3'UTR:MODIFIER:exon59/59:c.*1183_*1184dupAA:,ITPR1:ENST00000456211:3'UTR:MODIFIER:exon58/58:c.*1183_*1184dupAA:		rs3079679;rs36064013;rs71779262	0.0000	0.0000	0,0,0	0,0,0,0,0	0.6316							147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15,606658|Spinocerebellar ataxia 29,congenital nonprogressive,117360|Gillespie syndrome,206700];				130	13					ITPR1 (inh=AD pLI=1.00), AC018816.3 (inh=n/a pLI=n/a)
chr3	8775589	8775589	C	T	hom	anno_omim	QUAL=20991;DP=272;AF=0.98;MQM=60;TRIO=HOM,272,0.98,HET,405,0.52,HET,529,0.53	CAV3,SSUH2	synonymous	CAV3:ENST00000343849:synonymous:LOW:exon1/2:c.27C>T:p.Leu9Leu,CAV3:ENST00000397368:synonymous:LOW:exon1/3:c.27C>T:p.Leu9Leu		rs1974763	0.0425	0.0873	639,570,3	0.0229,0.0442,0.0013,0.1275,0.0277	0.0867							601253 [CAV3 (confirmed) Muscular dystrophy,limb-girdle,type IC,607801|Rippling muscle disease,606072|Creatine phosphokinase,elevated serum,123320|Myopathy,distal,Tateyama type,614321|Cardiomyopathy,familial hypertrophic,192600|Long QT syndrome 9,611818];	RCV000024400.1 [not provided]; RCV000039803.10 [other]; RCV000241900.1 [benign]; RCV000284784.1 [likely benign]; RCV000324622.1 [likely benign]; RCV000339745.1 [likely benign]; RCV000379199.1 [likely benign]; RCV000397797.1 [likely benign]; 			29	400	2	[2] auto-classification 14.09.2017  			CAV3 (inh=AR+AD pLI=0.34), SSUH2 (inh=n/a pLI=0.00)
chr3	8787220	8787220	T	C	het	anno_omim	QUAL=4850;DP=193;AF=0.45;MQM=59;TRIO=HET,193,0.45,HET,236,0.47,WT,308,0.00	CAV3	synonymous	CAV3:ENST00000343849:synonymous:LOW:exon2/2:c.123T>C:p.Phe41Phe,CAV3:ENST00000397368:synonymous:LOW:exon2/3:c.123T>C:p.Phe41Phe		rs13087941	0.1530	0.1886	2652,1897,430	0.2890,0.0844,0.0059,0.2372,0.0671	0.2411							601253 [CAV3 (confirmed) Muscular dystrophy,limb-girdle,type IC,607801|Rippling muscle disease,606072|Creatine phosphokinase,elevated serum,123320|Myopathy,distal,Tateyama type,614321|Cardiomyopathy,familial hypertrophic,192600|Long QT syndrome 9,611818];	RCV000024401.3 [not provided]; RCV000039797.11 [other]; RCV000246688.1 [benign]; RCV000271441.1 [likely benign]; RCV000310948.1 [likely benign]; RCV000326617.1 [likely benign]; RCV000366101.1 [likely benign]; RCV000393888.1 [likely benign]; 		COSM1131343	86	642	2	[2] auto-classification 14.09.2017  			CAV3 (inh=AR+AD pLI=0.34)
chr3	8788096	8788096	T	C	het	anno_omim	QUAL=8265;DP=411;AF=0.53;MQM=60;TRIO=HET,411,0.53,HET,195,0.55,WT,268,0.00	CAV3	3'UTR	CAV3:ENST00000343849:3'UTR:MODIFIER:exon2/2:c.*543T>C:,CAV3:ENST00000397368:3'UTR:MODIFIER:exon3/3:c.*447T>C:		rs13093809	0.0503	0.0000	0,0,0	0,0,0,0,0	0.1057							601253 [CAV3 (confirmed) Muscular dystrophy,limb-girdle,type IC,607801|Rippling muscle disease,606072|Creatine phosphokinase,elevated serum,123320|Myopathy,distal,Tateyama type,614321|Cardiomyopathy,familial hypertrophic,192600|Long QT syndrome 9,611818];	RCV000024402.1 [not provided]; RCV000259430.1 [likely benign]; RCV000301199.1 [likely benign]; RCV000314609.1 [likely benign]; RCV000354374.1 [likely benign]; RCV000369265.1 [likely benign]; 			7	63					CAV3 (inh=AR+AD pLI=0.34)
chr3	8788198	8788198	A	T	het	anno_omim	QUAL=9928;DP=253;AF=0.53;MQM=60;TRIO=HET,253,0.53,HET,199,0.49,HET,268,0.53	CAV3	3'UTR	CAV3:ENST00000343849:3'UTR:MODIFIER:exon2/2:c.*645A>T:,CAV3:ENST00000397368:3'UTR:MODIFIER:exon3/3:c.*549A>T:		rs11476	0.3482	0.0000	0,0,0	0,0,0,0,0	0.4307							601253 [CAV3 (confirmed) Muscular dystrophy,limb-girdle,type IC,607801|Rippling muscle disease,606072|Creatine phosphokinase,elevated serum,123320|Myopathy,distal,Tateyama type,614321|Cardiomyopathy,familial hypertrophic,192600|Long QT syndrome 9,611818];	RCV000024384.1 [not provided]; RCV000283263.1 [likely benign]; RCV000286772.1 [likely benign]; RCV000323134.1 [likely benign]; RCV000377518.1 [likely benign]; RCV000381151.1 [likely benign]; 			40	123					CAV3 (inh=AR+AD pLI=0.34)
chr3	8788336	8788336	A	G	het	anno_omim	QUAL=10593;DP=318;AF=0.48;MQM=59;TRIO=HET,318,0.48,HET,238,0.48,HET,320,0.51	CAV3	3'UTR	CAV3:ENST00000343849:3'UTR:MODIFIER:exon2/2:c.*783A>G:,CAV3:ENST00000397368:3'UTR:MODIFIER:exon3/3:c.*687A>G:		rs7629329	0.2716	0.0000	0,0,0	0,0,0,0,0	0.3095							601253 [CAV3 (confirmed) Muscular dystrophy,limb-girdle,type IC,607801|Rippling muscle disease,606072|Creatine phosphokinase,elevated serum,123320|Myopathy,distal,Tateyama type,614321|Cardiomyopathy,familial hypertrophic,192600|Long QT syndrome 9,611818];	RCV000024404.1 [not provided]; RCV000294459.1 [likely benign]; RCV000347017.1 [likely benign]; RCV000352834.1 [likely benign]; RCV000390368.1 [likely benign]; RCV000396877.1 [likely benign]; 			27	125					CAV3 (inh=AR+AD pLI=0.34)
chr3	8788364	8788364	C	-	het	anno_omim	QUAL=12072;DP=402;AF=0.51;MQM=59;TRIO=HET,402,0.51,HET,252,0.51,WT,313,0.50	CAV3	3'UTR	CAV3:ENST00000343849:3'UTR:MODIFIER:exon2/2:c.*813delC:,CAV3:ENST00000397368:3'UTR:MODIFIER:exon3/3:c.*717delC:		rs66667169	0.0467	0.0000	0,0,0	0,0,0,0,0	0.0945							601253 [CAV3 (confirmed) Muscular dystrophy,limb-girdle,type IC,607801|Rippling muscle disease,606072|Creatine phosphokinase,elevated serum,123320|Myopathy,distal,Tateyama type,614321|Cardiomyopathy,familial hypertrophic,192600|Long QT syndrome 9,611818];	RCV000277007.1 [likely benign]; RCV000289785.1 [likely benign]; RCV000329785.1 [likely benign]; RCV000386519.1 [likely benign]; RCV000387830.1 [likely benign]; 			5	59					CAV3 (inh=AR+AD pLI=0.34)
chr3	10085536	10085536	A	G	het	low_MQM;anno_omim	QUAL=7196;DP=415;AF=0.31;MQM=43;TRIO=HET,415,0.31,HET,375,0.30,HET,490,0.30	FANCD2	synonymous	FANCD2:ENST00000287647:synonymous:LOW:exon14/43:c.1122A>G:p.Val374Val,FANCD2:ENST00000383806:synonymous:LOW:exon14/43:c.1122A>G:p.Val374Val,FANCD2:ENST00000383807:synonymous:LOW:exon14/44:c.1122A>G:p.Val374Val,FANCD2:ENST00000419585:synonymous:LOW:exon14/44:c.1122A>G:p.Val374Val		rs34046352	0.0000	0.1239	37,0,37	0.3091,0.0956,0.0391,0.1116,0.1379	0.1939							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000247209.1 [benign]; RCV000377963.1 [benign]; 		COSM3759562, COSM3759563	1	1199	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00)
chr3	10088266	10088266	G	T	het	anno_omim	QUAL=4244;DP=255;AF=0.18;MQM=50;TRIO=HET,255,0.18,HET,202,0.20,HET,363,0.41	FANCD2	splice_region&synonymous	FANCD2:ENST00000287647:splice_region&synonymous:LOW:exon15/43:c.1137G>T:p.Val379Val,FANCD2:ENST00000383806:splice_region&synonymous:LOW:exon15/43:c.1137G>T:p.Val379Val,FANCD2:ENST00000383807:splice_region&synonymous:LOW:exon15/44:c.1137G>T:p.Val379Val,FANCD2:ENST00000419585:splice_region&synonymous:LOW:exon15/44:c.1137G>T:p.Val379Val		rs72492997	0.0000	0.3745	0,0,0	0.4291,0.3100,0.3431,0.4041,0.2597	0.4393							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000347785.1 [benign]; 		COSM4157095, COSM4157094	1	1364	2	[2] auto-classification 14.09.2017  			FANCD2 (inh=AR pLI=0.00)
chr3	10088299	10088299	C	T	het	low_MQM;anno_omim	QUAL=5895;DP=332;AF=0.19;MQM=48;TRIO=HET,332,0.19,HET,244,0.23,HET,449,0.43	FANCD2	synonymous	FANCD2:ENST00000287647:synonymous:LOW:exon15/43:c.1170C>T:p.Ser390Ser,FANCD2:ENST00000383806:synonymous:LOW:exon15/43:c.1170C>T:p.Ser390Ser,FANCD2:ENST00000383807:synonymous:LOW:exon15/44:c.1170C>T:p.Ser390Ser,FANCD2:ENST00000419585:synonymous:LOW:exon15/44:c.1170C>T:p.Ser390Ser		rs112887807	0.0000	0.4304	0,0,0	0.4669,0.3840,0.4149,0.4511,0.3520	0.4501							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000400148.1 [benign]; 			1	1212	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00)
chr3	10088308	10088308	T	C	het	low_MQM;anno_omim	QUAL=6472;DP=302;AF=0.21;MQM=48;TRIO=HET,302,0.21,HET,249,0.23,HET,463,0.43	FANCD2	synonymous	FANCD2:ENST00000287647:synonymous:LOW:exon15/43:c.1179T>C:p.Thr393Thr,FANCD2:ENST00000383806:synonymous:LOW:exon15/43:c.1179T>C:p.Thr393Thr,FANCD2:ENST00000383807:synonymous:LOW:exon15/44:c.1179T>C:p.Thr393Thr,FANCD2:ENST00000419585:synonymous:LOW:exon15/44:c.1179T>C:p.Thr393Thr		rs72492998	0.0000	0.4331	0,0,0	0.4674,0.3850,0.4167,0.4530,0.3618	0.4504							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000289250.1 [benign]; 		COSM4152592, COSM4152593	0	1090	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00)
chr3	10088343	10088343	A	G	het	low_MQM;anno_omim	QUAL=6096;DP=425;AF=0.15;MQM=45;TRIO=HET,425,0.15,HET,256,0.23,HET,472,0.43	FANCD2	missense	FANCD2:ENST00000287647:missense:MODERATE:exon15/43:c.1214A>G:p.Asn405Ser,FANCD2:ENST00000383806:missense:MODERATE:exon15/43:c.1214A>G:p.Asn405Ser,FANCD2:ENST00000383807:missense:MODERATE:exon15/44:c.1214A>G:p.Asn405Ser,FANCD2:ENST00000419585:missense:MODERATE:exon15/44:c.1214A>G:p.Asn405Ser		rs73126218	0.0000	0.4201	0,0,0	0.4642,0.3719,0.4034,0.4419,0.3327	0.4320	0.2110	T,T,T,T	T	B,B	T,T,T,T	3.37	613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000352188.1 [benign]; 		COSM4152595, COSM4152594	0	608	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00)
chr3	10089723	10089723	G	A	het	anno_omim	QUAL=9610;DP=278;AF=0.29;MQM=58;TRIO=HET,278,0.29,HET,255,0.37,HET,430,0.50	FANCD2	synonymous	FANCD2:ENST00000287647:synonymous:LOW:exon16/43:c.1401G>A:p.Thr467Thr,FANCD2:ENST00000383806:synonymous:LOW:exon16/43:c.1401G>A:p.Thr467Thr,FANCD2:ENST00000383807:synonymous:LOW:exon16/44:c.1401G>A:p.Thr467Thr,FANCD2:ENST00000419585:synonymous:LOW:exon16/44:c.1401G>A:p.Thr467Thr		rs12330369	0.0000	0.4495	0,0,0	0.4791,0.3944,0.4213,0.4633,0.4207	0.4237							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000354534.1 [benign]; 		COSM4157098, COSM4157099	0	239	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00)
chr3	10089738	10089738	A	G	het	anno_omim	QUAL=8689;DP=247;AF=0.27;MQM=57;TRIO=HET,247,0.27,HET,241,0.37,HET,410,0.51	FANCD2	splice_region&intron	FANCD2:ENST00000287647:splice_region&intron:LOW:exon16/42:c.1413+3A>G:,FANCD2:ENST00000383806:splice_region&intron:LOW:exon16/42:c.1413+3A>G:,FANCD2:ENST00000383807:splice_region&intron:LOW:exon16/43:c.1413+3A>G:,FANCD2:ENST00000419585:splice_region&intron:LOW:exon16/43:c.1413+3A>G:		rs62245508	0.0000	0.4417	0,0,0	0.4742,0.3849,0.4112,0.4556,0.4123	0.3949							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000259684.1 [benign]; 			0	233	1	[1] old entry - no details available	n/a (1xTP, 0xFP)		FANCD2 (inh=AR pLI=0.00)
chr3	10091049	10091049	C	T	het	low_MQM;anno_omim	QUAL=1065;DP=159;AF=0.36;MQM=38;TRIO=HET,159,0.36,HET,108,0.10,WT,151,0.07	FANCD2	splice_region&intron	FANCD2:ENST00000287647:splice_region&intron:LOW:exon16/42:c.1414-9C>T:,FANCD2:ENST00000383806:splice_region&intron:LOW:exon16/42:c.1414-9C>T:,FANCD2:ENST00000383807:splice_region&intron:LOW:exon16/43:c.1414-9C>T:,FANCD2:ENST00000419585:splice_region&intron:LOW:exon16/43:c.1414-9C>T:		rs35557429	0.0000	0.0719	212,81,45	0.2120,0.0608,0.0211,0.0587,0.0884	0.0983							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000230800.2 [other]; RCV000249372.1 [benign]; 			16	148	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00)
chr3	10091153	10091153	C	T	het	low_MQM;anno_omim	QUAL=35;DP=310;AF=0.15;MQM=37;TRIO=HET,310,0.15,HET,185,0.15,HET,237,0.14	FANCD2	synonymous	FANCD2:ENST00000287647:synonymous:LOW:exon17/43:c.1509C>T:p.Asn503Asn,FANCD2:ENST00000383806:synonymous:LOW:exon17/43:c.1509C>T:p.Asn503Asn,FANCD2:ENST00000383807:synonymous:LOW:exon17/44:c.1509C>T:p.Asn503Asn,FANCD2:ENST00000419585:synonymous:LOW:exon17/44:c.1509C>T:p.Asn503Asn		rs6785756	0.0000	0.0075	97,35,34	0.0269,0.0068,0.0007,0.0059,0.0081	0.1551							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000254141.1 [benign]; 			35	406	2	[2] auto-classification 14.09.2017  			FANCD2 (inh=AR pLI=0.00)
chr3	10106532	10106532	C	T	het	low_MQM;anno_omim	QUAL=6345;DP=212;AF=0.39;MQM=43;TRIO=HET,212,0.39,HET,171,0.48,HET,240,0.48	FANCD2	missense	FANCD2:ENST00000287647:missense:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu,FANCD2:ENST00000383806:missense:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu,FANCD2:ENST00000383807:missense:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu,FANCD2:ENST00000419585:missense:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu		rs3864017	0.0000	0.1545	988,525,211	0.2804,0.1427,0.0588,0.1502,0.1680	0.1871	-0.1810	T,T,T,T	T	B,B	T,T,T,T	1.75	613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000120989.2 [benign]; RCV000372215.1 [benign]; 			81	1098	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00)
chr3	10138069	10138069	T	G	het	anno_omim	QUAL=5928;DP=281;AF=0.47;MQM=60;TRIO=HET,281,0.47,HET,78,0.59,HET,112,0.44	FANCD2,FANCD2OS	synonymous,3'UTR,intron	FANCD2:ENST00000287647:synonymous:LOW:exon42/43:c.4098T>G:p.Leu1366Leu,FANCD2:ENST00000383807:synonymous:LOW:exon42/44:c.4098T>G:p.Leu1366Leu,FANCD2:ENST00000419585:synonymous:LOW:exon42/44:c.4098T>G:p.Leu1366Leu,FANCD2:ENST00000383806:3'UTR:MODIFIER:exon41/43:c.*254T>G:,FANCD2OS:ENST00000524279:intron:MODIFIER:exon2/2:c.*43+7813A>C:		rs2272125	0.2422	0.1868	2695,850,1177	0.4741,0.1820,0.0864,0.1576,0.2072	0.2404							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000252662.1 [benign]; RCV000264931.1 [benign]; 	CM066071 [CLASS=DP MUT=ALT PHEN="Breast cancer increased risk association with" GENE=FANCD2]; 	COSM3759565, COSM3759566	122	1107	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10140671	10140671	G	A	het	anno_omim	QUAL=13940;DP=474;AF=0.42;MQM=59;TRIO=HET,474,0.42,HET,311,0.43,HET,452,0.46	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:ENST00000287647:3'UTR:MODIFIER:exon43/43:c.*37G>A:,FANCD2:ENST00000383806:intron:MODIFIER:exon42/42:c.*437+172G>A:,FANCD2:ENST00000383807:intron:MODIFIER:exon43/43:c.4281+172G>A:,FANCD2:ENST00000419585:intron:MODIFIER:exon43/43:c.4281+172G>A:,FANCD2OS:ENST00000524279:intron:MODIFIER:exon2/2:c.*43+5211C>T:		rs7626117	0.3452	0.2285	4893,1088,2964	0.7552,0.2055,0.0866,0.1772,0.2296	0.3366							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000325651.1 [benign]; 			147	1167					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10140696	10140696	A	G	het	anno_omim	QUAL=14993;DP=517;AF=0.46;MQM=60;TRIO=HET,517,0.46,HET,305,0.45,HET,428,0.48	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:ENST00000287647:3'UTR:MODIFIER:exon43/43:c.*62A>G:,FANCD2:ENST00000383806:intron:MODIFIER:exon42/42:c.*437+197A>G:,FANCD2:ENST00000383807:intron:MODIFIER:exon43/43:c.4281+197A>G:,FANCD2:ENST00000419585:intron:MODIFIER:exon43/43:c.4281+197A>G:,FANCD2OS:ENST00000524279:intron:MODIFIER:exon2/2:c.*43+5186T>C:		rs7647987	0.2412	0.0000	0,0,0	0,0,0,0,0	0.2408							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000290667.1 [benign]; 			74	604					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10141065	10141065	T	G	het	anno_omim	QUAL=4667;DP=159;AF=0.55;MQM=60;TRIO=HET,159,0.55,HET,84,0.62,HET,67,0.57	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:ENST00000287647:3'UTR:MODIFIER:exon43/43:c.*431T>G:,FANCD2:ENST00000383806:intron:MODIFIER:exon42/42:c.*437+566T>G:,FANCD2:ENST00000383807:intron:MODIFIER:exon43/43:c.4281+566T>G:,FANCD2:ENST00000419585:intron:MODIFIER:exon43/43:c.4281+566T>G:,FANCD2OS:ENST00000524279:intron:MODIFIER:exon2/2:c.*43+4817A>C:	FLAM_C	rs3826	0.2420	0.0000	0,0,0	0,0,0,0,0	0.2408							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000392441.1 [benign]; 			5	61					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10141184	10141184	C	T	het	anno_omim	QUAL=738;DP=56;AF=0.48;MQM=58;TRIO=HET,56,0.48,HET,16,0.31,HET,14,0.36	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:ENST00000287647:3'UTR:MODIFIER:exon43/43:c.*550C>T:,FANCD2:ENST00000383806:intron:MODIFIER:exon42/42:c.*437+685C>T:,FANCD2:ENST00000383807:intron:MODIFIER:exon43/43:c.4281+685C>T:,FANCD2:ENST00000419585:intron:MODIFIER:exon43/43:c.4281+685C>T:,FANCD2OS:ENST00000524279:intron:MODIFIER:exon2/2:c.*43+4698G>A:	AluSg	rs11716842	0.2061	0.0000	0,0,0	0,0,0,0,0	0.3123							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000392450.1 [benign]; 			47	98					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10142949	10142949	C	T	het	anno_omim	QUAL=6640;DP=168;AF=0.47;MQM=60;TRIO=HET,168,0.47,HET,189,0.45,HET,221,0.48	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:ENST00000383806:3'UTR:MODIFIER:exon43/43:c.*515C>T:,FANCD2:ENST00000383807:3'UTR:MODIFIER:exon44/44:c.*3C>T:,FANCD2:ENST00000419585:3'UTR:MODIFIER:exon44/44:c.*3C>T:,FANCD2OS:ENST00000524279:intron:MODIFIER:exon2/2:c.*43+2933G>A:		rs3172417	0.2147	0.3281	7582,6000,24	0.0752,0.1951,0.1219,0.4262,0.2345	0.3312							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000251855.1 [benign]; 		COSN166813	654	1899	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10143274	10143274	C	T	het	anno_omim	QUAL=7537;DP=244;AF=0.50;MQM=59;TRIO=HET,244,0.50,HET,159,0.53,HET,216,0.47	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:ENST00000383806:3'UTR:MODIFIER:exon43/43:c.*840C>T:,FANCD2:ENST00000383807:3'UTR:MODIFIER:exon44/44:c.*328C>T:,FANCD2:ENST00000419585:3'UTR:MODIFIER:exon44/44:c.*328C>T:,FANCD2OS:ENST00000524279:intron:MODIFIER:exon2/2:c.*43+2608G>A:	AluSc8	rs58275763	0.1917	0.0000	0,0,0	0,0,0,0,0	0.2065							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];				4	52					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10143328	10143328	A	T	het	anno_omim	QUAL=11469;DP=350;AF=0.52;MQM=58;TRIO=HET,350,0.52,HET,268,0.50,HET,314,0.46	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:ENST00000383806:3'UTR:MODIFIER:exon43/43:c.*894A>T:,FANCD2:ENST00000383807:3'UTR:MODIFIER:exon44/44:c.*382A>T:,FANCD2:ENST00000419585:3'UTR:MODIFIER:exon44/44:c.*382A>T:,FANCD2OS:ENST00000524279:intron:MODIFIER:exon2/2:c.*43+2554T>A:	AluSc8	rs59318799	0.1925	0.0000	0,0,0	0,0,0,0,0	0.2076							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];				3	55					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	12526006	12526006	G	A	het	anno_omim	QUAL=4839;DP=56;AF=0.41;MQM=60;TRIO=HET,56,0.41,HOM,190,0.98,WT,306,0.00	TSEN2	5'UTR	TSEN2:ENST00000314571:5'UTR:MODIFIER:exon1/11:c.-28G>A:,TSEN2:ENST00000383797:5'UTR:MODIFIER:exon1/11:c.-28G>A:,TSEN2:ENST00000454502:5'UTR:MODIFIER:exon1/13:c.-28G>A:,TSEN2:ENST00000402228:5'UTR:MODIFIER:exon1/12:c.-139G>A:		rs3806662	0.0791	0.0000	0,0,0	0,0,0,0,0	0.0890							608753 [TSEN2 (provisional) Pontocerebellar hypoplasia type 2B,612389];	RCV000302493.1 [likely benign]; 			5	23					TSEN2 (inh=AR pLI=0.00)
chr3	12526188	12526188	G	T	het	anno_omim	QUAL=7476;DP=215;AF=0.52;MQM=60;TRIO=HET,215,0.52,WT,301,0.00,HET,361,0.53	TSEN2	5'UTR,intron	TSEN2:ENST00000284995:5'UTR:MODIFIER:exon1/12:c.-209G>T:,TSEN2:ENST00000444864:5'UTR:MODIFIER:exon1/9:c.-209G>T:,TSEN2:ENST00000314571:intron:MODIFIER:exon1/10:c.-18+172G>T:,TSEN2:ENST00000383797:intron:MODIFIER:exon1/10:c.-18+172G>T:,TSEN2:ENST00000454502:intron:MODIFIER:exon1/12:c.-18+172G>T:,TSEN2:ENST00000402228:intron:MODIFIER:exon1/11:c.-18+61G>T:		rs709161	0.4545	0.0000	0,0,0	0,0,0,0,0	0.5432							608753 [TSEN2 (provisional) Pontocerebellar hypoplasia type 2B,612389];	RCV000330522.1 [benign]; 			55	108					TSEN2 (inh=AR pLI=0.00)
chr3	12544829	12544829	G	A	het	anno_omim	QUAL=7396;DP=137;AF=0.60;MQM=60;TRIO=HET,137,0.60,HOM,183,0.99,WT,243,0.00	TSEN2	missense	TSEN2:ENST00000284995:missense:MODERATE:exon5/12:c.377G>A:p.Arg126His,TSEN2:ENST00000314571:missense:MODERATE:exon5/11:c.377G>A:p.Arg126His,TSEN2:ENST00000383797:missense:MODERATE:exon5/11:c.377G>A:p.Arg126His,TSEN2:ENST00000454502:missense:MODERATE:exon5/13:c.377G>A:p.Arg126His,TSEN2:ENST00000402228:missense:MODERATE:exon5/12:c.377G>A:p.Arg126His,TSEN2:ENST00000444864:missense:MODERATE:exon5/9:c.377G>A:p.Arg126His,TSEN2:ENST00000415684:missense:MODERATE:exon4/10:c.377G>A:p.Arg126His		rs33955793	0.0587	0.0778	827,113,21	0.0617,0.3177,0.0135,0.0590,0.0312	0.0875	-0.3930	T,T,T,T,T,T,T,T,T	T	B,B,B,B	T,T,T,T,T,T,T,T	0.14	608753 [TSEN2 (provisional) Pontocerebellar hypoplasia type 2B,612389];	RCV000082253.7 [benign]; RCV000310262.1 [benign]; 			15	312	2	[2] auto-classification 14.09.2017  			TSEN2 (inh=AR pLI=0.00)
chr3	12571421	12571421	T	-	het	anno_omim	QUAL=4836;DP=244;AF=0.51;MQM=59;TRIO=HET,244,0.51,WT,156,0.05,HET,231,0.50	TSEN2,C3orf83	3'UTR,intron	TSEN2:ENST00000444864:3'UTR:MODIFIER:exon9/9:c.*22delT:,TSEN2:ENST00000284995:intron:MODIFIER:exon10/11:c.1248+61delT:,TSEN2:ENST00000314571:intron:MODIFIER:exon9/10:c.1170+61delT:,TSEN2:ENST00000383797:intron:MODIFIER:exon9/10:c.1197+61delT:,TSEN2:ENST00000454502:intron:MODIFIER:exon11/12:c.1071+61delT:,TSEN2:ENST00000402228:intron:MODIFIER:exon10/11:c.1248+61delT:,TSEN2:ENST00000415684:intron:MODIFIER:exon8/9:c.1170+61delT:		rs35445022	0.0000	0.2084	318,249,0	0.0985,0.2029,0.1174,0.2610,0.0930	0.1942							608753 [TSEN2 (provisional) Pontocerebellar hypoplasia type 2B,612389];				73	955					TSEN2 (inh=AR pLI=0.00), MKRN2OS (inh=n/a pLI=n/a)
chr3	12574512	12574512	G	T	het	anno_omim	QUAL=3570;DP=256;AF=0.48;MQM=60;TRIO=HET,256,0.48,WT,38,0.00,HET,42,0.40	TSEN2,C3orf83	3'UTR	TSEN2:ENST00000284995:3'UTR:MODIFIER:exon12/12:c.*292G>T:,TSEN2:ENST00000314571:3'UTR:MODIFIER:exon11/11:c.*292G>T:,TSEN2:ENST00000383797:3'UTR:MODIFIER:exon11/11:c.*292G>T:,TSEN2:ENST00000454502:3'UTR:MODIFIER:exon13/13:c.*292G>T:,TSEN2:ENST00000402228:3'UTR:MODIFIER:exon12/12:c.*292G>T:,TSEN2:ENST00000415684:3'UTR:MODIFIER:exon10/10:c.*292G>T:		rs299643	0.4219	0.0000	0,0,0	0,0,0,0,0	0.5020							608753 [TSEN2 (provisional) Pontocerebellar hypoplasia type 2B,612389];	RCV000301498.1 [benign]; 			55	103					TSEN2 (inh=AR pLI=0.00), MKRN2OS (inh=n/a pLI=n/a)
chr3	12625747	12625747	G	A	het	anno_omim	QUAL=21864;DP=460;AF=0.52;MQM=59;TRIO=HET,460,0.52,HOM,514,0.99,WT,701,0.00	RAF1	3'UTR	RAF1:ENST00000442415:3'UTR:MODIFIER:exon18/18:c.*266C>T:,RAF1:ENST00000251849:3'UTR:MODIFIER:exon17/17:c.*266C>T:		rs1051208	0.1739	0.0000	0,0,0	0,0,0,0,0	0.1815							164760 [RAF1 (confirmed) Noonan syndrome 5,611553|LEOPARD syndrome 2,611554|Cardiomyopathy,dilated,1NN,615916];	RCV000273821.1 [likely benign]; RCV000368248.1 [likely benign]; 			8	67					RAF1 (inh=AD pLI=1.00)
chr3	14183410	14183410	T	C	het	anno_omim	QUAL=17617;DP=296;AF=0.47;MQM=59;TRIO=HET,296,0.47,HOM,336,0.99,HET,375,0.42	TMEM43,RP11-434D12.1	3'UTR	TMEM43:ENST00000306077:3'UTR:MODIFIER:exon12/12:c.*115T>C:		rs1043943	0.6891	0.0000	0,0,0	0,0,0,0,0	0.6576							612048 [TMEM43 (confirmed) Arrhythmogenic right ventricular dysplasia 5,604400|Emery-Dreifuss muscular dystrophy 7,AD,614302];	RCV000366934.1 [likely benign]; RCV000374920.1 [benign]; 			81	94					TMEM43 (inh=AD pLI=0.00), RP11-434D12.1 (inh=n/a pLI=n/a)
chr3	14183758	14183758	A	G	het	anno_omim	QUAL=12675;DP=370;AF=0.52;MQM=60;TRIO=HET,370,0.52,HOM,254,0.99,WT,324,0.00	TMEM43,RP11-434D12.1	3'UTR	TMEM43:ENST00000306077:3'UTR:MODIFIER:exon12/12:c.*463A>G:		rs1043953	0.0927	0.0000	0,0,0	0,0,0,0,0	0.1537							612048 [TMEM43 (confirmed) Arrhythmogenic right ventricular dysplasia 5,604400|Emery-Dreifuss muscular dystrophy 7,AD,614302];	RCV000284996.1 [likely benign]; RCV000295901.1 [likely benign]; 			7	73					TMEM43 (inh=AD pLI=0.00), RP11-434D12.1 (inh=n/a pLI=n/a)
chr3	14184074	14184074	A	C	het	anno_omim	QUAL=11978;DP=399;AF=0.54;MQM=60;TRIO=HET,399,0.54,HOM,204,0.99,WT,286,0.00	TMEM43,RP11-434D12.1	3'UTR	TMEM43:ENST00000306077:3'UTR:MODIFIER:exon12/12:c.*779A>C:		rs13069	0.1300	0.0000	0,0,0	0,0,0,0,0	0.1900							612048 [TMEM43 (confirmed) Arrhythmogenic right ventricular dysplasia 5,604400|Emery-Dreifuss muscular dystrophy 7,AD,614302];	RCV000287769.1 [likely benign]; RCV000296687.1 [likely benign]; 			10	84					TMEM43 (inh=AD pLI=0.00), RP11-434D12.1 (inh=n/a pLI=n/a)
chr3	14184669	14184669	T	C	het	anno_omim	QUAL=10614;DP=303;AF=0.48;MQM=60;TRIO=HET,303,0.48,HOM,207,1.00,WT,229,0.00	TMEM43,RP11-434D12.1	3'UTR	TMEM43:ENST00000306077:3'UTR:MODIFIER:exon12/12:c.*1374T>C:		rs8516	0.1048	0.0000	0,0,0	0,0,0,0,0	0.1641							612048 [TMEM43 (confirmed) Arrhythmogenic right ventricular dysplasia 5,604400|Emery-Dreifuss muscular dystrophy 7,AD,614302];	RCV000302250.1 [likely benign]; RCV000318138.1 [likely benign]; 			7	73					TMEM43 (inh=AD pLI=0.00), RP11-434D12.1 (inh=n/a pLI=n/a)
chr3	14184719	14184719	T	C	het	anno_omim	QUAL=9704;DP=331;AF=0.46;MQM=60;TRIO=HET,331,0.46,HOM,171,1.00,WT,205,0.00	TMEM43,RP11-434D12.1	3'UTR	TMEM43:ENST00000306077:3'UTR:MODIFIER:exon12/12:c.*1424T>C:		rs10468	0.1306	0.0000	0,0,0	0,0,0,0,0	0.1899							612048 [TMEM43 (confirmed) Arrhythmogenic right ventricular dysplasia 5,604400|Emery-Dreifuss muscular dystrophy 7,AD,614302];	RCV000340739.1 [likely benign]; RCV000372953.1 [likely benign]; 			10	83					TMEM43 (inh=AD pLI=0.00), RP11-434D12.1 (inh=n/a pLI=n/a)
chr3	14186757	14186757	C	G	hom	anno_omim	QUAL=17949;DP=277;AF=1.00;MQM=60;TRIO=HOM,277,1.00,HOM,130,1.00,HOM,157,1.00	XPC,RP11-434D12.1,AC093495.4	3'UTR	XPC:ENST00000285021:3'UTR:MODIFIER:exon16/16:c.*684G>C:		rs1126547	0.9189	0.9177	3487,770,66	0.0000,0.0000,0.0000,0.8865,0.9269	0.9051							613208 [XPC (confirmed) Xeroderma pigmentosum,group C,278720];	RCV000355609.1 [benign]; RCV000397507.1 [likely benign]; 			492	144					XPC (inh=AR pLI=0.00), RP11-434D12.1 (inh=n/a pLI=n/a), AC093495.4 (inh=n/a pLI=n/a)
chr3	14186823	14186823	T	C	het	anno_omim	QUAL=12347;DP=302;AF=0.55;MQM=59;TRIO=HET,302,0.55,HOM,245,1.00,WT,301,0.00	RP11-434D12.1,AC093495.4,XPC	3'UTR	XPC:ENST00000285021:3'UTR:MODIFIER:exon16/16:c.*618A>G:		rs2470458	0.1078	0.1288	122,56,2	0.0000,0.0000,0.0000,0.1978,0.1071	0.1643							613208 [XPC (confirmed) Xeroderma pigmentosum,group C,278720];	RCV000263158.1 [likely benign]; RCV000305702.1 [likely benign]; 			29	204	2	[2] auto-classification 14.09.2017  			RP11-434D12.1 (inh=n/a pLI=n/a), AC093495.4 (inh=n/a pLI=n/a), XPC (inh=AR pLI=0.00)
chr3	14186830	14186830	A	T	het	anno_omim	QUAL=12742;DP=313;AF=0.55;MQM=59;TRIO=HET,313,0.55,HOM,251,1.00,WT,312,0.00	RP11-434D12.1,XPC,AC093495.4	3'UTR	XPC:ENST00000285021:3'UTR:MODIFIER:exon16/16:c.*611T>A:		rs2470352	0.1082	0.1282	121,55,2	0.0000,0.0000,0.0000,0.1961,0.1068	0.1650							613208 [XPC (confirmed) Xeroderma pigmentosum,group C,278720];	RCV000296984.1 [likely benign]; RCV000353421.1 [likely benign]; 			30	206					RP11-434D12.1 (inh=n/a pLI=n/a), XPC (inh=AR pLI=0.00), AC093495.4 (inh=n/a pLI=n/a)
chr3	14187345	14187345	G	C	het	anno_omim	QUAL=6477;DP=216;AF=0.44;MQM=59;TRIO=HET,216,0.44,HOM,137,0.99,WT,223,0.00	XPC,RP11-434D12.1,AC093495.4	3'UTR	XPC:ENST00000285021:3'UTR:MODIFIER:exon16/16:c.*96C>G:		rs2229090	0.2550	0.3533	2507,1406,39	0.1982,0.3850,0.4781,0.3540,0.2893	0.2496							613208 [XPC (confirmed) Xeroderma pigmentosum,group C,278720];	RCV000273637.1 [likely benign]; RCV000289517.1 [benign]; 			47	230					XPC (inh=AR pLI=0.00), RP11-434D12.1 (inh=n/a pLI=n/a), AC093495.4 (inh=n/a pLI=n/a)
chr3	14187449	14187449	G	T	het	pred_pathogenic;anno_omim	QUAL=13423;DP=305;AF=0.47;MQM=59;TRIO=HET,305,0.47,HOM,198,1.00,HET,331,0.45	XPC,RP11-434D12.1,AC093495.4	missense	XPC:ENST00000285021:missense:MODERATE:exon16/16:c.2815C>A:p.Gln939Lys,XPC:ENST00000449060:missense:MODERATE:exon16/16:c.2704C>A:p.Gln902Lys		rs2228001	0.6847	0.6325	24273,11654,2594	0.7290,0.7087,0.6449,0.5912,0.6510	0.6556	2.9050	T,T	T	B,B	T,T	12.01	613208 [XPC (confirmed) Xeroderma pigmentosum,group C,278720];	RCV000170436.2 [benign]; RCV000211268.1 [drug response]; RCV000331098.1 [likely benign]; RCV000380504.1 [benign]; 		COSM4002478	1158	1628	2	[2] auto-classification 14.09.2017  			XPC (inh=AR pLI=0.00), RP11-434D12.1 (inh=n/a pLI=n/a), AC093495.4 (inh=n/a pLI=n/a)
chr3	14190237	14190237	T	G	het	anno_omim	QUAL=15305;DP=202;AF=0.50;MQM=59;TRIO=HET,202,0.50,HOM,266,1.00,HET,363,0.55	XPC	splice_region&intron	XPC:ENST00000285021:splice_region&intron:LOW:exon12/15:c.2251-6A>C:,XPC:ENST00000449060:splice_region&intron:LOW:exon12/15:c.2140-6A>C:		rs2279017	0.6797	0.6302	24122,11660,2445	0.7073,0.7059,0.6455,0.5914,0.6479	0.6502							613208 [XPC (confirmed) Xeroderma pigmentosum,group C,278720];	RCV000170435.2 [benign]; RCV000301008.1 [benign]; 			1160	1631	2	[2] auto-classification 14.09.2017  			XPC (inh=AR pLI=0.00)
chr3	14197987	14197987	A	T	hom	anno_omim	QUAL=26408;DP=155;AF=1.00;MQM=60;TRIO=HOM,155,1.00,HOM,290,1.00,HOM,394,1.00	XPC	synonymous	XPC:ENST00000285021:synonymous:LOW:exon10/16:c.1881T>A:p.Ala627Ala,XPC:ENST00000449060:synonymous:LOW:exon10/16:c.1770T>A:p.Ala590Ala		rs2958057	1.0000	1.0000	60391,33370,4907	1.0000,1.0000,1.0000,1.0000,1.0000	1.0000							613208 [XPC (confirmed) Xeroderma pigmentosum,group C,278720];	RCV000170433.1 [benign]; 			3494	0	2	[2] auto-classification 14.09.2017  			XPC (inh=AR pLI=0.00)
chr3	14199887	14199887	G	A	het	anno_omim	QUAL=14092;DP=425;AF=0.50;MQM=60;TRIO=HET,425,0.50,HOM,303,0.99,WT,390,0.00	XPC	missense	XPC:ENST00000285021:missense:MODERATE:exon9/16:c.1496C>T:p.Ala499Val,XPC:ENST00000449060:missense:MODERATE:exon9/16:c.1385C>T:p.Ala462Val		rs2228000	0.2330	0.2378	3688,2040,44	0.0924,0.2190,0.3576,0.2454,0.1963	0.2439		T,T	T	B,B	T,T	3.20	613208 [XPC (confirmed) Xeroderma pigmentosum,group C,278720];	RCV000122343.2 [benign]; RCV000325908.1 [benign]; 	CM057944 [CLASS=DP MUT=ALT PHEN="Lung cancer association with" GENE=XPC]; 		211	1164	2	[2] auto-classification 14.09.2017  			XPC (inh=AR pLI=0.00)
chr3	14220095	14220095	C	G	het	anno_omim	QUAL=9826;DP=110;AF=0.48;MQM=60;TRIO=HET,110,0.48,HOM,195,1.00,HET,212,0.51	LSM3,XPC	5'UTR_premature_start_codon_gain,5'UTR	LSM3:ENST00000306024:5'UTR_premature_start_codon_gain:LOW:exon1/4:c.-266C>G:,XPC:ENST00000285021:5'UTR:MODIFIER:exon1/16:c.-27G>C:,LSM3:ENST00000306024:5'UTR:MODIFIER:exon1/4:c.-266C>G:		rs2607775	0.3279	0.4211	11016,7269,639	0.3803,0.4308,0.0449,0.4748,0.3968	0.4170							613208 [XPC (confirmed) Xeroderma pigmentosum,group C,278720];	RCV000247851.1 [benign]; RCV000346126.1 [benign]; 			685	1572	2	[2] auto-classification 14.09.2017  			LSM3 (inh=n/a pLI=0.00), XPC (inh=AR pLI=0.00)
chr3	15677019	15677019	G	A	het	pred_pathogenic;anno_omim;anno_pathogenic_clinvar;anno_pathogenic_hgmd	QUAL=8630;DP=263;AF=0.51;MQM=59;TRIO=HET,263,0.51,WT,309,0.00,HET,394,0.54	BTD	missense	BTD:ENST00000437172:missense:MODERATE:exon4/6:c.139G>A:p.Gly47Arg,BTD:ENST00000449107:missense:MODERATE:exon2/4:c.139G>A:p.Gly47Arg,BTD:ENST00000303498:missense:MODERATE:exon2/4:c.133G>A:p.Gly45Arg,BTD:ENST00000383778:missense:MODERATE:exon2/4:c.73G>A:p.Gly25Arg		rs34885143	0.0038	0.0100	11,9,0	0.0029,0.0039,0.0000,0.0134,0.0047	0.0119	-0.0370	T,T,T,T,T,T	T	B,B,B	D,D,D,D,D,D	3.52	609019 [BTD (provisional) Biotinidase deficiency,253260];	RCV000021888.2 [pathogenic]; RCV000021889.1 [pathogenic]; RCV000021890.1 [pathogenic]; RCV000185799.2 [other]; 	CM993540 [CLASS=DM? MUT=ALT PHEN="Biotinidase deficiency" GENE=BTD]; 		1	72	2	[2] old entry - no details available			BTD (inh=AR pLI=0.00)
chr3	24159008	24159008	G	A	het	anno_omim	QUAL=9716;DP=343;AF=0.46;MQM=60;TRIO=HET,343,0.46,WT,278,0.00,HET,425,0.49	THRB	3'UTR	THRB:ENST00000396671:3'UTR:MODIFIER:exon11/11:c.*5367C>T:	MLT1K	rs2167116	0.2145	0.0000	0,0,0	0,0,0,0,0	0.1912							190160 [THRB (confirmed) Thyroid hormone resistance,188570|Thyroid hormone resistance,autosomal recessive,274300|Thyroid hormone resistance,selective pituitary,145650];	RCV000260123.1 [benign]; 			1	34					THRB (inh=AR+AD pLI=0.99)
chr3	24159023	24159023	G	A	het	anno_omim	QUAL=9377;DP=340;AF=0.48;MQM=60;TRIO=HET,340,0.48,WT,257,0.00,HET,384,0.51	THRB	3'UTR	THRB:ENST00000396671:3'UTR:MODIFIER:exon11/11:c.*5352C>T:	MLT1K	rs56204436	0.1160	0.0000	0,0,0	0,0,0,0,0	0.1193							190160 [THRB (confirmed) Thyroid hormone resistance,188570|Thyroid hormone resistance,autosomal recessive,274300|Thyroid hormone resistance,selective pituitary,145650];	RCV000317658.1 [benign]; 			1	27					THRB (inh=AR+AD pLI=0.99)
chr3	24159387	24159387	A	G	het	anno_omim	QUAL=17336;DP=236;AF=0.54;MQM=60;TRIO=HET,236,0.54,HOM,270,1.00,HET,355,0.52	THRB	3'UTR	THRB:ENST00000396671:3'UTR:MODIFIER:exon11/11:c.*4988T>C:		rs1349265	0.4802	0.0000	0,0,0	0,0,0,0,0	0.5403							190160 [THRB (confirmed) Thyroid hormone resistance,188570|Thyroid hormone resistance,autosomal recessive,274300|Thyroid hormone resistance,selective pituitary,145650];	RCV000399046.1 [benign]; 			102	102					THRB (inh=AR+AD pLI=0.99)
chr3	24168981	24168981	C	T	het	anno_omim	QUAL=336;DP=23;AF=0.48;MQM=60;TRIO=HET,23,0.48,HET,27,0.41,WT,57,0.00	THRB	splice_region&intron	THRB:ENST00000280696:splice_region&intron:LOW:exon6/6:c.1189+9G>A:,THRB:ENST00000396671:splice_region&intron:LOW:exon10/10:c.1144+9G>A:,THRB:ENST00000356447:splice_region&intron:LOW:exon9/9:c.1144+9G>A:,THRB:ENST00000416420:splice_region&intron:LOW:exon11/11:c.1144+9G>A:		rs13063628	0.0629	0.1103	912,696,17	0.0629,0.0575,0.0004,0.1435,0.0779	0.1175							190160 [THRB (confirmed) Thyroid hormone resistance,188570|Thyroid hormone resistance,autosomal recessive,274300|Thyroid hormone resistance,selective pituitary,145650];	RCV000248310.1 [benign]; RCV000360381.1 [benign]; 			45	434	2	[2] auto-classification 14.09.2017  			THRB (inh=AR+AD pLI=0.99)
chr3	24270500	24270500	-	A	hom	anno_omim	QUAL=6532;DP=138;AF=0.97;MQM=59;TRIO=HOM,138,0.97,HET,95,0.48,HET,107,0.48	THRB	splice_region&intron	THRB:ENST00000396671:splice_region&intron:LOW:exon3/10:c.-42-9dupT:,THRB:ENST00000356447:splice_region&intron:LOW:exon2/9:c.-42-9dupT:,THRB:ENST00000416420:splice_region&intron:LOW:exon4/11:c.-42-9dupT:		rs397841135	0.0000	0.3224	7102,2298,1738	0.5763,0.2282,0.5321,0.2610,0.3930	0.3678							190160 [THRB (confirmed) Thyroid hormone resistance,188570|Thyroid hormone resistance,autosomal recessive,274300|Thyroid hormone resistance,selective pituitary,145650];	RCV000372287.1 [benign]; 			196	788	2	[2] auto-classification 14.09.2017  			THRB (inh=AR+AD pLI=0.99)
chr3	30733402	30733403	TA	-	hom	low_DP;anno_omim	QUAL=84;DP=7;AF=0.71;MQM=60;TRIO=HOM,7,0.71,HOM,2,0.50,WT,107,0.48	TGFBR2	3'UTR	TGFBR2:ENST00000359013:3'UTR:MODIFIER:exon8/8:c.*328_*329delAT:,TGFBR2:ENST00000295754:3'UTR:MODIFIER:exon7/7:c.*328_*329delAT:	(TA)n	rs750106981	0.0000	0.0000	0,0,0	0,0,0,0,0	0.3265							190182 [TGFBR2 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 6,614331|Esophageal cancer,somatic,133239|Loeys-Dietz syndrome 2,610168];				64	24					TGFBR2 (inh=AD pLI=0.04)
chr3	30735156	30735156	C	T	het	anno_omim	QUAL=9002;DP=397;AF=0.49;MQM=60;TRIO=HET,397,0.49,WT,223,0.00,HET,265,0.55	TGFBR2	3'UTR	TGFBR2:ENST00000359013:3'UTR:MODIFIER:exon8/8:c.*2065C>T:,TGFBR2:ENST00000295754:3'UTR:MODIFIER:exon7/7:c.*2065C>T:		rs11466536	0.0232	0.0000	0,0,0	0,0,0,0,0	0.0457							190182 [TGFBR2 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 6,614331|Esophageal cancer,somatic,133239|Loeys-Dietz syndrome 2,610168];	RCV000288089.1 [benign]; RCV000345353.1 [benign]; RCV000389525.1 [benign]; 			1	20					TGFBR2 (inh=AD pLI=0.04)
chr3	30735330	30735330	-	T	het	anno_omim	QUAL=2196;DP=229;AF=0.32;MQM=59;TRIO=HET,229,0.32,WT,159,0.00,HET,206,0.45	TGFBR2	3'UTR	TGFBR2:ENST00000359013:3'UTR:MODIFIER:exon8/8:c.*2248dupT:,TGFBR2:ENST00000295754:3'UTR:MODIFIER:exon7/7:c.*2248dupT:		rs542768261	0.2065	0.0000	0,0,0	0,0,0,0,0	0.2832							190182 [TGFBR2 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 6,614331|Esophageal cancer,somatic,133239|Loeys-Dietz syndrome 2,610168];	RCV000260690.1 [benign]; RCV000299574.1 [benign]; RCV000356795.1 [benign]; 			16	73					TGFBR2 (inh=AD pLI=0.04)
chr3	33055721	33055721	A	G	hom	pred_pathogenic;anno_omim	QUAL=20080;DP=125;AF=1.00;MQM=59;TRIO=HOM,125,1.00,HOM,195,1.00,HOM,332,1.00	GLB1	missense	GLB1:ENST00000445488:missense:MODERATE:exon16/17:c.1705T>C:p.Cys569Arg,GLB1:ENST00000307363:missense:MODERATE:exon15/16:c.1561T>C:p.Cys521Arg,GLB1:ENST00000399402:missense:MODERATE:exon15/16:c.1471T>C:p.Cys491Arg,GLB1:ENST00000307377:missense:MODERATE:exon12/13:c.1168T>C:p.Cys390Arg		rs4302331	0.9271	0.9800	58208,33273,2982	0.7803,0.9877,1.0000,0.9986,0.9995	0.9831	0.3470	T,T,T,T	T	B	D,D,D,D	6.85	611458 [GLB1 (confirmed) GM1-gangliosidosis,type I,230500|GM1-gangliosidosis,type II,230600|GM1-gangliosidosis,type III,230650|Mucopolysaccharidosis type IVB (Morquio),253010];	RCV000153326.2 [benign]; 			3785	38	2	[2] Peter Bauer 25.08.2014			GLB1 (inh=AR pLI=0.00)
chr3	33138544	33138544	A	G	het	low_DP;anno_omim	QUAL=3476;DP=17;AF=0.53;MQM=60;TRIO=HET,17,0.53,HOM,115,1.00,WT,204,0.01	GLB1	synonymous	GLB1:ENST00000445488:synonymous:LOW:exon1/17:c.34T>C:p.Leu12Leu,GLB1:ENST00000307363:synonymous:LOW:exon1/16:c.34T>C:p.Leu12Leu,GLB1:ENST00000307377:synonymous:LOW:exon1/13:c.34T>C:p.Leu12Leu		rs7614776	0.9277	0.9052	48924,25458,3600	0.8692,0.9595,0.9997,0.8802,0.9532	0.9085							611458 [GLB1 (confirmed) GM1-gangliosidosis,type I,230500|GM1-gangliosidosis,type II,230600|GM1-gangliosidosis,type III,230650|Mucopolysaccharidosis type IVB (Morquio),253010];	RCV000078712.9 [other]; RCV000302471.1 [benign]; RCV000392270.1 [benign]; 		COSM4157974, COSM4157973	3036	659	2	[2] auto-classification 14.09.2017  			GLB1 (inh=AR pLI=0.00)
chr3	33138549	33138549	G	A	het	low_DP;pred_pathogenic;anno_omim	QUAL=3131;DP=17;AF=0.41;MQM=60;TRIO=HET,17,0.41,HOM,114,0.97,WT,201,0.01	GLB1	missense	GLB1:ENST00000445488:missense:MODERATE:exon1/17:c.29C>T:p.Pro10Leu,GLB1:ENST00000307363:missense:MODERATE:exon1/16:c.29C>T:p.Pro10Leu,GLB1:ENST00000307377:missense:MODERATE:exon1/13:c.29C>T:p.Pro10Leu		rs7637099	0.4319	0.5625	19740,12821,102	0.1457,0.5380,0.5149,0.6254,0.5766	0.5676	0.1970	T,T,T,D,T	T	B,B	D,D,D,D,D	12.82	611458 [GLB1 (confirmed) GM1-gangliosidosis,type I,230500|GM1-gangliosidosis,type II,230600|GM1-gangliosidosis,type III,230650|Mucopolysaccharidosis type IVB (Morquio),253010];	RCV000078711.9 [other]; RCV000340960.1 [benign]; RCV000402607.1 [benign]; 	CM055955 [CLASS=R MUT=ALT PHEN="Gangliosidosis GM1" GENE=GLB1]; 	COSM4157976, COSM4157975	1503	1623	2	[2] auto-classification 14.09.2017  			GLB1 (inh=AR pLI=0.00)
chr3	33174156	33174156	T	G	het	anno_omim	QUAL=10182;DP=208;AF=0.44;MQM=60;TRIO=HET,208,0.44,HOM,256,1.00,WT,339,0.00	CRTAP	synonymous	CRTAP:ENST00000320954:synonymous:LOW:exon5/7:c.1032T>G:p.Thr344Thr,CRTAP:ENST00000449224:synonymous:LOW:exon4/6:c.903T>G:p.Thr301Thr		rs1135127	0.2935	0.3752	9267,6573,378	0.2652,0.1911,0.1334,0.4438,0.4142	0.3704							605497 [CRTAP (confirmed) Osteogenesis imperfecta,type VII,610682];	RCV000246595.1 [benign]; RCV000263971.1 [benign]; 		COSM149349	428	962	2	[2] auto-classification 14.09.2017  			CRTAP (inh=AR pLI=0.00)
chr3	33174168	33174168	G	A	het	anno_omim	QUAL=9298;DP=174;AF=0.42;MQM=60;TRIO=HET,174,0.42,HOM,243,1.00,WT,322,0.00	CRTAP	synonymous	CRTAP:ENST00000320954:synonymous:LOW:exon5/7:c.1044G>A:p.Ser348Ser,CRTAP:ENST00000449224:synonymous:LOW:exon4/6:c.915G>A:p.Ser305Ser		rs1135128	0.2935	0.3751	9265,6572,378	0.2652,0.1911,0.1333,0.4438,0.4139	0.3704							605497 [CRTAP (confirmed) Osteogenesis imperfecta,type VII,610682];	RCV000251530.1 [benign]; RCV000321518.1 [benign]; 			428	961	2	[2] auto-classification 14.09.2017  			CRTAP (inh=AR pLI=0.00)
chr3	33185027	33185027	-	GAACTA	het	anno_omim	QUAL=7427;DP=306;AF=0.47;MQM=59;TRIO=HET,306,0.47,HOM,125,0.98,WT,159,0.00	CRTAP	3'UTR	CRTAP:ENST00000320954:3'UTR:MODIFIER:exon7/7:c.*1090_*1095dupACTAGA:	L2a	rs5847775	0.3387	0.0000	0,0,0	0,0,0,0,0	0.4680							605497 [CRTAP (confirmed) Osteogenesis imperfecta,type VII,610682];				65	74					CRTAP (inh=AR pLI=0.00)
chr3	33185407	33185407	G	A	het	anno_omim	QUAL=8951;DP=350;AF=0.49;MQM=59;TRIO=HET,350,0.49,WT,329,0.00,HET,426,0.50	CRTAP	3'UTR	CRTAP:ENST00000320954:3'UTR:MODIFIER:exon7/7:c.*1467G>A:	L2a	rs4678475	0.3019	0.0000	0,0,0	0,0,0,0,0	0.2609							605497 [CRTAP (confirmed) Osteogenesis imperfecta,type VII,610682];	RCV000281743.1 [benign]; 			16	53					CRTAP (inh=AR pLI=0.00)
chr3	33185798	33185798	T	A	hom	anno_omim	QUAL=19458;DP=256;AF=1.00;MQM=59;TRIO=HOM,256,1.00,HOM,159,1.00,HOM,180,1.00	CRTAP,RP11-627J17.1	3'UTR	CRTAP:ENST00000320954:3'UTR:MODIFIER:exon7/7:c.*1858T>A:	L2a	rs4678476	0.8960	0.0000	0,0,0	0,0,0,0,0	0.9405							605497 [CRTAP (confirmed) Osteogenesis imperfecta,type VII,610682];	RCV000391352.1 [benign]; 			175	2					CRTAP (inh=AR pLI=0.00), RP11-627J17.1 (inh=n/a pLI=n/a)
chr3	33186356	33186356	T	C	het	anno_omim	QUAL=5877;DP=216;AF=0.53;MQM=60;TRIO=HET,216,0.53,WT,141,0.01,HET,236,0.46	CRTAP,RP11-627J17.1	3'UTR	CRTAP:ENST00000320954:3'UTR:MODIFIER:exon7/7:c.*2416T>C:	L2a	rs1127898	0.3610	0.0000	0,0,0	0,0,0,0,0	0.2892							605497 [CRTAP (confirmed) Osteogenesis imperfecta,type VII,610682];	RCV000370650.1 [benign]; 			15	84					CRTAP (inh=AR pLI=0.00), RP11-627J17.1 (inh=n/a pLI=n/a)
chr3	33187425	33187425	G	A	het	anno_omim	QUAL=15652;DP=523;AF=0.50;MQM=60;TRIO=HET,523,0.50,HOM,283,0.99,WT,350,0.00	CRTAP,RP11-627J17.1	3'UTR	CRTAP:ENST00000320954:3'UTR:MODIFIER:exon7/7:c.*3485G>A:		rs1132392	0.3199	0.0000	0,0,0	0,0,0,0,0	0.4544							605497 [CRTAP (confirmed) Osteogenesis imperfecta,type VII,610682];	RCV000260313.1 [benign]; 			82	110					CRTAP (inh=AR pLI=0.00), RP11-627J17.1 (inh=n/a pLI=n/a)
chr3	33187831	33187831	C	T	het	anno_omim	QUAL=8142;DP=181;AF=0.48;MQM=60;TRIO=HET,181,0.48,WT,357,0.00,HET,461,0.51	CRTAP,RP11-627J17.1	3'UTR	CRTAP:ENST00000320954:3'UTR:MODIFIER:exon7/7:c.*3891C>T:		rs4678478	0.3037	0.0000	0,0,0	0,0,0,0,0	0.2404							605497 [CRTAP (confirmed) Osteogenesis imperfecta,type VII,610682];	RCV000267264.1 [benign]; 			15	84					CRTAP (inh=AR pLI=0.00), RP11-627J17.1 (inh=n/a pLI=n/a)
chr3	33189163	33189163	T	A	het	anno_omim	QUAL=3055;DP=175;AF=0.49;MQM=60;TRIO=HET,175,0.49,HET,71,0.51,WT,100,0.00	CRTAP,RP11-627J17.1	3'UTR	CRTAP:ENST00000320954:3'UTR:MODIFIER:exon7/7:c.*5223T>A:		rs192685869	0.0008	0.0000	0,0,0	0,0,0,0,0	0.0007							605497 [CRTAP (confirmed) Osteogenesis imperfecta,type VII,610682];				0	6					CRTAP (inh=AR pLI=0.00), RP11-627J17.1 (inh=n/a pLI=n/a)
chr3	41241154	41241154	C	G	het	anno_omim	QUAL=1790;DP=90;AF=0.49;MQM=59;TRIO=HET,90,0.49,HET,98,0.43,WT,107,0.00	CTNNB1	5'UTR_premature_start_codon_gain,5'UTR,intron	CTNNB1:ENST00000349496:5'UTR_premature_start_codon_gain:LOW:exon1/15:c.-56C>G:,CTNNB1:ENST00000396183:5'UTR_premature_start_codon_gain:LOW:exon1/16:c.-56C>G:,CTNNB1:ENST00000453024:5'UTR_premature_start_codon_gain:LOW:exon1/17:c.-209C>G:,CTNNB1:ENST00000396185:5'UTR_premature_start_codon_gain:LOW:exon1/16:c.-56C>G:,CTNNB1:ENST00000349496:5'UTR:MODIFIER:exon1/15:c.-56C>G:,CTNNB1:ENST00000396183:5'UTR:MODIFIER:exon1/16:c.-56C>G:,CTNNB1:ENST00000453024:5'UTR:MODIFIER:exon1/17:c.-209C>G:,CTNNB1:ENST00000396185:5'UTR:MODIFIER:exon1/16:c.-56C>G:,CTNNB1:ENST00000405570:intron:MODIFIER:exon2/15:c.-49+3957C>G:		rs11564435	0.0032	0.0000	0,0,0	0,0,0,0,0	0.0090							116806 [CTNNB1 (confirmed) Mental retardation,autosomal dominant 19,615075|Colorectal cancer,somatic,114500|Pilomatricoma,somatic,132600|Ovarian cancer,somatic,167000|Hepatocellular carcinoma,somatic,114550|Medulloblastoma,somatic,155255];				0	8					CTNNB1 (inh=AD pLI=1.00)
chr3	41281388	41281388	T	G	het	anno_omim	QUAL=2042;DP=76;AF=0.45;MQM=59;TRIO=HET,76,0.45,HET,46,0.59,HET,60,0.52	CTNNB1	3'UTR	CTNNB1:ENST00000349496:3'UTR:MODIFIER:exon15/15:c.*555T>G:,CTNNB1:ENST00000396183:3'UTR:MODIFIER:exon16/16:c.*91T>G:,CTNNB1:ENST00000396185:3'UTR:MODIFIER:exon16/16:c.*250T>G:		rs2953	0.3652	0.0000	0,0,0	0,0,0,0,0	0.4016							116806 [CTNNB1 (confirmed) Mental retardation,autosomal dominant 19,615075|Colorectal cancer,somatic,114500|Pilomatricoma,somatic,132600|Ovarian cancer,somatic,167000|Hepatocellular carcinoma,somatic,114550|Medulloblastoma,somatic,155255];				49	112					CTNNB1 (inh=AD pLI=1.00)
chr3	41281413	41281413	T	A	het	anno_omim	QUAL=931;DP=87;AF=0.25;MQM=60;TRIO=HET,87,0.25,HOM,17,0.47,HET,14,0.29	CTNNB1	3'UTR	CTNNB1:ENST00000349496:3'UTR:MODIFIER:exon15/15:c.*580T>A:,CTNNB1:ENST00000396183:3'UTR:MODIFIER:exon16/16:c.*116T>A:,CTNNB1:ENST00000396185:3'UTR:MODIFIER:exon16/16:c.*275T>A:	(T)n	rs4135387	0.2700	0.0000	0,0,0	0,0,0,0,0	0.5152							116806 [CTNNB1 (confirmed) Mental retardation,autosomal dominant 19,615075|Colorectal cancer,somatic,114500|Pilomatricoma,somatic,132600|Ovarian cancer,somatic,167000|Hepatocellular carcinoma,somatic,114550|Medulloblastoma,somatic,155255];				15	126					CTNNB1 (inh=AD pLI=1.00)
chr3	41281600	41281600	-	TAAT	het	anno_omim	QUAL=1812;DP=122;AF=0.46;MQM=60;TRIO=HET,122,0.46,HET,15,0.80,HET,14,0.36	CTNNB1	3'UTR	CTNNB1:ENST00000349496:3'UTR:MODIFIER:exon15/15:c.*769_*772dupAATT:,CTNNB1:ENST00000396183:3'UTR:MODIFIER:exon16/16:c.*305_*308dupAATT:,CTNNB1:ENST00000396185:3'UTR:MODIFIER:exon16/16:c.*464_*467dupAATT:		rs3834205;rs71623294	0.3580	0.0000	0,0,0	0,0,0,0,0	0.3969							116806 [CTNNB1 (confirmed) Mental retardation,autosomal dominant 19,615075|Colorectal cancer,somatic,114500|Pilomatricoma,somatic,132600|Ovarian cancer,somatic,167000|Hepatocellular carcinoma,somatic,114550|Medulloblastoma,somatic,155255];				48	112					CTNNB1 (inh=AD pLI=1.00)
chr3	43761441	43761441	A	G	hom	anno_omim	QUAL=24205;DP=383;AF=1.00;MQM=60;TRIO=HOM,383,1.00,HET,221,0.44,HOM,263,1.00	ABHD5				rs3733156	0.5487	0.0000	0,0,0	0,0,0,0,0	0.5927							604780 [ABHD5 (confirmed) Chanarin-Dorfman syndrome,275630];	RCV000308938.1 [benign]; 			110	103					ABHD5 (inh=AR pLI=0.00)
chr3	46944274	46944274	T	C	het	anno_omim	QUAL=22780;DP=363;AF=0.44;MQM=59;TRIO=HET,363,0.44,HOM,372,0.99,HET,473,0.54	PTH1R	synonymous	PTH1R:ENST00000313049:synonymous:LOW:exon13/14:c.1389T>C:p.Asn463Asn,PTH1R:ENST00000449590:synonymous:LOW:exon15/16:c.1389T>C:p.Asn463Asn,PTH1R:ENST00000418619:synonymous:LOW:exon15/16:c.1389T>C:p.Asn463Asn,PTH1R:ENST00000430002:synonymous:LOW:exon14/15:c.1389T>C:p.Asn463Asn		rs1138518	0.6434	0.6141	22990,12787,3275	0.8020,0.5694,0.4540,0.6215,0.5807	0.6623							168468 [PTH1R (confirmed) Metaphyseal chondrodysplasia,Murk Jansen type,156400|Chondrodysplasia,Blomstrand type,215045|Eiken syndrome,600002|Failure of tooth eruption,primary,125350];	RCV000288818.1 [benign]; RCV000404246.1 [benign]; 		COSM149372	833	917	2	[2] auto-classification 14.09.2017  			PTH1R (inh=AR+AD pLI=0.74)
chr3	46945000	46945000	G	A	het	pred_pathogenic;anno_omim	QUAL=3447;DP=148;AF=0.53;MQM=59;TRIO=HET,148,0.53,WT,106,0.00,HET,126,0.50	PTH1R	missense	PTH1R:ENST00000313049:missense:MODERATE:exon14/14:c.1636G>A:p.Glu546Lys,PTH1R:ENST00000449590:missense:MODERATE:exon16/16:c.1636G>A:p.Glu546Lys,PTH1R:ENST00000418619:missense:MODERATE:exon16/16:c.1636G>A:p.Glu546Lys,PTH1R:ENST00000430002:missense:MODERATE:exon15/15:c.1636G>A:p.Glu546Lys		rs77048718	0.0086	0.0166	27,25,0	0.0039,0.0113,0.0000,0.0247,0.0049	0.0167	1.8400	T,T,T,T,.,T	T	B	T,T,T,T,T	17.14	168468 [PTH1R (confirmed) Metaphyseal chondrodysplasia,Murk Jansen type,156400|Chondrodysplasia,Blomstrand type,215045|Eiken syndrome,600002|Failure of tooth eruption,primary,125350];	RCV000261080.1 [likely benign]; RCV000369795.1 [likely benign]; 			1	74					PTH1R (inh=AR+AD pLI=0.74)
chr3	46945263	46945263	-	A	het	anno_omim	QUAL=947;DP=81;AF=0.32;MQM=59;TRIO=HET,81,0.32,HOM,33,0.91,WT,56,0.00	PTH1R	3'UTR	PTH1R:ENST00000313049:3'UTR:MODIFIER:exon14/14:c.*127dupA:,PTH1R:ENST00000449590:3'UTR:MODIFIER:exon16/16:c.*127dupA:,PTH1R:ENST00000418619:3'UTR:MODIFIER:exon16/16:c.*127dupA:	A-rich	rs552713678	0.1532	0.0000	0,0,0	0,0,0,0,0	0.1864							168468 [PTH1R (confirmed) Metaphyseal chondrodysplasia,Murk Jansen type,156400|Chondrodysplasia,Blomstrand type,215045|Eiken syndrome,600002|Failure of tooth eruption,primary,125350];	RCV000268644.1 [benign]; RCV000377157.1 [benign]; 			14	82					PTH1R (inh=AR+AD pLI=0.74)
chr3	48508585	48508585	C	T	het	anno_omim	QUAL=6156;DP=287;AF=0.47;MQM=59;TRIO=HET,287,0.47,WT,188,0.01,HET,246,0.48	TREX1	synonymous	TREX1:ENST00000422277:synonymous:LOW:exon1/1:c.696C>T:p.Tyr232Tyr,TREX1:ENST00000296443:synonymous:LOW:exon3/3:c.531C>T:p.Tyr177Tyr,TREX1:ENST00000433541:synonymous:LOW:exon4/4:c.114C>T:p.Tyr38Tyr,TREX1:ENST00000436480:synonymous:LOW:exon2/2:c.531C>T:p.Tyr177Tyr,TREX1:ENST00000444177:synonymous:LOW:exon2/2:c.501C>T:p.Tyr167Tyr,TREX1:ENST00000456089:synonymous:LOW:exon2/2:c.114C>T:p.Tyr38Tyr		rs11797	0.3133	0.3706	8747,6279,391	0.2723,0.1993,0.3080,0.4352,0.3176	0.3693							606609 [TREX1 (confirmed) Aicardi-Goutieres syndrome 1,dominant and recessive,225750|Chilblain lupus,610448|Vasculopathy,retinal,with cerebral leukodystrophy,192315|Systemic lupus erythematosus,susceptibility to,152700];	RCV000082324.6 [benign]; RCV000341237.1 [benign]; RCV000405847.1 [benign]; 		COSM4002723	411	1043	2	[2] auto-classification 14.09.2017  			TREX1 (inh=AR+AD pLI=0.09)
chr3	48605076	48605076	A	-	het	anno_omim	QUAL=2480;DP=64;AF=0.52;MQM=59;TRIO=HET,64,0.52,HET,199,0.47,WT,270,0.00	COL7A1	splice_region&intron	COL7A1:ENST00000328333:splice_region&intron:LOW:exon107/117:c.7984-7delT:,COL7A1:ENST00000454817:splice_region&intron:LOW:exon106/116:c.7888-7delT:		rs397989501	0.0697	0.0421	169,43,37	0.0787,0.0258,0.1072,0.0310,0.0419	0.0483							120120 [COL7A1 (confirmed) Epidermolysis bullosa dystrophica,AD,131750|Epidermolysis bullosa dystrophica,AR,226600|Epidermolysis bullosa,pretibial,131850|EBD,Bart type,132000|EBD,localisata variant|Transient bullous of the newborn,131705|Epidermolysis bullosa pruriginosa,604129|Toenail dystrophy,isolated,607523|EBD inversa,226600];	RCV000380496.1 [likely benign]; 			10	158	2	[2] auto-classification 14.09.2017  			COL7A1 (inh=AR+AD pLI=0.00)
chr3	48625266	48625266	T	C	hom	anno_omim	QUAL=11578;DP=251;AF=0.99;MQM=59;TRIO=HOM,251,0.99,HET,136,0.52,HET,161,0.53	COL7A1	synonymous	COL7A1:ENST00000328333:synonymous:LOW:exon21/118:c.2817A>G:p.Pro939Pro,COL7A1:ENST00000454817:synonymous:LOW:exon21/117:c.2817A>G:p.Pro939Pro		rs1264194	0.6811	0.6799	28442,16228,4229	0.9049,0.5915,0.3799,0.7020,0.6490	0.7408							120120 [COL7A1 (confirmed) Epidermolysis bullosa dystrophica,AD,131750|Epidermolysis bullosa dystrophica,AR,226600|Epidermolysis bullosa,pretibial,131850|EBD,Bart type,132000|EBD,localisata variant|Transient bullous of the newborn,131705|Epidermolysis bullosa pruriginosa,604129|Toenail dystrophy,isolated,607523|EBD inversa,226600];	RCV000243500.1 [benign]; RCV000408231.1 [benign]; 		COSM446657	960	885	2	[2] auto-classification 14.09.2017  			COL7A1 (inh=AR+AD pLI=0.00)
chr3	49162040	49162040	T	G	het	pred_pathogenic;anno_omim	QUAL=2496;DP=108;AF=0.43;MQM=60;TRIO=HET,108,0.43,HET,82,0.62,WT,102,0.00	LAMB2	missense	LAMB2:ENST00000305544:missense:MODERATE:exon22/32:c.3115A>C:p.Thr1039Pro,LAMB2:ENST00000418109:missense:MODERATE:exon23/33:c.3115A>C:p.Thr1039Pro		rs747604203	0.0000	0.0001	0,0,0	0.0000,0.0000,0.0000,0.0001,0.0000	0.0001	1.8160	D,D	T	B	T,T	22.80	150325 [LAMB2 (confirmed) Nephrotic syndrome,type 5,with or without ocular abnormalities,614199|Pierson syndrome,609049];	RCV000333358.1 [uncertain significance]; RCV000387637.1 [uncertain significance]; 			0	2					LAMB2 (inh=AR pLI=0.00)
chr3	49506273	49506273	-	T	het	anno_omim	QUAL=1277;DP=46;AF=0.76;MQM=58;TRIO=HET,46,0.76,HOM,14,0.71,HOM,9,1.00	DAG1	5'UTR	DAG1:ENST00000515359:5'UTR:MODIFIER:exon1/3:c.-320dupT:	AluJb	rs71080520	0.6699	0.0000	0,0,0	0,0,0,0,0	0.6077							128239 [DAG1 (provisional) Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,9,613818|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,9,616538];				33	83					DAG1 (inh=AR pLI=0.94)
chr3	49506299	49506299	C	T	hom	anno_omim	QUAL=1799;DP=40;AF=1.00;MQM=59;TRIO=HOM,40,1.00,HOM,15,1.00,HOM,14,1.00	DAG1	5'UTR	DAG1:ENST00000515359:5'UTR:MODIFIER:exon1/3:c.-306C>T:	AluJb	rs6797164	0.9659	0.0000	0,0,0	0,0,0,0,0	0.9748							128239 [DAG1 (provisional) Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,9,613818|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,9,616538];				149	0					DAG1 (inh=AR pLI=0.94)
chr3	49507847	49507847	G	A	hom	low_DP;anno_omim	QUAL=184;DP=4;AF=1.00;MQM=60;TRIO=HOM,4,1.00,HET,6,0.50,HET,5,0.60	DAG1	5'UTR,intron	DAG1:ENST00000308775:5'UTR:MODIFIER:exon1/3:c.-136G>A:,DAG1:ENST00000538711:5'UTR:MODIFIER:exon1/4:c.-193G>A:,DAG1:ENST00000539901:5'UTR:MODIFIER:exon1/3:c.-276G>A:,DAG1:ENST00000541308:5'UTR:MODIFIER:exon1/4:c.-287G>A:,DAG1:ENST00000545947:5'UTR:MODIFIER:exon1/6:c.-440G>A:,DAG1:ENST00000515359:intron:MODIFIER:exon1/2:c.-117+1359G>A:		rs4855839	0.5829	0.0000	0,0,0	0,0,0,0,0	0.4318							128239 [DAG1 (provisional) Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,9,613818|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,9,616538];				31	74					DAG1 (inh=AR pLI=0.94)
chr3	49548008	49548008	C	G	hom	pred_pathogenic;anno_omim	QUAL=35044;DP=312;AF=1.00;MQM=60;TRIO=HOM,312,1.00,HOM,341,1.00,HOM,448,1.00	DAG1	missense	DAG1:ENST00000308775:missense:MODERATE:exon2/3:c.41C>G:p.Ser14Trp,DAG1:ENST00000515359:missense:MODERATE:exon2/3:c.41C>G:p.Ser14Trp,DAG1:ENST00000538711:missense:MODERATE:exon3/4:c.41C>G:p.Ser14Trp,DAG1:ENST00000539901:missense:MODERATE:exon2/3:c.41C>G:p.Ser14Trp,DAG1:ENST00000541308:missense:MODERATE:exon3/4:c.41C>G:p.Ser14Trp,DAG1:ENST00000545947:missense:MODERATE:exon5/6:c.41C>G:p.Ser14Trp		rs2131107	0.9659	0.9923	59800,33354,4367	0.9162,0.9959,1.0000,0.9999,0.9998	0.9939	2.0690	T,T,T,T,T,T,T,T,T,T,T,T,T,.	T	B	T,T,T,T,T,T,T,T,T,T,T,T,T	14.90	128239 [DAG1 (provisional) Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,9,613818|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,9,616538];	RCV000214409.1 [benign]; 			2105	4	2	[2] auto-classification 14.09.2017  			DAG1 (inh=AR pLI=0.94)
chr3	49570882	49570882	T	C	hom	anno_omim	QUAL=6774;DP=174;AF=1.00;MQM=59;TRIO=HOM,174,1.00,HET,50,0.42,HET,61,0.52	DAG1	3'UTR	DAG1:ENST00000308775:3'UTR:MODIFIER:exon3/3:c.*250T>C:,DAG1:ENST00000515359:3'UTR:MODIFIER:exon3/3:c.*250T>C:,DAG1:ENST00000538711:3'UTR:MODIFIER:exon4/4:c.*250T>C:,DAG1:ENST00000539901:3'UTR:MODIFIER:exon3/3:c.*250T>C:,DAG1:ENST00000541308:3'UTR:MODIFIER:exon4/4:c.*250T>C:,DAG1:ENST00000545947:3'UTR:MODIFIER:exon6/6:c.*250T>C:		rs1050088	0.5541	0.5639	2135,268,24	0.2949,0.0000,0.9461,0.3810,0.6618	0.5387							128239 [DAG1 (provisional) Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,9,613818|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,9,616538];	RCV000024448.1 [not provided]; 			338	731					DAG1 (inh=AR pLI=0.94)
chr3	49572894	49572894	T	C	hom	anno_omim	QUAL=13192;DP=163;AF=1.00;MQM=59;TRIO=HOM,163,1.00,HOM,120,1.00,HOM,141,1.00	DAG1	3'UTR	DAG1:ENST00000308775:3'UTR:MODIFIER:exon3/3:c.*2262T>C:,DAG1:ENST00000515359:3'UTR:MODIFIER:exon3/3:c.*2262T>C:,DAG1:ENST00000538711:3'UTR:MODIFIER:exon4/4:c.*2262T>C:,DAG1:ENST00000539901:3'UTR:MODIFIER:exon3/3:c.*2262T>C:,DAG1:ENST00000541308:3'UTR:MODIFIER:exon4/4:c.*2262T>C:,DAG1:ENST00000545947:3'UTR:MODIFIER:exon6/6:c.*2262T>C:		rs6446283	0.9758	0.0000	0,0,0	0,0,0,0,0	0.9814							128239 [DAG1 (provisional) Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,9,613818|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,9,616538];				258	0					DAG1 (inh=AR pLI=0.94)
chr3	52017423	52017423	G	C	het	low_DP;anno_omim	QUAL=264;DP=10;AF=0.60;MQM=60;TRIO=HET,10,0.60,HET,18,0.39,WT,36,0.00	ABHD14B,ACY1,ABHD14A-ACY1	5'UTR,intron	ABHD14B:ENST00000483233:5'UTR:MODIFIER:exon1/5:c.-505C>G:,ACY1:ENST00000458031:intron:MODIFIER:exon3/16:c.253-640G>C:,ABHD14A-ACY1:ENST00000463937:intron:MODIFIER:exon3/15:c.398-1800G>C:		rs554462231	0.0018	0.0000	0,0,0	0,0,0,0,0	0.0019							104620 [ACY1 (confirmed) Aminoacylase 1 deficiency,609924];				0	3					ABHD14B (inh=n/a pLI=0.12), ACY1 (inh=AR pLI=0.00), ABHD14A-ACY1 (inh=n/a pLI=0.00)
chr3	53122969	53122969	G	A	het	low_MQM;anno_omim	QUAL=972;DP=78;AF=0.46;MQM=45;TRIO=HET,78,0.46,HET,19,0.42,WT,24,0.00	RFT1,RP11-894J14.5	3'UTR	RFT1:ENST00000296292:3'UTR:MODIFIER:exon13/13:c.*2950C>T:	AluSx4	rs2082093	0.4904	0.0000	0,0,0	0,0,0,0,0	0.4947							611908 [RFT1 (confirmed) Congenital disorder of glycosylation,type In,612015];	RCV000265760.1 [benign]; 			50	75					RFT1 (inh=AR pLI=0.00), RP11-894J14.5 (inh=n/a pLI=n/a)
chr3	53123032	53123032	C	T	hom	low_MQM;anno_omim	QUAL=3186;DP=95;AF=0.94;MQM=47;TRIO=HOM,95,0.94,HET,37,0.49,HET,34,0.56	RFT1,RP11-894J14.5	3'UTR	RFT1:ENST00000296292:3'UTR:MODIFIER:exon13/13:c.*2887G>A:	AluSx4	rs2099162	0.7185	0.0000	0,0,0	0,0,0,0,0	0.6582							611908 [RFT1 (confirmed) Congenital disorder of glycosylation,type In,612015];	RCV000320857.1 [benign]; 			83	66					RFT1 (inh=AR pLI=0.00), RP11-894J14.5 (inh=n/a pLI=n/a)
chr3	53123079	53123079	A	T	het	anno_omim	QUAL=2056;DP=126;AF=0.48;MQM=57;TRIO=HET,126,0.48,WT,57,0.00,HET,65,0.54	RFT1,RP11-894J14.5	3'UTR	RFT1:ENST00000296292:3'UTR:MODIFIER:exon13/13:c.*2840T>A:	AluSx4	rs9875573	0.1699	0.0000	0,0,0	0,0,0,0,0	0.1554							611908 [RFT1 (confirmed) Congenital disorder of glycosylation,type In,612015];	RCV000380214.1 [likely benign]; 			1	43					RFT1 (inh=AR pLI=0.00), RP11-894J14.5 (inh=n/a pLI=n/a)
chr3	53123273	53123273	A	G	het	anno_omim	QUAL=6809;DP=283;AF=0.53;MQM=59;TRIO=HET,283,0.53,HET,219,0.52,WT,315,0.00	RFT1,RP11-894J14.5	3'UTR	RFT1:ENST00000296292:3'UTR:MODIFIER:exon13/13:c.*2646T>C:		rs891368	0.4904	0.0000	0,0,0	0,0,0,0,0	0.4950							611908 [RFT1 (confirmed) Congenital disorder of glycosylation,type In,612015];	RCV000385844.1 [benign]; 			67	112					RFT1 (inh=AR pLI=0.00), RP11-894J14.5 (inh=n/a pLI=n/a)
chr3	53123486	53123486	G	A	het	anno_omim	QUAL=6342;DP=271;AF=0.48;MQM=59;TRIO=HET,271,0.48,HET,234,0.59,WT,328,0.00	RFT1,RP11-894J14.5	3'UTR	RFT1:ENST00000296292:3'UTR:MODIFIER:exon13/13:c.*2433C>T:		rs1078968	0.4904	0.0000	0,0,0	0,0,0,0,0	0.4949							611908 [RFT1 (confirmed) Congenital disorder of glycosylation,type In,612015];	RCV000351024.1 [benign]; 			67	113					RFT1 (inh=AR pLI=0.00), RP11-894J14.5 (inh=n/a pLI=n/a)
chr3	53125297	53125297	G	C	het	anno_omim	QUAL=5271;DP=292;AF=0.46;MQM=60;TRIO=HET,292,0.46,WT,124,0.00,HET,138,0.52	RFT1,RP11-894J14.5	3'UTR	RFT1:ENST00000296292:3'UTR:MODIFIER:exon13/13:c.*622C>G:	L2a	rs7645611	0.1669	0.0000	0,0,0	0,0,0,0,0	0.1490							611908 [RFT1 (confirmed) Congenital disorder of glycosylation,type In,612015];	RCV000397822.1 [likely benign]; 			2	56					RFT1 (inh=AR pLI=0.00), RP11-894J14.5 (inh=n/a pLI=n/a)
chr3	53125469	53125469	G	A	hom	anno_omim	QUAL=15301;DP=311;AF=1.00;MQM=60;TRIO=HOM,311,1.00,HET,199,0.43,HET,234,0.48	RFT1,RP11-894J14.5	3'UTR	RFT1:ENST00000296292:3'UTR:MODIFIER:exon13/13:c.*450C>T:		rs2564922	0.6508	0.0000	0,0,0	0,0,0,0,0	0.6444							611908 [RFT1 (confirmed) Congenital disorder of glycosylation,type In,612015];	RCV000400025.1 [benign]; 			104	97					RFT1 (inh=AR pLI=0.00), RP11-894J14.5 (inh=n/a pLI=n/a)
chr3	53125585	53125585	T	C	het	anno_omim	QUAL=5035;DP=302;AF=0.46;MQM=60;TRIO=HET,302,0.46,HET,104,0.50,WT,137,0.01	RFT1,RP11-894J14.5	3'UTR	RFT1:ENST00000296292:3'UTR:MODIFIER:exon13/13:c.*334A>G:		rs2564921	0.4904	0.0000	0,0,0	0,0,0,0,0	0.4961							611908 [RFT1 (confirmed) Congenital disorder of glycosylation,type In,612015];	RCV000365605.1 [benign]; 			67	113					RFT1 (inh=AR pLI=0.00), RP11-894J14.5 (inh=n/a pLI=n/a)
chr3	53125922	53125922	T	C	het	anno_omim	QUAL=6838;DP=304;AF=0.45;MQM=59;TRIO=HET,304,0.45,HET,234,0.55,WT,261,0.00	RFT1,RP11-894J14.5	synonymous	RFT1:ENST00000296292:synonymous:LOW:exon13/13:c.1623A>G:p.Thr541Thr,RFT1:ENST00000394738:synonymous:LOW:exon12/12:c.1506A>G:p.Thr502Thr		rs11242	0.4904	0.5510	19154,10709,334	0.2447,0.6698,0.7419,0.5673,0.4801	0.5625							611908 [RFT1 (confirmed) Congenital disorder of glycosylation,type In,612015];	RCV000082329.4 [benign]; RCV000353816.1 [benign]; 			642	992	2	[2] auto-classification 14.09.2017  			RFT1 (inh=AR pLI=0.00), RP11-894J14.5 (inh=n/a pLI=n/a)
chr3	55499781	55499781	T	C	hom	anno_omim	QUAL=7361;DP=119;AF=0.99;MQM=60;TRIO=HOM,119,0.99,HET,116,0.58,HET,131,0.51	WNT5A	3'UTR	WNT5A:ENST00000264634:3'UTR:MODIFIER:exon5/5:c.*4339A>G:,WNT5A:ENST00000474267:3'UTR:MODIFIER:exon6/6:c.*4339A>G:		rs1047898	0.4840	0.0000	0,0,0	0,0,0,0,0	0.4347							164975 [WNT5A (provisional) Robinow syndrome,autosomal dominant 1,180700];	RCV000326383.1 [benign]; 			44	116					WNT5A (inh=AD pLI=0.97)
chr3	55500408	55500408	T	A	hom	anno_omim	QUAL=8051;DP=151;AF=1.00;MQM=60;TRIO=HOM,151,1.00,HET,101,0.51,HET,143,0.49	WNT5A	3'UTR	WNT5A:ENST00000264634:3'UTR:MODIFIER:exon5/5:c.*3712A>T:,WNT5A:ENST00000474267:3'UTR:MODIFIER:exon6/6:c.*3712A>T:		rs10865994	0.4595	0.0000	0,0,0	0,0,0,0,0	0.4149							164975 [WNT5A (provisional) Robinow syndrome,autosomal dominant 1,180700];	RCV000338759.1 [benign]; 			43	116					WNT5A (inh=AD pLI=0.97)
chr3	55501002	55501002	G	C	hom	anno_omim	QUAL=16748;DP=263;AF=1.00;MQM=60;TRIO=HOM,263,1.00,HET,132,0.54,HOM,177,1.00	WNT5A	3'UTR	WNT5A:ENST00000264634:3'UTR:MODIFIER:exon5/5:c.*3118C>G:,WNT5A:ENST00000474267:3'UTR:MODIFIER:exon6/6:c.*3118C>G:		rs669889	0.8095	0.0000	0,0,0	0,0,0,0,0	0.7480							164975 [WNT5A (provisional) Robinow syndrome,autosomal dominant 1,180700];	RCV000385334.1 [benign]; 			126	89					WNT5A (inh=AD pLI=0.97)
chr3	55501175	55501175	T	C	hom	anno_omim	QUAL=13138;DP=252;AF=1.00;MQM=60;TRIO=HOM,252,1.00,HET,166,0.45,HET,201,0.53	WNT5A	3'UTR	WNT5A:ENST00000264634:3'UTR:MODIFIER:exon5/5:c.*2945A>G:,WNT5A:ENST00000474267:3'UTR:MODIFIER:exon6/6:c.*2945A>G:		rs1829556	0.4655	0.0000	0,0,0	0,0,0,0,0	0.4207							164975 [WNT5A (provisional) Robinow syndrome,autosomal dominant 1,180700];	RCV000275582.1 [benign]; 			43	116					WNT5A (inh=AD pLI=0.97)
chr3	55501393	55501393	T	-	hom	anno_omim	QUAL=1574;DP=114;AF=0.61;MQM=59;TRIO=HOM,114,0.61,HET,51,0.43,WT,56,0.32	WNT5A	3'UTR	WNT5A:ENST00000264634:3'UTR:MODIFIER:exon5/5:c.*2727delA:,WNT5A:ENST00000474267:3'UTR:MODIFIER:exon6/6:c.*2727delA:	(T)n	rs34280613;rs397873965	0.0000	0.0000	0,0,0	0,0,0,0,0	0.3599							164975 [WNT5A (provisional) Robinow syndrome,autosomal dominant 1,180700];				44	35					WNT5A (inh=AD pLI=0.97)
chr3	55502167	55502168	AA	-	hom	anno_omim	QUAL=635;DP=44;AF=0.00;MQM=59;TRIO=HOM,44,0.00,HOM,19,0.00,HOM,23,0.22	WNT5A	3'UTR	WNT5A:ENST00000264634:3'UTR:MODIFIER:exon5/5:c.*1952_*1953delTT:,WNT5A:ENST00000474267:3'UTR:MODIFIER:exon6/6:c.*1952_*1953delTT:	(A)n	rs796958500	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1399							164975 [WNT5A (provisional) Robinow syndrome,autosomal dominant 1,180700];	RCV000277253.1 [uncertain significance]; 			20	9					WNT5A (inh=AD pLI=0.97)
chr3	58080583	58080583	A	G	het	pred_pathogenic;anno_omim	QUAL=5362;DP=250;AF=0.45;MQM=60;TRIO=HET,250,0.45,HET,219,0.48,WT,291,0.00	FLNB	missense	FLNB:ENST00000490882:missense:MODERATE:exon5/47:c.808A>G:p.Met270Val,FLNB:ENST00000295956:missense:MODERATE:exon5/46:c.808A>G:p.Met270Val,FLNB:ENST00000358537:missense:MODERATE:exon5/45:c.808A>G:p.Met270Val,FLNB:ENST00000429972:missense:MODERATE:exon5/46:c.808A>G:p.Met270Val,FLNB:ENST00000348383:missense:MODERATE:exon5/45:c.808A>G:p.Met270Val,FLNB:ENST00000357272:missense:MODERATE:exon5/47:c.808A>G:p.Met270Val,FLNB:ENST00000493452:missense:MODERATE:exon4/44:c.301A>G:p.Met101Val,FLNB:ENST00000419752:missense:MODERATE:exon4/45:c.301A>G:p.Met101Val		rs145036794	0.0002	0.0006	0,0,0	0.0006,0.0005,0.0000,0.0008,0.0000	0.0008	2.5940	T,T,T,T,T,T,T,T	T	B,B,B,B,B,B	D,D,D,D,D,D,D,D	11.37	603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome,272460|Larsen syndrome,150250|Atelosteogenesis,type I,108720|Atelosteogenesis,type III,108721|Boomerang dysplasia,112310];	RCV000238833.2 [uncertain significance]; 		COSM1485422, COSM1485423	0	5	3	[3] Stephan Waldm?ller 12.08.2014			FLNB (inh=AR+AD pLI=0.00)
chr3	58081888	58081888	T	C	het	anno_omim	QUAL=8922;DP=298;AF=0.45;MQM=59;TRIO=HET,298,0.45,WT,353,0.00,HET,453,0.47	FLNB	synonymous	FLNB:ENST00000490882:synonymous:LOW:exon6/47:c.927T>C:p.Ser309Ser,FLNB:ENST00000295956:synonymous:LOW:exon6/46:c.927T>C:p.Ser309Ser,FLNB:ENST00000358537:synonymous:LOW:exon6/45:c.927T>C:p.Ser309Ser,FLNB:ENST00000429972:synonymous:LOW:exon6/46:c.927T>C:p.Ser309Ser,FLNB:ENST00000348383:synonymous:LOW:exon6/45:c.927T>C:p.Ser309Ser,FLNB:ENST00000357272:synonymous:LOW:exon6/47:c.927T>C:p.Ser309Ser,FLNB:ENST00000493452:synonymous:LOW:exon5/44:c.420T>C:p.Ser140Ser,FLNB:ENST00000419752:synonymous:LOW:exon5/45:c.420T>C:p.Ser140Ser		rs1522384	0.6420	0.4647	15585,3520,1517	0.5387,0.6978,0.9761,0.3246,0.5923	0.4668							603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome,272460|Larsen syndrome,150250|Atelosteogenesis,type I,108720|Atelosteogenesis,type III,108721|Boomerang dysplasia,112310];	RCV000248165.1 [benign]; RCV000367630.1 [likely benign]; 			287	963	2	[2] auto-classification 14.09.2017  			FLNB (inh=AR+AD pLI=0.00)
chr3	58109162	58109162	G	A	het	pred_pathogenic;anno_omim	QUAL=6801;DP=178;AF=0.53;MQM=60;TRIO=HET,178,0.53,WT,253,0.01,HET,363,0.51	FLNB	missense	FLNB:ENST00000490882:missense:MODERATE:exon21/47:c.3469G>A:p.Asp1157Asn,FLNB:ENST00000295956:missense:MODERATE:exon21/46:c.3469G>A:p.Asp1157Asn,FLNB:ENST00000358537:missense:MODERATE:exon21/45:c.3469G>A:p.Asp1157Asn,FLNB:ENST00000429972:missense:MODERATE:exon21/46:c.3469G>A:p.Asp1157Asn,FLNB:ENST00000348383:missense:MODERATE:exon21/45:c.3469G>A:p.Asp1157Asn,FLNB:ENST00000357272:missense:MODERATE:exon21/47:c.3469G>A:p.Asp1157Asn,FLNB:ENST00000493452:missense:MODERATE:exon20/44:c.2962G>A:p.Asp988Asn,FLNB:ENST00000419752:missense:MODERATE:exon20/45:c.2962G>A:p.Asp988Asn		rs1131356	0.5461	0.3732	10732,2038,923	0.4263,0.5549,0.9129,0.2470,0.4855	0.3749	9.8690	T,T,T,T,T,T,T,T	T	D,D,D,P,D,D	D,D,D,D,D,D,D,D	26.30	603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome,272460|Larsen syndrome,150250|Atelosteogenesis,type I,108720|Atelosteogenesis,type III,108721|Boomerang dysplasia,112310];	RCV000250004.2 [benign]; RCV000333788.1 [likely benign]; 		COSM4158258, COSM4158257, COSM4158256	189	792	2	[2] auto-classification 14.09.2017  			FLNB (inh=AR+AD pLI=0.00)
chr3	58112440	58112440	A	G	het	anno_omim	QUAL=12449;DP=251;AF=0.53;MQM=60;TRIO=HET,251,0.53,HET,171,0.46,HOM,227,1.00	FLNB	synonymous	FLNB:ENST00000490882:synonymous:LOW:exon24/47:c.4173A>G:p.Ala1391Ala,FLNB:ENST00000295956:synonymous:LOW:exon24/46:c.4173A>G:p.Ala1391Ala,FLNB:ENST00000358537:synonymous:LOW:exon24/45:c.4173A>G:p.Ala1391Ala,FLNB:ENST00000429972:synonymous:LOW:exon24/46:c.4173A>G:p.Ala1391Ala,FLNB:ENST00000348383:synonymous:LOW:exon24/45:c.4173A>G:p.Ala1391Ala,FLNB:ENST00000357272:synonymous:LOW:exon24/47:c.4173A>G:p.Ala1391Ala,FLNB:ENST00000493452:synonymous:LOW:exon23/44:c.3666A>G:p.Ala1222Ala,FLNB:ENST00000419752:synonymous:LOW:exon23/45:c.3666A>G:p.Ala1222Ala		rs2362903	0.8333	0.7079	31452,13071,4263	0.9053,0.7887,0.9990,0.6247,0.7596	0.7197							603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome,272460|Larsen syndrome,150250|Atelosteogenesis,type I,108720|Atelosteogenesis,type III,108721|Boomerang dysplasia,112310];	RCV000242336.1 [benign]; RCV000296871.1 [likely benign]; 		COSM4158260, COSM4158259, COSM4158261	947	932	2	[2] auto-classification 14.09.2017  			FLNB (inh=AR+AD pLI=0.00)
chr3	58112488	58112488	C	T	het	anno_omim	QUAL=4167;DP=168;AF=0.49;MQM=59;TRIO=HET,168,0.49,WT,123,0.00,HET,167,0.49	FLNB	splice_region&synonymous	FLNB:ENST00000490882:splice_region&synonymous:LOW:exon24/47:c.4221C>T:p.Pro1407Pro,FLNB:ENST00000295956:splice_region&synonymous:LOW:exon24/46:c.4221C>T:p.Pro1407Pro,FLNB:ENST00000358537:splice_region&synonymous:LOW:exon24/45:c.4221C>T:p.Pro1407Pro,FLNB:ENST00000429972:splice_region&synonymous:LOW:exon24/46:c.4221C>T:p.Pro1407Pro,FLNB:ENST00000348383:splice_region&synonymous:LOW:exon24/45:c.4221C>T:p.Pro1407Pro,FLNB:ENST00000357272:splice_region&synonymous:LOW:exon24/47:c.4221C>T:p.Pro1407Pro,FLNB:ENST00000493452:splice_region&synonymous:LOW:exon23/44:c.3714C>T:p.Pro1238Pro,FLNB:ENST00000419752:splice_region&synonymous:LOW:exon23/45:c.3714C>T:p.Pro1238Pro		rs2362904	0.6486	0.4091	13314,2047,2719	0.7248,0.5732,0.9741,0.2482,0.5074	0.4270							603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome,272460|Larsen syndrome,150250|Atelosteogenesis,type I,108720|Atelosteogenesis,type III,108721|Boomerang dysplasia,112310];	RCV000247133.1 [benign]; RCV000277932.1 [likely benign]; 		COSM4158262, COSM4158264, COSM4158263	224	795	2	[2] auto-classification 14.09.2017  			FLNB (inh=AR+AD pLI=0.00)
chr3	58118555	58118555	G	A	het	pred_pathogenic;anno_omim	QUAL=9295;DP=268;AF=0.46;MQM=60;TRIO=HET,268,0.46,WT,343,0.00,HET,484,0.48	FLNB	missense	FLNB:ENST00000490882:missense:MODERATE:exon27/47:c.4504G>A:p.Val1502Met,FLNB:ENST00000295956:missense:MODERATE:exon26/46:c.4411G>A:p.Val1471Met,FLNB:ENST00000358537:missense:MODERATE:exon26/45:c.4411G>A:p.Val1471Met,FLNB:ENST00000429972:missense:MODERATE:exon26/46:c.4411G>A:p.Val1471Met,FLNB:ENST00000348383:missense:MODERATE:exon26/45:c.4411G>A:p.Val1471Met,FLNB:ENST00000357272:missense:MODERATE:exon26/47:c.4411G>A:p.Val1471Met,FLNB:ENST00000493452:missense:MODERATE:exon25/44:c.3904G>A:p.Val1302Met,FLNB:ENST00000419752:missense:MODERATE:exon25/45:c.3904G>A:p.Val1302Met		rs12632456	0.6082	0.3952	12348,2052,1840	0.5964,0.5631,0.9736,0.2469,0.5016	0.3939	2.9510	T,T,T,T,T,T,T,T	T	B,B,B,B,B,B	D,D,D,D,D,D,D,D	26.60	603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome,272460|Larsen syndrome,150250|Atelosteogenesis,type I,108720|Atelosteogenesis,type III,108721|Boomerang dysplasia,112310];	RCV000247641.1 [benign]; RCV000271883.1 [likely benign]; 		COSM4158266, COSM4158267, COSM4158265	216	796	2	[2] auto-classification 14.09.2017  			FLNB (inh=AR+AD pLI=0.00)
chr3	58145363	58145363	A	C	het	pred_pathogenic;anno_omim	QUAL=56;DP=154;AF=0.26;MQM=59;TRIO=HET,154,0.26,WT,162,0.00,WT,190,0.00	FLNB	missense,3'UTR	FLNB:ENST00000490882:missense:MODERATE:exon43/47:c.7064A>C:p.His2355Pro,FLNB:ENST00000295956:missense:MODERATE:exon42/46:c.6971A>C:p.His2324Pro,FLNB:ENST00000358537:missense:MODERATE:exon41/45:c.6899A>C:p.His2300Pro,FLNB:ENST00000429972:missense:MODERATE:exon42/46:c.6938A>C:p.His2313Pro,FLNB:ENST00000348383:missense:MODERATE:exon41/45:c.6848A>C:p.His2283Pro,FLNB:ENST00000493452:missense:MODERATE:exon40/44:c.6392A>C:p.His2131Pro,FLNB:ENST00000419752:missense:MODERATE:exon41/45:c.6431A>C:p.His2144Pro,FLNB:ENST00000357272:3'UTR:MODIFIER:exon43/47:c.*588A>C:		rs202222289	0.0000	0.0031	0,0,0	0.0038,0.0021,0.0004,0.0043,0.0006	0.0015	9.3390	T,T,T,T,T,T,T	D	B,B,B,B,B,B	D,D,D,D,D,D,D	20.10	603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome,272460|Larsen syndrome,150250|Atelosteogenesis,type I,108720|Atelosteogenesis,type III,108721|Boomerang dysplasia,112310];			COSM304726	0	33					FLNB (inh=AR+AD pLI=0.00)
chr3	58154327	58154327	C	T	het	anno_omim	QUAL=7770;DP=297;AF=0.48;MQM=59;TRIO=HET,297,0.48,WT,296,0.00,HET,377,0.48	FLNB,FLNB-AS1	synonymous,3'UTR,intron	FLNB:ENST00000490882:synonymous:LOW:exon45/47:c.7452C>T:p.Ser2484Ser,FLNB:ENST00000295956:synonymous:LOW:exon44/46:c.7359C>T:p.Ser2453Ser,FLNB:ENST00000358537:synonymous:LOW:exon43/45:c.7287C>T:p.Ser2429Ser,FLNB:ENST00000429972:synonymous:LOW:exon44/46:c.7326C>T:p.Ser2442Ser,FLNB:ENST00000348383:synonymous:LOW:exon43/45:c.7236C>T:p.Ser2412Ser,FLNB:ENST00000493452:synonymous:LOW:exon42/44:c.6780C>T:p.Ser2260Ser,FLNB:ENST00000419752:synonymous:LOW:exon43/45:c.6819C>T:p.Ser2273Ser,FLNB:ENST00000357272:3'UTR:MODIFIER:exon45/47:c.*976C>T:,FLNB-AS1:ENST00000488720:intron:MODIFIER:exon1/1:n.140+1897G>A:		rs8640	0.5713	0.3852	11362,2159,1400	0.5212,0.5390,0.9155,0.2548,0.4969	0.3842							603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome,272460|Larsen syndrome,150250|Atelosteogenesis,type I,108720|Atelosteogenesis,type III,108721|Boomerang dysplasia,112310];	RCV000243570.1 [benign]; RCV000395617.1 [likely benign]; 			209	813	2	[2] auto-classification 14.09.2017  			FLNB (inh=AR+AD pLI=0.00), FLNB-AS1 (inh=n/a pLI=n/a)
chr3	58157519	58157519	G	C	het	anno_omim	QUAL=20302;DP=379;AF=0.49;MQM=60;TRIO=HET,379,0.49,HET,288,0.52,HOM,369,1.00	FLNB	3'UTR	FLNB:ENST00000295956:3'UTR:MODIFIER:exon46/46:c.*1030G>C:,FLNB:ENST00000358537:3'UTR:MODIFIER:exon45/45:c.*1030G>C:,FLNB:ENST00000429972:3'UTR:MODIFIER:exon46/46:c.*1030G>C:,FLNB:ENST00000348383:3'UTR:MODIFIER:exon45/45:c.*1030G>C:,FLNB:ENST00000357272:3'UTR:MODIFIER:exon47/47:c.*2456G>C:,FLNB:ENST00000419752:3'UTR:MODIFIER:exon45/45:c.*1030G>C:		rs1131264	0.6931	0.0000	0,0,0	0,0,0,0,0	0.5335							603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome,272460|Larsen syndrome,150250|Atelosteogenesis,type I,108720|Atelosteogenesis,type III,108721|Boomerang dysplasia,112310];	RCV000405717.1 [likely benign]; 			47	113					FLNB (inh=AR+AD pLI=0.00)
chr3	58157799	58157799	T	G	het	anno_omim;trio_denovo	QUAL=46;DP=193;AF=0.27;MQM=58;TRIO=HET,193,0.27,WT,188,0.01,WT,196,0.03	FLNB	3'UTR	FLNB:ENST00000295956:3'UTR:MODIFIER:exon46/46:c.*1310T>G:,FLNB:ENST00000358537:3'UTR:MODIFIER:exon45/45:c.*1310T>G:,FLNB:ENST00000429972:3'UTR:MODIFIER:exon46/46:c.*1310T>G:,FLNB:ENST00000348383:3'UTR:MODIFIER:exon45/45:c.*1310T>G:,FLNB:ENST00000357272:3'UTR:MODIFIER:exon47/47:c.*2736T>G:,FLNB:ENST00000419752:3'UTR:MODIFIER:exon45/45:c.*1310T>G:		rs761905985	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0033							603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome,272460|Larsen syndrome,150250|Atelosteogenesis,type I,108720|Atelosteogenesis,type III,108721|Boomerang dysplasia,112310];				0	30					FLNB (inh=AR+AD pLI=0.00)
chr3	58413405	58413405	T	C	het	anno_omim	QUAL=2000;DP=132;AF=0.41;MQM=60;TRIO=HET,132,0.41,WT,58,0.00,HET,75,0.51	PDHB	3'UTR	PDHB:ENST00000302746:3'UTR:MODIFIER:exon10/10:c.*356A>G:,PDHB:ENST00000485460:3'UTR:MODIFIER:exon11/11:c.*356A>G:		rs1126737	0.3674	0.4889	418,38,0	0.0000,0.0000,0.0000,0.3555,0.5292	0.3267							179060 [PDHB (provisional) Pyruvate dehydrogenase E1-beta deficiency,614111];	RCV000272368.1 [benign]; 			56	250					PDHB (inh=AR pLI=0.36)
chr3	58413408	58413408	A	G	het	anno_omim	QUAL=3603;DP=137;AF=0.59;MQM=59;TRIO=HET,137,0.59,HOM,61,1.00,WT,77,0.00	PDHB	3'UTR	PDHB:ENST00000302746:3'UTR:MODIFIER:exon10/10:c.*353T>C:,PDHB:ENST00000485460:3'UTR:MODIFIER:exon11/11:c.*353T>C:		rs1126735	0.1847	0.3209	332,185,0	0.0000,0.0000,0.0000,0.4794,0.2651	0.2848							179060 [PDHB (provisional) Pyruvate dehydrogenase E1-beta deficiency,614111];	RCV000324992.1 [benign]; 			66	307	2	[2] auto-classification 14.09.2017  			PDHB (inh=AR pLI=0.36)
chr3	58413465	58413465	G	C	hom	anno_omim	QUAL=16218;DP=258;AF=1.00;MQM=59;TRIO=HOM,258,1.00,HOM,160,1.00,HET,192,0.53	PDHB	3'UTR	PDHB:ENST00000302746:3'UTR:MODIFIER:exon10/10:c.*296C>G:,PDHB:ENST00000485460:3'UTR:MODIFIER:exon11/11:c.*296C>G:,PDHB:ENST00000474765:3'UTR:MODIFIER:exon9/9:c.*390C>G:		rs7231	0.7418	0.7950	3406,888,41	0.0000,0.0000,0.0000,0.8115,0.7916	0.7706							179060 [PDHB (provisional) Pyruvate dehydrogenase E1-beta deficiency,614111];	RCV000381952.1 [benign]; 			411	212					PDHB (inh=AR pLI=0.36)
chr3	58413518	58413518	T	G	het	anno_omim	QUAL=10454;DP=207;AF=0.56;MQM=60;TRIO=HET,207,0.56,HOM,231,1.00,WT,277,0.00	PDHB	3'UTR	PDHB:ENST00000302746:3'UTR:MODIFIER:exon10/10:c.*243A>C:,PDHB:ENST00000485460:3'UTR:MODIFIER:exon11/11:c.*243A>C:,PDHB:ENST00000474765:3'UTR:MODIFIER:exon9/9:c.*337A>C:		rs1126722	0.2005	0.2944	544,289,8	0.3208,0.0000,0.0000,0.4508,0.2399	0.2896							179060 [PDHB (provisional) Pyruvate dehydrogenase E1-beta deficiency,614111];	RCV000285224.1 [benign]; 			68	306					PDHB (inh=AR pLI=0.36)
chr3	58413662	58413662	G	A	het	anno_omim	QUAL=8186;DP=248;AF=0.42;MQM=60;TRIO=HET,248,0.42,WT,288,0.00,HET,378,0.55	PDHB	3'UTR	PDHB:ENST00000302746:3'UTR:MODIFIER:exon10/10:c.*99C>T:,PDHB:ENST00000485460:3'UTR:MODIFIER:exon11/11:c.*99C>T:,PDHB:ENST00000474765:3'UTR:MODIFIER:exon9/9:c.*193C>T:		rs7230	0.3672	0.4084	2235,587,10	0.1376,0.5133,0.8243,0.3655,0.4110	0.3179							179060 [PDHB (provisional) Pyruvate dehydrogenase E1-beta deficiency,614111];	RCV000376551.1 [benign]; 			56	254					PDHB (inh=AR pLI=0.36)
chr3	58413669	58413669	G	T	het	anno_omim	QUAL=13150;DP=274;AF=0.57;MQM=60;TRIO=HET,274,0.57,HOM,276,1.00,WT,375,0.01	PDHB	3'UTR	PDHB:ENST00000302746:3'UTR:MODIFIER:exon10/10:c.*92C>A:,PDHB:ENST00000485460:3'UTR:MODIFIER:exon11/11:c.*92C>A:,PDHB:ENST00000474765:3'UTR:MODIFIER:exon9/9:c.*186C>A:		rs4228	0.2047	0.3390	2180,1608,100	0.3096,0.3081,0.0015,0.4293,0.2458	0.2908							179060 [PDHB (provisional) Pyruvate dehydrogenase E1-beta deficiency,614111];	RCV000284383.1 [benign]; 			69	307					PDHB (inh=AR pLI=0.36)
chr3	58416535	58416535	C	T	het	anno_omim	QUAL=30480;DP=283;AF=0.47;MQM=60;TRIO=HET,283,1.00,HOM,311,0.99,WT,410,1.00	PDHB	splice_region&intron,synonymous	PDHB:ENST00000485460:splice_region&intron:LOW:exon6/10:c.404-20G>A:,PDHB:ENST00000302746:synonymous:LOW:exon6/10:c.438G>A:p.Gly146Gly,PDHB:ENST00000474765:synonymous:LOW:exon5/9:c.384G>A:p.Gly128Gly		rs1126551	0.2047	0.2832	5680,4480,230	0.2095,0.2290,0.0009,0.3622,0.2162	0.2889							179060 [PDHB (provisional) Pyruvate dehydrogenase E1-beta deficiency,614111];	RCV000117898.2 [likely benign]; RCV000367428.1 [benign]; 		COSM3760211	278	950	2	[2] auto-classification 14.09.2017  			PDHB (inh=AR pLI=0.36)
chr3	58416538	58416538	T	C	hom	anno_omim	QUAL=30480;DP=283;AF=0.47;MQM=60;TRIO=HOM,283,1.00,HOM,311,0.99,HOM,410,1.00	PDHB	synonymous,intron	PDHB:ENST00000302746:synonymous:LOW:exon6/10:c.435A>G:p.Arg145Arg,PDHB:ENST00000474765:synonymous:LOW:exon5/9:c.381A>G:p.Arg127Arg,PDHB:ENST00000485460:intron:MODIFIER:exon6/10:c.404-23A>G:		rs4264746	0.9848	0.9948	60093,33348,4655	0.9457,0.9967,0.9999,0.9997,1.0000	0.9960							179060 [PDHB (provisional) Pyruvate dehydrogenase E1-beta deficiency,614111];				2102	6	2	[2] auto-classification 14.09.2017  			PDHB (inh=AR pLI=0.36)
chr3	63850298	63850298	T	G	het	anno_omim	QUAL=12280;DP=300;AF=0.45;MQM=59;TRIO=HET,300,0.45,HET,167,0.47,HOM,251,1.00	ATXN7	5'UTR	ATXN7:ENST00000398590:5'UTR:MODIFIER:exon1/14:c.-488T>G:,ATXN7:ENST00000295900:5'UTR:MODIFIER:exon1/13:c.-488T>G:		rs6779372	0.7492	0.0000	0,0,0	0,0,0,0,0	0.7483							607640 [ATXN7 (confirmed) Spinocerebellar ataxia 7,164500];				135	87					ATXN7 (inh=AD pLI=0.93)
chr3	63850299	63850299	G	C	het	anno_omim	QUAL=12280;DP=300;AF=0.45;MQM=59;TRIO=HET,300,0.45,HET,167,0.47,HOM,251,1.00	ATXN7	5'UTR	ATXN7:ENST00000398590:5'UTR:MODIFIER:exon1/14:c.-487G>C:,ATXN7:ENST00000295900:5'UTR:MODIFIER:exon1/13:c.-487G>C:		rs3733120	0.7490	0.0000	0,0,0	0,0,0,0,0	0.7485							607640 [ATXN7 (confirmed) Spinocerebellar ataxia 7,164500];				135	87					ATXN7 (inh=AD pLI=0.93)
chr3	63850660	63850660	C	G	het	anno_omim	QUAL=6045;DP=266;AF=0.52;MQM=59;TRIO=HET,266,0.52,WT,173,0.00,HET,225,0.50	ATXN7	5'UTR	ATXN7:ENST00000398590:5'UTR:MODIFIER:exon1/14:c.-126C>G:,ATXN7:ENST00000295900:5'UTR:MODIFIER:exon1/13:c.-126C>G:		rs3733121	0.1088	0.0000	0,0,0	0,0,0,0,0	0.0919							607640 [ATXN7 (confirmed) Spinocerebellar ataxia 7,164500];				4	60					ATXN7 (inh=AD pLI=0.93)
chr3	63967900	63967900	A	G	het	pred_pathogenic;anno_omim	QUAL=4861;DP=176;AF=0.48;MQM=60;TRIO=HET,176,0.48,WT,140,0.00,HET,202,0.53	ATXN7	missense	ATXN7:ENST00000398590:missense:MODERATE:exon7/14:c.791A>G:p.Lys264Arg,ATXN7:ENST00000295900:missense:MODERATE:exon7/13:c.791A>G:p.Lys264Arg,ATXN7:ENST00000487717:missense:MODERATE:exon6/12:c.791A>G:p.Lys264Arg,ATXN7:ENST00000538065:missense:MODERATE:exon5/12:c.791A>G:p.Lys264Arg,ATXN7:ENST00000484332:missense:MODERATE:exon3/9:c.356A>G:p.Lys119Arg		rs1053338	0.1146	0.1344	1256,660,9	0.0368,0.2191,0.1590,0.1386,0.1315	0.1362	4.0620	T,T,T,T,T	T	D,B,B	T,T,T,T,T	13.92	607640 [ATXN7 (confirmed) Spinocerebellar ataxia 7,164500];	RCV000116489.2 [likely benign]; 	CM1413188 [CLASS=DP MUT=ALT PHEN="Breast cancer susceptibility to" GENE=ATXN7]; 		55	485	2	[2] auto-classification 14.09.2017  			ATXN7 (inh=AD pLI=0.93)
chr3	63981635	63981635	C	T	het	anno_omim	QUAL=7048;DP=278;AF=0.51;MQM=59;TRIO=HET,278,0.51,HET,260,0.56,WT,327,0.00	ATXN7	synonymous	ATXN7:ENST00000398590:synonymous:LOW:exon12/14:c.2137C>T:p.Leu713Leu,ATXN7:ENST00000295900:synonymous:LOW:exon12/13:c.2137C>T:p.Leu713Leu,ATXN7:ENST00000487717:synonymous:LOW:exon11/12:c.2137C>T:p.Leu713Leu,ATXN7:ENST00000538065:synonymous:LOW:exon10/12:c.2137C>T:p.Leu713Leu,ATXN7:ENST00000484332:synonymous:LOW:exon8/9:c.1702C>T:p.Leu568Leu		rs3733125	0.0905	0.0968	739,381,2	0.0151,0.0341,0.2184,0.1041,0.0748	0.1076							607640 [ATXN7 (confirmed) Spinocerebellar ataxia 7,164500];	RCV000116486.2 [likely benign]; 		COSM149408	28	360	2	[2] auto-classification 14.09.2017  			ATXN7 (inh=AD pLI=0.93)
chr3	63982082	63982082	G	A	hom	anno_omim	QUAL=21351;DP=255;AF=0.99;MQM=60;TRIO=HOM,255,0.99,HET,209,0.55,HOM,316,1.00	ATXN7	missense	ATXN7:ENST00000398590:missense:MODERATE:exon12/14:c.2584G>A:p.Val862Met,ATXN7:ENST00000295900:missense:MODERATE:exon12/13:c.2584G>A:p.Val862Met,ATXN7:ENST00000487717:missense:MODERATE:exon11/12:c.2584G>A:p.Val862Met,ATXN7:ENST00000538065:missense:MODERATE:exon10/12:c.2584G>A:p.Val862Met,ATXN7:ENST00000484332:missense:MODERATE:exon8/9:c.2149G>A:p.Val717Met		rs3774729	0.4377	0.3477	7726,3392,1615	0.5754,0.2933,0.4951,0.3203,0.2983	0.4131	-0.2650	T,T,T,T,T,T	T	B,B,B	T,T,T,T,T,T	7.16	607640 [ATXN7 (confirmed) Spinocerebellar ataxia 7,164500];	RCV000116488.2 [likely benign]; 		COSM1567155, COSM1567156	253	889	2	[2] auto-classification 14.09.2017  			ATXN7 (inh=AD pLI=0.93)
chr3	63986047	63986047	T	-	het	anno_omim	QUAL=5586;DP=199;AF=0.46;MQM=59;TRIO=HET,199,0.46,WT,66,0.00,HOM,113,0.97	ATXN7	3'UTR	ATXN7:ENST00000398590:3'UTR:MODIFIER:exon14/14:c.*815delT:,ATXN7:ENST00000295900:3'UTR:MODIFIER:exon13/13:c.*907delT:,ATXN7:ENST00000538065:3'UTR:MODIFIER:exon12/12:c.*815delT:		rs397841163	0.1999	0.0000	0,0,0	0,0,0,0,0	0.1724							607640 [ATXN7 (confirmed) Spinocerebellar ataxia 7,164500];				4	73					ATXN7 (inh=AD pLI=0.93)
chr3	63986170	63986170	A	G	hom	anno_omim	QUAL=23462;DP=394;AF=1.00;MQM=59;TRIO=HOM,394,1.00,HET,208,0.48,HOM,256,1.00	ATXN7	3'UTR	ATXN7:ENST00000398590:3'UTR:MODIFIER:exon14/14:c.*935A>G:,ATXN7:ENST00000295900:3'UTR:MODIFIER:exon13/13:c.*1027A>G:,ATXN7:ENST00000538065:3'UTR:MODIFIER:exon12/12:c.*935A>G:		rs13272	0.5104	0.0000	0,0,0	0,0,0,0,0	0.4614							607640 [ATXN7 (confirmed) Spinocerebellar ataxia 7,164500];				27	114					ATXN7 (inh=AD pLI=0.93)
chr3	63988171	63988171	C	T	het	anno_omim	QUAL=11836;DP=355;AF=0.47;MQM=59;TRIO=HET,355,0.47,WT,171,0.00,HOM,245,1.00	ATXN7	3'UTR	ATXN7:ENST00000398590:3'UTR:MODIFIER:exon14/14:c.*2936C>T:,ATXN7:ENST00000295900:3'UTR:MODIFIER:exon13/13:c.*3028C>T:,ATXN7:ENST00000538065:3'UTR:MODIFIER:exon12/12:c.*2936C>T:	(TG)n	rs3733126	0.1861	0.0000	0,0,0	0,0,0,0,0	0.1593							607640 [ATXN7 (confirmed) Spinocerebellar ataxia 7,164500];				4	74					ATXN7 (inh=AD pLI=0.93)
chr3	63988174	63988174	C	T	het	anno_omim	QUAL=6462;DP=354;AF=0.51;MQM=59;TRIO=HET,354,0.51,HET,164,0.42,WT,240,0.00	ATXN7	3'UTR	ATXN7:ENST00000398590:3'UTR:MODIFIER:exon14/14:c.*2939C>T:,ATXN7:ENST00000295900:3'UTR:MODIFIER:exon13/13:c.*3031C>T:,ATXN7:ENST00000538065:3'UTR:MODIFIER:exon12/12:c.*2939C>T:	(TG)n	rs3733127	0.2634	0.0000	0,0,0	0,0,0,0,0	0.2579							607640 [ATXN7 (confirmed) Spinocerebellar ataxia 7,164500];				3	67					ATXN7 (inh=AD pLI=0.93)
chr3	81643167	81643167	T	C	hom	pred_pathogenic;anno_omim	QUAL=27307;DP=330;AF=1.00;MQM=60;TRIO=HOM,330,1.00,HOM,223,1.00,HOM,281,1.00	GBE1	missense	GBE1:ENST00000429644:missense:MODERATE:exon8/16:c.1000A>G:p.Ile334Val,GBE1:ENST00000489715:missense:MODERATE:exon8/16:c.877A>G:p.Ile293Val		rs2172397	0.9836	0.9728	26318,13594,2692	0.9949,0.9917,0.9997,0.9678,0.9618	0.9754	5.5970	T,T,T,T	T	B,B	T,T	7.74	607839 [GBE1 (provisional) Glycogen storage disease IV,232500|Polyglucosan body disease,adult form,263570];				3036	211	2	[2] auto-classification 14.09.2017  			GBE1 (inh=AR pLI=0.00)
chr3	81698130	81698130	T	C	het	pred_pathogenic;anno_omim	QUAL=4841;DP=211;AF=0.47;MQM=60;TRIO=HET,211,0.47,WT,103,0.00,HET,156,0.52	GBE1	missense	GBE1:ENST00000429644:missense:MODERATE:exon5/16:c.568A>G:p.Arg190Gly,GBE1:ENST00000489715:missense:MODERATE:exon5/16:c.445A>G:p.Arg149Gly		rs2229519	0.3215	0.3746	5135,2559,322	0.3184,0.3881,0.4875,0.3675,0.3357	0.3263	3.4770	D,D,D	T	B,B	D,D	23.10	607839 [GBE1 (provisional) Glycogen storage disease IV,232500|Polyglucosan body disease,adult form,263570];	RCV000178721.2 [benign]; RCV000318439.1 [benign]; RCV000375379.1 [benign]; 			268	1274	1	[1] auto-classification 16.06.2016  [2] harmuth 13.04.2016; in-house frequency: 156x hom/ 700x het and is also too frequent in open databases			GBE1 (inh=AR pLI=0.00)
chr3	81810702	81810702	-	G	hom	anno_omim	QUAL=1354;DP=24;AF=0.92;MQM=59;TRIO=HOM,24,0.92,HOM,14,1.00,HOM,14,1.00	GBE1	5'UTR	GBE1:ENST00000429644:5'UTR:MODIFIER:exon1/16:c.-35dupC:		rs11391701	0.9968	0.9998	38368,21124,2671	0.9993,1.0000,0.9998,0.9998,0.9999	1.0000							607839 [GBE1 (provisional) Glycogen storage disease IV,232500|Polyglucosan body disease,adult form,263570];				3055	44					GBE1 (inh=AR pLI=0.00)
chr3	81810725	81810725	C	T	het	low_DP;anno_omim	QUAL=161;DP=14;AF=0.64;MQM=58;TRIO=HET,14,0.64,WT,10,0.00,HET,11,0.27	GBE1	5'UTR	GBE1:ENST00000429644:5'UTR:MODIFIER:exon1/16:c.-57G>A:		rs2290081	0.4209	0.4536	2523,1143,280	0.5451,0.5007,0.5898,0.4481,0.3970	0.4073							607839 [GBE1 (provisional) Glycogen storage disease IV,232500|Polyglucosan body disease,adult form,263570];				333	1294					GBE1 (inh=AR pLI=0.00)
chr3	87308831	87308831	C	T	hom	anno_omim	QUAL=2157;DP=46;AF=1.00;MQM=60;TRIO=HOM,46,1.00,HOM,9,1.00,HOM,16,1.00	POU1F1	3'UTR	POU1F1:ENST00000350375:3'UTR:MODIFIER:exon6/6:c.*213G>A:		rs6792500	1.0000	0.0000	0,0,0	0,0,0,0,0	1.0000							173110 [POU1F1 (confirmed) Pituitary hormone deficiency,combined,1,613038];	RCV000280492.1 [benign]; RCV000407251.1 [benign]; 			232	0					POU1F1 (inh=AR+AD pLI=0.62)
chr3	87308904	87308904	T	A	het	anno_omim	QUAL=3569;DP=151;AF=0.57;MQM=60;TRIO=HET,151,0.57,HOM,43,1.00,WT,62,0.00	POU1F1	3'UTR	POU1F1:ENST00000344265:3'UTR:MODIFIER:exon6/6:c.*140A>T:,POU1F1:ENST00000350375:3'UTR:MODIFIER:exon6/6:c.*140A>T:		rs33936108	0.2508	0.0000	0,0,0	0,0,0,0,0	0.3315							173110 [POU1F1 (confirmed) Pituitary hormone deficiency,combined,1,613038];	RCV000308985.1 [likely benign]; RCV000337782.1 [benign]; 			41	115					POU1F1 (inh=AR+AD pLI=0.62)
chr3	101370530	101370531	AA	-	hom		QUAL=429;DP=88;AF=0.30;MQM=59;TRIO=HOM,88,0.30,WT,38,0.13,HOM,64,0.27	ZBTB11	splice_region&intron	ZBTB11:ENST00000312938:splice_region&intron:LOW:exon10/10:c.2645-4_2645-3delTT:	(A)n	rs796206524	0.0000	0.2316	9,1,8	0.2580,0.2035,0.2231,0.2371,0.1920	0.1943											24	7	2	[2] auto-classification 14.09.2017  			ZBTB11 (inh=n/a pLI=0.27)
chr3	101383562	101383562	G	A	het		QUAL=5784;DP=267;AF=0.50;MQM=60;TRIO=HET,267,0.50,WT,163,0.00,HET,203,0.42	ZBTB11	splice_region&intron	ZBTB11:ENST00000312938:splice_region&intron:LOW:exon4/10:c.1624-4C>T:		rs11712748	0.3307	0.3273	6673,4027,969	0.4271,0.2344,0.2897,0.3486,0.2424	0.3579										COSM4002354	147	650	2	[2] auto-classification 14.09.2017  			ZBTB11 (inh=n/a pLI=0.27)
chr3	121488995	121488995	C	G	hom	anno_omim	QUAL=16903;DP=307;AF=1.00;MQM=59;TRIO=HOM,307,1.00,HET,124,0.56,HOM,166,1.00	IQCB1	3'UTR	IQCB1:ENST00000310864:3'UTR:MODIFIER:exon15/15:c.*197G>C:,IQCB1:ENST00000349820:3'UTR:MODIFIER:exon12/12:c.*197G>C:		rs1135750	0.6212	0.0000	0,0,0	0,0,0,0,0	0.6367							609237 [IQCB1 (provisional) Senior-Loken syndrome 5,609254];	RCV000394184.1 [benign]; 			81	107					IQCB1 (inh=AR pLI=0.00)
chr3	121500699	121500699	C	T	het	pred_pathogenic;anno_omim	QUAL=3175;DP=194;AF=0.51;MQM=60;TRIO=HET,194,0.51,WT,57,0.00,HET,76,0.43	IQCB1	missense	IQCB1:ENST00000310864:missense:MODERATE:exon13/15:c.1301G>A:p.Cys434Tyr,IQCB1:ENST00000349820:missense:MODERATE:exon10/12:c.902G>A:p.Cys301Tyr		rs17849995	0.3027	0.2889	6050,1960,301	0.2372,0.5908,0.1677,0.2385,0.3940	0.3003	2.8010	T,T	T	B,P	T,T	22.00	609237 [IQCB1 (provisional) Senior-Loken syndrome 5,609254];	RCV000245543.1 [benign]; RCV000369501.1 [benign]; 			150	814	2	[2] auto-classification 14.09.2017  			IQCB1 (inh=AR pLI=0.00)
chr3	121526204	121526204	G	A	hom	anno_omim	QUAL=17764;DP=308;AF=1.00;MQM=59;TRIO=HOM,308,1.00,HET,119,0.50,HOM,187,0.99	IQCB1	synonymous	IQCB1:ENST00000310864:synonymous:LOW:exon7/15:c.574C>T:p.Leu192Leu,IQCB1:ENST00000349820:synonymous:LOW:exon7/12:c.574C>T:p.Leu192Leu		rs4543051	0.6200	0.6275	24452,12877,2663	0.7172,0.7531,0.3038,0.6217,0.6626	0.6364							609237 [IQCB1 (provisional) Senior-Loken syndrome 5,609254];	RCV000179799.2 [benign]; RCV000372741.1 [benign]; 			787	927	2	[2] auto-classification 14.09.2017  			IQCB1 (inh=AR pLI=0.00)
chr3	121553853	121553858	CTCCCA	-	hom	anno_omim	QUAL=9992;DP=199;AF=0.99;MQM=59;TRIO=HOM,199,0.99,HET,140,0.45,HOM,153,1.00	IQCB1	5'UTR	IQCB1:ENST00000310864:5'UTR:MODIFIER:exon1/15:c.-147_-142delTGGGAG:,IQCB1:ENST00000349820:5'UTR:MODIFIER:exon1/12:c.-147_-142delTGGGAG:		rs72421117	0.6218	0.0000	0,0,0	0,0,0,0,0	0.6310							609237 [IQCB1 (provisional) Senior-Loken syndrome 5,609254];	RCV000313102.1 [benign]; 			82	108					IQCB1 (inh=AR pLI=0.00)
chr3	121903266	121903266	G	A	hom	low_DP;anno_omim	QUAL=3024;DP=12;AF=1.00;MQM=60;TRIO=HOM,12,1.00,HET,44,0.50,HOM,76,0.97	CASR	5'UTR,intron	CASR:ENST00000498619:5'UTR:MODIFIER:exon1/7:c.-353G>A:,CASR:ENST00000490131:intron:MODIFIER:exon1/6:c.-243+607G>A:		rs9883981	0.2179	0.0000	0,0,0	0,0,0,0,0	0.1909							601199 [CASR (confirmed) Hypocalciuric hypercalcemia,type I,145980|Hyperparathyroidism,neonatal,239200|Hypocalcemia,autosomal dominant,601198|Hypocalcemia,autosomal dominant,with Bartter syndrome,601198|Epilepsy idiopathic generalized,susceptibility to,8,612899|Hypercalciuric hypercalcemia|Calcium,serum level of];				10	53					CASR (inh=AD pLI=0.37)
chr3	122003045	122003045	G	C	hom	anno_omim	QUAL=35494;DP=330;AF=1.00;MQM=59;TRIO=HOM,330,1.00,HOM,362,1.00,HOM,413,1.00	CASR	synonymous	CASR:ENST00000498619:synonymous:LOW:exon7/7:c.2274G>C:p.Pro758Pro,CASR:ENST00000490131:synonymous:LOW:exon7/7:c.2244G>C:p.Pro748Pro,CASR:ENST00000296154:synonymous:LOW:exon6/6:c.2244G>C:p.Pro748Pro		rs2036400	0.9728	0.9916	59427,33130,4241	0.9081,0.9952,1.0000,0.9998,1.0000	0.9936							601199 [CASR (confirmed) Hypocalciuric hypercalcemia,type I,145980|Hyperparathyroidism,neonatal,239200|Hypocalcemia,autosomal dominant,601198|Hypocalcemia,autosomal dominant,with Bartter syndrome,601198|Epilepsy idiopathic generalized,susceptibility to,8,612899|Hypercalciuric hypercalcemia|Calcium,serum level of];	RCV000152932.2 [benign]; 			2092	13	2	[2] auto-classification 14.09.2017  			CASR (inh=AD pLI=0.37)
chr3	122003832	122003832	G	C	het	pred_pathogenic;anno_omim	QUAL=20480;DP=276;AF=0.49;MQM=59;TRIO=HET,276,0.49,HET,309,0.56,HOM,391,1.00	CASR	missense	CASR:ENST00000498619:missense:MODERATE:exon7/7:c.3061G>C:p.Glu1021Gln,CASR:ENST00000490131:missense:MODERATE:exon7/7:c.3031G>C:p.Glu1011Gln,CASR:ENST00000296154:missense:MODERATE:exon6/6:c.3031G>C:p.Glu1011Gln		rs1801726	0.9241	0.9446	54228,30247,3532	0.8263,0.9820,0.9835,0.9521,0.9522	0.9501	1.1740	T,T,T	T	B	D,D,D	0.11	601199 [CASR (confirmed) Hypocalciuric hypercalcemia,type I,145980|Hyperparathyroidism,neonatal,239200|Hypocalcemia,autosomal dominant,601198|Hypocalcemia,autosomal dominant,with Bartter syndrome,601198|Epilepsy idiopathic generalized,susceptibility to,8,612899|Hypercalciuric hypercalcemia|Calcium,serum level of];	RCV000152934.3 [benign]; 			1939	167	2	[2] auto-classification 14.09.2017  			CASR (inh=AD pLI=0.37)
chr3	122004098	122004098	A	T	het	anno_omim	QUAL=16926;DP=339;AF=0.48;MQM=60;TRIO=HET,339,0.48,HET,221,0.48,HOM,325,1.00	CASR	3'UTR	CASR:ENST00000498619:3'UTR:MODIFIER:exon7/7:c.*60A>T:,CASR:ENST00000490131:3'UTR:MODIFIER:exon7/7:c.*60A>T:,CASR:ENST00000296154:3'UTR:MODIFIER:exon6/6:c.*60A>T:		rs4677948	0.9201	0.0000	0,0,0	0,0,0,0,0	0.9119							601199 [CASR (confirmed) Hypocalciuric hypercalcemia,type I,145980|Hyperparathyroidism,neonatal,239200|Hypocalcemia,autosomal dominant,601198|Hypocalcemia,autosomal dominant,with Bartter syndrome,601198|Epilepsy idiopathic generalized,susceptibility to,8,612899|Hypercalciuric hypercalcemia|Calcium,serum level of];	RCV000283415.1 [benign]; RCV000287022.1 [benign]; RCV000341909.1 [benign]; RCV000403732.1 [benign]; 			1734	147					CASR (inh=AD pLI=0.37)
chr3	122004612	122004612	C	G	hom	anno_omim	QUAL=40168;DP=445;AF=1.00;MQM=59;TRIO=HOM,445,1.00,HOM,358,1.00,HOM,425,1.00	CASR	3'UTR	CASR:ENST00000498619:3'UTR:MODIFIER:exon7/7:c.*574C>G:		rs6438718	0.9687	0.0000	0,0,0	0,0,0,0,0	0.9710							601199 [CASR (confirmed) Hypocalciuric hypercalcemia,type I,145980|Hyperparathyroidism,neonatal,239200|Hypocalcemia,autosomal dominant,601198|Hypocalcemia,autosomal dominant,with Bartter syndrome,601198|Epilepsy idiopathic generalized,susceptibility to,8,612899|Hypercalciuric hypercalcemia|Calcium,serum level of];	RCV000285264.1 [benign]; RCV000321599.1 [benign]; RCV000376273.1 [benign]; RCV000379619.1 [benign]; 			231	1					CASR (inh=AD pLI=0.37)
chr3	122005053	122005053	A	G	het	anno_omim	QUAL=6478;DP=231;AF=0.49;MQM=60;TRIO=HET,231,0.49,WT,219,0.00,HET,270,0.51	CASR	3'UTR	CASR:ENST00000498619:3'UTR:MODIFIER:exon7/7:c.*1015A>G:		rs9740	0.1815	0.0000	0,0,0	0,0,0,0,0	0.2752							601199 [CASR (confirmed) Hypocalciuric hypercalcemia,type I,145980|Hyperparathyroidism,neonatal,239200|Hypocalcemia,autosomal dominant,601198|Hypocalcemia,autosomal dominant,with Bartter syndrome,601198|Epilepsy idiopathic generalized,susceptibility to,8,612899|Hypercalciuric hypercalcemia|Calcium,serum level of];	RCV000269865.1 [benign]; RCV000324896.1 [benign]; RCV000384053.1 [benign]; RCV000388912.1 [benign]; 			23	96					CASR (inh=AD pLI=0.37)
chr3	122005236	122005236	T	C	het	anno_omim	QUAL=6045;DP=321;AF=0.45;MQM=59;TRIO=HET,321,0.45,WT,106,0.01,HET,151,0.55	CASR	3'UTR	CASR:ENST00000498619:3'UTR:MODIFIER:exon7/7:c.*1198T>C:	MIRb	rs10190	0.5331	0.0000	0,0,0	0,0,0,0,0	0.5547							601199 [CASR (confirmed) Hypocalciuric hypercalcemia,type I,145980|Hyperparathyroidism,neonatal,239200|Hypocalcemia,autosomal dominant,601198|Hypocalcemia,autosomal dominant,with Bartter syndrome,601198|Epilepsy idiopathic generalized,susceptibility to,8,612899|Hypercalciuric hypercalcemia|Calcium,serum level of];	RCV000273862.1 [benign]; RCV000319605.1 [benign]; RCV000374172.1 [benign]; RCV000386740.1 [benign]; 			98	73					CASR (inh=AD pLI=0.37)
chr3	128622922	128622922	G	A	het	pred_pathogenic;anno_omim;anno_pathogenic_clinvar	QUAL=11119;DP=423;AF=0.46;MQM=60;TRIO=HET,423,0.46,WT,363,0.00,HET,526,0.48	ACAD9	missense	ACAD9:ENST00000308982:missense:MODERATE:exon10/18:c.976G>A:p.Ala326Thr		rs115532916	0.0078	0.0182	35,29,0	0.0025,0.0055,0.0001,0.0258,0.0045	0.0267	6.9770	D,D	D	D,D	D	34.00	611103 [ACAD9 (confirmed) Mitochondrial complex I deficiency due to ACAD9 deficiency,611126];	RCV000123467.1 [benign]; RCV000201693.1 [pathogenic]; RCV000395019.1 [likely benign]; 			1	120	2	[2] Peter Bauer 28.01.2015			ACAD9 (inh=AR pLI=0.00)
chr3	128887147	128887147	C	T	hom	anno_omim	QUAL=28052;DP=310;AF=1.00;MQM=59;TRIO=HOM,310,1.00,HOM,232,1.00,HOM,315,1.00	RP11,434H6.7,CNBP	intergenic_region	CNBP:ENSG00000273437-ENSG00000169714:intergenic_region:MODIFIER::n.128887147C>T:		rs9880375	0.9780	0.0000	0,0,0	0,0,0,0,0	0.9801							116955 [CNBP (confirmed) Myotonic dystrophy 2,602668];				218	11					PRPF31 (inh=AD pLI=0.97), 434H6.7 (inh=n/a pLI=n/a), CNBP (inh=AD pLI=0.92)
chr3	128887527	128887527	A	G	hom	anno_omim	QUAL=7096;DP=139;AF=0.99;MQM=60;TRIO=HOM,139,0.99,HOM,44,1.00,HOM,37,1.00	RP11,434H6.7,CNBP	intergenic_region	CNBP:ENSG00000273437-ENSG00000169714:intergenic_region:MODIFIER::n.128887527A>G:	AluSq2	rs12633752	0.8764	0.0000	0,0,0	0,0,0,0,0	0.9186							116955 [CNBP (confirmed) Myotonic dystrophy 2,602668];				160	10					PRPF31 (inh=AD pLI=0.97), 434H6.7 (inh=n/a pLI=n/a), CNBP (inh=AD pLI=0.92)
chr3	128887783	128887783	-	A	het	low_DP;anno_omim	QUAL=140;DP=9;AF=0.78;MQM=54;TRIO=HET,9,0.78,WT,1,0.00,HET,5,0.80	RP11,434H6.7,CNBP	intergenic_region	CNBP:ENSG00000273437-ENSG00000169714:intergenic_region:MODIFIER::n.128887783_128887784insA:	AluY	rs11401192	0.8157	0.0000	0,0,0	0,0,0,0,0	0.8609							116955 [CNBP (confirmed) Myotonic dystrophy 2,602668];				63	20					PRPF31 (inh=AD pLI=0.97), 434H6.7 (inh=n/a pLI=n/a), CNBP (inh=AD pLI=0.92)
chr3	128887862	128887862	A	G	hom	low_DP;low_MQM;anno_omim	QUAL=323;DP=11;AF=1.00;MQM=43;TRIO=HOM,11,1.00,WT,1,0.00,WT,5,0.80	RP11,434H6.7,CNBP	intergenic_region	CNBP:ENSG00000273437-ENSG00000169714:intergenic_region:MODIFIER::n.128887862A>G:	AluY	rs6792159	0.9687	0.0000	0,0,0	0,0,0,0,0	0.9737							116955 [CNBP (confirmed) Myotonic dystrophy 2,602668];				92	7					PRPF31 (inh=AD pLI=0.97), 434H6.7 (inh=n/a pLI=n/a), CNBP (inh=AD pLI=0.92)
chr3	128890350	128890350	G	A	hom	anno_omim	QUAL=37084;DP=385;AF=1.00;MQM=59;TRIO=HOM,385,1.00,HOM,338,1.00,HOM,409,1.00	CNBP	splice_region&synonymous,synonymous	CNBP:ENST00000500450:splice_region&synonymous:LOW:exon3/5:c.105C>T:p.Asp35Asp,CNBP:ENST00000504813:splice_region&synonymous:LOW:exon3/5:c.126C>T:p.Asp42Asp,CNBP:ENST00000441626:synonymous:LOW:exon3/5:c.156C>T:p.Asp52Asp,CNBP:ENST00000502976:synonymous:LOW:exon3/5:c.135C>T:p.Asp45Asp,CNBP:ENST00000422453:synonymous:LOW:exon3/5:c.156C>T:p.Asp52Asp,CNBP:ENST00000446936:synonymous:LOW:exon3/5:c.135C>T:p.Asp45Asp,CNBP:ENST00000451728:synonymous:LOW:exon3/5:c.156C>T:p.Asp52Asp		rs4303883	0.7572	0.8900	49449,31266,983	0.4312,0.8706,0.8834,0.9677,0.8555	0.9001							116955 [CNBP (confirmed) Myotonic dystrophy 2,602668];				1840	245	2	[2] auto-classification 14.09.2017  			CNBP (inh=AD pLI=0.92)
chr3	142168331	142168331	C	T	het	anno_omim	QUAL=23422;DP=520;AF=0.43;MQM=60;TRIO=HET,520,0.43,HET,318,0.50,HOM,404,1.00	ATR	synonymous	ATR:ENST00000350721:synonymous:LOW:exon47/47:c.7875G>A:p.Gln2625Gln,ATR:ENST00000383101:synonymous:LOW:exon46/46:c.7683G>A:p.Gln2561Gln		rs1802904	0.9163	0.8646	45665,23944,4913	0.9721,0.7549,0.9302,0.8463,0.9348	0.8880							601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	RCV000079601.6 [other]; RCV000366216.1 [benign]; 			2959	921	1	[1] Ilnaz Sepahi 29-03-2016 batch import			ATR (inh=AR pLI=0.70)
chr3	142178144	142178144	C	T	het	anno_omim	QUAL=10045;DP=396;AF=0.44;MQM=60;TRIO=HET,396,0.44,HET,178,0.48,HET,272,0.44	ATR	missense	ATR:ENST00000350721:missense:MODERATE:exon43/47:c.7274G>A:p.Arg2425Gln,ATR:ENST00000383101:missense:MODERATE:exon42/46:c.7082G>A:p.Arg2361Gln		rs2229032	0.1022	0.1328	1212,874,28	0.0808,0.0969,0.1019,0.1571,0.0939	0.1332	0.0440	T,T	T	B	T,T	11.30	601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	RCV000145330.2 [benign]; RCV000321936.1 [likely benign]; 		COSM149485	85	983	1	[1] Ilnaz Sepahi 29-03-2016 batch import			ATR (inh=AR pLI=0.70)
chr3	142277575	142277575	A	T	het	anno_omim	QUAL=7934;DP=161;AF=0.53;MQM=60;TRIO=HET,161,0.53,HET,172,0.52,HET,220,0.55	ATR	synonymous	ATR:ENST00000350721:synonymous:LOW:exon8/47:c.1776T>A:p.Gly592Gly,ATR:ENST00000383101:synonymous:LOW:exon7/46:c.1584T>A:p.Gly528Gly		rs2227930	0.5980	0.5529	19239,11031,3356	0.8024,0.4389,0.4642,0.5741,0.4362	0.6300							601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	RCV000145291.5 [other]; RCV000306424.1 [benign]; 		COSM149486	1341	1876	1	[1] Ilnaz Sepahi 29-03-2016 batch import			ATR (inh=AR pLI=0.70)
chr3	142281612	142281612	A	G	het	anno_omim	QUAL=8138;DP=255;AF=0.49;MQM=60;TRIO=HET,255,0.49,HET,163,0.49,HET,202,0.51	ATR	missense	ATR:ENST00000350721:missense:MODERATE:exon4/47:c.632T>C:p.Met211Thr,ATR:ENST00000383101:missense:MODERATE:exon4/46:c.632T>C:p.Met211Thr		rs2227928	0.5974	0.5540	19098,10972,3300	0.8000,0.4404,0.4658,0.5752,0.4390	0.6291	1.2730	T,T	T	B	T,T	1.62	601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	RCV000079600.6 [other]; RCV000267092.1 [benign]; 		COSM149487	1340	1875	1	[1] Ilnaz Sepahi 29-03-2016 batch import			ATR (inh=AR pLI=0.70)
chr3	150644247	150644247	C	T	het	anno_omim	QUAL=8586;DP=297;AF=0.52;MQM=59;TRIO=HET,297,0.52,HOM,154,1.00,WT,161,0.01	CLRN1,CLRN1-AS1,RP11-166N6.3,RP11-166N6.2	3'UTR,intron	CLRN1:ENST00000295911:3'UTR:MODIFIER:exon4/4:c.*392G>A:,CLRN1-AS1:ENST00000476886:intron:MODIFIER:exon1/4:n.123+73854C>T:		rs3796239	0.6408	0.0000	0,0,0	0,0,0,0,0	0.5791							606397 [CLRN1 (confirmed) Usher syndrome,type 3A,276902|Retinitis pigmentosa 61,614180];				95	104					CLRN1 (inh=AR pLI=0.00), CLRN1-AS1 (inh=n/a pLI=n/a), RP11-166N6.3 (inh=n/a pLI=n/a), RP11-166N6.2 (inh=n/a pLI=n/a)
chr3	150645351	150645351	G	A	het	anno_omim	QUAL=5156;DP=252;AF=0.43;MQM=60;TRIO=HET,252,0.43,HOM,71,1.00,WT,148,0.00	CLRN1,CLRN1-AS1,RP11-166N6.3,RP11-166N6.2	3'UTR,intron	CLRN1:ENST00000327047:3'UTR:MODIFIER:exon3/3:c.*372C>T:,CLRN1-AS1:ENST00000476886:intron:MODIFIER:exon1/4:n.123+74958G>A:,CLRN1:ENST00000295911:intron:MODIFIER:exon3/3:c.342+501C>T:		rs4680058	0.7778	0.6038	2011,520,79	0.0000,0.0000,0.0000,0.5993,0.5933	0.7557							606397 [CLRN1 (confirmed) Usher syndrome,type 3A,276902|Retinitis pigmentosa 61,614180];	RCV000313684.1 [benign]; RCV000368414.1 [benign]; 			335	251					CLRN1 (inh=AR pLI=0.00), CLRN1-AS1 (inh=n/a pLI=n/a), RP11-166N6.3 (inh=n/a pLI=n/a), RP11-166N6.2 (inh=n/a pLI=n/a)
chr3	150645408	150645408	G	A	het	anno_omim	QUAL=5632;DP=241;AF=0.50;MQM=59;TRIO=HET,241,0.50,HOM,77,1.00,WT,125,0.00	CLRN1,CLRN1-AS1,RP11-166N6.3,RP11-166N6.2	3'UTR,intron	CLRN1:ENST00000327047:3'UTR:MODIFIER:exon3/3:c.*315C>T:,CLRN1-AS1:ENST00000476886:intron:MODIFIER:exon1/4:n.123+75015G>A:,CLRN1:ENST00000295911:intron:MODIFIER:exon3/3:c.342+444C>T:		rs1456138	0.7768	0.6293	2081,568,90	0.9120,0.0000,0.0000,0.6315,0.6149	0.7562							606397 [CLRN1 (confirmed) Usher syndrome,type 3A,276902|Retinitis pigmentosa 61,614180];	RCV000273387.1 [benign]; RCV000319087.1 [benign]; 			335	251					CLRN1 (inh=AR pLI=0.00), CLRN1-AS1 (inh=n/a pLI=n/a), RP11-166N6.3 (inh=n/a pLI=n/a), RP11-166N6.2 (inh=n/a pLI=n/a)
chr3	150645419	150645420	AC	-	het	anno_omim	QUAL=3375;DP=208;AF=0.50;MQM=59;TRIO=HET,208,0.50,HOM,62,0.94,WT,97,0.07	CLRN1,CLRN1-AS1,RP11-166N6.3,RP11-166N6.2	3'UTR,intron	CLRN1:ENST00000327047:3'UTR:MODIFIER:exon3/3:c.*303_*304delGT:,CLRN1-AS1:ENST00000476886:intron:MODIFIER:exon1/4:n.123+75053_123+75054delCA:,CLRN1:ENST00000295911:intron:MODIFIER:exon3/3:c.342+432_342+433delGT:	(AC)n	rs34027634;rs397897647	0.6300	0.4455	299,94,6	0.0000,0.0000,0.0000,0.4609,0.4418	0.5210							606397 [CLRN1 (confirmed) Usher syndrome,type 3A,276902|Retinitis pigmentosa 61,614180];	RCV000291402.1 [benign]; RCV000376478.1 [benign]; 			231	75					CLRN1 (inh=AR pLI=0.00), CLRN1-AS1 (inh=n/a pLI=n/a), RP11-166N6.3 (inh=n/a pLI=n/a), RP11-166N6.2 (inh=n/a pLI=n/a)
chr3	150661842	150661842	T	G	het	anno_omim	QUAL=9913;DP=419;AF=0.49;MQM=59;TRIO=HET,419,0.49,WT,338,0.00,HET,439,0.42	CLRN1,CLRN1-AS1,RP11-166N6.2	5'UTR,intron	CLRN1:ENST00000295911:5'UTR:MODIFIER:exon1/4:c.-211A>C:,CLRN1-AS1:ENST00000476886:intron:MODIFIER:exon1/4:n.123+91449T>G:,CLRN1:ENST00000328863:intron:MODIFIER:exon1/3:c.254-2294A>C:,CLRN1:ENST00000327047:intron:MODIFIER:exon1/2:c.254-2294A>C:	L2a	rs11914988	0.2720	0.0000	0,0,0	0,0,0,0,0	0.2092							606397 [CLRN1 (confirmed) Usher syndrome,type 3A,276902|Retinitis pigmentosa 61,614180];				116	504					CLRN1 (inh=AR pLI=0.00), CLRN1-AS1 (inh=n/a pLI=n/a), RP11-166N6.2 (inh=n/a pLI=n/a)
chr3	150690566	150690566	T	C	het	anno_omim	QUAL=28019;DP=422;AF=0.52;MQM=59;TRIO=HET,422,0.52,HOM,471,1.00,HET,601,0.51	CLRN1,CLRN1-AS1,RP11-166N6.2	5'UTR,intron,non_coding_transcript_exon	CLRN1:ENST00000327047:5'UTR:MODIFIER:exon1/3:c.-71A>G:,CLRN1-AS1:ENST00000476886:intron:MODIFIER:exon1/4:n.124-90147T>C:,CLRN1-AS1:ENST00000465576:non_coding_transcript_exon:MODIFIER:exon1/6:n.102T>C:		rs3796240	0.4692	0.5500	15307,9075,649	0.4112,0.5920,0.4702,0.5698,0.5607	0.5220							606397 [CLRN1 (confirmed) Usher syndrome,type 3A,276902|Retinitis pigmentosa 61,614180];	RCV000298678.1 [likely benign]; RCV000401177.1 [likely benign]; 			186	271					CLRN1 (inh=AR pLI=0.00), CLRN1-AS1 (inh=n/a pLI=n/a), RP11-166N6.2 (inh=n/a pLI=n/a)
chr3	155572067	155572067	G	A	het	anno_omim	QUAL=2580;DP=61;AF=0.57;MQM=60;TRIO=HET,61,0.57,HET,136,0.52,WT,175,0.00	SLC33A1	5'UTR	SLC33A1:ENST00000359479:5'UTR:MODIFIER:exon1/7:c.-281C>T:,SLC33A1:ENST00000392845:5'UTR:MODIFIER:exon1/6:c.-281C>T:		rs560777515	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0024							603690 [SLC33A1 (confirmed) Spastic paraplegia 42,autosomal dominant,612539|Congenital cataracts,hearing loss,and neurodegeneration,614482];	RCV000342609.1 [uncertain significance]; 			0	4					SLC33A1 (inh=AR+AD pLI=0.10)
chr3	158362391	158362391	C	T	hom	anno_omim	QUAL=10101;DP=156;AF=0.99;MQM=59;TRIO=HOM,156,0.99,HOM,127,1.00,HET,213,0.46	GFM1	5'UTR	GFM1:ENST00000264263:5'UTR:MODIFIER:exon1/19:c.-33C>T:,GFM1:ENST00000486715:5'UTR:MODIFIER:exon1/18:c.-33C>T:,GFM1:ENST00000478576:5'UTR:MODIFIER:exon1/14:c.-33C>T:		rs28372852	0.1474	0.2044	379,223,14	0.1583,0.1972,0.1285,0.2661,0.1597	0.1806							606639 [GFM1 (confirmed) Combined oxidative phosphorylation deficiency 1,609060];	RCV000295077.1 [likely benign]; 			97	647					GFM1 (inh=AR pLI=0.00)
chr3	158362441	158362441	T	C	hom	anno_omim	QUAL=11953;DP=230;AF=1.00;MQM=59;TRIO=HOM,230,1.00,HOM,116,1.00,HET,220,0.44	GFM1	synonymous	GFM1:ENST00000264263:synonymous:LOW:exon1/19:c.18T>C:p.Ala6Ala,GFM1:ENST00000486715:synonymous:LOW:exon1/18:c.18T>C:p.Ala6Ala,GFM1:ENST00000478576:synonymous:LOW:exon1/14:c.18T>C:p.Ala6Ala		rs1864507	0.5831	0.6302	7683,3873,1112	0.7501,0.6664,0.4635,0.6274,0.6207	0.5747							606639 [GFM1 (confirmed) Combined oxidative phosphorylation deficiency 1,609060];	RCV000282348.1 [benign]; 		COSM3721924	708	1009	2	[2] auto-classification 14.09.2017  			GFM1 (inh=AR pLI=0.00)
chr3	158366900	158366900	G	A	hom	pred_pathogenic;anno_omim	QUAL=12890;DP=239;AF=0.99;MQM=60;TRIO=HOM,239,0.99,HOM,115,1.00,HET,140,0.36	GFM1,LXN	missense	GFM1:ENST00000264263:missense:MODERATE:exon5/19:c.643G>A:p.Val215Ile,GFM1:ENST00000486715:missense:MODERATE:exon5/18:c.643G>A:p.Val215Ile,GFM1:ENST00000478576:missense:MODERATE:exon5/14:c.643G>A:p.Val215Ile		rs2303909	0.5833	0.5467	18614,9501,2707	0.7238,0.5708,0.3250,0.5329,0.6047	0.5756	3.3150	T,T,T	T	B,B,B	T,T,T	13.77	606639 [GFM1 (confirmed) Combined oxidative phosphorylation deficiency 1,609060];	RCV000334159.1 [benign]; 		COSM4002505	708	1011	2	[2] auto-classification 14.09.2017  			GFM1 (inh=AR pLI=0.00), LXN (inh=n/a pLI=0.00)
chr3	158409262	158409262	C	T	hom	anno_omim	QUAL=17169;DP=298;AF=1.00;MQM=60;TRIO=HOM,298,1.00,HOM,142,1.00,HET,236,0.48	GFM1	3'UTR	GFM1:ENST00000264263:3'UTR:MODIFIER:exon19/19:c.*6C>T:,GFM1:ENST00000486715:3'UTR:MODIFIER:exon18/18:c.*6C>T:		rs1047355	0.4091	0.3657	8751,4710,1822	0.5971,0.3039,0.1439,0.3729,0.3765	0.4033							606639 [GFM1 (confirmed) Combined oxidative phosphorylation deficiency 1,609060];	RCV000317038.1 [benign]; 			351	1017					GFM1 (inh=AR pLI=0.00)
chr3	158409482	158409482	C	T	hom	anno_omim	QUAL=3311;DP=89;AF=1.00;MQM=60;TRIO=HOM,89,1.00,HOM,7,1.00,HET,6,0.50	GFM1	3'UTR	GFM1:ENST00000264263:3'UTR:MODIFIER:exon19/19:c.*226C>T:,GFM1:ENST00000486715:3'UTR:MODIFIER:exon18/18:c.*226C>T:		rs1047366	0.5833	0.0000	0,0,0	0,0,0,0,0	0.5760							606639 [GFM1 (confirmed) Combined oxidative phosphorylation deficiency 1,609060];	RCV000262965.1 [benign]; 			76	115					GFM1 (inh=AR pLI=0.00)
chr3	158409708	158409710	TTG	-	hom	anno_omim	QUAL=8403;DP=164;AF=0.99;MQM=59;TRIO=HOM,164,0.99,HOM,78,1.00,HET,90,0.41	GFM1	3'UTR	GFM1:ENST00000264263:3'UTR:MODIFIER:exon19/19:c.*454_*456delGTT:,GFM1:ENST00000486715:3'UTR:MODIFIER:exon18/18:c.*454_*456delGTT:		rs367730845	0.1472	0.0000	0,0,0	0,0,0,0,0	0.1746							606639 [GFM1 (confirmed) Combined oxidative phosphorylation deficiency 1,609060];	RCV000377206.1 [likely benign]; 			10	78					GFM1 (inh=AR pLI=0.00)
chr3	158409947	158409947	T	A	hom	anno_omim	QUAL=9752;DP=152;AF=0.99;MQM=60;TRIO=HOM,152,0.99,HOM,96,1.00,HET,134,0.53	GFM1	3'UTR	GFM1:ENST00000264263:3'UTR:MODIFIER:exon19/19:c.*691T>A:,GFM1:ENST00000486715:3'UTR:MODIFIER:exon18/18:c.*691T>A:		rs8650	0.4091	0.0000	0,0,0	0,0,0,0,0	0.4030							606639 [GFM1 (confirmed) Combined oxidative phosphorylation deficiency 1,609060];	RCV000288969.1 [benign]; 			37	108					GFM1 (inh=AR pLI=0.00)
chr3	182755209	182755209	T	G	hom	anno_omim	QUAL=11069;DP=188;AF=0.99;MQM=60;TRIO=HOM,188,0.99,HET,202,0.50,HET,245,0.47	MCCC1	missense	MCCC1:ENST00000265594:missense:MODERATE:exon13/19:c.1391A>C:p.His464Pro,MCCC1:ENST00000492597:missense:MODERATE:exon12/18:c.1064A>C:p.His355Pro,MCCC1:ENST00000539926:missense:MODERATE:exon11/16:c.986A>C:p.His329Pro		rs2270968	0.4649	0.6249	25068,17346,404	0.2700,0.5595,0.3327,0.7230,0.6015	0.6296	1.1180	T,T,T,T,T,T	T	B,B,B	T,T,T,T	17.25	609010 [MCCC1 (confirmed) 3-Methylcrotonyl-CoA carboxylase 1 deficiency,210200];	RCV000081992.4 [benign]; RCV000262405.1 [benign]; 	CM162758 [CLASS=R MUT=ALT PHEN="3-methylcrotonyl-CoA carboxylase deficiency" GENE=MCCC1]; 	COSM4002526	1116	979	2	[2] auto-classification 14.09.2017  			MCCC1 (inh=AR pLI=0.00)
chr3	182790249	182790249	G	A	hom	anno_omim	QUAL=16280;DP=188;AF=1.00;MQM=60;TRIO=HOM,188,1.00,HOM,116,1.00,HOM,201,1.00	MCCC1	synonymous,5'UTR	MCCC1:ENST00000265594:synonymous:LOW:exon5/19:c.396C>T:p.Leu132Leu,MCCC1:ENST00000492597:synonymous:LOW:exon4/18:c.69C>T:p.Leu23Leu,MCCC1:ENST00000539926:5'UTR:MODIFIER:exon3/16:c.-10C>T:		rs7622479	0.9155	0.9297	52539,28967,3232	0.7930,0.9577,0.9997,0.9317,0.9470	0.9324							609010 [MCCC1 (confirmed) 3-Methylcrotonyl-CoA carboxylase 1 deficiency,210200];	RCV000081994.5 [benign]; RCV000291937.1 [benign]; 			2000	335	2	[2] auto-classification 14.09.2017  			MCCC1 (inh=AR pLI=0.00)
chr3	182817328	182817328	C	G	hom	anno_omim	QUAL=16483;DP=74;AF=0.99;MQM=59;TRIO=HOM,74,0.99,HOM,207,1.00,HOM,268,1.00	MCCC1	5'UTR,intron	MCCC1:ENST00000265594:5'UTR:MODIFIER:exon1/19:c.-100G>C:,MCCC1:ENST00000492597:intron:MODIFIER:exon1/17:c.-101-4935G>C:		rs937652	0.5449	0.0000	0,0,0	0,0,0,0,0	0.6241							609010 [MCCC1 (confirmed) 3-Methylcrotonyl-CoA carboxylase 1 deficiency,210200];	RCV000392572.1 [benign]; 			246	177					MCCC1 (inh=AR pLI=0.00)
chr3	190023552	190023552	T	C	hom	anno_omim	QUAL=12141;DP=226;AF=0.98;MQM=59;TRIO=HOM,226,0.98,HOM,87,1.00,HET,140,0.52	CLDN1	3'UTR	CLDN1:ENST00000295522:3'UTR:MODIFIER:exon4/4:c.*2514A>G:		rs8298	0.7212	0.0000	0,0,0	0,0,0,0,0	0.6873							603718 [CLDN1 (confirmed) Ichthyosis,leukocyte vacuoles,alopecia,and sclerosing cholangitis,607626];				86	99					CLDN1 (inh=AR pLI=0.06)
chr3	190023837	190023837	A	G	hom	anno_omim	QUAL=21492;DP=390;AF=0.99;MQM=60;TRIO=HOM,390,0.99,HOM,177,0.99,HET,249,0.46	CLDN1	3'UTR	CLDN1:ENST00000295522:3'UTR:MODIFIER:exon4/4:c.*2229T>C:		rs8798	0.7143	0.0000	0,0,0	0,0,0,0,0	0.6814							603718 [CLDN1 (confirmed) Ichthyosis,leukocyte vacuoles,alopecia,and sclerosing cholangitis,607626];				88	100					CLDN1 (inh=AR pLI=0.06)
chr3	190024057	190024057	C	T	hom	anno_omim	QUAL=34483;DP=644;AF=0.99;MQM=60;TRIO=HOM,644,0.99,HOM,263,0.99,HET,333,0.50	CLDN1	3'UTR	CLDN1:ENST00000295522:3'UTR:MODIFIER:exon4/4:c.*2009G>A:		rs1364722	0.7005	0.0000	0,0,0	0,0,0,0,0	0.6720							603718 [CLDN1 (confirmed) Ichthyosis,leukocyte vacuoles,alopecia,and sclerosing cholangitis,607626];				88	101					CLDN1 (inh=AR pLI=0.06)
chr3	190024103	190024103	T	C	hom	anno_omim	QUAL=30764;DP=551;AF=1.00;MQM=59;TRIO=HOM,551,1.00,HOM,249,1.00,HET,296,0.50	CLDN1	3'UTR	CLDN1:ENST00000295522:3'UTR:MODIFIER:exon4/4:c.*1963A>G:		rs1895708	0.7021	0.0000	0,0,0	0,0,0,0,0	0.6732							603718 [CLDN1 (confirmed) Ichthyosis,leukocyte vacuoles,alopecia,and sclerosing cholangitis,607626];				88	101					CLDN1 (inh=AR pLI=0.06)
chr3	190024188	190024188	G	A	hom	anno_omim	QUAL=25001;DP=476;AF=1.00;MQM=60;TRIO=HOM,476,1.00,HOM,192,1.00,HET,243,0.47	CLDN1	3'UTR	CLDN1:ENST00000295522:3'UTR:MODIFIER:exon4/4:c.*1878C>T:		rs2204226	0.6969	0.0000	0,0,0	0,0,0,0,0	0.6704							603718 [CLDN1 (confirmed) Ichthyosis,leukocyte vacuoles,alopecia,and sclerosing cholangitis,607626];				88	101					CLDN1 (inh=AR pLI=0.06)
chr3	190024457	190024457	A	G	hom	anno_omim	QUAL=37159;DP=555;AF=0.99;MQM=60;TRIO=HOM,555,0.99,HOM,400,1.00,HET,538,0.45	CLDN1	3'UTR	CLDN1:ENST00000295522:3'UTR:MODIFIER:exon4/4:c.*1609T>C:	MIRc	rs9290928	0.7011	0.0000	0,0,0	0,0,0,0,0	0.6718							603718 [CLDN1 (confirmed) Ichthyosis,leukocyte vacuoles,alopecia,and sclerosing cholangitis,607626];				88	100					CLDN1 (inh=AR pLI=0.06)
chr3	190024643	190024643	G	T	hom	anno_omim	QUAL=55820;DP=714;AF=0.99;MQM=59;TRIO=HOM,714,0.99,HOM,727,1.00,HET,1010,0.47	CLDN1	3'UTR	CLDN1:ENST00000295522:3'UTR:MODIFIER:exon4/4:c.*1423C>A:		rs1060680	0.1166	0.0000	0,0,0	0,0,0,0,0	0.1555							603718 [CLDN1 (confirmed) Ichthyosis,leukocyte vacuoles,alopecia,and sclerosing cholangitis,607626];				9	72					CLDN1 (inh=AR pLI=0.06)
chr3	190025617	190025617	T	A	hom	anno_omim	QUAL=15939;DP=236;AF=0.99;MQM=60;TRIO=HOM,236,0.99,HOM,163,1.00,HET,199,0.54	CLDN1	3'UTR	CLDN1:ENST00000295522:3'UTR:MODIFIER:exon4/4:c.*449A>T:		rs9825098	0.6975	0.0000	0,0,0	0,0,0,0,0	0.6654							603718 [CLDN1 (confirmed) Ichthyosis,leukocyte vacuoles,alopecia,and sclerosing cholangitis,607626];				88	101					CLDN1 (inh=AR pLI=0.06)
chr3	190025618	190025618	A	G	hom	anno_omim	QUAL=15939;DP=236;AF=0.99;MQM=60;TRIO=HOM,236,0.99,HOM,163,1.00,HET,199,0.54	CLDN1	3'UTR	CLDN1:ENST00000295522:3'UTR:MODIFIER:exon4/4:c.*448T>C:		rs9842576	0.6969	0.0000	0,0,0	0,0,0,0,0	0.6651							603718 [CLDN1 (confirmed) Ichthyosis,leukocyte vacuoles,alopecia,and sclerosing cholangitis,607626];				88	101					CLDN1 (inh=AR pLI=0.06)
chr3	190025805	190025805	G	T	hom	anno_omim	QUAL=9946;DP=213;AF=0.99;MQM=60;TRIO=HOM,213,0.99,HOM,59,1.00,HET,83,0.51	CLDN1	3'UTR	CLDN1:ENST00000295522:3'UTR:MODIFIER:exon4/4:c.*261C>A:		rs1043747	0.7007	0.0000	0,0,0	0,0,0,0,0	0.6720							603718 [CLDN1 (confirmed) Ichthyosis,leukocyte vacuoles,alopecia,and sclerosing cholangitis,607626];				88	101					CLDN1 (inh=AR pLI=0.06)
chr3	190030680	190030680	A	G	hom	anno_omim	QUAL=16519;DP=131;AF=1.00;MQM=60;TRIO=HOM,131,1.00,HOM,173,1.00,HOM,236,1.00	CLDN1	synonymous	CLDN1:ENST00000295522:synonymous:LOW:exon2/4:c.369T>C:p.Gly123Gly		rs9869263	0.8111	0.8334	42235,24128,3079	0.7692,0.7870,0.8234,0.8505,0.8250	0.8323							603718 [CLDN1 (confirmed) Ichthyosis,leukocyte vacuoles,alopecia,and sclerosing cholangitis,607626];	RCV000175932.2 [benign]; 			1520	531	2	[2] auto-classification 14.09.2017  			CLDN1 (inh=AR pLI=0.06)
chr3	190040008	190040008	C	G	het	anno_omim	QUAL=4694;DP=196;AF=0.45;MQM=59;TRIO=HET,196,0.45,HET,222,0.54,WT,290,0.00	CLDN1	5'UTR	CLDN1:ENST00000295522:5'UTR:MODIFIER:exon1/4:c.-13G>C:		rs17429833	0.0509	0.0682	311,223,7	0.0350,0.0434,0.0156,0.0851,0.0545	0.0668							603718 [CLDN1 (confirmed) Ichthyosis,leukocyte vacuoles,alopecia,and sclerosing cholangitis,607626];	RCV000251825.2 [benign]; 			11	303					CLDN1 (inh=AR pLI=0.06)
chr3	190040207	190040207	C	A	het	anno_omim	QUAL=5053;DP=283;AF=0.55;MQM=60;TRIO=HET,283,0.55,HOM,38,1.00,HET,61,0.52	CLDN1	5'UTR	CLDN1:ENST00000295522:5'UTR:MODIFIER:exon1/4:c.-212G>T:		rs12696600	0.6625	0.0000	0,0,0	0,0,0,0,0	0.6014							603718 [CLDN1 (confirmed) Ichthyosis,leukocyte vacuoles,alopecia,and sclerosing cholangitis,607626];				49	114					CLDN1 (inh=AR pLI=0.06)
chr3	193355074	193355074	T	C	hom	anno_omim	QUAL=10928;DP=158;AF=1.00;MQM=60;TRIO=HOM,158,1.00,HET,105,0.42,HOM,149,0.99	OPA1	splice_region&intron	OPA1:ENST00000361510:splice_region&intron:LOW:exon10/30:c.1035+4T>C:,OPA1:ENST00000361150:splice_region&intron:LOW:exon8/28:c.873+4T>C:,OPA1:ENST00000361715:splice_region&intron:LOW:exon9/29:c.927+4T>C:,OPA1:ENST00000361828:splice_region&intron:LOW:exon9/29:c.924+4T>C:,OPA1:ENST00000361908:splice_region&intron:LOW:exon9/29:c.981+4T>C:,OPA1:ENST00000392438:splice_region&intron:LOW:exon8/28:c.870+4T>C:		rs166850	0.9229	0.8718	46256,23201,4866	0.9681,0.8987,0.9609,0.8342,0.8980	0.8884							605290 [OPA1 (confirmed) Optic atrophy 1,165500|Glaucoma,normal tension,susceptibility to,606657|Optic atrophy plus syndrome,125250|Behr syndrome,210000|Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type),616896];	RCV000081773.7 [benign]; RCV000275012.1 [benign]; 			2714	1011	2	[2] auto-classification 14.09.2017  			OPA1 (inh=AR+AD pLI=0.99)
chr3	193412672	193412672	A	G	het	anno_omim	QUAL=12970;DP=327;AF=0.54;MQM=60;TRIO=HET,327,0.54,WT,233,0.01,HOM,252,1.00	OPA1	3'UTR	OPA1:ENST00000361510:3'UTR:MODIFIER:exon31/31:c.*283A>G:,OPA1:ENST00000361150:3'UTR:MODIFIER:exon29/29:c.*283A>G:,OPA1:ENST00000361715:3'UTR:MODIFIER:exon30/30:c.*283A>G:,OPA1:ENST00000361828:3'UTR:MODIFIER:exon30/30:c.*283A>G:,OPA1:ENST00000361908:3'UTR:MODIFIER:exon30/30:c.*283A>G:,OPA1:ENST00000392438:3'UTR:MODIFIER:exon29/29:c.*283A>G:		rs1061648	0.6412	0.0000	0,0,0	0,0,0,0,0	0.6253							605290 [OPA1 (confirmed) Optic atrophy 1,165500|Glaucoma,normal tension,susceptibility to,606657|Optic atrophy plus syndrome,125250|Behr syndrome,210000|Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type),616896];	RCV000261365.1 [benign]; 			98	100					OPA1 (inh=AR+AD pLI=0.99)
chr3	193412949	193412949	T	C	hom	anno_omim	QUAL=20036;DP=335;AF=0.99;MQM=60;TRIO=HOM,335,0.99,HET,187,0.50,HOM,192,1.00	OPA1	3'UTR	OPA1:ENST00000361510:3'UTR:MODIFIER:exon31/31:c.*560T>C:,OPA1:ENST00000361150:3'UTR:MODIFIER:exon29/29:c.*560T>C:,OPA1:ENST00000361715:3'UTR:MODIFIER:exon30/30:c.*560T>C:,OPA1:ENST00000361828:3'UTR:MODIFIER:exon30/30:c.*560T>C:,OPA1:ENST00000361908:3'UTR:MODIFIER:exon30/30:c.*560T>C:,OPA1:ENST00000392438:3'UTR:MODIFIER:exon29/29:c.*560T>C:		rs7643844	0.9137	0.0000	0,0,0	0,0,0,0,0	0.8879							605290 [OPA1 (confirmed) Optic atrophy 1,165500|Glaucoma,normal tension,susceptibility to,606657|Optic atrophy plus syndrome,125250|Behr syndrome,210000|Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type),616896];	RCV000265010.1 [benign]; 			168	58					OPA1 (inh=AR+AD pLI=0.99)
chr3	193413502	193413502	C	T	het	anno_omim	QUAL=8562;DP=277;AF=0.53;MQM=60;TRIO=HET,277,0.53,WT,127,0.00,HOM,135,1.00	OPA1	3'UTR	OPA1:ENST00000361510:3'UTR:MODIFIER:exon31/31:c.*1113C>T:,OPA1:ENST00000361150:3'UTR:MODIFIER:exon29/29:c.*1113C>T:,OPA1:ENST00000361715:3'UTR:MODIFIER:exon30/30:c.*1113C>T:,OPA1:ENST00000361828:3'UTR:MODIFIER:exon30/30:c.*1113C>T:,OPA1:ENST00000361908:3'UTR:MODIFIER:exon30/30:c.*1113C>T:,OPA1:ENST00000392438:3'UTR:MODIFIER:exon29/29:c.*1113C>T:		rs12630	0.5958	0.0000	0,0,0	0,0,0,0,0	0.5471							605290 [OPA1 (confirmed) Optic atrophy 1,165500|Glaucoma,normal tension,susceptibility to,606657|Optic atrophy plus syndrome,125250|Behr syndrome,210000|Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type),616896];	RCV000290844.1 [benign]; 			72	100					OPA1 (inh=AR+AD pLI=0.99)
chr3	193413732	193413732	A	G	het	anno_omim	QUAL=13276;DP=339;AF=0.51;MQM=60;TRIO=HET,339,0.51,WT,215,0.00,HOM,263,1.00	OPA1	3'UTR	OPA1:ENST00000361510:3'UTR:MODIFIER:exon31/31:c.*1343A>G:,OPA1:ENST00000361150:3'UTR:MODIFIER:exon29/29:c.*1343A>G:,OPA1:ENST00000361715:3'UTR:MODIFIER:exon30/30:c.*1343A>G:,OPA1:ENST00000361828:3'UTR:MODIFIER:exon30/30:c.*1343A>G:,OPA1:ENST00000361908:3'UTR:MODIFIER:exon30/30:c.*1343A>G:,OPA1:ENST00000392438:3'UTR:MODIFIER:exon29/29:c.*1343A>G:		rs1056366	0.6963	0.0000	0,0,0	0,0,0,0,0	0.6675							605290 [OPA1 (confirmed) Optic atrophy 1,165500|Glaucoma,normal tension,susceptibility to,606657|Optic atrophy plus syndrome,125250|Behr syndrome,210000|Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type),616896];	RCV000348053.1 [benign]; 			98	101					OPA1 (inh=AR+AD pLI=0.99)
chr3	196769762	196769762	-	T	hom		QUAL=13796;DP=207;AF=0.99;MQM=59;TRIO=HOM,207,0.99,HOM,116,1.00,HOM,100,1.00	DLG1	3'UTR	DLG1:ENST00000346964:3'UTR:MODIFIER:exon26/26:c.*1731dupA:,DLG1:ENST00000314062:3'UTR:MODIFIER:exon24/24:c.*1731dupA:,DLG1:ENST00000357674:3'UTR:MODIFIER:exon25/25:c.*1731dupA:		rs386399009	0.0000	0.0000	0,0,0	0,0,0,0,0	0.7485											126	94					DLG1 (inh=n/a pLI=1.00)
chr3	196769797	196769797	A	G	hom		QUAL=15370;DP=247;AF=1.00;MQM=59;TRIO=HOM,247,1.00,HOM,103,1.00,HOM,103,1.00	DLG1	3'UTR	DLG1:ENST00000346964:3'UTR:MODIFIER:exon26/26:c.*1697T>C:,DLG1:ENST00000314062:3'UTR:MODIFIER:exon24/24:c.*1697T>C:,DLG1:ENST00000357674:3'UTR:MODIFIER:exon25/25:c.*1697T>C:		rs7753	0.6174	0.0000	0,0,0	0,0,0,0,0	0.5949											90	108					DLG1 (inh=n/a pLI=1.00)
chr3	196769982	196769982	C	G	het		QUAL=11418;DP=366;AF=0.48;MQM=60;TRIO=HET,366,0.48,HOM,131,1.00,HET,178,0.50	DLG1	3'UTR	DLG1:ENST00000346964:3'UTR:MODIFIER:exon26/26:c.*1512G>C:,DLG1:ENST00000314062:3'UTR:MODIFIER:exon24/24:c.*1512G>C:,DLG1:ENST00000357674:3'UTR:MODIFIER:exon25/25:c.*1512G>C:		rs7641	0.3636	0.0000	0,0,0	0,0,0,0,0	0.3488											37	109					DLG1 (inh=n/a pLI=1.00)
chr3	196770356	196770359	AAGG	-	hom		QUAL=9507;DP=165;AF=0.99;MQM=59;TRIO=HOM,165,0.99,HOM,69,1.00,HOM,103,1.00	DLG1	3'UTR	DLG1:ENST00000346964:3'UTR:MODIFIER:exon26/26:c.*1135_*1138delCCTT:,DLG1:ENST00000314062:3'UTR:MODIFIER:exon24/24:c.*1135_*1138delCCTT:,DLG1:ENST00000357674:3'UTR:MODIFIER:exon25/25:c.*1135_*1138delCCTT:		rs569151903	0.7562	0.0000	0,0,0	0,0,0,0,0	0.7445											121	97					DLG1 (inh=n/a pLI=1.00)
chr3	196771245	196771245	G	A	hom		QUAL=34015;DP=501;AF=1.00;MQM=59;TRIO=HOM,501,1.00,HOM,257,1.00,HOM,280,1.00	DLG1	3'UTR	DLG1:ENST00000346964:3'UTR:MODIFIER:exon26/26:c.*249C>T:,DLG1:ENST00000314062:3'UTR:MODIFIER:exon24/24:c.*249C>T:,DLG1:ENST00000357674:3'UTR:MODIFIER:exon25/25:c.*249C>T:,DLG1:ENST00000419354:3'UTR:MODIFIER:exon26/26:c.*249C>T:,DLG1:ENST00000452595:3'UTR:MODIFIER:exon21/21:c.*249C>T:,DLG1:ENST00000422288:3'UTR:MODIFIER:exon23/23:c.*249C>T:		rs4916600	0.7478	0.0000	0,0,0	0,0,0,0,0	0.7373											125	94					DLG1 (inh=n/a pLI=1.00)
chr3	196865242	196865242	C	T	het	pred_pathogenic;anno_pathogenic_hgmd	QUAL=2528;DP=146;AF=0.46;MQM=60;TRIO=HET,146,0.46,WT,55,0.00,HET,72,0.54	DLG1	missense	DLG1:ENST00000346964:missense:MODERATE:exon10/26:c.833G>A:p.Arg278Gln,DLG1:ENST00000314062:missense:MODERATE:exon8/24:c.680G>A:p.Arg227Gln,DLG1:ENST00000357674:missense:MODERATE:exon9/25:c.734G>A:p.Arg245Gln,DLG1:ENST00000419354:missense:MODERATE:exon10/26:c.833G>A:p.Arg278Gln,DLG1:ENST00000452595:missense:MODERATE:exon5/21:c.485G>A:p.Arg162Gln,DLG1:ENST00000422288:missense:MODERATE:exon7/23:c.680G>A:p.Arg227Gln,DLG1:ENST00000448528:missense:MODERATE:exon10/26:c.833G>A:p.Arg278Gln,DLG1:ENST00000443183:missense:MODERATE:exon5/22:c.485G>A:p.Arg162Gln,DLG1:ENST00000450955:missense:MODERATE:exon8/24:c.734G>A:p.Arg245Gln,DLG1:ENST00000392382:missense:MODERATE:exon9/25:c.734G>A:p.Arg245Gln		rs1134986	0.1280	0.1551	1948,737,4	0.0282,0.1292,0.0719,0.1487,0.3404	0.1566	7.4450	T,T,T,T,T,T,T,T,T,T,T,T,T	T	B,B,D,D,D,P,D	T,T,T,T,T,T,T,T,T,T,T	24.20			CM146495 [CLASS=DM? MUT=ALT PHEN="Crohn's disease susceptibility to" GENE=DLG1]; 		89	479	3	[3] auto-classification 14.09.2017  			DLG1 (inh=n/a pLI=1.00)
chr4	1807894	1807894	G	A	hom	anno_omim	QUAL=33835;DP=132;AF=0.99;MQM=59;TRIO=HOM,132,0.99,HOM,410,1.00,HOM,568,1.00	FGFR3	synonymous	FGFR3:ENST00000340107:synonymous:LOW:exon14/18:c.1959G>A:p.Thr653Thr,FGFR3:ENST00000481110:synonymous:LOW:exon14/17:c.1956G>A:p.Thr652Thr,FGFR3:ENST00000412135:synonymous:LOW:exon12/16:c.1617G>A:p.Thr539Thr,FGFR3:ENST00000440486:synonymous:LOW:exon14/18:c.1953G>A:p.Thr651Thr,FGFR3:ENST00000260795:synonymous:LOW:exon13/17:c.1953G>A:p.Thr651Thr,FGFR3:ENST00000352904:synonymous:LOW:exon11/15:c.1617G>A:p.Thr539Thr		rs7688609	0.9561	0.9873	58288,32669,3762	0.8619,0.9932,1.0000,0.9995,0.9999	0.9901							134934 [FGFR3 (confirmed) Achondroplasia,100800|Hypochondroplasia,146000|Thanatophoric dysplasia,type I,187600|Crouzon syndrome with acanthosis nigricans,612247|Muenke syndrome,602849|Bladder cancer,somatic,109800|Colorectal cancer,somatic,114500|Cervical cancer,somatic,603956|LADD syndrome,149730|CATSHL syndrome,610474|Nevus,epidermal,somatic,162900|Thanatophoric dysplasia,type II,187601|Spermatocytic seminoma,somatic,273300|SADDAN,616482];				2211	11	2	[2] auto-classification 14.09.2017  			FGFR3 (inh=AR+AD pLI=0.00)
chr4	1809128	1809129	GT	-	hom	anno_omim	QUAL=6769;DP=61;AF=0.87;MQM=59;TRIO=HOM,61,0.87,HOM,87,0.99,HOM,108,0.96	FGFR3	3'UTR	FGFR3:ENST00000340107:3'UTR:MODIFIER:exon18/18:c.*156_*157delTG:,FGFR3:ENST00000481110:3'UTR:MODIFIER:exon17/17:c.*130_*131delTG:,FGFR3:ENST00000412135:3'UTR:MODIFIER:exon16/16:c.*156_*157delTG:,FGFR3:ENST00000440486:3'UTR:MODIFIER:exon18/18:c.*156_*157delTG:,FGFR3:ENST00000260795:3'UTR:MODIFIER:exon17/17:c.*156_*157delTG:,FGFR3:ENST00000352904:3'UTR:MODIFIER:exon15/15:c.*156_*157delTG:	(TG)n	rs34562534;rs796200908	0.0000	0.6816	1890,694,149	0.7517,0.0000,0.0000,0.7214,0.6513	0.9688							134934 [FGFR3 (confirmed) Achondroplasia,100800|Hypochondroplasia,146000|Thanatophoric dysplasia,type I,187600|Crouzon syndrome with acanthosis nigricans,612247|Muenke syndrome,602849|Bladder cancer,somatic,109800|Colorectal cancer,somatic,114500|Cervical cancer,somatic,603956|LADD syndrome,149730|CATSHL syndrome,610474|Nevus,epidermal,somatic,162900|Thanatophoric dysplasia,type II,187601|Spermatocytic seminoma,somatic,273300|SADDAN,616482];			COSN504966, COSN504965	1435	240					FGFR3 (inh=AR+AD pLI=0.00)
chr4	1809787	1809787	C	T	hom	anno_omim	QUAL=9298;DP=166;AF=0.99;MQM=59;TRIO=HOM,166,0.99,HOM,70,0.99,HOM,85,1.00	FGFR3	3'UTR	FGFR3:ENST00000340107:3'UTR:MODIFIER:exon18/18:c.*798C>T:,FGFR3:ENST00000481110:3'UTR:MODIFIER:exon17/17:c.*772C>T:,FGFR3:ENST00000412135:3'UTR:MODIFIER:exon16/16:c.*798C>T:,FGFR3:ENST00000440486:3'UTR:MODIFIER:exon18/18:c.*798C>T:,FGFR3:ENST00000260795:3'UTR:MODIFIER:exon17/17:c.*798C>T:,FGFR3:ENST00000352904:3'UTR:MODIFIER:exon15/15:c.*798C>T:		rs3135904	0.8982	0.0000	0,0,0	0,0,0,0,0	0.9084							134934 [FGFR3 (confirmed) Achondroplasia,100800|Hypochondroplasia,146000|Thanatophoric dysplasia,type I,187600|Crouzon syndrome with acanthosis nigricans,612247|Muenke syndrome,602849|Bladder cancer,somatic,109800|Colorectal cancer,somatic,114500|Cervical cancer,somatic,603956|LADD syndrome,149730|CATSHL syndrome,610474|Nevus,epidermal,somatic,162900|Thanatophoric dysplasia,type II,187601|Spermatocytic seminoma,somatic,273300|SADDAN,616482];				258	4					FGFR3 (inh=AR+AD pLI=0.00)
chr4	1981229	1981229	G	T	het		QUAL=6389;DP=262;AF=0.52;MQM=59;TRIO=HET,262,0.52,HET,237,0.48,WT,288,0.00	WHSC1	3'UTR	WHSC1:ENST00000382891:3'UTR:MODIFIER:exon22/22:c.*593G>T:,WHSC1:ENST00000382892:3'UTR:MODIFIER:exon23/23:c.*593G>T:,WHSC1:ENST00000382895:3'UTR:MODIFIER:exon24/24:c.*593G>T:		rs73202837	0.0443	0.0000	0,0,0	0,0,0,0,0	0.0591								RCV000268221.1 [likely benign]; 			0	22					NSD2 (inh=AD pLI=1.00)
chr4	3475252	3475252	T	C	hom	anno_omim	QUAL=7670;DP=62;AF=1.00;MQM=60;TRIO=HOM,62,1.00,HOM,60,1.00,HOM,134,1.00	DOK7	synonymous	DOK7:ENST00000389653:synonymous:LOW:exon3/10:c.220T>C:p.Leu74Leu,DOK7:ENST00000340083:synonymous:LOW:exon3/7:c.220T>C:p.Leu74Leu,DOK7:ENST00000507039:synonymous:LOW:exon3/7:c.220T>C:p.Leu74Leu		rs4325970	1.0000	1.0000	59627,32806,4807	0.9999,1.0000,1.0000,1.0000,1.0000	1.0000							610285 [DOK7 (confirmed) Myasthenic syndrome,congenital,10,254300|Fetal akinesia deformation sequence,208150];	RCV000177424.1 [benign]; 			2104	0	2	[2] auto-classification 14.09.2017  			DOK7 (inh=AR pLI=0.00)
chr4	3494600	3494600	A	G	hom	pred_pathogenic;anno_omim	QUAL=6715;DP=89;AF=0.99;MQM=60;TRIO=HOM,89,0.99,HET,157,0.52,HET,206,0.47	DOK7	missense,3'UTR	DOK7:ENST00000389653:missense:MODERATE:exon7/10:c.887A>G:p.Gln296Arg,DOK7:ENST00000340083:missense:MODERATE:exon7/7:c.887A>G:p.Gln296Arg,DOK7:ENST00000507039:3'UTR:MODIFIER:exon7/7:c.*108A>G:		rs6811423	0.2181	0.2685	2920,1258,10	0.0636,0.1933,0.5368,0.2630,0.2461	0.2312	1.6510	T,T	T	B,B	T,T	0.04	610285 [DOK7 (confirmed) Myasthenic syndrome,congenital,10,254300|Fetal akinesia deformation sequence,208150];	RCV000116896.3 [benign]; 		COSM4159034, COSM447809	101	646	2	[2] auto-classification 14.09.2017  			DOK7 (inh=AR pLI=0.00)
chr4	3494826	3494826	A	C	hom	anno_omim	QUAL=1332;DP=23;AF=1.00;MQM=59;TRIO=HOM,23,1.00,HET,35,0.40,HET,41,0.46	DOK7	synonymous,3'UTR	DOK7:ENST00000389653:synonymous:LOW:exon7/10:c.1113A>C:p.Ser371Ser,DOK7:ENST00000340083:synonymous:LOW:exon7/7:c.1113A>C:p.Ser371Ser,DOK7:ENST00000507039:3'UTR:MODIFIER:exon7/7:c.*334A>C:		rs6811856	0.2169	0.3001	1576,709,9	0.0858,0.2532,0.5379,0.3092,0.2421	0.2243							610285 [DOK7 (confirmed) Myasthenic syndrome,congenital,10,254300|Fetal akinesia deformation sequence,208150];	RCV000116884.3 [benign]; 		COSM3760590, COSM3760589	99	632	2	[2] auto-classification 14.09.2017  			DOK7 (inh=AR pLI=0.00)
chr4	3494847	3494847	G	A	hom	anno_omim	QUAL=1186;DP=28;AF=0.89;MQM=59;TRIO=HOM,28,0.89,HET,28,0.54,HET,36,0.44	DOK7	synonymous,3'UTR	DOK7:ENST00000389653:synonymous:LOW:exon7/10:c.1134G>A:p.Ala378Ala,DOK7:ENST00000340083:synonymous:LOW:exon7/7:c.1134G>A:p.Ala378Ala,DOK7:ENST00000507039:3'UTR:MODIFIER:exon7/7:c.*355G>A:		rs6831659	0.2149	0.2981	1923,822,10	0.0919,0.2483,0.5423,0.2944,0.2471	0.2218							610285 [DOK7 (confirmed) Myasthenic syndrome,congenital,10,254300|Fetal akinesia deformation sequence,208150];	RCV000116885.3 [benign]; 		COSM3749873, COSM3749874	95	611	2	[2] auto-classification 14.09.2017  			DOK7 (inh=AR pLI=0.00)
chr4	3494898	3494898	C	T	hom	anno_omim;trio_recessive	QUAL=2130;DP=53;AF=0.98;MQM=59;TRIO=HOM,53,0.98,HET,25,0.56,HET,36,0.44	DOK7	synonymous,3'UTR	DOK7:ENST00000389653:synonymous:LOW:exon7/10:c.1185C>T:p.Tyr395Tyr,DOK7:ENST00000340083:synonymous:LOW:exon7/7:c.1185C>T:p.Tyr395Tyr,DOK7:ENST00000507039:3'UTR:MODIFIER:exon7/7:c.*406C>T:		rs6850908	0.2196	0.2722	2979,1280,14	0.0877,0.1898,0.5326,0.2610,0.2455	0.2314							610285 [DOK7 (confirmed) Myasthenic syndrome,congenital,10,254300|Fetal akinesia deformation sequence,208150];	RCV000116887.3 [benign]; 		COSM3760591, COSM447810	97	639	3	[3] auto-classification 14.09.2017  			DOK7 (inh=AR pLI=0.00)
chr4	3495446	3495446	C	T	hom	anno_omim	QUAL=10481;DP=114;AF=0.97;MQM=59;TRIO=HOM,114,0.97,HET,153,0.42,HOM,186,0.99	DOK7	3'UTR,intron	DOK7:ENST00000340083:3'UTR:MODIFIER:exon7/7:c.*218C>T:,DOK7:ENST00000507039:3'UTR:MODIFIER:exon7/7:c.*954C>T:,DOK7:ENST00000389653:intron:MODIFIER:exon7/9:c.1497+236C>T:		rs10022432	0.6342	0.0000	0,0,0	0,0,0,0,0	0.5588							610285 [DOK7 (confirmed) Myasthenic syndrome,congenital,10,254300|Fetal akinesia deformation sequence,208150];				86	109					DOK7 (inh=AR pLI=0.00)
chr4	3495477	3495477	T	C	hom	anno_omim	QUAL=16894;DP=139;AF=0.99;MQM=59;TRIO=HOM,139,0.99,HOM,178,1.00,HOM,228,1.00	DOK7	3'UTR,intron	DOK7:ENST00000340083:3'UTR:MODIFIER:exon7/7:c.*249T>C:,DOK7:ENST00000507039:3'UTR:MODIFIER:exon7/7:c.*985T>C:,DOK7:ENST00000389653:intron:MODIFIER:exon7/9:c.1497+267T>C:		rs2858030	0.7406	0.0000	0,0,0	0,0,0,0,0	0.6967							610285 [DOK7 (confirmed) Myasthenic syndrome,congenital,10,254300|Fetal akinesia deformation sequence,208150];				128	88					DOK7 (inh=AR pLI=0.00)
chr4	3495941	3495941	T	C	hom	anno_omim	QUAL=5213;DP=91;AF=0.99;MQM=59;TRIO=HOM,91,0.99,HET,93,0.43,HET,116,0.51	DOK7	3'UTR,intron	DOK7:ENST00000340083:3'UTR:MODIFIER:exon7/7:c.*713T>C:,DOK7:ENST00000507039:3'UTR:MODIFIER:exon7/7:c.*1449T>C:,DOK7:ENST00000389653:intron:MODIFIER:exon7/9:c.1497+731T>C:		rs1054661	0.4367	0.0000	0,0,0	0,0,0,0,0	0.3808							610285 [DOK7 (confirmed) Myasthenic syndrome,congenital,10,254300|Fetal akinesia deformation sequence,208150];				43	106					DOK7 (inh=AR pLI=0.00)
chr4	3496150	3496150	A	G	hom	anno_omim	QUAL=23183;DP=236;AF=1.00;MQM=59;TRIO=HOM,236,1.00,HET,291,0.44,HOM,378,1.00	DOK7	3'UTR,intron	DOK7:ENST00000340083:3'UTR:MODIFIER:exon7/7:c.*922A>G:,DOK7:ENST00000507039:3'UTR:MODIFIER:exon7/7:c.*1658A>G:,DOK7:ENST00000389653:intron:MODIFIER:exon7/9:c.1497+940A>G:		rs1054662	0.6554	0.0000	0,0,0	0,0,0,0,0	0.5755							610285 [DOK7 (confirmed) Myasthenic syndrome,congenital,10,254300|Fetal akinesia deformation sequence,208150];				86	109					DOK7 (inh=AR pLI=0.00)
chr4	3496205	3496205	C	T	hom	anno_omim	QUAL=23217;DP=160;AF=0.99;MQM=60;TRIO=HOM,160,0.99,HOM,263,1.00,HOM,329,1.00	DOK7	3'UTR,intron	DOK7:ENST00000340083:3'UTR:MODIFIER:exon7/7:c.*977C>T:,DOK7:ENST00000507039:3'UTR:MODIFIER:exon7/7:c.*1713C>T:,DOK7:ENST00000389653:intron:MODIFIER:exon7/9:c.1497+995C>T:		rs2105849	0.7390	0.0000	0,0,0	0,0,0,0,0	0.6941							610285 [DOK7 (confirmed) Myasthenic syndrome,congenital,10,254300|Fetal akinesia deformation sequence,208150];				126	89					DOK7 (inh=AR pLI=0.00)
chr4	5564191	5564191	A	T	hom	anno_omim	QUAL=15522;DP=268;AF=1.00;MQM=60;TRIO=HOM,268,1.00,HOM,105,1.00,HOM,126,1.00	EVC2	3'UTR,intron	EVC2:ENST00000344408:3'UTR:MODIFIER:exon22/22:c.*384T>A:,EVC2:ENST00000310917:3'UTR:MODIFIER:exon22/22:c.*384T>A:,EVC2:ENST00000344938:intron:MODIFIER:exon21/21:c.3659+2794T>A:		rs2287576	0.5409	0.0000	0,0,0	0,0,0,0,0	0.6271							607261 [EVC2 (confirmed) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];	RCV000354242.1 [benign]; 			120	77					EVC2 (inh=AR+AD pLI=0.00)
chr4	5570221	5570221	G	A	het	anno_omim	QUAL=4952;DP=86;AF=0.50;MQM=60;TRIO=HET,86,0.50,HET,62,0.48,HOM,106,1.00	EVC2	synonymous	EVC2:ENST00000344408:synonymous:LOW:exon20/22:c.3507C>T:p.His1169His,EVC2:ENST00000344938:synonymous:LOW:exon20/22:c.3507C>T:p.His1169His,EVC2:ENST00000310917:synonymous:LOW:exon20/22:c.3267C>T:p.His1089His		rs12511039	0.4409	0.4847	7484,2238,122	0.2367,0.5547,0.8718,0.4184,0.5566	0.3906							607261 [EVC2 (confirmed) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];	RCV000176126.2 [benign]; RCV000328377.1 [benign]; 		COSM3760662, COSM330193	298	905	2	[2] auto-classification 14.09.2017  			EVC2 (inh=AR+AD pLI=0.00)
chr4	5710647	5710647	A	G	het	anno_omim	QUAL=4383;DP=113;AF=0.50;MQM=60;TRIO=HET,113,0.50,WT,193,0.02,HET,244,0.49	EVC2	5'UTR	EVC2:ENST00000310917:5'UTR:MODIFIER:exon1/22:c.-104T>C:		rs2013183	0.3800	0.0000	0,0,0	0,0,0,0,0	0.3401							607261 [EVC2 (confirmed) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];				52	107					EVC2 (inh=AR+AD pLI=0.00)
chr4	5710856	5710856	G	A	het	anno_omim	QUAL=740;DP=52;AF=0.50;MQM=60;TRIO=HET,52,0.50,HET,17,0.59,WT,40,0.00	EVC2	5'UTR	EVC2:ENST00000310917:5'UTR:MODIFIER:exon1/22:c.-313C>T:		rs3755842	0.2133	0.0000	0,0,0	0,0,0,0,0	0.2553							607261 [EVC2 (confirmed) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];				17	82					EVC2 (inh=AR+AD pLI=0.00)
chr4	5710988	5710990	AGG	-	het	anno_omim	QUAL=562;DP=70;AF=0.41;MQM=59;TRIO=HET,70,0.41,HET,21,0.38,WT,31,0.00	EVC2	5'UTR	EVC2:ENST00000310917:5'UTR:MODIFIER:exon1/22:c.-447_-445delCCT:	(AGG)n	rs67550450;rs772310935	0.2274	0.0000	0,0,0	0,0,0,0,0	0.2830							607261 [EVC2 (confirmed) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];				19	85					EVC2 (inh=AR+AD pLI=0.00)
chr4	5711095	5711095	G	A	het	anno_omim	QUAL=3299;DP=109;AF=0.50;MQM=59;TRIO=HET,109,0.50,HET,97,0.46,HET,107,0.49	EVC2	5'UTR	EVC2:ENST00000310917:5'UTR:MODIFIER:exon1/22:c.-552C>T:		rs10000314	0.4625	0.0000	0,0,0	0,0,0,0,0	0.5007							607261 [EVC2 (confirmed) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];				59	93					EVC2 (inh=AR+AD pLI=0.00)
chr4	5721049	5721049	A	G	het	anno_omim	QUAL=9743;DP=307;AF=0.45;MQM=60;TRIO=HET,307,0.45,WT,404,0.00,HET,469,0.50	EVC	synonymous	EVC:ENST00000264956:synonymous:LOW:exon2/21:c.249A>G:p.Ser83Ser,EVC:ENST00000382674:synonymous:LOW:exon2/24:c.249A>G:p.Ser83Ser,EVC:ENST00000509451:synonymous:LOW:exon2/12:c.249A>G:p.Ser83Ser		rs35870680	0.0695	0.1153	1009,753,5	0.0266,0.0554,0.0002,0.1486,0.1308	0.1158							604831 [EVC (provisional) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];	RCV000242088.1 [benign]; RCV000300455.1 [benign]; RCV000355391.1 [benign]; 		COSM3760673	58	557	2	[2] auto-classification 14.09.2017  			EVC (inh=AR+AD pLI=0.00)
chr4	5743509	5743509	C	T	hom	anno_omim	QUAL=14833;DP=275;AF=1.00;MQM=60;TRIO=HOM,275,1.00,HOM,83,1.00,HOM,130,1.00	EVC	synonymous	EVC:ENST00000264956:synonymous:LOW:exon6/21:c.769C>T:p.Leu257Leu,EVC:ENST00000382674:synonymous:LOW:exon6/24:c.769C>T:p.Leu257Leu,EVC:ENST00000509451:synonymous:LOW:exon6/12:c.769C>T:p.Leu257Leu		rs6446393	0.9667	0.9456	54081,29003,5020	0.9913,0.9829,0.9994,0.9343,0.9063	0.9533							604831 [EVC (provisional) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];	RCV000179557.2 [benign]; RCV000284741.1 [benign]; RCV000337462.1 [benign]; 			1817	281	2	[2] auto-classification 14.09.2017  			EVC (inh=AR+AD pLI=0.00)
chr4	5743512	5743512	T	C	hom	pred_pathogenic;anno_omim	QUAL=14833;DP=275;AF=1.00;MQM=60;TRIO=HOM,275,1.00,HET,83,1.00,HET,130,1.00	EVC	missense	EVC:ENST00000264956:missense:MODERATE:exon6/21:c.772T>C:p.Tyr258His,EVC:ENST00000382674:missense:MODERATE:exon6/24:c.772T>C:p.Tyr258His,EVC:ENST00000509451:missense:MODERATE:exon6/12:c.772T>C:p.Tyr258His		rs6414624	0.7448	0.7951	38535,21387,1423	0.5351,0.8108,0.9117,0.8027,0.8264	0.7967	1.9260	T,T,T	T	B	T,T,T	8.78	604831 [EVC (provisional) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];	RCV000179558.2 [benign]; RCV000297646.1 [benign]; RCV000400923.1 [benign]; 			1271	708	2	[2] auto-classification 14.09.2017  			EVC (inh=AR+AD pLI=0.00)
chr4	5747072	5747072	C	T	het	anno_omim	QUAL=1445;DP=35;AF=0.60;MQM=60;TRIO=HET,35,0.60,HOM,24,0.96,HET,32,0.34	EVC	splice_region&intron	EVC:ENST00000264956:splice_region&intron:LOW:exon7/20:c.939+4C>T:,EVC:ENST00000382674:splice_region&intron:LOW:exon7/23:c.939+4C>T:,EVC:ENST00000509451:splice_region&intron:LOW:exon7/11:c.939+4C>T:		rs2286343	0.4093	0.3729	9048,3301,402	0.2840,0.5390,0.6587,0.3180,0.4041	0.3816							604831 [EVC (provisional) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];	RCV000248656.1 [benign]; RCV000268637.1 [benign]; RCV000321339.1 [benign]; 			284	922	2	[2] auto-classification 14.09.2017  			EVC (inh=AR+AD pLI=0.00)
chr4	5747078	5747078	A	G	het	anno_omim	QUAL=755;DP=33;AF=0.39;MQM=60;TRIO=HET,33,0.39,WT,22,0.05,HET,30,0.67	EVC	splice_region&intron	EVC:ENST00000264956:splice_region&intron:LOW:exon7/20:c.939+10A>G:,EVC:ENST00000382674:splice_region&intron:LOW:exon7/23:c.939+10A>G:,EVC:ENST00000509451:splice_region&intron:LOW:exon7/11:c.939+10A>G:		rs2286342	0.5931	0.6295	24638,15565,2662	0.7173,0.4609,0.3415,0.6851,0.5964	0.6674							604831 [EVC (provisional) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];	RCV000244100.1 [benign]; RCV000281637.1 [benign]; RCV000373771.1 [benign]; 			909	922	2	[2] auto-classification 14.09.2017  			EVC (inh=AR+AD pLI=0.00)
chr4	5750003	5750003	A	G	het	anno_omim	QUAL=6951;DP=251;AF=0.54;MQM=60;TRIO=HET,251,0.54,WT,175,0.00,HET,217,0.59	EVC,CRMP1	synonymous	EVC:ENST00000264956:synonymous:LOW:exon8/21:c.1068A>G:p.Leu356Leu,EVC:ENST00000382674:synonymous:LOW:exon8/24:c.1068A>G:p.Leu356Leu,EVC:ENST00000509451:synonymous:LOW:exon8/12:c.1068A>G:p.Leu356Leu		rs33929747	0.2175	0.2925	5696,4231,69	0.1031,0.3189,0.1814,0.3556,0.1931	0.2974							604831 [EVC (provisional) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];	RCV000252072.1 [benign]; RCV000310572.1 [benign]; RCV000365218.1 [benign]; 			245	905	2	[2] auto-classification 14.09.2017  			EVC (inh=AR+AD pLI=0.00), CRMP1 (inh=n/a pLI=0.95)
chr4	5755542	5755542	C	A	het	anno_omim	QUAL=18364;DP=164;AF=0.55;MQM=60;TRIO=HET,164,0.55,HET,287,0.54,HOM,383,1.00	EVC,CRMP1	missense	EVC:ENST00000264956:missense:MODERATE:exon10/21:c.1346C>A:p.Thr449Lys,EVC:ENST00000382674:missense:MODERATE:exon10/24:c.1346C>A:p.Thr449Lys,EVC:ENST00000509451:missense:MODERATE:exon10/12:c.1346C>A:p.Thr449Lys		rs2302075	0.8446	0.7965	38777,20992,4783	0.9587,0.6996,0.8089,0.7922,0.7842	0.8332	0.3130	T,T,T	T	B	T,T,T	5.81	604831 [EVC (provisional) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];	RCV000153204.4 [benign]; RCV000360127.1 [benign]; RCV000390155.1 [benign]; 			1264	723	2	[2] auto-classification 14.09.2017  			EVC (inh=AR+AD pLI=0.00), CRMP1 (inh=n/a pLI=0.95)
chr4	5785442	5785442	G	A	hom	pred_pathogenic;anno_omim	QUAL=9497;DP=140;AF=0.99;MQM=60;TRIO=HOM,140,0.99,HET,198,0.48,HET,226,0.54	EVC,CRMP1	missense	EVC:ENST00000264956:missense:MODERATE:exon12/21:c.1727G>A:p.Arg576Gln,EVC:ENST00000382674:missense:MODERATE:exon12/24:c.1727G>A:p.Arg576Gln		rs1383180	0.3015	0.3472	7250,4461,210	0.2071,0.4928,0.3176,0.3769,0.2321	0.3487	4.5440	T,T	T	D	T,T	24.90	604831 [EVC (provisional) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];	RCV000254232.1 [benign]; RCV000315414.1 [benign]; RCV000369969.1 [benign]; 		COSM3760684	272	976	2	[2] auto-classification 14.09.2017  			EVC (inh=AR+AD pLI=0.00), CRMP1 (inh=n/a pLI=0.95)
chr4	5803669	5803669	T	C	het	anno_omim	QUAL=2986;DP=84;AF=0.48;MQM=60;TRIO=HET,84,0.48,HOM,45,1.00,HET,53,0.47	EVC,CRMP1	splice_region&intron	EVC:ENST00000264956:splice_region&intron:LOW:exon15/20:c.2305-8T>C:,EVC:ENST00000382674:splice_region&intron:LOW:exon15/23:c.2305-8T>C:		rs1031919	0.6905	0.7270	31597,17587,2630	0.7217,0.6483,0.5587,0.7338,0.8211	0.7242							604831 [EVC (provisional) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];	RCV000245625.1 [benign]; RCV000288198.1 [benign]; RCV000348046.1 [benign]; 			1146	799	2	[2] auto-classification 14.09.2017  			EVC (inh=AR+AD pLI=0.00), CRMP1 (inh=n/a pLI=0.95)
chr4	5812778	5812778	G	A	het	anno_omim	QUAL=15841;DP=250;AF=0.47;MQM=60;TRIO=HET,250,0.47,HOM,275,1.00,HET,341,0.48	EVC,CRMP1	3'UTR	EVC:ENST00000264956:3'UTR:MODIFIER:exon21/21:c.*14G>A:,EVC:ENST00000382674:3'UTR:MODIFIER:exon21/24:c.*14G>A:		rs2291151	0.5337	0.6099	18375,10766,1831	0.6473,0.4780,0.3883,0.6318,0.6478	0.6128							604831 [EVC (provisional) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];	RCV000250767.1 [benign]; RCV000352324.1 [benign]; RCV000393278.1 [benign]; 		COSN167150	792	958					EVC (inh=AR+AD pLI=0.00), CRMP1 (inh=n/a pLI=0.95)
chr4	5812974	5812974	C	A	het	anno_omim	QUAL=6853;DP=374;AF=0.48;MQM=60;TRIO=HET,374,0.48,HET,204,0.42,WT,339,0.01	EVC,CRMP1	3'UTR	EVC:ENST00000264956:3'UTR:MODIFIER:exon21/21:c.*210C>A:,EVC:ENST00000382674:3'UTR:MODIFIER:exon21/24:c.*210C>A:		rs16837692	0.0885	0.0000	0,0,0	0,0,0,0,0	0.1367							604831 [EVC (provisional) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];	RCV000306076.1 [benign]; RCV000353920.1 [benign]; 			3	48					EVC (inh=AR+AD pLI=0.00), CRMP1 (inh=n/a pLI=0.95)
chr4	5813695	5813695	T	C	het	anno_omim	QUAL=36965;DP=492;AF=0.54;MQM=59;TRIO=HET,492,0.54,HOM,672,1.00,HET,792,0.51	EVC,CRMP1	3'UTR	EVC:ENST00000264956:3'UTR:MODIFIER:exon21/21:c.*931T>C:,EVC:ENST00000382674:3'UTR:MODIFIER:exon21/24:c.*931T>C:		rs6840435	0.4369	0.0000	0,0,0	0,0,0,0,0	0.5736							604831 [EVC (provisional) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];	RCV000280739.1 [benign]; RCV000338164.1 [benign]; 			53	122					EVC (inh=AR+AD pLI=0.00), CRMP1 (inh=n/a pLI=0.95)
chr4	5813824	5813824	A	C	het	anno_omim	QUAL=6300;DP=385;AF=0.23;MQM=53;TRIO=HET,385,0.23,HET,656,0.42,WT,1032,0.00	EVC,CRMP1	3'UTR	EVC:ENST00000264956:3'UTR:MODIFIER:exon21/21:c.*1060A>C:,EVC:ENST00000382674:3'UTR:MODIFIER:exon21/24:c.*1060A>C:		rs71599848	0.1168	0.0000	0,0,0	0,0,0,0,0	0.0262							604831 [EVC (provisional) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];	RCV000312762.1 [benign]; RCV000397345.1 [benign]; 			2	53					EVC (inh=AR+AD pLI=0.00), CRMP1 (inh=n/a pLI=0.95)
chr4	5813876	5813876	T	C	het	anno_omim	QUAL=5959;DP=330;AF=0.14;MQM=53;TRIO=HET,330,0.14,HET,515,0.51,WT,741,0.03	EVC,CRMP1	3'UTR	EVC:ENST00000264956:3'UTR:MODIFIER:exon21/21:c.*1112T>C:,EVC:ENST00000382674:3'UTR:MODIFIER:exon21/24:c.*1112T>C:		rs28460555	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1724							604831 [EVC (provisional) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];				5	71					EVC (inh=AR+AD pLI=0.00), CRMP1 (inh=n/a pLI=0.95)
chr4	5813887	5813887	A	G	het	anno_omim	QUAL=7656;DP=424;AF=0.23;MQM=53;TRIO=HET,424,0.23,HET,575,0.50,WT,814,0.03	EVC,CRMP1	3'UTR	EVC:ENST00000264956:3'UTR:MODIFIER:exon21/21:c.*1123A>G:,EVC:ENST00000382674:3'UTR:MODIFIER:exon21/24:c.*1123A>G:		rs112378896	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0114							604831 [EVC (provisional) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];				1	54					EVC (inh=AR+AD pLI=0.00), CRMP1 (inh=n/a pLI=0.95)
chr4	5814608	5814608	T	-	het	anno_omim	QUAL=20065;DP=401;AF=0.47;MQM=59;TRIO=HET,401,0.47,HOM,344,1.00,HET,462,0.47	EVC,CRMP1	3'UTR	EVC:ENST00000264956:3'UTR:MODIFIER:exon21/21:c.*1845delT:,EVC:ENST00000382674:3'UTR:MODIFIER:exon21/24:c.*1845delT:		rs397690241	0.3748	0.0000	0,0,0	0,0,0,0,0	0.4203							604831 [EVC (provisional) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];	RCV000334732.1 [benign]; RCV000396615.1 [benign]; 			37	118					EVC (inh=AR+AD pLI=0.00), CRMP1 (inh=n/a pLI=0.95)
chr4	5815181	5815181	T	C	het	anno_omim	QUAL=4595;DP=213;AF=0.46;MQM=59;TRIO=HET,213,0.46,HOM,42,0.90,HET,59,0.37	EVC,CRMP1	3'UTR	EVC:ENST00000264956:3'UTR:MODIFIER:exon21/21:c.*2417T>C:,EVC:ENST00000382674:3'UTR:MODIFIER:exon21/24:c.*2417T>C:	AluSx3	rs6848370	0.7230	0.0000	0,0,0	0,0,0,0,0	0.7576							604831 [EVC (provisional) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];	RCV000320168.1 [benign]; RCV000356240.1 [benign]; 			111	106					EVC (inh=AR+AD pLI=0.00), CRMP1 (inh=n/a pLI=0.95)
chr4	5815381	5815381	G	A	het	anno_omim	QUAL=9630;DP=213;AF=0.39;MQM=60;TRIO=HET,213,0.39,HOM,147,1.00,HET,239,0.49	EVC,CRMP1	3'UTR	EVC:ENST00000264956:3'UTR:MODIFIER:exon21/21:c.*2617G>A:,EVC:ENST00000382674:3'UTR:MODIFIER:exon21/24:c.*2617G>A:	L3	rs3733186	0.3876	0.0000	0,0,0	0,0,0,0,0	0.4315							604831 [EVC (provisional) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];	RCV000291760.1 [benign]; RCV000346690.1 [benign]; 			36	122					EVC (inh=AR+AD pLI=0.00), CRMP1 (inh=n/a pLI=0.95)
chr4	5815444	5815444	G	A	het	anno_omim	QUAL=2988;DP=191;AF=0.46;MQM=59;TRIO=HET,191,0.46,HET,118,0.47,WT,200,0.01	EVC,CRMP1	3'UTR	EVC:ENST00000264956:3'UTR:MODIFIER:exon21/21:c.*2680G>A:,EVC:ENST00000382674:3'UTR:MODIFIER:exon21/24:c.*2680G>A:		rs3733187	0.0745	0.0000	0,0,0	0,0,0,0,0	0.1301							604831 [EVC (provisional) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];	RCV000295943.1 [benign]; RCV000402734.1 [benign]; 			3	53					EVC (inh=AR+AD pLI=0.00), CRMP1 (inh=n/a pLI=0.95)
chr4	5815477	5815477	C	T	het	anno_omim	QUAL=9549;DP=200;AF=0.51;MQM=59;TRIO=HET,200,0.51,HOM,136,1.00,HET,193,0.52	EVC,CRMP1	3'UTR	EVC:ENST00000264956:3'UTR:MODIFIER:exon21/21:c.*2713C>T:,EVC:ENST00000382674:3'UTR:MODIFIER:exon21/24:c.*2713C>T:		rs3733188	0.3852	0.0000	0,0,0	0,0,0,0,0	0.4298							604831 [EVC (provisional) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];	RCV000298149.1 [benign]; RCV000401280.1 [benign]; 			36	121					EVC (inh=AR+AD pLI=0.00), CRMP1 (inh=n/a pLI=0.95)
chr4	5815635	5815635	C	T	het	anno_omim	QUAL=6422;DP=282;AF=0.47;MQM=59;TRIO=HET,282,0.47,HET,289,0.46,WT,321,0.00	EVC,CRMP1	3'UTR	EVC:ENST00000264956:3'UTR:MODIFIER:exon21/21:c.*2871C>T:,EVC:ENST00000382674:3'UTR:MODIFIER:exon21/24:c.*2871C>T:		rs3733189	0.0731	0.0000	0,0,0	0,0,0,0,0	0.1294							604831 [EVC (provisional) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];	RCV000267907.1 [benign]; RCV000352963.1 [benign]; 			3	53					EVC (inh=AR+AD pLI=0.00), CRMP1 (inh=n/a pLI=0.95)
chr4	5815929	5815929	T	C	het	anno_omim	QUAL=7936;DP=250;AF=0.48;MQM=60;TRIO=HET,250,0.48,HET,401,0.48,WT,495,0.00	EVC,CRMP1	3'UTR,intron	EVC:ENST00000264956:3'UTR:MODIFIER:exon21/21:c.*3165T>C:,EVC:ENST00000382674:intron:MODIFIER:exon21/23:c.*3125+40T>C:	LTR89	rs3755847	0.0815	0.0000	0,0,0	0,0,0,0,0	0.1349							604831 [EVC (provisional) Ellis-van Creveld syndrome,225500|Weyers acrofacial dysostosis,193530];	RCV000289033.1 [benign]; RCV000383501.1 [benign]; 			3	53					EVC (inh=AR+AD pLI=0.00), CRMP1 (inh=n/a pLI=0.95)
chr4	6292915	6292915	A	G	het	anno_omim	QUAL=3047;DP=68;AF=0.43;MQM=59;TRIO=HET,68,0.43,HET,204,0.50,WT,246,0.00	WFS1	splice_region&intron	WFS1:ENST00000226760:splice_region&intron:LOW:exon4/7:c.461-9A>G:,WFS1:ENST00000503569:splice_region&intron:LOW:exon4/7:c.461-9A>G:		rs10010131	0.7288	0.6555	26281,11622,2223	0.6573,0.7549,0.9348,0.5964,0.7090	0.6607							606201 [WFS1 (confirmed) Wolfram syndrome,222300|Deafness,autosomal dominant 6/14/38,600965|Wolfram-like syndrome,autosomal dominant,614296|Diabetes mellitus,noninsulin-dependent,association with,125853|Cataract 41,116400];	RCV000004785.4 [other]; RCV000038664.7 [other]; RCV000273205.1 [benign]; RCV000325882.1 [benign]; 			1326	1588	2	[2] auto-classification 14.09.2017  			WFS1 (inh=AR+AD pLI=n/a)
chr4	6293696	6293696	C	G	het	anno_omim	QUAL=2363;DP=58;AF=0.50;MQM=59;TRIO=HET,58,0.50,HOM,52,1.00,WT,67,0.04	WFS1	synonymous	WFS1:ENST00000226760:synonymous:LOW:exon6/8:c.684C>G:p.Arg228Arg,WFS1:ENST00000503569:synonymous:LOW:exon6/8:c.684C>G:p.Arg228Arg		rs1801213	0.7564	0.7212	28093,13548,2082	0.6842,0.7895,0.9366,0.6791,0.7732	0.7158	-0.0970		T			12.77	606201 [WFS1 (confirmed) Wolfram syndrome,222300|Deafness,autosomal dominant 6/14/38,600965|Wolfram-like syndrome,autosomal dominant,614296|Diabetes mellitus,noninsulin-dependent,association with,125853|Cataract 41,116400];	RCV000038665.7 [other]; RCV000261705.1 [benign]; RCV000319343.1 [benign]; 		COSM448012	1661	1421	2	[2] auto-classification 14.09.2017  			WFS1 (inh=AR+AD pLI=n/a)
chr4	6302519	6302519	G	A	het	pred_pathogenic;anno_omim	QUAL=21813;DP=394;AF=0.51;MQM=60;TRIO=HET,394,0.51,HOM,524,0.99,WT,661,0.00	WFS1	missense	WFS1:ENST00000226760:missense:MODERATE:exon8/8:c.997G>A:p.Val333Ile,WFS1:ENST00000503569:missense:MODERATE:exon8/8:c.997G>A:p.Val333Ile		rs1801212	0.8844	0.7818	37650,17117,4752	0.9555,0.8124,0.9979,0.7173,0.8433	0.7950	3.7380	T,T	T	B	D,D	5.06	606201 [WFS1 (confirmed) Wolfram syndrome,222300|Deafness,autosomal dominant 6/14/38,600965|Wolfram-like syndrome,autosomal dominant,614296|Diabetes mellitus,noninsulin-dependent,association with,125853|Cataract 41,116400];	RCV000038668.8 [benign]; RCV000259675.1 [benign]; 	CM115388 [CLASS=DFP MUT=ALT PHEN="Wolframin variant" GENE=WFS1]; 		1931	1263	2	[2] auto-classification 14.09.2017  			WFS1 (inh=AR+AD pLI=n/a)
chr4	6302707	6302707	C	T	het	anno_omim	QUAL=9445;DP=280;AF=0.51;MQM=60;TRIO=HET,280,0.51,HET,442,0.53,WT,561,0.00	WFS1	synonymous	WFS1:ENST00000226760:synonymous:LOW:exon8/8:c.1185C>T:p.Val395Val,WFS1:ENST00000503569:synonymous:LOW:exon8/8:c.1185C>T:p.Val395Val		rs1801206	0.6416	0.6245	24439,11648,1139	0.4646,0.7443,0.9358,0.5907,0.6352	0.6336							606201 [WFS1 (confirmed) Wolfram syndrome,222300|Deafness,autosomal dominant 6/14/38,600965|Wolfram-like syndrome,autosomal dominant,614296|Diabetes mellitus,noninsulin-dependent,association with,125853|Cataract 41,116400];	RCV000038635.10 [other]; RCV000344908.1 [benign]; RCV000380942.1 [benign]; 			1249	1610	2	[2] auto-classification 14.09.2017  			WFS1 (inh=AR+AD pLI=n/a)
chr4	6303022	6303022	C	T	het	anno_omim	QUAL=7238;DP=225;AF=0.49;MQM=60;TRIO=HET,225,0.49,HET,321,0.53,WT,344,0.01	WFS1	synonymous	WFS1:ENST00000226760:synonymous:LOW:exon8/8:c.1500C>T:p.Asn500Asn,WFS1:ENST00000503569:synonymous:LOW:exon8/8:c.1500C>T:p.Asn500Asn		rs1801214	0.7294	0.6595	26970,12016,2381	0.6736,0.7600,0.9441,0.6010,0.7013	0.6642							606201 [WFS1 (confirmed) Wolfram syndrome,222300|Deafness,autosomal dominant 6/14/38,600965|Wolfram-like syndrome,autosomal dominant,614296|Diabetes mellitus,noninsulin-dependent,association with,125853|Cataract 41,116400];	RCV000038641.10 [other]; RCV000294241.1 [benign]; RCV000330600.1 [benign]; 			1316	1602	2	[2] auto-classification 14.09.2017  			WFS1 (inh=AR+AD pLI=n/a)
chr4	6303354	6303354	G	A	het	pred_pathogenic;anno_omim	QUAL=4679;DP=265;AF=0.48;MQM=60;TRIO=HET,265,0.48,HET,143,0.50,WT,201,0.00	WFS1	missense	WFS1:ENST00000226760:missense:MODERATE:exon8/8:c.1832G>A:p.Arg611His,WFS1:ENST00000503569:missense:MODERATE:exon8/8:c.1832G>A:p.Arg611His		rs734312	0.4692	0.5367	18996,9719,74	0.1072,0.6665,0.8363,0.5397,0.5648	0.5516	4.7040	T,T	T	B	D,D	11.69	606201 [WFS1 (confirmed) Wolfram syndrome,222300|Deafness,autosomal dominant 6/14/38,600965|Wolfram-like syndrome,autosomal dominant,614296|Diabetes mellitus,noninsulin-dependent,association with,125853|Cataract 41,116400];	RCV000038646.10 [other]; RCV000339307.1 [benign]; RCV000404430.1 [benign]; 		COSM149634	985	1674	2	[2] auto-classification 14.09.2017  			WFS1 (inh=AR+AD pLI=n/a)
chr4	6303955	6303955	G	A	het	anno_omim	QUAL=5440;DP=196;AF=0.49;MQM=59;TRIO=HET,196,0.49,HET,251,0.50,WT,319,0.00	WFS1	synonymous	WFS1:ENST00000226760:synonymous:LOW:exon8/8:c.2433G>A:p.Lys811Lys,WFS1:ENST00000503569:synonymous:LOW:exon8/8:c.2433G>A:p.Lys811Lys		rs1046314	0.6532	0.6294	24206,11393,1309	0.5066,0.7468,0.9364,0.5918,0.6375	0.6359							606201 [WFS1 (confirmed) Wolfram syndrome,222300|Deafness,autosomal dominant 6/14/38,600965|Wolfram-like syndrome,autosomal dominant,614296|Diabetes mellitus,noninsulin-dependent,association with,125853|Cataract 41,116400];	RCV000038659.10 [other]; RCV000292566.1 [benign]; RCV000352148.1 [benign]; 		COSM3760688	1246	1623	2	[2] auto-classification 14.09.2017  			WFS1 (inh=AR+AD pLI=n/a)
chr4	6304087	6304087	A	G	het	anno_omim	QUAL=9970;DP=210;AF=0.50;MQM=60;TRIO=HET,210,0.50,HOM,247,1.00,WT,292,0.01	WFS1	synonymous	WFS1:ENST00000226760:synonymous:LOW:exon8/8:c.2565A>G:p.Ser855Ser,WFS1:ENST00000503569:synonymous:LOW:exon8/8:c.2565A>G:p.Ser855Ser		rs1046316	0.7800	0.7228	31745,15023,2981	0.7613,0.7931,0.9368,0.6767,0.7673	0.7244							606201 [WFS1 (confirmed) Wolfram syndrome,222300|Deafness,autosomal dominant 6/14/38,600965|Wolfram-like syndrome,autosomal dominant,614296|Diabetes mellitus,noninsulin-dependent,association with,125853|Cataract 41,116400];	RCV000038660.10 [other]; RCV000272258.1 [benign]; RCV000329623.1 [benign]; 		COSM448013	1686	1423	2	[2] auto-classification 14.09.2017  			WFS1 (inh=AR+AD pLI=n/a)
chr4	6304242	6304242	T	C	het	anno_omim	QUAL=13842;DP=179;AF=0.59;MQM=59;TRIO=HET,179,0.59,HOM,359,1.00,WT,477,0.01	WFS1	3'UTR	WFS1:ENST00000226760:3'UTR:MODIFIER:exon8/8:c.*47T>C:,WFS1:ENST00000503569:3'UTR:MODIFIER:exon8/8:c.*47T>C:		rs1046317	0.7837	0.7248	30808,14412,2933	0.7807,0.7954,0.9459,0.6765,0.7594	0.7269							606201 [WFS1 (confirmed) Wolfram syndrome,222300|Deafness,autosomal dominant 6/14/38,600965|Wolfram-like syndrome,autosomal dominant,614296|Diabetes mellitus,noninsulin-dependent,association with,125853|Cataract 41,116400];	RCV000288103.1 [benign]; RCV000393152.1 [benign]; 			1335	1048					WFS1 (inh=AR+AD pLI=n/a)
chr4	6304286	6304286	C	T	het	anno_omim	QUAL=13815;DP=224;AF=0.60;MQM=60;TRIO=HET,224,0.60,HOM,388,1.00,WT,525,0.01	WFS1	3'UTR	WFS1:ENST00000226760:3'UTR:MODIFIER:exon8/8:c.*91C>T:,WFS1:ENST00000503569:3'UTR:MODIFIER:exon8/8:c.*91C>T:		rs1046319	0.8480	0.0000	0,0,0	0,0,0,0,0	0.7617							606201 [WFS1 (confirmed) Wolfram syndrome,222300|Deafness,autosomal dominant 6/14/38,600965|Wolfram-like syndrome,autosomal dominant,614296|Diabetes mellitus,noninsulin-dependent,association with,125853|Cataract 41,116400];	RCV000314379.1 [benign]; RCV000397008.1 [benign]; 			122	81					WFS1 (inh=AR+AD pLI=n/a)
chr4	6304344	6304344	G	A	het	anno_omim	QUAL=10458;DP=251;AF=0.54;MQM=60;TRIO=HET,251,0.54,HET,521,0.51,WT,678,0.00	WFS1	3'UTR	WFS1:ENST00000226760:3'UTR:MODIFIER:exon8/8:c.*149G>A:,WFS1:ENST00000503569:3'UTR:MODIFIER:exon8/8:c.*149G>A:		rs1046320	0.6066	0.0000	0,0,0	0,0,0,0,0	0.5473							606201 [WFS1 (confirmed) Wolfram syndrome,222300|Deafness,autosomal dominant 6/14/38,600965|Wolfram-like syndrome,autosomal dominant,614296|Diabetes mellitus,noninsulin-dependent,association with,125853|Cataract 41,116400];	RCV000317741.1 [benign]; RCV000356153.1 [benign]; 			77	98					WFS1 (inh=AR+AD pLI=n/a)
chr4	6304762	6304762	C	G	het	anno_omim	QUAL=4725;DP=191;AF=0.49;MQM=60;TRIO=HET,191,0.49,WT,141,0.00,HET,159,0.57	WFS1	3'UTR	WFS1:ENST00000226760:3'UTR:MODIFIER:exon8/8:c.*567C>G:		rs12508118	0.0114	0.0000	0,0,0	0,0,0,0,0	0.0276							606201 [WFS1 (confirmed) Wolfram syndrome,222300|Deafness,autosomal dominant 6/14/38,600965|Wolfram-like syndrome,autosomal dominant,614296|Diabetes mellitus,noninsulin-dependent,association with,125853|Cataract 41,116400];	RCV000336866.1 [likely benign]; RCV000403353.1 [likely benign]; 			2	17					WFS1 (inh=AR+AD pLI=n/a)
chr4	6304799	6304799	G	C	het	anno_omim	QUAL=4113;DP=192;AF=0.47;MQM=59;TRIO=HET,192,0.47,HET,126,0.53,WT,148,0.01	WFS1	3'UTR	WFS1:ENST00000226760:3'UTR:MODIFIER:exon8/8:c.*604G>C:		rs9457	0.6262	0.0000	0,0,0	0,0,0,0,0	0.5517							606201 [WFS1 (confirmed) Wolfram syndrome,222300|Deafness,autosomal dominant 6/14/38,600965|Wolfram-like syndrome,autosomal dominant,614296|Diabetes mellitus,noninsulin-dependent,association with,125853|Cataract 41,116400];	RCV000302430.1 [benign]; RCV000341007.1 [benign]; 			78	94					WFS1 (inh=AR+AD pLI=n/a)
chr4	6304878	6304878	C	T	het	anno_omim	QUAL=3660;DP=187;AF=0.55;MQM=60;TRIO=HET,187,0.55,HET,134,0.47,WT,179,0.01	WFS1	3'UTR	WFS1:ENST00000226760:3'UTR:MODIFIER:exon8/8:c.*683C>T:		rs3200	0.6476	0.0000	0,0,0	0,0,0,0,0	0.5838							606201 [WFS1 (confirmed) Wolfram syndrome,222300|Deafness,autosomal dominant 6/14/38,600965|Wolfram-like syndrome,autosomal dominant,614296|Diabetes mellitus,noninsulin-dependent,association with,125853|Cataract 41,116400];	RCV000278025.1 [benign]; RCV000388760.1 [benign]; 			79	97					WFS1 (inh=AR+AD pLI=n/a)
chr4	15568992	15568992	T	C	hom	anno_omim	QUAL=19703;DP=236;AF=1.00;MQM=59;TRIO=HOM,236,1.00,HOM,232,1.00,HET,327,0.53	CC2D2A	splice_region&intron	CC2D2A:ENST00000413206:splice_region&intron:LOW:exon24/36:c.3183-8T>C:,CC2D2A:ENST00000424120:splice_region&intron:LOW:exon24/36:c.3183-8T>C:,CC2D2A:ENST00000503292:splice_region&intron:LOW:exon25/37:c.3183-8T>C:,CC2D2A:ENST00000389652:splice_region&intron:LOW:exon22/33:c.3036-8T>C:		rs13121363	0.6625	0.7122	30227,17461,1967	0.6415,0.7978,0.5382,0.7299,0.7195	0.7089							612013 [CC2D2A (confirmed) Joubert syndrome 9,612285|Meckel syndrome 6,612284|COACH syndrome,216360];	RCV000114172.3 [other]; RCV000277403.1 [benign]; RCV000367210.1 [benign]; 			1690	1276	2	[2] auto-classification 14.09.2017  			CC2D2A (inh=AR pLI=0.00)
chr4	15603069	15603069	G	C	hom	anno_omim	QUAL=21251;DP=298;AF=1.00;MQM=60;TRIO=HOM,298,1.00,HOM,229,1.00,HET,296,0.46	CC2D2A	3'UTR	CC2D2A:ENST00000413206:3'UTR:MODIFIER:exon37/37:c.*21G>C:,CC2D2A:ENST00000424120:3'UTR:MODIFIER:exon37/37:c.*21G>C:,CC2D2A:ENST00000503292:3'UTR:MODIFIER:exon38/38:c.*21G>C:,CC2D2A:ENST00000389652:3'UTR:MODIFIER:exon34/34:c.*21G>C:		rs1134634	0.5669	0.6053	7077,4110,793	0.5645,0.5267,0.5171,0.6230,0.6880	0.5779							612013 [CC2D2A (confirmed) Joubert syndrome 9,612285|Meckel syndrome 6,612284|COACH syndrome,216360];	RCV000243242.1 [benign]; RCV000291712.1 [likely benign]; RCV000381390.1 [likely benign]; 			1163	1328					CC2D2A (inh=AR pLI=0.00)
chr4	17488064	17488064	T	C	hom	anno_omim	QUAL=31275;DP=285;AF=1.00;MQM=60;TRIO=HOM,285,1.00,HOM,305,1.00,HOM,362,0.99	QDPR	3'UTR,intron	QDPR:ENST00000281243:3'UTR:MODIFIER:exon7/7:c.*690A>G:,QDPR:ENST00000513615:intron:MODIFIER:exon6/6:c.*119+738A>G:		rs1031326	0.6260	0.0000	0,0,0	0,0,0,0,0	0.6290							612676 [QDPR (confirmed) Hyperphenylalaninemia,BH4-deficient,C,261630];	RCV000396492.1 [benign]; 			91	99					QDPR (inh=AR pLI=0.07)
chr4	17488072	17488072	T	C	hom	anno_omim	QUAL=33779;DP=341;AF=1.00;MQM=59;TRIO=HOM,341,1.00,HOM,313,0.99,HOM,374,1.00	QDPR	3'UTR,intron	QDPR:ENST00000281243:3'UTR:MODIFIER:exon7/7:c.*682A>G:,QDPR:ENST00000513615:intron:MODIFIER:exon6/6:c.*119+730A>G:		rs699459	0.6595	0.0000	0,0,0	0,0,0,0,0	0.6699							612676 [QDPR (confirmed) Hyperphenylalaninemia,BH4-deficient,C,261630];	RCV000306402.1 [benign]; 			106	91					QDPR (inh=AR pLI=0.07)
chr4	17488132	17488132	A	G	hom	anno_omim	QUAL=19115;DP=355;AF=0.99;MQM=60;TRIO=HOM,355,0.99,HET,272,0.46,HET,355,0.45	QDPR	3'UTR,intron	QDPR:ENST00000281243:3'UTR:MODIFIER:exon7/7:c.*622T>C:,QDPR:ENST00000513615:intron:MODIFIER:exon6/6:c.*119+670T>C:		rs10604	0.2324	0.0000	0,0,0	0,0,0,0,0	0.2791							612676 [QDPR (confirmed) Hyperphenylalaninemia,BH4-deficient,C,261630];	RCV000360834.1 [benign]; 			31	94					QDPR (inh=AR pLI=0.07)
chr4	17488244	17488244	G	A	hom	anno_omim	QUAL=20107;DP=300;AF=1.00;MQM=60;TRIO=HOM,300,1.00,HOM,147,0.99,HOM,174,0.99	QDPR	3'UTR,intron	QDPR:ENST00000281243:3'UTR:MODIFIER:exon7/7:c.*510C>T:,QDPR:ENST00000428702:3'UTR:MODIFIER:exon6/6:c.*510C>T:,QDPR:ENST00000513615:intron:MODIFIER:exon6/6:c.*119+558C>T:		rs1031327	0.6585	0.0000	0,0,0	0,0,0,0,0	0.6722							612676 [QDPR (confirmed) Hyperphenylalaninemia,BH4-deficient,C,261630];	RCV000302420.1 [benign]; 			106	93					QDPR (inh=AR pLI=0.07)
chr4	17488286	17488286	T	G	hom	anno_omim	QUAL=17438;DP=242;AF=1.00;MQM=60;TRIO=HOM,242,1.00,HOM,135,0.99,HOM,154,1.00	QDPR	3'UTR,intron	QDPR:ENST00000281243:3'UTR:MODIFIER:exon7/7:c.*468A>C:,QDPR:ENST00000428702:3'UTR:MODIFIER:exon6/6:c.*468A>C:,QDPR:ENST00000513615:intron:MODIFIER:exon6/6:c.*119+516A>C:		rs699460	0.6591	0.0000	0,0,0	0,0,0,0,0	0.6721							612676 [QDPR (confirmed) Hyperphenylalaninemia,BH4-deficient,C,261630];	RCV000357320.1 [benign]; 			106	93					QDPR (inh=AR pLI=0.07)
chr4	17488508	17488508	C	-	hom	anno_omim	QUAL=23517;DP=455;AF=0.98;MQM=59;TRIO=HOM,455,0.98,HET,356,0.51,HET,461,0.46	QDPR	3'UTR,intron	QDPR:ENST00000281243:3'UTR:MODIFIER:exon7/7:c.*246delG:,QDPR:ENST00000428702:3'UTR:MODIFIER:exon6/6:c.*246delG:,QDPR:ENST00000513615:intron:MODIFIER:exon6/6:c.*119+294delG:		rs71810044	0.1877	0.0000	0,0,0	0,0,0,0,0	0.2362							612676 [QDPR (confirmed) Hyperphenylalaninemia,BH4-deficient,C,261630];	RCV000387060.1 [benign]; 			24	92					QDPR (inh=AR pLI=0.07)
chr4	17488533	17488533	C	T	hom	anno_omim	QUAL=38687;DP=436;AF=1.00;MQM=59;TRIO=HOM,436,1.00,HOM,328,1.00,HOM,428,1.00	QDPR	3'UTR,intron	QDPR:ENST00000281243:3'UTR:MODIFIER:exon7/7:c.*221G>A:,QDPR:ENST00000428702:3'UTR:MODIFIER:exon6/6:c.*221G>A:,QDPR:ENST00000513615:intron:MODIFIER:exon6/6:c.*119+269G>A:		rs1049582	0.6589	0.0000	0,0,0	0,0,0,0,0	0.6688							612676 [QDPR (confirmed) Hyperphenylalaninemia,BH4-deficient,C,261630];	RCV000293200.1 [benign]; 			106	92					QDPR (inh=AR pLI=0.07)
chr4	17488534	17488534	A	G	hom	anno_omim	QUAL=38687;DP=436;AF=1.00;MQM=59;TRIO=HOM,436,1.00,HOM,328,1.00,HOM,428,1.00	QDPR	3'UTR,intron	QDPR:ENST00000281243:3'UTR:MODIFIER:exon7/7:c.*220T>C:,QDPR:ENST00000428702:3'UTR:MODIFIER:exon6/6:c.*220T>C:,QDPR:ENST00000513615:intron:MODIFIER:exon6/6:c.*119+268T>C:		rs1049581	0.6593	0.0000	0,0,0	0,0,0,0,0	0.6687							612676 [QDPR (confirmed) Hyperphenylalaninemia,BH4-deficient,C,261630];	RCV000383998.1 [benign]; 			106	92					QDPR (inh=AR pLI=0.07)
chr4	17503382	17503382	C	T	hom	anno_omim	QUAL=13171;DP=317;AF=0.99;MQM=60;TRIO=HOM,317,0.99,HET,117,0.55,HET,201,0.43	QDPR	synonymous	QDPR:ENST00000281243:synonymous:LOW:exon4/7:c.396G>A:p.Leu132Leu,QDPR:ENST00000513615:synonymous:LOW:exon4/7:c.396G>A:p.Leu132Leu,QDPR:ENST00000428702:synonymous:LOW:exon3/6:c.303G>A:p.Leu101Leu,QDPR:ENST00000508623:synonymous:LOW:exon4/5:c.396G>A:p.Leu132Leu		rs2597775	0.2324	0.2879	5710,3657,299	0.2407,0.1406,0.0101,0.3308,0.3849	0.2828							612676 [QDPR (confirmed) Hyperphenylalaninemia,BH4-deficient,C,261630];	RCV000241633.1 [benign]; RCV000397696.1 [benign]; 			268	938	2	[2] auto-classification 14.09.2017  			QDPR (inh=AR pLI=0.07)
chr4	52888026	52888026	A	C	hom	anno_omim	QUAL=10103;DP=172;AF=1.00;MQM=60;TRIO=HOM,172,1.00,HOM,61,1.00,HOM,87,0.99	SGCB	3'UTR	SGCB:ENST00000381431:3'UTR:MODIFIER:exon6/6:c.*2097T>G:		rs170424	0.4786	0.0000	0,0,0	0,0,0,0,0	0.5737							600900 [SGCB (confirmed) Muscular dystrophy,limb-girdle,type 2E,604286];	RCV000277701.1 [benign]; RCV000369836.1 [benign]; 			129	88					SGCB (inh=AR pLI=0.00)
chr4	56236328	56236328	C	T	het	anno_omim	QUAL=8042;DP=406;AF=0.49;MQM=59;TRIO=HET,406,0.49,HET,268,0.44,WT,326,0.01	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:ENST00000264228:3'UTR:MODIFIER:exon5/5:c.*70C>T:,SRD5A3-AS1:ENST00000433175:intron:MODIFIER:exon2/4:n.269-2998G>A:,SRD5A3-AS1:ENST00000510637:intron:MODIFIER:exon3/3:n.364-2998G>A:,SRD5A3-AS1:ENST00000596312:intron:MODIFIER:exon4/4:n.581-2998G>A:,SRD5A3-AS1:ENST00000598906:intron:MODIFIER:exon4/4:n.568-2998G>A:,SRD5A3-AS1:ENST00000596289:intron:MODIFIER:exon6/6:n.676-2998G>A:,SRD5A3-AS1:ENST00000595103:intron:MODIFIER:exon4/4:n.465-2998G>A:,SRD5A3-AS1:ENST00000595734:intron:MODIFIER:exon5/5:n.676-2998G>A:,SRD5A3-AS1:ENST00000608086:intron:MODIFIER:exon2/2:n.605-2998G>A:,SRD5A3-AS1:ENST00000609500:intron:MODIFIER:exon3/3:n.441-2998G>A:,SRD5A3-AS1:ENST00000608558:intron:MODIFIER:exon5/5:n.567-2998G>A:,SRD5A3-AS1:ENST00000608265:intron:MODIFIER:exon5/5:n.598-2998G>A:,SRD5A3-AS1:ENST00000609051:intron:MODIFIER:exon6/6:n.674-2998G>A:,SRD5A3-AS1:ENST00000609487:intron:MODIFIER:exon5/5:n.573-2998G>A:,SRD5A3-AS1:ENST00000609580:intron:MODIFIER:exon4/4:n.590-2998G>A:,SRD5A3-AS1:ENST00000609700:intron:MODIFIER:exon4/4:n.463-2998G>A:,SRD5A3-AS1:ENST00000609573:intron:MODIFIER:exon7/7:n.695-2998G>A:		rs2538	0.2676	0.0000	0,0,0	0,0,0,0,0	0.2912							611715 [SRD5A3 (confirmed) Congenital disorder of glycosylation,type Iq,612379|Kahrizi syndrome,612713];	RCV000308866.1 [likely benign]; 			129	251					SRD5A3 (inh=AR pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	56236568	56236575	AACCGAAA	-	het	anno_omim	QUAL=7858;DP=219;AF=0.53;MQM=59;TRIO=HET,219,0.99,HET,88,0.66,WT,82,0.60	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:ENST00000264228:3'UTR:MODIFIER:exon5/5:c.*319_*326delACCGAAAA:,SRD5A3-AS1:ENST00000433175:intron:MODIFIER:exon2/4:n.269-3245_269-3238delTTTCGGTT:,SRD5A3-AS1:ENST00000510637:intron:MODIFIER:exon3/3:n.364-3245_364-3238delTTTCGGTT:,SRD5A3-AS1:ENST00000596312:intron:MODIFIER:exon4/4:n.581-3245_581-3238delTTTCGGTT:,SRD5A3-AS1:ENST00000598906:intron:MODIFIER:exon4/4:n.568-3245_568-3238delTTTCGGTT:,SRD5A3-AS1:ENST00000596289:intron:MODIFIER:exon6/6:n.676-3245_676-3238delTTTCGGTT:,SRD5A3-AS1:ENST00000595103:intron:MODIFIER:exon4/4:n.465-3245_465-3238delTTTCGGTT:,SRD5A3-AS1:ENST00000595734:intron:MODIFIER:exon5/5:n.676-3245_676-3238delTTTCGGTT:,SRD5A3-AS1:ENST00000608086:intron:MODIFIER:exon2/2:n.605-3245_605-3238delTTTCGGTT:,SRD5A3-AS1:ENST00000609500:intron:MODIFIER:exon3/3:n.441-3245_441-3238delTTTCGGTT:,SRD5A3-AS1:ENST00000608558:intron:MODIFIER:exon5/5:n.567-3245_567-3238delTTTCGGTT:,SRD5A3-AS1:ENST00000608265:intron:MODIFIER:exon5/5:n.598-3245_598-3238delTTTCGGTT:,SRD5A3-AS1:ENST00000609051:intron:MODIFIER:exon6/6:n.674-3245_674-3238delTTTCGGTT:,SRD5A3-AS1:ENST00000609487:intron:MODIFIER:exon5/5:n.573-3245_573-3238delTTTCGGTT:,SRD5A3-AS1:ENST00000609580:intron:MODIFIER:exon4/4:n.590-3245_590-3238delTTTCGGTT:,SRD5A3-AS1:ENST00000609700:intron:MODIFIER:exon4/4:n.463-3245_463-3238delTTTCGGTT:,SRD5A3-AS1:ENST00000609573:intron:MODIFIER:exon7/7:n.695-3245_695-3238delTTTCGGTT:		rs767292453	0.2678	0.0000	0,0,0	0,0,0,0,0	0.2901							611715 [SRD5A3 (confirmed) Congenital disorder of glycosylation,type Iq,612379|Kahrizi syndrome,612713];	RCV000369292.1 [likely benign]; 			29	82					SRD5A3 (inh=AR pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	56236579	56236579	C	T	het	anno_omim	QUAL=7858;DP=219;AF=0.53;MQM=59;TRIO=HET,219,0.99,WT,88,0.66,HET,82,0.60	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:ENST00000264228:3'UTR:MODIFIER:exon5/5:c.*321C>T:,SRD5A3-AS1:ENST00000433175:intron:MODIFIER:exon2/4:n.269-3249G>A:,SRD5A3-AS1:ENST00000510637:intron:MODIFIER:exon3/3:n.364-3249G>A:,SRD5A3-AS1:ENST00000596312:intron:MODIFIER:exon4/4:n.581-3249G>A:,SRD5A3-AS1:ENST00000598906:intron:MODIFIER:exon4/4:n.568-3249G>A:,SRD5A3-AS1:ENST00000596289:intron:MODIFIER:exon6/6:n.676-3249G>A:,SRD5A3-AS1:ENST00000595103:intron:MODIFIER:exon4/4:n.465-3249G>A:,SRD5A3-AS1:ENST00000595734:intron:MODIFIER:exon5/5:n.676-3249G>A:,SRD5A3-AS1:ENST00000608086:intron:MODIFIER:exon2/2:n.605-3249G>A:,SRD5A3-AS1:ENST00000609500:intron:MODIFIER:exon3/3:n.441-3249G>A:,SRD5A3-AS1:ENST00000608558:intron:MODIFIER:exon5/5:n.567-3249G>A:,SRD5A3-AS1:ENST00000608265:intron:MODIFIER:exon5/5:n.598-3249G>A:,SRD5A3-AS1:ENST00000609051:intron:MODIFIER:exon6/6:n.674-3249G>A:,SRD5A3-AS1:ENST00000609487:intron:MODIFIER:exon5/5:n.573-3249G>A:,SRD5A3-AS1:ENST00000609580:intron:MODIFIER:exon4/4:n.590-3249G>A:,SRD5A3-AS1:ENST00000609700:intron:MODIFIER:exon4/4:n.463-3249G>A:,SRD5A3-AS1:ENST00000609573:intron:MODIFIER:exon7/7:n.695-3249G>A:		rs13149568	0.3592	0.0000	0,0,0	0,0,0,0,0	0.3488							611715 [SRD5A3 (confirmed) Congenital disorder of glycosylation,type Iq,612379|Kahrizi syndrome,612713];	RCV000276891.1 [benign]; 			20	100					SRD5A3 (inh=AR pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	56236599	56236610	CACACACACACA	-	hom	anno_omim	QUAL=3519;DP=105;AF=0.69;MQM=59;TRIO=HOM,105,0.88,HOM,67,0.66,WT,72,0.49	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:ENST00000264228:3'UTR:MODIFIER:exon5/5:c.*371_*382delCACACACACACA:,SRD5A3-AS1:ENST00000433175:intron:MODIFIER:exon2/4:n.269-3280_269-3269delTGTGTGTGTGTG:,SRD5A3-AS1:ENST00000510637:intron:MODIFIER:exon3/3:n.364-3280_364-3269delTGTGTGTGTGTG:,SRD5A3-AS1:ENST00000596312:intron:MODIFIER:exon4/4:n.581-3280_581-3269delTGTGTGTGTGTG:,SRD5A3-AS1:ENST00000598906:intron:MODIFIER:exon4/4:n.568-3280_568-3269delTGTGTGTGTGTG:,SRD5A3-AS1:ENST00000596289:intron:MODIFIER:exon6/6:n.676-3280_676-3269delTGTGTGTGTGTG:,SRD5A3-AS1:ENST00000595103:intron:MODIFIER:exon4/4:n.465-3280_465-3269delTGTGTGTGTGTG:,SRD5A3-AS1:ENST00000595734:intron:MODIFIER:exon5/5:n.676-3280_676-3269delTGTGTGTGTGTG:,SRD5A3-AS1:ENST00000608086:intron:MODIFIER:exon2/2:n.605-3280_605-3269delTGTGTGTGTGTG:,SRD5A3-AS1:ENST00000609500:intron:MODIFIER:exon3/3:n.441-3280_441-3269delTGTGTGTGTGTG:,SRD5A3-AS1:ENST00000608558:intron:MODIFIER:exon5/5:n.567-3280_567-3269delTGTGTGTGTGTG:,SRD5A3-AS1:ENST00000608265:intron:MODIFIER:exon5/5:n.598-3280_598-3269delTGTGTGTGTGTG:,SRD5A3-AS1:ENST00000609051:intron:MODIFIER:exon6/6:n.674-3280_674-3269delTGTGTGTGTGTG:,SRD5A3-AS1:ENST00000609487:intron:MODIFIER:exon5/5:n.573-3280_573-3269delTGTGTGTGTGTG:,SRD5A3-AS1:ENST00000609580:intron:MODIFIER:exon4/4:n.590-3280_590-3269delTGTGTGTGTGTG:,SRD5A3-AS1:ENST00000609700:intron:MODIFIER:exon4/4:n.463-3280_463-3269delTGTGTGTGTGTG:,SRD5A3-AS1:ENST00000609573:intron:MODIFIER:exon7/7:n.695-3280_695-3269delTGTGTGTGTGTG:	(CA)n	rs148010163;rs57961190	0.0000	0.0000	0,0,0	0,0,0,0,0	0.2650							611715 [SRD5A3 (confirmed) Congenital disorder of glycosylation,type Iq,612379|Kahrizi syndrome,612713];				52	5					SRD5A3 (inh=AR pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	56236804	56236804	G	A	het	anno_omim	QUAL=3488;DP=173;AF=0.50;MQM=59;TRIO=HET,173,0.50,HET,93,0.54,WT,111,0.00	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:ENST00000264228:3'UTR:MODIFIER:exon5/5:c.*546G>A:,SRD5A3-AS1:ENST00000433175:intron:MODIFIER:exon2/4:n.269-3474C>T:,SRD5A3-AS1:ENST00000510637:intron:MODIFIER:exon3/3:n.364-3474C>T:,SRD5A3-AS1:ENST00000596312:intron:MODIFIER:exon4/4:n.581-3474C>T:,SRD5A3-AS1:ENST00000598906:intron:MODIFIER:exon4/4:n.568-3474C>T:,SRD5A3-AS1:ENST00000596289:intron:MODIFIER:exon6/6:n.676-3474C>T:,SRD5A3-AS1:ENST00000595103:intron:MODIFIER:exon4/4:n.465-3474C>T:,SRD5A3-AS1:ENST00000595734:intron:MODIFIER:exon5/5:n.676-3474C>T:,SRD5A3-AS1:ENST00000608086:intron:MODIFIER:exon2/2:n.605-3474C>T:,SRD5A3-AS1:ENST00000609500:intron:MODIFIER:exon3/3:n.441-3474C>T:,SRD5A3-AS1:ENST00000608558:intron:MODIFIER:exon5/5:n.567-3474C>T:,SRD5A3-AS1:ENST00000608265:intron:MODIFIER:exon5/5:n.598-3474C>T:,SRD5A3-AS1:ENST00000609051:intron:MODIFIER:exon6/6:n.674-3474C>T:,SRD5A3-AS1:ENST00000609487:intron:MODIFIER:exon5/5:n.573-3474C>T:,SRD5A3-AS1:ENST00000609580:intron:MODIFIER:exon4/4:n.590-3474C>T:,SRD5A3-AS1:ENST00000609700:intron:MODIFIER:exon4/4:n.463-3474C>T:,SRD5A3-AS1:ENST00000609573:intron:MODIFIER:exon7/7:n.695-3474C>T:	AluJb	rs573960	0.2676	0.0000	0,0,0	0,0,0,0,0	0.2916							611715 [SRD5A3 (confirmed) Congenital disorder of glycosylation,type Iq,612379|Kahrizi syndrome,612713];	RCV000376255.1 [likely benign]; 			23	58					SRD5A3 (inh=AR pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	56237137	56237137	C	T	het	anno_omim	QUAL=2071;DP=122;AF=0.57;MQM=59;TRIO=HET,122,0.57,HET,23,0.43,WT,29,0.00	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:ENST00000264228:3'UTR:MODIFIER:exon5/5:c.*879C>T:,SRD5A3-AS1:ENST00000433175:intron:MODIFIER:exon2/4:n.269-3807G>A:,SRD5A3-AS1:ENST00000510637:intron:MODIFIER:exon3/3:n.364-3807G>A:,SRD5A3-AS1:ENST00000596312:intron:MODIFIER:exon4/4:n.581-3807G>A:,SRD5A3-AS1:ENST00000598906:intron:MODIFIER:exon4/4:n.568-3807G>A:,SRD5A3-AS1:ENST00000596289:intron:MODIFIER:exon6/6:n.676-3807G>A:,SRD5A3-AS1:ENST00000595103:intron:MODIFIER:exon4/4:n.465-3807G>A:,SRD5A3-AS1:ENST00000595734:intron:MODIFIER:exon5/5:n.676-3807G>A:,SRD5A3-AS1:ENST00000608086:intron:MODIFIER:exon2/2:n.605-3807G>A:,SRD5A3-AS1:ENST00000609500:intron:MODIFIER:exon3/3:n.441-3807G>A:,SRD5A3-AS1:ENST00000608558:intron:MODIFIER:exon5/5:n.567-3807G>A:,SRD5A3-AS1:ENST00000608265:intron:MODIFIER:exon5/5:n.598-3807G>A:,SRD5A3-AS1:ENST00000609051:intron:MODIFIER:exon6/6:n.674-3807G>A:,SRD5A3-AS1:ENST00000609487:intron:MODIFIER:exon5/5:n.573-3807G>A:,SRD5A3-AS1:ENST00000609580:intron:MODIFIER:exon4/4:n.590-3807G>A:,SRD5A3-AS1:ENST00000609700:intron:MODIFIER:exon4/4:n.463-3807G>A:,SRD5A3-AS1:ENST00000609573:intron:MODIFIER:exon7/7:n.695-3807G>A:		rs576732	0.2674	0.0000	0,0,0	0,0,0,0,0	0.2914							611715 [SRD5A3 (confirmed) Congenital disorder of glycosylation,type Iq,612379|Kahrizi syndrome,612713];	RCV000380494.1 [likely benign]; 			26	86					SRD5A3 (inh=AR pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	56237327	56237327	G	A	hom	anno_omim	QUAL=10324;DP=236;AF=1.00;MQM=59;TRIO=HOM,236,1.00,HET,78,0.41,HET,128,0.48	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:ENST00000264228:3'UTR:MODIFIER:exon5/5:c.*1069G>A:,SRD5A3-AS1:ENST00000433175:intron:MODIFIER:exon2/4:n.268+3711C>T:,SRD5A3-AS1:ENST00000510637:intron:MODIFIER:exon3/3:n.363+3711C>T:,SRD5A3-AS1:ENST00000596312:intron:MODIFIER:exon4/4:n.580+3711C>T:,SRD5A3-AS1:ENST00000598906:intron:MODIFIER:exon4/4:n.567+3711C>T:,SRD5A3-AS1:ENST00000596289:intron:MODIFIER:exon6/6:n.675+3711C>T:,SRD5A3-AS1:ENST00000595103:intron:MODIFIER:exon4/4:n.464+3711C>T:,SRD5A3-AS1:ENST00000595734:intron:MODIFIER:exon5/5:n.675+3711C>T:,SRD5A3-AS1:ENST00000608086:intron:MODIFIER:exon2/2:n.604+3711C>T:,SRD5A3-AS1:ENST00000609500:intron:MODIFIER:exon3/3:n.440+3711C>T:,SRD5A3-AS1:ENST00000608558:intron:MODIFIER:exon5/5:n.566+3711C>T:,SRD5A3-AS1:ENST00000608265:intron:MODIFIER:exon5/5:n.597+3711C>T:,SRD5A3-AS1:ENST00000609051:intron:MODIFIER:exon6/6:n.673+3711C>T:,SRD5A3-AS1:ENST00000609487:intron:MODIFIER:exon5/5:n.572+3711C>T:,SRD5A3-AS1:ENST00000609580:intron:MODIFIER:exon4/4:n.589+3711C>T:,SRD5A3-AS1:ENST00000609700:intron:MODIFIER:exon4/4:n.462+3711C>T:,SRD5A3-AS1:ENST00000609573:intron:MODIFIER:exon7/7:n.694+3711C>T:		rs501679	0.6887	0.0000	0,0,0	0,0,0,0,0	0.6639							611715 [SRD5A3 (confirmed) Congenital disorder of glycosylation,type Iq,612379|Kahrizi syndrome,612713];	RCV000345775.1 [benign]; 			85	112					SRD5A3 (inh=AR pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	56238263	56238263	T	C	het	anno_omim	QUAL=4155;DP=210;AF=0.54;MQM=60;TRIO=HET,210,0.54,HET,102,0.38,WT,148,0.01	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:ENST00000264228:3'UTR:MODIFIER:exon5/5:c.*2005T>C:,SRD5A3-AS1:ENST00000433175:intron:MODIFIER:exon2/4:n.268+2775A>G:,SRD5A3-AS1:ENST00000510637:intron:MODIFIER:exon3/3:n.363+2775A>G:,SRD5A3-AS1:ENST00000596312:intron:MODIFIER:exon4/4:n.580+2775A>G:,SRD5A3-AS1:ENST00000598906:intron:MODIFIER:exon4/4:n.567+2775A>G:,SRD5A3-AS1:ENST00000596289:intron:MODIFIER:exon6/6:n.675+2775A>G:,SRD5A3-AS1:ENST00000595103:intron:MODIFIER:exon4/4:n.464+2775A>G:,SRD5A3-AS1:ENST00000595734:intron:MODIFIER:exon5/5:n.675+2775A>G:,SRD5A3-AS1:ENST00000608086:intron:MODIFIER:exon2/2:n.604+2775A>G:,SRD5A3-AS1:ENST00000609500:intron:MODIFIER:exon3/3:n.440+2775A>G:,SRD5A3-AS1:ENST00000608558:intron:MODIFIER:exon5/5:n.566+2775A>G:,SRD5A3-AS1:ENST00000608265:intron:MODIFIER:exon5/5:n.597+2775A>G:,SRD5A3-AS1:ENST00000609051:intron:MODIFIER:exon6/6:n.673+2775A>G:,SRD5A3-AS1:ENST00000609487:intron:MODIFIER:exon5/5:n.572+2775A>G:,SRD5A3-AS1:ENST00000609580:intron:MODIFIER:exon4/4:n.589+2775A>G:,SRD5A3-AS1:ENST00000609700:intron:MODIFIER:exon4/4:n.462+2775A>G:,SRD5A3-AS1:ENST00000609573:intron:MODIFIER:exon7/7:n.694+2775A>G:		rs819269	0.2692	0.0000	0,0,0	0,0,0,0,0	0.2917							611715 [SRD5A3 (confirmed) Congenital disorder of glycosylation,type Iq,612379|Kahrizi syndrome,612713];	RCV000356067.1 [likely benign]; 			14	53					SRD5A3 (inh=AR pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	56238321	56238321	G	A	het	anno_omim	QUAL=5156;DP=315;AF=0.49;MQM=60;TRIO=HET,315,0.49,HET,97,0.43,WT,149,0.01	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:ENST00000264228:3'UTR:MODIFIER:exon5/5:c.*2063G>A:,SRD5A3-AS1:ENST00000433175:intron:MODIFIER:exon2/4:n.268+2717C>T:,SRD5A3-AS1:ENST00000510637:intron:MODIFIER:exon3/3:n.363+2717C>T:,SRD5A3-AS1:ENST00000596312:intron:MODIFIER:exon4/4:n.580+2717C>T:,SRD5A3-AS1:ENST00000598906:intron:MODIFIER:exon4/4:n.567+2717C>T:,SRD5A3-AS1:ENST00000596289:intron:MODIFIER:exon6/6:n.675+2717C>T:,SRD5A3-AS1:ENST00000595103:intron:MODIFIER:exon4/4:n.464+2717C>T:,SRD5A3-AS1:ENST00000595734:intron:MODIFIER:exon5/5:n.675+2717C>T:,SRD5A3-AS1:ENST00000608086:intron:MODIFIER:exon2/2:n.604+2717C>T:,SRD5A3-AS1:ENST00000609500:intron:MODIFIER:exon3/3:n.440+2717C>T:,SRD5A3-AS1:ENST00000608558:intron:MODIFIER:exon5/5:n.566+2717C>T:,SRD5A3-AS1:ENST00000608265:intron:MODIFIER:exon5/5:n.597+2717C>T:,SRD5A3-AS1:ENST00000609051:intron:MODIFIER:exon6/6:n.673+2717C>T:,SRD5A3-AS1:ENST00000609487:intron:MODIFIER:exon5/5:n.572+2717C>T:,SRD5A3-AS1:ENST00000609580:intron:MODIFIER:exon4/4:n.589+2717C>T:,SRD5A3-AS1:ENST00000609700:intron:MODIFIER:exon4/4:n.462+2717C>T:,SRD5A3-AS1:ENST00000609573:intron:MODIFIER:exon7/7:n.694+2717C>T:		rs73236134	0.0162	0.0000	0,0,0	0,0,0,0,0	0.0459							611715 [SRD5A3 (confirmed) Congenital disorder of glycosylation,type Iq,612379|Kahrizi syndrome,612713];	RCV000263698.1 [likely benign]; 			0	21					SRD5A3 (inh=AR pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	56238626	56238626	G	A	het	anno_omim	QUAL=10173;DP=465;AF=0.48;MQM=60;TRIO=HET,465,0.48,HET,318,0.49,WT,467,0.01	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:ENST00000264228:3'UTR:MODIFIER:exon5/5:c.*2368G>A:,SRD5A3-AS1:ENST00000433175:intron:MODIFIER:exon2/4:n.268+2412C>T:,SRD5A3-AS1:ENST00000510637:intron:MODIFIER:exon3/3:n.363+2412C>T:,SRD5A3-AS1:ENST00000596312:intron:MODIFIER:exon4/4:n.580+2412C>T:,SRD5A3-AS1:ENST00000598906:intron:MODIFIER:exon4/4:n.567+2412C>T:,SRD5A3-AS1:ENST00000596289:intron:MODIFIER:exon6/6:n.675+2412C>T:,SRD5A3-AS1:ENST00000595103:intron:MODIFIER:exon4/4:n.464+2412C>T:,SRD5A3-AS1:ENST00000595734:intron:MODIFIER:exon5/5:n.675+2412C>T:,SRD5A3-AS1:ENST00000608086:intron:MODIFIER:exon2/2:n.604+2412C>T:,SRD5A3-AS1:ENST00000609500:intron:MODIFIER:exon3/3:n.440+2412C>T:,SRD5A3-AS1:ENST00000608558:intron:MODIFIER:exon5/5:n.566+2412C>T:,SRD5A3-AS1:ENST00000608265:intron:MODIFIER:exon5/5:n.597+2412C>T:,SRD5A3-AS1:ENST00000609051:intron:MODIFIER:exon6/6:n.673+2412C>T:,SRD5A3-AS1:ENST00000609487:intron:MODIFIER:exon5/5:n.572+2412C>T:,SRD5A3-AS1:ENST00000609580:intron:MODIFIER:exon4/4:n.589+2412C>T:,SRD5A3-AS1:ENST00000609700:intron:MODIFIER:exon4/4:n.462+2412C>T:,SRD5A3-AS1:ENST00000609573:intron:MODIFIER:exon7/7:n.694+2412C>T:		rs819270	0.2676	0.0000	0,0,0	0,0,0,0,0	0.2916							611715 [SRD5A3 (confirmed) Congenital disorder of glycosylation,type Iq,612379|Kahrizi syndrome,612713];	RCV000293555.1 [likely benign]; 			14	53					SRD5A3 (inh=AR pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	56238847	56238847	G	A	hom	anno_omim	QUAL=16006;DP=337;AF=0.99;MQM=60;TRIO=HOM,337,0.99,HET,174,0.46,HET,242,0.51	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:ENST00000264228:3'UTR:MODIFIER:exon5/5:c.*2589G>A:,SRD5A3-AS1:ENST00000433175:intron:MODIFIER:exon2/4:n.268+2191C>T:,SRD5A3-AS1:ENST00000510637:intron:MODIFIER:exon3/3:n.363+2191C>T:,SRD5A3-AS1:ENST00000596312:intron:MODIFIER:exon4/4:n.580+2191C>T:,SRD5A3-AS1:ENST00000598906:intron:MODIFIER:exon4/4:n.567+2191C>T:,SRD5A3-AS1:ENST00000596289:intron:MODIFIER:exon6/6:n.675+2191C>T:,SRD5A3-AS1:ENST00000595103:intron:MODIFIER:exon4/4:n.464+2191C>T:,SRD5A3-AS1:ENST00000595734:intron:MODIFIER:exon5/5:n.675+2191C>T:,SRD5A3-AS1:ENST00000608086:intron:MODIFIER:exon2/2:n.604+2191C>T:,SRD5A3-AS1:ENST00000609500:intron:MODIFIER:exon3/3:n.440+2191C>T:,SRD5A3-AS1:ENST00000608558:intron:MODIFIER:exon5/5:n.566+2191C>T:,SRD5A3-AS1:ENST00000608265:intron:MODIFIER:exon5/5:n.597+2191C>T:,SRD5A3-AS1:ENST00000609051:intron:MODIFIER:exon6/6:n.673+2191C>T:,SRD5A3-AS1:ENST00000609487:intron:MODIFIER:exon5/5:n.572+2191C>T:,SRD5A3-AS1:ENST00000609580:intron:MODIFIER:exon4/4:n.589+2191C>T:,SRD5A3-AS1:ENST00000609700:intron:MODIFIER:exon4/4:n.462+2191C>T:,SRD5A3-AS1:ENST00000609573:intron:MODIFIER:exon7/7:n.694+2191C>T:		rs819271	0.7500	0.0000	0,0,0	0,0,0,0,0	0.7203							611715 [SRD5A3 (confirmed) Congenital disorder of glycosylation,type Iq,612379|Kahrizi syndrome,612713];	RCV000335842.1 [benign]; 			52	73					SRD5A3 (inh=AR pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	56239103	56239103	A	-	hom	anno_omim	QUAL=1680;DP=97;AF=0.71;MQM=59;TRIO=HOM,97,0.71,HET,25,0.36,HET,27,0.48	SRD5A3,SRD5A3-AS1	3'UTR,intron	SRD5A3:ENST00000264228:3'UTR:MODIFIER:exon5/5:c.*2858delA:,SRD5A3-AS1:ENST00000433175:intron:MODIFIER:exon2/4:n.268+1935delT:,SRD5A3-AS1:ENST00000510637:intron:MODIFIER:exon3/3:n.363+1935delT:,SRD5A3-AS1:ENST00000596312:intron:MODIFIER:exon4/4:n.580+1935delT:,SRD5A3-AS1:ENST00000598906:intron:MODIFIER:exon4/4:n.567+1935delT:,SRD5A3-AS1:ENST00000596289:intron:MODIFIER:exon6/6:n.675+1935delT:,SRD5A3-AS1:ENST00000595103:intron:MODIFIER:exon4/4:n.464+1935delT:,SRD5A3-AS1:ENST00000595734:intron:MODIFIER:exon5/5:n.675+1935delT:,SRD5A3-AS1:ENST00000608086:intron:MODIFIER:exon2/2:n.604+1935delT:,SRD5A3-AS1:ENST00000609500:intron:MODIFIER:exon3/3:n.440+1935delT:,SRD5A3-AS1:ENST00000608558:intron:MODIFIER:exon5/5:n.566+1935delT:,SRD5A3-AS1:ENST00000608265:intron:MODIFIER:exon5/5:n.597+1935delT:,SRD5A3-AS1:ENST00000609051:intron:MODIFIER:exon6/6:n.673+1935delT:,SRD5A3-AS1:ENST00000609487:intron:MODIFIER:exon5/5:n.572+1935delT:,SRD5A3-AS1:ENST00000609580:intron:MODIFIER:exon4/4:n.589+1935delT:,SRD5A3-AS1:ENST00000609700:intron:MODIFIER:exon4/4:n.462+1935delT:,SRD5A3-AS1:ENST00000609573:intron:MODIFIER:exon7/7:n.694+1935delT:		rs750107327	0.0000	0.0000	0,0,0	0,0,0,0,0	0.5994							611715 [SRD5A3 (confirmed) Congenital disorder of glycosylation,type Iq,612379|Kahrizi syndrome,612713];	RCV000307927.1 [uncertain significance]; 			51	66					SRD5A3 (inh=AR pLI=0.04), SRD5A3-AS1 (inh=n/a pLI=n/a)
chr4	68603535	68603535	C	A	het	anno_omim	QUAL=6105;DP=244;AF=0.39;MQM=60;TRIO=HET,244,0.39,HET,84,0.52,HET,134,0.63	UBA6-AS1	intron	UBA6-AS1:ENST00000500538:intron:MODIFIER:exon5/7:n.1838+5472C>A:,UBA6-AS1:ENST00000502758:intron:MODIFIER:exon1/5:n.202+5472C>A:		rs1038426	0.3452	0.0000	0,0,0	0,0,0,0,0	0.3769							138850 [GNRHR (confirmed) Hypogonadotropic hypogonadism 7 without anosmia,146110];	RCV000386570.1 [likely benign]; 	CR113071 [CLASS=DFP MUT=ALT PHEN="Polycystic ovary syndrome association with" GENE=GNRHR]; 		49	112					UBA6-AS1 (inh=n/a pLI=n/a)
chr4	68603702	68603702	C	T	het	anno_omim	QUAL=2107;DP=134;AF=0.40;MQM=59;TRIO=HET,134,0.40,HET,32,0.38,HET,32,0.50	UBA6-AS1	intron	UBA6-AS1:ENST00000500538:intron:MODIFIER:exon5/7:n.1838+5639C>T:,UBA6-AS1:ENST00000502758:intron:MODIFIER:exon1/5:n.202+5639C>T:		rs1038427	0.3452	0.0000	0,0,0	0,0,0,0,0	0.3771							138850 [GNRHR (confirmed) Hypogonadotropic hypogonadism 7 without anosmia,146110];	RCV000290190.1 [likely benign]; 			47	102					UBA6-AS1 (inh=n/a pLI=n/a)
chr4	68603757	68603757	A	G	het	anno_omim	QUAL=2454;DP=112;AF=0.55;MQM=60;TRIO=HET,112,0.55,WT,23,0.00,HET,46,0.65	UBA6-AS1	intron	UBA6-AS1:ENST00000500538:intron:MODIFIER:exon5/7:n.1838+5694A>G:,UBA6-AS1:ENST00000502758:intron:MODIFIER:exon1/5:n.202+5694A>G:	(AATTAT)n	rs2319657	0.0421	0.0000	0,0,0	0,0,0,0,0	0.0678							138850 [GNRHR (confirmed) Hypogonadotropic hypogonadism 7 without anosmia,146110];				3	23					UBA6-AS1 (inh=n/a pLI=n/a)
chr4	68604032	68604032	C	T	het	anno_omim	QUAL=2272;DP=158;AF=0.42;MQM=60;TRIO=HET,158,0.42,HET,20,0.40,HET,37,0.43	UBA6-AS1	intron	UBA6-AS1:ENST00000500538:intron:MODIFIER:exon5/7:n.1838+5969C>T:,UBA6-AS1:ENST00000502758:intron:MODIFIER:exon1/5:n.202+5969C>T:	Charlie4a	rs7666201	0.3492	0.0000	0,0,0	0,0,0,0,0	0.3808							138850 [GNRHR (confirmed) Hypogonadotropic hypogonadism 7 without anosmia,146110];	RCV000381028.1 [likely benign]; 			49	110					UBA6-AS1 (inh=n/a pLI=n/a)
chr4	68604143	68604143	C	T	het	anno_omim	QUAL=4228;DP=180;AF=0.46;MQM=60;TRIO=HET,180,0.46,HET,78,0.47,HET,101,0.44	UBA6-AS1	intron	UBA6-AS1:ENST00000500538:intron:MODIFIER:exon5/7:n.1838+6080C>T:,UBA6-AS1:ENST00000502758:intron:MODIFIER:exon1/5:n.202+6080C>T:		rs17635749	0.1773	0.0000	0,0,0	0,0,0,0,0	0.2232							138850 [GNRHR (confirmed) Hypogonadotropic hypogonadism 7 without anosmia,146110];	RCV000343215.1 [likely benign]; 			20	93					UBA6-AS1 (inh=n/a pLI=n/a)
chr4	68604307	68604307	A	C	het	anno_omim	QUAL=6432;DP=233;AF=0.52;MQM=60;TRIO=HET,233,0.52,HET,106,0.42,HET,137,0.52	UBA6-AS1	intron	UBA6-AS1:ENST00000500538:intron:MODIFIER:exon5/7:n.1838+6244A>C:,UBA6-AS1:ENST00000502758:intron:MODIFIER:exon1/5:n.202+6244A>C:		rs12508464	0.1855	0.0000	0,0,0	0,0,0,0,0	0.2290							138850 [GNRHR (confirmed) Hypogonadotropic hypogonadism 7 without anosmia,146110];	RCV000354694.1 [likely benign]; 			20	93					UBA6-AS1 (inh=n/a pLI=n/a)
chr4	68604938	68604938	C	A	het	anno_omim	QUAL=10082;DP=284;AF=0.52;MQM=60;TRIO=HET,284,0.52,HET,199,0.48,HET,252,0.54	UBA6-AS1	intron	UBA6-AS1:ENST00000500538:intron:MODIFIER:exon5/7:n.1838+6875C>A:,UBA6-AS1:ENST00000502758:intron:MODIFIER:exon1/5:n.202+6875C>A:		rs13150734	0.1855	0.0000	0,0,0	0,0,0,0,0	0.2291							138850 [GNRHR (confirmed) Hypogonadotropic hypogonadism 7 without anosmia,146110];	RCV000328188.1 [likely benign]; 			20	94					UBA6-AS1 (inh=n/a pLI=n/a)
chr4	68605369	68605369	A	G	het	anno_omim	QUAL=7668;DP=365;AF=0.51;MQM=60;TRIO=HET,365,0.51,HET,94,0.44,HET,128,0.45	GNRHR,UBA6-AS1	3'UTR,intron	GNRHR:ENST00000226413:3'UTR:MODIFIER:exon3/3:c.*829T>C:,UBA6-AS1:ENST00000500538:intron:MODIFIER:exon5/7:n.1838+7306A>G:,UBA6-AS1:ENST00000502758:intron:MODIFIER:exon1/5:n.202+7306A>G:		rs17635850	0.3492	0.0000	0,0,0	0,0,0,0,0	0.3800							138850 [GNRHR (confirmed) Hypogonadotropic hypogonadism 7 without anosmia,146110];	RCV000338992.1 [likely benign]; 			49	113					GNRHR (inh=AD pLI=0.01), UBA6-AS1 (inh=n/a pLI=n/a)
chr4	68605389	68605389	G	A	het	anno_omim	QUAL=7201;DP=331;AF=0.50;MQM=60;TRIO=HET,331,0.50,HET,100,0.44,HET,123,0.46	GNRHR,UBA6-AS1	3'UTR,intron	GNRHR:ENST00000226413:3'UTR:MODIFIER:exon3/3:c.*809C>T:,UBA6-AS1:ENST00000500538:intron:MODIFIER:exon5/7:n.1838+7326G>A:,UBA6-AS1:ENST00000502758:intron:MODIFIER:exon1/5:n.202+7326G>A:		rs35683646	0.1859	0.0000	0,0,0	0,0,0,0,0	0.2280							138850 [GNRHR (confirmed) Hypogonadotropic hypogonadism 7 without anosmia,146110];	RCV000281409.1 [likely benign]; 			20	94					GNRHR (inh=AD pLI=0.01), UBA6-AS1 (inh=n/a pLI=n/a)
chr4	68605396	68605396	C	G	het	anno_omim	QUAL=7398;DP=334;AF=0.49;MQM=60;TRIO=HET,334,0.49,HET,109,0.47,HET,124,0.46	GNRHR,UBA6-AS1	3'UTR,intron	GNRHR:ENST00000226413:3'UTR:MODIFIER:exon3/3:c.*802G>C:,UBA6-AS1:ENST00000500538:intron:MODIFIER:exon5/7:n.1838+7333C>G:,UBA6-AS1:ENST00000502758:intron:MODIFIER:exon1/5:n.202+7333C>G:		rs35610027	0.1859	0.0000	0,0,0	0,0,0,0,0	0.2280							138850 [GNRHR (confirmed) Hypogonadotropic hypogonadism 7 without anosmia,146110];	RCV000393012.1 [likely benign]; 			20	93					GNRHR (inh=AD pLI=0.01), UBA6-AS1 (inh=n/a pLI=n/a)
chr4	68605615	68605615	T	C	het	anno_omim	QUAL=7429;DP=277;AF=0.51;MQM=59;TRIO=HET,277,0.51,HET,156,0.53,HET,187,0.41	GNRHR,UBA6-AS1	3'UTR,intron	GNRHR:ENST00000226413:3'UTR:MODIFIER:exon3/3:c.*583A>G:,UBA6-AS1:ENST00000500538:intron:MODIFIER:exon5/7:n.1838+7552T>C:,UBA6-AS1:ENST00000502758:intron:MODIFIER:exon1/5:n.202+7552T>C:		rs35845954	0.1855	0.0000	0,0,0	0,0,0,0,0	0.2287							138850 [GNRHR (confirmed) Hypogonadotropic hypogonadism 7 without anosmia,146110];	RCV000351476.1 [likely benign]; 			20	94					GNRHR (inh=AD pLI=0.01), UBA6-AS1 (inh=n/a pLI=n/a)
chr4	68620277	68620277	T	C	hom	anno_omim	QUAL=15725;DP=278;AF=1.00;MQM=60;TRIO=HOM,278,1.00,HOM,84,1.00,HOM,114,1.00	UBA6-AS1	intron	UBA6-AS1:ENST00000500538:intron:MODIFIER:exon5/7:n.1839-630T>C:,UBA6-AS1:ENST00000502758:intron:MODIFIER:exon4/5:n.416+319T>C:		rs2627260	0.9810	0.0000	0,0,0	0,0,0,0,0	0.9805							138850 [GNRHR (confirmed) Hypogonadotropic hypogonadism 7 without anosmia,146110];	RCV000317207.1 [benign]; 			229	3					UBA6-AS1 (inh=n/a pLI=n/a)
chr4	68620957	68620957	T	C	het	anno_omim	QUAL=5435;DP=198;AF=0.66;MQM=59;TRIO=HET,198,0.66,WT,87,0.00,HET,137,0.49	UBA6-AS1	non_coding_transcript_exon	UBA6-AS1:ENST00000500538:non_coding_transcript_exon:MODIFIER:exon6/8:n.1889T>C:,UBA6-AS1:ENST00000502758:non_coding_transcript_exon:MODIFIER:exon5/6:n.467T>C:		rs6552113	0.4663	0.0000	0,0,0	0,0,0,0,0	0.4617							138850 [GNRHR (confirmed) Hypogonadotropic hypogonadism 7 without anosmia,146110];	RCV000307832.1 [likely benign]; 			64	113					UBA6-AS1 (inh=n/a pLI=n/a)
chr4	68621197	68621197	A	G	het	anno_omim	QUAL=4216;DP=162;AF=0.61;MQM=60;TRIO=HET,162,0.61,WT,49,0.00,HET,76,0.71	UBA6-AS1	intron	UBA6-AS1:ENST00000500538:intron:MODIFIER:exon6/7:n.1905+224A>G:,UBA6-AS1:ENST00000502758:intron:MODIFIER:exon5/5:n.483+224A>G:	L2a	rs2062303	0.4417	0.0000	0,0,0	0,0,0,0,0	0.4454							138850 [GNRHR (confirmed) Hypogonadotropic hypogonadism 7 without anosmia,146110];	RCV000353486.1 [likely benign]; 			64	111					UBA6-AS1 (inh=n/a pLI=n/a)
chr4	68621308	68621308	A	G	het	anno_omim	QUAL=4739;DP=202;AF=0.50;MQM=60;TRIO=HET,202,0.50,WT,123,0.01,HET,150,0.52	UBA6-AS1	intron	UBA6-AS1:ENST00000500538:intron:MODIFIER:exon6/7:n.1905+335A>G:,UBA6-AS1:ENST00000502758:intron:MODIFIER:exon5/5:n.483+335A>G:		rs2062302	0.4669	0.0000	0,0,0	0,0,0,0,0	0.4591							138850 [GNRHR (confirmed) Hypogonadotropic hypogonadism 7 without anosmia,146110];	RCV000332699.1 [likely benign]; 			64	111					UBA6-AS1 (inh=n/a pLI=n/a)
chr4	68621332	68621332	C	T	het	anno_omim	QUAL=6840;DP=249;AF=0.59;MQM=60;TRIO=HET,249,0.59,WT,149,0.01,HET,194,0.54	UBA6-AS1	intron	UBA6-AS1:ENST00000500538:intron:MODIFIER:exon6/7:n.1905+359C>T:,UBA6-AS1:ENST00000502758:intron:MODIFIER:exon5/5:n.483+359C>T:	LTR16D	rs2062301	0.4659	0.0000	0,0,0	0,0,0,0,0	0.4586							138850 [GNRHR (confirmed) Hypogonadotropic hypogonadism 7 without anosmia,146110];	RCV000389546.1 [likely benign]; 			64	111					UBA6-AS1 (inh=n/a pLI=n/a)
chr4	68621550	68621550	G	A	het	anno_omim	QUAL=4756;DP=229;AF=0.55;MQM=60;TRIO=HET,229,0.55,WT,56,0.00,HET,92,0.51	UBA6-AS1	intron	UBA6-AS1:ENST00000500538:intron:MODIFIER:exon6/7:n.1905+577G>A:,UBA6-AS1:ENST00000502758:intron:MODIFIER:exon5/5:n.483+577G>A:		rs13138607	0.4661	0.0000	0,0,0	0,0,0,0,0	0.4613							138850 [GNRHR (confirmed) Hypogonadotropic hypogonadism 7 without anosmia,146110];	RCV000291948.1 [likely benign]; 			65	112					UBA6-AS1 (inh=n/a pLI=n/a)
chr4	68621586	68621586	A	-	het	anno_omim	QUAL=4478;DP=245;AF=0.52;MQM=60;TRIO=HET,245,0.52,WT,49,0.04,HET,84,0.57	UBA6-AS1	intron	UBA6-AS1:ENST00000500538:intron:MODIFIER:exon6/7:n.1905+622delA:,UBA6-AS1:ENST00000502758:intron:MODIFIER:exon5/5:n.483+622delA:		rs34993359	0.4675	0.0000	0,0,0	0,0,0,0,0	0.4764							138850 [GNRHR (confirmed) Hypogonadotropic hypogonadism 7 without anosmia,146110];	RCV000344654.1 [likely benign]; 			66	110					UBA6-AS1 (inh=n/a pLI=n/a)
chr4	72425863	72425863	C	T	hom	anno_omim	QUAL=27049;DP=237;AF=1.00;MQM=60;TRIO=HOM,237,1.00,HOM,256,1.00,HOM,333,1.00	SLC4A4	synonymous	SLC4A4:ENST00000425175:synonymous:LOW:exon23/25:c.2991C>T:p.His997His,SLC4A4:ENST00000264485:synonymous:LOW:exon23/26:c.2991C>T:p.His997His,SLC4A4:ENST00000351898:synonymous:LOW:exon21/24:c.2739C>T:p.His913His,SLC4A4:ENST00000340595:synonymous:LOW:exon20/23:c.2859C>T:p.His953His		rs1453458	0.7823	0.8891	48487,30393,2232	0.6506,0.8655,0.7562,0.9547,0.8317	0.8933							603345 [SLC4A4 (provisional) Renal tubular acidosis,proximal,with ocular abnormalities,604278];				1734	348	2	[2] auto-classification 14.09.2017  			SLC4A4 (inh=AR pLI=1.00)
chr4	72433759	72433759	C	T	hom	anno_omim	QUAL=21945;DP=299;AF=1.00;MQM=60;TRIO=HOM,299,1.00,HOM,148,1.00,HOM,217,1.00	SLC4A4	3'UTR	SLC4A4:ENST00000425175:3'UTR:MODIFIER:exon25/25:c.*149C>T:,SLC4A4:ENST00000264485:3'UTR:MODIFIER:exon26/26:c.*291C>T:,SLC4A4:ENST00000351898:3'UTR:MODIFIER:exon24/24:c.*291C>T:,SLC4A4:ENST00000340595:3'UTR:MODIFIER:exon23/23:c.*291C>T:		rs1453453	0.9115	0.0000	0,0,0	0,0,0,0,0	0.9330							603345 [SLC4A4 (provisional) Renal tubular acidosis,proximal,with ocular abnormalities,604278];				224	8					SLC4A4 (inh=AR pLI=1.00)
chr4	72433879	72433879	G	C	hom	anno_omim	QUAL=35339;DP=501;AF=1.00;MQM=59;TRIO=HOM,501,1.00,HOM,250,1.00,HOM,313,1.00	SLC4A4	3'UTR	SLC4A4:ENST00000425175:3'UTR:MODIFIER:exon25/25:c.*269G>C:,SLC4A4:ENST00000264485:3'UTR:MODIFIER:exon26/26:c.*411G>C:,SLC4A4:ENST00000351898:3'UTR:MODIFIER:exon24/24:c.*411G>C:,SLC4A4:ENST00000340595:3'UTR:MODIFIER:exon23/23:c.*411G>C:		rs1453452	0.8882	0.0000	0,0,0	0,0,0,0,0	0.9120							603345 [SLC4A4 (provisional) Renal tubular acidosis,proximal,with ocular abnormalities,604278];	RCV000372159.1 [benign]; 			224	8					SLC4A4 (inh=AR pLI=1.00)
chr4	72434457	72434457	T	A	het	anno_omim	QUAL=6533;DP=258;AF=0.46;MQM=60;TRIO=HET,258,0.46,WT,182,0.00,HET,245,0.51	SLC4A4	3'UTR	SLC4A4:ENST00000425175:3'UTR:MODIFIER:exon25/25:c.*847T>A:,SLC4A4:ENST00000264485:3'UTR:MODIFIER:exon26/26:c.*989T>A:,SLC4A4:ENST00000340595:3'UTR:MODIFIER:exon23/23:c.*989T>A:		rs34921070	0.0286	0.0000	0,0,0	0,0,0,0,0	0.0588							603345 [SLC4A4 (provisional) Renal tubular acidosis,proximal,with ocular abnormalities,604278];	RCV000308244.1 [likely benign]; 			3	28					SLC4A4 (inh=AR pLI=1.00)
chr4	72435944	72435973	TAACTCATCATTTCAGCCTCTGAGTAGAGG	-	hom	anno_omim	QUAL=15889;DP=263;AF=1.00;MQM=59;TRIO=HOM,263,1.00,HOM,145,1.00,HOM,198,0.99	SLC4A4	3'UTR	SLC4A4:ENST00000425175:3'UTR:MODIFIER:exon25/25:c.*2337_*2366delCTCATCATTTCAGCCTCTGAGTAGAGGTAA:,SLC4A4:ENST00000340595:3'UTR:MODIFIER:exon23/23:c.*2479_*2508delCTCATCATTTCAGCCTCTGAGTAGAGGTAA:		rs71822971	0.3185	0.0000	0,0,0	0,0,0,0,0	0.4452							603345 [SLC4A4 (provisional) Renal tubular acidosis,proximal,with ocular abnormalities,604278];				51	107					SLC4A4 (inh=AR pLI=1.00)
chr4	72436235	72436235	A	G	hom	anno_omim	QUAL=31106;DP=427;AF=1.00;MQM=60;TRIO=HOM,427,1.00,HOM,216,1.00,HOM,289,1.00	SLC4A4	3'UTR	SLC4A4:ENST00000425175:3'UTR:MODIFIER:exon25/25:c.*2625A>G:,SLC4A4:ENST00000340595:3'UTR:MODIFIER:exon23/23:c.*2767A>G:		rs1043218	0.6206	0.0000	0,0,0	0,0,0,0,0	0.7048							603345 [SLC4A4 (provisional) Renal tubular acidosis,proximal,with ocular abnormalities,604278];	RCV000319414.1 [benign]; 			126	85					SLC4A4 (inh=AR pLI=1.00)
chr4	72436498	72436498	G	A	hom	anno_omim	QUAL=29711;DP=322;AF=1.00;MQM=60;TRIO=HOM,322,1.00,HOM,252,1.00,HOM,338,1.00	SLC4A4	3'UTR	SLC4A4:ENST00000425175:3'UTR:MODIFIER:exon25/25:c.*2888G>A:,SLC4A4:ENST00000340595:3'UTR:MODIFIER:exon23/23:c.*3030G>A:		rs9997127	0.9191	0.0000	0,0,0	0,0,0,0,0	0.9412							603345 [SLC4A4 (provisional) Renal tubular acidosis,proximal,with ocular abnormalities,604278];				224	8					SLC4A4 (inh=AR pLI=1.00)
chr4	72436804	72436804	G	A	hom	anno_omim	QUAL=27566;DP=426;AF=1.00;MQM=60;TRIO=HOM,426,1.00,HOM,168,1.00,HOM,231,1.00	SLC4A4	3'UTR	SLC4A4:ENST00000425175:3'UTR:MODIFIER:exon25/25:c.*3194G>A:,SLC4A4:ENST00000340595:3'UTR:MODIFIER:exon23/23:c.*3336G>A:		rs9997398	0.9191	0.0000	0,0,0	0,0,0,0,0	0.9401							603345 [SLC4A4 (provisional) Renal tubular acidosis,proximal,with ocular abnormalities,604278];				224	8					SLC4A4 (inh=AR pLI=1.00)
chr4	79186171	79186171	G	A	hom	anno_omim	QUAL=26911;DP=357;AF=1.00;MQM=60;TRIO=HOM,357,1.00,HOM,209,1.00,HOM,278,1.00	FRAS1	splice_region&intron	FRAS1:ENST00000264895:splice_region&intron:LOW:exon6/73:c.604-8G>A:,FRAS1:ENST00000264899:splice_region&intron:LOW:exon6/18:c.604-8G>A:,FRAS1:ENST00000325942:splice_region&intron:LOW:exon6/41:c.604-8G>A:		rs2867014	0.9221	0.9741	56632,32848,3056	0.7984,0.9793,0.9509,0.9964,0.9863	0.9773							607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000252006.1 [benign]; RCV000381460.1 [benign]; 		COSM4003160, COSM4003159, COSM4003158, COSM4003161	2066	42	2	[2] auto-classification 14.09.2017  			FRAS1 (inh=AR pLI=0.00)
chr4	79188595	79188595	C	T	het	anno_omim	QUAL=6576;DP=176;AF=0.51;MQM=59;TRIO=HET,176,0.51,WT,319,0.00,HET,411,0.46	FRAS1	splice_region&intron	FRAS1:ENST00000264895:splice_region&intron:LOW:exon9/73:c.981+9C>T:,FRAS1:ENST00000264899:splice_region&intron:LOW:exon9/18:c.981+9C>T:,FRAS1:ENST00000325942:splice_region&intron:LOW:exon9/41:c.981+9C>T:		rs112081709	0.0092	0.0222	27,23,0	0.0041,0.0057,0.0003,0.0320,0.0080	0.0188							607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000308483.1 [likely benign]; 			1	87					FRAS1 (inh=AR pLI=0.00)
chr4	79205699	79205699	T	A	het	pred_pathogenic;anno_omim	QUAL=10843;DP=209;AF=0.46;MQM=60;TRIO=HET,209,0.46,HET,292,0.47,HET,410,0.48	FRAS1	missense	FRAS1:ENST00000264895:missense:MODERATE:exon13/74:c.1396T>A:p.Leu466Ile,FRAS1:ENST00000264899:missense:MODERATE:exon13/19:c.1396T>A:p.Leu466Ile,FRAS1:ENST00000325942:missense:MODERATE:exon13/42:c.1396T>A:p.Leu466Ile		rs12504081	0.3211	0.3508	7558,4179,160	0.1874,0.4288,0.3877,0.3573,0.3278	0.3595	0.9550	.,T,T,T,T	T,T	.,P,P,D,D	.,T,T,T	21.10	607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000243148.1 [benign]; RCV000333069.1 [benign]; 		COSM4003163, COSM4003162, COSM4003164, COSM4003165	252	990	2	[2] auto-classification 14.09.2017  			FRAS1 (inh=AR pLI=0.00)
chr4	79238649	79238649	T	C	het	anno_omim	QUAL=9255;DP=192;AF=0.43;MQM=60;TRIO=HET,192,0.43,HET,147,0.41,HOM,194,1.00	FRAS1	synonymous	FRAS1:ENST00000264895:synonymous:LOW:exon17/74:c.1947T>C:p.His649His,FRAS1:ENST00000264899:synonymous:LOW:exon17/19:c.1947T>C:p.His649His,FRAS1:ENST00000325942:synonymous:LOW:exon17/42:c.1947T>C:p.His649His		rs345514	0.0000	0.7442	33581,19735,3516	0.8499,0.7279,0.6986,0.7701,0.5928	0.7902	-2.4890		T,T			0.03	607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000175235.2 [benign]; RCV000407507.1 [benign]; 		COSM4159211, COSM4159212, COSM4159210, COSM4159209	1075	844	2	[2] auto-classification 14.09.2017  			FRAS1 (inh=AR pLI=0.00)
chr4	79240063	79240063	A	G	het	anno_omim	QUAL=8809;DP=263;AF=0.56;MQM=59;TRIO=HET,263,0.56,HET,175,0.45,HET,216,0.53	FRAS1	missense	FRAS1:ENST00000264895:missense:MODERATE:exon18/74:c.2060A>G:p.Asp687Gly,FRAS1:ENST00000264899:missense:MODERATE:exon18/19:c.2060A>G:p.Asp687Gly,FRAS1:ENST00000325942:missense:MODERATE:exon18/42:c.2060A>G:p.Asp687Gly		rs345513	0.4343	0.4101	10166,5124,1170	0.4846,0.4680,0.4252,0.3953,0.3731	0.4215	0.4320	T,T,T,.,.	T,T,.	B,B,B,.,.	T,T,T,.,.	0.01	607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000252679.1 [benign]; RCV000312084.1 [benign]; 		COSM4003168, COSM4003166, COSM4003167, COSM4003169	339	1010	2	[2] auto-classification 14.09.2017  			FRAS1 (inh=AR pLI=0.00)
chr4	79372930	79372930	C	T	hom	anno_omim	QUAL=18800;DP=171;AF=0.99;MQM=60;TRIO=HOM,171,0.99,HOM,171,1.00,HOM,241,1.00	FRAS1	synonymous	FRAS1:ENST00000264895:synonymous:LOW:exon46/74:c.6468C>T:p.His2156His		rs753752	0.5795	0.6829	27638,18398,1428	0.5504,0.6826,0.5490,0.7523,0.5114	0.6815	-2.3510		T			7.84	607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000178609.3 [benign]; RCV000309112.1 [benign]; 		COSM1131036, COSM1131035	981	861	2	[2] auto-classification 14.09.2017  			FRAS1 (inh=AR pLI=0.00)
chr4	79385632	79385632	C	T	het	pred_pathogenic;anno_omim	QUAL=10054;DP=353;AF=0.55;MQM=60;TRIO=HET,353,0.55,WT,254,0.00,HET,344,0.54	FRAS1	synonymous	FRAS1:ENST00000264895:synonymous:LOW:exon49/74:c.6924C>T:p.Val2308Val		rs13123710	0.0244	0.0583	286,239,1	0.0132,0.0179,0.0002,0.0841,0.0283	0.0585	2.6800					13.93	607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000253422.1 [benign]; RCV000354292.1 [likely benign]; 			11	232	2	[2] auto-classification 14.09.2017  			FRAS1 (inh=AR pLI=0.00)
chr4	79385719	79385719	G	A	het	anno_omim	QUAL=11143;DP=284;AF=0.56;MQM=60;TRIO=HET,284,0.56,HET,232,0.46,HET,323,0.52	FRAS1	synonymous	FRAS1:ENST00000264895:synonymous:LOW:exon49/74:c.7011G>A:p.Ala2337Ala		rs6851427	0.2975	0.3658	8459,5063,140	0.1684,0.4777,0.3183,0.3900,0.3014	0.3717	-2.2490		T			9.91	607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000246034.1 [benign]; RCV000376269.1 [benign]; 		COSM3760769, COSM3760770	276	940	2	[2] auto-classification 14.09.2017  			FRAS1 (inh=AR pLI=0.00)
chr4	79387442	79387442	C	T	het	anno_omim	QUAL=13885;DP=359;AF=0.46;MQM=59;TRIO=HET,359,0.46,HET,351,0.46,HET,538,0.44	FRAS1	synonymous	FRAS1:ENST00000264895:synonymous:LOW:exon50/74:c.7110C>T:p.His2370His		rs7660664	0.3221	0.3169	6533,4256,1175	0.4914,0.2042,0.2240,0.3582,0.1781	0.3780	-0.0540		T			12.91	607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000249146.1 [benign]; RCV000351573.1 [benign]; 		COSM1131033, COSM1131032	219	903	2	[2] auto-classification 14.09.2017  			FRAS1 (inh=AR pLI=0.00)
chr4	79387464	79387464	A	G	hom	pred_pathogenic;anno_omim	QUAL=42740;DP=437;AF=1.00;MQM=60;TRIO=HOM,437,1.00,HOM,353,1.00,HOM,540,1.00	FRAS1	missense	FRAS1:ENST00000264895:missense:MODERATE:exon50/74:c.7132A>G:p.Lys2378Glu		rs7684722	0.9677	0.9901	59254,33229,4018	0.9035,0.9920,1.0000,0.9979,0.9999	0.9913	7.6740	.,T	T,T	.,B	.,T	17.36	607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000253922.1 [benign]; RCV000395153.1 [benign]; 			2092	15	2	[2] auto-classification 14.09.2017  			FRAS1 (inh=AR pLI=0.00)
chr4	79400868	79400868	C	T	het	anno_omim	QUAL=7615;DP=308;AF=0.49;MQM=59;TRIO=HET,308,0.49,HET,171,0.44,HET,221,0.48	FRAS1	synonymous	FRAS1:ENST00000264895:synonymous:LOW:exon56/74:c.8439C>T:p.Asp2813Asp		rs11098194	0.2913	0.3905	7770,4810,133	0.1824,0.5091,0.3412,0.4116,0.3193	0.3720	1.3810		T			6.49	607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000251274.1 [benign]; RCV000385525.1 [benign]; 		COSM3760774, COSM3760773	272	894	2	[2] auto-classification 14.09.2017  			FRAS1 (inh=AR pLI=0.00)
chr4	79420869	79420869	C	T	het	anno_omim	QUAL=2918;DP=169;AF=0.41;MQM=60;TRIO=HET,169,0.41,HET,95,0.56,WT,144,0.00	FRAS1	splice_region&intron	FRAS1:ENST00000264895:splice_region&intron:LOW:exon60/73:c.9116-6C>T:		rs76630865	0.1725	0.1790	2016,1223,146	0.1725,0.1253,0.2203,0.1908,0.1432	0.1876							607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000241899.1 [benign]; 			88	611	2	[2] auto-classification 14.09.2017  			FRAS1 (inh=AR pLI=0.00)
chr4	79420870	79420870	C	G	het	anno_omim	QUAL=2918;DP=169;AF=0.41;MQM=60;TRIO=HET,169,0.41,HET,95,0.56,WT,144,0.00	FRAS1	splice_region&intron	FRAS1:ENST00000264895:splice_region&intron:LOW:exon60/73:c.9116-5C>G:		rs7695038	0.5917	0.5076	16318,6527,2057	0.6449,0.4476,0.7084,0.4403,0.6593	0.5051							607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000250938.1 [benign]; RCV000263121.1 [benign]; 			588	977	2	[2] auto-classification 14.09.2017  			FRAS1 (inh=AR pLI=0.00)
chr4	79437155	79437155	C	T	het	anno_omim	QUAL=4201;DP=204;AF=0.43;MQM=60;TRIO=HET,204,0.43,HET,222,0.44,WT,306,0.00	FRAS1	synonymous	FRAS1:ENST00000264895:synonymous:LOW:exon66/74:c.10377C>T:p.Thr3459Thr		rs3749487	0.1765	0.1910	2009,1201,163	0.1927,0.1401,0.2497,0.1994,0.1529	0.1931	-1.6450		T			12.18	607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000244857.1 [benign]; RCV000378270.1 [benign]; 		COSM1131030, COSM1131029	87	621	2	[2] auto-classification 14.09.2017  			FRAS1 (inh=AR pLI=0.00)
chr4	79447763	79447763	T	C	het	anno_omim	QUAL=7261;DP=397;AF=0.46;MQM=60;TRIO=HET,397,0.46,HET,170,0.55,WT,240,0.00	FRAS1	missense	FRAS1:ENST00000264895:missense:MODERATE:exon70/74:c.10877T>C:p.Val3626Ala		rs34670941	0.1454	0.1762	773,305,110	0.2194,0.1522,0.3079,0.1617,0.1454	0.1365	0.3720	T	T	B	T	0.32	607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000250854.1 [benign]; RCV000388114.1 [benign]; 			26	384	2	[2] auto-classification 14.09.2017  			FRAS1 (inh=AR pLI=0.00)
chr4	79455714	79455714	C	G	het	anno_omim	QUAL=8830;DP=468;AF=0.47;MQM=60;TRIO=HET,468,0.47,HET,269,0.45,WT,366,0.01	FRAS1	synonymous	FRAS1:ENST00000264895:synonymous:LOW:exon71/74:c.11037C>G:p.Pro3679Pro		rs4975070	0.5150	0.4884	15351,6473,591	0.3385,0.4744,0.7841,0.4381,0.6524	0.4898	0.4930		T			10.72	607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000245809.1 [benign]; RCV000292730.1 [benign]; 		COSM4005806, COSM4005805	550	982	2	[2] auto-classification 14.09.2017  			FRAS1 (inh=AR pLI=0.00)
chr4	79455733	79455733	C	T	het	anno_omim	QUAL=7620;DP=412;AF=0.47;MQM=60;TRIO=HET,412,0.47,HET,250,0.43,WT,337,0.01	FRAS1	synonymous	FRAS1:ENST00000264895:synonymous:LOW:exon71/74:c.11056C>T:p.Leu3686Leu		rs4975139	0.5150	0.4884	15331,6469,590	0.3384,0.4742,0.7833,0.4383,0.6523	0.4895	1.1260		T			12.50	607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000250559.1 [benign]; RCV000333665.1 [benign]; 		COSM4005807, COSM4005808	551	980	2	[2] auto-classification 14.09.2017  			FRAS1 (inh=AR pLI=0.00)
chr4	79462311	79462311	T	A	het	anno_omim	QUAL=5826;DP=261;AF=0.48;MQM=60;TRIO=HET,261,0.48,HET,95,0.44,HET,143,0.45	FRAS1				rs72659058	0.1056	0.2467	1095,948,27	0.1456,0.1570,0.0038,0.3098,0.1177	0.1963							607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000372407.1 [benign]; 			76	427					FRAS1 (inh=AR pLI=0.00)
chr4	79462560	79462560	A	T	het	anno_omim	QUAL=14676;DP=479;AF=0.50;MQM=60;TRIO=HET,479,0.50,HET,263,0.50,HET,346,0.50	FRAS1				rs3749485	0.2023	0.0000	0,0,0	0,0,0,0,0	0.2621							607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000342970.1 [benign]; 			20	102					FRAS1 (inh=AR pLI=0.00)
chr4	79464432	79464432	C	T	het	anno_omim	QUAL=15437;DP=372;AF=0.50;MQM=60;TRIO=HET,372,0.50,HET,353,0.47,HET,449,0.52	FRAS1				rs3811747	0.6617	0.0000	0,0,0	0,0,0,0,0	0.6388							607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000395453.1 [benign]; 			106	97					FRAS1 (inh=AR pLI=0.00)
chr4	79464767	79464767	T	C	het	anno_omim	QUAL=18066;DP=420;AF=0.54;MQM=60;TRIO=HET,420,0.54,HET,390,0.57,HET,413,0.50	FRAS1				rs11098227	0.6617	0.0000	0,0,0	0,0,0,0,0	0.6439							607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000360200.1 [benign]; 			108	98					FRAS1 (inh=AR pLI=0.00)
chr4	79464978	79464978	G	A	het	anno_omim	QUAL=10586;DP=314;AF=0.45;MQM=59;TRIO=HET,314,0.45,HET,211,0.54,HET,267,0.50	FRAS1				rs11098228	0.6404	0.0000	0,0,0	0,0,0,0,0	0.6144							607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000365626.1 [benign]; 			93	105					FRAS1 (inh=AR pLI=0.00)
chr4	79465100	79465100	-	TTTT	het	anno_omim	QUAL=12525;DP=454;AF=0.48;MQM=59;TRIO=HET,454,0.48,HET,231,0.50,HET,336,0.49	FRAS1				rs397724155	0.6406	0.0000	0,0,0	0,0,0,0,0	0.6109							607830 [FRAS1 (provisional) Fraser syndrome,219000];	RCV000331007.1 [benign]; 			93	104					FRAS1 (inh=AR pLI=0.00)
chr4	80823880	80823880	-	T	hom	anno_omim	QUAL=4998;DP=185;AF=0.73;MQM=59;TRIO=HOM,185,0.73,HET,69,0.36,HOM,83,0.76	ANTXR2	3'UTR	ANTXR2:ENST00000403729:3'UTR:MODIFIER:exon17/17:c.*4702dupA:		rs34821632;rs397702828	0.5996	0.0000	0,0,0	0,0,0,0,0	0.5953							608041 [ANTXR2 (provisional) Hyaline fibromatosis syndrome,228600];				77	137					ANTXR2 (inh=AR pLI=0.41)
chr4	80824302	80824302	-	A	het	anno_omim	QUAL=9376;DP=165;AF=0.65;MQM=58;TRIO=HET,165,0.87,WT,112,0.94,HET,165,0.94	ANTXR2	3'UTR	ANTXR2:ENST00000403729:3'UTR:MODIFIER:exon17/17:c.*4280dupT:	AluSz6	rs373264816	0.0000	0.0000	0,0,0	0,0,0,0,0	0.3212							608041 [ANTXR2 (provisional) Hyaline fibromatosis syndrome,228600];				1	8					ANTXR2 (inh=AR pLI=0.41)
chr4	80824311	80824311	G	A	hom	anno_omim	QUAL=9376;DP=165;AF=0.65;MQM=58;TRIO=HOM,165,0.87,HOM,112,0.94,HOM,165,0.94	ANTXR2	3'UTR	ANTXR2:ENST00000403729:3'UTR:MODIFIER:exon17/17:c.*4272C>T:	AluSz6	rs56708107	0.4858	0.0000	0,0,0	0,0,0,0,0	0.5589							608041 [ANTXR2 (provisional) Hyaline fibromatosis syndrome,228600];				14	169					ANTXR2 (inh=AR pLI=0.41)
chr4	80824527	80824527	A	T	hom	anno_omim	QUAL=14991;DP=312;AF=0.78;MQM=59;TRIO=HOM,312,0.78,HET,137,0.40,HOM,188,0.78	ANTXR2	3'UTR	ANTXR2:ENST00000403729:3'UTR:MODIFIER:exon17/17:c.*4056T>A:		rs11946205	0.2516	0.0000	0,0,0	0,0,0,0,0	0.3147							608041 [ANTXR2 (provisional) Hyaline fibromatosis syndrome,228600];				28	122					ANTXR2 (inh=AR pLI=0.41)
chr4	80824888	80824888	A	G	hom	anno_omim	QUAL=19263;DP=310;AF=1.00;MQM=60;TRIO=HOM,310,1.00,HOM,125,1.00,HOM,162,1.00	ANTXR2	3'UTR	ANTXR2:ENST00000403729:3'UTR:MODIFIER:exon17/17:c.*3695T>C:		rs4611863	0.9798	0.0000	0,0,0	0,0,0,0,0	0.9836							608041 [ANTXR2 (provisional) Hyaline fibromatosis syndrome,228600];				232	0					ANTXR2 (inh=AR pLI=0.41)
chr4	80825271	80825271	A	-	hom	anno_omim	QUAL=9431;DP=197;AF=0.99;MQM=60;TRIO=HOM,197,0.99,HOM,41,1.00,HOM,53,0.98	ANTXR2	3'UTR	ANTXR2:ENST00000403729:3'UTR:MODIFIER:exon17/17:c.*3312delT:		rs796643476	0.4858	0.0000	0,0,0	0,0,0,0,0	0.5648							608041 [ANTXR2 (provisional) Hyaline fibromatosis syndrome,228600];				76	111					ANTXR2 (inh=AR pLI=0.41)
chr4	80826920	80826920	C	T	het	anno_omim	QUAL=5010;DP=325;AF=0.44;MQM=60;TRIO=HET,325,0.44,HET,117,0.45,WT,147,0.00	ANTXR2	3'UTR	ANTXR2:ENST00000403729:3'UTR:MODIFIER:exon17/17:c.*1663G>A:		rs113322831	0.0200	0.0000	0,0,0	0,0,0,0,0	0.0318							608041 [ANTXR2 (provisional) Hyaline fibromatosis syndrome,228600];				1	27					ANTXR2 (inh=AR pLI=0.41)
chr4	80827062	80827062	T	C	hom	anno_omim	QUAL=23516;DP=251;AF=1.00;MQM=60;TRIO=HOM,251,1.00,HOM,194,1.00,HOM,281,1.00	ANTXR2	3'UTR	ANTXR2:ENST00000403729:3'UTR:MODIFIER:exon17/17:c.*1521A>G:		rs7747	0.8516	0.0000	0,0,0	0,0,0,0,0	0.8023							608041 [ANTXR2 (provisional) Hyaline fibromatosis syndrome,228600];				151	71					ANTXR2 (inh=AR pLI=0.41)
chr4	80827798	80827798	A	G	hom	anno_omim	QUAL=34009;DP=456;AF=1.00;MQM=60;TRIO=HOM,456,1.00,HOM,251,1.00,HOM,328,1.00	ANTXR2	3'UTR	ANTXR2:ENST00000403729:3'UTR:MODIFIER:exon17/17:c.*785T>C:		rs63539261	0.8492	0.0000	0,0,0	0,0,0,0,0	0.7990							608041 [ANTXR2 (provisional) Hyaline fibromatosis syndrome,228600];				150	72					ANTXR2 (inh=AR pLI=0.41)
chr4	80827799	80827799	A	C	hom	anno_omim	QUAL=34009;DP=456;AF=1.00;MQM=60;TRIO=HOM,456,1.00,HOM,251,1.00,HOM,328,1.00	ANTXR2	3'UTR	ANTXR2:ENST00000403729:3'UTR:MODIFIER:exon17/17:c.*784T>G:		rs1139638	0.8494	0.0000	0,0,0	0,0,0,0,0	0.7989							608041 [ANTXR2 (provisional) Hyaline fibromatosis syndrome,228600];				150	72					ANTXR2 (inh=AR pLI=0.41)
chr4	80905990	80905990	C	G	hom	pred_pathogenic;anno_omim	QUAL=4954;DP=87;AF=0.99;MQM=60;TRIO=HOM,87,0.99,HET,52,0.44,HOM,49,1.00	ANTXR2	missense	ANTXR2:ENST00000307333:missense:MODERATE:exon13/16:c.1069G>C:p.Ala357Pro,ANTXR2:ENST00000403729:missense:MODERATE:exon13/17:c.1069G>C:p.Ala357Pro,ANTXR2:ENST00000404191:missense:MODERATE:exon13/17:c.838G>C:p.Ala280Pro,ANTXR2:ENST00000346652:missense:MODERATE:exon9/12:c.760G>C:p.Ala254Pro		rs12647691	0.8027	0.7699	32664,15944,2320	0.7215,0.8744,0.9468,0.7285,0.8262	0.7683	2.2410	T,T,T,T	T	B,B,B	T,T,T,T	1.67	608041 [ANTXR2 (provisional) Hyaline fibromatosis syndrome,228600];	RCV000284632.1 [benign]; 	CM121492 [CLASS=DFP MUT=ALT PHEN="Anthrax toxin sensitivity association with" GENE=ANTXR2]; 	COSM3760783, COSM3760782	1176	792	2	[2] auto-classification 14.09.2017  			ANTXR2 (inh=AR pLI=0.41)
chr4	80977078	80977078	T	G	hom	anno_omim	QUAL=9673;DP=182;AF=0.99;MQM=60;TRIO=HOM,182,0.99,HET,80,0.51,HOM,84,1.00	ANTXR2	splice_region&intron	ANTXR2:ENST00000307333:splice_region&intron:LOW:exon4/15:c.378+8A>C:,ANTXR2:ENST00000403729:splice_region&intron:LOW:exon4/16:c.378+8A>C:,ANTXR2:ENST00000404191:splice_region&intron:LOW:exon4/16:c.147+8A>C:,ANTXR2:ENST00000346652:splice_region&intron:LOW:exon4/11:c.378+8A>C:,ANTXR2:ENST00000295465:splice_region&intron:LOW:exon4/10:c.378+8A>C:		rs4594664	0.6973	0.7023	9612,3853,571	0.5694,0.8284,0.9504,0.6565,0.7520	0.6750							608041 [ANTXR2 (provisional) Hyaline fibromatosis syndrome,228600];	RCV000275377.1 [benign]; 			829	951	2	[2] auto-classification 14.09.2017  			ANTXR2 (inh=AR pLI=0.41)
chr4	84188850	84188850	G	A	het	anno_omim	QUAL=2678;DP=143;AF=0.45;MQM=59;TRIO=HET,143,0.45,WT,116,0.00,HET,111,0.46	COQ2	synonymous	COQ2:ENST00000311469:synonymous:LOW:exon6/7:c.990C>T:p.Ser330Ser,COQ2:ENST00000439031:synonymous:LOW:exon6/7:c.879C>T:p.Ser293Ser,COQ2:ENST00000311461:synonymous:LOW:exon6/7:c.840C>T:p.Ser280Ser		rs1129617	0.2103	0.2788	1012,529,24	0.1393,0.3538,0.1612,0.3100,0.2922	0.2587							609825 [COQ2 (provisional) Coenzyme Q10 deficiency,primary,1,607426|Multiple system atrophy,susceptibility to,146500];	RCV000116809.4 [other]; RCV000385321.1 [likely benign]; 			218	1218	2	[2] auto-classification 14.09.2017  			COQ2 (inh=AR pLI=0.00)
chr4	84191031	84191031	A	G	het	anno_omim	QUAL=10873;DP=217;AF=0.50;MQM=60;TRIO=HET,217,0.50,HOM,174,1.00,HET,208,0.50	COQ2	synonymous	COQ2:ENST00000311469:synonymous:LOW:exon5/7:c.894T>C:p.Asp298Asp,COQ2:ENST00000439031:synonymous:LOW:exon5/7:c.783T>C:p.Asp261Asp,COQ2:ENST00000311461:synonymous:LOW:exon5/7:c.744T>C:p.Asp248Asp		rs6535454	0.7782	0.7380	32565,16698,3262	0.8187,0.6871,0.8450,0.7136,0.7423	0.7596							609825 [COQ2 (provisional) Coenzyme Q10 deficiency,primary,1,607426|Multiple system atrophy,susceptibility to,146500];	RCV000116808.4 [other]; RCV000350741.1 [benign]; 			1469	1260	2	[2] auto-classification 14.09.2017  			COQ2 (inh=AR pLI=0.00)
chr4	84205872	84205872	C	A	hom	low_DP;anno_omim	QUAL=682;DP=5;AF=1.00;MQM=60;TRIO=HOM,5,1.00,HOM,10,1.00,HOM,9,1.00	COQ2	missense	COQ2:ENST00000311469:missense:MODERATE:exon1/7:c.196G>T:p.Val66Leu,COQ2:ENST00000439031:missense:MODERATE:exon1/7:c.85G>T:p.Val29Leu,COQ2:ENST00000311461:missense:MODERATE:exon1/7:c.46G>T:p.Val16Leu		rs6818847	0.6498	0.7249	3350,959,47	0.5104,0.0000,0.9008,0.7131,0.7306	0.7157	-1.9210	T,T,T	T	B	T,T,T	5.04	609825 [COQ2 (provisional) Coenzyme Q10 deficiency,primary,1,607426|Multiple system atrophy,susceptibility to,146500];	RCV000116807.5 [other]; RCV000297119.1 [benign]; 			1319	1105	2	[2] auto-classification 14.09.2017  			COQ2 (inh=AR pLI=0.00)
chr4	87684031	87684031	A	G	het		QUAL=11295;DP=340;AF=0.44;MQM=60;TRIO=HET,340,0.44,HOM,245,1.00,WT,388,0.00	PTPN13	synonymous	PTPN13:ENST00000436978:synonymous:LOW:exon24/48:c.3705A>G:p.Pro1235Pro,PTPN13:ENST00000427191:synonymous:LOW:exon23/47:c.3648A>G:p.Pro1216Pro,PTPN13:ENST00000316707:synonymous:LOW:exon21/45:c.3132A>G:p.Pro1044Pro,PTPN13:ENST00000411767:synonymous:LOW:exon24/48:c.3705A>G:p.Pro1235Pro,PTPN13:ENST00000511467:synonymous:LOW:exon23/47:c.3705A>G:p.Pro1235Pro		rs710832	0.7109	0.7113	30965,18126,3402	0.8311,0.6951,0.7053,0.7362,0.5477	0.7549											1015	903	2	[2] auto-classification 14.09.2017  			PTPN13 (inh=n/a pLI=0.00)
chr4	87685796	87685796	T	G	het	pred_pathogenic	QUAL=6322;DP=262;AF=0.48;MQM=60;TRIO=HET,262,0.48,HET,178,0.62,WT,196,0.01	PTPN13	missense	PTPN13:ENST00000436978:missense:MODERATE:exon25/48:c.4068T>G:p.Phe1356Leu,PTPN13:ENST00000427191:missense:MODERATE:exon24/47:c.4011T>G:p.Phe1337Leu,PTPN13:ENST00000316707:missense:MODERATE:exon22/45:c.3495T>G:p.Phe1165Leu,PTPN13:ENST00000411767:missense:MODERATE:exon25/48:c.4068T>G:p.Phe1356Leu,PTPN13:ENST00000511467:missense:MODERATE:exon24/47:c.4068T>G:p.Phe1356Leu		rs10033029	0.0521	0.1503	379,323,12	0.0770,0.1647,0.0280,0.2068,0.0676	0.0827	2.6660	T,T,T,T,T,T	T	B,B,B,B	T,T,T,T,T	10.67					22	368	2	[2] auto-classification 14.09.2017  			PTPN13 (inh=n/a pLI=0.00)
chr4	87692393	87692393	G	A	het	pred_pathogenic	QUAL=9875;DP=478;AF=0.49;MQM=60;TRIO=HET,478,0.49,HET,312,0.50,WT,413,0.00	PTPN13	missense	PTPN13:ENST00000436978:missense:MODERATE:exon31/48:c.4888G>A:p.Glu1630Lys,PTPN13:ENST00000427191:missense:MODERATE:exon30/47:c.4816G>A:p.Glu1606Lys,PTPN13:ENST00000316707:missense:MODERATE:exon28/45:c.4300G>A:p.Glu1434Lys,PTPN13:ENST00000411767:missense:MODERATE:exon31/48:c.4873G>A:p.Glu1625Lys,PTPN13:ENST00000511467:missense:MODERATE:exon30/47:c.4888G>A:p.Glu1630Lys		rs12500797	0.0443	0.0993	441,376,4	0.0289,0.0624,0.0151,0.1344,0.0620	0.0793	5.2760	T,T,T,T,T,T	T	B,B,B,B	T,T,T,T,T	20.10			CM067710 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=PTPN13]; 		24	371	2	[2] auto-classification 14.09.2017  			PTPN13 (inh=n/a pLI=0.00)
chr4	87696470	87696470	A	G	het		QUAL=4625;DP=269;AF=0.49;MQM=60;TRIO=HET,269,0.49,HET,82,0.50,WT,114,0.00	PTPN13	synonymous	PTPN13:ENST00000436978:synonymous:LOW:exon34/48:c.5670A>G:p.Thr1890Thr,PTPN13:ENST00000427191:synonymous:LOW:exon33/47:c.5598A>G:p.Thr1866Thr,PTPN13:ENST00000316707:synonymous:LOW:exon31/45:c.5082A>G:p.Thr1694Thr,PTPN13:ENST00000411767:synonymous:LOW:exon34/48:c.5655A>G:p.Thr1885Thr,PTPN13:ENST00000511467:synonymous:LOW:exon33/47:c.5670A>G:p.Thr1890Thr		rs12507034	0.0705	0.0855	519,404,51	0.1000,0.0453,0.0116,0.1092,0.0503	0.0991											26	380	2	[2] auto-classification 14.09.2017  			PTPN13 (inh=n/a pLI=0.00)
chr4	87696476	87696476	G	A	het		QUAL=4425;DP=260;AF=0.48;MQM=60;TRIO=HET,260,0.48,HET,84,0.51,WT,116,0.00	PTPN13	synonymous	PTPN13:ENST00000436978:synonymous:LOW:exon34/48:c.5676G>A:p.Thr1892Thr,PTPN13:ENST00000427191:synonymous:LOW:exon33/47:c.5604G>A:p.Thr1868Thr,PTPN13:ENST00000316707:synonymous:LOW:exon31/45:c.5088G>A:p.Thr1696Thr,PTPN13:ENST00000411767:synonymous:LOW:exon34/48:c.5661G>A:p.Thr1887Thr,PTPN13:ENST00000511467:synonymous:LOW:exon33/47:c.5676G>A:p.Thr1892Thr		rs12499471	0.0705	0.0857	520,404,52	0.1003,0.0453,0.0116,0.1094,0.0504	0.0994											26	381	2	[2] auto-classification 14.09.2017  			PTPN13 (inh=n/a pLI=0.00)
chr4	87736307	87736307	A	C	het		QUAL=4562;DP=249;AF=0.41;MQM=60;TRIO=HET,249,0.41,HET,147,0.48,WT,178,0.00	PTPN13	3'UTR	PTPN13:ENST00000436978:3'UTR:MODIFIER:exon48/48:c.*603A>C:,PTPN13:ENST00000427191:3'UTR:MODIFIER:exon47/47:c.*603A>C:		rs17750575	0.0657	0.0000	0,0,0	0,0,0,0,0	0.0947											0	39					PTPN13 (inh=n/a pLI=0.00)
chr4	88584148	88584148	C	T	het	anno_omim	QUAL=7638;DP=277;AF=0.47;MQM=60;TRIO=HET,277,0.47,WT,301,0.01,HET,382,0.46	DMP1,RP11-742B18.1	synonymous	DMP1:ENST00000339673:synonymous:LOW:exon6/6:c.1218C>T:p.Ser406Ser,DMP1:ENST00000282479:synonymous:LOW:exon5/5:c.1170C>T:p.Ser390Ser		rs2615498	0.1757	0.1915	2452,1239,25	0.0643,0.1085,0.2332,0.1947,0.2830	0.1898							600980 [DMP1 (confirmed) Hypophosphatemic rickets,AR,241520];	RCV000266071.1 [benign]; 		COSM3760817	113	668	2	[2] auto-classification 14.09.2017  			DMP1 (inh=AR pLI=0.00), RP11-742B18.1 (inh=n/a pLI=n/a)
chr4	88584160	88584160	G	A	het	anno_omim	QUAL=8226;DP=285;AF=0.49;MQM=60;TRIO=HET,285,0.49,WT,281,0.01,HET,369,0.46	DMP1,RP11-742B18.1	synonymous	DMP1:ENST00000339673:synonymous:LOW:exon6/6:c.1230G>A:p.Glu410Glu,DMP1:ENST00000282479:synonymous:LOW:exon5/5:c.1182G>A:p.Glu394Glu		rs2615497	0.3213	0.2595	4358,1760,849	0.4073,0.1451,0.2510,0.2321,0.3514	0.2779							600980 [DMP1 (confirmed) Hypophosphatemic rickets,AR,241520];	RCV000321108.1 [benign]; 		COSM3760818	187	778	2	[2] auto-classification 14.09.2017  			DMP1 (inh=AR pLI=0.00), RP11-742B18.1 (inh=n/a pLI=n/a)
chr4	88584507	88584507	G	A	het	anno_omim	QUAL=8482;DP=304;AF=0.50;MQM=60;TRIO=HET,304,0.50,WT,263,0.00,HET,321,0.49	DMP1,RP11-742B18.1	3'UTR	DMP1:ENST00000339673:3'UTR:MODIFIER:exon6/6:c.*35G>A:,DMP1:ENST00000282479:3'UTR:MODIFIER:exon5/5:c.*35G>A:		rs2627724	0.3213	0.2596	4346,1761,832	0.4088,0.1451,0.2508,0.2324,0.3518	0.2786							600980 [DMP1 (confirmed) Hypophosphatemic rickets,AR,241520];	RCV000351172.1 [benign]; 			169	722					DMP1 (inh=AR pLI=0.00), RP11-742B18.1 (inh=n/a pLI=n/a)
chr4	88585079	88585079	A	G	het	anno_omim	QUAL=8169;DP=438;AF=0.53;MQM=60;TRIO=HET,438,0.53,WT,123,0.01,HET,138,0.49	DMP1,RP11-742B18.1	3'UTR	DMP1:ENST00000339673:3'UTR:MODIFIER:exon6/6:c.*607A>G:,DMP1:ENST00000282479:3'UTR:MODIFIER:exon5/5:c.*607A>G:	L2c	rs2627725	0.6661	0.0000	0,0,0	0,0,0,0,0	0.6178							600980 [DMP1 (confirmed) Hypophosphatemic rickets,AR,241520];	RCV000359119.1 [benign]; 			62	113					DMP1 (inh=AR pLI=0.00), RP11-742B18.1 (inh=n/a pLI=n/a)
chr4	88585218	88585219	TT	-	het	anno_omim	QUAL=11094;DP=222;AF=0.50;MQM=59;TRIO=HET,222,0.50,HET,151,0.52,HET,174,0.49	DMP1,RP11-742B18.1	3'UTR	DMP1:ENST00000339673:3'UTR:MODIFIER:exon6/6:c.*757_*758delTT:,DMP1:ENST00000282479:3'UTR:MODIFIER:exon5/5:c.*757_*758delTT:		rs35239689;rs60181711	0.3486	0.0000	0,0,0	0,0,0,0,0	0.3038							600980 [DMP1 (confirmed) Hypophosphatemic rickets,AR,241520];	RCV000300425.1 [benign]; 			23	97					DMP1 (inh=AR pLI=0.00), RP11-742B18.1 (inh=n/a pLI=n/a)
chr4	88585218	88585218	T	-	het	anno_omim	QUAL=11094;DP=222;AF=0.43;MQM=59;TRIO=HET,222,0.43,HET,151,0.37,HET,174,0.40	DMP1,RP11-742B18.1	3'UTR	DMP1:ENST00000339673:3'UTR:MODIFIER:exon6/6:c.*758delT:,DMP1:ENST00000282479:3'UTR:MODIFIER:exon5/5:c.*758delT:		rs34488194;rs35239689;rs398083277;rs545768168	0.4824	0.0000	0,0,0	0,0,0,0,0	0.4733							600980 [DMP1 (confirmed) Hypophosphatemic rickets,AR,241520];				51	102					DMP1 (inh=AR pLI=0.00), RP11-742B18.1 (inh=n/a pLI=n/a)
chr4	103611845	103611845	C	T	hom	anno_omim	QUAL=8499;DP=148;AF=0.99;MQM=60;TRIO=HOM,148,0.99,HET,135,0.50,HET,164,0.50	MANBA	missense	MANBA:ENST00000226578:missense:MODERATE:exon6/17:c.757G>A:p.Val253Ile,MANBA:ENST00000505239:missense:MODERATE:exon5/16:c.586G>A:p.Val196Ile		rs227368	0.3766	0.4427	12586,7817,184	0.1860,0.2962,0.4462,0.4836,0.4912	0.4436	-0.2430	T,T	T	B,B	T,T	6.84	609489 [MANBA (confirmed) Mannosidosis,beta,248510];	RCV000354084.1 [benign]; 		COSM4155100	528	976	2	[2] auto-classification 14.09.2017  			MANBA (inh=AR pLI=0.00)
chr4	107270027	107270027	G	A	het	anno_omim	QUAL=8735;DP=363;AF=0.48;MQM=60;TRIO=HET,363,0.48,WT,228,0.00,HET,263,0.56	AIMP1	3'UTR	AIMP1:ENST00000394701:3'UTR:MODIFIER:exon7/7:c.*1178G>A:,AIMP1:ENST00000442366:3'UTR:MODIFIER:exon7/7:c.*1178G>A:		rs13534	0.1785	0.0000	0,0,0	0,0,0,0,0	0.1991							603605 [AIMP1 (provisional) Leukodystrophy,hypomyelinating,3,260600];				15	85					AIMP1 (inh=AR pLI=0.00)
chr4	108931039	108931039	T	C	hom	pred_pathogenic;anno_omim	QUAL=21968;DP=353;AF=1.00;MQM=60;TRIO=HOM,353,1.00,HOM,151,0.99,HOM,187,1.00	HADH	missense	HADH:ENST00000403312:missense:MODERATE:exon2/9:c.434T>C:p.Leu145Pro,HADH:ENST00000603302:missense:MODERATE:exon2/9:c.257T>C:p.Leu86Pro,HADH:ENST00000309522:missense:MODERATE:exon2/8:c.257T>C:p.Leu86Pro,HADH:ENST00000505878:missense:MODERATE:exon3/9:c.269T>C:p.Leu90Pro,HADH:ENST00000454409:missense:MODERATE:exon2/8:c.269T>C:p.Leu90Pro		rs4956145	0.8690	0.9151	51193,28932,2554	0.6957,0.9680,0.9733,0.9311,0.9006	0.9216	4.8010	T,T,T,T	T	B,B,B	T,T,T	10.80	601609 [HADH (confirmed) 3-hydroxyacyl-CoA dehydrogenase deficiency,231530|Hyperinsulinemic hypoglycemia,familial,4,609975];	RCV000153344.2 [benign]; 			1786	305	2	[2] auto-classification 14.09.2017  			HADH (inh=AR pLI=0.00)
chr4	110661937	110661937	G	A	hom	anno_omim	QUAL=13180;DP=253;AF=1.00;MQM=60;TRIO=HOM,253,1.00,HOM,75,1.00,HOM,86,1.00	CFI	3'UTR	CFI:ENST00000394635:3'UTR:MODIFIER:exon14/14:c.*112C>T:,CFI:ENST00000394634:3'UTR:MODIFIER:exon13/13:c.*112C>T:,CFI:ENST00000512148:3'UTR:MODIFIER:exon12/12:c.*112C>T:		rs551	0.9537	0.9882	27997,14744,1528	0.8533,0.9903,1.0000,0.9994,1.0000	0.9892							217030 [CFI (confirmed) Complement factor I deficiency,610984|Hemolytic uremic syndrome,atypical,susceptibility to,3,612923|Macular degeneration,age-related,13,susceptibility to,615439];	RCV000344762.1 [benign]; 			1585	15					CFI (inh=AR pLI=0.00)
chr4	110678925	110678925	T	C	hom	pred_pathogenic;anno_omim	QUAL=8991;DP=168;AF=1.00;MQM=59;TRIO=HOM,168,1.00,HOM,44,1.00,HOM,61,1.00	CFI	missense,intron	CFI:ENST00000394635:missense:MODERATE:exon8/14:c.922A>G:p.Thr308Ala,CFI:ENST00000394634:missense:MODERATE:exon7/13:c.898A>G:p.Thr300Ala,CFI:ENST00000512148:intron:MODIFIER:exon6/11:c.883+2501A>G:		rs11098044	0.9669	0.9906	54184,29997,3457	0.8909,0.9951,1.0000,0.9995,0.9999	0.9923	-0.2530	T,T,T	T	B,B	D,D	0.01	217030 [CFI (confirmed) Complement factor I deficiency,610984|Hemolytic uremic syndrome,atypical,susceptibility to,3,612923|Macular degeneration,age-related,13,susceptibility to,615439];				2081	14	2	[2] auto-classification 14.09.2017  			CFI (inh=AR pLI=0.00)
chr4	113565887	113565889	AAG	-	het	anno_omim	QUAL=2516;DP=107;AF=0.52;MQM=59;TRIO=HET,107,0.52,HET,102,0.50,WT,121,0.00	LARP7	disruptive_inframe_deletion	LARP7:ENST00000509061:disruptive_inframe_deletion:MODERATE:exon4/15:c.86_88delAAG:p.Glu29del,LARP7:ENST00000344442:disruptive_inframe_deletion:MODERATE:exon2/13:c.65_67delAAG:p.Glu22del,LARP7:ENST00000324052:disruptive_inframe_deletion:MODERATE:exon2/13:c.65_67delAAG:p.Glu22del		rs570445594	0.0012	0.0027	1,0,0	0.0011,0.0011,0.0000,0.0040,0.0014	0.0028							612026 [LARP7 (provisional) Alazami syndrome,615071];				0	15					LARP7 (inh=AR pLI=0.02)
chr4	119201532	119201533	TT	-	het	anno_omim	QUAL=7817;DP=307;AF=0.54;MQM=59;TRIO=HET,307,0.54,HOM,128,0.99,WT,161,0.00	PRSS12	3'UTR	PRSS12:ENST00000296498:3'UTR:MODIFIER:exon13/13:c.*1558_*1559delAA:		rs397839202	0.2312	0.0000	0,0,0	0,0,0,0,0	0.2796							606709 [PRSS12 (provisional) Mental retardation,autosomal recessive 1,249500];	RCV000355255.1 [benign]; 			16	60					PRSS12 (inh=AR pLI=0.00)
chr4	119201587	119201587	C	T	het	anno_omim	QUAL=7535;DP=364;AF=0.45;MQM=60;TRIO=HET,364,0.45,WT,183,0.00,HET,238,0.49	PRSS12	3'UTR	PRSS12:ENST00000296498:3'UTR:MODIFIER:exon13/13:c.*1504G>A:		rs1045817	0.0958	0.0000	0,0,0	0,0,0,0,0	0.1206							606709 [PRSS12 (provisional) Mental retardation,autosomal recessive 1,249500];	RCV000262931.1 [likely benign]; 			9	47					PRSS12 (inh=AR pLI=0.00)
chr4	119219909	119219909	C	A	het	pred_pathogenic;anno_omim	QUAL=8295;DP=248;AF=0.55;MQM=60;TRIO=HET,248,0.55,WT,269,0.00,HET,362,0.53	PRSS12	missense	PRSS12:ENST00000296498:missense:MODERATE:exon9/13:c.1816G>T:p.Ala606Ser		rs28661939	0.1246	0.1479	1534,739,83	0.1225,0.1373,0.0554,0.1435,0.2069	0.1493	0.8120	T	T	B	D	15.33	606709 [PRSS12 (provisional) Mental retardation,autosomal recessive 1,249500];	RCV000118070.2 [likely benign]; RCV000272402.1 [likely benign]; 			59	540	2	[2] auto-classification 14.09.2017  			PRSS12 (inh=AR pLI=0.00)
chr4	119237348	119237348	T	C	het	anno_omim	QUAL=10549;DP=223;AF=0.53;MQM=60;TRIO=HET,223,0.53,WT,170,0.01,HOM,232,1.00	PRSS12	synonymous	PRSS12:ENST00000296498:synonymous:LOW:exon6/13:c.1281A>G:p.Gln427Gln		rs2292597	0.5453	0.5547	18794,9996,1198	0.4779,0.5176,0.5917,0.5473,0.6056	0.5549							606709 [PRSS12 (provisional) Mental retardation,autosomal recessive 1,249500];	RCV000118068.2 [likely benign]; RCV000376373.1 [benign]; 		COSM149728	701	974	2	[2] auto-classification 14.09.2017  			PRSS12 (inh=AR pLI=0.00)
chr4	122742217	122742217	T	C	hom		QUAL=18127;DP=245;AF=1.00;MQM=60;TRIO=HOM,245,1.00,HOM,103,1.00,HOM,199,1.00	CCNA2	missense	CCNA2:ENST00000274026:missense:MODERATE:exon3/8:c.487A>G:p.Ile163Val		rs769242	0.9687	0.9629	56293,30604,5095	0.9898,0.9815,0.9411,0.9578,0.9727	0.9672	1.1430	T	T	B	T	8.60					2000	105	2	[2] auto-classification 14.09.2017  			CCNA2 (inh=n/a pLI=0.99)
chr4	122744942	122744942	G	A	hom		QUAL=10408;DP=61;AF=0.98;MQM=60;TRIO=HOM,61,0.98,HOM,186,1.00,HET,214,0.54	CCNA2	5'UTR_premature_start_codon_gain,5'UTR	CCNA2:ENST00000274026:5'UTR_premature_start_codon_gain:LOW:exon1/8:c.-159C>T:,CCNA2:ENST00000274026:5'UTR:MODIFIER:exon1/8:c.-159C>T:	(CAGCC)n	rs769238	0.2494	0.0000	0,0,0	0,0,0,0,0	0.2879											33	96	2	[2] auto-classification 14.09.2017  			CCNA2 (inh=n/a pLI=0.99)
chr4	122744979	122744979	G	A	het		QUAL=2234;DP=52;AF=0.46;MQM=60;TRIO=HET,52,0.46,HET,141,0.53,WT,191,0.00	CCNA2	5'UTR_premature_start_codon_gain,5'UTR	CCNA2:ENST00000274026:5'UTR_premature_start_codon_gain:LOW:exon1/8:c.-196C>T:,CCNA2:ENST00000274026:5'UTR:MODIFIER:exon1/8:c.-196C>T:		rs769237	0.0208	0.0000	0,0,0	0,0,0,0,0	0.0143											0	17					CCNA2 (inh=n/a pLI=0.99)
chr4	122745729	122745729	C	T	hom	anno_omim	QUAL=11636;DP=199;AF=1.00;MQM=60;TRIO=HOM,199,1.00,HOM,114,1.00,HET,137,0.43	BBS7	3'UTR	BBS7:ENST00000264499:3'UTR:MODIFIER:exon19/19:c.*1286G>A:		rs1507996	0.1723	0.0000	0,0,0	0,0,0,0,0	0.2234							607590 [BBS7 (confirmed) Bardet-Biedl syndrome 7,615984];	RCV000260314.1 [likely benign]; 			26	78					BBS7 (inh=AR pLI=0.00)
chr4	122746325	122746325	A	G	hom	anno_omim	QUAL=22203;DP=411;AF=1.00;MQM=60;TRIO=HOM,411,1.00,HOM,160,0.99,HET,217,0.54	BBS7	3'UTR	BBS7:ENST00000264499:3'UTR:MODIFIER:exon19/19:c.*690T>C:	MamSINE1	rs3217753	0.2494	0.0000	0,0,0	0,0,0,0,0	0.2882							607590 [BBS7 (confirmed) Bardet-Biedl syndrome 7,615984];	RCV000401212.1 [benign]; 			33	97					BBS7 (inh=AR pLI=0.00)
chr4	145701128	145701128	T	G	hom		QUAL=25863;DP=364;AF=1.00;MQM=60;TRIO=HOM,364,1.00,HOM,174,1.00,HOM,240,1.00	HHIP,HSPD1P5	intergenic_region	HSPD1P5:ENSG00000164161-ENSG00000249193:intergenic_region:MODIFIER::n.145701128T>G:		rs4835188	0.9589	0.0000	0,0,0	0,0,0,0,0	0.9640											152	0					HHIP (inh=n/a pLI=0.98), HSPD1P5 (inh=n/a pLI=n/a)
chr4	146579194	146579194	T	C	het	anno_omim	QUAL=5920;DP=286;AF=0.47;MQM=60;TRIO=HET,286,0.47,HET,77,0.45,HET,132,0.45	MMAA	3'UTR	MMAA:ENST00000281317:3'UTR:MODIFIER:exon7/7:c.*2608T>C:	MSTB	rs7699187	0.5657	0.0000	0,0,0	0,0,0,0,0	0.4946							607481 [MMAA (provisional) Methylmalonic aciduria,vitamin B12-responsive,251100];	RCV000338170.1 [benign]; 			33	77					MMAA (inh=AR pLI=0.00)
chr4	146579354	146579354	A	T	het	anno_omim	QUAL=4150;DP=147;AF=0.43;MQM=60;TRIO=HET,147,0.43,HET,86,0.49,HET,127,0.44	MMAA	3'UTR	MMAA:ENST00000281317:3'UTR:MODIFIER:exon7/7:c.*2768A>T:	MSTB	rs7699166	0.5657	0.0000	0,0,0	0,0,0,0,0	0.4945							607481 [MMAA (provisional) Methylmalonic aciduria,vitamin B12-responsive,251100];	RCV000302001.1 [benign]; 			41	89					MMAA (inh=AR pLI=0.00)
chr4	146579452	146579452	A	G	het	anno_omim	QUAL=7531;DP=422;AF=0.45;MQM=60;TRIO=HET,422,0.45,WT,103,0.00,HET,180,0.50	MMAA	3'UTR	MMAA:ENST00000281317:3'UTR:MODIFIER:exon7/7:c.*2866A>G:	MIR:MIR	rs17020500	0.2742	0.0000	0,0,0	0,0,0,0,0	0.2264							607481 [MMAA (provisional) Methylmalonic aciduria,vitamin B12-responsive,251100];	RCV000309727.1 [benign]; 			12	86					MMAA (inh=AR pLI=0.00)
chr4	146579844	146579844	A	-	het	anno_omim	QUAL=253;DP=266;AF=0.30;MQM=59;TRIO=HET,266,0.30,WT,81,0.41,WT,99,0.17	MMAA	3'UTR	MMAA:ENST00000281317:3'UTR:MODIFIER:exon7/7:c.*3274delA:	(A)n	rs33978754	0.2766	0.0000	0,0,0	0,0,0,0,0	0.2701							607481 [MMAA (provisional) Methylmalonic aciduria,vitamin B12-responsive,251100];	RCV000374061.1 [likely benign]; 			13	91					MMAA (inh=AR pLI=0.00)
chr4	149000024	149000024	C	T	hom	anno_omim	QUAL=21264;DP=399;AF=0.99;MQM=60;TRIO=HOM,399,0.99,HOM,115,1.00,HOM,161,0.99	NR3C2	3'UTR	NR3C2:ENST00000355292:3'UTR:MODIFIER:exon9/9:c.*2471G>A:,NR3C2:ENST00000344721:3'UTR:MODIFIER:exon9/9:c.*2471G>A:,NR3C2:ENST00000358102:3'UTR:MODIFIER:exon9/9:c.*2471G>A:		rs2871	0.7163	0.0000	0,0,0	0,0,0,0,0	0.6682							600983 [NR3C2 (confirmed) Pseudohypoaldosteronism type I,autosomal dominant,177735|Hypertension,early-onset,autosomal dominant,with exacerbation in pregnancy,605115];	RCV000351462.1 [benign]; 			118	110					NR3C2 (inh=AD pLI=0.93)
chr4	149001085	149001085	T	C	hom	anno_omim	QUAL=19988;DP=332;AF=1.00;MQM=60;TRIO=HOM,332,1.00,HOM,172,1.00,HET,259,0.54	NR3C2	3'UTR	NR3C2:ENST00000355292:3'UTR:MODIFIER:exon9/9:c.*1410A>G:,NR3C2:ENST00000344721:3'UTR:MODIFIER:exon9/9:c.*1410A>G:,NR3C2:ENST00000358102:3'UTR:MODIFIER:exon9/9:c.*1410A>G:		rs5534	0.5535	0.0000	0,0,0	0,0,0,0,0	0.4963							600983 [NR3C2 (confirmed) Pseudohypoaldosteronism type I,autosomal dominant,177735|Hypertension,early-onset,autosomal dominant,with exacerbation in pregnancy,605115];	RCV000298395.1 [benign]; 			85	118					NR3C2 (inh=AD pLI=0.93)
chr4	149002017	149002017	T	-	hom	anno_omim	QUAL=5959;DP=121;AF=0.99;MQM=59;TRIO=HOM,121,0.99,HOM,31,1.00,HOM,37,1.00	NR3C2	3'UTR	NR3C2:ENST00000355292:3'UTR:MODIFIER:exon9/9:c.*478delA:,NR3C2:ENST00000344721:3'UTR:MODIFIER:exon9/9:c.*478delA:,NR3C2:ENST00000358102:3'UTR:MODIFIER:exon9/9:c.*478delA:,NR3C2:ENST00000512865:3'UTR:MODIFIER:exon8/8:c.*478delA:	(T)n	rs397779293;rs63748994	0.0000	0.7082	2874,771,34	0.3900,0.0000,0.0000,0.6908,0.7330	0.6932							600983 [NR3C2 (confirmed) Pseudohypoaldosteronism type I,autosomal dominant,177735|Hypertension,early-onset,autosomal dominant,with exacerbation in pregnancy,605115];				701	708					NR3C2 (inh=AD pLI=0.93)
chr4	149356516	149356516	A	G	hom	anno_omim	QUAL=33543;DP=397;AF=0.99;MQM=59;TRIO=HOM,397,0.99,HOM,265,1.00,HOM,371,1.00	NR3C2	synonymous	NR3C2:ENST00000355292:synonymous:LOW:exon2/9:c.1497T>C:p.Asp499Asp,NR3C2:ENST00000344721:synonymous:LOW:exon2/9:c.1497T>C:p.Asp499Asp,NR3C2:ENST00000358102:synonymous:LOW:exon2/9:c.1497T>C:p.Asp499Asp,NR3C2:ENST00000512865:synonymous:LOW:exon2/8:c.1497T>C:p.Asp499Asp,NR3C2:ENST00000511528:synonymous:LOW:exon1/8:c.1497T>C:p.Asp499Asp		rs5525	0.8920	0.8819	47268,26588,4307	0.9105,0.7647,0.8567,0.8929,0.9005	0.8891							600983 [NR3C2 (confirmed) Pseudohypoaldosteronism type I,autosomal dominant,177735|Hypertension,early-onset,autosomal dominant,with exacerbation in pregnancy,605115];	RCV000253646.1 [benign]; RCV000348059.1 [benign]; 			1760	325	2	[2] auto-classification 14.09.2017  			NR3C2 (inh=AD pLI=0.93)
chr4	149357475	149357475	C	T	hom	pred_pathogenic;anno_omim	QUAL=27706;DP=370;AF=1.00;MQM=60;TRIO=HOM,370,1.00,HOM,236,1.00,HOM,247,1.00	NR3C2	missense	NR3C2:ENST00000355292:missense:MODERATE:exon2/9:c.538G>A:p.Val180Ile,NR3C2:ENST00000344721:missense:MODERATE:exon2/9:c.538G>A:p.Val180Ile,NR3C2:ENST00000358102:missense:MODERATE:exon2/9:c.538G>A:p.Val180Ile,NR3C2:ENST00000512865:missense:MODERATE:exon2/8:c.538G>A:p.Val180Ile,NR3C2:ENST00000511528:missense:MODERATE:exon1/8:c.538G>A:p.Val180Ile		rs5522	0.8920	0.8812	47201,26545,4300	0.9095,0.7635,0.8561,0.8921,0.9004	0.8885	-0.3800	T,T,T,T,T,T,T	T	B,B	D,D,D,D,D,D	0.01	600983 [NR3C2 (confirmed) Pseudohypoaldosteronism type I,autosomal dominant,177735|Hypertension,early-onset,autosomal dominant,with exacerbation in pregnancy,605115];	RCV000245161.1 [benign]; RCV000313848.1 [benign]; 			1756	327	2	[2] auto-classification 14.09.2017  			NR3C2 (inh=AD pLI=0.93)
chr4	149358014	149358014	G	C	hom	anno_omim	QUAL=17721;DP=310;AF=1.00;MQM=60;TRIO=HOM,310,1.00,HET,251,0.54,HET,318,0.50	NR3C2	splice_region,5'UTR	NR3C2:ENST00000355292:splice_region:LOW:exon2/9:c.-2C>G:,NR3C2:ENST00000344721:splice_region:LOW:exon2/9:c.-2C>G:,NR3C2:ENST00000358102:splice_region:LOW:exon2/9:c.-2C>G:,NR3C2:ENST00000512865:splice_region:LOW:exon2/8:c.-2C>G:,NR3C2:ENST00000355292:5'UTR:MODIFIER:exon2/9:c.-2C>G:,NR3C2:ENST00000344721:5'UTR:MODIFIER:exon2/9:c.-2C>G:,NR3C2:ENST00000358102:5'UTR:MODIFIER:exon2/9:c.-2C>G:,NR3C2:ENST00000512865:5'UTR:MODIFIER:exon2/8:c.-2C>G:		rs2070951	0.5008	0.5511	16376,7303,255	0.2603,0.5990,0.7719,0.5183,0.6371	0.5327							600983 [NR3C2 (confirmed) Pseudohypoaldosteronism type I,autosomal dominant,177735|Hypertension,early-onset,autosomal dominant,with exacerbation in pregnancy,605115];	RCV000248688.1 [benign]; RCV000355928.1 [benign]; 			508	969	2	[2] auto-classification 14.09.2017  			NR3C2 (inh=AD pLI=0.93)
chr4	159601676	159601676	C	T	hom	pred_pathogenic;anno_omim	QUAL=25364;DP=259;AF=1.00;MQM=60;TRIO=HOM,259,1.00,HOM,228,1.00,HOM,272,1.00	ETFDH	missense,intron	ETFDH:ENST00000511912:missense:MODERATE:exon2/13:c.92C>T:p.Thr31Ile,ETFDH:ENST00000307738:intron:MODIFIER:exon1/11:c.35-1671C>T:		rs11559290	0.6727	0.8119	42011,25002,287	0.2352,0.7328,0.9750,0.8665,0.8729	0.8208	1.1210	T	T	B	D	16.37	231675 [ETFDH (confirmed) Glutaric acidemia IIC,231680];	RCV000081080.4 [benign]; RCV000355141.1 [benign]; 		COSM4158888	1921	559	2	[2] auto-classification 14.09.2017  			ETFDH (inh=AR pLI=0.00)
chr4	178352679	178352679	T	G	hom	anno_omim	QUAL=11591;DP=228;AF=1.00;MQM=60;TRIO=HOM,228,1.00,HOM,45,1.00,HOM,77,1.00	AGA	3'UTR	AGA:ENST00000264595:3'UTR:MODIFIER:exon9/9:c.*183A>C:		rs1061814	0.4569	0.6106	2634,1161,36	0.3333,0.5461,0.5537,0.6691,0.6034	0.5715							613228 [AGA (confirmed) Aspartylglucosaminuria,208400];	RCV000389140.1 [benign]; 			263	302					AGA (inh=AR pLI=0.00)
chr4	178359960	178359960	G	C	hom	pred_pathogenic;anno_omim	QUAL=19377;DP=243;AF=1.00;MQM=60;TRIO=HOM,243,1.00,HOM,154,1.00,HOM,203,1.00	AGA	missense	AGA:ENST00000264595:missense:MODERATE:exon4/9:c.446C>G:p.Thr149Ser		rs2228119	0.9209	0.9782	58324,33314,3038	0.7642,0.9877,0.9999,0.9995,0.9999	0.9828	-0.1550	.,T,T	T,T	.,B	.,D,D	0.01	613228 [AGA (confirmed) Aspartylglucosaminuria,208400];	RCV000077944.5 [benign]; RCV000394488.1 [benign]; 			2087	18	2	[2] auto-classification 14.09.2017  			AGA (inh=AR pLI=0.00)
chr4	184369040	184369040	G	A	hom		QUAL=12196;DP=289;AF=1.00;MQM=60;TRIO=HOM,289,1.00,HET,99,0.56,HET,141,0.42	CDKN2AIP	3'UTR	CDKN2AIP:ENST00000504169:3'UTR:MODIFIER:exon3/3:c.*460G>A:,CDKN2AIP:ENST00000302350:3'UTR:MODIFIER:exon3/3:c.*1791G>A:		rs3187025	0.0719	0.0000	0,0,0	0,0,0,0,0	0.0873											7	39					CDKN2AIP (inh=n/a pLI=0.99)
chr4	186068637	186068637	A	G	hom	anno_omim	QUAL=14520;DP=213;AF=0.99;MQM=60;TRIO=HOM,213,0.99,HOM,123,1.00,HOM,119,1.00	SLC25A4	3'UTR	SLC25A4:ENST00000281456:3'UTR:MODIFIER:exon4/4:c.*512A>G:		rs7660552	0.9365	0.0000	0,0,0	0,0,0,0,0	0.8968							103220 [SLC25A4 (confirmed) Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal dominant 2,609283|Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD,617184|Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR,615418];	RCV000265917.1 [benign]; 			189	37					SLC25A4 (inh=AR+AD pLI=0.48)
chr4	186069178	186069178	T	C	hom	anno_omim	QUAL=10524;DP=154;AF=1.00;MQM=59;TRIO=HOM,154,1.00,HET,101,0.49,HOM,139,0.99	SLC25A4	3'UTR	SLC25A4:ENST00000281456:3'UTR:MODIFIER:exon4/4:c.*1053T>C:	MLT1A0	rs55905558	0.4399	0.0000	0,0,0	0,0,0,0,0	0.4365							103220 [SLC25A4 (confirmed) Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal dominant 2,609283|Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD,617184|Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR,615418];	RCV000282068.1 [benign]; 			51	64					SLC25A4 (inh=AR+AD pLI=0.48)
chr4	186070432	186070432	T	C	hom	anno_omim	QUAL=38759;DP=462;AF=1.00;MQM=59;TRIO=HOM,462,1.00,HET,450,0.50,HOM,565,1.00	SLC25A4	3'UTR	SLC25A4:ENST00000281456:3'UTR:MODIFIER:exon4/4:c.*2307T>C:		rs2046535	0.4687	0.0000	0,0,0	0,0,0,0,0	0.4406							103220 [SLC25A4 (confirmed) Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal dominant 2,609283|Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD,617184|Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR,615418];	RCV000308687.1 [benign]; 			61	97					SLC25A4 (inh=AR+AD pLI=0.48)
chr4	186071068	186071068	G	A	hom	anno_omim	QUAL=22208;DP=337;AF=1.00;MQM=59;TRIO=HOM,337,1.00,HET,195,0.46,HOM,260,1.00	SLC25A4	3'UTR	SLC25A4:ENST00000281456:3'UTR:MODIFIER:exon4/4:c.*2943G>A:		rs7675110	0.4305	0.0000	0,0,0	0,0,0,0,0	0.4414							103220 [SLC25A4 (confirmed) Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal dominant 2,609283|Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD,617184|Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR,615418];	RCV000295164.1 [benign]; 			59	98					SLC25A4 (inh=AR+AD pLI=0.48)
chr4	186997767	186997767	C	A	het	anno_omim	QUAL=9373;DP=259;AF=0.48;MQM=60;TRIO=HET,259,0.48,HET,139,0.49,HOM,161,0.99	TLR3	splice_region,5'UTR	TLR3:ENST00000296795:splice_region:LOW:exon2/5:c.-7C>A:,TLR3:ENST00000296795:5'UTR:MODIFIER:exon2/5:c.-7C>A:		rs3775296	0.1817	0.1825	2017,1125,125	0.1560,0.1647,0.2368,0.1865,0.1634	0.1829							603029 [TLR3 (provisional) Herpes simplex encephalitis,susceptibility to,2 613002|HIV1 infection,resistance to,609423];				79	620	2	[2] auto-classification 14.09.2017  			TLR3 (inh=n/a pLI=0.00)
chr4	187004074	187004074	C	T	het	pred_pathogenic;anno_omim	QUAL=7682;DP=360;AF=0.49;MQM=59;TRIO=HET,360,0.49,HET,232,0.48,WT,299,0.01	TLR3	missense	TLR3:ENST00000296795:missense:MODERATE:exon4/5:c.1234C>T:p.Leu412Phe,TLR3:ENST00000504367:missense:MODERATE:exon2/3:c.403C>T:p.Leu135Phe		rs3775291	0.2318	0.2712	4813,2945,20	0.0658,0.2852,0.3374,0.2952,0.2367	0.2789	4.0310	D,D,D,D	T	D	T,T,T	23.80	603029 [TLR3 (provisional) Herpes simplex encephalitis,susceptibility to,2 613002|HIV1 infection,resistance to,609423];	RCV000034357.3 [other]; 	CM073380 [CLASS=DFP MUT=ALT PHEN="Altered activity association with" GENE=TLR3]; 	COSM149771	156	861	1	[1] Ute Grasshoff 13.08.2014			TLR3 (inh=n/a pLI=0.00)
chr4	187004217	187004217	C	T	het	anno_omim	QUAL=18798;DP=458;AF=0.51;MQM=60;TRIO=HET,458,0.51,HET,239,0.49,HOM,290,1.00	TLR3	synonymous	TLR3:ENST00000296795:synonymous:LOW:exon4/5:c.1377C>T:p.Phe459Phe,TLR3:ENST00000504367:synonymous:LOW:exon2/3:c.546C>T:p.Phe182Phe		rs3775290	0.2722	0.3007	5608,3033,193	0.1997,0.3567,0.3277,0.2989,0.3185	0.3023							603029 [TLR3 (provisional) Herpes simplex encephalitis,susceptibility to,2 613002|HIV1 infection,resistance to,609423];			COSM1428947	186	855	2	[2] auto-classification 14.09.2017  			TLR3 (inh=n/a pLI=0.00)
chr4	187158034	187158034	G	A	het	pred_pathogenic;anno_omim;anno_pathogenic_clinvar	QUAL=18120;DP=372;AF=0.49;MQM=59;TRIO=HET,372,0.49,HOM,280,1.00,HET,382,0.44	KLKB1	missense	KLKB1:ENST00000264690:missense:MODERATE:exon5/15:c.428G>A:p.Ser143Asn,KLKB1:ENST00000513864:missense:MODERATE:exon5/14:c.428G>A:p.Ser143Asn		rs3733402	0.6046	0.5365	18108,8547,2824	0.7374,0.6354,0.6668,0.5037,0.3940	0.6006	3.7480	T,T,T,T,T,T,.	T,T	B,.	D,D,D,D,D,.	0.07	229000 [KLKB1 (provisional) Fletcher factor (prekallikrein) deficiency,612423];	RCV000012817.25 [pathogenic]; 		COSM3760537, COSM149774	513	1014	2	[2] old entry - no details available			KLKB1 (inh=AR pLI=0.00)
chr4	187179210	187179210	T	C	het	pred_pathogenic;anno_omim	QUAL=13107;DP=184;AF=0.48;MQM=60;TRIO=HET,184,0.48,HOM,238,0.98,HET,295,0.50	KLKB1	missense,synonymous	KLKB1:ENST00000513864:missense:MODERATE:exon14/14:c.1621T>C:p.Trp541Arg,KLKB1:ENST00000264690:synonymous:LOW:exon15/15:c.1761T>C:p.Asn587Asn		rs925453	0.6581	0.6682	27709,15526,2259	0.6564,0.7240,0.8600,0.6804,0.4793	0.6957	-3.8940	.,T,T	T,T	.,B	.,D	0.11	229000 [KLKB1 (provisional) Fletcher factor (prekallikrein) deficiency,612423];				896	910	2	[2] auto-classification 14.09.2017  			KLKB1 (inh=AR pLI=0.00)
chr4	187179486	187179486	A	G	het	anno_omim	QUAL=14781;DP=313;AF=0.49;MQM=60;TRIO=HET,313,0.49,HOM,228,1.00,HET,293,0.53	KLKB1	3'UTR	KLKB1:ENST00000264690:3'UTR:MODIFIER:exon15/15:c.*120A>G:,KLKB1:ENST00000513864:3'UTR:MODIFIER:exon14/14:c.*238A>G:	MIRb	rs3087505	0.9185	0.0000	0,0,0	0,0,0,0,0	0.9073							229000 [KLKB1 (provisional) Fletcher factor (prekallikrein) deficiency,612423];				180	49					KLKB1 (inh=AR pLI=0.00)
chr4	190874234	190874234	C	T	het	low_MQM;gene_blacklist;pred_pathogenic	QUAL=2910;DP=199;AF=0.16;MQM=41;TRIO=HET,199,0.16,HET,169,0.33,HET,239,0.36	FRG1	missense	FRG1:ENST00000226798:missense:MODERATE:exon4/9:c.271C>T:p.Pro91Ser		rs200620299	0.0000	0.4387	0,0,0	0.4558,0.4510,0.4628,0.4465,0.3840	0.4242	7.0600	D,D	D	D	T,T	29.80					0	57	2	[2] auto-classification 14.09.2017  			FRG1 (inh=n/a pLI=0.00)
chr4	190878597	190878597	C	T	het	low_MQM;gene_blacklist	QUAL=13138;DP=536;AF=0.44;MQM=34;TRIO=HET,536,0.44,HET,473,0.45,HET,637,0.51	FRG1	synonymous	FRG1:ENST00000226798:synonymous:LOW:exon6/9:c.477C>T:p.Cys159Cys		rs62345290	0.0000	0.4977	0,0,0	0.4969,0.4996,0.4991,0.4968,0.4991	0.4986										COSM4158962	0	1849	2	[2] auto-classification 14.09.2017  			FRG1 (inh=n/a pLI=0.00)
chr4	190878654	190878654	C	G	het	low_MQM;gene_blacklist;pred_pathogenic	QUAL=3798;DP=485;AF=0.21;MQM=33;TRIO=HET,485,0.21,HET,475,0.26,HET,637,0.26	FRG1	missense	FRG1:ENST00000226798:missense:MODERATE:exon6/9:c.534C>G:p.Ile178Met		rs78653319	0.0000	0.4769	1,0,0	0.4807,0.4661,0.4752,0.4775,0.4858	0.4752	0.0290	D,D,D	T	P	T,T	23.20				COSM4158963	0	168	2	[2] auto-classification 14.09.2017  			FRG1 (inh=n/a pLI=0.00)
chr4	190878661	190878661	A	T	het	low_MQM;gene_blacklist	QUAL=11975;DP=473;AF=0.41;MQM=34;TRIO=HET,473,0.41,HET,478,0.42,HET,633,0.48	FRG1	splice_region&intron	FRG1:ENST00000226798:splice_region&intron:LOW:exon6/8:c.537+4A>T:		rs62345291	0.0000	0.4992	2,1,1	0.4988,0.4997,0.4998,0.4989,0.5000	0.4993											1	1933	2	[2] auto-classification 14.09.2017  			FRG1 (inh=n/a pLI=0.00)
chr5	231111	231111	T	C	hom	anno_omim	QUAL=11160;DP=109;AF=1.00;MQM=56;TRIO=HOM,109,1.00,HOM,118,1.00,HOM,144,1.00	SDHA	synonymous	SDHA:ENST00000264932:synonymous:LOW:exon7/15:c.891T>C:p.Pro297Pro,SDHA:ENST00000504309:synonymous:LOW:exon7/13:c.891T>C:p.Pro297Pro,SDHA:ENST00000510361:synonymous:LOW:exon6/14:c.747T>C:p.Pro249Pro		rs1126417	0.6534	0.7078	31200,19114,3161	0.7843,0.6455,0.3281,0.7574,0.6801	0.7402							600857 [SDHA (confirmed) Leigh syndrome,256000|Mitochondrial respiratory chain complex II deficiency,252011|Cardiomyopathy,dilated,1GG,613642|Paragangliomas 5,614165];	RCV000118321.3 [other]; RCV000162482.1 [benign]; RCV000308030.1 [likely benign]; RCV000347829.1 [likely benign]; RCV000400279.1 [likely benign]; 		COSM4159838	1119	897	2	[2] auto-classification 14.09.2017  			SDHA (inh=AR+AD pLI=0.00)
chr5	1393588	1393590	TGT	-	het	anno_omim	QUAL=6481;DP=331;AF=0.47;MQM=59;TRIO=HET,331,0.47,HET,265,0.52,WT,350,0.00	SLC6A3	3'UTR	SLC6A3:ENST00000270349:3'UTR:MODIFIER:exon15/15:c.*1260_*1262delACA:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0003							126455 [SLC6A3 (confirmed) Nicotine dependence,protection against,188890|Parkinsonism-dystonia,infantile,613135];				0	3					SLC6A3 (inh=AR pLI=1.00)
chr5	6599493	6599493	G	-	het	anno_omim	QUAL=3527;DP=127;AF=0.49;MQM=58;TRIO=HET,127,0.49,HET,51,0.47,HET,114,0.51	NSUN2	3'UTR	NSUN2:ENST00000264670:3'UTR:MODIFIER:exon19/19:c.*546delC:,NSUN2:ENST00000539938:3'UTR:MODIFIER:exon18/18:c.*546delC:		rs200230801	0.0248	0.0000	0,0,0	0,0,0,0,0	0.0371							610916 [NSUN2 (provisional) Mental retardation,autosomal recessive 5,611091];	RCV000385790.1 [likely benign]; 			0	32					NSUN2 (inh=AR pLI=0.96)
chr5	6599940	6599940	C	T	het	anno_omim	QUAL=8656;DP=361;AF=0.47;MQM=59;TRIO=HET,361,0.47,HET,299,0.56,WT,470,0.00	NSUN2	3'UTR	NSUN2:ENST00000264670:3'UTR:MODIFIER:exon19/19:c.*99G>A:,NSUN2:ENST00000539938:3'UTR:MODIFIER:exon18/18:c.*99G>A:,NSUN2:ENST00000506139:3'UTR:MODIFIER:exon18/18:c.*99G>A:		rs3776448	0.1462	0.0000	0,0,0	0,0,0,0,0	0.1249							610916 [NSUN2 (provisional) Mental retardation,autosomal recessive 5,611091];	RCV000389172.1 [likely benign]; 			3	51					NSUN2 (inh=AR pLI=0.96)
chr5	6600064	6600064	G	T	het	anno_omim	QUAL=16863;DP=407;AF=0.52;MQM=59;TRIO=HET,407,0.52,HET,371,0.49,HET,574,0.53	NSUN2	missense	NSUN2:ENST00000264670:missense:MODERATE:exon19/19:c.2279C>A:p.Pro760Gln,NSUN2:ENST00000539938:missense:MODERATE:exon18/18:c.1571C>A:p.Pro524Gln,NSUN2:ENST00000506139:missense:MODERATE:exon18/18:c.2174C>A:p.Pro725Gln		rs61744358	0.0551	0.0588	230,152,17	0.0669,0.0270,0.0000,0.0701,0.0672	0.0592	0.6020	T,T,T	T	B,B,B	T,T,T	7.56	610916 [NSUN2 (provisional) Mental retardation,autosomal recessive 5,611091];	RCV000117858.2 [likely benign]; RCV000396216.1 [likely benign]; 			28	326	2	[2] auto-classification 14.09.2017  			NSUN2 (inh=AR pLI=0.96)
chr5	6600150	6600150	G	A	het	anno_omim	QUAL=12581;DP=444;AF=0.47;MQM=59;TRIO=HET,444,0.47,HET,600,0.49,WT,851,0.00	NSUN2	synonymous	NSUN2:ENST00000264670:synonymous:LOW:exon19/19:c.2193C>T:p.Asp731Asp,NSUN2:ENST00000539938:synonymous:LOW:exon18/18:c.1485C>T:p.Asp495Asp,NSUN2:ENST00000506139:synonymous:LOW:exon18/18:c.2088C>T:p.Asp696Asp		rs3822434	0.1735	0.1743	2085,729,46	0.0905,0.2745,0.2342,0.1455,0.2100	0.1791							610916 [NSUN2 (provisional) Mental retardation,autosomal recessive 5,611091];	RCV000117856.2 [likely benign]; RCV000342691.1 [benign]; 		COSM1438254	51	523	2	[2] auto-classification 14.09.2017  			NSUN2 (inh=AR pLI=0.96)
chr5	6622122	6622122	T	A	het	anno_omim	QUAL=9717;DP=252;AF=0.47;MQM=60;TRIO=HET,252,0.47,HET,246,0.48,HET,300,0.47	NSUN2	splice_region&intron,intron	NSUN2:ENST00000264670:splice_region&intron:LOW:exon6/18:c.622+7A>T:,NSUN2:ENST00000506139:splice_region&intron:LOW:exon5/17:c.517+7A>T:,NSUN2:ENST00000539938:intron:MODIFIER:exon5/17:c.-87+1205A>T:		rs16877704	0.0160	0.0384	130,109,1	0.0107,0.0206,0.0000,0.0564,0.0147	0.0386							610916 [NSUN2 (provisional) Mental retardation,autosomal recessive 5,611091];	RCV000117861.2 [likely benign]; RCV000322271.1 [likely benign]; 			9	197					NSUN2 (inh=AR pLI=0.96)
chr5	7869235	7869235	T	C	het	anno_omim	QUAL=4611;DP=51;AF=0.35;MQM=60;TRIO=HET,51,0.35,HET,132,0.52,HET,228,0.47	MTRR	5'UTR	MTRR:ENST00000264668:5'UTR:MODIFIER:exon1/15:c.-12T>C:		rs72716536	0.2290	0.1587	2132,387,521	0.3238,0.3702,0.1651,0.1043,0.1576	0.1651							602568 [MTRR (provisional) Homocystinuria-megaloblastic anemia,cbl E type,236270|Neural tube defects,folate-sensitive,susceptibility to,601634];	RCV000126883.2 [benign]; RCV000362823.1 [benign]; 			44	462					MTRR (inh=AR pLI=0.00)
chr5	7878192	7878192	T	C	het	anno_omim	QUAL=12145;DP=510;AF=0.47;MQM=59;TRIO=HET,510,0.47,HET,427,0.49,WT,614,0.00	MTRR	synonymous,3'UTR	MTRR:ENST00000264668:synonymous:LOW:exon5/15:c.618T>C:p.Leu206Leu,MTRR:ENST00000440940:synonymous:LOW:exon5/15:c.537T>C:p.Leu179Leu,MTRR:ENST00000341013:3'UTR:MODIFIER:exon4/8:c.*206T>C:		rs161870	0.2530	0.1711	2515,475,787	0.3894,0.3807,0.1820,0.1153,0.1465	0.1895	-3.7990		T			0.02	602568 [MTRR (provisional) Homocystinuria-megaloblastic anemia,cbl E type,236270|Neural tube defects,folate-sensitive,susceptibility to,601634];	RCV000126885.2 [benign]; RCV000307309.1 [benign]; 			51	521	2	[2] auto-classification 14.09.2017  			MTRR (inh=AR pLI=0.00)
chr5	7885959	7885959	A	G	het	anno_omim	QUAL=4987;DP=139;AF=0.55;MQM=60;TRIO=HET,139,0.55,HET,239,0.50,WT,344,0.00	MTRR	missense,3'UTR	MTRR:ENST00000264668:missense:MODERATE:exon7/15:c.1130A>G:p.Lys377Arg,MTRR:ENST00000440940:missense:MODERATE:exon7/15:c.1049A>G:p.Lys350Arg,MTRR:ENST00000341013:3'UTR:MODIFIER:exon6/8:c.*718A>G:		rs162036	0.2532	0.1711	2514,474,785	0.3892,0.3799,0.1810,0.1154,0.1471	0.1894	1.2300	T,T	T	B	T,T	8.29	602568 [MTRR (provisional) Homocystinuria-megaloblastic anemia,cbl E type,236270|Neural tube defects,folate-sensitive,susceptibility to,601634];	RCV000126870.2 [benign]; RCV000144925.1 [uncertain significance]; RCV000317483.1 [benign]; 			51	521	2	[2] auto-classification 14.09.2017  			MTRR (inh=AR pLI=0.00)
chr5	7897191	7897191	C	T	het	pred_pathogenic;anno_omim	QUAL=6665;DP=260;AF=0.51;MQM=59;TRIO=HET,260,0.51,HET,223,0.51,WT,255,0.00	MTRR	missense	MTRR:ENST00000264668:missense:MODERATE:exon14/15:c.1864C>T:p.His622Tyr,MTRR:ENST00000440940:missense:MODERATE:exon14/15:c.1783C>T:p.His595Tyr		rs10380	0.2194	0.1509	2003,337,542	0.3309,0.3658,0.1563,0.0964,0.1396	0.1634	0.5320	T,T	T	B	D,D	5.61	602568 [MTRR (provisional) Homocystinuria-megaloblastic anemia,cbl E type,236270|Neural tube defects,folate-sensitive,susceptibility to,601634];	RCV000126880.2 [benign]; RCV000144924.1 [uncertain significance]; RCV000302798.1 [benign]; 	CM083724 [CLASS=DFP MUT=ALT PHEN="Pancreatic cancer increased risk association with" GENE=MTRR]; 		38	459	1	[1] auto-classification 16.06.2016  [2] harmuth 06.04.2016; ih-frequency homo: 21, het: 177			MTRR (inh=AR pLI=0.00)
chr5	7897283	7897283	G	A	het	anno_omim	QUAL=8325;DP=366;AF=0.48;MQM=60;TRIO=HET,366,0.48,HET,298,0.51,WT,325,0.00	MTRR	synonymous	MTRR:ENST00000264668:synonymous:LOW:exon14/15:c.1956G>A:p.Val652Val,MTRR:ENST00000440940:synonymous:LOW:exon14/15:c.1875G>A:p.Val625Val		rs12347	0.2438	0.1678	2431,470,756	0.3826,0.3770,0.1564,0.1143,0.1468	0.1854							602568 [MTRR (provisional) Homocystinuria-megaloblastic anemia,cbl E type,236270|Neural tube defects,folate-sensitive,susceptibility to,601634];	RCV000126881.2 [benign]; RCV000341345.1 [benign]; 			50	514	2	[2] auto-classification 14.09.2017  			MTRR (inh=AR pLI=0.00)
chr5	7900712	7900712	G	A	het	anno_omim	QUAL=2506;DP=214;AF=0.40;MQM=60;TRIO=HET,214,0.40,HET,27,0.44,WT,35,0.03	MTRR	3'UTR	MTRR:ENST00000264668:3'UTR:MODIFIER:exon15/15:c.*541G>A:,MTRR:ENST00000440940:3'UTR:MODIFIER:exon15/15:c.*541G>A:		rs9332	0.2472	0.0000	0,0,0	0,0,0,0,0	0.1881							602568 [MTRR (provisional) Homocystinuria-megaloblastic anemia,cbl E type,236270|Neural tube defects,folate-sensitive,susceptibility to,601634];	RCV000389294.1 [benign]; 			7	43					MTRR (inh=AR pLI=0.00)
chr5	10250430	10250430	G	A	hom	anno_omim	QUAL=4950;DP=51;AF=1.00;MQM=60;TRIO=HOM,51,1.00,HOM,51,1.00,HOM,68,1.00	CCT5	5'UTR,intron	CCT5:ENST00000280326:5'UTR:MODIFIER:exon1/11:c.-23G>A:,CCT5:ENST00000515390:5'UTR:MODIFIER:exon1/10:c.-23G>A:,CCT5:ENST00000503026:intron:MODIFIER:exon1/10:c.42+273G>A:		rs2548546	0.6853	0.7889	38433,24216,1013	0.4457,0.7951,0.8682,0.8558,0.6624	0.7990							610150 [CCT5 (provisional) Neuropathy,hereditary sensory,with spastic paraplegia,256840];	RCV000279502.1 [benign]; 			1747	766					CCT5 (inh=AR pLI=1.00)
chr5	10250443	10250443	T	C	hom	anno_omim	QUAL=4797;DP=44;AF=1.00;MQM=60;TRIO=HOM,44,1.00,HOM,51,1.00,HOM,64,1.00	CCT5	5'UTR_premature_start_codon_gain,5'UTR,intron	CCT5:ENST00000280326:5'UTR_premature_start_codon_gain:LOW:exon1/11:c.-10T>C:,CCT5:ENST00000515390:5'UTR_premature_start_codon_gain:LOW:exon1/10:c.-10T>C:,CCT5:ENST00000280326:5'UTR:MODIFIER:exon1/11:c.-10T>C:,CCT5:ENST00000515390:5'UTR:MODIFIER:exon1/10:c.-10T>C:,CCT5:ENST00000503026:intron:MODIFIER:exon1/10:c.42+286T>C:		rs2578618	0.6853	0.7892	38594,24311,1021	0.4455,0.7963,0.8685,0.8561,0.6624	0.7992							610150 [CCT5 (provisional) Neuropathy,hereditary sensory,with spastic paraplegia,256840];	RCV000336837.1 [benign]; 			1784	776	2	[2] auto-classification 14.09.2017  			CCT5 (inh=AR pLI=1.00)
chr5	10254817	10254817	A	G	hom	anno_omim	QUAL=16305;DP=156;AF=1.00;MQM=59;TRIO=HOM,156,1.00,HOM,165,1.00,HOM,194,1.00	CCT5	synonymous,intron	CCT5:ENST00000280326:synonymous:LOW:exon3/11:c.198A>G:p.Gly66Gly,CCT5:ENST00000503026:synonymous:LOW:exon3/11:c.135A>G:p.Gly45Gly,CCT5:ENST00000515676:synonymous:LOW:exon3/11:c.84A>G:p.Gly28Gly,CCT5:ENST00000515390:intron:MODIFIER:exon2/9:c.166+500A>G:,CCT5:ENST00000506600:intron:MODIFIER:exon2/9:c.52+500A>G:		rs2578617	0.6859	0.7895	38838,24492,1032	0.4455,0.7962,0.8697,0.8563,0.6621	0.7993							610150 [CCT5 (provisional) Neuropathy,hereditary sensory,with spastic paraplegia,256840];	RCV000292326.1 [benign]; 			1783	775	2	[2] auto-classification 14.09.2017  			CCT5 (inh=AR pLI=1.00)
chr5	10256161	10256161	T	C	hom	anno_omim	QUAL=16114;DP=276;AF=1.00;MQM=60;TRIO=HOM,276,1.00,HOM,105,1.00,HOM,123,1.00	CCT5	synonymous	CCT5:ENST00000280326:synonymous:LOW:exon4/11:c.426T>C:p.Arg142Arg,CCT5:ENST00000503026:synonymous:LOW:exon4/11:c.363T>C:p.Arg121Arg,CCT5:ENST00000515390:synonymous:LOW:exon3/10:c.261T>C:p.Arg87Arg,CCT5:ENST00000515676:synonymous:LOW:exon4/11:c.312T>C:p.Arg104Arg,CCT5:ENST00000506600:synonymous:LOW:exon3/10:c.147T>C:p.Arg49Arg		rs1042392	0.6925	0.7948	39246,24749,1097	0.4623,0.7991,0.8777,0.8612,0.6635	0.8044							610150 [CCT5 (provisional) Neuropathy,hereditary sensory,with spastic paraplegia,256840];	RCV000349478.1 [benign]; 			1805	758	2	[2] auto-classification 14.09.2017  			CCT5 (inh=AR pLI=1.00)
chr5	10262740	10262740	C	A	hom	anno_omim	QUAL=11823;DP=85;AF=0.99;MQM=60;TRIO=HOM,85,0.99,HOM,114,1.00,HOM,188,1.00	CCT5	splice_region&intron	CCT5:ENST00000280326:splice_region&intron:LOW:exon9/10:c.1317+10C>A:,CCT5:ENST00000503026:splice_region&intron:LOW:exon9/10:c.1254+10C>A:,CCT5:ENST00000515390:splice_region&intron:LOW:exon8/9:c.1152+10C>A:,CCT5:ENST00000515676:splice_region&intron:LOW:exon9/10:c.1203+10C>A:,CCT5:ENST00000506600:splice_region&intron:LOW:exon8/9:c.1038+10C>A:		rs2578642	0.6859	0.7894	38834,24488,1033	0.4456,0.7961,0.8695,0.8563,0.6622	0.7993							610150 [CCT5 (provisional) Neuropathy,hereditary sensory,with spastic paraplegia,256840];	RCV000316106.1 [benign]; 			1781	775	2	[2] auto-classification 14.09.2017  			CCT5 (inh=AR pLI=1.00)
chr5	10264962	10264962	A	G	hom	anno_omim	QUAL=18719;DP=259;AF=1.00;MQM=59;TRIO=HOM,259,1.00,HOM,134,1.00,HOM,176,1.00	CCT5,CTD-2256P15.4	3'UTR	CCT5:ENST00000280326:3'UTR:MODIFIER:exon11/11:c.*67A>G:,CCT5:ENST00000503026:3'UTR:MODIFIER:exon11/11:c.*67A>G:,CCT5:ENST00000515390:3'UTR:MODIFIER:exon10/10:c.*67A>G:,CCT5:ENST00000515676:3'UTR:MODIFIER:exon11/11:c.*67A>G:,CCT5:ENST00000506600:3'UTR:MODIFIER:exon10/10:c.*67A>G:		rs544	0.6857	0.0000	0,0,0	0,0,0,0,0	0.7421							610150 [CCT5 (provisional) Neuropathy,hereditary sensory,with spastic paraplegia,256840];	RCV000295243.1 [benign]; 			1020	469					CCT5 (inh=AR pLI=1.00), CTD-2256P15.4 (inh=n/a pLI=n/a)
chr5	10265076	10265076	C	T	hom	anno_omim	QUAL=13475;DP=220;AF=1.00;MQM=59;TRIO=HOM,220,1.00,HOM,83,1.00,HOM,110,1.00	CCT5,CTD-2256P15.4	3'UTR	CCT5:ENST00000280326:3'UTR:MODIFIER:exon11/11:c.*181C>T:,CCT5:ENST00000503026:3'UTR:MODIFIER:exon11/11:c.*181C>T:,CCT5:ENST00000506600:3'UTR:MODIFIER:exon10/10:c.*181C>T:		rs699113	0.6859	0.0000	0,0,0	0,0,0,0,0	0.7418							610150 [CCT5 (provisional) Neuropathy,hereditary sensory,with spastic paraplegia,256840];	RCV000381495.1 [benign]; 			152	71					CCT5 (inh=AR pLI=1.00), CTD-2256P15.4 (inh=n/a pLI=n/a)
chr5	10265278	10265278	A	G	hom	anno_omim	QUAL=21680;DP=375;AF=1.00;MQM=60;TRIO=HOM,375,1.00,HOM,143,1.00,HOM,167,1.00	CCT5,CTD-2256P15.4	3'UTR	CCT5:ENST00000280326:3'UTR:MODIFIER:exon11/11:c.*383A>G:		rs2662533	0.6859	0.0000	0,0,0	0,0,0,0,0	0.7414							610150 [CCT5 (provisional) Neuropathy,hereditary sensory,with spastic paraplegia,256840];	RCV000305058.1 [benign]; 			153	70					CCT5 (inh=AR pLI=1.00), CTD-2256P15.4 (inh=n/a pLI=n/a)
chr5	10265462	10265462	G	A	hom	anno_omim	QUAL=24262;DP=225;AF=1.00;MQM=59;TRIO=HOM,225,1.00,HOM,245,1.00,HOM,312,1.00	CCT5,CTD-2256P15.4	3'UTR	CCT5:ENST00000280326:3'UTR:MODIFIER:exon11/11:c.*567G>A:		rs2607286	0.0000	0.0000	0,0,0	0,0,0,0,0	0.7418							610150 [CCT5 (provisional) Neuropathy,hereditary sensory,with spastic paraplegia,256840];				152	70					CCT5 (inh=AR pLI=1.00), CTD-2256P15.4 (inh=n/a pLI=n/a)
chr5	10265488	10265488	A	G	hom	anno_omim	QUAL=22612;DP=228;AF=1.00;MQM=59;TRIO=HOM,228,1.00,HOM,219,1.00,HOM,268,1.00	CCT5,CTD-2256P15.4	3'UTR	CCT5:ENST00000280326:3'UTR:MODIFIER:exon11/11:c.*593A>G:		rs2578640	0.6861	0.0000	0,0,0	0,0,0,0,0	0.7419							610150 [CCT5 (provisional) Neuropathy,hereditary sensory,with spastic paraplegia,256840];	RCV000274243.1 [benign]; 			152	70					CCT5 (inh=AR pLI=1.00), CTD-2256P15.4 (inh=n/a pLI=n/a)
chr5	10265719	10265719	C	G	hom	anno_omim	QUAL=31559;DP=547;AF=1.00;MQM=59;TRIO=HOM,547,1.00,HOM,200,1.00,HOM,229,1.00	CCT5,CTD-2256P15.4	3'UTR	CCT5:ENST00000280326:3'UTR:MODIFIER:exon11/11:c.*824C>G:		rs2578639	0.6631	0.0000	0,0,0	0,0,0,0,0	0.7200							610150 [CCT5 (provisional) Neuropathy,hereditary sensory,with spastic paraplegia,256840];	RCV000388774.1 [benign]; 			153	70					CCT5 (inh=AR pLI=1.00), CTD-2256P15.4 (inh=n/a pLI=n/a)
chr5	10265886	10265886	-	TCTAT	hom	anno_omim	QUAL=16103;DP=251;AF=0.98;MQM=59;TRIO=HOM,251,0.98,HOM,134,0.99,HOM,144,1.00	CCT5,CTD-2256P15.4	3'UTR	CCT5:ENST00000280326:3'UTR:MODIFIER:exon11/11:c.*994_*995insATTCT:	MIR	rs112586209;rs70943997	0.6809	0.0000	0,0,0	0,0,0,0,0	0.7376							610150 [CCT5 (provisional) Neuropathy,hereditary sensory,with spastic paraplegia,256840];				153	65					CCT5 (inh=AR pLI=1.00), CTD-2256P15.4 (inh=n/a pLI=n/a)
chr5	10266067	10266067	G	T	hom	anno_omim	QUAL=36470;DP=437;AF=1.00;MQM=60;TRIO=HOM,437,1.00,HOM,296,1.00,HOM,378,1.00	CCT5,CTD-2256P15.4	3'UTR	CCT5:ENST00000280326:3'UTR:MODIFIER:exon11/11:c.*1172G>T:		rs2578638	0.8880	0.0000	0,0,0	0,0,0,0,0	0.9285							610150 [CCT5 (provisional) Neuropathy,hereditary sensory,with spastic paraplegia,256840];	RCV000278944.1 [benign]; 			184	43					CCT5 (inh=AR pLI=1.00), CTD-2256P15.4 (inh=n/a pLI=n/a)
chr5	11117583	11117583	C	T	het		QUAL=9316;DP=395;AF=0.52;MQM=60;TRIO=HET,395,0.52,WT,207,0.00,HET,342,0.51	CTNND2	synonymous	CTNND2:ENST00000304623:synonymous:LOW:exon13/22:c.2256G>A:p.Gly752Gly,CTNND2:ENST00000359640:synonymous:LOW:exon13/21:c.2256G>A:p.Gly752Gly,CTNND2:ENST00000511377:synonymous:LOW:exon12/21:c.1983G>A:p.Gly661Gly,CTNND2:ENST00000458100:synonymous:LOW:exon12/21:c.957G>A:p.Gly319Gly,CTNND2:ENST00000503622:synonymous:LOW:exon10/19:c.1245G>A:p.Gly415Gly		rs2285975	0.2236	0.1184	1649,108,182	0.1959,0.0546,0.4499,0.0551,0.2209	0.1200										COSM4003253	19	235	2	[2] auto-classification 14.09.2017  			CTNND2 (inh=n/a pLI=1.00)
chr5	16474795	16474795	C	T	hom	anno_omim	QUAL=333;DP=159;AF=0.38;MQM=57;TRIO=HOM,159,0.38,HOM,36,0.17,WT,41,0.02	FAM134B	3'UTR	FAM134B:ENST00000306320:3'UTR:MODIFIER:exon9/9:c.*55G>A:,FAM134B:ENST00000399793:3'UTR:MODIFIER:exon7/7:c.*55G>A:	(TTTTTC)n	rs879020809	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0409							613114 [FAM134B (provisional) Neuropathy,hereditary sensory and autonomic,type IIB,613115];				20	50					RETREG1 (inh=AR pLI=0.01)
chr5	16478200	16478200	G	A	hom	anno_omim	QUAL=12416;DP=202;AF=1.00;MQM=60;TRIO=HOM,202,1.00,HOM,74,1.00,HOM,103,1.00	FAM134B	synonymous	FAM134B:ENST00000306320:synonymous:LOW:exon7/9:c.816C>T:p.Asp272Asp,FAM134B:ENST00000399793:synonymous:LOW:exon5/7:c.393C>T:p.Asp131Asp		rs162848	0.6775	0.6661	25890,15604,3106	0.8074,0.5488,0.5290,0.7018,0.6094	0.7038							613114 [FAM134B (provisional) Neuropathy,hereditary sensory and autonomic,type IIB,613115];	RCV000360491.1 [benign]; 			1133	950	2	[2] auto-classification 14.09.2017  			RETREG1 (inh=AR pLI=0.01)
chr5	16508898	16508898	T	C	het	anno_omim	QUAL=5947;DP=257;AF=0.46;MQM=60;TRIO=HET,257,0.46,HET,226,0.50,WT,307,0.00	FAM134B	5'UTR,intron	FAM134B:ENST00000399793:5'UTR:MODIFIER:exon1/7:c.-177A>G:,FAM134B:ENST00000306320:intron:MODIFIER:exon3/8:c.459-25317A>G:		rs33684	0.5431	0.0000	0,0,0	0,0,0,0,0	0.6168							613114 [FAM134B (provisional) Neuropathy,hereditary sensory and autonomic,type IIB,613115];				222	187					RETREG1 (inh=AR pLI=0.01)
chr5	33988581	33988581	C	A	het	anno_omim	QUAL=7274;DP=321;AF=0.44;MQM=60;TRIO=HET,321,0.44,WT,223,0.00,HET,247,0.55	RP11-1084J3.4,AMACR	3'UTR,intron	AMACR:ENST00000335606:3'UTR:MODIFIER:exon5/5:c.*617G>T:,AMACR:ENST00000382072:3'UTR:MODIFIER:exon4/4:c.*1008G>T:,AMACR:ENST00000382085:intron:MODIFIER:exon5/5:c.1132-115G>T:		rs12659370	0.0749	0.0000	0,0,0	0,0,0,0,0	0.0430							604489 [AMACR (provisional) Alpha-methylacyl-CoA racemase deficiency,614307|Bile acid synthesis defect,congenital,4,214950];	RCV000350176.1 [likely benign]; RCV000403059.1 [likely benign]; 			2	25					RP11-1084J3.4 (inh=n/a pLI=n/a), AMACR (inh=AR pLI=0.13)
chr5	33989518	33989518	C	T	hom	pred_pathogenic;anno_omim	QUAL=26504;DP=333;AF=0.99;MQM=60;TRIO=HOM,333,0.99,HET,255,0.49,HOM,384,1.00	AMACR,RP11-1084J3.4	missense,3'UTR	AMACR:ENST00000382085:missense:MODERATE:exon5/6:c.829G>A:p.Glu277Lys,AMACR:ENST00000335606:missense:MODERATE:exon5/5:c.829G>A:p.Glu277Lys,AMACR:ENST00000502637:missense:MODERATE:exon5/5:c.784G>A:p.Glu262Lys,AMACR:ENST00000382072:3'UTR:MODIFIER:exon4/4:c.*71G>A:		rs2278008	0.6961	0.7016	30827,18374,3205	0.7825,0.6460,0.8556,0.7429,0.4216	0.7488	2.0460	T,T,T	T	B,B,B	T,T,T	19.02	604489 [AMACR (provisional) Alpha-methylacyl-CoA racemase deficiency,614307|Bile acid synthesis defect,congenital,4,214950];	RCV000116324.2 [likely benign]; RCV000302812.1 [benign]; RCV000368392.1 [benign]; 		COSM3761202	1613	1308	2	[2] auto-classification 14.09.2017  			AMACR (inh=AR pLI=0.13), RP11-1084J3.4 (inh=n/a pLI=n/a)
chr5	33998768	33998768	C	A	het	pred_pathogenic;anno_omim	QUAL=6587;DP=204;AF=0.49;MQM=60;TRIO=HET,204,0.49,HET,138,0.50,HET,167,0.57	AMACR,RP11-1084J3.4	missense	AMACR:ENST00000382085:missense:MODERATE:exon4/6:c.717G>T:p.Gln239His,AMACR:ENST00000335606:missense:MODERATE:exon4/5:c.717G>T:p.Gln239His,AMACR:ENST00000382072:missense:MODERATE:exon3/4:c.556G>T:p.Val186Phe,AMACR:ENST00000502637:missense:MODERATE:exon4/5:c.672G>T:p.Gln224His,AMACR:ENST00000441713:missense:MODERATE:exon3/4:c.556G>T:p.Val186Phe,AMACR:ENST00000426255:missense:MODERATE:exon4/5:c.717G>T:p.Gln239His,AMACR:ENST00000512079:missense:MODERATE:exon4/5:c.717G>T:p.Gln239His,AMACR:ENST00000382068:missense:MODERATE:exon3/4:c.556G>T:p.Val186Phe		rs34677	0.1144	0.1268	1051,604,17	0.0650,0.0569,0.1757,0.1349,0.1427	0.1270	1.8670	D,D,D,T,T	T,T	B,B,B,B,D,P	T,T,T,T,T	23.30	604489 [AMACR (provisional) Alpha-methylacyl-CoA racemase deficiency,614307|Bile acid synthesis defect,congenital,4,214950];	RCV000116323.2 [likely benign]; RCV000306332.1 [likely benign]; 		COSM149809	41	759	2	[2] auto-classification 14.09.2017  			AMACR (inh=AR pLI=0.13), RP11-1084J3.4 (inh=n/a pLI=n/a)
chr5	33998883	33998883	A	G	hom	anno_omim	QUAL=15948;DP=239;AF=0.99;MQM=60;TRIO=HOM,239,0.99,HET,151,0.59,HOM,177,1.00	AMACR,RP11-1084J3.4	missense,synonymous	AMACR:ENST00000382085:missense:MODERATE:exon4/6:c.602T>C:p.Leu201Ser,AMACR:ENST00000335606:missense:MODERATE:exon4/5:c.602T>C:p.Leu201Ser,AMACR:ENST00000502637:missense:MODERATE:exon4/5:c.557T>C:p.Leu186Ser,AMACR:ENST00000426255:missense:MODERATE:exon4/5:c.602T>C:p.Leu201Ser,AMACR:ENST00000512079:missense:MODERATE:exon4/5:c.602T>C:p.Leu201Ser,AMACR:ENST00000382072:synonymous:LOW:exon3/4:c.441T>C:p.Ile147Ile,AMACR:ENST00000441713:synonymous:LOW:exon3/4:c.441T>C:p.Ile147Ile,AMACR:ENST00000382068:synonymous:LOW:exon3/4:c.441T>C:p.Ile147Ile		rs2287939	0.7149	0.6994	30273,16686,3479	0.8166,0.7390,0.8286,0.7070,0.4907	0.7389	-0.7150	T,T,T	T	B,B,B	T,T,T	0.09	604489 [AMACR (provisional) Alpha-methylacyl-CoA racemase deficiency,614307|Bile acid synthesis defect,congenital,4,214950];	RCV000116322.2 [likely benign]; RCV000276161.1 [benign]; 			1497	1407	2	[2] auto-classification 14.09.2017  			AMACR (inh=AR pLI=0.13), RP11-1084J3.4 (inh=n/a pLI=n/a)
chr5	38475507	38475507	G	A	het	anno_omim	QUAL=4792;DP=119;AF=0.50;MQM=60;TRIO=HET,119,0.50,HET,93,0.60,HET,130,0.51	LIFR	3'UTR	LIFR:ENST00000263409:3'UTR:MODIFIER:exon20/20:c.*6190C>T:		rs1046224	0.3728	0.0000	0,0,0	0,0,0,0,0	0.3207							151443 [LIFR (confirmed) Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome,601559];	RCV000317607.1 [benign]; 			27	102					LIFR (inh=AR pLI=0.00)
chr5	38476027	38476027	T	C	het	anno_omim	QUAL=9811;DP=309;AF=0.50;MQM=59;TRIO=HET,309,0.50,HET,145,0.57,HET,228,0.54	LIFR	3'UTR	LIFR:ENST00000263409:3'UTR:MODIFIER:exon20/20:c.*5670A>G:		rs3822425	0.3255	0.0000	0,0,0	0,0,0,0,0	0.3109							151443 [LIFR (confirmed) Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome,601559];	RCV000308441.1 [benign]; 			29	101					LIFR (inh=AR pLI=0.00)
chr5	38476624	38476624	-	T	het	anno_omim	QUAL=3600;DP=279;AF=0.38;MQM=59;TRIO=HET,279,0.38,HET,96,0.44,HET,136,0.41	LIFR	3'UTR	LIFR:ENST00000263409:3'UTR:MODIFIER:exon20/20:c.*5072dupA:		rs397997444	0.3107	0.0000	0,0,0	0,0,0,0,0	0.3068							151443 [LIFR (confirmed) Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome,601559];	RCV000331944.1 [benign]; 			23	105					LIFR (inh=AR pLI=0.00)
chr5	38477863	38477863	G	C	het	anno_omim	QUAL=8891;DP=294;AF=0.49;MQM=60;TRIO=HET,294,0.49,HET,162,0.51,HET,196,0.53	LIFR	3'UTR	LIFR:ENST00000263409:3'UTR:MODIFIER:exon20/20:c.*3834C>G:		rs34130318	0.3223	0.0000	0,0,0	0,0,0,0,0	0.3080							151443 [LIFR (confirmed) Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome,601559];	RCV000271506.1 [benign]; 			27	100					LIFR (inh=AR pLI=0.00)
chr5	38480227	38480227	A	C	het	anno_omim	QUAL=6130;DP=259;AF=0.52;MQM=60;TRIO=HET,259,0.52,HET,66,0.55,HET,111,0.50	LIFR	3'UTR	LIFR:ENST00000263409:3'UTR:MODIFIER:exon20/20:c.*1470T>G:	(AACA)n	rs13156520	0.3181	0.0000	0,0,0	0,0,0,0,0	0.3110							151443 [LIFR (confirmed) Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome,601559];	RCV000376016.1 [benign]; 			27	102					LIFR (inh=AR pLI=0.00)
chr5	38481271	38481271	C	T	het	anno_omim	QUAL=7323;DP=429;AF=0.44;MQM=60;TRIO=HET,429,0.44,HET,200,0.49,WT,247,0.00	LIFR	3'UTR	LIFR:ENST00000263409:3'UTR:MODIFIER:exon20/20:c.*426G>A:,LIFR:ENST00000453190:3'UTR:MODIFIER:exon20/20:c.*426G>A:		rs116625329	0.0048	0.0000	0,0,0	0,0,0,0,0	0.0172							151443 [LIFR (confirmed) Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome,601559];				0	11					LIFR (inh=AR pLI=0.00)
chr5	38481335	38481335	C	T	het	anno_omim	QUAL=13609;DP=469;AF=0.48;MQM=60;TRIO=HET,469,0.48,HET,261,0.49,HET,323,0.50	LIFR	3'UTR	LIFR:ENST00000263409:3'UTR:MODIFIER:exon20/20:c.*362G>A:,LIFR:ENST00000453190:3'UTR:MODIFIER:exon20/20:c.*362G>A:		rs1005017	0.7290	0.0000	0,0,0	0,0,0,0,0	0.7019							151443 [LIFR (confirmed) Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome,601559];	RCV000275248.1 [benign]; 			103	101					LIFR (inh=AR pLI=0.00)
chr5	38482731	38482731	T	C	het	pred_pathogenic;anno_omim	QUAL=1475;DP=95;AF=0.54;MQM=60;TRIO=HET,95,0.54,HET,13,0.38,WT,16,0.00	LIFR	missense	LIFR:ENST00000263409:missense:MODERATE:exon19/20:c.2630A>G:p.Glu877Gly,LIFR:ENST00000453190:missense:MODERATE:exon19/20:c.2630A>G:p.Glu877Gly			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000	3.9330	T,T	T	D	T,T	25.70	151443 [LIFR (confirmed) Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome,601559];				0	2					LIFR (inh=AR pLI=0.00)
chr5	38528952	38528953	AC	-	hom	anno_omim	QUAL=2915;DP=21;AF=0.67;MQM=59;TRIO=HOM,21,0.86,HET,54,0.98,HET,77,0.94	LIFR	splice_region&intron	LIFR:ENST00000263409:splice_region&intron:LOW:exon2/19:c.143-11_143-10delGT:,LIFR:ENST00000453190:splice_region&intron:LOW:exon2/19:c.143-11_143-10delGT:	(AC)n	rs34759137;rs760641742	0.0000	0.3454	80,56,1	0.2017,0.3103,0.2720,0.3796,0.3566	0.3340							151443 [LIFR (confirmed) Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome,601559];	RCV000308475.1 [uncertain significance]; 			818	245	2	[2] auto-classification 14.09.2017  			LIFR (inh=AR pLI=0.00)
chr5	38919158	38919158	G	A	het	pred_pathogenic;anno_omim	QUAL=4304;DP=153;AF=0.52;MQM=60;TRIO=HET,153,0.52,WT,150,0.00,HET,176,0.51	OSMR	missense	OSMR:ENST00000274276:missense:MODERATE:exon11/18:c.1579G>A:p.Glu527Lys		rs10941412	0.1464	0.1558	1607,957,306	0.2498,0.0871,0.0009,0.1748,0.1388	0.1854	2.3480	T,T	T	P	T,T	22.00	601743 [OSMR (confirmed) Amyloidosis,primary localized cutaneous,1,105250];				47	532	2	[2] auto-classification 14.09.2017  			OSMR (inh=AD pLI=0.00)
chr5	38933749	38933749	C	T	hom	anno_omim	QUAL=17042;DP=300;AF=0.99;MQM=60;TRIO=HOM,300,0.99,HET,313,0.49,HET,306,0.45	OSMR	3'UTR	OSMR:ENST00000274276:3'UTR:MODIFIER:exon18/18:c.*203C>T:		rs1239344	0.4491	0.0000	0,0,0	0,0,0,0,0	0.4475							601743 [OSMR (confirmed) Amyloidosis,primary localized cutaneous,1,105250];				37	117					OSMR (inh=AD pLI=0.00)
chr5	38935101	38935101	G	C	hom	anno_omim	QUAL=10822;DP=178;AF=0.99;MQM=54;TRIO=HOM,178,0.99,HET,187,0.52,HET,229,0.50	OSMR	3'UTR	OSMR:ENST00000274276:3'UTR:MODIFIER:exon18/18:c.*1555G>C:	AluSp	rs357252	0.6404	0.0000	0,0,0	0,0,0,0,0	0.6628							601743 [OSMR (confirmed) Amyloidosis,primary localized cutaneous,1,105250];				57	70					OSMR (inh=AD pLI=0.00)
chr5	38935412	38935414	CAA	-	hom	anno_omim	QUAL=23560;DP=367;AF=0.99;MQM=59;TRIO=HOM,367,0.99,HET,491,0.49,HET,624,0.48	OSMR	3'UTR	OSMR:ENST00000274276:3'UTR:MODIFIER:exon18/18:c.*1870_*1872delAAC:		rs16351	0.6432	0.0000	0,0,0	0,0,0,0,0	0.6612							601743 [OSMR (confirmed) Amyloidosis,primary localized cutaneous,1,105250];				57	70					OSMR (inh=AD pLI=0.00)
chr5	38935682	38935682	C	T	hom	anno_omim	QUAL=6228;DP=170;AF=1.00;MQM=60;TRIO=HOM,170,1.00,HET,27,0.63,HET,51,0.25	OSMR	3'UTR	OSMR:ENST00000274276:3'UTR:MODIFIER:exon18/18:c.*2136C>T:		rs7318	0.3620	0.0000	0,0,0	0,0,0,0,0	0.3891							601743 [OSMR (confirmed) Amyloidosis,primary localized cutaneous,1,105250];				23	76					OSMR (inh=AD pLI=0.00)
chr5	39285139	39285139	T	A	hom	anno_omim	QUAL=24140;DP=391;AF=0.99;MQM=59;TRIO=HOM,391,0.99,HOM,154,0.98,HOM,205,0.98	C9	3'UTR	C9:ENST00000263408:3'UTR:MODIFIER:exon11/11:c.*162A>T:		rs261738	0.8067	0.0000	0,0,0	0,0,0,0,0	0.8377							120940 [C9 (confirmed) C9 deficiency,613825|Macular degeneration,age-related,15,susceptibility to,615591];				161	70					C9 (inh=n/a pLI=0.00)
chr5	39342308	39342308	C	T	het	anno_omim	QUAL=8217;DP=269;AF=0.49;MQM=60;TRIO=HET,269,0.49,HOM,150,1.00,WT,200,0.00	C9	splice_region&intron	C9:ENST00000263408:splice_region&intron:LOW:exon1/10:c.78-10G>A:		rs476569	0.6278	0.5364	18011,8200,3495	0.8198,0.6218,0.5110,0.4964,0.5256	0.5691							120940 [C9 (confirmed) C9 deficiency,613825|Macular degeneration,age-related,15,susceptibility to,615591];				626	1017	2	[2] auto-classification 14.09.2017  			C9 (inh=n/a pLI=0.00)
chr5	40949997	40949997	C	T	hom	anno_omim	QUAL=17688;DP=147;AF=1.00;MQM=60;TRIO=HOM,147,1.00,HOM,191,1.00,HOM,213,1.00	C7	splice_region&intron	C7:ENST00000313164:splice_region&intron:LOW:exon8/17:c.983-9C>T:		rs1450656	0.6585	0.6909	12563,6452,1565	0.7583,0.6901,0.7400,0.6913,0.6234	0.6733							217070 [C7 (confirmed) C7 deficiency,610102];				910	923	2	[2] auto-classification 14.09.2017  			C7 (inh=AR pLI=0.00)
chr5	40955561	40955561	G	C	hom	pred_pathogenic;anno_omim	QUAL=32233;DP=360;AF=1.00;MQM=60;TRIO=HOM,360,1.00,HOM,280,1.00,HOM,359,1.00	C7	missense	C7:ENST00000313164:missense:MODERATE:exon10/18:c.1166G>C:p.Ser389Thr		rs1063499	0.4812	0.5700	20093,12300,512	0.3275,0.5765,0.5720,0.6052,0.5365	0.5752	1.3790	T,T	T	P	T	23.40	217070 [C7 (confirmed) C7 deficiency,610102];			COSM3761227	759	1009	2	[2] auto-classification 14.09.2017  			C7 (inh=AR pLI=0.00)
chr5	40981769	40981771	CTT	-	het	anno_omim	QUAL=8742;DP=364;AF=0.45;MQM=59;TRIO=HET,364,0.45,HET,438,0.52,WT,545,0.00	C7	3'UTR	C7:ENST00000313164:3'UTR:MODIFIER:exon18/18:c.*99_*101delTCT:		rs35249475	0.3009	0.0000	0,0,0	0,0,0,0,0	0.2696							217070 [C7 (confirmed) C7 deficiency,610102];				12	89					C7 (inh=AR pLI=0.00)
chr5	40982175	40982175	T	C	het	anno_omim	QUAL=5668;DP=243;AF=0.51;MQM=60;TRIO=HET,243,0.51,HET,190,0.51,WT,243,0.00	C7	3'UTR	C7:ENST00000313164:3'UTR:MODIFIER:exon18/18:c.*500T>C:		rs16870568	0.3015	0.0000	0,0,0	0,0,0,0,0	0.2723							217070 [C7 (confirmed) C7 deficiency,610102];				12	77					C7 (inh=AR pLI=0.00)
chr5	40982460	40982460	C	T	het	anno_omim	QUAL=1102;DP=93;AF=0.48;MQM=54;TRIO=HET,93,0.48,HET,11,0.36,WT,15,0.00	C7	3'UTR	C7:ENST00000313164:3'UTR:MODIFIER:exon18/18:c.*785C>T:	AluSx1	rs12153342	0.2240	0.0000	0,0,0	0,0,0,0,0	0.1963							217070 [C7 (confirmed) C7 deficiency,610102];				13	86					C7 (inh=AR pLI=0.00)
chr5	40982620	40982620	G	T	het	anno_omim	QUAL=2194;DP=151;AF=0.44;MQM=60;TRIO=HET,151,0.44,HET,61,0.46,WT,88,0.00	C7	3'UTR	C7:ENST00000313164:3'UTR:MODIFIER:exon18/18:c.*945G>T:		rs1061442	0.2238	0.0000	0,0,0	0,0,0,0,0	0.1949							217070 [C7 (confirmed) C7 deficiency,610102];				12	89					C7 (inh=AR pLI=0.00)
chr5	40982622	40982622	G	T	het	anno_omim	QUAL=2194;DP=151;AF=0.44;MQM=60;TRIO=HET,151,0.44,HET,61,0.46,WT,88,0.00	C7	3'UTR	C7:ENST00000313164:3'UTR:MODIFIER:exon18/18:c.*947G>T:		rs1061443	0.2113	0.0000	0,0,0	0,0,0,0,0	0.1837							217070 [C7 (confirmed) C7 deficiency,610102];				12	89					C7 (inh=AR pLI=0.00)
chr5	40982977	40982977	A	G	het	anno_omim	QUAL=1829;DP=162;AF=0.38;MQM=60;TRIO=HET,162,0.38,HET,26,0.46,WT,23,0.00	C7	3'UTR	C7:ENST00000313164:3'UTR:MODIFIER:exon18/18:c.*1302A>G:		rs14190	0.2115	0.0000	0,0,0	0,0,0,0,0	0.1851							217070 [C7 (confirmed) C7 deficiency,610102];				12	86					C7 (inh=AR pLI=0.00)
chr5	41142573	41142573	G	T	het	anno_omim	QUAL=4933;DP=300;AF=0.45;MQM=60;TRIO=HET,300,0.45,HET,112,0.45,WT,150,0.00	C6	3'UTR	C6:ENST00000263413:3'UTR:MODIFIER:exon18/18:c.*354C>A:,C6:ENST00000337836:3'UTR:MODIFIER:exon18/18:c.*354C>A:		rs10067242	0.0172	0.0000	0,0,0	0,0,0,0,0	0.0234							217050 [C6 (confirmed) C6 deficiency,612446|Combined C6/C7 deficiency];				0	22					C6 (inh=AR pLI=0.00)
chr5	41142606	41142606	C	T	het	anno_omim	QUAL=6067;DP=377;AF=0.47;MQM=60;TRIO=HET,377,0.47,HET,134,0.44,WT,201,0.00	C6	3'UTR	C6:ENST00000263413:3'UTR:MODIFIER:exon18/18:c.*321G>A:,C6:ENST00000337836:3'UTR:MODIFIER:exon18/18:c.*321G>A:		rs9200	0.6707	0.0000	0,0,0	0,0,0,0,0	0.5711							217050 [C6 (confirmed) C6 deficiency,612446|Combined C6/C7 deficiency];				68	111					C6 (inh=AR pLI=0.00)
chr5	41158863	41158863	G	A	hom	anno_omim	QUAL=25822;DP=242;AF=1.00;MQM=60;TRIO=HOM,242,1.00,HOM,248,1.00,HOM,297,1.00	C6	synonymous	C6:ENST00000263413:synonymous:LOW:exon13/18:c.1881C>T:p.Asp627Asp,C6:ENST00000337836:synonymous:LOW:exon13/18:c.1881C>T:p.Asp627Asp		rs6866352	0.9982	0.9996	60472,33296,5202	1.0000,1.0000,0.9937,1.0000,1.0000	0.9996							217050 [C6 (confirmed) C6 deficiency,612446|Combined C6/C7 deficiency];				2123	0	2	[2] auto-classification 14.09.2017  			C6 (inh=AR pLI=0.00)
chr5	41199959	41199959	G	T	het	pred_pathogenic;anno_omim	QUAL=10556;DP=252;AF=0.52;MQM=60;TRIO=HET,252,0.52,HET,261,0.48,HET,314,0.47	C6	missense	C6:ENST00000263413:missense:MODERATE:exon4/18:c.356C>A:p.Ala119Glu,C6:ENST00000337836:missense:MODERATE:exon4/18:c.356C>A:p.Ala119Glu		rs1801033	0.5539	0.5936	21755,13246,1588	0.5529,0.5306,0.4330,0.6273,0.6065	0.5991	2.5510	T,T,T	T	B	T,T,T	10.34	217050 [C6 (confirmed) C6 deficiency,612446|Combined C6/C7 deficiency];			COSM4159876	875	962	2	[2] auto-classification 14.09.2017  			C6 (inh=AR pLI=0.00)
chr5	52394019	52394019	C	-	het	anno_omim	QUAL=1192;DP=70;AF=0.49;MQM=60;TRIO=HET,70,0.49,HET,21,0.52,HET,24,0.46	MOCS2	3'UTR	MOCS2:ENST00000396954:3'UTR:MODIFIER:exon7/7:c.*413delG:,MOCS2:ENST00000361377:3'UTR:MODIFIER:exon6/6:c.*749delG:,MOCS2:ENST00000450852:3'UTR:MODIFIER:exon7/7:c.*900delG:,MOCS2:ENST00000510818:3'UTR:MODIFIER:exon7/7:c.*853delG:,MOCS2:ENST00000508922:3'UTR:MODIFIER:exon6/6:c.*820delG:		rs3839261	0.1520	0.0000	0,0,0	0,0,0,0,0	0.1426							603708 [MOCS2 (provisional) Molybdenum cofactor deficiency B,252160];	RCV000267699.1 [likely benign]; RCV000388960.1 [benign]; 			3	58					MOCS2 (inh=AR pLI=0.04)
chr5	52397311	52397311	T	C	het	anno_omim	QUAL=3770;DP=187;AF=0.51;MQM=60;TRIO=HET,187,0.51,HET,83,0.57,WT,114,0.00	MOCS2	synonymous,3'UTR,intron	MOCS2:ENST00000396954:synonymous:LOW:exon5/7:c.255A>G:p.Lys85Lys,MOCS2:ENST00000450852:3'UTR:MODIFIER:exon5/7:c.*175A>G:,MOCS2:ENST00000510818:3'UTR:MODIFIER:exon5/7:c.*175A>G:,MOCS2:ENST00000508922:3'UTR:MODIFIER:exon5/6:c.*175A>G:,MOCS2:ENST00000584946:3'UTR:MODIFIER:exon4/6:c.*47A>G:,MOCS2:ENST00000527216:3'UTR:MODIFIER:exon5/6:c.*175A>G:,MOCS2:ENST00000361377:intron:MODIFIER:exon4/5:c.*146+616A>G:,MOCS2:ENST00000582677:intron:MODIFIER:exon3/4:c.*19-947A>G:		rs2233216	0.0363	0.0381	120,49,3	0.0206,0.0668,0.0776,0.0353,0.0271	0.0389							603708 [MOCS2 (provisional) Molybdenum cofactor deficiency B,252160];	RCV000292675.1 [likely benign]; 			5	156					MOCS2 (inh=AR pLI=0.04)
chr5	52398005	52398005	T	C	het	pred_pathogenic;anno_omim	QUAL=6455;DP=306;AF=0.44;MQM=60;TRIO=HET,306,0.44,HET,178,0.60,WT,276,0.00	MOCS2	missense,3'UTR,intron	MOCS2:ENST00000396954:missense:MODERATE:exon4/7:c.148A>G:p.Thr50Ala,MOCS2:ENST00000361377:3'UTR:MODIFIER:exon4/6:c.*68A>G:,MOCS2:ENST00000450852:3'UTR:MODIFIER:exon4/7:c.*68A>G:,MOCS2:ENST00000510818:3'UTR:MODIFIER:exon4/7:c.*68A>G:,MOCS2:ENST00000508922:3'UTR:MODIFIER:exon4/6:c.*68A>G:,MOCS2:ENST00000527216:3'UTR:MODIFIER:exon4/6:c.*68A>G:,MOCS2:ENST00000582677:intron:MODIFIER:exon3/4:c.*19-1641A>G:,MOCS2:ENST00000584946:intron:MODIFIER:exon3/5:c.*19-666A>G:		rs2233213	0.0363	0.0392	116,47,3	0.0211,0.0679,0.0795,0.0366,0.0278	0.0389	4.5420	T,D	T	B	T	12.85	603708 [MOCS2 (provisional) Molybdenum cofactor deficiency B,252160];	RCV000349961.1 [likely benign]; 			5	159	1	[1] ahbuchr1 18.04.2016 MAF>5%			MOCS2 (inh=AR pLI=0.04)
chr5	52405174	52405174	C	A	het	anno_omim	QUAL=6401;DP=121;AF=0.58;MQM=60;TRIO=HET,121,0.58,HET,119,0.60,HET,204,0.51	MOCS2	5'UTR_premature_start_codon_gain,5'UTR,intron	MOCS2:ENST00000396954:5'UTR_premature_start_codon_gain:LOW:exon1/7:c.-263G>T:,MOCS2:ENST00000396954:5'UTR:MODIFIER:exon1/7:c.-263G>T:,MOCS2:ENST00000361377:intron:MODIFIER:exon1/5:c.18+368G>T:,MOCS2:ENST00000450852:intron:MODIFIER:exon1/6:c.18+368G>T:,MOCS2:ENST00000510818:intron:MODIFIER:exon1/6:c.18+368G>T:,MOCS2:ENST00000508922:intron:MODIFIER:exon1/5:c.18+368G>T:,MOCS2:ENST00000582677:intron:MODIFIER:exon1/4:c.18+368G>T:,MOCS2:ENST00000584946:intron:MODIFIER:exon1/5:c.18+368G>T:,MOCS2:ENST00000527216:intron:MODIFIER:exon1/5:c.3+641G>T:		rs77585010	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1323							603708 [MOCS2 (provisional) Molybdenum cofactor deficiency B,252160];				3	60	2	[2] auto-classification 14.09.2017  			MOCS2 (inh=AR pLI=0.04)
chr5	52942083	52942083	A	C	hom	anno_omim	QUAL=17221;DP=218;AF=1.00;MQM=60;TRIO=HOM,218,1.00,HOM,126,1.00,HOM,209,1.00	NDUFS4	synonymous	NDUFS4:ENST00000296684:synonymous:LOW:exon3/5:c.198A>C:p.Gly66Gly		rs31304	0.9435	0.9553	54795,30657,4900	0.9755,0.9838,0.8517,0.9644,0.9434	0.9594							602694 [NDUFS4 (provisional) Leigh syndrome,256000|Mitochondrial complex I deficiency,252010];	RCV000117714.2 [likely benign]; RCV000280222.1 [benign]; RCV000342200.1 [benign]; 			1955	147	2	[2] auto-classification 14.09.2017  			NDUFS4 (inh=AR pLI=0.00)
chr5	52942197	52942197	A	G	het	anno_omim	QUAL=7848;DP=400;AF=0.52;MQM=60;TRIO=HET,400,0.52,HET,189,0.48,WT,294,0.00	NDUFS4	synonymous	NDUFS4:ENST00000296684:synonymous:LOW:exon3/5:c.312A>G:p.Arg104Arg		rs31303	0.8001	0.7735	36419,19269,3799	0.8540,0.8022,0.7631,0.7599,0.7711	0.7861							602694 [NDUFS4 (provisional) Leigh syndrome,256000|Mitochondrial complex I deficiency,252010];	RCV000117715.2 [likely benign]; RCV000302455.1 [benign]; RCV000398452.1 [benign]; 		COSM4159887	1165	793	2	[2] auto-classification 14.09.2017  			NDUFS4 (inh=AR pLI=0.00)
chr5	52979097	52979097	G	A	het	anno_omim	QUAL=5923;DP=294;AF=0.51;MQM=60;TRIO=HET,294,0.51,HET,138,0.50,WT,175,0.01	NDUFS4	3'UTR	NDUFS4:ENST00000296684:3'UTR:MODIFIER:exon5/5:c.*46G>A:		rs567	0.3786	0.4485	12338,7266,394	0.2819,0.5561,0.2756,0.4718,0.4475	0.4577							602694 [NDUFS4 (provisional) Leigh syndrome,256000|Mitochondrial complex I deficiency,252010];	RCV000270413.1 [likely benign]; RCV000313869.1 [likely benign]; 			430	927					NDUFS4 (inh=AR pLI=0.00)
chr5	55660603	55660603	T	G	het		QUAL=8189;DP=292;AF=0.47;MQM=60;TRIO=HET,292,0.47,HET,155,0.50,HET,210,0.47	RP11,155L15.1,HMGN1P17	intergenic_region	HMGN1P17:ENSG00000249697-ENSG00000250787:intergenic_region:MODIFIER::n.55660603T>G:	L2c	rs1900155	0.3728	0.0000	0,0,0	0,0,0,0,0	0.3581											24	82					PRPF31 (inh=AD pLI=0.97), 155L15.1 (inh=n/a pLI=n/a), HMGN1P17 (inh=n/a pLI=n/a)
chr5	60170337	60170337	A	G	het	anno_omim	QUAL=5724;DP=204;AF=0.52;MQM=60;TRIO=HET,204,0.52,HOM,52,0.98,HET,79,0.53	ERCC8	3'UTR	ERCC8:ENST00000265038:3'UTR:MODIFIER:exon12/12:c.*105T>C:,ERCC8:ENST00000426742:3'UTR:MODIFIER:exon13/13:c.*105T>C:,ERCC8:ENST00000543101:3'UTR:MODIFIER:exon11/11:c.*105T>C:		rs3117	0.3067	0.0000	0,0,0	0,0,0,0,0	0.3692							609412 [ERCC8 (confirmed) Cockayne syndrome,type A,216400|UV-sensitive syndrome 2,614621];	RCV000363687.1 [benign]; 			75	210					ERCC8 (inh=AR pLI=0.00)
chr5	60240986	60240986	A	G	het	anno_omim	QUAL=7404;DP=282;AF=0.47;MQM=59;TRIO=HET,282,0.47,WT,273,0.00,HET,372,0.47	NDUFAF2	5'UTR	NDUFAF2:ENST00000296597:5'UTR:MODIFIER:exon1/4:c.-97A>G:		rs158922	0.7242	0.0000	0,0,0	0,0,0,0,0	0.6699							609653 [NDUFAF2 (provisional) Mitochondrial complex I deficiency,252010|Leigh syndrome,256000];	RCV000297972.1 [benign]; RCV000337453.1 [benign]; RCV000401969.1 [benign]; 			97	113					NDUFAF2 (inh=n/a pLI=0.00)
chr5	60241142	60241142	G	A	het	anno_omim	QUAL=7788;DP=238;AF=0.51;MQM=54;TRIO=HET,238,0.51,WT,334,0.00,HET,414,0.48	NDUFAF2	synonymous	NDUFAF2:ENST00000296597:synonymous:LOW:exon1/4:c.60G>A:p.Lys20Lys,NDUFAF2:ENST00000511107:synonymous:LOW:exon1/3:c.60G>A:p.Lys20Lys		rs158921	0.6929	0.6388	23562,10617,1815	0.6137,0.7480,0.9284,0.5877,0.6488	0.6492							609653 [NDUFAF2 (provisional) Mitochondrial complex I deficiency,252010|Leigh syndrome,256000];	RCV000117705.2 [likely benign]; RCV000278856.1 [benign]; RCV000290995.1 [benign]; RCV000348449.1 [benign]; 		COSM3761271	752	1055	2	[2] auto-classification 14.09.2017  			NDUFAF2 (inh=n/a pLI=0.00)
chr5	68788261	68788261	G	A	hom	anno_omim	QUAL=10225;DP=51;AF=1.00;MQM=59;TRIO=HOM,51,1.00,HOM,130,1.00,HOM,162,0.99	OCLN,RP11-241G9.3	5'UTR	OCLN:ENST00000355237:5'UTR:MODIFIER:exon1/9:c.-294G>A:		rs3733742	0.8516	0.0000	0,0,0	0,0,0,0,0	0.8637							602876 [OCLN (confirmed) Pseudo-TORCH syndrome 1,251290];				173	55					OCLN (inh=AR pLI=0.49), RP11-241G9.3 (inh=n/a pLI=n/a)
chr5	68850922	68850922	G	C	het	low_MQM;anno_omim	QUAL=215;DP=45;AF=0.38;MQM=28;TRIO=HET,45,0.38,HOM,6,1.00,WT,11,0.00	OCLN,GUSBP3	3'UTR	OCLN:ENST00000355237:3'UTR:MODIFIER:exon9/9:c.*1424G>C:	AluSx4	rs76123058	0.5627	0.0000	0,0,0	0,0,0,0,0	0.5032							602876 [OCLN (confirmed) Pseudo-TORCH syndrome 1,251290];				73	23					OCLN (inh=AR pLI=0.49), GUSBP3 (inh=n/a pLI=n/a)
chr5	68853877	68853877	C	T	het	low_MQM;anno_omim	QUAL=6382;DP=341;AF=0.33;MQM=28;TRIO=HET,341,0.33,WT,198,0.01,HET,385,0.65	OCLN,GUSBP3	3'UTR	OCLN:ENST00000355237:3'UTR:MODIFIER:exon9/9:c.*4379C>T:		rs200773462	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1992							602876 [OCLN (confirmed) Pseudo-TORCH syndrome 1,251290];				2	42					OCLN (inh=AR pLI=0.49), GUSBP3 (inh=n/a pLI=n/a)
chr5	70883136	70883136	A	G	het	low_DP;anno_omim	QUAL=1130;DP=6;AF=0.67;MQM=59;TRIO=HET,6,0.67,HOM,28,1.00,HET,34,0.35	MCCC2	5'UTR	MCCC2:ENST00000340941:5'UTR:MODIFIER:exon1/17:c.-117A>G:		rs11746722	0.0000	0.0000	0,0,0	0,0,0,0,0	0.7784							609014 [MCCC2 (confirmed) 3-Methylcrotonyl-CoA carboxylase 2 deficiency,210210];				153	57					MCCC2 (inh=AR pLI=0.00)
chr5	70945075	70945075	A	G	hom	anno_omim	QUAL=24705;DP=223;AF=0.99;MQM=59;TRIO=HOM,223,0.99,HOM,252,1.00,HOM,305,1.00	MCCC2	synonymous	MCCC2:ENST00000340941:synonymous:LOW:exon14/17:c.1368A>G:p.Ala456Ala,MCCC2:ENST00000323375:synonymous:LOW:exon13/16:c.1254A>G:p.Ala418Ala		rs10064079	0.8514	0.8781	47117,25267,2558	0.7010,0.9256,0.9838,0.8696,0.9298	0.8845							609014 [MCCC2 (confirmed) 3-Methylcrotonyl-CoA carboxylase 2 deficiency,210210];	RCV000082093.5 [benign]; RCV000333305.1 [benign]; 			1634	438	2	[2] auto-classification 14.09.2017  			MCCC2 (inh=AR pLI=0.00)
chr5	70952934	70952934	C	T	hom	anno_omim	QUAL=21922;DP=377;AF=1.00;MQM=59;TRIO=HOM,377,1.00,HOM,124,1.00,HOM,150,1.00	MCCC2	3'UTR	MCCC2:ENST00000340941:3'UTR:MODIFIER:exon17/17:c.*247C>T:,MCCC2:ENST00000323375:3'UTR:MODIFIER:exon16/16:c.*247C>T:	MIR	rs1135667	0.8111	0.0000	0,0,0	0,0,0,0,0	0.7924							609014 [MCCC2 (confirmed) 3-Methylcrotonyl-CoA carboxylase 2 deficiency,210210];	RCV000384930.1 [benign]; 			165	44					MCCC2 (inh=AR pLI=0.00)
chr5	70953280	70953280	G	T	het	anno_omim	QUAL=4434;DP=200;AF=0.53;MQM=59;TRIO=HET,200,0.53,WT,138,0.00,HET,245,0.36	MCCC2	3'UTR	MCCC2:ENST00000340941:3'UTR:MODIFIER:exon17/17:c.*593G>T:	AluSz	rs60069076	0.1154	0.0000	0,0,0	0,0,0,0,0	0.0997							609014 [MCCC2 (confirmed) 3-Methylcrotonyl-CoA carboxylase 2 deficiency,210210];	RCV000404190.1 [likely benign]; 			1	27					MCCC2 (inh=AR pLI=0.00)
chr5	70953930	70953930	G	C	hom	anno_omim	QUAL=38850;DP=419;AF=1.00;MQM=59;TRIO=HOM,419,1.00,HOM,292,1.00,HOM,482,1.00	MCCC2	3'UTR	MCCC2:ENST00000340941:3'UTR:MODIFIER:exon17/17:c.*1243G>C:	L2c	rs7731970	0.0000	0.0000	0,0,0	0,0,0,0,0	0.8096							609014 [MCCC2 (confirmed) 3-Methylcrotonyl-CoA carboxylase 2 deficiency,210210];				130	35					MCCC2 (inh=AR pLI=0.00)
chr5	73981270	73981270	T	C	hom	low_DP;anno_omim	QUAL=4412;DP=17;AF=0.94;MQM=59;TRIO=HOM,17,0.94,HOM,86,1.00,HET,144,0.40	HEXB	missense,intron	HEXB:ENST00000261416:missense:MODERATE:exon1/14:c.185T>C:p.Leu62Ser,HEXB:ENST00000511181:intron:MODIFIER:exon1/13:c.-376-3883T>C:		rs820878	0.9814	0.9708	53506,28644,4303	0.9923,0.9834,0.9999,0.9620,0.9659	0.9739	0.9630	T	T		T	0.10	606873 [HEXB (confirmed) Sandhoff disease,infantile,juvenile,and adult forms,268800];	RCV000153357.2 [benign]; 		COSM450042	3049	205	2	[2] old entry - no details available [import GPD] Julia Bickmann 2014-04-01 14:28:01 -type: mutation details L62S wurde bisher nur einmal im Zusammenhang mit einer infantilen Sandhoff-Erkrankung beschrieben (Zhang et al., 1995); das Kind trug eine 50kb-Deletion auf dem anderen HEXB-Allel; die Hexosaminidase-Aktivit?t war nicht bestimmt worden. In Abh?ngigkeit von der Restaktivit?t der HEX kann bei HEXB-Mutationen ein breites Symptomenspektrum bis hin zur Symptomfreiheit bestehen.  Die HEX-Akt. Bestimmung ist daher obligat.			HEXB (inh=AR pLI=0.00)
chr5	73985215	73985215	A	G	het	pred_pathogenic;anno_omim	QUAL=9391;DP=365;AF=0.48;MQM=60;TRIO=HET,365,0.48,WT,301,0.00,HET,344,0.51	HEXB	missense,5'UTR	HEXB:ENST00000261416:missense:MODERATE:exon2/14:c.362A>G:p.Lys121Arg,HEXB:ENST00000511181:5'UTR:MODIFIER:exon2/14:c.-314A>G:		rs11556045	0.2226	0.1988	2615,1053,383	0.2656,0.2604,0.1579,0.1747,0.2457	0.2020	-0.9130	T	T	B	D	0.01	606873 [HEXB (confirmed) Sandhoff disease,infantile,juvenile,and adult forms,268800];	RCV000004078.2 [benign]; RCV000079063.5 [benign]; RCV000336190.1 [likely benign]; 		COSM149850	133	958	2	[2] auto-classification 14.09.2017  			HEXB (inh=AR pLI=0.00)
chr5	74009327	74009327	A	G	het	anno_omim	QUAL=5289;DP=173;AF=0.50;MQM=60;TRIO=HET,173,0.50,HET,203,0.58,WT,248,0.00	HEXB	splice_region&intron	HEXB:ENST00000261416:splice_region&intron:LOW:exon6/13:c.772-4A>G:,HEXB:ENST00000511181:splice_region&intron:LOW:exon6/13:c.97-4A>G:		rs17561000	0.0395	0.0729	502,386,2	0.0146,0.0357,0.0006,0.0980,0.0498	0.0725							606873 [HEXB (confirmed) Sandhoff disease,infantile,juvenile,and adult forms,268800];	RCV000079066.5 [benign]; RCV000351167.1 [likely benign]; 			26	476	2	[2] auto-classification 14.09.2017  			HEXB (inh=AR pLI=0.00)
chr5	76704849	76704849	T	C	hom	anno_omim	QUAL=23492;DP=244;AF=1.00;MQM=59;TRIO=HOM,244,1.00,HOM,211,1.00,HOM,284,1.00	PDE8B	synonymous,intron	PDE8B:ENST00000264917:synonymous:LOW:exon14/22:c.1497T>C:p.Pro499Pro,PDE8B:ENST00000340978:synonymous:LOW:exon13/21:c.1356T>C:p.Pro452Pro,PDE8B:ENST00000346042:synonymous:LOW:exon11/19:c.1206T>C:p.Pro402Pro,PDE8B:ENST00000342343:synonymous:LOW:exon13/21:c.1437T>C:p.Pro479Pro,PDE8B:ENST00000333194:intron:MODIFIER:exon13/20:c.1365+1567T>C:		rs186753	0.0000	1.0000	60699,33367,5201	1.0000,1.0000,1.0000,1.0000,1.0000	1.0000							603390 [PDE8B (confirmed) Pigmented nodular adrenocortical disease,primary,3,614190|Striatal degeneration,autosomal dominant,609161];				2108	0	2	[2] auto-classification 14.09.2017  			PDE8B (inh=AD pLI=0.99)
chr5	76722442	76722442	C	T	het	anno_omim	QUAL=7617;DP=347;AF=0.54;MQM=60;TRIO=HET,347,0.54,HET,150,0.61,WT,179,0.00	PDE8B,WDR41	3'UTR	PDE8B:ENST00000264917:3'UTR:MODIFIER:exon22/22:c.*63C>T:,PDE8B:ENST00000340978:3'UTR:MODIFIER:exon21/21:c.*63C>T:,PDE8B:ENST00000346042:3'UTR:MODIFIER:exon19/19:c.*63C>T:,PDE8B:ENST00000333194:3'UTR:MODIFIER:exon21/21:c.*63C>T:,PDE8B:ENST00000342343:3'UTR:MODIFIER:exon21/21:c.*63C>T:,PDE8B:ENST00000505283:3'UTR:MODIFIER:exon9/9:c.*63C>T:		rs62362531	0.1098	0.0000	0,0,0	0,0,0,0,0	0.1128							603390 [PDE8B (confirmed) Pigmented nodular adrenocortical disease,primary,3,614190|Striatal degeneration,autosomal dominant,609161];	RCV000272908.1 [benign]; 			33	330					PDE8B (inh=AD pLI=0.99), WDR41 (inh=n/a pLI=0.00)
chr5	76722443	76722443	G	A	het	anno_omim	QUAL=11334;DP=346;AF=0.45;MQM=59;TRIO=HET,346,0.45,HET,150,0.39,HOM,177,1.00	PDE8B,WDR41	3'UTR	PDE8B:ENST00000264917:3'UTR:MODIFIER:exon22/22:c.*64G>A:,PDE8B:ENST00000340978:3'UTR:MODIFIER:exon21/21:c.*64G>A:,PDE8B:ENST00000346042:3'UTR:MODIFIER:exon19/19:c.*64G>A:,PDE8B:ENST00000333194:3'UTR:MODIFIER:exon21/21:c.*64G>A:,PDE8B:ENST00000342343:3'UTR:MODIFIER:exon21/21:c.*64G>A:,PDE8B:ENST00000505283:3'UTR:MODIFIER:exon9/9:c.*64G>A:		rs40594	0.6611	0.0000	0,0,0	0,0,0,0,0	0.5992							603390 [PDE8B (confirmed) Pigmented nodular adrenocortical disease,primary,3,614190|Striatal degeneration,autosomal dominant,609161];	RCV000267169.1 [benign]; 			478	695					PDE8B (inh=AD pLI=0.99), WDR41 (inh=n/a pLI=0.00)
chr5	76722877	76722877	C	-	het	anno_omim	QUAL=7042;DP=294;AF=0.37;MQM=59;TRIO=HET,294,0.48,WT,93,0.55,HET,126,1.00	WDR41,PDE8B	3'UTR	PDE8B:ENST00000264917:3'UTR:MODIFIER:exon22/22:c.*498delC:,PDE8B:ENST00000340978:3'UTR:MODIFIER:exon21/21:c.*498delC:,PDE8B:ENST00000346042:3'UTR:MODIFIER:exon19/19:c.*498delC:,PDE8B:ENST00000505283:3'UTR:MODIFIER:exon9/9:c.*498delC:		rs567378113	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0188							603390 [PDE8B (confirmed) Pigmented nodular adrenocortical disease,primary,3,614190|Striatal degeneration,autosomal dominant,609161];				0	12					WDR41 (inh=n/a pLI=0.00), PDE8B (inh=AD pLI=0.99)
chr5	76722891	76722891	T	C	het	anno_omim	QUAL=9578;DP=304;AF=0.49;MQM=59;TRIO=HET,304,0.49,HET,96,0.51,HOM,143,1.00	PDE8B,WDR41	3'UTR	PDE8B:ENST00000264917:3'UTR:MODIFIER:exon22/22:c.*512T>C:,PDE8B:ENST00000340978:3'UTR:MODIFIER:exon21/21:c.*512T>C:,PDE8B:ENST00000346042:3'UTR:MODIFIER:exon19/19:c.*512T>C:,PDE8B:ENST00000505283:3'UTR:MODIFIER:exon9/9:c.*512T>C:		rs460267	0.4455	0.0000	0,0,0	0,0,0,0,0	0.4401							603390 [PDE8B (confirmed) Pigmented nodular adrenocortical disease,primary,3,614190|Striatal degeneration,autosomal dominant,609161];	RCV000366496.1 [benign]; 			49	117					PDE8B (inh=AD pLI=0.99), WDR41 (inh=n/a pLI=0.00)
chr5	76723227	76723228	AA	-	hom	anno_omim	QUAL=1218;DP=35;AF=0.80;MQM=59;TRIO=HOM,35,0.80,HOM,3,1.00,HOM,17,0.71	PDE8B,WDR41	splice_region,3'UTR	PDE8B:ENST00000340978:splice_region:LOW:exon21/21:c.*863_*864delAA:,PDE8B:ENST00000346042:splice_region:LOW:exon19/19:c.*863_*864delAA:,PDE8B:ENST00000264917:3'UTR:MODIFIER:exon22/22:c.*863_*864delAA:,PDE8B:ENST00000340978:3'UTR:MODIFIER:exon21/21:c.*863_*864delAA:,PDE8B:ENST00000346042:3'UTR:MODIFIER:exon19/19:c.*863_*864delAA:,PDE8B:ENST00000505283:3'UTR:MODIFIER:exon9/9:c.*863_*864delAA:	(A)n	rs771815865	0.6236	0.0000	0,0,0	0,0,0,0,0	0.3909							603390 [PDE8B (confirmed) Pigmented nodular adrenocortical disease,primary,3,614190|Striatal degeneration,autosomal dominant,609161];	RCV000262351.1 [benign]; 			81	46	2	[2] auto-classification 14.09.2017  			PDE8B (inh=AD pLI=0.99), WDR41 (inh=n/a pLI=0.00)
chr5	77425028	77425028	A	T	hom	pred_pathogenic;anno_omim	QUAL=12409;DP=224;AF=1.00;MQM=60;TRIO=HOM,224,1.00,HOM,97,1.00,HET,158,0.45	AP3B1	missense	AP3B1:ENST00000255194:missense:MODERATE:exon16/27:c.1754T>A:p.Val585Glu,AP3B1:ENST00000519295:missense:MODERATE:exon16/27:c.1607T>A:p.Val536Glu		rs6453373	0.0000	0.8628	46196,28358,4696	0.9500,0.8407,0.4310,0.9220,0.7985	0.9047	6.3070	T,T,T,T	T	B	T,T	10.84	603401 [AP3B1 (provisional) Hermansky-Pudlak syndrome 2,608233];	RCV000150163.2 [benign]; RCV000324616.1 [benign]; 			1727	345	2	[2] auto-classification 14.09.2017  			AP3B1 (inh=AR pLI=1.00)
chr5	78073245	78073245	C	A	hom	anno_omim	QUAL=8578;DP=105;AF=1.00;MQM=60;TRIO=HOM,105,1.00,HOM,70,1.00,HOM,87,1.00	ARSB	3'UTR	ARSB:ENST00000264914:3'UTR:MODIFIER:exon8/8:c.*2975G>T:	L1MB5	rs3088247	0.7374	0.0000	0,0,0	0,0,0,0,0	0.7923							611542 [ARSB (confirmed) Mucopolysaccharidosis type VI (Maroteaux-Lamy),253200];	RCV000360826.1 [benign]; 			102	56					ARSB (inh=AR pLI=0.00)
chr5	78074198	78074198	A	C	het	anno_omim	QUAL=18779;DP=419;AF=0.48;MQM=60;TRIO=HET,419,0.48,WT,300,0.00,HOM,407,1.00	ARSB	3'UTR	ARSB:ENST00000264914:3'UTR:MODIFIER:exon8/8:c.*2022T>G:		rs7704939	0.4467	0.0000	0,0,0	0,0,0,0,0	0.4393							611542 [ARSB (confirmed) Mucopolysaccharidosis type VI (Maroteaux-Lamy),253200];	RCV000383970.1 [benign]; 			45	107					ARSB (inh=AR pLI=0.00)
chr5	78074751	78074751	G	A	het	anno_omim	QUAL=2370;DP=166;AF=0.50;MQM=59;TRIO=HET,166,0.50,WT,24,0.00,HET,26,0.50	ARSB	3'UTR	ARSB:ENST00000264914:3'UTR:MODIFIER:exon8/8:c.*1469C>T:	AluJr	rs55710452	0.0427	0.0000	0,0,0	0,0,0,0,0	0.0716							611542 [ARSB (confirmed) Mucopolysaccharidosis type VI (Maroteaux-Lamy),253200];	RCV000404729.1 [likely benign]; 			4	37					ARSB (inh=AR pLI=0.00)
chr5	78074918	78074918	C	A	het	anno_omim	QUAL=4624;DP=148;AF=0.53;MQM=60;TRIO=HET,148,0.53,HET,48,0.60,HOM,62,1.00	ARSB	3'UTR	ARSB:ENST00000264914:3'UTR:MODIFIER:exon8/8:c.*1302G>T:		rs754566	0.5026	0.0000	0,0,0	0,0,0,0,0	0.5356							611542 [ARSB (confirmed) Mucopolysaccharidosis type VI (Maroteaux-Lamy),253200];	RCV000306657.1 [benign]; 			75	107					ARSB (inh=AR pLI=0.00)
chr5	78135201	78135201	C	T	het	anno_omim	QUAL=2336;DP=158;AF=0.38;MQM=60;TRIO=HET,158,0.38,HET,70,0.51,WT,123,0.00	ARSB	synonymous	ARSB:ENST00000264914:synonymous:LOW:exon6/8:c.1191G>A:p.Pro397Pro,ARSB:ENST00000396151:synonymous:LOW:exon7/8:c.1191G>A:p.Pro397Pro,ARSB:ENST00000565165:synonymous:LOW:exon7/8:c.1191G>A:p.Pro397Pro		rs25413	0.2592	0.2007	3295,1263,1388	0.5154,0.1012,0.0439,0.1904,0.2272	0.2574							611542 [ARSB (confirmed) Mucopolysaccharidosis type VI (Maroteaux-Lamy),253200];	RCV000078001.5 [benign]; RCV000372416.1 [benign]; 		COSM3761329, COSM3761330	125	741	2	[2] auto-classification 14.09.2017  			ARSB (inh=AR pLI=0.00)
chr5	78181477	78181477	C	T	het	pred_pathogenic;anno_omim	QUAL=10429;DP=288;AF=0.54;MQM=59;TRIO=HET,288,0.54,HET,211,0.52,HET,300,0.49	ARSB	missense	ARSB:ENST00000264914:missense:MODERATE:exon5/8:c.1072G>A:p.Val358Met,ARSB:ENST00000396151:missense:MODERATE:exon6/8:c.1072G>A:p.Val358Met,ARSB:ENST00000565165:missense:MODERATE:exon6/8:c.1072G>A:p.Val358Met		rs1065757	0.2855	0.3907	10273,6619,62	0.1061,0.4457,0.3804,0.4417,0.2544	0.3997	3.9850	T,T	T	D,D	D,D	26.70	611542 [ARSB (confirmed) Mucopolysaccharidosis type VI (Maroteaux-Lamy),253200];	RCV000077997.5 [benign]; RCV000352809.1 [benign]; 	CM088428 [CLASS=FP MUT=ALT PHEN="Reduced activity" GENE=ARSB]; 		305	968	2	[2] auto-classification 14.09.2017  			ARSB (inh=AR pLI=0.00)
chr5	78181577	78181577	T	C	het	anno_omim	QUAL=4922;DP=160;AF=0.49;MQM=60;TRIO=HET,160,0.49,WT,192,0.00,HET,253,0.51	ARSB	synonymous	ARSB:ENST00000264914:synonymous:LOW:exon5/8:c.972A>G:p.Gly324Gly,ARSB:ENST00000396151:synonymous:LOW:exon6/8:c.972A>G:p.Gly324Gly,ARSB:ENST00000565165:synonymous:LOW:exon6/8:c.972A>G:p.Gly324Gly		rs72762973	0.0266	0.0527	221,173,3	0.0131,0.0283,0.0000,0.0736,0.0152	0.0607							611542 [ARSB (confirmed) Mucopolysaccharidosis type VI (Maroteaux-Lamy),253200];	RCV000078006.5 [benign]; RCV000381815.1 [likely benign]; 			7	183	2	[2] auto-classification 14.09.2017  			ARSB (inh=AR pLI=0.00)
chr5	78281373	78281373	T	C	hom	anno_omim	QUAL=13240;DP=248;AF=1.00;MQM=60;TRIO=HOM,248,1.00,HOM,79,1.00,HOM,96,1.00	ARSB	5'UTR	ARSB:ENST00000264914:5'UTR:MODIFIER:exon1/8:c.-302A>G:,ARSB:ENST00000396151:5'UTR:MODIFIER:exon2/8:c.-302A>G:,ARSB:ENST00000565165:5'UTR:MODIFIER:exon2/8:c.-302A>G:		rs163127	0.9052	0.0000	0,0,0	0,0,0,0,0	0.9442							611542 [ARSB (confirmed) Mucopolysaccharidosis type VI (Maroteaux-Lamy),253200];	RCV000369905.1 [benign]; 			228	4					ARSB (inh=AR pLI=0.00)
chr5	78281635	78281635	T	C	het	anno_omim	QUAL=7383;DP=363;AF=0.52;MQM=60;TRIO=HET,363,0.52,HET,230,0.50,WT,258,0.00	ARSB	intron	ARSB:ENST00000396151:intron:MODIFIER:exon1/7:c.-311+87A>G:,ARSB:ENST00000565165:intron:MODIFIER:exon1/7:c.-311+87A>G:		rs59558132	0.1719	0.0000	0,0,0	0,0,0,0,0	0.1666							611542 [ARSB (confirmed) Mucopolysaccharidosis type VI (Maroteaux-Lamy),253200];	RCV000328506.1 [likely benign]; 			14	69					ARSB (inh=AR pLI=0.00)
chr5	78281909	78281909	-	TG	hom	anno_omim	QUAL=30786;DP=312;AF=0.99;MQM=59;TRIO=HOM,312,0.99,HOM,266,1.00,HOM,375,0.99	ARSB	5'UTR	ARSB:ENST00000396151:5'UTR:MODIFIER:exon1/8:c.-499_-498insCA:,ARSB:ENST00000565165:5'UTR:MODIFIER:exon1/8:c.-499_-498insCA:		rs397805372	0.9519	0.0000	0,0,0	0,0,0,0,0	0.9840							611542 [ARSB (confirmed) Mucopolysaccharidosis type VI (Maroteaux-Lamy),253200];	RCV000341282.1 [benign]; 			228	4					ARSB (inh=AR pLI=0.00)
chr5	78281977	78281977	G	C	het	anno_omim	QUAL=11600;DP=530;AF=0.50;MQM=59;TRIO=HET,530,0.50,HET,307,0.54,WT,402,0.00	ARSB,DMGDH	intergenic_region	DMGDH:ENSG00000113273-ENSG00000132837:intergenic_region:MODIFIER::n.78281977G>C:		rs62377914	0.1456	0.0000	0,0,0	0,0,0,0,0	0.1443							611542 [ARSB (confirmed) Mucopolysaccharidosis type VI (Maroteaux-Lamy),253200];	RCV000335980.1 [likely benign]; 			13	66					ARSB (inh=AR pLI=0.00), DMGDH (inh=AR pLI=0.00)
chr5	78282029	78282029	T	C	het	anno_omim	QUAL=10920;DP=554;AF=0.48;MQM=59;TRIO=HET,554,0.48,HET,260,0.54,WT,362,0.00	ARSB,DMGDH	intergenic_region	DMGDH:ENSG00000113273-ENSG00000132837:intergenic_region:MODIFIER::n.78282029T>C:		rs57586329	0.1629	0.0000	0,0,0	0,0,0,0,0	0.1612							611542 [ARSB (confirmed) Mucopolysaccharidosis type VI (Maroteaux-Lamy),253200];	RCV000403354.1 [likely benign]; 			12	60					ARSB (inh=AR pLI=0.00), DMGDH (inh=AR pLI=0.00)
chr5	78282249	78282249	T	C	het	anno_omim	QUAL=11762;DP=291;AF=0.55;MQM=60;TRIO=HET,291,0.55,HET,130,0.54,HOM,171,1.00	ARSB,DMGDH	intergenic_region	DMGDH:ENSG00000113273-ENSG00000132837:intergenic_region:MODIFIER::n.78282249T>C:	LTR37A	rs163126	0.8163	0.0000	0,0,0	0,0,0,0,0	0.8413							611542 [ARSB (confirmed) Mucopolysaccharidosis type VI (Maroteaux-Lamy),253200];	RCV000403805.1 [benign]; 			109	50					ARSB (inh=AR pLI=0.00), DMGDH (inh=AR pLI=0.00)
chr5	88015545	88015545	A	C	hom	anno_omim	QUAL=15078;DP=317;AF=0.00;MQM=60;TRIO=HOM,317,0.00,HET,98,0.39,HET,115,0.00	MEF2C,CTC-467M3.1	3'UTR,intron	MEF2C:ENST00000340208:3'UTR:MODIFIER:exon12/12:c.*2876T>G:,MEF2C:ENST00000424173:3'UTR:MODIFIER:exon11/11:c.*2876T>G:,MEF2C:ENST00000504921:3'UTR:MODIFIER:exon10/10:c.*2876T>G:,CTC-467M3.1:ENST00000510274:intron:MODIFIER:exon3/3:n.256-2896A>C:		rs34316	0.4824	0.0000	0,0,0	0,0,0,0,0	0.5141							600662 [MEF2C (confirmed) Mental retardation,stereotypic movements,epilepsy,and/or cerebral malformations,613443|Chromosome 5q14.3 deletion syndrome,613443];	RCV000380721.1 [benign]; 			63	123					MEF2C (inh=n/a pLI=0.00), MEF2C-AS2 (inh=n/a pLI=n/a)
chr5	88016008	88016008	A	G	hom	anno_omim	QUAL=30854;DP=452;AF=1.00;MQM=59;TRIO=HOM,452,1.00,HOM,311,1.00,HET,454,0.48	MEF2C,CTC-467M3.1	3'UTR,intron	MEF2C:ENST00000340208:3'UTR:MODIFIER:exon12/12:c.*2413T>C:,MEF2C:ENST00000424173:3'UTR:MODIFIER:exon11/11:c.*2413T>C:,MEF2C:ENST00000504921:3'UTR:MODIFIER:exon10/10:c.*2413T>C:,CTC-467M3.1:ENST00000510274:intron:MODIFIER:exon3/3:n.256-2433A>G:		rs34317	0.7013	0.0000	0,0,0	0,0,0,0,0	0.7031							600662 [MEF2C (confirmed) Mental retardation,stereotypic movements,epilepsy,and/or cerebral malformations,613443|Chromosome 5q14.3 deletion syndrome,613443];	RCV000279558.1 [benign]; 			116	98					MEF2C (inh=n/a pLI=0.00), MEF2C-AS2 (inh=n/a pLI=n/a)
chr5	88016153	88016153	-	T	hom	anno_omim	QUAL=6856;DP=213;AF=0.82;MQM=59;TRIO=HOM,213,0.82,HOM,57,0.86,HET,89,0.40	MEF2C,CTC-467M3.1	3'UTR,intron	MEF2C:ENST00000340208:3'UTR:MODIFIER:exon12/12:c.*2267dupA:,MEF2C:ENST00000424173:3'UTR:MODIFIER:exon11/11:c.*2267dupA:,MEF2C:ENST00000504921:3'UTR:MODIFIER:exon10/10:c.*2267dupA:,CTC-467M3.1:ENST00000510274:intron:MODIFIER:exon3/3:n.256-2276dupT:		rs398109145	0.6384	0.0000	0,0,0	0,0,0,0,0	0.6591							600662 [MEF2C (confirmed) Mental retardation,stereotypic movements,epilepsy,and/or cerebral malformations,613443|Chromosome 5q14.3 deletion syndrome,613443];	RCV000348923.1 [benign]; 			79	94					MEF2C (inh=n/a pLI=0.00), MEF2C-AS2 (inh=n/a pLI=n/a)
chr5	88016605	88016605	T	-	hom	anno_omim	QUAL=9887;DP=286;AF=1.00;MQM=60;TRIO=HOM,286,1.00,HOM,29,1.00,HET,35,0.63	MEF2C,CTC-467M3.1	3'UTR,intron	MEF2C:ENST00000340208:3'UTR:MODIFIER:exon12/12:c.*1816delA:,MEF2C:ENST00000424173:3'UTR:MODIFIER:exon11/11:c.*1816delA:,MEF2C:ENST00000504921:3'UTR:MODIFIER:exon10/10:c.*1816delA:,MEF2C:ENST00000514028:3'UTR:MODIFIER:exon11/11:c.*1816delA:,MEF2C:ENST00000437473:3'UTR:MODIFIER:exon11/11:c.*1816delA:,CTC-467M3.1:ENST00000510274:intron:MODIFIER:exon3/3:n.256-1829delT:		rs397780880	0.4828	0.0000	0,0,0	0,0,0,0,0	0.5186							600662 [MEF2C (confirmed) Mental retardation,stereotypic movements,epilepsy,and/or cerebral malformations,613443|Chromosome 5q14.3 deletion syndrome,613443];	RCV000269394.1 [benign]; 			68	117					MEF2C (inh=n/a pLI=0.00), MEF2C-AS2 (inh=n/a pLI=n/a)
chr5	88179070	88179070	A	G	het	low_DP;anno_omim	QUAL=111;DP=7;AF=0.43;MQM=60;TRIO=HET,7,0.43,WT,17,0.00,HET,16,0.44	MEF2C	5'UTR,intron	MEF2C:ENST00000504921:5'UTR:MODIFIER:exon1/10:c.-441T>C:,MEF2C:ENST00000340208:intron:MODIFIER:exon2/11:c.-143+4249T>C:,MEF2C:ENST00000424173:intron:MODIFIER:exon2/10:c.-143+4249T>C:	(GC)n		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0015							600662 [MEF2C (confirmed) Mental retardation,stereotypic movements,epilepsy,and/or cerebral malformations,613443|Chromosome 5q14.3 deletion syndrome,613443];				3	14					MEF2C (inh=n/a pLI=0.00)
chr5	90107108	90107108	A	G	hom	anno_omim	QUAL=14045;DP=173;AF=0.99;MQM=60;TRIO=HOM,173,0.99,HOM,101,1.00,HOM,153,1.00	GPR98	missense	GPR98:ENST00000405460:missense:MODERATE:exon74/90:c.16031A>G:p.Glu5344Gly,GPR98:ENST00000425867:missense:MODERATE:exon10/26:c.3014A>G:p.Glu1005Gly		rs2438374	0.9461	0.9686	56122,31251,3507	0.8514,0.9809,1.0000,0.9723,0.9934	0.9697	1.3490	T,T,T	T	B,B,B	T,T	11.33	602851 [GPR98 (confirmed) Febrile seizures,familial,4,604352|Usher syndrome,type 2C,605472|Usher syndrome,type 2C,GPR98/PDZD7 digenic,605472];	RCV000039538.9 [other]; 			1975	127	2	[2] auto-classification 14.09.2017  			ADGRV1 (inh=AR+AD pLI=0.00)
chr5	90119324	90119324	G	A	hom	anno_omim	QUAL=34744;DP=393;AF=1.00;MQM=60;TRIO=HOM,393,1.00,HOM,298,1.00,HOM,380,1.00	GPR98	missense	GPR98:ENST00000405460:missense:MODERATE:exon76/90:c.16279G>A:p.Val5427Met,GPR98:ENST00000425867:missense:MODERATE:exon12/26:c.3262G>A:p.Val1088Met		rs2438378	0.9722	0.9920	59457,33328,4077	0.9120,0.9955,1.0000,0.9994,0.9998	0.9931	-0.0070	T,T,T	T	B,B,B	T,T	0.01	602851 [GPR98 (confirmed) Febrile seizures,familial,4,604352|Usher syndrome,type 2C,605472|Usher syndrome,type 2C,GPR98/PDZD7 digenic,605472];	RCV000039541.6 [other]; 			2095	16	2	[2] auto-classification 14.09.2017  			ADGRV1 (inh=AR+AD pLI=0.00)
chr5	90151589	90151589	G	A	het	pred_pathogenic;anno_omim	QUAL=6450;DP=244;AF=0.46;MQM=60;TRIO=HET,244,0.46,HOM,121,0.99,WT,156,0.00	GPR98	missense	GPR98:ENST00000405460:missense:MODERATE:exon82/90:c.17626G>A:p.Val5876Ile,GPR98:ENST00000425867:missense:MODERATE:exon18/26:c.4609G>A:p.Val1537Ile		rs2247870	0.4591	0.5393	18353,9977,172	0.1915,0.7531,0.5499,0.5468,0.5501	0.5435	2.8990	T,T,T	T	B,B,B	T,T	20.50	602851 [GPR98 (confirmed) Febrile seizures,familial,4,604352|Usher syndrome,type 2C,605472|Usher syndrome,type 2C,GPR98/PDZD7 digenic,605472];	RCV000039547.5 [other]; 		COSM149886	609	996	2	[2] auto-classification 14.09.2017  			ADGRV1 (inh=AR+AD pLI=0.00)
chr5	90449031	90449031	T	C	hom	anno_omim	QUAL=14009;DP=179;AF=1.00;MQM=60;TRIO=HOM,179,1.00,HOM,115,1.00,HOM,151,1.00	GPR98	splice_region&intron	GPR98:ENST00000405460:splice_region&intron:LOW:exon88/89:c.18625-7T>C:,GPR98:ENST00000425867:splice_region&intron:LOW:exon24/25:c.5608-7T>C:		rs7726023	0.8984	0.9264	41170,23329,2844	0.8690,0.9232,0.8993,0.9352,0.9384	0.9252							602851 [GPR98 (confirmed) Febrile seizures,familial,4,604352|Usher syndrome,type 2C,605472|Usher syndrome,type 2C,GPR98/PDZD7 digenic,605472];	RCV000039555.5 [other]; 			1844	246	2	[2] auto-classification 14.09.2017  			ADGRV1 (inh=AR+AD pLI=0.00)
chr5	118788196	118788196	C	G	het	anno_omim	QUAL=9595;DP=183;AF=0.57;MQM=59;TRIO=HET,183,0.57,WT,164,0.01,HOM,243,1.00	HSD17B4	5'UTR	HSD17B4:ENST00000256216:5'UTR:MODIFIER:exon1/24:c.-75C>G:,HSD17B4:ENST00000515320:5'UTR:MODIFIER:exon1/23:c.-75C>G:		rs26180	0.4064	0.0000	0,0,0	0,0,0,0,0	0.4427							601860 [HSD17B4 (provisional) D-bifunctional protein deficiency,261515|Perrault syndrome 1,233400];	RCV000294626.1 [benign]; RCV000316794.1 [benign]; 			196	314					HSD17B4 (inh=AR pLI=0.00)
chr5	118811533	118811533	G	A	het	pred_pathogenic;anno_omim	QUAL=11627;DP=385;AF=0.51;MQM=59;TRIO=HET,385,0.51,WT,139,0.00,HOM,191,1.00	HSD17B4	missense,5'UTR	HSD17B4:ENST00000504811:missense:MODERATE:exon7/25:c.392G>A:p.Arg131His,HSD17B4:ENST00000256216:missense:MODERATE:exon6/24:c.317G>A:p.Arg106His,HSD17B4:ENST00000515320:missense:MODERATE:exon5/23:c.263G>A:p.Arg88His,HSD17B4:ENST00000510025:missense:MODERATE:exon7/25:c.245G>A:p.Arg82His,HSD17B4:ENST00000414835:5'UTR:MODIFIER:exon6/24:c.-95G>A:		rs25640	0.3626	0.4400	12496,7227,164	0.1695,0.5682,0.5166,0.4643,0.3511	0.4514	7.6330	D,D,D,D	T	P,B,P,B	D,D,D,D	34.00	601860 [HSD17B4 (provisional) D-bifunctional protein deficiency,261515|Perrault syndrome 1,233400];	RCV000179310.3 [benign]; RCV000362861.1 [benign]; RCV000391832.1 [benign]; 		COSM1432658	604	1254	2	[2] Ute Grasshoff 08.07.2014			HSD17B4 (inh=AR pLI=0.00)
chr5	118861713	118861713	A	G	het	pred_pathogenic;anno_omim	QUAL=12673;DP=284;AF=0.45;MQM=60;TRIO=HET,284,0.45,WT,229,0.00,HOM,283,1.00	HSD17B4	missense	HSD17B4:ENST00000504811:missense:MODERATE:exon20/25:c.1750A>G:p.Ile584Val,HSD17B4:ENST00000256216:missense:MODERATE:exon19/24:c.1675A>G:p.Ile559Val,HSD17B4:ENST00000515320:missense:MODERATE:exon18/23:c.1621A>G:p.Ile541Val,HSD17B4:ENST00000510025:missense:MODERATE:exon20/25:c.1603A>G:p.Ile535Val,HSD17B4:ENST00000414835:missense:MODERATE:exon19/24:c.1255A>G:p.Ile419Val,HSD17B4:ENST00000513628:missense:MODERATE:exon14/19:c.1264A>G:p.Ile422Val,HSD17B4:ENST00000509514:missense:MODERATE:exon15/20:c.889A>G:p.Ile297Val		rs11205	0.4002	0.4110	10654,5794,812	0.3915,0.5341,0.4060,0.4153,0.2844	0.4185	3.8360	T,T,T,T,T,T,T	T	B,B,B,B,B	T,T,T,T,T,T,T	21.10	601860 [HSD17B4 (provisional) D-bifunctional protein deficiency,261515|Perrault syndrome 1,233400];	RCV000221678.2 [benign]; RCV000290935.1 [benign]; RCV000385277.1 [benign]; 		COSM1130959	542	1401	2	[2] auto-classification 14.09.2017  			HSD17B4 (inh=AR pLI=0.00)
chr5	118877933	118877933	-	A	het	anno_omim	QUAL=5117;DP=270;AF=0.45;MQM=59;TRIO=HET,270,0.45,WT,76,0.01,HOM,88,0.97	HSD17B4	3'UTR	HSD17B4:ENST00000504811:3'UTR:MODIFIER:exon25/25:c.*250dupA:,HSD17B4:ENST00000256216:3'UTR:MODIFIER:exon24/24:c.*250dupA:,HSD17B4:ENST00000515320:3'UTR:MODIFIER:exon23/23:c.*250dupA:,HSD17B4:ENST00000510025:3'UTR:MODIFIER:exon25/25:c.*250dupA:,HSD17B4:ENST00000414835:3'UTR:MODIFIER:exon24/24:c.*250dupA:,HSD17B4:ENST00000509514:3'UTR:MODIFIER:exon20/20:c.*250dupA:		rs149778406;rs34381335	0.5639	0.0000	0,0,0	0,0,0,0,0	0.5943							601860 [HSD17B4 (provisional) D-bifunctional protein deficiency,261515|Perrault syndrome 1,233400];				84	106					HSD17B4 (inh=AR pLI=0.00)
chr5	125877635	125877635	A	G	hom	anno_omim	QUAL=3793;DP=76;AF=1.00;MQM=59;TRIO=HOM,76,1.00,HET,32,0.59,HOM,30,1.00	ALDH7A1	3'UTR	ALDH7A1:ENST00000409134:3'UTR:MODIFIER:exon18/18:c.*3022T>C:		rs2035471	0.4718	0.0000	0,0,0	0,0,0,0,0	0.5343							107323 [ALDH7A1 (confirmed) Epilepsy,pyridoxine-dependent,266100];	RCV000262757.1 [benign]; 			45	69					ALDH7A1 (inh=AR pLI=0.00)
chr5	125877659	125877659	-	A	hom	anno_omim	QUAL=2938;DP=48;AF=0.81;MQM=60;TRIO=HOM,48,0.81,HOM,26,0.81,HOM,31,0.90	ALDH7A1	3'UTR	ALDH7A1:ENST00000409134:3'UTR:MODIFIER:exon18/18:c.*2997dupT:		rs397760043	0.9625	0.0000	0,0,0	0,0,0,0,0	0.9867							107323 [ALDH7A1 (confirmed) Epilepsy,pyridoxine-dependent,266100];	RCV000320284.1 [benign]; 			132	22					ALDH7A1 (inh=AR pLI=0.00)
chr5	125877838	125877838	G	A	hom	anno_omim	QUAL=1231;DP=47;AF=0.32;MQM=57;TRIO=HOM,47,0.32,HOM,12,0.33,HOM,19,0.11	ALDH7A1	3'UTR	ALDH7A1:ENST00000409134:3'UTR:MODIFIER:exon18/18:c.*2819C>T:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0272							107323 [ALDH7A1 (confirmed) Epilepsy,pyridoxine-dependent,266100];				1	12					ALDH7A1 (inh=AR pLI=0.00)
chr5	125878158	125878158	C	T	hom	anno_omim	QUAL=18498;DP=282;AF=0.99;MQM=59;TRIO=HOM,282,0.99,HET,176,0.47,HOM,230,1.00	ALDH7A1	3'UTR	ALDH7A1:ENST00000409134:3'UTR:MODIFIER:exon18/18:c.*2499G>A:	AluJr	rs7715516	0.4856	0.0000	0,0,0	0,0,0,0,0	0.5403							107323 [ALDH7A1 (confirmed) Epilepsy,pyridoxine-dependent,266100];	RCV000402037.1 [benign]; 			45	70					ALDH7A1 (inh=AR pLI=0.00)
chr5	125878908	125878908	C	A	hom	anno_omim	QUAL=19970;DP=390;AF=0.99;MQM=59;TRIO=HOM,390,0.99,HET,226,0.54,HET,328,0.49	ALDH7A1	3'UTR	ALDH7A1:ENST00000409134:3'UTR:MODIFIER:exon18/18:c.*1749G>T:		rs744722	0.3732	0.0000	0,0,0	0,0,0,0,0	0.4366							107323 [ALDH7A1 (confirmed) Epilepsy,pyridoxine-dependent,266100];	RCV000320250.1 [benign]; 			35	108					ALDH7A1 (inh=AR pLI=0.00)
chr5	125878909	125878909	A	T	hom	anno_omim	QUAL=19970;DP=390;AF=0.99;MQM=59;TRIO=HOM,390,0.99,HET,226,0.54,HET,328,0.49	ALDH7A1	3'UTR	ALDH7A1:ENST00000409134:3'UTR:MODIFIER:exon18/18:c.*1748T>A:		rs744721	0.3732	0.0000	0,0,0	0,0,0,0,0	0.4362							107323 [ALDH7A1 (confirmed) Epilepsy,pyridoxine-dependent,266100];	RCV000280862.1 [benign]; 			35	108					ALDH7A1 (inh=AR pLI=0.00)
chr5	125878955	125878955	A	-	hom	anno_omim	QUAL=22583;DP=397;AF=0.99;MQM=59;TRIO=HOM,397,0.99,HET,153,0.55,HOM,232,0.99	ALDH7A1	3'UTR	ALDH7A1:ENST00000409134:3'UTR:MODIFIER:exon18/18:c.*1702delT:		rs796838466	0.5705	0.0000	0,0,0	0,0,0,0,0	0.6120							107323 [ALDH7A1 (confirmed) Epilepsy,pyridoxine-dependent,266100];	RCV000296078.1 [benign]; 			67	107					ALDH7A1 (inh=AR pLI=0.00)
chr5	125879549	125879549	C	T	hom	anno_omim	QUAL=12141;DP=250;AF=1.00;MQM=60;TRIO=HOM,250,1.00,HET,94,0.47,HOM,103,1.00	ALDH7A1	3'UTR	ALDH7A1:ENST00000409134:3'UTR:MODIFIER:exon18/18:c.*1108G>A:		rs1483780	0.4916	0.0000	0,0,0	0,0,0,0,0	0.5315							107323 [ALDH7A1 (confirmed) Epilepsy,pyridoxine-dependent,266100];	RCV000263699.1 [benign]; 			66	112					ALDH7A1 (inh=AR pLI=0.00)
chr5	125879677	125879677	G	T	het	anno_omim	QUAL=71;DP=136;AF=0.14;MQM=60;TRIO=HET,136,0.14,HET,41,0.12,HET,58,0.26	ALDH7A1	3'UTR	ALDH7A1:ENST00000409134:3'UTR:MODIFIER:exon18/18:c.*980C>A:	AluSx1	rs74892068	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1573							107323 [ALDH7A1 (confirmed) Epilepsy,pyridoxine-dependent,266100];				0	11					ALDH7A1 (inh=AR pLI=0.00)
chr5	125879850	125879850	G	C	hom	anno_omim	QUAL=2106;DP=69;AF=0.99;MQM=59;TRIO=HOM,69,0.99,HET,3,0.33,HOM,6,1.00	ALDH7A1	3'UTR	ALDH7A1:ENST00000409134:3'UTR:MODIFIER:exon18/18:c.*807C>G:	AluSx1	rs1807	0.5759	0.0000	0,0,0	0,0,0,0,0	0.6111							107323 [ALDH7A1 (confirmed) Epilepsy,pyridoxine-dependent,266100];	RCV000395618.1 [benign]; 			65	85					ALDH7A1 (inh=AR pLI=0.00)
chr5	125879981	125879981	G	A	hom	anno_omim	QUAL=4828;DP=85;AF=1.00;MQM=59;TRIO=HOM,85,1.00,HOM,32,1.00,HOM,35,1.00	ALDH7A1	3'UTR	ALDH7A1:ENST00000409134:3'UTR:MODIFIER:exon18/18:c.*676C>T:		rs7447380	0.9974	0.0000	0,0,0	0,0,0,0,0	0.9969							107323 [ALDH7A1 (confirmed) Epilepsy,pyridoxine-dependent,266100];				232	0					ALDH7A1 (inh=AR pLI=0.00)
chr5	125880589	125880589	T	C	hom	anno_omim	QUAL=10830;DP=209;AF=1.00;MQM=58;TRIO=HOM,209,1.00,HET,128,0.45,HET,161,0.57	ALDH7A1	3'UTR	ALDH7A1:ENST00000409134:3'UTR:MODIFIER:exon18/18:c.*68A>G:,ALDH7A1:ENST00000447989:3'UTR:MODIFIER:exon16/16:c.*68A>G:,ALDH7A1:ENST00000553117:3'UTR:MODIFIER:exon16/16:c.*68A>G:		rs2775	0.3606	0.0000	0,0,0	0,0,0,0,0	0.4294							107323 [ALDH7A1 (confirmed) Epilepsy,pyridoxine-dependent,266100];	RCV000277754.1 [benign]; 			307	619					ALDH7A1 (inh=AR pLI=0.00)
chr5	125931022	125931022	T	G	hom	anno_omim	QUAL=1293;DP=24;AF=1.00;MQM=59;TRIO=HOM,24,1.00,HET,30,0.40,HET,33,0.52	ALDH7A1	5'UTR	ALDH7A1:ENST00000409134:5'UTR:MODIFIER:exon1/18:c.-132A>C:,ALDH7A1:ENST00000447989:5'UTR:MODIFIER:exon1/16:c.-51A>C:,ALDH7A1:ENST00000553117:5'UTR:MODIFIER:exon1/16:c.-132A>C:		rs900641	0.2464	0.0000	0,0,0	0,0,0,0,0	0.2288							107323 [ALDH7A1 (confirmed) Epilepsy,pyridoxine-dependent,266100];	RCV000326835.1 [benign]; 			29	393					ALDH7A1 (inh=AR pLI=0.00)
chr5	126112580	126112580	T	C	het	anno_omim	QUAL=462;DP=35;AF=0.40;MQM=60;TRIO=HET,35,0.40,HET,33,0.36,WT,43,0.00	LMNB1				rs35091677	0.2324	0.0000	0,0,0	0,0,0,0,0	0.2099							150340 [LMNB1 (confirmed) Leukodystrophy,adult-onset,autosomal dominant,169500];	RCV000397765.1 [benign]; 			7	48					LMNB1 (inh=AD pLI=0.95)
chr5	126171999	126171999	T	C	hom	anno_omim	QUAL=17467;DP=215;AF=1.00;MQM=60;TRIO=HOM,215,1.00,HOM,116,1.00,HOM,198,1.00	LMNB1	3'UTR	LMNB1:ENST00000261366:3'UTR:MODIFIER:exon11/11:c.*43T>C:		rs1051643	0.6727	0.6751	27655,14739,2303	0.6760,0.6637,0.6795,0.6652,0.6994	0.6753							150340 [LMNB1 (confirmed) Leukodystrophy,adult-onset,autosomal dominant,169500];	RCV000369546.1 [benign]; 			870	859					LMNB1 (inh=AD pLI=0.95)
chr5	126172195	126172195	C	T	het	anno_omim	QUAL=3724;DP=125;AF=0.50;MQM=60;TRIO=HET,125,0.50,HOM,45,1.00,HET,54,0.44	LMNB1	3'UTR	LMNB1:ENST00000261366:3'UTR:MODIFIER:exon11/11:c.*239C>T:		rs1051644	0.4479	0.0000	0,0,0	0,0,0,0,0	0.4292							150340 [LMNB1 (confirmed) Leukodystrophy,adult-onset,autosomal dominant,169500];	RCV000277393.1 [benign]; 			51	115					LMNB1 (inh=AD pLI=0.95)
chr5	127594512	127594512	T	C	hom	anno_omim	QUAL=18597;DP=247;AF=1.00;MQM=60;TRIO=HOM,247,1.00,HOM,135,1.00,HOM,185,1.00	FBN2	3'UTR	FBN2:ENST00000262464:3'UTR:MODIFIER:exon65/65:c.*635A>G:,FBN2:ENST00000508053:3'UTR:MODIFIER:exon71/71:c.*635A>G:		rs27858	0.9856	0.0000	0,0,0	0,0,0,0,0	0.9717							612570 [FBN2 (provisional) Contractural arachnodactyly,congenital,121050|Macular degeneration,early-onset,616118];	RCV000372113.1 [benign]; 			216	15					FBN2 (inh=AD pLI=1.00)
chr5	127638759	127638759	A	G	het	anno_omim	QUAL=3966;DP=268;AF=0.45;MQM=60;TRIO=HET,268,0.45,HET,68,0.54,WT,128,0.00	FBN2	synonymous	FBN2:ENST00000262464:synonymous:LOW:exon46/65:c.5823T>C:p.His1941His,FBN2:ENST00000508053:synonymous:LOW:exon52/71:c.5823T>C:p.His1941His		rs11955288	0.0929	0.0949	584,328,52	0.0993,0.1016,0.0557,0.0982,0.1044	0.0938							612570 [FBN2 (provisional) Contractural arachnodactyly,congenital,121050|Macular degeneration,early-onset,616118];	RCV000117025.4 [benign]; RCV000245587.1 [benign]; RCV000278198.1 [likely benign]; 		COSM4159390, COSM4159389	34	345	2	[2] auto-classification 14.09.2017  			FBN2 (inh=AD pLI=1.00)
chr5	127640783	127640783	G	A	het	anno_omim	QUAL=7403;DP=180;AF=0.47;MQM=60;TRIO=HET,180,0.47,HET,147,0.50,HET,246,0.53	FBN2	splice_region&intron	FBN2:ENST00000262464:splice_region&intron:LOW:exon44/64:c.5675-9C>T:,FBN2:ENST00000508053:splice_region&intron:LOW:exon50/70:c.5675-9C>T:		rs27713	0.7344	0.7258	26406,14136,1341	0.6247,0.6973,0.8524,0.7170,0.7493	0.7089							612570 [FBN2 (provisional) Contractural arachnodactyly,congenital,121050|Macular degeneration,early-onset,616118];	RCV000117024.5 [other]; RCV000374659.1 [benign]; 			1081	873	2	[2] auto-classification 14.09.2017  			FBN2 (inh=AD pLI=1.00)
chr5	127685135	127685135	C	T	hom	pred_pathogenic;anno_omim	QUAL=15309;DP=302;AF=1.00;MQM=60;TRIO=HOM,302,1.00,HET,206,0.42,HET,275,0.48	FBN2	missense	FBN2:ENST00000262464:missense:MODERATE:exon23/65:c.2893G>A:p.Val965Ile,FBN2:ENST00000508053:missense:MODERATE:exon29/71:c.2893G>A:p.Val965Ile,FBN2:ENST00000508989:missense:MODERATE:exon22/33:c.2794G>A:p.Val932Ile		rs154001	0.7310	0.7234	32094,15903,1986	0.6221,0.8277,0.9366,0.6911,0.7366	0.7280	3.8840	T,T,T	T	B,B	D,D,D	22.30	612570 [FBN2 (provisional) Contractural arachnodactyly,congenital,121050|Macular degeneration,early-onset,616118];	RCV000117020.4 [benign]; RCV000244792.1 [benign]; RCV000342582.1 [benign]; 			1091	822	2	[2] auto-classification 14.09.2017  			FBN2 (inh=AD pLI=1.00)
chr5	127873094	127873094	G	A	het	pred_pathogenic;anno_omim	QUAL=2017;DP=53;AF=0.62;MQM=59;TRIO=HET,53,0.62,HET,134,0.49,WT,192,0.01	FBN2	missense	FBN2:ENST00000262464:missense:MODERATE:exon1/65:c.203C>T:p.Ala68Val,FBN2:ENST00000508053:missense:MODERATE:exon7/71:c.203C>T:p.Ala68Val,FBN2:ENST00000508989:missense:MODERATE:exon1/33:c.203C>T:p.Ala68Val		rs62390671	0.0148	0.0331	68,61,0	0.0138,0.0181,0.0000,0.0475,0.0141	0.0352	1.9370	T,T,T,T	T	B,B,B,B	D,D,D,T	15.39	612570 [FBN2 (provisional) Contractural arachnodactyly,congenital,121050|Macular degeneration,early-onset,616118];	RCV000079963.10 [other]; RCV000247352.1 [benign]; RCV000383512.1 [likely benign]; 			1	143					FBN2 (inh=AD pLI=1.00)
chr5	127873605	127873605	T	C	het	anno_omim	QUAL=2624;DP=76;AF=0.41;MQM=59;TRIO=HET,76,0.41,HET,59,0.61,HET,69,0.57	FBN2	5'UTR	FBN2:ENST00000262464:5'UTR:MODIFIER:exon1/65:c.-309A>G:,FBN2:ENST00000508053:5'UTR:MODIFIER:exon7/71:c.-309A>G:		rs7732639	0.4375	0.0000	0,0,0	0,0,0,0,0	0.4331							612570 [FBN2 (provisional) Contractural arachnodactyly,congenital,121050|Macular degeneration,early-onset,616118];	RCV000406164.1 [benign]; 			16	86					FBN2 (inh=AD pLI=1.00)
chr5	131705458	131705458	C	G	het	low_DP;anno_omim	QUAL=134;DP=6;AF=0.83;MQM=60;TRIO=HET,6,0.83,WT,4,0.00,HET,8,0.38	SLC22A5,AC034220.3	5'UTR	SLC22A5:ENST00000245407:5'UTR:MODIFIER:exon1/10:c.-207C>G:		rs2631367	0.7330	0.0000	0,0,0	0,0,0,0,0	0.6154							603377 [SLC22A5 (confirmed) Carnitine deficiency,systemic primary,212140];	RCV000265402.1 [benign]; 			57	95					SLC22A5 (inh=AR pLI=0.00), AC034220.3 (inh=n/a pLI=n/a)
chr5	131705949	131705949	T	C	het	anno_omim	QUAL=3123;DP=39;AF=0.31;MQM=57;TRIO=HET,39,0.31,WT,217,0.00,HET,311,0.44	SLC22A5	synonymous	SLC22A5:ENST00000435065:synonymous:LOW:exon1/11:c.285T>C:p.Leu95Leu,SLC22A5:ENST00000245407:synonymous:LOW:exon1/10:c.285T>C:p.Leu95Leu	(GGAGCT)n	rs2631365	0.4862	0.4968	6001,2365,201	0.3883,0.4097,0.6512,0.4421,0.6338	0.4335							603377 [SLC22A5 (confirmed) Carnitine deficiency,systemic primary,212140];	RCV000080053.5 [benign]; RCV000406963.1 [benign]; 		COSM4005841, COSM4005840	453	957	2	[2] auto-classification 14.09.2017  			SLC22A5 (inh=AR pLI=0.00)
chr5	131706028	131706028	G	T	het	pred_pathogenic;anno_omim;anno_pathogenic_clinvar;anno_pathogenic_hgmd	QUAL=7123;DP=178;AF=0.39;MQM=59;TRIO=HET,178,0.39,WT,355,0.00,HET,467,0.50	SLC22A5	missense	SLC22A5:ENST00000435065:missense:MODERATE:exon1/11:c.364G>T:p.Asp122Tyr,SLC22A5:ENST00000245407:missense:MODERATE:exon1/10:c.364G>T:p.Asp122Tyr		rs201082652	0.0000	0.0004	0,0,0	0.0000,0.0001,0.0000,0.0005,0.0007	0.0004	6.0270	D,D,D	D	D,D	D,T,T	26.30	603377 [SLC22A5 (confirmed) Carnitine deficiency,systemic primary,212140];	RCV000022318.3 [pathogenic]; RCV000186160.3 [pathogenic]; 	CM104584 [CLASS=DM MUT=ALT PHEN="Carnitine deficiency systemic primary" GENE=SLC22A5]; 		0	6					SLC22A5 (inh=AR pLI=0.00)
chr5	131719999	131719999	A	G	hom	anno_omim	QUAL=28847;DP=218;AF=1.00;MQM=60;TRIO=HOM,218,1.00,HOM,290,1.00,HOM,408,1.00	SLC22A5	splice_region&intron	SLC22A5:ENST00000435065:splice_region&intron:LOW:exon4/10:c.724+6A>G:,SLC22A5:ENST00000245407:splice_region&intron:LOW:exon3/9:c.652+6A>G:		rs4551059	1.0000	1.0000	60705,33370,5203	1.0000,1.0000,1.0000,1.0000,1.0000	1.0000							603377 [SLC22A5 (confirmed) Carnitine deficiency,systemic primary,212140];	RCV000022335.3 [benign]; RCV000080057.6 [benign]; 			2109	0	2	[2] auto-classification 14.09.2017  			SLC22A5 (inh=AR pLI=0.00)
chr5	131721174	131721174	A	G	het	anno_omim	QUAL=9108;DP=430;AF=0.51;MQM=60;TRIO=HET,430,0.51,WT,239,0.00,HET,315,0.50	SLC22A5	synonymous	SLC22A5:ENST00000435065:synonymous:LOW:exon5/11:c.879A>G:p.Leu293Leu,SLC22A5:ENST00000245407:synonymous:LOW:exon4/10:c.807A>G:p.Leu269Leu		rs274558	0.4862	0.4393	12476,5231,669	0.3564,0.3137,0.6407,0.3936,0.6291	0.4360							603377 [SLC22A5 (confirmed) Carnitine deficiency,systemic primary,212140];	RCV000080060.5 [benign]; RCV000402674.1 [benign]; 		COSM3760912, COSM3760913	450	980	2	[2] auto-classification 14.09.2017  			SLC22A5 (inh=AR pLI=0.00)
chr5	131730011	131730011	C	T	het	anno_omim	QUAL=11989;DP=478;AF=0.47;MQM=59;TRIO=HET,478,0.47,WT,329,0.00,HET,441,0.52	SLC22A5	3'UTR	SLC22A5:ENST00000245407:3'UTR:MODIFIER:exon10/10:c.*47C>T:		rs1045020	0.0517	0.1033	909,622,3	0.0218,0.0915,0.0010,0.1296,0.0608	0.1029							603377 [SLC22A5 (confirmed) Carnitine deficiency,systemic primary,212140];	RCV000022391.3 [likely benign]; 			22	376					SLC22A5 (inh=AR pLI=0.00)
chr5	131730053	131730053	A	-	hom	anno_omim	QUAL=30418;DP=319;AF=0.97;MQM=59;TRIO=HOM,319,0.97,HOM,294,0.98,HOM,391,0.97	SLC22A5	3'UTR	SLC22A5:ENST00000245407:3'UTR:MODIFIER:exon10/10:c.*92delA:		rs397999277	0.7552	0.0000	0,0,0	0,0,0,0,0	0.7648							603377 [SLC22A5 (confirmed) Carnitine deficiency,systemic primary,212140];	RCV000278333.1 [benign]; 			330	163					SLC22A5 (inh=AR pLI=0.00)
chr5	131730807	131730807	T	C	hom	anno_omim	QUAL=20582;DP=404;AF=1.00;MQM=59;TRIO=HOM,404,1.00,HOM,100,0.99,HOM,116,1.00	SLC22A5	3'UTR	SLC22A5:ENST00000245407:3'UTR:MODIFIER:exon10/10:c.*843T>C:	(TTTG)n	rs274548	0.7442	0.0000	0,0,0	0,0,0,0,0	0.7529							603377 [SLC22A5 (confirmed) Carnitine deficiency,systemic primary,212140];	RCV000347688.1 [benign]; 			158	66					SLC22A5 (inh=AR pLI=0.00)
chr5	131730920	131730920	T	A	het	anno_omim	QUAL=2071;DP=88;AF=0.50;MQM=59;TRIO=HET,88,0.50,HET,31,0.58,HET,40,0.53	SLC22A5	3'UTR	SLC22A5:ENST00000245407:3'UTR:MODIFIER:exon10/10:c.*956T>A:	(T)n	rs72795171	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0392							603377 [SLC22A5 (confirmed) Carnitine deficiency,systemic primary,212140];				15	76					SLC22A5 (inh=AR pLI=0.00)
chr5	131730923	131730923	A	C	het	anno_omim	QUAL=2071;DP=88;AF=0.50;MQM=59;TRIO=HET,88,0.50,HET,31,0.58,HET,40,0.53	SLC22A5	3'UTR	SLC22A5:ENST00000245407:3'UTR:MODIFIER:exon10/10:c.*959A>C:		rs14701	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0118							603377 [SLC22A5 (confirmed) Carnitine deficiency,systemic primary,212140];				16	124					SLC22A5 (inh=AR pLI=0.00)
chr5	131731304	131731304	A	T	hom	anno_omim	QUAL=10677;DP=230;AF=1.00;MQM=60;TRIO=HOM,230,1.00,HOM,41,1.00,HOM,66,1.00	SLC22A5	splice_region,3'UTR	SLC22A5:ENST00000245407:splice_region:LOW:exon10/10:c.*1340A>T:,SLC22A5:ENST00000245407:3'UTR:MODIFIER:exon10/10:c.*1340A>T:		rs274547	0.7442	0.0000	0,0,0	0,0,0,0,0	0.7529							603377 [SLC22A5 (confirmed) Carnitine deficiency,systemic primary,212140];				158	64	2	[2] auto-classification 14.09.2017  			SLC22A5 (inh=AR pLI=0.00)
chr5	131892979	131892979	G	A	hom	anno_omim	QUAL=13652;DP=182;AF=0.99;MQM=60;TRIO=HOM,182,0.99,HOM,103,1.00,HOM,159,1.00	RAD50	5'UTR	RAD50:ENST00000265335:5'UTR:MODIFIER:exon1/25:c.-38G>A:,RAD50:ENST00000378823:5'UTR:MODIFIER:exon1/25:c.-455G>A:		rs4526098	0.9249	0.9752	57988,33161,2994	0.7598,0.9862,1.0000,0.9969,0.9922	0.9797							604040 [RAD50 (provisional) Nijmegen breakage syndrome-like disorder,613078];				3793	60					RAD50 (inh=AR pLI=0.00)
chr5	132203997	132203997	A	G	het	anno_omim	QUAL=19542;DP=406;AF=0.48;MQM=59;TRIO=HET,406,0.48,WT,326,0.00,HOM,435,1.00	UQCRQ,LEAP2	intergenic_region	LEAP2:ENSG00000164405-ENSG00000164406:intergenic_region:MODIFIER::n.132203997A>G:	MIR	rs17166297	0.1707	0.0000	0,0,0	0,0,0,0,0	0.1996							612080 [UQCRQ (provisional) Mitochondrial complex III deficiency,nuclear type 4,615159];	RCV000360846.1 [likely benign]; 			10	49					UQCRQ (inh=AR pLI=0.09), LEAP2 (inh=n/a pLI=0.01)
chr5	132204031	132204031	G	A	het	anno_omim	QUAL=16599;DP=377;AF=0.49;MQM=59;TRIO=HET,377,0.49,WT,301,0.00,HOM,368,0.99	UQCRQ,LEAP2	intergenic_region	LEAP2:ENSG00000164405-ENSG00000164406:intergenic_region:MODIFIER::n.132204031G>A:	MIR	rs17624157	0.0479	0.0000	0,0,0	0,0,0,0,0	0.0994							612080 [UQCRQ (provisional) Mitochondrial complex III deficiency,nuclear type 4,615159];	RCV000321398.1 [likely benign]; 			9	43					UQCRQ (inh=AR pLI=0.09), LEAP2 (inh=n/a pLI=0.01)
chr5	132204448	132204448	G	-	het	anno_omim	QUAL=13741;DP=412;AF=0.47;MQM=59;TRIO=HET,412,0.47,HOM,293,1.00,WT,363,0.00	UQCRQ,LEAP2	intergenic_region	LEAP2:ENSG00000164405-ENSG00000164406:intergenic_region:MODIFIER::n.132204448delG:		rs67367845	0.4253	0.0000	0,0,0	0,0,0,0,0	0.4475							612080 [UQCRQ (provisional) Mitochondrial complex III deficiency,nuclear type 4,615159];	RCV000293411.1 [likely benign]; 			40	78					UQCRQ (inh=AR pLI=0.09), LEAP2 (inh=n/a pLI=0.01)
chr5	132204467	132204467	A	G	het	anno_omim	QUAL=15584;DP=491;AF=0.49;MQM=59;TRIO=HET,491,0.49,HOM,294,1.00,WT,368,0.00	UQCRQ,LEAP2	intergenic_region	LEAP2:ENSG00000164405-ENSG00000164406:intergenic_region:MODIFIER::n.132204467A>G:		rs254284	0.0000	0.0000	0,0,0	0,0,0,0,0	0.4253							612080 [UQCRQ (provisional) Mitochondrial complex III deficiency,nuclear type 4,615159];				41	79					UQCRQ (inh=AR pLI=0.09), LEAP2 (inh=n/a pLI=0.01)
chr5	137206560	137206560	A	C	hom	pred_pathogenic;anno_omim	QUAL=21668;DP=180;AF=1.00;MQM=59;TRIO=HOM,180,1.00,HOM,242,1.00,HOM,261,1.00	MYOT,RP11-381K20.2	missense,splice_region&intron,intron	MYOT:ENST00000239926:missense:MODERATE:exon2/10:c.220A>C:p.Lys74Gln,MYOT:ENST00000515645:splice_region&intron:LOW:exon2/10:c.-120-6A>C:,MYOT:ENST00000421631:intron:MODIFIER:exon2/9:c.-197+346A>C:		rs6890689	0.0000	0.9959	60215,33356,4749	0.9557,0.9983,1.0000,0.9998,0.9999	0.9967	2.8090	T	T	B	T	0.66	604103 [MYOT (confirmed) Muscular dystrophy,limb-girdle,type 1A,159000|Myopathy,myofibrillar,3,609200|Myopathy,spheroid body,182920];	RCV000153527.3 [benign]; 			2026	3	2	[2] old entry - no details available			MYOT (inh=AD pLI=0.00), RP11-381K20.2 (inh=n/a pLI=n/a)
chr5	138456815	138456815	T	C	het	anno_omim	QUAL=16336;DP=246;AF=0.52;MQM=59;TRIO=HET,246,0.52,WT,298,0.00,HOM,406,1.00	SIL1	synonymous	SIL1:ENST00000509534:synonymous:LOW:exon4/11:c.174A>G:p.Thr58Thr,SIL1:ENST00000394817:synonymous:LOW:exon3/10:c.153A>G:p.Thr51Thr,SIL1:ENST00000265195:synonymous:LOW:exon4/11:c.153A>G:p.Thr51Thr		rs3088052	0.4269	0.4354	12233,6708,2342	0.6709,0.4148,0.1686,0.4464,0.3906	0.4987							608005 [SIL1 (confirmed) Marinesco-Sjogren syndrome,248800];	RCV000082151.8 [other]; RCV000270107.1 [benign]; 			761	1870	1	[1] Florian Harmuth 23.11.2015 [n/a] comment imported from detected variant: frequency is almost 50% in different databases			SIL1 (inh=AR pLI=0.00)
chr5	138609609	138609609	C	G	het	anno_omim	QUAL=5213;DP=232;AF=0.50;MQM=60;TRIO=HET,232,0.50,WT,195,0.00,HET,245,0.45	MATR3,SIL1	5'UTR	MATR3:ENST00000509990:5'UTR:MODIFIER:exon1/17:c.-528C>G:		rs11242456	0.4203	0.6325	2230,568,10	0.0000,0.0000,0.0000,0.6416,0.6466	0.5968							164015 [MATR3 (provisional) Amyotrophic lateral sclerosis 21,606070];	RCV000312604.1 [benign]; 			242	259					MATR3 (inh=AD pLI=1.00), SIL1 (inh=AR pLI=0.00)
chr5	138614072	138614072	T	G	het	anno_omim;trio_denovo	QUAL=363;DP=266;AF=0.45;MQM=60;TRIO=HET,266,0.45,WT,166,0.01,WT,203,0.00	MATR3,SIL1	5'UTR,intron	MATR3:ENST00000394800:5'UTR:MODIFIER:exon3/19:c.-405T>G:,MATR3:ENST00000361059:5'UTR:MODIFIER:exon3/18:c.-282T>G:,MATR3:ENST00000504203:5'UTR:MODIFIER:exon3/17:c.-207T>G:,MATR3:ENST00000502929:5'UTR:MODIFIER:exon3/20:c.-508T>G:,MATR3:ENST00000509990:intron:MODIFIER:exon2/16:c.-256-668T>G:		rs776067427	0.0000	0.0001	0,0,0	0.0000,0.0000,0.0000,0.0004,0.0000	0.0011							164015 [MATR3 (provisional) Amyotrophic lateral sclerosis 21,606070];				0	25					MATR3 (inh=AD pLI=1.00), SIL1 (inh=AR pLI=0.00)
chr5	138642997	138642997	-	T	het	anno_omim	QUAL=6447;DP=239;AF=0.47;MQM=59;TRIO=HET,239,0.47,WT,72,0.00,HOM,117,0.99	MATR3	5'UTR,intron	MATR3:ENST00000394800:5'UTR:MODIFIER:exon6/19:c.-103dupT:,MATR3:ENST00000509990:5'UTR:MODIFIER:exon4/17:c.-103dupT:,MATR3:ENST00000361059:5'UTR:MODIFIER:exon5/18:c.-103dupT:,MATR3:ENST00000502929:5'UTR:MODIFIER:exon7/20:c.-103dupT:,MATR3:ENST00000394805:5'UTR:MODIFIER:exon2/15:c.-103dupT:,MATR3:ENST00000510056:5'UTR:MODIFIER:exon2/14:c.-103dupT:,MATR3:ENST00000504203:intron:MODIFIER:exon4/16:c.-102-7362dupT:,MATR3:ENST00000502499:intron:MODIFIER:exon1/12:c.-40-8384dupT:,MATR3:ENST00000503811:intron:MODIFIER:exon1/13:c.49-7362dupT:		rs112107315;rs59150359	0.4317	0.0000	0,0,0	0,0,0,0,0	0.5481							164015 [MATR3 (provisional) Amyotrophic lateral sclerosis 21,606070];				81	84					MATR3 (inh=AD pLI=1.00)
chr5	138643062	138643062	T	A	het	anno_omim	QUAL=6225;DP=182;AF=0.55;MQM=59;TRIO=HET,182,0.55,WT,85,0.00,HOM,120,1.00	MATR3	5'UTR,intron	MATR3:ENST00000394800:5'UTR:MODIFIER:exon6/19:c.-43T>A:,MATR3:ENST00000509990:5'UTR:MODIFIER:exon4/17:c.-43T>A:,MATR3:ENST00000361059:5'UTR:MODIFIER:exon5/18:c.-43T>A:,MATR3:ENST00000502929:5'UTR:MODIFIER:exon7/20:c.-43T>A:,MATR3:ENST00000394805:5'UTR:MODIFIER:exon2/15:c.-43T>A:,MATR3:ENST00000510056:5'UTR:MODIFIER:exon2/14:c.-43T>A:,MATR3:ENST00000504203:intron:MODIFIER:exon4/16:c.-102-7302T>A:,MATR3:ENST00000502499:intron:MODIFIER:exon1/12:c.-40-8324T>A:,MATR3:ENST00000503811:intron:MODIFIER:exon1/13:c.49-7302T>A:		rs12153162	0.4465	0.6510	19481,12762,240	0.3225,0.6927,0.2842,0.7135,0.6754	0.6752							164015 [MATR3 (provisional) Amyotrophic lateral sclerosis 21,606070];	RCV000253508.1 [benign]; RCV000265860.1 [benign]; 			773	654					MATR3 (inh=AD pLI=1.00)
chr5	138665756	138665756	G	A	het	anno_omim	QUAL=7146;DP=293;AF=0.50;MQM=59;TRIO=HET,293,0.50,WT,71,0.00,HOM,95,1.00	MATR3	3'UTR	MATR3:ENST00000394800:3'UTR:MODIFIER:exon19/19:c.*672G>A:,MATR3:ENST00000361059:3'UTR:MODIFIER:exon18/18:c.*672G>A:,MATR3:ENST00000502929:3'UTR:MODIFIER:exon20/20:c.*672G>A:,MATR3:ENST00000394805:3'UTR:MODIFIER:exon15/15:c.*672G>A:,MATR3:ENST00000502499:3'UTR:MODIFIER:exon13/13:c.*672G>A:		rs7305	0.0000	0.6235	2459,799,9	0.2086,0.0000,0.0000,0.6676,0.6454	0.6006							164015 [MATR3 (provisional) Amyotrophic lateral sclerosis 21,606070];	RCV000285762.1 [benign]; 			283	296					MATR3 (inh=AD pLI=1.00)
chr5	138666372	138666372	T	G	het	anno_omim	QUAL=5329;DP=257;AF=0.44;MQM=60;TRIO=HET,257,0.44,WT,42,0.00,HOM,73,1.00	MATR3	3'UTR	MATR3:ENST00000394800:3'UTR:MODIFIER:exon19/19:c.*1288T>G:,MATR3:ENST00000394805:3'UTR:MODIFIER:exon15/15:c.*1288T>G:		rs10515507	0.4000	0.6574	2424,680,5	0.0000,0.0000,0.0000,0.6986,0.6637	0.6087							164015 [MATR3 (provisional) Amyotrophic lateral sclerosis 21,606070];	RCV000308658.1 [benign]; 			257	254					MATR3 (inh=AD pLI=1.00)
chr5	140027216	140027216	T	C	het	anno_omim	QUAL=4824;DP=169;AF=0.49;MQM=60;TRIO=HET,169,0.49,WT,241,0.00,HET,259,0.45	NDUFA2,IK	5'UTR	NDUFA2:ENST00000252102:5'UTR:MODIFIER:exon1/3:c.-48A>G:,NDUFA2:ENST00000512088:5'UTR:MODIFIER:exon1/3:c.-48A>G:		rs778593	0.3778	0.4773	7804,4470,296	0.3635,0.4632,0.5110,0.4925,0.4425	0.4172							602137 [NDUFA2 (confirmed) Leigh syndrome due to mitochondrial complex I deficiency,256000];	RCV000355665.1 [likely benign]; 			311	893					NDUFA2 (inh=AR pLI=0.34), IK (inh=n/a pLI=0.00)
chr5	140027304	140027304	T	C	het	anno_omim	QUAL=3283;DP=189;AF=0.44;MQM=60;TRIO=HET,189,0.44,WT,134,0.00,HET,152,0.43	NDUFA2,IK	5'UTR_premature_start_codon_gain,5'UTR	NDUFA2:ENST00000252102:5'UTR_premature_start_codon_gain:LOW:exon1/3:c.-136A>G:,NDUFA2:ENST00000252102:5'UTR:MODIFIER:exon1/3:c.-136A>G:		rs778594	0.3776	0.4900	4137,2347,159	0.3890,0.4885,0.5409,0.5192,0.4258	0.4180							602137 [NDUFA2 (confirmed) Leigh syndrome due to mitochondrial complex I deficiency,256000];	RCV000333463.1 [likely benign]; 			93	274	2	[2] auto-classification 14.09.2017  			NDUFA2 (inh=AR pLI=0.34), IK (inh=n/a pLI=0.00)
chr5	146435580	146435580	A	G	het	anno_omim	QUAL=10513;DP=286;AF=0.42;MQM=60;TRIO=HET,286,0.42,HET,156,0.53,HOM,187,1.00	PPP2R2B	5'UTR,intron	PPP2R2B:ENST00000394414:5'UTR:MODIFIER:exon1/10:c.-279T>C:,PPP2R2B:ENST00000356826:5'UTR:MODIFIER:exon1/10:c.-477T>C:,PPP2R2B:ENST00000394410:intron:MODIFIER:exon2/10:c.-49+25042T>C:,PPP2R2B:ENST00000504198:intron:MODIFIER:exon2/9:c.88+25042T>C:,PPP2R2B:ENST00000394409:intron:MODIFIER:exon1/9:c.50+25042T>C:		rs1480153	0.6585	0.0000	0,0,0	0,0,0,0,0	0.7008							604325 [PPP2R2B (provisional) Spinocerebellar ataxia 12,604326];				100	119					PPP2R2B (inh=AD pLI=0.90)
chr5	147469113	147469113	G	A	het	anno_omim	QUAL=10471;DP=388;AF=0.46;MQM=60;TRIO=HET,388,0.46,HET,487,0.47,WT,635,0.00	SPINK5	synonymous	SPINK5:ENST00000359874:synonymous:LOW:exon7/34:c.531G>A:p.Arg177Arg,SPINK5:ENST00000398454:synonymous:LOW:exon7/28:c.531G>A:p.Arg177Arg,SPINK5:ENST00000256084:synonymous:LOW:exon7/33:c.531G>A:p.Arg177Arg		rs35121983	0.0469	0.0337	107,14,12	0.0484,0.0127,0.0471,0.0206,0.0950	0.0315							605010 [SPINK5 (provisional) Netherton syndrome,256500|Atopy,147050];	RCV000128216.2 [benign]; RCV000261854.1 [likely benign]; 		COSM149969	1	109					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147475386	147475386	A	G	het	anno_omim	QUAL=7594;DP=246;AF=0.51;MQM=60;TRIO=HET,246,0.51,HET,139,0.47,HET,207,0.46	SPINK5	missense	SPINK5:ENST00000359874:missense:MODERATE:exon10/34:c.800A>G:p.Gln267Arg,SPINK5:ENST00000398454:missense:MODERATE:exon10/28:c.800A>G:p.Gln267Arg,SPINK5:ENST00000256084:missense:MODERATE:exon10/33:c.800A>G:p.Gln267Arg		rs6892205	0.5090	0.5213	16635,8528,1026	0.4604,0.7280,0.4866,0.5064,0.4895	0.5320	-4.0170	T,T,T,T	T	B,B,B	T,T,T,T	0.01	605010 [SPINK5 (provisional) Netherton syndrome,256500|Atopy,147050];	RCV000128217.1 [benign]; RCV000253065.1 [benign]; RCV000350117.1 [benign]; 		COSM4003377, COSM4003378	571	1017	2	[2] auto-classification 15.09.2017  			SPINK5 (inh=AR+AD pLI=0.00)
chr5	147477551	147477551	C	T	het	pred_pathogenic;anno_omim	QUAL=7329;DP=198;AF=0.49;MQM=60;TRIO=HET,198,0.49,HET,172,0.53,HET,202,0.48	SPINK5	missense	SPINK5:ENST00000359874:missense:MODERATE:exon11/34:c.1004C>T:p.Ala335Val,SPINK5:ENST00000398454:missense:MODERATE:exon11/28:c.1004C>T:p.Ala335Val,SPINK5:ENST00000256084:missense:MODERATE:exon11/33:c.1004C>T:p.Ala335Val		rs34482796	0.4465	0.5070	15959,8512,445	0.2960,0.7220,0.4851,0.5060,0.4896	0.5201	0.0650	T,T,T,T	T	B,B,B	T,T,T,T	23.10	605010 [SPINK5 (provisional) Netherton syndrome,256500|Atopy,147050];	RCV000128218.1 [benign]; RCV000247440.1 [benign]; RCV000346513.1 [benign]; 			558	1015	2	[2] auto-classification 15.09.2017  			SPINK5 (inh=AR+AD pLI=0.00)
chr5	147480027	147480027	G	A	het	anno_omim	QUAL=12361;DP=199;AF=0.52;MQM=59;TRIO=HET,199,0.52,HET,265,0.57,HET,377,0.56	SPINK5	missense	SPINK5:ENST00000359874:missense:MODERATE:exon13/34:c.1103G>A:p.Ser368Asn,SPINK5:ENST00000398454:missense:MODERATE:exon13/28:c.1103G>A:p.Ser368Asn,SPINK5:ENST00000256084:missense:MODERATE:exon13/33:c.1103G>A:p.Ser368Asn		rs2303063	0.4315	0.5057	16068,8742,304	0.2416,0.7186,0.4806,0.5121,0.4916	0.5199	0.0360	T,T,T,T	T	B,B,B	T,T,T,T	7.21	605010 [SPINK5 (provisional) Netherton syndrome,256500|Atopy,147050];	RCV000249359.1 [benign]; RCV000343258.1 [benign]; 	CM013814 [CLASS=DP MUT=ALT PHEN="Atopy maternally inherited association with" GENE=SPINK5]; 	COSM4003379, COSM4003380	566	1003	2	[2] auto-classification 15.09.2017  			SPINK5 (inh=AR+AD pLI=0.00)
chr5	147480080	147480080	G	A	het	pred_pathogenic;anno_omim	QUAL=12983;DP=389;AF=0.47;MQM=60;TRIO=HET,389,0.47,HET,313,0.45,HET,430,0.43	SPINK5	missense	SPINK5:ENST00000359874:missense:MODERATE:exon13/34:c.1156G>A:p.Asp386Asn,SPINK5:ENST00000398454:missense:MODERATE:exon13/28:c.1156G>A:p.Asp386Asn,SPINK5:ENST00000256084:missense:MODERATE:exon13/33:c.1156G>A:p.Asp386Asn		rs2303064	0.3482	0.2119	3871,550,1206	0.4951,0.1333,0.4451,0.1249,0.3562	0.2499	1.8960	T,T,T,T	T	B,B,B,B	T,T,T,T	23.50	605010 [SPINK5 (provisional) Netherton syndrome,256500|Atopy,147050];	RCV000128219.2 [benign]; RCV000303587.1 [benign]; 			83	544	2	[2] auto-classification 15.09.2017  			SPINK5 (inh=AR+AD pLI=0.00)
chr5	147480112	147480112	T	C	het	anno_omim	QUAL=14746;DP=297;AF=0.53;MQM=60;TRIO=HET,297,0.53,HET,307,0.55,HET,400,0.58	SPINK5	synonymous	SPINK5:ENST00000359874:synonymous:LOW:exon13/34:c.1188T>C:p.His396His,SPINK5:ENST00000398454:synonymous:LOW:exon13/28:c.1188T>C:p.His396His,SPINK5:ENST00000256084:synonymous:LOW:exon13/33:c.1188T>C:p.His396His		rs2303065	0.4329	0.5072	16217,8832,309	0.2425,0.7202,0.4827,0.5136,0.4919	0.5206							605010 [SPINK5 (provisional) Netherton syndrome,256500|Atopy,147050];	RCV000128220.1 [benign]; RCV000243483.1 [benign]; RCV000358416.1 [benign]; 		COSM149970, COSM4003381	565	1003	2	[2] auto-classification 15.09.2017  			SPINK5 (inh=AR+AD pLI=0.00)
chr5	147480955	147480955	A	G	het	anno_omim	QUAL=9090;DP=207;AF=0.49;MQM=60;TRIO=HET,207,0.49,HET,240,0.52,HET,291,0.47	SPINK5	missense	SPINK5:ENST00000359874:missense:MODERATE:exon14/34:c.1258A>G:p.Lys420Glu,SPINK5:ENST00000398454:missense:MODERATE:exon14/28:c.1258A>G:p.Lys420Glu,SPINK5:ENST00000256084:missense:MODERATE:exon14/33:c.1258A>G:p.Lys420Glu		rs2303067	0.4331	0.5079	16138,8797,306	0.2433,0.7208,0.4843,0.5144,0.4921	0.5209	0.1530	T,T,T,T	T	B,B,B	T,T,T,T	7.83	605010 [SPINK5 (provisional) Netherton syndrome,256500|Atopy,147050];	RCV000005585.2 [other]; RCV000005586.2 [other]; RCV000005587.2 [other]; RCV000248431.2 [benign]; RCV000299337.1 [benign]; 		COSM4003382, COSM4003383	565	1002	2	[2] auto-classification 15.09.2017  			SPINK5 (inh=AR+AD pLI=0.00)
chr5	147481430	147481430	A	G	het	anno_omim	QUAL=12030;DP=315;AF=0.50;MQM=59;TRIO=HET,315,0.50,HET,287,0.49,HET,337,0.49	SPINK5	synonymous	SPINK5:ENST00000359874:synonymous:LOW:exon15/34:c.1389A>G:p.Gly463Gly,SPINK5:ENST00000398454:synonymous:LOW:exon15/28:c.1389A>G:p.Gly463Gly,SPINK5:ENST00000256084:synonymous:LOW:exon15/33:c.1389A>G:p.Gly463Gly		rs6896303	0.4329	0.5076	16230,8836,309	0.2424,0.7208,0.4841,0.5139,0.4919	0.5209							605010 [SPINK5 (provisional) Netherton syndrome,256500|Atopy,147050];	RCV000250366.1 [benign]; RCV000259308.1 [benign]; 		COSM4003384, COSM149971	566	1001	2	[2] auto-classification 15.09.2017  			SPINK5 (inh=AR+AD pLI=0.00)
chr5	147486677	147486677	C	A	het	anno_omim	QUAL=14922;DP=334;AF=0.51;MQM=59;TRIO=HET,334,0.51,HET,348,0.46,HET,511,0.48	SPINK5	synonymous	SPINK5:ENST00000359874:synonymous:LOW:exon17/34:c.1557C>A:p.Gly519Gly,SPINK5:ENST00000398454:synonymous:LOW:exon17/28:c.1557C>A:p.Gly519Gly,SPINK5:ENST00000256084:synonymous:LOW:exon17/33:c.1557C>A:p.Gly519Gly		rs880687	0.4293	0.5061	16185,8818,288	0.2318,0.7204,0.4843,0.5131,0.4918	0.5197							605010 [SPINK5 (provisional) Netherton syndrome,256500|Atopy,147050];	RCV000253690.1 [benign]; RCV000275565.1 [benign]; 		COSM4003385, COSM149972	563	1006	2	[2] auto-classification 15.09.2017  			SPINK5 (inh=AR+AD pLI=0.00)
chr5	147488367	147488367	C	T	het	anno_omim	QUAL=8238;DP=291;AF=0.40;MQM=60;TRIO=HET,291,0.40,HET,202,0.47,HET,235,0.47	SPINK5	synonymous	SPINK5:ENST00000359874:synonymous:LOW:exon18/34:c.1659C>T:p.Val553Val,SPINK5:ENST00000398454:synonymous:LOW:exon18/28:c.1659C>T:p.Val553Val,SPINK5:ENST00000256084:synonymous:LOW:exon18/33:c.1659C>T:p.Val553Val	GA-rich	rs2303071	0.6020	0.5527	18995,8871,2833	0.7617,0.7446,0.4830,0.5150,0.4925	0.5870							605010 [SPINK5 (provisional) Netherton syndrome,256500|Atopy,147050];	RCV000175321.2 [benign]; RCV000345642.1 [benign]; 		COSM149973, COSM449063	564	984	2	[2] auto-classification 15.09.2017  			SPINK5 (inh=AR+AD pLI=0.00)
chr5	147498019	147498019	G	A	het	pred_pathogenic;anno_omim	QUAL=11689;DP=291;AF=0.52;MQM=60;TRIO=HET,291,0.52,HET,236,0.47,HET,392,0.47	SPINK5	missense	SPINK5:ENST00000359874:missense:MODERATE:exon23/34:c.2132G>A:p.Arg711Gln,SPINK5:ENST00000398454:missense:MODERATE:exon23/28:c.2132G>A:p.Arg711Gln,SPINK5:ENST00000256084:missense:MODERATE:exon23/33:c.2132G>A:p.Arg711Gln		rs3777134	0.4884	0.5830	21117,12616,603	0.3518,0.7540,0.4685,0.6157,0.5087	0.5939	0.4400	T,T,T,T	T	B,B,B	T,T,T,T	22.70	605010 [SPINK5 (provisional) Netherton syndrome,256500|Atopy,147050];	RCV000247596.1 [benign]; RCV000338362.1 [benign]; 		COSM4003386, COSM149974	757	977	2	[2] auto-classification 15.09.2017  			SPINK5 (inh=AR+AD pLI=0.00)
chr5	147499616	147499616	C	T	het	anno_omim	QUAL=11668;DP=348;AF=0.50;MQM=60;TRIO=HET,348,0.50,HET,226,0.52,HET,313,0.47	SPINK5	synonymous	SPINK5:ENST00000359874:synonymous:LOW:exon25/34:c.2358C>T:p.Leu786Leu,SPINK5:ENST00000398454:synonymous:LOW:exon25/28:c.2358C>T:p.Leu786Leu,SPINK5:ENST00000256084:synonymous:LOW:exon25/33:c.2358C>T:p.Leu786Leu		rs17704908	0.4874	0.5829	20947,12512,601	0.3523,0.7542,0.4659,0.6157,0.5089	0.5935							605010 [SPINK5 (provisional) Netherton syndrome,256500|Atopy,147050];	RCV000250545.1 [benign]; RCV000402422.1 [benign]; 		COSM4003388, COSM4003387	757	975	2	[2] auto-classification 15.09.2017  			SPINK5 (inh=AR+AD pLI=0.00)
chr5	147499670	147499670	C	T	het	anno_omim	QUAL=11194;DP=354;AF=0.48;MQM=60;TRIO=HET,354,0.48,HET,247,0.48,HET,340,0.46	SPINK5	synonymous	SPINK5:ENST00000359874:synonymous:LOW:exon25/34:c.2412C>T:p.Gly804Gly,SPINK5:ENST00000398454:synonymous:LOW:exon25/28:c.2412C>T:p.Gly804Gly,SPINK5:ENST00000256084:synonymous:LOW:exon25/33:c.2412C>T:p.Gly804Gly		rs33920397	0.4884	0.5825	21043,12566,601	0.3515,0.7533,0.4669,0.6153,0.5085	0.5936							605010 [SPINK5 (provisional) Netherton syndrome,256500|Atopy,147050];	RCV000242523.1 [benign]; RCV000367051.1 [benign]; 		COSM4003389, COSM149975	757	975	2	[2] auto-classification 15.09.2017  			SPINK5 (inh=AR+AD pLI=0.00)
chr5	147499891	147499891	G	T	het	anno_omim	QUAL=8411;DP=326;AF=0.47;MQM=60;TRIO=HET,326,0.47,HET,358,0.51,WT,418,0.00	SPINK5	missense	SPINK5:ENST00000359874:missense:MODERATE:exon26/34:c.2475G>T:p.Glu825Asp,SPINK5:ENST00000398454:missense:MODERATE:exon26/28:c.2475G>T:p.Glu825Asp,SPINK5:ENST00000256084:missense:MODERATE:exon26/33:c.2475G>T:p.Glu825Asp		rs2303070	0.1745	0.1563	1229,249,42	0.1293,0.0757,0.3379,0.1097,0.3109	0.1289	-0.6140	T,T,T,T	T	B,B,B,B	T,T,T,T	11.84	605010 [SPINK5 (provisional) Netherton syndrome,256500|Atopy,147050];	RCV000128223.2 [benign]; RCV000272403.1 [benign]; 			50	443	2	[2] auto-classification 15.09.2017  			SPINK5 (inh=AR+AD pLI=0.00)
chr5	147505116	147505116	G	A	het	anno_omim	QUAL=16075;DP=471;AF=0.45;MQM=59;TRIO=HET,471,0.45,HET,325,0.49,HET,459,0.51	SPINK5	synonymous,intron	SPINK5:ENST00000359874:synonymous:LOW:exon29/34:c.2769G>A:p.Ala923Ala,SPINK5:ENST00000256084:intron:MODIFIER:exon28/32:c.2740-170G>A:		rs3764930	0.4533	0.5748	20523,12421,306	0.2495,0.7493,0.4711,0.6156,0.5101	0.5855							605010 [SPINK5 (provisional) Netherton syndrome,256500|Atopy,147050];			COSM4003390	751	976	2	[2] auto-classification 15.09.2017  			SPINK5 (inh=AR+AD pLI=0.00)
chr5	147510866	147510866	T	C	het	anno_omim	QUAL=9858;DP=266;AF=0.47;MQM=60;TRIO=HET,266,0.47,HET,237,0.48,HET,290,0.47	SPINK5	synonymous	SPINK5:ENST00000359874:synonymous:LOW:exon32/34:c.3099T>C:p.Gly1033Gly,SPINK5:ENST00000256084:synonymous:LOW:exon31/33:c.3009T>C:p.Gly1003Gly		rs2400478	0.5092	0.5888	21404,12623,854	0.4194,0.7572,0.4692,0.6159,0.5075	0.5987							605010 [SPINK5 (provisional) Netherton syndrome,256500|Atopy,147050];	RCV000243537.1 [benign]; RCV000351049.1 [benign]; 		COSM149978, COSM149977	763	976	2	[2] auto-classification 15.09.2017  			SPINK5 (inh=AR+AD pLI=0.00)
chr5	147516598	147516598	T	C	het	anno_omim	QUAL=8313;DP=212;AF=0.53;MQM=60;TRIO=HET,212,0.53,HET,160,0.57,HET,227,0.48	SPINK5	3'UTR	SPINK5:ENST00000359874:3'UTR:MODIFIER:exon34/34:c.*44T>C:,SPINK5:ENST00000256084:3'UTR:MODIFIER:exon33/33:c.*44T>C:		rs4349706	0.4910	0.4117	10657,4872,1635	0.5814,0.2431,0.5316,0.3844,0.4932	0.4380							605010 [SPINK5 (provisional) Netherton syndrome,256500|Atopy,147050];	RCV000323363.1 [benign]; 			344	928					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147516762	147516762	C	G	het	anno_omim	QUAL=16228;DP=543;AF=0.43;MQM=59;TRIO=HET,543,0.43,HET,295,0.55,HET,422,0.50	SPINK5	3'UTR	SPINK5:ENST00000359874:3'UTR:MODIFIER:exon34/34:c.*208C>G:,SPINK5:ENST00000256084:3'UTR:MODIFIER:exon33/33:c.*208C>G:		rs3088193	0.4910	0.0000	0,0,0	0,0,0,0,0	0.4381							605010 [SPINK5 (provisional) Netherton syndrome,256500|Atopy,147050];	RCV000318164.1 [benign]; 			37	103					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147516884	147516884	T	C	het	anno_omim	QUAL=5063;DP=251;AF=0.45;MQM=59;TRIO=HET,251,0.45,HET,165,0.54,WT,202,0.00	SPINK5,SPINK14	intergenic_region	SPINK14:ENSG00000133710-ENSG00000196800:intergenic_region:MODIFIER::n.147516884T>C:		rs72660265	0.1743	0.0000	0,0,0	0,0,0,0,0	0.1043							605010 [SPINK5 (provisional) Netherton syndrome,256500|Atopy,147050];	RCV000278242.1 [benign]; 			6	42					SPINK5 (inh=AR+AD pLI=0.00), SPINK14 (inh=n/a pLI=0.02)
chr5	147516914	147516914	-	CTC	het	anno_omim	QUAL=4328;DP=189;AF=0.39;MQM=59;TRIO=HET,189,0.39,HET,89,0.44,HET,136,0.51	SPINK5,SPINK14	intergenic_region	SPINK14:ENSG00000133710-ENSG00000196800:intergenic_region:MODIFIER::n.147516914_147516915insCTC:		rs35952402;rs397704765	0.4910	0.0000	0,0,0	0,0,0,0,0	0.4364							605010 [SPINK5 (provisional) Netherton syndrome,256500|Atopy,147050];	RCV000387737.1 [benign]; 			37	102					SPINK5 (inh=AR+AD pLI=0.00), SPINK14 (inh=n/a pLI=0.02)
chr5	148361720	148361720	-	T	hom	anno_omim	QUAL=8848;DP=108;AF=0.87;MQM=59;TRIO=HOM,108,0.87,HOM,94,0.95,HOM,137,0.91	SH3TC2				rs397725504	0.4810	0.0000	0,0,0	0,0,0,0,0	0.4832							608206 [SH3TC2 (provisional) Charcot-Marie-Tooth disease,type 4C,601596|Mononeuropathy of the median nerve,mild,613353];	RCV000327529.1 [likely benign]; RCV000384368.1 [likely benign]; 			68	80					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148364355	148364355	A	G	hom	anno_omim	QUAL=34928;DP=459;AF=1.00;MQM=59;TRIO=HOM,459,1.00,HOM,265,0.99,HOM,332,1.00	SH3TC2				rs2217638	0.8023	0.0000	0,0,0	0,0,0,0,0	0.7764							608206 [SH3TC2 (provisional) Charcot-Marie-Tooth disease,type 4C,601596|Mononeuropathy of the median nerve,mild,613353];	RCV000290364.1 [benign]; RCV000328936.1 [benign]; 			166	72					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148364701	148364701	C	T	hom	anno_omim	QUAL=14297;DP=233;AF=1.00;MQM=59;TRIO=HOM,233,1.00,HOM,105,1.00,HOM,148,1.00	SH3TC2				rs4560536	0.4716	0.0000	0,0,0	0,0,0,0,0	0.5146							608206 [SH3TC2 (provisional) Charcot-Marie-Tooth disease,type 4C,601596|Mononeuropathy of the median nerve,mild,613353];	RCV000289231.1 [likely benign]; RCV000381325.1 [likely benign]; 			96	100					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148364709	148364709	-	A	het	anno_omim	QUAL=7135;DP=219;AF=0.71;MQM=59;TRIO=HET,219,0.71,HOM,76,0.80,HOM,98,0.81	SH3TC2				rs398109536	0.6817	0.0000	0,0,0	0,0,0,0,0	0.7472							608206 [SH3TC2 (provisional) Charcot-Marie-Tooth disease,type 4C,601596|Mononeuropathy of the median nerve,mild,613353];	RCV000341925.1 [benign]; RCV000380226.1 [benign]; 			102	122					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148365234	148365234	T	C	hom	anno_omim	QUAL=27137;DP=444;AF=0.99;MQM=60;TRIO=HOM,444,0.99,HOM,176,1.00,HOM,200,1.00	SH3TC2			L1ME1	rs930205	0.5092	0.0000	0,0,0	0,0,0,0,0	0.5100							608206 [SH3TC2 (provisional) Charcot-Marie-Tooth disease,type 4C,601596|Mononeuropathy of the median nerve,mild,613353];	RCV000335430.1 [likely benign]; RCV000375959.1 [likely benign]; 			89	85					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148365720	148365720	C	A	hom	anno_omim	QUAL=30772;DP=377;AF=1.00;MQM=60;TRIO=HOM,377,1.00,HOM,234,1.00,HOM,315,1.00	SH3TC2			MIR	rs10040598	0.7973	0.0000	0,0,0	0,0,0,0,0	0.7731							608206 [SH3TC2 (provisional) Charcot-Marie-Tooth disease,type 4C,601596|Mononeuropathy of the median nerve,mild,613353];	RCV000307128.1 [benign]; RCV000366485.1 [benign]; 			164	71					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148366571	148366571	T	C	hom	anno_omim	QUAL=19443;DP=374;AF=1.00;MQM=60;TRIO=HOM,374,1.00,HOM,93,1.00,HOM,131,0.99	SH3TC2				rs4235739	0.6234	0.0000	0,0,0	0,0,0,0,0	0.5814							608206 [SH3TC2 (provisional) Charcot-Marie-Tooth disease,type 4C,601596|Mononeuropathy of the median nerve,mild,613353];	RCV000294977.1 [benign]; RCV000345191.1 [benign]; 			105	106					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148367324	148367324	A	G	hom	anno_omim	QUAL=22978;DP=418;AF=1.00;MQM=59;TRIO=HOM,418,1.00,HOM,98,1.00,HOM,188,1.00	SH3TC2				rs10040798	0.7881	0.0000	0,0,0	0,0,0,0,0	0.7665							608206 [SH3TC2 (provisional) Charcot-Marie-Tooth disease,type 4C,601596|Mononeuropathy of the median nerve,mild,613353];	RCV000330950.1 [benign]; RCV000366902.1 [benign]; 			164	72					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148367373	148367376	TGTG	-	hom	anno_omim	QUAL=1515;DP=49;AF=0.47;MQM=59;TRIO=HOM,49,0.47,HOM,45,0.44,HOM,62,0.44	SH3TC2			(TG)n	rs878950160	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1604							608206 [SH3TC2 (provisional) Charcot-Marie-Tooth disease,type 4C,601596|Mononeuropathy of the median nerve,mild,613353];	RCV000312003.1 [uncertain significance]; RCV000392874.1 [uncertain significance]; 			13	9					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148367643	148367643	C	T	hom	anno_omim	QUAL=19934;DP=333;AF=1.00;MQM=59;TRIO=HOM,333,1.00,HOM,183,1.00,HET,257,0.46	SH3TC2				rs4705303	0.4613	0.0000	0,0,0	0,0,0,0,0	0.4550							608206 [SH3TC2 (provisional) Charcot-Marie-Tooth disease,type 4C,601596|Mononeuropathy of the median nerve,mild,613353];	RCV000278313.1 [likely benign]; RCV000338018.1 [likely benign]; 			91	108					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148368254	148368254	T	G	hom	anno_omim	QUAL=19402;DP=268;AF=0.99;MQM=60;TRIO=HOM,268,0.99,HOM,148,0.99,HOM,211,0.99	SH3TC2			MLT1F	rs4543254	0.6180	0.0000	0,0,0	0,0,0,0,0	0.5763							608206 [SH3TC2 (provisional) Charcot-Marie-Tooth disease,type 4C,601596|Mononeuropathy of the median nerve,mild,613353];	RCV000319489.1 [benign]; RCV000385662.1 [benign]; 			94	81					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148368451	148368451	A	G	hom	anno_omim	QUAL=26442;DP=492;AF=1.00;MQM=60;TRIO=HOM,492,1.00,HOM,141,1.00,HOM,183,1.00	SH3TC2				rs4562031	0.7981	0.0000	0,0,0	0,0,0,0,0	0.7741							608206 [SH3TC2 (provisional) Charcot-Marie-Tooth disease,type 4C,601596|Mononeuropathy of the median nerve,mild,613353];	RCV000287464.1 [benign]; RCV000389063.1 [benign]; 			164	69					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148372163	148372163	G	TT	hom	anno_omim	QUAL=4406;DP=40;AF=0.30;MQM=53;TRIO=HOM,40,0.30,HOM,8,0.00,HOM,28,0.00	SH3TC2					0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							608206 [SH3TC2 (provisional) Charcot-Marie-Tooth disease,type 4C,601596|Mononeuropathy of the median nerve,mild,613353];				0	0					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148373306	148373306	C	T	het	anno_omim	QUAL=6556;DP=201;AF=0.55;MQM=60;TRIO=HET,201,0.55,HOM,117,1.00,WT,148,0.00	SH3TC2				rs13166730	0.0723	0.0000	0,0,0	0,0,0,0,0	0.1054							608206 [SH3TC2 (provisional) Charcot-Marie-Tooth disease,type 4C,601596|Mononeuropathy of the median nerve,mild,613353];	RCV000266379.1 [likely benign]; RCV000321531.1 [likely benign]; 			5	73					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148374164	148374167	TGGT	-	hom	anno_omim	QUAL=4373;DP=37;AF=0.92;MQM=59;TRIO=HOM,37,0.92,HOM,126,0.98,HET,163,0.48	SH3TC2			(TGGT)n	rs72253703	0.0000	0.0000	0,0,0	0,0,0,0,0	0.4591							608206 [SH3TC2 (provisional) Charcot-Marie-Tooth disease,type 4C,601596|Mononeuropathy of the median nerve,mild,613353];	RCV000309325.1 [uncertain significance]; RCV000342655.1 [uncertain significance]; 			67	8					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148381138	148381138	C	T	hom	anno_omim	QUAL=24849;DP=509;AF=0.99;MQM=60;TRIO=HOM,509,0.99,HOM,183,1.00,HET,192,0.51	SH3TC2				rs1019927	0.9904	0.0000	0,0,0	0,0,0,0,0	0.9789							608206 [SH3TC2 (provisional) Charcot-Marie-Tooth disease,type 4C,601596|Mononeuropathy of the median nerve,mild,613353];	RCV000312130.1 [benign]; RCV000394389.1 [benign]; 			242	14					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148383412	148383412	C	A	hom	low_DP;anno_omim	QUAL=207;DP=19;AF=0.16;MQM=60;TRIO=HOM,19,0.16,HOM,10,0.00,HOM,10,0.10	SH3TC2			FRAM		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							608206 [SH3TC2 (provisional) Charcot-Marie-Tooth disease,type 4C,601596|Mononeuropathy of the median nerve,mild,613353];				0	1					SH3TC2 (inh=AR+AD pLI=0.00)
chr5	148407708	148407708	A	C	hom	anno_omim	QUAL=19009;DP=215;AF=1.00;MQM=59;TRIO=HOM,215,1.00,HOM,277,1.00,HET,364,0.45	SH3TC2	synonymous	SH3TC2:ENST00000515425:synonymous:LOW:exon11/17:c.1587T>G:p.Arg529Arg,SH3TC2:ENST00000538184:synonymous:LOW:exon7/13:c.228T>G:p.Arg76Arg,SH3TC2:ENST00000512049:synonymous:LOW:exon11/17:c.1566T>G:p.Arg522Arg,SH3TC2:ENST00000394358:synonymous:LOW:exon12/12:c.1242T>G:p.Arg414Arg		rs1432794	0.9906	0.9785	58110,31287,5147	0.9952,0.9905,0.9998,0.9684,0.9867	0.9791							608206 [SH3TC2 (provisional) Charcot-Marie-Tooth disease,type 4C,601596|Mononeuropathy of the median nerve,mild,613353];	RCV000118336.4 [other]; RCV000362334.1 [benign]; RCV000405810.1 [benign]; 			2007	99	2	[2] auto-classification 15.09.2017  			SH3TC2 (inh=AR+AD pLI=0.00)
chr5	149360877	149360877	T	C	hom	pred_pathogenic;anno_omim	QUAL=31042;DP=373;AF=1.00;MQM=59;TRIO=HOM,373,1.00,HOM,257,1.00,HOM,324,1.00	SLC26A2	missense	SLC26A2:ENST00000286298:missense:MODERATE:exon3/3:c.1721T>C:p.Ile574Thr		rs30832	0.0000	0.9928	59817,32644,5173	0.9983,0.9977,1.0000,0.9891,0.9947	0.9935	1.6390	T	T	B	D	0.01	606718 [SLC26A2 (confirmed) Diastrophic dysplasia,222600|Atelosteogenesis II,256050|Achondrogenesis Ib,600972|Epiphyseal dysplasia,multiple,4,226900|Diastrophic dysplasia,broad bone-platyspondylic variant,222600|De la Chapelle dysplasia,256050];	RCV000176982.2 [benign]; RCV000265444.1 [benign]; RCV000271433.1 [benign]; RCV000320835.1 [benign]; RCV000360315.1 [benign]; RCV000384666.1 [benign]; 			2083	25	2	[2] old entry - no details available			SLC26A2 (inh=AR pLI=0.00)
chr5	149362400	149362400	T	G	het	anno_omim	QUAL=13143;DP=395;AF=0.48;MQM=59;TRIO=HET,395,0.48,WT,198,0.01,HOM,243,1.00	SLC26A2	3'UTR	SLC26A2:ENST00000286298:3'UTR:MODIFIER:exon3/3:c.*1024T>G:		rs8073	0.2740	0.0000	0,0,0	0,0,0,0,0	0.2065							606718 [SLC26A2 (confirmed) Diastrophic dysplasia,222600|Atelosteogenesis II,256050|Achondrogenesis Ib,600972|Epiphyseal dysplasia,multiple,4,226900|Diastrophic dysplasia,broad bone-platyspondylic variant,222600|De la Chapelle dysplasia,256050];	RCV000260778.1 [benign]; RCV000319505.1 [benign]; RCV000322895.1 [benign]; RCV000371846.1 [benign]; RCV000379855.1 [benign]; 			13	89					SLC26A2 (inh=AR pLI=0.00)
chr5	149364780	149364780	C	T	hom	anno_omim	QUAL=34230;DP=509;AF=0.99;MQM=59;TRIO=HOM,509,0.99,HET,300,0.55,HOM,435,1.00	SLC26A2	3'UTR	SLC26A2:ENST00000286298:3'UTR:MODIFIER:exon3/3:c.*3404C>T:		rs30833	0.9920	0.0000	0,0,0	0,0,0,0,0	0.9894							606718 [SLC26A2 (confirmed) Diastrophic dysplasia,222600|Atelosteogenesis II,256050|Achondrogenesis Ib,600972|Epiphyseal dysplasia,multiple,4,226900|Diastrophic dysplasia,broad bone-platyspondylic variant,222600|De la Chapelle dysplasia,256050];	RCV000266589.1 [benign]; RCV000272616.1 [benign]; RCV000326393.1 [benign]; RCV000327968.1 [benign]; RCV000381077.1 [benign]; 			225	7					SLC26A2 (inh=AR pLI=0.00)
chr5	149365837	149365837	T	-	het	anno_omim	QUAL=1791;DP=97;AF=0.54;MQM=60;TRIO=HET,97,0.54,WT,21,0.00,HOM,24,1.00	SLC26A2	3'UTR	SLC26A2:ENST00000286298:3'UTR:MODIFIER:exon3/3:c.*4469delT:		rs397883627	0.4681	0.0000	0,0,0	0,0,0,0,0	0.4095							606718 [SLC26A2 (confirmed) Diastrophic dysplasia,222600|Atelosteogenesis II,256050|Achondrogenesis Ib,600972|Epiphyseal dysplasia,multiple,4,226900|Diastrophic dysplasia,broad bone-platyspondylic variant,222600|De la Chapelle dysplasia,256050];	RCV000272293.1 [benign]; RCV000295584.1 [benign]; RCV000329667.1 [benign]; RCV000383113.1 [benign]; RCV000387479.1 [benign]; 			33	111					SLC26A2 (inh=AR pLI=0.00)
chr5	149907533	149907533	T	G	hom	anno_omim	QUAL=28917;DP=417;AF=1.00;MQM=59;TRIO=HOM,417,1.00,HET,558,0.52,HET,769,0.48	NDST1	synonymous	NDST1:ENST00000261797:synonymous:LOW:exon3/15:c.681T>G:p.Val227Val,NDST1:ENST00000523767:synonymous:LOW:exon3/14:c.681T>G:p.Val227Val		rs2273235	0.3658	0.4512	12745,7315,426	0.2876,0.5764,0.3172,0.4664,0.4286	0.4563							600853 [NDST1 (confirmed) Mental retardation,autosomal recessive 46,616116];			COSM4159647	385	1013	2	[2] auto-classification 15.09.2017  			NDST1 (inh=AR pLI=1.00)
chr5	149907602	149907602	A	G	hom	anno_omim	QUAL=23691;DP=290;AF=0.99;MQM=59;TRIO=HOM,290,0.99,HET,553,0.51,HET,724,0.48	NDST1	synonymous	NDST1:ENST00000261797:synonymous:LOW:exon3/15:c.750A>G:p.Pro250Pro,NDST1:ENST00000523767:synonymous:LOW:exon3/14:c.750A>G:p.Pro250Pro		rs2273234	0.2995	0.4206	11292,6936,139	0.1632,0.5665,0.1625,0.4606,0.4201	0.4280							600853 [NDST1 (confirmed) Mental retardation,autosomal recessive 46,616116];				369	1016	2	[2] auto-classification 15.09.2017  			NDST1 (inh=AR pLI=1.00)
chr5	149919739	149919739	G	C	hom	anno_omim	QUAL=19358;DP=287;AF=0.99;MQM=59;TRIO=HOM,287,0.99,HET,205,0.54,HOM,249,1.00	NDST1	synonymous	NDST1:ENST00000261797:synonymous:LOW:exon8/15:c.1662G>C:p.Thr554Thr,NDST1:ENST00000523767:synonymous:LOW:exon8/14:c.1662G>C:p.Thr554Thr		rs1290147	0.8069	0.7156	31517,14234,4433	0.9228,0.7549,0.7894,0.6527,0.7713	0.7448							600853 [NDST1 (confirmed) Mental retardation,autosomal recessive 46,616116];				883	933	2	[2] auto-classification 15.09.2017  			NDST1 (inh=AR pLI=1.00)
chr5	149933899	149933899	A	T	het	low_DP;anno_omim	QUAL=148;DP=18;AF=0.50;MQM=60;TRIO=HET,18,0.50,HET,6,0.17,WT,6,0.00	NDST1	3'UTR	NDST1:ENST00000261797:3'UTR:MODIFIER:exon15/15:c.*1005A>T:	(TA)n		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0001							600853 [NDST1 (confirmed) Mental retardation,autosomal recessive 46,616116];				0	2					NDST1 (inh=AR pLI=1.00)
chr5	149935171	149935171	T	C	hom	anno_omim	QUAL=26579;DP=253;AF=1.00;MQM=59;TRIO=HOM,253,1.00,HOM,378,1.00,HET,498,0.52	NDST1	3'UTR	NDST1:ENST00000261797:3'UTR:MODIFIER:exon15/15:c.*2277T>C:		rs13181064	0.5735	0.0000	0,0,0	0,0,0,0,0	0.6582							600853 [NDST1 (confirmed) Mental retardation,autosomal recessive 46,616116];				142	79					NDST1 (inh=AR pLI=1.00)
chr5	149935680	149935680	A	G	hom	anno_omim	QUAL=23359;DP=447;AF=0.99;MQM=59;TRIO=HOM,447,0.99,HET,282,0.47,HET,414,0.51	NDST1	3'UTR	NDST1:ENST00000261797:3'UTR:MODIFIER:exon15/15:c.*2786A>G:	MamRep137	rs11542921	0.2430	0.0000	0,0,0	0,0,0,0,0	0.3159							600853 [NDST1 (confirmed) Mental retardation,autosomal recessive 46,616116];				28	122					NDST1 (inh=AR pLI=1.00)
chr5	149937496	149937496	A	-	hom	anno_omim	QUAL=11897;DP=224;AF=0.98;MQM=59;TRIO=HOM,224,0.98,HET,195,0.49,HET,300,0.46	NDST1	3'UTR	NDST1:ENST00000261797:3'UTR:MODIFIER:exon15/15:c.*4602delA:		rs36071594	0.2426	0.0000	0,0,0	0,0,0,0,0	0.3145							600853 [NDST1 (confirmed) Mental retardation,autosomal recessive 46,616116];				27	122					NDST1 (inh=AR pLI=1.00)
chr5	149937739	149937739	G	A	hom	anno_omim	QUAL=12713;DP=227;AF=1.00;MQM=60;TRIO=HOM,227,1.00,HET,214,0.50,HET,256,0.46	NDST1	3'UTR	NDST1:ENST00000261797:3'UTR:MODIFIER:exon15/15:c.*4845G>A:		rs11994	0.3131	0.0000	0,0,0	0,0,0,0,0	0.3563							600853 [NDST1 (confirmed) Mental retardation,autosomal recessive 46,616116];				29	122					NDST1 (inh=AR pLI=1.00)
chr5	155754192	155754192	C	G	het	anno_omim	QUAL=13161;DP=214;AF=0.47;MQM=60;TRIO=HET,214,0.47,HOM,233,1.00,HET,286,0.55	SGCD	5'UTR,intron	SGCD:ENST00000337851:5'UTR:MODIFIER:exon1/9:c.-94C>G:,SGCD:ENST00000435422:5'UTR:MODIFIER:exon1/8:c.-51C>G:,SGCD:ENST00000447401:5'UTR:MODIFIER:exon1/8:c.-94C>G:,SGCD:ENST00000517913:intron:MODIFIER:exon3/9:c.-43-2352C>G:		rs13170573	0.4605	0.0000	0,0,0	0,0,0,0,0	0.3742							601411 [SGCD (confirmed) Muscular dystrophy,limb-girdle,type 2F,601287|Cardiomyopathy,dilated,1L,606685];	RCV000041400.2 [benign]; RCV000262050.1 [benign]; RCV000297384.1 [benign]; RCV000354555.1 [benign]; 			64	135					SGCD (inh=AR+AD pLI=0.00)
chr5	155771579	155771579	T	C	het	anno_omim	QUAL=7855;DP=194;AF=0.53;MQM=59;TRIO=HET,194,0.53,HOM,105,1.00,HET,139,0.49	SGCD	synonymous	SGCD:ENST00000337851:synonymous:LOW:exon3/9:c.84T>C:p.Tyr28Tyr,SGCD:ENST00000517913:synonymous:LOW:exon5/10:c.84T>C:p.Tyr28Tyr,SGCD:ENST00000435422:synonymous:LOW:exon2/8:c.81T>C:p.Tyr27Tyr,SGCD:ENST00000447401:synonymous:LOW:exon3/8:c.84T>C:p.Tyr28Tyr		rs1801193	0.4854	0.4661	13829,6317,346	0.2672,0.4422,0.7835,0.4360,0.5586	0.4678							601411 [SGCD (confirmed) Muscular dystrophy,limb-girdle,type 2F,601287|Cardiomyopathy,dilated,1L,606685];	RCV000041413.9 [benign]; RCV000283555.1 [benign]; RCV000326284.1 [benign]; RCV000383249.1 [benign]; 		COSM4159670, COSM4159671	523	1067	2	[2] auto-classification 15.09.2017  			SGCD (inh=AR+AD pLI=0.00)
chr5	156187928	156187928	C	T	het	anno_omim	QUAL=13867;DP=516;AF=0.47;MQM=60;TRIO=HET,516,0.47,HET,253,0.51,HET,322,0.49	SGCD	3'UTR	SGCD:ENST00000435422:3'UTR:MODIFIER:exon8/8:c.*1527C>T:		rs284445	0.2073	0.0000	0,0,0	0,0,0,0,0	0.2646							601411 [SGCD (confirmed) Muscular dystrophy,limb-girdle,type 2F,601287|Cardiomyopathy,dilated,1L,606685];	RCV000279631.1 [benign]; RCV000315995.1 [benign]; RCV000374429.1 [benign]; 			30	82					SGCD (inh=AR+AD pLI=0.00)
chr5	156193118	156193118	G	A	hom	anno_omim	QUAL=22806;DP=369;AF=1.00;MQM=59;TRIO=HOM,369,1.00,HOM,124,1.00,HOM,195,1.00	SGCD	3'UTR	SGCD:ENST00000435422:3'UTR:MODIFIER:exon8/8:c.*6717G>A:		rs1827368	0.9271	0.0000	0,0,0	0,0,0,0,0	0.8952							601411 [SGCD (confirmed) Muscular dystrophy,limb-girdle,type 2F,601287|Cardiomyopathy,dilated,1L,606685];	RCV000278707.1 [benign]; RCV000333002.1 [benign]; RCV000373610.1 [benign]; 			184	43					SGCD (inh=AR+AD pLI=0.00)
chr5	156680685	156680685	A	G	hom	anno_omim	QUAL=29098;DP=353;AF=0.99;MQM=59;TRIO=HOM,353,0.99,HOM,230,1.00,HOM,324,1.00	ITK	3'UTR	ITK:ENST00000422843:3'UTR:MODIFIER:exon17/17:c.*997A>G:		rs27988	0.8335	0.0000	0,0,0	0,0,0,0,0	0.9015							186973 [ITK (confirmed) Lymphoproliferative syndrome 1,613011];	RCV000295939.1 [benign]; 			182	46					ITK (inh=AR pLI=0.00)
chr5	158742014	158742014	G	T	hom	anno_omim	QUAL=24041;DP=168;AF=1.00;MQM=59;TRIO=HOM,168,1.00,HOM,275,1.00,HOM,343,1.00	IL12B,AC008697.1	3'UTR	IL12B:ENST00000231228:3'UTR:MODIFIER:exon8/8:c.*1095C>A:		rs1368439	0.9203	0.0000	0,0,0	0,0,0,0,0	0.8746							161561 [IL12B (confirmed) Immunodeficiency 29,mycobacteriosis,614890];	RCV000267660.1 [benign]; 			166	59					IL12B (inh=n/a pLI=0.00), AC008697.1 (inh=n/a pLI=n/a)
chr5	161324898	161324898	A	G	hom	anno_omim	QUAL=9342;DP=199;AF=1.00;MQM=59;TRIO=HOM,199,1.00,HOM,52,1.00,HET,70,0.63	GABRA1	3'UTR	GABRA1:ENST00000428797:3'UTR:MODIFIER:exon11/11:c.*470A>G:,GABRA1:ENST00000437025:3'UTR:MODIFIER:exon10/10:c.*470A>G:,GABRA1:ENST00000420560:3'UTR:MODIFIER:exon10/10:c.*470A>G:,GABRA1:ENST00000444819:3'UTR:MODIFIER:exon10/10:c.*470A>G:		rs2290732	0.5811	0.0000	0,0,0	0,0,0,0,0	0.5861							137160 [GABRA1 (confirmed) Epilepsy,juvenile myoclonic,susceptibility to,5,611136|Epilepsy,childhood absence,susceptibility to,4,611136|Epileptic encephalopathy,early infantile,19,615744];	RCV000308049.1 [likely benign]; 			81	116					GABRA1 (inh=n/a pLI=0.96)
chr5	161325934	161325934	A	C	hom	anno_omim	QUAL=16323;DP=289;AF=1.00;MQM=60;TRIO=HOM,289,1.00,HOM,102,1.00,HET,168,0.63	GABRA1	3'UTR	GABRA1:ENST00000428797:3'UTR:MODIFIER:exon11/11:c.*1506A>C:,GABRA1:ENST00000437025:3'UTR:MODIFIER:exon10/10:c.*1506A>C:,GABRA1:ENST00000420560:3'UTR:MODIFIER:exon10/10:c.*1506A>C:,GABRA1:ENST00000444819:3'UTR:MODIFIER:exon10/10:c.*1506A>C:		rs998754	0.5805	0.0000	0,0,0	0,0,0,0,0	0.5867							137160 [GABRA1 (confirmed) Epilepsy,juvenile myoclonic,susceptibility to,5,611136|Epilepsy,childhood absence,susceptibility to,4,611136|Epileptic encephalopathy,early infantile,19,615744];	RCV000319995.1 [likely benign]; 			82	116					GABRA1 (inh=n/a pLI=0.96)
chr5	161494852	161494852	C	T	het	anno_omim	QUAL=7294;DP=256;AF=0.48;MQM=60;TRIO=HET,256,0.48,WT,278,0.00,HET,381,0.44	GABRG2	5'UTR	GABRG2:ENST00000414552:5'UTR:MODIFIER:exon1/11:c.-154C>T:,GABRG2:ENST00000356592:5'UTR:MODIFIER:exon1/10:c.-154C>T:,GABRG2:ENST00000361925:5'UTR:MODIFIER:exon1/9:c.-154C>T:		rs3219203	0.0361	0.0000	0,0,0	0,0,0,0,0	0.0621							137164 [GABRG2 (confirmed) Epilepsy,generalized,with febrile seizures plus,type 3,611277|Epilepsy,childhood absence,susceptibility to,2,607681|Febrile seizures,familial,8,611277];	RCV000288933.1 [likely benign]; RCV000341647.1 [likely benign]; 			0	34					GABRG2 (inh=AD pLI=0.96)
chr5	161529571	161529571	A	G	hom	anno_omim	QUAL=2378;DP=31;AF=1.00;MQM=60;TRIO=HOM,31,1.00,HOM,20,1.00,HOM,26,1.00	GABRG2	missense,intron	GABRG2:ENST00000414552:missense:MODERATE:exon6/11:c.643A>G:p.Ile215Val,GABRG2:ENST00000356592:intron:MODIFIER:exon5/9:c.631+1248A>G:,GABRG2:ENST00000361925:intron:MODIFIER:exon5/8:c.631+1248A>G:,GABRG2:ENST00000393933:intron:MODIFIER:exon6/9:c.346+1248A>G:	AluJb	rs211035	0.8213	0.8206	3639,835,70	0.0000,0.0000,0.0000,0.7808,0.8363	0.8240		T	T	B	T	0.35	137164 [GABRG2 (confirmed) Epilepsy,generalized,with febrile seizures plus,type 3,611277|Epilepsy,childhood absence,susceptibility to,2,607681|Febrile seizures,familial,8,611277];				1204	569	2	[2] auto-classification 15.09.2017  			GABRG2 (inh=AD pLI=0.96)
chr5	172659511	172659511	C	A	hom	anno_omim	QUAL=5397;DP=37;AF=0.92;MQM=60;TRIO=HOM,37,0.92,HOM,113,0.99,HET,96,0.53	NKX2-5	3'UTR	NKX2-5:ENST00000329198:3'UTR:MODIFIER:exon2/2:c.*61G>T:		rs703752	0.2556	0.0000	0,0,0	0,0,0,0,0	0.3084							600584 [NKX2-5 (confirmed) Atrial septal defect 7,with or without AV conduction defects,108900|Tetralogy of Fallot,187500|Hypothyroidism,congenital nongoitrous,5,225250|Ventricular septal defect 3,614432|Hypoplastic left heart syndrome 2,614435|Conotruncal heart malformations,variable,217095];	RCV000192692.1 [benign]; 			217	635					NKX2-5 (inh=AR+AD pLI=0.86)
chr5	176636882	176636882	C	T	het	anno_omim	QUAL=6352;DP=214;AF=0.51;MQM=60;TRIO=HET,214,0.51,HOM,108,0.99,WT,119,0.00	NSD1	synonymous	NSD1:ENST00000439151:synonymous:LOW:exon5/23:c.1482C>T:p.Cys494Cys,NSD1:ENST00000354179:synonymous:LOW:exon6/24:c.675C>T:p.Cys225Cys,NSD1:ENST00000347982:synonymous:LOW:exon6/24:c.675C>T:p.Cys225Cys,NSD1:ENST00000361032:synonymous:LOW:exon2/20:c.1173C>T:p.Cys391Cys		rs1363405	0.4681	0.2999	6927,1374,2480	0.6913,0.3144,0.5314,0.2016,0.3425	0.3742							606681 [NSD1 (confirmed) Sotos syndrome 1,117550|Leukemia,acute myeloid,601626|Beckwith-Wiedemann syndrome,130650];	RCV000082100.6 [benign]; RCV000319604.1 [benign]; RCV000371717.1 [benign]; 			130	806	2	[2] auto-classification 15.09.2017  			NSD1 (inh=AD pLI=1.00)
chr5	176637149	176637149	G	A	het	anno_omim	QUAL=8454;DP=304;AF=0.44;MQM=60;TRIO=HET,304,0.44,HOM,165,0.98,WT,235,0.00	NSD1	synonymous	NSD1:ENST00000439151:synonymous:LOW:exon5/23:c.1749G>A:p.Glu583Glu,NSD1:ENST00000354179:synonymous:LOW:exon6/24:c.942G>A:p.Glu314Glu,NSD1:ENST00000347982:synonymous:LOW:exon6/24:c.942G>A:p.Glu314Glu,NSD1:ENST00000361032:synonymous:LOW:exon2/20:c.1440G>A:p.Glu480Glu		rs3733874	0.0000	0.1765	2686,572,21	0.0810,0.2503,0.5123,0.1225,0.2223	0.1783							606681 [NSD1 (confirmed) Sotos syndrome 1,117550|Leukemia,acute myeloid,601626|Beckwith-Wiedemann syndrome,130650];	RCV000082103.6 [benign]; RCV000283379.1 [benign]; RCV000379961.1 [benign]; 			45	495	2	[2] auto-classification 15.09.2017  			NSD1 (inh=AD pLI=1.00)
chr5	176637240	176637240	G	T	het	pred_pathogenic;anno_omim	QUAL=12381;DP=517;AF=0.44;MQM=59;TRIO=HET,517,0.44,HOM,205,0.99,WT,306,0.00	NSD1	missense	NSD1:ENST00000439151:missense:MODERATE:exon5/23:c.1840G>T:p.Val614Leu,NSD1:ENST00000354179:missense:MODERATE:exon6/24:c.1033G>T:p.Val345Leu,NSD1:ENST00000347982:missense:MODERATE:exon6/24:c.1033G>T:p.Val345Leu,NSD1:ENST00000361032:missense:MODERATE:exon2/20:c.1531G>T:p.Val511Leu		rs3733875	0.2286	0.1762	2633,566,20	0.0763,0.2505,0.5123,0.1226,0.2251	0.1780	-0.3010	T,T,T,T,T	T	B,B,B	D,D,D,D	0.01	606681 [NSD1 (confirmed) Sotos syndrome 1,117550|Leukemia,acute myeloid,601626|Beckwith-Wiedemann syndrome,130650];	RCV000082107.6 [benign]; RCV000291627.1 [benign]; RCV000344352.1 [benign]; 			45	494	2	[2] auto-classification 15.09.2017  			NSD1 (inh=AD pLI=1.00)
chr5	176637576	176637576	T	C	het	pred_pathogenic;anno_omim	QUAL=12405;DP=605;AF=0.47;MQM=60;TRIO=HET,605,0.47,HOM,151,1.00,WT,268,0.00	NSD1	missense	NSD1:ENST00000439151:missense:MODERATE:exon5/23:c.2176T>C:p.Ser726Pro,NSD1:ENST00000354179:missense:MODERATE:exon6/24:c.1369T>C:p.Ser457Pro,NSD1:ENST00000347982:missense:MODERATE:exon6/24:c.1369T>C:p.Ser457Pro,NSD1:ENST00000361032:missense:MODERATE:exon2/20:c.1867T>C:p.Ser623Pro		rs28932178	0.2496	0.1987	3137,808,47	0.1053,0.2585,0.5125,0.1479,0.2519	0.2019	0.3970	D,D,D,D,D	T	D,P,P	D,D,D,D	0.01	606681 [NSD1 (confirmed) Sotos syndrome 1,117550|Leukemia,acute myeloid,601626|Beckwith-Wiedemann syndrome,130650];	RCV000082108.6 [benign]; RCV000313455.1 [benign]; RCV000354270.1 [benign]; 			60	600	2	[2] auto-classification 15.09.2017  			NSD1 (inh=AD pLI=1.00)
chr5	176721198	176721198	T	C	het	anno_omim	QUAL=11521;DP=380;AF=0.51;MQM=59;TRIO=HET,380,0.51,WT,150,0.00,HOM,213,1.00	NSD1	synonymous	NSD1:ENST00000439151:synonymous:LOW:exon23/23:c.6829T>C:p.Leu2277Leu,NSD1:ENST00000354179:synonymous:LOW:exon24/24:c.6022T>C:p.Leu2008Leu,NSD1:ENST00000347982:synonymous:LOW:exon24/24:c.6022T>C:p.Leu2008Leu,NSD1:ENST00000361032:synonymous:LOW:exon20/20:c.6520T>C:p.Leu2174Leu		rs28580074	0.7714	0.8242	42011,25695,4422	0.9243,0.7491,0.4868,0.8768,0.7799	0.8480							606681 [NSD1 (confirmed) Sotos syndrome 1,117550|Leukemia,acute myeloid,601626|Beckwith-Wiedemann syndrome,130650];	RCV000082138.7 [other]; RCV000127260.1 [benign]; RCV000268880.1 [benign]; RCV000379229.1 [benign]; 		COSM4003461, COSM150019	1705	499	2	[2] auto-classification 15.09.2017  			NSD1 (inh=AD pLI=1.00)
chr5	176726002	176726002	T	C	het	anno_omim	QUAL=13743;DP=458;AF=0.48;MQM=60;TRIO=HET,458,0.48,WT,254,0.00,HOM,250,1.00	NSD1	3'UTR	NSD1:ENST00000439151:3'UTR:MODIFIER:exon23/23:c.*3542T>C:,NSD1:ENST00000354179:3'UTR:MODIFIER:exon24/24:c.*3542T>C:,NSD1:ENST00000361032:3'UTR:MODIFIER:exon20/20:c.*3542T>C:		rs4976682	0.7640	0.0000	0,0,0	0,0,0,0,0	0.8406							606681 [NSD1 (confirmed) Sotos syndrome 1,117550|Leukemia,acute myeloid,601626|Beckwith-Wiedemann syndrome,130650];	RCV000273146.1 [benign]; RCV000364585.1 [benign]; 			186	42					NSD1 (inh=AD pLI=1.00)
chr5	176727058	176727058	G	C	hom	anno_omim	QUAL=1467;DP=28;AF=0.39;MQM=54;TRIO=HOM,28,0.39,HOM,9,0.00,HOM,33,0.00	NSD1	3'UTR	NSD1:ENST00000439151:3'UTR:MODIFIER:exon23/23:c.*4598G>C:,NSD1:ENST00000354179:3'UTR:MODIFIER:exon24/24:c.*4598G>C:,NSD1:ENST00000361032:3'UTR:MODIFIER:exon20/20:c.*4598G>C:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							606681 [NSD1 (confirmed) Sotos syndrome 1,117550|Leukemia,acute myeloid,601626|Beckwith-Wiedemann syndrome,130650];				0	1					NSD1 (inh=AD pLI=1.00)
chr5	176727072	176727072	G	C	hom	anno_omim	QUAL=1467;DP=28;AF=0.39;MQM=54;TRIO=HOM,28,0.39,HOM,9,0.00,HOM,33,0.00	NSD1	3'UTR	NSD1:ENST00000439151:3'UTR:MODIFIER:exon23/23:c.*4612G>C:,NSD1:ENST00000354179:3'UTR:MODIFIER:exon24/24:c.*4612G>C:,NSD1:ENST00000361032:3'UTR:MODIFIER:exon20/20:c.*4612G>C:	(C)n	rs867075292	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1921							606681 [NSD1 (confirmed) Sotos syndrome 1,117550|Leukemia,acute myeloid,601626|Beckwith-Wiedemann syndrome,130650];				5	6					NSD1 (inh=AD pLI=1.00)
chr5	177031348	177031348	T	C	het	anno_omim	QUAL=4589;DP=50;AF=0.42;MQM=59;TRIO=HET,50,0.42,HOM,115,0.99,HET,113,0.38	B4GALT7	synonymous	B4GALT7:ENST00000029410:synonymous:LOW:exon2/6:c.219T>C:p.Arg73Arg		rs11537644	0.6613	0.6608	23835,12353,1963	0.6639,0.7320,0.7514,0.6478,0.6137	0.6621							604327 [B4GALT7 (confirmed) Ehlers-Danlos syndrome with short stature and limb anomalies,130070];			COSM3761139	873	953	2	[2] auto-classification 15.09.2017  			B4GALT7 (inh=AR pLI=0.00)
chr5	177035964	177035964	T	C	het	anno_omim	QUAL=12525;DP=191;AF=0.50;MQM=59;TRIO=HET,191,0.50,HOM,214,1.00,HET,263,0.52	B4GALT7	synonymous	B4GALT7:ENST00000029410:synonymous:LOW:exon5/6:c.777T>C:p.His259His		rs729459	0.6050	0.5903	21537,10771,1974	0.6181,0.6604,0.7778,0.5661,0.5079	0.6001							604327 [B4GALT7 (confirmed) Ehlers-Danlos syndrome with short stature and limb anomalies,130070];			COSM3761140	669	1040	2	[2] auto-classification 15.09.2017  			B4GALT7 (inh=AR pLI=0.00)
chr5	177422876	177422876	T	C	hom	pred_pathogenic;anno_omim	QUAL=17249;DP=172;AF=1.00;MQM=59;TRIO=HOM,172,1.00,HOM,177,1.00,HOM,249,1.00	PROP1	missense	PROP1:ENST00000308304:missense:MODERATE:exon1/3:c.59A>G:p.Asn20Ser		rs7445271	0.9994	0.9999	60692,33365,5194	0.9991,1.0000,1.0000,1.0000,1.0000	0.9999	-0.4890	T	T	B	D	0.01	601538 [PROP1 (provisional) Pituitary hormone deficiency,combined,2,262600];				2108	0	2	[2] auto-classification 15.09.2017  			PROP1 (inh=AR pLI=0.30)
chr5	177422908	177422908	A	G	hom	anno_omim	QUAL=15860;DP=149;AF=0.99;MQM=60;TRIO=HOM,149,0.99,HET,232,0.48,HOM,304,1.00	PROP1	synonymous	PROP1:ENST00000308304:synonymous:LOW:exon1/3:c.27T>C:p.Ala9Ala		rs1135320	0.4477	0.4758	14261,6913,404	0.2781,0.5630,0.5785,0.4530,0.5725	0.4841							601538 [PROP1 (provisional) Pituitary hormone deficiency,combined,2,262600];	RCV000377173.1 [benign]; 		COSM4159781	533	1020	2	[2] auto-classification 15.09.2017  			PROP1 (inh=AR pLI=0.30)
chr5	177423144	177423144	T	G	hom	anno_omim	QUAL=32074;DP=354;AF=0.99;MQM=59;TRIO=HOM,354,0.99,HET,408,0.46,HOM,531,1.00	PROP1	5'UTR	PROP1:ENST00000308304:5'UTR:MODIFIER:exon1/3:c.-210A>C:		rs13187293	0.3303	0.0000	0,0,0	0,0,0,0,0	0.2906							601538 [PROP1 (provisional) Pituitary hormone deficiency,combined,2,262600];	RCV000337498.1 [likely benign]; 			40	101					PROP1 (inh=AR pLI=0.30)
chr6	3224825	3224825	A	-	hom	anno_omim	QUAL=42698;DP=395;AF=0.99;MQM=59;TRIO=HOM,395,0.99,HOM,422,1.00,HOM,551,0.99	TUBB2B	3'UTR	TUBB2B:ENST00000259818:3'UTR:MODIFIER:exon4/4:c.*160delT:		rs398000197	0.0000	0.0000	0,0,0	0,0,0,0,0	0.9451							615101 [TUBB2A (provisional) Cortical dysplasia,complex,with other brain malformations 5,615763]:612850 [TUBB2B (provisional) Polymicrogyria,symmetric or asymmetric,610031];				197	33					TUBB2B (inh=AD pLI=n/a)
chr6	7542148	7542148	-	A	het	anno_high_impact;anno_omim	QUAL=1795;DP=60;AF=0.52;MQM=59;TRIO=HET,60,0.52,HET,115,0.43,WT,121,0.01	DSP	frameshift&start_lost	DSP:ENST00000379802:frameshift&start_lost:HIGH:exon1/24:c.1dupA:p.Met1fs,DSP:ENST00000418664:frameshift&start_lost:HIGH:exon1/24:c.1dupA:p.Met1fs		rs606231377	0.1997	0.1994	1480,549,173	0.2722,0.2824,0.3023,0.1686,0.1516	0.1716							125647 [DSP (confirmed) Keratosis palmoplantaris striata II,612908|Cardiomyopathy,dilated,with woolly hair and keratoderma,605676|Arrhythmogenic right ventricular dysplasia 8,607450|Skin fragility-woolly hair syndrome,607655|Epidermolysis bullosa,lethal acantholytic,609638|Dilated cardiomyopathy with woolly hair,keratoderma,and tooth agenesis,615821];	RCV000029674.1 [uncertain significance]; RCV000037982.7 [other]; RCV000292424.1 [benign]; RCV000332106.1 [benign]; RCV000346732.1 [benign]; RCV000389020.1,RCV000029674.1 [benign,uncertain significance]; RCV000037982.7 [other]; RCV000292424.1 [benign]; RCV000332106.1 [benign]; RCV000346732.1 [benign]; RCV000389020.1 [benign]; 			49	469	1	[1] auto-classification 16.06.2016  [2] old entry - no details available			DSP (inh=AR+AD pLI=1.00)
chr6	7542274	7542274	T	C	het	anno_omim	QUAL=1094;DP=20;AF=0.25;MQM=60;TRIO=HET,20,0.25,WT,63,0.00,HET,71,0.61	DSP	synonymous	DSP:ENST00000379802:synonymous:LOW:exon1/24:c.126T>C:p.Tyr42Tyr,DSP:ENST00000418664:synonymous:LOW:exon1/24:c.126T>C:p.Tyr42Tyr		rs36087964	0.0609	0.0980	95,49,18	0.1685,0.0678,0.0358,0.1147,0.0604	0.0638							125647 [DSP (confirmed) Keratosis palmoplantaris striata II,612908|Cardiomyopathy,dilated,with woolly hair and keratoderma,605676|Arrhythmogenic right ventricular dysplasia 8,607450|Skin fragility-woolly hair syndrome,607655|Epidermolysis bullosa,lethal acantholytic,609638|Dilated cardiomyopathy with woolly hair,keratoderma,and tooth agenesis,615821];	RCV000037988.3 [benign]; RCV000288715.1 [benign]; RCV000341384.1 [benign]; RCV000379727.1 [benign]; RCV000380793.1 [benign]; 		COSM451787	11	233	2	[2] auto-classification 15.09.2017  			DSP (inh=AR+AD pLI=1.00)
chr6	7563983	7563983	T	G	hom	anno_omim	QUAL=32492;DP=451;AF=1.00;MQM=59;TRIO=HOM,451,1.00,HOM,231,1.00,HOM,314,1.00	DSP	synonymous	DSP:ENST00000379802:synonymous:LOW:exon6/24:c.741T>G:p.Ala247Ala,DSP:ENST00000418664:synonymous:LOW:exon6/24:c.741T>G:p.Ala247Ala		rs2806234	1.0000	0.9991	60601,33273,5200	0.9997,1.0000,1.0000,0.9986,0.9999	0.9995							125647 [DSP (confirmed) Keratosis palmoplantaris striata II,612908|Cardiomyopathy,dilated,with woolly hair and keratoderma,605676|Arrhythmogenic right ventricular dysplasia 8,607450|Skin fragility-woolly hair syndrome,607655|Epidermolysis bullosa,lethal acantholytic,609638|Dilated cardiomyopathy with woolly hair,keratoderma,and tooth agenesis,615821];	RCV000038088.2 [likely benign]; 			2220	4	2	[2] auto-classification 15.09.2017  			DSP (inh=AR+AD pLI=1.00)
chr6	7565727	7565727	A	T	het	pred_pathogenic;anno_omim	QUAL=7274;DP=228;AF=0.50;MQM=60;TRIO=HET,228,0.50,WT,281,0.00,HET,404,0.47	DSP	missense	DSP:ENST00000379802:missense:MODERATE:exon7/24:c.913A>T:p.Ile305Phe,DSP:ENST00000418664:missense:MODERATE:exon7/24:c.913A>T:p.Ile305Phe		rs17604693	0.0184	0.0299	85,59,0	0.0063,0.0141,0.0004,0.0394,0.0362	0.0297	9.2100	D,D,D	D	P,P	D,D	27.80	125647 [DSP (confirmed) Keratosis palmoplantaris striata II,612908|Cardiomyopathy,dilated,with woolly hair and keratoderma,605676|Arrhythmogenic right ventricular dysplasia 8,607450|Skin fragility-woolly hair syndrome,607655|Epidermolysis bullosa,lethal acantholytic,609638|Dilated cardiomyopathy with woolly hair,keratoderma,and tooth agenesis,615821];	RCV000029686.1 [benign]; RCV000038119.5 [other]; RCV000143884.1 [uncertain significance]; RCV000202852.1 [benign]; RCV000249794.1 [benign]; RCV000310554.1 [likely benign]; RCV000349765.1 [likely benign]; RCV000362961.1 [likely benign]; RCV000395135.1 [likely benign]; 	CM150219 [CLASS=R MUT=ALT PHEN="Arrhythmogenic right ventricular cardiomyopathy" GENE=DSP]; 	COSM1685467	6	181	1	[3] Stephan Waldm?ller 09.11.2015 [n/a] comment imported from detected variant: HGMD: DM? f?r ARVC, VUS3, swal 151109 [1] ahstamm1 05.07.2017			DSP (inh=AR+AD pLI=1.00)
chr6	7572262	7572262	A	G	hom	anno_omim	QUAL=14095;DP=198;AF=1.00;MQM=60;TRIO=HOM,198,1.00,HOM,98,1.00,HOM,146,1.00	DSP	synonymous	DSP:ENST00000379802:synonymous:LOW:exon15/24:c.2091A>G:p.Gly697Gly,DSP:ENST00000418664:synonymous:LOW:exon15/24:c.2091A>G:p.Gly697Gly		rs2076304	0.7744	0.7614	35334,19903,3342	0.8012,0.7622,0.8130,0.7720,0.6862	0.7676							125647 [DSP (confirmed) Keratosis palmoplantaris striata II,612908|Cardiomyopathy,dilated,with woolly hair and keratoderma,605676|Arrhythmogenic right ventricular dysplasia 8,607450|Skin fragility-woolly hair syndrome,607655|Epidermolysis bullosa,lethal acantholytic,609638|Dilated cardiomyopathy with woolly hair,keratoderma,and tooth agenesis,615821];	RCV000038004.2 [benign]; 			1312	792	2	[2] auto-classification 15.09.2017  			DSP (inh=AR+AD pLI=1.00)
chr6	7576527	7576527	G	A	hom	anno_omim	QUAL=10117;DP=178;AF=1.00;MQM=60;TRIO=HOM,178,1.00,HOM,56,1.00,HOM,89,1.00	DSP	splice_region&synonymous	DSP:ENST00000379802:splice_region&synonymous:LOW:exon19/24:c.2631G>A:p.Arg877Arg,DSP:ENST00000418664:splice_region&synonymous:LOW:exon19/24:c.2631G>A:p.Arg877Arg		rs1016835	0.7354	0.7718	36242,21321,2142	0.6448,0.7717,0.8046,0.7998,0.7461	0.7741							125647 [DSP (confirmed) Keratosis palmoplantaris striata II,612908|Cardiomyopathy,dilated,with woolly hair and keratoderma,605676|Arrhythmogenic right ventricular dysplasia 8,607450|Skin fragility-woolly hair syndrome,607655|Epidermolysis bullosa,lethal acantholytic,609638|Dilated cardiomyopathy with woolly hair,keratoderma,and tooth agenesis,615821];	RCV000038011.3 [benign]; RCV000250214.1 [benign]; RCV000289404.1 [benign]; RCV000292946.1 [benign]; RCV000352543.1 [benign]; RCV000388191.1 [benign]; 			1385	724	2	[2] auto-classification 15.09.2017  			DSP (inh=AR+AD pLI=1.00)
chr6	7584617	7584617	C	T	hom	anno_omim	QUAL=23047;DP=442;AF=1.00;MQM=59;TRIO=HOM,442,1.00,HET,161,0.51,HOM,222,0.99	DSP	synonymous	DSP:ENST00000379802:synonymous:LOW:exon24/24:c.7122C>T:p.Thr2374Thr,DSP:ENST00000418664:synonymous:LOW:exon24/24:c.5325C>T:p.Thr1775Thr		rs2076300	0.2117	0.2881	5622,4248,152	0.1681,0.1799,0.0682,0.3568,0.2592	0.2894							125647 [DSP (confirmed) Keratosis palmoplantaris striata II,612908|Cardiomyopathy,dilated,with woolly hair and keratoderma,605676|Arrhythmogenic right ventricular dysplasia 8,607450|Skin fragility-woolly hair syndrome,607655|Epidermolysis bullosa,lethal acantholytic,609638|Dilated cardiomyopathy with woolly hair,keratoderma,and tooth agenesis,615821];	RCV000038083.3 [benign]; RCV000280755.1 [benign]; RCV000295739.1 [benign]; RCV000348344.1 [benign]; RCV000391444.1 [benign]; 		COSM150043	304	980	2	[2] auto-classification 15.09.2017  			DSP (inh=AR+AD pLI=1.00)
chr6	7585967	7585967	G	C	hom	anno_omim	QUAL=18002;DP=258;AF=1.00;MQM=59;TRIO=HOM,258,1.00,HET,178,0.49,HOM,260,0.99	DSP	synonymous	DSP:ENST00000379802:synonymous:LOW:exon24/24:c.8472G>C:p.Gly2824Gly,DSP:ENST00000418664:synonymous:LOW:exon24/24:c.6675G>C:p.Gly2225Gly		rs2744380	0.7095	0.7117	30649,16753,2060	0.6397,0.7338,0.8066,0.7101,0.7272	0.7138							125647 [DSP (confirmed) Keratosis palmoplantaris striata II,612908|Cardiomyopathy,dilated,with woolly hair and keratoderma,605676|Arrhythmogenic right ventricular dysplasia 8,607450|Skin fragility-woolly hair syndrome,607655|Epidermolysis bullosa,lethal acantholytic,609638|Dilated cardiomyopathy with woolly hair,keratoderma,and tooth agenesis,615821];	RCV000038104.4 [benign]; RCV000241982.1 [benign]; RCV000273141.1 [benign]; RCV000304085.1 [benign]; RCV000328251.1 [benign]; RCV000363396.1 [benign]; 			1125	879	2	[2] auto-classification 15.09.2017  			DSP (inh=AR+AD pLI=1.00)
chr6	16305506	16305506	A	-	het	anno_omim	QUAL=69;DP=146;AF=0.20;MQM=59;TRIO=HET,146,0.20,HET,76,0.22,WT,98,0.13	ATXN1	3'UTR	ATXN1:ENST00000244769:3'UTR:MODIFIER:exon9/9:c.*1054delT:,ATXN1:ENST00000436367:3'UTR:MODIFIER:exon8/8:c.*1054delT:		rs878992657	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0053							601556 [ATXN1 (confirmed) Spinocerebellar ataxia 1,164400];				0	25					ATXN1 (inh=AD pLI=0.40)
chr6	16327615	16327615	A	G	het	anno_omim	QUAL=4440;DP=107;AF=0.42;MQM=59;TRIO=HET,107,0.42,HET,146,0.40,HET,186,0.45	ATXN1	synonymous	ATXN1:ENST00000244769:synonymous:LOW:exon8/9:c.927T>C:p.Ala309Ala,ATXN1:ENST00000436367:synonymous:LOW:exon7/8:c.927T>C:p.Ala309Ala		rs179990	0.7802	0.7320	32824,15394,3257	0.7949,0.8507,0.8625,0.6797,0.7766	0.7301							601556 [ATXN1 (confirmed) Spinocerebellar ataxia 1,164400];	RCV000116475.2 [likely benign]; 		COSM3761638	986	907	2	[2] auto-classification 15.09.2017  			ATXN1 (inh=AD pLI=0.40)
chr6	18122506	18122506	G	A	het	pred_pathogenic;anno_omim;anno_pathogenic_hgmd	QUAL=2093;DP=56;AF=0.57;MQM=59;TRIO=HET,56,0.57,WT,90,0.00,HET,108,0.62	NHLRC1	missense	NHLRC1:ENST00000340650:missense:MODERATE:exon1/1:c.332C>T:p.Pro111Leu		rs10949483	0.3429	0.4211	8525,4596,226	0.2691,0.5735,0.4314,0.4264,0.3515	0.4032	1.4920	D	D	B	D	18.92	608072 [NHLRC1 (confirmed) Epilepsy,progressive myoclonic 2B (Lafora),254780];	RCV000117782.7 [benign]; RCV000280891.1 [benign]; 	CM065338 [CLASS=DM? MUT=ALT PHEN="Myoclonic epilepsy of Lafora" GENE=NHLRC1]; 	COSM3749962	459	1561	2	[2] old entry - no details available [n/a] comment imported from detected variant: GS140155; too often in 1000g and esp6500 and in house; 18.06.2014; FH 			NHLRC1 (inh=AR pLI=0.04)
chr6	24532392	24532392	T	C	het	anno_omim	QUAL=5964;DP=268;AF=0.46;MQM=60;TRIO=HET,268,0.46,HET,198,0.53,WT,304,0.00	ALDH5A1	synonymous	ALDH5A1:ENST00000348925:synonymous:LOW:exon10/11:c.1428T>C:p.Asp476Asp,ALDH5A1:ENST00000546278:synonymous:LOW:exon10/11:c.1125T>C:p.Asp375Asp,ALDH5A1:ENST00000357578:synonymous:LOW:exon9/10:c.1389T>C:p.Asp463Asp,ALDH5A1:ENST00000491546:synonymous:LOW:exon8/9:c.1305T>C:p.Asp435Asp		rs58747567	0.0026	0.0062	7,7,0	0.0023,0.0031,0.0000,0.0100,0.0010	0.0074							610045 [ALDH5A1 (confirmed) Succinic semialdehyde dehydrogenase deficiency,271980];	RCV000367251.1 [benign]; 			0	27	2	[2] swoedl 19.10.2016			ALDH5A1 (inh=AR pLI=0.00)
chr6	24532412	24532412	G	A	het	anno_omim	QUAL=4652;DP=203;AF=0.43;MQM=60;TRIO=HET,203,0.43,HET,192,0.52,WT,289,0.00	ALDH5A1	splice_region&intron	ALDH5A1:ENST00000348925:splice_region&intron:LOW:exon10/10:c.1441+7G>A:,ALDH5A1:ENST00000546278:splice_region&intron:LOW:exon10/10:c.1138+7G>A:,ALDH5A1:ENST00000357578:splice_region&intron:LOW:exon9/9:c.1402+7G>A:,ALDH5A1:ENST00000491546:splice_region&intron:LOW:exon8/8:c.1318+7G>A:		rs12211574	0.0507	0.0808	506,363,2	0.0243,0.0353,0.0073,0.1019,0.0907	0.0795							610045 [ALDH5A1 (confirmed) Succinic semialdehyde dehydrogenase deficiency,271980];	RCV000265081.1 [likely benign]; 			16	285	2	[2] auto-classification 15.09.2017  			ALDH5A1 (inh=AR pLI=0.00)
chr6	24535179	24535179	T	G	het	anno_omim	QUAL=8505;DP=392;AF=0.48;MQM=60;TRIO=HET,392,0.48,HET,235,0.58,WT,272,0.00	ALDH5A1	3'UTR	ALDH5A1:ENST00000357578:3'UTR:MODIFIER:exon10/10:c.*1239T>G:		rs191960134	0.0026	0.0000	0,0,0	0,0,0,0,0	0.0074							610045 [ALDH5A1 (confirmed) Succinic semialdehyde dehydrogenase deficiency,271980];	RCV000277246.1 [uncertain significance]; 			0	4					ALDH5A1 (inh=AR pLI=0.00)
chr6	24535817	24535817	A	G	het	anno_omim	QUAL=3074;DP=216;AF=0.40;MQM=56;TRIO=HET,216,0.40,HET,117,0.37,WT,140,0.01	ALDH5A1	3'UTR	ALDH5A1:ENST00000357578:3'UTR:MODIFIER:exon10/10:c.*1877A>G:	AluY	rs41271787	0.0026	0.0000	0,0,0	0,0,0,0,0	0.0073							610045 [ALDH5A1 (confirmed) Succinic semialdehyde dehydrogenase deficiency,271980];				0	3					ALDH5A1 (inh=AR pLI=0.00)
chr6	26027135	26027135	G	A	het		QUAL=3021;DP=148;AF=0.48;MQM=60;TRIO=HET,148,0.48,HET,125,0.52,WT,168,0.01	HIST1H4B	3'UTR	HIST1H4B:ENST00000377364:3'UTR:MODIFIER:exon1/1:c.*34C>T:		rs3752420	0.3918	0.4103	9809,4918,151	0.1865,0.4685,0.7311,0.3985,0.3879	0.4130											252	688					HIST1H4B (inh=n/a pLI=0.01)
chr6	26027433	26027433	G	A	het		QUAL=3851;DP=174;AF=0.47;MQM=60;TRIO=HET,174,0.47,HET,194,0.48,WT,233,0.00	HIST1H4B	synonymous	HIST1H4B:ENST00000377364:synonymous:LOW:exon1/1:c.48C>T:p.Ala16Ala		rs3752419	0.3944	0.4047	10715,5188,165	0.1849,0.4670,0.7288,0.3947,0.3732	0.4126										COSM4160437	270	764	2	[2] auto-classification 15.09.2017  			HIST1H4B (inh=n/a pLI=0.01)
chr6	31830593	31830593	A	C	het	anno_omim	QUAL=8056;DP=413;AF=0.50;MQM=59;TRIO=HET,413,0.50,HET,298,0.46,WT,453,0.00	NEU1	5'UTR	NEU1:ENST00000375631:5'UTR:MODIFIER:exon1/6:c.-40T>G:		rs41267082	0.0511	0.0455	197,63,2	0.0138,0.0462,0.1340,0.0451,0.0211	0.0457							608272 [NEU1 (confirmed) Sialidosis,type I,256550|Sialidosis,type II,256550];	RCV000320437.1 [likely benign]; 			3	211					NEU1 (inh=AR pLI=0.00)
chr6	31964621	31964621	-	CT	het	low_MQM;anno_high_impact;anno_omim;anno_pathogenic_hgmd	QUAL=163;DP=21;AF=0.57;MQM=36;TRIO=HET,21,0.57,HET,14,0.14,WT,2,0.00	C4A	frameshift	C4A:ENST00000428956:frameshift:HIGH:exon29/41:c.3694_3695dupTC:p.Val1233fs,C4A:ENST00000498271:frameshift:HIGH:exon29/40:c.3694_3695dupTC:p.Val1233fs		rs760602547	0.0000	0.0047	0,0,0	0.0000,0.0000,0.0000,0.0078,0.0006	0.0112							120810 [C4A (confirmed) C4a deficiency,614380|Blood group,Rodgers,614374];		CI931069 [CLASS=DM MUT=ALT PHEN="Complement C4a deficiency" GENE=C4A]; 		1	20	3	[3] auto-classification 15.09.2017  			C4A (inh=AR pLI=n/a)
chr6	31973863	31973863	C	T	het	low_MQM;anno_omim	QUAL=7831;DP=151;AF=0.50;MQM=48;TRIO=HET,151,0.50,WT,213,0.00,HOM,222,0.99	CYP21A1P	splice_region&intron	CYP21A1P:ENST00000354927:splice_region&intron:LOW:exon2/9:n.292+9C>T:		rs28361033	0.4123	0.5372	12668,7204,514	0.4002,0.6694,0.4067,0.5653,0.4307	0.4842							120810 [C4A (confirmed) C4a deficiency,614380|Blood group,Rodgers,614374]:613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency,201910|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency,201910];			COSN167727	649	748	2	[2] auto-classification 15.09.2017  			CYP21A1P (inh=n/a pLI=n/a)
chr6	31975463	31975463	T	C	het	low_MQM;anno_omim	QUAL=703;DP=78;AF=0.14;MQM=37;TRIO=HET,78,0.14,WT,236,0.00,HOM,35,0.97	CYP21A1P	non_coding_transcript_exon	CYP21A1P:ENST00000354927:non_coding_transcript_exon:MODIFIER:exon8/10:n.948T>C:		rs370433041	0.0541	0.0023	19,1,3	0.0060,0.0011,0.0035,0.0014,0.0048	0.0713							120810 [C4A (confirmed) C4a deficiency,614380|Blood group,Rodgers,614374]:613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency,201910|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency,201910];				33	31	2	[2] Ute Grasshoff 24.11.2015			CYP21A1P (inh=n/a pLI=n/a)
chr6	31975577	31975577	T	C	hom	low_MQM;anno_omim	QUAL=359;DP=20;AF=1.00;MQM=34;TRIO=HOM,20,1.00,WT,248,0.08,HOM,5,1.00	CYP21A1P	non_coding_transcript_exon	CYP21A1P:ENST00000354927:non_coding_transcript_exon:MODIFIER:exon8/10:n.1062T>C:		rs147390813	0.2943	0.0006	6,3,0	0.0000,0.0001,0.0002,0.0003,0.0031	0.1184							120810 [C4A (confirmed) C4a deficiency,614380|Blood group,Rodgers,614374]:613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency,201910|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency,201910];				437	75					CYP21A1P (inh=n/a pLI=n/a)
chr6	31976228	31976228	C	T	hom	low_MQM;anno_omim	QUAL=6263;DP=114;AF=0.89;MQM=44;TRIO=HOM,114,0.89,HET,370,0.48,WT,258,0.03	CYP21A1P				rs182239097	0.2656	0.0000	0,0,0	0,0,0,0,0	0.2441							120810 [C4A (confirmed) C4a deficiency,614380|Blood group,Rodgers,614374]:613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency,201910|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency,201910]:600985 [TNXB (provisional) Ehlers-Danlos syndrome due to tenascin X deficiency,606408|Vesicoureteral reflux 8,615963];				63	255					CYP21A1P (inh=n/a pLI=n/a)
chr6	31994782	31994782	C	T	het	low_DP;low_MQM;anno_omim	QUAL=2728;DP=5;AF=0.20;MQM=29;TRIO=HET,5,0.20,HOM,77,1.00,HET,141,0.45	C4B	synonymous	C4B:ENST00000435363:synonymous:LOW:exon20/41:c.2475C>T:p.Val825Val,C4B:ENST00000425700:synonymous:LOW:exon20/40:c.2475C>T:p.Val825Val		rs451637	0.1028	0.1844	2087,1733,15	0.0597,0.0728,0.1229,0.2687,0.0825	0.1741							613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency,201910|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency,201910]:600985 [TNXB (provisional) Ehlers-Danlos syndrome due to tenascin X deficiency,606408|Vesicoureteral reflux 8,615963];			COSM4160886, COSM4160885	190	379	2	[2] auto-classification 15.09.2017  			C4B (inh=n/a pLI=n/a)
chr6	31997401	31997401	G	A	het	low_MQM;anno_omim	QUAL=455;DP=39;AF=0.51;MQM=31;TRIO=HET,39,0.51,WT,63,0.00,HET,67,0.22	C4B	synonymous	C4B:ENST00000435363:synonymous:LOW:exon29/41:c.3735G>A:p.Pro1245Pro,C4B:ENST00000425700:synonymous:LOW:exon29/40:c.3735G>A:p.Pro1245Pro		rs12526327	0.0000	0.2397	11,3,0	0.0492,0.3320,0.2108,0.2576,0.1980	0.2112							613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency,201910|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency,201910]:600985 [TNXB (provisional) Ehlers-Danlos syndrome due to tenascin X deficiency,606408|Vesicoureteral reflux 8,615963];				3	705	2	[2] auto-classification 15.09.2017  			C4B (inh=n/a pLI=n/a)
chr6	32006119	32006119	A	C	het	anno_omim	QUAL=3871;DP=159;AF=0.53;MQM=52;TRIO=HET,159,0.53,HET,165,0.49,WT,225,0.00	CYP21A2	5'UTR	CYP21A2:ENST00000418967:5'UTR:MODIFIER:exon1/10:c.-81A>C:		rs554941446	0.0026	0.0000	0,0,0	0,0,0,0,0	0.0127							613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency,201910|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency,201910]:600985 [TNXB (provisional) Ehlers-Danlos syndrome due to tenascin X deficiency,606408|Vesicoureteral reflux 8,615963];				0	6					CYP21A2 (inh=AR pLI=0.67)
chr6	32006215	32006217	CTG	-	het	low_MQM;anno_omim	QUAL=2805;DP=138;AF=0.48;MQM=45;TRIO=HET,138,0.48,WT,241,0.00,HET,335,0.39	CYP21A2	disruptive_inframe_deletion	CYP21A2:ENST00000418967:disruptive_inframe_deletion:MODERATE:exon1/10:c.29_31delTGC:p.Leu10del,CYP21A2:ENST00000435122:disruptive_inframe_deletion:MODERATE:exon1/9:c.29_31delTGC:p.Leu10del	(TGC)n	rs754295868	0.2169	0.2924	787,441,4	0.0773,0.3877,0.2198,0.3665,0.2529	0.3089							613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency,201910|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency,201910]:600985 [TNXB (provisional) Ehlers-Danlos syndrome due to tenascin X deficiency,606408|Vesicoureteral reflux 8,615963];	RCV000079017.5 [benign]; 		COSM1077762	250	770	2	[2] auto-classification 15.09.2017  			CYP21A2 (inh=AR pLI=0.67)
chr6	32006317	32006317	C	T	hom	low_MQM;anno_omim	QUAL=20502;DP=205;AF=1.00;MQM=40;TRIO=HOM,205,1.00,HET,292,0.51,HOM,419,1.00	CYP21A2	synonymous	CYP21A2:ENST00000418967:synonymous:LOW:exon1/10:c.118C>T:p.Leu40Leu,CYP21A2:ENST00000435122:synonymous:LOW:exon1/9:c.118C>T:p.Leu40Leu		rs6468	0.0000	0.7891	29981,15454,3159	0.8849,0.8389,0.7022,0.7722,0.8106	0.8190							613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency,201910|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency,201910]:600985 [TNXB (provisional) Ehlers-Danlos syndrome due to tenascin X deficiency,606408|Vesicoureteral reflux 8,615963];	RCV000244556.1 [benign]; 		COSM4160891	1186	748	2	[2] auto-classification 15.09.2017  			CYP21A2 (inh=AR pLI=0.67)
chr6	32006337	32006337	C	A	hom	low_MQM;anno_omim	QUAL=18897;DP=187;AF=1.00;MQM=37;TRIO=HOM,187,1.00,HET,272,0.52,HOM,389,0.99	CYP21A2	synonymous	CYP21A2:ENST00000418967:synonymous:LOW:exon1/10:c.138C>A:p.Pro46Pro,CYP21A2:ENST00000435122:synonymous:LOW:exon1/9:c.138C>A:p.Pro46Pro		rs6464	0.0000	0.6636	15896,8501,1149	0.6526,0.7491,0.6035,0.6653,0.6365	0.7046							613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency,201910|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency,201910]:600985 [TNXB (provisional) Ehlers-Danlos syndrome due to tenascin X deficiency,606408|Vesicoureteral reflux 8,615963];	RCV000247881.1 [benign]; 		COSM4160892	899	913	2	[2] auto-classification 15.09.2017  			CYP21A2 (inh=AR pLI=0.67)
chr6	32006597	32006597	C	T	het	low_MQM;anno_omim	QUAL=9594;DP=93;AF=0.53;MQM=49;TRIO=HET,93,0.53,WT,172,0.01,HOM,289,1.00	CYP21A2	splice_region&intron,intron	CYP21A2:ENST00000418967:splice_region&intron:LOW:exon2/9:c.292+9C>T:,CYP21A2:ENST00000435122:intron:MODIFIER:exon1/8:c.202+196C>T:		rs6462	0.7115	0.7421	21254,11276,1484	0.6964,0.8499,0.7041,0.7399,0.7168	0.7368							613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency,201910|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency,201910]:600985 [TNXB (provisional) Ehlers-Danlos syndrome due to tenascin X deficiency,606408|Vesicoureteral reflux 8,615963];	RCV000251542.1 [benign]; 			1046	916	2	[2] auto-classification 15.09.2017  			CYP21A2 (inh=AR pLI=0.67)
chr6	32006886	32006886	G	A	het	anno_omim	QUAL=2289;DP=78;AF=0.46;MQM=59;TRIO=HET,78,0.46,WT,210,0.02,HET,146,0.47	CYP21A2	missense	CYP21A2:ENST00000418967:missense:MODERATE:exon3/10:c.308G>A:p.Arg103Lys,CYP21A2:ENST00000435122:missense:MODERATE:exon2/9:c.218G>A:p.Arg73Lys		rs6474	0.2149	0.3341	5625,3562,20	0.0641,0.4755,0.2155,0.3750,0.2508	0.3179	-1.0340	T,T,T,T	T	B,B	T,T,T,T	0.01	613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency,201910|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency,201910]:600985 [TNXB (provisional) Ehlers-Danlos syndrome due to tenascin X deficiency,606408|Vesicoureteral reflux 8,615963];	RCV000055817.1 [benign]; RCV000245772.1 [benign]; 		COSM1319109	282	882	2	[2] auto-classification 15.09.2017  			CYP21A2 (inh=AR pLI=0.67)
chr6	32008963	32008963	C	T	het	low_MQM;anno_omim	QUAL=15751;DP=113;AF=0.57;MQM=48;TRIO=HET,113,0.57,HET,288,0.47,HOM,416,0.98	CYP21A2,TNXB	3'UTR	CYP21A2:ENST00000418967:3'UTR:MODIFIER:exon10/10:c.*52C>T:,TNXB:ENST00000375244:3'UTR:MODIFIER:exon44/44:c.*163G>A:,CYP21A2:ENST00000435122:3'UTR:MODIFIER:exon9/9:c.*52C>T:,TNXB:ENST00000451343:3'UTR:MODIFIER:exon13/13:c.*163G>A:,TNXB:ENST00000375247:3'UTR:MODIFIER:exon44/44:c.*163G>A:		rs1058152	0.4996	0.5638	12122,6662,301	0.4464,0.6430,0.6163,0.5752,0.5021	0.5504							613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency,201910|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency,201910]:600985 [TNXB (provisional) Ehlers-Danlos syndrome due to tenascin X deficiency,606408|Vesicoureteral reflux 8,615963];				343	912					CYP21A2 (inh=AR pLI=0.67), TNXB (inh=AR pLI=0.77)
chr6	32009456	32009456	A	G	het	low_MQM;gene_blacklist;anno_omim	QUAL=4803;DP=169;AF=0.27;MQM=46;TRIO=HET,169,0.27,WT,342,0.00,HET,434,0.44	TNXB	intron	TNXB:ENST00000375244:intron:MODIFIER:exon43/43:c.12633+92T>C:,TNXB:ENST00000451343:intron:MODIFIER:exon12/12:c.1920+92T>C:,TNXB:ENST00000375247:intron:MODIFIER:exon43/43:c.12627+92T>C:		rs3128757	0.0000	0.0000	0,0,0	0,0,0,0,0	0.2432							613815 [CYP21A2 (confirmed) Adrenal hyperplasia,congenital,due to 21-hydroxylase deficiency,201910|Hyperandrogenism,nonclassic type,due to 21-hydroxylase deficiency,201910]:600985 [TNXB (provisional) Ehlers-Danlos syndrome due to tenascin X deficiency,606408|Vesicoureteral reflux 8,615963];				24	88					TNXB (inh=AR pLI=0.77)
chr6	32793981	32793981	A	C	het	anno_omim	QUAL=11037;DP=308;AF=0.51;MQM=59;TRIO=HET,308,0.51,HET,118,0.53,HOM,162,1.00	TAP2	3'UTR,intron	TAP2:ENST00000374897:3'UTR:MODIFIER:exon12/12:c.*2702T>G:,TAP2:ENST00000452392:intron:MODIFIER:exon11/14:c.1932+3196T>G:,TAP2:ENST00000374899:intron:MODIFIER:exon11/11:c.1932+3196T>G:		rs1044043	0.8211	0.0000	0,0,0	0,0,0,0,0	0.8191							170261 [TAP2 (confirmed) Bare lymphocyte syndrome,type I,due to TAP2 deficiency,604571|Wegener-like granulomatosis];				155	85					TAP2 (inh=AR pLI=0.00)
chr6	32795032	32795032	G	A	het	anno_omim	QUAL=7880;DP=363;AF=0.52;MQM=60;TRIO=HET,363,0.52,WT,209,0.00,HET,280,0.42	TAP2	3'UTR,intron	TAP2:ENST00000374897:3'UTR:MODIFIER:exon12/12:c.*1651C>T:,TAP2:ENST00000452392:intron:MODIFIER:exon11/14:c.1932+2145C>T:,TAP2:ENST00000374899:intron:MODIFIER:exon11/11:c.1932+2145C>T:		rs10484565	0.0511	0.0000	0,0,0	0,0,0,0,0	0.0692							170261 [TAP2 (confirmed) Bare lymphocyte syndrome,type I,due to TAP2 deficiency,604571|Wegener-like granulomatosis];				1	33					TAP2 (inh=AR pLI=0.00)
chr6	32796451	32796451	A	C	het	anno_omim	QUAL=1644;DP=102;AF=0.38;MQM=59;TRIO=HET,102,0.38,WT,45,0.00,HET,79,0.44	TAP2	3'UTR,intron	TAP2:ENST00000374897:3'UTR:MODIFIER:exon12/12:c.*232T>G:,TAP2:ENST00000452392:intron:MODIFIER:exon11/14:c.1932+726T>G:,TAP2:ENST00000374899:intron:MODIFIER:exon11/11:c.1932+726T>G:		rs141809764	0.0038	0.0000	0,0,0	0,0,0,0,0	0.0054							170261 [TAP2 (confirmed) Bare lymphocyte syndrome,type I,due to TAP2 deficiency,604571|Wegener-like granulomatosis];				0	5					TAP2 (inh=AR pLI=0.00)
chr6	32796793	32796793	G	A	het	pred_pathogenic;anno_omim	QUAL=4028;DP=187;AF=0.47;MQM=59;TRIO=HET,187,0.47,HET,168,0.48,WT,252,0.00	TAP2	missense,intron	TAP2:ENST00000374897:missense:MODERATE:exon12/12:c.1951C>T:p.Arg651Cys,TAP2:ENST00000452392:intron:MODIFIER:exon11/14:c.1932+384C>T:,TAP2:ENST00000374899:intron:MODIFIER:exon11/11:c.1932+384C>T:		rs4148876	0.0585	0.0763	66,42,0	0.0213,0.1737,0.0671,0.1049,0.0483	0.0768	0.0370	T	T	P,P	D	5.98	170261 [TAP2 (confirmed) Bare lymphocyte syndrome,type I,due to TAP2 deficiency,604571|Wegener-like granulomatosis];		CM077979 [CLASS=DP MUT=ALT PHEN="Diabetes type 1 association with" GENE=TAP2]; 		8	246	2	[2] auto-classification 15.09.2017  			TAP2 (inh=AR pLI=0.00)
chr6	32800224	32800224	C	A	het	anno_omim	QUAL=2818;DP=165;AF=0.52;MQM=60;TRIO=HET,165,0.52,HET,81,0.43,WT,99,0.00	TAP2	synonymous	TAP2:ENST00000452392:synonymous:LOW:exon7/15:c.1158G>T:p.Gly386Gly,TAP2:ENST00000374897:synonymous:LOW:exon7/12:c.1158G>T:p.Gly386Gly,TAP2:ENST00000374899:synonymous:LOW:exon7/12:c.1158G>T:p.Gly386Gly		rs2228397	0.2442	0.2546	3643,1674,239	0.2370,0.3776,0.2463,0.2383,0.2739	0.2572							170261 [TAP2 (confirmed) Bare lymphocyte syndrome,type I,due to TAP2 deficiency,604571|Wegener-like granulomatosis];				169	808	2	[2] auto-classification 15.09.2017  			TAP2 (inh=AR pLI=0.00)
chr6	32806530	32806530	C	G	het	anno_omim	QUAL=2080;DP=66;AF=0.64;MQM=60;TRIO=HET,66,0.64,WT,47,0.00,HET,85,0.56	TAP2	5'UTR	TAP2:ENST00000452392:5'UTR:MODIFIER:exon1/15:c.-105G>C:,TAP2:ENST00000374897:5'UTR:MODIFIER:exon1/12:c.-105G>C:		rs146973617	0.0032	0.0000	0,0,0	0,0,0,0,0	0.0050							170261 [TAP2 (confirmed) Bare lymphocyte syndrome,type I,due to TAP2 deficiency,604571|Wegener-like granulomatosis];				0	7					TAP2 (inh=AR pLI=0.00)
chr6	32813279	32813279	C	A	hom	anno_omim	QUAL=26004;DP=438;AF=0.99;MQM=59;TRIO=HOM,438,0.99,HET,412,0.48,HET,605,0.52	TAP1,PSMB9,TAPSAR1	3'UTR,intron,non_coding_transcript_exon	TAP1:ENST00000354258:3'UTR:MODIFIER:exon11/11:c.*77G>T:,TAP1:ENST00000425148:3'UTR:MODIFIER:exon11/11:c.*77G>T:,PSMB9:ENST00000395330:intron:MODIFIER:exon1/5:c.-10+1228C>A:,TAPSAR1:ENST00000453426:non_coding_transcript_exon:MODIFIER:exon2/2:n.274C>A:		rs1057373	0.0909	0.0000	0,0,0	0,0,0,0,0	0.0900							170260 [TAP1 (confirmed) Bare lymphocyte syndrome,type I,604571];				12	97					TAP1 (inh=AR pLI=0.29), PSMB9 (inh=n/a pLI=0.23), PSMB8-AS1 (inh=n/a pLI=n/a)
chr6	32814909	32814909	C	T	het	pred_pathogenic;anno_omim;anno_pathogenic_clinvar;anno_pathogenic_hgmd	QUAL=4880;DP=272;AF=0.46;MQM=60;TRIO=HET,272,0.46,WT,172,0.00,HET,189,0.40	TAP1,PSMB9	missense,intron	TAP1:ENST00000354258:missense:MODERATE:exon10/11:c.2156G>A:p.Arg719Gln,TAP1:ENST00000425148:missense:MODERATE:exon10/11:c.1373G>A:p.Arg458Gln,PSMB9:ENST00000395330:intron:MODIFIER:exon1/5:c.-10+2858C>T:		rs121917702	0.0008	0.0016	1,1,0	0.0001,0.0000,0.0000,0.0027,0.0002	0.0012	3.0610	D,D	D	P	D,D	34.00	170260 [TAP1 (confirmed) Bare lymphocyte syndrome,type I,604571];	RCV000014734.4 [pathogenic]; 	CM963078 [CLASS=DM MUT=ALT PHEN="HLA class I deficiency" GENE=TAP1]; 		0	7					TAP1 (inh=AR pLI=0.29), PSMB9 (inh=n/a pLI=0.23)
chr6	32814975	32814975	T	C	hom	pred_pathogenic;anno_omim	QUAL=9508;DP=207;AF=0.99;MQM=59;TRIO=HOM,207,0.99,HET,141,0.55,HET,161,0.38	TAP1,PSMB9	missense,intron	TAP1:ENST00000354258:missense:MODERATE:exon10/11:c.2090A>G:p.Asp697Gly,TAP1:ENST00000425148:missense:MODERATE:exon10/11:c.1307A>G:p.Asp436Gly,PSMB9:ENST00000395330:intron:MODIFIER:exon1/5:c.-10+2924T>C:		rs1135216	0.1915	0.1739	1823,753,239	0.2380,0.1921,0.1548,0.1528,0.2175	0.1787	4.9980	T,T	T	B	D,D	11.88	170260 [TAP1 (confirmed) Bare lymphocyte syndrome,type I,604571];	RCV000014733.2 [benign]; 	CM920657 [CLASS=DP MUT=ALT PHEN="Nasopharyngeal carcinoma reduced risk association with" GENE=TAP1]; 	COSM4161045	48	546	2	[2] auto-classification 15.09.2017  			TAP1 (inh=AR pLI=0.29), PSMB9 (inh=n/a pLI=0.23)
chr6	32818774	32818774	T	C	hom	pred_pathogenic;anno_omim	QUAL=15037;DP=231;AF=0.99;MQM=59;TRIO=HOM,231,0.99,HET,263,0.54,HET,332,0.55	TAP1,PSMB9	missense,intron	TAP1:ENST00000354258:missense:MODERATE:exon4/11:c.1177A>G:p.Ile393Val,TAP1:ENST00000425148:missense:MODERATE:exon4/11:c.394A>G:p.Ile132Val,PSMB9:ENST00000395330:intron:MODIFIER:exon1/5:c.-9-5141T>C:		rs1057141	0.2282	0.2047	2584,1032,318	0.2661,0.1882,0.2192,0.1791,0.2750	0.2059	-0.5640	T,T	T	B	D,D	0.06	170260 [TAP1 (confirmed) Bare lymphocyte syndrome,type I,604571];	RCV000014732.2 [benign]; 	CM920656 [CLASS=DP MUT=ALT PHEN="Nasopharyngeal carcinoma reduced risk association with" GENE=TAP1]; 		67	602	2	[2] auto-classification 15.09.2017  			TAP1 (inh=AR pLI=0.29), PSMB9 (inh=n/a pLI=0.23)
chr6	33267672	33267672	A	G	hom	anno_omim	QUAL=35312;DP=496;AF=0.99;MQM=59;TRIO=HOM,496,0.99,HOM,471,1.00,HET,565,0.44	TAPBP	3'UTR	TAPBP:ENST00000434618:3'UTR:MODIFIER:exon8/8:c.*1865T>C:	L2b	rs1059288	0.5905	0.0000	0,0,0	0,0,0,0,0	0.5855							601962 [TAPBP (provisional) Bare lymphocyte syndrome,type I,604571];				82	103					TAPBP (inh=AR pLI=0.00)
chr6	33267908	33267908	G	A	het	anno_omim	QUAL=9073;DP=363;AF=0.48;MQM=59;TRIO=HET,363,0.48,WT,332,0.00,HET,414,0.47	TAPBP	3'UTR	TAPBP:ENST00000434618:3'UTR:MODIFIER:exon8/8:c.*1629C>T:		rs147996331	0.0020	0.0000	0,0,0	0,0,0,0,0	0.0104							601962 [TAPBP (provisional) Bare lymphocyte syndrome,type I,604571];				1	7					TAPBP (inh=AR pLI=0.00)
chr6	33268437	33268437	-	AGAAAAAA	hom	anno_omim	QUAL=2536;DP=80;AF=0.99;MQM=53;TRIO=HOM,80,0.99,HOM,15,1.00,HET,18,0.50	TAPBP	3'UTR	TAPBP:ENST00000434618:3'UTR:MODIFIER:exon8/8:c.*1092_*1099dupTTTTTTCT:	AluY	rs71536179	0.0000	0.0000	0,0,0	0,0,0,0,0	0.5477							601962 [TAPBP (provisional) Bare lymphocyte syndrome,type I,604571];				58	60					TAPBP (inh=AR pLI=0.00)
chr6	33268737	33268737	C	A	het	low_MQM;anno_omim	QUAL=704;DP=69;AF=0.48;MQM=45;TRIO=HET,69,0.48,WT,2,0.00,HET,2,0.50	TAPBP	3'UTR	TAPBP:ENST00000434618:3'UTR:MODIFIER:exon8/8:c.*800G>T:	AluY	rs3130259	0.2210	0.0000	0,0,0	0,0,0,0,0	0.2543							601962 [TAPBP (provisional) Bare lymphocyte syndrome,type I,604571];				25	29					TAPBP (inh=AR pLI=0.00)
chr6	33272813	33272813	T	G	het	low_QUAL;pred_pathogenic;anno_omim	QUAL=17;DP=134;AF=0.43;MQM=59;TRIO=HET,134,0.43,WT,238,0.02,WT,315,0.02	TAPBP	missense	TAPBP:ENST00000426633:missense:MODERATE:exon4/7:c.821A>C:p.His274Pro,TAPBP:ENST00000434618:missense:MODERATE:exon4/8:c.821A>C:p.His274Pro,TAPBP:ENST00000475304:missense:MODERATE:exon5/9:c.875A>C:p.His292Pro,TAPBP:ENST00000489157:missense:MODERATE:exon3/7:c.560A>C:p.His187Pro,TAPBP:ENST00000456592:missense:MODERATE:exon4/8:c.821A>C:p.His274Pro		rs201276892	0.0000	0.0223	0,0,0	0.0246,0.0073,0.0069,0.0169,0.0723	0.0351	2.2540	D,D,T,D,D,.,.	T	D,D,D,D,D,D	T,T,T,T,T	25.50	601962 [TAPBP (provisional) Bare lymphocyte syndrome,type I,604571];				0	47					TAPBP (inh=AR pLI=0.00)
chr6	33272855	33272855	G	C	hom	anno_omim	QUAL=24421;DP=265;AF=0.99;MQM=59;TRIO=HOM,265,0.99,HOM,339,1.00,HET,462,0.51	TAPBP	missense	TAPBP:ENST00000426633:missense:MODERATE:exon4/7:c.779C>G:p.Thr260Arg,TAPBP:ENST00000434618:missense:MODERATE:exon4/8:c.779C>G:p.Thr260Arg,TAPBP:ENST00000475304:missense:MODERATE:exon5/9:c.833C>G:p.Thr278Arg,TAPBP:ENST00000489157:missense:MODERATE:exon3/7:c.518C>G:p.Thr173Arg,TAPBP:ENST00000456592:missense:MODERATE:exon4/8:c.779C>G:p.Thr260Arg		rs2071888	0.5913	0.5682	20032,10182,2907	0.7477,0.5378,0.3724,0.5525,0.6550	0.5863	0.9400	T,T,T,T,T,.,.	T	B,B,B,B	T,T,T,T,T	2.41	601962 [TAPBP (provisional) Bare lymphocyte syndrome,type I,604571];		CM056992 [CLASS=DP MUT=ALT PHEN="Rheumatoid arthritis juvenile association with" GENE=TAPBP]; 	COSM1180607, COSM1180608	674	1033	2	[2] auto-classification 15.09.2017  			TAPBP (inh=AR pLI=0.00)
chr6	33281842	33281842	G	T	het	anno_omim	QUAL=7103;DP=126;AF=0.44;MQM=59;TRIO=HET,126,0.44,HET,206,0.43,HET,280,0.52	TAPBP	5'UTR	TAPBP:ENST00000426633:5'UTR:MODIFIER:exon1/7:c.-24C>A:,TAPBP:ENST00000434618:5'UTR:MODIFIER:exon1/8:c.-24C>A:,TAPBP:ENST00000475304:5'UTR:MODIFIER:exon1/9:c.-24C>A:,TAPBP:ENST00000489157:5'UTR:MODIFIER:exon1/7:c.-24C>A:,TAPBP:ENST00000456592:5'UTR:MODIFIER:exon1/8:c.-24C>A:		rs2239841	0.2206	0.2965	5751,3310,15	0.0551,0.3782,0.2450,0.3154,0.3087	0.2992							601962 [TAPBP (provisional) Bare lymphocyte syndrome,type I,604571];				185	729					TAPBP (inh=AR pLI=0.00)
chr6	33281843	33281843	A	T	het	anno_omim	QUAL=7103;DP=126;AF=0.44;MQM=59;TRIO=HET,126,0.44,HET,206,0.43,HET,280,0.52	TAPBP	5'UTR	TAPBP:ENST00000426633:5'UTR:MODIFIER:exon1/7:c.-25T>A:,TAPBP:ENST00000434618:5'UTR:MODIFIER:exon1/8:c.-25T>A:,TAPBP:ENST00000475304:5'UTR:MODIFIER:exon1/9:c.-25T>A:,TAPBP:ENST00000489157:5'UTR:MODIFIER:exon1/7:c.-25T>A:,TAPBP:ENST00000456592:5'UTR:MODIFIER:exon1/8:c.-25T>A:		rs2239840	0.2206	0.2962	5749,3309,15	0.0551,0.3776,0.2448,0.3152,0.3087	0.2991							601962 [TAPBP (provisional) Bare lymphocyte syndrome,type I,604571];				185	729					TAPBP (inh=AR pLI=0.00)
chr6	33282002	33282002	C	T	hom	anno_omim	QUAL=8695;DP=100;AF=0.98;MQM=60;TRIO=HOM,100,0.98,HOM,152,0.99,HET,196,0.55	TAPBP	5'UTR	TAPBP:ENST00000434618:5'UTR:MODIFIER:exon1/8:c.-184G>A:,TAPBP:ENST00000475304:5'UTR:MODIFIER:exon1/9:c.-184G>A:,TAPBP:ENST00000489157:5'UTR:MODIFIER:exon1/7:c.-184G>A:,TAPBP:ENST00000456592:5'UTR:MODIFIER:exon1/8:c.-184G>A:		rs3106189	0.5186	0.0000	0,0,0	0,0,0,0,0	0.5158							601962 [TAPBP (provisional) Bare lymphocyte syndrome,type I,604571];				69	105					TAPBP (inh=AR pLI=0.00)
chr6	33408542	33408542	G	A	het	anno_omim	QUAL=2341;DP=66;AF=0.47;MQM=59;TRIO=HET,66,0.47,HET,72,0.49,HET,59,0.56	SYNGAP1	synonymous	SYNGAP1:ENST00000418600:synonymous:LOW:exon11/19:c.1713G>A:p.Ser571Ser,SYNGAP1:ENST00000293748:synonymous:LOW:exon11/19:c.1713G>A:p.Ser571Ser,SYNGAP1:ENST00000428982:synonymous:LOW:exon9/17:c.1536G>A:p.Ser512Ser		rs411136	0.4377	0.4861	8796,4235,338	0.3616,0.4747,0.6658,0.4715,0.5374	0.4036							603384 [SYNGAP1 (confirmed) Mental retardation,autosomal dominant 5,612621];	RCV000118564.2 [likely benign]; 		COSM150074, COSM150073	353	1030	2	[2] auto-classification 15.09.2017  			SYNGAP1 (inh=AD pLI=1.00)
chr6	35423662	35423662	A	C	het	anno_omim	QUAL=2462;DP=63;AF=0.52;MQM=60;TRIO=HET,63,0.52,HET,72,0.44,HET,70,0.53	FANCE	synonymous	FANCE:ENST00000229769:synonymous:LOW:exon2/10:c.387A>C:p.Pro129Pro		rs4713867	0.7780	0.7211	31791,15371,3918	0.8694,0.8254,0.6838,0.6807,0.7478	0.7434							613976 [FANCE (provisional) Fanconi anemia,complementation group E,600901];	RCV000246343.1 [benign]; RCV000357472.1 [benign]; 			1836	1724	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCE (inh=AR pLI=0.00)
chr6	42931628	42931631	TTTA	-	het	low_DP;anno_omim	QUAL=525;DP=7;AF=0.29;MQM=58;TRIO=HET,7,0.29,WT,16,0.00,HOM,19,1.00	PEX6	3'UTR	PEX6:ENST00000304611:3'UTR:MODIFIER:exon17/17:c.*442_*445delTAAA:		rs144286892	0.6474	0.0000	0,0,0	0,0,0,0,0	0.6422							606628 [GNMT (provisional) Glycine N-methyltransferase deficiency,606664]:601498 [PEX6 (confirmed) Peroxisome biogenesis disorder 4A (Zellweger),614862|Peroxisome biogenesis disorder 4B,614863|Heimler syndrome 2,616617];	RCV000360304.1 [benign]; 			84	69					PEX6 (inh=AR pLI=0.00)
chr6	42932200	42932200	G	T	het	pred_pathogenic;anno_omim	QUAL=2505;DP=99;AF=0.45;MQM=60;TRIO=HET,99,0.45,WT,69,0.00,HET,71,0.97	PEX6	missense,3'UTR	PEX6:ENST00000304611:missense:MODERATE:exon17/17:c.2816C>A:p.Pro939Gln,PEX6:ENST00000244546:3'UTR:MODIFIER:exon15/15:c.*352C>A:		rs1129187	0.3315	0.3911	9823,6476,723	0.3784,0.2515,0.1023,0.4453,0.4237	0.4000	0.2320	T	T	B	D	14.40	601498 [PEX6 (confirmed) Peroxisome biogenesis disorder 4A (Zellweger),614862|Peroxisome biogenesis disorder 4B,614863|Heimler syndrome 2,616617];	RCV000078574.6 [benign]; RCV000407233.1 [benign]; 		COSM1444600	412	1032	2	[2] auto-classification 15.09.2017  			PEX6 (inh=AR pLI=0.00)
chr6	42932202	42932202	C	T	het	anno_omim	QUAL=2505;DP=99;AF=0.45;MQM=60;TRIO=HET,99,0.45,WT,69,0.00,HOM,71,0.97	PEX6	synonymous,3'UTR	PEX6:ENST00000304611:synonymous:LOW:exon17/17:c.2814G>A:p.Glu938Glu,PEX6:ENST00000244546:3'UTR:MODIFIER:exon15/15:c.*350G>A:		rs1129186	0.4936	0.4911	15519,8954,2749	0.7339,0.3045,0.1904,0.5230,0.5099	0.5511							601498 [PEX6 (confirmed) Peroxisome biogenesis disorder 4A (Zellweger),614862|Peroxisome biogenesis disorder 4B,614863|Heimler syndrome 2,616617];	RCV000078573.6 [benign]; RCV000292393.1 [benign]; 		COSM1444601	602	997	2	[2] auto-classification 15.09.2017  			PEX6 (inh=AR pLI=0.00)
chr6	42942779	42942779	A	G	het	anno_omim	QUAL=7160;DP=188;AF=0.51;MQM=60;TRIO=HET,188,0.51,WT,242,0.00,HET,339,0.54	PEX6	splice_region&intron	PEX6:ENST00000304611:splice_region&intron:LOW:exon1/16:c.883-3T>C:,PEX6:ENST00000244546:splice_region&intron:LOW:exon1/14:c.883-3T>C:		rs9986447	0.2897	0.3776	9493,6582,266	0.2316,0.2475,0.1028,0.4441,0.4231	0.3742							601498 [PEX6 (confirmed) Peroxisome biogenesis disorder 4A (Zellweger),614862|Peroxisome biogenesis disorder 4B,614863|Heimler syndrome 2,616617];	RCV000078578.5 [benign]; RCV000296765.1 [benign]; 			414	1032	2	[2] auto-classification 15.09.2017  			PEX6 (inh=AR pLI=0.00)
chr6	42946490	42946490	C	A	het	anno_omim	QUAL=1692;DP=75;AF=0.44;MQM=59;TRIO=HET,75,0.44,WT,68,0.01,HET,88,0.57	PEX6	synonymous	PEX6:ENST00000304611:synonymous:LOW:exon1/17:c.399G>T:p.Val133Val,PEX6:ENST00000244546:synonymous:LOW:exon1/15:c.399G>T:p.Val133Val		rs9462858	0.3319	0.4494	1242,436,36	0.4652,0.0000,0.1473,0.4904,0.4356	0.4011							601498 [PEX6 (confirmed) Peroxisome biogenesis disorder 4A (Zellweger),614862|Peroxisome biogenesis disorder 4B,614863|Heimler syndrome 2,616617];	RCV000078576.6 [benign]; RCV000288691.1 [benign]; 		COSM3749975	418	1015	2	[2] auto-classification 15.09.2017  			PEX6 (inh=AR pLI=0.00)
chr6	42946943	42946943	G	A	het	anno_omim	QUAL=5954;DP=212;AF=0.41;MQM=60;TRIO=HET,212,0.41,WT,225,0.00,HET,348,0.48	PEX6	5'UTR	PEX6:ENST00000304611:5'UTR:MODIFIER:exon1/17:c.-55C>T:		rs9462859	0.3339	0.0000	0,0,0	0,0,0,0,0	0.4026							601498 [PEX6 (confirmed) Peroxisome biogenesis disorder 4A (Zellweger),614862|Peroxisome biogenesis disorder 4B,614863|Heimler syndrome 2,616617];	RCV000408150.1 [benign]; 			372	816					PEX6 (inh=AR pLI=0.00)
chr6	43584323	43584323	-	A	het	anno_omim	QUAL=2288;DP=187;AF=0.29;MQM=59;TRIO=HET,187,0.29,WT,108,0.09,HOM,138,0.57	POLH,GTPBP2	intron	POLH:ENST00000535400:intron:MODIFIER:exon10/10:c.*164+1879dupA:	AluSg4	rs368089629	0.1971	0.0000	0,0,0	0,0,0,0,0	0.2919							603968 [POLH (confirmed) Xeroderma pigmentosum,variant type,278750];	RCV000266624.1 [benign]; 			9	52					POLH (inh=AR pLI=0.00), GTPBP2 (inh=n/a pLI=0.88)
chr6	49398861	49398861	T	C	hom	anno_omim	QUAL=15901;DP=227;AF=1.00;MQM=60;TRIO=HOM,227,1.00,HOM,174,0.99,HET,192,0.51	MUT	3'UTR	MUT:ENST00000274813:3'UTR:MODIFIER:exon13/13:c.*580A>G:		rs11757098	0.1136	0.0000	0,0,0	0,0,0,0,0	0.1105							609058 [MUT (confirmed) Methylmalonic aciduria,mut(0) type,251000];	RCV000356186.1 [likely benign]; 			7	51					MUT (inh=AR pLI=0.00)
chr6	49399315	49399315	T	C	het	anno_omim	QUAL=3475;DP=214;AF=0.47;MQM=60;TRIO=HET,214,0.47,HET,87,0.39,WT,104,0.00	MUT	3'UTR	MUT:ENST00000274813:3'UTR:MODIFIER:exon13/13:c.*126A>G:		rs192605776	0.0014	0.0000	0,0,0	0,0,0,0,0	0.0027							609058 [MUT (confirmed) Methylmalonic aciduria,mut(0) type,251000];	RCV000328175.1 [uncertain significance]; 			0	4					MUT (inh=AR pLI=0.00)
chr6	49403282	49403282	T	C	hom	pred_pathogenic;anno_omim	QUAL=18083;DP=308;AF=1.00;MQM=60;TRIO=HOM,308,1.00,HOM,173,1.00,HET,233,0.44	MUT	missense	MUT:ENST00000274813:missense:MODERATE:exon12/13:c.2011A>G:p.Ile671Val		rs8589	0.5495	0.5768	20583,12465,1819	0.5992,0.2938,0.4755,0.6154,0.6514	0.6019	3.8290	T,T	T	B	D	3.02	609058 [MUT (confirmed) Methylmalonic aciduria,mut(0) type,251000];	RCV000078444.5 [benign]; RCV000372712.1 [benign]; 	CM0911477 [CLASS=R MUT=ALT PHEN="Methylmalonic aciduria" GENE=MUT]; 	COSM4004063	802	983	2	[2] Ute Grasshoff 28.10.2015			MUT (inh=AR pLI=0.00)
chr6	49425521	49425521	C	T	hom	anno_omim	QUAL=28703;DP=570;AF=0.99;MQM=60;TRIO=HOM,570,0.99,HOM,235,1.00,HET,323,0.46	MUT	synonymous	MUT:ENST00000274813:synonymous:LOW:exon3/13:c.636G>A:p.Lys212Lys		rs2229384	0.5515	0.5736	20580,12475,1731	0.5800,0.2897,0.4905,0.6126,0.6504	0.5984							609058 [MUT (confirmed) Methylmalonic aciduria,mut(0) type,251000];	RCV000078447.6 [benign]; RCV000276310.1 [benign]; 			988	1221	2	[2] auto-classification 15.09.2017  			MUT (inh=AR pLI=0.00)
chr6	51480486	51480486	G	T	hom	anno_omim	QUAL=15885;DP=205;AF=1.00;MQM=60;TRIO=HOM,205,1.00,HET,172,0.55,HOM,213,1.00	PKHD1,RP3-335N17.2	3'UTR	PKHD1:ENST00000371117:3'UTR:MODIFIER:exon67/67:c.*3393C>A:		rs2784198	0.6867	0.0000	0,0,0	0,0,0,0,0	0.6411							606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease,263200];	RCV000266442.1 [benign]; 			83	109					PKHD1 (inh=AR pLI=0.00), RP3-335N17.2 (inh=n/a pLI=n/a)
chr6	51480853	51480853	T	C	hom	anno_omim	QUAL=10185;DP=210;AF=1.00;MQM=59;TRIO=HOM,210,1.00,HET,56,0.48,HOM,91,0.98	PKHD1,RP3-335N17.2	3'UTR	PKHD1:ENST00000371117:3'UTR:MODIFIER:exon67/67:c.*3026A>G:		rs2784199	0.7548	0.0000	0,0,0	0,0,0,0,0	0.7073							606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease,263200];	RCV000318185.1 [benign]; 			98	101					PKHD1 (inh=AR pLI=0.00), RP3-335N17.2 (inh=n/a pLI=n/a)
chr6	51481315	51481315	T	C	hom	anno_omim	QUAL=15904;DP=299;AF=1.00;MQM=59;TRIO=HOM,299,1.00,HET,127,0.51,HOM,156,1.00	PKHD1,RP3-335N17.2	3'UTR	PKHD1:ENST00000371117:3'UTR:MODIFIER:exon67/67:c.*2564A>G:		rs1414504	0.8834	0.0000	0,0,0	0,0,0,0,0	0.8884							606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease,263200];	RCV000348066.1 [benign]; 			171	52					PKHD1 (inh=AR pLI=0.00), RP3-335N17.2 (inh=n/a pLI=n/a)
chr6	51481671	51481671	T	C	het	anno_omim	QUAL=6272;DP=349;AF=0.48;MQM=60;TRIO=HET,349,0.48,WT,106,0.00,HET,151,0.47	PKHD1,RP3-335N17.2	3'UTR	PKHD1:ENST00000371117:3'UTR:MODIFIER:exon67/67:c.*2208A>G:	L2	rs2784200	0.1316	0.0000	0,0,0	0,0,0,0,0	0.1274							606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease,263200];	RCV000304505.1 [likely benign]; 			5	40					PKHD1 (inh=AR pLI=0.00), RP3-335N17.2 (inh=n/a pLI=n/a)
chr6	51483505	51483505	A	G	hom	anno_omim	QUAL=63772;DP=859;AF=1.00;MQM=60;TRIO=HOM,859,1.00,HOM,469,1.00,HOM,585,1.00	PKHD1,RP3-335N17.2	3'UTR	PKHD1:ENST00000371117:3'UTR:MODIFIER:exon67/67:c.*374T>C:		rs2784201	0.9968	0.0000	0,0,0	0,0,0,0,0	0.9964							606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease,263200];	RCV000273846.1 [benign]; 			231	1					PKHD1 (inh=AR pLI=0.00), RP3-335N17.2 (inh=n/a pLI=n/a)
chr6	51483961	51483961	T	C	het	pred_pathogenic;anno_omim	QUAL=11232;DP=436;AF=0.50;MQM=59;TRIO=HET,436,0.50,HET,169,0.54,HET,237,0.50	PKHD1,RP3-335N17.2	missense	PKHD1:ENST00000371117:missense:MODERATE:exon67/67:c.12143A>G:p.Gln4048Arg		rs9381994	0.5657	0.5630	19326,9873,1178	0.4771,0.6559,0.5727,0.5453,0.6327	0.5669	0.4300	T	T	B	D	21.60	606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease,263200];	RCV000082526.6 [benign]; RCV000325223.1 [benign]; 	CM1513513 [CLASS=R MUT=ALT PHEN="Polycystic kidney disease" GENE=PKHD1]; 	COSM1445058	653	1117	2	[2] auto-classification 15.09.2017  			PKHD1 (inh=AR pLI=0.00), RP3-335N17.2 (inh=n/a pLI=n/a)
chr6	51491884	51491884	T	C	het	pred_pathogenic;anno_omim	QUAL=7382;DP=219;AF=0.47;MQM=60;TRIO=HET,219,0.47,HET,171,0.54,HET,214,0.46	PKHD1	missense	PKHD1:ENST00000371117:missense:MODERATE:exon66/67:c.11696A>G:p.Gln3899Arg		rs4715227	0.5533	0.5550	18800,9647,1205	0.4797,0.6500,0.5441,0.5390,0.6207	0.5591	1.9650	D	T	B	D	19.85	606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease,263200];	RCV000082522.6 [benign]; RCV000376208.1 [benign]; 		COSM4004068	625	1119	2	[2] auto-classification 15.09.2017  			PKHD1 (inh=AR pLI=0.00)
chr6	51586771	51586771	G	A	hom	anno_omim	QUAL=15803;DP=307;AF=0.47;MQM=60;TRIO=HOM,307,0.99,HET,218,0.53,HET,297,0.51	PKHD1	3'UTR,intron	PKHD1:ENST00000340994:3'UTR:MODIFIER:exon61/61:c.*13C>T:,PKHD1:ENST00000371117:intron:MODIFIER:exon60/66:c.10156+22412C>T:		rs9349593	0.7660	0.6506	26722,9600,3178	0.7827,0.8038,0.8981,0.5373,0.7749	0.6598							606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease,263200];				717	988					PKHD1 (inh=AR pLI=0.00)
chr6	51586772	51586772	C	T	het	anno_omim	QUAL=15803;DP=307;AF=0.47;MQM=59;TRIO=HET,307,0.99,HET,218,0.53,WT,297,0.51	PKHD1	3'UTR,intron	PKHD1:ENST00000340994:3'UTR:MODIFIER:exon61/61:c.*12G>A:,PKHD1:ENST00000371117:intron:MODIFIER:exon60/66:c.10156+22411G>A:		rs45451196	0.2194	0.1691	1988,724,757	0.3801,0.1314,0.0890,0.1516,0.1722	0.2167							606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease,263200];			COSN167788	64	561					PKHD1 (inh=AR pLI=0.00)
chr6	51613177	51613177	C	T	het	anno_omim	QUAL=7691;DP=222;AF=0.54;MQM=59;TRIO=HET,222,0.54,WT,264,0.00,HET,330,0.53	PKHD1	synonymous	PKHD1:ENST00000371117:synonymous:LOW:exon58/67:c.9237G>A:p.Ala3079Ala,PKHD1:ENST00000340994:synonymous:LOW:exon58/61:c.9237G>A:p.Ala3079Ala		rs765525	0.3860	0.4041	11292,4413,49	0.0889,0.5820,0.7055,0.3620,0.4897	0.4204							606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease,263200];	RCV000082591.6 [benign]; RCV000351510.1 [benign]; 			294	964	2	[2] auto-classification 15.09.2017  			PKHD1 (inh=AR pLI=0.00)
chr6	51732807	51732807	C	T	hom	anno_omim	QUAL=21165;DP=269;AF=1.00;MQM=60;TRIO=HOM,269,1.00,HOM,158,0.99,HOM,228,1.00	PKHD1	synonymous	PKHD1:ENST00000371117:synonymous:LOW:exon48/67:c.7587G>A:p.Gly2529Gly,PKHD1:ENST00000340994:synonymous:LOW:exon48/61:c.7587G>A:p.Gly2529Gly		rs12210295	0.3676	0.5067	17299,13446,613	0.3433,0.3058,0.1220,0.6346,0.4333	0.4995							606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease,263200];	RCV000082571.6 [benign]; RCV000273935.1 [benign]; 		COSM1179828, COSM1179827	870	1016	2	[2] auto-classification 15.09.2017  			PKHD1 (inh=AR pLI=0.00)
chr6	51875250	51875250	A	C	hom	pred_pathogenic;anno_omim	QUAL=24114;DP=193;AF=1.00;MQM=60;TRIO=HOM,193,1.00,HOM,232,1.00,HOM,334,1.00	PKHD1	missense	PKHD1:ENST00000371117:missense:MODERATE:exon35/67:c.5608T>G:p.Leu1870Val,PKHD1:ENST00000340994:missense:MODERATE:exon35/61:c.5608T>G:p.Leu1870Val		rs2435322	0.9559	0.9872	59245,33342,3858	0.8610,0.9933,1.0000,0.9996,0.9999	0.9899	5.0500	T,T,T	T	B,B	D,D	3.30	606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease,263200];	RCV000082560.6 [benign]; RCV000329286.1 [benign]; 	CM1513512 [CLASS=R MUT=ALT PHEN="Polycystic kidney disease" GENE=PKHD1]; 		2194	12	2	[2] auto-classification 15.09.2017  			PKHD1 (inh=AR pLI=0.00)
chr6	51890823	51890823	G	A	hom	pred_pathogenic;anno_omim	QUAL=16326;DP=248;AF=1.00;MQM=59;TRIO=HOM,248,1.00,HET,159,0.55,HOM,229,0.99	PKHD1	missense	PKHD1:ENST00000371117:missense:MODERATE:exon32/67:c.3785C>T:p.Ala1262Val,PKHD1:ENST00000340994:missense:MODERATE:exon32/61:c.3785C>T:p.Ala1262Val		rs9296669	0.3546	0.4698	14368,9136,109	0.1530,0.6659,0.3563,0.5252,0.3601	0.4799	0.2650	T,T,T	T	B,B	D,D	0.16	606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease,263200];	RCV000082549.6 [benign]; RCV000282648.1 [benign]; 		COSM4004073, COSM4004072	566	1045	2	[2] auto-classification 15.09.2017  			PKHD1 (inh=AR pLI=0.00)
chr6	51890852	51890852	C	G	het	anno_omim	QUAL=6389;DP=213;AF=0.52;MQM=59;TRIO=HET,213,0.52,WT,174,0.00,HET,288,0.50	PKHD1	synonymous	PKHD1:ENST00000371117:synonymous:LOW:exon32/67:c.3756G>C:p.Leu1252Leu,PKHD1:ENST00000340994:synonymous:LOW:exon32/61:c.3756G>C:p.Leu1252Leu		rs9689306	0.0186	0.0379	144,123,0	0.0093,0.0235,0.0002,0.0562,0.0091	0.0390							606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease,263200];	RCV000153717.4 [benign]; RCV000314391.1 [likely benign]; 		COSM3762128, COSM3762127	4	158					PKHD1 (inh=AR pLI=0.00)
chr6	51893107	51893107	T	C	het	pred_pathogenic;anno_omim;anno_pathogenic_hgmd	QUAL=5549;DP=290;AF=0.49;MQM=60;TRIO=HET,290,0.49,HET,154,0.53,WT,188,0.00	PKHD1	missense	PKHD1:ENST00000371117:missense:MODERATE:exon30/67:c.3407A>G:p.Tyr1136Cys,PKHD1:ENST00000340994:missense:MODERATE:exon30/61:c.3407A>G:p.Tyr1136Cys		rs41273726	0.0026	0.0079	14,12,0	0.0014,0.0019,0.0001,0.0119,0.0022	0.0133	-0.0620	T,T,T	T	P,P	D,D	0.07	606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease,263200];	RCV000153718.4 [other]; RCV000168029.3 [other]; RCV000224414.1 [likely benign]; 	CM051142 [CLASS=DM? MUT=ALT PHEN="Polycystic kidney disease" GENE=PKHD1]; 		2	67	3	[3] auto-classification 15.09.2017  			PKHD1 (inh=AR pLI=0.00)
chr6	51914956	51914956	G	A	hom	pred_pathogenic;anno_omim	QUAL=5159;DP=96;AF=1.00;MQM=60;TRIO=HOM,96,1.00,HET,51,0.43,HOM,59,1.00	PKHD1	missense&splice_region	PKHD1:ENST00000371117:missense&splice_region:MODERATE:exon22/67:c.2278C>T:p.Arg760Cys,PKHD1:ENST00000340994:missense&splice_region:MODERATE:exon22/61:c.2278C>T:p.Arg760Cys		rs9370096	0.3558	0.4652	14183,8985,110	0.1534,0.6698,0.3764,0.5198,0.3375	0.4771	-0.4870	T,T,T	T	B,B	D,D	18.79	606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease,263200];	RCV000082536.6 [benign]; RCV000278857.1 [benign]; 			559	1045	2	[2] auto-classification 15.09.2017  			PKHD1 (inh=AR pLI=0.00)
chr6	51924774	51924774	A	G	hom	anno_omim	QUAL=25599;DP=327;AF=1.00;MQM=60;TRIO=HOM,327,1.00,HOM,188,1.00,HOM,270,1.00	PKHD1	synonymous	PKHD1:ENST00000371117:synonymous:LOW:exon15/67:c.1185T>C:p.Asp395Asp,PKHD1:ENST00000340994:synonymous:LOW:exon15/61:c.1185T>C:p.Asp395Asp		rs1896976	0.9583	0.9883	59343,33329,3980	0.8757,0.9927,1.0000,0.9995,0.9999	0.9906							606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease,263200];	RCV000082524.6 [benign]; RCV000169626.2 [benign]; 			2192	14	2	[2] auto-classification 15.09.2017  			PKHD1 (inh=AR pLI=0.00)
chr6	52357260	52357260	C	A	hom	anno_omim	QUAL=14733;DP=202;AF=1.00;MQM=60;TRIO=HOM,202,1.00,HOM,128,1.00,HOM,139,1.00	EFHC1	3'UTR,intron	EFHC1:ENST00000371068:3'UTR:MODIFIER:exon11/11:c.*121C>A:,EFHC1:ENST00000538167:3'UTR:MODIFIER:exon11/11:c.*121C>A:,EFHC1:ENST00000433625:intron:MODIFIER:exon10/10:c.1578+2112C>A:		rs7757370	0.9000	0.8947	11217,4932,959	0.8517,0.9178,0.9732,0.8791,0.9148	0.8940							608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1,254770|Epilepsy,juvenile absence,susceptibility to,1,607631];	RCV000353494.1 [benign]; 			491	141					EFHC1 (inh=n/a pLI=0.00)
chr6	52358010	52358010	C	G	het	anno_omim	QUAL=5830;DP=142;AF=0.45;MQM=59;TRIO=HET,142,0.45,HOM,137,1.00,WT,169,0.00	EFHC1	3'UTR,intron	EFHC1:ENST00000371068:3'UTR:MODIFIER:exon11/11:c.*871C>G:,EFHC1:ENST00000538167:3'UTR:MODIFIER:exon11/11:c.*871C>G:,EFHC1:ENST00000433625:intron:MODIFIER:exon10/10:c.1578+2862C>G:	MLT2B4	rs78956562	0.1721	0.1754	180,30,0	0.0000,0.0000,0.0000,0.1515,0.1833	0.1524							608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1,254770|Epilepsy,juvenile absence,susceptibility to,1,607631];	RCV000326025.1 [likely benign]; 			14	123					EFHC1 (inh=n/a pLI=0.00)
chr6	52358020	52358020	A	T	hom	anno_omim	QUAL=13286;DP=134;AF=1.00;MQM=59;TRIO=HOM,134,1.00,HOM,137,1.00,HOM,159,1.00	EFHC1	3'UTR,intron	EFHC1:ENST00000371068:3'UTR:MODIFIER:exon11/11:c.*881A>T:,EFHC1:ENST00000538167:3'UTR:MODIFIER:exon11/11:c.*881A>T:,EFHC1:ENST00000433625:intron:MODIFIER:exon10/10:c.1578+2872A>T:	MLT2B4	rs6926242	0.9331	0.9020	4405,1019,76	0.0000,0.0000,0.0000,0.8637,0.9155	0.9139							608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1,254770|Epilepsy,juvenile absence,susceptibility to,1,607631];	RCV000385142.1 [likely benign]; 			447	123					EFHC1 (inh=n/a pLI=0.00)
chr6	52358319	52358319	G	A	hom	anno_omim	QUAL=5762;DP=103;AF=0.98;MQM=59;TRIO=HOM,103,0.98,HOM,46,1.00,HOM,50,1.00	EFHC1	3'UTR,intron	EFHC1:ENST00000371068:3'UTR:MODIFIER:exon11/11:c.*1180G>A:,EFHC1:ENST00000538167:3'UTR:MODIFIER:exon11/11:c.*1180G>A:,EFHC1:ENST00000433625:intron:MODIFIER:exon10/10:c.1578+3171G>A:	AluSx	rs4455668	0.9000	0.8945	3309,807,57	0.0000,0.0000,0.0000,0.8614,0.9085	0.8935							608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1,254770|Epilepsy,juvenile absence,susceptibility to,1,607631];	RCV000329068.1 [benign]; 			456	130					EFHC1 (inh=n/a pLI=0.00)
chr6	52358453	52358453	-	A	het	anno_omim	QUAL=4445;DP=213;AF=0.41;MQM=59;TRIO=HET,213,0.41,HOM,116,0.84,WT,170,0.01	EFHC1	3'UTR,intron	EFHC1:ENST00000371068:3'UTR:MODIFIER:exon11/11:c.*1325dupA:,EFHC1:ENST00000538167:3'UTR:MODIFIER:exon11/11:c.*1325dupA:,EFHC1:ENST00000433625:intron:MODIFIER:exon10/10:c.1578+3316dupA:	AluSx	rs35994917;rs539728759	0.2278	0.3281	4,0,0	0.0000,0.0000,0.0000,0.3212,0.3310	0.3439							608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1,254770|Epilepsy,juvenile absence,susceptibility to,1,607631];	RCV000383689.1 [likely benign]; 			7	157					EFHC1 (inh=n/a pLI=0.00)
chr6	52358887	52358887	-	CA	hom	anno_omim	QUAL=18566;DP=269;AF=0.95;MQM=59;TRIO=HOM,269,0.95,HOM,156,0.99,HOM,206,0.97	EFHC1	3'UTR,intron	EFHC1:ENST00000371068:3'UTR:MODIFIER:exon11/11:c.*1749_*1750insAC:,EFHC1:ENST00000538167:3'UTR:MODIFIER:exon11/11:c.*1749_*1750insAC:,EFHC1:ENST00000433625:intron:MODIFIER:exon10/10:c.1578+3740_1578+3741insAC:		rs58779695;rs77236493	0.8996	0.8983	4372,1014,65	0.0000,0.0000,0.0000,0.8618,0.9129	0.8958							608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1,254770|Epilepsy,juvenile absence,susceptibility to,1,607631];				482	152					EFHC1 (inh=n/a pLI=0.00)
chr6	52360283	52360283	T	A	hom	anno_omim	QUAL=20852;DP=322;AF=1.00;MQM=60;TRIO=HOM,322,1.00,HOM,214,1.00,HET,287,0.47	EFHC1	3'UTR,intron	EFHC1:ENST00000371068:3'UTR:MODIFIER:exon11/11:c.*3144T>A:,EFHC1:ENST00000538167:3'UTR:MODIFIER:exon11/11:c.*3144T>A:,EFHC1:ENST00000433625:intron:MODIFIER:exon10/10:c.1578+5135T>A:	LTR78	rs3789772	0.6991	0.6546	2355,587,46	0.0000,0.0000,0.0000,0.6574,0.6512	0.7031							608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1,254770|Epilepsy,juvenile absence,susceptibility to,1,607631];	RCV000365942.1 [likely benign]; 			280	248					EFHC1 (inh=n/a pLI=0.00)
chr6	52360545	52360545	T	C	het	anno_omim	QUAL=10124;DP=439;AF=0.49;MQM=59;TRIO=HET,439,0.49,WT,263,0.00,HET,366,0.47	EFHC1	3'UTR,intron	EFHC1:ENST00000371068:3'UTR:MODIFIER:exon11/11:c.*3406T>C:,EFHC1:ENST00000538167:3'UTR:MODIFIER:exon11/11:c.*3406T>C:,EFHC1:ENST00000433625:intron:MODIFIER:exon10/10:c.1578+5397T>C:		rs6919266	0.2794	0.4492	16,7,1	0.0000,0.0000,0.0000,0.0000,0.0000	0.3808							608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1,254770|Epilepsy,juvenile absence,susceptibility to,1,607631];	RCV000303058.1 [likely benign]; 			109	264					EFHC1 (inh=n/a pLI=0.00)
chr6	81053642	81053642	G	A	hom	anno_omim	QUAL=28010;DP=455;AF=1.00;MQM=60;TRIO=HOM,455,1.00,HOM,279,1.00,HET,342,0.46	BCKDHB	3'UTR,intron	BCKDHB:ENST00000320393:3'UTR:MODIFIER:exon10/10:c.*121G>A:,BCKDHB:ENST00000545529:3'UTR:MODIFIER:exon11/11:c.*737G>A:,BCKDHB:ENST00000356489:intron:MODIFIER:exon10/10:c.*8+113G>A:		rs926733	0.7151	0.0000	0,0,0	0,0,0,0,0	0.7765							248611 [BCKDHB (confirmed) Maple syrup urine disease,type Ib,248600];	RCV000338517.1 [benign]; 			152	54					BCKDHB (inh=AR pLI=0.00)
chr6	81053717	81053719	TTG	-	hom	anno_omim	QUAL=8662;DP=210;AF=0.98;MQM=59;TRIO=HOM,210,0.98,HOM,78,1.00,HET,93,0.43	BCKDHB	3'UTR,intron	BCKDHB:ENST00000320393:3'UTR:MODIFIER:exon10/10:c.*210_*212delGTT:,BCKDHB:ENST00000545529:3'UTR:MODIFIER:exon11/11:c.*826_*828delGTT:,BCKDHB:ENST00000356489:intron:MODIFIER:exon10/10:c.*8+202_*8+204delGTT:	AluSx1	rs869224641	0.0000	0.0000	0,0,0	0,0,0,0,0	0.7750							248611 [BCKDHB (confirmed) Maple syrup urine disease,type Ib,248600];				153	54					BCKDHB (inh=AR pLI=0.00)
chr6	81053814	81053814	T	C	hom	anno_omim	QUAL=4791;DP=92;AF=0.98;MQM=56;TRIO=HOM,92,0.98,HOM,52,1.00,HET,56,0.41	BCKDHB	3'UTR,intron	BCKDHB:ENST00000320393:3'UTR:MODIFIER:exon10/10:c.*293T>C:,BCKDHB:ENST00000545529:3'UTR:MODIFIER:exon11/11:c.*909T>C:,BCKDHB:ENST00000356489:intron:MODIFIER:exon10/10:c.*8+285T>C:	AluSx1	rs926732	0.7155	0.0000	0,0,0	0,0,0,0,0	0.7757							248611 [BCKDHB (confirmed) Maple syrup urine disease,type Ib,248600];	RCV000312717.1 [benign]; 			131	38					BCKDHB (inh=AR pLI=0.00)
chr6	81053825	81053825	G	A	hom	anno_omim	QUAL=4332;DP=77;AF=0.99;MQM=54;TRIO=HOM,77,0.99,HOM,50,1.00,HET,50,0.46	BCKDHB	3'UTR,intron	BCKDHB:ENST00000320393:3'UTR:MODIFIER:exon10/10:c.*304G>A:,BCKDHB:ENST00000545529:3'UTR:MODIFIER:exon11/11:c.*920G>A:,BCKDHB:ENST00000356489:intron:MODIFIER:exon10/10:c.*8+296G>A:	AluSx1	rs926731	0.7159	0.0000	0,0,0	0,0,0,0,0	0.7758							248611 [BCKDHB (confirmed) Maple syrup urine disease,type Ib,248600];	RCV000348834.1 [benign]; 			132	38					BCKDHB (inh=AR pLI=0.00)
chr6	81053866	81053866	C	T	hom	anno_omim	QUAL=5283;DP=139;AF=0.99;MQM=55;TRIO=HOM,139,0.99,HOM,34,1.00,HET,29,0.38	BCKDHB	3'UTR,intron	BCKDHB:ENST00000320393:3'UTR:MODIFIER:exon10/10:c.*345C>T:,BCKDHB:ENST00000545529:3'UTR:MODIFIER:exon11/11:c.*961C>T:,BCKDHB:ENST00000356489:intron:MODIFIER:exon10/10:c.*8+337C>T:	AluSx1	rs1811844	0.5899	0.0000	0,0,0	0,0,0,0,0	0.6703							248611 [BCKDHB (confirmed) Maple syrup urine disease,type Ib,248600];	RCV000389995.1 [benign]; 			133	41					BCKDHB (inh=AR pLI=0.00)
chr6	81053916	81053916	G	T	hom	anno_omim	QUAL=4782;DP=148;AF=0.99;MQM=59;TRIO=HOM,148,0.99,HOM,12,1.00,HET,15,0.33	BCKDHB	3'UTR,intron	BCKDHB:ENST00000320393:3'UTR:MODIFIER:exon10/10:c.*395G>T:,BCKDHB:ENST00000545529:3'UTR:MODIFIER:exon11/11:c.*1011G>T:,BCKDHB:ENST00000356489:intron:MODIFIER:exon10/10:c.*8+387G>T:	AluSx1	rs4706116	0.9585	0.0000	0,0,0	0,0,0,0,0	0.9592							248611 [BCKDHB (confirmed) Maple syrup urine disease,type Ib,248600];	RCV000314077.1 [benign]; 			165	16					BCKDHB (inh=AR pLI=0.00)
chr6	81054066	81054067	TT	-	hom	low_DP;anno_omim	QUAL=139;DP=12;AF=0.83;MQM=58;TRIO=HOM,12,0.83,WT,12,1.00,HET,2,1.00	BCKDHB	3'UTR,intron	BCKDHB:ENST00000320393:3'UTR:MODIFIER:exon10/10:c.*559_*560delTT:,BCKDHB:ENST00000545529:3'UTR:MODIFIER:exon11/11:c.*1175_*1176delTT:,BCKDHB:ENST00000356489:intron:MODIFIER:exon10/10:c.*8+551_*8+552delTT:	AluSc	rs869223033	0.8930	0.0000	0,0,0	0,0,0,0,0	0.7216							248611 [BCKDHB (confirmed) Maple syrup urine disease,type Ib,248600];	RCV000264302.1 [benign]; 			91	10					BCKDHB (inh=AR pLI=0.00)
chr6	81054148	81054148	T	C	hom	anno_omim	QUAL=2388;DP=71;AF=1.00;MQM=57;TRIO=HOM,71,1.00,HOM,5,1.00,HET,19,0.53	BCKDHB	3'UTR,intron	BCKDHB:ENST00000320393:3'UTR:MODIFIER:exon10/10:c.*627T>C:,BCKDHB:ENST00000545529:3'UTR:MODIFIER:exon11/11:c.*1243T>C:,BCKDHB:ENST00000356489:intron:MODIFIER:exon10/10:c.*8+619T>C:	AluSc	rs4706838	0.7153	0.0000	0,0,0	0,0,0,0,0	0.7765							248611 [BCKDHB (confirmed) Maple syrup urine disease,type Ib,248600];	RCV000324200.1 [benign]; 			133	39					BCKDHB (inh=AR pLI=0.00)
chr6	81054252	81054252	C	T	hom	anno_omim	QUAL=4916;DP=92;AF=1.00;MQM=51;TRIO=HOM,92,1.00,HOM,58,1.00,HET,66,0.44	BCKDHB	3'UTR,intron	BCKDHB:ENST00000320393:3'UTR:MODIFIER:exon10/10:c.*731C>T:,BCKDHB:ENST00000545529:3'UTR:MODIFIER:exon11/11:c.*1347C>T:,BCKDHB:ENST00000356489:intron:MODIFIER:exon10/10:c.*8+723C>T:	AluSc	rs4706117	0.3998	0.0000	0,0,0	0,0,0,0,0	0.3964							248611 [BCKDHB (confirmed) Maple syrup urine disease,type Ib,248600];	RCV000315644.1 [benign]; 			55	86					BCKDHB (inh=AR pLI=0.00)
chr6	81054310	81054310	C	T	hom	anno_omim	QUAL=7972;DP=125;AF=0.99;MQM=56;TRIO=HOM,125,0.99,HOM,98,1.00,HET,138,0.43	BCKDHB	3'UTR,intron	BCKDHB:ENST00000320393:3'UTR:MODIFIER:exon10/10:c.*789C>T:,BCKDHB:ENST00000545529:3'UTR:MODIFIER:exon11/11:c.*1405C>T:,BCKDHB:ENST00000356489:intron:MODIFIER:exon10/10:c.*8+781C>T:	AluSc	rs4706118	0.7155	0.0000	0,0,0	0,0,0,0,0	0.7753							248611 [BCKDHB (confirmed) Maple syrup urine disease,type Ib,248600];	RCV000280897.1 [benign]; 			154	53					BCKDHB (inh=AR pLI=0.00)
chr6	81054326	81054326	T	C	hom	anno_omim	QUAL=8497;DP=114;AF=0.99;MQM=59;TRIO=HOM,114,0.99,HOM,113,1.00,HET,158,0.46	BCKDHB	3'UTR,intron	BCKDHB:ENST00000320393:3'UTR:MODIFIER:exon10/10:c.*805T>C:,BCKDHB:ENST00000545529:3'UTR:MODIFIER:exon11/11:c.*1421T>C:,BCKDHB:ENST00000356489:intron:MODIFIER:exon10/10:c.*8+797T>C:	AluSc	rs4706839	0.7155	0.0000	0,0,0	0,0,0,0,0	0.7752							248611 [BCKDHB (confirmed) Maple syrup urine disease,type Ib,248600];	RCV000349945.1 [benign]; 			159	52					BCKDHB (inh=AR pLI=0.00)
chr6	81054515	81054515	G	A	hom	anno_omim	QUAL=19876;DP=335;AF=1.00;MQM=60;TRIO=HOM,335,1.00,HOM,170,0.99,HET,255,0.46	BCKDHB	3'UTR,intron	BCKDHB:ENST00000320393:3'UTR:MODIFIER:exon10/10:c.*994G>A:,BCKDHB:ENST00000545529:3'UTR:MODIFIER:exon11/11:c.*1610G>A:,BCKDHB:ENST00000356489:intron:MODIFIER:exon10/10:c.*8+986G>A:		rs4502885	0.7153	0.0000	0,0,0	0,0,0,0,0	0.7766							248611 [BCKDHB (confirmed) Maple syrup urine disease,type Ib,248600];	RCV000306621.1 [benign]; 			159	61					BCKDHB (inh=AR pLI=0.00)
chr6	81054663	81054663	C	G	hom	anno_omim	QUAL=14710;DP=224;AF=1.00;MQM=60;TRIO=HOM,224,1.00,HOM,138,1.00,HET,178,0.53	BCKDHB	3'UTR,intron	BCKDHB:ENST00000320393:3'UTR:MODIFIER:exon10/10:c.*1142C>G:,BCKDHB:ENST00000545529:3'UTR:MODIFIER:exon11/11:c.*1758C>G:,BCKDHB:ENST00000356489:intron:MODIFIER:exon10/10:c.*9-1029C>G:		rs1042367	0.6887	0.0000	0,0,0	0,0,0,0,0	0.7558							248611 [BCKDHB (confirmed) Maple syrup urine disease,type Ib,248600];	RCV000397289.1 [benign]; 			159	60					BCKDHB (inh=AR pLI=0.00)
chr6	81054762	81054762	A	G	hom	anno_omim	QUAL=15976;DP=267;AF=1.00;MQM=60;TRIO=HOM,267,1.00,HOM,134,1.00,HET,187,0.53	BCKDHB	3'UTR,intron	BCKDHB:ENST00000320393:3'UTR:MODIFIER:exon10/10:c.*1241A>G:,BCKDHB:ENST00000545529:3'UTR:MODIFIER:exon11/11:c.*1857A>G:,BCKDHB:ENST00000356489:intron:MODIFIER:exon10/10:c.*9-930A>G:		rs1042368	0.7153	0.0000	0,0,0	0,0,0,0,0	0.7765							248611 [BCKDHB (confirmed) Maple syrup urine disease,type Ib,248600];	RCV000304701.1 [benign]; 			159	61					BCKDHB (inh=AR pLI=0.00)
chr6	81054965	81054965	T	C	hom	anno_omim	QUAL=12762;DP=306;AF=1.00;MQM=60;TRIO=HOM,306,1.00,HOM,43,1.00,HET,79,0.57	BCKDHB	3'UTR,intron	BCKDHB:ENST00000320393:3'UTR:MODIFIER:exon10/10:c.*1444T>C:,BCKDHB:ENST00000545529:3'UTR:MODIFIER:exon11/11:c.*2060T>C:,BCKDHB:ENST00000356489:intron:MODIFIER:exon10/10:c.*9-727T>C:		rs3805848	0.7153	0.0000	0,0,0	0,0,0,0,0	0.7765							248611 [BCKDHB (confirmed) Maple syrup urine disease,type Ib,248600];	RCV000260047.1 [benign]; 			158	62					BCKDHB (inh=AR pLI=0.00)
chr6	81055299	81055299	A	G	hom	anno_omim	QUAL=22313;DP=317;AF=1.00;MQM=59;TRIO=HOM,317,1.00,HOM,234,1.00,HET,309,0.51	BCKDHB	3'UTR,intron	BCKDHB:ENST00000320393:3'UTR:MODIFIER:exon10/10:c.*1778A>G:,BCKDHB:ENST00000545529:3'UTR:MODIFIER:exon11/11:c.*2394A>G:,BCKDHB:ENST00000356489:intron:MODIFIER:exon10/10:c.*9-393A>G:		rs7758761	0.7149	0.0000	0,0,0	0,0,0,0,0	0.7763							248611 [BCKDHB (confirmed) Maple syrup urine disease,type Ib,248600];	RCV000374633.1 [benign]; 			158	62					BCKDHB (inh=AR pLI=0.00)
chr6	81055331	81055331	T	C	hom	anno_omim	QUAL=23186;DP=352;AF=1.00;MQM=60;TRIO=HOM,352,1.00,HOM,230,1.00,HET,322,0.46	BCKDHB	3'UTR,intron	BCKDHB:ENST00000320393:3'UTR:MODIFIER:exon10/10:c.*1810T>C:,BCKDHB:ENST00000545529:3'UTR:MODIFIER:exon11/11:c.*2426T>C:,BCKDHB:ENST00000356489:intron:MODIFIER:exon10/10:c.*9-361T>C:		rs7740932	0.7153	0.0000	0,0,0	0,0,0,0,0	0.7765							248611 [BCKDHB (confirmed) Maple syrup urine disease,type Ib,248600];	RCV000330559.1 [benign]; 			158	62					BCKDHB (inh=AR pLI=0.00)
chr6	81055396	81055396	G	A	hom	anno_omim	QUAL=25947;DP=387;AF=1.00;MQM=59;TRIO=HOM,387,1.00,HOM,275,1.00,HET,409,0.49	BCKDHB	3'UTR,intron	BCKDHB:ENST00000320393:3'UTR:MODIFIER:exon10/10:c.*1875G>A:,BCKDHB:ENST00000545529:3'UTR:MODIFIER:exon11/11:c.*2491G>A:,BCKDHB:ENST00000356489:intron:MODIFIER:exon10/10:c.*9-296G>A:		rs7759304	0.7153	0.0000	0,0,0	0,0,0,0,0	0.7764							248611 [BCKDHB (confirmed) Maple syrup urine disease,type Ib,248600];	RCV000389776.1 [benign]; 			159	61					BCKDHB (inh=AR pLI=0.00)
chr6	81055413	81055413	T	C	hom	anno_omim	QUAL=27888;DP=420;AF=1.00;MQM=59;TRIO=HOM,420,1.00,HOM,286,1.00,HET,416,0.49	BCKDHB	3'UTR,intron	BCKDHB:ENST00000320393:3'UTR:MODIFIER:exon10/10:c.*1892T>C:,BCKDHB:ENST00000545529:3'UTR:MODIFIER:exon11/11:c.*2508T>C:,BCKDHB:ENST00000356489:intron:MODIFIER:exon10/10:c.*9-279T>C:		rs7740958	0.7153	0.0000	0,0,0	0,0,0,0,0	0.7764							248611 [BCKDHB (confirmed) Maple syrup urine disease,type Ib,248600];	RCV000295762.1 [benign]; 			159	61					BCKDHB (inh=AR pLI=0.00)
chr6	81055792	81055792	G	A	hom	anno_omim	QUAL=8195;DP=181;AF=1.00;MQM=60;TRIO=HOM,181,1.00,HOM,46,0.98,HET,50,0.44	BCKDHB	3'UTR	BCKDHB:ENST00000320393:3'UTR:MODIFIER:exon10/10:c.*2271G>A:,BCKDHB:ENST00000356489:3'UTR:MODIFIER:exon11/11:c.*109G>A:,BCKDHB:ENST00000545529:3'UTR:MODIFIER:exon11/11:c.*2887G>A:		rs15062	0.7159	0.0000	0,0,0	0,0,0,0,0	0.7767							248611 [BCKDHB (confirmed) Maple syrup urine disease,type Ib,248600];	RCV000381873.1 [benign]; 			160	60					BCKDHB (inh=AR pLI=0.00)
chr6	81055803	81055803	C	T	hom	anno_omim	QUAL=8089;DP=175;AF=0.99;MQM=60;TRIO=HOM,175,0.99,HOM,51,0.98,HET,49,0.41	BCKDHB	3'UTR	BCKDHB:ENST00000320393:3'UTR:MODIFIER:exon10/10:c.*2282C>T:,BCKDHB:ENST00000356489:3'UTR:MODIFIER:exon11/11:c.*120C>T:,BCKDHB:ENST00000545529:3'UTR:MODIFIER:exon11/11:c.*2898C>T:		rs10864	0.7157	0.0000	0,0,0	0,0,0,0,0	0.7765							248611 [BCKDHB (confirmed) Maple syrup urine disease,type Ib,248600];	RCV000289821.1 [benign]; 			160	60					BCKDHB (inh=AR pLI=0.00)
chr6	88221391	88221391	C	T	het	anno_omim	QUAL=11721;DP=536;AF=0.49;MQM=60;TRIO=HET,536,0.49,HET,354,0.50,WT,459,0.00	SLC35A1	3'UTR	SLC35A1:ENST00000369552:3'UTR:MODIFIER:exon8/8:c.*147C>T:,SLC35A1:ENST00000369556:3'UTR:MODIFIER:exon7/7:c.*147C>T:,SLC35A1:ENST00000544441:3'UTR:MODIFIER:exon7/7:c.*147C>T:		rs55960393	0.0230	0.0000	0,0,0	0,0,0,0,0	0.0310							605634 [SLC35A1 (confirmed) Congenital disorder of glycosylation,type IIf,603585];	RCV000391275.1 [likely benign]; 			0	12					SLC35A1 (inh=AR pLI=0.21)
chr6	88221546	88221546	A	G	hom	anno_omim	QUAL=21539;DP=470;AF=1.00;MQM=59;TRIO=HOM,470,1.00,HET,174,0.51,HET,244,0.52	SLC35A1	3'UTR	SLC35A1:ENST00000369552:3'UTR:MODIFIER:exon8/8:c.*302A>G:,SLC35A1:ENST00000369556:3'UTR:MODIFIER:exon7/7:c.*302A>G:,SLC35A1:ENST00000544441:3'UTR:MODIFIER:exon7/7:c.*302A>G:		rs1051131	0.6392	0.0000	0,0,0	0,0,0,0,0	0.5975							605634 [SLC35A1 (confirmed) Congenital disorder of glycosylation,type IIf,603585];	RCV000368571.1 [benign]; RCV000402620.1 [benign]; 			59	109					SLC35A1 (inh=AR pLI=0.21)
chr6	88221763	88221763	-	TGAA	hom	anno_omim	QUAL=15837;DP=328;AF=0.96;MQM=59;TRIO=HOM,328,0.96,HET,185,0.53,HET,317,0.49	SLC35A1	3'UTR	SLC35A1:ENST00000369552:3'UTR:MODIFIER:exon8/8:c.*521_*522insAATG:,SLC35A1:ENST00000369556:3'UTR:MODIFIER:exon7/7:c.*521_*522insAATG:		rs10681831	0.6556	0.0000	0,0,0	0,0,0,0,0	0.5075							605634 [SLC35A1 (confirmed) Congenital disorder of glycosylation,type IIf,603585];				60	107					SLC35A1 (inh=AR pLI=0.21)
chr6	88221767	88221767	-	TAAC	het	anno_omim	QUAL=8042;DP=304;AF=0.54;MQM=59;TRIO=HET,304,0.54,WT,179,0.00,HET,305,0.50	SLC35A1	3'UTR	SLC35A1:ENST00000369552:3'UTR:MODIFIER:exon8/8:c.*525_*528dupAACT:,SLC35A1:ENST00000369556:3'UTR:MODIFIER:exon7/7:c.*525_*528dupAACT:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							605634 [SLC35A1 (confirmed) Congenital disorder of glycosylation,type IIf,603585];				16	81					SLC35A1 (inh=AR pLI=0.21)
chr6	88221892	88221892	T	G	hom	anno_omim	QUAL=12811;DP=306;AF=1.00;MQM=59;TRIO=HOM,306,1.00,HET,83,0.55,HET,109,0.47	SLC35A1	3'UTR	SLC35A1:ENST00000369552:3'UTR:MODIFIER:exon8/8:c.*648T>G:,SLC35A1:ENST00000369556:3'UTR:MODIFIER:exon7/7:c.*648T>G:		rs1051148	0.6386	0.0000	0,0,0	0,0,0,0,0	0.5972							605634 [SLC35A1 (confirmed) Congenital disorder of glycosylation,type IIf,603585];	RCV000321728.1 [benign]; RCV000364789.1 [benign]; 			60	107					SLC35A1 (inh=AR pLI=0.21)
chr6	88240570	88240570	C	T	het	anno_omim	QUAL=7833;DP=336;AF=0.49;MQM=59;TRIO=HET,336,0.49,WT,199,0.00,HET,271,0.48	RARS2	missense	RARS2:ENST00000369536:missense:MODERATE:exon9/20:c.703G>A:p.Val235Met		rs35862137	0.0206	0.0321	89,52,1	0.0096,0.0149,0.0007,0.0385,0.0423	0.0347	-1.0730	T	T	B	T	0.55	611524 [RARS2 (confirmed) Pontocerebellar hypoplasia,type 6,611523];	RCV000118126.2 [benign]; RCV000279986.1 [likely benign]; 			5	185					RARS2 (inh=AR pLI=0.00)
chr6	89883013	89883013	A	T	het		QUAL=9035;DP=161;AF=0.53;MQM=60;TRIO=HET,161,0.53,HET,91,0.45,HOM,178,0.99	PM20D2,GABRR1	intergenic_region	GABRR1:ENSG00000146281-ENSG00000146276:intergenic_region:MODIFIER::n.89883013A>T:		rs9353650	0.1625	0.0000	0,0,0	0,0,0,0,0	0.1579											10	55					PM20D2 (inh=n/a pLI=0.00), GABRR1 (inh=n/a pLI=0.00)
chr6	97337537	97337537	C	T	hom	anno_omim	QUAL=24361;DP=446;AF=1.00;MQM=59;TRIO=HOM,446,1.00,HET,322,0.46,HET,432,0.50	NDUFAF4	3'UTR	NDUFAF4:ENST00000316149:3'UTR:MODIFIER:exon3/3:c.*1443G>A:		rs7758762	0.2748	0.0000	0,0,0	0,0,0,0,0	0.2365							611776 [NDUFAF4 (confirmed) Mitochondrial complex I deficiency,252010];	RCV000262685.1 [likely benign]; 			23	79					NDUFAF4 (inh=XLD pLI=0.38)
chr6	97338598	97338598	A	T	hom	anno_omim	QUAL=38394;DP=460;AF=1.00;MQM=59;TRIO=HOM,460,1.00,HOM,308,1.00,HOM,426,1.00	NDUFAF4	3'UTR	NDUFAF4:ENST00000316149:3'UTR:MODIFIER:exon3/3:c.*382T>A:		rs1971475	0.9341	0.0000	0,0,0	0,0,0,0,0	0.9011							611776 [NDUFAF4 (confirmed) Mitochondrial complex I deficiency,252010];	RCV000299285.1 [benign]; 			178	52					NDUFAF4 (inh=XLD pLI=0.38)
chr6	97338679	97338679	A	T	hom	anno_omim	QUAL=17675;DP=330;AF=0.99;MQM=60;TRIO=HOM,330,0.99,HET,198,0.50,HET,281,0.48	NDUFAF4	3'UTR	NDUFAF4:ENST00000316149:3'UTR:MODIFIER:exon3/3:c.*301T>A:		rs1854268	0.2750	0.0000	0,0,0	0,0,0,0,0	0.2359							611776 [NDUFAF4 (confirmed) Mitochondrial complex I deficiency,252010];	RCV000369579.1 [likely benign]; 			23	79					NDUFAF4 (inh=XLD pLI=0.38)
chr6	97339078	97339078	A	G	hom	anno_omim	QUAL=13233;DP=244;AF=1.00;MQM=60;TRIO=HOM,244,1.00,HET,99,0.59,HOM,109,0.99	NDUFAF4	synonymous	NDUFAF4:ENST00000316149:synonymous:LOW:exon3/3:c.430T>C:p.Leu144Leu		rs6684	0.5150	0.5178	16639,8429,792	0.3898,0.6080,0.7268,0.5025,0.5015	0.5257							611776 [NDUFAF4 (confirmed) Mitochondrial complex I deficiency,252010];	RCV000117707.2 [likely benign]; RCV000271558.1 [likely benign]; 		COSM3762230	555	1056	2	[2] auto-classification 15.09.2017  			NDUFAF4 (inh=XLD pLI=0.38)
chr6	97339088	97339088	C	T	hom	anno_omim	QUAL=15509;DP=248;AF=1.00;MQM=60;TRIO=HOM,248,1.00,HOM,101,1.00,HOM,114,1.00	NDUFAF4	synonymous	NDUFAF4:ENST00000316149:synonymous:LOW:exon3/3:c.420G>A:p.Gln140Gln		rs11402	0.9339	0.8944	48572,24796,4675	0.9512,0.9460,0.9991,0.8633,0.9025	0.9008							611776 [NDUFAF4 (confirmed) Mitochondrial complex I deficiency,252010];	RCV000117706.2 [likely benign]; RCV000328919.1 [benign]; 			1610	473	2	[2] auto-classification 15.09.2017  			NDUFAF4 (inh=XLD pLI=0.38)
chr6	97339275	97339275	-	A	hom	anno_omim	QUAL=4493;DP=119;AF=0.85;MQM=59;TRIO=HOM,119,0.85,HOM,52,0.87,HOM,52,0.81	NDUFAF4	splice_region&intron	NDUFAF4:ENST00000316149:splice_region&intron:LOW:exon2/2:c.241-9dupT:		rs34213186;rs397799265	0.6701	0.6070	10741,5817,962	0.6146,0.6244,0.6511,0.6035,0.5563	0.8539							611776 [NDUFAF4 (confirmed) Mitochondrial complex I deficiency,252010];	RCV000376533.1 [likely benign]; 			1248	795	2	[2] auto-classification 15.09.2017  			NDUFAF4 (inh=XLD pLI=0.38)
chr6	100837889	100837889	T	A	het	anno_omim	QUAL=14543;DP=413;AF=0.48;MQM=60;TRIO=HET,413,0.48,HET,267,0.53,HET,352,0.52	SIM1	3'UTR	SIM1:ENST00000262901:3'UTR:MODIFIER:exon11/11:c.*348A>T:,SIM1:ENST00000369208:3'UTR:MODIFIER:exon12/12:c.*348A>T:		rs1395119	0.3988	0.0000	0,0,0	0,0,0,0,0	0.3631							603128 [SIM1 (confirmed) Obesity,severe,601665];	RCV000265406.1 [benign]; 			37	112					SIM1 (inh=n/a pLI=1.00)
chr6	100988267	100988267	A	-	het	low_QUAL	QUAL=9;DP=188;AF=0.18;MQM=59;TRIO=HET,188,0.18,WT,67,0.22,WT,105,0.10	ASCC3	splice_region&intron	ASCC3:ENST00000369162:splice_region&intron:LOW:exon36/41:c.5551-4delT:		rs760353390	0.0000	0.4182	13,1,12	0.4346,0.4273,0.4196,0.4202,0.3902	0.3659										COSM1620704	4	77	2	[2] auto-classification 15.09.2017  			ASCC3 (inh=n/a pLI=0.00)
chr6	101094554	101094554	A	G	hom		QUAL=19828;DP=309;AF=0.99;MQM=60;TRIO=HOM,309,0.99,HET,209,0.53,HOM,210,1.00	ASCC3	synonymous	ASCC3:ENST00000369162:synonymous:LOW:exon22/42:c.3570T>C:p.Pro1190Pro		rs239239	0.5713	0.5419	18410,9136,1860	0.5987,0.6652,0.7450,0.5234,0.3949	0.5644										COSM3761400	601	1031	2	[2] auto-classification 15.09.2017  			ASCC3 (inh=n/a pLI=0.00)
chr6	101215224	101215224	A	-	hom		QUAL=12587;DP=196;AF=0.95;MQM=59;TRIO=HOM,196,0.95,HOM,117,0.97,HOM,131,0.95	ASCC3	splice_region&intron	ASCC3:ENST00000369162:splice_region&intron:LOW:exon8/41:c.1396-3delT:,ASCC3:ENST00000522650:splice_region&intron:LOW:exon8/12:c.1396-3delT:		rs397888735	0.9696	0.9896	58759,32771,4206	0.9063,0.9940,0.9985,0.9975,0.9980	0.9929											2096	19	2	[2] auto-classification 15.09.2017  			ASCC3 (inh=n/a pLI=0.00)
chr6	101296389	101296389	G	A	het	pred_pathogenic	QUAL=12038;DP=424;AF=0.49;MQM=60;TRIO=HET,424,0.49,WT,170,0.01,HOM,188,1.00	ASCC3	missense	ASCC3:ENST00000369162:missense:MODERATE:exon4/42:c.436C>T:p.Leu146Phe,ASCC3:ENST00000522650:missense:MODERATE:exon4/13:c.436C>T:p.Leu146Phe		rs9390698	0.2454	0.3651	8953,6620,77	0.1244,0.3925,0.2457,0.4458,0.2120	0.3771	2.5230	T,T,T	T	B,B,B	T,T,T	13.00				COSM150148	360	997	2	[2] auto-classification 15.09.2017  			ASCC3 (inh=n/a pLI=0.00)
chr6	101304332	101304332	T	C	het		QUAL=6830;DP=286;AF=0.53;MQM=60;TRIO=HET,286,0.53,WT,120,0.01,HET,201,0.48	ASCC3	3'UTR,intron	ASCC3:ENST00000369143:3'UTR:MODIFIER:exon4/4:c.*2652A>G:,ASCC3:ENST00000369162:intron:MODIFIER:exon3/41:c.241+7608A>G:,ASCC3:ENST00000522650:intron:MODIFIER:exon3/12:c.241+7608A>G:		rs78942177	0.0395	0.0000	0,0,0	0,0,0,0,0	0.0393											0	27					ASCC3 (inh=n/a pLI=0.00)
chr6	101304644	101304644	C	T	het		QUAL=7234;DP=336;AF=0.51;MQM=60;TRIO=HET,336,0.51,WT,173,0.00,HET,205,0.48	ASCC3	3'UTR,intron	ASCC3:ENST00000369143:3'UTR:MODIFIER:exon4/4:c.*2340G>A:,ASCC3:ENST00000369162:intron:MODIFIER:exon3/41:c.241+7296G>A:,ASCC3:ENST00000522650:intron:MODIFIER:exon3/12:c.241+7296G>A:	L1ME3	rs80004866	0.0058	0.0000	0,0,0	0,0,0,0,0	0.0101											0	3					ASCC3 (inh=n/a pLI=0.00)
chr6	101304829	101304829	C	T	het		QUAL=9062;DP=319;AF=0.43;MQM=60;TRIO=HET,319,0.43,WT,146,0.01,HOM,171,1.00	ASCC3	3'UTR,intron	ASCC3:ENST00000369143:3'UTR:MODIFIER:exon4/4:c.*2155G>A:,ASCC3:ENST00000369162:intron:MODIFIER:exon3/41:c.241+7111G>A:,ASCC3:ENST00000522650:intron:MODIFIER:exon3/12:c.241+7111G>A:	L1ME3	rs705599	0.6667	0.0000	0,0,0	0,0,0,0,0	0.7158											83	62					ASCC3 (inh=n/a pLI=0.00)
chr6	101305983	101305983	A	T	hom		QUAL=5702;DP=141;AF=1.00;MQM=60;TRIO=HOM,141,1.00,HOM,8,1.00,HOM,18,1.00	ASCC3	3'UTR,intron	ASCC3:ENST00000369143:3'UTR:MODIFIER:exon4/4:c.*1001T>A:,ASCC3:ENST00000369162:intron:MODIFIER:exon3/41:c.241+5957T>A:,ASCC3:ENST00000522650:intron:MODIFIER:exon3/12:c.241+5957T>A:	L1ME3	rs846793	0.9471	0.0000	0,0,0	0,0,0,0,0	0.9342											141	20					ASCC3 (inh=n/a pLI=0.00)
chr6	101306006	101306010	TAAAT	-	het		QUAL=1568;DP=124;AF=0.47;MQM=60;TRIO=HET,124,0.47,WT,8,0.00,HET,17,0.47	ASCC3	3'UTR,intron	ASCC3:ENST00000369143:3'UTR:MODIFIER:exon4/4:c.*974_*978delATTTA:,ASCC3:ENST00000369162:intron:MODIFIER:exon3/41:c.241+5930_241+5934delATTTA:,ASCC3:ENST00000522650:intron:MODIFIER:exon3/12:c.241+5930_241+5934delATTTA:	L1ME3	rs67936868	0.1601	0.0000	0,0,0	0,0,0,0,0	0.2172											10	64					ASCC3 (inh=n/a pLI=0.00)
chr6	101312097	101312097	C	T	hom		QUAL=12444;DP=164;AF=1.00;MQM=60;TRIO=HOM,164,1.00,HOM,82,1.00,HOM,136,1.00	ASCC3	splice_region&intron	ASCC3:ENST00000369162:splice_region&intron:LOW:exon2/41:c.91-7G>A:,ASCC3:ENST00000522650:splice_region&intron:LOW:exon2/12:c.91-7G>A:,ASCC3:ENST00000369143:splice_region&intron:LOW:exon2/3:c.91-7G>A:		rs846791	0.9800	0.9605	55882,30230,5020	0.9917,0.9896,0.9840,0.9525,0.9581	0.9612											1929	175	2	[2] auto-classification 15.09.2017  			ASCC3 (inh=n/a pLI=0.00)
chr6	101329173	101329173	A	C	het		QUAL=22120;DP=184;AF=0.52;MQM=59;TRIO=HET,184,0.52,WT,502,0.00,HOM,659,0.99	ASCC3	5'UTR_premature_start_codon_gain,5'UTR	ASCC3:ENST00000369162:5'UTR_premature_start_codon_gain:LOW:exon1/42:c.-278T>G:,ASCC3:ENST00000522650:5'UTR_premature_start_codon_gain:LOW:exon1/13:c.-278T>G:,ASCC3:ENST00000369143:5'UTR_premature_start_codon_gain:LOW:exon1/4:c.-278T>G:,ASCC3:ENST00000369162:5'UTR:MODIFIER:exon1/42:c.-278T>G:,ASCC3:ENST00000522650:5'UTR:MODIFIER:exon1/13:c.-278T>G:,ASCC3:ENST00000369143:5'UTR:MODIFIER:exon1/4:c.-278T>G:	(CAGA)n	rs12530388	0.5194	0.0000	0,0,0	0,0,0,0,0	0.5054											60	109	2	[2] auto-classification 15.09.2017  			ASCC3 (inh=n/a pLI=0.00)
chr6	102376517	102376517	G	A	het	anno_omim	QUAL=5101;DP=196;AF=0.53;MQM=60;TRIO=HET,196,0.53,WT,172,0.00,HET,193,0.52	GRIK2	splice_region&intron	GRIK2:ENST00000421544:splice_region&intron:LOW:exon13/15:c.2085+10G>A:,GRIK2:ENST00000369138:splice_region&intron:LOW:exon13/16:c.2085+10G>A:,GRIK2:ENST00000413795:splice_region&intron:LOW:exon13/16:c.2085+10G>A:,GRIK2:ENST00000318991:splice_region&intron:LOW:exon13/15:c.2085+10G>A:,GRIK2:ENST00000369137:splice_region&intron:LOW:exon12/14:c.1857+10G>A:,GRIK2:ENST00000369134:splice_region&intron:LOW:exon13/15:c.1938+10G>A:		rs2243355	0.1705	0.2764	5091,3711,20	0.0553,0.2299,0.0578,0.3408,0.2654	0.2781							138244 [GRIK2 (confirmed) Mental retardation,autosomal recessive,6,611092];	RCV000117160.2 [likely benign]; 			223	906	2	[2] auto-classification 15.09.2017  			GRIK2 (inh=AR pLI=0.99)
chr6	102503317	102503317	G	A	het	anno_omim	QUAL=1679;DP=53;AF=0.51;MQM=60;TRIO=HET,53,0.51,HOM,17,1.00,HET,34,0.56	GRIK2	synonymous	GRIK2:ENST00000421544:synonymous:LOW:exon15/16:c.2424G>A:p.Glu808Glu,GRIK2:ENST00000369138:synonymous:LOW:exon15/17:c.2424G>A:p.Glu808Glu,GRIK2:ENST00000413795:synonymous:LOW:exon15/17:c.2424G>A:p.Glu808Glu,GRIK2:ENST00000318991:synonymous:LOW:exon15/16:c.2424G>A:p.Glu808Glu,GRIK2:ENST00000369137:synonymous:LOW:exon14/15:c.2196G>A:p.Glu732Glu,GRIK2:ENST00000369134:synonymous:LOW:exon15/16:c.2277G>A:p.Glu759Glu		rs2227283	0.3275	0.3913	9631,6345,417	0.2800,0.4330,0.3415,0.4325,0.2847	0.3981							138244 [GRIK2 (confirmed) Mental retardation,autosomal recessive,6,611092];	RCV000117164.2 [likely benign]; 		COSM3761402, COSM3761401, COSM3761403	366	1038	2	[2] auto-classification 15.09.2017  			GRIK2 (inh=AR pLI=0.99)
chr6	107475278	107475278	-	A	het	anno_omim	QUAL=2037;DP=204;AF=0.39;MQM=59;TRIO=HET,204,0.39,HET,97,0.46,WT,132,0.02	PDSS2	3'UTR	PDSS2:ENST00000369037:3'UTR:MODIFIER:exon8/8:c.*544dupT:	AluSq2	rs35619837;rs397807908	0.1815	0.0000	0,0,0	0,0,0,0,0	0.2481							610564 [PDSS2 (confirmed) Coenzyme Q10 deficiency,primary,3,614652];	RCV000286678.1 [likely benign]; 			15	93					PDSS2 (inh=AR pLI=0.00)
chr6	107475512	107475512	C	T	het	anno_omim	QUAL=6426;DP=220;AF=0.49;MQM=60;TRIO=HET,220,0.49,WT,204,0.00,HET,269,0.51	PDSS2	3'UTR	PDSS2:ENST00000369037:3'UTR:MODIFIER:exon8/8:c.*311G>A:		rs41292442	0.0333	0.0000	0,0,0	0,0,0,0,0	0.0565							610564 [PDSS2 (confirmed) Coenzyme Q10 deficiency,primary,3,614652];	RCV000390812.1 [uncertain significance]; 			0	34					PDSS2 (inh=AR pLI=0.00)
chr6	108363645	108363645	G	C	het	anno_omim	QUAL=1821;DP=83;AF=0.66;MQM=58;TRIO=HET,83,0.66,WT,30,0.00,HET,39,0.67	OSTM1	3'UTR	OSTM1:ENST00000193322:3'UTR:MODIFIER:exon6/6:c.*2344C>G:	AluJb	rs113263335	0.1392	0.0000	0,0,0	0,0,0,0,0	0.0813							607649 [OSTM1 (provisional) Osteopetrosis,autosomal recessive 5,259720];	RCV000316918.1 [benign]; 			2	15					OSTM1 (inh=AR pLI=0.06)
chr6	108363660	108363660	C	A	het	anno_omim	QUAL=1748;DP=79;AF=0.66;MQM=59;TRIO=HET,79,0.66,WT,37,0.00,HET,52,0.60	OSTM1	3'UTR	OSTM1:ENST00000193322:3'UTR:MODIFIER:exon6/6:c.*2329G>T:	AluJb	rs112792700	0.1392	0.0000	0,0,0	0,0,0,0,0	0.0787							607649 [OSTM1 (provisional) Osteopetrosis,autosomal recessive 5,259720];	RCV000355405.1 [benign]; 			0	15					OSTM1 (inh=AR pLI=0.06)
chr6	108363688	108363688	T	C	het	anno_omim	QUAL=2544;DP=117;AF=0.56;MQM=59;TRIO=HET,117,0.56,WT,47,0.00,HET,63,0.56	OSTM1	3'UTR	OSTM1:ENST00000193322:3'UTR:MODIFIER:exon6/6:c.*2301A>G:	AluJb	rs9386700	0.3441	0.0000	0,0,0	0,0,0,0,0	0.3286							607649 [OSTM1 (provisional) Osteopetrosis,autosomal recessive 5,259720];	RCV000320564.1 [benign]; 			13	73					OSTM1 (inh=AR pLI=0.06)
chr6	108363706	108363706	A	G	het	anno_omim	QUAL=2907;DP=142;AF=0.55;MQM=59;TRIO=HET,142,0.55,WT,53,0.02,HET,66,0.59	OSTM1	3'UTR	OSTM1:ENST00000193322:3'UTR:MODIFIER:exon6/6:c.*2283T>C:	AluJb	rs112283202	0.1392	0.0000	0,0,0	0,0,0,0,0	0.0818							607649 [OSTM1 (provisional) Osteopetrosis,autosomal recessive 5,259720];	RCV000379201.1 [benign]; 			1	16					OSTM1 (inh=AR pLI=0.06)
chr6	108363936	108363936	G	A	het	anno_omim	QUAL=10544;DP=459;AF=0.52;MQM=60;TRIO=HET,459,0.52,WT,232,0.00,HET,280,0.53	OSTM1	3'UTR	OSTM1:ENST00000193322:3'UTR:MODIFIER:exon6/6:c.*2053C>T:		rs17069215	0.0757	0.0000	0,0,0	0,0,0,0,0	0.0314							607649 [OSTM1 (provisional) Osteopetrosis,autosomal recessive 5,259720];	RCV000290425.1 [likely benign]; 			0	26					OSTM1 (inh=AR pLI=0.06)
chr6	108364106	108364106	A	G	het	anno_omim	QUAL=8915;DP=432;AF=0.56;MQM=60;TRIO=HET,432,0.56,WT,127,0.00,HET,168,0.47	OSTM1	3'UTR	OSTM1:ENST00000193322:3'UTR:MODIFIER:exon6/6:c.*1883T>C:		rs7662	0.3441	0.0000	0,0,0	0,0,0,0,0	0.3256							607649 [OSTM1 (provisional) Osteopetrosis,autosomal recessive 5,259720];	RCV000294002.1 [benign]; 			16	100					OSTM1 (inh=AR pLI=0.06)
chr6	108364548	108364548	T	-	het	anno_omim	QUAL=7042;DP=313;AF=0.46;MQM=59;TRIO=HET,313,0.46,WT,184,0.00,HET,286,0.50	OSTM1	3'UTR	OSTM1:ENST00000193322:3'UTR:MODIFIER:exon6/6:c.*1441delA:		rs140320992	0.1256	0.0000	0,0,0	0,0,0,0,0	0.0728							607649 [OSTM1 (provisional) Osteopetrosis,autosomal recessive 5,259720];	RCV000402959.1 [benign]; 			0	27					OSTM1 (inh=AR pLI=0.06)
chr6	108364637	108364637	T	C	het	anno_omim	QUAL=6267;DP=318;AF=0.55;MQM=60;TRIO=HET,318,0.55,WT,79,0.00,HET,125,0.54	OSTM1	3'UTR	OSTM1:ENST00000193322:3'UTR:MODIFIER:exon6/6:c.*1352A>G:		rs9372179	0.0757	0.0000	0,0,0	0,0,0,0,0	0.0314							607649 [OSTM1 (provisional) Osteopetrosis,autosomal recessive 5,259720];	RCV000360961.1 [likely benign]; 			0	26					OSTM1 (inh=AR pLI=0.06)
chr6	108364655	108364655	A	G	het	anno_omim	QUAL=5211;DP=251;AF=0.57;MQM=60;TRIO=HET,251,0.57,WT,59,0.00,HET,108,0.49	OSTM1	3'UTR	OSTM1:ENST00000193322:3'UTR:MODIFIER:exon6/6:c.*1334T>C:		rs9374008	0.0757	0.0000	0,0,0	0,0,0,0,0	0.0314							607649 [OSTM1 (provisional) Osteopetrosis,autosomal recessive 5,259720];	RCV000268721.1 [likely benign]; 			0	26					OSTM1 (inh=AR pLI=0.06)
chr6	108365658	108365658	T	C	het	anno_omim	QUAL=2929;DP=144;AF=0.55;MQM=60;TRIO=HET,144,0.55,WT,50,0.00,HET,55,0.53	OSTM1	3'UTR	OSTM1:ENST00000193322:3'UTR:MODIFIER:exon6/6:c.*331A>G:		rs9320250	0.4764	0.0000	0,0,0	0,0,0,0,0	0.4144							607649 [OSTM1 (provisional) Osteopetrosis,autosomal recessive 5,259720];	RCV000391311.1 [benign]; 			21	103					OSTM1 (inh=AR pLI=0.06)
chr6	110106234	110106234	A	G	hom	anno_omim	QUAL=21830;DP=318;AF=0.99;MQM=60;TRIO=HOM,318,0.99,HOM,133,1.00,HOM,230,0.98	FIG4	splice_region&intron	FIG4:ENST00000230124:splice_region&intron:LOW:exon17/22:c.1948+3A>G:,FIG4:ENST00000441478:splice_region&intron:LOW:exon12/16:c.1117+3A>G:		rs10499054	0.3588	0.5265	18582,14556,244	0.1942,0.4265,0.3269,0.6607,0.3579	0.5290							609390 [FIG4 (provisional) Charcot-Marie-Tooth disease,type 4J,611228|Amyotrophic lateral sclerosis 11,612577|Yunis-Varon syndrome,216340|Polymicrogyria,bilateral temporooccipital,612691];	RCV000244780.2 [benign]; RCV000287031.1 [benign]; RCV000321790.1 [benign]; 			1046	1195	2	[2] auto-classification 15.09.2017  			FIG4 (inh=AR+AD pLI=0.00)
chr6	110146303	110146303	G	A	hom	anno_omim	QUAL=20286;DP=276;AF=0.99;MQM=60;TRIO=HOM,276,0.99,HOM,226,1.00,HET,332,0.53	FIG4	synonymous	FIG4:ENST00000230124:synonymous:LOW:exon23/23:c.2559G>A:p.Ser853Ser,FIG4:ENST00000441478:synonymous:LOW:exon17/17:c.1641G>A:p.Ser547Ser		rs1127771	0.3958	0.4289	11975,5732,114	0.1434,0.5026,0.5766,0.4125,0.5476	0.4391							609390 [FIG4 (provisional) Charcot-Marie-Tooth disease,type 4J,611228|Amyotrophic lateral sclerosis 11,612577|Yunis-Varon syndrome,216340|Polymicrogyria,bilateral temporooccipital,612691];	RCV000245906.1 [benign]; RCV000321034.1 [benign]; RCV000375677.1 [benign]; 			555	1307	2	[2] auto-classification 15.09.2017  			FIG4 (inh=AR+AD pLI=0.00)
chr6	110146588	110146588	C	T	hom	anno_omim	QUAL=22876;DP=275;AF=0.99;MQM=59;TRIO=HOM,275,0.99,HOM,297,1.00,HET,385,0.49	FIG4	3'UTR	FIG4:ENST00000230124:3'UTR:MODIFIER:exon23/23:c.*120C>T:,FIG4:ENST00000441478:3'UTR:MODIFIER:exon17/17:c.*120C>T:		rs1127775	0.4483	0.0000	0,0,0	0,0,0,0,0	0.3698							609390 [FIG4 (provisional) Charcot-Marie-Tooth disease,type 4J,611228|Amyotrophic lateral sclerosis 11,612577|Yunis-Varon syndrome,216340|Polymicrogyria,bilateral temporooccipital,612691];	RCV000308451.1 [benign]; RCV000400280.1 [benign]; 			48	114					FIG4 (inh=AR+AD pLI=0.00)
chr6	129381026	129381026	C	A	hom	anno_omim	QUAL=20222;DP=223;AF=1.00;MQM=60;TRIO=HOM,223,1.00,HOM,194,1.00,HOM,219,1.00	LAMA2	synonymous	LAMA2:ENST00000421865:synonymous:LOW:exon3/65:c.381C>A:p.Thr127Thr		rs4404787	0.9367	0.9578	55756,31416,4252	0.9024,0.9850,0.9742,0.9705,0.9023	0.9609							156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient,607855|Muscular dystrophy,congenital,due to partial LAMA2 deficiency,607855];	RCV000078766.6 [benign]; RCV000374091.1 [benign]; 			2034	136	2	[2] auto-classification 15.09.2017  			LAMA2 (inh=AR pLI=0.00)
chr6	129571330	129571330	G	A	het	anno_omim	QUAL=8124;DP=348;AF=0.46;MQM=60;TRIO=HET,348,0.46,WT,248,0.00,HET,330,0.45	LAMA2	missense	LAMA2:ENST00000421865:missense:MODERATE:exon13/65:c.1856G>A:p.Arg619His		rs3816665	0.2710	0.1828	2946,585,1562	0.5435,0.1276,0.0832,0.1346,0.2377	0.2530	-1.5750	T,T,T	T	B,B	T	0.77	156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient,607855|Muscular dystrophy,congenital,due to partial LAMA2 deficiency,607855];	RCV000078752.7 [benign]; RCV000285061.1 [benign]; 			74	606	2	[2] auto-classification 15.09.2017  			LAMA2 (inh=AR pLI=0.00)
chr6	129612808	129612808	A	G	het	anno_omim	QUAL=7216;DP=285;AF=0.54;MQM=60;TRIO=HET,285,0.54,WT,131,0.00,HET,199,0.57	LAMA2	synonymous	LAMA2:ENST00000421865:synonymous:LOW:exon20/65:c.2799A>G:p.Gln933Gln		rs1027199	0.3139	0.2683	4524,1657,543	0.3266,0.2813,0.4405,0.2253,0.2976	0.2719							156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient,607855|Muscular dystrophy,congenital,due to partial LAMA2 deficiency,607855];	RCV000078759.6 [benign]; RCV000315857.1 [benign]; 		COSM3761478	144	810	2	[2] auto-classification 15.09.2017  			LAMA2 (inh=AR pLI=0.00)
chr6	129691132	129691132	C	G	hom	anno_omim	QUAL=14999;DP=303;AF=0.99;MQM=60;TRIO=HOM,303,0.99,HET,189,0.46,HET,258,0.47	LAMA2	synonymous	LAMA2:ENST00000421865:synonymous:LOW:exon34/65:c.4956C>G:p.Thr1652Thr		rs17057184	0.0966	0.0857	614,154,69	0.1111,0.1919,0.0303,0.0631,0.1298	0.0885							156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient,607855|Muscular dystrophy,congenital,due to partial LAMA2 deficiency,607855];	RCV000078774.6 [benign]; RCV000264034.1 [likely benign]; 			25	307	2	[2] auto-classification 15.09.2017  			LAMA2 (inh=AR pLI=0.00)
chr6	129722389	129722389	A	G	het	anno_omim	QUAL=14678;DP=322;AF=0.51;MQM=59;TRIO=HET,322,0.51,HOM,328,1.00,WT,431,0.00	LAMA2	synonymous	LAMA2:ENST00000421865:synonymous:LOW:exon38/65:c.5466A>G:p.Glu1822Glu		rs3749877	0.5445	0.4979	15361,7378,2018	0.6222,0.4696,0.5674,0.4678,0.5381	0.5112							156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient,607855|Muscular dystrophy,congenital,due to partial LAMA2 deficiency,607855];	RCV000078777.6 [benign]; RCV000387332.1 [benign]; 			521	1055	2	[2] auto-classification 15.09.2017  			LAMA2 (inh=AR pLI=0.00)
chr6	129722425	129722425	G	A	het	anno_omim	QUAL=18733;DP=531;AF=0.47;MQM=59;TRIO=HET,531,0.47,HOM,375,1.00,WT,484,0.00	LAMA2	synonymous	LAMA2:ENST00000421865:synonymous:LOW:exon38/65:c.5502G>A:p.Glu1834Glu		rs3749878	0.5433	0.4963	15250,7305,2017	0.6228,0.4686,0.5662,0.4658,0.5379	0.5089							156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient,607855|Muscular dystrophy,congenital,due to partial LAMA2 deficiency,607855];	RCV000078778.6 [benign]; RCV000338699.1 [benign]; 		COSM4160174	521	1054	2	[2] auto-classification 15.09.2017  			LAMA2 (inh=AR pLI=0.00)
chr6	129762112	129762112	G	A	het	anno_omim	QUAL=7817;DP=289;AF=0.50;MQM=59;TRIO=HET,289,0.50,WT,284,0.00,HET,321,0.50	LAMA2	synonymous	LAMA2:ENST00000421865:synonymous:LOW:exon43/65:c.6237G>A:p.Thr2079Thr		rs2297738	0.1825	0.1683	1867,800,105	0.1391,0.2274,0.2160,0.1514,0.1700	0.1730							156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient,607855|Muscular dystrophy,congenital,due to partial LAMA2 deficiency,607855];	RCV000078786.7 [benign]; RCV000314145.1 [likely benign]; 		COSM3761479	57	582	2	[2] auto-classification 15.09.2017  			LAMA2 (inh=AR pLI=0.00)
chr6	129807629	129807629	C	T	het	pred_pathogenic;anno_omim	QUAL=3996;DP=202;AF=0.49;MQM=60;TRIO=HET,202,0.49,HET,143,0.45,WT,199,0.00	LAMA2	missense	LAMA2:ENST00000421865:missense:MODERATE:exon56/65:c.7760C>T:p.Ala2587Val		rs2229848	0.5839	0.6678	27343,16984,1093	0.4567,0.6736,0.6090,0.7148,0.6458	0.6724	4.4990	T,T,T,T	D	D,D	T	34.00	156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient,607855|Muscular dystrophy,congenital,due to partial LAMA2 deficiency,607855];	RCV000153440.2 [benign]; 		COSM1440401	1092	876	2	[2] auto-classification 15.09.2017  			LAMA2 (inh=AR pLI=0.00)
chr6	129807699	129807699	G	C	het	anno_omim	QUAL=6298;DP=340;AF=0.48;MQM=60;TRIO=HET,340,0.48,HET,181,0.44,WT,249,0.00	LAMA2	synonymous	LAMA2:ENST00000421865:synonymous:LOW:exon56/65:c.7830G>C:p.Val2610Val		rs2229849	0.5843	0.6682	27409,17019,1102	0.4587,0.6740,0.6102,0.7149,0.6458	0.6727							156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient,607855|Muscular dystrophy,congenital,due to partial LAMA2 deficiency,607855];	RCV000078800.7 [benign]; RCV000262042.1 [benign]; 			1092	876	2	[2] auto-classification 15.09.2017  			LAMA2 (inh=AR pLI=0.00)
chr6	129807714	129807714	G	A	het	anno_omim	QUAL=15812;DP=332;AF=0.55;MQM=60;TRIO=HET,332,0.55,HET,181,0.56,HOM,249,1.00	LAMA2	synonymous	LAMA2:ENST00000421865:synonymous:LOW:exon56/65:c.7845G>A:p.Pro2615Pro		rs2229850	0.4038	0.3080	6146,2190,1514	0.5382,0.3079,0.3912,0.2597,0.3134	0.3535							156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient,607855|Muscular dystrophy,congenital,due to partial LAMA2 deficiency,607855];	RCV000078801.7 [benign]; RCV000300807.1 [benign]; 			170	827	2	[2] auto-classification 15.09.2017  			LAMA2 (inh=AR pLI=0.00)
chr6	129837681	129837683	AAT	-	hom	anno_omim	QUAL=9285;DP=243;AF=1.00;MQM=59;TRIO=HOM,243,1.00,HET,36,0.69,HOM,55,1.00	LAMA2	3'UTR	LAMA2:ENST00000421865:3'UTR:MODIFIER:exon65/65:c.*193_*195delATA:		rs371188338	0.7051	0.0000	0,0,0	0,0,0,0,0	0.7471							156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient,607855|Muscular dystrophy,congenital,due to partial LAMA2 deficiency,607855];	RCV000358086.1 [benign]; 			148	77					LAMA2 (inh=AR pLI=0.00)
chr6	132212889	132212890	TT	-	hom	anno_omim	QUAL=166;DP=42;AF=0.31;MQM=60;TRIO=HOM,42,0.31,WT,12,0.08,WT,17,0.29	ENPP1	3'UTR	ENPP1:ENST00000360971:3'UTR:MODIFIER:exon25/25:c.*1255_*1256delTT:		rs769107294	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							173335 [ENPP1 (confirmed) Diabetes mellitus,non-insulin-dependent,susceptibility to,125853|Obesity,susceptibility to,601665|Arterial calcification,generalized,of infancy,1,208000|Hypophosphatemic rickets,autosomal recessive,2,613312|Cole disease,615522];				1	0					ENPP1 (inh=AR+AD pLI=0.00)
chr6	135715915	135715915	G	A	het	anno_omim	QUAL=261;DP=23;AF=0.57;MQM=60;TRIO=HET,23,0.57,WT,2,0.00,WT,12,0.00	AHI1	splice_region&synonymous	AHI1:ENST00000367800:splice_region&synonymous:LOW:exon21/27:c.3108C>T:p.Thr1036Thr,AHI1:ENST00000457866:splice_region&synonymous:LOW:exon22/28:c.3108C>T:p.Thr1036Thr,AHI1:ENST00000417892:splice_region&synonymous:LOW:exon10/19:c.1170C>T:p.Thr390Thr,AHI1:ENST00000327035:splice_region&synonymous:LOW:exon22/23:c.3108C>T:p.Thr1036Thr		rs761976492	0.0000	0.0001	0,0,0	0.0001,0.0000,0.0002,0.0000,0.0002	0.0001	-3.5700		T			6.43	608894 [AHI1 (confirmed) Joubert syndrome 3,608629];				0	1					AHI1 (inh=AR pLI=0.00)
chr6	135818897	135818897	C	A	het	low_DP;anno_omim	QUAL=4655;DP=10;AF=0.50;MQM=59;TRIO=HET,10,0.50,HOM,113,1.00,HET,163,0.47	AHI1,LINC00271	5'UTR	AHI1:ENST00000457866:5'UTR:MODIFIER:exon1/28:c.-293G>T:		rs13197384	0.3011	0.0000	5,2,0	0.0000,0.0000,0.0000,0.0000,0.0000	0.3909							608894 [AHI1 (confirmed) Joubert syndrome 3,608629];	RCV000383693.1 [benign]; 			149	513					AHI1 (inh=AR pLI=0.00), LINC00271 (inh=n/a pLI=n/a)
chr6	137166790	137166790	A	C	het	pred_pathogenic;anno_omim	QUAL=8128;DP=364;AF=0.49;MQM=60;TRIO=HET,364,0.49,WT,203,0.00,HET,268,0.46	PEX7	missense	PEX7:ENST00000318471:missense:MODERATE:exon4/10:c.377A>C:p.Gln126Pro,PEX7:ENST00000541292:missense:MODERATE:exon4/11:c.377A>C:p.Gln126Pro		rs113268723	0.0014	0.0038	0,0,0	0.0008,0.0022,0.0000,0.0051,0.0002	0.0042	5.5310	T,T	T	P	D,D	23.60	601757 [PEX7 (provisional) Rhizomelic chondrodysplasia punctata,type 1,215100|Peroxisome biogenesis disorder 9B,614879];	RCV000245920.2 [benign]; 			0	16	1	[1] ahdeinn1 10.03.2017 VUS1, NDE, 10.03.2017, da ExAc > 1% [3] Julia Bickmann 19.11.2014 			PEX7 (inh=AR pLI=0.00)
chr6	137234919	137234919	-	GTA	het	anno_omim	QUAL=6226;DP=277;AF=0.51;MQM=59;TRIO=HET,277,0.51,HOM,93,1.00,WT,110,0.00	PEX7	3'UTR	PEX7:ENST00000318471:3'UTR:MODIFIER:exon10/10:c.*257_*258insAGT:,PEX7:ENST00000541292:3'UTR:MODIFIER:exon11/11:c.*494_*495insAGT:		rs141139220	0.5230	0.0000	0,0,0	0,0,0,0,0	0.5106							601757 [PEX7 (provisional) Rhizomelic chondrodysplasia punctata,type 1,215100|Peroxisome biogenesis disorder 9B,614879];				63	119					PEX7 (inh=AR pLI=0.00)
chr6	137234970	137234970	T	G	het	anno_omim	QUAL=3823;DP=186;AF=0.48;MQM=60;TRIO=HET,186,0.48,HOM,56,1.00,WT,61,0.00	PEX7	3'UTR	PEX7:ENST00000318471:3'UTR:MODIFIER:exon10/10:c.*306T>G:,PEX7:ENST00000541292:3'UTR:MODIFIER:exon11/11:c.*543T>G:		rs1050803	0.5206	0.0000	0,0,0	0,0,0,0,0	0.5098							601757 [PEX7 (provisional) Rhizomelic chondrodysplasia punctata,type 1,215100|Peroxisome biogenesis disorder 9B,614879];	RCV000291136.1 [benign]; RCV000380781.1 [benign]; 			62	119					PEX7 (inh=AR pLI=0.00)
chr6	143810682	143810682	A	T	het	low_DP;anno_omim	QUAL=129;DP=12;AF=0.50;MQM=60;TRIO=HET,12,0.50,HOM,2,1.00,WT,3,0.00	PEX3,RP1-20N2.6	3'UTR	PEX3:ENST00000367591:3'UTR:MODIFIER:exon12/12:c.*319A>T:	(AT)n	rs223234	0.7927	0.0000	0,0,0	0,0,0,0,0	0.7977							603164 [PEX3 (confirmed) Peroxisome biogenesis disorder 10A (Zellweger),614882|Peroxisome biogenesis disorder 10B,617370];	RCV000380691.1 [benign]; 			96	57					PEX3 (inh=AR pLI=0.00), RP1-20N2.6 (inh=n/a pLI=n/a)
chr6	143810909	143810909	A	G	het	anno_omim	QUAL=982;DP=62;AF=0.48;MQM=59;TRIO=HET,62,0.48,HET,15,0.53,WT,18,0.00	PEX3,RP1-20N2.6	3'UTR	PEX3:ENST00000367591:3'UTR:MODIFIER:exon12/12:c.*546A>G:		rs10809	0.1290	0.0000	0,0,0	0,0,0,0,0	0.1693							603164 [PEX3 (confirmed) Peroxisome biogenesis disorder 10A (Zellweger),614882|Peroxisome biogenesis disorder 10B,617370];	RCV000399211.1 [likely benign]; 			8	91					PEX3 (inh=AR pLI=0.00), RP1-20N2.6 (inh=n/a pLI=n/a)
chr6	144509845	144509845	-	A	hom	anno_omim	QUAL=894;DP=36;AF=0.64;MQM=59;TRIO=HOM,36,0.64,HOM,12,0.83,HET,22,0.36	STX11,TPT1P4	intergenic_region	TPT1P4:ENSG00000135604-ENSG00000217027:intergenic_region:MODIFIER::n.144509845_144509846insA:		rs397725572	0.5583	0.0000	0,0,0	0,0,0,0,0	0.5126							605014 [STX11 (confirmed) Hemophagocytic lymphohistiocytosis,familial,4,603552];	RCV000287281.1 [other]; 			15	111					STX11 (inh=AR pLI=0.02), TPT1P4 (inh=n/a pLI=n/a)
chr6	144509855	144509855	C	T	het	low_MQM;anno_omim	QUAL=36;DP=52;AF=0.35;MQM=48;TRIO=HET,52,0.35,WT,9,0.00,WT,14,0.00	STX11,TPT1P4	intergenic_region	TPT1P4:ENSG00000135604-ENSG00000217027:intergenic_region:MODIFIER::n.144509855C>T:	AluSc8	rs148087652	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0007							605014 [STX11 (confirmed) Hemophagocytic lymphohistiocytosis,familial,4,603552];				11	64					STX11 (inh=AR pLI=0.02), TPT1P4 (inh=n/a pLI=n/a)
chr6	144510421	144510421	A	C	het	anno_omim	QUAL=5810;DP=178;AF=0.49;MQM=59;TRIO=HET,178,0.49,HET,100,0.57,HET,146,0.53	STX11,TPT1P4	intergenic_region	TPT1P4:ENSG00000135604-ENSG00000217027:intergenic_region:MODIFIER::n.144510421A>C:	AluJo	rs4896705	0.2730	0.0000	0,0,0	0,0,0,0,0	0.2886							605014 [STX11 (confirmed) Hemophagocytic lymphohistiocytosis,familial,4,603552];	RCV000266623.1 [benign]; 			26	93					STX11 (inh=AR pLI=0.02), TPT1P4 (inh=n/a pLI=n/a)
chr6	144510926	144510926	C	T	het	anno_omim	QUAL=8979;DP=352;AF=0.49;MQM=60;TRIO=HET,352,0.49,HET,179,0.50,HET,189,0.40	STX11,TPT1P4	intergenic_region	TPT1P4:ENSG00000135604-ENSG00000217027:intergenic_region:MODIFIER::n.144510926C>T:		rs3734227	0.2670	0.0000	0,0,0	0,0,0,0,0	0.2782							605014 [STX11 (confirmed) Hemophagocytic lymphohistiocytosis,familial,4,603552];	RCV000375338.1 [likely benign]; 			23	109					STX11 (inh=AR pLI=0.02), TPT1P4 (inh=n/a pLI=n/a)
chr6	144512671	144512671	-	A	hom	anno_omim	QUAL=10671;DP=259;AF=0.88;MQM=59;TRIO=HOM,259,0.88,HOM,66,0.88,HOM,65,0.85	STX11,TPT1P4	intergenic_region	TPT1P4:ENSG00000135604-ENSG00000217027:intergenic_region:MODIFIER::n.144512671_144512672insA:		rs11397393;rs397795966	0.9277	0.0000	0,0,0	0,0,0,0,0	0.9417							605014 [STX11 (confirmed) Hemophagocytic lymphohistiocytosis,familial,4,603552];	RCV000282258.1 [benign]; 			186	48					STX11 (inh=AR pLI=0.02), TPT1P4 (inh=n/a pLI=n/a)
chr6	145947080	145947080	C	T	hom	anno_omim	QUAL=29676;DP=388;AF=1.00;MQM=60;TRIO=HOM,388,1.00,HOM,205,0.99,HOM,308,0.99	EPM2A	3'UTR	EPM2A:ENST00000367519:3'UTR:MODIFIER:exon4/4:c.*1472G>A:	MIRb	rs1045820	0.4471	0.0000	0,0,0	0,0,0,0,0	0.4541							608072 [EPM2A (confirmed) Epilepsy,progressive myoclonic 2B (Lafora),254780]:607566 [EPM2A (confirmed) Epilepsy,progressive myoclonic 2A (Lafora),254780];				64	108					EPM2A (inh=AR pLI=0.00)
chr6	146056848	146056848	T	C	het	low_DP;anno_omim	QUAL=90;DP=5;AF=0.60;MQM=60;TRIO=HET,5,0.60,WT,205,0.99,HOM,2,1.00	EPM2A,RP3-466P17.1	5'UTR_premature_start_codon_gain,5'UTR	EPM2A:ENST00000367519:5'UTR_premature_start_codon_gain:LOW:exon1/4:c.-214A>G:,EPM2A:ENST00000367519:5'UTR:MODIFIER:exon1/4:c.-214A>G:		rs2235481	0.7352	0.0000	0,0,0	0,0,0,0,0	0.7229							608072 [EPM2A (confirmed) Epilepsy,progressive myoclonic 2B (Lafora),254780]:607566 [EPM2A (confirmed) Epilepsy,progressive myoclonic 2A (Lafora),254780];				51	33	2	[2] auto-classification 15.09.2017  			EPM2A (inh=AR pLI=0.00), RP3-466P17.1 (inh=n/a pLI=n/a)
chr6	152443468	152443468	G	T	het	anno_omim	QUAL=13547;DP=539;AF=0.49;MQM=59;TRIO=HET,539,0.49,HET,484,0.54,WT,732,0.00	SYNE1,ESR1	3'UTR,intron	SYNE1:ENST00000265368:3'UTR:MODIFIER:exon146/146:c.*103C>A:,SYNE1:ENST00000367255:3'UTR:MODIFIER:exon146/146:c.*103C>A:,SYNE1:ENST00000539504:3'UTR:MODIFIER:exon17/17:c.*103C>A:,SYNE1:ENST00000356820:3'UTR:MODIFIER:exon61/61:c.*103C>A:,SYNE1:ENST00000423061:3'UTR:MODIFIER:exon146/146:c.*103C>A:,SYNE1:ENST00000341594:3'UTR:MODIFIER:exon147/147:c.*103C>A:,SYNE1:ENST00000448038:3'UTR:MODIFIER:exon147/147:c.*103C>A:,ESR1:ENST00000427531:intron:MODIFIER:exon6/6:c.851-2933G>T:		rs2250122	0.2452	0.0000	0,0,0	0,0,0,0,0	0.1938							608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];	RCV000259269.1 [benign]; RCV000356387.1 [benign]; 			14	88					SYNE1 (inh=AR+AD pLI=0.00), ESR1 (inh=AR pLI=0.99)
chr6	152464839	152464839	A	G	het	anno_omim	QUAL=15246;DP=432;AF=0.52;MQM=60;TRIO=HET,432,0.52,HOM,292,1.00,WT,387,0.01	SYNE1	synonymous	SYNE1:ENST00000265368:synonymous:LOW:exon138/146:c.25038T>C:p.Arg8346Arg,SYNE1:ENST00000367255:synonymous:LOW:exon138/146:c.25038T>C:p.Arg8346Arg,SYNE1:ENST00000539504:synonymous:LOW:exon9/17:c.1503T>C:p.Arg501Arg,SYNE1:ENST00000356820:synonymous:LOW:exon53/61:c.8610T>C:p.Arg2870Arg,SYNE1:ENST00000423061:synonymous:LOW:exon138/146:c.24894T>C:p.Arg8298Arg,SYNE1:ENST00000341594:synonymous:LOW:exon139/147:c.23874T>C:p.Arg7958Arg,SYNE1:ENST00000448038:synonymous:LOW:exon139/147:c.24894T>C:p.Arg8298Arg,SYNE1:ENST00000354674:synonymous:LOW:exon10/18:c.1572T>C:p.Arg524Arg		rs2256135	0.6897	0.6109	23222,10072,3002	0.7573,0.7291,0.7003,0.5482,0.6901	0.6144							608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];	RCV000118470.3 [other]; RCV000313035.1 [benign]; RCV000367836.1 [benign]; 			1136	1720	2	[2] auto-classification 15.09.2017  			SYNE1 (inh=AR+AD pLI=0.00)
chr6	152466674	152466674	T	C	het	anno_omim	QUAL=7249;DP=316;AF=0.49;MQM=60;TRIO=HET,316,0.49,HET,245,0.52,WT,295,0.00	SYNE1	synonymous,intron	SYNE1:ENST00000423061:synonymous:LOW:exon137/146:c.24780A>G:p.Glu8260Glu,SYNE1:ENST00000448038:synonymous:LOW:exon138/147:c.24780A>G:p.Glu8260Glu,SYNE1:ENST00000354674:synonymous:LOW:exon9/18:c.1458A>G:p.Glu486Glu,SYNE1:ENST00000265368:intron:MODIFIER:exon137/145:c.24977-1774A>G:,SYNE1:ENST00000367255:intron:MODIFIER:exon137/145:c.24977-1774A>G:,SYNE1:ENST00000539504:intron:MODIFIER:exon8/16:c.1442-1774A>G:,SYNE1:ENST00000356820:intron:MODIFIER:exon52/60:c.8549-1774A>G:,SYNE1:ENST00000341594:intron:MODIFIER:exon138/146:c.23813-1774A>G:		rs2747662	0.3662	0.3452	7689,3414,609	0.3402,0.5190,0.2955,0.3171,0.4119	0.3517							608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];	RCV000118469.2 [benign]; RCV000277927.1 [benign]; RCV000333086.1 [benign]; 		COSM3761563, COSM3761562	422	1593	2	[2] auto-classification 15.09.2017  			SYNE1 (inh=AR+AD pLI=0.00)
chr6	152469188	152469188	C	G	het	pred_pathogenic;anno_omim	QUAL=3713;DP=171;AF=0.47;MQM=60;TRIO=HET,171,0.47,HET,135,0.55,WT,209,0.00	SYNE1	missense	SYNE1:ENST00000265368:missense:MODERATE:exon137/146:c.24968G>C:p.Gly8323Ala,SYNE1:ENST00000367255:missense:MODERATE:exon137/146:c.24968G>C:p.Gly8323Ala,SYNE1:ENST00000539504:missense:MODERATE:exon8/17:c.1433G>C:p.Gly478Ala,SYNE1:ENST00000356820:missense:MODERATE:exon52/61:c.8540G>C:p.Gly2847Ala,SYNE1:ENST00000423061:missense:MODERATE:exon136/146:c.24755G>C:p.Gly8252Ala,SYNE1:ENST00000341594:missense:MODERATE:exon138/147:c.23804G>C:p.Gly7935Ala,SYNE1:ENST00000448038:missense:MODERATE:exon137/147:c.24755G>C:p.Gly8252Ala,SYNE1:ENST00000354674:missense:MODERATE:exon8/18:c.1433G>C:p.Gly478Ala		rs2252755	0.3994	0.3592	8245,3497,1029	0.4441,0.5248,0.2989,0.3230,0.4191	0.3635	2.6650	T,T,T,T,T,T,T,T,.,T,T,T	T	B,B,B,B,B	T,T,T,T,T,T,T,T,T,T	9.18	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];	RCV000118468.3 [other]; RCV000259202.1 [benign]; RCV000355142.1 [benign]; 			443	1604	2	[2] auto-classification 15.09.2017  			SYNE1 (inh=AR+AD pLI=0.00)
chr6	152469204	152469204	G	A	het	pred_pathogenic;anno_omim	QUAL=3829;DP=183;AF=0.44;MQM=60;TRIO=HET,183,0.44,HET,157,0.54,WT,230,0.00	SYNE1	missense	SYNE1:ENST00000265368:missense:MODERATE:exon137/146:c.24952C>T:p.Leu8318Phe,SYNE1:ENST00000367255:missense:MODERATE:exon137/146:c.24952C>T:p.Leu8318Phe,SYNE1:ENST00000539504:missense:MODERATE:exon8/17:c.1417C>T:p.Leu473Phe,SYNE1:ENST00000356820:missense:MODERATE:exon52/61:c.8524C>T:p.Leu2842Phe,SYNE1:ENST00000423061:missense:MODERATE:exon136/146:c.24739C>T:p.Leu8247Phe,SYNE1:ENST00000341594:missense:MODERATE:exon138/147:c.23788C>T:p.Leu7930Phe,SYNE1:ENST00000448038:missense:MODERATE:exon137/147:c.24739C>T:p.Leu8247Phe,SYNE1:ENST00000354674:missense:MODERATE:exon8/18:c.1417C>T:p.Leu473Phe		rs141716975	0.0022	0.0053	2,2,0	0.0007,0.0014,0.0004,0.0071,0.0066	0.0053	6.9680	D,D,D,T,D,T,D,D,.,T,T,T	T	B,B,P,B,B	T,T,T,T,T,T,T,T,T,T	22.00	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];	RCV000174640.2 [other]; RCV000266178.1 [likely benign]; RCV000321230.1 [likely benign]; 			1	46	2	VUS2, MR, 14.07.2016, ExAC >0,5% [3] Julia Bickmann 29.01.2015 [2] ahrautm1 14.07.2016			SYNE1 (inh=AR+AD pLI=0.00)
chr6	152469331	152469331	C	T	het	anno_omim	QUAL=5708;DP=231;AF=0.48;MQM=60;TRIO=HET,231,0.48,HET,259,0.48,WT,375,0.00	SYNE1	synonymous	SYNE1:ENST00000265368:synonymous:LOW:exon137/146:c.24825G>A:p.Pro8275Pro,SYNE1:ENST00000367255:synonymous:LOW:exon137/146:c.24825G>A:p.Pro8275Pro,SYNE1:ENST00000539504:synonymous:LOW:exon8/17:c.1290G>A:p.Pro430Pro,SYNE1:ENST00000356820:synonymous:LOW:exon52/61:c.8397G>A:p.Pro2799Pro,SYNE1:ENST00000423061:synonymous:LOW:exon136/146:c.24612G>A:p.Pro8204Pro,SYNE1:ENST00000341594:synonymous:LOW:exon138/147:c.23661G>A:p.Pro7887Pro,SYNE1:ENST00000448038:synonymous:LOW:exon137/147:c.24612G>A:p.Pro8204Pro,SYNE1:ENST00000354674:synonymous:LOW:exon8/18:c.1290G>A:p.Pro430Pro		rs2252748	0.3395	0.3130	6398,2580,499	0.3071,0.4892,0.2943,0.2768,0.4011	0.3194							608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];	RCV000118467.3 [other]; RCV000345658.1 [benign]; RCV000381473.1 [benign]; 		COSM3761568, COSM3761564, COSM3761567, COSM3761566, COSM3761565	338	1501	1	[1] old entry - no details available			SYNE1 (inh=AR+AD pLI=0.00)
chr6	152532702	152532702	T	C	het	pred_pathogenic;anno_omim	QUAL=7134;DP=340;AF=0.50;MQM=60;TRIO=HET,340,0.50,WT,146,0.00,HET,235,0.42	SYNE1	missense	SYNE1:ENST00000265368:missense:MODERATE:exon124/146:c.22516A>G:p.Ser7506Gly,SYNE1:ENST00000367255:missense:MODERATE:exon124/146:c.22516A>G:p.Ser7506Gly,SYNE1:ENST00000356820:missense:MODERATE:exon39/61:c.6088A>G:p.Ser2030Gly,SYNE1:ENST00000423061:missense:MODERATE:exon123/146:c.22303A>G:p.Ser7435Gly,SYNE1:ENST00000341594:missense:MODERATE:exon125/147:c.21352A>G:p.Ser7118Gly,SYNE1:ENST00000448038:missense:MODERATE:exon124/147:c.22303A>G:p.Ser7435Gly		rs35763277	0.0046	0.0137	24,22,0	0.0033,0.0020,0.0000,0.0205,0.0029	0.0129	7.9410	T,T,T,T,T,T,T,T	T	D,D,D,D	T,T,T,T,T,T,T,T	27.90	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];	RCV000118462.2 [likely benign]; RCV000348766.1 [likely benign]; RCV000394571.1 [likely benign]; 			0	125					SYNE1 (inh=AR+AD pLI=0.00)
chr6	152534768	152534768	C	T	het	anno_omim	QUAL=7394;DP=293;AF=0.48;MQM=60;TRIO=HET,293,0.48,WT,213,0.00,HET,275,0.50	SYNE1	synonymous	SYNE1:ENST00000265368:synonymous:LOW:exon123/146:c.22473G>A:p.Leu7491Leu,SYNE1:ENST00000367255:synonymous:LOW:exon123/146:c.22473G>A:p.Leu7491Leu,SYNE1:ENST00000356820:synonymous:LOW:exon38/61:c.6045G>A:p.Leu2015Leu,SYNE1:ENST00000423061:synonymous:LOW:exon122/146:c.22260G>A:p.Leu7420Leu,SYNE1:ENST00000341594:synonymous:LOW:exon124/147:c.21309G>A:p.Leu7103Leu,SYNE1:ENST00000448038:synonymous:LOW:exon123/147:c.22260G>A:p.Leu7420Leu		rs34891041	0.0206	0.0261	60,47,7	0.0463,0.0073,0.0068,0.0328,0.0064	0.0329							608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];	RCV000118461.3 [other]; RCV000298409.1 [likely benign]; RCV000394551.1 [likely benign]; 			4	197					SYNE1 (inh=AR+AD pLI=0.00)
chr6	152540278	152540278	A	C	hom	anno_omim	QUAL=26106;DP=310;AF=1.00;MQM=59;TRIO=HOM,310,1.00,HOM,215,1.00,HOM,278,1.00	SYNE1	missense	SYNE1:ENST00000265368:missense:MODERATE:exon120/146:c.21904T>G:p.Phe7302Val,SYNE1:ENST00000367255:missense:MODERATE:exon120/146:c.21904T>G:p.Phe7302Val,SYNE1:ENST00000356820:missense:MODERATE:exon35/61:c.5476T>G:p.Phe1826Val,SYNE1:ENST00000423061:missense:MODERATE:exon119/146:c.21691T>G:p.Phe7231Val,SYNE1:ENST00000341594:missense:MODERATE:exon121/147:c.20740T>G:p.Phe6914Val,SYNE1:ENST00000448038:missense:MODERATE:exon120/147:c.21691T>G:p.Phe7231Val		rs2147377	0.9956	0.9923	59771,32617,5183	0.9981,0.9946,1.0000,0.9886,0.9988	0.9922	1.3490	T,T,T,T,T,T,T	T	B,B,B,B	T,T,T,T,T,T,T	0.98	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];	RCV000118459.4 [other]; RCV000269574.1 [benign]; RCV000361971.1 [benign]; 			3489	68	1	[1] old entry - no details available	n/a (11xTP, 0xFP)		SYNE1 (inh=AR+AD pLI=0.00)
chr6	152615200	152615200	G	A	hom	anno_omim	QUAL=18883;DP=366;AF=1.00;MQM=60;TRIO=HOM,366,1.00,HET,245,0.57,HET,296,0.48	SYNE1	synonymous	SYNE1:ENST00000265368:synonymous:LOW:exon94/146:c.17745C>T:p.His5915His,SYNE1:ENST00000367255:synonymous:LOW:exon94/146:c.17745C>T:p.His5915His,SYNE1:ENST00000356820:synonymous:LOW:exon9/61:c.1317C>T:p.His439His,SYNE1:ENST00000423061:synonymous:LOW:exon93/146:c.17532C>T:p.His5844His,SYNE1:ENST00000341594:synonymous:LOW:exon95/147:c.16581C>T:p.His5527His,SYNE1:ENST00000448038:synonymous:LOW:exon94/147:c.17532C>T:p.His5844His		rs12664753	0.1478	0.1875	2359,1241,12	0.0368,0.2182,0.1907,0.1932,0.2189	0.1913							608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];	RCV000118454.3 [other]; RCV000330934.1 [benign]; RCV000385411.1 [benign]; 			157	1061	1	[1] Julia Bickmann 18.09.2014	n/a (2xTP, 0xFP)		SYNE1 (inh=AR+AD pLI=0.00)
chr6	152629773	152629773	A	-	het	anno_omim	QUAL=484;DP=155;AF=0.17;MQM=59;TRIO=HET,155,0.17,HET,70,0.51,WT,86,0.16	SYNE1	splice_region&intron	SYNE1:ENST00000265368:splice_region&intron:LOW:exon90/145:c.17207-10delT:,SYNE1:ENST00000367255:splice_region&intron:LOW:exon90/145:c.17203-6delT:,SYNE1:ENST00000356820:splice_region&intron:LOW:exon5/60:c.779-10delT:,SYNE1:ENST00000423061:splice_region&intron:LOW:exon89/145:c.16994-10delT:,SYNE1:ENST00000341594:splice_region&intron:LOW:exon91/146:c.16039-6delT:,SYNE1:ENST00000448038:splice_region&intron:LOW:exon90/146:c.16994-10delT:		rs535229755;rs55633181;rs796838050	0.4265	0.4174	1972,899,64	0.3202,0.4995,0.5168,0.4073,0.4128	0.4328							608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];	RCV000203031.1 [benign]; 			436	1508	2	[2] auto-classification 15.09.2017  			SYNE1 (inh=AR+AD pLI=0.00)
chr6	152647681	152647681	A	T	het	pred_pathogenic;anno_omim	QUAL=16374;DP=488;AF=0.50;MQM=60;TRIO=HET,488,0.50,HET,323,0.53,HET,425,0.51	SYNE1	missense	SYNE1:ENST00000265368:missense:MODERATE:exon79/146:c.15043T>A:p.Leu5015Met,SYNE1:ENST00000367255:missense:MODERATE:exon79/146:c.15043T>A:p.Leu5015Met,SYNE1:ENST00000423061:missense:MODERATE:exon78/146:c.14830T>A:p.Leu4944Met,SYNE1:ENST00000341594:missense:MODERATE:exon82/147:c.14284T>A:p.Leu4762Met,SYNE1:ENST00000448038:missense:MODERATE:exon79/147:c.14830T>A:p.Leu4944Met		rs2306916	0.8147	0.7797	37372,19174,4518	0.9316,0.8756,0.8384,0.7581,0.6443	0.8331	2.9340	T,T,T,T,T	T	B,B,B,B	T,T,T,T,T	16.07	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];	RCV000118448.3 [other]; RCV000296846.1 [benign]; RCV000335569.1 [benign]; 			1902	1380	2	[2] auto-classification 15.09.2017  			SYNE1 (inh=AR+AD pLI=0.00)
chr6	152652034	152652034	A	T	het	anno_omim	QUAL=9480;DP=189;AF=0.58;MQM=60;TRIO=HET,189,0.58,HET,189,0.56,HET,257,0.57	SYNE1	missense	SYNE1:ENST00000265368:missense:MODERATE:exon78/146:c.13786T>A:p.Ser4596Thr,SYNE1:ENST00000367255:missense:MODERATE:exon78/146:c.13786T>A:p.Ser4596Thr,SYNE1:ENST00000423061:missense:MODERATE:exon77/146:c.13573T>A:p.Ser4525Thr,SYNE1:ENST00000341594:missense:MODERATE:exon81/147:c.13027T>A:p.Ser4343Thr,SYNE1:ENST00000448038:missense:MODERATE:exon78/147:c.13573T>A:p.Ser4525Thr		rs6911096	0.8033	0.7760	36980,19174,4081	0.8869,0.8730,0.8461,0.7577,0.6448	0.8219	-2.5130	T,T,T,T,T	T	B,B,B,B	T,T,T,T,T	0.01	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];	RCV000118444.3 [other]; RCV000290438.1 [benign]; RCV000387036.1 [benign]; 		COSM450728, COSM450729, COSM1487365	1901	1380	2	[2] auto-classification 15.09.2017  			SYNE1 (inh=AR+AD pLI=0.00)
chr6	152658062	152658062	C	G	het	pred_pathogenic;anno_omim	QUAL=7816;DP=318;AF=0.44;MQM=60;TRIO=HET,318,0.44,WT,173,0.01,HET,310,0.50	SYNE1	missense	SYNE1:ENST00000265368:missense:MODERATE:exon76/146:c.12442G>C:p.Asp4148His,SYNE1:ENST00000367255:missense:MODERATE:exon76/146:c.12442G>C:p.Asp4148His,SYNE1:ENST00000423061:missense:MODERATE:exon75/146:c.12229G>C:p.Asp4077His,SYNE1:ENST00000341594:missense:MODERATE:exon78/147:c.12037G>C:p.Asp4013His,SYNE1:ENST00000448038:missense:MODERATE:exon76/147:c.12229G>C:p.Asp4077His		rs117501809	0.0124	0.0272	70,46,0	0.0063,0.0103,0.0002,0.0358,0.0296	0.0255	7.8150	D,D,D,D,D	T	D,D,D,D	T,T,T,T,T	32.00	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];	RCV000118441.2 [likely benign]; RCV000270994.1 [likely benign]; RCV000365811.1 [likely benign]; 			10	237					SYNE1 (inh=AR+AD pLI=0.00)
chr6	152658142	152658142	T	C	het	anno_omim	QUAL=7102;DP=155;AF=0.51;MQM=60;TRIO=HET,155,0.51,HET,133,0.50,HET,247,0.53	SYNE1	missense	SYNE1:ENST00000265368:missense:MODERATE:exon76/146:c.12362A>G:p.Lys4121Arg,SYNE1:ENST00000367255:missense:MODERATE:exon76/146:c.12362A>G:p.Lys4121Arg,SYNE1:ENST00000423061:missense:MODERATE:exon75/146:c.12149A>G:p.Lys4050Arg,SYNE1:ENST00000341594:missense:MODERATE:exon78/147:c.11957A>G:p.Lys3986Arg,SYNE1:ENST00000448038:missense:MODERATE:exon76/147:c.12149A>G:p.Lys4050Arg		rs9479297	0.7931	0.7547	34481,18325,4464	0.9281,0.7058,0.8545,0.7478,0.6211	0.8208	1.4310	T,T,T,T,T	T	B,B,B,B	T,T,T,T,T	6.36	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];	RCV000118439.4 [other]; RCV000267635.1 [benign]; RCV000317782.1 [benign]; 			1846	1404	2	[2] auto-classification 15.09.2017  			SYNE1 (inh=AR+AD pLI=0.00)
chr6	152697675	152697675	G	T	het	anno_omim	QUAL=4423;DP=228;AF=0.49;MQM=60;TRIO=HET,228,0.49,HET,133,0.44,WT,220,0.00	SYNE1	synonymous	SYNE1:ENST00000265368:synonymous:LOW:exon58/146:c.9165C>A:p.Ser3055Ser,SYNE1:ENST00000367255:synonymous:LOW:exon58/146:c.9165C>A:p.Ser3055Ser,SYNE1:ENST00000423061:synonymous:LOW:exon58/146:c.9186C>A:p.Ser3062Ser,SYNE1:ENST00000341594:synonymous:LOW:exon61/147:c.9282C>A:p.Ser3094Ser,SYNE1:ENST00000448038:synonymous:LOW:exon59/147:c.9186C>A:p.Ser3062Ser		rs117020413	0.0068	0.0135	23,10,0	0.0024,0.0061,0.0000,0.0140,0.0300	0.0124	1.2490		T			6.88	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];	RCV000249270.1 [likely benign]; RCV000292676.1 [likely benign]; RCV000374319.1 [likely benign]; 			1	105					SYNE1 (inh=AR+AD pLI=0.00)
chr6	152772264	152772264	A	G	hom	pred_pathogenic;anno_omim	QUAL=18097;DP=347;AF=1.00;MQM=59;TRIO=HOM,347,1.00,HET,199,0.47,HET,278,0.54	SYNE1	missense	SYNE1:ENST00000265368:missense:MODERATE:exon26/146:c.3104T>C:p.Val1035Ala,SYNE1:ENST00000367255:missense:MODERATE:exon26/146:c.3104T>C:p.Val1035Ala,SYNE1:ENST00000423061:missense:MODERATE:exon26/146:c.3125T>C:p.Val1042Ala,SYNE1:ENST00000341594:missense:MODERATE:exon29/147:c.3302T>C:p.Val1101Ala,SYNE1:ENST00000448038:missense:MODERATE:exon27/147:c.3125T>C:p.Val1042Ala,SYNE1:ENST00000367253:missense:MODERATE:exon24/36:c.3104T>C:p.Val1035Ala,SYNE1:ENST00000367248:missense:MODERATE:exon25/32:c.3074T>C:p.Val1025Ala,SYNE1:ENST00000413186:missense:MODERATE:exon24/31:c.3104T>C:p.Val1035Ala		rs214976	0.6072	0.4812	15138,6165,2930	0.7486,0.3196,0.7569,0.4291,0.5196	0.5270	8.6440	D,D,D,D,D,D,D,D	D	B,B,B,B,B,B	T,T,T,T,T,D,D,D	23.40	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];	RCV000118478.3 [other]; RCV000283687.1 [benign]; RCV000340993.1 [benign]; 			762	1707	1	[1] old entry - no details available			SYNE1 (inh=AR+AD pLI=0.00)
chr6	152774753	152774753	C	T	het	pred_pathogenic;anno_omim	QUAL=4906;DP=244;AF=0.50;MQM=59;TRIO=HET,244,0.50,HET,123,0.59,WT,142,0.00	SYNE1	missense	SYNE1:ENST00000265368:missense:MODERATE:exon25/146:c.2995G>A:p.Glu999Lys,SYNE1:ENST00000367255:missense:MODERATE:exon25/146:c.2995G>A:p.Glu999Lys,SYNE1:ENST00000423061:missense:MODERATE:exon25/146:c.3016G>A:p.Glu1006Lys,SYNE1:ENST00000341594:missense:MODERATE:exon28/147:c.3193G>A:p.Glu1065Lys,SYNE1:ENST00000448038:missense:MODERATE:exon26/147:c.3016G>A:p.Glu1006Lys,SYNE1:ENST00000367253:missense:MODERATE:exon23/36:c.2995G>A:p.Glu999Lys,SYNE1:ENST00000367248:missense:MODERATE:exon24/32:c.2965G>A:p.Glu989Lys,SYNE1:ENST00000413186:missense:MODERATE:exon23/31:c.2995G>A:p.Glu999Lys,SYNE1:ENST00000495090:missense:MODERATE:exon12/12:c.1696G>A:p.Glu566Lys		rs148346599	0.0020	0.0034	2,0,0	0.0001,0.0001,0.0000,0.0032,0.0032	0.0038	7.3880	D,D,D,D,D,D,T,D,T	T	P,P,P,D,D,P,D	T,T,T,T,T,T,T,T,T	27.30	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];	RCV000310826.1 [likely benign]; RCV000314697.1 [benign]; RCV000400469.1 [likely benign]; 		COSM231095, COSM231094	0	14					SYNE1 (inh=AR+AD pLI=0.00)
chr6	152809527	152809527	A	T	hom	anno_omim	QUAL=8860;DP=181;AF=1.00;MQM=59;TRIO=HOM,181,1.00,HET,88,0.56,HET,136,0.45	SYNE1	splice_region&intron	SYNE1:ENST00000265368:splice_region&intron:LOW:exon12/145:c.1047+4T>A:,SYNE1:ENST00000367255:splice_region&intron:LOW:exon12/145:c.1047+4T>A:,SYNE1:ENST00000423061:splice_region&intron:LOW:exon12/145:c.1068+4T>A:,SYNE1:ENST00000341594:splice_region&intron:LOW:exon12/146:c.1047+4T>A:,SYNE1:ENST00000448038:splice_region&intron:LOW:exon13/146:c.1068+4T>A:,SYNE1:ENST00000367253:splice_region&intron:LOW:exon10/35:c.1047+4T>A:,SYNE1:ENST00000367248:splice_region&intron:LOW:exon11/31:c.1017+4T>A:,SYNE1:ENST00000413186:splice_region&intron:LOW:exon10/30:c.1047+4T>A:,SYNE1:ENST00000466159:splice_region&intron:LOW:exon10/17:c.1047+4T>A:		rs9397106	0.5893	0.4810	14464,6127,2331	0.6737,0.3159,0.7564,0.4370,0.5286	0.5098							608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];	RCV000118432.4 [other]; RCV000320090.1 [benign]; RCV000374713.1 [benign]; 			772	1682	1	[1] Julia Bickmann 18.09.2014	n/a (4xTP, 0xFP)		SYNE1 (inh=AR+AD pLI=0.00)
chr6	152958461	152958461	G	A	het	anno_omim	QUAL=1282;DP=52;AF=0.52;MQM=60;TRIO=HET,52,0.52,WT,86,0.00,HET,104,0.38	SYNE1	5'UTR	SYNE1:ENST00000265368:5'UTR:MODIFIER:exon1/146:c.-529C>T:,SYNE1:ENST00000367255:5'UTR:MODIFIER:exon1/146:c.-529C>T:,SYNE1:ENST00000341594:5'UTR:MODIFIER:exon1/147:c.-529C>T:,SYNE1:ENST00000448038:5'UTR:MODIFIER:exon1/147:c.-529C>T:		rs9478345	0.3301	0.0000	0,0,0	0,0,0,0,0	0.3290							608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];				22	113					SYNE1 (inh=AR+AD pLI=0.00)
chr6	157522360	157522360	G	A	het	anno_omim	QUAL=6665;DP=203;AF=0.56;MQM=59;TRIO=HET,203,0.56,HET,311,0.50,WT,419,0.00	ARID1B	synonymous	ARID1B:ENST00000367148:synonymous:LOW:exon18/20:c.4752G>A:p.Pro1584Pro,ARID1B:ENST00000350026:synonymous:LOW:exon17/19:c.4593G>A:p.Pro1531Pro,ARID1B:ENST00000346085:synonymous:LOW:exon18/20:c.4632G>A:p.Pro1544Pro,ARID1B:ENST00000275248:synonymous:LOW:exon18/20:c.4578G>A:p.Pro1526Pro		rs61738955	0.0184	0.0269	52,40,0	0.0060,0.0219,0.0001,0.0367,0.0144	0.0278							614556 [ARID1B (confirmed) Coffin-Siris syndrome 1,135900];	RCV000114277.1 [benign]; 			7	123					ARID1B (inh=AD pLI=1.00)
chr6	157529844	157529844	C	T	het	anno_omim	QUAL=393;DP=105;AF=0.37;MQM=55;TRIO=HET,105,0.37,WT,37,0.11,HET,39,0.15	ARID1B	3'UTR	ARID1B:ENST00000367148:3'UTR:MODIFIER:exon20/20:c.*819C>T:,ARID1B:ENST00000350026:3'UTR:MODIFIER:exon19/19:c.*819C>T:,ARID1B:ENST00000346085:3'UTR:MODIFIER:exon20/20:c.*819C>T:,ARID1B:ENST00000275248:3'UTR:MODIFIER:exon20/20:c.*819C>T:	(T)n	rs879242544	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0012							614556 [ARID1B (confirmed) Coffin-Siris syndrome 1,135900];				2	38					ARID1B (inh=AD pLI=1.00)
chr6	157529849	157529849	C	T	hom	anno_omim	QUAL=878;DP=73;AF=0.52;MQM=54;TRIO=HOM,73,0.52,HOM,6,0.50,HOM,9,0.56	ARID1B	3'UTR	ARID1B:ENST00000367148:3'UTR:MODIFIER:exon20/20:c.*824C>T:,ARID1B:ENST00000350026:3'UTR:MODIFIER:exon19/19:c.*824C>T:,ARID1B:ENST00000346085:3'UTR:MODIFIER:exon20/20:c.*824C>T:,ARID1B:ENST00000275248:3'UTR:MODIFIER:exon20/20:c.*824C>T:	(T)n	rs139366986	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							614556 [ARID1B (confirmed) Coffin-Siris syndrome 1,135900];				14	108					ARID1B (inh=AD pLI=1.00)
chr6	158613375	158613375	A	-	het	anno_omim	QUAL=1051;DP=224;AF=0.21;MQM=59;TRIO=HET,224,0.21,HET,68,0.56,WT,87,0.09	GTF2H5	3'UTR	GTF2H5:ENST00000607778:3'UTR:MODIFIER:exon3/3:c.*198delA:		rs3841147	0.3193	0.0000	0,0,0	0,0,0,0,0	0.1784							608780 [GTF2H5 (confirmed) Trichothiodystrophy 3,photosensitive,616395];				8	90					GTF2H5 (inh=AR pLI=0.05)
chr6	158613603	158613603	A	C	het	anno_omim	QUAL=12177;DP=328;AF=0.49;MQM=60;TRIO=HET,328,0.49,HET,273,0.45,HET,316,0.56	GTF2H5	3'UTR	GTF2H5:ENST00000607778:3'UTR:MODIFIER:exon3/3:c.*414A>C:		rs4425618	0.4239	0.0000	0,0,0	0,0,0,0,0	0.3797							608780 [GTF2H5 (confirmed) Trichothiodystrophy 3,photosensitive,616395];				24	102					GTF2H5 (inh=AR pLI=0.05)
chr6	158613910	158613910	G	A	het	anno_omim	QUAL=3157;DP=132;AF=0.54;MQM=60;TRIO=HET,132,0.54,HET,47,0.66,HET,59,0.46	GTF2H5	3'UTR	GTF2H5:ENST00000607778:3'UTR:MODIFIER:exon3/3:c.*721G>A:	FRAM	rs9457163	0.4239	0.0000	0,0,0	0,0,0,0,0	0.3750							608780 [GTF2H5 (confirmed) Trichothiodystrophy 3,photosensitive,616395];				22	80					GTF2H5 (inh=AR pLI=0.05)
chr6	158614236	158614236	-	AGGAGGATGGCTTAAGCCC	het	anno_omim	QUAL=5018;DP=125;AF=0.26;MQM=59;TRIO=HET,125,0.26,HET,121,0.45,HET,161,0.53	GTF2H5	3'UTR	GTF2H5:ENST00000607778:3'UTR:MODIFIER:exon3/3:c.*1053_*1054insATGGCTTAAGCCCAGGAGG:	AluJo	rs6149883	0.3786	0.0000	0,0,0	0,0,0,0,0	0.3695							608780 [GTF2H5 (confirmed) Trichothiodystrophy 3,photosensitive,616395];				20	86					GTF2H5 (inh=AR pLI=0.05)
chr6	158614528	158614528	G	A	het	anno_omim	QUAL=7503;DP=338;AF=0.49;MQM=59;TRIO=HET,338,0.49,WT,181,0.00,HET,239,0.48	GTF2H5	3'UTR	GTF2H5:ENST00000607778:3'UTR:MODIFIER:exon3/3:c.*1339G>A:		rs35508045	0.0935	0.0000	0,0,0	0,0,0,0,0	0.1215							608780 [GTF2H5 (confirmed) Trichothiodystrophy 3,photosensitive,616395];				7	63					GTF2H5 (inh=AR pLI=0.05)
chr6	158615926	158615926	A	T	het	anno_omim	QUAL=11204;DP=389;AF=0.50;MQM=60;TRIO=HET,389,0.50,HET,202,0.47,HET,249,0.49	GTF2H5	3'UTR	GTF2H5:ENST00000607778:3'UTR:MODIFIER:exon3/3:c.*2737A>T:		rs1019682	0.7798	0.0000	0,0,0	0,0,0,0,0	0.7669							608780 [GTF2H5 (confirmed) Trichothiodystrophy 3,photosensitive,616395];				117	98					GTF2H5 (inh=AR pLI=0.05)
chr6	158616335	158616335	A	C	het	anno_omim	QUAL=4427;DP=204;AF=0.58;MQM=60;TRIO=HET,204,0.58,HET,35,0.46,HET,50,0.52	GTF2H5	3'UTR	GTF2H5:ENST00000607778:3'UTR:MODIFIER:exon3/3:c.*3146A>C:		rs10946159	0.3722	0.0000	0,0,0	0,0,0,0,0	0.3394							608780 [GTF2H5 (confirmed) Trichothiodystrophy 3,photosensitive,616395];				22	104					GTF2H5 (inh=AR pLI=0.05)
chr6	158616727	158616727	C	T	het	anno_omim	QUAL=11223;DP=443;AF=0.51;MQM=58;TRIO=HET,443,0.51,HET,152,0.54,HET,232,0.47	GTF2H5	3'UTR	GTF2H5:ENST00000607778:3'UTR:MODIFIER:exon3/3:c.*3538C>T:		rs1047876	0.4233	0.0000	0,0,0	0,0,0,0,0	0.3806							608780 [GTF2H5 (confirmed) Trichothiodystrophy 3,photosensitive,616395];				25	101					GTF2H5 (inh=AR pLI=0.05)
chr6	158616876	158616876	A	C	het	anno_omim	QUAL=7032;DP=312;AF=0.54;MQM=55;TRIO=HET,312,0.54,WT,133,0.00,HET,221,0.43	GTF2H5	3'UTR	GTF2H5:ENST00000607778:3'UTR:MODIFIER:exon3/3:c.*3687A>C:		rs4354181	0.0986	0.0000	0,0,0	0,0,0,0,0	0.1258							608780 [GTF2H5 (confirmed) Trichothiodystrophy 3,photosensitive,616395];				7	65					GTF2H5 (inh=AR pLI=0.05)
chr6	158617694	158617694	A	T	het	anno_omim	QUAL=5262;DP=300;AF=0.49;MQM=60;TRIO=HET,300,0.49,WT,103,0.00,HET,136,0.43	GTF2H5	3'UTR	GTF2H5:ENST00000607778:3'UTR:MODIFIER:exon3/3:c.*4505A>T:	HSMAR2	rs144679213	0.0126	0.0000	0,0,0	0,0,0,0,0	0.0169							608780 [GTF2H5 (confirmed) Trichothiodystrophy 3,photosensitive,616395];				1	14					GTF2H5 (inh=AR pLI=0.05)
chr6	158619409	158619409	G	A	hom	anno_omim	QUAL=32038;DP=470;AF=1.00;MQM=59;TRIO=HOM,470,1.00,HOM,214,1.00,HOM,285,1.00	GTF2H5	3'UTR	GTF2H5:ENST00000607778:3'UTR:MODIFIER:exon3/3:c.*6220G>A:		rs599345	0.8912	0.0000	0,0,0	0,0,0,0,0	0.8231							608780 [GTF2H5 (confirmed) Trichothiodystrophy 3,photosensitive,616395];				129	87					GTF2H5 (inh=AR pLI=0.05)
chr6	158619713	158619713	C	G	hom	anno_omim	QUAL=13106;DP=269;AF=0.99;MQM=59;TRIO=HOM,269,0.99,HOM,100,1.00,HET,149,0.37	GTF2H5	3'UTR	GTF2H5:ENST00000607778:3'UTR:MODIFIER:exon3/3:c.*6524C>G:	AluSz	rs615107	0.5677	0.0000	0,0,0	0,0,0,0,0	0.5476							608780 [GTF2H5 (confirmed) Trichothiodystrophy 3,photosensitive,616395];				84	106					GTF2H5 (inh=AR pLI=0.05)
chr6	158619948	158619948	G	C	het	anno_omim	QUAL=4640;DP=301;AF=0.48;MQM=60;TRIO=HET,301,0.48,WT,91,0.01,HET,96,0.34	GTF2H5	3'UTR	GTF2H5:ENST00000607778:3'UTR:MODIFIER:exon3/3:c.*6759G>C:		rs71563797	0.1032	0.0000	0,0,0	0,0,0,0,0	0.1265							608780 [GTF2H5 (confirmed) Trichothiodystrophy 3,photosensitive,616395];				7	62					GTF2H5 (inh=AR pLI=0.05)
chr6	161132146	161132146	C	T	het	anno_omim	QUAL=6046;DP=229;AF=0.47;MQM=55;TRIO=HET,229,0.47,HET,310,0.48,WT,369,0.00	PLG	synonymous	PLG:ENST00000308192:synonymous:LOW:exon4/19:c.330C>T:p.Asn110Asn,PLG:ENST00000366924:synonymous:LOW:exon4/4:c.330C>T:p.Asn110Asn		rs4757	0.2494	0.2627	5054,3267,1239	0.4892,0.1376,0.0010,0.3118,0.1447	0.3245							173350 [PLG (confirmed) Dysplasminogenemia,217090|Plasminogen deficiency,type I,217090];				273	899	2	[2] auto-classification 15.09.2017  			PLG (inh=AR pLI=0.00)
chr6	161132417	161132417	T	G	het	low_MQM;anno_omim	QUAL=6350;DP=322;AF=0.48;MQM=48;TRIO=HET,322,0.48,HET,209,0.47,WT,281,0.00	PLG	3'UTR,intron	PLG:ENST00000366924:3'UTR:MODIFIER:exon4/4:c.*190T>G:,PLG:ENST00000308192:intron:MODIFIER:exon4/18:c.407+194T>G:	MER2	rs4252082	0.2486	0.0000	0,0,0	0,0,0,0,0	0.3250							173350 [PLG (confirmed) Dysplasminogenemia,217090|Plasminogen deficiency,type I,217090];				17	74					PLG (inh=AR pLI=0.00)
chr6	161132725	161132725	T	C	het	anno_omim	QUAL=6300;DP=257;AF=0.53;MQM=57;TRIO=HET,257,0.53,HET,162,0.57,WT,198,0.00	PLG	3'UTR,intron	PLG:ENST00000366924:3'UTR:MODIFIER:exon4/4:c.*498T>C:,PLG:ENST00000308192:intron:MODIFIER:exon4/18:c.407+502T>C:		rs4252086	0.2486	0.0000	0,0,0	0,0,0,0,0	0.3252							173350 [PLG (confirmed) Dysplasminogenemia,217090|Plasminogen deficiency,type I,217090];				17	74	2	[2] auto-classification 15.09.2017  			PLG (inh=AR pLI=0.00)
chr6	161132804	161132804	T	C	het	anno_omim	QUAL=7321;DP=284;AF=0.53;MQM=56;TRIO=HET,284,0.53,HET,213,0.56,WT,317,0.00	PLG	3'UTR,intron	PLG:ENST00000366924:3'UTR:MODIFIER:exon4/4:c.*577T>C:,PLG:ENST00000308192:intron:MODIFIER:exon4/18:c.407+581T>C:		rs1853018	0.2486	0.0000	0,0,0	0,0,0,0,0	0.3250							173350 [PLG (confirmed) Dysplasminogenemia,217090|Plasminogen deficiency,type I,217090];				17	73	2	[2] auto-classification 15.09.2017  			PLG (inh=AR pLI=0.00)
chr6	161132830	161132830	G	A	hom	anno_omim	QUAL=30607;DP=347;AF=1.00;MQM=58;TRIO=HOM,347,1.00,HOM,243,1.00,HOM,332,1.00	PLG	3'UTR,intron	PLG:ENST00000366924:3'UTR:MODIFIER:exon4/4:c.*603G>A:,PLG:ENST00000308192:intron:MODIFIER:exon4/18:c.407+607G>A:		rs1830519	0.6066	0.0000	0,0,0	0,0,0,0,0	0.7057							173350 [PLG (confirmed) Dysplasminogenemia,217090|Plasminogen deficiency,type I,217090];				91	54					PLG (inh=AR pLI=0.00)
chr6	161137779	161137779	T	C	het	anno_omim	QUAL=5663;DP=133;AF=0.57;MQM=60;TRIO=HET,133,0.57,HET,55,0.58,HOM,97,0.99	PLG	synonymous	PLG:ENST00000308192:synonymous:LOW:exon7/19:c.771T>C:p.Cys257Cys		rs14224	0.4499	0.4217	10982,5880,1443	0.5299,0.3055,0.4383,0.4207,0.4559	0.4432							173350 [PLG (confirmed) Dysplasminogenemia,217090|Plasminogen deficiency,type I,217090];				410	1066	2	[2] auto-classification 15.09.2017  			PLG (inh=AR pLI=0.00)
chr6	161137790	161137790	G	A	het	pred_pathogenic;anno_omim	QUAL=1394;DP=112;AF=0.41;MQM=60;TRIO=HET,112,0.41,HET,51,0.41,WT,84,0.00	PLG	missense	PLG:ENST00000308192:missense:MODERATE:exon7/19:c.782G>A:p.Arg261His		rs4252187	0.0008	0.0031	1,1,0	0.0005,0.0004,0.0000,0.0049,0.0001	0.0027	4.4140	D	T	P	T	25.10	173350 [PLG (confirmed) Dysplasminogenemia,217090|Plasminogen deficiency,type I,217090];				0	12					PLG (inh=AR pLI=0.00)
chr6	161139480	161139480	C	T	het	anno_omim	QUAL=11006;DP=325;AF=0.54;MQM=60;TRIO=HET,325,0.54,HET,114,0.49,HOM,185,1.00	PLG	synonymous	PLG:ENST00000308192:synonymous:LOW:exon8/19:c.942C>T:p.Phe314Phe		rs1130656	0.3498	0.3786	8956,5424,342	0.2552,0.2742,0.4382,0.4026,0.4104	0.3749							173350 [PLG (confirmed) Dysplasminogenemia,217090|Plasminogen deficiency,type I,217090];			COSM1131985	318	972	2	[2] auto-classification 15.09.2017  			PLG (inh=AR pLI=0.00)
chr6	161139857	161139857	A	G	het	anno_omim	QUAL=5035;DP=219;AF=0.42;MQM=59;TRIO=HET,219,0.42,HET,186,0.58,WT,260,0.00	PLG	synonymous	PLG:ENST00000308192:synonymous:LOW:exon9/19:c.1083A>G:p.Gln361Gln		rs13231	0.1364	0.2155	3405,2875,155	0.1717,0.1044,0.0007,0.2939,0.0974	0.2291							173350 [PLG (confirmed) Dysplasminogenemia,217090|Plasminogen deficiency,type I,217090];				163	843	2	[2] auto-classification 15.09.2017  			PLG (inh=AR pLI=0.00)
chr6	161143608	161143608	T	C	het	anno_omim	QUAL=3780;DP=192;AF=0.43;MQM=60;TRIO=HET,192,0.43,HET,153,0.48,WT,189,0.01	PLG	splice_region&intron	PLG:ENST00000308192:splice_region&intron:LOW:exon10/18:c.1256+9T>C:		rs4252120	0.1400	0.2171	3457,2904,170	0.1779,0.1047,0.0007,0.2954,0.0992	0.2320							173350 [PLG (confirmed) Dysplasminogenemia,217090|Plasminogen deficiency,type I,217090];				164	847	2	[2] auto-classification 15.09.2017  			PLG (inh=AR pLI=0.00)
chr6	161152240	161152240	G	A	het	anno_omim	QUAL=4322;DP=217;AF=0.48;MQM=60;TRIO=HET,217,0.48,HET,153,0.51,WT,199,0.00	PLG	missense	PLG:ENST00000308192:missense:MODERATE:exon11/19:c.1414G>A:p.Asp472Asn		rs4252125	0.1398	0.2171	3455,2903,170	0.1781,0.1048,0.0007,0.2954,0.0989	0.2316	0.0580	T	T	B	T	0.10	173350 [PLG (confirmed) Dysplasminogenemia,217090|Plasminogen deficiency,type I,217090];		CM043559 [CLASS=DFP MUT=ALT PHEN="Invasive aspergillosis susceptibility" GENE=PLG]; 		161	849	2	[2] auto-classification 15.09.2017  			PLG (inh=AR pLI=0.00)
chr6	161174658	161174658	G	A	het	low_MQM;anno_omim	QUAL=11403;DP=243;AF=0.52;MQM=46;TRIO=HET,243,0.52,HOM,180,1.00,HET,198,0.50	PLG,RP11,235G24.1	intergenic_region	235G24.1:ENSG00000122194-ENSG00000224371:intergenic_region:MODIFIER::n.161174658G>A:		rs783167	0.8738	0.0000	0,0,0	0,0,0,0,0	0.8438							173350 [PLG (confirmed) Dysplasminogenemia,217090|Plasminogen deficiency,type I,217090];				102	48					PLG (inh=AR pLI=0.00), PRPF31 (inh=AD pLI=0.97), 235G24.1 (inh=n/a pLI=n/a)
chr6	161174933	161174933	C	T	het	anno_omim	QUAL=14184;DP=456;AF=0.47;MQM=60;TRIO=HET,456,0.47,WT,539,0.00,HET,656,0.49	PLG,RP11,235G24.1	intergenic_region	235G24.1:ENSG00000122194-ENSG00000224371:intergenic_region:MODIFIER::n.161174933C>T:		rs4252199	0.0110	0.0000	0,0,0	0,0,0,0,0	0.0133							173350 [PLG (confirmed) Dysplasminogenemia,217090|Plasminogen deficiency,type I,217090];				1	8					PLG (inh=AR pLI=0.00), PRPF31 (inh=AD pLI=0.97), 235G24.1 (inh=n/a pLI=n/a)
chr6	161175004	161175004	C	T	het	anno_omim	QUAL=13966;DP=537;AF=0.51;MQM=55;TRIO=HET,537,0.51,HET,541,0.48,WT,653,0.00	PLG,RP11,235G24.1	intergenic_region	235G24.1:ENSG00000122194-ENSG00000224371:intergenic_region:MODIFIER::n.161175004C>T:		rs4252181	0.1126	0.0000	0,0,0	0,0,0,0,0	0.1987							173350 [PLG (confirmed) Dysplasminogenemia,217090|Plasminogen deficiency,type I,217090];				11	69					PLG (inh=AR pLI=0.00), PRPF31 (inh=AD pLI=0.97), 235G24.1 (inh=n/a pLI=n/a)
chr6	161768651	161768651	G	T	het	anno_omim	QUAL=238;DP=37;AF=0.35;MQM=54;TRIO=HET,37,0.35,WT,541,0.48,HOM,2,1.00	PARK2	3'UTR	PARK2:ENST00000366898:3'UTR:MODIFIER:exon12/12:c.*2480C>A:	AluSg4	rs68121389	0.4990	0.0000	0,0,0	0,0,0,0,0	0.3417							602544 [PARK2 (confirmed) Parkinson disease,juvenile,type 2,600116|Adenocarcinoma of lung,somatic,211980|Adenocarcinoma,ovarian,somatic,167000|Leprosy,susceptibility to,607572];	RCV000377590.1 [benign]; 			27	53					PRKN (inh=AR pLI=0.02)
chr6	161769835	161769835	T	C	het	anno_omim	QUAL=11219;DP=420;AF=0.53;MQM=59;TRIO=HET,420,0.53,WT,359,0.00,HET,444,0.48	PARK2	3'UTR	PARK2:ENST00000366898:3'UTR:MODIFIER:exon12/12:c.*1296A>G:,PARK2:ENST00000366896:3'UTR:MODIFIER:exon9/9:c.*1296A>G:,PARK2:ENST00000366897:3'UTR:MODIFIER:exon11/11:c.*1296A>G:		rs3734464	0.0577	0.0000	0,0,0	0,0,0,0,0	0.0836							602544 [PARK2 (confirmed) Parkinson disease,juvenile,type 2,600116|Adenocarcinoma of lung,somatic,211980|Adenocarcinoma,ovarian,somatic,167000|Leprosy,susceptibility to,607572];	RCV000376877.1 [likely benign]; 			2	51					PRKN (inh=AR pLI=0.02)
chr6	167369897	167369897	C	A	het	low_DP;anno_omim	QUAL=1197;DP=18;AF=0.56;MQM=59;TRIO=HET,18,0.56,WT,60,0.02,HET,86,0.52	RNASET2	5'UTR,intron	RNASET2:ENST00000366855:5'UTR:MODIFIER:exon1/10:c.-474G>T:,RNASET2:ENST00000508775:5'UTR:MODIFIER:exon1/9:c.-227G>T:,RNASET2:ENST00000476238:intron:MODIFIER:exon1/9:c.-9-218G>T:		rs1044059	0.6737	0.0000	0,0,0	0,0,0,0,0	0.5791							612944 [RNASET2 (provisional) Leukoencephalopathy,cystic,without megalencephaly,612951];	RCV000402342.1 [benign]; 			67	100					RNASET2 (inh=AR pLI=0.01)
chr6	167369992	167369992	A	G	het	low_DP;anno_omim	QUAL=598;DP=11;AF=0.64;MQM=60;TRIO=HET,11,0.64,WT,26,0.00,HET,38,0.58	RNASET2	5'UTR,intron	RNASET2:ENST00000366855:5'UTR:MODIFIER:exon1/10:c.-569T>C:,RNASET2:ENST00000508775:5'UTR:MODIFIER:exon1/9:c.-322T>C:,RNASET2:ENST00000476238:intron:MODIFIER:exon1/9:c.-9-313T>C:		rs2247325	0.6396	0.0000	0,0,0	0,0,0,0,0	0.4827							612944 [RNASET2 (provisional) Leukoencephalopathy,cystic,without megalencephaly,612951];	RCV000260374.1 [benign]; 			36	88					RNASET2 (inh=AR pLI=0.01)
chr6	170871040	170871040	A	G	het	low_DP;anno_omim	QUAL=7055;DP=16;AF=0.00;MQM=59;TRIO=HET,16,0.00,WT,449,0.31,HET,379,0.47	TBP	synonymous	TBP:ENST00000230354:synonymous:LOW:exon3/8:c.216A>G:p.Gln72Gln,TBP:ENST00000392092:synonymous:LOW:exon3/8:c.216A>G:p.Gln72Gln,TBP:ENST00000540980:synonymous:LOW:exon2/7:c.156A>G:p.Gln52Gln	(GCA)n	rs55736770	0.0000	0.0082	3,2,0	0.0046,0.0024,0.0173,0.0090,0.0114	0.0807							600075 [TBP (confirmed) Spinocerebellar ataxia 17,607136|Parkinson disease,susceptibility to,168600];	RCV000118598.2 [likely benign]; 		COSM3723811	34	391	2	[2] auto-classification 15.09.2017  			TBP (inh=AD pLI=0.49)
chr6	170871043	170871043	G	A	het	low_DP;anno_omim	QUAL=7055;DP=16;AF=0.00;MQM=59;TRIO=HET,16,0.00,WT,449,0.31,HET,379,0.47	TBP	synonymous	TBP:ENST00000230354:synonymous:LOW:exon3/8:c.219G>A:p.Gln73Gln,TBP:ENST00000392092:synonymous:LOW:exon3/8:c.219G>A:p.Gln73Gln,TBP:ENST00000540980:synonymous:LOW:exon2/7:c.159G>A:p.Gln53Gln	(GCA)n	rs764035011	0.0000	0.0001	0,0,0	0.0000,0.0000,0.0000,0.0001,0.0002	0.0009							600075 [TBP (confirmed) Spinocerebellar ataxia 17,607136|Parkinson disease,susceptibility to,168600];			COSM1076231	8	52	1	[1] Tanja Benkert 20.04.2015 [n/a] comment imported from detected variant: 20.04.2015, TCB: Poly-Q, auch in Kontrolle (SCA-V4)			TBP (inh=AD pLI=0.49)
chr6	170871046	170871046	A	G	het	low_DP;anno_omim	QUAL=7055;DP=16;AF=0.00;MQM=59;TRIO=HET,16,0.00,WT,449,0.29,HET,379,0.00	TBP	synonymous	TBP:ENST00000230354:synonymous:LOW:exon3/8:c.222A>G:p.Gln74Gln,TBP:ENST00000392092:synonymous:LOW:exon3/8:c.222A>G:p.Gln74Gln,TBP:ENST00000540980:synonymous:LOW:exon2/7:c.162A>G:p.Gln54Gln	(GCA)n	rs62430309	0.0000	0.0029	4,3,0	0.0004,0.0006,0.0024,0.0034,0.0057	0.0645							600075 [TBP (confirmed) Spinocerebellar ataxia 17,607136|Parkinson disease,susceptibility to,168600];			COSM2156799	75	290	2	[2] auto-classification 15.09.2017  			TBP (inh=AD pLI=0.49)
chr6	170871049	170871049	G	A	het	low_DP;anno_omim	QUAL=7055;DP=16;AF=0.00;MQM=59;TRIO=HET,16,0.00,WT,449,0.31,HET,379,0.47	TBP	synonymous	TBP:ENST00000230354:synonymous:LOW:exon3/8:c.225G>A:p.Gln75Gln,TBP:ENST00000392092:synonymous:LOW:exon3/8:c.225G>A:p.Gln75Gln,TBP:ENST00000540980:synonymous:LOW:exon2/7:c.165G>A:p.Gln55Gln	(GCA)n	rs56241301	0.0000	0.0066	3,2,0	0.0015,0.0017,0.0024,0.0074,0.0074	0.0621							600075 [TBP (confirmed) Spinocerebellar ataxia 17,607136|Parkinson disease,susceptibility to,168600];			COSM595316	52	249	1	[1] Tanja Benkert 20.04.2015 [n/a] comment imported from detected variant: 20.04.2015, TCB: Poly-Q, auch in Kontrolle (SCA-V4)			TBP (inh=AD pLI=0.49)
chr6	170878793	170878793	T	C	hom	anno_omim	QUAL=17626;DP=309;AF=1.00;MQM=59;TRIO=HOM,309,1.00,HET,250,0.49,HET,338,0.47	TBP	synonymous	TBP:ENST00000230354:synonymous:LOW:exon6/8:c.771T>C:p.Asn257Asn,TBP:ENST00000392092:synonymous:LOW:exon6/8:c.771T>C:p.Asn257Asn,TBP:ENST00000540980:synonymous:LOW:exon5/7:c.711T>C:p.Asn237Asn		rs1042327	0.6146	0.5319	17709,8802,2320	0.6648,0.4475,0.7946,0.5124,0.4683	0.5633	0.3870		T			7.96	600075 [TBP (confirmed) Spinocerebellar ataxia 17,607136|Parkinson disease,susceptibility to,168600];	RCV000118601.2 [likely benign]; 			580	1086	2	[2] auto-classification 15.09.2017  			TBP (inh=AD pLI=0.49)
chr7	286402	286402	A	G	het	anno_omim	QUAL=5419;DP=165;AF=0.36;MQM=59;TRIO=HET,165,0.36,HOM,147,0.99,WT,325,0.00	FAM20C	synonymous	FAM20C:ENST00000313766:synonymous:LOW:exon4/10:c.885A>G:p.Thr295Thr		rs141256626	0.2883	0.2681	691,195,228	0.5267,0.1852,0.1392,0.2346,0.2482	0.3020							611061 [FAM20C (confirmed) Raine syndrome,259775];	RCV000303341.1 [benign]; 		COSM4162129	102	725	2	[2] auto-classification 15.09.2017  			FAM20C (inh=AR pLI=0.59)
chr7	4831675	4831675	G	A	het	anno_omim	QUAL=1962;DP=63;AF=0.49;MQM=60;TRIO=HET,63,0.49,HET,116,0.47,WT,150,0.00	AP5Z1				rs140612456	0.0136	0.0000	0,0,0	0,0,0,0,0	0.0434							613653 [AP5Z1 (confirmed) Spastic paraplegia 48,autosomal recessive,613647];				0	20					AP5Z1 (inh=AR pLI=n/a)
chr7	6026775	6026775	T	C	hom	pred_pathogenic;anno_omim	QUAL=31806;DP=190;AF=0.99;MQM=56;TRIO=HOM,190,0.99,HOM,324,1.00,HOM,487,1.00	PMS2	missense,intron	PMS2:ENST00000265849:missense:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu,PMS2:ENST00000441476:missense:MODERATE:exon8/12:c.1303A>G:p.Lys435Glu,PMS2:ENST00000406569:missense:MODERATE:exon11/12:c.1621A>G:p.Lys541Glu,PMS2:ENST00000382321:intron:MODIFIER:exon7/10:c.804-4153A>G:		rs2228006	0.8832	0.8514	44055,24216,4305	0.9229,0.6563,0.9238,0.8550,0.8961	0.8722	1.4430	T,T,T,T	T	B,B,B	T,T,D	0.14	600259 [PMS2 (confirmed) Mismatch repair cancer syndrome,276300|Colorectal cancer,hereditary nonpolyposis,type 4,614337];	RCV000121840.3 [benign]; 		COSM4162329	3137	1028	1	[1] Tanja Benkert 16.04.2015			PMS2 (inh=AR+AD pLI=0.00)
chr7	6026959	6026959	G	C	het	low_MQM;pred_pathogenic;anno_omim;anno_pathogenic_hgmd	QUAL=3707;DP=175;AF=0.38;MQM=47;TRIO=HET,175,0.38,WT,120,0.00,HET,198,0.51	PMS2	missense,intron	PMS2:ENST00000265849:missense:MODERATE:exon11/15:c.1437C>G:p.His479Gln,PMS2:ENST00000441476:missense:MODERATE:exon8/12:c.1119C>G:p.His373Gln,PMS2:ENST00000406569:missense:MODERATE:exon11/12:c.1437C>G:p.His479Gln,PMS2:ENST00000382321:intron:MODIFIER:exon7/10:c.804-4337C>G:		rs63750685	0.0028	0.0046	3,2,0	0.0093,0.0015,0.0008,0.0045,0.0030	0.0073	0.1820	T,T,T,T	T	B,B,B	T,T,D	0.65	600259 [PMS2 (confirmed) Mismatch repair cancer syndrome,276300|Colorectal cancer,hereditary nonpolyposis,type 4,614337];	RCV000034615.3 [benign]; RCV000076809.5 [uncertain significance]; RCV000121844.2 [benign]; RCV000162366.1 [benign]; 	CM1612932 [CLASS=DM? MUT=ALT PHEN="Breast and/or ovarian cancer" GENE=PMS2]; 		0	32	3	[3] Ilnaz Sepahi 29-03-2016 batch import			PMS2 (inh=AR+AD pLI=0.00)
chr7	6026988	6026988	G	A	hom	pred_pathogenic;anno_omim	QUAL=9619;DP=217;AF=1.00;MQM=52;TRIO=HOM,217,1.00,HET,102,0.48,HET,165,0.48	PMS2	missense,intron	PMS2:ENST00000265849:missense:MODERATE:exon11/15:c.1408C>T:p.Pro470Ser,PMS2:ENST00000441476:missense:MODERATE:exon8/12:c.1090C>T:p.Pro364Ser,PMS2:ENST00000406569:missense:MODERATE:exon11/12:c.1408C>T:p.Pro470Ser,PMS2:ENST00000382321:intron:MODIFIER:exon7/10:c.804-4366C>T:		rs1805321	0.3582	0.3854	9186,5718,417	0.2804,0.3887,0.3774,0.4137,0.3559	0.3879	0.2650	T,T,T,T	T	B,B,B	T,T,D	0.09	600259 [PMS2 (confirmed) Mismatch repair cancer syndrome,276300|Colorectal cancer,hereditary nonpolyposis,type 4,614337];	RCV000030364.4 [benign]; RCV000034614.1 [benign]; RCV000079103.7 [benign]; RCV000130721.2 [benign]; RCV000144645.1 [benign]; 		COSM3736445	780	2003	1	[1] old entry - no details available			PMS2 (inh=AR+AD pLI=0.00)
chr7	6036980	6036980	G	C	hom	anno_omim	QUAL=7014;DP=124;AF=1.00;MQM=60;TRIO=HOM,124,1.00,HOM,47,1.00,HOM,40,1.00	PMS2	synonymous	PMS2:ENST00000265849:synonymous:LOW:exon7/15:c.780C>G:p.Ser260Ser,PMS2:ENST00000441476:synonymous:LOW:exon4/12:c.462C>G:p.Ser154Ser,PMS2:ENST00000382321:synonymous:LOW:exon7/11:c.780C>G:p.Ser260Ser,PMS2:ENST00000406569:synonymous:LOW:exon7/12:c.780C>G:p.Ser260Ser		rs1805319	0.8313	0.8109	39906,22309,3695	0.8459,0.6438,0.9219,0.8199,0.8172	0.8205							600259 [PMS2 (confirmed) Mismatch repair cancer syndrome,276300|Colorectal cancer,hereditary nonpolyposis,type 4,614337];	RCV000030372.4 [benign]; RCV000079112.6 [benign]; RCV000131484.2 [benign]; 		COSM4162330	2871	1248	1	[1] Ilnaz Sepahi 29-03-2016 batch import			PMS2 (inh=AR+AD pLI=0.00)
chr7	6037058	6037058	A	-	hom	low_DP;anno_omim	QUAL=344;DP=17;AF=0.47;MQM=59;TRIO=HOM,17,0.47,HET,32,0.50,HET,29,0.34	PMS2	splice_region&intron	PMS2:ENST00000265849:splice_region&intron:LOW:exon6/14:c.706-4delT:,PMS2:ENST00000441476:splice_region&intron:LOW:exon3/11:c.388-4delT:,PMS2:ENST00000382321:splice_region&intron:LOW:exon6/10:c.706-4delT:,PMS2:ENST00000406569:splice_region&intron:LOW:exon6/11:c.706-4delT:	(A)n	rs549498051;rs549793612;rs60794673;rs796382014	0.4531	0.4423	321,196,10	0.4081,0.4302,0.4613,0.4425,0.4520	0.4480							600259 [PMS2 (confirmed) Mismatch repair cancer syndrome,276300|Colorectal cancer,hereditary nonpolyposis,type 4,614337];	RCV000203188.1 [benign]; RCV000415703.1,RCV000203188.1 [uncertain significance,benign]; RCV000415703.1 [uncertain significance]; 			820	1993	2	[2] auto-classification 15.09.2017  			PMS2 (inh=AR+AD pLI=0.00)
chr7	22980929	22980929	-	AC	het	anno_omim	QUAL=4808;DP=127;AF=0.48;MQM=59;TRIO=HET,127,0.48,WT,66,0.00,HOM,100,1.00	FAM126A	3'UTR	FAM126A:ENST00000432176:3'UTR:MODIFIER:exon11/11:c.*4278_*4279insGT:		rs35708583;rs55691833	0.4275	0.0000	0,0,0	0,0,0,0,0	0.3884							610531 [FAM126A (provisional) Leukodystrophy,hypomyelinating,5,610532];	RCV000330372.1 [benign]; 			34	107					FAM126A (inh=AR pLI=0.80)
chr7	22981404	22981404	T	G	het	anno_omim	QUAL=4841;DP=150;AF=0.41;MQM=59;TRIO=HET,150,0.41,HOM,102,1.00,WT,128,0.01	FAM126A	3'UTR	FAM126A:ENST00000432176:3'UTR:MODIFIER:exon11/11:c.*3804A>C:		rs34683819	0.2250	0.0000	0,0,0	0,0,0,0,0	0.2725							610531 [FAM126A (provisional) Leukodystrophy,hypomyelinating,5,610532];	RCV000319011.1 [benign]; 			33	88					FAM126A (inh=AR pLI=0.80)
chr7	22981528	22981528	T	C	het	anno_omim	QUAL=8018;DP=203;AF=0.50;MQM=59;TRIO=HET,203,0.50,WT,86,0.00,HOM,167,0.99	FAM126A	3'UTR	FAM126A:ENST00000432176:3'UTR:MODIFIER:exon11/11:c.*3680A>G:		rs3815348	0.4275	0.0000	0,0,0	0,0,0,0,0	0.3904							610531 [FAM126A (provisional) Leukodystrophy,hypomyelinating,5,610532];	RCV000283853.1 [benign]; 			34	106					FAM126A (inh=AR pLI=0.80)
chr7	22982207	22982207	T	C	het	anno_omim	QUAL=8371;DP=261;AF=0.56;MQM=60;TRIO=HET,261,0.56,WT,94,0.00,HOM,139,0.99	FAM126A	3'UTR	FAM126A:ENST00000432176:3'UTR:MODIFIER:exon11/11:c.*3001A>G:		rs2286495	0.4277	0.0000	0,0,0	0,0,0,0,0	0.3906							610531 [FAM126A (provisional) Leukodystrophy,hypomyelinating,5,610532];	RCV000346964.1 [benign]; 			34	108					FAM126A (inh=AR pLI=0.80)
chr7	22982547	22982547	G	A	het	anno_omim	QUAL=5820;DP=276;AF=0.46;MQM=60;TRIO=HET,276,0.46,HOM,80,0.96,WT,152,0.00	FAM126A	3'UTR	FAM126A:ENST00000432176:3'UTR:MODIFIER:exon11/11:c.*2661C>T:		rs13222017	0.2206	0.0000	0,0,0	0,0,0,0,0	0.2697							610531 [FAM126A (provisional) Leukodystrophy,hypomyelinating,5,610532];	RCV000315359.1 [benign]; 			31	89					FAM126A (inh=AR pLI=0.80)
chr7	22982826	22982827	AT	-	het	anno_omim	QUAL=7427;DP=298;AF=0.50;MQM=59;TRIO=HET,298,0.50,WT,99,0.00,HOM,114,0.99	FAM126A	3'UTR	FAM126A:ENST00000432176:3'UTR:MODIFIER:exon11/11:c.*2381_*2382delAT:		rs143367578	0.1086	0.0000	0,0,0	0,0,0,0,0	0.1069							610531 [FAM126A (provisional) Leukodystrophy,hypomyelinating,5,610532];	RCV000261140.1 [likely benign]; 			5	65					FAM126A (inh=AR pLI=0.80)
chr7	22983600	22983600	T	C	het	anno_omim	QUAL=10760;DP=428;AF=0.48;MQM=60;TRIO=HET,428,0.48,HOM,158,1.00,WT,215,0.00	FAM126A	3'UTR	FAM126A:ENST00000432176:3'UTR:MODIFIER:exon11/11:c.*1608A>G:		rs10488277	0.2250	0.0000	0,0,0	0,0,0,0,0	0.2733							610531 [FAM126A (provisional) Leukodystrophy,hypomyelinating,5,610532];	RCV000385752.1 [benign]; 			31	91					FAM126A (inh=AR pLI=0.80)
chr7	22983702	22983702	A	T	hom	anno_omim	QUAL=32399;DP=490;AF=1.00;MQM=59;TRIO=HOM,490,1.00,HOM,239,1.00,HOM,308,0.99	FAM126A	3'UTR	FAM126A:ENST00000432176:3'UTR:MODIFIER:exon11/11:c.*1506T>A:		rs4607514	0.6671	0.0000	0,0,0	0,0,0,0,0	0.6819							610531 [FAM126A (provisional) Leukodystrophy,hypomyelinating,5,610532];	RCV000351086.1 [benign]; 			403	318					FAM126A (inh=AR pLI=0.80)
chr7	22983890	22983890	T	C	hom	anno_omim	QUAL=30281;DP=340;AF=1.00;MQM=60;TRIO=HOM,340,1.00,HOM,226,1.00,HOM,350,1.00	FAM126A	3'UTR	FAM126A:ENST00000432176:3'UTR:MODIFIER:exon11/11:c.*1318A>G:		rs1583511	0.6721	0.0000	0,0,0	0,0,0,0,0	0.6874							610531 [FAM126A (provisional) Leukodystrophy,hypomyelinating,5,610532];	RCV000406825.1 [benign]; 			119	92					FAM126A (inh=AR pLI=0.80)
chr7	22984772	22984772	A	C	het	anno_omim	QUAL=17653;DP=505;AF=0.46;MQM=59;TRIO=HET,505,0.46,WT,265,0.00,HOM,347,0.99	FAM126A	3'UTR	FAM126A:ENST00000432176:3'UTR:MODIFIER:exon11/11:c.*436T>G:,FAM126A:ENST00000409923:3'UTR:MODIFIER:exon12/12:c.*1038T>G:		rs10085448	0.4301	0.0000	0,0,0	0,0,0,0,0	0.3873							610531 [FAM126A (provisional) Leukodystrophy,hypomyelinating,5,610532];	RCV000384924.1 [benign]; 			34	107					FAM126A (inh=AR pLI=0.80)
chr7	22984773	22984773	G	A	het	anno_omim	QUAL=17653;DP=505;AF=0.46;MQM=59;TRIO=HET,505,0.46,WT,265,0.00,HOM,347,0.99	FAM126A	3'UTR	FAM126A:ENST00000432176:3'UTR:MODIFIER:exon11/11:c.*435C>T:,FAM126A:ENST00000409923:3'UTR:MODIFIER:exon12/12:c.*1037C>T:		rs10085739	0.4273	0.0000	0,0,0	0,0,0,0,0	0.3872							610531 [FAM126A (provisional) Leukodystrophy,hypomyelinating,5,610532];	RCV000331632.1 [benign]; 			34	107					FAM126A (inh=AR pLI=0.80)
chr7	22984824	22984824	T	C	hom	anno_omim	QUAL=37253;DP=592;AF=1.00;MQM=60;TRIO=HOM,592,1.00,HOM,246,1.00,HOM,303,1.00	FAM126A	3'UTR	FAM126A:ENST00000432176:3'UTR:MODIFIER:exon11/11:c.*384A>G:,FAM126A:ENST00000409923:3'UTR:MODIFIER:exon12/12:c.*986A>G:		rs2286494	0.6530	0.0000	0,0,0	0,0,0,0,0	0.6642							610531 [FAM126A (provisional) Leukodystrophy,hypomyelinating,5,610532];	RCV000388447.1 [benign]; 			117	93					FAM126A (inh=AR pLI=0.80)
chr7	22984967	22984967	A	G	het	anno_omim	QUAL=7369;DP=286;AF=0.47;MQM=60;TRIO=HET,286,0.47,HOM,116,0.99,WT,156,0.02	FAM126A	3'UTR	FAM126A:ENST00000432176:3'UTR:MODIFIER:exon11/11:c.*241T>C:,FAM126A:ENST00000409923:3'UTR:MODIFIER:exon12/12:c.*843T>C:		rs2286493	0.2025	0.0000	0,0,0	0,0,0,0,0	0.2583							610531 [FAM126A (provisional) Leukodystrophy,hypomyelinating,5,610532];	RCV000335061.1 [benign]; 			30	90					FAM126A (inh=AR pLI=0.80)
chr7	23015831	23015831	T	C	het	pred_pathogenic;anno_omim	QUAL=11183;DP=269;AF=0.52;MQM=60;TRIO=HET,269,0.52,WT,203,0.00,HOM,225,1.00	FAM126A	splice_region&synonymous	FAM126A:ENST00000432176:splice_region&synonymous:LOW:exon7/11:c.624A>G:p.Ser208Ser,FAM126A:ENST00000409923:splice_region&synonymous:LOW:exon7/12:c.624A>G:p.Ser208Ser		rs3735231	0.3748	0.3738	8519,4256,634	0.3545,0.4026,0.4830,0.3598,0.3736	0.3694	1.6430		T			11.59	610531 [FAM126A (provisional) Leukodystrophy,hypomyelinating,5,610532];	RCV000020929.3 [benign]; RCV000244607.1 [benign]; 			302	1190	1	[1] old entry - no details available			FAM126A (inh=AR pLI=0.80)
chr7	30634661	30634661	C	G	hom	low_DP;anno_omim	QUAL=3762;DP=19;AF=1.00;MQM=59;TRIO=HOM,19,1.00,HOM,44,1.00,HOM,71,1.00	GARS	missense	GARS:ENST00000389266:missense:MODERATE:exon1/17:c.124C>G:p.Pro42Ala		rs1049402	0.6494	0.7030	10805,6788,464	0.5825,0.6520,0.6331,0.7688,0.6227	0.7042	-0.6710	T	T	B	T	0.01	600287 [GARS (confirmed) Charcot-Marie-Tooth disease,type 2D,601472|Neuropathy,distal hereditary motor,type VA,600794];	RCV000249303.1 [benign]; RCV000305283.1 [benign]; RCV000340289.1 [benign]; RCV000396526.1 [benign]; 		COSM3762627	1522	930	2	[2] auto-classification 15.09.2017  			GARS (inh=AD pLI=0.79)
chr7	30673345	30673345	C	T	hom	anno_omim	QUAL=20047;DP=205;AF=1.00;MQM=60;TRIO=HOM,205,1.00,HOM,185,1.00,HOM,241,1.00	GARS	splice_region&intron	GARS:ENST00000389266:splice_region&intron:LOW:exon16/16:c.2095-6C>T:		rs2240401	0.4042	0.5525	19754,13801,124	0.1507,0.5569,0.4851,0.6436,0.4149	0.5597							600287 [GARS (confirmed) Charcot-Marie-Tooth disease,type 2D,601472|Neuropathy,distal hereditary motor,type VA,600794];	RCV000241978.1 [benign]; RCV000301521.1 [benign]; RCV000367864.1 [benign]; RCV000393359.1 [benign]; 		COSM4004448	961	1219	2	[2] auto-classification 15.09.2017  			GARS (inh=AD pLI=0.79)
chr7	30673513	30673513	A	-	hom	anno_omim	QUAL=9245;DP=277;AF=0.63;MQM=59;TRIO=HOM,277,0.63,HOM,189,0.73,HOM,238,0.72	GARS	3'UTR	GARS:ENST00000389266:3'UTR:MODIFIER:exon17/17:c.*51delA:		rs70983380;rs755441530	0.0000	0.4340	1411,1015,47	0.3441,0.4375,0.3782,0.4724,0.3535	0.5766							600287 [GARS (confirmed) Charcot-Marie-Tooth disease,type 2D,601472|Neuropathy,distal hereditary motor,type VA,600794];	RCV000280689.1 [uncertain significance]; RCV000338090.1 [uncertain significance]; RCV000406647.1 [uncertain significance]; 			551	1005					GARS (inh=AD pLI=0.79)
chr7	44184403	44184403	C	T	het	anno_omim	QUAL=2265;DP=118;AF=0.51;MQM=59;TRIO=HET,118,0.51,HET,79,0.51,WT,119,0.00	GCK	3'UTR	GCK:ENST00000345378:3'UTR:MODIFIER:exon10/10:c.*332G>A:,GCK:ENST00000403799:3'UTR:MODIFIER:exon10/10:c.*332G>A:,GCK:ENST00000395796:3'UTR:MODIFIER:exon11/11:c.*332G>A:		rs13306388	0.1520	0.0000	0,0,0	0,0,0,0,0	0.1810							138079 [GCK (confirmed) MODY,type II,125851|Diabetes mellitus,noninsulin-dependent,late onset,125853|Hyperinsulinemic hypoglycemia,familial,3,602485|Diabetes mellitus,permanent neonatal,606176];	RCV000290517.1 [benign]; RCV000296546.1 [benign]; RCV000344515.1 [benign]; RCV000382811.1 [benign]; 			14	89					GCK (inh=AD pLI=0.20)
chr7	47865325	47865325	C	A	hom	anno_omim	QUAL=19261;DP=316;AF=1.00;MQM=60;TRIO=HOM,316,1.00,HOM,142,1.00,HOM,150,1.00	PKD1L1,HUS1	intron	PKD1L1:ENST00000289672:intron:MODIFIER:exon45/56:c.6854+1623G>T:		rs4720618	0.9802	0.0000	0,0,0	0,0,0,0,0	0.9844							609721 [PKD1L1 (provisional) Heterotaxy,visceral,8,autosomal,617205];				152	0					PKD1L1 (inh=n/a pLI=0.00), HUS1 (inh=n/a pLI=0.00)
chr7	50560382	50560382	A	T	het	anno_omim	QUAL=7046;DP=287;AF=0.57;MQM=59;TRIO=HET,287,0.57,HOM,140,0.99,WT,227,0.00	DDC	3'UTR,intron	DDC:ENST00000380984:3'UTR:MODIFIER:exon10/10:c.*249T>A:,DDC:ENST00000357936:intron:MODIFIER:exon9/14:c.944+2666T>A:,DDC:ENST00000431062:intron:MODIFIER:exon6/11:c.665+2666T>A:,DDC:ENST00000426377:intron:MODIFIER:exon7/12:c.710+2666T>A:,DDC:ENST00000444124:intron:MODIFIER:exon9/14:c.944+2666T>A:		rs866666526	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							107930 [DDC (confirmed) Aromatic L-amino acid decarboxylase deficiency,608643];				19	2					DDC (inh=AR pLI=0.00)
chr7	50560384	50560388	TTTCC	-	het	anno_omim	QUAL=7046;DP=287;AF=0.57;MQM=59;TRIO=HET,287,0.57,HOM,140,0.99,WT,227,0.00	DDC	3'UTR,intron	DDC:ENST00000380984:3'UTR:MODIFIER:exon10/10:c.*243_*247delGGAAA:,DDC:ENST00000357936:intron:MODIFIER:exon9/14:c.944+2660_944+2664delGGAAA:,DDC:ENST00000431062:intron:MODIFIER:exon6/11:c.665+2660_665+2664delGGAAA:,DDC:ENST00000426377:intron:MODIFIER:exon7/12:c.710+2660_710+2664delGGAAA:,DDC:ENST00000444124:intron:MODIFIER:exon9/14:c.944+2660_944+2664delGGAAA:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							107930 [DDC (confirmed) Aromatic L-amino acid decarboxylase deficiency,608643];				19	2					DDC (inh=AR pLI=0.00)
chr7	50560391	50560391	-	CTC	het	anno_omim	QUAL=8282;DP=301;AF=0.55;MQM=59;TRIO=HET,301,0.55,HOM,156,1.00,WT,246,0.00	DDC	3'UTR,intron	DDC:ENST00000380984:3'UTR:MODIFIER:exon10/10:c.*239_*240insGAG:,DDC:ENST00000357936:intron:MODIFIER:exon9/14:c.944+2656_944+2657insGAG:,DDC:ENST00000431062:intron:MODIFIER:exon6/11:c.665+2656_665+2657insGAG:,DDC:ENST00000426377:intron:MODIFIER:exon7/12:c.710+2656_710+2657insGAG:,DDC:ENST00000444124:intron:MODIFIER:exon9/14:c.944+2656_944+2657insGAG:		rs774393354	0.0000	0.0000	0,0,0	0,0,0,0,0	0.5250							107930 [DDC (confirmed) Aromatic L-amino acid decarboxylase deficiency,608643];				19	2					DDC (inh=AR pLI=0.00)
chr7	50560394	50560394	G	TCCTCTCTC	het	anno_omim	QUAL=8376;DP=287;AF=0.55;MQM=59;TRIO=HET,287,0.55,HOM,159,1.00,WT,243,0.00	DDC	3'UTR,intron	DDC:ENST00000380984:3'UTR:MODIFIER:exon10/10:c.*237delCinsGAGAGAGGA:,DDC:ENST00000357936:intron:MODIFIER:exon9/14:c.944+2654delCinsGAGAGAGGA:,DDC:ENST00000431062:intron:MODIFIER:exon6/11:c.665+2654delCinsGAGAGAGGA:,DDC:ENST00000426377:intron:MODIFIER:exon7/12:c.710+2654delCinsGAGAGAGGA:,DDC:ENST00000444124:intron:MODIFIER:exon9/14:c.944+2654delCinsGAGAGAGGA:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							107930 [DDC (confirmed) Aromatic L-amino acid decarboxylase deficiency,608643];				18	1					DDC (inh=AR pLI=0.00)
chr7	50611735	50611735	T	C	hom	anno_omim	QUAL=33279;DP=235;AF=1.00;MQM=59;TRIO=HOM,235,1.00,HOM,343,1.00,HOM,466,1.00	DDC	missense	DDC:ENST00000357936:missense:MODERATE:exon2/15:c.49A>G:p.Met17Val,DDC:ENST00000431062:missense:MODERATE:exon1/12:c.49A>G:p.Met17Val,DDC:ENST00000426377:missense:MODERATE:exon2/13:c.49A>G:p.Met17Val,DDC:ENST00000444124:missense:MODERATE:exon2/15:c.49A>G:p.Met17Val,DDC:ENST00000380984:missense:MODERATE:exon2/10:c.49A>G:p.Met17Val		rs6264	0.9932	0.9982	60489,33368,5000	0.9801,0.9991,0.9999,1.0000,0.9999	0.9986	-0.6030	T,T,T,T,T,T	T	B	T,T,T,T,T,T	0.36	107930 [DDC (confirmed) Aromatic L-amino acid decarboxylase deficiency,608643];				2306	2	2	[2] auto-classification 15.09.2017  			DDC (inh=AR pLI=0.00)
chr7	50628740	50628743	CTCT	-	het	anno_omim	QUAL=7905;DP=256;AF=0.46;MQM=59;TRIO=HET,256,0.46,WT,218,0.00,HOM,185,0.99	DDC	5'UTR,intron	DDC:ENST00000357936:5'UTR:MODIFIER:exon1/15:c.-61_-58delAGAG:,DDC:ENST00000426377:5'UTR:MODIFIER:exon1/13:c.-61_-58delAGAG:,DDC:ENST00000380984:5'UTR:MODIFIER:exon1/10:c.-61_-58delAGAG:,DDC:ENST00000444124:intron:MODIFIER:exon1/14:c.-29+4239_-29+4242delAGAG:	(CT)n	rs10600316;rs3837091	0.2929	0.0000	0,0,0	0,0,0,0,0	0.2520							107930 [DDC (confirmed) Aromatic L-amino acid decarboxylase deficiency,608643];	RCV000369935.1 [benign]; 			30	149					DDC (inh=AR pLI=0.00)
chr7	65425894	65425894	A	G	hom	pred_pathogenic;anno_omim	QUAL=31959;DP=465;AF=0.99;MQM=59;TRIO=HOM,465,0.99,HET,593,0.50,HET,757,0.48	GUSB	missense	GUSB:ENST00000304895:missense:MODERATE:exon12/12:c.1946T>C:p.Leu649Pro,GUSB:ENST00000345660:missense:MODERATE:exon11/11:c.1793T>C:p.Leu598Pro,GUSB:ENST00000421103:missense:MODERATE:exon10/10:c.1508T>C:p.Leu503Pro		rs9530	0.5807	0.5796	21049,10611,711	0.3646,0.5650,0.8363,0.5640,0.6391	0.5855	-0.0470	T,T,T	T	B,B	D,D,D	0.37	611499 [GUSB (confirmed) Mucopolysaccharidosis VII,253220];	RCV000078327.5 [benign]; RCV000394365.1 [benign]; 			720	1002	2	[2] auto-classification 15.09.2017  			GUSB (inh=AR pLI=0.00)
chr7	65447242	65447242	C	A	het	anno_omim	QUAL=439;DP=24;AF=0.54;MQM=59;TRIO=HET,24,0.54,HET,15,0.73,WT,22,0.00	GUSB	5'UTR	GUSB:ENST00000304895:5'UTR:MODIFIER:exon1/12:c.-72G>T:		rs2279904	0.0377	0.0000	0,0,0	0,0,0,0,0	0.0399							611499 [GUSB (confirmed) Mucopolysaccharidosis VII,253220];	RCV000390830.1 [likely benign]; 			1	20					GUSB (inh=AR pLI=0.00)
chr7	66104909	66104909	G	C	het	anno_omim	QUAL=5392;DP=248;AF=0.50;MQM=59;TRIO=HET,248,0.50,HET,185,0.50,WT,218,0.00	KCTD7	3'UTR,intron	KCTD7:ENST00000275532:3'UTR:MODIFIER:exon4/4:c.*690G>C:,KCTD7:ENST00000443322:intron:MODIFIER:exon4/4:c.867-472G>C:		rs4718382	0.0407	0.0000	0,0,0	0,0,0,0,0	0.0420							611725 [KCTD7 (provisional) Epilepsy,progressive myoclonic 3,with or without intracellular inclusions,611726];	RCV000297291.1 [likely benign]; 			0	27					KCTD7 (inh=AR pLI=0.50)
chr7	66105163	66105163	C	G	het	anno_omim	QUAL=18258;DP=344;AF=0.50;MQM=59;TRIO=HET,344,0.50,HOM,273,1.00,HET,335,0.56	KCTD7	3'UTR,intron	KCTD7:ENST00000275532:3'UTR:MODIFIER:exon4/4:c.*944C>G:,KCTD7:ENST00000443322:intron:MODIFIER:exon4/4:c.867-218C>G:		rs9791712	0.6238	0.0000	0,0,0	0,0,0,0,0	0.6723							611725 [KCTD7 (provisional) Epilepsy,progressive myoclonic 3,with or without intracellular inclusions,611726];	RCV000323024.1 [benign]; 			78	126					KCTD7 (inh=AR pLI=0.50)
chr7	66105198	66105198	C	A	het	anno_omim	QUAL=14975;DP=247;AF=0.51;MQM=60;TRIO=HET,247,0.51,HOM,238,1.00,HET,292,0.55	KCTD7	3'UTR,intron	KCTD7:ENST00000275532:3'UTR:MODIFIER:exon4/4:c.*979C>A:,KCTD7:ENST00000443322:intron:MODIFIER:exon4/4:c.867-183C>A:		rs9791713	0.6236	0.0000	0,0,0	0,0,0,0,0	0.6720							611725 [KCTD7 (provisional) Epilepsy,progressive myoclonic 3,with or without intracellular inclusions,611726];	RCV000361429.1 [benign]; 			78	126					KCTD7 (inh=AR pLI=0.50)
chr7	66105946	66105946	G	C	het	anno_omim	QUAL=6332;DP=306;AF=0.44;MQM=60;TRIO=HET,306,0.44,HET,250,0.48,WT,318,0.00	KCTD7	3'UTR	KCTD7:ENST00000275532:3'UTR:MODIFIER:exon4/4:c.*1727G>C:		rs17229513	0.0371	0.0000	0,0,0	0,0,0,0,0	0.0395							611725 [KCTD7 (provisional) Epilepsy,progressive myoclonic 3,with or without intracellular inclusions,611726];	RCV000279549.1 [likely benign]; 			0	27					KCTD7 (inh=AR pLI=0.50)
chr7	66106875	66106875	A	G	het	anno_omim	QUAL=21078;DP=379;AF=0.53;MQM=60;TRIO=HET,379,0.53,HOM,334,1.00,HET,352,0.54	KCTD7	3'UTR	KCTD7:ENST00000275532:3'UTR:MODIFIER:exon4/4:c.*2656A>G:		rs1860469	0.6234	0.0000	0,0,0	0,0,0,0,0	0.6719							611725 [KCTD7 (provisional) Epilepsy,progressive myoclonic 3,with or without intracellular inclusions,611726];	RCV000266102.1 [benign]; 			78	126					KCTD7 (inh=AR pLI=0.50)
chr7	73442480	73442480	C	T	het	low_DP;anno_omim	QUAL=129;DP=5;AF=0.60;MQM=60;TRIO=HET,5,0.60,WT,8,0.00,HET,11,0.45	ELN	5'UTR_premature_start_codon_gain,5'UTR	ELN:ENST00000358929:5'UTR_premature_start_codon_gain:LOW:exon1/34:c.-38C>T:,ELN:ENST00000445912:5'UTR_premature_start_codon_gain:LOW:exon1/32:c.-38C>T:,ELN:ENST00000252034:5'UTR_premature_start_codon_gain:LOW:exon1/33:c.-38C>T:,ELN:ENST00000320492:5'UTR_premature_start_codon_gain:LOW:exon1/29:c.-38C>T:,ELN:ENST00000414324:5'UTR_premature_start_codon_gain:LOW:exon1/31:c.-38C>T:,ELN:ENST00000380562:5'UTR_premature_start_codon_gain:LOW:exon1/33:c.-38C>T:,ELN:ENST00000358929:5'UTR:MODIFIER:exon1/34:c.-38C>T:,ELN:ENST00000445912:5'UTR:MODIFIER:exon1/32:c.-38C>T:,ELN:ENST00000252034:5'UTR:MODIFIER:exon1/33:c.-38C>T:,ELN:ENST00000320492:5'UTR:MODIFIER:exon1/29:c.-38C>T:,ELN:ENST00000414324:5'UTR:MODIFIER:exon1/31:c.-38C>T:,ELN:ENST00000380562:5'UTR:MODIFIER:exon1/33:c.-38C>T:		rs41410045	0.0260	0.0211	54,3,0	0.0030,0.0121,0.0370,0.0104,0.0763	0.0184							608512 [NCF1 (provisional) Chronic granulomatous disease due to deficiency of NCF-1,233700]:130160 [ELN (confirmed) Supravalvar aortic stenosis,185500|Cutis laxa,autosomal dominant,123700];	RCV000195554.1 [benign]; RCV000300581.1 [benign]; RCV000406190.1 [benign]; 			4	81					ELN (inh=AR pLI=0.00)
chr7	73483531	73483531	-	A	het	anno_omim	QUAL=4590;DP=145;AF=0.48;MQM=59;TRIO=HET,145,0.48,WT,181,0.00,HET,246,0.50	ELN	3'UTR	ELN:ENST00000358929:3'UTR:MODIFIER:exon34/34:c.*501_*502insA:,ELN:ENST00000252034:3'UTR:MODIFIER:exon33/33:c.*501_*502insA:,ELN:ENST00000320492:3'UTR:MODIFIER:exon29/29:c.*501_*502insA:,ELN:ENST00000414324:3'UTR:MODIFIER:exon31/31:c.*501_*502insA:,ELN:ENST00000380575:3'UTR:MODIFIER:exon30/30:c.*501_*502insA:,ELN:ENST00000380584:3'UTR:MODIFIER:exon29/29:c.*501_*502insA:,ELN:ENST00000458204:3'UTR:MODIFIER:exon32/32:c.*501_*502insA:,ELN:ENST00000357036:3'UTR:MODIFIER:exon32/32:c.*501_*502insA:,ELN:ENST00000429192:3'UTR:MODIFIER:exon31/31:c.*501_*502insA:,ELN:ENST00000380553:3'UTR:MODIFIER:exon25/25:c.*501_*502insA:,ELN:ENST00000380576:3'UTR:MODIFIER:exon32/32:c.*501_*502insA:		rs34208922	0.2901	0.0000	0,0,0	0,0,0,0,0	0.2880							608512 [NCF1 (provisional) Chronic granulomatous disease due to deficiency of NCF-1,233700]:130160 [ELN (confirmed) Supravalvar aortic stenosis,185500|Cutis laxa,autosomal dominant,123700];	RCV000265718.1 [benign]; RCV000358024.1 [benign]; 			8	99					ELN (inh=AR pLI=0.00)
chr7	74193668	74193668	G	A	het	low_DP;low_MQM;anno_omim	QUAL=11518;DP=14;AF=0.71;MQM=36;TRIO=HET,14,0.71,HET,275,0.80,HET,542,0.59	NCF1,STAG3L2	missense,intron	NCF1:ENST00000289473:missense:MODERATE:exon4/11:c.295G>A:p.Gly99Ser,STAG3L2:ENST00000380775:intron:MODIFIER:exon8/9:n.1166-56032C>T:		rs10614	0.6312	0.4984	7339,4021,264	0.3351,0.4644,0.4197,0.5162,0.6151	0.7078	0.5180	T,T,T,.	T	B,B	T,T,T	0.03	608512 [NCF1 (provisional) Chronic granulomatous disease due to deficiency of NCF-1,233700];			COSM4162428	1021	989	2	[2] auto-classification 15.09.2017  			NCF1 (inh=AR pLI=0.92), STAG3L2 (inh=n/a pLI=n/a)
chr7	75163169	75163169	A	G	hom	anno_omim	QUAL=28291;DP=241;AF=1.00;MQM=59;TRIO=HOM,241,1.00,HOM,282,1.00,HOM,348,1.00	HIP1	3'UTR	HIP1:ENST00000336926:3'UTR:MODIFIER:exon31/31:c.*4324T>C:		rs1167827	0.5280	0.0000	0,0,0	0,0,0,0,0	0.6035							601767 [HIP1 (confirmed) Prostate cancer,progression of,176807];				51	77					HIP1 (inh=n/a pLI=1.00)
chr7	75166401	75166401	C	T	hom	anno_omim	QUAL=31149;DP=310;AF=0.99;MQM=59;TRIO=HOM,310,0.99,HOM,317,0.99,HOM,382,1.00	HIP1	3'UTR	HIP1:ENST00000336926:3'UTR:MODIFIER:exon31/31:c.*1092G>A:,HIP1:ENST00000434438:3'UTR:MODIFIER:exon29/29:c.*1092G>A:		rs1167830	0.3758	0.0000	0,0,0	0,0,0,0,0	0.4294							601767 [HIP1 (confirmed) Prostate cancer,progression of,176807];				37	98					HIP1 (inh=n/a pLI=1.00)
chr7	75166426	75166426	C	T	hom	anno_omim	QUAL=21458;DP=220;AF=0.99;MQM=59;TRIO=HOM,220,0.99,HET,284,0.50,HOM,347,1.00	HIP1	3'UTR	HIP1:ENST00000336926:3'UTR:MODIFIER:exon31/31:c.*1067G>A:,HIP1:ENST00000434438:3'UTR:MODIFIER:exon29/29:c.*1067G>A:		rs55859405	0.0940	0.0000	0,0,0	0,0,0,0,0	0.0828							601767 [HIP1 (confirmed) Prostate cancer,progression of,176807];				3	22					HIP1 (inh=n/a pLI=1.00)
chr7	75183403	75183403	A	G	hom	anno_omim	QUAL=14789;DP=174;AF=1.00;MQM=59;TRIO=HOM,174,1.00,HOM,131,0.98,HOM,178,1.00	HIP1	splice_region&intron	HIP1:ENST00000336926:splice_region&intron:LOW:exon21/30:c.2158+9T>C:,HIP1:ENST00000434438:splice_region&intron:LOW:exon21/28:c.2158+9T>C:		rs1167807	0.6759	0.6247	22903,10533,3491	0.8314,0.7108,0.7135,0.5777,0.6142	0.6394							601767 [HIP1 (confirmed) Prostate cancer,progression of,176807];			COSM3950799	693	1033	2	[2] auto-classification 15.09.2017  			HIP1 (inh=n/a pLI=1.00)
chr7	75513062	75513062	A	G	hom		QUAL=26003;DP=234;AF=1.00;MQM=59;TRIO=HOM,234,1.00,HOM,262,1.00,HOM,332,1.00	RHBDD2	synonymous	RHBDD2:ENST00000006777:synonymous:LOW:exon3/4:c.633A>G:p.Ala211Ala,RHBDD2:ENST00000318622:synonymous:LOW:exon4/5:c.210A>G:p.Ala70Ala,RHBDD2:ENST00000428119:synonymous:LOW:exon2/3:c.210A>G:p.Ala70Ala		rs42183	0.9866	0.9677	56605,30549,4852	0.9941,0.9915,0.9999,0.9566,0.9910	0.9672	-2.5140	T	T			0.22					1616	90	2	[2] auto-classification 15.09.2017  			RHBDD2 (inh=n/a pLI=0.65)
chr7	75544455	75544455	A	C	hom	low_DP;anno_omim	QUAL=354;DP=4;AF=1.00;MQM=60;TRIO=HOM,4,1.00,HET,26,0.38,HET,31,0.19	POR	5'UTR	POR:ENST00000461988:5'UTR:MODIFIER:exon1/16:c.-47A>C:,POR:ENST00000419840:5'UTR:MODIFIER:exon1/15:c.-605A>C:		rs3823884	0.4836	0.0000	0,0,0	0,0,0,0,0	0.4305							124015 [POR (confirmed) Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis,201750|Disordered steroidogenesis due to cytochrome P450 oxidoreductase,613571];	RCV000379412.1 [benign]; 			122	574					POR (inh=AR pLI=0.00)
chr7	75583325	75583325	A	G	het	anno_omim	QUAL=4004;DP=122;AF=0.47;MQM=60;TRIO=HET,122,0.47,HET,248,0.46,WT,323,0.00	POR	synonymous,5'UTR	POR:ENST00000461988:synonymous:LOW:exon2/16:c.15A>G:p.Gly5Gly,POR:ENST00000394893:synonymous:LOW:exon2/15:c.15A>G:p.Gly5Gly,POR:ENST00000419840:5'UTR:MODIFIER:exon2/15:c.-544A>G:		rs10262966	0.1046	0.0745	315,2,265	0.3455,0.0709,0.0070,0.0098,0.1074	0.0778							124015 [POR (confirmed) Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis,201750|Disordered steroidogenesis due to cytochrome P450 oxidoreductase,613571];	RCV000018413.29 [other]; 			4	81	2	[2] auto-classification 15.09.2017  			POR (inh=AR pLI=0.00)
chr7	75609677	75609677	A	G	het	anno_omim	QUAL=8006;DP=136;AF=0.53;MQM=59;TRIO=HET,136,0.53,HET,207,0.47,HET,295,0.51	POR	synonymous,5'UTR	POR:ENST00000461988:synonymous:LOW:exon5/16:c.387A>G:p.Pro129Pro,POR:ENST00000394893:synonymous:LOW:exon5/15:c.387A>G:p.Pro129Pro,POR:ENST00000419840:5'UTR:MODIFIER:exon5/15:c.-172A>G:,POR:ENST00000545601:5'UTR:MODIFIER:exon1/11:c.-65A>G:		rs1135612	0.2494	0.2659	4863,2221,20	0.0746,0.4346,0.4688,0.2590,0.2040	0.2745	-5.4830		T			0.11	124015 [POR (confirmed) Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis,201750|Disordered steroidogenesis due to cytochrome P450 oxidoreductase,613571];	RCV000248116.1 [benign]; RCV000363541.1 [likely benign]; 		COSM453393	145	805	2	[2] auto-classification 15.09.2017  			POR (inh=AR pLI=0.00)
chr7	75614953	75614953	T	C	hom	anno_omim	QUAL=5471;DP=65;AF=1.00;MQM=59;TRIO=HOM,65,1.00,HOM,63,1.00,HOM,58,1.00	POR	synonymous	POR:ENST00000461988:synonymous:LOW:exon13/16:c.1455T>C:p.Ala485Ala,POR:ENST00000419840:synonymous:LOW:exon13/15:c.897T>C:p.Ala299Ala,POR:ENST00000394893:synonymous:LOW:exon13/15:c.1455T>C:p.Ala485Ala,POR:ENST00000545601:synonymous:LOW:exon8/11:c.879T>C:p.Ala293Ala,POR:ENST00000450476:synonymous:LOW:exon9/12:c.1152T>C:p.Ala384Ala,POR:ENST00000439269:synonymous:LOW:exon7/10:c.669T>C:p.Ala223Ala		rs2228104	0.8353	0.9226	39379,24462,1441	0.6735,0.8597,0.8582,0.9656,0.9336	0.9213	-6.5840		T			0.41	124015 [POR (confirmed) Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis,201750|Disordered steroidogenesis due to cytochrome P450 oxidoreductase,613571];	RCV000127583.3 [benign]; RCV000308656.1 [benign]; 		COSM4162446, COSM4162445	1953	156	2	[2] auto-classification 15.09.2017  			POR (inh=AR pLI=0.00)
chr7	75615287	75615287	G	A	het	anno_omim	QUAL=6043;DP=200;AF=0.49;MQM=59;TRIO=HET,200,0.49,HET,285,0.55,WT,385,0.01	POR	synonymous,intron	POR:ENST00000461988:synonymous:LOW:exon14/16:c.1716G>A:p.Ser572Ser,POR:ENST00000394893:synonymous:LOW:exon14/15:c.1716G>A:p.Ser572Ser,POR:ENST00000545601:synonymous:LOW:exon9/11:c.1140G>A:p.Ser380Ser,POR:ENST00000450476:synonymous:LOW:exon10/12:c.1413G>A:p.Ser471Ser,POR:ENST00000439269:synonymous:LOW:exon8/10:c.930G>A:p.Ser310Ser,POR:ENST00000419840:intron:MODIFIER:exon13/14:c.976-248G>A:		rs1057870	0.1953	0.3811	2930,2239,46	0.2213,0.3371,0.0523,0.4461,0.3212	0.2852	-2.3900		T			8.21	124015 [POR (confirmed) Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis,201750|Disordered steroidogenesis due to cytochrome P450 oxidoreductase,613571];	RCV000243975.1 [benign]; RCV000356109.1 [likely benign]; 		COSM3762835, COSM3762836	261	924	2	[2] auto-classification 15.09.2017  			POR (inh=AR pLI=0.00)
chr7	75615875	75615875	G	A	het	anno_omim	QUAL=3664;DP=153;AF=0.50;MQM=60;TRIO=HET,153,0.50,HET,127,0.59,WT,143,0.00	POR	3'UTR	POR:ENST00000461988:3'UTR:MODIFIER:exon16/16:c.*76G>A:,POR:ENST00000419840:3'UTR:MODIFIER:exon15/15:c.*114G>A:,POR:ENST00000394893:3'UTR:MODIFIER:exon15/15:c.*312G>A:,POR:ENST00000545601:3'UTR:MODIFIER:exon11/11:c.*76G>A:,POR:ENST00000450476:3'UTR:MODIFIER:exon12/12:c.*114G>A:,POR:ENST00000439269:3'UTR:MODIFIER:exon10/10:c.*76G>A:		rs55909219	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0007							124015 [POR (confirmed) Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis,201750|Disordered steroidogenesis due to cytochrome P450 oxidoreductase,613571];	RCV000283879.1 [uncertain significance]; 			0	3					POR (inh=AR pLI=0.00)
chr7	82993252	82993252	G	A	het	low_MQM;anno_omim	QUAL=379;DP=20;AF=0.65;MQM=40;TRIO=HET,20,0.65,WT,10,0.00,HOM,9,1.00	SEMA3E	3'UTR	SEMA3E:ENST00000307792:3'UTR:MODIFIER:exon17/17:c.*3650C>T:	AluYb8	rs111864994	0.0747	0.0000	0,0,0	0,0,0,0,0	0.0733							608166 [SEMA3E (provisional) CHARGE syndrome,214800];				2	27					SEMA3E (inh=AD pLI=0.03)
chr7	82993432	82993432	G	A	het	low_MQM;anno_omim	QUAL=3568;DP=185;AF=0.49;MQM=43;TRIO=HET,185,0.49,WT,107,0.00,HET,151,0.50	SEMA3E	3'UTR	SEMA3E:ENST00000307792:3'UTR:MODIFIER:exon17/17:c.*3470C>T:	AluYb8	rs181922588	0.0096	0.0000	0,0,0	0,0,0,0,0	0.0217							608166 [SEMA3E (provisional) CHARGE syndrome,214800];				0	20					SEMA3E (inh=AD pLI=0.03)
chr7	82993568	82993568	T	C	het	anno_omim	QUAL=13643;DP=383;AF=0.52;MQM=59;TRIO=HET,383,0.52,WT,245,0.00,HOM,266,0.98	SEMA3E	3'UTR	SEMA3E:ENST00000307792:3'UTR:MODIFIER:exon17/17:c.*3334A>G:		rs112935076	0.1008	0.0000	0,0,0	0,0,0,0,0	0.0980							608166 [SEMA3E (provisional) CHARGE syndrome,214800];				4	49					SEMA3E (inh=AD pLI=0.03)
chr7	82994067	82994067	C	G	het	anno_omim	QUAL=12135;DP=344;AF=0.46;MQM=59;TRIO=HET,344,0.46,WT,205,0.00,HOM,242,1.00	SEMA3E	3'UTR	SEMA3E:ENST00000307792:3'UTR:MODIFIER:exon17/17:c.*2835G>C:		rs73709849	0.1008	0.0000	0,0,0	0,0,0,0,0	0.0980							608166 [SEMA3E (provisional) CHARGE syndrome,214800];				4	49					SEMA3E (inh=AD pLI=0.03)
chr7	82995006	82995006	T	A	het	anno_omim	QUAL=5405;DP=152;AF=0.51;MQM=60;TRIO=HET,152,0.51,HOM,100,1.00,WT,141,0.02	SEMA3E	3'UTR	SEMA3E:ENST00000307792:3'UTR:MODIFIER:exon17/17:c.*1896A>T:		rs2723017	0.6384	0.0000	0,0,0	0,0,0,0,0	0.6292							608166 [SEMA3E (provisional) CHARGE syndrome,214800];				122	97					SEMA3E (inh=AD pLI=0.03)
chr7	82995443	82995443	A	G	het	anno_omim	QUAL=2714;DP=170;AF=0.41;MQM=60;TRIO=HET,170,0.41,HET,51,0.63,WT,65,0.00	SEMA3E	3'UTR	SEMA3E:ENST00000307792:3'UTR:MODIFIER:exon17/17:c.*1459T>C:		rs571661220	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0021							608166 [SEMA3E (provisional) CHARGE syndrome,214800];				0	7					SEMA3E (inh=AD pLI=0.03)
chr7	82995774	82995774	A	-	het	anno_omim	QUAL=4635;DP=196;AF=0.53;MQM=60;TRIO=HET,196,0.53,WT,48,0.02,HOM,60,1.00	SEMA3E	3'UTR	SEMA3E:ENST00000307792:3'UTR:MODIFIER:exon17/17:c.*1128delT:		rs146062755	0.1010	0.0000	0,0,0	0,0,0,0,0	0.0978							608166 [SEMA3E (provisional) CHARGE syndrome,214800];				4	47					SEMA3E (inh=AD pLI=0.03)
chr7	82996706	82996706	A	T	het	anno_omim	QUAL=7934;DP=361;AF=0.53;MQM=60;TRIO=HET,361,0.53,WT,69,0.00,HOM,80,1.00	SEMA3E	3'UTR	SEMA3E:ENST00000307792:3'UTR:MODIFIER:exon17/17:c.*196T>A:		rs3801661	0.0907	0.0000	0,0,0	0,0,0,0,0	0.0882							608166 [SEMA3E (provisional) CHARGE syndrome,214800];				4	49					SEMA3E (inh=AD pLI=0.03)
chr7	82996831	82996831	A	T	het	anno_omim	QUAL=2850;DP=201;AF=0.46;MQM=59;TRIO=HET,201,0.46,HET,38,0.58,WT,38,0.00	SEMA3E	3'UTR	SEMA3E:ENST00000307792:3'UTR:MODIFIER:exon17/17:c.*71T>A:,SEMA3E:ENST00000427262:3'UTR:MODIFIER:exon17/17:c.*71T>A:		rs75164403	0.1046	0.0000	0,0,0	0,0,0,0,0	0.0845							608166 [SEMA3E (provisional) CHARGE syndrome,214800];				11	115					SEMA3E (inh=AD pLI=0.03)
chr7	83029438	83029438	C	T	het	anno_omim	QUAL=9443;DP=236;AF=0.55;MQM=60;TRIO=HET,236,0.55,HOM,187,0.99,WT,284,0.00	SEMA3E	synonymous	SEMA3E:ENST00000307792:synonymous:LOW:exon11/17:c.1272G>A:p.Leu424Leu,SEMA3E:ENST00000427262:synonymous:LOW:exon11/17:c.1092G>A:p.Leu364Leu		rs2722974	0.3395	0.4223	11543,6819,84	0.1173,0.4364,0.4643,0.4477,0.4520	0.4262							608166 [SEMA3E (provisional) CHARGE syndrome,214800];	RCV000241775.1 [benign]; 			414	1032	2	[2] auto-classification 15.09.2017  			SEMA3E (inh=AD pLI=0.03)
chr7	83037731	83037731	C	G	het	pred_pathogenic;anno_omim	QUAL=8461;DP=230;AF=0.49;MQM=60;TRIO=HET,230,0.49,WT,127,0.00,HOM,181,1.00	SEMA3E	missense	SEMA3E:ENST00000307792:missense:MODERATE:exon6/17:c.623G>C:p.Arg208Pro,SEMA3E:ENST00000427262:missense:MODERATE:exon6/17:c.443G>C:p.Arg148Pro		rs61729612	0.0976	0.1132	885,621,34	0.0743,0.1231,0.1202,0.1297,0.0628	0.1166	1.1470	T,T,T,T	T	B	T,T,T	23.20	608166 [SEMA3E (provisional) CHARGE syndrome,214800];	RCV000251301.1 [benign]; 		COSM4162479	29	431	2	[2] auto-classification 15.09.2017  			SEMA3E (inh=AD pLI=0.03)
chr7	83037751	83037751	C	A	het	anno_omim	QUAL=7069;DP=201;AF=0.52;MQM=60;TRIO=HET,201,0.52,HOM,139,1.00,WT,191,0.00	SEMA3E	synonymous	SEMA3E:ENST00000307792:synonymous:LOW:exon6/17:c.603G>T:p.Ala201Ala,SEMA3E:ENST00000427262:synonymous:LOW:exon6/17:c.423G>T:p.Ala141Ala		rs2722985	0.5563	0.6078	23793,11809,245	0.2068,0.7331,0.8792,0.5942,0.6620	0.6165							608166 [SEMA3E (provisional) CHARGE syndrome,214800];	RCV000246563.1 [benign]; 		COSM3762861	736	1015	2	[2] auto-classification 15.09.2017  			SEMA3E (inh=AD pLI=0.03)
chr7	83278198	83278198	G	A	hom	anno_omim	QUAL=84;DP=107;AF=0.26;MQM=59;TRIO=HOM,107,0.26,WT,30,0.03,WT,111,0.02	SEMA3E	5'UTR_premature_start_codon_gain,5'UTR	SEMA3E:ENST00000307792:5'UTR_premature_start_codon_gain:LOW:exon1/17:c.-340C>T:,SEMA3E:ENST00000307792:5'UTR:MODIFIER:exon1/17:c.-340C>T:		rs200070960	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0242							608166 [SEMA3E (provisional) CHARGE syndrome,214800];				0	19					SEMA3E (inh=AD pLI=0.03)
chr7	83278227	83278227	C	A	het	anno_omim	QUAL=3505;DP=238;AF=0.38;MQM=58;TRIO=HET,238,0.38,HOM,52,1.00,WT,158,0.01	SEMA3E	5'UTR	SEMA3E:ENST00000307792:5'UTR:MODIFIER:exon1/17:c.-369G>T:	(A)n	rs302114	0.7534	0.0000	0,0,0	0,0,0,0,0	0.6427							608166 [SEMA3E (provisional) CHARGE syndrome,214800];				78	127					SEMA3E (inh=AD pLI=0.03)
chr7	87079406	87079406	T	A	het	anno_omim	QUAL=5897;DP=254;AF=0.51;MQM=60;TRIO=HET,254,0.51,WT,189,0.00,HET,212,0.48	ABCB4	splice_region&synonymous	ABCB4:ENST00000265723:splice_region&synonymous:LOW:exon8/28:c.711A>T:p.Ile237Ile,ABCB4:ENST00000359206:splice_region&synonymous:LOW:exon8/28:c.711A>T:p.Ile237Ile,ABCB4:ENST00000358400:splice_region&synonymous:LOW:exon8/27:c.711A>T:p.Ile237Ile,ABCB4:ENST00000453593:splice_region&synonymous:LOW:exon7/26:c.711A>T:p.Ile237Ile,ABCB4:ENST00000545634:splice_region&synonymous:LOW:exon7/27:c.711A>T:p.Ile237Ile		rs2109505	0.2614	0.2101	2748,1022,514	0.3119,0.2126,0.2739,0.1784,0.2411	0.2227							171060 [ABCB4 (confirmed) Cholestasis,progressive familial intrahepatic 3,602347|Cholestasis,intrahepatic,of pregnancy,3,614972|Gallbladder disease 1,600803];	RCV000247989.2 [benign]; RCV000275204.1 [likely benign]; RCV000385962.1 [likely benign]; 	CM031116 [CLASS=DP MUT=ALT PHEN="Intrahepatic cholestasis of pregnancy association" GENE=ABCB4]; 	COSM3982275	74	640	2	[2] auto-classification 15.09.2017  			ABCB4 (inh=AR+AD pLI=0.00)
chr7	87092185	87092185	G	A	het	anno_omim	QUAL=1542;DP=87;AF=0.48;MQM=60;TRIO=HET,87,0.48,WT,38,0.00,HET,48,0.46	ABCB4	synonymous	ABCB4:ENST00000265723:synonymous:LOW:exon4/28:c.175C>T:p.Leu59Leu,ABCB4:ENST00000359206:synonymous:LOW:exon4/28:c.175C>T:p.Leu59Leu,ABCB4:ENST00000358400:synonymous:LOW:exon4/27:c.175C>T:p.Leu59Leu,ABCB4:ENST00000453593:synonymous:LOW:exon3/26:c.175C>T:p.Leu59Leu,ABCB4:ENST00000545634:synonymous:LOW:exon3/27:c.175C>T:p.Leu59Leu		rs2302387	0.2524	0.1753	2299,650,1032	0.4432,0.1764,0.2063,0.1418,0.1372	0.2271							171060 [ABCB4 (confirmed) Cholestasis,progressive familial intrahepatic 3,602347|Cholestasis,intrahepatic,of pregnancy,3,614972|Gallbladder disease 1,600803];	RCV000245179.1 [benign]; RCV000340525.1 [benign]; RCV000400898.1 [benign]; 			55	528	2	[2] auto-classification 15.09.2017  			ABCB4 (inh=AR+AD pLI=0.00)
chr7	92129162	92129162	A	-	hom	anno_omim	QUAL=10069;DP=167;AF=0.89;MQM=60;TRIO=HOM,167,0.89,HOM,115,0.84,HOM,158,0.86	PEX1	splice_region&intron	PEX1:ENST00000248633:splice_region&intron:LOW:exon15/23:c.2584-10delT:,PEX1:ENST00000438045:splice_region&intron:LOW:exon12/20:c.1618-10delT:,PEX1:ENST00000428214:splice_region&intron:LOW:exon14/22:c.2413-10delT:,PEX1:ENST00000541751:splice_region&intron:LOW:exon9/10:c.*162-10delT:		rs5885806;rs878955850	0.0000	0.6319	14857,9143,874	0.5664,0.6158,0.6094,0.6498,0.5841	0.7314							602136 [PEX1 (confirmed) Peroxisome biogenesis disorder 1A (Zellweger),214100|Peroxisome biogenesis disorder 1B (NALD/IRD),601539|Heimler syndrome 1,234580];	RCV000353186.1 [uncertain significance]; 			1278	580	2	[2] Ute Grasshoff 09.04.2015			PEX1 (inh=AR pLI=0.00)
chr7	92131289	92131289	G	T	hom	anno_omim	QUAL=23261;DP=421;AF=1.00;MQM=60;TRIO=HOM,421,1.00,HOM,113,1.00,HOM,201,1.00	PEX1	synonymous,intron	PEX1:ENST00000248633:synonymous:LOW:exon14/24:c.2331C>A:p.Gly777Gly,PEX1:ENST00000438045:synonymous:LOW:exon11/21:c.1365C>A:p.Gly455Gly,PEX1:ENST00000428214:synonymous:LOW:exon13/23:c.2160C>A:p.Gly720Gly,PEX1:ENST00000541751:intron:MODIFIER:exon8/10:c.478-302C>A:		rs10278857	0.9499	0.9218	51668,27598,4958	0.9761,0.9358,0.9677,0.9090,0.9267	0.9211							602136 [PEX1 (confirmed) Peroxisome biogenesis disorder 1A (Zellweger),214100|Peroxisome biogenesis disorder 1B (NALD/IRD),601539|Heimler syndrome 1,234580];	RCV000078920.8 [other]; RCV000380113.1 [benign]; 			1803	294	2	[2] auto-classification 15.09.2017  			PEX1 (inh=AR pLI=0.00)
chr7	94039032	94039032	C	T	het	anno_omim	QUAL=13081;DP=336;AF=0.56;MQM=60;TRIO=HET,336,0.56,HET,299,0.46,HET,351,0.50	COL1A2	splice_region&intron	COL1A2:ENST00000297268:splice_region&intron:LOW:exon18/51:c.937-3C>T:		rs42519	0.8243	0.7742	36721,19160,4223	0.9007,0.8202,0.9151,0.7578,0.6502	0.8161							120160 [COL1A2 (confirmed) Ehlers-Danlos syndrome,type VIIB,130060|Osteogenesis imperfecta,type IV,166220|Osteogenesis imperfecta,type III,259420|Osteogenesis imperfecta,type II,166210|Osteoporosis,postmenopausal,166710|Ehlers-Danlos syndrome,cardiac valvular form,225320];	RCV000253006.2 [benign]; RCV000274743.1 [benign]; RCV000329587.1 [benign]; 	CS151749 [CLASS=R MUT=ALT PHEN="Osteogenesis imperfecta" GENE=COL1A2]; 		1115	805	2	[2] Ute Grasshoff 24.11.2015			COL1A2 (inh=AR+AD pLI=1.00)
chr7	94041937	94041937	A	C	het	anno_omim	QUAL=8906;DP=239;AF=0.51;MQM=59;TRIO=HET,239,0.51,HET,183,0.49,HET,234,0.57	COL1A2	synonymous	COL1A2:ENST00000297268:synonymous:LOW:exon25/52:c.1446A>C:p.Pro482Pro		rs412777	0.3273	0.3459	7333,4586,646	0.3572,0.2336,0.3270,0.3726,0.2930	0.3579							120160 [COL1A2 (confirmed) Ehlers-Danlos syndrome,type VIIB,130060|Osteogenesis imperfecta,type IV,166220|Osteogenesis imperfecta,type III,259420|Osteogenesis imperfecta,type II,166210|Osteoporosis,postmenopausal,166710|Ehlers-Danlos syndrome,cardiac valvular form,225320];	RCV000252784.1 [benign]; RCV000367790.1 [benign]; RCV000395576.1 [benign]; 		COSM1452968	277	930	2	[2] auto-classification 15.09.2017  			COL1A2 (inh=AR+AD pLI=1.00)
chr7	94043239	94043239	C	G	het	pred_pathogenic;anno_omim	QUAL=19066;DP=626;AF=0.47;MQM=60;TRIO=HET,626,0.47,HET,394,0.49,HET,499,0.49	COL1A2	missense	COL1A2:ENST00000297268:missense:MODERATE:exon28/52:c.1645C>G:p.Pro549Ala		rs42524	0.8217	0.7693	36256,18737,4121	0.8895,0.8341,0.9151,0.7499,0.6445	0.8092	1.2480	T,T	T	B	D	11.45	120160 [COL1A2 (confirmed) Ehlers-Danlos syndrome,type VIIB,130060|Osteogenesis imperfecta,type IV,166220|Osteogenesis imperfecta,type III,259420|Osteogenesis imperfecta,type II,166210|Osteoporosis,postmenopausal,166710|Ehlers-Danlos syndrome,cardiac valvular form,225320];	RCV000244604.1 [benign]; RCV000269609.1 [benign]; RCV000323983.1 [benign]; 		COSM3762900	1102	813	2	[2] auto-classification 15.09.2017  			COL1A2 (inh=AR+AD pLI=1.00)
chr7	99699169	99699169	A	T	het	anno_omim	QUAL=438;DP=20;AF=0.45;MQM=60;TRIO=HET,20,0.45,WT,26,0.04,HET,30,0.53	MCM7	5'UTR	MCM7:ENST00000303887:5'UTR:MODIFIER:exon1/15:c.-252T>A:,MCM7:ENST00000343023:5'UTR:MODIFIER:exon1/9:c.-252T>A:		rs1534310	0.2772	0.0000	0,0,0	0,0,0,0,0	0.2575							602296 [AP4M1 (confirmed) Spastic paraplegia 50,autosomal recessive,612936];				13	74					MCM7 (inh=n/a pLI=0.00)
chr7	99704796	99704796	A	T	hom	anno_omim	QUAL=6416;DP=128;AF=1.00;MQM=59;TRIO=HOM,128,1.00,HOM,48,0.98,HOM,54,1.00	AP4M1,TAF6	3'UTR,intron	AP4M1:ENST00000429084:3'UTR:MODIFIER:exon15/15:c.*291A>T:,TAF6:ENST00000472509:3'UTR:MODIFIER:exon14/14:c.*73T>A:,AP4M1:ENST00000359593:3'UTR:MODIFIER:exon15/15:c.*291A>T:,TAF6:ENST00000453269:3'UTR:MODIFIER:exon15/15:c.*73T>A:,TAF6:ENST00000452041:3'UTR:MODIFIER:exon15/15:c.*73T>A:,TAF6:ENST00000344095:3'UTR:MODIFIER:exon15/15:c.*73T>A:,TAF6:ENST00000418432:3'UTR:MODIFIER:exon14/14:c.*73T>A:,TAF6:ENST00000437822:3'UTR:MODIFIER:exon15/15:c.*73T>A:,AP4M1:ENST00000421755:intron:MODIFIER:exon15/15:c.*30+261A>T:		rs13309	0.6352	0.0000	0,0,0	0,0,0,0,0	0.5487							602296 [AP4M1 (confirmed) Spastic paraplegia 50,autosomal recessive,612936]:602955 [TAF6 (provisional) Alazami-Yuan syndrome,617126];				72	126					AP4M1 (inh=AR pLI=0.00), TAF6 (inh=n/a pLI=0.00)
chr7	103112862	103112862	C	T	hom	anno_omim	QUAL=19845;DP=379;AF=1.00;MQM=60;TRIO=HOM,379,1.00,HOM,87,1.00,HOM,118,1.00	RELN,CTB-107G13.1	3'UTR	RELN:ENST00000424685:3'UTR:MODIFIER:exon65/65:c.*397G>A:,RELN:ENST00000343529:3'UTR:MODIFIER:exon64/64:c.*397G>A:,RELN:ENST00000428762:3'UTR:MODIFIER:exon65/65:c.*397G>A:		rs7811262	0.9984	0.0000	0,0,0	0,0,0,0,0	0.9899							600514 [RELN (confirmed) Lissencephaly 2 (Norman-Roberts type),257320|Epilepsy,familial temporal lobe,7,616436];	RCV000292267.1 [benign]; 			232	0					RELN (inh=AR+AD pLI=1.00), CTB-107G13.1 (inh=n/a pLI=n/a)
chr7	103138517	103138517	C	G	hom	anno_omim	QUAL=23510;DP=207;AF=1.00;MQM=59;TRIO=HOM,207,1.00,HOM,217,1.00,HOM,300,1.00	RELN,CTB-107G13.1	splice_region&intron	RELN:ENST00000424685:splice_region&intron:LOW:exon54/64:c.8843+7G>C:,RELN:ENST00000343529:splice_region&intron:LOW:exon54/63:c.8843+7G>C:,RELN:ENST00000428762:splice_region&intron:LOW:exon54/64:c.8843+7G>C:		rs2711885	0.9956	0.9870	59119,32274,5179	0.9977,0.9948,0.9999,0.9834,0.9895	0.9870							600514 [RELN (confirmed) Lissencephaly 2 (Norman-Roberts type),257320|Epilepsy,familial temporal lobe,7,616436];	RCV000081246.8 [other]; RCV000320073.1 [benign]; 			3178	96	2	[2] auto-classification 15.09.2017  			RELN (inh=AR+AD pLI=1.00), CTB-107G13.1 (inh=n/a pLI=n/a)
chr7	103155705	103155705	A	G	het	anno_omim	QUAL=3825;DP=132;AF=0.49;MQM=59;TRIO=HET,132,0.49,HOM,78,0.97,WT,64,0.00	RELN	synonymous	RELN:ENST00000424685:synonymous:LOW:exon50/65:c.8046T>C:p.His2682His,RELN:ENST00000343529:synonymous:LOW:exon50/64:c.8046T>C:p.His2682His,RELN:ENST00000428762:synonymous:LOW:exon50/65:c.8046T>C:p.His2682His		rs2229864	0.6484	0.4722	15217,4311,3118	0.7732,0.4588,0.8038,0.3581,0.6219	0.5053							600514 [RELN (confirmed) Lissencephaly 2 (Norman-Roberts type),257320|Epilepsy,familial temporal lobe,7,616436];	RCV000081242.8 [other]; RCV000404542.1 [benign]; 			606	1535	2	[2] auto-classification 15.09.2017  			RELN (inh=AR+AD pLI=1.00)
chr7	103155864	103155864	A	G	het	anno_omim	QUAL=1904;DP=78;AF=0.33;MQM=59;TRIO=HET,78,0.33,HOM,50,0.96,WT,42,0.00	RELN	synonymous	RELN:ENST00000424685:synonymous:LOW:exon50/65:c.7887T>C:p.Pro2629Pro,RELN:ENST00000343529:synonymous:LOW:exon50/64:c.7887T>C:p.Pro2629Pro,RELN:ENST00000428762:synonymous:LOW:exon50/65:c.7887T>C:p.Pro2629Pro		rs56345626	0.1749	0.1816	2079,1124,72	0.1364,0.1506,0.2781,0.1828,0.1590	0.1806							600514 [RELN (confirmed) Lissencephaly 2 (Norman-Roberts type),257320|Epilepsy,familial temporal lobe,7,616436];	RCV000118171.3 [other]; RCV000393435.1 [benign]; 		COSM3762300	138	997	2	[2] auto-classification 15.09.2017  			RELN (inh=AR+AD pLI=1.00)
chr7	103202406	103202406	C	A	hom	anno_omim	QUAL=3463;DP=90;AF=0.02;MQM=57;TRIO=HOM,90,0.02,HOM,24,0.13,HOM,28,0.07	RELN	splice_region&intron	RELN:ENST00000424685:splice_region&intron:LOW:exon34/64:c.5211-6G>T:,RELN:ENST00000343529:splice_region&intron:LOW:exon34/63:c.5211-6G>T:,RELN:ENST00000428762:splice_region&intron:LOW:exon34/64:c.5211-6G>T:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0041							600514 [RELN (confirmed) Lissencephaly 2 (Norman-Roberts type),257320|Epilepsy,familial temporal lobe,7,616436];			COSM1622159	6	23					RELN (inh=AR+AD pLI=1.00)
chr7	103206001	103206001	-	A	het	anno_omim	QUAL=4072;DP=147;AF=0.75;MQM=59;TRIO=HET,147,0.75,HET,123,0.44,HET,148,0.41	RELN	splice_region&intron	RELN:ENST00000424685:splice_region&intron:LOW:exon33/64:c.4937-4dupT:,RELN:ENST00000343529:splice_region&intron:LOW:exon33/63:c.4937-4dupT:,RELN:ENST00000428762:splice_region&intron:LOW:exon33/64:c.4937-4dupT:		rs35268159;rs397763920	0.2508	0.3149	367,232,42	0.3335,0.2190,0.1601,0.3410,0.3207	0.3489							600514 [RELN (confirmed) Lissencephaly 2 (Norman-Roberts type),257320|Epilepsy,familial temporal lobe,7,616436];	RCV000273179.1 [benign]; 			147	1379	2	[2] auto-classification 15.09.2017  			RELN (inh=AR+AD pLI=1.00)
chr7	103389954	103389954	A	G	het	anno_omim	QUAL=8034;DP=288;AF=0.52;MQM=60;TRIO=HET,288,0.52,WT,215,0.00,HET,288,0.50	RELN	splice_region&intron	RELN:ENST00000424685:splice_region&intron:LOW:exon5/64:c.578-3T>C:,RELN:ENST00000343529:splice_region&intron:LOW:exon5/63:c.578-3T>C:,RELN:ENST00000428762:splice_region&intron:LOW:exon5/64:c.578-3T>C:		rs607755	0.4655	0.4960	15270,9719,1029	0.4439,0.3886,0.3725,0.5388,0.5142	0.4920							600514 [RELN (confirmed) Lissencephaly 2 (Norman-Roberts type),257320|Epilepsy,familial temporal lobe,7,616436];	RCV000081236.8 [other]; RCV000402466.1 [benign]; 			946	1595	2	[2] auto-classification 15.09.2017  			RELN (inh=AR+AD pLI=1.00)
chr7	107545799	107545799	T	C	het	anno_omim	QUAL=10834;DP=245;AF=0.53;MQM=60;TRIO=HET,245,0.53,HET,118,0.53,HOM,178,0.99	DLD	splice_region&intron,intron	DLD:ENST00000205402:splice_region&intron:LOW:exon6/13:c.439-7T>C:,DLD:ENST00000537148:splice_region&intron:LOW:exon4/11:c.142-7T>C:,DLD:ENST00000440410:splice_region&intron:LOW:exon5/12:c.370-7T>C:,DLD:ENST00000437604:intron:MODIFIER:exon6/12:c.438+296T>C:		rs10263341	0.7161	0.6182	23373,11110,3206	0.7950,0.5710,0.8489,0.5826,0.5651	0.6630							238331 [DLD (confirmed) Dihydrolipoamide dehydrogenase deficiency,246900];	RCV000179713.3 [other]; RCV000264516.1 [benign]; RCV000301000.1 [benign]; RCV000355848.1 [benign]; 			820	931	2	[2] auto-classification 15.09.2017  			DLD (inh=AR pLI=0.37)
chr7	107559502	107559502	A	C	het	anno_omim	QUAL=8505;DP=361;AF=0.50;MQM=59;TRIO=HET,361,0.50,WT,202,0.00,HET,292,0.48	DLD	synonymous	DLD:ENST00000205402:synonymous:LOW:exon13/14:c.1422A>C:p.Gly474Gly,DLD:ENST00000537148:synonymous:LOW:exon11/12:c.1125A>C:p.Gly375Gly,DLD:ENST00000440410:synonymous:LOW:exon12/13:c.1353A>C:p.Gly451Gly,DLD:ENST00000437604:synonymous:LOW:exon12/13:c.1278A>C:p.Gly426Gly		rs34453495	0.0048	0.0088	7,4,0	0.0018,0.0069,0.0002,0.0125,0.0003	0.0108							238331 [DLD (confirmed) Dihydrolipoamide dehydrogenase deficiency,246900];	RCV000124696.2 [benign]; 			0	41					DLD (inh=AR pLI=0.37)
chr7	107559722	107559722	A	T	het	anno_omim	QUAL=3693;DP=197;AF=0.50;MQM=60;TRIO=HET,197,0.50,HET,15,0.33,HET,46,0.67	DLD	3'UTR	DLD:ENST00000205402:3'UTR:MODIFIER:exon14/14:c.*18A>T:,DLD:ENST00000537148:3'UTR:MODIFIER:exon12/12:c.*18A>T:,DLD:ENST00000440410:3'UTR:MODIFIER:exon13/13:c.*18A>T:,DLD:ENST00000437604:3'UTR:MODIFIER:exon13/13:c.*18A>T:		rs8721	0.2758	0.3602	7987,5250,71	0.1135,0.3810,0.3410,0.4064,0.2891	0.3614							238331 [DLD (confirmed) Dihydrolipoamide dehydrogenase deficiency,246900];	RCV000124697.3 [benign]; RCV000279168.1 [benign]; RCV000350587.1 [benign]; RCV000400340.1 [benign]; 			321	927					DLD (inh=AR pLI=0.37)
chr7	107559911	107559911	G	A	het	anno_omim	QUAL=7556;DP=267;AF=0.48;MQM=60;TRIO=HET,267,0.48,HET,55,0.62,HOM,94,1.00	DLD	3'UTR	DLD:ENST00000205402:3'UTR:MODIFIER:exon14/14:c.*207G>A:,DLD:ENST00000537148:3'UTR:MODIFIER:exon12/12:c.*207G>A:,DLD:ENST00000440410:3'UTR:MODIFIER:exon13/13:c.*207G>A:,DLD:ENST00000437604:3'UTR:MODIFIER:exon13/13:c.*207G>A:		rs4564	0.7107	0.0000	0,0,0	0,0,0,0,0	0.6605							238331 [DLD (confirmed) Dihydrolipoamide dehydrogenase deficiency,246900];	RCV000267242.1 [benign]; RCV000324559.1 [benign]; RCV000358247.1 [benign]; 			103	96					DLD (inh=AR pLI=0.37)
chr7	107560191	107560191	C	T	het	anno_omim	QUAL=12956;DP=255;AF=0.53;MQM=60;TRIO=HET,255,0.53,HET,159,0.41,HOM,223,1.00	DLD	3'UTR	DLD:ENST00000205402:3'UTR:MODIFIER:exon14/14:c.*487C>T:		rs4518	0.7145	0.0000	0,0,0	0,0,0,0,0	0.6659							238331 [DLD (confirmed) Dihydrolipoamide dehydrogenase deficiency,246900];	RCV000290158.1 [benign]; RCV000347564.1 [benign]; RCV000393003.1 [benign]; 			105	97					DLD (inh=AR pLI=0.37)
chr7	107560651	107560651	G	T	het	anno_omim	QUAL=10513;DP=345;AF=0.45;MQM=60;TRIO=HET,345,0.45,HET,219,0.49,HET,306,0.45	DLD	3'UTR	DLD:ENST00000205402:3'UTR:MODIFIER:exon14/14:c.*947G>T:		rs7777259	0.2724	0.0000	0,0,0	0,0,0,0,0	0.3215							238331 [DLD (confirmed) Dihydrolipoamide dehydrogenase deficiency,246900];	RCV000275277.1 [likely benign]; RCV000332301.1 [likely benign]; RCV000386065.1 [likely benign]; 			49	110					DLD (inh=AR pLI=0.37)
chr7	107560682	107560682	T	C	het	anno_omim	QUAL=19296;DP=478;AF=0.47;MQM=59;TRIO=HET,478,0.47,HET,263,0.42,HOM,325,1.00	DLD	3'UTR	DLD:ENST00000205402:3'UTR:MODIFIER:exon14/14:c.*978T>C:		rs2158835	0.7147	0.0000	0,0,0	0,0,0,0,0	0.6632							238331 [DLD (confirmed) Dihydrolipoamide dehydrogenase deficiency,246900];	RCV000288290.1 [benign]; RCV000328083.1 [benign]; RCV000384986.1 [benign]; 			104	95					DLD (inh=AR pLI=0.37)
chr7	107561155	107561155	T	C	het	anno_omim	QUAL=13231;DP=364;AF=0.49;MQM=60;TRIO=HET,364,0.49,HET,140,0.54,HOM,201,1.00	DLD	3'UTR	DLD:ENST00000205402:3'UTR:MODIFIER:exon14/14:c.*1451T>C:	L1MEb	rs2108223	0.7153	0.0000	0,0,0	0,0,0,0,0	0.6631							238331 [DLD (confirmed) Dihydrolipoamide dehydrogenase deficiency,246900];	RCV000276849.1 [benign]; RCV000312034.1 [benign]; RCV000370203.1 [benign]; 			102	73					DLD (inh=AR pLI=0.37)
chr7	107561392	107561392	G	A	het	anno_omim	QUAL=12412;DP=443;AF=0.47;MQM=60;TRIO=HET,443,0.47,HET,169,0.56,HET,269,0.55	DLD	3'UTR	DLD:ENST00000205402:3'UTR:MODIFIER:exon14/14:c.*1688G>A:	L1MEb	rs8440	0.2722	0.0000	0,0,0	0,0,0,0,0	0.3212							238331 [DLD (confirmed) Dihydrolipoamide dehydrogenase deficiency,246900];	RCV000272023.1 [likely benign]; RCV000329448.1 [likely benign]; RCV000369006.1 [likely benign]; 			49	109					DLD (inh=AR pLI=0.37)
chr7	112092211	112092211	T	-	hom		QUAL=15061;DP=306;AF=0.82;MQM=59;TRIO=HOM,306,0.82,HET,225,0.49,HOM,307,0.82	IFRD1	intron	IFRD1:ENST00000005558:intron:MODIFIER:exon2/12:c.94+1386delT:,IFRD1:ENST00000403825:intron:MODIFIER:exon1/11:c.94+1386delT:,IFRD1:ENST00000429071:intron:MODIFIER:exon1/3:c.94+1386delT:	AluJr	rs796411555	0.8345	0.0000	0,0,0	0,0,0,0,0	0.7838											88	49					IFRD1 (inh=n/a pLI=0.11)
chr7	112092347	112092347	C	T	het		QUAL=6059;DP=249;AF=0.51;MQM=60;TRIO=HET,249,0.51,WT,199,0.00,HET,231,0.47	IFRD1	intron	IFRD1:ENST00000005558:intron:MODIFIER:exon2/12:c.94+1510C>T:,IFRD1:ENST00000403825:intron:MODIFIER:exon1/11:c.94+1510C>T:,IFRD1:ENST00000429071:intron:MODIFIER:exon1/3:c.94+1510C>T:	AluJr	rs4727771	0.2087	0.0000	0,0,0	0,0,0,0,0	0.1495											4	29					IFRD1 (inh=n/a pLI=0.11)
chr7	112112892	112112892	G	A	het		QUAL=6121;DP=253;AF=0.50;MQM=60;TRIO=HET,253,0.50,HET,225,0.47,WT,306,0.00	IFRD1	synonymous	IFRD1:ENST00000005558:synonymous:LOW:exon12/13:c.1242G>A:p.Thr414Thr,IFRD1:ENST00000403825:synonymous:LOW:exon11/12:c.1242G>A:p.Thr414Thr,IFRD1:ENST00000535603:synonymous:LOW:exon11/12:c.1092G>A:p.Thr364Thr		rs11542468	0.0453	0.0655	345,210,9	0.0335,0.0411,0.0004,0.0762,0.1043	0.0643										COSM3762331	8	329	2	[2] auto-classification 15.09.2017  			IFRD1 (inh=n/a pLI=0.11)
chr7	112115658	112115658	C	T	het		QUAL=3823;DP=236;AF=0.47;MQM=60;TRIO=HET,236,0.47,WT,69,0.00,HET,65,0.49	IFRD1	3'UTR	IFRD1:ENST00000403825:3'UTR:MODIFIER:exon12/12:c.*84C>T:,IFRD1:ENST00000535603:3'UTR:MODIFIER:exon12/12:c.*84C>T:		rs7817	0.3930	0.0000	0,0,0	0,0,0,0,0	0.4618									CR092300 [CLASS=DFP MUT=ALT PHEN="Severity in cystic fibrosis association with" GENE=IFRD1]; 		92	212					IFRD1 (inh=n/a pLI=0.11)
chr7	112116198	112116198	G	A	het		QUAL=16936;DP=410;AF=0.57;MQM=60;TRIO=HET,410,0.57,HOM,311,1.00,WT,435,0.00	IFRD1	3'UTR	IFRD1:ENST00000403825:3'UTR:MODIFIER:exon12/12:c.*624G>A:		rs7467	0.2851	0.0000	0,0,0	0,0,0,0,0	0.3219											21	99					IFRD1 (inh=n/a pLI=0.11)
chr7	112116537	112116537	A	C	het		QUAL=7686;DP=318;AF=0.47;MQM=59;TRIO=HET,318,0.47,WT,307,0.00,HET,413,0.44	IFRD1			AluJo	rs2190587	0.3990	0.0000	0,0,0	0,0,0,0,0	0.4661											32	75					IFRD1 (inh=n/a pLI=0.11)
chr7	112116659	112116659	T	C	hom		QUAL=25247;DP=369;AF=0.99;MQM=59;TRIO=HOM,369,0.99,HOM,263,1.00,HET,429,0.48	IFRD1			AluJo	rs2190588	0.7049	0.0000	0,0,0	0,0,0,0,0	0.8115											90	55					IFRD1 (inh=n/a pLI=0.11)
chr7	112116685	112116685	C	T	het		QUAL=8613;DP=360;AF=0.46;MQM=59;TRIO=HET,360,0.46,WT,239,0.00,HET,382,0.47	IFRD1			AluJo	rs12532656	0.1034	0.0000	0,0,0	0,0,0,0,0	0.0598											1	19					IFRD1 (inh=n/a pLI=0.11)
chr7	112116980	112116980	C	T	het		QUAL=6888;DP=305;AF=0.48;MQM=60;TRIO=HET,305,0.48,WT,175,0.00,HET,248,0.48	IFRD1				rs1054043	0.3994	0.0000	0,0,0	0,0,0,0,0	0.4653											32	75					IFRD1 (inh=n/a pLI=0.11)
chr7	114330185	114330186	TT	-	hom	anno_omim	QUAL=326;DP=67;AF=0.48;MQM=59;TRIO=HOM,67,0.48,HOM,16,0.38,HOM,23,0.57	FOXP2	splice_region,3'UTR,non_coding_transcript	FOXP2:ENST00000393498:splice_region:LOW:exon17/17:c.*219_*220delTT:,FOXP2:ENST00000408937:3'UTR:MODIFIER:exon18/18:c.*219_*220delTT:,FOXP2:ENST00000393494:3'UTR:MODIFIER:exon17/17:c.*219_*220delTT:,FOXP2:ENST00000403559:3'UTR:MODIFIER:exon18/18:c.*219_*220delTT:,FOXP2:ENST00000393498:3'UTR:MODIFIER:exon17/17:c.*219_*220delTT:,FOXP2:ENST00000393498:non_coding_transcript:MODIFIER:exon17/17:c.*219_*220delTT:	(T)n	rs58777789;rs796306184	0.0000	0.2943	27,18,0	0.0000,0.0000,0.0000,0.3062,0.2950	0.3136							605317 [FOXP2 (confirmed) Speech-language disorder-1,602081];	RCV000290888.1 [uncertain significance]; 			142	109	2	[2] auto-classification 15.09.2017  			FOXP2 (inh=AD pLI=1.00)
chr7	114331999	114331999	A	-	het	anno_omim	QUAL=1920;DP=253;AF=0.27;MQM=58;TRIO=HET,253,0.27,HET,68,0.38,HET,121,0.27	FOXP2	3'UTR	FOXP2:ENST00000408937:3'UTR:MODIFIER:exon18/18:c.*2030delA:,FOXP2:ENST00000403559:3'UTR:MODIFIER:exon18/18:c.*2030delA:	(A)n	rs58804519;rs796214969	0.2430	0.4199	90,62,2	0.3000,0.0000,0.0000,0.4483,0.4161	0.3392							605317 [FOXP2 (confirmed) Speech-language disorder-1,602081];	RCV000303357.1 [benign]; 			1	204					FOXP2 (inh=AD pLI=1.00)
chr7	114332246	114332246	G	T	het	anno_omim	QUAL=11061;DP=435;AF=0.51;MQM=60;TRIO=HET,435,0.51,HET,189,0.48,HET,194,0.52	FOXP2	3'UTR	FOXP2:ENST00000408937:3'UTR:MODIFIER:exon18/18:c.*2265G>T:,FOXP2:ENST00000403559:3'UTR:MODIFIER:exon18/18:c.*2265G>T:		rs12705977	0.2230	0.3262	589,160,3	0.0000,0.0000,0.0000,0.3316,0.3308	0.3442							605317 [FOXP2 (confirmed) Speech-language disorder-1,602081];	RCV000320009.1 [benign]; 			85	268					FOXP2 (inh=AD pLI=1.00)
chr7	117188736	117188736	C	A	het	low_MQM;pred_pathogenic;anno_omim	QUAL=818;DP=176;AF=0.32;MQM=32;TRIO=HET,176,0.32,HET,95,0.16,WT,146,0.07	CFTR	missense,intron	CFTR:ENST00000003084:missense:MODERATE:exon10/27:c.1251C>A:p.Asn417Lys,CFTR:ENST00000454343:intron:MODIFIER:exon9/25:c.1209+6574C>A:	(AAAAC)n	rs4727853	0.0000	0.0189	0,0,0	0.0352,0.0091,0.0093,0.0241,0.0072	0.2927	-0.0310	T,T	T	B	D,D	0.20	602421 [CFTR (confirmed) Cystic fibrosis,219700|Congenital bilateral absence of vas deferens,277180|Sweat chloride elevation without CF|Pancreatitis,idiopathic,167800|Hypertrypsinemia,neonatal|Bronchiectasis with or without elevated sweat chloride 1,modifier of,211400];	RCV000173697.1 [benign]; RCV000224343.1 [benign]; RCV000366455.1 [likely benign]; 		COSM4161731	0	131	2	[2] auto-classification 15.09.2017  			CFTR (inh=AR pLI=0.00)
chr7	117188750	117188750	C	T	het	low_MQM;pred_pathogenic;anno_omim	QUAL=255;DP=192;AF=0.20;MQM=33;TRIO=HET,192,0.20,WT,113,0.10,WT,154,0.05	CFTR	missense,intron	CFTR:ENST00000003084:missense:MODERATE:exon10/27:c.1265C>T:p.Ser422Phe,CFTR:ENST00000454343:intron:MODIFIER:exon9/25:c.1209+6588C>T:		rs201880593	0.0000	0.0025	0,0,0	0.0033,0.0014,0.0013,0.0033,0.0009	0.0501	3.1910	T,T	D	B	D,D	13.07	602421 [CFTR (confirmed) Cystic fibrosis,219700|Congenital bilateral absence of vas deferens,277180|Sweat chloride elevation without CF|Pancreatitis,idiopathic,167800|Hypertrypsinemia,neonatal|Bronchiectasis with or without elevated sweat chloride 1,modifier of,211400];			COSM1284105	0	23	2	[2] auto-classification 15.09.2017  			CFTR (inh=AR pLI=0.00)
chr7	117188797	117188797	A	G	het	low_MQM;pred_pathogenic;anno_omim	QUAL=516;DP=260;AF=0.20;MQM=34;TRIO=HET,260,0.20,WT,138,0.08,WT,187,0.04	CFTR	missense,intron	CFTR:ENST00000003084:missense:MODERATE:exon10/27:c.1312A>G:p.Thr438Ala,CFTR:ENST00000454343:intron:MODIFIER:exon9/25:c.1209+6635A>G:		rs201434579	0.0000	0.0024	0,0,0	0.0029,0.0014,0.0022,0.0029,0.0011	0.0504	0.1610	T,T	T	B	D,D	6.33	602421 [CFTR (confirmed) Cystic fibrosis,219700|Congenital bilateral absence of vas deferens,277180|Sweat chloride elevation without CF|Pancreatitis,idiopathic,167800|Hypertrypsinemia,neonatal|Bronchiectasis with or without elevated sweat chloride 1,modifier of,211400];	RCV000173699.1 [uncertain significance]; RCV000265349.1 [uncertain significance]; 		COSM3734028	0	32					CFTR (inh=AR pLI=0.00)
chr7	117188850	117188850	G	T	het	low_MQM;anno_omim	QUAL=580;DP=391;AF=0.21;MQM=34;TRIO=HET,391,0.21,WT,159,0.06,WT,203,0.03	CFTR	synonymous,intron	CFTR:ENST00000003084:synonymous:LOW:exon10/27:c.1365G>T:p.Ala455Ala,CFTR:ENST00000454343:intron:MODIFIER:exon9/25:c.1209+6688G>T:		rs79074685	0.0000	0.0007	0,0,0	0.0014,0.0001,0.0005,0.0008,0.0002	0.1284							602421 [CFTR (confirmed) Cystic fibrosis,219700|Congenital bilateral absence of vas deferens,277180|Sweat chloride elevation without CF|Pancreatitis,idiopathic,167800|Hypertrypsinemia,neonatal|Bronchiectasis with or without elevated sweat chloride 1,modifier of,211400];			COSM3774275	0	45					CFTR (inh=AR pLI=0.00)
chr7	117199533	117199533	G	A	het	pred_pathogenic;anno_omim	QUAL=8169;DP=227;AF=0.50;MQM=60;TRIO=HET,227,0.50,HOM,105,1.00,HET,157,0.55	CFTR	missense	CFTR:ENST00000003084:missense:MODERATE:exon11/27:c.1408G>A:p.Val470Met,CFTR:ENST00000454343:missense:MODERATE:exon10/26:c.1225G>A:p.Val409Met		rs213950	0.5821	0.4830	15242,5854,3908	0.8670,0.5215,0.4267,0.4172,0.4844	0.5815	2.6080	T,T,T	T	B	D,D,D	13.09	602421 [CFTR (confirmed) Cystic fibrosis,219700|Congenital bilateral absence of vas deferens,277180|Sweat chloride elevation without CF|Pancreatitis,idiopathic,167800|Hypertrypsinemia,neonatal|Bronchiectasis with or without elevated sweat chloride 1,modifier of,211400];	RCV000007550.3 [other]; RCV000036517.10 [other]; 		COSM3762337	307	1032	2	[2] auto-classification 15.09.2017  			CFTR (inh=AR pLI=0.00)
chr7	121714653	121714653	C	T	het	anno_omim	QUAL=5006;DP=159;AF=0.49;MQM=60;TRIO=HET,159,0.49,WT,88,0.00,HOM,85,1.00	PTPRZ1,AASS	intergenic_region	AASS:ENSG00000106278-ENSG00000008311:intergenic_region:MODIFIER::n.121714653C>T:	L1MB8	rs12217	0.6697	0.0000	0,0,0	0,0,0,0,0	0.6467							605113 [AASS (provisional) Hyperlysinemia,238700|Saccharopinuria,268700];				58	68					PTPRZ1 (inh=n/a pLI=0.99), AASS (inh=AR pLI=0.00)
chr7	121715965	121715965	C	T	het	anno_omim	QUAL=4067;DP=148;AF=0.51;MQM=60;TRIO=HET,148,0.51,WT,46,0.00,HOM,65,1.00	AASS				rs1206380	0.6673	0.0000	0,0,0	0,0,0,0,0	0.6426							605113 [AASS (provisional) Hyperlysinemia,238700|Saccharopinuria,268700];				75	102					AASS (inh=AR pLI=0.00)
chr7	121738926	121738926	T	A	hom	low_DP;low_MQM;anno_omim	QUAL=45;DP=18;AF=0.50;MQM=48;TRIO=HOM,18,0.50,WT,4,0.00,HOM,3,0.33	AASS	splice_region&intron	AASS:ENST00000393376:splice_region&intron:LOW:exon12/22:c.1407-6A>T:,AASS:ENST00000417368:splice_region&intron:LOW:exon13/23:c.1407-6A>T:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							605113 [AASS (provisional) Hyperlysinemia,238700|Saccharopinuria,268700];				0	5	2	[2] Stefanie Beck-Woedl 07.10.2015		GS150233_01: in GS150233_01 vermutl. Artefakt, swal 150921	AASS (inh=AR pLI=0.00)
chr7	127950724	127950724	C	T	het	anno_omim	QUAL=9569;DP=364;AF=0.47;MQM=59;TRIO=HET,364,0.47,WT,330,0.00,HET,443,0.47	RBM28	3'UTR	RBM28:ENST00000223073:3'UTR:MODIFIER:exon19/19:c.*126G>A:,RBM28:ENST00000415472:3'UTR:MODIFIER:exon15/15:c.*126G>A:		rs141043380	0.0126	0.0000	0,0,0	0,0,0,0,0	0.0360							612074 [RBM28 (confirmed) Alopecia,neurologic defects,and endocrinopathy syndrome,612079];				1	23					RBM28 (inh=AR pLI=0.00)
chr7	127950725	127950725	G	A	het	anno_omim	QUAL=21590;DP=364;AF=0.51;MQM=60;TRIO=HET,364,0.51,HOM,330,1.00,HET,447,0.53	RBM28	3'UTR	RBM28:ENST00000223073:3'UTR:MODIFIER:exon19/19:c.*125C>T:,RBM28:ENST00000415472:3'UTR:MODIFIER:exon15/15:c.*125C>T:		rs12850	0.3399	0.0000	0,0,0	0,0,0,0,0	0.3137							612074 [RBM28 (confirmed) Alopecia,neurologic defects,and endocrinopathy syndrome,612079];				33	105					RBM28 (inh=AR pLI=0.00)
chr7	128470482	128470482	G	A	hom	low_DP;anno_omim	QUAL=1058;DP=2;AF=1.00;MQM=59;TRIO=HOM,2,1.00,HOM,18,1.00,HOM,26,1.00	FLNC	5'UTR	FLNC:ENST00000325888:5'UTR:MODIFIER:exon1/48:c.-210G>A:,FLNC:ENST00000346177:5'UTR:MODIFIER:exon1/47:c.-210G>A:	(CCCGG)n	rs2639138	1.0000	0.0000	0,0,0	0,0,0,0,0	1.0000							102565 [FLNC (confirmed) Myopathy,myofibrillar,5,609524|Myopathy,distal,4,614065|Cardiomyopathy,familial hypertrophic,26|Cardiomyopathy,familial restrictive 5,617047];				199	0					FLNC (inh=AD pLI=1.00)
chr7	128487866	128487866	T	C	hom	anno_omim	QUAL=6140;DP=49;AF=1.00;MQM=60;TRIO=HOM,49,1.00,HOM,69,1.00,HOM,81,1.00	FLNC	synonymous	FLNC:ENST00000325888:synonymous:LOW:exon25/48:c.4404T>C:p.Asp1468Asp,FLNC:ENST00000346177:synonymous:LOW:exon25/47:c.4404T>C:p.Asp1468Asp		rs2249128	0.9906	0.9973	59996,33309,4599	0.9695,0.9987,1.0000,0.9999,0.9999	0.9978							102565 [FLNC (confirmed) Myopathy,myofibrillar,5,609524|Myopathy,distal,4,614065|Cardiomyopathy,familial hypertrophic,26|Cardiomyopathy,familial restrictive 5,617047];	RCV000221141.2 [benign]; 			2111	1	2	[2] auto-classification 15.09.2017  			FLNC (inh=AD pLI=1.00)
chr7	128489228	128489228	T	C	het	anno_omim	QUAL=3312;DP=165;AF=0.50;MQM=59;TRIO=HET,165,0.50,WT,92,0.01,HET,138,0.48	FLNC	splice_region&intron	FLNC:ENST00000325888:splice_region&intron:LOW:exon28/47:c.4928-7T>C:,FLNC:ENST00000346177:splice_region&intron:LOW:exon28/46:c.4928-7T>C:		rs201957008	0.0040	0.0047	3,2,0	0.0007,0.0023,0.0000,0.0050,0.0114	0.0043							102565 [FLNC (confirmed) Myopathy,myofibrillar,5,609524|Myopathy,distal,4,614065|Cardiomyopathy,familial hypertrophic,26|Cardiomyopathy,familial restrictive 5,617047];	RCV000176925.2 [benign]; 			0	25					FLNC (inh=AD pLI=1.00)
chr7	139784641	139784641	A	G	hom		QUAL=1483;DP=38;AF=1.00;MQM=60;TRIO=HOM,38,1.00,HOM,5,1.00,HOM,7,1.00	KDM7A	3'UTR	KDM7A:ENST00000397560:3'UTR:MODIFIER:exon20/20:c.*6253T>C:		rs12703525	0.9960	0.0000	0,0,0	0,0,0,0,0	0.9935											227	3					KDM7A (inh=n/a pLI=1.00)
chr7	139785024	139785024	C	A	het		QUAL=8610;DP=313;AF=0.51;MQM=60;TRIO=HET,313,0.51,HET,180,0.49,HET,246,0.51	KDM7A	3'UTR	KDM7A:ENST00000397560:3'UTR:MODIFIER:exon20/20:c.*5870G>T:		rs10984	0.3596	0.0000	0,0,0	0,0,0,0,0	0.4075											57	97					KDM7A (inh=n/a pLI=1.00)
chr7	139785028	139785030	AAG	-	het		QUAL=8610;DP=313;AF=0.51;MQM=59;TRIO=HET,313,0.51,WT,180,0.49,HET,246,0.51	KDM7A	3'UTR	KDM7A:ENST00000397560:3'UTR:MODIFIER:exon20/20:c.*5864_*5866delCTT:		rs371560827	0.1991	0.0000	0,0,0	0,0,0,0,0	0.2017											17	65					KDM7A (inh=n/a pLI=1.00)
chr7	139786186	139786186	G	A	het		QUAL=3119;DP=166;AF=0.51;MQM=60;TRIO=HET,166,0.51,HET,26,0.42,HET,53,0.40	KDM7A	3'UTR	KDM7A:ENST00000397560:3'UTR:MODIFIER:exon20/20:c.*4708C>T:		rs11972958	0.3712	0.0000	0,0,0	0,0,0,0,0	0.4195											57	97					KDM7A (inh=n/a pLI=1.00)
chr7	139787189	139787189	G	A	het		QUAL=9686;DP=529;AF=0.46;MQM=60;TRIO=HET,529,0.46,WT,191,0.02,HET,225,0.50	KDM7A	3'UTR	KDM7A:ENST00000397560:3'UTR:MODIFIER:exon20/20:c.*3705C>T:		rs1476619	0.1687	0.0000	0,0,0	0,0,0,0,0	0.2089											32	83					KDM7A (inh=n/a pLI=1.00)
chr7	139787853	139787853	A	-	het		QUAL=8099;DP=260;AF=0.52;MQM=59;TRIO=HET,260,0.52,HET,163,0.52,HET,178,0.51	KDM7A	3'UTR	KDM7A:ENST00000397560:3'UTR:MODIFIER:exon20/20:c.*3041delT:		rs398006590	0.3598	0.0000	0,0,0	0,0,0,0,0	0.4078											58	97					KDM7A (inh=n/a pLI=1.00)
chr7	139797431	139797431	G	T	het	pred_pathogenic	QUAL=5884;DP=294;AF=0.50;MQM=60;TRIO=HET,294,0.50,WT,172,0.00,HET,192,0.44	KDM7A	missense	KDM7A:ENST00000397560:missense:MODERATE:exon15/20:c.1930C>A:p.Arg644Ser,KDM7A:ENST00000006967:missense:MODERATE:exon15/18:c.1930C>A:p.Arg644Ser		rs6950119	0.3275	0.3218	6322,3998,730	0.3977,0.2310,0.2571,0.3472,0.2964	0.3330	2.4720	T,T	T	B	T,T	18.85				COSM321080	261	749	2	[2] auto-classification 15.09.2017  			KDM7A (inh=n/a pLI=1.00)
chr7	139801777	139801777	T	G	het		QUAL=6373;DP=194;AF=0.52;MQM=60;TRIO=HET,194,0.52,WT,222,0.00,HET,299,0.48	KDM7A	synonymous	KDM7A:ENST00000397560:synonymous:LOW:exon12/20:c.1612A>C:p.Arg538Arg,KDM7A:ENST00000006967:synonymous:LOW:exon12/18:c.1612A>C:p.Arg538Arg		rs1062277	0.3335	0.3223	6492,4085,766	0.3988,0.2300,0.2562,0.3469,0.3003	0.3354										COSM3762429	261	746	2	[2] auto-classification 15.09.2017  			KDM7A (inh=n/a pLI=1.00)
chr7	143016928	143016928	C	T	het	anno_omim	QUAL=6089;DP=242;AF=0.50;MQM=60;TRIO=HET,242,0.50,HET,247,0.47,WT,324,0.00	CLCN1	synonymous	CLCN1:ENST00000343257:synonymous:LOW:exon2/23:c.261C>T:p.Thr87Thr		rs6962852	0.3229	0.2966	6310,3421,1707	0.5730,0.1435,0.0426,0.3157,0.3124	0.3497							118425 [CLCN1 (provisional) Myotonia congenita,recessive,255700|Myotonia congenita,dominant,160800|Myotonia levior,recessive];	RCV000353487.1 [benign]; 		COSM3762451	297	929	2	[2] auto-classification 15.09.2017  			CLCN1 (inh=AR+AD pLI=0.00)
chr7	143017807	143017807	G	T	hom	pred_pathogenic;anno_omim	QUAL=23061;DP=237;AF=1.00;MQM=59;TRIO=HOM,237,1.00,HOM,180,1.00,HOM,307,1.00	CLCN1	missense	CLCN1:ENST00000343257:missense:MODERATE:exon3/23:c.352G>T:p.Gly118Trp		rs10282312	0.9936	0.9861	59039,31948,5160	0.9959,0.9959,1.0000,0.9783,0.9982	0.9853	5.9710	T	T	B	D	18.83	118425 [CLCN1 (provisional) Myotonia congenita,recessive,255700|Myotonia congenita,dominant,160800|Myotonia levior,recessive];				2056	54	2	[2] old entry - no details available			CLCN1 (inh=AR+AD pLI=0.00)
chr7	143036337	143036337	C	T	het	anno_omim	QUAL=7301;DP=328;AF=0.41;MQM=60;TRIO=HET,328,0.41,HET,130,0.52,HET,195,0.47	CLCN1	splice_region&intron	CLCN1:ENST00000343257:splice_region&intron:LOW:exon12/22:c.1402-9C>T:		rs2272252	0.4143	0.4108	10743,6061,1715	0.5687,0.2995,0.2627,0.4246,0.4228	0.4356							118425 [CLCN1 (provisional) Myotonia congenita,recessive,255700|Myotonia congenita,dominant,160800|Myotonia levior,recessive];	RCV000367247.1 [benign]; 		COSM4004350	420	993	2	[2] auto-classification 15.09.2017  			CLCN1 (inh=AR+AD pLI=0.00)
chr7	143043240	143043240	C	T	het	pred_pathogenic;anno_omim	QUAL=9069;DP=121;AF=0.47;MQM=60;TRIO=HET,121,0.47,HET,271,0.47,HET,367,0.47	CLCN1	missense	CLCN1:ENST00000343257:missense:MODERATE:exon18/23:c.2180C>T:p.Pro727Leu		rs13438232	0.3694	0.3974	9877,6021,928	0.4206,0.2921,0.2615,0.4245,0.4245	0.3943	0.8500	T	T	B	D	15.32	118425 [CLCN1 (provisional) Myotonia congenita,recessive,255700|Myotonia congenita,dominant,160800|Myotonia levior,recessive];	RCV000343234.1 [benign]; 		COSM3737851	412	995	2	[2] auto-classification 15.09.2017  			CLCN1 (inh=AR+AD pLI=0.00)
chr7	145813854	145813854	G	A	hom	anno_omim	QUAL=1103;DP=25;AF=1.00;MQM=60;TRIO=HOM,25,1.00,HET,16,0.38,HET,24,0.58	CNTNAP2	5'UTR	CNTNAP2:ENST00000361727:5'UTR:MODIFIER:exon1/24:c.-115G>A:		rs2462603	0.5120	0.0000	0,0,0	0,0,0,0,0	0.5100							604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome,610042|Autism susceptibility 15,612100|Pitt-Hopkins like syndrome 1,610042];	RCV000368639.1 [benign]; RCV000403598.1 [benign]; 			75	107					CNTNAP2 (inh=AR pLI=0.00)
chr7	145814006	145814006	T	A	het	low_QUAL;low_DP;pred_pathogenic;anno_omim	QUAL=21;DP=7;AF=0.43;MQM=50;TRIO=HET,7,0.43,WT,2,0.00,WT,1,0.00	CNTNAP2	missense	CNTNAP2:ENST00000361727:missense:MODERATE:exon1/24:c.38T>A:p.Leu13His			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000	4.1240	D	T	B	D	22.80	604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome,610042|Autism susceptibility 15,612100|Pitt-Hopkins like syndrome 1,610042];				0	0					CNTNAP2 (inh=AR pLI=0.00)
chr7	145814017	145814017	A	C	het	low_QUAL;low_DP;pred_pathogenic;anno_omim	QUAL=21;DP=8;AF=0.50;MQM=50;TRIO=HET,8,0.50,WT,2,0.00,WT,1,0.00	CNTNAP2	missense	CNTNAP2:ENST00000361727:missense:MODERATE:exon1/24:c.49A>C:p.Ile17Leu			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0001	0.7260	T	T	B	D	0.07	604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome,610042|Autism susceptibility 15,612100|Pitt-Hopkins like syndrome 1,610042];				0	0					CNTNAP2 (inh=AR pLI=0.00)
chr7	147092861	147092861	G	A	het	anno_omim	QUAL=5843;DP=188;AF=0.53;MQM=59;TRIO=HET,188,0.53,HET,253,0.50,WT,311,0.00	CNTNAP2	synonymous	CNTNAP2:ENST00000361727:synonymous:LOW:exon10/24:c.1659G>A:p.Ala553Ala		rs34592169	0.0937	0.1875	2610,1938,14	0.0494,0.2077,0.0030,0.2369,0.1329	0.1908							604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome,610042|Autism susceptibility 15,612100|Pitt-Hopkins like syndrome 1,610042];	RCV000081587.8 [other]; RCV000332935.1 [benign]; RCV000389811.1 [benign]; 		COSM3762462	78	667	2	[2] auto-classification 15.09.2017  			CNTNAP2 (inh=AR pLI=0.00)
chr7	148106477	148106477	C	G	het	anno_omim	QUAL=12290;DP=248;AF=0.50;MQM=59;TRIO=HET,248,0.50,HOM,192,0.99,HET,239,0.47	CNTNAP2	splice_region&intron	CNTNAP2:ENST00000361727:splice_region&intron:LOW:exon22/23:c.3716-6C>G:,CNTNAP2:ENST00000538075:splice_region&intron:LOW:exon7/8:c.893-6C>G:		rs77025884	0.0000	0.0046	10,7,0	0.0049,0.0029,0.0043,0.0047,0.0062	0.0720							604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome,610042|Autism susceptibility 15,612100|Pitt-Hopkins like syndrome 1,610042];	RCV000081603.8 [benign]; 		COSM3785030	684	982	2	[2] auto-classification 15.09.2017  			CNTNAP2 (inh=AR pLI=0.00)
chr7	148106490	148106490	G	A	het	anno_omim	QUAL=13121;DP=267;AF=0.47;MQM=59;TRIO=HET,267,0.47,HOM,211,1.00,HET,267,0.46	CNTNAP2	synonymous	CNTNAP2:ENST00000361727:synonymous:LOW:exon23/24:c.3723G>A:p.Ala1241Ala,CNTNAP2:ENST00000538075:synonymous:LOW:exon8/9:c.900G>A:p.Ala300Ala		rs9648691	0.5491	0.5407	18239,10331,2268	0.6646,0.2868,0.3685,0.5595,0.6140	0.5892							604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome,610042|Autism susceptibility 15,612100|Pitt-Hopkins like syndrome 1,610042];	RCV000081604.8 [other]; RCV000264064.1 [benign]; RCV000358915.1 [benign]; 		COSM3762466	685	984	2	[2] auto-classification 15.09.2017  			CNTNAP2 (inh=AR pLI=0.00)
chr7	148112872	148112872	-	A	hom	anno_omim	QUAL=3834;DP=154;AF=0.76;MQM=59;TRIO=HOM,154,0.76,HET,42,0.31,HOM,56,0.86	CNTNAP2	3'UTR	CNTNAP2:ENST00000361727:3'UTR:MODIFIER:exon24/24:c.*175dupA:,CNTNAP2:ENST00000538075:3'UTR:MODIFIER:exon9/9:c.*175dupA:		rs397763623	0.5226	0.0000	0,0,0	0,0,0,0,0	0.5397							604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome,610042|Autism susceptibility 15,612100|Pitt-Hopkins like syndrome 1,610042];	RCV000282167.1 [benign]; RCV000336012.1 [benign]; 			70	120					CNTNAP2 (inh=AR pLI=0.00)
chr7	148112987	148112987	C	A	het	anno_omim	QUAL=5955;DP=232;AF=0.52;MQM=60;TRIO=HET,232,0.52,HET,86,0.53,HET,128,0.48	CNTNAP2	3'UTR	CNTNAP2:ENST00000361727:3'UTR:MODIFIER:exon24/24:c.*279C>A:,CNTNAP2:ENST00000538075:3'UTR:MODIFIER:exon9/9:c.*279C>A:		rs987456	0.6607	0.0000	0,0,0	0,0,0,0,0	0.7182							604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome,610042|Autism susceptibility 15,612100|Pitt-Hopkins like syndrome 1,610042];	RCV000301852.1 [benign]; RCV000347489.1 [benign]; 			151	74					CNTNAP2 (inh=AR pLI=0.00)
chr7	148113624	148113628	TAGTT	-	hom	anno_omim	QUAL=20916;DP=344;AF=0.99;MQM=59;TRIO=HOM,344,0.99,HOM,156,1.00,HOM,172,1.00	CNTNAP2	3'UTR	CNTNAP2:ENST00000361727:3'UTR:MODIFIER:exon24/24:c.*921_*925delTAGTT:		rs569195865	0.9844	0.0000	0,0,0	0,0,0,0,0	0.9866							604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome,610042|Autism susceptibility 15,612100|Pitt-Hopkins like syndrome 1,610042];	RCV000316499.1 [benign]; RCV000380508.1 [benign]; 			232	0					CNTNAP2 (inh=AR pLI=0.00)
chr7	148113895	148113895	G	A	het	anno_omim	QUAL=9303;DP=356;AF=0.51;MQM=60;TRIO=HET,356,0.51,WT,264,0.00,HET,339,0.49	CNTNAP2	3'UTR	CNTNAP2:ENST00000361727:3'UTR:MODIFIER:exon24/24:c.*1187G>A:		rs2530312	0.3746	0.0000	0,0,0	0,0,0,0,0	0.3264							604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome,610042|Autism susceptibility 15,612100|Pitt-Hopkins like syndrome 1,610042];	RCV000300173.1 [benign]; RCV000353051.1 [benign]; 			48	103					CNTNAP2 (inh=AR pLI=0.00)
chr7	148114265	148114265	A	C	het	anno_omim	QUAL=8183;DP=335;AF=0.48;MQM=60;TRIO=HET,335,0.48,WT,188,0.01,HET,300,0.48	CNTNAP2	3'UTR	CNTNAP2:ENST00000361727:3'UTR:MODIFIER:exon24/24:c.*1557A>C:		rs3194	0.3944	0.0000	0,0,0	0,0,0,0,0	0.3439							604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome,610042|Autism susceptibility 15,612100|Pitt-Hopkins like syndrome 1,610042];	RCV000281058.1 [benign]; RCV000338399.1 [benign]; 			52	103					CNTNAP2 (inh=AR pLI=0.00)
chr7	148114865	148114865	A	G	het	anno_omim	QUAL=6559;DP=368;AF=0.49;MQM=60;TRIO=HET,368,0.49,WT,113,0.00,HET,156,0.44	CNTNAP2	3'UTR	CNTNAP2:ENST00000361727:3'UTR:MODIFIER:exon24/24:c.*2157A>G:		rs1062072	0.5371	0.0000	0,0,0	0,0,0,0,0	0.4620							604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome,610042|Autism susceptibility 15,612100|Pitt-Hopkins like syndrome 1,610042];	RCV000334512.1 [benign]; RCV000379277.1 [benign]; 			60	101					CNTNAP2 (inh=AR pLI=0.00)
chr7	148115639	148115640	AA	-	het	anno_omim	QUAL=10090;DP=291;AF=0.57;MQM=59;TRIO=HET,291,0.57,HET,231,0.47,HET,263,0.48	CNTNAP2	3'UTR	CNTNAP2:ENST00000361727:3'UTR:MODIFIER:exon24/24:c.*2935_*2936delAA:		rs869179688	0.7817	0.0000	0,0,0	0,0,0,0,0	0.8058							604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome,610042|Autism susceptibility 15,612100|Pitt-Hopkins like syndrome 1,610042];	RCV000340157.1 [benign]; RCV000383226.1 [benign]; 			156	67					CNTNAP2 (inh=AR pLI=0.00)
chr7	148116450	148116450	A	G	het	anno_omim	QUAL=8144;DP=313;AF=0.56;MQM=60;TRIO=HET,313,0.56,WT,190,0.00,HET,245,0.53	CNTNAP2	3'UTR	CNTNAP2:ENST00000361727:3'UTR:MODIFIER:exon24/24:c.*3742A>G:		rs2530311	0.5210	0.0000	0,0,0	0,0,0,0,0	0.4468							604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome,610042|Autism susceptibility 15,612100|Pitt-Hopkins like syndrome 1,610042];	RCV000281772.1 [benign]; RCV000394541.1 [benign]; 			56	103					CNTNAP2 (inh=AR pLI=0.00)
chr7	148117505	148117505	G	C	het	anno_omim	QUAL=12304;DP=349;AF=0.45;MQM=60;TRIO=HET,349,0.45,HET,258,0.50,HET,346,0.53	CNTNAP2	3'UTR	CNTNAP2:ENST00000361727:3'UTR:MODIFIER:exon24/24:c.*4797G>C:		rs2717829	0.7935	0.0000	0,0,0	0,0,0,0,0	0.8145							604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome,610042|Autism susceptibility 15,612100|Pitt-Hopkins like syndrome 1,610042];	RCV000320910.1 [benign]; RCV000379990.1 [benign]; 			157	66					CNTNAP2 (inh=AR pLI=0.00)
chr7	148117642	148117642	C	T	het	anno_omim	QUAL=6567;DP=297;AF=0.47;MQM=60;TRIO=HET,297,0.47,WT,158,0.01,HET,230,0.47	CNTNAP2	3'UTR	CNTNAP2:ENST00000361727:3'UTR:MODIFIER:exon24/24:c.*4934C>T:		rs2530310	0.3860	0.0000	0,0,0	0,0,0,0,0	0.3314							604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome,610042|Autism susceptibility 15,612100|Pitt-Hopkins like syndrome 1,610042];	RCV000291529.1 [benign]; RCV000381253.1 [benign]; 			48	106					CNTNAP2 (inh=AR pLI=0.00)
chr8	1729217	1729217	C	T	hom	anno_omim	QUAL=20979;DP=268;AF=1.00;MQM=59;TRIO=HOM,268,1.00,HOM,168,0.99,HOM,238,1.00	CLN8	3'UTR	CLN8:ENST00000331222:3'UTR:MODIFIER:exon3/3:c.*484C>T:		rs11778824	0.8097	0.0000	0,0,0	0,0,0,0,0	0.8525							607837 [CLN8 (provisional) Ceroid lipofuscinosis,neuronal,8,600143|Ceroid lipofuscinosis,neuronal,8,Northern epilepsy variant,610003];				172	47					CLN8 (inh=AR pLI=0.00)
chr8	1729514	1729514	A	G	hom	anno_omim	QUAL=8939;DP=116;AF=1.00;MQM=56;TRIO=HOM,116,1.00,HOM,71,1.00,HOM,105,1.00	CLN8	3'UTR	CLN8:ENST00000331222:3'UTR:MODIFIER:exon3/3:c.*781A>G:	AluSz	rs1137514	0.6220	0.0000	0,0,0	0,0,0,0,0	0.6595							607837 [CLN8 (provisional) Ceroid lipofuscinosis,neuronal,8,600143|Ceroid lipofuscinosis,neuronal,8,Northern epilepsy variant,610003];				92	77					CLN8 (inh=AR pLI=0.00)
chr8	1729582	1729582	-	TGG	hom	anno_omim	QUAL=12720;DP=155;AF=0.97;MQM=59;TRIO=HOM,155,0.97,HOM,105,1.00,HOM,169,1.00	CLN8	3'UTR	CLN8:ENST00000331222:3'UTR:MODIFIER:exon3/3:c.*853_*855dupTGG:		rs397698661	0.6190	0.0000	0,0,0	0,0,0,0,0	0.6599							607837 [CLN8 (provisional) Ceroid lipofuscinosis,neuronal,8,600143|Ceroid lipofuscinosis,neuronal,8,Northern epilepsy variant,610003];				101	93					CLN8 (inh=AR pLI=0.00)
chr8	1730119	1730119	-	TG	hom	anno_omim	QUAL=9835;DP=112;AF=0.81;MQM=59;TRIO=HOM,112,0.81,HOM,112,0.89,HOM,188,0.87	CLN8	3'UTR	CLN8:ENST00000331222:3'UTR:MODIFIER:exon3/3:c.*1413_*1414dupTG:		rs878945350	0.5948	0.0000	0,0,0	0,0,0,0,0	0.6183							607837 [CLN8 (provisional) Ceroid lipofuscinosis,neuronal,8,600143|Ceroid lipofuscinosis,neuronal,8,Northern epilepsy variant,610003];				94	35					CLN8 (inh=AR pLI=0.00)
chr8	1732224	1732224	G	C	hom	anno_omim	QUAL=17435;DP=229;AF=1.00;MQM=55;TRIO=HOM,229,1.00,HOM,165,0.99,HOM,172,1.00	CLN8	3'UTR	CLN8:ENST00000331222:3'UTR:MODIFIER:exon3/3:c.*3491G>C:	AluSz	rs10089222	0.7123	0.0000	0,0,0	0,0,0,0,0	0.7326							607837 [CLN8 (provisional) Ceroid lipofuscinosis,neuronal,8,600143|Ceroid lipofuscinosis,neuronal,8,Northern epilepsy variant,610003];				104	61					CLN8 (inh=AR pLI=0.00)
chr8	1732580	1732580	C	G	hom	anno_omim	QUAL=29394;DP=318;AF=1.00;MQM=59;TRIO=HOM,318,1.00,HOM,283,1.00,HOM,317,1.00	CLN8	3'UTR	CLN8:ENST00000331222:3'UTR:MODIFIER:exon3/3:c.*3847C>G:	MLT1A1	rs7827009	0.8079	0.0000	0,0,0	0,0,0,0,0	0.8519							607837 [CLN8 (provisional) Ceroid lipofuscinosis,neuronal,8,600143|Ceroid lipofuscinosis,neuronal,8,Northern epilepsy variant,610003];				146	38					CLN8 (inh=AR pLI=0.00)
chr8	1732756	1732756	C	A	hom	anno_omim	QUAL=32013;DP=288;AF=0.99;MQM=59;TRIO=HOM,288,0.99,HOM,287,1.00,HOM,432,1.00	CLN8	3'UTR	CLN8:ENST00000331222:3'UTR:MODIFIER:exon3/3:c.*4023C>A:		rs7827285	0.8057	0.0000	0,0,0	0,0,0,0,0	0.8503							607837 [CLN8 (provisional) Ceroid lipofuscinosis,neuronal,8,600143|Ceroid lipofuscinosis,neuronal,8,Northern epilepsy variant,610003];				161	44					CLN8 (inh=AR pLI=0.00)
chr8	1734452	1734452	C	G	hom	anno_omim	QUAL=6686;DP=131;AF=1.00;MQM=60;TRIO=HOM,131,1.00,HOM,32,1.00,HOM,53,1.00	CLN8	3'UTR	CLN8:ENST00000331222:3'UTR:MODIFIER:exon3/3:c.*5719C>G:		rs3812477	0.6983	0.0000	0,0,0	0,0,0,0,0	0.7207							607837 [CLN8 (provisional) Ceroid lipofuscinosis,neuronal,8,600143|Ceroid lipofuscinosis,neuronal,8,Northern epilepsy variant,610003];				133	89					CLN8 (inh=AR pLI=0.00)
chr8	1857548	1857548	T	C	het	anno_omim	QUAL=4354;DP=179;AF=0.51;MQM=59;TRIO=HET,179,0.51,HET,51,0.63,HET,123,0.41	ARHGEF10	synonymous	ARHGEF10:ENST00000398564:synonymous:LOW:exon18/29:c.2130T>C:p.Tyr710Tyr,ARHGEF10:ENST00000349830:synonymous:LOW:exon18/29:c.2055T>C:p.Tyr685Tyr,ARHGEF10:ENST00000520359:synonymous:LOW:exon17/28:c.1941T>C:p.Tyr647Tyr,ARHGEF10:ENST00000518288:synonymous:LOW:exon19/30:c.2127T>C:p.Tyr709Tyr,ARHGEF10:ENST00000262112:synonymous:LOW:exon18/28:c.2130T>C:p.Tyr710Tyr		rs2294038	0.1569	0.1527	1464,753,76	0.1217,0.2026,0.1675,0.1510,0.1296	0.1560							608136 [ARHGEF10 (confirmed) Slowed nerve conduction velocity,AD,608236];			COSM3982453, COSM3982452	46	526	2	[2] auto-classification 15.09.2017  			ARHGEF10 (inh=AD pLI=0.00)
chr8	1876631	1876631	C	T	het	anno_omim	QUAL=3055;DP=147;AF=0.54;MQM=60;TRIO=HET,147,0.54,HET,107,0.42,WT,162,0.00	ARHGEF10	synonymous	ARHGEF10:ENST00000398564:synonymous:LOW:exon24/29:c.2811C>T:p.Ile937Ile,ARHGEF10:ENST00000349830:synonymous:LOW:exon24/29:c.2736C>T:p.Ile912Ile,ARHGEF10:ENST00000520359:synonymous:LOW:exon23/28:c.2622C>T:p.Ile874Ile,ARHGEF10:ENST00000518288:synonymous:LOW:exon25/30:c.2808C>T:p.Ile936Ile,ARHGEF10:ENST00000262112:synonymous:LOW:exon23/28:c.2724C>T:p.Ile908Ile		rs2272611	0.1444	0.1564	1592,690,85	0.1201,0.2600,0.1634,0.1451,0.1389	0.1610							608136 [ARHGEF10 (confirmed) Slowed nerve conduction velocity,AD,608236];			COSM1455922, COSM1455921	57	516	2	[2] auto-classification 15.09.2017  			ARHGEF10 (inh=AD pLI=0.00)
chr8	1900911	1900911	C	T	het	anno_omim	QUAL=3105;DP=137;AF=0.53;MQM=59;TRIO=HET,137,0.53,HET,123,0.50,WT,150,0.00	ARHGEF10	synonymous	ARHGEF10:ENST00000398564:synonymous:LOW:exon28/29:c.3513C>T:p.His1171His,ARHGEF10:ENST00000349830:synonymous:LOW:exon28/29:c.3438C>T:p.His1146His,ARHGEF10:ENST00000520359:synonymous:LOW:exon27/28:c.3324C>T:p.His1108His,ARHGEF10:ENST00000518288:synonymous:LOW:exon29/30:c.3510C>T:p.His1170His,ARHGEF10:ENST00000262112:synonymous:LOW:exon27/28:c.3426C>T:p.His1142His		rs2272608	0.2151	0.1619	1853,514,530	0.3152,0.2481,0.2231,0.1237,0.1363	0.1849							608136 [ARHGEF10 (confirmed) Slowed nerve conduction velocity,AD,608236];			COSM3982456, COSM3982455	50	468	2	[2] auto-classification 15.09.2017  			ARHGEF10 (inh=AD pLI=0.00)
chr8	1905615	1905615	G	A	het	anno_omim	QUAL=8863;DP=350;AF=0.47;MQM=60;TRIO=HET,350,0.47,WT,284,0.00,HET,357,0.49	ARHGEF10	3'UTR	ARHGEF10:ENST00000398564:3'UTR:MODIFIER:exon29/29:c.*186G>A:,ARHGEF10:ENST00000349830:3'UTR:MODIFIER:exon29/29:c.*186G>A:,ARHGEF10:ENST00000520359:3'UTR:MODIFIER:exon28/28:c.*186G>A:,ARHGEF10:ENST00000518288:3'UTR:MODIFIER:exon30/30:c.*186G>A:,ARHGEF10:ENST00000262112:3'UTR:MODIFIER:exon28/28:c.*186G>A:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							608136 [ARHGEF10 (confirmed) Slowed nerve conduction velocity,AD,608236];				0	2					ARHGEF10 (inh=AD pLI=0.00)
chr8	1905728	1905728	G	A	hom	anno_omim	QUAL=16176;DP=192;AF=1.00;MQM=59;TRIO=HOM,192,1.00,HOM,148,1.00,HOM,158,1.00	ARHGEF10	3'UTR	ARHGEF10:ENST00000398564:3'UTR:MODIFIER:exon29/29:c.*299G>A:,ARHGEF10:ENST00000349830:3'UTR:MODIFIER:exon29/29:c.*299G>A:,ARHGEF10:ENST00000520359:3'UTR:MODIFIER:exon28/28:c.*299G>A:,ARHGEF10:ENST00000518288:3'UTR:MODIFIER:exon30/30:c.*299G>A:,ARHGEF10:ENST00000262112:3'UTR:MODIFIER:exon28/28:c.*299G>A:		rs6558566	0.9453	0.0000	0,0,0	0,0,0,0,0	0.9373							608136 [ARHGEF10 (confirmed) Slowed nerve conduction velocity,AD,608236];				213	19					ARHGEF10 (inh=AD pLI=0.00)
chr8	1905823	1905823	A	G	het	anno_omim	QUAL=2822;DP=164;AF=0.48;MQM=60;TRIO=HET,164,0.48,HET,54,0.48,WT,53,0.02	ARHGEF10	3'UTR	ARHGEF10:ENST00000398564:3'UTR:MODIFIER:exon29/29:c.*394A>G:,ARHGEF10:ENST00000349830:3'UTR:MODIFIER:exon29/29:c.*394A>G:,ARHGEF10:ENST00000520359:3'UTR:MODIFIER:exon28/28:c.*394A>G:,ARHGEF10:ENST00000518288:3'UTR:MODIFIER:exon30/30:c.*394A>G:,ARHGEF10:ENST00000262112:3'UTR:MODIFIER:exon28/28:c.*394A>G:		rs6991392	0.3970	0.0000	0,0,0	0,0,0,0,0	0.3754							608136 [ARHGEF10 (confirmed) Slowed nerve conduction velocity,AD,608236];				43	114					ARHGEF10 (inh=AD pLI=0.00)
chr8	1906630	1906630	G	T	hom	anno_omim	QUAL=52487;DP=415;AF=1.00;MQM=59;TRIO=HOM,415,1.00,HOM,559,1.00,HOM,667,1.00	ARHGEF10	3'UTR	ARHGEF10:ENST00000398564:3'UTR:MODIFIER:exon29/29:c.*1201G>T:,ARHGEF10:ENST00000349830:3'UTR:MODIFIER:exon29/29:c.*1201G>T:,ARHGEF10:ENST00000520359:3'UTR:MODIFIER:exon28/28:c.*1201G>T:,ARHGEF10:ENST00000518288:3'UTR:MODIFIER:exon30/30:c.*1201G>T:,ARHGEF10:ENST00000262112:3'UTR:MODIFIER:exon28/28:c.*1201G>T:		rs14375	0.9519	0.0000	0,0,0	0,0,0,0,0	0.9436							608136 [ARHGEF10 (confirmed) Slowed nerve conduction velocity,AD,608236];				213	19					ARHGEF10 (inh=AD pLI=0.00)
chr8	6264130	6264130	G	C	het	low_DP;anno_omim	QUAL=2173;DP=11;AF=0.27;MQM=60;TRIO=HET,11,0.27,HOM,48,1.00,HET,54,0.59	MCPH1,RP11-115C21.2	5'UTR	MCPH1:ENST00000344683:5'UTR:MODIFIER:exon1/14:c.-59G>C:,MCPH1:ENST00000519480:5'UTR:MODIFIER:exon1/8:c.-59G>C:		rs2305023	0.5387	0.0000	0,0,0	0,0,0,0,0	0.6518							607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive,251200];	RCV000365880.1 [benign]; 			1049	705					MCPH1 (inh=AR pLI=0.00), RP11-115C21.2 (inh=n/a pLI=n/a)
chr8	6272399	6272399	G	T	het	anno_omim	QUAL=5864;DP=204;AF=0.48;MQM=60;TRIO=HET,204,0.48,HOM,70,1.00,HET,81,0.51	MCPH1	synonymous	MCPH1:ENST00000344683:synonymous:LOW:exon3/14:c.228G>T:p.Val76Val,MCPH1:ENST00000519480:synonymous:LOW:exon3/8:c.228G>T:p.Val76Val,MCPH1:ENST00000522905:synonymous:LOW:exon3/7:c.228G>T:p.Val76Val		rs2305022	0.6781	0.7719	36743,21237,956	0.4386,0.8663,0.7917,0.7973,0.7403	0.7795							607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive,251200];	RCV000146307.2 [other]; RCV000373167.1 [benign]; 			1215	778	2	[2] auto-classification 15.09.2017  			MCPH1 (inh=AR pLI=0.00)
chr8	6296550	6296550	G	T	hom	anno_omim	QUAL=24334;DP=277;AF=1.00;MQM=60;TRIO=HOM,277,1.00,HOM,200,1.00,HOM,269,1.00	MCPH1	missense,intron	MCPH1:ENST00000344683:missense:MODERATE:exon6/14:c.513G>T:p.Arg171Ser,MCPH1:ENST00000519480:missense:MODERATE:exon6/8:c.513G>T:p.Arg171Ser,MCPH1:ENST00000522905:intron:MODIFIER:exon5/6:c.436+2867G>T:		rs2442513	0.9169	0.9662	56549,32517,2976	0.7779,0.9872,0.9883,0.9874,0.9564	0.9688	-0.2920	T,T	T	B,B	T,T	0.01	607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive,251200];				2017	94	2	[2] auto-classification 15.09.2017  			MCPH1 (inh=AR pLI=0.00)
chr8	6302106	6302106	C	A	het	pred_pathogenic;anno_omim	QUAL=10134;DP=369;AF=0.54;MQM=60;TRIO=HET,369,0.54,WT,230,0.00,HET,351,0.50	MCPH1	missense	MCPH1:ENST00000344683:missense:MODERATE:exon8/14:c.863C>A:p.Pro288His,MCPH1:ENST00000519480:missense:MODERATE:exon8/8:c.863C>A:p.Pro288His,MCPH1:ENST00000522905:missense:MODERATE:exon7/7:c.719C>A:p.Pro240His		rs35590577	0.0693	0.0289	215,6,199	0.2007,0.0189,0.0001,0.0130,0.0109	0.0689	2.1950	D,D,D	T	D,D,D	T,T,T	25.10	607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive,251200];	RCV000146333.2 [benign]; RCV000356618.1 [likely benign]; 			2	99	2	[2] auto-classification 15.09.2017  			MCPH1 (inh=AR pLI=0.00)
chr8	6302183	6302183	G	C	het	pred_pathogenic;anno_omim	QUAL=20871;DP=440;AF=0.50;MQM=60;TRIO=HET,440,0.50,HOM,289,1.00,HET,394,0.55	MCPH1	missense	MCPH1:ENST00000344683:missense:MODERATE:exon8/14:c.940G>C:p.Asp314His,MCPH1:ENST00000519480:missense:MODERATE:exon8/8:c.940G>C:p.Asp314His,MCPH1:ENST00000522905:missense:MODERATE:exon7/7:c.796G>C:p.Asp266His		rs930557	0.6448	0.7714	36968,21790,538	0.3278,0.8665,0.7933,0.8092,0.7533	0.7809	0.3110	T,D,D	T	D,D,D	T,T,T	23.50	607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive,251200];	RCV000020903.1 [benign]; RCV000146337.2 [other]; RCV000353105.1 [benign]; 			1275	714	2	[2] auto-classification 15.09.2017  			MCPH1 (inh=AR pLI=0.00)
chr8	6302418	6302418	A	G	hom	anno_omim	QUAL=29954;DP=275;AF=1.00;MQM=59;TRIO=HOM,275,1.00,HOM,310,1.00,HOM,358,1.00	MCPH1	missense	MCPH1:ENST00000344683:missense:MODERATE:exon8/14:c.1175A>G:p.Asp392Gly,MCPH1:ENST00000519480:missense:MODERATE:exon8/8:c.1175A>G:p.Asp392Gly,MCPH1:ENST00000522905:missense:MODERATE:exon7/7:c.1031A>G:p.Asp344Gly		rs2515569	0.9944	0.9980	60074,33307,4660	0.9759,0.9995,0.9999,1.0000,1.0000	0.9982	-3.5300	T,T,T	T	B,B,B	T,T,T	0.01	607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive,251200];	RCV000082198.7 [other]; RCV000267656.1 [benign]; 			2108	4	2	[2] auto-classification 15.09.2017  			MCPH1 (inh=AR pLI=0.00)
chr8	6302671	6302671	C	T	het	anno_omim	QUAL=8317;DP=282;AF=0.54;MQM=60;TRIO=HET,282,0.54,WT,211,0.00,HET,279,0.56	MCPH1	synonymous	MCPH1:ENST00000344683:synonymous:LOW:exon8/14:c.1428C>T:p.Phe476Phe,MCPH1:ENST00000519480:synonymous:LOW:exon8/8:c.1428C>T:p.Phe476Phe,MCPH1:ENST00000522905:synonymous:LOW:exon7/7:c.1284C>T:p.Phe428Phe		rs2920676	0.2081	0.0852	1241,14,880	0.4218,0.0570,0.1565,0.0199,0.1530	0.1420							607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive,251200];	RCV000082200.6 [benign]; RCV000382916.1 [benign]; 			14	200	2	[2] auto-classification 15.09.2017  			MCPH1 (inh=AR pLI=0.00)
chr8	6303025	6303025	G	A	het	anno_omim	QUAL=20055;DP=466;AF=0.51;MQM=59;TRIO=HET,466,0.51,HOM,297,1.00,HET,318,0.49	MCPH1	synonymous	MCPH1:ENST00000344683:synonymous:LOW:exon8/14:c.1782G>A:p.Thr594Thr,MCPH1:ENST00000519480:synonymous:LOW:exon8/8:c.1782G>A:p.Thr594Thr,MCPH1:ENST00000522905:synonymous:LOW:exon7/7:c.1638G>A:p.Thr546Thr		rs2584	0.1322	0.2616	4880,3762,25	0.0566,0.2819,0.0227,0.3386,0.1377	0.2623							607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive,251200];	RCV000146282.2 [benign]; RCV000336395.1 [likely benign]; 			186	758	2	[2] auto-classification 15.09.2017  			MCPH1 (inh=AR pLI=0.00)
chr8	6303409	6303409	T	G	het	anno_omim	QUAL=6240;DP=336;AF=0.47;MQM=60;TRIO=HET,336,0.47,WT,169,0.00,HET,211,0.40	MCPH1	splice_region,3'UTR,intron	MCPH1:ENST00000522905:splice_region:LOW:exon7/7:c.*333T>G:,MCPH1:ENST00000519480:3'UTR:MODIFIER:exon8/8:c.*333T>G:,MCPH1:ENST00000522905:3'UTR:MODIFIER:exon7/7:c.*333T>G:,MCPH1:ENST00000344683:intron:MODIFIER:exon8/13:c.1825+341T>G:		rs2916750	0.2935	0.0000	0,0,0	0,0,0,0,0	0.2522							607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive,251200];				5	52	2	[2] auto-classification 15.09.2017  			MCPH1 (inh=AR pLI=0.00)
chr8	6303434	6303434	T	A	het	anno_omim	QUAL=10273;DP=234;AF=0.50;MQM=60;TRIO=HET,234,0.50,HOM,143,1.00,HET,168,0.61	MCPH1	3'UTR,intron	MCPH1:ENST00000519480:3'UTR:MODIFIER:exon8/8:c.*358T>A:,MCPH1:ENST00000344683:intron:MODIFIER:exon8/13:c.1825+366T>A:		rs2515570	0.6536	0.0000	0,0,0	0,0,0,0,0	0.6938							607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive,251200];				94	52					MCPH1 (inh=AR pLI=0.00)
chr8	6303511	6303511	T	A	het	anno_omim	QUAL=6086;DP=187;AF=0.52;MQM=60;TRIO=HET,187,0.52,HOM,67,1.00,HET,77,0.61	MCPH1	3'UTR,intron	MCPH1:ENST00000519480:3'UTR:MODIFIER:exon8/8:c.*435T>A:,MCPH1:ENST00000344683:intron:MODIFIER:exon8/13:c.1825+443T>A:		rs1054073	0.6691	0.0000	0,0,0	0,0,0,0,0	0.7061							607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive,251200];				95	51					MCPH1 (inh=AR pLI=0.00)
chr8	6303614	6303614	A	C	het	anno_omim	QUAL=3503;DP=150;AF=0.54;MQM=59;TRIO=HET,150,0.54,HOM,20,1.00,HET,44,0.50	MCPH1	3'UTR,intron	MCPH1:ENST00000519480:3'UTR:MODIFIER:exon8/8:c.*538A>C:,MCPH1:ENST00000344683:intron:MODIFIER:exon8/13:c.1825+546A>C:		rs1054074	0.6609	0.0000	0,0,0	0,0,0,0,0	0.7054							607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive,251200];				94	52					MCPH1 (inh=AR pLI=0.00)
chr8	6303846	6303846	A	G	het	anno_omim	QUAL=4298;DP=132;AF=0.49;MQM=60;TRIO=HET,132,0.49,WT,125,0.01,HET,206,0.49	MCPH1	3'UTR,intron	MCPH1:ENST00000519480:3'UTR:MODIFIER:exon8/8:c.*770A>G:,MCPH1:ENST00000344683:intron:MODIFIER:exon8/13:c.1825+778A>G:		rs79010412	0.0705	0.0000	0,0,0	0,0,0,0,0	0.0696							607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive,251200];				0	5					MCPH1 (inh=AR pLI=0.00)
chr8	6303859	6303859	C	T	het	anno_omim	QUAL=9093;DP=121;AF=0.50;MQM=60;TRIO=HET,121,0.50,HOM,135,0.99,HET,237,0.52	MCPH1	3'UTR,intron	MCPH1:ENST00000519480:3'UTR:MODIFIER:exon8/8:c.*783C>T:,MCPH1:ENST00000344683:intron:MODIFIER:exon8/13:c.1825+791C>T:		rs2440415	0.6442	0.0000	0,0,0	0,0,0,0,0	0.6906							607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive,251200];				95	51					MCPH1 (inh=AR pLI=0.00)
chr8	6304259	6304259	G	A	het	anno_omim	QUAL=5365;DP=154;AF=0.44;MQM=60;TRIO=HET,154,0.44,HOM,79,1.00,HET,89,0.53	MCPH1	intron	MCPH1:ENST00000344683:intron:MODIFIER:exon8/13:c.1825+1191G>A:		rs2515571	0.6534	0.0000	0,0,0	0,0,0,0,0	0.6930							607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive,251200];				95	51					MCPH1 (inh=AR pLI=0.00)
chr8	6304348	6304348	C	T	het	anno_omim	QUAL=7549;DP=186;AF=0.49;MQM=60;TRIO=HET,186,0.49,HOM,110,1.00,HET,139,0.50	MCPH1	intron	MCPH1:ENST00000344683:intron:MODIFIER:exon8/13:c.1825+1280C>T:		rs2166006	0.6725	0.0000	0,0,0	0,0,0,0,0	0.7163							607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive,251200];				95	52					MCPH1 (inh=AR pLI=0.00)
chr8	6304522	6304535	CAGGCAGGGGTGTC	-	het	anno_omim	QUAL=8119;DP=212;AF=0.56;MQM=59;TRIO=HET,212,0.56,HOM,149,1.00,HET,245,0.41	MCPH1	intron	MCPH1:ENST00000344683:intron:MODIFIER:exon8/13:c.1825+1463_1825+1476delGTGTCCAGGCAGGG:		rs370636933	0.6482	0.0000	0,0,0	0,0,0,0,0	0.6909							607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive,251200];				64	85					MCPH1 (inh=AR pLI=0.00)
chr8	6304694	6304694	A	G	het	anno_omim	QUAL=13738;DP=249;AF=0.51;MQM=60;TRIO=HET,249,0.51,HOM,204,1.00,HET,282,0.51	MCPH1	intron	MCPH1:ENST00000344683:intron:MODIFIER:exon8/13:c.1825+1626A>G:		rs1129703	0.6573	0.0000	0,0,0	0,0,0,0,0	0.7032							607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive,251200];				95	52					MCPH1 (inh=AR pLI=0.00)
chr8	6304730	6304730	A	C	het	anno_omim	QUAL=12580;DP=278;AF=0.49;MQM=60;TRIO=HET,278,0.49,HOM,172,1.00,HET,252,0.51	MCPH1	intron	MCPH1:ENST00000344683:intron:MODIFIER:exon8/13:c.1825+1662A>C:		rs1129704	0.6492	0.0000	0,0,0	0,0,0,0,0	0.7024							607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive,251200];				95	52					MCPH1 (inh=AR pLI=0.00)
chr8	6304814	6304814	A	G	het	anno_omim	QUAL=14667;DP=247;AF=0.49;MQM=60;TRIO=HET,247,0.49,HOM,227,1.00,HET,289,0.52	MCPH1	intron	MCPH1:ENST00000344683:intron:MODIFIER:exon8/13:c.1825+1746A>G:		rs1129706	0.6573	0.0000	0,0,0	0,0,0,0,0	0.7036							607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive,251200];				95	52					MCPH1 (inh=AR pLI=0.00)
chr8	8559832	8559832	G	A	het		QUAL=1679;DP=39;AF=0.54;MQM=59;TRIO=HET,39,0.54,HOM,47,1.00,WT,79,0.00	CLDN23,AC087269.1	5'UTR	CLDN23:ENST00000519106:5'UTR:MODIFIER:exon1/1:c.-77G>A:		rs9644774	0.2163	0.0000	0,0,0	0,0,0,0,0	0.3051											27	106					CLDN23 (inh=n/a pLI=0.00), AC087269.1 (inh=n/a pLI=n/a)
chr8	10581882	10581882	A	C	hom		QUAL=21014;DP=321;AF=1.00;MQM=60;TRIO=HOM,321,1.00,HOM,159,1.00,HOM,207,1.00	SOX7	3'UTR	SOX7:ENST00000304501:3'UTR:MODIFIER:exon2/2:c.*1366T>G:		rs11250064	0.6781	0.0000	0,0,0	0,0,0,0,0	0.7014											104	100					SOX7 (inh=n/a pLI=0.13)
chr8	10582523	10582523	T	G	het		QUAL=1023;DP=77;AF=0.48;MQM=58;TRIO=HET,77,0.48,WT,11,0.00,HET,15,0.47	SOX7	3'UTR	SOX7:ENST00000304501:3'UTR:MODIFIER:exon2/2:c.*725A>C:	AluSq2	rs145522498	0.0296	0.0000	0,0,0	0,0,0,0,0	0.0473											1	26					SOX7 (inh=n/a pLI=0.13)
chr8	10583203	10583203	A	G	hom		QUAL=26903;DP=215;AF=1.00;MQM=59;TRIO=HOM,215,1.00,HOM,295,1.00,HOM,341,1.00	SOX7	3'UTR	SOX7:ENST00000553390:3'UTR:MODIFIER:exon6/6:c.*45T>C:,SOX7:ENST00000554914:3'UTR:MODIFIER:exon6/6:c.*45T>C:,SOX7:ENST00000304501:3'UTR:MODIFIER:exon2/2:c.*45T>C:		rs10110624	0.6500	0.6501	24815,14571,3315	0.8243,0.5040,0.3469,0.6801,0.6869	0.6891											730	652					SOX7 (inh=n/a pLI=0.13)
chr8	10583506	10583506	A	G	het		QUAL=2777;DP=74;AF=0.51;MQM=59;TRIO=HET,74,0.51,HOM,64,1.00,WT,73,0.00	SOX7	synonymous	SOX7:ENST00000553390:synonymous:LOW:exon6/6:c.1065T>C:p.Leu355Leu,SOX7:ENST00000554914:synonymous:LOW:exon6/6:c.1065T>C:p.Leu355Leu,SOX7:ENST00000304501:synonymous:LOW:exon2/2:c.909T>C:p.Leu303Leu		rs4841432	0.4327	0.3709	8812,4334,2921	0.7556,0.2927,0.1523,0.3680,0.3164	0.4574											217	783	2	[2] auto-classification 15.09.2017  			SOX7 (inh=n/a pLI=0.13)
chr8	22021933	22021933	C	T	het	pred_pathogenic;anno_omim	QUAL=2513;DP=172;AF=0.54;MQM=59;TRIO=HET,172,0.54,WT,66,0.00,HET,66,0.64	SFTPC	missense,3'UTR	SFTPC:ENST00000520605:missense:MODERATE:exon4/4:c.431C>T:p.Ala144Val,SFTPC:ENST00000318561:3'UTR:MODIFIER:exon6/6:c.*173C>T:,SFTPC:ENST00000521315:3'UTR:MODIFIER:exon5/5:c.*379C>T:,SFTPC:ENST00000524255:3'UTR:MODIFIER:exon5/5:c.*165C>T:		rs1126931	0.1044	0.2060	175,41,1	0.0733,0.0000,0.0000,0.2022,0.2231	0.1731	-1.7130	D	T		T	8.09	178620 [SFTPC (confirmed) Surfactant metabolism dysfunction,pulmonary,2,610913];	RCV000262820.1 [likely benign]; RCV000269681.1 [benign]; RCV000326755.1 [benign]; 			46	462	2	[2] auto-classification 15.09.2017  			SFTPC (inh=AD pLI=0.07)
chr8	24809067	24809067	C	T	hom	anno_omim	QUAL=29216;DP=397;AF=1.00;MQM=60;TRIO=HOM,397,1.00,HOM,215,1.00,HOM,283,1.00	NEFL	non_coding_transcript_exon	NEFL:ENST00000221169:non_coding_transcript_exon:MODIFIER:exon4/4:n.3484G>A:		rs2979704	0.7196	0.0000	0,0,0	0,0,0,0,0	0.7794							162280 [NEFL (confirmed) Charcot-Marie-Tooth disease,type 2E,607684|Charcot-Marie-Tooth disease,type 1F,607734];	RCV000311138.1 [benign]; 			170	77					NEFL (inh=AR+AD pLI=n/a)
chr8	24809636	24809636	C	G	hom	anno_omim	QUAL=19101;DP=242;AF=1.00;MQM=60;TRIO=HOM,242,1.00,HOM,147,1.00,HOM,201,1.00	NEFL	non_coding_transcript_exon	NEFL:ENST00000221169:non_coding_transcript_exon:MODIFIER:exon4/4:n.2915G>C:		rs2976439	0.5427	0.0000	0,0,0	0,0,0,0,0	0.5403							162280 [NEFL (confirmed) Charcot-Marie-Tooth disease,type 2E,607684|Charcot-Marie-Tooth disease,type 1F,607734];	RCV000264408.1 [benign]; 			91	121					NEFL (inh=AR+AD pLI=n/a)
chr8	24810088	24810088	T	A	hom	anno_omim	QUAL=33012;DP=382;AF=1.00;MQM=59;TRIO=HOM,382,1.00,HOM,299,1.00,HOM,344,1.00	NEFL	non_coding_transcript_exon	NEFL:ENST00000221169:non_coding_transcript_exon:MODIFIER:exon4/4:n.2463A>T:		rs1059111	0.7208	0.0000	0,0,0	0,0,0,0,0	0.7800							162280 [NEFL (confirmed) Charcot-Marie-Tooth disease,type 2E,607684|Charcot-Marie-Tooth disease,type 1F,607734];	RCV000294023.1 [benign]; 			179	79					NEFL (inh=AR+AD pLI=n/a)
chr8	24811065	24811065	G	-	hom	anno_omim	QUAL=33485;DP=197;AF=0.99;MQM=59;TRIO=HOM,197,0.99,HOM,377,1.00,HOM,558,1.00	NEFL	non_coding_transcript_exon	NEFL:ENST00000221169:non_coding_transcript_exon:MODIFIER:exon3/4:n.2009delC:		rs397788090	1.0000	1.0000	59987,33132,4877	1.0000,0.9999,1.0000,1.0000,1.0000	1.0000							162280 [NEFL (confirmed) Charcot-Marie-Tooth disease,type 2E,607684|Charcot-Marie-Tooth disease,type 1F,607734];				2109	0	1	[1] auto-classification 16.06.2016  [2] Ute Grasshoff 24.11.2015			NEFL (inh=AR+AD pLI=n/a)
chr8	27317337	27317337	A	G	hom	anno_omim	QUAL=41620;DP=281;AF=1.00;MQM=59;TRIO=HOM,281,1.00,HOM,416,0.99,HOM,600,1.00	CHRNA2	3'UTR	CHRNA2:ENST00000407991:3'UTR:MODIFIER:exon7/7:c.*1809T>C:,CHRNA2:ENST00000520933:3'UTR:MODIFIER:exon6/6:c.*1809T>C:		rs2280375	0.8057	0.0000	0,0,0	0,0,0,0,0	0.8500							118502 [CHRNA2 (confirmed) Epilepsy,nocturnal frontal lobe,type 4,610353];	RCV000302439.1 [benign]; 			171	55					CHRNA2 (inh=AD pLI=0.00)
chr8	27317445	27317445	G	T	het	anno_omim	QUAL=20525;DP=187;AF=0.57;MQM=60;TRIO=HET,187,0.57,HOM,374,1.00,HET,582,0.52	CHRNA2	3'UTR	CHRNA2:ENST00000407991:3'UTR:MODIFIER:exon7/7:c.*1701C>A:,CHRNA2:ENST00000520933:3'UTR:MODIFIER:exon6/6:c.*1701C>A:		rs1057137	0.4052	0.0000	0,0,0	0,0,0,0,0	0.4124							118502 [CHRNA2 (confirmed) Epilepsy,nocturnal frontal lobe,type 4,610353];	RCV000365839.1 [benign]; 			30	118					CHRNA2 (inh=AD pLI=0.00)
chr8	27317762	27317762	G	A	het	anno_omim	QUAL=4911;DP=185;AF=0.52;MQM=59;TRIO=HET,185,0.52,WT,166,0.00,HET,234,0.48	CHRNA2	3'UTR	CHRNA2:ENST00000407991:3'UTR:MODIFIER:exon7/7:c.*1384C>T:,CHRNA2:ENST00000520933:3'UTR:MODIFIER:exon6/6:c.*1384C>T:		rs2280376	0.2218	0.0000	0,0,0	0,0,0,0,0	0.2309							118502 [CHRNA2 (confirmed) Epilepsy,nocturnal frontal lobe,type 4,610353];	RCV000386550.1 [benign]; 			18	95					CHRNA2 (inh=AD pLI=0.00)
chr8	27317987	27317987	A	G	het	anno_omim	QUAL=7647;DP=289;AF=0.49;MQM=59;TRIO=HET,289,0.49,WT,280,0.00,HET,387,0.45	CHRNA2	3'UTR	CHRNA2:ENST00000407991:3'UTR:MODIFIER:exon7/7:c.*1159T>C:,CHRNA2:ENST00000520933:3'UTR:MODIFIER:exon6/6:c.*1159T>C:		rs1560344	0.3654	0.0000	0,0,0	0,0,0,0,0	0.4119							118502 [CHRNA2 (confirmed) Epilepsy,nocturnal frontal lobe,type 4,610353];	RCV000338226.1 [benign]; 			48	123					CHRNA2 (inh=AD pLI=0.00)
chr8	27318391	27318391	C	T	het	anno_omim	QUAL=6893;DP=277;AF=0.48;MQM=59;TRIO=HET,277,0.48,WT,221,0.00,HET,303,0.48	CHRNA2	3'UTR	CHRNA2:ENST00000407991:3'UTR:MODIFIER:exon7/7:c.*755G>A:,CHRNA2:ENST00000520933:3'UTR:MODIFIER:exon6/6:c.*755G>A:		rs2292974	0.3614	0.0000	0,0,0	0,0,0,0,0	0.4099							118502 [CHRNA2 (confirmed) Epilepsy,nocturnal frontal lobe,type 4,610353];	RCV000363849.1 [benign]; 			47	122					CHRNA2 (inh=AD pLI=0.00)
chr8	27318425	27318425	C	A	het	anno_omim	QUAL=7218;DP=289;AF=0.51;MQM=59;TRIO=HET,289,0.51,WT,206,0.00,HET,265,0.49	CHRNA2	3'UTR	CHRNA2:ENST00000407991:3'UTR:MODIFIER:exon7/7:c.*721G>T:,CHRNA2:ENST00000520933:3'UTR:MODIFIER:exon6/6:c.*721G>T:		rs2292975	0.3590	0.0000	0,0,0	0,0,0,0,0	0.4080							118502 [CHRNA2 (confirmed) Epilepsy,nocturnal frontal lobe,type 4,610353];	RCV000269317.1 [benign]; 			47	122					CHRNA2 (inh=AD pLI=0.00)
chr8	27318544	27318544	A	G	hom	anno_omim	QUAL=26622;DP=238;AF=1.00;MQM=59;TRIO=HOM,238,1.00,HOM,275,1.00,HOM,332,1.00	CHRNA2	3'UTR	CHRNA2:ENST00000407991:3'UTR:MODIFIER:exon7/7:c.*602T>C:,CHRNA2:ENST00000520933:3'UTR:MODIFIER:exon6/6:c.*602T>C:		rs2292976	0.7867	0.0000	0,0,0	0,0,0,0,0	0.8397							118502 [CHRNA2 (confirmed) Epilepsy,nocturnal frontal lobe,type 4,610353];	RCV000369848.1 [benign]; 			171	55					CHRNA2 (inh=AD pLI=0.00)
chr8	27318635	27318635	C	G	hom	anno_omim	QUAL=27758;DP=296;AF=0.99;MQM=59;TRIO=HOM,296,0.99,HOM,264,1.00,HOM,330,1.00	CHRNA2	3'UTR	CHRNA2:ENST00000407991:3'UTR:MODIFIER:exon7/7:c.*511G>C:,CHRNA2:ENST00000520933:3'UTR:MODIFIER:exon6/6:c.*511G>C:		rs2292977	0.7819	0.0000	0,0,0	0,0,0,0,0	0.8292							118502 [CHRNA2 (confirmed) Epilepsy,nocturnal frontal lobe,type 4,610353];	RCV000274845.1 [benign]; 			164	62					CHRNA2 (inh=AD pLI=0.00)
chr8	27324822	27324822	T	C	hom	anno_omim	QUAL=14302;DP=222;AF=1.00;MQM=60;TRIO=HOM,222,1.00,HET,236,0.50,HET,317,0.50	CHRNA2	missense	CHRNA2:ENST00000407991:missense:MODERATE:exon5/7:c.373A>G:p.Thr125Ala,CHRNA2:ENST00000520933:missense:MODERATE:exon4/6:c.373A>G:p.Thr125Ala,CHRNA2:ENST00000240132:missense:MODERATE:exon5/7:c.328A>G:p.Thr110Ala		rs891398	0.6102	0.5311	17658,8288,3096	0.7708,0.5938,0.6506,0.5000,0.4024	0.5883	0.6030	T,T,T	T	B	T,T,T	0.01	118502 [CHRNA2 (confirmed) Epilepsy,nocturnal frontal lobe,type 4,610353];	RCV000116712.4 [other]; RCV000355819.1 [benign]; 	CM144682 [CLASS=DP MUT=ALT PHEN="Nicotine dependence association with" GENE=CHRNA2]; 		536	1008	2	[2] auto-classification 15.09.2017  			CHRNA2 (inh=AD pLI=0.00)
chr8	27336446	27336446	T	G	het	anno_omim	QUAL=207;DP=117;AF=0.34;MQM=58;TRIO=HET,117,0.34,WT,121,0.02,WT,187,0.03	CHRNA2	5'UTR	CHRNA2:ENST00000407991:5'UTR:MODIFIER:exon1/7:c.-242A>C:,CHRNA2:ENST00000240132:5'UTR:MODIFIER:exon1/7:c.-242A>C:		rs368160505	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0050							118502 [CHRNA2 (confirmed) Epilepsy,nocturnal frontal lobe,type 4,610353];				0	59					CHRNA2 (inh=AD pLI=0.00)
chr8	27661066	27661066	-	ACAC	het	anno_omim	QUAL=9079;DP=220;AF=0.27;MQM=57;TRIO=HET,220,0.27,HET,79,0.42,WT,128,0.00	ESCO2	3'UTR,intron	ESCO2:ENST00000305188:3'UTR:MODIFIER:exon11/11:c.*126_*129dupACAC:,ESCO2:ENST00000397418:intron:MODIFIER:exon9/11:c.685+191_685+194dupACAC:	(AC)n	rs144484866	0.0000	0.0000	0,0,0	0,0,0,0,0	0.2845							609353 [ESCO2 (confirmed) Roberts syndrome,268300|SC phocomelia syndrome,269000];	RCV000325452.1 [uncertain significance]; 			0	0					ESCO2 (inh=AR pLI=0.18)
chr8	27661066	27661066	-	AC	het	anno_omim	QUAL=9079;DP=220;AF=0.48;MQM=59;TRIO=HET,220,0.48,HET,79,0.42,HOM,128,0.87	ESCO2	3'UTR,intron	ESCO2:ENST00000305188:3'UTR:MODIFIER:exon11/11:c.*128_*129dupAC:,ESCO2:ENST00000397418:intron:MODIFIER:exon9/11:c.685+193_685+194dupAC:	(AC)n	rs144484866;rs56062620	0.0000	0.0000	0,0,0	0,0,0,0,0	0.4491							609353 [ESCO2 (confirmed) Roberts syndrome,268300|SC phocomelia syndrome,269000];	RCV000291483.1 [uncertain significance]; 			86	50					ESCO2 (inh=AR pLI=0.18)
chr8	27661085	27661085	G	A	het	anno_omim	QUAL=9079;DP=220;AF=0.48;MQM=57;TRIO=HET,220,0.75,HET,79,0.84,WT,128,0.87	ESCO2	3'UTR,intron	ESCO2:ENST00000305188:3'UTR:MODIFIER:exon11/11:c.*130G>A:,ESCO2:ENST00000397418:intron:MODIFIER:exon9/11:c.685+195G>A:	(AC)n	rs62498042	0.4970	0.0000	0,0,0	0,0,0,0,0	0.4298							609353 [ESCO2 (confirmed) Roberts syndrome,268300|SC phocomelia syndrome,269000];	RCV000400982.1 [benign]; 			15	64					ESCO2 (inh=AR pLI=0.18)
chr8	33356562	33356562	G	-	het	anno_omim	QUAL=12249;DP=331;AF=0.44;MQM=60;TRIO=HET,331,0.44,HOM,177,1.00,HET,221,0.49	MAK16,TTI2	3'UTR	MAK16:ENST00000360128:3'UTR:MODIFIER:exon10/10:c.*416delG:,TTI2:ENST00000360742:3'UTR:MODIFIER:exon7/7:c.*129delC:,TTI2:ENST00000431156:3'UTR:MODIFIER:exon8/8:c.*129delC:		rs397698667	0.5815	0.0000	0,0,0	0,0,0,0,0	0.6476							614426 [TTI2 (provisional) Mental retardation,autosomal recessive 39,615541];				61	72					MAK16 (inh=n/a pLI=0.99), TTI2 (inh=AR pLI=0.00)
chr8	33369944	33369944	T	C	het	pred_pathogenic;anno_omim	QUAL=13859;DP=288;AF=0.49;MQM=59;TRIO=HET,288,0.49,HOM,188,1.00,HET,304,0.52	TTI2	missense	TTI2:ENST00000360742:missense:MODERATE:exon1/7:c.188A>G:p.Glu63Gly,TTI2:ENST00000431156:missense:MODERATE:exon2/8:c.188A>G:p.Glu63Gly,TTI2:ENST00000520636:missense:MODERATE:exon1/6:c.188A>G:p.Glu63Gly		rs2304748	0.5068	0.5614	19675,12776,1112	0.4626,0.3893,0.5677,0.6177,0.4786	0.5657	0.7680	D,D,D,D,T,T	T	B,B,B	T,T,T,T	15.23	614426 [TTI2 (provisional) Mental retardation,autosomal recessive 39,615541];				680	1041	2	[2] auto-classification 15.09.2017  			TTI2 (inh=AR pLI=0.00)
chr8	33369994	33369994	A	G	het	anno_omim	QUAL=15371;DP=416;AF=0.48;MQM=59;TRIO=HET,416,0.48,HOM,190,0.99,HET,321,0.52	TTI2	synonymous	TTI2:ENST00000360742:synonymous:LOW:exon1/7:c.138T>C:p.Asn46Asn,TTI2:ENST00000431156:synonymous:LOW:exon2/8:c.138T>C:p.Asn46Asn,TTI2:ENST00000520636:synonymous:LOW:exon1/6:c.138T>C:p.Asn46Asn		rs3098657	0.5789	0.6016	22504,14012,2332	0.6713,0.4122,0.5685,0.6471,0.4990	0.6433							614426 [TTI2 (provisional) Mental retardation,autosomal recessive 39,615541];				754	1027	2	[2] auto-classification 15.09.2017  			TTI2 (inh=AR pLI=0.00)
chr8	33370261	33370261	G	A	het	anno_omim	QUAL=1767;DP=113;AF=0.43;MQM=60;TRIO=HET,113,0.43,HOM,15,1.00,HET,31,0.35	TTI2	5'UTR,intron	TTI2:ENST00000360742:5'UTR:MODIFIER:exon1/7:c.-130C>T:,TTI2:ENST00000431156:intron:MODIFIER:exon1/7:c.-99-31C>T:		rs34226219	0.2206	0.0000	0,0,0	0,0,0,0,0	0.3063							614426 [TTI2 (provisional) Mental retardation,autosomal recessive 39,615541];				33	123					TTI2 (inh=AR pLI=0.00)
chr8	38000267	38000267	T	C	hom	anno_omim	QUAL=27669;DP=285;AF=1.00;MQM=59;TRIO=HOM,285,1.00,HOM,255,1.00,HOM,344,1.00	ASH2L			AluSx	rs3990403	0.5505	0.0000	0,0,0	0,0,0,0,0	0.6978							600617 [STAR (provisional) Lipoid adrenal hyperplasia,201710];	RCV000406235.1 [benign]; 			166	62					ASH2L (inh=n/a pLI=1.00)
chr8	38000824	38000827	TTTT	-	hom	anno_omim	QUAL=1482;DP=64;AF=0.05;MQM=60;TRIO=HOM,64,0.05,WT,27,0.11,WT,58,0.00	ASH2L			AluSc8		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							600617 [STAR (provisional) Lipoid adrenal hyperplasia,201710];				0	0					ASH2L (inh=n/a pLI=1.00)
chr8	38005835	38005835	T	C	hom	anno_omim	QUAL=13399;DP=136;AF=1.00;MQM=59;TRIO=HOM,136,1.00,HOM,138,1.00,HOM,156,1.00	STAR	synonymous	STAR:ENST00000276449:synonymous:LOW:exon3/7:c.189A>G:p.Leu63Leu		rs2229620	0.9954	0.9986	60504,33353,5041	0.9842,0.9997,0.9999,1.0000,1.0000	0.9990						8.02	600617 [STAR (provisional) Lipoid adrenal hyperplasia,201710];			COSM4162974	2111	1	2	[2] auto-classification 15.09.2017  			STAR (inh=AR pLI=0.00)
chr8	38326046	38326046	G	A	het	low_DP;anno_omim	QUAL=653;DP=7;AF=0.57;MQM=60;TRIO=HET,7,0.57,HET,11,0.27,HOM,21,1.00	FGFR1	5'UTR_premature_start_codon_gain,5'UTR	FGFR1:ENST00000397091:5'UTR_premature_start_codon_gain:LOW:exon1/18:c.-636C>T:,FGFR1:ENST00000341462:5'UTR_premature_start_codon_gain:LOW:exon1/18:c.-636C>T:,FGFR1:ENST00000447712:5'UTR_premature_start_codon_gain:LOW:exon1/18:c.-636C>T:,FGFR1:ENST00000532791:5'UTR_premature_start_codon_gain:LOW:exon1/18:c.-636C>T:,FGFR1:ENST00000356207:5'UTR_premature_start_codon_gain:LOW:exon1/17:c.-636C>T:,FGFR1:ENST00000335922:5'UTR_premature_start_codon_gain:LOW:exon1/19:c.-728C>T:,FGFR1:ENST00000326324:5'UTR_premature_start_codon_gain:LOW:exon1/17:c.-636C>T:,FGFR1:ENST00000397091:5'UTR:MODIFIER:exon1/18:c.-636C>T:,FGFR1:ENST00000341462:5'UTR:MODIFIER:exon1/18:c.-636C>T:,FGFR1:ENST00000447712:5'UTR:MODIFIER:exon1/18:c.-636C>T:,FGFR1:ENST00000532791:5'UTR:MODIFIER:exon1/18:c.-636C>T:,FGFR1:ENST00000356207:5'UTR:MODIFIER:exon1/17:c.-636C>T:,FGFR1:ENST00000335922:5'UTR:MODIFIER:exon1/19:c.-728C>T:,FGFR1:ENST00000326324:5'UTR:MODIFIER:exon1/17:c.-636C>T:	(GCCGCCC)n	rs3213849	0.3407	0.0000	0,0,0	0,0,0,0,0	0.3478							136350 [FGFR1 (confirmed) Pfeiffer syndrome,101600|Jackson-Weiss syndrome,123150|Hypogonadotropic hypogonadism 2 with or without anosmia,147950|Osteoglophonic dysplasia,166250|Trigonocephaly 1,190440|Hartsfield syndrome,615465|Encephalocraniocutaneous lipomatosis,613001];	RCV000275562.1 [benign]; RCV000276380.1 [benign]; RCV000326643.1 [benign]; RCV000330645.1 [benign]; RCV000370929.1 [benign]; 			32	79	2	[2] auto-classification 15.09.2017  			FGFR1 (inh=AD pLI=0.99)
chr8	38326161	38326161	G	A	hom	anno_omim	QUAL=2238;DP=49;AF=1.00;MQM=60;TRIO=HOM,49,1.00,HOM,23,1.00,HOM,25,1.00	FGFR1	5'UTR	FGFR1:ENST00000341462:5'UTR:MODIFIER:exon1/18:c.-751C>T:,FGFR1:ENST00000447712:5'UTR:MODIFIER:exon1/18:c.-751C>T:		rs2445003	0.9569	0.0000	0,0,0	0,0,0,0,0	0.9591							136350 [FGFR1 (confirmed) Pfeiffer syndrome,101600|Jackson-Weiss syndrome,123150|Hypogonadotropic hypogonadism 2 with or without anosmia,147950|Osteoglophonic dysplasia,166250|Trigonocephaly 1,190440|Hartsfield syndrome,615465|Encephalocraniocutaneous lipomatosis,613001];	RCV000278211.1 [benign]; RCV000337915.1 [benign]; RCV000341549.1 [benign]; RCV000391766.1 [benign]; RCV000392555.1 [benign]; 			211	0					FGFR1 (inh=AD pLI=0.99)
chr8	43054553	43054553	T	C	hom	anno_omim	QUAL=30540;DP=411;AF=1.00;MQM=60;TRIO=HOM,411,1.00,HOM,231,1.00,HOM,302,1.00	HGSNAT	synonymous	HGSNAT:ENST00000458501:synonymous:LOW:exon18/18:c.1833T>C:p.Tyr611Tyr,HGSNAT:ENST00000379644:synonymous:LOW:exon18/18:c.1749T>C:p.Tyr583Tyr,HGSNAT:ENST00000297798:synonymous:LOW:exon9/9:c.945T>C:p.Tyr315Tyr,HGSNAT:ENST00000521576:synonymous:LOW:exon9/9:c.900T>C:p.Tyr300Tyr		rs1126058	0.9916	0.9974	52329,29275,4110	0.9715,0.9983,1.0000,0.9999,0.9999	0.9979							610453 [HGSNAT (confirmed) Mucopolysaccharidosis type IIIC (Sanfilippo C),252930|Retinitis pigmentosa 73,616544];	RCV000082655.5 [benign]; RCV000407246.1 [benign]; 			2103	8	2	[2] auto-classification 15.09.2017  			HGSNAT (inh=AR pLI=0.00)
chr8	43056513	43056513	T	C	hom	anno_omim	QUAL=33068;DP=217;AF=1.00;MQM=59;TRIO=HOM,217,1.00,HOM,428,1.00,HOM,438,1.00	HGSNAT	3'UTR	HGSNAT:ENST00000458501:3'UTR:MODIFIER:exon18/18:c.*1801T>C:,HGSNAT:ENST00000379644:3'UTR:MODIFIER:exon18/18:c.*1801T>C:	L2d2	rs3739431	0.8219	0.0000	0,0,0	0,0,0,0,0	0.8880							610453 [HGSNAT (confirmed) Mucopolysaccharidosis type IIIC (Sanfilippo C),252930|Retinitis pigmentosa 73,616544];	RCV000391978.1 [benign]; 			212	20					HGSNAT (inh=AR pLI=0.00)
chr8	48805816	48805816	-	G	hom	anno_high_impact;anno_omim	QUAL=16843;DP=177;AF=0.97;MQM=59;TRIO=HOM,177,0.97,HOM,176,1.00,HOM,212,1.00	PRKDC	frameshift&splice_region	PRKDC:ENST00000314191:frameshift&splice_region:HIGH:exon31/87:c.3729dupC:p.Arg1244fs,PRKDC:ENST00000338368:frameshift&splice_region:HIGH:exon31/86:c.3729dupC:p.Arg1244fs		rs397814002	1.0000	1.0000	58497,32352,4644	0.9999,0.9999,1.0000,1.0000,1.0000	1.0000							600899 [PRKDC (confirmed) Immunodeficiency 26,with or without neurologic abnormalities,615966];				2415	0	1	[1] old entry - no details available			PRKDC (inh=AR pLI=1.00)
chr8	48846519	48846519	T	C	hom	anno_omim	QUAL=17742;DP=262;AF=1.00;MQM=60;TRIO=HOM,262,1.00,HOM,191,1.00,HET,242,0.55	PRKDC	splice_region&intron	PRKDC:ENST00000314191:splice_region&intron:LOW:exon15/86:c.1623+6A>G:,PRKDC:ENST00000338368:splice_region&intron:LOW:exon15/85:c.1623+6A>G:		rs1231202	0.9836	0.9599	55684,29495,4825	0.9922,0.9756,0.9997,0.9400,0.9930	0.9656							600899 [PRKDC (confirmed) Immunodeficiency 26,with or without neurologic abnormalities,615966];				2178	219	2	[2] auto-classification 15.09.2017  			PRKDC (inh=AR pLI=1.00)
chr8	61178574	61178574	T	C	hom	anno_omim	QUAL=18635;DP=280;AF=1.00;MQM=59;TRIO=HOM,280,1.00,HOM,189,1.00,HET,233,0.50	CA8	synonymous	CA8:ENST00000317995:synonymous:LOW:exon3/9:c.327A>G:p.Glu109Glu		rs7464181	0.5010	0.4279	11930,5706,3069	0.7665,0.3106,0.2567,0.4165,0.4354	0.5015							114815 [CA8 (provisional) Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3,613227];	RCV000116510.2 [likely benign]; 		COSM3763364	597	1595	2	[2] auto-classification 15.09.2017  			CA8 (inh=AR pLI=0.78)
chr8	61193760	61193760	T	G	hom	anno_omim	QUAL=12585;DP=51;AF=0.98;MQM=59;TRIO=HOM,51,0.98,HOM,267,1.00,HET,400,0.36	CA8	5'UTR	CA8:ENST00000317995:5'UTR:MODIFIER:exon1/9:c.-54A>C:		rs10101374	0.6266	0.0000	0,0,0	0,0,0,0,0	0.5963							114815 [CA8 (provisional) Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3,613227];				931	1361					CA8 (inh=AR pLI=0.78)
chr8	61193809	61193809	A	G	hom	anno_omim	QUAL=14485;DP=90;AF=1.00;MQM=59;TRIO=HOM,90,1.00,HOM,282,1.00,HET,412,0.37	CA8	5'UTR	CA8:ENST00000317995:5'UTR:MODIFIER:exon1/9:c.-103T>C:		rs10086341	0.6258	0.0000	0,0,0	0,0,0,0,0	0.5950							114815 [CA8 (provisional) Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3,613227];				79	93					CA8 (inh=AR pLI=0.78)
chr8	61193828	61193828	A	G	hom	anno_omim	QUAL=14962;DP=95;AF=0.99;MQM=59;TRIO=HOM,95,0.99,HOM,293,1.00,HET,425,0.37	CA8	5'UTR	CA8:ENST00000317995:5'UTR:MODIFIER:exon1/9:c.-122T>C:		rs10086352	0.4329	0.0000	0,0,0	0,0,0,0,0	0.4316							114815 [CA8 (provisional) Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3,613227];				45	90					CA8 (inh=AR pLI=0.78)
chr8	61193843	61193843	C	G	hom	anno_omim	QUAL=15298;DP=91;AF=1.00;MQM=59;TRIO=HOM,91,1.00,HOM,286,1.00,HET,425,0.38	CA8	5'UTR	CA8:ENST00000317995:5'UTR:MODIFIER:exon1/9:c.-137G>C:		rs10086449	0.4329	0.0000	0,0,0	0,0,0,0,0	0.4321							114815 [CA8 (provisional) Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3,613227];				41	89					CA8 (inh=AR pLI=0.78)
chr8	61779681	61779681	A	C	het	anno_omim	QUAL=15277;DP=505;AF=0.51;MQM=60;TRIO=HET,505,0.51,HOM,164,1.00,HET,224,0.49	CHD7,RP11,33I11.3	intergenic_region	33I11.3:ENSG00000171316-ENSG00000271377:intergenic_region:MODIFIER::n.61779681A>C:		rs4738834	0.5004	0.0000	0,0,0	0,0,0,0,0	0.4728							608892 [CHD7 (confirmed) CHARGE syndrome,214800|Hypogonadotropic hypogonadism 5 with or without anosmia,612370];	RCV000305229.1 [benign]; RCV000406415.1 [benign]; 			56	65					CHD7 (inh=AD pLI=1.00), PRPF31 (inh=AD pLI=0.97), 33I11.3 (inh=n/a pLI=n/a)
chr8	61779936	61779936	T	G	het	anno_omim	QUAL=15991;DP=539;AF=0.51;MQM=60;TRIO=HET,539,0.51,HOM,188,0.99,HET,291,0.43	CHD7,RP11,33I11.3	intergenic_region	33I11.3:ENSG00000171316-ENSG00000271377:intergenic_region:MODIFIER::n.61779936T>G:		rs4237040	0.4958	0.0000	0,0,0	0,0,0,0,0	0.4714							608892 [CHD7 (confirmed) CHARGE syndrome,214800|Hypogonadotropic hypogonadism 5 with or without anosmia,612370];	RCV000335254.1 [benign]; RCV000404449.1 [benign]; 			56	64					CHD7 (inh=AD pLI=1.00), PRPF31 (inh=AD pLI=0.97), 33I11.3 (inh=n/a pLI=n/a)
chr8	61780220	61780220	T	C	het	anno_omim	QUAL=13092;DP=419;AF=0.53;MQM=60;TRIO=HET,419,0.53,HOM,141,1.00,HET,233,0.50	CHD7,RP11,33I11.3	intergenic_region	33I11.3:ENSG00000171316-ENSG00000271377:intergenic_region:MODIFIER::n.61780220T>C:		rs2280917	0.7376	0.0000	0,0,0	0,0,0,0,0	0.6998							608892 [CHD7 (confirmed) CHARGE syndrome,214800|Hypogonadotropic hypogonadism 5 with or without anosmia,612370];	RCV000292386.1 [benign]; RCV000392132.1 [benign]; 			72	58					CHD7 (inh=AD pLI=1.00), PRPF31 (inh=AD pLI=0.97), 33I11.3 (inh=n/a pLI=n/a)
chr8	61780289	61780289	C	T	het	anno_omim	QUAL=12048;DP=361;AF=0.47;MQM=60;TRIO=HET,361,0.47,HOM,155,1.00,HET,219,0.49	CHD7,RP11,33I11.3	intergenic_region	33I11.3:ENSG00000171316-ENSG00000271377:intergenic_region:MODIFIER::n.61780289C>T:		rs6985168	0.4962	0.0000	0,0,0	0,0,0,0,0	0.4753							608892 [CHD7 (confirmed) CHARGE syndrome,214800|Hypogonadotropic hypogonadism 5 with or without anosmia,612370];	RCV000314602.1 [benign]; RCV000362265.1 [benign]; 			57	64					CHD7 (inh=AD pLI=1.00), PRPF31 (inh=AD pLI=0.97), 33I11.3 (inh=n/a pLI=n/a)
chr8	62562872	62562872	C	T	het	anno_omim	QUAL=22750;DP=431;AF=0.52;MQM=60;TRIO=HET,431,0.52,HET,304,0.51,HOM,384,1.00	ASPH	intron	ASPH:ENST00000379454:intron:MODIFIER:exon5/24:c.490+737G>A:,ASPH:ENST00000541428:intron:MODIFIER:exon5/24:c.403+737G>A:,ASPH:ENST00000356457:intron:MODIFIER:exon5/13:c.490+737G>A:,ASPH:ENST00000518068:intron:MODIFIER:exon5/12:c.490+737G>A:,ASPH:ENST00000517903:intron:MODIFIER:exon6/14:c.448+737G>A:,ASPH:ENST00000445642:intron:MODIFIER:exon6/15:c.448+737G>A:,ASPH:ENST00000517847:intron:MODIFIER:exon6/14:c.448+737G>A:,ASPH:ENST00000522835:intron:MODIFIER:exon6/13:c.448+737G>A:		rs2350590	0.8045	0.0000	0,0,0	0,0,0,0,0	0.8410							600582 [ASPH (confirmed) Traboulsi syndrome,601552];				106	41					ASPH (inh=AR pLI=0.00)
chr8	62563764	62563764	A	G	het	anno_omim	QUAL=12109;DP=262;AF=0.53;MQM=60;TRIO=HET,262,0.53,HET,154,0.46,HOM,205,1.00	ASPH	intron	ASPH:ENST00000379454:intron:MODIFIER:exon4/24:c.416-81T>C:,ASPH:ENST00000541428:intron:MODIFIER:exon4/24:c.329-81T>C:,ASPH:ENST00000356457:intron:MODIFIER:exon4/13:c.416-81T>C:,ASPH:ENST00000518068:intron:MODIFIER:exon4/12:c.416-81T>C:,ASPH:ENST00000517903:intron:MODIFIER:exon5/14:c.374-81T>C:,ASPH:ENST00000445642:intron:MODIFIER:exon5/15:c.374-81T>C:,ASPH:ENST00000517847:intron:MODIFIER:exon5/14:c.374-81T>C:,ASPH:ENST00000522835:intron:MODIFIER:exon5/13:c.374-81T>C:		rs7016141	0.8051	0.0000	0,0,0	0,0,0,0,0	0.8415							600582 [ASPH (confirmed) Traboulsi syndrome,601552];				268	96					ASPH (inh=AR pLI=0.00)
chr8	62565897	62565897	G	A	het	anno_omim	QUAL=19385;DP=585;AF=0.47;MQM=60;TRIO=HET,585,0.47,WT,244,0.00,HOM,360,1.00	ASPH	intron	ASPH:ENST00000379454:intron:MODIFIER:exon4/24:c.415+230C>T:,ASPH:ENST00000541428:intron:MODIFIER:exon4/24:c.328+230C>T:,ASPH:ENST00000356457:intron:MODIFIER:exon4/13:c.415+230C>T:,ASPH:ENST00000518068:intron:MODIFIER:exon4/12:c.415+230C>T:,ASPH:ENST00000517903:intron:MODIFIER:exon5/14:c.373+230C>T:,ASPH:ENST00000445642:intron:MODIFIER:exon5/15:c.373+230C>T:,ASPH:ENST00000517847:intron:MODIFIER:exon5/14:c.373+230C>T:,ASPH:ENST00000522835:intron:MODIFIER:exon5/13:c.373+230C>T:	MIRc	rs949761	0.1034	0.0000	0,0,0	0,0,0,0,0	0.1513							600582 [ASPH (confirmed) Traboulsi syndrome,601552];				2	34					ASPH (inh=AR pLI=0.00)
chr8	62567097	62567097	C	T	het	anno_omim	QUAL=19342;DP=678;AF=0.45;MQM=60;TRIO=HET,678,0.45,WT,243,0.00,HOM,344,0.99	ASPH	intron	ASPH:ENST00000379454:intron:MODIFIER:exon3/24:c.323-878G>A:,ASPH:ENST00000541428:intron:MODIFIER:exon3/24:c.236-878G>A:,ASPH:ENST00000356457:intron:MODIFIER:exon3/13:c.323-878G>A:,ASPH:ENST00000518068:intron:MODIFIER:exon3/12:c.323-878G>A:,ASPH:ENST00000517903:intron:MODIFIER:exon4/14:c.281-878G>A:,ASPH:ENST00000445642:intron:MODIFIER:exon4/15:c.281-878G>A:,ASPH:ENST00000517847:intron:MODIFIER:exon4/14:c.281-878G>A:,ASPH:ENST00000522835:intron:MODIFIER:exon4/13:c.281-878G>A:		rs10504331	0.1034	0.0000	0,0,0	0,0,0,0,0	0.1515							600582 [ASPH (confirmed) Traboulsi syndrome,601552];				2	34					ASPH (inh=AR pLI=0.00)
chr8	62567214	62567214	G	C	het	anno_omim	QUAL=19950;DP=387;AF=0.52;MQM=60;TRIO=HET,387,0.52,HET,252,0.46,HOM,349,1.00	ASPH	intron	ASPH:ENST00000379454:intron:MODIFIER:exon3/24:c.323-995C>G:,ASPH:ENST00000541428:intron:MODIFIER:exon3/24:c.236-995C>G:,ASPH:ENST00000356457:intron:MODIFIER:exon3/13:c.323-995C>G:,ASPH:ENST00000518068:intron:MODIFIER:exon3/12:c.323-995C>G:,ASPH:ENST00000517903:intron:MODIFIER:exon4/14:c.281-995C>G:,ASPH:ENST00000445642:intron:MODIFIER:exon4/15:c.281-995C>G:,ASPH:ENST00000517847:intron:MODIFIER:exon4/14:c.281-995C>G:,ASPH:ENST00000522835:intron:MODIFIER:exon4/13:c.281-995C>G:		rs9283975	0.7829	0.0000	0,0,0	0,0,0,0,0	0.8226							600582 [ASPH (confirmed) Traboulsi syndrome,601552];				105	42					ASPH (inh=AR pLI=0.00)
chr8	63972324	63972324	C	T	het	anno_omim	QUAL=304;DP=20;AF=0.55;MQM=60;TRIO=HET,20,0.55,HET,4,0.50,HOM,2,1.00	TTPA				rs6472068	0.5284	0.0000	0,0,0	0,0,0,0,0	0.5183							600415 [TTPA (confirmed) Ataxia with isolated vitamin E deficiency,277460];	RCV000362358.1 [benign]; 			35	49					TTPA (inh=AR pLI=0.01)
chr8	63972718	63972718	C	T	het	anno_omim	QUAL=14550;DP=364;AF=0.47;MQM=60;TRIO=HET,364,0.47,HOM,184,0.99,HET,303,0.50	TTPA	3'UTR	TTPA:ENST00000260116:3'UTR:MODIFIER:exon5/5:c.*1093G>A:		rs4587328	0.6755	0.0000	0,0,0	0,0,0,0,0	0.6046							600415 [TTPA (confirmed) Ataxia with isolated vitamin E deficiency,277460];	RCV000285681.1 [benign]; 			43	68					TTPA (inh=AR pLI=0.01)
chr8	63973233	63973235	AAA	-	het	anno_omim	QUAL=3355;DP=146;AF=0.43;MQM=59;TRIO=HET,146,0.43,HOM,81,0.83,HET,70,0.54	TTPA	3'UTR	TTPA:ENST00000260116:3'UTR:MODIFIER:exon5/5:c.*576_*578delTTT:	AluSz6	rs35504965;rs759014557	0.6747	0.0000	0,0,0	0,0,0,0,0	0.6219							600415 [TTPA (confirmed) Ataxia with isolated vitamin E deficiency,277460];	RCV000314689.1 [benign]; 			46	64					TTPA (inh=AR pLI=0.01)
chr8	63978659	63978659	A	-	hom	anno_omim	QUAL=14908;DP=190;AF=1.00;MQM=59;TRIO=HOM,190,1.00,HOM,123,0.99,HOM,171,0.99	TTPA	splice_region&intron	TTPA:ENST00000260116:splice_region&intron:LOW:exon2/4:c.359-3delT:		rs398008072	1.0000	1.0000	59537,32668,5107	1.0000,1.0000,1.0000,1.0000,1.0000	1.0000							600415 [TTPA (confirmed) Ataxia with isolated vitamin E deficiency,277460];	RCV000078673.4 [benign]; RCV000383973.1 [benign]; 			3253	0	2	[2] auto-classification 15.09.2017  			TTPA (inh=AR pLI=0.01)
chr8	75262798	75262798	G	C	hom	anno_omim	QUAL=36496;DP=272;AF=1.00;MQM=59;TRIO=HOM,272,1.00,HOM,361,1.00,HOM,501,1.00	GDAP1	synonymous,intron	GDAP1:ENST00000220822:synonymous:LOW:exon1/6:c.102G>C:p.Ser34Ser,GDAP1:ENST00000434412:intron:MODIFIER:exon1/5:c.-64+91G>C:		rs7828201	0.9956	0.9973	60381,33363,5201	1.0000,0.9999,1.0000,1.0000,0.9808	1.0000							606598 [GDAP1 (confirmed) Charcot-Marie-Tooth disease,type 4A,214400|Charcot-Marie-Tooth disease,axonal,with vocal cord paresis,607706|Charcot-Marie-Tooth disease,axonal,type 2K,607831|Charcot-Marie-Tooth disease,recessive intermediate,A,608340];			COSM4163063	2111	1	2	[2] auto-classification 15.09.2017  			GDAP1 (inh=AR+AD pLI=0.00)
chr8	75274141	75274141	T	G	het	anno_omim	QUAL=13573;DP=293;AF=0.47;MQM=59;TRIO=HET,293,0.47,WT,249,0.01,HOM,318,0.99	GDAP1	synonymous	GDAP1:ENST00000220822:synonymous:LOW:exon4/6:c.507T>G:p.Ser169Ser,GDAP1:ENST00000434412:synonymous:LOW:exon4/6:c.303T>G:p.Ser101Ser		rs11554166	0.2192	0.2774	5106,3653,70	0.1177,0.1695,0.3128,0.3277,0.2072	0.2793							606598 [GDAP1 (confirmed) Charcot-Marie-Tooth disease,type 4A,214400|Charcot-Marie-Tooth disease,axonal,with vocal cord paresis,607706|Charcot-Marie-Tooth disease,axonal,type 2K,607831|Charcot-Marie-Tooth disease,recessive intermediate,A,608340];	RCV000251902.1 [benign]; RCV000325881.1 [benign]; RCV000380453.1 [benign]; 		COSM3763403	219	850	2	[2] auto-classification 15.09.2017  			GDAP1 (inh=AR+AD pLI=0.00)
chr8	75277399	75277399	A	G	hom	anno_omim	QUAL=20051;DP=268;AF=1.00;MQM=60;TRIO=HOM,268,1.00,HOM,155,1.00,HOM,190,1.00	GDAP1	3'UTR	GDAP1:ENST00000220822:3'UTR:MODIFIER:exon6/6:c.*797A>G:		rs7007283	0.9898	0.9876	5259,1363,93	0.0000,0.0000,0.0000,0.9985,0.9832	0.9949							606598 [GDAP1 (confirmed) Charcot-Marie-Tooth disease,type 4A,214400|Charcot-Marie-Tooth disease,axonal,with vocal cord paresis,607706|Charcot-Marie-Tooth disease,axonal,type 2K,607831|Charcot-Marie-Tooth disease,recessive intermediate,A,608340];	RCV000309016.1 [benign]; RCV000363745.1 [benign]; 			649	2					GDAP1 (inh=AR+AD pLI=0.00)
chr8	75278457	75278457	A	G	het	anno_omim	QUAL=18609;DP=768;AF=0.53;MQM=60;TRIO=HET,768,0.53,WT,161,0.00,HOM,235,1.00	GDAP1	3'UTR	GDAP1:ENST00000220822:3'UTR:MODIFIER:exon6/6:c.*1855A>G:		rs6472842	0.2668	0.2413	414,180,17	0.2401,0.0000,0.0000,0.3116,0.2056	0.3120							606598 [GDAP1 (confirmed) Charcot-Marie-Tooth disease,type 4A,214400|Charcot-Marie-Tooth disease,axonal,with vocal cord paresis,607706|Charcot-Marie-Tooth disease,axonal,type 2K,607831|Charcot-Marie-Tooth disease,recessive intermediate,A,608340];	RCV000283960.1 [benign]; RCV000378391.1 [benign]; 			75	267					GDAP1 (inh=AR+AD pLI=0.00)
chr8	75278816	75278816	A	G	het	anno_omim	QUAL=12804;DP=404;AF=0.51;MQM=60;TRIO=HET,404,0.51,WT,139,0.00,HOM,214,1.00	GDAP1	3'UTR	GDAP1:ENST00000220822:3'UTR:MODIFIER:exon6/6:c.*2214A>G:		rs10504580	0.2294	0.2329	343,132,2	0.0000,0.0000,0.0000,0.3104,0.2057	0.2815							606598 [GDAP1 (confirmed) Charcot-Marie-Tooth disease,type 4A,214400|Charcot-Marie-Tooth disease,axonal,with vocal cord paresis,607706|Charcot-Marie-Tooth disease,axonal,type 2K,607831|Charcot-Marie-Tooth disease,recessive intermediate,A,608340];	RCV000308042.1 [benign]; RCV000391330.1 [benign]; 			75	266					GDAP1 (inh=AR+AD pLI=0.00)
chr8	75279333	75279333	C	AAA	hom	anno_omim	QUAL=1637;DP=71;AF=0.11;MQM=54;TRIO=HOM,71,0.11,HOM,85,0.04,HOM,99,0.00	GDAP1					0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							606598 [GDAP1 (confirmed) Charcot-Marie-Tooth disease,type 4A,214400|Charcot-Marie-Tooth disease,axonal,with vocal cord paresis,607706|Charcot-Marie-Tooth disease,axonal,type 2K,607831|Charcot-Marie-Tooth disease,recessive intermediate,A,608340];				0	1					GDAP1 (inh=AR+AD pLI=0.00)
chr8	77892834	77892834	A	T	het	anno_omim	QUAL=8995;DP=238;AF=0.56;MQM=60;TRIO=HET,238,0.56,HET,190,0.43,HET,252,0.50	PEX2	3'UTR	PEX2:ENST00000357039:3'UTR:MODIFIER:exon4/4:c.*2663T>A:,PEX2:ENST00000419564:3'UTR:MODIFIER:exon4/4:c.*2663T>A:	MLT1K	rs28435921	0.5180	0.0000	0,0,0	0,0,0,0,0	0.4890							170993 [PEX2 (confirmed) Peroxisome biogenesis disorder 5A (Zellweger),614866|Peroxisome biogenesis disorder 5B,614867];	RCV000316203.1 [benign]; 			76	85					PEX2 (inh=AR pLI=0.06)
chr8	77893120	77893120	T	C	hom	anno_omim	QUAL=29461;DP=430;AF=1.00;MQM=60;TRIO=HOM,430,1.00,HOM,211,1.00,HOM,238,1.00	PEX2	3'UTR	PEX2:ENST00000357039:3'UTR:MODIFIER:exon4/4:c.*2377A>G:,PEX2:ENST00000419564:3'UTR:MODIFIER:exon4/4:c.*2377A>G:		rs4388434	0.9543	0.0000	0,0,0	0,0,0,0,0	0.9492							170993 [PEX2 (confirmed) Peroxisome biogenesis disorder 5A (Zellweger),614866|Peroxisome biogenesis disorder 5B,614867];	RCV000275336.1 [benign]; 			222	10					PEX2 (inh=AR pLI=0.06)
chr8	77894303	77894303	T	C	hom	anno_omim	QUAL=15691;DP=245;AF=1.00;MQM=60;TRIO=HOM,245,1.00,HOM,112,1.00,HOM,113,1.00	PEX2	3'UTR	PEX2:ENST00000357039:3'UTR:MODIFIER:exon4/4:c.*1194A>G:,PEX2:ENST00000419564:3'UTR:MODIFIER:exon4/4:c.*1194A>G:		rs4311633	0.9858	0.0000	0,0,0	0,0,0,0,0	0.9778							170993 [PEX2 (confirmed) Peroxisome biogenesis disorder 5A (Zellweger),614866|Peroxisome biogenesis disorder 5B,614867];	RCV000324558.1 [benign]; 			222	10					PEX2 (inh=AR pLI=0.06)
chr8	77894770	77894770	A	G	hom	anno_omim	QUAL=19738;DP=336;AF=0.99;MQM=59;TRIO=HOM,336,0.99,HOM,110,1.00,HOM,172,1.00	PEX2	3'UTR	PEX2:ENST00000357039:3'UTR:MODIFIER:exon4/4:c.*727T>C:,PEX2:ENST00000419564:3'UTR:MODIFIER:exon4/4:c.*727T>C:	AluSc8	rs4610720	0.9543	0.0000	0,0,0	0,0,0,0,0	0.9491							170993 [PEX2 (confirmed) Peroxisome biogenesis disorder 5A (Zellweger),614866|Peroxisome biogenesis disorder 5B,614867];	RCV000335628.1 [benign]; 			221	9					PEX2 (inh=AR pLI=0.06)
chr8	77895865	77895865	A	G	hom	pred_pathogenic;anno_omim	QUAL=21972;DP=274;AF=1.00;MQM=60;TRIO=HOM,274,1.00,HOM,159,1.00,HOM,216,1.00	PEX2	missense	PEX2:ENST00000357039:missense:MODERATE:exon4/4:c.550T>C:p.Cys184Arg,PEX2:ENST00000419564:missense:MODERATE:exon4/4:c.550T>C:p.Cys184Arg,PEX2:ENST00000520103:missense:MODERATE:exon3/3:c.550T>C:p.Cys184Arg,PEX2:ENST00000522527:missense:MODERATE:exon3/3:c.550T>C:p.Cys184Arg		rs10087163	0.9962	0.9878	59201,32347,5149	0.9975,0.9976,1.0000,0.9846,0.9959	0.9872	6.1730	T,T,T,T	T	B	T,T,T,T	2.37	170993 [PEX2 (confirmed) Peroxisome biogenesis disorder 5A (Zellweger),614866|Peroxisome biogenesis disorder 5B,614867];	RCV000153682.2 [benign]; 			3178	78	2	[2] auto-classification 15.09.2017  			PEX2 (inh=AR pLI=0.06)
chr8	77912230	77912230	G	T	het	anno_omim	QUAL=4444;DP=147;AF=0.51;MQM=60;TRIO=HET,147,0.51,WT,155,0.00,HET,203,0.50	PEX2	5'UTR	PEX2:ENST00000357039:5'UTR:MODIFIER:exon1/4:c.-164C>A:,PEX2:ENST00000419564:5'UTR:MODIFIER:exon2/4:c.-165C>A:,PEX2:ENST00000520103:5'UTR:MODIFIER:exon2/3:c.-22C>A:,PEX2:ENST00000522527:5'UTR:MODIFIER:exon1/3:c.-132C>A:		rs12718	0.2778	0.2518	428,84,24	0.2724,0.0000,0.0000,0.1959,0.2759	0.2510							170993 [PEX2 (confirmed) Peroxisome biogenesis disorder 5A (Zellweger),614866|Peroxisome biogenesis disorder 5B,614867];	RCV000292942.1 [benign]; 			72	515					PEX2 (inh=AR pLI=0.06)
chr8	77912424	77912424	T	G	hom	anno_omim	QUAL=35393;DP=432;AF=1.00;MQM=59;TRIO=HOM,432,1.00,HOM,296,1.00,HOM,390,1.00	PEX2	5'UTR,intron	PEX2:ENST00000357039:5'UTR:MODIFIER:exon1/4:c.-358A>C:,PEX2:ENST00000522527:5'UTR:MODIFIER:exon1/3:c.-326A>C:,PEX2:ENST00000419564:intron:MODIFIER:exon1/3:c.-303-56A>C:,PEX2:ENST00000520103:intron:MODIFIER:exon1/2:c.-160-56A>C:		rs10081480	0.9655	0.0000	0,0,0	0,0,0,0,0	0.9570							170993 [PEX2 (confirmed) Peroxisome biogenesis disorder 5A (Zellweger),614866|Peroxisome biogenesis disorder 5B,614867];				250	11					PEX2 (inh=AR pLI=0.06)
chr8	86376130	86376130	A	T	hom	low_DP;anno_omim	QUAL=1235;DP=15;AF=1.00;MQM=59;TRIO=HOM,15,1.00,HOM,17,1.00,HOM,15,0.93	CA2,RP11-317J10.2	5'UTR	CA2:ENST00000285379:5'UTR:MODIFIER:exon1/7:c.-181A>T:		rs11261477	0.9988	0.0000	0,0,0	0,0,0,0,0	0.9874							611492 [CA2 (confirmed) Osteopetrosis,autosomal recessive 3,with renal tubular acidosis,259730];	RCV000363093.1 [benign]; 			210	5					CA2 (inh=AR pLI=0.10), RP11-317J10.2 (inh=n/a pLI=n/a)
chr8	86389403	86389403	T	C	hom	anno_omim	QUAL=36634;DP=405;AF=1.00;MQM=60;TRIO=HOM,405,1.00,HOM,329,0.99,HOM,402,1.00	CA2	synonymous	CA2:ENST00000285379:synonymous:LOW:exon6/7:c.562T>C:p.Leu188Leu		rs703	0.5777	0.5893	21573,12965,2655	0.7144,0.5274,0.4722,0.6223,0.4385	0.6444							611492 [CA2 (confirmed) Osteopetrosis,autosomal recessive 3,with renal tubular acidosis,259730];	RCV000242714.1 [benign]; RCV000386953.1 [benign]; 		COSM3982612	837	928	1	Prima vista kein Anhalt f?r Splice Defekt, swal, 160405 [1] ahwalds1 05.04.2016			CA2 (inh=AR pLI=0.10)
chr8	90946056	90946056	A	G	het	anno_omim	QUAL=5398;DP=212;AF=0.52;MQM=60;TRIO=HET,212,0.52,WT,48,0.00,HOM,71,1.00	NBN	3'UTR	NBN:ENST00000265433:3'UTR:MODIFIER:exon16/16:c.*1754T>C:,NBN:ENST00000409330:3'UTR:MODIFIER:exon16/16:c.*1754T>C:	L1MEf	rs9995	0.3355	0.0000	0,0,0	0,0,0,0,0	0.3271							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	RCV000397319.1 [benign]; 			17	64					NBN (inh=AR pLI=0.00)
chr8	90946601	90946601	T	G	het	anno_omim	QUAL=20538;DP=534;AF=0.49;MQM=60;TRIO=HET,534,0.49,WT,328,0.00,HOM,406,1.00	NBN	3'UTR	NBN:ENST00000265433:3'UTR:MODIFIER:exon16/16:c.*1209A>C:,NBN:ENST00000409330:3'UTR:MODIFIER:exon16/16:c.*1209A>C:	LTR67B	rs1063054	0.3353	0.0000	0,0,0	0,0,0,0,0	0.3273							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	RCV000366927.1 [benign]; 			18	94					NBN (inh=AR pLI=0.00)
chr8	90947269	90947269	C	G	het	anno_omim	QUAL=6151;DP=224;AF=0.52;MQM=60;TRIO=HET,224,0.52,WT,68,0.00,HOM,99,0.98	NBN	3'UTR	NBN:ENST00000265433:3'UTR:MODIFIER:exon16/16:c.*541G>C:,NBN:ENST00000409330:3'UTR:MODIFIER:exon16/16:c.*541G>C:		rs2735383	0.3303	0.0000	0,0,0	0,0,0,0,0	0.3233							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	RCV000272651.1 [benign]; 	CR121123 [CLASS=DFP MUT=ALT PHEN="Lung cancer increased risk association with" GENE=NBN]; 		18	94					NBN (inh=AR pLI=0.00)
chr8	90947409	90947409	G	C	het	anno_omim	QUAL=3852;DP=199;AF=0.51;MQM=60;TRIO=HET,199,0.51,HET,60,0.63,WT,90,0.00	NBN	3'UTR	NBN:ENST00000265433:3'UTR:MODIFIER:exon16/16:c.*401C>G:,NBN:ENST00000409330:3'UTR:MODIFIER:exon16/16:c.*401C>G:	L1ME4b	rs104895030	0.0012	0.0000	0,0,0	0,0,0,0,0	0.0052							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	RCV000114873.1 [not provided]; RCV000316124.1 [uncertain significance]; 			0	4					NBN (inh=AR pLI=0.00)
chr8	90947537	90947537	C	T	het	anno_omim	QUAL=6771;DP=200;AF=0.48;MQM=60;TRIO=HET,200,0.48,WT,105,0.00,HOM,130,1.00	NBN	3'UTR	NBN:ENST00000265433:3'UTR:MODIFIER:exon16/16:c.*273G>A:,NBN:ENST00000409330:3'UTR:MODIFIER:exon16/16:c.*273G>A:	L1ME4b	rs1063053	0.3219	0.0000	0,0,0	0,0,0,0,0	0.3160							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	RCV000373039.1 [benign]; 			18	93					NBN (inh=AR pLI=0.00)
chr8	90958422	90958422	T	C	het	anno_omim	QUAL=8837;DP=281;AF=0.48;MQM=60;TRIO=HET,281,0.48,WT,96,0.01,HOM,163,1.00	NBN	synonymous	NBN:ENST00000265433:synonymous:LOW:exon13/16:c.2016A>G:p.Pro672Pro,NBN:ENST00000409330:synonymous:LOW:exon13/16:c.1770A>G:p.Pro590Pro		rs1061302	0.3528	0.3451	7411,3552,277	0.2278,0.3452,0.4444,0.3280,0.4301	0.3470							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	RCV000162357.1 [benign]; RCV000243757.1 [benign]; RCV000393183.1 [benign]; 		COSM3763441	475	1840	1	[1] Alexandra Doehring 27.08.2015			NBN (inh=AR pLI=0.00)
chr8	90958530	90958530	T	C	het	anno_omim	QUAL=8109;DP=286;AF=0.50;MQM=60;TRIO=HET,286,0.50,WT,104,0.01,HOM,137,0.99	NBN	splice_region&intron	NBN:ENST00000265433:splice_region&intron:LOW:exon12/15:c.1915-7A>G:,NBN:ENST00000409330:splice_region&intron:LOW:exon12/15:c.1669-7A>G:		rs2308962	0.3790	0.3529	7684,3567,522	0.3151,0.3481,0.4442,0.3284,0.4290	0.3535							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	RCV000251758.1 [benign]; RCV000363485.1 [benign]; 			476	1853	1	[1] Alexandra Doehring 27.08.2015			NBN (inh=AR pLI=0.00)
chr8	90967711	90967711	A	G	het	anno_omim	QUAL=5887;DP=177;AF=0.50;MQM=60;TRIO=HET,177,0.50,WT,100,0.00,HOM,116,0.98	NBN	synonymous	NBN:ENST00000265433:synonymous:LOW:exon10/16:c.1197T>C:p.Asp399Asp,NBN:ENST00000409330:synonymous:LOW:exon10/16:c.951T>C:p.Asp317Asp		rs709816	0.6086	0.4676	14308,4457,3067	0.7691,0.5891,0.6466,0.3671,0.5164	0.5139							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	RCV000162376.1 [benign]; RCV000173761.2 [benign]; RCV000322749.1 [benign]; 		COSM3763442	619	1945	1	[1] Alexandra Doehring 27.08.2015			NBN (inh=AR pLI=0.00)
chr8	90990479	90990479	C	G	het	pred_pathogenic;anno_omim	QUAL=10500;DP=286;AF=0.45;MQM=60;TRIO=HET,286,0.45,WT,138,0.00,HOM,217,1.00	NBN	missense	NBN:ENST00000265433:missense:MODERATE:exon5/16:c.553G>C:p.Glu185Gln,NBN:ENST00000409330:missense:MODERATE:exon5/16:c.307G>C:p.Glu103Gln		rs1805794	0.3570	0.3453	7417,3546,292	0.2357,0.3451,0.4438,0.3275,0.4294	0.3472	2.1330	T,T,T,T	T	B	T,T,T	6.33	602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	RCV000121620.3 [benign]; RCV000162358.2 [benign]; RCV000374656.1 [benign]; 	CM034886 [CLASS=DP MUT=ALT PHEN="Lung cancer association with" GENE=NBN]; 	COSM3763443	472	1849	1	[1] Christopher Schroeder 27.04.2015			NBN (inh=AR pLI=0.00)
chr8	90995019	90995019	C	T	het	anno_omim	QUAL=13525;DP=408;AF=0.43;MQM=60;TRIO=HET,408,0.43,WT,210,0.00,HOM,269,1.00	NBN	synonymous,5'UTR	NBN:ENST00000265433:synonymous:LOW:exon2/16:c.102G>A:p.Leu34Leu,NBN:ENST00000409330:5'UTR:MODIFIER:exon2/16:c.-145G>A:		rs1063045	0.3792	0.3527	7704,3573,531	0.3136,0.3477,0.4446,0.3283,0.4297	0.3536							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	RCV000162359.1 [benign]; RCV000242759.1 [benign]; RCV000387572.1 [benign]; 		COSM3763444	479	1829	1	[1] Alexandra Doehring 27.08.2015			NBN (inh=AR pLI=0.00)
chr8	94794620	94794620	C	T	het	anno_omim	QUAL=5438;DP=134;AF=0.49;MQM=60;TRIO=HET,134,0.49,HOM,116,1.00,WT,142,0.01	TMEM67	splice_region&intron	TMEM67:ENST00000453321:splice_region&intron:LOW:exon10/27:c.1066-3C>T:,TMEM67:ENST00000409623:splice_region&intron:LOW:exon11/28:c.823-3C>T:		rs3097427	0.7151	0.6341	24646,11127,3055	0.7684,0.7274,0.8363,0.5814,0.6154	0.6545							609884 [TMEM67 (confirmed) Meckel syndrome 3,607361|Joubert syndrome 6,610688|Bardet-Biedl syndrome 14,modifier of,615991|COACH syndrome,216360|Nephronophthisis 11,613550];	RCV000082681.9 [other]; RCV000310098.1 [benign]; RCV000364741.1 [benign]; RCV000397297.1 [benign]; 			1108	1427	2	[2] auto-classification 15.09.2017  			TMEM67 (inh=AR pLI=0.00)
chr8	94808165	94808165	A	G	het	pred_pathogenic;anno_omim	QUAL=4452;DP=220;AF=0.45;MQM=60;TRIO=HET,220,0.45,HOM,58,1.00,WT,93,0.00	TMEM67	missense	TMEM67:ENST00000453321:missense:MODERATE:exon18/28:c.1810A>G:p.Ile604Val,TMEM67:ENST00000409623:missense:MODERATE:exon19/29:c.1567A>G:p.Ile523Val		rs3134031	0.6929	0.6369	25016,12052,2777	0.7283,0.7448,0.7419,0.5993,0.6254	0.6453	0.3570	T,T	T	B,B	D,D	1.81	609884 [TMEM67 (confirmed) Meckel syndrome 3,607361|Joubert syndrome 6,610688|Bardet-Biedl syndrome 14,modifier of,615991|COACH syndrome,216360|Nephronophthisis 11,613550];	RCV000114244.3 [other]; RCV000278248.1 [benign]; RCV000323495.1 [benign]; RCV000378100.1 [benign]; 		COSM3763454, COSM3763455, COSM3763456	1188	1563	2	[2] auto-classification 15.09.2017  			TMEM67 (inh=AR pLI=0.00)
chr8	94929079	94929079	T	A	hom	low_DP;anno_omim	QUAL=364;DP=3;AF=1.00;MQM=60;TRIO=HOM,3,1.00,HOM,7,1.00,HET,11,0.55	PDP1				rs4469422	0.4966	0.0000	0,0,0	0,0,0,0,0	0.4263							605993 [PDP1 (provisional) Pyruvate dehydrogenase phosphatase deficiency,608782];	RCV000367981.1 [benign]; 			45	74					PDP1 (inh=AR pLI=0.34)
chr8	94935937	94935937	T	C	het	anno_omim	QUAL=16765;DP=558;AF=0.45;MQM=60;TRIO=HET,558,0.45,HOM,203,1.00,HET,280,0.48	PDP1	3'UTR	PDP1:ENST00000396200:3'UTR:MODIFIER:exon3/3:c.*36T>C:,PDP1:ENST00000297598:3'UTR:MODIFIER:exon2/2:c.*36T>C:,PDP1:ENST00000520728:3'UTR:MODIFIER:exon3/3:c.*36T>C:,PDP1:ENST00000517764:3'UTR:MODIFIER:exon2/2:c.*36T>C:		rs4735258	0.4952	0.4676	13945,5556,805	0.4077,0.6913,0.6826,0.4084,0.4890	0.4751							605993 [PDP1 (provisional) Pyruvate dehydrogenase phosphatase deficiency,608782];	RCV000291077.1 [benign]; 			382	873					PDP1 (inh=AR pLI=0.34)
chr8	94936532	94936532	G	C	het	anno_omim	QUAL=10112;DP=301;AF=0.52;MQM=60;TRIO=HET,301,0.52,HOM,110,1.00,HET,167,0.49	PDP1	3'UTR	PDP1:ENST00000396200:3'UTR:MODIFIER:exon3/3:c.*631G>C:,PDP1:ENST00000297598:3'UTR:MODIFIER:exon2/2:c.*631G>C:,PDP1:ENST00000520728:3'UTR:MODIFIER:exon3/3:c.*631G>C:		rs911	0.5939	0.0000	0,0,0	0,0,0,0,0	0.5116							605993 [PDP1 (provisional) Pyruvate dehydrogenase phosphatase deficiency,608782];	RCV000367070.1 [benign]; 			41	110					PDP1 (inh=AR pLI=0.34)
chr8	96047806	96047806	-	A	hom	anno_omim	QUAL=2743;DP=91;AF=0.79;MQM=59;TRIO=HOM,91,0.79,HET,36,0.81,HOM,34,0.88	NDUFAF6	splice_region&intron	NDUFAF6:ENST00000396124:splice_region&intron:LOW:exon3/8:c.420+15dupA:,NDUFAF6:ENST00000396113:splice_region&intron:LOW:exon9/14:c.144+15dupA:,NDUFAF6:ENST00000396111:splice_region&intron:LOW:exon4/9:c.144+15dupA:,NDUFAF6:ENST00000542894:splice_region&intron:LOW:exon3/8:c.264+15dupA:,NDUFAF6:ENST00000286687:splice_region&intron:LOW:exon3/9:c.-161+15dupA:		rs34960210;rs397749867	0.6376	0.5179	1933,1128,159	0.5099,0.5152,0.5154,0.5199,0.5082	0.9150							612392 [NDUFAF6 (provisional) Leigh syndrome due to mitochondrial complex I deficiency,256000];				1149	901	1	[1] old entry - no details available			NDUFAF6 (inh=AR pLI=0.00)
chr8	96070181	96070181	T	C	hom	anno_omim	QUAL=8781;DP=96;AF=1.00;MQM=60;TRIO=HOM,96,1.00,HOM,83,1.00,HOM,95,1.00	NDUFAF6	3'UTR,intron	NDUFAF6:ENST00000396124:3'UTR:MODIFIER:exon9/9:c.*16T>C:,NDUFAF6:ENST00000396113:3'UTR:MODIFIER:exon15/15:c.*16T>C:,NDUFAF6:ENST00000396111:3'UTR:MODIFIER:exon10/10:c.*16T>C:,NDUFAF6:ENST00000286687:intron:MODIFIER:exon9/9:c.417+5723T>C:		rs2678832	0.9265	0.9433	49924,26745,3260	0.8462,0.9394,0.9998,0.9429,0.9866	0.9433							612392 [NDUFAF6 (provisional) Leigh syndrome due to mitochondrial complex I deficiency,256000];				1869	179					NDUFAF6 (inh=AR pLI=0.00)
chr8	97239126	97239126	T	C	hom	anno_omim	QUAL=10876;DP=237;AF=1.00;MQM=60;TRIO=HOM,237,1.00,HOM,61,1.00,HET,82,0.60	UQCRB	3'UTR	UQCRB:ENST00000287022:3'UTR:MODIFIER:exon4/4:c.*4157A>G:		rs7827095	0.5100	0.4778	1259,303,51	0.0000,0.0000,0.0000,0.4838,0.4737	0.5648							191330 [UQCRB (provisional) Mitochondrial complex III deficiency,nuclear type 3,615158];				154	263					UQCRB (inh=AR pLI=0.21)
chr8	97239613	97239613	A	C	hom	anno_omim	QUAL=16670;DP=181;AF=1.00;MQM=57;TRIO=HOM,181,1.00,HOM,232,1.00,HET,283,0.52	UQCRB	3'UTR	UQCRB:ENST00000287022:3'UTR:MODIFIER:exon4/4:c.*3670T>G:		rs2292836	0.3664	0.4170	981,298,21	0.0000,0.0000,0.0000,0.4755,0.3986	0.4696							191330 [UQCRB (provisional) Mitochondrial complex III deficiency,nuclear type 3,615158];				161	305					UQCRB (inh=AR pLI=0.21)
chr8	97240129	97240129	C	T	hom	anno_omim	QUAL=14559;DP=312;AF=0.99;MQM=51;TRIO=HOM,312,0.99,HOM,88,0.99,HET,124,0.58	UQCRB	3'UTR	UQCRB:ENST00000287022:3'UTR:MODIFIER:exon4/4:c.*3154G>A:		rs10504961	0.3664	0.4169	981,299,20	0.0000,0.0000,0.0000,0.4758,0.3986	0.4702							191330 [UQCRB (provisional) Mitochondrial complex III deficiency,nuclear type 3,615158];				162	308					UQCRB (inh=AR pLI=0.21)
chr8	97240847	97240847	A	G	hom	anno_omim	QUAL=27248;DP=346;AF=1.00;MQM=59;TRIO=HOM,346,1.00,HOM,303,1.00,HET,409,0.53	UQCRB	3'UTR	UQCRB:ENST00000287022:3'UTR:MODIFIER:exon4/4:c.*2436T>C:	MIR	rs13253635	0.3666	0.4174	982,299,21	0.0000,0.0000,0.0000,0.4762,0.3991	0.4709							191330 [UQCRB (provisional) Mitochondrial complex III deficiency,nuclear type 3,615158];				162	300					UQCRB (inh=AR pLI=0.21)
chr8	97242124	97242124	G	A	hom	anno_omim	QUAL=19159;DP=309;AF=1.00;MQM=59;TRIO=HOM,309,1.00,HOM,186,0.99,HET,229,0.53	UQCRB	3'UTR	UQCRB:ENST00000287022:3'UTR:MODIFIER:exon4/4:c.*1159C>T:		rs7002575	0.3658	0.4166	978,296,20	0.0000,0.0000,0.0000,0.4747,0.3986	0.4666							191330 [UQCRB (provisional) Mitochondrial complex III deficiency,nuclear type 3,615158];				162	304					UQCRB (inh=AR pLI=0.21)
chr8	97242134	97242135	CT	-	hom	anno_omim	QUAL=18731;DP=316;AF=1.00;MQM=59;TRIO=HOM,316,1.00,HOM,200,0.98,HET,247,0.53	UQCRB	3'UTR	UQCRB:ENST00000287022:3'UTR:MODIFIER:exon4/4:c.*1148_*1149delAG:		rs35954659	0.2330	0.3377	659,174,4	0.0000,0.0000,0.0000,0.3557,0.3385	0.3243							191330 [UQCRB (provisional) Mitochondrial complex III deficiency,nuclear type 3,615158];				107	294					UQCRB (inh=AR pLI=0.21)
chr8	97242849	97242849	C	T	hom	anno_omim	QUAL=13068;DP=245;AF=1.00;MQM=59;TRIO=HOM,245,1.00,HOM,88,1.00,HET,141,0.49	UQCRB	3'UTR	UQCRB:ENST00000287022:3'UTR:MODIFIER:exon4/4:c.*434G>A:		rs7836698	0.2336	0.3382	660,175,4	0.0000,0.0000,0.0000,0.3572,0.3385	0.3278							191330 [UQCRB (provisional) Mitochondrial complex III deficiency,nuclear type 3,615158];				107	295					UQCRB (inh=AR pLI=0.21)
chr8	97243720	97243720	G	A	hom	anno_omim	QUAL=18858;DP=284;AF=0.99;MQM=60;TRIO=HOM,284,0.99,HOM,175,1.00,HET,281,0.54	UQCRB	synonymous,intron	UQCRB:ENST00000518406:synonymous:LOW:exon4/5:c.282C>T:p.His94His,UQCRB:ENST00000523920:synonymous:LOW:exon4/4:c.282C>T:p.His94His,UQCRB:ENST00000287022:intron:MODIFIER:exon3/3:c.258+282C>T:,UQCRB:ENST00000517523:intron:MODIFIER:exon3/3:c.*21+40C>T:	MIR3	rs2292835	0.2334	0.3419	724,233,5	0.1806,0.0000,0.0000,0.3688,0.3399	0.3282							191330 [UQCRB (provisional) Mitochondrial complex III deficiency,nuclear type 3,615158];				290	942	2	[2] auto-classification 15.09.2017  			UQCRB (inh=AR pLI=0.21)
chr8	100133706	100133706	T	G	het	anno_high_impact;anno_omim	QUAL=19339;DP=360;AF=0.49;MQM=60;TRIO=HET,360,0.49,HOM,282,1.00,HET,369,0.53	VPS13B	stop_gained,intron	VPS13B:ENST00000441350:stop_gained:HIGH:exon8/8:c.1239T>G:p.Tyr413*,VPS13B:ENST00000358544:intron:MODIFIER:exon8/61:c.1206+33T>G:,VPS13B:ENST00000355155:intron:MODIFIER:exon8/17:c.1206+33T>G:,VPS13B:ENST00000395996:intron:MODIFIER:exon8/62:c.1206+33T>G:,VPS13B:ENST00000357162:intron:MODIFIER:exon8/61:c.1206+33T>G:		rs7460625	0.7051	0.7504	34863,21188,2427	0.6865,0.4938,0.5476,0.7980,0.8689	0.7491	0.0410					3.40	607817 [VPS13B (confirmed) Cohen syndrome,216550];	RCV000245799.1 [benign]; 			1407	616	1	[1] auto-classification 16.06.2016  [2] old entry - no details available			VPS13B (inh=AR pLI=0.00)
chr8	100844595	100844595	A	T	het	anno_high_impact;pred_pathogenic;anno_omim	QUAL=81;DP=103;AF=0.20;MQM=54;TRIO=HET,103,0.20,WT,85,0.01,HET,99,0.12	VPS13B	splice_acceptor	VPS13B:ENST00000358544:splice_acceptor:HIGH:exon51/61:c.9406-2A>T:,VPS13B:ENST00000395996:splice_acceptor:HIGH:exon52/62:c.*5189-2A>T:,VPS13B:ENST00000357162:splice_acceptor:HIGH:exon51/61:c.9331-2A>T:		rs74485751	0.3738	0.0828	0,0,0	0.0388,0.0000,0.0000,0.0630,0.1425	0.1026	6.2810					23.60	607817 [VPS13B (confirmed) Cohen syndrome,216550];				7	13	2	[2] kehrer 22.04.2016 H?ufigkeit			VPS13B (inh=AR pLI=0.00)
chr8	100844758	100844758	T	C	het	anno_omim	QUAL=9409;DP=344;AF=0.51;MQM=60;TRIO=HET,344,0.51,WT,287,0.00,HET,385,0.49	VPS13B	synonymous,3'UTR	VPS13B:ENST00000358544:synonymous:LOW:exon52/62:c.9567T>C:p.Ser3189Ser,VPS13B:ENST00000357162:synonymous:LOW:exon52/62:c.9492T>C:p.Ser3164Ser,VPS13B:ENST00000395996:3'UTR:MODIFIER:exon53/63:c.*5350T>C:		rs36074608	0.1971	0.1926	2869,959,32	0.0758,0.4054,0.3477,0.1655,0.1536	0.2050							607817 [VPS13B (confirmed) Cohen syndrome,216550];	RCV000081923.9 [other]; RCV000366445.1 [benign]; 		COSM3982312, COSM3982313	62	580	2	[2] auto-classification 15.09.2017  			VPS13B (inh=AR pLI=0.00)
chr8	100888323	100888325	TAT	-	hom	anno_omim	QUAL=10226;DP=213;AF=1.00;MQM=59;TRIO=HOM,213,1.00,HET,135,0.55,HET,142,0.61	VPS13B,COX6C	3'UTR	VPS13B:ENST00000358544:3'UTR:MODIFIER:exon62/62:c.*434_*436delTTA:,VPS13B:ENST00000395996:3'UTR:MODIFIER:exon63/63:c.*8286_*8288delTTA:,VPS13B:ENST00000357162:3'UTR:MODIFIER:exon62/62:c.*434_*436delTTA:		rs10542428	0.5519	0.0000	0,0,0	0,0,0,0,0	0.4975							607817 [VPS13B (confirmed) Cohen syndrome,216550];	RCV000301501.1 [benign]; 			39	123					VPS13B (inh=AR pLI=0.00), COX6C (inh=n/a pLI=0.23)
chr8	103218466	103218466	-	A	het	anno_omim	QUAL=2979;DP=165;AF=0.45;MQM=59;TRIO=HET,165,0.45,WT,83,0.00,HET,124,0.48	RRM2B	3'UTR	RRM2B:ENST00000251810:3'UTR:MODIFIER:exon9/9:c.*1894dupT:		rs150629554	0.0853	0.0000	0,0,0	0,0,0,0,0	0.1183							604712 [RRM2B (provisional) Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy),612075|Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal dominant 5,613077|Mitochondrial DNA depletion syndrome 8B (MNGIE type),612075];	RCV000339322.1 [benign]; RCV000407292.1 [benign]; 			5	41					RRM2B (inh=AR+AD pLI=0.16)
chr8	103218873	103218873	C	G	het	anno_omim	QUAL=5313;DP=292;AF=0.47;MQM=60;TRIO=HET,292,0.47,WT,127,0.00,HET,139,0.42	RRM2B	3'UTR	RRM2B:ENST00000251810:3'UTR:MODIFIER:exon9/9:c.*1488G>C:		rs1265116	0.0777	0.0000	0,0,0	0,0,0,0,0	0.0955							604712 [RRM2B (provisional) Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy),612075|Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal dominant 5,613077|Mitochondrial DNA depletion syndrome 8B (MNGIE type),612075];	RCV000261106.1 [benign]; RCV000316397.1 [benign]; 			3	32					RRM2B (inh=AR+AD pLI=0.16)
chr8	103220351	103220351	A	G	hom	anno_omim	QUAL=18458;DP=305;AF=1.00;MQM=60;TRIO=HOM,305,1.00,HOM,108,1.00,HOM,149,1.00	RRM2B	3'UTR	RRM2B:ENST00000251810:3'UTR:MODIFIER:exon9/9:c.*10T>C:		rs1265117	1.0000	0.9999	60515,33321,5108	0.9999,1.0000,0.9992,1.0000,0.9999	1.0000							604712 [RRM2B (provisional) Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy),612075|Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal dominant 5,613077|Mitochondrial DNA depletion syndrome 8B (MNGIE type),612075];				3363	1					RRM2B (inh=AR+AD pLI=0.16)
chr8	105440271	105440271	G	C	het	anno_omim	QUAL=4536;DP=230;AF=0.55;MQM=60;TRIO=HET,230,0.55,HET,68,0.65,WT,87,0.00	DPYS	synonymous	DPYS:ENST00000351513:synonymous:LOW:exon6/10:c.1029C>G:p.Thr343Thr		rs117104587	0.0046	0.0105	6,4,0	0.0024,0.0054,0.0001,0.0124,0.0194	0.0101							613326 [DPYS (provisional) Dihydropyrimidinuria,222748];	RCV000086522.1 [not provided]; RCV000400960.1 [uncertain significance]; 			0	39					DPYS (inh=AR pLI=0.00)
chr8	105479149	105479149	A	G	het	low_DP;anno_omim	QUAL=941;DP=6;AF=0.50;MQM=60;TRIO=HET,6,0.50,WT,37,0.00,HOM,35,1.00	DPYS	5'UTR	DPYS:ENST00000351513:5'UTR:MODIFIER:exon1/10:c.-1T>C:		rs2959023	0.6362	0.6384	1301,322,107	0.6706,0.0000,0.0000,0.6299,0.6328	0.6262							613326 [DPYS (provisional) Dihydropyrimidinuria,222748];	RCV000086534.1 [not provided]; RCV000260513.1 [benign]; 			780	913					DPYS (inh=AR pLI=0.00)
chr8	119936246	119936246	C	T	het	anno_omim	QUAL=4759;DP=300;AF=0.52;MQM=59;TRIO=HET,300,0.52,WT,55,0.00,HET,63,0.41	TNFRSF11B	3'UTR	TNFRSF11B:ENST00000297350:3'UTR:MODIFIER:exon5/5:c.*367G>A:		rs7815884	0.0887	0.0000	0,0,0	0,0,0,0,0	0.0827							602643 [TNFRSF11B (confirmed) Paget disease of bone 5,juvenile-onset,239000];	RCV000382499.1 [benign]; 			0	4					TNFRSF11B (inh=AR pLI=0.27)
chr8	119936330	119936330	-	T	het	anno_omim	QUAL=2112;DP=194;AF=0.38;MQM=59;TRIO=HET,194,0.38,WT,86,0.05,HET,111,0.39	TNFRSF11B	3'UTR	TNFRSF11B:ENST00000297350:3'UTR:MODIFIER:exon5/5:c.*282dupA:		rs112977670	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0254							602643 [TNFRSF11B (confirmed) Paget disease of bone 5,juvenile-onset,239000];				0	6					TNFRSF11B (inh=AR pLI=0.27)
chr8	119936669	119936669	A	G	het	anno_omim	QUAL=9350;DP=362;AF=0.51;MQM=59;TRIO=HET,362,0.51,WT,268,0.01,HET,380,0.45	TNFRSF11B	synonymous	TNFRSF11B:ENST00000297350:synonymous:LOW:exon5/5:c.1150T>C:p.Leu384Leu		rs1804854	0.0881	0.0261	451,0,450	0.2829,0.0128,0.0000,0.0009,0.0004	0.0823							602643 [TNFRSF11B (confirmed) Paget disease of bone 5,juvenile-onset,239000];	RCV000402907.1 [benign]; 			3	22	2	[2] auto-classification 15.09.2017  			TNFRSF11B (inh=AR pLI=0.27)
chr8	119941173	119941173	A	G	hom	anno_omim	QUAL=16709;DP=244;AF=1.00;MQM=60;TRIO=HOM,244,1.00,HET,182,0.44,HOM,222,1.00	TNFRSF11B	splice_region&intron	TNFRSF11B:ENST00000297350:splice_region&intron:LOW:exon2/4:c.401-5T>C:		rs3134046	0.9237	0.9339	52979,29951,4361	0.9163,0.8564,0.8667,0.9476,0.9671	0.9317							602643 [TNFRSF11B (confirmed) Paget disease of bone 5,juvenile-onset,239000];	RCV000177160.3 [benign]; RCV000299224.1 [benign]; 			1884	217	2	[2] auto-classification 15.09.2017  			TNFRSF11B (inh=AR pLI=0.27)
chr8	119964052	119964052	G	C	hom	anno_omim	QUAL=2850;DP=30;AF=1.00;MQM=60;TRIO=HOM,30,1.00,HOM,47,0.98,HET,79,0.42	TNFRSF11B	missense	TNFRSF11B:ENST00000297350:missense:MODERATE:exon1/5:c.9C>G:p.Asn3Lys		rs2073618	0.6667	0.6024	11044,4287,2280	0.8753,0.5297,0.7680,0.5453,0.5945	0.5971	0.6450	T	T	B	T	15.99	602643 [TNFRSF11B (confirmed) Paget disease of bone 5,juvenile-onset,239000];	RCV000250490.1 [benign]; RCV000291754.1 [benign]; 	CM045665 [CLASS=DP MUT=ALT PHEN="Osteoporotic fractures association with" GENE=TNFRSF11B]; 	COSM453917, COSM1488949	597	1027	2	[2] auto-classification 15.09.2017  			TNFRSF11B (inh=AR pLI=0.27)
chr8	119964283	119964283	G	A	hom	anno_omim	QUAL=2636;DP=56;AF=0.98;MQM=60;TRIO=HOM,56,0.98,HET,51,0.43,HET,68,0.44	TNFRSF11B	5'UTR	TNFRSF11B:ENST00000297350:5'UTR:MODIFIER:exon1/5:c.-223C>T:		rs2073617	0.6216	0.0000	0,0,0	0,0,0,0,0	0.5660							602643 [TNFRSF11B (confirmed) Paget disease of bone 5,juvenile-onset,239000];	RCV000404609.1 [benign]; 			60	116					TNFRSF11B (inh=AR pLI=0.27)
chr8	120803637	120803637	C	G	het	pred_pathogenic;anno_omim	QUAL=11597;DP=341;AF=0.43;MQM=60;TRIO=HET,341,0.43,HET,239,0.50,HET,294,0.56	TAF2	missense	TAF2:ENST00000378164:missense:MODERATE:exon11/26:c.1340G>C:p.Ser447Thr		rs9297605	0.6583	0.6851	28820,16734,3013	0.7600,0.6807,0.4566,0.7079,0.6647	0.6983	4.7700	T,.	T,T	B,.	T,.	13.85	604912 [TAF2 (provisional) Mental retardation,autosomal recessive 40,615599];			COSM3982377, COSM150523	1122	804	2	[2] auto-classification 15.09.2017  			TAF2 (inh=AR pLI=0.57)
chr8	133133361	133133361	C	T	het	anno_omim	QUAL=11887;DP=360;AF=0.47;MQM=60;TRIO=HET,360,0.47,HOM,146,0.99,HET,219,0.46	KCNQ3	3'UTR	KCNQ3:ENST00000388996:3'UTR:MODIFIER:exon15/15:c.*8148G>A:		rs1437822	0.1352	0.0000	0,0,0	0,0,0,0,0	0.2020							602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];	RCV000262306.1 [benign]; RCV000301153.1 [benign]; 			11	74					KCNQ3 (inh=AD pLI=0.99)
chr8	133134003	133134003	G	A	het	anno_omim	QUAL=2036;DP=77;AF=0.57;MQM=60;TRIO=HET,77,0.57,WT,48,0.00,HET,66,0.58	KCNQ3	3'UTR	KCNQ3:ENST00000388996:3'UTR:MODIFIER:exon15/15:c.*7506C>T:		rs11785257	0.1222	0.0000	0,0,0	0,0,0,0,0	0.1600							602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];	RCV000340625.1 [benign]; RCV000378860.1 [benign]; 			2	55					KCNQ3 (inh=AD pLI=0.99)
chr8	133134288	133134288	G	A	het	anno_omim	QUAL=15554;DP=285;AF=0.44;MQM=60;TRIO=HET,285,0.44,HOM,266,1.00,HET,343,0.46	KCNQ3	3'UTR	KCNQ3:ENST00000388996:3'UTR:MODIFIER:exon15/15:c.*7221C>T:		rs2436124	0.1352	0.0000	0,0,0	0,0,0,0,0	0.2018							602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];	RCV000329099.1 [benign]; RCV000358302.1 [benign]; 			11	74					KCNQ3 (inh=AD pLI=0.99)
chr8	133134366	133134366	T	C	het	anno_omim	QUAL=13891;DP=397;AF=0.46;MQM=60;TRIO=HET,397,0.46,HOM,192,1.00,HET,266,0.44	KCNQ3	3'UTR	KCNQ3:ENST00000388996:3'UTR:MODIFIER:exon15/15:c.*7143A>G:	MIRb	rs2436125	0.1352	0.0000	0,0,0	0,0,0,0,0	0.2015							602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];	RCV000279047.1 [benign]; RCV000380491.1 [benign]; 			11	74					KCNQ3 (inh=AD pLI=0.99)
chr8	133134390	133134390	G	A	het	anno_omim	QUAL=14876;DP=386;AF=0.46;MQM=60;TRIO=HET,386,0.46,HOM,209,1.00,HET,301,0.44	KCNQ3	3'UTR	KCNQ3:ENST00000388996:3'UTR:MODIFIER:exon15/15:c.*7119C>T:	MIRb	rs2436126	0.1352	0.0000	0,0,0	0,0,0,0,0	0.2014							602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];	RCV000282775.1 [benign]; RCV000347079.1 [benign]; 			11	74					KCNQ3 (inh=AD pLI=0.99)
chr8	133134434	133134434	T	C	het	anno_omim	QUAL=15946;DP=423;AF=0.48;MQM=60;TRIO=HET,423,0.48,HOM,226,1.00,HET,323,0.44	KCNQ3	3'UTR	KCNQ3:ENST00000388996:3'UTR:MODIFIER:exon15/15:c.*7075A>G:	MIRb	rs2436127	0.1348	0.0000	0,0,0	0,0,0,0,0	0.2004							602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];	RCV000352720.1 [benign]; RCV000405641.1 [benign]; 			11	73					KCNQ3 (inh=AD pLI=0.99)
chr8	133134476	133134476	A	G	het	anno_omim	QUAL=18323;DP=520;AF=0.45;MQM=60;TRIO=HET,520,0.45,HOM,239,1.00,HET,365,0.48	KCNQ3	3'UTR	KCNQ3:ENST00000388996:3'UTR:MODIFIER:exon15/15:c.*7033T>C:	MIRb	rs2436128	0.1348	0.0000	0,0,0	0,0,0,0,0	0.2003							602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];	RCV000313012.1 [benign]; RCV000367650.1 [benign]; 			11	74					KCNQ3 (inh=AD pLI=0.99)
chr8	133134553	133134553	T	C	het	anno_omim	QUAL=14369;DP=373;AF=0.45;MQM=60;TRIO=HET,373,0.45,HOM,202,1.00,HET,319,0.47	KCNQ3	3'UTR	KCNQ3:ENST00000388996:3'UTR:MODIFIER:exon15/15:c.*6956A>G:		rs2469630	0.1360	0.0000	0,0,0	0,0,0,0,0	0.2023							602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];	RCV000259863.1 [benign]; RCV000354805.1 [benign]; 			11	74					KCNQ3 (inh=AD pLI=0.99)
chr8	133134635	133134635	G	C	het	anno_omim	QUAL=12070;DP=378;AF=0.44;MQM=60;TRIO=HET,378,0.44,HOM,157,1.00,HET,217,0.46	KCNQ3	3'UTR	KCNQ3:ENST00000388996:3'UTR:MODIFIER:exon15/15:c.*6874C>G:	L4_C_Mam	rs2436129	0.1348	0.0000	0,0,0	0,0,0,0,0	0.2012							602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];	RCV000324405.1 [benign]; RCV000360374.1 [benign]; 			11	74					KCNQ3 (inh=AD pLI=0.99)
chr8	133135169	133135169	C	T	het	anno_omim	QUAL=10936;DP=308;AF=0.50;MQM=60;TRIO=HET,308,0.50,HOM,128,0.99,HET,185,0.51	KCNQ3	3'UTR	KCNQ3:ENST00000388996:3'UTR:MODIFIER:exon15/15:c.*6340G>A:		rs2469629	0.1392	0.0000	0,0,0	0,0,0,0,0	0.2049							602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];	RCV000264257.1 [benign]; RCV000359034.1 [benign]; 			11	74					KCNQ3 (inh=AD pLI=0.99)
chr8	133135577	133135577	T	G	het	anno_omim	QUAL=15381;DP=321;AF=0.51;MQM=59;TRIO=HET,321,0.51,HOM,245,1.00,HET,290,0.46	KCNQ3	3'UTR	KCNQ3:ENST00000388996:3'UTR:MODIFIER:exon15/15:c.*5932A>C:		rs2436130	0.1352	0.0000	0,0,0	0,0,0,0,0	0.2018							602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];	RCV000301653.1 [benign]; RCV000347178.1 [benign]; 			11	74					KCNQ3 (inh=AD pLI=0.99)
chr8	133135790	133135790	G	A	het	anno_omim	QUAL=7835;DP=314;AF=0.47;MQM=60;TRIO=HET,314,0.47,WT,207,0.01,HET,299,0.48	KCNQ3	3'UTR	KCNQ3:ENST00000388996:3'UTR:MODIFIER:exon15/15:c.*5719C>T:		rs11786417	0.1222	0.0000	0,0,0	0,0,0,0,0	0.1602							602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];	RCV000314411.1 [benign]; RCV000369033.1 [benign]; 			2	55					KCNQ3 (inh=AD pLI=0.99)
chr8	133136551	133136551	T	C	hom	anno_omim	QUAL=20848;DP=262;AF=1.00;MQM=59;TRIO=HOM,262,1.00,HOM,146,1.00,HOM,223,1.00	KCNQ3	3'UTR	KCNQ3:ENST00000388996:3'UTR:MODIFIER:exon15/15:c.*4958A>G:		rs1437824	0.7228	0.0000	0,0,0	0,0,0,0,0	0.8196							602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];	RCV000264487.1 [benign]; RCV000359207.1 [benign]; 			106	44					KCNQ3 (inh=AD pLI=0.99)
chr8	133136762	133136762	-	CTGT	hom	anno_omim	QUAL=22274;DP=190;AF=0.98;MQM=59;TRIO=HOM,190,0.98,HOM,218,1.00,HOM,303,0.99	KCNQ3	3'UTR	KCNQ3:ENST00000388996:3'UTR:MODIFIER:exon15/15:c.*4746_*4747insACAG:		rs112550767	0.2863	0.0000	0,0,0	0,0,0,0,0	0.4158							602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];	RCV000295226.1 [benign]; RCV000389474.1 [benign]; 			44	75					KCNQ3 (inh=AD pLI=0.99)
chr8	133137266	133137266	T	A	hom	anno_omim	QUAL=26613;DP=381;AF=0.99;MQM=60;TRIO=HOM,381,0.99,HOM,205,1.00,HOM,221,1.00	KCNQ3	3'UTR	KCNQ3:ENST00000388996:3'UTR:MODIFIER:exon15/15:c.*4243A>T:		rs2436131	0.2863	0.0000	0,0,0	0,0,0,0,0	0.4196							602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];	RCV000269907.1 [benign]; RCV000362145.1 [benign]; 			44	75					KCNQ3 (inh=AD pLI=0.99)
chr8	133137532	133137532	C	T	hom	anno_omim	QUAL=16213;DP=288;AF=0.99;MQM=59;TRIO=HOM,288,0.99,HOM,92,1.00,HOM,119,1.00	KCNQ3	3'UTR	KCNQ3:ENST00000388996:3'UTR:MODIFIER:exon15/15:c.*3977G>A:		rs2469628	0.3109	0.0000	0,0,0	0,0,0,0,0	0.4418							602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];	RCV000286936.1 [benign]; RCV000339629.1 [benign]; 			44	75					KCNQ3 (inh=AD pLI=0.99)
chr8	133137912	133137912	C	T	hom	anno_omim	QUAL=15931;DP=303;AF=1.00;MQM=60;TRIO=HOM,303,1.00,HOM,77,1.00,HOM,87,1.00	KCNQ3	3'UTR	KCNQ3:ENST00000388996:3'UTR:MODIFIER:exon15/15:c.*3597G>A:		rs1025436	0.7208	0.0000	0,0,0	0,0,0,0,0	0.8189							602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];	RCV000340577.1 [benign]; RCV000383538.1 [benign]; 			104	46					KCNQ3 (inh=AD pLI=0.99)
chr8	133138474	133138474	T	C	het	anno_omim	QUAL=16747;DP=243;AF=0.48;MQM=60;TRIO=HET,243,0.99,HOM,136,1.00,HET,179,0.99	KCNQ3	3'UTR	KCNQ3:ENST00000388996:3'UTR:MODIFIER:exon15/15:c.*3035A>G:		rs2469627	0.1432	0.0000	0,0,0	0,0,0,0,0	0.2168							602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];	RCV000332027.1 [benign]; RCV000388882.1 [benign]; 			14	74					KCNQ3 (inh=AD pLI=0.99)
chr8	133138477	133138477	T	C	hom	anno_omim	QUAL=16747;DP=243;AF=0.48;MQM=60;TRIO=HOM,243,0.99,HOM,136,1.00,HOM,179,0.99	KCNQ3	3'UTR	KCNQ3:ENST00000388996:3'UTR:MODIFIER:exon15/15:c.*3032A>G:		rs2469626	0.2931	0.0000	0,0,0	0,0,0,0,0	0.4335							602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];	RCV000293171.1 [benign]; RCV000350482.1 [benign]; 			48	73					KCNQ3 (inh=AD pLI=0.99)
chr8	133139755	133139755	G	A	hom	anno_omim	QUAL=43706;DP=579;AF=0.99;MQM=60;TRIO=HOM,579,0.99,HOM,344,0.99,HOM,419,1.00	KCNQ3	3'UTR	KCNQ3:ENST00000388996:3'UTR:MODIFIER:exon15/15:c.*1754C>T:		rs977939	0.2686	0.0000	0,0,0	0,0,0,0,0	0.3810							602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];	RCV000340516.1 [benign]; RCV000391929.1 [benign]; 			41	79					KCNQ3 (inh=AD pLI=0.99)
chr8	133140755	133140760	TGTGTG	-	hom	anno_omim	QUAL=3782;DP=104;AF=0.56;MQM=59;TRIO=HOM,104,0.56,WT,58,0.47,HOM,115,0.54	KCNQ3	3'UTR	KCNQ3:ENST00000388996:3'UTR:MODIFIER:exon15/15:c.*749_*754delCACACA:	(TG)n	rs201964249	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1561							602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];				46	0					KCNQ3 (inh=AD pLI=0.99)
chr8	133883671	133883671	C	T	het	gene_blacklist;pred_pathogenic;anno_omim	QUAL=10247;DP=332;AF=0.43;MQM=59;TRIO=HET,332,0.43,WT,320,0.00,HET,514,0.52	TG	missense	TG:ENST00000220616:missense:MODERATE:exon4/48:c.353C>T:p.Pro118Leu,TG:ENST00000377869:missense:MODERATE:exon4/47:c.353C>T:p.Pro118Leu		rs114322847	0.0058	0.0147	19,15,0	0.0044,0.0060,0.0000,0.0221,0.0039	0.0147	5.2540	T,T,.	D	D	D,D	24.50	188450 [TG (confirmed) Thyroid dyshormonogenesis 3,274700|Autoimmune thyroid disease,susceptibility to,3,608175];				1	69					TG (inh=AR pLI=0.00)
chr8	133900252	133900252	T	G	het	gene_blacklist;pred_pathogenic;anno_omim	QUAL=1826;DP=103;AF=0.45;MQM=59;TRIO=HET,103,0.45,HET,71,0.55,WT,70,0.00	TG	missense	TG:ENST00000220616:missense:MODERATE:exon10/48:c.2200T>G:p.Ser734Ala,TG:ENST00000377869:missense:MODERATE:exon10/47:c.2200T>G:p.Ser734Ala		rs180223	0.6763	0.5870	20870,9287,2702	0.7285,0.5441,0.7609,0.5328,0.6525	0.5960	6.0760	T,T,.	T	B	T,T	6.49	188450 [TG (confirmed) Thyroid dyshormonogenesis 3,274700|Autoimmune thyroid disease,susceptibility to,3,608175];	RCV000013534.3 [other]; RCV000253912.1 [benign]; RCV000309189.1 [likely benign]; 		COSM4162675	686	1028	2	[2] auto-classification 15.09.2017  			TG (inh=AR pLI=0.00)
chr8	133900386	133900386	T	C	het	gene_blacklist;anno_omim	QUAL=6312;DP=283;AF=0.56;MQM=59;TRIO=HET,283,0.56,HET,209,0.46,WT,285,0.00	TG	synonymous	TG:ENST00000220616:synonymous:LOW:exon10/48:c.2334T>C:p.Pro778Pro,TG:ENST00000377869:synonymous:LOW:exon10/47:c.2334T>C:p.Pro778Pro		rs2069550	0.6727	0.5829	20815,9308,2601	0.7134,0.5390,0.7609,0.5295,0.6529	0.5914							188450 [TG (confirmed) Thyroid dyshormonogenesis 3,274700|Autoimmune thyroid disease,susceptibility to,3,608175];	RCV000246346.1 [benign]; RCV000331886.1 [likely benign]; 			687	1030	2	[2] auto-classification 15.09.2017  			TG (inh=AR pLI=0.00)
chr8	133909974	133909974	A	G	het	gene_blacklist;anno_omim	QUAL=8746;DP=436;AF=0.50;MQM=59;TRIO=HET,436,0.50,HET,247,0.50,WT,343,0.01	TG	missense	TG:ENST00000220616:missense:MODERATE:exon12/48:c.3082A>G:p.Met1028Val,TG:ENST00000377869:missense:MODERATE:exon12/47:c.3082A>G:p.Met1028Val		rs853326	0.6749	0.5842	21191,9469,2712	0.7247,0.5410,0.7598,0.5304,0.6500	0.5956	-0.4530	T,T	T	B	T,T	0.01	188450 [TG (confirmed) Thyroid dyshormonogenesis 3,274700|Autoimmune thyroid disease,susceptibility to,3,608175];	RCV000013535.3 [other]; RCV000254213.1 [benign]; RCV000368266.1 [likely benign]; 		COSM4162676	690	1029	2	[2] auto-classification 15.09.2017  			TG (inh=AR pLI=0.00)
chr8	133920518	133920518	A	G	hom	gene_blacklist;pred_pathogenic;anno_omim	QUAL=15198;DP=232;AF=1.00;MQM=59;TRIO=HOM,232,1.00,HOM,161,1.00,HET,199,0.50	TG	missense	TG:ENST00000220616:missense:MODERATE:exon18/48:c.3935A>G:p.Asp1312Gly,TG:ENST00000377869:missense:MODERATE:exon18/47:c.3935A>G:p.Asp1312Gly		rs2069556	0.3988	0.5697	21204,13133,123	0.1405,0.6989,0.3684,0.6263,0.5739	0.5801	4.2890	T,T,T	T	B	T,T	0.75	188450 [TG (confirmed) Thyroid dyshormonogenesis 3,274700|Autoimmune thyroid disease,susceptibility to,3,608175];	RCV000241944.1 [benign]; RCV000280505.1 [likely benign]; 		COSM1454960	789	962	2	[2] auto-classification 15.09.2017  			TG (inh=AR pLI=0.00)
chr8	133931748	133931748	T	C	hom	gene_blacklist;anno_omim	QUAL=18648;DP=358;AF=0.99;MQM=60;TRIO=HOM,358,0.99,HOM,154,0.99,HET,218,0.49	TG	synonymous,5'UTR	TG:ENST00000220616:synonymous:LOW:exon21/48:c.4506T>C:p.Ala1502Ala,TG:ENST00000377869:synonymous:LOW:exon21/47:c.4506T>C:p.Ala1502Ala,TG:ENST00000542445:5'UTR:MODIFIER:exon1/27:c.-193T>C:		rs853304	0.4738	0.5915	21933,13093,804	0.3934,0.7111,0.3658,0.6252,0.5741	0.5966	-0.6180		T			0.02	188450 [TG (confirmed) Thyroid dyshormonogenesis 3,274700|Autoimmune thyroid disease,susceptibility to,3,608175];	RCV000244917.1 [benign]; RCV000267031.1 [likely benign]; 		COSM150549	791	956	2	[2] auto-classification 15.09.2017  			TG (inh=AR pLI=0.00)
chr8	133975283	133975283	G	A	hom	gene_blacklist;pred_pathogenic;anno_omim	QUAL=14137;DP=222;AF=1.00;MQM=60;TRIO=HOM,222,1.00,HOM,139,1.00,HET,202,0.52	TG	missense	TG:ENST00000220616:missense:MODERATE:exon29/48:c.5512G>A:p.Asp1838Asn,TG:ENST00000377869:missense:MODERATE:exon28/47:c.5341G>A:p.Asp1781Asn,TG:ENST00000542445:missense:MODERATE:exon8/27:c.622G>A:p.Asp208Asn		rs2069561	0.3468	0.4846	15551,9018,67	0.0964,0.6612,0.3604,0.5178,0.5016	0.4973	0.5280	T,T,D,T,.	T,T	B,B,.	T,T,T,.	3.74	188450 [TG (confirmed) Thyroid dyshormonogenesis 3,274700|Autoimmune thyroid disease,susceptibility to,3,608175];	RCV000242253.1 [benign]; RCV000305066.1 [likely benign]; 		COSM150550	552	991	2	[2] auto-classification 15.09.2017  			TG (inh=AR pLI=0.00)
chr8	133984058	133984058	C	T	het	gene_blacklist;anno_omim	QUAL=8440;DP=310;AF=0.49;MQM=59;TRIO=HET,310,0.49,WT,294,0.00,HET,322,0.55	TG	missense	TG:ENST00000220616:missense:MODERATE:exon33/48:c.5995C>T:p.Arg1999Trp,TG:ENST00000377869:missense:MODERATE:exon32/47:c.5824C>T:p.Arg1942Trp,TG:ENST00000542445:missense:MODERATE:exon12/27:c.1105C>T:p.Arg369Trp,TG:ENST00000519543:missense:MODERATE:exon5/19:c.457C>T:p.Arg153Trp		rs2076740	0.3325	0.3226	6808,4063,1350	0.5075,0.1904,0.1707,0.3481,0.2745	0.3689	0.0500	T,T,T,T,T,.	T,T	B,B,B,.	T,T,T,T,.	17.87	188450 [TG (confirmed) Thyroid dyshormonogenesis 3,274700|Autoimmune thyroid disease,susceptibility to,3,608175];	RCV000013533.3 [other]; RCV000251808.1 [benign]; RCV000277644.1 [likely benign]; 	CM035973 [CLASS=DP MUT=ALT PHEN="Autoimmune thyroid disease association with" GENE=TG]; 	COSM3982409	269	946	2	[2] auto-classification 15.09.2017  			TG (inh=AR pLI=0.00)
chr8	134250165	134250165	A	G	het	anno_omim	QUAL=4828;DP=215;AF=0.47;MQM=59;TRIO=HET,215,0.47,HET,175,0.53,WT,236,0.00	NDRG1	3'UTR	NDRG1:ENST00000323851:3'UTR:MODIFIER:exon16/16:c.*956T>C:,NDRG1:ENST00000354944:3'UTR:MODIFIER:exon15/15:c.*956T>C:,NDRG1:ENST00000537882:3'UTR:MODIFIER:exon15/15:c.*956T>C:,NDRG1:ENST00000414097:3'UTR:MODIFIER:exon16/16:c.*956T>C:		rs1049697	0.8303	0.0000	0,0,0	0,0,0,0,0	0.8141							605262 [NDRG1 (provisional) Charcot-Marie-Tooth disease,type 4D,601455];	RCV000270893.1 [benign]; 			147	76					NDRG1 (inh=AR pLI=0.05)
chr8	134250430	134250430	C	T	het	anno_omim	QUAL=7645;DP=342;AF=0.51;MQM=59;TRIO=HET,342,0.51,HET,256,0.49,WT,366,0.00	NDRG1	3'UTR	NDRG1:ENST00000323851:3'UTR:MODIFIER:exon16/16:c.*691G>A:,NDRG1:ENST00000354944:3'UTR:MODIFIER:exon15/15:c.*691G>A:,NDRG1:ENST00000537882:3'UTR:MODIFIER:exon15/15:c.*691G>A:,NDRG1:ENST00000414097:3'UTR:MODIFIER:exon16/16:c.*691G>A:		rs1049694	0.2718	0.0000	0,0,0	0,0,0,0,0	0.3057							605262 [NDRG1 (provisional) Charcot-Marie-Tooth disease,type 4D,601455];	RCV000320327.1 [benign]; 			24	99					NDRG1 (inh=AR pLI=0.05)
chr8	134292516	134292516	A	G	hom	anno_omim	QUAL=23790;DP=298;AF=1.00;MQM=59;TRIO=HOM,298,1.00,HET,246,0.56,HOM,328,0.99	NDRG1	splice_region&intron,intron	NDRG1:ENST00000323851:splice_region&intron:LOW:exon2/15:c.64-6T>C:,NDRG1:ENST00000354944:splice_region&intron:LOW:exon2/14:c.64-6T>C:,NDRG1:ENST00000537882:splice_region&intron:LOW:exon2/14:c.-74-6T>C:,NDRG1:ENST00000414097:splice_region&intron:LOW:exon2/15:c.64-6T>C:,NDRG1:ENST00000518176:intron:MODIFIER:exon2/5:c.48+3991T>C:,NDRG1:ENST00000522476:intron:MODIFIER:exon1/13:c.-99-15621T>C:,NDRG1:ENST00000518066:intron:MODIFIER:exon2/3:c.36+4003T>C:		rs2272653	0.6134	0.5635	20102,11176,3883	0.8662,0.4619,0.4642,0.5779,0.4342	0.6519							605262 [NDRG1 (provisional) Charcot-Marie-Tooth disease,type 4D,601455];	RCV000254177.1 [benign]; RCV000380925.1 [benign]; 			694	1007	2	[2] auto-classification 15.09.2017  			NDRG1 (inh=AR pLI=0.05)
chr8	134309134	134309134	G	A	het	anno_omim	QUAL=1462;DP=59;AF=0.53;MQM=60;TRIO=HET,59,0.53,HET,62,0.60,WT,98,0.00	NDRG1	5'UTR,intron	NDRG1:ENST00000414097:5'UTR:MODIFIER:exon1/16:c.-173C>T:,NDRG1:ENST00000323851:intron:MODIFIER:exon1/15:c.-19+243C>T:,NDRG1:ENST00000354944:intron:MODIFIER:exon1/14:c.-19+243C>T:,NDRG1:ENST00000537882:intron:MODIFIER:exon1/14:c.-156+243C>T:,NDRG1:ENST00000518176:intron:MODIFIER:exon1/5:c.-19+243C>T:,NDRG1:ENST00000522476:intron:MODIFIER:exon1/13:c.-100+243C>T:,NDRG1:ENST00000518066:intron:MODIFIER:exon1/3:c.-19+243C>T:		rs10108354	0.0847	0.0000	0,0,0	0,0,0,0,0	0.1045							605262 [NDRG1 (provisional) Charcot-Marie-Tooth disease,type 4D,601455];				6	45					NDRG1 (inh=AR pLI=0.05)
chr8	140624798	140624798	-	G	hom	anno_omim	QUAL=27195;DP=228;AF=0.99;MQM=59;TRIO=HOM,228,0.99,HOM,283,1.00,HOM,363,1.00	KCNK9				rs386414214	1.0000	0.0000	0,0,0	0,0,0,0,0	1.0000							605874 [KCNK9 (confirmed) Birk-Barel mental retardation dysmorphism syndrome,612292];	RCV000285741.1 [benign]; 			232	0					KCNK9 (inh=AD pLI=0.13)
chr8	140743200	140743200	G	A	hom	anno_omim	QUAL=6554;DP=91;AF=1.00;MQM=59;TRIO=HOM,91,1.00,HET,132,0.55,HET,174,0.60	TRAPPC9	3'UTR	TRAPPC9:ENST00000389328:3'UTR:MODIFIER:exon23/23:c.*104C>T:,TRAPPC9:ENST00000389327:3'UTR:MODIFIER:exon22/22:c.*104C>T:,TRAPPC9:ENST00000438773:3'UTR:MODIFIER:exon23/23:c.*104C>T:	GA-rich	rs199226	0.2007	0.0000	0,0,0	0,0,0,0,0	0.1876							611966 [TRAPPC9 (provisional) Mental retardation,autosomal recessive 13,613192];	RCV000327095.1 [benign]; 			5	62					TRAPPC9 (inh=AR pLI=0.00)
chr8	141310644	141310644	G	A	het	anno_omim	QUAL=10928;DP=364;AF=0.48;MQM=60;TRIO=HET,364,0.48,HET,540,0.47,WT,677,0.00	TRAPPC9	synonymous	TRAPPC9:ENST00000389328:synonymous:LOW:exon11/23:c.1986C>T:p.Asn662Asn,TRAPPC9:ENST00000389327:synonymous:LOW:exon10/22:c.1665C>T:p.Asn555Asn,TRAPPC9:ENST00000438773:synonymous:LOW:exon11/23:c.1692C>T:p.Asn564Asn		rs12549048	0.3558	0.2676	5520,1066,285	0.2371,0.4178,0.6341,0.1759,0.3656	0.2750	0.2020		T			12.89	611966 [TRAPPC9 (provisional) Mental retardation,autosomal recessive 13,613192];	RCV000118668.3 [other]; RCV000319877.1 [benign]; 			100	640	2	[2] auto-classification 15.09.2017  			TRAPPC9 (inh=AR pLI=0.00)
chr8	141445350	141445370	AGAAAACAAAAAACAAAAACC	-	het	anno_omim	QUAL=10485;DP=184;AF=0.98;MQM=59;TRIO=HET,184,0.98,HET,168,0.97,HET,185,0.97	TRAPPC9	splice_region&intron	TRAPPC9:ENST00000389328:splice_region&intron:LOW:exon3/22:c.1025-31_1025-11delGGTTTTTGTTTTTTGTTTTCT:,TRAPPC9:ENST00000389327:splice_region&intron:LOW:exon3/21:c.731-31_731-11delGGTTTTTGTTTTTTGTTTTCT:,TRAPPC9:ENST00000438773:splice_region&intron:LOW:exon3/22:c.731-31_731-11delGGTTTTTGTTTTTTGTTTTCT:	(AAAACAA)n	rs11267571	0.7768	0.7333	27026,12824,1535	0.6021,0.7582,0.9920,0.6827,0.8626	0.7542							611966 [TRAPPC9 (provisional) Mental retardation,autosomal recessive 13,613192];				57	1846	2	[2] auto-classification 15.09.2017  			TRAPPC9 (inh=AR pLI=0.00)
chr8	141461062	141461062	G	A	het	anno_omim	QUAL=16667;DP=332;AF=0.46;MQM=60;TRIO=HET,332,0.46,HET,241,0.55,HOM,303,1.00	TRAPPC9	synonymous	TRAPPC9:ENST00000389328:synonymous:LOW:exon2/23:c.705C>T:p.Asn235Asn,TRAPPC9:ENST00000389327:synonymous:LOW:exon2/22:c.411C>T:p.Asn137Asn,TRAPPC9:ENST00000438773:synonymous:LOW:exon2/23:c.411C>T:p.Asn137Asn		rs3735803	0.4667	0.4680	13536,7670,893	0.4133,0.3118,0.5265,0.4788,0.5063	0.4762							611966 [TRAPPC9 (provisional) Mental retardation,autosomal recessive 13,613192];	RCV000118685.3 [other]; RCV000334004.1 [benign]; 			473	1037	2	[2] auto-classification 15.09.2017  			TRAPPC9 (inh=AR pLI=0.00)
chr8	141461185	141461185	A	G	het	anno_omim	QUAL=13227;DP=182;AF=0.48;MQM=60;TRIO=HET,182,0.48,HET,217,0.47,HOM,271,0.99	TRAPPC9	synonymous	TRAPPC9:ENST00000389328:synonymous:LOW:exon2/23:c.582T>C:p.Phe194Phe,TRAPPC9:ENST00000389327:synonymous:LOW:exon2/22:c.288T>C:p.Phe96Phe,TRAPPC9:ENST00000438773:synonymous:LOW:exon2/23:c.288T>C:p.Phe96Phe		rs3735802	0.5389	0.5447	18260,10740,1545	0.5489,0.3568,0.5483,0.5674,0.5593	0.5661							611966 [TRAPPC9 (provisional) Mental retardation,autosomal recessive 13,613192];	RCV000118681.3 [other]; RCV000384914.1 [benign]; 			669	1012	2	[2] auto-classification 15.09.2017  			TRAPPC9 (inh=AR pLI=0.00)
chr8	141461266	141461266	A	G	het	anno_omim	QUAL=10353;DP=239;AF=0.44;MQM=59;TRIO=HET,239,0.44,HET,178,0.43,HOM,206,1.00	TRAPPC9	synonymous	TRAPPC9:ENST00000389328:synonymous:LOW:exon2/23:c.501T>C:p.Gly167Gly,TRAPPC9:ENST00000389327:synonymous:LOW:exon2/22:c.207T>C:p.Gly69Gly,TRAPPC9:ENST00000438773:synonymous:LOW:exon2/23:c.207T>C:p.Gly69Gly		rs3735801	0.5379	0.5439	18207,10738,1546	0.5491,0.3563,0.5479,0.5675,0.5545	0.5668							611966 [TRAPPC9 (provisional) Mental retardation,autosomal recessive 13,613192];	RCV000118680.3 [other]; RCV000322051.1 [benign]; 			671	1008	2	[2] auto-classification 15.09.2017  			TRAPPC9 (inh=AR pLI=0.00)
chr8	143953937	143953937	A	C	het	anno_omim	QUAL=12017;DP=429;AF=0.53;MQM=60;TRIO=HET,429,0.53,HET,193,0.47,HET,273,0.48	CYP11B1,GML			MLT1A0-int	rs4736312	0.6963	0.0000	0,0,0	0,0,0,0,0	0.6168							610613 [CYP11B1 (confirmed) Adrenal hyperplasia,congenital,due to 11-beta-hydroxylase deficiency,202010|Aldosteronism,glucocorticoid-remediable,103900];	RCV000265547.1 [benign]; RCV000364820.1 [benign]; 			70	72					CYP11B1 (inh=AR+AD pLI=0.00), GML (inh=n/a pLI=0.44)
chr8	143954223	143954223	C	A	het	anno_omim	QUAL=12749;DP=412;AF=0.53;MQM=60;TRIO=HET,412,0.53,HET,240,0.60,HET,270,0.47	CYP11B1,GML			MLT1A0	rs1134096	0.6961	0.0000	0,0,0	0,0,0,0,0	0.6169							610613 [CYP11B1 (confirmed) Adrenal hyperplasia,congenital,due to 11-beta-hydroxylase deficiency,202010|Aldosteronism,glucocorticoid-remediable,103900];	RCV000350010.1 [benign]; RCV000385918.1 [benign]; 			75	74					CYP11B1 (inh=AR+AD pLI=0.00), GML (inh=n/a pLI=0.44)
chr8	143954290	143954290	G	A	het	anno_omim	QUAL=14300;DP=443;AF=0.48;MQM=59;TRIO=HET,443,0.48,HET,307,0.56,HET,340,0.46	CYP11B1,GML			MLT1A0	rs1134095	0.6941	0.0000	0,0,0	0,0,0,0,0	0.6167							610613 [CYP11B1 (confirmed) Adrenal hyperplasia,congenital,due to 11-beta-hydroxylase deficiency,202010|Aldosteronism,glucocorticoid-remediable,103900];	RCV000347968.1 [benign]; RCV000400210.1 [benign]; 			75	76					CYP11B1 (inh=AR+AD pLI=0.00), GML (inh=n/a pLI=0.44)
chr8	143954747	143954747	T	C	het	anno_omim	QUAL=12770;DP=390;AF=0.51;MQM=59;TRIO=HET,390,0.51,HET,263,0.49,HET,308,0.52	CYP11B1,GML	3'UTR	CYP11B1:ENST00000292427:3'UTR:MODIFIER:exon9/9:c.*1042A>G:		rs7003319	0.6957	0.0000	0,0,0	0,0,0,0,0	0.6164							610613 [CYP11B1 (confirmed) Adrenal hyperplasia,congenital,due to 11-beta-hydroxylase deficiency,202010|Aldosteronism,glucocorticoid-remediable,103900];	RCV000343186.1 [benign]; RCV000401464.1 [benign]; 			96	105					CYP11B1 (inh=AR+AD pLI=0.00), GML (inh=n/a pLI=0.44)
chr8	143954769	143954769	G	A	het	anno_omim	QUAL=12168;DP=391;AF=0.47;MQM=57;TRIO=HET,391,0.47,HET,270,0.49,HET,316,0.52	CYP11B1,GML	3'UTR	CYP11B1:ENST00000292427:3'UTR:MODIFIER:exon9/9:c.*1020C>T:		rs5017238	0.6957	0.0000	0,0,0	0,0,0,0,0	0.6168							610613 [CYP11B1 (confirmed) Adrenal hyperplasia,congenital,due to 11-beta-hydroxylase deficiency,202010|Aldosteronism,glucocorticoid-remediable,103900];	RCV000297239.1 [benign]; RCV000356758.1 [benign]; 			96	105					CYP11B1 (inh=AR+AD pLI=0.00), GML (inh=n/a pLI=0.44)
chr8	143955051	143955051	C	T	het	anno_omim	QUAL=21317;DP=311;AF=0.44;MQM=59;TRIO=HET,311,0.44,HET,628,0.50,HET,781,0.50	CYP11B1,GML	3'UTR	CYP11B1:ENST00000292427:3'UTR:MODIFIER:exon9/9:c.*738G>A:		rs5304	0.6957	0.0000	0,0,0	0,0,0,0,0	0.6168							610613 [CYP11B1 (confirmed) Adrenal hyperplasia,congenital,due to 11-beta-hydroxylase deficiency,202010|Aldosteronism,glucocorticoid-remediable,103900];	RCV000284379.1 [benign]; RCV000383461.1 [benign]; 			96	107					CYP11B1 (inh=AR+AD pLI=0.00), GML (inh=n/a pLI=0.44)
chr8	143955095	143955095	A	G	het	anno_omim	QUAL=18874;DP=393;AF=0.45;MQM=59;TRIO=HET,393,0.45,HET,551,0.49,HET,672,0.48	CYP11B1,GML	3'UTR	CYP11B1:ENST00000292427:3'UTR:MODIFIER:exon9/9:c.*694T>C:		rs5303	0.7462	0.0000	0,0,0	0,0,0,0,0	0.6606							610613 [CYP11B1 (confirmed) Adrenal hyperplasia,congenital,due to 11-beta-hydroxylase deficiency,202010|Aldosteronism,glucocorticoid-remediable,103900];	RCV000282385.1 [benign]; RCV000394822.1 [benign]; 			96	107					CYP11B1 (inh=AR+AD pLI=0.00), GML (inh=n/a pLI=0.44)
chr8	143955273	143955273	T	C	het	anno_omim	QUAL=20125;DP=453;AF=0.51;MQM=59;TRIO=HET,453,0.51,HET,525,0.51,HET,655,0.45	CYP11B1,GML	3'UTR	CYP11B1:ENST00000377675:3'UTR:MODIFIER:exon11/11:c.*516A>G:,CYP11B1:ENST00000292427:3'UTR:MODIFIER:exon9/9:c.*516A>G:,CYP11B1:ENST00000517471:3'UTR:MODIFIER:exon8/8:c.*516A>G:		rs5301	0.5745	0.0000	0,0,0	0,0,0,0,0	0.4902							610613 [CYP11B1 (confirmed) Adrenal hyperplasia,congenital,due to 11-beta-hydroxylase deficiency,202010|Aldosteronism,glucocorticoid-remediable,103900];	RCV000273065.1 [benign]; RCV000363072.1 [benign]; 			68	115					CYP11B1 (inh=AR+AD pLI=0.00), GML (inh=n/a pLI=0.44)
chr8	143955318	143955318	T	G	het	anno_omim	QUAL=17586;DP=388;AF=0.42;MQM=59;TRIO=HET,388,0.42,HET,508,0.52,HET,603,0.45	CYP11B1,GML	3'UTR	CYP11B1:ENST00000377675:3'UTR:MODIFIER:exon11/11:c.*471A>C:,CYP11B1:ENST00000292427:3'UTR:MODIFIER:exon9/9:c.*471A>C:,CYP11B1:ENST00000517471:3'UTR:MODIFIER:exon8/8:c.*471A>C:		rs12543598	0.7512	0.0000	0,0,0	0,0,0,0,0	0.6717							610613 [CYP11B1 (confirmed) Adrenal hyperplasia,congenital,due to 11-beta-hydroxylase deficiency,202010|Aldosteronism,glucocorticoid-remediable,103900];	RCV000259195.1 [benign]; RCV000379427.1 [benign]; 			96	107					CYP11B1 (inh=AR+AD pLI=0.00), GML (inh=n/a pLI=0.44)
chr8	143955471	143955471	T	C	het	anno_omim	QUAL=12469;DP=304;AF=0.49;MQM=59;TRIO=HET,304,0.49,HET,292,0.49,HET,378,0.52	CYP11B1,GML	3'UTR	CYP11B1:ENST00000377675:3'UTR:MODIFIER:exon11/11:c.*318A>G:,CYP11B1:ENST00000292427:3'UTR:MODIFIER:exon9/9:c.*318A>G:,CYP11B1:ENST00000517471:3'UTR:MODIFIER:exon8/8:c.*318A>G:		rs5299	0.6957	0.0000	0,0,0	0,0,0,0,0	0.6166							610613 [CYP11B1 (confirmed) Adrenal hyperplasia,congenital,due to 11-beta-hydroxylase deficiency,202010|Aldosteronism,glucocorticoid-remediable,103900];	RCV000296570.1 [benign]; RCV000388596.1 [benign]; 			96	107					CYP11B1 (inh=AR+AD pLI=0.00), GML (inh=n/a pLI=0.44)
chr8	143960597	143960597	G	A	het	anno_omim	QUAL=10335;DP=127;AF=0.56;MQM=59;TRIO=HET,127,0.56,HET,302,0.53,HET,410,0.50	CYP11B1,GML	synonymous	CYP11B1:ENST00000377675:synonymous:LOW:exon3/11:c.381C>T:p.Asp127Asp,CYP11B1:ENST00000292427:synonymous:LOW:exon2/9:c.246C>T:p.Asp82Asp,CYP11B1:ENST00000517471:synonymous:LOW:exon2/8:c.246C>T:p.Asp82Asp		rs5283	0.3027	0.3979	10240,6426,64	0.0999,0.4273,0.3030,0.4393,0.4124	0.4094							610613 [CYP11B1 (confirmed) Adrenal hyperplasia,congenital,due to 11-beta-hydroxylase deficiency,202010|Aldosteronism,glucocorticoid-remediable,103900];	RCV000293653.1 [benign]; RCV000385596.1 [benign]; 		COSM4162721	419	1032	2	[2] auto-classification 15.09.2017  			CYP11B1 (inh=AR+AD pLI=0.00), GML (inh=n/a pLI=0.44)
chr8	143961005	143961005	T	C	het	anno_omim	QUAL=7892;DP=182;AF=0.49;MQM=59;TRIO=HET,182,0.49,HET,239,0.51,HET,242,0.45	CYP11B1,GML	synonymous	CYP11B1:ENST00000377675:synonymous:LOW:exon1/11:c.225A>G:p.Leu75Leu,CYP11B1:ENST00000292427:synonymous:LOW:exon1/9:c.225A>G:p.Leu75Leu,CYP11B1:ENST00000517471:synonymous:LOW:exon1/8:c.225A>G:p.Leu75Leu		rs6410	0.5841	0.5724	20338,9825,996	0.4362,0.6198,0.7586,0.5417,0.6490	0.5803							610613 [CYP11B1 (confirmed) Adrenal hyperplasia,congenital,due to 11-beta-hydroxylase deficiency,202010|Aldosteronism,glucocorticoid-remediable,103900];	RCV000309802.1 [benign]; RCV000396739.1 [benign]; 			744	1005	2	[2] auto-classification 15.09.2017  			CYP11B1 (inh=AR+AD pLI=0.00), GML (inh=n/a pLI=0.44)
chr8	143992218	143992218	A	G	het	anno_omim	QUAL=16719;DP=404;AF=0.51;MQM=59;TRIO=HET,404,0.51,HET,400,0.52,HET,476,0.47	CYP11B2,GML	3'UTR	CYP11B2:ENST00000323110:3'UTR:MODIFIER:exon9/9:c.*1178T>C:		rs3802228	0.5988	0.0000	0,0,0	0,0,0,0,0	0.6231							124080 [CYP11B2 (confirmed) Hypoaldosteronism,congenital,due to CMO II deficiency,610600|Hypoaldosteronism,congenital,due to CMO I deficiency,203400|Low renin hypertension,susceptibility to|Aldosterone to renin ratio raised];	RCV000263179.1 [benign]; RCV000330291.1 [benign]; RCV000387104.1 [benign]; 			87	109					CYP11B2 (inh=AR pLI=0.00), GML (inh=n/a pLI=0.44)
chr8	143992661	143992661	C	T	het	anno_omim	QUAL=20623;DP=363;AF=0.47;MQM=59;TRIO=HET,363,0.47,HET,698,0.47,HET,763,0.43	CYP11B2,GML	3'UTR	CYP11B2:ENST00000323110:3'UTR:MODIFIER:exon9/9:c.*735G>A:		rs28491316	0.3099	0.0000	0,0,0	0,0,0,0,0	0.3561							124080 [CYP11B2 (confirmed) Hypoaldosteronism,congenital,due to CMO II deficiency,610600|Hypoaldosteronism,congenital,due to CMO I deficiency,203400|Low renin hypertension,susceptibility to|Aldosterone to renin ratio raised];	RCV000274392.1 [benign]; RCV000332815.1 [benign]; RCV000387341.1 [benign]; 			51	120					CYP11B2 (inh=AR pLI=0.00), GML (inh=n/a pLI=0.44)
chr8	143992864	143992864	C	A	het	anno_omim	QUAL=20981;DP=463;AF=0.41;MQM=59;TRIO=HET,463,0.41,HET,572,0.50,HET,694,0.50	CYP11B2,GML	3'UTR	CYP11B2:ENST00000323110:3'UTR:MODIFIER:exon9/9:c.*532G>T:		rs3802230	0.5958	0.0000	0,0,0	0,0,0,0,0	0.6211							124080 [CYP11B2 (confirmed) Hypoaldosteronism,congenital,due to CMO II deficiency,610600|Hypoaldosteronism,congenital,due to CMO I deficiency,203400|Low renin hypertension,susceptibility to|Aldosterone to renin ratio raised];	RCV000306434.1 [benign]; RCV000346205.1 [benign]; RCV000394920.1 [benign]; 			87	109					CYP11B2 (inh=AR pLI=0.00), GML (inh=n/a pLI=0.44)
chr8	143993101	143993101	-	GGA	het	anno_omim	QUAL=8624;DP=261;AF=0.44;MQM=59;TRIO=HET,261,0.44,HET,232,0.49,HET,269,0.53	CYP11B2,GML	3'UTR	CYP11B2:ENST00000323110:3'UTR:MODIFIER:exon9/9:c.*292_*294dupTCC:		rs377036717;rs3839864	0.7748	0.0000	0,0,0	0,0,0,0,0	0.6893							124080 [CYP11B2 (confirmed) Hypoaldosteronism,congenital,due to CMO II deficiency,610600|Hypoaldosteronism,congenital,due to CMO I deficiency,203400|Low renin hypertension,susceptibility to|Aldosterone to renin ratio raised];	RCV000284409.1 [benign]; RCV000320734.1 [benign]; RCV000378643.1 [benign]; 			98	105					CYP11B2 (inh=AR pLI=0.00), GML (inh=n/a pLI=0.44)
chr8	143993157	143993157	A	G	hom	anno_omim	QUAL=22709;DP=217;AF=1.00;MQM=59;TRIO=HOM,217,1.00,HOM,264,1.00,HOM,250,1.00	CYP11B2,GML	3'UTR	CYP11B2:ENST00000323110:3'UTR:MODIFIER:exon9/9:c.*239T>C:		rs9297975	0.9990	0.0000	0,0,0	0,0,0,0,0	0.9986							124080 [CYP11B2 (confirmed) Hypoaldosteronism,congenital,due to CMO II deficiency,610600|Hypoaldosteronism,congenital,due to CMO I deficiency,203400|Low renin hypertension,susceptibility to|Aldosterone to renin ratio raised];	RCV000289248.1 [benign]; RCV000344283.1 [benign]; RCV000384561.1 [benign]; 			232	0					CYP11B2 (inh=AR pLI=0.00), GML (inh=n/a pLI=0.44)
chr8	143994702	143994702	G	T	het	anno_omim	QUAL=4466;DP=62;AF=0.53;MQM=50;TRIO=HET,62,0.53,HET,138,0.52,HET,166,0.51	CYP11B2,GML	splice_region&synonymous	CYP11B2:ENST00000323110:splice_region&synonymous:LOW:exon6/9:c.1120C>A:p.Arg374Arg		rs4538	0.6076	0.5922	21108,10299,1112	0.4895,0.6072,0.8016,0.5620,0.6439	0.5990							124080 [CYP11B2 (confirmed) Hypoaldosteronism,congenital,due to CMO II deficiency,610600|Hypoaldosteronism,congenital,due to CMO I deficiency,203400|Low renin hypertension,susceptibility to|Aldosterone to renin ratio raised];	RCV000294441.1 [benign]; RCV000334245.1 [benign]; RCV000388744.1 [benign]; 		COSM454129	809	963	3	[3] auto-classification 15.09.2017  			CYP11B2 (inh=AR pLI=0.00), GML (inh=n/a pLI=0.44)
chr8	143995761	143995761	C	T	hom	anno_omim	QUAL=34663;DP=259;AF=1.00;MQM=59;TRIO=HOM,259,1.00,HOM,347,1.00,HOM,491,1.00	CYP11B2,GML	synonymous	CYP11B2:ENST00000323110:synonymous:LOW:exon5/9:c.873G>A:p.Ala291Ala		rs4536	0.8235	0.9094	51128,31890,4646	0.9454,0.8548,0.4798,0.9779,0.8557	0.9334							124080 [CYP11B2 (confirmed) Hypoaldosteronism,congenital,due to CMO II deficiency,610600|Hypoaldosteronism,congenital,due to CMO I deficiency,203400|Low renin hypertension,susceptibility to|Aldosterone to renin ratio raised];	RCV000263084.1 [benign]; RCV000315890.1 [benign]; RCV000354330.1 [benign]; 			1922	175	2	[2] auto-classification 15.09.2017  			CYP11B2 (inh=AR pLI=0.00), GML (inh=n/a pLI=0.44)
chr8	143996539	143996539	T	C	het	anno_omim	QUAL=10762;DP=166;AF=0.48;MQM=54;TRIO=HET,166,0.48,HET,320,0.48,HET,422,0.49	CYP11B2,GML	missense	CYP11B2:ENST00000323110:missense:MODERATE:exon3/9:c.518A>G:p.Lys173Arg		rs4539	0.3464	0.4189	10586,6607,276	0.2327,0.4342,0.2930,0.4523,0.4240	0.4244	-0.6680	T	T	B	T	0.01	124080 [CYP11B2 (confirmed) Hypoaldosteronism,congenital,due to CMO II deficiency,610600|Hypoaldosteronism,congenital,due to CMO I deficiency,203400|Low renin hypertension,susceptibility to|Aldosterone to renin ratio raised];	RCV000269208.1 [benign]; RCV000307908.1 [benign]; RCV000366140.1 [benign]; 	CM962423 [CLASS=DP MUT=ALT PHEN="Low renin hypertension association with" GENE=CYP11B2]; 	COSM4006860	460	1033	2	[2] auto-classification 15.09.2017  			CYP11B2 (inh=AR pLI=0.00), GML (inh=n/a pLI=0.44)
chr8	143996553	143996553	G	A	het	anno_omim	QUAL=11254;DP=196;AF=0.47;MQM=55;TRIO=HET,196,0.47,HET,315,0.48,HET,424,0.50	CYP11B2,GML	synonymous	CYP11B2:ENST00000323110:synonymous:LOW:exon3/9:c.504C>T:p.Phe168Phe		rs4546	0.3454	0.4189	10689,6665,273	0.2295,0.4342,0.2934,0.4524,0.4249	0.4247							124080 [CYP11B2 (confirmed) Hypoaldosteronism,congenital,due to CMO II deficiency,610600|Hypoaldosteronism,congenital,due to CMO I deficiency,203400|Low renin hypertension,susceptibility to|Aldosterone to renin ratio raised];	RCV000273968.1 [benign]; RCV000331401.1 [benign]; RCV000370864.1 [benign]; 		COSM1569160	460	1031	2	[2] auto-classification 15.09.2017  			CYP11B2 (inh=AR pLI=0.00), GML (inh=n/a pLI=0.44)
chr8	144989452	144989452	T	C	het	gene_blacklist;anno_omim	QUAL=1198;DP=23;AF=0.48;MQM=60;TRIO=HET,23,0.48,WT,53,0.00,HET,66,0.56	PLEC	3'UTR	PLEC:ENST00000322810:3'UTR:MODIFIER:exon32/32:c.*893A>G:,PLEC:ENST00000345136:3'UTR:MODIFIER:exon32/32:c.*893A>G:,PLEC:ENST00000357649:3'UTR:MODIFIER:exon32/32:c.*893A>G:,PLEC:ENST00000354589:3'UTR:MODIFIER:exon32/32:c.*893A>G:,PLEC:ENST00000398774:3'UTR:MODIFIER:exon32/32:c.*893A>G:,PLEC:ENST00000354958:3'UTR:MODIFIER:exon32/32:c.*893A>G:,PLEC:ENST00000356346:3'UTR:MODIFIER:exon32/32:c.*893A>G:,PLEC:ENST00000436759:3'UTR:MODIFIER:exon33/33:c.*893A>G:		rs189205952	0.0006	0.0000	0,0,0	0,0,0,0,0	0.0005							601282 [PLEC (confirmed) Epidermolysis bullosa simplex with muscular dystrophy,226670|Epidermolysis bullosa simplex,Ogna type,131950|Epidermolysis bullosa simplex with pyloric atresia,612138|Muscular dystrophy,limb-girdle,type 2Q,613723|Epidermolysis bullosa simplex with nail dystrophy,616487];				0	2					PLEC (inh=AR+AD pLI=0.02)
chr8	144995964	144995964	G	A	het	gene_blacklist;anno_omim	QUAL=4193;DP=146;AF=0.51;MQM=59;TRIO=HET,146,0.51,WT,210,0.00,HET,265,0.44	PLEC	synonymous	PLEC:ENST00000322810:synonymous:LOW:exon32/32:c.8436C>T:p.Gly2812Gly,PLEC:ENST00000345136:synonymous:LOW:exon32/32:c.8025C>T:p.Gly2675Gly,PLEC:ENST00000357649:synonymous:LOW:exon32/32:c.8037C>T:p.Gly2679Gly,PLEC:ENST00000354589:synonymous:LOW:exon32/32:c.8025C>T:p.Gly2675Gly,PLEC:ENST00000398774:synonymous:LOW:exon32/32:c.7929C>T:p.Gly2643Gly,PLEC:ENST00000354958:synonymous:LOW:exon32/32:c.7959C>T:p.Gly2653Gly,PLEC:ENST00000356346:synonymous:LOW:exon32/32:c.7983C>T:p.Gly2661Gly,PLEC:ENST00000436759:synonymous:LOW:exon33/33:c.8106C>T:p.Gly2702Gly,PLEC:ENST00000527096:synonymous:LOW:exon32/32:c.8094C>T:p.Gly2698Gly		rs35139934	0.0276	0.0590	288,244,1	0.0116,0.0413,0.0006,0.0832,0.0362	0.0591							601282 [PLEC (confirmed) Epidermolysis bullosa simplex with muscular dystrophy,226670|Epidermolysis bullosa simplex,Ogna type,131950|Epidermolysis bullosa simplex with pyloric atresia,612138|Muscular dystrophy,limb-girdle,type 2Q,613723|Epidermolysis bullosa simplex with nail dystrophy,616487];	RCV000117978.5 [other]; 		COSM4162792, COSM4162791, COSM4162789, COSM4162790, COSM4162793, COSM4162788	31	343	2	[2] auto-classification 15.09.2017  			PLEC (inh=AR+AD pLI=0.02)
chr8	144997503	144997503	G	A	het	gene_blacklist;anno_omim	QUAL=3304;DP=102;AF=0.40;MQM=60;TRIO=HET,102,0.40,HET,210,0.48,WT,259,0.00	PLEC	synonymous	PLEC:ENST00000322810:synonymous:LOW:exon31/32:c.7005C>T:p.Thr2335Thr,PLEC:ENST00000345136:synonymous:LOW:exon31/32:c.6594C>T:p.Thr2198Thr,PLEC:ENST00000357649:synonymous:LOW:exon31/32:c.6606C>T:p.Thr2202Thr,PLEC:ENST00000354589:synonymous:LOW:exon31/32:c.6594C>T:p.Thr2198Thr,PLEC:ENST00000398774:synonymous:LOW:exon31/32:c.6498C>T:p.Thr2166Thr,PLEC:ENST00000354958:synonymous:LOW:exon31/32:c.6528C>T:p.Thr2176Thr,PLEC:ENST00000356346:synonymous:LOW:exon31/32:c.6552C>T:p.Thr2184Thr,PLEC:ENST00000436759:synonymous:LOW:exon32/33:c.6675C>T:p.Thr2225Thr,PLEC:ENST00000527096:synonymous:LOW:exon31/32:c.6663C>T:p.Thr2221Thr		rs144242254	0.0016	0.0014	1,0,0	0.0000,0.0013,0.0001,0.0018,0.0013	0.0013							601282 [PLEC (confirmed) Epidermolysis bullosa simplex with muscular dystrophy,226670|Epidermolysis bullosa simplex,Ogna type,131950|Epidermolysis bullosa simplex with pyloric atresia,612138|Muscular dystrophy,limb-girdle,type 2Q,613723|Epidermolysis bullosa simplex with nail dystrophy,616487];	RCV000177614.2 [uncertain significance]; 			1	13					PLEC (inh=AR+AD pLI=0.02)
chr8	145004546	145004546	G	A	hom	low_DP;gene_blacklist;anno_omim	QUAL=1003;DP=14;AF=1.00;MQM=60;TRIO=HOM,14,1.00,HOM,11,1.00,HOM,12,1.00	PLEC	splice_region&intron	PLEC:ENST00000322810:splice_region&intron:LOW:exon20/31:c.2868+6C>T:,PLEC:ENST00000345136:splice_region&intron:LOW:exon20/31:c.2457+6C>T:,PLEC:ENST00000357649:splice_region&intron:LOW:exon20/31:c.2469+6C>T:,PLEC:ENST00000354589:splice_region&intron:LOW:exon20/31:c.2457+6C>T:,PLEC:ENST00000398774:splice_region&intron:LOW:exon20/31:c.2361+6C>T:,PLEC:ENST00000354958:splice_region&intron:LOW:exon20/31:c.2391+6C>T:,PLEC:ENST00000356346:splice_region&intron:LOW:exon20/31:c.2415+6C>T:,PLEC:ENST00000436759:splice_region&intron:LOW:exon21/32:c.2538+6C>T:,PLEC:ENST00000527096:splice_region&intron:LOW:exon20/31:c.2526+6C>T:		rs11780911	0.5719	0.7411	15015,10543,338	0.4468,0.6679,0.6658,0.8304,0.6283	0.7140							601282 [PLEC (confirmed) Epidermolysis bullosa simplex with muscular dystrophy,226670|Epidermolysis bullosa simplex,Ogna type,131950|Epidermolysis bullosa simplex with pyloric atresia,612138|Muscular dystrophy,limb-girdle,type 2Q,613723|Epidermolysis bullosa simplex with nail dystrophy,616487];	RCV000117959.7 [other]; 			1289	699	2	[2] auto-classification 15.09.2017  			PLEC (inh=AR+AD pLI=0.02)
chr8	145024450	145024450	C	T	het	gene_blacklist;pred_pathogenic;anno_omim	QUAL=4700;DP=106;AF=0.53;MQM=59;TRIO=HET,106,0.53,HET,261,0.54,WT,329,0.00	PLEC	missense,intron	PLEC:ENST00000322810:missense:MODERATE:exon1/32:c.425G>A:p.Arg142Gln,PLEC:ENST00000354958:intron:MODIFIER:exon1/31:c.46+3444G>A:,PLEC:ENST00000356346:intron:MODIFIER:exon1/31:c.71-11590G>A:,PLEC:ENST00000436759:intron:MODIFIER:exon2/32:c.194-11590G>A:,PLEC:ENST00000527096:intron:MODIFIER:exon1/31:c.194-11590G>A:		rs558227477	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0001	2.5110	D	T	B	T	23.50	601282 [PLEC (confirmed) Epidermolysis bullosa simplex with muscular dystrophy,226670|Epidermolysis bullosa simplex,Ogna type,131950|Epidermolysis bullosa simplex with pyloric atresia,612138|Muscular dystrophy,limb-girdle,type 2Q,613723|Epidermolysis bullosa simplex with nail dystrophy,616487];				0	2					PLEC (inh=AR+AD pLI=0.02)
chr8	145699382	145699384	CTC	-	het		QUAL=7327;DP=276;AF=0.52;MQM=58;TRIO=HET,276,0.52,HET,369,0.51,WT,459,0.00	KIFC2,FOXH1	3'UTR	KIFC2:ENST00000301332:3'UTR:MODIFIER:exon17/17:c.*551_*553delCCT:,FOXH1:ENST00000377317:3'UTR:MODIFIER:exon3/3:c.*237_*239delGAG:,KIFC2:ENST00000301331:3'UTR:MODIFIER:exon12/12:c.*1127_*1129delCCT:		rs550365735	0.0012	0.0000	0,0,0	0,0,0,0,0	0.0004								RCV000283821.1 [uncertain significance]; 			0	2					KIFC2 (inh=n/a pLI=0.00), FOXH1 (inh=n/a pLI=0.01)
chr8	145699601	145699601	T	C	hom		QUAL=17184;DP=157;AF=1.00;MQM=59;TRIO=HOM,157,1.00,HOM,185,0.99,HOM,217,1.00	FOXH1	3'UTR	FOXH1:ENST00000377317:3'UTR:MODIFIER:exon3/3:c.*20A>G:		rs2721176	0.9457	0.9709	42177,25590,3618	0.9851,0.8950,0.7930,0.9992,0.9980	0.9822								RCV000252700.2 [benign]; RCV000402838.1 [benign]; 			2048	11					FOXH1 (inh=n/a pLI=0.01)
chr8	145700346	145700346	T	A	het	pred_pathogenic	QUAL=1709;DP=64;AF=0.45;MQM=60;TRIO=HET,64,0.45,WT,122,0.00,HET,116,0.51	FOXH1	missense	FOXH1:ENST00000377317:missense:MODERATE:exon3/3:c.373A>T:p.Thr125Ser		rs112028242	0.0266	0.0081	30,0,30	0.0991,0.0044,0.0002,0.0002,0.0000	0.0220	2.3370	T,T	T	D	D	23.20		RCV000177182.2 [benign]; RCV000376248.1 [likely benign]; 			0	12					FOXH1 (inh=n/a pLI=0.01)
chr8	145701453	145701453	A	C	hom		QUAL=2881;DP=44;AF=0.98;MQM=59;TRIO=HOM,44,0.98,HOM,17,0.94,HOM,34,1.00	FOXH1	5'UTR_premature_start_codon_gain,5'UTR	FOXH1:ENST00000377317:5'UTR_premature_start_codon_gain:LOW:exon1/3:c.-314T>G:,FOXH1:ENST00000377317:5'UTR:MODIFIER:exon1/3:c.-314T>G:		rs750472	0.4443	0.0000	0,0,0	0,0,0,0,0	0.5104								RCV000298563.1 [benign]; 			67	108	2	[2] auto-classification 15.09.2017  			FOXH1 (inh=n/a pLI=0.01)
chr9	271638	271638	C	T	het	pred_pathogenic;anno_omim	QUAL=14394;DP=356;AF=0.53;MQM=60;TRIO=HET,356,0.53,HOM,301,1.00,WT,322,0.00	DOCK8,RP11-59O6.3	missense,5'UTR	DOCK8:ENST00000453981:missense:MODERATE:exon2/48:c.65C>T:p.Ala22Val,DOCK8:ENST00000432829:5'UTR:MODIFIER:exon2/48:c.-140C>T:		rs506121	0.3077	0.3245	1198,518,103	0.2905,0.2805,0.3807,0.3366,0.3033	0.3393	1.4180	D,D	T	B	T	24.80	611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive,243700];	RCV000150504.3 [benign]; RCV000210052.1 [benign]; RCV000295061.1 [benign]; 		COSM3982814	222	936	2	[2] auto-classification 15.09.2017  			DOCK8 (inh=AR pLI=0.00), RP11-59O6.3 (inh=n/a pLI=n/a)
chr9	286491	286491	G	A	het	pred_pathogenic;anno_omim	QUAL=7367;DP=188;AF=0.48;MQM=60;TRIO=HET,188,0.48,HET,192,0.46,HET,275,0.48	DOCK8	missense,5'UTR	DOCK8:ENST00000453981:missense:MODERATE:exon3/48:c.187G>A:p.Asp63Asn,DOCK8:ENST00000432829:5'UTR:MODIFIER:exon3/48:c.-18G>A:,DOCK8:ENST00000469391:5'UTR:MODIFIER:exon2/46:c.-18G>A:		rs3209441	0.0701	0.1234	1179,957,7	0.0301,0.0665,0.0023,0.1655,0.1169	0.1227	9.4790	D,T	T	D	T	32.00	611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive,243700];	RCV000150505.3 [benign]; RCV000276708.1 [likely benign]; 			70	516	2	[2] auto-classification 15.09.2017  			DOCK8 (inh=AR pLI=0.00)
chr9	286593	286593	C	A	het	pred_pathogenic;anno_omim	QUAL=11803;DP=277;AF=0.49;MQM=60;TRIO=HET,277,0.49,HET,228,0.58,HET,321,0.59	DOCK8	missense	DOCK8:ENST00000453981:missense:MODERATE:exon3/48:c.289C>A:p.Pro97Thr,DOCK8:ENST00000432829:missense:MODERATE:exon3/48:c.85C>A:p.Pro29Thr,DOCK8:ENST00000469391:missense:MODERATE:exon2/46:c.85C>A:p.Pro29Thr		rs529208	0.5298	0.5206	16792,8156,852	0.4029,0.5422,0.7443,0.4940,0.5477	0.5251	3.1490	D,D,D,T,T,D	T	D,P,P	T,T,T,T,T	23.60	611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive,243700];	RCV000155526.2 [benign]; RCV000210057.1 [benign]; RCV000273069.1 [benign]; 		COSM3763875, COSM3763874	530	1017	2	[2] auto-classification 15.09.2017  			DOCK8 (inh=AR pLI=0.00)
chr9	312124	312124	T	C	het	anno_omim	QUAL=8963;DP=142;AF=0.53;MQM=59;TRIO=HET,142,0.53,HET,267,0.51,HET,282,0.52	DOCK8	synonymous	DOCK8:ENST00000453981:synonymous:LOW:exon6/48:c.699T>C:p.Asn233Asn,DOCK8:ENST00000432829:synonymous:LOW:exon6/48:c.495T>C:p.Asn165Asn,DOCK8:ENST00000469391:synonymous:LOW:exon5/46:c.495T>C:p.Asn165Asn		rs2039045	0.1643	0.1681	1905,1074,344	0.2496,0.1634,0.0056,0.1816,0.1537	0.1870							611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive,243700];	RCV000150506.3 [benign]; RCV000314699.1 [benign]; 			70	608	2	[2] auto-classification 15.09.2017  			DOCK8 (inh=AR pLI=0.00)
chr9	334337	334337	A	G	het	anno_omim	QUAL=9217;DP=211;AF=0.47;MQM=60;TRIO=HET,211,0.47,HOM,148,1.00,HET,188,0.46	DOCK8	missense	DOCK8:ENST00000453981:missense:MODERATE:exon11/48:c.1238A>G:p.Asn413Ser,DOCK8:ENST00000432829:missense:MODERATE:exon11/48:c.1034A>G:p.Asn345Ser,DOCK8:ENST00000469391:missense:MODERATE:exon10/46:c.1034A>G:p.Asn345Ser		rs10970979	0.1997	0.2488	4204,3002,270	0.2207,0.1424,0.0317,0.3010,0.2604	0.2484	0.4170	T,T,T,T	T	B,B	T,T,T	7.69	611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive,243700];	RCV000150508.2 [benign]; RCV000364547.1 [benign]; 		COSM3765452, COSM3765451	215	886	2	[2] auto-classification 15.09.2017  			DOCK8 (inh=AR pLI=0.00)
chr9	370244	370244	A	G	het	anno_omim	QUAL=20135;DP=406;AF=0.44;MQM=60;TRIO=HET,406,0.44,HOM,301,0.99,HET,408,0.51	DOCK8	synonymous,5'UTR	DOCK8:ENST00000453981:synonymous:LOW:exon16/48:c.1812A>G:p.Lys604Lys,DOCK8:ENST00000432829:synonymous:LOW:exon16/48:c.1608A>G:p.Lys536Lys,DOCK8:ENST00000469391:synonymous:LOW:exon15/46:c.1608A>G:p.Lys536Lys,DOCK8:ENST00000382329:synonymous:LOW:exon3/35:c.213A>G:p.Lys71Lys,DOCK8:ENST00000382331:5'UTR:MODIFIER:exon3/13:c.-144A>G:		rs913703	0.2159	0.2226	3228,1843,421	0.2815,0.1961,0.0699,0.2347,0.2494	0.2218							611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive,243700];	RCV000155528.3 [benign]; RCV000377272.1 [benign]; 		COSM3763926, COSM3763925	131	773	2	[2] auto-classification 15.09.2017  			DOCK8 (inh=AR pLI=0.00)
chr9	377111	377111	G	C	het	anno_omim	QUAL=5599;DP=167;AF=0.43;MQM=59;TRIO=HET,167,0.43,HOM,97,0.99,HET,135,0.42	DOCK8	synonymous	DOCK8:ENST00000453981:synonymous:LOW:exon20/48:c.2340G>C:p.Leu780Leu,DOCK8:ENST00000432829:synonymous:LOW:exon20/48:c.2136G>C:p.Leu712Leu,DOCK8:ENST00000469391:synonymous:LOW:exon19/46:c.2136G>C:p.Leu712Leu,DOCK8:ENST00000382331:synonymous:LOW:exon6/13:c.246G>C:p.Leu82Leu,DOCK8:ENST00000382329:synonymous:LOW:exon7/35:c.741G>C:p.Leu247Leu		rs10814431	0.2286	0.2332	3272,1891,414	0.2906,0.2035,0.0708,0.2475,0.2606	0.2372							611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive,243700];	RCV000150510.3 [benign]; RCV000296192.1 [benign]; 		COSM3763936, COSM3763935	139	777	2	[2] auto-classification 15.09.2017  			DOCK8 (inh=AR pLI=0.00)
chr9	390512	390512	C	T	het	anno_omim	QUAL=20055;DP=324;AF=0.53;MQM=59;TRIO=HET,324,0.53,HOM,321,1.00,HET,372,0.50	DOCK8	synonymous	DOCK8:ENST00000453981:synonymous:LOW:exon24/48:c.2916C>T:p.Thr972Thr,DOCK8:ENST00000432829:synonymous:LOW:exon24/48:c.2712C>T:p.Thr904Thr,DOCK8:ENST00000469391:synonymous:LOW:exon22/46:c.2616C>T:p.Thr872Thr,DOCK8:ENST00000382331:synonymous:LOW:exon10/13:c.822C>T:p.Thr274Thr,DOCK8:ENST00000382329:synonymous:LOW:exon11/35:c.1317C>T:p.Thr439Thr		rs2297075	0.2550	0.2344	3600,1858,730	0.3722,0.2085,0.0791,0.2372,0.2511	0.2589							611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive,243700];	RCV000155529.3 [benign]; RCV000379965.1 [benign]; 		COSM1179612, COSM1179613	133	765	2	[2] auto-classification 15.09.2017  			DOCK8 (inh=AR pLI=0.00)
chr9	429719	429719	T	C	hom	anno_omim	QUAL=26415;DP=294;AF=1.00;MQM=60;TRIO=HOM,294,1.00,HOM,219,1.00,HOM,306,1.00	DOCK8	synonymous	DOCK8:ENST00000453981:synonymous:LOW:exon36/48:c.4491T>C:p.Phe1497Phe,DOCK8:ENST00000432829:synonymous:LOW:exon36/48:c.4287T>C:p.Phe1429Phe,DOCK8:ENST00000469391:synonymous:LOW:exon34/46:c.4191T>C:p.Phe1397Phe,DOCK8:ENST00000382329:synonymous:LOW:exon23/35:c.2892T>C:p.Phe964Phe		rs7854035	0.9994	0.9978	60443,33169,5196	0.9993,0.9959,0.9999,0.9970,0.9998	0.9979							611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive,243700];	RCV000155534.1 [benign]; 			2103	8	2	[2] auto-classification 15.09.2017  			DOCK8 (inh=AR pLI=0.00)
chr9	432330	432330	C	G	hom	anno_omim	QUAL=17048;DP=209;AF=1.00;MQM=60;TRIO=HOM,209,1.00,HET,192,0.49,HOM,255,1.00	DOCK8	splice_region&intron	DOCK8:ENST00000453981:splice_region&intron:LOW:exon37/47:c.4785+6C>G:,DOCK8:ENST00000432829:splice_region&intron:LOW:exon37/47:c.4581+6C>G:,DOCK8:ENST00000469391:splice_region&intron:LOW:exon35/45:c.4485+6C>G:,DOCK8:ENST00000382329:splice_region&intron:LOW:exon24/34:c.3186+6C>G:		rs7036567	0.7143	0.7577	35655,19625,1209	0.4819,0.8582,0.9871,0.7669,0.6888	0.7660							611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive,243700];	RCV000150514.2 [benign]; RCV000403442.1 [benign]; 			1179	773	2	[2] auto-classification 15.09.2017  			DOCK8 (inh=AR pLI=0.00)
chr9	433978	433978	A	G	hom	anno_omim	QUAL=20539;DP=261;AF=1.00;MQM=60;TRIO=HOM,261,1.00,HET,216,0.52,HOM,299,1.00	DOCK8	splice_region&intron	DOCK8:ENST00000453981:splice_region&intron:LOW:exon38/47:c.4886+3A>G:,DOCK8:ENST00000432829:splice_region&intron:LOW:exon38/47:c.4682+3A>G:,DOCK8:ENST00000469391:splice_region&intron:LOW:exon36/45:c.4586+3A>G:,DOCK8:ENST00000382329:splice_region&intron:LOW:exon25/34:c.3287+3A>G:		rs2360712	0.7210	0.7588	35664,19535,1311	0.5047,0.8587,0.9871,0.7655,0.6870	0.7665							611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive,243700];	RCV000150515.2 [benign]; RCV000309557.1 [benign]; 			1169	783	2	[2] auto-classification 15.09.2017  			DOCK8 (inh=AR pLI=0.00)
chr9	441952	441952	G	A	het	anno_omim	QUAL=9539;DP=276;AF=0.44;MQM=60;TRIO=HET,276,0.44,WT,161,0.01,HOM,199,1.00	DOCK8	synonymous	DOCK8:ENST00000453981:synonymous:LOW:exon42/48:c.5433G>A:p.Glu1811Glu,DOCK8:ENST00000432829:synonymous:LOW:exon42/48:c.5229G>A:p.Glu1743Glu,DOCK8:ENST00000469391:synonymous:LOW:exon40/46:c.5133G>A:p.Glu1711Glu,DOCK8:ENST00000382329:synonymous:LOW:exon29/35:c.3834G>A:p.Glu1278Glu		rs1887957	0.8039	0.8201	41298,22413,1852	0.5954,0.8865,0.9968,0.8197,0.8199	0.8253							611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive,243700];	RCV000155535.2 [benign]; RCV000210054.1 [benign]; RCV000262385.1 [benign]; 		COSM4163900, COSM4163899	1399	628	2	[2] auto-classification 15.09.2017  			DOCK8 (inh=AR pLI=0.00)
chr9	449798	449798	G	A	het	anno_omim	QUAL=4306;DP=159;AF=0.48;MQM=60;TRIO=HET,159,0.48,WT,125,0.00,HET,213,0.44	DOCK8	synonymous	DOCK8:ENST00000453981:synonymous:LOW:exon45/48:c.5832G>A:p.Pro1944Pro,DOCK8:ENST00000432829:synonymous:LOW:exon45/48:c.5628G>A:p.Pro1876Pro,DOCK8:ENST00000469391:synonymous:LOW:exon43/46:c.5532G>A:p.Pro1844Pro,DOCK8:ENST00000382329:synonymous:LOW:exon32/35:c.4233G>A:p.Pro1411Pro		rs10491684	0.0717	0.0702	370,202,106	0.1525,0.0418,0.0001,0.0778,0.0392	0.0923							611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive,243700];	RCV000150517.2 [benign]; RCV000298530.1 [likely benign]; 			14	270	2	[2] auto-classification 15.09.2017  			DOCK8 (inh=AR pLI=0.00)
chr9	464920	464920	G	A	het	anno_omim	QUAL=12175;DP=442;AF=0.45;MQM=59;TRIO=HET,442,0.45,WT,164,0.00,HOM,211,1.00	DOCK8,RP11-165F24.3	3'UTR	DOCK8:ENST00000453981:3'UTR:MODIFIER:exon48/48:c.*701G>A:,DOCK8:ENST00000432829:3'UTR:MODIFIER:exon48/48:c.*701G>A:,DOCK8:ENST00000382329:3'UTR:MODIFIER:exon35/35:c.*701G>A:		rs3780338	0.8560	0.0000	0,0,0	0,0,0,0,0	0.8202							611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive,243700];	RCV000334208.1 [benign]; 			139	83					DOCK8 (inh=AR pLI=0.00), RP11-165F24.3 (inh=n/a pLI=n/a)
chr9	470302	470302	T	C	het	anno_omim	QUAL=4169;DP=254;AF=0.56;MQM=59;TRIO=HET,254,0.56,WT,84,0.01,HET,114,0.45	KANK1,RP11-165F24.3	5'UTR	KANK1:ENST00000382303:5'UTR:MODIFIER:exon1/16:c.-641T>C:		rs151242444	0.0130	0.0000	0,0,0	0,0,0,0,0	0.0080							607704 [KANK1 (confirmed) Cerebral palsy,spastic quadriplegic,2,612900];				0	4					KANK1 (inh=AD pLI=n/a), RP11-165F24.3 (inh=n/a pLI=n/a)
chr9	707077	707077	C	T	hom	anno_omim	QUAL=15751;DP=178;AF=0.99;MQM=60;TRIO=HOM,178,0.99,HOM,221,0.99,HET,331,0.51	KANK1	5'UTR_premature_start_codon_gain,5'UTR,intron	KANK1:ENST00000382293:5'UTR_premature_start_codon_gain:LOW:exon1/11:c.-608C>T:,KANK1:ENST00000382293:5'UTR:MODIFIER:exon1/11:c.-608C>T:,KANK1:ENST00000382297:intron:MODIFIER:exon2/11:c.38-3727C>T:,KANK1:ENST00000382303:intron:MODIFIER:exon6/15:c.38-3727C>T:		rs7871551	0.3676	0.0000	0,0,0	0,0,0,0,0	0.4396							607704 [KANK1 (confirmed) Cerebral palsy,spastic quadriplegic,2,612900];				56	116	2	[2] auto-classification 15.09.2017  			KANK1 (inh=AD pLI=n/a)
chr9	712060	712060	G	C	hom	pred_pathogenic;anno_omim	QUAL=18655;DP=308;AF=0.99;MQM=59;TRIO=HOM,308,0.99,HET,290,0.44,HET,451,0.48	KANK1	missense	KANK1:ENST00000382297:missense:MODERATE:exon3/12:c.1294G>C:p.Glu432Gln,KANK1:ENST00000382303:missense:MODERATE:exon7/16:c.1294G>C:p.Glu432Gln,KANK1:ENST00000382293:missense:MODERATE:exon2/11:c.820G>C:p.Glu274Gln		rs4465020	0.2352	0.3392	8021,5294,32	0.0719,0.1768,0.1238,0.3994,0.4698	0.3338	2.0530	T,T,T,T	T	B,B	T,T,T	0.17	607704 [KANK1 (confirmed) Cerebral palsy,spastic quadriplegic,2,612900];			COSM1132467, COSM1132465	387	951	2	[2] auto-classification 15.09.2017  			KANK1 (inh=AD pLI=n/a)
chr9	712599	712599	C	T	hom	anno_omim	QUAL=36999;DP=543;AF=1.00;MQM=60;TRIO=HOM,543,1.00,HET,592,0.52,HET,815,0.54	KANK1	synonymous	KANK1:ENST00000382297:synonymous:LOW:exon3/12:c.1833C>T:p.Asn611Asn,KANK1:ENST00000382303:synonymous:LOW:exon7/16:c.1833C>T:p.Asn611Asn,KANK1:ENST00000382293:synonymous:LOW:exon2/11:c.1359C>T:p.Asn453Asn		rs11789987	0.2530	0.3486	8269,5478,89	0.1333,0.1826,0.1246,0.4058,0.4683	0.3418							607704 [KANK1 (confirmed) Cerebral palsy,spastic quadriplegic,2,612900];			COSM1462713, COSM3750179, COSM1462714	396	957	2	[2] auto-classification 15.09.2017  			KANK1 (inh=AD pLI=n/a)
chr9	742342	742342	A	G	hom	anno_omim	QUAL=2904;DP=40;AF=1.00;MQM=60;TRIO=HOM,40,1.00,HOM,17,1.00,HOM,40,1.00	KANK1	synonymous	KANK1:ENST00000382297:synonymous:LOW:exon10/12:c.3834A>G:p.Gly1278Gly,KANK1:ENST00000382303:synonymous:LOW:exon14/16:c.3834A>G:p.Gly1278Gly,KANK1:ENST00000382293:synonymous:LOW:exon9/11:c.3360A>G:p.Gly1120Gly		rs10733535	0.9976	0.9953	60119,32897,5192	0.9990,0.9962,1.0000,0.9932,0.9987	0.9954							607704 [KANK1 (confirmed) Cerebral palsy,spastic quadriplegic,2,612900];			COSM3763986, COSM3763984, COSM3763985	2090	23	2	[2] auto-classification 15.09.2017  			KANK1 (inh=AD pLI=n/a)
chr9	2039793	2039793	A	C	hom	anno_omim	QUAL=5241;DP=60;AF=0.98;MQM=59;TRIO=HOM,60,0.98,HET,131,0.53,HET,156,0.53	SMARCA2	missense	SMARCA2:ENST00000349721:missense:MODERATE:exon4/34:c.683A>C:p.Gln228Pro,SMARCA2:ENST00000357248:missense:MODERATE:exon4/33:c.683A>C:p.Gln228Pro,SMARCA2:ENST00000382203:missense:MODERATE:exon4/34:c.683A>C:p.Gln228Pro,SMARCA2:ENST00000382194:missense:MODERATE:exon3/32:c.683A>C:p.Gln228Pro	(GCA)n	rs62534884	0.0292	0.0390	82,70,0	0.0091,0.0302,0.0004,0.0560,0.0172	0.0400	0.7910	T,T,T,T,T	T	B,B	T,T,T,T,T	5.29	600014 [SMARCA2 (provisional) Nicolaides-Baraitser syndrome,601358];	RCV000114294.1 [benign]; RCV000351026.1 [benign]; 		COSM1461691, COSM1461690	24	204					SMARCA2 (inh=AD pLI=1.00)
chr9	2116037	2116037	G	A	het	anno_omim	QUAL=2800;DP=69;AF=0.52;MQM=60;TRIO=HET,69,0.52,WT,116,0.00,HET,164,0.47	SMARCA2	synonymous	SMARCA2:ENST00000349721:synonymous:LOW:exon25/34:c.3672G>A:p.Glu1224Glu,SMARCA2:ENST00000357248:synonymous:LOW:exon25/33:c.3672G>A:p.Glu1224Glu,SMARCA2:ENST00000382203:synonymous:LOW:exon25/34:c.3672G>A:p.Glu1224Glu,SMARCA2:ENST00000382194:synonymous:LOW:exon24/32:c.3672G>A:p.Glu1224Glu		rs6601	0.2354	0.1380	2349,355,1832	0.6072,0.0647,0.0175,0.1052,0.1029	0.2344							600014 [SMARCA2 (provisional) Nicolaides-Baraitser syndrome,601358];	RCV000114289.2 [likely benign]; RCV000360701.1 [benign]; 		COSM3763857, COSM3763856	34	407	2	[2] auto-classification 15.09.2017  			SMARCA2 (inh=AD pLI=1.00)
chr9	2622121	2622121	A	G	hom	low_DP;anno_omim	QUAL=2093;DP=4;AF=1.00;MQM=59;TRIO=HOM,4,1.00,HOM,33,1.00,HOM,36,1.00	VLDLR,RP11-125B21.2	5'UTR	VLDLR:ENST00000382100:5'UTR:MODIFIER:exon1/19:c.-69A>G:,VLDLR:ENST00000382099:5'UTR:MODIFIER:exon1/18:c.-69A>G:		rs12379259	0.8123	0.0000	0,0,0	0,0,0,0,0	0.8230							192977 [VLDLR (confirmed) Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1,224050];	RCV000335588.1 [benign]; 			1585	909					VLDLR (inh=AR pLI=0.00), RP11-125B21.2 (inh=n/a pLI=n/a)
chr9	2622146	2622146	-	CGG	hom	low_DP;anno_omim	QUAL=181;DP=1;AF=1.00;MQM=59;TRIO=HOM,1,1.00,HET,26,0.27,HET,25,0.44	VLDLR,RP11-125B21.2	5'UTR	VLDLR:ENST00000382100:5'UTR:MODIFIER:exon1/19:c.-21_-19dupGGC:,VLDLR:ENST00000382099:5'UTR:MODIFIER:exon1/18:c.-21_-19dupGGC:		rs555425887;rs770767853	0.0000	0.3376	178,42,2	0.0000,0.0000,0.0000,0.3308,0.3583	0.3036							192977 [VLDLR (confirmed) Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1,224050];				397	1190					VLDLR (inh=AR pLI=0.00), RP11-125B21.2 (inh=n/a pLI=n/a)
chr9	6532477	6532477	G	A	het	anno_omim	QUAL=1928;DP=76;AF=0.51;MQM=58;TRIO=HET,76,0.51,HOM,21,1.00,HET,24,0.63	GLDC	3'UTR	GLDC:ENST00000321612:3'UTR:MODIFIER:exon25/25:c.*540C>T:		rs7848919	0.7712	0.0000	0,0,0	0,0,0,0,0	0.7161							238300 [GLDC (confirmed) Glycine encephalopathy,605899];	RCV000333967.1 [benign]; 			109	97					GLDC (inh=AR pLI=0.00)
chr9	6532511	6532512	AA	-	het	anno_omim	QUAL=850;DP=82;AF=0.13;MQM=50;TRIO=HET,82,0.13,HET,26,0.00,WT,34,0.47	GLDC	3'UTR	GLDC:ENST00000321612:3'UTR:MODIFIER:exon25/25:c.*505_*506delTT:		rs145481724	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1219							238300 [GLDC (confirmed) Glycine encephalopathy,605899];	RCV000387900.1 [uncertain significance]; 			5	43					GLDC (inh=AR pLI=0.00)
chr9	6532544	6532544	G	A	het	low_MQM;anno_omim	QUAL=3512;DP=129;AF=0.48;MQM=41;TRIO=HET,129,0.48,HOM,50,1.00,HET,61,0.54	GLDC	3'UTR	GLDC:ENST00000321612:3'UTR:MODIFIER:exon25/25:c.*473C>T:		rs1061407	0.7516	0.0000	0,0,0	0,0,0,0,0	0.6932							238300 [GLDC (confirmed) Glycine encephalopathy,605899];	RCV000274736.1 [benign]; 			97	106					GLDC (inh=AR pLI=0.00)
chr9	6533010	6533010	C	G	het	anno_omim	QUAL=16809;DP=270;AF=0.50;MQM=56;TRIO=HET,270,0.50,HOM,292,1.00,HET,363,0.48	GLDC	3'UTR	GLDC:ENST00000321612:3'UTR:MODIFIER:exon25/25:c.*7G>C:		rs2228098	0.7552	0.6859	29234,12907,2674	0.7158,0.8044,0.9503,0.6213,0.7168	0.6900							238300 [GLDC (confirmed) Glycine encephalopathy,605899];	RCV000251539.1 [benign]; RCV000286373.1 [benign]; 			1075	1125					GLDC (inh=AR pLI=0.00)
chr9	33112715	33112718	TTCT	-	het	anno_omim	QUAL=5376;DP=310;AF=0.50;MQM=59;TRIO=HET,310,0.50,WT,110,0.00,HET,162,0.51	B4GALT1	3'UTR,intron	B4GALT1:ENST00000379731:3'UTR:MODIFIER:exon6/6:c.*734_*737delAGAA:,B4GALT1:ENST00000535206:intron:MODIFIER:exon2/2:c.649-7939_649-7936delAGAA:		rs537888935	0.0046	0.0000	0,0,0	0,0,0,0,0	0.0090							137060 [B4GALT1 (provisional) Congenital disorder of glycosylation,type IId,607091];	RCV000323528.1 [uncertain significance]; 			0	7					B4GALT1 (inh=AR pLI=0.49)
chr9	33113196	33113196	G	T	hom	anno_omim	QUAL=15493;DP=244;AF=1.00;MQM=60;TRIO=HOM,244,1.00,HOM,114,0.98,HOM,125,1.00	B4GALT1	3'UTR,intron	B4GALT1:ENST00000379731:3'UTR:MODIFIER:exon6/6:c.*256C>A:,B4GALT1:ENST00000535206:intron:MODIFIER:exon2/2:c.649-8417C>A:		rs7019896	0.9485	0.0000	0,0,0	0,0,0,0,0	0.9321							137060 [B4GALT1 (provisional) Congenital disorder of glycosylation,type IId,607091];	RCV000352521.1 [benign]; 			213	19					B4GALT1 (inh=AR pLI=0.49)
chr9	35060302	35060302	T	C	het	anno_omim	QUAL=3715;DP=154;AF=0.51;MQM=60;TRIO=HET,154,0.51,HET,53,0.47,HET,67,0.64	VCP	splice_region&intron	VCP:ENST00000358901:splice_region&intron:LOW:exon13/16:c.1695+8A>G:		rs684562	0.4087	0.5865	22983,16416,378	0.2690,0.6721,0.0906,0.7032,0.5042	0.5930							601023 [VCP (confirmed) Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1,167320|Amyotrophic lateral sclerosis 14,with or without frontotemporal dementia,613954|Charcot-Marie-Tooth disease,type 2Y,616687];	RCV000254320.1 [benign]; RCV000367237.1 [benign]; RCV000393728.1 [benign]; 			964	1034	2	[2] auto-classification 15.09.2017  			VCP (inh=AD pLI=1.00)
chr9	35061693	35061693	-	ACAGTACACAA	het	anno_omim	QUAL=6691;DP=138;AF=0.46;MQM=59;TRIO=HET,138,0.46,HET,188,0.51,HET,239,0.52	VCP	splice_region&intron	VCP:ENST00000358901:splice_region&intron:LOW:exon9/16:c.1082-18_1082-8dupTTGTGTACTGT:		rs11272867;rs6150985	0.4083	0.5805	22507,16066,365	0.2646,0.6646,0.0898,0.6966,0.5010	0.5258							601023 [VCP (confirmed) Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1,167320|Amyotrophic lateral sclerosis 14,with or without frontotemporal dementia,613954|Charcot-Marie-Tooth disease,type 2Y,616687];	RCV000243886.1 [benign]; RCV000321686.1 [benign]; RCV000383262.1 [benign]; 			960	1024	2	[2] auto-classification 15.09.2017  			VCP (inh=AD pLI=1.00)
chr9	35062972	35062972	C	T	het	anno_omim	QUAL=13221;DP=310;AF=0.49;MQM=60;TRIO=HET,310,0.49,HET,312,0.47,HET,394,0.53	VCP	splice_region&intron	VCP:ENST00000358901:splice_region&intron:LOW:exon7/16:c.811+3G>A:		rs514492	0.7011	0.7442	34218,20040,2862	0.7403,0.8514,0.4643,0.7744,0.7090	0.7477							601023 [VCP (confirmed) Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1,167320|Amyotrophic lateral sclerosis 14,with or without frontotemporal dementia,613954|Charcot-Marie-Tooth disease,type 2Y,616687];	RCV000244946.1 [benign]; RCV000294534.1 [benign]; RCV000382040.1 [benign]; 		COSM150600	1308	856	2	[2] auto-classification 15.09.2017  			VCP (inh=AD pLI=1.00)
chr9	35074917	35074917	T	C	het	anno_omim	QUAL=7576;DP=208;AF=0.51;MQM=59;TRIO=HET,208,0.51,HET,141,0.58,HET,223,0.48	FANCG	splice_region&intron	FANCG:ENST00000378643:splice_region&intron:LOW:exon12/13:c.1636+7A>G:		rs587118	0.2202	0.3957	11389,8269,33	0.0810,0.5121,0.0039,0.4965,0.2672	0.4029							602956 [FANCG (confirmed) Fanconi anemia,complementation group G,614082];	RCV000247570.1 [benign]; RCV000275986.1 [benign]; RCV000367549.1 [benign]; RCV000394450.1 [benign]; 			936	1898	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCG (inh=n/a pLI=0.00)
chr9	35657741	35657741	A	G	het	anno_omim	QUAL=1252;DP=55;AF=0.49;MQM=60;TRIO=HET,55,0.49,HET,70,0.49,WT,74,0.00	SIT1,RMRP	intergenic_region	RMRP:ENSG00000137078-ENSG00000269900:intergenic_region:MODIFIER::n.35657741A>G:		rs71521283	0.1558	0.3695	225,69,0	0.0000,0.0000,0.0000,0.3921,0.3704	0.2165							157660 [RMRP (confirmed) Cartilage-hair hypoplasia,250250|Metaphyseal dysplasia without hypotrichosis,250460|Anauxetic dysplasia 1,607095];				48	241					SIT1 (inh=n/a pLI=0.04), RMRP (inh=AR pLI=n/a)
chr9	71650752	71650752	A	G	hom	anno_omim	QUAL=4451;DP=23;AF=1.00;MQM=60;TRIO=HOM,23,1.00,HOM,57,1.00,HOM,78,1.00	FXN	synonymous	FXN:ENST00000377270:synonymous:LOW:exon1/5:c.54A>G:p.Pro18Pro,FXN:ENST00000396364:synonymous:LOW:exon1/5:c.54A>G:p.Pro18Pro,FXN:ENST00000396366:synonymous:LOW:exon1/5:c.54A>G:p.Pro18Pro	(ACCCAG)n	rs2481598	0.9848	0.9993	5328,1350,99	0.9714,0.0000,0.0000,1.0000,0.9999	0.9979							606829 [FXN (confirmed) Friedreich ataxia,229300|Friedreich ataxia with retained reflexes,229300];	RCV000117105.4 [other]; RCV000252378.1 [benign]; 			3794	3	2	[2] auto-classification 15.09.2017  			FXN (inh=AR pLI=0.82)
chr9	71688476	71688476	T	G	het	anno_omim	QUAL=21108;DP=781;AF=0.51;MQM=59;TRIO=HET,781,0.51,HET,334,0.56,HET,413,0.50	FXN	3'UTR,intron	FXN:ENST00000377270:3'UTR:MODIFIER:exon5/5:c.*798T>G:,FXN:ENST00000396364:intron:MODIFIER:exon4/4:c.482+8525T>G:		rs11145043	0.3281	0.0000	0,0,0	0,0,0,0,0	0.4012							606829 [FXN (confirmed) Friedreich ataxia,229300|Friedreich ataxia with retained reflexes,229300];				49	115					FXN (inh=AR pLI=0.82)
chr9	71689436	71689436	A	-	het	anno_omim	QUAL=617;DP=107;AF=0.50;MQM=59;TRIO=HET,107,0.50,HET,53,0.64,WT,65,0.18	FXN	intron	FXN:ENST00000396364:intron:MODIFIER:exon4/4:c.482+9498delA:	AluSx	rs34933249	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0720							606829 [FXN (confirmed) Friedreich ataxia,229300|Friedreich ataxia with retained reflexes,229300];				9	9					FXN (inh=AR pLI=0.82)
chr9	71690150	71690150	T	G	hom	anno_omim	QUAL=13268;DP=213;AF=1.00;MQM=52;TRIO=HOM,213,1.00,HOM,76,1.00,HOM,132,1.00	FXN	intron	FXN:ENST00000396364:intron:MODIFIER:exon4/4:c.482+10199T>G:	AluSx	rs7875272	0.9916	0.0000	0,0,0	0,0,0,0,0	0.9938							606829 [FXN (confirmed) Friedreich ataxia,229300|Friedreich ataxia with retained reflexes,229300];				164	0					FXN (inh=AR pLI=0.82)
chr9	71690452	71690452	T	A	het	anno_omim	QUAL=12163;DP=395;AF=0.49;MQM=60;TRIO=HET,395,0.49,HET,255,0.44,HET,352,0.46	FXN	intron	FXN:ENST00000396364:intron:MODIFIER:exon4/4:c.482+10501T>A:		rs7875693	0.6617	0.0000	0,0,0	0,0,0,0,0	0.5904							606829 [FXN (confirmed) Friedreich ataxia,229300|Friedreich ataxia with retained reflexes,229300];				55	70					FXN (inh=AR pLI=0.82)
chr9	71690482	71690482	T	G	het	anno_omim	QUAL=11468;DP=344;AF=0.49;MQM=60;TRIO=HET,344,0.49,HET,277,0.43,HET,386,0.47	FXN	intron	FXN:ENST00000396364:intron:MODIFIER:exon4/4:c.482+10531T>G:		rs7849347	0.6643	0.0000	0,0,0	0,0,0,0,0	0.5903							606829 [FXN (confirmed) Friedreich ataxia,229300|Friedreich ataxia with retained reflexes,229300];				56	70					FXN (inh=AR pLI=0.82)
chr9	71690684	71690684	G	T	hom	anno_omim	QUAL=24918;DP=295;AF=1.00;MQM=59;TRIO=HOM,295,1.00,HOM,216,1.00,HOM,274,1.00	FXN	intron	FXN:ENST00000396364:intron:MODIFIER:exon4/4:c.482+10733G>T:	AluJb	rs6560541	0.9898	0.0000	0,0,0	0,0,0,0,0	0.9924							606829 [FXN (confirmed) Friedreich ataxia,229300|Friedreich ataxia with retained reflexes,229300];				178	0					FXN (inh=AR pLI=0.82)
chr9	71690872	71690872	C	T	het	anno_omim	QUAL=5322;DP=290;AF=0.52;MQM=59;TRIO=HET,290,0.52,HET,97,0.49,WT,125,0.00	FXN	intron	FXN:ENST00000396364:intron:MODIFIER:exon4/4:c.482+10921C>T:	AluJb	rs188391059	0.0010	0.0000	0,0,0	0,0,0,0,0	0.0017							606829 [FXN (confirmed) Friedreich ataxia,229300|Friedreich ataxia with retained reflexes,229300];				0	2					FXN (inh=AR pLI=0.82)
chr9	71691134	71691134	T	-	het	anno_omim	QUAL=1520;DP=135;AF=0.50;MQM=59;TRIO=HET,135,0.50,HET,55,0.45,HET,73,0.55	FXN	intron	FXN:ENST00000396364:intron:MODIFIER:exon4/4:c.482+11196delT:	MIRb	rs11310316	0.7163	0.0000	0,0,0	0,0,0,0,0	0.5192							606829 [FXN (confirmed) Friedreich ataxia,229300|Friedreich ataxia with retained reflexes,229300];				51	57					FXN (inh=AR pLI=0.82)
chr9	71692705	71692705	C	G	hom	anno_omim	QUAL=8777;DP=118;AF=1.00;MQM=54;TRIO=HOM,118,1.00,HOM,69,1.00,HOM,104,1.00	FXN	intron	FXN:ENST00000396364:intron:MODIFIER:exon4/4:c.482+12754C>G:	AluSx	rs7848466	0.9898	0.0000	0,0,0	0,0,0,0,0	0.9882							606829 [FXN (confirmed) Friedreich ataxia,229300|Friedreich ataxia with retained reflexes,229300];				227	0					FXN (inh=AR pLI=0.82)
chr9	71693128	71693128	G	C	hom	anno_omim	QUAL=35198;DP=424;AF=1.00;MQM=60;TRIO=HOM,424,1.00,HOM,279,1.00,HOM,361,1.00	FXN	intron	FXN:ENST00000396364:intron:MODIFIER:exon4/4:c.482+13177G>C:	MER91C	rs7866579	0.9920	0.0000	0,0,0	0,0,0,0,0	0.9933							606829 [FXN (confirmed) Friedreich ataxia,229300|Friedreich ataxia with retained reflexes,229300];				226	0					FXN (inh=AR pLI=0.82)
chr9	79792440	79792440	G	A	het	low_DP;anno_omim	QUAL=186;DP=11;AF=0.36;MQM=60;TRIO=HET,11,0.36,WT,10,0.00,HET,15,0.60	VPS13A,VPS13A-AS1	5'UTR,intron	VPS13A:ENST00000360280:5'UTR:MODIFIER:exon1/72:c.-181G>A:,VPS13A:ENST00000376634:5'UTR:MODIFIER:exon1/69:c.-181G>A:,VPS13A:ENST00000376636:5'UTR:MODIFIER:exon1/71:c.-181G>A:,VPS13A-AS1:ENST00000415172:intron:MODIFIER:exon1/1:n.368+103C>T:		rs117488726	0.0759	0.0000	0,0,0	0,0,0,0,0	0.0984							605978 [VPS13A (confirmed) Choreoacanthocytosis,200150];	RCV000316336.1 [likely benign]; 			7	45					VPS13A (inh=AR pLI=0.00), VPS13A-AS1 (inh=n/a pLI=n/a)
chr9	79936415	79936415	A	G	het	anno_omim	QUAL=5102;DP=230;AF=0.53;MQM=60;TRIO=HET,230,0.53,WT,117,0.00,HET,134,0.54	VPS13A	synonymous	VPS13A:ENST00000360280:synonymous:LOW:exon44/72:c.5583A>G:p.Thr1861Thr,VPS13A:ENST00000376634:synonymous:LOW:exon44/69:c.5583A>G:p.Thr1861Thr,VPS13A:ENST00000376636:synonymous:LOW:exon43/71:c.5466A>G:p.Thr1822Thr,VPS13A:ENST00000357409:synonymous:LOW:exon44/69:c.5583A>G:p.Thr1861Thr		rs17423984	0.0487	0.0758	422,243,3	0.0181,0.0302,0.0007,0.0906,0.1271	0.0719	0.1070		T			1.42	605978 [VPS13A (confirmed) Choreoacanthocytosis,200150];	RCV000302242.1 [likely benign]; 		COSM3764012, COSM3764011, COSM3764010	24	556	2	[2] auto-classification 15.09.2017  			VPS13A (inh=AR pLI=0.00)
chr9	79954425	79954425	A	T	het	anno_omim	QUAL=112;DP=112;AF=0.24;MQM=54;TRIO=HET,112,0.24,WT,36,0.00,WT,37,0.00	VPS13A	splice_region&intron	VPS13A:ENST00000360280:splice_region&intron:LOW:exon47/71:c.6379-7A>T:,VPS13A:ENST00000376634:splice_region&intron:LOW:exon47/68:c.6379-7A>T:,VPS13A:ENST00000376636:splice_region&intron:LOW:exon46/70:c.6262-7A>T:,VPS13A:ENST00000357409:splice_region&intron:LOW:exon47/68:c.6379-7A>T:	(T)n	rs759586753	0.0000	0.1314	0,0,0	0.0385,0.1035,0.1218,0.1104,0.1401	0.0729							605978 [VPS13A (confirmed) Choreoacanthocytosis,200150];				5	79	2	[2] auto-classification 15.09.2017  			VPS13A (inh=AR pLI=0.00)
chr9	79954545	79954545	T	C	het	anno_omim	QUAL=9943;DP=321;AF=0.44;MQM=60;TRIO=HET,321,0.44,HET,229,0.48,HET,285,0.49	VPS13A	synonymous	VPS13A:ENST00000360280:synonymous:LOW:exon48/72:c.6492T>C:p.Asp2164Asp,VPS13A:ENST00000376634:synonymous:LOW:exon48/69:c.6492T>C:p.Asp2164Asp,VPS13A:ENST00000376636:synonymous:LOW:exon47/71:c.6375T>C:p.Asp2125Asp,VPS13A:ENST00000357409:synonymous:LOW:exon48/69:c.6492T>C:p.Asp2164Asp		rs7025532	0.1627	0.1819	2013,1205,238	0.2231,0.0804,0.0384,0.2023,0.2150	0.1889							605978 [VPS13A (confirmed) Choreoacanthocytosis,200150];	RCV000373807.1 [likely benign]; 		COSM3764013, COSM3764014, COSM3764015	150	1061	2	[2] auto-classification 15.09.2017  			VPS13A (inh=AR pLI=0.00)
chr9	79984232	79984232	T	C	het	anno_omim	QUAL=8863;DP=342;AF=0.49;MQM=60;TRIO=HET,342,0.49,WT,163,0.00,HET,281,0.56	VPS13A	synonymous	VPS13A:ENST00000360280:synonymous:LOW:exon63/72:c.8571T>C:p.Tyr2857Tyr,VPS13A:ENST00000376634:synonymous:LOW:exon63/69:c.8571T>C:p.Tyr2857Tyr,VPS13A:ENST00000376636:synonymous:LOW:exon62/71:c.8454T>C:p.Tyr2818Tyr,VPS13A:ENST00000357409:synonymous:LOW:exon63/69:c.8571T>C:p.Tyr2857Tyr		rs17340192	0.0517	0.0759	426,250,3	0.0266,0.0303,0.0006,0.0903,0.1256	0.0725							605978 [VPS13A (confirmed) Choreoacanthocytosis,200150];	RCV000287482.1 [likely benign]; 		COSM3764016, COSM3764017, COSM3764018	23	511	2	[2] auto-classification 15.09.2017  			VPS13A (inh=AR pLI=0.00)
chr9	79986057	79986057	A	G	het	anno_omim	QUAL=15260;DP=408;AF=0.52;MQM=59;TRIO=HET,408,0.52,HET,297,0.55,HET,416,0.50	VPS13A	synonymous	VPS13A:ENST00000360280:synonymous:LOW:exon67/72:c.9069A>G:p.Gly3023Gly,VPS13A:ENST00000376634:synonymous:LOW:exon67/69:c.9069A>G:p.Gly3023Gly,VPS13A:ENST00000376636:synonymous:LOW:exon66/71:c.8952A>G:p.Gly2984Gly,VPS13A:ENST00000357409:synonymous:LOW:exon67/69:c.9069A>G:p.Gly3023Gly		rs3737289	0.4151	0.4505	12564,6158,517	0.3152,0.6027,0.3733,0.4322,0.5434	0.4552							605978 [VPS13A (confirmed) Choreoacanthocytosis,200150];	RCV000393264.1 [benign]; 			662	1613	2	[2] auto-classification 15.09.2017  			VPS13A (inh=AR pLI=0.00)
chr9	79997881	79997881	T	C	het	anno_omim	QUAL=11452;DP=368;AF=0.46;MQM=60;TRIO=HET,368,0.46,HET,197,0.51,HET,277,0.53	VPS13A	3'UTR,intron	VPS13A:ENST00000376634:3'UTR:MODIFIER:exon69/69:c.*666T>C:,VPS13A:ENST00000360280:intron:MODIFIER:exon68/71:c.9189+878T>C:,VPS13A:ENST00000376636:intron:MODIFIER:exon67/70:c.9072+878T>C:,VPS13A:ENST00000357409:intron:MODIFIER:exon68/68:c.9189+878T>C:		rs10869921	0.3844	0.0000	0,0,0	0,0,0,0,0	0.3723							605978 [VPS13A (confirmed) Choreoacanthocytosis,200150];				48	136					VPS13A (inh=AR pLI=0.00)
chr9	79999824	79999824	T	C	het	anno_omim	QUAL=4925;DP=215;AF=0.50;MQM=60;TRIO=HET,215,0.50,WT,105,0.00,HET,162,0.45	VPS13A	3'UTR,intron	VPS13A:ENST00000357409:3'UTR:MODIFIER:exon69/69:c.*225T>C:,VPS13A:ENST00000360280:intron:MODIFIER:exon68/71:c.9189+2821T>C:,VPS13A:ENST00000376636:intron:MODIFIER:exon67/70:c.9072+2821T>C:		rs7872010	0.0731	0.0000	0,0,0	0,0,0,0,0	0.0780							605978 [VPS13A (confirmed) Choreoacanthocytosis,200150];				2	43					VPS13A (inh=AR pLI=0.00)
chr9	80031144	80031144	G	A	het	anno_omim	QUAL=4179;DP=168;AF=0.51;MQM=60;TRIO=HET,168,0.51,HET,58,0.50,HET,68,0.56	VPS13A	3'UTR	VPS13A:ENST00000360280:3'UTR:MODIFIER:exon72/72:c.*222G>A:,VPS13A:ENST00000376636:3'UTR:MODIFIER:exon71/71:c.*222G>A:,VPS13A:ENST00000484581:3'UTR:MODIFIER:exon5/5:c.*222G>A:,VPS13A:ENST00000376646:3'UTR:MODIFIER:exon6/6:c.*222G>A:		rs12343797	0.1653	0.0000	0,0,0	0,0,0,0,0	0.1976							605978 [VPS13A (confirmed) Choreoacanthocytosis,200150];	RCV000270493.1 [likely benign]; 			16	115					VPS13A (inh=AR pLI=0.00)
chr9	80031946	80031946	C	T	het	anno_omim	QUAL=7991;DP=243;AF=0.48;MQM=60;TRIO=HET,243,0.48,HET,151,0.50,HET,194,0.53	VPS13A	3'UTR	VPS13A:ENST00000360280:3'UTR:MODIFIER:exon72/72:c.*1024C>T:,VPS13A:ENST00000376636:3'UTR:MODIFIER:exon71/71:c.*1024C>T:,VPS13A:ENST00000376646:3'UTR:MODIFIER:exon6/6:c.*1024C>T:		rs9186	0.5757	0.0000	0,0,0	0,0,0,0,0	0.5250							605978 [VPS13A (confirmed) Choreoacanthocytosis,200150];	RCV000373033.1 [benign]; 			62	151					VPS13A (inh=AR pLI=0.00)
chr9	80032300	80032300	C	A	het	anno_omim	QUAL=11116;DP=379;AF=0.47;MQM=59;TRIO=HET,379,0.47,HET,203,0.44,HET,294,0.49	VPS13A	3'UTR	VPS13A:ENST00000360280:3'UTR:MODIFIER:exon72/72:c.*1378C>A:,VPS13A:ENST00000376636:3'UTR:MODIFIER:exon71/71:c.*1378C>A:,VPS13A:ENST00000376646:3'UTR:MODIFIER:exon6/6:c.*1378C>A:		rs13286867	0.2494	0.0000	0,0,0	0,0,0,0,0	0.3028							605978 [VPS13A (confirmed) Choreoacanthocytosis,200150];	RCV000293418.1 [benign]; 			37	127					VPS13A (inh=AR pLI=0.00)
chr9	94087622	94087622	T	G	het	anno_omim	QUAL=7005;DP=329;AF=0.56;MQM=60;TRIO=HET,329,0.56,WT,126,0.00,HET,154,0.47	AUH	synonymous,intron	AUH:ENST00000375731:synonymous:LOW:exon4/10:c.483A>C:p.Ile161Ile,AUH:ENST00000422391:synonymous:LOW:exon4/7:c.483A>C:p.Ile161Ile,AUH:ENST00000303617:intron:MODIFIER:exon3/8:c.419-27264A>C:		rs7874056	0.0895	0.0866	593,331,183	0.1831,0.0487,0.0162,0.0988,0.0439	0.1122							600529 [AUH (provisional) 3-methylglutaconic aciduria,type I,250950];	RCV000116490.3 [other]; RCV000369919.1 [likely benign]; 		COSM3764058	22	438	2	[2] auto-classification 15.09.2017  			AUH (inh=AR pLI=0.01)
chr9	94830356	94830356	C	A	het	pred_pathogenic;anno_omim	QUAL=6680;DP=323;AF=0.51;MQM=60;TRIO=HET,323,0.51,WT,112,0.00,HET,186,0.51	SPTLC1	missense	SPTLC1:ENST00000262554:missense:MODERATE:exon6/15:c.452G>T:p.Arg151Leu		rs45461899	0.0116	0.0220	51,42,0	0.0038,0.0115,0.0000,0.0311,0.0170	0.0203	3.9190	D	T	B,B	D	33.00	605712 [SPTLC1 (provisional) Neuropathy,hereditary sensory and autonomic,type IA,162400];	RCV000313112.1 [likely benign]; 			2	95					SPTLC1 (inh=AD pLI=0.00)
chr9	97862118	97862118	C	T	het	anno_omim	QUAL=12662;DP=292;AF=0.48;MQM=60;TRIO=HET,292,0.48,HET,365,0.47,HET,413,0.49	FANCC	3'UTR	FANCC:ENST00000289081:3'UTR:MODIFIER:exon15/15:c.*1871G>A:,FANCC:ENST00000375305:3'UTR:MODIFIER:exon15/15:c.*1871G>A:		rs4647558	0.4135	0.0000	0,0,0	0,0,0,0,0	0.3807							613899 [FANCC (confirmed) Fanconi anemia,complementation group C,227645];	RCV000360013.1 [benign]; 			31	121					FANCC (inh=AR pLI=0.00)
chr9	97862701	97862701	A	G	het	anno_omim	QUAL=12121;DP=352;AF=0.51;MQM=60;TRIO=HET,352,0.51,HET,244,0.53,HET,259,0.54	FANCC	3'UTR	FANCC:ENST00000289081:3'UTR:MODIFIER:exon15/15:c.*1288T>C:,FANCC:ENST00000375305:3'UTR:MODIFIER:exon15/15:c.*1288T>C:		rs4647554	0.5028	0.0000	0,0,0	0,0,0,0,0	0.4580							613899 [FANCC (confirmed) Fanconi anemia,complementation group C,227645];	RCV000334241.1 [benign]; 			32	125					FANCC (inh=AR pLI=0.00)
chr9	97872712	97872712	C	T	hom	anno_omim	QUAL=10896;DP=215;AF=1.00;MQM=60;TRIO=HOM,215,1.00,HOM,55,1.00,HOM,64,1.00	FANCC	intron	FANCC:ENST00000289081:intron:MODIFIER:exon13/14:c.1329+1033G>A:,FANCC:ENST00000375305:intron:MODIFIER:exon13/14:c.1329+1033G>A:		rs10429619	0.9980	0.0000	0,0,0	0,0,0,0,0	0.9956							613899 [FANCC (confirmed) Fanconi anemia,complementation group C,227645];				151	1					FANCC (inh=AR pLI=0.00)
chr9	97873004	97873007	TAAC	-	het	anno_omim	QUAL=4053;DP=182;AF=0.47;MQM=59;TRIO=HET,182,0.47,WT,129,0.01,HET,194,0.46	FANCC	intron	FANCC:ENST00000289081:intron:MODIFIER:exon13/14:c.1329+738_1329+741delGTTA:,FANCC:ENST00000375305:intron:MODIFIER:exon13/14:c.1329+738_1329+741delGTTA:		rs71934724	0.1350	0.0000	0,0,0	0,0,0,0,0	0.1297							613899 [FANCC (confirmed) Fanconi anemia,complementation group C,227645];				9	48					FANCC (inh=AR pLI=0.00)
chr9	97873339	97873339	G	A	het	anno_omim	QUAL=7688;DP=162;AF=0.48;MQM=59;TRIO=HET,162,0.48,HET,200,0.53,HET,258,0.52	FANCC	intron	FANCC:ENST00000289081:intron:MODIFIER:exon13/14:c.1329+406C>T:,FANCC:ENST00000375305:intron:MODIFIER:exon13/14:c.1329+406C>T:		rs879492	0.4167	0.0000	0,0,0	0,0,0,0,0	0.3858							613899 [FANCC (confirmed) Fanconi anemia,complementation group C,227645];				20	78					FANCC (inh=AR pLI=0.00)
chr9	97873435	97873435	G	A	het	anno_omim	QUAL=6382;DP=169;AF=0.51;MQM=60;TRIO=HET,169,0.51,HET,134,0.56,HET,171,0.53	FANCC	intron	FANCC:ENST00000289081:intron:MODIFIER:exon13/14:c.1329+310C>T:,FANCC:ENST00000375305:intron:MODIFIER:exon13/14:c.1329+310C>T:		rs2404457	0.4111	0.3979	994,244,20	0.2290,0.0000,0.5596,0.3756,0.4155	0.4369							613899 [FANCC (confirmed) Fanconi anemia,complementation group C,227645];				336	963					FANCC (inh=AR pLI=0.00)
chr9	98229389	98229389	C	G	hom	anno_omim	QUAL=8503;DP=165;AF=0.99;MQM=60;TRIO=HOM,165,0.99,HOM,58,1.00,HOM,72,1.00	PTCH1	splice_region&intron	PTCH1:ENST00000331920:splice_region&intron:LOW:exon15/23:c.2560+9G>C:,PTCH1:ENST00000418258:splice_region&intron:LOW:exon15/23:c.2107+9G>C:,PTCH1:ENST00000421141:splice_region&intron:LOW:exon15/23:c.2107+9G>C:,PTCH1:ENST00000437951:splice_region&intron:LOW:exon15/23:c.2362+9G>C:,PTCH1:ENST00000430669:splice_region&intron:LOW:exon15/22:c.2362+9G>C:,PTCH1:ENST00000429896:splice_region&intron:LOW:exon15/23:c.2107+9G>C:,PTCH1:ENST00000375274:splice_region&intron:LOW:exon15/23:c.2557+9G>C:		rs2066829	0.3906	0.3583	8491,4561,2155	0.6417,0.1747,0.3414,0.3718,0.2609	0.4487							601309 [PTCH1 (confirmed) Basal cell nevus syndrome,109400|Basal cell carcinoma,somatic,605462|Holoprosencephaly 7,610828];	RCV000252294.1 [benign]; RCV000294663.1 [benign]; RCV000333289.1 [benign]; 			526	1836	1	[1] Ilnaz Sepahi 29-03-2016 batch import			PTCH1 (inh=AD pLI=1.00)
chr9	98238358	98238358	G	A	hom	anno_omim	QUAL=14352;DP=213;AF=0.99;MQM=59;TRIO=HOM,213,0.99,HOM,87,0.99,HOM,171,0.99	PTCH1	synonymous	PTCH1:ENST00000331920:synonymous:LOW:exon12/24:c.1686C>T:p.Ala562Ala,PTCH1:ENST00000418258:synonymous:LOW:exon12/24:c.1233C>T:p.Ala411Ala,PTCH1:ENST00000421141:synonymous:LOW:exon12/24:c.1233C>T:p.Ala411Ala,PTCH1:ENST00000437951:synonymous:LOW:exon12/24:c.1488C>T:p.Ala496Ala,PTCH1:ENST00000430669:synonymous:LOW:exon12/23:c.1488C>T:p.Ala496Ala,PTCH1:ENST00000429896:synonymous:LOW:exon12/24:c.1233C>T:p.Ala411Ala,PTCH1:ENST00000375274:synonymous:LOW:exon12/24:c.1683C>T:p.Ala561Ala		rs2066836	0.0919	0.1739	2070,1597,9	0.0313,0.0847,0.1039,0.2225,0.1408	0.1725							601309 [PTCH1 (confirmed) Basal cell nevus syndrome,109400|Basal cell carcinoma,somatic,605462|Holoprosencephaly 7,610828];	RCV000250191.1 [benign]; RCV000342546.1 [likely benign]; RCV000376238.1 [likely benign]; 		COSM1756288, COSM1756290, COSM1756289, COSM1756287	184	1324	1	[1] Ilnaz Sepahi 29-03-2016 batch import			PTCH1 (inh=AD pLI=1.00)
chr9	98269419	98269419	G	-	hom	anno_omim	QUAL=19876;DP=173;AF=1.00;MQM=59;TRIO=HOM,173,1.00,HOM,218,0.99,HOM,304,1.00	PTCH1,RP11-435O5.5	5'UTR,intron	PTCH1:ENST00000418258:5'UTR:MODIFIER:exon1/24:c.-453delC:,PTCH1:ENST00000331920:intron:MODIFIER:exon1/23:c.202-538delC:,PTCH1:ENST00000421141:intron:MODIFIER:exon1/23:c.-252-538delC:,PTCH1:ENST00000437951:intron:MODIFIER:exon1/23:c.4-538delC:,PTCH1:ENST00000430669:intron:MODIFIER:exon1/22:c.4-538delC:,PTCH1:ENST00000429896:intron:MODIFIER:exon1/23:c.-253+92delC:,PTCH1:ENST00000375274:intron:MODIFIER:exon1/23:c.199-538delC:,PTCH1:ENST00000468211:intron:MODIFIER:exon1/4:c.4-538delC:		rs397728992	0.2228	0.0000	0,0,0	0,0,0,0,0	0.2551							601309 [PTCH1 (confirmed) Basal cell nevus syndrome,109400|Basal cell carcinoma,somatic,605462|Holoprosencephaly 7,610828];				15	75					PTCH1 (inh=AD pLI=1.00), RP11-435O5.5 (inh=n/a pLI=n/a)
chr9	98270321	98270328	GTGAGTGT	-	hom	anno_omim	QUAL=17651;DP=78;AF=1.00;MQM=59;TRIO=HOM,78,1.00,HOM,254,1.00,HOM,373,0.98	PTCH1	5'UTR,intron,non_coding_transcript	PTCH1:ENST00000421141:5'UTR:MODIFIER:exon1/24:c.-22231_-358delACACTCAC:,PTCH1:ENST00000331920:intron:MODIFIER:exon1/23:c.201+115_201+122delACACTCAC:,PTCH1:ENST00000437951:intron:MODIFIER:exon1/23:c.4-1447_4-1440delACACTCAC:,PTCH1:ENST00000430669:intron:MODIFIER:exon1/22:c.4-1447_4-1440delACACTCAC:,PTCH1:ENST00000375274:intron:MODIFIER:exon1/23:c.199-1447_199-1440delACACTCAC:,PTCH1:ENST00000468211:intron:MODIFIER:exon1/4:c.4-1447_4-1440delACACTCAC:,PTCH1:ENST00000421141:non_coding_transcript:MODIFIER:exon1/24:c.-22231_-358delACACTCAC:	(GT)n	rs148507954;rs71366292	0.0000	0.0000	0,0,0	0,0,0,0,0	0.2230							601309 [PTCH1 (confirmed) Basal cell nevus syndrome,109400|Basal cell carcinoma,somatic,605462|Holoprosencephaly 7,610828];				9	67					PTCH1 (inh=AD pLI=1.00)
chr9	100459578	100459578	T	C	hom	anno_omim	QUAL=6735;DP=63;AF=0.98;MQM=59;TRIO=HOM,63,0.98,HET,104,0.28,HOM,150,1.00	XPA	5'UTR	XPA:ENST00000375128:5'UTR:MODIFIER:exon1/6:c.-4A>G:		rs1800975	0.6464	0.6335	22195,12832,2430	0.8039,0.6319,0.4981,0.6576,0.5287	0.6936							611153 [XPA (confirmed) Xeroderma pigmentosum,group A,278700];	RCV000170427.2 [benign]; RCV000286055.1 [benign]; 	CR044772 [CLASS=DP MUT=ALT PHEN="Lung adenocarcinoma risk association with" GENE=XPA]; 		1571	1447					XPA (inh=AR pLI=0.00)
chr9	100615553	100615553	A	G	het	low_DP;anno_omim	QUAL=903;DP=4;AF=0.75;MQM=59;TRIO=HET,4,0.75,WT,48,0.00,HET,86,0.51	FOXE1	5'UTR	FOXE1:ENST00000375123:5'UTR:MODIFIER:exon1/1:c.-644A>G:		rs13302470	0.6859	0.0000	0,0,0	0,0,0,0,0	0.6393							602617 [FOXE1 (confirmed) Bamforth-Lazarus syndrome,241850|Thyroid cancer,nonmedullary,4,616534];				73	80					FOXE1 (inh=AR pLI=n/a)
chr9	100615572	100615572	G	A	het	low_DP;anno_omim	QUAL=1078;DP=7;AF=0.43;MQM=59;TRIO=HET,7,0.43,WT,62,0.00,HET,105,0.52	FOXE1	5'UTR_premature_start_codon_gain,5'UTR	FOXE1:ENST00000375123:5'UTR_premature_start_codon_gain:LOW:exon1/1:c.-625G>A:,FOXE1:ENST00000375123:5'UTR:MODIFIER:exon1/1:c.-625G>A:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							602617 [FOXE1 (confirmed) Bamforth-Lazarus syndrome,241850|Thyroid cancer,nonmedullary,4,616534];				0	1					FOXE1 (inh=AR pLI=n/a)
chr9	100615660	100615660	G	C	hom	anno_omim	QUAL=5019;DP=31;AF=1.00;MQM=59;TRIO=HOM,31,1.00,HET,152,0.53,HET,194,0.49	FOXE1	5'UTR	FOXE1:ENST00000375123:5'UTR:MODIFIER:exon1/1:c.-537G>C:		rs7849497	0.8830	0.0000	0,0,0	0,0,0,0,0	0.8135							602617 [FOXE1 (confirmed) Bamforth-Lazarus syndrome,241850|Thyroid cancer,nonmedullary,4,616534];				138	74					FOXE1 (inh=AR pLI=n/a)
chr9	100615914	100615914	A	G	het	anno_omim	QUAL=662;DP=22;AF=0.45;MQM=60;TRIO=HET,22,0.45,WT,26,0.00,HET,51,0.45	FOXE1	5'UTR	FOXE1:ENST00000375123:5'UTR:MODIFIER:exon1/1:c.-283A>G:		rs1867277	0.6859	0.0000	0,0,0	0,0,0,0,0	0.6390							602617 [FOXE1 (confirmed) Bamforth-Lazarus syndrome,241850|Thyroid cancer,nonmedullary,4,616534];				83	108					FOXE1 (inh=AR pLI=n/a)
chr9	100615949	100615949	C	A	het	anno_omim	QUAL=1434;DP=28;AF=0.46;MQM=60;TRIO=HET,28,0.46,WT,113,0.00,HET,157,0.45	FOXE1	5'UTR	FOXE1:ENST00000375123:5'UTR:MODIFIER:exon1/1:c.-248C>A:		rs1867278	0.6859	0.0000	0,0,0	0,0,0,0,0	0.6387							602617 [FOXE1 (confirmed) Bamforth-Lazarus syndrome,241850|Thyroid cancer,nonmedullary,4,616534];				82	112					FOXE1 (inh=AR pLI=n/a)
chr9	100616041	100616041	T	C	hom	low_DP;anno_omim	QUAL=1277;DP=12;AF=0.92;MQM=60;TRIO=HOM,12,0.92,HET,42,0.48,HET,56,0.52	FOXE1	5'UTR	FOXE1:ENST00000375123:5'UTR:MODIFIER:exon1/1:c.-156T>C:		rs1867279	0.8830	0.0000	0,0,0	0,0,0,0,0	0.8137							602617 [FOXE1 (confirmed) Bamforth-Lazarus syndrome,241850|Thyroid cancer,nonmedullary,4,616534];				133	66					FOXE1 (inh=AR pLI=n/a)
chr9	100616066	100616066	G	C	het	low_DP;anno_omim	QUAL=403;DP=12;AF=0.50;MQM=60;TRIO=HET,12,0.50,WT,25,0.00,HET,30,0.53	FOXE1	5'UTR	FOXE1:ENST00000375123:5'UTR:MODIFIER:exon1/1:c.-131G>C:		rs1867280	0.6861	0.0000	0,0,0	0,0,0,0,0	0.6397							602617 [FOXE1 (confirmed) Bamforth-Lazarus syndrome,241850|Thyroid cancer,nonmedullary,4,616534];				75	88					FOXE1 (inh=AR pLI=n/a)
chr9	100616583	100616583	T	C	hom	anno_omim	QUAL=2544;DP=41;AF=1.00;MQM=60;TRIO=HOM,41,1.00,HET,59,0.59,HET,78,0.53	FOXE1	synonymous	FOXE1:ENST00000375123:synonymous:LOW:exon1/1:c.387T>C:p.Leu129Leu		rs3021523	0.8828	0.8005	38874,18153,4531	0.9430,0.8571,0.9972,0.7443,0.7869	0.8144							602617 [FOXE1 (confirmed) Bamforth-Lazarus syndrome,241850|Thyroid cancer,nonmedullary,4,616534];	RCV000081101.5 [benign]; 		COSM4163149	1232	737	2	[2] auto-classification 15.09.2017  			FOXE1 (inh=AR pLI=n/a)
chr9	100616692	100616692	G	C	het	low_QUAL;low_DP;pred_pathogenic;anno_omim	QUAL=10;DP=10;AF=0.30;MQM=55;TRIO=HET,10,0.30,WT,4,0.00,WT,13,0.00	FOXE1	missense	FOXE1:ENST00000375123:missense:MODERATE:exon1/1:c.496G>C:p.Ala166Pro			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000	1.2530	D	D	P	D	22.90	602617 [FOXE1 (confirmed) Bamforth-Lazarus syndrome,241850|Thyroid cancer,nonmedullary,4,616534];				0	0					FOXE1 (inh=AR pLI=n/a)
chr9	100617375	100617375	T	C	hom	anno_omim	QUAL=18056;DP=258;AF=0.99;MQM=59;TRIO=HOM,258,0.99,HET,416,0.49,HET,514,0.45	FOXE1	3'UTR	FOXE1:ENST00000375123:3'UTR:MODIFIER:exon1/1:c.*57T>C:		rs7046645	0.8828	0.0000	0,0,0	0,0,0,0,0	0.8132							602617 [FOXE1 (confirmed) Bamforth-Lazarus syndrome,241850|Thyroid cancer,nonmedullary,4,616534];				1116	672					FOXE1 (inh=AR pLI=n/a)
chr9	100617433	100617433	A	C	het	anno_omim	QUAL=6611;DP=156;AF=0.54;MQM=59;TRIO=HET,156,0.54,HET,387,0.49,WT,461,0.00	FOXE1	3'UTR	FOXE1:ENST00000375123:3'UTR:MODIFIER:exon1/1:c.*115A>C:		rs7043516	0.1813	0.0000	0,0,0	0,0,0,0,0	0.1700							602617 [FOXE1 (confirmed) Bamforth-Lazarus syndrome,241850|Thyroid cancer,nonmedullary,4,616534];				4	63					FOXE1 (inh=AR pLI=n/a)
chr9	100617479	100617479	G	T	het	anno_omim	QUAL=6396;DP=173;AF=0.51;MQM=59;TRIO=HET,173,0.51,WT,306,0.00,HET,424,0.43	FOXE1	3'UTR	FOXE1:ENST00000375123:3'UTR:MODIFIER:exon1/1:c.*161G>T:		rs1443434	0.6861	0.0000	0,0,0	0,0,0,0,0	0.6393							602617 [FOXE1 (confirmed) Bamforth-Lazarus syndrome,241850|Thyroid cancer,nonmedullary,4,616534];				83	113					FOXE1 (inh=AR pLI=n/a)
chr9	100617583	100617583	T	C	het	anno_omim	QUAL=8372;DP=295;AF=0.47;MQM=60;TRIO=HET,295,0.47,WT,316,0.01,HET,427,0.46	FOXE1	3'UTR	FOXE1:ENST00000375123:3'UTR:MODIFIER:exon1/1:c.*265T>C:		rs1443435	0.6861	0.0000	0,0,0	0,0,0,0,0	0.6399							602617 [FOXE1 (confirmed) Bamforth-Lazarus syndrome,241850|Thyroid cancer,nonmedullary,4,616534];				84	112					FOXE1 (inh=AR pLI=n/a)
chr9	100617649	100617649	A	G	het	anno_omim	QUAL=9064;DP=373;AF=0.50;MQM=60;TRIO=HET,373,0.50,WT,280,0.00,HET,363,0.48	FOXE1	3'UTR	FOXE1:ENST00000375123:3'UTR:MODIFIER:exon1/1:c.*331A>G:		rs41274258	0.0152	0.0000	0,0,0	0,0,0,0,0	0.0377							602617 [FOXE1 (confirmed) Bamforth-Lazarus syndrome,241850|Thyroid cancer,nonmedullary,4,616534];				0	20					FOXE1 (inh=AR pLI=n/a)
chr9	100618660	100618660	G	A	het	anno_omim	QUAL=4027;DP=225;AF=0.46;MQM=60;TRIO=HET,225,0.46,HET,78,0.62,WT,147,0.00	FOXE1	3'UTR	FOXE1:ENST00000375123:3'UTR:MODIFIER:exon1/1:c.*1342G>A:		rs10984009	0.0956	0.0000	0,0,0	0,0,0,0,0	0.1030							602617 [FOXE1 (confirmed) Bamforth-Lazarus syndrome,241850|Thyroid cancer,nonmedullary,4,616534];				1	47					FOXE1 (inh=AR pLI=n/a)
chr9	101913690	101913690	T	G	het	anno_omim	QUAL=1636;DP=117;AF=0.53;MQM=59;TRIO=HET,117,0.53,HET,3,0.33,HOM,12,1.00	TGFBR1	3'UTR	TGFBR1:ENST00000552516:3'UTR:MODIFIER:exon9/9:c.*2103T>G:,TGFBR1:ENST00000374994:3'UTR:MODIFIER:exon9/9:c.*2103T>G:,TGFBR1:ENST00000374990:3'UTR:MODIFIER:exon8/8:c.*2103T>G:	(T)n	rs7871490	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1248							190181 [TGFBR1 (confirmed) Loeys-Dietz syndrome 1,609192|Multiple self-healing squamous epithelioma,susceptibility to,132800];	RCV000266960.1 [uncertain significance]; RCV000307304.1 [uncertain significance]; RCV000361934.1 [uncertain significance]; 			2	61					TGFBR1 (inh=AD pLI=0.95)
chr9	103015184	103015184	T	C	het	anno_omim	QUAL=4818;DP=123;AF=0.56;MQM=60;TRIO=HET,123,0.56,HOM,100,1.00,WT,142,0.00	INVS	splice_region&intron	INVS:ENST00000262457:splice_region&intron:LOW:exon9/16:c.1235-5T>C:,INVS:ENST00000541287:splice_region&intron:LOW:exon10/16:c.947-5T>C:,INVS:ENST00000262456:splice_region&intron:LOW:exon9/17:c.1235-5T>C:		rs2245216	0.2105	0.3224	6743,5428,109	0.1524,0.1579,0.1038,0.4170,0.2368	0.3090							243305 [INVS (confirmed) Nephronophthisis 2,infantile,602088];	RCV000081626.5 [benign]; RCV000333501.1 [benign]; 		COSM150650	306	957	2	[2] auto-classification 15.09.2017  			INVS (inh=AR pLI=0.00)
chr9	103054951	103054951	T	C	het	anno_omim	QUAL=15678;DP=232;AF=0.47;MQM=60;TRIO=HET,232,0.47,HOM,290,1.00,HET,341,0.47	INVS	synonymous,intron	INVS:ENST00000262457:synonymous:LOW:exon14/17:c.2412T>C:p.Ser804Ser,INVS:ENST00000541287:synonymous:LOW:exon15/17:c.2124T>C:p.Ser708Ser,INVS:ENST00000262456:intron:MODIFIER:exon14/17:c.2179+233T>C:		rs2787374	0.4073	0.4676	14861,10875,1792	0.5898,0.2368,0.1081,0.5716,0.2957	0.5305							243305 [INVS (confirmed) Nephronophthisis 2,infantile,602088];	RCV000081629.5 [benign]; RCV000399311.1 [benign]; 		COSM3763489, COSM3763490	559	990	2	[2] auto-classification 15.09.2017  			INVS (inh=AR pLI=0.00)
chr9	103063422	103063425	CACA	-	hom	anno_omim	QUAL=525;DP=29;AF=0.90;MQM=58;TRIO=HOM,29,0.90,HOM,16,0.44,HOM,5,0.00	INVS,TEX10	intergenic_region	TEX10:ENSG00000119509-ENSG00000136891:intergenic_region:MODIFIER::n.103063422_103063425delCACA:	(CA)n		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0451							243305 [INVS (confirmed) Nephronophthisis 2,infantile,602088];	RCV000317814.1 [uncertain significance]; 			5	0					INVS (inh=AR pLI=0.00), TEX10 (inh=n/a pLI=1.00)
chr9	104183194	104183194	C	T	het	anno_omim	QUAL=12616;DP=425;AF=0.48;MQM=60;TRIO=HET,425,0.48,HOM,225,0.99,WT,360,0.00	ALDOB	3'UTR	ALDOB:ENST00000374855:3'UTR:MODIFIER:exon9/9:c.*897G>A:	HAL1ME	rs17772839	0.0625	0.0000	0,0,0	0,0,0,0,0	0.0722							612724 [ALDOB (confirmed) Fructose intolerance,229600];	RCV000393044.1 [likely benign]; 			6	35					ALDOB (inh=AR pLI=0.00)
chr9	104183479	104183479	T	C	het	anno_omim	QUAL=7857;DP=237;AF=0.52;MQM=60;TRIO=HET,237,0.52,HOM,144,0.98,WT,130,0.00	ALDOB	3'UTR	ALDOB:ENST00000374855:3'UTR:MODIFIER:exon9/9:c.*612A>G:	MER5B	rs41296049	0.0625	0.0000	0,0,0	0,0,0,0,0	0.0721							612724 [ALDOB (confirmed) Fructose intolerance,229600];	RCV000358465.1 [likely benign]; 			6	34					ALDOB (inh=AR pLI=0.00)
chr9	104183539	104183539	A	T	het	anno_omim	QUAL=11018;DP=425;AF=0.48;MQM=59;TRIO=HET,425,0.48,HOM,193,0.98,WT,232,0.00	ALDOB	3'UTR	ALDOB:ENST00000374855:3'UTR:MODIFIER:exon9/9:c.*552T>A:	MER5B	rs41308902	0.0627	0.0000	0,0,0	0,0,0,0,0	0.0723							612724 [ALDOB (confirmed) Fructose intolerance,229600];	RCV000323875.1 [likely benign]; 			6	35					ALDOB (inh=AR pLI=0.00)
chr9	104183586	104183586	G	T	het	anno_omim	QUAL=11867;DP=466;AF=0.46;MQM=60;TRIO=HET,466,0.46,HOM,194,0.98,WT,255,0.00	ALDOB	3'UTR	ALDOB:ENST00000374855:3'UTR:MODIFIER:exon9/9:c.*505C>A:		rs17772845	0.0625	0.0000	0,0,0	0,0,0,0,0	0.0722							612724 [ALDOB (confirmed) Fructose intolerance,229600];	RCV000371488.1 [likely benign]; 			6	35					ALDOB (inh=AR pLI=0.00)
chr9	104183885	104183885	G	T	het	anno_omim	QUAL=8417;DP=362;AF=0.45;MQM=60;TRIO=HET,362,0.45,HOM,127,1.00,WT,162,0.01	ALDOB	3'UTR	ALDOB:ENST00000374855:3'UTR:MODIFIER:exon9/9:c.*206C>A:		rs17772869	0.0561	0.0000	0,0,0	0,0,0,0,0	0.0676							612724 [ALDOB (confirmed) Fructose intolerance,229600];	RCV000292298.1 [likely benign]; 			6	35					ALDOB (inh=AR pLI=0.00)
chr9	104183969	104183969	C	T	het	anno_omim	QUAL=5481;DP=192;AF=0.47;MQM=60;TRIO=HET,192,0.47,HOM,98,1.00,WT,119,0.00	ALDOB	3'UTR	ALDOB:ENST00000374855:3'UTR:MODIFIER:exon9/9:c.*122G>A:		rs41310087	0.0397	0.0000	0,0,0	0,0,0,0,0	0.0506							612724 [ALDOB (confirmed) Fructose intolerance,229600];	RCV000395004.1 [likely benign]; 			6	65					ALDOB (inh=AR pLI=0.00)
chr9	108398678	108398678	A	G	het	anno_omim	QUAL=13681;DP=248;AF=0.53;MQM=60;TRIO=HET,248,0.53,HET,327,0.55,HET,398,0.52	FKTN	3'UTR,intron	FKTN:ENST00000223528:3'UTR:MODIFIER:exon10/10:c.*1133A>G:,FKTN:ENST00000448551:intron:MODIFIER:exon11/11:c.1270+1249A>G:,FKTN:ENST00000357998:intron:MODIFIER:exon9/9:c.1270+1249A>G:		rs2768282	0.1354	0.0000	0,0,0	0,0,0,0,0	0.1237							607440 [FKTN (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,4,253800|Muscular dystrophy-dystroglycanopathy (congenital without mental retardation),type B,4,613152|Cardiomyopathy,dilated,1X,611615|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,4,611588];	RCV000293508.1 [uncertain significance]; RCV000348334.1 [uncertain significance]; 			9	91					FKTN (inh=AR pLI=0.00)
chr9	108399825	108399825	T	C	het	anno_omim	QUAL=17626;DP=580;AF=0.53;MQM=60;TRIO=HET,580,0.53,HET,311,0.41,HET,425,0.50	FKTN	3'UTR,intron	FKTN:ENST00000223528:3'UTR:MODIFIER:exon10/10:c.*2280T>C:,FKTN:ENST00000448551:intron:MODIFIER:exon11/11:c.1270+2396T>C:,FKTN:ENST00000357998:intron:MODIFIER:exon9/9:c.1270+2396T>C:		rs1024366	0.1342	0.0000	0,0,0	0,0,0,0,0	0.1233							607440 [FKTN (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,4,253800|Muscular dystrophy-dystroglycanopathy (congenital without mental retardation),type B,4,613152|Cardiomyopathy,dilated,1X,611615|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,4,611588];	RCV000405538.1 [benign]; 			9	90					FKTN (inh=AR pLI=0.00)
chr9	108402805	108402805	G	T	het	anno_omim	QUAL=1511;DP=87;AF=0.48;MQM=58;TRIO=HET,87,0.48,HET,16,0.38,HET,25,0.64	FKTN	3'UTR	FKTN:ENST00000223528:3'UTR:MODIFIER:exon10/10:c.*5260G>T:	AluSz	rs2010861	0.1318	0.0000	0,0,0	0,0,0,0,0	0.1208							607440 [FKTN (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,4,253800|Muscular dystrophy-dystroglycanopathy (congenital without mental retardation),type B,4,613152|Cardiomyopathy,dilated,1X,611615|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,4,611588];	RCV000317327.1 [uncertain significance]; RCV000371858.1 [uncertain significance]; 			8	88					FKTN (inh=AR pLI=0.00)
chr9	108402836	108402836	A	-	het	anno_omim	QUAL=131;DP=86;AF=0.21;MQM=58;TRIO=HET,86,0.21,WT,23,0.04,WT,41,0.12	FKTN	3'UTR	FKTN:ENST00000223528:3'UTR:MODIFIER:exon10/10:c.*5303delA:	AluSz	rs879263714	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0030							607440 [FKTN (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,4,253800|Muscular dystrophy-dystroglycanopathy (congenital without mental retardation),type B,4,613152|Cardiomyopathy,dilated,1X,611615|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,4,611588];				0	13					FKTN (inh=AR pLI=0.00)
chr9	111653574	111653574	C	G	hom	anno_omim	QUAL=13554;DP=258;AF=1.00;MQM=60;TRIO=HOM,258,1.00,HET,202,0.40,HET,282,0.47	IKBKAP	synonymous	IKBKAP:ENST00000374647:synonymous:LOW:exon28/37:c.3069G>C:p.Leu1023Leu,IKBKAP:ENST00000537196:synonymous:LOW:exon21/30:c.2022G>C:p.Leu674Leu		rs1063110	0.3155	0.3913	10015,6650,72	0.0998,0.4131,0.4483,0.4452,0.3087	0.4009							603722 [IKBKAP (confirmed) Dysautonomia,familial,223900];	RCV000245896.1 [benign]; RCV000338102.1 [likely benign]; 		COSM3763506	398	1010	2	[2] auto-classification 15.09.2017  			ELP1 (inh=AR pLI=0.00)
chr9	111696389	111696389	G	C	het	anno_omim	QUAL=1620;DP=41;AF=0.49;MQM=59;TRIO=HET,41,0.49,HET,105,0.48,WT,166,0.00	IKBKAP	5'UTR	IKBKAP:ENST00000374647:5'UTR:MODIFIER:exon1/37:c.-301C>G:		rs2275641	0.3520	0.0000	0,0,0	0,0,0,0,0	0.3651							603722 [IKBKAP (confirmed) Dysautonomia,familial,223900];	RCV000368493.1 [likely benign]; 			29	101					ELP1 (inh=AR pLI=0.00)
chr9	113457726	113457726	G	A	het	anno_omim	QUAL=8213;DP=220;AF=0.49;MQM=60;TRIO=HET,220,0.49,HET,170,0.49,HET,233,0.52	MUSK	synonymous	MUSK:ENST00000189978:synonymous:LOW:exon4/14:c.402G>A:p.Glu134Glu,MUSK:ENST00000374440:synonymous:LOW:exon4/6:c.48G>A:p.Glu16Glu,MUSK:ENST00000374448:synonymous:LOW:exon4/15:c.402G>A:p.Glu134Glu,MUSK:ENST00000416899:synonymous:LOW:exon4/13:c.402G>A:p.Glu134Glu,MUSK:ENST00000374439:synonymous:LOW:exon2/4:c.48G>A:p.Glu16Glu		rs10980531	0.1701	0.2416	717,380,41	0.1905,0.2354,0.3367,0.2641,0.2078	0.1719							601296 [MUSK (confirmed) Myasthenic syndrome,congenital,9,associated with acetylcholine receptor deficiency,616325|Fetal akinesia deformation sequence,208150];	RCV000117647.2 [benign]; RCV000348451.1 [benign]; 			78	618	2	[2] auto-classification 15.09.2017  			MUSK (inh=AR pLI=0.00)
chr9	116023498	116023498	C	T	het		QUAL=5709;DP=226;AF=0.52;MQM=53;TRIO=HET,226,0.52,WT,174,0.00,HET,238,0.52	SLC31A1,CDC26	3'UTR,intron	SLC31A1:ENST00000374212:3'UTR:MODIFIER:exon5/5:c.*745C>T:,SLC31A1:ENST00000374210:intron:MODIFIER:exon5/5:c.408+910C>T:	AluSq2	rs139028783	0.0096	0.0000	0,0,0	0,0,0,0,0	0.0118											0	6					SLC31A1 (inh=n/a pLI=0.52), CDC26 (inh=n/a pLI=0.65)
chr9	116023979	116023979	A	C	het		QUAL=8036;DP=263;AF=0.56;MQM=59;TRIO=HET,263,0.56,WT,188,0.01,HET,282,0.53	SLC31A1,CDC26	3'UTR,intron	SLC31A1:ENST00000374212:3'UTR:MODIFIER:exon5/5:c.*1226A>C:,SLC31A1:ENST00000374210:intron:MODIFIER:exon5/5:c.408+1391A>C:	MER5A	rs41280225	0.1384	0.0000	0,0,0	0,0,0,0,0	0.1065											3	42					SLC31A1 (inh=n/a pLI=0.52), CDC26 (inh=n/a pLI=0.65)
chr9	116025024	116025024	A	C	het		QUAL=8842;DP=433;AF=0.50;MQM=59;TRIO=HET,433,0.50,HET,234,0.50,WT,267,0.00	SLC31A1,CDC26	3'UTR,intron	SLC31A1:ENST00000374212:3'UTR:MODIFIER:exon5/5:c.*2271A>C:,SLC31A1:ENST00000374210:intron:MODIFIER:exon5/5:c.408+2436A>C:		rs10759637	0.5092	0.0000	0,0,0	0,0,0,0,0	0.4761											49	110					SLC31A1 (inh=n/a pLI=0.52), CDC26 (inh=n/a pLI=0.65)
chr9	116026255	116026255	G	C	het		QUAL=7780;DP=355;AF=0.54;MQM=59;TRIO=HET,355,0.54,HET,189,0.53,WT,250,0.00	SLC31A1,CDC26	3'UTR,intron	SLC31A1:ENST00000374212:3'UTR:MODIFIER:exon5/5:c.*3502G>C:,SLC31A1:ENST00000374210:intron:MODIFIER:exon5/5:c.409-2261G>C:		rs1143245	0.3185	0.0000	0,0,0	0,0,0,0,0	0.2131											11	75					SLC31A1 (inh=n/a pLI=0.52), CDC26 (inh=n/a pLI=0.65)
chr9	119462112	119462112	C	T	hom	anno_omim	QUAL=27330;DP=359;AF=1.00;MQM=60;TRIO=HOM,359,1.00,HOM,216,1.00,HOM,254,1.00	TRIM32,ASTN2	3'UTR,intron	TRIM32:ENST00000373983:3'UTR:MODIFIER:exon2/2:c.*129C>T:,TRIM32:ENST00000450136:3'UTR:MODIFIER:exon2/2:c.*129C>T:,ASTN2:ENST00000313400:intron:MODIFIER:exon16/22:c.2806+25938G>A:,ASTN2:ENST00000373996:intron:MODIFIER:exon16/22:c.2794+25938G>A:,ASTN2:ENST00000361209:intron:MODIFIER:exon15/21:c.2653+25938G>A:,ASTN2:ENST00000361477:intron:MODIFIER:exon15/22:c.-39+25938G>A:		rs3019	0.9491	0.0000	0,0,0	0,0,0,0,0	0.9408							602290 [TRIM32 (confirmed) Muscular dystrophy,limb-girdle,type 2H,254110|Bardet-Biedl syndrome 11,615988];	RCV000284772.1 [benign]; RCV000339744.1 [benign]; 			205	26					TRIM32 (inh=AR pLI=0.10), ASTN2 (inh=n/a pLI=0.99)
chr9	119463189	119463189	T	C	het	anno_omim	QUAL=9991;DP=356;AF=0.54;MQM=60;TRIO=HET,356,0.54,WT,326,0.00,HET,327,0.54	TRIM32,ASTN2	3'UTR,intron	TRIM32:ENST00000373983:3'UTR:MODIFIER:exon2/2:c.*1206T>C:,TRIM32:ENST00000450136:3'UTR:MODIFIER:exon2/2:c.*1206T>C:,ASTN2:ENST00000313400:intron:MODIFIER:exon16/22:c.2806+24861A>G:,ASTN2:ENST00000373996:intron:MODIFIER:exon16/22:c.2794+24861A>G:,ASTN2:ENST00000361209:intron:MODIFIER:exon15/21:c.2653+24861A>G:,ASTN2:ENST00000361477:intron:MODIFIER:exon15/22:c.-39+24861A>G:		rs2281627	0.2680	0.0000	0,0,0	0,0,0,0,0	0.2906							602290 [TRIM32 (confirmed) Muscular dystrophy,limb-girdle,type 2H,254110|Bardet-Biedl syndrome 11,615988];	RCV000304648.1 [likely benign]; RCV000407378.1 [likely benign]; 			28	123					TRIM32 (inh=AR pLI=0.10), ASTN2 (inh=n/a pLI=0.99)
chr9	123170733	123170733	C	G	hom	anno_omim	QUAL=29763;DP=361;AF=0.99;MQM=59;TRIO=HOM,361,0.99,HOM,275,1.00,HOM,338,1.00	CDK5RAP2	missense	CDK5RAP2:ENST00000349780:missense:MODERATE:exon31/38:c.4618G>C:p.Val1540Leu,CDK5RAP2:ENST00000359309:missense:MODERATE:exon30/37:c.4495G>C:p.Val1499Leu,CDK5RAP2:ENST00000360822:missense:MODERATE:exon30/37:c.4522G>C:p.Val1508Leu,CDK5RAP2:ENST00000360190:missense:MODERATE:exon31/37:c.4618G>C:p.Val1540Leu		rs4837768	0.7532	0.7691	36224,18864,1789	0.5846,0.8930,0.8287,0.7528,0.8248	0.7774	-0.0830	T,T,T,T,T,T,T	T	B,B,B,B,B	T,T,T,T,T,T	12.10	608201 [CDK5RAP2 (confirmed) Microcephaly 3,primary,autosomal recessive,604804];	RCV000020841.1 [benign]; RCV000145488.2 [other]; RCV000331745.1 [benign]; 			1217	775	2	[2] auto-classification 15.09.2017  			CDK5RAP2 (inh=AR pLI=0.00)
chr9	123215872	123215872	G	C	het	anno_omim	QUAL=9842;DP=386;AF=0.48;MQM=60;TRIO=HET,386,0.48,WT,325,0.00,HET,408,0.50	CDK5RAP2	missense	CDK5RAP2:ENST00000349780:missense:MODERATE:exon21/38:c.2655C>G:p.Phe885Leu,CDK5RAP2:ENST00000359309:missense:MODERATE:exon21/37:c.2655C>G:p.Phe885Leu,CDK5RAP2:ENST00000360822:missense:MODERATE:exon20/37:c.2559C>G:p.Phe853Leu,CDK5RAP2:ENST00000360190:missense:MODERATE:exon21/37:c.2655C>G:p.Phe885Leu		rs112600265	0.0014	0.0040	0,0,0	0.0014,0.0039,0.0000,0.0054,0.0022	0.0036	0.5100	T,T,T,T,T	T	B,B,B,B	T,T,T,T,T	9.02	608201 [CDK5RAP2 (confirmed) Microcephaly 3,primary,autosomal recessive,604804];	RCV000345743.1 [uncertain significance]; 			1	16	3	[3] Stephan Waldm?ller 12.08.2014			CDK5RAP2 (inh=AR pLI=0.00)
chr9	123291036	123291036	C	G	hom	pred_pathogenic;anno_omim	QUAL=34573;DP=329;AF=1.00;MQM=60;TRIO=HOM,329,1.00,HOM,332,1.00,HOM,385,1.00	CDK5RAP2	missense	CDK5RAP2:ENST00000349780:missense:MODERATE:exon9/38:c.865G>C:p.Glu289Gln,CDK5RAP2:ENST00000359309:missense:MODERATE:exon9/37:c.865G>C:p.Glu289Gln,CDK5RAP2:ENST00000360822:missense:MODERATE:exon9/37:c.865G>C:p.Glu289Gln,CDK5RAP2:ENST00000360190:missense:MODERATE:exon9/37:c.865G>C:p.Glu289Gln		rs4836822	0.8011	0.8772	47115,28550,2381	0.6762,0.8601,0.7243,0.9253,0.8795	0.8796	2.5270	T,T,T,T,T,T	T	P,B,P	T,T,T,T,T	18.25	608201 [CDK5RAP2 (confirmed) Microcephaly 3,primary,autosomal recessive,604804];	RCV000020847.1 [benign]; RCV000145507.2 [other]; RCV000407188.1 [benign]; 			1717	368	2	[2] auto-classification 15.09.2017  			CDK5RAP2 (inh=AR pLI=0.00)
chr9	123342259	123342259	C	A	hom	anno_omim	QUAL=6138;DP=91;AF=1.00;MQM=60;TRIO=HOM,91,1.00,HOM,41,1.00,HOM,69,1.00	CDK5RAP2	5'UTR	CDK5RAP2:ENST00000349780:5'UTR:MODIFIER:exon1/38:c.-3G>T:,CDK5RAP2:ENST00000359309:5'UTR:MODIFIER:exon1/37:c.-3G>T:,CDK5RAP2:ENST00000360822:5'UTR:MODIFIER:exon1/37:c.-3G>T:,CDK5RAP2:ENST00000360190:5'UTR:MODIFIER:exon1/37:c.-3G>T:		rs932975	0.9804	0.9921	58644,32739,4293	0.9223,0.9952,1.0000,0.9986,0.9998	0.9935							608201 [CDK5RAP2 (confirmed) Microcephaly 3,primary,autosomal recessive,604804];	RCV000081944.6 [benign]; RCV000387394.1 [benign]; 			2094	18					CDK5RAP2 (inh=AR pLI=0.00)
chr9	123342275	123342275	A	G	hom	anno_omim	QUAL=5221;DP=79;AF=1.00;MQM=60;TRIO=HOM,79,1.00,HOM,41,1.00,HOM,62,1.00	CDK5RAP2	5'UTR	CDK5RAP2:ENST00000349780:5'UTR:MODIFIER:exon1/38:c.-19T>C:,CDK5RAP2:ENST00000359309:5'UTR:MODIFIER:exon1/37:c.-19T>C:,CDK5RAP2:ENST00000360822:5'UTR:MODIFIER:exon1/37:c.-19T>C:,CDK5RAP2:ENST00000360190:5'UTR:MODIFIER:exon1/37:c.-19T>C:		rs932974	0.9655	0.9878	56249,31622,3699	0.8763,0.9907,1.0000,0.9984,0.9998	0.9896							608201 [CDK5RAP2 (confirmed) Microcephaly 3,primary,autosomal recessive,604804];	RCV000081943.5 [benign]; RCV000338769.1 [benign]; 			2054	20					CDK5RAP2 (inh=AR pLI=0.00)
chr9	123714876	123714876	C	T	het	anno_omim	QUAL=7325;DP=310;AF=0.48;MQM=60;TRIO=HET,310,0.48,HET,235,0.57,WT,333,0.00	C5	3'UTR	C5:ENST00000223642:3'UTR:MODIFIER:exon41/41:c.*141G>A:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							120900 [C5 (confirmed) C5 deficiency,609536|Eculizumab,poor response to,615749];				0	2					C5 (inh=AR pLI=0.00)
chr9	123769200	123769200	C	T	hom	anno_omim	QUAL=23907;DP=282;AF=1.00;MQM=60;TRIO=HOM,282,1.00,HOM,187,1.00,HOM,250,1.00	C5	missense	C5:ENST00000223642:missense:MODERATE:exon19/41:c.2404G>A:p.Val802Ile		rs17611	0.4048	0.4586	13996,6618,45	0.0800,0.5489,0.5539,0.4420,0.6347	0.4727	0.1000	T,T	T	B	T	18.88	120900 [C5 (confirmed) C5 deficiency,609536|Eculizumab,poor response to,615749];		CM093430 [CLASS=DP MUT=ALT PHEN="Ischemic stroke association with" GENE=C5]; 		462	1039	2	[2] auto-classification 15.09.2017  			C5 (inh=AR pLI=0.00)
chr9	123780005	123780005	G	A	hom	anno_omim	QUAL=28153;DP=396;AF=0.99;MQM=60;TRIO=HOM,396,0.99,HOM,202,1.00,HOM,246,1.00	C5	synonymous	C5:ENST00000223642:synonymous:LOW:exon13/41:c.1632C>T:p.Tyr544Tyr		rs25681	0.4058	0.4570	13895,6570,43	0.0793,0.5486,0.5537,0.4405,0.6303	0.4711							120900 [C5 (confirmed) C5 deficiency,609536|Eculizumab,poor response to,615749];			COSM1459729	453	1044	2	[2] auto-classification 15.09.2017  			C5 (inh=AR pLI=0.00)
chr9	124083614	124083614	C	T	het	anno_omim	QUAL=5903;DP=262;AF=0.46;MQM=59;TRIO=HET,262,0.46,HET,311,0.47,WT,418,0.00	GSN	synonymous	GSN:ENST00000373818:synonymous:LOW:exon10/17:c.1413C>T:p.Gly471Gly,GSN:ENST00000373823:synonymous:LOW:exon18/25:c.1260C>T:p.Gly420Gly,GSN:ENST00000341272:synonymous:LOW:exon11/18:c.1260C>T:p.Gly420Gly,GSN:ENST00000373808:synonymous:LOW:exon10/17:c.1260C>T:p.Gly420Gly,GSN:ENST00000394353:synonymous:LOW:exon12/19:c.1293C>T:p.Gly431Gly,GSN:ENST00000412819:synonymous:LOW:exon12/19:c.1260C>T:p.Gly420Gly,GSN:ENST00000436847:synonymous:LOW:exon12/19:c.1293C>T:p.Gly431Gly,GSN:ENST00000449733:synonymous:LOW:exon12/19:c.1260C>T:p.Gly420Gly,GSN:ENST00000545652:synonymous:LOW:exon10/17:c.1284C>T:p.Gly428Gly,GSN:ENST00000373807:synonymous:LOW:exon6/12:c.606C>T:p.Gly202Gly		rs2304393	0.0855	0.0625	355,103,37	0.0796,0.0262,0.1676,0.0503,0.0740	0.0625							137350 [GSN (provisional) Amyloidosis,Finnish type,105120];	RCV000349867.1 [benign]; 			9	295	2	[2] auto-classification 15.09.2017  			GSN (inh=AD pLI=0.00)
chr9	129453229	129453229	A	G	hom	anno_omim	QUAL=8960;DP=110;AF=1.00;MQM=59;TRIO=HOM,110,1.00,HET,105,0.55,HOM,131,0.99	LMX1B	synonymous	LMX1B:ENST00000355497:synonymous:LOW:exon3/8:c.441A>G:p.Glu147Glu,LMX1B:ENST00000526117:synonymous:LOW:exon3/8:c.441A>G:p.Glu147Glu,LMX1B:ENST00000373474:synonymous:LOW:exon3/8:c.441A>G:p.Glu147Glu,LMX1B:ENST00000425646:synonymous:LOW:exon3/8:c.372A>G:p.Glu124Glu,LMX1B:ENST00000561065:synonymous:LOW:exon3/8:c.372A>G:p.Glu124Glu		rs2277158	0.4800	0.4496	11975,5956,1445	0.5354,0.4605,0.5517,0.4298,0.4356	0.4526							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000251599.1 [benign]; RCV000321575.1 [benign]; 		COSM3763642, COSM3763643, COSM3763641	393	1045	2	[2] auto-classification 15.09.2017  			LMX1B (inh=AD pLI=0.82)
chr9	129455587	129455587	G	C	hom	anno_omim	QUAL=9114;DP=85;AF=1.00;MQM=59;TRIO=HOM,85,1.00,HET,128,0.40,HOM,172,0.99	LMX1B	synonymous	LMX1B:ENST00000355497:synonymous:LOW:exon4/8:c.726G>C:p.Ser242Ser,LMX1B:ENST00000526117:synonymous:LOW:exon4/8:c.726G>C:p.Ser242Ser,LMX1B:ENST00000373474:synonymous:LOW:exon4/8:c.726G>C:p.Ser242Ser,LMX1B:ENST00000425646:synonymous:LOW:exon4/8:c.657G>C:p.Ser219Ser,LMX1B:ENST00000561065:synonymous:LOW:exon4/8:c.657G>C:p.Ser219Ser		rs13295990	0.4393	0.4702	8617,4539,644	0.4389,0.4943,0.5796,0.4630,0.4567	0.4342							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000243969.2 [benign]; RCV000349276.1 [benign]; 			391	1043	2	[2] auto-classification 15.09.2017  			LMX1B (inh=AD pLI=0.82)
chr9	129459181	129459181	C	T	het	anno_omim	QUAL=4899;DP=117;AF=0.49;MQM=59;TRIO=HET,117,0.49,WT,254,0.00,HET,304,0.48	LMX1B	3'UTR	LMX1B:ENST00000355497:3'UTR:MODIFIER:exon8/8:c.*451C>T:,LMX1B:ENST00000425646:3'UTR:MODIFIER:exon8/8:c.*451C>T:		rs71497630	0.1516	0.0000	0,0,0	0,0,0,0,0	0.1144							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000303244.1 [benign]; 			2	52					LMX1B (inh=AD pLI=0.82)
chr9	129459314	129459314	C	T	het	anno_omim	QUAL=13134;DP=326;AF=0.45;MQM=59;TRIO=HET,326,0.45,HET,378,0.47,HET,494,0.44	LMX1B	3'UTR	LMX1B:ENST00000355497:3'UTR:MODIFIER:exon8/8:c.*584C>T:,LMX1B:ENST00000425646:3'UTR:MODIFIER:exon8/8:c.*584C>T:		rs34200683	0.2181	0.0000	0,0,0	0,0,0,0,0	0.2422							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000363724.1 [benign]; 			20	126					LMX1B (inh=AD pLI=0.82)
chr9	129459438	129459438	G	A	het	anno_omim	QUAL=8308;DP=161;AF=0.45;MQM=60;TRIO=HET,161,0.45,HET,278,0.46,HET,363,0.40	LMX1B	3'UTR	LMX1B:ENST00000355497:3'UTR:MODIFIER:exon8/8:c.*708G>A:,LMX1B:ENST00000425646:3'UTR:MODIFIER:exon8/8:c.*708G>A:		rs10987413	0.2057	0.0000	0,0,0	0,0,0,0,0	0.2286							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000368638.1 [benign]; 			17	124					LMX1B (inh=AD pLI=0.82)
chr9	129459478	129459478	C	T	het	anno_omim	QUAL=7256;DP=197;AF=0.46;MQM=59;TRIO=HET,197,0.46,HET,219,0.46,HET,322,0.40	LMX1B	3'UTR	LMX1B:ENST00000355497:3'UTR:MODIFIER:exon8/8:c.*748C>T:,LMX1B:ENST00000425646:3'UTR:MODIFIER:exon8/8:c.*748C>T:		rs10987414	0.2340	0.0000	0,0,0	0,0,0,0,0	0.2553							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000276381.1 [benign]; 			20	127					LMX1B (inh=AD pLI=0.82)
chr9	129459662	129459662	G	T	het	anno_omim	QUAL=9261;DP=458;AF=0.47;MQM=59;TRIO=HET,458,0.47,WT,229,0.00,HET,266,0.56	LMX1B	3'UTR	LMX1B:ENST00000355497:3'UTR:MODIFIER:exon8/8:c.*932G>T:,LMX1B:ENST00000425646:3'UTR:MODIFIER:exon8/8:c.*932G>T:		rs28687510	0.2298	0.0000	0,0,0	0,0,0,0,0	0.1834							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000372190.1 [benign]; 			2	53					LMX1B (inh=AD pLI=0.82)
chr9	129459985	129459985	A	G	het	anno_omim	QUAL=5786;DP=226;AF=0.50;MQM=60;TRIO=HET,226,0.50,WT,244,0.00,HET,250,0.49	LMX1B	3'UTR	LMX1B:ENST00000355497:3'UTR:MODIFIER:exon8/8:c.*1255A>G:,LMX1B:ENST00000425646:3'UTR:MODIFIER:exon8/8:c.*1255A>G:	L3b	rs16929236	0.2302	0.0000	0,0,0	0,0,0,0,0	0.1837							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000282993.1 [benign]; 			2	41					LMX1B (inh=AD pLI=0.82)
chr9	129460119	129460119	T	G	hom	anno_omim	QUAL=4189;DP=34;AF=0.35;MQM=56;TRIO=HOM,34,1.00,WT,95,0.43,HET,68,0.94	LMX1B	3'UTR	LMX1B:ENST00000355497:3'UTR:MODIFIER:exon8/8:c.*1389T>G:,LMX1B:ENST00000425646:3'UTR:MODIFIER:exon8/8:c.*1389T>G:	(TGTTT)n	rs13300385	0.1641	0.0000	0,0,0	0,0,0,0,0	0.1185							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000394099.1 [benign]; 			8	27					LMX1B (inh=AD pLI=0.82)
chr9	129460123	129460123	G	T	hom	anno_omim	QUAL=4189;DP=34;AF=0.35;MQM=56;TRIO=HOM,34,1.00,WT,95,0.43,HET,68,0.94	LMX1B	3'UTR	LMX1B:ENST00000355497:3'UTR:MODIFIER:exon8/8:c.*1393G>T:,LMX1B:ENST00000425646:3'UTR:MODIFIER:exon8/8:c.*1393G>T:	(TGTTT)n	rs13299451	0.1613	0.0000	0,0,0	0,0,0,0,0	0.1108							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000313143.1 [benign]; 			10	26					LMX1B (inh=AD pLI=0.82)
chr9	129460203	129460203	G	A	het	low_MQM;anno_omim	QUAL=2120;DP=133;AF=0.44;MQM=48;TRIO=HET,133,0.44,WT,133,0.00,HET,99,0.35	LMX1B	3'UTR	LMX1B:ENST00000355497:3'UTR:MODIFIER:exon8/8:c.*1473G>A:,LMX1B:ENST00000425646:3'UTR:MODIFIER:exon8/8:c.*1473G>A:	AluSp	rs13299609	0.1508	0.0000	0,0,0	0,0,0,0,0	0.1148							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000370211.1 [benign]; 			2	37					LMX1B (inh=AD pLI=0.82)
chr9	129460312	129460312	A	G	hom	anno_omim	QUAL=11431;DP=164;AF=0.99;MQM=56;TRIO=HOM,164,0.99,HET,143,0.44,HOM,166,0.99	LMX1B	3'UTR	LMX1B:ENST00000355497:3'UTR:MODIFIER:exon8/8:c.*1582A>G:,LMX1B:ENST00000425646:3'UTR:MODIFIER:exon8/8:c.*1582A>G:	AluSp	rs10987415	0.4103	0.0000	0,0,0	0,0,0,0,0	0.3954							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000358180.1 [benign]; 			37	78					LMX1B (inh=AD pLI=0.82)
chr9	129460396	129460396	C	T	het	anno_omim	QUAL=11244;DP=248;AF=0.53;MQM=56;TRIO=HET,248,0.53,HET,288,0.46,HET,370,0.54	LMX1B	3'UTR	LMX1B:ENST00000355497:3'UTR:MODIFIER:exon8/8:c.*1666C>T:,LMX1B:ENST00000425646:3'UTR:MODIFIER:exon8/8:c.*1666C>T:	AluSp	rs10987416	0.2169	0.0000	0,0,0	0,0,0,0,0	0.2382							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000288172.1 [benign]; 			11	83					LMX1B (inh=AD pLI=0.82)
chr9	129460722	129460722	T	C	hom	anno_omim	QUAL=21495;DP=419;AF=1.00;MQM=59;TRIO=HOM,419,1.00,HET,247,0.49,HET,356,0.52	LMX1B	3'UTR	LMX1B:ENST00000355497:3'UTR:MODIFIER:exon8/8:c.*1992T>C:,LMX1B:ENST00000425646:3'UTR:MODIFIER:exon8/8:c.*1992T>C:	L3	rs34776870	0.1955	0.0000	0,0,0	0,0,0,0,0	0.1571							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000397676.1 [benign]; 			3	42					LMX1B (inh=AD pLI=0.82)
chr9	129460727	129460727	G	A	hom	anno_omim	QUAL=20742;DP=419;AF=0.99;MQM=59;TRIO=HOM,419,0.99,HET,253,0.48,HET,352,0.53	LMX1B	3'UTR	LMX1B:ENST00000355497:3'UTR:MODIFIER:exon8/8:c.*1997G>A:,LMX1B:ENST00000425646:3'UTR:MODIFIER:exon8/8:c.*1997G>A:	L3	rs35632228	0.1953	0.0000	0,0,0	0,0,0,0,0	0.1546							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000356475.1 [benign]; 			3	42					LMX1B (inh=AD pLI=0.82)
chr9	129461123	129461123	T	C	hom	anno_omim	QUAL=8085;DP=157;AF=0.57;MQM=59;TRIO=HOM,157,1.00,HOM,60,1.00,HOM,61,1.00	LMX1B	3'UTR	LMX1B:ENST00000355497:3'UTR:MODIFIER:exon8/8:c.*2393T>C:,LMX1B:ENST00000425646:3'UTR:MODIFIER:exon8/8:c.*2393T>C:		rs10120414	0.8714	0.0000	0,0,0	0,0,0,0,0	0.9047							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000325189.1 [benign]; 			203	29					LMX1B (inh=AD pLI=0.82)
chr9	129461124	129461124	G	C	het	anno_omim	QUAL=8085;DP=157;AF=0.57;MQM=59;TRIO=HET,157,1.00,WT,60,1.00,HET,61,1.00	LMX1B	3'UTR	LMX1B:ENST00000355497:3'UTR:MODIFIER:exon8/8:c.*2394G>C:,LMX1B:ENST00000425646:3'UTR:MODIFIER:exon8/8:c.*2394G>C:		rs10760451	0.4089	0.0000	0,0,0	0,0,0,0,0	0.4478							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000363812.1 [benign]; 			31	111					LMX1B (inh=AD pLI=0.82)
chr9	129461319	129461320	TT	-	het	anno_omim	QUAL=3786;DP=181;AF=0.46;MQM=59;TRIO=HET,181,0.46,HET,147,0.27,HET,172,0.37	LMX1B	3'UTR	LMX1B:ENST00000355497:3'UTR:MODIFIER:exon8/8:c.*2590_*2591delTT:,LMX1B:ENST00000425646:3'UTR:MODIFIER:exon8/8:c.*2590_*2591delTT:		rs560251761	0.3754	0.0000	0,0,0	0,0,0,0,0	0.4152							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000328842.1 [benign]; 			35	104					LMX1B (inh=AD pLI=0.82)
chr9	129462501	129462501	G	T	het	anno_omim	QUAL=12151;DP=317;AF=0.53;MQM=60;TRIO=HET,317,0.53,HET,272,0.46,HET,375,0.50	LMX1B	3'UTR	LMX1B:ENST00000355497:3'UTR:MODIFIER:exon8/8:c.*3771G>T:,LMX1B:ENST00000425646:3'UTR:MODIFIER:exon8/8:c.*3771G>T:		rs10987417	0.5407	0.0000	0,0,0	0,0,0,0,0	0.4422							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000275603.1 [benign]; 			54	114					LMX1B (inh=AD pLI=0.82)
chr9	129462563	129462563	A	G	het	anno_omim	QUAL=13475;DP=321;AF=0.48;MQM=60;TRIO=HET,321,0.48,HET,347,0.45,HET,462,0.50	LMX1B	3'UTR	LMX1B:ENST00000355497:3'UTR:MODIFIER:exon8/8:c.*3833A>G:,LMX1B:ENST00000425646:3'UTR:MODIFIER:exon8/8:c.*3833A>G:		rs10987418	0.5481	0.0000	0,0,0	0,0,0,0,0	0.4516							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000290870.1 [benign]; 			54	115					LMX1B (inh=AD pLI=0.82)
chr9	129462594	129462594	T	C	het	anno_omim	QUAL=14410;DP=284;AF=0.49;MQM=59;TRIO=HET,284,0.49,HET,399,0.46,HET,533,0.51	LMX1B,RP11-489N22.3	3'UTR	LMX1B:ENST00000355497:3'UTR:MODIFIER:exon8/8:c.*3864T>C:,LMX1B:ENST00000425646:3'UTR:MODIFIER:exon8/8:c.*3864T>C:		rs10987419	0.5483	0.0000	0,0,0	0,0,0,0,0	0.4526							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000345393.1 [benign]; 			54	116					LMX1B (inh=AD pLI=0.82), RP11-489N22.3 (inh=n/a pLI=n/a)
chr9	129462687	129462687	C	A	het	anno_omim	QUAL=17614;DP=333;AF=0.48;MQM=60;TRIO=HET,333,0.48,HET,477,0.49,HET,637,0.50	LMX1B,RP11-489N22.3	3'UTR	LMX1B:ENST00000355497:3'UTR:MODIFIER:exon8/8:c.*3957C>A:,LMX1B:ENST00000425646:3'UTR:MODIFIER:exon8/8:c.*3957C>A:		rs10987422	0.5323	0.0000	0,0,0	0,0,0,0,0	0.4393							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000394311.1 [benign]; 			54	115					LMX1B (inh=AD pLI=0.82), RP11-489N22.3 (inh=n/a pLI=n/a)
chr9	129462901	129462901	T	C	hom	anno_omim	QUAL=21460;DP=227;AF=1.00;MQM=59;TRIO=HOM,227,1.00,HET,280,0.46,HOM,362,1.00	LMX1B,RP11-489N22.3	3'UTR	LMX1B:ENST00000355497:3'UTR:MODIFIER:exon8/8:c.*4171T>C:,LMX1B:ENST00000425646:3'UTR:MODIFIER:exon8/8:c.*4171T>C:	(CACGCA)n	rs3814119	0.5511	0.0000	0,0,0	0,0,0,0,0	0.4731							602575 [LMX1B (confirmed) Nail-patella syndrome,161200];	RCV000353178.1 [benign]; 			56	117					LMX1B (inh=AD pLI=0.82), RP11-489N22.3 (inh=n/a pLI=n/a)
chr9	130629139	130629139	T	G	hom	anno_omim	QUAL=5420;DP=60;AF=1.00;MQM=60;TRIO=HOM,60,1.00,HOM,35,1.00,HOM,74,1.00	AK1	3'UTR	AK1:ENST00000373176:3'UTR:MODIFIER:exon7/7:c.*1148A>C:	LFSINE_Vert	rs913987	0.7087	0.0000	0,0,0	0,0,0,0,0	0.7123							103000 [AK1 (confirmed) Hemolytic anemia due to adenylate kinase deficiency,612631];				154	70					AK1 (inh=AR pLI=0.65)
chr9	130629527	130629527	G	T	hom	anno_omim	QUAL=7876;DP=91;AF=0.98;MQM=57;TRIO=HOM,91,0.98,HOM,79,1.00,HOM,103,0.99	AK1	3'UTR	AK1:ENST00000373176:3'UTR:MODIFIER:exon7/7:c.*760C>A:	AluSx	rs2249308	0.9181	0.0000	0,0,0	0,0,0,0,0	0.9274							103000 [AK1 (confirmed) Hemolytic anemia due to adenylate kinase deficiency,612631];				194	37					AK1 (inh=AR pLI=0.65)
chr9	130630233	130630233	G	T	hom	anno_omim	QUAL=39405;DP=187;AF=1.00;MQM=59;TRIO=HOM,187,1.00,HOM,482,1.00,HOM,614,1.00	AK1,RP11-203J24.9	3'UTR	AK1:ENST00000373176:3'UTR:MODIFIER:exon7/7:c.*54C>A:		rs4226	0.6817	0.0000	0,0,0	0,0,0,0,0	0.6951							103000 [AK1 (confirmed) Hemolytic anemia due to adenylate kinase deficiency,612631];				1169	672					AK1 (inh=AR pLI=0.65), RP11-203J24.9 (inh=n/a pLI=n/a)
chr9	130630639	130630639	A	G	hom	anno_omim	QUAL=24473;DP=259;AF=1.00;MQM=59;TRIO=HOM,259,1.00,HOM,250,1.00,HOM,273,1.00	AK1,RP11-203J24.9	synonymous	AK1:ENST00000223836:synonymous:LOW:exon5/6:c.525T>C:p.Pro175Pro,AK1:ENST00000373176:synonymous:LOW:exon6/7:c.477T>C:p.Pro159Pro,AK1:ENST00000373156:synonymous:LOW:exon6/7:c.477T>C:p.Pro159Pro		rs913986	0.9982	0.9995	56343,31274,4781	0.9940,0.9999,1.0000,1.0000,1.0000	0.9995	-4.9500		T			13.82	103000 [AK1 (confirmed) Hemolytic anemia due to adenylate kinase deficiency,612631];				2113	0	2	[2] auto-classification 15.09.2017  			AK1 (inh=AR pLI=0.65), RP11-203J24.9 (inh=n/a pLI=n/a)
chr9	130698029	130698029	G	C	hom	anno_omim	QUAL=35788;DP=368;AF=1.00;MQM=59;TRIO=HOM,368,1.00,HOM,307,1.00,HOM,420,1.00	DPM2,RP11-203J24.8	missense	DPM2:ENST00000314392:missense:MODERATE:exon4/4:c.227C>G:p.Thr76Ser		rs7997	0.6835	0.7873	38367,24522,2292	0.6671,0.8108,0.4533,0.8579,0.7030	0.7935	0.1410	T	T	B	T	0.13	603564 [DPM2 (provisional) Congenital disorder of glycosylation,type Iu,615042];	RCV000116901.1 [benign]; RCV000364982.1 [benign]; 		COSM3982740	1121	486	2	[2] auto-classification 15.09.2017  			DPM2 (inh=AR pLI=0.02), RP11-203J24.8 (inh=n/a pLI=n/a)
chr9	130698043	130698043	A	G	hom	anno_omim	QUAL=33736;DP=334;AF=1.00;MQM=60;TRIO=HOM,334,1.00,HOM,309,1.00,HOM,392,1.00	DPM2,RP11-203J24.8	synonymous	DPM2:ENST00000314392:synonymous:LOW:exon4/4:c.213T>C:p.Tyr71Tyr		rs6781	0.7310	0.8139	40571,24672,2304	0.6687,0.8819,0.6674,0.8606,0.7109	0.8192							603564 [DPM2 (provisional) Congenital disorder of glycosylation,type Iu,615042];	RCV000116900.4 [benign]; RCV000265670.1 [benign]; 			1138	477	2	[2] auto-classification 15.09.2017  			DPM2 (inh=AR pLI=0.02), RP11-203J24.8 (inh=n/a pLI=n/a)
chr9	130700251	130700251	T	C	hom	anno_omim	QUAL=36008;DP=430;AF=1.00;MQM=59;TRIO=HOM,430,1.00,HOM,330,1.00,HOM,409,1.00	DPM2,RP11-203J24.8	5'UTR	DPM2:ENST00000314392:5'UTR:MODIFIER:exon1/4:c.-152A>G:		rs6478802	0.6839	0.0000	0,0,0	0,0,0,0,0	0.7937							603564 [DPM2 (provisional) Congenital disorder of glycosylation,type Iu,615042];	RCV000386486.1 [benign]; 			181	44					DPM2 (inh=AR pLI=0.02), RP11-203J24.8 (inh=n/a pLI=n/a)
chr9	130700727	130700727	T	C	hom	anno_omim	QUAL=23385;DP=259;AF=1.00;MQM=59;TRIO=HOM,259,1.00,HOM,212,1.00,HOM,269,1.00	RP11-203J24.8,DPM2	5'UTR	DPM2:ENST00000314392:5'UTR:MODIFIER:exon1/4:c.-628A>G:		rs3758327	0.6839	0.0000	0,0,0	0,0,0,0,0	0.7937							603564 [DPM2 (provisional) Congenital disorder of glycosylation,type Iu,615042];	RCV000309328.1 [benign]; 			180	45	2	[2] auto-classification 15.09.2017  			RP11-203J24.8 (inh=n/a pLI=n/a), DPM2 (inh=AR pLI=0.02)
chr9	131285955	131285955	A	G	het	pred_pathogenic;anno_omim	QUAL=758;DP=64;AF=0.45;MQM=60;TRIO=HET,64,0.45,HET,24,0.33,WT,60,0.00	GLE1	missense,5'UTR	GLE1:ENST00000309971:missense:MODERATE:exon6/16:c.727A>G:p.Ile243Val,GLE1:ENST00000372770:missense:MODERATE:exon6/14:c.727A>G:p.Ile243Val,GLE1:ENST00000539582:5'UTR:MODIFIER:exon5/15:c.-36A>G:		rs2275260	0.3474	0.2679	4751,1439,746	0.3853,0.3169,0.4420,0.2066,0.3272	0.2671	1.7440	T,T	T	B,B	T,T	0.01	603371 [GLE1 (confirmed) Lethal congenital contracture syndrome 1,253310|Arthrogryposis,lethal,with anterior horn cell disease,611890];	RCV000179351.2 [benign]; RCV000334555.1 [benign]; RCV000405131.1 [benign]; 	CM1310812 [CLASS=R MUT=ALT PHEN="Arthrogryposis & hypoplasia" GENE=GLE1]; 		141	773	2	[2] old entry - no details available			GLE1 (inh=AR pLI=0.00)
chr9	131303522	131303522	G	A	het	anno_omim	QUAL=4448;DP=191;AF=0.49;MQM=60;TRIO=HET,191,0.49,HET,155,0.49,WT,163,0.01	GLE1,RP11-216B9.6	3'UTR	GLE1:ENST00000309971:3'UTR:MODIFIER:exon16/16:c.*73G>A:,GLE1:ENST00000539582:3'UTR:MODIFIER:exon15/15:c.*73G>A:		rs10760563	0.2660	0.0000	0,0,0	0,0,0,0,0	0.2058							603371 [GLE1 (confirmed) Lethal congenital contracture syndrome 1,253310|Arthrogryposis,lethal,with anterior horn cell disease,611890];	RCV000324283.1 [benign]; RCV000371900.1 [benign]; 			32	209					GLE1 (inh=AR pLI=0.00), RP11-216B9.6 (inh=n/a pLI=n/a)
chr9	131346218	131346218	A	C	hom	anno_omim	QUAL=37049;DP=247;AF=1.00;MQM=59;TRIO=HOM,247,1.00,HOM,398,1.00,HOM,532,1.00	SPTAN1	synonymous	SPTAN1:ENST00000358161:synonymous:LOW:exon16/56:c.2163A>C:p.Ala721Ala,SPTAN1:ENST00000372731:synonymous:LOW:exon16/56:c.2163A>C:p.Ala721Ala,SPTAN1:ENST00000372739:synonymous:LOW:exon16/57:c.2163A>C:p.Ala721Ala		rs10760566	0.9698	0.9914	59701,33359,4277	0.9067,0.9949,1.0000,0.9998,0.9996	0.9929							182810 [SPTAN1 (confirmed) Epileptic encephalopathy,early infantile,5,613477];				2104	10	2	[2] auto-classification 15.09.2017  			SPTAN1 (inh=AD pLI=1.00)
chr9	131360750	131360750	C	T	hom	anno_omim	QUAL=16616;DP=225;AF=1.00;MQM=59;TRIO=HOM,225,1.00,HOM,133,1.00,HOM,160,1.00	SPTAN1	synonymous	SPTAN1:ENST00000358161:synonymous:LOW:exon25/56:c.3486C>T:p.Leu1162Leu,SPTAN1:ENST00000372731:synonymous:LOW:exon25/56:c.3486C>T:p.Leu1162Leu,SPTAN1:ENST00000372739:synonymous:LOW:exon25/57:c.3486C>T:p.Leu1162Leu		rs2227864	0.6428	0.8064	39037,26231,1134	0.4910,0.7891,0.5170,0.8964,0.7815	0.8050							182810 [SPTAN1 (confirmed) Epileptic encephalopathy,early infantile,5,613477];	RCV000147626.2 [benign]; RCV000390746.1 [benign]; 			1628	433	2	[2] auto-classification 15.09.2017  			SPTAN1 (inh=AD pLI=1.00)
chr9	131375701	131375701	A	G	hom	anno_omim	QUAL=27141;DP=263;AF=1.00;MQM=60;TRIO=HOM,263,1.00,HOM,234,1.00,HOM,332,1.00	SPTAN1	synonymous	SPTAN1:ENST00000358161:synonymous:LOW:exon40/56:c.5085A>G:p.Leu1695Leu,SPTAN1:ENST00000372731:synonymous:LOW:exon39/56:c.5070A>G:p.Leu1690Leu,SPTAN1:ENST00000372739:synonymous:LOW:exon40/57:c.5085A>G:p.Leu1695Leu		rs1415568	0.9848	0.9959	60218,33367,4754	0.9561,0.9972,1.0000,1.0000,0.9998	0.9966							182810 [SPTAN1 (confirmed) Epileptic encephalopathy,early infantile,5,613477];				2107	7	2	[2] auto-classification 15.09.2017  			SPTAN1 (inh=AD pLI=1.00)
chr9	131379967	131379967	C	T	hom	anno_omim	QUAL=28391;DP=283;AF=1.00;MQM=59;TRIO=HOM,283,1.00,HOM,252,1.00,HOM,377,1.00	SPTAN1	synonymous	SPTAN1:ENST00000358161:synonymous:LOW:exon42/56:c.5406C>T:p.Thr1802Thr,SPTAN1:ENST00000372731:synonymous:LOW:exon41/56:c.5391C>T:p.Thr1797Thr,SPTAN1:ENST00000372739:synonymous:LOW:exon42/57:c.5406C>T:p.Thr1802Thr		rs2227862	0.6170	0.7913	39713,26898,787	0.3907,0.7772,0.5010,0.8972,0.7642	0.7976							182810 [SPTAN1 (confirmed) Epileptic encephalopathy,early infantile,5,613477];	RCV000147636.3 [benign]; RCV000406015.1 [benign]; 		COSM4163385, COSM4163386	1620	443	2	[2] auto-classification 15.09.2017  			SPTAN1 (inh=AD pLI=1.00)
chr9	131670919	131670919	T	C	hom	anno_omim	QUAL=23089;DP=249;AF=1.00;MQM=59;TRIO=HOM,249,1.00,HOM,314,0.99,HET,416,0.55	LRRC8A	synonymous	LRRC8A:ENST00000259324:synonymous:LOW:exon3/4:c.1476T>C:p.Arg492Arg,LRRC8A:ENST00000372600:synonymous:LOW:exon3/4:c.1476T>C:p.Arg492Arg,LRRC8A:ENST00000372599:synonymous:LOW:exon2/3:c.1476T>C:p.Arg492Arg		rs3750319	0.5711	0.6944	28974,16911,487	0.3153,0.7949,0.6903,0.7286,0.6694	0.7052							608360 [LRRC8A (confirmed) Agammaglobulinemia 5,613506];				1055	857	2	[2] auto-classification 15.09.2017  			LRRC8A (inh=AD pLI=0.92)
chr9	131679892	131679892	C	T	hom	anno_omim	QUAL=11683;DP=129;AF=0.99;MQM=60;TRIO=HOM,129,0.99,HOM,171,1.00,HET,179,0.55	LRRC8A	3'UTR	LRRC8A:ENST00000259324:3'UTR:MODIFIER:exon4/4:c.*1242C>T:,LRRC8A:ENST00000372600:3'UTR:MODIFIER:exon4/4:c.*1242C>T:,LRRC8A:ENST00000372599:3'UTR:MODIFIER:exon3/3:c.*1242C>T:		rs9031	0.5118	0.0000	0,0,0	0,0,0,0,0	0.5691							608360 [LRRC8A (confirmed) Agammaglobulinemia 5,613506];				113	99					LRRC8A (inh=AD pLI=0.92)
chr9	131679897	131679897	A	G	hom	anno_omim	QUAL=15058;DP=130;AF=1.00;MQM=60;TRIO=HOM,130,1.00,HOM,171,1.00,HOM,182,1.00	LRRC8A	3'UTR	LRRC8A:ENST00000259324:3'UTR:MODIFIER:exon4/4:c.*1247A>G:,LRRC8A:ENST00000372600:3'UTR:MODIFIER:exon4/4:c.*1247A>G:,LRRC8A:ENST00000372599:3'UTR:MODIFIER:exon3/3:c.*1247A>G:		rs10819453	0.9974	0.0000	0,0,0	0,0,0,0,0	0.9963							608360 [LRRC8A (confirmed) Agammaglobulinemia 5,613506];				232	0					LRRC8A (inh=AD pLI=0.92)
chr9	131680177	131680177	G	T	het	anno_omim	QUAL=8052;DP=296;AF=0.49;MQM=59;TRIO=HET,296,0.49,HET,335,0.49,WT,429,0.00	LRRC8A	3'UTR	LRRC8A:ENST00000259324:3'UTR:MODIFIER:exon4/4:c.*1527G>T:,LRRC8A:ENST00000372600:3'UTR:MODIFIER:exon4/4:c.*1527G>T:,LRRC8A:ENST00000372599:3'UTR:MODIFIER:exon3/3:c.*1527G>T:		rs11542344	0.0262	0.0000	0,0,0	0,0,0,0,0	0.0491							608360 [LRRC8A (confirmed) Agammaglobulinemia 5,613506];				4	22					LRRC8A (inh=AD pLI=0.92)
chr9	132575797	132575797	A	T	het	anno_omim	QUAL=5659;DP=258;AF=0.47;MQM=60;TRIO=HET,258,0.47,WT,167,0.00,HET,211,0.47	TOR1A	3'UTR	TOR1A:ENST00000351698:3'UTR:MODIFIER:exon5/5:c.*454T>A:		rs1045441	0.0681	0.0000	0,0,0	0,0,0,0,0	0.0715							605204 [TOR1A (confirmed) Dystonia-1,torsion,128100|Dystonia-1,modifier of];	RCV000355909.1 [likely benign]; 			5	54					TOR1A (inh=AD pLI=0.17)
chr9	132575828	132575828	A	-	het	anno_omim	QUAL=4153;DP=256;AF=0.50;MQM=59;TRIO=HET,256,0.50,HET,132,0.49,WT,162,0.01	TOR1A	3'UTR	TOR1A:ENST00000351698:3'UTR:MODIFIER:exon5/5:c.*423delT:		rs573629050	0.0136	0.0000	0,0,0	0,0,0,0,0	0.0101							605204 [TOR1A (confirmed) Dystonia-1,torsion,128100|Dystonia-1,modifier of];	RCV000259565.1 [likely benign]; 			4	19					TOR1A (inh=AD pLI=0.17)
chr9	132576037	132576037	G	C	het	anno_omim	QUAL=2975;DP=136;AF=0.49;MQM=60;TRIO=HET,136,0.49,WT,62,0.00,HET,104,0.49	TOR1A	3'UTR	TOR1A:ENST00000351698:3'UTR:MODIFIER:exon5/5:c.*214C>G:		rs1183	0.0681	0.0000	0,0,0	0,0,0,0,0	0.0716							605204 [TOR1A (confirmed) Dystonia-1,torsion,128100|Dystonia-1,modifier of];	RCV000326607.1 [likely benign]; 			5	53					TOR1A (inh=AD pLI=0.17)
chr9	132585058	132585058	G	A	het	anno_omim	QUAL=5796;DP=260;AF=0.48;MQM=60;TRIO=HET,260,0.48,HET,289,0.41,WT,367,0.00	TOR1A	synonymous	TOR1A:ENST00000351698:synonymous:LOW:exon2/5:c.246C>T:p.Ala82Ala		rs2296793	0.2262	0.2275	3176,1911,254	0.2217,0.1777,0.2074,0.2411,0.2149	0.2253							605204 [TOR1A (confirmed) Dystonia-1,torsion,128100|Dystonia-1,modifier of];	RCV000242539.1 [benign]; RCV000298379.1 [likely benign]; 		COSM150726	130	836	2	[2] auto-classification 15.09.2017  			TOR1A (inh=AD pLI=0.17)
chr9	133364757	133364757	T	C	het	anno_omim	QUAL=5532;DP=137;AF=0.49;MQM=57;TRIO=HET,137,0.49,WT,230,0.00,HET,269,0.57	ASS1	synonymous	ASS1:ENST00000352480:synonymous:LOW:exon12/15:c.876T>C:p.His292His,ASS1:ENST00000372394:synonymous:LOW:exon13/16:c.876T>C:p.His292His,ASS1:ENST00000372393:synonymous:LOW:exon13/16:c.876T>C:p.His292His		rs1057484	0.0767	0.0942	630,394,65	0.1129,0.0416,0.0013,0.1098,0.0692	0.1132							603470 [ASS1 (confirmed) Citrullinemia,215700];	RCV000078028.6 [benign]; RCV000378731.1 [likely benign]; 			34	363	2	[2] auto-classification 15.09.2017  			ASS1 (inh=AR pLI=0.00)
chr9	133376666	133376681	GTGTGTGTGTGTGTGT	-	hom	anno_omim	QUAL=831;DP=21;AF=0.14;MQM=60;TRIO=HOM,21,0.19,WT,24,0.63,WT,21,0.62	ASS1,FUBP3	intergenic_region	FUBP3:ENSG00000130707-ENSG00000107164:intergenic_region:MODIFIER::n.133376666_133376681delGTGTGTGTGTGTGTGT:	(GT)n		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							603470 [ASS1 (confirmed) Citrullinemia,215700];				2	1					ASS1 (inh=AR pLI=0.00), FUBP3 (inh=n/a pLI=0.86)
chr9	134385436	134385436	A	G	hom	pred_pathogenic;anno_omim	QUAL=21086;DP=213;AF=0.99;MQM=60;TRIO=HOM,213,0.99,HET,312,0.47,HOM,382,1.00	POMT1	missense,intron	POMT1:ENST00000372228:missense:MODERATE:exon8/20:c.752A>G:p.Gln251Arg,POMT1:ENST00000404875:intron:MODIFIER:exon6/17:c.348+53A>G:,POMT1:ENST00000423007:intron:MODIFIER:exon8/19:c.699+53A>G:,POMT1:ENST00000341012:intron:MODIFIER:exon7/18:c.537+53A>G:,POMT1:ENST00000419118:intron:MODIFIER:exon5/16:c.243+53A>G:,POMT1:ENST00000402686:intron:MODIFIER:exon8/19:c.699+53A>G:,POMT1:ENST00000541219:intron:MODIFIER:exon2/12:c.34-211A>G:,POMT1:ENST00000354713:intron:MODIFIER:exon7/18:c.609+53A>G:		rs2296949	0.8706	0.9230	52010,30185,2838	0.7388,0.8361,0.9157,0.9510,0.9698	0.9244	1.3280	T,T,T	T	B	T,D,T	0.02	607423 [POMT1 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,1,236670|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,1,613155|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,1,609308];	RCV000216907.1 [benign]; 			1930	172	2	[2] auto-classification 15.09.2017  			POMT1 (inh=AR pLI=0.00)
chr9	134386744	134386744	T	C	hom	pred_pathogenic;anno_omim	QUAL=10758;DP=131;AF=1.00;MQM=59;TRIO=HOM,131,1.00,HET,102,0.49,HOM,166,1.00	POMT1	synonymous	POMT1:ENST00000372228:synonymous:LOW:exon10/20:c.942T>C:p.Thr314Thr,POMT1:ENST00000404875:synonymous:LOW:exon8/18:c.525T>C:p.Thr175Thr,POMT1:ENST00000423007:synonymous:LOW:exon10/20:c.876T>C:p.Thr292Thr,POMT1:ENST00000341012:synonymous:LOW:exon9/19:c.714T>C:p.Thr238Thr,POMT1:ENST00000419118:synonymous:LOW:exon7/17:c.420T>C:p.Thr140Thr,POMT1:ENST00000402686:synonymous:LOW:exon10/20:c.876T>C:p.Thr292Thr,POMT1:ENST00000541219:synonymous:LOW:exon4/13:c.210T>C:p.Thr70Thr,POMT1:ENST00000354713:synonymous:LOW:exon9/19:c.786T>C:p.Thr262Thr		rs10901065	0.8708	0.9231	52033,30195,2847	0.7393,0.8362,0.9162,0.9510,0.9697	0.9245	-1.7260	D,D	T		D	5.99	607423 [POMT1 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,1,236670|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,1,613155|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,1,609308];	RCV000153752.3 [benign]; 			1930	172	2	[2] auto-classification 15.09.2017  			POMT1 (inh=AR pLI=0.00)
chr9	134387488	134387488	T	C	hom	anno_omim	QUAL=22363;DP=287;AF=0.99;MQM=60;TRIO=HOM,287,0.99,HET,260,0.53,HOM,298,1.00	POMT1	synonymous	POMT1:ENST00000372228:synonymous:LOW:exon11/20:c.1113T>C:p.Asp371Asp,POMT1:ENST00000404875:synonymous:LOW:exon9/18:c.696T>C:p.Asp232Asp,POMT1:ENST00000423007:synonymous:LOW:exon11/20:c.1047T>C:p.Asp349Asp,POMT1:ENST00000341012:synonymous:LOW:exon10/19:c.885T>C:p.Asp295Asp,POMT1:ENST00000419118:synonymous:LOW:exon8/17:c.591T>C:p.Asp197Asp,POMT1:ENST00000402686:synonymous:LOW:exon11/20:c.1047T>C:p.Asp349Asp,POMT1:ENST00000541219:synonymous:LOW:exon5/13:c.381T>C:p.Asp127Asp,POMT1:ENST00000354713:synonymous:LOW:exon10/19:c.957T>C:p.Asp319Asp		rs3739494	0.8708	0.9232	51995,30184,2844	0.7404,0.8360,0.9157,0.9511,0.9697	0.9245							607423 [POMT1 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,1,236670|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,1,613155|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,1,609308];	RCV000153753.4 [benign]; 			1931	172	2	[2] auto-classification 15.09.2017  			POMT1 (inh=AR pLI=0.00)
chr9	134398534	134398534	T	C	hom	anno_omim	QUAL=21150;DP=151;AF=0.99;MQM=59;TRIO=HOM,151,0.99,HET,298,0.55,HOM,401,1.00	POMT1	splice_region,3'UTR	POMT1:ENST00000541219:splice_region:LOW:exon13/13:c.*41T>C:,POMT1:ENST00000372228:3'UTR:MODIFIER:exon20/20:c.*41T>C:,POMT1:ENST00000404875:3'UTR:MODIFIER:exon18/18:c.*41T>C:,POMT1:ENST00000423007:3'UTR:MODIFIER:exon20/20:c.*41T>C:,POMT1:ENST00000341012:3'UTR:MODIFIER:exon19/19:c.*41T>C:,POMT1:ENST00000419118:3'UTR:MODIFIER:exon17/17:c.*41T>C:,POMT1:ENST00000402686:3'UTR:MODIFIER:exon20/20:c.*41T>C:,POMT1:ENST00000541219:3'UTR:MODIFIER:exon13/13:c.*41T>C:,POMT1:ENST00000354713:3'UTR:MODIFIER:exon19/19:c.*41T>C:		rs3739495	0.8704	0.9245	47097,27263,2415	0.7371,0.8379,0.9175,0.9514,0.9703	0.9236							607423 [POMT1 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,1,236670|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,1,613155|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,1,609308];	RCV000244228.1 [benign]; RCV000408356.1 [benign]; 			1799	170	2	[2] auto-classification 15.09.2017  			POMT1 (inh=AR pLI=0.00)
chr9	134398719	134398719	T	C	hom	anno_omim	QUAL=28648;DP=365;AF=1.00;MQM=59;TRIO=HOM,365,1.00,HET,310,0.52,HOM,418,0.99	POMT1	3'UTR	POMT1:ENST00000372228:3'UTR:MODIFIER:exon20/20:c.*226T>C:,POMT1:ENST00000404875:3'UTR:MODIFIER:exon18/18:c.*226T>C:,POMT1:ENST00000423007:3'UTR:MODIFIER:exon20/20:c.*226T>C:,POMT1:ENST00000341012:3'UTR:MODIFIER:exon19/19:c.*226T>C:,POMT1:ENST00000419118:3'UTR:MODIFIER:exon17/17:c.*226T>C:,POMT1:ENST00000402686:3'UTR:MODIFIER:exon20/20:c.*226T>C:,POMT1:ENST00000354713:3'UTR:MODIFIER:exon19/19:c.*226T>C:		rs3824395	0.8708	0.0000	0,0,0	0,0,0,0,0	0.8944							607423 [POMT1 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,1,236670|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,1,613155|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,1,609308];	RCV000307484.1 [benign]; RCV000343623.1 [benign]; 			201	26					POMT1 (inh=AR pLI=0.00)
chr9	134398771	134398771	T	C	hom	anno_omim	QUAL=28031;DP=284;AF=1.00;MQM=59;TRIO=HOM,284,1.00,HET,334,0.53,HOM,444,1.00	POMT1	3'UTR	POMT1:ENST00000372228:3'UTR:MODIFIER:exon20/20:c.*278T>C:,POMT1:ENST00000404875:3'UTR:MODIFIER:exon18/18:c.*278T>C:,POMT1:ENST00000423007:3'UTR:MODIFIER:exon20/20:c.*278T>C:,POMT1:ENST00000341012:3'UTR:MODIFIER:exon19/19:c.*278T>C:,POMT1:ENST00000402686:3'UTR:MODIFIER:exon20/20:c.*278T>C:,POMT1:ENST00000354713:3'UTR:MODIFIER:exon19/19:c.*278T>C:		rs10793885	0.8712	0.0000	0,0,0	0,0,0,0,0	0.8935							607423 [POMT1 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,1,236670|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,1,613155|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,1,609308];	RCV000276888.1 [benign]; 			203	25					POMT1 (inh=AR pLI=0.00)
chr9	134398778	134398778	A	G	hom	anno_omim	QUAL=33140;DP=261;AF=0.99;MQM=59;TRIO=HOM,261,0.99,HOM,332,1.00,HOM,440,1.00	POMT1	3'UTR	POMT1:ENST00000372228:3'UTR:MODIFIER:exon20/20:c.*285A>G:,POMT1:ENST00000404875:3'UTR:MODIFIER:exon18/18:c.*285A>G:,POMT1:ENST00000423007:3'UTR:MODIFIER:exon20/20:c.*285A>G:,POMT1:ENST00000341012:3'UTR:MODIFIER:exon19/19:c.*285A>G:,POMT1:ENST00000402686:3'UTR:MODIFIER:exon20/20:c.*285A>G:,POMT1:ENST00000354713:3'UTR:MODIFIER:exon19/19:c.*285A>G:		rs4740259	0.9812	0.0000	0,0,0	0,0,0,0,0	0.9787							607423 [POMT1 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,1,236670|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,1,613155|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,1,609308];	RCV000311425.1 [benign]; 			231	1					POMT1 (inh=AR pLI=0.00)
chr9	134398841	134398841	C	T	hom	anno_omim	QUAL=20370;DP=178;AF=0.99;MQM=59;TRIO=HOM,178,0.99,HET,261,0.50,HOM,366,1.00	POMT1	3'UTR	POMT1:ENST00000372228:3'UTR:MODIFIER:exon20/20:c.*348C>T:,POMT1:ENST00000404875:3'UTR:MODIFIER:exon18/18:c.*348C>T:,POMT1:ENST00000423007:3'UTR:MODIFIER:exon20/20:c.*348C>T:,POMT1:ENST00000341012:3'UTR:MODIFIER:exon19/19:c.*348C>T:,POMT1:ENST00000402686:3'UTR:MODIFIER:exon20/20:c.*348C>T:		rs7857419	0.8664	0.0000	0,0,0	0,0,0,0,0	0.8758							607423 [POMT1 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,1,236670|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,1,613155|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,1,609308];	RCV000262116.1 [benign]; 			192	35					POMT1 (inh=AR pLI=0.00)
chr9	134398946	134398946	T	C	hom	anno_omim	QUAL=11520;DP=164;AF=1.00;MQM=59;TRIO=HOM,164,1.00,HET,200,0.56,HET,268,0.51	POMT1	3'UTR	POMT1:ENST00000372228:3'UTR:MODIFIER:exon20/20:c.*453T>C:,POMT1:ENST00000404875:3'UTR:MODIFIER:exon18/18:c.*453T>C:,POMT1:ENST00000423007:3'UTR:MODIFIER:exon20/20:c.*453T>C:,POMT1:ENST00000341012:3'UTR:MODIFIER:exon19/19:c.*453T>C:,POMT1:ENST00000402686:3'UTR:MODIFIER:exon20/20:c.*453T>C:		rs11005	0.7490	0.0000	0,0,0	0,0,0,0,0	0.7020							607423 [POMT1 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,1,236670|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,1,613155|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,1,609308];	RCV000371769.1 [benign]; 			139	86					POMT1 (inh=AR pLI=0.00)
chr9	135202829	135202829	T	C	hom	pred_pathogenic;anno_omim	QUAL=23269;DP=326;AF=1.00;MQM=60;TRIO=HOM,326,1.00,HOM,171,1.00,HOM,205,1.00	SETX	missense	SETX:ENST00000372169:missense:MODERATE:exon10/27:c.4156A>G:p.Ile1386Val,SETX:ENST00000224140:missense:MODERATE:exon10/26:c.4156A>G:p.Ile1386Val,SETX:ENST00000393220:missense:MODERATE:exon10/25:c.4156A>G:p.Ile1386Val		rs543573	0.5561	0.7252	33935,23205,761	0.3804,0.7945,0.2984,0.8335,0.6346	0.7366	-0.6580	T,T,T	T	B,B,B	D,D,D	0.01	608465 [SETX (confirmed) Amyotrophic lateral sclerosis 4,juvenile,602433|Spinocerebellar ataxia,autosomal recessive 1,606002];	RCV000081696.8 [other]; RCV000298134.1 [benign]; RCV000391406.1 [benign]; 		COSM3982759, COSM150732	2569	1148	2	[2] auto-classification 15.09.2017  			SETX (inh=AR+AD pLI=0.20)
chr9	135203231	135203231	C	T	hom	pred_pathogenic;anno_omim	QUAL=14736;DP=201;AF=0.99;MQM=59;TRIO=HOM,201,0.99,HOM,96,0.98,HOM,164,1.00	SETX	missense	SETX:ENST00000372169:missense:MODERATE:exon10/27:c.3754G>A:p.Gly1252Arg,SETX:ENST00000224140:missense:MODERATE:exon10/26:c.3754G>A:p.Gly1252Arg,SETX:ENST00000393220:missense:MODERATE:exon10/25:c.3754G>A:p.Gly1252Arg		rs1183768	0.5561	0.7251	33914,23192,758	0.3804,0.7941,0.2982,0.8334,0.6346	0.7365	0.4900	T,T,T	T	B,B,B	D,D,D	17.34	608465 [SETX (confirmed) Amyotrophic lateral sclerosis 4,juvenile,602433|Spinocerebellar ataxia,autosomal recessive 1,606002];	RCV000081695.8 [other]; RCV000293963.1 [benign]; RCV000351274.1 [benign]; 		COSM3982760, COSM150733	2560	1157	2	[2] auto-classification 15.09.2017  			SETX (inh=AR+AD pLI=0.20)
chr9	135203409	135203409	A	C	hom	pred_pathogenic;anno_omim	QUAL=15430;DP=321;AF=1.00;MQM=60;TRIO=HOM,321,1.00,HOM,62,1.00,HOM,83,0.99	SETX	missense	SETX:ENST00000372169:missense:MODERATE:exon10/27:c.3576T>G:p.Asp1192Glu,SETX:ENST00000224140:missense:MODERATE:exon10/26:c.3576T>G:p.Asp1192Glu,SETX:ENST00000393220:missense:MODERATE:exon10/25:c.3576T>G:p.Asp1192Glu		rs1185193	0.6406	0.7635	36812,24117,2182	0.6476,0.8104,0.3062,0.8500,0.6532	0.7695	-0.9950	T,T,T	T	B,B,B	D,D,D	0.01	608465 [SETX (confirmed) Amyotrophic lateral sclerosis 4,juvenile,602433|Spinocerebellar ataxia,autosomal recessive 1,606002];	RCV000081694.8 [other]; RCV000278408.1 [benign]; RCV000389540.1 [benign]; 			2688	1060	2	[2] auto-classification 15.09.2017  			SETX (inh=AR+AD pLI=0.20)
chr9	135206460	135206460	A	G	hom	anno_omim	QUAL=29150;DP=516;AF=1.00;MQM=60;TRIO=HOM,516,1.00,HOM,171,0.99,HOM,190,1.00	SETX	synonymous	SETX:ENST00000372169:synonymous:LOW:exon9/27:c.1077T>C:p.Tyr359Tyr,SETX:ENST00000224140:synonymous:LOW:exon9/26:c.1077T>C:p.Tyr359Tyr,SETX:ENST00000393220:synonymous:LOW:exon9/25:c.1077T>C:p.Tyr359Tyr		rs9411449	0.6266	0.7477	35321,23221,2007	0.6230,0.8048,0.3022,0.8340,0.6354	0.7538							608465 [SETX (confirmed) Amyotrophic lateral sclerosis 4,juvenile,602433|Spinocerebellar ataxia,autosomal recessive 1,606002];	RCV000081691.8 [other]; RCV000324127.1 [benign]; RCV000381219.1 [benign]; 		COSM150734, COSM4163458	2593	1143	2	[2] auto-classification 15.09.2017  			SETX (inh=AR+AD pLI=0.20)
chr9	135767185	135767185	C	T	het	anno_omim	QUAL=8687;DP=411;AF=0.45;MQM=60;TRIO=HET,411,0.45,WT,312,0.00,HET,375,0.42	TSC1	3'UTR	TSC1:ENST00000298552:3'UTR:MODIFIER:exon23/23:c.*4437G>A:,TSC1:ENST00000440111:3'UTR:MODIFIER:exon21/21:c.*4437G>A:,TSC1:ENST00000545250:3'UTR:MODIFIER:exon20/20:c.*4437G>A:		rs11553763	0.1034	0.0000	0,0,0	0,0,0,0,0	0.1084							605284 [TSC1 (confirmed) Tuberous sclerosis-1,191100|Lymphangioleiomyomatosis,606690|Focal cortical dysplasia,type II,somatic,607341];	RCV000333342.1 [benign]; RCV000387639.1 [benign]; 			1	29					TSC1 (inh=AD pLI=1.00)
chr9	135770115	135770115	C	T	hom	anno_omim	QUAL=14553;DP=257;AF=1.00;MQM=59;TRIO=HOM,257,1.00,HOM,93,1.00,HOM,106,1.00	TSC1	3'UTR	TSC1:ENST00000298552:3'UTR:MODIFIER:exon23/23:c.*1507G>A:,TSC1:ENST00000440111:3'UTR:MODIFIER:exon21/21:c.*1507G>A:,TSC1:ENST00000545250:3'UTR:MODIFIER:exon20/20:c.*1507G>A:		rs739441	0.7734	0.0000	0,0,0	0,0,0,0,0	0.7857							605284 [TSC1 (confirmed) Tuberous sclerosis-1,191100|Lymphangioleiomyomatosis,606690|Focal cortical dysplasia,type II,somatic,607341];	RCV000293568.1 [benign]; RCV000373877.1 [benign]; 			119	73					TSC1 (inh=AD pLI=1.00)
chr9	135770134	135770134	G	A	het	anno_omim	QUAL=7494;DP=299;AF=0.48;MQM=59;TRIO=HET,299,0.48,WT,107,0.00,HOM,126,1.00	TSC1	3'UTR	TSC1:ENST00000298552:3'UTR:MODIFIER:exon23/23:c.*1488C>T:,TSC1:ENST00000440111:3'UTR:MODIFIER:exon21/21:c.*1488C>T:,TSC1:ENST00000545250:3'UTR:MODIFIER:exon20/20:c.*1488C>T:		rs739442	0.4507	0.0000	0,0,0	0,0,0,0,0	0.4478							605284 [TSC1 (confirmed) Tuberous sclerosis-1,191100|Lymphangioleiomyomatosis,606690|Focal cortical dysplasia,type II,somatic,607341];	RCV000348515.1 [benign]; RCV000393355.1 [benign]; 			55	104					TSC1 (inh=AD pLI=1.00)
chr9	135770250	135770250	A	C	het	anno_omim	QUAL=10462;DP=268;AF=0.44;MQM=59;TRIO=HET,268,0.44,HET,231,0.55,HET,325,0.52	TSC1	3'UTR	TSC1:ENST00000298552:3'UTR:MODIFIER:exon23/23:c.*1372T>G:,TSC1:ENST00000440111:3'UTR:MODIFIER:exon21/21:c.*1372T>G:,TSC1:ENST00000545250:3'UTR:MODIFIER:exon20/20:c.*1372T>G:		rs58612431	0.2196	0.0000	0,0,0	0,0,0,0,0	0.2410							605284 [TSC1 (confirmed) Tuberous sclerosis-1,191100|Lymphangioleiomyomatosis,606690|Focal cortical dysplasia,type II,somatic,607341];	RCV000264627.1 [benign]; RCV000359363.1 [benign]; 			7	62					TSC1 (inh=AD pLI=1.00)
chr9	135770300	135770300	G	A	het	anno_omim	QUAL=19647;DP=399;AF=0.45;MQM=60;TRIO=HET,399,0.45,HET,265,0.52,HOM,357,1.00	TSC1	3'UTR	TSC1:ENST00000298552:3'UTR:MODIFIER:exon23/23:c.*1322C>T:,TSC1:ENST00000440111:3'UTR:MODIFIER:exon21/21:c.*1322C>T:,TSC1:ENST00000545250:3'UTR:MODIFIER:exon20/20:c.*1322C>T:		rs2809243	0.5521	0.0000	0,0,0	0,0,0,0,0	0.5514							605284 [TSC1 (confirmed) Tuberous sclerosis-1,191100|Lymphangioleiomyomatosis,606690|Focal cortical dysplasia,type II,somatic,607341];	RCV000305720.1 [benign]; RCV000360906.1 [benign]; 			67	123					TSC1 (inh=AD pLI=1.00)
chr9	135770347	135770347	A	C	hom	anno_omim	QUAL=32149;DP=351;AF=1.00;MQM=59;TRIO=HOM,351,1.00,HOM,276,0.99,HOM,373,1.00	TSC1	3'UTR	TSC1:ENST00000298552:3'UTR:MODIFIER:exon23/23:c.*1275T>G:,TSC1:ENST00000440111:3'UTR:MODIFIER:exon21/21:c.*1275T>G:,TSC1:ENST00000545250:3'UTR:MODIFIER:exon20/20:c.*1275T>G:		rs2809244	0.7482	0.0000	0,0,0	0,0,0,0,0	0.7442							605284 [TSC1 (confirmed) Tuberous sclerosis-1,191100|Lymphangioleiomyomatosis,606690|Focal cortical dysplasia,type II,somatic,607341];	RCV000261435.1 [benign]; RCV000316720.1 [benign]; 			118	89					TSC1 (inh=AD pLI=1.00)
chr9	135772717	135772717	G	A	het	anno_omim	QUAL=11310;DP=295;AF=0.49;MQM=59;TRIO=HET,295,0.49,HET,246,0.58,HET,270,0.52	TSC1	synonymous	TSC1:ENST00000298552:synonymous:LOW:exon22/23:c.2829C>T:p.Ala943Ala,TSC1:ENST00000440111:synonymous:LOW:exon20/21:c.2829C>T:p.Ala943Ala,TSC1:ENST00000545250:synonymous:LOW:exon19/20:c.2676C>T:p.Ala892Ala		rs4962081	0.0621	0.0758	457,224,37	0.0879,0.1558,0.0276,0.0767,0.0476	0.0795							605284 [TSC1 (confirmed) Tuberous sclerosis-1,191100|Lymphangioleiomyomatosis,606690|Focal cortical dysplasia,type II,somatic,607341];	RCV000042257.3 [benign]; RCV000054906.1 [not provided]; RCV000055028.1 [not provided]; RCV000055028.1 [not provided]; RCV000118693.8 [other]; RCV000162946.1 [benign]; RCV000370584.1 [benign]; 			11	362	2	[2] auto-classification 15.09.2017  			TSC1 (inh=AD pLI=1.00)
chr9	135773001	135773001	A	-	hom	anno_omim	QUAL=1122;DP=45;AF=0.38;MQM=59;TRIO=HOM,45,0.38,WT,21,0.33,WT,26,0.12	TSC1	splice_region&intron	TSC1:ENST00000298552:splice_region&intron:LOW:exon20/22:c.2626-4delT:,TSC1:ENST00000440111:splice_region&intron:LOW:exon18/20:c.2626-4delT:,TSC1:ENST00000545250:splice_region&intron:LOW:exon17/19:c.2473-4delT:	(A)n	rs118203716	0.3427	0.2827	1,1,0	0.3340,0.2771,0.2973,0.2811,0.2332	0.2126							605284 [TSC1 (confirmed) Tuberous sclerosis-1,191100|Lymphangioleiomyomatosis,606690|Focal cortical dysplasia,type II,somatic,607341];	RCV000042234.3 [benign]; RCV000313026.1 [benign]; 			46	129					TSC1 (inh=AD pLI=1.00)
chr9	135782221	135782221	T	C	het	anno_omim	QUAL=3635;DP=178;AF=0.53;MQM=60;TRIO=HET,178,0.53,HET,99,0.47,WT,140,0.00	TSC1	splice_region&synonymous	TSC1:ENST00000298552:splice_region&synonymous:LOW:exon14/23:c.1335A>G:p.Glu445Glu,TSC1:ENST00000440111:splice_region&synonymous:LOW:exon12/21:c.1335A>G:p.Glu445Glu,TSC1:ENST00000545250:splice_region&synonymous:LOW:exon11/20:c.1182A>G:p.Glu394Glu		rs7862221	0.1386	0.1371	1225,741,254	0.2248,0.0849,0.0870,0.1487,0.1062	0.1581							605284 [TSC1 (confirmed) Tuberous sclerosis-1,191100|Lymphangioleiomyomatosis,606690|Focal cortical dysplasia,type II,somatic,607341];	RCV000042015.3 [benign]; RCV000118690.7 [other]; RCV000162953.1 [benign]; RCV000287833.1 [benign]; 		COSM3763712	60	710					TSC1 (inh=AD pLI=1.00)
chr9	135786904	135786904	A	G	het	pred_pathogenic;anno_omim	QUAL=6103;DP=322;AF=0.44;MQM=60;TRIO=HET,322,0.44,HET,192,0.51,WT,215,0.00	TSC1	missense	TSC1:ENST00000298552:missense:MODERATE:exon10/23:c.965T>C:p.Met322Thr,TSC1:ENST00000440111:missense:MODERATE:exon8/21:c.965T>C:p.Met322Thr,TSC1:ENST00000545250:missense:MODERATE:exon7/20:c.812T>C:p.Met271Thr,TSC1:ENST00000403810:missense:MODERATE:exon10/10:c.965T>C:p.Met322Thr		rs1073123	0.1352	0.1290	1104,639,250	0.2223,0.0822,0.0864,0.1376,0.1022	0.1499	1.3780	T,T,T,T,T,T	T	B,B,B,B,B,B	D,D,D,D,D	6.71	605284 [TSC1 (confirmed) Tuberous sclerosis-1,191100|Lymphangioleiomyomatosis,606690|Focal cortical dysplasia,type II,somatic,607341];	RCV000034613.5 [benign]; RCV000054853.2 [benign]; RCV000054992.1 [not provided]; RCV000054997.1 [not provided]; RCV000054997.1 [not provided]; RCV000118695.8 [other]; RCV000162954.1 [benign]; RCV000355920.1 [benign]; 	CM131323 [CLASS=DP MUT=ALT PHEN="Respiratory disease aspirin-exacerbated association with" GENE=TSC1]; 	COSM3763713	55	677					TSC1 (inh=AD pLI=1.00)
chr9	135974079	135974079	G	C	het		QUAL=12689;DP=236;AF=0.42;MQM=59;TRIO=HET,236,0.42,HOM,201,1.00,HET,323,0.46	RALGDS	synonymous	RALGDS:ENST00000542690:synonymous:LOW:exon23/23:c.2853C>G:p.Leu951Leu,RALGDS:ENST00000372047:synonymous:LOW:exon18/18:c.2604C>G:p.Leu868Leu,RALGDS:ENST00000372050:synonymous:LOW:exon18/18:c.2640C>G:p.Leu880Leu,RALGDS:ENST00000393160:synonymous:LOW:exon18/18:c.2475C>G:p.Leu825Leu,RALGDS:ENST00000393157:synonymous:LOW:exon18/18:c.2637C>G:p.Leu879Leu,RALGDS:ENST00000372062:synonymous:LOW:exon18/18:c.2553C>G:p.Leu851Leu		rs1062356	0.8275	0.8416	43048,24211,3818	0.8572,0.8846,0.7657,0.8523,0.8397	0.8410											1528	532					RALGDS (inh=n/a pLI=0.30)
chr9	135974100	135974100	G	A	het		QUAL=4947;DP=221;AF=0.41;MQM=60;TRIO=HET,221,0.41,HET,215,0.51,WT,337,0.00	RALGDS	synonymous	RALGDS:ENST00000542690:synonymous:LOW:exon23/23:c.2832C>T:p.Thr944Thr,RALGDS:ENST00000372047:synonymous:LOW:exon18/18:c.2583C>T:p.Thr861Thr,RALGDS:ENST00000372050:synonymous:LOW:exon18/18:c.2619C>T:p.Thr873Thr,RALGDS:ENST00000393160:synonymous:LOW:exon18/18:c.2454C>T:p.Thr818Thr,RALGDS:ENST00000393157:synonymous:LOW:exon18/18:c.2616C>T:p.Thr872Thr,RALGDS:ENST00000372062:synonymous:LOW:exon18/18:c.2532C>T:p.Thr844Thr		rs886017	0.4916	0.5423	18396,9569,464	0.3008,0.5742,0.6224,0.5343,0.6621	0.5462											662	1001					RALGDS (inh=n/a pLI=0.30)
chr9	135985796	135985796	C	T	het		QUAL=3891;DP=157;AF=0.51;MQM=60;TRIO=HET,157,0.51,HET,201,0.47,WT,272,0.00	RALGDS	synonymous	RALGDS:ENST00000542690:synonymous:LOW:exon8/23:c.588G>A:p.Val196Val,RALGDS:ENST00000372047:synonymous:LOW:exon3/18:c.375G>A:p.Val125Val,RALGDS:ENST00000372050:synonymous:LOW:exon3/18:c.375G>A:p.Val125Val,RALGDS:ENST00000393160:synonymous:LOW:exon3/18:c.210G>A:p.Val70Val,RALGDS:ENST00000393157:synonymous:LOW:exon3/18:c.372G>A:p.Val124Val,RALGDS:ENST00000372062:synonymous:LOW:exon3/18:c.324G>A:p.Val108Val		rs3761824	0.2486	0.2853	5054,3159,113	0.1563,0.2213,0.2826,0.3096,0.3271	0.2818										COSM4163476, COSM4163477, COSM4163475, COSM4163478	184	870					RALGDS (inh=n/a pLI=0.30)
chr9	136223366	136223366	G	A	hom	low_DP;anno_omim	QUAL=175;DP=3;AF=1.00;MQM=60;TRIO=HOM,3,1.00,HOM,1,1.00,HOM,2,1.00	SURF1				rs523304	0.5120	0.5354	992,273,15	0.0000,0.0000,0.0000,0.6073,0.5116	0.5108							185620 [SURF1 (confirmed) Leigh syndrome,due to COX IV deficiency,256000|Charcot-Marie-Tooth disease,type 4K,616684];	RCV000128344.1 [benign]; RCV000286961.1 [benign]; 			475	759					SURF1 (inh=AR pLI=0.00)
chr9	136291063	136291063	C	T	hom	anno_omim	QUAL=32083;DP=343;AF=0.99;MQM=59;TRIO=HOM,343,0.99,HOM,326,0.99,HOM,388,1.00	ADAMTS13	synonymous	ADAMTS13:ENST00000371929:synonymous:LOW:exon5/29:c.420C>T:p.Ala140Ala,ADAMTS13:ENST00000371916:synonymous:LOW:exon5/27:c.420C>T:p.Ala140Ala,ADAMTS13:ENST00000371911:synonymous:LOW:exon5/8:c.420C>T:p.Ala140Ala,ADAMTS13:ENST00000355699:synonymous:LOW:exon5/29:c.420C>T:p.Ala140Ala,ADAMTS13:ENST00000356589:synonymous:LOW:exon5/29:c.420C>T:p.Ala140Ala		rs3118667	0.5819	0.5504	18927,9627,1196	0.4811,0.5695,0.8449,0.5349,0.5429	0.5505							604134 [ADAMTS13 (provisional) Thrombotic thrombocytopenic purpura,familial,274150];			COSM1460807	675	973					ADAMTS13 (inh=AR pLI=0.00)
chr9	136304497	136304497	A	G	hom	anno_omim	QUAL=31669;DP=268;AF=1.00;MQM=59;TRIO=HOM,268,1.00,HOM,333,1.00,HOM,390,1.00	ADAMTS13	synonymous,3'UTR	ADAMTS13:ENST00000371929:synonymous:LOW:exon15/29:c.1716A>G:p.Thr572Thr,ADAMTS13:ENST00000355699:synonymous:LOW:exon15/29:c.1716A>G:p.Thr572Thr,ADAMTS13:ENST00000356589:synonymous:LOW:exon15/29:c.1623A>G:p.Thr541Thr,ADAMTS13:ENST00000536611:synonymous:LOW:exon9/14:c.732A>G:p.Thr244Thr,ADAMTS13:ENST00000371916:3'UTR:MODIFIER:exon13/27:c.*584A>G:		rs3124768	0.5160	0.4718	14527,6664,695	0.3596,0.5054,0.8224,0.4384,0.5144	0.4754							604134 [ADAMTS13 (provisional) Thrombotic thrombocytopenic purpura,familial,274150];		CM1213383 [CLASS=FP MUT=ALT PHEN="Reduced expression" GENE=ADAMTS13]; 	COSM4163494	495	989					ADAMTS13 (inh=AR pLI=0.00)
chr9	136412170	136412170	C	T	hom	anno_omim	QUAL=23599;DP=140;AF=0.99;MQM=60;TRIO=HOM,140,0.99,HET,372,0.54,HOM,479,1.00	ADAMTSL2	synonymous	ADAMTSL2:ENST00000393061:synonymous:LOW:exon9/19:c.1101C>T:p.Asp367Asp,ADAMTSL2:ENST00000354484:synonymous:LOW:exon9/19:c.774C>T:p.Asp258Asp,ADAMTSL2:ENST00000393060:synonymous:LOW:exon9/19:c.774C>T:p.Asp258Asp		rs2073874	0.7240	0.8194	41810,27676,3235	0.7879,0.6125,0.5216,0.9109,0.7468	0.8525							612277 [ADAMTSL2 (provisional) Geleophysic dysplasia 1,231050];	RCV000304229.1 [benign]; 			1623	444					ADAMTSL2 (inh=AR pLI=0.07)
chr9	136412236	136412236	A	T	hom	anno_omim	QUAL=37057;DP=328;AF=0.99;MQM=59;TRIO=HOM,328,0.99,HET,514,0.50,HOM,641,1.00	ADAMTSL2	synonymous	ADAMTSL2:ENST00000393061:synonymous:LOW:exon9/19:c.1167A>T:p.Ala389Ala,ADAMTSL2:ENST00000354484:synonymous:LOW:exon9/19:c.840A>T:p.Ala280Ala,ADAMTSL2:ENST00000393060:synonymous:LOW:exon9/19:c.840A>T:p.Ala280Ala		rs2073875	0.7246	0.8197	41848,27706,3236	0.7880,0.6129,0.5211,0.9113,0.7472	0.8523							612277 [ADAMTSL2 (provisional) Geleophysic dysplasia 1,231050];	RCV000361313.1 [benign]; 			1626	442					ADAMTSL2 (inh=AR pLI=0.07)
chr9	136412255	136412255	A	C	hom	anno_omim	QUAL=36693;DP=288;AF=1.00;MQM=59;TRIO=HOM,288,1.00,HET,520,0.52,HOM,639,1.00	ADAMTSL2	synonymous	ADAMTSL2:ENST00000393061:synonymous:LOW:exon9/19:c.1186A>C:p.Arg396Arg,ADAMTSL2:ENST00000354484:synonymous:LOW:exon9/19:c.859A>C:p.Arg287Arg,ADAMTSL2:ENST00000393060:synonymous:LOW:exon9/19:c.859A>C:p.Arg287Arg		rs2073876	0.7246	0.8198	41848,27707,3236	0.7881,0.6130,0.5215,0.9113,0.7472	0.8523							612277 [ADAMTSL2 (provisional) Geleophysic dysplasia 1,231050];	RCV000397418.1 [benign]; 			1626	443					ADAMTSL2 (inh=AR pLI=0.07)
chr9	136440144	136440144	G	A	hom	low_MQM;anno_omim	QUAL=5138;DP=66;AF=1.00;MQM=46;TRIO=HOM,66,1.00,HET,76,0.38,HOM,95,0.99	ADAMTSL2	3'UTR	ADAMTSL2:ENST00000393061:3'UTR:MODIFIER:exon19/19:c.*158G>A:,ADAMTSL2:ENST00000354484:3'UTR:MODIFIER:exon19/19:c.*158G>A:,ADAMTSL2:ENST00000393060:3'UTR:MODIFIER:exon19/19:c.*158G>A:		rs1105952	0.4637	0.0000	0,0,0	0,0,0,0,0	0.5971							612277 [ADAMTSL2 (provisional) Geleophysic dysplasia 1,231050];	RCV000377166.1 [benign]; 			67	108					ADAMTSL2 (inh=AR pLI=0.07)
chr9	139323201	139323201	A	G	het	anno_omim	QUAL=5771;DP=252;AF=0.57;MQM=60;TRIO=HET,252,0.57,HET,138,0.57,WT,161,0.00	INPP5E	3'UTR	INPP5E:ENST00000371712:3'UTR:MODIFIER:exon10/10:c.*926T>C:		rs1128877	0.1278	0.0000	0,0,0	0,0,0,0,0	0.0972							613037 [INPP5E (provisional) Mental retardation,truncal obesity,retinal dystrophy,and micropenis,610156|Joubert syndrome 1,213300];	RCV000361000.1 [likely benign]; 			4	61					INPP5E (inh=AR pLI=0.39)
chr9	139323311	139323311	T	C	het	anno_omim	QUAL=11105;DP=186;AF=0.60;MQM=59;TRIO=HET,186,0.60,HOM,188,0.99,HET,233,0.48	INPP5E	3'UTR	INPP5E:ENST00000371712:3'UTR:MODIFIER:exon10/10:c.*816A>G:		rs8413	0.3658	0.0000	0,0,0	0,0,0,0,0	0.3838							613037 [INPP5E (provisional) Mental retardation,truncal obesity,retinal dystrophy,and micropenis,610156|Joubert syndrome 1,213300];	RCV000321574.1 [benign]; 			48	112					INPP5E (inh=AR pLI=0.39)
chr9	139323424	139323424	T	C	het	anno_omim	QUAL=8631;DP=159;AF=0.55;MQM=59;TRIO=HET,159,0.55,HOM,140,0.98,HET,146,0.51	INPP5E	3'UTR	INPP5E:ENST00000371712:3'UTR:MODIFIER:exon10/10:c.*703A>G:		rs1128874	0.3776	0.0000	0,0,0	0,0,0,0,0	0.3993							613037 [INPP5E (provisional) Mental retardation,truncal obesity,retinal dystrophy,and micropenis,610156|Joubert syndrome 1,213300];	RCV000296422.1 [benign]; 			51	114					INPP5E (inh=AR pLI=0.39)
chr9	139323497	139323497	C	T	het	anno_omim	QUAL=3322;DP=135;AF=0.49;MQM=59;TRIO=HET,135,0.49,HET,127,0.57,WT,141,0.00	INPP5E	3'UTR	INPP5E:ENST00000371712:3'UTR:MODIFIER:exon10/10:c.*630G>A:		rs539039743	0.0004	0.0000	0,0,0	0,0,0,0,0	0.0005							613037 [INPP5E (provisional) Mental retardation,truncal obesity,retinal dystrophy,and micropenis,610156|Joubert syndrome 1,213300];	RCV000348979.1 [uncertain significance]; 			0	2					INPP5E (inh=AR pLI=0.39)
chr9	139323799	139323799	A	G	het	anno_omim	QUAL=9671;DP=134;AF=0.57;MQM=59;TRIO=HET,134,0.57,HOM,186,0.99,HET,229,0.43	INPP5E	3'UTR	INPP5E:ENST00000371712:3'UTR:MODIFIER:exon10/10:c.*328T>C:		rs35763810	0.3828	0.0000	0,0,0	0,0,0,0,0	0.4098							613037 [INPP5E (provisional) Mental retardation,truncal obesity,retinal dystrophy,and micropenis,610156|Joubert syndrome 1,213300];	RCV000390164.1 [benign]; 			49	116					INPP5E (inh=AR pLI=0.39)
chr9	139324740	139324740	C	T	het	anno_omim	QUAL=3799;DP=110;AF=0.57;MQM=60;TRIO=HET,110,0.57,HET,196,0.51,WT,276,0.00	INPP5E	synonymous	INPP5E:ENST00000371712:synonymous:LOW:exon9/10:c.1791G>A:p.Pro597Pro		rs10870182	0.1284	0.1364	229,71,4	0.0514,0.1878,0.1596,0.1306,0.1683	0.1474							613037 [INPP5E (provisional) Mental retardation,truncal obesity,retinal dystrophy,and micropenis,610156|Joubert syndrome 1,213300];	RCV000117269.4 [other]; RCV000360862.1 [likely benign]; 			54	701					INPP5E (inh=AR pLI=0.39)
chr9	139326304	139326304	G	A	het	anno_omim	QUAL=807;DP=40;AF=0.38;MQM=59;TRIO=HET,40,0.38,HET,56,0.54,WT,57,0.00	INPP5E	synonymous	INPP5E:ENST00000371712:synonymous:LOW:exon7/10:c.1521C>T:p.His507His		rs10870188	0.1214	0.1427	1288,510,7	0.0398,0.2744,0.1490,0.1323,0.1657	0.1416							613037 [INPP5E (provisional) Mental retardation,truncal obesity,retinal dystrophy,and micropenis,610156|Joubert syndrome 1,213300];	RCV000117267.4 [other]; RCV000262680.1 [likely benign]; 		COSM1162712	55	683					INPP5E (inh=AR pLI=0.39)
chr9	139327034	139327034	A	G	het	anno_omim	QUAL=7739;DP=114;AF=0.54;MQM=59;TRIO=HET,114,0.54,HOM,132,1.00,HET,143,0.61	INPP5E	synonymous	INPP5E:ENST00000371712:synonymous:LOW:exon6/10:c.1284T>C:p.Gly428Gly		rs10870194	0.3778	0.4004	1662,879,204	0.3948,0.5775,0.2574,0.4568,0.3452	0.4208							613037 [INPP5E (provisional) Mental retardation,truncal obesity,retinal dystrophy,and micropenis,610156|Joubert syndrome 1,213300];	RCV000117265.3 [other]; RCV000291204.1 [benign]; 		COSM3722170	578	1512					INPP5E (inh=AR pLI=0.39)
chr9	139327439	139327439	A	G	het	anno_omim	QUAL=32677;DP=287;AF=0.52;MQM=59;TRIO=HET,287,0.52,HOM,660,0.99,HET,835,0.42	INPP5E	synonymous	INPP5E:ENST00000371712:synonymous:LOW:exon5/10:c.1248T>C:p.Thr416Thr		rs10781542	0.3784	0.4194	10634,6412,754	0.3952,0.5833,0.1957,0.4490,0.3505	0.4198							613037 [INPP5E (provisional) Mental retardation,truncal obesity,retinal dystrophy,and micropenis,610156|Joubert syndrome 1,213300];	RCV000117264.3 [other]; RCV000400377.1 [benign]; 			593	1562					INPP5E (inh=AR pLI=0.39)
chr9	139328551	139328551	T	C	het	anno_omim	QUAL=2305;DP=97;AF=0.46;MQM=60;TRIO=HET,97,0.46,HET,129,0.40,WT,165,0.00	INPP5E	synonymous	INPP5E:ENST00000371712:synonymous:LOW:exon3/10:c.972A>G:p.Pro324Pro		rs10870199	0.1238	0.1596	1213,502,4	0.0336,0.2966,0.1706,0.1503,0.1823	0.1441							613037 [INPP5E (provisional) Mental retardation,truncal obesity,retinal dystrophy,and micropenis,610156|Joubert syndrome 1,213300];	RCV000117276.4 [other]; RCV000297520.1 [likely benign]; 		COSM3763772	54	713					INPP5E (inh=AR pLI=0.39)
chr9	139726239	139726239	A	G	hom		QUAL=26466;DP=211;AF=1.00;MQM=59;TRIO=HOM,211,1.00,HOM,275,1.00,HOM,357,1.00	RABL6	synonymous	RABL6:ENST00000371663:synonymous:LOW:exon6/15:c.525A>G:p.Gly175Gly,RABL6:ENST00000371671:synonymous:LOW:exon6/8:c.525A>G:p.Gly175Gly,RABL6:ENST00000311502:synonymous:LOW:exon6/15:c.525A>G:p.Gly175Gly,RABL6:ENST00000357466:synonymous:LOW:exon6/10:c.525A>G:p.Gly175Gly,RABL6:ENST00000432842:synonymous:LOW:exon6/14:c.411A>G:p.Gly137Gly,RABL6:ENST00000371675:synonymous:LOW:exon6/15:c.180A>G:p.Gly60Gly		rs2811748	0.8167	0.8475	43413,25653,3796	0.8813,0.7275,0.7712,0.8791,0.7874	0.8766	-1.1310		T			9.25				COSM4163585, COSM4163586, COSM4163584	1534	519					RABL6 (inh=n/a pLI=0.97)
chr9	139731969	139731969	C	T	hom	low_DP	QUAL=856;DP=7;AF=1.00;MQM=56;TRIO=HOM,7,1.00,HOM,12,1.00,HOM,13,1.00	RABL6	synonymous	RABL6:ENST00000371663:synonymous:LOW:exon9/15:c.984C>T:p.Ala328Ala,RABL6:ENST00000311502:synonymous:LOW:exon9/15:c.981C>T:p.Ala327Ala,RABL6:ENST00000357466:synonymous:LOW:exon9/10:c.981C>T:p.Ala327Ala,RABL6:ENST00000432842:synonymous:LOW:exon9/14:c.867C>T:p.Ala289Ala,RABL6:ENST00000371675:synonymous:LOW:exon9/15:c.636C>T:p.Ala212Ala		rs2811742	0.7666	0.8050	6608,2900,359	0.7455,0.7521,0.8067,0.8094,0.8139	0.7930										COSM3763796, COSM455622, COSM455621	1347	591					RABL6 (inh=n/a pLI=0.97)
chr9	139732331	139732331	G	C	hom	pred_pathogenic	QUAL=12927;DP=100;AF=1.00;MQM=59;TRIO=HOM,100,1.00,HOM,159,1.00,HOM,183,1.00	RABL6	missense,intron	RABL6:ENST00000371663:missense:MODERATE:exon10/15:c.1147G>C:p.Glu383Gln,RABL6:ENST00000311502:missense:MODERATE:exon10/15:c.1144G>C:p.Glu382Gln,RABL6:ENST00000432842:missense:MODERATE:exon10/14:c.1030G>C:p.Glu344Gln,RABL6:ENST00000371675:missense:MODERATE:exon10/15:c.799G>C:p.Glu267Gln,RABL6:ENST00000357466:intron:MODIFIER:exon9/9:c.1079+264G>C:		rs2811741	0.8055	0.8145	7251,3259,722	0.7997,0.7205,0.8710,0.8164,0.8164	0.8221	3.6890	T,T,T,T,T	T	D,D,P	T,T,T,T,T	16.48					1395	628					RABL6 (inh=n/a pLI=0.97)
chr9	139981627	139981627	A	G	hom	anno_omim	QUAL=18102;DP=58;AF=1.00;MQM=60;TRIO=HOM,58,1.00,HOM,231,1.00,HOM,315,1.00	MAN1B1	missense	MAN1B1:ENST00000371589:missense:MODERATE:exon1/13:c.176A>G:p.Asn59Ser		rs968733	0.9054	0.9759	38578,22191,1633	0.7398,0.9817,0.9909,0.9985,0.9931	0.9788	0.9110	T	T	B	T	0.02	604346 [MAN1B1 (provisional) Mental retardation,autosomal recessive 15,614202];	RCV000117582.2 [likely benign]; RCV000277681.1 [benign]; 		COSM4163617	2071	39					MAN1B1 (inh=AR pLI=0.00)
chr9	140002989	140002989	T	C	hom	anno_omim	QUAL=20124;DP=155;AF=0.99;MQM=59;TRIO=HOM,155,0.99,HOM,341,1.00,HET,441,0.44	MAN1B1	synonymous	MAN1B1:ENST00000371589:synonymous:LOW:exon13/13:c.2046T>C:p.Asp682Asp,MAN1B1:ENST00000474902:synonymous:LOW:exon11/11:c.1155T>C:p.Asp385Asp		rs4880091	0.8099	0.7663	35940,18905,4714	0.9514,0.7776,0.7133,0.7515,0.7720	0.7904	1.0730		T,T			0.01	604346 [MAN1B1 (provisional) Mental retardation,autosomal recessive 15,614202];	RCV000117585.2 [likely benign]; RCV000318326.1 [benign]; 		COSM4138895	1196	790					MAN1B1 (inh=AR pLI=0.00)
chr9	140003427	140003427	A	G	hom	anno_omim	QUAL=8896;DP=141;AF=0.99;MQM=59;TRIO=HOM,141,0.99,HOM,102,1.00,HET,107,0.49	MAN1B1	3'UTR	MAN1B1:ENST00000371589:3'UTR:MODIFIER:exon13/13:c.*384A>G:,MAN1B1:ENST00000474902:3'UTR:MODIFIER:exon11/11:c.*384A>G:		rs4567	0.5519	0.4936	1497,416,73	0.5125,0.0000,0.0000,0.4851,0.4898	0.5151	-3.1640		T			1.68	604346 [MAN1B1 (provisional) Mental retardation,autosomal recessive 15,614202];	RCV000384948.1 [benign]; 			445	983					MAN1B1 (inh=AR pLI=0.00)
chr9	140003640	140003640	G	A	hom	anno_omim	QUAL=15398;DP=196;AF=0.98;MQM=60;TRIO=HOM,196,0.98,HOM,211,1.00,HET,248,0.53	MAN1B1,DPP7	intergenic_region	DPP7:ENSG00000177239-ENSG00000176978:intergenic_region:MODIFIER::n.140003640G>A:		rs7853336	0.4040	0.2881	529,191,48	0.4194,0.0000,0.0000,0.3283,0.2503	0.3519							604346 [MAN1B1 (provisional) Mental retardation,autosomal recessive 15,614202];	RCV000341912.1 [benign]; 			53	266					MAN1B1 (inh=AR pLI=0.00), DPP7 (inh=n/a pLI=0.00)
chr9	140729844	140729844	G	C	het	anno_omim	QUAL=4269;DP=196;AF=0.46;MQM=59;TRIO=HET,196,0.46,HET,162,0.52,WT,238,0.00	EHMT1	3'UTR	EHMT1:ENST00000460843:3'UTR:MODIFIER:exon27/27:c.*439G>C:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0001							607001 [EHMT1 (confirmed) Kleefstra syndrome,610253];				0	2					EHMT1 (inh=AD pLI=1.00)
chr10	6053374	6053374	A	G	het	anno_omim	QUAL=26947;DP=574;AF=0.50;MQM=59;TRIO=HET,574,0.50,HOM,624,0.99,WT,820,0.00	IL2RA	3'UTR	IL2RA:ENST00000379959:3'UTR:MODIFIER:exon8/8:c.*1461T>C:	MER5A	rs12244380	0.3548	0.0000	0,0,0	0,0,0,0,0	0.3963							147730 [IL2RA (confirmed) Immunodeficiency 41 with lymphoproliferation and autoimmunity,606367|Diabetes,mellitus,insulin-dependent,susceptibility to,10,601942];	RCV000332829.1 [benign]; 			24	78					IL2RA (inh=AR pLI=0.88)
chr10	6053568	6053568	C	T	hom	anno_omim	QUAL=30049;DP=322;AF=0.99;MQM=59;TRIO=HOM,322,0.99,HET,392,0.46,HOM,497,1.00	IL2RA	3'UTR	IL2RA:ENST00000379959:3'UTR:MODIFIER:exon8/8:c.*1267G>A:	AluJr	rs1570538	0.3760	0.0000	0,0,0	0,0,0,0,0	0.4202							147730 [IL2RA (confirmed) Immunodeficiency 41 with lymphoproliferation and autoimmunity,606367|Diabetes,mellitus,insulin-dependent,susceptibility to,10,601942];	RCV000281841.1 [benign]; 			43	85					IL2RA (inh=AR pLI=0.88)
chr10	6066200	6066200	C	G	hom	anno_omim	QUAL=12161;DP=102;AF=1.00;MQM=60;TRIO=HOM,102,1.00,HET,314,0.50,HET,399,0.50	IL2RA	splice_region&intron	IL2RA:ENST00000379959:splice_region&intron:LOW:exon3/7:c.367+7G>C:,IL2RA:ENST00000379954:splice_region&intron:LOW:exon3/6:c.367+7G>C:,IL2RA:ENST00000256876:splice_region&intron:LOW:exon3/7:c.367+7G>C:		rs11256369	0.1793	0.2126	3019,1778,41	0.0837,0.1104,0.2498,0.2280,0.2386	0.2119							147730 [IL2RA (confirmed) Immunodeficiency 41 with lymphoproliferation and autoimmunity,606367|Diabetes,mellitus,insulin-dependent,susceptibility to,10,601942];	RCV000323644.1 [benign]; 			108	706					IL2RA (inh=AR pLI=0.88)
chr10	14949856	14949856	C	T	het	low_MQM;anno_omim	QUAL=640;DP=70;AF=0.57;MQM=44;TRIO=HET,70,0.57,HET,39,0.15,HET,62,0.31	DCLRE1C	3'UTR,intron	DCLRE1C:ENST00000453695:3'UTR:MODIFIER:exon14/14:c.*551G>A:,DCLRE1C:ENST00000378289:intron:MODIFIER:exon13/13:c.1157-8545G>A:	AluSp	rs373280996	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							605988 [DCLRE1C (confirmed) Severe combined immunodeficiency,Athabascan type,602450|Omenn syndrome,603554];				1	100					DCLRE1C (inh=AR pLI=0.00)
chr10	26993598	26993598	T	-	het	anno_omim	QUAL=2622;DP=84;AF=0.48;MQM=60;TRIO=HET,84,0.48,HOM,31,1.00,HET,43,0.58	PDSS1	splice_region&intron	PDSS1:ENST00000376215:splice_region&intron:LOW:exon2/11:c.163-5delT:,PDSS1:ENST00000376203:splice_region&intron:LOW:exon2/9:c.163-5delT:		rs863224161	0.2374	0.3058	5907,3779,51	0.0964,0.3497,0.3224,0.3381,0.2654	0.3129							607429 [PDSS1 (provisional) Coenzyme Q10 deficiency,primary,2,614651];	RCV000199022.1 [benign]; RCV000302465.1,RCV000199022.1 [likely benign,benign]; RCV000302465.1 [likely benign]; 			377	1464					PDSS1 (inh=AR pLI=0.26)
chr10	38344700	38344700	C	G	het	pred_pathogenic	QUAL=15695;DP=373;AF=0.49;MQM=57;TRIO=HET,373,0.49,HET,350,0.50,HET,422,0.55	ZNF33A	missense,intron	ZNF33A:ENST00000432900:missense:MODERATE:exon4/4:c.1666C>G:p.Gln556Glu,ZNF33A:ENST00000374618:missense:MODERATE:exon5/5:c.1648C>G:p.Gln550Glu,ZNF33A:ENST00000458705:missense:MODERATE:exon5/5:c.1645C>G:p.Gln549Glu,ZNF33A:ENST00000307441:missense:MODERATE:exon4/4:c.1645C>G:p.Gln549Glu,ZNF33A:ENST00000469037:intron:MODIFIER:exon5/5:c.387+1261C>G:		rs2505232	0.4770	0.4463	12613,7105,1354	0.5167,0.5404,0.5652,0.4584,0.2744	0.4592	4.3420	T,T,T,T	T	B,B,B	T,T,T,T	0.01					370	831					ZNF33A (inh=n/a pLI=0.00)
chr10	38346092	38346092	C	T	het		QUAL=6228;DP=300;AF=0.50;MQM=60;TRIO=HET,300,0.50,HET,153,0.52,WT,213,0.00	ZNF33A	3'UTR,intron	ZNF33A:ENST00000374618:3'UTR:MODIFIER:exon5/5:c.*604C>T:,ZNF33A:ENST00000458705:3'UTR:MODIFIER:exon5/5:c.*604C>T:,ZNF33A:ENST00000469037:intron:MODIFIER:exon5/5:c.387+2653C>T:	L1MD2	rs2142349	0.0128	0.0000	0,0,0	0,0,0,0,0	0.0224											0	10					ZNF33A (inh=n/a pLI=0.00)
chr10	43595968	43595968	A	G	het	anno_omim	QUAL=1504;DP=31;AF=0.52;MQM=59;TRIO=HET,31,0.52,HET,71,0.68,WT,98,0.00	RET	synonymous	RET:ENST00000355710:synonymous:LOW:exon2/20:c.135A>G:p.Ala45Ala,RET:ENST00000340058:synonymous:LOW:exon2/19:c.135A>G:p.Ala45Ala		rs1800858	0.7536	0.7365	33200,17899,4676	0.9516,0.7545,0.5491,0.7351,0.7313	0.7726							164761 [RET (confirmed) Multiple endocrine neoplasia IIA,171400|Medullary thyroid carcinoma,155240|Multiple endocrine neoplasia IIB,162300|Central hypoventilation syndrome,congenital,209880|Pheochromocytoma,171300|Hirschsprung disease,susceptibility to,1,142623];	RCV000153833.3 [benign]; 		COSM4144677, COSM4144678	2189	1530	1	[1] old entry - no details available			RET (inh=AR+AD pLI=1.00)
chr10	43606687	43606687	A	G	hom	anno_omim	QUAL=9839;DP=67;AF=1.00;MQM=60;TRIO=HOM,67,1.00,HOM,131,0.98,HOM,128,1.00	RET	synonymous	RET:ENST00000355710:synonymous:LOW:exon7/20:c.1296A>G:p.Ala432Ala,RET:ENST00000340058:synonymous:LOW:exon7/19:c.1296A>G:p.Ala432Ala		rs1800860	0.7752	0.7061	30695,15829,3890	0.8647,0.5310,0.8075,0.6902,0.7410	0.7388							164761 [RET (confirmed) Multiple endocrine neoplasia IIA,171400|Medullary thyroid carcinoma,155240|Multiple endocrine neoplasia IIB,162300|Central hypoventilation syndrome,congenital,209880|Pheochromocytoma,171300|Hirschsprung disease,susceptibility to,1,142623];	RCV000082048.7 [benign]; RCV000131068.2 [benign]; RCV000265973.1 [benign]; RCV000285939.1 [benign]; RCV000321087.1 [benign]; RCV000380264.1 [benign]; 	CM033447 [CLASS=DP MUT=ALT PHEN="Hirschsprung disease association with" GENE=RET]; 		1974	1672	1	[1] Ilnaz Sepahi 29-03-2016 batch import			RET (inh=AR+AD pLI=1.00)
chr10	43613843	43613843	G	T	het	anno_omim	QUAL=6292;DP=191;AF=0.48;MQM=60;TRIO=HET,191,0.48,HOM,94,1.00,HET,111,0.46	RET	synonymous	RET:ENST00000355710:synonymous:LOW:exon13/20:c.2307G>T:p.Leu769Leu,RET:ENST00000340058:synonymous:LOW:exon13/19:c.2307G>T:p.Leu769Leu		rs1800861	0.7125	0.7419	33769,19608,4074	0.8852,0.7684,0.4999,0.7685,0.6419	0.7799							164761 [RET (confirmed) Multiple endocrine neoplasia IIA,171400|Medullary thyroid carcinoma,155240|Multiple endocrine neoplasia IIB,162300|Central hypoventilation syndrome,congenital,209880|Pheochromocytoma,171300|Hirschsprung disease,susceptibility to,1,142623];	RCV000153835.3 [benign]; 			2255	1509	1	[1] Ilnaz Sepahi 29-03-2016 batch import			RET (inh=AR+AD pLI=1.00)
chr10	43622217	43622217	T	C	het	anno_omim	QUAL=11261;DP=205;AF=0.57;MQM=59;TRIO=HET,205,0.57,HOM,158,1.00,HET,258,0.49	RET	3'UTR,intron	RET:ENST00000340058:3'UTR:MODIFIER:exon19/19:c.*15T>C:,RET:ENST00000355710:intron:MODIFIER:exon19/19:c.3187+47T>C:		rs2075912	0.7550	0.8031	33460,19436,3910	0.9186,0.8035,0.5352,0.8291,0.7458	0.8233							164761 [RET (confirmed) Multiple endocrine neoplasia IIA,171400|Medullary thyroid carcinoma,155240|Multiple endocrine neoplasia IIB,162300|Central hypoventilation syndrome,congenital,209880|Pheochromocytoma,171300|Hirschsprung disease,susceptibility to,1,142623];	RCV000151742.2 [benign]; 	CS032426 [CLASS=DP MUT=ALT PHEN="Hirschsprung disease association with" GENE=RET]; 		2553	1180					RET (inh=AR+AD pLI=1.00)
chr10	43622368	43622368	T	A	het	anno_omim	QUAL=4430;DP=165;AF=0.51;MQM=59;TRIO=HET,165,0.51,HOM,52,1.00,HET,60,0.40	RET	3'UTR,intron	RET:ENST00000340058:3'UTR:MODIFIER:exon19/19:c.*166T>A:,RET:ENST00000355710:intron:MODIFIER:exon19/19:c.3187+198T>A:		rs2075913	0.6607	0.0000	0,0,0	0,0,0,0,0	0.7505							164761 [RET (confirmed) Multiple endocrine neoplasia IIA,171400|Medullary thyroid carcinoma,155240|Multiple endocrine neoplasia IIB,162300|Central hypoventilation syndrome,congenital,209880|Pheochromocytoma,171300|Hirschsprung disease,susceptibility to,1,142623];				84	54					RET (inh=AR+AD pLI=1.00)
chr10	43622933	43622933	T	C	het	anno_omim	QUAL=26813;DP=414;AF=0.50;MQM=60;TRIO=HET,414,0.50,HOM,439,1.00,HET,533,0.51	RET	3'UTR,intron	RET:ENST00000340058:3'UTR:MODIFIER:exon19/19:c.*731T>C:,RET:ENST00000355710:intron:MODIFIER:exon19/19:c.3188-627T>C:		rs2565200	0.7654	0.0000	0,0,0	0,0,0,0,0	0.8320							164761 [RET (confirmed) Multiple endocrine neoplasia IIA,171400|Medullary thyroid carcinoma,155240|Multiple endocrine neoplasia IIB,162300|Central hypoventilation syndrome,congenital,209880|Pheochromocytoma,171300|Hirschsprung disease,susceptibility to,1,142623];				99	46					RET (inh=AR+AD pLI=1.00)
chr10	43623812	43623812	C	T	het	anno_omim	QUAL=13119;DP=303;AF=0.51;MQM=60;TRIO=HET,303,0.51,HOM,194,1.00,HET,232,0.47	RET	3'UTR	RET:ENST00000355710:3'UTR:MODIFIER:exon20/20:c.*95C>T:		rs17028	0.1366	0.0000	0,0,0	0,0,0,0,0	0.1764							164761 [RET (confirmed) Multiple endocrine neoplasia IIA,171400|Medullary thyroid carcinoma,155240|Multiple endocrine neoplasia IIB,162300|Central hypoventilation syndrome,congenital,209880|Pheochromocytoma,171300|Hirschsprung disease,susceptibility to,1,142623];	RCV000276472.1 [likely benign]; RCV000311724.1 [likely benign]; RCV000333449.1 [likely benign]; RCV000368704.1 [likely benign]; 			10	142					RET (inh=AR+AD pLI=1.00)
chr10	43624317	43624317	A	T	het	anno_omim	QUAL=6319;DP=182;AF=0.47;MQM=59;TRIO=HET,182,0.47,HOM,81,1.00,HET,114,0.50	RET	3'UTR	RET:ENST00000355710:3'UTR:MODIFIER:exon20/20:c.*600A>T:		rs2742240	0.7524	0.0000	0,0,0	0,0,0,0,0	0.8152							164761 [RET (confirmed) Multiple endocrine neoplasia IIA,171400|Medullary thyroid carcinoma,155240|Multiple endocrine neoplasia IIB,162300|Central hypoventilation syndrome,congenital,209880|Pheochromocytoma,171300|Hirschsprung disease,susceptibility to,1,142623];				152	70					RET (inh=AR+AD pLI=1.00)
chr10	43624833	43624833	T	C	het	anno_omim	QUAL=19762;DP=364;AF=0.48;MQM=60;TRIO=HET,364,0.48,HOM,346,0.99,HET,341,0.46	RET	3'UTR	RET:ENST00000355710:3'UTR:MODIFIER:exon20/20:c.*1116T>C:		rs2435355	0.1899	0.0000	0,0,0	0,0,0,0,0	0.2247							164761 [RET (confirmed) Multiple endocrine neoplasia IIA,171400|Medullary thyroid carcinoma,155240|Multiple endocrine neoplasia IIB,162300|Central hypoventilation syndrome,congenital,209880|Pheochromocytoma,171300|Hirschsprung disease,susceptibility to,1,142623];	RCV000260152.1 [likely benign]; RCV000284603.1 [likely benign]; RCV000324757.1 [likely benign]; RCV000379318.1 [likely benign]; 			13	88					RET (inh=AR+AD pLI=1.00)
chr10	43625223	43625223	G	A	het	anno_omim	QUAL=18009;DP=420;AF=0.54;MQM=59;TRIO=HET,420,0.54,HOM,226,1.00,HET,391,0.46	RET	3'UTR	RET:ENST00000355710:3'UTR:MODIFIER:exon20/20:c.*1506G>A:		rs2742241	0.7472	0.0000	0,0,0	0,0,0,0,0	0.8119							164761 [RET (confirmed) Multiple endocrine neoplasia IIA,171400|Medullary thyroid carcinoma,155240|Multiple endocrine neoplasia IIB,162300|Central hypoventilation syndrome,congenital,209880|Pheochromocytoma,171300|Hirschsprung disease,susceptibility to,1,142623];	RCV000271216.1 [benign]; RCV000326221.1 [benign]; RCV000362237.1 [benign]; RCV000366478.1 [benign]; 			153	68					RET (inh=AR+AD pLI=1.00)
chr10	50664895	50664897	AAT	-	het	anno_omim	QUAL=7558;DP=341;AF=0.55;MQM=59;TRIO=HET,341,0.55,HET,286,0.48,WT,339,0.00	ERCC6,RP11-123B3.2	3'UTR	ERCC6:ENST00000355832:3'UTR:MODIFIER:exon21/21:c.*1964_*1966delATT:		rs147228327	0.0349	0.0000	0,0,0	0,0,0,0,0	0.0646							609413 [ERCC6 (confirmed) Cockayne syndrome,type B,133540|Cerebrooculofacioskeletal syndrome 1,214150|De Sanctis-Cacchione syndrome,278800|Macular degeneration,age-related,susceptibility to,5,613761|UV-sensitive syndrome 1,600630|Lung cancer,susceptibility to,211980|Premature ovarian failure 11,616946];	RCV000271052.1 [benign]; RCV000309810.1 [benign]; RCV000362224.1 [benign]; 			5	30					ERCC6 (inh=AR+AD pLI=0.00), RP11-123B3.2 (inh=n/a pLI=n/a)
chr10	50667105	50667105	T	C	het	pred_pathogenic;anno_omim	QUAL=15915;DP=247;AF=0.50;MQM=59;TRIO=HET,247,0.50,HET,231,0.50,HOM,303,1.00	ERCC6,RP11-123B3.2	missense	ERCC6:ENST00000355832:missense:MODERATE:exon21/21:c.4238A>G:p.Gln1413Arg,ERCC6:ENST00000542458:missense:MODERATE:exon15/15:c.2348A>G:p.Gln783Arg		rs2228529	0.1789	0.2178	3279,1699,83	0.1251,0.1634,0.0520,0.2243,0.3480	0.2181	0.1010	T,T,T	T	B	D,T	0.06	609413 [ERCC6 (confirmed) Cockayne syndrome,type B,133540|Cerebrooculofacioskeletal syndrome 1,214150|De Sanctis-Cacchione syndrome,278800|Macular degeneration,age-related,susceptibility to,5,613761|UV-sensitive syndrome 1,600630|Lung cancer,susceptibility to,211980|Premature ovarian failure 11,616946];	RCV000117001.5 [other]; RCV000292311.1 [benign]; RCV000346112.1 [benign]; RCV000402619.1 [benign]; 		COSM427630	139	847					ERCC6 (inh=AR+AD pLI=0.00), RP11-123B3.2 (inh=n/a pLI=n/a)
chr10	50678369	50678369	T	C	het	pred_pathogenic;anno_omim	QUAL=12517;DP=230;AF=0.57;MQM=59;TRIO=HET,230,0.57,HET,203,0.49,HOM,209,0.99	ERCC6,RP11-123B3.2	missense	ERCC6:ENST00000355832:missense:MODERATE:exon18/21:c.3637A>G:p.Arg1213Gly,ERCC6:ENST00000542458:missense:MODERATE:exon12/15:c.1747A>G:p.Arg583Gly		rs2228527	0.1847	0.2203	3325,1708,118	0.1481,0.1645,0.0521,0.2250,0.3480	0.2200	1.7160	T,T,T	T	B	D,T	13.04	609413 [ERCC6 (confirmed) Cockayne syndrome,type B,133540|Cerebrooculofacioskeletal syndrome 1,214150|De Sanctis-Cacchione syndrome,278800|Macular degeneration,age-related,susceptibility to,5,613761|UV-sensitive syndrome 1,600630|Lung cancer,susceptibility to,211980|Premature ovarian failure 11,616946];	RCV000116998.6 [other]; RCV000272009.1 [benign]; RCV000329399.1 [benign]; RCV000367801.1 [benign]; 	CM980633 [CLASS=DP MUT=ALT PHEN="Colorectal cancer increased risk association with" GENE=ERCC6]; 	COSM3751836	144	850					ERCC6 (inh=AR+AD pLI=0.00), RP11-123B3.2 (inh=n/a pLI=n/a)
chr10	50678717	50678717	T	C	het	pred_pathogenic;anno_omim	QUAL=29118;DP=472;AF=0.49;MQM=60;TRIO=HET,472,0.49,HET,356,0.59,HOM,521,1.00	ERCC6,RP11-123B3.2	missense	ERCC6:ENST00000355832:missense:MODERATE:exon18/21:c.3289A>G:p.Met1097Val,ERCC6:ENST00000542458:missense:MODERATE:exon12/15:c.1399A>G:p.Met467Val		rs2228526	0.1825	0.2186	3293,1702,93	0.1318,0.1637,0.0521,0.2244,0.3481	0.2185	-0.2110	T,T,T	T	B	D,T	0.01	609413 [ERCC6 (confirmed) Cockayne syndrome,type B,133540|Cerebrooculofacioskeletal syndrome 1,214150|De Sanctis-Cacchione syndrome,278800|Macular degeneration,age-related,susceptibility to,5,613761|UV-sensitive syndrome 1,600630|Lung cancer,susceptibility to,211980|Premature ovarian failure 11,616946];	RCV000116997.6 [other]; RCV000287947.1 [benign]; RCV000322054.1 [benign]; RCV000378942.1 [benign]; 	CM076169 [CLASS=DP MUT=ALT PHEN="Reduced chromosomal damage in coke oven workers association with" GENE=ERCC6]; 	COSM3751837	141	846					ERCC6 (inh=AR+AD pLI=0.00), RP11-123B3.2 (inh=n/a pLI=n/a)
chr10	50701156	50701156	G	A	het	anno_omim	QUAL=10492;DP=205;AF=0.49;MQM=60;TRIO=HET,205,0.49,HET,146,0.49,HOM,190,1.00	ERCC6	splice_region&intron,intron	ERCC6:ENST00000355832:splice_region&intron:LOW:exon8/20:c.1821+7C>T:,ERCC6:ENST00000542458:intron:MODIFIER:exon2/14:c.-70+7428C>T:		rs4253132	0.8770	0.8887	48044,25622,2737	0.7254,0.9408,0.9992,0.8774,0.9391	0.8950							609413 [ERCC6 (confirmed) Cockayne syndrome,type B,133540|Cerebrooculofacioskeletal syndrome 1,214150|De Sanctis-Cacchione syndrome,278800|Macular degeneration,age-related,susceptibility to,5,613761|UV-sensitive syndrome 1,600630|Lung cancer,susceptibility to,211980|Premature ovarian failure 11,616946];	RCV000170371.2 [benign]; RCV000302397.1 [benign]; RCV000357202.1 [benign]; RCV000404616.1 [benign]; 			1826	446					ERCC6 (inh=AR+AD pLI=0.00)
chr10	50740876	50740876	G	C	het	anno_omim	QUAL=13156;DP=175;AF=0.49;MQM=59;TRIO=HET,175,0.49,HET,228,0.47,HOM,280,1.00	ERCC6,ERCC6-PGBD3,PGBD3	synonymous	ERCC6:ENST00000355832:synonymous:LOW:exon2/21:c.135C>G:p.Leu45Leu,PGBD3:ENST00000603152:synonymous:LOW:exon2/6:c.135C>G:p.Leu45Leu		rs2228524	0.5909	0.6946	30180,18280,767	0.3800,0.6211,0.5379,0.7399,0.8132	0.6995							609413 [ERCC6 (confirmed) Cockayne syndrome,type B,133540|Cerebrooculofacioskeletal syndrome 1,214150|De Sanctis-Cacchione syndrome,278800|Macular degeneration,age-related,susceptibility to,5,613761|UV-sensitive syndrome 1,600630|Lung cancer,susceptibility to,211980|Premature ovarian failure 11,616946];	RCV000116995.5 [other]; RCV000309121.1 [benign]; RCV000367258.1 [benign]; RCV000403290.1 [benign]; 			1278	860					ERCC6 (inh=AR+AD pLI=0.00), ERCC6-PGBD3 (inh=n/a pLI=n/a), PGBD3 (inh=n/a pLI=0.00)
chr10	50821191	50821191	G	T	het	anno_omim	QUAL=10865;DP=252;AF=0.48;MQM=59;TRIO=HET,252,0.48,HET,282,0.53,HET,326,0.48	CHAT	5'UTR,intron	CHAT:ENST00000351556:5'UTR:MODIFIER:exon1/16:c.-298G>T:,CHAT:ENST00000395559:5'UTR:MODIFIER:exon1/15:c.-126G>T:,CHAT:ENST00000339797:intron:MODIFIER:exon1/14:c.-68-3357G>T:		rs3729496	0.4307	0.0000	0,0,0	0,0,0,0,0	0.5430							118490 [CHAT (confirmed) Myasthenic syndrome,congenital,6,presynaptic,254210];				116	98					CHAT (inh=AR pLI=0.01)
chr10	50863147	50863147	T	C	hom	anno_omim	QUAL=14486;DP=229;AF=1.00;MQM=59;TRIO=HOM,229,1.00,HOM,118,1.00,HOM,129,1.00	CHAT	synonymous	CHAT:ENST00000337653:synonymous:LOW:exon12/15:c.1641T>C:p.His547His,CHAT:ENST00000339797:synonymous:LOW:exon12/15:c.1287T>C:p.His429His,CHAT:ENST00000351556:synonymous:LOW:exon13/16:c.1287T>C:p.His429His,CHAT:ENST00000395559:synonymous:LOW:exon12/15:c.1287T>C:p.His429His,CHAT:ENST00000395562:synonymous:LOW:exon13/16:c.1395T>C:p.His465His,CHAT:ENST00000455728:synonymous:LOW:exon12/15:c.1287T>C:p.His429His		rs8178992	0.7935	0.8491	44227,27257,2476	0.6932,0.6662,0.7947,0.9042,0.8649	0.8446							118490 [CHAT (confirmed) Myasthenic syndrome,congenital,6,presynaptic,254210];	RCV000116692.3 [benign]; 		COSM4144745, COSM4144746	1657	417					CHAT (inh=AR pLI=0.01)
chr10	64572038	64572038	T	-	hom	anno_omim	QUAL=18614;DP=254;AF=1.00;MQM=59;TRIO=HOM,254,1.00,HOM,170,0.99,HOM,181,1.00	EGR2	3'UTR	EGR2:ENST00000242480:3'UTR:MODIFIER:exon2/2:c.*929delA:,EGR2:ENST00000411732:3'UTR:MODIFIER:exon3/3:c.*929delA:,EGR2:ENST00000439032:3'UTR:MODIFIER:exon4/4:c.*929delA:		rs398013782	0.9944	0.0000	0,0,0	0,0,0,0,0	0.9939							129010 [EGR2 (provisional) Neuropathy,congenital hypomyelinating,1,605253|Charcot-Marie-Tooth disease,type 1D,607678|Dejerine-Sottas disease,145900];				232	0					EGR2 (inh=AR+AD pLI=0.62)
chr10	64573771	64573771	C	T	hom	anno_omim	QUAL=36295;DP=175;AF=1.00;MQM=59;TRIO=HOM,175,1.00,HOM,475,1.00,HOM,568,1.00	EGR2	synonymous	EGR2:ENST00000242480:synonymous:LOW:exon2/2:c.627G>A:p.Pro209Pro,EGR2:ENST00000411732:synonymous:LOW:exon3/3:c.477G>A:p.Pro159Pro,EGR2:ENST00000439032:synonymous:LOW:exon4/4:c.627G>A:p.Pro209Pro		rs224083	0.9860	0.9953	60144,33365,4686	0.9493,0.9972,1.0000,0.9999,0.9997	0.9962							129010 [EGR2 (provisional) Neuropathy,congenital hypomyelinating,1,605253|Charcot-Marie-Tooth disease,type 1D,607678|Dejerine-Sottas disease,145900];	RCV000383101.1 [benign]; 			2113	0					EGR2 (inh=AR+AD pLI=0.62)
chr10	70748784	70748784	G	A	het	anno_omim	QUAL=6877;DP=190;AF=0.51;MQM=59;TRIO=HET,190,0.51,HET,186,0.49,HET,251,0.49	KIAA1279	missense	KIAA1279:ENST00000361983:missense:MODERATE:exon1/7:c.196G>A:p.Gly66Ser		rs2255607	0.3538	0.4137	10594,7462,598	0.3574,0.2777,0.3857,0.4783,0.3100	0.4155	0.2110	T	T	B	T	0.26	609367 [KIAA1279 (provisional) Goldberg-Shprintzen megacolon syndrome,609460];	RCV000146132.2 [benign]; 		COSM3751905	436	992					KIF1BP (inh=AR pLI=0.05)
chr10	70776594	70776594	A	C	het	anno_omim	QUAL=4926;DP=203;AF=0.54;MQM=60;TRIO=HET,203,0.54,HET,39,0.56,HET,77,0.60	KIAA1279	3'UTR	KIAA1279:ENST00000361983:3'UTR:MODIFIER:exon7/7:c.*422A>C:		rs6864	0.3638	0.0000	0,0,0	0,0,0,0,0	0.4228							609367 [KIAA1279 (provisional) Goldberg-Shprintzen megacolon syndrome,609460];				40	116					KIF1BP (inh=AR pLI=0.05)
chr10	71332204	71332204	A	G	hom	pred_pathogenic;anno_omim	QUAL=10824;DP=105;AF=1.00;MQM=59;TRIO=HOM,105,1.00,HOM,100,1.00,HOM,143,1.00	NEUROG3	missense	NEUROG3:ENST00000242462:missense:MODERATE:exon2/2:c.596T>C:p.Phe199Ser		rs4536103	0.4299	0.5860	11362,7860,197	0.3710,0.5838,0.3655,0.6621,0.4746	0.5603	1.4960	T	T	B	D	2.01	604882 [NEUROG3 (provisional) Diarrhea 4,malabsorptive,congenital,610370];	RCV000117780.2 [likely benign]; 	CM068025 [CLASS=DP MUT=ALT PHEN="Diabetes type 2 association with" GENE=NEUROG3]; 	COSM3749111	796	922					NEUROG3 (inh=AR pLI=0.00)
chr10	72357713	72357713	C	T	hom	anno_omim	QUAL=38260;DP=545;AF=0.99;MQM=59;TRIO=HOM,545,0.99,HOM,300,0.99,HOM,408,1.00	PRF1	3'UTR	PRF1:ENST00000373209:3'UTR:MODIFIER:exon3/3:c.*96G>A:,PRF1:ENST00000441259:3'UTR:MODIFIER:exon3/3:c.*96G>A:	MER30	rs1889490	0.5779	0.0000	0,0,0	0,0,0,0,0	0.5079							170280 [PRF1 (confirmed) Hemophagocytic lymphohistiocytosis,familial,2,603553|Lymphoma,non-Hodgkin,605027|Aplastic anemia,609135];	RCV000375811.1 [benign]; 			33	107					PRF1 (inh=AR pLI=0.00)
chr10	72358577	72358577	G	A	hom	anno_omim	QUAL=27545;DP=200;AF=1.00;MQM=59;TRIO=HOM,200,1.00,HOM,311,1.00,HOM,401,1.00	PRF1	synonymous	PRF1:ENST00000373209:synonymous:LOW:exon3/3:c.900C>T:p.His300His,PRF1:ENST00000441259:synonymous:LOW:exon3/3:c.900C>T:p.His300His		rs885822	0.6959	0.6357	24936,11530,3341	0.8031,0.6910,0.7648,0.5861,0.6157	0.6731							170280 [PRF1 (confirmed) Hemophagocytic lymphohistiocytosis,familial,2,603553|Lymphoma,non-Hodgkin,605027|Aplastic anemia,609135];	RCV000248849.1 [benign]; RCV000306406.1 [benign]; 		COSM3765513	776	1000					PRF1 (inh=AR pLI=0.00)
chr10	73270906	73270906	T	C	hom	anno_omim	QUAL=40725;DP=329;AF=0.99;MQM=59;TRIO=HOM,329,0.99,HOM,419,1.00,HOM,547,1.00	CDH23,CDH23-AS1	synonymous,intron	CDH23:ENST00000224721:synonymous:LOW:exon5/69:c.366T>C:p.Val122Val,CDH23:ENST00000398842:synonymous:LOW:exon6/14:c.366T>C:p.Val122Val,CDH23:ENST00000398809:synonymous:LOW:exon6/14:c.366T>C:p.Val122Val,CDH23:ENST00000461841:synonymous:LOW:exon6/14:c.501T>C:p.Val167Val,CDH23:ENST00000299366:synonymous:LOW:exon6/26:c.501T>C:p.Val167Val,CDH23-AS1:ENST00000428918:intron:MODIFIER:exon1/2:n.96+629A>G:		rs3802720	0.7346	0.6721	28139,14978,4298	0.9361,0.4426,0.7765,0.6703,0.6037	0.7527							605516 [CDH23 (confirmed) Usher syndrome,type 1D,601067|Deafness,autosomal recessive 12,601386|Usher syndrome,type 1D/F digenic,601067];	RCV000039162.3 [benign]; RCV000288261.1 [likely benign]; RCV000380358.1 [likely benign]; 		COSM4144828, COSM4144829, COSM4144830, COSM4144827	909	956					CDH23 (inh=AR pLI=0.05), CDH23-AS1 (inh=n/a pLI=n/a)
chr10	73377314	73377314	C	G	hom	gene_blacklist;anno_omim	QUAL=25262;DP=237;AF=1.00;MQM=60;TRIO=HOM,237,1.00,HOM,248,1.00,HOM,344,0.99	CDH23	intron	CDH23:ENST00000224721:intron:MODIFIER:exon10/68:c.1149+164C>G:,CDH23:ENST00000398842:intron:MODIFIER:exon11/13:c.1134+164C>G:,CDH23:ENST00000398809:intron:MODIFIER:exon11/13:c.1134+164C>G:,CDH23:ENST00000461841:intron:MODIFIER:exon11/13:c.1269+164C>G:,CDH23:ENST00000299366:intron:MODIFIER:exon11/25:c.1269+164C>G:	Charlie7a	rs7903772	0.5495	0.0000	0,0,0	0,0,0,0,0	0.6175							605516 [CDH23 (confirmed) Usher syndrome,type 1D,601067|Deafness,autosomal recessive 12,601386|Usher syndrome,type 1D/F digenic,601067];				81	63					CDH23 (inh=AR pLI=0.05)
chr10	73406599	73406599	G	A	het	gene_blacklist;anno_omim	QUAL=10677;DP=210;AF=0.54;MQM=60;TRIO=HET,210,0.54,HET,242,0.50,HET,358,0.51	CDH23	3'UTR,intron	CDH23:ENST00000398809:3'UTR:MODIFIER:exon14/14:c.*81G>A:,CDH23:ENST00000224721:intron:MODIFIER:exon13/68:c.1464+225G>A:,CDH23:ENST00000299366:intron:MODIFIER:exon14/25:c.1584+225G>A:		rs2305210	0.2592	0.0000	0,0,0	0,0,0,0,0	0.3112							605516 [CDH23 (confirmed) Usher syndrome,type 1D,601067|Deafness,autosomal recessive 12,601386|Usher syndrome,type 1D/F digenic,601067];				21	127					CDH23 (inh=AR pLI=0.05)
chr10	73406636	73406636	C	T	het	gene_blacklist;anno_omim	QUAL=7816;DP=221;AF=0.43;MQM=60;TRIO=HET,221,0.43,HET,194,0.48,HET,272,0.46	CDH23	3'UTR,intron	CDH23:ENST00000398809:3'UTR:MODIFIER:exon14/14:c.*118C>T:,CDH23:ENST00000224721:intron:MODIFIER:exon13/68:c.1464+262C>T:,CDH23:ENST00000299366:intron:MODIFIER:exon14/25:c.1584+262C>T:		rs11598249	0.2368	0.0000	0,0,0	0,0,0,0,0	0.2454							605516 [CDH23 (confirmed) Usher syndrome,type 1D,601067|Deafness,autosomal recessive 12,601386|Usher syndrome,type 1D/F digenic,601067];				17	68					CDH23 (inh=AR pLI=0.05)
chr10	73407220	73407220	A	-	hom	low_DP;gene_blacklist;anno_omim	QUAL=279;DP=13;AF=0.92;MQM=56;TRIO=HOM,13,0.92,HOM,1,1.00,WT,272,0.46	CDH23	intron	CDH23:ENST00000224721:intron:MODIFIER:exon13/68:c.1464+858delA:,CDH23:ENST00000299366:intron:MODIFIER:exon14/25:c.1584+858delA:	AluSz	rs113373333;rs56367143	0.8317	0.0000	0,0,0	0,0,0,0,0	0.8476							605516 [CDH23 (confirmed) Usher syndrome,type 1D,601067|Deafness,autosomal recessive 12,601386|Usher syndrome,type 1D/F digenic,601067];				48	12					CDH23 (inh=AR pLI=0.05)
chr10	73434906	73434906	G	A	hom	gene_blacklist;anno_omim	QUAL=25363;DP=401;AF=1.00;MQM=59;TRIO=HOM,401,1.00,HOM,258,0.99,HET,383,0.48	CDH23	missense	CDH23:ENST00000224721:missense:MODERATE:exon14/69:c.1502G>A:p.Ser501Asn,CDH23:ENST00000299366:missense:MODERATE:exon15/26:c.1622G>A:p.Ser541Asn		rs10999947	0.2524	0.2724	4500,2314,301	0.2539,0.3098,0.2918,0.2632,0.2700	0.2816	0.4000	T,T,T,T,T,T	T	B,B,B		10.40	605516 [CDH23 (confirmed) Usher syndrome,type 1D,601067|Deafness,autosomal recessive 12,601386|Usher syndrome,type 1D/F digenic,601067];	RCV000039108.3 [benign]; RCV000279658.1 [likely benign]; RCV000316088.1 [likely benign]; 			160	772					CDH23 (inh=AR pLI=0.05)
chr10	73492079	73492079	A	G	het	pred_pathogenic;anno_omim	QUAL=19200;DP=203;AF=0.40;MQM=59;TRIO=HET,203,0.40,HET,349,0.54,HOM,399,1.00	CDH23,C10orf105	missense,intron	CDH23:ENST00000224721:missense:MODERATE:exon31/69:c.4066A>G:p.Asn1356Asp,C10orf105:ENST00000398786:intron:MODIFIER:exon1/1:c.-6+5406T>C:		rs1227065	0.7821	0.8159	31531,18061,2288	0.7809,0.8058,0.8475,0.8267,0.8047	0.8059	7.6660	T,T,T,T	T	B		1.49	605516 [CDH23 (confirmed) Usher syndrome,type 1D,601067|Deafness,autosomal recessive 12,601386|Usher syndrome,type 1D/F digenic,601067];	RCV000039171.7 [benign]; RCV000345614.1 [likely benign]; RCV000397439.1 [likely benign]; 			1417	608					CDH23 (inh=AR pLI=0.05), C10orf105 (inh=n/a pLI=n/a)
chr10	73501556	73501556	G	A	het	gene_blacklist;pred_pathogenic;anno_omim	QUAL=25178;DP=353;AF=0.52;MQM=60;TRIO=HET,353,0.52,HET,402,0.53,HOM,539,1.00	CDH23	missense	CDH23:ENST00000224721:missense:MODERATE:exon37/69:c.4738G>A:p.Ala1580Thr		rs1227051	0.7288	0.7753	34657,19701,1730	0.6276,0.7827,0.8314,0.7868,0.7875	0.7734	6.2020	T,T,T,T	T	B		9.88	605516 [CDH23 (confirmed) Usher syndrome,type 1D,601067|Deafness,autosomal recessive 12,601386|Usher syndrome,type 1D/F digenic,601067];	RCV000039189.3 [benign]; RCV000275255.1 [likely benign]; RCV000328065.1 [likely benign]; 			1303	694					CDH23 (inh=AR pLI=0.05)
chr10	73537614	73537614	G	A	het	gene_blacklist;anno_omim	QUAL=932;DP=47;AF=0.51;MQM=60;TRIO=HET,47,0.51,HET,42,0.43,WT,56,0.00	CDH23	missense	CDH23:ENST00000224721:missense:MODERATE:exon38/69:c.5038G>A:p.Val1680Ile		rs17712523	0.1322	0.1789	2098,1315,9	0.0328,0.1385,0.1604,0.2000,0.1974	0.1800	0.1020	T,T,T	T	B		16.96	605516 [CDH23 (confirmed) Usher syndrome,type 1D,601067|Deafness,autosomal recessive 12,601386|Usher syndrome,type 1D/F digenic,601067];	RCV000039194.3 [benign]; RCV000086975.1 [not provided]; RCV000310492.1 [likely benign]; RCV000394559.1 [likely benign]; 		COSM146951	83	629					CDH23 (inh=AR pLI=0.05)
chr10	73550117	73550117	C	G	het	gene_blacklist;pred_pathogenic;anno_omim	QUAL=7302;DP=153;AF=0.42;MQM=60;TRIO=HET,153,0.42,HET,232,0.42,HET,313,0.44	CDH23	missense	CDH23:ENST00000224721:missense:MODERATE:exon45/69:c.6011C>G:p.Thr2004Ser		rs11592462	0.3452	0.4291	11548,7665,379	0.2895,0.2793,0.1640,0.4856,0.5217	0.4238	1.6610	T,T,T	T	B		14.01	605516 [CDH23 (confirmed) Usher syndrome,type 1D,601067|Deafness,autosomal recessive 12,601386|Usher syndrome,type 1D/F digenic,601067];	RCV000039232.7 [benign]; RCV000338564.1 [likely benign]; RCV000405485.1 [likely benign]; 		COSM3751946	522	1011					CDH23 (inh=AR pLI=0.05)
chr10	73569749	73569749	C	T	het	gene_blacklist;anno_omim	QUAL=9699;DP=253;AF=0.51;MQM=60;TRIO=HET,253,0.51,WT,461,0.00,HET,583,0.46	CDH23	synonymous	CDH23:ENST00000224721:synonymous:LOW:exon60/69:c.8910C>T:p.Pro2970Pro,CDH23:ENST00000398788:synonymous:LOW:exon14/23:c.2175C>T:p.Pro725Pro		rs11000009	0.0809	0.1141	924,627,48	0.1003,0.0590,0.0029,0.1373,0.1351	0.1107							605516 [CDH23 (confirmed) Usher syndrome,type 1D,601067|Deafness,autosomal recessive 12,601386|Usher syndrome,type 1D/F digenic,601067];	RCV000039294.6 [benign]; RCV000290902.1 [likely benign]; RCV000348155.1 [likely benign]; 			53	551					CDH23 (inh=AR pLI=0.05)
chr10	73575384	73575384	A	G	het	gene_blacklist;anno_omim	QUAL=12043;DP=186;AF=0.46;MQM=60;TRIO=HET,186,0.46,HOM,225,1.00,HET,242,0.54	CDH23	3'UTR	CDH23:ENST00000398788:3'UTR:MODIFIER:exon23/23:c.*349A>G:		rs1867978	0.7893	0.0000	0,0,0	0,0,0,0,0	0.7644							605516 [CDH23 (confirmed) Usher syndrome,type 1D,601067|Deafness,autosomal recessive 12,601386|Usher syndrome,type 1D/F digenic,601067];	RCV000277087.1 [benign]; RCV000301787.1 [likely benign]; RCV000311190.1 [benign]; RCV000368083.1 [benign]; RCV000369416.1 [benign]; RCV000407454.1 [likely benign]; 			115	102					CDH23 (inh=AR pLI=0.05)
chr10	75009977	75009977	A	-	het	anno_omim	QUAL=120;DP=31;AF=0.35;MQM=54;TRIO=HET,31,0.35,HOM,4,1.00,HET,6,0.50	MRPS16,DNAJC9-AS1	3'UTR,intron	MRPS16:ENST00000372945:3'UTR:MODIFIER:exon3/3:c.*633delT:,DNAJC9-AS1:ENST00000440197:intron:MODIFIER:exon2/3:n.182+1784delA:,MRPS16:ENST00000416782:intron:MODIFIER:exon2/3:c.274+1544delT:,MRPS16:ENST00000372940:intron:MODIFIER:exon2/2:c.275-901delT:	AluY	rs555061429	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1383							609204 [MRPS16 (confirmed) Combined oxidative phosphorylation deficiency 2,610498];				3	38					MRPS16 (inh=AR pLI=0.08), DNAJC9-AS1 (inh=n/a pLI=n/a)
chr10	75936611	75936611	C	T	hom	anno_omim	QUAL=5205;DP=26;AF=0.96;MQM=59;TRIO=HOM,26,0.96,HET,106,0.51,HOM,114,0.99	ADK	5'UTR_premature_start_codon_gain,5'UTR,intron	ADK:ENST00000372734:5'UTR_premature_start_codon_gain:LOW:exon1/11:c.-20C>T:,ADK:ENST00000541550:5'UTR_premature_start_codon_gain:LOW:exon1/10:c.-20C>T:,ADK:ENST00000372734:5'UTR:MODIFIER:exon1/11:c.-20C>T:,ADK:ENST00000541550:5'UTR:MODIFIER:exon1/10:c.-20C>T:,ADK:ENST00000286621:intron:MODIFIER:exon1/10:c.66-23911C>T:,ADK:ENST00000539909:intron:MODIFIER:exon1/9:c.66-23911C>T:		rs10824095	0.6302	0.6812	27735,18112,3019	0.7955,0.5738,0.3817,0.7539,0.5558	0.7322							102750 [ADK (confirmed) Hypermethioninemia due to adenosine kinase deficiency,614300];	RCV000293153.1 [benign]; 			1210	720					ADK (inh=AR pLI=0.32)
chr10	76468851	76468851	C	T	het	anno_omim	QUAL=3986;DP=181;AF=0.52;MQM=60;TRIO=HET,181,0.52,HOM,46,0.98,WT,96,0.00	ADK	3'UTR	ADK:ENST00000372734:3'UTR:MODIFIER:exon11/11:c.*648C>T:		rs1189553	0.8500	0.0000	0,0,0	0,0,0,0,0	0.8099							102750 [ADK (confirmed) Hypermethioninemia due to adenosine kinase deficiency,614300];	RCV000307240.1 [benign]; 			147	74					ADK (inh=AR pLI=0.32)
chr10	82031937	82031937	-	CCAGCCTGAA	het	anno_omim	QUAL=5057;DP=244;AF=0.46;MQM=59;TRIO=HET,244,0.46,HET,204,0.49,WT,319,0.00	MAT1A	3'UTR	MAT1A:ENST00000372213:3'UTR:MODIFIER:exon9/9:c.*1599_*1600insTTCAGGCTGG:		rs145159688	0.4900	0.0000	0,0,0	0,0,0,0,0	0.4115							610550 [MAT1A (provisional) Hypermethioninemia,persistent,autosomal dominant,due to methionine adenosyltransferase I/III deficiency,250850|Methionine adenosyltransferase deficiency,autosomal recessive,250850];	RCV000301350.1 [benign]; 			33	104					MAT1A (inh=AR+AD pLI=0.75)
chr10	82032240	82032240	A	G	het	anno_omim	QUAL=9759;DP=267;AF=0.48;MQM=60;TRIO=HET,267,0.48,HOM,247,0.99,WT,284,0.00	MAT1A	3'UTR	MAT1A:ENST00000372213:3'UTR:MODIFIER:exon9/9:c.*1297T>C:		rs1985908	0.4982	0.0000	0,0,0	0,0,0,0,0	0.3588							610550 [MAT1A (provisional) Hypermethioninemia,persistent,autosomal dominant,due to methionine adenosyltransferase I/III deficiency,250850|Methionine adenosyltransferase deficiency,autosomal recessive,250850];	RCV000275391.1 [benign]; 			33	92					MAT1A (inh=AR+AD pLI=0.75)
chr10	82033594	82033594	G	A	het	anno_omim	QUAL=18954;DP=486;AF=0.48;MQM=59;TRIO=HET,486,0.48,HET,419,0.51,HET,544,0.50	MAT1A	synonymous	MAT1A:ENST00000372213:synonymous:LOW:exon9/9:c.1131C>T:p.Tyr377Tyr		rs2993763	0.5869	0.5124	16539,6889,2909	0.7470,0.5506,0.4586,0.4560,0.6267	0.5316							610550 [MAT1A (provisional) Hypermethioninemia,persistent,autosomal dominant,due to methionine adenosyltransferase I/III deficiency,250850|Methionine adenosyltransferase deficiency,autosomal recessive,250850];	RCV000247170.1 [benign]; RCV000330172.1 [benign]; 		COSM3751998	510	1028					MAT1A (inh=AR+AD pLI=0.75)
chr10	82034842	82034842	A	G	het	anno_omim	QUAL=3648;DP=177;AF=0.48;MQM=59;TRIO=HET,177,0.48,HOM,30,1.00,HET,80,0.35	MAT1A	synonymous	MAT1A:ENST00000372213:synonymous:LOW:exon7/9:c.882T>C:p.Ala294Ala		rs10887711	0.8405	0.7441	20007,7937,2472	0.8864,0.8182,0.9724,0.6594,0.8262	0.7328							610550 [MAT1A (provisional) Hypermethioninemia,persistent,autosomal dominant,due to methionine adenosyltransferase I/III deficiency,250850|Methionine adenosyltransferase deficiency,autosomal recessive,250850];	RCV000247603.2 [benign]; RCV000397356.1 [benign]; 		COSM428025	1002	845					MAT1A (inh=AR+AD pLI=0.75)
chr10	82034854	82034854	T	C	het	anno_omim	QUAL=3402;DP=152;AF=0.50;MQM=59;TRIO=HET,152,0.50,HOM,31,1.00,HET,78,0.38	MAT1A	synonymous	MAT1A:ENST00000372213:synonymous:LOW:exon7/9:c.870A>G:p.Val290Val		rs10788546	0.8409	0.7504	26294,10521,3162	0.8923,0.8277,0.9759,0.6638,0.8313	0.7329							610550 [MAT1A (provisional) Hypermethioninemia,persistent,autosomal dominant,due to methionine adenosyltransferase I/III deficiency,250850|Methionine adenosyltransferase deficiency,autosomal recessive,250850];	RCV000243664.2 [benign]; RCV000289020.1 [benign]; 			1003	849					MAT1A (inh=AR+AD pLI=0.75)
chr10	82040052	82040052	A	G	hom	anno_omim	QUAL=21601;DP=165;AF=0.99;MQM=60;TRIO=HOM,165,0.99,HOM,241,1.00,HOM,297,0.99	MAT1A	synonymous	MAT1A:ENST00000372213:synonymous:LOW:exon5/9:c.426T>C:p.Ala142Ala		rs1143694	0.8634	0.7543	35357,14968,4554	0.9355,0.8269,0.9765,0.6688,0.8382	0.7657							610550 [MAT1A (provisional) Hypermethioninemia,persistent,autosomal dominant,due to methionine adenosyltransferase I/III deficiency,250850|Methionine adenosyltransferase deficiency,autosomal recessive,250850];	RCV000251869.1 [benign]; RCV000358819.1 [benign]; 		COSM4144914	1107	791					MAT1A (inh=AR+AD pLI=0.75)
chr10	82049251	82049251	-	TTCTTC	hom	anno_omim	QUAL=12518;DP=125;AF=0.90;MQM=59;TRIO=HOM,125,0.90,HOM,176,0.91,HET,216,0.50	MAT1A	5'UTR	MAT1A:ENST00000372213:5'UTR:MODIFIER:exon1/9:c.-78_-73dupGAAGAA:	(TTC)n	rs10694757;rs145126070	0.7696	0.0000	0,0,0	0,0,0,0,0	0.6678							610550 [MAT1A (provisional) Hypermethioninemia,persistent,autosomal dominant,due to methionine adenosyltransferase I/III deficiency,250850|Methionine adenosyltransferase deficiency,autosomal recessive,250850];	RCV000325963.1 [benign]; 			201	169					MAT1A (inh=AR+AD pLI=0.75)
chr10	83637775	83637775	C	G	het	pred_pathogenic	QUAL=8421;DP=288;AF=0.47;MQM=60;TRIO=HET,288,0.47,WT,136,0.00,HOM,166,0.99	NRG3	missense&splice_region,missense,intron	NRG3:ENST00000372142:missense&splice_region:MODERATE:exon1/11:c.59C>G:p.Thr20Arg,NRG3:ENST00000404576:missense:MODERATE:exon1/10:c.59C>G:p.Thr20Arg,NRG3:ENST00000556918:missense:MODERATE:exon1/11:c.59C>G:p.Thr20Arg,NRG3:ENST00000404547:intron:MODIFIER:exon1/9:c.823+1856C>G:,NRG3:ENST00000372141:intron:MODIFIER:exon1/8:c.823+1856C>G:		rs1884282	0.1394	0.1453	244,48,39	0.1842,0.1220,0.0681,0.1089,0.1836	0.1283	-0.8040	D,T,D	T	B	T,T,T	2.95				COSM146979	24	362					NRG3 (inh=n/a pLI=0.21)
chr10	84746576	84746576	C	T	hom		QUAL=24632;DP=284;AF=1.00;MQM=59;TRIO=HOM,284,1.00,HOM,208,1.00,HOM,253,1.00	NRG3	3'UTR	NRG3:ENST00000372142:3'UTR:MODIFIER:exon11/11:c.*1215C>T:		rs3763704	0.9307	0.0000	0,0,0	0,0,0,0,0	0.9127											204	27					NRG3 (inh=n/a pLI=0.21)
chr10	84746621	84746621	A	G	hom		QUAL=23542;DP=376;AF=1.00;MQM=60;TRIO=HOM,376,1.00,HOM,222,1.00,HET,265,0.51	NRG3	3'UTR	NRG3:ENST00000372142:3'UTR:MODIFIER:exon11/11:c.*1260A>G:		rs8421	0.3464	0.0000	0,0,0	0,0,0,0,0	0.4400											72	116					NRG3 (inh=n/a pLI=0.21)
chr10	87359561	87359561	T	A	hom	low_DP	QUAL=107;DP=6;AF=0.17;MQM=60;TRIO=HOM,6,0.83,WT,222,1.00,HET,8,0.50	GRID1	3'UTR	GRID1:ENST00000327946:3'UTR:MODIFIER:exon16/16:c.*2469A>T:	(AT)n	rs200266031	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0062											2	18					GRID1 (inh=n/a pLI=0.95)
chr10	87359563	87359563	T	A	het	low_DP	QUAL=107;DP=6;AF=0.17;MQM=60;TRIO=HET,6,0.83,WT,222,1.00,WT,8,0.50	GRID1	3'UTR	GRID1:ENST00000327946:3'UTR:MODIFIER:exon16/16:c.*2467A>T:	(AT)n	rs866354599	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0028											2	5					GRID1 (inh=n/a pLI=0.95)
chr10	87359676	87359676	T	A	het		QUAL=227;DP=70;AF=0.20;MQM=53;TRIO=HET,70,0.31,HOM,13,0.77,HET,31,0.23	GRID1	3'UTR	GRID1:ENST00000327946:3'UTR:MODIFIER:exon16/16:c.*2354A>T:	(TC)n	rs12253218	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000											14	80					GRID1 (inh=n/a pLI=0.95)
chr10	87359697	87359697	A	C	het		QUAL=61;DP=70;AF=0.24;MQM=51;TRIO=HET,70,0.24,WT,49,0.10,WT,72,0.08	GRID1	3'UTR	GRID1:ENST00000327946:3'UTR:MODIFIER:exon16/16:c.*2333T>G:	(CA)n	rs201962779	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0025											2	25					GRID1 (inh=n/a pLI=0.95)
chr10	87359826	87359826	A	G	hom		QUAL=12310;DP=175;AF=0.99;MQM=59;TRIO=HOM,175,0.99,HOM,121,1.00,HET,177,0.59	GRID1	3'UTR	GRID1:ENST00000327946:3'UTR:MODIFIER:exon16/16:c.*2204T>C:		rs2664405	0.6500	0.0000	0,0,0	0,0,0,0,0	0.6331											83	117					GRID1 (inh=n/a pLI=0.95)
chr10	87360712	87360712	G	C	hom		QUAL=20210;DP=279;AF=0.99;MQM=59;TRIO=HOM,279,0.99,HOM,225,0.99,HET,352,0.51	GRID1	3'UTR	GRID1:ENST00000327946:3'UTR:MODIFIER:exon16/16:c.*1318C>G:		rs2616672	0.6506	0.0000	0,0,0	0,0,0,0,0	0.6345											84	117					GRID1 (inh=n/a pLI=0.95)
chr10	87360723	87360723	A	G	hom		QUAL=20900;DP=282;AF=0.99;MQM=59;TRIO=HOM,282,0.99,HOM,241,1.00,HET,355,0.52	GRID1	3'UTR	GRID1:ENST00000327946:3'UTR:MODIFIER:exon16/16:c.*1307T>C:		rs2664404	0.6506	0.0000	0,0,0	0,0,0,0,0	0.6351											84	117					GRID1 (inh=n/a pLI=0.95)
chr10	87361961	87361961	G	A	hom		QUAL=1983;DP=44;AF=1.00;MQM=59;TRIO=HOM,44,1.00,HET,31,0.48,HET,41,0.51	GRID1	3'UTR	GRID1:ENST00000327946:3'UTR:MODIFIER:exon16/16:c.*69C>T:,GRID1:ENST00000536331:3'UTR:MODIFIER:exon9/9:c.*69C>T:	(TG)n	rs1054979	0.3618	0.0000	0,0,0	0,0,0,0,0	0.3799											192	393					GRID1 (inh=n/a pLI=0.95)
chr10	87898729	87898729	G	A	hom		QUAL=15879;DP=208;AF=0.98;MQM=59;TRIO=HOM,208,0.98,HET,364,0.49,HET,458,0.48	GRID1	synonymous	GRID1:ENST00000327946:synonymous:LOW:exon4/16:c.573C>T:p.Asp191Asp		rs17106320	0.1809	0.1483	1594,765,326	0.2549,0.0931,0.0775,0.1432,0.2022	0.1562											63	621					GRID1 (inh=n/a pLI=0.95)
chr10	88428303	88428303	G	A	het	anno_omim	QUAL=7589;DP=240;AF=0.54;MQM=59;TRIO=HET,240,0.54,WT,271,0.00,HET,360,0.53	LDB3	5'UTR	LDB3:ENST00000429277:5'UTR:MODIFIER:exon1/14:c.-48G>A:,LDB3:ENST00000352360:5'UTR:MODIFIER:exon1/10:c.-48G>A:,LDB3:ENST00000458213:5'UTR:MODIFIER:exon1/14:c.-48G>A:		rs2803556	0.0597	0.0000	0,0,0	0,0,0,0,0	0.0953							605906 [LDB3 (confirmed) Myopathy,myofibrillar,4,609452|Cardiomyopathy,dilated,1C,with or without LVNC,601493|Cardiomyopathy,hypertrophic,24,601493|Left ventricular noncompaction 3,601493];	RCV000126610.3 [benign]; 			2	57					LDB3 (inh=AD pLI=0.00)
chr10	88428335	88428335	T	C	hom	anno_omim	QUAL=25960;DP=143;AF=1.00;MQM=59;TRIO=HOM,143,1.00,HOM,322,1.00,HOM,388,0.99	LDB3	splice_region&intron	LDB3:ENST00000429277:splice_region&intron:LOW:exon1/13:c.-24+8T>C:,LDB3:ENST00000352360:splice_region&intron:LOW:exon1/9:c.-24+8T>C:,LDB3:ENST00000458213:splice_region&intron:LOW:exon1/13:c.-24+8T>C:		rs2803558	0.7522	0.0000	0,0,0	0,0,0,0,0	0.7234							605906 [LDB3 (confirmed) Myopathy,myofibrillar,4,609452|Cardiomyopathy,dilated,1C,with or without LVNC,601493|Cardiomyopathy,hypertrophic,24,601493|Left ventricular noncompaction 3,601493];	RCV000126612.2 [benign]; RCV000308499.1 [likely benign]; RCV000370149.1 [likely benign]; RCV000393181.1 [likely benign]; RCV000393189.1 [likely benign]; 			220	196					LDB3 (inh=AD pLI=0.00)
chr10	88494752	88494752	A	-	hom	anno_omim	QUAL=2860;DP=102;AF=0.67;MQM=59;TRIO=HOM,102,0.67,HOM,28,0.79,HOM,45,0.76	LDB3	3'UTR	LDB3:ENST00000429277:3'UTR:MODIFIER:exon14/14:c.*2033delA:,LDB3:ENST00000352360:3'UTR:MODIFIER:exon10/10:c.*2033delA:,LDB3:ENST00000458213:3'UTR:MODIFIER:exon14/14:c.*2033delA:,LDB3:ENST00000263066:3'UTR:MODIFIER:exon13/13:c.*2033delA:,LDB3:ENST00000361373:3'UTR:MODIFIER:exon13/13:c.*2033delA:		rs11314847;rs571839799;rs753169910	0.8584	0.0000	0,0,0	0,0,0,0,0	0.6374							605906 [LDB3 (confirmed) Myopathy,myofibrillar,4,609452|Cardiomyopathy,dilated,1C,with or without LVNC,601493|Cardiomyopathy,hypertrophic,24,601493|Left ventricular noncompaction 3,601493];				76	116					LDB3 (inh=AD pLI=0.00)
chr10	88494809	88494809	-	AC	hom	anno_omim	QUAL=396;DP=21;AF=0.43;MQM=57;TRIO=HOM,21,0.43,HOM,3,1.00,HOM,7,0.29	LDB3	3'UTR	LDB3:ENST00000429277:3'UTR:MODIFIER:exon14/14:c.*2123_*2124dupAC:,LDB3:ENST00000352360:3'UTR:MODIFIER:exon10/10:c.*2123_*2124dupAC:,LDB3:ENST00000458213:3'UTR:MODIFIER:exon14/14:c.*2123_*2124dupAC:,LDB3:ENST00000263066:3'UTR:MODIFIER:exon13/13:c.*2123_*2124dupAC:,LDB3:ENST00000361373:3'UTR:MODIFIER:exon13/13:c.*2123_*2124dupAC:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0610							605906 [LDB3 (confirmed) Myopathy,myofibrillar,4,609452|Cardiomyopathy,dilated,1C,with or without LVNC,601493|Cardiomyopathy,hypertrophic,24,601493|Left ventricular noncompaction 3,601493];				1	2					LDB3 (inh=AD pLI=0.00)
chr10	89623716	89623716	G	A	het	low_DP;anno_omim	QUAL=125;DP=3;AF=0.33;MQM=60;TRIO=HET,3,0.33,WT,10,0.00,HET,11,0.64	PTEN	5'UTR	PTEN:ENST00000371953:5'UTR:MODIFIER:exon1/9:c.-511G>A:	(GGC)n	rs12573787	0.1603	0.0000	0,0,0	0,0,0,0,0	0.1187							601728 [PTEN (confirmed) Cowden syndrome 1,158350|Lhermitte-Duclos syndrome,158350|Bannayan-Riley-Ruvalcaba syndrome,153480|Meningioma,607174|Glioma susceptibility 2,613028|Macrocephaly/autism syndrome,605309|PTEN hamartoma tumor syndrome|VATER association with macrocephaly and ventriculomegaly,276950|Prostate cancer,somatic,176807|Malignant melanoma,somatic,155600|Endometrial carcinoma,somatic,608089|Squamous cell carcinoma,head and neck,somatic,275355];				2	26					PTEN (inh=AD pLI=0.98)
chr10	89623861	89623861	T	-	hom	low_DP;anno_omim	QUAL=1192;DP=4;AF=1.00;MQM=58;TRIO=HOM,4,1.00,HOM,16,0.94,HOM,22,1.00	PTEN	5'UTR	PTEN:ENST00000371953:5'UTR:MODIFIER:exon1/9:c.-366delT:	(CGG)n	rs71022512	1.0000	0.0000	0,0,0	0,0,0,0,0	0.9975							601728 [PTEN (confirmed) Cowden syndrome 1,158350|Lhermitte-Duclos syndrome,158350|Bannayan-Riley-Ruvalcaba syndrome,153480|Meningioma,607174|Glioma susceptibility 2,613028|Macrocephaly/autism syndrome,605309|PTEN hamartoma tumor syndrome|VATER association with macrocephaly and ventriculomegaly,276950|Prostate cancer,somatic,176807|Malignant melanoma,somatic,155600|Endometrial carcinoma,somatic,608089|Squamous cell carcinoma,head and neck,somatic,275355];				220	0	1	[1] auto-classification 16.06.2016  			PTEN (inh=AD pLI=0.98)
chr10	89623901	89623901	G	C	hom	anno_omim	QUAL=1757;DP=25;AF=1.00;MQM=50;TRIO=HOM,25,1.00,HOM,16,1.00,HOM,22,1.00	PTEN	5'UTR	PTEN:ENST00000371953:5'UTR:MODIFIER:exon1/9:c.-326G>C:		rs2943772	1.0000	0.0000	0,0,0	0,0,0,0,0	0.9996							601728 [PTEN (confirmed) Cowden syndrome 1,158350|Lhermitte-Duclos syndrome,158350|Bannayan-Riley-Ruvalcaba syndrome,153480|Meningioma,607174|Glioma susceptibility 2,613028|Macrocephaly/autism syndrome,605309|PTEN hamartoma tumor syndrome|VATER association with macrocephaly and ventriculomegaly,276950|Prostate cancer,somatic,176807|Malignant melanoma,somatic,155600|Endometrial carcinoma,somatic,608089|Squamous cell carcinoma,head and neck,somatic,275355];				238	0					PTEN (inh=AD pLI=0.98)
chr10	90771829	90771829	T	C	het	anno_omim	QUAL=9521;DP=300;AF=0.55;MQM=60;TRIO=HET,300,0.55,HOM,154,0.98,WT,234,0.01	FAS	synonymous	FAS:ENST00000355740:synonymous:LOW:exon7/9:c.642T>C:p.Thr214Thr,FAS:ENST00000352159:synonymous:LOW:exon7/9:c.642T>C:p.Thr214Thr,FAS:ENST00000357339:synonymous:LOW:exon6/8:c.579T>C:p.Thr193Thr,FAS:ENST00000355279:synonymous:LOW:exon7/8:c.642T>C:p.Thr214Thr		rs2234978	0.7754	0.7561	35133,16231,2363	0.6762,0.8665,0.9831,0.6988,0.8261	0.7651							134637 [FAS (confirmed) Autoimmune lymphoproliferative syndrome,601859|Squamous cell carcinoma,burn scar-related,somatic|Autoimmune lymphoproliferative syndrome,type IA,601859];	RCV000244361.1 [benign]; RCV000284596.1 [benign]; 			1123	813					FAS (inh=AD pLI=0.73)
chr10	95552653	95552653	T	C	hom	anno_omim	QUAL=20561;DP=264;AF=1.00;MQM=60;TRIO=HOM,264,1.00,HOM,165,1.00,HOM,212,1.00	LGI1	synonymous	LGI1:ENST00000371418:synonymous:LOW:exon6/8:c.657T>C:p.Phe219Phe,LGI1:ENST00000542308:synonymous:LOW:exon4/6:c.513T>C:p.Phe171Phe,LGI1:ENST00000371413:synonymous:LOW:exon6/8:c.657T>C:p.Phe219Phe		rs1111820	0.9774	0.9928	59851,33261,4529	0.9332,0.9942,1.0000,0.9984,0.9999	0.9939							604619 [LGI1 (confirmed) Epilepsy,familial temporal lobe,1,600512];				2108	6					LGI1 (inh=AD pLI=1.00)
chr10	95892129	95892129	T	A	het	pred_pathogenic;anno_omim	QUAL=15012;DP=609;AF=0.48;MQM=60;TRIO=HET,609,0.48,HET,658,0.50,WT,768,0.00	PLCE1	missense	PLCE1:ENST00000260766:missense:MODERATE:exon3/33:c.1405T>A:p.Ser469Thr,PLCE1:ENST00000371380:missense:MODERATE:exon2/32:c.1405T>A:p.Ser469Thr,PLCE1:ENST00000371385:missense:MODERATE:exon2/32:c.481T>A:p.Ser161Thr,PLCE1:ENST00000371375:missense:MODERATE:exon2/31:c.481T>A:p.Ser161Thr		rs17508082	0.0172	0.0313	85,74,0	0.0052,0.0271,0.0001,0.0448,0.0104	0.0310	3.4920	D,D,D,D	T	B,B,B	T,T,T,T	21.60	608414 [PLCE1 (confirmed) Nephrotic syndrome,type 3,610725];	RCV000250368.1 [benign]; RCV000302907.1 [likely benign]; 			10	206					PLCE1 (inh=AR pLI=0.20)
chr10	96039597	96039597	G	C	het	anno_omim	QUAL=7484;DP=306;AF=0.50;MQM=59;TRIO=HET,306,0.50,HET,336,0.46,WT,490,0.00	PLCE1,PLCE1-AS1	missense,non_coding_transcript_exon	PLCE1:ENST00000260766:missense:MODERATE:exon20/33:c.4724G>C:p.Arg1575Pro,PLCE1:ENST00000371380:missense:MODERATE:exon19/32:c.4724G>C:p.Arg1575Pro,PLCE1:ENST00000371385:missense:MODERATE:exon19/32:c.3800G>C:p.Arg1267Pro,PLCE1:ENST00000371375:missense:MODERATE:exon19/31:c.3800G>C:p.Arg1267Pro,PLCE1-AS1:ENST00000596633:non_coding_transcript_exon:MODIFIER:exon3/3:n.1120C>G:,PLCE1-AS1:ENST00000425267:non_coding_transcript_exon:MODIFIER:exon4/4:n.835C>G:		rs2274224	0.4862	0.4378	11866,6347,1515	0.5541,0.3472,0.5496,0.4346,0.4277	0.4707	0.7950	T,T,T,T	T	B,B,B	T,T,T,T	13.37	608414 [PLCE1 (confirmed) Nephrotic syndrome,type 3,610725];	RCV000254331.1 [benign]; RCV000394591.1 [benign]; 			530	1020					PLCE1 (inh=AR pLI=0.20), PLCE1-AS1 (inh=n/a pLI=n/a)
chr10	96058298	96058298	C	T	het	pred_pathogenic;anno_omim	QUAL=8558;DP=408;AF=0.49;MQM=60;TRIO=HET,408,0.49,HET,306,0.54,WT,398,0.00	PLCE1	missense	PLCE1:ENST00000260766:missense:MODERATE:exon24/33:c.5330C>T:p.Thr1777Ile,PLCE1:ENST00000371380:missense:MODERATE:exon23/32:c.5330C>T:p.Thr1777Ile,PLCE1:ENST00000371385:missense:MODERATE:exon23/32:c.4406C>T:p.Thr1469Ile,PLCE1:ENST00000371375:missense:MODERATE:exon23/31:c.4406C>T:p.Thr1469Ile		rs3765524	0.3079	0.2711	4911,2783,909	0.4226,0.1558,0.2339,0.2826,0.2646	0.3104	5.1480	T,T,T,T	T	B,B,B	T,T,T,T	13.94	608414 [PLCE1 (confirmed) Nephrotic syndrome,type 3,610725];	RCV000245651.1 [benign]; RCV000354149.1 [benign]; 	CM105437 [CLASS=DP MUT=ALT PHEN="Gastric adenocarcinoma and oesophageal SCC association with" GENE=PLCE1]; 		254	917					PLCE1 (inh=AR pLI=0.20)
chr10	96058433	96058433	G	A	het	anno_omim	QUAL=5680;DP=231;AF=0.48;MQM=60;TRIO=HET,231,0.48,HET,239,0.52,WT,300,0.00	PLCE1	splice_region&intron	PLCE1:ENST00000260766:splice_region&intron:LOW:exon24/32:c.5458+7G>A:,PLCE1:ENST00000371380:splice_region&intron:LOW:exon23/31:c.5458+7G>A:,PLCE1:ENST00000371385:splice_region&intron:LOW:exon23/31:c.4534+7G>A:,PLCE1:ENST00000371375:splice_region&intron:LOW:exon23/30:c.4534+7G>A:		rs17516758	0.1068	0.1372	1360,876,45	0.0971,0.0744,0.0021,0.1597,0.1753	0.1412							608414 [PLCE1 (confirmed) Nephrotic syndrome,type 3,610725];	RCV000250395.1 [benign]; RCV000266326.1 [likely benign]; 			87	640					PLCE1 (inh=AR pLI=0.20)
chr10	96066341	96066341	A	G	het	pred_pathogenic;anno_omim	QUAL=8447;DP=355;AF=0.53;MQM=60;TRIO=HET,355,0.53,HET,281,0.49,WT,366,0.00	PLCE1	missense	PLCE1:ENST00000260766:missense:MODERATE:exon26/33:c.5780A>G:p.His1927Arg,PLCE1:ENST00000371380:missense:MODERATE:exon25/32:c.5780A>G:p.His1927Arg,PLCE1:ENST00000371385:missense:MODERATE:exon25/32:c.4856A>G:p.His1619Arg,PLCE1:ENST00000371375:missense:MODERATE:exon25/31:c.4856A>G:p.His1619Arg		rs2274223	0.2985	0.2846	5213,3247,609	0.3519,0.1603,0.2356,0.3092,0.2845	0.3086	3.0200	T,T,T,T	T	B,B,B	T,T,T,T	4.78	608414 [PLCE1 (confirmed) Nephrotic syndrome,type 3,610725];	RCV000250112.1 [benign]; RCV000376111.1 [benign]; 	CM105436 [CLASS=DP MUT=ALT PHEN="Gastric adenocarcinoma and oesophageal SCC association with" GENE=PLCE1]; 		282	956					PLCE1 (inh=AR pLI=0.20)
chr10	96087728	96087728	A	G	het	pred_pathogenic;anno_omim	QUAL=3905;DP=247;AF=0.51;MQM=60;TRIO=HET,247,0.51,HET,78,0.51,WT,95,0.00	PLCE1,NOC3L	3'UTR,intron	PLCE1:ENST00000260766:3'UTR:MODIFIER:exon33/33:c.*28A>G:,PLCE1:ENST00000371380:3'UTR:MODIFIER:exon32/32:c.*28A>G:,PLCE1:ENST00000371385:3'UTR:MODIFIER:exon32/32:c.*28A>G:,NOC3L:ENST00000543788:intron:MODIFIER:exon14/14:c.1488+6663T>C:		rs3203713	0.1054	0.1453	1214,780,45	0.1085,0.0793,0.0018,0.1694,0.1819	0.1412	2.1340	T	T			13.74	608414 [PLCE1 (confirmed) Nephrotic syndrome,type 3,610725];	RCV000292908.1 [likely benign]; 			67	509					PLCE1 (inh=AR pLI=0.20), NOC3L (inh=n/a pLI=0.00)
chr10	97365820	97365820	G	A	het	anno_omim	QUAL=5482;DP=219;AF=0.53;MQM=60;TRIO=HET,219,0.53,HET,75,0.53,HET,109,0.50	ALDH18A1	3'UTR	ALDH18A1:ENST00000371224:3'UTR:MODIFIER:exon18/18:c.*699C>T:,ALDH18A1:ENST00000371221:3'UTR:MODIFIER:exon18/18:c.*699C>T:		rs4037	0.2005	0.0000	0,0,0	0,0,0,0,0	0.2726							138250 [ALDH18A1 (confirmed) Cutis laxa,autosomal recessive,type IIIA,219150|Spastic paraplegia 9A,autosomal dominant,601162|Spastic paraplegia 9B,autosomal recessive,616586|Cutis laxa,autosomal dominant 3,616603];	RCV000273322.1 [benign]; 			24	109					ALDH18A1 (inh=AR+AD pLI=0.86)
chr10	97366364	97366364	C	T	het	anno_omim	QUAL=6119;DP=208;AF=0.50;MQM=60;TRIO=HET,208,0.50,HET,63,0.54,HOM,86,1.00	ALDH18A1	3'UTR	ALDH18A1:ENST00000371224:3'UTR:MODIFIER:exon18/18:c.*155G>A:,ALDH18A1:ENST00000371221:3'UTR:MODIFIER:exon18/18:c.*155G>A:		rs1053905	0.2979	0.0000	0,0,0	0,0,0,0,0	0.4233							138250 [ALDH18A1 (confirmed) Cutis laxa,autosomal recessive,type IIIA,219150|Spastic paraplegia 9A,autosomal dominant,601162|Spastic paraplegia 9B,autosomal recessive,616586|Cutis laxa,autosomal dominant 3,616603];	RCV000336778.1 [benign]; 			64	125					ALDH18A1 (inh=AR+AD pLI=0.86)
chr10	97388162	97388162	G	A	het	pred_pathogenic;anno_omim	QUAL=11993;DP=284;AF=0.49;MQM=60;TRIO=HET,284,0.49,WT,227,0.00,HOM,265,1.00	ALDH18A1	missense	ALDH18A1:ENST00000371224:missense:MODERATE:exon8/18:c.896C>T:p.Thr299Ile,ALDH18A1:ENST00000371221:missense:MODERATE:exon8/18:c.890C>T:p.Thr297Ile		rs2275272	0.0717	0.1030	782,603,10	0.0443,0.0621,0.0379,0.1324,0.0606	0.1053	6.1520	T,D	T	B,B	T,T	25.40	138250 [ALDH18A1 (confirmed) Cutis laxa,autosomal recessive,type IIIA,219150|Spastic paraplegia 9A,autosomal dominant,601162|Spastic paraplegia 9B,autosomal recessive,616586|Cutis laxa,autosomal dominant 3,616603];	RCV000243312.1 [benign]; RCV000346020.1 [likely benign]; 			51	515					ALDH18A1 (inh=AR+AD pLI=0.86)
chr10	97515949	97515949	G	T	het	anno_omim	QUAL=7343;DP=357;AF=0.49;MQM=60;TRIO=HET,357,0.49,WT,208,0.00,HET,242,0.51	ENTPD1,ENTPD1-AS1	5'UTR_premature_start_codon_gain,5'UTR,intron,non_coding_transcript_exon	ENTPD1:ENST00000371203:5'UTR_premature_start_codon_gain:LOW:exon1/9:c.-311G>T:,ENTPD1:ENST00000539125:5'UTR_premature_start_codon_gain:LOW:exon1/8:c.-193G>T:,ENTPD1:ENST00000371205:5'UTR_premature_start_codon_gain:LOW:exon1/10:c.-48G>T:,ENTPD1:ENST00000371203:5'UTR:MODIFIER:exon1/9:c.-311G>T:,ENTPD1:ENST00000539125:5'UTR:MODIFIER:exon1/8:c.-193G>T:,ENTPD1:ENST00000371205:5'UTR:MODIFIER:exon1/10:c.-48G>T:,ENTPD1:ENST00000371207:intron:MODIFIER:exon1/9:c.52+426G>T:,ENTPD1:ENST00000453258:intron:MODIFIER:exon1/9:c.37+44199G>T:,ENTPD1:ENST00000543964:intron:MODIFIER:exon1/8:c.-181+426G>T:,ENTPD1-AS1:ENST00000416301:non_coding_transcript_exon:MODIFIER:exon6/6:n.1255C>A:		rs200451742	0.0004	0.0013	0,0,0	0.0014,0.0010,0.0011,0.0017,0.0000	0.0012							601752 [ENTPD1 (provisional) Spastic paraplegia 64,autosomal recessive,615683];				0	7					ENTPD1 (inh=AR pLI=0.52), ENTPD1-AS1 (inh=n/a pLI=n/a)
chr10	97628170	97628170	T	C	het	anno_omim	QUAL=18965;DP=469;AF=0.50;MQM=59;TRIO=HET,469,0.50,WT,287,0.00,HOM,385,1.00	ENTPD1,ENTPD1-AS1,RP11-429G19.3,RP11-248J23.7	3'UTR,intron	ENTPD1:ENST00000371207:3'UTR:MODIFIER:exon10/10:c.*2030T>C:,ENTPD1:ENST00000453258:3'UTR:MODIFIER:exon10/10:c.*2030T>C:,ENTPD1:ENST00000543964:3'UTR:MODIFIER:exon9/9:c.*2030T>C:,ENTPD1:ENST00000371203:3'UTR:MODIFIER:exon9/9:c.*2030T>C:,ENTPD1:ENST00000539125:3'UTR:MODIFIER:exon8/8:c.*2030T>C:,ENTPD1-AS1:ENST00000416301:intron:MODIFIER:exon3/5:n.418+8105A>G:,ENTPD1-AS1:ENST00000451364:intron:MODIFIER:exon3/3:n.360-6744A>G:		rs3181115	0.0499	0.0000	0,0,0	0,0,0,0,0	0.0895							601752 [ENTPD1 (provisional) Spastic paraplegia 64,autosomal recessive,615683];				4	54					ENTPD1 (inh=AR pLI=0.52), ENTPD1-AS1 (inh=n/a pLI=n/a), RP11-429G19.3 (inh=n/a pLI=n/a), RP11-248J23.7 (inh=n/a pLI=n/a)
chr10	97630523	97630523	C	T	het	anno_omim	QUAL=18962;DP=400;AF=0.47;MQM=60;TRIO=HET,400,0.47,HET,250,0.49,HOM,336,1.00	ENTPD1,ENTPD1-AS1,RP11-429G19.3,RP11-248J23.7	3'UTR,intron	ENTPD1:ENST00000371207:3'UTR:MODIFIER:exon10/10:c.*4383C>T:,ENTPD1:ENST00000543964:3'UTR:MODIFIER:exon9/9:c.*4383C>T:,ENTPD1:ENST00000371203:3'UTR:MODIFIER:exon9/9:c.*4383C>T:,ENTPD1:ENST00000539125:3'UTR:MODIFIER:exon8/8:c.*4383C>T:,ENTPD1-AS1:ENST00000416301:intron:MODIFIER:exon3/5:n.418+5752G>A:,ENTPD1-AS1:ENST00000451364:intron:MODIFIER:exon3/3:n.359+5752G>A:		rs10736094	0.5841	0.0000	0,0,0	0,0,0,0,0	0.6569							601752 [ENTPD1 (provisional) Spastic paraplegia 64,autosomal recessive,615683];				98	101					ENTPD1 (inh=AR pLI=0.52), ENTPD1-AS1 (inh=n/a pLI=n/a), RP11-429G19.3 (inh=n/a pLI=n/a), RP11-248J23.7 (inh=n/a pLI=n/a)
chr10	97631051	97631051	T	C	het	anno_omim	QUAL=12960;DP=411;AF=0.48;MQM=59;TRIO=HET,411,0.48,HET,131,0.57,HOM,171,0.98	ENTPD1,ENTPD1-AS1,RP11-429G19.3,RP11-248J23.7	3'UTR,intron	ENTPD1:ENST00000371207:3'UTR:MODIFIER:exon10/10:c.*4911T>C:,ENTPD1:ENST00000543964:3'UTR:MODIFIER:exon9/9:c.*4911T>C:,ENTPD1:ENST00000371203:3'UTR:MODIFIER:exon9/9:c.*4911T>C:,ENTPD1:ENST00000539125:3'UTR:MODIFIER:exon8/8:c.*4911T>C:,ENTPD1-AS1:ENST00000416301:intron:MODIFIER:exon3/5:n.418+5224A>G:,ENTPD1-AS1:ENST00000451364:intron:MODIFIER:exon3/3:n.359+5224A>G:		rs2153914	0.5865	0.0000	0,0,0	0,0,0,0,0	0.6584							601752 [ENTPD1 (provisional) Spastic paraplegia 64,autosomal recessive,615683];				98	102					ENTPD1 (inh=AR pLI=0.52), ENTPD1-AS1 (inh=n/a pLI=n/a), RP11-429G19.3 (inh=n/a pLI=n/a), RP11-248J23.7 (inh=n/a pLI=n/a)
chr10	97631172	97631172	A	C	het	anno_omim	QUAL=11223;DP=361;AF=0.48;MQM=60;TRIO=HET,361,0.48,WT,150,0.00,HOM,208,0.99	ENTPD1,ENTPD1-AS1,RP11-429G19.3,RP11-248J23.7	3'UTR,intron	ENTPD1:ENST00000371207:3'UTR:MODIFIER:exon10/10:c.*5032A>C:,ENTPD1:ENST00000543964:3'UTR:MODIFIER:exon9/9:c.*5032A>C:,ENTPD1:ENST00000371203:3'UTR:MODIFIER:exon9/9:c.*5032A>C:,ENTPD1:ENST00000539125:3'UTR:MODIFIER:exon8/8:c.*5032A>C:,ENTPD1-AS1:ENST00000416301:intron:MODIFIER:exon3/5:n.418+5103T>G:,ENTPD1-AS1:ENST00000451364:intron:MODIFIER:exon3/3:n.359+5103T>G:		rs34630379	0.0541	0.0000	0,0,0	0,0,0,0,0	0.0949							601752 [ENTPD1 (provisional) Spastic paraplegia 64,autosomal recessive,615683];				4	54					ENTPD1 (inh=AR pLI=0.52), ENTPD1-AS1 (inh=n/a pLI=n/a), RP11-429G19.3 (inh=n/a pLI=n/a), RP11-248J23.7 (inh=n/a pLI=n/a)
chr10	97633021	97633021	C	T	het	anno_omim	QUAL=18297;DP=328;AF=0.50;MQM=59;TRIO=HET,328,0.50,HET,260,0.40,HOM,345,1.00	ENTPD1,ENTPD1-AS1,RP11-429G19.3,RP11-248J23.7	3'UTR,intron	ENTPD1:ENST00000371207:3'UTR:MODIFIER:exon10/10:c.*6881C>T:,ENTPD1:ENST00000543964:3'UTR:MODIFIER:exon9/9:c.*6881C>T:,ENTPD1:ENST00000371203:3'UTR:MODIFIER:exon9/9:c.*6881C>T:,ENTPD1:ENST00000539125:3'UTR:MODIFIER:exon8/8:c.*6881C>T:,ENTPD1-AS1:ENST00000416301:intron:MODIFIER:exon3/5:n.418+3254G>A:,ENTPD1-AS1:ENST00000451364:intron:MODIFIER:exon3/3:n.359+3254G>A:	L3	rs11188513	0.5839	0.0000	0,0,0	0,0,0,0,0	0.6568							601752 [ENTPD1 (provisional) Spastic paraplegia 64,autosomal recessive,615683];				98	100					ENTPD1 (inh=AR pLI=0.52), ENTPD1-AS1 (inh=n/a pLI=n/a), RP11-429G19.3 (inh=n/a pLI=n/a), RP11-248J23.7 (inh=n/a pLI=n/a)
chr10	97633470	97633470	T	C	het	anno_omim	QUAL=12915;DP=310;AF=0.53;MQM=59;TRIO=HET,310,0.53,WT,239,0.00,HOM,263,1.00	ENTPD1,ENTPD1-AS1,RP11-248J23.7,RP11-429G19.3	3'UTR,intron	ENTPD1:ENST00000371207:3'UTR:MODIFIER:exon10/10:c.*7330T>C:,ENTPD1:ENST00000543964:3'UTR:MODIFIER:exon9/9:c.*7330T>C:,ENTPD1:ENST00000371203:3'UTR:MODIFIER:exon9/9:c.*7330T>C:,ENTPD1:ENST00000539125:3'UTR:MODIFIER:exon8/8:c.*7330T>C:,ENTPD1-AS1:ENST00000416301:intron:MODIFIER:exon3/5:n.418+2805A>G:,ENTPD1-AS1:ENST00000451364:intron:MODIFIER:exon3/3:n.359+2805A>G:	THE1A	rs11592937	0.0497	0.0000	0,0,0	0,0,0,0,0	0.0900							601752 [ENTPD1 (provisional) Spastic paraplegia 64,autosomal recessive,615683];				5	36					ENTPD1 (inh=AR pLI=0.52), ENTPD1-AS1 (inh=n/a pLI=n/a), RP11-248J23.7 (inh=n/a pLI=n/a), RP11-429G19.3 (inh=n/a pLI=n/a)
chr10	97990583	97990583	A	G	hom	anno_omim	QUAL=14500;DP=202;AF=1.00;MQM=60;TRIO=HOM,202,1.00,HOM,158,1.00,HET,198,0.55	BLNK	synonymous	BLNK:ENST00000224337:synonymous:LOW:exon4/17:c.171T>C:p.Pro57Pro,BLNK:ENST00000371176:synonymous:LOW:exon4/16:c.171T>C:p.Pro57Pro,BLNK:ENST00000413476:synonymous:LOW:exon4/16:c.171T>C:p.Pro57Pro,BLNK:ENST00000427367:synonymous:LOW:exon4/17:c.171T>C:p.Pro57Pro		rs727852	0.4613	0.6384	23363,15833,277	0.2467,0.7305,0.4828,0.7164,0.5206	0.6408							604515 [BLNK (provisional) Agammaglobulinemia 4,613502];			COSM147002	962	880					BLNK (inh=AR pLI=0.99)
chr10	101469605	101469605	G	A	hom	anno_omim	QUAL=38982;DP=520;AF=1.00;MQM=60;TRIO=HOM,520,1.00,HET,402,0.44,HOM,508,1.00	CUTC				rs2300983	0.8263	0.0000	0,0,0	0,0,0,0,0	0.8425							603646 [COX15 (confirmed) Leigh syndrome due to cytochrome c oxidase deficiency,256000|Cardioencephalomyopathy,fatal infantile,due to cytochrome c oxidase deficiency 2,615119];	RCV000289074.1 [benign]; 			113	35					CUTC (inh=n/a pLI=0.02)
chr10	101470858	101470858	-	A	hom	anno_omim	QUAL=10597;DP=243;AF=0.96;MQM=59;TRIO=HOM,243,0.96,HET,54,0.43,HOM,78,1.00	CUTC				rs397764905	0.8227	0.0000	0,0,0	0,0,0,0,0	0.8313							603646 [COX15 (confirmed) Leigh syndrome due to cytochrome c oxidase deficiency,256000|Cardioencephalomyopathy,fatal infantile,due to cytochrome c oxidase deficiency 2,615119];	RCV000361237.1 [benign]; 			113	35					CUTC (inh=n/a pLI=0.02)
chr10	101470927	101470927	A	G	hom	anno_omim	QUAL=10632;DP=266;AF=1.00;MQM=59;TRIO=HOM,266,1.00,HET,77,0.49,HET,92,0.42	CUTC				rs10883407	0.1264	0.0000	0,0,0	0,0,0,0,0	0.1091							603646 [COX15 (confirmed) Leigh syndrome due to cytochrome c oxidase deficiency,256000|Cardioencephalomyopathy,fatal infantile,due to cytochrome c oxidase deficiency 2,615119];	RCV000303474.1 [likely benign]; 			3	25					CUTC (inh=n/a pLI=0.02)
chr10	101473218	101473218	A	G	hom	anno_omim	QUAL=18289;DP=250;AF=0.99;MQM=60;TRIO=HOM,250,0.99,HET,183,0.49,HOM,231,1.00	COX15,CUTC	missense	COX15:ENST00000370483:missense:MODERATE:exon9/9:c.1120T>C:p.Phe374Leu	L3	rs2231687	0.8271	0.8610	44825,25308,2970	0.7618,0.8993,0.7743,0.8737,0.8797	0.8646	0.2480	T	T	B		10.16	603646 [COX15 (confirmed) Leigh syndrome due to cytochrome c oxidase deficiency,256000|Cardioencephalomyopathy,fatal infantile,due to cytochrome c oxidase deficiency 2,615119];	RCV000116814.2 [other]; RCV000259999.1 [benign]; 			1637	421					COX15 (inh=AR pLI=0.00), CUTC (inh=n/a pLI=0.02)
chr10	101473535	101473535	C	T	hom	anno_omim	QUAL=17617;DP=296;AF=1.00;MQM=56;TRIO=HOM,296,1.00,HET,141,0.52,HOM,195,1.00	COX15,CUTC	3'UTR,intron	COX15:ENST00000016171:3'UTR:MODIFIER:exon9/9:c.*809G>A:,COX15:ENST00000370483:intron:MODIFIER:exon8/8:c.1102-299G>A:	AluSq2	rs7073616	0.8518	0.0000	0,0,0	0,0,0,0,0	0.8615							603646 [COX15 (confirmed) Leigh syndrome due to cytochrome c oxidase deficiency,256000|Cardioencephalomyopathy,fatal infantile,due to cytochrome c oxidase deficiency 2,615119];				113	35					COX15 (inh=AR pLI=0.00), CUTC (inh=n/a pLI=0.02)
chr10	102747363	102747363	G	T	het		QUAL=16033;DP=534;AF=0.51;MQM=60;TRIO=HET,534,0.51,HET,370,0.50,HET,487,0.49	C10orf2				rs3740484	0.4121	0.0000	0,0,0	0,0,0,0,0	0.3437								RCV000124045.1 [benign]; RCV000269417.1 [benign]; RCV000304511.1 [benign]; RCV000326884.1 [benign]; RCV000361730.1 [benign]; 			24	117					TWNK (inh=AR+AD pLI=0.99)
chr10	102750621	102750621	C	T	het		QUAL=5407;DP=282;AF=0.47;MQM=60;TRIO=HET,282,0.47,HET,220,0.45,WT,298,0.00	C10orf2	splice_region&intron	C10orf2:ENST00000311916:splice_region&intron:LOW:exon3/4:c.1593-5C>T:,C10orf2:ENST00000370228:splice_region&intron:LOW:exon3/4:c.1593-5C>T:		rs3740485	0.3760	0.2752	5495,1347,1029	0.4469,0.3755,0.5520,0.1999,0.2963	0.2839								RCV000124041.2 [benign]; RCV000273221.1 [benign]; RCV000328346.1 [benign]; RCV000331870.1 [benign]; RCV000386399.1 [benign]; 			143	1076					TWNK (inh=AR+AD pLI=0.99)
chr10	102750623	102750623	T	C	het		QUAL=5407;DP=282;AF=0.47;MQM=60;TRIO=HET,282,0.47,HET,220,0.45,WT,298,0.00	C10orf2	splice_region&intron	C10orf2:ENST00000311916:splice_region&intron:LOW:exon3/4:c.1593-3T>C:,C10orf2:ENST00000370228:splice_region&intron:LOW:exon3/4:c.1593-3T>C:		rs3740486	0.3760	0.2752	5496,1346,1029	0.4469,0.3755,0.5524,0.1999,0.2963	0.2839								RCV000124042.2 [benign]; RCV000288050.1 [benign]; RCV000343097.1 [benign]; RCV000379002.1 [benign]; RCV000382498.1 [benign]; 			143	1076					TWNK (inh=AR+AD pLI=0.99)
chr10	102750783	102750783	C	A	het		QUAL=6242;DP=217;AF=0.53;MQM=60;TRIO=HET,217,0.53,HET,276,0.49,WT,340,0.00	C10orf2	splice_region&intron,3'UTR	C10orf2:ENST00000311916:splice_region&intron:LOW:exon4/4:c.1734+16C>A:,C10orf2:ENST00000370228:3'UTR:MODIFIER:exon4/5:c.*1C>A:		rs3740487	0.3758	0.2755	5487,1344,1027	0.4474,0.3760,0.5529,0.2002,0.2965	0.2872								RCV000124043.2 [benign]; 			145	1077					TWNK (inh=AR+AD pLI=0.99)
chr10	102754033	102754033	A	T	het		QUAL=8136;DP=342;AF=0.54;MQM=60;TRIO=HET,342,0.54,HET,270,0.53,WT,387,0.00	C10orf2	3'UTR	C10orf2:ENST00000311916:3'UTR:MODIFIER:exon5/5:c.*766A>T:,C10orf2:ENST00000370228:3'UTR:MODIFIER:exon5/5:c.*1116A>T:		rs3740488	0.3748	0.0000	0,0,0	0,0,0,0,0	0.2873								RCV000312968.1 [benign]; RCV000346808.1 [benign]; RCV000352677.1 [benign]; RCV000406316.1 [benign]; 			12	84					TWNK (inh=AR+AD pLI=0.99)
chr10	104596924	104596924	C	A	hom	anno_omim	QUAL=4722;DP=94;AF=1.00;MQM=59;TRIO=HOM,94,1.00,HET,61,0.49,HOM,54,1.00	CYP17A1	synonymous	CYP17A1:ENST00000369887:synonymous:LOW:exon1/8:c.195G>T:p.Ser65Ser		rs6163	0.4103	0.3974	9728,5086,683	0.3653,0.4016,0.5648,0.3914,0.3614	0.4008							609300 [CYP17A1 (confirmed) 17-alpha-hydroxylase/17,20-lyase deficiency,202110|17,20-lyase deficiency,isolated,202110];	RCV000366126.1 [benign]; 		COSM3751499	376	981					CYP17A1 (inh=AR pLI=0.04)
chr10	104596981	104596981	G	A	hom	anno_omim	QUAL=8546;DP=152;AF=0.99;MQM=59;TRIO=HOM,152,0.99,HET,103,0.44,HOM,111,1.00	CYP17A1	synonymous	CYP17A1:ENST00000369887:synonymous:LOW:exon1/8:c.138C>T:p.His46His		rs6162	0.4425	0.4248	11081,5549,693	0.3684,0.4084,0.5658,0.4092,0.4791	0.4233							609300 [CYP17A1 (confirmed) 17-alpha-hydroxylase/17,20-lyase deficiency,202110|17,20-lyase deficiency,isolated,202110];	RCV000403468.1 [benign]; 		COSM3751500	440	1002					CYP17A1 (inh=AR pLI=0.04)
chr10	104597152	104597152	A	G	hom	anno_omim	QUAL=18487;DP=251;AF=0.99;MQM=59;TRIO=HOM,251,0.99,HET,213,0.52,HOM,242,1.00	CYP17A1	5'UTR	CYP17A1:ENST00000369887:5'UTR:MODIFIER:exon1/8:c.-34T>C:		rs743572	0.4105	0.4001	9368,4905,624	0.3673,0.4043,0.5658,0.3941,0.3653	0.4009							609300 [CYP17A1 (confirmed) 17-alpha-hydroxylase/17,20-lyase deficiency,202110|17,20-lyase deficiency,isolated,202110];	RCV000354477.1 [benign]; 	CR942079 [CLASS=DP MUT=ALT PHEN="Polycystic ovaries association with" GENE=CYP17A1]; 		349	884					CYP17A1 (inh=AR pLI=0.04)
chr10	105791355	105791355	C	T	het	anno_omim	QUAL=9980;DP=370;AF=0.48;MQM=60;TRIO=HET,370,0.48,HET,157,0.47,HET,232,0.50	COL17A1	3'UTR	COL17A1:ENST00000353479:3'UTR:MODIFIER:exon56/56:c.*638G>A:,COL17A1:ENST00000369733:3'UTR:MODIFIER:exon52/52:c.*638G>A:		rs9425	0.1885	0.0000	0,0,0	0,0,0,0,0	0.2012							113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type,226650|Epidermolysis bullosa,junctional,localisata variant,226650|Epithelial recurrent erosion dystrophy,122400];	RCV000376614.1 [benign]; 			7	64					COL17A1 (inh=AR+AD pLI=0.00)
chr10	105791630	105791630	A	-	het	anno_omim	QUAL=13642;DP=345;AF=0.51;MQM=59;TRIO=HET,345,0.51,HET,330,0.49,HET,429,0.49	COL17A1	3'UTR	COL17A1:ENST00000353479:3'UTR:MODIFIER:exon56/56:c.*363delT:,COL17A1:ENST00000369733:3'UTR:MODIFIER:exon52/52:c.*363delT:		rs113786874	0.2466	0.0000	0,0,0	0,0,0,0,0	0.2279							113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type,226650|Epidermolysis bullosa,junctional,localisata variant,226650|Epithelial recurrent erosion dystrophy,122400];	RCV000379845.1 [benign]; 			12	65					COL17A1 (inh=AR+AD pLI=0.00)
chr10	105791929	105791929	C	G	het	anno_omim	QUAL=12027;DP=364;AF=0.52;MQM=59;TRIO=HET,364,0.52,HET,239,0.51,HET,358,0.42	COL17A1	3'UTR	COL17A1:ENST00000353479:3'UTR:MODIFIER:exon56/56:c.*64G>C:,COL17A1:ENST00000369733:3'UTR:MODIFIER:exon52/52:c.*64G>C:		rs805687	0.2288	0.0000	0,0,0	0,0,0,0,0	0.2301							113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type,226650|Epidermolysis bullosa,junctional,localisata variant,226650|Epithelial recurrent erosion dystrophy,122400];	RCV000317208.1 [benign]; 			59	417					COL17A1 (inh=AR+AD pLI=0.00)
chr10	105796399	105796399	G	C	het	anno_omim	QUAL=3985;DP=69;AF=0.42;MQM=60;TRIO=HET,69,0.42,HET,93,0.55,HET,140,0.59	COL17A1	splice_region&intron	COL17A1:ENST00000353479:splice_region&intron:LOW:exon47/55:c.3278-9C>G:,COL17A1:ENST00000369733:splice_region&intron:LOW:exon44/51:c.3143-9C>G:		rs2274098	0.6915	0.7804	37104,22537,1286	0.5033,0.7824,0.8563,0.8261,0.7273	0.7860							113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type,226650|Epidermolysis bullosa,junctional,localisata variant,226650|Epithelial recurrent erosion dystrophy,122400];	RCV000244046.1 [benign]; RCV000333063.1 [benign]; 			1355	647					COL17A1 (inh=AR+AD pLI=0.00)
chr10	105796819	105796819	A	G	hom	anno_omim	QUAL=32186;DP=239;AF=1.00;MQM=60;TRIO=HOM,239,1.00,HOM,338,1.00,HOM,435,1.00	COL17A1	synonymous	COL17A1:ENST00000353479:synonymous:LOW:exon47/56:c.3261T>C:p.Ile1087Ile,COL17A1:ENST00000369733:synonymous:LOW:exon44/52:c.3126T>C:p.Ile1042Ile		rs2476958	0.9860	0.9964	55550,31287,4211	0.9578,0.9991,1.0000,1.0000,1.0000	0.9971							113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type,226650|Epidermolysis bullosa,junctional,localisata variant,226650|Epithelial recurrent erosion dystrophy,122400];	RCV000252056.1 [benign]; RCV000288544.1 [benign]; 			2106	1					COL17A1 (inh=AR+AD pLI=0.00)
chr10	105798872	105798872	T	C	het	anno_omim	QUAL=12251;DP=396;AF=0.45;MQM=60;TRIO=HET,396,0.45,HET,329,0.34,HET,406,0.48	COL17A1	synonymous	COL17A1:ENST00000353479:synonymous:LOW:exon44/56:c.2904A>G:p.Pro968Pro,COL17A1:ENST00000369733:synonymous:LOW:exon41/52:c.2769A>G:p.Pro923Pro		rs2274100	0.6815	0.7768	37240,22857,1302	0.4992,0.7837,0.8055,0.8271,0.7250	0.7819							113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type,226650|Epidermolysis bullosa,junctional,localisata variant,226650|Epithelial recurrent erosion dystrophy,122400];	RCV000242121.1 [benign]; RCV000339063.1 [benign]; 		COSM3751514	1354	652					COL17A1 (inh=AR+AD pLI=0.00)
chr10	105799216	105799216	G	T	het	anno_omim	QUAL=9298;DP=244;AF=0.52;MQM=59;TRIO=HET,244,0.52,HET,199,0.49,HET,265,0.52	COL17A1	synonymous,intron	COL17A1:ENST00000353479:synonymous:LOW:exon43/56:c.2883C>A:p.Pro961Pro,COL17A1:ENST00000369733:intron:MODIFIER:exon40/51:c.2762-337C>A:		rs2296219	0.6835	0.7769	37320,22756,1206	0.4808,0.7818,0.8593,0.8251,0.7185	0.7822							113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type,226650|Epidermolysis bullosa,junctional,localisata variant,226650|Epithelial recurrent erosion dystrophy,122400];	RCV000250170.1 [benign]; RCV000393118.1 [benign]; 		COSM3751515	1351	648					COL17A1 (inh=AR+AD pLI=0.00)
chr10	105801253	105801253	G	A	het	anno_omim	QUAL=4997;DP=151;AF=0.45;MQM=59;TRIO=HET,151,0.45,HET,113,0.49,HET,137,0.63	COL17A1	synonymous	COL17A1:ENST00000353479:synonymous:LOW:exon37/56:c.2595C>T:p.Arg865Arg,COL17A1:ENST00000369733:synonymous:LOW:exon37/52:c.2595C>T:p.Arg865Arg		rs4918079	0.6739	0.7725	36341,22479,1244	0.5002,0.7788,0.7881,0.8242,0.7117	0.7758							113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type,226650|Epidermolysis bullosa,junctional,localisata variant,226650|Epithelial recurrent erosion dystrophy,122400];	RCV000246830.1 [benign]; RCV000276483.1 [benign]; 	CM144867 [CLASS=DP MUT=ALT PHEN="Ossification of posterior longitudinal ligament association with" GENE=COL17A1]; 	COSM3751516	1340	662					COL17A1 (inh=AR+AD pLI=0.00)
chr10	105810400	105810400	T	C	het	pred_pathogenic;anno_omim	QUAL=28202;DP=426;AF=0.50;MQM=60;TRIO=HET,426,0.50,HOM,456,1.00,HET,586,0.50	COL17A1	missense	COL17A1:ENST00000353479:missense:MODERATE:exon27/56:c.2107A>G:p.Met703Val,COL17A1:ENST00000369733:missense:MODERATE:exon27/52:c.2107A>G:p.Met703Val		rs805722	0.6937	0.7803	37505,22415,1454	0.5263,0.8279,0.7900,0.8191,0.7538	0.7852	-0.2220	T,T	T	B	D,D	0.01	113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type,226650|Epidermolysis bullosa,junctional,localisata variant,226650|Epithelial recurrent erosion dystrophy,122400];	RCV000249875.1 [benign]; RCV000390866.1 [benign]; 		COSM1178415	1319	696					COL17A1 (inh=AR+AD pLI=0.00)
chr10	105816916	105816916	C	T	hom	pred_pathogenic;anno_omim	QUAL=25000;DP=117;AF=0.99;MQM=59;TRIO=HOM,117,0.99,HOM,292,1.00,HOM,370,1.00	COL17A1	missense	COL17A1:ENST00000353479:missense:MODERATE:exon17/56:c.1282G>A:p.Gly428Ser,COL17A1:ENST00000369733:missense:MODERATE:exon17/52:c.1282G>A:p.Gly428Ser		rs805698	0.8185	0.9357	53798,32795,1593	0.5610,0.9470,0.8875,0.9922,0.9475	0.9400	0.8810	T,T,T	T	B,B	D,D	6.68	113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type,226650|Epidermolysis bullosa,junctional,localisata variant,226650|Epithelial recurrent erosion dystrophy,122400];	RCV000244902.1 [benign]; RCV000344715.1 [benign]; 	CM144866 [CLASS=DP MUT=ALT PHEN="Ossification of posterior longitudinal ligament association with" GENE=COL17A1]; 		2008	94					COL17A1 (inh=AR+AD pLI=0.00)
chr10	105819956	105819956	G	A	het	anno_omim	QUAL=27562;DP=420;AF=0.52;MQM=59;TRIO=HET,420,0.52,HOM,465,1.00,HET,572,0.47	COL17A1	synonymous	COL17A1:ENST00000353479:synonymous:LOW:exon14/56:c.1062C>T:p.Ala354Ala,COL17A1:ENST00000369733:synonymous:LOW:exon14/52:c.1062C>T:p.Ala354Ala,COL17A1:ENST00000393211:synonymous:LOW:exon14/15:c.1062C>T:p.Ala354Ala		rs805701	0.5525	0.6473	26225,15108,512	0.3151,0.7711,0.6937,0.6729,0.6315	0.6579							113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type,226650|Epidermolysis bullosa,junctional,localisata variant,226650|Epithelial recurrent erosion dystrophy,122400];	RCV000246164.1 [benign]; RCV000265171.1 [benign]; 			899	944					COL17A1 (inh=AR+AD pLI=0.00)
chr10	105824333	105824333	G	A	het	pred_pathogenic;anno_omim	QUAL=1983;DP=50;AF=0.48;MQM=60;TRIO=HET,50,0.48,HOM,39,0.97,HET,23,0.48	COL17A1	missense	COL17A1:ENST00000353479:missense:MODERATE:exon10/56:c.629C>T:p.Thr210Met,COL17A1:ENST00000369733:missense:MODERATE:exon10/52:c.629C>T:p.Thr210Met,COL17A1:ENST00000393211:missense:MODERATE:exon10/15:c.629C>T:p.Thr210Met		rs805708	0.5649	0.6740	27226,16148,617	0.3617,0.7817,0.6933,0.7062,0.6419	0.6767	6.8340	T,T,T,T	T	D,D,P	T,T,T	23.20	113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type,226650|Epidermolysis bullosa,junctional,localisata variant,226650|Epithelial recurrent erosion dystrophy,122400];	RCV000252360.1 [benign]; RCV000264886.1 [benign]; 			950	913					COL17A1 (inh=AR+AD pLI=0.00)
chr10	112361870	112361870	A	G	hom	anno_omim	QUAL=17448;DP=230;AF=1.00;MQM=58;TRIO=HOM,230,1.00,HOM,129,1.00,HOM,170,1.00	SMC3	synonymous	SMC3:ENST00000361804:synonymous:LOW:exon25/29:c.3039A>G:p.Ser1013Ser		rs2419565	0.9868	0.9963	60202,33298,4794	0.9644,0.9987,1.0000,0.9991,0.9998	0.9969							606062 [SMC3 (provisional) Cornelia de Lange syndrome 3,610759];	RCV000147595.2 [benign]; RCV000323853.1 [benign]; 			2108	5					SMC3 (inh=AD pLI=1.00)
chr10	112773063	112773063	G	-	het	anno_omim	QUAL=1928;DP=201;AF=0.40;MQM=59;TRIO=HET,201,0.40,WT,47,0.00,HET,80,0.29	SHOC2	3'UTR	SHOC2:ENST00000369452:3'UTR:MODIFIER:exon9/9:c.*1487delG:,SHOC2:ENST00000265277:3'UTR:MODIFIER:exon8/8:c.*1487delG:		rs143768227	0.0525	0.0000	0,0,0	0,0,0,0,0	0.0545							602775 [SHOC2 (provisional) Noonan-like syndrome with loose anagen hair,607721];	RCV000352708.1 [benign]; 			0	21					SHOC2 (inh=AD pLI=0.99)
chr10	119302341	119302341	-	T	hom	anno_omim	QUAL=2081;DP=66;AF=0.45;MQM=59;TRIO=HOM,66,0.45,HOM,71,0.68,HOM,123,0.58	EMX2,EMX2OS	5'UTR,intron	EMX2:ENST00000553456:5'UTR:MODIFIER:exon1/3:c.-424dupT:,EMX2OS:ENST00000551288:intron:MODIFIER:exon2/3:n.574+1475dupA:			0.5284	0.0000	0,0,0	0,0,0,0,0	0.6395							600035 [EMX2 (provisional) Schizencephaly,269160];				67	72					EMX2 (inh=n/a pLI=0.94), EMX2OS (inh=n/a pLI=n/a)
chr10	119302449	119302449	G	A	het	anno_omim	QUAL=411;DP=76;AF=0.34;MQM=52;TRIO=HET,76,0.34,HET,17,0.35,HET,21,0.10	EMX2,EMX2OS	5'UTR,intron	EMX2:ENST00000553456:5'UTR:MODIFIER:exon1/3:c.-330G>A:,EMX2OS:ENST00000551288:intron:MODIFIER:exon2/3:n.574+1368C>T:	(A)n	rs879001240	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0758							600035 [EMX2 (provisional) Schizencephaly,269160];				0	108					EMX2 (inh=n/a pLI=0.94), EMX2OS (inh=n/a pLI=n/a)
chr10	119302459	119302459	G	A	het	low_QUAL;low_MQM;anno_omim	QUAL=19;DP=68;AF=0.21;MQM=44;TRIO=HET,68,0.21,HET,13,0.23,WT,23,0.04	EMX2,EMX2OS	5'UTR,intron	EMX2:ENST00000553456:5'UTR:MODIFIER:exon1/3:c.-320G>A:,EMX2OS:ENST00000551288:intron:MODIFIER:exon2/3:n.574+1358C>T:	(A)n	rs878875506	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0330							600035 [EMX2 (provisional) Schizencephaly,269160];				0	69					EMX2 (inh=n/a pLI=0.94), EMX2OS (inh=n/a pLI=n/a)
chr10	119308060	119308063	AGAG	-	hom	anno_omim	QUAL=11167;DP=94;AF=0.95;MQM=59;TRIO=HOM,94,0.95,HOM,143,0.92,HOM,187,0.97	EMX2	3'UTR	EMX2:ENST00000553456:3'UTR:MODIFIER:exon3/3:c.*338_*341delGAGA:,EMX2:ENST00000442245:3'UTR:MODIFIER:exon2/2:c.*402_*405delGAGA:	(GAGA)n	rs34929200;rs66710107	0.9497	0.0000	0,0,0	0,0,0,0,0	0.8824							600035 [EMX2 (provisional) Schizencephaly,269160];				211	14					EMX2 (inh=n/a pLI=0.94)
chr10	121436362	121436362	A	G	het	anno_omim	QUAL=10002;DP=385;AF=0.53;MQM=59;TRIO=HET,385,0.53,HET,153,0.54,HET,234,0.49	BAG3	synonymous	BAG3:ENST00000369085:synonymous:LOW:exon4/4:c.1296A>G:p.Val432Val		rs196295	0.7065	0.7409	33720,20379,2977	0.7517,0.6310,0.5208,0.7819,0.7637	0.7508							603883 [BAG3 (provisional) Myopathy,myofibrillar,6,612954|Cardiomyopathy,dilated,1HH,613881];	RCV000037886.8 [benign]; RCV000243961.1 [benign]; RCV000280713.1 [benign]; RCV000399004.1 [benign]; 			1382	692					BAG3 (inh=AD pLI=0.53)
chr10	121437032	121437034	TTG	-	het	anno_omim	QUAL=9345;DP=390;AF=0.50;MQM=59;TRIO=HET,390,0.50,WT,276,0.00,HET,386,0.51	BAG3	3'UTR	BAG3:ENST00000369085:3'UTR:MODIFIER:exon4/4:c.*243_*245delGTT:		rs71758126	0.4585	0.0000	0,0,0	0,0,0,0,0	0.5413							603883 [BAG3 (provisional) Myopathy,myofibrillar,6,612954|Cardiomyopathy,dilated,1HH,613881];	RCV000343159.1 [benign]; RCV000395361.1 [benign]; 			87	103					BAG3 (inh=AD pLI=0.53)
chr10	123239112	123239112	G	A	het	anno_omim	QUAL=12951;DP=198;AF=0.48;MQM=59;TRIO=HET,198,0.48,HOM,238,1.00,HET,288,0.42	FGFR2	synonymous,3'UTR	FGFR2:ENST00000357555:synonymous:LOW:exon17/17:c.2107C>T:p.Leu703Leu,FGFR2:ENST00000369061:3'UTR:MODIFIER:exon15/15:c.*259C>T:,FGFR2:ENST00000358487:3'UTR:MODIFIER:exon18/18:c.*259C>T:,FGFR2:ENST00000478859:3'UTR:MODIFIER:exon17/17:c.*259C>T:,FGFR2:ENST00000356226:3'UTR:MODIFIER:exon16/16:c.*259C>T:,FGFR2:ENST00000369060:3'UTR:MODIFIER:exon16/16:c.*259C>T:		rs1047057	0.4143	0.5311	3140,1421,27	0.1575,0.6839,0.3866,0.5602,0.6054	0.5559							176943 [FGFR2 (confirmed) Crouzon syndrome,123500|Jackson-Weiss syndrome,123150|Beare-Stevenson cutis gyrata syndrome,123790|Pfeiffer syndrome,101600|Apert syndrome,101200|Saethre-Chotzen syndrome,101400|Craniosynostosis,nonspecific|Gastric cancer,somatic,613659|Craniofacial-skeletal-dermatologic dysplasia,101600|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis,207410|Scaphocephaly and Axenfeld-Rieger anomaly|LADD syndrome,149730|Scaphocephaly,maxillary retrusion,and mental retardation,609579|Bent bone dysplasia syndrome,614592];	RCV000264030.1 [benign]; RCV000302746.1 [benign]; RCV000304323.1 [benign]; RCV000310102.1 [benign]; RCV000343896.1 [benign]; RCV000355233.1 [benign]; RCV000361106.1 [benign]; RCV000398132.1 [benign]; RCV000398152.1 [benign]; 		COSM147070	701	1061					FGFR2 (inh=AR+AD pLI=1.00)
chr10	123298158	123298158	T	C	hom	anno_omim	QUAL=40379;DP=412;AF=1.00;MQM=59;TRIO=HOM,412,1.00,HET,469,0.55,HOM,618,1.00	FGFR2	synonymous	FGFR2:ENST00000457416:synonymous:LOW:exon6/18:c.696A>G:p.Val232Val,FGFR2:ENST00000369061:synonymous:LOW:exon5/15:c.696A>G:p.Val232Val,FGFR2:ENST00000357555:synonymous:LOW:exon5/17:c.429A>G:p.Val143Val,FGFR2:ENST00000358487:synonymous:LOW:exon6/18:c.696A>G:p.Val232Val,FGFR2:ENST00000356226:synonymous:LOW:exon4/16:c.351A>G:p.Val117Val,FGFR2:ENST00000369060:synonymous:LOW:exon6/16:c.696A>G:p.Val232Val,FGFR2:ENST00000369059:synonymous:LOW:exon4/16:c.351A>G:p.Val117Val,FGFR2:ENST00000346997:synonymous:LOW:exon5/17:c.696A>G:p.Val232Val,FGFR2:ENST00000351936:synonymous:LOW:exon6/18:c.696A>G:p.Val232Val,FGFR2:ENST00000360144:synonymous:LOW:exon5/17:c.429A>G:p.Val143Val,FGFR2:ENST00000369056:synonymous:LOW:exon5/17:c.696A>G:p.Val232Val,FGFR2:ENST00000359354:synonymous:LOW:exon6/7:c.696A>G:p.Val232Val		rs1047100	0.7953	0.7797	37171,19910,2915	0.7477,0.8188,0.9234,0.7711,0.7443	0.7813							176943 [FGFR2 (confirmed) Crouzon syndrome,123500|Jackson-Weiss syndrome,123150|Beare-Stevenson cutis gyrata syndrome,123790|Pfeiffer syndrome,101600|Apert syndrome,101200|Saethre-Chotzen syndrome,101400|Craniosynostosis,nonspecific|Gastric cancer,somatic,613659|Craniofacial-skeletal-dermatologic dysplasia,101600|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis,207410|Scaphocephaly and Axenfeld-Rieger anomaly|LADD syndrome,149730|Scaphocephaly,maxillary retrusion,and mental retardation,609579|Bent bone dysplasia syndrome,614592];	RCV000250550.1 [benign]; RCV000264031.1 [benign]; RCV000268420.1 [benign]; RCV000270961.1 [benign]; RCV000308616.1 [benign]; RCV000316516.1 [benign]; RCV000321550.1 [benign]; RCV000363146.1 [benign]; RCV000365600.1 [benign]; RCV000378516.1 [benign]; 			1367	741					FGFR2 (inh=AR+AD pLI=1.00)
chr10	123357561	123357561	C	T	hom	low_DP;anno_omim	QUAL=1869;DP=12;AF=0.92;MQM=60;TRIO=HOM,12,0.92,HET,29,0.55,HOM,52,1.00	FGFR2	5'UTR	FGFR2:ENST00000457416:5'UTR:MODIFIER:exon1/18:c.-236G>A:,FGFR2:ENST00000358487:5'UTR:MODIFIER:exon1/18:c.-236G>A:,FGFR2:ENST00000356226:5'UTR:MODIFIER:exon1/16:c.-236G>A:,FGFR2:ENST00000369060:5'UTR:MODIFIER:exon1/16:c.-236G>A:,FGFR2:ENST00000369059:5'UTR:MODIFIER:exon1/16:c.-236G>A:,FGFR2:ENST00000351936:5'UTR:MODIFIER:exon1/18:c.-236G>A:,FGFR2:ENST00000360144:5'UTR:MODIFIER:exon1/17:c.-236G>A:,FGFR2:ENST00000359354:5'UTR:MODIFIER:exon1/7:c.-236G>A:		rs1047111	0.7103	0.0000	0,0,0	0,0,0,0,0	0.7401							176943 [FGFR2 (confirmed) Crouzon syndrome,123500|Jackson-Weiss syndrome,123150|Beare-Stevenson cutis gyrata syndrome,123790|Pfeiffer syndrome,101600|Apert syndrome,101200|Saethre-Chotzen syndrome,101400|Craniosynostosis,nonspecific|Gastric cancer,somatic,613659|Craniofacial-skeletal-dermatologic dysplasia,101600|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis,207410|Scaphocephaly and Axenfeld-Rieger anomaly|LADD syndrome,149730|Scaphocephaly,maxillary retrusion,and mental retardation,609579|Bent bone dysplasia syndrome,614592];	RCV000270363.1 [benign]; RCV000301938.1 [benign]; RCV000309774.1 [benign]; RCV000332515.1 [benign]; RCV000341554.1 [benign]; RCV000359107.1 [benign]; RCV000362123.1 [benign]; RCV000404795.1 [benign]; RCV000405669.1 [benign]; 			154	62					FGFR2 (inh=AR+AD pLI=1.00)
chr10	126107506	126107506	A	C	het	anno_omim	QUAL=8062;DP=148;AF=0.59;MQM=60;TRIO=HET,148,0.59,HOM,126,1.00,HET,186,0.49	OAT	5'UTR	OAT:ENST00000539214:5'UTR:MODIFIER:exon1/9:c.-280T>G:		rs4144117	0.8630	0.0000	0,0,0	0,0,0,0,0	0.8277							613349 [OAT (confirmed) Gyrate atrophy of choroid and retina with or without ornithinemia,258870];	RCV000268468.1 [benign]; 			156	71					OAT (inh=AR pLI=0.00)
chr11	791462	791462	G	A	het	anno_omim	QUAL=4079;DP=132;AF=0.48;MQM=60;TRIO=HET,132,0.48,WT,117,0.00,HET,208,0.51	SLC25A22	3'UTR	SLC25A22:ENST00000320230:3'UTR:MODIFIER:exon10/10:c.*453C>T:		rs4963153	0.2993	0.0000	0,0,0	0,0,0,0,0	0.3977							609302 [SLC25A22 (provisional) Epileptic encephalopathy,early infantile,3,609304];	RCV000401091.1 [benign]; 			47	113					SLC25A22 (inh=AR pLI=0.57)
chr11	1861760	1861760	T	C	hom	anno_omim	QUAL=21630;DP=176;AF=0.99;MQM=59;TRIO=HOM,176,0.99,HOM,227,1.00,HOM,329,1.00	TNNI2	splice_region&synonymous	TNNI2:ENST00000252898:splice_region&synonymous:LOW:exon4/7:c.60T>C:p.Ser20Ser,TNNI2:ENST00000381911:splice_region&synonymous:LOW:exon5/8:c.60T>C:p.Ser20Ser,TNNI2:ENST00000381906:splice_region&synonymous:LOW:exon5/8:c.60T>C:p.Ser20Ser,TNNI2:ENST00000381905:splice_region&synonymous:LOW:exon3/6:c.60T>C:p.Ser20Ser		rs907610	0.8277	0.8760	44552,24284,2076	0.6686,0.9067,0.9879,0.8788,0.8822	0.8796							191043 [TNNI2 (confirmed) Arthrogryposis multiplex congenita,distal,type 2B,601680];	RCV000080081.9 [other]; RCV000128669.1 [not provided]; RCV000320562.1 [likely benign]; RCV000361293.1 [likely benign]; 		COSM4145619	1606	470					TNNI2 (inh=AD pLI=0.09)
chr11	1959707	1959707	C	T	het	anno_omim	QUAL=836;DP=32;AF=0.47;MQM=59;TRIO=HET,32,0.47,HET,26,0.50,HET,41,0.37	TNNT3	synonymous	TNNT3:ENST00000397301:synonymous:LOW:exon17/17:c.795C>T:p.Gly265Gly,TNNT3:ENST00000278317:synonymous:LOW:exon16/16:c.762C>T:p.Gly254Gly,TNNT3:ENST00000360603:synonymous:LOW:exon15/15:c.744C>T:p.Gly248Gly,TNNT3:ENST00000381548:synonymous:LOW:exon16/16:c.768C>T:p.Gly256Gly,TNNT3:ENST00000381549:synonymous:LOW:exon15/15:c.738C>T:p.Gly246Gly,TNNT3:ENST00000381561:synonymous:LOW:exon16/16:c.771C>T:p.Gly257Gly,TNNT3:ENST00000381579:synonymous:LOW:exon15/15:c.738C>T:p.Gly246Gly,TNNT3:ENST00000381589:synonymous:LOW:exon16/16:c.756C>T:p.Gly252Gly,TNNT3:ENST00000381558:synonymous:LOW:exon15/15:c.738C>T:p.Gly246Gly,TNNT3:ENST00000397304:synonymous:LOW:exon12/12:c.705C>T:p.Gly235Gly,TNNT3:ENST00000446240:synonymous:LOW:exon12/12:c.705C>T:p.Gly235Gly		rs4727	0.1370	0.1452	1645,842,7	0.0367,0.0763,0.3489,0.1546,0.1002	0.1470							600692 [TNNT3 (confirmed) Arthyrgryposis,distal,type 2B,601680];	RCV000024568.1 [not provided]; RCV000118647.2 [benign]; RCV000334912.1 [likely benign]; RCV000373168.1 [likely benign]; 		COSM3752283, COSM3752285, COSM3752284	75	541					TNNT3 (inh=AD pLI=0.00)
chr11	2187855	2187855	G	C	het	low_DP;anno_omim	QUAL=2184;DP=16;AF=0.63;MQM=60;TRIO=HET,16,0.63,WT,127,0.00,HET,158,0.53	TH	splice_region&intron,intron	TH:ENST00000381178:splice_region&intron:LOW:exon9/13:c.1070+8C>G:,TH:ENST00000381175:splice_region&intron:LOW:exon9/13:c.1058+8C>G:,TH:ENST00000352909:splice_region&intron:LOW:exon8/12:c.977+8C>G:,TH:ENST00000333684:intron:MODIFIER:exon6/10:c.708-76C>G:		rs12419447	0.1799	0.3690	2558,2162,34	0.2104,0.3679,0.0724,0.4754,0.1948	0.2785							191290 [TH (confirmed) Segawa syndrome,recessive,605407];	RCV000250457.2 [benign]; RCV000278788.1 [benign]; 			289	1171					TH (inh=AR pLI=0.00)
chr11	2188238	2188238	C	T	het	anno_omim	QUAL=1472;DP=35;AF=0.43;MQM=60;TRIO=HET,35,0.43,WT,72,0.00,HET,94,0.51	TH	synonymous,intron	TH:ENST00000381178:synonymous:LOW:exon8/14:c.813G>A:p.Lys271Lys,TH:ENST00000381175:synonymous:LOW:exon8/14:c.801G>A:p.Lys267Lys,TH:ENST00000352909:synonymous:LOW:exon7/13:c.720G>A:p.Lys240Lys,TH:ENST00000333684:intron:MODIFIER:exon6/10:c.707+427G>A:		rs6357	0.1546	0.3060	2044,1694,44	0.1801,0.2575,0.0651,0.3937,0.1630	0.2402							191290 [TH (confirmed) Segawa syndrome,recessive,605407];	RCV000252592.1 [benign]; RCV000287153.1 [benign]; 		COSM3752293	222	1127					TH (inh=AR pLI=0.00)
chr11	3877114	3877118	TCTCT	-	het	anno_omim	QUAL=2916;DP=78;AF=0.40;MQM=59;TRIO=HET,78,0.40,HET,78,0.33,HOM,79,0.99	STIM1	5'UTR	STIM1:ENST00000300737:5'UTR:MODIFIER:exon1/12:c.-370_-366delTCTTC:	(TCTCT)n	rs147711952	0.2688	0.0000	0,0,0	0,0,0,0,0	0.2947							605921 [STIM1 (provisional) Immunodeficiency 10,612783|Myopathy,tubular aggregate,1 160565|Stormorken syndrome,185070];				28	107					STIM1 (inh=AR+AD pLI=0.93)
chr11	4103524	4103524	A	G	hom	pred_pathogenic;anno_omim	QUAL=16507;DP=217;AF=0.99;MQM=60;TRIO=HOM,217,0.99,HET,179,0.43,HOM,244,1.00	STIM1	synonymous	STIM1:ENST00000300737:synonymous:LOW:exon8/12:c.1080A>G:p.Gln360Gln,STIM1:ENST00000527651:synonymous:LOW:exon8/13:c.1080A>G:p.Gln360Gln,STIM1:ENST00000533977:synonymous:LOW:exon5/9:c.561A>G:p.Gln187Gln		rs2304891	0.3890	0.4996	15744,10562,190	0.1703,0.5149,0.4467,0.5662,0.4555	0.5030	1.7940		T			5.98	605921 [STIM1 (provisional) Immunodeficiency 10,612783|Myopathy,tubular aggregate,1 160565|Stormorken syndrome,185070];	RCV000250516.1 [benign]; 		COSM428967	629	966					STIM1 (inh=AR+AD pLI=0.93)
chr11	4113395	4113395	G	A	hom	anno_omim	QUAL=22561;DP=311;AF=1.00;MQM=59;TRIO=HOM,311,1.00,HET,252,0.51,HOM,293,1.00	STIM1	3'UTR	STIM1:ENST00000300737:3'UTR:MODIFIER:exon12/12:c.*367G>A:		rs1561876	0.6941	0.0000	0,0,0	0,0,0,0,0	0.7261							605921 [STIM1 (provisional) Immunodeficiency 10,612783|Myopathy,tubular aggregate,1 160565|Stormorken syndrome,185070];				173	49					STIM1 (inh=AR+AD pLI=0.93)
chr11	4113471	4113471	G	A	het	anno_omim	QUAL=13495;DP=361;AF=0.52;MQM=59;TRIO=HET,361,0.52,HET,305,0.52,HET,358,0.48	STIM1	3'UTR	STIM1:ENST00000300737:3'UTR:MODIFIER:exon12/12:c.*443G>A:		rs76833585	0.0397	0.0000	0,0,0	0,0,0,0,0	0.0567							605921 [STIM1 (provisional) Immunodeficiency 10,612783|Myopathy,tubular aggregate,1 160565|Stormorken syndrome,185070];				3	23					STIM1 (inh=AR+AD pLI=0.93)
chr11	5248243	5248243	A	G	het	anno_omim	QUAL=23335;DP=418;AF=0.49;MQM=59;TRIO=HET,418,0.49,HET,367,0.47,HOM,425,1.00	HBB	synonymous	HBB:ENST00000335295:synonymous:LOW:exon1/3:c.9T>C:p.His3His		rs713040	0.7143	0.7671	36531,23436,3939	0.8693,0.6442,0.4963,0.8380,0.6338	0.8159							141900 [HBB (confirmed) Sickle cell anemia,603903|Thalassemias,beta-,613985|Erythremias,beta-|Methemoglobinemias,beta-|Heinz body anemias,beta-,140700|Thalassemia-beta,dominant inclusion-body,603902|Hereditary persistence of fetal hemoglobin,141749|Delta-beta thalassemia,141749|Malaria,resistance to,611162];	RCV000173144.2 [benign]; RCV000271089.1 [benign]; RCV000328523.1 [benign]; RCV000362141.1 [benign]; 			1421	619					HBB (inh=AR+AD pLI=0.00)
chr11	6411936	6411941	GCTGGC	-	het	anno_omim	QUAL=3986;DP=53;AF=0.74;MQM=59;TRIO=HET,53,0.91,HOM,36,1.00,WT,47,1.00	SMPD1	disruptive_inframe_deletion	SMPD1:ENST00000342245:disruptive_inframe_deletion:MODERATE:exon1/6:c.138_143delGCTGGC:p.Leu47_Ala48del,SMPD1:ENST00000299397:disruptive_inframe_deletion:MODERATE:exon1/5:c.138_143delGCTGGC:p.Leu47_Ala48del,SMPD1:ENST00000356761:disruptive_inframe_deletion:MODERATE:exon1/6:c.138_143delGCTGGC:p.Leu47_Ala48del,SMPD1:ENST00000527275:disruptive_inframe_deletion:MODERATE:exon1/6:c.138_143delGCTGGC:p.Leu47_Ala48del	(CTGGCG)n	rs3838786;rs558809956	0.0000	0.2239	6066,4023,610	0.3228,0.0997,0.0740,0.2524,0.2295	0.2910							607608 [SMPD1 (confirmed) Niemann-Pick disease,type A,257200|Niemann-Pick disease,type B,607616];	RCV000248934.2,RCV000248934.2 [benign,benign]; 		COSM930080, COSM930081	343	947					SMPD1 (inh=AR pLI=0.00)
chr11	6411935	6411935	T	C	het	anno_omim	QUAL=3986;DP=53;AF=0.74;MQM=60;TRIO=HET,53,0.91,WT,36,1.00,HOM,47,1.00	SMPD1	missense	SMPD1:ENST00000342245:missense:MODERATE:exon1/6:c.107T>C:p.Val36Ala,SMPD1:ENST00000299397:missense:MODERATE:exon1/5:c.107T>C:p.Val36Ala,SMPD1:ENST00000356761:missense:MODERATE:exon1/6:c.107T>C:p.Val36Ala,SMPD1:ENST00000527275:missense:MODERATE:exon1/6:c.107T>C:p.Val36Ala	(CTGGCG)n	rs1050228	0.5613	0.5580	18416,8580,254	0.2323,0.7525,0.7827,0.5304,0.5777	0.5542	0.5000	T,T,T,T	T	B,B	T,T,T,T	0.02	607608 [SMPD1 (confirmed) Niemann-Pick disease,type A,257200|Niemann-Pick disease,type B,607616];	RCV000079189.5 [benign]; RCV000315171.1 [benign]; 	CM154141 [CLASS=R MUT=ALT PHEN="Niemann-Pick disease" GENE=SMPD1]; 	COSM1561696, COSM1561695	664	1053	2	[2] Ute Grasshoff 28.10.2015			SMPD1 (inh=AR pLI=0.00)
chr11	6415463	6415463	G	A	het	pred_pathogenic;anno_omim	QUAL=13168;DP=363;AF=0.51;MQM=59;TRIO=HET,363,0.51,HOM,265,0.99,WT,342,0.00	SMPD1	missense	SMPD1:ENST00000342245:missense:MODERATE:exon6/6:c.1522G>A:p.Gly508Arg,SMPD1:ENST00000299397:missense:MODERATE:exon5/5:c.1390G>A:p.Gly464Arg,SMPD1:ENST00000356761:missense:MODERATE:exon6/6:c.1354G>A:p.Gly452Arg,SMPD1:ENST00000527275:missense:MODERATE:exon6/6:c.1519G>A:p.Gly507Arg		rs1050239	0.1500	0.1917	2401,1754,95	0.1358,0.1701,0.1399,0.2265,0.1214	0.1984	6.2260	T,T,T,T	T	P,P,P	D,D,D,D	22.60	607608 [SMPD1 (confirmed) Niemann-Pick disease,type A,257200|Niemann-Pick disease,type B,607616];	RCV000079195.5 [benign]; RCV000336908.1 [likely benign]; 	CM1415110 [CLASS=DP MUT=ALT PHEN="Allergy self-reported association with" GENE=SMPD1]; 	COSM3752608, COSM3752609	92	718					SMPD1 (inh=AR pLI=0.00)
chr11	6634149	6634149	C	T	het	anno_omim	QUAL=19952;DP=358;AF=0.49;MQM=59;TRIO=HET,358,0.49,HOM,313,1.00,HET,395,0.52	TPP1	3'UTR	TPP1:ENST00000299427:3'UTR:MODIFIER:exon13/13:c.*1628G>A:,TPP1:ENST00000533371:3'UTR:MODIFIER:exon12/12:c.*1628G>A:	L2c	rs7488	0.8103	0.0000	0,0,0	0,0,0,0,0	0.7513							607998 [TPP1 (confirmed) Ceroid lipofuscinosis,neuronal,2,204500|Spinocerebellar ataxia,autosomal recessive 7,609270];	RCV000363243.1 [benign]; 			115	65					TPP1 (inh=AR pLI=0.03)
chr11	6634189	6634189	G	A	het	anno_omim	QUAL=14138;DP=437;AF=0.49;MQM=59;TRIO=HET,437,0.49,HET,289,0.52,HET,340,0.51	TPP1	3'UTR	TPP1:ENST00000299427:3'UTR:MODIFIER:exon13/13:c.*1588C>T:,TPP1:ENST00000533371:3'UTR:MODIFIER:exon12/12:c.*1588C>T:	L2c	rs7487	0.4489	0.0000	0,0,0	0,0,0,0,0	0.4494							607998 [TPP1 (confirmed) Ceroid lipofuscinosis,neuronal,2,204500|Spinocerebellar ataxia,autosomal recessive 7,609270];	RCV000273317.1 [benign]; 			67	91					TPP1 (inh=AR pLI=0.03)
chr11	6637740	6637743	TTTT	-	hom	anno_omim	QUAL=1108;DP=49;AF=0.16;MQM=59;TRIO=HOM,49,0.16,HOM,44,0.05,HOM,53,0.06	TPP1	splice_region&intron	TPP1:ENST00000299427:splice_region&intron:LOW:exon7/12:c.887-9_887-6delAAAA:,TPP1:ENST00000533371:splice_region&intron:LOW:exon6/11:c.158-9_158-6delAAAA:	(T)n	rs769864650	0.0000	0.0272	0,0,0	0.0643,0.0438,0.0420,0.0338,0.0073	0.0093							607998 [TPP1 (confirmed) Ceroid lipofuscinosis,neuronal,2,204500|Spinocerebellar ataxia,autosomal recessive 7,609270];				62	2					TPP1 (inh=AR pLI=0.03)
chr11	9800601	9800601	G	A	het	anno_omim	QUAL=6576;DP=189;AF=0.50;MQM=60;TRIO=HET,189,0.50,HET,66,0.61,HOM,88,1.00	SBF2,SBF2-AS1	3'UTR,intron	SBF2:ENST00000256190:3'UTR:MODIFIER:exon40/40:c.*1364C>T:,SBF2-AS1:ENST00000498905:intron:MODIFIER:exon1/2:n.212+20551G>A:,SBF2-AS1:ENST00000527406:intron:MODIFIER:exon1/1:n.211-1322G>A:,SBF2-AS1:ENST00000499953:intron:MODIFIER:exon1/3:n.209-1322G>A:,SBF2-AS1:ENST00000525636:intron:MODIFIER:exon1/3:n.122-763G>A:,SBF2-AS1:ENST00000534671:intron:MODIFIER:exon1/2:n.36-1322G>A:		rs10118	0.6108	0.0000	0,0,0	0,0,0,0,0	0.6437							607697 [SBF2 (confirmed) Charcot-Marie-Tooth disease,type 4B2,604563];	RCV000278813.1 [benign]; 			98	112					SBF2 (inh=AR pLI=0.38), SBF2-AS1 (inh=n/a pLI=n/a)
chr11	9801925	9801925	T	G	het	anno_omim	QUAL=20468;DP=272;AF=0.47;MQM=60;TRIO=HET,272,0.47,HET,304,0.46,HOM,414,1.00	SBF2-AS1,SBF2	splice_region&non_coding_transcript_exon,3'UTR,intron	SBF2-AS1:ENST00000527406:splice_region&non_coding_transcript_exon:LOW:exon2/2:n.213T>G:,SBF2-AS1:ENST00000499953:splice_region&non_coding_transcript_exon:LOW:exon2/4:n.211T>G:,SBF2-AS1:ENST00000525636:splice_region&non_coding_transcript_exon:LOW:exon3/4:n.250T>G:,SBF2-AS1:ENST00000534671:splice_region&non_coding_transcript_exon:LOW:exon2/3:n.38T>G:,SBF2:ENST00000256190:3'UTR:MODIFIER:exon40/40:c.*40A>C:,SBF2-AS1:ENST00000498905:intron:MODIFIER:exon1/2:n.212+21875T>G:		rs3751000	0.3275	0.3090	5548,2156,529	0.3297,0.4565,0.3724,0.2664,0.3401	0.3074							607697 [SBF2 (confirmed) Charcot-Marie-Tooth disease,type 4B2,604563];	RCV000299034.1 [benign]; 			189	789					SBF2-AS1 (inh=n/a pLI=n/a), SBF2 (inh=AR pLI=0.38)
chr11	9812236	9812236	G	A	hom	anno_omim	QUAL=9387;DP=145;AF=1.00;MQM=59;TRIO=HOM,145,1.00,HOM,58,1.00,HOM,82,1.00	SBF2,SBF2-AS1	splice_region&intron,intron	SBF2:ENST00000256190:splice_region&intron:LOW:exon33/39:c.4571-6C>T:,SBF2-AS1:ENST00000498905:intron:MODIFIER:exon1/2:n.213-17159G>A:,SBF2-AS1:ENST00000499953:intron:MODIFIER:exon3/3:n.479-180G>A:,SBF2-AS1:ENST00000525636:intron:MODIFIER:exon3/3:n.447+10114G>A:,SBF2-AS1:ENST00000534671:intron:MODIFIER:exon2/2:n.235+10114G>A:,SBF2-AS1:ENST00000526617:intron:MODIFIER:exon1/1:n.120-180G>A:		rs2645029	0.8027	0.8584	44419,26489,3513	0.8540,0.8611,0.6902,0.8979,0.7515	0.8807							607697 [SBF2 (confirmed) Charcot-Marie-Tooth disease,type 4B2,604563];	RCV000249680.1 [benign]; RCV000349837.1 [benign]; 			1615	422					SBF2 (inh=AR pLI=0.38), SBF2-AS1 (inh=n/a pLI=n/a)
chr11	13514417	13514417	C	T	het	anno_omim	QUAL=9272;DP=233;AF=0.50;MQM=60;TRIO=HET,233,0.50,HET,133,0.49,HOM,139,1.00	PTH	splice_region&intron	PTH:ENST00000282091:splice_region&intron:LOW:exon1/2:c.-5-10G>A:,PTH:ENST00000529816:splice_region&intron:LOW:exon1/2:c.-5-10G>A:		rs694	0.4177	0.5579	19191,13468,337	0.2599,0.3543,0.3077,0.6516,0.6000	0.5479							168450 [PTH (confirmed) Hypoparathyroidism,autosomal dominant,146200|Hypoparathyroidism,autosomal recessive,146200];	RCV000254294.1 [benign]; RCV000289575.1 [benign]; 			861	879					PTH (inh=AD pLI=0.27)
chr11	17408025	17408025	A	G	het	anno_omim	QUAL=4454;DP=177;AF=0.51;MQM=60;TRIO=HET,177,0.51,HET,231,0.42,WT,267,0.00	KCNJ11	3'UTR	KCNJ11:ENST00000339994:3'UTR:MODIFIER:exon1/1:c.*441T>C:,KCNJ11:ENST00000528731:3'UTR:MODIFIER:exon2/2:c.*441T>C:		rs2285676	0.4689	0.0000	0,0,0	0,0,0,0,0	0.4466							600937 [KCNJ11 (confirmed) Hyperinsulinemic hypoglycemia,familial,2,601820|Diabetes,permanent neonatal,with or without neurologic features,606176|Diabetes mellitus,type 2,susceptibility to,125853|Diabetes mellitus,transient neonatal,3,610582|Maturity-onset diabetes of the young,type 13,616329];	RCV000301359.1 [likely benign]; RCV000356199.1 [likely benign]; RCV000400519.1 [likely benign]; 			20	119					KCNJ11 (inh=AR+AD pLI=0.31)
chr11	17408251	17408251	G	A	het	anno_omim	QUAL=5891;DP=260;AF=0.48;MQM=59;TRIO=HET,260,0.48,HET,299,0.44,WT,422,0.00	KCNJ11	3'UTR	KCNJ11:ENST00000339994:3'UTR:MODIFIER:exon1/1:c.*215C>T:,KCNJ11:ENST00000528731:3'UTR:MODIFIER:exon2/2:c.*215C>T:		rs5210	0.4677	0.0000	0,0,0	0,0,0,0,0	0.4457							600937 [KCNJ11 (confirmed) Hyperinsulinemic hypoglycemia,familial,2,601820|Diabetes,permanent neonatal,with or without neurologic features,606176|Diabetes mellitus,type 2,susceptibility to,125853|Diabetes mellitus,transient neonatal,3,610582|Maturity-onset diabetes of the young,type 13,616329];	RCV000293997.1 [likely benign]; RCV000348877.1 [likely benign]; RCV000395953.1 [likely benign]; 	CS035715 [CLASS=DFP MUT=ALT PHEN="Diabetes type 2 association with" GENE=KCNJ11]; 		20	119					KCNJ11 (inh=AR+AD pLI=0.31)
chr11	17408404	17408404	C	T	hom	anno_omim	QUAL=27272;DP=218;AF=0.99;MQM=59;TRIO=HOM,218,0.99,HOM,450,0.99,HET,620,0.50	KCNJ11	3'UTR	KCNJ11:ENST00000339994:3'UTR:MODIFIER:exon1/1:c.*62G>A:,KCNJ11:ENST00000528731:3'UTR:MODIFIER:exon2/2:c.*62G>A:		rs5213	0.7358	0.0000	0,0,0	0,0,0,0,0	0.7115							600937 [KCNJ11 (confirmed) Hyperinsulinemic hypoglycemia,familial,2,601820|Diabetes,permanent neonatal,with or without neurologic features,606176|Diabetes mellitus,type 2,susceptibility to,125853|Diabetes mellitus,transient neonatal,3,610582|Maturity-onset diabetes of the young,type 13,616329];	RCV000275742.1 [likely benign]; RCV000324987.1 [likely benign]; RCV000370291.1 [likely benign]; 			662	714					KCNJ11 (inh=AR+AD pLI=0.31)
chr11	17408630	17408630	C	T	hom	pred_pathogenic;anno_omim	QUAL=39002;DP=337;AF=0.99;MQM=59;TRIO=HOM,337,0.99,HOM,617,1.00,HET,763,0.48	KCNJ11	missense	KCNJ11:ENST00000339994:missense:MODERATE:exon1/1:c.1009G>A:p.Val337Ile,KCNJ11:ENST00000528731:missense:MODERATE:exon2/2:c.748G>A:p.Val250Ile		rs5215	0.7306	0.6448	25728,13093,4355	0.9147,0.6097,0.6396,0.6260,0.6271	0.7014	-0.1400	T,T	T	B	D,D	12.36	600937 [KCNJ11 (confirmed) Hyperinsulinemic hypoglycemia,familial,2,601820|Diabetes,permanent neonatal,with or without neurologic features,606176|Diabetes mellitus,type 2,susceptibility to,125853|Diabetes mellitus,transient neonatal,3,610582|Maturity-onset diabetes of the young,type 13,616329];	RCV000146099.2 [benign]; RCV000262909.1 [likely benign]; RCV000315713.1 [likely benign]; RCV000357357.1 [likely benign]; 			929	1023					KCNJ11 (inh=AR+AD pLI=0.31)
chr11	17408838	17408838	G	C	het	anno_omim	QUAL=9816;DP=276;AF=0.47;MQM=59;TRIO=HET,276,0.47,WT,413,0.00,HET,495,0.51	KCNJ11	synonymous	KCNJ11:ENST00000339994:synonymous:LOW:exon1/1:c.801C>G:p.Leu267Leu,KCNJ11:ENST00000528731:synonymous:LOW:exon2/2:c.540C>G:p.Leu180Leu		rs5216	0.0134	0.0174	26,12,0	0.0043,0.0105,0.0000,0.0220,0.0242	0.0170							600937 [KCNJ11 (confirmed) Hyperinsulinemic hypoglycemia,familial,2,601820|Diabetes,permanent neonatal,with or without neurologic features,606176|Diabetes mellitus,type 2,susceptibility to,125853|Diabetes mellitus,transient neonatal,3,610582|Maturity-onset diabetes of the young,type 13,616329];	RCV000146118.3 [benign]; RCV000289500.1 [likely benign]; RCV000351492.1 [likely benign]; RCV000381795.1 [likely benign]; 	CM156016 [CLASS=R MUT=ALT PHEN="Hyperinsulinaemic hypoglycaemia" GENE=KCNJ11]; 		2	101					KCNJ11 (inh=AR+AD pLI=0.31)
chr11	17409069	17409069	G	A	het	anno_omim	QUAL=6285;DP=215;AF=0.49;MQM=60;TRIO=HET,215,0.49,HET,313,0.50,WT,384,0.00	KCNJ11	synonymous	KCNJ11:ENST00000339994:synonymous:LOW:exon1/1:c.570C>T:p.Ala190Ala,KCNJ11:ENST00000528731:synonymous:LOW:exon2/2:c.309C>T:p.Ala103Ala		rs5218	0.2274	0.2582	4538,2773,34	0.0646,0.1315,0.4879,0.2958,0.1631	0.2592							600937 [KCNJ11 (confirmed) Hyperinsulinemic hypoglycemia,familial,2,601820|Diabetes,permanent neonatal,with or without neurologic features,606176|Diabetes mellitus,type 2,susceptibility to,125853|Diabetes mellitus,transient neonatal,3,610582|Maturity-onset diabetes of the young,type 13,616329];	RCV000146111.2 [benign]; RCV000300958.1 [likely benign]; RCV000353536.1 [likely benign]; RCV000398496.1 [likely benign]; 		COSM3752262	152	804					KCNJ11 (inh=AR+AD pLI=0.31)
chr11	17409572	17409572	T	C	hom	pred_pathogenic;anno_omim	QUAL=22496;DP=234;AF=1.00;MQM=59;TRIO=HOM,234,1.00,HOM,377,0.99,HET,439,0.49	KCNJ11	missense,intron	KCNJ11:ENST00000339994:missense:MODERATE:exon1/1:c.67A>G:p.Lys23Glu,KCNJ11:ENST00000528731:intron:MODIFIER:exon1/1:c.-16-179A>G:		rs5219	0.7370	0.6471	25897,13054,4555	0.9367,0.6110,0.6401,0.6261,0.6275	0.7081	2.0650	T	T	B	D	0.13	600937 [KCNJ11 (confirmed) Hyperinsulinemic hypoglycemia,familial,2,601820|Diabetes,permanent neonatal,with or without neurologic features,606176|Diabetes mellitus,type 2,susceptibility to,125853|Diabetes mellitus,transient neonatal,3,610582|Maturity-onset diabetes of the young,type 13,616329];	RCV000009214.4 [other]; RCV000009215.4 [drug response]; RCV000020356.2 [benign]; RCV000146116.3 [benign]; RCV000281825.1 [other]; RCV000294608.1 [other]; RCV000385348.1 [likely benign]; 		COSM3765554	928	1024					KCNJ11 (inh=AR+AD pLI=0.31)
chr11	17410136	17410136	A	G	het	anno_omim	QUAL=619;DP=57;AF=0.51;MQM=55;TRIO=HET,57,0.51,WT,24,0.00,HET,39,0.18	KCNJ11	5'UTR,intron	KCNJ11:ENST00000339994:5'UTR:MODIFIER:exon1/1:c.-498T>C:,KCNJ11:ENST00000528731:intron:MODIFIER:exon1/1:c.-17+585T>C:	AluSg	rs529946415	0.0030	0.0000	0,0,0	0,0,0,0,0	0.0038							600937 [KCNJ11 (confirmed) Hyperinsulinemic hypoglycemia,familial,2,601820|Diabetes,permanent neonatal,with or without neurologic features,606176|Diabetes mellitus,type 2,susceptibility to,125853|Diabetes mellitus,transient neonatal,3,610582|Maturity-onset diabetes of the young,type 13,616329];	RCV000270522.1 [other]; RCV000307819.1 [other]; RCV000310444.1 [uncertain significance]; RCV000404230.1 [likely benign]; 			0	2					KCNJ11 (inh=AR+AD pLI=0.31)
chr11	17410145	17410145	A	-	het	anno_omim	QUAL=752;DP=46;AF=0.50;MQM=57;TRIO=HET,46,0.50,HET,19,0.63,WT,31,0.00	KCNJ11	5'UTR,intron	KCNJ11:ENST00000339994:5'UTR:MODIFIER:exon1/1:c.-507delT:,KCNJ11:ENST00000528731:intron:MODIFIER:exon1/1:c.-17+576delT:	AluSg	rs397808534	0.0000	0.0000	0,0,0	0,0,0,0,0	0.4456							600937 [KCNJ11 (confirmed) Hyperinsulinemic hypoglycemia,familial,2,601820|Diabetes,permanent neonatal,with or without neurologic features,606176|Diabetes mellitus,type 2,susceptibility to,125853|Diabetes mellitus,transient neonatal,3,610582|Maturity-onset diabetes of the young,type 13,616329];				17	88					KCNJ11 (inh=AR+AD pLI=0.31)
chr11	17418477	17418477	C	A	hom	pred_pathogenic;anno_omim	QUAL=12018;DP=118;AF=0.97;MQM=60;TRIO=HOM,118,0.97,HOM,198,0.99,HET,331,0.46	ABCC8	missense	ABCC8:ENST00000302539:missense:MODERATE:exon33/39:c.4108G>T:p.Ala1370Ser,ABCC8:ENST00000389817:missense:MODERATE:exon33/39:c.4105G>T:p.Ala1369Ser		rs757110	0.7264	0.6431	25565,12982,4579	0.9382,0.6094,0.6206,0.6246,0.6155	0.7072	0.1700	T,T,.	T,T	B,.	D,D,.	10.25	600509 [ABCC8 (confirmed) Hyperinsulinemic hypoglycemia,familial,1,256450|Hypoglycemia of infancy,leucine-sensitive,240800|Diabetes mellitus,transient neonatal 2,610374|Diabetes mellitus,noninsulin-dependent,125853|Diabetes mellitus,permanent neonatal,606176];	RCV000144996.2 [other]; RCV000269263.1 [benign]; RCV000326750.1 [benign]; RCV000388290.1 [benign]; 			890	992					ABCC8 (inh=AR+AD pLI=0.00)
chr11	17419279	17419279	C	T	het	anno_omim	QUAL=5196;DP=126;AF=0.58;MQM=59;TRIO=HET,126,0.58,WT,131,0.00,HET,218,0.61	ABCC8	synonymous	ABCC8:ENST00000302539:synonymous:LOW:exon31/39:c.3822G>A:p.Arg1274Arg,ABCC8:ENST00000389817:synonymous:LOW:exon31/39:c.3819G>A:p.Arg1273Arg		rs1799859	0.3910	0.2962	6572,2174,2599	0.7098,0.3876,0.0875,0.2582,0.2906	0.3631	0.3110		T			16.01	600509 [ABCC8 (confirmed) Hyperinsulinemic hypoglycemia,familial,1,256450|Hypoglycemia of infancy,leucine-sensitive,240800|Diabetes mellitus,transient neonatal 2,610374|Diabetes mellitus,noninsulin-dependent,125853|Diabetes mellitus,permanent neonatal,606176];	RCV000144994.3 [other]; RCV000276828.1 [benign]; RCV000330489.1 [benign]; RCV000389902.1 [benign]; 	CM981881 [CLASS=DP MUT=ALT PHEN="Hyperinsulinaemia association with" GENE=ABCC8]; 	COSM3752264	210	892					ABCC8 (inh=AR+AD pLI=0.00)
chr11	17448704	17448704	G	A	het	anno_omim	QUAL=3423;DP=141;AF=0.44;MQM=60;TRIO=HET,141,0.44,HET,225,0.44,WT,340,0.00	ABCC8	splice_region&intron	ABCC8:ENST00000302539:splice_region&intron:LOW:exon15/38:c.2117-3C>T:,ABCC8:ENST00000389817:splice_region&intron:LOW:exon15/38:c.2117-3C>T:		rs1799854	0.3684	0.4346	11790,6320,135	0.1699,0.6263,0.5997,0.4455,0.3308	0.4404							600509 [ABCC8 (confirmed) Hyperinsulinemic hypoglycemia,familial,1,256450|Hypoglycemia of infancy,leucine-sensitive,240800|Diabetes mellitus,transient neonatal 2,610374|Diabetes mellitus,noninsulin-dependent,125853|Diabetes mellitus,permanent neonatal,606176];	RCV000144983.3 [other]; RCV000306691.1 [benign]; RCV000341582.1 [benign]; RCV000396912.1 [benign]; 	CS991507 [CLASS=DP MUT=ALT PHEN="Diabetes mellitus 2 association with" GENE=ABCC8]; 		405	990					ABCC8 (inh=AR+AD pLI=0.00)
chr11	17496516	17496516	A	G	het	anno_omim	QUAL=8988;DP=331;AF=0.50;MQM=59;TRIO=HET,331,0.50,HET,407,0.45,WT,532,0.00	ABCC8	synonymous	ABCC8:ENST00000302539:synonymous:LOW:exon2/39:c.207T>C:p.Pro69Pro,ABCC8:ENST00000389817:synonymous:LOW:exon2/39:c.207T>C:p.Pro69Pro		rs1048099	0.4393	0.4740	13970,8522,818	0.4001,0.5634,0.3640,0.5018,0.4658	0.4751							600509 [ABCC8 (confirmed) Hyperinsulinemic hypoglycemia,familial,1,256450|Hypoglycemia of infancy,leucine-sensitive,240800|Diabetes mellitus,transient neonatal 2,610374|Diabetes mellitus,noninsulin-dependent,125853|Diabetes mellitus,permanent neonatal,606176];	RCV000144982.3 [other]; RCV000314568.1 [benign]; RCV000334473.1 [benign]; RCV000405380.1 [benign]; 	CM129527 [CLASS=DFP MUT=ALT PHEN="Diabetes mellitus protection against" GENE=ABCC8]; 	COSM3752266	570	1031					ABCC8 (inh=AR+AD pLI=0.00)
chr11	17515459	17515459	-	TGTT	hom	anno_omim	QUAL=8861;DP=150;AF=0.94;MQM=59;TRIO=HOM,150,0.94,HOM,71,1.00,HET,81,0.48	USH1C	3'UTR	USH1C:ENST00000318024:3'UTR:MODIFIER:exon21/21:c.*451_*452insAACA:,USH1C:ENST00000527720:3'UTR:MODIFIER:exon20/20:c.*451_*452insAACA:,USH1C:ENST00000527020:3'UTR:MODIFIER:exon20/20:c.*451_*452insAACA:		rs10649542	0.9453	0.0000	0,0,0	0,0,0,0,0	0.9534							605242 [USH1C (confirmed) Usher syndrome,type 1C,276904|Deafness,autosomal recessive 18A,602092];	RCV000292469.1 [benign]; RCV000347392.1 [benign]; 			221	11					USH1C (inh=AR pLI=0.00)
chr11	17515668	17515668	T	C	het	anno_omim	QUAL=8900;DP=324;AF=0.48;MQM=59;TRIO=HET,324,0.48,HET,430,0.47,WT,575,0.00	USH1C	3'UTR	USH1C:ENST00000318024:3'UTR:MODIFIER:exon21/21:c.*243A>G:,USH1C:ENST00000527720:3'UTR:MODIFIER:exon20/20:c.*243A>G:,USH1C:ENST00000527020:3'UTR:MODIFIER:exon20/20:c.*243A>G:		rs1055581	0.3826	0.0000	0,0,0	0,0,0,0,0	0.4466							605242 [USH1C (confirmed) Usher syndrome,type 1C,276904|Deafness,autosomal recessive 18A,602092];	RCV000303954.1 [likely benign]; RCV000358662.1 [likely benign]; 			54	113					USH1C (inh=AR pLI=0.00)
chr11	17515693	17515693	G	A	het	anno_omim	QUAL=9016;DP=324;AF=0.47;MQM=59;TRIO=HET,324,0.47,HET,434,0.48,WT,584,0.00	USH1C	3'UTR	USH1C:ENST00000318024:3'UTR:MODIFIER:exon21/21:c.*218C>T:,USH1C:ENST00000527720:3'UTR:MODIFIER:exon20/20:c.*218C>T:,USH1C:ENST00000527020:3'UTR:MODIFIER:exon20/20:c.*218C>T:		rs1055577	0.3666	0.0000	0,0,0	0,0,0,0,0	0.4329							605242 [USH1C (confirmed) Usher syndrome,type 1C,276904|Deafness,autosomal recessive 18A,602092];	RCV000264175.1 [likely benign]; RCV000319324.1 [likely benign]; 			53	113					USH1C (inh=AR pLI=0.00)
chr11	17515833	17515833	A	G	het	anno_omim	QUAL=7290;DP=284;AF=0.52;MQM=59;TRIO=HET,284,0.52,HET,308,0.49,WT,441,0.00	USH1C	3'UTR	USH1C:ENST00000318024:3'UTR:MODIFIER:exon21/21:c.*78T>C:,USH1C:ENST00000527720:3'UTR:MODIFIER:exon20/20:c.*78T>C:,USH1C:ENST00000527020:3'UTR:MODIFIER:exon20/20:c.*78T>C:		rs1055574	0.3704	0.4536	8142,5336,674	0.4329,0.3497,0.3338,0.4983,0.3940	0.4373							605242 [USH1C (confirmed) Usher syndrome,type 1C,276904|Deafness,autosomal recessive 18A,602092];	RCV000244578.1 [benign]; RCV000294252.1 [likely benign]; RCV000330604.1 [likely benign]; 			368	968					USH1C (inh=AR pLI=0.00)
chr11	17519742	17519742	C	G	het	pred_pathogenic;anno_omim	QUAL=8770;DP=370;AF=0.48;MQM=59;TRIO=HET,370,0.48,HET,365,0.49,WT,584,0.00	USH1C	missense	USH1C:ENST00000005226:missense:MODERATE:exon24/27:c.2457G>C:p.Glu819Asp,USH1C:ENST00000318024:missense:MODERATE:exon19/21:c.1557G>C:p.Glu519Asp,USH1C:ENST00000527720:missense:MODERATE:exon18/20:c.1464G>C:p.Glu488Asp,USH1C:ENST00000527020:missense:MODERATE:exon18/20:c.1500G>C:p.Glu500Asp		rs1064074	0.4209	0.4875	14857,10035,925	0.4213,0.3533,0.3068,0.5497,0.4496	0.4841	0.6000	T,T,D,D	T	B,B,B	T,T,T,T	24.40	605242 [USH1C (confirmed) Usher syndrome,type 1C,276904|Deafness,autosomal recessive 18A,602092];	RCV000041279.3 [benign]; RCV000302668.1 [likely benign]; RCV000390848.1 [likely benign]; 		COSM3736036, COSM3736035	577	1017					USH1C (inh=AR pLI=0.00)
chr11	17542439	17542439	T	C	hom	anno_omim	QUAL=20959;DP=222;AF=0.99;MQM=59;TRIO=HOM,222,0.99,HET,255,0.51,HOM,348,0.99	USH1C	synonymous	USH1C:ENST00000005226:synonymous:LOW:exon14/27:c.1188A>G:p.Pro396Pro,USH1C:ENST00000318024:synonymous:LOW:exon14/21:c.1188A>G:p.Pro396Pro,USH1C:ENST00000527720:synonymous:LOW:exon13/20:c.1095A>G:p.Pro365Pro,USH1C:ENST00000527020:synonymous:LOW:exon13/20:c.1131A>G:p.Pro377Pro		rs2240487	0.5164	0.5689	20210,11477,602	0.3400,0.6779,0.6642,0.5850,0.5198	0.5762							605242 [USH1C (confirmed) Usher syndrome,type 1C,276904|Deafness,autosomal recessive 18A,602092];	RCV000041251.3 [benign]; RCV000351095.1 [likely benign]; RCV000395027.1 [likely benign]; 		COSM4145600, COSM4145599	688	1009					USH1C (inh=AR pLI=0.00)
chr11	22214877	22214877	-	AGGAGGAGGGGAATGAGGAGGAGG	het	anno_omim	QUAL=6989;DP=78;AF=0.28;MQM=59;TRIO=HET,78,0.28,WT,296,0.00,HOM,251,0.96	ANO5	5'UTR	ANO5:ENST00000324559:5'UTR:MODIFIER:exon1/22:c.-156_-155insAGGGGAATGAGGAGGAGGAGGAGG:	GA-rich	rs139514865;rs71034576	0.7814	0.0000	0,0,0	0,0,0,0,0	0.0000							608662 [ANO5 (confirmed) Gnathodiaphyseal dysplasia,166260|Muscular dystrophy,limb-girdle,type 2L,611307|Miyoshi muscular dystrophy 3,613319];				307	128					ANO5 (inh=AR+AD pLI=0.00)
chr11	22214903	22214903	G	C	het	anno_omim	QUAL=9448;DP=67;AF=0.45;MQM=59;TRIO=HET,67,0.45,WT,289,0.00,HOM,299,1.00	ANO5	5'UTR	ANO5:ENST00000324559:5'UTR:MODIFIER:exon1/22:c.-136G>C:	GA-rich	rs12792259	0.7899	0.0000	0,0,0	0,0,0,0,0	0.8311							608662 [ANO5 (confirmed) Gnathodiaphyseal dysplasia,166260|Muscular dystrophy,limb-girdle,type 2L,611307|Miyoshi muscular dystrophy 3,613319];	RCV000128763.1 [not provided]; RCV000267576.1 [benign]; RCV000301651.1 [benign]; RCV000406447.1 [benign]; 			313	135					ANO5 (inh=AR+AD pLI=0.00)
chr11	22242729	22242729	T	C	het	anno_omim	QUAL=13430;DP=368;AF=0.57;MQM=60;TRIO=HET,368,0.57,WT,203,0.01,HOM,230,1.00	ANO5	synonymous	ANO5:ENST00000324559:synonymous:LOW:exon5/22:c.267T>C:p.Asp89Asp		rs4312063	0.7899	0.7772	37046,21355,4526	0.9336,0.5884,0.5576,0.8026,0.8030	0.8322							608662 [ANO5 (confirmed) Gnathodiaphyseal dysplasia,166260|Muscular dystrophy,limb-girdle,type 2L,611307|Miyoshi muscular dystrophy 3,613319];	RCV000082848.7 [benign]; RCV000128783.1 [not provided]; RCV000282244.1 [benign]; RCV000334993.1 [benign]; 		COSM3998372	1383	659					ANO5 (inh=AR+AD pLI=0.00)
chr11	22271870	22271870	A	T	het	anno_omim	QUAL=7567;DP=188;AF=0.46;MQM=60;TRIO=HET,188,0.46,WT,146,0.00,HOM,161,0.99	ANO5	missense	ANO5:ENST00000324559:missense:MODERATE:exon10/22:c.966A>T:p.Leu322Phe		rs7481951	0.0000	0.4835	15551,11314,142	0.1630,0.2840,0.1824,0.5892,0.5057	0.4801	-0.0010	T	T	B	T	13.12	608662 [ANO5 (confirmed) Gnathodiaphyseal dysplasia,166260|Muscular dystrophy,limb-girdle,type 2L,611307|Miyoshi muscular dystrophy 3,613319];	RCV000082855.8 [benign]; RCV000128791.1 [not provided]; RCV000261985.1 [likely benign]; RCV000386589.1 [likely benign]; 		COSM3998373	674	1020					ANO5 (inh=AR+AD pLI=0.00)
chr11	22301411	22301412	TT	-	hom	anno_omim	QUAL=3247;DP=131;AF=0.37;MQM=59;TRIO=HOM,131,0.37,WT,33,0.88,HOM,51,0.02	ANO5	3'UTR	ANO5:ENST00000324559:3'UTR:MODIFIER:exon22/22:c.*112_*113delTT:	(T)n	rs398015551;rs67178076	0.0000	0.0000	0,0,0	0,0,0,0,0	0.5410							608662 [ANO5 (confirmed) Gnathodiaphyseal dysplasia,166260|Muscular dystrophy,limb-girdle,type 2L,611307|Miyoshi muscular dystrophy 3,613319];	RCV000268860.1 [uncertain significance]; RCV000364161.1 [uncertain significance]; 			138	55					ANO5 (inh=AR+AD pLI=0.00)
chr11	22301807	22301807	A	G	het	anno_omim	QUAL=11079;DP=321;AF=0.55;MQM=60;TRIO=HET,321,0.55,WT,136,0.00,HOM,182,1.00	ANO5	3'UTR	ANO5:ENST00000324559:3'UTR:MODIFIER:exon22/22:c.*496A>G:		rs10766930	0.4441	0.0000	0,0,0	0,0,0,0,0	0.5448							608662 [ANO5 (confirmed) Gnathodiaphyseal dysplasia,166260|Muscular dystrophy,limb-girdle,type 2L,611307|Miyoshi muscular dystrophy 3,613319];	RCV000307969.1 [likely benign]; RCV000366171.1 [likely benign]; 			90	115					ANO5 (inh=AR+AD pLI=0.00)
chr11	22302597	22302597	G	T	het	anno_omim	QUAL=7443;DP=223;AF=0.47;MQM=60;TRIO=HET,223,0.47,WT,116,0.01,HOM,144,1.00	ANO5	3'UTR	ANO5:ENST00000324559:3'UTR:MODIFIER:exon22/22:c.*1286G>T:		rs7925081	0.5675	0.0000	0,0,0	0,0,0,0,0	0.6590							608662 [ANO5 (confirmed) Gnathodiaphyseal dysplasia,166260|Muscular dystrophy,limb-girdle,type 2L,611307|Miyoshi muscular dystrophy 3,613319];	RCV000346894.1 [likely benign]; RCV000402414.1 [likely benign]; 			93	110					ANO5 (inh=AR+AD pLI=0.00)
chr11	22303068	22303068	A	-	het	anno_omim	QUAL=12520;DP=245;AF=0.49;MQM=60;TRIO=HET,245,0.49,WT,226,0.00,HOM,303,0.99	ANO5	3'UTR	ANO5:ENST00000324559:3'UTR:MODIFIER:exon22/22:c.*1762delA:		rs398015552	0.4702	0.0000	0,0,0	0,0,0,0,0	0.5652							608662 [ANO5 (confirmed) Gnathodiaphyseal dysplasia,166260|Muscular dystrophy,limb-girdle,type 2L,611307|Miyoshi muscular dystrophy 3,613319];	RCV000335659.1 [likely benign]; RCV000400689.1 [likely benign]; 			89	115					ANO5 (inh=AR+AD pLI=0.00)
chr11	22303201	22303204	AAGA	-	het	anno_omim	QUAL=13829;DP=277;AF=0.55;MQM=59;TRIO=HET,277,0.55,WT,226,0.00,HOM,322,1.00	ANO5	3'UTR	ANO5:ENST00000324559:3'UTR:MODIFIER:exon22/22:c.*1894_*1897delAAGA:		rs397786204	0.4527	0.0000	0,0,0	0,0,0,0,0	0.5489							608662 [ANO5 (confirmed) Gnathodiaphyseal dysplasia,166260|Muscular dystrophy,limb-girdle,type 2L,611307|Miyoshi muscular dystrophy 3,613319];	RCV000301948.1 [likely benign]; RCV000401485.1 [likely benign]; 			89	115					ANO5 (inh=AR+AD pLI=0.00)
chr11	22303406	22303406	G	A	het	anno_omim	QUAL=8189;DP=398;AF=0.51;MQM=60;TRIO=HET,398,0.51,HOM,76,1.00,WT,119,0.00	ANO5	3'UTR	ANO5:ENST00000324559:3'UTR:MODIFIER:exon22/22:c.*2095G>A:		rs142192440	0.0052	0.0000	0,0,0	0,0,0,0,0	0.0161							608662 [ANO5 (confirmed) Gnathodiaphyseal dysplasia,166260|Muscular dystrophy,limb-girdle,type 2L,611307|Miyoshi muscular dystrophy 3,613319];	RCV000271617.1 [uncertain significance]; RCV000328962.1 [uncertain significance]; 			1	9					ANO5 (inh=AR+AD pLI=0.00)
chr11	22304489	22304489	C	G	het	anno_omim	QUAL=7759;DP=219;AF=0.49;MQM=60;TRIO=HET,219,0.49,WT,94,0.00,HOM,148,1.00	ANO5	3'UTR	ANO5:ENST00000324559:3'UTR:MODIFIER:exon22/22:c.*3178C>G:		rs6483841	0.6929	0.0000	0,0,0	0,0,0,0,0	0.7274							608662 [ANO5 (confirmed) Gnathodiaphyseal dysplasia,166260|Muscular dystrophy,limb-girdle,type 2L,611307|Miyoshi muscular dystrophy 3,613319];	RCV000259448.1 [benign]; RCV000370241.1 [benign]; 			104	103					ANO5 (inh=AR+AD pLI=0.00)
chr11	22644893	22644893	-	T	hom	anno_omim	QUAL=7748;DP=181;AF=0.99;MQM=59;TRIO=HOM,181,0.99,HOM,31,1.00,HOM,28,1.00	FANCF	3'UTR	FANCF:ENST00000327470:3'UTR:MODIFIER:exon1/1:c.*1338dupA:		rs45554234	0.0000	0.0000	0,0,0	0,0,0,0,0	0.9594							613897 [FANCF (provisional) Fanconi anemia,complementation group F,603467];	RCV000329822.1 [uncertain significance]; 			229	3					FANCF (inh=AR pLI=0.00)
chr11	22645413	22645413	G	A	hom	anno_omim	QUAL=5736;DP=101;AF=0.92;MQM=59;TRIO=HOM,101,0.92,HOM,55,1.00,HOM,64,0.98	FANCF	3'UTR	FANCF:ENST00000327470:3'UTR:MODIFIER:exon1/1:c.*819C>T:	AluSx3	rs450946	0.9491	0.0000	0,0,0	0,0,0,0,0	0.9660							613897 [FANCF (provisional) Fanconi anemia,complementation group F,603467];	RCV000372401.1 [benign]; 			195	0					FANCF (inh=AR pLI=0.00)
chr11	22645600	22645600	C	T	hom	anno_omim	QUAL=9065;DP=174;AF=1.00;MQM=60;TRIO=HOM,174,1.00,HOM,46,1.00,HOM,63,1.00	FANCF	3'UTR	FANCF:ENST00000327470:3'UTR:MODIFIER:exon1/1:c.*632G>A:		rs444923	0.9714	0.0000	0,0,0	0,0,0,0,0	0.9707							613897 [FANCF (provisional) Fanconi anemia,complementation group F,603467];	RCV000341199.1 [benign]; 			232	0					FANCF (inh=AR pLI=0.00)
chr11	22646025	22646025	G	A	hom	anno_omim	QUAL=26262;DP=383;AF=0.99;MQM=59;TRIO=HOM,383,0.99,HOM,194,1.00,HOM,215,1.00	FANCF	3'UTR	FANCF:ENST00000327470:3'UTR:MODIFIER:exon1/1:c.*207C>T:		rs4447177	0.7037	0.0000	0,0,0	0,0,0,0,0	0.7326							613897 [FANCF (provisional) Fanconi anemia,complementation group F,603467];	RCV000274375.1 [benign]; 			154	64					FANCF (inh=AR pLI=0.00)
chr11	30352473	30352473	-	AG	hom		QUAL=13795;DP=217;AF=0.99;MQM=59;TRIO=HOM,217,0.99,HOM,105,0.99,HOM,131,0.99	ARL14EP	5'UTR	ARL14EP:ENST00000282032:5'UTR:MODIFIER:exon2/4:c.-23_-22insAG:		rs35824273	0.0000	0.6882	28383,13960,3255	0.8044,0.6255,0.8996,0.6559,0.6871	0.7054											830	901					ARL14EP (inh=n/a pLI=0.15)
chr11	30358475	30358475	A	T	hom		QUAL=19051;DP=316;AF=1.00;MQM=59;TRIO=HOM,316,1.00,HOM,128,1.00,HOM,135,1.00	ARL14EP	3'UTR	ARL14EP:ENST00000282032:3'UTR:MODIFIER:exon4/4:c.*133A>T:		rs1222206	1.0000	0.0000	0,0,0	0,0,0,0,0	1.0000											230	2					ARL14EP (inh=n/a pLI=0.15)
chr11	31807524	31807524	C	T	hom	anno_omim	QUAL=19723;DP=270;AF=1.00;MQM=60;TRIO=HOM,270,1.00,HOM,133,1.00,HOM,182,1.00	PAX6	3'UTR	PAX6:ENST00000419022:3'UTR:MODIFIER:exon14/14:c.*3958G>A:		rs3026401	0.6432	0.0000	0,0,0	0,0,0,0,0	0.7094							607108 [PAX6 (confirmed) Aniridia,106210|Cataract with late-onset corneal dystrophy,106210|Anterior segment dysgenesis 5,multiple subtypes,604229|Foveal hypoplasia 1,136520|Keratitis,148190|Optic nerve hypoplasia,165550|Morning glory disc anomaly,120430|Coloboma of optic nerve,120430|Coloboma,ocular,120200];	RCV000272675.1 [benign]; RCV000273772.1 [benign]; RCV000307913.1 [benign]; RCV000327646.1 [benign]; RCV000333466.1 [benign]; RCV000362607.1 [benign]; RCV000386873.1 [benign]; 			148	89					PAX6 (inh=AR+AD pLI=1.00)
chr11	31808235	31808235	-	AAAA	hom	anno_omim	QUAL=16640;DP=196;AF=0.98;MQM=59;TRIO=HOM,196,0.98,HOM,141,0.98,HOM,183,0.99	PAX6,Z83307.3	3'UTR	PAX6:ENST00000419022:3'UTR:MODIFIER:exon14/14:c.*3246_*3247insTTTT:		rs34919147;rs397768344	0.4946	0.0000	0,0,0	0,0,0,0,0	0.7106							607108 [PAX6 (confirmed) Aniridia,106210|Cataract with late-onset corneal dystrophy,106210|Anterior segment dysgenesis 5,multiple subtypes,604229|Foveal hypoplasia 1,136520|Keratitis,148190|Optic nerve hypoplasia,165550|Morning glory disc anomaly,120430|Coloboma of optic nerve,120430|Coloboma,ocular,120200];	RCV000270087.1 [benign]; RCV000299243.1 [benign]; RCV000305344.1 [benign]; RCV000358681.1 [benign]; RCV000359957.1 [benign]; RCV000392032.1 [benign]; RCV000392047.1 [benign]; 			143	95					PAX6 (inh=AR+AD pLI=1.00), Z83307.3 (inh=n/a pLI=n/a)
chr11	31808280	31808280	C	T	hom	anno_omim	QUAL=18260;DP=226;AF=1.00;MQM=59;TRIO=HOM,226,1.00,HOM,150,1.00,HOM,184,1.00	PAX6,Z83307.3	3'UTR	PAX6:ENST00000419022:3'UTR:MODIFIER:exon14/14:c.*3202G>A:		rs608293	0.8498	0.0000	0,0,0	0,0,0,0,0	0.8759							607108 [PAX6 (confirmed) Aniridia,106210|Cataract with late-onset corneal dystrophy,106210|Anterior segment dysgenesis 5,multiple subtypes,604229|Foveal hypoplasia 1,136520|Keratitis,148190|Optic nerve hypoplasia,165550|Morning glory disc anomaly,120430|Coloboma of optic nerve,120430|Coloboma,ocular,120200];	RCV000271960.1 [benign]; RCV000277532.1 [benign]; RCV000325808.1 [benign]; RCV000331769.1 [benign]; RCV000332589.1 [benign]; RCV000366442.1 [benign]; RCV000386337.1 [benign]; 			185	64					PAX6 (inh=AR+AD pLI=1.00), Z83307.3 (inh=n/a pLI=n/a)
chr11	31808585	31808585	-	AAAT	hom	anno_omim	QUAL=15487;DP=224;AF=1.00;MQM=59;TRIO=HOM,224,1.00,HOM,108,1.00,HOM,151,0.99	PAX6	3'UTR	PAX6:ENST00000419022:3'UTR:MODIFIER:exon14/14:c.*2893_*2896dupATTT:	(ATAA)n	rs10623053;rs397795797	0.8478	0.0000	0,0,0	0,0,0,0,0	0.8748							607108 [PAX6 (confirmed) Aniridia,106210|Cataract with late-onset corneal dystrophy,106210|Anterior segment dysgenesis 5,multiple subtypes,604229|Foveal hypoplasia 1,136520|Keratitis,148190|Optic nerve hypoplasia,165550|Morning glory disc anomaly,120430|Coloboma of optic nerve,120430|Coloboma,ocular,120200];	RCV000279797.1 [benign]; RCV000295258.1 [benign]; RCV000330541.1 [benign]; RCV000337230.1 [benign]; RCV000352420.1 [benign]; RCV000387389.1 [benign]; RCV000401427.1 [benign]; 			182	63					PAX6 (inh=AR+AD pLI=1.00)
chr11	31808775	31808775	G	A	het	anno_omim	QUAL=11224;DP=299;AF=0.50;MQM=59;TRIO=HET,299,0.50,HOM,246,0.99,WT,285,0.00	PAX6	3'UTR	PAX6:ENST00000419022:3'UTR:MODIFIER:exon14/14:c.*2707C>T:		rs3026398	0.1540	0.0000	0,0,0	0,0,0,0,0	0.2285							607108 [PAX6 (confirmed) Aniridia,106210|Cataract with late-onset corneal dystrophy,106210|Anterior segment dysgenesis 5,multiple subtypes,604229|Foveal hypoplasia 1,136520|Keratitis,148190|Optic nerve hypoplasia,165550|Morning glory disc anomaly,120430|Coloboma of optic nerve,120430|Coloboma,ocular,120200];	RCV000276213.1 [benign]; RCV000306938.1 [benign]; RCV000311393.1 [benign]; RCV000314986.1 [benign]; RCV000363855.1 [benign]; RCV000368371.1 [benign]; RCV000392121.1 [benign]; 			18	93					PAX6 (inh=AR+AD pLI=1.00)
chr11	31809322	31809322	C	T	het	anno_omim	QUAL=10656;DP=276;AF=0.53;MQM=60;TRIO=HET,276,0.53,WT,166,0.01,HOM,208,1.00	PAX6	3'UTR	PAX6:ENST00000419022:3'UTR:MODIFIER:exon14/14:c.*2160G>A:		rs12421026	0.4479	0.0000	0,0,0	0,0,0,0,0	0.4373							607108 [PAX6 (confirmed) Aniridia,106210|Cataract with late-onset corneal dystrophy,106210|Anterior segment dysgenesis 5,multiple subtypes,604229|Foveal hypoplasia 1,136520|Keratitis,148190|Optic nerve hypoplasia,165550|Morning glory disc anomaly,120430|Coloboma of optic nerve,120430|Coloboma,ocular,120200];	RCV000267117.1 [benign]; RCV000270682.1 [benign]; RCV000282254.1 [benign]; RCV000322069.1 [benign]; RCV000325742.1 [benign]; RCV000376648.1 [benign]; RCV000380270.1 [benign]; 			62	127					PAX6 (inh=AR+AD pLI=1.00)
chr11	31810298	31810298	T	A	hom	anno_omim	QUAL=28875;DP=397;AF=1.00;MQM=60;TRIO=HOM,397,1.00,HOM,201,1.00,HOM,281,1.00	PAX6	3'UTR	PAX6:ENST00000419022:3'UTR:MODIFIER:exon14/14:c.*1184A>T:		rs1506	0.6609	0.0000	0,0,0	0,0,0,0,0	0.7235							607108 [PAX6 (confirmed) Aniridia,106210|Cataract with late-onset corneal dystrophy,106210|Anterior segment dysgenesis 5,multiple subtypes,604229|Foveal hypoplasia 1,136520|Keratitis,148190|Optic nerve hypoplasia,165550|Morning glory disc anomaly,120430|Coloboma of optic nerve,120430|Coloboma,ocular,120200];	RCV000280988.1 [benign]; RCV000286998.1 [benign]; RCV000298746.1 [benign]; RCV000338402.1 [benign]; RCV000339784.1 [benign]; RCV000398435.1 [benign]; RCV000399005.1 [benign]; 			149	88					PAX6 (inh=AR+AD pLI=1.00)
chr11	32456298	32456298	G	A	het	anno_omim	QUAL=2439;DP=75;AF=0.36;MQM=60;TRIO=HET,75,0.36,HET,170,0.49,WT,234,0.00	WT1	synonymous	WT1:ENST00000332351:synonymous:LOW:exon1/10:c.594C>T:p.Asn198Asn,WT1:ENST00000448076:synonymous:LOW:exon1/10:c.594C>T:p.Asn198Asn		rs2234583	0.1212	0.0806	598,148,366	0.2917,0.0438,0.0036,0.0701,0.0744	0.1243							607102 [WT1 (confirmed) Wilms tumor,type 1,194070|Denys-Drash syndrome,194080|Nephrotic syndrome,type 4,256370|Frasier syndrome,136680|Meacham syndrome,608978|Mesothelioma,somatic,156240];	RCV000247609.2 [benign]; RCV000293694.1 [likely benign]; RCV000348640.1 [likely benign]; RCV000393785.1 [likely benign]; RCV000403336.1 [likely benign]; 			25	343					WT1 (inh=AR+AD pLI=n/a)
chr11	32456694	32456694	C	A	het	low_DP;anno_omim	QUAL=193;DP=9;AF=0.67;MQM=60;TRIO=HET,9,0.67,HET,11,0.55,WT,11,0.00	WT1	synonymous	WT1:ENST00000332351:synonymous:LOW:exon1/10:c.198G>T:p.Pro66Pro,WT1:ENST00000448076:synonymous:LOW:exon1/10:c.198G>T:p.Pro66Pro		rs2234582	0.3017	0.3299	520,108,51	0.6047,0.0000,0.0000,0.3086,0.3304	0.2960							607102 [WT1 (confirmed) Wilms tumor,type 1,194070|Denys-Drash syndrome,194080|Nephrotic syndrome,type 4,256370|Frasier syndrome,136680|Meacham syndrome,608978|Mesothelioma,somatic,156240];	RCV000254527.2 [benign]; RCV000277367.1 [benign]; RCV000313693.1 [benign]; RCV000354183.1 [benign]; RCV000367093.1 [benign]; 		COSM4145655	167	724					WT1 (inh=AR+AD pLI=n/a)
chr11	33724780	33724780	T	C	hom	anno_omim	QUAL=18464;DP=359;AF=0.99;MQM=59;TRIO=HOM,359,0.99,HET,218,0.50,HET,293,0.51	CD59	intron	CD59:ENST00000534312:intron:MODIFIER:exon3/3:c.308-4720A>G:		rs704697	0.5096	0.0000	0,0,0	0,0,0,0,0	0.5240							107271 [CD59 (confirmed) Hemolytic anemia,CD59-mediated,with or without immune-mediated polyneuropathy,612300];				67	121					CD59 (inh=AR pLI=0.07)
chr11	33724992	33724992	T	C	hom	anno_omim	QUAL=16971;DP=334;AF=0.98;MQM=59;TRIO=HOM,334,0.98,HET,222,0.50,HET,290,0.48	CD59	intron	CD59:ENST00000534312:intron:MODIFIER:exon3/3:c.308-4932A>G:		rs1047581	0.2103	0.0000	0,0,0	0,0,0,0,0	0.2701							107271 [CD59 (confirmed) Hemolytic anemia,CD59-mediated,with or without immune-mediated polyneuropathy,612300];				24	100					CD59 (inh=AR pLI=0.07)
chr11	33726222	33726222	G	A	hom	anno_omim	QUAL=18874;DP=381;AF=0.99;MQM=60;TRIO=HOM,381,0.99,HET,248,0.49,HET,312,0.52	CD59	intron	CD59:ENST00000534312:intron:MODIFIER:exon3/3:c.307+5530C>T:	MIR	rs1546727	0.1589	0.0000	0,0,0	0,0,0,0,0	0.2265							107271 [CD59 (confirmed) Hemolytic anemia,CD59-mediated,with or without immune-mediated polyneuropathy,612300];				24	94					CD59 (inh=AR pLI=0.07)
chr11	33726290	33726290	C	A	hom	anno_omim	QUAL=12935;DP=241;AF=0.98;MQM=59;TRIO=HOM,241,0.98,HET,209,0.50,HET,266,0.51	CD59	intron	CD59:ENST00000534312:intron:MODIFIER:exon3/3:c.307+5462G>T:		rs36093484	0.1863	0.0000	0,0,0	0,0,0,0,0	0.2414							107271 [CD59 (confirmed) Hemolytic anemia,CD59-mediated,with or without immune-mediated polyneuropathy,612300];				24	97					CD59 (inh=AR pLI=0.07)
chr11	33726544	33726544	C	G	hom	anno_omim	QUAL=12829;DP=257;AF=1.00;MQM=60;TRIO=HOM,257,1.00,HET,144,0.49,HET,177,0.53	CD59	intron	CD59:ENST00000534312:intron:MODIFIER:exon3/3:c.307+5208G>C:		rs12364970	0.1571	0.0000	0,0,0	0,0,0,0,0	0.2263							107271 [CD59 (confirmed) Hemolytic anemia,CD59-mediated,with or without immune-mediated polyneuropathy,612300];				24	98					CD59 (inh=AR pLI=0.07)
chr11	33726980	33726980	A	G	hom	anno_omim	QUAL=22961;DP=345;AF=0.99;MQM=59;TRIO=HOM,345,0.99,HOM,233,0.99,HET,337,0.51	CD59	intron	CD59:ENST00000534312:intron:MODIFIER:exon3/3:c.307+4772T>C:		rs7046	0.6410	0.0000	0,0,0	0,0,0,0,0	0.6636							107271 [CD59 (confirmed) Hemolytic anemia,CD59-mediated,with or without immune-mediated polyneuropathy,612300];				83	111					CD59 (inh=AR pLI=0.07)
chr11	33728614	33728614	T	G	hom	anno_omim	QUAL=15620;DP=358;AF=0.99;MQM=60;TRIO=HOM,358,0.99,HET,146,0.48,HET,199,0.44	CD59	intron	CD59:ENST00000534312:intron:MODIFIER:exon3/3:c.307+3138A>C:		rs831618	0.5092	0.0000	0,0,0	0,0,0,0,0	0.5245							107271 [CD59 (confirmed) Hemolytic anemia,CD59-mediated,with or without immune-mediated polyneuropathy,612300];				67	120					CD59 (inh=AR pLI=0.07)
chr11	33730060	33730060	A	C	hom	anno_omim	QUAL=4099;DP=95;AF=0.98;MQM=60;TRIO=HOM,95,0.98,HET,46,0.70,HET,50,0.50	CD59	intron	CD59:ENST00000534312:intron:MODIFIER:exon3/3:c.307+1692T>G:		rs11032350	0.1583	0.0000	0,0,0	0,0,0,0,0	0.2259							107271 [CD59 (confirmed) Hemolytic anemia,CD59-mediated,with or without immune-mediated polyneuropathy,612300];				24	94					CD59 (inh=AR pLI=0.07)
chr11	33730261	33730261	G	T	hom	anno_omim	QUAL=13859;DP=198;AF=0.98;MQM=59;TRIO=HOM,198,0.98,HET,243,0.58,HET,318,0.47	CD59	3'UTR,intron	CD59:ENST00000395850:3'UTR:MODIFIER:exon4/4:c.*1411C>A:,CD59:ENST00000534312:intron:MODIFIER:exon3/3:c.307+1491C>A:		rs7357	0.1867	0.0000	0,0,0	0,0,0,0,0	0.2413							107271 [CD59 (confirmed) Hemolytic anemia,CD59-mediated,with or without immune-mediated polyneuropathy,612300];				24	99					CD59 (inh=AR pLI=0.07)
chr11	33731406	33731406	C	T	hom	anno_omim	QUAL=13732;DP=274;AF=1.00;MQM=60;TRIO=HOM,274,1.00,HET,169,0.47,HET,215,0.48	CD59	3'UTR,intron	CD59:ENST00000395850:3'UTR:MODIFIER:exon4/4:c.*266G>A:,CD59:ENST00000533403:3'UTR:MODIFIER:exon5/5:c.*415G>A:,CD59:ENST00000351554:3'UTR:MODIFIER:exon5/5:c.*266G>A:,CD59:ENST00000415002:3'UTR:MODIFIER:exon3/3:c.*266G>A:,CD59:ENST00000445143:3'UTR:MODIFIER:exon4/4:c.*266G>A:,CD59:ENST00000426650:3'UTR:MODIFIER:exon4/4:c.*266G>A:,CD59:ENST00000534312:intron:MODIFIER:exon3/3:c.307+346G>A:		rs842	0.1863	0.0000	0,0,0	0,0,0,0,0	0.2414							107271 [CD59 (confirmed) Hemolytic anemia,CD59-mediated,with or without immune-mediated polyneuropathy,612300];				25	100					CD59 (inh=AR pLI=0.07)
chr11	33757941	33757941	A	G	hom	anno_omim	QUAL=4502;DP=33;AF=0.97;MQM=60;TRIO=HOM,33,0.97,HOM,77,1.00,HET,106,0.53	CD59	5'UTR_premature_start_codon_gain,5'UTR	CD59:ENST00000395850:5'UTR_premature_start_codon_gain:LOW:exon1/4:c.-32T>C:,CD59:ENST00000533403:5'UTR_premature_start_codon_gain:LOW:exon1/5:c.-32T>C:,CD59:ENST00000351554:5'UTR_premature_start_codon_gain:LOW:exon1/5:c.-77T>C:,CD59:ENST00000527577:5'UTR_premature_start_codon_gain:LOW:exon1/5:c.-148T>C:,CD59:ENST00000528700:5'UTR_premature_start_codon_gain:LOW:exon1/6:c.-193T>C:,CD59:ENST00000395850:5'UTR:MODIFIER:exon1/4:c.-32T>C:,CD59:ENST00000533403:5'UTR:MODIFIER:exon1/5:c.-32T>C:,CD59:ENST00000351554:5'UTR:MODIFIER:exon1/5:c.-77T>C:,CD59:ENST00000527577:5'UTR:MODIFIER:exon1/5:c.-148T>C:,CD59:ENST00000528700:5'UTR:MODIFIER:exon1/6:c.-193T>C:		rs13614	0.6468	0.0000	0,0,0	0,0,0,0,0	0.6923							107271 [CD59 (confirmed) Hemolytic anemia,CD59-mediated,with or without immune-mediated polyneuropathy,612300];				94	112					CD59 (inh=AR pLI=0.07)
chr11	34937697	34937697	T	C	hom	anno_omim	QUAL=2015;DP=29;AF=0.38;MQM=59;TRIO=HOM,29,0.93,HET,41,0.56,HOM,35,1.00	PDHX,APIP	5'UTR,intron	PDHX:ENST00000448838:5'UTR:MODIFIER:exon1/11:c.-222T>C:,APIP:ENST00000278359:intron:MODIFIER:exon1/8:c.13+78A>G:,APIP:ENST00000395787:intron:MODIFIER:exon1/6:c.57+78A>G:		rs2016814	0.7722	0.0000	0,0,0	0,0,0,0,0	0.7949							608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency,245349];	RCV000290955.1 [benign]; 			145	81					PDHX (inh=AR pLI=0.00), APIP (inh=n/a pLI=0.00)
chr11	34937698	34937698	G	A	het	anno_omim	QUAL=2015;DP=29;AF=0.38;MQM=59;TRIO=HET,29,0.93,WT,41,0.56,HOM,35,1.00	PDHX,APIP	5'UTR,intron	PDHX:ENST00000448838:5'UTR:MODIFIER:exon1/11:c.-221G>A:,APIP:ENST00000278359:intron:MODIFIER:exon1/8:c.13+77C>T:,APIP:ENST00000395787:intron:MODIFIER:exon1/6:c.57+77C>T:		rs16926448	0.1927	0.0000	0,0,0	0,0,0,0,0	0.1883							608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency,245349];	RCV000348341.1 [benign]; 			10	39					PDHX (inh=AR pLI=0.00), APIP (inh=n/a pLI=0.00)
chr11	34937901	34937901	A	G	hom	anno_omim	QUAL=3895;DP=46;AF=0.96;MQM=59;TRIO=HOM,46,0.96,HET,56,0.52,HOM,65,1.00	PDHX,APIP	5'UTR_premature_start_codon_gain,5'UTR	PDHX:ENST00000448838:5'UTR_premature_start_codon_gain:LOW:exon1/11:c.-18A>G:,APIP:ENST00000395787:5'UTR:MODIFIER:exon1/7:c.-70T>C:,PDHX:ENST00000448838:5'UTR:MODIFIER:exon1/11:c.-18A>G:		rs2956112	0.7626	0.7921	20446,11997,1396	0.7980,0.6461,0.8554,0.8191,0.7543	0.7874							608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency,245349];	RCV000356024.1 [benign]; 			2011	989					PDHX (inh=AR pLI=0.00), APIP (inh=n/a pLI=0.00)
chr11	34938001	34938001	A	G	het	low_DP;anno_omim	QUAL=1138;DP=19;AF=0.58;MQM=59;TRIO=HET,19,0.58,WT,17,0.00,HOM,30,1.00	PDHX,APIP	missense,5'UTR	PDHX:ENST00000448838:missense:MODERATE:exon1/11:c.83A>G:p.Glu28Gly,APIP:ENST00000395787:5'UTR:MODIFIER:exon1/7:c.-170T>C:		rs113073242	0.1927	0.2306	33,1,30	0.4551,0.0000,0.0000,0.1648,0.1278	0.1873	0.1540	T	T	B	T	5.61	608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency,245349];	RCV000266950.1 [benign]; 		COSM3749158	79	643					PDHX (inh=AR pLI=0.00), APIP (inh=n/a pLI=0.00)
chr11	34938072	34938074	GGC	-	het	anno_omim	QUAL=1628;DP=23;AF=0.43;MQM=59;TRIO=HET,23,1.00,WT,19,0.37,HOM,46,1.00	PDHX	intron	PDHX:ENST00000448838:intron:MODIFIER:exon1/10:c.115+41_115+43delCGG:		rs371074122	0.0000	0.2302	57,6,43	0.4283,0.0000,0.0000,0.1789,0.1726	0.1839							608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency,245349];	RCV000362815.1 [benign]; 			94	579					PDHX (inh=AR pLI=0.00)
chr11	34938074	34938074	C	T	het	anno_omim	QUAL=1628;DP=23;AF=0.43;MQM=60;TRIO=HET,23,1.00,HET,19,0.37,WT,46,1.00	PDHX	intron	PDHX:ENST00000448838:intron:MODIFIER:exon1/10:c.115+41C>T:		rs112032820	0.1206	0.3263	74,62,4	0.1806,0.0000,0.0000,0.4250,0.2071	0.2198							608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency,245349];	RCV000270554.1 [benign]; 			212	1052					PDHX (inh=AR pLI=0.00)
chr11	34938079	34938079	G	C	het	anno_omim	QUAL=1246;DP=37;AF=0.46;MQM=59;TRIO=HET,37,0.46,WT,27,0.00,HOM,44,0.98	PDHX	intron	PDHX:ENST00000448838:intron:MODIFIER:exon1/10:c.115+46G>C:		rs375130125	0.1925	0.1761	66,9,49	0.4082,0.0000,0.0000,0.1220,0.1526	0.1841							608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency,245349];	RCV000328825.1 [benign]; 			77	592					PDHX (inh=AR pLI=0.00)
chr11	34938115	34938115	C	A	het	anno_omim	QUAL=1929;DP=131;AF=0.47;MQM=60;TRIO=HET,131,0.47,HET,65,0.49,WT,87,0.02	PDHX	intron	PDHX:ENST00000448838:intron:MODIFIER:exon1/10:c.115+82C>A:		rs2956110	0.5719	0.0000	0,0,0	0,0,0,0,0	0.6010							608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency,245349];	RCV000385759.1 [benign]; 			208	201					PDHX (inh=AR pLI=0.00)
chr11	34938199	34938199	C	G	het	anno_omim	QUAL=6751;DP=108;AF=0.66;MQM=59;TRIO=HET,108,0.66,WT,124,0.00,HOM,175,0.99	PDHX	5'UTR,intron	PDHX:ENST00000227868:5'UTR:MODIFIER:exon1/11:c.-4C>G:,PDHX:ENST00000430469:5'UTR:MODIFIER:exon1/6:c.-4C>G:,PDHX:ENST00000448838:intron:MODIFIER:exon1/10:c.115+166C>G:		rs3818401	0.1925	0.1381	1459,449,764	0.4067,0.0671,0.1005,0.1210,0.1151	0.1886							608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency,245349];	RCV000284713.1 [benign]; RCV000389336.1 [benign]; 			79	688					PDHX (inh=AR pLI=0.00)
chr11	34938265	34938265	C	T	hom	anno_omim	QUAL=9483;DP=77;AF=0.48;MQM=59;TRIO=HOM,77,0.99,HET,132,0.51,HOM,199,0.99	PDHX	synonymous,intron	PDHX:ENST00000227868:synonymous:LOW:exon1/11:c.63C>T:p.Pro21Pro,PDHX:ENST00000430469:synonymous:LOW:exon1/6:c.63C>T:p.Pro21Pro,PDHX:ENST00000448838:intron:MODIFIER:exon1/10:c.115+232C>T:		rs2956109	0.7646	0.7744	35869,21045,3058	0.7834,0.5922,0.8473,0.8024,0.7426	0.7895							608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency,245349];	RCV000335880.1 [benign]; RCV000376293.1 [benign]; 			2072	1041					PDHX (inh=AR pLI=0.00)
chr11	34938269	34938269	C	T	het	anno_omim	QUAL=9483;DP=77;AF=0.48;MQM=60;TRIO=HET,77,0.99,WT,132,0.51,HOM,199,0.99	PDHX	missense,intron	PDHX:ENST00000227868:missense:MODERATE:exon1/11:c.67C>T:p.Arg23Cys,PDHX:ENST00000430469:missense:MODERATE:exon1/6:c.67C>T:p.Arg23Cys,PDHX:ENST00000448838:intron:MODIFIER:exon1/10:c.115+236C>T:		rs1049306	0.1925	0.1384	1438,445,743	0.3999,0.0679,0.1015,0.1213,0.1177	0.1884	-0.0800	T,T,T	T	B,B	T,T,T	12.06	608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency,245349];	RCV000342110.1 [benign]; RCV000406992.1 [benign]; 			78	692					PDHX (inh=AR pLI=0.00)
chr11	34938310	34938310	T	C	het	anno_omim	QUAL=8801;DP=139;AF=0.52;MQM=59;TRIO=HET,139,0.52,WT,158,0.01,HOM,230,1.00	PDHX	synonymous,intron	PDHX:ENST00000227868:synonymous:LOW:exon1/11:c.108T>C:p.Ser36Ser,PDHX:ENST00000430469:synonymous:LOW:exon1/6:c.108T>C:p.Ser36Ser,PDHX:ENST00000448838:intron:MODIFIER:exon1/10:c.115+277T>C:		rs1049307	0.1927	0.1677	1207,357,631	0.4205,0.0947,0.1326,0.1476,0.1345	0.1880							608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency,245349];	RCV000297676.1 [benign]; RCV000338943.1 [benign]; 			78	692					PDHX (inh=AR pLI=0.00)
chr11	34969112	34969112	A	G	het	pred_pathogenic;anno_omim	QUAL=5287;DP=233;AF=0.48;MQM=60;TRIO=HET,233,0.48,HET,163,0.53,WT,244,0.00	PDHX	missense	PDHX:ENST00000227868:missense:MODERATE:exon3/11:c.301A>G:p.Thr101Ala,PDHX:ENST00000448838:missense:MODERATE:exon3/11:c.256A>G:p.Thr86Ala,PDHX:ENST00000430469:missense:MODERATE:exon3/6:c.301A>G:p.Thr101Ala		rs11539202	0.1088	0.2197	3654,3176,27	0.0743,0.1083,0.0007,0.3111,0.1248	0.2191	8.1290	T,T,T,T,T	T	D,B,B	T,T,T,T,T	23.50	608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency,245349];	RCV000361091.1 [benign]; 		COSM3752346	256	1276					PDHX (inh=AR pLI=0.00)
chr11	34991727	34991727	T	C	het	anno_omim	QUAL=5750;DP=248;AF=0.50;MQM=60;TRIO=HET,248,0.50,HET,187,0.52,WT,199,0.00	PDHX	synonymous,intron	PDHX:ENST00000227868:synonymous:LOW:exon7/11:c.858T>C:p.Val286Val,PDHX:ENST00000448838:synonymous:LOW:exon7/11:c.813T>C:p.Val271Val,PDHX:ENST00000430469:intron:MODIFIER:exon3/5:c.343-14390T>C:		rs497582	0.5705	0.6438	25844,16343,746	0.3778,0.5109,0.7547,0.6995,0.6084	0.6467							608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency,245349];	RCV000344720.1 [benign]; 		COSM4145675, COSM4145674	1497	1375					PDHX (inh=AR pLI=0.00)
chr11	35017205	35017205	G	T	het	anno_omim	QUAL=7911;DP=357;AF=0.53;MQM=59;TRIO=HET,357,0.53,HET,200,0.49,WT,238,0.00	PDHX	3'UTR	PDHX:ENST00000227868:3'UTR:MODIFIER:exon11/11:c.*486G>T:,PDHX:ENST00000448838:3'UTR:MODIFIER:exon11/11:c.*486G>T:		rs9326	0.6248	0.0000	0,0,0	0,0,0,0,0	0.6540							608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency,245349];	RCV000383839.1 [benign]; 			99	105					PDHX (inh=AR pLI=0.00)
chr11	35017363	35017363	C	A	hom	anno_omim	QUAL=22371;DP=439;AF=1.00;MQM=59;TRIO=HOM,439,1.00,HET,176,0.40,HOM,180,0.99	PDHX	3'UTR	PDHX:ENST00000227868:3'UTR:MODIFIER:exon11/11:c.*644C>A:,PDHX:ENST00000448838:3'UTR:MODIFIER:exon11/11:c.*644C>A:		rs7808	0.7816	0.0000	0,0,0	0,0,0,0,0	0.8065							608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency,245349];	RCV000270716.1 [benign]; 			138	80					PDHX (inh=AR pLI=0.00)
chr11	36595600	36595600	A	G	het	anno_omim	QUAL=7408;DP=283;AF=0.51;MQM=59;TRIO=HET,283,0.51,WT,262,0.00,HET,313,0.45	RAG1	missense	RAG1:ENST00000299440:missense:MODERATE:exon2/2:c.746A>G:p.His249Arg		rs3740955	0.6134	0.4470	13935,3540,2722	0.7251,0.6959,0.7808,0.3284,0.4695	0.4742	0.1690	T,T	T	B	T,T	0.01	179615 [RAG1 (confirmed) Severe combined immunodeficiency,B cell-negative,601457|Omenn syndrome,603554|Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion,severe cytomegalovirus infection,and autoimmunity,609889|Combined cellular and humoral immune defects with granulomas,233650];		CM122460 [CLASS=R MUT=ALT PHEN="Immunodeficiency severe combined" GENE=RAG1]; 		301	983	2	[2] old entry - no details available			RAG1 (inh=AR pLI=0.00)
chr11	36601170	36601170	G	A	het	anno_omim	QUAL=2486;DP=171;AF=0.44;MQM=59;TRIO=HET,171,0.44,WT,30,0.00,HET,51,0.49	RAG1,RAG2	3'UTR	RAG1:ENST00000299440:3'UTR:MODIFIER:exon2/2:c.*3184G>A:		rs1056403	0.6126	0.0000	0,0,0	0,0,0,0,0	0.4761							179615 [RAG1 (confirmed) Severe combined immunodeficiency,B cell-negative,601457|Omenn syndrome,603554|Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion,severe cytomegalovirus infection,and autoimmunity,609889|Combined cellular and humoral immune defects with granulomas,233650];	RCV000331349.1 [benign]; RCV000365249.1 [benign]; 			35	109					RAG1 (inh=AR pLI=0.00), RAG2 (inh=AR pLI=0.01)
chr11	36613807	36613807	T	C	het	anno_omim	QUAL=4907;DP=211;AF=0.52;MQM=60;TRIO=HET,211,0.52,WT,115,0.00,HET,130,0.55	RAG2,RAG1	3'UTR	RAG2:ENST00000311485:3'UTR:MODIFIER:exon2/2:c.*328A>G:		rs10836573	0.6132	0.0000	0,0,0	0,0,0,0,0	0.4734							179615 [RAG1 (confirmed) Severe combined immunodeficiency,B cell-negative,601457|Omenn syndrome,603554|Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion,severe cytomegalovirus infection,and autoimmunity,609889|Combined cellular and humoral immune defects with granulomas,233650]:179616 [RAG2 (confirmed) Severe combined immunodeficiency,B cell-negative,601457|Omenn syndrome,603554|Combined cellular and humoral immune defects with granulomas,233650];	RCV000286048.1 [benign]; RCV000382631.1 [benign]; 			33	111					RAG2 (inh=AR pLI=0.01), RAG1 (inh=AR pLI=0.00)
chr11	44117102	44117102	T	C	het	anno_omim	QUAL=12731;DP=443;AF=0.57;MQM=60;TRIO=HET,443,0.57,HOM,206,0.99,WT,291,0.00	EXT2	5'UTR	EXT2:ENST00000533608:5'UTR:MODIFIER:exon1/14:c.-331T>C:		rs10458911	0.3061	0.0000	0,0,0	0,0,0,0,0	0.2475							608210 [EXT2 (confirmed) Exostoses,multiple,type 2,133701|Seizures,scoliosis,and macrocephaly syndrome,616682];	RCV000342075.1 [benign]; 			19	78					EXT2 (inh=AD pLI=0.00)
chr11	44117122	44117122	G	A	hom	anno_omim	QUAL=20974;DP=400;AF=0.99;MQM=59;TRIO=HOM,400,0.99,HOM,202,1.00,HET,292,0.51	EXT2	5'UTR	EXT2:ENST00000533608:5'UTR:MODIFIER:exon1/14:c.-311G>A:		rs3923808	0.5208	0.0000	0,0,0	0,0,0,0,0	0.5125							608210 [EXT2 (confirmed) Exostoses,multiple,type 2,133701|Seizures,scoliosis,and macrocephaly syndrome,616682];	RCV000400767.1 [benign]; 			70	104					EXT2 (inh=AD pLI=0.00)
chr11	44283297	44283297	T	C	hom	anno_omim	QUAL=43895;DP=309;AF=1.00;MQM=59;TRIO=HOM,309,1.00,HOM,450,1.00,HOM,605,1.00	ALX4	3'UTR	ALX4:ENST00000329255:3'UTR:MODIFIER:exon4/4:c.*3107A>G:		rs4755239	0.9073	0.0000	0,0,0	0,0,0,0,0	0.9004							605420 [ALX4 (provisional) Parietal foramina 2,609597|Frontonasal dysplasia 2,613451|Craniosynostosis 5,susceptibility to,615529];	RCV000325133.1 [benign]; 			183	44					ALX4 (inh=AD pLI=0.23)
chr11	44283722	44283722	G	A	het	anno_omim	QUAL=20423;DP=295;AF=0.52;MQM=59;TRIO=HET,295,0.52,HOM,353,1.00,HET,435,0.48	ALX4	3'UTR	ALX4:ENST00000329255:3'UTR:MODIFIER:exon4/4:c.*2682C>T:		rs897005	0.7326	0.0000	0,0,0	0,0,0,0,0	0.6749							605420 [ALX4 (provisional) Parietal foramina 2,609597|Frontonasal dysplasia 2,613451|Craniosynostosis 5,susceptibility to,615529];	RCV000401847.1 [benign]; 			99	110					ALX4 (inh=AD pLI=0.23)
chr11	44284294	44284294	T	C	hom	anno_omim	QUAL=17791;DP=288;AF=1.00;MQM=59;TRIO=HOM,288,1.00,HOM,115,1.00,HOM,148,1.00	ALX4	3'UTR	ALX4:ENST00000329255:3'UTR:MODIFIER:exon4/4:c.*2110A>G:		rs7105993	0.9918	0.0000	0,0,0	0,0,0,0,0	0.9913							605420 [ALX4 (provisional) Parietal foramina 2,609597|Frontonasal dysplasia 2,613451|Craniosynostosis 5,susceptibility to,615529];	RCV000361732.1 [benign]; 			232	0					ALX4 (inh=AD pLI=0.23)
chr11	44285857	44285857	T	C	hom	anno_omim	QUAL=21833;DP=148;AF=0.99;MQM=59;TRIO=HOM,148,0.99,HOM,258,1.00,HOM,315,1.00	ALX4	3'UTR	ALX4:ENST00000329255:3'UTR:MODIFIER:exon4/4:c.*547A>G:		rs4755796	0.8848	0.0000	0,0,0	0,0,0,0,0	0.7968							605420 [ALX4 (provisional) Parietal foramina 2,609597|Frontonasal dysplasia 2,613451|Craniosynostosis 5,susceptibility to,615529];	RCV000327880.1 [benign]; 			151	73					ALX4 (inh=AD pLI=0.23)
chr11	44285887	44285887	G	A	hom	anno_omim	QUAL=23222;DP=159;AF=0.99;MQM=59;TRIO=HOM,159,0.99,HOM,263,1.00,HOM,324,1.00	ALX4	3'UTR	ALX4:ENST00000329255:3'UTR:MODIFIER:exon4/4:c.*517C>T:		rs4755797	0.7560	0.0000	0,0,0	0,0,0,0,0	0.6672							605420 [ALX4 (provisional) Parietal foramina 2,609597|Frontonasal dysplasia 2,613451|Craniosynostosis 5,susceptibility to,615529];	RCV000264610.1 [benign]; 			118	93					ALX4 (inh=AD pLI=0.23)
chr11	44286176	44286176	G	A	hom	anno_omim	QUAL=6206;DP=80;AF=0.99;MQM=59;TRIO=HOM,80,0.99,HET,142,0.46,HET,177,0.56	ALX4	3'UTR	ALX4:ENST00000329255:3'UTR:MODIFIER:exon4/4:c.*228C>T:		rs4755798	0.1991	0.0000	0,0,0	0,0,0,0,0	0.2236							605420 [ALX4 (provisional) Parietal foramina 2,609597|Frontonasal dysplasia 2,613451|Craniosynostosis 5,susceptibility to,615529];	RCV000280630.1 [likely benign]; 			16	92					ALX4 (inh=AD pLI=0.23)
chr11	44289071	44289071	G	A	hom	anno_omim	QUAL=8111;DP=125;AF=0.99;MQM=60;TRIO=HOM,125,0.99,HET,135,0.50,HET,195,0.55	ALX4	synonymous	ALX4:ENST00000329255:synonymous:LOW:exon3/4:c.879C>T:p.Leu293Leu		rs12419361	0.1036	0.1097	752,394,17	0.0553,0.1006,0.0935,0.1098,0.1387	0.1115							605420 [ALX4 (provisional) Parietal foramina 2,609597|Frontonasal dysplasia 2,613451|Craniosynostosis 5,susceptibility to,615529];	RCV000272001.1 [likely benign]; 			49	438					ALX4 (inh=AD pLI=0.23)
chr11	44297054	44297054	T	C	hom	anno_omim	QUAL=8585;DP=59;AF=1.00;MQM=60;TRIO=HOM,59,1.00,HOM,107,1.00,HOM,110,1.00	ALX4	synonymous	ALX4:ENST00000329255:synonymous:LOW:exon2/4:c.621A>G:p.Ser207Ser		rs10769028	0.9916	0.9975	60402,33362,4920	0.9728,0.9995,0.9999,0.9999,0.9997	0.9980							605420 [ALX4 (provisional) Parietal foramina 2,609597|Frontonasal dysplasia 2,613451|Craniosynostosis 5,susceptibility to,615529];	RCV000323653.1 [benign]; 		COSM4145711	2110	3					ALX4 (inh=AD pLI=0.23)
chr11	44331309	44331309	G	A	het	low_DP;pred_pathogenic;anno_omim	QUAL=1705;DP=5;AF=0.40;MQM=60;TRIO=HET,5,0.40,HET,63,0.44,HET,90,0.56	ALX4	missense	ALX4:ENST00000329255:missense:MODERATE:exon1/4:c.304C>T:p.Pro102Ser	(GCGGCT)n	rs12421995	0.3720	0.6028	2981,913,8	0.1433,0.6092,0.6481,0.5672,0.6633	0.4660		D	T	B	T	5.21	605420 [ALX4 (provisional) Parietal foramina 2,609597|Frontonasal dysplasia 2,613451|Craniosynostosis 5,susceptibility to,615529];	RCV000282185.1 [benign]; 		COSM3749161	454	978					ALX4 (inh=AD pLI=0.23)
chr11	44331509	44331509	C	G	het	pred_pathogenic;anno_omim	QUAL=5741;DP=58;AF=0.50;MQM=60;TRIO=HET,58,0.50,HET,185,0.53,HET,239,0.45	ALX4	missense	ALX4:ENST00000329255:missense:MODERATE:exon1/4:c.104G>C:p.Arg35Thr		rs3824915	0.4726	0.5914	11196,5385,291	0.3730,0.5164,0.5897,0.5723,0.7794	0.5065	5.2690	D	T	B	D	28.50	605420 [ALX4 (provisional) Parietal foramina 2,609597|Frontonasal dysplasia 2,613451|Craniosynostosis 5,susceptibility to,615529];	RCV000352665.1 [benign]; 		COSM3752366	592	1018					ALX4 (inh=AD pLI=0.23)
chr11	45832935	45832935	G	A	hom	anno_omim	QUAL=15267;DP=186;AF=0.99;MQM=59;TRIO=HOM,186,0.99,HET,292,0.55,HET,427,0.56	SLC35C1	3'UTR	SLC35C1:ENST00000314134:3'UTR:MODIFIER:exon2/2:c.*49G>A:,SLC35C1:ENST00000442528:3'UTR:MODIFIER:exon3/3:c.*49G>A:,SLC35C1:ENST00000456334:3'UTR:MODIFIER:exon3/3:c.*49G>A:		rs1139266	0.4513	0.6741	2211,1758,25	0.2500,0.6751,0.3562,0.7781,0.6923	0.6269							605881 [SLC35C1 (confirmed) Congenital disorder of glycosylation,type IIc,266265];	RCV000243982.1 [benign]; RCV000330911.1 [benign]; 			1029	621					SLC35C1 (inh=AR pLI=0.15)
chr11	45834044	45834044	C	T	hom	anno_omim	QUAL=18675;DP=206;AF=0.98;MQM=60;TRIO=HOM,206,0.98,HOM,188,1.00,HOM,220,1.00	SLC35C1	3'UTR	SLC35C1:ENST00000314134:3'UTR:MODIFIER:exon2/2:c.*1158C>T:,SLC35C1:ENST00000456334:3'UTR:MODIFIER:exon3/3:c.*1158C>T:	MLT1A0	rs4756027	0.7206	0.0000	0,0,0	0,0,0,0,0	0.8328							605881 [SLC35C1 (confirmed) Congenital disorder of glycosylation,type IIc,266265];	RCV000344613.1 [benign]; 			360	126					SLC35C1 (inh=AR pLI=0.15)
chr11	45834198	45834198	T	C	hom	anno_omim	QUAL=18808;DP=235;AF=0.99;MQM=59;TRIO=HOM,235,0.99,HOM,157,1.00,HOM,210,1.00	SLC35C1	3'UTR	SLC35C1:ENST00000314134:3'UTR:MODIFIER:exon2/2:c.*1312T>C:,SLC35C1:ENST00000456334:3'UTR:MODIFIER:exon3/3:c.*1312T>C:	MLT1A0	rs7943306	0.6538	0.7743	3296,1095,39	0.0000,0.0000,0.0000,0.8921,0.7426	0.7967							605881 [SLC35C1 (confirmed) Congenital disorder of glycosylation,type IIc,266265];	RCV000314257.1 [benign]; 			1098	383					SLC35C1 (inh=AR pLI=0.15)
chr11	45931502	45931502	G	A	hom	anno_omim	QUAL=19327;DP=177;AF=0.98;MQM=60;TRIO=HOM,177,0.98,HET,248,0.48,HOM,361,1.00	PEX16	3'UTR	PEX16:ENST00000241041:3'UTR:MODIFIER:exon11/11:c.*138C>T:		rs10838529	0.3936	0.0000	0,0,0	0,0,0,0,0	0.5348							603360 [PEX16 (provisional) Peroxisome biogenesis disorder 8A (Zellweger),614876|Peroxisome biogenesis disorder 8B,614877];	RCV000267975.1 [benign]; 			119	83					PEX16 (inh=AR pLI=0.00)
chr11	45935384	45935384	A	G	hom	anno_omim	QUAL=21005;DP=184;AF=1.00;MQM=59;TRIO=HOM,184,1.00,HET,255,0.46,HOM,393,1.00	PEX16	synonymous	PEX16:ENST00000241041:synonymous:LOW:exon9/11:c.873T>C:p.Tyr291Tyr,PEX16:ENST00000378750:synonymous:LOW:exon9/11:c.873T>C:p.Tyr291Tyr,PEX16:ENST00000532681:synonymous:LOW:exon9/11:c.588T>C:p.Tyr196Tyr		rs1132349	0.6891	0.8155	42019,27922,1802	0.5907,0.5555,0.4318,0.9175,0.8722	0.8108							603360 [PEX16 (provisional) Peroxisome biogenesis disorder 8A (Zellweger),614876|Peroxisome biogenesis disorder 8B,614877];	RCV000248969.1 [benign]; RCV000389065.1 [benign]; 		COSM4145722, COSM4145721	1669	409					PEX16 (inh=AR pLI=0.00)
chr11	45937267	45937267	C	T	hom	pred_pathogenic;anno_omim	QUAL=30239;DP=244;AF=1.00;MQM=60;TRIO=HOM,244,1.00,HOM,304,1.00,HOM,451,1.00	PEX16	missense	PEX16:ENST00000241041:missense:MODERATE:exon4/11:c.346G>A:p.Val116Ile,PEX16:ENST00000378750:missense:MODERATE:exon4/11:c.346G>A:p.Val116Ile,PEX16:ENST00000532681:missense:MODERATE:exon4/11:c.61G>A:p.Val21Ile		rs10742772	1.0000	1.0000	60695,33362,5202	1.0000,1.0000,1.0000,1.0000,1.0000	1.0000	3.7850	T,T,T,T	T	B,B	T,T,T,T	16.46	603360 [PEX16 (provisional) Peroxisome biogenesis disorder 8A (Zellweger),614876|Peroxisome biogenesis disorder 8B,614877];				2113	0					PEX16 (inh=AR pLI=0.00)
chr11	47238522	47238522	T	C	hom	anno_omim	QUAL=1242;DP=20;AF=1.00;MQM=60;TRIO=HOM,20,1.00,HOM,10,1.00,HOM,10,1.00	DDB2	synonymous,intron	DDB2:ENST00000256996:synonymous:LOW:exon3/10:c.378T>C:p.Thr126Thr,DDB2:ENST00000378600:synonymous:LOW:exon3/6:c.378T>C:p.Thr126Thr,DDB2:ENST00000378601:synonymous:LOW:exon3/9:c.378T>C:p.Thr126Thr,DDB2:ENST00000378603:intron:MODIFIER:exon2/8:c.264+499T>C:		rs326212	0.9942	0.9987	60550,33369,5055	0.9858,0.9997,1.0000,1.0000,0.9999	0.9990							600811 [DDB2 (provisional) Xeroderma pigmentosum,group E,DDB-negative subtype,278740];				3492	1					DDB2 (inh=AR pLI=0.01)
chr11	47460306	47460306	A	G	hom	low_DP;anno_omim	QUAL=1604;DP=17;AF=1.00;MQM=60;TRIO=HOM,17,1.00,HET,21,0.57,HOM,28,1.00	RAPSN	synonymous	RAPSN:ENST00000524487:synonymous:LOW:exon5/6:c.991T>C:p.Leu331Leu,RAPSN:ENST00000298854:synonymous:LOW:exon7/8:c.1143T>C:p.Pro381Pro,RAPSN:ENST00000352508:synonymous:LOW:exon5/6:c.966T>C:p.Pro322Pro,RAPSN:ENST00000529341:synonymous:LOW:exon5/5:c.966T>C:p.Pro322Pro		rs7126210	0.6248	0.6837	10399,5850,425	0.4500,0.6250,0.6249,0.7154,0.7758	0.6641							601592 [RAPSN (provisional) Myasthenic syndrome,congenital,11,associated with acetylcholine receptor deficiency,616326|Fetal akinesia deformation sequence,208150];	RCV000118117.3 [other]; RCV000292191.1 [benign]; RCV000347078.1 [benign]; 		COSM3931321	1188	770					RAPSN (inh=AR pLI=0.03)
chr11	47463484	47463484	G	-	hom	anno_omim	QUAL=2246;DP=23;AF=1.00;MQM=59;TRIO=HOM,23,1.00,HET,49,0.29,HOM,53,1.00	RAPSN	splice_region&intron	RAPSN:ENST00000524487:splice_region&intron:LOW:exon2/5:c.532-11delC:,RAPSN:ENST00000298854:splice_region&intron:LOW:exon3/7:c.691-11delC:,RAPSN:ENST00000352508:splice_region&intron:LOW:exon3/5:c.691-11delC:,RAPSN:ENST00000529341:splice_region&intron:LOW:exon3/4:c.691-11delC:		rs397825047	0.6108	0.7106	10475,5999,322	0.4300,0.6687,0.6563,0.7439,0.7779	0.6794							601592 [RAPSN (provisional) Myasthenic syndrome,congenital,11,associated with acetylcholine receptor deficiency,616326|Fetal akinesia deformation sequence,208150];	RCV000178237.2 [benign]; RCV000288381.1 [benign]; RCV000382725.1 [benign]; 			1139	671					RAPSN (inh=AR pLI=0.03)
chr11	47469439	47469439	A	G	hom	anno_omim	QUAL=29279;DP=289;AF=1.00;MQM=59;TRIO=HOM,289,1.00,HET,422,0.45,HOM,522,1.00	RAPSN	synonymous	RAPSN:ENST00000524487:synonymous:LOW:exon2/6:c.456T>C:p.Tyr152Tyr,RAPSN:ENST00000298854:synonymous:LOW:exon2/8:c.456T>C:p.Tyr152Tyr,RAPSN:ENST00000352508:synonymous:LOW:exon2/6:c.456T>C:p.Tyr152Tyr,RAPSN:ENST00000529341:synonymous:LOW:exon2/5:c.456T>C:p.Tyr152Tyr		rs7111873	0.6256	0.6847	27963,16859,899	0.4273,0.6098,0.6450,0.7234,0.7823	0.6809							601592 [RAPSN (provisional) Myasthenic syndrome,congenital,11,associated with acetylcholine receptor deficiency,616326|Fetal akinesia deformation sequence,208150];	RCV000118119.3 [other]; RCV000315533.1 [benign]; RCV000367686.1 [benign]; 			1191	774					RAPSN (inh=AR pLI=0.03)
chr11	60236272	60236272	A	G	het	anno_omim	QUAL=13559;DP=347;AF=0.54;MQM=60;TRIO=HET,347,0.54,HOM,268,1.00,WT,327,0.01	MS4A1	3'UTR	MS4A1:ENST00000345732:3'UTR:MODIFIER:exon7/7:c.*331A>G:,MS4A1:ENST00000532073:3'UTR:MODIFIER:exon7/7:c.*331A>G:,MS4A1:ENST00000534668:3'UTR:MODIFIER:exon7/7:c.*331A>G:,MS4A1:ENST00000528313:3'UTR:MODIFIER:exon4/4:c.*331A>G:,MS4A1:ENST00000389939:3'UTR:MODIFIER:exon6/6:c.*331A>G:		rs1051756	0.6380	0.0000	0,0,0	0,0,0,0,0	0.5876							112210 [MS4A1 (confirmed) Immunodeficiency,common variable,5,613495];				81	110					MS4A1 (inh=AR pLI=0.02)
chr11	60237234	60237234	T	C	het	anno_omim	QUAL=4996;DP=239;AF=0.51;MQM=60;TRIO=HET,239,0.51,HET,141,0.50,WT,187,0.00	MS4A1	3'UTR	MS4A1:ENST00000345732:3'UTR:MODIFIER:exon7/7:c.*1293T>C:,MS4A1:ENST00000532073:3'UTR:MODIFIER:exon7/7:c.*1293T>C:,MS4A1:ENST00000534668:3'UTR:MODIFIER:exon7/7:c.*1293T>C:,MS4A1:ENST00000389939:3'UTR:MODIFIER:exon6/6:c.*1293T>C:		rs1051461	0.2228	0.0000	0,0,0	0,0,0,0,0	0.2746							112210 [MS4A1 (confirmed) Immunodeficiency,common variable,5,613495];				27	104					MS4A1 (inh=AR pLI=0.02)
chr11	60237991	60237991	T	C	het	anno_omim	QUAL=7828;DP=351;AF=0.52;MQM=60;TRIO=HET,351,0.52,HOM,81,1.00,WT,105,0.00	MS4A1	3'UTR	MS4A1:ENST00000345732:3'UTR:MODIFIER:exon7/7:c.*2050T>C:,MS4A1:ENST00000534668:3'UTR:MODIFIER:exon7/7:c.*2050T>C:,MS4A1:ENST00000389939:3'UTR:MODIFIER:exon6/6:c.*2050T>C:		rs1051593	0.4756	0.0000	0,0,0	0,0,0,0,0	0.4819							112210 [MS4A1 (confirmed) Immunodeficiency,common variable,5,613495];				56	120					MS4A1 (inh=AR pLI=0.02)
chr11	60238054	60238054	C	T	het	anno_omim	QUAL=6663;DP=272;AF=0.49;MQM=60;TRIO=HET,272,0.49,HOM,94,1.00,WT,123,0.00	MS4A1	3'UTR	MS4A1:ENST00000345732:3'UTR:MODIFIER:exon7/7:c.*2113C>T:,MS4A1:ENST00000534668:3'UTR:MODIFIER:exon7/7:c.*2113C>T:,MS4A1:ENST00000389939:3'UTR:MODIFIER:exon6/6:c.*2113C>T:		rs1051594	0.4742	0.0000	0,0,0	0,0,0,0,0	0.4798							112210 [MS4A1 (confirmed) Immunodeficiency,common variable,5,613495];				57	120					MS4A1 (inh=AR pLI=0.02)
chr11	61165280	61165280	G	A	het	anno_omim	QUAL=4496;DP=136;AF=0.45;MQM=59;TRIO=HET,136,0.45,HET,65,0.43,HOM,82,1.00	TMEM216	synonymous	TMEM216:ENST00000334888:synonymous:LOW:exon4/5:c.264G>A:p.Pro88Pro,TMEM216:ENST00000515837:synonymous:LOW:exon4/5:c.264G>A:p.Pro88Pro,TMEM216:ENST00000398979:synonymous:LOW:exon4/5:c.81G>A:p.Pro27Pro		rs3741265	0.8558	0.8659	45445,24981,2828	0.7574,0.8855,0.9660,0.8649,0.8613	0.8711							613277 [TMEM216 (confirmed) Joubert syndrome 2,608091|Meckel syndrome 2,603194];	RCV000114238.3 [other]; RCV000361073.1 [benign]; RCV000405990.1 [benign]; 			2500	708					TMEM216 (inh=AR pLI=0.00)
chr11	61165731	61165731	-	A	het	anno_high_impact;anno_omim	QUAL=7846;DP=189;AF=0.54;MQM=59;TRIO=HET,189,0.54,HET,103,0.55,HOM,126,0.99	TMEM216	splice_acceptor,splice_region&intron	TMEM216:ENST00000334888:splice_acceptor:HIGH:exon4/4:c.432-2_432-1insA:,TMEM216:ENST00000515837:splice_region&intron:LOW:exon4/4:c.432-11_432-10insA:,TMEM216:ENST00000398979:splice_region&intron:LOW:exon4/4:c.249-11_249-10insA:		rs11382548	0.8558	0.8593	43189,23691,2710	0.7547,0.8727,0.9625,0.8574,0.8588	0.8693							613277 [TMEM216 (confirmed) Joubert syndrome 2,608091|Meckel syndrome 2,603194];	RCV000154006.3 [benign]; RCV000270481.1 [benign]; RCV000325554.1 [benign]; 			2473	696	1	[1] auto-classification 16.06.2016  [2] Ute Grasshoff 09.04.2015			TMEM216 (inh=AR pLI=0.00)
chr11	61165741	61165741	G	C	het	anno_high_impact;pred_pathogenic;anno_omim	QUAL=8618;DP=187;AF=0.55;MQM=59;TRIO=HET,187,0.55,HET,121,0.54,HOM,143,0.99	TMEM216	splice_acceptor,missense	TMEM216:ENST00000515837:splice_acceptor:HIGH:exon4/4:c.432-1G>C:,TMEM216:ENST00000398979:splice_acceptor:HIGH:exon4/4:c.249-1G>C:,TMEM216:ENST00000334888:missense:MODERATE:exon5/5:c.440G>C:p.Arg147Thr		rs10897158	0.7196	0.8153	40102,23265,640	0.3612,0.8512,0.9588,0.8478,0.8261	0.8303	0.7930	.,.,T	.,T		.,D	23.80	613277 [TMEM216 (confirmed) Joubert syndrome 2,608091|Meckel syndrome 2,603194];	RCV000114239.5 [benign]; RCV000200066.4 [benign]; RCV000291379.1 [benign]; 		COSM1582850	2385	802	1	[1] auto-classification 16.06.2016  [2] Ute Grasshoff 09.04.2015			TMEM216 (inh=AR pLI=0.00)
chr11	61166306	61166306	G	A	het	anno_omim	QUAL=919;DP=112;AF=0.34;MQM=60;TRIO=HET,112,0.34,WT,4,0.00,HOM,7,1.00	TMEM216	3'UTR	TMEM216:ENST00000334888:3'UTR:MODIFIER:exon5/5:c.*558G>A:,TMEM216:ENST00000515837:3'UTR:MODIFIER:exon5/5:c.*558G>A:		rs7607	0.7196	0.0000	0,0,0	0,0,0,0,0	0.7305							613277 [TMEM216 (confirmed) Joubert syndrome 2,608091|Meckel syndrome 2,603194];	RCV000329368.1 [benign]; RCV000377140.1 [benign]; 			175	49					TMEM216 (inh=AR pLI=0.00)
chr11	61717607	61717607	C	T	het	anno_omim	QUAL=7597;DP=297;AF=0.48;MQM=60;TRIO=HET,297,0.48,WT,349,0.00,HET,395,0.47	BEST1	5'UTR	BEST1:ENST00000378043:5'UTR:MODIFIER:exon1/11:c.-329C>T:,BEST1:ENST00000378042:5'UTR:MODIFIER:exon1/10:c.-509C>T:,BEST1:ENST00000301774:5'UTR:MODIFIER:exon1/5:c.-683C>T:,BEST1:ENST00000534553:5'UTR:MODIFIER:exon1/5:c.-504C>T:		rs972354	0.3490	0.0000	0,0,0	0,0,0,0,0	0.1617							607854 [BEST1 (confirmed) Macular dystrophy,vitelliform,2,153700|Bestrophinopathy,autosomal recessive,611809|Vitreoretinochoroidopathy,193220|Microcornea,rod-cone dystrophy,cataract,and posterior staphyloma,193220|Retinitis pigmentosa-50,613194|Retinitis pigmentosa,concentric,613194];	RCV000304307.1 [benign]; RCV000361256.1 [benign]; RCV000392337.1 [benign]; 			5	48					BEST1 (inh=AR+AD pLI=0.00)
chr11	61717715	61717715	T	C	het	anno_omim	QUAL=12101;DP=352;AF=0.51;MQM=60;TRIO=HET,352,0.51,HET,285,0.51,HET,313,0.47	BEST1	5'UTR	BEST1:ENST00000378043:5'UTR:MODIFIER:exon1/11:c.-221T>C:,BEST1:ENST00000378042:5'UTR:MODIFIER:exon1/10:c.-401T>C:,BEST1:ENST00000301774:5'UTR:MODIFIER:exon1/5:c.-575T>C:,BEST1:ENST00000534553:5'UTR:MODIFIER:exon1/5:c.-396T>C:		rs972353	0.6793	0.0000	0,0,0	0,0,0,0,0	0.5051							607854 [BEST1 (confirmed) Macular dystrophy,vitelliform,2,153700|Bestrophinopathy,autosomal recessive,611809|Vitreoretinochoroidopathy,193220|Microcornea,rod-cone dystrophy,cataract,and posterior staphyloma,193220|Retinitis pigmentosa-50,613194|Retinitis pigmentosa,concentric,613194];	RCV000298197.1 [benign]; RCV000355356.1 [benign]; RCV000392227.1 [benign]; 			31	107					BEST1 (inh=AR+AD pLI=0.00)
chr11	61719387	61719387	T	C	het	anno_omim	QUAL=462;DP=34;AF=0.50;MQM=60;TRIO=HET,34,0.50,HET,8,0.13,HET,12,0.50	BEST1	synonymous,5'UTR,intron	BEST1:ENST00000378043:synonymous:LOW:exon2/11:c.109T>C:p.Leu37Leu,BEST1:ENST00000435278:synonymous:LOW:exon2/7:c.109T>C:p.Leu37Leu,BEST1:ENST00000378042:5'UTR:MODIFIER:exon2/10:c.-72T>C:,BEST1:ENST00000449131:intron:MODIFIER:exon1/8:c.-29+1488T>C:,BEST1:ENST00000301774:intron:MODIFIER:exon1/4:c.-391+1488T>C:,BEST1:ENST00000534553:intron:MODIFIER:exon1/4:c.-212+1488T>C:		rs1800007	0.6805	0.4847	17100,3272,2778	0.7287,0.6532,0.9087,0.3119,0.7022	0.5058							607854 [BEST1 (confirmed) Macular dystrophy,vitelliform,2,153700|Bestrophinopathy,autosomal recessive,611809|Vitreoretinochoroidopathy,193220|Microcornea,rod-cone dystrophy,cataract,and posterior staphyloma,193220|Retinitis pigmentosa-50,613194|Retinitis pigmentosa,concentric,613194];	RCV000086084.1 [not provided]; RCV000152861.4 [benign]; RCV000283689.1 [benign]; RCV000341149.1 [benign]; RCV000398665.1 [benign]; 		COSM3752558	307	888					BEST1 (inh=AR+AD pLI=0.00)
chr11	61727438	61727438	C	T	het	pred_pathogenic;anno_omim	QUAL=6090;DP=244;AF=0.50;MQM=60;TRIO=HET,244,0.50,WT,163,0.01,HET,246,0.50	BEST1,FTH1	missense,synonymous,intron	BEST1:ENST00000526988:missense:MODERATE:exon8/9:c.908C>T:p.Pro303Leu,BEST1:ENST00000449131:synonymous:LOW:exon8/9:c.843C>T:p.Pro281Pro,BEST1:ENST00000378043:synonymous:LOW:exon9/11:c.1023C>T:p.Pro341Pro,BEST1:ENST00000378042:synonymous:LOW:exon8/10:c.762C>T:p.Pro254Pro,BEST1:ENST00000301774:intron:MODIFIER:exon4/4:c.-16-2289C>T:,BEST1:ENST00000534553:intron:MODIFIER:exon4/4:c.164-2289C>T:,BEST1:ENST00000435278:intron:MODIFIER:exon6/6:c.715-2289C>T:,FTH1:ENST00000529191:intron:MODIFIER:exon1/1:c.115-39G>A:,FTH1:ENST00000529631:intron:MODIFIER:exon1/1:c.115-62G>A:		rs1801390	0.0140	0.0249	40,22,7	0.0353,0.0137,0.0013,0.0296,0.0054	0.0312	-3.4650	D	D	B,B	D	6.49	607854 [BEST1 (confirmed) Macular dystrophy,vitelliform,2,153700|Bestrophinopathy,autosomal recessive,611809|Vitreoretinochoroidopathy,193220|Microcornea,rod-cone dystrophy,cataract,and posterior staphyloma,193220|Retinitis pigmentosa-50,613194|Retinitis pigmentosa,concentric,613194];	RCV000086082.1 [not provided]; RCV000303310.1 [benign]; RCV000342198.1 [benign]; RCV000358637.1 [benign]; RCV000392142.1 [benign]; 			2	97					BEST1 (inh=AR+AD pLI=0.00), FTH1 (inh=AD pLI=0.92)
chr11	61730036	61730036	G	A	het	anno_omim	QUAL=8556;DP=293;AF=0.55;MQM=59;TRIO=HET,293,0.55,HET,213,0.52,HET,252,0.45	BEST1,FTH1	synonymous,3'UTR,intron	BEST1:ENST00000449131:synonymous:LOW:exon9/9:c.1230G>A:p.Thr410Thr,BEST1:ENST00000378043:synonymous:LOW:exon10/11:c.1410G>A:p.Thr470Thr,BEST1:ENST00000378042:synonymous:LOW:exon9/10:c.1149G>A:p.Thr383Thr,BEST1:ENST00000301774:synonymous:LOW:exon5/5:c.294G>A:p.Thr98Thr,BEST1:ENST00000534553:3'UTR:MODIFIER:exon5/5:c.*305G>A:,FTH1:ENST00000529191:intron:MODIFIER:exon1/1:c.115-2637C>T:,FTH1:ENST00000529631:intron:MODIFIER:exon1/1:c.115-2660C>T:		rs149698	0.1122	0.2271	3986,3382,31	0.0778,0.1725,0.0045,0.3167,0.0902	0.2272							607854 [BEST1 (confirmed) Macular dystrophy,vitelliform,2,153700|Bestrophinopathy,autosomal recessive,611809|Vitreoretinochoroidopathy,193220|Microcornea,rod-cone dystrophy,cataract,and posterior staphyloma,193220|Retinitis pigmentosa-50,613194|Retinitis pigmentosa,concentric,613194];	RCV000173795.2 [benign]; RCV000301873.1 [benign]; RCV000365872.1 [benign]; RCV000392906.1 [benign]; RCV000401921.1 [benign]; 		COSM3752559, COSM3752560	194	827					BEST1 (inh=AR+AD pLI=0.00), FTH1 (inh=AD pLI=0.92)
chr11	63990997	63990997	C	-	het	anno_omim	QUAL=5728;DP=157;AF=0.45;MQM=59;TRIO=HET,157,0.45,HET,172,0.52,HET,240,0.48	FERMT3	3'UTR	FERMT3:ENST00000279227:3'UTR:MODIFIER:exon15/15:c.*35delC:,FERMT3:ENST00000345728:3'UTR:MODIFIER:exon15/15:c.*35delC:		rs5792315	0.0000	0.5153	9066,3303,1610	0.7656,0.6256,0.4207,0.4545,0.5762	0.5102							607901 [FERMT3 (confirmed) Leukocyte adhesion deficiency,type III,612840];				398	881					FERMT3 (inh=AR pLI=0.26)
chr11	65485727	65485727	T	G	hom	anno_omim	QUAL=30748;DP=387;AF=0.99;MQM=59;TRIO=HOM,387,0.99,HET,348,0.49,HOM,445,0.99	RNASEH2C,KAT5	3'UTR,intron	RNASEH2C:ENST00000308418:3'UTR:MODIFIER:exon4/4:c.*1527A>C:,KAT5:ENST00000341318:intron:MODIFIER:exon10/12:c.1265-334T>G:,KAT5:ENST00000377046:intron:MODIFIER:exon11/13:c.1166-334T>G:,KAT5:ENST00000352980:intron:MODIFIER:exon10/12:c.1010-334T>G:,KAT5:ENST00000530446:intron:MODIFIER:exon9/11:c.1109-334T>G:,KAT5:ENST00000534650:intron:MODIFIER:exon8/10:c.533-334T>G:		rs521678	0.8249	0.0000	0,0,0	0,0,0,0,0	0.8900							610330 [RNASEH2C (provisional) Aicardi-Goutieres syndrome 3,610329];	RCV000363567.1 [benign]; 			196	34					RNASEH2C (inh=AR pLI=0.51), KAT5 (inh=n/a pLI=0.47)
chr11	65636053	65636053	T	C	hom	pred_pathogenic;anno_omim	QUAL=27488;DP=338;AF=1.00;MQM=59;TRIO=HOM,338,1.00,HOM,245,1.00,HOM,308,1.00	EFEMP2	missense	EFEMP2:ENST00000307998:missense:MODERATE:exon8/11:c.775A>G:p.Ile259Val,EFEMP2:ENST00000528176:missense:MODERATE:exon8/11:c.775A>G:p.Ile259Val		rs601314	0.8946	0.9695	57465,33186,2374	0.6773,0.9842,1.0000,0.9981,0.9986	0.9755	0.5430	T,T	T	B,B	T,D	0.39	604633 [EFEMP2 (provisional) Cutis laxa,autosomal recessive,type IB,614437];	RCV000032273.1 [benign]; RCV000155538.2 [benign]; RCV000378680.1 [benign]; 			2118	42					EFEMP2 (inh=AR pLI=0.03)
chr11	65638719	65638719	G	A	hom	anno_omim	QUAL=15870;DP=113;AF=1.00;MQM=60;TRIO=HOM,113,1.00,HET,266,0.52,HOM,327,1.00	EFEMP2	synonymous	EFEMP2:ENST00000307998:synonymous:LOW:exon4/11:c.276C>T:p.His92His,EFEMP2:ENST00000528176:synonymous:LOW:exon4/11:c.276C>T:p.His92His		rs633800	0.3211	0.4503	13690,8944,130	0.1534,0.2736,0.2015,0.5165,0.5716	0.4492							604633 [EFEMP2 (provisional) Cutis laxa,autosomal recessive,type IB,614437];	RCV000150612.2 [benign]; RCV000375568.1 [benign]; 		COSM3752644	585	1076					EFEMP2 (inh=AR pLI=0.03)
chr11	66282095	66282095	G	A	het	pred_pathogenic;anno_omim	QUAL=6493;DP=140;AF=0.49;MQM=60;TRIO=HET,140,0.49,WT,96,0.00,HOM,169,1.00	BBS1,CTD-3074O7.11	missense,synonymous	BBS1:ENST00000537537:missense:MODERATE:exon3/9:c.89G>A:p.Cys30Tyr,BBS1:ENST00000318312:synonymous:LOW:exon4/17:c.378G>A:p.Leu126Leu,BBS1:ENST00000455748:synonymous:LOW:exon4/13:c.378G>A:p.Leu126Leu,BBS1:ENST00000393994:synonymous:LOW:exon4/13:c.378G>A:p.Leu126Leu		rs2298806	0.2117	0.2233	3285,1868,79	0.1340,0.1307,0.2654,0.2348,0.2119	0.2419	1.1130	T	T		D	7.29	209901 [BBS1 (confirmed) Bardet-Biedl syndrome 1,209900];	RCV000247494.1 [benign]; RCV000262515.1 [benign]; 		COSM147274, COSM3998544	88	707					BBS1 (inh=AR pLI=0.00), CTD-3074O7.11 (inh=n/a pLI=n/a)
chr11	66288733	66288733	G	C	het	anno_omim	QUAL=4205;DP=105;AF=0.52;MQM=60;TRIO=HET,105,0.52,WT,69,0.00,HOM,99,0.98	CTD-3074O7.11,BBS1,ZDHHC24	splice_region&intron,3'UTR,intron	BBS1:ENST00000318312:splice_region&intron:LOW:exon8/16:c.724-8G>C:,BBS1:ENST00000537537:splice_region&intron:LOW:exon6/8:c.388-8G>C:,BBS1:ENST00000455748:splice_region&intron:LOW:exon4/12:c.433-8G>C:,ZDHHC24:ENST00000526986:3'UTR:MODIFIER:exon5/5:c.*226C>G:,BBS1:ENST00000393994:intron:MODIFIER:exon8/12:c.723+1514G>C:		rs10896125	0.2426	0.2321	3458,1862,251	0.2317,0.1347,0.2643,0.2349,0.2123	0.2690							209901 [BBS1 (confirmed) Bardet-Biedl syndrome 1,209900];	RCV000082204.5 [benign]; RCV000385461.1 [benign]; 		COSM3998545, COSM147275	89	711					CTD-3074O7.11 (inh=n/a pLI=n/a), BBS1 (inh=AR pLI=0.00), ZDHHC24 (inh=n/a pLI=0.01)
chr11	66297363	66297363	C	T	het	anno_omim	QUAL=11063;DP=206;AF=0.50;MQM=59;TRIO=HET,206,0.50,WT,189,0.00,HOM,274,1.00	CTD-3074O7.11,BBS1,ZDHHC24	synonymous,intron	BBS1:ENST00000318312:synonymous:LOW:exon14/17:c.1413C>T:p.Leu471Leu,BBS1:ENST00000455748:synonymous:LOW:exon10/13:c.1122C>T:p.Leu374Leu,BBS1:ENST00000393994:synonymous:LOW:exon11/13:c.1026C>T:p.Leu342Leu,ZDHHC24:ENST00000526986:intron:MODIFIER:exon2/4:c.560-404G>A:		rs3816492	0.1434	0.2089	2812,1803,11	0.0430,0.1298,0.1252,0.2402,0.2105	0.2081							209901 [BBS1 (confirmed) Bardet-Biedl syndrome 1,209900];	RCV000243070.1 [benign]; RCV000369667.1 [benign]; 		COSM3752663, COSM3752662	86	694					CTD-3074O7.11 (inh=n/a pLI=n/a), BBS1 (inh=AR pLI=0.00), ZDHHC24 (inh=n/a pLI=0.01)
chr11	66299515	66299515	A	G	hom	anno_omim	QUAL=11302;DP=175;AF=0.99;MQM=59;TRIO=HOM,175,0.99,HET,104,0.54,HOM,155,1.00	CTD-3074O7.11,BBS1,ZDHHC24	3'UTR,intron	BBS1:ENST00000318312:3'UTR:MODIFIER:exon17/17:c.*7A>G:,BBS1:ENST00000455748:3'UTR:MODIFIER:exon13/13:c.*7A>G:,BBS1:ENST00000393994:3'UTR:MODIFIER:exon13/13:c.*269A>G:,ZDHHC24:ENST00000526986:intron:MODIFIER:exon2/4:c.560-2556T>C:		rs8432	0.6128	0.5894	13682,8183,2600	0.8550,0.3990,0.5609,0.6157,0.4266	0.6816							209901 [BBS1 (confirmed) Bardet-Biedl syndrome 1,209900];	RCV000241930.1 [benign]; RCV000270220.1 [benign]; 			715	958					CTD-3074O7.11 (inh=n/a pLI=n/a), BBS1 (inh=AR pLI=0.00), ZDHHC24 (inh=n/a pLI=0.01)
chr11	66300348	66300348	A	G	het	anno_omim	QUAL=1902;DP=57;AF=0.49;MQM=60;TRIO=HET,57,0.49,WT,33,0.00,HOM,42,0.98	CTD-3074O7.11,BBS1,ZDHHC24	3'UTR,intron	BBS1:ENST00000318312:3'UTR:MODIFIER:exon17/17:c.*840A>G:,ZDHHC24:ENST00000526986:intron:MODIFIER:exon2/4:c.560-3389T>C:		rs3741360	0.2358	0.0000	0,0,0	0,0,0,0,0	0.2611							209901 [BBS1 (confirmed) Bardet-Biedl syndrome 1,209900];	RCV000406652.1 [likely benign]; 			9	85					CTD-3074O7.11 (inh=n/a pLI=n/a), BBS1 (inh=AR pLI=0.00), ZDHHC24 (inh=n/a pLI=0.01)
chr11	66458980	66458980	G	A	het	anno_omim	QUAL=7340;DP=96;AF=0.57;MQM=59;TRIO=HET,96,0.57,WT,117,0.00,HOM,205,1.00	SPTBN2	synonymous	SPTBN2:ENST00000309996:synonymous:LOW:exon26/37:c.5340C>T:p.Asn1780Asn,SPTBN2:ENST00000533211:synonymous:LOW:exon27/38:c.5340C>T:p.Asn1780Asn,SPTBN2:ENST00000529997:synonymous:LOW:exon25/35:c.5340C>T:p.Asn1780Asn		rs623022	0.0631	0.0659	366,173,1	0.0106,0.0519,0.1086,0.0625,0.0722	0.0652							604985 [SPTBN2 (confirmed) Spinocerebellar ataxia 5,600224|Spinocerebellar ataxia,autosomal recessive 14,615386];	RCV000319541.1 [likely benign]; 			12	296					SPTBN2 (inh=AR+AD pLI=1.00)
chr11	66460527	66460527	C	T	het	anno_omim	QUAL=4377;DP=97;AF=0.60;MQM=59;TRIO=HET,97,0.60,WT,74,0.01,HOM,98,0.98	SPTBN2	synonymous	SPTBN2:ENST00000309996:synonymous:LOW:exon24/37:c.4899G>A:p.Leu1633Leu,SPTBN2:ENST00000533211:synonymous:LOW:exon25/38:c.4899G>A:p.Leu1633Leu,SPTBN2:ENST00000529997:synonymous:LOW:exon23/35:c.4899G>A:p.Leu1633Leu		rs639938	0.0777	0.0695	378,171,13	0.0555,0.0539,0.1082,0.0619,0.0721	0.0780							604985 [SPTBN2 (confirmed) Spinocerebellar ataxia 5,600224|Spinocerebellar ataxia,autosomal recessive 14,615386];	RCV000404452.1 [likely benign]; 		COSM3998546, COSM3998547	14	298					SPTBN2 (inh=AR+AD pLI=1.00)
chr11	66468469	66468469	A	G	het	anno_omim	QUAL=4644;DP=97;AF=0.46;MQM=60;TRIO=HET,97,0.46,WT,128,0.01,HOM,118,0.98	SPTBN2	missense	SPTBN2:ENST00000309996:missense:MODERATE:exon16/37:c.3101T>C:p.Val1034Ala,SPTBN2:ENST00000533211:missense:MODERATE:exon17/38:c.3101T>C:p.Val1034Ala,SPTBN2:ENST00000529997:missense:MODERATE:exon15/35:c.3101T>C:p.Val1034Ala		rs506028	0.2057	0.1335	1312,375,379	0.2877,0.0927,0.2567,0.1043,0.1133	0.1698	-0.1020	T,T,T	T	B	T,T,T	0.01	604985 [SPTBN2 (confirmed) Spinocerebellar ataxia 5,600224|Spinocerebellar ataxia,autosomal recessive 14,615386];	RCV000118411.2 [likely benign]; RCV000390858.1 [benign]; 		COSM3752672, COSM3752673	36	598					SPTBN2 (inh=AR+AD pLI=1.00)
chr11	66472274	66472274	T	C	hom	pred_pathogenic;anno_omim	QUAL=5420;DP=28;AF=1.00;MQM=60;TRIO=HOM,28,1.00,HOM,74,1.00,HOM,72,1.00	SPTBN2	missense	SPTBN2:ENST00000309996:missense:MODERATE:exon14/37:c.2473A>G:p.Ser825Gly,SPTBN2:ENST00000533211:missense:MODERATE:exon15/38:c.2473A>G:p.Ser825Gly,SPTBN2:ENST00000529997:missense:MODERATE:exon13/35:c.2473A>G:p.Ser825Gly		rs4930388	0.9878	0.9969	56199,30704,4050	0.9636,0.9985,1.0000,0.9998,0.9999	0.9974	2.0170	T,T,T	T	B	T,T,T	6.02	604985 [SPTBN2 (confirmed) Spinocerebellar ataxia 5,600224|Spinocerebellar ataxia,autosomal recessive 14,615386];	RCV000336627.1 [benign]; 		COSM3752675, COSM3752674	3248	8					SPTBN2 (inh=AR+AD pLI=1.00)
chr11	66481633	66481633	G	A	het	anno_omim	QUAL=12361;DP=418;AF=0.53;MQM=60;TRIO=HET,418,0.53,HET,528,0.48,WT,634,0.00	SPTBN2	synonymous	SPTBN2:ENST00000309996:synonymous:LOW:exon6/37:c.585C>T:p.Asn195Asn,SPTBN2:ENST00000533211:synonymous:LOW:exon7/38:c.585C>T:p.Asn195Asn,SPTBN2:ENST00000529997:synonymous:LOW:exon5/35:c.585C>T:p.Asn195Asn		rs34775878	0.0407	0.0818	586,514,2	0.0194,0.0647,0.0002,0.1188,0.0429	0.0815							604985 [SPTBN2 (confirmed) Spinocerebellar ataxia 5,600224|Spinocerebellar ataxia,autosomal recessive 14,615386];	RCV000118412.2 [likely benign]; RCV000321710.1 [likely benign]; 			50	655					SPTBN2 (inh=AR+AD pLI=1.00)
chr11	67758895	67758895	G	C	het	low_DP;low_MQM;anno_omim	QUAL=247;DP=14;AF=0.71;MQM=43;TRIO=HET,14,0.71,HOM,7,1.00,WT,14,0.00	UNC93B1	3'UTR	UNC93B1:ENST00000227471:3'UTR:MODIFIER:exon12/12:c.*122C>G:		rs7932	0.2302	0.0000	0,0,0	0,0,0,0,0	0.2552							608204 [UNC93B1 (confirmed) Herpes simplex encephalitis,susceptibility to,1,610551];				18	77					UNC93B1 (inh=n/a pLI=0.51)
chr11	67759254	67759254	G	C	het	low_MQM;anno_omim	QUAL=2164;DP=22;AF=0.27;MQM=35;TRIO=HET,22,0.27,HOM,78,0.99,HET,97,0.24	UNC93B1	synonymous	UNC93B1:ENST00000227471:synonymous:LOW:exon12/12:c.1554C>G:p.Arg518Arg		rs7149	0.2566	0.0564	32,9,6	0.2067,0.0000,0.0275,0.0757,0.0425	0.3325							608204 [UNC93B1 (confirmed) Herpes simplex encephalitis,susceptibility to,1,610551];			COSM1288831	88	316					UNC93B1 (inh=n/a pLI=0.51)
chr11	67765163	67765163	-	G	hom	anno_high_impact;anno_omim	QUAL=14494;DP=74;AF=0.97;MQM=59;TRIO=HOM,74,0.97,HOM,175,1.00,HOM,251,1.00	UNC93B1	splice_acceptor&splice_donor	UNC93B1:ENST00000227471:splice_acceptor&splice_donor:HIGH:exon7/11:c.886-1dupC:		rs5792426	1.0000	1.0000	60061,33107,4866	1.0000,1.0000,1.0000,1.0000,1.0000	1.0000							608204 [UNC93B1 (confirmed) Herpes simplex encephalitis,susceptibility to,1,610551];			COSM1356479	2116	0	1	[1] auto-classification 16.06.2016  [2] Ute Grasshoff 24.11.2015			UNC93B1 (inh=n/a pLI=0.51)
chr11	67804074	67804074	C	T	het	anno_omim	QUAL=12374;DP=195;AF=0.52;MQM=59;TRIO=HET,195,0.52,HOM,337,1.00,WT,384,0.00	NDUFS8	3'UTR	NDUFS8:ENST00000313468:3'UTR:MODIFIER:exon7/7:c.*14C>T:,NDUFS8:ENST00000528492:3'UTR:MODIFIER:exon3/3:c.*14C>T:		rs1051806	0.1699	0.1545	1549,1008,286	0.2419,0.0884,0.1369,0.1766,0.1021	0.1734							602141 [NDUFS8 (confirmed) Leigh syndrome due to mitochondrial complex I deficiency,256000];	RCV000285968.1 [likely benign]; RCV000313524.1 [benign]; RCV000326666.1 [likely benign]; 			76	576					NDUFS8 (inh=AR pLI=0.01)
chr11	67814979	67814979	G	C	hom	anno_omim	QUAL=18974;DP=146;AF=1.00;MQM=59;TRIO=HOM,146,1.00,HOM,199,1.00,HOM,264,1.00	TCIRG1	synonymous	TCIRG1:ENST00000265686:synonymous:LOW:exon11/20:c.1245G>C:p.Leu415Leu,TCIRG1:ENST00000532635:synonymous:LOW:exon6/15:c.597G>C:p.Leu199Leu		rs2471829	0.9698	0.9928	59623,33159,4404	0.9226,0.9964,1.0000,0.9995,1.0000	0.9943	0.4660		T			10.60	604592 [TCIRG1 (confirmed) Osteopetrosis,autosomal recessive 1,259700];	RCV000224273.1 [benign]; 			2103	10					TCIRG1 (inh=AR pLI=0.00)
chr11	68133035	68133035	T	C	het	anno_omim	QUAL=2030;DP=59;AF=0.58;MQM=57;TRIO=HET,59,0.58,HET,133,0.44,WT,200,0.00	LRP5	splice_region&intron	LRP5:ENST00000294304:splice_region&intron:LOW:exon4/22:c.884-4T>C:		rs314776	0.4032	0.3765	10142,5257,2532	0.6963,0.5372,0.0967,0.3970,0.1678	0.4482							603506 [LRP5 (confirmed) Osteoporosis-pseudoglioma syndrome,259770|Bone mineral density variability 1,601884|Hyperostosis,endosteal,144750|van Buchem disease,type 2,607636|Osteosclerosis,144750|Osteoporosis,166710|Exudative vitreoretinopathy 4,601813|Osteopetrosis,autosomal dominant 1,607634];	RCV000252412.2 [benign]; 		COSM3765595	321	997					LRP5 (inh=AR+AD pLI=1.00)
chr11	68171013	68171013	T	C	hom	anno_omim	QUAL=7263;DP=66;AF=1.00;MQM=59;TRIO=HOM,66,1.00,HOM,76,1.00,HOM,91,1.00	LRP5	synonymous	LRP5:ENST00000294304:synonymous:LOW:exon8/23:c.1647T>C:p.Phe549Phe		rs545382	0.8415	0.9001	49650,27709,2102	0.6311,0.9427,0.9884,0.9114,0.9211	0.9070							603506 [LRP5 (confirmed) Osteoporosis-pseudoglioma syndrome,259770|Bone mineral density variability 1,601884|Hyperostosis,endosteal,144750|van Buchem disease,type 2,607636|Osteosclerosis,144750|Osteoporosis,166710|Exudative vitreoretinopathy 4,601813|Osteopetrosis,autosomal dominant 1,607634];	RCV000253993.1 [benign]; 		COSM4146219	1700	392					LRP5 (inh=AR+AD pLI=1.00)
chr11	68174122	68174122	G	A	het	anno_omim	QUAL=9828;DP=293;AF=0.51;MQM=59;TRIO=HET,293,0.51,HET,443,0.55,WT,544,0.00	LRP5	synonymous	LRP5:ENST00000294304:synonymous:LOW:exon9/23:c.1932G>A:p.Glu644Glu		rs2277268	0.0559	0.0598	227,155,20	0.0701,0.0401,0.0430,0.0714,0.0359	0.0587							603506 [LRP5 (confirmed) Osteoporosis-pseudoglioma syndrome,259770|Bone mineral density variability 1,601884|Hyperostosis,endosteal,144750|van Buchem disease,type 2,607636|Osteosclerosis,144750|Osteoporosis,166710|Exudative vitreoretinopathy 4,601813|Osteopetrosis,autosomal dominant 1,607634];	RCV000246217.1 [benign]; 			8	274					LRP5 (inh=AR+AD pLI=1.00)
chr11	68177614	68177614	T	C	het	anno_omim	QUAL=3358;DP=146;AF=0.45;MQM=59;TRIO=HET,146,0.45,HET,188,0.45,WT,228,0.00	LRP5	splice_region&intron	LRP5:ENST00000294304:splice_region&intron:LOW:exon10/22:c.2318+6T>C:		rs4988322	0.0559	0.0667	219,152,18	0.0778,0.0459,0.0485,0.0795,0.0384	0.0593							603506 [LRP5 (confirmed) Osteoporosis-pseudoglioma syndrome,259770|Bone mineral density variability 1,601884|Hyperostosis,endosteal,144750|van Buchem disease,type 2,607636|Osteosclerosis,144750|Osteoporosis,166710|Exudative vitreoretinopathy 4,601813|Osteopetrosis,autosomal dominant 1,607634];	RCV000246341.1 [benign]; 			8	278					LRP5 (inh=AR+AD pLI=1.00)
chr11	68192690	68192690	G	A	het	anno_omim	QUAL=8939;DP=192;AF=0.51;MQM=60;TRIO=HET,192,0.51,WT,170,0.00,HOM,218,1.00	LRP5	synonymous	LRP5:ENST00000294304:synonymous:LOW:exon15/23:c.3357G>A:p.Val1119Val		rs556442	0.5793	0.6755	29005,15721,282	0.2312,0.7043,0.7315,0.6856,0.7868	0.6839							603506 [LRP5 (confirmed) Osteoporosis-pseudoglioma syndrome,259770|Bone mineral density variability 1,601884|Hyperostosis,endosteal,144750|van Buchem disease,type 2,607636|Osteosclerosis,144750|Osteoporosis,166710|Exudative vitreoretinopathy 4,601813|Osteopetrosis,autosomal dominant 1,607634];	RCV000246826.1 [benign]; 		COSM3752692	934	932					LRP5 (inh=AR+AD pLI=1.00)
chr11	68522216	68522216	T	C	het	anno_omim	QUAL=10787;DP=490;AF=0.50;MQM=60;TRIO=HET,490,0.50,HET,312,0.50,WT,392,0.00	CPT1A	3'UTR	CPT1A:ENST00000540367:3'UTR:MODIFIER:exon18/18:c.*68A>G:,CPT1A:ENST00000376618:3'UTR:MODIFIER:exon19/19:c.*68A>G:		rs75022915	0.0104	0.0000	0,0,0	0,0,0,0,0	0.0183							600528 [CPT1A (confirmed) CPT deficiency,hepatic,type IA,255120];				2	111					CPT1A (inh=AR pLI=0.94)
chr11	68523910	68523910	T	C	het	anno_omim	QUAL=10879;DP=292;AF=0.54;MQM=59;TRIO=HET,292,0.54,HET,135,0.60,HOM,139,0.99	CPT1A	3'UTR,intron	CPT1A:ENST00000265641:3'UTR:MODIFIER:exon19/19:c.*1202A>G:,CPT1A:ENST00000540367:intron:MODIFIER:exon17/17:c.2236-1591A>G:,CPT1A:ENST00000376618:intron:MODIFIER:exon18/18:c.2236-1591A>G:		rs2278908	0.6488	0.0000	0,0,0	0,0,0,0,0	0.6625							600528 [CPT1A (confirmed) CPT deficiency,hepatic,type IA,255120];				119	113					CPT1A (inh=AR pLI=0.94)
chr11	68524053	68524053	G	A	het	anno_omim	QUAL=4188;DP=148;AF=0.52;MQM=59;TRIO=HET,148,0.52,HET,53,0.49,HOM,59,1.00	CPT1A	3'UTR,intron	CPT1A:ENST00000265641:3'UTR:MODIFIER:exon19/19:c.*1059C>T:,CPT1A:ENST00000540367:intron:MODIFIER:exon17/17:c.2236-1734C>T:,CPT1A:ENST00000376618:intron:MODIFIER:exon18/18:c.2236-1734C>T:		rs2278907	0.5625	0.0000	0,0,0	0,0,0,0,0	0.5452							600528 [CPT1A (confirmed) CPT deficiency,hepatic,type IA,255120];				84	135					CPT1A (inh=AR pLI=0.94)
chr11	68549340	68549340	A	G	hom	anno_omim	QUAL=37439;DP=324;AF=1.00;MQM=60;TRIO=HOM,324,1.00,HOM,341,1.00,HOM,492,1.00	CPT1A	synonymous	CPT1A:ENST00000265641:synonymous:LOW:exon11/19:c.1251T>C:p.Phe417Phe,CPT1A:ENST00000540367:synonymous:LOW:exon10/18:c.1251T>C:p.Phe417Phe,CPT1A:ENST00000376618:synonymous:LOW:exon11/19:c.1251T>C:p.Phe417Phe,CPT1A:ENST00000539743:synonymous:LOW:exon10/18:c.1251T>C:p.Phe417Phe	L3	rs2228502	0.8926	0.9313	52771,30243,3693	0.8421,0.9477,0.9112,0.9518,0.8867	0.9334							600528 [CPT1A (confirmed) CPT deficiency,hepatic,type IA,255120];	RCV000153103.4 [benign]; 			1811	270					CPT1A (inh=AR pLI=0.94)
chr11	68560787	68560787	C	T	het	anno_omim	QUAL=3290;DP=140;AF=0.54;MQM=60;TRIO=HET,140,0.54,HET,93,0.60,WT,111,0.00	CPT1A	synonymous	CPT1A:ENST00000265641:synonymous:LOW:exon9/19:c.963G>A:p.Glu321Glu,CPT1A:ENST00000540367:synonymous:LOW:exon8/18:c.963G>A:p.Glu321Glu,CPT1A:ENST00000376618:synonymous:LOW:exon9/19:c.963G>A:p.Glu321Glu,CPT1A:ENST00000539743:synonymous:LOW:exon8/18:c.963G>A:p.Glu321Glu,CPT1A:ENST00000538994:synonymous:LOW:exon4/5:c.219G>A:p.Glu73Glu		rs2229737	0.0509	0.1036	557,444,11	0.0447,0.1077,0.0327,0.1377,0.0326	0.0927							600528 [CPT1A (confirmed) CPT deficiency,hepatic,type IA,255120];	RCV000079919.6 [benign]; 		COSM3752694, COSM3752695	22	355					CPT1A (inh=AR pLI=0.94)
chr11	68562328	68562328	C	T	het	pred_pathogenic;anno_omim;anno_pathogenic_clinvar;anno_pathogenic_hgmd	QUAL=9826;DP=418;AF=0.49;MQM=60;TRIO=HET,418,0.49,WT,338,0.00,HET,401,0.52	CPT1A	missense	CPT1A:ENST00000265641:missense:MODERATE:exon8/19:c.823G>A:p.Ala275Thr,CPT1A:ENST00000540367:missense:MODERATE:exon7/18:c.823G>A:p.Ala275Thr,CPT1A:ENST00000376618:missense:MODERATE:exon8/19:c.823G>A:p.Ala275Thr,CPT1A:ENST00000539743:missense:MODERATE:exon7/18:c.823G>A:p.Ala275Thr,CPT1A:ENST00000538994:missense:MODERATE:exon3/5:c.79G>A:p.Ala27Thr		rs2229738	0.0238	0.0647	388,297,2	0.0124,0.0197,0.0002,0.0897,0.0244	0.0701	0.2480	T,T,T,T,T	T	B,B,B	D,D,D,D	12.21	600528 [CPT1A (confirmed) CPT deficiency,hepatic,type IA,255120];	RCV000055868.1 [pathogenic]; RCV000180224.2 [benign]; 	CM033597 [CLASS=DM? MUT=ALT PHEN="Carnitine palmitoyltransferase 1 deficiency" GENE=CPT1A]; 		12	273	2	[2] Peter Bauer 05.08.2014			CPT1A (inh=AR pLI=0.94)
chr11	68671419	68671419	C	T	het	anno_omim	QUAL=1697;DP=65;AF=0.48;MQM=60;TRIO=HET,65,0.48,HOM,50,0.96,WT,105,0.00	IGHMBP2	5'UTR	IGHMBP2:ENST00000255078:5'UTR:MODIFIER:exon1/15:c.-2C>T:,IGHMBP2:ENST00000539224:5'UTR:MODIFIER:exon1/5:c.-2C>T:		rs4930624	0.1160	0.2481	1037,900,20	0.1421,0.3011,0.0404,0.3545,0.0882	0.1881							600502 [IGHMBP2 (provisional) Neuronopathy,distal hereditary motor,type VI,604320|Charcot-Marie-Tooth disease,axonal,type 2S,616155];	RCV000251714.2 [benign]; RCV000349227.1 [benign]; 			113	717					IGHMBP2 (inh=AR pLI=0.00)
chr11	68671477	68671477	T	C	het	low_DP;anno_omim	QUAL=2470;DP=17;AF=0.47;MQM=60;TRIO=HET,17,0.47,HOM,55,1.00,HET,91,0.42	IGHMBP2	synonymous	IGHMBP2:ENST00000255078:synonymous:LOW:exon1/15:c.57T>C:p.Leu19Leu,IGHMBP2:ENST00000539224:synonymous:LOW:exon1/5:c.57T>C:p.Leu19Leu		rs1249463	0.6751	0.7590	5684,2673,466	0.6323,0.7909,0.4412,0.8261,0.7504	0.7702							600502 [IGHMBP2 (provisional) Neuronopathy,distal hereditary motor,type VI,604320|Charcot-Marie-Tooth disease,axonal,type 2S,616155];	RCV000246174.2 [benign]; RCV000400134.1 [benign]; 			1447	593					IGHMBP2 (inh=AR pLI=0.00)
chr11	68678962	68678962	T	C	het	pred_pathogenic;anno_omim	QUAL=18544;DP=273;AF=0.49;MQM=60;TRIO=HET,273,0.49,HOM,316,1.00,HET,457,0.45	IGHMBP2	missense,synonymous	IGHMBP2:ENST00000255078:missense:MODERATE:exon5/15:c.602T>C:p.Leu201Ser,IGHMBP2:ENST00000539224:synonymous:LOW:exon4/5:c.504T>C:p.Phe168Phe		rs560096	0.6805	0.7719	36809,23109,2139	0.6396,0.7883,0.4958,0.8314,0.7458	0.7744	-0.0700	T	T	B	D	0.07	600502 [IGHMBP2 (provisional) Neuronopathy,distal hereditary motor,type VI,604320|Charcot-Marie-Tooth disease,axonal,type 2S,616155];	RCV000248264.1 [benign]; RCV000324070.1 [benign]; 		COSM4146225	1450	597					IGHMBP2 (inh=AR pLI=0.00)
chr11	68682402	68682402	A	G	het	anno_omim	QUAL=4997;DP=166;AF=0.51;MQM=60;TRIO=HET,166,0.51,HOM,96,0.99,WT,113,0.00	IGHMBP2	missense,3'UTR	IGHMBP2:ENST00000255078:missense:MODERATE:exon6/15:c.823A>G:p.Ile275Val,IGHMBP2:ENST00000539224:3'UTR:MODIFIER:exon5/5:c.*146A>G:		rs10896380	0.1198	0.1819	2378,1979,70	0.1220,0.1804,0.0214,0.2448,0.0676	0.1828	1.5760	T	T	B	T	8.17	600502 [IGHMBP2 (provisional) Neuronopathy,distal hereditary motor,type VI,604320|Charcot-Marie-Tooth disease,axonal,type 2S,616155];	RCV000244835.1 [benign]; RCV000388182.1 [benign]; 		COSM1178425	115	715					IGHMBP2 (inh=AR pLI=0.00)
chr11	68701948	68701948	C	T	het	anno_omim	QUAL=12471;DP=202;AF=0.51;MQM=60;TRIO=HET,202,0.51,HOM,325,0.99,WT,451,0.00	IGHMBP2	synonymous	IGHMBP2:ENST00000255078:synonymous:LOW:exon11/15:c.1554C>T:p.Val518Val		rs11228413	0.1328	0.2299	2103,1685,134	0.2094,0.2313,0.0385,0.2866,0.0973	0.1894							600502 [IGHMBP2 (provisional) Neuronopathy,distal hereditary motor,type VI,604320|Charcot-Marie-Tooth disease,axonal,type 2S,616155];	RCV000254390.1 [benign]; RCV000276501.1 [benign]; 		COSM429749	115	720					IGHMBP2 (inh=AR pLI=0.00)
chr11	68704028	68704028	C	T	het	pred_pathogenic;anno_omim	QUAL=5643;DP=117;AF=0.40;MQM=59;TRIO=HET,117,0.40,HOM,152,0.99,WT,170,0.01	IGHMBP2	missense	IGHMBP2:ENST00000255078:missense:MODERATE:exon13/15:c.2080C>T:p.Arg694Trp		rs2236654	0.1330	0.1896	2409,1934,147	0.1764,0.1822,0.0280,0.2473,0.0770	0.1897	0.1980	D	T	B	D	23.40	600502 [IGHMBP2 (provisional) Neuronopathy,distal hereditary motor,type VI,604320|Charcot-Marie-Tooth disease,axonal,type 2S,616155];	RCV000247088.2 [benign]; RCV000340149.1 [benign]; 		COSM3722147	115	720					IGHMBP2 (inh=AR pLI=0.00)
chr11	68707454	68707454	T	C	het	anno_omim	QUAL=3523;DP=115;AF=0.50;MQM=59;TRIO=HET,115,0.50,HOM,45,1.00,HET,73,0.51	IGHMBP2	3'UTR	IGHMBP2:ENST00000255078:3'UTR:MODIFIER:exon15/15:c.*255T>C:		rs564244	0.6709	0.0000	0,0,0	0,0,0,0,0	0.7461							600502 [IGHMBP2 (provisional) Neuronopathy,distal hereditary motor,type VI,604320|Charcot-Marie-Tooth disease,axonal,type 2S,616155];	RCV000303046.1 [benign]; 			151	74					IGHMBP2 (inh=AR pLI=0.00)
chr11	68707880	68707880	T	C	het	anno_omim	QUAL=4916;DP=146;AF=0.51;MQM=59;TRIO=HET,146,0.51,HOM,103,0.99,WT,119,0.00	IGHMBP2	3'UTR	IGHMBP2:ENST00000255078:3'UTR:MODIFIER:exon15/15:c.*681T>C:		rs9095	0.1536	0.0000	0,0,0	0,0,0,0,0	0.2100							600502 [IGHMBP2 (provisional) Neuronopathy,distal hereditary motor,type VI,604320|Charcot-Marie-Tooth disease,axonal,type 2S,616155];	RCV000332785.1 [benign]; 			13	100					IGHMBP2 (inh=AR pLI=0.00)
chr11	70049523	70049523	A	G	het	low_DP;anno_omim	QUAL=1236;DP=15;AF=0.47;MQM=60;TRIO=HET,15,0.47,HOM,39,1.00,WT,57,0.02	FADD	5'UTR	FADD:ENST00000301838:5'UTR:MODIFIER:exon1/2:c.-43A>G:		rs1131677	0.5327	0.5124	2231,1103,134	0.5601,0.4849,0.6153,0.5914,0.4369	0.5712							602457 [FADD (confirmed) Infections,recurrent,with encephalopathy,hepatic dysfunction,and cardiovasuclar malformations,613759];				575	914					FADD (inh=AR pLI=0.67)
chr11	70053123	70053123	-	TGT	het	anno_omim	QUAL=2575;DP=80;AF=0.51;MQM=59;TRIO=HET,80,0.51,HOM,63,1.00,WT,102,0.00	FADD,RP11-805J14.5	3'UTR	FADD:ENST00000301838:3'UTR:MODIFIER:exon2/2:c.*545_*547dupTGT:	G-rich	rs397720848	0.4653	0.0000	0,0,0	0,0,0,0,0	0.4961							602457 [FADD (confirmed) Infections,recurrent,with encephalopathy,hepatic dysfunction,and cardiovasuclar malformations,613759];				66	118					FADD (inh=AR pLI=0.67), RP11-805J14.5 (inh=n/a pLI=n/a)
chr11	70053487	70053487	C	T	het	anno_omim	QUAL=10131;DP=325;AF=0.42;MQM=60;TRIO=HET,325,0.42,HOM,204,1.00,WT,280,0.00	FADD,RP11-805J14.5	3'UTR	FADD:ENST00000301838:3'UTR:MODIFIER:exon2/2:c.*908C>T:		rs1131715	0.5405	0.0000	0,0,0	0,0,0,0,0	0.5787							602457 [FADD (confirmed) Infections,recurrent,with encephalopathy,hepatic dysfunction,and cardiovasuclar malformations,613759];				72	114					FADD (inh=AR pLI=0.67), RP11-805J14.5 (inh=n/a pLI=n/a)
chr11	70314597	70314597	T	A	hom	anno_omim	QUAL=29450;DP=385;AF=1.00;MQM=60;TRIO=HOM,385,1.00,HOM,216,1.00,HOM,301,1.00	SHANK2	3'UTR	SHANK2:ENST00000449833:3'UTR:MODIFIER:exon10/10:c.*4377A>T:		rs513996	0.9635	0.0000	0,0,0	0,0,0,0,0	0.9697							603290 [SHANK2 (provisional) Autism susceptibility 17,613436];				255	1					SHANK2 (inh=AD pLI=1.00)
chr11	70316391	70316391	A	G	het	anno_omim	QUAL=17026;DP=399;AF=0.47;MQM=59;TRIO=HET,399,0.47,HET,280,0.48,HOM,272,1.00	SHANK2	3'UTR	SHANK2:ENST00000338508:3'UTR:MODIFIER:exon33/33:c.*2583T>C:,SHANK2:ENST00000449833:3'UTR:MODIFIER:exon10/10:c.*2583T>C:,SHANK2:ENST00000409161:3'UTR:MODIFIER:exon10/10:c.*2583T>C:,SHANK2:ENST00000423696:3'UTR:MODIFIER:exon16/16:c.*2583T>C:		rs55678639	0.2173	0.0000	0,0,0	0,0,0,0,0	0.2671							603290 [SHANK2 (provisional) Autism susceptibility 17,613436];				22	129					SHANK2 (inh=AD pLI=1.00)
chr11	70318714	70318714	A	G	hom	anno_omim	QUAL=25930;DP=249;AF=1.00;MQM=59;TRIO=HOM,249,1.00,HOM,260,1.00,HOM,306,1.00	SHANK2	3'UTR	SHANK2:ENST00000338508:3'UTR:MODIFIER:exon33/33:c.*260T>C:,SHANK2:ENST00000449833:3'UTR:MODIFIER:exon10/10:c.*260T>C:,SHANK2:ENST00000409161:3'UTR:MODIFIER:exon10/10:c.*260T>C:,SHANK2:ENST00000423696:3'UTR:MODIFIER:exon16/16:c.*260T>C:		rs578657	0.9683	0.0000	0,0,0	0,0,0,0,0	0.9721							603290 [SHANK2 (provisional) Autism susceptibility 17,613436];				262	1					SHANK2 (inh=AD pLI=1.00)
chr11	70666765	70666765	C	T	het	anno_omim	QUAL=471;DP=20;AF=0.40;MQM=60;TRIO=HET,20,0.40,HET,32,0.53,WT,54,0.00	SHANK2	synonymous	SHANK2:ENST00000338508:synonymous:LOW:exon18/33:c.1200G>A:p.Ala400Ala,SHANK2:ENST00000423696:synonymous:LOW:exon2/16:c.60G>A:p.Ala20Ala		rs11237599	0.0931	0.1511	89,71,0	0.0417,0.0000,0.1140,0.2560,0.0798	0.1699							603290 [SHANK2 (provisional) Autism susceptibility 17,613436];				80	557					SHANK2 (inh=AD pLI=1.00)
chr11	70935766	70935766	T	C	het	anno_omim	QUAL=15957;DP=315;AF=0.46;MQM=60;TRIO=HET,315,0.46,HOM,263,1.00,HET,373,0.43	SHANK2				rs3020047	0.7468	0.0000	0,0,0	0,0,0,0,0	0.6017							603290 [SHANK2 (provisional) Autism susceptibility 17,613436];	RCV000307493.1 [likely benign]; 			56	105					SHANK2 (inh=AD pLI=1.00)
chr11	71145687	71145687	T	C	hom	anno_omim	QUAL=18606;DP=214;AF=1.00;MQM=59;TRIO=HOM,214,1.00,HOM,164,1.00,HOM,201,1.00	DHCR7	3'UTR	DHCR7:ENST00000355527:3'UTR:MODIFIER:exon9/9:c.*734A>G:,DHCR7:ENST00000407721:3'UTR:MODIFIER:exon9/9:c.*734A>G:	LTR41B	rs7690	0.7736	0.0000	0,0,0	0,0,0,0,0	0.8703							602858 [DHCR7 (confirmed) Smith-Lemli-Opitz syndrome,270400];	RCV000265019.1 [benign]; 			205	19					DHCR7 (inh=AR pLI=0.00)
chr11	71145778	71145778	G	A	hom	anno_omim	QUAL=22902;DP=200;AF=0.99;MQM=59;TRIO=HOM,200,0.99,HOM,234,1.00,HOM,299,1.00	DHCR7	3'UTR	DHCR7:ENST00000355527:3'UTR:MODIFIER:exon9/9:c.*643C>T:,DHCR7:ENST00000407721:3'UTR:MODIFIER:exon9/9:c.*643C>T:		rs1044535	0.7436	0.0000	0,0,0	0,0,0,0,0	0.8533							602858 [DHCR7 (confirmed) Smith-Lemli-Opitz syndrome,270400];	RCV000335396.1 [benign]; 			198	21					DHCR7 (inh=AR pLI=0.00)
chr11	71145941	71145941	G	A	het	anno_omim	QUAL=17450;DP=209;AF=0.44;MQM=60;TRIO=HET,209,0.44,HET,290,0.49,HOM,388,0.99	DHCR7	3'UTR	DHCR7:ENST00000355527:3'UTR:MODIFIER:exon9/9:c.*480C>T:,DHCR7:ENST00000407721:3'UTR:MODIFIER:exon9/9:c.*480C>T:	LTR41B	rs1790345	0.3594	0.0000	0,0,0	0,0,0,0,0	0.2931							602858 [DHCR7 (confirmed) Smith-Lemli-Opitz syndrome,270400];	RCV000389863.1 [likely benign]; 			10	98					DHCR7 (inh=AR pLI=0.00)
chr11	71146249	71146260	AGCAAGGAACAG	-	het	anno_omim	QUAL=19666;DP=236;AF=0.47;MQM=59;TRIO=HET,236,0.47,HET,372,0.51,HOM,480,1.00	DHCR7	3'UTR	DHCR7:ENST00000355527:3'UTR:MODIFIER:exon9/9:c.*161_*172delCTGTTCCTTGCT:,DHCR7:ENST00000407721:3'UTR:MODIFIER:exon9/9:c.*161_*172delCTGTTCCTTGCT:		rs368755383	0.3544	0.4544	1513,287,69	0.4942,0.4663,0.5503,0.3968,0.4826	0.2928							602858 [DHCR7 (confirmed) Smith-Lemli-Opitz syndrome,270400];	RCV000307027.1 [likely benign]; 			122	621					DHCR7 (inh=AR pLI=0.00)
chr11	71146577	71146577	G	A	het	anno_omim	QUAL=3677;DP=116;AF=0.46;MQM=59;TRIO=HET,116,0.46,HET,299,0.46,WT,428,0.00	DHCR7	synonymous	DHCR7:ENST00000355527:synonymous:LOW:exon9/9:c.1272C>T:p.Gly424Gly,DHCR7:ENST00000407721:synonymous:LOW:exon9/9:c.1272C>T:p.Gly424Gly		rs909217	0.3820	0.5499	19688,15390,493	0.3200,0.5246,0.3933,0.6938,0.2105	0.5601							602858 [DHCR7 (confirmed) Smith-Lemli-Opitz syndrome,270400];	RCV000079641.6 [benign]; RCV000352975.1 [likely benign]; 		COSM329305	901	841					DHCR7 (inh=AR pLI=0.00)
chr11	71146691	71146691	A	G	hom	pred_pathogenic;anno_omim	QUAL=13139;DP=104;AF=1.00;MQM=59;TRIO=HOM,104,1.00,HOM,172,1.00,HOM,172,1.00	DHCR7	synonymous	DHCR7:ENST00000355527:synonymous:LOW:exon9/9:c.1158T>C:p.Asp386Asp,DHCR7:ENST00000407721:synonymous:LOW:exon9/9:c.1158T>C:p.Asp386Asp		rs760241	0.7564	0.8531	44219,28936,2543	0.7140,0.7206,0.7847,0.9418,0.6782	0.8649	-0.7980	D	T		D	0.01	602858 [DHCR7 (confirmed) Smith-Lemli-Opitz syndrome,270400];	RCV000079639.6 [benign]; RCV000276871.1 [benign]; 		COSM429787, COSM1475860	1710	352					DHCR7 (inh=AR pLI=0.00)
chr11	71152461	71152461	A	G	hom	anno_omim	QUAL=31128;DP=249;AF=1.00;MQM=60;TRIO=HOM,249,1.00,HOM,307,1.00,HOM,436,1.00	DHCR7	synonymous	DHCR7:ENST00000355527:synonymous:LOW:exon6/9:c.438T>C:p.Asn146Asn,DHCR7:ENST00000407721:synonymous:LOW:exon6/9:c.438T>C:p.Asn146Asn		rs949177	0.8073	0.8748	46425,29488,3574	0.8356,0.7563,0.8501,0.9435,0.6872	0.9048							602858 [DHCR7 (confirmed) Smith-Lemli-Opitz syndrome,270400];	RCV000079654.6 [benign]; RCV000355894.1 [benign]; 			1730	326					DHCR7 (inh=AR pLI=0.00)
chr11	71155153	71155153	A	G	hom	anno_omim	QUAL=28422;DP=248;AF=1.00;MQM=59;TRIO=HOM,248,1.00,HOM,270,1.00,HOM,371,1.00	DHCR7	synonymous	DHCR7:ENST00000355527:synonymous:LOW:exon4/9:c.207T>C:p.Thr69Thr,DHCR7:ENST00000407721:synonymous:LOW:exon4/9:c.207T>C:p.Thr69Thr		rs1790334	0.8101	0.8755	45276,28900,3465	0.8429,0.7542,0.8511,0.9431,0.6874	0.9070							602858 [DHCR7 (confirmed) Smith-Lemli-Opitz syndrome,270400];	RCV000079649.6 [benign]; RCV000368185.1 [benign]; 		COSM4146259, COSM4146260	1734	330					DHCR7 (inh=AR pLI=0.00)
chr11	71155171	71155171	C	T	het	anno_omim	QUAL=6706;DP=256;AF=0.55;MQM=59;TRIO=HET,256,0.55,HET,285,0.46,WT,374,0.00	DHCR7	synonymous	DHCR7:ENST00000355527:synonymous:LOW:exon4/9:c.189G>A:p.Gln63Gln,DHCR7:ENST00000407721:synonymous:LOW:exon4/9:c.189G>A:p.Gln63Gln		rs1044482	0.4010	0.5719	19162,15003,756	0.4149,0.5516,0.3899,0.7015,0.2209	0.5820							602858 [DHCR7 (confirmed) Smith-Lemli-Opitz syndrome,270400];	RCV000079647.6 [benign]; RCV000271282.1 [likely benign]; 		COSM3931425, COSM3931426	911	828					DHCR7 (inh=AR pLI=0.00)
chr11	71159429	71159429	G	A	hom	anno_omim	QUAL=3481;DP=37;AF=0.97;MQM=59;TRIO=HOM,37,0.97,HET,81,0.56,HET,97,0.60	DHCR7	5'UTR	DHCR7:ENST00000355527:5'UTR:MODIFIER:exon1/9:c.-225C>T:,DHCR7:ENST00000407721:5'UTR:MODIFIER:exon1/9:c.-202C>T:		rs4944946	0.3534	0.0000	0,0,0	0,0,0,0,0	0.5397							602858 [DHCR7 (confirmed) Smith-Lemli-Opitz syndrome,270400];	RCV000402332.1 [likely benign]; 			121	92					DHCR7 (inh=AR pLI=0.00)
chr11	74165954	74165954	G	C	het	anno_omim	QUAL=10086;DP=410;AF=0.45;MQM=60;TRIO=HET,410,0.45,HET,407,0.48,WT,503,0.00	KCNE3,RP11-702H23.4	3'UTR	KCNE3:ENST00000310128:3'UTR:MODIFIER:exon3/3:c.*2343C>G:		rs34315739	0.1677	0.0000	0,0,0	0,0,0,0,0	0.1489							604433 [KCNE3 (provisional) Brugada syndrome 6,613119];	RCV000270258.1 [likely benign]; 			3	56					KCNE3 (inh=AD pLI=0.44), RP11-702H23.4 (inh=n/a pLI=n/a)
chr11	74166278	74166278	G	A	hom	anno_omim	QUAL=19111;DP=321;AF=1.00;MQM=60;TRIO=HOM,321,1.00,HOM,113,1.00,HOM,145,1.00	KCNE3,RP11-702H23.4	3'UTR	KCNE3:ENST00000310128:3'UTR:MODIFIER:exon3/3:c.*2019C>T:		rs9516	0.5960	0.0000	0,0,0	0,0,0,0,0	0.5945							604433 [KCNE3 (provisional) Brugada syndrome 6,613119];	RCV000374272.1 [likely benign]; 			60	128					KCNE3 (inh=AD pLI=0.44), RP11-702H23.4 (inh=n/a pLI=n/a)
chr11	74166320	74166320	T	G	hom	anno_omim	QUAL=20899;DP=285;AF=0.99;MQM=59;TRIO=HOM,285,0.99,HOM,153,1.00,HOM,201,1.00	KCNE3,RP11-702H23.4	3'UTR	KCNE3:ENST00000310128:3'UTR:MODIFIER:exon3/3:c.*1977A>C:		rs7789	0.4247	0.0000	0,0,0	0,0,0,0,0	0.4284							604433 [KCNE3 (provisional) Brugada syndrome 6,613119];	RCV000282115.1 [likely benign]; 			45	117					KCNE3 (inh=AD pLI=0.44), RP11-702H23.4 (inh=n/a pLI=n/a)
chr11	74166781	74166781	-	T	het	anno_omim	QUAL=2040;DP=193;AF=0.40;MQM=56;TRIO=HET,193,0.40,HET,94,0.41,WT,140,0.00	KCNE3,RP11-702H23.4,RP11-702H23.6	3'UTR	KCNE3:ENST00000310128:3'UTR:MODIFIER:exon3/3:c.*1515dupA:	AluSx1	rs141878274	0.2863	0.0000	0,0,0	0,0,0,0,0	0.2475							604433 [KCNE3 (provisional) Brugada syndrome 6,613119];	RCV000395884.1 [likely benign]; 			4	46					KCNE3 (inh=AD pLI=0.44), RP11-702H23.4 (inh=n/a pLI=n/a), RP11-702H23.6 (inh=n/a pLI=n/a)
chr11	74166859	74166859	A	G	hom	anno_omim	QUAL=11391;DP=167;AF=0.99;MQM=51;TRIO=HOM,167,0.99,HOM,86,0.99,HOM,126,0.99	KCNE3,RP11-702H23.6,RP11-702H23.4	3'UTR	KCNE3:ENST00000310128:3'UTR:MODIFIER:exon3/3:c.*1438T>C:	AluSx1	rs35833816	0.5956	0.0000	0,0,0	0,0,0,0,0	0.5448							604433 [KCNE3 (provisional) Brugada syndrome 6,613119];	RCV000346048.1 [likely benign]; 			34	83					KCNE3 (inh=AD pLI=0.44), RP11-702H23.6 (inh=n/a pLI=n/a), RP11-702H23.4 (inh=n/a pLI=n/a)
chr11	74166866	74166866	G	A	hom	anno_omim	QUAL=11466;DP=162;AF=0.99;MQM=52;TRIO=HOM,162,0.99,HOM,87,0.99,HOM,124,0.99	KCNE3,RP11-702H23.6,RP11-702H23.4	3'UTR	KCNE3:ENST00000310128:3'UTR:MODIFIER:exon3/3:c.*1431C>T:	AluSx1	rs28705219	0.5671	0.0000	0,0,0	0,0,0,0,0	0.5118							604433 [KCNE3 (provisional) Brugada syndrome 6,613119];	RCV000389926.1 [likely benign]; 			34	80					KCNE3 (inh=AD pLI=0.44), RP11-702H23.6 (inh=n/a pLI=n/a), RP11-702H23.4 (inh=n/a pLI=n/a)
chr11	74167201	74167206	ATATAT	-	hom	low_DP;anno_omim	QUAL=173;DP=6;AF=1.00;MQM=60;TRIO=HOM,6,1.00,WT,29,0.00,WT,32,0.00	KCNE3,RP11-702H23.6,RP11-702H23.4	3'UTR	KCNE3:ENST00000310128:3'UTR:MODIFIER:exon3/3:c.*1091_*1096delATATAT:	AluSx1:(AT)n	rs113583236;rs56871652;rs773139324	0.0000	0.0000	0,0,0	0,0,0,0,0	0.6650							604433 [KCNE3 (provisional) Brugada syndrome 6,613119];	RCV000386156.1 [uncertain significance]; 			25	0					KCNE3 (inh=AD pLI=0.44), RP11-702H23.6 (inh=n/a pLI=n/a), RP11-702H23.4 (inh=n/a pLI=n/a)
chr11	74167388	74167388	G	A	het	anno_omim	QUAL=5424;DP=175;AF=0.39;MQM=55;TRIO=HET,175,0.56,HET,99,0.57,HET,155,0.79	KCNE3,RP11-702H23.6,RP11-702H23.4	3'UTR	KCNE3:ENST00000310128:3'UTR:MODIFIER:exon3/3:c.*909C>T:	AluSx1	rs41258394	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0189							604433 [KCNE3 (provisional) Brugada syndrome 6,613119];	RCV000336440.1 [uncertain significance]; 			4	39					KCNE3 (inh=AD pLI=0.44), RP11-702H23.6 (inh=n/a pLI=n/a), RP11-702H23.4 (inh=n/a pLI=n/a)
chr11	74167409	74167409	T	C	hom	anno_omim	QUAL=15881;DP=193;AF=1.00;MQM=59;TRIO=HOM,193,1.00,HOM,129,0.99,HOM,213,1.00	KCNE3,RP11-702H23.6,RP11-702H23.4	3'UTR	KCNE3:ENST00000310128:3'UTR:MODIFIER:exon3/3:c.*888A>G:		rs12272502	0.5667	0.0000	0,0,0	0,0,0,0,0	0.5129							604433 [KCNE3 (provisional) Brugada syndrome 6,613119];	RCV000399322.1 [likely benign]; 			41	78					KCNE3 (inh=AD pLI=0.44), RP11-702H23.6 (inh=n/a pLI=n/a), RP11-702H23.4 (inh=n/a pLI=n/a)
chr11	74167630	74167630	A	G	hom	anno_omim	QUAL=22404;DP=239;AF=1.00;MQM=60;TRIO=HOM,239,1.00,HOM,193,1.00,HOM,246,1.00	KCNE3,RP11-702H23.6,RP11-702H23.4	3'UTR	KCNE3:ENST00000310128:3'UTR:MODIFIER:exon3/3:c.*667T>C:	Arthur1B	rs12271177	0.5733	0.0000	0,0,0	0,0,0,0,0	0.5224							604433 [KCNE3 (provisional) Brugada syndrome 6,613119];	RCV000311159.1 [likely benign]; 			52	115					KCNE3 (inh=AD pLI=0.44), RP11-702H23.6 (inh=n/a pLI=n/a), RP11-702H23.4 (inh=n/a pLI=n/a)
chr11	74168411	74168411	A	G	het	anno_omim	QUAL=4218;DP=162;AF=0.47;MQM=60;TRIO=HET,162,0.47,HET,166,0.57,WT,267,0.00	KCNE3,RP11-702H23.4	synonymous	KCNE3:ENST00000310128:synonymous:LOW:exon3/3:c.198T>C:p.Phe66Phe,KCNE3:ENST00000525550:synonymous:LOW:exon2/2:c.198T>C:p.Phe66Phe		rs2270676	0.1412	0.1336	1245,458,90	0.1306,0.0873,0.1281,0.1151,0.2119	0.1389							604433 [KCNE3 (provisional) Brugada syndrome 6,613119];	RCV000245979.1 [benign]; RCV000250331.1 [benign]; RCV000399032.1 [likely benign]; 	CM057459 [CLASS=DP MUT=ALT PHEN="Meniere's disease association with" GENE=KCNE3]; 		35	430					KCNE3 (inh=AD pLI=0.44), RP11-702H23.4 (inh=n/a pLI=n/a)
chr11	76853783	76853783	T	C	het	pred_pathogenic;anno_omim	QUAL=9836;DP=139;AF=0.51;MQM=59;TRIO=HET,139,0.51,WT,136,0.01,HOM,263,1.00	MYO7A	missense	MYO7A:ENST00000409709:missense:MODERATE:exon3/49:c.47T>C:p.Leu16Ser,MYO7A:ENST00000409893:missense:MODERATE:exon3/27:c.47T>C:p.Leu16Ser,MYO7A:ENST00000458637:missense:MODERATE:exon3/49:c.47T>C:p.Leu16Ser,MYO7A:ENST00000409619:missense:MODERATE:exon4/50:c.14T>C:p.Leu5Ser		rs1052030	0.5136	0.4348	9797,3817,2689	0.7720,0.4188,0.5181,0.3780,0.4527	0.4611	4.4690	T,T,T,T,T,T,T,T	T	B,B,B	D,D,D,D	8.79	276903 [MYO7A (confirmed) Usher syndrome,type 1B,276900|Deafness,autosomal recessive 2,600060|Deafness,autosomal dominant 11,601317];	RCV000036163.4 [benign]; RCV000132571.1 [likely benign]; RCV000261128.1 [benign]; RCV000318604.1 [benign]; RCV000353260.1 [benign]; 		COSM4146342	346	947					MYO7A (inh=AR+AD pLI=0.00)
chr11	76868392	76868392	A	G	het	pred_pathogenic;anno_omim;anno_pathogenic_hgmd	QUAL=8814;DP=272;AF=0.50;MQM=60;TRIO=HET,272,0.50,WT,284,0.00,HET,367,0.53	MYO7A	missense	MYO7A:ENST00000409709:missense:MODERATE:exon8/49:c.803A>G:p.Lys268Arg,MYO7A:ENST00000409893:missense:MODERATE:exon8/27:c.803A>G:p.Lys268Arg,MYO7A:ENST00000458637:missense:MODERATE:exon8/49:c.803A>G:p.Lys268Arg,MYO7A:ENST00000409619:missense:MODERATE:exon9/50:c.770A>G:p.Lys257Arg		rs184866544	0.0006	0.0011	0,0,0	0.0001,0.0008,0.0000,0.0019,0.0000	0.0010	0.6210	T,T,T,T,T,T,T,T	D	B,B,B	D,D,D,D	15.69	276903 [MYO7A (confirmed) Usher syndrome,type 1B,276900|Deafness,autosomal recessive 2,600060|Deafness,autosomal dominant 11,601317];	RCV000155225.3 [other]; 	CM112920 [CLASS=DM? MUT=ALT PHEN="Usher syndrome 2" GENE=MYO7A]; 		0	3					MYO7A (inh=AR+AD pLI=0.00)
chr11	76895855	76895855	C	G	het	pred_pathogenic;anno_omim	QUAL=10477;DP=348;AF=0.53;MQM=60;TRIO=HET,348,0.53,HET,472,0.47,WT,558,0.00	MYO7A	3'UTR,intron	MYO7A:ENST00000409893:3'UTR:MODIFIER:exon27/27:c.*61C>G:,MYO7A:ENST00000409709:intron:MODIFIER:exon27/48:c.3503+95C>G:,MYO7A:ENST00000458637:intron:MODIFIER:exon27/48:c.3503+95C>G:,MYO7A:ENST00000409619:intron:MODIFIER:exon28/49:c.3470+95C>G:	MIRb	rs576982361	0.0010	0.0027	0,0,0	0.0006,0.0018,0.0000,0.0059,0.0004	0.0019	-0.0160	D	T			3.41	276903 [MYO7A (confirmed) Usher syndrome,type 1B,276900|Deafness,autosomal recessive 2,600060|Deafness,autosomal dominant 11,601317];				0	8					MYO7A (inh=AR+AD pLI=0.00)
chr11	76926245	76926245	C	T	het	anno_omim	QUAL=6869;DP=268;AF=0.53;MQM=60;TRIO=HET,268,0.53,HET,134,0.50,HET,174,0.52	MYO7A	3'UTR	MYO7A:ENST00000409709:3'UTR:MODIFIER:exon49/49:c.*504C>T:,MYO7A:ENST00000458637:3'UTR:MODIFIER:exon49/49:c.*504C>T:		rs34765389	0.0339	0.0000	0,0,0	0,0,0,0,0	0.0648							276903 [MYO7A (confirmed) Usher syndrome,type 1B,276900|Deafness,autosomal recessive 2,600060|Deafness,autosomal dominant 11,601317];	RCV000282133.1 [likely benign]; RCV000320801.1 [likely benign]; RCV000374295.1 [likely benign]; 			0	39					MYO7A (inh=AR+AD pLI=0.00)
chr11	77811990	77811990	T	C	hom	anno_omim	QUAL=14759;DP=121;AF=1.00;MQM=59;TRIO=HOM,121,1.00,HOM,154,1.00,HOM,187,1.00	ALG8	splice_region,3'UTR	ALG8:ENST00000299626:splice_region:LOW:exon13/13:c.*20A>G:,ALG8:ENST00000299626:3'UTR:MODIFIER:exon13/13:c.*20A>G:		rs1263505	0.8327	0.8319	42282,24157,4541	0.9342,0.6844,0.7542,0.8504,0.8331	0.8601							608103 [ALG8 (provisional) Congenital disorder of glycosylation,type Ih,608104];	RCV000082154.5 [benign]; RCV000377689.1 [benign]; 			1549	471					ALG8 (inh=n/a pLI=0.00)
chr11	77825320	77825320	T	C	hom	pred_pathogenic;anno_omim	QUAL=19441;DP=248;AF=0.99;MQM=60;TRIO=HOM,248,0.99,HOM,223,1.00,HET,351,0.46	ALG8	missense	ALG8:ENST00000299626:missense:MODERATE:exon6/13:c.665A>G:p.Asn222Ser,ALG8:ENST00000376156:missense:MODERATE:exon6/14:c.665A>G:p.Asn222Ser		rs665278	0.1464	0.1991	2626,1804,18	0.0639,0.2110,0.1020,0.2303,0.2065	0.2024	0.5410	.,.,T,T,T,T,T,T,T	T,T	.,B,B,B	.,D,D,D,D,D,D,D	0.99	608103 [ALG8 (provisional) Congenital disorder of glycosylation,type Ih,608104];	RCV000082158.5 [other]; RCV000312261.1 [likely benign]; 		COSM3752755	145	709					ALG8 (inh=n/a pLI=0.00)
chr11	87013438	87013438	G	A	hom	pred_pathogenic	QUAL=19888;DP=225;AF=1.00;MQM=60;TRIO=HOM,225,1.00,HOM,146,1.00,HOM,233,1.00	TMEM135	missense	TMEM135:ENST00000305494:missense:MODERATE:exon8/15:c.652G>A:p.Gly218Arg,TMEM135:ENST00000340353:missense:MODERATE:exon7/14:c.586G>A:p.Gly196Arg,TMEM135:ENST00000532959:missense:MODERATE:exon5/12:c.265G>A:p.Gly89Arg,TMEM135:ENST00000535167:missense:MODERATE:exon7/14:c.235G>A:p.Gly79Arg		rs2276102	0.5829	0.6239	24141,14924,1951	0.6132,0.4575,0.4753,0.6677,0.6830	0.6189	2.4950	T,T,T,T,T	T	B,B	T,T,T,T	11.02					968	927					TMEM135 (inh=n/a pLI=0.88)
chr11	87036784	87036784	T	C	hom		QUAL=23599;DP=350;AF=1.00;MQM=60;TRIO=HOM,350,1.00,HOM,167,0.99,HOM,202,0.99	RP11,777F6.3,PSMA2P1	intergenic_region	PSMA2P1:ENSG00000270510-ENSG00000254582:intergenic_region:MODIFIER::n.87036784T>C:		rs10898669	0.2306	0.3313	627,245,3	0.0000,0.0000,0.0000,0.4146,0.3090	0.3077											71	279					PRPF31 (inh=AD pLI=0.97), 777F6.3 (inh=n/a pLI=n/a), PSMA2P1 (inh=n/a pLI=n/a)
chr11	87037139	87037139	T	A	het		QUAL=6485;DP=262;AF=0.56;MQM=60;TRIO=HET,262,0.66,WT,117,0.22,HET,179,0.63	RP11,777F6.3,PSMA2P1	intergenic_region	PSMA2P1:ENSG00000270510-ENSG00000254582:intergenic_region:MODIFIER::n.87037139T>A:		rs551809652	0.0006	0.0000	0,0,0	0,0,0,0,0	0.0007											0	2					PRPF31 (inh=AD pLI=0.97), 777F6.3 (inh=n/a pLI=n/a), PSMA2P1 (inh=n/a pLI=n/a)
chr11	87037202	87037202	T	C	hom		QUAL=24302;DP=301;AF=0.99;MQM=59;TRIO=HOM,301,0.99,HOM,181,1.00,HOM,289,1.00	RP11,777F6.3,PSMA2P1	intergenic_region	PSMA2P1:ENSG00000270510-ENSG00000254582:intergenic_region:MODIFIER::n.87037202T>C:		rs12276145	0.2151	0.3310	626,249,3	0.0000,0.0000,0.0000,0.4155,0.3079	0.3031											71	278					PRPF31 (inh=AD pLI=0.97), 777F6.3 (inh=n/a pLI=n/a), PSMA2P1 (inh=n/a pLI=n/a)
chr11	87037565	87037565	T	C	hom		QUAL=35015;DP=482;AF=1.00;MQM=60;TRIO=HOM,482,1.00,HOM,228,0.99,HOM,348,1.00	RP11,777F6.3,PSMA2P1	intergenic_region	PSMA2P1:ENSG00000270510-ENSG00000254582:intergenic_region:MODIFIER::n.87037565T>C:		rs7926724	0.4461	0.5730	1775,570,19	0.0000,0.0000,0.0000,0.6365,0.5580	0.5263											214	278					PRPF31 (inh=AD pLI=0.97), 777F6.3 (inh=n/a pLI=n/a), PSMA2P1 (inh=n/a pLI=n/a)
chr11	87037680	87037680	A	G	hom		QUAL=14545;DP=216;AF=1.00;MQM=59;TRIO=HOM,216,1.00,HOM,113,1.00,HOM,167,1.00	RP11,777F6.3,PSMA2P1	intergenic_region	PSMA2P1:ENSG00000270510-ENSG00000254582:intergenic_region:MODIFIER::n.87037680A>G:	(TCCTT)n	rs12282551	0.3502	0.4716	1222,401,16	0.0000,0.0000,0.0000,0.5503,0.4480	0.4349											150	288					PRPF31 (inh=AD pLI=0.97), 777F6.3 (inh=n/a pLI=n/a), PSMA2P1 (inh=n/a pLI=n/a)
chr11	87037743	87037743	G	A	hom		QUAL=13879;DP=193;AF=0.99;MQM=59;TRIO=HOM,193,0.99,HOM,105,1.00,HOM,123,1.00	RP11,777F6.3,PSMA2P1	intergenic_region	PSMA2P1:ENSG00000270510-ENSG00000254582:intergenic_region:MODIFIER::n.87037743G>A:		rs10898670	0.3385	0.4709	1220,402,13	0.0000,0.0000,0.0000,0.5510,0.4479	0.4329											150	288					PRPF31 (inh=AD pLI=0.97), 777F6.3 (inh=n/a pLI=n/a), PSMA2P1 (inh=n/a pLI=n/a)
chr11	87037954	87037955	TT	-	hom		QUAL=2248;DP=88;AF=0.42;MQM=59;TRIO=HOM,88,0.42,HOM,43,0.58,WT,42,0.36	RP11,777F6.3,PSMA2P1	intergenic_region	PSMA2P1:ENSG00000270510-ENSG00000254582:intergenic_region:MODIFIER::n.87037954_87037955delTT:	(T)n	rs756445728	0.0000	0.2815	5,1,0	0.0000,0.0000,0.0000,0.2780,0.2849	0.2705											119	57					PRPF31 (inh=AD pLI=0.97), 777F6.3 (inh=n/a pLI=n/a), PSMA2P1 (inh=n/a pLI=n/a)
chr11	87039402	87039402	G	A	hom		QUAL=19340;DP=277;AF=1.00;MQM=59;TRIO=HOM,277,1.00,HOM,136,0.99,HOM,188,1.00	RP11,777F6.3,PSMA2P1	intergenic_region	PSMA2P1:ENSG00000270510-ENSG00000254582:intergenic_region:MODIFIER::n.87039402G>A:		rs4480563	0.3411	0.4620	1171,399,12	0.0000,0.0000,0.0000,0.5504,0.4352	0.4304											149	289					PRPF31 (inh=AD pLI=0.97), 777F6.3 (inh=n/a pLI=n/a), PSMA2P1 (inh=n/a pLI=n/a)
chr11	87039467	87039467	T	G	hom		QUAL=20642;DP=299;AF=1.00;MQM=58;TRIO=HOM,299,1.00,HOM,143,1.00,HOM,175,0.99	RP11,777F6.3,PSMA2P1	intergenic_region	PSMA2P1:ENSG00000270510-ENSG00000254582:intergenic_region:MODIFIER::n.87039467T>G:	L1PB3	rs4644661	0.3413	0.4601	1163,397,12	0.0000,0.0000,0.0000,0.5466,0.4339	0.4300											149	289					PRPF31 (inh=AD pLI=0.97), 777F6.3 (inh=n/a pLI=n/a), PSMA2P1 (inh=n/a pLI=n/a)
chr11	87039532	87039532	C	T	hom		QUAL=21042;DP=295;AF=1.00;MQM=60;TRIO=HOM,295,1.00,HOM,148,0.99,HOM,196,1.00	RP11,777F6.3,PSMA2P1	intergenic_region	PSMA2P1:ENSG00000270510-ENSG00000254582:intergenic_region:MODIFIER::n.87039532C>T:	L1PB3	rs4318005	0.3411	0.4612	1168,397,12	0.0000,0.0000,0.0000,0.5484,0.4347	0.4302											149	289					PRPF31 (inh=AD pLI=0.97), 777F6.3 (inh=n/a pLI=n/a), PSMA2P1 (inh=n/a pLI=n/a)
chr11	88045583	88045583	A	G	het	anno_omim	QUAL=12386;DP=249;AF=0.49;MQM=60;TRIO=HET,249,0.49,HOM,212,1.00,HET,255,0.40	CTSC	missense	CTSC:ENST00000227266:missense:MODERATE:exon3/7:c.458T>C:p.Ile153Thr		rs217086	0.9309	0.8861	47848,23928,4334	0.9139,0.9230,0.9995,0.8460,0.9427	0.8838	-0.6170	T,T,.	T,.	B,.	T,.	0.01	602365 [CTSC (confirmed) Papillon-Lefevre syndrome,245000|Haim-Munk syndrome,245010|Periodontitis 1,juvenile,170650];			COSM3752799	1577	493	2	[2] old entry - no details available			CTSC (inh=AR pLI=0.00)
chr11	88053979	88053979	T	C	het	anno_omim	QUAL=5870;DP=130;AF=0.58;MQM=60;TRIO=HET,130,0.58,HOM,77,1.00,HET,106,0.55	CTSC	splice_region,3'UTR,intron	CTSC:ENST00000524463:splice_region:LOW:exon4/4:c.*5622A>G:,CTSC:ENST00000524463:3'UTR:MODIFIER:exon4/4:c.*5622A>G:,CTSC:ENST00000227266:intron:MODIFIER:exon2/6:c.319-8257A>G:		rs217053	0.8239	0.0000	0,0,0	0,0,0,0,0	0.7974							602365 [CTSC (confirmed) Papillon-Lefevre syndrome,245000|Haim-Munk syndrome,245010|Periodontitis 1,juvenile,170650];				108	54					CTSC (inh=AR pLI=0.00)
chr11	88054346	88054346	G	C	het	anno_omim	QUAL=959;DP=59;AF=0.49;MQM=60;TRIO=HET,59,0.49,HOM,7,1.00,HET,9,0.44	CTSC	3'UTR,intron	CTSC:ENST00000524463:3'UTR:MODIFIER:exon4/4:c.*5255C>G:,CTSC:ENST00000227266:intron:MODIFIER:exon2/6:c.319-8624C>G:	L1PA10	rs217054	0.8516	0.0000	0,0,0	0,0,0,0,0	0.7724							602365 [CTSC (confirmed) Papillon-Lefevre syndrome,245000|Haim-Munk syndrome,245010|Periodontitis 1,juvenile,170650];				100	54					CTSC (inh=AR pLI=0.00)
chr11	88054571	88054571	G	A	het	anno_omim	QUAL=819;DP=46;AF=0.43;MQM=59;TRIO=HET,46,0.43,HOM,7,1.00,HET,12,0.50	CTSC	3'UTR,intron	CTSC:ENST00000524463:3'UTR:MODIFIER:exon4/4:c.*5030C>T:,CTSC:ENST00000227266:intron:MODIFIER:exon2/6:c.319-8849C>T:	L1PA10	rs10830669	0.1861	0.0000	0,0,0	0,0,0,0,0	0.2833							602365 [CTSC (confirmed) Papillon-Lefevre syndrome,245000|Haim-Munk syndrome,245010|Periodontitis 1,juvenile,170650];				36	71					CTSC (inh=AR pLI=0.00)
chr11	88055089	88055089	C	T	het	anno_omim	QUAL=6241;DP=207;AF=0.49;MQM=60;TRIO=HET,207,0.49,HOM,76,1.00,HET,78,0.53	CTSC	3'UTR,intron	CTSC:ENST00000524463:3'UTR:MODIFIER:exon4/4:c.*4512G>A:,CTSC:ENST00000227266:intron:MODIFIER:exon2/6:c.319-9367G>A:	L1PA10	rs217055	0.9311	0.0000	0,0,0	0,0,0,0,0	0.8733							602365 [CTSC (confirmed) Papillon-Lefevre syndrome,245000|Haim-Munk syndrome,245010|Periodontitis 1,juvenile,170650];				113	46					CTSC (inh=AR pLI=0.00)
chr11	88055170	88055170	G	A	het	anno_omim	QUAL=4462;DP=110;AF=0.52;MQM=60;TRIO=HET,110,0.52,HOM,68,1.00,HET,55,0.49	CTSC	3'UTR,intron	CTSC:ENST00000524463:3'UTR:MODIFIER:exon4/4:c.*4431C>T:,CTSC:ENST00000227266:intron:MODIFIER:exon2/6:c.319-9448C>T:	L1PA10	rs596261	0.3456	0.0000	0,0,0	0,0,0,0,0	0.4300							602365 [CTSC (confirmed) Papillon-Lefevre syndrome,245000|Haim-Munk syndrome,245010|Periodontitis 1,juvenile,170650];				48	78					CTSC (inh=AR pLI=0.00)
chr11	88055291	88055291	T	C	het	anno_omim	QUAL=2904;DP=141;AF=0.48;MQM=60;TRIO=HET,141,0.48,HOM,27,1.00,HET,30,0.50	CTSC	3'UTR,intron	CTSC:ENST00000524463:3'UTR:MODIFIER:exon4/4:c.*4310A>G:,CTSC:ENST00000227266:intron:MODIFIER:exon2/6:c.319-9569A>G:	L1PA10	rs12288615	0.2037	0.0000	0,0,0	0,0,0,0,0	0.3008							602365 [CTSC (confirmed) Papillon-Lefevre syndrome,245000|Haim-Munk syndrome,245010|Periodontitis 1,juvenile,170650];				35	74					CTSC (inh=AR pLI=0.00)
chr11	88055789	88055789	A	T	het	anno_omim	QUAL=1617;DP=70;AF=0.56;MQM=54;TRIO=HET,70,0.56,HOM,12,1.00,HET,14,0.71	CTSC	3'UTR,intron	CTSC:ENST00000524463:3'UTR:MODIFIER:exon4/4:c.*3812T>A:,CTSC:ENST00000227266:intron:MODIFIER:exon2/6:c.319-10067T>A:	L1P3	rs452648	0.8650	0.0000	0,0,0	0,0,0,0,0	0.7819							602365 [CTSC (confirmed) Papillon-Lefevre syndrome,245000|Haim-Munk syndrome,245010|Periodontitis 1,juvenile,170650];				100	52					CTSC (inh=AR pLI=0.00)
chr11	88055794	88055794	A	G	het	anno_omim	QUAL=1714;DP=69;AF=0.55;MQM=53;TRIO=HET,69,0.55,HOM,12,1.00,HET,15,0.67	CTSC	3'UTR,intron	CTSC:ENST00000524463:3'UTR:MODIFIER:exon4/4:c.*3807T>C:,CTSC:ENST00000227266:intron:MODIFIER:exon2/6:c.319-10072T>C:	L1P3	rs442528	0.8650	0.0000	0,0,0	0,0,0,0,0	0.7820							602365 [CTSC (confirmed) Papillon-Lefevre syndrome,245000|Haim-Munk syndrome,245010|Periodontitis 1,juvenile,170650];				100	51					CTSC (inh=AR pLI=0.00)
chr11	88056130	88056130	A	G	het	anno_omim	QUAL=1830;DP=71;AF=0.51;MQM=58;TRIO=HET,71,0.51,HOM,17,1.00,HET,27,0.59	CTSC	3'UTR,intron	CTSC:ENST00000524463:3'UTR:MODIFIER:exon4/4:c.*3471T>C:,CTSC:ENST00000227266:intron:MODIFIER:exon2/6:c.319-10408T>C:	L1P3	rs217056	0.7899	0.0000	0,0,0	0,0,0,0,0	0.7317							602365 [CTSC (confirmed) Papillon-Lefevre syndrome,245000|Haim-Munk syndrome,245010|Periodontitis 1,juvenile,170650];				93	61					CTSC (inh=AR pLI=0.00)
chr11	88056396	88056396	T	G	het	anno_omim	QUAL=1376;DP=47;AF=0.62;MQM=59;TRIO=HET,47,0.62,HOM,15,1.00,HET,12,0.33	CTSC	3'UTR,intron	CTSC:ENST00000524463:3'UTR:MODIFIER:exon4/4:c.*3205A>C:,CTSC:ENST00000227266:intron:MODIFIER:exon2/6:c.319-10674A>C:	L1P3	rs217057	0.7895	0.0000	0,0,0	0,0,0,0,0	0.7316							602365 [CTSC (confirmed) Papillon-Lefevre syndrome,245000|Haim-Munk syndrome,245010|Periodontitis 1,juvenile,170650];				93	61					CTSC (inh=AR pLI=0.00)
chr11	88056942	88056942	G	A	het	low_DP;anno_omim	QUAL=312;DP=19;AF=0.37;MQM=59;TRIO=HET,19,0.37,HOM,5,1.00,HET,7,0.29	CTSC	3'UTR,intron	CTSC:ENST00000524463:3'UTR:MODIFIER:exon4/4:c.*2659C>T:,CTSC:ENST00000227266:intron:MODIFIER:exon2/6:c.318+11163C>T:	L1P3	rs217058	0.9083	0.0000	0,0,0	0,0,0,0,0	0.8539							602365 [CTSC (confirmed) Papillon-Lefevre syndrome,245000|Haim-Munk syndrome,245010|Periodontitis 1,juvenile,170650];				100	20					CTSC (inh=AR pLI=0.00)
chr11	94151547	94151547	-	T	het	anno_omim	QUAL=3341;DP=244;AF=0.40;MQM=59;TRIO=HET,244,0.40,HET,188,0.41,WT,268,0.06	AP000765.1,MRE11A	intergenic_region	MRE11A:ENSG00000263966-ENSG00000020922:intergenic_region:MODIFIER::n.94151547_94151548insT:		rs200848216	0.1270	0.0000	0,0,0	0,0,0,0,0	0.1685							600814 [MRE11A (provisional) Ataxia-telangiectasia-like disorder 1,604391];	RCV000282301.1 [likely benign]; 			10	73					AP000765.1 (inh=n/a pLI=n/a), MRE11 (inh=AR+AD pLI=0.00)
chr11	94152631	94152631	-	GGGAGAGAGAGAGA	hom	anno_omim	QUAL=1523;DP=74;AF=0.00;MQM=60;TRIO=HOM,74,0.49,HOM,15,0.40,WT,36,0.58	AP000765.1,MRE11A	intergenic_region	MRE11A:ENSG00000263966-ENSG00000020922:intergenic_region:MODIFIER::n.94152631_94152632insGGGAGAGAGAGAGA:	(GA)n		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							600814 [MRE11A (provisional) Ataxia-telangiectasia-like disorder 1,604391];	RCV000389620.1 [uncertain significance]; 			1	3					AP000765.1 (inh=n/a pLI=n/a), MRE11 (inh=AR+AD pLI=0.00)
chr11	94212048	94212048	C	T	het	anno_omim	QUAL=7179;DP=156;AF=0.46;MQM=60;TRIO=HET,156,0.46,WT,149,0.00,HOM,173,0.99	MRE11A	splice_region&intron	MRE11A:ENST00000407439:splice_region&intron:LOW:exon5/19:c.412-6G>A:,MRE11A:ENST00000323929:splice_region&intron:LOW:exon5/19:c.403-6G>A:,MRE11A:ENST00000323977:splice_region&intron:LOW:exon5/18:c.403-6G>A:,MRE11A:ENST00000393241:splice_region&intron:LOW:exon5/19:c.403-6G>A:,MRE11A:ENST00000540013:splice_region&intron:LOW:exon5/7:c.403-6G>A:		rs535801	0.3131	0.3252	6588,3086,210	0.2028,0.4275,0.4058,0.3062,0.3509	0.3345							600814 [MRE11A (provisional) Ataxia-telangiectasia-like disorder 1,604391];	RCV000117634.3 [other]; RCV000277270.1 [benign]; 			583	2324	1	[1] Ilnaz Sepahi 29-03-2016 batch import			MRE11 (inh=AR+AD pLI=0.00)
chr11	95566048	95566048	G	A	het	anno_omim	QUAL=2941;DP=146;AF=0.54;MQM=60;TRIO=HET,146,0.54,HET,72,0.57,WT,136,0.00	MTMR2	splice_region,3'UTR	MTMR2:ENST00000346299:splice_region:LOW:exon15/15:c.*2406C>T:,MTMR2:ENST00000393223:splice_region:LOW:exon17/17:c.*2406C>T:,MTMR2:ENST00000346299:3'UTR:MODIFIER:exon15/15:c.*2406C>T:,MTMR2:ENST00000393223:3'UTR:MODIFIER:exon17/17:c.*2406C>T:		rs16922613	0.0298	0.0000	0,0,0	0,0,0,0,0	0.0178							603557 [MTMR2 (confirmed) Charcot-Marie-Tooth disease,type 4B1,601382];	RCV000260908.1 [likely benign]; 			0	12					MTMR2 (inh=AR pLI=0.21)
chr11	102980324	102980324	C	T	hom	anno_omim	QUAL=12477;DP=207;AF=0.99;MQM=59;TRIO=HOM,207,0.99,HET,234,0.44,HET,352,0.47	DYNC2H1	synonymous	DYNC2H1:ENST00000398093:synonymous:LOW:exon1/90:c.21C>T:p.Asp7Asp,DYNC2H1:ENST00000375735:synonymous:LOW:exon1/89:c.21C>T:p.Asp7Asp,DYNC2H1:ENST00000334267:synonymous:LOW:exon1/20:c.21C>T:p.Asp7Asp		rs17301028	0.0411	0.0761	407,302,3	0.0178,0.0429,0.0002,0.0986,0.0944	0.0739							603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly,613091];	RCV000319173.1 [likely benign]; RCV000373826.1 [likely benign]; 			25	349					DYNC2H1 (inh=n/a pLI=0.00)
chr11	103029516	103029516	A	G	hom	pred_pathogenic;anno_omim	QUAL=9808;DP=171;AF=1.00;MQM=60;TRIO=HOM,171,1.00,HOM,48,1.00,HOM,73,1.00	DYNC2H1	missense,intron	DYNC2H1:ENST00000398093:missense:MODERATE:exon27/90:c.4238A>G:p.Lys1413Arg,DYNC2H1:ENST00000375735:missense:MODERATE:exon27/89:c.4238A>G:p.Lys1413Arg,DYNC2H1:ENST00000334267:intron:MODIFIER:exon15/19:c.2205+24368A>G:		rs688906	0.6683	0.7126	5704,2722,293	0.5038,0.7599,0.7981,0.7426,0.7232	0.7394	4.1300	T,T	T	B,B	T,T	20.30	603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly,613091];	RCV000176721.1 [benign]; RCV000281569.1 [benign]; RCV000334296.1 [benign]; 			1177	769					DYNC2H1 (inh=n/a pLI=0.00)
chr11	103047007	103047007	C	A	hom	anno_omim	QUAL=12900;DP=192;AF=1.00;MQM=60;TRIO=HOM,192,1.00,HOM,76,1.00,HOM,127,1.00	DYNC2H1	synonymous,intron	DYNC2H1:ENST00000398093:synonymous:LOW:exon37/90:c.5718C>A:p.Thr1906Thr,DYNC2H1:ENST00000375735:synonymous:LOW:exon37/89:c.5718C>A:p.Thr1906Thr,DYNC2H1:ENST00000334267:intron:MODIFIER:exon15/19:c.2205+41859C>A:		rs585692	0.9313	0.9178	10622,4998,1304	0.9812,0.9622,0.8994,0.9195,0.8876	0.9481							603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly,613091];	RCV000153168.3 [benign]; RCV000275629.1 [benign]; RCV000330716.1 [benign]; 			1748	339	2	[2] Stephan Waldm?ller 19.10.2015			DYNC2H1 (inh=n/a pLI=0.00)
chr11	103057048	103057048	A	G	hom	anno_omim	QUAL=20027;DP=226;AF=1.00;MQM=60;TRIO=HOM,226,1.00,HOM,183,1.00,HOM,223,1.00	DYNC2H1	synonymous,intron	DYNC2H1:ENST00000398093:synonymous:LOW:exon42/90:c.6711A>G:p.Arg2237Arg,DYNC2H1:ENST00000375735:synonymous:LOW:exon42/89:c.6711A>G:p.Arg2237Arg,DYNC2H1:ENST00000334267:intron:MODIFIER:exon15/19:c.2205+51900A>G:		rs658804	0.5715	0.6204	23424,13354,1323	0.5209,0.7726,0.5424,0.6334,0.5591	0.6263							603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly,613091];	RCV000273552.1 [benign]; RCV000368121.1 [benign]; 			881	942					DYNC2H1 (inh=n/a pLI=0.00)
chr11	103058126	103058126	C	T	hom	anno_omim	QUAL=14047;DP=198;AF=1.00;MQM=60;TRIO=HOM,198,1.00,HOM,103,1.00,HOM,138,1.00	DYNC2H1	synonymous,intron	DYNC2H1:ENST00000398093:synonymous:LOW:exon43/90:c.6951C>T:p.His2317His,DYNC2H1:ENST00000375735:synonymous:LOW:exon43/89:c.6951C>T:p.His2317His,DYNC2H1:ENST00000334267:intron:MODIFIER:exon15/19:c.2205+52978C>T:		rs586592	0.6170	0.6330	24445,13441,2150	0.6628,0.7757,0.5429,0.6339,0.5592	0.6368							603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly,613091];	RCV000079444.4 [benign]; RCV000290279.1 [benign]; RCV000384618.1 [benign]; 			892	945					DYNC2H1 (inh=n/a pLI=0.00)
chr11	103082590	103082590	G	A	hom	pred_pathogenic;anno_omim	QUAL=13998;DP=230;AF=1.00;MQM=60;TRIO=HOM,230,1.00,HOM,83,1.00,HOM,105,1.00	DYNC2H1	missense,intron	DYNC2H1:ENST00000398093:missense:MODERATE:exon54/90:c.8612G>A:p.Arg2871Gln,DYNC2H1:ENST00000375735:missense:MODERATE:exon54/89:c.8612G>A:p.Arg2871Gln,DYNC2H1:ENST00000334267:intron:MODIFIER:exon15/19:c.2205+77442G>A:		rs589623	0.7384	0.7874	8800,4453,565	0.6392,0.8605,0.8091,0.8181,0.7783	0.7936	4.3360	T,T	T	B,B	T,T	23.30	603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly,613091];	RCV000303608.1 [benign]; RCV000403673.1 [benign]; 		COSM147316	1378	645					DYNC2H1 (inh=n/a pLI=0.00)
chr11	103153788	103153788	C	A	het	anno_omim	QUAL=5176;DP=322;AF=0.46;MQM=60;TRIO=HET,322,0.46,HET,93,0.52,WT,163,0.00	DYNC2H1	synonymous,intron	DYNC2H1:ENST00000398093:synonymous:LOW:exon74/90:c.10885C>A:p.Arg3629Arg,DYNC2H1:ENST00000375735:synonymous:LOW:exon73/89:c.10864C>A:p.Arg3622Arg,DYNC2H1:ENST00000334267:intron:MODIFIER:exon15/19:c.2205+148640C>A:		rs117178504	0.0042	0.0075	3,3,0	0.0032,0.0091,0.0000,0.0109,0.0009	0.0071							603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly,613091];	RCV000205607.1 [benign]; 			0	28					DYNC2H1 (inh=n/a pLI=0.00)
chr11	103158278	103158278	C	T	het	pred_pathogenic;anno_omim	QUAL=6218;DP=285;AF=0.46;MQM=60;TRIO=HET,285,0.46,WT,159,0.00,HET,230,0.50	DYNC2H1	missense,intron	DYNC2H1:ENST00000398093:missense:MODERATE:exon76/90:c.11060C>T:p.Ala3687Val,DYNC2H1:ENST00000375735:missense:MODERATE:exon75/89:c.11039C>T:p.Ala3680Val,DYNC2H1:ENST00000334267:intron:MODIFIER:exon15/19:c.2206-148393C>T:		rs10895391	0.2863	0.3329	6544,3984,170	0.1970,0.2145,0.2963,0.3562,0.4107	0.3190	6.1230	T,T	T	B,B	T,T	25.00	603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly,613091];	RCV000294784.1 [benign]; RCV000333401.1 [benign]; 			244	946	2	[2] Stephan Waldm?ller 19.10.2015			DYNC2H1 (inh=n/a pLI=0.00)
chr11	103229027	103229027	T	C	het	anno_omim	QUAL=10430;DP=253;AF=0.53;MQM=60;TRIO=HET,253,0.53,HOM,141,1.00,HET,168,0.48	DYNC2H1	synonymous,intron	DYNC2H1:ENST00000398093:synonymous:LOW:exon84/90:c.12117T>C:p.Asp4039Asp,DYNC2H1:ENST00000375735:synonymous:LOW:exon83/89:c.12096T>C:p.Asp4032Asp,DYNC2H1:ENST00000334267:intron:MODIFIER:exon15/19:c.2206-77644T>C:		rs2566913	0.4950	0.6589	16885,10514,341	0.3809,0.7849,0.5889,0.7027,0.5652	0.6189							603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly,613091];	RCV000279105.1 [benign]; RCV000336461.1 [benign]; 			866	956					DYNC2H1 (inh=n/a pLI=0.00)
chr11	103270607	103270607	G	A	het	anno_omim	QUAL=5738;DP=158;AF=0.46;MQM=60;TRIO=HET,158,0.46,WT,76,0.00,HOM,124,1.00	DYNC2H1	splice_region&intron,intron	DYNC2H1:ENST00000398093:splice_region&intron:LOW:exon85/89:c.12387+7G>A:,DYNC2H1:ENST00000375735:splice_region&intron:LOW:exon84/88:c.12366+7G>A:,DYNC2H1:ENST00000334267:intron:MODIFIER:exon15/19:c.2206-36064G>A:		rs10895417	0.5377	0.4912	14633,6500,1858	0.6137,0.5551,0.5408,0.4462,0.5574	0.5026							603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly,613091];	RCV000314601.1 [benign]; RCV000362268.1 [benign]; 			480	1031	2	[2] Stephan Waldm?ller 19.10.2015			DYNC2H1 (inh=n/a pLI=0.00)
chr11	107992312	107992312	C	G	het	anno_omim	QUAL=2502;DP=81;AF=0.63;MQM=59;TRIO=HET,81,0.63,HET,103,0.48,WT,110,0.00	ACAT1,RP11-144G7.2	5'UTR	ACAT1:ENST00000265838:5'UTR:MODIFIER:exon1/12:c.-22C>G:,ACAT1:ENST00000299355:5'UTR:MODIFIER:exon1/6:c.-22C>G:		rs3741054	0.0954	0.1673	240,93,10	0.1130,0.1243,0.0174,0.1859,0.1748	0.1420							607809 [ACAT1 (confirmed) Alpha-methylacetoacetic aciduria,203750];	RCV000337537.1 [likely benign]; 			42	470					ACAT1 (inh=AR pLI=0.00), RP11-144G7.2 (inh=n/a pLI=n/a)
chr11	107992325	107992325	T	A	het	anno_omim	QUAL=4348;DP=136;AF=0.38;MQM=59;TRIO=HET,136,0.38,WT,95,0.00,HOM,110,1.00	ACAT1,RP11-144G7.2	5'UTR	ACAT1:ENST00000265838:5'UTR:MODIFIER:exon1/12:c.-9T>A:,ACAT1:ENST00000299355:5'UTR:MODIFIER:exon1/6:c.-9T>A:		rs3741055	0.3137	0.3881	1348,357,8	0.1019,0.3944,0.3333,0.3559,0.4749	0.3635							607809 [ACAT1 (confirmed) Alpha-methylacetoacetic aciduria,203750];	RCV000077928.5 [benign]; RCV000336276.1 [benign]; 			353	918					ACAT1 (inh=AR pLI=0.00), RP11-144G7.2 (inh=n/a pLI=n/a)
chr11	107992346	107992346	G	C	het	pred_pathogenic;anno_omim	QUAL=3958;DP=127;AF=0.35;MQM=59;TRIO=HET,127,0.35,WT,86,0.00,HOM,100,1.00	ACAT1,RP11-144G7.2	missense	ACAT1:ENST00000265838:missense:MODERATE:exon1/12:c.13G>C:p.Ala5Pro,ACAT1:ENST00000299355:missense:MODERATE:exon1/6:c.13G>C:p.Ala5Pro		rs3741056	0.3319	0.4014	1372,362,18	0.1623,0.4237,0.3417,0.3655,0.4756	0.3673	-0.1180	D,T	T	B,B	D,D	17.60	607809 [ACAT1 (confirmed) Alpha-methylacetoacetic aciduria,203750];	RCV000077929.5 [benign]; RCV000391653.1 [benign]; 		COSM3752118	355	915					ACAT1 (inh=AR pLI=0.00), RP11-144G7.2 (inh=n/a pLI=n/a)
chr11	108009660	108009660	C	A	het	anno_omim	QUAL=5557;DP=202;AF=0.42;MQM=60;TRIO=HET,202,0.42,HET,308,0.45,WT,395,0.00	ACAT1	synonymous	ACAT1:ENST00000265838:synonymous:LOW:exon6/12:c.471C>A:p.Ser157Ser		rs35188041	0.1270	0.1555	1659,997,206	0.1902,0.1076,0.0200,0.1716,0.1712	0.1670	0.1580		T			16.92	607809 [ACAT1 (confirmed) Alpha-methylacetoacetic aciduria,203750];	RCV000077930.4 [benign]; RCV000366294.1 [likely benign]; 		COSM1350699	44	511					ACAT1 (inh=AR pLI=0.00)
chr11	108018894	108018897	AATT	-	het	anno_omim	QUAL=5426;DP=271;AF=0.49;MQM=59;TRIO=HET,271,0.49,HET,211,0.58,WT,270,0.00	ACAT1,NPAT	intergenic_region	NPAT:ENSG00000075239-ENSG00000149308:intergenic_region:MODIFIER::n.108018894_108018897delAATT:		rs112801981;rs577109182	0.2039	0.0000	0,0,0	0,0,0,0,0	0.2907							607809 [ACAT1 (confirmed) Alpha-methylacetoacetic aciduria,203750];	RCV000345943.1 [benign]; 			30	84					ACAT1 (inh=AR pLI=0.00), NPAT (inh=n/a pLI=0.14)
chr11	108093833	108093833	G	A	het	anno_omim	QUAL=17303;DP=341;AF=0.45;MQM=60;TRIO=HET,341,0.45,WT,397,0.00,HOM,501,0.99	ATM	5'UTR	ATM:ENST00000278616:5'UTR:MODIFIER:exon1/63:c.-111G>A:		rs189037	0.4760	0.0000	0,0,0	0,0,0,0,0	0.4859							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];	RCV000304644.1 [benign]; 	CR109394 [CLASS=DFP MUT=ALT PHEN="Longevity association with" GENE=ATM]; 		95	94					ATM (inh=AR+AD pLI=0.00)
chr11	108183167	108183167	A	G	hom	anno_omim	QUAL=14951;DP=213;AF=1.00;MQM=60;TRIO=HOM,213,1.00,HOM,92,1.00,HOM,142,1.00	ATM,C11orf65	missense,intron	ATM:ENST00000278616:missense:MODERATE:exon40/63:c.5948A>G:p.Asn1983Ser,ATM:ENST00000452508:missense:MODERATE:exon41/64:c.5948A>G:p.Asn1983Ser,C11orf65:ENST00000525729:intron:MODIFIER:exon6/6:c.641-3369T>C:		rs659243	1.0000	1.0000	60654,33353,5170	1.0000,1.0000,1.0000,1.0000,1.0000	1.0000	-1.0580	T,T	T	B,B	T,T	0.01	607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];	RCV000120149.2 [benign]; 			5729	0	1	[3] Ilnaz Sepahi 29-03-2016 batch import [1] ahdoeha1 31.03.2016: GC-HBOC class 1 [n/a] harmuth 02.09.2016; observed base G is the wildtype base (hg38) which means that we sequenced the wildtype 			ATM (inh=AR+AD pLI=0.00), C11orf65 (inh=n/a pLI=0.00)
chr11	108236783	108236783	G	T	het	anno_omim	QUAL=1517;DP=72;AF=0.49;MQM=58;TRIO=HET,72,0.49,WT,19,0.00,HOM,25,1.00	ATM,C11orf65	3'UTR,intron	ATM:ENST00000278616:3'UTR:MODIFIER:exon63/63:c.*548G>T:,ATM:ENST00000452508:3'UTR:MODIFIER:exon64/64:c.*548G>T:,C11orf65:ENST00000525729:intron:MODIFIER:exon6/6:c.640+19864C>A:		rs227092	0.5184	0.0000	0,0,0	0,0,0,0,0	0.5152							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];	RCV000291267.1 [benign]; 			78	65					ATM (inh=AR+AD pLI=0.00), C11orf65 (inh=n/a pLI=0.00)
chr11	108237839	108237839	C	T	het	anno_omim	QUAL=1686;DP=93;AF=0.33;MQM=52;TRIO=HET,93,0.33,WT,37,0.03,HOM,34,1.00	ATM,C11orf65	3'UTR,intron	ATM:ENST00000278616:3'UTR:MODIFIER:exon63/63:c.*1604C>T:,ATM:ENST00000452508:3'UTR:MODIFIER:exon64/64:c.*1604C>T:,C11orf65:ENST00000525729:intron:MODIFIER:exon6/6:c.640+18808G>A:	AluSc8	rs227091	0.5182	0.0000	0,0,0	0,0,0,0,0	0.5153							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];	RCV000338616.1 [benign]; 			77	70					ATM (inh=AR+AD pLI=0.00), C11orf65 (inh=n/a pLI=0.00)
chr11	108239628	108239628	G	T	het	anno_omim	QUAL=7099;DP=332;AF=0.52;MQM=60;TRIO=HET,332,0.52,WT,88,0.01,HOM,83,1.00	ATM,C11orf65	3'UTR,intron	ATM:ENST00000278616:3'UTR:MODIFIER:exon63/63:c.*3393G>T:,ATM:ENST00000452508:3'UTR:MODIFIER:exon64/64:c.*3393G>T:,C11orf65:ENST00000525729:intron:MODIFIER:exon6/6:c.640+17019C>A:		rs4585	0.5345	0.0000	0,0,0	0,0,0,0,0	0.5275							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];	RCV000274160.1 [benign]; 			99	99					ATM (inh=AR+AD pLI=0.00), C11orf65 (inh=n/a pLI=0.00)
chr11	111654621	111654625	TATAT	-	het	anno_omim	QUAL=2854;DP=196;AF=0.56;MQM=59;TRIO=HET,196,0.56,HET,83,0.46,WT,125,0.00	ALG9				rs66517706	0.2372	0.0000	0,0,0	0,0,0,0,0	0.2356							606941 [ALG9 (confirmed) Congenital disorder of glycosylation,type Il,608776|Gillessen-Kaesbach-Nishimura syndrome,263210];				19	108					ALG9 (inh=AR pLI=0.00)
chr11	111654647	111654647	-	A	het	anno_omim	QUAL=6246;DP=215;AF=0.62;MQM=59;TRIO=HET,215,0.75,HET,56,0.71,WT,72,0.43	ALG9					0.0000	0.0000	0,0,0	0,0,0,0,0	0.2389							606941 [ALG9 (confirmed) Congenital disorder of glycosylation,type Il,608776|Gillessen-Kaesbach-Nishimura syndrome,263210];	RCV000363122.1 [uncertain significance]; 			0	8					ALG9 (inh=AR pLI=0.00)
chr11	111654648	111654648	T	A	hom	anno_omim	QUAL=6246;DP=215;AF=0.62;MQM=59;TRIO=HOM,215,0.75,HOM,56,0.71,HET,72,0.43	ALG9				rs2554994	0.0000	0.0000	0,0,0	0,0,0,0,0	0.6962							606941 [ALG9 (confirmed) Congenital disorder of glycosylation,type Il,608776|Gillessen-Kaesbach-Nishimura syndrome,263210];	RCV000270520.1 [uncertain significance]; 			35	171					ALG9 (inh=AR pLI=0.00)
chr11	111654670	111654678	GACAAAACA	-	het	anno_omim	QUAL=2623;DP=200;AF=0.46;MQM=58;TRIO=HET,200,0.46,HET,62,0.56,WT,69,0.00	ALG9			GA-rich	rs72428193	0.0000	0.0000	0,0,0	0,0,0,0,0	0.2374							606941 [ALG9 (confirmed) Congenital disorder of glycosylation,type Il,608776|Gillessen-Kaesbach-Nishimura syndrome,263210];				26	102					ALG9 (inh=AR pLI=0.00)
chr11	111724133	111724133	C	T	het	pred_pathogenic;anno_omim	QUAL=9187;DP=316;AF=0.47;MQM=60;TRIO=HET,316,0.47,HET,224,0.49,HET,251,0.39	ALG9	missense,3'UTR	ALG9:ENST00000531154:missense:MODERATE:exon8/15:c.352G>A:p.Val118Ile,ALG9:ENST00000398006:missense:MODERATE:exon8/15:c.352G>A:p.Val118Ile,ALG9:ENST00000524880:3'UTR:MODIFIER:exon12/19:c.*695G>A:		rs10502151	0.3265	0.3510	7918,3581,92	0.1398,0.4123,0.5790,0.3285,0.3912	0.3564	6.0710	T,T,T	T	P,B,P	T,T	22.20	606941 [ALG9 (confirmed) Congenital disorder of glycosylation,type Il,608776|Gillessen-Kaesbach-Nishimura syndrome,263210];			COSM3998221, COSM3998222, COSM3998223	267	928					ALG9 (inh=AR pLI=0.00)
chr11	111742146	111742146	G	-	hom	anno_high_impact;anno_omim	QUAL=10671;DP=28;AF=1.00;MQM=59;TRIO=HOM,28,1.00,HOM,125,1.00,HOM,221,1.00	ALG9	frameshift	ALG9:ENST00000524880:frameshift:HIGH:exon5/19:c.760delC:p.Arg254fs		rs10708475	1.0000	1.0000	6194,1836,287	1.0000,0.0000,1.0000,1.0000,1.0000	1.0000							606941 [ALG9 (confirmed) Congenital disorder of glycosylation,type Il,608776|Gillessen-Kaesbach-Nishimura syndrome,263210];				2073	0	1	[1] auto-classification 16.06.2016  [2] Ute Grasshoff 24.11.2015			ALG9 (inh=AR pLI=0.00)
chr11	111781047	111781047	A	C	het	pred_pathogenic;anno_omim	QUAL=4806;DP=213;AF=0.48;MQM=60;TRIO=HET,213,0.48,HET,182,0.47,WT,267,0.00	CRYAB	missense,splice_region&intron	CRYAB:ENST00000533971:missense:MODERATE:exon2/2:c.328T>G:p.Cys110Gly,CRYAB:ENST00000227251:splice_region&intron:LOW:exon3/3:c.324+4T>G:,CRYAB:ENST00000526180:splice_region&intron:LOW:exon2/2:c.324+4T>G:,CRYAB:ENST00000533280:splice_region&intron:LOW:exon2/2:c.123+4T>G:,CRYAB:ENST00000525823:splice_region&intron:LOW:exon1/1:c.123+4T>G:,CRYAB:ENST00000533475:splice_region&intron:LOW:exon3/3:c.324+4T>G:,CRYAB:ENST00000527950:splice_region&intron:LOW:exon3/3:c.324+4T>G:,CRYAB:ENST00000531198:splice_region&intron:LOW:exon4/4:c.324+4T>G:		rs11603779	0.2398	0.2695	4615,2908,218	0.2133,0.2936,0.1823,0.2914,0.2506	0.2741		T	T	B	D	0.09	123590 [CRYAB (confirmed) Myopathy,myofibrillar,2,608810|Cataract 16,multiple types,613763|Myopathy,myofibrillar,fatal infantile hypertrophy,alpha-B crystallin-related,613869|Cardiomyopathy,dilated,1II,615184];	RCV000037213.4 [benign]; RCV000252961.1 [benign]; RCV000268709.1 [benign]; RCV000308725.1 [benign]; RCV000363435.1 [benign]; 		COSM3998232	225	892					CRYAB (inh=AR+AD pLI=0.01)
chr11	118175439	118175439	G	A	het	anno_omim	QUAL=3974;DP=213;AF=0.42;MQM=60;TRIO=HET,213,0.42,HET,62,0.47,HET,85,0.52	CD3E	5'UTR	CD3E:ENST00000361763:5'UTR:MODIFIER:exon1/9:c.-112G>A:		rs2231440	0.2290	0.0000	0,0,0	0,0,0,0,0	0.2547							186830 [CD3E (provisional) Immunodeficiency 18,615615|Immunodeficiency 18,SCID variant,615615];	RCV000370695.1 [benign]; 			20	106					CD3E (inh=AR+AD pLI=0.30)
chr11	118178007	118178007	C	T	het	anno_omim	QUAL=4651;DP=153;AF=0.48;MQM=60;TRIO=HET,153,0.48,HET,107,0.48,HET,125,0.56	CD3E	synonymous	CD3E:ENST00000361763:synonymous:LOW:exon3/9:c.54C>T:p.Gly18Gly,CD3E:ENST00000528600:synonymous:LOW:exon2/7:c.54C>T:p.Gly18Gly		rs1126924	0.2254	0.3061	6374,3322,39	0.0737,0.5297,0.1925,0.3160,0.3068	0.3199							186830 [CD3E (provisional) Immunodeficiency 18,615615|Immunodeficiency 18,SCID variant,615615];	RCV000330794.1 [benign]; 		COSM147335	192	922					CD3E (inh=AR+AD pLI=0.30)
chr11	118215076	118215079	GGCT	-	het	anno_omim	QUAL=3500;DP=158;AF=0.51;MQM=59;TRIO=HET,158,0.51,HET,193,0.55,WT,240,0.00	CD3G	5'UTR	CD3G:ENST00000532917:5'UTR:MODIFIER:exon1/7:c.-46_-43delGCTG:,CD3G:ENST00000392883:5'UTR:MODIFIER:exon1/6:c.-226_-223delGCTG:	(CTGG)n	rs68070310	0.4026	0.0000	0,0,0	0,0,0,0,0	0.3130							186740 [CD3G (confirmed) Immunodeficiency 17,CD3 gamma deficient,615607];	RCV000267460.1 [likely benign]; RCV000342221.1,RCV000267460.1 [benign,likely benign]; RCV000342221.1 [benign]; 			190	649					CD3G (inh=AR pLI=0.03)
chr11	118221349	118221349	T	C	het	anno_omim	QUAL=752;DP=70;AF=0.33;MQM=60;TRIO=HET,70,0.33,HET,24,0.50,WT,47,0.00	CD3G	synonymous,intron	CD3G:ENST00000532917:synonymous:LOW:exon4/7:c.390T>C:p.Ala130Ala,CD3G:ENST00000392883:intron:MODIFIER:exon3/5:c.127+664T>C:		rs3753059	0.2963	0.2190	3926,848,115	0.1597,0.0925,0.4878,0.1606,0.4533	0.2156							186740 [CD3G (confirmed) Immunodeficiency 17,CD3 gamma deficient,615607];	RCV000288417.1 [likely benign]; 		COSM3998253	138	667					CD3G (inh=AR pLI=0.03)
chr11	118221350	118221350	G	T	het	pred_pathogenic;anno_omim	QUAL=752;DP=70;AF=0.33;MQM=60;TRIO=HET,70,0.33,HET,24,0.50,WT,47,0.00	CD3G	missense,intron	CD3G:ENST00000532917:missense:MODERATE:exon4/7:c.391G>T:p.Val131Phe,CD3G:ENST00000392883:intron:MODIFIER:exon3/5:c.127+665G>T:		rs3753058	0.2975	0.2189	3923,846,115	0.1597,0.0925,0.4874,0.1606,0.4536	0.2155	0.3220	D	T	P	T	25.90	186740 [CD3G (confirmed) Immunodeficiency 17,CD3 gamma deficient,615607];	RCV000352643.1 [likely benign]; 		COSM3931231	138	667					CD3G (inh=AR pLI=0.03)
chr11	118224059	118224059	A	G	het	anno_omim	QUAL=4090;DP=252;AF=0.52;MQM=60;TRIO=HET,252,0.52,WT,20,0.00,HET,48,0.54	CD3G	3'UTR	CD3G:ENST00000532917:3'UTR:MODIFIER:exon7/7:c.*244A>G:,CD3G:ENST00000392883:3'UTR:MODIFIER:exon6/6:c.*244A>G:		rs45508093	0.0721	0.0000	0,0,0	0,0,0,0,0	0.1136							186740 [CD3G (confirmed) Immunodeficiency 17,CD3 gamma deficient,615607];	RCV000349036.1 [likely benign]; 			7	65					CD3G (inh=AR pLI=0.03)
chr11	118224268	118224268	G	T	het	anno_omim	QUAL=1147;DP=116;AF=0.39;MQM=54;TRIO=HET,116,0.39,HET,21,0.67,WT,25,0.08	CD3G	3'UTR	CD3G:ENST00000532917:3'UTR:MODIFIER:exon7/7:c.*453G>T:,CD3G:ENST00000392883:3'UTR:MODIFIER:exon6/6:c.*453G>T:	AluSz	rs45477194	0.2977	0.0000	0,0,0	0,0,0,0,0	0.2023							186740 [CD3G (confirmed) Immunodeficiency 17,CD3 gamma deficient,615607];	RCV000305705.1 [likely benign]; 			9	59					CD3G (inh=AR pLI=0.03)
chr11	118898436	118898436	C	-	hom	anno_high_impact;anno_omim	QUAL=54851;DP=295;AF=1.00;MQM=59;TRIO=HOM,295,1.00,HOM,679,1.00,HOM,852,1.00	SLC37A4	frameshift&splice_region,splice_acceptor	SLC37A4:ENST00000357590:frameshift&splice_region:HIGH:exon6/12:c.527delG:p.Gly176fs,SLC37A4:ENST00000538950:frameshift&splice_region:HIGH:exon6/11:c.308delG:p.Gly103fs,SLC37A4:ENST00000545985:frameshift&splice_region:HIGH:exon6/11:c.527delG:p.Gly176fs,SLC37A4:ENST00000330775:splice_acceptor:HIGH:exon4/10:c.526-2delG:		rs547203028	1.0000	1.0000	60059,33162,4885	1.0000,1.0000,1.0000,1.0000,1.0000	1.0000							602671 [SLC37A4 (confirmed) Glycogen storage disease Ib,232220|Glycogen storage disease Ic,232240];				2113	0	1	[1] auto-classification 16.06.2016  [2] Ute Grasshoff 24.11.2015			SLC37A4 (inh=AR pLI=0.00)
chr11	118901166	118901166	C	G	het	anno_omim	QUAL=7627;DP=89;AF=0.38;MQM=59;TRIO=HET,89,0.38,HET,126,0.54,HOM,178,0.99	SLC37A4	5'UTR_premature_start_codon_gain,5'UTR,intron	SLC37A4:ENST00000545985:5'UTR_premature_start_codon_gain:LOW:exon2/11:c.-420G>C:,SLC37A4:ENST00000545985:5'UTR:MODIFIER:exon2/11:c.-420G>C:,SLC37A4:ENST00000357590:intron:MODIFIER:exon2/11:c.-196+92G>C:,SLC37A4:ENST00000538950:intron:MODIFIER:exon1/10:c.-345+393G>C:,SLC37A4:ENST00000330775:intron:MODIFIER:exon1/10:c.-196+393G>C:		rs2846281	0.8496	0.0000	0,0,0	0,0,0,0,0	0.8027							602671 [SLC37A4 (confirmed) Glycogen storage disease Ib,232220|Glycogen storage disease Ic,232240];	RCV000281378.1 [benign]; 			152	71					SLC37A4 (inh=AR pLI=0.00)
chr11	118967524	118967524	C	T	het	anno_omim	QUAL=17357;DP=251;AF=0.47;MQM=60;TRIO=HET,251,0.47,HET,272,0.50,HOM,338,1.00	DPAGT1	3'UTR	DPAGT1:ENST00000354202:3'UTR:MODIFIER:exon9/9:c.*184G>A:,DPAGT1:ENST00000409993:3'UTR:MODIFIER:exon11/11:c.*184G>A:,DPAGT1:ENST00000432443:3'UTR:MODIFIER:exon7/7:c.*184G>A:		rs8551	0.4367	0.0000	0,0,0	0,0,0,0,0	0.3820							191350 [DPAGT1 (confirmed) Congenital disorder of glycosylation,type Ij,608093|Myasthenic syndrome,congenital,13,with tubular aggregates,614750];	RCV000313130.1 [benign]; RCV000404523.1 [benign]; 			44	106					DPAGT1 (inh=AR pLI=0.00)
chr11	118967758	118967758	T	C	het	pred_pathogenic;anno_omim	QUAL=20347;DP=372;AF=0.52;MQM=59;TRIO=HET,372,0.52,HET,276,0.53,HOM,352,1.00	DPAGT1	missense	DPAGT1:ENST00000354202:missense:MODERATE:exon9/9:c.1177A>G:p.Ile393Val,DPAGT1:ENST00000409993:missense:MODERATE:exon11/11:c.1177A>G:p.Ile393Val,DPAGT1:ENST00000432443:missense:MODERATE:exon7/7:c.934A>G:p.Ile312Val		rs643788	0.4333	0.4215	11492,6311,443	0.2912,0.2454,0.6466,0.4323,0.4815	0.4181	-0.3200	T,T,T	T	B,B	D,D,D	0.01	191350 [DPAGT1 (confirmed) Congenital disorder of glycosylation,type Ij,608093|Myasthenic syndrome,congenital,13,with tubular aggregates,614750];	RCV000079665.6 [benign]; RCV000277995.1 [benign]; RCV000354528.1 [benign]; 			436	1011					DPAGT1 (inh=AR pLI=0.00)
chr11	119209979	119209979	T	A	het	anno_omim	QUAL=2849;DP=124;AF=0.48;MQM=60;TRIO=HET,124,0.48,HET,162,0.44,WT,243,0.00	MFRP,C1QTNF5	3'UTR	MFRP:ENST00000530681:3'UTR:MODIFIER:exon15/15:c.*1690A>T:,C1QTNF5:ENST00000445041:3'UTR:MODIFIER:exon15/15:c.*62A>T:,C1QTNF5:ENST00000528368:3'UTR:MODIFIER:exon3/3:c.*62A>T:,MFRP:ENST00000555262:3'UTR:MODIFIER:exon15/15:c.*1690A>T:		rs9640	0.1378	0.0000	0,0,0	0,0,0,0,0	0.1627							606227 [MFRP (provisional) Microphthalmia,isolated 5,611040|Nanophthalmos 2,609549];	RCV000332420.1 [likely benign]; RCV000372083.1 [likely benign]; 			19	311					MFRP (inh=AR pLI=0.00), C1QTNF5 (inh=AD pLI=0.83)
chr11	119216231	119216231	A	G	hom	anno_omim	QUAL=6365;DP=100;AF=1.00;MQM=60;TRIO=HOM,100,1.00,HOM,43,1.00,HOM,55,1.00	MFRP,C1QTNF5	synonymous,5'UTR	MFRP:ENST00000530681:synonymous:LOW:exon5/15:c.540T>C:p.His180His,MFRP:ENST00000449574:synonymous:LOW:exon5/13:c.540T>C:p.His180His,MFRP:ENST00000555262:synonymous:LOW:exon5/15:c.540T>C:p.His180His,MFRP:ENST00000360167:synonymous:LOW:exon5/10:c.540T>C:p.His180His,C1QTNF5:ENST00000445041:5'UTR:MODIFIER:exon5/15:c.-2097T>C:		rs2510143	0.9020	0.9364	53245,30591,4010	0.8780,0.8580,0.8715,0.9588,0.9705	0.9321							606227 [MFRP (provisional) Microphthalmia,isolated 5,611040|Nanophthalmos 2,609549];	RCV000153496.3 [benign]; RCV000276256.1 [likely benign]; RCV000311491.1 [benign]; 		COSM4145393	1893	138					MFRP (inh=AR pLI=0.00), C1QTNF5 (inh=AD pLI=0.83)
chr11	119216504	119216504	C	T	het	anno_omim	QUAL=1596;DP=86;AF=0.44;MQM=59;TRIO=HET,86,0.44,HOM,24,1.00,WT,38,0.03	MFRP,C1QTNF5	missense,5'UTR_premature_start_codon_gain,5'UTR	MFRP:ENST00000530681:missense:MODERATE:exon4/15:c.406G>A:p.Val136Met,MFRP:ENST00000449574:missense:MODERATE:exon4/13:c.406G>A:p.Val136Met,MFRP:ENST00000555262:missense:MODERATE:exon4/15:c.406G>A:p.Val136Met,MFRP:ENST00000360167:missense:MODERATE:exon4/10:c.406G>A:p.Val136Met,C1QTNF5:ENST00000445041:5'UTR_premature_start_codon_gain:LOW:exon4/15:c.-2231G>A:,C1QTNF5:ENST00000445041:5'UTR:MODIFIER:exon4/15:c.-2231G>A:		rs3814762	0.1821	0.2664	4745,3585,43	0.0899,0.1551,0.1926,0.3285,0.2201	0.2656	-1.8680	T,T,T	T	B,B	T,T,T	0.24	606227 [MFRP (provisional) Microphthalmia,isolated 5,611040|Nanophthalmos 2,609549];	RCV000153499.5 [benign]; RCV000279501.1 [likely benign]; RCV000374001.1 [likely benign]; 			239	866					MFRP (inh=AR pLI=0.00), C1QTNF5 (inh=AD pLI=0.83)
chr11	119217254	119217254	C	T	het	anno_omim	QUAL=9480;DP=259;AF=0.49;MQM=59;TRIO=HET,259,0.49,HOM,207,1.00,WT,323,0.00	MFRP,C1QTNF5	5'UTR	MFRP:ENST00000530681:5'UTR:MODIFIER:exon1/15:c.-31G>A:,C1QTNF5:ENST00000445041:5'UTR:MODIFIER:exon1/15:c.-2667G>A:,MFRP:ENST00000449574:5'UTR:MODIFIER:exon1/13:c.-31G>A:,MFRP:ENST00000555262:5'UTR:MODIFIER:exon1/15:c.-31G>A:,MFRP:ENST00000360167:5'UTR:MODIFIER:exon1/10:c.-31G>A:		rs883247	0.6356	0.5951	21471,11104,1496	0.5365,0.5825,0.7230,0.5792,0.6604	0.5922							606227 [MFRP (provisional) Microphthalmia,isolated 5,611040|Nanophthalmos 2,609549];	RCV000347276.1 [likely benign]; RCV000400633.1 [likely benign]; 			798	791					MFRP (inh=AR pLI=0.00), C1QTNF5 (inh=AD pLI=0.83)
chr11	119217311	119217311	G	A	het	anno_omim	QUAL=7836;DP=208;AF=0.53;MQM=60;TRIO=HET,208,0.53,HOM,171,1.00,WT,276,0.01	MFRP,C1QTNF5	5'UTR_premature_start_codon_gain,5'UTR	MFRP:ENST00000530681:5'UTR_premature_start_codon_gain:LOW:exon1/15:c.-88C>T:,C1QTNF5:ENST00000445041:5'UTR_premature_start_codon_gain:LOW:exon1/15:c.-2724C>T:,MFRP:ENST00000449574:5'UTR_premature_start_codon_gain:LOW:exon1/13:c.-88C>T:,MFRP:ENST00000555262:5'UTR_premature_start_codon_gain:LOW:exon1/15:c.-88C>T:,MFRP:ENST00000360167:5'UTR_premature_start_codon_gain:LOW:exon1/10:c.-88C>T:,MFRP:ENST00000530681:5'UTR:MODIFIER:exon1/15:c.-88C>T:,C1QTNF5:ENST00000445041:5'UTR:MODIFIER:exon1/15:c.-2724C>T:,MFRP:ENST00000449574:5'UTR:MODIFIER:exon1/13:c.-88C>T:,MFRP:ENST00000555262:5'UTR:MODIFIER:exon1/15:c.-88C>T:,MFRP:ENST00000360167:5'UTR:MODIFIER:exon1/10:c.-88C>T:		rs883245	0.5839	0.0000	0,0,0	0,0,0,0,0	0.4969							606227 [MFRP (provisional) Microphthalmia,isolated 5,611040|Nanophthalmos 2,609549];	RCV000300755.1 [likely benign]; RCV000355624.1 [likely benign]; 			56	66					MFRP (inh=AR pLI=0.00), C1QTNF5 (inh=AD pLI=0.83)
chr11	119510644	119510644	A	C	hom	anno_omim	QUAL=23199;DP=227;AF=1.00;MQM=59;TRIO=HOM,227,1.00,HOM,196,1.00,HOM,313,1.00	PVRL1,RP11-196E1.3	missense	PVRL1:ENST00000341398:missense:MODERATE:exon6/8:c.1082T>G:p.Val361Gly		rs7940667	0.8728	0.9164	51183,28172,2686	0.7171,0.9645,0.9487,0.9195,0.9793	0.9219	0.0680	T	T	B	T	1.20	600644 [PVRL1 (confirmed) Cleft lip/palate-ectodermal dysplasia syndrome,225060|Orofacial cleft 7,225060];		CM066206 [CLASS=DP MUT=ALT PHEN="Cleft lip / palate association with" GENE=PVRL1]; 		1853	250					NECTIN1 (inh=AR pLI=0.50), RP11-196E1.3 (inh=n/a pLI=n/a)
chr11	119545224	119545224	-	G	het	anno_omim	QUAL=3997;DP=112;AF=0.47;MQM=59;TRIO=HET,112,0.47,HOM,114,0.98,WT,156,0.00	PVRL1	intron	PVRL1:ENST00000264025:intron:MODIFIER:exon5/5:c.1003+644dupC:,PVRL1:ENST00000341398:intron:MODIFIER:exon5/7:c.1003+644dupC:		rs113705862;rs534319501;rs763447380	0.1040	0.0000	0,0,0	0,0,0,0,0	0.1211							600644 [PVRL1 (confirmed) Cleft lip/palate-ectodermal dysplasia syndrome,225060|Orofacial cleft 7,225060];				6	81					NECTIN1 (inh=AR pLI=0.50)
chr11	121178302	121178302	A	C	het	anno_omim	QUAL=14865;DP=274;AF=0.54;MQM=60;TRIO=HET,274,0.54,HET,195,0.45,HOM,273,1.00	SC5D	3'UTR	SC5D:ENST00000264027:3'UTR:MODIFIER:exon5/5:c.*81A>C:,SC5D:ENST00000534230:3'UTR:MODIFIER:exon6/6:c.*81A>C:,SC5D:ENST00000392789:3'UTR:MODIFIER:exon5/5:c.*81A>C:		rs1061332	0.7246	0.0000	0,0,0	0,0,0,0,0	0.7190							602286 [SC5D (confirmed) Lathosterolosis,607330];	RCV000314437.1 [benign]; 			110	97					SC5D (inh=AR pLI=0.10)
chr11	121179847	121179847	A	T	het	anno_omim	QUAL=18253;DP=325;AF=0.54;MQM=60;TRIO=HET,325,0.54,HET,234,0.51,HOM,323,1.00	SC5D,BMPR1APS2	intergenic_region	BMPR1APS2:ENSG00000109929-ENSG00000232460:intergenic_region:MODIFIER::n.121179847A>T:	MLT1J2	rs2060008	0.4221	0.0000	0,0,0	0,0,0,0,0	0.5038							602286 [SC5D (confirmed) Lathosterolosis,607330];	RCV000397918.1 [benign]; 			61	110					SC5D (inh=AR pLI=0.10), BMPR1APS2 (inh=n/a pLI=n/a)
chr11	121181184	121181184	G	T	hom	anno_omim	QUAL=3701;DP=110;AF=0.00;MQM=60;TRIO=HOM,110,0.00,HOM,28,0.14,HOM,64,0.03	SC5D,BMPR1APS2	intergenic_region	BMPR1APS2:ENSG00000109929-ENSG00000232460:intergenic_region:MODIFIER::n.121181184G>T:	AluY		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0054							602286 [SC5D (confirmed) Lathosterolosis,607330];				0	0					SC5D (inh=AR pLI=0.10), BMPR1APS2 (inh=n/a pLI=n/a)
chr11	121183145	121183145	T	C	het	anno_omim	QUAL=6409;DP=192;AF=0.49;MQM=59;TRIO=HET,192,0.49,HET,69,0.61,HOM,80,1.00	SC5D,BMPR1APS2	intergenic_region	BMPR1APS2:ENSG00000109929-ENSG00000232460:intergenic_region:MODIFIER::n.121183145T>C:		rs35288685	0.3934	0.0000	0,0,0	0,0,0,0,0	0.4764							602286 [SC5D (confirmed) Lathosterolosis,607330];	RCV000283126.1 [benign]; 			61	113					SC5D (inh=AR pLI=0.10), BMPR1APS2 (inh=n/a pLI=n/a)
chr11	126139100	126139100	T	C	hom	anno_omim	QUAL=24943;DP=182;AF=0.99;MQM=60;TRIO=HOM,182,0.99,HOM,285,1.00,HOM,347,1.00	FOXRED1	5'UTR	FOXRED1:ENST00000263578:5'UTR:MODIFIER:exon1/11:c.-2T>C:,FOXRED1:ENST00000442061:5'UTR:MODIFIER:exon1/10:c.-291T>C:		rs1786702	0.7861	0.7891	38033,19007,1620	0.5634,0.8712,0.9988,0.7600,0.8818	0.7961							613622 [FOXRED1 (provisional) Leigh syndrome due to mitochondrial complex I deficiency,256000|Mitochondrial complex I deficiency,252010];	RCV000381743.1 [benign]; 			1228	733					FOXRED1 (inh=AR pLI=0.00)
chr11	126146290	126146290	T	G	het	pred_pathogenic;anno_omim	QUAL=281;DP=48;AF=0.67;MQM=59;TRIO=HET,48,0.67,WT,62,0.13,WT,82,0.16	FOXRED1	missense&splice_region	FOXRED1:ENST00000263578:missense&splice_region:MODERATE:exon9/11:c.973T>G:p.Tyr325Asp,FOXRED1:ENST00000442061:missense&splice_region:MODERATE:exon8/10:c.463T>G:p.Tyr155Asp,FOXRED1:ENST00000532125:missense&splice_region:MODERATE:exon9/11:c.931T>G:p.Tyr311Asp		rs201062084	0.2644	0.4552	0,0,0	0.4562,0.4772,0.4765,0.4514,0.4255	0.3004	7.1660	D,D,D	D	B,P,B	D,D,D	24.00	613622 [FOXRED1 (provisional) Leigh syndrome due to mitochondrial complex I deficiency,256000|Mitochondrial complex I deficiency,252010];			COSM3746238	0	106					FOXRED1 (inh=AR pLI=0.00)
chr11	126147697	126147697	G	A	het	anno_omim	QUAL=6022;DP=196;AF=0.40;MQM=60;TRIO=HET,196,0.40,HET,157,0.45,HET,225,0.47	FOXRED1	3'UTR	FOXRED1:ENST00000263578:3'UTR:MODIFIER:exon11/11:c.*113G>A:,FOXRED1:ENST00000442061:3'UTR:MODIFIER:exon10/10:c.*113G>A:,FOXRED1:ENST00000532125:3'UTR:MODIFIER:exon11/11:c.*113G>A:		rs667627	0.1314	0.2138	1917,1466,51	0.1485,0.1142,0.0452,0.2721,0.1760	0.1881							613622 [FOXRED1 (provisional) Leigh syndrome due to mitochondrial complex I deficiency,256000|Mitochondrial complex I deficiency,252010];	RCV000371864.1 [likely benign]; 			29	224					FOXRED1 (inh=AR pLI=0.00)
chr11	126293799	126293799	C	G	het	anno_omim	QUAL=2156;DP=78;AF=0.45;MQM=59;TRIO=HET,78,0.45,HOM,50,0.98,WT,61,0.00	KIRREL3,ST3GAL4	3'UTR	KIRREL3:ENST00000525144:3'UTR:MODIFIER:exon17/17:c.*676G>C:,KIRREL3:ENST00000529097:3'UTR:MODIFIER:exon16/16:c.*676G>C:		rs948053	0.5783	0.0000	0,0,0	0,0,0,0,0	0.5514							607761 [KIRREL3 (provisional) Mental retardation,autosomal dominant 4,612581];				70	112					KIRREL3 (inh=AD pLI=0.98), ST3GAL4 (inh=n/a pLI=0.44)
chr11	126294080	126294080	C	G	hom	anno_omim	QUAL=12747;DP=135;AF=0.99;MQM=59;TRIO=HOM,135,0.99,HOM,125,0.98,HOM,147,0.99	KIRREL3,ST3GAL4	3'UTR	KIRREL3:ENST00000525144:3'UTR:MODIFIER:exon17/17:c.*395G>C:,KIRREL3:ENST00000529097:3'UTR:MODIFIER:exon16/16:c.*395G>C:		rs7113456	0.7179	0.0000	0,0,0	0,0,0,0,0	0.6783							607761 [KIRREL3 (provisional) Mental retardation,autosomal dominant 4,612581];				86	122					KIRREL3 (inh=AD pLI=0.98), ST3GAL4 (inh=n/a pLI=0.44)
chr11	126294237	126294237	G	A	het	anno_omim	QUAL=3821;DP=138;AF=0.47;MQM=59;TRIO=HET,138,0.47,WT,159,0.01,HET,200,0.50	KIRREL3,ST3GAL4	3'UTR	KIRREL3:ENST00000525144:3'UTR:MODIFIER:exon17/17:c.*238C>T:,KIRREL3:ENST00000529097:3'UTR:MODIFIER:exon16/16:c.*238C>T:,KIRREL3:ENST00000416561:3'UTR:MODIFIER:exon6/6:c.*238C>T:		rs34642230	0.1190	0.0000	0,0,0	0,0,0,0,0	0.1109							607761 [KIRREL3 (provisional) Mental retardation,autosomal dominant 4,612581];				2	53					KIRREL3 (inh=AD pLI=0.98), ST3GAL4 (inh=n/a pLI=0.44)
chr11	126294261	126294261	T	C	het	anno_omim	QUAL=8927;DP=172;AF=0.48;MQM=60;TRIO=HET,172,0.48,WT,180,0.00,HOM,230,0.99	KIRREL3,ST3GAL4	3'UTR	KIRREL3:ENST00000525144:3'UTR:MODIFIER:exon17/17:c.*214A>G:,KIRREL3:ENST00000529097:3'UTR:MODIFIER:exon16/16:c.*214A>G:,KIRREL3:ENST00000416561:3'UTR:MODIFIER:exon6/6:c.*214A>G:		rs3802815	0.3874	0.0000	0,0,0	0,0,0,0,0	0.4509							607761 [KIRREL3 (provisional) Mental retardation,autosomal dominant 4,612581];				41	96					KIRREL3 (inh=AD pLI=0.98), ST3GAL4 (inh=n/a pLI=0.44)
chr11	126294817	126294817	G	A	hom	anno_omim	QUAL=10398;DP=64;AF=1.00;MQM=59;TRIO=HOM,64,1.00,HOM,146,0.99,HOM,189,1.00	KIRREL3,ST3GAL4	synonymous	KIRREL3:ENST00000525144:synonymous:LOW:exon17/17:c.1995C>T:p.Gly665Gly,KIRREL3:ENST00000529097:synonymous:LOW:exon16/16:c.1959C>T:p.Gly653Gly,KIRREL3:ENST00000416561:synonymous:LOW:exon6/6:c.396C>T:p.Gly132Gly		rs948052	0.7037	0.6713	26534,13761,2444	0.7185,0.5879,0.9022,0.6531,0.6579	0.6796							607761 [KIRREL3 (provisional) Mental retardation,autosomal dominant 4,612581];	RCV000117432.2 [likely benign]; 			946	930					KIRREL3 (inh=AD pLI=0.98), ST3GAL4 (inh=n/a pLI=0.44)
chr11	128708423	128708423	G	A	het	anno_omim	QUAL=8161;DP=420;AF=0.49;MQM=60;TRIO=HET,420,0.49,HET,231,0.45,WT,268,0.00	KCNJ1	3'UTR	KCNJ1:ENST00000392665:3'UTR:MODIFIER:exon2/2:c.*597C>T:,KCNJ1:ENST00000392666:3'UTR:MODIFIER:exon3/3:c.*597C>T:,KCNJ1:ENST00000440599:3'UTR:MODIFIER:exon3/3:c.*597C>T:,KCNJ1:ENST00000324036:3'UTR:MODIFIER:exon4/4:c.*597C>T:		rs117189807	0.0108	0.0000	0,0,0	0,0,0,0,0	0.0128							600359 [KCNJ1 (confirmed) Bartter syndrome,type 2,241200];	RCV000357906.1 [uncertain significance]; 			0	8					KCNJ1 (inh=AR pLI=0.00)
chr11	128737188	128737188	A	G	hom	anno_omim	QUAL=30920;DP=378;AF=1.00;MQM=59;TRIO=HOM,378,1.00,HOM,222,1.00,HOM,338,1.00	KCNJ1	5'UTR	KCNJ1:ENST00000392665:5'UTR:MODIFIER:exon1/2:c.-142T>C:,KCNJ1:ENST00000392666:5'UTR:MODIFIER:exon1/3:c.-312T>C:,KCNJ1:ENST00000440599:5'UTR:MODIFIER:exon1/3:c.-275T>C:,KCNJ1:ENST00000324036:5'UTR:MODIFIER:exon1/4:c.-445T>C:		rs2855790	0.8185	0.0000	0,0,0	0,0,0,0,0	0.8214							600359 [KCNJ1 (confirmed) Bartter syndrome,type 2,241200];				173	54					KCNJ1 (inh=AR pLI=0.00)
chr12	431586	431586	T	A	het	pred_pathogenic	QUAL=3006;DP=105;AF=0.56;MQM=60;TRIO=HET,105,0.56,WT,110,0.00,HET,154,0.44	KDM5A	missense	KDM5A:ENST00000399788:missense:MODERATE:exon17/28:c.2423A>T:p.His808Leu,KDM5A:ENST00000382815:missense:MODERATE:exon17/28:c.2423A>T:p.His808Leu		rs74894801	0.0084	0.0164	22,17,0	0.0047,0.0054,0.0007,0.0239,0.0101	0.0161	5.8510	T,T,T,T,T	T	B,B,B	T,T,T	18.26					1	77					KDM5A (inh=n/a pLI=1.00)
chr12	498282	498283	GT	-	hom	low_DP	QUAL=1201;DP=5;AF=0.00;MQM=51;TRIO=HOM,5,0.00,WT,15,0.00,HOM,71,0.11	KDM5A	5'UTR	KDM5A:ENST00000399788:5'UTR:MODIFIER:exon1/28:c.-26_-25delAC:,KDM5A:ENST00000382815:5'UTR:MODIFIER:exon1/28:c.-26_-25delAC:		rs796202342	0.0000	0.0109	0,0,0	0.0028,0.0047,0.0032,0.0088,0.0237	0.0030											0	1					KDM5A (inh=n/a pLI=1.00)
chr12	862641	862641	T	G	het	anno_omim	QUAL=1290;DP=36;AF=0.64;MQM=59;TRIO=HET,36,0.64,WT,68,0.00,HET,79,0.47	WNK1	5'UTR	WNK1:ENST00000535572:5'UTR:MODIFIER:exon1/26:c.-91T>G:,WNK1:ENST00000315939:5'UTR:MODIFIER:exon1/28:c.-91T>G:,WNK1:ENST00000537687:5'UTR:MODIFIER:exon1/28:c.-91T>G:,WNK1:ENST00000447667:5'UTR:MODIFIER:exon1/3:c.-91T>G:		rs3088353	0.3399	0.0000	0,0,0	0,0,0,0,0	0.4224							605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC,614492|Neuropathy,hereditary sensory and autonomic,type II,201300];	RCV000265340.1 [benign]; RCV000320343.1 [benign]; 			45	115					WNK1 (inh=AR+AD pLI=1.00)
chr12	862989	862989	T	C	hom	anno_omim	QUAL=10318;DP=118;AF=1.00;MQM=59;TRIO=HOM,118,1.00,HOM,98,1.00,HOM,116,1.00	WNK1	synonymous	WNK1:ENST00000530271:synonymous:LOW:exon1/30:c.258T>C:p.Cys86Cys,WNK1:ENST00000535572:synonymous:LOW:exon1/26:c.258T>C:p.Cys86Cys,WNK1:ENST00000315939:synonymous:LOW:exon1/28:c.258T>C:p.Cys86Cys,WNK1:ENST00000537687:synonymous:LOW:exon1/28:c.258T>C:p.Cys86Cys,WNK1:ENST00000447667:synonymous:LOW:exon1/3:c.258T>C:p.Cys86Cys		rs3168640	0.9756	0.9924	58554,32517,4124	0.9125,0.9973,0.9999,0.9999,0.9999	0.9943							605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC,614492|Neuropathy,hereditary sensory and autonomic,type II,201300];	RCV000246196.2 [benign]; RCV000304597.1 [benign]; RCV000391424.1 [benign]; 			2111	2					WNK1 (inh=AR+AD pLI=1.00)
chr12	863152	863152	G	A	het	pred_pathogenic;anno_omim	QUAL=3792;DP=153;AF=0.53;MQM=59;TRIO=HET,153,0.53,WT,112,0.00,HET,207,0.46	WNK1	missense	WNK1:ENST00000530271:missense:MODERATE:exon1/30:c.421G>A:p.Ala141Thr,WNK1:ENST00000535572:missense:MODERATE:exon1/26:c.421G>A:p.Ala141Thr,WNK1:ENST00000315939:missense:MODERATE:exon1/28:c.421G>A:p.Ala141Thr,WNK1:ENST00000537687:missense:MODERATE:exon1/28:c.421G>A:p.Ala141Thr,WNK1:ENST00000447667:missense:MODERATE:exon1/3:c.421G>A:p.Ala141Thr		rs11554421	0.0745	0.1633	689,375,6	0.0368,0.0961,0.1011,0.1790,0.1739	0.1234	2.0540	D,D,D,D,D	T	B,B,B	T,T,T,T,T	11.74	605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC,614492|Neuropathy,hereditary sensory and autonomic,type II,201300];	RCV000126341.2 [benign]; RCV000274665.1 [benign]; RCV000369345.1 [benign]; 		COSM3753517, COSM3753516	42	454					WNK1 (inh=AR+AD pLI=1.00)
chr12	939302	939302	A	G	hom	anno_omim	QUAL=33876;DP=255;AF=1.00;MQM=60;TRIO=HOM,255,1.00,HOM,395,1.00,HOM,412,1.00	WNK1	synonymous	WNK1:ENST00000530271:synonymous:LOW:exon4/30:c.1287A>G:p.Ala429Ala,WNK1:ENST00000535572:synonymous:LOW:exon4/26:c.1287A>G:p.Ala429Ala,WNK1:ENST00000315939:synonymous:LOW:exon4/28:c.1287A>G:p.Ala429Ala,WNK1:ENST00000537687:synonymous:LOW:exon4/28:c.1287A>G:p.Ala429Ala		rs10774466	0.6935	0.7451	34121,19376,1544	0.5494,0.7726,0.8653,0.7601,0.7040	0.7496							605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC,614492|Neuropathy,hereditary sensory and autonomic,type II,201300];	RCV000243912.1 [benign]; RCV000338242.1 [benign]; RCV000374093.1 [benign]; 		COSM3753538	1123	833					WNK1 (inh=AR+AD pLI=1.00)
chr12	968489	968489	T	C	het	anno_omim	QUAL=4595;DP=250;AF=0.38;MQM=60;TRIO=HET,250,0.38,WT,172,0.00,HET,210,0.45	WNK1	synonymous	WNK1:ENST00000530271:synonymous:LOW:exon6/30:c.1479T>C:p.Asp493Asp,WNK1:ENST00000535572:synonymous:LOW:exon6/26:c.1479T>C:p.Asp493Asp,WNK1:ENST00000315939:synonymous:LOW:exon6/28:c.1479T>C:p.Asp493Asp,WNK1:ENST00000537687:synonymous:LOW:exon6/28:c.1479T>C:p.Asp493Asp,WNK1:ENST00000340908:synonymous:LOW:exon3/25:c.258T>C:p.Asp86Asp		rs2286006	0.0935	0.1488	1643,1002,17	0.0466,0.0706,0.0672,0.1694,0.1767	0.1478							605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC,614492|Neuropathy,hereditary sensory and autonomic,type II,201300];	RCV000126337.2 [benign]; RCV000312056.1 [benign]; RCV000369034.1 [benign]; 		COSM3753547, COSM3753546	71	554					WNK1 (inh=AR+AD pLI=1.00)
chr12	974355	974355	-	C	hom	anno_high_impact;anno_omim	QUAL=11265;DP=145;AF=1.00;MQM=59;TRIO=HOM,145,1.00,HET,135,0.50,HOM,199,0.99	WNK1	frameshift,intron	WNK1:ENST00000530271:frameshift:HIGH:exon9/30:c.2220dupC:p.Phe741fs,WNK1:ENST00000535572:intron:MODIFIER:exon8/25:c.2139+2920dupC:,WNK1:ENST00000315939:intron:MODIFIER:exon8/27:c.2139+2920dupC:,WNK1:ENST00000537687:intron:MODIFIER:exon8/27:c.2140-2676dupC:,WNK1:ENST00000340908:intron:MODIFIER:exon5/24:c.918+2920dupC:		rs397768556	0.5184	0.5445	1852,575,64	0.4698,0.0000,0.5588,0.5662,0.5405	0.5581							605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC,614492|Neuropathy,hereditary sensory and autonomic,type II,201300];				685	951	1	[1] auto-classification 16.06.2016  [2] old entry - no details available			WNK1 (inh=AR+AD pLI=1.00)
chr12	974404	974404	T	C	hom	anno_omim	QUAL=17910;DP=227;AF=1.00;MQM=59;TRIO=HOM,227,1.00,HOM,227,0.99,HET,363,0.43	WNK1	synonymous,intron	WNK1:ENST00000530271:synonymous:LOW:exon9/30:c.2268T>C:p.Pro756Pro,WNK1:ENST00000535572:intron:MODIFIER:exon8/25:c.2139+2968T>C:,WNK1:ENST00000315939:intron:MODIFIER:exon8/27:c.2139+2968T>C:,WNK1:ENST00000537687:intron:MODIFIER:exon8/27:c.2140-2628T>C:,WNK1:ENST00000340908:intron:MODIFIER:exon5/24:c.918+2968T>C:		rs7300829	0.6540	0.6031	2301,609,144	0.6993,0.0000,0.6048,0.5724,0.6127	0.6457							605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC,614492|Neuropathy,hereditary sensory and autonomic,type II,201300];				644	938					WNK1 (inh=AR+AD pLI=1.00)
chr12	987482	987482	G	A	hom	anno_omim	QUAL=10681;DP=172;AF=0.99;MQM=59;TRIO=HOM,172,0.99,HOM,66,1.00,HOM,101,1.00	WNK1	synonymous	WNK1:ENST00000530271:synonymous:LOW:exon12/30:c.3822G>A:p.Gln1274Gln,WNK1:ENST00000535572:synonymous:LOW:exon10/26:c.2325G>A:p.Gln775Gln,WNK1:ENST00000315939:synonymous:LOW:exon10/28:c.2328G>A:p.Gln776Gln,WNK1:ENST00000537687:synonymous:LOW:exon11/28:c.3567G>A:p.Gln1189Gln,WNK1:ENST00000340908:synonymous:LOW:exon7/25:c.1107G>A:p.Gln369Gln		rs1012729	0.6795	0.7340	33053,19022,1583	0.5561,0.7671,0.8004,0.7535,0.6833	0.7385	-0.8680		T			4.22	605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC,614492|Neuropathy,hereditary sensory and autonomic,type II,201300];	RCV000249177.1 [benign]; RCV000265691.1 [benign]; RCV000358053.1 [benign]; 		COSM3753549, COSM3753548	1084	856					WNK1 (inh=AR+AD pLI=1.00)
chr12	987533	987533	-	T	het	anno_omim	QUAL=1393;DP=111;AF=0.59;MQM=59;TRIO=HET,111,0.59,HOM,25,0.72,HOM,42,0.64	WNK1	intron	WNK1:ENST00000530271:intron:MODIFIER:exon12/29:c.3867+21dupT:,WNK1:ENST00000535572:intron:MODIFIER:exon10/25:c.2370+21dupT:,WNK1:ENST00000315939:intron:MODIFIER:exon10/27:c.2373+21dupT:,WNK1:ENST00000537687:intron:MODIFIER:exon11/27:c.3612+21dupT:,WNK1:ENST00000340908:intron:MODIFIER:exon7/24:c.1152+21dupT:		rs398116010;rs570861980;rs5795952	0.4421	0.4607	481,279,35	0.4107,0.4682,0.4757,0.4654,0.4512	0.6757							605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC,614492|Neuropathy,hereditary sensory and autonomic,type II,201300];	RCV000202746.1,RCV000202746.1 [benign,benign]; 			460	1005					WNK1 (inh=AR+AD pLI=1.00)
chr12	990912	990912	A	C	het	anno_omim	QUAL=19731;DP=400;AF=0.50;MQM=60;TRIO=HET,400,0.50,HOM,286,1.00,HET,374,0.53	WNK1	missense	WNK1:ENST00000530271:missense:MODERATE:exon15/30:c.4660A>C:p.Thr1554Pro,WNK1:ENST00000535572:missense:MODERATE:exon11/26:c.2425A>C:p.Thr809Pro,WNK1:ENST00000315939:missense:MODERATE:exon13/28:c.3166A>C:p.Thr1056Pro,WNK1:ENST00000537687:missense:MODERATE:exon13/28:c.3946A>C:p.Thr1316Pro,WNK1:ENST00000340908:missense:MODERATE:exon10/25:c.1945A>C:p.Thr649Pro		rs956868	0.8528	0.8314	42059,23307,3857	0.8624,0.8603,0.7978,0.8348,0.8328	0.8317	0.0100	.,T,T,T,T,T,T	T,T	.,B,B,B	.,T,T,T,T,T	0.06	605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC,614492|Neuropathy,hereditary sensory and autonomic,type II,201300];	RCV000251124.1 [benign]; RCV000332623.1 [benign]; RCV000368653.1 [benign]; 			1480	560					WNK1 (inh=AR+AD pLI=1.00)
chr12	993930	993930	C	T	het	anno_omim	QUAL=14198;DP=317;AF=0.51;MQM=60;TRIO=HET,317,0.51,HOM,215,1.00,HET,262,0.47	WNK1	synonymous	WNK1:ENST00000530271:synonymous:LOW:exon21/30:c.5454C>T:p.Asn1818Asn,WNK1:ENST00000535572:synonymous:LOW:exon17/26:c.3219C>T:p.Asn1073Asn,WNK1:ENST00000315939:synonymous:LOW:exon19/28:c.3960C>T:p.Asn1320Asn,WNK1:ENST00000537687:synonymous:LOW:exon19/28:c.4740C>T:p.Asn1580Asn,WNK1:ENST00000340908:synonymous:LOW:exon16/25:c.2739C>T:p.Asn913Asn		rs7300444	0.3990	0.4192	10950,6561,457	0.3013,0.4226,0.5156,0.4409,0.3472	0.4205							605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC,614492|Neuropathy,hereditary sensory and autonomic,type II,201300];	RCV000126339.2 [benign]; RCV000294740.1 [benign]; RCV000389073.1 [benign]; 		COSM3753553, COSM3753554	373	953					WNK1 (inh=AR+AD pLI=1.00)
chr12	994014	994014	C	T	het	anno_omim	QUAL=6000;DP=257;AF=0.53;MQM=59;TRIO=HET,257,0.53,WT,180,0.00,HET,223,0.47	WNK1	synonymous	WNK1:ENST00000530271:synonymous:LOW:exon21/30:c.5538C>T:p.Thr1846Thr,WNK1:ENST00000535572:synonymous:LOW:exon17/26:c.3303C>T:p.Thr1101Thr,WNK1:ENST00000315939:synonymous:LOW:exon19/28:c.4044C>T:p.Thr1348Thr,WNK1:ENST00000537687:synonymous:LOW:exon19/28:c.4824C>T:p.Thr1608Thr,WNK1:ENST00000340908:synonymous:LOW:exon16/25:c.2823C>T:p.Thr941Thr		rs10849577	0.1158	0.1554	1649,900,14	0.0466,0.1275,0.2020,0.1591,0.1616	0.1564							605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC,614492|Neuropathy,hereditary sensory and autonomic,type II,201300];	RCV000126340.2 [benign]; RCV000349618.1 [benign]; RCV000403645.1 [benign]; 		COSM3998995, COSM3998996	65	545					WNK1 (inh=AR+AD pLI=1.00)
chr12	994487	994487	G	C	hom	anno_omim	QUAL=30159;DP=470;AF=1.00;MQM=59;TRIO=HOM,470,1.00,HOM,190,1.00,HOM,255,1.00	WNK1	missense	WNK1:ENST00000530271:missense:MODERATE:exon21/30:c.6011G>C:p.Cys2004Ser,WNK1:ENST00000535572:missense:MODERATE:exon17/26:c.3776G>C:p.Cys1259Ser,WNK1:ENST00000315939:missense:MODERATE:exon19/28:c.4517G>C:p.Cys1506Ser,WNK1:ENST00000537687:missense:MODERATE:exon19/28:c.5297G>C:p.Cys1766Ser,WNK1:ENST00000340908:missense:MODERATE:exon16/25:c.3296G>C:p.Cys1099Ser		rs7955371	0.9868	0.9963	60269,33358,4809	0.9613,0.9978,1.0000,0.9999,0.9998	0.9969	0.1530	T,T,T,T,T,T	T	B,B,B	T,T,T,T,T	0.01	605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC,614492|Neuropathy,hereditary sensory and autonomic,type II,201300];	RCV000246878.1 [benign]; RCV000263201.1 [benign]; RCV000318455.1 [benign]; 			2112	2					WNK1 (inh=AR+AD pLI=1.00)
chr12	1017197	1017197	C	T	hom	anno_omim	QUAL=26695;DP=206;AF=1.00;MQM=60;TRIO=HOM,206,1.00,HOM,274,1.00,HOM,373,1.00	WNK1	synonymous	WNK1:ENST00000530271:synonymous:LOW:exon29/30:c.8322C>T:p.Tyr2774Tyr,WNK1:ENST00000535572:synonymous:LOW:exon25/26:c.6084C>T:p.Tyr2028Tyr,WNK1:ENST00000315939:synonymous:LOW:exon27/28:c.6828C>T:p.Tyr2276Tyr,WNK1:ENST00000537687:synonymous:LOW:exon27/28:c.7608C>T:p.Tyr2536Tyr,WNK1:ENST00000340908:synonymous:LOW:exon24/25:c.5607C>T:p.Tyr1869Tyr		rs4766334	0.9870	0.9964	59903,33156,4714	0.9615,0.9979,1.0000,0.9999,0.9998	0.9970							605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC,614492|Neuropathy,hereditary sensory and autonomic,type II,201300];	RCV000242168.1 [benign]; RCV000267038.1 [benign]; RCV000326897.1 [benign]; 		COSM4146468, COSM4146469	2111	2					WNK1 (inh=AR+AD pLI=1.00)
chr12	1019453	1019453	-	ATC	het	anno_omim	QUAL=12313;DP=353;AF=0.44;MQM=59;TRIO=HET,353,0.44,HOM,150,1.00,HET,239,0.53	WNK1	3'UTR	WNK1:ENST00000535572:3'UTR:MODIFIER:exon26/26:c.*1496_*1498dupATC:,WNK1:ENST00000315939:3'UTR:MODIFIER:exon28/28:c.*1496_*1498dupATC:,WNK1:ENST00000537687:3'UTR:MODIFIER:exon28/28:c.*1496_*1498dupATC:,WNK1:ENST00000340908:3'UTR:MODIFIER:exon25/25:c.*1496_*1498dupATC:		rs3072752;rs397783428	0.0000	0.0000	0,0,0	0,0,0,0,0	0.3678							605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC,614492|Neuropathy,hereditary sensory and autonomic,type II,201300];				24	100					WNK1 (inh=AR+AD pLI=1.00)
chr12	1019944	1019944	G	A	hom	anno_omim	QUAL=25808;DP=339;AF=1.00;MQM=60;TRIO=HOM,339,1.00,HOM,203,1.00,HOM,244,1.00	WNK1	3'UTR	WNK1:ENST00000535572:3'UTR:MODIFIER:exon26/26:c.*1986G>A:,WNK1:ENST00000315939:3'UTR:MODIFIER:exon28/28:c.*1986G>A:,WNK1:ENST00000537687:3'UTR:MODIFIER:exon28/28:c.*1986G>A:,WNK1:ENST00000340908:3'UTR:MODIFIER:exon25/25:c.*1986G>A:		rs2023944	0.9872	0.0000	0,0,0	0,0,0,0,0	0.9884							605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC,614492|Neuropathy,hereditary sensory and autonomic,type II,201300];	RCV000285694.1 [benign]; RCV000406509.1 [benign]; 			232	0					WNK1 (inh=AR+AD pLI=1.00)
chr12	1020266	1020266	T	C	het	anno_omim	QUAL=8066;DP=391;AF=0.47;MQM=60;TRIO=HET,391,0.47,WT,149,0.00,HET,213,0.56	WNK1	3'UTR	WNK1:ENST00000535572:3'UTR:MODIFIER:exon26/26:c.*2308T>C:,WNK1:ENST00000315939:3'UTR:MODIFIER:exon28/28:c.*2308T>C:,WNK1:ENST00000537687:3'UTR:MODIFIER:exon28/28:c.*2308T>C:,WNK1:ENST00000340908:3'UTR:MODIFIER:exon25/25:c.*2308T>C:		rs1060499	0.1192	0.0000	0,0,0	0,0,0,0,0	0.1391							605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC,614492|Neuropathy,hereditary sensory and autonomic,type II,201300];	RCV000290908.1 [benign]; RCV000382968.1 [benign]; 			9	69					WNK1 (inh=AR+AD pLI=1.00)
chr12	5020435	5020435	G	A	het	anno_omim	QUAL=1067;DP=59;AF=0.47;MQM=60;TRIO=HET,59,0.47,HET,49,0.51,WT,86,0.00	KCNA1	5'UTR	KCNA1:ENST00000382545:5'UTR:MODIFIER:exon2/2:c.-110G>A:		rs35678382	0.1583	0.0000	0,0,0	0,0,0,0,0	0.1244							176260 [KCNA1 (confirmed) Episodic ataxia/myokymia syndrome,160120];	RCV000331891.1 [benign]; RCV000367845.1 [benign]; 			6	50					KCNA1 (inh=AD pLI=0.05)
chr12	5021984	5021984	T	A	het	anno_omim	QUAL=14967;DP=262;AF=0.56;MQM=60;TRIO=HET,262,0.56,HOM,360,1.00,WT,427,0.00	KCNA1	synonymous	KCNA1:ENST00000382545:synonymous:LOW:exon2/2:c.1440T>A:p.Thr480Thr		rs4766309	0.8205	0.7385	33542,15798,3831	0.8566,0.7567,0.9627,0.6883,0.7293	0.7611							176260 [KCNA1 (confirmed) Episodic ataxia/myokymia syndrome,160120];	RCV000117314.4 [other]; RCV000297286.1 [benign]; RCV000361409.1 [benign]; 			1562	1405	1	[1] Julia Bickmann 23.09.2014	n/a (1xTP, 0xFP)		KCNA1 (inh=AD pLI=0.05)
chr12	5026471	5026471	C	T	het	anno_omim	QUAL=13343;DP=356;AF=0.49;MQM=60;TRIO=HET,356,0.49,HOM,269,0.99,WT,339,0.00	KCNA1	3'UTR	KCNA1:ENST00000382545:3'UTR:MODIFIER:exon2/2:c.*4439C>T:		rs12424292	0.2438	0.0000	0,0,0	0,0,0,0,0	0.2244							176260 [KCNA1 (confirmed) Episodic ataxia/myokymia syndrome,160120];	RCV000292257.1 [benign]; RCV000351825.1 [benign]; 			11	74					KCNA1 (inh=AD pLI=0.05)
chr12	6457062	6457062	T	C	hom	anno_omim	QUAL=8153;DP=107;AF=1.00;MQM=59;TRIO=HOM,107,1.00,HOM,113,1.00,HET,131,0.46	SCNN1A	missense,3'UTR	SCNN1A:ENST00000360168:missense:MODERATE:exon12/12:c.2164A>G:p.Thr722Ala,SCNN1A:ENST00000358945:missense:MODERATE:exon13/13:c.2053A>G:p.Thr685Ala,SCNN1A:ENST00000540037:missense:MODERATE:exon11/11:c.1087A>G:p.Thr363Ala,SCNN1A:ENST00000228916:missense:MODERATE:exon13/13:c.1987A>G:p.Thr663Ala,SCNN1A:ENST00000543768:missense:MODERATE:exon13/13:c.2056A>G:p.Thr686Ala,SCNN1A:ENST00000396966:3'UTR:MODIFIER:exon11/11:c.*393A>G:		rs2228576	0.7406	0.7133	22085,10769,2783	0.9079,0.7678,0.5443,0.6882,0.7485	0.7453	-0.5860	T,T,T,T,T	T	B,B,B	T,T,T,T,T	0.01	600228 [SCNN1A (confirmed) Pseudohypoaldosteronism,type I,264350|Bronchiectasis with or without elevated sweat chloride 2,613021];	RCV000151811.3 [benign]; RCV000295920.1 [benign]; RCV000325126.1 [benign]; 	CM994637 [CLASS=DFP MUT=ALT PHEN="Hypertension reduced risk association with" GENE=SCNN1A]; 	COSM1747194	1081	794					SCNN1A (inh=AR+AD pLI=0.00)
chr12	6484709	6484709	T	C	het	anno_omim	QUAL=1098;DP=22;AF=0.55;MQM=60;TRIO=HET,22,0.55,WT,30,0.00,HOM,29,1.00	SCNN1A,LTBR	5'UTR,intron	SCNN1A:ENST00000228916:5'UTR:MODIFIER:exon1/13:c.-93A>G:,LTBR:ENST00000539925:5'UTR:MODIFIER:exon1/10:c.-13T>C:,SCNN1A:ENST00000543768:intron:MODIFIER:exon1/12:c.16-706A>G:		rs10849447	0.7568	0.5821	1920,204,73	0.0000,0.0000,0.0000,0.3842,0.6435	0.6706							600228 [SCNN1A (confirmed) Pseudohypoaldosteronism,type I,264350|Bronchiectasis with or without elevated sweat chloride 2,613021];	RCV000299434.1 [benign]; RCV000356647.1 [benign]; 			442	767					SCNN1A (inh=AR+AD pLI=0.00), LTBR (inh=n/a pLI=0.43)
chr12	7045178	7045178	G	A	het	pred_pathogenic;anno_omim	QUAL=918;DP=29;AF=0.66;MQM=60;TRIO=HET,29,0.66,HET,55,0.38,WT,69,0.00	ATN1	missense	ATN1:ENST00000356654:missense:MODERATE:exon5/10:c.748G>A:p.Gly250Ser,ATN1:ENST00000396684:missense:MODERATE:exon5/10:c.748G>A:p.Gly250Ser		rs148694613	0.0030	0.0068	5,5,0	0.0023,0.0025,0.0000,0.0107,0.0007	0.0070	2.6350	D,D,D	T	B,B	T,T,T	18.73	607462 [ATN1 (confirmed) Dentatorubro-pallidoluysian atrophy,125370];				0	30					ATN1 (inh=AD pLI=1.00)
chr12	7048292	7048292	C	T	het	pred_pathogenic;anno_omim;trio_denovo	QUAL=2234;DP=215;AF=0.46;MQM=60;TRIO=HET,215,0.46,WT,303,0.00,WT,420,0.00	ATN1	missense	ATN1:ENST00000356654:missense:MODERATE:exon7/10:c.3166C>T:p.His1056Tyr,ATN1:ENST00000396684:missense:MODERATE:exon7/10:c.3166C>T:p.His1056Tyr	(CACCAG)n		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000	7.6510	D,D,D,D	D	P	D,D,D	28.60	607462 [ATN1 (confirmed) Dentatorubro-pallidoluysian atrophy,125370];				0	1					ATN1 (inh=AD pLI=1.00)
chr12	7242204	7242204	C	T	het	pred_pathogenic;anno_omim	QUAL=3000;DP=121;AF=0.40;MQM=60;TRIO=HET,121,0.40,HOM,69,0.96,WT,94,0.00	C1R,C1RL	missense	C1R:ENST00000542285:missense:MODERATE:exon4/11:c.547G>A:p.Glu183Lys		rs1126605	0.1749	0.1174	1215,265,109	0.1473,0.0543,0.3676,0.0859,0.1571	0.1160	-0.4440	T,T,T,T,T,T	T	B,B,B	D,D	0.01	613785 [C1R (confirmed) Ehlers-Danlos syndrome,periodontal type,1,130080];				27	353					C1R (inh=AR pLI=n/a), C1RL (inh=n/a pLI=0.00)
chr12	7242299	7242299	G	A	het	pred_pathogenic;anno_omim	QUAL=2242;DP=125;AF=0.53;MQM=59;TRIO=HET,125,0.53,WT,61,0.02,HET,74,0.39	C1R,C1RL	missense	C1R:ENST00000542285:missense:MODERATE:exon4/11:c.452C>T:p.Ser151Leu		rs1801046	0.2392	0.2337	3593,1941,159	0.1794,0.1254,0.3712,0.2385,0.2212	0.2368	0.0160	T,T,T,T,T,T,T,T,T	T	B,B,B	D,D,D,T,T	8.17	613785 [C1R (confirmed) Ehlers-Danlos syndrome,periodontal type,1,130080];				115	721					C1R (inh=AR pLI=n/a), C1RL (inh=n/a pLI=0.00)
chr12	7363574	7363574	C	G	het	anno_omim	QUAL=11760;DP=280;AF=0.50;MQM=59;TRIO=HET,280,0.50,HOM,261,1.00,WT,270,0.00	PEX5	3'UTR,intron	PEX5:ENST00000266563:3'UTR:MODIFIER:exon15/15:c.*755C>G:,PEX5:ENST00000266564:3'UTR:MODIFIER:exon15/15:c.*755C>G:,PEX5:ENST00000455147:intron:MODIFIER:exon17/17:c.*19+736C>G:		rs1057225	0.4321	0.0000	0,0,0	0,0,0,0,0	0.4283							600414 [PEX5 (confirmed) Peroxisome biogenesis disorder 2A (Zellweger),214110|Peroxisome biogenesis disorder 2B,202370|Rhizomelic chondrodysplasia punctata,type 5,616716];	RCV000374463.1 [benign]; 			39	70					PEX5 (inh=AR pLI=0.40)
chr12	8755737	8755737	C	T	hom	anno_omim	QUAL=3179;DP=24;AF=0.00;MQM=60;TRIO=HOM,24,0.00,HOM,15,0.07,HOM,27,0.15	AICDA	3'UTR	AICDA:ENST00000229335:3'UTR:MODIFIER:exon5/5:c.*1143G>A:	(TTCTCT)n		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0006							605257 [AICDA (confirmed) Immunodeficiency with hyper-IgM,type 2,605258];				0	0					AICDA (inh=AR pLI=0.00)
chr12	8757481	8757481	G	A	het	anno_omim	QUAL=2804;DP=195;AF=0.42;MQM=59;TRIO=HET,195,0.42,HET,31,0.48,HET,70,0.31	AICDA	synonymous	AICDA:ENST00000229335:synonymous:LOW:exon4/5:c.465C>T:p.His155His,AICDA:ENST00000537228:synonymous:LOW:exon4/5:c.435C>T:p.His145His		rs2028373	0.4842	0.5904	21560,13501,541	0.3273,0.6619,0.5021,0.6375,0.5432	0.5966	-0.1680		T			2.15	605257 [AICDA (confirmed) Immunodeficiency with hyper-IgM,type 2,605258];	RCV000242942.2 [benign]; RCV000317701.1 [benign]; 			818	929					AICDA (inh=AR pLI=0.00)
chr12	8757522	8757522	-	A	hom	anno_omim	QUAL=911;DP=36;AF=0.56;MQM=59;TRIO=HOM,36,0.56,HOM,11,0.91,HOM,30,0.83	AICDA	splice_region&intron,intron	AICDA:ENST00000229335:splice_region&intron:LOW:exon3/4:c.428-5dupT:,AICDA:ENST00000537228:intron:MODIFIER:exon3/4:c.428-35dupT:		rs397718057;rs5796316	0.6424	0.5635	6110,3495,306	0.4811,0.5381,0.5994,0.5751,0.5378	0.8638							605257 [AICDA (confirmed) Immunodeficiency with hyper-IgM,type 2,605258];	RCV000295883.1 [benign]; 			943	558	1	[1] old entry - no details available			AICDA (inh=AR pLI=0.00)
chr12	8765447	8765447	T	C	hom	anno_omim	QUAL=34885;DP=384;AF=1.00;MQM=60;TRIO=HOM,384,1.00,HOM,284,1.00,HOM,413,1.00	AICDA	5'UTR_premature_start_codon_gain,5'UTR	AICDA:ENST00000229335:5'UTR_premature_start_codon_gain:LOW:exon1/5:c.-84A>G:,AICDA:ENST00000537228:5'UTR_premature_start_codon_gain:LOW:exon1/5:c.-84A>G:,AICDA:ENST00000229335:5'UTR:MODIFIER:exon1/5:c.-84A>G:,AICDA:ENST00000537228:5'UTR:MODIFIER:exon1/5:c.-84A>G:		rs1345004	0.9954	0.0000	0,0,0	0,0,0,0,0	0.9954							605257 [AICDA (confirmed) Immunodeficiency with hyper-IgM,type 2,605258];	RCV000269201.1 [benign]; 			565	2					AICDA (inh=AR pLI=0.00)
chr12	13714729	13714729	T	C	hom	anno_omim	QUAL=28867;DP=407;AF=1.00;MQM=59;TRIO=HOM,407,1.00,HOM,205,1.00,HOM,270,1.00	GRIN2B	3'UTR	GRIN2B:ENST00000609686:3'UTR:MODIFIER:exon13/13:c.*988A>G:		rs1805477	0.8914	0.0000	0,0,0	0,0,0,0,0	0.9066							138252 [GRIN2B (provisional) Mental retardation,autosomal dominant 6,613970|Epileptic encephalopathy,early infantile,27,616139];	RCV000389607.1 [likely benign]; 			425	3					GRIN2B (inh=AD pLI=1.00)
chr12	13715308	13715308	A	C	het	anno_omim	QUAL=8140;DP=414;AF=0.49;MQM=60;TRIO=HET,414,0.49,HET,203,0.50,WT,308,0.01	GRIN2B	3'UTR	GRIN2B:ENST00000609686:3'UTR:MODIFIER:exon13/13:c.*409T>G:		rs890	0.2750	0.0000	0,0,0	0,0,0,0,0	0.3580							138252 [GRIN2B (provisional) Mental retardation,autosomal dominant 6,613970|Epileptic encephalopathy,early infantile,27,616139];	RCV000339902.1 [likely benign]; 			98	224					GRIN2B (inh=AD pLI=1.00)
chr12	13716638	13716638	G	A	het	anno_omim	QUAL=6448;DP=238;AF=0.39;MQM=59;TRIO=HET,238,0.39,WT,306,0.00,HET,350,0.48	GRIN2B	synonymous	GRIN2B:ENST00000609686:synonymous:LOW:exon13/13:c.3534C>T:p.His1178His		rs1806191	0.2476	0.3915	10739,8298,201	0.1987,0.4446,0.0142,0.4995,0.2318	0.3999							138252 [GRIN2B (provisional) Mental retardation,autosomal dominant 6,613970|Epileptic encephalopathy,early infantile,27,616139];	RCV000117197.2 [likely benign]; RCV000313654.1 [likely benign]; 		COSM4146926	517	1112					GRIN2B (inh=AD pLI=1.00)
chr12	14019157	14019157	C	T	het	anno_omim	QUAL=1380;DP=79;AF=0.43;MQM=59;TRIO=HET,79,0.43,WT,47,0.00,HET,54,0.54	GRIN2B	5'UTR	GRIN2B:ENST00000609686:5'UTR:MODIFIER:exon2/13:c.-15G>A:		rs12818068	0.0379	0.0820	509,440,1	0.0174,0.0388,0.0003,0.1190,0.0290	0.0907							138252 [GRIN2B (provisional) Mental retardation,autosomal dominant 6,613970|Epileptic encephalopathy,early infantile,27,616139];	RCV000125318.2 [benign]; RCV000289774.1 [likely benign]; 			33	382					GRIN2B (inh=AD pLI=1.00)
chr12	25358650	25358650	A	T	hom	anno_omim	QUAL=10937;DP=265;AF=1.00;MQM=57;TRIO=HOM,265,1.00,HOM,47,1.00,HET,64,0.50	KRAS,LYRM5	3'UTR,intron	KRAS:ENST00000311936:3'UTR:MODIFIER:exon5/5:c.*4079T>A:,LYRM5:ENST00000553788:intron:MODIFIER:exon3/3:c.45+1709A>T:		rs12245	0.5483	0.0000	0,0,0	0,0,0,0,0	0.5008							190070 [KRAS (confirmed) Lung cancer,somatic,211980|Bladder cancer,somatic,109800|Pancreatic carcinoma,somatic,260350|Gastric cancer,somatic,137215|Leukemia,acute myeloid,601626|Noonan syndrome 3,609942|Cardiofaciocutaneous syndrome 2,615278|Breast cancer,somatic,114480|Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200|RAS-associated autoimmune leukoproliferative disorder,614470];	RCV000333232.1 [likely benign]; RCV000366899.1 [likely benign]; 	CR1010511 [CLASS=DP MUT=ALT PHEN="Ovarian cancer increased risk association with" GENE=KRAS]; 		68	128					KRAS (inh=AD pLI=0.00), ETFRF1 (inh=n/a pLI=0.00)
chr12	25358663	25358664	TT	-	hom	anno_omim	QUAL=8471;DP=235;AF=0.99;MQM=56;TRIO=HOM,235,0.99,HOM,37,1.00,HET,53,0.49	KRAS,LYRM5	3'UTR,intron	KRAS:ENST00000311936:3'UTR:MODIFIER:exon5/5:c.*4065_*4066delAA:,LYRM5:ENST00000553788:intron:MODIFIER:exon3/3:c.45+1728_45+1729delTT:		rs57698689;rs796922820	0.5435	0.0000	0,0,0	0,0,0,0,0	0.4950							190070 [KRAS (confirmed) Lung cancer,somatic,211980|Bladder cancer,somatic,109800|Pancreatic carcinoma,somatic,260350|Gastric cancer,somatic,137215|Leukemia,acute myeloid,601626|Noonan syndrome 3,609942|Cardiofaciocutaneous syndrome 2,615278|Breast cancer,somatic,114480|Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200|RAS-associated autoimmune leukoproliferative disorder,614470];	RCV000323439.1 [likely benign]; RCV000380266.1 [likely benign]; 			67	126					KRAS (inh=AD pLI=0.00), ETFRF1 (inh=n/a pLI=0.00)
chr12	25358828	25358828	T	G	hom	anno_omim	QUAL=7935;DP=143;AF=1.00;MQM=60;TRIO=HOM,143,1.00,HOM,61,1.00,HET,74,0.54	KRAS,LYRM5	3'UTR,intron	KRAS:ENST00000311936:3'UTR:MODIFIER:exon5/5:c.*3901A>C:,LYRM5:ENST00000553788:intron:MODIFIER:exon3/3:c.45+1887T>G:		rs12587	0.5483	0.0000	0,0,0	0,0,0,0,0	0.5007							190070 [KRAS (confirmed) Lung cancer,somatic,211980|Bladder cancer,somatic,109800|Pancreatic carcinoma,somatic,260350|Gastric cancer,somatic,137215|Leukemia,acute myeloid,601626|Noonan syndrome 3,609942|Cardiofaciocutaneous syndrome 2,615278|Breast cancer,somatic,114480|Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200|RAS-associated autoimmune leukoproliferative disorder,614470];	RCV000282245.1 [likely benign]; RCV000401125.1 [likely benign]; 			67	128					KRAS (inh=AD pLI=0.00), ETFRF1 (inh=n/a pLI=0.00)
chr12	25358943	25358943	T	C	hom	anno_omim	QUAL=15667;DP=367;AF=0.99;MQM=59;TRIO=HOM,367,0.99,HOM,77,1.00,HET,102,0.46	KRAS,LYRM5	3'UTR,intron	KRAS:ENST00000311936:3'UTR:MODIFIER:exon5/5:c.*3786A>G:,LYRM5:ENST00000553788:intron:MODIFIER:exon3/3:c.45+2002T>C:		rs8720	0.5485	0.0000	0,0,0	0,0,0,0,0	0.5011							190070 [KRAS (confirmed) Lung cancer,somatic,211980|Bladder cancer,somatic,109800|Pancreatic carcinoma,somatic,260350|Gastric cancer,somatic,137215|Leukemia,acute myeloid,601626|Noonan syndrome 3,609942|Cardiofaciocutaneous syndrome 2,615278|Breast cancer,somatic,114480|Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200|RAS-associated autoimmune leukoproliferative disorder,614470];	RCV000334990.1 [likely benign]; RCV000401993.1 [likely benign]; 			67	126					KRAS (inh=AD pLI=0.00), ETFRF1 (inh=n/a pLI=0.00)
chr12	25358969	25358969	T	G	hom	anno_omim	QUAL=12878;DP=297;AF=0.99;MQM=59;TRIO=HOM,297,0.99,HOM,63,1.00,HET,93,0.49	KRAS,LYRM5	3'UTR,intron	KRAS:ENST00000311936:3'UTR:MODIFIER:exon5/5:c.*3760A>C:,LYRM5:ENST00000553788:intron:MODIFIER:exon3/3:c.45+2028T>G:		rs1137196	0.4333	0.0000	0,0,0	0,0,0,0,0	0.3877							190070 [KRAS (confirmed) Lung cancer,somatic,211980|Bladder cancer,somatic,109800|Pancreatic carcinoma,somatic,260350|Gastric cancer,somatic,137215|Leukemia,acute myeloid,601626|Noonan syndrome 3,609942|Cardiofaciocutaneous syndrome 2,615278|Breast cancer,somatic,114480|Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200|RAS-associated autoimmune leukoproliferative disorder,614470];	RCV000314184.1 [likely benign]; RCV000371183.1 [likely benign]; 			53	115					KRAS (inh=AD pLI=0.00), ETFRF1 (inh=n/a pLI=0.00)
chr12	25359328	25359328	A	T	hom	anno_omim	QUAL=11447;DP=199;AF=0.99;MQM=59;TRIO=HOM,199,0.99,HOM,93,1.00,HET,153,0.42	KRAS,LYRM5	3'UTR,intron	KRAS:ENST00000311936:3'UTR:MODIFIER:exon5/5:c.*3401T>A:,LYRM5:ENST00000553788:intron:MODIFIER:exon3/3:c.45+2387A>T:		rs1137189	0.5481	0.0000	0,0,0	0,0,0,0,0	0.4987							190070 [KRAS (confirmed) Lung cancer,somatic,211980|Bladder cancer,somatic,109800|Pancreatic carcinoma,somatic,260350|Gastric cancer,somatic,137215|Leukemia,acute myeloid,601626|Noonan syndrome 3,609942|Cardiofaciocutaneous syndrome 2,615278|Breast cancer,somatic,114480|Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200|RAS-associated autoimmune leukoproliferative disorder,614470];	RCV000349055.1 [likely benign]; RCV000400744.1 [likely benign]; 			67	128					KRAS (inh=AD pLI=0.00), ETFRF1 (inh=n/a pLI=0.00)
chr12	25359352	25359352	G	A	hom	anno_omim	QUAL=11558;DP=222;AF=0.99;MQM=59;TRIO=HOM,222,0.99,HOM,76,0.99,HET,136,0.44	KRAS,LYRM5	3'UTR,intron	KRAS:ENST00000311936:3'UTR:MODIFIER:exon5/5:c.*3377C>T:,LYRM5:ENST00000553788:intron:MODIFIER:exon3/3:c.45+2411G>A:		rs1137188	0.5485	0.0000	0,0,0	0,0,0,0,0	0.5010							190070 [KRAS (confirmed) Lung cancer,somatic,211980|Bladder cancer,somatic,109800|Pancreatic carcinoma,somatic,260350|Gastric cancer,somatic,137215|Leukemia,acute myeloid,601626|Noonan syndrome 3,609942|Cardiofaciocutaneous syndrome 2,615278|Breast cancer,somatic,114480|Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200|RAS-associated autoimmune leukoproliferative disorder,614470];	RCV000309178.1 [likely benign]; RCV000347746.1 [likely benign]; 			67	128					KRAS (inh=AD pLI=0.00), ETFRF1 (inh=n/a pLI=0.00)
chr12	25359465	25359465	A	-	hom	anno_omim	QUAL=14928;DP=310;AF=1.00;MQM=59;TRIO=HOM,310,1.00,HOM,105,1.00,HET,172,0.45	KRAS,LYRM5	3'UTR,intron	KRAS:ENST00000311936:3'UTR:MODIFIER:exon5/5:c.*3264delT:,LYRM5:ENST00000553788:intron:MODIFIER:exon3/3:c.45+2525delA:		rs796285705	0.5485	0.0000	0,0,0	0,0,0,0,0	0.5007							190070 [KRAS (confirmed) Lung cancer,somatic,211980|Bladder cancer,somatic,109800|Pancreatic carcinoma,somatic,260350|Gastric cancer,somatic,137215|Leukemia,acute myeloid,601626|Noonan syndrome 3,609942|Cardiofaciocutaneous syndrome 2,615278|Breast cancer,somatic,114480|Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200|RAS-associated autoimmune leukoproliferative disorder,614470];	RCV000304310.1 [likely benign]; RCV000393670.1 [likely benign]; 			68	128					KRAS (inh=AD pLI=0.00), ETFRF1 (inh=n/a pLI=0.00)
chr12	25359841	25359841	T	C	hom	anno_omim	QUAL=6843;DP=174;AF=1.00;MQM=60;TRIO=HOM,174,1.00,HOM,18,1.00,HET,38,0.55	KRAS,LYRM5	3'UTR,intron	KRAS:ENST00000311936:3'UTR:MODIFIER:exon5/5:c.*2888A>G:,LYRM5:ENST00000553788:intron:MODIFIER:exon3/3:c.46-2288T>C:		rs13096	0.5256	0.0000	0,0,0	0,0,0,0,0	0.4827							190070 [KRAS (confirmed) Lung cancer,somatic,211980|Bladder cancer,somatic,109800|Pancreatic carcinoma,somatic,260350|Gastric cancer,somatic,137215|Leukemia,acute myeloid,601626|Noonan syndrome 3,609942|Cardiofaciocutaneous syndrome 2,615278|Breast cancer,somatic,114480|Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200|RAS-associated autoimmune leukoproliferative disorder,614470];	RCV000333153.1 [likely benign]; RCV000385382.1 [likely benign]; 			66	126					KRAS (inh=AD pLI=0.00), ETFRF1 (inh=n/a pLI=0.00)
chr12	25360138	25360138	T	C	hom	anno_omim	QUAL=31421;DP=309;AF=0.99;MQM=59;TRIO=HOM,309,0.99,HOM,263,1.00,HOM,405,1.00	KRAS,LYRM5	3'UTR,intron	KRAS:ENST00000311936:3'UTR:MODIFIER:exon5/5:c.*2591A>G:,LYRM5:ENST00000553788:intron:MODIFIER:exon3/3:c.46-1991T>C:	L2a	rs4963858	0.9886	0.0000	0,0,0	0,0,0,0,0	0.9914							190070 [KRAS (confirmed) Lung cancer,somatic,211980|Bladder cancer,somatic,109800|Pancreatic carcinoma,somatic,260350|Gastric cancer,somatic,137215|Leukemia,acute myeloid,601626|Noonan syndrome 3,609942|Cardiofaciocutaneous syndrome 2,615278|Breast cancer,somatic,114480|Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200|RAS-associated autoimmune leukoproliferative disorder,614470];				254	1					KRAS (inh=AD pLI=0.00), ETFRF1 (inh=n/a pLI=0.00)
chr12	25360449	25360449	-	A	het	anno_omim	QUAL=4164;DP=136;AF=0.71;MQM=59;TRIO=HET,136,0.71,HOM,38,0.84,HOM,41,0.83	KRAS,LYRM5	3'UTR,intron	KRAS:ENST00000311936:3'UTR:MODIFIER:exon5/5:c.*2279dupT:,LYRM5:ENST00000553788:intron:MODIFIER:exon3/3:c.46-1669dupA:	AluSz	rs397747594	0.8788	0.0000	0,0,0	0,0,0,0,0	0.9229							190070 [KRAS (confirmed) Lung cancer,somatic,211980|Bladder cancer,somatic,109800|Pancreatic carcinoma,somatic,260350|Gastric cancer,somatic,137215|Leukemia,acute myeloid,601626|Noonan syndrome 3,609942|Cardiofaciocutaneous syndrome 2,615278|Breast cancer,somatic,114480|Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200|RAS-associated autoimmune leukoproliferative disorder,614470];	RCV000298757.1 [likely benign]; RCV000370101.1 [likely benign]; 			140	112					KRAS (inh=AD pLI=0.00), ETFRF1 (inh=n/a pLI=0.00)
chr12	25361091	25361091	T	C	hom	anno_omim	QUAL=17642;DP=287;AF=1.00;MQM=59;TRIO=HOM,287,1.00,HOM,120,1.00,HOM,157,1.00	KRAS,LYRM5	3'UTR,intron	KRAS:ENST00000311936:3'UTR:MODIFIER:exon5/5:c.*1638A>G:,LYRM5:ENST00000553788:intron:MODIFIER:exon3/3:c.46-1038T>C:		rs4597149	0.9974	0.0000	0,0,0	0,0,0,0,0	0.9945							190070 [KRAS (confirmed) Lung cancer,somatic,211980|Bladder cancer,somatic,109800|Pancreatic carcinoma,somatic,260350|Gastric cancer,somatic,137215|Leukemia,acute myeloid,601626|Noonan syndrome 3,609942|Cardiofaciocutaneous syndrome 2,615278|Breast cancer,somatic,114480|Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200|RAS-associated autoimmune leukoproliferative disorder,614470];	RCV000324189.1 [likely benign]; RCV000378636.1 [likely benign]; 			255	0					KRAS (inh=AD pLI=0.00), ETFRF1 (inh=n/a pLI=0.00)
chr12	25361101	25361101	-	A	het	anno_omim	QUAL=8155;DP=240;AF=0.78;MQM=59;TRIO=HET,240,0.78,HOM,92,0.91,HET,129,0.43	KRAS,LYRM5	3'UTR,intron	KRAS:ENST00000311936:3'UTR:MODIFIER:exon5/5:c.*1627dupT:,LYRM5:ENST00000553788:intron:MODIFIER:exon3/3:c.46-1016dupA:		rs398116239	0.5711	0.0000	0,0,0	0,0,0,0,0	0.5675							190070 [KRAS (confirmed) Lung cancer,somatic,211980|Bladder cancer,somatic,109800|Pancreatic carcinoma,somatic,260350|Gastric cancer,somatic,137215|Leukemia,acute myeloid,601626|Noonan syndrome 3,609942|Cardiofaciocutaneous syndrome 2,615278|Breast cancer,somatic,114480|Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200|RAS-associated autoimmune leukoproliferative disorder,614470];	RCV000280925.1 [likely benign]; RCV000375331.1 [likely benign]; 			91	110					KRAS (inh=AD pLI=0.00), ETFRF1 (inh=n/a pLI=0.00)
chr12	25362217	25362217	A	G	hom	anno_omim	QUAL=14119;DP=266;AF=1.00;MQM=60;TRIO=HOM,266,1.00,HOM,103,1.00,HET,149,0.48	LYRM5,KRAS	3'UTR	LYRM5:ENST00000553788:3'UTR:MODIFIER:exon4/4:c.*20A>G:,KRAS:ENST00000311936:3'UTR:MODIFIER:exon5/5:c.*512T>C:,KRAS:ENST00000557334:3'UTR:MODIFIER:exon3/3:c.*512T>C:		rs9266	0.5491	0.6359	2234,513,17	0.3731,0.0000,0.0000,0.6104,0.6518	0.5799							190070 [KRAS (confirmed) Lung cancer,somatic,211980|Bladder cancer,somatic,109800|Pancreatic carcinoma,somatic,260350|Gastric cancer,somatic,137215|Leukemia,acute myeloid,601626|Noonan syndrome 3,609942|Cardiofaciocutaneous syndrome 2,615278|Breast cancer,somatic,114480|Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200|RAS-associated autoimmune leukoproliferative disorder,614470];	RCV000342340.1 [likely benign]; RCV000398489.1 [likely benign]; 	CR1415243 [CLASS=FP MUT=ALT PHEN="Reduced promoter activity" GENE=KRAS]; 		462	770					ETFRF1 (inh=n/a pLI=0.00), KRAS (inh=AD pLI=0.00)
chr12	25362465	25362465	G	A	hom	anno_omim	QUAL=19026;DP=324;AF=1.00;MQM=58;TRIO=HOM,324,1.00,HOM,114,1.00,HOM,163,1.00	KRAS,LYRM5	3'UTR	KRAS:ENST00000256078:3'UTR:MODIFIER:exon6/6:c.*385C>T:,LYRM5:ENST00000553788:3'UTR:MODIFIER:exon4/4:c.*268G>A:,KRAS:ENST00000311936:3'UTR:MODIFIER:exon5/5:c.*264C>T:,KRAS:ENST00000557334:3'UTR:MODIFIER:exon3/3:c.*264C>T:		rs4285970	0.9972	0.0000	0,0,0	0,0,0,0,0	0.9984							190070 [KRAS (confirmed) Lung cancer,somatic,211980|Bladder cancer,somatic,109800|Pancreatic carcinoma,somatic,260350|Gastric cancer,somatic,137215|Leukemia,acute myeloid,601626|Noonan syndrome 3,609942|Cardiofaciocutaneous syndrome 2,615278|Breast cancer,somatic,114480|Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200|RAS-associated autoimmune leukoproliferative disorder,614470];				266	0					KRAS (inh=AD pLI=0.00), ETFRF1 (inh=n/a pLI=0.00)
chr12	25362552	25362552	A	C	hom	anno_omim	QUAL=14601;DP=266;AF=0.99;MQM=60;TRIO=HOM,266,0.99,HOM,109,1.00,HET,171,0.51	KRAS,LYRM5	3'UTR	KRAS:ENST00000256078:3'UTR:MODIFIER:exon6/6:c.*298T>G:,LYRM5:ENST00000553788:3'UTR:MODIFIER:exon4/4:c.*355A>C:,KRAS:ENST00000311936:3'UTR:MODIFIER:exon5/5:c.*177T>G:,KRAS:ENST00000557334:3'UTR:MODIFIER:exon3/3:c.*177T>G:		rs712	0.5206	0.0000	0,0,0	0,0,0,0,0	0.4771							190070 [KRAS (confirmed) Lung cancer,somatic,211980|Bladder cancer,somatic,109800|Pancreatic carcinoma,somatic,260350|Gastric cancer,somatic,137215|Leukemia,acute myeloid,601626|Noonan syndrome 3,609942|Cardiofaciocutaneous syndrome 2,615278|Breast cancer,somatic,114480|Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200|RAS-associated autoimmune leukoproliferative disorder,614470];	RCV000332687.1 [likely benign]; RCV000382642.1 [likely benign]; 	CR1415242 [CLASS=FP MUT=ALT PHEN="Reduced promoter activity" GENE=KRAS]; 		67	128					KRAS (inh=AD pLI=0.00), ETFRF1 (inh=n/a pLI=0.00)
chr12	25368462	25368462	C	T	hom	anno_omim	QUAL=14340;DP=205;AF=1.00;MQM=60;TRIO=HOM,205,1.00,HOM,93,1.00,HOM,146,1.00	KRAS	synonymous,intron	KRAS:ENST00000256078:synonymous:LOW:exon5/6:c.483G>A:p.Arg161Arg,KRAS:ENST00000311936:intron:MODIFIER:exon4/4:c.451-5617G>A:,KRAS:ENST00000557334:intron:MODIFIER:exon2/2:c.112-5617G>A:		rs4362222	0.9976	0.9995	60632,33359,5147	0.9949,0.9997,1.0000,1.0000,1.0000	0.9996							190070 [KRAS (confirmed) Lung cancer,somatic,211980|Bladder cancer,somatic,109800|Pancreatic carcinoma,somatic,260350|Gastric cancer,somatic,137215|Leukemia,acute myeloid,601626|Noonan syndrome 3,609942|Cardiofaciocutaneous syndrome 2,615278|Breast cancer,somatic,114480|Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200|RAS-associated autoimmune leukoproliferative disorder,614470];	RCV000039808.3 [benign]; RCV000149847.3 [benign]; 			2286	0					KRAS (inh=AD pLI=0.00)
chr12	31226934	31226934	C	T	het	low_MQM;anno_omim;trio_denovo	QUAL=52;DP=85;AF=0.25;MQM=44;TRIO=HET,85,0.25,WT,211,0.00,WT,258,0.02	DDX11	5'UTR,intron	DDX11:ENST00000407793:5'UTR:MODIFIER:exon1/27:c.-96C>T:,DDX11:ENST00000542838:5'UTR:MODIFIER:exon1/27:c.-96C>T:,DDX11:ENST00000251758:5'UTR:MODIFIER:exon1/28:c.-96C>T:,DDX11:ENST00000350437:5'UTR:MODIFIER:exon1/26:c.-96C>T:,DDX11:ENST00000228264:intron:MODIFIER:exon1/26:c.-10+31C>T:,DDX11:ENST00000545668:intron:MODIFIER:exon1/26:c.-5+31C>T:		rs74087917	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0086							601150 [DDX11 (provisional) Warsaw breakage syndrome,613398];				0	26					DDX11 (inh=AR pLI=n/a)
chr12	31256995	31256995	G	A	hom	anno_omim	QUAL=12123;DP=181;AF=0.98;MQM=50;TRIO=HOM,181,0.98,HOM,142,1.00,HET,197,0.53	DDX11	3'UTR	DDX11:ENST00000407793:3'UTR:MODIFIER:exon27/27:c.*28G>A:,DDX11:ENST00000251758:3'UTR:MODIFIER:exon28/28:c.*2267G>A:,DDX11:ENST00000228264:3'UTR:MODIFIER:exon27/27:c.*225G>A:,DDX11:ENST00000545668:3'UTR:MODIFIER:exon27/27:c.*28G>A:,DDX11:ENST00000350437:3'UTR:MODIFIER:exon26/26:c.*225G>A:		rs11545332	0.1546	0.2505	530,274,6	0.0582,0.1620,0.1016,0.2898,0.2698	0.2299							601150 [DDX11 (provisional) Warsaw breakage syndrome,613398];				116	678					DDX11 (inh=AR pLI=n/a)
chr12	32735236	32735236	C	T	het	anno_omim	QUAL=11852;DP=543;AF=0.44;MQM=60;TRIO=HET,543,0.44,WT,342,0.00,HET,455,0.50	FGD4	synonymous,5'UTR	FGD4:ENST00000534526:synonymous:LOW:exon4/17:c.846C>T:p.Asp282Asp,FGD4:ENST00000531134:synonymous:LOW:exon4/17:c.690C>T:p.Asp230Asp,FGD4:ENST00000472289:synonymous:LOW:exon4/4:c.435C>T:p.Asp145Asp,FGD4:ENST00000427716:synonymous:LOW:exon4/17:c.435C>T:p.Asp145Asp,FGD4:ENST00000546442:synonymous:LOW:exon3/16:c.156C>T:p.Asp52Asp,FGD4:ENST00000525053:synonymous:LOW:exon4/17:c.771C>T:p.Asp257Asp,FGD4:ENST00000266482:5'UTR:MODIFIER:exon4/17:c.-410C>T:		rs904582	0.4671	0.4107	10927,4889,2424	0.6839,0.5083,0.2279,0.3798,0.4221	0.4487							611104 [FGD4 (confirmed) Charcot-Marie-Tooth disease,type 4H,609311];	RCV000368855.1 [benign]; 			380	966					FGD4 (inh=AR pLI=0.34)
chr12	32778581	32778581	T	C	het	anno_omim	QUAL=4518;DP=185;AF=0.49;MQM=60;TRIO=HET,185,0.49,WT,109,0.00,HET,173,0.50	FGD4	splice_region&intron	FGD4:ENST00000534526:splice_region&intron:LOW:exon13/16:c.2047-7T>C:,FGD4:ENST00000531134:splice_region&intron:LOW:exon13/16:c.1891-7T>C:,FGD4:ENST00000427716:splice_region&intron:LOW:exon13/16:c.1636-7T>C:,FGD4:ENST00000266482:splice_region&intron:LOW:exon14/16:c.892-7T>C:,FGD4:ENST00000546442:splice_region&intron:LOW:exon12/15:c.1357-7T>C:,FGD4:ENST00000525053:splice_region&intron:LOW:exon13/16:c.1972-7T>C:		rs11052113	0.1402	0.1318	1264,523,258	0.2256,0.2351,0.0100,0.1227,0.1305	0.1388							611104 [FGD4 (confirmed) Charcot-Marie-Tooth disease,type 4H,609311];	RCV000277525.1 [likely benign]; 			43	504					FGD4 (inh=AR pLI=0.34)
chr12	32794600	32794600	A	C	het	anno_omim	QUAL=6019;DP=288;AF=0.47;MQM=60;TRIO=HET,288,0.47,WT,167,0.00,HET,185,0.48	FGD4	3'UTR	FGD4:ENST00000427716:3'UTR:MODIFIER:exon17/17:c.*1133A>C:		rs10844268	0.3616	0.0000	0,0,0	0,0,0,0,0	0.3322							611104 [FGD4 (confirmed) Charcot-Marie-Tooth disease,type 4H,609311];	RCV000334527.1 [benign]; 			31	104					FGD4 (inh=AR pLI=0.34)
chr12	32794921	32794921	A	G	het	anno_omim	QUAL=6481;DP=295;AF=0.54;MQM=59;TRIO=HET,295,0.54,WT,118,0.00,HET,131,0.58	FGD4	3'UTR	FGD4:ENST00000427716:3'UTR:MODIFIER:exon17/17:c.*1454A>G:		rs7964947	0.3171	0.0000	0,0,0	0,0,0,0,0	0.3048							611104 [FGD4 (confirmed) Charcot-Marie-Tooth disease,type 4H,609311];	RCV000360536.1 [benign]; 			27	102					FGD4 (inh=AR pLI=0.34)
chr12	32794959	32794959	T	G	het	anno_omim	QUAL=6215;DP=278;AF=0.50;MQM=59;TRIO=HET,278,0.50,WT,143,0.00,HET,153,0.56	FGD4	3'UTR	FGD4:ENST00000427716:3'UTR:MODIFIER:exon17/17:c.*1492T>G:		rs7980205	0.3618	0.0000	0,0,0	0,0,0,0,0	0.3319							611104 [FGD4 (confirmed) Charcot-Marie-Tooth disease,type 4H,609311];	RCV000325578.1 [benign]; 			31	104					FGD4 (inh=AR pLI=0.34)
chr12	32795421	32795421	A	G	het	anno_omim	QUAL=2479;DP=152;AF=0.51;MQM=60;TRIO=HET,152,0.51,WT,16,0.00,HET,32,0.59	FGD4	3'UTR	FGD4:ENST00000427716:3'UTR:MODIFIER:exon17/17:c.*1954A>G:		rs1239829	0.7418	0.0000	0,0,0	0,0,0,0,0	0.5921							611104 [FGD4 (confirmed) Charcot-Marie-Tooth disease,type 4H,609311];	RCV000389845.1 [benign]; 			67	100					FGD4 (inh=AR pLI=0.34)
chr12	32796604	32796604	T	-	het	anno_omim	QUAL=2414;DP=164;AF=0.54;MQM=59;TRIO=HET,164,0.54,WT,27,0.04,HET,29,0.62	FGD4	3'UTR	FGD4:ENST00000427716:3'UTR:MODIFIER:exon17/17:c.*3148delT:		rs797002948	0.3351	0.0000	0,0,0	0,0,0,0,0	0.3352							611104 [FGD4 (confirmed) Charcot-Marie-Tooth disease,type 4H,609311];	RCV000333825.1 [benign]; 			28	108					FGD4 (inh=AR pLI=0.34)
chr12	32797237	32797237	G	T	het	anno_omim	QUAL=4856;DP=237;AF=0.44;MQM=60;TRIO=HET,237,0.44,WT,135,0.00,HET,167,0.49	FGD4	3'UTR	FGD4:ENST00000427716:3'UTR:MODIFIER:exon17/17:c.*3770G>T:		rs11052123	0.4337	0.0000	0,0,0	0,0,0,0,0	0.4289							611104 [FGD4 (confirmed) Charcot-Marie-Tooth disease,type 4H,609311];	RCV000286713.1 [benign]; 			60	103					FGD4 (inh=AR pLI=0.34)
chr12	32797822	32797822	-	A	het	anno_omim	QUAL=769;DP=195;AF=0.27;MQM=59;TRIO=HET,195,0.27,WT,79,0.04,HET,78,0.35	FGD4	3'UTR	FGD4:ENST00000427716:3'UTR:MODIFIER:exon17/17:c.*4369dupA:		rs35874340;rs397713417;rs59282238	0.2957	0.0000	0,0,0	0,0,0,0,0	0.2908							611104 [FGD4 (confirmed) Charcot-Marie-Tooth disease,type 4H,609311];	RCV000332236.1 [benign]; 			10	64					FGD4 (inh=AR pLI=0.34)
chr12	32797905	32797905	A	G	het	anno_omim	QUAL=6330;DP=312;AF=0.50;MQM=60;TRIO=HET,312,0.50,WT,140,0.00,HET,156,0.51	FGD4	3'UTR	FGD4:ENST00000427716:3'UTR:MODIFIER:exon17/17:c.*4438A>G:		rs11052124	0.4966	0.0000	0,0,0	0,0,0,0,0	0.4878							611104 [FGD4 (confirmed) Charcot-Marie-Tooth disease,type 4H,609311];	RCV000367614.1 [benign]; 			61	102					FGD4 (inh=AR pLI=0.34)
chr12	32798458	32798458	A	G	hom	anno_omim	QUAL=6497;DP=144;AF=0.99;MQM=59;TRIO=HOM,144,0.99,HOM,26,1.00,HOM,35,1.00	FGD4	3'UTR	FGD4:ENST00000427716:3'UTR:MODIFIER:exon17/17:c.*4991A>G:	AluSg	rs1239830	0.9902	0.0000	0,0,0	0,0,0,0,0	0.9891							611104 [FGD4 (confirmed) Charcot-Marie-Tooth disease,type 4H,609311];	RCV000336307.1 [benign]; 			204	0					FGD4 (inh=AR pLI=0.34)
chr12	32798665	32798665	G	A	het	anno_omim	QUAL=3742;DP=158;AF=0.50;MQM=56;TRIO=HET,158,0.50,WT,114,0.02,HET,166,0.45	FGD4	3'UTR	FGD4:ENST00000427716:3'UTR:MODIFIER:exon17/17:c.*5198G>A:	AluSg	rs1133509	0.4677	0.0000	0,0,0	0,0,0,0,0	0.4627							611104 [FGD4 (confirmed) Charcot-Marie-Tooth disease,type 4H,609311];	RCV000310944.1 [benign]; 			60	102					FGD4 (inh=AR pLI=0.34)
chr12	32899495	32899495	C	T	het	anno_omim	QUAL=217;DP=27;AF=0.33;MQM=60;TRIO=HET,27,0.33,WT,11,0.00,HET,10,0.40	YARS2	3'UTR	YARS2:ENST00000324868:3'UTR:MODIFIER:exon5/5:c.*643G>A:	AluSz6	rs11052214	0.1266	0.0000	0,0,0	0,0,0,0,0	0.1358							610957 [YARS2 (provisional) Myopathy,lactic acidosis,and sideroblastic anemia 2,613561];	RCV000319068.1 [likely benign]; RCV000371457.1 [likely benign]; RCV000406313.1 [benign]; 			10	35					YARS2 (inh=AR pLI=0.00)
chr12	32899929	32899929	C	G	het	anno_omim	QUAL=5695;DP=289;AF=0.48;MQM=60;TRIO=HET,289,0.48,WT,124,0.01,HET,182,0.48	YARS2	3'UTR	YARS2:ENST00000324868:3'UTR:MODIFIER:exon5/5:c.*209G>C:		rs10844337	0.1438	0.0000	0,0,0	0,0,0,0,0	0.1441							610957 [YARS2 (provisional) Myopathy,lactic acidosis,and sideroblastic anemia 2,613561];	RCV000305932.1 [likely benign]; RCV000322564.1 [benign]; RCV000392192.1 [likely benign]; 			10	57					YARS2 (inh=AR pLI=0.00)
chr12	32908237	32908237	C	A	het	pred_pathogenic;anno_omim	QUAL=3547;DP=229;AF=0.47;MQM=59;TRIO=HET,229,0.47,WT,105,0.00,HET,158,0.47	YARS2	missense	YARS2:ENST00000324868:missense:MODERATE:exon1/5:c.572G>T:p.Gly191Val		rs11539445	0.1266	0.1259	1011,648,149	0.1714,0.0690,0.0782,0.1413,0.1104	0.1324	4.2110	T	T	B	T	23.00	610957 [YARS2 (provisional) Myopathy,lactic acidosis,and sideroblastic anemia 2,613561];	RCV000280875.1 [likely benign]; RCV000377688.1 [likely benign]; 	CM1312757 [CLASS=FP MUT=ALT PHEN="Reduced catalytic efficiency" GENE=YARS2]; 	COSM3753192	58	476					YARS2 (inh=AR pLI=0.00)
chr12	32908518	32908518	G	A	het	anno_omim	QUAL=9548;DP=407;AF=0.56;MQM=59;TRIO=HET,407,0.56,WT,278,0.00,HET,379,0.48	YARS2	synonymous	YARS2:ENST00000324868:synonymous:LOW:exon1/5:c.291C>T:p.Gly97Gly		rs11539444	0.1270	0.1264	1018,651,152	0.1729,0.0689,0.0787,0.1420,0.1106	0.1325							610957 [YARS2 (provisional) Myopathy,lactic acidosis,and sideroblastic anemia 2,613561];	RCV000126351.1 [benign]; RCV000310151.1 [likely benign]; RCV000362476.1 [likely benign]; 		COSM3753193	58	475					YARS2 (inh=AR pLI=0.00)
chr12	44182706	44182706	A	G	het	anno_omim	QUAL=3945;DP=180;AF=0.53;MQM=60;TRIO=HET,180,0.53,HET,106,0.54,WT,150,0.00	IRAK4	3'UTR	IRAK4:ENST00000431837:3'UTR:MODIFIER:exon11/11:c.*2188A>G:	MSTB-int	rs1141168	0.4225	0.0000	0,0,0	0,0,0,0,0	0.4280							606883 [IRAK4 (provisional) IRAK4 deficiency,607676|Invasive pneumococcal disease,recurrent isolated,1,610799];	RCV000395832.1 [benign]; 			56	83					IRAK4 (inh=AR pLI=0.00)
chr12	48236386	48236386	T	A	het	low_MQM;anno_omim	QUAL=1275;DP=75;AF=0.45;MQM=49;TRIO=HET,75,0.45,HOM,19,1.00,WT,26,0.00	VDR	3'UTR	VDR:ENST00000395324:3'UTR:MODIFIER:exon10/10:c.*2143A>T:,VDR:ENST00000229022:3'UTR:MODIFIER:exon11/11:c.*2143A>T:	AluSp	rs2853562	0.5433	0.0000	0,0,0	0,0,0,0,0	0.5581							601769 [VDR (provisional) Rickets,vitamin D-resistant,type IIA,277440|Osteoporosis,involutional,166710];	RCV000339222.1 [likely benign]; 			48	76					VDR (inh=AR+AD pLI=0.39)
chr12	48236550	48236550	G	C	hom	anno_omim	QUAL=22719;DP=329;AF=0.99;MQM=59;TRIO=HOM,329,0.99,HOM,206,1.00,HOM,206,1.00	VDR	3'UTR	VDR:ENST00000550325:3'UTR:MODIFIER:exon10/10:c.*1979C>G:,VDR:ENST00000395324:3'UTR:MODIFIER:exon10/10:c.*1979C>G:,VDR:ENST00000229022:3'UTR:MODIFIER:exon11/11:c.*1979C>G:,VDR:ENST00000549336:3'UTR:MODIFIER:exon10/10:c.*1979C>G:	AluSp	rs2544043	0.9782	0.0000	0,0,0	0,0,0,0,0	0.9521							601769 [VDR (provisional) Rickets,vitamin D-resistant,type IIA,277440|Osteoporosis,involutional,166710];	RCV000373120.1 [benign]; 			144	22					VDR (inh=AR+AD pLI=0.39)
chr12	48236623	48236623	G	T	het	anno_omim	QUAL=14045;DP=237;AF=0.60;MQM=60;TRIO=HET,237,0.60,HOM,314,1.00,WT,306,0.00	VDR	3'UTR	VDR:ENST00000550325:3'UTR:MODIFIER:exon10/10:c.*1906C>A:,VDR:ENST00000395324:3'UTR:MODIFIER:exon10/10:c.*1906C>A:,VDR:ENST00000229022:3'UTR:MODIFIER:exon11/11:c.*1906C>A:,VDR:ENST00000549336:3'UTR:MODIFIER:exon10/10:c.*1906C>A:	MIRc	rs9729	0.5026	0.0000	0,0,0	0,0,0,0,0	0.5237							601769 [VDR (provisional) Rickets,vitamin D-resistant,type IIA,277440|Osteoporosis,involutional,166710];	RCV000262137.1 [likely benign]; 			49	79					VDR (inh=AR+AD pLI=0.39)
chr12	48237736	48237736	A	-	het	anno_omim	QUAL=8380;DP=216;AF=0.50;MQM=59;TRIO=HET,216,0.50,HOM,207,1.00,WT,287,0.00	VDR	3'UTR	VDR:ENST00000550325:3'UTR:MODIFIER:exon10/10:c.*793delT:,VDR:ENST00000395324:3'UTR:MODIFIER:exon10/10:c.*793delT:,VDR:ENST00000229022:3'UTR:MODIFIER:exon11/11:c.*793delT:,VDR:ENST00000549336:3'UTR:MODIFIER:exon10/10:c.*793delT:		rs78783628	0.0000	0.0000	0,0,0	0,0,0,0,0	0.5003							601769 [VDR (provisional) Rickets,vitamin D-resistant,type IIA,277440|Osteoporosis,involutional,166710];				61	121					VDR (inh=AR+AD pLI=0.39)
chr12	48238221	48238221	G	T	het	anno_omim	QUAL=6431;DP=209;AF=0.57;MQM=59;TRIO=HET,209,0.57,HOM,122,0.98,WT,130,0.00	VDR	3'UTR	VDR:ENST00000550325:3'UTR:MODIFIER:exon10/10:c.*308C>A:,VDR:ENST00000395324:3'UTR:MODIFIER:exon10/10:c.*308C>A:,VDR:ENST00000229022:3'UTR:MODIFIER:exon11/11:c.*308C>A:,VDR:ENST00000549336:3'UTR:MODIFIER:exon10/10:c.*308C>A:		rs739837	0.4942	0.0000	0,0,0	0,0,0,0,0	0.5250							601769 [VDR (provisional) Rickets,vitamin D-resistant,type IIA,277440|Osteoporosis,involutional,166710];	RCV000351615.1 [likely benign]; 			61	122					VDR (inh=AR+AD pLI=0.39)
chr12	48238757	48238757	A	G	het	anno_omim	QUAL=14273;DP=254;AF=0.48;MQM=59;TRIO=HET,254,0.48,HOM,400,0.99,WT,547,0.00	VDR	synonymous	VDR:ENST00000550325:synonymous:LOW:exon10/10:c.1206T>C:p.Ile402Ile,VDR:ENST00000395324:synonymous:LOW:exon10/10:c.1056T>C:p.Ile352Ile,VDR:ENST00000229022:synonymous:LOW:exon11/11:c.1056T>C:p.Ile352Ile,VDR:ENST00000549336:synonymous:LOW:exon10/10:c.1056T>C:p.Ile352Ile,VDR:ENST00000535672:synonymous:LOW:exon9/9:c.960T>C:p.Ile320Ile		rs731236	0.2766	0.3339	7505,5336,418	0.2794,0.1997,0.0541,0.3988,0.3493	0.3291							601769 [VDR (provisional) Rickets,vitamin D-resistant,type IIA,277440|Osteoporosis,involutional,166710];	RCV000361773.1 [likely benign]; 		COSM431157, COSM3753247	345	1040					VDR (inh=AR+AD pLI=0.39)
chr12	48272895	48272895	A	G	hom	anno_high_impact;pred_pathogenic;anno_omim	QUAL=4369;DP=48;AF=1.00;MQM=60;TRIO=HOM,48,1.00,HOM,48,1.00,HOM,48,1.00	VDR	start_lost,missense,5'UTR	VDR:ENST00000395324:start_lost:HIGH:exon3/10:c.2T>C:p.Met1?,VDR:ENST00000229022:start_lost:HIGH:exon4/11:c.2T>C:p.Met1?,VDR:ENST00000549336:start_lost:HIGH:exon3/10:c.2T>C:p.Met1?,VDR:ENST00000550325:missense:MODERATE:exon3/10:c.152T>C:p.Met51Thr,VDR:ENST00000535672:5'UTR:MODIFIER:exon2/9:c.-247T>C:		rs2228570	0.6715	0.6376	25052,12547,3235	0.7880,0.5204,0.5448,0.6138,0.7671	0.6483	4.2980	D,D,D,D,D,D,D	T	B,P	D,D,D,D,D,D,D	23.00	601769 [VDR (provisional) Rickets,vitamin D-resistant,type IIA,277440|Osteoporosis,involutional,166710];	RCV000280730.1 [benign]; 	CM972826 [CLASS=DFP MUT=ALT PHEN="Higher bone mineral density association with" GENE=VDR]; 	COSM3753248	1023	893	1	[1] auto-classification 16.06.2016  [2] Ute Grasshoff 24.11.2015			VDR (inh=AR+AD pLI=0.39)
chr12	48293716	48293716	G	T	het	anno_omim	QUAL=16795;DP=313;AF=0.50;MQM=60;TRIO=HET,313,0.50,WT,341,0.00,HOM,407,1.00	VDR,RP11-89H19.1	5'UTR,intron	VDR:ENST00000229022:5'UTR:MODIFIER:exon2/11:c.-180C>A:,VDR:ENST00000550325:intron:MODIFIER:exon1/9:c.67+4631C>A:,VDR:ENST00000395324:intron:MODIFIER:exon1/9:c.-83-17159C>A:,VDR:ENST00000549336:intron:MODIFIER:exon1/9:c.-84+5022C>A:,VDR:ENST00000535672:intron:MODIFIER:exon1/8:c.-251+5022C>A:		rs11168293	0.1661	0.0000	0,0,0	0,0,0,0,0	0.2800							601769 [VDR (provisional) Rickets,vitamin D-resistant,type IIA,277440|Osteoporosis,involutional,166710];	RCV000341708.1 [likely benign]; 			18	57					VDR (inh=AR+AD pLI=0.39), RP11-89H19.1 (inh=n/a pLI=n/a)
chr12	48375568	48375568	A	G	het	anno_omim	QUAL=20953;DP=232;AF=0.41;MQM=59;TRIO=HET,232,0.41,HOM,397,0.99,HET,525,0.50	COL2A1	synonymous	COL2A1:ENST00000380518:synonymous:LOW:exon36/54:c.2400T>C:p.Asn800Asn,COL2A1:ENST00000337299:synonymous:LOW:exon35/53:c.2193T>C:p.Asn731Asn		rs1635553	0.4828	0.4896	2790,1189,317	0.4751,0.4083,0.5703,0.4798,0.5035	0.4612							120140 [COL2A1 (confirmed) Stickler syndrome,type I,108300|Kniest dysplasia,156550|Achondrogenesis,type II or hypochondrogenesis,200610|SED congenita,183900|SMED Strudwick type,184250|Epiphyseal dysplasia,multiple,with myopia and deafness,132450|Spondyloperipheral dysplasia,271700|Osteoarthritis with mild chondrodysplasia,604864|Vitreoretinopathy with phalangeal epiphyseal dysplasia|Platyspondylic skeletal dysplasia,Torrance type,151210|Avascular necrosis of the femoral head,608805|Legg-Calve-Perthes disease,150600|Stickler sydrome,type I,nonsyndromic ocular,609508|Czech dysplasia,609162|Spondyloepiphyseal dysplasia,Stanescu type,616583];	RCV000079724.6 [benign]; RCV000316658.1 [likely benign]; RCV000371359.1 [likely benign]; 		COSM1606169, COSM1606168	437	1053					COL2A1 (inh=AR+AD pLI=1.00)
chr12	48376291	48376291	G	A	het	anno_omim	QUAL=15820;DP=296;AF=0.47;MQM=59;TRIO=HET,296,0.47,HOM,266,1.00,HET,313,0.59	COL2A1	synonymous	COL2A1:ENST00000380518:synonymous:LOW:exon34/54:c.2295C>T:p.Gly765Gly,COL2A1:ENST00000337299:synonymous:LOW:exon33/53:c.2088C>T:p.Gly696Gly		rs2276454	0.4297	0.3958	9914,5059,631	0.3450,0.2368,0.5968,0.3889,0.4778	0.3894							120140 [COL2A1 (confirmed) Stickler syndrome,type I,108300|Kniest dysplasia,156550|Achondrogenesis,type II or hypochondrogenesis,200610|SED congenita,183900|SMED Strudwick type,184250|Epiphyseal dysplasia,multiple,with myopia and deafness,132450|Spondyloperipheral dysplasia,271700|Osteoarthritis with mild chondrodysplasia,604864|Vitreoretinopathy with phalangeal epiphyseal dysplasia|Platyspondylic skeletal dysplasia,Torrance type,151210|Avascular necrosis of the femoral head,608805|Legg-Calve-Perthes disease,150600|Stickler sydrome,type I,nonsyndromic ocular,609508|Czech dysplasia,609162|Spondyloepiphyseal dysplasia,Stanescu type,616583];	RCV000249196.1 [benign]; RCV000292068.1 [likely benign]; RCV000385327.1 [likely benign]; 			340	1038					COL2A1 (inh=AR+AD pLI=1.00)
chr12	48391416	48391416	G	T	het	anno_omim	QUAL=7844;DP=195;AF=0.53;MQM=59;TRIO=HET,195,0.53,HOM,197,0.98,WT,249,0.00	COL2A1	synonymous	COL2A1:ENST00000380518:synonymous:LOW:exon7/54:c.504C>A:p.Gly168Gly,COL2A1:ENST00000337299:synonymous:LOW:exon6/53:c.297C>A:p.Gly99Gly	(GACCAGGGG)n	rs3737548	0.2192	0.2052	2642,1526,119	0.1596,0.1497,0.3261,0.2143,0.1900	0.2052							120140 [COL2A1 (confirmed) Stickler syndrome,type I,108300|Kniest dysplasia,156550|Achondrogenesis,type II or hypochondrogenesis,200610|SED congenita,183900|SMED Strudwick type,184250|Epiphyseal dysplasia,multiple,with myopia and deafness,132450|Spondyloperipheral dysplasia,271700|Osteoarthritis with mild chondrodysplasia,604864|Vitreoretinopathy with phalangeal epiphyseal dysplasia|Platyspondylic skeletal dysplasia,Torrance type,151210|Avascular necrosis of the femoral head,608805|Legg-Calve-Perthes disease,150600|Stickler sydrome,type I,nonsyndromic ocular,609508|Czech dysplasia,609162|Spondyloepiphyseal dysplasia,Stanescu type,616583];	RCV000179829.3 [benign]; RCV000260987.1 [likely benign]; RCV000332793.1 [likely benign]; 		COSM3753254, COSM3753255	75	659					COL2A1 (inh=AR+AD pLI=1.00)
chr12	48391657	48391657	T	A	het	pred_pathogenic;anno_omim	QUAL=11112;DP=513;AF=0.52;MQM=60;TRIO=HET,513,0.52,HET,364,0.48,WT,481,0.00	COL2A1	missense	COL2A1:ENST00000380518:missense:MODERATE:exon6/54:c.426A>T:p.Glu142Asp,COL2A1:ENST00000337299:missense:MODERATE:exon5/53:c.219A>T:p.Glu73Asp		rs34392760	0.0180	0.0381	117,108,0	0.0082,0.0248,0.0001,0.0570,0.0132	0.0376	0.5040	T,T,T	T	B,B	D,D	14.60	120140 [COL2A1 (confirmed) Stickler syndrome,type I,108300|Kniest dysplasia,156550|Achondrogenesis,type II or hypochondrogenesis,200610|SED congenita,183900|SMED Strudwick type,184250|Epiphyseal dysplasia,multiple,with myopia and deafness,132450|Spondyloperipheral dysplasia,271700|Osteoarthritis with mild chondrodysplasia,604864|Vitreoretinopathy with phalangeal epiphyseal dysplasia|Platyspondylic skeletal dysplasia,Torrance type,151210|Avascular necrosis of the femoral head,608805|Legg-Calve-Perthes disease,150600|Stickler sydrome,type I,nonsyndromic ocular,609508|Czech dysplasia,609162|Spondyloepiphyseal dysplasia,Stanescu type,616583];	RCV000252660.1 [benign]; RCV000274081.1 [likely benign]; RCV000371064.1 [likely benign]; 			3	188					COL2A1 (inh=AR+AD pLI=1.00)
chr12	49418435	49418435	A	C	het	anno_omim	QUAL=2479;DP=113;AF=0.50;MQM=60;TRIO=HET,113,0.50,HET,106,0.45,WT,144,0.00	KMT2D	synonymous	KMT2D:ENST00000301067:synonymous:LOW:exon50/54:c.15978T>G:p.Leu5326Leu		rs55776396	0.0174	0.0273	66,43,1	0.0044,0.0158,0.0000,0.0340,0.0263	0.0314							602113 [KMT2D (provisional) Kabuki syndrome 1,147920];	RCV000080152.6 [benign]; RCV000365512.1 [likely benign]; 			5	180					KMT2D (inh=AD pLI=1.00)
chr12	49424534	49424534	G	A	het	anno_omim	QUAL=1799;DP=87;AF=0.54;MQM=60;TRIO=HET,87,0.54,WT,53,0.00,HET,65,0.54	KMT2D	synonymous	KMT2D:ENST00000301067:synonymous:LOW:exon41/54:c.13689C>T:p.Pro4563Pro		rs11168830	0.1228	0.0946	1243,47,12	0.0569,0.3497,0.2635,0.0386,0.0854	0.1022							602113 [KMT2D (provisional) Kabuki syndrome 1,147920];	RCV000080132.7 [benign]; RCV000264135.1 [benign]; 		COSM3753293, COSM3753292	11	189					KMT2D (inh=AD pLI=1.00)
chr12	49426460	49426460	A	G	het	pred_pathogenic;anno_omim	QUAL=6875;DP=210;AF=0.41;MQM=59;TRIO=HET,210,0.41,HET,358,0.53,WT,454,0.00	KMT2D	missense	KMT2D:ENST00000301067:missense:MODERATE:exon39/54:c.12028T>C:p.Ser4010Pro		rs80132640	0.0172	0.0288	56,35,1	0.0048,0.0177,0.0001,0.0354,0.0282	0.0309	1.4120	D	T	B	T	1.10	602113 [KMT2D (provisional) Kabuki syndrome 1,147920];	RCV000080117.8 [benign]; RCV000353616.1 [likely benign]; 			5	177					KMT2D (inh=AD pLI=1.00)
chr12	49427652	49427652	C	T	het	anno_omim	QUAL=13869;DP=308;AF=0.46;MQM=59;TRIO=HET,308,0.46,HET,388,0.49,HET,515,0.51	KMT2D	synonymous	KMT2D:ENST00000301067:synonymous:LOW:exon39/54:c.10836G>A:p.Gln3612Gln	(TGC)n	rs3782357	0.4435	0.4616	3953,1823,660	0.5737,0.3430,0.4838,0.4352,0.5087	0.4374							602113 [KMT2D (provisional) Kabuki syndrome 1,147920];	RCV000080105.7 [benign]; RCV000287333.1 [benign]; 		COSM431202, COSM431203	311	995					KMT2D (inh=AD pLI=1.00)
chr12	49434074	49434074	C	A	het	anno_omim	QUAL=649;DP=26;AF=0.46;MQM=59;TRIO=HET,26,0.46,HET,19,0.63,HET,24,0.46	KMT2D	synonymous	KMT2D:ENST00000301067:synonymous:LOW:exon31/54:c.7479G>T:p.Gly2493Gly		rs10747559	0.4355	0.4197	9996,5433,993	0.4780,0.2743,0.4376,0.4189,0.4848	0.4424							602113 [KMT2D (provisional) Kabuki syndrome 1,147920];	RCV000080211.7 [benign]; RCV000404970.1 [benign]; 		COSM3722550, COSM3722551	386	1064					KMT2D (inh=AD pLI=1.00)
chr12	49442562	49442563	AG	-	het	anno_omim	QUAL=7161;DP=294;AF=0.49;MQM=59;TRIO=HET,294,0.49,HET,334,0.48,WT,437,0.00	KMT2D	splice_region&intron	KMT2D:ENST00000301067:splice_region&intron:LOW:exon12/53:c.4021-11_4021-10delCT:		rs55776244	0.0539	0.0384	138,37,78	0.1363,0.0216,0.0000,0.0332,0.0269	0.0679							602113 [KMT2D (provisional) Kabuki syndrome 1,147920];	RCV000080177.7 [benign]; RCV000363557.1 [benign]; 			5	182					KMT2D (inh=AD pLI=1.00)
chr12	49444545	49444545	G	A	het	anno_omim	QUAL=1097;DP=54;AF=0.48;MQM=59;TRIO=HET,54,0.48,HET,25,0.40,HET,25,0.52	KMT2D	synonymous	KMT2D:ENST00000301067:synonymous:LOW:exon11/54:c.2826C>T:p.Ile942Ile		rs2241726	0.4036	0.3796	8821,4499,894	0.4288,0.2507,0.4160,0.3687,0.4536	0.4069							602113 [KMT2D (provisional) Kabuki syndrome 1,147920];	RCV000080169.7 [benign]; RCV000302786.1 [benign]; 		COSM147497, COSM3753294	321	982					KMT2D (inh=AD pLI=1.00)
chr12	49448463	49448463	C	T	het	anno_omim;anno_pathogenic_hgmd	QUAL=2811;DP=130;AF=0.51;MQM=59;TRIO=HET,130,0.51,HET,101,0.50,WT,136,0.00	KMT2D	missense	KMT2D:ENST00000301067:missense:MODERATE:exon3/54:c.248G>A:p.Arg83Gln		rs55865069	0.0164	0.0277	53,34,1	0.0050,0.0161,0.0000,0.0346,0.0253	0.0308	0.6130	T,T	T	B	T	19.80	602113 [KMT2D (provisional) Kabuki syndrome 1,147920];	RCV000080166.7 [benign]; RCV000328729.1 [likely benign]; 	CM165012 [CLASS=DM? MUT=ALT PHEN="Atrioventricular septum defect" GENE=KMT2D]; 	COSM3773643, COSM3773644	5	170					KMT2D (inh=AD pLI=1.00)
chr12	51135275	51135275	T	C	hom	anno_omim	QUAL=47585;DP=460;AF=1.00;MQM=60;TRIO=HOM,460,1.00,HOM,465,1.00,HOM,546,1.00	DIP2B	synonymous	DIP2B:ENST00000301180:synonymous:LOW:exon37/38:c.4431T>C:p.Ile1477Ile		rs1866422	0.9599	0.9884	59362,33338,3978	0.8751,0.9931,1.0000,0.9996,0.9998	0.9908							611379 [DIP2B (provisional) Mental retardation,FRA12A type,136630];				2107	8					DIP2B (inh=n/a pLI=1.00)
chr12	51139279	51139279	A	G	hom	anno_omim	QUAL=10730;DP=181;AF=0.99;MQM=60;TRIO=HOM,181,0.99,HET,147,0.49,HET,210,0.57	DIP2B	3'UTR	DIP2B:ENST00000301180:3'UTR:MODIFIER:exon38/38:c.*657A>G:		rs4768914	0.2905	0.0000	0,0,0	0,0,0,0,0	0.3078							611379 [DIP2B (provisional) Mental retardation,FRA12A type,136630];				17	95					DIP2B (inh=n/a pLI=1.00)
chr12	51139692	51139692	T	G	hom	anno_omim	QUAL=12555;DP=310;AF=0.99;MQM=60;TRIO=HOM,310,0.99,HET,99,0.42,HET,133,0.45	DIP2B	3'UTR	DIP2B:ENST00000301180:3'UTR:MODIFIER:exon38/38:c.*1070T>G:		rs35845404	0.2907	0.0000	0,0,0	0,0,0,0,0	0.3078							611379 [DIP2B (provisional) Mental retardation,FRA12A type,136630];				16	96					DIP2B (inh=n/a pLI=1.00)
chr12	51139803	51139803	C	A	hom	anno_omim	QUAL=9694;DP=195;AF=1.00;MQM=60;TRIO=HOM,195,1.00,HET,108,0.45,HET,171,0.43	DIP2B	3'UTR	DIP2B:ENST00000301180:3'UTR:MODIFIER:exon38/38:c.*1181C>A:		rs3742063	0.2534	0.0000	0,0,0	0,0,0,0,0	0.2769							611379 [DIP2B (provisional) Mental retardation,FRA12A type,136630];				16	96					DIP2B (inh=n/a pLI=1.00)
chr12	51139892	51139892	C	T	hom	anno_omim	QUAL=12200;DP=262;AF=1.00;MQM=60;TRIO=HOM,262,1.00,HET,146,0.40,HET,214,0.43	DIP2B	3'UTR	DIP2B:ENST00000301180:3'UTR:MODIFIER:exon38/38:c.*1270C>T:		rs3742064	0.2740	0.0000	0,0,0	0,0,0,0,0	0.2942							611379 [DIP2B (provisional) Mental retardation,FRA12A type,136630];				16	96					DIP2B (inh=n/a pLI=1.00)
chr12	51140410	51140410	C	G	hom	anno_omim	QUAL=28644;DP=389;AF=1.00;MQM=60;TRIO=HOM,389,1.00,HOM,225,1.00,HOM,271,1.00	DIP2B	3'UTR	DIP2B:ENST00000301180:3'UTR:MODIFIER:exon38/38:c.*1788C>G:		rs7303202	0.8389	0.0000	0,0,0	0,0,0,0,0	0.9286							611379 [DIP2B (provisional) Mental retardation,FRA12A type,136630];				214	18					DIP2B (inh=n/a pLI=1.00)
chr12	51141883	51141883	A	G	hom	anno_omim	QUAL=29929;DP=373;AF=1.00;MQM=60;TRIO=HOM,373,1.00,HOM,253,1.00,HOM,305,1.00	DIP2B	3'UTR	DIP2B:ENST00000301180:3'UTR:MODIFIER:exon38/38:c.*3261A>G:		rs4768915	0.7953	0.0000	0,0,0	0,0,0,0,0	0.8837							611379 [DIP2B (provisional) Mental retardation,FRA12A type,136630];				214	18					DIP2B (inh=n/a pLI=1.00)
chr12	53703021	53703021	G	A	hom	anno_omim	QUAL=9602;DP=148;AF=0.99;MQM=60;TRIO=HOM,148,0.99,HOM,71,1.00,HOM,98,1.00	AAAS	synonymous	AAAS:ENST00000209873:synonymous:LOW:exon9/16:c.855C>T:p.Phe285Phe,AAAS:ENST00000394384:synonymous:LOW:exon8/15:c.756C>T:p.Phe252Phe,AAAS:ENST00000550286:synonymous:LOW:exon8/15:c.483C>T:p.Phe161Phe		rs1546808	0.9153	0.9745	57989,33276,2750	0.7275,0.9868,0.9999,0.9987,0.9995	0.9798							605378 [AAAS (confirmed) Achalasia-addisonianism-alacrimia syndrome,231550];	RCV000116212.2 [likely benign]; RCV000378616.1 [benign]; 			2087	24					AAAS (inh=AR pLI=0.00)
chr12	56082025	56082025	G	C	het	anno_omim	QUAL=14845;DP=612;AF=0.52;MQM=60;TRIO=HET,612,0.52,HET,495,0.50,WT,656,0.00	ITGA7	synonymous	ITGA7:ENST00000555728:synonymous:LOW:exon24/26:c.3150C>G:p.Ser1050Ser,ITGA7:ENST00000553804:synonymous:LOW:exon23/25:c.3030C>G:p.Ser1010Ser,ITGA7:ENST00000257879:synonymous:LOW:exon23/25:c.3018C>G:p.Ser1006Ser,ITGA7:ENST00000347027:synonymous:LOW:exon23/25:c.3000C>G:p.Ser1000Ser,ITGA7:ENST00000452168:synonymous:LOW:exon23/25:c.2739C>G:p.Ser913Ser,ITGA7:ENST00000257880:synonymous:LOW:exon24/27:c.3150C>G:p.Ser1050Ser,ITGA7:ENST00000394229:synonymous:LOW:exon23/26:c.3018C>G:p.Ser1006Ser,ITGA7:ENST00000394230:synonymous:LOW:exon23/26:c.3030C>G:p.Ser1010Ser		rs17117883	0.0443	0.0416	134,77,17	0.0625,0.0205,0.0008,0.0470,0.0499	0.0478							600536 [ITGA7 (provisional) Muscular dystrophy,congenital,due to ITGA7 deficiency,613204];	RCV000117295.3 [other]; RCV000368589.1 [uncertain significance]; 		COSM1128538, COSM1128539	12	235					ITGA7 (inh=AR pLI=0.00)
chr12	56089344	56089344	A	G	het	anno_omim	QUAL=2330;DP=107;AF=0.42;MQM=59;TRIO=HET,107,0.42,WT,129,0.00,HET,136,0.46	ITGA7	synonymous	ITGA7:ENST00000555728:synonymous:LOW:exon15/26:c.2097T>C:p.Cys699Cys,ITGA7:ENST00000553804:synonymous:LOW:exon14/25:c.1977T>C:p.Cys659Cys,ITGA7:ENST00000257879:synonymous:LOW:exon14/25:c.1965T>C:p.Cys655Cys,ITGA7:ENST00000347027:synonymous:LOW:exon14/25:c.1947T>C:p.Cys649Cys,ITGA7:ENST00000452168:synonymous:LOW:exon14/25:c.1686T>C:p.Cys562Cys,ITGA7:ENST00000257880:synonymous:LOW:exon15/27:c.2097T>C:p.Cys699Cys,ITGA7:ENST00000394229:synonymous:LOW:exon14/26:c.1965T>C:p.Cys655Cys,ITGA7:ENST00000394230:synonymous:LOW:exon14/26:c.1977T>C:p.Cys659Cys		rs7971022	0.0098	0.0164	24,15,0	0.0033,0.0035,0.0000,0.0226,0.0191	0.0163							600536 [ITGA7 (provisional) Muscular dystrophy,congenital,due to ITGA7 deficiency,613204];	RCV000079980.8 [other]; RCV000287455.1 [uncertain significance]; 			1	83					ITGA7 (inh=AR pLI=0.00)
chr12	56089357	56089357	C	T	het	anno_omim	QUAL=7536;DP=166;AF=0.38;MQM=59;TRIO=HET,166,0.38,HET,149,0.54,HOM,151,1.00	ITGA7	missense	ITGA7:ENST00000555728:missense:MODERATE:exon15/26:c.2084G>A:p.Arg695His,ITGA7:ENST00000553804:missense:MODERATE:exon14/25:c.1964G>A:p.Arg655His,ITGA7:ENST00000257879:missense:MODERATE:exon14/25:c.1952G>A:p.Arg651His,ITGA7:ENST00000347027:missense:MODERATE:exon14/25:c.1934G>A:p.Arg645His,ITGA7:ENST00000452168:missense:MODERATE:exon14/25:c.1673G>A:p.Arg558His,ITGA7:ENST00000257880:missense:MODERATE:exon15/27:c.2084G>A:p.Arg695His,ITGA7:ENST00000394229:missense:MODERATE:exon14/26:c.1952G>A:p.Arg651His,ITGA7:ENST00000394230:missense:MODERATE:exon14/26:c.1964G>A:p.Arg655His		rs1800974	0.5994	0.5854	22147,8870,590	0.3344,0.7328,0.9394,0.5172,0.7032	0.5926	0.2040	T,T,T,T,T,T,T,T	T	B,B,B,B	T,T,T,T,T,T,T,T	18.52	600536 [ITGA7 (provisional) Muscular dystrophy,congenital,due to ITGA7 deficiency,613204];	RCV000079979.6 [benign]; RCV000392154.1 [benign]; 	CM067685 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=ITGA7]; 	COSM4147273, COSM4147274, COSM4147272, COSM4147275	596	1030					ITGA7 (inh=AR pLI=0.00)
chr12	56398454	56398454	G	C	hom	anno_omim	QUAL=23432;DP=261;AF=1.00;MQM=60;TRIO=HOM,261,1.00,HOM,210,1.00,HOM,283,1.00	SUOX	synonymous,3'UTR	SUOX:ENST00000266971:synonymous:LOW:exon5/5:c.1281G>C:p.Ser427Ser,SUOX:ENST00000356124:synonymous:LOW:exon4/4:c.1281G>C:p.Ser427Ser,SUOX:ENST00000394115:synonymous:LOW:exon6/6:c.1281G>C:p.Ser427Ser,SUOX:ENST00000548274:synonymous:LOW:exon5/5:c.1281G>C:p.Ser427Ser,SUOX:ENST00000394109:synonymous:LOW:exon3/3:c.1281G>C:p.Ser427Ser,SUOX:ENST00000551841:3'UTR:MODIFIER:exon5/5:c.*469G>C:		rs773115	0.7522	0.8730	47850,27916,655	0.3531,0.9387,0.9303,0.9146,0.9442	0.8853							606887 [SUOX (provisional) Sulfite oxidase deficiency,272300];	RCV000118423.3 [other]; RCV000363638.1 [benign]; 			1800	291					SUOX (inh=AR pLI=0.00)
chr12	56473808	56473808	T	C	het	anno_omim	QUAL=1499;DP=35;AF=0.60;MQM=59;TRIO=HET,35,0.60,HET,37,0.59,HET,52,0.46	ERBB3	5'UTR	ERBB3:ENST00000267101:5'UTR:MODIFIER:exon1/28:c.-277T>C:		rs7297175	0.6508	0.0000	0,0,0	0,0,0,0,0	0.5808							190151 [ERBB3 (confirmed) Lethal congenital contractural syndrome 2,607598];				68	68					ERBB3 (inh=AR pLI=0.00)
chr12	56477694	56477694	A	T	het	anno_omim	QUAL=12299;DP=205;AF=0.44;MQM=59;TRIO=HET,205,0.44,HET,356,0.48,HET,482,0.52	ERBB3	splice_region&intron,intron	ERBB3:ENST00000267101:splice_region&intron:LOW:exon2/27:c.234+8A>T:,ERBB3:ENST00000411731:splice_region&intron:LOW:exon2/2:c.234+8A>T:,ERBB3:ENST00000415288:splice_region&intron:LOW:exon3/28:c.57+8A>T:,ERBB3:ENST00000450146:intron:MODIFIER:exon1/14:c.-147+3586A>T:		rs2271194	0.5923	0.6173	24096,11601,525	0.3185,0.7895,0.7859,0.5891,0.7170	0.6272							190151 [ERBB3 (confirmed) Lethal congenital contractural syndrome 2,607598];				938	968					ERBB3 (inh=AR pLI=0.00)
chr12	56493822	56493822	A	C	het	anno_omim	QUAL=15969;DP=417;AF=0.49;MQM=59;TRIO=HET,417,0.49,HET,342,0.52,HET,442,0.51	ERBB3	splice_region&intron	ERBB3:ENST00000267101:splice_region&intron:LOW:exon25/27:c.3129+9A>C:,ERBB3:ENST00000450146:splice_region&intron:LOW:exon12/14:c.1200+9A>C:,ERBB3:ENST00000415288:splice_region&intron:LOW:exon26/28:c.2952+9A>C:,ERBB3:ENST00000553131:splice_region&intron:LOW:exon8/10:c.852+9A>C:,ERBB3:ENST00000549832:splice_region&intron:LOW:exon3/5:c.489+9A>C:		rs2292238	0.2951	0.3612	8237,5447,198	0.1879,0.3811,0.3450,0.4027,0.2866	0.3655							190151 [ERBB3 (confirmed) Lethal congenital contractural syndrome 2,607598];			COSM3998886, COSM3998887	275	987					ERBB3 (inh=AR pLI=0.00)
chr12	56494991	56494991	G	A	het	anno_omim	QUAL=7856;DP=193;AF=0.52;MQM=60;TRIO=HET,193,0.52,HET,198,0.51,HET,252,0.48	ERBB3	synonymous	ERBB3:ENST00000267101:synonymous:LOW:exon27/28:c.3348G>A:p.Arg1116Arg,ERBB3:ENST00000450146:synonymous:LOW:exon14/15:c.1419G>A:p.Arg473Arg,ERBB3:ENST00000415288:synonymous:LOW:exon28/29:c.3171G>A:p.Arg1057Arg,ERBB3:ENST00000553131:synonymous:LOW:exon10/11:c.1071G>A:p.Arg357Arg,ERBB3:ENST00000549832:synonymous:LOW:exon5/6:c.708G>A:p.Arg236Arg		rs2271189	0.2522	0.3417	7518,5186,93	0.1251,0.3598,0.3193,0.3935,0.2509	0.3470							190151 [ERBB3 (confirmed) Lethal congenital contractural syndrome 2,607598];				260	970					ERBB3 (inh=AR pLI=0.00)
chr12	65108160	65108160	G	C	het	anno_omim	QUAL=16111;DP=573;AF=0.49;MQM=60;TRIO=HET,573,0.49,HOM,284,0.99,WT,371,0.00	GNS	3'UTR	GNS:ENST00000418919:3'UTR:MODIFIER:exon13/13:c.*2361C>G:,GNS:ENST00000258145:3'UTR:MODIFIER:exon14/14:c.*2361C>G:		rs1061743	0.6064	0.0000	0,0,0	0,0,0,0,0	0.5513							607664 [GNS (provisional) Mucopolysaccharidosis type IIID,252940];	RCV000307546.1 [benign]; 			78	134					GNS (inh=AR pLI=0.08)
chr12	65108586	65108586	G	C	het	anno_omim	QUAL=5333;DP=251;AF=0.46;MQM=60;TRIO=HET,251,0.46,WT,116,0.00,HET,166,0.50	GNS	3'UTR	GNS:ENST00000418919:3'UTR:MODIFIER:exon13/13:c.*1935C>G:,GNS:ENST00000258145:3'UTR:MODIFIER:exon14/14:c.*1935C>G:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0002							607664 [GNS (provisional) Mucopolysaccharidosis type IIID,252940];				0	2					GNS (inh=AR pLI=0.08)
chr12	65109168	65109168	C	T	het	anno_omim	QUAL=5596;DP=203;AF=0.46;MQM=56;TRIO=HET,203,0.46,HOM,107,0.99,WT,129,0.00	GNS	3'UTR	GNS:ENST00000418919:3'UTR:MODIFIER:exon13/13:c.*1353G>A:,GNS:ENST00000258145:3'UTR:MODIFIER:exon14/14:c.*1353G>A:	AluSx3	rs1269548	0.5939	0.0000	0,0,0	0,0,0,0,0	0.5390							607664 [GNS (provisional) Mucopolysaccharidosis type IIID,252940];	RCV000324716.1 [benign]; 			80	127					GNS (inh=AR pLI=0.08)
chr12	65110141	65110141	G	A	het	anno_omim	QUAL=11986;DP=483;AF=0.50;MQM=60;TRIO=HET,483,0.50,HOM,182,1.00,WT,306,0.01	GNS	3'UTR	GNS:ENST00000418919:3'UTR:MODIFIER:exon13/13:c.*380C>T:,GNS:ENST00000258145:3'UTR:MODIFIER:exon14/14:c.*380C>T:	(GT)n	rs674	0.7157	0.0000	0,0,0	0,0,0,0,0	0.6484							607664 [GNS (provisional) Mucopolysaccharidosis type IIID,252940];	RCV000299072.1 [benign]; 			79	136					GNS (inh=AR pLI=0.08)
chr12	65110252	65110252	G	A	het	anno_omim	QUAL=13124;DP=520;AF=0.48;MQM=60;TRIO=HET,520,0.48,HOM,206,1.00,WT,337,0.00	GNS	3'UTR	GNS:ENST00000543646:3'UTR:MODIFIER:exon15/15:c.*269C>T:,GNS:ENST00000418919:3'UTR:MODIFIER:exon13/13:c.*269C>T:,GNS:ENST00000258145:3'UTR:MODIFIER:exon14/14:c.*269C>T:		rs2279597	0.1953	0.0000	0,0,0	0,0,0,0,0	0.2128							607664 [GNS (provisional) Mucopolysaccharidosis type IIID,252940];	RCV000358700.1 [likely benign]; 			15	104					GNS (inh=AR pLI=0.08)
chr12	65146532	65146532	C	T	het	anno_omim	QUAL=7720;DP=352;AF=0.42;MQM=60;TRIO=HET,352,0.42,HOM,125,1.00,WT,175,0.00	GNS	synonymous,intron	GNS:ENST00000543646:synonymous:LOW:exon3/15:c.294G>A:p.Pro98Pro,GNS:ENST00000418919:synonymous:LOW:exon1/13:c.30G>A:p.Pro10Pro,GNS:ENST00000258145:synonymous:LOW:exon2/14:c.198G>A:p.Pro66Pro,GNS:ENST00000542058:intron:MODIFIER:exon1/12:c.193-4834G>A:		rs1147096	0.0000	0.6550	25120,11214,3804	0.9069,0.5686,0.8753,0.6006,0.6738	0.7087							607664 [GNS (provisional) Mucopolysaccharidosis type IIID,252940];	RCV000079972.5 [benign]; RCV000337177.1 [benign]; 			780	1020					GNS (inh=AR pLI=0.08)
chr12	66218507	66218507	-	TCTCTG	hom	low_DP;anno_omim	QUAL=3401;DP=1;AF=0.00;MQM=60;TRIO=HOM,1,0.00,HOM,42,0.19,WT,92,0.48	HMGA2,RPSAP52	5'UTR,intron	HMGA2:ENST00000536545:5'UTR:MODIFIER:exon1/4:c.-539_-538insGTCTCT:,HMGA2:ENST00000403681:5'UTR:MODIFIER:exon1/5:c.-539_-538insGTCTCT:,HMGA2:ENST00000393578:5'UTR:MODIFIER:exon1/4:c.-539_-538insGTCTCT:,HMGA2:ENST00000425208:5'UTR:MODIFIER:exon1/4:c.-539_-538insGTCTCT:,HMGA2:ENST00000354636:5'UTR:MODIFIER:exon1/4:c.-539_-538insGTCTCT:,RPSAP52:ENST00000489520:intron:MODIFIER:exon1/1:n.132+2115_132+2116insCAGAGA:	(TC)n		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0090							600698 [HMGA2 (confirmed) Leiomyoma,uterine,somatic,150699];				0	0					HMGA2 (inh=AD pLI=0.73), RPSAP52 (inh=n/a pLI=n/a)
chr12	66358120	66358121	TT	-	het	anno_omim	QUAL=4137;DP=287;AF=0.50;MQM=59;TRIO=HET,287,0.50,HET,62,0.60,WT,117,0.00	HMGA2	3'UTR	HMGA2:ENST00000403681:3'UTR:MODIFIER:exon5/5:c.*1048_*1049delTT:	(TC)n	rs10573247	0.3327	0.0000	0,0,0	0,0,0,0,0	0.2028							600698 [HMGA2 (confirmed) Leiomyoma,uterine,somatic,150699];				5	78					HMGA2 (inh=AD pLI=0.73)
chr12	66358347	66358347	C	T	het	anno_omim	QUAL=6508;DP=188;AF=0.57;MQM=60;TRIO=HET,188,0.57,HOM,107,1.00,WT,174,0.01	HMGA2	3'UTR	HMGA2:ENST00000403681:3'UTR:MODIFIER:exon5/5:c.*1275C>T:		rs1042725	0.5825	0.0000	0,0,0	0,0,0,0,0	0.4762							600698 [HMGA2 (confirmed) Leiomyoma,uterine,somatic,150699];				67	114					HMGA2 (inh=AD pLI=0.73)
chr12	66358571	66358571	C	A	het	anno_omim	QUAL=3224;DP=194;AF=0.52;MQM=60;TRIO=HET,194,0.52,HET,48,0.46,WT,47,0.00	HMGA2	3'UTR	HMGA2:ENST00000403681:3'UTR:MODIFIER:exon5/5:c.*1499C>A:		rs1042729	0.0176	0.0000	0,0,0	0,0,0,0,0	0.0366							600698 [HMGA2 (confirmed) Leiomyoma,uterine,somatic,150699];				1	26					HMGA2 (inh=AD pLI=0.73)
chr12	66359752	66359752	C	A	het	anno_omim	QUAL=9267;DP=397;AF=0.50;MQM=60;TRIO=HET,397,0.50,HOM,129,0.99,WT,188,0.01	HMGA2	3'UTR	HMGA2:ENST00000403681:3'UTR:MODIFIER:exon5/5:c.*2680C>A:		rs8756	0.6919	0.0000	0,0,0	0,0,0,0,0	0.5502							600698 [HMGA2 (confirmed) Leiomyoma,uterine,somatic,150699];				74	111					HMGA2 (inh=AD pLI=0.73)
chr12	66360068	66360068	C	T	het	anno_omim	QUAL=8874;DP=367;AF=0.49;MQM=60;TRIO=HET,367,0.49,HET,328,0.50,WT,473,0.00	HMGA2	3'UTR	HMGA2:ENST00000403681:3'UTR:MODIFIER:exon5/5:c.*2996C>T:		rs11175982	0.3325	0.0000	0,0,0	0,0,0,0,0	0.2048							600698 [HMGA2 (confirmed) Leiomyoma,uterine,somatic,150699];				5	78					HMGA2 (inh=AD pLI=0.73)
chr12	66741538	66741538	T	-	het	anno_omim	QUAL=4146;DP=203;AF=0.51;MQM=59;TRIO=HET,203,0.51,HET,63,0.62,HET,89,0.49	GRIP1	3'UTR	GRIP1:ENST00000359742:3'UTR:MODIFIER:exon25/25:c.*1261delA:,GRIP1:ENST00000398016:3'UTR:MODIFIER:exon24/24:c.*1261delA:,GRIP1:ENST00000286445:3'UTR:MODIFIER:exon24/24:c.*1261delA:		rs397850337	0.4770	0.0000	0,0,0	0,0,0,0,0	0.4675							604597 [GRIP1 (provisional) Fraser syndrome,219000];	RCV000308024.1 [benign]; 			50	116					GRIP1 (inh=AR pLI=0.92)
chr12	66742183	66742183	A	G	het	anno_omim	QUAL=15616;DP=529;AF=0.49;MQM=60;TRIO=HET,529,0.49,HET,296,0.48,HET,378,0.50	GRIP1	3'UTR	GRIP1:ENST00000359742:3'UTR:MODIFIER:exon25/25:c.*616T>C:,GRIP1:ENST00000398016:3'UTR:MODIFIER:exon24/24:c.*616T>C:,GRIP1:ENST00000286445:3'UTR:MODIFIER:exon24/24:c.*616T>C:		rs1168308	0.5038	0.0000	0,0,0	0,0,0,0,0	0.4820							604597 [GRIP1 (provisional) Fraser syndrome,219000];	RCV000291068.1 [benign]; 			49	117					GRIP1 (inh=AR pLI=0.92)
chr12	66786091	66786091	G	C	hom	pred_pathogenic;anno_omim	QUAL=13465;DP=139;AF=1.00;MQM=60;TRIO=HOM,139,1.00,HOM,134,1.00,HOM,152,1.00	GRIP1	missense	GRIP1:ENST00000359742:missense:MODERATE:exon19/25:c.2461C>G:p.Gln821Glu,GRIP1:ENST00000398016:missense:MODERATE:exon18/24:c.2305C>G:p.Gln769Glu,GRIP1:ENST00000286445:missense:MODERATE:exon19/24:c.2461C>G:p.Gln821Glu		rs13277	0.8437	0.9494	55143,33228,1967	0.6285,0.8525,0.9441,0.9979,0.9928	0.9513	7.3090	T,T,T,T,T,T	T	B,B,B,B	T,T,T,T,T,T	5.74	604597 [GRIP1 (provisional) Fraser syndrome,219000];	RCV000247437.1 [benign]; RCV000328734.1 [benign]; 			2069	34					GRIP1 (inh=AR pLI=0.92)
chr12	66786171	66786171	A	C	het	anno_omim;anno_pathogenic_hgmd	QUAL=8180;DP=381;AF=0.53;MQM=59;TRIO=HET,381,0.53,WT,182,0.00,HET,219,0.53	GRIP1	missense	GRIP1:ENST00000359742:missense:MODERATE:exon19/25:c.2381T>G:p.Met794Arg,GRIP1:ENST00000398016:missense:MODERATE:exon18/24:c.2225T>G:p.Met742Arg,GRIP1:ENST00000286445:missense:MODERATE:exon19/24:c.2381T>G:p.Met794Arg		rs144494437	0.0014	0.0018	2,1,0	0.0003,0.0010,0.0000,0.0026,0.0007	0.0023	1.3260	.,T,T,T,T,T,T	T,T	.,B,B,B,B	.,T,T,T,T,T,T	0.06	604597 [GRIP1 (provisional) Fraser syndrome,219000];	RCV000216399.1 [likely benign]; 	CM112031 [CLASS=DM MUT=ALT PHEN="Autism" GENE=GRIP1]; 		0	28	3	[3] Stephan Waldm?ller 13.08.2014 [n/a] comment imported from detected variant: Nur 1 Bericht mit Assoziation			GRIP1 (inh=AR pLI=0.92)
chr12	81102891	81102891	C	A	het	anno_omim	QUAL=14036;DP=379;AF=0.46;MQM=60;TRIO=HET,379,0.46,HET,308,0.47,HET,449,0.50	MYF6	3'UTR	MYF6:ENST00000228641:3'UTR:MODIFIER:exon3/3:c.*152C>A:		rs3120	0.1064	0.0000	0,0,0	0,0,0,0,0	0.1773							159991 [MYF6 (confirmed) Myopathy,centronuclear,3,614408];	RCV000386200.1 [likely benign]; 			17	79					MYF6 (inh=AD pLI=0.08)
chr12	81102921	81102921	T	C	het	anno_omim	QUAL=20318;DP=341;AF=0.45;MQM=59;TRIO=HET,341,0.45,HET,260,0.48,HOM,419,1.00	MYF6	3'UTR	MYF6:ENST00000228641:3'UTR:MODIFIER:exon3/3:c.*182T>C:		rs3121	0.4585	0.0000	0,0,0	0,0,0,0,0	0.4817							159991 [MYF6 (confirmed) Myopathy,centronuclear,3,614408];	RCV000292087.1 [benign]; 			36	101					MYF6 (inh=AD pLI=0.08)
chr12	81103085	81103085	A	G	het	anno_omim	QUAL=8522;DP=484;AF=0.48;MQM=60;TRIO=HET,484,0.48,HET,83,0.45,HET,132,0.47	MYF6	3'UTR	MYF6:ENST00000228641:3'UTR:MODIFIER:exon3/3:c.*346A>G:		rs1047183	0.1056	0.0000	0,0,0	0,0,0,0,0	0.1761							159991 [MYF6 (confirmed) Myopathy,centronuclear,3,614408];	RCV000342986.1 [likely benign]; 			17	79					MYF6 (inh=AD pLI=0.08)
chr12	81103144	81103144	A	G	het	anno_omim	QUAL=3987;DP=125;AF=0.50;MQM=60;TRIO=HET,125,0.50,HET,39,0.41,HOM,64,1.00	MYF6	3'UTR	MYF6:ENST00000228641:3'UTR:MODIFIER:exon3/3:c.*405A>G:		rs1047185	0.4585	0.0000	0,0,0	0,0,0,0,0	0.4820							159991 [MYF6 (confirmed) Myopathy,centronuclear,3,614408];	RCV000406980.1 [benign]; 			36	100					MYF6 (inh=AD pLI=0.08)
chr12	88483273	88483273	A	-	hom	anno_omim	QUAL=8604;DP=145;AF=1.00;MQM=59;TRIO=HOM,145,1.00,HOM,67,1.00,HOM,71,1.00	CEP290	splice_region&intron	CEP290:ENST00000309041:splice_region&intron:LOW:exon30/53:c.3580-9delT:,CEP290:ENST00000547691:splice_region&intron:LOW:exon5/28:c.754-9delT:,CEP290:ENST00000552810:splice_region&intron:LOW:exon30/53:c.3574-9delT:,CEP290:ENST00000397838:splice_region&intron:LOW:exon22/45:c.754-9delT:		rs398020484	0.8736	0.9161	6265,3194,382	0.7121,0.9342,0.9828,0.9455,0.8963	0.9302							610142 [CEP290 (confirmed) Joubert syndrome 5,610188|Senior-Loken syndrome 6,610189|Leber congenital amaurosis 10,611755|Meckel syndrome 4,611134|Bardet-Biedl syndrome 14,615991];	RCV000082247.5 [benign]; RCV000196108.3 [benign]; RCV000196108.3 [benign]; RCV000196108.3 [benign]; RCV000268851.1 [benign]; RCV000307583.1 [benign]; RCV000313246.1 [benign]; RCV000364690.1 [benign]; RCV000370292.1 [benign]; 			2926	373					CEP290 (inh=AR pLI=0.00)
chr12	88505078	88505078	T	C	hom	anno_omim	QUAL=13777;DP=207;AF=1.00;MQM=60;TRIO=HOM,207,1.00,HOM,85,1.00,HOM,120,1.00	CEP290	synonymous,5'UTR	CEP290:ENST00000309041:synonymous:LOW:exon22/54:c.2274A>G:p.Ser758Ser,CEP290:ENST00000552810:synonymous:LOW:exon22/54:c.2268A>G:p.Ser756Ser,CEP290:ENST00000397838:5'UTR:MODIFIER:exon14/46:c.-553A>G:		rs2468255	0.7646	0.8888	28347,16074,567	0.4686,0.9288,0.9758,0.9289,0.8881	0.8937							610142 [CEP290 (confirmed) Joubert syndrome 5,610188|Senior-Loken syndrome 6,610189|Leber congenital amaurosis 10,611755|Meckel syndrome 4,611134|Bardet-Biedl syndrome 14,615991];	RCV000114186.2 [likely benign]; 			2861	473					CEP290 (inh=AR pLI=0.00)
chr12	102154900	102154900	A	G	het	anno_omim	QUAL=5242;DP=244;AF=0.50;MQM=60;TRIO=HET,244,0.50,WT,148,0.00,HET,167,0.50	GNPTAB	splice_region&intron	GNPTAB:ENST00000299314:splice_region&intron:LOW:exon15/20:c.3135+5T>C:		rs759935	0.6905	0.6015	22256,9352,2819	0.7402,0.5731,0.9021,0.5368,0.6259	0.6188							607840 [GNPTAB (confirmed) Mucolipidosis III alpha/beta,252600|Mucolipidosis II alpha/beta,252500];	RCV000082191.5 [benign]; RCV000270011.1 [benign]; RCV000362355.1 [benign]; 			675	1015					GNPTAB (inh=AR pLI=0.00)
chr12	102158763	102158763	T	C	het	anno_omim	QUAL=8992;DP=439;AF=0.47;MQM=60;TRIO=HET,439,0.47,WT,210,0.01,HET,302,0.46	GNPTAB	synonymous	GNPTAB:ENST00000299314:synonymous:LOW:exon13/21:c.1932A>G:p.Thr644Thr		rs10778148	0.6514	0.5885	21589,9378,2161	0.6407,0.5642,0.9014,0.5316,0.6234	0.5901							607840 [GNPTAB (confirmed) Mucolipidosis III alpha/beta,252600|Mucolipidosis II alpha/beta,252500];	RCV000082189.5 [benign]; RCV000268458.1 [benign]; RCV000301696.1 [benign]; 		COSM1127589	665	1018					GNPTAB (inh=AR pLI=0.00)
chr12	102789901	102789901	G	A	het	anno_omim	QUAL=7375;DP=350;AF=0.48;MQM=60;TRIO=HET,350,0.48,WT,143,0.00,HET,230,0.48	IGF1	3'UTR	IGF1:ENST00000456098:3'UTR:MODIFIER:exon5/5:c.*6418C>T:,IGF1:ENST00000337514:3'UTR:MODIFIER:exon4/4:c.*6384C>T:		rs6222	0.0202	0.0000	0,0,0	0,0,0,0,0	0.0249							147440 [IGF1 (confirmed) Growth retardation with deafness and mental retardation due to IGF1 deficiency,608747];	RCV000292383.1 [likely benign]; 			0	8					IGF1 (inh=AR pLI=0.47)
chr12	102790780	102790780	A	T	het	anno_omim	QUAL=1769;DP=102;AF=0.61;MQM=59;TRIO=HET,102,0.61,HET,11,0.55,HOM,4,1.00	IGF1	3'UTR	IGF1:ENST00000456098:3'UTR:MODIFIER:exon5/5:c.*5539T>A:,IGF1:ENST00000337514:3'UTR:MODIFIER:exon4/4:c.*5505T>A:	AluSx3	rs1140655	0.6190	0.0000	0,0,0	0,0,0,0,0	0.6645							147440 [IGF1 (confirmed) Growth retardation with deafness and mental retardation due to IGF1 deficiency,608747];	RCV000304519.1 [benign]; 			115	66					IGF1 (inh=AR pLI=0.47)
chr12	102791801	102791801	A	-	het	anno_omim	QUAL=2529;DP=148;AF=0.60;MQM=60;TRIO=HET,148,0.60,WT,21,0.00,HET,28,0.57	IGF1	3'UTR	IGF1:ENST00000456098:3'UTR:MODIFIER:exon5/5:c.*4518delT:,IGF1:ENST00000337514:3'UTR:MODIFIER:exon4/4:c.*4484delT:		rs397844200	0.0204	0.0000	0,0,0	0,0,0,0,0	0.0332							147440 [IGF1 (confirmed) Growth retardation with deafness and mental retardation due to IGF1 deficiency,608747];	RCV000392650.1 [likely benign]; 			0	9					IGF1 (inh=AR pLI=0.47)
chr12	102791881	102791881	C	A	het	anno_omim	QUAL=161;DP=56;AF=0.16;MQM=50;TRIO=HET,56,0.16,WT,6,0.17,WT,17,0.18	IGF1	3'UTR	IGF1:ENST00000456098:3'UTR:MODIFIER:exon5/5:c.*4438G>T:,IGF1:ENST00000337514:3'UTR:MODIFIER:exon4/4:c.*4404G>T:	(A)n	rs201936984	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0069							147440 [IGF1 (confirmed) Growth retardation with deafness and mental retardation due to IGF1 deficiency,608747];	RCV000357290.1 [uncertain significance]; 			2	3					IGF1 (inh=AR pLI=0.47)
chr12	102792897	102792897	G	A	hom	anno_omim	QUAL=3286;DP=112;AF=0.36;MQM=59;TRIO=HOM,112,0.36,WT,83,0.00,HOM,139,0.53	IGF1	3'UTR	IGF1:ENST00000456098:3'UTR:MODIFIER:exon5/5:c.*3422C>T:,IGF1:ENST00000337514:3'UTR:MODIFIER:exon4/4:c.*3388C>T:	(TG)n	rs5742705	0.0208	0.0000	0,0,0	0,0,0,0,0	0.0251							147440 [IGF1 (confirmed) Growth retardation with deafness and mental retardation due to IGF1 deficiency,608747];	RCV000392965.1 [likely benign]; 			1	8					IGF1 (inh=AR pLI=0.47)
chr12	102793569	102793569	C	T	het	anno_omim	QUAL=12575;DP=367;AF=0.50;MQM=60;TRIO=HET,367,0.50,WT,191,0.00,HOM,231,0.99	IGF1	3'UTR	IGF1:ENST00000456098:3'UTR:MODIFIER:exon5/5:c.*2750G>A:,IGF1:ENST00000337514:3'UTR:MODIFIER:exon4/4:c.*2716G>A:		rs6214	0.4269	0.0000	0,0,0	0,0,0,0,0	0.4509							147440 [IGF1 (confirmed) Growth retardation with deafness and mental retardation due to IGF1 deficiency,608747];	RCV000307677.1 [benign]; 			39	125					IGF1 (inh=AR pLI=0.47)
chr12	102793921	102793921	T	C	het	anno_omim	QUAL=2771;DP=158;AF=0.47;MQM=60;TRIO=HET,158,0.47,WT,29,0.00,HOM,52,0.54	IGF1	3'UTR	IGF1:ENST00000456098:3'UTR:MODIFIER:exon5/5:c.*2398A>G:,IGF1:ENST00000337514:3'UTR:MODIFIER:exon4/4:c.*2364A>G:		rs5742704	0.0208	0.0000	0,0,0	0,0,0,0,0	0.0262							147440 [IGF1 (confirmed) Growth retardation with deafness and mental retardation due to IGF1 deficiency,608747];	RCV000378960.1 [likely benign]; 			2	7					IGF1 (inh=AR pLI=0.47)
chr12	103237468	103237468	G	C	hom	anno_omim	QUAL=2175;DP=46;AF=1.00;MQM=60;TRIO=HOM,46,1.00,HOM,8,1.00,HOM,14,1.00	PAH	synonymous	PAH:ENST00000553106:synonymous:LOW:exon11/13:c.1155C>G:p.Leu385Leu,PAH:ENST00000307000:synonymous:LOW:exon12/14:c.1140C>G:p.Leu380Leu		rs772897	0.8403	0.8582	44804,24014,3307	0.7994,0.9203,0.8414,0.8473,0.8865	0.8617							612349 [PAH (confirmed) Phenylketonuria,261600|Hyperphenylalaninemia,non-PKU mild,261600];	RCV000153631.2 [benign]; 			1485	578					PAH (inh=AR pLI=0.00)
chr12	103248924	103248924	C	T	hom	anno_omim	QUAL=22067;DP=160;AF=1.00;MQM=59;TRIO=HOM,160,1.00,HOM,216,1.00,HOM,331,1.00	PAH	synonymous	PAH:ENST00000553106:synonymous:LOW:exon6/13:c.696G>A:p.Gln232Gln,PAH:ENST00000307000:synonymous:LOW:exon7/14:c.681G>A:p.Gln227Gln		rs1126758	0.5465	0.5785	21720,11666,3117	0.7752,0.6963,0.0919,0.5909,0.5713	0.6309							612349 [PAH (confirmed) Phenylketonuria,261600|Hyperphenylalaninemia,non-PKU mild,261600];	RCV000153637.2 [benign]; 			700	1010					PAH (inh=AR pLI=0.00)
chr12	103351826	103351826	T	C	het	anno_omim	QUAL=5207;DP=123;AF=0.48;MQM=60;TRIO=HET,123,0.48,HOM,119,1.00,WT,189,0.00	ASCL1,PAH	5'UTR	ASCL1:ENST00000266744:5'UTR:MODIFIER:exon1/2:c.-197T>C:		rs9782	0.3001	0.0000	0,0,0	0,0,0,0,0	0.3486							100790 [ASCL1 (confirmed) Central hypoventilation syndrome,congenital,209880|Haddad syndrome,209880];				17	114					ASCL1 (inh=AD pLI=0.36), PAH (inh=AR pLI=0.00)
chr12	103353209	103353209	A	-	hom	anno_omim	QUAL=11469;DP=144;AF=0.99;MQM=59;TRIO=HOM,144,0.99,HOM,111,0.99,HOM,135,0.99	ASCL1	3'UTR	ASCL1:ENST00000266744:3'UTR:MODIFIER:exon2/2:c.*126delA:	(AAAAGA)n	rs398020887	0.9760	0.0000	0,0,0	0,0,0,0,0	0.9771							100790 [ASCL1 (confirmed) Central hypoventilation syndrome,congenital,209880|Haddad syndrome,209880];				183	16					ASCL1 (inh=AD pLI=0.36)
chr12	103353525	103353525	T	C	hom	anno_omim	QUAL=16460;DP=160;AF=1.00;MQM=60;TRIO=HOM,160,1.00,HOM,145,1.00,HOM,218,1.00	ASCL1	3'UTR	ASCL1:ENST00000266744:3'UTR:MODIFIER:exon2/2:c.*433T>C:		rs1391682	0.9764	0.0000	0,0,0	0,0,0,0,0	0.9783							100790 [ASCL1 (confirmed) Central hypoventilation syndrome,congenital,209880|Haddad syndrome,209880];				214	18					ASCL1 (inh=AD pLI=0.36)
chr12	103353538	103353538	A	G	hom	anno_omim	QUAL=17302;DP=182;AF=1.00;MQM=60;TRIO=HOM,182,1.00,HOM,153,1.00,HOM,214,1.00	ASCL1	3'UTR	ASCL1:ENST00000266744:3'UTR:MODIFIER:exon2/2:c.*446A>G:		rs2291854	0.8215	0.0000	0,0,0	0,0,0,0,0	0.8202							100790 [ASCL1 (confirmed) Central hypoventilation syndrome,congenital,209880|Haddad syndrome,209880];				153	73					ASCL1 (inh=AD pLI=0.36)
chr12	103354187	103354187	T	-	hom	anno_omim	QUAL=8773;DP=174;AF=0.98;MQM=59;TRIO=HOM,174,0.98,HOM,47,1.00,HOM,61,1.00	ASCL1	3'UTR	ASCL1:ENST00000266744:3'UTR:MODIFIER:exon2/2:c.*1103delT:		rs34660835	0.8494	0.0000	0,0,0	0,0,0,0,0	0.8611							100790 [ASCL1 (confirmed) Central hypoventilation syndrome,congenital,209880|Haddad syndrome,209880];				177	51					ASCL1 (inh=AD pLI=0.36)
chr12	106838340	106838340	T	C	het	anno_omim	QUAL=7998;DP=369;AF=0.48;MQM=59;TRIO=HET,369,0.48,HET,267,0.50,WT,299,0.00	POLR3B	synonymous	POLR3B:ENST00000228347:synonymous:LOW:exon19/28:c.2055T>C:p.Tyr685Tyr,POLR3B:ENST00000539066:synonymous:LOW:exon19/28:c.1881T>C:p.Tyr627Tyr		rs10861607	0.3179	0.3143	7200,2541,16	0.0525,0.3993,0.7056,0.2741,0.3500	0.3211							614366 [POLR3B (provisional) Leukodystrophy,hypomyelinating,8,with or without oligodontia and/or hypogonadotropic hypogonadism,614381];	RCV000118025.2 [likely benign]; RCV000294165.1 [benign]; 		COSM1358426	295	1448					POLR3B (inh=AR pLI=0.00)
chr12	106848414	106848414	A	G	het	pred_pathogenic;anno_omim	QUAL=5181;DP=267;AF=0.48;MQM=60;TRIO=HET,267,0.48,WT,143,0.00,HET,167,0.41	POLR3B	missense	POLR3B:ENST00000228347:missense:MODERATE:exon20/28:c.2218A>G:p.Thr740Ala,POLR3B:ENST00000539066:missense:MODERATE:exon20/28:c.2044A>G:p.Thr682Ala		rs17038460	0.0266	0.0470	160,134,0	0.0147,0.0398,0.0000,0.0670,0.0177	0.0466	9.3000	D,D	T	B	T,T	23.60	614366 [POLR3B (provisional) Leukodystrophy,hypomyelinating,8,with or without oligodontia and/or hypogonadotropic hypogonadism,614381];	RCV000118026.2 [likely benign]; RCV000288077.1 [likely benign]; 			29	456					POLR3B (inh=AR pLI=0.00)
chr12	106903321	106903321	T	C	het	anno_omim	QUAL=7302;DP=322;AF=0.51;MQM=60;TRIO=HET,322,0.51,HET,210,0.52,WT,279,0.00	POLR3B,RP11-144F15.1	synonymous	POLR3B:ENST00000228347:synonymous:LOW:exon28/28:c.3396T>C:p.Asn1132Asn,POLR3B:ENST00000539066:synonymous:LOW:exon28/28:c.3222T>C:p.Asn1074Asn		rs13561	0.3249	0.3241	7398,2815,34	0.0776,0.4029,0.6749,0.2889,0.3559	0.3306							614366 [POLR3B (provisional) Leukodystrophy,hypomyelinating,8,with or without oligodontia and/or hypogonadotropic hypogonadism,614381];	RCV000118027.2 [likely benign]; RCV000329648.1 [benign]; 		COSM3752870	312	1499					POLR3B (inh=AR pLI=0.00), RP11-144F15.1 (inh=n/a pLI=n/a)
chr12	106903674	106903674	A	G	het	anno_omim	QUAL=4366;DP=270;AF=0.48;MQM=60;TRIO=HET,270,0.48,HET,81,0.42,WT,140,0.00	POLR3B,RP11-144F15.1	3'UTR	POLR3B:ENST00000228347:3'UTR:MODIFIER:exon28/28:c.*347A>G:,POLR3B:ENST00000539066:3'UTR:MODIFIER:exon28/28:c.*347A>G:		rs2288266	0.3249	0.0000	0,0,0	0,0,0,0,0	0.2564							614366 [POLR3B (provisional) Leukodystrophy,hypomyelinating,8,with or without oligodontia and/or hypogonadotropic hypogonadism,614381];	RCV000294586.1 [benign]; 			15	90					POLR3B (inh=AR pLI=0.00), RP11-144F15.1 (inh=n/a pLI=n/a)
chr12	109993255	109993255	T	A	hom	low_DP;anno_omim	QUAL=6208;DP=15;AF=0.27;MQM=60;TRIO=HOM,15,0.27,HOM,33,0.00,HOM,50,0.00	MMAB	3'UTR	MMAB:ENST00000545712:3'UTR:MODIFIER:exon9/9:c.*1578A>T:	AluSx1		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							607568 [MMAB (provisional) Methylmalonic aciduria,vitamin B12-responsive,due to defect in synthesis of adenosylcobalamin,cblB complementation type,251110];				0	0					MMAB (inh=AR pLI=0.00)
chr12	109994454	109994463	CACACACACA	-	hom	anno_omim	QUAL=2880;DP=55;AF=0.00;MQM=59;TRIO=HOM,55,0.02,WT,38,0.50,HOM,120,0.58	MMAB	3'UTR	MMAB:ENST00000545712:3'UTR:MODIFIER:exon9/9:c.*370_*379delTGTGTGTGTG:	(CA)n	rs762567631	0.0000	0.0495	3,0,0	0.0000,0.0000,0.0000,0.0630,0.0445	0.0000							607568 [MMAB (provisional) Methylmalonic aciduria,vitamin B12-responsive,due to defect in synthesis of adenosylcobalamin,cblB complementation type,251110];				0	47					MMAB (inh=AR pLI=0.00)
chr12	109994455	109994455	A	T	hom	anno_omim	QUAL=2880;DP=55;AF=0.00;MQM=59;TRIO=HOM,55,0.02,WT,38,0.50,HOM,120,0.58	MMAB	3'UTR	MMAB:ENST00000545712:3'UTR:MODIFIER:exon9/9:c.*378T>A:	(CA)n	rs66497319	0.0000	0.0574	1,0,0	0.0000,0.0000,0.0000,0.0461,0.0477	0.0276							607568 [MMAB (provisional) Methylmalonic aciduria,vitamin B12-responsive,due to defect in synthesis of adenosylcobalamin,cblB complementation type,251110];	RCV000354578.1 [likely benign]; 			2	79					MMAB (inh=AR pLI=0.00)
chr12	109994457	109994457	A	T	hom	anno_omim	QUAL=2880;DP=55;AF=0.00;MQM=59;TRIO=HOM,55,0.02,WT,38,0.50,HOM,120,0.58	MMAB	3'UTR	MMAB:ENST00000545712:3'UTR:MODIFIER:exon9/9:c.*376T>A:	(CA)n	rs527861371	0.1494	0.0277	1,0,0	0.0000,0.0000,0.0000,0.0200,0.0229	0.0571							607568 [MMAB (provisional) Methylmalonic aciduria,vitamin B12-responsive,due to defect in synthesis of adenosylcobalamin,cblB complementation type,251110];	RCV000259215.1 [likely benign]; 			0	77					MMAB (inh=AR pLI=0.00)
chr12	110240838	110240838	T	G	het	anno_omim	QUAL=10306;DP=240;AF=0.53;MQM=60;TRIO=HET,240,0.53,HET,203,0.53,HET,341,0.48	TRPV4	synonymous	TRPV4:ENST00000261740:synonymous:LOW:exon4/16:c.670A>C:p.Arg224Arg,TRPV4:ENST00000418703:synonymous:LOW:exon3/15:c.670A>C:p.Arg224Arg,TRPV4:ENST00000346520:synonymous:LOW:exon4/15:c.670A>C:p.Arg224Arg,TRPV4:ENST00000392719:synonymous:LOW:exon4/15:c.670A>C:p.Arg224Arg,TRPV4:ENST00000536838:synonymous:LOW:exon4/16:c.568A>C:p.Arg190Arg,TRPV4:ENST00000537083:synonymous:LOW:exon3/14:c.670A>C:p.Arg224Arg,TRPV4:ENST00000541794:synonymous:LOW:exon3/14:c.670A>C:p.Arg224Arg,TRPV4:ENST00000544971:synonymous:LOW:exon3/13:c.670A>C:p.Arg224Arg		rs3825394	0.7544	0.6340	25572,9130,2574	0.7033,0.7518,0.9534,0.5254,0.8108	0.6332							605427 [TRPV4 (confirmed) Brachyolmia type 3,113500|Spondylometaphyseal dysplasia,Kozlowski type,184252|Metatropic dysplasia,156530|Hereditary motor and sensory neuropathy,type IIc,606071|Scapuloperoneal spinal muscular atrophy,181405|Sodium serum level QTL 1,613508|Parastremmatic dwarfism,168400|SED,Maroteaux type,184095|Spinal muscular atrophy,distal,congenital nonprogressive,600175|Digital arthropathy-brachydactyly,familial,606835|Avascular necrosis of femoral head,primary,2,617383];	RCV000248184.1 [benign]; RCV000278253.1 [benign]; RCV000293693.1 [benign]; RCV000318188.1 [benign]; RCV000352038.1 [benign]; RCV000372711.1 [benign]; RCV000387910.1 [benign]; 		COSM3752895	874	1297					TRPV4 (inh=AD pLI=0.00)
chr12	110784907	110784907	-	ATCA	het	anno_omim	QUAL=3137;DP=189;AF=0.51;MQM=56;TRIO=HET,189,0.51,HET,96,0.49,WT,120,0.00	ATP2A2	3'UTR,intron	ATP2A2:ENST00000539276:3'UTR:MODIFIER:exon20/20:c.*633_*636dupATCA:,ATP2A2:ENST00000395494:3'UTR:MODIFIER:exon19/19:c.*633_*636dupATCA:,ATP2A2:ENST00000308664:intron:MODIFIER:exon20/20:c.2980+782_2980+785dupATCA:		rs112750891	0.1378	0.0000	0,0,0	0,0,0,0,0	0.1269							108740 [ATP2A2 (confirmed) Darier disease,124200|Acrokeratosis verruciformis,101900];				1	35					ATP2A2 (inh=AD pLI=1.00)
chr12	112944602	112944602	G	-	het	anno_omim	QUAL=4477;DP=230;AF=0.48;MQM=58;TRIO=HET,230,0.48,HET,157,0.46,WT,233,0.00	PTPN11	3'UTR	PTPN11:ENST00000351677:3'UTR:MODIFIER:exon16/16:c.*1006delG:	MLT1H	rs146940557	0.0351	0.0000	0,0,0	0,0,0,0,0	0.0531							176876 [PTPN11 (confirmed) Noonan syndrome 1,163950|LEOPARD syndrome 1,151100|Leukemia,juvenile myelomonocytic,somatic,607785|Metachondromatosis,156250];	RCV000296025.1 [likely benign]; RCV000349825.1 [likely benign]; RCV000387928.1 [likely benign]; 			3	31					PTPN11 (inh=AD pLI=1.00)
chr12	116397088	116397088	A	T	het	anno_omim	QUAL=565;DP=47;AF=0.53;MQM=59;TRIO=HET,47,0.53,WT,72,0.51,WT,4,0.00	MED13L	3'UTR	MED13L:ENST00000281928:3'UTR:MODIFIER:exon31/31:c.*1983T>A:	(TT)n	rs12423578	0.1745	0.0000	0,0,0	0,0,0,0,0	0.2028							608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1,608808|Mental retardation and distinctive facial features with or without cardiac defects,616789];				11	59					MED13L (inh=AD pLI=1.00)
chr12	116398626	116398626	A	C	het	anno_omim	QUAL=14359;DP=397;AF=0.52;MQM=60;TRIO=HET,397,0.52,WT,238,0.00,HOM,279,1.00	MED13L	3'UTR	MED13L:ENST00000281928:3'UTR:MODIFIER:exon31/31:c.*445T>G:		rs66898998	0.1324	0.0000	0,0,0	0,0,0,0,0	0.2763							608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1,608808|Mental retardation and distinctive facial features with or without cardiac defects,616789];				32	109					MED13L (inh=AD pLI=1.00)
chr12	116406910	116406910	G	A	het	anno_omim	QUAL=4903;DP=191;AF=0.49;MQM=59;TRIO=HET,191,0.49,HET,183,0.54,WT,188,0.00	MED13L	splice_region&intron	MED13L:ENST00000281928:splice_region&intron:LOW:exon27/30:c.6068-8C>T:		rs61936939	0.0046	0.0110	10,7,0	0.0027,0.0117,0.0000,0.0148,0.0044	0.0117							608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1,608808|Mental retardation and distinctive facial features with or without cardiac defects,616789];	RCV000226253.1 [benign]; 			2	41					MED13L (inh=AD pLI=1.00)
chr12	116408538	116408538	A	G	het	anno_omim	QUAL=5899;DP=271;AF=0.50;MQM=60;TRIO=HET,271,0.50,HET,190,0.47,WT,265,0.00	MED13L	synonymous	MED13L:ENST00000281928:synonymous:LOW:exon27/31:c.5928T>C:p.Thr1976Thr		rs2304460	0.1528	0.1694	1863,1117,43	0.0887,0.1176,0.1381,0.1817,0.2012	0.1680	0.4130		T			9.63	608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1,608808|Mental retardation and distinctive facial features with or without cardiac defects,616789];			COSM147620	77	608					MED13L (inh=AD pLI=1.00)
chr12	116429689	116429689	A	G	het	anno_omim	QUAL=8726;DP=307;AF=0.53;MQM=59;TRIO=HET,307,0.53,HET,387,0.48,WT,552,0.00	MED13L	synonymous	MED13L:ENST00000281928:synonymous:LOW:exon17/31:c.3070T>C:p.Leu1024Leu		rs1865787	0.1558	0.1732	1904,1165,30	0.0823,0.1182,0.1403,0.1868,0.2075	0.1701							608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1,608808|Mental retardation and distinctive facial features with or without cardiac defects,616789];				76	616					MED13L (inh=AD pLI=1.00)
chr12	116445448	116445448	G	A	het	anno_omim	QUAL=908;DP=49;AF=0.43;MQM=55;TRIO=HET,49,0.43,HET,35,0.14,HET,69,0.22	MED13L	splice_region&intron	MED13L:ENST00000281928:splice_region&intron:LOW:exon10/30:c.2013-7C>T:	(A)n	rs199749418	0.0000	0.0492	0,0,0	0.0352,0.0000,0.0000,0.0433,0.0000	0.1227							608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1,608808|Mental retardation and distinctive facial features with or without cardiac defects,616789];			COSM3746277	3	246	2	Prima Vista kein Anhalt f?r Splice-Defekt; 160704 In 151162_01 vermutlich Artefakt [2] ahwalds1 05.07.2016			MED13L (inh=AD pLI=1.00)
chr12	116445450	116445450	C	A	het	anno_omim	QUAL=908;DP=49;AF=0.43;MQM=55;TRIO=HET,49,0.43,HET,35,0.14,HET,69,0.22	MED13L	splice_region&intron	MED13L:ENST00000281928:splice_region&intron:LOW:exon10/30:c.2013-9G>T:	(A)n	rs200367922	0.0000	0.0553	0,0,0	0.0344,0.1367,0.0671,0.0523,0.0950	0.0993							608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1,608808|Mental retardation and distinctive facial features with or without cardiac defects,616789];			COSM3746278	23	381	2	Prima Vista kein Anhalt f?r Splice-Defekt; 160704 In 151162_01 vermutlich Artefakt [2] ahwalds1 05.07.2016			MED13L (inh=AD pLI=1.00)
chr12	116446445	116446445	C	T	het	anno_omim	QUAL=6597;DP=260;AF=0.49;MQM=60;TRIO=HET,260,0.49,HET,235,0.53,WT,323,0.00	MED13L	synonymous	MED13L:ENST00000281928:synonymous:LOW:exon10/31:c.1773G>A:p.Gln591Gln		rs3741768	0.1434	0.1638	1764,1083,21	0.0653,0.1129,0.1293,0.1785,0.1959	0.1630							608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1,608808|Mental retardation and distinctive facial features with or without cardiac defects,616789];			COSM3752943	71	604					MED13L (inh=AD pLI=1.00)
chr12	116457090	116457090	C	T	het	anno_omim	QUAL=7654;DP=352;AF=0.47;MQM=60;TRIO=HET,352,0.47,HET,249,0.52,WT,348,0.00	MED13L	synonymous	MED13L:ENST00000281928:synonymous:LOW:exon7/31:c.948G>A:p.Lys316Lys		rs61748072	0.0044	0.0105	11,8,0	0.0025,0.0113,0.0000,0.0141,0.0040	0.0111							608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1,608808|Mental retardation and distinctive facial features with or without cardiac defects,616789];	RCV000230147.1 [benign]; 			1	41					MED13L (inh=AD pLI=1.00)
chr12	119632307	119632307	A	G	het	anno_omim	QUAL=2876;DP=127;AF=0.57;MQM=60;TRIO=HET,127,0.57,WT,99,0.00,HET,97,0.46	HSPB8	3'UTR	HSPB8:ENST00000281938:3'UTR:MODIFIER:exon3/3:c.*644A>G:		rs11038	0.3802	0.0000	0,0,0	0,0,0,0,0	0.3333							608014 [HSPB8 (confirmed) Neuropathy,distal hereditary motor,type IIA,158590|Charcot-Marie-Tooth disease,axonal,type 2L,608673];	RCV000277778.1 [likely benign]; RCV000332840.1 [likely benign]; 			17	99					HSPB8 (inh=AD pLI=0.03)
chr12	119632347	119632347	G	A	het	anno_omim	QUAL=2513;DP=99;AF=0.61;MQM=60;TRIO=HET,99,0.61,WT,70,0.00,HET,74,0.50	HSPB8	3'UTR	HSPB8:ENST00000281938:3'UTR:MODIFIER:exon3/3:c.*684G>A:		rs1133026	0.1370	0.0000	0,0,0	0,0,0,0,0	0.1649							608014 [HSPB8 (confirmed) Neuropathy,distal hereditary motor,type IIA,158590|Charcot-Marie-Tooth disease,axonal,type 2L,608673];	RCV000318196.1 [likely benign]; RCV000377443.1 [likely benign]; 			9	81					HSPB8 (inh=AD pLI=0.03)
chr12	119632511	119632516	TAATAA	-	het	anno_omim	QUAL=1684;DP=49;AF=0.80;MQM=59;TRIO=HET,49,0.80,WT,3,0.00,HOM,36,0.97	HSPB8	3'UTR	HSPB8:ENST00000281938:3'UTR:MODIFIER:exon3/3:c.*866_*871delTAATAA:	(AAT)n	rs112223147;rs555638888	0.0000	0.0000	0,0,0	0,0,0,0,0	0.2789							608014 [HSPB8 (confirmed) Neuropathy,distal hereditary motor,type IIA,158590|Charcot-Marie-Tooth disease,axonal,type 2L,608673];				65	36					HSPB8 (inh=AD pLI=0.03)
chr12	120941215	120941215	T	C	het		QUAL=5130;DP=257;AF=0.51;MQM=59;TRIO=HET,257,0.51,HET,138,0.47,WT,219,0.00	COQ5	3'UTR	COQ5:ENST00000288532:3'UTR:MODIFIER:exon7/7:c.*372A>G:		rs7471	0.2646	0.0000	0,0,0	0,0,0,0,0	0.2708											22	94					COQ5 (inh=n/a pLI=0.00)
chr12	120966921	120966921	A	G	het		QUAL=4057;DP=282;AF=0.46;MQM=59;TRIO=HET,282,0.46,HET,95,0.58,WT,145,0.00	COQ5	synonymous	COQ5:ENST00000288532:synonymous:LOW:exon1/7:c.24T>C:p.Ala8Ala,COQ5:ENST00000445328:synonymous:LOW:exon1/6:c.24T>C:p.Ala8Ala		rs3742052	0.2646	0.3070	5778,2926,49	0.1131,0.3018,0.5079,0.3069,0.2999	0.3056										COSM3752963	183	823					COQ5 (inh=n/a pLI=0.00)
chr12	121432117	121432117	G	C	hom	anno_omim	QUAL=11738;DP=131;AF=0.98;MQM=59;TRIO=HOM,131,0.98,HET,276,0.54,HET,370,0.54	HNF1A	synonymous,intron	HNF1A:ENST00000541395:synonymous:LOW:exon4/9:c.864G>C:p.Gly288Gly,HNF1A:ENST00000257555:synonymous:LOW:exon4/10:c.864G>C:p.Gly288Gly,HNF1A:ENST00000400024:synonymous:LOW:exon4/7:c.864G>C:p.Gly288Gly,HNF1A:ENST00000402929:synonymous:LOW:exon4/6:c.864G>C:p.Gly288Gly,HNF1A:ENST00000543427:synonymous:LOW:exon5/7:c.513G>C:p.Gly171Gly,HNF1A:ENST00000544413:synonymous:LOW:exon4/10:c.864G>C:p.Gly288Gly,HNF1A:ENST00000538626:intron:MODIFIER:exon1/1:c.73-3177G>C:		rs56348580	0.1811	0.2788	3183,2067,136	0.2155,0.4862,0.0010,0.3303,0.1095	0.2655							142410 [HNF1A (confirmed) MODY,type III,600496|Diabetes mellitus,noninsulin-dependent,2,125853|Diabetes mellitus,insulin-dependent,222100|Hepatic adenoma,somatic,142330|Renal cell carcinoma,144700|Diabetes mellitus,insulin-dependent,20,612520];	RCV000117234.4 [benign]; RCV000331151.1 [benign]; 	CM067044 [CLASS=DP MUT=ALT PHEN="Diabetes type 2 association with" GENE=HNF1A]; 		178	859	2	[2] old entry - no details available			HNF1A (inh=AD pLI=0.97)
chr12	121437382	121437382	A	G	hom	pred_pathogenic;anno_omim	QUAL=13894;DP=76;AF=1.00;MQM=59;TRIO=HOM,76,1.00,HOM,165,1.00,HOM,215,1.00	HNF1A	missense	HNF1A:ENST00000541395:missense:MODERATE:exon8/9:c.1813A>G:p.Ser605Gly,HNF1A:ENST00000257555:missense:MODERATE:exon9/10:c.1720A>G:p.Ser574Gly,HNF1A:ENST00000544413:missense:MODERATE:exon9/10:c.1741A>G:p.Ser581Gly	(CCAG)n	rs1169305	0.9852	0.9959	57820,31915,4361	0.9534,0.9975,0.9998,0.9999,0.9999	0.9966	0.3180	T,T,T,T,T,T	T	B	D,D,D	5.41	142410 [HNF1A (confirmed) MODY,type III,600496|Diabetes mellitus,noninsulin-dependent,2,125853|Diabetes mellitus,insulin-dependent,222100|Hepatic adenoma,somatic,142330|Renal cell carcinoma,144700|Diabetes mellitus,insulin-dependent,20,612520];	RCV000030490.2 [not provided]; RCV000121200.1 [not provided]; 			2233	1	2	[2] old entry - no details available			HNF1A (inh=AD pLI=0.97)
chr12	121440263	121440263	G	A	hom	pred_pathogenic;anno_omim	QUAL=9074;DP=164;AF=0.99;MQM=59;TRIO=HOM,164,0.99,HET,144,0.51,HET,178,0.50	HNF1A,C12orf43	3'UTR	HNF1A:ENST00000541395:3'UTR:MODIFIER:exon9/9:c.*1268G>A:,HNF1A:ENST00000257555:3'UTR:MODIFIER:exon10/10:c.*1268G>A:,C12orf43:ENST00000445832:3'UTR:MODIFIER:exon6/6:c.*1693C>T:		rs41279096	0.1054	0.0859	48,8,1	0.0000,0.0000,0.0000,0.0975,0.0818	0.1381	0.2980	D	T			3.34	142410 [HNF1A (confirmed) MODY,type III,600496|Diabetes mellitus,noninsulin-dependent,2,125853|Diabetes mellitus,insulin-dependent,222100|Hepatic adenoma,somatic,142330|Renal cell carcinoma,144700|Diabetes mellitus,insulin-dependent,20,612520];	RCV000322383.1 [benign]; 			24	292					HNF1A (inh=AD pLI=0.97), C12orf43 (inh=n/a pLI=0.00)
chr12	122064774	122064779	CCGCCA	-	hom	low_DP;anno_omim	QUAL=622;DP=11;AF=0.91;MQM=59;TRIO=HOM,11,0.91,HOM,6,0.83,HOM,13,1.00	ORAI1	disruptive_inframe_deletion	ORAI1:ENST00000330079:disruptive_inframe_deletion:MODERATE:exon1/2:c.138_143delACCGCC:p.Pro47_Pro48del	(GCCACC)n	rs141919534;rs531278468	0.9998	0.9941	50849,27505,3399	0.9990,0.9963,0.9938,0.9929,0.9948	0.9945							610277 [ORAI1 (provisional) Immunodeficiency 9,612782|Myopathy,tubular aggregate,2,615883];	RCV000173541.1 [benign]; 		COSM430547	1994	74					ORAI1 (inh=AR pLI=0.00)
chr12	122295335	122295335	T	C	hom	pred_pathogenic;anno_omim	QUAL=21457;DP=184;AF=1.00;MQM=59;TRIO=HOM,184,1.00,HOM,204,1.00,HOM,292,1.00	HPD	missense,5'UTR	HPD:ENST00000289004:missense:MODERATE:exon4/14:c.97A>G:p.Thr33Ala,HPD:ENST00000543163:5'UTR:MODIFIER:exon5/15:c.-21A>G:		rs1154510	0.8764	0.8502	44159,24898,4816	0.9622,0.7197,0.8520,0.8635,0.8465	0.8704	3.8970	T,T	T		T	1.00	609695 [HPD (confirmed) Tyrosinemia,type III,276710|Hawkinsinuria,140350];			COSM3736057	1609	475	2	[2] old entry - no details available			HPD (inh=AR+AD pLI=0.01)
chr12	122756470	122756470	C	A	het		QUAL=4279;DP=231;AF=0.42;MQM=60;TRIO=HET,231,0.42,WT,93,0.00,HET,143,0.48	CLIP1	3'UTR	CLIP1:ENST00000361654:3'UTR:MODIFIER:exon24/24:c.*952G>T:,CLIP1:ENST00000545889:3'UTR:MODIFIER:exon21/21:c.*952G>T:,CLIP1:ENST00000302528:3'UTR:MODIFIER:exon24/24:c.*952G>T:,CLIP1:ENST00000358808:3'UTR:MODIFIER:exon25/25:c.*952G>T:		rs112052364	0.0012	0.0000	0,0,0	0,0,0,0,0	0.0014											0	7					CLIP1 (inh=n/a pLI=0.97)
chr12	122812503	122812503	G	C	hom		QUAL=18678;DP=198;AF=0.99;MQM=59;TRIO=HOM,198,0.99,HET,250,0.48,HOM,313,0.99	CLIP1	missense	CLIP1:ENST00000540338:missense:MODERATE:exon16/25:c.3240C>G:p.Asp1080Glu,CLIP1:ENST00000361654:missense:MODERATE:exon15/24:c.2874C>G:p.Asp958Glu,CLIP1:ENST00000545889:missense:MODERATE:exon12/21:c.1965C>G:p.Asp655Glu,CLIP1:ENST00000302528:missense:MODERATE:exon15/24:c.3207C>G:p.Asp1069Glu,CLIP1:ENST00000358808:missense:MODERATE:exon16/25:c.3207C>G:p.Asp1069Glu,CLIP1:ENST00000537178:missense:MODERATE:exon15/24:c.3102C>G:p.Asp1034Glu		rs1129167	0.4066	0.5625	20626,13576,125	0.1448,0.5215,0.3790,0.6358,0.5975	0.5694	0.2800	T,T,T,T,T,T,T	T	B,B,B	T,T,T,T,T	0.15					711	950					CLIP1 (inh=n/a pLI=0.97)
chr12	122817580	122817580	A	G	het	pred_pathogenic	QUAL=4918;DP=231;AF=0.53;MQM=60;TRIO=HET,231,0.53,HET,132,0.51,WT,185,0.00	CLIP1	missense	CLIP1:ENST00000540338:missense:MODERATE:exon14/25:c.2821T>C:p.Ser941Pro,CLIP1:ENST00000361654:missense:MODERATE:exon13/24:c.2455T>C:p.Ser819Pro,CLIP1:ENST00000545889:missense:MODERATE:exon10/21:c.1546T>C:p.Ser516Pro,CLIP1:ENST00000302528:missense:MODERATE:exon13/24:c.2788T>C:p.Ser930Pro,CLIP1:ENST00000358808:missense:MODERATE:exon14/25:c.2788T>C:p.Ser930Pro,CLIP1:ENST00000537178:missense:MODERATE:exon13/24:c.2683T>C:p.Ser895Pro		rs17883517	0.0313	0.0631	311,284,4	0.0168,0.0440,0.0000,0.0950,0.0171	0.0625	8.6630	D,D,D,D,D,D,D	T	D,D,D	T,T,T,T,T,T	31.00				COSM3752995, COSM3752996	10	274					CLIP1 (inh=n/a pLI=0.97)
chr12	122956772	122956772	G	T	hom		QUAL=3568;DP=81;AF=0.00;MQM=60;TRIO=HOM,81,0.00,HOM,23,0.13,HOM,35,0.09	CLIP1,ZCCHC8	intergenic_region	ZCCHC8:ENSG00000130779-ENSG00000033030:intergenic_region:MODIFIER::n.122956772G>T:	AluSp		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0159											1	0					CLIP1 (inh=n/a pLI=0.97), ZCCHC8 (inh=n/a pLI=0.78)
chr12	122956842	122956842	A	C	hom		QUAL=3797;DP=79;AF=1.00;MQM=52;TRIO=HOM,79,1.00,HET,38,0.55,HOM,52,1.00	CLIP1,ZCCHC8	intergenic_region	ZCCHC8:ENSG00000130779-ENSG00000033030:intergenic_region:MODIFIER::n.122956842A>C:	AluSp	rs11608711	0.5791	0.0000	0,0,0	0,0,0,0,0	0.6239											59	84					CLIP1 (inh=n/a pLI=0.97), ZCCHC8 (inh=n/a pLI=0.78)
chr12	122957085	122957085	G	A	hom	low_DP	QUAL=238;DP=7;AF=1.00;MQM=59;TRIO=HOM,7,1.00,HOM,1,1.00,HOM,1,1.00	CLIP1,ZCCHC8	intergenic_region	ZCCHC8:ENSG00000130779-ENSG00000033030:intergenic_region:MODIFIER::n.122957085G>A:		rs7132830	0.5789	0.0000	0,0,0	0,0,0,0,0	0.6211											35	36					CLIP1 (inh=n/a pLI=0.97), ZCCHC8 (inh=n/a pLI=0.78)
chr12	123718301	123718301	C	T	het	anno_omim	QUAL=9125;DP=215;AF=0.55;MQM=60;TRIO=HET,215,0.55,HOM,150,1.00,HET,169,0.53	C12orf65,MPHOSPH9	intron	C12orf65:ENST00000253233:intron:MODIFIER:exon1/2:c.-29+223C>T:		rs1727332	0.5569	0.0000	0,0,0	0,0,0,0,0	0.5984							613541 [C12ORF65 (provisional) Combined oxidative phosphorylation deficiency 7,613559|Spastic paraplegia 55,autosomal recessive,615035];				113	93					C12orf65 (inh=AR pLI=0.17), MPHOSPH9 (inh=n/a pLI=0.00)
chr12	123738494	123738494	C	T	het	anno_omim	QUAL=6428;DP=264;AF=0.56;MQM=60;TRIO=HET,264,0.56,WT,155,0.00,HET,217,0.53	C12orf65,RP11-282O18.3	synonymous	C12orf65:ENST00000253233:synonymous:LOW:exon2/3:c.273C>T:p.Ile91Ile,C12orf65:ENST00000366329:synonymous:LOW:exon2/3:c.273C>T:p.Ile91Ile,C12orf65:ENST00000429587:synonymous:LOW:exon1/2:c.273C>T:p.Ile91Ile		rs2280424	0.0909	0.0569	410,57,10	0.0439,0.0648,0.2629,0.0372,0.0423	0.0565							613541 [C12ORF65 (provisional) Combined oxidative phosphorylation deficiency 7,613559|Spastic paraplegia 55,autosomal recessive,615035];	RCV000249717.1 [benign]; RCV000277121.1 [likely benign]; 		COSM3998691	9	231					C12orf65 (inh=AR pLI=0.17), RP11-282O18.3 (inh=n/a pLI=n/a)
chr12	123741706	123741706	C	A	het	anno_omim	QUAL=2423;DP=139;AF=0.52;MQM=60;TRIO=HET,139,0.52,WT,70,0.00,HET,71,0.37	C12orf65,RP11-282O18.3	3'UTR	C12orf65:ENST00000253233:3'UTR:MODIFIER:exon3/3:c.*128C>A:,C12orf65:ENST00000366329:3'UTR:MODIFIER:exon3/3:c.*128C>A:,C12orf65:ENST00000429587:3'UTR:MODIFIER:exon2/2:c.*128C>A:		rs11554169	0.0935	0.0000	0,0,0	0,0,0,0,0	0.0492							613541 [C12ORF65 (provisional) Combined oxidative phosphorylation deficiency 7,613559|Spastic paraplegia 55,autosomal recessive,615035];	RCV000386593.1 [likely benign]; 			0	36					C12orf65 (inh=AR pLI=0.17), RP11-282O18.3 (inh=n/a pLI=n/a)
chr12	123741776	123741776	T	C	hom	anno_omim	QUAL=14250;DP=222;AF=0.99;MQM=59;TRIO=HOM,222,0.99,HOM,104,1.00,HOM,123,1.00	C12orf65,RP11-282O18.3	3'UTR	C12orf65:ENST00000253233:3'UTR:MODIFIER:exon3/3:c.*198T>C:,C12orf65:ENST00000366329:3'UTR:MODIFIER:exon3/3:c.*198T>C:,C12orf65:ENST00000429587:3'UTR:MODIFIER:exon2/2:c.*198T>C:	AluSx1	rs1969354	0.6514	0.0000	0,0,0	0,0,0,0,0	0.6465							613541 [C12ORF65 (provisional) Combined oxidative phosphorylation deficiency 7,613559|Spastic paraplegia 55,autosomal recessive,615035];	RCV000382713.1 [benign]; 			138	79					C12orf65 (inh=AR pLI=0.17), RP11-282O18.3 (inh=n/a pLI=n/a)
chr12	123742032	123742032	A	C	het	anno_omim	QUAL=4174;DP=194;AF=0.51;MQM=57;TRIO=HET,194,0.51,WT,71,0.03,HET,113,0.60	C12orf65,RP11-282O18.3	3'UTR	C12orf65:ENST00000253233:3'UTR:MODIFIER:exon3/3:c.*454A>C:,C12orf65:ENST00000366329:3'UTR:MODIFIER:exon3/3:c.*454A>C:,C12orf65:ENST00000429587:3'UTR:MODIFIER:exon2/2:c.*454A>C:	AluSx1	rs76029248	0.0933	0.0000	0,0,0	0,0,0,0,0	0.0492							613541 [C12ORF65 (provisional) Combined oxidative phosphorylation deficiency 7,613559|Spastic paraplegia 55,autosomal recessive,615035];	RCV000394629.1 [likely benign]; 			1	26					C12orf65 (inh=AR pLI=0.17), RP11-282O18.3 (inh=n/a pLI=n/a)
chr12	123742061	123742061	G	A	het	anno_omim	QUAL=6284;DP=220;AF=0.50;MQM=59;TRIO=HET,220,0.50,HOM,75,1.00,HET,127,0.38	C12orf65,RP11-282O18.3	3'UTR	C12orf65:ENST00000253233:3'UTR:MODIFIER:exon3/3:c.*483G>A:,C12orf65:ENST00000366329:3'UTR:MODIFIER:exon3/3:c.*483G>A:,C12orf65:ENST00000429587:3'UTR:MODIFIER:exon2/2:c.*483G>A:	AluSx1	rs1969355	0.5573	0.0000	0,0,0	0,0,0,0,0	0.5977							613541 [C12ORF65 (provisional) Combined oxidative phosphorylation deficiency 7,613559|Spastic paraplegia 55,autosomal recessive,615035];	RCV000339566.1 [benign]; 			91	69					C12orf65 (inh=AR pLI=0.17), RP11-282O18.3 (inh=n/a pLI=n/a)
chr12	123742093	123742093	T	G	hom	anno_omim	QUAL=14962;DP=258;AF=1.00;MQM=59;TRIO=HOM,258,1.00,HOM,83,1.00,HOM,140,1.00	C12orf65,RP11-282O18.3	3'UTR	C12orf65:ENST00000253233:3'UTR:MODIFIER:exon3/3:c.*515T>G:,C12orf65:ENST00000366329:3'UTR:MODIFIER:exon3/3:c.*515T>G:,C12orf65:ENST00000429587:3'UTR:MODIFIER:exon2/2:c.*515T>G:		rs1533703	0.6506	0.0000	0,0,0	0,0,0,0,0	0.6479							613541 [C12ORF65 (provisional) Combined oxidative phosphorylation deficiency 7,613559|Spastic paraplegia 55,autosomal recessive,615035];	RCV000398841.1 [benign]; 			114	57					C12orf65 (inh=AR pLI=0.17), RP11-282O18.3 (inh=n/a pLI=n/a)
chr12	123742271	123742274	AAAG	-	het	anno_omim	QUAL=2401;DP=125;AF=0.58;MQM=59;TRIO=HET,125,0.58,WT,23,0.00,HET,53,0.60	C12orf65,RP11-282O18.3	3'UTR	C12orf65:ENST00000253233:3'UTR:MODIFIER:exon3/3:c.*696_*699delGAAA:,C12orf65:ENST00000366329:3'UTR:MODIFIER:exon3/3:c.*696_*699delGAAA:	L1ME3B	rs202152701	0.0933	0.0000	0,0,0	0,0,0,0,0	0.0475							613541 [C12ORF65 (provisional) Combined oxidative phosphorylation deficiency 7,613559|Spastic paraplegia 55,autosomal recessive,615035];	RCV000336587.1 [likely benign]; 			0	22					C12orf65 (inh=AR pLI=0.17), RP11-282O18.3 (inh=n/a pLI=n/a)
chr12	123742287	123742289	TAC	-	het	anno_omim	QUAL=2815;DP=135;AF=0.59;MQM=59;TRIO=HET,135,0.59,WT,28,0.00,HET,57,0.60	C12orf65,RP11-282O18.3	3'UTR	C12orf65:ENST00000253233:3'UTR:MODIFIER:exon3/3:c.*711_*713delCTA:,C12orf65:ENST00000366329:3'UTR:MODIFIER:exon3/3:c.*711_*713delCTA:	L1ME3B	rs148010033	0.0933	0.0000	0,0,0	0,0,0,0,0	0.0477							613541 [C12ORF65 (provisional) Combined oxidative phosphorylation deficiency 7,613559|Spastic paraplegia 55,autosomal recessive,615035];	RCV000315504.1 [likely benign]; 			0	22					C12orf65 (inh=AR pLI=0.17), RP11-282O18.3 (inh=n/a pLI=n/a)
chr12	124105848	124105848	A	G	hom	anno_omim	QUAL=32887;DP=354;AF=1.00;MQM=60;TRIO=HOM,354,1.00,HOM,264,1.00,HOM,404,1.00	EIF2B1	3'UTR	EIF2B1:ENST00000424014:3'UTR:MODIFIER:exon9/9:c.*455T>C:		rs7137332	0.9972	0.0000	0,0,0	0,0,0,0,0	0.9915							606686 [EIF2B1 (provisional) Leukoencephalopathy with vanishing white matter,603896];				230	2					EIF2B1 (inh=AR pLI=0.10)
chr12	124197099	124197099	C	T	het	low_DP;anno_omim	QUAL=288;DP=7;AF=0.43;MQM=60;TRIO=HET,7,0.43,HET,6,0.50,HET,19,0.58	ATP6V0A2	5'UTR	ATP6V0A2:ENST00000330342:5'UTR:MODIFIER:exon1/20:c.-14C>T:		rs1139320	0.2722	0.4825	3200,2075,284	0.5663,0.4400,0.1890,0.5393,0.3855	0.3608							611716 [ATP6V0A2 (confirmed) Cutis laxa,autosomal recessive,type IIA,219200|Wrinkly skin syndrome,278250];	RCV000081542.5 [other]; RCV000305731.1 [likely benign]; RCV000339426.1 [benign]; RCV000407551.1 [likely benign]; 			284	881					ATP6V0A2 (inh=AR pLI=0.00)
chr12	124209332	124209332	T	C	het	anno_omim	QUAL=6780;DP=217;AF=0.53;MQM=60;TRIO=HET,217,0.53,HET,141,0.49,HET,159,0.48	ATP6V0A2	synonymous	ATP6V0A2:ENST00000330342:synonymous:LOW:exon4/20:c.426T>C:p.Asn142Asn		rs1139789	0.7510	0.6792	28565,12919,2481	0.6889,0.8091,0.9453,0.6230,0.6688	0.6857							611716 [ATP6V0A2 (confirmed) Cutis laxa,autosomal recessive,type IIA,219200|Wrinkly skin syndrome,278250];	RCV000081551.6 [benign]; RCV000394212.1 [benign]; 		COSM3753015	850	971					ATP6V0A2 (inh=AR pLI=0.00)
chr12	124210782	124210782	T	C	het	anno_omim	QUAL=9892;DP=287;AF=0.47;MQM=60;TRIO=HET,287,0.47,HET,218,0.47,HET,262,0.53	ATP6V0A2	synonymous	ATP6V0A2:ENST00000330342:synonymous:LOW:exon5/20:c.471T>C:p.Ser157Ser		rs1399961	0.7498	0.6756	28301,12692,2473	0.6879,0.8078,0.9453,0.6172,0.6687	0.6822							611716 [ATP6V0A2 (confirmed) Cutis laxa,autosomal recessive,type IIA,219200|Wrinkly skin syndrome,278250];	RCV000081553.5 [benign]; RCV000369580.1 [benign]; 		COSM3753016	843	972					ATP6V0A2 (inh=AR pLI=0.00)
chr12	124229429	124229429	T	C	het	anno_omim	QUAL=18224;DP=324;AF=0.52;MQM=59;TRIO=HET,324,0.52,HET,479,0.51,HET,591,0.49	ATP6V0A2	splice_region&synonymous	ATP6V0A2:ENST00000330342:splice_region&synonymous:LOW:exon13/20:c.1515T>C:p.Asn505Asn		rs7135542	0.7995	0.6934	29854,12976,3617	0.8343,0.8156,0.9485,0.6244,0.6697	0.7082							611716 [ATP6V0A2 (confirmed) Cutis laxa,autosomal recessive,type IIA,219200|Wrinkly skin syndrome,278250];	RCV000081547.5 [benign]; RCV000374481.1 [benign]; 		COSM1127520	856	968					ATP6V0A2 (inh=AR pLI=0.00)
chr12	124243707	124243707	T	C	het	anno_omim	QUAL=8074;DP=260;AF=0.54;MQM=60;TRIO=HET,260,0.54,HET,147,0.40,HET,201,0.52	ATP6V0A2	3'UTR	ATP6V0A2:ENST00000330342:3'UTR:MODIFIER:exon20/20:c.*1128T>C:		rs10744162	0.6176	0.0000	0,0,0	0,0,0,0,0	0.5517							611716 [ATP6V0A2 (confirmed) Cutis laxa,autosomal recessive,type IIA,219200|Wrinkly skin syndrome,278250];	RCV000339651.1 [benign]; 			82	101					ATP6V0A2 (inh=AR pLI=0.00)
chr12	124244272	124244272	C	G	het	anno_omim	QUAL=12643;DP=355;AF=0.48;MQM=60;TRIO=HET,355,0.48,HET,264,0.50,HET,347,0.52	ATP6V0A2	3'UTR	ATP6V0A2:ENST00000330342:3'UTR:MODIFIER:exon20/20:c.*1693C>G:		rs10846553	0.7915	0.0000	0,0,0	0,0,0,0,0	0.7021							611716 [ATP6V0A2 (confirmed) Cutis laxa,autosomal recessive,type IIA,219200|Wrinkly skin syndrome,278250];	RCV000330111.1 [benign]; 			89	106					ATP6V0A2 (inh=AR pLI=0.00)
chr12	124246004	124246004	G	A	het	anno_omim	QUAL=16881;DP=461;AF=0.46;MQM=60;TRIO=HET,461,0.46,HET,363,0.53,HET,445,0.51	ATP6V0A2	3'UTR	ATP6V0A2:ENST00000330342:3'UTR:MODIFIER:exon20/20:c.*3425G>A:		rs2333834	0.6066	0.0000	0,0,0	0,0,0,0,0	0.5398							611716 [ATP6V0A2 (confirmed) Cutis laxa,autosomal recessive,type IIA,219200|Wrinkly skin syndrome,278250];	RCV000380607.1 [benign]; 			80	104					ATP6V0A2 (inh=AR pLI=0.00)
chr13	20761763	20761763	A	G	hom	anno_omim	QUAL=22115;DP=286;AF=1.00;MQM=59;TRIO=HOM,286,1.00,HOM,159,1.00,HOM,230,1.00	GJB2	3'UTR	GJB2:ENST00000382844:3'UTR:MODIFIER:exon1/1:c.*1277T>C:,GJB2:ENST00000382848:3'UTR:MODIFIER:exon2/2:c.*1277T>C:		rs7988691	0.9972	0.0000	0,0,0	0,0,0,0,0	0.9975							121011 [GJB2 (confirmed) Deafness,autosomal recessive 1A,220290|Deafness,autosomal dominant 3A,601544|Vohwinkel syndrome,124500|Keratoderma,palmoplantar,with deafness,148350|Keratitis-ichthyosis-deafness syndrome,148210|Hystrix-like ichthyosis with deafness,602540|Bart-Pumphrey syndrome,149200];	RCV000276545.1 [benign]; RCV000326865.1 [benign]; RCV000329812.1 [benign]; RCV000381445.1 [benign]; RCV000389084.1 [benign]; 			232	0					GJB2 (inh=n/a pLI=0.00)
chr13	20761888	20761888	C	T	hom	anno_omim	QUAL=20406;DP=246;AF=1.00;MQM=60;TRIO=HOM,246,1.00,HOM,157,1.00,HOM,207,1.00	GJB2	3'UTR	GJB2:ENST00000382844:3'UTR:MODIFIER:exon1/1:c.*1152G>A:,GJB2:ENST00000382848:3'UTR:MODIFIER:exon2/2:c.*1152G>A:		rs7623	0.8934	0.0000	0,0,0	0,0,0,0,0	0.9055							121011 [GJB2 (confirmed) Deafness,autosomal recessive 1A,220290|Deafness,autosomal dominant 3A,601544|Vohwinkel syndrome,124500|Keratoderma,palmoplantar,with deafness,148350|Keratitis-ichthyosis-deafness syndrome,148210|Hystrix-like ichthyosis with deafness,602540|Bart-Pumphrey syndrome,149200];	RCV000268670.1 [benign]; RCV000274368.1 [benign]; RCV000315488.1 [benign]; RCV000363347.1 [benign]; RCV000369038.1 [benign]; 			211	21					GJB2 (inh=n/a pLI=0.00)
chr13	20761973	20761973	C	A	hom	anno_omim	QUAL=30430;DP=477;AF=1.00;MQM=59;TRIO=HOM,477,1.00,HOM,189,1.00,HOM,265,1.00	GJB2	3'UTR	GJB2:ENST00000382844:3'UTR:MODIFIER:exon1/1:c.*1067G>T:,GJB2:ENST00000382848:3'UTR:MODIFIER:exon2/2:c.*1067G>T:		rs9237	0.8702	0.0000	0,0,0	0,0,0,0,0	0.8765							121011 [GJB2 (confirmed) Deafness,autosomal recessive 1A,220290|Deafness,autosomal dominant 3A,601544|Vohwinkel syndrome,124500|Keratoderma,palmoplantar,with deafness,148350|Keratitis-ichthyosis-deafness syndrome,148210|Hystrix-like ichthyosis with deafness,602540|Bart-Pumphrey syndrome,149200];	RCV000265290.1 [benign]; RCV000320457.1 [benign]; RCV000328529.1 [benign]; RCV000379737.1 [benign]; RCV000383076.1 [benign]; 			192	40					GJB2 (inh=n/a pLI=0.00)
chr13	20762956	20762956	A	G	hom	anno_omim	QUAL=35620;DP=468;AF=0.99;MQM=60;TRIO=HOM,468,0.99,HOM,279,1.00,HOM,359,1.00	GJB2	3'UTR	GJB2:ENST00000382844:3'UTR:MODIFIER:exon1/1:c.*84T>C:,GJB2:ENST00000382848:3'UTR:MODIFIER:exon2/2:c.*84T>C:		rs3751385	0.6867	0.0000	0,0,0	0,0,0,0,0	0.7467							121011 [GJB2 (confirmed) Deafness,autosomal recessive 1A,220290|Deafness,autosomal dominant 3A,601544|Vohwinkel syndrome,124500|Keratoderma,palmoplantar,with deafness,148350|Keratitis-ichthyosis-deafness syndrome,148210|Hystrix-like ichthyosis with deafness,602540|Bart-Pumphrey syndrome,149200];	RCV000029940.1 [benign]; RCV000266913.1 [benign]; RCV000302407.1 [benign]; RCV000324393.1 [benign]; RCV000359458.1 [benign]; RCV000372078.1 [benign]; 			298	139					GJB2 (inh=n/a pLI=0.00)
chr13	20978006	20978006	A	G	hom		QUAL=33137;DP=385;AF=1.00;MQM=59;TRIO=HOM,385,1.00,HOM,294,1.00,HOM,372,1.00	CRYL1	3'UTR	CRYL1:ENST00000298248:3'UTR:MODIFIER:exon8/8:c.*262T>C:,CRYL1:ENST00000382812:3'UTR:MODIFIER:exon9/9:c.*262T>C:		rs7165	0.6903	0.0000	0,0,0	0,0,0,0,0	0.6987											126	93					CRYL1 (inh=n/a pLI=0.00)
chr13	21063524	21063524	A	G	het		QUAL=9586;DP=240;AF=0.50;MQM=60;TRIO=HET,240,0.50,WT,196,0.00,HOM,219,1.00	CRYL1	synonymous	CRYL1:ENST00000298248:synonymous:LOW:exon3/8:c.261T>C:p.Gly87Gly,CRYL1:ENST00000382812:synonymous:LOW:exon4/9:c.195T>C:p.Gly65Gly		rs14236	0.2704	0.2292	3587,1867,990	0.4482,0.1254,0.1343,0.2361,0.1982	0.2869										COSM3753610	98	619					CRYL1 (inh=n/a pLI=0.00)
chr13	23824783	23824783	T	G	hom	anno_omim	QUAL=9039;DP=128;AF=1.00;MQM=60;TRIO=HOM,128,1.00,HOM,91,1.00,HET,122,0.57	SGCG	synonymous	SGCG:ENST00000218867:synonymous:LOW:exon4/8:c.312T>G:p.Leu104Leu,SGCG:ENST00000537476:synonymous:LOW:exon5/9:c.312T>G:p.Leu104Leu,SGCG:ENST00000545013:synonymous:LOW:exon5/9:c.312T>G:p.Leu104Leu		rs1800351	0.5248	0.4343	11651,4678,2403	0.6874,0.3930,0.6887,0.3831,0.3860	0.4885							608896 [SGCG (confirmed) Muscular dystrophy,limb-girdle,type 2C,253700];	RCV000078404.7 [benign]; RCV000302440.1 [benign]; RCV000360063.1 [benign]; 		COSM3753619	313	928					SGCG (inh=AR pLI=0.01)
chr13	23898509	23898509	T	C	het	anno_omim	QUAL=7196;DP=153;AF=0.53;MQM=60;TRIO=HET,153,0.53,WT,89,0.01,HOM,169,0.99	SGCG	splice_region&synonymous	SGCG:ENST00000218867:splice_region&synonymous:LOW:exon8/8:c.705T>C:p.Leu235Leu,SGCG:ENST00000537476:splice_region&synonymous:LOW:exon9/9:c.705T>C:p.Leu235Leu,SGCG:ENST00000545013:splice_region&synonymous:LOW:exon9/9:c.705T>C:p.Leu235Leu		rs1800353	0.6298	0.6744	28194,14968,836	0.3989,0.8182,0.7690,0.6700,0.7165	0.6866							608896 [SGCG (confirmed) Muscular dystrophy,limb-girdle,type 2C,253700];	RCV000078407.7 [benign]; RCV000278365.1 [benign]; RCV000293880.1 [likely benign]; RCV000373060.1 [benign]; 			1012	896					SGCG (inh=AR pLI=0.01)
chr13	23898664	23898664	A	G	hom	pred_pathogenic;anno_omim	QUAL=13522;DP=172;AF=1.00;MQM=59;TRIO=HOM,172,1.00,HOM,94,1.00,HOM,166,1.00	SGCG	missense	SGCG:ENST00000218867:missense:MODERATE:exon8/8:c.860A>G:p.Asn287Ser,SGCG:ENST00000537476:missense:MODERATE:exon9/9:c.860A>G:p.Asn287Ser,SGCG:ENST00000545013:missense:MODERATE:exon9/9:c.860A>G:p.Asn287Ser		rs1800354	0.8778	0.8817	47373,25293,2853	0.7394,0.9380,0.9992,0.8710,0.9142	0.8865	4.0170	T,T,T	T	B	D,D,D	4.80	608896 [SGCG (confirmed) Muscular dystrophy,limb-girdle,type 2C,253700];	RCV000153942.4 [benign]; RCV000348757.1 [benign]; 		COSM4147635	1591	516	2	[2] Ute Grasshoff 24.11.2015			SGCG (inh=AR pLI=0.01)
chr13	23898934	23898934	G	A	het	anno_omim	QUAL=16094;DP=484;AF=0.51;MQM=60;TRIO=HET,484,0.51,HOM,299,0.99,WT,443,0.01	SGCG	3'UTR	SGCG:ENST00000218867:3'UTR:MODIFIER:exon8/8:c.*254G>A:,SGCG:ENST00000537476:3'UTR:MODIFIER:exon9/9:c.*254G>A:		rs3751371	0.3502	0.0000	0,0,0	0,0,0,0,0	0.3197							608896 [SGCG (confirmed) Muscular dystrophy,limb-girdle,type 2C,253700];	RCV000315861.1 [benign]; RCV000354144.1 [likely benign]; RCV000372732.1 [benign]; RCV000394244.1 [benign]; 			54	100					SGCG (inh=AR pLI=0.01)
chr13	23898975	23898975	T	C	het	anno_omim	QUAL=19551;DP=421;AF=0.50;MQM=60;TRIO=HET,421,0.50,WT,340,0.01,HOM,444,0.99	SGCG	3'UTR	SGCG:ENST00000218867:3'UTR:MODIFIER:exon8/8:c.*295T>C:,SGCG:ENST00000537476:3'UTR:MODIFIER:exon9/9:c.*295T>C:		rs3829352	0.3480	0.0000	0,0,0	0,0,0,0,0	0.3757							608896 [SGCG (confirmed) Muscular dystrophy,limb-girdle,type 2C,253700];	RCV000261794.1 [likely benign]; RCV000319133.1 [likely benign]; RCV000391543.1 [likely benign]; 			45	93					SGCG (inh=AR pLI=0.01)
chr13	23903220	23903224	TAAAG	-	het	anno_omim	QUAL=6118;DP=238;AF=0.53;MQM=59;TRIO=HET,238,0.53,WT,131,0.00,HET,221,0.57	SACS	3'UTR	SACS:ENST00000382292:3'UTR:MODIFIER:exon9/9:c.*1051_*1055delCTTTA:,SACS:ENST00000402364:3'UTR:MODIFIER:exon8/8:c.*1051_*1055delCTTTA:,SACS:ENST00000382298:3'UTR:MODIFIER:exon10/10:c.*1051_*1055delCTTTA:		rs66920661	0.0345	0.0000	0,0,0	0,0,0,0,0	0.0858							604490 [SACS (provisional) Spastic ataxia,Charlevoix-Saguenay type,270550];	RCV000305184.1 [likely benign]; RCV000359875.1 [likely benign]; RCV000400201.1 [likely benign]; 			5	34					SACS (inh=AR pLI=0.00)
chr13	23903791	23903791	A	G	het	anno_omim	QUAL=13471;DP=471;AF=0.49;MQM=60;TRIO=HET,471,0.49,WT,195,0.02,HOM,221,0.98	SACS	3'UTR	SACS:ENST00000382292:3'UTR:MODIFIER:exon9/9:c.*484T>C:,SACS:ENST00000402364:3'UTR:MODIFIER:exon8/8:c.*484T>C:,SACS:ENST00000382298:3'UTR:MODIFIER:exon10/10:c.*484T>C:		rs4770433	0.3444	0.0000	0,0,0	0,0,0,0,0	0.3726							604490 [SACS (provisional) Spastic ataxia,Charlevoix-Saguenay type,270550];	RCV000271293.1 [likely benign]; RCV000315525.1 [likely benign]; RCV000365800.1 [likely benign]; 			49	104					SACS (inh=AR pLI=0.00)
chr13	23907677	23907677	C	T	hom	anno_omim	QUAL=25269;DP=361;AF=1.00;MQM=60;TRIO=HOM,361,1.00,HOM,176,1.00,HOM,222,1.00	SACS	synonymous	SACS:ENST00000382292:synonymous:LOW:exon9/9:c.10338G>A:p.Gln3446Gln,SACS:ENST00000402364:synonymous:LOW:exon8/8:c.8088G>A:p.Gln2696Gln,SACS:ENST00000382298:synonymous:LOW:exon10/10:c.10338G>A:p.Gln3446Gln		rs2737701	0.9854	0.9957	60154,33342,4714	0.9525,0.9983,1.0000,0.9999,0.9999	0.9966							604490 [SACS (provisional) Spastic ataxia,Charlevoix-Saguenay type,270550];	RCV000118229.3 [other]; RCV000270430.1 [benign]; 			3822	10					SACS (inh=AR pLI=0.00)
chr13	23908034	23908034	A	G	het	anno_omim	QUAL=14080;DP=403;AF=0.52;MQM=60;TRIO=HET,403,0.52,WT,198,0.00,HOM,259,1.00	SACS	synonymous	SACS:ENST00000382292:synonymous:LOW:exon9/9:c.9981T>C:p.Ala3327Ala,SACS:ENST00000402364:synonymous:LOW:exon8/8:c.7731T>C:p.Ala2577Ala,SACS:ENST00000382298:synonymous:LOW:exon10/10:c.9981T>C:p.Ala3327Ala		rs2737700	0.3387	0.4061	10250,6340,153	0.1697,0.4234,0.3995,0.4383,0.3948	0.4116							604490 [SACS (provisional) Spastic ataxia,Charlevoix-Saguenay type,270550];	RCV000118235.3 [other]; RCV000331174.1 [likely benign]; 		COSM3999043	654	1829					SACS (inh=AR pLI=0.00)
chr13	23929095	23929095	T	C	het	anno_omim	QUAL=9491;DP=327;AF=0.50;MQM=60;TRIO=HET,327,0.50,HOM,164,0.98,WT,249,0.00	SACS	synonymous,5'UTR_premature_start_codon_gain,5'UTR	SACS:ENST00000382292:synonymous:LOW:exon7/9:c.1656A>G:p.Leu552Leu,SACS:ENST00000382298:synonymous:LOW:exon8/10:c.1656A>G:p.Leu552Leu,SACS:ENST00000402364:5'UTR_premature_start_codon_gain:LOW:exon6/8:c.-595A>G:,SACS:ENST00000402364:5'UTR:MODIFIER:exon6/8:c.-595A>G:		rs1536365	0.0867	0.1140	873,525,2	0.0196,0.0861,0.1160,0.1241,0.1345	0.1123	-0.2340		T			0.63	604490 [SACS (provisional) Spastic ataxia,Charlevoix-Saguenay type,270550];	RCV000118231.3 [other]; RCV000321187.1 [likely benign]; 		COSM3753620, COSM3753621	67	794					SACS (inh=AR pLI=0.00)
chr13	23930055	23930055	A	T	het	pred_pathogenic;anno_omim	QUAL=9434;DP=392;AF=0.45;MQM=60;TRIO=HET,392,0.45,HOM,155,0.99,WT,249,0.01	SACS	missense,5'UTR	SACS:ENST00000382292:missense:MODERATE:exon7/9:c.696T>A:p.Asn232Lys,SACS:ENST00000382298:missense:MODERATE:exon8/10:c.696T>A:p.Asn232Lys,SACS:ENST00000402364:5'UTR:MODIFIER:exon6/8:c.-1555T>A:		rs2031640	0.0865	0.1145	871,522,2	0.0196,0.0865,0.1157,0.1246,0.1346	0.1122	0.5360	T,T,.	T,T	P,P,B,.	D,D,.	22.80	604490 [SACS (provisional) Spastic ataxia,Charlevoix-Saguenay type,270550];	RCV000118233.3 [other]; RCV000304888.1 [likely benign]; 		COSM3753622, COSM3753623	65	797					SACS (inh=AR pLI=0.00)
chr13	23949252	23949252	G	A	het	low_DP;anno_omim	QUAL=677;DP=15;AF=0.27;MQM=60;TRIO=HET,15,0.27,WT,33,0.00,HET,62,0.50	SACS	splice_region&intron	SACS:ENST00000382292:splice_region&intron:LOW:exon2/8:c.171+6C>T:,SACS:ENST00000402364:splice_region&intron:LOW:exon2/7:c.-1992+6C>T:,SACS:ENST00000382298:splice_region&intron:LOW:exon3/9:c.171+6C>T:		rs3751368	0.0895	0.1047	69,30,1	0.0584,0.0000,0.0000,0.1654,0.0819	0.1614							604490 [SACS (provisional) Spastic ataxia,Charlevoix-Saguenay type,270550];	RCV000242640.1 [benign]; RCV000300554.1 [likely benign]; 			100	1001					SACS (inh=AR pLI=0.00)
chr13	24007783	24007783	C	T	het	anno_omim	QUAL=3459;DP=142;AF=0.56;MQM=60;TRIO=HET,142,0.56,HET,133,0.52,WT,178,0.00	SACS	5'UTR	SACS:ENST00000382298:5'UTR:MODIFIER:exon1/10:c.-531G>A:		rs73154650	0.0300	0.0000	0,0,0	0,0,0,0,0	0.0281							604490 [SACS (provisional) Spastic ataxia,Charlevoix-Saguenay type,270550];	RCV000342904.1 [uncertain significance]; 			0	15					SACS (inh=AR pLI=0.00)
chr13	25456631	25456631	-	T	het	anno_omim	QUAL=8249;DP=403;AF=0.43;MQM=59;TRIO=HET,403,0.43,WT,307,0.00,HET,351,0.48	RNF17,CENPJ	intergenic_region	CENPJ:ENSG00000132972-ENSG00000151849:intergenic_region:MODIFIER::n.25456631_25456632insT:		rs397718122;rs58955593	0.3239	0.0000	0,0,0	0,0,0,0,0	0.3391							609279 [CENPJ (confirmed) Microcephaly 6,primary,autosomal recessive,608393|Seckel syndrome 4,613676];	RCV000273764.1 [benign]; RCV000368335.1 [benign]; 			30	116					RNF17 (inh=n/a pLI=1.00), CENPJ (inh=AR pLI=0.00)
chr13	25457005	25457007	CTT	-	het	anno_omim	QUAL=5832;DP=319;AF=0.54;MQM=59;TRIO=HET,319,0.54,HET,171,0.54,WT,186,0.00	RNF17,CENPJ	intergenic_region	CENPJ:ENSG00000132972-ENSG00000151849:intergenic_region:MODIFIER::n.25457005_25457007delCTT:		rs796638364	0.1587	0.0000	0,0,0	0,0,0,0,0	0.2388							609279 [CENPJ (confirmed) Microcephaly 6,primary,autosomal recessive,608393|Seckel syndrome 4,613676];	RCV000306011.1 [benign]; RCV000360685.1 [benign]; 			27	85					RNF17 (inh=n/a pLI=1.00), CENPJ (inh=AR pLI=0.00)
chr13	25457207	25457207	T	C	hom	anno_omim	QUAL=18779;DP=270;AF=1.00;MQM=60;TRIO=HOM,270,1.00,HOM,124,1.00,HOM,180,1.00	CENPJ	3'UTR	CENPJ:ENST00000381884:3'UTR:MODIFIER:exon17/17:c.*108A>G:,CENPJ:ENST00000545981:3'UTR:MODIFIER:exon16/16:c.*779A>G:		rs9318911	0.9667	0.0000	0,0,0	0,0,0,0,0	0.9822							609279 [CENPJ (confirmed) Microcephaly 6,primary,autosomal recessive,608393|Seckel syndrome 4,613676];				231	1					CENPJ (inh=AR pLI=0.00)
chr13	25466774	25466774	T	C	hom	anno_omim	QUAL=7049;DP=88;AF=1.00;MQM=59;TRIO=HOM,88,1.00,HOM,88,1.00,HET,121,0.55	CENPJ	splice_region&intron	CENPJ:ENST00000381884:splice_region&intron:LOW:exon10/16:c.3216+7A>G:,CENPJ:ENST00000545981:splice_region&intron:LOW:exon10/15:c.3216+7A>G:		rs9318917	0.7372	0.8036	39655,23064,2190	0.6509,0.8895,0.8460,0.8302,0.6726	0.8090							609279 [CENPJ (confirmed) Microcephaly 6,primary,autosomal recessive,608393|Seckel syndrome 4,613676];	RCV000145574.5 [benign]; RCV000342658.1 [benign]; RCV000395412.1 [benign]; 			1345	654					CENPJ (inh=AR pLI=0.00)
chr13	25466955	25466955	T	C	het	anno_omim	QUAL=6907;DP=226;AF=0.48;MQM=60;TRIO=HET,226,0.48,HET,148,0.47,HET,190,0.56	CENPJ	synonymous	CENPJ:ENST00000381884:synonymous:LOW:exon10/17:c.3042A>G:p.Glu1014Glu,CENPJ:ENST00000545981:synonymous:LOW:exon10/16:c.3042A>G:p.Glu1014Glu		rs3742165	0.4840	0.5395	18371,9675,435	0.2882,0.6548,0.7101,0.5368,0.4977	0.5495	0.1810		T			3.16	609279 [CENPJ (confirmed) Microcephaly 6,primary,autosomal recessive,608393|Seckel syndrome 4,613676];	RCV000145573.3 [benign]; RCV000298966.1 [benign]; RCV000402333.1 [benign]; 		COSM4147658	595	1021					CENPJ (inh=AR pLI=0.00)
chr13	32676114	32676114	A	G	het		QUAL=6562;DP=292;AF=0.47;MQM=60;TRIO=HET,292,0.47,HET,186,0.56,WT,252,0.01	FRY	synonymous	FRY:ENST00000380250:synonymous:LOW:exon3/61:c.285A>G:p.Thr95Thr		rs364995	0.5815	0.6047	22418,13360,1665	0.5901,0.5088,0.3820,0.6313,0.6533	0.6131										COSM3753642, COSM3753641	833	968					FRY (inh=n/a pLI=1.00)
chr13	32758834	32758834	A	G	het		QUAL=5146;DP=201;AF=0.49;MQM=60;TRIO=HET,201,0.49,HOM,80,1.00,WT,111,0.01	FRY	splice_region&intron	FRY:ENST00000380250:splice_region&intron:LOW:exon25/60:c.3146+6A>G:		rs798971	0.8217	0.7885	37731,18675,2948	0.7753,0.7723,0.9892,0.7491,0.8482	0.7882											1221	767					FRY (inh=n/a pLI=1.00)
chr13	32776603	32776603	T	C	het		QUAL=5456;DP=242;AF=0.50;MQM=59;TRIO=HET,242,0.50,HET,181,0.51,WT,249,0.00	FRY	synonymous	FRY:ENST00000380250:synonymous:LOW:exon31/61:c.3957T>C:p.Leu1319Leu		rs2428249	0.3458	0.3848	9423,5682,866	0.4216,0.4598,0.1631,0.4110,0.2762	0.4209										COSM3765691	284	979					FRY (inh=n/a pLI=1.00)
chr13	32811607	32811607	G	A	hom	pred_pathogenic	QUAL=16321;DP=177;AF=0.99;MQM=60;TRIO=HOM,177,0.99,HOM,231,1.00,HET,302,0.52	FRY	missense	FRY:ENST00000380250:missense:MODERATE:exon44/61:c.5902G>A:p.Gly1968Ser		rs2806639	0.2159	0.2811	5441,3587,546	0.3297,0.2705,0.0013,0.3271,0.1664	0.3323	1.8580	T,T	T	B	T	15.05					185	895					FRY (inh=n/a pLI=1.00)
chr13	32890572	32890572	G	A	het	anno_omim	QUAL=6867;DP=301;AF=0.52;MQM=60;TRIO=HET,301,0.52,HET,200,0.50,WT,239,0.00	BRCA2	5'UTR	BRCA2:ENST00000380152:5'UTR:MODIFIER:exon2/27:c.-26G>A:,BRCA2:ENST00000544455:5'UTR:MODIFIER:exon2/28:c.-26G>A:		rs1799943	0.2093	0.2465	3755,2063,51	0.1005,0.1895,0.3805,0.2581,0.2829	0.2455							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	RCV000112977.3 [benign]; RCV000114981.1 [not provided]; RCV000246798.1 [benign]; RCV000312794.1 [benign]; RCV000397056.1 [benign]; 	CR068211 [CLASS=DFP MUT=ALT PHEN="Breast cancer sporadic protection against" GENE=BRCA2]; 		268	1586					BRCA2 (inh=AR+AD pLI=0.00)
chr13	32906729	32906729	A	C	het	anno_omim	QUAL=10264;DP=395;AF=0.51;MQM=60;TRIO=HET,395,0.51,HET,133,0.54,HET,193,0.51	BRCA2	missense	BRCA2:ENST00000380152:missense:MODERATE:exon10/27:c.1114A>C:p.Asn372His,BRCA2:ENST00000544455:missense:MODERATE:exon10/28:c.1114A>C:p.Asn372His		rs144848	0.2494	0.2779	4939,2667,82	0.1249,0.3049,0.2728,0.2819,0.3558	0.2795	0.7570	T,T,T	T		T,T	0.01	600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	RCV000009916.7 [benign]; RCV000034427.1 [benign]; RCV000120303.6 [benign]; RCV000130720.3 [benign]; RCV000207052.1 [uncertain significance]; RCV000260146.1 [benign]; RCV000320173.1 [benign]; 	CM002750 [CLASS=DFP MUT=ALT PHEN="Breast cancer association with" GENE=BRCA2]; 	COSM147663, COSM3753646	350	1732	1	[1] old entry - no details available			BRCA2 (inh=AR+AD pLI=0.00)
chr13	32911888	32911888	A	G	het	anno_omim	QUAL=6648;DP=349;AF=0.51;MQM=59;TRIO=HET,349,0.51,HET,118,0.56,WT,158,0.00	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous:LOW:exon11/27:c.3396A>G:p.Lys1132Lys,BRCA2:ENST00000544455:synonymous:LOW:exon11/28:c.3396A>G:p.Lys1132Lys		rs1801406	0.2668	0.2945	5391,3115,273	0.2292,0.2087,0.3848,0.3064,0.2924	0.2984							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	RCV000113170.4 [benign]; RCV000114982.2 [benign]; RCV000130987.2 [benign]; RCV000152873.5 [benign]; RCV000337515.1 [benign]; RCV000375777.1 [benign]; 			417	1892	1	[1] Ulrike Faust 13.06.2015			BRCA2 (inh=AR+AD pLI=0.00)
chr13	32913055	32913055	A	G	hom	anno_omim	QUAL=17062;DP=273;AF=1.00;MQM=60;TRIO=HOM,273,1.00,HOM,115,1.00,HOM,123,1.00	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous:LOW:exon11/27:c.4563A>G:p.Leu1521Leu,BRCA2:ENST00000544455:synonymous:LOW:exon11/28:c.4563A>G:p.Leu1521Leu		rs206075	0.9740	0.9931	59672,33182,4417	0.9264,0.9967,0.9999,0.9995,0.9999	0.9945							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	RCV000119245.2 [benign]; RCV000132170.2 [benign]; RCV000152875.8 [benign]; RCV000257902.2 [benign]; RCV000340564.1 [benign]; 			4344	18	1	[1] Ulrike Faust 13.06.2015			BRCA2 (inh=AR+AD pLI=0.00)
chr13	32915005	32915005	G	C	hom	anno_omim	QUAL=26943;DP=415;AF=1.00;MQM=59;TRIO=HOM,415,1.00,HOM,165,1.00,HOM,228,1.00	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous:LOW:exon11/27:c.6513G>C:p.Val2171Val,BRCA2:ENST00000544455:synonymous:LOW:exon11/28:c.6513G>C:p.Val2171Val		rs206076	0.9736	0.9930	59677,33272,4398	0.9253,0.9967,0.9999,0.9995,0.9998	0.9943							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	RCV000119246.2 [benign]; RCV000152878.8 [benign]; RCV000162377.1 [benign]; RCV000257903.2 [benign]; RCV000261979.1 [benign]; 		COSM4147690, COSM4147689	4345	20	1	[1] old entry - no details available			BRCA2 (inh=AR+AD pLI=0.00)
chr13	32929232	32929232	A	G	het	anno_omim	QUAL=10727;DP=475;AF=0.49;MQM=60;TRIO=HET,475,0.49,HET,387,0.45,WT,505,0.00	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous:LOW:exon14/27:c.7242A>G:p.Ser2414Ser,BRCA2:ENST00000544455:synonymous:LOW:exon14/28:c.7242A>G:p.Ser2414Ser		rs1799955	0.2326	0.2244	3228,1556,231	0.2116,0.1796,0.3847,0.2143,0.2161	0.2299							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	RCV000113739.4 [benign]; RCV000123992.2 [benign]; RCV000130994.2 [benign]; RCV000152882.5 [benign]; RCV000336026.1 [benign]; RCV000394273.1 [benign]; 			214	1568	1	[1] Ulrike Faust 13.06.2015			BRCA2 (inh=AR+AD pLI=0.00)
chr13	32929387	32929387	T	C	hom	pred_pathogenic;anno_omim	QUAL=25309;DP=291;AF=1.00;MQM=60;TRIO=HOM,291,1.00,HOM,219,1.00,HOM,281,1.00	BRCA2	missense	BRCA2:ENST00000380152:missense:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala,BRCA2:ENST00000544455:missense:MODERATE:exon14/28:c.7397T>C:p.Val2466Ala		rs169547	0.9758	0.9937	59912,33304,4522	0.9330,0.9970,0.9999,0.9996,0.9998	0.9950	2.3530	T,T	T		T,T	0.37	600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	RCV000120357.6 [benign]; RCV000207137.1 [uncertain significance]; 			4348	18	2	[2] old entry - no details available			BRCA2 (inh=AR+AD pLI=0.00)
chr13	32973439	32973439	A	G	het	anno_omim	QUAL=5679;DP=295;AF=0.47;MQM=60;TRIO=HET,295,0.47,HET,154,0.46,WT,195,0.00	BRCA2	intron	BRCA2:ENST00000544455:intron:MODIFIER:exon27/27:c.*440+92A>G:		rs11571836	0.1975	0.0000	0,0,0	0,0,0,0,0	0.1982							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	RCV000191876.1 [benign]; RCV000279399.1 [benign]; RCV000341382.1 [benign]; 			15	111					BRCA2 (inh=AR+AD pLI=0.00)
chr13	32973737	32973737	T	-	het	anno_omim	QUAL=2483;DP=210;AF=0.43;MQM=59;TRIO=HET,210,0.43,HET,45,0.42,WT,86,0.02	BRCA2	splice_region,3'UTR	BRCA2:ENST00000544455:splice_region:LOW:exon28/28:c.*441delT:,BRCA2:ENST00000544455:3'UTR:MODIFIER:exon28/28:c.*441delT:		rs139813105	0.2310	0.0000	0,0,0	0,0,0,0,0	0.2351							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	RCV000254751.1 [benign]; RCV000273874.1 [benign]; RCV000370559.1 [benign]; 			15	112					BRCA2 (inh=AR+AD pLI=0.00)
chr13	36877519	36877519	-	ATA	het	anno_omim	QUAL=4900;DP=309;AF=0.48;MQM=59;TRIO=HET,309,0.48,HET,90,0.50,WT,147,0.00	SPG20	3'UTR	SPG20:ENST00000355182:3'UTR:MODIFIER:exon9/9:c.*980_*982dupTAT:,SPG20:ENST00000438666:3'UTR:MODIFIER:exon9/9:c.*980_*982dupTAT:,SPG20:ENST00000451493:3'UTR:MODIFIER:exon9/9:c.*980_*982dupTAT:		rs200142976	0.0040	0.0000	0,0,0	0,0,0,0,0	0.0050							607111 [SPG20 (provisional) Troyer syndrome,275900];				0	8					SPART (inh=AR pLI=0.00)
chr13	36877656	36877656	C	T	het	anno_omim	QUAL=1731;DP=116;AF=0.53;MQM=59;TRIO=HET,116,0.53,WT,22,0.00,HET,28,0.36	SPG20	3'UTR	SPG20:ENST00000355182:3'UTR:MODIFIER:exon9/9:c.*846G>A:,SPG20:ENST00000438666:3'UTR:MODIFIER:exon9/9:c.*846G>A:,SPG20:ENST00000451493:3'UTR:MODIFIER:exon9/9:c.*846G>A:		rs1054152	0.1382	0.0000	0,0,0	0,0,0,0,0	0.1654							607111 [SPG20 (provisional) Troyer syndrome,275900];	RCV000265378.1 [likely benign]; 			10	72					SPART (inh=AR pLI=0.00)
chr13	36877878	36877878	T	C	hom	anno_omim	QUAL=12135;DP=165;AF=0.99;MQM=60;TRIO=HOM,165,0.99,HOM,100,1.00,HOM,102,1.00	SPG20	3'UTR	SPG20:ENST00000355182:3'UTR:MODIFIER:exon9/9:c.*624A>G:,SPG20:ENST00000438666:3'UTR:MODIFIER:exon9/9:c.*624A>G:,SPG20:ENST00000451493:3'UTR:MODIFIER:exon9/9:c.*624A>G:,SPG20:ENST00000494062:3'UTR:MODIFIER:exon10/10:c.*624A>G:		rs2148049	0.9890	0.0000	0,0,0	0,0,0,0,0	0.9895							607111 [SPG20 (provisional) Troyer syndrome,275900];	RCV000380694.1 [benign]; 			232	0					SPART (inh=AR pLI=0.00)
chr13	36920849	36920849	-	C	het	anno_omim	QUAL=1899;DP=48;AF=0.54;MQM=60;TRIO=HET,48,0.54,WT,199,0.00,HET,235,0.45	SPG20,SPG20OS	5'UTR,intron	SPG20:ENST00000451493:5'UTR:MODIFIER:exon1/9:c.-134dupG:,SPG20:ENST00000355182:intron:MODIFIER:exon1/8:c.-2-10881dupG:,SPG20OS:ENST00000379848:intron:MODIFIER:exon1/3:c.-88+212dupC:		rs146524559	0.2800	0.0000	0,0,0	0,0,0,0,0	0.3505							607111 [SPG20 (provisional) Troyer syndrome,275900];				40	94					SPART (inh=AR pLI=0.00), SPART-AS1 (inh=n/a pLI=n/a)
chr13	36920890	36920890	G	C	hom	anno_omim	QUAL=12961;DP=44;AF=0.98;MQM=59;TRIO=HOM,44,0.98,HOM,164,1.00,HOM,217,1.00	SPG20,SPG20OS	5'UTR,intron	SPG20:ENST00000451493:5'UTR:MODIFIER:exon1/9:c.-174C>G:,SPG20:ENST00000355182:intron:MODIFIER:exon1/8:c.-2-10921C>G:,SPG20OS:ENST00000379848:intron:MODIFIER:exon1/3:c.-88+246G>C:		rs4943362	1.0000	0.0000	0,0,0	0,0,0,0,0	1.0000							607111 [SPG20 (provisional) Troyer syndrome,275900];				232	0					SPART (inh=AR pLI=0.00), SPART-AS1 (inh=n/a pLI=n/a)
chr13	36944274	36944274	C	T	het	low_DP;anno_omim	QUAL=145;DP=13;AF=0.46;MQM=60;TRIO=HET,13,0.46,HOM,1,1.00,HOM,1,1.00	SPG20	5'UTR	SPG20:ENST00000355182:5'UTR:MODIFIER:exon1/9:c.-51G>A:		rs4287440	0.7476	0.0000	0,0,0	0,0,0,0,0	0.6938							607111 [SPG20 (provisional) Troyer syndrome,275900];				88	77					SPART (inh=AR pLI=0.00)
chr13	37401918	37401918	T	-	hom	anno_omim	QUAL=21338;DP=228;AF=1.00;MQM=59;TRIO=HOM,228,1.00,HOM,186,0.99,HOM,264,1.00	RFXAP	3'UTR	RFXAP:ENST00000255476:3'UTR:MODIFIER:exon3/3:c.*33delT:		rs398022347	0.8011	0.8784	45811,27682,2680	0.7342,0.8425,0.7124,0.9239,0.8834	0.8793							601861 [RFXAP (provisional) Bare lymphocyte syndrome,type II,complementation group D,209920];	RCV000375835.1 [benign]; 			1615	341					RFXAP (inh=AR+AD pLI=0.44)
chr13	37402440	37402440	T	C	hom	anno_omim	QUAL=19274;DP=297;AF=1.00;MQM=59;TRIO=HOM,297,1.00,HOM,123,1.00,HOM,156,1.00	RFXAP	3'UTR	RFXAP:ENST00000255476:3'UTR:MODIFIER:exon3/3:c.*550T>C:		rs9547679	0.7961	0.0000	0,0,0	0,0,0,0,0	0.8453							601861 [RFXAP (provisional) Bare lymphocyte syndrome,type II,complementation group D,209920];	RCV000285256.1 [benign]; 			178	51					RFXAP (inh=AR+AD pLI=0.44)
chr13	37403143	37403143	G	A	het	anno_omim	QUAL=8686;DP=349;AF=0.48;MQM=59;TRIO=HET,349,0.48,WT,202,0.00,HET,313,0.51	RFXAP	3'UTR	RFXAP:ENST00000255476:3'UTR:MODIFIER:exon3/3:c.*1253G>A:		rs10976	0.1414	0.0000	0,0,0	0,0,0,0,0	0.1731							601861 [RFXAP (provisional) Bare lymphocyte syndrome,type II,complementation group D,209920];	RCV000408366.1 [likely benign]; 			10	69					RFXAP (inh=AR+AD pLI=0.44)
chr13	39262057	39262057	G	A	hom	anno_omim	QUAL=15525;DP=93;AF=1.00;MQM=60;TRIO=HOM,93,1.00,HOM,181,1.00,HOM,231,1.00	FREM2	synonymous	FREM2:ENST00000280481:synonymous:LOW:exon1/24:c.576G>A:p.Glu192Glu		rs1868464	1.0000	1.0000	45999,24829,3896	0.9996,1.0000,1.0000,1.0000,1.0000	1.0000							608945 [FREM2 (provisional) Fraser syndrome,219000];	RCV000250281.1 [benign]; RCV000347448.1 [benign]; 		COSM4147704	2114	0					FREM2 (inh=AR pLI=0.00)
chr13	39263714	39263714	T	C	hom	pred_pathogenic;anno_omim	QUAL=33208;DP=333;AF=1.00;MQM=59;TRIO=HOM,333,1.00,HOM,325,1.00,HOM,416,1.00	FREM2	missense	FREM2:ENST00000280481:missense:MODERATE:exon1/24:c.2233T>C:p.Ser745Pro		rs2496423	1.0000	1.0000	60494,33299,5198	0.9997,1.0000,1.0000,1.0000,0.9999	1.0000	3.1680	T	T	B	T	5.98	608945 [FREM2 (provisional) Fraser syndrome,219000];	RCV000173610.2 [benign]; RCV000357309.1 [benign]; 			2113	0					FREM2 (inh=AR pLI=0.00)
chr13	39264690	39264690	T	C	het	anno_omim	QUAL=12315;DP=398;AF=0.47;MQM=59;TRIO=HET,398,0.47,HET,214,0.48,HET,282,0.57	FREM2	missense	FREM2:ENST00000280481:missense:MODERATE:exon1/24:c.3209T>C:p.Phe1070Ser		rs2496425	0.4812	0.3473	8569,2562,3014	0.7606,0.4399,0.4028,0.2748,0.3002	0.4251	0.9280	T	T	B	T	6.48	608945 [FREM2 (provisional) Fraser syndrome,219000];	RCV000173599.1 [benign]; RCV000380412.1 [benign]; 	CM065186 [CLASS=DP MUT=ALT PHEN="Colorectal cancer increased risk association with" GENE=FREM2]; 	COSM1366801	196	851					FREM2 (inh=AR pLI=0.00)
chr13	39343822	39343822	C	T	het	pred_pathogenic;anno_omim	QUAL=9392;DP=318;AF=0.48;MQM=60;TRIO=HET,318,0.48,HET,178,0.49,HET,297,0.47	FREM2	missense	FREM2:ENST00000280481:missense:MODERATE:exon4/24:c.5518C>T:p.Arg1840Trp		rs9603422	0.1418	0.1215	1023,437,259	0.2203,0.0537,0.1719,0.1155,0.1246	0.1409	0.8450	D	T	D	T	24.10	608945 [FREM2 (provisional) Fraser syndrome,219000];	RCV000301753.1 [likely benign]; 			50	449					FREM2 (inh=AR pLI=0.00)
chr13	39422624	39422624	C	T	het	pred_pathogenic;anno_omim	QUAL=3261;DP=136;AF=0.48;MQM=60;TRIO=HET,136,0.48,WT,126,0.00,HET,124,0.52	FREM2	missense	FREM2:ENST00000280481:missense:MODERATE:exon8/24:c.6196C>T:p.Arg2066Cys		rs9548505	0.1096	0.1224	1333,348,104	0.1405,0.3419,0.0007,0.1000,0.1281	0.1314	4.8040	D	T	P,D	T	35.00	608945 [FREM2 (provisional) Fraser syndrome,219000];	RCV000288508.1 [benign]; 		COSM3753678	33	397					FREM2 (inh=AR pLI=0.00)
chr13	39424253	39424253	C	G	het	pred_pathogenic;anno_omim	QUAL=3222;DP=225;AF=0.45;MQM=60;TRIO=HET,225,0.45,WT,60,0.00,HET,66,0.47	FREM2	missense	FREM2:ENST00000280481:missense:MODERATE:exon9/24:c.6458C>G:p.Thr2153Ser		rs9548506	0.0919	0.1172	1225,338,35	0.0843,0.3376,0.0007,0.1000,0.1280	0.1270	3.4960	T	T	B,B	T	0.46	608945 [FREM2 (provisional) Fraser syndrome,219000];	RCV000391684.1 [benign]; 		COSM3753679	32	393					FREM2 (inh=AR pLI=0.00)
chr13	39424254	39424254	T	C	het	anno_omim	QUAL=3222;DP=225;AF=0.45;MQM=60;TRIO=HET,225,0.45,WT,60,0.00,HET,66,0.47	FREM2	synonymous	FREM2:ENST00000280481:synonymous:LOW:exon9/24:c.6459T>C:p.Thr2153Thr		rs9548507	0.0919	0.1172	1223,337,35	0.0843,0.3375,0.0007,0.0999,0.1280	0.1270							608945 [FREM2 (provisional) Fraser syndrome,219000];	RCV000300256.1 [benign]; 		COSM3753680	32	393					FREM2 (inh=AR pLI=0.00)
chr13	39430314	39430314	C	T	het	pred_pathogenic;anno_omim	QUAL=15444;DP=264;AF=0.44;MQM=60;TRIO=HET,264,0.44,HET,191,0.57,HOM,292,1.00	FREM2	missense	FREM2:ENST00000280481:missense:MODERATE:exon12/24:c.6977C>T:p.Thr2326Ile		rs9548509	0.7720	0.7398	33703,16210,2911	0.7502,0.8477,0.9726,0.6953,0.7147	0.7477	6.1370	T	T	B,B	T	14.53	608945 [FREM2 (provisional) Fraser syndrome,219000];	RCV000241670.1 [benign]; RCV000369162.1 [benign]; 		COSM432379	1025	891					FREM2 (inh=AR pLI=0.00)
chr13	39433606	39433606	A	G	het	anno_omim	QUAL=27482;DP=416;AF=0.53;MQM=60;TRIO=HET,416,0.53,WT,496,0.00,HOM,709,0.99	FREM2	synonymous	FREM2:ENST00000280481:synonymous:LOW:exon14/24:c.7398A>G:p.Thr2466Thr		rs9532292	0.4367	0.3734	9063,3345,1621	0.5602,0.4937,0.3913,0.3136,0.4486	0.3789							608945 [FREM2 (provisional) Fraser syndrome,219000];	RCV000244828.1 [benign]; RCV000381500.1 [benign]; 		COSM3753681	270	964					FREM2 (inh=AR pLI=0.00)
chr13	39455916	39455916	T	C	het	anno_omim	QUAL=10901;DP=472;AF=0.49;MQM=60;TRIO=HET,472,0.49,WT,191,0.01,HET,325,0.51	FREM2	3'UTR	FREM2:ENST00000280481:3'UTR:MODIFIER:exon24/24:c.*992T>C:		rs9532297	0.0845	0.0000	0,0,0	0,0,0,0,0	0.0818							608945 [FREM2 (provisional) Fraser syndrome,219000];	RCV000407772.1 [benign]; 			4	43					FREM2 (inh=AR pLI=0.00)
chr13	39455965	39455965	C	T	het	anno_omim	QUAL=10593;DP=491;AF=0.45;MQM=60;TRIO=HET,491,0.45,WT,232,0.00,HET,349,0.49	FREM2	3'UTR	FREM2:ENST00000280481:3'UTR:MODIFIER:exon24/24:c.*1041C>T:		rs9548521	0.0675	0.0000	0,0,0	0,0,0,0,0	0.0661							608945 [FREM2 (provisional) Fraser syndrome,219000];	RCV000304836.1 [likely benign]; 			3	31					FREM2 (inh=AR pLI=0.00)
chr13	39456352	39456352	A	G	het	anno_omim	QUAL=9492;DP=408;AF=0.45;MQM=59;TRIO=HET,408,0.45,HET,165,0.52,HET,176,0.49	FREM2	3'UTR	FREM2:ENST00000280481:3'UTR:MODIFIER:exon24/24:c.*1428A>G:		rs9548522	0.4339	0.0000	0,0,0	0,0,0,0,0	0.4715							608945 [FREM2 (provisional) Fraser syndrome,219000];	RCV000263845.1 [benign]; 			51	124					FREM2 (inh=AR pLI=0.00)
chr13	39456391	39456391	G	A	het	anno_omim	QUAL=7839;DP=443;AF=0.47;MQM=60;TRIO=HET,443,0.47,WT,165,0.00,HET,177,0.49	FREM2	3'UTR	FREM2:ENST00000280481:3'UTR:MODIFIER:exon24/24:c.*1467G>A:		rs9548523	0.0675	0.0000	0,0,0	0,0,0,0,0	0.0662							608945 [FREM2 (provisional) Fraser syndrome,219000];	RCV000316827.1 [likely benign]; 			3	31					FREM2 (inh=AR pLI=0.00)
chr13	39457064	39457064	C	G	het	anno_omim	QUAL=18088;DP=627;AF=0.49;MQM=60;TRIO=HET,627,0.49,HET,298,0.50,HET,416,0.51	FREM2	3'UTR	FREM2:ENST00000280481:3'UTR:MODIFIER:exon24/24:c.*2140C>G:		rs7324632	0.4339	0.0000	0,0,0	0,0,0,0,0	0.4721							608945 [FREM2 (provisional) Fraser syndrome,219000];	RCV000341891.1 [benign]; 			51	124					FREM2 (inh=AR pLI=0.00)
chr13	39459389	39459389	C	T	het	anno_omim	QUAL=6613;DP=194;AF=0.43;MQM=59;TRIO=HET,194,0.43,HET,96,0.46,HOM,100,1.00	FREM2	3'UTR	FREM2:ENST00000280481:3'UTR:MODIFIER:exon24/24:c.*4465C>T:		rs2027770	0.7474	0.0000	0,0,0	0,0,0,0,0	0.7430							608945 [FREM2 (provisional) Fraser syndrome,219000];	RCV000315258.1 [benign]; 			98	111					FREM2 (inh=AR pLI=0.00)
chr13	39460259	39460259	A	G	het	anno_omim	QUAL=4047;DP=224;AF=0.47;MQM=60;TRIO=HET,224,0.47,WT,78,0.00,HET,93,0.49	FREM2,PLA2G12AP2	intergenic_region	PLA2G12AP2:ENSG00000150893-ENSG00000225221:intergenic_region:MODIFIER::n.39460259A>G:		rs9548524	0.0843	0.0000	0,0,0	0,0,0,0,0	0.0816							608945 [FREM2 (provisional) Fraser syndrome,219000];	RCV000279086.1 [benign]; 			4	43					FREM2 (inh=AR pLI=0.00), PLA2G12AP2 (inh=n/a pLI=n/a)
chr13	39460415	39460415	G	A	het	anno_omim	QUAL=13061;DP=353;AF=0.48;MQM=59;TRIO=HET,353,0.48,HET,133,0.56,HOM,201,1.00	FREM2,PLA2G12AP2	intergenic_region	PLA2G12AP2:ENSG00000150893-ENSG00000225221:intergenic_region:MODIFIER::n.39460415G>A:		rs2226913	0.7504	0.0000	0,0,0	0,0,0,0,0	0.7451							608945 [FREM2 (provisional) Fraser syndrome,219000];	RCV000320239.1 [benign]; 			98	110					FREM2 (inh=AR pLI=0.00), PLA2G12AP2 (inh=n/a pLI=n/a)
chr13	39460486	39460486	C	G	het	anno_omim	QUAL=8979;DP=276;AF=0.51;MQM=59;TRIO=HET,276,0.51,HET,148,0.53,HET,203,0.61	FREM2,PLA2G12AP2	intergenic_region	PLA2G12AP2:ENSG00000150893-ENSG00000225221:intergenic_region:MODIFIER::n.39460486C>G:	(ATAC)n	rs1945507	0.4341	0.0000	0,0,0	0,0,0,0,0	0.4677							608945 [FREM2 (provisional) Fraser syndrome,219000];	RCV000295552.1 [benign]; 			51	122					FREM2 (inh=AR pLI=0.00), PLA2G12AP2 (inh=n/a pLI=n/a)
chr13	39460540	39460540	T	-	het	anno_omim	QUAL=4247;DP=114;AF=0.45;MQM=59;TRIO=HET,114,0.45,HET,89,0.52,HOM,101,0.93	FREM2,PLA2G12AP2	intergenic_region	PLA2G12AP2:ENSG00000150893-ENSG00000225221:intergenic_region:MODIFIER::n.39460540delT:	AluSp	rs5802961	0.7486	0.0000	0,0,0	0,0,0,0,0	0.7383							608945 [FREM2 (provisional) Fraser syndrome,219000];	RCV000385673.1 [benign]; 			71	91					FREM2 (inh=AR pLI=0.00), PLA2G12AP2 (inh=n/a pLI=n/a)
chr13	39460657	39460657	C	T	het	anno_omim	QUAL=3444;DP=153;AF=0.50;MQM=59;TRIO=HET,153,0.50,HET,41,0.56,HET,61,0.54	FREM2,PLA2G12AP2	intergenic_region	PLA2G12AP2:ENSG00000150893-ENSG00000225221:intergenic_region:MODIFIER::n.39460657C>T:	AluSp	rs1945505	0.4343	0.0000	0,0,0	0,0,0,0,0	0.4734							608945 [FREM2 (provisional) Fraser syndrome,219000];	RCV000382194.1 [benign]; 			40	94					FREM2 (inh=AR pLI=0.00), PLA2G12AP2 (inh=n/a pLI=n/a)
chr13	41382711	41382711	A	T	het	anno_omim	QUAL=4536;DP=166;AF=0.54;MQM=55;TRIO=HET,166,0.54,WT,153,0.00,HET,185,0.48	SLC25A15	missense	SLC25A15:ENST00000338625:missense:MODERATE:exon6/7:c.760A>T:p.Ile254Leu		rs17849654	0.3227	0.3725	8648,5828,193	0.1958,0.3438,0.3651,0.4208,0.2749	0.3764	1.3490	T,T	T	B,B	T	0.01	603861 [SLC25A15 (confirmed) Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome,238970];	RCV000128071.2 [benign]; RCV000273122.1 [benign]; 		COSM3753692	571	1509					SLC25A15 (inh=AR pLI=0.00)
chr13	41384156	41384156	A	G	het	anno_omim	QUAL=6076;DP=241;AF=0.53;MQM=59;TRIO=HET,241,0.53,WT,165,0.01,HET,213,0.51	SLC25A15	3'UTR	SLC25A15:ENST00000338625:3'UTR:MODIFIER:exon7/7:c.*353A>G:		rs9549293	0.4237	0.0000	0,0,0	0,0,0,0,0	0.3888							603861 [SLC25A15 (confirmed) Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome,238970];	RCV000372205.1 [benign]; 			55	129					SLC25A15 (inh=AR pLI=0.00)
chr13	41384318	41384318	A	G	het	anno_omim	QUAL=1988;DP=122;AF=0.53;MQM=58;TRIO=HET,122,0.53,WT,23,0.00,HET,28,0.64	SLC25A15,MIR621	intergenic_region	MIR621:ENSG00000102743-ENSG00000207652:intergenic_region:MODIFIER::n.41384318A>G:	AluSz	rs7322603	0.4237	0.0000	0,0,0	0,0,0,0,0	0.3892							603861 [SLC25A15 (confirmed) Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome,238970];	RCV000337207.1 [benign]; 			52	118					SLC25A15 (inh=AR pLI=0.00), MIR621 (inh=n/a pLI=n/a)
chr13	41384382	41384382	C	T	het	anno_omim	QUAL=2071;DP=145;AF=0.50;MQM=51;TRIO=HET,145,0.50,WT,12,0.00,HET,28,0.54	SLC25A15,MIR621	intergenic_region	MIR621:ENSG00000102743-ENSG00000207652:intergenic_region:MODIFIER::n.41384382C>T:	AluSz	rs7321976	0.4237	0.0000	0,0,0	0,0,0,0,0	0.3889							603861 [SLC25A15 (confirmed) Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome,238970];	RCV000398781.1 [benign]; 			47	104					SLC25A15 (inh=AR pLI=0.00), MIR621 (inh=n/a pLI=n/a)
chr13	48517289	48517289	A	G	hom	anno_omim	QUAL=30309;DP=439;AF=1.00;MQM=60;TRIO=HOM,439,1.00,HOM,213,1.00,HOM,267,1.00	SUCLA2	3'UTR	SUCLA2:ENST00000378654:3'UTR:MODIFIER:exon11/11:c.*217T>C:,SUCLA2:ENST00000544100:3'UTR:MODIFIER:exon12/12:c.*217T>C:		rs4941618	0.9419	0.0000	0,0,0	0,0,0,0,0	0.9377							603921 [SUCLA2 (confirmed) Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria),612073];	RCV000322278.1 [benign]; 			197	32					SUCLA2 (inh=AR pLI=0.03)
chr13	48547467	48547467	A	T	hom	pred_pathogenic;anno_omim	QUAL=12839;DP=205;AF=1.00;MQM=59;TRIO=HOM,205,1.00,HET,124,0.48,HOM,140,1.00	SUCLA2	missense	SUCLA2:ENST00000378654:missense:MODERATE:exon5/11:c.595T>A:p.Ser199Thr,SUCLA2:ENST00000544100:missense:MODERATE:exon6/12:c.193T>A:p.Ser65Thr,SUCLA2:ENST00000534875:missense:MODERATE:exon5/11:c.421T>A:p.Ser141Thr,SUCLA2:ENST00000543413:missense:MODERATE:exon6/12:c.421T>A:p.Ser141Thr		rs7320366	0.6835	0.7516	34944,22378,1754	0.5817,0.6240,0.7925,0.8190,0.6369	0.7482	4.7410	T,T,T,T,T,T,T,T,T,T	T	B	T,T,T,T,T,T	14.64	603921 [SUCLA2 (confirmed) Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria),612073];	RCV000128327.3 [benign]; RCV000300356.1 [benign]; 			1270	727					SUCLA2 (inh=AR pLI=0.03)
chr13	48563008	48563008	G	A	hom	anno_omim	QUAL=17856;DP=277;AF=1.00;MQM=60;TRIO=HOM,277,1.00,HET,162,0.40,HOM,207,1.00	SUCLA2	splice_region&intron	SUCLA2:ENST00000378654:splice_region&intron:LOW:exon3/10:c.371+9C>T:,SUCLA2:ENST00000544100:splice_region&intron:LOW:exon4/11:c.-32+9C>T:,SUCLA2:ENST00000534875:splice_region&intron:LOW:exon3/10:c.197+9C>T:,SUCLA2:ENST00000543413:splice_region&intron:LOW:exon4/11:c.197+9C>T:		rs6561424	0.6835	0.7515	34812,22285,1738	0.5820,0.6237,0.7925,0.8189,0.6368	0.7480							603921 [SUCLA2 (confirmed) Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria),612073];	RCV000177179.3 [benign]; RCV000360855.1 [benign]; 			1264	710					SUCLA2 (inh=AR pLI=0.03)
chr13	78470350	78470350	A	G	hom	anno_omim	QUAL=7356;DP=160;AF=1.00;MQM=60;TRIO=HOM,160,1.00,HOM,38,1.00,HOM,36,1.00	EDNRB	3'UTR	EDNRB:ENST00000377211:3'UTR:MODIFIER:exon8/8:c.*1985T>C:,EDNRB:ENST00000446573:3'UTR:MODIFIER:exon7/7:c.*227T>C:,EDNRB:ENST00000334286:3'UTR:MODIFIER:exon7/7:c.*1985T>C:		rs4885491	0.9255	0.0000	0,0,0	0,0,0,0,0	0.8975							131244 [EDNRB (confirmed) Hirschsprung disease,susceptibility to,2,600155|ABCD syndrome,600501|Waardenburg syndrome,type 4A,277580];				162	66					EDNRB (inh=AR+AD pLI=0.02)
chr13	78470568	78470568	G	A	het	anno_omim	QUAL=3341;DP=213;AF=0.47;MQM=60;TRIO=HET,213,0.47,WT,64,0.03,HET,60,0.58	EDNRB	3'UTR	EDNRB:ENST00000377211:3'UTR:MODIFIER:exon8/8:c.*1767C>T:,EDNRB:ENST00000446573:3'UTR:MODIFIER:exon7/7:c.*9C>T:,EDNRB:ENST00000334286:3'UTR:MODIFIER:exon7/7:c.*1767C>T:		rs3027092	0.0146	0.0228	7,4,0	0.0023,0.0148,0.0622,0.0263,0.0149	0.0238							131244 [EDNRB (confirmed) Hirschsprung disease,susceptibility to,2,600155|ABCD syndrome,600501|Waardenburg syndrome,type 4A,277580];	RCV000217389.1 [benign]; RCV000267567.1 [likely benign]; RCV000324935.1 [likely benign]; 			1	59					EDNRB (inh=AR+AD pLI=0.02)
chr13	78477674	78477674	A	G	hom	anno_omim	QUAL=24512;DP=334;AF=0.99;MQM=59;TRIO=HOM,334,0.99,HOM,183,1.00,HOM,226,1.00	EDNRB	synonymous	EDNRB:ENST00000377211:synonymous:LOW:exon3/8:c.822T>C:p.Ser274Ser,EDNRB:ENST00000446573:synonymous:LOW:exon2/7:c.552T>C:p.Ser184Ser,EDNRB:ENST00000334286:synonymous:LOW:exon2/7:c.552T>C:p.Ser184Ser		rs5348	0.9838	0.9949	59991,33323,4723	0.9528,0.9979,0.9999,0.9998,0.9949	0.9959							131244 [EDNRB (confirmed) Hirschsprung disease,susceptibility to,2,600155|ABCD syndrome,600501|Waardenburg syndrome,type 4A,277580];	RCV000220746.1 [benign]; 			2110	3					EDNRB (inh=AR+AD pLI=0.02)
chr13	78549635	78549635	C	T	het	low_DP;anno_omim	QUAL=139;DP=9;AF=0.44;MQM=60;TRIO=HET,9,0.44,WT,7,0.00,HET,6,0.67	RNF219-AS1	intron	RNF219-AS1:ENST00000607862:intron:MODIFIER:exon1/2:n.230+55582C>T:	HERVE_a-int	rs12720104	0.0146	0.0000	0,0,0	0,0,0,0,0	0.0234							131244 [EDNRB (confirmed) Hirschsprung disease,susceptibility to,2,600155|ABCD syndrome,600501|Waardenburg syndrome,type 4A,277580];				0	3					RNF219-AS1 (inh=n/a pLI=n/a)
chr13	100635377	100635377	C	T	het	anno_omim	QUAL=7505;DP=233;AF=0.46;MQM=59;TRIO=HET,233,0.46,WT,385,0.00,HET,462,0.44	ZIC2	synonymous	ZIC2:ENST00000376335:synonymous:LOW:exon1/3:c.1059C>T:p.His353His		rs1831992	0.0417	0.0799	549,492,3	0.0188,0.0546,0.0000,0.1163,0.0264	0.0812							603073 [ZIC2 (provisional) Holoprosencephaly 5,609637];	RCV000081471.5 [benign]; 			26	374					ZIC2 (inh=AD pLI=n/a)
chr13	100638392	100638392	G	A	hom	anno_omim	QUAL=27395;DP=553;AF=0.99;MQM=59;TRIO=HOM,553,0.99,HET,170,0.49,HOM,288,0.98	ZIC2	3'UTR	ZIC2:ENST00000376335:3'UTR:MODIFIER:exon3/3:c.*456G>A:		rs13542	0.3105	0.0000	0,0,0	0,0,0,0,0	0.2856							603073 [ZIC2 (provisional) Holoprosencephaly 5,609637];				36	182					ZIC2 (inh=AD pLI=n/a)
chr13	102373563	102373563	A	T	hom	anno_omim	QUAL=25448;DP=327;AF=1.00;MQM=60;TRIO=HOM,327,1.00,HOM,168,1.00,HOM,261,1.00	FGF14,ITGBL1	3'UTR	FGF14:ENST00000376131:3'UTR:MODIFIER:exon5/5:c.*1618T>A:		rs15608	0.8325	0.0000	0,0,0	0,0,0,0,0	0.7614							601515 [FGF14 (confirmed) Spinocerebellar ataxia 27,609307];	RCV000404703.1 [benign]; 			144	107					FGF14 (inh=AD pLI=0.72), ITGBL1 (inh=n/a pLI=0.17)
chr13	102373569	102373569	C	A	het	anno_omim	QUAL=9563;DP=322;AF=0.45;MQM=60;TRIO=HET,322,0.45,HOM,178,0.99,WT,273,0.00	FGF14,ITGBL1	3'UTR	FGF14:ENST00000376131:3'UTR:MODIFIER:exon5/5:c.*1612G>T:		rs1046197	0.3431	0.0000	0,0,0	0,0,0,0,0	0.2916							601515 [FGF14 (confirmed) Spinocerebellar ataxia 27,609307];	RCV000343974.1 [benign]; 			26	140					FGF14 (inh=AD pLI=0.72), ITGBL1 (inh=n/a pLI=0.17)
chr13	102373790	102373790	-	TTTA	hom	anno_omim	QUAL=24827;DP=406;AF=0.98;MQM=59;TRIO=HOM,406,0.98,HOM,159,0.99,HOM,201,0.99	FGF14,ITGBL1	3'UTR	FGF14:ENST00000376131:3'UTR:MODIFIER:exon5/5:c.*1387_*1390dupTAAA:		rs10626847;rs5806245	0.4169	0.0000	0,0,0	0,0,0,0,0	0.3806							601515 [FGF14 (confirmed) Spinocerebellar ataxia 27,609307];	RCV000304271.1 [benign]; 			47	141					FGF14 (inh=AD pLI=0.72), ITGBL1 (inh=n/a pLI=0.17)
chr13	102374208	102374208	-	T	hom	anno_omim	QUAL=3478;DP=117;AF=0.61;MQM=59;TRIO=HOM,117,0.61,HOM,80,0.69,HOM,101,0.64	FGF14,ITGBL1	3'UTR	FGF14:ENST00000376131:3'UTR:MODIFIER:exon5/5:c.*972dupA:		rs397768294;rs557319654	0.3570	0.0000	0,0,0	0,0,0,0,0	0.3616							601515 [FGF14 (confirmed) Spinocerebellar ataxia 27,609307];	RCV000386280.1 [benign]; 			20	158					FGF14 (inh=AD pLI=0.72), ITGBL1 (inh=n/a pLI=0.17)
chr13	103498198	103498198	A	G	het	anno_omim	QUAL=3289;DP=110;AF=0.44;MQM=59;TRIO=HET,110,0.44,HET,53,0.53,HOM,64,1.00	ERCC5,BIVM-ERCC5	5'UTR,intron	ERCC5:ENST00000355739:5'UTR:MODIFIER:exon1/15:c.-419A>G:,ERCC5:ENST00000535557:5'UTR:MODIFIER:exon1/7:c.-419A>G:,BIVM-ERCC5:ENST00000602836:intron:MODIFIER:exon9/20:c.1363+6045A>G:		rs751402	0.6889	0.0000	0,0,0	0,0,0,0,0	0.7593							133530 [ERCC5 (confirmed) Xeroderma pigmentosum,group G,278780|Xeroderma pigmentosum,group G/Cockayne syndrome,278780|Cerebrooculofacioskeletal syndrome 3,616570];	RCV000392824.1 [benign]; 			139	78					ERCC5 (inh=AR pLI=0.00), BIVM-ERCC5 (inh=n/a pLI=n/a)
chr13	103498375	103498375	T	C	het	anno_omim	QUAL=15543;DP=268;AF=0.45;MQM=60;TRIO=HET,268,0.45,HET,254,0.46,HOM,317,0.99	ERCC5,BIVM-ERCC5	5'UTR,intron	ERCC5:ENST00000355739:5'UTR:MODIFIER:exon1/15:c.-242T>C:,ERCC5:ENST00000535557:5'UTR:MODIFIER:exon1/7:c.-242T>C:,BIVM-ERCC5:ENST00000602836:intron:MODIFIER:exon9/20:c.1364-6093T>C:		rs2296147	0.2979	0.0000	0,0,0	0,0,0,0,0	0.3702							133530 [ERCC5 (confirmed) Xeroderma pigmentosum,group G,278780|Xeroderma pigmentosum,group G/Cockayne syndrome,278780|Cerebrooculofacioskeletal syndrome 3,616570];	RCV000278463.1 [benign]; 			47	112					ERCC5 (inh=AR pLI=0.00), BIVM-ERCC5 (inh=n/a pLI=n/a)
chr13	103504517	103504517	T	C	het	anno_omim	QUAL=8021;DP=158;AF=0.51;MQM=60;TRIO=HET,158,0.51,HET,113,0.55,HOM,129,0.99	BIVM-ERCC5,ERCC5	synonymous	BIVM-ERCC5:ENST00000602836:synonymous:LOW:exon10/21:c.1413T>C:p.His471His,ERCC5:ENST00000355739:synonymous:LOW:exon2/15:c.138T>C:p.His46His,ERCC5:ENST00000535557:synonymous:LOW:exon2/7:c.138T>C:p.His46His		rs1047768	0.4930	0.5291	18075,11535,2239	0.6545,0.2777,0.2660,0.5861,0.4982	0.5913							133530 [ERCC5 (confirmed) Xeroderma pigmentosum,group G,278780|Xeroderma pigmentosum,group G/Cockayne syndrome,278780|Cerebrooculofacioskeletal syndrome 3,616570];	RCV000116990.3 [other]; RCV000272532.1 [benign]; 		COSM3753565	1121	1716					BIVM-ERCC5 (inh=n/a pLI=n/a), ERCC5 (inh=AR pLI=0.00)
chr13	103527849	103527849	G	C	hom	pred_pathogenic;anno_omim	QUAL=17138;DP=245;AF=1.00;MQM=60;TRIO=HOM,245,1.00,HOM,118,1.00,HOM,156,1.00	ERCC5	missense	ERCC5:ENST00000355739:missense:MODERATE:exon15/15:c.3157G>C:p.Gly1053Arg,ERCC5:ENST00000375954:missense:MODERATE:exon6/6:c.856G>C:p.Gly286Arg		rs9514066	0.9982	0.9994	60603,33354,5133	0.9941,0.9995,1.0000,1.0000,1.0000	0.9995	3.2550	T,D,D,T	T	P	T,T	23.00	133530 [ERCC5 (confirmed) Xeroderma pigmentosum,group G,278780|Xeroderma pigmentosum,group G/Cockayne syndrome,278780|Cerebrooculofacioskeletal syndrome 3,616570];	RCV000120845.1 [not provided]; 			3497	2					ERCC5 (inh=AR pLI=0.00)
chr13	103527930	103527930	G	C	hom	anno_omim	QUAL=16156;DP=255;AF=0.99;MQM=60;TRIO=HOM,255,0.99,HOM,108,1.00,HOM,130,1.00	ERCC5	missense	ERCC5:ENST00000355739:missense:MODERATE:exon15/15:c.3238G>C:p.Gly1080Arg,ERCC5:ENST00000375954:missense:MODERATE:exon6/6:c.937G>C:p.Gly313Arg		rs9514067	0.9972	0.9993	60574,33341,5128	0.9940,0.9995,1.0000,1.0000,0.9992	0.9994	-0.3730	T,T,T,T	T	B	T,T	0.04	133530 [ERCC5 (confirmed) Xeroderma pigmentosum,group G,278780|Xeroderma pigmentosum,group G/Cockayne syndrome,278780|Cerebrooculofacioskeletal syndrome 3,616570];	RCV000120846.1 [not provided]; 			3494	2	1	[1] harmuth 11.02.2016; bei 1700 homo Beobachtungen in unser db ist es sicher der Wildtyp			ERCC5 (inh=AR pLI=0.00)
chr13	103528337	103528337	G	A	hom	anno_omim	QUAL=25215;DP=335;AF=1.00;MQM=60;TRIO=HOM,335,1.00,HOM,186,0.99,HOM,259,1.00	ERCC5	3'UTR	ERCC5:ENST00000355739:3'UTR:MODIFIER:exon15/15:c.*84G>A:		rs873601	0.5495	0.0000	0,0,0	0,0,0,0,0	0.5895							133530 [ERCC5 (confirmed) Xeroderma pigmentosum,group G,278780|Xeroderma pigmentosum,group G/Cockayne syndrome,278780|Cerebrooculofacioskeletal syndrome 3,616570];	RCV000342790.1 [benign]; 			122	92					ERCC5 (inh=AR pLI=0.00)
chr13	110818598	110818598	T	G	het	pred_pathogenic;anno_omim	QUAL=9472;DP=306;AF=0.50;MQM=60;TRIO=HET,306,0.50,HET,218,0.43,HET,259,0.49	COL4A1	missense	COL4A1:ENST00000375820:missense:MODERATE:exon45/52:c.4002A>C:p.Gln1334His		rs3742207	0.2883	0.3098	6036,3924,420	0.2868,0.1758,0.2500,0.3417,0.3372	0.3042	0.4600	T,T,T	T	B	D	8.70	120130 [COL4A1 (confirmed) Porencephaly 1,175780|Brain small vessel disease with or without ocular anomalies,607595|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle cramps,611773|Hemorrhage,intracerebral,susceptibility to,614519|Retinal arteries,tortuosity of,180000];	RCV000178573.2 [benign]; RCV000269625.1 [benign]; RCV000326846.1 [benign]; RCV000388359.1 [benign]; 	CM083606 [CLASS=DP MUT=ALT PHEN="Myocardial infarction protection association with" GENE=COL4A1]; 	COSM3736082, COSM3736081	243	961					COL4A1 (inh=AD pLI=1.00)
chr13	110819586	110819586	G	A	het	anno_omim	QUAL=8372;DP=160;AF=0.48;MQM=60;TRIO=HET,160,0.48,HET,219,0.54,HET,284,0.49	COL4A1	splice_region&intron	COL4A1:ENST00000375820:splice_region&intron:LOW:exon43/51:c.3877-9C>T:		rs589985	0.6554	0.6728	27659,14576,1577	0.5556,0.8209,0.6557,0.6611,0.6741	0.6812							120130 [COL4A1 (confirmed) Porencephaly 1,175780|Brain small vessel disease with or without ocular anomalies,607595|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle cramps,611773|Hemorrhage,intracerebral,susceptibility to,614519|Retinal arteries,tortuosity of,180000];	RCV000246560.1 [benign]; RCV000270389.1 [benign]; RCV000310269.1 [benign]; RCV000362657.1 [benign]; 			923	954					COL4A1 (inh=AD pLI=1.00)
chr13	110827574	110827574	T	A	hom	anno_omim	QUAL=15280;DP=184;AF=1.00;MQM=60;TRIO=HOM,184,1.00,HET,183,0.47,HOM,247,1.00	COL4A1	synonymous	COL4A1:ENST00000375820:synonymous:LOW:exon37/52:c.3189A>T:p.Arg1063Arg		rs874203	0.3179	0.3515	7525,4271,388	0.2804,0.3954,0.2874,0.3592,0.3674	0.3540							120130 [COL4A1 (confirmed) Porencephaly 1,175780|Brain small vessel disease with or without ocular anomalies,607595|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle cramps,611773|Hemorrhage,intracerebral,susceptibility to,614519|Retinal arteries,tortuosity of,180000];	RCV000252826.1 [benign]; RCV000295246.1 [benign]; RCV000352486.1 [benign]; RCV000402267.1 [benign]; 			262	907					COL4A1 (inh=AD pLI=1.00)
chr13	110827580	110827580	C	T	hom	anno_omim	QUAL=14700;DP=171;AF=0.99;MQM=60;TRIO=HOM,171,0.99,HET,189,0.47,HOM,256,1.00	COL4A1	synonymous	COL4A1:ENST00000375820:synonymous:LOW:exon37/52:c.3183G>A:p.Gly1061Gly		rs874204	0.3181	0.3515	7529,4277,386	0.2801,0.3956,0.2877,0.3593,0.3674	0.3541							120130 [COL4A1 (confirmed) Porencephaly 1,175780|Brain small vessel disease with or without ocular anomalies,607595|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle cramps,611773|Hemorrhage,intracerebral,susceptibility to,614519|Retinal arteries,tortuosity of,180000];	RCV000247662.1 [benign]; RCV000312646.1 [benign]; RCV000356008.1 [benign]; RCV000401840.1 [benign]; 			262	907					COL4A1 (inh=AD pLI=1.00)
chr13	110833702	110833702	C	T	hom	anno_omim	QUAL=10751;DP=171;AF=0.99;MQM=59;TRIO=HOM,171,0.99,HET,143,0.41,HOM,153,0.98	COL4A1	synonymous	COL4A1:ENST00000375820:synonymous:LOW:exon29/52:c.2130G>A:p.Pro710Pro		rs16975492	0.3071	0.3477	7309,4163,299	0.2429,0.3924,0.2846,0.3573,0.3761	0.3506							120130 [COL4A1 (confirmed) Porencephaly 1,175780|Brain small vessel disease with or without ocular anomalies,607595|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle cramps,611773|Hemorrhage,intracerebral,susceptibility to,614519|Retinal arteries,tortuosity of,180000];	RCV000250703.1 [benign]; RCV000307335.1 [benign]; RCV000342375.1 [benign]; RCV000398706.1 [benign]; 		COSM4147573	259	907					COL4A1 (inh=AD pLI=1.00)
chr13	110839550	110839550	T	G	hom	pred_pathogenic;anno_omim	QUAL=17149;DP=148;AF=0.99;MQM=59;TRIO=HOM,148,0.99,HOM,172,1.00,HOM,233,1.00	COL4A1	missense	COL4A1:ENST00000375820:missense:MODERATE:exon25/52:c.1663A>C:p.Thr555Pro		rs536174	1.0000	1.0000	60706,33370,5203	1.0000,1.0000,1.0000,1.0000,1.0000	1.0000	5.9870	T	T	B	D	3.98	120130 [COL4A1 (confirmed) Porencephaly 1,175780|Brain small vessel disease with or without ocular anomalies,607595|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle cramps,611773|Hemorrhage,intracerebral,susceptibility to,614519|Retinal arteries,tortuosity of,180000];	RCV000245629.2 [benign]; RCV000299532.1 [benign]; RCV000359055.1 [benign]; RCV000391710.1 [benign]; 			2112	1					COL4A1 (inh=AD pLI=1.00)
chr13	110857895	110857895	A	G	hom	anno_omim	QUAL=33307;DP=486;AF=1.00;MQM=59;TRIO=HOM,486,1.00,HOM,231,1.00,HOM,318,1.00	COL4A1	splice_region&intron	COL4A1:ENST00000375820:splice_region&intron:LOW:exon15/51:c.859-10T>C:,COL4A1:ENST00000543140:splice_region&intron:LOW:exon15/24:c.859-10T>C:		rs677877	0.5964	0.6222	24081,13926,913	0.4156,0.4895,0.7664,0.6446,0.6851	0.6219							120130 [COL4A1 (confirmed) Porencephaly 1,175780|Brain small vessel disease with or without ocular anomalies,607595|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle cramps,611773|Hemorrhage,intracerebral,susceptibility to,614519|Retinal arteries,tortuosity of,180000];	RCV000246292.1 [benign]; RCV000287138.1 [benign]; RCV000340823.1 [benign]; RCV000376905.1 [benign]; 			928	957					COL4A1 (inh=AD pLI=1.00)
chr13	110859743	110859743	C	T	hom	anno_omim	QUAL=15099;DP=201;AF=1.00;MQM=60;TRIO=HOM,201,1.00,HOM,101,1.00,HOM,162,1.00	COL4A1	splice_region&intron	COL4A1:ENST00000375820:splice_region&intron:LOW:exon13/51:c.780+7G>A:,COL4A1:ENST00000543140:splice_region&intron:LOW:exon13/24:c.780+7G>A:		rs598893	0.5960	0.6211	24010,13898,910	0.4138,0.4884,0.7616,0.6438,0.6845	0.6207							120130 [COL4A1 (confirmed) Porencephaly 1,175780|Brain small vessel disease with or without ocular anomalies,607595|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle cramps,611773|Hemorrhage,intracerebral,susceptibility to,614519|Retinal arteries,tortuosity of,180000];	RCV000245991.1 [benign]; RCV000263276.1 [benign]; RCV000318467.1 [benign]; RCV000353343.1 [benign]; 			927	956					COL4A1 (inh=AD pLI=1.00)
chr13	110866265	110866265	G	A	hom	anno_omim	QUAL=12910;DP=224;AF=0.99;MQM=59;TRIO=HOM,224,0.99,HET,195,0.50,HET,309,0.51	COL4A1	splice_region&intron	COL4A1:ENST00000375820:splice_region&intron:LOW:exon3/51:c.234+8C>T:,COL4A1:ENST00000543140:splice_region&intron:LOW:exon3/24:c.234+8C>T:		rs9521650	0.1304	0.1429	1412,888,35	0.0901,0.0980,0.2515,0.1603,0.0841	0.1412							120130 [COL4A1 (confirmed) Porencephaly 1,175780|Brain small vessel disease with or without ocular anomalies,607595|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle cramps,611773|Hemorrhage,intracerebral,susceptibility to,614519|Retinal arteries,tortuosity of,180000];	RCV000177133.2 [benign]; RCV000283020.1 [benign]; RCV000318401.1 [benign]; RCV000375383.1 [benign]; 			58	485					COL4A1 (inh=AD pLI=1.00)
chr13	111077197	111077197	G	A	het	anno_omim	QUAL=14518;DP=256;AF=0.53;MQM=60;TRIO=HET,256,0.53,HET,242,0.53,HOM,260,1.00	COL4A2	synonymous	COL4A2:ENST00000360467:synonymous:LOW:exon5/48:c.297G>A:p.Thr99Thr		rs4238272	0.9427	0.9614	55860,30956,3576	0.8557,0.9840,0.9999,0.9632,0.9707	0.9644							120090 [COL4A2 (confirmed) Porencephaly 2,614483|Hemorrhage,intracerebral,susceptibility to,614519];	RCV000325831.1 [benign]; 			1937	175					COL4A2 (inh=AD pLI=0.00)
chr13	111098226	111098226	C	T	het	anno_omim	QUAL=2639;DP=136;AF=0.47;MQM=60;TRIO=HET,136,0.47,WT,75,0.00,HET,90,0.48	COL4A2	synonymous	COL4A2:ENST00000360467:synonymous:LOW:exon17/48:c.1008C>T:p.Pro336Pro		rs4103	0.4828	0.5137	16167,9407,779	0.3948,0.5016,0.5242,0.5294,0.5234	0.5106							120090 [COL4A2 (confirmed) Porencephaly 2,614483|Hemorrhage,intracerebral,susceptibility to,614519];	RCV000369813.1 [benign]; 		COSM1365445	555	1017					COL4A2 (inh=AD pLI=0.00)
chr13	111111173	111111173	G	A	het	anno_omim	QUAL=16779;DP=368;AF=0.50;MQM=59;TRIO=HET,368,0.50,HOM,249,1.00,HET,317,0.51	COL4A2,COL4A2-AS2	synonymous,intron	COL4A2:ENST00000360467:synonymous:LOW:exon22/48:c.1488G>A:p.Pro496Pro,COL4A2-AS2:ENST00000458403:intron:MODIFIER:exon1/4:n.266-540C>T:		rs7990214	0.4914	0.5288	17896,12114,1962	0.6313,0.3730,0.2260,0.6020,0.4757	0.5642							120090 [COL4A2 (confirmed) Porencephaly 2,614483|Hemorrhage,intracerebral,susceptibility to,614519];	RCV000341336.1 [benign]; 		COSM3999021	753	986					COL4A2 (inh=AD pLI=0.00), COL4A2-AS2 (inh=n/a pLI=n/a)
chr13	111111235	111111235	G	A	het	pred_pathogenic;anno_omim	QUAL=10915;DP=143;AF=0.46;MQM=59;TRIO=HET,143,0.46,HOM,210,1.00,HET,268,0.48	COL4A2,COL4A2-AS2	missense,intron	COL4A2:ENST00000360467:missense:MODERATE:exon22/48:c.1550G>A:p.Arg517Lys,COL4A2-AS2:ENST00000458403:intron:MODIFIER:exon1/4:n.266-602C>T:		rs7990383	0.5092	0.5390	17979,11948,2311	0.6886,0.3760,0.2315,0.6056,0.4896	0.5774	-1.2950	T,T	T	B	D	0.01	120090 [COL4A2 (confirmed) Porencephaly 2,614483|Hemorrhage,intracerebral,susceptibility to,614519];	RCV000394894.1 [benign]; 		COSM3931786	754	985					COL4A2 (inh=AD pLI=0.00), COL4A2-AS2 (inh=n/a pLI=n/a)
chr13	111117745	111117745	C	T	het	anno_omim	QUAL=4020;DP=136;AF=0.55;MQM=60;TRIO=HET,136,0.55,HOM,67,1.00,WT,92,0.02	COL4A2	splice_region&intron	COL4A2:ENST00000360467:splice_region&intron:LOW:exon24/47:c.1777-7C>T:		rs3803236	0.5140	0.5383	17734,11700,1981	0.6520,0.3939,0.3018,0.6013,0.4878	0.5721							120090 [COL4A2 (confirmed) Porencephaly 2,614483|Hemorrhage,intracerebral,susceptibility to,614519];	RCV000371352.1 [benign]; 			749	967					COL4A2 (inh=AD pLI=0.00)
chr13	111121620	111121620	C	T	het	pred_pathogenic;anno_omim	QUAL=2521;DP=195;AF=0.47;MQM=59;TRIO=HET,195,0.47,HET,99,0.31,WT,150,0.00	COL4A2	missense	COL4A2:ENST00000360467:missense:MODERATE:exon28/48:c.2152C>T:p.Pro718Ser		rs9583500	0.1909	0.2554	1736,1173,364	0.3839,0.1875,0.0229,0.3018,0.1351	0.2195	1.2810	T,T	T	B	D	8.81	120090 [COL4A2 (confirmed) Porencephaly 2,614483|Hemorrhage,intracerebral,susceptibility to,614519];	RCV000375113.1 [benign]; 			123	670					COL4A2 (inh=AD pLI=0.00)
chr13	111130519	111130519	C	T	het	anno_omim	QUAL=2459;DP=79;AF=0.62;MQM=59;TRIO=HET,79,0.62,HOM,54,0.98,WT,68,0.00	COL4A2	splice_region&intron	COL4A2:ENST00000360467:splice_region&intron:LOW:exon30/47:c.2587+8C>T:		rs2281974	0.4691	0.4087	7042,2486,1156	0.5686,0.4076,0.5062,0.3476,0.5268	0.3867							120090 [COL4A2 (confirmed) Porencephaly 2,614483|Hemorrhage,intracerebral,susceptibility to,614519];	RCV000350640.1 [benign]; 			260	874					COL4A2 (inh=AD pLI=0.00)
chr13	111154058	111154058	T	A	hom	low_DP;anno_omim	QUAL=657;DP=11;AF=1.00;MQM=60;TRIO=HOM,11,1.00,HOM,4,1.00,HOM,5,1.00	COL4A2	synonymous	COL4A2:ENST00000360467:synonymous:LOW:exon41/48:c.3804T>A:p.Pro1268Pro		rs439831	0.9395	0.9840	58581,33264,3312	0.8223,0.9923,0.9999,0.9986,0.9996	0.9863							120090 [COL4A2 (confirmed) Porencephaly 2,614483|Hemorrhage,intracerebral,susceptibility to,614519];				2036	11					COL4A2 (inh=AD pLI=0.00)
chr13	111154061	111154061	T	C	hom	low_DP;anno_omim	QUAL=657;DP=11;AF=1.00;MQM=60;TRIO=HOM,11,1.00,HOM,4,1.00,HOM,5,1.00	COL4A2	synonymous	COL4A2:ENST00000360467:synonymous:LOW:exon41/48:c.3807T>C:p.Gly1269Gly		rs409858	0.9395	0.9840	58579,33262,3310	0.8223,0.9923,0.9999,0.9986,0.9996	0.9863							120090 [COL4A2 (confirmed) Porencephaly 2,614483|Hemorrhage,intracerebral,susceptibility to,614519];				2039	11					COL4A2 (inh=AD pLI=0.00)
chr13	111155773	111155773	T	C	hom	anno_omim	QUAL=3656;DP=69;AF=0.99;MQM=59;TRIO=HOM,69,0.99,HOM,25,1.00,HOM,32,1.00	COL4A2,COL4A2-AS1	synonymous,intron	COL4A2:ENST00000360467:synonymous:LOW:exon43/48:c.4083T>C:p.Thr1361Thr,COL4A2-AS1:ENST00000417970:intron:MODIFIER:exon2/2:n.187-498A>G:		rs438758	0.9802	0.9934	41431,23365,3096	0.9546,0.9944,0.9755,0.9992,0.9990	0.9943							120090 [COL4A2 (confirmed) Porencephaly 2,614483|Hemorrhage,intracerebral,susceptibility to,614519];				2107	6					COL4A2 (inh=AD pLI=0.00), COL4A2-AS1 (inh=n/a pLI=n/a)
chr13	111156250	111156250	G	A	het	low_DP;pred_pathogenic;anno_omim	QUAL=171;DP=17;AF=0.53;MQM=60;TRIO=HET,17,0.53,HOM,1,1.00,WT,5,0.00	COL4A2,COL4A2-AS1	missense,intron	COL4A2:ENST00000360467:missense:MODERATE:exon44/48:c.4195G>A:p.Val1399Ile,COL4A2-AS1:ENST00000417970:intron:MODIFIER:exon2/2:n.187-975C>T:		rs45520539	0.0144	0.0307	77,64,0	0.0071,0.0125,0.0008,0.0445,0.0097	0.0301	-0.5270	T,T	T	B	D	1.51	120090 [COL4A2 (confirmed) Porencephaly 2,614483|Hemorrhage,intracerebral,susceptibility to,614519];	RCV000356521.1 [likely benign]; 			3	157					COL4A2 (inh=AD pLI=0.00), COL4A2-AS1 (inh=n/a pLI=n/a)
chr13	111156499	111156499	C	T	hom	anno_omim	QUAL=18090;DP=109;AF=1.00;MQM=60;TRIO=HOM,109,1.00,HOM,225,1.00,HOM,250,1.00	COL4A2,COL4A2-AS1	synonymous,intron	COL4A2:ENST00000360467:synonymous:LOW:exon45/48:c.4290C>T:p.Phe1430Phe,COL4A2-AS1:ENST00000417970:intron:MODIFIER:exon2/2:n.187-1224G>A:		rs4771683	0.9359	0.9833	58522,33267,3251	0.8146,0.9921,0.9999,0.9986,0.9994	0.9858							120090 [COL4A2 (confirmed) Porencephaly 2,614483|Hemorrhage,intracerebral,susceptibility to,614519];			COSM4147578	2101	12					COL4A2 (inh=AD pLI=0.00), COL4A2-AS1 (inh=n/a pLI=n/a)
chr13	111158874	111158874	A	G	hom	anno_omim	QUAL=21638;DP=195;AF=1.00;MQM=59;TRIO=HOM,195,1.00,HOM,197,1.00,HOM,290,1.00	COL4A2,COL4A2-AS1	synonymous,intron	COL4A2:ENST00000360467:synonymous:LOW:exon46/48:c.4515A>G:p.Pro1505Pro,COL4A2-AS1:ENST00000417970:intron:MODIFIER:exon2/2:n.186+1120T>C:		rs445348	0.7520	0.8329	40861,26131,2866	0.7818,0.7612,0.5860,0.8971,0.7820	0.8339							120090 [COL4A2 (confirmed) Porencephaly 2,614483|Hemorrhage,intracerebral,susceptibility to,614519];	RCV000387441.1 [benign]; 			1715	366					COL4A2 (inh=AD pLI=0.00), COL4A2-AS1 (inh=n/a pLI=n/a)
chr13	111160304	111160304	G	A	het	anno_omim	QUAL=8224;DP=261;AF=0.55;MQM=59;TRIO=HET,261,0.55,WT,366,0.00,HET,469,0.47	COL4A2,COL4A2-AS1	synonymous,intron	COL4A2:ENST00000360467:synonymous:LOW:exon47/48:c.4617G>A:p.Ala1539Ala,COL4A2-AS1:ENST00000417970:intron:MODIFIER:exon1/2:n.81+142C>T:		rs391859	0.1008	0.1010	775,314,37	0.0801,0.2149,0.1470,0.0919,0.0664	0.1049							120090 [COL4A2 (confirmed) Porencephaly 2,614483|Hemorrhage,intracerebral,susceptibility to,614519];	RCV000383562.1 [benign]; 			31	389					COL4A2 (inh=AD pLI=0.00), COL4A2-AS1 (inh=n/a pLI=n/a)
chr13	111164614	111164614	T	C	het	anno_omim	QUAL=8708;DP=279;AF=0.58;MQM=59;TRIO=HET,279,0.58,WT,88,0.02,HOM,151,1.00	COL4A2	3'UTR	COL4A2:ENST00000360467:3'UTR:MODIFIER:exon48/48:c.*76T>C:		rs422733	0.4663	0.0000	0,0,0	0,0,0,0,0	0.5346							120090 [COL4A2 (confirmed) Porencephaly 2,614483|Hemorrhage,intracerebral,susceptibility to,614519];	RCV000286656.1 [benign]; 			177	241					COL4A2 (inh=AD pLI=0.00)
chr13	111164629	111164630	AA	-	het	anno_omim	QUAL=6058;DP=196;AF=0.52;MQM=59;TRIO=HET,196,0.52,WT,70,0.03,HOM,141,0.95	COL4A2	3'UTR	COL4A2:ENST00000360467:3'UTR:MODIFIER:exon48/48:c.*101_*102delAA:		rs397838577	0.4677	0.0000	0,0,0	0,0,0,0,0	0.5535							120090 [COL4A2 (confirmed) Porencephaly 2,614483|Hemorrhage,intracerebral,susceptibility to,614519];	RCV000322953.1 [benign]; 			159	194					COL4A2 (inh=AD pLI=0.00)
chr13	111164955	111164955	C	G	het	anno_omim	QUAL=11639;DP=188;AF=0.48;MQM=59;TRIO=HET,188,0.48,HOM,194,1.00,HET,270,0.54	COL4A2	3'UTR	COL4A2:ENST00000360467:3'UTR:MODIFIER:exon48/48:c.*417C>G:		rs10509	0.8868	0.0000	0,0,0	0,0,0,0,0	0.8824							120090 [COL4A2 (confirmed) Porencephaly 2,614483|Hemorrhage,intracerebral,susceptibility to,614519];	RCV000404461.1 [benign]; 			192	34					COL4A2 (inh=AD pLI=0.00)
chr13	111165079	111165079	C	T	het	anno_omim	QUAL=10656;DP=269;AF=0.45;MQM=60;TRIO=HET,269,0.45,HOM,242,0.99,WT,270,0.00	COL4A2	3'UTR	COL4A2:ENST00000360467:3'UTR:MODIFIER:exon48/48:c.*541C>T:		rs1049906	0.5054	0.0000	0,0,0	0,0,0,0,0	0.4454							120090 [COL4A2 (confirmed) Porencephaly 2,614483|Hemorrhage,intracerebral,susceptibility to,614519];	RCV000397445.1 [benign]; 			44	104					COL4A2 (inh=AD pLI=0.00)
chr13	111165265	111165265	G	C	het	anno_omim	QUAL=4711;DP=146;AF=0.51;MQM=59;TRIO=HET,146,0.51,HOM,91,0.99,WT,113,0.03	COL4A2	3'UTR	COL4A2:ENST00000360467:3'UTR:MODIFIER:exon48/48:c.*727G>C:		rs15457	0.5108	0.0000	0,0,0	0,0,0,0,0	0.4511							120090 [COL4A2 (confirmed) Porencephaly 2,614483|Hemorrhage,intracerebral,susceptibility to,614519];	RCV000268815.1 [benign]; 			45	104					COL4A2 (inh=AD pLI=0.00)
chr14	20757383	20757383	A	G	het		QUAL=2597;DP=148;AF=0.53;MQM=60;TRIO=HET,148,0.53,HET,52,0.62,WT,49,0.00	TTC5	3'UTR	TTC5:ENST00000258821:3'UTR:MODIFIER:exon10/10:c.*403T>C:	A-rich	rs74596138	0.1140	0.0000	0,0,0	0,0,0,0,0	0.0540											0	26					TTC5 (inh=n/a pLI=0.00)
chr14	20764585	20764585	A	C	het		QUAL=20752;DP=395;AF=0.52;MQM=60;TRIO=HET,395,0.52,HET,285,0.48,HOM,356,1.00	TTC5	synonymous	TTC5:ENST00000258821:synonymous:LOW:exon6/10:c.660T>G:p.Ala220Ala		rs1953552	0.4012	0.4585	13125,8312,359	0.2600,0.4849,0.4829,0.4981,0.4108	0.4626	-0.0430		T			5.74				COSM1128303	396	852					TTC5 (inh=n/a pLI=0.00)
chr14	20770036	20770036	T	C	hom		QUAL=41162;DP=427;AF=1.00;MQM=59;TRIO=HOM,427,1.00,HOM,326,1.00,HOM,513,1.00	TTC5	missense	TTC5:ENST00000258821:missense:MODERATE:exon2/10:c.140A>G:p.Gln47Arg		rs3742945	0.7456	0.7368	33266,18133,2884	0.7420,0.8309,0.8004,0.7354,0.6492	0.7431	-0.3360	T	T	B	T	0.34				COSM1179594	959	628					TTC5 (inh=n/a pLI=0.00)
chr14	20937588	20937588	G	A	het	anno_omim	QUAL=8993;DP=437;AF=0.54;MQM=59;TRIO=HET,437,0.54,HET,274,0.50,WT,416,0.00	PNP	5'UTR	PNP:ENST00000361505:5'UTR:MODIFIER:exon1/6:c.-96G>A:		rs17881206	0.0058	0.0000	0,0,0	0,0,0,0,0	0.0031							164050 [PNP (confirmed) Immunodeficiency due to purine nucleoside phosphorylase deficiency,613179];	RCV000291266.1 [uncertain significance]; 			0	7					PNP (inh=AR pLI=0.07)
chr14	20942744	20942744	A	G	het	anno_omim	QUAL=13749;DP=259;AF=0.51;MQM=60;TRIO=HET,259,0.51,HOM,337,0.99,WT,418,0.00	PNP	splice_region&intron	PNP:ENST00000361505:splice_region&intron:LOW:exon3/5:c.285+10A>G:		rs1713420	0.2023	0.1943	2549,1492,528	0.3182,0.1338,0.1121,0.2065,0.1589	0.2192							164050 [PNP (confirmed) Immunodeficiency due to purine nucleoside phosphorylase deficiency,613179];	RCV000317230.1 [benign]; 			90	636					PNP (inh=AR pLI=0.07)
chr14	20945355	20945355	C	T	het	anno_omim	QUAL=5281;DP=263;AF=0.48;MQM=60;TRIO=HET,263,0.48,HET,192,0.46,WT,221,0.00	PNP,RNASE10	intergenic_region	RNASE10:ENSG00000198805-ENSG00000182545:intergenic_region:MODIFIER::n.20945355C>T:		rs17878900	0.0647	0.0000	0,0,0	0,0,0,0,0	0.0360							164050 [PNP (confirmed) Immunodeficiency due to purine nucleoside phosphorylase deficiency,613179];	RCV000301354.1 [likely benign]; 			0	12					PNP (inh=AR pLI=0.07), RNASE10 (inh=n/a pLI=0.01)
chr14	20945488	20945488	T	C	hom	anno_omim	QUAL=47450;DP=619;AF=1.00;MQM=59;TRIO=HOM,619,1.00,HOM,417,1.00,HOM,442,1.00	PNP,RNASE10	intergenic_region	RNASE10:ENSG00000198805-ENSG00000182545:intergenic_region:MODIFIER::n.20945488T>C:		rs1760933	0.9774	0.0000	0,0,0	0,0,0,0,0	0.9642							164050 [PNP (confirmed) Immunodeficiency due to purine nucleoside phosphorylase deficiency,613179];	RCV000335164.1 [benign]; 			139	13					PNP (inh=AR pLI=0.07), RNASE10 (inh=n/a pLI=0.01)
chr14	23242828	23242828	T	C	hom	anno_omim	QUAL=12854;DP=178;AF=0.99;MQM=60;TRIO=HOM,178,0.99,HOM,112,0.99,HOM,125,1.00	SLC7A7	synonymous	SLC7A7:ENST00000285850:synonymous:LOW:exon11/11:c.1527A>G:p.Lys509Lys,SLC7A7:ENST00000555702:synonymous:LOW:exon11/11:c.1527A>G:p.Lys509Lys,SLC7A7:ENST00000397532:synonymous:LOW:exon10/10:c.1527A>G:p.Lys509Lys,SLC7A7:ENST00000397529:synonymous:LOW:exon10/10:c.1527A>G:p.Lys509Lys,SLC7A7:ENST00000397528:synonymous:LOW:exon11/11:c.1527A>G:p.Lys509Lys,SLC7A7:ENST00000554517:synonymous:LOW:exon9/9:c.729A>G:p.Lys243Lys		rs1061040	0.7855	0.8651	46223,26587,1361	0.5077,0.9409,0.9324,0.8923,0.8924	0.8770							603593 [SLC7A7 (confirmed) Lysinuric protein intolerance,222700];	RCV000128147.2 [benign]; RCV000398235.1 [benign]; 			1709	383					SLC7A7 (inh=AR pLI=0.00)
chr14	23282110	23282110	A	G	het	anno_omim	QUAL=2667;DP=79;AF=0.42;MQM=59;TRIO=HET,79,0.42,HOM,73,1.00,WT,83,0.00	SLC7A7	splice_region&synonymous,intron	SLC7A7:ENST00000285850:splice_region&synonymous:LOW:exon3/11:c.498T>C:p.Ile166Ile,SLC7A7:ENST00000555702:splice_region&synonymous:LOW:exon3/11:c.498T>C:p.Ile166Ile,SLC7A7:ENST00000397532:splice_region&synonymous:LOW:exon2/10:c.498T>C:p.Ile166Ile,SLC7A7:ENST00000397529:splice_region&synonymous:LOW:exon2/10:c.498T>C:p.Ile166Ile,SLC7A7:ENST00000397528:splice_region&synonymous:LOW:exon3/11:c.498T>C:p.Ile166Ile,SLC7A7:ENST00000554517:intron:MODIFIER:exon1/8:c.-300+6737T>C:		rs8018462	0.5821	0.5603	19314,9431,1158	0.4901,0.7214,0.7935,0.5373,0.4620	0.5666							603593 [SLC7A7 (confirmed) Lysinuric protein intolerance,222700];	RCV000128149.2 [benign]; RCV000333159.1 [benign]; 			551	1052					SLC7A7 (inh=AR pLI=0.00)
chr14	23282449	23282449	C	T	het	anno_omim	QUAL=7646;DP=281;AF=0.54;MQM=59;TRIO=HET,281,0.54,HOM,128,1.00,WT,142,0.01	SLC7A7	synonymous,intron	SLC7A7:ENST00000285850:synonymous:LOW:exon3/11:c.159G>A:p.Ser53Ser,SLC7A7:ENST00000555702:synonymous:LOW:exon3/11:c.159G>A:p.Ser53Ser,SLC7A7:ENST00000397532:synonymous:LOW:exon2/10:c.159G>A:p.Ser53Ser,SLC7A7:ENST00000397529:synonymous:LOW:exon2/10:c.159G>A:p.Ser53Ser,SLC7A7:ENST00000397528:synonymous:LOW:exon3/11:c.159G>A:p.Ser53Ser,SLC7A7:ENST00000554517:intron:MODIFIER:exon1/8:c.-300+6398G>A:		rs1805059	0.6060	0.6073	22980,12266,1276	0.4973,0.7532,0.7935,0.6051,0.4833	0.6174							603593 [SLC7A7 (confirmed) Lysinuric protein intolerance,222700];	RCV000128148.2 [benign]; RCV000396503.1 [benign]; 		COSM3753883	713	1065					SLC7A7 (inh=AR pLI=0.00)
chr14	23284572	23284572	A	G	het	anno_omim	QUAL=7856;DP=231;AF=0.42;MQM=59;TRIO=HET,231,0.42,HOM,175,0.99,WT,264,0.01	SLC7A7	5'UTR,intron	SLC7A7:ENST00000285850:5'UTR:MODIFIER:exon2/11:c.-92T>C:,SLC7A7:ENST00000555702:5'UTR:MODIFIER:exon2/11:c.-86T>C:,SLC7A7:ENST00000397532:5'UTR:MODIFIER:exon1/10:c.-86T>C:,SLC7A7:ENST00000397528:5'UTR:MODIFIER:exon2/11:c.-86T>C:,SLC7A7:ENST00000397529:intron:MODIFIER:exon1/9:c.-42-1923T>C:,SLC7A7:ENST00000554517:intron:MODIFIER:exon1/8:c.-300+4275T>C:		rs2281677	0.5781	0.5294	1992,691,83	0.5103,0.0000,0.6436,0.6092,0.4754	0.5871							603593 [SLC7A7 (confirmed) Lysinuric protein intolerance,222700];	RCV000367365.1 [benign]; 			206	339					SLC7A7 (inh=AR pLI=0.00)
chr14	23588642	23588642	G	A	het	anno_omim	QUAL=16509;DP=263;AF=0.50;MQM=59;TRIO=HET,263,0.50,HET,270,0.49,HOM,315,0.99	CEBPE	5'UTR	CEBPE:ENST00000206513:5'UTR:MODIFIER:exon1/2:c.-342C>T:		rs12434881	0.3231	0.0000	0,0,0	0,0,0,0,0	0.3670							600749 [CEBPE (provisional) Specific granule deficiency,245480];				31	74					CEBPE (inh=AR pLI=0.00)
chr14	23588731	23588731	G	C	het	anno_omim	QUAL=15139;DP=198;AF=0.49;MQM=59;TRIO=HET,198,0.49,HET,247,0.46,HOM,327,0.99	CEBPE	5'UTR	CEBPE:ENST00000206513:5'UTR:MODIFIER:exon1/2:c.-431C>G:		rs2239635	0.6643	0.0000	0,0,0	0,0,0,0,0	0.6705							600749 [CEBPE (provisional) Specific granule deficiency,245480];				64	79					CEBPE (inh=AR pLI=0.00)
chr14	23902753	23902753	G	A	het	anno_omim	QUAL=7033;DP=141;AF=0.45;MQM=59;TRIO=HET,141,0.45,WT,118,0.02,HOM,181,1.00	MYH7	synonymous	MYH7:ENST00000355349:synonymous:LOW:exon3/40:c.189C>T:p.Thr63Thr		rs2069540	0.5204	0.4889	14779,7595,2050	0.6284,0.4254,0.3692,0.4780,0.5906	0.5085							160760 [MYH7 (confirmed) Cardiomyopathy,hypertrophic,1,192600|Cardiomyopathy,dilated,1S,613426|Myopathy,myosin storage,autosomal dominant,608358|Laing distal myopathy,160500|Scapuloperoneal syndrome,myopathic type,181430|Left ventricular noncompaction 5,613426|Myopathy,myosin storage,autosomal recessive,255160];	RCV000035752.5 [benign]; RCV000248228.1 [benign]; RCV000297610.1 [benign]; RCV000312955.1 [benign]; RCV000337511.1 [benign]; RCV000352455.1 [benign]; RCV000399650.1 [benign]; RCV000400497.1 [benign]; 		COSM3753910	575	1061					MYH7 (inh=AD pLI=0.00)
chr14	24718380	24718401	CTCCGGGAGCCCTGGACTCCCC	-	het	anno_omim	QUAL=11379;DP=153;AF=0.99;MQM=59;TRIO=HET,153,0.99,HOM,159,1.00,HOM,206,1.00	TGM1	3'UTR	TGM1:ENST00000206765:3'UTR:MODIFIER:exon15/15:c.*118_*139delGGGGAGTCCAGGGCTCCCGGAG:		rs531264904	0.9914	0.0000	0,0,0	0,0,0,0,0	0.9929							190195 [TGM1 (confirmed) Ichthyosis,congenital,autosomal recessive 1,242300];				41	196					TGM1 (inh=AR pLI=0.00)
chr14	24718515	24718515	G	A	hom	anno_omim	QUAL=25620;DP=294;AF=0.99;MQM=59;TRIO=HOM,294,0.99,HOM,343,1.00,HET,446,0.49	TGM1	3'UTR	TGM1:ENST00000206765:3'UTR:MODIFIER:exon15/15:c.*4C>T:,TGM1:ENST00000544573:3'UTR:MODIFIER:exon9/9:c.*4C>T:		rs2229463	0.7163	0.7913	38491,24275,2501	0.6955,0.8538,0.5814,0.8539,0.6753	0.7962							190195 [TGM1 (confirmed) Ichthyosis,congenital,autosomal recessive 1,242300];				1505	553					TGM1 (inh=AR pLI=0.00)
chr14	29238048	29238048	C	-	het	anno_omim	QUAL=2766;DP=182;AF=0.46;MQM=59;TRIO=HET,182,0.46,WT,81,0.00,HET,113,0.48	FOXG1	3'UTR	FOXG1:ENST00000313071:3'UTR:MODIFIER:exon1/1:c.*100delC:,FOXG1:ENST00000382535:3'UTR:MODIFIER:exon2/2:c.*100delC:		rs397788971	0.0737	0.0000	0,0,0	0,0,0,0,0	0.0631							164874 [FOXG1 (confirmed) Rett syndrome,congenital variant,613454];				0	27					FOXG1 (inh=AD pLI=n/a)
chr14	32047217	32047217	T	C	het	anno_omim	QUAL=8895;DP=360;AF=0.48;MQM=60;TRIO=HET,360,0.48,HET,360,0.48,WT,353,0.01	NUBPL	intron	NUBPL:ENST00000281081:intron:MODIFIER:exon3/10:c.291+12963T>C:	L2c	rs7142098	0.3041	0.3886	864,169,6	0.0000,0.0000,0.0000,0.3336,0.4115	0.3532							613621 [NUBPL (provisional) Mitochondrial complex I deficiency,252010];				274	928					NUBPL (inh=AR pLI=0.00)
chr14	32183848	32183848	C	T	het	anno_omim	QUAL=16210;DP=249;AF=0.51;MQM=59;TRIO=HET,249,1.00,HET,136,1.00,WT,166,1.00	NUBPL	intron	NUBPL:ENST00000281081:intron:MODIFIER:exon6/10:c.513+41068C>T:,NUBPL:ENST00000536705:intron:MODIFIER:exon4/8:c.225+41068C>T:	MSTB	rs11623835	0.2829	0.0000	0,0,0	0,0,0,0,0	0.2997							613621 [NUBPL (provisional) Mitochondrial complex I deficiency,252010];				26	66					NUBPL (inh=AR pLI=0.00)
chr14	32183849	32183849	A	G	hom	anno_omim	QUAL=16210;DP=249;AF=0.51;MQM=59;TRIO=HOM,249,1.00,HOM,136,1.00,HOM,166,1.00	NUBPL	intron	NUBPL:ENST00000281081:intron:MODIFIER:exon6/10:c.513+41069A>G:,NUBPL:ENST00000536705:intron:MODIFIER:exon4/8:c.225+41069A>G:	MSTB	rs11156699	0.7063	0.0000	0,0,0	0,0,0,0,0	0.7400							613621 [NUBPL (provisional) Mitochondrial complex I deficiency,252010];				142	9					NUBPL (inh=AR pLI=0.00)
chr14	32183970	32183970	A	T	het	anno_omim	QUAL=4632;DP=252;AF=0.50;MQM=59;TRIO=HET,252,0.50,HET,101,0.57,WT,105,0.00	NUBPL	intron	NUBPL:ENST00000281081:intron:MODIFIER:exon6/10:c.513+41190A>T:,NUBPL:ENST00000536705:intron:MODIFIER:exon4/8:c.225+41190A>T:	MLT1L	rs11624772	0.2829	0.0000	0,0,0	0,0,0,0,0	0.2998							613621 [NUBPL (provisional) Mitochondrial complex I deficiency,252010];				26	66					NUBPL (inh=AR pLI=0.00)
chr14	35180389	35180389	T	A	het	anno_omim	QUAL=7032;DP=233;AF=0.52;MQM=59;TRIO=HET,233,0.52,HOM,78,1.00,HET,115,0.54	CFL2	3'UTR	CFL2:ENST00000298159:3'UTR:MODIFIER:exon4/4:c.*1682A>T:,CFL2:ENST00000341223:3'UTR:MODIFIER:exon4/4:c.*1682A>T:		rs712301	0.3421	0.4130	972,410,20	0.3671,0.0000,0.0000,0.5380,0.3718	0.4619							601443 [CFL2 (confirmed) Nemaline myopathy 7,autosomal recessive,610687];	RCV000269932.1 [benign]; 			178	292					CFL2 (inh=AR pLI=0.16)
chr14	35180678	35180678	T	-	het	anno_omim	QUAL=15673;DP=297;AF=0.55;MQM=59;TRIO=HET,297,0.55,HOM,222,1.00,HET,293,0.55	CFL2	3'UTR	CFL2:ENST00000298159:3'UTR:MODIFIER:exon4/4:c.*1393delA:,CFL2:ENST00000341223:3'UTR:MODIFIER:exon4/4:c.*1393delA:		rs398024763	0.6595	0.7591	3602,1221,187	0.8232,0.0000,0.0000,0.8209,0.7398	0.7636							601443 [CFL2 (confirmed) Nemaline myopathy 7,autosomal recessive,610687];	RCV000308670.1 [benign]; 			400	218					CFL2 (inh=AR pLI=0.16)
chr14	36986023	36986023	A	-	hom	anno_omim	QUAL=837;DP=102;AF=0.10;MQM=59;TRIO=HOM,102,0.10,HET,89,0.26,WT,132,0.10	NKX2-1,RP11-896J10.3	3'UTR	NKX2-1:ENST00000354822:3'UTR:MODIFIER:exon3/3:c.*460delT:,NKX2-1:ENST00000498187:3'UTR:MODIFIER:exon2/2:c.*460delT:,NKX2-1:ENST00000518149:3'UTR:MODIFIER:exon3/3:c.*460delT:		rs5807883	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1233							600635 [NKX2-1 (provisional) Thyroid cancer,monmedullary,1,188550|Chorea,hereditary benign,118700|Choreoathetosis,hypothyroidism,and neonatal respiratory distress,610978];	RCV000286589.1 [uncertain significance]; RCV000334608.1 [uncertain significance]; 			16	43					NKX2-1 (inh=AD pLI=0.08), RP11-896J10.3 (inh=n/a pLI=n/a)
chr14	36986273	36986273	A	T	hom	anno_omim	QUAL=4795;DP=100;AF=0.94;MQM=60;TRIO=HOM,100,0.95,HET,30,0.97,HOM,39,1.00	NKX2-1,RP11-896J10.3	3'UTR	NKX2-1:ENST00000354822:3'UTR:MODIFIER:exon3/3:c.*210T>A:,NKX2-1:ENST00000498187:3'UTR:MODIFIER:exon2/2:c.*210T>A:,NKX2-1:ENST00000518149:3'UTR:MODIFIER:exon3/3:c.*210T>A:		rs10139625	0.6218	0.0000	0,0,0	0,0,0,0,0	0.6747							600635 [NKX2-1 (provisional) Thyroid cancer,monmedullary,1,188550|Chorea,hereditary benign,118700|Choreoathetosis,hypothyroidism,and neonatal respiratory distress,610978];	RCV000274909.1 [benign]; RCV000369541.1 [benign]; 			98	107					NKX2-1 (inh=AD pLI=0.08), RP11-896J10.3 (inh=n/a pLI=n/a)
chr14	50087753	50087753	T	C	het	anno_omim	QUAL=8353;DP=50;AF=0.38;MQM=60;TRIO=HET,50,0.38,HET,130,0.43,HOM,234,0.99	MGAT2,RP11-649E7.5	5'UTR	MGAT2:ENST00000305386:5'UTR:MODIFIER:exon1/1:c.-234T>C:		rs7519	0.2953	0.4935	1352,444,4	0.0000,0.0000,0.0000,0.5695,0.4808	0.4260							602616 [MGAT2 (provisional) Congenital disorder of glycosylation,type IIa,212066];	RCV000329751.1 [benign]; RCV000389040.1 [benign]; 			434	732					MGAT2 (inh=AR pLI=0.96), RP11-649E7.5 (inh=n/a pLI=n/a)
chr14	50712569	50712569	A	G	hom	anno_omim	QUAL=15904;DP=221;AF=0.99;MQM=59;TRIO=HOM,221,0.99,HOM,197,1.00,HET,233,0.47	L2HGDH	3'UTR,intron	L2HGDH:ENST00000267436:3'UTR:MODIFIER:exon10/10:c.*1207T>C:,L2HGDH:ENST00000421284:3'UTR:MODIFIER:exon11/11:c.*287T>C:,L2HGDH:ENST00000261699:intron:MODIFIER:exon9/9:c.1197-8126T>C:	AluSq2	rs7157035	0.8377	0.0000	0,0,0	0,0,0,0,0	0.8725							609584 [L2HGDH (confirmed) L-2-hydroxyglutaric aciduria,236792];				168	61					L2HGDH (inh=AR pLI=0.31)
chr14	50712797	50712797	T	C	hom	anno_omim	QUAL=8504;DP=153;AF=1.00;MQM=54;TRIO=HOM,153,1.00,HOM,74,1.00,HET,141,0.51	L2HGDH	3'UTR,intron	L2HGDH:ENST00000267436:3'UTR:MODIFIER:exon10/10:c.*979A>G:,L2HGDH:ENST00000421284:3'UTR:MODIFIER:exon11/11:c.*59A>G:,L2HGDH:ENST00000261699:intron:MODIFIER:exon9/9:c.1197-8354A>G:	AluSq2	rs1964845	0.8902	0.0000	0,0,0	0,0,0,0,0	0.9128							609584 [L2HGDH (confirmed) L-2-hydroxyglutaric aciduria,236792];				159	44					L2HGDH (inh=AR pLI=0.31)
chr14	50712852	50712852	T	A	hom	anno_omim	QUAL=8940;DP=189;AF=0.87;MQM=57;TRIO=HOM,189,0.87,HOM,89,0.90,HET,166,0.36	L2HGDH	splice_region&intron,3'UTR,intron	L2HGDH:ENST00000421284:splice_region&intron:LOW:exon10/10:c.*18-14A>T:,L2HGDH:ENST00000267436:3'UTR:MODIFIER:exon10/10:c.*924A>T:,L2HGDH:ENST00000261699:intron:MODIFIER:exon9/9:c.1197-8409A>T:	AluSq2	rs6572652	0.8377	0.0000	0,0,0	0,0,0,0,0	0.8528							609584 [L2HGDH (confirmed) L-2-hydroxyglutaric aciduria,236792];				102	74					L2HGDH (inh=AR pLI=0.31)
chr14	50712980	50712980	A	G	het	anno_omim	QUAL=5125;DP=196;AF=0.49;MQM=59;TRIO=HET,196,0.49,HOM,88,1.00,WT,150,0.00	L2HGDH	3'UTR,intron	L2HGDH:ENST00000267436:3'UTR:MODIFIER:exon10/10:c.*796T>C:,L2HGDH:ENST00000261699:intron:MODIFIER:exon9/9:c.1197-8537T>C:,L2HGDH:ENST00000421284:intron:MODIFIER:exon10/10:c.*18-142T>C:	AluJb	rs74541550	0.2756	0.0000	0,0,0	0,0,0,0,0	0.2413							609584 [L2HGDH (confirmed) L-2-hydroxyglutaric aciduria,236792];				11	55					L2HGDH (inh=AR pLI=0.31)
chr14	50713679	50713679	T	G	hom	anno_omim	QUAL=10438;DP=185;AF=1.00;MQM=59;TRIO=HOM,185,1.00,HOM,62,1.00,HOM,78,1.00	L2HGDH	3'UTR,intron	L2HGDH:ENST00000267436:3'UTR:MODIFIER:exon10/10:c.*97A>C:,L2HGDH:ENST00000261699:intron:MODIFIER:exon9/9:c.1197-9236A>C:,L2HGDH:ENST00000421284:intron:MODIFIER:exon10/10:c.*17+80A>C:		rs7143186	0.9990	0.0000	0,0,0	0,0,0,0,0	0.9973							609584 [L2HGDH (confirmed) L-2-hydroxyglutaric aciduria,236792];				229	2					L2HGDH (inh=AR pLI=0.31)
chr14	50769717	50769717	G	A	hom	anno_omim	QUAL=21683;DP=381;AF=1.00;MQM=60;TRIO=HOM,381,1.00,HOM,201,1.00,HET,220,0.50	L2HGDH	synonymous	L2HGDH:ENST00000267436:synonymous:LOW:exon2/10:c.159C>T:p.Ile53Ile,L2HGDH:ENST00000261699:synonymous:LOW:exon2/10:c.159C>T:p.Ile53Ile,L2HGDH:ENST00000421284:synonymous:LOW:exon2/11:c.159C>T:p.Ile53Ile,L2HGDH:ENST00000555423:synonymous:LOW:exon2/6:c.159C>T:p.Ile53Ile,L2HGDH:ENST00000555610:synonymous:LOW:exon2/6:c.159C>T:p.Ile53Ile		rs2297995	0.5966	0.5701	19824,10678,1970	0.6178,0.4705,0.6581,0.5669,0.5730	0.5955							609584 [L2HGDH (confirmed) L-2-hydroxyglutaric aciduria,236792];	RCV000146249.1 [likely benign]; 		COSM4150800, COSM4150799	1054	1605					L2HGDH (inh=AR pLI=0.31)
chr14	50778816	50778816	A	C	hom	pred_pathogenic;anno_omim	QUAL=5287;DP=44;AF=0.98;MQM=59;TRIO=HOM,44,0.98,HOM,84,1.00,HET,117,0.51	L2HGDH	missense	L2HGDH:ENST00000267436:missense:MODERATE:exon1/10:c.53T>G:p.Leu18Arg,L2HGDH:ENST00000261699:missense:MODERATE:exon1/10:c.53T>G:p.Leu18Arg,L2HGDH:ENST00000421284:missense:MODERATE:exon1/11:c.53T>G:p.Leu18Arg,L2HGDH:ENST00000555423:missense:MODERATE:exon1/6:c.53T>G:p.Leu18Arg,L2HGDH:ENST00000555610:missense:MODERATE:exon1/6:c.53T>G:p.Leu18Arg		rs2275591	0.5727	0.5999	16174,9166,1257	0.5989,0.5625,0.6375,0.6078,0.5650	0.5831	-4.0100	T,T,T,T,T,T	T	B,B	D,D,D,D,D	0.01	609584 [L2HGDH (confirmed) L-2-hydroxyglutaric aciduria,236792];	RCV000146250.1 [likely benign]; 		COSM3753977, COSM433105	1071	1606					L2HGDH (inh=AR pLI=0.31)
chr14	51054598	51054598	A	G	het	anno_omim	QUAL=7700;DP=213;AF=0.49;MQM=60;TRIO=HET,213,0.49,WT,229,0.00,HET,363,0.55	ATL1	synonymous	ATL1:ENST00000357032:synonymous:LOW:exon2/14:c.84A>G:p.Pro28Pro,ATL1:ENST00000441560:synonymous:LOW:exon3/14:c.84A>G:p.Pro28Pro,ATL1:ENST00000354525:synonymous:LOW:exon2/13:c.84A>G:p.Pro28Pro,ATL1:ENST00000358385:synonymous:LOW:exon2/14:c.84A>G:p.Pro28Pro		rs35014209	0.1641	0.1359	1425,664,552	0.3238,0.0866,0.0767,0.1377,0.0764	0.1802							606439 [ATL1 (confirmed) Spastic paraplegia 3A,autosomal dominant,182600|Neuropathy,hereditary sensory,type ID,613708];	RCV000020724.1 [benign]; RCV000116421.3 [other]; RCV000335510.1 [benign]; 		COSM3753981	50	647					ATL1 (inh=AD pLI=0.99)
chr14	51057727	51057727	G	A	hom	anno_omim	QUAL=15292;DP=293;AF=1.00;MQM=60;TRIO=HOM,293,1.00,HET,213,0.43,HET,245,0.46	ATL1	synonymous	ATL1:ENST00000357032:synonymous:LOW:exon3/14:c.351G>A:p.Glu117Glu,ATL1:ENST00000441560:synonymous:LOW:exon4/14:c.351G>A:p.Glu117Glu,ATL1:ENST00000354525:synonymous:LOW:exon3/13:c.351G>A:p.Glu117Glu,ATL1:ENST00000358385:synonymous:LOW:exon3/14:c.351G>A:p.Glu117Glu		rs1060197	0.8215	0.7633	35571,17438,4515	0.9317,0.8330,0.8206,0.7237,0.7446	0.8022							606439 [ATL1 (confirmed) Spastic paraplegia 3A,autosomal dominant,182600|Neuropathy,hereditary sensory,type ID,613708];	RCV000020720.1 [benign]; RCV000116420.2 [likely benign]; RCV000392328.1 [benign]; 			1390	1061	1	[1] old entry - no details available	n/a (2xTP, 0xFP)		ATL1 (inh=AD pLI=0.99)
chr14	51062357	51062357	G	A	het	anno_omim	QUAL=5485;DP=205;AF=0.49;MQM=59;TRIO=HET,205,0.49,WT,165,0.00,HET,230,0.49	ATL1	splice_region&intron	ATL1:ENST00000357032:splice_region&intron:LOW:exon6/13:c.630+7G>A:,ATL1:ENST00000441560:splice_region&intron:LOW:exon7/13:c.630+7G>A:,ATL1:ENST00000354525:splice_region&intron:LOW:exon6/12:c.630+7G>A:,ATL1:ENST00000358385:splice_region&intron:LOW:exon6/13:c.630+7G>A:		rs3759588	0.1494	0.1331	1300,692,398	0.2789,0.0859,0.0756,0.1399,0.0768	0.1689							606439 [ATL1 (confirmed) Spastic paraplegia 3A,autosomal dominant,182600|Neuropathy,hereditary sensory,type ID,613708];	RCV000123709.1 [benign]; RCV000362910.1 [benign]; 		COSM3999276	51	639					ATL1 (inh=AD pLI=0.99)
chr14	55308770	55308770	C	A	hom	anno_omim	QUAL=8146;DP=154;AF=1.00;MQM=60;TRIO=HOM,154,1.00,HOM,48,1.00,HOM,59,1.00	GCH1	3'UTR	GCH1:ENST00000395514:3'UTR:MODIFIER:exon7/7:c.*1019G>T:,GCH1:ENST00000543643:3'UTR:MODIFIER:exon7/7:c.*1015G>T:,GCH1:ENST00000491895:3'UTR:MODIFIER:exon6/6:c.*1965G>T:,GCH1:ENST00000536224:3'UTR:MODIFIER:exon6/6:c.*987G>T:		rs6572984	0.9900	0.0000	0,0,0	0,0,0,0,0	0.9910							600225 [GCH1 (provisional) Dystonia,DOPA-responsive,with or without hyperphenylalaninemia,128230|Hyperphenylalaninemia,BH4-deficient,B,233910];				266	0					GCH1 (inh=AD pLI=0.94)
chr14	55369502	55369502	A	G	hom	low_DP;anno_omim	QUAL=1272;DP=9;AF=1.00;MQM=59;TRIO=HOM,9,1.00,HOM,14,1.00,HOM,21,1.00	GCH1	5'UTR	GCH1:ENST00000395514:5'UTR:MODIFIER:exon1/7:c.-121T>C:,GCH1:ENST00000543643:5'UTR:MODIFIER:exon1/7:c.-121T>C:,GCH1:ENST00000491895:5'UTR:MODIFIER:exon1/6:c.-121T>C:,GCH1:ENST00000536224:5'UTR:MODIFIER:exon1/6:c.-121T>C:		rs1753589	0.9457	0.0000	0,0,0	0,0,0,0,0	0.9614							600225 [GCH1 (provisional) Dystonia,DOPA-responsive,with or without hyperphenylalaninemia,128230|Hyperphenylalaninemia,BH4-deficient,B,233910];	RCV000265291.1 [benign]; RCV000357872.1 [benign]; 			268	6					GCH1 (inh=AD pLI=0.94)
chr14	57268443	57268443	C	T	het	anno_omim	QUAL=5031;DP=279;AF=0.43;MQM=59;TRIO=HET,279,0.43,HET,144,0.49,WT,193,0.00	OTX2	3'UTR	OTX2:ENST00000339475:3'UTR:MODIFIER:exon5/5:c.*10G>A:		rs171978	0.0315	0.0662	338,303,3	0.0149,0.0491,0.0000,0.0987,0.0190	0.0647							600037 [OTX2 (confirmed) Microphthalmia,syndromic 5,610125|Pituitary hormone deficiency,combined,6,613986|Retinal dystrophy,early-onset,with or without pituitary dysfunction,610125];	RCV000265380.1 [likely benign]; RCV000318117.1 [likely benign]; RCV000357798.1 [likely benign]; RCV000364347.1 [benign]; RCV000375013.1 [likely benign]; 			22	338					OTX2 (inh=AD pLI=0.74)
chr14	64491695	64491695	T	C	hom	gene_blacklist;anno_omim	QUAL=28525;DP=395;AF=1.00;MQM=59;TRIO=HOM,395,1.00,HOM,231,1.00,HOM,253,1.00	SYNE2	missense,5'UTR	SYNE2:ENST00000358025:missense:MODERATE:exon40/116:c.5906T>C:p.Met1969Thr,SYNE2:ENST00000344113:missense:MODERATE:exon40/115:c.5906T>C:p.Met1969Thr,SYNE2:ENST00000554584:missense:MODERATE:exon39/115:c.5906T>C:p.Met1969Thr,SYNE2:ENST00000357395:5'UTR:MODIFIER:exon40/116:c.-5009T>C:		rs4902264	0.6789	0.8118	40789,25249,878	0.4132,0.8016,0.7883,0.8695,0.8087	0.8163	0.1190	T,T,T,T	T	B,B	T,T,T	0.19	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant,612999];	RCV000118541.1 [benign]; RCV000350785.1 [benign]; 			1590	551					SYNE2 (inh=AD pLI=0.00)
chr14	64494278	64494278	C	T	hom	gene_blacklist;anno_omim	QUAL=16646;DP=287;AF=1.00;MQM=60;TRIO=HOM,287,1.00,HOM,96,1.00,HOM,119,1.00	SYNE2	synonymous,5'UTR	SYNE2:ENST00000358025:synonymous:LOW:exon43/116:c.6481C>T:p.Leu2161Leu,SYNE2:ENST00000344113:synonymous:LOW:exon43/115:c.6481C>T:p.Leu2161Leu,SYNE2:ENST00000554584:synonymous:LOW:exon42/115:c.6481C>T:p.Leu2161Leu,SYNE2:ENST00000357395:5'UTR:MODIFIER:exon43/116:c.-4434C>T:		rs10151127	0.7520	0.8693	46325,27862,1488	0.5470,0.9370,0.8353,0.9137,0.8283	0.8766							608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant,612999];	RCV000118543.2 [benign]; RCV000339334.1 [benign]; 			1740	440					SYNE2 (inh=AD pLI=0.00)
chr14	64496749	64496749	C	T	hom	gene_blacklist;anno_omim	QUAL=12599;DP=218;AF=1.00;MQM=60;TRIO=HOM,218,1.00,HOM,85,1.00,HOM,97,1.00	SYNE2	missense,5'UTR	SYNE2:ENST00000358025:missense:MODERATE:exon44/116:c.6851C>T:p.Ala2284Val,SYNE2:ENST00000344113:missense:MODERATE:exon44/115:c.6851C>T:p.Ala2284Val,SYNE2:ENST00000554584:missense:MODERATE:exon43/115:c.6851C>T:p.Ala2284Val,SYNE2:ENST00000357395:5'UTR:MODIFIER:exon44/116:c.-4064C>T:		rs4027402	0.6719	0.8122	40858,25441,856	0.4075,0.8285,0.7810,0.8730,0.7860	0.8179	0.3380	T,T,T,T	T	B,B	T,T,T	11.46	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant,612999];	RCV000118544.1 [benign]; RCV000364940.1 [benign]; 			1581	561					SYNE2 (inh=AD pLI=0.00)
chr14	64497930	64497930	G	A	hom	gene_blacklist;anno_omim	QUAL=33185;DP=485;AF=1.00;MQM=60;TRIO=HOM,485,1.00,HOM,230,1.00,HOM,308,0.99	SYNE2	missense,5'UTR	SYNE2:ENST00000358025:missense:MODERATE:exon45/116:c.7076G>A:p.Ser2359Asn,SYNE2:ENST00000344113:missense:MODERATE:exon45/115:c.7076G>A:p.Ser2359Asn,SYNE2:ENST00000554584:missense:MODERATE:exon44/115:c.7076G>A:p.Ser2359Asn,SYNE2:ENST00000357395:5'UTR:MODIFIER:exon45/116:c.-3839G>A:		rs4027404	0.7025	0.8209	41396,25465,1249	0.5005,0.8328,0.7824,0.8733,0.7895	0.8252	0.9820	T,T,T,T	T	B,B	T,T,T	5.52	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant,612999];	RCV000118548.1 [benign]; RCV000281736.1 [benign]; 			1594	556					SYNE2 (inh=AD pLI=0.00)
chr14	64498037	64498037	G	A	hom	gene_blacklist;pred_pathogenic;anno_omim	QUAL=23671;DP=284;AF=1.00;MQM=59;TRIO=HOM,284,1.00,HOM,190,1.00,HOM,274,1.00	SYNE2	missense,5'UTR	SYNE2:ENST00000358025:missense:MODERATE:exon45/116:c.7183G>A:p.Ala2395Thr,SYNE2:ENST00000344113:missense:MODERATE:exon45/115:c.7183G>A:p.Ala2395Thr,SYNE2:ENST00000554584:missense:MODERATE:exon44/115:c.7183G>A:p.Ala2395Thr,SYNE2:ENST00000357395:5'UTR:MODIFIER:exon45/116:c.-3732G>A:		rs4027405	0.8373	0.8924	48092,27760,2937	0.7782,0.9470,0.8479,0.9137,0.8451	0.8951	1.8170	T,T,T,T	T	B,B	T,T,T	22.90	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant,612999];	RCV000118551.1 [benign]; RCV000393202.1 [benign]; 			1764	427					SYNE2 (inh=AD pLI=0.00)
chr14	64519035	64519035	A	G	hom	gene_blacklist;anno_omim	QUAL=25977;DP=298;AF=0.99;MQM=60;TRIO=HOM,298,0.99,HOM,234,1.00,HOM,262,1.00	SYNE2	missense,5'UTR	SYNE2:ENST00000358025:missense:MODERATE:exon48/116:c.8404A>G:p.Ser2802Gly,SYNE2:ENST00000344113:missense:MODERATE:exon48/115:c.8404A>G:p.Ser2802Gly,SYNE2:ENST00000554584:missense:MODERATE:exon48/115:c.8503A>G:p.Ser2835Gly,SYNE2:ENST00000357395:5'UTR:MODIFIER:exon48/116:c.-2511A>G:		rs1890908	0.8618	0.9068	49811,28871,3670	0.8666,0.9554,0.8491,0.9299,0.8195	0.9162	-1.6090	T,T,T,T	T	B,B	T,T,T	0.01	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant,612999];	RCV000118553.1 [benign]; RCV000280345.1 [benign]; 			1864	336					SYNE2 (inh=AD pLI=0.00)
chr14	64519455	64519455	A	G	hom	gene_blacklist;anno_omim	QUAL=31160;DP=407;AF=1.00;MQM=59;TRIO=HOM,407,1.00,HOM,231,1.00,HOM,315,1.00	SYNE2	missense,5'UTR	SYNE2:ENST00000358025:missense:MODERATE:exon48/116:c.8824A>G:p.Ile2942Val,SYNE2:ENST00000344113:missense:MODERATE:exon48/115:c.8824A>G:p.Ile2942Val,SYNE2:ENST00000554584:missense:MODERATE:exon48/115:c.8923A>G:p.Ile2975Val,SYNE2:ENST00000357395:5'UTR:MODIFIER:exon48/116:c.-2091A>G:		rs3829767	0.6651	0.8031	39757,24554,758	0.3874,0.8198,0.7874,0.8603,0.7882	0.8082	-0.8420	T,T,T,T	T	B,B	T,T,T	0.01	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant,612999];	RCV000118556.1 [benign]; RCV000377044.1 [benign]; 			1568	579					SYNE2 (inh=AD pLI=0.00)
chr14	64522674	64522674	G	C	hom	gene_blacklist;pred_pathogenic;anno_omim	QUAL=21764;DP=285;AF=1.00;MQM=59;TRIO=HOM,285,1.00,HOM,180,0.99,HOM,224,1.00	SYNE2	missense,5'UTR	SYNE2:ENST00000358025:missense:MODERATE:exon49/116:c.9757G>C:p.Asp3253His,SYNE2:ENST00000344113:missense:MODERATE:exon49/115:c.9757G>C:p.Asp3253His,SYNE2:ENST00000554584:missense:MODERATE:exon49/115:c.9856G>C:p.Asp3286His,SYNE2:ENST00000357395:5'UTR:MODIFIER:exon49/116:c.-1158G>C:		rs8010911	0.6813	0.8076	40017,24574,972	0.4440,0.8225,0.7869,0.8600,0.7881	0.8117	2.7620	T,T,T,T	T	B,B	T,T,T	24.40	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant,612999];	RCV000118560.1 [benign]; RCV000384721.1 [benign]; 			1564	573					SYNE2 (inh=AD pLI=0.00)
chr14	64522843	64522843	A	G	hom	gene_blacklist;pred_pathogenic;anno_omim	QUAL=40103;DP=430;AF=1.00;MQM=60;TRIO=HOM,430,1.00,HOM,367,1.00,HOM,451,1.00	SYNE2	missense,5'UTR	SYNE2:ENST00000358025:missense:MODERATE:exon49/116:c.9926A>G:p.His3309Arg,SYNE2:ENST00000344113:missense:MODERATE:exon49/115:c.9926A>G:p.His3309Arg,SYNE2:ENST00000554584:missense:MODERATE:exon49/115:c.10025A>G:p.His3342Arg,SYNE2:ENST00000357395:5'UTR:MODIFIER:exon49/116:c.-989A>G:		rs8010699	0.6823	0.8074	40218,24698,987	0.4444,0.8225,0.7873,0.8599,0.7877	0.8122	1.1020	D,D,T,T	T	B,B	T,T,T	0.57	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant,612999];	RCV000118561.1 [benign]; RCV000344125.1 [benign]; 			1568	581					SYNE2 (inh=AD pLI=0.00)
chr14	64565536	64565536	C	T	het	anno_omim	QUAL=8560;DP=377;AF=0.53;MQM=60;TRIO=HET,377,0.53,WT,247,0.00,HET,316,0.47	SYNE2,ESR2	synonymous,intron	SYNE2:ENST00000358025:synonymous:LOW:exon63/116:c.12378C>T:p.Ser4126Ser,SYNE2:ENST00000357395:synonymous:LOW:exon64/116:c.1533C>T:p.Ser511Ser,SYNE2:ENST00000344113:synonymous:LOW:exon63/115:c.12378C>T:p.Ser4126Ser,SYNE2:ENST00000554584:synonymous:LOW:exon63/115:c.12477C>T:p.Ser4159Ser,SYNE2:ENST00000555002:synonymous:LOW:exon14/67:c.2280C>T:p.Ser760Ser,SYNE2:ENST00000394768:synonymous:LOW:exon11/63:c.1533C>T:p.Ser511Ser,ESR2:ENST00000542956:intron:MODIFIER:exon8/8:c.1407-13766G>A:		rs36007735	0.0024	0.0056	3,3,0	0.0011,0.0014,0.0000,0.0083,0.0026	0.0066							608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant,612999];	RCV000179624.1 [benign]; RCV000278335.1 [likely benign]; 		COSM1240354	0	44					SYNE2 (inh=AD pLI=0.00), ESR2 (inh=n/a pLI=0.00)
chr14	64612845	64612845	C	T	het	anno_omim	QUAL=7498;DP=259;AF=0.56;MQM=60;TRIO=HET,259,0.56,WT,157,0.00,HET,240,0.58	SYNE2,ESR2	synonymous,intron	SYNE2:ENST00000358025:synonymous:LOW:exon84/116:c.15543C>T:p.Ile5181Ile,SYNE2:ENST00000357395:synonymous:LOW:exon85/116:c.4698C>T:p.Ile1566Ile,SYNE2:ENST00000344113:synonymous:LOW:exon84/115:c.15543C>T:p.Ile5181Ile,SYNE2:ENST00000554584:synonymous:LOW:exon82/115:c.15294C>T:p.Ile5098Ile,SYNE2:ENST00000555002:synonymous:LOW:exon35/67:c.5445C>T:p.Ile1815Ile,SYNE2:ENST00000394768:synonymous:LOW:exon32/63:c.4698C>T:p.Ile1566Ile,ESR2:ENST00000542956:intron:MODIFIER:exon8/8:c.1407-61075G>A:		rs11629287	0.4419	0.3709	8457,3585,1500	0.5463,0.4028,0.5121,0.3324,0.3280	0.4080							608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant,612999];	RCV000118519.1 [benign]; RCV000273835.1 [benign]; 		COSM1128227	241	931					SYNE2 (inh=AD pLI=0.00), ESR2 (inh=n/a pLI=0.00)
chr14	64612858	64612858	C	A	het	anno_omim	QUAL=8063;DP=264;AF=0.57;MQM=60;TRIO=HET,264,0.57,WT,177,0.01,HET,268,0.57	SYNE2,ESR2	missense,intron	SYNE2:ENST00000358025:missense:MODERATE:exon84/116:c.15556C>A:p.Leu5186Met,SYNE2:ENST00000357395:missense:MODERATE:exon85/116:c.4711C>A:p.Leu1571Met,SYNE2:ENST00000344113:missense:MODERATE:exon84/115:c.15556C>A:p.Leu5186Met,SYNE2:ENST00000554584:missense:MODERATE:exon82/115:c.15307C>A:p.Leu5103Met,SYNE2:ENST00000555002:missense:MODERATE:exon35/67:c.5458C>A:p.Leu1820Met,SYNE2:ENST00000394768:missense:MODERATE:exon32/63:c.4711C>A:p.Leu1571Met,ESR2:ENST00000542956:intron:MODIFIER:exon8/8:c.1407-61088G>T:		rs10151658	0.6318	0.5031	16305,6360,3881	0.8630,0.4955,0.6524,0.4356,0.5065	0.5669	-0.5950	T,T,T,T,T,T,T	T	B,B,B,B	T,T,T,T,T,T	1.26	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant,612999];	RCV000118520.1 [benign]; RCV000331267.1 [benign]; 		COSM1128226	489	1062					SYNE2 (inh=AD pLI=0.00), ESR2 (inh=n/a pLI=0.00)
chr14	64637147	64637147	C	A	het	anno_omim	QUAL=7273;DP=202;AF=0.50;MQM=60;TRIO=HET,202,0.50,WT,286,0.00,HET,388,0.50	SYNE2,ESR2	synonymous,intron	SYNE2:ENST00000358025:synonymous:LOW:exon94/116:c.17202C>A:p.Leu5734Leu,SYNE2:ENST00000357395:synonymous:LOW:exon95/116:c.6357C>A:p.Leu2119Leu,SYNE2:ENST00000344113:synonymous:LOW:exon94/115:c.17202C>A:p.Leu5734Leu,SYNE2:ENST00000555002:synonymous:LOW:exon45/67:c.7104C>A:p.Leu2368Leu,SYNE2:ENST00000394768:synonymous:LOW:exon42/63:c.6357C>A:p.Leu2119Leu,SYNE2:ENST00000554584:intron:MODIFIER:exon91/114:c.16719+108C>A:,ESR2:ENST00000542956:intron:MODIFIER:exon8/8:c.1406+64541G>T:		rs7161192	0.3658	0.3510	6653,3213,668	0.3813,0.2824,0.5817,0.3389,0.3018	0.3496							608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant,612999];	RCV000118525.1 [benign]; RCV000390655.1 [benign]; 			218	938					SYNE2 (inh=AD pLI=0.00), ESR2 (inh=n/a pLI=0.00)
chr14	64656855	64656855	T	C	het	anno_omim	QUAL=5887;DP=227;AF=0.51;MQM=60;TRIO=HET,227,0.51,WT,138,0.01,HET,210,0.50	SYNE2,ESR2	synonymous,intron	SYNE2:ENST00000358025:synonymous:LOW:exon99/116:c.17938T>C:p.Leu5980Leu,SYNE2:ENST00000357395:synonymous:LOW:exon100/116:c.7093T>C:p.Leu2365Leu,SYNE2:ENST00000344113:synonymous:LOW:exon99/115:c.17938T>C:p.Leu5980Leu,SYNE2:ENST00000554584:synonymous:LOW:exon97/115:c.17527T>C:p.Leu5843Leu,SYNE2:ENST00000555002:synonymous:LOW:exon50/67:c.7840T>C:p.Leu2614Leu,SYNE2:ENST00000394768:synonymous:LOW:exon47/63:c.7093T>C:p.Leu2365Leu,ESR2:ENST00000542956:intron:MODIFIER:exon8/8:c.1406+44833A>G:		rs2256191	0.4870	0.3943	10411,4412,2967	0.7543,0.3568,0.3801,0.3590,0.3884	0.4513							608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant,612999];	RCV000118528.1 [benign]; RCV000272822.1 [benign]; 		COSM3999320, COSM3999321	357	1013					SYNE2 (inh=AD pLI=0.00), ESR2 (inh=n/a pLI=0.00)
chr14	64681193	64681193	C	T	het	anno_omim	QUAL=4326;DP=189;AF=0.49;MQM=60;TRIO=HET,189,0.49,WT,51,0.00,HOM,73,1.00	SYNE2,ESR2	splice_region&intron,intron	SYNE2:ENST00000358025:splice_region&intron:LOW:exon106/115:c.19333+5C>T:,SYNE2:ENST00000357395:splice_region&intron:LOW:exon107/115:c.8488+5C>T:,SYNE2:ENST00000344113:splice_region&intron:LOW:exon106/114:c.19333+5C>T:,SYNE2:ENST00000554584:splice_region&intron:LOW:exon107/114:c.19159+5C>T:,SYNE2:ENST00000555002:splice_region&intron:LOW:exon57/66:c.9235+5C>T:,SYNE2:ENST00000394768:splice_region&intron:LOW:exon54/62:c.8488+5C>T:,SYNE2:ENST00000555022:splice_region&intron:LOW:exon7/15:c.967+5C>T:,SYNE2:ENST00000554805:splice_region&intron:LOW:exon5/13:c.682+5C>T:,SYNE2:ENST00000458046:splice_region&intron:LOW:exon1/10:c.235+5C>T:,ESR2:ENST00000542956:intron:MODIFIER:exon8/8:c.1406+20495G>A:		rs1152590	0.5833	0.4702	12006,4538,2895	0.7698,0.4244,0.7022,0.4119,0.4399	0.4996							608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant,612999];	RCV000118529.2 [benign]; RCV000372153.1 [benign]; 			391	982					SYNE2 (inh=AD pLI=0.00), ESR2 (inh=n/a pLI=0.00)
chr14	64686125	64686125	G	T	het	anno_omim	QUAL=5745;DP=115;AF=0.39;MQM=60;TRIO=HET,115,0.39,WT,110,0.00,HOM,156,1.00	SYNE2,ESR2	synonymous,intron	SYNE2:ENST00000358025:synonymous:LOW:exon110/116:c.19857G>T:p.Leu6619Leu,SYNE2:ENST00000357395:synonymous:LOW:exon110/116:c.8943G>T:p.Leu2981Leu,SYNE2:ENST00000344113:synonymous:LOW:exon109/115:c.19788G>T:p.Leu6596Leu,SYNE2:ENST00000554584:synonymous:LOW:exon109/115:c.19536G>T:p.Leu6512Leu,SYNE2:ENST00000555002:synonymous:LOW:exon61/67:c.9759G>T:p.Leu3253Leu,SYNE2:ENST00000394768:synonymous:LOW:exon57/63:c.8943G>T:p.Leu2981Leu,SYNE2:ENST00000555022:synonymous:LOW:exon10/16:c.1422G>T:p.Leu474Leu,SYNE2:ENST00000554805:synonymous:LOW:exon8/14:c.1137G>T:p.Leu379Leu,SYNE2:ENST00000458046:synonymous:LOW:exon5/11:c.759G>T:p.Leu253Leu,SYNE2:ENST00000441438:synonymous:LOW:exon3/9:c.381G>T:p.Leu127Leu,ESR2:ENST00000542956:intron:MODIFIER:exon8/8:c.1406+15563C>A:		rs35648226	0.2097	0.2410	3759,2615,223	0.2156,0.1237,0.0957,0.2817,0.2525	0.2365							608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant,612999];	RCV000118530.1 [benign]; RCV000289541.1 [benign]; 			176	887					SYNE2 (inh=AD pLI=0.00), ESR2 (inh=n/a pLI=0.00)
chr14	64692630	64692630	G	C	het	anno_omim	QUAL=7140;DP=229;AF=0.46;MQM=60;TRIO=HET,229,0.46,WT,118,0.00,HOM,134,1.00	SYNE2,ESR2	3'UTR,intron	SYNE2:ENST00000358025:3'UTR:MODIFIER:exon116/116:c.*386G>C:,SYNE2:ENST00000357395:3'UTR:MODIFIER:exon116/116:c.*386G>C:,SYNE2:ENST00000344113:3'UTR:MODIFIER:exon115/115:c.*386G>C:,SYNE2:ENST00000555002:3'UTR:MODIFIER:exon67/67:c.*386G>C:,SYNE2:ENST00000394768:3'UTR:MODIFIER:exon63/63:c.*386G>C:,SYNE2:ENST00000555022:3'UTR:MODIFIER:exon16/16:c.*386G>C:,SYNE2:ENST00000554805:3'UTR:MODIFIER:exon14/14:c.*386G>C:,SYNE2:ENST00000458046:3'UTR:MODIFIER:exon11/11:c.*386G>C:,SYNE2:ENST00000441438:3'UTR:MODIFIER:exon9/9:c.*386G>C:,ESR2:ENST00000542956:intron:MODIFIER:exon8/8:c.1406+9058C>G:		rs1152582	0.6895	0.0000	0,0,0	0,0,0,0,0	0.6592							608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant,612999];	RCV000385648.1 [benign]; 			78	109					SYNE2 (inh=AD pLI=0.00), ESR2 (inh=n/a pLI=0.00)
chr14	64692825	64692825	G	A	het	anno_omim	QUAL=5936;DP=177;AF=0.41;MQM=60;TRIO=HET,177,0.41,WT,114,0.00,HOM,128,1.00	SYNE2,ESR2	3'UTR,intron	SYNE2:ENST00000358025:3'UTR:MODIFIER:exon116/116:c.*581G>A:,SYNE2:ENST00000357395:3'UTR:MODIFIER:exon116/116:c.*581G>A:,SYNE2:ENST00000344113:3'UTR:MODIFIER:exon115/115:c.*581G>A:,SYNE2:ENST00000555002:3'UTR:MODIFIER:exon67/67:c.*581G>A:,SYNE2:ENST00000394768:3'UTR:MODIFIER:exon63/63:c.*581G>A:,SYNE2:ENST00000555022:3'UTR:MODIFIER:exon16/16:c.*581G>A:,SYNE2:ENST00000554805:3'UTR:MODIFIER:exon14/14:c.*581G>A:,SYNE2:ENST00000458046:3'UTR:MODIFIER:exon11/11:c.*581G>A:,SYNE2:ENST00000441438:3'UTR:MODIFIER:exon9/9:c.*581G>A:,ESR2:ENST00000542956:intron:MODIFIER:exon8/8:c.1406+8863C>T:		rs7229	0.6909	0.0000	0,0,0	0,0,0,0,0	0.6633							608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant,612999];	RCV000373373.1 [benign]; 			77	108					SYNE2 (inh=AD pLI=0.00), ESR2 (inh=n/a pLI=0.00)
chr14	66974474	66974474	T	C	het	anno_omim	QUAL=3493;DP=150;AF=0.48;MQM=59;TRIO=HET,150,0.48,WT,124,0.01,HET,164,0.48	GPHN,RP11-72M17.1	5'UTR	GPHN:ENST00000315266:5'UTR:MODIFIER:exon1/22:c.-772T>C:,GPHN:ENST00000478722:5'UTR:MODIFIER:exon1/23:c.-772T>C:		rs928553	0.4507	0.2890	607,100,118	0.6434,0.0000,0.0000,0.2122,0.2938	0.3171							603930 [GPHN (confirmed) Molybdenum cofactor deficiency C,615501];				103	479					GPHN (inh=n/a pLI=1.00), RP11-72M17.1 (inh=n/a pLI=n/a)
chr14	67147816	67147816	T	C	het	anno_omim	QUAL=3322;DP=175;AF=0.49;MQM=60;TRIO=HET,175,0.49,WT,75,0.00,HET,87,0.49	GPHN	splice_region&intron	GPHN:ENST00000543237:splice_region&intron:LOW:exon1/24:c.65-9T>C:,GPHN:ENST00000315266:splice_region&intron:LOW:exon1/21:c.65-9T>C:,GPHN:ENST00000478722:splice_region&intron:LOW:exon1/22:c.65-9T>C:,GPHN:ENST00000459628:splice_region&intron:LOW:exon1/10:c.65-9T>C:,GPHN:ENST00000305960:splice_region&intron:LOW:exon1/20:c.65-9T>C:		rs3759753	0.4503	0.2661	6113,784,2292	0.6621,0.4415,0.4690,0.1482,0.3131	0.3165							603930 [GPHN (confirmed) Molybdenum cofactor deficiency C,615501];	RCV000252877.1 [benign]; 		COSM147798, COSM3999345	120	604					GPHN (inh=n/a pLI=1.00)
chr14	68213571	68213571	C	T	hom	anno_omim	QUAL=44420;DP=555;AF=1.00;MQM=60;TRIO=HOM,555,1.00,HOM,333,1.00,HOM,471,1.00	ZFYVE26	3'UTR	ZFYVE26:ENST00000347230:3'UTR:MODIFIER:exon42/42:c.*1582G>A:		rs8017209	0.9501	0.0000	0,0,0	0,0,0,0,0	0.9521							612012 [ZFYVE26 (confirmed) Spastic paraplegia 15,autosomal recessive,270700];	RCV000388011.1 [benign]; 			228	4					ZFYVE26 (inh=AR pLI=0.00)
chr14	68213744	68213744	G	A	hom	anno_omim	QUAL=24824;DP=364;AF=1.00;MQM=59;TRIO=HOM,364,1.00,HOM,177,1.00,HOM,213,1.00	ZFYVE26	3'UTR	ZFYVE26:ENST00000347230:3'UTR:MODIFIER:exon42/42:c.*1409C>T:		rs10288	0.9501	0.0000	0,0,0	0,0,0,0,0	0.9520							612012 [ZFYVE26 (confirmed) Spastic paraplegia 15,autosomal recessive,270700];	RCV000270156.1 [benign]; 			227	5					ZFYVE26 (inh=AR pLI=0.00)
chr14	68213792	68213792	A	G	hom	anno_omim	QUAL=28149;DP=369;AF=1.00;MQM=59;TRIO=HOM,369,1.00,HOM,223,0.99,HOM,291,0.99	ZFYVE26	3'UTR	ZFYVE26:ENST00000347230:3'UTR:MODIFIER:exon42/42:c.*1361T>C:		rs1044126	0.3135	0.0000	0,0,0	0,0,0,0,0	0.4546							612012 [ZFYVE26 (confirmed) Spastic paraplegia 15,autosomal recessive,270700];	RCV000325247.1 [benign]; 			72	107					ZFYVE26 (inh=AR pLI=0.00)
chr14	68234539	68234539	T	C	hom	anno_omim	QUAL=35153;DP=312;AF=1.00;MQM=60;TRIO=HOM,312,1.00,HOM,304,1.00,HOM,476,1.00	ZFYVE26	missense	ZFYVE26:ENST00000347230:missense:MODERATE:exon31/42:c.5672A>G:p.Asn1891Ser,ZFYVE26:ENST00000555452:missense:MODERATE:exon31/35:c.5672A>G:p.Asn1891Ser		rs3742883	0.9032	0.9546	55500,32425,3741	0.8483,0.8880,0.8599,0.9858,0.9760	0.9551	-0.3940	T,T,T	T	B	T,T	0.01	612012 [ZFYVE26 (confirmed) Spastic paraplegia 15,autosomal recessive,270700];	RCV000118901.2 [likely benign]; RCV000318199.1 [benign]; 			2675	85					ZFYVE26 (inh=AR pLI=0.00)
chr14	68249499	68249499	C	T	hom	pred_pathogenic;anno_omim	QUAL=11258;DP=238;AF=0.99;MQM=59;TRIO=HOM,238,0.99,HET,136,0.51,HET,159,0.54	ZFYVE26	missense&splice_region	ZFYVE26:ENST00000347230:missense&splice_region:MODERATE:exon21/42:c.4370G>A:p.Cys1457Tyr,ZFYVE26:ENST00000555452:missense&splice_region:MODERATE:exon21/35:c.4370G>A:p.Cys1457Tyr		rs2235967	0.1601	0.2632	5052,4072,40	0.0770,0.1698,0.0223,0.3484,0.2184	0.2619	2.5290	T,T,T	T	B,B	T,T	13.79	612012 [ZFYVE26 (confirmed) Spastic paraplegia 15,autosomal recessive,270700];	RCV000118900.3 [other]; RCV000360357.1 [likely benign]; 		COSM3754058	354	1187					ZFYVE26 (inh=AR pLI=0.00)
chr14	68257485	68257485	C	T	hom	anno_omim	QUAL=7472;DP=104;AF=0.99;MQM=60;TRIO=HOM,104,0.99,HET,154,0.54,HET,213,0.46	ZFYVE26	synonymous	ZFYVE26:ENST00000347230:synonymous:LOW:exon15/42:c.2559G>A:p.Leu853Leu,ZFYVE26:ENST00000555452:synonymous:LOW:exon15/35:c.2559G>A:p.Leu853Leu		rs7143196	0.0747	0.1456	1669,1409,8	0.0385,0.0959,0.0171,0.2022,0.0715	0.1502							612012 [ZFYVE26 (confirmed) Spastic paraplegia 15,autosomal recessive,270700];	RCV000118895.2 [likely benign]; RCV000314307.1 [likely benign]; 			106	826					ZFYVE26 (inh=AR pLI=0.00)
chr14	75476071	75476071	G	C	hom	anno_omim	QUAL=37658;DP=442;AF=0.99;MQM=59;TRIO=HOM,442,0.99,HET,431,0.50,HOM,571,0.99	EIF2B2	3'UTR	EIF2B2:ENST00000266126:3'UTR:MODIFIER:exon8/8:c.*180G>C:		rs4556	0.5176	0.0000	0,0,0	0,0,0,0,0	0.4700							606454 [EIF2B2 (provisional) Leukoencephalopathy with vanishing white matter,603896|Ovarioleukodystrophy,603896];	RCV000295805.1 [benign]; RCV000299748.1 [likely benign]; 			64	129					EIF2B2 (inh=AR pLI=0.00)
chr14	77741394	77741394	T	C	hom	anno_omim	QUAL=9414;DP=201;AF=1.00;MQM=59;TRIO=HOM,201,1.00,HET,71,0.46,HOM,81,0.98	POMT2	3'UTR	POMT2:ENST00000261534:3'UTR:MODIFIER:exon21/21:c.*2325A>G:		rs11547793	0.2913	0.0000	0,0,0	0,0,0,0,0	0.2171							607439 [POMT2 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,2,613150|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,2,613156|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,2,613158];	RCV000405359.1 [likely benign]; 			20	88					POMT2 (inh=AR pLI=0.00)
chr14	77741977	77741977	C	T	hom	anno_omim	QUAL=20064;DP=312;AF=0.99;MQM=59;TRIO=HOM,312,0.99,HET,210,0.54,HOM,254,1.00	POMT2	3'UTR	POMT2:ENST00000261534:3'UTR:MODIFIER:exon21/21:c.*1742G>A:		rs12894594	0.8522	0.0000	0,0,0	0,0,0,0,0	0.8362							607439 [POMT2 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,2,613150|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,2,613156|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,2,613158];	RCV000342374.1 [benign]; 			165	56					POMT2 (inh=AR pLI=0.00)
chr14	77742218	77742218	C	T	hom	anno_omim	QUAL=18940;DP=232;AF=0.98;MQM=60;TRIO=HOM,232,0.98,HET,245,0.51,HOM,280,1.00	POMT2	3'UTR	POMT2:ENST00000261534:3'UTR:MODIFIER:exon21/21:c.*1501G>A:		rs4141640	0.8558	0.0000	0,0,0	0,0,0,0,0	0.8434							607439 [POMT2 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,2,613150|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,2,613156|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,2,613158];	RCV000370357.1 [benign]; 			165	58					POMT2 (inh=AR pLI=0.00)
chr14	77743644	77743644	G	A	hom	anno_omim	QUAL=10214;DP=141;AF=0.96;MQM=60;TRIO=HOM,141,0.96,HET,92,0.62,HOM,151,0.99	POMT2	3'UTR	POMT2:ENST00000261534:3'UTR:MODIFIER:exon21/21:c.*75C>T:		rs1055592	0.2686	0.0000	0,0,0	0,0,0,0,0	0.1993							607439 [POMT2 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,2,613150|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,2,613156|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,2,613158];	RCV000357869.1 [likely benign]; 			20	81					POMT2 (inh=AR pLI=0.00)
chr14	77745193	77745193	A	C	hom	anno_omim	QUAL=23108;DP=126;AF=1.00;MQM=59;TRIO=HOM,126,1.00,HET,339,0.53,HOM,480,1.00	POMT2	synonymous	POMT2:ENST00000261534:synonymous:LOW:exon19/21:c.1911T>G:p.Leu637Leu		rs3209079	0.8470	0.8176	40497,22244,3618	0.8368,0.7247,0.9650,0.8197,0.7749	0.8324	-0.7790		T			1.69	607439 [POMT2 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,2,613150|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,2,613156|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,2,613158];	RCV000153051.3 [benign]; 		COSM4148271	1470	567					POMT2 (inh=AR pLI=0.00)
chr14	77751925	77751925	C	T	hom	anno_omim	QUAL=16953;DP=186;AF=1.00;MQM=60;TRIO=HOM,186,1.00,HET,194,0.52,HOM,257,1.00	POMT2	synonymous	POMT2:ENST00000261534:synonymous:LOW:exon13/21:c.1383G>A:p.Arg461Arg		rs2270419	0.8582	0.8208	41097,22217,3920	0.8690,0.7178,0.9651,0.8162,0.7988	0.8391							607439 [POMT2 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,2,613150|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,2,613156|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,2,613158];	RCV000153056.3 [benign]; 		COSM4148272	1461	579					POMT2 (inh=AR pLI=0.00)
chr14	77893276	77893276	G	A	het	anno_omim	QUAL=10822;DP=339;AF=0.45;MQM=60;TRIO=HET,339,0.45,HET,270,0.51,HET,341,0.39	VIPAS39	3'UTR	VIPAS39:ENST00000327028:3'UTR:MODIFIER:exon20/20:c.*683C>T:,VIPAS39:ENST00000343765:3'UTR:MODIFIER:exon21/21:c.*683C>T:,VIPAS39:ENST00000553888:3'UTR:MODIFIER:exon20/20:c.*683C>T:,VIPAS39:ENST00000557658:3'UTR:MODIFIER:exon20/20:c.*683C>T:		rs4223	0.4896	0.0000	0,0,0	0,0,0,0,0	0.4478							613401 [VIPAS39 (provisional) Arthrogryposis,renal dysfunction,and cholestasis 2,613404];				58	111					VIPAS39 (inh=AR pLI=0.00)
chr14	77893431	77893431	A	G	hom	anno_omim	QUAL=28179;DP=346;AF=1.00;MQM=59;TRIO=HOM,346,1.00,HOM,245,1.00,HOM,267,1.00	VIPAS39	3'UTR	VIPAS39:ENST00000327028:3'UTR:MODIFIER:exon20/20:c.*528T>C:,VIPAS39:ENST00000343765:3'UTR:MODIFIER:exon21/21:c.*528T>C:,VIPAS39:ENST00000553888:3'UTR:MODIFIER:exon20/20:c.*528T>C:,VIPAS39:ENST00000557658:3'UTR:MODIFIER:exon20/20:c.*528T>C:		rs8009177	0.9764	0.0000	0,0,0	0,0,0,0,0	0.9841							613401 [VIPAS39 (provisional) Arthrogryposis,renal dysfunction,and cholestasis 2,613404];				232	0					VIPAS39 (inh=AR pLI=0.00)
chr14	77923783	77923783	C	T	het	anno_omim	QUAL=12548;DP=376;AF=0.43;MQM=60;TRIO=HET,376,0.43,HET,332,0.52,HET,426,0.47	VIPAS39	5'UTR,intron	VIPAS39:ENST00000556412:5'UTR:MODIFIER:exon1/20:c.-45G>A:,VIPAS39:ENST00000553888:5'UTR:MODIFIER:exon1/20:c.-346G>A:,VIPAS39:ENST00000327028:intron:MODIFIER:exon1/19:c.-272+55G>A:,VIPAS39:ENST00000343765:intron:MODIFIER:exon1/20:c.-272+55G>A:,VIPAS39:ENST00000557658:intron:MODIFIER:exon1/19:c.-1+55G>A:,VIPAS39:ENST00000448935:intron:MODIFIER:exon1/18:c.-1+55G>A:		rs11845345	0.1396	0.2265	285,37,0	0.0000,0.0000,0.0000,0.1667,0.2550	0.1949							613401 [VIPAS39 (provisional) Arthrogryposis,renal dysfunction,and cholestasis 2,613404];				68	489					VIPAS39 (inh=AR pLI=0.00)
chr14	77973953	77973953	-	CA	hom	anno_omim	QUAL=14258;DP=206;AF=0.97;MQM=58;TRIO=HOM,206,0.97,HOM,132,1.00,HOM,128,1.00	SPTLC2	3'UTR	SPTLC2:ENST00000216484:3'UTR:MODIFIER:exon12/12:c.*4673_*4674insTG:	AluSz6	rs58831828	0.8512	0.0000	0,0,0	0,0,0,0,0	0.8393							605713 [SPTLC2 (provisional) Neuropathy,hereditary sensory and autonomic,type IC,613640];	RCV000263277.1 [benign]; 			188	40					SPTLC2 (inh=AD pLI=0.82)
chr14	77973982	77973982	T	C	hom	anno_omim	QUAL=19233;DP=312;AF=1.00;MQM=59;TRIO=HOM,312,1.00,HOM,133,1.00,HOM,144,1.00	SPTLC2	3'UTR	SPTLC2:ENST00000216484:3'UTR:MODIFIER:exon12/12:c.*4645A>G:		rs10132095	0.9451	0.0000	0,0,0	0,0,0,0,0	0.9577							605713 [SPTLC2 (provisional) Neuropathy,hereditary sensory and autonomic,type IC,613640];	RCV000316158.1 [benign]; 			227	3					SPTLC2 (inh=AD pLI=0.82)
chr14	77974181	77974181	C	A	hom	anno_omim	QUAL=9626;DP=178;AF=0.99;MQM=59;TRIO=HOM,178,0.99,HOM,55,1.00,HOM,62,1.00	SPTLC2	3'UTR	SPTLC2:ENST00000216484:3'UTR:MODIFIER:exon12/12:c.*4446G>T:		rs11159268	0.5962	0.0000	0,0,0	0,0,0,0,0	0.5612							605713 [SPTLC2 (provisional) Neuropathy,hereditary sensory and autonomic,type IC,613640];	RCV000376513.1 [benign]; 			90	111					SPTLC2 (inh=AD pLI=0.82)
chr14	77974990	77974990	C	T	hom	anno_omim	QUAL=27089;DP=409;AF=0.99;MQM=60;TRIO=HOM,409,0.99,HOM,215,1.00,HOM,219,1.00	SPTLC2	3'UTR	SPTLC2:ENST00000216484:3'UTR:MODIFIER:exon12/12:c.*3637G>A:		rs1063271	0.7690	0.0000	0,0,0	0,0,0,0,0	0.7607							605713 [SPTLC2 (provisional) Neuropathy,hereditary sensory and autonomic,type IC,613640];	RCV000360818.1 [benign]; 			152	73					SPTLC2 (inh=AD pLI=0.82)
chr14	77975015	77975015	A	T	hom	anno_omim	QUAL=23646;DP=343;AF=1.00;MQM=60;TRIO=HOM,343,1.00,HOM,169,1.00,HOM,200,1.00	SPTLC2	3'UTR	SPTLC2:ENST00000216484:3'UTR:MODIFIER:exon12/12:c.*3612T>A:		rs2364160	0.9475	0.0000	0,0,0	0,0,0,0,0	0.9591							605713 [SPTLC2 (provisional) Neuropathy,hereditary sensory and autonomic,type IC,613640];	RCV000268443.1 [benign]; 			232	0					SPTLC2 (inh=AD pLI=0.82)
chr14	77975103	77975103	T	G	hom	anno_omim	QUAL=18932;DP=285;AF=1.00;MQM=60;TRIO=HOM,285,1.00,HOM,131,1.00,HOM,160,1.00	SPTLC2	3'UTR	SPTLC2:ENST00000216484:3'UTR:MODIFIER:exon12/12:c.*3524A>C:		rs1063270	0.7762	0.0000	0,0,0	0,0,0,0,0	0.7694							605713 [SPTLC2 (provisional) Neuropathy,hereditary sensory and autonomic,type IC,613640];	RCV000359692.1 [benign]; 			152	73					SPTLC2 (inh=AD pLI=0.82)
chr14	77976325	77976325	T	C	hom	anno_omim	QUAL=21897;DP=320;AF=1.00;MQM=60;TRIO=HOM,320,1.00,HOM,144,1.00,HOM,192,0.99	SPTLC2	3'UTR	SPTLC2:ENST00000216484:3'UTR:MODIFIER:exon12/12:c.*2302A>G:		rs11159269	0.7606	0.0000	0,0,0	0,0,0,0,0	0.7571							605713 [SPTLC2 (provisional) Neuropathy,hereditary sensory and autonomic,type IC,613640];	RCV000333490.1 [benign]; 			152	73					SPTLC2 (inh=AD pLI=0.82)
chr14	78028803	78028803	A	G	hom	anno_omim	QUAL=12515;DP=167;AF=0.99;MQM=60;TRIO=HOM,167,0.99,HOM,91,1.00,HOM,123,1.00	SPTLC2	synonymous	SPTLC2:ENST00000216484:synonymous:LOW:exon6/12:c.786T>C:p.Asn262Asn		rs2364602	0.8375	0.9029	50110,29097,2098	0.6300,0.7867,0.9945,0.9340,0.9638	0.9051	1.1100		T			5.32	605713 [SPTLC2 (provisional) Neuropathy,hereditary sensory and autonomic,type IC,613640];	RCV000294134.1 [benign]; 			1874	224					SPTLC2 (inh=AD pLI=0.82)
chr14	81562998	81562998	T	C	het	anno_omim	QUAL=5322;DP=204;AF=0.50;MQM=60;TRIO=HET,204,0.50,HET,224,0.46,WT,284,0.00	TSHR	synonymous	TSHR:ENST00000298171:synonymous:LOW:exon7/10:c.561T>C:p.Asn187Asn,TSHR:ENST00000541158:synonymous:LOW:exon8/11:c.561T>C:p.Asn187Asn,TSHR:ENST00000342443:synonymous:LOW:exon7/9:c.561T>C:p.Asn187Asn,TSHR:ENST00000554263:synonymous:LOW:exon7/8:c.561T>C:p.Asn187Asn,TSHR:ENST00000554435:synonymous:LOW:exon7/9:c.561T>C:p.Asn187Asn		rs2075179	0.3001	0.1913	3097,654,1528	0.5423,0.1202,0.3361,0.1386,0.1652	0.2662							603372 [TSHR (confirmed) Hypothyroidism,congenital,nongoitrous,1 275200|Thyroid adenoma,hyperfunctioning,somatic|Hyperthyroidism,nonautoimmune,609152|Thyroid carcinoma with thyrotoxicosis|Hyperthyroidism,familial gestational,603373];	RCV000248392.1 [benign]; RCV000312123.1 [likely benign]; RCV000371329.1 [likely benign]; 		COSM147826, COSM3754139	65	527					TSHR (inh=AR+AD pLI=0.00)
chr14	81574959	81574959	A	G	het	anno_omim	QUAL=11607;DP=400;AF=0.49;MQM=59;TRIO=HET,400,0.49,HET,292,0.41,HET,365,0.42	TSHR,RP11-114N19.3	synonymous,3'UTR,intron	TSHR:ENST00000342443:synonymous:LOW:exon9/9:c.696A>G:p.Leu232Leu,TSHR:ENST00000554435:synonymous:LOW:exon9/9:c.759A>G:p.Leu253Leu,TSHR:ENST00000554263:3'UTR:MODIFIER:exon8/8:c.*159A>G:,TSHR:ENST00000298171:intron:MODIFIER:exon8/9:c.692+163A>G:,TSHR:ENST00000541158:intron:MODIFIER:exon9/10:c.692+163A>G:		rs3783942	0.6112	0.6468	25939,14472,2079	0.6303,0.6679,0.3397,0.6584,0.7449	0.6463							603372 [TSHR (confirmed) Hypothyroidism,congenital,nongoitrous,1 275200|Thyroid adenoma,hyperfunctioning,somatic|Hyperthyroidism,nonautoimmune,609152|Thyroid carcinoma with thyrotoxicosis|Hyperthyroidism,familial gestational,603373];				987	963					TSHR (inh=AR+AD pLI=0.00), RP11-114N19.3 (inh=n/a pLI=n/a)
chr14	81575005	81575005	C	A	het	anno_omim	QUAL=16713;DP=600;AF=0.46;MQM=60;TRIO=HET,600,0.46,HET,383,0.41,HET,508,0.45	TSHR,RP11-114N19.3	missense,3'UTR,intron	TSHR:ENST00000342443:missense:MODERATE:exon9/9:c.742C>A:p.Arg248Ser,TSHR:ENST00000554435:missense:MODERATE:exon9/9:c.805C>A:p.Arg269Ser,TSHR:ENST00000554263:3'UTR:MODIFIER:exon8/8:c.*205C>A:,TSHR:ENST00000298171:intron:MODIFIER:exon8/9:c.692+209C>A:,TSHR:ENST00000541158:intron:MODIFIER:exon9/10:c.692+209C>A:		rs3783941	0.6102	0.6465	25847,14428,2044	0.6265,0.6673,0.3403,0.6584,0.7452	0.6460	-0.9880	T,T	T	B,B	T,T	3.45	603372 [TSHR (confirmed) Hypothyroidism,congenital,nongoitrous,1 275200|Thyroid adenoma,hyperfunctioning,somatic|Hyperthyroidism,nonautoimmune,609152|Thyroid carcinoma with thyrotoxicosis|Hyperthyroidism,familial gestational,603373];	RCV000122257.1 [not provided]; 			987	961					TSHR (inh=AR+AD pLI=0.00), RP11-114N19.3 (inh=n/a pLI=n/a)
chr14	81610583	81610583	G	C	hom	anno_omim	QUAL=16098;DP=186;AF=0.99;MQM=60;TRIO=HOM,186,0.99,HOM,147,1.00,HOM,165,0.99	TSHR,RP11-114N19.3	missense	TSHR:ENST00000298171:missense:MODERATE:exon10/10:c.2181G>C:p.Glu727Asp,TSHR:ENST00000541158:missense:MODERATE:exon11/11:c.2181G>C:p.Glu727Asp		rs1991517	0.8968	0.9004	49233,27565,4600	0.9409,0.8768,0.8252,0.9090,0.9131	0.8977	-0.1250	T,T,T	T	B	T,T	0.01	603372 [TSHR (confirmed) Hypothyroidism,congenital,nongoitrous,1 275200|Thyroid adenoma,hyperfunctioning,somatic|Hyperthyroidism,nonautoimmune,609152|Thyroid carcinoma with thyrotoxicosis|Hyperthyroidism,familial gestational,603373];	RCV000122254.2 [benign]; RCV000302729.1 [likely benign]; RCV000392451.1 [likely benign]; 			1797	296					TSHR (inh=AR+AD pLI=0.00), RP11-114N19.3 (inh=n/a pLI=n/a)
chr14	81610942	81610942	C	T	het	anno_omim	QUAL=13161;DP=304;AF=0.51;MQM=59;TRIO=HET,304,0.51,HOM,159,1.00,HET,269,0.51	TSHR,RP11-114N19.3	3'UTR	TSHR:ENST00000298171:3'UTR:MODIFIER:exon10/10:c.*245C>T:,TSHR:ENST00000541158:3'UTR:MODIFIER:exon11/11:c.*245C>T:		rs7144481	0.8433	0.0000	0,0,0	0,0,0,0,0	0.8458							603372 [TSHR (confirmed) Hypothyroidism,congenital,nongoitrous,1 275200|Thyroid adenoma,hyperfunctioning,somatic|Hyperthyroidism,nonautoimmune,609152|Thyroid carcinoma with thyrotoxicosis|Hyperthyroidism,familial gestational,603373];	RCV000340818.1 [likely benign]; RCV000398726.1 [likely benign]; 			178	51					TSHR (inh=AR+AD pLI=0.00), RP11-114N19.3 (inh=n/a pLI=n/a)
chr14	81611849	81611849	T	A	het	anno_omim	QUAL=12124;DP=331;AF=0.54;MQM=59;TRIO=HET,331,0.54,HOM,135,1.00,HET,189,0.48	TSHR,RP11-114N19.3	3'UTR	TSHR:ENST00000298171:3'UTR:MODIFIER:exon10/10:c.*1152T>A:,TSHR:ENST00000541158:3'UTR:MODIFIER:exon11/11:c.*1152T>A:		rs2288494	0.8472	0.0000	0,0,0	0,0,0,0,0	0.8482							603372 [TSHR (confirmed) Hypothyroidism,congenital,nongoitrous,1 275200|Thyroid adenoma,hyperfunctioning,somatic|Hyperthyroidism,nonautoimmune,609152|Thyroid carcinoma with thyrotoxicosis|Hyperthyroidism,familial gestational,603373];	RCV000288117.1 [likely benign]; RCV000396098.1 [likely benign]; 			178	51					TSHR (inh=AR+AD pLI=0.00), RP11-114N19.3 (inh=n/a pLI=n/a)
chr14	81611850	81611850	-	T	het	anno_omim	QUAL=12124;DP=331;AF=0.54;MQM=59;TRIO=HET,331,0.54,HOM,135,1.00,HET,189,0.48	TSHR,RP11-114N19.3	3'UTR	TSHR:ENST00000298171:3'UTR:MODIFIER:exon10/10:c.*1154dupT:,TSHR:ENST00000541158:3'UTR:MODIFIER:exon11/11:c.*1154dupT:		rs3214569	0.8476	0.0000	0,0,0	0,0,0,0,0	0.8482							603372 [TSHR (confirmed) Hypothyroidism,congenital,nongoitrous,1 275200|Thyroid adenoma,hyperfunctioning,somatic|Hyperthyroidism,nonautoimmune,609152|Thyroid carcinoma with thyrotoxicosis|Hyperthyroidism,familial gestational,603373];	RCV000345465.1 [likely benign]; RCV000400446.1 [likely benign]; 			178	51					TSHR (inh=AR+AD pLI=0.00), RP11-114N19.3 (inh=n/a pLI=n/a)
chr14	81611919	81611919	G	C	het	anno_omim	QUAL=12577;DP=429;AF=0.54;MQM=59;TRIO=HET,429,0.54,HET,203,0.45,HET,256,0.52	TSHR,RP11-114N19.3	3'UTR	TSHR:ENST00000298171:3'UTR:MODIFIER:exon10/10:c.*1222G>C:,TSHR:ENST00000541158:3'UTR:MODIFIER:exon11/11:c.*1222G>C:		rs2288495	0.2931	0.0000	0,0,0	0,0,0,0,0	0.3861							603372 [TSHR (confirmed) Hypothyroidism,congenital,nongoitrous,1 275200|Thyroid adenoma,hyperfunctioning,somatic|Hyperthyroidism,nonautoimmune,609152|Thyroid carcinoma with thyrotoxicosis|Hyperthyroidism,familial gestational,603373];	RCV000310384.1 [likely benign]; RCV000349021.1 [likely benign]; 			67	107					TSHR (inh=AR+AD pLI=0.00), RP11-114N19.3 (inh=n/a pLI=n/a)
chr14	81612114	81612114	T	C	het	anno_omim	QUAL=9036;DP=241;AF=0.53;MQM=60;TRIO=HET,241,0.53,HET,178,0.50,HET,210,0.54	TSHR,RP11-114N19.3	3'UTR	TSHR:ENST00000298171:3'UTR:MODIFIER:exon10/10:c.*1417T>C:,TSHR:ENST00000541158:3'UTR:MODIFIER:exon11/11:c.*1417T>C:		rs2288496	0.2935	0.0000	0,0,0	0,0,0,0,0	0.3868							603372 [TSHR (confirmed) Hypothyroidism,congenital,nongoitrous,1 275200|Thyroid adenoma,hyperfunctioning,somatic|Hyperthyroidism,nonautoimmune,609152|Thyroid carcinoma with thyrotoxicosis|Hyperthyroidism,familial gestational,603373];	RCV000299426.1 [likely benign]; RCV000356567.1 [likely benign]; 			67	106					TSHR (inh=AR+AD pLI=0.00), RP11-114N19.3 (inh=n/a pLI=n/a)
chr14	88399623	88399623	T	C	hom	anno_omim	QUAL=19205;DP=265;AF=1.00;MQM=60;TRIO=HOM,265,1.00,HET,160,0.49,HOM,258,1.00	GALC	3'UTR	GALC:ENST00000261304:3'UTR:MODIFIER:exon17/17:c.*1453A>G:	L1ME2	rs405567	0.4479	0.0000	0,0,0	0,0,0,0,0	0.4859							606890 [GALC (confirmed) Krabbe disease,245200];	RCV000358158.1 [benign]; 			56	101					GALC (inh=AR pLI=0.00)
chr14	88400087	88400087	C	T	hom	anno_omim	QUAL=27201;DP=512;AF=1.00;MQM=60;TRIO=HOM,512,1.00,HOM,144,1.00,HOM,179,1.00	GALC	3'UTR	GALC:ENST00000261304:3'UTR:MODIFIER:exon17/17:c.*989G>A:,GALC:ENST00000544807:3'UTR:MODIFIER:exon17/17:c.*230G>A:		rs370559	0.9409	0.0000	0,0,0	0,0,0,0,0	0.9576							606890 [GALC (confirmed) Krabbe disease,245200];	RCV000322846.1 [benign]; 			270	2					GALC (inh=AR pLI=0.00)
chr14	88400353	88400353	C	T	hom	anno_omim	QUAL=36486;DP=571;AF=1.00;MQM=60;TRIO=HOM,571,1.00,HET,311,0.50,HOM,432,0.99	GALC	splice_region&intron,3'UTR	GALC:ENST00000544807:splice_region&intron:LOW:exon16/16:c.1744-10G>A:,GALC:ENST00000261304:3'UTR:MODIFIER:exon17/17:c.*723G>A:		rs412915	0.4475	0.4363	1083,333,34	0.0000,0.0000,0.3651,0.4949,0.4137	0.4861							606890 [GALC (confirmed) Krabbe disease,245200];	RCV000264088.1 [benign]; 			700	1577					GALC (inh=AR pLI=0.00)
chr14	88400449	88400449	T	C	hom	anno_omim	QUAL=26941;DP=543;AF=1.00;MQM=60;TRIO=HOM,543,1.00,HOM,141,1.00,HOM,179,0.99	GALC	3'UTR,intron	GALC:ENST00000261304:3'UTR:MODIFIER:exon17/17:c.*627A>G:,GALC:ENST00000544807:intron:MODIFIER:exon16/16:c.1744-106A>G:		rs413750	0.9409	0.0000	0,0,0	0,0,0,0,0	0.9575							606890 [GALC (confirmed) Krabbe disease,245200];	RCV000373804.1 [benign]; 			273	2					GALC (inh=AR pLI=0.00)
chr14	88400450	88400450	G	A	hom	anno_omim	QUAL=26941;DP=543;AF=1.00;MQM=60;TRIO=HOM,543,1.00,HET,141,1.00,HOM,179,0.99	GALC	3'UTR,intron	GALC:ENST00000261304:3'UTR:MODIFIER:exon17/17:c.*626C>T:,GALC:ENST00000544807:intron:MODIFIER:exon16/16:c.1744-107C>T:		rs432946	0.4475	0.0000	0,0,0	0,0,0,0,0	0.4862							606890 [GALC (confirmed) Krabbe disease,245200];	RCV000279227.1 [benign]; 			63	126					GALC (inh=AR pLI=0.00)
chr14	88401213	88401213	T	C	hom	pred_pathogenic;anno_omim	QUAL=28141;DP=326;AF=1.00;MQM=59;TRIO=HOM,326,1.00,HOM,243,1.00,HOM,312,1.00	GALC	missense,intron	GALC:ENST00000261304:missense:MODERATE:exon17/17:c.1921A>G:p.Thr641Ala,GALC:ENST00000393569:missense:MODERATE:exon17/17:c.1843A>G:p.Thr615Ala,GALC:ENST00000393568:missense:MODERATE:exon16/16:c.1852A>G:p.Thr618Ala,GALC:ENST00000544807:intron:MODIFIER:exon16/16:c.1744-870A>G:		rs421262	0.9407	0.9828	58239,33275,3619	0.8608,0.9918,0.9375,0.9996,0.9975	0.9848	0.5190	T,T,T,T	T	B	D,D,D	0.01	606890 [GALC (confirmed) Krabbe disease,245200];	RCV000078197.6 [benign]; RCV000290698.1 [benign]; 			3803	23	2	[2] old entry - no details available			GALC (inh=AR pLI=0.00)
chr14	88407734	88407734	G	C	hom	anno_omim	QUAL=8703;DP=185;AF=0.99;MQM=59;TRIO=HOM,185,0.99,HOM,57,1.00,HOM,82,1.00	GALC	splice_region&intron	GALC:ENST00000261304:splice_region&intron:LOW:exon15/16:c.1834+5C>G:,GALC:ENST00000544807:splice_region&intron:LOW:exon15/16:c.1666+5C>G:,GALC:ENST00000393569:splice_region&intron:LOW:exon15/16:c.1756+5C>G:,GALC:ENST00000393568:splice_region&intron:LOW:exon14/15:c.1765+5C>G:		rs448805	0.9409	0.9830	57978,33136,3573	0.8611,0.9919,0.9378,0.9997,0.9975	0.9843							606890 [GALC (confirmed) Krabbe disease,245200];	RCV000078196.6 [benign]; RCV000398764.1 [benign]; 			3798	24					GALC (inh=AR pLI=0.00)
chr14	88407875	88407875	T	A	hom	anno_omim	QUAL=21043;DP=308;AF=1.00;MQM=60;TRIO=HOM,308,1.00,HOM,134,1.00,HOM,197,0.99	GALC	synonymous	GALC:ENST00000261304:synonymous:LOW:exon15/17:c.1698A>T:p.Val566Val,GALC:ENST00000544807:synonymous:LOW:exon15/17:c.1530A>T:p.Val510Val,GALC:ENST00000393569:synonymous:LOW:exon15/17:c.1620A>T:p.Val540Val,GALC:ENST00000393568:synonymous:LOW:exon14/16:c.1629A>T:p.Val543Val		rs421466	0.9409	0.9828	58347,33328,3624	0.8604,0.9920,0.9374,0.9996,0.9975	0.9849							606890 [GALC (confirmed) Krabbe disease,245200];	RCV000078195.6 [benign]; RCV000360908.1 [benign]; 			3799	22					GALC (inh=AR pLI=0.00)
chr14	88407888	88407888	A	G	hom	pred_pathogenic;anno_omim	QUAL=16485;DP=277;AF=1.00;MQM=60;TRIO=HOM,277,1.00,HET,122,0.49,HOM,182,0.99	GALC	missense	GALC:ENST00000261304:missense:MODERATE:exon15/17:c.1685T>C:p.Ile562Thr,GALC:ENST00000544807:missense:MODERATE:exon15/17:c.1517T>C:p.Ile506Thr,GALC:ENST00000393569:missense:MODERATE:exon15/17:c.1607T>C:p.Ile536Thr,GALC:ENST00000393568:missense:MODERATE:exon14/16:c.1616T>C:p.Ile539Thr		rs398607	0.4475	0.4406	12358,7521,1838	0.6089,0.3034,0.1827,0.4746,0.4216	0.4859	9.2700	D,D,T,D,D	T	B,B,B,B	D,D,D,D	22.90	606890 [GALC (confirmed) Krabbe disease,245200];	RCV000078194.6 [benign]; RCV000399633.1 [benign]; 	CM140252 [CLASS=DFP MUT=ALT PHEN="Krabbe disease late-onset" GENE=GALC]; 	COSM3754140	837	1868					GALC (inh=AR pLI=0.00)
chr14	88411947	88411947	T	C	hom	anno_omim	QUAL=9979;DP=186;AF=1.00;MQM=59;TRIO=HOM,186,1.00,HOM,62,1.00,HOM,86,1.00	GALC	synonymous	GALC:ENST00000261304:synonymous:LOW:exon14/17:c.1620A>G:p.Thr540Thr,GALC:ENST00000544807:synonymous:LOW:exon14/17:c.1452A>G:p.Thr484Thr,GALC:ENST00000393569:synonymous:LOW:exon14/17:c.1542A>G:p.Thr514Thr,GALC:ENST00000393568:synonymous:LOW:exon13/16:c.1551A>G:p.Thr517Thr		rs367327	0.9427	0.9832	58378,33309,3665	0.8652,0.9920,0.9376,0.9996,0.9975	0.9853							606890 [GALC (confirmed) Krabbe disease,245200];	RCV000153295.2 [benign]; 			3807	22					GALC (inh=AR pLI=0.00)
chr14	88414211	88414211	G	A	hom	anno_omim	QUAL=13369;DP=218;AF=1.00;MQM=60;TRIO=HOM,218,1.00,HET,221,0.51,HET,303,0.51	GALC	synonymous	GALC:ENST00000261304:synonymous:LOW:exon13/17:c.1350C>T:p.Ser450Ser,GALC:ENST00000544807:synonymous:LOW:exon13/17:c.1182C>T:p.Ser394Ser,GALC:ENST00000393569:synonymous:LOW:exon13/17:c.1272C>T:p.Ser424Ser,GALC:ENST00000393568:synonymous:LOW:exon12/16:c.1281C>T:p.Ser427Ser		rs398076	0.3666	0.3734	8642,5333,905	0.4290,0.2664,0.1820,0.4015,0.3886	0.3908							606890 [GALC (confirmed) Krabbe disease,245200];	RCV000078191.6 [benign]; RCV000277817.1 [benign]; 		COSM3999388	585	1797					GALC (inh=AR pLI=0.00)
chr14	88417096	88417096	A	-	hom	anno_omim	QUAL=12020;DP=186;AF=0.95;MQM=59;TRIO=HOM,186,0.95,HOM,87,0.93,HOM,160,0.96	GALC	splice_region&intron	GALC:ENST00000261304:splice_region&intron:LOW:exon10/16:c.1162-4delT:,GALC:ENST00000544807:splice_region&intron:LOW:exon10/16:c.994-4delT:,GALC:ENST00000393569:splice_region&intron:LOW:exon10/16:c.1084-4delT:,GALC:ENST00000393568:splice_region&intron:LOW:exon9/15:c.1093-4delT:		rs11300320;rs398099546	0.9483	0.9775	50900,28362,3134	0.8513,0.9835,0.9924,0.9878,0.9919	0.9749							606890 [GALC (confirmed) Krabbe disease,245200];	RCV000078190.4 [benign]; RCV000292380.1 [benign]; 			3709	102	2	[2] Peter Bauer 27.08.2014			GALC (inh=AR pLI=0.00)
chr14	89042180	89042180	T	G	hom	anno_omim	QUAL=12496;DP=187;AF=1.00;MQM=59;TRIO=HOM,187,1.00,HET,137,0.42,HOM,146,1.00	ZC3H14	splice_region&intron	ZC3H14:ENST00000251038:splice_region&intron:LOW:exon7/16:c.1023-4T>G:,ZC3H14:ENST00000359301:splice_region&intron:LOW:exon7/14:c.921-4T>G:,ZC3H14:ENST00000302216:splice_region&intron:LOW:exon7/13:c.1023-4T>G:,ZC3H14:ENST00000556945:splice_region&intron:LOW:exon7/14:c.1023-4T>G:,ZC3H14:ENST00000557607:splice_region&intron:LOW:exon6/12:c.558-4T>G:,ZC3H14:ENST00000555755:splice_region&intron:LOW:exon7/16:c.1023-4T>G:,ZC3H14:ENST00000393514:splice_region&intron:LOW:exon7/15:c.1023-4T>G:,ZC3H14:ENST00000336693:splice_region&intron:LOW:exon7/14:c.921-4T>G:		rs1469602	0.4858	0.6188	24782,17739,560	0.3337,0.4073,0.3436,0.7295,0.5733	0.6179							613279 [ZC3H14 (provisional) Mental retardation,autosomal recessive 56,617125];	RCV000118883.2 [likely benign]; 		COSM3999396	1020	857					ZC3H14 (inh=AR pLI=1.00)
chr14	89078927	89078927	A	G	hom	anno_omim	QUAL=10975;DP=182;AF=1.00;MQM=60;TRIO=HOM,182,1.00,HOM,65,1.00,HOM,73,1.00	ZC3H14,EML5	3'UTR	ZC3H14:ENST00000251038:3'UTR:MODIFIER:exon17/17:c.*832A>G:,EML5:ENST00000554922:3'UTR:MODIFIER:exon44/44:c.*3235T>C:,ZC3H14:ENST00000359301:3'UTR:MODIFIER:exon15/15:c.*832A>G:		rs8008847	0.9103	0.0000	0,0,0	0,0,0,0,0	0.9548							613279 [ZC3H14 (provisional) Mental retardation,autosomal recessive 56,617125];				225	7					ZC3H14 (inh=AR pLI=1.00), EML5 (inh=n/a pLI=0.16)
chr14	92347680	92347680	A	G	hom	anno_omim	QUAL=25913;DP=322;AF=1.00;MQM=59;TRIO=HOM,322,1.00,HOM,304,1.00,HET,457,0.51	FBLN5	synonymous	FBLN5:ENST00000267620:synonymous:LOW:exon10/12:c.1068T>C:p.Ile356Ile,FBLN5:ENST00000342058:synonymous:LOW:exon9/11:c.945T>C:p.Ile315Ile,FBLN5:ENST00000556154:synonymous:LOW:exon9/11:c.960T>C:p.Ile320Ile		rs2430347	0.7849	0.7609	35359,17889,3216	0.7858,0.8834,0.8419,0.7323,0.7383	0.7706							604580 [FBLN5 (confirmed) Cutis laxa,autosomal recessive,type IA,219100|Cutis laxa,autosomal dominant 2,614434|Macular degeneration,age-related,3,608895|Neuropathy,hereditary,with or without age-related macular degeneration,608895];	RCV000150685.3 [benign]; RCV000336959.1 [benign]; RCV000403489.1 [benign]; 			1141	797					FBLN5 (inh=AR+AD pLI=1.00)
chr14	92413987	92413987	G	A	het	anno_omim	QUAL=6101;DP=277;AF=0.53;MQM=59;TRIO=HET,277,0.53,HET,99,0.56,HET,167,0.44	FBLN5	5'UTR	FBLN5:ENST00000342058:5'UTR:MODIFIER:exon1/11:c.-414C>T:		rs7149187	0.2508	0.0000	0,0,0	0,0,0,0,0	0.2633							604580 [FBLN5 (confirmed) Cutis laxa,autosomal recessive,type IA,219100|Cutis laxa,autosomal dominant 2,614434|Macular degeneration,age-related,3,608895|Neuropathy,hereditary,with or without age-related macular degeneration,608895];	RCV000342843.1 [benign]; RCV000404509.1 [benign]; 			30	91					FBLN5 (inh=AR+AD pLI=1.00)
chr14	92525145	92525145	A	G	het	anno_omim	QUAL=8556;DP=324;AF=0.50;MQM=59;TRIO=HET,324,0.50,HET,173,0.41,HET,228,0.45	ATXN3,RP11-529H20.5	3'UTR	ATXN3:ENST00000545170:3'UTR:MODIFIER:exon11/11:c.*5519T>C:,ATXN3:ENST00000429774:3'UTR:MODIFIER:exon11/11:c.*5519T>C:		rs1047795	0.3007	0.0000	0,0,0	0,0,0,0,0	0.2678							607047 [ATXN3 (confirmed) Machado-Joseph disease,109150];				14	85					ATXN3 (inh=AD pLI=0.18), RP11-529H20.5 (inh=n/a pLI=n/a)
chr14	92525290	92525290	A	-	het	anno_omim	QUAL=103;DP=135;AF=0.21;MQM=59;TRIO=HET,135,0.21,HET,25,0.32,WT,30,0.20	ATXN3,RP11-529H20.5	3'UTR	ATXN3:ENST00000545170:3'UTR:MODIFIER:exon11/11:c.*5374delT:,ATXN3:ENST00000429774:3'UTR:MODIFIER:exon11/11:c.*5374delT:		rs762458117	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0535							607047 [ATXN3 (confirmed) Machado-Joseph disease,109150];				0	46					ATXN3 (inh=AD pLI=0.18), RP11-529H20.5 (inh=n/a pLI=n/a)
chr14	92525471	92525471	C	T	hom	anno_omim	QUAL=10510;DP=117;AF=0.99;MQM=60;TRIO=HOM,117,0.99,HOM,89,1.00,HOM,117,1.00	ATXN3,RP11-529H20.5	3'UTR	ATXN3:ENST00000545170:3'UTR:MODIFIER:exon11/11:c.*5193G>A:,ATXN3:ENST00000429774:3'UTR:MODIFIER:exon11/11:c.*5193G>A:		rs8022758	0.7508	0.0000	0,0,0	0,0,0,0,0	0.7778							607047 [ATXN3 (confirmed) Machado-Joseph disease,109150];				128	90					ATXN3 (inh=AD pLI=0.18), RP11-529H20.5 (inh=n/a pLI=n/a)
chr14	92525613	92525613	C	T	het	anno_omim	QUAL=2733;DP=131;AF=0.41;MQM=59;TRIO=HET,131,0.41,HET,38,0.53,HET,55,0.58	ATXN3,RP11-529H20.5	3'UTR	ATXN3:ENST00000545170:3'UTR:MODIFIER:exon11/11:c.*5051G>A:,ATXN3:ENST00000429774:3'UTR:MODIFIER:exon11/11:c.*5051G>A:		rs10151945	0.4706	0.0000	0,0,0	0,0,0,0,0	0.4480							607047 [ATXN3 (confirmed) Machado-Joseph disease,109150];				33	107					ATXN3 (inh=AD pLI=0.18), RP11-529H20.5 (inh=n/a pLI=n/a)
chr14	92525998	92525998	-	A	het	anno_omim	QUAL=1923;DP=105;AF=0.49;MQM=59;TRIO=HET,105,0.49,HET,33,0.52,HET,40,0.55	ATXN3	3'UTR	ATXN3:ENST00000545170:3'UTR:MODIFIER:exon11/11:c.*4665dupT:,ATXN3:ENST00000429774:3'UTR:MODIFIER:exon11/11:c.*4665dupT:	AluSx1	rs552780970	0.3085	0.0000	0,0,0	0,0,0,0,0	0.2743							607047 [ATXN3 (confirmed) Machado-Joseph disease,109150];				10	65					ATXN3 (inh=AD pLI=0.18)
chr14	92526157	92526157	G	A	het	anno_omim	QUAL=2831;DP=174;AF=0.49;MQM=58;TRIO=HET,174,0.49,HET,42,0.50,HET,57,0.39	ATXN3	3'UTR	ATXN3:ENST00000545170:3'UTR:MODIFIER:exon11/11:c.*4507C>T:,ATXN3:ENST00000429774:3'UTR:MODIFIER:exon11/11:c.*4507C>T:	AluSx1	rs112733683	0.3143	0.0000	0,0,0	0,0,0,0,0	0.2783							607047 [ATXN3 (confirmed) Machado-Joseph disease,109150];				12	62					ATXN3 (inh=AD pLI=0.18)
chr14	92526240	92526240	A	C	het	anno_omim	QUAL=1459;DP=99;AF=0.42;MQM=59;TRIO=HET,99,0.42,HET,27,0.63,HET,34,0.32	ATXN3	3'UTR	ATXN3:ENST00000545170:3'UTR:MODIFIER:exon11/11:c.*4424T>G:,ATXN3:ENST00000429774:3'UTR:MODIFIER:exon11/11:c.*4424T>G:		rs67089639	0.3007	0.0000	0,0,0	0,0,0,0,0	0.2666							607047 [ATXN3 (confirmed) Machado-Joseph disease,109150];				11	64					ATXN3 (inh=AD pLI=0.18)
chr14	92526429	92526429	T	G	het	anno_omim	QUAL=312;DP=29;AF=0.48;MQM=56;TRIO=HET,29,0.48,HOM,1,1.00,HET,2,0.50	ATXN3	3'UTR	ATXN3:ENST00000545170:3'UTR:MODIFIER:exon11/11:c.*4235A>C:,ATXN3:ENST00000429774:3'UTR:MODIFIER:exon11/11:c.*4235A>C:	AluSq2	rs8009456	0.3143	0.0000	0,0,0	0,0,0,0,0	0.2798							607047 [ATXN3 (confirmed) Machado-Joseph disease,109150];				8	20					ATXN3 (inh=AD pLI=0.18)
chr14	92526630	92526630	A	G	het	low_DP;anno_omim	QUAL=33;DP=7;AF=0.43;MQM=60;TRIO=HET,7,0.43,WT,1,0.00,HET,2,0.50	ATXN3	3'UTR	ATXN3:ENST00000545170:3'UTR:MODIFIER:exon11/11:c.*4034T>C:,ATXN3:ENST00000429774:3'UTR:MODIFIER:exon11/11:c.*4034T>C:	AluSz	rs8008405	0.3139	0.0000	0,0,0	0,0,0,0,0	0.2676							607047 [ATXN3 (confirmed) Machado-Joseph disease,109150];				5	31					ATXN3 (inh=AD pLI=0.18)
chr14	92527145	92527145	T	C	het	anno_omim	QUAL=4098;DP=147;AF=0.51;MQM=59;TRIO=HET,147,0.51,HET,61,0.56,HET,104,0.51	ATXN3	3'UTR	ATXN3:ENST00000545170:3'UTR:MODIFIER:exon11/11:c.*3519A>G:,ATXN3:ENST00000429774:3'UTR:MODIFIER:exon11/11:c.*3519A>G:,ATXN3:ENST00000393287:3'UTR:MODIFIER:exon11/11:c.*3519A>G:	AluSg4	rs1134378	0.3149	0.0000	0,0,0	0,0,0,0,0	0.2720							607047 [ATXN3 (confirmed) Machado-Joseph disease,109150];				14	85					ATXN3 (inh=AD pLI=0.18)
chr14	92527164	92527164	T	C	het	anno_omim	QUAL=4438;DP=186;AF=0.51;MQM=59;TRIO=HET,186,0.51,HET,59,0.51,HET,100,0.52	ATXN3	3'UTR	ATXN3:ENST00000545170:3'UTR:MODIFIER:exon11/11:c.*3500A>G:,ATXN3:ENST00000429774:3'UTR:MODIFIER:exon11/11:c.*3500A>G:,ATXN3:ENST00000393287:3'UTR:MODIFIER:exon11/11:c.*3500A>G:	AluSg4	rs1134377	0.3141	0.0000	0,0,0	0,0,0,0,0	0.2743							607047 [ATXN3 (confirmed) Machado-Joseph disease,109150];				14	81					ATXN3 (inh=AD pLI=0.18)
chr14	92527399	92527399	A	G	het	anno_omim	QUAL=7526;DP=312;AF=0.49;MQM=59;TRIO=HET,312,0.49,HET,86,0.48,HET,169,0.54	ATXN3	3'UTR	ATXN3:ENST00000545170:3'UTR:MODIFIER:exon11/11:c.*3265T>C:,ATXN3:ENST00000429774:3'UTR:MODIFIER:exon11/11:c.*3265T>C:,ATXN3:ENST00000393287:3'UTR:MODIFIER:exon11/11:c.*3265T>C:		rs1055996	0.2406	0.0000	0,0,0	0,0,0,0,0	0.2281							607047 [ATXN3 (confirmed) Machado-Joseph disease,109150];				14	81					ATXN3 (inh=AD pLI=0.18)
chr14	92527977	92527977	T	C	het	anno_omim	QUAL=13012;DP=449;AF=0.50;MQM=60;TRIO=HET,449,0.50,HET,239,0.51,HET,261,0.55	ATXN3	3'UTR	ATXN3:ENST00000545170:3'UTR:MODIFIER:exon11/11:c.*2687A>G:,ATXN3:ENST00000429774:3'UTR:MODIFIER:exon11/11:c.*2687A>G:,ATXN3:ENST00000393287:3'UTR:MODIFIER:exon11/11:c.*2687A>G:		rs11628764	0.1761	0.0000	0,0,0	0,0,0,0,0	0.2207							607047 [ATXN3 (confirmed) Machado-Joseph disease,109150];				17	91					ATXN3 (inh=AD pLI=0.18)
chr14	92528429	92528429	C	T	het	anno_omim	QUAL=5287;DP=175;AF=0.46;MQM=59;TRIO=HET,175,0.46,HET,98,0.54,HET,169,0.53	ATXN3	3'UTR	ATXN3:ENST00000545170:3'UTR:MODIFIER:exon11/11:c.*2235G>A:,ATXN3:ENST00000429774:3'UTR:MODIFIER:exon11/11:c.*2235G>A:,ATXN3:ENST00000393287:3'UTR:MODIFIER:exon11/11:c.*2235G>A:	AluSx1	rs8019545	0.3165	0.0000	0,0,0	0,0,0,0,0	0.2812							607047 [ATXN3 (confirmed) Machado-Joseph disease,109150];				15	79					ATXN3 (inh=AD pLI=0.18)
chr14	92530282	92530282	C	A	het	anno_omim	QUAL=8597;DP=302;AF=0.54;MQM=59;TRIO=HET,302,0.54,HET,156,0.49,HET,154,0.51	ATXN3	3'UTR	ATXN3:ENST00000545170:3'UTR:MODIFIER:exon11/11:c.*382G>T:,ATXN3:ENST00000429774:3'UTR:MODIFIER:exon11/11:c.*382G>T:,ATXN3:ENST00000393287:3'UTR:MODIFIER:exon11/11:c.*382G>T:,ATXN3:ENST00000502250:3'UTR:MODIFIER:exon8/8:c.*382G>T:		rs910369	0.2877	0.0000	0,0,0	0,0,0,0,0	0.2573							607047 [ATXN3 (confirmed) Machado-Joseph disease,109150];				14	85					ATXN3 (inh=AD pLI=0.18)
chr14	92530513	92530513	C	T	het	anno_omim	QUAL=4455;DP=229;AF=0.46;MQM=60;TRIO=HET,229,0.46,HET,64,0.53,HET,69,0.55	ATXN3	3'UTR	ATXN3:ENST00000545170:3'UTR:MODIFIER:exon11/11:c.*151G>A:,ATXN3:ENST00000429774:3'UTR:MODIFIER:exon11/11:c.*151G>A:,ATXN3:ENST00000393287:3'UTR:MODIFIER:exon11/11:c.*151G>A:,ATXN3:ENST00000502250:3'UTR:MODIFIER:exon8/8:c.*151G>A:,ATXN3:ENST00000503767:3'UTR:MODIFIER:exon10/10:c.*151G>A:,ATXN3:ENST00000340660:3'UTR:MODIFIER:exon10/10:c.*151G>A:		rs709930	0.2819	0.0000	0,0,0	0,0,0,0,0	0.2570							607047 [ATXN3 (confirmed) Machado-Joseph disease,109150];				14	85					ATXN3 (inh=AD pLI=0.18)
chr14	92537379	92537379	T	C	het	low_DP;anno_omim	QUAL=291;DP=8;AF=0.13;MQM=58;TRIO=HET,8,0.13,HET,35,0.29,HET,32,0.25	ATXN3	synonymous	ATXN3:ENST00000545170:synonymous:LOW:exon10/11:c.918A>G:p.Gln306Gln,ATXN3:ENST00000429774:synonymous:LOW:exon10/11:c.870A>G:p.Gln290Gln,ATXN3:ENST00000393287:synonymous:LOW:exon10/11:c.891A>G:p.Gln297Gln,ATXN3:ENST00000502250:synonymous:LOW:exon7/8:c.354A>G:p.Gln118Gln,ATXN3:ENST00000503767:synonymous:LOW:exon9/10:c.846A>G:p.Gln282Gln,ATXN3:ENST00000340660:synonymous:LOW:exon9/10:c.726A>G:p.Gln242Gln,ATXN3:ENST00000532032:synonymous:LOW:exon10/10:c.891A>G:p.Gln297Gln	(CTG)n	rs12896583	0.0000	0.3342	136,60,40	0.4305,0.3412,0.2868,0.3418,0.2839	0.0206							607047 [ATXN3 (confirmed) Machado-Joseph disease,109150];	RCV000116484.2 [likely benign]; 		COSM3749284, COSM3749285, COSM433493	8	485					ATXN3 (inh=AD pLI=0.18)
chr14	92548785	92548785	C	T	het	pred_pathogenic;anno_omim	QUAL=9368;DP=218;AF=0.47;MQM=60;TRIO=HET,218,0.47,HET,227,0.58,HET,279,0.48	ATXN3	missense	ATXN3:ENST00000545170:missense:MODERATE:exon8/11:c.634G>A:p.Val212Met,ATXN3:ENST00000429774:missense:MODERATE:exon7/11:c.589G>A:p.Val197Met,ATXN3:ENST00000393287:missense:MODERATE:exon8/11:c.634G>A:p.Val212Met,ATXN3:ENST00000502250:missense:MODERATE:exon5/8:c.97G>A:p.Val33Met,ATXN3:ENST00000503767:missense:MODERATE:exon7/10:c.589G>A:p.Val197Met,ATXN3:ENST00000340660:missense:MODERATE:exon7/10:c.469G>A:p.Val157Met,ATXN3:ENST00000532032:missense:MODERATE:exon8/10:c.634G>A:p.Val212Met		rs1048755	0.3251	0.2714	4838,2011,615	0.3384,0.1562,0.4413,0.2449,0.3463	0.2734	2.2370	T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T	T	B,B,B,B,B	T,T,T,T,T,T,T,T,T,T,T,T,T,T	21.20	607047 [ATXN3 (confirmed) Machado-Joseph disease,109150];	RCV000116481.2 [likely benign]; 		COSM3754168, COSM3754167, COSM3754169	158	777					ATXN3 (inh=AD pLI=0.18)
chr14	92549586	92549586	G	A	het	anno_omim	QUAL=6481;DP=307;AF=0.51;MQM=59;TRIO=HET,307,0.51,HET,103,0.48,HET,149,0.38	ATXN3	synonymous,5'UTR_premature_start_codon_gain,5'UTR	ATXN3:ENST00000545170:synonymous:LOW:exon7/11:c.492C>T:p.Val164Val,ATXN3:ENST00000429774:synonymous:LOW:exon6/11:c.447C>T:p.Val149Val,ATXN3:ENST00000393287:synonymous:LOW:exon7/11:c.492C>T:p.Val164Val,ATXN3:ENST00000503767:synonymous:LOW:exon6/10:c.447C>T:p.Val149Val,ATXN3:ENST00000340660:synonymous:LOW:exon6/10:c.327C>T:p.Val109Val,ATXN3:ENST00000532032:synonymous:LOW:exon7/10:c.492C>T:p.Val164Val,ATXN3:ENST00000502250:5'UTR_premature_start_codon_gain:LOW:exon4/8:c.-46C>T:,ATXN3:ENST00000502250:5'UTR:MODIFIER:exon4/8:c.-46C>T:		rs16999141	0.5667	0.5028	15770,7814,2396	0.6778,0.3659,0.5392,0.4850,0.5671	0.5337							607047 [ATXN3 (confirmed) Machado-Joseph disease,109150];	RCV000116480.2 [likely benign]; 		COSM147835	540	1056					ATXN3 (inh=AD pLI=0.18)
chr14	93673580	93673580	A	G	het		QUAL=2422;DP=87;AF=0.37;MQM=59;TRIO=HET,87,0.37,WT,148,0.00,HET,190,0.51	UBR7,RP11-371E8.4	5'UTR	UBR7:ENST00000013070:5'UTR:MODIFIER:exon1/11:c.-57A>G:,UBR7:ENST00000416753:5'UTR:MODIFIER:exon1/10:c.-151A>G:		rs2255370	0.3622	0.4092	1351,321,145	0.5000,0.4620,0.1162,0.3483,0.4503	0.3617											241	862					UBR7 (inh=n/a pLI=0.43), RP11-371E8.4 (inh=n/a pLI=n/a)
chr14	93693422	93693422	C	T	het		QUAL=13827;DP=392;AF=0.49;MQM=59;TRIO=HET,392,0.49,HET,286,0.53,HET,385,0.50	UBR7	3'UTR	UBR7:ENST00000013070:3'UTR:MODIFIER:exon11/11:c.*41C>T:,UBR7:ENST00000416753:3'UTR:MODIFIER:exon10/10:c.*41C>T:		rs2905	0.1945	0.2996	4801,3511,16	0.0716,0.2665,0.3085,0.3588,0.1951	0.2787											207	883					UBR7 (inh=n/a pLI=0.43)
chr14	93693604	93693604	T	G	het		QUAL=15362;DP=366;AF=0.50;MQM=60;TRIO=HET,366,0.50,HET,370,0.45,HET,505,0.48	UBR7	3'UTR	UBR7:ENST00000013070:3'UTR:MODIFIER:exon11/11:c.*223T>G:,UBR7:ENST00000416753:3'UTR:MODIFIER:exon10/10:c.*223T>G:		rs10144530	0.3878	0.3776	975,500,30	0.3717,0.4158,0.5470,0.5031,0.3064	0.4559											168	314					UBR7 (inh=n/a pLI=0.43)
chr14	93693831	93693831	C	T	het		QUAL=12044;DP=358;AF=0.53;MQM=60;TRIO=HET,358,0.53,HET,221,0.52,HET,285,0.53	UBR7	3'UTR	UBR7:ENST00000013070:3'UTR:MODIFIER:exon11/11:c.*450C>T:,UBR7:ENST00000416753:3'UTR:MODIFIER:exon10/10:c.*450C>T:		rs11621915	0.1939	0.2190	378,224,1	0.0674,0.0000,0.0000,0.3293,0.1742	0.2706											75	293					UBR7 (inh=n/a pLI=0.43)
chr14	97321689	97321689	C	T	het	anno_omim	QUAL=8859;DP=190;AF=0.53;MQM=60;TRIO=HET,190,0.53,HET,192,0.56,HET,274,0.52	VRK1	synonymous	VRK1:ENST00000216639:synonymous:LOW:exon8/13:c.705C>T:p.Gly235Gly		rs2230532	0.4167	0.3892	10581,4415,157	0.1729,0.5043,0.8518,0.3599,0.3201	0.3999	-0.6900		T			17.47	602168 [VRK1 (provisional) Pontocerebellar hypoplasia type 1A,607596];	RCV000118848.3 [other]; RCV000262267.1 [benign]; 			414	1458					VRK1 (inh=AR pLI=0.04)
chr14	106321590	106321590	C	A	hom		QUAL=21838;DP=279;AF=1.00;MQM=59;TRIO=HOM,279,1.00,HOM,215,1.00,HOM,268,1.00	IGHM	missense	IGHM:ENST00000390559:missense:MODERATE:exon2/4:c.644G>T:p.Gly215Val		rs12365	0.9149	0.9744	53543,31053,2148	0.7246,0.9840,0.9999,0.9946,0.9966	0.9764											1944	41					IGHM (inh=AR pLI=n/a)
chr14	106321913	106321913	G	A	hom		QUAL=23027;DP=305;AF=0.99;MQM=59;TRIO=HOM,305,0.99,HOM,199,0.99,HOM,246,0.99	IGHM	synonymous	IGHM:ENST00000390559:synonymous:LOW:exon2/4:c.321C>T:p.Ala107Ala		rs1136534	0.5631	0.5279	16813,8406,2257	0.6907,0.5921,0.5377,0.5078,0.4747	0.5592											538	969					IGHM (inh=AR pLI=n/a)
chr15	23043896	23043896	G	A	hom	anno_omim	QUAL=22297;DP=379;AF=1.00;MQM=60;TRIO=HOM,379,1.00,HOM,123,1.00,HOM,169,1.00	NIPA1	3'UTR	NIPA1:ENST00000337435:3'UTR:MODIFIER:exon5/5:c.*4933C>T:,NIPA1:ENST00000437912:3'UTR:MODIFIER:exon5/5:c.*4933C>T:		rs7181789	0.5557	0.0000	0,0,0	0,0,0,0,0	0.5746							608145 [NIPA1 (confirmed) Spastic paraplegia 6,autosomal dominant,600363];	RCV000401961.1 [benign]; 			60	123					NIPA1 (inh=AD pLI=0.21)
chr15	23046770	23046770	-	AA	het	anno_omim	QUAL=10432;DP=383;AF=0.49;MQM=59;TRIO=HET,383,0.49,HOM,173,0.99,WT,233,0.01	NIPA1	3'UTR	NIPA1:ENST00000337435:3'UTR:MODIFIER:exon5/5:c.*2058_*2059insTT:,NIPA1:ENST00000437912:3'UTR:MODIFIER:exon5/5:c.*2058_*2059insTT:		rs3057642	0.7214	0.0000	0,0,0	0,0,0,0,0	0.6560							608145 [NIPA1 (confirmed) Spastic paraplegia 6,autosomal dominant,600363];	RCV000266600.1 [benign]; 			125	89					NIPA1 (inh=AD pLI=0.21)
chr15	23046848	23046848	T	C	hom	anno_omim	QUAL=30589;DP=472;AF=1.00;MQM=59;TRIO=HOM,472,1.00,HOM,199,1.00,HOM,238,1.00	NIPA1	3'UTR	NIPA1:ENST00000337435:3'UTR:MODIFIER:exon5/5:c.*1981A>G:,NIPA1:ENST00000437912:3'UTR:MODIFIER:exon5/5:c.*1981A>G:		rs6606822	1.0000	0.0000	0,0,0	0,0,0,0,0	0.9998							608145 [NIPA1 (confirmed) Spastic paraplegia 6,autosomal dominant,600363];	RCV000357863.1 [benign]; 			232	0					NIPA1 (inh=AD pLI=0.21)
chr15	23046855	23046855	G	T	hom	anno_omim	QUAL=27198;DP=398;AF=1.00;MQM=59;TRIO=HOM,398,1.00,HOM,185,1.00,HOM,228,1.00	NIPA1	3'UTR	NIPA1:ENST00000337435:3'UTR:MODIFIER:exon5/5:c.*1974C>A:,NIPA1:ENST00000437912:3'UTR:MODIFIER:exon5/5:c.*1974C>A:		rs6606823	0.9639	0.0000	0,0,0	0,0,0,0,0	0.9347							608145 [NIPA1 (confirmed) Spastic paraplegia 6,autosomal dominant,600363];	RCV000265292.1 [benign]; 			197	35					NIPA1 (inh=AD pLI=0.21)
chr15	23046902	23046902	T	C	het	anno_omim	QUAL=10778;DP=344;AF=0.50;MQM=59;TRIO=HET,344,0.50,HOM,186,1.00,WT,217,0.01	NIPA1	3'UTR	NIPA1:ENST00000337435:3'UTR:MODIFIER:exon5/5:c.*1927A>G:,NIPA1:ENST00000437912:3'UTR:MODIFIER:exon5/5:c.*1927A>G:		rs17807140	0.2558	0.0000	0,0,0	0,0,0,0,0	0.2831							608145 [NIPA1 (confirmed) Spastic paraplegia 6,autosomal dominant,600363];	RCV000375079.1 [benign]; 			24	92					NIPA1 (inh=AD pLI=0.21)
chr15	23046982	23046982	-	T	het	anno_omim	QUAL=9285;DP=275;AF=0.50;MQM=59;TRIO=HET,275,0.50,HOM,191,0.97,WT,194,0.02	NIPA1	3'UTR	NIPA1:ENST00000337435:3'UTR:MODIFIER:exon5/5:c.*1846dupA:,NIPA1:ENST00000437912:3'UTR:MODIFIER:exon5/5:c.*1846dupA:		rs113532349	0.2722	0.0000	0,0,0	0,0,0,0,0	0.3014							608145 [NIPA1 (confirmed) Spastic paraplegia 6,autosomal dominant,600363];	RCV000317044.1 [benign]; 			24	92					NIPA1 (inh=AD pLI=0.21)
chr15	23047857	23047857	G	A	het	anno_omim	QUAL=8939;DP=251;AF=0.50;MQM=59;TRIO=HET,251,0.50,HOM,178,0.99,WT,245,0.00	NIPA1	3'UTR	NIPA1:ENST00000337435:3'UTR:MODIFIER:exon5/5:c.*972C>T:,NIPA1:ENST00000437912:3'UTR:MODIFIER:exon5/5:c.*972C>T:,NIPA1:ENST00000538684:3'UTR:MODIFIER:exon6/6:c.*972C>T:	Tigger3a	rs8025849	0.6879	0.0000	0,0,0	0,0,0,0,0	0.6279							608145 [NIPA1 (confirmed) Spastic paraplegia 6,autosomal dominant,600363];	RCV000276623.1 [benign]; 			122	88					NIPA1 (inh=AD pLI=0.21)
chr15	23048542	23048542	A	G	het	anno_omim	QUAL=12873;DP=343;AF=0.52;MQM=60;TRIO=HET,343,0.52,HOM,250,1.00,WT,312,0.00	NIPA1	3'UTR	NIPA1:ENST00000337435:3'UTR:MODIFIER:exon5/5:c.*287T>C:,NIPA1:ENST00000437912:3'UTR:MODIFIER:exon5/5:c.*287T>C:,NIPA1:ENST00000538684:3'UTR:MODIFIER:exon6/6:c.*287T>C:,NIPA1:ENST00000561183:3'UTR:MODIFIER:exon5/5:c.*287T>C:		rs3812924	0.1893	0.0000	0,0,0	0,0,0,0,0	0.2220							608145 [NIPA1 (confirmed) Spastic paraplegia 6,autosomal dominant,600363];	RCV000326090.1 [benign]; 			24	93					NIPA1 (inh=AD pLI=0.21)
chr15	23052632	23052632	T	C	het	anno_omim	QUAL=6668;DP=193;AF=0.47;MQM=60;TRIO=HET,193,0.47,HOM,147,0.99,WT,224,0.00	NIPA1	synonymous,5'UTR	NIPA1:ENST00000337435:synonymous:LOW:exon4/5:c.441A>G:p.Thr147Thr,NIPA1:ENST00000437912:synonymous:LOW:exon4/5:c.216A>G:p.Thr72Thr,NIPA1:ENST00000561183:synonymous:LOW:exon4/5:c.216A>G:p.Thr72Thr,NIPA1:ENST00000538684:5'UTR:MODIFIER:exon5/6:c.-70A>G:		rs11263683	0.7041	0.7359	33561,17397,1324	0.4952,0.8774,0.8141,0.7221,0.8447	0.7449							608145 [NIPA1 (confirmed) Spastic paraplegia 6,autosomal dominant,600363];	RCV000117820.2 [likely benign]; RCV000298408.1 [benign]; 		COSM3999473	1427	1059					NIPA1 (inh=AD pLI=0.21)
chr15	23931507	23931507	G	A	hom	anno_omim	QUAL=7973;DP=176;AF=0.99;MQM=59;TRIO=HOM,176,0.99,HET,87,0.51,HET,126,0.47	NDN	synonymous	NDN:ENST00000331837:synonymous:LOW:exon1/1:c.858C>T:p.Asp286Asp		rs2192206	0.1895	0.2268	3136,1558,9	0.0450,0.3062,0.3844,0.2234,0.2216	0.2206							602117 [NDN (confirmed) Prader-Willi syndrome,176270];			COSM3754246	125	727					NDN (inh=n/a pLI=0.47)
chr15	25219512	25219512	T	C	hom	anno_omim	QUAL=35242;DP=308;AF=0.99;MQM=60;TRIO=HOM,308,0.99,HOM,343,1.00,HOM,440,1.00	SNRPN,SNURF	5'UTR,3'UTR,intron	SNRPN:ENST00000444203:5'UTR:MODIFIER:exon1/8:c.-393T>C:,SNRPN:ENST00000400098:5'UTR:MODIFIER:exon6/12:c.-89T>C:,SNRPN:ENST00000400100:5'UTR:MODIFIER:exon7/13:c.-89T>C:,SNRPN:ENST00000400097:5'UTR:MODIFIER:exon6/12:c.-89T>C:,SNRPN:ENST00000390687:5'UTR:MODIFIER:exon4/10:c.-89T>C:,SNRPN:ENST00000554227:5'UTR:MODIFIER:exon5/12:c.-393T>C:,SNRPN:ENST00000577565:5'UTR:MODIFIER:exon4/10:c.-89T>C:,SNURF:ENST00000338094:3'UTR:MODIFIER:exon4/10:c.*100T>C:,SNURF:ENST00000551312:intron:MODIFIER:exon3/7:c.*46-5171T>C:,SNRPN:ENST00000346403:intron:MODIFIER:exon3/9:c.-67-22T>C:		rs705	0.5218	0.0000	0,0,0	0,0,0,0,0	0.5339							182279 [SNRPN (provisional) Prader-Willi syndrome,176270];	RCV000302218.1 [likely benign]; 			95	218					SNRPN (inh=AD pLI=0.85), SNURF (inh=n/a pLI=0.78)
chr15	32460419	32460419	C	T	het	low_DP;low_MQM;anno_omim	QUAL=326;DP=4;AF=0.50;MQM=26;TRIO=HET,4,0.50,HET,73,0.27,HET,117,0.24	CHRNA7	synonymous	CHRNA7:ENST00000454250:synonymous:LOW:exon10/10:c.1356C>T:p.Gly452Gly,CHRNA7:ENST00000306901:synonymous:LOW:exon10/10:c.1269C>T:p.Gly423Gly,CHRNA7:ENST00000455693:synonymous:LOW:exon8/8:c.726C>T:p.Gly242Gly		rs1042724	0.0000	0.4590	119,82,9	0.4239,0.4721,0.4133,0.4800,0.4199	0.3840							118511 [CHRNA7 (confirmed) Schizophrenia,neurophysiologic defect in];			COSM4148629, COSM4148628	49	1154					CHRNA7 (inh=n/a pLI=n/a)
chr15	32461233	32461233	T	C	hom	low_MQM;anno_omim	QUAL=993;DP=25;AF=0.04;MQM=32;TRIO=HOM,25,0.04,WT,50,0.00,HOM,26,0.27	CHRNA7	3'UTR	CHRNA7:ENST00000306901:3'UTR:MODIFIER:exon10/10:c.*574T>C:		rs67960669	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0020							118511 [CHRNA7 (confirmed) Schizophrenia,neurophysiologic defect in];				2	3					CHRNA7 (inh=n/a pLI=n/a)
chr15	34522679	34522679	C	T	hom	anno_omim	QUAL=11998;DP=157;AF=1.00;MQM=59;TRIO=HOM,157,1.00,HET,134,0.43,HOM,169,1.00	EMC4,SLC12A6	intergenic_region	SLC12A6:ENSG00000128463-ENSG00000140199:intergenic_region:MODIFIER::n.34522679C>T:		rs4530104	0.5449	0.0000	0,0,0	0,0,0,0,0	0.5867							604878 [SLC12A6 (confirmed) Agenesis of the corpus callosum with peripheral neuropathy,218000];	RCV000267812.1 [benign]; 			95	105					EMC4 (inh=n/a pLI=0.91), SLC12A6 (inh=AR pLI=0.98)
chr15	34522985	34522985	C	G	hom	anno_omim	QUAL=21793;DP=253;AF=1.00;MQM=60;TRIO=HOM,253,1.00,HOM,199,1.00,HOM,208,1.00	EMC4,SLC12A6	intergenic_region	SLC12A6:ENSG00000128463-ENSG00000140199:intergenic_region:MODIFIER::n.34522985C>G:		rs4238571	0.9671	0.0000	0,0,0	0,0,0,0,0	0.9679							604878 [SLC12A6 (confirmed) Agenesis of the corpus callosum with peripheral neuropathy,218000];	RCV000293353.1 [benign]; 			231	1					EMC4 (inh=n/a pLI=0.91), SLC12A6 (inh=AR pLI=0.98)
chr15	34524590	34524590	A	G	hom	anno_omim	QUAL=15754;DP=221;AF=1.00;MQM=59;TRIO=HOM,221,1.00,HOM,112,0.99,HOM,152,1.00	EMC4,SLC12A6	intergenic_region	SLC12A6:ENSG00000128463-ENSG00000140199:intergenic_region:MODIFIER::n.34524590A>G:	AluSz	rs6495640	0.9457	0.0000	0,0,0	0,0,0,0,0	0.9533							604878 [SLC12A6 (confirmed) Agenesis of the corpus callosum with peripheral neuropathy,218000];	RCV000390176.1 [benign]; 			194	1					EMC4 (inh=n/a pLI=0.91), SLC12A6 (inh=AR pLI=0.98)
chr15	34524995	34524995	G	T	hom	anno_omim	QUAL=26473;DP=336;AF=1.00;MQM=59;TRIO=HOM,336,1.00,HET,274,0.50,HOM,377,1.00	EMC4,SLC12A6	intergenic_region	SLC12A6:ENSG00000128463-ENSG00000140199:intergenic_region:MODIFIER::n.34524995G>T:		rs4779660	0.7895	0.0000	0,0,0	0,0,0,0,0	0.7803							604878 [SLC12A6 (confirmed) Agenesis of the corpus callosum with peripheral neuropathy,218000];	RCV000377910.1 [benign]; 			158	69					EMC4 (inh=n/a pLI=0.91), SLC12A6 (inh=AR pLI=0.98)
chr15	34525035	34525035	T	C	hom	anno_omim	QUAL=30096;DP=404;AF=0.99;MQM=59;TRIO=HOM,404,0.99,HET,295,0.51,HOM,395,1.00	EMC4,SLC12A6	intergenic_region	SLC12A6:ENSG00000128463-ENSG00000140199:intergenic_region:MODIFIER::n.34525035T>C:		rs4780233	0.5861	0.0000	0,0,0	0,0,0,0,0	0.6183							604878 [SLC12A6 (confirmed) Agenesis of the corpus callosum with peripheral neuropathy,218000];	RCV000267883.1 [benign]; 			95	109					EMC4 (inh=n/a pLI=0.91), SLC12A6 (inh=AR pLI=0.98)
chr15	34525258	34525258	A	G	het	anno_omim	QUAL=5560;DP=341;AF=0.48;MQM=60;TRIO=HET,341,0.48,HET,95,0.52,WT,168,0.00	EMC4,SLC12A6	intergenic_region	SLC12A6:ENSG00000128463-ENSG00000140199:intergenic_region:MODIFIER::n.34525258A>G:		rs75307067	0.0421	0.0000	0,0,0	0,0,0,0,0	0.0641							604878 [SLC12A6 (confirmed) Agenesis of the corpus callosum with peripheral neuropathy,218000];	RCV000372915.1 [likely benign]; 			0	37					EMC4 (inh=n/a pLI=0.91), SLC12A6 (inh=AR pLI=0.98)
chr15	34528948	34528948	G	A	hom	anno_omim	QUAL=29103;DP=351;AF=1.00;MQM=60;TRIO=HOM,351,1.00,HET,307,0.50,HOM,429,1.00	SLC12A6	synonymous	SLC12A6:ENST00000354181:synonymous:LOW:exon23/26:c.3003C>T:p.Leu1001Leu,SLC12A6:ENST00000397707:synonymous:LOW:exon21/24:c.2958C>T:p.Leu986Leu,SLC12A6:ENST00000560611:synonymous:LOW:exon22/25:c.3003C>T:p.Leu1001Leu,SLC12A6:ENST00000458406:synonymous:LOW:exon23/26:c.2826C>T:p.Leu942Leu,SLC12A6:ENST00000397702:synonymous:LOW:exon23/26:c.2826C>T:p.Leu942Leu,SLC12A6:ENST00000451844:synonymous:LOW:exon20/23:c.2439C>T:p.Leu813Leu,SLC12A6:ENST00000560164:synonymous:LOW:exon21/24:c.2439C>T:p.Leu813Leu,SLC12A6:ENST00000290209:synonymous:LOW:exon22/25:c.2850C>T:p.Leu950Leu,SLC12A6:ENST00000558667:synonymous:LOW:exon23/26:c.3003C>T:p.Leu1001Leu,SLC12A6:ENST00000558589:synonymous:LOW:exon23/26:c.2976C>T:p.Leu992Leu		rs4577050	0.5721	0.6510	26234,15441,995	0.4346,0.6958,0.6805,0.6778,0.6071	0.6592							604878 [SLC12A6 (confirmed) Agenesis of the corpus callosum with peripheral neuropathy,218000];	RCV000147486.2 [benign]; RCV000265452.1 [benign]; 		COSM3754266, COSM3754264, COSM3754265	895	937					SLC12A6 (inh=AR pLI=0.98)
chr15	34551082	34551082	G	A	het	anno_omim	QUAL=9292;DP=381;AF=0.47;MQM=60;TRIO=HET,381,0.47,HET,348,0.50,WT,427,0.00	SLC12A6	synonymous	SLC12A6:ENST00000354181:synonymous:LOW:exon5/26:c.475C>T:p.Leu159Leu,SLC12A6:ENST00000397707:synonymous:LOW:exon3/24:c.430C>T:p.Leu144Leu,SLC12A6:ENST00000560611:synonymous:LOW:exon4/25:c.475C>T:p.Leu159Leu,SLC12A6:ENST00000458406:synonymous:LOW:exon5/26:c.298C>T:p.Leu100Leu,SLC12A6:ENST00000397702:synonymous:LOW:exon5/26:c.298C>T:p.Leu100Leu,SLC12A6:ENST00000451844:synonymous:LOW:exon3/23:c.58C>T:p.Leu20Leu,SLC12A6:ENST00000560164:synonymous:LOW:exon4/24:c.58C>T:p.Leu20Leu,SLC12A6:ENST00000290209:synonymous:LOW:exon4/25:c.322C>T:p.Leu108Leu,SLC12A6:ENST00000558667:synonymous:LOW:exon5/26:c.475C>T:p.Leu159Leu,SLC12A6:ENST00000558589:synonymous:LOW:exon5/26:c.448C>T:p.Leu150Leu		rs7164902	0.2768	0.2511	4022,1945,240	0.2101,0.1853,0.3385,0.2423,0.3406	0.2469							604878 [SLC12A6 (confirmed) Agenesis of the corpus callosum with peripheral neuropathy,218000];	RCV000147488.2 [benign]; RCV000271997.1 [benign]; 		COSM3754270, COSM3754271, COSM3754272	169	794					SLC12A6 (inh=AR pLI=0.98)
chr15	34610964	34610964	G	C	het	anno_omim	QUAL=8053;DP=569;AF=0.46;MQM=59;TRIO=HET,569,0.46,HET,184,0.47,WT,240,0.00	SLC12A6	5'UTR,intron	SLC12A6:ENST00000290209:5'UTR:MODIFIER:exon1/25:c.-85C>G:,SLC12A6:ENST00000354181:intron:MODIFIER:exon2/25:c.271+17647C>G:,SLC12A6:ENST00000397707:intron:MODIFIER:exon1/23:c.271+17647C>G:,SLC12A6:ENST00000560611:intron:MODIFIER:exon1/24:c.271+17647C>G:,SLC12A6:ENST00000458406:intron:MODIFIER:exon2/25:c.94+17647C>G:,SLC12A6:ENST00000397702:intron:MODIFIER:exon2/25:c.94+17647C>G:,SLC12A6:ENST00000558667:intron:MODIFIER:exon2/25:c.271+17647C>G:,SLC12A6:ENST00000558589:intron:MODIFIER:exon2/25:c.244+17647C>G:		rs347867	0.4515	0.0000	0,0,0	0,0,0,0,0	0.3931							604878 [SLC12A6 (confirmed) Agenesis of the corpus callosum with peripheral neuropathy,218000];				26	86					SLC12A6 (inh=AR pLI=0.98)
chr15	34629024	34629024	C	T	het	anno_omim	QUAL=3904;DP=261;AF=0.48;MQM=60;TRIO=HET,261,0.48,HET,85,0.55,WT,115,0.00	SLC12A6	5'UTR,intron	SLC12A6:ENST00000397707:5'UTR:MODIFIER:exon1/24:c.-143G>A:,SLC12A6:ENST00000560611:5'UTR:MODIFIER:exon1/25:c.-143G>A:,SLC12A6:ENST00000354181:intron:MODIFIER:exon1/25:c.-72-71G>A:,SLC12A6:ENST00000458406:intron:MODIFIER:exon1/25:c.-98-222G>A:,SLC12A6:ENST00000397702:intron:MODIFIER:exon1/25:c.-98-222G>A:,SLC12A6:ENST00000558667:intron:MODIFIER:exon1/25:c.-6-137G>A:,SLC12A6:ENST00000558589:intron:MODIFIER:exon1/25:c.-14-156G>A:		rs73374490	0.2107	0.0000	0,0,0	0,0,0,0,0	0.1486							604878 [SLC12A6 (confirmed) Agenesis of the corpus callosum with peripheral neuropathy,218000];	RCV000290170.1 [benign]; RCV000319657.1 [likely benign]; 			5	58					SLC12A6 (inh=AR pLI=0.98)
chr15	40710723	40710723	G	A	hom	anno_omim	QUAL=28457;DP=517;AF=1.00;MQM=60;TRIO=HOM,517,1.00,HET,455,0.48,HET,556,0.47	IVD	3'UTR	IVD:ENST00000487418:3'UTR:MODIFIER:exon12/12:c.*261G>A:,IVD:ENST00000249760:3'UTR:MODIFIER:exon12/12:c.*261G>A:,IVD:ENST00000479013:3'UTR:MODIFIER:exon11/11:c.*261G>A:		rs2075624	0.3578	0.0000	0,0,0	0,0,0,0,0	0.2499							607036 [IVD (provisional) Isovaleric acidemia,243500];	RCV000319888.1 [benign]; 			21	99					IVD (inh=AR pLI=0.00)
chr15	40711270	40711270	C	G	hom	anno_omim	QUAL=9415;DP=147;AF=1.00;MQM=57;TRIO=HOM,147,1.00,HOM,102,0.99,HET,155,0.47	IVD	3'UTR	IVD:ENST00000249760:3'UTR:MODIFIER:exon12/12:c.*808C>G:,IVD:ENST00000479013:3'UTR:MODIFIER:exon11/11:c.*808C>G:	AluSq2	rs2075625	0.5074	0.0000	0,0,0	0,0,0,0,0	0.4742							607036 [IVD (provisional) Isovaleric acidemia,243500];	RCV000310233.1 [benign]; 			430	737					IVD (inh=AR pLI=0.00)
chr15	40711933	40711933	G	A	hom	low_MQM;anno_omim	QUAL=2268;DP=59;AF=0.98;MQM=48;TRIO=HOM,59,0.98,HOM,7,1.00,HOM,13,1.00	IVD	3'UTR	IVD:ENST00000249760:3'UTR:MODIFIER:exon12/12:c.*1471G>A:,IVD:ENST00000479013:3'UTR:MODIFIER:exon11/11:c.*1471G>A:	AluSg7	rs4923865	0.5869	0.0000	0,0,0	0,0,0,0,0	0.5961							607036 [IVD (provisional) Isovaleric acidemia,243500];	RCV000266746.1 [benign]; 			91	72					IVD (inh=AR pLI=0.00)
chr15	40712039	40712039	C	G	hom	anno_omim	QUAL=1268;DP=40;AF=1.00;MQM=55;TRIO=HOM,40,1.00,HOM,3,1.00,HET,3,0.33	IVD	3'UTR	IVD:ENST00000249760:3'UTR:MODIFIER:exon12/12:c.*1577C>G:,IVD:ENST00000479013:3'UTR:MODIFIER:exon11/11:c.*1577C>G:	AluSg	rs11630850	0.5068	0.0000	0,0,0	0,0,0,0,0	0.4751							607036 [IVD (provisional) Isovaleric acidemia,243500];	RCV000298491.1 [benign]; 			62	68					IVD (inh=AR pLI=0.00)
chr15	40712072	40712072	C	T	hom	anno_omim	QUAL=1142;DP=37;AF=0.97;MQM=52;TRIO=HOM,37,0.97,HOM,5,1.00,HET,4,0.75	IVD	3'UTR	IVD:ENST00000249760:3'UTR:MODIFIER:exon12/12:c.*1610C>T:,IVD:ENST00000479013:3'UTR:MODIFIER:exon11/11:c.*1610C>T:	AluSg	rs11630878	0.5070	0.0000	0,0,0	0,0,0,0,0	0.4713							607036 [IVD (provisional) Isovaleric acidemia,243500];	RCV000352977.1 [benign]; 			58	82					IVD (inh=AR pLI=0.00)
chr15	40712349	40712349	G	-	hom	anno_omim	QUAL=18434;DP=219;AF=1.00;MQM=59;TRIO=HOM,219,1.00,HOM,178,0.99,HET,247,0.99	IVD	3'UTR	IVD:ENST00000249760:3'UTR:MODIFIER:exon12/12:c.*1893delG:,IVD:ENST00000479013:3'UTR:MODIFIER:exon11/11:c.*1893delG:		rs398026948	0.5070	0.0000	0,0,0	0,0,0,0,0	0.4713							607036 [IVD (provisional) Isovaleric acidemia,243500];	RCV000262767.1 [benign]; 			72	137					IVD (inh=AR pLI=0.00)
chr15	40712737	40712737	T	C	hom	anno_omim	QUAL=20211;DP=193;AF=0.99;MQM=60;TRIO=HOM,193,0.99,HOM,191,0.99,HOM,258,1.00	IVD	3'UTR	IVD:ENST00000249760:3'UTR:MODIFIER:exon12/12:c.*2275T>C:,IVD:ENST00000479013:3'UTR:MODIFIER:exon11/11:c.*2275T>C:		rs11790	0.6112	0.0000	0,0,0	0,0,0,0,0	0.6177							607036 [IVD (provisional) Isovaleric acidemia,243500];	RCV000387858.1 [benign]; 			693	737					IVD (inh=AR pLI=0.00)
chr15	40713306	40713306	T	C	hom	anno_omim	QUAL=22519;DP=356;AF=0.99;MQM=59;TRIO=HOM,356,0.99,HOM,205,0.99,HET,308,0.56	IVD	3'UTR	IVD:ENST00000249760:3'UTR:MODIFIER:exon12/12:c.*2844T>C:,IVD:ENST00000479013:3'UTR:MODIFIER:exon11/11:c.*2844T>C:		rs7207	0.5072	0.0000	0,0,0	0,0,0,0,0	0.4732							607036 [IVD (provisional) Isovaleric acidemia,243500];	RCV000401680.1 [benign]; 			69	131					IVD (inh=AR pLI=0.00)
chr15	40713491	40713491	A	-	hom	anno_omim	QUAL=13402;DP=218;AF=0.98;MQM=59;TRIO=HOM,218,0.98,HOM,160,0.99,HET,207,0.48	IVD	splice_region,3'UTR	IVD:ENST00000479013:splice_region:LOW:exon11/11:c.*3036delA:,IVD:ENST00000249760:3'UTR:MODIFIER:exon12/12:c.*3036delA:,IVD:ENST00000479013:3'UTR:MODIFIER:exon11/11:c.*3036delA:		rs5812161	0.5072	0.0000	0,0,0	0,0,0,0,0	0.4749							607036 [IVD (provisional) Isovaleric acidemia,243500];	RCV000407960.1 [benign]; 			68	131					IVD (inh=AR pLI=0.00)
chr15	42704105	42704105	C	T	hom	anno_omim	QUAL=35856;DP=376;AF=0.99;MQM=59;TRIO=HOM,376,0.99,HOM,363,1.00,HOM,429,1.00	CAPN3,RP11-164J13.1	3'UTR,intron	CAPN3:ENST00000397163:3'UTR:MODIFIER:exon24/24:c.*134C>T:,CAPN3:ENST00000356316:3'UTR:MODIFIER:exon27/27:c.*134C>T:,CAPN3:ENST00000349748:3'UTR:MODIFIER:exon21/21:c.*134C>T:,CAPN3:ENST00000397200:3'UTR:MODIFIER:exon13/13:c.*134C>T:,CAPN3:ENST00000337571:3'UTR:MODIFIER:exon9/9:c.*134C>T:,CAPN3:ENST00000569136:3'UTR:MODIFIER:exon11/11:c.*134C>T:,CAPN3:ENST00000397204:3'UTR:MODIFIER:exon10/10:c.*134C>T:,CAPN3:ENST00000561817:intron:MODIFIER:exon8/8:c.445-179C>T:		rs3098423	0.9912	0.0000	0,0,0	0,0,0,0,0	0.9706							114240 [CAPN3 (confirmed) Muscular dystrophy,limb-girdle,type 2A,253600];	RCV000259632.1 [benign]; RCV000312848.1 [benign]; RCV000401564.1 [benign]; 			537	11					CAPN3 (inh=AR pLI=0.00), RP11-164J13.1 (inh=n/a pLI=n/a)
chr15	43212818	43212818	C	G	hom	low_DP;anno_omim	QUAL=888;DP=4;AF=1.00;MQM=58;TRIO=HOM,4,1.00,HOM,5,1.00,HOM,23,1.00	TTBK2	5'UTR	TTBK2:ENST00000567840:5'UTR:MODIFIER:exon1/12:c.-250G>C:,TTBK2:ENST00000567274:5'UTR:MODIFIER:exon1/11:c.-250G>C:		rs12437637	0.5387	0.0000	0,0,0	0,0,0,0,0	0.5785							611695 [TTBK2 (confirmed) Spinocerebellar ataxia 11,604432];	RCV000262105.1 [benign]; 			94	43					TTBK2 (inh=AD pLI=1.00)
chr15	43236612	43236612	C	T	hom	anno_omim	QUAL=18226;DP=257;AF=1.00;MQM=60;TRIO=HOM,257,1.00,HOM,119,1.00,HOM,174,1.00	UBR1	3'UTR	UBR1:ENST00000290650:3'UTR:MODIFIER:exon47/47:c.*915G>A:,UBR1:ENST00000382177:3'UTR:MODIFIER:exon46/46:c.*3700G>A:		rs7178567	0.8442	0.0000	0,0,0	0,0,0,0,0	0.8605							605981 [UBR1 (confirmed) Johanson-Blizzard syndrome,243800];				191	39					UBR1 (inh=AR pLI=0.32)
chr15	43237203	43237203	T	C	hom	anno_omim	QUAL=11867;DP=202;AF=1.00;MQM=60;TRIO=HOM,202,1.00,HOM,67,1.00,HOM,86,1.00	UBR1	3'UTR	UBR1:ENST00000290650:3'UTR:MODIFIER:exon47/47:c.*324A>G:,UBR1:ENST00000382177:3'UTR:MODIFIER:exon46/46:c.*3109A>G:		rs3803341	0.7869	0.0000	0,0,0	0,0,0,0,0	0.8113							605981 [UBR1 (confirmed) Johanson-Blizzard syndrome,243800];				189	40					UBR1 (inh=AR pLI=0.32)
chr15	43237414	43237414	C	T	het	anno_omim	QUAL=9199;DP=390;AF=0.49;MQM=60;TRIO=HET,390,0.49,HET,297,0.53,WT,381,0.00	UBR1	3'UTR	UBR1:ENST00000290650:3'UTR:MODIFIER:exon47/47:c.*113G>A:,UBR1:ENST00000382177:3'UTR:MODIFIER:exon46/46:c.*2898G>A:		rs62020698	0.0347	0.0000	0,0,0	0,0,0,0,0	0.0521							605981 [UBR1 (confirmed) Johanson-Blizzard syndrome,243800];				2	40					UBR1 (inh=AR pLI=0.32)
chr15	44943757	44943757	A	G	het	pred_pathogenic;anno_omim	QUAL=21575;DP=339;AF=0.53;MQM=59;TRIO=HET,339,0.53,HOM,374,1.00,HET,464,0.48	SPG11	missense	SPG11:ENST00000261866:missense:MODERATE:exon6/40:c.1388T>C:p.Phe463Ser,SPG11:ENST00000535302:missense:MODERATE:exon6/38:c.1388T>C:p.Phe463Ser,SPG11:ENST00000427534:missense:MODERATE:exon6/37:c.1388T>C:p.Phe463Ser,SPG11:ENST00000558319:missense:MODERATE:exon6/32:c.1388T>C:p.Phe463Ser,SPG11:ENST00000559193:missense:MODERATE:exon6/12:c.1388T>C:p.Phe463Ser		rs3759871	0.4748	0.4660	13393,7070,1456	0.5289,0.5656,0.4674,0.4594,0.3710	0.4841	1.2260	T,T,T	T	B,B,B,B	T,T,T	23.10	610844 [SPG11 (confirmed) Spastic paraplegia 11,autosomal recessive,604360|Amyotrophic lateral sclerosis 5,juvenile,602099|Charcot-Marie-Tooth disease,axonal,type 2X,616668];	RCV000034172.2 [benign]; RCV000118403.2 [likely benign]; RCV000377866.1 [benign]; 		COSM147894	514	1244	1	[1] old entry - no details available			SPG11 (inh=AR pLI=0.00)
chr15	45385496	45385496	A	T	het	anno_omim	QUAL=9616;DP=337;AF=0.47;MQM=60;TRIO=HET,337,0.47,HOM,192,0.99,WT,305,0.00	DUOX2	3'UTR	DUOX2:ENST00000389039:3'UTR:MODIFIER:exon34/34:c.*852T>A:,DUOX2:ENST00000603300:3'UTR:MODIFIER:exon34/34:c.*852T>A:		rs4775744	0.2302	0.0000	0,0,0	0,0,0,0,0	0.2208							606759 [DUOX2 (confirmed) Thyroid dyshormonogenesis 6,607200];	RCV000327846.1 [likely benign]; 			3	39					DUOX2 (inh=AR pLI=0.00)
chr15	45392075	45392075	G	A	hom	pred_pathogenic;anno_omim	QUAL=18718;DP=123;AF=0.99;MQM=59;TRIO=HOM,123,0.99,HET,313,0.51,HOM,359,1.00	DUOX2	missense	DUOX2:ENST00000389039:missense:MODERATE:exon25/34:c.3200C>T:p.Ser1067Leu,DUOX2:ENST00000603300:missense:MODERATE:exon25/34:c.3200C>T:p.Ser1067Leu		rs269868	0.7202	0.8644	47538,28550,377	0.2553,0.8539,0.9425,0.9248,0.9420	0.8768	7.9340	D	T	B		23.00	606759 [DUOX2 (confirmed) Thyroid dyshormonogenesis 6,607200];	RCV000252016.1 [benign]; RCV000394986.1 [benign]; 		COSM4148787	1803	283	2	[2] old entry - no details available			DUOX2 (inh=AR pLI=0.00)
chr15	45400358	45400358	C	G	hom	anno_omim	QUAL=15127;DP=147;AF=0.99;MQM=59;TRIO=HOM,147,0.99,HOM,126,1.00,HOM,219,1.00	DUOX2	synonymous	DUOX2:ENST00000389039:synonymous:LOW:exon13/34:c.1461G>C:p.Gly487Gly,DUOX2:ENST00000603300:synonymous:LOW:exon13/34:c.1461G>C:p.Gly487Gly		rs269860	0.8614	0.9410	54417,31502,1980	0.6115,0.9405,0.9791,0.9716,0.9856	0.9491							606759 [DUOX2 (confirmed) Thyroid dyshormonogenesis 6,607200];	RCV000254488.1 [benign]; RCV000364666.1 [benign]; 		COSM4148789	2008	102					DUOX2 (inh=AR pLI=0.00)
chr15	45404066	45404066	G	A	hom	low_DP;pred_pathogenic;anno_omim	QUAL=1615;DP=16;AF=1.00;MQM=59;TRIO=HOM,16,1.00,HET,19,0.53,HOM,33,1.00	DUOX2	missense	DUOX2:ENST00000389039:missense:MODERATE:exon5/34:c.413C>T:p.Pro138Leu,DUOX2:ENST00000603300:missense:MODERATE:exon5/34:c.413C>T:p.Pro138Leu		rs2001616	0.7600	0.8624	45622,26862,943	0.4270,0.8479,0.9036,0.9038,0.9279	0.8710	2.4090	T	T	B		16.34	606759 [DUOX2 (confirmed) Thyroid dyshormonogenesis 6,607200];	RCV000251571.1 [benign]; RCV000396025.1 [benign]; 		COSM4148790	1735	345					DUOX2 (inh=AR pLI=0.00)
chr15	45408414	45408414	C	G	hom	pred_pathogenic;anno_omim	QUAL=28364;DP=219;AF=1.00;MQM=59;TRIO=HOM,219,1.00,HOM,301,1.00,HOM,398,1.00	DUOXA2	missense	DUOXA2:ENST00000323030:missense:MODERATE:exon3/6:c.298C>G:p.Arg100Gly		rs2576090	0.8584	0.9621	56765,33327,1497	0.5532,0.9868,1.0000,0.9995,0.9996	0.9693	7.3630	T	T	B	T	12.32	612772 [DUOXA2 (provisional) Thyroid dyshormonogenesis 5,274900];	RCV000250029.1 [benign]; 			2099	11					DUOXA2 (inh=AR pLI=0.00)
chr15	45408710	45408710	A	G	hom	anno_omim	QUAL=11425;DP=106;AF=1.00;MQM=59;TRIO=HOM,106,1.00,HOM,122,1.00,HOM,151,1.00	DUOXA2	splice_region&intron	DUOXA2:ENST00000323030:splice_region&intron:LOW:exon3/5:c.341-4A>G:		rs2554459	0.9203	0.9819	58282,33236,3025	0.7878,0.9933,1.0000,0.9997,0.9996	0.9854							612772 [DUOXA2 (provisional) Thyroid dyshormonogenesis 5,274900];	RCV000247778.1 [benign]; 			2100	15					DUOXA2 (inh=AR pLI=0.00)
chr15	45408933	45408933	T	C	hom	anno_omim	QUAL=10075;DP=104;AF=1.00;MQM=59;TRIO=HOM,104,1.00,HET,124,0.55,HOM,183,1.00	DUOXA2	splice_region&intron	DUOXA2:ENST00000323030:splice_region&intron:LOW:exon4/5:c.554+6T>C:		rs2576092	0.7642	0.8765	46739,27701,817	0.4164,0.8542,0.9384,0.9193,0.9335	0.8821							612772 [DUOXA2 (provisional) Thyroid dyshormonogenesis 5,274900];	RCV000252536.1 [benign]; 			1765	320					DUOXA2 (inh=AR pLI=0.00)
chr15	48580713	48580713	T	C	hom	pred_pathogenic;anno_omim	QUAL=23445;DP=335;AF=1.00;MQM=60;TRIO=HOM,335,1.00,HOM,151,1.00,HOM,238,1.00	SLC12A1	missense&splice_region	SLC12A1:ENST00000380993:missense&splice_region:MODERATE:exon23/27:c.2873T>C:p.Val958Ala,SLC12A1:ENST00000396577:missense&splice_region:MODERATE:exon23/27:c.2873T>C:p.Val958Ala,SLC12A1:ENST00000558405:missense&splice_region:MODERATE:exon22/26:c.2873T>C:p.Val958Ala		rs1552311	0.9978	0.9992	13825,6167,1679	0.9938,1.0000,1.0000,1.0000,1.0000	0.9995	1.0800	T,T	T	B,B	D,D	0.54	600839 [SLC12A1 (confirmed) Bartter syndrome,type 1,601678];	RCV000248948.1 [benign]; RCV000323585.1 [benign]; 			2112	0					SLC12A1 (inh=AR pLI=0.00)
chr15	48595192	48595192	G	T	hom	anno_omim	QUAL=19221;DP=330;AF=1.00;MQM=60;TRIO=HOM,330,1.00,HET,150,0.51,HOM,193,1.00	SLC12A1	splice_region,3'UTR	SLC12A1:ENST00000558405:splice_region:LOW:exon26/26:c.*110G>T:,SLC12A1:ENST00000380993:3'UTR:MODIFIER:exon27/27:c.*110G>T:,SLC12A1:ENST00000396577:3'UTR:MODIFIER:exon27/27:c.*110G>T:,SLC12A1:ENST00000558405:3'UTR:MODIFIER:exon26/26:c.*110G>T:		rs8025278	0.7352	0.0000	0,0,0	0,0,0,0,0	0.8205							600839 [SLC12A1 (confirmed) Bartter syndrome,type 1,601678];	RCV000348266.1 [benign]; 			210	22					SLC12A1 (inh=AR pLI=0.00)
chr15	48595366	48595366	A	G	hom	anno_omim	QUAL=18065;DP=278;AF=0.99;MQM=60;TRIO=HOM,278,0.99,HET,143,0.49,HOM,218,1.00	SLC12A1	3'UTR	SLC12A1:ENST00000380993:3'UTR:MODIFIER:exon27/27:c.*284A>G:,SLC12A1:ENST00000396577:3'UTR:MODIFIER:exon27/27:c.*284A>G:		rs12902028	0.6961	0.0000	0,0,0	0,0,0,0,0	0.8195							600839 [SLC12A1 (confirmed) Bartter syndrome,type 1,601678];	RCV000305368.1 [benign]; 			213	18					SLC12A1 (inh=AR pLI=0.00)
chr15	48596166	48596166	A	T	hom	anno_omim	QUAL=13630;DP=205;AF=1.00;MQM=60;TRIO=HOM,205,1.00,HOM,96,1.00,HOM,128,1.00	SLC12A1	3'UTR	SLC12A1:ENST00000380993:3'UTR:MODIFIER:exon27/27:c.*1084A>T:,SLC12A1:ENST00000396577:3'UTR:MODIFIER:exon27/27:c.*1084A>T:		rs12438818	0.8207	0.0000	0,0,0	0,0,0,0,0	0.9028							600839 [SLC12A1 (confirmed) Bartter syndrome,type 1,601678];	RCV000374469.1 [benign]; 			220	12					SLC12A1 (inh=AR pLI=0.00)
chr15	48701029	48701029	C	T	hom	anno_omim	QUAL=26474;DP=399;AF=1.00;MQM=59;TRIO=HOM,399,1.00,HOM,183,0.99,HOM,221,1.00	FBN1	3'UTR	FBN1:ENST00000316623:3'UTR:MODIFIER:exon66/66:c.*2158G>A:		rs11070641	0.7823	0.0000	0,0,0	0,0,0,0,0	0.7469							134797 [FBN1 (confirmed) Marfan syndrome,154700|Marfan lipodystrophy syndrome,616914|Ectopia lentis,familial,129600|MASS syndrome,604308|Weill-Marchesani syndrome 2,dominant,608328|Stiff skin syndrome,184900|Acromicric dysplasia,102370|Geleophysic dysplasia 2,614185];	RCV000264532.1 [benign]; RCV000309412.1 [benign]; RCV000313560.1 [benign]; RCV000348604.1 [benign]; RCV000359463.1 [benign]; RCV000362911.1 [benign]; RCV000402950.1 [benign]; RCV000406604.1 [benign]; 			142	75					FBN1 (inh=AD pLI=1.00)
chr15	48701612	48701612	A	C	hom	anno_omim	QUAL=31868;DP=416;AF=1.00;MQM=60;TRIO=HOM,416,1.00,HOM,254,1.00,HOM,324,1.00	FBN1	3'UTR	FBN1:ENST00000316623:3'UTR:MODIFIER:exon66/66:c.*1575T>G:		rs4775760	0.6569	0.0000	0,0,0	0,0,0,0,0	0.6756							134797 [FBN1 (confirmed) Marfan syndrome,154700|Marfan lipodystrophy syndrome,616914|Ectopia lentis,familial,129600|MASS syndrome,604308|Weill-Marchesani syndrome 2,dominant,608328|Stiff skin syndrome,184900|Acromicric dysplasia,102370|Geleophysic dysplasia 2,614185];	RCV000263577.1 [benign]; RCV000276624.1 [benign]; RCV000294620.1 [benign]; RCV000330398.1 [benign]; RCV000334072.1 [benign]; RCV000356014.1 [benign]; RCV000368857.1 [benign]; RCV000381682.1 [benign]; 			140	77					FBN1 (inh=AD pLI=1.00)
chr15	48702457	48702457	C	A	hom	anno_omim	QUAL=37677;DP=408;AF=1.00;MQM=59;TRIO=HOM,408,1.00,HOM,323,1.00,HOM,408,1.00	FBN1	3'UTR	FBN1:ENST00000316623:3'UTR:MODIFIER:exon66/66:c.*730G>T:		rs13598	0.9193	0.0000	0,0,0	0,0,0,0,0	0.8821							134797 [FBN1 (confirmed) Marfan syndrome,154700|Marfan lipodystrophy syndrome,616914|Ectopia lentis,familial,129600|MASS syndrome,604308|Weill-Marchesani syndrome 2,dominant,608328|Stiff skin syndrome,184900|Acromicric dysplasia,102370|Geleophysic dysplasia 2,614185];	RCV000293740.1 [benign]; RCV000294541.1 [benign]; RCV000297172.1 [benign]; RCV000336986.1 [benign]; RCV000351824.1 [benign]; RCV000354587.1 [benign]; RCV000394077.1 [benign]; RCV000401006.1 [benign]; 			185	45					FBN1 (inh=AD pLI=1.00)
chr15	48702873	48702873	G	A	hom	anno_omim	QUAL=52448;DP=607;AF=1.00;MQM=59;TRIO=HOM,607,1.00,HOM,437,1.00,HOM,555,1.00	FBN1	3'UTR	FBN1:ENST00000316623:3'UTR:MODIFIER:exon66/66:c.*314C>T:		rs1042078	0.6000	0.0000	0,0,0	0,0,0,0,0	0.6287							134797 [FBN1 (confirmed) Marfan syndrome,154700|Marfan lipodystrophy syndrome,616914|Ectopia lentis,familial,129600|MASS syndrome,604308|Weill-Marchesani syndrome 2,dominant,608328|Stiff skin syndrome,184900|Acromicric dysplasia,102370|Geleophysic dysplasia 2,614185];	RCV000275580.1 [benign]; RCV000305212.1 [benign]; RCV000310625.1 [benign]; RCV000340144.1 [benign]; RCV000345741.1 [benign]; RCV000365337.1 [benign]; RCV000399351.1 [benign]; RCV000401289.1 [benign]; 			119	94					FBN1 (inh=AD pLI=1.00)
chr15	48807637	48807637	C	T	hom	pred_pathogenic;anno_omim	QUAL=34238;DP=399;AF=0.99;MQM=59;TRIO=HOM,399,0.99,HOM,299,1.00,HOM,396,1.00	FBN1	missense	FBN1:ENST00000316623:missense:MODERATE:exon12/66:c.1415G>A:p.Cys472Tyr		rs4775765	1.0000	1.0000	60683,33360,5200	1.0000,1.0000,1.0000,1.0000,1.0000	1.0000	5.9640	T	T	B	D	15.61	134797 [FBN1 (confirmed) Marfan syndrome,154700|Marfan lipodystrophy syndrome,616914|Ectopia lentis,familial,129600|MASS syndrome,604308|Weill-Marchesani syndrome 2,dominant,608328|Stiff skin syndrome,184900|Acromicric dysplasia,102370|Geleophysic dysplasia 2,614185];	RCV000223162.1 [not provided]; 			2162	0					FBN1 (inh=AD pLI=1.00)
chr15	48902965	48902965	G	A	het	anno_omim	QUAL=7462;DP=364;AF=0.45;MQM=60;TRIO=HET,364,0.45,WT,187,0.00,HET,238,0.51	FBN1	synonymous	FBN1:ENST00000316623:synonymous:LOW:exon4/66:c.306C>T:p.Cys102Cys		rs25388	0.0008	0.0041	2,2,0	0.0011,0.0012,0.0000,0.0062,0.0004	0.0038							134797 [FBN1 (confirmed) Marfan syndrome,154700|Marfan lipodystrophy syndrome,616914|Ectopia lentis,familial,129600|MASS syndrome,604308|Weill-Marchesani syndrome 2,dominant,608328|Stiff skin syndrome,184900|Acromicric dysplasia,102370|Geleophysic dysplasia 2,614185];	RCV000154417.4 [benign]; RCV000230637.1 [benign]; RCV000230637.1 [benign]; RCV000253616.2 [likely benign]; RCV000287932.1 [likely benign]; RCV000293746.1 [likely benign]; RCV000313423.1 [likely benign]; RCV000347453.1 [likely benign]; RCV000348609.1 [likely benign]; RCV000382318.1 [likely benign]; RCV000407439.1 [likely benign]; 			0	12					FBN1 (inh=AD pLI=1.00)
chr15	49044538	49044538	C	G	hom	anno_omim	QUAL=11290;DP=183;AF=1.00;MQM=60;TRIO=HOM,183,1.00,HET,176,0.52,HET,215,0.58	CEP152	splice_region&intron	CEP152:ENST00000380950:splice_region&intron:LOW:exon21/26:c.3466+8G>C:,CEP152:ENST00000399334:splice_region&intron:LOW:exon21/25:c.3466+8G>C:,CEP152:ENST00000325747:splice_region&intron:LOW:exon20/24:c.3187+8G>C:		rs2306187	0.3247	0.1989	3511,562,1308	0.5149,0.2450,0.4893,0.1278,0.1398	0.2590							613529 [CEP152 (provisional) Microcephaly 9,primary,autosomal recessive,614852|Seckel syndrome 5,613823];	RCV000081686.7 [benign]; RCV000281663.1 [benign]; RCV000339078.1 [benign]; 			51	473					CEP152 (inh=AR pLI=0.00)
chr15	49103244	49103244	T	C	hom	anno_omim	QUAL=9220;DP=172;AF=1.00;MQM=59;TRIO=HOM,172,1.00,HET,133,0.50,HET,177,0.47	CEP152,RP11-485O10.3	5'UTR	CEP152:ENST00000380950:5'UTR:MODIFIER:exon1/27:c.-94A>G:		rs2304546	0.1971	0.0000	0,0,0	0,0,0,0,0	0.1161							613529 [CEP152 (provisional) Microcephaly 9,primary,autosomal recessive,614852|Seckel syndrome 5,613823];	RCV000330536.1 [benign]; RCV000385024.1 [benign]; 			2	38					CEP152 (inh=AR pLI=0.00), RP11-485O10.3 (inh=n/a pLI=n/a)
chr15	51296015	51296015	G	A	het	anno_omim	QUAL=6371;DP=300;AF=0.47;MQM=60;TRIO=HET,300,0.47,WT,117,0.00,HET,184,0.50	AP4E1	3'UTR	AP4E1:ENST00000261842:3'UTR:MODIFIER:exon21/21:c.*1156G>A:,AP4E1:ENST00000560508:3'UTR:MODIFIER:exon21/21:c.*1156G>A:		rs2619685	0.1566	0.0000	0,0,0	0,0,0,0,0	0.1455							607244 [AP4E1 (provisional) Spastic paraplegia 51,autosomal recessive,613744|Stuttering,familial persistent,1,184450];				4	66					AP4E1 (inh=AR pLI=0.98)
chr15	52601750	52601750	A	G	hom	anno_omim	QUAL=38808;DP=377;AF=1.00;MQM=59;TRIO=HOM,377,1.00,HOM,396,1.00,HOM,436,1.00	MYO5A	3'UTR	MYO5A:ENST00000358212:3'UTR:MODIFIER:exon42/42:c.*4143T>C:,MYO5A:ENST00000399231:3'UTR:MODIFIER:exon41/41:c.*4143T>C:,MYO5A:ENST00000356338:3'UTR:MODIFIER:exon40/40:c.*4143T>C:,MYO5A:ENST00000399233:3'UTR:MODIFIER:exon40/40:c.*4143T>C:		rs2414136	0.9770	0.0000	0,0,0	0,0,0,0,0	0.9778							160777 [MYO5A (confirmed) Griscelli syndrome,type 1,214450];				227	0					MYO5A (inh=AR pLI=0.99)
chr15	52603363	52603363	G	A	hom	anno_omim	QUAL=25234;DP=487;AF=0.99;MQM=59;TRIO=HOM,487,0.99,HET,347,0.48,HET,452,0.47	MYO5A	3'UTR	MYO5A:ENST00000358212:3'UTR:MODIFIER:exon42/42:c.*2530C>T:,MYO5A:ENST00000399231:3'UTR:MODIFIER:exon41/41:c.*2530C>T:,MYO5A:ENST00000356338:3'UTR:MODIFIER:exon40/40:c.*2530C>T:,MYO5A:ENST00000399233:3'UTR:MODIFIER:exon40/40:c.*2530C>T:		rs7176482	0.3063	0.0000	0,0,0	0,0,0,0,0	0.4881							160777 [MYO5A (confirmed) Griscelli syndrome,type 1,214450];				76	109					MYO5A (inh=AR pLI=0.99)
chr15	52604136	52604136	-	TTTGTCATT	hom	anno_omim	QUAL=11039;DP=229;AF=0.97;MQM=59;TRIO=HOM,229,0.97,HOM,41,1.00,HOM,62,0.98	MYO5A	3'UTR	MYO5A:ENST00000358212:3'UTR:MODIFIER:exon42/42:c.*1756_*1757insAATGACAAA:,MYO5A:ENST00000399231:3'UTR:MODIFIER:exon41/41:c.*1756_*1757insAATGACAAA:,MYO5A:ENST00000356338:3'UTR:MODIFIER:exon40/40:c.*1756_*1757insAATGACAAA:,MYO5A:ENST00000399233:3'UTR:MODIFIER:exon40/40:c.*1756_*1757insAATGACAAA:		rs11282676	0.9766	0.0000	0,0,0	0,0,0,0,0	0.9765							160777 [MYO5A (confirmed) Griscelli syndrome,type 1,214450];				230	2					MYO5A (inh=AR pLI=0.99)
chr15	52667552	52667552	G	A	hom	anno_omim	QUAL=30002;DP=395;AF=1.00;MQM=59;TRIO=HOM,395,1.00,HOM,237,1.00,HOM,285,1.00	MYO5A	synonymous	MYO5A:ENST00000358212:synonymous:LOW:exon20/42:c.2526C>T:p.Ile842Ile,MYO5A:ENST00000399231:synonymous:LOW:exon20/41:c.2526C>T:p.Ile842Ile,MYO5A:ENST00000356338:synonymous:LOW:exon20/40:c.2526C>T:p.Ile842Ile,MYO5A:ENST00000399233:synonymous:LOW:exon20/40:c.2526C>T:p.Ile842Ile,MYO5A:ENST00000553916:synonymous:LOW:exon20/41:c.2526C>T:p.Ile842Ile		rs2414145	0.8446	0.9518	55390,33103,1738	0.5965,0.9827,0.9735,0.9960,0.9310	0.9593							160777 [MYO5A (confirmed) Griscelli syndrome,type 1,214450];				2031	83					MYO5A (inh=AR pLI=0.99)
chr15	52689526	52689526	T	C	hom	anno_omim	QUAL=34585;DP=389;AF=0.99;MQM=59;TRIO=HOM,389,0.99,HOM,287,1.00,HOM,389,1.00	MYO5A	synonymous	MYO5A:ENST00000358212:synonymous:LOW:exon10/42:c.1191A>G:p.Thr397Thr,MYO5A:ENST00000399231:synonymous:LOW:exon10/41:c.1191A>G:p.Thr397Thr,MYO5A:ENST00000356338:synonymous:LOW:exon10/40:c.1191A>G:p.Thr397Thr,MYO5A:ENST00000399233:synonymous:LOW:exon10/40:c.1191A>G:p.Thr397Thr,MYO5A:ENST00000553916:synonymous:LOW:exon10/41:c.1191A>G:p.Thr397Thr		rs2924130	0.9617	0.9896	59189,33361,3794	0.8787,0.9952,1.0000,0.9999,0.9998	0.9913							160777 [MYO5A (confirmed) Griscelli syndrome,type 1,214450];				2117	2					MYO5A (inh=AR pLI=0.99)
chr15	52689631	52689631	T	G	hom	pred_pathogenic;anno_omim	QUAL=22056;DP=168;AF=1.00;MQM=59;TRIO=HOM,168,1.00,HOM,214,1.00,HOM,309,1.00	MYO5A	missense	MYO5A:ENST00000358212:missense:MODERATE:exon10/42:c.1086A>C:p.Glu362Asp,MYO5A:ENST00000399231:missense:MODERATE:exon10/41:c.1086A>C:p.Glu362Asp,MYO5A:ENST00000356338:missense:MODERATE:exon10/40:c.1086A>C:p.Glu362Asp,MYO5A:ENST00000399233:missense:MODERATE:exon10/40:c.1086A>C:p.Glu362Asp,MYO5A:ENST00000553916:missense:MODERATE:exon10/41:c.1086A>C:p.Glu362Asp		rs1724577	0.8868	0.9629	56334,33115,2483	0.7121,0.9875,0.9824,0.9962,0.9345	0.9686	-0.1140	T,T,T,T,T	T	B,B	D,D,D,D,D	1.04	160777 [MYO5A (confirmed) Griscelli syndrome,type 1,214450];			COSM4128296, COSM4128297	2046	70					MYO5A (inh=AR pLI=0.99)
chr15	55495545	55495545	T	C	het	anno_omim	QUAL=8724;DP=396;AF=0.49;MQM=59;TRIO=HET,396,0.49,WT,193,0.00,HET,247,0.50	RAB27A	3'UTR	RAB27A:ENST00000396307:3'UTR:MODIFIER:exon6/6:c.*2160A>G:		rs62020099	0.0036	0.0000	0,0,0	0,0,0,0,0	0.0066							603868 [RAB27A (provisional) Griscelli syndrome,type 2,607624];				0	4					RAB27A (inh=AR pLI=0.00)
chr15	55495698	55495698	C	T	het	low_MQM;anno_omim	QUAL=2225;DP=143;AF=0.48;MQM=43;TRIO=HET,143,0.48,HET,70,0.47,WT,128,0.01	RAB27A	3'UTR	RAB27A:ENST00000396307:3'UTR:MODIFIER:exon6/6:c.*2007G>A:	AluY	rs6493769	0.2654	0.0000	0,0,0	0,0,0,0,0	0.2592							603868 [RAB27A (provisional) Griscelli syndrome,type 2,607624];	RCV000382963.1 [benign]; 			6	44					RAB27A (inh=AR pLI=0.00)
chr15	55495774	55495774	A	G	het	anno_omim	QUAL=1105;DP=84;AF=0.37;MQM=51;TRIO=HET,84,0.37,HET,53,0.43,WT,90,0.00	RAB27A	3'UTR	RAB27A:ENST00000396307:3'UTR:MODIFIER:exon6/6:c.*1931T>C:	AluY	rs6493770	0.2652	0.0000	0,0,0	0,0,0,0,0	0.2743							603868 [RAB27A (provisional) Griscelli syndrome,type 2,607624];	RCV000288579.1 [benign]; 			6	44					RAB27A (inh=AR pLI=0.00)
chr15	55495779	55495779	A	T	het	anno_omim	QUAL=1168;DP=59;AF=0.42;MQM=54;TRIO=HET,59,0.42,HET,38,0.45,WT,72,0.00	RAB27A	3'UTR	RAB27A:ENST00000396307:3'UTR:MODIFIER:exon6/6:c.*1926T>A:	AluY	rs8028801	0.2656	0.0000	0,0,0	0,0,0,0,0	0.3342							603868 [RAB27A (provisional) Griscelli syndrome,type 2,607624];	RCV000348181.1 [benign]; 			6	44					RAB27A (inh=AR pLI=0.00)
chr15	55495782	55495782	-	TTA	het	anno_omim	QUAL=1168;DP=59;AF=0.42;MQM=54;TRIO=HET,59,0.42,HET,38,0.45,WT,72,0.00	RAB27A	3'UTR	RAB27A:ENST00000396307:3'UTR:MODIFIER:exon6/6:c.*1922_*1923insTAA:	AluY	rs555244731	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							603868 [RAB27A (provisional) Griscelli syndrome,type 2,607624];	RCV000383908.1 [uncertain significance]; 			0	0					RAB27A (inh=AR pLI=0.00)
chr15	55495786	55495786	T	A	het	anno_omim	QUAL=1161;DP=89;AF=0.31;MQM=54;TRIO=HET,89,0.31,HET,61,0.34,WT,81,0.00	RAB27A	3'UTR	RAB27A:ENST00000396307:3'UTR:MODIFIER:exon6/6:c.*1919A>T:	AluY	rs867969605	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							603868 [RAB27A (provisional) Griscelli syndrome,type 2,607624];				0	0					RAB27A (inh=AR pLI=0.00)
chr15	55495790	55495790	T	A	het	anno_omim	QUAL=1161;DP=89;AF=0.31;MQM=54;TRIO=HET,89,0.31,HET,61,0.34,WT,81,0.00	RAB27A	3'UTR	RAB27A:ENST00000396307:3'UTR:MODIFIER:exon6/6:c.*1915A>T:	AluY		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							603868 [RAB27A (provisional) Griscelli syndrome,type 2,607624];				0	0					RAB27A (inh=AR pLI=0.00)
chr15	55495801	55495801	T	A	het	anno_omim	QUAL=1668;DP=95;AF=0.46;MQM=51;TRIO=HET,95,0.46,HET,60,0.55,WT,69,0.01	RAB27A	3'UTR	RAB27A:ENST00000396307:3'UTR:MODIFIER:exon6/6:c.*1904A>T:	AluY	rs28620827	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1286							603868 [RAB27A (provisional) Griscelli syndrome,type 2,607624];				3	46					RAB27A (inh=AR pLI=0.00)
chr15	55495963	55495963	T	C	het	anno_omim	QUAL=5457;DP=288;AF=0.45;MQM=59;TRIO=HET,288,0.45,HET,174,0.49,WT,269,0.00	RAB27A	3'UTR	RAB27A:ENST00000336787:3'UTR:MODIFIER:exon7/7:c.*1742A>G:,RAB27A:ENST00000396307:3'UTR:MODIFIER:exon6/6:c.*1742A>G:		rs1061824	0.2652	0.0000	0,0,0	0,0,0,0,0	0.2603							603868 [RAB27A (provisional) Griscelli syndrome,type 2,607624];	RCV000304619.1 [benign]; 			9	45					RAB27A (inh=AR pLI=0.00)
chr15	55496043	55496043	T	A	het	anno_omim	QUAL=3034;DP=138;AF=0.48;MQM=60;TRIO=HET,138,0.48,HET,122,0.47,WT,176,0.01	RAB27A	3'UTR	RAB27A:ENST00000336787:3'UTR:MODIFIER:exon7/7:c.*1662A>T:,RAB27A:ENST00000396307:3'UTR:MODIFIER:exon6/6:c.*1662A>T:		rs1061823	0.2654	0.0000	0,0,0	0,0,0,0,0	0.2607							603868 [RAB27A (provisional) Griscelli syndrome,type 2,607624];	RCV000301016.1 [benign]; 			9	46					RAB27A (inh=AR pLI=0.00)
chr15	55496058	55496058	A	C	het	anno_omim	QUAL=2922;DP=141;AF=0.46;MQM=60;TRIO=HET,141,0.46,HET,112,0.47,WT,161,0.01	RAB27A	3'UTR	RAB27A:ENST00000336787:3'UTR:MODIFIER:exon7/7:c.*1647T>G:,RAB27A:ENST00000396307:3'UTR:MODIFIER:exon6/6:c.*1647T>G:		rs1061822	0.2654	0.0000	0,0,0	0,0,0,0,0	0.2604							603868 [RAB27A (provisional) Griscelli syndrome,type 2,607624];	RCV000355996.1 [benign]; 			10	45					RAB27A (inh=AR pLI=0.00)
chr15	55496111	55496111	T	C	het	anno_omim	QUAL=2898;DP=196;AF=0.41;MQM=60;TRIO=HET,196,0.41,HET,66,0.50,WT,91,0.00	RAB27A	3'UTR	RAB27A:ENST00000336787:3'UTR:MODIFIER:exon7/7:c.*1594A>G:,RAB27A:ENST00000396307:3'UTR:MODIFIER:exon6/6:c.*1594A>G:		rs1061821	0.2652	0.0000	0,0,0	0,0,0,0,0	0.2605							603868 [RAB27A (provisional) Griscelli syndrome,type 2,607624];	RCV000311768.1 [benign]; 			8	46					RAB27A (inh=AR pLI=0.00)
chr15	55496278	55496278	C	T	het	anno_omim	QUAL=3459;DP=205;AF=0.53;MQM=59;TRIO=HET,205,0.53,HET,44,0.50,WT,60,0.00	RAB27A	3'UTR	RAB27A:ENST00000336787:3'UTR:MODIFIER:exon7/7:c.*1427G>A:,RAB27A:ENST00000396307:3'UTR:MODIFIER:exon6/6:c.*1427G>A:		rs1061875	0.2652	0.0000	0,0,0	0,0,0,0,0	0.2580							603868 [RAB27A (provisional) Griscelli syndrome,type 2,607624];	RCV000325244.1 [benign]; 			9	64					RAB27A (inh=AR pLI=0.00)
chr15	55496287	55496287	A	T	het	anno_omim	QUAL=3189;DP=186;AF=0.51;MQM=59;TRIO=HET,186,0.51,HET,46,0.50,WT,58,0.00	RAB27A	3'UTR	RAB27A:ENST00000336787:3'UTR:MODIFIER:exon7/7:c.*1418T>A:,RAB27A:ENST00000396307:3'UTR:MODIFIER:exon6/6:c.*1418T>A:		rs1061874	0.2654	0.0000	0,0,0	0,0,0,0,0	0.2577							603868 [RAB27A (provisional) Griscelli syndrome,type 2,607624];	RCV000384508.1 [benign]; 			9	64					RAB27A (inh=AR pLI=0.00)
chr15	55496756	55496756	T	C	het	anno_omim	QUAL=6441;DP=344;AF=0.47;MQM=60;TRIO=HET,344,0.47,HET,178,0.46,WT,247,0.00	RAB27A	3'UTR	RAB27A:ENST00000336787:3'UTR:MODIFIER:exon7/7:c.*949A>G:,RAB27A:ENST00000396307:3'UTR:MODIFIER:exon6/6:c.*949A>G:		rs1061873	0.2650	0.0000	0,0,0	0,0,0,0,0	0.2605							603868 [RAB27A (provisional) Griscelli syndrome,type 2,607624];	RCV000341280.1 [benign]; 			9	64					RAB27A (inh=AR pLI=0.00)
chr15	55496769	55496769	G	T	het	anno_omim	QUAL=6403;DP=335;AF=0.46;MQM=60;TRIO=HET,335,0.46,HET,176,0.47,WT,265,0.00	RAB27A	3'UTR	RAB27A:ENST00000336787:3'UTR:MODIFIER:exon7/7:c.*936C>A:,RAB27A:ENST00000396307:3'UTR:MODIFIER:exon6/6:c.*936C>A:		rs1061870	0.2652	0.0000	0,0,0	0,0,0,0,0	0.2605							603868 [RAB27A (provisional) Griscelli syndrome,type 2,607624];	RCV000373109.1 [benign]; 			9	64					RAB27A (inh=AR pLI=0.00)
chr15	55496853	55496853	G	A	het	anno_omim	QUAL=4364;DP=264;AF=0.46;MQM=60;TRIO=HET,264,0.46,HET,112,0.47,WT,204,0.00	RAB27A	3'UTR	RAB27A:ENST00000336787:3'UTR:MODIFIER:exon7/7:c.*852C>T:,RAB27A:ENST00000396307:3'UTR:MODIFIER:exon6/6:c.*852C>T:		rs3179664	0.3267	0.0000	0,0,0	0,0,0,0,0	0.3150							603868 [RAB27A (provisional) Griscelli syndrome,type 2,607624];	RCV000338342.1 [benign]; 			10	64					RAB27A (inh=AR pLI=0.00)
chr15	55497691	55497691	G	A	het	anno_omim	QUAL=10480;DP=537;AF=0.47;MQM=60;TRIO=HET,537,0.47,HET,358,0.45,WT,399,0.00	RAB27A	3'UTR	RAB27A:ENST00000336787:3'UTR:MODIFIER:exon7/7:c.*14C>T:,RAB27A:ENST00000396307:3'UTR:MODIFIER:exon6/6:c.*14C>T:,RAB27A:ENST00000564609:3'UTR:MODIFIER:exon7/7:c.*14C>T:,RAB27A:ENST00000569493:3'UTR:MODIFIER:exon7/7:c.*14C>T:		rs1050931	0.2648	0.2007	3129,1157,1301	0.4985,0.0983,0.1167,0.1814,0.2201	0.2605							603868 [RAB27A (provisional) Griscelli syndrome,type 2,607624];	RCV000253078.1 [benign]; RCV000320993.1 [benign]; 		COSN164951	97	623					RAB27A (inh=AR pLI=0.00)
chr15	65369395	65369395	C	T	hom	low_DP;pred_pathogenic;anno_omim	QUAL=293;DP=2;AF=1.00;MQM=60;TRIO=HOM,2,1.00,HOM,11,1.00,WT,14,0.00	KBTBD13	missense	KBTBD13:ENST00000432196:missense:MODERATE:exon1/1:c.242C>T:p.Ala81Val		rs2919358	0.5218	0.4003	814,220,49	0.6138,0.0000,0.0000,0.4181,0.3759	0.4663	7.2510	T	T	P	T	28.30	613727 [KBTBD13 (provisional) Nemaline myopathy 6,autosomal dominant,609273];	RCV000117309.2 [benign]; RCV000368854.1 [benign]; 		COSM3749303	363	869					KBTBD13 (inh=AD pLI=0.00)
chr15	65369531	65369531	G	T	het	low_DP;anno_omim	QUAL=472;DP=2;AF=0.50;MQM=60;TRIO=HET,2,0.50,HOM,17,1.00,WT,14,0.00	KBTBD13	synonymous	KBTBD13:ENST00000432196:synonymous:LOW:exon1/1:c.378G>T:p.Ala126Ala		rs2946642	0.5016	0.4024	763,201,35	0.5536,0.0000,0.0000,0.4172,0.3861	0.4643							613727 [KBTBD13 (provisional) Nemaline myopathy 6,autosomal dominant,609273];	RCV000117310.2 [benign]; RCV000315819.1 [benign]; 		COSM3754413	371	873					KBTBD13 (inh=AD pLI=0.00)
chr15	65369951	65369951	A	G	hom	anno_omim	QUAL=3542;DP=21;AF=1.00;MQM=59;TRIO=HOM,21,1.00,HOM,43,1.00,HOM,54,1.00	KBTBD13	synonymous	KBTBD13:ENST00000432196:synonymous:LOW:exon1/1:c.798A>G:p.Glu266Glu		rs2919359	0.9038	0.8853	30318,15899,1992	0.9076,0.8698,0.9808,0.8671,0.9084	0.8737							613727 [KBTBD13 (provisional) Nemaline myopathy 6,autosomal dominant,609273];	RCV000117312.2 [benign]; RCV000287772.1 [benign]; 		COSM3749304	1575	466					KBTBD13 (inh=AD pLI=0.00)
chr15	65370353	65370353	T	C	hom	anno_omim	QUAL=16649;DP=113;AF=0.99;MQM=59;TRIO=HOM,113,0.99,HOM,183,1.00,HOM,257,1.00	KBTBD13	synonymous	KBTBD13:ENST00000432196:synonymous:LOW:exon1/1:c.1200T>C:p.Gly400Gly		rs2919360	0.9894	0.9961	55898,30708,3823	0.9712,0.9965,1.0000,0.9973,1.0000	0.9959							613727 [KBTBD13 (provisional) Nemaline myopathy 6,autosomal dominant,609273];	RCV000117308.2 [benign]; RCV000359041.1 [benign]; 		COSM3754414	2085	15					KBTBD13 (inh=AD pLI=0.00)
chr15	65370652	65370652	T	C	het	anno_omim	QUAL=14467;DP=352;AF=0.51;MQM=59;TRIO=HET,352,0.51,WT,284,0.00,HOM,329,0.98	KBTBD13	3'UTR	KBTBD13:ENST00000432196:3'UTR:MODIFIER:exon1/1:c.*122T>C:		rs12901617	0.3908	0.0000	0,0,0	0,0,0,0,0	0.4162							613727 [KBTBD13 (provisional) Nemaline myopathy 6,autosomal dominant,609273];	RCV000389026.1 [benign]; 			36	79					KBTBD13 (inh=AD pLI=0.00)
chr15	65370835	65370835	C	T	hom	anno_omim	QUAL=23617;DP=305;AF=1.00;MQM=59;TRIO=HOM,305,1.00,HOM,192,1.00,HOM,270,1.00	KBTBD13	3'UTR	KBTBD13:ENST00000432196:3'UTR:MODIFIER:exon1/1:c.*305C>T:		rs2946643	0.8894	0.0000	0,0,0	0,0,0,0,0	0.8546							613727 [KBTBD13 (provisional) Nemaline myopathy 6,autosomal dominant,609273];	RCV000294476.1 [benign]; 			123	23					KBTBD13 (inh=AD pLI=0.00)
chr15	65371050	65371050	A	G	het	anno_omim	QUAL=14560;DP=420;AF=0.49;MQM=60;TRIO=HET,420,0.49,WT,157,0.00,HOM,281,1.00	KBTBD13	3'UTR	KBTBD13:ENST00000432196:3'UTR:MODIFIER:exon1/1:c.*520A>G:		rs12904843	0.3433	0.0000	0,0,0	0,0,0,0,0	0.3696							613727 [KBTBD13 (provisional) Nemaline myopathy 6,autosomal dominant,609273];	RCV000385367.1 [benign]; 			29	85					KBTBD13 (inh=AD pLI=0.00)
chr15	65371427	65371427	A	G	het	anno_omim	QUAL=16453;DP=287;AF=0.51;MQM=60;TRIO=HET,287,0.51,WT,304,0.01,HOM,419,1.00	KBTBD13	3'UTR	KBTBD13:ENST00000432196:3'UTR:MODIFIER:exon1/1:c.*897A>G:		rs12905499	0.3832	0.0000	0,0,0	0,0,0,0,0	0.3990							613727 [KBTBD13 (provisional) Nemaline myopathy 6,autosomal dominant,609273];	RCV000343355.1 [benign]; 			31	83					KBTBD13 (inh=AD pLI=0.00)
chr15	68499321	68499321	T	C	het	anno_omim	QUAL=1317;DP=39;AF=0.49;MQM=60;TRIO=HET,39,0.49,HOM,21,1.00,HET,28,0.39	RP11-315D16.2				rs8028241	0.4842	0.0000	0,0,0	0,0,0,0,0	0.5687							606725 [CLN6 (confirmed) Ceroid lipofuscinosis,neuronal,6,601780|Ceroid lipofuscinosis,neuronal,Kufs type,adult onset,204300];	RCV000328369.1 [benign]; 			66	118					RP11-315D16.2 (inh=n/a pLI=n/a)
chr15	68499661	68499661	G	A	het	low_DP;anno_omim	QUAL=353;DP=16;AF=0.50;MQM=60;TRIO=HET,16,0.50,HOM,7,1.00,WT,2,0.00	CLN6,RP11-315D16.2	3'UTR	CLN6:ENST00000249806:3'UTR:MODIFIER:exon7/7:c.*817C>T:		rs8142	0.4050	0.0000	0,0,0	0,0,0,0,0	0.5005							606725 [CLN6 (confirmed) Ceroid lipofuscinosis,neuronal,6,601780|Ceroid lipofuscinosis,neuronal,Kufs type,adult onset,204300];	RCV000355138.1 [benign]; 			62	105					CLN6 (inh=AR pLI=0.38), RP11-315D16.2 (inh=n/a pLI=n/a)
chr15	68500318	68500321	ACAC	-	het	anno_omim	QUAL=6602;DP=98;AF=0.32;MQM=59;TRIO=HET,98,0.32,HOM,106,0.00,HET,157,0.35	CLN6,RP11-315D16.2	3'UTR	CLN6:ENST00000249806:3'UTR:MODIFIER:exon7/7:c.*157_*160delGTGT:,CLN6:ENST00000565471:3'UTR:MODIFIER:exon3/3:c.*157_*160delGTGT:,CLN6:ENST00000418702:3'UTR:MODIFIER:exon5/5:c.*157_*160delGTGT:	(CA)n	rs141886537;rs748086627;rs780072735	0.0000	0.0000	0,0,0	0,0,0,0,0	0.4817							606725 [CLN6 (confirmed) Ceroid lipofuscinosis,neuronal,6,601780|Ceroid lipofuscinosis,neuronal,Kufs type,adult onset,204300];	RCV000350982.1 [uncertain significance]; 			125	60					CLN6 (inh=AR pLI=0.38), RP11-315D16.2 (inh=n/a pLI=n/a)
chr15	68500317	68500317	-	AC	het	anno_omim	QUAL=6602;DP=98;AF=0.51;MQM=59;TRIO=HET,98,0.51,WT,106,0.93,HET,157,0.52	CLN6,RP11-315D16.2	3'UTR	CLN6:ENST00000249806:3'UTR:MODIFIER:exon7/7:c.*159_*160dupGT:,CLN6:ENST00000565471:3'UTR:MODIFIER:exon3/3:c.*159_*160dupGT:,CLN6:ENST00000418702:3'UTR:MODIFIER:exon5/5:c.*159_*160dupGT:	(CA)n	rs138882836;rs201282122;rs765543395;rs780072735	0.3345	0.0000	0,0,0	0,0,0,0,0	0.3749							606725 [CLN6 (confirmed) Ceroid lipofuscinosis,neuronal,6,601780|Ceroid lipofuscinosis,neuronal,Kufs type,adult onset,204300];	RCV000338546.1 [other]; 			45	63					CLN6 (inh=AR pLI=0.38), RP11-315D16.2 (inh=n/a pLI=n/a)
chr15	72635829	72635829	A	C	hom	anno_omim	QUAL=8020;DP=136;AF=1.00;MQM=59;TRIO=HOM,136,1.00,HOM,53,1.00,HOM,61,1.00	HEXA,RP11-106M3.3,RP11-106M3.2	3'UTR	HEXA:ENST00000268097:3'UTR:MODIFIER:exon14/14:c.*589T>G:		rs11629508	0.6933	0.0000	0,0,0	0,0,0,0,0	0.7406							606869 [HEXA (confirmed) Tay-Sachs disease,272800|GM2-gangliosidosis,several forms,272800|Hex A pseudodeficiency,272800];	RCV000301101.1 [benign]; 			202	30					HEXA (inh=AR pLI=0.00), RP11-106M3.3 (inh=n/a pLI=n/a), RP11-106M3.2 (inh=n/a pLI=n/a)
chr15	72635903	72635903	C	T	hom	anno_omim	QUAL=9523;DP=122;AF=0.99;MQM=60;TRIO=HOM,122,0.99,HOM,85,1.00,HOM,101,1.00	HEXA,RP11-106M3.3,RP11-106M3.2	3'UTR	HEXA:ENST00000268097:3'UTR:MODIFIER:exon14/14:c.*515G>A:		rs3087652	0.6929	0.0000	0,0,0	0,0,0,0,0	0.7407							606869 [HEXA (confirmed) Tay-Sachs disease,272800|GM2-gangliosidosis,several forms,272800|Hex A pseudodeficiency,272800];	RCV000275354.1 [benign]; 			202	30					HEXA (inh=AR pLI=0.00), RP11-106M3.3 (inh=n/a pLI=n/a), RP11-106M3.2 (inh=n/a pLI=n/a)
chr15	72637795	72637795	T	C	hom	anno_omim	QUAL=21227;DP=246;AF=1.00;MQM=60;TRIO=HOM,246,1.00,HOM,205,1.00,HOM,216,1.00	HEXA,RP11-106M3.3,RP11-106M3.2	synonymous,3'UTR	HEXA:ENST00000566304:synonymous:LOW:exon13/14:c.1551A>G:p.Glu517Glu,HEXA:ENST00000268097:synonymous:LOW:exon13/14:c.1518A>G:p.Glu506Glu,HEXA:ENST00000567159:synonymous:LOW:exon13/13:c.1518A>G:p.Glu506Glu,HEXA:ENST00000457859:3'UTR:MODIFIER:exon11/11:c.*178A>G:		rs4777502	0.8770	0.9641	57123,33251,1969	0.6142,0.9834,1.0000,0.9982,0.9992	0.9714							606869 [HEXA (confirmed) Tay-Sachs disease,272800|GM2-gangliosidosis,several forms,272800|Hex A pseudodeficiency,272800];	RCV000079051.9 [other]; RCV000291094.1 [benign]; 			3895	53					HEXA (inh=AR pLI=0.00), RP11-106M3.3 (inh=n/a pLI=n/a), RP11-106M3.2 (inh=n/a pLI=n/a)
chr15	72638892	72638892	T	C	hom	pred_pathogenic;anno_omim	QUAL=7793;DP=88;AF=1.00;MQM=60;TRIO=HOM,88,1.00,HOM,58,1.00,HOM,93,1.00	HEXA,RP11-106M3.2,RP11-106M3.3	missense,intron	HEXA:ENST00000566304:missense:MODERATE:exon11/14:c.1339A>G:p.Ile447Val,HEXA:ENST00000268097:missense:MODERATE:exon11/14:c.1306A>G:p.Ile436Val,HEXA:ENST00000567159:missense:MODERATE:exon11/13:c.1306A>G:p.Ile436Val,HEXA:ENST00000429918:missense:MODERATE:exon9/10:c.787A>G:p.Ile263Val,HEXA:ENST00000457859:intron:MODIFIER:exon9/10:c.498-226A>G:		rs1800431	0.8764	0.9643	57089,33227,1971	0.6167,0.9831,0.9999,0.9982,0.9986	0.9712	-0.2020	T,T	T	B,B	D,D	13.21	606869 [HEXA (confirmed) Tay-Sachs disease,272800|GM2-gangliosidosis,several forms,272800|Hex A pseudodeficiency,272800];	RCV000079049.9 [other]; RCV000283218.1 [benign]; 			3892	55					HEXA (inh=AR pLI=0.00), RP11-106M3.2 (inh=n/a pLI=n/a), RP11-106M3.3 (inh=n/a pLI=n/a)
chr15	72668304	72668304	A	G	het	pred_pathogenic;anno_omim;anno_pathogenic_hgmd	QUAL=4138;DP=126;AF=0.52;MQM=59;TRIO=HET,126,0.52,WT,183,0.01,HET,227,0.47	HEXA,RP11-106M3.2	missense,5'UTR	HEXA:ENST00000566304:missense:MODERATE:exon1/14:c.10T>C:p.Ser4Pro,HEXA:ENST00000268097:missense:MODERATE:exon1/14:c.10T>C:p.Ser4Pro,HEXA:ENST00000567159:missense:MODERATE:exon1/13:c.10T>C:p.Ser4Pro,HEXA:ENST00000429918:5'UTR:MODIFIER:exon1/10:c.-352T>C:		rs146938346	0.0000	0.0001	0,0,0	0.0000,0.0001,0.0000,0.0002,0.0000	0.0002	-0.1370	T	D	B,B	D	17.79	606869 [HEXA (confirmed) Tay-Sachs disease,272800|GM2-gangliosidosis,several forms,272800|Hex A pseudodeficiency,272800];		CM045965 [CLASS=DM? MUT=ALT PHEN="Beta-hexosaminidase pseudodeficiency" GENE=HEXA]; 		0	8					HEXA (inh=AR pLI=0.00), RP11-106M3.2 (inh=n/a pLI=n/a)
chr15	72978552	72978552	C	T	het	anno_omim	QUAL=2373;DP=121;AF=0.31;MQM=60;TRIO=HET,121,0.31,HET,82,0.56,HET,81,0.43	BBS4	5'UTR	BBS4:ENST00000542334:5'UTR:MODIFIER:exon1/15:c.-486C>T:,BBS4:ENST00000268057:5'UTR:MODIFIER:exon1/16:c.-17C>T:,BBS4:ENST00000539603:5'UTR:MODIFIER:exon1/17:c.-111C>T:		rs56368716	0.0375	0.0839	94,83,0	0.0196,0.1348,0.0000,0.1484,0.0224	0.0730							600374 [BBS4 (confirmed) Bardet-Biedl syndrome 4,615982];	RCV000173544.2 [benign]; RCV000371581.1 [likely benign]; 			19	313					BBS4 (inh=AR pLI=0.00)
chr15	73002035	73002035	G	A	hom	anno_omim	QUAL=24132;DP=294;AF=1.00;MQM=59;TRIO=HOM,294,1.00,HOM,208,1.00,HOM,244,1.00	BBS4	splice_region&intron	BBS4:ENST00000395205:splice_region&intron:LOW:exon2/15:c.101-6G>A:,BBS4:ENST00000542334:splice_region&intron:LOW:exon1/14:c.-445-6G>A:,BBS4:ENST00000268057:splice_region&intron:LOW:exon2/15:c.77-6G>A:,BBS4:ENST00000539603:splice_region&intron:LOW:exon3/16:c.41-6G>A:		rs8033604	0.9421	0.9831	58833,33340,3448	0.8135,0.9927,1.0000,0.9996,0.9999	0.9869							600374 [BBS4 (confirmed) Bardet-Biedl syndrome 4,615982];	RCV000252464.1 [benign]; RCV000292222.1 [benign]; 			2101	15					BBS4 (inh=AR pLI=0.00)
chr15	73023937	73023937	T	C	hom	anno_omim	QUAL=40926;DP=372;AF=1.00;MQM=60;TRIO=HOM,372,1.00,HOM,388,1.00,HOM,482,1.00	BBS4	synonymous	BBS4:ENST00000395205:synonymous:LOW:exon12/16:c.930T>C:p.Phe310Phe,BBS4:ENST00000542334:synonymous:LOW:exon11/15:c.390T>C:p.Phe130Phe,BBS4:ENST00000268057:synonymous:LOW:exon12/16:c.906T>C:p.Phe302Phe,BBS4:ENST00000539603:synonymous:LOW:exon13/17:c.870T>C:p.Phe290Phe		rs12914333	0.9605	0.9875	59279,33354,3854	0.8612,0.9947,1.0000,0.9998,1.0000	0.9902							600374 [BBS4 (confirmed) Bardet-Biedl syndrome 4,615982];	RCV000152839.3 [benign]; 			2104	11					BBS4 (inh=AR pLI=0.00)
chr15	73027478	73027478	T	C	hom	anno_omim	QUAL=31562;DP=376;AF=1.00;MQM=59;TRIO=HOM,376,1.00,HET,345,0.53,HOM,430,1.00	BBS4	missense	BBS4:ENST00000395205:missense:MODERATE:exon13/16:c.1085T>C:p.Ile362Thr,BBS4:ENST00000542334:missense:MODERATE:exon12/15:c.545T>C:p.Ile182Thr,BBS4:ENST00000268057:missense:MODERATE:exon13/16:c.1061T>C:p.Ile354Thr,BBS4:ENST00000539603:missense:MODERATE:exon14/17:c.1025T>C:p.Ile342Thr		rs2277598	0.4289	0.5743	21186,14353,508	0.3095,0.4942,0.2454,0.6557,0.5980	0.5753	-0.2460	T,T,T,T	T	B,B,B,B	T,T,T,T	3.05	600374 [BBS4 (confirmed) Bardet-Biedl syndrome 4,615982];	RCV000020938.3 [benign]; RCV000132688.1 [likely benign]; RCV000152842.4 [benign]; 		COSM3999597, COSM3999596	876	958					BBS4 (inh=AR pLI=0.00)
chr15	74472199	74472199	C	T	hom	anno_omim	QUAL=20115;DP=265;AF=0.99;MQM=59;TRIO=HOM,265,0.99,HOM,234,1.00,HET,330,0.51	STRA6	3'UTR	STRA6:ENST00000395105:3'UTR:MODIFIER:exon19/19:c.*222G>A:,STRA6:ENST00000423167:3'UTR:MODIFIER:exon19/19:c.*222G>A:,STRA6:ENST00000323940:3'UTR:MODIFIER:exon19/19:c.*222G>A:,STRA6:ENST00000449139:3'UTR:MODIFIER:exon19/19:c.*222G>A:,STRA6:ENST00000416286:3'UTR:MODIFIER:exon18/18:c.*222G>A:,STRA6:ENST00000535552:3'UTR:MODIFIER:exon19/19:c.*222G>A:		rs10910	0.5327	0.0000	0,0,0	0,0,0,0,0	0.5500							610745 [STRA6 (provisional) Microphthalmia,syndromic 9,601186|Microphthalmia,isolated,with coloboma 8,601186];	RCV000318472.1 [benign]; 			121	96					STRA6 (inh=AR pLI=0.00)
chr15	74476340	74476340	G	C	het	anno_omim	QUAL=5824;DP=70;AF=0.54;MQM=60;TRIO=HET,70,0.54,WT,134,0.00,HOM,174,0.99	STRA6	splice_region&intron	STRA6:ENST00000563965:splice_region&intron:LOW:exon13/18:c.1284-10C>G:,STRA6:ENST00000395105:splice_region&intron:LOW:exon13/18:c.1167-10C>G:,STRA6:ENST00000423167:splice_region&intron:LOW:exon13/18:c.1140-10C>G:,STRA6:ENST00000323940:splice_region&intron:LOW:exon13/18:c.1167-10C>G:,STRA6:ENST00000449139:splice_region&intron:LOW:exon13/18:c.1167-10C>G:,STRA6:ENST00000416286:splice_region&intron:LOW:exon12/17:c.1143-10C>G:,STRA6:ENST00000535552:splice_region&intron:LOW:exon13/18:c.1278-10C>G:,STRA6:ENST00000574278:splice_region&intron:LOW:exon13/18:c.1212-10C>G:		rs2277608	0.2081	0.1953	2696,770,44	0.0929,0.3239,0.3505,0.1517,0.2696	0.1996							610745 [STRA6 (provisional) Microphthalmia,syndromic 9,601186|Microphthalmia,isolated,with coloboma 8,601186];	RCV000248979.1 [benign]; RCV000329298.1 [benign]; 		COSM147951	84	592					STRA6 (inh=AR pLI=0.00)
chr15	74487024	74487024	A	G	het	anno_omim	QUAL=19397;DP=386;AF=0.50;MQM=60;TRIO=HET,386,0.50,WT,324,0.00,HOM,449,1.00	STRA6	3'UTR,intron	STRA6:ENST00000432245:3'UTR:MODIFIER:exon6/6:c.*919T>C:,STRA6:ENST00000563965:intron:MODIFIER:exon7/18:c.714+619T>C:,STRA6:ENST00000395105:intron:MODIFIER:exon7/18:c.597+619T>C:,STRA6:ENST00000423167:intron:MODIFIER:exon7/18:c.570+619T>C:,STRA6:ENST00000323940:intron:MODIFIER:exon7/18:c.597+619T>C:,STRA6:ENST00000449139:intron:MODIFIER:exon7/18:c.597+619T>C:,STRA6:ENST00000416286:intron:MODIFIER:exon6/17:c.573+619T>C:,STRA6:ENST00000535552:intron:MODIFIER:exon7/18:c.708+619T>C:,STRA6:ENST00000574278:intron:MODIFIER:exon7/18:c.642+619T>C:	L2a	rs58138979	0.0531	0.0000	0,0,0	0,0,0,0,0	0.0867							610745 [STRA6 (provisional) Microphthalmia,syndromic 9,601186|Microphthalmia,isolated,with coloboma 8,601186];				5	37					STRA6 (inh=AR pLI=0.00)
chr15	74487036	74487036	T	A	het	anno_omim	QUAL=20211;DP=377;AF=0.51;MQM=59;TRIO=HET,377,0.51,WT,322,0.00,HOM,474,1.00	STRA6	3'UTR,intron	STRA6:ENST00000432245:3'UTR:MODIFIER:exon6/6:c.*907A>T:,STRA6:ENST00000563965:intron:MODIFIER:exon7/18:c.714+607A>T:,STRA6:ENST00000395105:intron:MODIFIER:exon7/18:c.597+607A>T:,STRA6:ENST00000423167:intron:MODIFIER:exon7/18:c.570+607A>T:,STRA6:ENST00000323940:intron:MODIFIER:exon7/18:c.597+607A>T:,STRA6:ENST00000449139:intron:MODIFIER:exon7/18:c.597+607A>T:,STRA6:ENST00000416286:intron:MODIFIER:exon6/17:c.573+607A>T:,STRA6:ENST00000535552:intron:MODIFIER:exon7/18:c.708+607A>T:,STRA6:ENST00000574278:intron:MODIFIER:exon7/18:c.642+607A>T:	L2a	rs351224	0.4922	0.0000	0,0,0	0,0,0,0,0	0.4466							610745 [STRA6 (provisional) Microphthalmia,syndromic 9,601186|Microphthalmia,isolated,with coloboma 8,601186];				46	96					STRA6 (inh=AR pLI=0.00)
chr15	74495556	74495557	TG	-	het	anno_omim	QUAL=698;DP=52;AF=0.46;MQM=60;TRIO=HET,52,0.46,HOM,10,1.00,WT,11,0.00	RP11-60L3.1,STRA6	intron	STRA6:ENST00000423167:intron:MODIFIER:exon1/18:c.-15-934_-15-933delCA:,STRA6:ENST00000323940:intron:MODIFIER:exon1/18:c.-15-934_-15-933delCA:,STRA6:ENST00000449139:intron:MODIFIER:exon1/18:c.-15-934_-15-933delCA:,STRA6:ENST00000416286:intron:MODIFIER:exon1/17:c.-15-934_-15-933delCA:,STRA6:ENST00000535552:intron:MODIFIER:exon1/18:c.97-934_97-933delCA:,STRA6:ENST00000574278:intron:MODIFIER:exon1/18:c.31-934_31-933delCA:,STRA6:ENST00000432245:intron:MODIFIER:exon1/5:c.-15-934_-15-933delCA:		rs372268345	0.2927	0.0000	0,0,0	0,0,0,0,0	0.2629							610745 [STRA6 (provisional) Microphthalmia,syndromic 9,601186|Microphthalmia,isolated,with coloboma 8,601186];				26	106					RP11-60L3.1 (inh=n/a pLI=n/a), STRA6 (inh=AR pLI=0.00)
chr15	74500105	74500105	G	A	het	anno_omim	QUAL=7501;DP=268;AF=0.49;MQM=59;TRIO=HET,268,0.49,HET,363,0.50,WT,426,0.00	STRA6,RP11-60L3.1	5'UTR_premature_start_codon_gain,5'UTR,intron	STRA6:ENST00000574278:5'UTR_premature_start_codon_gain:LOW:exon1/19:c.-38C>T:,STRA6:ENST00000574278:5'UTR:MODIFIER:exon1/19:c.-38C>T:,STRA6:ENST00000423167:intron:MODIFIER:exon1/18:c.-16+1036C>T:,STRA6:ENST00000323940:intron:MODIFIER:exon1/18:c.-16+1036C>T:,STRA6:ENST00000449139:intron:MODIFIER:exon1/18:c.-16+4363C>T:,STRA6:ENST00000416286:intron:MODIFIER:exon1/17:c.-16+4363C>T:,STRA6:ENST00000535552:intron:MODIFIER:exon1/18:c.96+1595C>T:,STRA6:ENST00000432245:intron:MODIFIER:exon1/5:c.-16+1036C>T:		rs12915846	0.1999	0.2198	269,71,2	0.1085,0.0000,0.0000,0.2273,0.2180	0.2295							610745 [STRA6 (provisional) Microphthalmia,syndromic 9,601186|Microphthalmia,isolated,with coloboma 8,601186];				137	680					STRA6 (inh=AR pLI=0.00), RP11-60L3.1 (inh=n/a pLI=n/a)
chr15	74500238	74500238	C	T	het	anno_omim	QUAL=10287;DP=262;AF=0.50;MQM=59;TRIO=HET,262,0.50,HET,609,0.48,WT,686,0.00	STRA6,RP11-60L3.1	5'UTR,intron	STRA6:ENST00000574278:5'UTR:MODIFIER:exon1/19:c.-171G>A:,STRA6:ENST00000423167:intron:MODIFIER:exon1/18:c.-16+903G>A:,STRA6:ENST00000323940:intron:MODIFIER:exon1/18:c.-16+903G>A:,STRA6:ENST00000449139:intron:MODIFIER:exon1/18:c.-16+4230G>A:,STRA6:ENST00000416286:intron:MODIFIER:exon1/17:c.-16+4230G>A:,STRA6:ENST00000535552:intron:MODIFIER:exon1/18:c.96+1462G>A:,STRA6:ENST00000432245:intron:MODIFIER:exon1/5:c.-16+903G>A:		rs10152959	0.2260	0.0000	0,0,0	0,0,0,0,0	0.2216							610745 [STRA6 (provisional) Microphthalmia,syndromic 9,601186|Microphthalmia,isolated,with coloboma 8,601186];				11	77					STRA6 (inh=AR pLI=0.00), RP11-60L3.1 (inh=n/a pLI=n/a)
chr15	74658315	74658315	-	A	hom	low_DP;anno_omim	QUAL=2609;DP=12;AF=0.83;MQM=60;TRIO=HOM,12,0.83,HOM,42,1.00,HOM,48,1.00	CYP11A1,CTD-2311M21.3	5'UTR,intron	CYP11A1:ENST00000358632:5'UTR:MODIFIER:exon1/9:c.-465dupT:,CYP11A1:ENST00000419019:5'UTR:MODIFIER:exon1/8:c.-309dupT:,CYP11A1:ENST00000268053:intron:MODIFIER:exon1/8:c.269+1342dupT:,CYP11A1:ENST00000541301:intron:MODIFIER:exon1/4:c.269+1342dupT:		rs386383486;rs79534403	0.9998	0.0000	0,0,0	0,0,0,0,0	1.0000							118485 [CYP11A1 (confirmed) Adrenal insufficiency,congenital,with 46XY sex reversal,partial or complete,613743];				226	0					CYP11A1 (inh=AR pLI=0.00), CTD-2311M21.3 (inh=n/a pLI=n/a)
chr15	75185670	75185670	A	G	het	anno_omim	QUAL=6205;DP=104;AF=0.52;MQM=60;TRIO=HET,104,0.52,HOM,162,1.00,WT,189,0.00	MPI	missense,splice_region&intron,intron	MPI:ENST00000565576:missense:MODERATE:exon5/5:c.679A>G:p.Ser227Gly,MPI:ENST00000352410:splice_region&intron:LOW:exon5/7:c.670+9A>G:,MPI:ENST00000566377:splice_region&intron:LOW:exon5/6:c.670+9A>G:,MPI:ENST00000563422:splice_region&intron:LOW:exon5/5:c.670+9A>G:,MPI:ENST00000563786:splice_region&intron:LOW:exon5/7:c.610+9A>G:,MPI:ENST00000535694:splice_region&intron:LOW:exon4/6:c.520+9A>G:,MPI:ENST00000562606:splice_region&intron:LOW:exon5/5:c.610+9A>G:,MPI:ENST00000564003:intron:MODIFIER:exon3/3:c.337+527A>G:,MPI:ENST00000323744:intron:MODIFIER:exon4/6:c.487+527A>G:		rs7495739	0.3383	0.4375	12640,9238,543	0.3338,0.5187,0.2276,0.5263,0.1975	0.4431							154550 [MPI (confirmed) Congenital disorder of glycosylation,type Ib,602579];	RCV000080014.5 [benign]; RCV000298232.1 [benign]; 		COSM4128400	449	1015					MPI (inh=AR pLI=0.00)
chr15	75189930	75189930	A	G	het	anno_omim	QUAL=5925;DP=182;AF=0.47;MQM=60;TRIO=HET,182,0.47,HOM,124,0.99,WT,195,0.00	MPI	synonymous,3'UTR	MPI:ENST00000352410:synonymous:LOW:exon8/8:c.1131A>G:p.Val377Val,MPI:ENST00000563786:synonymous:LOW:exon8/8:c.1071A>G:p.Val357Val,MPI:ENST00000535694:synonymous:LOW:exon7/7:c.981A>G:p.Val327Val,MPI:ENST00000323744:synonymous:LOW:exon7/7:c.948A>G:p.Val316Val,MPI:ENST00000566377:3'UTR:MODIFIER:exon7/7:c.*58A>G:		rs1130741	0.3387	0.4376	12747,9315,548	0.3326,0.5188,0.2289,0.5271,0.1971	0.4445							154550 [MPI (confirmed) Congenital disorder of glycosylation,type Ib,602579];	RCV000080011.5 [benign]; RCV000328204.1 [benign]; 			451	1015					MPI (inh=AR pLI=0.00)
chr15	76508684	76508684	T	A	hom	anno_omim	QUAL=14989;DP=221;AF=1.00;MQM=60;TRIO=HOM,221,1.00,HOM,107,1.00,HOM,137,1.00	ETFA,C15orf27	3'UTR	ETFA:ENST00000557943:3'UTR:MODIFIER:exon12/12:c.*216A>T:,ETFA:ENST00000433983:3'UTR:MODIFIER:exon11/11:c.*216A>T:		rs1803550	0.9742	0.0000	0,0,0	0,0,0,0,0	0.9785							608053 [ETFA (confirmed) Glutaric acidemia IIA,231680];	RCV000313076.1 [benign]; 			231	0					ETFA (inh=AR pLI=0.01), TMEM266 (inh=n/a pLI=0.00)
chr15	76673716	76673716	T	C	het		QUAL=6918;DP=189;AF=0.54;MQM=60;TRIO=HET,189,0.54,HOM,145,0.99,WT,186,0.00	SCAPER	splice_region&intron	SCAPER:ENST00000324767:splice_region&intron:LOW:exon27/30:c.3705+3A>G:,SCAPER:ENST00000538941:splice_region&intron:LOW:exon28/31:c.2967+3A>G:,SCAPER:ENST00000563290:splice_region&intron:LOW:exon28/31:c.3705+3A>G:		rs3765115	0.4157	0.4249	8160,3189,383	0.3297,0.4666,0.5960,0.3772,0.5611	0.3706											239	749					SCAPER (inh=n/a pLI=0.04)
chr15	76726465	76726465	G	T	het		QUAL=5853;DP=228;AF=0.45;MQM=60;TRIO=HET,228,0.45,HOM,115,1.00,WT,202,0.00	SCAPER	missense	SCAPER:ENST00000324767:missense:MODERATE:exon25/31:c.3265C>A:p.Pro1089Thr,SCAPER:ENST00000538941:missense:MODERATE:exon26/32:c.2527C>A:p.Pro843Thr,SCAPER:ENST00000563290:missense:MODERATE:exon26/32:c.3265C>A:p.Pro1089Thr		rs1607017	0.3560	0.3504	8098,3389,78	0.1264,0.3702,0.5609,0.3185,0.4964	0.3534	0.6870	T,T,.	T	B,B	T,T	6.65					219	729					SCAPER (inh=n/a pLI=0.04)
chr15	77085740	77085740	C	A	hom		QUAL=14755;DP=104;AF=1.00;MQM=60;TRIO=HOM,104,1.00,HOM,175,1.00,HOM,196,1.00	SCAPER	splice_region&intron,intron	SCAPER:ENST00000538941:splice_region&intron:LOW:exon7/31:c.-125-8G>T:,SCAPER:ENST00000324767:intron:MODIFIER:exon7/30:c.772+1881G>T:,SCAPER:ENST00000563290:intron:MODIFIER:exon8/31:c.772+1881G>T:	MER21B	rs3102707	0.9673	0.0000	0,0,0	0,0,0,0,0	0.9723											152	0					SCAPER (inh=n/a pLI=0.04)
chr15	77087785	77087785	T	C	het		QUAL=2918;DP=109;AF=0.50;MQM=60;TRIO=HET,109,0.50,HOM,55,1.00,WT,66,0.00	SCAPER	splice_region&intron	SCAPER:ENST00000324767:splice_region&intron:LOW:exon6/30:c.612-4A>G:,SCAPER:ENST00000538941:splice_region&intron:LOW:exon6/31:c.-286-4A>G:,SCAPER:ENST00000563290:splice_region&intron:LOW:exon7/31:c.612-4A>G:		rs11852395	0.3532	0.3547	7222,2797,110	0.1581,0.3902,0.5455,0.3147,0.5126	0.3463											193	706					SCAPER (inh=n/a pLI=0.04)
chr15	77176158	77176158	T	C	het	anno_high_impact;pred_pathogenic	QUAL=4564;DP=159;AF=0.39;MQM=60;TRIO=HET,159,0.39,HOM,96,0.99,WT,124,0.00	SCAPER	start_lost	SCAPER:ENST00000324767:start_lost:HIGH:exon1/31:c.1A>G:p.Met1?,SCAPER:ENST00000563290:start_lost:HIGH:exon2/32:c.1A>G:p.Met1?		rs3812908	0.4177	0.4036	4526,1605,337	0.3697,0.4519,0.5470,0.3540,0.5183	0.3253	2.6450	T,.	T,T	P,.	T,.	11.99					210	733	1	[1] auto-classification 16.06.2016  			SCAPER (inh=n/a pLI=0.04)
chr15	77176200	77176200	A	T	het		QUAL=5090;DP=202;AF=0.40;MQM=60;TRIO=HET,202,0.40,HOM,100,0.98,WT,136,0.01	SCAPER	5'UTR	SCAPER:ENST00000324767:5'UTR:MODIFIER:exon1/31:c.-42T>A:,SCAPER:ENST00000563290:5'UTR:MODIFIER:exon2/32:c.-42T>A:		rs3812909	0.4169	0.3859	3539,1191,276	0.3570,0.4183,0.5220,0.3350,0.5059	0.3255	0.4960		T			1.87					204	711					SCAPER (inh=n/a pLI=0.04)
chr15	85326955	85326955	G	A	het	pred_pathogenic	QUAL=5783;DP=229;AF=0.51;MQM=59;TRIO=HET,229,0.51,WT,191,0.00,HET,213,0.52	ZNF592	missense	ZNF592:ENST00000299927:missense:MODERATE:exon1/8:c.1049G>A:p.Arg350His,ZNF592:ENST00000560079:missense:MODERATE:exon4/11:c.1049G>A:p.Arg350His		rs61737677	0.0138	0.0084	7,1,3	0.0275,0.0067,0.0076,0.0082,0.0022	0.0119	4.6240	D	T	D	T	25.30					0	51					ZNF592 (inh=AR pLI=0.95)
chr15	85347114	85347114	T	C	hom		QUAL=23059;DP=261;AF=1.00;MQM=59;TRIO=HOM,261,1.00,HOM,190,1.00,HOM,284,1.00	ZNF592	3'UTR	ZNF592:ENST00000299927:3'UTR:MODIFIER:exon8/8:c.*1490T>C:,ZNF592:ENST00000560079:3'UTR:MODIFIER:exon11/11:c.*1490T>C:		rs9806315	0.8670	0.0000	0,0,0	0,0,0,0,0	0.8512											140	81					ZNF592 (inh=AR pLI=0.95)
chr15	85347673	85347673	T	C	het		QUAL=5005;DP=192;AF=0.47;MQM=60;TRIO=HET,192,0.47,WT,175,0.00,HET,204,0.51	ZNF592	3'UTR	ZNF592:ENST00000299927:3'UTR:MODIFIER:exon8/8:c.*2049T>C:,ZNF592:ENST00000560079:3'UTR:MODIFIER:exon11/11:c.*2049T>C:		rs114257982	0.0280	0.0000	0,0,0	0,0,0,0,0	0.0247											0	4					ZNF592 (inh=AR pLI=0.95)
chr15	85348172	85348172	G	T	het		QUAL=9076;DP=370;AF=0.50;MQM=60;TRIO=HET,370,0.50,HET,286,0.55,WT,399,0.00	ZNF592	3'UTR	ZNF592:ENST00000299927:3'UTR:MODIFIER:exon8/8:c.*2548G>T:,ZNF592:ENST00000560079:3'UTR:MODIFIER:exon11/11:c.*2548G>T:	MIRb	rs1719	0.0585	0.0000	0,0,0	0,0,0,0,0	0.0631											2	28					ZNF592 (inh=AR pLI=0.95)
chr15	85348551	85348551	G	C	het		QUAL=5778;DP=268;AF=0.48;MQM=60;TRIO=HET,268,0.48,WT,106,0.00,HET,157,0.57	ZNF592	3'UTR	ZNF592:ENST00000299927:3'UTR:MODIFIER:exon8/8:c.*2927G>C:,ZNF592:ENST00000560079:3'UTR:MODIFIER:exon11/11:c.*2927G>C:		rs117658444	0.0142	0.0000	0,0,0	0,0,0,0,0	0.0120											0	4					ZNF592 (inh=AR pLI=0.95)
chr15	89835937	89835937	A	G	het	anno_omim	QUAL=7547;DP=289;AF=0.54;MQM=59;TRIO=HET,289,0.54,HET,255,0.51,WT,291,0.00	FANCI	missense	FANCI:ENST00000310775:missense:MODERATE:exon21/38:c.2011A>G:p.Ile671Val,FANCI:ENST00000300027:missense:MODERATE:exon21/37:c.2011A>G:p.Ile671Val		rs139814895	0.0038	0.0039	3,0,0	0.0000,0.0008,0.0139,0.0011,0.0055	0.0050	1.0600	T,T,T	T	B,B,B	T,T,T	14.58	611360 [FANCI (provisional) Fanconi anemia,complementation group I,609053];	RCV000228217.2 [other]; 			0	15					FANCI (inh=AR pLI=0.00)
chr15	89837139	89837139	G	T	het	anno_omim	QUAL=3724;DP=218;AF=0.44;MQM=60;TRIO=HET,218,0.44,HET,117,0.42,WT,154,0.00	FANCI	synonymous	FANCI:ENST00000310775:synonymous:LOW:exon23/38:c.2367G>T:p.Ala789Ala,FANCI:ENST00000300027:synonymous:LOW:exon23/37:c.2367G>T:p.Ala789Ala		rs11857960	0.0789	0.0280	301,2,291	0.2372,0.0200,0.0139,0.0042,0.0062	0.0734							611360 [FANCI (provisional) Fanconi anemia,complementation group I,609053];	RCV000242536.1 [benign]; RCV000397172.1 [likely benign]; 			2	45					FANCI (inh=AR pLI=0.00)
chr15	89838236	89838236	G	A	hom	anno_omim	QUAL=29395;DP=417;AF=1.00;MQM=60;TRIO=HOM,417,1.00,HOM,181,1.00,HOM,293,1.00	FANCI	synonymous,intron	FANCI:ENST00000310775:synonymous:LOW:exon24/38:c.2547G>A:p.Lys849Lys,FANCI:ENST00000300027:intron:MODIFIER:exon23/36:c.2456+1008G>A:		rs7183618	0.9808	0.9594	11000,4586,1263	0.9926,0.9755,1.0000,0.9475,0.9779	0.9567							611360 [FANCI (provisional) Fanconi anemia,complementation group I,609053];				2159	202					FANCI (inh=AR pLI=0.00)
chr15	89838293	89838293	A	C	het	anno_omim	QUAL=5454;DP=266;AF=0.50;MQM=60;TRIO=HET,266,0.50,HET,154,0.51,WT,247,0.00	FANCI	missense,intron	FANCI:ENST00000310775:missense:MODERATE:exon24/38:c.2604A>C:p.Glu868Asp,FANCI:ENST00000300027:intron:MODIFIER:exon23/36:c.2456+1065A>C:		rs118031800	0.0038	0.0045	2,0,0	0.0000,0.0049,0.0048,0.0011,0.0051	0.0050	-0.0490	T	T	B	T	8.04	611360 [FANCI (provisional) Fanconi anemia,complementation group I,609053];	RCV000230137.2 [other]; 			0	15					FANCI (inh=AR pLI=0.00)
chr15	89848645	89848645	-	T	het	anno_omim	QUAL=14030;DP=634;AF=0.53;MQM=59;TRIO=HET,634,0.53,HET,519,0.50,WT,668,0.00	FANCI	splice_region&intron	FANCI:ENST00000310775:splice_region&intron:LOW:exon30/37:c.3255+6dupT:,FANCI:ENST00000300027:splice_region&intron:LOW:exon29/36:c.3075+6dupT:		rs878854178	0.0036	0.0039	3,0,0	0.0000,0.0008,0.0148,0.0011,0.0050	0.0050							611360 [FANCI (provisional) Fanconi anemia,complementation group I,609053];	RCV000227226.1 [benign]; 			0	15					FANCI (inh=AR pLI=0.00)
chr15	89858602	89858602	T	C	het	anno_omim	QUAL=11685;DP=204;AF=0.44;MQM=60;TRIO=HET,204,0.44,HOM,178,1.00,HET,298,0.55	FANCI	synonymous	FANCI:ENST00000310775:synonymous:LOW:exon37/38:c.3906T>C:p.Gly1302Gly,FANCI:ENST00000300027:synonymous:LOW:exon36/37:c.3726T>C:p.Gly1242Gly		rs1138465	0.4123	0.4123	10413,5346,1018	0.4419,0.3994,0.4291,0.4001,0.4042	0.4372							611360 [FANCI (provisional) Fanconi anemia,complementation group I,609053];	RCV000251297.1 [benign]; RCV000329693.1 [likely benign]; RCV000348737.1 [benign]; 		COSM3754561, COSM3754560	379	1105					FANCI (inh=AR pLI=0.00)
chr15	89860350	89860350	A	C	het	anno_omim	QUAL=3570;DP=164;AF=0.53;MQM=60;TRIO=HET,164,0.53,HOM,21,1.00,HET,54,0.39	FANCI,POLG	3'UTR,intron	FANCI:ENST00000310775:3'UTR:MODIFIER:exon38/38:c.*660A>C:,FANCI:ENST00000300027:3'UTR:MODIFIER:exon37/37:c.*660A>C:,POLG:ENST00000268124:intron:MODIFIER:exon22/22:c.3643+257T>G:,POLG:ENST00000442287:intron:MODIFIER:exon22/22:c.3643+257T>G:		rs1061316	0.4459	0.0000	0,0,0	0,0,0,0,0	0.4844							611360 [FANCI (provisional) Fanconi anemia,complementation group I,609053]:174763 [POLG (provisional) Progressive external ophthalmoplegia,autosomal recessive 1,258450|Progressive external ophthalmoplegia,autosomal dominant 1,157640|Mitochondrial DNA depletion syndrome 4B (MNGIE type),613662|Mitochondrial DNA depletion syndrome 4A (Alpers type),203700|Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE),607459];	RCV000274297.1 [benign]; RCV000331693.1 [benign]; 			24	103					FANCI (inh=AR pLI=0.00), POLG (inh=AR+AD pLI=0.00)
chr15	89867380	89867380	C	T	het	anno_omim	QUAL=4087;DP=258;AF=0.44;MQM=60;TRIO=HET,258,0.44,HET,158,0.44,WT,235,0.00	POLG	synonymous	POLG:ENST00000268124:synonymous:LOW:exon11/23:c.2028G>A:p.Ala676Ala,POLG:ENST00000442287:synonymous:LOW:exon11/23:c.2028G>A:p.Ala676Ala		rs373550219	0.0000	0.0004	0,0,0	0.0000,0.0006,0.0000,0.0005,0.0003	0.0003							174763 [POLG (provisional) Progressive external ophthalmoplegia,autosomal recessive 1,258450|Progressive external ophthalmoplegia,autosomal dominant 1,157640|Mitochondrial DNA depletion syndrome 4B (MNGIE type),613662|Mitochondrial DNA depletion syndrome 4A (Alpers type),203700|Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE),607459];	RCV000127516.2 [other]; RCV000263177.1 [uncertain significance]; 			0	13					POLG (inh=AR+AD pLI=0.00)
chr15	89872249	89872249	C	T	het	anno_omim;anno_pathogenic_hgmd	QUAL=3930;DP=203;AF=0.47;MQM=59;TRIO=HET,203,0.47,HET,138,0.48,WT,162,0.00	POLG	synonymous	POLG:ENST00000268124:synonymous:LOW:exon4/23:c.948G>A:p.Lys316Lys,POLG:ENST00000442287:synonymous:LOW:exon4/23:c.948G>A:p.Lys316Lys		rs61756401	0.0036	0.0039	3,0,0	0.0000,0.0008,0.0148,0.0012,0.0046	0.0050							174763 [POLG (provisional) Progressive external ophthalmoplegia,autosomal recessive 1,258450|Progressive external ophthalmoplegia,autosomal dominant 1,157640|Mitochondrial DNA depletion syndrome 4B (MNGIE type),613662|Mitochondrial DNA depletion syndrome 4A (Alpers type),203700|Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE),607459];	RCV000118023.4 [other]; 	CM133443 [CLASS=DM? MUT=ALT PHEN="SANDO" GENE=POLG]; 		0	19	2	[2] Stephan Waldm?ller 13.08.2014			POLG (inh=AR+AD pLI=0.00)
chr15	90171306	90171306	A	G	het	anno_omim	QUAL=9630;DP=383;AF=0.50;MQM=59;TRIO=HET,383,0.50,WT,282,0.01,HET,369,0.49	KIF7,TICRR	3'UTR	KIF7:ENST00000394412:3'UTR:MODIFIER:exon19/19:c.*344T>C:		rs1054435	0.4485	0.0000	0,0,0	0,0,0,0,0	0.4075							611254 [KIF7 (provisional) Hydrolethalus syndrome 2,614120|Acrocallosal syndrome,200990|Joubert syndrome 12,200990|Al-Gazali-Bakalinova syndrome,607131];	RCV000383066.1 [benign]; 			40	109					KIF7 (inh=AR pLI=0.00), TICRR (inh=n/a pLI=0.00)
chr15	90172600	90172600	G	A	het	anno_omim	QUAL=1277;DP=60;AF=0.63;MQM=59;TRIO=HET,60,0.63,WT,33,0.00,HET,53,0.47	KIF7,TICRR	splice_region&intron	KIF7:ENST00000394412:splice_region&intron:LOW:exon17/18:c.3517+6C>T:		rs74251725	0.2752	0.3199	5557,3286,56	0.1183,0.2859,0.3636,0.3331,0.4050	0.3079							611254 [KIF7 (provisional) Hydrolethalus syndrome 2,614120|Acrocallosal syndrome,200990|Joubert syndrome 12,200990|Al-Gazali-Bakalinova syndrome,607131];	RCV000117423.4 [other]; RCV000396714.1 [benign]; 			285	904					KIF7 (inh=AR pLI=0.00), TICRR (inh=n/a pLI=0.00)
chr15	90173734	90173734	-	AG	het	anno_omim	QUAL=6988;DP=118;AF=0.36;MQM=59;TRIO=HET,118,0.36,HOM,138,1.00,HET,188,0.51	KIF7,TICRR	splice_region&intron	KIF7:ENST00000394412:splice_region&intron:LOW:exon15/18:c.3112-11_3112-10insCT:		rs35820949	0.4922	0.5474	3268,1570,505	0.5998,0.4799,0.3052,0.5819,0.5138	0.5702							611254 [KIF7 (provisional) Hydrolethalus syndrome 2,614120|Acrocallosal syndrome,200990|Joubert syndrome 12,200990|Al-Gazali-Bakalinova syndrome,607131];	RCV000252342.2 [benign]; RCV000328696.1 [benign]; 			599	1022					KIF7 (inh=AR pLI=0.00), TICRR (inh=n/a pLI=0.00)
chr15	90174789	90174789	C	T	het	anno_omim	QUAL=1125;DP=54;AF=0.33;MQM=60;TRIO=HET,54,0.33,HET,25,0.88,HET,47,0.28	KIF7	synonymous	KIF7:ENST00000394412:synonymous:LOW:exon15/19:c.3048G>A:p.Ser1016Ser		rs9672286	0.4511	0.5270	5814,3549,539	0.4974,0.4398,0.3702,0.5706,0.5081	0.5418							611254 [KIF7 (provisional) Hydrolethalus syndrome 2,614120|Acrocallosal syndrome,200990|Joubert syndrome 12,200990|Al-Gazali-Bakalinova syndrome,607131];	RCV000082817.8 [other]; RCV000274985.1 [benign]; 		COSM3932192, COSM3932193	590	1024					KIF7 (inh=AR pLI=0.00)
chr15	90174824	90174824	C	T	het	anno_omim	QUAL=1375;DP=59;AF=0.44;MQM=60;TRIO=HET,59,0.44,HET,22,0.86,HET,50,0.34	KIF7	missense	KIF7:ENST00000394412:missense:MODERATE:exon15/19:c.3013G>A:p.Gly1005Arg		rs12900805	0.4393	0.5128	3876,2157,361	0.4634,0.4272,0.3305,0.5572,0.5086	0.5315	1.1430	T	T	B,B	T	12.42	611254 [KIF7 (provisional) Hydrolethalus syndrome 2,614120|Acrocallosal syndrome,200990|Joubert syndrome 12,200990|Al-Gazali-Bakalinova syndrome,607131];	RCV000082815.8 [other]; RCV000332349.1 [benign]; 			590	1024					KIF7 (inh=AR pLI=0.00)
chr15	90176073	90176073	C	A	het	low_DP;pred_pathogenic;anno_omim	QUAL=710;DP=18;AF=0.11;MQM=60;TRIO=HET,18,0.11,HOM,17,1.00,HET,32,0.41	KIF7	missense	KIF7:ENST00000394412:missense:MODERATE:exon14/19:c.2873G>T:p.Ser958Ile		rs3803530	0.4383	0.5255	16267,10811,1038	0.4564,0.3976,0.3306,0.5820,0.4979	0.5301	1.1000	T	T	B,B	T	22.50	611254 [KIF7 (provisional) Hydrolethalus syndrome 2,614120|Acrocallosal syndrome,200990|Joubert syndrome 12,200990|Al-Gazali-Bakalinova syndrome,607131];	RCV000082813.8 [other]; RCV000316792.1 [benign]; 			588	976					KIF7 (inh=AR pLI=0.00)
chr15	90176432	90176432	T	G	hom	anno_omim	QUAL=10444;DP=86;AF=1.00;MQM=60;TRIO=HOM,86,1.00,HOM,88,1.00,HOM,153,1.00	KIF7	synonymous	KIF7:ENST00000394412:synonymous:LOW:exon13/19:c.2658A>C:p.Ala886Ala		rs3803531	0.7945	0.8618	40722,25357,2898	0.7917,0.7181,0.7193,0.9101,0.8686	0.8601							611254 [KIF7 (provisional) Hydrolethalus syndrome 2,614120|Acrocallosal syndrome,200990|Joubert syndrome 12,200990|Al-Gazali-Bakalinova syndrome,607131];	RCV000117420.4 [other]; RCV000373784.1 [benign]; 		COSM147979	1703	394					KIF7 (inh=AR pLI=0.00)
chr15	90191827	90191827	T	C	hom	low_DP;anno_omim	QUAL=709;DP=15;AF=1.00;MQM=60;TRIO=HOM,15,1.00,HOM,5,1.00,HOM,6,1.00	KIF7	missense	KIF7:ENST00000394412:missense:MODERATE:exon5/19:c.1102A>G:p.Thr368Ala	(CCGCTCG)n	rs8037349	0.8614	0.8912	5930,2140,604	0.9653,0.0000,0.8137,0.8894,0.8820	0.9100	-0.4760	T	T	B	T	0.01	611254 [KIF7 (provisional) Hydrolethalus syndrome 2,614120|Acrocallosal syndrome,200990|Joubert syndrome 12,200990|Al-Gazali-Bakalinova syndrome,607131];	RCV000082811.9 [other]; RCV000394862.1 [benign]; 		COSM4128555	1690	374					KIF7 (inh=AR pLI=0.00)
chr15	90195967	90195967	C	G	hom	anno_omim	QUAL=27263;DP=234;AF=1.00;MQM=60;TRIO=HOM,234,1.00,HOM,298,0.99,HOM,367,1.00	KIF7	synonymous	KIF7:ENST00000394412:synonymous:LOW:exon2/19:c.195G>C:p.Ala65Ala		rs8179066	0.8602	0.8937	8050,3473,1003	0.9639,0.7956,0.7749,0.9019,0.8796	0.9129							611254 [KIF7 (provisional) Hydrolethalus syndrome 2,614120|Acrocallosal syndrome,200990|Joubert syndrome 12,200990|Al-Gazali-Bakalinova syndrome,607131];	RCV000117415.7 [other]; RCV000373043.1 [benign]; 			1710	382					KIF7 (inh=AR pLI=0.00)
chr15	90196008	90196008	C	T	het	pred_pathogenic;anno_omim	QUAL=5839;DP=173;AF=0.54;MQM=59;TRIO=HET,173,0.54,WT,286,0.00,HET,348,0.45	KIF7	missense	KIF7:ENST00000394412:missense:MODERATE:exon2/19:c.154G>A:p.Asp52Asn		rs8179065	0.2424	0.2697	779,303,4	0.0728,0.2655,0.4510,0.2733,0.3023	0.2652	0.7100	T	T	B	T	22.80	611254 [KIF7 (provisional) Hydrolethalus syndrome 2,614120|Acrocallosal syndrome,200990|Joubert syndrome 12,200990|Al-Gazali-Bakalinova syndrome,607131];	RCV000117413.4 [other]; RCV000278498.1 [benign]; 		COSM3754564	185	877					KIF7 (inh=AR pLI=0.00)
chr15	91312823	91312823	T	C	hom	anno_omim	QUAL=1935;DP=56;AF=1.00;MQM=60;TRIO=HOM,56,1.00,HET,10,0.30,HET,8,0.88	BLM	splice_region&intron	BLM:ENST00000355112:splice_region&intron:LOW:exon12/21:c.2555+7T>C:,BLM:ENST00000560509:splice_region&intron:LOW:exon12/19:c.2555+7T>C:		rs3815003	0.3666	0.2956	5554,2506,1864	0.6001,0.2317,0.3168,0.2853,0.1842	0.3771							604610 [BLM (confirmed) Bloom syndrome,210900];	RCV000078057.8 [other]; RCV000297248.1 [benign]; 			320	1446	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BLM (inh=AR pLI=0.00)
chr15	91337479	91337479	G	A	het	anno_omim	QUAL=3535;DP=150;AF=0.47;MQM=60;TRIO=HET,150,0.47,WT,111,0.00,HET,128,0.48	BLM	synonymous	BLM:ENST00000355112:synonymous:LOW:exon16/22:c.3102G>A:p.Thr1034Thr,BLM:ENST00000560509:synonymous:LOW:exon16/20:c.3102G>A:p.Thr1034Thr		rs2227933	0.1512	0.1611	1682,1159,184	0.1883,0.0860,0.1737,0.1880,0.0887	0.1872							604610 [BLM (confirmed) Bloom syndrome,210900];	RCV000078059.8 [other]; RCV000123848.2 [benign]; RCV000366766.1 [likely benign]; 			141	1132	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BLM (inh=AR pLI=0.00)
chr15	91346923	91346923	C	A	het	anno_omim	QUAL=6620;DP=263;AF=0.52;MQM=60;TRIO=HET,263,0.52,WT,195,0.00,HET,246,0.50	BLM	synonymous,intron	BLM:ENST00000355112:synonymous:LOW:exon18/22:c.3531C>A:p.Ala1177Ala,BLM:ENST00000560509:intron:MODIFIER:exon17/19:c.3358+5356C>A:		rs2227934	0.1332	0.1553	1569,1157,68	0.1223,0.0834,0.1738,0.1880,0.0892	0.1683							604610 [BLM (confirmed) Bloom syndrome,210900];	RCV000078060.8 [other]; RCV000363720.1 [likely benign]; 			139	1121	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BLM (inh=AR pLI=0.00)
chr15	91354505	91354505	C	T	het	anno_omim	QUAL=8301;DP=258;AF=0.49;MQM=59;TRIO=HET,258,0.49,WT,216,0.00,HET,341,0.56	BLM	synonymous	BLM:ENST00000355112:synonymous:LOW:exon21/22:c.3945C>T:p.Leu1315Leu,BLM:ENST00000560509:synonymous:LOW:exon19/20:c.3552C>T:p.Leu1184Leu		rs1063147	0.1328	0.1557	1589,1170,81	0.1263,0.0798,0.1708,0.1889,0.0889	0.1684							604610 [BLM (confirmed) Bloom syndrome,210900];	RCV000078061.8 [other]; RCV000320678.1 [likely benign]; 			143	1132	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BLM (inh=AR pLI=0.00)
chr15	91354521	91354521	G	A	het	anno_omim	QUAL=11068;DP=281;AF=0.50;MQM=60;TRIO=HET,281,0.50,HOM,233,0.99,WT,354,0.00	BLM	missense	BLM:ENST00000355112:missense:MODERATE:exon21/22:c.3961G>A:p.Val1321Ile,BLM:ENST00000560509:missense:MODERATE:exon19/20:c.3568G>A:p.Val1190Ile		rs7167216	0.0671	0.0663	309,164,35	0.0923,0.0360,0.0243,0.0664,0.0656	0.0855	-0.6680	T,T,T	T	B,B	T	0.60	604610 [BLM (confirmed) Bloom syndrome,210900];	RCV000116501.4 [other]; RCV000281046.1 [likely benign]; 			19	429	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BLM (inh=AR pLI=0.00)
chr15	91543761	91543761	C	T	het	pred_pathogenic;anno_omim	QUAL=20759;DP=414;AF=0.48;MQM=60;TRIO=HET,414,0.48,HOM,312,1.00,HET,429,0.49	VPS33B	missense	VPS33B:ENST00000333371:missense:MODERATE:exon20/23:c.1540G>A:p.Gly514Ser,VPS33B:ENST00000535843:missense:MODERATE:exon19/22:c.1267G>A:p.Gly423Ser,VPS33B:ENST00000535906:missense:MODERATE:exon19/22:c.1459G>A:p.Gly487Ser		rs11073964	0.7678	0.5629	21914,5394,4150	0.8921,0.7618,0.9965,0.4045,0.6897	0.5849	4.2670	T,T,T,T	T	B,B	T,T,T	20.90	608552 [VPS33B (provisional) Arthrogryposis,renal dysfunction,and cholestasis 1,208085];	RCV000253189.1 [benign]; RCV000305164.1 [benign]; 		COSM3754589	501	1013					VPS33B (inh=AR pLI=0.00)
chr15	91548601	91548601	G	A	het	anno_omim	QUAL=18207;DP=292;AF=0.51;MQM=59;TRIO=HET,292,0.51,HOM,298,1.00,HET,387,0.50	VPS33B	splice_region&intron	VPS33B:ENST00000333371:splice_region&intron:LOW:exon14/22:c.1105+9C>T:,VPS33B:ENST00000535843:splice_region&intron:LOW:exon13/21:c.832+9C>T:,VPS33B:ENST00000535906:splice_region&intron:LOW:exon13/21:c.1024+9C>T:		rs3826033	0.2081	0.1797	2808,595,2	0.0304,0.3288,0.5036,0.1313,0.2066	0.1867							608552 [VPS33B (provisional) Arthrogryposis,renal dysfunction,and cholestasis 1,208085];	RCV000249496.1 [benign]; RCV000261543.1 [benign]; 		COSM3999688	47	499					VPS33B (inh=AR pLI=0.00)
chr15	91565804	91565804	A	G	het	anno_omim	QUAL=13244;DP=455;AF=0.52;MQM=59;TRIO=HET,455,0.52,HOM,187,0.99,HET,206,0.49	VPS33B	5'UTR	VPS33B:ENST00000333371:5'UTR:MODIFIER:exon1/23:c.-325T>C:,VPS33B:ENST00000535906:5'UTR:MODIFIER:exon1/22:c.-325T>C:		rs11073967	0.7566	0.0000	0,0,0	0,0,0,0,0	0.5678							608552 [VPS33B (provisional) Arthrogryposis,renal dysfunction,and cholestasis 1,208085];	RCV000327280.1 [benign]; 			44	120					VPS33B (inh=AR pLI=0.00)
chr15	97347632	97347632	C	T	het		QUAL=7034;DP=234;AF=0.50;MQM=60;TRIO=HET,234,0.50,HOM,128,0.99,WT,300,0.00	SPATA8,RN7SKP181	intergenic_region	RN7SKP181:ENSG00000185594-ENSG00000223120:intergenic_region:MODIFIER::n.97347632C>T:		rs12902162	0.2879	0.0000	0,0,0	0,0,0,0,0	0.2548											21	68					SPATA8 (inh=n/a pLI=0.16), RN7SKP181 (inh=n/a pLI=n/a)
chr15	101109677	101109677	C	A	hom		QUAL=9270;DP=149;AF=0.98;MQM=60;TRIO=HOM,149,0.98,HET,135,0.59,HET,181,0.53	LINS	missense	LINS:ENST00000314742:missense:MODERATE:exon7/7:c.2040G>T:p.Arg680Ser		rs8451	0.3115	0.3850	9739,7089,359	0.2752,0.1816,0.2096,0.4580,0.3838	0.3834	-0.3100	T	T	B	T	9.49				COSM147993	437	1001					LINS1 (inh=AR pLI=0.00)
chr15	101109794	101109794	C	G	hom		QUAL=8183;DP=178;AF=1.00;MQM=60;TRIO=HOM,178,1.00,HET,68,0.56,HET,92,0.55	LINS	missense	LINS:ENST00000314742:missense:MODERATE:exon7/7:c.1923G>C:p.Glu641Asp		rs12157	0.3115	0.3848	9733,7085,359	0.2748,0.1816,0.2095,0.4579,0.3837	0.3831	0.0660	T	T	B	T	0.23				COSM3999451	437	1002					LINS1 (inh=AR pLI=0.00)
chr15	101109818	101109818	G	A	hom		QUAL=8847;DP=204;AF=0.99;MQM=59;TRIO=HOM,204,0.99,HET,75,0.53,HET,90,0.53	LINS	synonymous	LINS:ENST00000314742:synonymous:LOW:exon7/7:c.1899C>T:p.Asp633Asp		rs12460	0.4563	0.5056	15889,10248,746	0.3886,0.3661,0.4987,0.5527,0.4985	0.5047										COSM4148339	676	977					LINS1 (inh=AR pLI=0.00)
chr15	101109893	101109893	C	A	hom		QUAL=8560;DP=195;AF=0.99;MQM=60;TRIO=HOM,195,0.99,HET,118,0.50,HET,110,0.51	LINS	synonymous	LINS:ENST00000314742:synonymous:LOW:exon7/7:c.1824G>T:p.Gly608Gly		rs6598356	0.3117	0.3848	9709,7071,356	0.2743,0.1815,0.2098,0.4579,0.3837	0.3827										COSM3999452	434	1006					LINS1 (inh=AR pLI=0.00)
chr15	101110265	101110265	T	A	hom		QUAL=14328;DP=336;AF=1.00;MQM=60;TRIO=HOM,336,1.00,HET,114,0.50,HET,144,0.48	LINS	synonymous	LINS:ENST00000314742:synonymous:LOW:exon7/7:c.1452A>T:p.Thr484Thr		rs2411836	0.3115	0.3860	9286,6832,342	0.2781,0.1811,0.2083,0.4595,0.3859	0.3831										COSM147994	436	984					LINS1 (inh=AR pLI=0.00)
chr15	101110302	101110302	C	G	hom		QUAL=17335;DP=429;AF=1.00;MQM=59;TRIO=HOM,429,1.00,HET,97,0.52,HET,139,0.53	LINS	missense	LINS:ENST00000314742:missense:MODERATE:exon7/7:c.1415G>C:p.Ser472Thr		rs2411837	0.2548	0.3438	7753,5790,123	0.1563,0.1589,0.1874,0.4208,0.3395	0.3273	-0.1740	T	T	B	T	8.76				COSM147995	348	932					LINS1 (inh=AR pLI=0.00)
chr15	101113862	101113862	C	T	hom	pred_pathogenic	QUAL=9828;DP=192;AF=1.00;MQM=60;TRIO=HOM,192,1.00,HOM,62,1.00,HOM,67,1.00	LINS	missense	LINS:ENST00000314742:missense:MODERATE:exon5/7:c.1216G>A:p.Val406Met,LINS:ENST00000561308:missense:MODERATE:exon5/5:c.1216G>A:p.Val406Met,LINS:ENST00000560133:missense:MODERATE:exon5/5:c.859G>A:p.Val287Met		rs12719734	0.8952	0.9542	55343,32548,4654	0.9519,0.9649,0.6076,0.9915,0.9623	0.9622	2.0920	T	T	B,B	T	8.46					2070	37					LINS1 (inh=AR pLI=0.00)
chr15	101113950	101113950	A	G	hom		QUAL=12849;DP=281;AF=1.00;MQM=60;TRIO=HOM,281,1.00,HET,164,0.44,HET,207,0.51	LINS	synonymous	LINS:ENST00000314742:synonymous:LOW:exon5/7:c.1128T>C:p.Ser376Ser,LINS:ENST00000561308:synonymous:LOW:exon5/5:c.1128T>C:p.Ser376Ser,LINS:ENST00000560133:synonymous:LOW:exon5/5:c.771T>C:p.Ser257Ser		rs12592868	0.3275	0.3885	9876,7092,488	0.3136,0.1827,0.2096,0.4583,0.3841	0.3940										COSM147996, COSM3999453	435	1007					LINS1 (inh=AR pLI=0.00)
chr15	101114418	101114418	G	A	hom		QUAL=5208;DP=140;AF=1.00;MQM=60;TRIO=HOM,140,1.00,HET,33,0.58,HET,37,0.54	LINS	synonymous	LINS:ENST00000314742:synonymous:LOW:exon5/7:c.660C>T:p.Phe220Phe,LINS:ENST00000561308:synonymous:LOW:exon5/5:c.660C>T:p.Phe220Phe,LINS:ENST00000560133:synonymous:LOW:exon5/5:c.303C>T:p.Phe101Phe		rs8039437	0.3143	0.3867	9596,6970,340	0.2855,0.1821,0.2104,0.4588,0.3840	0.3856										COSM3722370, COSM3722371	429	987					LINS1 (inh=AR pLI=0.00)
chr15	101120963	101120963	T	C	hom		QUAL=29635;DP=568;AF=1.00;MQM=59;TRIO=HOM,568,1.00,HET,332,0.50,HET,461,0.51	LINS	missense,intron	LINS:ENST00000314742:missense:MODERATE:exon2/7:c.85A>G:p.Ile29Val,LINS:ENST00000561308:missense:MODERATE:exon2/5:c.85A>G:p.Ile29Val,LINS:ENST00000560133:intron:MODIFIER:exon2/4:c.42+43A>G:		rs11247226	0.2985	0.3836	9489,6974,237	0.2247,0.1821,0.2103,0.4608,0.3903	0.3749	-2.6700	T	T	B,B	T	0.01				COSM3936696, COSM3936697	433	995					LINS1 (inh=AR pLI=0.00)
chr15	101142449	101142449	G	T	hom		QUAL=6482;DP=117;AF=0.97;MQM=59;TRIO=HOM,117,0.97,HET,131,0.42,HET,188,0.48	LINS				rs7166822	0.3448	0.0000	0,0,0	0,0,0,0,0	0.3836											40	104					LINS1 (inh=AR pLI=0.00)
chr16	1250559	1250559	T	C	hom	anno_omim	QUAL=11079;DP=85;AF=0.98;MQM=59;TRIO=HOM,85,0.98,HET,338,0.46,HET,399,0.49	CACNA1H	synonymous	CACNA1H:ENST00000348261:synonymous:LOW:exon7/35:c.1107T>C:p.Ile369Ile,CACNA1H:ENST00000358590:synonymous:LOW:exon7/34:c.1107T>C:p.Ile369Ile,CACNA1H:ENST00000565831:synonymous:LOW:exon6/33:c.1107T>C:p.Ile369Ile		rs8044363	0.3327	0.3774	9204,5909,1130	0.4870,0.2604,0.1115,0.4205,0.3165	0.4398							607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6,611942|Epilepsy,childhood absence,susceptibility to,6,611942|Hyperaldosteronism,familial,type IV,617027];	RCV000152871.3 [benign]; 	CM071580 [CLASS=DP MUT=ALT PHEN="Epilepsy childhood absence association with" GENE=CACNA1H]; 	COSM3999710, COSM3999709, COSM3999711	295	926					CACNA1H (inh=n/a pLI=0.76)
chr16	1252259	1252259	A	G	hom	low_DP;anno_omim	QUAL=286;DP=2;AF=1.00;MQM=60;TRIO=HOM,2,1.00,HET,10,0.60,HET,9,0.56	CACNA1H	synonymous	CACNA1H:ENST00000348261:synonymous:LOW:exon9/35:c.1809A>G:p.Arg603Arg,CACNA1H:ENST00000358590:synonymous:LOW:exon9/34:c.1809A>G:p.Arg603Arg,CACNA1H:ENST00000565831:synonymous:LOW:exon8/33:c.1809A>G:p.Arg603Arg		rs9934839	0.3966	0.5185	4284,2879,466	0.6578,0.4662,0.2709,0.5702,0.3899	0.5074							607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6,611942|Epilepsy,childhood absence,susceptibility to,6,611942|Hyperaldosteronism,familial,type IV,617027];	RCV000082063.4 [benign]; 		COSM3754631, COSM3754630, COSM3754629	392	921					CACNA1H (inh=n/a pLI=0.76)
chr16	1260481	1260481	T	C	het	anno_omim	QUAL=13561;DP=109;AF=0.50;MQM=59;TRIO=HET,109,0.50,HOM,273,1.00,HET,368,0.46	CACNA1H	synonymous	CACNA1H:ENST00000348261:synonymous:LOW:exon19/35:c.3957T>C:p.Asp1319Asp,CACNA1H:ENST00000358590:synonymous:LOW:exon19/34:c.3957T>C:p.Asp1319Asp,CACNA1H:ENST00000565831:synonymous:LOW:exon18/33:c.3957T>C:p.Asp1319Asp		rs8063574	0.9199	0.8602	44276,21587,4008	0.9111,0.8725,0.9995,0.8124,0.9413	0.8598							607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6,611942|Epilepsy,childhood absence,susceptibility to,6,611942|Hyperaldosteronism,familial,type IV,617027];	RCV000082071.4 [benign]; 		COSM4128659, COSM4128661, COSM4128660	1489	569					CACNA1H (inh=n/a pLI=0.76)
chr16	1261219	1261219	A	G	het	anno_omim	QUAL=15495;DP=90;AF=0.38;MQM=59;TRIO=HET,90,0.38,HOM,300,0.99,HET,393,0.51	CACNA1H	synonymous	CACNA1H:ENST00000348261:synonymous:LOW:exon22/35:c.4275A>G:p.Ser1425Ser,CACNA1H:ENST00000358590:synonymous:LOW:exon22/34:c.4275A>G:p.Ser1425Ser,CACNA1H:ENST00000565831:synonymous:LOW:exon21/33:c.4275A>G:p.Ser1425Ser		rs2753326	0.7097	0.6431	25385,11745,2618	0.7332,0.7405,0.8938,0.5953,0.5587	0.6607							607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6,611942|Epilepsy,childhood absence,susceptibility to,6,611942|Hyperaldosteronism,familial,type IV,617027];			COSM3765849, COSM3765850, COSM3765851	760	1023					CACNA1H (inh=n/a pLI=0.76)
chr16	1261222	1261222	A	G	het	anno_omim	QUAL=15495;DP=90;AF=0.38;MQM=59;TRIO=HET,90,0.38,HOM,300,0.99,HET,393,0.51	CACNA1H	synonymous	CACNA1H:ENST00000348261:synonymous:LOW:exon22/35:c.4278A>G:p.Ser1426Ser,CACNA1H:ENST00000358590:synonymous:LOW:exon22/34:c.4278A>G:p.Ser1426Ser,CACNA1H:ENST00000565831:synonymous:LOW:exon21/33:c.4278A>G:p.Ser1426Ser		rs2753325	0.7097	0.6432	25402,11754,2624	0.7340,0.7405,0.8938,0.5954,0.5586	0.6611							607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6,611942|Epilepsy,childhood absence,susceptibility to,6,611942|Hyperaldosteronism,familial,type IV,617027];			COSM3765854, COSM3765852, COSM3765853	760	1023					CACNA1H (inh=n/a pLI=0.76)
chr16	1261282	1261282	T	C	het	anno_omim	QUAL=15583;DP=74;AF=0.50;MQM=59;TRIO=HET,74,0.50,HOM,316,1.00,HET,382,0.50	CACNA1H	synonymous	CACNA1H:ENST00000348261:synonymous:LOW:exon22/35:c.4338T>C:p.Ile1446Ile,CACNA1H:ENST00000358590:synonymous:LOW:exon22/34:c.4338T>C:p.Ile1446Ile,CACNA1H:ENST00000565831:synonymous:LOW:exon21/33:c.4338T>C:p.Ile1446Ile		rs4984637	0.9177	0.8597	44695,21924,4005	0.9065,0.8717,0.9994,0.8127,0.9419	0.8598							607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6,611942|Epilepsy,childhood absence,susceptibility to,6,611942|Hyperaldosteronism,familial,type IV,617027];			COSM3765857, COSM3765855, COSM3765856	1494	567					CACNA1H (inh=n/a pLI=0.76)
chr16	1268494	1268494	C	T	het	anno_omim	QUAL=20503;DP=194;AF=0.47;MQM=60;TRIO=HET,194,0.47,HOM,424,0.99,HET,512,0.47	CACNA1H	synonymous	CACNA1H:ENST00000348261:synonymous:LOW:exon33/35:c.5730C>T:p.Asp1910Asp,CACNA1H:ENST00000358590:synonymous:LOW:exon32/34:c.5712C>T:p.Asp1904Asp,CACNA1H:ENST00000565831:synonymous:LOW:exon31/33:c.5712C>T:p.Asp1904Asp		rs2745136	0.6991	0.6224	4475,2095,539	0.6939,0.7271,0.8979,0.6326,0.5454	0.6530							607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6,611942|Epilepsy,childhood absence,susceptibility to,6,611942|Hyperaldosteronism,familial,type IV,617027];			COSM434641, COSM434640, COSM3754639	757	1026					CACNA1H (inh=n/a pLI=0.76)
chr16	1269029	1269029	T	C	het	anno_omim	QUAL=2003;DP=26;AF=0.38;MQM=60;TRIO=HET,26,0.38,HOM,47,0.98,HET,62,0.32	CACNA1H	synonymous	CACNA1H:ENST00000348261:synonymous:LOW:exon34/35:c.5947T>C:p.Leu1983Leu,CACNA1H:ENST00000358590:synonymous:LOW:exon33/34:c.5929T>C:p.Leu1977Leu,CACNA1H:ENST00000565831:synonymous:LOW:exon32/33:c.5929T>C:p.Leu1977Leu		rs2738893	0.6917	0.6104	3593,1506,397	0.6659,0.6856,0.9104,0.6316,0.5452	0.6514							607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6,611942|Epilepsy,childhood absence,susceptibility to,6,611942|Hyperaldosteronism,familial,type IV,617027];				755	1026					CACNA1H (inh=n/a pLI=0.76)
chr16	1270162	1270162	G	A	het	anno_omim	QUAL=4330;DP=47;AF=0.45;MQM=60;TRIO=HET,47,0.45,HOM,86,1.00,HET,133,0.52	CACNA1H	missense	CACNA1H:ENST00000348261:missense:MODERATE:exon35/35:c.6230G>A:p.Arg2077His,CACNA1H:ENST00000358590:missense:MODERATE:exon34/34:c.6212G>A:p.Arg2071His,CACNA1H:ENST00000565831:missense:MODERATE:exon33/33:c.6212G>A:p.Arg2071His		rs1054645	0.7007	0.6628	20660,9821,1832	0.7188,0.7568,0.8921,0.6117,0.5871	0.6561	-0.6630	T,T	T	B,B	T,T	10.19	607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6,611942|Epilepsy,childhood absence,susceptibility to,6,611942|Hyperaldosteronism,familial,type IV,617027];	RCV000082076.4 [benign]; 		COSM3754643, COSM434644, COSM434645	753	1005					CACNA1H (inh=n/a pLI=0.76)
chr16	1270349	1270349	T	C	het	anno_omim	QUAL=2349;DP=59;AF=0.39;MQM=60;TRIO=HET,59,0.39,HOM,42,1.00,HET,52,0.54	CACNA1H	synonymous	CACNA1H:ENST00000348261:synonymous:LOW:exon35/35:c.6417T>C:p.Asp2139Asp,CACNA1H:ENST00000358590:synonymous:LOW:exon34/34:c.6399T>C:p.Asp2133Asp,CACNA1H:ENST00000565831:synonymous:LOW:exon33/33:c.6399T>C:p.Asp2133Asp		rs4247094	0.9139	0.8583	35348,17568,2683	0.9034,0.8737,0.9992,0.8137,0.9278	0.8593							607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6,611942|Epilepsy,childhood absence,susceptibility to,6,611942|Hyperaldosteronism,familial,type IV,617027];	RCV000082078.4 [benign]; 		COSM3749326, COSM3749327, COSM3749328	1457	507					CACNA1H (inh=n/a pLI=0.76)
chr16	1271189	1271189	G	A	het	anno_omim	QUAL=10720;DP=128;AF=0.48;MQM=59;TRIO=HET,128,0.48,HOM,201,1.00,HET,260,0.53	CACNA1H	3'UTR	CACNA1H:ENST00000348261:3'UTR:MODIFIER:exon35/35:c.*195G>A:,CACNA1H:ENST00000358590:3'UTR:MODIFIER:exon34/34:c.*195G>A:		rs2248457	0.6933	0.0000	0,0,0	0,0,0,0,0	0.6502							607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6,611942|Epilepsy,childhood absence,susceptibility to,6,611942|Hyperaldosteronism,familial,type IV,617027];				77	121					CACNA1H (inh=n/a pLI=0.76)
chr16	1495243	1495243	T	G	hom	anno_omim	QUAL=3454;DP=53;AF=1.00;MQM=60;TRIO=HOM,53,1.00,HET,37,0.57,HOM,44,1.00	CLCN7	3'UTR	CLCN7:ENST00000448525:3'UTR:MODIFIER:exon24/24:c.*1389A>C:,CLCN7:ENST00000382745:3'UTR:MODIFIER:exon25/25:c.*1389A>C:		rs710900	0.9189	0.0000	0,0,0	0,0,0,0,0	0.9033							602727 [CLCN7 (confirmed) Osteopetrosis,autosomal recessive 4,611490|Osteopetrosis,autosomal dominant 2,166600];	RCV000396092.1 [benign]; 			190	40					CLCN7 (inh=AR+AD pLI=0.98)
chr16	1495745	1495745	G	A	hom	anno_omim	QUAL=1892;DP=24;AF=0.92;MQM=59;TRIO=HOM,24,0.92,HET,15,0.67,HOM,40,1.00	CLCN7,LA16c-390E6.5	3'UTR	CLCN7:ENST00000262318:3'UTR:MODIFIER:exon24/24:c.*528C>T:,CLCN7:ENST00000448525:3'UTR:MODIFIER:exon24/24:c.*887C>T:,CLCN7:ENST00000382745:3'UTR:MODIFIER:exon25/25:c.*887C>T:		rs6600146	0.9066	0.0000	0,0,0	0,0,0,0,0	0.8659							602727 [CLCN7 (confirmed) Osteopetrosis,autosomal recessive 4,611490|Osteopetrosis,autosomal dominant 2,166600];	RCV000374837.1 [benign]; 			167	57					CLCN7 (inh=AR+AD pLI=0.98), LA16c-390E6.5 (inh=n/a pLI=n/a)
chr16	1495746	1495746	G	A	hom	anno_omim	QUAL=1892;DP=24;AF=0.92;MQM=59;TRIO=HOM,24,0.92,HET,15,0.67,HOM,40,1.00	CLCN7,LA16c-390E6.5	3'UTR	CLCN7:ENST00000262318:3'UTR:MODIFIER:exon24/24:c.*527C>T:,CLCN7:ENST00000448525:3'UTR:MODIFIER:exon24/24:c.*886C>T:,CLCN7:ENST00000382745:3'UTR:MODIFIER:exon25/25:c.*886C>T:		rs1050834	0.9066	0.0000	0,0,0	0,0,0,0,0	0.8659							602727 [CLCN7 (confirmed) Osteopetrosis,autosomal recessive 4,611490|Osteopetrosis,autosomal dominant 2,166600];	RCV000266296.1 [benign]; 			167	57					CLCN7 (inh=AR+AD pLI=0.98), LA16c-390E6.5 (inh=n/a pLI=n/a)
chr16	1503879	1503879	T	A	het	anno_omim	QUAL=8668;DP=226;AF=0.50;MQM=60;TRIO=HET,226,0.50,HET,189,0.56,HET,252,0.51	CLCN7	synonymous	CLCN7:ENST00000262318:synonymous:LOW:exon13/24:c.1098A>T:p.Ala366Ala,CLCN7:ENST00000448525:synonymous:LOW:exon13/24:c.1098A>T:p.Ala366Ala,CLCN7:ENST00000382745:synonymous:LOW:exon14/25:c.1170A>T:p.Ala390Ala		rs2235579	0.5559	0.5335	17293,8469,1355	0.5168,0.5826,0.6689,0.5070,0.5422	0.5339							602727 [CLCN7 (confirmed) Osteopetrosis,autosomal recessive 4,611490|Osteopetrosis,autosomal dominant 2,166600];	RCV000241746.1 [benign]; RCV000303073.1 [benign]; 		COSM3754669	544	1098					CLCN7 (inh=AR+AD pLI=0.98)
chr16	2150466	2150466	T	A	het	low_MQM;gene_blacklist;pred_pathogenic;anno_omim;anno_pathogenic_hgmd	QUAL=4004;DP=161;AF=0.43;MQM=48;TRIO=HET,161,0.43,HET,266,0.44,WT,346,0.00	PKD1	missense	PKD1:ENST00000262304:missense:MODERATE:exon27/46:c.9499A>T:p.Ile3167Phe,PKD1:ENST00000423118:missense:MODERATE:exon27/46:c.9499A>T:p.Ile3167Phe		rs139945204	0.0002	0.0011	2,2,0	0.0000,0.0002,0.0000,0.0016,0.0008	0.0029	1.3330	D,D,D	T	P,D	T,T	26.00	601313 [PKD1 (confirmed) Polycystic kidney disease,adult type I,173900];		CM022663 [CLASS=DM MUT=ALT PHEN="Polycystic kidney disease 1" GENE=PKD1]; 	COSM3754779	0	6					PKD1 (inh=AD pLI=1.00)
chr16	2160494	2160494	C	T	het	gene_blacklist;anno_omim	QUAL=4601;DP=250;AF=0.48;MQM=59;TRIO=HET,250,0.48,HET,120,0.61,WT,151,0.01	PKD1	synonymous	PKD1:ENST00000262304:synonymous:LOW:exon15/46:c.4674G>A:p.Thr1558Thr,PKD1:ENST00000423118:synonymous:LOW:exon15/46:c.4674G>A:p.Thr1558Thr		rs79884128	0.0711	0.0757	424,194,0	0.0108,0.0521,0.1838,0.0756,0.0716	0.0768							601313 [PKD1 (confirmed) Polycystic kidney disease,adult type I,173900];	RCV000249784.1 [benign]; 		COSM3754780	13	284					PKD1 (inh=AD pLI=1.00)
chr16	2164808	2164808	C	T	het	low_DP;low_MQM;gene_blacklist;anno_omim	QUAL=3112;DP=10;AF=0.30;MQM=31;TRIO=HET,10,0.30,HOM,90,1.00,HET,153,0.40	PKD1	missense	PKD1:ENST00000262304:missense:MODERATE:exon11/46:c.2216G>A:p.Arg739Gln,PKD1:ENST00000423118:missense:MODERATE:exon11/46:c.2216G>A:p.Arg739Gln		rs40433	0.9792	0.9587	4288,1221,255	0.9923,0.0000,0.0000,0.9179,0.9747	0.9750	0.0910	T,T	T	B,B	T,T	0.16	601313 [PKD1 (confirmed) Polycystic kidney disease,adult type I,173900];			COSM4128808	860	82					PKD1 (inh=AD pLI=1.00)
chr16	2167874	2167874	G	A	het	low_MQM;gene_blacklist;anno_omim	QUAL=5445;DP=78;AF=0.86;MQM=30;TRIO=HET,78,0.86,HOM,118,1.00,HET,122,0.56	PKD1	synonymous	PKD1:ENST00000262304:synonymous:LOW:exon5/46:c.1119C>T:p.Leu373Leu,PKD1:ENST00000423118:synonymous:LOW:exon5/46:c.1119C>T:p.Leu373Leu		rs35842	0.9443	0.9051	1062,323,151	0.9748,0.0000,0.0000,0.8295,0.9421	0.8967							601313 [PKD1 (confirmed) Polycystic kidney disease,adult type I,173900];			COSM4128810	513	252					PKD1 (inh=AD pLI=1.00)
chr16	2167970	2167970	G	A	het	low_DP;low_MQM;gene_blacklist;anno_omim	QUAL=615;DP=19;AF=0.37;MQM=29;TRIO=HET,19,0.37,WT,89,0.00,HET,83,0.48	PKD1	synonymous	PKD1:ENST00000262304:synonymous:LOW:exon5/46:c.1023C>T:p.Ala341Ala,PKD1:ENST00000423118:synonymous:LOW:exon5/46:c.1023C>T:p.Ala341Ala		rs11643513	0.0260	0.0273	7,3,0	0.0115,0.0000,0.0000,0.0461,0.0174	0.0496							601313 [PKD1 (confirmed) Polycystic kidney disease,adult type I,173900];	RCV000242828.1 [benign]; 			6	70					PKD1 (inh=AD pLI=1.00)
chr16	2331430	2331430	A	G	hom	anno_omim	QUAL=25801;DP=287;AF=0.99;MQM=59;TRIO=HOM,287,0.99,HOM,229,1.00,HOM,307,1.00	ABCA3	synonymous	ABCA3:ENST00000301732:synonymous:LOW:exon27/33:c.4116T>C:p.Ser1372Ser,ABCA3:ENST00000382381:synonymous:LOW:exon26/32:c.3942T>C:p.Ser1314Ser		rs149532	0.9010	0.9192	51391,27749,3132	0.7780,0.9490,0.9999,0.9128,0.9546	0.9231							601615 [ABCA3 (provisional) Surfactant metabolism dysfunction,pulmonary,3,610921];	RCV000150112.1 [benign]; 		COSM4128822	1714	376					ABCA3 (inh=AR pLI=0.00)
chr16	2348528	2348528	G	C	het	anno_omim	QUAL=2519;DP=121;AF=0.43;MQM=60;TRIO=HET,121,0.43,HET,139,0.42,WT,204,0.00	ABCA3	synonymous	ABCA3:ENST00000301732:synonymous:LOW:exon15/33:c.1755C>G:p.Pro585Pro,ABCA3:ENST00000382381:synonymous:LOW:exon14/32:c.1581C>G:p.Pro527Pro		rs323043	0.0817	0.1434	1572,1299,28	0.0671,0.0650,0.0250,0.1948,0.0773	0.1420							601615 [ABCA3 (provisional) Surfactant metabolism dysfunction,pulmonary,3,610921];	RCV000155454.1 [benign]; RCV000365741.1 [likely benign]; 		COSM3754801	59	577					ABCA3 (inh=AR pLI=0.00)
chr16	2551147	2551147	C	T	het	anno_omim	QUAL=4290;DP=179;AF=0.48;MQM=59;TRIO=HET,179,0.48,HET,195,0.48,WT,223,0.00	TBC1D24,RP11-20I23.1	3'UTR	TBC1D24:ENST00000293970:3'UTR:MODIFIER:exon8/8:c.*188C>T:,TBC1D24:ENST00000567020:3'UTR:MODIFIER:exon7/7:c.*188C>T:,TBC1D24:ENST00000434757:3'UTR:MODIFIER:exon7/7:c.*188C>T:		rs62040717	0.0284	0.0000	0,0,0	0,0,0,0,0	0.0700							613577 [TBC1D24 (provisional) Myoclonic epilepsy,infantile,familial,605021|Epileptic encephalopathy,early infantile,16,615338|DOOR syndrome,220500|Deafness,autosomal recessive 86,614617|Deafness,autosomal dominant 65,616044];	RCV000403871.1 [likely benign]; 			2	45					TBC1D24 (inh=AR pLI=0.00), RP11-20I23.1 (inh=n/a pLI=n/a)
chr16	3292398	3292398	A	G	het	low_MQM;anno_omim	QUAL=300;DP=20;AF=0.60;MQM=45;TRIO=HET,20,0.60,HOM,3,1.00,WT,4,0.00	MEFV	3'UTR	MEFV:ENST00000219596:3'UTR:MODIFIER:exon10/10:c.*743T>C:,MEFV:ENST00000339854:3'UTR:MODIFIER:exon10/10:c.*743T>C:	AluSx	rs170387	0.6943	0.0000	0,0,0	0,0,0,0,0	0.6305							608107 [MEFV (confirmed) Familial Mediterranean fever,AR,249100|Familial Mediterranean fever,AD,134610];	RCV000293660.1 [likely benign]; 			40	55					MEFV (inh=AR+AD pLI=0.00)
chr16	3292666	3292666	T	C	het	anno_omim	QUAL=7979;DP=149;AF=0.42;MQM=55;TRIO=HET,149,0.42,HOM,222,1.00,WT,239,0.00	MEFV	3'UTR	MEFV:ENST00000219596:3'UTR:MODIFIER:exon10/10:c.*475A>G:,MEFV:ENST00000339854:3'UTR:MODIFIER:exon10/10:c.*475A>G:	AluSx	rs11466052	0.6514	0.0000	0,0,0	0,0,0,0,0	0.5941							608107 [MEFV (confirmed) Familial Mediterranean fever,AR,249100|Familial Mediterranean fever,AD,134610];	RCV000291003.1 [likely benign]; 			56	105					MEFV (inh=AR+AD pLI=0.00)
chr16	3292667	3292667	G	C	het	anno_omim	QUAL=7979;DP=149;AF=0.42;MQM=55;TRIO=HET,149,0.42,HOM,222,1.00,WT,239,0.00	MEFV	3'UTR	MEFV:ENST00000219596:3'UTR:MODIFIER:exon10/10:c.*474C>G:,MEFV:ENST00000339854:3'UTR:MODIFIER:exon10/10:c.*474C>G:	AluSx	rs11466051	0.6512	0.0000	0,0,0	0,0,0,0,0	0.5928							608107 [MEFV (confirmed) Familial Mediterranean fever,AR,249100|Familial Mediterranean fever,AD,134610];	RCV000345914.1 [likely benign]; 			56	105					MEFV (inh=AR+AD pLI=0.00)
chr16	3292673	3292675	AAA	-	hom	anno_omim	QUAL=3946;DP=86;AF=0.45;MQM=57;TRIO=HOM,86,0.45,HOM,179,0.75,WT,157,0.01	MEFV	3'UTR	MEFV:ENST00000219596:3'UTR:MODIFIER:exon10/10:c.*466_*468delTTT:,MEFV:ENST00000339854:3'UTR:MODIFIER:exon10/10:c.*466_*468delTTT:	AluSx	rs61379197;rs796294754	0.6571	0.0000	0,0,0	0,0,0,0,0	0.6015							608107 [MEFV (confirmed) Familial Mediterranean fever,AR,249100|Familial Mediterranean fever,AD,134610];	RCV000301778.1 [likely benign]; 			89	45					MEFV (inh=AR+AD pLI=0.00)
chr16	3292874	3292874	C	T	het	anno_omim	QUAL=15013;DP=229;AF=0.56;MQM=60;TRIO=HET,229,0.56,HOM,376,1.00,WT,432,0.00	MEFV	3'UTR	MEFV:ENST00000219596:3'UTR:MODIFIER:exon10/10:c.*267G>A:,MEFV:ENST00000339854:3'UTR:MODIFIER:exon10/10:c.*267G>A:		rs2741918	0.6462	0.0000	0,0,0	0,0,0,0,0	0.5878							608107 [MEFV (confirmed) Familial Mediterranean fever,AR,249100|Familial Mediterranean fever,AD,134610];	RCV000209906.2 [likely benign]; 			54	117					MEFV (inh=AR+AD pLI=0.00)
chr16	3292896	3292896	C	T	het	anno_omim	QUAL=16212;DP=303;AF=0.55;MQM=60;TRIO=HET,303,0.55,HOM,374,1.00,WT,401,0.00	MEFV	3'UTR	MEFV:ENST00000219596:3'UTR:MODIFIER:exon10/10:c.*245G>A:,MEFV:ENST00000339854:3'UTR:MODIFIER:exon10/10:c.*245G>A:		rs2741919	0.6398	0.0000	0,0,0	0,0,0,0,0	0.5832							608107 [MEFV (confirmed) Familial Mediterranean fever,AR,249100|Familial Mediterranean fever,AD,134610];	RCV000209870.2 [likely benign]; 			54	117					MEFV (inh=AR+AD pLI=0.00)
chr16	3293888	3293888	C	T	het	anno_omim	QUAL=16280;DP=300;AF=0.51;MQM=59;TRIO=HET,300,0.51,WT,327,0.00,HOM,384,1.00	MEFV	missense,synonymous	MEFV:ENST00000541159:missense:MODERATE:exon8/9:c.1306G>A:p.Gly436Arg,MEFV:ENST00000219596:synonymous:LOW:exon9/10:c.1764G>A:p.Pro588Pro,MEFV:ENST00000339854:synonymous:LOW:exon9/10:c.1224G>A:p.Pro408Pro,MEFV:ENST00000536379:synonymous:LOW:exon8/9:c.1131G>A:p.Pro377Pro		rs1231122	0.3536	0.3967	9774,6909,594	0.3415,0.2552,0.3838,0.4578,0.2715	0.4125	0.1690	T	T		T	9.74	608107 [MEFV (confirmed) Familial Mediterranean fever,AR,249100|Familial Mediterranean fever,AD,134610];	RCV000030177.2 [benign]; RCV000266471.1 [benign]; 		COSM3754866, COSM3754867	461	1005					MEFV (inh=AR+AD pLI=0.00)
chr16	3293922	3293922	A	T	het	pred_pathogenic;anno_omim	QUAL=17940;DP=303;AF=0.54;MQM=60;TRIO=HET,303,0.54,WT,365,0.00,HOM,434,1.00	MEFV	missense,intron	MEFV:ENST00000541159:missense:MODERATE:exon8/9:c.1272T>A:p.Asp424Glu,MEFV:ENST00000219596:intron:MODIFIER:exon8/9:c.1760-30T>A:,MEFV:ENST00000339854:intron:MODIFIER:exon8/9:c.1220-30T>A:,MEFV:ENST00000536379:intron:MODIFIER:exon7/8:c.1127-30T>A:		rs1231123	0.3113	0.3949	8787,6520,449	0.3163,0.2706,0.2943,0.4651,0.2671	0.3936	-0.0680	D	T		T	1.92	608107 [MEFV (confirmed) Familial Mediterranean fever,AR,249100|Familial Mediterranean fever,AD,134610];				444	1000					MEFV (inh=AR+AD pLI=0.00)
chr16	3297073	3297073	A	G	het	anno_omim	QUAL=11631;DP=147;AF=0.47;MQM=60;TRIO=HET,147,0.47,HOM,323,1.00,WT,366,0.01	MEFV	synonymous	MEFV:ENST00000219596:synonymous:LOW:exon5/10:c.1530T>C:p.Asp510Asp,MEFV:ENST00000339854:synonymous:LOW:exon5/10:c.990T>C:p.Asp330Asp,MEFV:ENST00000536379:synonymous:LOW:exon4/9:c.897T>C:p.Asp299Asp,MEFV:ENST00000541159:synonymous:LOW:exon4/9:c.897T>C:p.Asp299Asp		rs224206	0.6631	0.6104	23159,9953,2456	0.6864,0.7507,0.6519,0.5436,0.7317	0.6121							608107 [MEFV (confirmed) Familial Mediterranean fever,AR,249100|Familial Mediterranean fever,AD,134610];	RCV000030175.2 [other]; RCV000254381.1 [benign]; 			651	1007					MEFV (inh=AR+AD pLI=0.00)
chr16	3297175	3297175	T	C	het	anno_omim	QUAL=13298;DP=280;AF=0.51;MQM=59;TRIO=HET,280,0.51,HOM,315,1.00,WT,376,0.01	MEFV	synonymous	MEFV:ENST00000219596:synonymous:LOW:exon5/10:c.1428A>G:p.Gln476Gln,MEFV:ENST00000339854:synonymous:LOW:exon5/10:c.888A>G:p.Gln296Gln,MEFV:ENST00000536379:synonymous:LOW:exon4/9:c.795A>G:p.Gln265Gln,MEFV:ENST00000541159:synonymous:LOW:exon4/9:c.795A>G:p.Gln265Gln		rs224207	0.6506	0.6057	22800,9899,2177	0.6442,0.7479,0.6527,0.5421,0.7312	0.6082							608107 [MEFV (confirmed) Familial Mediterranean fever,AR,249100|Familial Mediterranean fever,AD,134610];	RCV000244842.1 [benign]; RCV000399975.1 [likely benign]; 			647	1007					MEFV (inh=AR+AD pLI=0.00)
chr16	3297181	3297181	C	T	het	anno_omim	QUAL=12085;DP=249;AF=0.50;MQM=59;TRIO=HET,249,0.50,HOM,303,1.00,WT,361,0.01	MEFV	synonymous	MEFV:ENST00000219596:synonymous:LOW:exon5/10:c.1422G>A:p.Glu474Glu,MEFV:ENST00000339854:synonymous:LOW:exon5/10:c.882G>A:p.Glu294Glu,MEFV:ENST00000536379:synonymous:LOW:exon4/9:c.789G>A:p.Glu263Glu,MEFV:ENST00000541159:synonymous:LOW:exon4/9:c.789G>A:p.Glu263Glu		rs224208	0.6390	0.6027	22578,9895,2139	0.6387,0.7478,0.6186,0.5420,0.7308	0.6052							608107 [MEFV (confirmed) Familial Mediterranean fever,AR,249100|Familial Mediterranean fever,AD,134610];	RCV000030172.2 [other]; RCV000253062.1 [benign]; 			645	1005					MEFV (inh=AR+AD pLI=0.00)
chr16	3299749	3299749	G	A	het	anno_omim	QUAL=2449;DP=86;AF=0.52;MQM=59;TRIO=HET,86,0.52,HOM,57,0.98,WT,59,0.00	MEFV	synonymous	MEFV:ENST00000219596:synonymous:LOW:exon3/10:c.942C>T:p.Arg314Arg,MEFV:ENST00000339854:synonymous:LOW:exon3/10:c.402C>T:p.Arg134Arg,MEFV:ENST00000536379:synonymous:LOW:exon2/9:c.309C>T:p.Arg103Arg,MEFV:ENST00000541159:synonymous:LOW:exon2/9:c.309C>T:p.Arg103Arg		rs224213	0.6907	0.6283	24123,10133,2666	0.7181,0.7590,0.7168,0.5543,0.7455	0.6281							608107 [MEFV (confirmed) Familial Mediterranean fever,AR,249100|Familial Mediterranean fever,AD,134610];	RCV000030188.2 [other]; RCV000243663.1 [benign]; 		COSM3754869, COSM3754868	682	976					MEFV (inh=AR+AD pLI=0.00)
chr16	3304573	3304573	G	T	hom	anno_omim	QUAL=2511;DP=56;AF=0.98;MQM=59;TRIO=HOM,56,0.98,HOM,21,1.00,HET,35,0.57	MEFV	synonymous,intron	MEFV:ENST00000219596:synonymous:LOW:exon2/10:c.495C>A:p.Ala165Ala,MEFV:ENST00000339854:intron:MODIFIER:exon1/9:c.277+1738C>A:,MEFV:ENST00000536379:intron:MODIFIER:exon1/8:c.277+1738C>A:,MEFV:ENST00000541159:intron:MODIFIER:exon1/8:c.277+1738C>A:		rs224223	0.3864	0.4907	6129,3819,562	0.5664,0.6768,0.2677,0.5589,0.2297	0.4783							608107 [MEFV (confirmed) Familial Mediterranean fever,AR,249100|Familial Mediterranean fever,AD,134610];	RCV000030184.2 [other]; RCV000242316.2 [benign]; 		COSM1128970	403	968					MEFV (inh=AR+AD pLI=0.00)
chr16	3304654	3304654	T	C	hom	low_DP;anno_omim	QUAL=937;DP=7;AF=1.00;MQM=59;TRIO=HOM,7,1.00,HOM,10,1.00,HET,31,0.68	MEFV	synonymous,intron	MEFV:ENST00000219596:synonymous:LOW:exon2/10:c.414A>G:p.Gly138Gly,MEFV:ENST00000339854:intron:MODIFIER:exon1/9:c.277+1657A>G:,MEFV:ENST00000536379:intron:MODIFIER:exon1/8:c.277+1657A>G:,MEFV:ENST00000541159:intron:MODIFIER:exon1/8:c.277+1657A>G:		rs224224	0.3866	0.4375	11379,6808,1066	0.5120,0.6191,0.1634,0.4853,0.2016	0.4790							608107 [MEFV (confirmed) Familial Mediterranean fever,AR,249100|Familial Mediterranean fever,AD,134610];	RCV000030183.2 [other]; RCV000126740.3 [benign]; 		COSM3754870	397	952					MEFV (inh=AR+AD pLI=0.00)
chr16	3304762	3304762	A	G	hom	anno_omim	QUAL=984;DP=25;AF=1.00;MQM=59;TRIO=HOM,25,1.00,HOM,3,1.00,HET,10,0.90	MEFV	synonymous,intron	MEFV:ENST00000219596:synonymous:LOW:exon2/10:c.306T>C:p.Asp102Asp,MEFV:ENST00000339854:intron:MODIFIER:exon1/9:c.277+1549T>C:,MEFV:ENST00000536379:intron:MODIFIER:exon1/8:c.277+1549T>C:,MEFV:ENST00000541159:intron:MODIFIER:exon1/8:c.277+1549T>C:		rs224225	0.3894	0.4382	12231,7333,1175	0.5094,0.6166,0.1601,0.4812,0.2154	0.4794							608107 [MEFV (confirmed) Familial Mediterranean fever,AR,249100|Familial Mediterranean fever,AD,134610];	RCV000030182.2 [other]; RCV000242621.2 [benign]; 		COSM435205	405	957					MEFV (inh=AR+AD pLI=0.00)
chr16	3775717	3775717	C	T	hom	anno_omim	QUAL=17917;DP=271;AF=1.00;MQM=59;TRIO=HOM,271,1.00,HOM,117,1.00,HOM,162,1.00	CREBBP	3'UTR	CREBBP:ENST00000262367:3'UTR:MODIFIER:exon31/31:c.*2002G>A:		rs1635400	0.9808	0.0000	0,0,0	0,0,0,0,0	0.9825							600140 [CREBBP (confirmed) Rubinstein-Taybi syndrome 1,180849];				229	3					CREBBP (inh=AD pLI=1.00)
chr16	3776414	3776426	CGCCCACCTCAGT	-	het	anno_omim	QUAL=10255;DP=92;AF=0.96;MQM=59;TRIO=HET,92,0.96,HET,188,0.96,HET,294,0.98	CREBBP	3'UTR	CREBBP:ENST00000262367:3'UTR:MODIFIER:exon31/31:c.*1293_*1305delACTGAGGTGGGCG:		rs113182995	0.9790	0.0000	0,0,0	0,0,0,0,0	0.9809							600140 [CREBBP (confirmed) Rubinstein-Taybi syndrome 1,180849];				47	191					CREBBP (inh=AD pLI=1.00)
chr16	5132636	5132636	C	T	hom	anno_omim	QUAL=15311;DP=188;AF=0.99;MQM=57;TRIO=HOM,188,0.99,HET,348,0.54,HET,412,0.47	ALG1	synonymous	ALG1:ENST00000262374:synonymous:LOW:exon11/13:c.1149C>T:p.Phe383Phe,ALG1:ENST00000588623:synonymous:LOW:exon12/14:c.816C>T:p.Phe272Phe,ALG1:ENST00000544428:synonymous:LOW:exon11/13:c.816C>T:p.Phe272Phe		rs1047732	0.5198	0.5243	17005,8740,793	0.3984,0.3896,0.6489,0.5134,0.6589	0.5213							605907 [ALG1 (provisional) Congenital disorder of glycosylation,type Ik,608540];	RCV000081982.5 [benign]; 		COSM3754927	524	849					ALG1 (inh=AR pLI=0.00)
chr16	5135380	5135380	A	G	hom	low_MQM;anno_omim	QUAL=15810;DP=317;AF=0.99;MQM=47;TRIO=HOM,317,0.99,HET,193,0.58,HET,259,0.47	ALG1,FAM86A	3'UTR	ALG1:ENST00000262374:3'UTR:MODIFIER:exon13/13:c.*498A>G:,FAM86A:ENST00000427587:3'UTR:MODIFIER:exon8/8:c.*253T>C:,ALG1:ENST00000588623:3'UTR:MODIFIER:exon14/14:c.*498A>G:,FAM86A:ENST00000458008:3'UTR:MODIFIER:exon7/7:c.*253T>C:		rs6775	0.5595	0.0000	0,0,0	0,0,0,0,0	0.5531							605907 [ALG1 (provisional) Congenital disorder of glycosylation,type Ik,608540];				49	84					ALG1 (inh=AR pLI=0.00), EEF2KMT (inh=n/a pLI=0.00)
chr16	5135947	5135947	C	G	hom	anno_omim	QUAL=11357;DP=187;AF=0.99;MQM=56;TRIO=HOM,187,0.99,HET,168,0.56,HET,250,0.51	FAM86A,ALG1	intron	FAM86A:ENST00000427587:intron:MODIFIER:exon7/7:c.893-214G>C:,FAM86A:ENST00000458008:intron:MODIFIER:exon6/6:c.791-214G>C:,FAM86A:ENST00000587133:intron:MODIFIER:exon5/5:c.710-214G>C:		rs4483845	0.5687	0.0000	0,0,0	0,0,0,0,0	0.5627							605907 [ALG1 (provisional) Congenital disorder of glycosylation,type Ik,608540];				75	111					EEF2KMT (inh=n/a pLI=0.00), ALG1 (inh=AR pLI=0.00)
chr16	5135979	5135979	T	C	hom	anno_omim	QUAL=20920;DP=235;AF=0.99;MQM=59;TRIO=HOM,235,0.99,HOM,173,0.99,HOM,260,1.00	FAM86A,ALG1	intron	FAM86A:ENST00000427587:intron:MODIFIER:exon7/7:c.893-246A>G:,FAM86A:ENST00000458008:intron:MODIFIER:exon6/6:c.791-246A>G:,FAM86A:ENST00000587133:intron:MODIFIER:exon5/5:c.710-246A>G:		rs4238853	0.9852	0.0000	0,0,0	0,0,0,0,0	0.9886							605907 [ALG1 (provisional) Congenital disorder of glycosylation,type Ik,608540];				232	0					EEF2KMT (inh=n/a pLI=0.00), ALG1 (inh=AR pLI=0.00)
chr16	5136320	5136320	G	A	hom	anno_omim	QUAL=8497;DP=112;AF=1.00;MQM=54;TRIO=HOM,112,1.00,HOM,84,1.00,HOM,101,1.00	FAM86A,ALG1	intron	FAM86A:ENST00000427587:intron:MODIFIER:exon7/7:c.893-587C>T:,FAM86A:ENST00000458008:intron:MODIFIER:exon6/6:c.791-587C>T:,FAM86A:ENST00000587133:intron:MODIFIER:exon5/5:c.710-587C>T:	AluSz	rs12922304	0.9599	0.0000	0,0,0	0,0,0,0,0	0.9666							605907 [ALG1 (provisional) Congenital disorder of glycosylation,type Ik,608540];				180	0					EEF2KMT (inh=n/a pLI=0.00), ALG1 (inh=AR pLI=0.00)
chr16	5136336	5136339	AAAA	-	hom	anno_omim	QUAL=3060;DP=81;AF=0.72;MQM=58;TRIO=HOM,81,0.72,HOM,55,0.67,HOM,68,0.50	FAM86A,ALG1	intron	FAM86A:ENST00000427587:intron:MODIFIER:exon7/7:c.893-606_893-603delTTTT:,FAM86A:ENST00000458008:intron:MODIFIER:exon6/6:c.791-606_791-603delTTTT:,FAM86A:ENST00000587133:intron:MODIFIER:exon5/5:c.710-606_710-603delTTTT:	AluSz	rs556079793	0.7480	0.0000	0,0,0	0,0,0,0,0	0.5544							605907 [ALG1 (provisional) Congenital disorder of glycosylation,type Ik,608540];				108	4					EEF2KMT (inh=n/a pLI=0.00), ALG1 (inh=AR pLI=0.00)
chr16	5136900	5136900	C	A	hom	anno_omim	QUAL=18076;DP=162;AF=1.00;MQM=56;TRIO=HOM,162,1.00,HOM,163,1.00,HOM,253,1.00	FAM86A,ALG1	intron	FAM86A:ENST00000427587:intron:MODIFIER:exon7/7:c.893-1167G>T:,FAM86A:ENST00000458008:intron:MODIFIER:exon6/6:c.791-1167G>T:,FAM86A:ENST00000587133:intron:MODIFIER:exon5/5:c.710-1167G>T:	AluSg	rs4786595	0.9599	0.0000	0,0,0	0,0,0,0,0	0.9680							605907 [ALG1 (provisional) Congenital disorder of glycosylation,type Ik,608540];				232	0					EEF2KMT (inh=n/a pLI=0.00), ALG1 (inh=AR pLI=0.00)
chr16	5136901	5136901	C	G	hom	anno_omim	QUAL=18076;DP=162;AF=1.00;MQM=56;TRIO=HOM,162,1.00,HOM,163,1.00,HOM,253,1.00	FAM86A,ALG1	intron	FAM86A:ENST00000427587:intron:MODIFIER:exon7/7:c.893-1168G>C:,FAM86A:ENST00000458008:intron:MODIFIER:exon6/6:c.791-1168G>C:,FAM86A:ENST00000587133:intron:MODIFIER:exon5/5:c.710-1168G>C:	AluSg	rs4786596	0.9599	0.0000	0,0,0	0,0,0,0,0	0.9682							605907 [ALG1 (provisional) Congenital disorder of glycosylation,type Ik,608540];				232	0					EEF2KMT (inh=n/a pLI=0.00), ALG1 (inh=AR pLI=0.00)
chr16	5137069	5137069	C	G	hom	anno_omim	QUAL=15265;DP=262;AF=1.00;MQM=58;TRIO=HOM,262,1.00,HET,233,0.48,HET,279,0.51	FAM86A,ALG1	intron	FAM86A:ENST00000427587:intron:MODIFIER:exon7/7:c.893-1336G>C:,FAM86A:ENST00000458008:intron:MODIFIER:exon6/6:c.791-1336G>C:,FAM86A:ENST00000587133:intron:MODIFIER:exon5/5:c.710-1336G>C:		rs12928220	0.3704	0.0000	0,0,0	0,0,0,0,0	0.3743							605907 [ALG1 (provisional) Congenital disorder of glycosylation,type Ik,608540];				47	109					EEF2KMT (inh=n/a pLI=0.00), ALG1 (inh=AR pLI=0.00)
chr16	5137285	5137285	A	G	hom	anno_omim	QUAL=30180;DP=441;AF=1.00;MQM=59;TRIO=HOM,441,1.00,HOM,218,1.00,HOM,260,1.00	FAM86A,ALG1	intron	FAM86A:ENST00000427587:intron:MODIFIER:exon7/7:c.893-1552T>C:,FAM86A:ENST00000458008:intron:MODIFIER:exon6/6:c.791-1552T>C:,FAM86A:ENST00000587133:intron:MODIFIER:exon5/5:c.710-1552T>C:		rs4786597	0.9619	0.0000	0,0,0	0,0,0,0,0	0.9689							605907 [ALG1 (provisional) Congenital disorder of glycosylation,type Ik,608540];				232	0					EEF2KMT (inh=n/a pLI=0.00), ALG1 (inh=AR pLI=0.00)
chr16	8873456	8873456	T	C	het	anno_omim	QUAL=8502;DP=151;AF=0.49;MQM=60;TRIO=HET,151,0.49,HET,267,0.51,HET,324,0.44	ABAT	splice_region&intron	ABAT:ENST00000567812:splice_region&intron:LOW:exon15/15:c.1426+9T>C:,ABAT:ENST00000268251:splice_region&intron:LOW:exon15/15:c.1381+9T>C:,ABAT:ENST00000396600:splice_region&intron:LOW:exon15/15:c.1381+9T>C:,ABAT:ENST00000425191:splice_region&intron:LOW:exon15/15:c.1381+9T>C:,ABAT:ENST00000569156:splice_region&intron:LOW:exon15/15:c.1381+9T>C:		rs1079348	0.3500	0.3065	5670,2655,1003	0.4429,0.2253,0.3586,0.2900,0.3437	0.3256							137150 [ABAT (provisional) GABA-transaminase deficiency,613163];	RCV000362298.1 [benign]; 			229	873					ABAT (inh=AR pLI=0.37)
chr16	8875529	8875529	G	T	het	anno_omim	QUAL=1449;DP=104;AF=0.41;MQM=59;TRIO=HET,104,0.41,HET,27,0.48,HET,24,0.46	ABAT,TMEM186	3'UTR	ABAT:ENST00000268251:3'UTR:MODIFIER:exon16/16:c.*242G>T:,ABAT:ENST00000396600:3'UTR:MODIFIER:exon16/16:c.*242G>T:		rs2270288	0.3738	0.0000	0,0,0	0,0,0,0,0	0.4065							137150 [ABAT (provisional) GABA-transaminase deficiency,613163];	RCV000264800.1 [benign]; 			59	98					ABAT (inh=AR pLI=0.37), TMEM186 (inh=n/a pLI=0.00)
chr16	8875545	8875545	G	C	het	anno_omim	QUAL=2021;DP=106;AF=0.56;MQM=60;TRIO=HET,106,0.56,HET,26,0.42,HET,17,0.65	ABAT,TMEM186	3'UTR	ABAT:ENST00000268251:3'UTR:MODIFIER:exon16/16:c.*258G>C:,ABAT:ENST00000396600:3'UTR:MODIFIER:exon16/16:c.*258G>C:		rs737695	0.3239	0.0000	0,0,0	0,0,0,0,0	0.3238							137150 [ABAT (provisional) GABA-transaminase deficiency,613163];	RCV000374511.1 [benign]; 			23	94					ABAT (inh=AR pLI=0.37), TMEM186 (inh=n/a pLI=0.00)
chr16	8875763	8875763	T	C	het	anno_omim	QUAL=2513;DP=75;AF=0.60;MQM=59;TRIO=HET,75,0.60,HET,58,0.47,HET,77,0.40	ABAT,TMEM186	3'UTR	ABAT:ENST00000268251:3'UTR:MODIFIER:exon16/16:c.*476T>C:,ABAT:ENST00000396600:3'UTR:MODIFIER:exon16/16:c.*476T>C:		rs1731071	0.3902	0.0000	0,0,0	0,0,0,0,0	0.3745							137150 [ABAT (provisional) GABA-transaminase deficiency,613163];	RCV000350077.1 [benign]; 			28	96					ABAT (inh=AR pLI=0.37), TMEM186 (inh=n/a pLI=0.00)
chr16	8875799	8875799	G	A	het	anno_omim	QUAL=3906;DP=112;AF=0.46;MQM=60;TRIO=HET,112,0.46,HET,76,0.51,HET,106,0.65	ABAT,TMEM186	3'UTR	ABAT:ENST00000268251:3'UTR:MODIFIER:exon16/16:c.*512G>A:,ABAT:ENST00000396600:3'UTR:MODIFIER:exon16/16:c.*512G>A:		rs3743798	0.3712	0.0000	0,0,0	0,0,0,0,0	0.3995							137150 [ABAT (provisional) GABA-transaminase deficiency,613163];	RCV000345259.1 [benign]; 			60	98					ABAT (inh=AR pLI=0.37), TMEM186 (inh=n/a pLI=0.00)
chr16	8875858	8875858	A	C	het	anno_omim	QUAL=5088;DP=222;AF=0.44;MQM=60;TRIO=HET,222,0.44,HET,100,0.44,HET,149,0.42	ABAT,TMEM186	3'UTR	ABAT:ENST00000268251:3'UTR:MODIFIER:exon16/16:c.*571A>C:,ABAT:ENST00000396600:3'UTR:MODIFIER:exon16/16:c.*571A>C:		rs1641031	0.3928	0.0000	0,0,0	0,0,0,0,0	0.3715							137150 [ABAT (provisional) GABA-transaminase deficiency,613163];	RCV000392956.1 [benign]; 			28	94					ABAT (inh=AR pLI=0.37), TMEM186 (inh=n/a pLI=0.00)
chr16	8875861	8875861	A	G	het	anno_omim	QUAL=5088;DP=222;AF=0.44;MQM=60;TRIO=HET,222,0.44,HET,100,0.44,HET,149,0.42	ABAT,TMEM186	3'UTR	ABAT:ENST00000268251:3'UTR:MODIFIER:exon16/16:c.*574A>G:,ABAT:ENST00000396600:3'UTR:MODIFIER:exon16/16:c.*574A>G:		rs1641032	0.3932	0.0000	0,0,0	0,0,0,0,0	0.3719							137150 [ABAT (provisional) GABA-transaminase deficiency,613163];	RCV000305624.1 [benign]; 			28	94					ABAT (inh=AR pLI=0.37), TMEM186 (inh=n/a pLI=0.00)
chr16	8876202	8876202	C	G	het	anno_omim	QUAL=11629;DP=319;AF=0.54;MQM=59;TRIO=HET,319,0.54,HET,247,0.49,HET,341,0.45	ABAT,TMEM186	3'UTR	ABAT:ENST00000268251:3'UTR:MODIFIER:exon16/16:c.*915C>G:,ABAT:ENST00000396600:3'UTR:MODIFIER:exon16/16:c.*915C>G:		rs3743801	0.3850	0.0000	0,0,0	0,0,0,0,0	0.4156							137150 [ABAT (provisional) GABA-transaminase deficiency,613163];	RCV000360321.1 [benign]; 			61	95					ABAT (inh=AR pLI=0.37), TMEM186 (inh=n/a pLI=0.00)
chr16	8876277	8876277	G	C	het	anno_omim	QUAL=12284;DP=302;AF=0.52;MQM=60;TRIO=HET,302,0.52,HET,298,0.47,HET,371,0.48	ABAT,TMEM186	3'UTR	ABAT:ENST00000268251:3'UTR:MODIFIER:exon16/16:c.*990G>C:,ABAT:ENST00000396600:3'UTR:MODIFIER:exon16/16:c.*990G>C:		rs4985000	0.6064	0.0000	0,0,0	0,0,0,0,0	0.6243							137150 [ABAT (provisional) GABA-transaminase deficiency,613163];	RCV000302021.1 [benign]; 			111	92					ABAT (inh=AR pLI=0.37), TMEM186 (inh=n/a pLI=0.00)
chr16	8876418	8876418	G	A	het	anno_omim	QUAL=15828;DP=375;AF=0.50;MQM=59;TRIO=HET,375,0.50,HET,337,0.48,HET,463,0.53	ABAT,TMEM186	3'UTR	ABAT:ENST00000268251:3'UTR:MODIFIER:exon16/16:c.*1131G>A:,ABAT:ENST00000396600:3'UTR:MODIFIER:exon16/16:c.*1131G>A:		rs7205816	0.5503	0.0000	0,0,0	0,0,0,0,0	0.5493							137150 [ABAT (provisional) GABA-transaminase deficiency,613163];	RCV000261569.1 [benign]; 			91	101					ABAT (inh=AR pLI=0.37), TMEM186 (inh=n/a pLI=0.00)
chr16	8876692	8876692	C	T	het	anno_omim	QUAL=15445;DP=462;AF=0.50;MQM=60;TRIO=HET,462,0.50,HET,301,0.51,HET,329,0.57	ABAT,TMEM186	3'UTR	ABAT:ENST00000268251:3'UTR:MODIFIER:exon16/16:c.*1405C>T:,ABAT:ENST00000396600:3'UTR:MODIFIER:exon16/16:c.*1405C>T:		rs7201586	0.2788	0.0000	0,0,0	0,0,0,0,0	0.2791							137150 [ABAT (provisional) GABA-transaminase deficiency,613163];	RCV000329279.1 [benign]; 			12	86					ABAT (inh=AR pLI=0.37), TMEM186 (inh=n/a pLI=0.00)
chr16	8876880	8876880	T	A	het	anno_omim	QUAL=11397;DP=249;AF=0.47;MQM=60;TRIO=HET,249,0.47,HET,251,0.55,HET,337,0.51	ABAT,TMEM186	3'UTR	ABAT:ENST00000268251:3'UTR:MODIFIER:exon16/16:c.*1593T>A:,ABAT:ENST00000396600:3'UTR:MODIFIER:exon16/16:c.*1593T>A:		rs1061842	0.3862	0.0000	0,0,0	0,0,0,0,0	0.4160							137150 [ABAT (provisional) GABA-transaminase deficiency,613163];	RCV000301413.1 [benign]; 			58	99					ABAT (inh=AR pLI=0.37), TMEM186 (inh=n/a pLI=0.00)
chr16	8877220	8877220	T	C	hom	anno_omim	QUAL=45031;DP=367;AF=1.00;MQM=60;TRIO=HOM,367,1.00,HOM,484,1.00,HOM,532,1.00	ABAT,TMEM186	3'UTR	ABAT:ENST00000268251:3'UTR:MODIFIER:exon16/16:c.*1933T>C:,ABAT:ENST00000396600:3'UTR:MODIFIER:exon16/16:c.*1933T>C:	L2c	rs4985036	0.9081	0.0000	0,0,0	0,0,0,0,0	0.9272							137150 [ABAT (provisional) GABA-transaminase deficiency,613163];	RCV000271048.1 [benign]; 			178	18					ABAT (inh=AR pLI=0.37), TMEM186 (inh=n/a pLI=0.00)
chr16	8877401	8877401	G	A	het	anno_omim	QUAL=18966;DP=423;AF=0.52;MQM=60;TRIO=HET,423,0.52,HET,432,0.50,HET,516,0.52	ABAT,TMEM186	3'UTR	ABAT:ENST00000268251:3'UTR:MODIFIER:exon16/16:c.*2114G>A:,ABAT:ENST00000396600:3'UTR:MODIFIER:exon16/16:c.*2114G>A:		rs11648372	0.6068	0.0000	0,0,0	0,0,0,0,0	0.6251							137150 [ABAT (provisional) GABA-transaminase deficiency,613163];	RCV000377409.1 [benign]; 			109	87					ABAT (inh=AR pLI=0.37), TMEM186 (inh=n/a pLI=0.00)
chr16	8877854	8877854	C	G	het	anno_omim	QUAL=5980;DP=248;AF=0.45;MQM=59;TRIO=HET,248,0.45,HET,95,0.45,HET,141,0.53	ABAT,TMEM186	3'UTR	ABAT:ENST00000268251:3'UTR:MODIFIER:exon16/16:c.*2567C>G:,ABAT:ENST00000396600:3'UTR:MODIFIER:exon16/16:c.*2567C>G:		rs12597124	0.6054	0.0000	0,0,0	0,0,0,0,0	0.6251							137150 [ABAT (provisional) GABA-transaminase deficiency,613163];	RCV000398947.1 [benign]; 			111	92					ABAT (inh=AR pLI=0.37), TMEM186 (inh=n/a pLI=0.00)
chr16	8900241	8900241	G	A	het	anno_omim	QUAL=540;DP=33;AF=0.55;MQM=60;TRIO=HET,33,0.55,WT,7,0.00,HET,8,0.63	PMM2	synonymous,intron	PMM2:ENST00000268261:synonymous:LOW:exon4/8:c.324G>A:p.Ala108Ala,PMM2:ENST00000566983:synonymous:LOW:exon4/8:c.243G>A:p.Ala81Ala,PMM2:ENST00000539622:synonymous:LOW:exon3/7:c.75G>A:p.Ala25Ala,PMM2:ENST00000537352:intron:MODIFIER:exon2/5:c.-29+4474G>A:,PMM2:ENST00000569958:intron:MODIFIER:exon2/4:c.178+4474G>A:		rs62031146	0.0148	0.0176	40,22,0	0.0050,0.0104,0.0000,0.0200,0.0352	0.0167							601785 [PMM2 (confirmed) Congenital disorder of glycosylation,type Ia,212065];	RCV000117997.3 [other]; RCV000262546.1 [uncertain significance]; 			4	145					PMM2 (inh=AR pLI=0.00)
chr16	8941818	8941818	A	C	het	anno_omim	QUAL=2768;DP=129;AF=0.40;MQM=60;TRIO=HET,129,0.40,HET,144,0.45,WT,173,0.00	PMM2,RP11-152P23.2	3'UTR	PMM2:ENST00000268261:3'UTR:MODIFIER:exon8/8:c.*136A>C:,PMM2:ENST00000539622:3'UTR:MODIFIER:exon7/7:c.*136A>C:,PMM2:ENST00000537352:3'UTR:MODIFIER:exon6/6:c.*136A>C:,PMM2:ENST00000569958:3'UTR:MODIFIER:exon5/5:c.*136A>C:		rs2075827	0.2590	0.0000	0,0,0	0,0,0,0,0	0.2685							601785 [PMM2 (confirmed) Congenital disorder of glycosylation,type Ia,212065];	RCV000311429.1 [likely benign]; 			13	84					PMM2 (inh=AR pLI=0.00), RP11-152P23.2 (inh=n/a pLI=n/a)
chr16	8941857	8941857	G	A	het	anno_omim	QUAL=3552;DP=217;AF=0.42;MQM=59;TRIO=HET,217,0.42,HET,139,0.41,WT,164,0.00	RP11-152P23.2,PMM2	3'UTR	PMM2:ENST00000268261:3'UTR:MODIFIER:exon8/8:c.*175G>A:,PMM2:ENST00000539622:3'UTR:MODIFIER:exon7/7:c.*175G>A:,PMM2:ENST00000537352:3'UTR:MODIFIER:exon6/6:c.*175G>A:,PMM2:ENST00000569958:3'UTR:MODIFIER:exon5/5:c.*175G>A:		rs2072688	0.2694	0.0000	0,0,0	0,0,0,0,0	0.2811							601785 [PMM2 (confirmed) Congenital disorder of glycosylation,type Ia,212065];	RCV000276181.1 [likely benign]; 			13	84					RP11-152P23.2 (inh=n/a pLI=n/a), PMM2 (inh=AR pLI=0.00)
chr16	8941934	8941934	C	A	het	anno_omim	QUAL=3219;DP=85;AF=0.55;MQM=60;TRIO=HET,85,0.55,HET,70,0.61,HET,67,0.70	PMM2,RP11-152P23.2	3'UTR	PMM2:ENST00000268261:3'UTR:MODIFIER:exon8/8:c.*252C>A:		rs2075828	0.3962	0.0000	0,0,0	0,0,0,0,0	0.4113							601785 [PMM2 (confirmed) Congenital disorder of glycosylation,type Ia,212065];	RCV000326434.1 [likely benign]; 			57	109					PMM2 (inh=AR pLI=0.00), RP11-152P23.2 (inh=n/a pLI=n/a)
chr16	8942473	8942473	G	C	hom	anno_omim	QUAL=18697;DP=293;AF=0.99;MQM=59;TRIO=HOM,293,0.99,HOM,129,1.00,HOM,173,0.99	RP11-152P23.2,PMM2,RP11-77H9.2	3'UTR	PMM2:ENST00000268261:3'UTR:MODIFIER:exon8/8:c.*791G>C:		rs2437722	0.9209	0.0000	0,0,0	0,0,0,0,0	0.9389							601785 [PMM2 (confirmed) Congenital disorder of glycosylation,type Ia,212065];	RCV000390225.1 [benign]; 			201	25					RP11-152P23.2 (inh=n/a pLI=n/a), PMM2 (inh=AR pLI=0.00), RP11-77H9.2 (inh=n/a pLI=n/a)
chr16	8942679	8942679	A	G	het	anno_omim	QUAL=4064;DP=157;AF=0.59;MQM=60;TRIO=HET,157,0.59,HET,112,0.54,WT,151,0.00	PMM2,RP11-77H9.2	3'UTR	PMM2:ENST00000268261:3'UTR:MODIFIER:exon8/8:c.*997A>G:		rs1056898	0.2905	0.0000	0,0,0	0,0,0,0,0	0.2998							601785 [PMM2 (confirmed) Congenital disorder of glycosylation,type Ia,212065];	RCV000317823.1 [likely benign]; 			13	84					PMM2 (inh=AR pLI=0.00), RP11-77H9.2 (inh=n/a pLI=n/a)
chr16	9848471	9848471	T	G	hom	anno_omim	QUAL=10929;DP=200;AF=1.00;MQM=60;TRIO=HOM,200,1.00,HOM,70,1.00,HOM,59,1.00	RP11-297M9.2				rs767749	0.7506	0.0000	0,0,0	0,0,0,0,0	0.7979							138253 [GRIN2A (provisional) Epilepsy,focal,with speech disorder and with or without mental retardation,245570];	RCV000372002.1 [benign]; 			309	105					RP11-297M9.2 (inh=n/a pLI=n/a)
chr16	9850397	9850397	A	G	hom	anno_omim	QUAL=28034;DP=325;AF=0.99;MQM=59;TRIO=HOM,325,0.99,HOM,240,1.00,HOM,280,1.00	RP11-297M9.2				rs1420040	0.4233	0.0000	0,0,0	0,0,0,0,0	0.4120							138253 [GRIN2A (provisional) Epilepsy,focal,with speech disorder and with or without mental retardation,245570];	RCV000297274.1 [benign]; 			85	211					RP11-297M9.2 (inh=n/a pLI=n/a)
chr16	9850857	9850857	G	C	hom	anno_omim	QUAL=36387;DP=441;AF=0.99;MQM=60;TRIO=HOM,441,0.99,HOM,298,1.00,HOM,372,0.99	RP11-297M9.2				rs9940680	0.4163	0.0000	0,0,0	0,0,0,0,0	0.4066							138253 [GRIN2A (provisional) Epilepsy,focal,with speech disorder and with or without mental retardation,245570];	RCV000388572.1 [benign]; 			85	209					RP11-297M9.2 (inh=n/a pLI=n/a)
chr16	9850878	9850878	T	C	hom	anno_omim	QUAL=29746;DP=312;AF=0.99;MQM=59;TRIO=HOM,312,0.99,HOM,267,1.00,HOM,339,0.99	RP11-297M9.2				rs9933624	0.4173	0.0000	0,0,0	0,0,0,0,0	0.4077							138253 [GRIN2A (provisional) Epilepsy,focal,with speech disorder and with or without mental retardation,245570];	RCV000280250.1 [benign]; 			87	210					RP11-297M9.2 (inh=n/a pLI=n/a)
chr16	9851122	9851122	C	T	hom	anno_omim	QUAL=24520;DP=414;AF=1.00;MQM=60;TRIO=HOM,414,1.00,HOM,156,0.98,HOM,184,0.99	RP11-297M9.2				rs8045712	0.3676	0.0000	0,0,0	0,0,0,0,0	0.3607							138253 [GRIN2A (provisional) Epilepsy,focal,with speech disorder and with or without mental retardation,245570];	RCV000341214.1 [benign]; 			81	208					RP11-297M9.2 (inh=n/a pLI=n/a)
chr16	9851188	9851188	G	A	hom	anno_omim	QUAL=13168;DP=256;AF=1.00;MQM=59;TRIO=HOM,256,1.00,HOM,71,1.00,HOM,96,1.00	RP11-297M9.2				rs8044472	0.7522	0.0000	0,0,0	0,0,0,0,0	0.7880							138253 [GRIN2A (provisional) Epilepsy,focal,with speech disorder and with or without mental retardation,245570];	RCV000403854.1 [benign]; 			308	103					RP11-297M9.2 (inh=n/a pLI=n/a)
chr16	9854389	9854389	C	G	hom	anno_omim	QUAL=30624;DP=462;AF=0.99;MQM=59;TRIO=HOM,462,0.99,HOM,233,1.00,HOM,255,1.00	GRIN2A	3'UTR	GRIN2A:ENST00000396573:3'UTR:MODIFIER:exon14/14:c.*2617G>C:		rs62034910	0.3740	0.0000	0,0,0	0,0,0,0,0	0.3645							138253 [GRIN2A (provisional) Epilepsy,focal,with speech disorder and with or without mental retardation,245570];	RCV000355830.1 [benign]; 			80	207					GRIN2A (inh=AD pLI=1.00)
chr16	10995933	10995933	A	G	hom	pred_pathogenic;anno_omim	QUAL=12974;DP=131;AF=0.99;MQM=60;TRIO=HOM,131,0.99,HOM,114,1.00,HOM,176,1.00	CIITA	missense,intron	CIITA:ENST00000324288:missense:MODERATE:exon7/20:c.520A>G:p.Arg174Gly,CIITA:ENST00000381835:intron:MODIFIER:exon6/17:c.481+518A>G:		rs8046121	0.9872	0.9959	60198,33353,4741	0.9548,0.9980,1.0000,0.9999,0.9999	0.9965	1.7160	T,T	T	B,B	T	10.50	600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A,209920|Rheumatoid arthritis,susceptibility to,180300];			COSM4128622	2114	3					CIITA (inh=AR+AD pLI=0.00)
chr16	11000848	11000848	G	C	het	anno_omim	QUAL=1857;DP=83;AF=0.59;MQM=60;TRIO=HET,83,0.59,WT,55,0.00,HET,46,0.50	CIITA	missense,intron	CIITA:ENST00000324288:missense:MODERATE:exon11/20:c.1499G>C:p.Gly500Ala,CIITA:ENST00000381835:intron:MODIFIER:exon9/17:c.860-1992G>C:		rs4774	0.2590	0.2932	5522,2877,353	0.2685,0.4776,0.1508,0.2970,0.2616	0.2972	0.7060	T,T	T	B,B,B	T	0.01	600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A,209920|Rheumatoid arthritis,susceptibility to,180300];	RCV000378352.1 [benign]; 	CM102885 [CLASS=DP MUT=ALT PHEN="Multiple sclerosis increased risk association with" GENE=CIITA]; 	COSM434601	187	832					CIITA (inh=AR+AD pLI=0.00)
chr16	11001691	11001691	C	T	het	anno_omim	QUAL=4716;DP=154;AF=0.54;MQM=59;TRIO=HET,154,0.54,WT,194,0.00,HET,246,0.48	CIITA	missense,intron	CIITA:ENST00000324288:missense:MODERATE:exon11/20:c.2342C>T:p.Ser781Leu,CIITA:ENST00000381835:intron:MODIFIER:exon9/17:c.860-1149C>T:		rs13330686	0.0397	0.0637	277,221,5	0.0360,0.0316,0.0006,0.0835,0.0525	0.0631	-0.2870	T,T	T	B,B,B,B	T	0.02	600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A,209920|Rheumatoid arthritis,susceptibility to,180300];	RCV000361096.1 [likely benign]; 			19	316					CIITA (inh=AR+AD pLI=0.00)
chr16	11001694	11001694	T	C	het	anno_omim	QUAL=4716;DP=154;AF=0.54;MQM=59;TRIO=HET,154,0.54,WT,194,0.00,HET,246,0.48	CIITA	missense,intron	CIITA:ENST00000324288:missense:MODERATE:exon11/20:c.2345T>C:p.Val782Ala,CIITA:ENST00000381835:intron:MODIFIER:exon9/17:c.860-1146T>C:		rs13336804	0.0399	0.0638	275,219,5	0.0361,0.0316,0.0006,0.0835,0.0528	0.0631	0.4060	T,T	T	B,B,B,B	T	0.01	600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A,209920|Rheumatoid arthritis,susceptibility to,180300];	RCV000266523.1 [likely benign]; 		COSM3754601	19	315					CIITA (inh=AR+AD pLI=0.00)
chr16	11001743	11001743	G	A	het	anno_omim	QUAL=2525;DP=119;AF=0.45;MQM=59;TRIO=HET,119,0.45,HET,115,0.59,WT,141,0.00	CIITA	synonymous,intron	CIITA:ENST00000324288:synonymous:LOW:exon11/20:c.2394G>A:p.Pro798Pro,CIITA:ENST00000381835:intron:MODIFIER:exon9/17:c.860-1097G>A:		rs2229320	0.1893	0.2122	2804,1448,12	0.0515,0.1418,0.3099,0.2126,0.2956	0.2119							600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A,209920|Rheumatoid arthritis,susceptibility to,180300];	RCV000321727.1 [benign]; 		COSM3754602	102	722					CIITA (inh=AR+AD pLI=0.00)
chr16	11001914	11001914	G	A	het	anno_omim	QUAL=1853;DP=89;AF=0.51;MQM=59;TRIO=HET,89,0.51,WT,50,0.00,HET,61,0.52	CIITA	synonymous,intron	CIITA:ENST00000324288:synonymous:LOW:exon11/20:c.2565G>A:p.Ala855Ala,CIITA:ENST00000381835:intron:MODIFIER:exon9/17:c.860-926G>A:		rs2229321	0.0397	0.0758	290,232,5	0.0447,0.0397,0.0007,0.0986,0.0580	0.0636							600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A,209920|Rheumatoid arthritis,susceptibility to,180300];	RCV000382292.1 [likely benign]; 		COSM3754603	19	314					CIITA (inh=AR+AD pLI=0.00)
chr16	11002904	11002904	G	A	het	anno_omim	QUAL=16957;DP=139;AF=0.44;MQM=59;TRIO=HET,139,0.44,HOM,326,0.99,HET,451,0.49	CIITA	synonymous	CIITA:ENST00000324288:synonymous:LOW:exon12/20:c.2676G>A:p.Thr892Thr,CIITA:ENST00000381835:synonymous:LOW:exon10/18:c.924G>A:p.Thr308Thr		rs2228238	0.6631	0.6840	28826,16292,1325	0.5100,0.5000,0.8514,0.7008,0.7321	0.6821							600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A,209920|Rheumatoid arthritis,susceptibility to,180300];	RCV000388213.1 [benign]; 			1051	856					CIITA (inh=AR+AD pLI=0.00)
chr16	11002927	11002927	A	G	hom	anno_omim	QUAL=36313;DP=270;AF=1.00;MQM=59;TRIO=HOM,270,1.00,HOM,375,1.00,HOM,513,1.00	CIITA	missense	CIITA:ENST00000324288:missense:MODERATE:exon12/20:c.2699A>G:p.Gln900Arg,CIITA:ENST00000381835:missense:MODERATE:exon10/18:c.947A>G:p.Gln316Arg		rs7197779	0.9287	0.9787	58319,33286,3054	0.7671,0.9916,1.0000,0.9996,0.9979	0.9834	0.8840	T,T	T	B,B	T,T	0.50	600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A,209920|Rheumatoid arthritis,susceptibility to,180300];	RCV000292677.1 [benign]; 			2095	18					CIITA (inh=AR+AD pLI=0.00)
chr16	11016045	11016045	C	T	het	anno_omim	QUAL=5588;DP=233;AF=0.48;MQM=59;TRIO=HET,233,0.48,WT,181,0.00,HET,261,0.49	CIITA	synonymous	CIITA:ENST00000324288:synonymous:LOW:exon17/20:c.3171C>T:p.Cys1057Cys,CIITA:ENST00000381835:synonymous:LOW:exon15/18:c.1419C>T:p.Cys473Cys		rs2229322	0.1048	0.1009	674,369,22	0.0782,0.0952,0.1648,0.1016,0.0847	0.1026							600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A,209920|Rheumatoid arthritis,susceptibility to,180300];	RCV000359080.1 [likely benign]; 		COSM3754604, COSM148019	31	385					CIITA (inh=AR+AD pLI=0.00)
chr16	11018622	11018622	T	C	het	anno_omim	QUAL=5541;DP=222;AF=0.53;MQM=60;TRIO=HET,222,0.53,HET,205,0.49,WT,247,0.01	CIITA	3'UTR	CIITA:ENST00000324288:3'UTR:MODIFIER:exon20/20:c.*910T>C:		rs1139564	0.6917	0.0000	0,0,0	0,0,0,0,0	0.7250							600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A,209920|Rheumatoid arthritis,susceptibility to,180300];	RCV000315324.1 [benign]; 			148	75					CIITA (inh=AR+AD pLI=0.00)
chr16	11642242	11642242	T	C	hom	anno_omim	QUAL=14602;DP=212;AF=1.00;MQM=60;TRIO=HOM,212,1.00,HOM,152,1.00,HET,192,0.52	LITAF	3'UTR	LITAF:ENST00000571688:3'UTR:MODIFIER:exon4/4:c.*1251A>G:,LITAF:ENST00000413364:3'UTR:MODIFIER:exon5/5:c.*1376A>G:,LITAF:ENST00000339430:3'UTR:MODIFIER:exon4/4:c.*1251A>G:		rs7102	0.4105	0.4049	916,193,16	0.0000,0.0000,0.0000,0.3837,0.4087	0.3875							603795 [LITAF (confirmed) Charcot-Marie-Tooth disease,type 1C,601098];	RCV000376300.1 [benign]; 			86	304					LITAF (inh=AD pLI=0.31)
chr16	11642445	11642445	T	-	het	anno_omim	QUAL=2375;DP=287;AF=0.42;MQM=59;TRIO=HET,287,0.42,HET,122,0.49,WT,131,0.15	LITAF	3'UTR	LITAF:ENST00000571688:3'UTR:MODIFIER:exon4/4:c.*1048delA:,LITAF:ENST00000413364:3'UTR:MODIFIER:exon5/5:c.*1173delA:,LITAF:ENST00000339430:3'UTR:MODIFIER:exon4/4:c.*1048delA:	(T)n	rs71778957	0.0000	0.4720	0,0,0	0.0000,0.0000,0.0000,0.4764,0.4696	0.4668							603795 [LITAF (confirmed) Charcot-Marie-Tooth disease,type 1C,601098];				12	320					LITAF (inh=AD pLI=0.31)
chr16	11642910	11642910	-	A	hom	anno_omim	QUAL=11573;DP=211;AF=0.95;MQM=59;TRIO=HOM,211,0.95,HOM,136,0.99,HET,165,0.42	LITAF	3'UTR	LITAF:ENST00000381810:3'UTR:MODIFIER:exon5/5:c.*382dupT:,LITAF:ENST00000571688:3'UTR:MODIFIER:exon4/4:c.*582dupT:,LITAF:ENST00000413364:3'UTR:MODIFIER:exon5/5:c.*707dupT:,LITAF:ENST00000339430:3'UTR:MODIFIER:exon4/4:c.*582dupT:		rs398119229;rs71406254	0.3732	0.3354	378,99,12	0.0000,0.0000,0.0000,0.3468,0.3273	0.3703							603795 [LITAF (confirmed) Charcot-Marie-Tooth disease,type 1C,601098];	RCV000304204.1 [benign]; 			63	303					LITAF (inh=AD pLI=0.31)
chr16	11647492	11647492	T	C	het	pred_pathogenic;anno_omim	QUAL=16068;DP=339;AF=0.43;MQM=60;TRIO=HET,339,0.43,WT,392,0.00,HOM,395,1.00	LITAF	missense,5'UTR_premature_start_codon_gain,5'UTR,intron	LITAF:ENST00000381810:missense:MODERATE:exon3/5:c.274A>G:p.Ile92Val,LITAF:ENST00000571688:missense:MODERATE:exon3/4:c.274A>G:p.Ile92Val,LITAF:ENST00000413364:missense:MODERATE:exon3/5:c.274A>G:p.Ile92Val,LITAF:ENST00000339430:missense:MODERATE:exon3/4:c.274A>G:p.Ile92Val,LITAF:ENST00000570904:missense:MODERATE:exon3/4:c.274A>G:p.Ile92Val,LITAF:ENST00000576036:missense:MODERATE:exon3/4:c.274A>G:p.Ile92Val,LITAF:ENST00000574763:missense:MODERATE:exon4/5:c.274A>G:p.Ile92Val,LITAF:ENST00000571976:missense:MODERATE:exon3/3:c.274A>G:p.Ile92Val,LITAF:ENST00000572255:5'UTR_premature_start_codon_gain:LOW:exon3/4:c.-6A>G:,LITAF:ENST00000572255:5'UTR:MODIFIER:exon3/4:c.-6A>G:,LITAF:ENST00000571459:intron:MODIFIER:exon2/2:c.220+2875A>G:		rs4280262	0.1026	0.1624	1860,1469,25	0.0648,0.1345,0.0684,0.2057,0.0984	0.1664	0.2440	T,T,T	T	B,B	D,D,D	0.01	603795 [LITAF (confirmed) Charcot-Marie-Tooth disease,type 1C,601098];	RCV000398802.1 [benign]; 	CM1410967 [CLASS=DFP MUT=ALT PHEN="Charcot-Marie-Tooth disease 1a/Neuropathy with liability to pressure palsies earlier onset association with" GENE=LITAF]; 		94	627					LITAF (inh=AD pLI=0.31)
chr16	14026007	14026007	G	A	hom	anno_omim	QUAL=26920;DP=302;AF=1.00;MQM=60;TRIO=HOM,302,1.00,HOM,242,1.00,HOM,284,1.00	ERCC4,CTD-2135D7.2	splice_region&intron	ERCC4:ENST00000311895:splice_region&intron:LOW:exon5/10:c.974-7G>A:,ERCC4:ENST00000575156:splice_region&intron:LOW:exon5/5:c.974-7G>A:		rs254942	0.9465	0.9661	56802,32023,5142	0.9954,0.9717,0.7878,0.9797,0.9783	0.9716							133520 [ERCC4 (confirmed) Xeroderma pigmentosum,group F,278760|XFE progeroid syndrome,610965|Fanconi anemia,complementation group Q,615272|Xeroderma pigmentosum,type F/Cockayne syndrome,278760];	RCV000246561.1 [benign]; RCV000318579.1 [benign]; 			3322	180					ERCC4 (inh=AR pLI=0.00), CTD-2135D7.2 (inh=n/a pLI=n/a)
chr16	14041958	14041958	T	C	het	anno_omim	QUAL=8506;DP=268;AF=0.49;MQM=59;TRIO=HET,268,0.49,WT,317,0.00,HET,387,0.50	ERCC4	synonymous	ERCC4:ENST00000311895:synonymous:LOW:exon11/11:c.2505T>C:p.Ser835Ser		rs1799801	0.2412	0.2723	4606,2859,175	0.1779,0.2260,0.2353,0.2943,0.3075	0.2725							133520 [ERCC4 (confirmed) Xeroderma pigmentosum,group F,278760|XFE progeroid syndrome,610965|Fanconi anemia,complementation group Q,615272|Xeroderma pigmentosum,type F/Cockayne syndrome,278760];	RCV000116988.3 [other]; RCV000265728.1 [benign]; 			364	1415					ERCC4 (inh=AR pLI=0.00)
chr16	14042108	14042108	G	A	het	anno_omim	QUAL=13845;DP=577;AF=0.50;MQM=59;TRIO=HET,577,0.50,WT,407,0.00,HET,481,0.48	ERCC4	synonymous	ERCC4:ENST00000311895:synonymous:LOW:exon11/11:c.2655G>A:p.Thr885Thr		rs16963255	0.0046	0.0109	10,7,0	0.0024,0.0023,0.0001,0.0138,0.0054	0.0141							133520 [ERCC4 (confirmed) Xeroderma pigmentosum,group F,278760|XFE progeroid syndrome,610965|Fanconi anemia,complementation group Q,615272|Xeroderma pigmentosum,type F/Cockayne syndrome,278760];	RCV000242822.1 [benign]; RCV000384807.1 [likely benign]; 			1	100					ERCC4 (inh=AR pLI=0.00)
chr16	14042688	14042688	G	T	het	anno_omim	QUAL=10690;DP=331;AF=0.47;MQM=60;TRIO=HET,331,0.47,WT,431,0.00,HET,535,0.46	ERCC4	3'UTR	ERCC4:ENST00000311895:3'UTR:MODIFIER:exon11/11:c.*484G>T:		rs3743538	0.3496	0.0000	0,0,0	0,0,0,0,0	0.3552							133520 [ERCC4 (confirmed) Xeroderma pigmentosum,group F,278760|XFE progeroid syndrome,610965|Fanconi anemia,complementation group Q,615272|Xeroderma pigmentosum,type F/Cockayne syndrome,278760];	RCV000338839.1 [benign]; 			29	103					ERCC4 (inh=AR pLI=0.00)
chr16	14042930	14042930	G	C	het	anno_omim	QUAL=5307;DP=283;AF=0.47;MQM=60;TRIO=HET,283,0.47,WT,101,0.01,HET,137,0.47	ERCC4	3'UTR	ERCC4:ENST00000311895:3'UTR:MODIFIER:exon11/11:c.*726G>C:		rs2276464	0.2376	0.0000	0,0,0	0,0,0,0,0	0.2409							133520 [ERCC4 (confirmed) Xeroderma pigmentosum,group F,278760|XFE progeroid syndrome,610965|Fanconi anemia,complementation group Q,615272|Xeroderma pigmentosum,type F/Cockayne syndrome,278760];	RCV000302862.1 [benign]; 			23	95					ERCC4 (inh=AR pLI=0.00)
chr16	14043014	14043014	G	A	het	anno_omim	QUAL=6709;DP=327;AF=0.50;MQM=59;TRIO=HET,327,0.50,WT,124,0.00,HET,189,0.49	ERCC4	3'UTR	ERCC4:ENST00000311895:3'UTR:MODIFIER:exon11/11:c.*810G>A:		rs2276465	0.2592	0.0000	0,0,0	0,0,0,0,0	0.2910							133520 [ERCC4 (confirmed) Xeroderma pigmentosum,group F,278760|XFE progeroid syndrome,610965|Fanconi anemia,complementation group Q,615272|Xeroderma pigmentosum,type F/Cockayne syndrome,278760];	RCV000269593.1 [benign]; 			23	104					ERCC4 (inh=AR pLI=0.00)
chr16	14043175	14043175	C	G	het	anno_omim	QUAL=6077;DP=187;AF=0.49;MQM=60;TRIO=HET,187,0.49,WT,190,0.00,HET,269,0.51	ERCC4	3'UTR	ERCC4:ENST00000311895:3'UTR:MODIFIER:exon11/11:c.*971C>G:		rs2276466	0.2372	0.0000	0,0,0	0,0,0,0,0	0.2399							133520 [ERCC4 (confirmed) Xeroderma pigmentosum,group F,278760|XFE progeroid syndrome,610965|Fanconi anemia,complementation group Q,615272|Xeroderma pigmentosum,type F/Cockayne syndrome,278760];	RCV000330321.1 [benign]; 			23	95					ERCC4 (inh=AR pLI=0.00)
chr16	14044717	14044717	C	A	het	anno_omim	QUAL=6305;DP=205;AF=0.57;MQM=59;TRIO=HET,205,0.57,WT,131,0.01,HET,220,0.51	ERCC4	3'UTR	ERCC4:ENST00000311895:3'UTR:MODIFIER:exon11/11:c.*2513C>A:		rs11075223	0.2592	0.0000	0,0,0	0,0,0,0,0	0.2911							133520 [ERCC4 (confirmed) Xeroderma pigmentosum,group F,278760|XFE progeroid syndrome,610965|Fanconi anemia,complementation group Q,615272|Xeroderma pigmentosum,type F/Cockayne syndrome,278760];	RCV000273445.1 [benign]; 			22	103					ERCC4 (inh=AR pLI=0.00)
chr16	14044776	14044776	C	-	het	anno_omim	QUAL=5367;DP=154;AF=0.53;MQM=59;TRIO=HET,154,0.53,WT,155,0.00,HET,230,0.53	ERCC4	3'UTR	ERCC4:ENST00000311895:3'UTR:MODIFIER:exon11/11:c.*2577delC:		rs796908123	0.2596	0.0000	0,0,0	0,0,0,0,0	0.2897							133520 [ERCC4 (confirmed) Xeroderma pigmentosum,group F,278760|XFE progeroid syndrome,610965|Fanconi anemia,complementation group Q,615272|Xeroderma pigmentosum,type F/Cockayne syndrome,278760];	RCV000192706.1 [likely benign]; RCV000314550.1 [benign]; 			22	104					ERCC4 (inh=AR pLI=0.00)
chr16	14044781	14044781	C	A	het	anno_omim	QUAL=5367;DP=154;AF=0.53;MQM=59;TRIO=HET,154,0.53,WT,155,0.00,HET,230,0.53	ERCC4	3'UTR	ERCC4:ENST00000311895:3'UTR:MODIFIER:exon11/11:c.*2577C>A:		rs56012340	0.2133	0.0000	0,0,0	0,0,0,0,0	0.2318							133520 [ERCC4 (confirmed) Xeroderma pigmentosum,group F,278760|XFE progeroid syndrome,610965|Fanconi anemia,complementation group Q,615272|Xeroderma pigmentosum,type F/Cockayne syndrome,278760];	RCV000194891.1 [likely benign]; RCV000369259.1 [benign]; 			17	94					ERCC4 (inh=AR pLI=0.00)
chr16	14045236	14045236	G	T	het	anno_omim	QUAL=4012;DP=218;AF=0.47;MQM=60;TRIO=HET,218,0.47,WT,85,0.00,HET,91,0.51	ERCC4	3'UTR	ERCC4:ENST00000311895:3'UTR:MODIFIER:exon11/11:c.*3032G>T:		rs4781562	0.2574	0.0000	0,0,0	0,0,0,0,0	0.2706							133520 [ERCC4 (confirmed) Xeroderma pigmentosum,group F,278760|XFE progeroid syndrome,610965|Fanconi anemia,complementation group Q,615272|Xeroderma pigmentosum,type F/Cockayne syndrome,278760];	RCV000380253.1 [benign]; 			17	91					ERCC4 (inh=AR pLI=0.00)
chr16	14045399	14045399	G	A	het	anno_omim	QUAL=8717;DP=389;AF=0.50;MQM=60;TRIO=HET,389,0.50,WT,233,0.00,HET,281,0.46	ERCC4	3'UTR	ERCC4:ENST00000311895:3'UTR:MODIFIER:exon11/11:c.*3195G>A:		rs4781563	0.2139	0.0000	0,0,0	0,0,0,0,0	0.2328							133520 [ERCC4 (confirmed) Xeroderma pigmentosum,group F,278760|XFE progeroid syndrome,610965|Fanconi anemia,complementation group Q,615272|Xeroderma pigmentosum,type F/Cockayne syndrome,278760];	RCV000346605.1 [benign]; 			17	94					ERCC4 (inh=AR pLI=0.00)
chr16	14046150	14046150	T	-	het	anno_omim	QUAL=6298;DP=378;AF=0.48;MQM=59;TRIO=HET,378,0.48,WT,68,0.00,HET,127,0.53	ERCC4	3'UTR	ERCC4:ENST00000311895:3'UTR:MODIFIER:exon11/11:c.*3953delT:		rs397778750	0.2133	0.0000	0,0,0	0,0,0,0,0	0.2336							133520 [ERCC4 (confirmed) Xeroderma pigmentosum,group F,278760|XFE progeroid syndrome,610965|Fanconi anemia,complementation group Q,615272|Xeroderma pigmentosum,type F/Cockayne syndrome,278760];	RCV000359931.1 [benign]; 			17	93					ERCC4 (inh=AR pLI=0.00)
chr16	20360101	20360101	G	A	hom	anno_omim	QUAL=6919;DP=73;AF=1.00;MQM=59;TRIO=HOM,73,1.00,HOM,75,1.00,HOM,84,1.00	UMOD	synonymous	UMOD:ENST00000396138:synonymous:LOW:exon3/11:c.669C>T:p.Cys223Cys,UMOD:ENST00000396142:synonymous:LOW:exon2/10:c.522C>T:p.Cys174Cys,UMOD:ENST00000396134:synonymous:LOW:exon4/12:c.621C>T:p.Cys207Cys,UMOD:ENST00000302509:synonymous:LOW:exon3/11:c.522C>T:p.Cys174Cys,UMOD:ENST00000424589:synonymous:LOW:exon4/12:c.621C>T:p.Cys207Cys,UMOD:ENST00000570689:synonymous:LOW:exon3/11:c.522C>T:p.Cys174Cys		rs7193058	0.5439	0.6040	2858,1456,352	0.7064,0.6111,0.3545,0.7513,0.4936	0.6888							191845 [UMOD (confirmed) Hyperuricemic nephropathy,familial juvenile 1,162000|Medullary cystic kidney disease 2,603860|Glomerulocystic kidney disease with hyperuricemia and isosthenuria,609886];	RCV000080093.6 [benign]; RCV000335513.1 [benign]; 		COSM3749349, COSM3749348	1018	851					UMOD (inh=AD pLI=0.00)
chr16	23197545	23197545	C	G	het	anno_omim	QUAL=3883;DP=130;AF=0.49;MQM=60;TRIO=HET,130,0.49,WT,144,0.00,HET,194,0.52	SCNN1G	splice_region&intron	SCNN1G:ENST00000300061:splice_region&intron:LOW:exon1/12:c.-44-4C>G:		rs5731	0.1969	0.2354	3475,1719,66	0.1215,0.4038,0.1505,0.2343,0.2321	0.2423							600761 [SCNN1G (confirmed) Liddle syndrome,177200|Pseudohypoaldosteronism,type I,264350|Bronchiectasis with or without elevated sweat chloride 3,613071];	RCV000321774.1 [benign]; RCV000376481.1 [benign]; 			122	685					SCNN1G (inh=AR+AD pLI=0.37)
chr16	23197562	23197562	A	G	het	anno_omim	QUAL=3951;DP=111;AF=0.48;MQM=60;TRIO=HET,111,0.48,WT,180,0.00,HET,231,0.52	SCNN1G	5'UTR	SCNN1G:ENST00000300061:5'UTR:MODIFIER:exon2/13:c.-31A>G:		rs5732	0.1969	0.2378	3674,1818,71	0.1244,0.4089,0.1511,0.2365,0.2333	0.2432							600761 [SCNN1G (confirmed) Liddle syndrome,177200|Pseudohypoaldosteronism,type I,264350|Bronchiectasis with or without elevated sweat chloride 3,613071];	RCV000267876.1 [benign]; RCV000322965.1 [benign]; 			124	703					SCNN1G (inh=AR+AD pLI=0.37)
chr16	23200761	23200761	T	C	het	anno_omim	QUAL=8899;DP=380;AF=0.49;MQM=59;TRIO=HET,380,0.49,WT,264,0.00,HET,357,0.48	SCNN1G	synonymous	SCNN1G:ENST00000300061:synonymous:LOW:exon3/13:c.387T>C:p.Tyr129Tyr		rs5734	0.2390	0.3023	5980,3366,136	0.1602,0.4450,0.1690,0.3166,0.2730	0.3095							600761 [SCNN1G (confirmed) Liddle syndrome,177200|Pseudohypoaldosteronism,type I,264350|Bronchiectasis with or without elevated sweat chloride 3,613071];	RCV000151819.2 [benign]; RCV000328934.1 [benign]; RCV000383542.1 [benign]; 			218	886					SCNN1G (inh=AR+AD pLI=0.37)
chr16	23200848	23200848	T	C	het	anno_omim	QUAL=9807;DP=311;AF=0.48;MQM=60;TRIO=HET,311,0.48,WT,336,0.00,HET,479,0.51	SCNN1G	synonymous	SCNN1G:ENST00000300061:synonymous:LOW:exon3/13:c.474T>C:p.Ile158Ile		rs5735	0.2392	0.3018	5991,3371,136	0.1593,0.4449,0.1689,0.3162,0.2725	0.3095							600761 [SCNN1G (confirmed) Liddle syndrome,177200|Pseudohypoaldosteronism,type I,264350|Bronchiectasis with or without elevated sweat chloride 3,613071];	RCV000151820.2 [benign]; RCV000300778.1 [benign]; RCV000355585.1 [benign]; 		COSM4128821	218	885					SCNN1G (inh=AR+AD pLI=0.37)
chr16	23227362	23227362	A	G	het	anno_omim	QUAL=16593;DP=340;AF=0.48;MQM=60;TRIO=HET,340,0.48,HET,240,0.53,HOM,295,1.00	SCNN1G	3'UTR	SCNN1G:ENST00000300061:3'UTR:MODIFIER:exon13/13:c.*572A>G:		rs5728	0.3395	0.0000	0,0,0	0,0,0,0,0	0.4152							600761 [SCNN1G (confirmed) Liddle syndrome,177200|Pseudohypoaldosteronism,type I,264350|Bronchiectasis with or without elevated sweat chloride 3,613071];	RCV000290607.1 [benign]; RCV000347941.1 [benign]; 			51	102					SCNN1G (inh=AR+AD pLI=0.37)
chr16	23227449	23227449	T	C	het	anno_omim	QUAL=12903;DP=318;AF=0.47;MQM=60;TRIO=HET,318,0.47,HET,186,0.47,HOM,219,1.00	SCNN1G	3'UTR	SCNN1G:ENST00000300061:3'UTR:MODIFIER:exon13/13:c.*659T>C:		rs9922851	0.3395	0.0000	0,0,0	0,0,0,0,0	0.4151							600761 [SCNN1G (confirmed) Liddle syndrome,177200|Pseudohypoaldosteronism,type I,264350|Bronchiectasis with or without elevated sweat chloride 3,613071];	RCV000300448.1 [benign]; RCV000398594.1 [benign]; 			49	93					SCNN1G (inh=AR+AD pLI=0.37)
chr16	23227579	23227579	T	C	het	anno_omim	QUAL=21112;DP=436;AF=0.51;MQM=59;TRIO=HET,436,0.51,HET,294,0.39,HOM,431,1.00	SCNN1G	3'UTR	SCNN1G:ENST00000300061:3'UTR:MODIFIER:exon13/13:c.*789T>C:	MIR	rs9923016	0.3389	0.0000	0,0,0	0,0,0,0,0	0.4144							600761 [SCNN1G (confirmed) Liddle syndrome,177200|Pseudohypoaldosteronism,type I,264350|Bronchiectasis with or without elevated sweat chloride 3,613071];	RCV000305014.1 [benign]; RCV000362088.1 [benign]; 			51	99					SCNN1G (inh=AR+AD pLI=0.37)
chr16	23360199	23360199	T	C	het	anno_omim	QUAL=6271;DP=311;AF=0.48;MQM=59;TRIO=HET,311,0.48,HET,270,0.44,WT,396,0.00	SCNN1B	synonymous	SCNN1B:ENST00000307331:synonymous:LOW:exon3/14:c.414T>C:p.Pro138Pro,SCNN1B:ENST00000343070:synonymous:LOW:exon2/13:c.279T>C:p.Pro93Pro,SCNN1B:ENST00000568085:synonymous:LOW:exon1/11:c.279T>C:p.Pro93Pro,SCNN1B:ENST00000568923:synonymous:LOW:exon1/12:c.279T>C:p.Pro93Pro		rs238547	0.7885	0.6355	26254,10387,4313	0.9115,0.4403,0.9830,0.5560,0.7912	0.6591							600760 [SCNN1B (confirmed) Liddle syndrome,177200|Pseudohypoaldosteronism,type I,264350|Bronchiectasis with or without elevated sweat chloride 1,211400];	RCV000151814.3 [benign]; RCV000266524.1 [benign]; RCV000307100.1 [benign]; RCV000361247.1 [benign]; 			837	958					SCNN1B (inh=AR+AD pLI=0.00)
chr16	23399964	23399964	G	T	hom	anno_omim	QUAL=210;DP=28;AF=0.11;MQM=60;TRIO=HOM,28,0.11,HOM,6,0.00,HOM,15,0.00	COG7	3'UTR	COG7:ENST00000307149:3'UTR:MODIFIER:exon17/17:c.*277C>A:	Alu		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0386							606978 [COG7 (confirmed) Congenital disorder of glycosylation,type IIe,608779];				0	1					COG7 (inh=n/a pLI=0.00)
chr16	23400054	23400054	T	C	het	anno_omim	QUAL=6299;DP=227;AF=0.44;MQM=57;TRIO=HET,227,0.44,HET,166,0.48,HET,201,0.48	COG7	3'UTR	COG7:ENST00000307149:3'UTR:MODIFIER:exon17/17:c.*187A>G:	AluSg	rs250588	0.3610	0.0000	0,0,0	0,0,0,0,0	0.3122							606978 [COG7 (confirmed) Congenital disorder of glycosylation,type IIe,608779];	RCV000364633.1 [benign]; 			13	79					COG7 (inh=n/a pLI=0.00)
chr16	23400194	23400194	G	A	het	anno_omim	QUAL=13345;DP=299;AF=0.54;MQM=59;TRIO=HET,299,0.54,HET,328,0.51,HET,439,0.49	COG7	3'UTR	COG7:ENST00000307149:3'UTR:MODIFIER:exon17/17:c.*47C>T:		rs250587	0.2436	0.2030	2715,1088,411	0.2815,0.1640,0.2869,0.1754,0.2287	0.2211							606978 [COG7 (confirmed) Congenital disorder of glycosylation,type IIe,608779];	RCV000398954.1 [likely benign]; 			62	512					COG7 (inh=n/a pLI=0.00)
chr16	23646191	23646191	T	C	het	anno_omim	QUAL=5941;DP=153;AF=0.52;MQM=60;TRIO=HET,153,0.52,WT,242,0.00,HET,272,0.53	PALB2	missense	PALB2:ENST00000261584:missense:MODERATE:exon4/13:c.1676A>G:p.Gln559Arg		rs152451	0.1508	0.1176	771,232,252	0.2251,0.0951,0.1952,0.0955,0.1156	0.1302	0.4010	T	T	B	T	0.01	610355 [PALB2 (provisional) Fanconi anemia,complementation group N,610832|Breast cancer,susceptibility to,114480|Pancreatic cancer,susceptibility to,3,613348];	RCV000114486.2 [other]; RCV000121747.3 [benign]; RCV000128962.4 [benign]; RCV000395533.1 [benign]; 	CM1312156 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=PALB2]; 		42	781	1	[1] Christopher Schroeder 27.04.2015			PALB2 (inh=AR+AD pLI=0.00)
chr16	28944396	28944396	C	G	hom	anno_omim	QUAL=10112;DP=104;AF=1.00;MQM=59;TRIO=HOM,104,1.00,HOM,90,1.00,HOM,134,0.99	CD19,RABEP2	missense	CD19:ENST00000538922:missense:MODERATE:exon3/15:c.520C>G:p.Leu174Val,CD19:ENST00000324662:missense:MODERATE:exon3/15:c.520C>G:p.Leu174Val,CD19:ENST00000567541:missense:MODERATE:exon3/14:c.520C>G:p.Leu174Val		rs2904880	0.8303	0.7293	33026,15765,4563	0.9425,0.5338,0.9107,0.6877,0.8223	0.7615	0.0920	T,T,T	T	B,B	T,T	1.94	107265 [CD19 (provisional) Immunodeficiency,common variable,3,613493];	RCV000325903.1 [benign]; 			1154	801					CD19 (inh=AR pLI=0.85), RABEP2 (inh=n/a pLI=0.00)
chr16	28950051	28950051	G	A	het	pred_pathogenic;anno_omim	QUAL=3273;DP=134;AF=0.41;MQM=60;TRIO=HET,134,0.41,HET,163,0.54,WT,181,0.00	CD19	missense	CD19:ENST00000538922:missense:MODERATE:exon13/15:c.1544G>A:p.Arg515His,CD19:ENST00000324662:missense:MODERATE:exon13/15:c.1541G>A:p.Arg514His,CD19:ENST00000567541:missense:MODERATE:exon13/14:c.1544G>A:p.Arg515His		rs34763945	0.0182	0.0398	130,97,3	0.0100,0.0177,0.0001,0.0544,0.0240	0.0402	0.2880	T,T,T,T	T	B,B	T,T	21.10	107265 [CD19 (provisional) Immunodeficiency,common variable,3,613493];	RCV000278853.1 [likely benign]; 			4	198					CD19 (inh=AR pLI=0.85)
chr16	29825126	29825126	T	C	hom	anno_omim	QUAL=21222;DP=118;AF=1.00;MQM=59;TRIO=HOM,118,1.00,HOM,243,1.00,HOM,341,1.00	PRRT2,AC009133.20	synonymous	PRRT2:ENST00000567659:synonymous:LOW:exon2/3:c.751T>C:p.Leu251Leu,PRRT2:ENST00000358758:synonymous:LOW:exon2/4:c.751T>C:p.Leu251Leu,PRRT2:ENST00000300797:synonymous:LOW:exon2/2:c.751T>C:p.Leu251Leu		rs11150573	0.9918	0.9980	59929,33124,4804	0.9762,0.9997,1.0000,1.0000,0.9999	0.9984							614386 [PRRT2 (provisional) Episodic kinesigenic dyskinesia 1,128200|Seizures,benign familial infantile,2,605751|Convulsions,familial infantile,with paroxysmal choreoathetosis,602066];	RCV000153784.2 [benign]; 			3075	0					PRRT2 (inh=AD pLI=0.30), AC009133.20 (inh=n/a pLI=n/a)
chr16	29826538	29826538	T	C	hom	anno_omim	QUAL=20237;DP=203;AF=1.00;MQM=59;TRIO=HOM,203,1.00,HOM,185,1.00,HOM,250,1.00	PRRT2,AC009133.20	3'UTR	PRRT2:ENST00000358758:3'UTR:MODIFIER:exon4/4:c.*579T>C:,PRRT2:ENST00000300797:3'UTR:MODIFIER:exon2/2:c.*1263T>C:		rs10204	0.7816	0.0000	0,0,0	0,0,0,0,0	0.7595							614386 [PRRT2 (provisional) Episodic kinesigenic dyskinesia 1,128200|Seizures,benign familial infantile,2,605751|Convulsions,familial infantile,with paroxysmal choreoathetosis,602066];				175	51					PRRT2 (inh=AD pLI=0.30), AC009133.20 (inh=n/a pLI=n/a)
chr16	30194840	30194840	A	G	het	anno_omim	QUAL=4124;DP=110;AF=0.48;MQM=60;TRIO=HET,110,0.48,HET,136,0.49,HET,162,0.38	CORO1A,RP11-455F5.5	5'UTR	CORO1A:ENST00000219150:5'UTR:MODIFIER:exon1/11:c.-208A>G:		rs930392	0.7911	0.0000	0,0,0	0,0,0,0,0	0.6732							605000 [CORO1A (provisional) Immunodeficiency 8,615401];				56	73					CORO1A (inh=AR pLI=0.95), RP11-455F5.5 (inh=n/a pLI=n/a)
chr16	30198151	30198151	A	G	het	anno_omim	QUAL=5983;DP=160;AF=0.58;MQM=59;TRIO=HET,160,0.58,HET,154,0.47,HET,181,0.43	CORO1A	synonymous	CORO1A:ENST00000219150:synonymous:LOW:exon4/11:c.336A>G:p.Pro112Pro,CORO1A:ENST00000570045:synonymous:LOW:exon5/12:c.336A>G:p.Pro112Pro,CORO1A:ENST00000565497:synonymous:LOW:exon4/10:c.336A>G:p.Pro112Pro		rs1132812	0.7941	0.6540	26673,10035,4050	0.9019,0.7831,0.9299,0.5531,0.6848	0.6723							605000 [CORO1A (provisional) Immunodeficiency 8,615401];			COSM3721331	789	962					CORO1A (inh=AR pLI=0.95)
chr16	31191482	31191482	A	G	hom	anno_omim	QUAL=21607;DP=243;AF=0.99;MQM=59;TRIO=HOM,243,0.99,HOM,200,1.00,HOM,282,1.00	FUS	5'UTR	FUS:ENST00000568685:5'UTR:MODIFIER:exon1/15:c.-54A>G:,FUS:ENST00000254108:5'UTR:MODIFIER:exon1/15:c.-54A>G:,FUS:ENST00000380244:5'UTR:MODIFIER:exon1/15:c.-54A>G:		rs929867	0.9391	0.9846	44807,25930,2605	0.8300,0.9909,1.0000,0.9993,0.9996	0.9874							137070 [FUS (confirmed) Amyotrophic lateral sclerosis 6,with or without frontotemporal dementia,608030|Tremor,hereditary essential,4,614782];	RCV000307180.1 [benign]; 			2545	10					FUS (inh=AR+AD pLI=1.00)
chr16	31193942	31193942	C	A	het	anno_omim	QUAL=11576;DP=416;AF=0.54;MQM=60;TRIO=HET,416,0.54,WT,334,0.00,HET,438,0.53	FUS,RP11-388M20.6	synonymous	FUS:ENST00000568685:synonymous:LOW:exon3/15:c.147C>A:p.Gly49Gly,FUS:ENST00000254108:synonymous:LOW:exon3/15:c.147C>A:p.Gly49Gly,FUS:ENST00000380244:synonymous:LOW:exon3/15:c.147C>A:p.Gly49Gly		rs741810	0.2790	0.3222	7130,3180,26	0.0667,0.3901,0.2462,0.3046,0.5183	0.3257							137070 [FUS (confirmed) Amyotrophic lateral sclerosis 6,with or without frontotemporal dementia,608030|Tremor,hereditary essential,4,614782];	RCV000251286.1 [benign]; RCV000356600.1 [benign]; 		COSM1377614, COSM3754865	275	1049					FUS (inh=AR+AD pLI=1.00), RP11-388M20.6 (inh=n/a pLI=n/a)
chr16	31195279	31195279	C	T	het	anno_omim	QUAL=3808;DP=239;AF=0.48;MQM=60;TRIO=HET,239,0.48,HET,111,0.53,WT,158,0.01	FUS	synonymous	FUS:ENST00000568685:synonymous:LOW:exon4/15:c.291C>T:p.Tyr97Tyr,FUS:ENST00000254108:synonymous:LOW:exon4/15:c.291C>T:p.Tyr97Tyr,FUS:ENST00000380244:synonymous:LOW:exon4/15:c.288C>T:p.Tyr96Tyr		rs1052352	0.4738	0.5186	17189,10275,360	0.2612,0.5348,0.7513,0.5502,0.4384	0.5277							137070 [FUS (confirmed) Amyotrophic lateral sclerosis 6,with or without frontotemporal dementia,608030|Tremor,hereditary essential,4,614782];	RCV000244413.1 [benign]; RCV000277026.1 [benign]; 			919	1229					FUS (inh=AR+AD pLI=1.00)
chr16	31202800	31202800	G	A	het	anno_omim;anno_pathogenic_hgmd	QUAL=6944;DP=374;AF=0.48;MQM=59;TRIO=HET,374,0.48,WT,178,0.00,HET,218,0.44	FUS	3'UTR	FUS:ENST00000568685:3'UTR:MODIFIER:exon15/15:c.*41G>A:,FUS:ENST00000254108:3'UTR:MODIFIER:exon15/15:c.*41G>A:,FUS:ENST00000380244:3'UTR:MODIFIER:exon15/15:c.*41G>A:		rs80301724	0.0044	0.0069	6,1,0	0.0014,0.0061,0.0000,0.0086,0.0097	0.0067							137070 [FUS (confirmed) Amyotrophic lateral sclerosis 6,with or without frontotemporal dementia,608030|Tremor,hereditary essential,4,614782];	RCV000340713.1 [likely benign]; 	CR121643 [CLASS=DM MUT=ALT PHEN="Amyotrophic lateral sclerosis" GENE=FUS]; 		2	53					FUS (inh=AR+AD pLI=1.00)
chr16	31203529	31203529	G	C	het	anno_omim	QUAL=7269;DP=381;AF=0.47;MQM=60;TRIO=HET,381,0.47,WT,185,0.00,HET,223,0.45	FUS,RP11,388M20.1	intergenic_region	388M20.1:ENSG00000089280-ENSG00000260060:intergenic_region:MODIFIER::n.31203529G>C:		rs4889537	0.2817	0.4227	1066,89,2	0.0000,0.0000,0.0000,0.2445,0.5028	0.3379							137070 [FUS (confirmed) Amyotrophic lateral sclerosis 6,with or without frontotemporal dementia,608030|Tremor,hereditary essential,4,614782];	RCV000328414.1 [benign]; 			55	232					FUS (inh=AR+AD pLI=1.00), PRPF31 (inh=AD pLI=0.97), 388M20.1 (inh=n/a pLI=n/a)
chr16	31204235	31204235	T	C	hom	anno_omim	QUAL=40393;DP=452;AF=1.00;MQM=60;TRIO=HOM,452,1.00,HOM,335,1.00,HOM,435,1.00	FUS,RP11,388M20.1	intergenic_region	388M20.1:ENSG00000089280-ENSG00000260060:intergenic_region:MODIFIER::n.31204235T>C:		rs11860134	0.9910	0.9994	5389,1374,89	0.0000,0.0000,0.0000,1.0000,1.0000	0.9981							137070 [FUS (confirmed) Amyotrophic lateral sclerosis 6,with or without frontotemporal dementia,608030|Tremor,hereditary essential,4,614782];	RCV000390213.1 [benign]; 			571	1					FUS (inh=AR+AD pLI=1.00), PRPF31 (inh=AD pLI=0.97), 388M20.1 (inh=n/a pLI=n/a)
chr16	56545175	56545175	T	C	het	pred_pathogenic;anno_omim	QUAL=12550;DP=337;AF=0.46;MQM=60;TRIO=HET,337,0.46,HOM,264,1.00,WT,388,0.00	BBS2	missense	BBS2:ENST00000245157:missense:MODERATE:exon3/17:c.367A>G:p.Ile123Val,BBS2:ENST00000568104:missense:MODERATE:exon3/16:c.367A>G:p.Ile123Val		rs11373	0.2636	0.2092	2948,1009,273	0.2292,0.3062,0.4101,0.1703,0.1939	0.2137	0.4020	T	T	B,B	D	0.23	606151 [BBS2 (confirmed) Bardet-Biedl syndrome 2,615981|Retinitis pigmentosa 74,616562];	RCV000241605.1 [benign]; RCV000261972.1 [benign]; 	CM144738 [CLASS=DFP MUT=ALT PHEN="Bardet-Biedl syndrome" GENE=BBS2]; 		80	629					BBS2 (inh=AR pLI=0.00)
chr16	56548501	56548501	C	T	hom	pred_pathogenic;anno_omim	QUAL=19343;DP=248;AF=1.00;MQM=60;TRIO=HOM,248,1.00,HOM,161,1.00,HOM,202,1.00	BBS2	missense	BBS2:ENST00000245157:missense:MODERATE:exon2/17:c.209G>A:p.Ser70Asn,BBS2:ENST00000568104:missense:MODERATE:exon2/16:c.209G>A:p.Ser70Asn		rs4784677	0.9964	0.9938	59947,32858,5179	0.9982,0.9953,0.9999,0.9923,0.9902	0.9965	5.0110	T	T		T	12.57	606151 [BBS2 (confirmed) Bardet-Biedl syndrome 2,615981|Retinitis pigmentosa 74,616562];	RCV000301991.1 [benign]; 			2068	47	2	[2] old entry - no details available [n/a] comment imported from detected variant: Wirkt falsch annotiert; 30.03.14, PB			BBS2 (inh=AR pLI=0.00)
chr16	56554016	56554016	A	G	hom	anno_omim	QUAL=8283;DP=100;AF=1.00;MQM=59;TRIO=HOM,100,1.00,HOM,65,1.00,HOM,119,1.00	BBS2	5'UTR	BBS2:ENST00000245157:5'UTR:MODIFIER:exon1/17:c.-242T>C:		rs12446354	0.9970	0.0000	0,0,0	0,0,0,0,0	0.9951							606151 [BBS2 (confirmed) Bardet-Biedl syndrome 2,615981|Retinitis pigmentosa 74,616562];	RCV000317329.1 [benign]; 			219	0					BBS2 (inh=AR pLI=0.00)
chr16	57495026	57495026	T	C	hom	anno_omim	QUAL=25237;DP=280;AF=1.00;MQM=59;TRIO=HOM,280,1.00,HOM,229,1.00,HOM,298,1.00	COQ9,AC009052.12	3'UTR	COQ9:ENST00000262507:3'UTR:MODIFIER:exon9/9:c.*490T>C:,COQ9:ENST00000567072:3'UTR:MODIFIER:exon8/8:c.*490T>C:		rs223870	0.9926	0.0000	0,0,0	0,0,0,0,0	0.9718							612837 [COQ9 (provisional) Coenzyme Q10 deficiency,primary,5,614654];	RCV000359269.1 [benign]; 			1417	88					COQ9 (inh=AR pLI=0.00), AC009052.12 (inh=n/a pLI=n/a)
chr16	66514962	66514962	C	T	het	anno_omim	QUAL=13035;DP=226;AF=0.49;MQM=59;TRIO=HET,226,0.49,HOM,335,0.99,WT,460,0.00	BEAN1,RP11-403P17.5,CTD-2258A20.5	3'UTR,intron	BEAN1:ENST00000536005:3'UTR:MODIFIER:exon5/5:c.*134C>T:,BEAN1:ENST00000299694:3'UTR:MODIFIER:exon4/4:c.*134C>T:,BEAN1:ENST00000561796:intron:MODIFIER:exon3/4:c.114-1823C>T:,BEAN1:ENST00000564819:intron:MODIFIER:exon2/2:c.114-1819C>T:	(CA)n	rs3743709	0.1110	0.0000	0,0,0	0,0,0,0,0	0.0821							612051 [BEAN1 (provisional) Spinocerebellar ataxia 31,117210]:188250 [TK2 (confirmed) Mitochondrial DNA depletion syndrome 2 (myopathic type),609560|Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal recessive 3,617069];				5	24					BEAN1 (inh=AD pLI=n/a), RP11-403P17.5 (inh=n/a pLI=n/a), CTD-2258A20.5 (inh=n/a pLI=n/a)
chr16	66527192	66527192	G	A	het	anno_omim	QUAL=5772;DP=97;AF=0.51;MQM=59;TRIO=HET,97,0.51,HOM,160,0.99,WT,184,0.00	BEAN1,RP11-403P17.5	missense	BEAN1:ENST00000561796:missense:MODERATE:exon5/5:c.475G>A:p.Gly159Arg		rs58468753	0.1114	0.0525	27,6,5	0.1396,0.0000,0.0000,0.0587,0.0387	0.0850							612051 [BEAN1 (provisional) Spinocerebellar ataxia 31,117210]:188250 [TK2 (confirmed) Mitochondrial DNA depletion syndrome 2 (myopathic type),609560|Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal recessive 3,617069];				19	235					BEAN1 (inh=AD pLI=n/a), RP11-403P17.5 (inh=n/a pLI=n/a)
chr16	66584002	66584002	T	C	het	pred_pathogenic;anno_omim	QUAL=8403;DP=259;AF=0.54;MQM=60;TRIO=HET,259,0.54,HOM,112,0.97,HET,156,0.57	TK2,Y_RNA	missense,5'UTR,intron	TK2:ENST00000299697:missense:MODERATE:exon1/10:c.89A>G:p.Lys30Arg,TK2:ENST00000451102:5'UTR:MODIFIER:exon1/10:c.-38A>G:,TK2:ENST00000544898:5'UTR:MODIFIER:exon1/11:c.-280A>G:,TK2:ENST00000545043:5'UTR:MODIFIER:exon1/9:c.-38A>G:,TK2:ENST00000564917:5'UTR:MODIFIER:exon1/10:c.-38A>G:,TK2:ENST00000417693:5'UTR:MODIFIER:exon1/9:c.-38A>G:,TK2:ENST00000527284:intron:MODIFIER:exon1/9:c.31+154A>G:		rs3743716	0.3259	0.2681	2735,378,1059	0.5843,0.4503,0.3824,0.1704,0.2691	0.2454	0.3800	T	T	B	D	6.44	188250 [TK2 (confirmed) Mitochondrial DNA depletion syndrome 2 (myopathic type),609560|Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal recessive 3,617069];	RCV000125522.1 [benign]; RCV000338994.1 [benign]; 		COSM435490	73	531					TK2 (inh=AR pLI=0.00), Y_RNA (inh=n/a pLI=n/a)
chr16	67311767	67311767	G	A	het		QUAL=6161;DP=278;AF=0.46;MQM=59;TRIO=HET,278,0.46,HET,306,0.45,WT,450,0.00	PLEKHG4	5'UTR	PLEKHG4:ENST00000360461:5'UTR:MODIFIER:exon1/21:c.-2181G>A:		rs8050745	0.2410	0.0000	0,0,0	0,0,0,0,0	0.2169											6	114					PLEKHG4 (inh=AD pLI=0.00)
chr16	67313805	67313805	G	A	het		QUAL=3344;DP=187;AF=0.45;MQM=59;TRIO=HET,187,0.45,HET,102,0.54,WT,156,0.00	PLEKHG4	5'UTR	PLEKHG4:ENST00000360461:5'UTR:MODIFIER:exon1/21:c.-143G>A:,PLEKHG4:ENST00000427155:5'UTR:MODIFIER:exon2/22:c.-143G>A:,PLEKHG4:ENST00000379344:5'UTR:MODIFIER:exon2/22:c.-143G>A:,PLEKHG4:ENST00000450733:5'UTR:MODIFIER:exon1/20:c.-143G>A:		rs141261466	0.0062	0.0000	0,0,0	0,0,0,0,0	0.0108											0	16					PLEKHG4 (inh=AD pLI=0.00)
chr16	67316234	67316234	C	T	het	pred_pathogenic	QUAL=2675;DP=125;AF=0.54;MQM=59;TRIO=HET,125,0.54,HET,107,0.49,WT,102,0.01	PLEKHG4	missense	PLEKHG4:ENST00000360461:missense:MODERATE:exon8/21:c.1235C>T:p.Thr412Ile,PLEKHG4:ENST00000427155:missense:MODERATE:exon9/22:c.1235C>T:p.Thr412Ile,PLEKHG4:ENST00000379344:missense:MODERATE:exon9/22:c.1235C>T:p.Thr412Ile,PLEKHG4:ENST00000450733:missense:MODERATE:exon7/20:c.992C>T:p.Thr331Ile		rs11860295	0.2440	0.1343	2240,217,1724	0.5906,0.0613,0.0027,0.0846,0.1569	0.2202	0.0090	T,T,T,T	T	P,B	T,T,T,T	20.70		RCV000117985.2 [likely benign]; 			58	480					PLEKHG4 (inh=AD pLI=0.00)
chr16	67318242	67318242	A	G	het		QUAL=1432;DP=94;AF=0.45;MQM=60;TRIO=HET,94,0.45,HET,82,0.34,WT,124,0.00	PLEKHG4	missense	PLEKHG4:ENST00000360461:missense:MODERATE:exon11/21:c.1574A>G:p.Asp525Gly,PLEKHG4:ENST00000427155:missense:MODERATE:exon12/22:c.1574A>G:p.Asp525Gly,PLEKHG4:ENST00000379344:missense:MODERATE:exon12/22:c.1574A>G:p.Asp525Gly,PLEKHG4:ENST00000450733:missense:MODERATE:exon10/20:c.1331A>G:p.Asp444Gly		rs8044843	0.2816	0.1641	2920,433,2029	0.6406,0.1104,0.0228,0.1150,0.1853	0.2552	0.6240	T,T,T,T	T	B,B	T,T,T,T	5.62		RCV000117986.2 [likely benign]; 		COSM3765919	88	617					PLEKHG4 (inh=AD pLI=0.00)
chr16	67320223	67320223	G	A	het	low_DP;pred_pathogenic	QUAL=184;DP=15;AF=0.47;MQM=60;TRIO=HET,15,0.47,HET,11,0.36,WT,24,0.00	PLEKHG4	missense	PLEKHG4:ENST00000360461:missense:MODERATE:exon14/21:c.2489G>A:p.Arg830His,PLEKHG4:ENST00000427155:missense:MODERATE:exon15/22:c.2489G>A:p.Arg830His,PLEKHG4:ENST00000379344:missense:MODERATE:exon15/22:c.2489G>A:p.Arg830His,PLEKHG4:ENST00000450733:missense:MODERATE:exon13/20:c.2246G>A:p.Arg749His		rs3868142	0.2414	0.1289	2253,234,1716	0.5714,0.0582,0.0026,0.0812,0.1546	0.2173	2.0690	D,D,D,D	T	B,B	T,T,T,T	23.60		RCV000117987.2 [likely benign]; 		COSM4129187	58	471					PLEKHG4 (inh=AD pLI=0.00)
chr16	67469733	67469733	C	A	het	anno_omim	QUAL=5923;DP=157;AF=0.53;MQM=59;TRIO=HET,157,0.53,HET,311,0.51,WT,353,0.00	HSD11B2	synonymous	HSD11B2:ENST00000326152:synonymous:LOW:exon2/5:c.468C>A:p.Thr156Thr		rs5479	0.0927	0.0587	357,76,202	0.1949,0.0323,0.0014,0.0455,0.0823	0.0799							614232 [HSD11B2 (confirmed) Apparent mineralocorticoid excess,218030];		CM057710 [CLASS=DP MUT=ALT PHEN="Hypertension association with" GENE=HSD11B2]; 	COSM4129203	27	221					HSD11B2 (inh=AR pLI=0.24)
chr16	67469915	67469915	G	A	het	anno_omim	QUAL=7862;DP=368;AF=0.44;MQM=59;TRIO=HET,368,0.44,HET,341,0.49,WT,385,0.00	HSD11B2	synonymous	HSD11B2:ENST00000326152:synonymous:LOW:exon3/5:c.534G>A:p.Glu178Glu		rs45483293	0.0144	0.0311	87,74,0	0.0086,0.0205,0.0000,0.0444,0.0110	0.0312							614232 [HSD11B2 (confirmed) Apparent mineralocorticoid excess,218030];				10	170					HSD11B2 (inh=AR pLI=0.24)
chr16	69373414	69373414	T	C	hom	anno_omim	QUAL=3355;DP=59;AF=0.98;MQM=60;TRIO=HOM,59,0.98,HET,48,0.52,HET,87,0.47	COG8,NIP7,RP11-343C2.9,RP11-343C2.7	synonymous,5'UTR	COG8:ENST00000306875:synonymous:LOW:exon1/6:c.42A>G:p.Thr14Thr,COG8:ENST00000562081:synonymous:LOW:exon1/4:c.42A>G:p.Thr14Thr,NIP7:ENST00000254940:5'UTR:MODIFIER:exon1/5:c.-319T>C:		rs11542583	0.2576	0.2968	5104,2940,519	0.3622,0.1687,0.1004,0.3174,0.3757	0.3016							606979 [COG8 (confirmed) Congenital disorder of glycosylation,type IIh,611182];	RCV000082299.4 [benign]; RCV000338035.1 [likely benign]; 		COSM4129245	214	847					COG8 (inh=AR pLI=0.00), NIP7 (inh=n/a pLI=0.60), RP11-343C2.9 (inh=n/a pLI=n/a), RP11-343C2.7 (inh=n/a pLI=n/a)
chr16	70287177	70287177	A	G	hom	anno_omim	QUAL=21255;DP=147;AF=0.99;MQM=59;TRIO=HOM,147,0.99,HOM,226,1.00,HOM,305,1.00	AARS	synonymous	AARS:ENST00000261772:synonymous:LOW:exon20/21:c.2715T>C:p.Val905Val		rs4081753	0.8812	0.8241	41311,20791,4840	0.9650,0.8265,0.9698,0.7918,0.7825	0.8640							601065 [AARS (confirmed) Charcot-Marie-Tooth disease,axonal,type 2N,613287|Epileptic encephalopathy,early infantile,29,616339];	RCV000364752.1 [benign]; 		COSM435653	1373	649					AARS (inh=AR+AD pLI=0.00)
chr16	70303580	70303580	G	A	het	anno_omim	QUAL=20552;DP=189;AF=0.49;MQM=60;TRIO=HET,189,0.49,HET,313,0.55,HOM,456,0.99	AARS	synonymous	AARS:ENST00000261772:synonymous:LOW:exon7/21:c.903C>T:p.His301His		rs2070203	0.4253	0.4659	13572,8545,1128	0.4699,0.3819,0.4142,0.5050,0.3371	0.5054							601065 [AARS (confirmed) Charcot-Marie-Tooth disease,axonal,type 2N,613287|Epileptic encephalopathy,early infantile,29,616339];	RCV000374249.1 [benign]; RCV000382444.1 [benign]; 	CM995271 [CLASS=FP MUT=ALT PHEN="Altered mRNA folding" GENE=AARS]; 		482	1040					AARS (inh=AR+AD pLI=0.00)
chr16	74747267	74747267	G	C	het	anno_omim	QUAL=3730;DP=241;AF=0.46;MQM=59;TRIO=HET,241,0.46,WT,97,0.00,HET,102,0.53	FA2H	3'UTR	FA2H:ENST00000219368:3'UTR:MODIFIER:exon7/7:c.*821C>G:		rs573058036	0.0014	0.0000	0,0,0	0,0,0,0,0	0.0030							611026 [FA2H (provisional) Spastic paraplegia 35,autosomal recessive,612319];	RCV000328142.1 [uncertain significance]; 			0	4					FA2H (inh=AR pLI=0.73)
chr16	74747451	74747451	C	G	het	anno_omim	QUAL=1405;DP=67;AF=0.52;MQM=59;TRIO=HET,67,0.52,HOM,18,1.00,WT,34,0.00	FA2H	3'UTR	FA2H:ENST00000219368:3'UTR:MODIFIER:exon7/7:c.*637G>C:		rs56033857	0.2378	0.0000	0,0,0	0,0,0,0,0	0.2962							611026 [FA2H (provisional) Spastic paraplegia 35,autosomal recessive,612319];	RCV000375512.1 [benign]; 			30	103					FA2H (inh=AR pLI=0.73)
chr16	74750405	74750405	G	A	het	anno_omim	QUAL=18154;DP=162;AF=0.49;MQM=60;TRIO=HET,162,0.49,HOM,338,0.99,HET,425,0.53	FA2H	synonymous	FA2H:ENST00000219368:synonymous:LOW:exon6/7:c.879C>T:p.Pro293Pro,FA2H:ENST00000544337:synonymous:LOW:exon4/5:c.240C>T:p.Pro80Pro		rs2301865	0.7252	0.7732	35691,21638,2641	0.7227,0.7592,0.6609,0.8119,0.6947	0.7773							611026 [FA2H (provisional) Spastic paraplegia 35,autosomal recessive,612319];	RCV000117012.1 [benign]; RCV000292801.1 [benign]; 			1697	886					FA2H (inh=AR pLI=0.73)
chr16	81399026	81399026	C	T	het	pred_pathogenic;anno_omim	QUAL=4104;DP=167;AF=0.49;MQM=60;TRIO=HET,167,0.49,WT,142,0.00,HET,178,0.46	GAN	missense	GAN:ENST00000568107:missense:MODERATE:exon9/11:c.1445C>T:p.Ala482Val		rs146576740	0.0008	0.0017	0,0,0	0.0003,0.0005,0.0000,0.0025,0.0009	0.0017	1.8290	T	T	B	T	17.04	605379 [GAN (confirmed) Giant axonal neuropathy-1,256850];	RCV000255353.1 [uncertain significance]; 			1	30	3	[3] Stephan Waldm?ller 13.08.2014			GAN (inh=AR pLI=0.04)
chr16	81411448	81411448	G	A	hom	anno_omim	QUAL=21087;DP=328;AF=0.99;MQM=60;TRIO=HOM,328,0.99,HOM,220,1.00,HET,298,0.45	GAN	3'UTR	GAN:ENST00000568107:3'UTR:MODIFIER:exon11/11:c.*247G>A:		rs2216769	0.6276	0.0000	0,0,0	0,0,0,0,0	0.5723							605379 [GAN (confirmed) Giant axonal neuropathy-1,256850];	RCV000346692.1 [benign]; 			91	108					GAN (inh=AR pLI=0.04)
chr16	81411673	81411673	C	G	hom	anno_omim	QUAL=31887;DP=451;AF=1.00;MQM=59;TRIO=HOM,451,1.00,HOM,368,1.00,HET,431,0.44	GAN	3'UTR	GAN:ENST00000568107:3'UTR:MODIFIER:exon11/11:c.*472C>G:		rs1816122	0.6711	0.0000	0,0,0	0,0,0,0,0	0.6130							605379 [GAN (confirmed) Giant axonal neuropathy-1,256850];	RCV000353280.1 [benign]; 			100	108					GAN (inh=AR pLI=0.04)
chr16	81411793	81411793	T	A	hom	anno_omim	QUAL=19915;DP=291;AF=0.99;MQM=60;TRIO=HOM,291,0.99,HOM,211,1.00,HET,264,0.45	GAN	3'UTR	GAN:ENST00000568107:3'UTR:MODIFIER:exon11/11:c.*592T>A:		rs1345895	0.6418	0.0000	0,0,0	0,0,0,0,0	0.5955							605379 [GAN (confirmed) Giant axonal neuropathy-1,256850];	RCV000273804.1 [benign]; 			100	106					GAN (inh=AR pLI=0.04)
chr16	81412168	81412168	G	A	hom	anno_omim	QUAL=14455;DP=272;AF=1.00;MQM=60;TRIO=HOM,272,1.00,HOM,87,1.00,HET,168,0.54	GAN	3'UTR	GAN:ENST00000568107:3'UTR:MODIFIER:exon11/11:c.*967G>A:		rs12920236	0.3055	0.0000	0,0,0	0,0,0,0,0	0.4085							605379 [GAN (confirmed) Giant axonal neuropathy-1,256850];	RCV000382338.1 [benign]; 			71	104					GAN (inh=AR pLI=0.04)
chr16	83941726	83941726	C	T	het	anno_omim;anno_pathogenic_hgmd	QUAL=2568;DP=107;AF=0.43;MQM=60;TRIO=HET,107,0.43,HET,133,0.51,WT,174,0.00	MLYCD	splice_region&intron	MLYCD:ENST00000262430:splice_region&intron:LOW:exon2/4:c.642-5C>T:		rs2278037	0.0773	0.0642	320,84,54	0.1069,0.1366,0.1299,0.0484,0.0164	0.0741							606761 [MLYCD (provisional) Malonyl-CoA decarboxylase deficiency,248360];	RCV000081530.5 [benign]; RCV000347623.1 [likely benign]; 	CS016047 [CLASS=DM? MUT=ALT PHEN="Malonyl-CoA decarboxylase deficiency" GENE=MLYCD]; 		9	159	2	[2] old entry - no details available			MLYCD (inh=AR pLI=0.00)
chr16	83941821	83941821	G	A	het	anno_omim	QUAL=4937;DP=258;AF=0.47;MQM=59;TRIO=HET,258,0.47,HET,159,0.52,WT,213,0.00	MLYCD,RP11-505K9.4	synonymous	MLYCD:ENST00000262430:synonymous:LOW:exon3/5:c.732G>A:p.Ser244Ser		rs2278038	0.0481	0.0560	283,89,2	0.0106,0.1335,0.1308,0.0482,0.0164	0.0579							606761 [MLYCD (provisional) Malonyl-CoA decarboxylase deficiency,248360];	RCV000126785.2 [benign]; RCV000406258.1 [likely benign]; 		COSM3755130	7	151					MLYCD (inh=AR pLI=0.00), RP11-505K9.4 (inh=n/a pLI=n/a)
chr16	83949506	83949506	T	C	het	anno_omim	QUAL=9360;DP=444;AF=0.51;MQM=60;TRIO=HET,444,0.51,HET,303,0.46,WT,349,0.00	MLYCD,RP11-505K9.4	3'UTR	MLYCD:ENST00000262430:3'UTR:MODIFIER:exon5/5:c.*412T>C:		rs1127382	0.1556	0.0000	0,0,0	0,0,0,0,0	0.1230							606761 [MLYCD (provisional) Malonyl-CoA decarboxylase deficiency,248360];	RCV000370065.1 [benign]; 			3	40					MLYCD (inh=AR pLI=0.00), RP11-505K9.4 (inh=n/a pLI=n/a)
chr16	85945231	85945231	C	T	het	anno_omim	QUAL=5656;DP=220;AF=0.49;MQM=60;TRIO=HET,220,0.49,HET,237,0.55,WT,240,0.00	IRF8	synonymous	IRF8:ENST00000268638:synonymous:LOW:exon4/9:c.414C>T:p.Cys138Cys		rs8052064	0.0875	0.1236	980,614,84	0.1366,0.1184,0.0043,0.1375,0.1018	0.1462							601565 [IRF8 (provisional) Immunodeficiency 32A,mycobacteriosis,autosomal dominant,614893|Immunodeficiency 32B,monocyte and dendritic cell deficiency,autosomal recessive,614894];				39	469					IRF8 (inh=AR pLI=0.93)
chr16	85955242	85955242	C	T	hom	anno_omim	QUAL=9855;DP=180;AF=1.00;MQM=60;TRIO=HOM,180,1.00,HET,159,0.52,HET,168,0.48	IRF8	3'UTR	IRF8:ENST00000268638:3'UTR:MODIFIER:exon9/9:c.*354C>T:		rs10514611	0.1905	0.0000	0,0,0	0,0,0,0,0	0.2420							601565 [IRF8 (provisional) Immunodeficiency 32A,mycobacteriosis,autosomal dominant,614893|Immunodeficiency 32B,monocyte and dendritic cell deficiency,autosomal recessive,614894];		CR127264 [CLASS=DFP MUT=ALT PHEN="Tuberculosis association with" GENE=IRF8]; 		18	71					IRF8 (inh=AR pLI=0.93)
chr16	85955304	85955304	G	T	hom	anno_omim	QUAL=11969;DP=221;AF=1.00;MQM=60;TRIO=HOM,221,1.00,HOM,79,1.00,HOM,78,1.00	IRF8	3'UTR	IRF8:ENST00000268638:3'UTR:MODIFIER:exon9/9:c.*416G>T:		rs1568391	0.6751	0.0000	0,0,0	0,0,0,0,0	0.6078							601565 [IRF8 (provisional) Immunodeficiency 32A,mycobacteriosis,autosomal dominant,614893|Immunodeficiency 32B,monocyte and dendritic cell deficiency,autosomal recessive,614894];				81	104					IRF8 (inh=AR pLI=0.93)
chr16	85955671	85955671	C	T	hom	anno_omim	QUAL=31120;DP=374;AF=1.00;MQM=59;TRIO=HOM,374,1.00,HOM,270,1.00,HOM,305,1.00	IRF8	3'UTR	IRF8:ENST00000268638:3'UTR:MODIFIER:exon9/9:c.*783C>T:		rs1044873	0.3548	0.0000	0,0,0	0,0,0,0,0	0.4148							601565 [IRF8 (provisional) Immunodeficiency 32A,mycobacteriosis,autosomal dominant,614893|Immunodeficiency 32B,monocyte and dendritic cell deficiency,autosomal recessive,614894];				39	108					IRF8 (inh=AR pLI=0.93)
chr16	85955730	85955730	A	-	hom	anno_omim	QUAL=30986;DP=333;AF=1.00;MQM=59;TRIO=HOM,333,1.00,HOM,311,1.00,HOM,359,1.00	IRF8	3'UTR	IRF8:ENST00000268638:3'UTR:MODIFIER:exon9/9:c.*843delA:		rs397844297	0.7362	0.0000	0,0,0	0,0,0,0,0	0.6525							601565 [IRF8 (provisional) Immunodeficiency 32A,mycobacteriosis,autosomal dominant,614893|Immunodeficiency 32B,monocyte and dendritic cell deficiency,autosomal recessive,614894];				83	103					IRF8 (inh=AR pLI=0.93)
chr16	85956044	85956044	A	T	hom	anno_omim	QUAL=4631;DP=118;AF=1.00;MQM=60;TRIO=HOM,118,1.00,HOM,16,1.00,HOM,16,1.00	IRF8	3'UTR	IRF8:ENST00000268638:3'UTR:MODIFIER:exon9/9:c.*1156A>T:		rs6638	0.6538	0.0000	0,0,0	0,0,0,0,0	0.5918							601565 [IRF8 (provisional) Immunodeficiency 32A,mycobacteriosis,autosomal dominant,614893|Immunodeficiency 32B,monocyte and dendritic cell deficiency,autosomal recessive,614894];				82	100					IRF8 (inh=AR pLI=0.93)
chr16	88494947	88494947	T	C	hom	gene_blacklist;anno_omim	QUAL=11401;DP=72;AF=1.00;MQM=59;TRIO=HOM,72,1.00,HOM,113,1.00,HOM,190,0.99	ZNF469	missense	ZNF469:ENST00000565624:missense:MODERATE:exon1/1:c.1069T>C:p.Ser357Pro,ZNF469:ENST00000437464:missense:MODERATE:exon1/2:c.1069T>C:p.Ser357Pro		rs11648572	0.9890	0.9827	7497,2594,595	0.9942,0.9849,1.0000,0.9740,0.9861	0.9754	-0.4430	T	T	B	T	0.01	612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000173223.1 [benign]; RCV000352613.1 [benign]; 		COSM4129466	1965	119					ZNF469 (inh=AR pLI=n/a)
chr16	88494976	88494976	A	C	hom	gene_blacklist;anno_omim	QUAL=12663;DP=108;AF=1.00;MQM=59;TRIO=HOM,108,1.00,HOM,122,1.00,HOM,185,1.00	ZNF469	missense	ZNF469:ENST00000565624:missense:MODERATE:exon1/1:c.1098A>C:p.Arg366Ser,ZNF469:ENST00000437464:missense:MODERATE:exon1/2:c.1098A>C:p.Arg366Ser		rs11640794	0.8550	0.9341	6850,2497,245	0.6406,0.9142,0.9257,0.9545,0.9660	0.9298	0.5620	T	T	B	T	0.01	612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000173224.1 [benign]; RCV000402834.1 [benign]; 			1837	238					ZNF469 (inh=AR pLI=n/a)
chr16	88495407	88495407	G	C	hom	gene_blacklist;anno_omim	QUAL=5351;DP=45;AF=1.00;MQM=59;TRIO=HOM,45,1.00,HOM,50,1.00,HOM,90,1.00	ZNF469	missense	ZNF469:ENST00000565624:missense:MODERATE:exon1/1:c.1529G>C:p.Gly510Ala,ZNF469:ENST00000437464:missense:MODERATE:exon1/2:c.1529G>C:p.Gly510Ala		rs7199961	0.9916	0.9996	6667,2144,323	0.9924,0.9953,1.0000,1.0000,1.0000	0.9992	0.1520	T	T	B	T	0.01	612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000266943.1 [benign]; 		COSM3755187	2091	2					ZNF469 (inh=AR pLI=n/a)
chr16	88495654	88495654	A	G	hom	gene_blacklist;anno_omim	QUAL=6047;DP=51;AF=1.00;MQM=59;TRIO=HOM,51,1.00,HOM,61,1.00,HOM,100,1.00	ZNF469	synonymous	ZNF469:ENST00000565624:synonymous:LOW:exon1/1:c.1776A>G:p.Pro592Pro,ZNF469:ENST00000437464:synonymous:LOW:exon1/2:c.1776A>G:p.Pro592Pro		rs12927001	0.8748	0.9444	6586,2406,265	0.7259,0.9245,0.9420,0.9566,0.9653	0.9345							612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000332131.1 [benign]; 		COSM4129467	1864	233					ZNF469 (inh=AR pLI=n/a)
chr16	88496008	88496008	T	C	het	gene_blacklist;anno_omim	QUAL=2465;DP=30;AF=0.47;MQM=59;TRIO=HET,30,0.47,HET,32,0.31,HOM,70,1.00	ZNF469	synonymous	ZNF469:ENST00000565624:synonymous:LOW:exon1/1:c.2130T>C:p.Pro710Pro,ZNF469:ENST00000437464:synonymous:LOW:exon1/2:c.2130T>C:p.Pro710Pro		rs12918876	0.6044	0.7420	3871,1356,50	0.3864,0.7366,0.6425,0.7591,0.7752	0.7033							612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000303039.1 [benign]; 		COSM4129468	1125	794					ZNF469 (inh=AR pLI=n/a)
chr16	88497031	88497031	T	C	hom	low_DP;gene_blacklist;anno_omim	QUAL=1997;DP=4;AF=1.00;MQM=60;TRIO=HOM,4,1.00,HOM,22,1.00,HOM,40,1.00	ZNF469	synonymous	ZNF469:ENST00000565624:synonymous:LOW:exon1/1:c.3153T>C:p.Ile1051Ile,ZNF469:ENST00000437464:synonymous:LOW:exon1/2:c.3153T>C:p.Ile1051Ile		rs9924504	1.0000	1.0000	5554,1442,164	1.0000,0.0000,0.0000,1.0000,1.0000	1.0000							612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000173219.2 [benign]; RCV000260279.1 [benign]; 			2072	2					ZNF469 (inh=AR pLI=n/a)
chr16	88497394	88497394	T	C	het	gene_blacklist;anno_omim	QUAL=1597;DP=57;AF=0.49;MQM=59;TRIO=HET,57,0.49,WT,76,0.00,HET,78,0.53	ZNF469	synonymous	ZNF469:ENST00000565624:synonymous:LOW:exon1/1:c.3516T>C:p.Arg1172Arg,ZNF469:ENST00000437464:synonymous:LOW:exon2/2:c.3432T>C:p.Arg1144Arg		rs111557381	0.0381	0.0556	25,5,4	0.0807,0.0431,0.0000,0.0474,0.0592	0.0578							612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000361351.1 [benign]; RCV000381675.1 [likely benign]; 		COSM3755188	10	197					ZNF469 (inh=AR pLI=n/a)
chr16	88497400	88497400	G	A	hom	gene_blacklist;anno_omim	QUAL=6012;DP=50;AF=0.96;MQM=59;TRIO=HOM,50,0.96,HOM,76,1.00,HOM,76,1.00	ZNF469	synonymous	ZNF469:ENST00000565624:synonymous:LOW:exon1/1:c.3522G>A:p.Pro1174Pro,ZNF469:ENST00000437464:synonymous:LOW:exon2/2:c.3438G>A:p.Pro1146Pro		rs9938800	0.9026	0.9603	6472,2108,248	0.7153,0.9423,1.0000,0.9672,0.9867	0.9628							612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000264366.1 [benign]; RCV000291992.1 [benign]; 		COSM3755189	1948	122					ZNF469 (inh=AR pLI=n/a)
chr16	88497446	88497446	A	G	het	gene_blacklist;anno_omim	QUAL=4954;DP=65;AF=0.62;MQM=59;TRIO=HET,65,0.62,HOM,86,1.00,HET,105,0.52	ZNF469	missense	ZNF469:ENST00000565624:missense:MODERATE:exon1/1:c.3568A>G:p.Lys1190Glu,ZNF469:ENST00000437464:missense:MODERATE:exon2/2:c.3484A>G:p.Lys1162Glu		rs7197071	0.8189	0.9022	6438,2480,172	0.5252,0.8801,0.9679,0.9411,0.9328	0.9079	-0.3040	T	T	B	T	3.02	612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000303459.1 [benign]; RCV000393906.1 [benign]; 		COSM3755190	1786	296					ZNF469 (inh=AR pLI=n/a)
chr16	88498221	88498221	C	T	hom	gene_blacklist;pred_pathogenic;anno_omim	QUAL=13563;DP=125;AF=0.97;MQM=59;TRIO=HOM,125,0.97,HOM,147,1.00,HOM,182,0.99	ZNF469	missense	ZNF469:ENST00000565624:missense:MODERATE:exon1/1:c.4343C>T:p.Pro1448Leu,ZNF469:ENST00000437464:missense:MODERATE:exon2/2:c.4259C>T:p.Pro1420Leu		rs4782300	0.8442	0.8748	7440,3382,649	0.7832,0.8886,0.8795,0.9105,0.8614	0.8963	2.7110	T	T	B	T	11.71	612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000335231.1 [benign]; RCV000360108.1 [benign]; 		COSM3755191	1666	410					ZNF469 (inh=AR pLI=n/a)
chr16	88498297	88498297	T	G	hom	gene_blacklist;anno_omim	QUAL=19052;DP=145;AF=1.00;MQM=59;TRIO=HOM,145,1.00,HOM,239,1.00,HOM,251,1.00	ZNF469	synonymous	ZNF469:ENST00000565624:synonymous:LOW:exon1/1:c.4419T>G:p.Ser1473Ser,ZNF469:ENST00000437464:synonymous:LOW:exon2/2:c.4335T>G:p.Ser1445Ser		rs12445417	0.8464	0.9278	8616,3898,311	0.5327,0.9342,0.9676,0.9713,0.9845	0.9523							612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000290308.1 [benign]; RCV000332940.1 [benign]; 		COSM4129472	1993	118					ZNF469 (inh=AR pLI=n/a)
chr16	88499539	88499539	C	G	hom	gene_blacklist;anno_omim	QUAL=18190;DP=252;AF=1.00;MQM=59;TRIO=HOM,252,1.00,HOM,151,1.00,HOM,190,1.00	ZNF469	synonymous	ZNF469:ENST00000565624:synonymous:LOW:exon1/1:c.5661C>G:p.Thr1887Thr,ZNF469:ENST00000437464:synonymous:LOW:exon2/2:c.5577C>G:p.Thr1859Thr		rs9931465	0.7796	0.8648	7264,3417,329	0.5648,0.8818,0.8813,0.9259,0.8777	0.8925							612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000341186.1 [benign]; 		COSM435898	1711	372					ZNF469 (inh=AR pLI=n/a)
chr16	88501034	88501034	G	C	het	gene_blacklist;anno_omim	QUAL=727;DP=47;AF=0.43;MQM=60;TRIO=HET,47,0.43,HET,17,0.53,HET,10,0.50	ZNF469	missense	ZNF469:ENST00000565624:missense:MODERATE:exon1/1:c.7156G>C:p.Gly2386Arg,ZNF469:ENST00000437464:missense:MODERATE:exon2/2:c.7072G>C:p.Gly2358Arg		rs12598474	0.2951	0.3093	896,513,69	0.2640,0.3073,0.4301,0.3766,0.2444	0.3626	-1.1320	T	T	B	T	1.28	612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000393479.1 [benign]; 		COSM472205	261	924					ZNF469 (inh=AR pLI=n/a)
chr16	88501971	88501971	T	A	het	gene_blacklist;anno_omim	QUAL=3792;DP=74;AF=0.46;MQM=60;TRIO=HET,74,0.46,HET,98,0.52,HET,131,0.52	ZNF469	missense	ZNF469:ENST00000565624:missense:MODERATE:exon1/1:c.8093T>A:p.Leu2698Gln,ZNF469:ENST00000437464:missense:MODERATE:exon2/2:c.8009T>A:p.Leu2670Gln		rs3812956	0.2943	0.3062	895,509,53	0.2268,0.3434,0.4565,0.3709,0.2464	0.3474	-1.0570	T	T	B	T	0.01	612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000286597.1 [benign]; RCV000330898.1 [benign]; 		COSM3755192	256	931					ZNF469 (inh=AR pLI=n/a)
chr16	88502482	88502482	C	T	het	gene_blacklist;anno_omim	QUAL=6290;DP=182;AF=0.61;MQM=59;TRIO=HET,182,0.61,HET,125,0.50,HET,160,0.54	ZNF469	synonymous	ZNF469:ENST00000565624:synonymous:LOW:exon1/1:c.8604C>T:p.Arg2868Arg,ZNF469:ENST00000437464:synonymous:LOW:exon2/2:c.8520C>T:p.Arg2840Arg		rs3812953	0.4700	0.5345	2564,900,138	0.3785,0.5181,0.4425,0.5161,0.5929	0.5042							612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000334561.1 [benign]; RCV000361549.1 [benign]; 		COSM435901	505	1031					ZNF469 (inh=AR pLI=n/a)
chr16	88502505	88502505	A	G	hom	gene_blacklist;pred_pathogenic;anno_omim	QUAL=11651;DP=118;AF=0.99;MQM=59;TRIO=HOM,118,0.99,HOM,114,1.00,HOM,146,1.00	ZNF469	missense	ZNF469:ENST00000565624:missense:MODERATE:exon1/1:c.8627A>G:p.His2876Arg,ZNF469:ENST00000437464:missense:MODERATE:exon2/2:c.8543A>G:p.His2848Arg		rs1983014	0.9962	0.9983	9014,3586,897	0.9849,1.0000,1.0000,0.9997,1.0000	0.9992	4.7990	T	T	B	T	0.01	612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000175671.1 [benign]; RCV000308538.1 [benign]; 			2114	0					ZNF469 (inh=AR pLI=n/a)
chr16	88504206	88504206	G	C	het	gene_blacklist;anno_omim	QUAL=2431;DP=55;AF=0.53;MQM=59;TRIO=HET,55,0.53,HET,215,0.39,WT,294,0.00	ZNF469	missense	ZNF469:ENST00000565624:missense:MODERATE:exon1/1:c.10328G>C:p.Gly3443Ala,ZNF469:ENST00000437464:missense:MODERATE:exon2/2:c.10244G>C:p.Gly3415Ala		rs140056980	0.0000	0.0018	0,0,0	0.0000,0.0000,0.0000,0.0056,0.0000	0.0013	0.5390	T	T	B	T	0.01	612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];				0	7					ZNF469 (inh=AR pLI=n/a)
chr16	88504850	88504850	G	C	het	gene_blacklist;pred_pathogenic;anno_omim	QUAL=6778;DP=130;AF=0.50;MQM=59;TRIO=HET,130,0.50,HET,175,0.52,HET,230,0.51	ZNF469	missense	ZNF469:ENST00000565624:missense:MODERATE:exon1/1:c.10972G>C:p.Glu3658Gln,ZNF469:ENST00000437464:missense:MODERATE:exon2/2:c.10888G>C:p.Glu3630Gln		rs1105066	0.3910	0.3255	845,368,169	0.5332,0.3667,0.4551,0.3849,0.2431	0.4615	-0.5190	D	T	B	T	7.15	612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000384193.1 [benign]; 			314	925					ZNF469 (inh=AR pLI=n/a)
chr16	88504868	88504868	A	G	hom	gene_blacklist;anno_omim	QUAL=14955;DP=100;AF=0.99;MQM=59;TRIO=HOM,100,0.99,HOM,168,1.00,HOM,234,1.00	ZNF469	missense	ZNF469:ENST00000565624:missense:MODERATE:exon1/1:c.10990A>G:p.Thr3664Ala,ZNF469:ENST00000437464:missense:MODERATE:exon2/2:c.10906A>G:p.Thr3636Ala		rs904783	0.9992	0.9998	7998,2965,661	0.9985,1.0000,1.0000,0.9998,1.0000	0.9999	-1.3970	T	T	B	T	0.03	612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000175660.1 [benign]; RCV000349645.1 [benign]; 		COSM4129476	2113	0					ZNF469 (inh=AR pLI=n/a)
chr16	88505635	88505635	A	G	het	gene_blacklist;anno_omim	QUAL=10113;DP=132;AF=0.48;MQM=59;TRIO=HET,132,0.48,HET,183,0.52,HOM,206,1.00	ZNF469	synonymous	ZNF469:ENST00000565624:synonymous:LOW:exon1/1:c.11757A>G:p.Pro3919Pro,ZNF469:ENST00000437464:synonymous:LOW:exon2/2:c.11673A>G:p.Pro3891Pro		rs4782301	0.7963	0.7886	5981,2403,638	0.7875,0.8417,0.7313,0.7727,0.8074	0.7852							612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000325525.1 [benign]; 			1329	676					ZNF469 (inh=AR pLI=n/a)
chr16	88505734	88505734	C	T	hom	gene_blacklist;anno_omim	QUAL=21675;DP=210;AF=1.00;MQM=59;TRIO=HOM,210,1.00,HOM,207,1.00,HOM,255,1.00	ZNF469	synonymous	ZNF469:ENST00000565624:synonymous:LOW:exon1/1:c.11856C>T:p.Ser3952Ser,ZNF469:ENST00000437464:synonymous:LOW:exon2/2:c.11772C>T:p.Ser3924Ser		rs4782362	0.9872	0.9957	9082,3711,856	0.9607,0.9916,1.0000,0.9997,1.0000	0.9978							612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000329575.1 [benign]; 			2107	2					ZNF469 (inh=AR pLI=n/a)
chr16	88505748	88505748	G	A	het	gene_blacklist;anno_omim	QUAL=3772;DP=176;AF=0.43;MQM=59;TRIO=HET,176,0.43,HET,194,0.43,WT,234,0.00	ZNF469	3'UTR	ZNF469:ENST00000565624:3'UTR:MODIFIER:exon1/1:c.*8G>A:,ZNF469:ENST00000437464:3'UTR:MODIFIER:exon2/2:c.*8G>A:		rs45504291	0.2214	0.2283	418,209,37	0.2253,0.3007,0.2891,0.2731,0.1850	0.2593							612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000386403.1 [benign]; 			137	722					ZNF469 (inh=AR pLI=n/a)
chr16	88506358	88506358	T	G	hom	gene_blacklist;anno_omim	QUAL=33589;DP=288;AF=1.00;MQM=59;TRIO=HOM,288,1.00,HOM,350,1.00,HOM,423,1.00	ZNF469	3'UTR	ZNF469:ENST00000565624:3'UTR:MODIFIER:exon1/1:c.*618T>G:,ZNF469:ENST00000437464:3'UTR:MODIFIER:exon2/2:c.*618T>G:		rs3859020	0.9473	0.0000	0,0,0	0,0,0,0,0	0.9302							612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000318656.1 [benign]; 			221	11					ZNF469 (inh=AR pLI=n/a)
chr16	88506528	88506528	G	A	hom	gene_blacklist;anno_omim	QUAL=21422;DP=206;AF=0.98;MQM=59;TRIO=HOM,206,0.98,HOM,214,1.00,HOM,303,1.00	ZNF469	3'UTR	ZNF469:ENST00000565624:3'UTR:MODIFIER:exon1/1:c.*788G>A:,ZNF469:ENST00000437464:3'UTR:MODIFIER:exon2/2:c.*788G>A:		rs3894713	0.9862	0.0000	0,0,0	0,0,0,0,0	0.9901							612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000293816.1 [benign]; 			232	0					ZNF469 (inh=AR pLI=n/a)
chr16	88506600	88506600	T	-	het	gene_blacklist;anno_omim	QUAL=10381;DP=184;AF=0.48;MQM=59;TRIO=HET,184,0.48,HET,199,0.48,HOM,248,0.94	ZNF469	3'UTR	ZNF469:ENST00000565624:3'UTR:MODIFIER:exon1/1:c.*870delT:,ZNF469:ENST00000437464:3'UTR:MODIFIER:exon2/2:c.*870delT:		rs35684712	0.5501	0.0000	0,0,0	0,0,0,0,0	0.5309							612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000290346.1 [benign]; 			96	102					ZNF469 (inh=AR pLI=n/a)
chr16	88506741	88506741	A	G	hom	gene_blacklist;anno_omim	QUAL=12053;DP=120;AF=1.00;MQM=59;TRIO=HOM,120,1.00,HOM,135,0.99,HOM,130,1.00	ZNF469	3'UTR	ZNF469:ENST00000565624:3'UTR:MODIFIER:exon1/1:c.*1001A>G:,ZNF469:ENST00000437464:3'UTR:MODIFIER:exon2/2:c.*1001A>G:		rs3848234	0.8409	0.0000	0,0,0	0,0,0,0,0	0.7991							612078 [ZNF469 (confirmed) Brittle cornea syndrome 1,229200];	RCV000408283.1 [benign]; 			166	61					ZNF469 (inh=AR pLI=n/a)
chr16	88713236	88713236	A	G	hom	pred_pathogenic;anno_omim	QUAL=21552;DP=203;AF=1.00;MQM=59;TRIO=HOM,203,1.00,HET,328,0.47,HOM,396,1.00	CYBA	missense	CYBA:ENST00000567174:missense:MODERATE:exon4/6:c.214T>C:p.Tyr72His,CYBA:ENST00000261623:missense:MODERATE:exon4/6:c.214T>C:p.Tyr72His,CYBA:ENST00000569359:missense:MODERATE:exon4/5:c.214T>C:p.Tyr72His		rs4673	0.6643	0.6908	29452,14998,1554	0.5487,0.7754,0.9123,0.6708,0.6339	0.6975	4.4150	T	T	D	D	11.69	608508 [CYBA (confirmed) Chronic granulomatous disease,autosomal,due to deficiency of CYBA,233690];	RCV000002351.2 [benign]; RCV000249071.1 [benign]; 		COSM3755197	856	968					CYBA (inh=AR pLI=0.00)
chr16	88713501	88713501	A	G	hom	anno_omim	QUAL=5378;DP=97;AF=1.00;MQM=59;TRIO=HOM,97,1.00,HET,55,0.45,HOM,62,1.00	CYBA	splice_region&intron	CYBA:ENST00000567174:splice_region&intron:LOW:exon3/5:c.203+8T>C:,CYBA:ENST00000261623:splice_region&intron:LOW:exon3/5:c.203+8T>C:,CYBA:ENST00000569359:splice_region&intron:LOW:exon3/4:c.203+8T>C:		rs4782393	0.3660	0.4821	12972,8034,427	0.3237,0.5571,0.2614,0.5188,0.4697	0.4723							608508 [CYBA (confirmed) Chronic granulomatous disease,autosomal,due to deficiency of CYBA,233690];	RCV000176978.2 [benign]; 			483	973					CYBA (inh=AR pLI=0.00)
chr16	88717386	88717386	T	C	hom	anno_omim	QUAL=1528;DP=21;AF=1.00;MQM=60;TRIO=HOM,21,1.00,HOM,12,1.00,HOM,21,1.00	CYBA	synonymous	CYBA:ENST00000567174:synonymous:LOW:exon1/6:c.36A>G:p.Glu12Glu,CYBA:ENST00000261623:synonymous:LOW:exon1/6:c.36A>G:p.Glu12Glu,CYBA:ENST00000569359:synonymous:LOW:exon1/5:c.36A>G:p.Glu12Glu		rs8053867	0.9956	0.9991	44806,25040,3395	0.9888,0.9995,1.0000,1.0000,1.0000	0.9993							608508 [CYBA (confirmed) Chronic granulomatous disease,autosomal,due to deficiency of CYBA,233690];			COSM4129484	2107	0					CYBA (inh=AR pLI=0.00)
chr16	89238190	89238190	G	A	hom	anno_omim	QUAL=6483;DP=92;AF=0.99;MQM=59;TRIO=HOM,92,0.99,HOM,114,0.98,HET,94,0.59	CDH15	5'UTR	CDH15:ENST00000289746:5'UTR:MODIFIER:exon1/14:c.-50G>A:		rs12927793	0.2510	0.4180	1657,1248,11	0.2105,0.3724,0.0117,0.6356,0.2844	0.4221							114019 [CDH15 (provisional) Mental retardation,autosomal dominant 3,612580];				599	929					CDH15 (inh=AD pLI=0.00)
chr16	89597221	89597221	A	G	het	anno_omim	QUAL=18013;DP=143;AF=0.48;MQM=59;TRIO=HET,143,0.48,HOM,367,1.00,HET,451,0.50	SPG7	splice_region&intron	SPG7:ENST00000268704:splice_region&intron:LOW:exon7/16:c.987+5A>G:,SPG7:ENST00000341316:splice_region&intron:LOW:exon7/9:c.987+5A>G:		rs4785691	0.5294	0.4731	14027,6950,910	0.4201,0.3554,0.6726,0.4536,0.5698	0.4736							602783 [SPG7 (provisional) Spastic paraplegia 7,autosomal recessive,607259];	RCV000251593.1 [benign]; RCV000298634.1 [benign]; 			885	1730					SPG7 (inh=AR+AD pLI=0.00)
chr16	89603586	89603586	A	G	het	anno_omim	QUAL=6304;DP=147;AF=0.47;MQM=59;TRIO=HET,147,0.47,HOM,101,1.00,HET,140,0.44	SPG7	3'UTR,intron	SPG7:ENST00000341316:3'UTR:MODIFIER:exon10/10:c.*268A>G:,SPG7:ENST00000268704:intron:MODIFIER:exon9/16:c.1324+4542A>G:		rs382745	0.5387	0.0000	0,0,0	0,0,0,0,0	0.4678							602783 [SPG7 (provisional) Spastic paraplegia 7,autosomal recessive,607259];				53	120					SPG7 (inh=AR+AD pLI=0.00)
chr16	89603698	89603698	-	T	het	anno_omim	QUAL=2982;DP=132;AF=0.42;MQM=60;TRIO=HET,132,0.42,WT,84,0.00,HET,116,0.59	SPG7	3'UTR,intron	SPG7:ENST00000341316:3'UTR:MODIFIER:exon10/10:c.*380_*381insT:,SPG7:ENST00000268704:intron:MODIFIER:exon9/16:c.1324+4654_1324+4655insT:		rs3833827	0.4359	0.0000	0,0,0	0,0,0,0,0	0.5130							602783 [SPG7 (provisional) Spastic paraplegia 7,autosomal recessive,607259];				59	121					SPG7 (inh=AR+AD pLI=0.00)
chr16	89623746	89623746	G	T	het	anno_omim	QUAL=4168;DP=221;AF=0.46;MQM=60;TRIO=HET,221,0.46,WT,121,0.00,HET,141,0.48	SPG7	3'UTR	SPG7:ENST00000268704:3'UTR:MODIFIER:exon17/17:c.*245G>T:		rs780776019	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							602783 [SPG7 (provisional) Spastic paraplegia 7,autosomal recessive,607259];				0	2					SPG7 (inh=AR+AD pLI=0.00)
chr16	89804336	89804336	T	-	het	anno_omim	QUAL=5699;DP=227;AF=0.49;MQM=59;TRIO=HET,227,0.49,WT,234,0.00,HET,298,0.46	FANCA,ZNF276	3'UTR,intron	FANCA:ENST00000389301:3'UTR:MODIFIER:exon43/43:c.*673delA:,ZNF276:ENST00000568064:3'UTR:MODIFIER:exon10/10:c.*19delT:,ZNF276:ENST00000443381:intron:MODIFIER:exon10/10:c.1574+23delT:,ZNF276:ENST00000446326:intron:MODIFIER:exon10/10:c.932+23delT:,ZNF276:ENST00000289816:intron:MODIFIER:exon10/10:c.1349+23delT:		rs17233826	0.0000	0.4862	16320,4399,2087	0.6363,0.6820,0.9793,0.3611,0.5081	0.4974							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	RCV000297540.1 [benign]; 			285	634					FANCA (inh=AR pLI=0.00), ZNF276 (inh=n/a pLI=0.00)
chr16	89804855	89804855	C	T	het	anno_omim	QUAL=9522;DP=319;AF=0.51;MQM=60;TRIO=HET,319,0.51,WT,332,0.00,HET,447,0.47	ZNF276,FANCA	3'UTR	ZNF276:ENST00000443381:3'UTR:MODIFIER:exon11/11:c.*201C>T:,FANCA:ENST00000389301:3'UTR:MODIFIER:exon43/43:c.*154G>A:,ZNF276:ENST00000289816:3'UTR:MODIFIER:exon11/11:c.*201C>T:,ZNF276:ENST00000568064:3'UTR:MODIFIER:exon10/10:c.*538C>T:,FANCA:ENST00000568369:3'UTR:MODIFIER:exon43/43:c.*251G>A:		rs1230	0.6977	0.0000	0,0,0	0,0,0,0,0	0.5412							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	RCV000339087.1 [benign]; 			25	71					ZNF276 (inh=n/a pLI=0.00), FANCA (inh=AR pLI=0.00)
chr16	89836323	89836323	C	T	het	pred_pathogenic;anno_omim	QUAL=6396;DP=219;AF=0.49;MQM=59;TRIO=HET,219,0.49,WT,203,0.00,HET,270,0.53	FANCA	missense	FANCA:ENST00000389301:missense:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp,FANCA:ENST00000568369:missense:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp		rs7195066	0.6667	0.4690	16070,3144,2387	0.6766,0.6797,0.9854,0.3064,0.5907	0.4758	0.3050	T	T	B,B	D	3.27	607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	RCV000120927.2 [benign]; RCV000292806.1 [benign]; 	CM137288 [CLASS=R MUT=ALT PHEN="Fanconi anaemia A" GENE=FANCA]; 	COSM435949	553	1759	2	[2] old entry - no details available			FANCA (inh=AR pLI=0.00)
chr16	89838078	89838078	A	G	het	anno_omim	QUAL=4280;DP=134;AF=0.48;MQM=59;TRIO=HET,134,0.48,WT,197,0.00,HET,251,0.47	FANCA	splice_region&intron	FANCA:ENST00000389301:splice_region&intron:LOW:exon23/42:c.2151+8T>C:,FANCA:ENST00000568369:splice_region&intron:LOW:exon23/42:c.2151+8T>C:		rs1800340	0.5599	0.4315	12977,3039,1411	0.5199,0.6644,0.7516,0.3015,0.5747	0.4371							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	RCV000244957.1 [benign]; RCV000398159.1 [benign]; 			479	1749	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCA (inh=AR pLI=0.00)
chr16	89849480	89849480	C	T	het	pred_pathogenic;anno_omim	QUAL=7910;DP=244;AF=0.53;MQM=60;TRIO=HET,244,0.53,WT,273,0.00,HET,319,0.55	FANCA	missense	FANCA:ENST00000389301:missense:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser,FANCA:ENST00000568369:missense:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser		rs2239359	0.6240	0.4995	16447,5298,2452	0.6852,0.6374,0.8551,0.3970,0.4906	0.5222	-0.0380	T	T	B,B	D	0.07	607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	RCV000120917.3 [benign]; RCV000389853.1 [benign]; 	CM137880 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA]; 		712	1960	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCA (inh=AR pLI=0.00)
chr16	89865103	89865103	T	A	het	anno_omim	QUAL=10095;DP=416;AF=0.48;MQM=60;TRIO=HET,416,0.48,WT,318,0.00,HET,411,0.47	FANCA	3'UTR,intron	FANCA:ENST00000389302:3'UTR:MODIFIER:exon11/11:c.*384A>T:,FANCA:ENST00000563673:3'UTR:MODIFIER:exon10/10:c.*413A>T:,FANCA:ENST00000389301:intron:MODIFIER:exon10/42:c.893+471A>T:,FANCA:ENST00000568369:intron:MODIFIER:exon10/42:c.893+471A>T:		rs11076626	0.6913	0.0000	0,0,0	0,0,0,0,0	0.5340							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];				49	101					FANCA (inh=AR pLI=0.00)
chr16	89865242	89865242	T	C	het	anno_omim	QUAL=5611;DP=230;AF=0.51;MQM=60;TRIO=HET,230,0.51,WT,193,0.00,HET,249,0.49	FANCA	3'UTR,intron	FANCA:ENST00000389302:3'UTR:MODIFIER:exon11/11:c.*245A>G:,FANCA:ENST00000563673:3'UTR:MODIFIER:exon10/10:c.*274A>G:,FANCA:ENST00000389301:intron:MODIFIER:exon10/42:c.893+332A>G:,FANCA:ENST00000568369:intron:MODIFIER:exon10/42:c.893+332A>G:		rs10852623	0.6871	0.0000	0,0,0	0,0,0,0,0	0.5311							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];				48	101					FANCA (inh=AR pLI=0.00)
chr16	89866043	89866043	T	C	het	anno_omim	QUAL=8225;DP=305;AF=0.48;MQM=59;TRIO=HET,305,0.48,WT,244,0.00,HET,334,0.50	FANCA	missense	FANCA:ENST00000389301:missense:MODERATE:exon9/43:c.796A>G:p.Thr266Ala,FANCA:ENST00000568369:missense:MODERATE:exon9/43:c.796A>G:p.Thr266Ala,FANCA:ENST00000389302:missense:MODERATE:exon9/11:c.796A>G:p.Thr266Ala,FANCA:ENST00000563673:missense:MODERATE:exon9/10:c.796A>G:p.Thr266Ala,FANCA:ENST00000534992:missense:MODERATE:exon9/11:c.796A>G:p.Thr266Ala,FANCA:ENST00000543736:missense:MODERATE:exon8/10:c.700A>G:p.Thr234Ala		rs7190823	0.6905	0.5166	18422,4824,2761	0.7267,0.6937,0.9847,0.3778,0.5923	0.5344	0.4020	T,T,T,T	T	B,B,B,B,B,B	T,T,T,T	0.01	607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	RCV000120967.2 [benign]; RCV000308742.1 [benign]; 	CM137879 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA]; 		719	1898	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCA (inh=AR pLI=0.00)
chr17	1247850	1247851	AG	-	het		QUAL=3405;DP=240;AF=0.46;MQM=59;TRIO=HET,240,0.46,HET,108,0.42,WT,132,0.00	YWHAE	3'UTR	YWHAE:ENST00000264335:3'UTR:MODIFIER:exon6/6:c.*890_*891delCT:,YWHAE:ENST00000571732:3'UTR:MODIFIER:exon7/7:c.*890_*891delCT:	(TTTAAG)n	rs147204530	0.0379	0.0000	0,0,0	0,0,0,0,0	0.0431											3	26					YWHAE (inh=n/a pLI=0.96)
chr17	1248466	1248466	C	T	het		QUAL=4907;DP=355;AF=0.44;MQM=60;TRIO=HET,355,0.44,HET,118,0.33,WT,160,0.00	YWHAE	3'UTR	YWHAE:ENST00000264335:3'UTR:MODIFIER:exon6/6:c.*275G>A:,YWHAE:ENST00000571732:3'UTR:MODIFIER:exon7/7:c.*275G>A:,YWHAE:ENST00000573026:3'UTR:MODIFIER:exon2/2:c.*275G>A:		rs7266	0.0379	0.0000	0,0,0	0,0,0,0,0	0.0430											3	26					YWHAE (inh=n/a pLI=0.96)
chr17	2586229	2586229	A	G	het	anno_omim	QUAL=25193;DP=581;AF=0.46;MQM=60;TRIO=HET,581,0.46,HET,323,0.47,HOM,418,1.00	PAFAH1B1	3'UTR	PAFAH1B1:ENST00000397195:3'UTR:MODIFIER:exon11/11:c.*1133A>G:		rs4790356	0.8367	0.0000	0,0,0	0,0,0,0,0	0.8474							601545 [PAFAH1B1 (confirmed) Lissencephaly 1,607432|Subcortical laminar heterotopia,607432];	RCV000365404.1 [benign]; 			195	37					PAFAH1B1 (inh=AR+AD pLI=1.00)
chr17	2588917	2588931	TTTTTTTTTTTTTTT	-	hom	anno_omim	QUAL=393;DP=20;AF=0.80;MQM=59;TRIO=HOM,20,0.80,HET,11,1.00,HOM,9,0.78	PAFAH1B1,RP11,74E22.6	intergenic_region	74E22.6:ENSG00000007168-ENSG00000272911:intergenic_region:MODIFIER::n.2588917_2588931delTTTTTTTTTTTTTTT:	(T)n	rs200593896;rs749202525;rs780861755	0.9982	0.0000	0,0,0	0,0,0,0,0	0.0000							601545 [PAFAH1B1 (confirmed) Lissencephaly 1,607432|Subcortical laminar heterotopia,607432];				46	6					PAFAH1B1 (inh=AR+AD pLI=1.00), PRPF31 (inh=AD pLI=0.97), 74E22.6 (inh=n/a pLI=n/a)
chr17	3377396	3377396	C	G	hom	anno_omim	QUAL=12534;DP=210;AF=1.00;MQM=60;TRIO=HOM,210,1.00,HET,108,0.49,HOM,132,1.00	ASPA,SPATA22	5'UTR,intron	ASPA:ENST00000456349:5'UTR:MODIFIER:exon1/7:c.-99C>G:,SPATA22:ENST00000541913:intron:MODIFIER:exon1/8:c.-73-4704G>C:		rs11078450	0.1945	0.0000	0,0,0	0,0,0,0,0	0.3752							608034 [ASPA (confirmed) Canavan disease,271900];				57	94					ASPA (inh=AR pLI=0.01), SPATA22 (inh=n/a pLI=0.00)
chr17	3402521	3402521	C	A	hom	anno_omim	QUAL=12679;DP=205;AF=1.00;MQM=59;TRIO=HOM,205,1.00,HOM,88,1.00,HOM,108,1.00	ASPA,SPATA22	3'UTR,intron	ASPA:ENST00000263080:3'UTR:MODIFIER:exon6/6:c.*139C>A:,SPATA22:ENST00000541913:intron:MODIFIER:exon1/8:c.-74+14185G>T:	L2d2	rs1552830	0.9992	0.0000	0,0,0	0,0,0,0,0	0.9994							608034 [ASPA (confirmed) Canavan disease,271900];				231	0					ASPA (inh=AR pLI=0.01), SPATA22 (inh=n/a pLI=0.00)
chr17	3540042	3540042	G	A	het	anno_omim	QUAL=3120;DP=145;AF=0.50;MQM=59;TRIO=HET,145,0.50,HET,111,0.51,WT,121,0.00	CTNS	5'UTR,intron	CTNS:ENST00000046640:5'UTR:MODIFIER:exon1/12:c.-313G>A:,CTNS:ENST00000441220:5'UTR:MODIFIER:exon1/10:c.-369G>A:,CTNS:ENST00000414524:5'UTR:MODIFIER:exon1/9:c.-510G>A:,CTNS:ENST00000381870:intron:MODIFIER:exon1/12:c.-230+40G>A:		rs17707869	0.1540	0.0000	0,0,0	0,0,0,0,0	0.1462							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	RCV000370497.1 [likely benign]; RCV000401897.1 [likely benign]; 			8	63					CTNS (inh=AR pLI=0.03)
chr17	3559823	3559823	G	A	het	anno_omim	QUAL=5371;DP=196;AF=0.45;MQM=60;TRIO=HET,196,0.45,HET,303,0.47,WT,423,0.00	CTNS,RP11-235E17.6	synonymous	CTNS:ENST00000381870:synonymous:LOW:exon8/13:c.504G>A:p.Thr168Thr,CTNS:ENST00000046640:synonymous:LOW:exon8/12:c.504G>A:p.Thr168Thr,CTNS:ENST00000441220:synonymous:LOW:exon5/10:c.180G>A:p.Thr60Thr,CTNS:ENST00000414524:synonymous:LOW:exon5/9:c.63G>A:p.Thr21Thr		rs1800528	0.1506	0.1864	2052,1095,9	0.0433,0.2401,0.2129,0.1907,0.1764	0.1838							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	RCV000246446.1 [benign]; RCV000277810.1 [likely benign]; RCV000370416.1 [likely benign]; 			83	568					CTNS (inh=AR pLI=0.03), RP11-235E17.6 (inh=n/a pLI=n/a)
chr17	3561396	3561396	C	T	hom	pred_pathogenic;anno_omim	QUAL=32296;DP=251;AF=0.99;MQM=59;TRIO=HOM,251,0.99,HOM,325,1.00,HOM,470,1.00	CTNS	missense	CTNS:ENST00000381870:missense:MODERATE:exon10/13:c.779C>T:p.Thr260Ile,CTNS:ENST00000046640:missense:MODERATE:exon10/12:c.779C>T:p.Thr260Ile,CTNS:ENST00000441220:missense:MODERATE:exon7/10:c.455C>T:p.Thr152Ile,CTNS:ENST00000414524:missense:MODERATE:exon7/9:c.338C>T:p.Thr113Ile		rs161400	0.8183	0.9183	51792,30388,1763	0.5849,0.9609,0.9313,0.9549,0.9212	0.9265	2.3950	T,T,T,T	T	B,B,B	D,D,D,D	11.82	606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	RCV000248355.1 [benign]; RCV000339531.1 [benign]; RCV000380229.1 [benign]; 			1859	241					CTNS (inh=AR pLI=0.03)
chr17	3564068	3564068	G	A	het	anno_omim	QUAL=2368;DP=161;AF=0.46;MQM=59;TRIO=HET,161,0.46,HET,71,0.42,WT,87,0.00	CTNS	3'UTR	CTNS:ENST00000381870:3'UTR:MODIFIER:exon13/13:c.*40G>A:,CTNS:ENST00000046640:3'UTR:MODIFIER:exon12/12:c.*405G>A:,CTNS:ENST00000441220:3'UTR:MODIFIER:exon10/10:c.*40G>A:		rs760273	0.1973	0.2117	2562,1313,86	0.1274,0.2504,0.2479,0.2089,0.2047	0.2136							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	RCV000295137.1 [likely benign]; RCV000399422.1 [likely benign]; 			94	603					CTNS (inh=AR pLI=0.03)
chr17	3564073	3564073	A	G	het	anno_omim	QUAL=2522;DP=166;AF=0.48;MQM=59;TRIO=HET,166,0.48,HET,71,0.39,WT,89,0.00	CTNS	3'UTR	CTNS:ENST00000381870:3'UTR:MODIFIER:exon13/13:c.*45A>G:,CTNS:ENST00000046640:3'UTR:MODIFIER:exon12/12:c.*410A>G:,CTNS:ENST00000441220:3'UTR:MODIFIER:exon10/10:c.*45A>G:		rs3826496	0.1977	0.2118	2543,1297,85	0.1274,0.2511,0.2482,0.2089,0.2041	0.2138							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	RCV000336136.1 [likely benign]; RCV000394000.1 [likely benign]; 			94	604					CTNS (inh=AR pLI=0.03)
chr17	3564084	3564084	T	C	het	anno_omim	QUAL=2312;DP=158;AF=0.49;MQM=59;TRIO=HET,158,0.49,HET,71,0.35,WT,96,0.00	CTNS	3'UTR	CTNS:ENST00000381870:3'UTR:MODIFIER:exon13/13:c.*56T>C:,CTNS:ENST00000046640:3'UTR:MODIFIER:exon12/12:c.*421T>C:,CTNS:ENST00000441220:3'UTR:MODIFIER:exon10/10:c.*56T>C:		rs760274	0.1973	0.0000	0,0,0	0,0,0,0,0	0.2026							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	RCV000301323.1 [likely benign]; RCV000356111.1 [likely benign]; 			94	601					CTNS (inh=AR pLI=0.03)
chr17	3564218	3564218	T	C	het	anno_omim	QUAL=4072;DP=258;AF=0.40;MQM=60;TRIO=HET,258,0.40,HET,187,0.40,WT,276,0.00	CTNS	3'UTR	CTNS:ENST00000381870:3'UTR:MODIFIER:exon13/13:c.*190T>C:,CTNS:ENST00000046640:3'UTR:MODIFIER:exon12/12:c.*555T>C:,CTNS:ENST00000441220:3'UTR:MODIFIER:exon10/10:c.*190T>C:		rs1048646	0.1983	0.0000	0,0,0	0,0,0,0,0	0.2053							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	RCV000327154.1 [likely benign]; RCV000362176.1 [likely benign]; 			10	79					CTNS (inh=AR pLI=0.03)
chr17	3564235	3564235	A	G	het	anno_omim	QUAL=5451;DP=325;AF=0.43;MQM=60;TRIO=HET,325,0.43,HET,209,0.43,WT,302,0.00	CTNS	3'UTR	CTNS:ENST00000381870:3'UTR:MODIFIER:exon13/13:c.*207A>G:,CTNS:ENST00000046640:3'UTR:MODIFIER:exon12/12:c.*572A>G:,CTNS:ENST00000441220:3'UTR:MODIFIER:exon10/10:c.*207A>G:		rs3826493	0.2053	0.0000	0,0,0	0,0,0,0,0	0.2053							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	RCV000272228.1 [likely benign]; RCV000327354.1 [likely benign]; 			10	79					CTNS (inh=AR pLI=0.03)
chr17	3564290	3564290	T	C	het	anno_omim	QUAL=6664;DP=348;AF=0.45;MQM=59;TRIO=HET,348,0.45,HET,203,0.45,WT,294,0.00	CTNS	3'UTR	CTNS:ENST00000381870:3'UTR:MODIFIER:exon13/13:c.*262T>C:,CTNS:ENST00000046640:3'UTR:MODIFIER:exon12/12:c.*627T>C:,CTNS:ENST00000441220:3'UTR:MODIFIER:exon10/10:c.*262T>C:	L3	rs1048647	0.1983	0.0000	0,0,0	0,0,0,0,0	0.2047							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	RCV000334075.1 [likely benign]; RCV000388542.1 [likely benign]; 			10	76					CTNS (inh=AR pLI=0.03)
chr17	3564294	3564294	T	C	het	anno_omim	QUAL=6664;DP=348;AF=0.45;MQM=59;TRIO=HET,348,0.45,HET,203,0.45,WT,294,0.00	CTNS	3'UTR	CTNS:ENST00000381870:3'UTR:MODIFIER:exon13/13:c.*266T>C:,CTNS:ENST00000046640:3'UTR:MODIFIER:exon12/12:c.*631T>C:,CTNS:ENST00000441220:3'UTR:MODIFIER:exon10/10:c.*266T>C:	L3	rs1048648	0.1981	0.0000	0,0,0	0,0,0,0,0	0.2046							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	RCV000280141.1 [likely benign]; RCV000335091.1 [likely benign]; 			10	77					CTNS (inh=AR pLI=0.03)
chr17	3564378	3564378	C	T	het	anno_omim	QUAL=6133;DP=261;AF=0.49;MQM=59;TRIO=HET,261,0.49,HET,184,0.59,WT,245,0.00	CTNS	3'UTR	CTNS:ENST00000381870:3'UTR:MODIFIER:exon13/13:c.*350C>T:,CTNS:ENST00000046640:3'UTR:MODIFIER:exon12/12:c.*715C>T:		rs1048649	0.1967	0.0000	0,0,0	0,0,0,0,0	0.2039							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	RCV000340873.1 [likely benign]; RCV000407349.1 [likely benign]; 			10	74					CTNS (inh=AR pLI=0.03)
chr17	3564401	3564401	T	G	hom	anno_omim	QUAL=22530;DP=274;AF=1.00;MQM=60;TRIO=HOM,274,1.00,HOM,176,1.00,HOM,260,1.00	CTNS	3'UTR	CTNS:ENST00000381870:3'UTR:MODIFIER:exon13/13:c.*373T>G:,CTNS:ENST00000046640:3'UTR:MODIFIER:exon12/12:c.*738T>G:		rs224562	0.9954	0.0000	0,0,0	0,0,0,0,0	0.9956							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	RCV000310153.1 [benign]; RCV000407354.1 [benign]; 			231	1					CTNS (inh=AR pLI=0.03)
chr17	3564687	3564687	C	T	het	anno_omim	QUAL=4156;DP=174;AF=0.35;MQM=59;TRIO=HET,174,0.35,HET,298,0.44,WT,492,0.00	CTNS	3'UTR	CTNS:ENST00000381870:3'UTR:MODIFIER:exon13/13:c.*659C>T:,CTNS:ENST00000046640:3'UTR:MODIFIER:exon12/12:c.*1024C>T:		rs1048673	0.1947	0.0000	0,0,0	0,0,0,0,0	0.1975							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	RCV000283184.1 [likely benign]; RCV000342825.1 [likely benign]; 			12	77					CTNS (inh=AR pLI=0.03)
chr17	3564688	3564688	A	G	het	anno_omim	QUAL=4156;DP=174;AF=0.35;MQM=59;TRIO=HET,174,0.35,HET,298,0.44,WT,492,0.00	CTNS	3'UTR	CTNS:ENST00000381870:3'UTR:MODIFIER:exon13/13:c.*660A>G:,CTNS:ENST00000046640:3'UTR:MODIFIER:exon12/12:c.*1025A>G:		rs1048674	0.1939	0.0000	0,0,0	0,0,0,0,0	0.1976							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	RCV000288903.1 [likely benign]; RCV000378727.1 [likely benign]; 			12	77					CTNS (inh=AR pLI=0.03)
chr17	3564693	3564693	-	GTC	het	anno_omim	QUAL=2232;DP=158;AF=0.30;MQM=59;TRIO=HET,158,0.30,HET,261,0.39,WT,481,0.00	CTNS	3'UTR	CTNS:ENST00000381870:3'UTR:MODIFIER:exon13/13:c.*666_*668dupGTC:,CTNS:ENST00000046640:3'UTR:MODIFIER:exon12/12:c.*1031_*1033dupGTC:		rs397831765	0.1923	0.0000	0,0,0	0,0,0,0,0	0.1978							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];				12	75					CTNS (inh=AR pLI=0.03)
chr17	3564716	3564716	T	G	het	anno_omim	QUAL=4836;DP=198;AF=0.44;MQM=59;TRIO=HET,198,0.44,HET,252,0.46,WT,417,0.00	CTNS	3'UTR	CTNS:ENST00000381870:3'UTR:MODIFIER:exon13/13:c.*688T>G:,CTNS:ENST00000046640:3'UTR:MODIFIER:exon12/12:c.*1053T>G:		rs1048677	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1939							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	RCV000297583.1 [uncertain significance]; RCV000357390.1 [uncertain significance]; 			2	49					CTNS (inh=AR pLI=0.03)
chr17	3564779	3564779	C	T	het	anno_omim	QUAL=3635;DP=220;AF=0.40;MQM=59;TRIO=HET,220,0.40,HET,202,0.39,WT,343,0.00	CTNS	3'UTR	CTNS:ENST00000381870:3'UTR:MODIFIER:exon13/13:c.*751C>T:,CTNS:ENST00000046640:3'UTR:MODIFIER:exon12/12:c.*1116C>T:		rs1048682	0.1929	0.0000	0,0,0	0,0,0,0,0	0.1988							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	RCV000262579.1 [likely benign]; RCV000322275.1 [likely benign]; 			11	77					CTNS (inh=AR pLI=0.03)
chr17	3564815	3564815	A	G	het	anno_omim	QUAL=3392;DP=233;AF=0.41;MQM=59;TRIO=HET,233,0.41,HET,158,0.35,WT,287,0.01	CTNS	3'UTR	CTNS:ENST00000381870:3'UTR:MODIFIER:exon13/13:c.*787A>G:,CTNS:ENST00000046640:3'UTR:MODIFIER:exon12/12:c.*1152A>G:		rs2235104	0.1871	0.0000	0,0,0	0,0,0,0,0	0.1972							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	RCV000288599.1 [likely benign]; RCV000345907.1 [likely benign]; 			12	76					CTNS (inh=AR pLI=0.03)
chr17	3564837	3564838	CT	-	het	anno_omim	QUAL=3439;DP=287;AF=0.42;MQM=59;TRIO=HET,287,0.42,HET,140,0.36,WT,255,0.00	CTNS,TAX1BP3	intergenic_region	TAX1BP3:ENSG00000040531-ENSG00000213977:intergenic_region:MODIFIER::n.3564837_3564838delCT:		rs397857879	0.1931	0.0000	0,0,0	0,0,0,0,0	0.2010							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	RCV000351600.1 [likely benign]; RCV000399291.1 [likely benign]; 			12	76					CTNS (inh=AR pLI=0.03), TAX1BP3 (inh=n/a pLI=0.00)
chr17	3565103	3565103	A	G	het	anno_omim	QUAL=5089;DP=146;AF=0.46;MQM=59;TRIO=HET,146,0.46,HOM,109,1.00,WT,159,0.01	CTNS,TAX1BP3	intergenic_region	TAX1BP3:ENSG00000040531-ENSG00000213977:intergenic_region:MODIFIER::n.3565103A>G:		rs161398	0.7420	0.0000	0,0,0	0,0,0,0,0	0.6710							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	RCV000279748.1 [benign]; RCV000371865.1 [benign]; 			105	99					CTNS (inh=AR pLI=0.03), TAX1BP3 (inh=n/a pLI=0.00)
chr17	3565606	3565606	A	-	hom	anno_omim	QUAL=8480;DP=156;AF=0.76;MQM=58;TRIO=HOM,156,0.76,HOM,101,0.80,HOM,164,0.79	CTNS,TAX1BP3	intergenic_region	TAX1BP3:ENSG00000040531-ENSG00000213977:intergenic_region:MODIFIER::n.3565606delA:	AluSq2	rs397856854	0.4742	0.0000	0,0,0	0,0,0,0,0	0.6689							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	RCV000312044.1 [benign]; RCV000389998.1 [benign]; 			134	93					CTNS (inh=AR pLI=0.03), TAX1BP3 (inh=n/a pLI=0.00)
chr17	3565969	3565969	T	C	hom	anno_omim	QUAL=21427;DP=210;AF=0.99;MQM=59;TRIO=HOM,210,0.99,HOM,219,1.00,HOM,261,1.00	CTNS,TAX1BP3	intergenic_region	TAX1BP3:ENSG00000040531-ENSG00000213977:intergenic_region:MODIFIER::n.3565969T>C:		rs161397	0.6384	0.0000	0,0,0	0,0,0,0,0	0.7266							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	RCV000347864.1 [benign]; RCV000386826.1 [benign]; 			157	68					CTNS (inh=AR pLI=0.03), TAX1BP3 (inh=n/a pLI=0.00)
chr17	3566045	3566045	-	C	hom	anno_omim	QUAL=12318;DP=125;AF=0.98;MQM=59;TRIO=HOM,125,0.98,HOM,136,1.00,HOM,154,1.00	CTNS,TAX1BP3	intergenic_region	TAX1BP3:ENSG00000040531-ENSG00000213977:intergenic_region:MODIFIER::n.3566045_3566046insC:		rs397702352	0.7676	0.0000	0,0,0	0,0,0,0,0	0.8155							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];				167	60					CTNS (inh=AR pLI=0.03), TAX1BP3 (inh=n/a pLI=0.00)
chr17	3566232	3566232	C	T	het	anno_omim	QUAL=6203;DP=252;AF=0.55;MQM=59;TRIO=HET,252,0.55,HOM,113,1.00,WT,126,0.01	TAX1BP3	3'UTR	TAX1BP3:ENST00000225525:3'UTR:MODIFIER:exon4/4:c.*810G>A:		rs7093	0.3616	0.0000	0,0,0	0,0,0,0,0	0.3368							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	RCV000327551.1 [benign]; RCV000384559.1 [benign]; 			39	100					TAX1BP3 (inh=n/a pLI=0.00)
chr17	4801125	4801125	C	G	het	anno_omim	QUAL=593;DP=26;AF=0.62;MQM=59;TRIO=HET,26,0.62,HET,28,0.61,WT,33,0.00	MINK1,CHRNE	3'UTR	MINK1:ENST00000355280:3'UTR:MODIFIER:exon32/32:c.*543C>G:,CHRNE:ENST00000293780:3'UTR:MODIFIER:exon12/12:c.*906G>C:,MINK1:ENST00000347992:3'UTR:MODIFIER:exon32/32:c.*543C>G:		rs9914357	0.2153	0.0000	0,0,0	0,0,0,0,0	0.1541							100725 [CHRNE (confirmed) Myasthenic syndrome,congenital,4A,slow-channel,605809|Myasthenic syndrome,congenital,4B,fast-channel,616324|Myasthenic syndrome,congenital,4C,associated with acetylcholine receptor deficiency,608931];	RCV000344016.1 [benign]; 			1	23					MINK1 (inh=n/a pLI=1.00), CHRNE (inh=AR pLI=0.00)
chr17	4801273	4801273	-	CTC	hom	anno_omim	QUAL=2426;DP=30;AF=0.83;MQM=58;TRIO=HOM,30,0.83,HOM,23,0.96,HOM,43,1.00	MINK1,CHRNE	3'UTR	MINK1:ENST00000355280:3'UTR:MODIFIER:exon32/32:c.*693_*695dupTCC:,CHRNE:ENST00000293780:3'UTR:MODIFIER:exon12/12:c.*755_*757dupGAG:,MINK1:ENST00000347992:3'UTR:MODIFIER:exon32/32:c.*693_*695dupTCC:		rs538982347	0.0000	0.0000	0,0,0	0,0,0,0,0	0.8534							100725 [CHRNE (confirmed) Myasthenic syndrome,congenital,4A,slow-channel,605809|Myasthenic syndrome,congenital,4B,fast-channel,616324|Myasthenic syndrome,congenital,4C,associated with acetylcholine receptor deficiency,608931];				106	42					MINK1 (inh=n/a pLI=1.00), CHRNE (inh=AR pLI=0.00)
chr17	4801286	4801286	C	T	hom	anno_omim	QUAL=2449;DP=33;AF=0.97;MQM=60;TRIO=HOM,33,0.97,HOM,28,0.82,HOM,44,0.93	MINK1,CHRNE	3'UTR	MINK1:ENST00000355280:3'UTR:MODIFIER:exon32/32:c.*704C>T:,CHRNE:ENST00000293780:3'UTR:MODIFIER:exon12/12:c.*745G>A:,MINK1:ENST00000347992:3'UTR:MODIFIER:exon32/32:c.*704C>T:		rs1053751	0.7712	0.0000	0,0,0	0,0,0,0,0	0.8209							100725 [CHRNE (confirmed) Myasthenic syndrome,congenital,4A,slow-channel,605809|Myasthenic syndrome,congenital,4B,fast-channel,616324|Myasthenic syndrome,congenital,4C,associated with acetylcholine receptor deficiency,608931];	RCV000380686.1 [benign]; 			114	31					MINK1 (inh=n/a pLI=1.00), CHRNE (inh=AR pLI=0.00)
chr17	4801288	4801288	A	C	hom	anno_omim	QUAL=2449;DP=33;AF=0.97;MQM=58;TRIO=HOM,33,0.97,HOM,28,0.82,HET,44,0.93	MINK1,CHRNE	3'UTR	MINK1:ENST00000355280:3'UTR:MODIFIER:exon32/32:c.*706A>C:,CHRNE:ENST00000293780:3'UTR:MODIFIER:exon12/12:c.*743T>G:,MINK1:ENST00000347992:3'UTR:MODIFIER:exon32/32:c.*706A>C:		rs1053754	0.3662	0.0000	0,0,0	0,0,0,0,0	0.5415							100725 [CHRNE (confirmed) Myasthenic syndrome,congenital,4A,slow-channel,605809|Myasthenic syndrome,congenital,4B,fast-channel,616324|Myasthenic syndrome,congenital,4C,associated with acetylcholine receptor deficiency,608931];	RCV000288680.1 [benign]; 			56	68					MINK1 (inh=n/a pLI=1.00), CHRNE (inh=AR pLI=0.00)
chr17	4802685	4802685	G	A	het	anno_omim	QUAL=2365;DP=110;AF=0.55;MQM=59;TRIO=HET,110,0.55,HET,58,0.71,WT,84,0.00	CHRNE	splice_region&intron	CHRNE:ENST00000293780:splice_region&intron:LOW:exon9/11:c.1033-6C>T:		rs2075763	0.1062	0.1205	86,14,1	0.0828,0.2584,0.3731,0.1068,0.1050	0.0961							100725 [CHRNE (confirmed) Myasthenic syndrome,congenital,4A,slow-channel,605809|Myasthenic syndrome,congenital,4B,fast-channel,616324|Myasthenic syndrome,congenital,4C,associated with acetylcholine receptor deficiency,608931];	RCV000116734.3 [other]; RCV000273943.1 [benign]; 			14	268					CHRNE (inh=AR pLI=0.00)
chr17	7127718	7127718	T	C	het	anno_omim	QUAL=5916;DP=292;AF=0.49;MQM=59;TRIO=HET,292,0.49,HET,244,0.46,WT,273,0.00	ACADVL	splice_region&intron	ACADVL:ENST00000543245:splice_region&intron:LOW:exon17/20:c.1674+6T>C:,ACADVL:ENST00000356839:splice_region&intron:LOW:exon16/19:c.1605+6T>C:,ACADVL:ENST00000350303:splice_region&intron:LOW:exon15/18:c.1539+6T>C:		rs17671352	0.5198	0.6000	21852,13466,920	0.4292,0.4762,0.4813,0.6415,0.6569	0.5995							609575 [ACADVL (confirmed) VLCAD deficiency,201475];	RCV000077908.7 [benign]; RCV000169539.2 [benign]; 			962	915					ACADVL (inh=AR pLI=0.00)
chr17	7360110	7360110	T	C	het	anno_omim	QUAL=9935;DP=355;AF=0.51;MQM=59;TRIO=HET,355,0.51,WT,266,0.00,HET,364,0.54	CHRNB1	3'UTR	CHRNB1:ENST00000306071:3'UTR:MODIFIER:exon11/11:c.*68T>C:,CHRNB1:ENST00000536404:3'UTR:MODIFIER:exon10/10:c.*68T>C:,CHRNB1:ENST00000576360:3'UTR:MODIFIER:exon10/10:c.*68T>C:,CHRNB1:ENST00000575379:3'UTR:MODIFIER:exon2/2:c.*68T>C:		rs2302764	0.3057	0.0000	0,0,0	0,0,0,0,0	0.1814							100710 [CHRNB1 (confirmed) Myasthenic syndrome,congenital,2A,slow-channel,616313|Myasthenic syndrome,congenital,2C,associated with acetylcholine receptor deficiency,616314];	RCV000274455.1 [benign]; 			81	442					CHRNB1 (inh=n/a pLI=0.00)
chr17	7490810	7490810	G	A	het	pred_pathogenic;anno_omim	QUAL=9223;DP=339;AF=0.50;MQM=59;TRIO=HET,339,0.50,HOM,175,1.00,WT,156,0.01	MPDU1	missense,3'UTR,intron	MPDU1:ENST00000250124:missense:MODERATE:exon7/7:c.685G>A:p.Ala229Thr,MPDU1:ENST00000396501:3'UTR:MODIFIER:exon6/6:c.*48G>A:,MPDU1:ENST00000423172:intron:MODIFIER:exon5/5:c.532+221G>A:		rs10852891	0.1562	0.1540	1582,983,164	0.1795,0.0897,0.1596,0.1675,0.1512	0.1503	0.8700	T,D	T,T	B,.	T,.	20.90	604041 [MPDU1 (confirmed) Congenital disorder of glycosylation,type If,609180];	RCV000081188.5 [benign]; RCV000379507.1 [likely benign]; 		COSM3766188	47	513					MPDU1 (inh=n/a pLI=0.14)
chr17	7491177	7491177	G	T	hom	anno_omim	QUAL=36340;DP=370;AF=1.00;MQM=59;TRIO=HOM,370,1.00,HOM,306,1.00,HOM,447,1.00	MPDU1	3'UTR,intron	MPDU1:ENST00000250124:3'UTR:MODIFIER:exon7/7:c.*308G>T:,MPDU1:ENST00000396501:3'UTR:MODIFIER:exon6/6:c.*415G>T:,MPDU1:ENST00000423172:intron:MODIFIER:exon5/5:c.532+588G>T:		rs4227	0.6819	0.8095	3712,912,51	0.6360,0.0000,0.0000,0.7781,0.8309	0.7148							604041 [MPDU1 (confirmed) Congenital disorder of glycosylation,type If,609180];	RCV000299242.1 [benign]; 			376	231					MPDU1 (inh=n/a pLI=0.14)
chr17	7750177	7750177	-	ACC	hom	low_DP	QUAL=172;DP=1;AF=1.00;MQM=60;TRIO=HOM,1,1.00,HOM,7,0.86,WT,6,1.00	KDM6B	disruptive_inframe_insertion	KDM6B:ENST00000254846:disruptive_inframe_insertion:MODERATE:exon9/22:c.789_791dupACC:p.Pro264dup,KDM6B:ENST00000448097:disruptive_inframe_insertion:MODERATE:exon9/23:c.789_791dupACC:p.Pro264dup	(CCA)n	rs771743551;rs779500270	0.0000	0.0308	38,17,8	0.0235,0.0079,0.0060,0.0234,0.0719	0.0435											34	2					KDM6B (inh=AR pLI=1.00)
chr17	10297658	10297658	A	G	het	anno_omim	QUAL=12506;DP=454;AF=0.48;MQM=55;TRIO=HET,454,0.48,WT,521,0.00,HET,612,0.45	MYH8,RP11-799N11.1,CTC-297N7.11	missense	MYH8:ENST00000403437:missense:MODERATE:exon35/40:c.5074T>C:p.Trp1692Arg		rs8069834	0.4854	0.5096	17218,11431,2748	0.7293,0.3773,0.1127,0.5861,0.3569	0.5858	0.9480	T,T	T	B	T	7.97	160741 [MYH8 (confirmed) Carney complex variant,608837|Trismus-pseudocamptodactyly syndrome,158300];	RCV000117692.2 [benign]; RCV000341726.1 [likely benign]; 		COSM3765969	707	954					MYH8 (inh=AD pLI=0.00), RP11-799N11.1 (inh=n/a pLI=n/a), CTC-297N7.11 (inh=n/a pLI=n/a)
chr17	10304500	10304500	C	T	het	anno_omim	QUAL=6565;DP=321;AF=0.46;MQM=60;TRIO=HET,321,0.46,WT,111,0.00,HET,167,0.62	MYH8,RP11-799N11.1,CTC-297N7.11	synonymous	MYH8:ENST00000403437:synonymous:LOW:exon25/40:c.3117G>A:p.Gly1039Gly		rs3744553	0.0505	0.0586	286,135,1	0.0187,0.0359,0.0220,0.0598,0.1124	0.0581							160741 [MYH8 (confirmed) Carney complex variant,608837|Trismus-pseudocamptodactyly syndrome,158300];	RCV000117687.2 [benign]; RCV000289687.1 [likely benign]; 		COSM3999995	12	220					MYH8 (inh=AD pLI=0.00), RP11-799N11.1 (inh=n/a pLI=n/a), CTC-297N7.11 (inh=n/a pLI=n/a)
chr17	10318636	10318636	A	G	het	anno_omim	QUAL=28920;DP=590;AF=0.52;MQM=59;TRIO=HET,590,0.52,HOM,427,1.00,HET,519,0.48	MYH8,RP11-799N11.1,CTC-297N7.11	synonymous	MYH8:ENST00000403437:synonymous:LOW:exon8/40:c.714T>C:p.Thr238Thr		rs8068729	0.8624	0.9224	52039,29586,2290	0.6665,0.9526,0.9998,0.9415,0.9230	0.9293							160741 [MYH8 (confirmed) Carney complex variant,608837|Trismus-pseudocamptodactyly syndrome,158300];	RCV000117694.2 [benign]; RCV000283465.1 [likely benign]; 			1789	309					MYH8 (inh=AD pLI=0.00), RP11-799N11.1 (inh=n/a pLI=n/a), CTC-297N7.11 (inh=n/a pLI=n/a)
chr17	10324980	10324980	C	T	het	anno_omim	QUAL=7813;DP=260;AF=0.44;MQM=60;TRIO=HET,260,0.44,HOM,87,0.99,HET,150,0.53	MYH8,RP11-799N11.1,CTC-297N7.11	splice_region,5'UTR	MYH8:ENST00000403437:splice_region:LOW:exon2/40:c.-31G>A:,MYH8:ENST00000403437:5'UTR:MODIFIER:exon2/40:c.-31G>A:		rs2277648	0.4365	0.0000	0,0,0	0,0,0,0,0	0.3275							160741 [MYH8 (confirmed) Carney complex variant,608837|Trismus-pseudocamptodactyly syndrome,158300];	RCV000349915.1 [likely benign]; 			31	99					MYH8 (inh=AD pLI=0.00), RP11-799N11.1 (inh=n/a pLI=n/a), CTC-297N7.11 (inh=n/a pLI=n/a)
chr17	10427924	10427924	G	A	het	low_MQM;anno_omim	QUAL=17043;DP=391;AF=0.42;MQM=47;TRIO=HET,391,0.42,HET,493,0.47,HET,602,0.51	MYH2,RP11-799N11.1,CTC-297N7.11	synonymous,intron	MYH2:ENST00000245503:synonymous:LOW:exon35/40:c.5034C>T:p.Ala1678Ala,MYH2:ENST00000397183:synonymous:LOW:exon35/40:c.5034C>T:p.Ala1678Ala,MYH2:ENST00000532183:intron:MODIFIER:exon16/16:c.1975-3175C>T:		rs1042236	0.3189	0.2561	5940,882,52	0.1105,0.4991,0.7535,0.1629,0.3178	0.2651							160740 [MYH2 (confirmed) Proximal myopathy and ophthalmoplegia,605637];	RCV000252048.2 [benign]; RCV000306693.1 [benign]; 		COSM3765976	69	557					MYH2 (inh=AR pLI=0.00), RP11-799N11.1 (inh=n/a pLI=n/a), CTC-297N7.11 (inh=n/a pLI=n/a)
chr17	10448769	10448769	A	T	het	anno_omim	QUAL=13996;DP=278;AF=0.47;MQM=59;TRIO=HET,278,0.47,HOM,228,0.99,HET,304,0.50	MYH2,CTC-297N7.11	synonymous	MYH2:ENST00000245503:synonymous:LOW:exon5/40:c.399T>A:p.Pro133Pro,MYH2:ENST00000532183:synonymous:LOW:exon4/17:c.399T>A:p.Pro133Pro,MYH2:ENST00000397183:synonymous:LOW:exon5/40:c.399T>A:p.Pro133Pro		rs11078850	0.5168	0.4808	15288,5671,517	0.3212,0.6164,0.8526,0.4098,0.5932	0.4869							160740 [MYH2 (confirmed) Proximal myopathy and ophthalmoplegia,605637];	RCV000243742.2 [benign]; RCV000354660.1 [benign]; 			424	997					MYH2 (inh=AR pLI=0.00), CTC-297N7.11 (inh=n/a pLI=n/a)
chr17	10450816	10450816	T	C	het	anno_omim	QUAL=20351;DP=291;AF=0.46;MQM=59;TRIO=HET,291,0.46,HOM,356,1.00,HET,439,0.52	MYH2,CTC-297N7.11	synonymous	MYH2:ENST00000245503:synonymous:LOW:exon4/40:c.324A>G:p.Glu108Glu,MYH2:ENST00000532183:synonymous:LOW:exon3/17:c.324A>G:p.Glu108Glu,MYH2:ENST00000397183:synonymous:LOW:exon4/40:c.324A>G:p.Glu108Glu		rs12600539	0.5435	0.4922	15912,5811,779	0.3890,0.6308,0.8665,0.4150,0.5956	0.4974							160740 [MYH2 (confirmed) Proximal myopathy and ophthalmoplegia,605637];	RCV000250668.2 [benign]; RCV000390577.1 [benign]; 		COSM3765977	441	997					MYH2 (inh=AR pLI=0.00), CTC-297N7.11 (inh=n/a pLI=n/a)
chr17	10453015	10453015	T	C	het	anno_omim	QUAL=7036;DP=427;AF=0.42;MQM=60;TRIO=HET,427,0.42,HET,254,0.46,WT,346,0.00	MYH2,CTC-297N7.11	5'UTR_premature_start_codon_gain,5'UTR	MYH2:ENST00000245503:5'UTR_premature_start_codon_gain:LOW:exon1/40:c.-126A>G:,MYH2:ENST00000245503:5'UTR:MODIFIER:exon1/40:c.-126A>G:		rs74967762	0.0765	0.0000	0,0,0	0,0,0,0,0	0.0346							160740 [MYH2 (confirmed) Proximal myopathy and ophthalmoplegia,605637];	RCV000285665.1 [likely benign]; 			0	11					MYH2 (inh=AR pLI=0.00), CTC-297N7.11 (inh=n/a pLI=n/a)
chr17	10536018	10536018	G	A	het	anno_omim	QUAL=20145;DP=311;AF=0.49;MQM=60;TRIO=HET,311,0.49,WT,365,0.00,HOM,504,1.00	MYH3	synonymous	MYH3:ENST00000226209:synonymous:LOW:exon33/40:c.4731C>T:p.Ile1577Ile,MYH3:ENST00000583535:synonymous:LOW:exon34/41:c.4731C>T:p.Ile1577Ile		rs2285479	0.4696	0.6090	24040,17495,504	0.3034,0.4461,0.3640,0.7240,0.5362	0.6121							160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A,193700|Arthrogryposis,distal,type 2B,601680|Arthrogryposis,distal,type 8,178110];	RCV000117675.2 [benign]; RCV000285592.1 [likely benign]; RCV000382183.1 [likely benign]; 		COSM4000000	1016	865					MYH3 (inh=AD pLI=0.00)
chr17	10541515	10541515	C	T	het	anno_omim	QUAL=23212;DP=270;AF=0.51;MQM=59;TRIO=HET,270,0.51,WT,478,0.01,HOM,651,1.00	MYH3	missense	MYH3:ENST00000226209:missense:MODERATE:exon26/40:c.3574G>A:p.Ala1192Thr,MYH3:ENST00000583535:missense:MODERATE:exon27/41:c.3574G>A:p.Ala1192Thr		rs2285477	0.5865	0.6902	29937,20587,1707	0.5756,0.5408,0.3770,0.7844,0.6268	0.6966	-0.4290	T	T	B	T	14.03	160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A,193700|Arthrogryposis,distal,type 2B,601680|Arthrogryposis,distal,type 8,178110];	RCV000117670.2 [benign]; RCV000259987.1 [likely benign]; RCV000317596.1 [likely benign]; 		COSM4000001	1215	749					MYH3 (inh=AD pLI=0.00)
chr17	10541741	10541741	A	G	het	anno_omim	QUAL=3334;DP=69;AF=0.43;MQM=59;TRIO=HET,69,0.43,HOM,106,0.98,WT,192,0.00	MYH3	synonymous	MYH3:ENST00000226209:synonymous:LOW:exon26/40:c.3348T>C:p.Ile1116Ile,MYH3:ENST00000583535:synonymous:LOW:exon27/41:c.3348T>C:p.Ile1116Ile		rs201626	0.2610	0.1888	3362,355,79	0.1412,0.3823,0.6097,0.0999,0.2312	0.1979							160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A,193700|Arthrogryposis,distal,type 2B,601680|Arthrogryposis,distal,type 8,178110];	RCV000117669.2 [benign]; RCV000303204.1 [likely benign]; RCV000355718.1 [likely benign]; 		COSM1749857	46	426					MYH3 (inh=AD pLI=0.00)
chr17	10542471	10542471	T	G	het	anno_omim	QUAL=9848;DP=274;AF=0.58;MQM=59;TRIO=HET,274,0.58,WT,142,0.01,HOM,171,0.99	MYH3	synonymous	MYH3:ENST00000226209:synonymous:LOW:exon24/40:c.3138A>C:p.Arg1046Arg,MYH3:ENST00000583535:synonymous:LOW:exon25/41:c.3138A>C:p.Arg1046Arg		rs2285475	0.4665	0.6085	24022,17511,486	0.2975,0.4464,0.3634,0.7244,0.5349	0.6118							160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A,193700|Arthrogryposis,distal,type 2B,601680|Arthrogryposis,distal,type 8,178110];	RCV000117668.2 [benign]; RCV000333596.1 [likely benign]; RCV000385658.1 [likely benign]; 		COSM4000003	1018	863					MYH3 (inh=AD pLI=0.00)
chr17	10542765	10542765	A	G	het	anno_omim	QUAL=9317;DP=206;AF=0.52;MQM=60;TRIO=HET,206,0.52,WT,158,0.01,HOM,202,1.00	MYH3	synonymous	MYH3:ENST00000226209:synonymous:LOW:exon23/40:c.2952T>C:p.Ser984Ser,MYH3:ENST00000583535:synonymous:LOW:exon24/41:c.2952T>C:p.Ser984Ser		rs2285474	0.4665	0.6094	23991,17489,485	0.2983,0.4465,0.3671,0.7246,0.5351	0.6119							160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A,193700|Arthrogryposis,distal,type 2B,601680|Arthrogryposis,distal,type 8,178110];	RCV000117665.2 [benign]; RCV000299935.1 [likely benign]; RCV000400223.1 [likely benign]; 		COSM4000004	1019	865					MYH3 (inh=AD pLI=0.00)
chr17	10542886	10542886	T	C	het	anno_omim	QUAL=12561;DP=232;AF=0.48;MQM=59;TRIO=HET,232,0.48,WT,242,0.00,HOM,297,0.99	MYH3	synonymous	MYH3:ENST00000226209:synonymous:LOW:exon22/40:c.2916A>G:p.Thr972Thr,MYH3:ENST00000583535:synonymous:LOW:exon23/41:c.2916A>G:p.Thr972Thr		rs2285472	0.4663	0.6085	24022,17513,486	0.2976,0.4464,0.3638,0.7244,0.5348	0.6118							160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A,193700|Arthrogryposis,distal,type 2B,601680|Arthrogryposis,distal,type 8,178110];	RCV000117664.2 [benign]; RCV000277869.1 [likely benign]; RCV000311920.1 [likely benign]; 		COSM4000005	1019	862					MYH3 (inh=AD pLI=0.00)
chr17	10543463	10543463	T	C	het	anno_omim	QUAL=17678;DP=262;AF=0.50;MQM=59;TRIO=HET,262,0.50,WT,365,0.01,HOM,441,1.00	MYH3	synonymous	MYH3:ENST00000226209:synonymous:LOW:exon21/40:c.2532A>G:p.Ala844Ala,MYH3:ENST00000583535:synonymous:LOW:exon22/41:c.2532A>G:p.Ala844Ala		rs2285469	0.4665	0.6085	24025,17513,486	0.2976,0.4463,0.3634,0.7244,0.5349	0.6118							160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A,193700|Arthrogryposis,distal,type 2B,601680|Arthrogryposis,distal,type 8,178110];	RCV000117662.2 [benign]; RCV000282605.1 [likely benign]; RCV000337349.1 [likely benign]; 		COSM4000006	1018	864					MYH3 (inh=AD pLI=0.00)
chr17	10544416	10544416	G	T	het	anno_omim	QUAL=14953;DP=290;AF=0.48;MQM=60;TRIO=HET,290,0.48,WT,279,0.01,HOM,358,1.00	MYH3	synonymous	MYH3:ENST00000226209:synonymous:LOW:exon18/40:c.2151C>A:p.Gly717Gly,MYH3:ENST00000583535:synonymous:LOW:exon19/41:c.2151C>A:p.Gly717Gly		rs876657	0.0000	0.6092	23980,17489,479	0.2998,0.4463,0.3635,0.7247,0.5351	0.6117							160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A,193700|Arthrogryposis,distal,type 2B,601680|Arthrogryposis,distal,type 8,178110];	RCV000117661.2 [benign]; RCV000324188.1 [likely benign]; RCV000360244.1 [likely benign]; 		COSM4000007	1018	851					MYH3 (inh=AD pLI=0.00)
chr17	10544697	10544697	A	-	het	anno_omim	QUAL=11033;DP=243;AF=0.55;MQM=59;TRIO=HET,243,0.55,WT,201,0.01,HOM,267,0.98	MYH3	splice_region&intron	MYH3:ENST00000226209:splice_region&intron:LOW:exon16/39:c.1960-8delT:,MYH3:ENST00000583535:splice_region&intron:LOW:exon17/40:c.1960-8delT:		rs397857823	0.4673	0.6242	23904,17389,472	0.3146,0.4717,0.3886,0.7311,0.5553	0.6352							160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A,193700|Arthrogryposis,distal,type 2B,601680|Arthrogryposis,distal,type 8,178110];	RCV000331324.1 [likely benign]; RCV000385731.1 [likely benign]; 			1021	856					MYH3 (inh=AD pLI=0.00)
chr17	10583714	10583714	G	C	hom	anno_omim	QUAL=13159;DP=235;AF=1.00;MQM=60;TRIO=HOM,235,1.00,HET,175,0.51,HET,202,0.57	SCO1	3'UTR	SCO1:ENST00000255390:3'UTR:MODIFIER:exon6/6:c.*722C>G:,SCO1:ENST00000577427:3'UTR:MODIFIER:exon6/6:c.*722C>G:		rs7512	0.4778	0.0000	0,0,0	0,0,0,0,0	0.4641							603644 [SCO1 (provisional) Mitochondrial complex IV deficiency,220110];	RCV000304976.1 [benign]; RCV000347088.1 [benign]; RCV000398310.1 [benign]; 			43	112					SCO1 (inh=AR pLI=0.51)
chr17	10584116	10584116	C	T	hom	anno_omim	QUAL=15078;DP=148;AF=1.00;MQM=59;TRIO=HOM,148,1.00,HOM,155,1.00,HOM,220,1.00	SCO1,CTC-297N7.10	3'UTR	SCO1:ENST00000255390:3'UTR:MODIFIER:exon6/6:c.*320G>A:,SCO1:ENST00000577427:3'UTR:MODIFIER:exon6/6:c.*320G>A:		rs2040570	1.0000	0.0000	0,0,0	0,0,0,0,0	1.0000							603644 [SCO1 (provisional) Mitochondrial complex IV deficiency,220110];	RCV000283552.1 [benign]; RCV000340923.1 [benign]; RCV000384875.1 [benign]; 			232	0					SCO1 (inh=AR pLI=0.51), CTC-297N7.10 (inh=n/a pLI=n/a)
chr17	13972811	13972811	G	A	hom	low_DP;anno_omim	QUAL=467;DP=4;AF=1.00;MQM=60;TRIO=HOM,4,1.00,HOM,2,1.00,HOM,10,1.00	COX10-AS1	non_coding_transcript_exon	COX10-AS1:ENST00000602743:non_coding_transcript_exon:MODIFIER:exon1/5:n.2C>T:		rs6502330	0.9956	0.0000	0,0,0	0,0,0,0,0	0.9948							602125 [COX10 (confirmed) Mitochondrial complex IV deficiency,220110|Leigh syndrome due to mitochondrial COX4 deficiency,256000];	RCV000336039.1 [benign]; RCV000390210.1 [benign]; 			196	2					COX10-AS1 (inh=n/a pLI=n/a)
chr17	13980058	13980058	A	T	het	pred_pathogenic;anno_omim	QUAL=9024;DP=434;AF=0.46;MQM=60;TRIO=HET,434,0.46,WT,230,0.00,HET,295,0.53	COX10	missense,5'UTR,intron	COX10:ENST00000261643:missense:MODERATE:exon3/7:c.184A>T:p.Thr62Ser,COX10:ENST00000429152:missense:MODERATE:exon3/3:c.184A>T:p.Thr62Ser,COX10:ENST00000536205:5'UTR:MODIFIER:exon3/6:c.-268A>T:,COX10:ENST00000537334:intron:MODIFIER:exon2/5:c.-153+2285A>T:		rs2230351	0.0615	0.0765	415,204,2	0.0117,0.1091,0.1147,0.0759,0.0464	0.0796	6.0420	.,T	T,T	.,B	.,T	17.10	602125 [COX10 (confirmed) Mitochondrial complex IV deficiency,220110|Leigh syndrome due to mitochondrial COX4 deficiency,256000];	RCV000124571.1 [benign]; RCV000311575.1 [likely benign]; RCV000401023.1 [likely benign]; 		COSM4000018	12	225					COX10 (inh=AR pLI=0.65)
chr17	13980350	13980350	G	A	het	pred_pathogenic;anno_omim	QUAL=19869;DP=406;AF=0.55;MQM=60;TRIO=HET,406,0.55,HOM,277,1.00,HET,385,0.50	COX10	missense,intron	COX10:ENST00000261643:missense:MODERATE:exon3/7:c.476G>A:p.Arg159Gln,COX10:ENST00000429152:missense:MODERATE:exon3/3:c.476G>A:p.Arg159Gln,COX10:ENST00000536205:missense:MODERATE:exon3/6:c.25G>A:p.Asp9Asn,COX10:ENST00000537334:intron:MODIFIER:exon2/5:c.-153+2577G>A:		rs2072279	0.4639	0.4945	14893,8373,1058	0.4462,0.5799,0.3777,0.5054,0.5026	0.4963	7.1630	T,T	T,T	B,B	T,T	27.00	602125 [COX10 (confirmed) Mitochondrial complex IV deficiency,220110|Leigh syndrome due to mitochondrial COX4 deficiency,256000];	RCV000124574.1 [benign]; RCV000268376.1 [benign]; RCV000322790.1 [benign]; 			569	1024					COX10 (inh=AR pLI=0.65)
chr17	14095309	14095309	A	G	het	anno_omim	QUAL=6582;DP=185;AF=0.45;MQM=52;TRIO=HET,185,0.45,HOM,105,0.99,HET,156,0.48	COX10	synonymous	COX10:ENST00000261643:synonymous:LOW:exon6/7:c.699A>G:p.Pro233Pro,COX10:ENST00000536205:synonymous:LOW:exon5/6:c.123A>G:p.Pro41Pro,COX10:ENST00000537334:synonymous:LOW:exon5/6:c.48A>G:p.Pro16Pro		rs2230354	0.5483	0.5850	20957,11887,1153	0.4707,0.5736,0.6026,0.5953,0.5990	0.5876							602125 [COX10 (confirmed) Mitochondrial complex IV deficiency,220110|Leigh syndrome due to mitochondrial COX4 deficiency,256000];	RCV000124560.2 [benign]; RCV000294930.1 [benign]; RCV000388928.1 [benign]; 		COSM3765989	746	994					COX10 (inh=AR pLI=0.65)
chr17	14110669	14110670	TT	-	het	anno_omim	QUAL=1904;DP=181;AF=0.46;MQM=59;TRIO=HET,181,0.46,HET,116,0.51,WT,131,0.02	COX10	3'UTR	COX10:ENST00000261643:3'UTR:MODIFIER:exon7/7:c.*151_*152delTT:,COX10:ENST00000536205:3'UTR:MODIFIER:exon6/6:c.*151_*152delTT:,COX10:ENST00000537334:3'UTR:MODIFIER:exon6/6:c.*151_*152delTT:		rs200239586	0.2021	0.0000	0,0,0	0,0,0,0,0	0.1767							602125 [COX10 (confirmed) Mitochondrial complex IV deficiency,220110|Leigh syndrome due to mitochondrial COX4 deficiency,256000];	RCV000332249.1 [benign]; RCV000386652.1 [benign]; 			6	51					COX10 (inh=AR pLI=0.65)
chr17	14110852	14110852	T	C	het	anno_omim	QUAL=5974;DP=218;AF=0.48;MQM=60;TRIO=HET,218,0.48,HET,275,0.48,WT,396,0.00	COX10	3'UTR	COX10:ENST00000261643:3'UTR:MODIFIER:exon7/7:c.*322T>C:,COX10:ENST00000537334:3'UTR:MODIFIER:exon6/6:c.*322T>C:		rs11078233	0.1991	0.0000	0,0,0	0,0,0,0,0	0.1776							602125 [COX10 (confirmed) Mitochondrial complex IV deficiency,220110|Leigh syndrome due to mitochondrial COX4 deficiency,256000];	RCV000285265.1 [benign]; RCV000341057.1 [benign]; 			6	59					COX10 (inh=AR pLI=0.65)
chr17	14110901	14110901	A	G	het	anno_omim	QUAL=5242;DP=230;AF=0.46;MQM=60;TRIO=HET,230,0.46,HET,241,0.44,WT,342,0.00	COX10	splice_region,3'UTR	COX10:ENST00000537334:splice_region:LOW:exon6/6:c.*371A>G:,COX10:ENST00000261643:3'UTR:MODIFIER:exon7/7:c.*371A>G:,COX10:ENST00000537334:3'UTR:MODIFIER:exon6/6:c.*371A>G:		rs11078234	0.2206	0.0000	0,0,0	0,0,0,0,0	0.1998							602125 [COX10 (confirmed) Mitochondrial complex IV deficiency,220110|Leigh syndrome due to mitochondrial COX4 deficiency,256000];	RCV000310611.1 [benign]; RCV000389973.1 [benign]; 			6	61					COX10 (inh=AR pLI=0.65)
chr17	14111176	14111176	C	A	het	anno_omim	QUAL=6349;DP=257;AF=0.47;MQM=59;TRIO=HET,257,0.47,HET,261,0.53,WT,321,0.00	COX10	3'UTR	COX10:ENST00000261643:3'UTR:MODIFIER:exon7/7:c.*646C>A:		rs7214082	0.1995	0.0000	0,0,0	0,0,0,0,0	0.1780							602125 [COX10 (confirmed) Mitochondrial complex IV deficiency,220110|Leigh syndrome due to mitochondrial COX4 deficiency,256000];	RCV000282929.1 [benign]; RCV000379280.1 [benign]; 			6	61					COX10 (inh=AR pLI=0.65)
chr17	14111287	14111287	T	C	het	anno_omim	QUAL=8350;DP=366;AF=0.49;MQM=60;TRIO=HET,366,0.49,HET,261,0.54,WT,309,0.00	COX10	3'UTR	COX10:ENST00000261643:3'UTR:MODIFIER:exon7/7:c.*757T>C:		rs1802618	0.2001	0.0000	0,0,0	0,0,0,0,0	0.1778							602125 [COX10 (confirmed) Mitochondrial complex IV deficiency,220110|Leigh syndrome due to mitochondrial COX4 deficiency,256000];	RCV000313440.1 [benign]; RCV000390456.1 [benign]; 			6	61					COX10 (inh=AR pLI=0.65)
chr17	14111361	14111362	CT	-	het	anno_omim	QUAL=7158;DP=330;AF=0.50;MQM=59;TRIO=HET,330,0.50,HET,312,0.48,WT,375,0.00	COX10	3'UTR	COX10:ENST00000261643:3'UTR:MODIFIER:exon7/7:c.*833_*834delCT:		rs397763766	0.1999	0.0000	0,0,0	0,0,0,0,0	0.1774							602125 [COX10 (confirmed) Mitochondrial complex IV deficiency,220110|Leigh syndrome due to mitochondrial COX4 deficiency,256000];	RCV000300799.1 [benign]; RCV000355513.1 [benign]; 			6	61					COX10 (inh=AR pLI=0.65)
chr17	14111606	14111606	T	C	het	anno_omim	QUAL=7928;DP=421;AF=0.50;MQM=59;TRIO=HET,421,0.50,HET,176,0.53,WT,208,0.00	COX10	3'UTR	COX10:ENST00000261643:3'UTR:MODIFIER:exon7/7:c.*1076T>C:		rs1050216	0.2133	0.0000	0,0,0	0,0,0,0,0	0.1925							602125 [COX10 (confirmed) Mitochondrial complex IV deficiency,220110|Leigh syndrome due to mitochondrial COX4 deficiency,256000];	RCV000266831.1 [benign]; RCV000361388.1 [benign]; 			6	61					COX10 (inh=AR pLI=0.65)
chr17	14111797	14111797	A	G	het	anno_omim	QUAL=6314;DP=322;AF=0.51;MQM=60;TRIO=HET,322,0.51,HET,139,0.50,WT,170,0.00	COX10	3'UTR	COX10:ENST00000261643:3'UTR:MODIFIER:exon7/7:c.*1267A>G:		rs75844637	0.0086	0.0000	0,0,0	0,0,0,0,0	0.0164							602125 [COX10 (confirmed) Mitochondrial complex IV deficiency,220110|Leigh syndrome due to mitochondrial COX4 deficiency,256000];				0	8					COX10 (inh=AR pLI=0.65)
chr17	14111915	14111915	C	T	het	anno_omim	QUAL=7095;DP=303;AF=0.48;MQM=60;TRIO=HET,303,0.48,WT,158,0.00,HET,224,0.54	COX10	3'UTR	COX10:ENST00000261643:3'UTR:MODIFIER:exon7/7:c.*1385C>T:		rs1050223	0.2266	0.0000	0,0,0	0,0,0,0,0	0.2640							602125 [COX10 (confirmed) Mitochondrial complex IV deficiency,220110|Leigh syndrome due to mitochondrial COX4 deficiency,256000];	RCV000292528.1 [likely benign]; RCV000349607.1 [likely benign]; 			31	85					COX10 (inh=AR pLI=0.65)
chr17	15133706	15133707	AG	-	hom	anno_omim	QUAL=10971;DP=260;AF=0.98;MQM=59;TRIO=HOM,260,0.98,HET,130,0.44,HET,170,0.52	PMP22	3'UTR	PMP22:ENST00000395938:3'UTR:MODIFIER:exon5/5:c.*527_*528delCT:,PMP22:ENST00000312280:3'UTR:MODIFIER:exon5/5:c.*527_*528delCT:		rs869161943	0.3193	0.0000	0,0,0	0,0,0,0,0	0.3403							601097 [PMP22 (confirmed) Charcot-Marie-Tooth disease,type 1A,118220|Dejerine-Sottas disease,145900|Neuropathy,recurrent,with pressure palsies,162500|Charcot-Marie-Tooth disease,type 1E,118300|Roussy-Levy syndrome,180800|Neuropathy,inflammatory demyelinating,139393];	RCV000280289.1 [likely benign]; RCV000342212.1 [likely benign]; 			36	118					PMP22 (inh=AR+AD pLI=0.83)
chr17	15134175	15134175	T	G	hom	anno_omim	QUAL=24063;DP=309;AF=1.00;MQM=60;TRIO=HOM,309,1.00,HOM,301,1.00,HET,387,0.45	PMP22	missense,3'UTR	PMP22:ENST00000494511:missense:MODERATE:exon3/3:c.363A>C:p.Lys121Asn,PMP22:ENST00000395938:3'UTR:MODIFIER:exon5/5:c.*59A>C:,PMP22:ENST00000312280:3'UTR:MODIFIER:exon5/5:c.*59A>C:,PMP22:ENST00000395936:3'UTR:MODIFIER:exon6/6:c.*251A>C:		rs13422	0.5954	0.5351	17161,8416,2590	0.7284,0.5323,0.6140,0.5110,0.5204	0.5539							601097 [PMP22 (confirmed) Charcot-Marie-Tooth disease,type 1A,118220|Dejerine-Sottas disease,145900|Neuropathy,recurrent,with pressure palsies,162500|Charcot-Marie-Tooth disease,type 1E,118300|Roussy-Levy syndrome,180800|Neuropathy,inflammatory demyelinating,139393];	RCV000330964.1 [benign]; RCV000355581.1 [benign]; 			601	999					PMP22 (inh=AR+AD pLI=0.83)
chr17	15931693	15931693	G	A	het	anno_omim	QUAL=9885;DP=293;AF=0.51;MQM=60;TRIO=HET,293,0.51,HET,202,0.46,HET,249,0.52	TTC19	3'UTR	TTC19:ENST00000486880:3'UTR:MODIFIER:exon10/10:c.*857G>A:,TTC19:ENST00000261647:3'UTR:MODIFIER:exon10/10:c.*857G>A:		rs72821769	0.0327	0.0570	27,20,0	0.0000,0.0000,0.0000,0.1199,0.0365	0.0665							613814 [TTC19 (provisional) Mitochondrial complex III deficiency,nuclear type 2,615157];	RCV000322473.1 [likely benign]; 			5	122					TTC19 (inh=AR pLI=0.00)
chr17	15932071	15932071	-	TT	hom	anno_omim	QUAL=6737;DP=123;AF=0.99;MQM=59;TRIO=HOM,123,0.99,HOM,62,1.00,HET,75,0.49	TTC19	3'UTR	TTC19:ENST00000486880:3'UTR:MODIFIER:exon10/10:c.*1236_*1237dupTT:,TTC19:ENST00000261647:3'UTR:MODIFIER:exon10/10:c.*1236_*1237dupTT:		rs386385756;rs61349729	0.4944	0.4930	1380,555,31	0.0000,0.0000,0.0000,0.6353,0.4435	0.5669							613814 [TTC19 (provisional) Mitochondrial complex III deficiency,nuclear type 2,615157];	RCV000288534.1 [likely benign]; 			236	320					TTC19 (inh=AR pLI=0.00)
chr17	15932420	15932420	-	GAG	het	anno_omim	QUAL=1937;DP=88;AF=0.47;MQM=59;TRIO=HET,88,0.47,WT,47,0.00,HET,95,0.43	TTC19				rs758709551	0.0000	0.0139	3,3,0	0.0000,0.0000,0.0000,0.0399,0.0050	0.0182							613814 [TTC19 (provisional) Mitochondrial complex III deficiency,nuclear type 2,615157];				0	28					TTC19 (inh=AR pLI=0.00)
chr17	15932422	15932422	-	AGTAAAAA	het	anno_omim	QUAL=1716;DP=85;AF=0.44;MQM=59;TRIO=HET,85,0.44,WT,43,0.00,HET,91,0.41	TTC19				rs778157002	0.0000	0.0139	3,3,0	0.0000,0.0000,0.0000,0.0400,0.0050	0.0183							613814 [TTC19 (provisional) Mitochondrial complex III deficiency,nuclear type 2,615157];				0	28					TTC19 (inh=AR pLI=0.00)
chr17	15932627	15932627	T	C	hom	anno_omim	QUAL=9314;DP=200;AF=1.00;MQM=59;TRIO=HOM,200,1.00,HOM,53,1.00,HET,84,0.45	NCOR1,TTC19	3'UTR	NCOR1:ENST00000268712:3'UTR:MODIFIER:exon46/46:c.*2983A>G:		rs9890012	0.3674	0.4462	1112,483,8	0.0000,0.0000,0.0000,0.6005,0.3991	0.4734							613814 [TTC19 (provisional) Mitochondrial complex III deficiency,nuclear type 2,615157];	RCV000383682.1 [likely benign]; 			186	294					NCOR1 (inh=n/a pLI=1.00), TTC19 (inh=AR pLI=0.00)
chr17	16842912	16842912	A	G	het	anno_omim	QUAL=874;DP=48;AF=0.40;MQM=59;TRIO=HET,48,0.40,HET,59,0.41,WT,66,0.00	TNFRSF13B	synonymous,intron	TNFRSF13B:ENST00000261652:synonymous:LOW:exon5/5:c.831T>C:p.Ser277Ser,TNFRSF13B:ENST00000583789:synonymous:LOW:exon4/4:c.693T>C:p.Ser231Ser,TNFRSF13B:ENST00000437538:intron:MODIFIER:exon4/10:c.635+58T>C:,TNFRSF13B:ENST00000579315:intron:MODIFIER:exon3/3:c.446-6422T>C:		rs11078355	0.5952	0.4943	15663,5421,1951	0.6134,0.5783,0.7921,0.4039,0.6165	0.4932							604907 [TNFRSF13B (provisional) Immunoglobulin A deficiency 2,609529|Immunodeficiency,common variable,2,240500];	RCV000249157.1 [benign]; RCV000347652.1 [benign]; 		COSM3766008	525	967					TNFRSF13B (inh=AR+AD pLI=0.00)
chr17	16852206	16852206	A	C	het	anno_omim	QUAL=6336;DP=242;AF=0.46;MQM=60;TRIO=HET,242,0.46,HET,284,0.48,WT,346,0.00	TNFRSF13B	synonymous	TNFRSF13B:ENST00000261652:synonymous:LOW:exon3/5:c.291T>G:p.Pro97Pro,TNFRSF13B:ENST00000437538:synonymous:LOW:exon2/11:c.153T>G:p.Pro51Pro,TNFRSF13B:ENST00000579315:synonymous:LOW:exon3/4:c.291T>G:p.Pro97Pro,TNFRSF13B:ENST00000583789:synonymous:LOW:exon2/4:c.153T>G:p.Pro51Pro		rs35062843	0.0485	0.0424	165,56,3	0.0238,0.0332,0.0080,0.0360,0.1062	0.0420							604907 [TNFRSF13B (provisional) Immunoglobulin A deficiency 2,609529|Immunodeficiency,common variable,2,240500];	RCV000252622.1 [benign]; RCV000359099.1 [likely benign]; 			4	184					TNFRSF13B (inh=AR+AD pLI=0.00)
chr17	16855878	16855878	C	T	hom	anno_omim	QUAL=18887;DP=173;AF=0.99;MQM=59;TRIO=HOM,173,0.99,HOM,190,0.99,HOM,266,0.99	TNFRSF13B	synonymous,intron	TNFRSF13B:ENST00000261652:synonymous:LOW:exon2/5:c.81G>A:p.Thr27Thr,TNFRSF13B:ENST00000579315:synonymous:LOW:exon2/4:c.81G>A:p.Thr27Thr,TNFRSF13B:ENST00000437538:intron:MODIFIER:exon1/10:c.62-3581G>A:,TNFRSF13B:ENST00000583789:intron:MODIFIER:exon1/3:c.62-3581G>A:		rs8072293	0.8996	0.8112	40369,18884,4689	0.9494,0.8507,0.9993,0.7524,0.8476	0.8245							604907 [TNFRSF13B (provisional) Immunoglobulin A deficiency 2,609529|Immunodeficiency,common variable,2,240500];	RCV000030561.1 [benign]; RCV000244388.1 [benign]; RCV000327385.1 [benign]; 			1227	740					TNFRSF13B (inh=AR+AD pLI=0.00)
chr17	17697094	17697096	CAG	-	hom	anno_omim	QUAL=2690;DP=47;AF=0.49;MQM=60;TRIO=HOM,47,0.49,HET,303,0.53,WT,362,0.10	RAI1	disruptive_inframe_deletion	RAI1:ENST00000353383:disruptive_inframe_deletion:MODERATE:exon3/6:c.870_872delGCA:p.Gln291del,RAI1:ENST00000261641:disruptive_inframe_deletion:MODERATE:exon1/3:c.870_872delGCA:p.Gln291del	(CAG)n	rs371983878;rs794727527;rs794727528;rs879071724	0.0000	0.2141	48,16,27	0.2924,0.2104,0.0779,0.2203,0.1578	0.1838							607642 [RAI1 (confirmed) Smith-Magenis syndrome,182290];	RCV000177381.5,RCV000177381.5 [benign,benign]; 		COSM1479304	28	112	1	[1] Ute Grasshoff 04.07.2014			RAI1 (inh=AD pLI=1.00)
chr17	17698254	17698254	G	A	hom	anno_omim	QUAL=8161;DP=142;AF=0.99;MQM=59;TRIO=HOM,142,0.99,HOM,56,1.00,HOM,79,0.99	RAI1	synonymous	RAI1:ENST00000353383:synonymous:LOW:exon3/6:c.1992G>A:p.Pro664Pro,RAI1:ENST00000261641:synonymous:LOW:exon1/3:c.1992G>A:p.Pro664Pro		rs8067439	0.3998	0.5069	17240,12958,1675	0.5671,0.3578,0.1494,0.6255,0.2553	0.5662							607642 [RAI1 (confirmed) Smith-Magenis syndrome,182290];	RCV000082257.8 [other]; 		COSM3766017, COSM3766018	684	991					RAI1 (inh=AD pLI=1.00)
chr17	17700573	17700573	T	C	het	anno_omim	QUAL=2518;DP=185;AF=0.44;MQM=59;TRIO=HET,185,0.44,HET,56,0.63,WT,106,0.00	RAI1	synonymous	RAI1:ENST00000353383:synonymous:LOW:exon3/6:c.4311T>C:p.Pro1437Pro,RAI1:ENST00000261641:synonymous:LOW:exon1/3:c.4311T>C:p.Pro1437Pro		rs4925112	0.0946	0.0646	505,128,339	0.2579,0.0328,0.0034,0.0579,0.0254	0.1114							607642 [RAI1 (confirmed) Smith-Magenis syndrome,182290];	RCV000082268.8 [other]; 			10	209					RAI1 (inh=AD pLI=1.00)
chr17	17700792	17700792	C	T	het	anno_omim	QUAL=2837;DP=86;AF=0.38;MQM=60;TRIO=HET,86,0.38,HET,176,0.55,WT,227,0.00	RAI1	synonymous	RAI1:ENST00000353383:synonymous:LOW:exon3/6:c.4530C>T:p.Pro1510Pro,RAI1:ENST00000261641:synonymous:LOW:exon1/3:c.4530C>T:p.Pro1510Pro		rs35686634	0.0731	0.0579	340,125,178	0.1866,0.0295,0.0035,0.0574,0.0254	0.0934							607642 [RAI1 (confirmed) Smith-Magenis syndrome,182290];	RCV000082270.8 [other]; 			9	200					RAI1 (inh=AD pLI=1.00)
chr17	17707105	17707105	T	C	het	anno_omim	QUAL=13511;DP=195;AF=0.48;MQM=59;TRIO=HET,195,0.48,HET,212,0.58,HOM,251,1.00	RAI1	synonymous,intron	RAI1:ENST00000353383:synonymous:LOW:exon4/6:c.5601T>C:p.Ile1867Ile,RAI1:ENST00000261641:intron:MODIFIER:exon1/2:c.4795-5376T>C:		rs3818717	0.2406	0.4214	12779,10732,166	0.1802,0.3140,0.0729,0.5684,0.2062	0.4250	-1.2000	T,T	T			7.67	607642 [RAI1 (confirmed) Smith-Magenis syndrome,182290];	RCV000082273.8 [other]; 		COSM3766019	545	1004					RAI1 (inh=AD pLI=1.00)
chr17	17714717	17714717	G	A	hom	anno_omim	QUAL=1212;DP=40;AF=0.20;MQM=60;TRIO=HOM,40,0.20,HOM,11,0.18,HOM,7,0.00	RAI1,SREBF1	3'UTR	RAI1:ENST00000353383:3'UTR:MODIFIER:exon6/6:c.*1422G>A:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							607642 [RAI1 (confirmed) Smith-Magenis syndrome,182290];				5	20					RAI1 (inh=AD pLI=1.00), SREBF1 (inh=n/a pLI=0.99)
chr17	19578873	19578873	A	T	hom	anno_high_impact;anno_omim	QUAL=18056;DP=331;AF=1.00;MQM=60;TRIO=HOM,331,1.00,HET,239,0.51,HET,308,0.47	ALDH3A2	stop_gained&splice_region,splice_acceptor,splice_region,splice_region&synonymous,3'UTR	ALDH3A2:ENST00000571163:stop_gained&splice_region:HIGH:exon3/3:c.229A>T:p.Arg77*,ALDH3A2:ENST00000581518:splice_acceptor:HIGH:exon11/11:c.*46-2A>T:,ALDH3A2:ENST00000339618:splice_region:LOW:exon11/11:c.*44A>T:,ALDH3A2:ENST00000176643:splice_region&synonymous:LOW:exon10/10:c.1446A>T:p.Ala482Ala,ALDH3A2:ENST00000395575:splice_region&synonymous:LOW:exon11/11:c.1446A>T:p.Ala482Ala,ALDH3A2:ENST00000579855:splice_region&synonymous:LOW:exon11/11:c.1446A>T:p.Ala482Ala,ALDH3A2:ENST00000339618:3'UTR:MODIFIER:exon11/11:c.*44A>T:		rs7216	0.6785	0.6154	24079,10338,1460	0.5318,0.7529,0.9911,0.5554,0.6689	0.6189							609523 [ALDH3A2 (confirmed) Sjogren-Larsson syndrome,270200];	RCV000283231.1 [benign]; 		COSM3766033	871	1267	2	[2] swoedl 11.07.2017			ALDH3A2 (inh=AR pLI=0.01)
chr17	19580494	19580494	A	G	hom	anno_omim	QUAL=23112;DP=528;AF=1.00;MQM=60;TRIO=HOM,528,1.00,HET,237,0.44,HET,288,0.43	ALDH3A2	3'UTR	ALDH3A2:ENST00000339618:3'UTR:MODIFIER:exon11/11:c.*1665A>G:,ALDH3A2:ENST00000176643:3'UTR:MODIFIER:exon10/10:c.*1609A>G:,ALDH3A2:ENST00000395575:3'UTR:MODIFIER:exon11/11:c.*1609A>G:,ALDH3A2:ENST00000579855:3'UTR:MODIFIER:exon11/11:c.*1609A>G:		rs7215	0.6042	0.0000	0,0,0	0,0,0,0,0	0.5141							609523 [ALDH3A2 (confirmed) Sjogren-Larsson syndrome,270200];	RCV000343374.1 [benign]; 			83	100					ALDH3A2 (inh=AR pLI=0.01)
chr17	19580761	19580762	AC	-	hom	anno_omim	QUAL=6063;DP=176;AF=0.98;MQM=59;TRIO=HOM,176,0.98,HET,58,0.50,HET,84,0.50	ALDH3A2	3'UTR	ALDH3A2:ENST00000339618:3'UTR:MODIFIER:exon11/11:c.*1935_*1936delCA:,ALDH3A2:ENST00000176643:3'UTR:MODIFIER:exon10/10:c.*1879_*1880delCA:,ALDH3A2:ENST00000395575:3'UTR:MODIFIER:exon11/11:c.*1879_*1880delCA:,ALDH3A2:ENST00000579855:3'UTR:MODIFIER:exon11/11:c.*1879_*1880delCA:		rs4646805	0.3273	0.0000	0,0,0	0,0,0,0,0	0.2595							609523 [ALDH3A2 (confirmed) Sjogren-Larsson syndrome,270200];	RCV000337707.1 [benign]; 			35	103					ALDH3A2 (inh=AR pLI=0.01)
chr17	26864302	26864302	G	C	het	pred_pathogenic;anno_omim	QUAL=10785;DP=116;AF=0.60;MQM=59;TRIO=HET,116,0.60,HOM,191,1.00,HET,243,0.50	FOXN1,RP11-192H23.4	missense	FOXN1:ENST00000226247:missense:MODERATE:exon8/8:c.1795G>C:p.Ala599Pro,FOXN1:ENST00000579795:missense:MODERATE:exon9/9:c.1795G>C:p.Ala599Pro		rs532648	0.3928	0.3229	6785,2847,1780	0.5878,0.3520,0.2171,0.2933,0.3121	0.3734	0.5980	T	T	B	D	0.01	600838 [FOXN1 (provisional) T-cell immunodeficiency,congenital alopecia,and nail dystrophy,601705];	RCV000399481.1 [benign]; 		COSM4000076	196	885					FOXN1 (inh=AR pLI=0.97), RP11-192H23.4 (inh=n/a pLI=n/a)
chr17	29483108	29483108	C	T	het	anno_omim	QUAL=4729;DP=242;AF=0.51;MQM=60;TRIO=HET,242,0.51,WT,191,0.00,HET,211,0.34	NF1	synonymous	NF1:ENST00000358273:synonymous:LOW:exon2/58:c.168C>T:p.Ser56Ser,NF1:ENST00000356175:synonymous:LOW:exon2/57:c.168C>T:p.Ser56Ser,NF1:ENST00000431387:synonymous:LOW:exon2/15:c.168C>T:p.Ser56Ser		rs17881168	0.0046	0.0120	14,11,1	0.0044,0.0042,0.0001,0.0179,0.0056	0.0153							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];	RCV000163256.1 [benign]; RCV000205406.2 [other]; RCV000215995.2 [benign]; RCV000289551.1 [likely benign]; RCV000324800.1 [likely benign]; RCV000381546.1 [likely benign]; 			3	142					NF1 (inh=AD pLI=1.00)
chr17	29508775	29508775	G	A	het	anno_omim	QUAL=6185;DP=330;AF=0.45;MQM=59;TRIO=HET,330,0.45,WT,146,0.00,HET,190,0.46	NF1	synonymous	NF1:ENST00000358273:synonymous:LOW:exon7/58:c.702G>A:p.Leu234Leu,NF1:ENST00000356175:synonymous:LOW:exon7/57:c.702G>A:p.Leu234Leu,NF1:ENST00000431387:synonymous:LOW:exon7/15:c.702G>A:p.Leu234Leu		rs1801052	0.5118	0.6228	24613,16345,471	0.2922,0.4920,0.5567,0.6987,0.6342	0.6280							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];	RCV000162647.1 [benign]; RCV000218671.2 [benign]; RCV000279983.1 [likely benign]; RCV000319858.1 [likely benign]; RCV000334631.1 [likely benign]; RCV000374483.1 [likely benign]; 		COSM3755377, COSM3755378	1911	1623					NF1 (inh=AD pLI=1.00)
chr17	29553485	29553485	G	A	het	anno_omim	QUAL=6887;DP=133;AF=0.53;MQM=59;TRIO=HET,133,0.53,HOM,113,1.00,HET,141,0.57	NF1	synonymous	NF1:ENST00000358273:synonymous:LOW:exon18/58:c.2034G>A:p.Pro678Pro,NF1:ENST00000356175:synonymous:LOW:exon18/57:c.2034G>A:p.Pro678Pro		rs2285892	0.4968	0.3827	9925,3078,2462	0.6840,0.5117,0.5333,0.3012,0.3710	0.4369							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];	RCV000162648.1 [benign]; RCV000219876.2 [benign]; RCV000296834.1 [likely benign]; RCV000356219.1 [likely benign]; RCV000371357.1 [likely benign]; RCV000400800.1 [likely benign]; 			343	1630					NF1 (inh=AD pLI=1.00)
chr17	29559088	29559088	C	T	het	anno_omim	QUAL=71;DP=66;AF=0.21;MQM=51;TRIO=HET,66,0.21,WT,25,0.08,WT,45,0.04	NF1	splice_region&intron	NF1:ENST00000358273:splice_region&intron:LOW:exon24/57:c.3198-3C>T:,NF1:ENST00000356175:splice_region&intron:LOW:exon24/56:c.3198-3C>T:		rs777759972	0.0000	0.0004	0,0,0	0.0000,0.0000,0.0009,0.0004,0.0009	0.0249							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];				6	33	2	[2] Stefanie Beck-Woedl 29.03.2015			NF1 (inh=AD pLI=1.00)
chr17	29702031	29702032	TA	-	hom	low_DP;anno_omim	QUAL=149;DP=6;AF=0.83;MQM=60;TRIO=HOM,6,0.83,HOM,1,1.00,WT,45,0.04	NF1	3'UTR,intron	NF1:ENST00000358273:3'UTR:MODIFIER:exon58/58:c.*873_*874delAT:,NF1:ENST00000356175:3'UTR:MODIFIER:exon57/57:c.*873_*874delAT:,NF1:ENST00000444181:intron:MODIFIER:exon15/16:c.1873+899_1873+900delAT:	(TA)n	rs34207771;rs369548314	0.5551	0.0000	0,0,0	0,0,0,0,0	0.4689							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];	RCV000285167.1 [benign]; RCV000291178.1 [benign]; RCV000343788.1 [benign]; RCV000381987.1 [benign]; 			35	53					NF1 (inh=AD pLI=1.00)
chr17	29703374	29703374	G	A	het	anno_omim	QUAL=12801;DP=278;AF=0.54;MQM=60;TRIO=HET,278,0.54,HOM,185,0.99,HET,207,0.56	NF1	3'UTR,intron	NF1:ENST00000358273:3'UTR:MODIFIER:exon58/58:c.*2201G>A:,NF1:ENST00000356175:3'UTR:MODIFIER:exon57/57:c.*2201G>A:,NF1:ENST00000444181:intron:MODIFIER:exon15/16:c.1873+2227G>A:		rs7406983	0.5306	0.0000	0,0,0	0,0,0,0,0	0.4668							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];	RCV000261900.1 [likely benign]; RCV000331091.1 [likely benign]; RCV000356839.1 [likely benign]; RCV000385830.1 [likely benign]; 			25	97					NF1 (inh=AD pLI=1.00)
chr17	29703438	29703438	C	G	het	anno_omim	QUAL=10318;DP=332;AF=0.47;MQM=60;TRIO=HET,332,0.47,HOM,124,0.99,HET,135,0.58	NF1	3'UTR,intron	NF1:ENST00000358273:3'UTR:MODIFIER:exon58/58:c.*2265C>G:,NF1:ENST00000356175:3'UTR:MODIFIER:exon57/57:c.*2265C>G:,NF1:ENST00000444181:intron:MODIFIER:exon15/16:c.1873+2291C>G:		rs1800845	0.5587	0.0000	0,0,0	0,0,0,0,0	0.4934							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];	RCV000283413.1 [benign]; RCV000343161.1 [benign]; RCV000346501.1 [benign]; RCV000377894.1 [benign]; 			25	98					NF1 (inh=AD pLI=1.00)
chr17	29704002	29704002	T	C	het	anno_omim	QUAL=10917;DP=424;AF=0.50;MQM=60;TRIO=HET,424,0.50,WT,340,0.01,HET,432,0.51	NF1	3'UTR,intron	NF1:ENST00000358273:3'UTR:MODIFIER:exon58/58:c.*2829T>C:,NF1:ENST00000356175:3'UTR:MODIFIER:exon57/57:c.*2829T>C:,NF1:ENST00000444181:intron:MODIFIER:exon15/16:c.1874-1904T>C:		rs1048317	0.6126	0.0000	0,0,0	0,0,0,0,0	0.6426							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];	RCV000271959.1 [likely benign]; RCV000287335.1 [likely benign]; RCV000322312.1 [likely benign]; RCV000376914.1 [likely benign]; 			93	106					NF1 (inh=AD pLI=1.00)
chr17	33901918	33901921	TAAG	-	het	anno_omim	QUAL=1871;DP=136;AF=0.51;MQM=59;TRIO=HET,136,0.51,HET,32,0.56,WT,41,0.00	PEX12	3'UTR	PEX12:ENST00000225873:3'UTR:MODIFIER:exon3/3:c.*880_*883delCTTA:		rs35050283	0.4465	0.0000	0,0,0	0,0,0,0,0	0.4841							601758 [PEX12 (provisional) Peroxisome biogenesis disorder 3A (Zellweger),614859|Peroxisome biogenesis disorder 3B,266510];	RCV000264131.1 [benign]; 			50	119					PEX12 (inh=AR pLI=0.00)
chr17	33901965	33901965	C	G	het	anno_omim	QUAL=4812;DP=197;AF=0.54;MQM=60;TRIO=HET,197,0.54,HET,69,0.51,HET,91,0.46	PEX12	3'UTR	PEX12:ENST00000225873:3'UTR:MODIFIER:exon3/3:c.*836G>C:		rs10068	0.4010	0.0000	0,0,0	0,0,0,0,0	0.3606							601758 [PEX12 (provisional) Peroxisome biogenesis disorder 3A (Zellweger),614859|Peroxisome biogenesis disorder 3B,266510];	RCV000321572.1 [benign]; 			33	114					PEX12 (inh=AR pLI=0.00)
chr17	33905468	33905468	A	G	hom	anno_omim	QUAL=13338;DP=185;AF=0.99;MQM=60;TRIO=HOM,185,0.99,HOM,167,1.00,HET,233,0.49	PEX12,AP2B1	5'UTR	PEX12:ENST00000225873:5'UTR:MODIFIER:exon1/3:c.-428T>C:		rs321600	0.8774	0.0000	0,0,0	0,0,0,0,0	0.8421							601758 [PEX12 (provisional) Peroxisome biogenesis disorder 3A (Zellweger),614859|Peroxisome biogenesis disorder 3B,266510];	RCV000347251.1 [benign]; 			147	76					PEX12 (inh=AR pLI=0.00), AP2B1 (inh=n/a pLI=1.00)
chr17	37822311	37822311	A	C	het	anno_omim	QUAL=9785;DP=201;AF=0.51;MQM=59;TRIO=HET,201,0.51,WT,230,0.00,HOM,238,1.00	TCAP	synonymous	TCAP:ENST00000309889:synonymous:LOW:exon2/2:c.453A>C:p.Ala151Ala,TCAP:ENST00000578283:synonymous:LOW:exon3/3:c.381A>C:p.Ala127Ala		rs1053651	0.5497	0.6706	27830,17324,955	0.4368,0.6277,0.3983,0.7255,0.7399	0.6698							604488 [TCAP (confirmed) Muscular dystrophy,limb-girdle,type 2G,601954|Cardiomyopathy,hypertrophic,25,607487];	RCV000037796.10 [benign]; RCV000251363.1 [benign]; RCV000299362.1 [likely benign]; RCV000337974.1 [likely benign]; RCV000395204.1 [likely benign]; 		COSM436493	1112	919					TCAP (inh=AR+AD pLI=0.08)
chr17	38783971	38783972	TT	-	hom	anno_omim	QUAL=4530;DP=118;AF=0.99;MQM=59;TRIO=HOM,118,0.99,HOM,16,1.00,HOM,23,1.00	SMARCE1	3'UTR	SMARCE1:ENST00000348513:3'UTR:MODIFIER:exon11/11:c.*1065_*1066delAA:		rs59835738;rs869254366	0.0000	0.0000	0,0,0	0,0,0,0,0	0.4597							603111 [SMARCE1 (provisional) Meningioma,familial,susceptibility to,607174|Coffin-Siris syndrome 5,616938];				56	100					SMARCE1 (inh=AD pLI=1.00)
chr17	40465420	40465420	G	A	het	anno_omim	QUAL=203;DP=65;AF=0.43;MQM=51;TRIO=HET,65,0.43,WT,39,0.15,HET,52,0.25	STAT3	3'UTR	STAT3:ENST00000264657:3'UTR:MODIFIER:exon24/24:c.*2343C>T:	(A)n	rs200029754	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0579							102582 [STAT3 (provisional) Hyper-IgE recurrent infection syndrome,147060|Autoimmune disease,multisystem,infantile-onset,1,615952];				1	44					STAT3 (inh=AD pLI=1.00)
chr17	40465422	40465422	C	A	het	anno_omim	QUAL=203;DP=65;AF=0.43;MQM=51;TRIO=HET,65,0.43,WT,39,0.15,HET,52,0.25	STAT3	3'UTR	STAT3:ENST00000264657:3'UTR:MODIFIER:exon24/24:c.*2341G>T:	(A)n		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0461							102582 [STAT3 (provisional) Hyper-IgE recurrent infection syndrome,147060|Autoimmune disease,multisystem,infantile-onset,1,615952];				0	40					STAT3 (inh=AD pLI=1.00)
chr17	40466092	40466092	G	A	het	anno_omim	QUAL=9468;DP=175;AF=0.56;MQM=60;TRIO=HET,175,0.56,HET,137,0.63,HOM,165,1.00	STAT3	3'UTR	STAT3:ENST00000264657:3'UTR:MODIFIER:exon24/24:c.*1671C>T:		rs1053004	0.4499	0.0000	0,0,0	0,0,0,0,0	0.4892							102582 [STAT3 (provisional) Hyper-IgE recurrent infection syndrome,147060|Autoimmune disease,multisystem,infantile-onset,1,615952];	RCV000323761.1 [benign]; 			92	115					STAT3 (inh=AD pLI=1.00)
chr17	40466869	40466869	C	T	het	anno_omim	QUAL=353;DP=181;AF=0.30;MQM=56;TRIO=HET,181,0.30,HET,54,0.19,HET,70,0.17	STAT3	3'UTR	STAT3:ENST00000264657:3'UTR:MODIFIER:exon24/24:c.*894G>A:	AluSc8		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0219							102582 [STAT3 (provisional) Hyper-IgE recurrent infection syndrome,147060|Autoimmune disease,multisystem,infantile-onset,1,615952];				15	46					STAT3 (inh=AD pLI=1.00)
chr17	40689455	40689455	T	C	hom	anno_omim	QUAL=21766;DP=200;AF=1.00;MQM=59;TRIO=HOM,200,1.00,HOM,198,1.00,HOM,295,1.00	NAGLU,RP11-400F19.8	synonymous	NAGLU:ENST00000225927:synonymous:LOW:exon2/6:c.423T>C:p.Ser141Ser		rs659497	0.9976	0.9947	60052,32838,5192	0.9989,0.9971,1.0000,0.9922,0.9979	0.9954							609701 [NAGLU (confirmed) Mucopolysaccharidosis type IIIB (Sanfilippo B),252920|Charcot-Marie-Tooth disease,axonal,type 2V,616491];	RCV000078458.5 [benign]; RCV000295179.1 [benign]; 			2093	24					NAGLU (inh=AR+AD pLI=0.00), RP11-400F19.8 (inh=n/a pLI=n/a)
chr17	40696233	40696233	C	G	hom	pred_pathogenic;anno_omim	QUAL=2856;DP=46;AF=0.98;MQM=59;TRIO=HOM,46,0.98,HOM,17,1.00,HOM,30,1.00	NAGLU,RP11-400F19.8	missense	NAGLU:ENST00000225927:missense:MODERATE:exon6/6:c.2209C>G:p.Arg737Gly		rs86312	0.8592	0.9055	49702,28044,2166	0.6548,0.9525,0.9984,0.9210,0.9300	0.9109	0.8780	D,T	T	B	D	23.70	609701 [NAGLU (confirmed) Mucopolysaccharidosis type IIIB (Sanfilippo B),252920|Charcot-Marie-Tooth disease,axonal,type 2V,616491];	RCV000078457.5 [benign]; RCV000388513.1 [benign]; 		COSM4130095	1754	348					NAGLU (inh=AR+AD pLI=0.00), RP11-400F19.8 (inh=n/a pLI=n/a)
chr17	42085150	42085150	T	C	hom	low_DP;anno_omim	QUAL=337;DP=7;AF=1.00;MQM=59;TRIO=HOM,7,1.00,HOM,4,1.00,HOM,2,1.00	NAGS	splice_region&intron	NAGS:ENST00000293404:splice_region&intron:LOW:exon6/6:c.1451+9T>C:		rs228773	0.9603	0.9432	24550,11656,1857	0.8851,0.9743,0.9995,0.9237,0.9834	0.9527							608300 [NAGS (confirmed) N-acetylglutamate synthase deficiency,237310];	RCV000250494.1 [benign]; RCV000282299.1 [benign]; 			1856	196					NAGS (inh=AR pLI=0.00)
chr17	42085972	42085972	C	T	hom	anno_omim	QUAL=15950;DP=286;AF=0.99;MQM=59;TRIO=HOM,286,0.99,HOM,146,1.00,HET,227,0.52	NAGS	3'UTR	NAGS:ENST00000293404:3'UTR:MODIFIER:exon7/7:c.*3C>T:		rs186636	0.4756	0.5660	20389,13970,861	0.4108,0.4141,0.2627,0.6465,0.6054	0.5623							608300 [NAGS (confirmed) N-acetylglutamate synthase deficiency,237310];	RCV000250223.1 [benign]; RCV000339592.1 [benign]; 			892	954					NAGS (inh=AR pLI=0.00)
chr17	42086180	42086180	C	T	hom	anno_omim	QUAL=32772;DP=365;AF=0.99;MQM=59;TRIO=HOM,365,0.99,HOM,282,1.00,HOM,386,1.00	NAGS	3'UTR	NAGS:ENST00000293404:3'UTR:MODIFIER:exon7/7:c.*211C>T:		rs640631	0.8948	0.0000	0,0,0	0,0,0,0,0	0.8714							608300 [NAGS (confirmed) N-acetylglutamate synthase deficiency,237310];	RCV000406871.1 [benign]; 			211	21					NAGS (inh=AR pLI=0.00)
chr17	42148205	42148205	C	T	het	anno_omim	QUAL=1286;DP=56;AF=0.64;MQM=58;TRIO=HET,56,0.64,HOM,25,0.96,WT,39,0.00	G6PC3	5'UTR_premature_start_codon_gain,5'UTR	G6PC3:ENST00000269097:5'UTR_premature_start_codon_gain:LOW:exon1/6:c.-129C>T:,G6PC3:ENST00000269097:5'UTR:MODIFIER:exon1/6:c.-129C>T:		rs228758	0.3231	0.5670	1438,377,1	0.1553,0.0000,0.0000,0.5760,0.5864	0.4520							611045 [G6PC3 (provisional) Neutropenia,severe congenital 4,autosomal recessive,612541|Dursun syndrome,612541];	RCV000312411.1 [benign]; 			184	315					G6PC3 (inh=AR pLI=0.00)
chr17	42983193	42983193	A	G	het	anno_omim	QUAL=6361;DP=170;AF=0.52;MQM=59;TRIO=HET,170,0.52,HET,158,0.54,HET,177,0.46	GFAP	3'UTR	GFAP:ENST00000253408:3'UTR:MODIFIER:exon9/9:c.*1522T>C:		rs17027	0.2438	0.0000	0,0,0	0,0,0,0,0	0.2772							137780 [GFAP (confirmed) Alexander disease,203450];	RCV000331184.1 [benign]; RCV000331524.1 [likely benign]; 			22	100					GFAP (inh=AD pLI=0.00)
chr17	42984085	42984085	C	T	het	anno_omim	QUAL=7716;DP=325;AF=0.50;MQM=59;TRIO=HET,325,0.50,WT,253,0.00,HET,325,0.50	GFAP	3'UTR	GFAP:ENST00000253408:3'UTR:MODIFIER:exon9/9:c.*630G>A:	FLAM_A	rs72828813	0.0036	0.0000	0,0,0	0,0,0,0,0	0.0072							137780 [GFAP (confirmed) Alexander disease,203450];	RCV000390405.1 [likely benign]; 			0	5					GFAP (inh=AD pLI=0.00)
chr17	42984687	42984687	G	C	het	anno_omim	QUAL=3909;DP=119;AF=0.55;MQM=59;TRIO=HET,119,0.55,HET,68,0.50,HET,100,0.53	GFAP	3'UTR	GFAP:ENST00000253408:3'UTR:MODIFIER:exon9/9:c.*28C>G:,GFAP:ENST00000588735:3'UTR:MODIFIER:exon3/3:c.*28C>G:		rs11558961	0.2438	0.2670	4378,2546,281	0.2299,0.2174,0.2470,0.2762,0.2780	0.2774							137780 [GFAP (confirmed) Alexander disease,203450];	RCV000056816.1 [not provided]; RCV000305452.1 [benign]; RCV000401615.1 [likely benign]; 			297	1335					GFAP (inh=AD pLI=0.00)
chr17	42987523	42987523	G	A	het	pred_pathogenic;anno_omim	QUAL=9188;DP=223;AF=0.45;MQM=59;TRIO=HET,223,0.45,HET,228,0.47,HET,355,0.50	GFAP	missense,intron	GFAP:ENST00000435360:missense:MODERATE:exon8/8:c.1277C>T:p.Thr426Met,GFAP:ENST00000253408:intron:MODIFIER:exon7/8:c.1171+460C>T:,GFAP:ENST00000588735:intron:MODIFIER:exon1/2:c.83-2039C>T:		rs9908084	0.1056	0.1375	1356,952,36	0.0893,0.0655,0.0064,0.1667,0.1601	0.1367	1.9410	D	T	B	D	9.57	137780 [GFAP (confirmed) Alexander disease,203450];			COSM3755582	123	1011					GFAP (inh=AD pLI=0.00)
chr17	42987524	42987524	T	C	het	pred_pathogenic;anno_omim	QUAL=9188;DP=223;AF=0.45;MQM=59;TRIO=HET,223,0.45,HET,228,0.47,HET,355,0.50	GFAP	missense,intron	GFAP:ENST00000435360:missense:MODERATE:exon8/8:c.1276A>G:p.Thr426Ala,GFAP:ENST00000253408:intron:MODIFIER:exon7/8:c.1171+459A>G:,GFAP:ENST00000588735:intron:MODIFIER:exon1/2:c.83-2040A>G:		rs9916491	0.2436	0.2675	4424,2575,266	0.2301,0.2184,0.2478,0.2765,0.2774	0.2768	0.7530	T	T	B	D	6.79	137780 [GFAP (confirmed) Alexander disease,203450];			COSM4000176	312	1397					GFAP (inh=AD pLI=0.00)
chr17	45196190	45196190	T	C	het	gene_blacklist	QUAL=8090;DP=277;AF=0.53;MQM=59;TRIO=HET,277,0.53,HET,132,0.57,HET,166,0.49	CDC27	3'UTR	CDC27:ENST00000066544:3'UTR:MODIFIER:exon19/19:c.*2111A>G:		rs1713494	0.2808	0.0000	0,0,0	0,0,0,0,0	0.3416											35	105					CDC27 (inh=n/a pLI=0.49)
chr17	45214558	45214558	G	A	het	low_MQM;gene_blacklist;anno_high_impact;pred_pathogenic	QUAL=72;DP=143;AF=0.16;MQM=37;TRIO=HET,143,0.16,WT,80,0.01,WT,122,0.07	CDC27	stop_gained	CDC27:ENST00000531206:stop_gained:HIGH:exon14/19:c.1891C>T:p.Arg631*,CDC27:ENST00000066544:stop_gained:HIGH:exon14/19:c.1873C>T:p.Arg625*,CDC27:ENST00000446365:stop_gained:HIGH:exon13/18:c.1690C>T:p.Arg564*,CDC27:ENST00000527547:stop_gained:HIGH:exon14/19:c.1870C>T:p.Arg624*		rs77685276	0.0000	0.4968	0,0,0	0.4938,0.4984,0.4977,0.4960,0.4989	0.4795	2.0410					41.00					0	49	2	[2] old entry - no details available			CDC27 (inh=n/a pLI=0.49)
chr17	45214682	45214682	A	G	het	low_MQM;gene_blacklist	QUAL=59;DP=169;AF=0.15;MQM=39;TRIO=HET,169,0.15,WT,81,0.01,WT,126,0.03	CDC27	synonymous	CDC27:ENST00000531206:synonymous:LOW:exon14/19:c.1767T>C:p.His589His,CDC27:ENST00000066544:synonymous:LOW:exon14/19:c.1749T>C:p.His583His,CDC27:ENST00000446365:synonymous:LOW:exon13/18:c.1566T>C:p.His522His,CDC27:ENST00000527547:synonymous:LOW:exon14/19:c.1746T>C:p.His582His		rs62075622	0.0000	0.4919	0,0,0	0.4855,0.4957,0.4947,0.4895,0.4986	0.4653										COSM4130203, COSM4130204	0	29					CDC27 (inh=n/a pLI=0.49)
chr17	45219669	45219669	G	A	het	low_MQM;gene_blacklist;pred_pathogenic	QUAL=87;DP=102;AF=0.25;MQM=26;TRIO=HET,102,0.25,WT,25,0.00,WT,34,0.00	CDC27	missense	CDC27:ENST00000531206:missense:MODERATE:exon11/19:c.1322C>T:p.Ser441Phe,CDC27:ENST00000066544:missense:MODERATE:exon11/19:c.1304C>T:p.Ser435Phe,CDC27:ENST00000446365:missense:MODERATE:exon10/18:c.1121C>T:p.Ser374Phe,CDC27:ENST00000527547:missense:MODERATE:exon11/19:c.1304C>T:p.Ser435Phe		rs11491191	0.0000	0.0348	0,0,0	0.0286,0.0199,0.0259,0.0364,0.0398	0.0039	4.9730	D,D,D,D	T	P,P,P,P	T,T,T,T	23.00				COSM3932634, COSM3932635	0	0					CDC27 (inh=n/a pLI=0.49)
chr17	45234303	45234303	G	C	het	low_MQM;gene_blacklist;pred_pathogenic	QUAL=453;DP=131;AF=0.36;MQM=34;TRIO=HET,131,0.36,HET,41,0.22,HET,44,0.23	CDC27	missense	CDC27:ENST00000531206:missense:MODERATE:exon7/19:c.818C>G:p.Ala273Gly,CDC27:ENST00000066544:missense:MODERATE:exon7/19:c.818C>G:p.Ala273Gly,CDC27:ENST00000446365:missense:MODERATE:exon6/18:c.635C>G:p.Ala212Gly,CDC27:ENST00000527547:missense:MODERATE:exon7/19:c.818C>G:p.Ala273Gly		rs200611688	0.0000	0.4774	0,0,0	0.4385,0.4915,0.4837,0.4732,0.4975	0.4896	9.2600	D,D,D,D,D	T	B,B,B,B	T,T,T,T,T	21.70				COSM1178872, COSM1178871	1	77					CDC27 (inh=n/a pLI=0.49)
chr17	45234407	45234407	A	-	het	low_MQM;gene_blacklist;anno_high_impact	QUAL=1934;DP=223;AF=0.35;MQM=34;TRIO=HET,223,0.35,HET,81,0.28,HET,107,0.35	CDC27	frameshift	CDC27:ENST00000531206:frameshift:HIGH:exon7/19:c.714delT:p.Val239fs,CDC27:ENST00000066544:frameshift:HIGH:exon7/19:c.714delT:p.Val239fs,CDC27:ENST00000446365:frameshift:HIGH:exon6/18:c.531delT:p.Val178fs,CDC27:ENST00000527547:frameshift:HIGH:exon7/19:c.714delT:p.Val239fs		rs112848754	0.0000	0.4952	0,0,0	0.4821,0.4993,0.4991,0.4943,0.4995	0.4980											0	135	1	[1] old entry - no details available			CDC27 (inh=n/a pLI=0.49)
chr17	45234417	45234417	A	G	het	low_MQM;gene_blacklist;pred_pathogenic	QUAL=1728;DP=208;AF=0.28;MQM=34;TRIO=HET,208,0.28,HET,75,0.29,HET,107,0.31	CDC27	missense	CDC27:ENST00000531206:missense:MODERATE:exon7/19:c.704T>C:p.Ile235Thr,CDC27:ENST00000066544:missense:MODERATE:exon7/19:c.704T>C:p.Ile235Thr,CDC27:ENST00000446365:missense:MODERATE:exon6/18:c.521T>C:p.Ile174Thr,CDC27:ENST00000527547:missense:MODERATE:exon7/19:c.704T>C:p.Ile235Thr		rs193061947	0.0000	0.4881	0,0,0	0.4639,0.4946,0.4955,0.4862,0.4980	0.4947	8.7540	T,T,T,T,T	T	B,B,B,B	T,T,T,T,T	18.40				COSM4130263, COSM4130264	0	122					CDC27 (inh=n/a pLI=0.49)
chr17	45234420	45234420	T	G	het	low_MQM;gene_blacklist;pred_pathogenic	QUAL=1728;DP=208;AF=0.28;MQM=34;TRIO=HET,208,0.28,HET,75,0.29,HET,107,0.31	CDC27	missense	CDC27:ENST00000531206:missense:MODERATE:exon7/19:c.701A>C:p.Tyr234Ser,CDC27:ENST00000066544:missense:MODERATE:exon7/19:c.701A>C:p.Tyr234Ser,CDC27:ENST00000446365:missense:MODERATE:exon6/18:c.518A>C:p.Tyr173Ser,CDC27:ENST00000527547:missense:MODERATE:exon7/19:c.701A>C:p.Tyr234Ser		rs78493795	0.0000	0.4898	0,0,0	0.4637,0.4977,0.4973,0.4881,0.4990	0.4955	7.5220	T,T,T,T,T	T	B,B,B,B	T,T,T,T,T	19.07				COSM3734971, COSM3734972	0	118					CDC27 (inh=n/a pLI=0.49)
chr17	45234449	45234449	G	A	het	low_MQM;gene_blacklist	QUAL=451;DP=179;AF=0.13;MQM=35;TRIO=HET,179,0.13,HET,76,0.21,HET,105,0.30	CDC27	synonymous	CDC27:ENST00000531206:synonymous:LOW:exon7/19:c.672C>T:p.Tyr224Tyr,CDC27:ENST00000066544:synonymous:LOW:exon7/19:c.672C>T:p.Tyr224Tyr,CDC27:ENST00000446365:synonymous:LOW:exon6/18:c.489C>T:p.Tyr163Tyr,CDC27:ENST00000527547:synonymous:LOW:exon7/19:c.672C>T:p.Tyr224Tyr		rs112216339	0.0000	0.4217	0,0,0	0.4240,0.4114,0.4057,0.4174,0.4527	0.4513										COSM1383886, COSM1383887	0	37					CDC27 (inh=n/a pLI=0.49)
chr17	45234707	45234707	T	A	het	low_MQM;gene_blacklist;pred_pathogenic	QUAL=682;DP=365;AF=0.20;MQM=36;TRIO=HET,365,0.20,WT,149,0.04,WT,149,0.02	CDC27	missense	CDC27:ENST00000531206:missense:MODERATE:exon6/19:c.519A>T:p.Leu173Phe,CDC27:ENST00000066544:missense:MODERATE:exon6/19:c.519A>T:p.Leu173Phe,CDC27:ENST00000446365:missense:MODERATE:exon5/18:c.336A>T:p.Leu112Phe,CDC27:ENST00000527547:missense:MODERATE:exon6/19:c.519A>T:p.Leu173Phe		rs75353677	0.0000	0.4633	0,0,0	0.4670,0.4623,0.4646,0.4597,0.4840	0.3164	0.5090	D,D,D,D,D	T	B,B,P,B	T,T,T,T,T	11.09				COSM1737257, COSM1737258	0	33					CDC27 (inh=n/a pLI=0.49)
chr17	45234710	45234710	A	C	het	low_MQM;gene_blacklist	QUAL=682;DP=365;AF=0.20;MQM=36;TRIO=HET,365,0.20,WT,149,0.04,WT,149,0.02	CDC27	synonymous	CDC27:ENST00000531206:synonymous:LOW:exon6/19:c.516T>G:p.Ser172Ser,CDC27:ENST00000066544:synonymous:LOW:exon6/19:c.516T>G:p.Ser172Ser,CDC27:ENST00000446365:synonymous:LOW:exon5/18:c.333T>G:p.Ser111Ser,CDC27:ENST00000527547:synonymous:LOW:exon6/19:c.516T>G:p.Ser172Ser		rs78395997	0.0000	0.3447	0,0,0	0.3325,0.3489,0.3450,0.3359,0.4147	0.1584										COSM4130284, COSM4130283	0	19					CDC27 (inh=n/a pLI=0.49)
chr17	45234713	45234713	T	C	het	low_MQM;gene_blacklist	QUAL=439;DP=360;AF=0.19;MQM=32;TRIO=HET,360,0.19,WT,143,0.02,WT,141,0.03	CDC27	synonymous	CDC27:ENST00000531206:synonymous:LOW:exon6/19:c.513A>G:p.Thr171Thr,CDC27:ENST00000066544:synonymous:LOW:exon6/19:c.513A>G:p.Thr171Thr,CDC27:ENST00000446365:synonymous:LOW:exon5/18:c.330A>G:p.Thr110Thr,CDC27:ENST00000527547:synonymous:LOW:exon6/19:c.513A>G:p.Thr171Thr		rs139751753	0.0000	0.0401	0,0,0	0.0297,0.0341,0.0387,0.0368,0.0755	0.0066										COSM1130261, COSM1130260	0	4					CDC27 (inh=n/a pLI=0.49)
chr17	45234760	45234760	-	A	het	gene_blacklist	QUAL=823;DP=103;AF=0.32;MQM=59;TRIO=HET,103,0.32,HET,59,0.29,HET,67,0.61	CDC27	splice_region&intron	CDC27:ENST00000531206:splice_region&intron:LOW:exon5/18:c.476-11dupT:,CDC27:ENST00000066544:splice_region&intron:LOW:exon5/18:c.476-11dupT:,CDC27:ENST00000446365:splice_region&intron:LOW:exon4/17:c.293-11dupT:,CDC27:ENST00000527547:splice_region&intron:LOW:exon5/18:c.476-11dupT:		rs11372544;rs577503859	0.2694	0.4021	560,341,43	0.3844,0.4389,0.2815,0.4237,0.3322	0.6074											359	644					CDC27 (inh=n/a pLI=0.49)
chr17	45368337	45368337	A	C	het	anno_omim	QUAL=18417;DP=235;AF=0.51;MQM=60;TRIO=HET,235,0.51,HET,298,0.55,HOM,349,0.99	ITGB3	synonymous	ITGB3:ENST00000559488:synonymous:LOW:exon9/15:c.1143A>C:p.Val381Val,ITGB3:ENST00000560629:synonymous:LOW:exon9/18:c.1107A>C:p.Val369Val,ITGB3:ENST00000571680:synonymous:LOW:exon9/9:c.1143A>C:p.Val381Val,ITGB3:ENST00000435993:synonymous:LOW:exon9/18:c.1002A>C:p.Val334Val		rs15908	0.4311	0.3902	9633,4589,970	0.4307,0.2727,0.5880,0.3720,0.4478	0.3933							173470 [ITGB3 (confirmed) Glanzmann thrombasthenia,273800|Thrombocytopenia,neonatal alloimmune|Myocardial infarction,susceptibility to,608446|Purpura,posttransfusion|Bleeding disorder,platelet-type,16,autosomal dominant,187800];	RCV000245014.1 [benign]; RCV000336334.1 [benign]; 			350	1020					ITGB3 (inh=AR+AD pLI=0.14)
chr17	45369777	45369777	A	G	het	anno_omim	QUAL=5610;DP=105;AF=0.51;MQM=59;TRIO=HET,105,0.51,WT,103,0.01,HOM,147,1.00	ITGB3	synonymous	ITGB3:ENST00000559488:synonymous:LOW:exon10/15:c.1533A>G:p.Glu511Glu,ITGB3:ENST00000560629:synonymous:LOW:exon10/18:c.1497A>G:p.Glu499Glu,ITGB3:ENST00000435993:synonymous:LOW:exon10/18:c.1392A>G:p.Glu464Glu		rs4642	0.2873	0.2871	5006,2824,359	0.2675,0.2199,0.3472,0.2930,0.2954	0.2891							173470 [ITGB3 (confirmed) Glanzmann thrombasthenia,273800|Thrombocytopenia,neonatal alloimmune|Myocardial infarction,susceptibility to,608446|Purpura,posttransfusion|Bleeding disorder,platelet-type,16,autosomal dominant,187800];	RCV000249975.1 [benign]; RCV000337655.1 [benign]; 		COSM1383908, COSM1383909, COSM4000179	205	883					ITGB3 (inh=AR+AD pLI=0.14)
chr17	45369789	45369789	G	A	het	anno_omim	QUAL=4968;DP=115;AF=0.45;MQM=59;TRIO=HET,115,0.45,WT,91,0.01,HOM,132,1.00	ITGB3	synonymous	ITGB3:ENST00000559488:synonymous:LOW:exon10/15:c.1545G>A:p.Arg515Arg,ITGB3:ENST00000560629:synonymous:LOW:exon10/18:c.1509G>A:p.Arg503Arg,ITGB3:ENST00000435993:synonymous:LOW:exon10/18:c.1404G>A:p.Arg468Arg		rs4634	0.2873	0.2873	5006,2822,359	0.2676,0.2197,0.3476,0.2932,0.2961	0.2890							173470 [ITGB3 (confirmed) Glanzmann thrombasthenia,273800|Thrombocytopenia,neonatal alloimmune|Myocardial infarction,susceptibility to,608446|Purpura,posttransfusion|Bleeding disorder,platelet-type,16,autosomal dominant,187800];	RCV000241947.1 [benign]; RCV000394843.1 [benign]; 		COSM4000180, COSM1383912, COSM1383913	205	883					ITGB3 (inh=AR+AD pLI=0.14)
chr17	45385012	45385012	C	T	het	anno_omim	QUAL=6444;DP=184;AF=0.53;MQM=60;TRIO=HET,184,0.53,HET,357,0.46,WT,377,0.00	ITGB3,RP11-290H9.4	splice_region&intron	ITGB3:ENST00000559488:splice_region&intron:LOW:exon14/14:c.2301+9C>T:,ITGB3:ENST00000560629:splice_region&intron:LOW:exon14/17:c.2265+9C>T:,ITGB3:ENST00000435993:splice_region&intron:LOW:exon14/17:c.2160+9C>T:		rs3809863	0.3990	0.4383	11551,7186,1198	0.4874,0.3471,0.2511,0.4734,0.3963	0.4653							173470 [ITGB3 (confirmed) Glanzmann thrombasthenia,273800|Thrombocytopenia,neonatal alloimmune|Myocardial infarction,susceptibility to,608446|Purpura,posttransfusion|Bleeding disorder,platelet-type,16,autosomal dominant,187800];	RCV000242227.1 [benign]; RCV000328155.1 [benign]; 			419	1049					ITGB3 (inh=AR+AD pLI=0.14), RP11-290H9.4 (inh=n/a pLI=n/a)
chr17	45388586	45388586	T	A	het	anno_omim	QUAL=7951;DP=292;AF=0.44;MQM=60;TRIO=HET,292,0.44,HOM,174,1.00,WT,271,0.01	ITGB3,RP11-290H9.4	3'UTR,intron	ITGB3:ENST00000559488:3'UTR:MODIFIER:exon15/15:c.*1016T>A:,ITGB3:ENST00000560629:intron:MODIFIER:exon14/17:c.2265+3583T>A:,ITGB3:ENST00000435993:intron:MODIFIER:exon14/17:c.2160+3583T>A:		rs3809865	0.7234	0.0000	0,0,0	0,0,0,0,0	0.7027							173470 [ITGB3 (confirmed) Glanzmann thrombasthenia,273800|Thrombocytopenia,neonatal alloimmune|Myocardial infarction,susceptibility to,608446|Purpura,posttransfusion|Bleeding disorder,platelet-type,16,autosomal dominant,187800];	RCV000370303.1 [benign]; 			130	88					ITGB3 (inh=AR+AD pLI=0.14), RP11-290H9.4 (inh=n/a pLI=n/a)
chr17	46020698	46020698	C	T	het	anno_omim	QUAL=6571;DP=261;AF=0.54;MQM=60;TRIO=HET,261,0.54,HET,233,0.49,WT,343,0.00	PNPO	synonymous,intron	PNPO:ENST00000225573:synonymous:LOW:exon2/7:c.165C>T:p.Ser55Ser,PNPO:ENST00000544840:synonymous:LOW:exon2/6:c.165C>T:p.Ser55Ser,PNPO:ENST00000434554:synonymous:LOW:exon2/6:c.165C>T:p.Ser55Ser,PNPO:ENST00000534893:intron:MODIFIER:exon1/5:c.-22-1284C>T:		rs11079804	0.1625	0.1822	2276,900,33	0.0668,0.3068,0.1875,0.1675,0.2450	0.1877							603287 [PNPO (provisional) Pyridoxamine 5'-phosphate oxidase deficiency,610090];	RCV000118001.3 [other]; RCV000297776.1 [benign]; 		COSM1179771	72	610					PNPO (inh=AR pLI=0.00)
chr17	46026031	46026031	G	C	het	anno_omim	QUAL=10136;DP=396;AF=0.47;MQM=59;TRIO=HET,396,0.47,HET,427,0.50,WT,579,0.00	RP11-6N17.9			MER5A1	rs1986694	0.1132	0.0000	0,0,0	0,0,0,0,0	0.0996							603287 [PNPO (provisional) Pyridoxamine 5'-phosphate oxidase deficiency,610090];	RCV000283286.1 [likely benign]; 			0	46					RP11-6N17.9 (inh=n/a pLI=n/a)
chr17	46026156	46026156	A	G	het	anno_omim	QUAL=18611;DP=264;AF=0.48;MQM=59;TRIO=HET,264,0.48,HOM,316,1.00,HET,427,0.47	RP11-6N17.9			Tigger19a	rs1986693	0.8079	0.0000	0,0,0	0,0,0,0,0	0.7472							603287 [PNPO (provisional) Pyridoxamine 5'-phosphate oxidase deficiency,610090];	RCV000340353.1 [benign]; 			153	71					RP11-6N17.9 (inh=n/a pLI=n/a)
chr17	48252804	48252804	T	C	hom	low_DP;anno_omim	QUAL=869;DP=10;AF=1.00;MQM=60;TRIO=HOM,10,1.00,HOM,4,1.00,HOM,15,1.00	SGCA,HILS1	3'UTR,intron	SGCA:ENST00000262018:3'UTR:MODIFIER:exon9/10:c.*6T>C:,SGCA:ENST00000344627:3'UTR:MODIFIER:exon7/8:c.*6T>C:,SGCA:ENST00000543315:3'UTR:MODIFIER:exon7/8:c.*6T>C:,HILS1:ENST00000504307:intron:MODIFIER:exon1/1:n.470-3266A>G:		rs2696288	0.9219	0.9566	54006,29806,3068	0.7952,0.9776,0.9998,0.9620,0.9895	0.9589							600119 [SGCA (confirmed) Muscular dystrophy,limb-girdle,type 2D,608099];	RCV000153940.3 [benign]; 			1960	128					SGCA (inh=AR pLI=0.19), HILS1 (inh=n/a pLI=n/a)
chr17	48261852	48261852	A	G	het	anno_omim	QUAL=2922;DP=185;AF=0.06;MQM=58;TRIO=HET,185,0.06,HET,52,0.19,WT,71,0.00	COL1A1	3'UTR	COL1A1:ENST00000225964:3'UTR:MODIFIER:exon51/51:c.*1011T>C:	A-rich	rs1061970	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1309							120150 [COL1A1 (confirmed) Osteogenesis imperfecta,type I,166200|Osteogenesis imperfecta,type II,166210|Osteogenesis imperfecta,type III,259420|Osteogenesis imperfecta,type IV,166220|Ehlers-Danlos syndrome,classic,130000|Ehlers-Danlos syndrome,type VIIA,130060|Caffey disease,114000|Bone mineral density variation QTL,osteoporosis,166710];				4	39					COL1A1 (inh=AR+AD pLI=1.00)
chr17	48262181	48262181	-	TGCT	het	anno_omim	QUAL=5040;DP=50;AF=0.50;MQM=59;TRIO=HET,50,0.50,WT,136,0.00,HOM,164,0.99	COL1A1	3'UTR	COL1A1:ENST00000225964:3'UTR:MODIFIER:exon51/51:c.*681_*682insAGCA:		rs112626388;rs35521741;rs3840870	0.5803	0.0000	0,0,0	0,0,0,0,0	0.6125							120150 [COL1A1 (confirmed) Osteogenesis imperfecta,type I,166200|Osteogenesis imperfecta,type II,166210|Osteogenesis imperfecta,type III,259420|Osteogenesis imperfecta,type IV,166220|Ehlers-Danlos syndrome,classic,130000|Ehlers-Danlos syndrome,type VIIA,130060|Caffey disease,114000|Bone mineral density variation QTL,osteoporosis,166710];	RCV000311883.1 [likely benign]; RCV000351512.1 [likely benign]; RCV000403912.1 [likely benign]; 			98	111					COL1A1 (inh=AR+AD pLI=1.00)
chr17	48262619	48262619	T	-	hom	anno_omim	QUAL=597;DP=31;AF=0.10;MQM=59;TRIO=HOM,31,0.10,HOM,6,0.00,HOM,20,0.10	COL1A1	3'UTR	COL1A1:ENST00000225964:3'UTR:MODIFIER:exon51/51:c.*244delA:	(T)n		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							120150 [COL1A1 (confirmed) Osteogenesis imperfecta,type I,166200|Osteogenesis imperfecta,type II,166210|Osteogenesis imperfecta,type III,259420|Osteogenesis imperfecta,type IV,166220|Ehlers-Danlos syndrome,classic,130000|Ehlers-Danlos syndrome,type VIIA,130060|Caffey disease,114000|Bone mineral density variation QTL,osteoporosis,166710];				0	0					COL1A1 (inh=AR+AD pLI=1.00)
chr17	48262775	48262775	A	G	het	anno_omim	QUAL=4489;DP=85;AF=0.41;MQM=59;TRIO=HET,85,0.41,HOM,128,0.98,WT,171,0.00	COL1A1	3'UTR	COL1A1:ENST00000225964:3'UTR:MODIFIER:exon51/51:c.*88T>C:		rs1061237	0.3786	0.0000	0,0,0	0,0,0,0,0	0.3149							120150 [COL1A1 (confirmed) Osteogenesis imperfecta,type I,166200|Osteogenesis imperfecta,type II,166210|Osteogenesis imperfecta,type III,259420|Osteogenesis imperfecta,type IV,166220|Ehlers-Danlos syndrome,classic,130000|Ehlers-Danlos syndrome,type VIIA,130060|Caffey disease,114000|Bone mineral density variation QTL,osteoporosis,166710];	RCV000287367.1 [likely benign]; RCV000322041.1 [likely benign]; RCV000376642.1 [likely benign]; 			18	91					COL1A1 (inh=AR+AD pLI=1.00)
chr17	48265475	48265475	A	G	het	anno_omim	QUAL=3233;DP=73;AF=0.49;MQM=59;TRIO=HET,73,0.49,HET,204,0.51,WT,283,0.01	COL1A1	synonymous	COL1A1:ENST00000225964:synonymous:LOW:exon44/51:c.3243T>C:p.Val1081Val		rs1800217	0.0040	0.0092	7,4,0	0.0021,0.0028,0.0000,0.0107,0.0151	0.0062							120150 [COL1A1 (confirmed) Osteogenesis imperfecta,type I,166200|Osteogenesis imperfecta,type II,166210|Osteogenesis imperfecta,type III,259420|Osteogenesis imperfecta,type IV,166220|Ehlers-Danlos syndrome,classic,130000|Ehlers-Danlos syndrome,type VIIA,130060|Caffey disease,114000|Bone mineral density variation QTL,osteoporosis,166710];	RCV000178543.1 [benign]; 			2	37					COL1A1 (inh=AR+AD pLI=1.00)
chr17	48265495	48265495	T	C	hom	pred_pathogenic;anno_omim	QUAL=14663;DP=67;AF=0.99;MQM=59;TRIO=HOM,67,0.99,HOM,175,1.00,HOM,246,1.00	COL1A1	missense	COL1A1:ENST00000225964:missense:MODERATE:exon44/51:c.3223A>G:p.Thr1075Ala		rs1800215	0.9788	0.9848	23381,11926,2154	0.9457,0.9894,1.0000,0.9859,0.9958	0.9851	0.5710	T	T	B	D	4.59	120150 [COL1A1 (confirmed) Osteogenesis imperfecta,type I,166200|Osteogenesis imperfecta,type II,166210|Osteogenesis imperfecta,type III,259420|Osteogenesis imperfecta,type IV,166220|Ehlers-Danlos syndrome,classic,130000|Ehlers-Danlos syndrome,type VIIA,130060|Caffey disease,114000|Bone mineral density variation QTL,osteoporosis,166710];	RCV000341625.1 [benign]; 		COSM4130378	2074	43					COL1A1 (inh=AR+AD pLI=1.00)
chr17	48268223	48268223	A	G	hom	anno_omim	QUAL=44290;DP=198;AF=1.00;MQM=59;TRIO=HOM,198,1.00,HOM,482,1.00,HOM,726,1.00	COL1A1	synonymous	COL1A1:ENST00000225964:synonymous:LOW:exon33/51:c.2298T>C:p.Thr766Thr		rs2734272	0.9998	0.9998	60645,33352,5192	0.9993,0.9999,0.9995,0.9999,0.9999	0.9999							120150 [COL1A1 (confirmed) Osteogenesis imperfecta,type I,166200|Osteogenesis imperfecta,type II,166210|Osteogenesis imperfecta,type III,259420|Osteogenesis imperfecta,type IV,166220|Ehlers-Danlos syndrome,classic,130000|Ehlers-Danlos syndrome,type VIIA,130060|Caffey disease,114000|Bone mineral density variation QTL,osteoporosis,166710];	RCV000247058.1 [benign]; RCV000265335.1 [likely benign]; RCV000328440.1 [likely benign]; RCV000383040.1 [likely benign]; 		COSM4130379	2116	1					COL1A1 (inh=AR+AD pLI=1.00)
chr17	48653354	48653354	C	A	het	anno_omim	QUAL=9926;DP=99;AF=0.45;MQM=60;TRIO=HET,99,0.45,HET,165,0.47,HOM,236,1.00	CACNA1G	synonymous	CACNA1G:ENST00000359106:synonymous:LOW:exon8/38:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000360761:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000354983:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000352832:synonymous:LOW:exon8/34:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000442258:synonymous:LOW:exon8/34:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000416767:synonymous:LOW:exon8/23:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000502264:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000503485:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000505165:synonymous:LOW:exon8/37:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000507336:synonymous:LOW:exon8/37:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000507510:synonymous:LOW:exon8/37:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000507609:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000507896:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000510115:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000510366:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000512389:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000513689:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000513964:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000514079:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000514181:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000514717:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000515165:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000515411:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000515765:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000429973:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:ENST00000358244:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg		rs12449998	0.5240	0.5554	3740,1310,44	0.2392,0.6245,0.9191,0.5099,0.6350	0.5217							604065 [CACNA1G (provisional) Spinocerebellar ataxia 42,616795];			COSM436875, COSM436878, COSM436877, COSM436876	524	1202					CACNA1G (inh=AD pLI=1.00)
chr17	48692881	48692881	C	T	het	anno_omim	QUAL=5304;DP=33;AF=0.48;MQM=59;TRIO=HET,33,0.48,HOM,191,0.99,WT,214,0.00	CACNA1G	splice_region&intron	CACNA1G:ENST00000359106:splice_region&intron:LOW:exon27/37:c.4911+8C>T:,CACNA1G:ENST00000360761:splice_region&intron:LOW:exon26/34:c.4842+8C>T:,CACNA1G:ENST00000354983:splice_region&intron:LOW:exon25/35:c.4809+8C>T:,CACNA1G:ENST00000352832:splice_region&intron:LOW:exon25/33:c.4809+8C>T:,CACNA1G:ENST00000442258:splice_region&intron:LOW:exon25/33:c.4788+8C>T:,CACNA1G:ENST00000502264:splice_region&intron:LOW:exon26/35:c.4842+8C>T:,CACNA1G:ENST00000503485:splice_region&intron:LOW:exon27/35:c.4809+8C>T:,CACNA1G:ENST00000505165:splice_region&intron:LOW:exon27/36:c.4911+8C>T:,CACNA1G:ENST00000507336:splice_region&intron:LOW:exon26/36:c.4878+8C>T:,CACNA1G:ENST00000507510:splice_region&intron:LOW:exon27/36:c.4911+8C>T:,CACNA1G:ENST00000507609:splice_region&intron:LOW:exon27/35:c.4911+8C>T:,CACNA1G:ENST00000507896:splice_region&intron:LOW:exon26/35:c.4878+8C>T:,CACNA1G:ENST00000510115:splice_region&intron:LOW:exon25/34:c.4809+8C>T:,CACNA1G:ENST00000510366:splice_region&intron:LOW:exon26/34:c.4755+8C>T:,CACNA1G:ENST00000512389:splice_region&intron:LOW:exon26/34:c.4878+8C>T:,CACNA1G:ENST00000513689:splice_region&intron:LOW:exon26/35:c.4776+8C>T:,CACNA1G:ENST00000513964:splice_region&intron:LOW:exon26/34:c.4776+8C>T:,CACNA1G:ENST00000514079:splice_region&intron:LOW:exon27/35:c.4932+8C>T:,CACNA1G:ENST00000514181:splice_region&intron:LOW:exon26/34:c.4857+8C>T:,CACNA1G:ENST00000514717:splice_region&intron:LOW:exon26/34:c.4740+8C>T:,CACNA1G:ENST00000515165:splice_region&intron:LOW:exon27/35:c.4911+8C>T:,CACNA1G:ENST00000515411:splice_region&intron:LOW:exon26/35:c.4857+8C>T:,CACNA1G:ENST00000515765:splice_region&intron:LOW:exon26/35:c.4878+8C>T:,CACNA1G:ENST00000429973:splice_region&intron:LOW:exon26/34:c.4857+8C>T:,CACNA1G:ENST00000358244:splice_region&intron:LOW:exon25/34:c.4809+8C>T:		rs8066527	0.2001	0.2842	4983,3686,296	0.2560,0.1492,0.0556,0.3450,0.2641	0.2884							604065 [CACNA1G (provisional) Spinocerebellar ataxia 42,616795];				268	982					CACNA1G (inh=AD pLI=1.00)
chr17	48703752	48703752	T	C	het	anno_omim	QUAL=4626;DP=156;AF=0.58;MQM=59;TRIO=HET,156,0.58,HOM,73,1.00,WT,94,0.01	CACNA1G	synonymous	CACNA1G:ENST00000359106:synonymous:LOW:exon38/38:c.6774T>C:p.Pro2258Pro,CACNA1G:ENST00000360761:synonymous:LOW:exon35/35:c.6426T>C:p.Pro2142Pro,CACNA1G:ENST00000354983:synonymous:LOW:exon36/36:c.6672T>C:p.Pro2224Pro,CACNA1G:ENST00000352832:synonymous:LOW:exon34/34:c.6393T>C:p.Pro2131Pro,CACNA1G:ENST00000442258:synonymous:LOW:exon34/34:c.6372T>C:p.Pro2124Pro,CACNA1G:ENST00000502264:synonymous:LOW:exon36/36:c.6561T>C:p.Pro2187Pro,CACNA1G:ENST00000503485:synonymous:LOW:exon36/36:c.6393T>C:p.Pro2131Pro,CACNA1G:ENST00000505165:synonymous:LOW:exon37/37:c.6258T>C:p.Pro2086Pro,CACNA1G:ENST00000507336:synonymous:LOW:exon37/37:c.6741T>C:p.Pro2247Pro,CACNA1G:ENST00000507510:synonymous:LOW:exon37/37:c.6639T>C:p.Pro2213Pro,CACNA1G:ENST00000507609:synonymous:LOW:exon36/36:c.6474T>C:p.Pro2158Pro,CACNA1G:ENST00000507896:synonymous:LOW:exon36/36:c.6225T>C:p.Pro2075Pro,CACNA1G:ENST00000510115:synonymous:LOW:exon35/35:c.6537T>C:p.Pro2179Pro,CACNA1G:ENST00000510366:synonymous:LOW:exon35/35:c.6339T>C:p.Pro2113Pro,CACNA1G:ENST00000512389:synonymous:LOW:exon35/35:c.6462T>C:p.Pro2154Pro,CACNA1G:ENST00000513689:synonymous:LOW:exon36/36:c.6504T>C:p.Pro2168Pro,CACNA1G:ENST00000513964:synonymous:LOW:exon35/35:c.6360T>C:p.Pro2120Pro,CACNA1G:ENST00000514079:synonymous:LOW:exon36/36:c.6516T>C:p.Pro2172Pro,CACNA1G:ENST00000514181:synonymous:LOW:exon35/35:c.6420T>C:p.Pro2140Pro,CACNA1G:ENST00000514717:synonymous:LOW:exon35/35:c.6324T>C:p.Pro2108Pro,CACNA1G:ENST00000515165:synonymous:LOW:exon36/36:c.6495T>C:p.Pro2165Pro,CACNA1G:ENST00000515411:synonymous:LOW:exon36/36:c.6585T>C:p.Pro2195Pro,CACNA1G:ENST00000515765:synonymous:LOW:exon36/36:c.6606T>C:p.Pro2202Pro,CACNA1G:ENST00000429973:synonymous:LOW:exon35/35:c.6441T>C:p.Pro2147Pro,CACNA1G:ENST00000358244:synonymous:LOW:exon35/35:c.6156T>C:p.Pro2052Pro		rs739925	0.3672	0.4165	9847,6278,1230	0.5383,0.2121,0.1804,0.4644,0.3822	0.4457							604065 [CACNA1G (provisional) Spinocerebellar ataxia 42,616795];			COSM4130401, COSM4130402, COSM4130403	476	1134					CACNA1G (inh=AD pLI=1.00)
chr17	48703986	48703986	G	A	het	anno_omim	QUAL=1621;DP=61;AF=0.57;MQM=59;TRIO=HET,61,0.57,WT,61,0.00,HET,85,0.45	CACNA1G	synonymous	CACNA1G:ENST00000359106:synonymous:LOW:exon38/38:c.7008G>A:p.Pro2336Pro,CACNA1G:ENST00000360761:synonymous:LOW:exon35/35:c.6660G>A:p.Pro2220Pro,CACNA1G:ENST00000354983:synonymous:LOW:exon36/36:c.6906G>A:p.Pro2302Pro,CACNA1G:ENST00000352832:synonymous:LOW:exon34/34:c.6627G>A:p.Pro2209Pro,CACNA1G:ENST00000442258:synonymous:LOW:exon34/34:c.6606G>A:p.Pro2202Pro,CACNA1G:ENST00000502264:synonymous:LOW:exon36/36:c.6795G>A:p.Pro2265Pro,CACNA1G:ENST00000503485:synonymous:LOW:exon36/36:c.6627G>A:p.Pro2209Pro,CACNA1G:ENST00000505165:synonymous:LOW:exon37/37:c.6492G>A:p.Pro2164Pro,CACNA1G:ENST00000507336:synonymous:LOW:exon37/37:c.6975G>A:p.Pro2325Pro,CACNA1G:ENST00000507510:synonymous:LOW:exon37/37:c.6873G>A:p.Pro2291Pro,CACNA1G:ENST00000507609:synonymous:LOW:exon36/36:c.6708G>A:p.Pro2236Pro,CACNA1G:ENST00000507896:synonymous:LOW:exon36/36:c.6459G>A:p.Pro2153Pro,CACNA1G:ENST00000510115:synonymous:LOW:exon35/35:c.6771G>A:p.Pro2257Pro,CACNA1G:ENST00000510366:synonymous:LOW:exon35/35:c.6573G>A:p.Pro2191Pro,CACNA1G:ENST00000512389:synonymous:LOW:exon35/35:c.6696G>A:p.Pro2232Pro,CACNA1G:ENST00000513689:synonymous:LOW:exon36/36:c.6738G>A:p.Pro2246Pro,CACNA1G:ENST00000513964:synonymous:LOW:exon35/35:c.6594G>A:p.Pro2198Pro,CACNA1G:ENST00000514079:synonymous:LOW:exon36/36:c.6750G>A:p.Pro2250Pro,CACNA1G:ENST00000514181:synonymous:LOW:exon35/35:c.6654G>A:p.Pro2218Pro,CACNA1G:ENST00000514717:synonymous:LOW:exon35/35:c.6558G>A:p.Pro2186Pro,CACNA1G:ENST00000515165:synonymous:LOW:exon36/36:c.6729G>A:p.Pro2243Pro,CACNA1G:ENST00000515411:synonymous:LOW:exon36/36:c.6819G>A:p.Pro2273Pro,CACNA1G:ENST00000515765:synonymous:LOW:exon36/36:c.6840G>A:p.Pro2280Pro,CACNA1G:ENST00000429973:synonymous:LOW:exon35/35:c.6675G>A:p.Pro2225Pro,CACNA1G:ENST00000358244:synonymous:LOW:exon35/35:c.6390G>A:p.Pro2130Pro		rs9893223	0.1927	0.1181	1359,126,600	0.3541,0.1936,0.0669,0.0611,0.2050	0.1375							604065 [CACNA1G (provisional) Spinocerebellar ataxia 42,616795];			COSM436909, COSM436907, COSM436908	20	324					CACNA1G (inh=AD pLI=1.00)
chr17	48704800	48704800	A	C	het	anno_omim	QUAL=1609;DP=64;AF=0.75;MQM=60;TRIO=HET,64,0.75,HOM,11,1.00,WT,7,0.00	CACNA1G,CTB-22K21.2	3'UTR	CACNA1G:ENST00000352832:3'UTR:MODIFIER:exon34/34:c.*688A>C:	(TATA)n	rs34036927	0.1348	0.0000	3,1,0	0.0000,0.0000,0.0000,0.0000,0.0000	0.4036							604065 [CACNA1G (provisional) Spinocerebellar ataxia 42,616795];				40	219					CACNA1G (inh=AD pLI=1.00), CTB-22K21.2 (inh=n/a pLI=n/a)
chr17	56283089	56283089	C	-	hom	anno_omim	QUAL=15383;DP=342;AF=0.97;MQM=59;TRIO=HOM,342,0.97,HET,200,0.50,HET,238,0.54	MKS1	3'UTR,intron	MKS1:ENST00000393119:3'UTR:MODIFIER:exon18/18:c.*351delG:,MKS1:ENST00000313863:3'UTR:MODIFIER:exon16/16:c.*443delG:,MKS1:ENST00000337050:intron:MODIFIER:exon16/16:c.1413-24delG:		rs35298266	0.0152	0.0219	7,4,0	0.0067,0.0387,0.0000,0.0369,0.0070	0.0457							609883 [MKS1 (confirmed) Meckel syndrome 1,249000|Bardet-Biedl syndrome 13,615990|Joubert syndrome 28,617121];				1	103					MKS1 (inh=AR pLI=0.00)
chr17	56290334	56290334	T	C	hom	anno_omim	QUAL=11582;DP=143;AF=0.99;MQM=60;TRIO=HOM,143,0.99,HOM,98,1.00,HOM,125,1.00	MKS1	splice_region&intron	MKS1:ENST00000393119:splice_region&intron:LOW:exon8/17:c.858+9A>G:,MKS1:ENST00000313863:splice_region&intron:LOW:exon8/15:c.858+9A>G:,MKS1:ENST00000337050:splice_region&intron:LOW:exon8/16:c.858+9A>G:,MKS1:ENST00000537529:splice_region&intron:LOW:exon8/17:c.828+9A>G:,MKS1:ENST00000546108:splice_region&intron:LOW:exon7/16:c.249+9A>G:		rs3826300	0.4808	0.4466	13147,6816,3120	0.7947,0.2692,0.2050,0.4512,0.4392	0.5413							609883 [MKS1 (confirmed) Meckel syndrome 1,249000|Bardet-Biedl syndrome 13,615990|Joubert syndrome 28,617121];	RCV000114214.3 [other]; RCV000313219.1 [benign]; RCV000367861.1 [benign]; 		COSM4000229, COSM4000228	433	1020					MKS1 (inh=AR pLI=0.00)
chr17	57076104	57076104	T	A	het	anno_omim	QUAL=3794;DP=179;AF=0.46;MQM=60;TRIO=HET,179,0.46,HET,28,0.54,HOM,37,1.00	TRIM37	3'UTR,intron	TRIM37:ENST00000262294:3'UTR:MODIFIER:exon24/24:c.*634A>T:,TRIM37:ENST00000376149:3'UTR:MODIFIER:exon23/23:c.*634A>T:,TRIM37:ENST00000393066:intron:MODIFIER:exon24/24:c.2891+638A>T:		rs28475409	0.3277	0.0000	0,0,0	0,0,0,0,0	0.3406							605073 [TRIM37 (confirmed) Mulibrey nanism,253250];	RCV000372594.1 [benign]; 			35	106					TRIM37 (inh=AR pLI=0.17)
chr17	57184162	57184162	A	C	het	low_DP;anno_omim	QUAL=1031;DP=15;AF=0.47;MQM=59;TRIO=HET,15,0.47,HET,17,0.35,HOM,29,0.97	TRIM37,AC099850.1	5'UTR	TRIM37:ENST00000393066:5'UTR:MODIFIER:exon1/25:c.-340T>G:,TRIM37:ENST00000376149:5'UTR:MODIFIER:exon1/23:c.-706T>G:,TRIM37:ENST00000393065:5'UTR:MODIFIER:exon1/23:c.-340T>G:		rs7503190	0.6118	0.0000	0,0,0	0,0,0,0,0	0.6584							605073 [TRIM37 (confirmed) Mulibrey nanism,253250];	RCV000276584.1 [benign]; 			74	92					TRIM37 (inh=AR pLI=0.17), AC099850.1 (inh=n/a pLI=n/a)
chr17	62006129	62006129	-	G	het	anno_omim	QUAL=965;DP=62;AF=0.50;MQM=59;TRIO=HET,62,0.50,WT,34,0.00,HET,37,0.54	CD79B	3'UTR	CD79B:ENST00000392795:3'UTR:MODIFIER:exon6/6:c.*456dupC:,CD79B:ENST00000006750:3'UTR:MODIFIER:exon6/6:c.*456dupC:		rs554643850	0.0014	0.0000	0,0,0	0,0,0,0,0	0.0051							147245 [CD79B (provisional) Agammaglobulinemia 6,612692];				0	3					CD79B (inh=AR pLI=0.95)
chr17	62006406	62006406	A	G	het	anno_omim	QUAL=1848;DP=101;AF=0.47;MQM=60;TRIO=HET,101,0.47,HET,65,0.46,WT,127,0.00	CD79B	3'UTR	CD79B:ENST00000392795:3'UTR:MODIFIER:exon6/6:c.*180T>C:,CD79B:ENST00000006750:3'UTR:MODIFIER:exon6/6:c.*180T>C:		rs147717759	0.0030	0.0000	0,0,0	0,0,0,0,0	0.0060							147245 [CD79B (provisional) Agammaglobulinemia 6,612692];				0	7					CD79B (inh=AR pLI=0.95)
chr17	62018002	62018002	C	A	het	anno_omim	QUAL=5440;DP=199;AF=0.52;MQM=60;TRIO=HET,199,0.52,WT,212,0.00,HET,242,0.50	SCN4A	3'UTR	SCN4A:ENST00000435607:3'UTR:MODIFIER:exon24/24:c.*129G>T:,SCN4A:ENST00000578147:3'UTR:MODIFIER:exon24/24:c.*129G>T:		rs140026321	0.0016	0.0000	0,0,0	0,0,0,0,0	0.0051							603967 [SCN4A (confirmed) Hyperkalemic periodic paralysis,type 2,170500|Paramyotonia congenita,168300|Myotonia congenita,atypical,acetazolamide-responsive,608390|Myasthenic syndrome,congenital,16,614198|Hypokalemic periodic paralysis,type 2,613345];	RCV000289000.1 [likely benign]; RCV000293949.1 [likely benign]; RCV000346264.1 [likely benign]; RCV000351216.1 [likely benign]; RCV000389473.1 [likely benign]; 			0	3					SCN4A (inh=AR+AD pLI=0.01)
chr17	62028920	62028920	C	G	het	pred_pathogenic;anno_omim	QUAL=4329;DP=194;AF=0.47;MQM=59;TRIO=HET,194,0.47,HET,170,0.52,WT,193,0.00	SCN4A	missense	SCN4A:ENST00000435607:missense:MODERATE:exon14/24:c.2717G>C:p.Ser906Thr,SCN4A:ENST00000578147:missense:MODERATE:exon14/24:c.2717G>C:p.Ser906Thr		rs41280102	0.0050	0.0095	8,6,0	0.0028,0.0070,0.0000,0.0152,0.0001	0.0099	0.5540	T	T	B	D	7.54	603967 [SCN4A (confirmed) Hyperkalemic periodic paralysis,type 2,170500|Paramyotonia congenita,168300|Myotonia congenita,atypical,acetazolamide-responsive,608390|Myasthenic syndrome,congenital,16,614198|Hypokalemic periodic paralysis,type 2,613345];	RCV000020269.1 [benign]; RCV000078659.8 [other]; RCV000288548.1 [likely benign]; RCV000342369.1 [likely benign]; RCV000348143.1 [likely benign]; RCV000382734.1 [likely benign]; RCV000398742.1 [likely benign]; 	CM034679 [CLASS=FP MUT=ALT PHEN="Impaired slow inactivation" GENE=SCN4A]; 		0	55	2	[2] Stefanie Beck-Woedl 11.12.2014			SCN4A (inh=AR+AD pLI=0.01)
chr17	62041068	62041068	T	C	hom	pred_pathogenic;anno_omim	QUAL=7750;DP=107;AF=1.00;MQM=60;TRIO=HOM,107,1.00,HOM,63,1.00,HOM,83,1.00	SCN4A	missense	SCN4A:ENST00000435607:missense:MODERATE:exon10/24:c.1570A>G:p.Ser524Gly,SCN4A:ENST00000578147:missense:MODERATE:exon10/24:c.1570A>G:p.Ser524Gly		rs6504191	0.9443	0.9288	50207,26766,3789	0.9061,0.9677,0.9994,0.9127,0.9627	0.9302	1.3430	T	T	B	D	0.03	603967 [SCN4A (confirmed) Hyperkalemic periodic paralysis,type 2,170500|Paramyotonia congenita,168300|Myotonia congenita,atypical,acetazolamide-responsive,608390|Myasthenic syndrome,congenital,16,614198|Hypokalemic periodic paralysis,type 2,613345];	RCV000118264.5 [benign]; RCV000279460.1 [benign]; RCV000294720.1 [benign]; RCV000336656.1 [benign]; RCV000351978.1 [benign]; RCV000400214.1 [benign]; 		COSM4130494	1826	279					SCN4A (inh=AR+AD pLI=0.01)
chr17	71197323	71197323	G	C	het	pred_pathogenic;anno_omim	QUAL=8285;DP=382;AF=0.48;MQM=59;TRIO=HET,382,0.48,WT,289,0.00,HET,377,0.39	COG1	missense	COG1:ENST00000299886:missense:MODERATE:exon7/14:c.1357G>C:p.Glu453Gln		rs62621249	0.0503	0.0670	359,255,8	0.0353,0.0431,0.0004,0.0855,0.0662	0.0682	4.1400	T,T	T	B,B,B	T,T	22.20	606973 [COG1 (confirmed) Congenital disorder of glycosylation,type IIg,611209];	RCV000081961.4 [benign]; RCV000275253.1 [likely benign]; 		COSM3755789	22	328					COG1 (inh=AR pLI=0.10)
chr17	72912265	72912265	C	G	hom	anno_omim	QUAL=9057;DP=94;AF=0.99;MQM=59;TRIO=HOM,94,0.99,HOM,132,1.00,HET,144,0.60	USH1G	3'UTR	USH1G:ENST00000319642:3'UTR:MODIFIER:exon3/3:c.*1903G>C:		rs1568448	0.3540	0.0000	0,0,0	0,0,0,0,0	0.3699							607696 [USH1G (confirmed) Usher syndrome,type 1G,606943];	RCV000280705.1 [benign]; 			43	105					USH1G (inh=AR pLI=0.00)
chr17	72913797	72913797	T	-	hom	anno_omim	QUAL=16403;DP=145;AF=0.99;MQM=59;TRIO=HOM,145,0.99,HOM,185,1.00,HOM,250,1.00	USH1G	3'UTR	USH1G:ENST00000319642:3'UTR:MODIFIER:exon3/3:c.*371delA:		rs55654382	1.0000	0.0000	0,0,0	0,0,0,0,0	1.0000							607696 [USH1G (confirmed) Usher syndrome,type 1G,606943];				232	0					USH1G (inh=AR pLI=0.00)
chr17	73269258	73269258	G	C	hom	anno_omim	QUAL=42827;DP=274;AF=1.00;MQM=59;TRIO=HOM,274,1.00,HOM,465,1.00,HOM,598,1.00	SLC25A19,RP11-649A18.12	3'UTR	SLC25A19:ENST00000320362:3'UTR:MODIFIER:exon9/9:c.*274C>G:,SLC25A19:ENST00000416858:3'UTR:MODIFIER:exon8/8:c.*274C>G:,SLC25A19:ENST00000402418:3'UTR:MODIFIER:exon6/6:c.*274C>G:,SLC25A19:ENST00000442286:3'UTR:MODIFIER:exon7/7:c.*274C>G:,SLC25A19:ENST00000580994:3'UTR:MODIFIER:exon8/8:c.*274C>G:		rs7198	0.5365	0.0000	0,0,0	0,0,0,0,0	0.5630							606521 [SLC25A19 (confirmed) Microcephaly,Amish type,607196|Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type),613710];	RCV000333409.1 [likely benign]; 			124	105					SLC25A19 (inh=AR pLI=0.93), RP11-649A18.12 (inh=n/a pLI=n/a)
chr17	73269530	73269530	A	G	hom	anno_omim	QUAL=34421;DP=301;AF=1.00;MQM=60;TRIO=HOM,301,1.00,HOM,319,1.00,HOM,441,1.00	SLC25A19,RP11-649A18.12	3'UTR	SLC25A19:ENST00000320362:3'UTR:MODIFIER:exon9/9:c.*2T>C:,SLC25A19:ENST00000416858:3'UTR:MODIFIER:exon8/8:c.*2T>C:,SLC25A19:ENST00000402418:3'UTR:MODIFIER:exon6/6:c.*2T>C:,SLC25A19:ENST00000442286:3'UTR:MODIFIER:exon7/7:c.*2T>C:,SLC25A19:ENST00000580994:3'UTR:MODIFIER:exon8/8:c.*2T>C:		rs1809352	0.9002	0.9290	51858,28159,3027	0.7692,0.9520,0.9997,0.9257,0.9794	0.9306							606521 [SLC25A19 (confirmed) Microcephaly,Amish type,607196|Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type),613710];	RCV000118365.1 [benign]; RCV000327662.1 [likely benign]; 			1814	281					SLC25A19 (inh=AR pLI=0.93), RP11-649A18.12 (inh=n/a pLI=n/a)
chr17	73269676	73269676	C	T	hom	anno_omim	QUAL=32496;DP=306;AF=1.00;MQM=59;TRIO=HOM,306,1.00,HOM,294,1.00,HOM,430,1.00	SLC25A19,RP11-649A18.12	synonymous	SLC25A19:ENST00000320362:synonymous:LOW:exon9/9:c.819G>A:p.Leu273Leu,SLC25A19:ENST00000416858:synonymous:LOW:exon8/8:c.819G>A:p.Leu273Leu,SLC25A19:ENST00000402418:synonymous:LOW:exon6/6:c.819G>A:p.Leu273Leu,SLC25A19:ENST00000442286:synonymous:LOW:exon7/7:c.819G>A:p.Leu273Leu,SLC25A19:ENST00000580994:synonymous:LOW:exon8/8:c.819G>A:p.Leu273Leu,SLC25A19:ENST00000375261:synonymous:LOW:exon5/5:c.648G>A:p.Leu216Leu		rs4789164	0.5302	0.6517	27604,15403,119	0.1409,0.7553,0.8673,0.6778,0.6347	0.6650							606521 [SLC25A19 (confirmed) Microcephaly,Amish type,607196|Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type),613710];	RCV000118371.2 [likely benign]; RCV000282825.1 [likely benign]; 			877	948					SLC25A19 (inh=AR pLI=0.93), RP11-649A18.12 (inh=n/a pLI=n/a)
chr17	73279624	73279624	A	G	hom	anno_omim	QUAL=10216;DP=91;AF=1.00;MQM=60;TRIO=HOM,91,1.00,HOM,100,1.00,HOM,132,1.00	SLC25A19	synonymous,intron	SLC25A19:ENST00000320362:synonymous:LOW:exon6/9:c.339T>C:p.Tyr113Tyr,SLC25A19:ENST00000416858:synonymous:LOW:exon5/8:c.339T>C:p.Tyr113Tyr,SLC25A19:ENST00000402418:synonymous:LOW:exon3/6:c.339T>C:p.Tyr113Tyr,SLC25A19:ENST00000442286:synonymous:LOW:exon4/7:c.339T>C:p.Tyr113Tyr,SLC25A19:ENST00000580994:synonymous:LOW:exon5/8:c.339T>C:p.Tyr113Tyr,SLC25A19:ENST00000375261:intron:MODIFIER:exon2/4:c.288+2761T>C:		rs7213318	0.8896	0.9617	55939,33017,3409	0.8112,0.9511,0.9267,0.9978,0.9197	0.9642							606521 [SLC25A19 (confirmed) Microcephaly,Amish type,607196|Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type),613710];	RCV000118368.2 [likely benign]; RCV000334842.1 [likely benign]; 		COSM4130610	2066	49					SLC25A19 (inh=AR pLI=0.93)
chr17	73285461	73285461	A	C	hom	anno_omim	QUAL=7895;DP=90;AF=1.00;MQM=59;TRIO=HOM,90,1.00,HOM,75,1.00,HOM,100,1.00	SLC25A19	5'UTR	SLC25A19:ENST00000320362:5'UTR:MODIFIER:exon1/9:c.-177T>G:,SLC25A19:ENST00000416858:5'UTR:MODIFIER:exon1/8:c.-155T>G:,SLC25A19:ENST00000442286:5'UTR:MODIFIER:exon1/7:c.-65T>G:,SLC25A19:ENST00000580994:5'UTR:MODIFIER:exon1/8:c.-139T>G:		rs2291033	0.8612	0.0000	0,0,0	0,0,0,0,0	0.9135							606521 [SLC25A19 (confirmed) Microcephaly,Amish type,607196|Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type),613710];	RCV000312441.1 [likely benign]; 			225	6					SLC25A19 (inh=AR pLI=0.93)
chr17	73518203	73518203	G	C	hom	pred_pathogenic;anno_omim	QUAL=21643;DP=189;AF=1.00;MQM=59;TRIO=HOM,189,1.00,HOM,221,1.00,HOM,295,0.99	TSEN54	missense	TSEN54:ENST00000333213:missense:MODERATE:exon8/11:c.1041G>C:p.Lys347Asn		rs9911502	0.4447	0.6414	10356,6865,111	0.2678,0.4666,0.5197,0.7034,0.6827	0.5863	3.6300	D	T	P	T	26.10	608755 [TSEN54 (provisional) Pontocerebellar hypoplasia type 2A,277470|Pontocerebellar hypoplasia type 4,225753|Pontocerebellar hypoplasia type 5,610204];	RCV000147767.5 [benign]; RCV000295979.1 [benign]; 		COSM437385	1387	1441					TSEN54 (inh=AR pLI=0.00)
chr17	73518284	73518284	G	C	hom	anno_omim	QUAL=15916;DP=112;AF=1.00;MQM=59;TRIO=HOM,112,1.00,HOM,186,1.00,HOM,229,1.00	TSEN54	synonymous	TSEN54:ENST00000333213:synonymous:LOW:exon8/11:c.1122G>C:p.Arg374Arg		rs6501820	0.8143	0.8717	8961,4099,1218	0.9806,0.5952,0.5943,0.8812,0.8893	0.8941							608755 [TSEN54 (provisional) Pontocerebellar hypoplasia type 2A,277470|Pontocerebellar hypoplasia type 4,225753|Pontocerebellar hypoplasia type 5,610204];	RCV000082834.6 [benign]; RCV000400655.1 [benign]; 			2655	546					TSEN54 (inh=AR pLI=0.00)
chr17	73519413	73519413	C	T	hom	pred_pathogenic;anno_omim	QUAL=33493;DP=358;AF=0.99;MQM=59;TRIO=HOM,358,0.99,HOM,355,1.00,HOM,431,1.00	TSEN54	missense	TSEN54:ENST00000333213:missense:MODERATE:exon9/11:c.1310C>T:p.Ala437Val		rs8064529	0.5613	0.6241	24545,15568,1756	0.5788,0.3725,0.4407,0.6811,0.6678	0.6416	0.3350	T	T	B	T	23.00	608755 [TSEN54 (provisional) Pontocerebellar hypoplasia type 2A,277470|Pontocerebellar hypoplasia type 4,225753|Pontocerebellar hypoplasia type 5,610204];	RCV000147771.2 [benign]; RCV000304359.1 [benign]; 			1404	1440					TSEN54 (inh=AR pLI=0.00)
chr17	73750859	73750859	C	G	hom	anno_omim	QUAL=22693;DP=189;AF=1.00;MQM=59;TRIO=HOM,189,1.00,HOM,398,1.00,HET,503,0.44	ITGB4,GALK1	synonymous,intron	ITGB4:ENST00000200181:synonymous:LOW:exon34/40:c.4521C>G:p.Pro1507Pro,ITGB4:ENST00000579662:synonymous:LOW:exon33/39:c.4311C>G:p.Pro1437Pro,ITGB4:ENST00000339591:synonymous:LOW:exon33/40:c.4311C>G:p.Pro1437Pro,ITGB4:ENST00000450894:synonymous:LOW:exon33/39:c.4311C>G:p.Pro1437Pro,ITGB4:ENST00000449880:synonymous:LOW:exon32/39:c.4311C>G:p.Pro1437Pro,GALK1:ENST00000225614:intron:MODIFIER:exon8/8:c.*23-3041G>C:		rs8669	0.3772	0.4520	13004,8106,94	0.1332,0.4723,0.4975,0.4923,0.4439	0.4558							147557 [ITGB4 (confirmed) Epidermolysis bullosa,junctional,with pyloric atresia,226730|Epidermolysis bullosa,junctional,non-Herlitz type,226650|Epidermolysis bullosa of hands and feet,131800];	RCV000244157.1 [benign]; RCV000289992.1 [benign]; RCV000375888.1 [benign]; 		COSM3755857, COSM3755858	437	1058					ITGB4 (inh=AR+AD pLI=0.00), GALK1 (inh=AR pLI=0.00)
chr17	73753503	73753503	T	C	hom	pred_pathogenic;anno_omim	QUAL=31656;DP=162;AF=0.98;MQM=59;TRIO=HOM,162,0.98,HOM,398,0.99,HOM,467,1.00	ITGB4,GALK1	missense,intron	ITGB4:ENST00000200181:missense:MODERATE:exon40/40:c.5336T>C:p.Leu1779Pro,ITGB4:ENST00000579662:missense:MODERATE:exon39/39:c.5126T>C:p.Leu1709Pro,ITGB4:ENST00000339591:missense:MODERATE:exon40/40:c.5285T>C:p.Leu1762Pro,ITGB4:ENST00000450894:missense:MODERATE:exon39/39:c.5126T>C:p.Leu1709Pro,ITGB4:ENST00000449880:missense:MODERATE:exon39/39:c.5285T>C:p.Leu1762Pro,GALK1:ENST00000225614:intron:MODIFIER:exon8/8:c.*22+612A>G:		rs871443	0.5715	0.7144	32047,19478,324	0.2505,0.8016,0.6420,0.7683,0.7262	0.7263	4.7950	T,T,T	T	D,P,P	T,T,T	26.10	147557 [ITGB4 (confirmed) Epidermolysis bullosa,junctional,with pyloric atresia,226730|Epidermolysis bullosa,junctional,non-Herlitz type,226650|Epidermolysis bullosa of hands and feet,131800];	RCV000247515.1 [benign]; RCV000294224.1 [benign]; RCV000322321.1 [benign]; 		COSM3722197, COSM3722198	1166	799					ITGB4 (inh=AR+AD pLI=0.00), GALK1 (inh=AR pLI=0.00)
chr17	73753661	73753661	C	T	hom	anno_omim	QUAL=23988;DP=172;AF=0.98;MQM=59;TRIO=HOM,172,0.98,HOM,289,1.00,HOM,390,1.00	ITGB4,GALK1	3'UTR,intron	ITGB4:ENST00000200181:3'UTR:MODIFIER:exon40/40:c.*25C>T:,ITGB4:ENST00000579662:3'UTR:MODIFIER:exon39/39:c.*25C>T:,ITGB4:ENST00000339591:3'UTR:MODIFIER:exon40/40:c.*25C>T:,ITGB4:ENST00000450894:3'UTR:MODIFIER:exon39/39:c.*25C>T:,ITGB4:ENST00000449880:3'UTR:MODIFIER:exon39/39:c.*25C>T:,GALK1:ENST00000225614:intron:MODIFIER:exon8/8:c.*22+454G>A:		rs9367	0.6530	0.7379	33375,20646,1478	0.5344,0.8083,0.5618,0.7902,0.6747	0.7452							147557 [ITGB4 (confirmed) Epidermolysis bullosa,junctional,with pyloric atresia,226730|Epidermolysis bullosa,junctional,non-Herlitz type,226650|Epidermolysis bullosa of hands and feet,131800];	RCV000279492.1 [benign]; RCV000287232.1 [benign]; 			1136	685					ITGB4 (inh=AR+AD pLI=0.00), GALK1 (inh=AR pLI=0.00)
chr17	73942196	73942196	C	G	het	anno_omim	QUAL=2292;DP=115;AF=0.48;MQM=60;TRIO=HET,115,0.48,HET,92,0.45,WT,117,0.00	ACOX1	3'UTR	ACOX1:ENST00000293217:3'UTR:MODIFIER:exon14/14:c.*633G>C:,ACOX1:ENST00000537812:3'UTR:MODIFIER:exon14/14:c.*633G>C:		rs71382188	0.0266	0.0000	0,0,0	0,0,0,0,0	0.0588							609751 [ACOX1 (confirmed) Peroxisomal acyl-CoA oxidase deficiency,264470];	RCV000298055.1 [likely benign]; 			0	32					ACOX1 (inh=AR pLI=0.09)
chr17	73949540	73949540	G	C	hom	anno_omim	QUAL=19540;DP=164;AF=0.98;MQM=60;TRIO=HOM,164,0.98,HOM,198,1.00,HOM,256,1.00	ACOX1	missense	ACOX1:ENST00000293217:missense:MODERATE:exon7/14:c.936C>G:p.Ile312Met,ACOX1:ENST00000537812:missense:MODERATE:exon7/14:c.822C>G:p.Ile274Met,ACOX1:ENST00000301608:missense:MODERATE:exon7/14:c.936C>G:p.Ile312Met		rs1135640	0.5507	0.6424	26247,14634,252	0.2161,0.7200,0.7919,0.6627,0.6484	0.6538	1.0860	T,T,T,T,T	T	B,B,B,B	T,T,T	17.91	609751 [ACOX1 (confirmed) Peroxisomal acyl-CoA oxidase deficiency,264470];	RCV000253358.1 [benign]; RCV000405630.1 [benign]; 		COSM3755874, COSM3755875	856	953					ACOX1 (inh=AR pLI=0.09)
chr17	75372339	75372339	C	T	het	anno_omim	QUAL=6849;DP=96;AF=0.59;MQM=59;TRIO=HET,96,0.59,HET,113,0.48,HOM,153,1.00	SEPT9,RP11-936I5.1	5'UTR,intron	SEPT9:ENST00000427674:5'UTR:MODIFIER:exon1/11:c.-558C>T:,SEPT9:ENST00000427177:intron:MODIFIER:exon2/11:c.77-25802C>T:,SEPT9:ENST00000591198:intron:MODIFIER:exon1/10:c.20-25802C>T:,SEPT9:ENST00000449803:intron:MODIFIER:exon2/11:c.-416-25802C>T:,SEPT9:ENST00000431235:intron:MODIFIER:exon2/11:c.-416-25802C>T:,SEPT9:ENST00000329047:intron:MODIFIER:exon1/10:c.23-25802C>T:,SEPT9:ENST00000590294:intron:MODIFIER:exon1/11:c.23-25802C>T:,SEPT9:ENST00000588690:intron:MODIFIER:exon1/11:c.-416-25802C>T:,SEPT9:ENST00000423034:intron:MODIFIER:exon1/10:c.55+2705C>T:		rs312826	0.6066	0.0000	0,0,0	0,0,0,0,0	0.6520							604061 [SEPT9 (confirmed) Leukemia,acute myeloid,therapy-related|Ovarian carcinoma|Amyotrophy,hereditary neuralgic,162100];				87	103					SEPT9 (inh=AD pLI=0.89), RP11-936I5.1 (inh=n/a pLI=n/a)
chr17	75494705	75494705	A	G	hom	anno_omim	QUAL=3637;DP=27;AF=1.00;MQM=59;TRIO=HOM,27,1.00,HOM,39,1.00,HOM,54,1.00	SEPT9	missense	SEPT9:ENST00000427177:missense:MODERATE:exon12/12:c.1726A>G:p.Met576Val,SEPT9:ENST00000591198:missense:MODERATE:exon11/11:c.1669A>G:p.Met557Val,SEPT9:ENST00000449803:missense:MODERATE:exon12/12:c.1234A>G:p.Met412Val,SEPT9:ENST00000431235:missense:MODERATE:exon12/12:c.1234A>G:p.Met412Val,SEPT9:ENST00000329047:missense:MODERATE:exon11/11:c.1672A>G:p.Met558Val,SEPT9:ENST00000590294:missense:MODERATE:exon11/12:c.1672A>G:p.Met558Val,SEPT9:ENST00000588690:missense:MODERATE:exon11/12:c.1234A>G:p.Met412Val,SEPT9:ENST00000423034:missense:MODERATE:exon11/11:c.1705A>G:p.Met569Val,SEPT9:ENST00000427674:missense:MODERATE:exon11/11:c.1234A>G:p.Met412Val,SEPT9:ENST00000585930:missense:MODERATE:exon10/10:c.1054A>G:p.Met352Val,SEPT9:ENST00000541152:missense:MODERATE:exon10/10:c.973A>G:p.Met325Val,SEPT9:ENST00000591088:missense:MODERATE:exon10/10:c.973A>G:p.Met325Val,SEPT9:ENST00000592951:missense:MODERATE:exon10/10:c.973A>G:p.Met325Val,SEPT9:ENST00000427180:missense:MODERATE:exon10/10:c.1390A>G:p.Met464Val		rs2627223	0.9066	0.9371	50761,28109,2740	0.7768,0.9714,0.9992,0.9385,0.9718	0.9390	0.0380	T,T,T,T,T,T,T,T	T	B,B,B,B,B,B	T,T,T,T,T,T	0.03	604061 [SEPT9 (confirmed) Leukemia,acute myeloid,therapy-related|Ovarian carcinoma|Amyotrophy,hereditary neuralgic,162100];	RCV000343437.1 [benign]; 		COSM4130688, COSM4130689, COSM4130691, COSM4130690, COSM4130692	1901	208					SEPT9 (inh=AD pLI=0.89)
chr17	75494787	75494787	-	C	hom	low_DP;anno_omim	QUAL=911;DP=6;AF=0.83;MQM=59;TRIO=HOM,6,0.83,HOM,11,0.91,HOM,26,0.96	SEPT9	3'UTR	SEPT9:ENST00000427177:3'UTR:MODIFIER:exon12/12:c.*55dupC:,SEPT9:ENST00000591198:3'UTR:MODIFIER:exon11/11:c.*55dupC:,SEPT9:ENST00000449803:3'UTR:MODIFIER:exon12/12:c.*55dupC:,SEPT9:ENST00000431235:3'UTR:MODIFIER:exon12/12:c.*55dupC:,SEPT9:ENST00000329047:3'UTR:MODIFIER:exon11/11:c.*55dupC:,SEPT9:ENST00000590294:3'UTR:MODIFIER:exon11/12:c.*55dupC:,SEPT9:ENST00000588690:3'UTR:MODIFIER:exon11/12:c.*55dupC:,SEPT9:ENST00000423034:3'UTR:MODIFIER:exon11/11:c.*55dupC:,SEPT9:ENST00000427674:3'UTR:MODIFIER:exon11/11:c.*55dupC:,SEPT9:ENST00000585930:3'UTR:MODIFIER:exon10/10:c.*55dupC:,SEPT9:ENST00000541152:3'UTR:MODIFIER:exon10/10:c.*55dupC:,SEPT9:ENST00000591088:3'UTR:MODIFIER:exon10/10:c.*55dupC:,SEPT9:ENST00000592951:3'UTR:MODIFIER:exon10/10:c.*55dupC:,SEPT9:ENST00000427180:3'UTR:MODIFIER:exon10/10:c.*55dupC:		rs5822173	0.9363	0.9067	8612,3906,601	0.8305,0.9287,0.9583,0.8948,0.9346	0.9362							604061 [SEPT9 (confirmed) Leukemia,acute myeloid,therapy-related|Ovarian carcinoma|Amyotrophy,hereditary neuralgic,162100];	RCV000340911.1 [benign]; 			1584	177					SEPT9 (inh=AD pLI=0.89)
chr17	75495840	75495840	T	C	hom	anno_omim	QUAL=8584;DP=69;AF=0.99;MQM=59;TRIO=HOM,69,0.99,HOM,90,1.00,HOM,126,1.00	SEPT9	3'UTR,intron	SEPT9:ENST00000427177:3'UTR:MODIFIER:exon12/12:c.*1100T>C:,SEPT9:ENST00000449803:3'UTR:MODIFIER:exon12/12:c.*1100T>C:,SEPT9:ENST00000431235:3'UTR:MODIFIER:exon12/12:c.*1100T>C:,SEPT9:ENST00000329047:3'UTR:MODIFIER:exon11/11:c.*1100T>C:,SEPT9:ENST00000423034:3'UTR:MODIFIER:exon11/11:c.*1100T>C:,SEPT9:ENST00000427674:3'UTR:MODIFIER:exon11/11:c.*1100T>C:,SEPT9:ENST00000541152:3'UTR:MODIFIER:exon10/10:c.*1100T>C:,SEPT9:ENST00000427180:3'UTR:MODIFIER:exon10/10:c.*1100T>C:,SEPT9:ENST00000590294:intron:MODIFIER:exon11/11:c.*108-649T>C:,SEPT9:ENST00000588690:intron:MODIFIER:exon11/11:c.*843+257T>C:		rs407525	0.9876	0.0000	0,0,0	0,0,0,0,0	0.9772							604061 [SEPT9 (confirmed) Leukemia,acute myeloid,therapy-related|Ovarian carcinoma|Amyotrophy,hereditary neuralgic,162100];				256	7					SEPT9 (inh=AD pLI=0.89)
chr17	75496342	75496342	T	C	hom	anno_omim	QUAL=17249;DP=139;AF=1.00;MQM=59;TRIO=HOM,139,1.00,HOM,183,1.00,HOM,222,1.00	SEPT9	splice_region&intron,3'UTR,intron	SEPT9:ENST00000588690:splice_region&intron:LOW:exon11/11:c.*844-4T>C:,SEPT9:ENST00000427177:3'UTR:MODIFIER:exon12/12:c.*1602T>C:,SEPT9:ENST00000449803:3'UTR:MODIFIER:exon12/12:c.*1602T>C:,SEPT9:ENST00000431235:3'UTR:MODIFIER:exon12/12:c.*1602T>C:,SEPT9:ENST00000329047:3'UTR:MODIFIER:exon11/11:c.*1602T>C:,SEPT9:ENST00000423034:3'UTR:MODIFIER:exon11/11:c.*1602T>C:,SEPT9:ENST00000427674:3'UTR:MODIFIER:exon11/11:c.*1602T>C:,SEPT9:ENST00000541152:3'UTR:MODIFIER:exon10/10:c.*1602T>C:,SEPT9:ENST00000427180:3'UTR:MODIFIER:exon10/10:c.*1602T>C:,SEPT9:ENST00000590294:intron:MODIFIER:exon11/11:c.*108-147T>C:		rs448767	0.9864	0.0000	0,0,0	0,0,0,0,0	0.9755							604061 [SEPT9 (confirmed) Leukemia,acute myeloid,therapy-related|Ovarian carcinoma|Amyotrophy,hereditary neuralgic,162100];				253	7					SEPT9 (inh=AD pLI=0.89)
chr17	75496361	75496361	A	G	hom	anno_omim	QUAL=20859;DP=193;AF=0.99;MQM=60;TRIO=HOM,193,0.99,HOM,212,1.00,HOM,251,1.00	SEPT9	3'UTR,intron	SEPT9:ENST00000427177:3'UTR:MODIFIER:exon12/12:c.*1621A>G:,SEPT9:ENST00000449803:3'UTR:MODIFIER:exon12/12:c.*1621A>G:,SEPT9:ENST00000431235:3'UTR:MODIFIER:exon12/12:c.*1621A>G:,SEPT9:ENST00000329047:3'UTR:MODIFIER:exon11/11:c.*1621A>G:,SEPT9:ENST00000588690:3'UTR:MODIFIER:exon12/12:c.*859A>G:,SEPT9:ENST00000423034:3'UTR:MODIFIER:exon11/11:c.*1621A>G:,SEPT9:ENST00000427674:3'UTR:MODIFIER:exon11/11:c.*1621A>G:,SEPT9:ENST00000541152:3'UTR:MODIFIER:exon10/10:c.*1621A>G:,SEPT9:ENST00000427180:3'UTR:MODIFIER:exon10/10:c.*1621A>G:,SEPT9:ENST00000590294:intron:MODIFIER:exon11/11:c.*108-128A>G:		rs2627222	0.9864	0.0000	0,0,0	0,0,0,0,0	0.9755							604061 [SEPT9 (confirmed) Leukemia,acute myeloid,therapy-related|Ovarian carcinoma|Amyotrophy,hereditary neuralgic,162100];				249	7					SEPT9 (inh=AD pLI=0.89)
chr17	75496460	75496460	T	C	hom	anno_omim	QUAL=5556;DP=78;AF=0.99;MQM=59;TRIO=HOM,78,0.99,HET,142,0.49,HET,154,0.55	SEPT9	3'UTR,intron	SEPT9:ENST00000427177:3'UTR:MODIFIER:exon12/12:c.*1720T>C:,SEPT9:ENST00000449803:3'UTR:MODIFIER:exon12/12:c.*1720T>C:,SEPT9:ENST00000431235:3'UTR:MODIFIER:exon12/12:c.*1720T>C:,SEPT9:ENST00000329047:3'UTR:MODIFIER:exon11/11:c.*1720T>C:,SEPT9:ENST00000588690:3'UTR:MODIFIER:exon12/12:c.*958T>C:,SEPT9:ENST00000423034:3'UTR:MODIFIER:exon11/11:c.*1720T>C:,SEPT9:ENST00000427674:3'UTR:MODIFIER:exon11/11:c.*1720T>C:,SEPT9:ENST00000541152:3'UTR:MODIFIER:exon10/10:c.*1720T>C:,SEPT9:ENST00000427180:3'UTR:MODIFIER:exon10/10:c.*1720T>C:,SEPT9:ENST00000590294:intron:MODIFIER:exon11/11:c.*108-29T>C:		rs445507	0.4321	0.0000	0,0,0	0,0,0,0,0	0.5308							604061 [SEPT9 (confirmed) Leukemia,acute myeloid,therapy-related|Ovarian carcinoma|Amyotrophy,hereditary neuralgic,162100];	RCV000323614.1 [benign]; 			65	112					SEPT9 (inh=AD pLI=0.89)
chr17	76127431	76127431	G	C	hom	anno_omim	QUAL=10661;DP=98;AF=1.00;MQM=59;TRIO=HOM,98,1.00,HOM,102,0.98,HOM,153,1.00	TMC8,TMC6	5'UTR,intron	TMC8:ENST00000318430:5'UTR:MODIFIER:exon2/16:c.-239G>C:,TMC8:ENST00000589691:5'UTR:MODIFIER:exon2/15:c.-427G>C:,TMC6:ENST00000322914:intron:MODIFIER:exon1/19:c.-75+991C>G:	MIRb	rs383603	0.6987	0.0000	0,0,0	0,0,0,0,0	0.7531							605828 [TMC6 (confirmed) Epidermodysplasia verruciformis,226400]:605829 [TMC8 (confirmed) Epidermodysplasia verruciformis,226400];				134	86					TMC8 (inh=n/a pLI=0.00), TMC6 (inh=n/a pLI=0.00)
chr17	76130575	76130575	A	T	hom	anno_omim	QUAL=10259;DP=84;AF=0.98;MQM=59;TRIO=HOM,84,0.98,HET,155,0.52,HOM,200,1.00	TMC8	missense	TMC8:ENST00000318430:missense:MODERATE:exon8/16:c.917A>T:p.Asn306Ile,TMC8:ENST00000589691:missense:MODERATE:exon7/15:c.248A>T:p.Asn83Ile		rs7208422	0.5523	0.5148	16335,8279,2409	0.6839,0.5531,0.4293,0.4988,0.5004	0.5462	1.3510	T	T	B,B	T	5.51	605829 [TMC8 (confirmed) Epidermodysplasia verruciformis,226400];		CM091876 [CLASS=DP MUT=ALT PHEN="Epidermodysplasia verruciformis susceptibility in HIV association" GENE=TMC8]; 		621	998					TMC8 (inh=n/a pLI=0.00)
chr17	76130947	76130947	G	T	het	anno_omim	QUAL=7515;DP=60;AF=0.58;MQM=59;TRIO=HET,60,0.58,HET,257,0.49,HET,283,0.52	TMC8	splice_region&intron	TMC8:ENST00000318430:splice_region&intron:LOW:exon8/15:c.988-4G>T:,TMC8:ENST00000589691:splice_region&intron:LOW:exon7/14:c.319-4G>T:		rs62079073	0.0777	0.0783	413,265,32	0.0887,0.0445,0.0968,0.0843,0.0565	0.0844							605829 [TMC8 (confirmed) Epidermodysplasia verruciformis,226400];				26	357					TMC8 (inh=n/a pLI=0.00)
chr17	76131070	76131070	G	A	het	anno_omim	QUAL=20535;DP=144;AF=0.50;MQM=59;TRIO=HET,144,0.50,HET,374,0.50,HOM,446,0.99	TMC8	synonymous	TMC8:ENST00000318430:synonymous:LOW:exon9/16:c.1107G>A:p.Glu369Glu,TMC8:ENST00000589691:synonymous:LOW:exon8/15:c.438G>A:p.Glu146Glu		rs12452890	0.5403	0.5343	17787,9533,2491	0.6911,0.6177,0.4197,0.5324,0.4310	0.5813							605829 [TMC8 (confirmed) Epidermodysplasia verruciformis,226400];				696	988					TMC8 (inh=n/a pLI=0.00)
chr17	76137198	76137198	T	G	hom	anno_omim	QUAL=3388;DP=47;AF=1.00;MQM=59;TRIO=HOM,47,1.00,HOM,32,1.00,HOM,36,1.00	TMC8	3'UTR	TMC8:ENST00000318430:3'UTR:MODIFIER:exon16/16:c.*5T>G:,TMC8:ENST00000589691:3'UTR:MODIFIER:exon15/15:c.*5T>G:		rs369764	0.9986	0.9955	49659,27823,3664	0.9982,0.9979,1.0000,0.9933,0.9982	0.9963							605829 [TMC8 (confirmed) Epidermodysplasia verruciformis,226400];				2021	18					TMC8 (inh=n/a pLI=0.00)
chr17	76137337	76137337	C	G	het	anno_omim	QUAL=4847;DP=95;AF=0.45;MQM=59;TRIO=HET,95,0.45,HET,62,0.53,HOM,89,1.00	TMC8	3'UTR	TMC8:ENST00000318430:3'UTR:MODIFIER:exon16/16:c.*144C>G:,TMC8:ENST00000589691:3'UTR:MODIFIER:exon15/15:c.*144C>G:		rs454138	0.6569	0.0000	0,0,0	0,0,0,0,0	0.6716							605829 [TMC8 (confirmed) Epidermodysplasia verruciformis,226400];				108	101					TMC8 (inh=n/a pLI=0.00)
chr17	76137477	76137477	T	G	het	anno_omim	QUAL=1839;DP=86;AF=0.50;MQM=60;TRIO=HET,86,0.50,HET,22,0.50,HET,38,0.42	TMC8	3'UTR	TMC8:ENST00000318430:3'UTR:MODIFIER:exon16/16:c.*284T>G:,TMC8:ENST00000589691:3'UTR:MODIFIER:exon15/15:c.*284T>G:		rs2871647	0.1296	0.0000	0,0,0	0,0,0,0,0	0.1248							605829 [TMC8 (confirmed) Epidermodysplasia verruciformis,226400];				6	58					TMC8 (inh=n/a pLI=0.00)
chr17	76138577	76138577	A	G	het	anno_omim	QUAL=14163;DP=234;AF=0.52;MQM=59;TRIO=HET,234,0.52,HET,214,0.51,HOM,276,1.00	TMC8	3'UTR	TMC8:ENST00000318430:3'UTR:MODIFIER:exon16/16:c.*1384A>G:,TMC8:ENST00000589691:3'UTR:MODIFIER:exon15/15:c.*1384A>G:		rs4789015	0.5795	0.0000	0,0,0	0,0,0,0,0	0.6012							605829 [TMC8 (confirmed) Epidermodysplasia verruciformis,226400];				90	106					TMC8 (inh=n/a pLI=0.00)
chr17	78075462	78075462	G	C	het	anno_omim	QUAL=1496;DP=95;AF=0.57;MQM=59;TRIO=HET,95,0.57,WT,21,0.00,HET,36,0.53	GAA	intron	GAA:ENST00000390015:intron:MODIFIER:exon1/20:c.-113+38G>C:		rs2304849	0.1180	0.0000	0,0,0	0,0,0,0,0	0.1616							606800 [GAA (confirmed) Glycogen storage disease II,232300];	RCV000352096.1 [likely benign]; RCV000381550.1 [likely benign]; 			11	73					GAA (inh=AR pLI=0.00)
chr17	78078709	78078709	T	C	hom	anno_omim	QUAL=3656;DP=53;AF=0.98;MQM=59;TRIO=HOM,53,0.98,HOM,38,1.00,HET,58,0.62	GAA	synonymous	GAA:ENST00000302262:synonymous:LOW:exon2/20:c.324T>C:p.Cys108Cys,GAA:ENST00000390015:synonymous:LOW:exon3/21:c.324T>C:p.Cys108Cys		rs1800300	0.7145	0.7367	32095,18688,2459	0.7094,0.5074,0.6370,0.7654,0.8214	0.7276							606800 [GAA (confirmed) Glycogen storage disease II,232300];	RCV000078180.6 [benign]; RCV000284275.1 [benign]; RCV000299885.1 [benign]; 		COSM3755978	1329	717					GAA (inh=AR pLI=0.00)
chr17	78079544	78079544	C	G	hom	anno_omim	QUAL=20803;DP=226;AF=1.00;MQM=60;TRIO=HOM,226,1.00,HOM,270,1.00,HET,379,0.51	GAA	splice_region&intron	GAA:ENST00000302262:splice_region&intron:LOW:exon2/19:c.547-4C>G:,GAA:ENST00000390015:splice_region&intron:LOW:exon3/20:c.547-4C>G:		rs3816256	0.6028	0.6759	28330,18491,1489	0.5416,0.4592,0.5294,0.7456,0.6700	0.6699							606800 [GAA (confirmed) Glycogen storage disease II,232300];	RCV000078182.6 [benign]; RCV000369731.1 [benign]; 			1235	774					GAA (inh=AR pLI=0.00)
chr17	78079597	78079597	A	G	hom	pred_pathogenic;anno_omim	QUAL=15938;DP=167;AF=0.99;MQM=59;TRIO=HOM,167,0.99,HOM,245,1.00,HET,344,0.47	GAA	missense	GAA:ENST00000302262:missense:MODERATE:exon3/20:c.596A>G:p.His199Arg,GAA:ENST00000390015:missense:MODERATE:exon4/21:c.596A>G:p.His199Arg		rs1042393	0.6008	0.6746	28199,18465,1486	0.5412,0.4591,0.5293,0.7455,0.6618	0.6686	-0.2170	T,T	T	B	D,D	0.01	606800 [GAA (confirmed) Glycogen storage disease II,232300];	RCV000078183.6 [benign]; RCV000275148.1 [benign]; 		COSM3755979	1234	775					GAA (inh=AR pLI=0.00)
chr17	78079643	78079643	C	T	het	anno_omim	QUAL=8107;DP=138;AF=0.50;MQM=60;TRIO=HET,138,0.50,HOM,212,1.00,WT,286,0.00	GAA	synonymous	GAA:ENST00000302262:synonymous:LOW:exon3/20:c.642C>T:p.Ser214Ser,GAA:ENST00000390015:synonymous:LOW:exon4/21:c.642C>T:p.Ser214Ser		rs1800301	0.1060	0.1802	2343,1763,29	0.0762,0.0961,0.0009,0.2307,0.1673	0.1790							606800 [GAA (confirmed) Glycogen storage disease II,232300];	RCV000078184.6 [benign]; RCV000330247.1 [likely benign]; 		COSM3755980	132	728					GAA (inh=AR pLI=0.00)
chr17	78079669	78079669	G	A	hom	pred_pathogenic;anno_omim	QUAL=10107;DP=121;AF=0.93;MQM=59;TRIO=HOM,121,0.93,HOM,184,0.99,HET,243,0.47	GAA	missense	GAA:ENST00000302262:missense:MODERATE:exon3/20:c.668G>A:p.Arg223His,GAA:ENST00000390015:missense:MODERATE:exon4/21:c.668G>A:p.Arg223His		rs1042395	0.6024	0.6760	28120,18333,1473	0.5423,0.4591,0.5291,0.7460,0.6701	0.6676	-0.0440	T,T	T	B	D,D	11.39	606800 [GAA (confirmed) Glycogen storage disease II,232300];	RCV000078185.6 [benign]; RCV000169616.2 [other]; 		COSM3721877	1236	771					GAA (inh=AR pLI=0.00)
chr17	78081526	78081526	-	GCAGCGG	hom	anno_omim	QUAL=9090;DP=30;AF=0.87;MQM=59;TRIO=HOM,30,0.87,HOM,198,0.97,HET,238,0.54	GAA	splice_region&intron	GAA:ENST00000302262:splice_region&intron:LOW:exon4/19:c.858+7_858+8insAGCGGGC:,GAA:ENST00000390015:splice_region&intron:LOW:exon5/20:c.858+7_858+8insAGCGGGC:		rs3071247;rs372331052	0.5929	0.6724	26638,17376,1313	0.5342,0.4529,0.5262,0.7440,0.6657	0.6659							606800 [GAA (confirmed) Glycogen storage disease II,232300];				1140	846					GAA (inh=AR pLI=0.00)
chr17	78082504	78082504	G	A	hom	anno_omim	QUAL=11662;DP=131;AF=0.98;MQM=59;TRIO=HOM,131,0.98,HOM,161,1.00,HET,215,0.50	GAA	synonymous	GAA:ENST00000302262:synonymous:LOW:exon8/20:c.1203G>A:p.Gln401Gln,GAA:ENST00000390015:synonymous:LOW:exon9/21:c.1203G>A:p.Gln401Gln		rs1800304	0.6028	0.6784	27460,17905,1391	0.5436,0.4620,0.5320,0.7474,0.6766	0.6705							606800 [GAA (confirmed) Glycogen storage disease II,232300];	RCV000078155.6 [benign]; RCV000344845.1 [benign]; 		COSM3755981	1240	765					GAA (inh=AR pLI=0.00)
chr17	78084769	78084769	G	A	het	anno_omim	QUAL=5763;DP=203;AF=0.41;MQM=60;TRIO=HET,203,0.41,WT,282,0.00,HET,316,0.49	GAA	synonymous	GAA:ENST00000302262:synonymous:LOW:exon11/20:c.1581G>A:p.Arg527Arg,GAA:ENST00000390015:synonymous:LOW:exon12/21:c.1581G>A:p.Arg527Arg		rs1042396	0.1595	0.2309	3584,2541,27	0.0627,0.2277,0.1214,0.2751,0.2156	0.2327							606800 [GAA (confirmed) Glycogen storage disease II,232300];	RCV000078160.6 [benign]; RCV000301295.1 [likely benign]; 		COSM148357	159	858					GAA (inh=AR pLI=0.00)
chr17	78091405	78091405	G	A	hom	low_DP;pred_pathogenic;anno_omim	QUAL=1008;DP=16;AF=1.00;MQM=59;TRIO=HOM,16,1.00,HOM,15,1.00,HET,15,0.33	GAA	missense	GAA:ENST00000302262:missense:MODERATE:exon17/20:c.2338G>A:p.Val780Ile,GAA:ENST00000390015:missense:MODERATE:exon18/21:c.2338G>A:p.Val780Ile		rs1126690	0.7119	0.7296	32675,19277,2490	0.7010,0.4712,0.6212,0.7645,0.8168	0.7265	-0.3890	T,T	T	B	D,D	0.40	606800 [GAA (confirmed) Glycogen storage disease II,232300];	RCV000078171.6 [benign]; RCV000336875.1 [benign]; 		COSM3755982	1331	706					GAA (inh=AR pLI=0.00)
chr17	78092063	78092063	G	A	hom	anno_omim	QUAL=6629;DP=58;AF=0.97;MQM=59;TRIO=HOM,58,0.97,HOM,116,0.99,HET,139,0.51	GAA	synonymous	GAA:ENST00000302262:synonymous:LOW:exon18/20:c.2553G>A:p.Gly851Gly,GAA:ENST00000390015:synonymous:LOW:exon19/21:c.2553G>A:p.Gly851Gly		rs1042397	0.5094	0.5805	20899,13839,1484	0.5401,0.4184,0.2798,0.6465,0.5826	0.5779							606800 [GAA (confirmed) Glycogen storage disease II,232300];	RCV000078176.6 [benign]; RCV000399277.1 [benign]; 		COSM3766205	965	912					GAA (inh=AR pLI=0.00)
chr17	78093549	78093549	G	T	hom	anno_omim	QUAL=882;DP=35;AF=0.94;MQM=60;TRIO=HOM,35,0.94,HET,9,0.33,HET,17,0.41	GAA	3'UTR	GAA:ENST00000302262:3'UTR:MODIFIER:exon20/20:c.*419G>T:,GAA:ENST00000390015:3'UTR:MODIFIER:exon21/21:c.*419G>T:		rs7567	0.1560	0.0000	0,0,0	0,0,0,0,0	0.1916							606800 [GAA (confirmed) Glycogen storage disease II,232300];	RCV000342723.1 [likely benign]; 			16	77					GAA (inh=AR pLI=0.00)
chr17	78183396	78183396	A	G	het	anno_omim	QUAL=33545;DP=274;AF=0.38;MQM=58;TRIO=HET,274,0.38,HET,814,0.47,HOM,851,0.98	SGSH	3'UTR	SGSH:ENST00000326317:3'UTR:MODIFIER:exon8/8:c.*855T>C:,SGSH:ENST00000534910:3'UTR:MODIFIER:exon7/7:c.*855T>C:		rs1046832	0.4507	0.0000	0,0,0	0,0,0,0,0	0.4881							605270 [SGSH (confirmed) Mucopolysaccharidosis type IIIA (Sanfilippo A),252900];	RCV000275910.1 [benign]; 			85	96					SGSH (inh=AR pLI=0.00)
chr17	78183403	78183403	G	C	het	anno_omim	QUAL=41641;DP=264;AF=0.40;MQM=58;TRIO=HET,264,0.40,HET,844,0.53,HOM,979,1.00	SGSH	3'UTR	SGSH:ENST00000326317:3'UTR:MODIFIER:exon8/8:c.*848C>G:,SGSH:ENST00000534910:3'UTR:MODIFIER:exon7/7:c.*848C>G:		rs709677	0.6542	0.0000	0,0,0	0,0,0,0,0	0.6650							605270 [SGSH (confirmed) Mucopolysaccharidosis type IIIA (Sanfilippo A),252900];	RCV000314605.1 [benign]; 			119	81					SGSH (inh=AR pLI=0.00)
chr17	78183411	78183411	T	C	het	anno_omim	QUAL=41950;DP=269;AF=0.42;MQM=58;TRIO=HET,269,0.42,HET,822,0.55,HOM,991,1.00	SGSH	3'UTR	SGSH:ENST00000326317:3'UTR:MODIFIER:exon8/8:c.*840A>G:,SGSH:ENST00000534910:3'UTR:MODIFIER:exon7/7:c.*840A>G:		rs709678	0.6470	0.0000	0,0,0	0,0,0,0,0	0.6657							605270 [SGSH (confirmed) Mucopolysaccharidosis type IIIA (Sanfilippo A),252900];	RCV000366910.1 [benign]; 			117	83					SGSH (inh=AR pLI=0.00)
chr17	78183936	78183936	G	A	het	anno_omim	QUAL=8167;DP=126;AF=0.43;MQM=60;TRIO=HET,126,0.43,HET,151,0.49,HOM,172,1.00	SGSH	3'UTR	SGSH:ENST00000326317:3'UTR:MODIFIER:exon8/8:c.*315C>T:,SGSH:ENST00000534910:3'UTR:MODIFIER:exon7/7:c.*315C>T:		rs2071148	0.4483	0.0000	0,0,0	0,0,0,0,0	0.4905							605270 [SGSH (confirmed) Mucopolysaccharidosis type IIIA (Sanfilippo A),252900];	RCV000379351.1 [benign]; 			83	98					SGSH (inh=AR pLI=0.00)
chr17	78184393	78184393	C	T	het	anno_omim	QUAL=4300;DP=160;AF=0.45;MQM=60;TRIO=HET,160,0.45,HET,229,0.50,WT,304,0.00	SGSH	missense	SGSH:ENST00000326317:missense:MODERATE:exon8/8:c.1367G>A:p.Arg456His,SGSH:ENST00000534910:missense:MODERATE:exon7/7:c.758G>A:p.Arg253His		rs7503034	0.3458	0.3592	7750,3342,233	0.2245,0.5518,0.4139,0.3281,0.4005	0.3681	-0.3080	T,T	T	B	T,T	3.78	605270 [SGSH (confirmed) Mucopolysaccharidosis type IIIA (Sanfilippo A),252900];	RCV000078352.5 [benign]; RCV000289567.1 [benign]; 		COSM3755983	274	875					SGSH (inh=AR pLI=0.00)
chr17	79478019	79478019	G	A	hom	anno_omim	QUAL=35479;DP=356;AF=0.98;MQM=59;TRIO=HOM,356,0.98,HOM,331,1.00,HOM,484,1.00	ACTG1	synonymous	ACTG1:ENST00000331925:synonymous:LOW:exon5/6:c.918C>T:p.Tyr306Tyr,ACTG1:ENST00000573283:synonymous:LOW:exon5/6:c.918C>T:p.Tyr306Tyr,ACTG1:ENST00000575842:synonymous:LOW:exon4/5:c.918C>T:p.Tyr306Tyr,ACTG1:ENST00000575087:synonymous:LOW:exon5/6:c.918C>T:p.Tyr306Tyr		rs1139405	0.7562	0.7902	38122,22217,2075	0.6345,0.6847,0.8763,0.8169,0.7882	0.7883							102560 [ACTG1 (confirmed) Deafness,autosomal dominant 20/26,604717|Baraitser-Winter syndrome 2,614583];	RCV000037126.5 [other]; 		COSM1387303	1377	642					ACTG1 (inh=AD pLI=0.22)
chr17	79479808	79479808	C	T	hom	low_DP;anno_omim	QUAL=226;DP=1;AF=1.00;MQM=60;TRIO=HOM,1,1.00,HET,7,0.43,HOM,7,1.00	ACTG1	5'UTR	ACTG1:ENST00000331925:5'UTR:MODIFIER:exon1/6:c.-55G>A:,ACTG1:ENST00000575087:5'UTR:MODIFIER:exon1/6:c.-183G>A:		rs7503278	0.7344	0.7934	3217,820,35	0.0000,0.0000,0.0000,0.8177,0.7899	0.7774							102560 [ACTG1 (confirmed) Deafness,autosomal dominant 20/26,604717|Baraitser-Winter syndrome 2,614583];				391	161					ACTG1 (inh=AD pLI=0.22)
chr17	79479843	79479843	C	G	hom	low_DP;anno_omim	QUAL=55;DP=1;AF=1.00;MQM=60;TRIO=HOM,1,1.00,WT,4,0.00,HET,11,0.36	ACTG1	5'UTR	ACTG1:ENST00000331925:5'UTR:MODIFIER:exon1/6:c.-90G>C:		rs542961891	0.0034	0.0154	3,0,0	0.0000,0.0000,0.0000,0.0160,0.0160	0.0076							102560 [ACTG1 (confirmed) Deafness,autosomal dominant 20/26,604717|Baraitser-Winter syndrome 2,614583];				1	9					ACTG1 (inh=AD pLI=0.22)
chr17	79891147	79891147	T	C	hom	anno_omim	QUAL=30092;DP=185;AF=0.99;MQM=60;TRIO=HOM,185,0.99,HOM,349,1.00,HOM,451,1.00	PYCR1	synonymous,3'UTR,intron	PYCR1:ENST00000402252:synonymous:LOW:exon8/8:c.984A>G:p.Ser328Ser,PYCR1:ENST00000329875:synonymous:LOW:exon7/7:c.903A>G:p.Ser301Ser,PYCR1:ENST00000403172:synonymous:LOW:exon7/7:c.810A>G:p.Ser270Ser,PYCR1:ENST00000577756:3'UTR:MODIFIER:exon6/6:c.*85A>G:,PYCR1:ENST00000337943:intron:MODIFIER:exon7/7:c.867+36A>G:		rs61747618	0.9860	0.9951	59613,32948,4604	0.9455,0.9984,1.0000,0.9999,0.9999	0.9963							179035 [PYCR1 (provisional) Cutis laxa,autosomal recessive,type IIB,612940|Cutis laxa,autosomal recessive,type IIIB,614438];			COSM4130834	2113	3					PYCR1 (inh=AR pLI=0.00)
chr17	80036877	80036877	A	G	het		QUAL=1584;DP=31;AF=0.45;MQM=59;TRIO=HET,31,0.45,HET,59,0.56,HET,79,0.41	FASN	3'UTR	FASN:ENST00000306749:3'UTR:MODIFIER:exon43/43:c.*142T>C:		rs11550611	0.5885	0.0000	0,0,0	0,0,0,0,0	0.6981											117	92					FASN (inh=n/a pLI=1.00)
chr17	80045086	80045086	G	C	het		QUAL=2064;DP=70;AF=0.49;MQM=59;TRIO=HET,70,0.49,HET,111,0.51,WT,126,0.00	FASN	synonymous	FASN:ENST00000306749:synonymous:LOW:exon21/43:c.3267C>G:p.Ala1089Ala		rs4485435	0.2230	0.2016	2331,851,383	0.3138,0.4627,0.1306,0.1819,0.0804	0.2139										COSM4130849	94	645					FASN (inh=n/a pLI=1.00)
chr17	80051183	80051183	A	G	het		QUAL=5891;DP=158;AF=0.46;MQM=59;TRIO=HET,158,0.46,WT,154,0.01,HOM,136,0.99	FASN	synonymous	FASN:ENST00000306749:synonymous:LOW:exon5/43:c.567T>C:p.Asn189Asn		rs2228309	0.3918	0.5373	10895,7835,893	0.5225,0.4048,0.2061,0.6015,0.4643	0.5230										COSM3756037	527	1029					FASN (inh=n/a pLI=1.00)
chr17	80572628	80572628	A	G	het		QUAL=5105;DP=270;AF=0.44;MQM=59;TRIO=HET,270,0.44,WT,117,0.00,HET,162,0.52	WDR45B,FOXK2	3'UTR	WDR45B:ENST00000392325:3'UTR:MODIFIER:exon10/10:c.*1167T>C:		rs1059672	0.6310	0.0000	0,0,0	0,0,0,0,0	0.5772											78	110					WDR45B (inh=n/a pLI=0.64), FOXK2 (inh=n/a pLI=0.92)
chr17	80573272	80573272	A	G	hom		QUAL=9647;DP=181;AF=1.00;MQM=58;TRIO=HOM,181,1.00,HET,140,0.46,HET,175,0.53	WDR45B,FOXK2	3'UTR	WDR45B:ENST00000392325:3'UTR:MODIFIER:exon10/10:c.*523T>C:		rs9271	0.8634	0.0000	0,0,0	0,0,0,0,0	0.8100											163	63					WDR45B (inh=n/a pLI=0.64), FOXK2 (inh=n/a pLI=0.92)
chr17	80579609	80579609	T	C	het	pred_pathogenic	QUAL=4538;DP=222;AF=0.49;MQM=60;TRIO=HET,222,0.49,WT,148,0.00,HET,180,0.47	WDR45B,FOXK2	missense	WDR45B:ENST00000392325:missense:MODERATE:exon6/10:c.494A>G:p.His165Arg		rs74895287	0.0132	0.0133	21,14,4	0.0328,0.0058,0.0000,0.0159,0.0057	0.0219	7.5030	T,T	T	B	T	18.85				COSM3756047	4	84					WDR45B (inh=n/a pLI=0.64), FOXK2 (inh=n/a pLI=0.92)
chr17	80585094	80585094	C	T	het		QUAL=5074;DP=196;AF=0.55;MQM=57;TRIO=HET,196,0.55,HET,202,0.48,WT,215,0.00	WDR45B,FOXK2	synonymous	WDR45B:ENST00000392325:synonymous:LOW:exon4/10:c.318G>A:p.Lys106Lys		rs2291393	0.2007	0.2315	3485,2039,65	0.1107,0.2832,0.1425,0.2450,0.2562	0.2368										COSM3756048	138	736					WDR45B (inh=n/a pLI=0.64), FOXK2 (inh=n/a pLI=0.92)
chr18	2917152	2917152	T	C	het	anno_omim	QUAL=7986;DP=339;AF=0.52;MQM=60;TRIO=HET,339,0.52,HET,243,0.49,WT,340,0.00	LPIN2	3'UTR	LPIN2:ENST00000261596:3'UTR:MODIFIER:exon20/20:c.*3139A>G:		rs1164	0.1420	0.0000	0,0,0	0,0,0,0,0	0.1815							605519 [LPIN2 (provisional) Majeed syndrome,609628];	RCV000373518.1 [benign]; 			12	72					LPIN2 (inh=n/a pLI=0.67)
chr18	2917357	2917357	G	A	het	anno_omim	QUAL=19697;DP=652;AF=0.52;MQM=60;TRIO=HET,652,0.52,HET,191,0.55,HOM,226,1.00	LPIN2	3'UTR	LPIN2:ENST00000261596:3'UTR:MODIFIER:exon20/20:c.*2934C>T:		rs7980	0.5455	0.0000	0,0,0	0,0,0,0,0	0.5200							605519 [LPIN2 (provisional) Majeed syndrome,609628];	RCV000306995.1 [benign]; 			85	111					LPIN2 (inh=n/a pLI=0.67)
chr18	2919343	2919343	-	T	hom	anno_omim	QUAL=15953;DP=375;AF=0.96;MQM=59;TRIO=HOM,375,0.96,HET,174,0.54,HET,222,0.54	LPIN2	3'UTR	LPIN2:ENST00000261596:3'UTR:MODIFIER:exon20/20:c.*947dupA:		rs3840906	0.3265	0.0000	0,0,0	0,0,0,0,0	0.3662							605519 [LPIN2 (provisional) Majeed syndrome,609628];	RCV000323381.1 [benign]; 			37	109					LPIN2 (inh=n/a pLI=0.67)
chr18	2919606	2919606	A	T	het	anno_omim	QUAL=11329;DP=292;AF=0.41;MQM=60;TRIO=HET,292,0.41,HOM,185,1.00,HET,260,0.51	LPIN2	3'UTR	LPIN2:ENST00000261596:3'UTR:MODIFIER:exon20/20:c.*685T>A:		rs607549	0.6913	0.0000	0,0,0	0,0,0,0,0	0.7149							605519 [LPIN2 (provisional) Majeed syndrome,609628];	RCV000360188.1 [benign]; 			126	87					LPIN2 (inh=n/a pLI=0.67)
chr18	3412167	3412167	C	T	hom	anno_omim	QUAL=1818;DP=49;AF=0.96;MQM=59;TRIO=HOM,49,0.96,HET,20,0.55,HOM,21,1.00	TGIF1	5'UTR	TGIF1:ENST00000401449:5'UTR:MODIFIER:exon1/4:c.-203C>T:		rs11571505	0.6166	0.0000	0,0,0	0,0,0,0,0	0.5995							602630 [TGIF1 (confirmed) Holoprosencephaly 4,142946];				70	114					TGIF1 (inh=AD pLI=0.09)
chr18	3447725	3447725	C	T	het	anno_omim	QUAL=8899;DP=597;AF=0.43;MQM=60;TRIO=HET,597,0.43,HET,215,0.52,WT,295,0.00	TGIF1	5'UTR,intron	TGIF1:ENST00000548489:5'UTR:MODIFIER:exon1/3:c.-13C>T:,TGIF1:ENST00000401449:intron:MODIFIER:exon2/3:c.-44-8627C>T:		rs238137	0.0837	0.0481	220,41,104	0.1440,0.0234,0.0911,0.0353,0.0185	0.0720							602630 [TGIF1 (confirmed) Holoprosencephaly 4,142946];				3	139					TGIF1 (inh=AD pLI=0.09)
chr18	3450455	3450455	C	A	het	anno_omim	QUAL=8859;DP=146;AF=0.47;MQM=59;TRIO=HET,146,0.47,HOM,246,0.99,WT,292,0.00	TGIF1	5'UTR,intron	TGIF1:ENST00000343820:5'UTR:MODIFIER:exon1/3:c.-33C>A:,TGIF1:ENST00000407501:5'UTR:MODIFIER:exon2/4:c.-33C>A:,TGIF1:ENST00000551402:5'UTR:MODIFIER:exon1/2:c.-33C>A:,TGIF1:ENST00000577543:5'UTR:MODIFIER:exon1/3:c.-33C>A:,TGIF1:ENST00000401449:intron:MODIFIER:exon2/3:c.-44-5897C>A:,TGIF1:ENST00000548489:intron:MODIFIER:exon1/2:c.58+2660C>A:,TGIF1:ENST00000405385:intron:MODIFIER:exon1/2:c.-45+387C>A:		rs238132	0.2839	0.2158	668,96,430	0.5906,0.1113,0.1808,0.1630,0.1652	0.2666							602630 [TGIF1 (confirmed) Holoprosencephaly 4,142946];	RCV000245689.1 [benign]; RCV000259321.1 [benign]; 			65	483					TGIF1 (inh=AD pLI=0.09)
chr18	3452223	3452223	T	-	het	anno_high_impact;anno_omim	QUAL=468;DP=22;AF=0.45;MQM=59;TRIO=HET,22,0.45,WT,33,0.00,HET,43,0.35	TGIF1	frameshift,intron	TGIF1:ENST00000330513:frameshift:HIGH:exon1/3:c.246delT:p.Pro83fs,TGIF1:ENST00000401449:intron:MODIFIER:exon2/3:c.-44-4129delT:,TGIF1:ENST00000548489:intron:MODIFIER:exon1/2:c.59-4129delT:,TGIF1:ENST00000343820:intron:MODIFIER:exon1/2:c.16+1720delT:,TGIF1:ENST00000407501:intron:MODIFIER:exon2/3:c.16+1720delT:,TGIF1:ENST00000405385:intron:MODIFIER:exon1/2:c.-45+2155delT:,TGIF1:ENST00000551402:intron:MODIFIER:exon1/1:c.16+1720delT:,TGIF1:ENST00000577543:intron:MODIFIER:exon1/2:c.16+1720delT:,TGIF1:ENST00000551541:intron:MODIFIER:exon1/2:c.-45+450delT:,TGIF1:ENST00000345133:intron:MODIFIER:exon1/2:c.-45+454delT:		rs11571510	0.2556	0.3296	6049,4473,371	0.3188,0.1821,0.0098,0.4129,0.2645	0.3607							602630 [TGIF1 (confirmed) Holoprosencephaly 4,142946];			COSM296436	280	698	1	[1] old entry - no details available			TGIF1 (inh=AD pLI=0.09)
chr18	3457606	3457606	C	T	het	pred_pathogenic;anno_omim	QUAL=6456;DP=241;AF=0.51;MQM=59;TRIO=HET,241,0.51,HET,237,0.54,WT,315,0.00	TGIF1	missense	TGIF1:ENST00000330513:missense:MODERATE:exon3/3:c.874C>T:p.Pro292Ser,TGIF1:ENST00000401449:missense:MODERATE:exon4/4:c.427C>T:p.Pro143Ser,TGIF1:ENST00000548489:missense:MODERATE:exon3/3:c.529C>T:p.Pro177Ser,TGIF1:ENST00000343820:missense:MODERATE:exon3/3:c.487C>T:p.Pro163Ser,TGIF1:ENST00000407501:missense:MODERATE:exon4/4:c.487C>T:p.Pro163Ser,TGIF1:ENST00000405385:missense:MODERATE:exon3/3:c.427C>T:p.Pro143Ser,TGIF1:ENST00000551541:missense:MODERATE:exon3/3:c.427C>T:p.Pro143Ser,TGIF1:ENST00000345133:missense:MODERATE:exon3/3:c.427C>T:p.Pro143Ser,TGIF1:ENST00000400167:missense:MODERATE:exon3/3:c.427C>T:p.Pro143Ser,TGIF1:ENST00000472042:missense:MODERATE:exon2/2:c.427C>T:p.Pro143Ser		rs4468717	0.0313	0.0602	302,211,0	0.0132,0.0368,0.0002,0.0783,0.0267	0.0644	3.6330	D,T,T,D,T,T,T,T,T,T,T,T,T	T	B,B,B	T,T,T,T,T,T,T,T,T,T,T,T,T	12.27	602630 [TGIF1 (confirmed) Holoprosencephaly 4,142946];	RCV000246246.1 [benign]; RCV000293052.1 [likely benign]; 	CM1411534 [CLASS=DP MUT=ALT PHEN="Myopia high-grade association with" GENE=TGIF1]; 		17	293					TGIF1 (inh=AD pLI=0.09)
chr18	6943264	6943264	G	A	hom	anno_omim	QUAL=28838;DP=288;AF=1.00;MQM=60;TRIO=HOM,288,1.00,HOM,275,1.00,HOM,337,1.00	LAMA1	synonymous	LAMA1:ENST00000389658:synonymous:LOW:exon62/63:c.8982C>T:p.Asp2994Asp		rs2016639	0.2861	0.3307	7376,3447,31	0.0665,0.4553,0.3114,0.3198,0.4476	0.3423							150320 [LAMA1 (provisional) Poretti-Boltshauser syndrome,615960];			COSM148377	238	863					LAMA1 (inh=AR pLI=0.00)
chr18	6980523	6980523	T	C	hom	anno_omim	QUAL=19935;DP=232;AF=1.00;MQM=59;TRIO=HOM,232,1.00,HOM,258,1.00,HET,292,0.51	LAMA1	missense	LAMA1:ENST00000389658:missense:MODERATE:exon42/63:c.6004A>G:p.Lys2002Glu		rs607230	0.6937	0.7278	32332,17088,1629	0.5626,0.8448,0.8308,0.7182,0.7272	0.7355	1.4670	T	T	B	T	17.60	150320 [LAMA1 (provisional) Poretti-Boltshauser syndrome,615960];				1091	853					LAMA1 (inh=AR pLI=0.00)
chr18	6985631	6985631	C	T	hom	anno_omim	QUAL=26754;DP=389;AF=0.99;MQM=60;TRIO=HOM,389,0.99,HOM,310,0.99,HET,367,0.47	LAMA1	synonymous	LAMA1:ENST00000389658:synonymous:LOW:exon38/63:c.5391G>A:p.Leu1797Leu		rs617206	0.5521	0.5151	16844,6495,1378	0.5134,0.7439,0.6904,0.4411,0.5529	0.5210							150320 [LAMA1 (provisional) Poretti-Boltshauser syndrome,615960];			COSM3756200	394	1040					LAMA1 (inh=AR pLI=0.00)
chr18	7008591	7008591	T	C	het	pred_pathogenic;anno_omim	QUAL=6657;DP=310;AF=0.54;MQM=60;TRIO=HET,310,0.54,HET,172,0.45,WT,242,0.00	LAMA1	missense	LAMA1:ENST00000389658:missense:MODERATE:exon28/63:c.4018A>G:p.Met1340Val		rs662471	0.1871	0.2384	3959,2876,287	0.2391,0.1366,0.0046,0.2920,0.1830	0.2617	-0.0350	D	T	B	T	9.36	150320 [LAMA1 (provisional) Poretti-Boltshauser syndrome,615960];				168	824					LAMA1 (inh=AR pLI=0.00)
chr18	7012123	7012123	A	G	het	anno_omim	QUAL=9426;DP=238;AF=0.46;MQM=60;TRIO=HET,238,0.46,HOM,219,1.00,WT,341,0.01	LAMA1	synonymous	LAMA1:ENST00000389658:synonymous:LOW:exon24/63:c.3378T>C:p.Gly1126Gly		rs9946794	0.4201	0.3774	9575,4683,3020	0.7764,0.3036,0.0535,0.3837,0.3158	0.4748							150320 [LAMA1 (provisional) Poretti-Boltshauser syndrome,615960];			COSM438362	301	979					LAMA1 (inh=AR pLI=0.00)
chr18	7017322	7017322	A	G	het	anno_omim	QUAL=18258;DP=440;AF=0.48;MQM=59;TRIO=HET,440,0.48,HOM,397,1.00,WT,564,0.00	LAMA1	synonymous	LAMA1:ENST00000389658:synonymous:LOW:exon20/63:c.2763T>C:p.Cys921Cys		rs539713	0.5475	0.5194	17510,9437,3769	0.8506,0.3143,0.2337,0.5338,0.5202	0.6080							150320 [LAMA1 (provisional) Poretti-Boltshauser syndrome,615960];			COSM4131076	669	1020					LAMA1 (inh=AR pLI=0.00)
chr18	7023371	7023371	A	G	het	anno_omim	QUAL=1440;DP=54;AF=0.48;MQM=60;TRIO=HET,54,0.48,HET,53,0.64,WT,60,0.00	LAMA1	synonymous	LAMA1:ENST00000389658:synonymous:LOW:exon19/63:c.2493T>C:p.Cys831Cys		rs684634	0.4373	0.3801	9955,4884,3110	0.7703,0.2839,0.1558,0.3833,0.2880	0.4745							150320 [LAMA1 (provisional) Poretti-Boltshauser syndrome,615960];			COSM1179774	266	969					LAMA1 (inh=AR pLI=0.00)
chr18	7033037	7033037	G	A	het	anno_omim	QUAL=8169;DP=284;AF=0.50;MQM=59;TRIO=HET,284,0.50,HOM,157,0.97,WT,225,0.00	LAMA1	synonymous	LAMA1:ENST00000389658:synonymous:LOW:exon15/63:c.2109C>T:p.Ala703Ala		rs621993	0.4066	0.4057	9166,5102,2046	0.6520,0.2999,0.1611,0.4224,0.3465	0.4572							150320 [LAMA1 (provisional) Poretti-Boltshauser syndrome,615960];				304	1015					LAMA1 (inh=AR pLI=0.00)
chr18	9117867	9117867	T	C	hom	anno_omim	QUAL=11262;DP=239;AF=1.00;MQM=60;TRIO=HOM,239,1.00,HOM,42,1.00,HOM,54,1.00	NDUFV2,RP11-21J18.1	missense	NDUFV2:ENST00000400033:missense:MODERATE:exon3/9:c.95T>C:p.Val32Ala,NDUFV2:ENST00000318388:missense:MODERATE:exon2/8:c.86T>C:p.Val29Ala		rs906807	0.7790	0.8001	39013,22176,2993	0.7593,0.7611,0.7098,0.8157,0.8607	0.7980	1.5370	T,T	T	B	T,T	9.71	600532 [NDUFV2 (confirmed) Mitochondrial complex I deficiency,252010];	RCV000009621.2 [uncertain significance]; RCV000117718.3 [other]; RCV000312272.1 [benign]; 		COSM3773839	1442	620					NDUFV2 (inh=AR pLI=0.01), RP11-21J18.1 (inh=n/a pLI=n/a)
chr18	9119489	9119489	A	T	het	anno_omim	QUAL=8746;DP=402;AF=0.50;MQM=55;TRIO=HET,402,0.50,HET,247,0.51,WT,299,0.00	NDUFV2,RP11-21J18.1	synonymous	NDUFV2:ENST00000400033:synonymous:LOW:exon5/9:c.210A>T:p.Val70Val,NDUFV2:ENST00000318388:synonymous:LOW:exon4/8:c.201A>T:p.Val67Val		rs41274300	0.0751	0.0850	542,368,110	0.1575,0.0449,0.0001,0.1029,0.0605	0.1037							600532 [NDUFV2 (confirmed) Mitochondrial complex I deficiency,252010];	RCV000117717.2 [likely benign]; RCV000366995.1 [likely benign]; 		COSM4131120	30	408					NDUFV2 (inh=AR pLI=0.01), RP11-21J18.1 (inh=n/a pLI=n/a)
chr18	9134344	9134344	T	C	het	anno_omim	QUAL=2987;DP=117;AF=0.55;MQM=60;TRIO=HET,117,0.55,HET,118,0.51,WT,143,0.00	RP11-21J18.1,RP11-143J12.2				rs62088771	0.0034	0.0000	0,0,0	0,0,0,0,0	0.0066							600532 [NDUFV2 (confirmed) Mitochondrial complex I deficiency,252010];				0	12					RP11-21J18.1 (inh=n/a pLI=n/a), RP11-143J12.2 (inh=n/a pLI=n/a)
chr18	12348285	12348285	T	C	hom	anno_omim	QUAL=15844;DP=215;AF=1.00;MQM=60;TRIO=HOM,215,1.00,HET,184,0.46,HOM,213,1.00	AFG3L2	synonymous	AFG3L2:ENST00000269143:synonymous:LOW:exon13/17:c.1650A>G:p.Glu550Glu		rs11553521	0.7099	0.7493	34444,20351,3067	0.7682,0.5525,0.6084,0.7813,0.7842	0.7758							604581 [AFG3L2 (confirmed) Spinocerebellar ataxia 28,610246|Spastic ataxia 5,autosomal recessive,614487];	RCV000116249.3 [other]; RCV000329004.1 [benign]; 		COSM148398	2391	1324					AFG3L2 (inh=AR+AD pLI=0.01)
chr18	12351342	12351342	C	T	hom	anno_omim	QUAL=16470;DP=202;AF=0.99;MQM=59;TRIO=HOM,202,0.99,HET,194,0.53,HOM,252,1.00	AFG3L2	synonymous	AFG3L2:ENST00000269143:synonymous:LOW:exon11/17:c.1389G>A:p.Leu463Leu		rs11080572	0.6232	0.7205	32215,20238,1251	0.4900,0.5411,0.5995,0.7789,0.7815	0.7185							604581 [AFG3L2 (confirmed) Spinocerebellar ataxia 28,610246|Spastic ataxia 5,autosomal recessive,614487];	RCV000116248.4 [other]; RCV000323296.1 [benign]; 		COSM148399	2363	1336					AFG3L2 (inh=AR+AD pLI=0.01)
chr18	12359920	12359920	G	A	hom	anno_omim	QUAL=14167;DP=179;AF=1.00;MQM=59;TRIO=HOM,179,1.00,HET,146,0.52,HOM,202,1.00	AFG3L2	splice_region&intron	AFG3L2:ENST00000269143:splice_region&intron:LOW:exon7/16:c.752+6C>T:		rs8097342	0.6196	0.7177	31953,20115,1248	0.4887,0.5413,0.6019,0.7764,0.7707	0.7159							604581 [AFG3L2 (confirmed) Spinocerebellar ataxia 28,610246|Spastic ataxia 5,autosomal recessive,614487];	RCV000179927.2 [benign]; RCV000340354.1 [benign]; 		COSM148400	2334	1285					AFG3L2 (inh=AR+AD pLI=0.01)
chr18	21119777	21119777	G	A	hom	anno_omim	QUAL=14838;DP=201;AF=1.00;MQM=59;TRIO=HOM,201,1.00,HET,207,0.48,HOM,209,1.00	NPC1	splice_region&synonymous	NPC1:ENST00000269228:splice_region&synonymous:LOW:exon18/25:c.2793C>T:p.Asn931Asn,NPC1:ENST00000412552:splice_region&synonymous:LOW:exon11/18:c.1839C>T:p.Asn613Asn		rs1140458	0.4840	0.4902	15043,7063,759	0.3823,0.6585,0.6266,0.4595,0.4861	0.4990							607623 [NPC1 (confirmed) Niemann-Pick disease,type C1,257220|Niemann-Pick disease,type D,257220];	RCV000020228.2 [benign]; RCV000078475.9 [other]; RCV000348906.1 [benign]; 		COSM437978	698	1642					NPC1 (inh=AR pLI=0.00)
chr18	21120444	21120444	T	C	hom	pred_pathogenic;anno_omim	QUAL=28222;DP=561;AF=1.00;MQM=59;TRIO=HOM,561,1.00,HET,198,0.54,HOM,223,0.99	NPC1	missense	NPC1:ENST00000269228:missense:MODERATE:exon17/25:c.2572A>G:p.Ile858Val,NPC1:ENST00000412552:missense:MODERATE:exon10/18:c.1618A>G:p.Ile540Val		rs1805082	0.4858	0.4947	15014,7024,758	0.3844,0.6616,0.6302,0.4639,0.4928	0.4999	4.9470	T,T,T	T	B,B	D,D	20.90	607623 [NPC1 (confirmed) Niemann-Pick disease,type C1,257220|Niemann-Pick disease,type D,257220];	RCV000020227.2 [benign]; RCV000078474.9 [other]; RCV000391750.1 [benign]; 			703	1652	1	[1] old entry - no details available			NPC1 (inh=AR pLI=0.00)
chr18	21123537	21123537	A	-	hom	anno_omim	QUAL=845;DP=60;AF=0.42;MQM=59;TRIO=HOM,60,0.42,HET,64,0.42,WT,49,0.22	NPC1	splice_region&intron	NPC1:ENST00000269228:splice_region&intron:LOW:exon13/24:c.2131-4delT:,NPC1:ENST00000412552:splice_region&intron:LOW:exon6/17:c.1177-4delT:	(A)n	rs11299077;rs533551695;rs796757567	0.5022	0.4576	165,73,30	0.4678,0.4639,0.4749,0.4485,0.4690	0.6399							607623 [NPC1 (confirmed) Niemann-Pick disease,type C1,257220|Niemann-Pick disease,type D,257220];				580	1694	2	[2] Stephan Waldm?ller 13.11.2014			NPC1 (inh=AR pLI=0.00)
chr18	21124917	21124917	G	C	het	low_DP;low_MQM;anno_omim	QUAL=870;DP=4;AF=0.00;MQM=49;TRIO=HET,4,0.00,WT,83,0.00,HET,73,0.34	NPC1	splice_region&intron	NPC1:ENST00000269228:splice_region&intron:LOW:exon12/24:c.1947+7C>G:,NPC1:ENST00000412552:splice_region&intron:LOW:exon5/17:c.993+7C>G:		rs56394541	0.0000	0.0001	0,0,0	0.0000,0.0000,0.0002,0.0001,0.0000	0.0010							607623 [NPC1 (confirmed) Niemann-Pick disease,type C1,257220|Niemann-Pick disease,type D,257220];				94	19	2	[2] Stefanie Beck-Woedl 20.03.2015			NPC1 (inh=AR pLI=0.00)
chr18	21124918	21124918	G	C	het	low_DP;low_MQM;anno_omim	QUAL=870;DP=4;AF=0.00;MQM=49;TRIO=HET,4,0.00,WT,83,0.00,HET,73,0.34	NPC1	splice_region&intron	NPC1:ENST00000269228:splice_region&intron:LOW:exon12/24:c.1947+6C>G:,NPC1:ENST00000412552:splice_region&intron:LOW:exon5/17:c.993+6C>G:		rs745432812	0.0000	0.0001	0,0,0	0.0000,0.0000,0.0002,0.0001,0.0000	0.0002							607623 [NPC1 (confirmed) Niemann-Pick disease,type C1,257220|Niemann-Pick disease,type D,257220];	RCV000290784.1 [uncertain significance]; 			0	9					NPC1 (inh=AR pLI=0.00)
chr18	21124945	21124945	C	G	hom	pred_pathogenic;anno_omim	QUAL=5168;DP=51;AF=0.98;MQM=59;TRIO=HOM,51,0.98,HET,110,0.24,HOM,113,1.00	NPC1	missense	NPC1:ENST00000269228:missense:MODERATE:exon12/25:c.1926G>C:p.Met642Ile,NPC1:ENST00000412552:missense:MODERATE:exon5/18:c.972G>C:p.Met324Ile		rs1788799	0.8317	0.7177	32007,13600,4398	0.9199,0.8180,0.9320,0.6379,0.7551	0.7419	3.3010	T,T,T	T	B,B	D,D	12.77	607623 [NPC1 (confirmed) Niemann-Pick disease,type C1,257220|Niemann-Pick disease,type D,257220];	RCV000078467.9 [other]; RCV000348137.1 [benign]; 			1440	1499					NPC1 (inh=AR pLI=0.00)
chr18	21134786	21134786	G	A	het	pred_pathogenic;anno_omim	QUAL=7443;DP=217;AF=0.48;MQM=60;TRIO=HET,217,0.48,WT,247,0.00,HET,361,0.52	NPC1	missense	NPC1:ENST00000269228:missense:MODERATE:exon9/25:c.1489C>T:p.His497Tyr,NPC1:ENST00000412552:missense:MODERATE:exon4/18:c.739C>T:p.His247Tyr		rs770838112	0.0000	0.0001	0,0,0	0.0000,0.0000,0.0000,0.0001,0.0000	0.0000	6.4200	T,T,T	T	B,B	T,T	14.29	607623 [NPC1 (confirmed) Niemann-Pick disease,type C1,257220|Niemann-Pick disease,type D,257220];				0	2	3	[3] Stephan Waldm?ller 13.08.2014			NPC1 (inh=AR pLI=0.00)
chr18	21140432	21140432	T	C	hom	pred_pathogenic;anno_omim	QUAL=2361;DP=42;AF=0.98;MQM=59;TRIO=HOM,42,0.98,HET,31,0.42,HOM,29,1.00	NPC1	missense	NPC1:ENST00000269228:missense:MODERATE:exon6/25:c.644A>G:p.His215Arg		rs1805081	0.2187	0.3287	7279,5277,37	0.0727,0.2322,0.2384,0.3965,0.2748	0.3324	0.5890	T,T	T	B	D	1.52	607623 [NPC1 (confirmed) Niemann-Pick disease,type C1,257220|Niemann-Pick disease,type D,257220];	RCV000078484.9 [other]; RCV000158944.1 [benign]; RCV000405719.1 [benign]; 			429	1504					NPC1 (inh=AR pLI=0.00)
chr18	21413869	21413869	T	C	het	anno_omim	QUAL=19977;DP=347;AF=0.48;MQM=59;TRIO=HET,347,0.48,HET,326,0.52,HOM,370,0.99	LAMA3	synonymous	LAMA3:ENST00000313654:synonymous:LOW:exon24/75:c.2901T>C:p.Ala967Ala,LAMA3:ENST00000399516:synonymous:LOW:exon24/74:c.2901T>C:p.Ala967Ala		rs9962023	0.6244	0.6631	27016,16761,1443	0.5386,0.5095,0.7650,0.7075,0.6205	0.6592							600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type,226700|Epidermolysis bullosa,generalized atrophic benign,226650|Laryngoonychocutaneous syndrome,245660];			COSM4130939	1031	892					LAMA3 (inh=AR pLI=0.00)
chr18	21437931	21437931	G	C	het	anno_omim	QUAL=25123;DP=355;AF=0.52;MQM=60;TRIO=HET,355,0.52,HET,392,0.53,HOM,525,0.99	LAMA3	synonymous	LAMA3:ENST00000313654:synonymous:LOW:exon33/75:c.4260G>C:p.Gly1420Gly,LAMA3:ENST00000399516:synonymous:LOW:exon33/74:c.4260G>C:p.Gly1420Gly		rs867449	0.3437	0.4962	16492,12782,336	0.2524,0.3352,0.1594,0.6182,0.4130	0.4942							600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type,226700|Epidermolysis bullosa,generalized atrophic benign,226650|Laryngoonychocutaneous syndrome,245660];				709	1000					LAMA3 (inh=AR pLI=0.00)
chr18	21441717	21441717	C	T	het	anno_omim	QUAL=10335;DP=134;AF=0.53;MQM=60;TRIO=HET,134,0.53,HET,141,0.50,HOM,222,1.00	LAMA3	synonymous	LAMA3:ENST00000313654:synonymous:LOW:exon35/75:c.4530C>T:p.Pro1510Pro,LAMA3:ENST00000399516:synonymous:LOW:exon35/74:c.4530C>T:p.Pro1510Pro		rs12965685	0.3407	0.4995	16084,12519,296	0.2461,0.3369,0.1621,0.6206,0.4193	0.4924							600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type,226700|Epidermolysis bullosa,generalized atrophic benign,226650|Laryngoonychocutaneous syndrome,245660];				709	999					LAMA3 (inh=AR pLI=0.00)
chr18	21481233	21481233	C	G	het	anno_omim	QUAL=4344;DP=246;AF=0.52;MQM=60;TRIO=HET,246,0.52,HET,96,0.46,WT,138,0.00	LAMA3	synonymous	LAMA3:ENST00000313654:synonymous:LOW:exon48/75:c.6147C>G:p.Ala2049Ala,LAMA3:ENST00000399516:synonymous:LOW:exon47/74:c.5979C>G:p.Ala1993Ala,LAMA3:ENST00000269217:synonymous:LOW:exon11/38:c.1320C>G:p.Ala440Ala,LAMA3:ENST00000587184:synonymous:LOW:exon10/37:c.1152C>G:p.Ala384Ala		rs1154226	0.1683	0.2343	3696,2434,17	0.0478,0.1908,0.1635,0.2662,0.2515	0.2384							600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type,226700|Epidermolysis bullosa,generalized atrophic benign,226650|Laryngoonychocutaneous syndrome,245660];	RCV000241986.1 [benign]; RCV000350792.1 [benign]; RCV000386499.1 [benign]; 		COSM1179775, COSM1179776	144	800					LAMA3 (inh=AR pLI=0.00)
chr18	21511034	21511034	C	A	het	anno_omim	QUAL=5183;DP=215;AF=0.55;MQM=60;TRIO=HET,215,0.55,HET,132,0.61,WT,197,0.00	LAMA3	missense	LAMA3:ENST00000313654:missense:MODERATE:exon65/75:c.8445C>A:p.Asn2815Lys,LAMA3:ENST00000399516:missense:MODERATE:exon64/74:c.8277C>A:p.Asn2759Lys,LAMA3:ENST00000269217:missense:MODERATE:exon28/38:c.3618C>A:p.Asn1206Lys,LAMA3:ENST00000587184:missense:MODERATE:exon27/37:c.3450C>A:p.Asn1150Lys		rs1154232	0.1567	0.1889	2374,1348,18	0.0583,0.1766,0.1619,0.1972,0.2329	0.1931	-0.0070	T,T,T	T	B,B,B,B	T,T,T	9.00	600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type,226700|Epidermolysis bullosa,generalized atrophic benign,226650|Laryngoonychocutaneous syndrome,245660];	RCV000250312.1 [benign]; RCV000264313.1 [benign]; RCV000328887.1 [benign]; 			100	660					LAMA3 (inh=AR pLI=0.00)
chr18	21511089	21511089	A	G	hom	anno_omim	QUAL=22691;DP=272;AF=1.00;MQM=60;TRIO=HOM,272,1.00,HOM,177,1.00,HOM,249,1.00	LAMA3	missense	LAMA3:ENST00000313654:missense:MODERATE:exon65/75:c.8500A>G:p.Ser2834Gly,LAMA3:ENST00000399516:missense:MODERATE:exon64/74:c.8332A>G:p.Ser2778Gly,LAMA3:ENST00000269217:missense:MODERATE:exon28/38:c.3673A>G:p.Ser1225Gly,LAMA3:ENST00000587184:missense:MODERATE:exon27/37:c.3505A>G:p.Ser1169Gly		rs1154233	1.0000	1.0000	60703,33370,5202	0.9999,1.0000,1.0000,1.0000,0.9999	1.0000	-1.2560	T,T,T	T	B,B,B,B	T,T,T	0.01	600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type,226700|Epidermolysis bullosa,generalized atrophic benign,226650|Laryngoonychocutaneous syndrome,245660];	RCV000242248.1 [benign]; RCV000270352.1 [benign]; RCV000383453.1 [benign]; 			2133	0					LAMA3 (inh=AR pLI=0.00)
chr18	21511172	21511172	G	C	hom	anno_omim	QUAL=17370;DP=193;AF=1.00;MQM=60;TRIO=HOM,193,1.00,HOM,154,1.00,HOM,201,1.00	LAMA3	splice_region&intron	LAMA3:ENST00000313654:splice_region&intron:LOW:exon65/74:c.8576+7G>C:,LAMA3:ENST00000399516:splice_region&intron:LOW:exon64/73:c.8408+7G>C:,LAMA3:ENST00000269217:splice_region&intron:LOW:exon28/37:c.3749+7G>C:,LAMA3:ENST00000587184:splice_region&intron:LOW:exon27/36:c.3581+7G>C:		rs1258107	0.9489	0.9732	57551,32496,4160	0.8938,0.9888,0.9999,0.9869,0.9338	0.9761							600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type,226700|Epidermolysis bullosa,generalized atrophic benign,226650|Laryngoonychocutaneous syndrome,245660];	RCV000247245.1 [benign]; RCV000325474.1 [benign]; RCV000389378.1 [benign]; 			2028	102					LAMA3 (inh=AR pLI=0.00)
chr18	21513768	21513768	C	T	het	anno_omim	QUAL=2822;DP=135;AF=0.46;MQM=60;TRIO=HET,135,0.46,HET,89,0.55,WT,105,0.04	LAMA3	synonymous	LAMA3:ENST00000313654:synonymous:LOW:exon67/75:c.8731C>T:p.Leu2911Leu,LAMA3:ENST00000399516:synonymous:LOW:exon66/74:c.8563C>T:p.Leu2855Leu,LAMA3:ENST00000269217:synonymous:LOW:exon30/38:c.3904C>T:p.Leu1302Leu,LAMA3:ENST00000587184:synonymous:LOW:exon29/37:c.3736C>T:p.Leu1246Leu		rs1131521	0.1484	0.1860	2331,1334,11	0.0363,0.1766,0.1618,0.1964,0.2323	0.1907							600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type,226700|Epidermolysis bullosa,generalized atrophic benign,226650|Laryngoonychocutaneous syndrome,245660];	RCV000252202.1 [benign]; RCV000309977.1 [benign]; RCV000362299.1 [benign]; 		COSM3756099, COSM3756100	100	657					LAMA3 (inh=AR pLI=0.00)
chr18	21529722	21529722	G	A	het	anno_omim	QUAL=10922;DP=225;AF=0.52;MQM=60;TRIO=HET,225,0.52,HET,178,0.49,HOM,190,1.00	LAMA3	splice_region&intron	LAMA3:ENST00000313654:splice_region&intron:LOW:exon70/74:c.9352-7G>A:,LAMA3:ENST00000399516:splice_region&intron:LOW:exon69/73:c.9184-7G>A:,LAMA3:ENST00000269217:splice_region&intron:LOW:exon33/37:c.4525-7G>A:,LAMA3:ENST00000587184:splice_region&intron:LOW:exon32/36:c.4357-7G>A:		rs2241643	0.3590	0.5377	19668,15371,360	0.2581,0.3479,0.1629,0.6781,0.4344	0.5367							600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type,226700|Epidermolysis bullosa,generalized atrophic benign,226650|Laryngoonychocutaneous syndrome,245660];	RCV000247590.1 [benign]; RCV000290820.1 [benign]; RCV000348031.1 [benign]; 			843	952					LAMA3 (inh=AR pLI=0.00)
chr18	21534701	21534701	C	A	het	anno_omim	QUAL=17672;DP=279;AF=0.47;MQM=60;TRIO=HET,279,0.47,HET,258,0.46,HOM,346,1.00	LAMA3	3'UTR	LAMA3:ENST00000313654:3'UTR:MODIFIER:exon75/75:c.*89C>A:,LAMA3:ENST00000269217:3'UTR:MODIFIER:exon38/38:c.*89C>A:		rs1051149	0.3596	0.0000	0,0,0	0,0,0,0,0	0.5170							600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type,226700|Epidermolysis bullosa,generalized atrophic benign,226650|Laryngoonychocutaneous syndrome,245660];	RCV000344067.1 [benign]; RCV000399433.1 [benign]; 			91	112					LAMA3 (inh=AR pLI=0.00)
chr18	21534703	21534703	C	T	het	anno_omim	QUAL=17672;DP=279;AF=0.47;MQM=60;TRIO=HET,279,0.47,HET,258,0.46,HOM,346,1.00	LAMA3	3'UTR	LAMA3:ENST00000313654:3'UTR:MODIFIER:exon75/75:c.*91C>T:,LAMA3:ENST00000269217:3'UTR:MODIFIER:exon38/38:c.*91C>T:		rs1051150	0.3596	0.0000	0,0,0	0,0,0,0,0	0.5170							600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type,226700|Epidermolysis bullosa,generalized atrophic benign,226650|Laryngoonychocutaneous syndrome,245660];	RCV000295082.1 [benign]; RCV000348785.1 [benign]; 			91	112					LAMA3 (inh=AR pLI=0.00)
chr18	31320229	31320229	A	G	het	anno_omim	QUAL=11713;DP=370;AF=0.49;MQM=60;TRIO=HET,370,0.49,HET,224,0.45,HET,265,0.55	ASXL3	missense	ASXL3:ENST00000269197:missense:MODERATE:exon11/12:c.2861A>G:p.Asn954Ser		rs2282632	0.7033	0.6029	22038,8392,2969	0.7890,0.7818,0.9087,0.5181,0.5671	0.6158	0.4050	T	T	B	T	1.54	615115 [ASXL3 (provisional) Bainbridge-Ropers syndrome,615485];				435	806					ASXL3 (inh=AD pLI=1.00)
chr18	31323848	31323848	A	G	het	pred_pathogenic;anno_omim	QUAL=9221;DP=383;AF=0.46;MQM=60;TRIO=HET,383,0.46,WT,303,0.00,HET,421,0.44	ASXL3	missense	ASXL3:ENST00000269197:missense:MODERATE:exon12/12:c.4036A>G:p.Ile1346Val		rs61995734	0.0246	0.0164	39,10,24	0.0613,0.0112,0.0001,0.0143,0.0130	0.0267	0.4170	D	T	B	T	8.26	615115 [ASXL3 (provisional) Bainbridge-Ropers syndrome,615485];				1	47					ASXL3 (inh=AD pLI=1.00)
chr18	31324934	31324934	A	G	het	anno_omim	QUAL=15392;DP=356;AF=0.52;MQM=59;TRIO=HET,356,0.52,HET,350,0.45,HET,506,0.50	ASXL3	missense	ASXL3:ENST00000269197:missense:MODERATE:exon12/12:c.5122A>G:p.Met1708Val		rs7232237	0.6791	0.5863	21888,8534,2669	0.7359,0.7764,0.9062,0.5052,0.5500	0.5986	-1.4340	T	T	B	T	0.01	615115 [ASXL3 (provisional) Bainbridge-Ropers syndrome,615485];				427	815					ASXL3 (inh=AD pLI=1.00)
chr18	31327296	31327296	A	C	het	anno_omim	QUAL=7616;DP=415;AF=0.50;MQM=60;TRIO=HET,415,0.50,WT,176,0.01,HET,221,0.52	ASXL3	3'UTR	ASXL3:ENST00000269197:3'UTR:MODIFIER:exon12/12:c.*737A>C:		rs7243541	0.2169	0.0000	0,0,0	0,0,0,0,0	0.1750							615115 [ASXL3 (provisional) Bainbridge-Ropers syndrome,615485];				2	53					ASXL3 (inh=AD pLI=1.00)
chr18	33713287	33713287	T	A	het	anno_omim	QUAL=12045;DP=383;AF=0.46;MQM=60;TRIO=HET,383,0.46,HET,272,0.48,HET,315,0.48	ELP2	splice_region&intron	ELP2:ENST00000442325:splice_region&intron:LOW:exon2/22:c.217+8T>A:,ELP2:ENST00000358232:splice_region&intron:LOW:exon2/21:c.217+8T>A:,ELP2:ENST00000351393:splice_region&intron:LOW:exon2/20:c.217+8T>A:,ELP2:ENST00000423854:splice_region&intron:LOW:exon2/18:c.217+8T>A:,ELP2:ENST00000350494:splice_region&intron:LOW:exon2/20:c.217+8T>A:,ELP2:ENST00000542824:splice_region&intron:LOW:exon2/19:c.217+8T>A:		rs1785905	0.3205	0.3443	7387,4583,754	0.3737,0.4060,0.1889,0.3741,0.2400	0.3652							616054 [ELP2 (provisional) Mental retardation,autosomal recessive 58,617270];				290	955					ELP2 (inh=n/a pLI=0.00)
chr18	33718326	33718326	A	C	het	anno_omim	QUAL=7291;DP=266;AF=0.42;MQM=60;TRIO=HET,266,0.42,HET,171,0.55,HET,150,0.49	ELP2	missense	ELP2:ENST00000442325:missense:MODERATE:exon4/23:c.382A>C:p.Thr128Pro,ELP2:ENST00000358232:missense:MODERATE:exon4/22:c.382A>C:p.Thr128Pro,ELP2:ENST00000351393:missense:MODERATE:exon4/21:c.382A>C:p.Thr128Pro,ELP2:ENST00000423854:missense:MODERATE:exon4/19:c.382A>C:p.Thr128Pro,ELP2:ENST00000350494:missense:MODERATE:exon4/21:c.382A>C:p.Thr128Pro,ELP2:ENST00000542824:missense:MODERATE:exon4/20:c.382A>C:p.Thr128Pro		rs1785934	0.3205	0.3427	7445,4635,756	0.3715,0.4047,0.1893,0.3724,0.2376	0.3649	0.6540	T,T,T,T,T,T	T	B,B,B,B,B,B	T,T,T,T,T,T	5.90	616054 [ELP2 (provisional) Mental retardation,autosomal recessive 58,617270];				289	958					ELP2 (inh=n/a pLI=0.00)
chr18	33719434	33719434	C	T	het	anno_omim	QUAL=6371;DP=155;AF=0.52;MQM=60;TRIO=HET,155,0.52,HET,133,0.48,HET,216,0.51	ELP2	synonymous,intron	ELP2:ENST00000442325:synonymous:LOW:exon6/23:c.576C>T:p.Ala192Ala,ELP2:ENST00000350494:synonymous:LOW:exon5/21:c.498C>T:p.Ala166Ala,ELP2:ENST00000358232:intron:MODIFIER:exon5/21:c.523+599C>T:,ELP2:ENST00000351393:intron:MODIFIER:exon4/20:c.445+1045C>T:,ELP2:ENST00000423854:intron:MODIFIER:exon4/18:c.445+1045C>T:,ELP2:ENST00000542824:intron:MODIFIER:exon4/19:c.445+1045C>T:		rs1785932	0.2452	0.2372	348,189,3	0.0000,0.0000,0.0000,0.3798,0.1868	0.3175							616054 [ELP2 (provisional) Mental retardation,autosomal recessive 58,617270];				256	875					ELP2 (inh=n/a pLI=0.00)
chr18	33725931	33725931	G	A	het	anno_omim	QUAL=9142;DP=325;AF=0.49;MQM=59;TRIO=HET,325,0.49,HET,177,0.44,HET,251,0.46	ELP2	missense	ELP2:ENST00000442325:missense:MODERATE:exon11/23:c.1108G>A:p.Val370Met,ELP2:ENST00000358232:missense:MODERATE:exon10/22:c.913G>A:p.Val305Met,ELP2:ENST00000351393:missense:MODERATE:exon9/21:c.835G>A:p.Val279Met,ELP2:ENST00000423854:missense:MODERATE:exon7/19:c.703G>A:p.Val235Met,ELP2:ENST00000350494:missense:MODERATE:exon10/21:c.1030G>A:p.Val344Met,ELP2:ENST00000542824:missense:MODERATE:exon9/20:c.835G>A:p.Val279Met		rs1785928	0.3217	0.3427	7458,4632,762	0.3752,0.4040,0.1889,0.3721,0.2377	0.3660	0.2480	T,T,T,T,T,T	T	B,B,B,B,B,B	T,T,T,T,T,T	3.76	616054 [ELP2 (provisional) Mental retardation,autosomal recessive 58,617270];			COSM1388588	289	958					ELP2 (inh=n/a pLI=0.00)
chr18	33750046	33750046	C	T	het	anno_omim	QUAL=5337;DP=121;AF=0.50;MQM=60;TRIO=HET,121,0.50,HET,120,0.57,HET,159,0.57	ELP2	synonymous	ELP2:ENST00000442325:synonymous:LOW:exon21/23:c.2292C>T:p.Cys764Cys,ELP2:ENST00000358232:synonymous:LOW:exon20/22:c.2097C>T:p.Cys699Cys,ELP2:ENST00000351393:synonymous:LOW:exon19/21:c.2019C>T:p.Cys673Cys,ELP2:ENST00000423854:synonymous:LOW:exon17/19:c.1887C>T:p.Cys629Cys,ELP2:ENST00000350494:synonymous:LOW:exon19/21:c.2082C>T:p.Cys694Cys,ELP2:ENST00000542824:synonymous:LOW:exon18/20:c.1887C>T:p.Cys629Cys		rs8299	0.3237	0.3507	7827,4961,762	0.3729,0.4087,0.1889,0.3851,0.2402	0.3716							616054 [ELP2 (provisional) Mental retardation,autosomal recessive 58,617270];			COSM1388592	309	975					ELP2 (inh=n/a pLI=0.00)
chr18	42260911	42260911	G	T	het	anno_omim	QUAL=2047;DP=110;AF=0.43;MQM=59;TRIO=HET,110,0.43,HET,71,0.54,WT,109,0.00	SETBP1	5'UTR_premature_start_codon_gain,5'UTR,intron	SETBP1:ENST00000282030:5'UTR_premature_start_codon_gain:LOW:exon1/6:c.-248G>T:,SETBP1:ENST00000282030:5'UTR:MODIFIER:exon1/6:c.-248G>T:,SETBP1:ENST00000426838:intron:MODIFIER:exon1/3:c.-173+551G>T:		rs563748893	0.0018	0.0000	0,0,0	0,0,0,0,0	0.0067							611060 [SETBP1 (confirmed) Schinzel-Giedion midface retraction syndrome,269150|Mental retardation,autosomal dominant 29,616078];	RCV000319325.1 [likely benign]; 		COSN148355	0	10					SETBP1 (inh=AD pLI=1.00)
chr18	42456653	42456653	G	A	hom	pred_pathogenic;anno_omim	QUAL=7046;DP=143;AF=1.00;MQM=59;TRIO=HOM,143,1.00,HET,91,0.47,HET,134,0.52	SETBP1	missense,intron	SETBP1:ENST00000426838:missense:MODERATE:exon4/4:c.664G>A:p.Ala222Thr,SETBP1:ENST00000282030:intron:MODIFIER:exon3/5:c.540+7405G>A:		rs663651	0.4930	0.5073	2819,1389,305	0.5245,0.4338,0.5129,0.5584,0.4287	0.5436	-0.9690	D	T	B		2.67	611060 [SETBP1 (confirmed) Schinzel-Giedion midface retraction syndrome,269150|Mental retardation,autosomal dominant 29,616078];	RCV000147471.1 [likely benign]; 			629	993					SETBP1 (inh=AD pLI=1.00)
chr18	42456670	42456670	-	TCTT	hom	anno_high_impact;anno_omim	QUAL=6204;DP=145;AF=0.96;MQM=59;TRIO=HOM,145,0.96,HET,80,0.46,HET,119,0.49	SETBP1	frameshift,intron	SETBP1:ENST00000426838:frameshift:HIGH:exon4/4:c.681_682insTCTT:p.Thr228fs,SETBP1:ENST00000282030:intron:MODIFIER:exon3/5:c.540+7422_540+7423insTCTT:		rs3085861	0.4938	0.5146	2765,1366,302	0.5247,0.4338,0.5195,0.5603,0.4445	0.5398							611060 [SETBP1 (confirmed) Schinzel-Giedion midface retraction syndrome,269150|Mental retardation,autosomal dominant 29,616078];	RCV000326176.1 [benign]; 		COSM1480329	629	994	1	[1] auto-classification 16.06.2016  [2] old entry - no details available			SETBP1 (inh=AD pLI=1.00)
chr18	42529996	42529996	G	C	het	pred_pathogenic;anno_omim	QUAL=5410;DP=191;AF=0.50;MQM=60;TRIO=HET,191,0.50,HET,251,0.49,WT,328,0.01	SETBP1	missense	SETBP1:ENST00000282030:missense:MODERATE:exon4/6:c.691G>C:p.Val231Leu		rs11082414	0.1567	0.1934	2511,1430,123	0.1580,0.1798,0.0130,0.2077,0.2538	0.1920	-0.1230	D	T	B	T	0.01	611060 [SETBP1 (confirmed) Schinzel-Giedion midface retraction syndrome,269150|Mental retardation,autosomal dominant 29,616078];	RCV000147472.1 [benign]; RCV000291334.1 [benign]; 			105	656					SETBP1 (inh=AD pLI=1.00)
chr18	42533130	42533130	A	G	hom	anno_omim	QUAL=18632;DP=291;AF=1.00;MQM=59;TRIO=HOM,291,1.00,HOM,126,1.00,HOM,177,0.99	SETBP1	synonymous	SETBP1:ENST00000282030:synonymous:LOW:exon4/6:c.3825A>G:p.Ser1275Ser		rs8096662	0.9069	0.8775	46900,24556,4935	0.9757,0.9628,0.9578,0.8584,0.7914	0.9062							611060 [SETBP1 (confirmed) Schinzel-Giedion midface retraction syndrome,269150|Mental retardation,autosomal dominant 29,616078];	RCV000147462.1 [benign]; RCV000324790.1 [benign]; 			1594	454					SETBP1 (inh=AD pLI=1.00)
chr18	42646635	42646635	T	-	het	anno_omim	QUAL=519;DP=115;AF=0.56;MQM=59;TRIO=HET,115,0.56,WT,24,0.21,HOM,21,0.67	SETBP1	3'UTR	SETBP1:ENST00000282030:3'UTR:MODIFIER:exon6/6:c.*2987delT:		rs34125334	0.3756	0.0000	0,0,0	0,0,0,0,0	0.3768							611060 [SETBP1 (confirmed) Schinzel-Giedion midface retraction syndrome,269150|Mental retardation,autosomal dominant 29,616078];	RCV000316690.1 [benign]; 			36	108					SETBP1 (inh=AD pLI=1.00)
chr18	46987023	46987023	C	G	het	anno_omim	QUAL=2411;DP=59;AF=0.51;MQM=59;TRIO=HET,59,0.51,HET,138,0.53,WT,165,0.01	DYM	5'UTR	DYM:ENST00000269445:5'UTR:MODIFIER:exon1/17:c.-309G>C:,DYM:ENST00000442713:5'UTR:MODIFIER:exon1/12:c.-309G>C:		rs28364579	0.1194	0.0000	0,0,0	0,0,0,0,0	0.0921							607461 [DYM (confirmed) Dyggve-Melchior-Clausen disease,223800|Smith-McCort dysplasia,607326];	RCV000268340.1 [benign]; RCV000323440.1 [benign]; 			2	34					DYM (inh=AR pLI=0.00)
chr18	52889712	52889712	-	A	het	anno_omim	QUAL=420;DP=108;AF=0.31;MQM=59;TRIO=HET,108,0.31,WT,26,0.04,HET,25,0.16	TCF4	3'UTR	TCF4:ENST00000354452:3'UTR:MODIFIER:exon20/20:c.*5553dupT:,TCF4:ENST00000356073:3'UTR:MODIFIER:exon20/20:c.*5553dupT:		rs71670792	0.2208	0.0000	0,0,0	0,0,0,0,0	0.3107							602272 [TCF4 (confirmed) Pitt-Hopkins syndrome,610954|Corneal dystrophy,Fuchs endothelial,3,613267];	RCV000282991.1 [benign]; 			4	111					TCF4 (inh=AD pLI=1.00)
chr18	52889967	52889967	T	C	het	anno_omim	QUAL=8118;DP=280;AF=0.50;MQM=60;TRIO=HET,280,0.50,WT,89,0.00,HOM,135,0.99	TCF4	3'UTR	TCF4:ENST00000354452:3'UTR:MODIFIER:exon20/20:c.*5299A>G:,TCF4:ENST00000356073:3'UTR:MODIFIER:exon20/20:c.*5299A>G:		rs1261085	0.3974	0.0000	0,0,0	0,0,0,0,0	0.4328							602272 [TCF4 (confirmed) Pitt-Hopkins syndrome,610954|Corneal dystrophy,Fuchs endothelial,3,613267];	RCV000397336.1 [benign]; 			43	117					TCF4 (inh=AD pLI=1.00)
chr18	52890160	52890160	A	G	het	anno_omim	QUAL=6287;DP=280;AF=0.47;MQM=60;TRIO=HET,280,0.47,WT,100,0.00,HOM,96,1.00	TCF4	3'UTR	TCF4:ENST00000354452:3'UTR:MODIFIER:exon20/20:c.*5106T>C:,TCF4:ENST00000356073:3'UTR:MODIFIER:exon20/20:c.*5106T>C:		rs1261084	0.4437	0.0000	0,0,0	0,0,0,0,0	0.4863							602272 [TCF4 (confirmed) Pitt-Hopkins syndrome,610954|Corneal dystrophy,Fuchs endothelial,3,613267];	RCV000261417.1 [benign]; 			52	112					TCF4 (inh=AD pLI=1.00)
chr18	52890913	52890914	TT	-	het	anno_omim	QUAL=2294;DP=164;AF=0.43;MQM=59;TRIO=HET,164,0.43,WT,25,0.00,HOM,70,0.80	TCF4	3'UTR	TCF4:ENST00000354452:3'UTR:MODIFIER:exon20/20:c.*4352_*4353delAA:,TCF4:ENST00000356073:3'UTR:MODIFIER:exon20/20:c.*4352_*4353delAA:		rs11431395;rs773076214	0.5080	0.0000	0,0,0	0,0,0,0,0	0.4170							602272 [TCF4 (confirmed) Pitt-Hopkins syndrome,610954|Corneal dystrophy,Fuchs endothelial,3,613267];	RCV000273208.1 [benign]; 			54	70					TCF4 (inh=AD pLI=1.00)
chr18	52890946	52890946	-	TC	het	anno_omim	QUAL=3981;DP=202;AF=0.47;MQM=59;TRIO=HET,202,0.47,WT,33,0.00,HOM,73,0.99	TCF4	3'UTR	TCF4:ENST00000354452:3'UTR:MODIFIER:exon20/20:c.*4319_*4320insGA:,TCF4:ENST00000356073:3'UTR:MODIFIER:exon20/20:c.*4319_*4320insGA:		rs373174214;rs61382440	0.4145	0.0000	0,0,0	0,0,0,0,0	0.4453							602272 [TCF4 (confirmed) Pitt-Hopkins syndrome,610954|Corneal dystrophy,Fuchs endothelial,3,613267];	RCV000394708.1 [benign]; 			32	96					TCF4 (inh=AD pLI=1.00)
chr18	52891284	52891284	T	-	het	anno_omim	QUAL=1817;DP=125;AF=0.53;MQM=60;TRIO=HET,125,0.53,WT,19,0.00,HET,43,0.56	TCF4	3'UTR	TCF4:ENST00000354452:3'UTR:MODIFIER:exon20/20:c.*3982delA:,TCF4:ENST00000356073:3'UTR:MODIFIER:exon20/20:c.*3982delA:	(T)n	rs35555522	0.2376	0.0000	0,0,0	0,0,0,0,0	0.2718							602272 [TCF4 (confirmed) Pitt-Hopkins syndrome,610954|Corneal dystrophy,Fuchs endothelial,3,613267];	RCV000265839.1 [benign]; 			12	93					TCF4 (inh=AD pLI=1.00)
chr18	52893255	52893255	-	A	het	anno_omim	QUAL=3220;DP=268;AF=0.47;MQM=59;TRIO=HET,268,0.47,WT,63,0.00,HET,58,0.40	TCF4	3'UTR	TCF4:ENST00000354452:3'UTR:MODIFIER:exon20/20:c.*2010dupT:,TCF4:ENST00000356073:3'UTR:MODIFIER:exon20/20:c.*2010dupT:		rs550740474	0.2240	0.0000	0,0,0	0,0,0,0,0	0.2583							602272 [TCF4 (confirmed) Pitt-Hopkins syndrome,610954|Corneal dystrophy,Fuchs endothelial,3,613267];	RCV000259881.1 [benign]; 			22	92					TCF4 (inh=AD pLI=1.00)
chr18	52893505	52893505	T	-	het	anno_omim	QUAL=9984;DP=384;AF=0.47;MQM=59;TRIO=HET,384,0.47,WT,147,0.01,HOM,206,0.97	TCF4	3'UTR	TCF4:ENST00000354452:3'UTR:MODIFIER:exon20/20:c.*1761delA:,TCF4:ENST00000356073:3'UTR:MODIFIER:exon20/20:c.*1761delA:		rs71674214	0.3460	0.0000	0,0,0	0,0,0,0,0	0.3830							602272 [TCF4 (confirmed) Pitt-Hopkins syndrome,610954|Corneal dystrophy,Fuchs endothelial,3,613267];	RCV000288677.1 [benign]; 			35	111					TCF4 (inh=AD pLI=1.00)
chr18	52895531	52895531	T	C	het	anno_omim	QUAL=6755;DP=241;AF=0.50;MQM=60;TRIO=HET,241,0.50,WT,89,0.00,HOM,116,1.00	TCF4	synonymous	TCF4:ENST00000398339:synonymous:LOW:exon20/21:c.2247A>G:p.Ser749Ser,TCF4:ENST00000354452:synonymous:LOW:exon19/20:c.1941A>G:p.Ser647Ser,TCF4:ENST00000356073:synonymous:LOW:exon19/20:c.1929A>G:p.Ser643Ser,TCF4:ENST00000568673:synonymous:LOW:exon18/19:c.1869A>G:p.Ser623Ser,TCF4:ENST00000457482:synonymous:LOW:exon12/13:c.1461A>G:p.Ser487Ser,TCF4:ENST00000543082:synonymous:LOW:exon17/18:c.1803A>G:p.Ser601Ser,TCF4:ENST00000540999:synonymous:LOW:exon18/19:c.1857A>G:p.Ser619Ser,TCF4:ENST00000537578:synonymous:LOW:exon18/19:c.1869A>G:p.Ser623Ser,TCF4:ENST00000564999:synonymous:LOW:exon19/20:c.1929A>G:p.Ser643Ser,TCF4:ENST00000568740:synonymous:LOW:exon18/19:c.1854A>G:p.Ser618Ser,TCF4:ENST00000537856:synonymous:LOW:exon14/15:c.1539A>G:p.Ser513Ser,TCF4:ENST00000544241:synonymous:LOW:exon15/16:c.1728A>G:p.Ser576Ser,TCF4:ENST00000561992:synonymous:LOW:exon15/16:c.1539A>G:p.Ser513Ser,TCF4:ENST00000561831:synonymous:LOW:exon12/13:c.1449A>G:p.Ser483Ser,TCF4:ENST00000565018:synonymous:LOW:exon19/20:c.1941A>G:p.Ser647Ser,TCF4:ENST00000570287:synonymous:LOW:exon12/13:c.1449A>G:p.Ser483Ser,TCF4:ENST00000564228:synonymous:LOW:exon15/16:c.1716A>G:p.Ser572Ser,TCF4:ENST00000567880:synonymous:LOW:exon16/17:c.1749A>G:p.Ser583Ser,TCF4:ENST00000566286:synonymous:LOW:exon18/19:c.1920A>G:p.Ser640Ser,TCF4:ENST00000566279:synonymous:LOW:exon17/18:c.1761A>G:p.Ser587Ser,TCF4:ENST00000564403:synonymous:LOW:exon19/20:c.1959A>G:p.Ser653Ser,TCF4:ENST00000570177:synonymous:LOW:exon14/15:c.1539A>G:p.Ser513Ser		rs8766	0.3425	0.3714	8710,5314,549	0.3208,0.3486,0.4446,0.3966,0.2694	0.3750							602272 [TCF4 (confirmed) Pitt-Hopkins syndrome,610954|Corneal dystrophy,Fuchs endothelial,3,613267];	RCV000079460.8 [benign]; RCV000405030.1 [benign]; 			309	1003					TCF4 (inh=AD pLI=1.00)
chr18	53070914	53070914	G	A	het	pred_pathogenic;anno_omim	QUAL=20870;DP=521;AF=0.52;MQM=60;TRIO=HET,521,0.52,WT,308,0.00,HOM,416,1.00	TCF4	missense,intron	TCF4:ENST00000544241:missense:MODERATE:exon1/16:c.32C>T:p.Ala11Val,TCF4:ENST00000564228:missense:MODERATE:exon1/16:c.32C>T:p.Ala11Val,TCF4:ENST00000398339:intron:MODIFIER:exon6/20:c.611-165C>T:,TCF4:ENST00000354452:intron:MODIFIER:exon5/19:c.305-165C>T:,TCF4:ENST00000356073:intron:MODIFIER:exon5/19:c.305-165C>T:,TCF4:ENST00000568673:intron:MODIFIER:exon4/18:c.233-165C>T:,TCF4:ENST00000543082:intron:MODIFIER:exon3/17:c.179-165C>T:,TCF4:ENST00000540999:intron:MODIFIER:exon4/18:c.233-165C>T:,TCF4:ENST00000537578:intron:MODIFIER:exon4/18:c.233-165C>T:,TCF4:ENST00000564999:intron:MODIFIER:exon5/19:c.305-165C>T:,TCF4:ENST00000568740:intron:MODIFIER:exon4/18:c.233-165C>T:,TCF4:ENST00000561992:intron:MODIFIER:exon1/15:c.-86-165C>T:,TCF4:ENST00000565018:intron:MODIFIER:exon5/19:c.305-165C>T:,TCF4:ENST00000567880:intron:MODIFIER:exon4/16:c.305-165C>T:,TCF4:ENST00000566286:intron:MODIFIER:exon4/18:c.299-165C>T:,TCF4:ENST00000566279:intron:MODIFIER:exon5/17:c.305-165C>T:,TCF4:ENST00000564403:intron:MODIFIER:exon5/19:c.305-165C>T:		rs17522826	0.1923	0.2173	695,261,8	0.0581,0.3050,0.5260,0.2326,0.1536	0.2124	2.9740	D	T	B	T	14.22	602272 [TCF4 (confirmed) Pitt-Hopkins syndrome,610954|Corneal dystrophy,Fuchs endothelial,3,613267];	RCV000147721.1 [likely benign]; 			82	637					TCF4 (inh=AD pLI=1.00)
chr18	53303101	53303101	C	G	hom	anno_omim	QUAL=14562;DP=180;AF=1.00;MQM=59;TRIO=HOM,180,1.00,HOM,106,1.00,HOM,164,1.00	TCF4,RPL21P126	missense,non_coding_transcript_exon	TCF4:ENST00000398339:missense:MODERATE:exon1/21:c.28G>C:p.Ala10Pro,RPL21P126:ENST00000470049:non_coding_transcript_exon:MODIFIER:exon1/1:n.38C>G:		rs611326	0.9968	0.9994	23663,11825,1809	0.9924,1.0000,1.0000,1.0000,0.9999	0.9996	1.4190	T	T	B	T	2.45	602272 [TCF4 (confirmed) Pitt-Hopkins syndrome,610954|Corneal dystrophy,Fuchs endothelial,3,613267];				1984	0	2	[2] Stefanie Beck-Woedl 30.07.2015			TCF4 (inh=AD pLI=1.00), RPL21P126 (inh=n/a pLI=n/a)
chr18	53303150	53303150	T	C	het	anno_omim	QUAL=3390;DP=124;AF=0.55;MQM=60;TRIO=HET,124,0.55,WT,91,0.00,HET,129,0.52	TCF4,RPL21P126	5'UTR_premature_start_codon_gain,5'UTR,non_coding_transcript_exon	TCF4:ENST00000398339:5'UTR_premature_start_codon_gain:LOW:exon1/21:c.-22A>G:,TCF4:ENST00000398339:5'UTR:MODIFIER:exon1/21:c.-22A>G:,RPL21P126:ENST00000470049:non_coding_transcript_exon:MODIFIER:exon1/1:n.87T>C:	OldhAT1	rs77891683	0.0048	0.0167	4,4,0	0.0033,0.0149,0.0005,0.0304,0.0006	0.0119							602272 [TCF4 (confirmed) Pitt-Hopkins syndrome,610954|Corneal dystrophy,Fuchs endothelial,3,613267];				1	48					TCF4 (inh=AD pLI=1.00), RPL21P126 (inh=n/a pLI=n/a)
chr18	55313705	55313705	T	-	het	anno_omim	QUAL=1262;DP=99;AF=0.45;MQM=60;TRIO=HET,99,0.45,WT,19,0.00,HET,40,0.30	ATP8B1,RP11-35G9.5,RP11-35G9.3	3'UTR	ATP8B1:ENST00000283684:3'UTR:MODIFIER:exon27/27:c.*2015delA:,ATP8B1:ENST00000536015:3'UTR:MODIFIER:exon28/28:c.*2015delA:		rs35833803	0.1753	0.0000	0,0,0	0,0,0,0,0	0.1706							602397 [ATP8B1 (provisional) Cholestasis,progressive familial intrahepatic 1,211600|Cholestasis,benign recurrent intrahepatic,243300|Cholestasis,intrahepatic,of pregnancy,1,147480];	RCV000403606.1 [benign]; 			3	50					ATP8B1 (inh=AR+AD pLI=0.00), RP11-35G9.5 (inh=n/a pLI=n/a), RP11-35G9.3 (inh=n/a pLI=n/a)
chr18	55314211	55314211	T	C	het	anno_omim	QUAL=2550;DP=143;AF=0.50;MQM=60;TRIO=HET,143,0.50,WT,34,0.00,HET,60,0.48	ATP8B1,RP11-35G9.5,RP11-35G9.3	3'UTR	ATP8B1:ENST00000283684:3'UTR:MODIFIER:exon27/27:c.*1509A>G:,ATP8B1:ENST00000536015:3'UTR:MODIFIER:exon28/28:c.*1509A>G:		rs1968274	0.3085	0.0000	0,0,0	0,0,0,0,0	0.2538							602397 [ATP8B1 (provisional) Cholestasis,progressive familial intrahepatic 1,211600|Cholestasis,benign recurrent intrahepatic,243300|Cholestasis,intrahepatic,of pregnancy,1,147480];	RCV000262371.1 [benign]; 			15	79					ATP8B1 (inh=AR+AD pLI=0.00), RP11-35G9.5 (inh=n/a pLI=n/a), RP11-35G9.3 (inh=n/a pLI=n/a)
chr18	55314820	55314820	C	A	het	anno_omim	QUAL=6789;DP=310;AF=0.52;MQM=60;TRIO=HET,310,0.52,WT,167,0.00,HET,216,0.41	ATP8B1,RP11-35G9.5,RP11-35G9.3	3'UTR	ATP8B1:ENST00000283684:3'UTR:MODIFIER:exon27/27:c.*900G>T:,ATP8B1:ENST00000536015:3'UTR:MODIFIER:exon28/28:c.*900G>T:		rs4940950	0.4661	0.0000	0,0,0	0,0,0,0,0	0.4645							602397 [ATP8B1 (provisional) Cholestasis,progressive familial intrahepatic 1,211600|Cholestasis,benign recurrent intrahepatic,243300|Cholestasis,intrahepatic,of pregnancy,1,147480];	RCV000380280.1 [benign]; 			60	112					ATP8B1 (inh=AR+AD pLI=0.00), RP11-35G9.5 (inh=n/a pLI=n/a), RP11-35G9.3 (inh=n/a pLI=n/a)
chr18	55317676	55317676	C	T	hom	pred_pathogenic;anno_omim	QUAL=32297;DP=351;AF=1.00;MQM=60;TRIO=HOM,351,1.00,HOM,298,1.00,HOM,377,1.00	ATP8B1,RP11-35G9.5,RP11-35G9.3	missense	ATP8B1:ENST00000283684:missense:MODERATE:exon26/27:c.3454G>A:p.Ala1152Thr,ATP8B1:ENST00000536015:missense:MODERATE:exon27/28:c.3454G>A:p.Ala1152Thr		rs222581	0.9998	0.9997	60671,33368,5171	0.9969,0.9999,1.0000,1.0000,1.0000	0.9998	2.0100	T,T	T	B	T,T	8.37	602397 [ATP8B1 (provisional) Cholestasis,progressive familial intrahepatic 1,211600|Cholestasis,benign recurrent intrahepatic,243300|Cholestasis,intrahepatic,of pregnancy,1,147480];				2117	0					ATP8B1 (inh=AR+AD pLI=0.00), RP11-35G9.5 (inh=n/a pLI=n/a), RP11-35G9.3 (inh=n/a pLI=n/a)
chr18	55362532	55362532	T	G	hom	anno_omim	QUAL=16478;DP=252;AF=1.00;MQM=60;TRIO=HOM,252,1.00,HOM,94,1.00,HOM,148,1.00	ATP8B1,RP11-35G9.5,RP11-35G9.3	synonymous	ATP8B1:ENST00000283684:synonymous:LOW:exon9/27:c.811A>C:p.Arg271Arg,ATP8B1:ENST00000536015:synonymous:LOW:exon10/28:c.811A>C:p.Arg271Arg		rs319443	0.9926	0.9972	60322,33323,4892	0.9702,0.9985,0.9998,0.9998,0.9999	0.9979							602397 [ATP8B1 (provisional) Cholestasis,progressive familial intrahepatic 1,211600|Cholestasis,benign recurrent intrahepatic,243300|Cholestasis,intrahepatic,of pregnancy,1,147480];	RCV000252875.1 [benign]; RCV000366441.1 [benign]; 			2117	1					ATP8B1 (inh=AR+AD pLI=0.00), RP11-35G9.5 (inh=n/a pLI=n/a), RP11-35G9.3 (inh=n/a pLI=n/a)
chr18	55364852	55364852	A	G	hom	anno_omim	QUAL=32554;DP=443;AF=1.00;MQM=59;TRIO=HOM,443,1.00,HOM,253,1.00,HOM,338,1.00	ATP8B1,RP11-35G9.5,RP11-35G9.3	splice_region&synonymous	ATP8B1:ENST00000283684:splice_region&synonymous:LOW:exon7/27:c.696T>C:p.Asp232Asp,ATP8B1:ENST00000536015:splice_region&synonymous:LOW:exon8/28:c.696T>C:p.Asp232Asp		rs319438	0.9946	0.9980	60416,33333,4978	0.9801,0.9988,0.9998,0.9997,0.9999	0.9985							602397 [ATP8B1 (provisional) Cholestasis,progressive familial intrahepatic 1,211600|Cholestasis,benign recurrent intrahepatic,243300|Cholestasis,intrahepatic,of pregnancy,1,147480];	RCV000243388.1 [benign]; RCV000313084.1 [benign]; 			2116	2					ATP8B1 (inh=AR+AD pLI=0.00), RP11-35G9.5 (inh=n/a pLI=n/a), RP11-35G9.3 (inh=n/a pLI=n/a)
chr18	77473127	77473127	C	T	hom	anno_omim	QUAL=11794;DP=188;AF=1.00;MQM=59;TRIO=HOM,188,1.00,HET,192,0.53,HET,232,0.54	CTDP1	missense	CTDP1:ENST00000299543:missense:MODERATE:exon7/13:c.1019C>T:p.Thr340Met,CTDP1:ENST00000075430:missense:MODERATE:exon7/12:c.1019C>T:p.Thr340Met		rs2279103	0.0827	0.1397	1387,1090,9	0.0325,0.0753,0.1250,0.1809,0.0729	0.1385	0.0990	T,T	T	B,B,B	T,T	10.18	604927 [CTDP1 (provisional) Congenital cataracts,facial dysmorphism,and neuropathy,604168];	RCV000246925.1 [benign]; 			36	499					CTDP1 (inh=AR pLI=0.92)
chr18	77513721	77513721	T	C	hom	anno_omim	QUAL=37390;DP=267;AF=0.99;MQM=59;TRIO=HOM,267,0.99,HOM,397,1.00,HOM,549,1.00	CTDP1	synonymous,3'UTR	CTDP1:ENST00000299543:synonymous:LOW:exon13/13:c.2817T>C:p.Asp939Asp,CTDP1:ENST00000075430:3'UTR:MODIFIER:exon12/12:c.*50T>C:		rs626169	0.8952	0.9666	56942,32743,2566	0.7018,0.9794,0.9998,0.9925,0.9874	0.9717							604927 [CTDP1 (provisional) Congenital cataracts,facial dysmorphism,and neuropathy,604168];	RCV000116845.3 [other]; 		COSM4131107	2065	49					CTDP1 (inh=AR pLI=0.92)
chr18	77513841	77513841	G	A	hom	anno_omim	QUAL=15305;DP=276;AF=0.99;MQM=59;TRIO=HOM,276,0.99,HET,252,0.48,HET,343,0.47	CTDP1	3'UTR	CTDP1:ENST00000299543:3'UTR:MODIFIER:exon13/13:c.*51G>A:,CTDP1:ENST00000075430:3'UTR:MODIFIER:exon12/12:c.*170G>A:		rs76088733	0.1306	0.2104	1814,1267,30	0.1014,0.0995,0.1128,0.2471,0.2259	0.1898							604927 [CTDP1 (provisional) Congenital cataracts,facial dysmorphism,and neuropathy,604168];				71	618					CTDP1 (inh=AR pLI=0.92)
chr19	863356	863356	C	T	het	anno_omim	QUAL=10057;DP=318;AF=0.52;MQM=59;TRIO=HET,318,0.52,HET,449,0.53,WT,568,0.00	CFD	3'UTR	CFD:ENST00000327726:3'UTR:MODIFIER:exon5/5:c.*118C>T:	AluJr	rs10506	0.2754	0.0000	0,0,0	0,0,0,0,0	0.1584							134350 [CFD (confirmed) Complement factor D deficiency,613912];				10	122					CFD (inh=AR pLI=0.02)
chr19	1388538	1388538	C	T	het	anno_omim	QUAL=3508;DP=69;AF=0.57;MQM=59;TRIO=HET,69,0.57,HOM,52,1.00,HET,72,0.56	NDUFS7	missense	NDUFS7:ENST00000414651:missense:MODERATE:exon3/7:c.68C>T:p.Pro23Leu,NDUFS7:ENST00000546283:missense:MODERATE:exon4/8:c.68C>T:p.Pro23Leu,NDUFS7:ENST00000233627:missense:MODERATE:exon3/8:c.68C>T:p.Pro23Leu,NDUFS7:ENST00000539480:missense:MODERATE:exon3/8:c.68C>T:p.Pro23Leu,NDUFS7:ENST00000313408:missense:MODERATE:exon3/7:c.68C>T:p.Pro23Leu		rs1142530	0.4557	0.5502	17944,11720,688	0.3874,0.5063,0.3044,0.6089,0.5803	0.5471	0.8850	T,T,T,T,T,T,T	T	B,B,B	T,T,T,T,T	4.17	601825 [NDUFS7 (provisional) Leigh syndrome,256000];	RCV000117716.2 [likely benign]; RCV000342300.1 [likely benign]; RCV000407392.1 [likely benign]; 		COSM4131259	812	1018					NDUFS7 (inh=AR pLI=0.75)
chr19	1398750	1398750	C	T	het	anno_omim	QUAL=8871;DP=308;AF=0.48;MQM=59;TRIO=HET,308,0.48,WT,350,0.00,HET,408,0.52	GAMT	synonymous,intron	GAMT:ENST00000447102:synonymous:LOW:exon5/5:c.735G>A:p.Ala245Ala,GAMT:ENST00000252288:intron:MODIFIER:exon5/5:c.570+165G>A:		rs74253480	0.0114	0.0101	2,1,0	0.0033,0.0153,0.0677,0.0188,0.0024	0.0102							601240 [GAMT (provisional) Cerebral creatine deficiency syndrome 2,612736];	RCV000125193.2 [benign]; 			0	34					GAMT (inh=AR pLI=0.00)
chr19	3631036	3631036	A	G	hom	anno_omim	QUAL=25253;DP=288;AF=1.00;MQM=59;TRIO=HOM,288,1.00,HOM,211,1.00,HOM,293,1.00	PIP5K1C	3'UTR	PIP5K1C:ENST00000335312:3'UTR:MODIFIER:exon18/18:c.*2129T>C:		rs4807493	0.8508	0.0000	0,0,0	0,0,0,0,0	0.8499							606102 [PIP5K1C (provisional) Lethal congenital contractural syndrome 3,611369];				163	62					PIP5K1C (inh=AR pLI=0.86)
chr19	3631569	3631569	C	G	hom	anno_omim	QUAL=1069;DP=33;AF=0.91;MQM=59;TRIO=HOM,33,0.91,HET,5,0.80,HOM,5,1.00	PIP5K1C	3'UTR	PIP5K1C:ENST00000335312:3'UTR:MODIFIER:exon18/18:c.*1596G>C:		rs4807494	0.8452	0.0000	0,0,0	0,0,0,0,0	0.8475							606102 [PIP5K1C (provisional) Lethal congenital contractural syndrome 3,611369];				149	60					PIP5K1C (inh=AR pLI=0.86)
chr19	3631694	3631694	G	A	hom	anno_omim	QUAL=2851;DP=66;AF=0.98;MQM=59;TRIO=HOM,66,0.98,HET,29,0.72,HOM,26,1.00	PIP5K1C	3'UTR	PIP5K1C:ENST00000335312:3'UTR:MODIFIER:exon18/18:c.*1471C>T:		rs4806946	0.3980	0.0000	0,0,0	0,0,0,0,0	0.4765							606102 [PIP5K1C (provisional) Lethal congenital contractural syndrome 3,611369];				98	98					PIP5K1C (inh=AR pLI=0.86)
chr19	3653525	3653525	C	T	het	anno_omim	QUAL=28340;DP=177;AF=0.45;MQM=59;TRIO=HET,177,0.45,HET,487,0.55,HOM,642,1.00	PIP5K1C	synonymous	PIP5K1C:ENST00000589578:synonymous:LOW:exon7/17:c.684G>A:p.Ser228Ser,PIP5K1C:ENST00000335312:synonymous:LOW:exon7/18:c.684G>A:p.Ser228Ser,PIP5K1C:ENST00000539785:synonymous:LOW:exon7/17:c.684G>A:p.Ser228Ser,PIP5K1C:ENST00000537021:synonymous:LOW:exon7/17:c.684G>A:p.Ser228Ser		rs2074957	0.5429	0.5603	19550,10423,1113	0.4617,0.7461,0.7002,0.5615,0.4169	0.5686							606102 [PIP5K1C (provisional) Lethal congenital contractural syndrome 3,611369];			COSM4131725	682	1013					PIP5K1C (inh=AR pLI=0.86)
chr19	4090422	4090422	G	T	het	anno_omim	QUAL=4652;DP=119;AF=0.52;MQM=59;TRIO=HET,119,0.52,HET,278,0.52,WT,363,0.00	MAP2K2	3'UTR	MAP2K2:ENST00000262948:3'UTR:MODIFIER:exon11/11:c.*174C>A:,MAP2K2:ENST00000394867:3'UTR:MODIFIER:exon12/12:c.*174C>A:		rs6630	0.1717	0.0000	0,0,0	0,0,0,0,0	0.1846							601263 [MAP2K2 (provisional) Cardiofaciocutaneous syndrome 4,615280];				1	32					MAP2K2 (inh=AD pLI=0.86)
chr19	4101062	4101062	G	T	het	anno_omim	QUAL=3999;DP=104;AF=0.51;MQM=53;TRIO=HET,104,0.51,HOM,94,1.00,WT,147,0.01	MAP2K2	synonymous	MAP2K2:ENST00000262948:synonymous:LOW:exon6/11:c.660C>A:p.Ile220Ile,MAP2K2:ENST00000394867:synonymous:LOW:exon7/12:c.369C>A:p.Ile123Ile		rs10250	0.4333	0.5472	8097,4588,241	0.3578,0.6709,0.6616,0.5702,0.4412	0.4783							601263 [MAP2K2 (provisional) Cardiofaciocutaneous syndrome 4,615280];	RCV000039490.3 [benign]; RCV000149846.1 [benign]; 		COSM439538, COSM1481088	460	1091					MAP2K2 (inh=AD pLI=0.86)
chr19	4102449	4102449	G	A	het	anno_omim	QUAL=6916;DP=138;AF=0.48;MQM=59;TRIO=HET,138,0.48,WT,322,0.00,HET,435,0.49	MAP2K2	splice_region&synonymous	MAP2K2:ENST00000262948:splice_region&synonymous:LOW:exon4/11:c.453C>T:p.Asp151Asp,MAP2K2:ENST00000394867:splice_region&synonymous:LOW:exon5/12:c.162C>T:p.Asp54Asp		rs17851657	0.1112	0.2315	1446,1006,11	0.0597,0.1468,0.0526,0.2757,0.2531	0.1639							601263 [MAP2K2 (provisional) Cardiofaciocutaneous syndrome 4,615280];	RCV000039484.3 [benign]; RCV000149845.3 [benign]; 		COSM4131862, COSM1129849	92	742					MAP2K2 (inh=AD pLI=0.86)
chr19	4117528	4117528	G	A	het	anno_omim	QUAL=4190;DP=181;AF=0.47;MQM=57;TRIO=HET,181,0.47,HET,176,0.51,WT,236,0.00	MAP2K2	synonymous,5'UTR_premature_start_codon_gain,5'UTR	MAP2K2:ENST00000262948:synonymous:LOW:exon2/11:c.192C>T:p.Val64Val,MAP2K2:ENST00000394867:5'UTR_premature_start_codon_gain:LOW:exon3/12:c.-100C>T:,MAP2K2:ENST00000394867:5'UTR:MODIFIER:exon3/12:c.-100C>T:		rs8157	0.0583	0.0619	294,157,25	0.0762,0.0284,0.0222,0.0650,0.0777	0.0710							601263 [MAP2K2 (provisional) Cardiofaciocutaneous syndrome 4,615280];	RCV000039473.3 [benign]; 			10	250					MAP2K2 (inh=AD pLI=0.86)
chr19	5891299	5891299	C	T	het	anno_omim	QUAL=935;DP=41;AF=0.49;MQM=59;TRIO=HET,41,0.49,WT,21,0.00,HOM,22,0.95	NDUFA11,FUT5,AC024592.12	3'UTR,intron	NDUFA11:ENST00000418389:3'UTR:MODIFIER:exon4/4:c.*1629G>A:,FUT5:ENST00000252675:intron:MODIFIER:exon3/4:c.-172+5165G>A:	AluSx1	rs1674158	0.4750	0.0000	0,0,0	0,0,0,0,0	0.4058							612638 [NDUFA11 (provisional) Mitochondrial complex I deficiency,252010];				25	69					NDUFA11 (inh=n/a pLI=0.54), FUT5 (inh=n/a pLI=0.00), AC024592.12 (inh=n/a pLI=n/a)
chr19	5891746	5891746	G	C	hom	anno_omim	QUAL=15158;DP=143;AF=1.00;MQM=59;TRIO=HOM,143,1.00,HET,229,0.46,HOM,268,1.00	NDUFA11,FUT5,AC024592.12	3'UTR,intron	NDUFA11:ENST00000418389:3'UTR:MODIFIER:exon4/4:c.*1182C>G:,FUT5:ENST00000252675:intron:MODIFIER:exon3/4:c.-172+4718C>G:	L2b	rs1678866	0.6272	0.0000	0,0,0	0,0,0,0,0	0.6011							612638 [NDUFA11 (provisional) Mitochondrial complex I deficiency,252010];				63	67					NDUFA11 (inh=n/a pLI=0.54), FUT5 (inh=n/a pLI=0.00), AC024592.12 (inh=n/a pLI=n/a)
chr19	5892267	5892267	G	T	het	anno_omim	QUAL=2609;DP=119;AF=0.52;MQM=59;TRIO=HET,119,0.52,HET,104,0.49,WT,170,0.01	NDUFA11,FUT5,AC024592.12	3'UTR,intron	NDUFA11:ENST00000418389:3'UTR:MODIFIER:exon4/4:c.*661C>A:,FUT5:ENST00000252675:intron:MODIFIER:exon3/4:c.-172+4197C>A:		rs74500071	0.0980	0.0000	0,0,0	0,0,0,0,0	0.1345							612638 [NDUFA11 (provisional) Mitochondrial complex I deficiency,252010];				3	29					NDUFA11 (inh=n/a pLI=0.54), FUT5 (inh=n/a pLI=0.00), AC024592.12 (inh=n/a pLI=n/a)
chr19	5892317	5892317	C	T	hom	anno_omim	QUAL=8557;DP=79;AF=0.97;MQM=60;TRIO=HOM,79,0.97,HET,86,0.51,HOM,173,0.99	NDUFA11,FUT5,AC024592.12	3'UTR,intron	NDUFA11:ENST00000418389:3'UTR:MODIFIER:exon4/4:c.*611G>A:,FUT5:ENST00000252675:intron:MODIFIER:exon3/4:c.-172+4147G>A:		rs1626918	0.6410	0.0000	0,0,0	0,0,0,0,0	0.6138							612638 [NDUFA11 (provisional) Mitochondrial complex I deficiency,252010];				457	550					NDUFA11 (inh=n/a pLI=0.54), FUT5 (inh=n/a pLI=0.00), AC024592.12 (inh=n/a pLI=n/a)
chr19	5892382	5892382	C	T	hom	anno_omim	QUAL=7545;DP=70;AF=1.00;MQM=60;TRIO=HOM,70,1.00,HET,65,0.46,HOM,151,1.00	NDUFA11,FUT5,AC024592.12	3'UTR,intron	NDUFA11:ENST00000418389:3'UTR:MODIFIER:exon4/4:c.*546G>A:,FUT5:ENST00000252675:intron:MODIFIER:exon3/4:c.-172+4082G>A:		rs1678867	0.7272	0.0000	0,0,0	0,0,0,0,0	0.6615							612638 [NDUFA11 (provisional) Mitochondrial complex I deficiency,252010];				674	644					NDUFA11 (inh=n/a pLI=0.54), FUT5 (inh=n/a pLI=0.00), AC024592.12 (inh=n/a pLI=n/a)
chr19	5892433	5892433	C	T	het	anno_omim	QUAL=4248;DP=84;AF=0.48;MQM=60;TRIO=HET,84,0.48,WT,51,0.02,HOM,114,0.99	NDUFA11,FUT5,AC024592.12	3'UTR,intron	NDUFA11:ENST00000418389:3'UTR:MODIFIER:exon4/4:c.*495G>A:,FUT5:ENST00000252675:intron:MODIFIER:exon3/4:c.-172+4031G>A:		rs1627779	0.4742	0.0000	0,0,0	0,0,0,0,0	0.4055							612638 [NDUFA11 (provisional) Mitochondrial complex I deficiency,252010];				267	712					NDUFA11 (inh=n/a pLI=0.54), FUT5 (inh=n/a pLI=0.00), AC024592.12 (inh=n/a pLI=n/a)
chr19	5892486	5892486	C	T	hom	anno_omim	QUAL=7001;DP=80;AF=1.00;MQM=59;TRIO=HOM,80,1.00,HET,68,0.57,HOM,119,1.00	NDUFA11,FUT5,AC024592.12	3'UTR,intron	NDUFA11:ENST00000418389:3'UTR:MODIFIER:exon4/4:c.*442G>A:,FUT5:ENST00000252675:intron:MODIFIER:exon3/4:c.-172+3978G>A:		rs1628564	0.5839	0.0000	0,0,0	0,0,0,0,0	0.5362							612638 [NDUFA11 (provisional) Mitochondrial complex I deficiency,252010];				489	736					NDUFA11 (inh=n/a pLI=0.54), FUT5 (inh=n/a pLI=0.00), AC024592.12 (inh=n/a pLI=n/a)
chr19	5892568	5892568	G	T	hom	anno_omim	QUAL=8458;DP=121;AF=0.98;MQM=59;TRIO=HOM,121,0.98,HET,85,0.54,HOM,116,1.00	NDUFA11,FUT5,AC024592.12	3'UTR,intron	NDUFA11:ENST00000418389:3'UTR:MODIFIER:exon4/4:c.*360C>A:,FUT5:ENST00000252675:intron:MODIFIER:exon3/4:c.-172+3896C>A:		rs1629368	0.5759	0.0000	0,0,0	0,0,0,0,0	0.5287							612638 [NDUFA11 (provisional) Mitochondrial complex I deficiency,252010];				486	735					NDUFA11 (inh=n/a pLI=0.54), FUT5 (inh=n/a pLI=0.00), AC024592.12 (inh=n/a pLI=n/a)
chr19	5892585	5892585	G	A	het	anno_omim	QUAL=2268;DP=128;AF=0.41;MQM=59;TRIO=HET,128,0.41,HET,84,0.55,WT,126,0.00	NDUFA11,FUT5,AC024592.12	3'UTR,intron	NDUFA11:ENST00000418389:3'UTR:MODIFIER:exon4/4:c.*343C>T:,FUT5:ENST00000252675:intron:MODIFIER:exon3/4:c.-172+3879C>T:		rs60236148	0.0891	0.0000	0,0,0	0,0,0,0,0	0.1112							612638 [NDUFA11 (provisional) Mitochondrial complex I deficiency,252010];				37	329					NDUFA11 (inh=n/a pLI=0.54), FUT5 (inh=n/a pLI=0.00), AC024592.12 (inh=n/a pLI=n/a)
chr19	5892743	5892743	C	T	het	anno_omim	QUAL=6632;DP=112;AF=0.46;MQM=59;TRIO=HET,112,0.46,WT,124,0.01,HOM,182,1.00	NDUFA11,FUT5,AC024592.12	3'UTR,intron	NDUFA11:ENST00000418389:3'UTR:MODIFIER:exon4/4:c.*185G>A:,FUT5:ENST00000252675:intron:MODIFIER:exon3/4:c.-172+3721G>A:		rs10432306	0.4127	0.0000	0,0,0	0,0,0,0,0	0.3507							612638 [NDUFA11 (provisional) Mitochondrial complex I deficiency,252010];				268	701					NDUFA11 (inh=n/a pLI=0.54), FUT5 (inh=n/a pLI=0.00), AC024592.12 (inh=n/a pLI=n/a)
chr19	5892770	5892770	C	T	hom	anno_omim	QUAL=12453;DP=107;AF=1.00;MQM=59;TRIO=HOM,107,1.00,HET,143,0.48,HOM,234,1.00	NDUFA11,FUT5,AC024592.12	3'UTR,intron	NDUFA11:ENST00000418389:3'UTR:MODIFIER:exon4/4:c.*158G>A:,FUT5:ENST00000252675:intron:MODIFIER:exon3/4:c.-172+3694G>A:		rs1631032	0.5859	0.0000	0,0,0	0,0,0,0,0	0.5415							612638 [NDUFA11 (provisional) Mitochondrial complex I deficiency,252010];				486	739					NDUFA11 (inh=n/a pLI=0.54), FUT5 (inh=n/a pLI=0.00), AC024592.12 (inh=n/a pLI=n/a)
chr19	5892954	5892954	T	C	het	pred_pathogenic;anno_omim	QUAL=12720;DP=174;AF=0.44;MQM=60;TRIO=HET,174,0.44,WT,272,0.00,HOM,352,0.99	NDUFA11,FUT5,AC024592.12	missense,intron	NDUFA11:ENST00000418389:missense:MODERATE:exon4/4:c.661A>G:p.Thr221Ala,FUT5:ENST00000252675:intron:MODIFIER:exon3/4:c.-172+3510A>G:	MIR	rs1678868	0.4770	0.5216	417,145,19	0.3131,0.0000,0.0000,0.4911,0.6163	0.4889	-0.0270	D	T	B		0.02	612638 [NDUFA11 (provisional) Mitochondrial complex I deficiency,252010];				369	923					NDUFA11 (inh=n/a pLI=0.54), FUT5 (inh=n/a pLI=0.00), AC024592.12 (inh=n/a pLI=n/a)
chr19	5903807	5903807	G	T	hom	anno_omim	QUAL=26139;DP=194;AF=0.97;MQM=59;TRIO=HOM,194,0.97,HET,375,0.53,HOM,560,1.00	NDUFA11				rs8108064	0.6815	0.6750	4379,1717,478	0.6383,0.7663,0.7247,0.6656,0.6887	0.6827							612638 [NDUFA11 (provisional) Mitochondrial complex I deficiency,252010];	RCV000294085.1 [likely benign]; 			372	409					NDUFA11 (inh=n/a pLI=0.54)
chr19	5903936	5903936	T	C	hom	anno_omim	QUAL=14537;DP=79;AF=0.99;MQM=59;TRIO=HOM,79,0.99,HET,204,0.55,HOM,312,1.00	NDUFA11				rs1056987	0.7266	0.7489	3262,674,101	0.7014,0.0000,0.0000,0.6746,0.7807	0.7288							612638 [NDUFA11 (provisional) Mitochondrial complex I deficiency,252010];	RCV000336107.1 [likely benign]; 			315	267					NDUFA11 (inh=n/a pLI=0.54)
chr19	6677989	6677989	G	A	het	anno_omim	QUAL=22178;DP=302;AF=0.49;MQM=59;TRIO=HET,302,0.49,HOM,390,1.00,HET,461,0.52	C3	synonymous	C3:ENST00000245907:synonymous:LOW:exon41/41:c.4896C>T:p.Pro1632Pro		rs17030	0.5329	0.5241	16781,8886,1266	0.4924,0.5020,0.5431,0.5169,0.5937	0.5241							120700 [C3 (confirmed) C3 deficiency,613779|Hemolytic uremic syndrome,atypical,susceptibility to,5,612925|Macular degeneration,age-related,9,611378];	RCV000283840.1 [benign]; RCV000323725.1 [benign]; RCV000378258.1 [benign]; 		COSM3766459	600	1019					C3 (inh=AR pLI=1.00)
chr19	6679511	6679511	C	T	het	anno_omim	QUAL=19508;DP=352;AF=0.53;MQM=59;TRIO=HET,352,0.53,HOM,319,1.00,HET,381,0.52	C3	splice_region&intron	C3:ENST00000245907:splice_region&intron:LOW:exon36/40:c.4457-4G>A:		rs2277984	0.5244	0.5215	16622,8906,1034	0.4503,0.5023,0.5457,0.5173,0.5976	0.5221							120700 [C3 (confirmed) C3 deficiency,613779|Hemolytic uremic syndrome,atypical,susceptibility to,5,612925|Macular degeneration,age-related,9,611378];	RCV000261116.1 [benign]; RCV000316465.1 [benign]; RCV000389627.1 [benign]; 			599	1020					C3 (inh=AR pLI=1.00)
chr19	6696597	6696597	G	A	hom	anno_omim	QUAL=37916;DP=282;AF=0.99;MQM=59;TRIO=HOM,282,0.99,HOM,472,1.00,HOM,524,1.00	C3	splice_region&intron	C3:ENST00000245907:splice_region&intron:LOW:exon22/40:c.2863+7C>T:		rs2287845	0.7324	0.6666	27443,12486,2543	0.7032,0.8210,0.8381,0.6111,0.7096	0.6723							120700 [C3 (confirmed) C3 deficiency,613779|Hemolytic uremic syndrome,atypical,susceptibility to,5,612925|Macular degeneration,age-related,9,611378];	RCV000281934.1 [benign]; RCV000317538.1 [benign]; RCV000374021.1 [benign]; 			893	946					C3 (inh=AR pLI=1.00)
chr19	6697406	6697406	A	G	hom	anno_omim	QUAL=14949;DP=208;AF=0.99;MQM=59;TRIO=HOM,208,0.99,HOM,140,1.00,HOM,138,1.00	C3	synonymous	C3:ENST00000245907:synonymous:LOW:exon21/41:c.2745T>C:p.Ala915Ala		rs423490	0.8149	0.7889	37958,19091,2952	0.7561,0.8969,0.9118,0.7564,0.8121	0.7960							120700 [C3 (confirmed) C3 deficiency,613779|Hemolytic uremic syndrome,atypical,susceptibility to,5,612925|Macular degeneration,age-related,9,611378];	RCV000308367.1 [benign]; RCV000342250.1 [benign]; RCV000394673.1 [benign]; 			1264	728					C3 (inh=AR pLI=1.00)
chr19	6702157	6702157	C	G	hom	anno_omim	QUAL=22860;DP=239;AF=0.98;MQM=59;TRIO=HOM,239,0.98,HOM,205,1.00,HOM,270,1.00	C3	synonymous	C3:ENST00000245907:synonymous:LOW:exon19/41:c.2421G>C:p.Val807Val		rs428453	0.7324	0.6664	27406,12467,2524	0.7012,0.8207,0.8375,0.6109,0.7100	0.6723							120700 [C3 (confirmed) C3 deficiency,613779|Hemolytic uremic syndrome,atypical,susceptibility to,5,612925|Macular degeneration,age-related,9,611378];	RCV000291985.1 [benign]; RCV000344527.1 [benign]; RCV000382623.1 [benign]; 		COSM3757394	893	945					C3 (inh=AR pLI=1.00)
chr19	6702598	6702598	G	A	hom	anno_omim	QUAL=20082;DP=187;AF=0.99;MQM=60;TRIO=HOM,187,0.99,HOM,193,1.00,HOM,265,1.00	C3	splice_region&intron	C3:ENST00000245907:splice_region&intron:LOW:exon17/40:c.2246-8C>T:		rs406514	0.8149	0.7888	37935,19094,2939	0.7542,0.8967,0.9119,0.7566,0.8115	0.7958							120700 [C3 (confirmed) C3 deficiency,613779|Hemolytic uremic syndrome,atypical,susceptibility to,5,612925|Macular degeneration,age-related,9,611378];	RCV000277187.1 [benign]; RCV000297613.1 [benign]; RCV000369463.1 [benign]; 			1263	728					C3 (inh=AR pLI=1.00)
chr19	7112265	7112265	G	A	het	anno_omim	QUAL=201;DP=26;AF=0.38;MQM=60;TRIO=HET,26,0.38,WT,3,0.00,HOM,1,1.00	ZNF557,INSR	intergenic_region	INSR:ENSG00000130544-ENSG00000171105:intergenic_region:MODIFIER::n.7112265G>A:		rs12150997	0.3019	0.0000	0,0,0	0,0,0,0,0	0.2245							147670 [INSR (confirmed) Leprechaunism,246200|Rabson-Mendenhall syndrome,262190|Diabetes mellitus,insulin-resistant,with acanthosis nigricans,610549|Hyperinsulinemic hypoglycemia,familial,5,609968];	RCV000313887.1 [benign]; RCV000370897.1 [benign]; RCV000395881.1 [benign]; 			10	59					ZNF557 (inh=n/a pLI=0.00), INSR (inh=AR+AD pLI=0.19)
chr19	7112593	7112593	G	A	het	anno_omim	QUAL=9762;DP=316;AF=0.50;MQM=59;TRIO=HET,316,0.50,WT,138,0.00,HOM,190,0.99	INSR	3'UTR	INSR:ENST00000341500:3'UTR:MODIFIER:exon21/21:c.*4474C>T:		rs1052371	0.3075	0.0000	0,0,0	0,0,0,0,0	0.2255							147670 [INSR (confirmed) Leprechaunism,246200|Rabson-Mendenhall syndrome,262190|Diabetes mellitus,insulin-resistant,with acanthosis nigricans,610549|Hyperinsulinemic hypoglycemia,familial,5,609968];	RCV000311008.1 [benign]; RCV000355368.1 [benign]; RCV000398125.1 [benign]; 			12	84					INSR (inh=AR+AD pLI=0.19)
chr19	7112645	7112645	C	A	het	anno_omim	QUAL=6610;DP=240;AF=0.48;MQM=60;TRIO=HET,240,0.48,WT,181,0.00,HET,265,0.54	INSR	3'UTR	INSR:ENST00000341500:3'UTR:MODIFIER:exon21/21:c.*4422G>T:		rs12642	0.1248	0.0000	0,0,0	0,0,0,0,0	0.1076							147670 [INSR (confirmed) Leprechaunism,246200|Rabson-Mendenhall syndrome,262190|Diabetes mellitus,insulin-resistant,with acanthosis nigricans,610549|Hyperinsulinemic hypoglycemia,familial,5,609968];	RCV000275766.1 [benign]; RCV000307297.1 [benign]; RCV000367915.1 [benign]; 			8	77					INSR (inh=AR+AD pLI=0.19)
chr19	7114213	7114213	C	A	het	anno_omim	QUAL=7488;DP=338;AF=0.41;MQM=60;TRIO=HET,338,0.41,WT,265,0.00,HET,347,0.48	INSR	3'UTR	INSR:ENST00000341500:3'UTR:MODIFIER:exon21/21:c.*2854G>T:		rs1864193	0.1282	0.0000	0,0,0	0,0,0,0,0	0.1083							147670 [INSR (confirmed) Leprechaunism,246200|Rabson-Mendenhall syndrome,262190|Diabetes mellitus,insulin-resistant,with acanthosis nigricans,610549|Hyperinsulinemic hypoglycemia,familial,5,609968];	RCV000264599.1 [benign]; RCV000303410.1 [benign]; RCV000360541.1 [benign]; 			8	75					INSR (inh=AR+AD pLI=0.19)
chr19	7114288	7114288	C	T	het	anno_omim	QUAL=19256;DP=375;AF=0.48;MQM=60;TRIO=HET,375,0.48,HOM,311,0.99,HET,416,0.50	INSR	3'UTR	INSR:ENST00000341500:3'UTR:MODIFIER:exon21/21:c.*2779G>A:		rs3745551	0.7177	0.0000	0,0,0	0,0,0,0,0	0.6750							147670 [INSR (confirmed) Leprechaunism,246200|Rabson-Mendenhall syndrome,262190|Diabetes mellitus,insulin-resistant,with acanthosis nigricans,610549|Hyperinsulinemic hypoglycemia,familial,5,609968];	RCV000295734.1 [benign]; RCV000350686.1 [benign]; RCV000404280.1 [benign]; 			90	102					INSR (inh=AR+AD pLI=0.19)
chr19	7114920	7114920	-	T	het	anno_omim	QUAL=2038;DP=90;AF=0.44;MQM=59;TRIO=HET,90,0.44,HOM,28,1.00,HET,43,0.44	INSR	3'UTR	INSR:ENST00000341500:3'UTR:MODIFIER:exon21/21:c.*2146dupA:		rs57473640;rs71915849	0.0000	0.0000	0,0,0	0,0,0,0,0	0.7239							147670 [INSR (confirmed) Leprechaunism,246200|Rabson-Mendenhall syndrome,262190|Diabetes mellitus,insulin-resistant,with acanthosis nigricans,610549|Hyperinsulinemic hypoglycemia,familial,5,609968];				80	119					INSR (inh=AR+AD pLI=0.19)
chr19	7115057	7115057	C	T	het	anno_omim	QUAL=862;DP=64;AF=0.45;MQM=60;TRIO=HET,64,0.45,WT,14,0.00,HET,15,0.47	INSR	3'UTR	INSR:ENST00000341500:3'UTR:MODIFIER:exon21/21:c.*2010G>A:		rs55972112	0.1250	0.0000	0,0,0	0,0,0,0,0	0.1073							147670 [INSR (confirmed) Leprechaunism,246200|Rabson-Mendenhall syndrome,262190|Diabetes mellitus,insulin-resistant,with acanthosis nigricans,610549|Hyperinsulinemic hypoglycemia,familial,5,609968];	RCV000262572.1 [benign]; RCV000317649.1 [benign]; RCV000353795.1 [benign]; 			9	70					INSR (inh=AR+AD pLI=0.19)
chr19	7115651	7115651	T	-	het	anno_omim	QUAL=18968;DP=342;AF=0.46;MQM=59;TRIO=HET,342,0.46,WT,328,0.00,HOM,504,1.00	INSR	3'UTR	INSR:ENST00000341500:3'UTR:MODIFIER:exon21/21:c.*1416delA:		rs3833238	0.3325	0.0000	0,0,0	0,0,0,0,0	0.2385							147670 [INSR (confirmed) Leprechaunism,246200|Rabson-Mendenhall syndrome,262190|Diabetes mellitus,insulin-resistant,with acanthosis nigricans,610549|Hyperinsulinemic hypoglycemia,familial,5,609968];	RCV000292651.1 [benign]; RCV000332408.1 [benign]; RCV000386880.1 [benign]; 			20	90					INSR (inh=AR+AD pLI=0.19)
chr19	7116136	7116136	-	T	hom	anno_omim	QUAL=1352;DP=115;AF=0.46;MQM=59;TRIO=HOM,115,0.46,HOM,27,0.59,HOM,30,0.50	INSR	3'UTR	INSR:ENST00000341500:3'UTR:MODIFIER:exon21/21:c.*930dupA:	(T)n	rs34045095;rs397813616	0.8291	0.0000	0,0,0	0,0,0,0,0	0.8078							147670 [INSR (confirmed) Leprechaunism,246200|Rabson-Mendenhall syndrome,262190|Diabetes mellitus,insulin-resistant,with acanthosis nigricans,610549|Hyperinsulinemic hypoglycemia,familial,5,609968];	RCV000284982.1 [benign]; RCV000346999.1 [benign]; RCV000377088.1 [benign]; 			76	77					INSR (inh=AR+AD pLI=0.19)
chr19	7116283	7116283	G	C	het	anno_omim	QUAL=6231;DP=243;AF=0.51;MQM=60;TRIO=HET,243,0.51,WT,186,0.00,HET,246,0.48	INSR	3'UTR	INSR:ENST00000341500:3'UTR:MODIFIER:exon21/21:c.*784C>G:		rs1051651	0.2959	0.0000	0,0,0	0,0,0,0,0	0.2266							147670 [INSR (confirmed) Leprechaunism,246200|Rabson-Mendenhall syndrome,262190|Diabetes mellitus,insulin-resistant,with acanthosis nigricans,610549|Hyperinsulinemic hypoglycemia,familial,5,609968];	RCV000259352.1 [benign]; RCV000316958.1 [benign]; RCV000360026.1 [benign]; 			20	76					INSR (inh=AR+AD pLI=0.19)
chr19	7116963	7116963	T	C	het	anno_omim	QUAL=6681;DP=173;AF=0.45;MQM=60;TRIO=HET,173,0.45,HET,98,0.46,HOM,113,1.00	INSR	3'UTR	INSR:ENST00000302850:3'UTR:MODIFIER:exon22/22:c.*104A>G:,INSR:ENST00000341500:3'UTR:MODIFIER:exon21/21:c.*104A>G:		rs1051690	0.8774	0.0000	0,0,0	0,0,0,0,0	0.8277							147670 [INSR (confirmed) Leprechaunism,246200|Rabson-Mendenhall syndrome,262190|Diabetes mellitus,insulin-resistant,with acanthosis nigricans,610549|Hyperinsulinemic hypoglycemia,familial,5,609968];	RCV000297534.1 [benign]; RCV000357012.1 [benign]; RCV000397487.1 [benign]; 			163	64					INSR (inh=AR+AD pLI=0.19)
chr19	7125297	7125297	G	A	het	anno_omim	QUAL=3431;DP=95;AF=0.48;MQM=59;TRIO=HET,95,0.48,WT,149,0.02,HET,222,0.46	INSR	synonymous	INSR:ENST00000302850:synonymous:LOW:exon17/22:c.3255C>T:p.His1085His,INSR:ENST00000341500:synonymous:LOW:exon16/21:c.3219C>T:p.His1073His		rs1799817	0.2925	0.2273	3491,1057,268	0.2317,0.2457,0.4232,0.1799,0.3179	0.2265							147670 [INSR (confirmed) Leprechaunism,246200|Rabson-Mendenhall syndrome,262190|Diabetes mellitus,insulin-resistant,with acanthosis nigricans,610549|Hyperinsulinemic hypoglycemia,familial,5,609968];	RCV000175129.1 [benign]; RCV000278910.1 [benign]; RCV000333104.1 [benign]; RCV000373687.1 [benign]; 	CM092295 [CLASS=DP MUT=ALT PHEN="Polycystic ovary syndrome in lean women association with" GENE=INSR]; 	COSM4001047, COSM4001048	121	703					INSR (inh=AR+AD pLI=0.19)
chr19	7141775	7141775	G	A	het	anno_omim	QUAL=1531;DP=50;AF=0.48;MQM=60;TRIO=HET,50,0.48,WT,36,0.00,HOM,32,1.00	INSR	synonymous	INSR:ENST00000302850:synonymous:LOW:exon13/22:c.2595C>T:p.Asn865Asn,INSR:ENST00000341500:synonymous:LOW:exon12/21:c.2559C>T:p.Asn853Asn		rs2229431	0.0869	0.0615	307,80,134	0.1545,0.0649,0.0711,0.0482,0.0441	0.0822							147670 [INSR (confirmed) Leprechaunism,246200|Rabson-Mendenhall syndrome,262190|Diabetes mellitus,insulin-resistant,with acanthosis nigricans,610549|Hyperinsulinemic hypoglycemia,familial,5,609968];	RCV000265366.1 [benign]; RCV000300575.1 [benign]; RCV000355369.1 [benign]; 			7	223					INSR (inh=AR+AD pLI=0.19)
chr19	7166376	7166376	C	T	het	anno_omim	QUAL=2869;DP=160;AF=0.49;MQM=60;TRIO=HET,160,0.49,HET,94,0.48,WT,119,0.00	INSR	synonymous	INSR:ENST00000302850:synonymous:LOW:exon8/22:c.1650G>A:p.Ala550Ala,INSR:ENST00000341500:synonymous:LOW:exon8/21:c.1650G>A:p.Ala550Ala		rs2059806	0.2448	0.2549	3909,2174,194	0.1904,0.2533,0.2493,0.2577,0.2628	0.2569							147670 [INSR (confirmed) Leprechaunism,246200|Rabson-Mendenhall syndrome,262190|Diabetes mellitus,insulin-resistant,with acanthosis nigricans,610549|Hyperinsulinemic hypoglycemia,familial,5,609968];	RCV000180111.1 [benign]; RCV000290514.1 [benign]; RCV000347847.1 [benign]; RCV000393623.1 [benign]; 	CM004252 [CLASS=DP MUT=ALT PHEN="Reduced diastolic blood pressure association with" GENE=INSR]; 	COSM148469, COSM4132751	150	801					INSR (inh=AR+AD pLI=0.19)
chr19	7593589	7593589	C	T	het	anno_omim	QUAL=24726;DP=182;AF=0.50;MQM=59;TRIO=HET,182,0.50,HOM,498,0.99,HET,630,0.50	MCOLN1	splice_region&synonymous	MCOLN1:ENST00000264079:splice_region&synonymous:LOW:exon8/14:c.984C>T:p.Asn328Asn		rs612862	0.2556	0.2875	5504,3980,301	0.2355,0.1584,0.1501,0.3416,0.2727	0.2872							605248 [MCOLN1 (confirmed) Mucolipidosis IV,252650];	RCV000254195.1 [benign]; RCV000380192.1 [likely benign]; 		COSM4132764	288	922					MCOLN1 (inh=AR pLI=0.04)
chr19	7703605	7703605	C	T	het	anno_omim	QUAL=543;DP=36;AF=0.42;MQM=60;TRIO=HET,36,0.42,HET,19,0.58,WT,19,0.00	STXBP2,CTD-3214H19.4	splice_region&intron	STXBP2:ENST00000441779:splice_region&intron:LOW:exon1/18:c.38-7C>T:,STXBP2:ENST00000221283:splice_region&intron:LOW:exon1/18:c.38-7C>T:,STXBP2:ENST00000414284:splice_region&intron:LOW:exon1/18:c.38-7C>T:		rs8104339	0.4824	0.4044	10443,4768,1346	0.5113,0.2883,0.6627,0.3781,0.3527	0.4451							601717 [STXBP2 (provisional) Hemophagocytic lymphohistiocytosis,familial,5,613101];	RCV000244568.1 [benign]; RCV000367298.1 [benign]; 			343	954					STXBP2 (inh=AR pLI=0.00), CTD-3214H19.4 (inh=n/a pLI=n/a)
chr19	7711221	7711221	T	C	het	anno_omim	QUAL=3411;DP=95;AF=0.48;MQM=59;TRIO=HET,95,0.48,HET,194,0.50,WT,326,0.00	STXBP2	synonymous	STXBP2:ENST00000441779:synonymous:LOW:exon16/19:c.1476T>C:p.Asp492Asp,STXBP2:ENST00000221283:synonymous:LOW:exon16/19:c.1443T>C:p.Asp481Asp,STXBP2:ENST00000414284:synonymous:LOW:exon16/19:c.1434T>C:p.Asp478Asp,STXBP2:ENST00000602355:synonymous:LOW:exon1/4:c.48T>C:p.Asp16Asp		rs10001	0.5042	0.4626	8932,3784,1061	0.5330,0.5268,0.7061,0.4201,0.3761	0.4468							601717 [STXBP2 (provisional) Hemophagocytic lymphohistiocytosis,familial,5,613101];	RCV000253160.1 [benign]; RCV000311684.1 [benign]; 		COSM1178455	326	950					STXBP2 (inh=AR pLI=0.00)
chr19	7712277	7712277	A	G	het	low_DP;anno_omim	QUAL=201;DP=12;AF=0.42;MQM=60;TRIO=HET,12,0.42,HET,17,0.41,WT,26,0.00	STXBP2	missense	STXBP2:ENST00000441779:missense:MODERATE:exon18/19:c.1609A>G:p.Ile537Val,STXBP2:ENST00000221283:missense:MODERATE:exon18/19:c.1576A>G:p.Ile526Val,STXBP2:ENST00000414284:missense:MODERATE:exon18/19:c.1567A>G:p.Ile523Val,STXBP2:ENST00000602355:missense:MODERATE:exon3/4:c.181A>G:p.Ile61Val		rs6791	0.7061	0.6352	24381,12303,2856	0.7752,0.6440,0.8211,0.6143,0.4921	0.6868	-0.1760	T,T,T,T	T	B,B,B,B	T,T,T	0.01	601717 [STXBP2 (provisional) Hemophagocytic lymphohistiocytosis,familial,5,613101];	RCV000250426.1 [benign]; RCV000308412.1 [benign]; 		COSM440643	770	996					STXBP2 (inh=AR pLI=0.00)
chr19	8376431	8376431	G	A	het		QUAL=8811;DP=318;AF=0.47;MQM=60;TRIO=HET,318,0.47,HET,459,0.45,WT,579,0.00	NDUFA7	synonymous	NDUFA7:ENST00000598884:synonymous:LOW:exon4/5:c.300C>T:p.Pro100Pro,NDUFA7:ENST00000301457:synonymous:LOW:exon4/4:c.300C>T:p.Pro100Pro		rs561	0.1382	0.1750	2182,1197,10	0.0480,0.3131,0.2136,0.1885,0.0665	0.1814											57	550					NDUFA7 (inh=n/a pLI=0.00)
chr19	10265312	10265312	T	C	hom	anno_omim	QUAL=16586;DP=200;AF=1.00;MQM=59;TRIO=HOM,200,1.00,HOM,161,1.00,HOM,168,1.00	DNMT1	synonymous	DNMT1:ENST00000359526:synonymous:LOW:exon21/41:c.1782A>G:p.Thr594Thr,DNMT1:ENST00000340748:synonymous:LOW:exon20/40:c.1734A>G:p.Thr578Thr,DNMT1:ENST00000540357:synonymous:LOW:exon20/40:c.1734A>G:p.Thr578Thr		rs721186	0.9958	0.9910	59584,32465,5165	0.9978,0.9932,1.0000,0.9867,0.9990	0.9908							126375 [DNMT1 (confirmed) Neuropathy,hereditary sensory,type IE,614116|Cerebellar ataxia,deafness,and narcolepsy,autosomal dominant,604121];	RCV000247150.1 [benign]; RCV000306290.1 [benign]; 			2152	44					DNMT1 (inh=AD pLI=1.00)
chr19	10267077	10267077	T	C	het	anno_omim	QUAL=7805;DP=225;AF=0.47;MQM=59;TRIO=HET,225,0.47,HET,186,0.54,HET,229,0.48	DNMT1	synonymous	DNMT1:ENST00000359526:synonymous:LOW:exon18/41:c.1389A>G:p.Pro463Pro,DNMT1:ENST00000340748:synonymous:LOW:exon17/40:c.1341A>G:p.Pro447Pro,DNMT1:ENST00000540357:synonymous:LOW:exon17/40:c.1341A>G:p.Pro447Pro		rs2228611	0.5339	0.5188	16554,8241,1413	0.5175,0.4856,0.6931,0.4969,0.5374	0.5186							126375 [DNMT1 (confirmed) Neuropathy,hereditary sensory,type IE,614116|Cerebellar ataxia,deafness,and narcolepsy,autosomal dominant,604121];	RCV000245855.1 [benign]; RCV000385434.1 [benign]; 			563	1064					DNMT1 (inh=AD pLI=1.00)
chr19	10270747	10270747	A	-	het	anno_omim	QUAL=7924;DP=270;AF=0.53;MQM=59;TRIO=HET,270,0.53,HET,181,0.52,HET,249,0.49	DNMT1	splice_region&intron	DNMT1:ENST00000359526:splice_region&intron:LOW:exon14/40:c.1044-8delT:,DNMT1:ENST00000340748:splice_region&intron:LOW:exon13/39:c.996-8delT:,DNMT1:ENST00000540357:splice_region&intron:LOW:exon13/39:c.996-8delT:		rs3079962;rs397859148;rs59599980;rs796846833	0.5795	0.6388	23788,14795,2955	0.7923,0.4033,0.4547,0.6904,0.6080	0.6856							126375 [DNMT1 (confirmed) Neuropathy,hereditary sensory,type IE,614116|Cerebellar ataxia,deafness,and narcolepsy,autosomal dominant,604121];	RCV000278836.1 [benign]; 			1011	956					DNMT1 (inh=AD pLI=1.00)
chr19	10939792	10939792	T	C	het	anno_omim	QUAL=3918;DP=163;AF=0.53;MQM=59;TRIO=HET,163,0.53,WT,149,0.00,HET,179,0.46	DNM2	synonymous	DNM2:ENST00000314646:synonymous:LOW:exon19/21:c.2139T>C:p.Ala713Ala,DNM2:ENST00000585892:synonymous:LOW:exon19/21:c.2139T>C:p.Ala713Ala,DNM2:ENST00000359692:synonymous:LOW:exon18/20:c.2127T>C:p.Ala709Ala,DNM2:ENST00000389253:synonymous:LOW:exon19/21:c.2139T>C:p.Ala713Ala,DNM2:ENST00000355667:synonymous:LOW:exon19/21:c.2139T>C:p.Ala713Ala,DNM2:ENST00000408974:synonymous:LOW:exon18/20:c.2127T>C:p.Ala709Ala		rs2229920	0.3383	0.3116	6082,2703,408	0.2827,0.2601,0.5759,0.2884,0.3150	0.3114							602378 [DNM2 (confirmed) Charcot-Marie-Tooth disease,dominant intermediate B,606482|Myopathy,centronuclear 1,160150|Charcot-Marie-Tooth disease,axonal type 2M,606482|Lethal congenital contracture syndrome 5,615368];	RCV000145914.3 [other]; RCV000312099.1 [benign]; RCV000371358.1 [benign]; 		COSM3766266, COSM3766265, COSM3766264	194	963					DNM2 (inh=AR+AD pLI=1.00)
chr19	11105608	11105608	T	C	het	anno_omim	QUAL=7091;DP=207;AF=0.48;MQM=60;TRIO=HET,207,0.48,WT,293,0.01,HET,377,0.49	SMARCA4	synonymous	SMARCA4:ENST00000358026:synonymous:LOW:exon9/36:c.1524T>C:p.His508His,SMARCA4:ENST00000344626:synonymous:LOW:exon9/35:c.1524T>C:p.His508His,SMARCA4:ENST00000429416:synonymous:LOW:exon10/36:c.1524T>C:p.His508His,SMARCA4:ENST00000541122:synonymous:LOW:exon10/35:c.1524T>C:p.His508His,SMARCA4:ENST00000589677:synonymous:LOW:exon10/35:c.1524T>C:p.His508His,SMARCA4:ENST00000444061:synonymous:LOW:exon10/35:c.1524T>C:p.His508His,SMARCA4:ENST00000590574:synonymous:LOW:exon9/34:c.1524T>C:p.His508His,SMARCA4:ENST00000413806:synonymous:LOW:exon8/33:c.1524T>C:p.His508His,SMARCA4:ENST00000450717:synonymous:LOW:exon8/33:c.1524T>C:p.His508His		rs7935	0.3115	0.3354	6930,3973,490	0.3112,0.1849,0.2383,0.3487,0.4378	0.3280							603254 [SMARCA4 (provisional) Rhabdoid tumor predisposition syndrome 2,613325|Coffin-Siris syndrome 4,614609];	RCV000114302.2 [benign]; RCV000264120.1 [benign]; 		COSM4131184, COSM4131185	443	1627					SMARCA4 (inh=AD pLI=1.00)
chr19	12772090	12772090	C	T	het	anno_omim	QUAL=8883;DP=221;AF=0.47;MQM=60;TRIO=HET,221,0.47,HET,485,0.51,WT,577,0.00	MAN2B1	missense	MAN2B1:ENST00000456935:missense:MODERATE:exon7/24:c.1010G>A:p.Arg337Gln,MAN2B1:ENST00000221363:missense:MODERATE:exon7/24:c.1010G>A:p.Arg337Gln		rs1133330	0.2484	0.3104	6628,4984,557	0.3249,0.1781,0.0490,0.3841,0.2351	0.3349	-0.0410	T,T,T	T	B,B	T,T	18.09	609458 [MAN2B1 (confirmed) Mannosidosis,alpha-,types I and II,248500];	RCV000079070.8 [other]; RCV000298455.1 [benign]; 		COSM1582962	342	966					MAN2B1 (inh=AR pLI=0.00)
chr19	12772165	12772165	G	A	het	pred_pathogenic;anno_omim	QUAL=8580;DP=240;AF=0.38;MQM=60;TRIO=HET,240,0.38,HET,540,0.48,WT,661,0.00	MAN2B1	missense	MAN2B1:ENST00000456935:missense:MODERATE:exon7/24:c.935C>T:p.Thr312Ile,MAN2B1:ENST00000221363:missense:MODERATE:exon7/24:c.935C>T:p.Thr312Ile		rs1054487	0.3279	0.3399	8097,5345,1594	0.5492,0.1939,0.0487,0.3977,0.2399	0.4055	1.9380	T,T,T	T	B,B	T,T	0.01	609458 [MAN2B1 (confirmed) Mannosidosis,alpha-,types I and II,248500];	RCV000079081.8 [other]; RCV000355741.1 [benign]; 		COSM1178457	372	963					MAN2B1 (inh=AR pLI=0.00)
chr19	12774208	12774208	G	C	het	anno_omim	QUAL=9143;DP=333;AF=0.47;MQM=59;TRIO=HET,333,0.47,WT,345,0.01,HET,433,0.47	MAN2B1	missense	MAN2B1:ENST00000456935:missense:MODERATE:exon6/24:c.832C>G:p.Leu278Val,MAN2B1:ENST00000221363:missense:MODERATE:exon6/24:c.832C>G:p.Leu278Val		rs1054486	0.2394	0.2567	4512,2834,779	0.3874,0.1416,0.0306,0.2930,0.1830	0.3112	-0.4280	T,T,T	T	B,B	T,T	0.01	609458 [MAN2B1 (confirmed) Mannosidosis,alpha-,types I and II,248500];	RCV000079080.8 [other]; RCV000368270.1 [benign]; 			181	841					MAN2B1 (inh=AR pLI=0.00)
chr19	13227354	13227354	G	A	het		QUAL=3910;DP=177;AF=0.53;MQM=60;TRIO=HET,177,0.53,WT,113,0.00,HET,158,0.49	TRMT1	5'UTR_premature_start_codon_gain,5'UTR,intron	TRMT1:ENST00000437766:5'UTR_premature_start_codon_gain:LOW:exon1/16:c.-141C>T:,TRMT1:ENST00000221504:5'UTR_premature_start_codon_gain:LOW:exon1/15:c.-141C>T:,TRMT1:ENST00000437766:5'UTR:MODIFIER:exon1/16:c.-141C>T:,TRMT1:ENST00000221504:5'UTR:MODIFIER:exon1/15:c.-141C>T:,TRMT1:ENST00000357720:intron:MODIFIER:exon1/16:c.-32-109C>T:,TRMT1:ENST00000592062:intron:MODIFIER:exon2/17:c.-32-109C>T:		rs2302159	0.0980	0.0000	0,0,0	0,0,0,0,0	0.0922											1	39					TRMT1 (inh=n/a pLI=0.00)
chr19	13317491	13317493	TTA	-	hom	anno_omim	QUAL=7687;DP=147;AF=0.99;MQM=59;TRIO=HOM,147,0.99,HOM,64,0.97,HET,85,0.59	CACNA1A	3'UTR	CACNA1A:ENST00000360228:3'UTR:MODIFIER:exon47/47:c.*634_*636delTAA:	(ATT)n	rs143342886;rs869287699	0.5569	0.0000	0,0,0	0,0,0,0,0	0.5270							601011 [CACNA1A (confirmed) Migraine,familial hemiplegic,1,141500|Episodic ataxia,type 2,108500|Spinocerebellar ataxia 6,183086|Migraine,familial hemiplegic,1,with progressive cerebellar ataxia,141500|Epileptic encephalopathy,early infantile,42,617106];				459	751					CACNA1A (inh=AD pLI=1.00)
chr19	13317759	13317770	TTTTTTTTTTTT	-	hom	low_DP;anno_omim	QUAL=246;DP=17;AF=0.18;MQM=60;TRIO=HOM,17,0.18,WT,9,0.00,HOM,5,0.00	CACNA1A	3'UTR	CACNA1A:ENST00000360228:3'UTR:MODIFIER:exon47/47:c.*357_*368delAAAAAAAAAAAA:	(T)n		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							601011 [CACNA1A (confirmed) Migraine,familial hemiplegic,1,141500|Episodic ataxia,type 2,108500|Spinocerebellar ataxia 6,183086|Migraine,familial hemiplegic,1,with progressive cerebellar ataxia,141500|Epileptic encephalopathy,early infantile,42,617106];				0	0					CACNA1A (inh=AD pLI=1.00)
chr19	13317980	13317980	G	T	hom	anno_omim	QUAL=3501;DP=41;AF=0.93;MQM=59;TRIO=HOM,41,0.93,HOM,52,1.00,HET,67,0.52	CACNA1A	3'UTR	CACNA1A:ENST00000360228:3'UTR:MODIFIER:exon47/47:c.*147C>A:		rs7254351	0.5080	0.0000	0,0,0	0,0,0,0,0	0.4635							601011 [CACNA1A (confirmed) Migraine,familial hemiplegic,1,141500|Episodic ataxia,type 2,108500|Spinocerebellar ataxia 6,183086|Migraine,familial hemiplegic,1,with progressive cerebellar ataxia,141500|Epileptic encephalopathy,early infantile,42,617106];				58	131					CACNA1A (inh=AD pLI=1.00)
chr19	13445208	13445208	C	T	het	anno_omim	QUAL=3163;DP=139;AF=0.42;MQM=60;TRIO=HET,139,0.42,HET,140,0.51,WT,138,0.00	CACNA1A	synonymous	CACNA1A:ENST00000360228:synonymous:LOW:exon8/47:c.1182G>A:p.Glu394Glu,CACNA1A:ENST00000573710:synonymous:LOW:exon8/47:c.1182G>A:p.Glu394Glu		rs2248069	0.6412	0.6857	28664,15595,1344	0.5256,0.8140,0.6417,0.6833,0.7246	0.6884							601011 [CACNA1A (confirmed) Migraine,familial hemiplegic,1,141500|Episodic ataxia,type 2,108500|Spinocerebellar ataxia 6,183086|Migraine,familial hemiplegic,1,with progressive cerebellar ataxia,141500|Epileptic encephalopathy,early infantile,42,617106];	RCV000079475.8 [other]; 			1487	1379	1	[1] Julia Bickmann 23.09.2014	n/a (2xTP, 0xFP)		CACNA1A (inh=AD pLI=1.00)
chr19	14038791	14038791	C	T	hom	pred_pathogenic;anno_omim	QUAL=11525;DP=211;AF=0.99;MQM=59;TRIO=HOM,211,0.99,HET,212,0.50,HET,242,0.50	CC2D1A	missense	CC2D1A:ENST00000318003:missense:MODERATE:exon23/29:c.2402C>T:p.Thr801Met,CC2D1A:ENST00000589606:missense:MODERATE:exon23/29:c.2402C>T:p.Thr801Met		rs2305777	0.1250	0.2104	3013,2348,12	0.0490,0.1480,0.0736,0.2678,0.1720	0.2109	3.9450	T,T	T	B,D,D	T	26.50	610055 [CC2D1A (provisional) Mental retardation,autosomal recessive 3,608443];	RCV000116591.2 [likely benign]; 		COSM4000530	140	711					CC2D1A (inh=AR pLI=0.00)
chr19	14040896	14040896	G	A	het	anno_omim	QUAL=2244;DP=84;AF=0.58;MQM=59;TRIO=HET,84,0.58,HET,99,0.52,WT,139,0.00	CC2D1A	missense	CC2D1A:ENST00000318003:missense:MODERATE:exon27/29:c.2716G>A:p.Ala906Thr,CC2D1A:ENST00000589606:missense:MODERATE:exon27/29:c.2713G>A:p.Ala905Thr		rs11669628	0.1332	0.1385	1154,558,11	0.0359,0.1036,0.2277,0.1379,0.1585	0.1329	-2.5760	T,T	T	B,B,B	T	5.17	610055 [CC2D1A (provisional) Mental retardation,autosomal recessive 3,608443];	RCV000116594.2 [likely benign]; 		COSM1750675	45	522					CC2D1A (inh=AR pLI=0.00)
chr19	15270583	15270583	G	A	hom	anno_omim	QUAL=23983;DP=322;AF=1.00;MQM=59;TRIO=HOM,322,1.00,HOM,269,1.00,HET,377,0.51	NOTCH3	3'UTR	NOTCH3:ENST00000263388:3'UTR:MODIFIER:exon33/33:c.*890C>T:		rs1044123	0.6238	0.0000	0,0,0	0,0,0,0,0	0.6969							600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1,125310|Myofibromatosis,infantile 2,615293|Lateral meningocele syndrome,130720];	RCV000337524.1 [benign]; 			112	90					NOTCH3 (inh=AD pLI=0.21)
chr19	15270665	15270665	C	T	hom	anno_omim	QUAL=22329;DP=270;AF=1.00;MQM=60;TRIO=HOM,270,1.00,HOM,270,1.00,HET,382,0.51	NOTCH3	3'UTR	NOTCH3:ENST00000263388:3'UTR:MODIFIER:exon33/33:c.*808G>A:		rs1044116	0.6238	0.0000	0,0,0	0,0,0,0,0	0.6971							600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1,125310|Myofibromatosis,infantile 2,615293|Lateral meningocele syndrome,130720];	RCV000362084.1 [benign]; 			112	90					NOTCH3 (inh=AD pLI=0.21)
chr19	15270805	15270805	C	A	hom	anno_omim	QUAL=8812;DP=134;AF=1.00;MQM=59;TRIO=HOM,134,1.00,HOM,100,0.99,HET,143,0.51	NOTCH3	3'UTR	NOTCH3:ENST00000263388:3'UTR:MODIFIER:exon33/33:c.*668G>T:		rs1044055	0.6234	0.0000	0,0,0	0,0,0,0,0	0.6964							600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1,125310|Myofibromatosis,infantile 2,615293|Lateral meningocele syndrome,130720];	RCV000267443.1 [benign]; 			112	90					NOTCH3 (inh=AD pLI=0.21)
chr19	15270910	15270910	A	G	hom	anno_omim	QUAL=5077;DP=125;AF=1.00;MQM=59;TRIO=HOM,125,1.00,HET,57,0.44,HET,68,0.54	NOTCH3	3'UTR	NOTCH3:ENST00000263388:3'UTR:MODIFIER:exon33/33:c.*563T>C:		rs77669983	0.0110	0.0000	0,0,0	0,0,0,0,0	0.0429							600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1,125310|Myofibromatosis,infantile 2,615293|Lateral meningocele syndrome,130720];	RCV000365612.1 [likely benign]; 			2	26					NOTCH3 (inh=AD pLI=0.21)
chr19	15271135	15271135	T	G	hom	anno_omim	QUAL=4660;DP=67;AF=1.00;MQM=59;TRIO=HOM,67,1.00,HOM,36,1.00,HOM,54,1.00	NOTCH3	3'UTR	NOTCH3:ENST00000263388:3'UTR:MODIFIER:exon33/33:c.*338A>C:	(TAAAAA)n	rs7247906	0.8708	0.0000	0,0,0	0,0,0,0,0	0.9138							600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1,125310|Myofibromatosis,infantile 2,615293|Lateral meningocele syndrome,130720];	RCV000334074.1 [benign]; 			144	46					NOTCH3 (inh=AD pLI=0.21)
chr19	15271771	15271771	G	A	hom	anno_omim	QUAL=3362;DP=25;AF=1.00;MQM=59;TRIO=HOM,25,1.00,HOM,62,1.00,HET,74,0.50	NOTCH3	missense	NOTCH3:ENST00000263388:missense:MODERATE:exon33/33:c.6668C>T:p.Ala2223Val		rs1044009	0.6294	0.7591	19791,12817,819	0.6000,0.6209,0.6421,0.8094,0.7382	0.7154	1.1220	T	T	B	T	9.60	600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1,125310|Myofibromatosis,infantile 2,615293|Lateral meningocele syndrome,130720];	RCV000249070.2 [benign]; RCV000278901.1 [benign]; 		COSM3756389, COSM3756390	1280	765					NOTCH3 (inh=AD pLI=0.21)
chr19	15273381	15273381	A	G	hom	anno_omim	QUAL=23110;DP=205;AF=1.00;MQM=60;TRIO=HOM,205,1.00,HOM,231,1.00,HOM,312,1.00	NOTCH3	splice_region&intron	NOTCH3:ENST00000263388:splice_region&intron:LOW:exon31/32:c.5816-8T>C:		rs4809030	0.8690	0.8745	46287,26814,4941	0.9765,0.7079,0.8065,0.8987,0.8552	0.9108							600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1,125310|Myofibromatosis,infantile 2,615293|Lateral meningocele syndrome,130720];	RCV000241820.1 [benign]; RCV000277327.1 [benign]; 			1765	398					NOTCH3 (inh=AD pLI=0.21)
chr19	15278057	15278057	A	G	hom	anno_omim	QUAL=9842;DP=135;AF=1.00;MQM=59;TRIO=HOM,135,1.00,HOM,83,1.00,HOM,111,1.00	NOTCH3	splice_region&intron	NOTCH3:ENST00000263388:splice_region&intron:LOW:exon29/32:c.5362+3T>C:		rs1548555	0.8700	0.8741	46647,26964,4975	0.9780,0.7052,0.8074,0.8986,0.8547	0.9112							600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1,125310|Myofibromatosis,infantile 2,615293|Lateral meningocele syndrome,130720];	RCV000246404.1 [benign]; RCV000288178.1 [benign]; 			1765	399					NOTCH3 (inh=AD pLI=0.21)
chr19	15285052	15285052	T	C	hom	anno_omim	QUAL=22803;DP=181;AF=1.00;MQM=59;TRIO=HOM,181,1.00,HOM,219,1.00,HOM,348,1.00	NOTCH3	synonymous	NOTCH3:ENST00000263388:synonymous:LOW:exon25/33:c.4563A>G:p.Pro1521Pro		rs1044006	0.8718	0.8812	34152,19607,3360	0.9789,0.7356,0.8188,0.9017,0.8632	0.9112							600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1,125310|Myofibromatosis,infantile 2,615293|Lateral meningocele syndrome,130720];	RCV000249034.1 [benign]; RCV000315021.1 [benign]; 		COSM438775, COSM1480700	1762	396					NOTCH3 (inh=AD pLI=0.21)
chr19	15292437	15292437	T	C	hom	anno_omim	QUAL=8496;DP=66;AF=1.00;MQM=59;TRIO=HOM,66,1.00,HOM,87,1.00,HOM,128,1.00	NOTCH3	synonymous	NOTCH3:ENST00000263388:synonymous:LOW:exon17/33:c.2742A>G:p.Pro914Pro		rs1043997	0.7390	0.8019	6280,2876,430	0.6123,0.7371,0.8040,0.8598,0.8010	0.8037							600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1,125310|Myofibromatosis,infantile 2,615293|Lateral meningocele syndrome,130720];	RCV000246643.1 [benign]; RCV000304759.1 [benign]; 		COSM4131310, COSM4131309	1589	537					NOTCH3 (inh=AD pLI=0.21)
chr19	15295134	15295134	G	A	hom	anno_omim	QUAL=13277;DP=125;AF=0.98;MQM=60;TRIO=HOM,125,0.98,HOM,212,1.00,HET,277,0.49	NOTCH3	synonymous	NOTCH3:ENST00000263388:synonymous:LOW:exon16/33:c.2538C>T:p.Cys846Cys		rs1043996	0.5200	0.6427	26200,17147,378	0.2652,0.4936,0.6073,0.7170,0.6509	0.6429							600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1,125310|Myofibromatosis,infantile 2,615293|Lateral meningocele syndrome,130720];	RCV000241854.1 [benign]; RCV000269025.1 [benign]; 		COSM4131311, COSM4131312	1053	912					NOTCH3 (inh=AD pLI=0.21)
chr19	15299051	15299051	G	A	het	pred_pathogenic;anno_omim;anno_pathogenic_hgmd	QUAL=2578;DP=127;AF=0.55;MQM=59;TRIO=HET,127,0.55,HET,88,0.48,WT,85,0.00	NOTCH3	missense	NOTCH3:ENST00000263388:missense:MODERATE:exon9/33:c.1487C>T:p.Pro496Leu		rs11670799	0.0036	0.0207	16,16,0	0.0045,0.0209,0.0000,0.0355,0.0011	0.0121	4.5180	D,D	D	P,P	D	25.10	600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1,125310|Myofibromatosis,infantile 2,615293|Lateral meningocele syndrome,130720];	RCV000253366.1 [benign]; RCV000301926.1 [likely benign]; 	CM162093 [CLASS=DM? MUT=ALT PHEN="Pulmonary arterial hypertension" GENE=NOTCH3]; 		2	75					NOTCH3 (inh=AD pLI=0.21)
chr19	15300136	15300136	A	G	het	anno_omim	QUAL=5245;DP=200;AF=0.50;MQM=59;TRIO=HET,200,0.50,HET,261,0.44,WT,292,0.00	NOTCH3	synonymous	NOTCH3:ENST00000263388:synonymous:LOW:exon7/33:c.1140T>C:p.Pro380Pro		rs61749020	0.0152	0.0256	62,54,2	0.0188,0.0198,0.0000,0.0353,0.0153	0.0264							600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1,125310|Myofibromatosis,infantile 2,615293|Lateral meningocele syndrome,130720];	RCV000252960.1 [benign]; RCV000362891.1 [likely benign]; 		COSM3773842, COSM3773843	3	171					NOTCH3 (inh=AD pLI=0.21)
chr19	15302844	15302844	T	C	hom	anno_omim	QUAL=37951;DP=211;AF=1.00;MQM=59;TRIO=HOM,211,1.00,HOM,462,1.00,HOM,555,1.00	NOTCH3	synonymous	NOTCH3:ENST00000263388:synonymous:LOW:exon4/33:c.606A>G:p.Ala202Ala		rs1043994	0.8558	0.8581	44532,25552,4278	0.9119,0.6915,0.8674,0.8802,0.8426	0.8808							600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1,125310|Myofibromatosis,infantile 2,615293|Lateral meningocele syndrome,130720];	RCV000242339.1 [benign]; RCV000374496.1 [benign]; 			1665	486					NOTCH3 (inh=AD pLI=0.21)
chr19	17935585	17935586	AA	-	het	anno_omim	QUAL=4025;DP=97;AF=0.61;MQM=59;TRIO=HET,97,0.61,HET,62,1.00,WT,124,0.42	INSL3,JAK3	intergenic_region	JAK3:ENSG00000248099-ENSG00000105639:intergenic_region:MODIFIER::n.17935585_17935586delAA:		rs796392933	0.3197	0.0000	0,0,0	0,0,0,0,0	0.3095							600173 [JAK3 (provisional) SCID,autosomal recessive,T-negative/B-positive type,600802];	RCV000333875.1 [benign]; 			16	67					INSL3 (inh=n/a pLI=0.03), JAK3 (inh=AR pLI=1.00)
chr19	17935626	17935626	T	C	het	anno_omim	QUAL=6482;DP=188;AF=0.49;MQM=59;TRIO=HET,188,0.49,HOM,80,1.00,HET,154,0.44	JAK3	3'UTR	JAK3:ENST00000458235:3'UTR:MODIFIER:exon24/24:c.*1926A>G:	L2c	rs11888	0.3980	0.0000	0,0,0	0,0,0,0,0	0.3798							600173 [JAK3 (provisional) SCID,autosomal recessive,T-negative/B-positive type,600802];	RCV000278899.1 [benign]; 			25	74					JAK3 (inh=AR pLI=1.00)
chr19	17936259	17936259	G	A	het	anno_omim	QUAL=3670;DP=146;AF=0.47;MQM=60;TRIO=HET,146,0.47,HOM,64,1.00,WT,64,0.00	JAK3	3'UTR	JAK3:ENST00000458235:3'UTR:MODIFIER:exon24/24:c.*1293C>T:		rs73014967	0.1591	0.0000	0,0,0	0,0,0,0,0	0.1667							600173 [JAK3 (provisional) SCID,autosomal recessive,T-negative/B-positive type,600802];	RCV000309786.1 [likely benign]; 			16	88					JAK3 (inh=AR pLI=1.00)
chr19	17936898	17936898	T	A	het	low_DP;anno_omim	QUAL=87;DP=18;AF=0.33;MQM=59;TRIO=HET,18,0.33,HET,4,0.25,WT,12,0.00	JAK3	3'UTR	JAK3:ENST00000458235:3'UTR:MODIFIER:exon24/24:c.*654A>T:		rs71332114	0.2077	0.0000	0,0,0	0,0,0,0,0	0.2820							600173 [JAK3 (provisional) SCID,autosomal recessive,T-negative/B-positive type,600802];	RCV000343033.1 [benign]; 			5	20					JAK3 (inh=AR pLI=1.00)
chr19	17937104	17937104	G	T	het	anno_omim	QUAL=478;DP=31;AF=0.65;MQM=50;TRIO=HET,31,0.65,HET,4,0.75,WT,7,0.00	JAK3	3'UTR	JAK3:ENST00000458235:3'UTR:MODIFIER:exon24/24:c.*448C>A:,JAK3:ENST00000527670:3'UTR:MODIFIER:exon23/23:c.*448C>A:	AluSz	rs3212802	0.2194	0.0000	0,0,0	0,0,0,0,0	0.2376							600173 [JAK3 (provisional) SCID,autosomal recessive,T-negative/B-positive type,600802];	RCV000309394.1 [benign]; 			3	27					JAK3 (inh=AR pLI=1.00)
chr19	17937429	17937429	A	G	het	anno_omim	QUAL=5338;DP=112;AF=0.57;MQM=60;TRIO=HET,112,0.57,HOM,122,1.00,WT,177,0.00	JAK3	3'UTR	JAK3:ENST00000458235:3'UTR:MODIFIER:exon24/24:c.*123T>C:,JAK3:ENST00000527670:3'UTR:MODIFIER:exon23/23:c.*123T>C:		rs3008	0.5401	0.0000	0,0,0	0,0,0,0,0	0.5234							600173 [JAK3 (provisional) SCID,autosomal recessive,T-negative/B-positive type,600802];	RCV000355256.1 [benign]; 			39	89					JAK3 (inh=AR pLI=1.00)
chr19	17945696	17945696	C	T	het	pred_pathogenic;anno_omim;anno_pathogenic_hgmd	QUAL=3841;DP=237;AF=0.52;MQM=60;TRIO=HET,237,0.52,HET,102,0.37,WT,150,0.00	JAK3	missense	JAK3:ENST00000458235:missense:MODERATE:exon16/24:c.2164G>A:p.Val722Ile,JAK3:ENST00000527670:missense:MODERATE:exon15/23:c.2164G>A:p.Val722Ile,JAK3:ENST00000534444:missense:MODERATE:exon16/23:c.2164G>A:p.Val722Ile		rs3213409	0.0036	0.0087	11,9,0	0.0023,0.0041,0.0000,0.0130,0.0051	0.0086	1.5240	D,D,D	T	B,B	T,T,T	16.20	600173 [JAK3 (provisional) SCID,autosomal recessive,T-negative/B-positive type,600802];	RCV000121262.1 [not provided]; 	CM000172 [CLASS=DM? MUT=ALT PHEN="Immunodeficiency severe combined" GENE=JAK3]; 	COSM34213	0	71					JAK3 (inh=AR pLI=1.00)
chr19	18001686	18001686	G	A	het	anno_omim	QUAL=4007;DP=120;AF=0.57;MQM=60;TRIO=HET,120,0.57,WT,174,0.01,HET,231,0.48	SLC5A5	splice_region&intron	SLC5A5:ENST00000222248:splice_region&intron:LOW:exon13/14:c.1652-9G>A:		rs4808708	0.1246	0.1795	2297,1742,64	0.1224,0.1089,0.0086,0.2286,0.1236	0.1862							601843 [SLC5A5 (provisional) Thyroid dyshormonogenesis 1,274400];	RCV000248822.1 [benign]; RCV000354638.1 [likely benign]; 			96	733					SLC5A5 (inh=AR pLI=0.74)
chr19	18004912	18004912	T	C	het	anno_omim	QUAL=3270;DP=203;AF=0.38;MQM=59;TRIO=HET,203,0.38,WT,116,0.01,HET,154,0.42	SLC5A5	3'UTR	SLC5A5:ENST00000222248:3'UTR:MODIFIER:exon15/15:c.*226T>C:		rs12327843	0.1520	0.0000	0,0,0	0,0,0,0,0	0.2191							601843 [SLC5A5 (provisional) Thyroid dyshormonogenesis 1,274400];	RCV000323427.1 [likely benign]; 			7	81					SLC5A5 (inh=AR pLI=0.74)
chr19	18180413	18180413	C	G	het	anno_omim	QUAL=10016;DP=108;AF=0.56;MQM=60;TRIO=HET,108,0.56,HET,320,0.48,HET,399,0.50	IL12RB1	missense	IL12RB1:ENST00000593993:missense:MODERATE:exon10/17:c.1132G>C:p.Gly378Arg,IL12RB1:ENST00000600835:missense:MODERATE:exon11/18:c.1132G>C:p.Gly378Arg		rs401502	0.2516	0.2841	5086,3432,190	0.1980,0.1516,0.3557,0.3224,0.2220	0.2847	-1.8560	T	T	B,B	T	1.88	601604 [IL12RB1 (provisional) Immunodeficiency 30,614891];	RCV000333588.1 [benign]; 	CM030471 [CLASS=DP MUT=ALT PHEN="Tuberculosis susceptibility to association with" GENE=IL12RB1]; 		225	904					IL12RB1 (inh=AR pLI=0.00)
chr19	18180451	18180451	A	G	het	anno_omim	QUAL=12484;DP=189;AF=0.52;MQM=59;TRIO=HET,189,0.52,HET,367,0.46,HET,474,0.51	IL12RB1	missense	IL12RB1:ENST00000593993:missense:MODERATE:exon10/17:c.1094T>C:p.Met365Thr,IL12RB1:ENST00000600835:missense:MODERATE:exon11/18:c.1094T>C:p.Met365Thr		rs375947	0.2686	0.2894	5295,3473,331	0.2565,0.1540,0.3566,0.3227,0.2228	0.3026	-0.9480	T	T	B,B	T	0.01	601604 [IL12RB1 (provisional) Immunodeficiency 30,614891];	RCV000353556.1 [benign]; 	CM030470 [CLASS=DP MUT=ALT PHEN="Tuberculosis susceptibility to association with" GENE=IL12RB1]; 	COSM4000563, COSM4000562	225	905					IL12RB1 (inh=AR pLI=0.00)
chr19	18181569	18181569	A	G	het	anno_omim	QUAL=5324;DP=120;AF=0.46;MQM=59;TRIO=HET,120,0.46,HET,168,0.47,HET,194,0.46	IL12RB1	3'UTR,intron	IL12RB1:ENST00000322153:3'UTR:MODIFIER:exon10/10:c.*450T>C:,IL12RB1:ENST00000593993:intron:MODIFIER:exon9/16:c.1022-1046T>C:,IL12RB1:ENST00000600835:intron:MODIFIER:exon10/17:c.1022-1046T>C:	AluJr	rs845380	0.6585	0.0000	0,0,0	0,0,0,0,0	0.6801							601604 [IL12RB1 (provisional) Immunodeficiency 30,614891];				81	64					IL12RB1 (inh=AR pLI=0.00)
chr19	18186575	18186575	G	A	het	anno_omim	QUAL=6615;DP=148;AF=0.43;MQM=60;TRIO=HET,148,0.43,HET,192,0.47,HET,227,0.49	IL12RB1	synonymous	IL12RB1:ENST00000593993:synonymous:LOW:exon7/17:c.684C>T:p.Pro228Pro,IL12RB1:ENST00000600835:synonymous:LOW:exon8/18:c.684C>T:p.Pro228Pro,IL12RB1:ENST00000322153:synonymous:LOW:exon7/10:c.684C>T:p.Pro228Pro		rs17852635	0.2298	0.2773	4994,3457,68	0.1252,0.1488,0.3540,0.3227,0.2223	0.2774							601604 [IL12RB1 (provisional) Immunodeficiency 30,614891];	RCV000342695.1 [benign]; 		COSM4000566, COSM4000564, COSM4000565	224	904					IL12RB1 (inh=AR pLI=0.00)
chr19	18186618	18186618	T	C	het	pred_pathogenic;anno_omim;anno_pathogenic_hgmd	QUAL=7824;DP=144;AF=0.55;MQM=59;TRIO=HET,144,0.55,HET,218,0.46,HET,261,0.50	IL12RB1	missense	IL12RB1:ENST00000593993:missense:MODERATE:exon7/17:c.641A>G:p.Gln214Arg,IL12RB1:ENST00000600835:missense:MODERATE:exon8/18:c.641A>G:p.Gln214Arg,IL12RB1:ENST00000322153:missense:MODERATE:exon7/10:c.641A>G:p.Gln214Arg		rs11575934	0.2294	0.2771	4992,3459,64	0.1232,0.1487,0.3546,0.3229,0.2217	0.2774	-0.2090	T,.	T	B,B,B	T,D	0.01	601604 [IL12RB1 (provisional) Immunodeficiency 30,614891];	RCV000395252.1 [benign]; 	CM984025 [CLASS=DM? MUT=ALT PHEN="Mycobacterial infection" GENE=IL12RB1]; 	COSM4131454, COSM4131452, COSM4131453	224	902	2	[2] old entry - no details available			IL12RB1 (inh=AR pLI=0.00)
chr19	18191664	18191664	C	G	het	anno_omim	QUAL=5030;DP=131;AF=0.50;MQM=59;TRIO=HET,131,0.50,HET,159,0.38,HET,194,0.54	IL12RB1	synonymous	IL12RB1:ENST00000593993:synonymous:LOW:exon4/17:c.387G>C:p.Val129Val,IL12RB1:ENST00000600835:synonymous:LOW:exon5/18:c.387G>C:p.Val129Val,IL12RB1:ENST00000322153:synonymous:LOW:exon4/10:c.387G>C:p.Val129Val		rs11086087	0.1300	0.1185	998,494,11	0.0554,0.0679,0.2724,0.1215,0.1069	0.1182							601604 [IL12RB1 (provisional) Immunodeficiency 30,614891];	RCV000339160.1 [benign]; 		COSM4000567, COSM4000569, COSM4000568	44	435					IL12RB1 (inh=AR pLI=0.00)
chr19	33882222	33882222	G	A	het	anno_omim	QUAL=900;DP=34;AF=0.59;MQM=60;TRIO=HET,34,0.59,HET,52,0.40,WT,79,0.00	PEPD	synonymous	PEPD:ENST00000244137:synonymous:LOW:exon13/15:c.1131C>T:p.His377His,PEPD:ENST00000397032:synonymous:LOW:exon11/13:c.1008C>T:p.His336His,PEPD:ENST00000436370:synonymous:LOW:exon11/13:c.939C>T:p.His313His		rs17569	0.0984	0.1484	1115,692,3	0.0320,0.0902,0.2494,0.1680,0.1081	0.1286							613230 [PEPD (confirmed) Prolidase deficiency,170100];	RCV000285859.1 [benign]; 			35	518					PEPD (inh=AR pLI=0.01)
chr19	33953912	33953912	A	G	het	anno_omim	QUAL=8399;DP=301;AF=0.48;MQM=60;TRIO=HET,301,0.48,HET,313,0.53,WT,436,0.00	PEPD	synonymous,intron	PEPD:ENST00000244137:synonymous:LOW:exon9/15:c.660T>C:p.Tyr220Tyr,PEPD:ENST00000436370:synonymous:LOW:exon7/13:c.468T>C:p.Tyr156Tyr,PEPD:ENST00000397032:intron:MODIFIER:exon7/12:c.548+15040T>C:		rs3745969	0.0298	0.0378	159,51,1	0.0059,0.0080,0.0757,0.0351,0.0351	0.0385							613230 [PEPD (confirmed) Prolidase deficiency,170100];	RCV000376172.1 [likely benign]; 			8	117					PEPD (inh=AR pLI=0.01)
chr19	34872382	34872382	G	A	het	anno_omim	QUAL=9051;DP=241;AF=0.49;MQM=60;TRIO=HET,241,0.49,WT,451,0.00,HET,560,0.44	GPI	synonymous	GPI:ENST00000415930:synonymous:LOW:exon9/18:c.795G>A:p.Lys265Lys,GPI:ENST00000356487:synonymous:LOW:exon9/18:c.762G>A:p.Lys254Lys,GPI:ENST00000586425:synonymous:LOW:exon9/16:c.762G>A:p.Lys254Lys		rs1864139	0.1200	0.0806	700,126,261	0.2154,0.0440,0.0009,0.0539,0.1790	0.0970							172400 [GPI (confirmed) Hemolytic anemia,nonspherocytic,due to glucose phosphate isomerase deficiency,613470];				24	332					GPI (inh=AR pLI=0.00)
chr19	34891482	34891482	C	G	het	anno_omim	QUAL=32356;DP=459;AF=0.48;MQM=60;TRIO=HET,459,0.48,HOM,548,1.00,HET,717,0.48	RP11-618P17.4,GPI	3'UTR	GPI:ENST00000415930:3'UTR:MODIFIER:exon18/18:c.*541C>G:		rs4619515	0.8826	0.0000	11,6,3	0.0000,0.0000,0.0000,0.0000,0.0000	0.9294							172400 [GPI (confirmed) Hemolytic anemia,nonspherocytic,due to glucose phosphate isomerase deficiency,613470];				132	18					RP11-618P17.4 (inh=n/a pLI=n/a), GPI (inh=AR pLI=0.00)
chr19	35524824	35524824	T	C	het	pred_pathogenic;anno_omim	QUAL=7370;DP=176;AF=0.47;MQM=60;TRIO=HET,176,0.47,WT,267,0.00,HET,397,0.52	SCN1B	missense,intron	SCN1B:ENST00000415950:missense:MODERATE:exon3/3:c.629T>C:p.Leu210Pro,SCN1B:ENST00000262631:intron:MODIFIER:exon3/5:c.448+181T>C:,SCN1B:ENST00000595652:intron:MODIFIER:exon3/5:c.235+181T>C:		rs55742440	0.3776	0.4262	3359,1869,617	0.5748,0.4259,0.3529,0.4522,0.3121	0.4247	0.0050	D	T	B	D	0.12	600235 [SCN1B (confirmed) Epilepsy,generalized,with febrile seizures plus,type 1,604233|Brugada syndrome 5,612838|Cardiac conduction defect,nonspecific,612838|Atrial fibrillation,familial,13,615377|Epileptic encephalopathy,early infantile,52,617350];	RCV000127905.4 [benign]; 		COSM4131651	375	995					SCN1B (inh=AR+AD pLI=0.21)
chr19	36139172	36139172	G	A	hom	anno_omim	QUAL=6853;DP=64;AF=0.98;MQM=59;TRIO=HOM,64,0.98,HET,178,0.49,HET,251,0.47	COX6B1	5'UTR	COX6B1:ENST00000246554:5'UTR:MODIFIER:exon1/4:c.-145G>A:		rs10420252	0.1148	0.0000	0,0,0	0,0,0,0,0	0.1020							124089 [COX6B1 (provisional) Mitochondrial complex IV deficiency,220110];	RCV000269405.1 [likely benign]; 			4	43					COX6B1 (inh=AR pLI=0.08)
chr19	36316710	36316710	T	C	hom	anno_omim	QUAL=14464;DP=225;AF=1.00;MQM=60;TRIO=HOM,225,1.00,HOM,147,1.00,HET,196,0.47	PRODH2,NPHS1	intergenic_region	NPHS1:ENSG00000250799-ENSG00000161270:intergenic_region:MODIFIER::n.36316710T>C:		rs80296922	0.0162	0.0000	0,0,0	0,0,0,0,0	0.0368							602716 [NPHS1 (provisional) Nephrotic syndrome,type 1,256300];	RCV000385786.1 [uncertain significance]; 			2	21					PRODH2 (inh=n/a pLI=0.00), NPHS1 (inh=AR pLI=0.00)
chr19	36317556	36317556	C	A	hom	anno_omim	QUAL=18795;DP=240;AF=0.98;MQM=60;TRIO=HOM,240,0.98,HOM,266,1.00,HET,275,0.48	NPHS1	splice_region&intron	NPHS1:ENST00000378910:splice_region&intron:LOW:exon28/28:c.3595-9G>T:,NPHS1:ENST00000353632:splice_region&intron:LOW:exon27/27:c.3475-9G>T:		rs77309273	0.0198	0.0407	148,96,1	0.0084,0.0180,0.0000,0.0548,0.0115	0.0513							602716 [NPHS1 (provisional) Nephrotic syndrome,type 1,256300];	RCV000252812.1 [benign]; RCV000309915.1 [likely benign]; 			5	158					NPHS1 (inh=AR pLI=0.00)
chr19	36322270	36322270	C	T	hom	anno_omim	QUAL=42098;DP=291;AF=0.97;MQM=59;TRIO=HOM,291,0.97,HOM,469,1.00,HOM,611,1.00	NPHS1	synonymous	NPHS1:ENST00000378910:synonymous:LOW:exon26/29:c.3315G>A:p.Ser1105Ser,NPHS1:ENST00000353632:synonymous:LOW:exon25/28:c.3195G>A:p.Ser1065Ser		rs2071327	0.3676	0.3923	10277,5006,51	0.1002,0.4190,0.6509,0.3846,0.4116	0.4002							602716 [NPHS1 (provisional) Nephrotic syndrome,type 1,256300];	RCV000246751.1 [benign]; RCV000361802.1 [likely benign]; 			285	942					NPHS1 (inh=AR pLI=0.00)
chr19	36342212	36342212	C	T	het	pred_pathogenic;anno_omim	QUAL=8700;DP=296;AF=0.48;MQM=60;TRIO=HET,296,0.48,HOM,170,0.99,WT,268,0.01	NPHS1	missense	NPHS1:ENST00000378910:missense:MODERATE:exon3/29:c.349G>A:p.Glu117Lys,NPHS1:ENST00000353632:missense:MODERATE:exon3/28:c.349G>A:p.Glu117Lys		rs3814995	0.2919	0.3148	6569,2984,40	0.0854,0.4341,0.6053,0.3052,0.2400	0.3237	2.5550	T,T	T	D	T,T	26.60	602716 [NPHS1 (provisional) Nephrotic syndrome,type 1,256300];	RCV000249474.1 [benign]; RCV000364963.1 [likely benign]; 		COSM3756680	181	825					NPHS1 (inh=AR pLI=0.00)
chr19	36487146	36487146	A	G	het	anno_omim	QUAL=3772;DP=171;AF=0.51;MQM=60;TRIO=HET,171,0.51,WT,106,0.00,HET,132,0.46	SDHAF1	3'UTR	SDHAF1:ENST00000378887:3'UTR:MODIFIER:exon1/1:c.*622A>G:		rs7925	0.0948	0.0000	0,0,0	0,0,0,0,0	0.1341							612848 [SDHAF1 (provisional) Mitochondrial complex II deficiency,252011];	RCV000261418.1 [likely benign]; 			15	46					SDHAF1 (inh=AR pLI=0.11)
chr19	36583651	36583651	G	A	het	anno_omim	QUAL=8944;DP=267;AF=0.49;MQM=59;TRIO=HET,267,0.49,WT,294,0.00,HET,429,0.50	WDR62	synonymous	WDR62:ENST00000401500:synonymous:LOW:exon19/32:c.2271G>A:p.Leu757Leu,WDR62:ENST00000270301:synonymous:LOW:exon19/32:c.2271G>A:p.Leu757Leu		rs61494900	0.1228	0.1064	880,422,273	0.2275,0.0723,0.0001,0.1111,0.0894	0.1317							613583 [WDR62 (confirmed) Microcephaly 2,primary,autosomal recessive,with or without cortical malformations,604317];	RCV000147931.2 [benign]; RCV000337058.1 [likely benign]; 			61	459					WDR62 (inh=AR pLI=0.00)
chr19	36590329	36590329	T	C	hom	anno_omim	QUAL=11753;DP=109;AF=1.00;MQM=59;TRIO=HOM,109,1.00,HET,184,0.48,HOM,216,0.99	WDR62	missense	WDR62:ENST00000401500:missense:MODERATE:exon22/32:c.2549T>C:p.Leu850Ser,WDR62:ENST00000270301:missense:MODERATE:exon22/32:c.2549T>C:p.Leu850Ser		rs2285745	0.6542	0.6426	24832,13944,2641	0.7283,0.6900,0.5803,0.6550,0.5027	0.6888	0.7020	T,T	T	B,B	T,T	1.48	613583 [WDR62 (confirmed) Microcephaly 2,primary,autosomal recessive,with or without cortical malformations,604317];	RCV000147938.2 [benign]; RCV000407227.1 [likely benign]; 		COSM4131728	868	948					WDR62 (inh=AR pLI=0.00)
chr19	36594063	36594063	C	T	het	anno_omim	QUAL=6694;DP=217;AF=0.54;MQM=59;TRIO=HET,217,0.54,WT,201,0.00,HET,307,0.49	WDR62	synonymous	WDR62:ENST00000401500:synonymous:LOW:exon29/32:c.3468C>T:p.Leu1156Leu,WDR62:ENST00000270301:synonymous:LOW:exon29/32:c.3453C>T:p.Leu1151Leu		rs17851502	0.1212	0.1060	860,422,257	0.2221,0.0712,0.0001,0.1114,0.0889	0.1305							613583 [WDR62 (confirmed) Microcephaly 2,primary,autosomal recessive,with or without cortical malformations,604317];	RCV000147957.2 [benign]; RCV000372454.1 [likely benign]; 			61	458					WDR62 (inh=AR pLI=0.00)
chr19	36594659	36594659	A	T	hom	anno_omim	QUAL=15292;DP=232;AF=1.00;MQM=59;TRIO=HOM,232,1.00,HET,285,0.53,HET,347,0.55	WDR62	missense	WDR62:ENST00000401500:missense:MODERATE:exon30/32:c.3929A>T:p.Gln1310Leu,WDR62:ENST00000270301:missense:MODERATE:exon30/32:c.3914A>T:p.Gln1305Leu		rs2074435	0.7296	0.6536	26222,12268,3229	0.7891,0.7698,0.7792,0.6074,0.6142	0.6784	0.5110	T,T	T	B,B	T,T	1.71	613583 [WDR62 (confirmed) Microcephaly 2,primary,autosomal recessive,with or without cortical malformations,604317];	RCV000079454.6 [benign]; RCV000403416.1 [benign]; 		COSM3756682	807	1000					WDR62 (inh=AR pLI=0.00)
chr19	36595436	36595436	A	C	hom	anno_omim	QUAL=2150;DP=33;AF=0.97;MQM=59;TRIO=HOM,33,0.97,HOM,25,1.00,HET,46,0.50	WDR62	missense	WDR62:ENST00000401500:missense:MODERATE:exon31/32:c.4170A>C:p.Leu1390Phe,WDR62:ENST00000270301:missense:MODERATE:exon31/32:c.4155A>C:p.Leu1385Phe		rs1008328	0.7163	0.7428	33744,19823,2495	0.6920,0.8018,0.7473,0.7708,0.6046	0.7514	0.3220	T,T	T	B,B	T,T	1.35	613583 [WDR62 (confirmed) Microcephaly 2,primary,autosomal recessive,with or without cortical malformations,604317];	RCV000147972.5 [benign]; RCV000353726.1 [benign]; 		COSM1129883	1227	765					WDR62 (inh=AR pLI=0.00)
chr19	38935280	38935280	A	G	het	anno_omim	QUAL=5140;DP=143;AF=0.52;MQM=59;TRIO=HET,143,0.52,WT,170,0.01,HET,238,0.52	RYR1	synonymous	RYR1:ENST00000359596:synonymous:LOW:exon7/106:c.594A>G:p.Leu198Leu,RYR1:ENST00000355481:synonymous:LOW:exon7/105:c.594A>G:p.Leu198Leu,RYR1:ENST00000360985:synonymous:LOW:exon7/105:c.594A>G:p.Leu198Leu		rs2229139	0.5433	0.6074	22424,13822,1384	0.5229,0.6782,0.6365,0.6491,0.4098	0.6091							180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1,145600|Central core disease,117000|Minicore myopathy with external ophthalmoplegia,255320|Neuromuscular disease,congenital,with uniform type 1 fiber,117000|King-Denborough syndrome,145600];	RCV000079154.8 [other]; RCV000119644.1 [not provided]; RCV000259980.1 [benign]; RCV000277554.1 [benign]; RCV000313910.1 [benign]; RCV000354818.1 [benign]; 			837	946					RYR1 (inh=AR+AD pLI=0.00)
chr19	38939408	38939408	T	C	het	anno_omim	QUAL=10388;DP=233;AF=0.44;MQM=59;TRIO=HET,233,0.44,HET,191,0.40,HOM,201,1.00	RYR1	synonymous	RYR1:ENST00000359596:synonymous:LOW:exon11/106:c.1077T>C:p.Ala359Ala,RYR1:ENST00000355481:synonymous:LOW:exon11/105:c.1077T>C:p.Ala359Ala,RYR1:ENST00000360985:synonymous:LOW:exon11/105:c.1077T>C:p.Ala359Ala		rs10406027	0.9040	0.8844	47713,26148,4496	0.9302,0.9142,0.9924,0.8851,0.7568	0.9058							180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1,145600|Central core disease,117000|Minicore myopathy with external ophthalmoplegia,255320|Neuromuscular disease,congenital,with uniform type 1 fiber,117000|King-Denborough syndrome,145600];	RCV000079119.8 [benign]; RCV000119418.1 [not provided]; RCV000293044.1 [benign]; RCV000349685.1 [benign]; RCV000384950.1 [benign]; RCV000387851.1 [benign]; 		COSM4131781	1598	501					RYR1 (inh=AR+AD pLI=0.00)
chr19	38946182	38946182	G	A	het	anno_omim	QUAL=22412;DP=281;AF=0.47;MQM=59;TRIO=HET,281,0.47,HET,346,0.53,HOM,484,1.00	RYR1	synonymous	RYR1:ENST00000359596:synonymous:LOW:exon15/106:c.1668G>A:p.Ser556Ser,RYR1:ENST00000355481:synonymous:LOW:exon15/105:c.1668G>A:p.Ser556Ser,RYR1:ENST00000360985:synonymous:LOW:exon15/105:c.1668G>A:p.Ser556Ser		rs2288888	0.5713	0.6366	25034,15457,1561	0.5481,0.6923,0.6292,0.6811,0.4501	0.6422							180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1,145600|Central core disease,117000|Minicore myopathy with external ophthalmoplegia,255320|Neuromuscular disease,congenital,with uniform type 1 fiber,117000|King-Denborough syndrome,145600];	RCV000079135.7 [benign]; RCV000119582.1 [not provided]; RCV000283069.1 [benign]; RCV000286535.1 [benign]; RCV000340367.1 [benign]; RCV000390356.1 [benign]; 			926	926					RYR1 (inh=AR+AD pLI=0.00)
chr19	38949904	38949904	C	T	het	anno_omim	QUAL=10920;DP=218;AF=0.56;MQM=59;TRIO=HET,218,0.56,HET,145,0.48,HOM,194,1.00	RYR1	synonymous	RYR1:ENST00000359596:synonymous:LOW:exon19/106:c.2286C>T:p.Pro762Pro,RYR1:ENST00000355481:synonymous:LOW:exon19/105:c.2286C>T:p.Pro762Pro,RYR1:ENST00000360985:synonymous:LOW:exon19/105:c.2286C>T:p.Pro762Pro		rs3745847	0.5541	0.6211	23949,14881,1456	0.5304,0.6836,0.6159,0.6679,0.4181	0.6271							180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1,145600|Central core disease,117000|Minicore myopathy with external ophthalmoplegia,255320|Neuromuscular disease,congenital,with uniform type 1 fiber,117000|King-Denborough syndrome,145600];	RCV000079136.7 [benign]; RCV000119595.1 [not provided]; RCV000267870.1 [benign]; RCV000302784.1 [benign]; RCV000325270.1 [benign]; RCV000359922.1 [benign]; 		COSM4131782	891	926					RYR1 (inh=AR+AD pLI=0.00)
chr19	38959680	38959680	C	T	hom	anno_omim	QUAL=29070;DP=199;AF=0.99;MQM=60;TRIO=HOM,199,0.99,HET,451,0.50,HOM,528,1.00	RYR1	synonymous	RYR1:ENST00000359596:synonymous:LOW:exon26/106:c.3456C>T:p.Ile1152Ile,RYR1:ENST00000355481:synonymous:LOW:exon26/105:c.3456C>T:p.Ile1152Ile,RYR1:ENST00000360985:synonymous:LOW:exon26/105:c.3456C>T:p.Ile1152Ile		rs11083462	0.4493	0.3956	9943,4353,1022	0.4376,0.3229,0.4425,0.3582,0.5410	0.3911							180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1,145600|Central core disease,117000|Minicore myopathy with external ophthalmoplegia,255320|Neuromuscular disease,congenital,with uniform type 1 fiber,117000|King-Denborough syndrome,145600];	RCV000079140.7 [benign]; RCV000119611.1 [not provided]; RCV000268115.1 [benign]; RCV000269655.1 [benign]; RCV000327094.1 [benign]; RCV000360884.1 [benign]; 		COSM148605	352	924					RYR1 (inh=AR+AD pLI=0.00)
chr19	38965952	38965952	T	C	het	anno_omim	QUAL=2738;DP=111;AF=0.43;MQM=60;TRIO=HET,111,0.43,HET,137,0.52,WT,175,0.00	RYR1	splice_region&intron	RYR1:ENST00000359596:splice_region&intron:LOW:exon28/105:c.4161-6T>C:,RYR1:ENST00000355481:splice_region&intron:LOW:exon28/104:c.4161-6T>C:,RYR1:ENST00000360985:splice_region&intron:LOW:exon28/104:c.4161-6T>C:		rs55845760	0.2171	0.2427	860,188,418	0.4648,0.2711,0.0825,0.1993,0.2339	0.1861							180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1,145600|Central core disease,117000|Minicore myopathy with external ophthalmoplegia,255320|Neuromuscular disease,congenital,with uniform type 1 fiber,117000|King-Denborough syndrome,145600];	RCV000079145.6 [benign]; RCV000264083.1 [benign]; RCV000281857.1 [benign]; RCV000321657.1 [benign]; RCV000373955.1 [benign]; 			52	507					RYR1 (inh=AR+AD pLI=0.00)
chr19	38981284	38981284	A	G	het	anno_omim	QUAL=12334;DP=284;AF=0.56;MQM=60;TRIO=HET,284,0.56,HOM,251,1.00,WT,251,0.01	RYR1	synonymous	RYR1:ENST00000359596:synonymous:LOW:exon37/106:c.6039A>G:p.Lys2013Lys,RYR1:ENST00000355481:synonymous:LOW:exon37/105:c.6039A>G:p.Lys2013Lys,RYR1:ENST00000360985:synonymous:LOW:exon37/105:c.6039A>G:p.Lys2013Lys		rs2228068	0.0751	0.0919	695,321,6	0.0339,0.0886,0.0036,0.0935,0.1845	0.0911							180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1,145600|Central core disease,117000|Minicore myopathy with external ophthalmoplegia,255320|Neuromuscular disease,congenital,with uniform type 1 fiber,117000|King-Denborough syndrome,145600];	RCV000079155.7 [benign]; RCV000119646.1 [not provided]; RCV000266290.1 [benign]; RCV000310744.1 [benign]; RCV000323764.1 [benign]; RCV000358631.1 [benign]; 		COSM4131783	35	426					RYR1 (inh=AR+AD pLI=0.00)
chr19	38983180	38983180	G	T	het	pred_pathogenic;anno_omim	QUAL=7646;DP=206;AF=0.42;MQM=59;TRIO=HET,206,0.42,HOM,190,0.99,WT,231,0.00	RYR1	missense	RYR1:ENST00000359596:missense:MODERATE:exon38/106:c.6178G>T:p.Gly2060Cys,RYR1:ENST00000355481:missense:MODERATE:exon38/105:c.6178G>T:p.Gly2060Cys,RYR1:ENST00000360985:missense:MODERATE:exon38/105:c.6178G>T:p.Gly2060Cys		rs35364374	0.0549	0.0694	447,176,1	0.0112,0.0783,0.0035,0.0688,0.1566	0.0688	0.6150	T,T,T	T	P,B	T,T,T	21.20	180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1,145600|Central core disease,117000|Minicore myopathy with external ophthalmoplegia,255320|Neuromuscular disease,congenital,with uniform type 1 fiber,117000|King-Denborough syndrome,145600];	RCV000056058.2 [benign]; RCV000079156.7 [benign]; RCV000119647.1 [not provided]; RCV000209979.1 [benign]; RCV000259584.1 [benign]; RCV000299979.1 [benign]; RCV000395150.1 [benign]; 			24	314					RYR1 (inh=AR+AD pLI=0.00)
chr19	38991516	38991516	G	A	het	anno_omim	QUAL=9443;DP=230;AF=0.54;MQM=59;TRIO=HET,230,0.54,WT,310,0.00,HET,458,0.54	RYR1	synonymous	RYR1:ENST00000359596:synonymous:LOW:exon47/106:c.7500G>A:p.Ala2500Ala,RYR1:ENST00000355481:synonymous:LOW:exon47/105:c.7500G>A:p.Ala2500Ala,RYR1:ENST00000360985:synonymous:LOW:exon47/105:c.7500G>A:p.Ala2500Ala		rs2228072	0.1508	0.1140	937,252,66	0.1184,0.0870,0.1594,0.0914,0.2269	0.1098							180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1,145600|Central core disease,117000|Minicore myopathy with external ophthalmoplegia,255320|Neuromuscular disease,congenital,with uniform type 1 fiber,117000|King-Denborough syndrome,145600];	RCV000079165.7 [benign]; RCV000300125.1 [benign]; RCV000349039.1 [benign]; RCV000357373.1 [benign]; RCV000403681.1 [benign]; 			32	419					RYR1 (inh=AR+AD pLI=0.00)
chr19	38991543	38991543	G	A	het	anno_omim	QUAL=10854;DP=297;AF=0.51;MQM=59;TRIO=HET,297,0.51,WT,342,0.00,HET,509,0.53	RYR1	synonymous	RYR1:ENST00000359596:synonymous:LOW:exon47/106:c.7527G>A:p.Val2509Val,RYR1:ENST00000355481:synonymous:LOW:exon47/105:c.7527G>A:p.Val2509Val,RYR1:ENST00000360985:synonymous:LOW:exon47/105:c.7527G>A:p.Val2509Val		rs2071088	0.1360	0.1116	913,253,41	0.0883,0.0860,0.1595,0.0915,0.2280	0.1077							180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1,145600|Central core disease,117000|Minicore myopathy with external ophthalmoplegia,255320|Neuromuscular disease,congenital,with uniform type 1 fiber,117000|King-Denborough syndrome,145600];	RCV000079166.7 [benign]; RCV000119720.1 [not provided]; RCV000267498.1 [benign]; RCV000298144.1 [benign]; RCV000359902.1 [benign]; RCV000397086.1 [benign]; 			32	415					RYR1 (inh=AR+AD pLI=0.00)
chr19	38993372	38993372	A	G	het	low_DP;anno_omim	QUAL=707;DP=13;AF=0.23;MQM=60;TRIO=HET,13,0.23,WT,22,0.00,HOM,26,1.00	RYR1	splice_region&intron	RYR1:ENST00000359596:splice_region&intron:LOW:exon48/105:c.7835+5A>G:,RYR1:ENST00000355481:splice_region&intron:LOW:exon48/104:c.7835+5A>G:,RYR1:ENST00000360985:splice_region&intron:LOW:exon48/104:c.7835+5A>G:		rs1469695	0.4219	0.3366	6386,2083,965	0.4667,0.4500,0.3497,0.2693,0.4444	0.3469							180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1,145600|Central core disease,117000|Minicore myopathy with external ophthalmoplegia,255320|Neuromuscular disease,congenital,with uniform type 1 fiber,117000|King-Denborough syndrome,145600];	RCV000079170.7 [benign]; RCV000119729.1 [not provided]; RCV000274147.1 [benign]; RCV000314041.1 [benign]; RCV000370968.1 [benign]; RCV000404387.1 [benign]; 			200	851					RYR1 (inh=AR+AD pLI=0.00)
chr19	38993547	38993547	C	T	het	anno_omim	QUAL=4909;DP=164;AF=0.51;MQM=59;TRIO=HET,164,0.51,WT,78,0.00,HOM,107,1.00	RYR1	synonymous	RYR1:ENST00000359596:synonymous:LOW:exon49/106:c.7863C>T:p.His2621His,RYR1:ENST00000355481:synonymous:LOW:exon49/105:c.7863C>T:p.His2621His,RYR1:ENST00000360985:synonymous:LOW:exon49/105:c.7863C>T:p.His2621His		rs2229142	0.2378	0.1821	2233,752,190	0.1923,0.1361,0.2941,0.1500,0.2867	0.1778							180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1,145600|Central core disease,117000|Minicore myopathy with external ophthalmoplegia,255320|Neuromuscular disease,congenital,with uniform type 1 fiber,117000|King-Denborough syndrome,145600];	RCV000079172.7 [benign]; RCV000119732.1 [not provided]; RCV000296738.1 [benign]; RCV000350558.1 [benign]; RCV000351618.1 [benign]; RCV000390814.1 [benign]; 		COSM148609	83	607					RYR1 (inh=AR+AD pLI=0.00)
chr19	38994910	38994910	G	A	het	anno_omim	QUAL=9306;DP=263;AF=0.50;MQM=59;TRIO=HET,263,0.50,WT,163,0.01,HOM,195,1.00	RYR1	synonymous	RYR1:ENST00000359596:synonymous:LOW:exon50/106:c.7977G>A:p.Thr2659Thr,RYR1:ENST00000355481:synonymous:LOW:exon50/105:c.7977G>A:p.Thr2659Thr,RYR1:ENST00000360985:synonymous:LOW:exon50/105:c.7977G>A:p.Thr2659Thr		rs2229144	0.4123	0.3261	6847,2252,1130	0.4705,0.4071,0.3435,0.2600,0.4468	0.3252							180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1,145600|Central core disease,117000|Minicore myopathy with external ophthalmoplegia,255320|Neuromuscular disease,congenital,with uniform type 1 fiber,117000|King-Denborough syndrome,145600];	RCV000079174.8 [benign]; RCV000119736.1 [not provided]; RCV000271603.1 [benign]; RCV000307899.1 [benign]; RCV000312792.1 [benign]; RCV000366261.1 [benign]; 		COSM148610	199	862					RYR1 (inh=AR+AD pLI=0.00)
chr19	38995438	38995438	T	C	het	anno_omim	QUAL=9122;DP=173;AF=0.51;MQM=59;TRIO=HET,173,0.51,WT,184,0.01,HOM,224,1.00	RYR1	synonymous	RYR1:ENST00000359596:synonymous:LOW:exon51/106:c.8118T>C:p.Ile2706Ile,RYR1:ENST00000355481:synonymous:LOW:exon51/105:c.8118T>C:p.Ile2706Ile,RYR1:ENST00000360985:synonymous:LOW:exon51/105:c.8118T>C:p.Ile2706Ile		rs2960340	0.4151	0.3264	6973,2271,1133	0.4696,0.4068,0.3426,0.2592,0.4552	0.3253							180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1,145600|Central core disease,117000|Minicore myopathy with external ophthalmoplegia,255320|Neuromuscular disease,congenital,with uniform type 1 fiber,117000|King-Denborough syndrome,145600];	RCV000079175.7 [benign]; RCV000119738.1 [not provided]; RCV000310752.1 [benign]; RCV000346944.1 [benign]; RCV000405618.1 [benign]; RCV000406007.1 [benign]; 		COSM148611	200	867					RYR1 (inh=AR+AD pLI=0.00)
chr19	38995510	38995510	T	C	het	anno_omim	QUAL=13993;DP=319;AF=0.49;MQM=59;TRIO=HET,319,0.49,WT,277,0.01,HOM,317,1.00	RYR1	synonymous	RYR1:ENST00000359596:synonymous:LOW:exon51/106:c.8190T>C:p.Asp2730Asp,RYR1:ENST00000355481:synonymous:LOW:exon51/105:c.8190T>C:p.Asp2730Asp,RYR1:ENST00000360985:synonymous:LOW:exon51/105:c.8190T>C:p.Asp2730Asp		rs2915951	0.4171	0.3294	7072,2345,1136	0.4704,0.4076,0.3434,0.2635,0.4553	0.3285							180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1,145600|Central core disease,117000|Minicore myopathy with external ophthalmoplegia,255320|Neuromuscular disease,congenital,with uniform type 1 fiber,117000|King-Denborough syndrome,145600];	RCV000079176.7 [benign]; RCV000119741.1 [not provided]; RCV000276810.1 [benign]; RCV000299073.1 [benign]; RCV000311779.1 [benign]; RCV000371398.1 [benign]; 		COSM148612	203	873					RYR1 (inh=AR+AD pLI=0.00)
chr19	38995975	38995975	G	A	het	anno_omim	QUAL=4727;DP=153;AF=0.47;MQM=60;TRIO=HET,153,0.47,WT,76,0.00,HOM,93,0.99	RYR1	synonymous	RYR1:ENST00000359596:synonymous:LOW:exon53/106:c.8337G>A:p.Glu2779Glu,RYR1:ENST00000355481:synonymous:LOW:exon53/105:c.8337G>A:p.Glu2779Glu,RYR1:ENST00000360985:synonymous:LOW:exon53/105:c.8337G>A:p.Glu2779Glu		rs2915952	0.4060	0.3294	6270,2046,892	0.4455,0.4094,0.3422,0.2649,0.4604	0.3189							180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1,145600|Central core disease,117000|Minicore myopathy with external ophthalmoplegia,255320|Neuromuscular disease,congenital,with uniform type 1 fiber,117000|King-Denborough syndrome,145600];	RCV000079177.7 [benign]; RCV000119745.1 [not provided]; RCV000293580.1 [benign]; RCV000344459.1 [benign]; RCV000348376.1 [benign]; RCV000383245.1 [benign]; 		COSM148613	200	862					RYR1 (inh=AR+AD pLI=0.00)
chr19	38996990	38996990	T	C	het	anno_omim	QUAL=13469;DP=249;AF=0.53;MQM=59;TRIO=HET,249,0.53,WT,268,0.01,HOM,330,0.99	RYR1	synonymous	RYR1:ENST00000359596:synonymous:LOW:exon55/106:c.8589T>C:p.Ser2863Ser,RYR1:ENST00000355481:synonymous:LOW:exon55/105:c.8589T>C:p.Ser2863Ser,RYR1:ENST00000360985:synonymous:LOW:exon55/105:c.8589T>C:p.Ser2863Ser		rs2229146	0.4081	0.3265	6923,2338,1002	0.4402,0.4059,0.3432,0.2631,0.4555	0.3256							180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1,145600|Central core disease,117000|Minicore myopathy with external ophthalmoplegia,255320|Neuromuscular disease,congenital,with uniform type 1 fiber,117000|King-Denborough syndrome,145600];	RCV000079178.7 [benign]; RCV000119753.1 [not provided]; RCV000281789.1 [benign]; RCV000304127.1 [benign]; RCV000339193.1 [benign]; RCV000403926.1 [benign]; 		COSM148614	203	871					RYR1 (inh=AR+AD pLI=0.00)
chr19	39002725	39002725	A	G	het	anno_omim	QUAL=3647;DP=101;AF=0.48;MQM=60;TRIO=HET,101,0.48,WT,110,0.00,HOM,89,0.98	RYR1	synonymous	RYR1:ENST00000359596:synonymous:LOW:exon62/106:c.9186A>G:p.Pro3062Pro,RYR1:ENST00000355481:synonymous:LOW:exon62/105:c.9186A>G:p.Pro3062Pro,RYR1:ENST00000360985:synonymous:LOW:exon62/105:c.9186A>G:p.Pro3062Pro		rs2071089	0.4069	0.3251	6688,2227,977	0.4402,0.4010,0.3409,0.2613,0.4573	0.3232							180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1,145600|Central core disease,117000|Minicore myopathy with external ophthalmoplegia,255320|Neuromuscular disease,congenital,with uniform type 1 fiber,117000|King-Denborough syndrome,145600];	RCV000079184.7 [benign]; RCV000119767.1 [not provided]; RCV000293902.1 [benign]; RCV000297297.1 [benign]; RCV000351185.1 [benign]; RCV000406849.1 [benign]; 		COSM3756756	200	869					RYR1 (inh=AR+AD pLI=0.00)
chr19	39010053	39010053	C	T	het	low_DP;anno_omim	QUAL=216;DP=7;AF=0.57;MQM=60;TRIO=HET,7,0.57,WT,7,0.00,HET,8,0.88	RYR1	synonymous	RYR1:ENST00000359596:synonymous:LOW:exon67/106:c.10218C>T:p.Tyr3406Tyr,RYR1:ENST00000355481:synonymous:LOW:exon67/105:c.10218C>T:p.Tyr3406Tyr,RYR1:ENST00000360985:synonymous:LOW:exon67/105:c.10218C>T:p.Tyr3406Tyr		rs41274330	0.1022	0.1055	516,56,1	0.0134,0.0961,0.2148,0.0698,0.2377	0.0759							180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1,145600|Central core disease,117000|Minicore myopathy with external ophthalmoplegia,255320|Neuromuscular disease,congenital,with uniform type 1 fiber,117000|King-Denborough syndrome,145600];	RCV000079116.7 [benign]; RCV000119405.1 [not provided]; RCV000262204.1 [benign]; RCV000301982.1 [benign]; RCV000317374.1 [benign]; RCV000356845.1 [benign]; 			24	283					RYR1 (inh=AR+AD pLI=0.00)
chr19	40900865	40900865	C	T	hom	anno_omim	QUAL=12699;DP=116;AF=0.97;MQM=59;TRIO=HOM,116,0.97,HOM,125,0.99,HOM,181,0.99	PRX	missense,3'UTR	PRX:ENST00000324001:missense:MODERATE:exon7/7:c.3394G>A:p.Gly1132Arg,PRX:ENST00000291825:3'UTR:MODIFIER:exon6/6:c.*3599G>A:		rs268674	0.9655	0.9469	54288,29495,5083	0.9902,0.9527,0.9790,0.9424,0.9203	0.9599	-0.1040	T,T	T	B	T	2.77	605725 [PRX (provisional) Dejerine-Sottas disease,145900|Charcot-Marie-Tooth disease,type 4F,614895];	RCV000118080.3 [other]; RCV000293783.1 [benign]; 		COSM3756794	1811	290					PRX (inh=AR+AD pLI=0.00)
chr19	40901604	40901604	A	G	het	anno_omim	QUAL=8452;DP=195;AF=0.54;MQM=59;TRIO=HET,195,0.54,HOM,203,0.99,WT,288,0.00	PRX	synonymous,3'UTR	PRX:ENST00000324001:synonymous:LOW:exon7/7:c.2655T>C:p.Pro885Pro,PRX:ENST00000291825:3'UTR:MODIFIER:exon6/6:c.*2860T>C:		rs268672	0.5319	0.5070	16573,8832,3336	0.8040,0.5177,0.1932,0.5129,0.4753	0.5686							605725 [PRX (provisional) Dejerine-Sottas disease,145900|Charcot-Marie-Tooth disease,type 4F,614895];	RCV000118076.2 [likely benign]; RCV000326806.1 [benign]; 		COSM4131847	551	1007					PRX (inh=AR+AD pLI=0.00)
chr19	40901614	40901614	A	G	het	pred_pathogenic;anno_omim	QUAL=8298;DP=210;AF=0.53;MQM=59;TRIO=HET,210,0.53,HOM,202,0.99,WT,272,0.01	PRX	missense,3'UTR	PRX:ENST00000324001:missense:MODERATE:exon7/7:c.2645T>C:p.Val882Ala,PRX:ENST00000291825:3'UTR:MODIFIER:exon6/6:c.*2850T>C:		rs268671	0.5319	0.5069	16557,8815,3340	0.8041,0.5175,0.1938,0.5124,0.4753	0.5680	2.6800	T,T	T	B	T	0.01	605725 [PRX (provisional) Dejerine-Sottas disease,145900|Charcot-Marie-Tooth disease,type 4F,614895];	RCV000118075.2 [likely benign]; RCV000388381.1 [benign]; 		COSM4000733	549	1008					PRX (inh=AR+AD pLI=0.00)
chr19	41892269	41892269	C	T	hom	anno_omim	QUAL=5873;DP=56;AF=1.00;MQM=60;TRIO=HOM,56,1.00,HOM,64,1.00,HOM,71,1.00	CTC-435M10.3,BCKDHA	intron	BCKDHA:ENST00000595085:intron:MODIFIER:exon1/8:c.210+7845C>T:	L2b	rs3826713	0.5044	0.0000	0,0,0	0,0,0,0,0	0.5608							608348 [BCKDHA (confirmed) Maple syrup urine disease,type Ia,248600];				75	107					CTC-435M10.3 (inh=n/a pLI=n/a), BCKDHA (inh=AR pLI=0.00)
chr19	41903220	41903220	G	A	hom	anno_omim	QUAL=29155;DP=249;AF=0.99;MQM=60;TRIO=HOM,249,0.99,HOM,293,1.00,HOM,400,1.00	EXOSC5,CTC-435M10.3,BCKDHA	missense,intron	EXOSC5:ENST00000221233:missense:MODERATE:exon1/6:c.14C>T:p.Thr5Met,EXOSC5:ENST00000596905:missense:MODERATE:exon1/5:c.14C>T:p.Thr5Met,BCKDHA:ENST00000595085:intron:MODIFIER:exon1/8:c.211-13322G>A:		rs10853751	0.6144	0.5954	22014,11928,3534	0.8262,0.4629,0.4321,0.5991,0.5903	0.6520	-0.0950	T	T	B	T	8.76	608348 [BCKDHA (confirmed) Maple syrup urine disease,type Ia,248600];				678	783					EXOSC5 (inh=n/a pLI=0.00), CTC-435M10.3 (inh=n/a pLI=n/a), BCKDHA (inh=AR pLI=0.00)
chr19	41903699	41903699	T	G	het	anno_omim	QUAL=754;DP=67;AF=0.36;MQM=60;TRIO=HET,67,0.36,HET,26,0.46,WT,40,0.00	BCKDHA,CTC-435M10.3	5'UTR,intron	BCKDHA:ENST00000269980:5'UTR:MODIFIER:exon1/9:c.-34T>G:,BCKDHA:ENST00000595085:intron:MODIFIER:exon1/8:c.211-12843T>G:		rs45500792	0.0825	0.1172	899,589,1	0.0379,0.0611,0.0546,0.1376,0.1628	0.1155							608348 [BCKDHA (confirmed) Maple syrup urine disease,type Ia,248600];	RCV000079215.5 [other]; RCV000337766.1 [likely benign]; 			40	524					BCKDHA (inh=AR pLI=0.00), CTC-435M10.3 (inh=n/a pLI=n/a)
chr19	41916549	41916549	C	A	het	pred_pathogenic;anno_omim	QUAL=2294;DP=67;AF=0.58;MQM=59;TRIO=HET,67,0.58,HET,140,0.45,WT,178,0.01	CTC-435M10.3,BCKDHA	missense,splice_region&intron	BCKDHA:ENST00000595085:missense:MODERATE:exon2/9:c.218C>A:p.Pro73His,BCKDHA:ENST00000269980:missense:MODERATE:exon2/9:c.116C>A:p.Pro39His,BCKDHA:ENST00000457836:splice_region&intron:LOW:exon1/8:c.58-8C>A:		rs11549936	0.0553	0.0985	711,538,1	0.0219,0.0540,0.0008,0.1291,0.1159	0.0992	-1.4150	T,T,T,T	T	B,B,B	D,D,D	2.13	608348 [BCKDHA (confirmed) Maple syrup urine disease,type Ia,248600];	RCV000079222.9 [other]; RCV000396713.1 [likely benign]; 		COSM4131898	37	512					CTC-435M10.3 (inh=n/a pLI=n/a), BCKDHA (inh=AR pLI=0.00)
chr19	41928652	41928652	C	T	hom	anno_omim	QUAL=16688;DP=129;AF=0.98;MQM=59;TRIO=HOM,129,0.98,HOM,186,0.99,HOM,247,1.00	CTC-435M10.3,BCKDHA	synonymous	BCKDHA:ENST00000595085:synonymous:LOW:exon7/9:c.1074C>T:p.Phe358Phe,BCKDHA:ENST00000269980:synonymous:LOW:exon7/9:c.972C>T:p.Phe324Phe,BCKDHA:ENST00000457836:synonymous:LOW:exon7/9:c.906C>T:p.Phe302Phe		rs284652	0.6164	0.5994	22181,12060,3531	0.8268,0.4705,0.4368,0.6043,0.5894	0.6548							608348 [BCKDHA (confirmed) Maple syrup urine disease,type Ia,248600];	RCV000079266.9 [other]; RCV000284317.1 [benign]; 		COSM3933055	830	969					CTC-435M10.3 (inh=n/a pLI=n/a), BCKDHA (inh=AR pLI=0.00)
chr19	41930396	41930396	A	G	hom	anno_omim	QUAL=4690;DP=74;AF=0.96;MQM=59;TRIO=HOM,74,0.96,HOM,43,1.00,HOM,52,1.00	BCKDHA,CTC-435M10.3	synonymous	BCKDHA:ENST00000595085:synonymous:LOW:exon9/9:c.1323A>G:p.Leu441Leu,BCKDHA:ENST00000269980:synonymous:LOW:exon9/9:c.1221A>G:p.Leu407Leu,BCKDHA:ENST00000457836:synonymous:LOW:exon9/9:c.1230A>G:p.Leu410Leu		rs4674	0.6170	0.6000	22302,12132,3540	0.8272,0.4707,0.4411,0.6046,0.5900	0.6565							608348 [BCKDHA (confirmed) Maple syrup urine disease,type Ia,248600];	RCV000079224.8 [other]; RCV000394945.1 [benign]; 			835	965					BCKDHA (inh=AR pLI=0.00), CTC-435M10.3 (inh=n/a pLI=n/a)
chr19	45854919	45854919	T	G	hom	pred_pathogenic;anno_omim	QUAL=20147;DP=138;AF=0.99;MQM=59;TRIO=HOM,138,0.99,HET,334,0.44,HOM,412,1.00	ERCC2	missense	ERCC2:ENST00000391945:missense:MODERATE:exon23/23:c.2251A>C:p.Lys751Gln,ERCC2:ENST00000391944:missense:MODERATE:exon21/21:c.2017A>C:p.Lys673Gln		rs13181	0.2366	0.3308	7354,5029,253	0.2262,0.1870,0.0757,0.3865,0.3738	0.3262	1.1980	T,T,T,T	T	B,B	T,D	10.56	126340 [ERCC2 (confirmed) Xeroderma pigmentosum,group D,278730|Trichothiodystrophy 1,photosensitive,601675|Cerebrooculofacioskeletal syndrome 2,610756];	RCV000120777.2 [benign]; RCV000282755.1 [benign]; 	CM004814 [CLASS=DFP MUT=ALT PHEN="Basal cell carcinoma reduced risk association with" GENE=ERCC2]; 	COSM4132125	773	2266					ERCC2 (inh=AR pLI=0.00)
chr19	45855524	45855524	G	A	hom	anno_omim	QUAL=7015;DP=136;AF=1.00;MQM=60;TRIO=HOM,136,1.00,HET,45,0.56,HOM,77,1.00	ERCC2	synonymous	ERCC2:ENST00000391945:synonymous:LOW:exon22/23:c.2133C>T:p.Asp711Asp,ERCC2:ENST00000391944:synonymous:LOW:exon20/21:c.1899C>T:p.Asp633Asp		rs1052555	0.1823	0.2859	5793,4062,58	0.1033,0.1384,0.0649,0.3466,0.3341	0.2834							126340 [ERCC2 (confirmed) Xeroderma pigmentosum,group D,278730|Trichothiodystrophy 1,photosensitive,601675|Cerebrooculofacioskeletal syndrome 2,610756];	RCV000249244.1 [benign]; RCV000334441.1 [benign]; 	CM052870 [CLASS=DP MUT=ALT PHEN="Reduced risk oligodendroglioma development association" GENE=ERCC2]; 	COSM3756953	650	2181					ERCC2 (inh=AR pLI=0.00)
chr19	45867259	45867259	C	T	hom	pred_pathogenic;anno_omim	QUAL=5146;DP=45;AF=1.00;MQM=60;TRIO=HOM,45,1.00,HET,70,0.46,HOM,99,1.00	ERCC2	missense,3'UTR	ERCC2:ENST00000391945:missense:MODERATE:exon10/23:c.934G>A:p.Asp312Asn,ERCC2:ENST00000391944:missense:MODERATE:exon8/21:c.700G>A:p.Asp234Asn,ERCC2:ENST00000485403:missense:MODERATE:exon9/12:c.862G>A:p.Asp288Asn,ERCC2:ENST00000391940:missense:MODERATE:exon10/13:c.862G>A:p.Asp288Asn,ERCC2:ENST00000221481:3'UTR:MODIFIER:exon7/8:c.*192G>A:		rs1799793	0.1945	0.3788	1102,479,9	0.1572,0.3660,0.1333,0.4372,0.3671	0.2908	7.1920	T,T,T,T,T	T	B,B,B	T,T,T	24.00	126340 [ERCC2 (confirmed) Xeroderma pigmentosum,group D,278730|Trichothiodystrophy 1,photosensitive,601675|Cerebrooculofacioskeletal syndrome 2,610756];	RCV000120789.2 [benign]; RCV000393523.1 [benign]; 	CM015299 [CLASS=DFP MUT=ALT PHEN="Increased response to UV association with" GENE=ERCC2]; 	COSM3749518, COSM3749519	757	2215					ERCC2 (inh=AR pLI=0.00)
chr19	45868309	45868309	T	G	hom	anno_omim	QUAL=23228;DP=138;AF=1.00;MQM=59;TRIO=HOM,138,1.00,HET,364,0.49,HOM,475,1.00	ERCC2	synonymous,intron	ERCC2:ENST00000391945:synonymous:LOW:exon6/23:c.468A>C:p.Arg156Arg,ERCC2:ENST00000485403:synonymous:LOW:exon5/12:c.396A>C:p.Arg132Arg,ERCC2:ENST00000391940:synonymous:LOW:exon6/13:c.396A>C:p.Arg132Arg,ERCC2:ENST00000391944:intron:MODIFIER:exon5/20:c.361-504A>C:,ERCC2:ENST00000221481:intron:MODIFIER:exon5/7:c.361-720A>C:		rs238406	0.6362	0.5898	21339,10481,3987	0.8762,0.5212,0.5167,0.5646,0.5987	0.6449							126340 [ERCC2 (confirmed) Xeroderma pigmentosum,group D,278730|Trichothiodystrophy 1,photosensitive,601675|Cerebrooculofacioskeletal syndrome 2,610756];	RCV000242247.1 [benign]; RCV000323397.1 [benign]; 			1646	2401					ERCC2 (inh=AR pLI=0.00)
chr19	45910672	45910672	A	G	hom	anno_omim	QUAL=9194;DP=201;AF=1.00;MQM=60;TRIO=HOM,201,1.00,HOM,56,1.00,HET,95,0.47	ERCC1,CD3EAP	3'UTR,intron	ERCC1:ENST00000300853:3'UTR:MODIFIER:exon10/10:c.*2261T>C:,ERCC1:ENST00000423698:3'UTR:MODIFIER:exon9/9:c.*2261T>C:,CD3EAP:ENST00000589804:intron:MODIFIER:exon2/2:c.170+179A>G:,CD3EAP:ENST00000309424:intron:MODIFIER:exon2/2:c.164+179A>G:	MER41D	rs1046282	0.3249	0.0000	0,0,0	0,0,0,0,0	0.2930							126380 [ERCC1 (confirmed) Cerebrooculofacioskeletal syndrome 4,610758];				20	80					ERCC1 (inh=AR pLI=0.00), CD3EAP (inh=n/a pLI=0.00)
chr19	45911320	45911320	A	-	hom	anno_omim	QUAL=21151;DP=212;AF=0.95;MQM=59;TRIO=HOM,212,0.95,HOM,328,0.98,HET,447,0.56	ERCC1,CD3EAP	3'UTR,intron	ERCC1:ENST00000300853:3'UTR:MODIFIER:exon10/10:c.*1613delT:,ERCC1:ENST00000423698:3'UTR:MODIFIER:exon9/9:c.*1613delT:,CD3EAP:ENST00000589804:intron:MODIFIER:exon2/2:c.171-62delA:,CD3EAP:ENST00000309424:intron:MODIFIER:exon2/2:c.165-62delA:	AluSx1	rs11314106	0.0000	0.0000	0,0,0	0,0,0,0,0	0.3725							126380 [ERCC1 (confirmed) Cerebrooculofacioskeletal syndrome 4,610758];				46	139					ERCC1 (inh=AR pLI=0.00), CD3EAP (inh=n/a pLI=0.00)
chr19	45912490	45912492	AAG	-	hom	anno_omim	QUAL=13792;DP=178;AF=0.98;MQM=59;TRIO=HOM,178,0.98,HOM,212,0.97,HET,233,0.55	CD3EAP,ERCC1	disruptive_inframe_deletion,3'UTR	CD3EAP:ENST00000589804:disruptive_inframe_deletion:MODERATE:exon3/3:c.1287_1289delGAA:p.Lys430del,CD3EAP:ENST00000309424:disruptive_inframe_deletion:MODERATE:exon3/3:c.1281_1283delGAA:p.Lys428del,ERCC1:ENST00000300853:3'UTR:MODIFIER:exon10/10:c.*441_*443delCTT:,ERCC1:ENST00000423698:3'UTR:MODIFIER:exon9/9:c.*441_*443delCTT:	(AAG)n	rs35729377;rs374686338	0.0000	0.2366	1707,1238,29	0.1242,0.1815,0.0564,0.2694,0.3187	0.2383							126380 [ERCC1 (confirmed) Cerebrooculofacioskeletal syndrome 4,610758];			COSM1481223	130	666					CD3EAP (inh=n/a pLI=0.00), ERCC1 (inh=AR pLI=0.00)
chr19	45912736	45912736	C	A	hom	anno_omim	QUAL=11258;DP=133;AF=1.00;MQM=59;TRIO=HOM,133,1.00,HOM,170,0.99,HET,180,0.48	CD3EAP,ERCC1	missense,3'UTR	CD3EAP:ENST00000589804:missense:MODERATE:exon3/3:c.1516C>A:p.Gln506Lys,CD3EAP:ENST00000309424:missense:MODERATE:exon3/3:c.1510C>A:p.Gln504Lys,ERCC1:ENST00000300853:3'UTR:MODIFIER:exon10/10:c.*197G>T:,ERCC1:ENST00000423698:3'UTR:MODIFIER:exon9/9:c.*197G>T:	(AGC)n	rs3212986	0.2951	0.3237	4297,1703,385	0.3510,0.4799,0.3577,0.2888,0.3303	0.2901	-1.3970	T	T	B,B	T	0.01	126380 [ERCC1 (confirmed) Cerebrooculofacioskeletal syndrome 4,610758];	RCV000211219.1 [drug response]; RCV000211315.1 [drug response]; RCV000211398.1 [drug response]; 			167	729					CD3EAP (inh=n/a pLI=0.00), ERCC1 (inh=AR pLI=0.00)
chr19	45923653	45923653	A	G	hom	anno_omim	QUAL=22904;DP=179;AF=0.99;MQM=60;TRIO=HOM,179,0.99,HOM,357,0.99,HET,456,0.52	ERCC1	synonymous	ERCC1:ENST00000013807:synonymous:LOW:exon3/8:c.354T>C:p.Asn118Asn,ERCC1:ENST00000300853:synonymous:LOW:exon4/10:c.354T>C:p.Asn118Asn,ERCC1:ENST00000423698:synonymous:LOW:exon3/9:c.138T>C:p.Asn46Asn,ERCC1:ENST00000340192:synonymous:LOW:exon4/9:c.354T>C:p.Asn118Asn,ERCC1:ENST00000591636:synonymous:LOW:exon3/6:c.354T>C:p.Asn118Asn,ERCC1:ENST00000589165:synonymous:LOW:exon4/10:c.354T>C:p.Asn118Asn		rs11615	0.6689	0.5085	16939,4659,4049	0.8872,0.7284,0.7365,0.3854,0.5387	0.5425							126380 [ERCC1 (confirmed) Cerebrooculofacioskeletal syndrome 4,610758];	RCV000211176.1 [drug response]; RCV000211179.1 [drug response]; RCV000211295.1 [drug response]; RCV000211304.1 [drug response]; RCV000211427.1 [drug response]; RCV000407425.1 [benign]; 			467	998					ERCC1 (inh=AR pLI=0.00)
chr19	45998346	45998346	C	A	hom	anno_omim	QUAL=13652;DP=244;AF=0.99;MQM=59;TRIO=HOM,244,0.99,HET,208,0.45,HET,330,0.45	RTN2,PPM1N	splice_region&intron,intron	RTN2:ENST00000245923:splice_region&intron:LOW:exon2/10:c.79+7G>T:,RTN2:ENST00000344680:splice_region&intron:LOW:exon2/9:c.79+7G>T:,RTN2:ENST00000590526:splice_region&intron:LOW:exon2/10:c.-744+7G>T:,PPM1N:ENST00000401705:intron:MODIFIER:exon1/4:c.-15-4861C>A:		rs2298887	0.1494	0.1569	1716,873,163	0.1728,0.0728,0.0799,0.1594,0.2300	0.1596							603183 [RTN2 (provisional) Spastic paraplegia 12,autosomal dominant,604805];				92	776					RTN2 (inh=AD pLI=0.64), PPM1N (inh=n/a pLI=0.00)
chr19	46031606	46031606	T	C	hom	anno_omim	QUAL=25304;DP=282;AF=1.00;MQM=59;TRIO=HOM,282,1.00,HOM,257,1.00,HOM,278,1.00	OPA3	3'UTR	OPA3:ENST00000323060:3'UTR:MODIFIER:exon2/2:c.*708A>G:		rs7259834	0.9888	0.0000	0,0,0	0,0,0,0,0	0.9794							606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III,258501|Optic atrophy 3 with cataract,165300];				223	9					OPA3 (inh=AR pLI=0.00)
chr19	46049982	46049982	A	G	hom	anno_omim	QUAL=853;DP=22;AF=1.00;MQM=60;TRIO=HOM,22,1.00,HOM,7,1.00,HOM,1,1.00	OPA3	3'UTR,intron	OPA3:ENST00000263275:3'UTR:MODIFIER:exon2/2:c.*6790T>C:,OPA3:ENST00000323060:intron:MODIFIER:exon1/1:c.143-17268T>C:	AluSz	rs10422253	0.7754	0.0000	0,0,0	0,0,0,0,0	0.7637							606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III,258501|Optic atrophy 3 with cataract,165300];	RCV000311918.1 [benign]; RCV000401947.1 [benign]; 			129	49					OPA3 (inh=AR pLI=0.00)
chr19	46050760	46050760	T	C	het	anno_omim	QUAL=17543;DP=384;AF=0.52;MQM=59;TRIO=HET,384,0.52,HET,395,0.54,HET,484,0.51	OPA3	3'UTR,intron	OPA3:ENST00000263275:3'UTR:MODIFIER:exon2/2:c.*6012A>G:,OPA3:ENST00000323060:intron:MODIFIER:exon1/1:c.143-18046A>G:	L2b	rs11083772	0.6380	0.0000	0,0,0	0,0,0,0,0	0.5756							606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III,258501|Optic atrophy 3 with cataract,165300];	RCV000344363.1 [benign]; RCV000407518.1 [benign]; 			73	72					OPA3 (inh=AR pLI=0.00)
chr19	46051915	46051915	T	A	het	anno_omim	QUAL=2467;DP=135;AF=0.44;MQM=59;TRIO=HET,135,0.44,HOM,46,0.96,WT,60,0.00	OPA3	3'UTR,intron	OPA3:ENST00000263275:3'UTR:MODIFIER:exon2/2:c.*4857A>T:,OPA3:ENST00000323060:intron:MODIFIER:exon1/1:c.143-19201A>T:	(T)n	rs4803833	0.7610	0.0000	0,0,0	0,0,0,0,0	0.6958							606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III,258501|Optic atrophy 3 with cataract,165300];	RCV000337162.1 [benign]; RCV000375401.1 [benign]; 			71	95					OPA3 (inh=AR pLI=0.00)
chr19	46051920	46051922	TTT	-	het	anno_omim	QUAL=1189;DP=101;AF=0.44;MQM=59;TRIO=HET,101,0.44,HOM,33,0.88,WT,37,0.00	OPA3	3'UTR,intron	OPA3:ENST00000263275:3'UTR:MODIFIER:exon2/2:c.*4850_*4852delAAA:,OPA3:ENST00000323060:intron:MODIFIER:exon1/1:c.143-19208_143-19206delAAA:	(T)n	rs761676585	0.7610	0.0000	0,0,0	0,0,0,0,0	0.7061							606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III,258501|Optic atrophy 3 with cataract,165300];	RCV000314705.1 [benign]; RCV000392404.1 [benign]; 			79	72					OPA3 (inh=AR pLI=0.00)
chr19	46052454	46052454	A	G	het	anno_omim	QUAL=18559;DP=392;AF=0.56;MQM=60;TRIO=HET,392,0.56,HOM,389,1.00,WT,530,0.00	OPA3	3'UTR,intron	OPA3:ENST00000263275:3'UTR:MODIFIER:exon2/2:c.*4318T>C:,OPA3:ENST00000323060:intron:MODIFIER:exon1/1:c.143-19740T>C:		rs4802261	0.7584	0.0000	0,0,0	0,0,0,0,0	0.7021							606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III,258501|Optic atrophy 3 with cataract,165300];	RCV000331372.1 [benign]; RCV000369693.1 [benign]; 			89	112					OPA3 (inh=AR pLI=0.00)
chr19	46052621	46052625	CAGGG	-	het	anno_omim	QUAL=11254;DP=178;AF=0.53;MQM=59;TRIO=HET,178,0.53,HOM,335,0.99,WT,403,0.00	OPA3	3'UTR,intron	OPA3:ENST00000263275:3'UTR:MODIFIER:exon2/2:c.*4147_*4151delCCCTG:,OPA3:ENST00000323060:intron:MODIFIER:exon1/1:c.143-19911_143-19907delCCCTG:		rs774875450	0.7584	0.0000	0,0,0	0,0,0,0,0	0.6971							606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III,258501|Optic atrophy 3 with cataract,165300];	RCV000277715.1 [benign]; RCV000325765.1 [benign]; 			90	111					OPA3 (inh=AR pLI=0.00)
chr19	46052898	46052898	C	T	het	anno_omim	QUAL=4822;DP=191;AF=0.52;MQM=55;TRIO=HET,191,0.52,HET,187,0.48,WT,213,0.00	OPA3	3'UTR,intron	OPA3:ENST00000263275:3'UTR:MODIFIER:exon2/2:c.*3874G>A:,OPA3:ENST00000323060:intron:MODIFIER:exon1/1:c.143-20184G>A:	AluSz6	rs62109650	0.1546	0.0000	0,0,0	0,0,0,0,0	0.2120							606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III,258501|Optic atrophy 3 with cataract,165300];	RCV000314945.1 [likely benign]; RCV000407934.1 [likely benign]; 			14	73					OPA3 (inh=AR pLI=0.00)
chr19	46053385	46053385	C	T	het	anno_omim	QUAL=1792;DP=96;AF=0.50;MQM=59;TRIO=HET,96,0.50,HOM,18,1.00,WT,21,0.00	OPA3	3'UTR,intron	OPA3:ENST00000263275:3'UTR:MODIFIER:exon2/2:c.*3387G>A:,OPA3:ENST00000323060:intron:MODIFIER:exon1/1:c.143-20671G>A:	AluSx1	rs3760844	0.7602	0.0000	0,0,0	0,0,0,0,0	0.7033							606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III,258501|Optic atrophy 3 with cataract,165300];	RCV000294229.1 [benign]; RCV000386198.1 [benign]; 			89	104					OPA3 (inh=AR pLI=0.00)
chr19	46053655	46053655	-	GCT	het	anno_omim	QUAL=10780;DP=277;AF=0.43;MQM=59;TRIO=HET,277,0.43,HOM,268,1.00,WT,336,0.01	OPA3	3'UTR,intron	OPA3:ENST00000263275:3'UTR:MODIFIER:exon2/2:c.*3114_*3116dupAGC:,OPA3:ENST00000323060:intron:MODIFIER:exon1/1:c.143-20944_143-20942dupAGC:		rs10650481;rs542311224	0.7574	0.0000	0,0,0	0,0,0,0,0	0.7007							606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III,258501|Optic atrophy 3 with cataract,165300];	RCV000273210.1 [benign]; RCV000377006.1 [benign]; 			90	111					OPA3 (inh=AR pLI=0.00)
chr19	46054822	46054822	C	T	het	anno_omim	QUAL=16321;DP=477;AF=0.46;MQM=59;TRIO=HET,477,0.46,HOM,374,0.99,WT,424,0.00	OPA3	3'UTR,intron	OPA3:ENST00000263275:3'UTR:MODIFIER:exon2/2:c.*1950G>A:,OPA3:ENST00000323060:intron:MODIFIER:exon1/1:c.143-22108G>A:	MLT1B	rs4404183	0.7568	0.0000	0,0,0	0,0,0,0,0	0.7005							606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III,258501|Optic atrophy 3 with cataract,165300];	RCV000309414.1 [benign]; RCV000407759.1 [benign]; 			78	77					OPA3 (inh=AR pLI=0.00)
chr19	46055477	46055477	-	T	het	anno_omim	QUAL=1647;DP=179;AF=0.44;MQM=60;TRIO=HET,179,0.44,HET,46,0.33,WT,74,0.00	OPA3	3'UTR,intron	OPA3:ENST00000263275:3'UTR:MODIFIER:exon2/2:c.*1294dupA:,OPA3:ENST00000323060:intron:MODIFIER:exon1/1:c.143-22764dupA:		rs74313320	0.3183	0.0000	0,0,0	0,0,0,0,0	0.3405							606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III,258501|Optic atrophy 3 with cataract,165300];	RCV000313908.1 [benign]; RCV000401562.1 [benign]; 			32	105					OPA3 (inh=AR pLI=0.00)
chr19	46055786	46055786	T	-	hom	anno_omim	QUAL=1174;DP=53;AF=0.57;MQM=59;TRIO=HOM,53,0.57,HOM,52,0.77,WT,52,0.31	OPA3	3'UTR,intron	OPA3:ENST00000263275:3'UTR:MODIFIER:exon2/2:c.*986delA:,OPA3:ENST00000323060:intron:MODIFIER:exon1/1:c.143-23072delA:	AluSg4	rs377547137	0.6052	0.0000	0,0,0	0,0,0,0,0	0.5211							606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III,258501|Optic atrophy 3 with cataract,165300];	RCV000351099.1 [benign]; RCV000387008.1 [benign]; 			55	42					OPA3 (inh=AR pLI=0.00)
chr19	46056620	46056620	C	T	het	anno_omim	QUAL=13551;DP=228;AF=0.49;MQM=59;TRIO=HET,228,0.49,HOM,356,1.00,WT,380,0.00	OPA3	3'UTR,intron	OPA3:ENST00000263275:3'UTR:MODIFIER:exon2/2:c.*152G>A:,OPA3:ENST00000544371:3'UTR:MODIFIER:exon2/2:c.*152G>A:,OPA3:ENST00000323060:intron:MODIFIER:exon1/1:c.143-23906G>A:		rs3826861	0.7107	0.0000	0,0,0	0,0,0,0,0	0.6696							606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III,258501|Optic atrophy 3 with cataract,165300];	RCV000318662.1 [benign]; RCV000357168.1 [benign]; 			90	111					OPA3 (inh=AR pLI=0.00)
chr19	46057081	46057081	A	G	het	anno_omim	QUAL=5140;DP=135;AF=0.52;MQM=60;TRIO=HET,135,0.52,HOM,113,1.00,WT,162,0.00	OPA3	synonymous,intron	OPA3:ENST00000263275:synonymous:LOW:exon2/2:c.231T>C:p.Ala77Ala,OPA3:ENST00000544371:synonymous:LOW:exon2/2:c.72T>C:p.Ala24Ala,OPA3:ENST00000323060:intron:MODIFIER:exon1/1:c.143-24367T>C:		rs3826860	0.7670	0.7076	29591,13637,2757	0.7710,0.8386,0.8758,0.6539,0.6794	0.7101							606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III,258501|Optic atrophy 3 with cataract,165300];	RCV000020908.1 [benign]; RCV000082252.9 [other]; RCV000132683.1 [likely benign]; RCV000288721.1 [benign]; RCV000400863.1 [benign]; 		COSM439792	1612	1746	1	[1] old entry - no details available			OPA3 (inh=AR pLI=0.00)
chr19	47258674	47258674	C	T	het	low_DP;anno_omim	QUAL=158;DP=18;AF=0.50;MQM=60;TRIO=HET,18,0.50,WT,8,0.00,HET,9,0.33	FKRP	5'UTR	FKRP:ENST00000318584:5'UTR:MODIFIER:exon4/4:c.-34C>T:,FKRP:ENST00000391909:5'UTR:MODIFIER:exon4/4:c.-34C>T:		rs3201779	0.1038	0.2286	1810,1393,16	0.0816,0.1172,0.0006,0.2893,0.2338	0.1872							606596 [FKRP (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,5,613153|Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation),type B,5,606612|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,5,607155];	RCV000082170.6 [benign]; 			138	665					FKRP (inh=AR pLI=0.00)
chr19	50411012	50411012	C	T	het	anno_omim	QUAL=4872;DP=185;AF=0.57;MQM=53;TRIO=HET,185,0.57,WT,128,0.00,HET,170,0.54	NUP62,IL4I1	3'UTR,intron	NUP62:ENST00000352066:3'UTR:MODIFIER:exon3/3:c.*484G>A:,NUP62:ENST00000422090:3'UTR:MODIFIER:exon2/2:c.*484G>A:,NUP62:ENST00000413454:3'UTR:MODIFIER:exon2/2:c.*484G>A:,IL4I1:ENST00000341114:intron:MODIFIER:exon2/9:c.-227-3434G>A:,IL4I1:ENST00000595948:intron:MODIFIER:exon2/9:c.-285-3434G>A:	AluSz	rs1127729	0.0677	0.0000	0,0,0	0,0,0,0,0	0.0935							605815 [NUP62 (confirmed) Striatonigral degeneration,infantile,271930];				4	54					NUP62 (inh=AR pLI=0.80), IL4I1 (inh=n/a pLI=0.26)
chr19	50411742	50411742	A	G	het	anno_omim	QUAL=29880;DP=294;AF=0.51;MQM=59;TRIO=HET,294,0.51,HET,483,0.51,HOM,640,1.00	NUP62,IL4I1	synonymous,intron	NUP62:ENST00000352066:synonymous:LOW:exon3/3:c.1323T>C:p.Asp441Asp,NUP62:ENST00000422090:synonymous:LOW:exon2/2:c.1323T>C:p.Asp441Asp,NUP62:ENST00000413454:synonymous:LOW:exon2/2:c.1323T>C:p.Asp441Asp,NUP62:ENST00000597029:synonymous:LOW:exon3/3:c.1323T>C:p.Asp441Asp,NUP62:ENST00000597723:synonymous:LOW:exon4/4:c.1095T>C:p.Asp365Asp,NUP62:ENST00000596217:synonymous:LOW:exon2/2:c.1323T>C:p.Asp441Asp,IL4I1:ENST00000341114:intron:MODIFIER:exon2/9:c.-227-4164T>C:,IL4I1:ENST00000595948:intron:MODIFIER:exon2/9:c.-285-4164T>C:		rs892028	0.9740	0.9444	54164,28535,5072	0.9886,0.9722,0.9995,0.9251,0.9460	0.9563							605815 [NUP62 (confirmed) Striatonigral degeneration,infantile,271930];	RCV000117863.2 [likely benign]; 			1839	265					NUP62 (inh=AR pLI=0.80), IL4I1 (inh=n/a pLI=0.26)
chr19	50412417	50412417	G	A	het	anno_omim	QUAL=5682;DP=64;AF=0.47;MQM=60;TRIO=HET,64,0.47,WT,147,0.00,HOM,167,1.00	NUP62,IL4I1	synonymous,intron	NUP62:ENST00000352066:synonymous:LOW:exon3/3:c.648C>T:p.Ser216Ser,NUP62:ENST00000422090:synonymous:LOW:exon2/2:c.648C>T:p.Ser216Ser,NUP62:ENST00000413454:synonymous:LOW:exon2/2:c.648C>T:p.Ser216Ser,NUP62:ENST00000597029:synonymous:LOW:exon3/3:c.648C>T:p.Ser216Ser,NUP62:ENST00000597723:synonymous:LOW:exon3/4:c.648C>T:p.Ser216Ser,NUP62:ENST00000596217:synonymous:LOW:exon2/2:c.648C>T:p.Ser216Ser,IL4I1:ENST00000341114:intron:MODIFIER:exon2/9:c.-227-4839C>T:,IL4I1:ENST00000595948:intron:MODIFIER:exon2/9:c.-285-4839C>T:		rs999583	0.8604	0.7919	38333,18884,4313	0.9110,0.8210,0.9643,0.7531,0.7665	0.8265							605815 [NUP62 (confirmed) Striatonigral degeneration,infantile,271930];	RCV000117865.2 [likely benign]; 		COSM3757052	1252	715					NUP62 (inh=AR pLI=0.80), IL4I1 (inh=n/a pLI=0.26)
chr19	51850290	51850290	G	A	het	pred_pathogenic;anno_omim	QUAL=5301;DP=80;AF=0.59;MQM=60;TRIO=HET,80,0.59,HOM,90,1.00,HET,133,0.47	ETFB,CTD-2616J11.9	missense	ETFB:ENST00000354232:missense:MODERATE:exon4/5:c.734C>T:p.Thr245Met,ETFB:ENST00000309244:missense:MODERATE:exon5/6:c.461C>T:p.Thr154Met		rs1130426	0.4197	0.4980	15226,10649,1277	0.5115,0.3201,0.2971,0.5721,0.3623	0.5333	3.6820	D,D	T	P,P	D,D	32.00	130410 [ETFB (confirmed) Glutaric acidemia IIB,231680];	RCV000079961.4 [benign]; 		COSM3721676, COSM3721677	788	1242					ETFB (inh=AR pLI=0.00), CTD-2616J11.9 (inh=n/a pLI=n/a)
chr19	54385820	54385820	C	T	hom	anno_omim	QUAL=5629;DP=43;AF=1.00;MQM=59;TRIO=HOM,43,1.00,HOM,64,1.00,HOM,89,1.00	PRKCG	synonymous	PRKCG:ENST00000540413:synonymous:LOW:exon1/19:c.72C>T:p.Ala24Ala,PRKCG:ENST00000536044:synonymous:LOW:exon1/10:c.72C>T:p.Ala24Ala,PRKCG:ENST00000263431:synonymous:LOW:exon1/18:c.72C>T:p.Ala24Ala		rs2547362	0.8964	0.9463	54518,30486,2768	0.7310,0.9661,0.9903,0.9573,0.9920	0.9508							176980 [PRKCG (confirmed) Spinocerebellar ataxia 14,605361];	RCV000118063.3 [other]; RCV000379683.1 [benign]; 			2947	203	2	[2] Julia Bickmann 18.09.2014	n/a (2xTP, 0xFP)		PRKCG (inh=AD pLI=1.00)
chr19	54394965	54394965	T	C	het	anno_omim	QUAL=9523;DP=175;AF=0.50;MQM=60;TRIO=HET,175,0.50,HET,253,0.45,HET,359,0.50	PRKCG	synonymous	PRKCG:ENST00000540413:synonymous:LOW:exon6/19:c.567T>C:p.Asn189Asn,PRKCG:ENST00000536044:synonymous:LOW:exon6/10:c.567T>C:p.Asn189Asn,PRKCG:ENST00000263431:synonymous:LOW:exon6/18:c.567T>C:p.Asn189Asn,PRKCG:ENST00000542049:synonymous:LOW:exon4/15:c.228T>C:p.Asn76Asn		rs3745406	0.3295	0.3978	9824,5601,233	0.2178,0.4693,0.3042,0.4114,0.4318	0.4069							176980 [PRKCG (confirmed) Spinocerebellar ataxia 14,605361];	RCV000118062.2 [likely benign]; RCV000407374.1 [benign]; 		COSM148736	541	1574	2	[2] Julia Bickmann 18.09.2014	n/a (1xTP, 0xFP)		PRKCG (inh=AD pLI=1.00)
chr19	54695163	54695163	T	C	het	low_DP;anno_omim	QUAL=185;DP=5;AF=0.60;MQM=60;TRIO=HET,5,0.60,WT,2,0.00,HOM,7,1.00	TSEN34	5'UTR,intron	TSEN34:ENST00000396388:5'UTR:MODIFIER:exon1/4:c.-53T>C:,TSEN34:ENST00000429671:intron:MODIFIER:exon1/5:c.-4-49T>C:,TSEN34:ENST00000302937:intron:MODIFIER:exon1/4:c.-4-49T>C:,TSEN34:ENST00000396383:intron:MODIFIER:exon1/4:c.-4-49T>C:		rs593073	0.7418	0.7937	4870,1825,381	0.8074,0.7096,0.4395,0.8158,0.7986	0.7978							608754 [TSEN34 (provisional) Pontocerebellar hypoplasia type 2C,612390];				1914	887					TSEN34 (inh=AR pLI=0.40)
chr19	54697079	54697079	C	T	het	anno_omim	QUAL=17624;DP=179;AF=0.50;MQM=60;TRIO=HET,179,0.50,HET,268,0.56,HOM,360,1.00	TSEN34	synonymous	TSEN34:ENST00000429671:synonymous:LOW:exon5/6:c.795C>T:p.Pro265Pro,TSEN34:ENST00000302937:synonymous:LOW:exon5/5:c.795C>T:p.Pro265Pro,TSEN34:ENST00000396383:synonymous:LOW:exon5/5:c.795C>T:p.Pro265Pro,TSEN34:ENST00000396388:synonymous:LOW:exon4/4:c.795C>T:p.Pro265Pro		rs7595	0.7482	0.7723	36753,22253,3502	0.8458,0.5975,0.4948,0.8160,0.8023	0.7980							608754 [TSEN34 (provisional) Pontocerebellar hypoplasia type 2C,612390];	RCV000147766.1 [benign]; RCV000284876.1 [benign]; 			2063	1065					TSEN34 (inh=AR pLI=0.40)
chr19	54697602	54697602	G	A	het	anno_omim	QUAL=4750;DP=128;AF=0.61;MQM=59;TRIO=HET,128,0.61,HET,40,0.68,HOM,62,1.00	TSEN34,CTD,3093M3.1	intergenic_region	3093M3.1:ENSG00000170892-ENSG00000268816:intergenic_region:MODIFIER::n.54697602G>A:	MIRb	rs36622	0.7482	0.0000	0,0,0	0,0,0,0,0	0.7981							608754 [TSEN34 (provisional) Pontocerebellar hypoplasia type 2C,612390];	RCV000296732.1 [benign]; 			298	141					TSEN34 (inh=AR pLI=0.40), CTD (inh=n/a pLI=n/a), 3093M3.1 (inh=n/a pLI=n/a)
chr19	54697714	54697714	C	T	het	anno_omim	QUAL=6082;DP=184;AF=0.51;MQM=60;TRIO=HET,184,0.51,HET,65,0.62,HOM,77,1.00	TSEN34,CTD,3093M3.1	intergenic_region	3093M3.1:ENSG00000170892-ENSG00000268816:intergenic_region:MODIFIER::n.54697714C>T:	MIRb	rs36621	0.7488	0.0000	0,0,0	0,0,0,0,0	0.7978							608754 [TSEN34 (provisional) Pontocerebellar hypoplasia type 2C,612390];	RCV000391988.1 [benign]; 			133	67					TSEN34 (inh=AR pLI=0.40), CTD (inh=n/a pLI=n/a), 3093M3.1 (inh=n/a pLI=n/a)
chr19	54698196	54698198	GGA	-	het	anno_omim	QUAL=9669;DP=296;AF=0.58;MQM=60;TRIO=HET,296,0.58,HET,115,0.52,HOM,165,1.00	CTD-3093M3.1				rs879960569	0.0000	0.0000	0,0,0	0,0,0,0,0	0.4722							608754 [TSEN34 (provisional) Pontocerebellar hypoplasia type 2C,612390];				71	128					CTD-3093M3.1 (inh=n/a pLI=n/a)
chr19	55644325	55644325	A	C	hom	low_DP;anno_omim	QUAL=250;DP=7;AF=1.00;MQM=60;TRIO=HOM,7,1.00,HOM,1,1.00,WT,165,1.00	TNNT1	synonymous	TNNT1:ENST00000588981:synonymous:LOW:exon14/14:c.795T>G:p.Arg265Arg,TNNT1:ENST00000587758:synonymous:LOW:exon14/14:c.714T>G:p.Arg238Arg,TNNT1:ENST00000291901:synonymous:LOW:exon14/14:c.747T>G:p.Arg249Arg,TNNT1:ENST00000356783:synonymous:LOW:exon13/13:c.714T>G:p.Arg238Arg,TNNT1:ENST00000588426:synonymous:LOW:exon10/10:c.438T>G:p.Arg146Arg,TNNT1:ENST00000536926:synonymous:LOW:exon13/13:c.714T>G:p.Arg238Arg,TNNT1:ENST00000587465:synonymous:LOW:exon11/11:c.537T>G:p.Arg179Arg,TNNT1:ENST00000585321:synonymous:LOW:exon10/10:c.537T>G:p.Arg179Arg		rs890868	0.9804	0.9892	48080,27722,4166	0.9999,0.9483,0.9325,0.9993,0.9986	0.9922							191041 [TNNT1 (confirmed) Nemaline myopathy 5,Amish type,605355];	RCV000154008.3 [benign]; 			2010	1					TNNT1 (inh=AR pLI=0.00)
chr19	55658387	55658387	T	C	het	pred_pathogenic;anno_omim	QUAL=900;DP=20;AF=0.55;MQM=59;TRIO=HET,20,0.55,WT,54,0.00,HET,64,0.45	TNNT1	missense&splice_region	TNNT1:ENST00000588981:missense&splice_region:MODERATE:exon3/14:c.35A>G:p.Glu12Gly,TNNT1:ENST00000587758:missense&splice_region:MODERATE:exon4/14:c.35A>G:p.Glu12Gly,TNNT1:ENST00000291901:missense&splice_region:MODERATE:exon3/14:c.35A>G:p.Glu12Gly,TNNT1:ENST00000356783:missense&splice_region:MODERATE:exon3/13:c.35A>G:p.Glu12Gly,TNNT1:ENST00000588426:missense&splice_region:MODERATE:exon3/10:c.10A>G:p.Ser4Gly,TNNT1:ENST00000536926:missense&splice_region:MODERATE:exon3/13:c.35A>G:p.Glu12Gly		rs112562759	0.0359	0.0815	348,282,1	0.0172,0.0469,0.0003,0.1120,0.0417	0.0769	2.0130	D,T,D,D	T	B,B,B,B	D,D,D	18.28	191041 [TNNT1 (confirmed) Nemaline myopathy 5,Amish type,605355];	RCV000024560.1 [not provided]; RCV000080082.7 [benign]; RCV000259493.1 [likely benign]; RCV000263178.1 [likely benign]; RCV000299675.1 [likely benign]; RCV000354576.1 [likely benign]; 			26	309					TNNT1 (inh=AR pLI=0.00)
chr19	55660537	55660537	T	C	hom	anno_omim	QUAL=17327;DP=142;AF=1.00;MQM=59;TRIO=HOM,142,1.00,HOM,178,1.00,HOM,234,1.00	TNNT1	5'UTR	TNNT1:ENST00000588981:5'UTR:MODIFIER:exon1/14:c.-20A>G:,TNNT1:ENST00000587758:5'UTR:MODIFIER:exon1/14:c.-115A>G:,TNNT1:ENST00000291901:5'UTR:MODIFIER:exon1/14:c.-20A>G:,TNNT1:ENST00000356783:5'UTR:MODIFIER:exon1/13:c.-20A>G:,TNNT1:ENST00000588426:5'UTR:MODIFIER:exon1/10:c.-45A>G:,TNNT1:ENST00000536926:5'UTR:MODIFIER:exon1/13:c.-20A>G:		rs9636153	0.8101	0.8315	3817,1005,70	0.7520,0.0000,0.0000,0.8343,0.8343	0.8598	-0.9490	T	T			0.51	191041 [TNNT1 (confirmed) Nemaline myopathy 5,Amish type,605355];	RCV000024550.1 [not provided]; RCV000272701.1 [likely benign]; RCV000289192.1 [likely benign]; RCV000344273.1 [likely benign]; RCV000380170.1 [likely benign]; RCV000383640.1 [likely benign]; 			1232	367					TNNT1 (inh=AR pLI=0.00)
chr20	3214819	3214819	T	G	het	anno_omim	QUAL=8624;DP=189;AF=0.45;MQM=60;TRIO=HET,189,0.45,WT,405,0.00,HET,523,0.50	SLC4A11	synonymous	SLC4A11:ENST00000380059:synonymous:LOW:exon5/20:c.562A>C:p.Arg188Arg,SLC4A11:ENST00000380056:synonymous:LOW:exon4/19:c.481A>C:p.Arg161Arg,SLC4A11:ENST00000539553:synonymous:LOW:exon5/20:c.433A>C:p.Arg145Arg		rs3827075	0.4798	0.4365	12113,5554,2180	0.6500,0.4607,0.5707,0.4051,0.3121	0.4933							610206 [SLC4A11 (confirmed) Corneal endothelial dystrophy,autosomal recessive,217700|Corneal endothelial dystrophy and perceptive deafness,217400|Corneal dystrophy,Fuchs endothelial,4,613268];	RCV000245921.1 [benign]; RCV000384700.1 [likely benign]; 			307	1013					SLC4A11 (inh=AR+AD pLI=0.00)
chr20	3215548	3215548	C	A	het	anno_omim	QUAL=7604;DP=350;AF=0.47;MQM=59;TRIO=HET,350,0.47,WT,235,0.00,HET,338,0.57	SLC4A11	splice_region&intron	SLC4A11:ENST00000380059:splice_region&intron:LOW:exon2/19:c.218-8G>T:,SLC4A11:ENST00000380056:splice_region&intron:LOW:exon1/18:c.137-8G>T:,SLC4A11:ENST00000539553:splice_region&intron:LOW:exon2/19:c.89-8G>T:		rs3803957	0.2724	0.2999	5646,2851,232	0.2107,0.3807,0.3913,0.2913,0.2539	0.3061							610206 [SLC4A11 (confirmed) Corneal endothelial dystrophy,autosomal recessive,217700|Corneal endothelial dystrophy and perceptive deafness,217400|Corneal dystrophy,Fuchs endothelial,4,613268];	RCV000243306.1 [benign]; RCV000386561.1 [likely benign]; 		COSM4001879, COSM4001880	156	829					SLC4A11 (inh=AR+AD pLI=0.00)
chr20	3218355	3218355	C	G	het	anno_omim	QUAL=5535;DP=147;AF=0.51;MQM=59;TRIO=HET,147,0.51,WT,207,0.00,HET,305,0.49	SLC4A11	5'UTR_premature_start_codon_gain,5'UTR,intron	SLC4A11:ENST00000380056:5'UTR_premature_start_codon_gain:LOW:exon1/19:c.-30G>C:,SLC4A11:ENST00000380056:5'UTR:MODIFIER:exon1/19:c.-30G>C:,SLC4A11:ENST00000380059:intron:MODIFIER:exon1/19:c.173-121G>C:,SLC4A11:ENST00000539553:intron:MODIFIER:exon1/19:c.44-121G>C:		rs3827076	0.4503	0.4119	10717,4934,1649	0.5642,0.4522,0.5528,0.3824,0.2986	0.4514							610206 [SLC4A11 (confirmed) Corneal endothelial dystrophy,autosomal recessive,217700|Corneal endothelial dystrophy and perceptive deafness,217400|Corneal dystrophy,Fuchs endothelial,4,613268];	RCV000338145.1 [likely benign]; 			251	880					SLC4A11 (inh=AR+AD pLI=0.00)
chr20	3218634	3218634	G	C	het	anno_omim	QUAL=3772;DP=116;AF=0.51;MQM=59;TRIO=HET,116,0.51,WT,107,0.00,HET,187,0.50	SLC4A11	missense,intron	SLC4A11:ENST00000380059:missense:MODERATE:exon1/20:c.77C>G:p.Pro26Arg,SLC4A11:ENST00000539553:intron:MODIFIER:exon1/19:c.44-400C>G:		rs3810562	0.6416	0.5711	2540,825,282	0.7879,0.5993,0.6892,0.5739,0.5188	0.6502	-0.8580	T	T	B	T	0.01	610206 [SLC4A11 (confirmed) Corneal endothelial dystrophy,autosomal recessive,217700|Corneal endothelial dystrophy and perceptive deafness,217400|Corneal dystrophy,Fuchs endothelial,4,613268];			COSM330384	613	976					SLC4A11 (inh=AR+AD pLI=0.00)
chr20	3870124	3870124	G	C	hom	low_DP;pred_pathogenic;anno_omim	QUAL=454;DP=2;AF=1.00;MQM=59;TRIO=HOM,2,1.00,HOM,11,1.00,HOM,4,1.00	PANK2	missense,intron	PANK2:ENST00000316562:missense:MODERATE:exon1/7:c.377G>C:p.Gly126Ala,PANK2:ENST00000610179:missense:MODERATE:exon1/7:c.8G>C:p.Gly3Ala,PANK2:ENST00000497424:intron:MODIFIER:exon1/6:c.-246+573G>C:		rs3737084	0.8792	0.8654	10763,6307,798	0.9761,0.9257,0.8246,0.8855,0.7683	0.8964	1.0190	T	T	B	D	9.54	606157 [PANK2 (provisional) Neurodegeneration with brain iron accumulation 1,234200|HARP syndrome,607236];	RCV000082679.4 [benign]; RCV000313320.1 [benign]; 		COSM4134538	2034	645					PANK2 (inh=AR pLI=0.01)
chr20	3891347	3891347	T	G	het	pred_pathogenic;anno_omim	QUAL=8779;DP=358;AF=0.45;MQM=60;TRIO=HET,358,0.45,WT,257,0.00,HET,341,0.49	PANK2	missense	PANK2:ENST00000316562:missense:MODERATE:exon3/7:c.1105T>G:p.Ser369Ala,PANK2:ENST00000497424:missense:MODERATE:exon3/7:c.232T>G:p.Ser78Ala,PANK2:ENST00000610179:missense:MODERATE:exon3/7:c.736T>G:p.Ser246Ala			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000	0.9130	T,T,T	D	B	D,D	7.60	606157 [PANK2 (provisional) Neurodegeneration with brain iron accumulation 1,234200|HARP syndrome,607236];				0	2	3	[3] Stephan Waldm?ller 13.08.2014			PANK2 (inh=AR pLI=0.01)
chr20	10618574	10618574	T	C	het	anno_omim	QUAL=6102;DP=217;AF=0.50;MQM=60;TRIO=HET,217,0.50,HOM,96,1.00,WT,117,0.01	JAG1	3'UTR	JAG1:ENST00000254958:3'UTR:MODIFIER:exon26/26:c.*1572A>G:,JAG1:ENST00000423891:3'UTR:MODIFIER:exon25/25:c.*68A>G:		rs8708	0.4742	0.0000	0,0,0	0,0,0,0,0	0.5495							601920 [JAG1 (confirmed) Alagille syndrome 1,118450|Tetralogy of Fallot,187500|Deafness,congenital heart defects,and posterior embryotoxon];	RCV000300443.1 [benign]; RCV000366943.1 [benign]; 			76	109					JAG1 (inh=AD pLI=1.00)
chr20	10620386	10620386	A	G	het	anno_omim	QUAL=7947;DP=264;AF=0.50;MQM=60;TRIO=HET,264,0.50,HOM,141,1.00,WT,182,0.01	JAG1	synonymous	JAG1:ENST00000254958:synonymous:LOW:exon26/26:c.3417T>C:p.Tyr1139Tyr,JAG1:ENST00000423891:synonymous:LOW:exon24/25:c.2940T>C:p.Tyr980Tyr		rs1051419	0.7127	0.6592	27182,13748,4203	0.8988,0.6292,0.4195,0.6405,0.7699	0.6923							601920 [JAG1 (confirmed) Alagille syndrome 1,118450|Tetralogy of Fallot,187500|Deafness,congenital heart defects,and posterior embryotoxon];	RCV000125430.3 [benign]; RCV000250727.1 [benign]; RCV000270345.1 [benign]; RCV000364728.1 [benign]; 		COSM149140, COSM3758426	977	996					JAG1 (inh=AD pLI=1.00)
chr20	10633237	10633237	G	A	het	anno_omim	QUAL=3252;DP=88;AF=0.64;MQM=59;TRIO=HET,88,0.64,HOM,65,0.98,WT,91,0.00	JAG1	synonymous	JAG1:ENST00000254958:synonymous:LOW:exon6/26:c.765C>T:p.Tyr255Tyr,JAG1:ENST00000423891:synonymous:LOW:exon4/25:c.288C>T:p.Tyr96Tyr		rs1131695	0.4233	0.4541	12652,7312,620	0.3491,0.4449,0.3311,0.4689,0.5313	0.4562							601920 [JAG1 (confirmed) Alagille syndrome 1,118450|Tetralogy of Fallot,187500|Deafness,congenital heart defects,and posterior embryotoxon];	RCV000132569.1 [likely benign]; RCV000199026.2 [benign]; RCV000254531.1 [benign]; RCV000293317.1 [benign]; RCV000398702.1 [benign]; 		COSM3758428, COSM3758427	609	1065	1	hohe Frequenz, keine splice site Ver?nderung[1] swoedl 28.06.2016			JAG1 (inh=AD pLI=1.00)
chr20	10653469	10653469	C	T	het	anno_omim	QUAL=6558;DP=247;AF=0.56;MQM=59;TRIO=HET,247,0.56,HET,343,0.46,WT,475,0.00	JAG1	synonymous	JAG1:ENST00000254958:synonymous:LOW:exon2/26:c.267G>A:p.Gly89Gly		rs1051415	0.0653	0.0940	658,447,8	0.0200,0.1208,0.1059,0.1107,0.0405	0.0960							601920 [JAG1 (confirmed) Alagille syndrome 1,118450|Tetralogy of Fallot,187500|Deafness,congenital heart defects,and posterior embryotoxon];	RCV000035331.4 [benign]; RCV000343444.1 [likely benign]; RCV000398297.1 [likely benign]; 			22	322					JAG1 (inh=AD pLI=1.00)
chr20	10654563	10654563	A	C	het	anno_omim	QUAL=3157;DP=96;AF=0.43;MQM=59;TRIO=HET,96,0.43,HET,94,0.43,HET,122,0.50	JAG1,RP11-103J8.1	5'UTR	JAG1:ENST00000254958:5'UTR:MODIFIER:exon1/26:c.-385T>G:		rs1051412	0.5545	0.0000	0,0,0	0,0,0,0,0	0.5390							601920 [JAG1 (confirmed) Alagille syndrome 1,118450|Tetralogy of Fallot,187500|Deafness,congenital heart defects,and posterior embryotoxon];	RCV000312591.1 [benign]; RCV000401777.1 [benign]; 			67	106					JAG1 (inh=AD pLI=1.00), RP11-103J8.1 (inh=n/a pLI=n/a)
chr20	13798449	13798470	ACAGTCATCAGTTTATTGTTAA	-	hom	anno_omim	QUAL=8851;DP=204;AF=1.00;MQM=59;TRIO=HOM,204,1.00,HET,117,0.59,HET,124,0.57	NDUFAF5	3'UTR	NDUFAF5:ENST00000378106:3'UTR:MODIFIER:exon11/11:c.*593_*614delACAGTCATCAGTTTATTGTTAA:		rs35624053	0.2426	0.3269	632,254,5	0.0000,0.0000,0.0000,0.4370,0.2917	0.3087							612360 [NDUFAF5 (provisional) Mitochondrial complex 1 deficiency,252010];				42	104					NDUFAF5 (inh=AR pLI=0.00)
chr20	13798776	13798776	T	C	hom	anno_omim	QUAL=24056;DP=229;AF=1.00;MQM=59;TRIO=HOM,229,1.00,HOM,256,1.00,HOM,269,1.00	NDUFAF5	3'UTR	NDUFAF5:ENST00000378106:3'UTR:MODIFIER:exon11/11:c.*920T>C:		rs2423752	0.8872	0.8569	4016,1283,93	0.9429,0.0000,0.0000,0.9611,0.8151	0.9400							612360 [NDUFAF5 (provisional) Mitochondrial complex 1 deficiency,252010];				209	24					NDUFAF5 (inh=AR pLI=0.00)
chr20	25281027	25281027	C	T	het	anno_omim	QUAL=4550;DP=142;AF=0.51;MQM=60;TRIO=HET,142,0.51,WT,178,0.00,HET,246,0.48	ABHD12	3'UTR,intron	ABHD12:ENST00000339157:3'UTR:MODIFIER:exon13/13:c.*454G>A:,ABHD12:ENST00000376542:intron:MODIFIER:exon12/12:c.1157+1828G>A:		rs41309917	0.0194	0.0000	0,0,0	0,0,0,0,0	0.0246							613599 [ABHD12 (provisional) Polyneuropathy,hearing loss,ataxia,retinitis pigmentosa,and cataract,612674];	RCV000332184.1 [likely benign]; 			0	16					ABHD12 (inh=AR pLI=0.00)
chr20	25288632	25288632	G	A	hom	anno_omim	QUAL=10403;DP=164;AF=0.98;MQM=59;TRIO=HOM,164,0.98,HOM,124,1.00,HET,155,0.43	ABHD12	synonymous	ABHD12:ENST00000376542:synonymous:LOW:exon9/13:c.837C>T:p.Arg279Arg,ABHD12:ENST00000339157:synonymous:LOW:exon9/13:c.837C>T:p.Arg279Arg		rs6107027	0.3361	0.4696	14984,9197,355	0.2574,0.6542,0.0102,0.5217,0.4948	0.4799							613599 [ABHD12 (provisional) Polyneuropathy,hearing loss,ataxia,retinitis pigmentosa,and cataract,612674];	RCV000116215.2 [likely benign]; RCV000369740.1 [benign]; 		COSM4134339, COSM4134340	1105	1844					ABHD12 (inh=AR pLI=0.00)
chr20	31022959	31022959	T	C	hom	anno_omim	QUAL=35809;DP=389;AF=1.00;MQM=59;TRIO=HOM,389,1.00,HOM,300,1.00,HOM,402,1.00	ASXL1	missense	ASXL1:ENST00000375687:missense:MODERATE:exon13/13:c.2444T>C:p.Leu815Pro,ASXL1:ENST00000306058:missense:MODERATE:exon12/12:c.2429T>C:p.Leu810Pro		rs6058694	1.0000	1.0000	60464,33254,5131	0.9999,1.0000,1.0000,1.0000,0.9999	1.0000	-0.1360	T,T,T,T,T	T	B,B	T,T	0.09	612990 [ASXL1 (provisional) Bohring-Opitz syndrome,605039|Myelodysplastic syndrome,somatic,614286];	RCV000120112.1 [not provided]; 			2195	0					ASXL1 (inh=AD pLI=0.00)
chr20	31024274	31024274	T	C	hom	anno_omim	QUAL=14470;DP=317;AF=0.99;MQM=59;TRIO=HOM,317,0.99,HOM,84,0.99,HET,123,0.50	ASXL1	synonymous	ASXL1:ENST00000375687:synonymous:LOW:exon13/13:c.3759T>C:p.Ser1253Ser,ASXL1:ENST00000306058:synonymous:LOW:exon12/12:c.3744T>C:p.Ser1248Ser		rs4911231	0.4058	0.4183	11590,5178,192	0.1939,0.4945,0.7699,0.3925,0.4118	0.4243							612990 [ASXL1 (provisional) Bohring-Opitz syndrome,605039|Myelodysplastic syndrome,somatic,614286];	RCV000397795.1 [benign]; 		COSM4134436, COSM4134435	298	968					ASXL1 (inh=AD pLI=0.00)
chr20	31025163	31025163	A	G	hom	anno_omim	QUAL=36544;DP=394;AF=1.00;MQM=60;TRIO=HOM,394,1.00,HOM,499,0.99,HET,534,0.54	ASXL1	3'UTR	ASXL1:ENST00000375687:3'UTR:MODIFIER:exon13/13:c.*22A>G:,ASXL1:ENST00000306058:3'UTR:MODIFIER:exon12/12:c.*22A>G:		rs2295764	0.4000	0.4065	11069,4730,184	0.1910,0.4872,0.7712,0.3739,0.4101	0.4121							612990 [ASXL1 (provisional) Bohring-Opitz syndrome,605039|Myelodysplastic syndrome,somatic,614286];	RCV000386449.1 [benign]; 			250	883					ASXL1 (inh=AD pLI=0.00)
chr20	31025231	31025231	T	C	hom	anno_omim	QUAL=30497;DP=356;AF=0.99;MQM=60;TRIO=HOM,356,0.99,HOM,391,0.99,HET,441,0.56	ASXL1	3'UTR	ASXL1:ENST00000375687:3'UTR:MODIFIER:exon13/13:c.*90T>C:,ASXL1:ENST00000306058:3'UTR:MODIFIER:exon12/12:c.*90T>C:		rs2295763	0.3998	0.0000	0,0,0	0,0,0,0,0	0.3593							612990 [ASXL1 (provisional) Bohring-Opitz syndrome,605039|Myelodysplastic syndrome,somatic,614286];	RCV000387762.1 [benign]; 			30	109					ASXL1 (inh=AD pLI=0.00)
chr20	31025535	31025535	A	G	hom	anno_omim	QUAL=22744;DP=368;AF=1.00;MQM=59;TRIO=HOM,368,1.00,HOM,232,1.00,HET,274,0.53	ASXL1	3'UTR	ASXL1:ENST00000375687:3'UTR:MODIFIER:exon13/13:c.*394A>G:,ASXL1:ENST00000306058:3'UTR:MODIFIER:exon12/12:c.*394A>G:		rs2295762	0.4289	0.0000	0,0,0	0,0,0,0,0	0.3878							612990 [ASXL1 (provisional) Bohring-Opitz syndrome,605039|Myelodysplastic syndrome,somatic,614286];	RCV000404106.1 [benign]; 			30	107					ASXL1 (inh=AD pLI=0.00)
chr20	31386347	31386347	T	C	hom	anno_omim	QUAL=6729;DP=150;AF=1.00;MQM=59;TRIO=HOM,150,1.00,HOM,42,1.00,HET,72,0.46	DNMT3B	synonymous,3'UTR	DNMT3B:ENST00000328111:synonymous:LOW:exon15/23:c.1572T>C:p.Cys524Cys,DNMT3B:ENST00000348286:synonymous:LOW:exon14/20:c.1512T>C:p.Cys504Cys,DNMT3B:ENST00000353855:synonymous:LOW:exon14/22:c.1512T>C:p.Cys504Cys,DNMT3B:ENST00000443239:synonymous:LOW:exon13/19:c.1386T>C:p.Cys462Cys,DNMT3B:ENST00000344505:synonymous:LOW:exon14/21:c.1512T>C:p.Cys504Cys,DNMT3B:ENST00000456297:synonymous:LOW:exon12/18:c.1284T>C:p.Cys428Cys,DNMT3B:ENST00000201963:synonymous:LOW:exon14/22:c.1548T>C:p.Cys516Cys,DNMT3B:ENST00000375623:3'UTR:MODIFIER:exon12/15:c.*220T>C:		rs6058891	0.7558	0.5806	22601,6622,3879	0.8634,0.7543,0.9973,0.4453,0.6599	0.5962							602900 [DNMT3B (confirmed) Immunodeficiency-centromeric instability-facial anomalies syndrome 1,242860];	RCV000307572.1 [benign]; 		COSM4134441, COSM4134442	489	1000					DNMT3B (inh=AR pLI=1.00)
chr20	31386449	31386449	T	C	hom	anno_omim	QUAL=1172;DP=26;AF=1.00;MQM=59;TRIO=HOM,26,1.00,HOM,11,1.00,HET,20,0.45	DNMT3B	splice_region&synonymous,splice_region,3'UTR	DNMT3B:ENST00000328111:splice_region&synonymous:LOW:exon15/23:c.1674T>C:p.Tyr558Tyr,DNMT3B:ENST00000348286:splice_region&synonymous:LOW:exon14/20:c.1614T>C:p.Tyr538Tyr,DNMT3B:ENST00000353855:splice_region&synonymous:LOW:exon14/22:c.1614T>C:p.Tyr538Tyr,DNMT3B:ENST00000443239:splice_region&synonymous:LOW:exon13/19:c.1488T>C:p.Tyr496Tyr,DNMT3B:ENST00000344505:splice_region&synonymous:LOW:exon14/21:c.1614T>C:p.Tyr538Tyr,DNMT3B:ENST00000375623:splice_region:LOW:exon12/15:c.*322T>C:,DNMT3B:ENST00000456297:splice_region&synonymous:LOW:exon12/18:c.1386T>C:p.Tyr462Tyr,DNMT3B:ENST00000201963:splice_region&synonymous:LOW:exon14/22:c.1650T>C:p.Tyr550Tyr,DNMT3B:ENST00000375623:3'UTR:MODIFIER:exon12/15:c.*322T>C:		rs2424922	0.7558	0.5792	22012,6451,3616	0.8646,0.7533,0.9973,0.4450,0.6586	0.5958							602900 [DNMT3B (confirmed) Immunodeficiency-centromeric instability-facial anomalies syndrome 1,242860];	RCV000343834.1 [benign]; 		COSM4134443, COSM4134444	484	999					DNMT3B (inh=AR pLI=1.00)
chr20	31387954	31387954	C	G	hom	anno_omim	QUAL=18395;DP=173;AF=0.99;MQM=59;TRIO=HOM,173,0.99,HOM,274,1.00,HET,352,0.51	DNMT3B	splice_region&intron	DNMT3B:ENST00000328111:splice_region&intron:LOW:exon16/22:c.1760-5C>G:,DNMT3B:ENST00000348286:splice_region&intron:LOW:exon15/19:c.1700-5C>G:,DNMT3B:ENST00000353855:splice_region&intron:LOW:exon15/21:c.1700-5C>G:,DNMT3B:ENST00000443239:splice_region&intron:LOW:exon14/18:c.1574-5C>G:,DNMT3B:ENST00000344505:splice_region&intron:LOW:exon15/20:c.1700-5C>G:,DNMT3B:ENST00000375623:splice_region&intron:LOW:exon13/14:c.*408-5C>G:,DNMT3B:ENST00000456297:splice_region&intron:LOW:exon13/17:c.1472-5C>G:,DNMT3B:ENST00000201963:splice_region&intron:LOW:exon15/21:c.1736-5C>G:		rs1997797	0.7141	0.5663	21416,6619,2755	0.7251,0.7444,0.9973,0.4436,0.6593	0.5692							602900 [DNMT3B (confirmed) Immunodeficiency-centromeric instability-facial anomalies syndrome 1,242860];	RCV000394272.1 [benign]; 			477	1011					DNMT3B (inh=AR pLI=1.00)
chr20	31388636	31388636	T	C	hom	anno_omim	QUAL=18738;DP=202;AF=1.00;MQM=59;TRIO=HOM,202,1.00,HOM,252,1.00,HET,348,0.50	DNMT3B	splice_region&intron	DNMT3B:ENST00000328111:splice_region&intron:LOW:exon17/22:c.1906-5T>C:,DNMT3B:ENST00000348286:splice_region&intron:LOW:exon16/19:c.1846-5T>C:,DNMT3B:ENST00000353855:splice_region&intron:LOW:exon16/21:c.1846-5T>C:,DNMT3B:ENST00000443239:splice_region&intron:LOW:exon15/18:c.1720-5T>C:,DNMT3B:ENST00000344505:splice_region&intron:LOW:exon16/20:c.1846-5T>C:,DNMT3B:ENST00000375623:splice_region&intron:LOW:exon14/14:c.*554-5T>C:,DNMT3B:ENST00000456297:splice_region&intron:LOW:exon14/17:c.1618-5T>C:,DNMT3B:ENST00000201963:splice_region&intron:LOW:exon16/21:c.1882-5T>C:	(CTCTCT)n	rs2424928	0.7426	0.5737	22080,6633,3366	0.8040,0.7488,0.9973,0.4440,0.6595	0.5818							602900 [DNMT3B (confirmed) Immunodeficiency-centromeric instability-facial anomalies syndrome 1,242860];	RCV000356980.1 [benign]; 			477	1014					DNMT3B (inh=AR pLI=1.00)
chr20	31396536	31396536	A	G	hom	anno_omim	QUAL=25677;DP=524;AF=1.00;MQM=59;TRIO=HOM,524,1.00,HOM,201,1.00,HET,242,0.47	DNMT3B	3'UTR	DNMT3B:ENST00000328111:3'UTR:MODIFIER:exon23/23:c.*827A>G:,DNMT3B:ENST00000348286:3'UTR:MODIFIER:exon20/20:c.*827A>G:,DNMT3B:ENST00000353855:3'UTR:MODIFIER:exon22/22:c.*827A>G:,DNMT3B:ENST00000344505:3'UTR:MODIFIER:exon21/21:c.*831A>G:,DNMT3B:ENST00000201963:3'UTR:MODIFIER:exon22/22:c.*827A>G:		rs2424932	0.8047	0.0000	0,0,0	0,0,0,0,0	0.7106							602900 [DNMT3B (confirmed) Immunodeficiency-centromeric instability-facial anomalies syndrome 1,242860];	RCV000368232.1 [benign]; 			89	105					DNMT3B (inh=AR pLI=1.00)
chr20	31397020	31397020	T	-	hom	anno_omim	QUAL=9076;DP=197;AF=1.00;MQM=53;TRIO=HOM,197,1.00,HOM,75,1.00,HET,84,0.49	DNMT3B	3'UTR	DNMT3B:ENST00000328111:3'UTR:MODIFIER:exon23/23:c.*1318delT:,DNMT3B:ENST00000348286:3'UTR:MODIFIER:exon20/20:c.*1318delT:,DNMT3B:ENST00000353855:3'UTR:MODIFIER:exon22/22:c.*1318delT:,DNMT3B:ENST00000344505:3'UTR:MODIFIER:exon21/21:c.*1322delT:,DNMT3B:ENST00000201963:3'UTR:MODIFIER:exon22/22:c.*1318delT:		rs398088406	0.7093	0.0000	0,0,0	0,0,0,0,0	0.5607							602900 [DNMT3B (confirmed) Immunodeficiency-centromeric instability-facial anomalies syndrome 1,242860];	RCV000269320.1 [benign]; 			49	112					DNMT3B (inh=AR pLI=1.00)
chr20	43034693	43034693	C	T	het	anno_omim	QUAL=1853;DP=90;AF=0.47;MQM=60;TRIO=HET,90,0.47,WT,89,0.00,HET,107,0.49	HNF4A	splice_region&intron	HNF4A:ENST00000316099:splice_region&intron:LOW:exon1/9:c.116-5C>T:,HNF4A:ENST00000316673:splice_region&intron:LOW:exon1/9:c.50-5C>T:,HNF4A:ENST00000609795:splice_region&intron:LOW:exon1/7:c.50-5C>T:,HNF4A:ENST00000457232:splice_region&intron:LOW:exon1/9:c.50-5C>T:,HNF4A:ENST00000443598:splice_region&intron:LOW:exon1/7:c.116-5C>T:,HNF4A:ENST00000415691:splice_region&intron:LOW:exon1/9:c.116-5C>T:		rs745975	0.1687	0.2008	2690,1802,55	0.0992,0.0958,0.1756,0.2300,0.2382	0.1975							600281 [HNF4A (confirmed) MODY,type I,125850|Diabetes mellitus,noninsulin-dependent,125853|Fanconi renotubular syndrome 4,with maturity-onset diabetes of the young,616026];	RCV000117237.3 [other]; RCV000268875.1 [likely benign]; RCV000361090.1 [likely benign]; 	CS004500 [CLASS=DP MUT=ALT PHEN="Diabetes type 2 association with" GENE=HNF4A]; 		100	661					HNF4A (inh=AD pLI=0.92)
chr20	43034783	43034783	C	T	het	anno_omim	QUAL=4710;DP=195;AF=0.51;MQM=59;TRIO=HET,195,0.51,WT,170,0.00,HET,206,0.49	HNF4A	synonymous	HNF4A:ENST00000316099:synonymous:LOW:exon2/10:c.201C>T:p.Ala67Ala,HNF4A:ENST00000316673:synonymous:LOW:exon2/10:c.135C>T:p.Ala45Ala,HNF4A:ENST00000609795:synonymous:LOW:exon2/8:c.135C>T:p.Ala45Ala,HNF4A:ENST00000457232:synonymous:LOW:exon2/10:c.135C>T:p.Ala45Ala,HNF4A:ENST00000443598:synonymous:LOW:exon2/8:c.201C>T:p.Ala67Ala,HNF4A:ENST00000415691:synonymous:LOW:exon2/10:c.201C>T:p.Ala67Ala		rs736823	0.0146	0.0336	115,101,2	0.0097,0.0169,0.0000,0.0504,0.0051	0.0386							600281 [HNF4A (confirmed) MODY,type I,125850|Diabetes mellitus,noninsulin-dependent,125853|Fanconi renotubular syndrome 4,with maturity-onset diabetes of the young,616026];	RCV000117236.3 [benign]; RCV000272263.1 [likely benign]; RCV000329726.1 [likely benign]; 			6	103					HNF4A (inh=AD pLI=0.92)
chr20	43059211	43059211	A	C	het	anno_omim	QUAL=24190;DP=447;AF=0.49;MQM=59;TRIO=HET,447,0.49,HOM,360,1.00,HET,487,0.52	HNF4A	3'UTR	HNF4A:ENST00000316099:3'UTR:MODIFIER:exon10/10:c.*906A>C:	L2d2	rs3212210	0.5713	0.0000	0,0,0	0,0,0,0,0	0.6338							600281 [HNF4A (confirmed) MODY,type I,125850|Diabetes mellitus,noninsulin-dependent,125853|Fanconi renotubular syndrome 4,with maturity-onset diabetes of the young,616026];	RCV000270968.1 [likely benign]; RCV000365535.1 [likely benign]; 			111	101					HNF4A (inh=AD pLI=0.92)
chr20	43059238	43059256	GAGGAAGAATGGTGTGGGA	-	het	anno_omim	QUAL=11965;DP=290;AF=0.59;MQM=59;TRIO=HET,290,0.59,HOM,332,0.99,WT,391,0.00	HNF4A	3'UTR	HNF4A:ENST00000316099:3'UTR:MODIFIER:exon10/10:c.*937_*955delAAGAATGGTGTGGGAGAGG:	L2d2	rs72137187	0.1881	0.0000	0,0,0	0,0,0,0,0	0.1829							600281 [HNF4A (confirmed) MODY,type I,125850|Diabetes mellitus,noninsulin-dependent,125853|Fanconi renotubular syndrome 4,with maturity-onset diabetes of the young,616026];				8	65					HNF4A (inh=AD pLI=0.92)
chr20	43059596	43059603	TCCTCCCT	-	het	anno_omim	QUAL=5107;DP=170;AF=0.49;MQM=59;TRIO=HET,170,0.49,WT,218,0.00,HET,327,0.54	HNF4A	3'UTR	HNF4A:ENST00000316099:3'UTR:MODIFIER:exon10/10:c.*1299_*1306delTCCTCCCT:	MIRb:MIR	rs868132750	0.0517	0.0000	0,0,0	0,0,0,0,0	0.0732							600281 [HNF4A (confirmed) MODY,type I,125850|Diabetes mellitus,noninsulin-dependent,125853|Fanconi renotubular syndrome 4,with maturity-onset diabetes of the young,616026];	RCV000302022.1 [likely benign]; RCV000356823.1 [likely benign]; 			0	29					HNF4A (inh=AD pLI=0.92)
chr20	43264927	43264927	C	T	hom	anno_omim	QUAL=16063;DP=247;AF=1.00;MQM=59;TRIO=HOM,247,1.00,HOM,125,1.00,HOM,149,1.00	ADA	splice_region&synonymous	ADA:ENST00000372874:splice_region&synonymous:LOW:exon2/12:c.36G>A:p.Val12Val,ADA:ENST00000537820:splice_region&synonymous:LOW:exon2/11:c.36G>A:p.Val12Val		rs394105	0.9822	0.9955	53996,30140,4118	0.9499,0.9982,1.0000,0.9999,1.0000	0.9964							608958 [ADA (confirmed) Severe combined immunodeficiency due to ADA deficiency,102700|Adenosine deaminase deficiency,partial,102700];				2116	2					ADA (inh=AR pLI=0.00)
chr20	44519643	44519643	G	A	het	anno_omim	QUAL=4131;DP=55;AF=0.49;MQM=60;TRIO=HET,55,0.49,HET,69,0.41,HOM,97,1.00	NEURL2,CTSA	5'UTR	NEURL2:ENST00000372518:5'UTR:MODIFIER:exon1/2:c.-13C>T:		rs2868362	0.3842	0.5824	2477,1828,34	0.2810,0.7090,0.5201,0.6285,0.5000	0.5058							613111 [CTSA (confirmed) Galactosialidosis,256540];	RCV000364953.1 [benign]; 			427	780					NEURL2 (inh=n/a pLI=0.00), CTSA (inh=AR pLI=0.00)
chr20	44520238	44520240	CTG	-	hom	anno_omim;anno_pathogenic_hgmd	QUAL=2584;DP=22;AF=0.50;MQM=60;TRIO=HOM,22,0.50,HET,69,0.55,HOM,63,0.98	CTSA	disruptive_inframe_deletion	CTSA:ENST00000372484:disruptive_inframe_deletion:MODERATE:exon2/15:c.108_110delGCT:p.Leu37del,CTSA:ENST00000354880:disruptive_inframe_deletion:MODERATE:exon2/14:c.108_110delGCT:p.Leu37del,CTSA:ENST00000191018:disruptive_inframe_deletion:MODERATE:exon2/15:c.54_56delGCT:p.Leu19del,CTSA:ENST00000372459:disruptive_inframe_deletion:MODERATE:exon1/14:c.54_56delGCT:p.Leu19del	(CTG)n	rs3080212;rs397784956	0.6494	0.6432	19878,10192,1647	0.6839,0.7314,0.6281,0.6256,0.6193	0.6510							613111 [CTSA (confirmed) Galactosialidosis,256540];	RCV000175578.1 [benign]; RCV000317016.1 [benign]; 	CD1413773 [CLASS=DM? MUT=ALT PHEN="Galactosialidosis" GENE=CTSA]; 	COSM443915	862	913	2	[2] Ute Grasshoff 28.10.2015			CTSA (inh=AR pLI=0.00)
chr20	44523547	44523547	G	A	het	anno_omim	QUAL=24393;DP=217;AF=0.49;MQM=59;TRIO=HET,217,0.49,HET,449,0.49,HOM,508,1.00	CTSA	splice_region&intron	CTSA:ENST00000372484:splice_region&intron:LOW:exon10/14:c.1002+7G>A:,CTSA:ENST00000354880:splice_region&intron:LOW:exon9/13:c.951+7G>A:,CTSA:ENST00000191018:splice_region&intron:LOW:exon10/14:c.948+7G>A:,CTSA:ENST00000372459:splice_region&intron:LOW:exon9/13:c.948+7G>A:		rs2075961	0.6783	0.6602	26737,13039,2302	0.6664,0.7948,0.6932,0.6243,0.6730	0.6646							613111 [CTSA (confirmed) Galactosialidosis,256540];	RCV000262630.1 [benign]; 			860	973					CTSA (inh=AR pLI=0.00)
chr20	44523782	44523782	C	T	het	anno_omim	QUAL=13927;DP=91;AF=0.46;MQM=60;TRIO=HET,91,0.46,HET,266,0.50,HOM,318,1.00	CTSA	splice_region&intron	CTSA:ENST00000372484:splice_region&intron:LOW:exon11/14:c.1142+10C>T:,CTSA:ENST00000354880:splice_region&intron:LOW:exon10/13:c.1091+10C>T:,CTSA:ENST00000191018:splice_region&intron:LOW:exon11/14:c.1088+10C>T:,CTSA:ENST00000372459:splice_region&intron:LOW:exon10/13:c.1088+10C>T:		rs4608591	0.6799	0.6608	26736,13016,2338	0.6719,0.7939,0.6936,0.6244,0.6736	0.6650							613111 [CTSA (confirmed) Galactosialidosis,256540];	RCV000261253.1 [benign]; 			862	970					CTSA (inh=AR pLI=0.00)
chr20	44746982	44746982	T	C	hom	anno_omim	QUAL=3938;DP=62;AF=1.00;MQM=60;TRIO=HOM,62,1.00,HOM,27,1.00,HOM,38,1.00	CD40	5'UTR	CD40:ENST00000372285:5'UTR:MODIFIER:exon1/9:c.-1T>C:,CD40:ENST00000372276:5'UTR:MODIFIER:exon1/8:c.-1T>C:		rs1883832	0.7712	0.7527	34693,18125,4613	0.9415,0.8153,0.5871,0.7372,0.7513	0.7954							109535 [CD40 (confirmed) Immunodeficiency with hyper-IgM,type 3,606843];	RCV000348388.1 [benign]; 			1135	831					CD40 (inh=AR pLI=0.66)
chr20	47626847	47626847	T	C	het	anno_omim	QUAL=10589;DP=310;AF=0.48;MQM=59;TRIO=HET,310,0.48,HET,225,0.48,HET,332,0.48	ARFGEF2	synonymous	ARFGEF2:ENST00000371917:synonymous:LOW:exon27/39:c.3663T>C:p.Gly1221Gly		rs2295580	0.3542	0.3195	6571,3519,1513	0.5322,0.2724,0.1611,0.3264,0.2852	0.3760							605371 [ARFGEF2 (confirmed) Periventricular heterotopia with microcephaly,608097];	RCV000116402.4 [other]; RCV000406191.1 [likely benign]; 		COSM1412311	240	936					ARFGEF2 (inh=AR pLI=1.00)
chr20	47651492	47651492	G	A	het	anno_omim	QUAL=13041;DP=359;AF=0.50;MQM=59;TRIO=HET,359,0.50,HET,286,0.51,HET,340,0.49	ARFGEF2	3'UTR	ARFGEF2:ENST00000371917:3'UTR:MODIFIER:exon39/39:c.*1756G>A:		rs6019602	0.3462	0.0000	0,0,0	0,0,0,0,0	0.3639							605371 [ARFGEF2 (confirmed) Periventricular heterotopia with microcephaly,608097];	RCV000323371.1 [likely benign]; 			15	99					ARFGEF2 (inh=AR pLI=1.00)
chr20	47652254	47652254	A	G	het	anno_omim	QUAL=6619;DP=171;AF=0.43;MQM=60;TRIO=HET,171,0.43,HET,128,0.59,HET,199,0.49	ARFGEF2	3'UTR	ARFGEF2:ENST00000371917:3'UTR:MODIFIER:exon39/39:c.*2518A>G:		rs707533	0.3462	0.0000	0,0,0	0,0,0,0,0	0.3643							605371 [ARFGEF2 (confirmed) Periventricular heterotopia with microcephaly,608097];	RCV000403352.1 [likely benign]; 			15	99					ARFGEF2 (inh=AR pLI=1.00)
chr20	47652338	47652338	A	G	het	anno_omim	QUAL=5564;DP=233;AF=0.41;MQM=60;TRIO=HET,233,0.41,HET,87,0.56,HET,126,0.49	ARFGEF2	3'UTR	ARFGEF2:ENST00000371917:3'UTR:MODIFIER:exon39/39:c.*2602A>G:		rs707534	0.3462	0.0000	0,0,0	0,0,0,0,0	0.3644							605371 [ARFGEF2 (confirmed) Periventricular heterotopia with microcephaly,608097];	RCV000337719.1 [likely benign]; 			15	99					ARFGEF2 (inh=AR pLI=1.00)
chr20	47652530	47652530	-	A	het	anno_omim	QUAL=248;DP=98;AF=0.38;MQM=59;TRIO=HET,98,0.38,HET,42,0.24,HET,48,0.29	ARFGEF2	3'UTR	ARFGEF2:ENST00000371917:3'UTR:MODIFIER:exon39/39:c.*2806dupA:		rs397957165	0.3411	0.0000	0,0,0	0,0,0,0,0	0.3832							605371 [ARFGEF2 (confirmed) Periventricular heterotopia with microcephaly,608097];	RCV000362044.1 [likely benign]; 			8	90					ARFGEF2 (inh=AR pLI=1.00)
chr20	49551780	49551780	-	A	het	anno_omim	QUAL=1620;DP=159;AF=0.40;MQM=59;TRIO=HET,159,0.40,WT,45,0.02,HET,63,0.52	DPM1,RP5-914P20.5	splice_region&intron	DPM1:ENST00000371588:splice_region&intron:LOW:exon8/8:c.679-8dupT:,DPM1:ENST00000371582:splice_region&intron:LOW:exon9/9:c.760-8dupT:,DPM1:ENST00000371583:splice_region&intron:LOW:exon8/8:c.664-8dupT:		rs11483542;rs397978438;rs560680352	0.3059	0.3342	2658,1234,630	0.4705,0.3540,0.3230,0.3258,0.2561	0.4189							603503 [DPM1 (provisional) Congenital disorder of glycosylation,type Ie,608799];				179	888					DPM1 (inh=AR pLI=0.54), RP5-914P20.5 (inh=n/a pLI=n/a)
chr20	57019491	57019492	AT	-	het	anno_omim	QUAL=6958;DP=347;AF=0.44;MQM=59;TRIO=HET,347,0.44,WT,232,0.00,HET,332,0.45	VAPB	3'UTR	VAPB:ENST00000475243:3'UTR:MODIFIER:exon6/6:c.*200_*201delAT:,VAPB:ENST00000395802:3'UTR:MODIFIER:exon3/3:c.*270_*271delAT:		rs571412501	0.0300	0.0406	9,0,0	0.0232,0.0495,0.0042,0.0517,0.0347	0.0512							605704 [VAPB (confirmed) Amyotrophic lateral sclerosis 8,608627|Spinal muscular atrophy,late-onset,Finkel type,182980];				0	1					VAPB (inh=AD pLI=0.74)
chr20	57019495	57019495	A	T	het	anno_omim	QUAL=6836;DP=232;AF=0.42;MQM=59;TRIO=HET,232,0.42,WT,216,0.00,HET,293,0.43	VAPB	3'UTR	VAPB:ENST00000475243:3'UTR:MODIFIER:exon6/6:c.*204A>T:,VAPB:ENST00000395802:3'UTR:MODIFIER:exon3/3:c.*274A>T:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							605704 [VAPB (confirmed) Amyotrophic lateral sclerosis 8,608627|Spinal muscular atrophy,late-onset,Finkel type,182980];				0	1					VAPB (inh=AD pLI=0.74)
chr20	57019496	57019496	T	G	het	anno_omim	QUAL=6836;DP=232;AF=0.42;MQM=59;TRIO=HET,232,0.42,WT,216,0.00,HET,293,0.43	VAPB	3'UTR	VAPB:ENST00000475243:3'UTR:MODIFIER:exon6/6:c.*205T>G:,VAPB:ENST00000395802:3'UTR:MODIFIER:exon3/3:c.*275T>G:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							605704 [VAPB (confirmed) Amyotrophic lateral sclerosis 8,608627|Spinal muscular atrophy,late-onset,Finkel type,182980];				0	1					VAPB (inh=AD pLI=0.74)
chr20	57019497	57019497	-	GGGG	het	anno_omim	QUAL=6836;DP=232;AF=0.42;MQM=59;TRIO=HET,232,0.42,WT,216,0.00,HET,293,0.43	VAPB	3'UTR	VAPB:ENST00000475243:3'UTR:MODIFIER:exon6/6:c.*207_*208insGGGG:,VAPB:ENST00000395802:3'UTR:MODIFIER:exon3/3:c.*277_*278insGGGG:		rs777453383	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							605704 [VAPB (confirmed) Amyotrophic lateral sclerosis 8,608627|Spinal muscular atrophy,late-onset,Finkel type,182980];				0	1					VAPB (inh=AD pLI=0.74)
chr20	57019499	57019499	T	A	het	anno_omim	QUAL=6836;DP=232;AF=0.42;MQM=59;TRIO=HET,232,0.42,WT,216,0.00,HET,293,0.43	VAPB	3'UTR	VAPB:ENST00000475243:3'UTR:MODIFIER:exon6/6:c.*208T>A:,VAPB:ENST00000395802:3'UTR:MODIFIER:exon3/3:c.*278T>A:		rs577029630	0.0300	0.0000	0,0,0	0,0,0,0,0	0.0000							605704 [VAPB (confirmed) Amyotrophic lateral sclerosis 8,608627|Spinal muscular atrophy,late-onset,Finkel type,182980];				0	1					VAPB (inh=AD pLI=0.74)
chr20	57019502	57019502	-	AT	het	anno_omim	QUAL=6836;DP=232;AF=0.42;MQM=59;TRIO=HET,232,0.42,WT,216,0.00,HET,293,0.43	VAPB	3'UTR	VAPB:ENST00000475243:3'UTR:MODIFIER:exon6/6:c.*211_*212insAT:,VAPB:ENST00000395802:3'UTR:MODIFIER:exon3/3:c.*281_*282insAT:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							605704 [VAPB (confirmed) Amyotrophic lateral sclerosis 8,608627|Spinal muscular atrophy,late-onset,Finkel type,182980];				0	1					VAPB (inh=AD pLI=0.74)
chr20	57019504	57019504	G	A	het	anno_omim	QUAL=6836;DP=232;AF=0.42;MQM=59;TRIO=HET,232,0.42,WT,216,0.00,HET,293,0.43	VAPB	3'UTR	VAPB:ENST00000475243:3'UTR:MODIFIER:exon6/6:c.*213G>A:,VAPB:ENST00000395802:3'UTR:MODIFIER:exon3/3:c.*283G>A:		rs202245892	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							605704 [VAPB (confirmed) Amyotrophic lateral sclerosis 8,608627|Spinal muscular atrophy,late-onset,Finkel type,182980];				0	1					VAPB (inh=AD pLI=0.74)
chr20	57019505	57019505	-	AAG	het	anno_omim	QUAL=6836;DP=232;AF=0.42;MQM=59;TRIO=HET,232,0.42,WT,216,0.00,HET,293,0.43	VAPB	3'UTR	VAPB:ENST00000475243:3'UTR:MODIFIER:exon6/6:c.*214_*215insAAG:,VAPB:ENST00000395802:3'UTR:MODIFIER:exon3/3:c.*284_*285insAAG:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							605704 [VAPB (confirmed) Amyotrophic lateral sclerosis 8,608627|Spinal muscular atrophy,late-onset,Finkel type,182980];				0	1					VAPB (inh=AD pLI=0.74)
chr20	57020741	57020758	TGTGTGTGTGTGTGTGTG	-	het	anno_omim	QUAL=3312;DP=271;AF=0.63;MQM=59;TRIO=HET,271,0.63,HET,143,0.59,WT,173,0.00	VAPB	3'UTR	VAPB:ENST00000475243:3'UTR:MODIFIER:exon6/6:c.*1469_*1486delGTGTGTGTGTGTGTGTGT:	(TG)n	rs138225455	0.0000	0.2978	137,51,10	0.3464,0.0000,0.0000,0.3101,0.2920	0.3702							605704 [VAPB (confirmed) Amyotrophic lateral sclerosis 8,608627|Spinal muscular atrophy,late-onset,Finkel type,182980];				103	86					VAPB (inh=AD pLI=0.74)
chr20	57022713	57022720	TGTGTGCA	-	hom	anno_omim	QUAL=12275;DP=143;AF=0.97;MQM=59;TRIO=HOM,143,0.97,HOM,164,0.99,HOM,158,0.99	VAPB	3'UTR	VAPB:ENST00000475243:3'UTR:MODIFIER:exon6/6:c.*3444_*3451delCATGTGTG:	(TGTGTGCA)n	rs201983028	0.9091	0.9146	4487,1101,76	0.0000,0.0000,0.0000,0.9007,0.9206	0.9267							605704 [VAPB (confirmed) Amyotrophic lateral sclerosis 8,608627|Spinal muscular atrophy,late-onset,Finkel type,182980];	RCV000271475.1 [benign]; RCV000363767.1 [benign]; 			462	99					VAPB (inh=AD pLI=0.74)
chr20	57023343	57023343	C	T	het	anno_omim	QUAL=7841;DP=425;AF=0.47;MQM=60;TRIO=HET,425,0.47,HET,263,0.43,WT,345,0.00	VAPB	3'UTR	VAPB:ENST00000475243:3'UTR:MODIFIER:exon6/6:c.*4052C>T:		rs76295834	0.0210	0.0222	5,2,0	0.0000,0.0000,0.0000,0.0403,0.0165	0.0779							605704 [VAPB (confirmed) Amyotrophic lateral sclerosis 8,608627|Spinal muscular atrophy,late-onset,Finkel type,182980];	RCV000334124.1 [likely benign]; RCV000370068.1 [likely benign]; 			2	67					VAPB (inh=AD pLI=0.74)
chr20	57023737	57023737	G	A	het	anno_omim	QUAL=5562;DP=312;AF=0.49;MQM=60;TRIO=HET,312,0.49,HET,116,0.53,WT,164,0.01	VAPB	3'UTR	VAPB:ENST00000475243:3'UTR:MODIFIER:exon6/6:c.*4446G>A:		rs79623348	0.0270	0.0260	6,2,0	0.0000,0.0000,0.0000,0.0400,0.0209	0.0830							605704 [VAPB (confirmed) Amyotrophic lateral sclerosis 8,608627|Spinal muscular atrophy,late-onset,Finkel type,182980];	RCV000273605.1 [likely benign]; RCV000368174.1 [likely benign]; 			2	67					VAPB (inh=AD pLI=0.74)
chr20	57024159	57024159	C	T	het	anno_omim	QUAL=3314;DP=170;AF=0.59;MQM=59;TRIO=HET,170,0.59,HET,75,0.44,WT,119,0.00	VAPB	3'UTR	VAPB:ENST00000475243:3'UTR:MODIFIER:exon6/6:c.*4868C>T:		rs74748993	0.0212	0.0220	5,2,0	0.0000,0.0000,0.0000,0.0400,0.0164	0.0780							605704 [VAPB (confirmed) Amyotrophic lateral sclerosis 8,608627|Spinal muscular atrophy,late-onset,Finkel type,182980];	RCV000321832.1 [likely benign]; RCV000376542.1 [likely benign]; 			2	67					VAPB (inh=AD pLI=0.74)
chr20	57024541	57024541	T	C	het	anno_omim	QUAL=4802;DP=319;AF=0.42;MQM=60;TRIO=HET,319,0.42,HET,154,0.41,WT,171,0.00	VAPB	3'UTR	VAPB:ENST00000475243:3'UTR:MODIFIER:exon6/6:c.*5250T>C:		rs6015274	0.4832	0.4272	1026,252,26	0.0000,0.0000,0.0000,0.4279,0.4207	0.5142							605704 [VAPB (confirmed) Amyotrophic lateral sclerosis 8,608627|Spinal muscular atrophy,late-onset,Finkel type,182980];	RCV000303935.1 [benign]; RCV000358667.1 [benign]; 			121	287					VAPB (inh=AD pLI=0.74)
chr20	57024589	57024589	C	T	het	anno_omim	QUAL=6082;DP=368;AF=0.45;MQM=60;TRIO=HET,368,0.45,HET,171,0.42,WT,220,0.00	VAPB	3'UTR	VAPB:ENST00000475243:3'UTR:MODIFIER:exon6/6:c.*5298C>T:		rs6015275	0.2091	0.2547	375,69,3	0.0000,0.0000,0.0000,0.2158,0.2695	0.2625							605704 [VAPB (confirmed) Amyotrophic lateral sclerosis 8,608627|Spinal muscular atrophy,late-onset,Finkel type,182980];	RCV000264156.1 [benign]; RCV000319356.1 [benign]; 			31	214					VAPB (inh=AD pLI=0.74)
chr20	57025407	57025410	TCTG	-	het	anno_omim	QUAL=9433;DP=420;AF=0.55;MQM=59;TRIO=HET,420,0.55,HET,320,0.53,WT,416,0.00	VAPB	3'UTR	VAPB:ENST00000475243:3'UTR:MODIFIER:exon6/6:c.*6121_*6124delCTGT:		rs143261907	0.0214	0.0223	5,2,0	0.0000,0.0000,0.0000,0.0407,0.0164	0.0774							605704 [VAPB (confirmed) Amyotrophic lateral sclerosis 8,608627|Spinal muscular atrophy,late-onset,Finkel type,182980];	RCV000328637.1 [likely benign]; RCV000383258.1 [likely benign]; 			2	67					VAPB (inh=AD pLI=0.74)
chr20	57415110	57415110	A	G	hom	anno_omim	QUAL=15038;DP=131;AF=0.99;MQM=59;TRIO=HOM,131,0.99,HOM,240,1.00,HET,294,0.51	GNAS,GNAS-AS1	5'UTR,intron,non_coding_transcript_exon	GNAS:ENST00000313949:5'UTR:MODIFIER:exon1/13:c.-52A>G:,GNAS:ENST00000371098:5'UTR:MODIFIER:exon1/4:c.-52A>G:,GNAS:ENST00000371075:5'UTR:MODIFIER:exon1/13:c.-52A>G:,GNAS-AS1:ENST00000424094:intron:MODIFIER:exon4/4:n.819+1882T>C:,GNAS-AS1:ENST00000598163:intron:MODIFIER:exon2/3:n.388+8824T>C:,GNAS-AS1:ENST00000443966:non_coding_transcript_exon:MODIFIER:exon1/1:n.790T>C:		rs1800900	0.5976	0.0000	0,0,0	0,0,0,0,0	0.5999							610540 [GNAS-AS1 (provisional) Pseudohypoparathyroidism,type IB,603233]:139320 [GNAS (confirmed) Pseudohypoparathyroidism Ia,103580|McCune-Albright syndrome,somatic,mosaic 174800|Pseudohypoparathyroidism Ic,612462|Osseous heteroplasia,progressive,166350|Pseudohypoparathyroidism Ib,603233|Acromegaly,somatic,102200|Pseudopseudohypoparathyroidism,612463|ACTH-independent macronodular adrenal hyperplasia,219080];				759	844					GNAS (inh=AD pLI=1.00), GNAS-AS1 (inh=AD pLI=n/a)
chr20	57478807	57478807	C	T	het	anno_omim	QUAL=32990;DP=596;AF=0.48;MQM=60;TRIO=HET,596,0.48,WT,577,0.00,HOM,796,1.00	GNAS	synonymous,3'UTR	GNAS:ENST00000371100:synonymous:LOW:exon5/13:c.2322C>T:p.Ile774Ile,GNAS:ENST00000371102:synonymous:LOW:exon4/12:c.2280C>T:p.Ile760Ile,GNAS:ENST00000371095:synonymous:LOW:exon4/12:c.351C>T:p.Ile117Ile,GNAS:ENST00000354359:synonymous:LOW:exon5/13:c.396C>T:p.Ile132Ile,GNAS:ENST00000371085:synonymous:LOW:exon5/13:c.393C>T:p.Ile131Ile,GNAS:ENST00000265620:synonymous:LOW:exon4/12:c.348C>T:p.Ile116Ile,GNAS:ENST00000306090:synonymous:LOW:exon5/13:c.351C>T:p.Ile117Ile,GNAS:ENST00000313949:3'UTR:MODIFIER:exon5/13:c.*296C>T:,GNAS:ENST00000371075:3'UTR:MODIFIER:exon5/13:c.*299C>T:		rs7121	0.6444	0.5473	18875,8501,2997	0.7605,0.6336,0.6302,0.5009,0.5698	0.5563	-0.3130		T			15.17	139320 [GNAS (confirmed) Pseudohypoparathyroidism Ia,103580|McCune-Albright syndrome,somatic,mosaic 174800|Pseudohypoparathyroidism Ic,612462|Osseous heteroplasia,progressive,166350|Pseudohypoparathyroidism Ib,603233|Acromegaly,somatic,102200|Pseudopseudohypoparathyroidism,612463|ACTH-independent macronodular adrenal hyperplasia,219080];	RCV000178784.1 [benign]; 		COSM3758661, COSM3758662	651	1060					GNAS (inh=AD pLI=1.00)
chr20	57899654	57899654	C	-	het	anno_omim	QUAL=2597;DP=152;AF=0.61;MQM=59;TRIO=HET,152,0.61,HET,93,0.56,WT,106,0.09	EDN3	3'UTR,intron	EDN3:ENST00000337938:3'UTR:MODIFIER:exon5/5:c.*149delC:,EDN3:ENST00000311585:3'UTR:MODIFIER:exon5/5:c.*241delC:,EDN3:ENST00000371025:3'UTR:MODIFIER:exon4/4:c.*241delC:,EDN3:ENST00000395654:3'UTR:MODIFIER:exon4/4:c.*149delC:,EDN3:ENST00000371028:intron:MODIFIER:exon5/5:c.*16-88delC:		rs11475273;rs754876648	0.0000	0.0000	0,0,0	0,0,0,0,0	0.2988							131242 [EDN3 (confirmed) Waardenburg syndrome,type 4B,613265|Central hypoventilation syndrome,congenital,209880|Hirschsprung disease,susceptibility to,4,613712];				9	84					EDN3 (inh=AR+AD pLI=0.07)
chr20	61974862	61974862	C	T	het	anno_omim	QUAL=8475;DP=152;AF=0.51;MQM=59;TRIO=HET,152,0.51,WT,393,0.00,HET,523,0.51	RNU6,994P,CHRNA4	intergenic_region	CHRNA4:ENSG00000222439-ENSG00000101204:intergenic_region:MODIFIER::n.61974862C>T:		rs45601435	0.0262	0.0609	33,18,0	0.0000,0.0000,0.0000,0.0963,0.0500	0.0458							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];				3	79					RNU6 (inh=n/a pLI=n/a), 994P (inh=n/a pLI=n/a), CHRNA4 (inh=AD pLI=0.02)
chr20	61974929	61974929	-	AT	het	anno_omim	QUAL=6694;DP=215;AF=0.47;MQM=59;TRIO=HET,215,0.47,WT,305,0.00,HET,399,0.48	RNU6,994P,CHRNA4	intergenic_region	CHRNA4:ENSG00000222439-ENSG00000101204:intergenic_region:MODIFIER::n.61974929_61974930insAT:	MER74A	rs79237427	0.1134	0.1922	228,33,1	0.0000,0.0000,0.0000,0.1406,0.2181	0.1126							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];				10	139					RNU6 (inh=n/a pLI=n/a), 994P (inh=n/a pLI=n/a), CHRNA4 (inh=AD pLI=0.02)
chr20	61974986	61974986	C	A	het	anno_omim	QUAL=4399;DP=111;AF=0.48;MQM=59;TRIO=HET,111,0.48,WT,202,0.00,HET,272,0.51	RNU6,994P,CHRNA4	intergenic_region	CHRNA4:ENSG00000222439-ENSG00000101204:intergenic_region:MODIFIER::n.61974986C>A:	MER74A	rs45543134	0.0789	0.1560	150,31,0	0.0000,0.0000,0.0000,0.1436,0.1674	0.0971							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];				10	128					RNU6 (inh=n/a pLI=n/a), 994P (inh=n/a pLI=n/a), CHRNA4 (inh=AD pLI=0.02)
chr20	61974991	61974991	-	G	het	anno_omim	QUAL=4203;DP=104;AF=0.51;MQM=59;TRIO=HET,104,0.51,WT,194,0.00,HET,257,0.51	RNU6,994P,CHRNA4	intergenic_region	CHRNA4:ENSG00000222439-ENSG00000101204:intergenic_region:MODIFIER::n.61974991_61974992insG:	MER74A	rs148816386	0.0292	0.0634	32,16,0	0.0000,0.0000,0.0000,0.0991,0.0526	0.0459							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];				3	73					RNU6 (inh=n/a pLI=n/a), 994P (inh=n/a pLI=n/a), CHRNA4 (inh=AD pLI=0.02)
chr20	61975084	61975084	A	G	het	anno_omim	QUAL=2452;DP=90;AF=0.51;MQM=59;TRIO=HET,90,0.51,WT,84,0.00,HET,121,0.54	RNU6,994P,CHRNA4	intergenic_region	CHRNA4:ENSG00000222439-ENSG00000101204:intergenic_region:MODIFIER::n.61975084A>G:	MER74A	rs45620536	0.0835	0.1605	143,31,0	0.0000,0.0000,0.0000,0.1503,0.1709	0.0971							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];				13	121					RNU6 (inh=n/a pLI=n/a), 994P (inh=n/a pLI=n/a), CHRNA4 (inh=AD pLI=0.02)
chr20	61975091	61975091	A	G	het	anno_omim	QUAL=2082;DP=84;AF=0.46;MQM=59;TRIO=HET,84,0.46,WT,82,0.00,HET,108,0.52	RNU6,994P,CHRNA4	intergenic_region	CHRNA4:ENSG00000222439-ENSG00000101204:intergenic_region:MODIFIER::n.61975091A>G:	MER74A	rs45600338	0.0771	0.1559	140,32,0	0.0000,0.0000,0.0000,0.1496,0.1651	0.0952							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];				13	119					RNU6 (inh=n/a pLI=n/a), 994P (inh=n/a pLI=n/a), CHRNA4 (inh=AD pLI=0.02)
chr20	61975378	61975378	A	G	het	anno_omim	QUAL=4978;DP=200;AF=0.47;MQM=59;TRIO=HET,200,0.47,WT,186,0.00,HET,251,0.48	RNU6,994P,CHRNA4	intergenic_region	CHRNA4:ENSG00000222439-ENSG00000101204:intergenic_region:MODIFIER::n.61975378A>G:	L1ME3	rs6090378	0.0677	0.1067	78,18,0	0.0000,0.0000,0.0000,0.0960,0.1134	0.0635							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];				4	72					RNU6 (inh=n/a pLI=n/a), 994P (inh=n/a pLI=n/a), CHRNA4 (inh=AD pLI=0.02)
chr20	61975624	61975624	G	C	het	anno_omim	QUAL=7365;DP=261;AF=0.46;MQM=60;TRIO=HET,261,0.46,WT,325,0.00,HET,334,0.50	CHRNA4	3'UTR	CHRNA4:ENST00000370263:3'UTR:MODIFIER:exon6/6:c.*2466C>G:	L1ME3	rs45494793	0.0296	0.0614	34,18,0	0.0300,0.0000,0.0000,0.0951,0.0505	0.0465							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];				3	77					CHRNA4 (inh=AD pLI=0.02)
chr20	61975829	61975829	-	T	het	anno_omim	QUAL=1818;DP=131;AF=0.44;MQM=59;TRIO=HET,131,0.44,WT,134,0.04,HET,145,0.41	CHRNA4	3'UTR	CHRNA4:ENST00000370263:3'UTR:MODIFIER:exon6/6:c.*2260dupA:		rs11480478;rs568329035	0.2746	0.2015	39,8,0	0.0000,0.0000,0.0000,0.2115,0.1940	0.2234							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];				29	237					CHRNA4 (inh=AD pLI=0.02)
chr20	61975846	61975846	-	A	het	anno_omim	QUAL=1249;DP=144;AF=0.40;MQM=59;TRIO=HET,144,0.40,WT,116,0.03,HET,122,0.38	CHRNA4	3'UTR	CHRNA4:ENST00000370263:3'UTR:MODIFIER:exon6/6:c.*2243dupT:		rs551959449	0.2885	0.4044	2,0,0	0.0000,0.0000,0.0000,0.3836,0.4133	0.4087							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];				37	279					CHRNA4 (inh=AD pLI=0.02)
chr20	61976028	61976028	G	A	het	anno_omim	QUAL=4541;DP=115;AF=0.49;MQM=59;TRIO=HET,115,0.49,WT,168,0.00,HET,210,0.53	CHRNA4	3'UTR	CHRNA4:ENST00000370263:3'UTR:MODIFIER:exon6/6:c.*2062C>T:		rs45536037	0.0296	0.0610	34,18,0	0.0000,0.0000,0.0000,0.0957,0.0501	0.0464							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];				3	79					CHRNA4 (inh=AD pLI=0.02)
chr20	61976032	61976032	A	G	het	anno_omim	QUAL=4541;DP=115;AF=0.49;MQM=59;TRIO=HET,115,0.49,WT,168,0.00,HET,210,0.53	CHRNA4	3'UTR	CHRNA4:ENST00000370263:3'UTR:MODIFIER:exon6/6:c.*2058T>C:		rs45523232	0.0296	0.0610	34,18,0	0.0000,0.0000,0.0000,0.0955,0.0502	0.0464							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];				3	79					CHRNA4 (inh=AD pLI=0.02)
chr20	61976530	61976530	C	T	het	anno_omim	QUAL=2407;DP=76;AF=0.42;MQM=60;TRIO=HET,76,0.42,WT,78,0.00,HET,129,0.52	CHRNA4	3'UTR	CHRNA4:ENST00000370263:3'UTR:MODIFIER:exon6/6:c.*1560G>A:		rs45476096	0.0262	0.0589	27,17,0	0.0000,0.0000,0.0000,0.0997,0.0459	0.0450							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];				3	77					CHRNA4 (inh=AD pLI=0.02)
chr20	61976920	61976920	T	C	het	anno_omim	QUAL=1199;DP=80;AF=0.48;MQM=60;TRIO=HET,80,0.48,WT,53,0.00,HET,48,0.42	CHRNA4	3'UTR	CHRNA4:ENST00000370263:3'UTR:MODIFIER:exon6/6:c.*1170A>G:		rs41283006	0.0487	0.1247	60,10,0	0.0000,0.0000,0.0000,0.1126,0.1346	0.0567							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];				3	79					CHRNA4 (inh=AD pLI=0.02)
chr20	61977015	61977015	C	T	het	anno_omim	QUAL=327;DP=35;AF=0.46;MQM=59;TRIO=HET,35,0.46,WT,17,0.00,HET,14,0.29	CHRNA4	3'UTR	CHRNA4:ENST00000370263:3'UTR:MODIFIER:exon6/6:c.*1075G>A:		rs41283008	0.0302	0.0614	34,18,0	0.0000,0.0000,0.0000,0.0963,0.0506	0.0464							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];				3	79					CHRNA4 (inh=AD pLI=0.02)
chr20	61977049	61977049	G	C	het	anno_omim	QUAL=335;DP=44;AF=0.39;MQM=59;TRIO=HET,44,0.39,WT,15,0.00,HET,13,0.23	CHRNA4	3'UTR	CHRNA4:ENST00000370263:3'UTR:MODIFIER:exon6/6:c.*1041C>G:		rs41283010	0.0302	0.0617	34,18,0	0.0000,0.0000,0.0000,0.0968,0.0508	0.0465							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];				3	79					CHRNA4 (inh=AD pLI=0.02)
chr20	61977335	61977335	A	G	het	anno_omim	QUAL=550;DP=42;AF=0.43;MQM=59;TRIO=HET,42,0.43,WT,22,0.00,HET,29,0.34	CHRNA4	3'UTR	CHRNA4:ENST00000370263:3'UTR:MODIFIER:exon6/6:c.*755T>C:		rs45624232	0.0751	0.1491	147,34,0	0.0000,0.0000,0.0000,0.1432,0.1577	0.0964							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];				10	137					CHRNA4 (inh=AD pLI=0.02)
chr20	61977373	61977373	G	A	het	anno_omim	QUAL=562;DP=38;AF=0.45;MQM=59;TRIO=HET,38,0.45,WT,32,0.00,HET,35,0.34	CHRNA4	3'UTR	CHRNA4:ENST00000370263:3'UTR:MODIFIER:exon6/6:c.*717C>T:		rs45556643	0.0304	0.0614	34,18,0	0.0000,0.0000,0.0000,0.0957,0.0509	0.0462							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];				3	78					CHRNA4 (inh=AD pLI=0.02)
chr20	61977556	61977556	G	A	het	anno_omim	QUAL=9544;DP=161;AF=0.53;MQM=60;TRIO=HET,161,0.53,HET,282,0.47,HET,310,0.55	CHRNA4	3'UTR	CHRNA4:ENST00000370263:3'UTR:MODIFIER:exon6/6:c.*534C>T:		rs2236196	0.6142	0.6256	2122,541,16	0.0000,0.0000,0.0000,0.6338,0.6217	0.7127							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];				325	267					CHRNA4 (inh=AD pLI=0.02)
chr20	61981104	61981104	C	T	het	anno_omim	QUAL=3933;DP=49;AF=0.39;MQM=60;TRIO=HET,49,0.39,HET,163,0.46,HET,226,0.50	CHRNA4	synonymous	CHRNA4:ENST00000370263:synonymous:LOW:exon5/6:c.1659G>A:p.Ala553Ala		rs1044397	0.3518	0.4750	14137,9170,80	0.1294,0.5228,0.3917,0.5317,0.4437	0.4829							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];	RCV000079314.9 [other]; 		COSM3758737	433	838					CHRNA4 (inh=AD pLI=0.02)
chr20	61981134	61981134	G	A	het	anno_omim	QUAL=6113;DP=103;AF=0.47;MQM=60;TRIO=HET,103,0.47,HET,189,0.51,HET,258,0.49	CHRNA4	synonymous	CHRNA4:ENST00000370263:synonymous:LOW:exon5/6:c.1629C>T:p.Ser543Ser		rs1044396	0.3235	0.4659	13598,9089,75	0.1287,0.5243,0.2591,0.5327,0.4426	0.4721							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];	RCV000079313.9 [other]; 		COSM3758738	430	832					CHRNA4 (inh=AD pLI=0.02)
chr20	61981536	61981536	A	G	hom	anno_omim	QUAL=14911;DP=110;AF=1.00;MQM=59;TRIO=HOM,110,1.00,HET,214,0.56,HOM,286,1.00	CHRNA4	synonymous	CHRNA4:ENST00000370263:synonymous:LOW:exon5/6:c.1227T>C:p.Cys409Cys		rs2229960	0.8708	0.9358	40678,23296,1633	0.6835,0.9637,0.9997,0.9505,0.9525	0.9392							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];	RCV000079311.9 [other]; 		COSM4134782	1856	229					CHRNA4 (inh=AD pLI=0.02)
chr20	61981554	61981554	C	A	hom	anno_omim	QUAL=14161;DP=105;AF=0.97;MQM=59;TRIO=HOM,105,0.97,HET,231,0.53,HOM,299,1.00	CHRNA4	synonymous	CHRNA4:ENST00000370263:synonymous:LOW:exon5/6:c.1209G>T:p.Pro403Pro		rs2229959	0.7338	0.8354	35239,21198,881	0.4992,0.9127,0.8655,0.8738,0.7836	0.8423							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];	RCV000079310.9 [other]; 		COSM4134783	1501	516					CHRNA4 (inh=AD pLI=0.02)
chr20	61982085	61982085	A	G	hom	anno_omim	QUAL=68729;DP=415;AF=1.00;MQM=59;TRIO=HOM,415,1.00,HET,1118,0.50,HOM,1336,1.00	CHRNA4	synonymous	CHRNA4:ENST00000370263:synonymous:LOW:exon5/6:c.678T>C:p.Cys226Cys		rs1044394	0.8636	0.9196	51602,28961,2215	0.6511,0.9550,0.9997,0.9343,0.9501	0.9234							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];	RCV000116723.4 [other]; 			1829	273					CHRNA4 (inh=AD pLI=0.02)
chr20	61982124	61982124	A	G	hom	anno_omim	QUAL=61752;DP=469;AF=0.99;MQM=59;TRIO=HOM,469,0.99,HET,987,0.50,HOM,1172,1.00	CHRNA4	synonymous	CHRNA4:ENST00000370263:synonymous:LOW:exon5/6:c.639T>C:p.Asp213Asp		rs1044393	0.7572	0.8353	42869,25323,1471	0.5335,0.9113,0.8655,0.8730,0.7804	0.8463							118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1,600513|Nicotine addiction,susceptibility to,188890];	RCV000116722.4 [other]; 			1504	542					CHRNA4 (inh=AD pLI=0.02)
chr20	62037879	62037879	A	C	het	low_QUAL;anno_omim	QUAL=21;DP=29;AF=0.52;MQM=59;TRIO=HET,29,0.52,WT,20,0.10,HET,48,0.21	KCNQ2	3'UTR	KCNQ2:ENST00000354587:3'UTR:MODIFIER:exon17/17:c.*118T>G:,KCNQ2:ENST00000357249:3'UTR:MODIFIER:exon16/16:c.*118T>G:,KCNQ2:ENST00000359125:3'UTR:MODIFIER:exon17/17:c.*118T>G:,KCNQ2:ENST00000359689:3'UTR:MODIFIER:exon18/18:c.*118T>G:,KCNQ2:ENST00000360480:3'UTR:MODIFIER:exon15/15:c.*118T>G:,KCNQ2:ENST00000370224:3'UTR:MODIFIER:exon16/16:c.*118T>G:,KCNQ2:ENST00000344462:3'UTR:MODIFIER:exon16/16:c.*118T>G:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0004							602235 [KCNQ2 (confirmed) Seizures,benign neonatal,1,121200|Myokymia,121200|Epileptic encephalopathy,early infantile,7,613720];				0	9					KCNQ2 (inh=AD pLI=1.00)
chr20	62038277	62038277	T	G	het	pred_pathogenic;anno_omim	QUAL=1090;DP=50;AF=0.52;MQM=60;TRIO=HET,50,0.52,HET,61,0.43,WT,105,0.00	KCNQ2	missense	KCNQ2:ENST00000354587:missense:MODERATE:exon17/17:c.2363A>C:p.Asn788Thr,KCNQ2:ENST00000357249:missense:MODERATE:exon16/16:c.2285A>C:p.Asn762Thr,KCNQ2:ENST00000359125:missense:MODERATE:exon17/17:c.2339A>C:p.Asn780Thr,KCNQ2:ENST00000359689:missense:MODERATE:exon18/18:c.2339A>C:p.Asn780Thr,KCNQ2:ENST00000360480:missense:MODERATE:exon15/15:c.2255A>C:p.Asn752Thr,KCNQ2:ENST00000370224:missense:MODERATE:exon16/16:c.2363A>C:p.Asn788Thr,KCNQ2:ENST00000344462:missense:MODERATE:exon16/16:c.2246A>C:p.Asn749Thr		rs1801475	0.5905	0.6372	19837,12061,1048	0.5318,0.5337,0.6432,0.6684,0.6257	0.6094	1.8720	T,T,T,T,T,T,T,T,T	T	B,B,B,B	T,T,T,T,T,T,T,T,T	0.01	602235 [KCNQ2 (confirmed) Seizures,benign neonatal,1,121200|Myokymia,121200|Epileptic encephalopathy,early infantile,7,613720];	RCV000020987.1 [benign]; RCV000082686.9 [benign]; RCV000348446.1 [benign]; 		COSM3758740, COSM3758739, COSM3758741	836	952					KCNQ2 (inh=AD pLI=1.00)
chr20	62565646	62565646	G	A	het	anno_omim	QUAL=2701;DP=128;AF=0.53;MQM=59;TRIO=HET,128,0.53,WT,68,0.00,HET,100,0.52	DNAJC5	3'UTR	DNAJC5:ENST00000360864:3'UTR:MODIFIER:exon5/5:c.*2725G>A:		rs11554628	0.0310	0.0000	0,0,0	0,0,0,0,0	0.0649							611203 [DNAJC5 (provisional) Ceroid lipofuscinosis,neuronal,4,Parry type,162350];	RCV000353528.1 [likely benign]; 			0	26					DNAJC5 (inh=AD pLI=0.86)
chr21	34787312	34787312	A	G	het	anno_omim	QUAL=5157;DP=230;AF=0.54;MQM=59;TRIO=HET,230,0.54,HET,188,0.44,WT,314,0.00	IFNGR2	missense,5'UTR	IFNGR2:ENST00000381995:missense:MODERATE:exon3/8:c.248A>G:p.Gln83Arg,IFNGR2:ENST00000290219:missense:MODERATE:exon2/7:c.191A>G:p.Gln64Arg,IFNGR2:ENST00000405436:5'UTR:MODIFIER:exon3/8:c.-47A>G:		rs9808753	0.2720	0.1963	2951,574,275	0.2348,0.2273,0.4459,0.1306,0.2879	0.1955	0.1630	T,T	T	B,B	T,T	0.01	147569 [IFNGR2 (confirmed) Immunodeficiency 28,mycobacteriosis,614889];			COSM3758854	70	500					IFNGR2 (inh=AR pLI=0.88)
chr21	34809693	34809693	C	T	het	anno_omim	QUAL=5611;DP=99;AF=0.52;MQM=59;TRIO=HET,99,0.52,HOM,88,1.00,HET,102,0.59	IFNGR2,TMEM50B	3'UTR	IFNGR2:ENST00000381995:3'UTR:MODIFIER:exon8/8:c.*424C>T:,IFNGR2:ENST00000290219:3'UTR:MODIFIER:exon7/7:c.*424C>T:,IFNGR2:ENST00000405436:3'UTR:MODIFIER:exon8/8:c.*424C>T:		rs1059293	0.6807	0.0000	0,0,0	0,0,0,0,0	0.5887							147569 [IFNGR2 (confirmed) Immunodeficiency 28,mycobacteriosis,614889];				51	111					IFNGR2 (inh=AR pLI=0.88), TMEM50B (inh=n/a pLI=0.30)
chr21	38123320	38123320	-	A	het	anno_omim	QUAL=2184;DP=219;AF=0.37;MQM=59;TRIO=HET,219,0.37,WT,74,0.03,HET,92,0.37	HLCS	3'UTR	HLCS:ENST00000336648:3'UTR:MODIFIER:exon12/12:c.*3226dupT:		rs762985167	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0921							609018 [HLCS (confirmed) Holocarboxylase synthetase deficiency,253270];	RCV000333447.1 [uncertain significance]; 			1	36					HLCS (inh=AR pLI=0.49)
chr21	38123404	38123404	-	AT	het	anno_omim	QUAL=4099;DP=275;AF=0.41;MQM=59;TRIO=HET,275,0.41,WT,80,0.00,HET,112,0.42	HLCS	3'UTR	HLCS:ENST00000336648:3'UTR:MODIFIER:exon12/12:c.*3141_*3142dupAT:		rs3031056;rs5843777	0.3524	0.0000	0,0,0	0,0,0,0,0	0.3928							609018 [HLCS (confirmed) Holocarboxylase synthetase deficiency,253270];	RCV000280668.1 [benign]; 			47	107					HLCS (inh=AR pLI=0.49)
chr21	38123925	38123925	C	T	het	anno_omim	QUAL=11779;DP=371;AF=0.56;MQM=59;TRIO=HET,371,0.56,WT,357,0.00,HET,452,0.53	HLCS	3'UTR	HLCS:ENST00000336648:3'UTR:MODIFIER:exon12/12:c.*2622G>A:,HLCS:ENST00000399120:3'UTR:MODIFIER:exon12/12:c.*2622G>A:		rs14407	0.4465	0.0000	0,0,0	0,0,0,0,0	0.4187							609018 [HLCS (confirmed) Holocarboxylase synthetase deficiency,253270];	RCV000389959.1 [benign]; 			51	105					HLCS (inh=AR pLI=0.49)
chr21	38308774	38308774	C	T	het	pred_pathogenic;anno_omim	QUAL=8708;DP=320;AF=0.50;MQM=60;TRIO=HET,320,0.50,HET,380,0.51,WT,446,0.00	HLCS	missense	HLCS:ENST00000336648:missense:MODERATE:exon5/12:c.971G>A:p.Arg324His,HLCS:ENST00000399120:missense:MODERATE:exon5/12:c.971G>A:p.Arg324His		rs61732501	0.0070	0.0097	10,8,0	0.0020,0.0036,0.0000,0.0109,0.0168	0.0101	-2.1740	T,T	D	B,B	D,D	4.57	609018 [HLCS (confirmed) Holocarboxylase synthetase deficiency,253270];	RCV000125363.2 [benign]; 			0	41					HLCS (inh=AR pLI=0.49)
chr21	38320006	38320006	C	G	het	anno_omim	QUAL=15822;DP=586;AF=0.48;MQM=60;TRIO=HET,586,0.48,HET,284,0.53,HET,336,0.53	HLCS	5'UTR,intron	HLCS:ENST00000399120:5'UTR:MODIFIER:exon3/12:c.-485G>C:,HLCS:ENST00000336648:intron:MODIFIER:exon2/11:c.-257-1552G>C:		rs13047776	0.4940	0.0000	0,0,0	0,0,0,0,0	0.4845							609018 [HLCS (confirmed) Holocarboxylase synthetase deficiency,253270];				49	72					HLCS (inh=AR pLI=0.49)
chr21	38320007	38320007	T	G	het	anno_omim	QUAL=15822;DP=586;AF=0.48;MQM=60;TRIO=HET,586,0.48,HET,284,0.53,HET,336,0.53	HLCS	5'UTR,intron	HLCS:ENST00000399120:5'UTR:MODIFIER:exon3/12:c.-486A>C:,HLCS:ENST00000336648:intron:MODIFIER:exon2/11:c.-257-1553A>C:		rs13048613	0.4948	0.0000	0,0,0	0,0,0,0,0	0.4845							609018 [HLCS (confirmed) Holocarboxylase synthetase deficiency,253270];				49	72					HLCS (inh=AR pLI=0.49)
chr21	38320591	38320591	G	A	hom	anno_omim	QUAL=876;DP=26;AF=0.31;MQM=58;TRIO=HOM,26,0.31,HOM,9,0.22,HOM,3,0.00	HLCS	splice_region&intron,intron	HLCS:ENST00000399120:splice_region&intron:LOW:exon2/11:c.-1066-4C>T:,HLCS:ENST00000336648:intron:MODIFIER:exon2/11:c.-257-2137C>T:	AluSg		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0103							609018 [HLCS (confirmed) Holocarboxylase synthetase deficiency,253270];				2	2					HLCS (inh=AR pLI=0.49)
chr21	38353268	38353268	-	TCCG	het	low_DP;anno_omim	QUAL=363;DP=9;AF=0.56;MQM=59;TRIO=HET,9,0.56,HET,37,0.49,WT,53,0.00	HLCS	intron	HLCS:ENST00000336648:intron:MODIFIER:exon1/11:c.-393+9186_-393+9189dupCGGA:		rs35269254;rs71328533	0.3405	0.0000	0,0,0	0,0,0,0,0	0.3691							609018 [HLCS (confirmed) Holocarboxylase synthetase deficiency,253270];				18	54					HLCS (inh=AR pLI=0.49)
chr21	38782911	38782911	T	C	het	anno_omim	QUAL=6622;DP=278;AF=0.53;MQM=59;TRIO=HET,278,0.53,WT,223,0.00,HET,228,0.53	DYRK1A	5'UTR	DYRK1A:ENST00000338785:5'UTR:MODIFIER:exon2/13:c.-138T>C:	FRAM	rs9981736	0.5543	0.0000	0,0,0	0,0,0,0,0	0.5659							600855 [DYRK1A (confirmed) Mental retardation,autosomal dominant 7,614104];				35	81					DYRK1A (inh=AD pLI=1.00)
chr21	38791581	38791581	A	C	het	anno_omim	QUAL=14186;DP=662;AF=0.49;MQM=60;TRIO=HET,662,0.49,WT,328,0.00,HET,412,0.54	DYRK1A	5'UTR,intron	DYRK1A:ENST00000451934:5'UTR:MODIFIER:exon1/10:c.-1096A>C:,DYRK1A:ENST00000321219:5'UTR:MODIFIER:exon1/11:c.-1096A>C:,DYRK1A:ENST00000339659:5'UTR:MODIFIER:exon1/11:c.-1096A>C:,DYRK1A:ENST00000338785:intron:MODIFIER:exon2/12:c.-76-1020A>C:		rs2835726	0.5000	0.0000	0,0,0	0,0,0,0,0	0.5072							600855 [DYRK1A (confirmed) Mental retardation,autosomal dominant 7,614104];				56	113					DYRK1A (inh=AD pLI=1.00)
chr21	38792131	38792131	T	C	het	anno_omim	QUAL=4963;DP=241;AF=0.48;MQM=60;TRIO=HET,241,0.48,WT,102,0.00,HET,137,0.56	DYRK1A	5'UTR,intron	DYRK1A:ENST00000451934:5'UTR:MODIFIER:exon1/10:c.-546T>C:,DYRK1A:ENST00000321219:5'UTR:MODIFIER:exon1/11:c.-546T>C:,DYRK1A:ENST00000339659:5'UTR:MODIFIER:exon1/11:c.-546T>C:,DYRK1A:ENST00000338785:intron:MODIFIER:exon2/12:c.-76-470T>C:		rs13049514	0.0996	0.0000	0,0,0	0,0,0,0,0	0.1302							600855 [DYRK1A (confirmed) Mental retardation,autosomal dominant 7,614104];				4	65					DYRK1A (inh=AD pLI=1.00)
chr21	44473425	44473425	G	A	hom	anno_omim	QUAL=21708;DP=276;AF=1.00;MQM=59;TRIO=HOM,276,1.00,HET,271,0.48,HOM,299,1.00	CBS	3'UTR	CBS:ENST00000398168:3'UTR:MODIFIER:exon18/18:c.*565C>T:,CBS:ENST00000398158:3'UTR:MODIFIER:exon17/17:c.*565C>T:,CBS:ENST00000398165:3'UTR:MODIFIER:exon17/17:c.*565C>T:,CBS:ENST00000359624:3'UTR:MODIFIER:exon18/18:c.*351C>T:,CBS:ENST00000352178:3'UTR:MODIFIER:exon17/17:c.*565C>T:	L1MB5	rs706209	0.3654	0.0000	0,0,0	0,0,0,0,0	0.3950							613381 [CBS (confirmed) Homocystinuria,B6-responsive and nonresponsive types,236200|Thrombosis,hyperhomocysteinemic,236200];	RCV000261214.1 [benign]; 			56	93					CBS (inh=AR pLI=0.01)
chr21	44473446	44473446	A	G	hom	anno_omim	QUAL=22057;DP=302;AF=1.00;MQM=59;TRIO=HOM,302,1.00,HET,244,0.47,HOM,283,1.00	CBS	3'UTR	CBS:ENST00000398168:3'UTR:MODIFIER:exon18/18:c.*544T>C:,CBS:ENST00000398158:3'UTR:MODIFIER:exon17/17:c.*544T>C:,CBS:ENST00000398165:3'UTR:MODIFIER:exon17/17:c.*544T>C:,CBS:ENST00000359624:3'UTR:MODIFIER:exon18/18:c.*330T>C:,CBS:ENST00000352178:3'UTR:MODIFIER:exon17/17:c.*544T>C:	L1MB5	rs706208	0.3662	0.0000	0,0,0	0,0,0,0,0	0.3945							613381 [CBS (confirmed) Homocystinuria,B6-responsive and nonresponsive types,236200|Thrombosis,hyperhomocysteinemic,236200];	RCV000316354.1 [benign]; 			53	97					CBS (inh=AR pLI=0.01)
chr21	44480616	44480616	G	A	hom	anno_omim	QUAL=12928;DP=116;AF=1.00;MQM=60;TRIO=HOM,116,1.00,HET,186,0.51,HOM,248,1.00	CBS	synonymous	CBS:ENST00000398168:synonymous:LOW:exon12/18:c.1080C>T:p.Ala360Ala,CBS:ENST00000398158:synonymous:LOW:exon12/17:c.1080C>T:p.Ala360Ala,CBS:ENST00000398165:synonymous:LOW:exon12/17:c.1080C>T:p.Ala360Ala,CBS:ENST00000359624:synonymous:LOW:exon12/18:c.1080C>T:p.Ala360Ala,CBS:ENST00000352178:synonymous:LOW:exon12/17:c.1080C>T:p.Ala360Ala,CBS:ENST00000544202:synonymous:LOW:exon10/15:c.816C>T:p.Ala272Ala		rs1801181	0.2955	0.3382	7601,4195,25	0.0663,0.1562,0.6207,0.3652,0.3308	0.3340	-2.6190		T			10.45	613381 [CBS (confirmed) Homocystinuria,B6-responsive and nonresponsive types,236200|Thrombosis,hyperhomocysteinemic,236200];	RCV000078107.7 [benign]; RCV000244095.1 [benign]; RCV000313339.1 [benign]; 		COSM3758919, COSM3758920	292	919					CBS (inh=AR pLI=0.01)
chr21	45193728	45193728	G	C	het	anno_omim	QUAL=5827;DP=241;AF=0.52;MQM=60;TRIO=HET,241,0.52,HET,199,0.54,WT,281,0.00	CSTB	3'UTR	CSTB:ENST00000291568:3'UTR:MODIFIER:exon3/3:c.*355C>G:	MIR	rs143062585	0.0070	0.0000	0,0,0	0,0,0,0,0	0.0073							601145 [CSTB (provisional) Epilepsy,progressive myoclonic 1A (Unverricht and Lundborg),254800];	RCV000388869.1 [uncertain significance]; 			0	14					CSTB (inh=AR pLI=0.00)
chr21	45709568	45709568	C	T	het	anno_omim	QUAL=3784;DP=115;AF=0.43;MQM=60;TRIO=HET,115,0.43,WT,150,0.00,HET,208,0.56	AIRE	synonymous	AIRE:ENST00000291582:synonymous:LOW:exon6/14:c.681C>T:p.Gly227Gly		rs1055311	0.1176	0.2222	3552,2538,16	0.0491,0.2497,0.0051,0.2767,0.1679	0.2271							607358 [AIRE (confirmed) Autoimmune polyendocrinopathy syndrome,type I,with or without reversible metaphyseal dysplasia,240300];	RCV000116302.3 [other]; 		COSM3758929	122	742					AIRE (inh=AR+AD pLI=0.00)
chr21	45712290	45712290	G	A	het	anno_omim;anno_pathogenic_hgmd	QUAL=1572;DP=98;AF=0.48;MQM=59;TRIO=HET,98,0.48,HET,106,0.39,WT,144,0.00	AIRE	splice_region&intron	AIRE:ENST00000291582:splice_region&intron:LOW:exon9/13:c.1095+6G>A:,AIRE:ENST00000329347:splice_region&intron:LOW:exon3/8:c.474+6G>A:,AIRE:ENST00000355347:splice_region&intron:LOW:exon3/7:c.474+6G>A:		rs1800525	0.1496	0.1321	166,43,15	0.1459,0.1450,0.4255,0.1302,0.1077	0.1146							607358 [AIRE (confirmed) Autoimmune polyendocrinopathy syndrome,type I,with or without reversible metaphyseal dysplasia,240300];	RCV000116292.4 [other]; 	CS1412655 [CLASS=DM? MUT=ALT PHEN="Autoimmune polyglandular syndrome type 2" GENE=AIRE]; 		34	438					AIRE (inh=AR+AD pLI=0.00)
chr21	45712977	45712977	T	C	het	anno_omim	QUAL=1990;DP=32;AF=0.38;MQM=60;TRIO=HET,32,0.38,HOM,36,0.97,HET,84,0.44	AIRE	splice_region&intron,synonymous	AIRE:ENST00000329347:splice_region&intron:LOW:exon4/8:c.508-14T>C:,AIRE:ENST00000291582:synonymous:LOW:exon10/14:c.1197T>C:p.Ala399Ala,AIRE:ENST00000355347:synonymous:LOW:exon4/8:c.576T>C:p.Ala192Ala		rs1800521	0.3562	0.3780	6924,3950,1081	0.5063,0.3218,0.2691,0.3899,0.3215	0.3846							607358 [AIRE (confirmed) Autoimmune polyendocrinopathy syndrome,type I,with or without reversible metaphyseal dysplasia,240300];	RCV000116299.3 [other]; 		COSM1483985, COSM444569	261	968					AIRE (inh=AR+AD pLI=0.00)
chr21	45714294	45714294	C	T	het	low_DP;pred_pathogenic;anno_omim;anno_pathogenic_hgmd	QUAL=332;DP=17;AF=0.53;MQM=60;TRIO=HET,17,0.53,HET,13,0.69,WT,12,0.00	AIRE	missense,synonymous	AIRE:ENST00000291582:missense:MODERATE:exon12/14:c.1411C>T:p.Arg471Cys,AIRE:ENST00000355347:missense:MODERATE:exon6/8:c.790C>T:p.Arg264Cys,AIRE:ENST00000329347:synonymous:LOW:exon7/9:c.708C>T:p.Cys236Cys		rs74203920	0.0044	0.0214	7,5,0	0.0044,0.0081,0.0000,0.0374,0.0010	0.0130	0.0570	D,D,D,D	D	P,P	D,D	22.70	607358 [AIRE (confirmed) Autoimmune polyendocrinopathy syndrome,type I,with or without reversible metaphyseal dysplasia,240300];	RCV000116295.3 [other]; 	CM109490 [CLASS=DM? MUT=ALT PHEN="Hypoparathyroidism without APECED" GENE=AIRE]; 		0	44					AIRE (inh=AR+AD pLI=0.00)
chr21	46311813	46311813	A	G	het	anno_omim	QUAL=10702;DP=113;AF=0.55;MQM=59;TRIO=HET,113,0.55,WT,222,0.00,HOM,298,1.00	ITGB2	synonymous	ITGB2:ENST00000302347:synonymous:LOW:exon11/16:c.1323T>C:p.Val441Val,ITGB2:ENST00000397852:synonymous:LOW:exon10/15:c.1323T>C:p.Val441Val,ITGB2:ENST00000397857:synonymous:LOW:exon11/16:c.1323T>C:p.Val441Val,ITGB2:ENST00000397854:synonymous:LOW:exon10/15:c.1152T>C:p.Val384Val,ITGB2:ENST00000355153:synonymous:LOW:exon11/16:c.1323T>C:p.Val441Val,ITGB2:ENST00000397850:synonymous:LOW:exon12/17:c.1323T>C:p.Val441Val		rs235326	0.7630	0.6888	29127,14797,4422	0.9251,0.5743,0.8034,0.6681,0.6523	0.7398							600065 [ITGB2 (confirmed) Leukocyte adhesion deficiency,116920];	RCV000279131.1 [benign]; 		COSM3766671	959	954					ITGB2 (inh=AR pLI=0.00)
chr21	46314907	46314907	T	A	hom	pred_pathogenic;anno_omim	QUAL=27322;DP=228;AF=1.00;MQM=60;TRIO=HOM,228,1.00,HOM,303,1.00,HOM,332,1.00	ITGB2	missense	ITGB2:ENST00000302347:missense:MODERATE:exon9/16:c.1062A>T:p.Gln354His,ITGB2:ENST00000397852:missense:MODERATE:exon8/15:c.1062A>T:p.Gln354His,ITGB2:ENST00000397857:missense:MODERATE:exon9/16:c.1062A>T:p.Gln354His,ITGB2:ENST00000397854:missense:MODERATE:exon8/15:c.891A>T:p.Gln297His,ITGB2:ENST00000355153:missense:MODERATE:exon9/16:c.1062A>T:p.Gln354His,ITGB2:ENST00000397850:missense:MODERATE:exon10/17:c.1062A>T:p.Gln354His		rs235330	1.0000	0.9999	60689,33355,5203	1.0000,1.0000,1.0000,0.9999,1.0000	0.9999	-0.9340	D,D,T,D,D,D,T	T	B,P	D,D,D,D,D,D	15.04	600065 [ITGB2 (confirmed) Leukocyte adhesion deficiency,116920];	RCV000087107.1 [not provided]; RCV000405921.1 [benign]; 		COSM4135040	2120	0					ITGB2 (inh=AR pLI=0.00)
chr21	46320313	46320313	C	T	het	anno_omim	QUAL=2594;DP=64;AF=0.44;MQM=59;TRIO=HET,64,0.44,HET,75,0.52,HET,90,0.52	ITGB2	synonymous	ITGB2:ENST00000302347:synonymous:LOW:exon7/16:c.819G>A:p.Gly273Gly,ITGB2:ENST00000397852:synonymous:LOW:exon6/15:c.819G>A:p.Gly273Gly,ITGB2:ENST00000397857:synonymous:LOW:exon7/16:c.819G>A:p.Gly273Gly,ITGB2:ENST00000397854:synonymous:LOW:exon6/15:c.648G>A:p.Gly216Gly,ITGB2:ENST00000355153:synonymous:LOW:exon7/16:c.819G>A:p.Gly273Gly,ITGB2:ENST00000397850:synonymous:LOW:exon8/17:c.819G>A:p.Gly273Gly		rs2230528	0.2230	0.2429	3830,1944,132	0.1686,0.3717,0.1377,0.2404,0.2932	0.2468							600065 [ITGB2 (confirmed) Leukocyte adhesion deficiency,116920];	RCV000087125.1 [not provided]; RCV000354913.1 [benign]; 			147	788					ITGB2 (inh=AR pLI=0.00)
chr21	46348700	46348700	T	G	hom	anno_omim	QUAL=12753;DP=132;AF=1.00;MQM=60;TRIO=HOM,132,1.00,HOM,135,1.00,HOM,139,1.00	ITGB2,ITGB2-AS1	5'UTR,non_coding_transcript_exon	ITGB2:ENST00000355153:5'UTR:MODIFIER:exon1/16:c.-135A>C:,ITGB2:ENST00000397850:5'UTR:MODIFIER:exon1/17:c.-365A>C:,ITGB2-AS1:ENST00000441379:non_coding_transcript_exon:MODIFIER:exon4/4:n.1389T>G:		rs9982872	0.9884	0.0000	0,0,0	0,0,0,0,0	0.9829							600065 [ITGB2 (confirmed) Leukocyte adhesion deficiency,116920];				229	3					ITGB2 (inh=AR pLI=0.00), ITGB2-AS1 (inh=n/a pLI=n/a)
chr21	46875564	46875564	T	C	het	anno_omim	QUAL=16418;DP=215;AF=0.48;MQM=59;TRIO=HET,215,0.48,HOM,287,1.00,HET,387,0.47	COL18A1	synonymous,intron	COL18A1:ENST00000359759:synonymous:LOW:exon1/41:c.120T>C:p.His40His,COL18A1:ENST00000355480:synonymous:LOW:exon1/41:c.120T>C:p.His40His,COL18A1:ENST00000400337:intron:MODIFIER:exon2/41:c.107-12592T>C:		rs914230	0.9884	0.9705	56851,30556,4837	0.9938,0.9819,0.9999,0.9575,0.9909	0.9703							120328 [COL18A1 (confirmed) Knobloch syndrome,type 1,267750];				1969	145					COL18A1 (inh=AR pLI=0.00)
chr21	46876083	46876083	A	G	het	anno_omim	QUAL=3841;DP=69;AF=0.61;MQM=59;TRIO=HET,69,0.61,HET,110,0.52,HET,135,0.44	COL18A1	synonymous,intron	COL18A1:ENST00000359759:synonymous:LOW:exon1/41:c.639A>G:p.Pro213Pro,COL18A1:ENST00000355480:synonymous:LOW:exon1/41:c.639A>G:p.Pro213Pro,COL18A1:ENST00000400337:intron:MODIFIER:exon2/41:c.107-12073A>G:		rs2236451	0.3756	0.3437	6980,3629,1394	0.5460,0.2698,0.3322,0.3359,0.3155	0.3843							120328 [COL18A1 (confirmed) Knobloch syndrome,type 1,267750];	RCV000245572.1 [benign]; 		COSM4004829, COSM4004828	274	883					COL18A1 (inh=AR pLI=0.00)
chr21	46908355	46908355	T	C	het	anno_omim	QUAL=6050;DP=233;AF=0.50;MQM=59;TRIO=HET,233,0.50,HET,241,0.51,WT,295,0.00	COL18A1	synonymous	COL18A1:ENST00000359759:synonymous:LOW:exon17/41:c.3165T>C:p.Leu1055Leu,COL18A1:ENST00000400337:synonymous:LOW:exon18/42:c.1920T>C:p.Leu640Leu,COL18A1:ENST00000355480:synonymous:LOW:exon17/41:c.2460T>C:p.Leu820Leu		rs11702425	0.3199	0.3052	5764,3096,691	0.3747,0.2528,0.2388,0.3057,0.3203	0.3220							120328 [COL18A1 (confirmed) Knobloch syndrome,type 1,267750];	RCV000249339.1 [benign]; RCV000342153.1 [benign]; 		COSM3758950, COSM3758951	218	853					COL18A1 (inh=AR pLI=0.00)
chr21	46924426	46924434	GGCCCCCCA	-	hom	low_DP;anno_omim	QUAL=782;DP=11;AF=0.91;MQM=59;TRIO=HOM,11,0.91,HOM,13,1.00,HOM,14,1.00	COL18A1,SLC19A1	disruptive_inframe_deletion,intron	COL18A1:ENST00000359759:disruptive_inframe_deletion:MODERATE:exon33/41:c.4083_4091delCCCAGGCCC:p.Pro1362_Pro1364del,COL18A1:ENST00000400337:disruptive_inframe_deletion:MODERATE:exon34/42:c.2838_2846delCCCAGGCCC:p.Pro947_Pro949del,COL18A1:ENST00000355480:disruptive_inframe_deletion:MODERATE:exon33/41:c.3378_3386delCCCAGGCCC:p.Pro1127_Pro1129del,SLC19A1:ENST00000567670:intron:MODIFIER:exon5/5:c.1294-5908_1294-5900delTGGGGGGCC:		rs149296338;rs78227997	0.0000	0.9694	29713,15968,1807	0.9532,0.9624,0.9993,0.9615,0.9916	0.9709							120328 [COL18A1 (confirmed) Knobloch syndrome,type 1,267750];			COSM1031439	1885	162	2	[2] old entry - no details available			COL18A1 (inh=AR pLI=0.00), SLC19A1 (inh=n/a pLI=0.01)
chr21	46927489	46927489	A	G	het	anno_omim	QUAL=2314;DP=124;AF=0.39;MQM=60;TRIO=HET,124,0.39,HET,150,0.39,WT,226,0.00	COL18A1,SLC19A1	synonymous,intron	COL18A1:ENST00000359759:synonymous:LOW:exon37/41:c.4476A>G:p.Thr1492Thr,COL18A1:ENST00000400337:synonymous:LOW:exon38/42:c.3231A>G:p.Thr1077Thr,COL18A1:ENST00000355480:synonymous:LOW:exon37/41:c.3771A>G:p.Thr1257Thr,SLC19A1:ENST00000567670:intron:MODIFIER:exon5/5:c.1294-8963T>C:		rs12483761	0.1184	0.1241	882,503,85	0.1497,0.1740,0.0165,0.1314,0.0872	0.1395							120328 [COL18A1 (confirmed) Knobloch syndrome,type 1,267750];	RCV000242753.1 [benign]; 			28	439					COL18A1 (inh=AR pLI=0.00), SLC19A1 (inh=n/a pLI=0.01)
chr21	46931109	46931109	G	A	het	pred_pathogenic;anno_omim;anno_pathogenic_clinvar	QUAL=2039;DP=80;AF=0.51;MQM=60;TRIO=HET,80,0.51,HET,94,0.46,WT,145,0.00	COL18A1,SLC19A1	missense,intron	COL18A1:ENST00000359759:missense:MODERATE:exon40/41:c.5023G>A:p.Asp1675Asn,COL18A1:ENST00000400337:missense:MODERATE:exon41/42:c.3778G>A:p.Asp1260Asn,COL18A1:ENST00000355480:missense:MODERATE:exon40/41:c.4318G>A:p.Asp1440Asn,SLC19A1:ENST00000567670:intron:MODIFIER:exon5/5:c.1294-12583C>T:		rs12483377	0.0443	0.1125	186,157,4	0.0624,0.0809,0.0331,0.1490,0.0599	0.0658	5.7980	T,T,T,T,D,T	T	D,D,D,D	T,T,T,T	27.70	120328 [COL18A1 (confirmed) Knobloch syndrome,type 1,267750];	RCV000018655.28 [pathogenic]; RCV000248578.1 [benign]; 		COSM1579620	12	331	2	[2] old entry - no details available			COL18A1 (inh=AR pLI=0.00), SLC19A1 (inh=n/a pLI=0.01)
chr21	46932618	46932618	G	C	het	anno_omim	QUAL=4605;DP=203;AF=0.49;MQM=59;TRIO=HET,203,0.49,HET,165,0.50,WT,177,0.00	COL18A1,SLC19A1	3'UTR,intron	COL18A1:ENST00000359759:3'UTR:MODIFIER:exon41/41:c.*306G>C:,COL18A1:ENST00000400337:3'UTR:MODIFIER:exon42/42:c.*306G>C:,COL18A1:ENST00000355480:3'UTR:MODIFIER:exon41/41:c.*306G>C:,SLC19A1:ENST00000567670:intron:MODIFIER:exon5/5:c.1293+13113C>G:		rs17004785	0.1036	0.0000	0,0,0	0,0,0,0,0	0.1129							120328 [COL18A1 (confirmed) Knobloch syndrome,type 1,267750];	RCV000340934.1 [likely benign]; 			2	48					COL18A1 (inh=AR pLI=0.00), SLC19A1 (inh=n/a pLI=0.01)
chr21	47410931	47410931	T	C	hom	anno_omim	QUAL=6012;DP=121;AF=0.99;MQM=60;TRIO=HOM,121,0.99,HET,90,0.47,HET,136,0.45	COL6A1	synonymous	COL6A1:ENST00000361866:synonymous:LOW:exon15/35:c.1095T>C:p.Gly365Gly		rs1980982	0.5449	0.5315	17619,10012,2922	0.7506,0.4120,0.3496,0.5491,0.5221	0.5908							120220 [COL6A1 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090];	RCV000079742.6 [benign]; RCV000358186.1 [benign]; 		COSM3758956	657	1017					COL6A1 (inh=AD pLI=1.00)
chr21	47423389	47423389	G	A	hom	pred_pathogenic;anno_omim	QUAL=6589;DP=89;AF=0.96;MQM=59;TRIO=HOM,89,0.96,HET,154,0.54,HET,184,0.55	COL6A1	missense	COL6A1:ENST00000361866:missense:MODERATE:exon35/35:c.2549G>A:p.Arg850His		rs1053312	0.2702	0.2888	4969,2844,771	0.4114,0.3026,0.1570,0.3034,0.2287	0.3151	-0.0010	T	T	B	D	22.30	120220 [COL6A1 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090];	RCV000079798.6 [benign]; RCV000305303.1 [benign]; 		COSM3758957	199	828					COL6A1 (inh=AD pLI=1.00)
chr21	47423507	47423507	G	A	hom	anno_omim	QUAL=3249;DP=43;AF=0.95;MQM=59;TRIO=HOM,43,0.95,HET,79,0.53,HET,93,0.55	COL6A1	synonymous	COL6A1:ENST00000361866:synonymous:LOW:exon35/35:c.2667G>A:p.Ala889Ala		rs1053315;rs71336107	0.2682	0.2859	5021,2870,764	0.3974,0.2993,0.1571,0.3000,0.2284	0.3137							120220 [COL6A1 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090];	RCV000079801.8 [other]; RCV000381032.1 [benign]; 		COSM329269	198	822					COL6A1 (inh=AD pLI=1.00)
chr21	47423636	47423636	C	T	hom	anno_omim	QUAL=2636;DP=75;AF=0.96;MQM=59;TRIO=HOM,75,0.96,HET,45,0.47,HET,27,0.37	COL6A1	synonymous	COL6A1:ENST00000361866:synonymous:LOW:exon35/35:c.2796C>T:p.Ser932Ser		rs1053320	0.2642	0.2715	4530,2543,809	0.4036,0.2857,0.1568,0.2838,0.2036	0.3092							120220 [COL6A1 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090];	RCV000079807.6 [benign]; RCV000374356.1 [benign]; 		COSM444608	167	770					COL6A1 (inh=AD pLI=1.00)
chr21	47424187	47424187	A	G	hom	anno_omim	QUAL=8431;DP=139;AF=1.00;MQM=59;TRIO=HOM,139,1.00,HOM,87,0.99,HET,127,0.44	COL6A1	3'UTR	COL6A1:ENST00000361866:3'UTR:MODIFIER:exon35/35:c.*260A>G:		rs1053331	0.8704	0.0000	0,0,0	0,0,0,0,0	0.8839							120220 [COL6A1 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090];	RCV000261714.1 [benign]; 			197	61					COL6A1 (inh=AD pLI=1.00)
chr21	47424275	47424287	CTCCTGCCCTGCC	-	het	anno_omim	QUAL=3219;DP=56;AF=0.95;MQM=59;TRIO=HET,56,0.95,HET,92,0.57,HET,140,0.46	COL6A1	3'UTR	COL6A1:ENST00000361866:3'UTR:MODIFIER:exon35/35:c.*357_*369delTGCCCTCCTGCCC:	(GCCCT)n	rs752193493	0.0469	0.0000	0,0,0	0,0,0,0,0	0.0734							120220 [COL6A1 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090];				2	45					COL6A1 (inh=AD pLI=1.00)
chr21	47424346	47424346	A	G	hom	anno_omim	QUAL=11974;DP=98;AF=0.99;MQM=59;TRIO=HOM,98,0.99,HOM,178,1.00,HET,277,0.53	COL6A1	3'UTR	COL6A1:ENST00000361866:3'UTR:MODIFIER:exon35/35:c.*419A>G:		rs9254	0.8820	0.0000	0,0,0	0,0,0,0,0	0.8903							120220 [COL6A1 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090];	RCV000284968.1 [benign]; 			204	62					COL6A1 (inh=AD pLI=1.00)
chr21	47538960	47538960	G	A	hom	pred_pathogenic;anno_omim	QUAL=24132;DP=209;AF=1.00;MQM=59;TRIO=HOM,209,1.00,HOM,243,1.00,HOM,315,1.00	COL6A2	missense	COL6A2:ENST00000300527:missense:MODERATE:exon14/28:c.1196G>A:p.Ser399Asn,COL6A2:ENST00000310645:missense:MODERATE:exon14/28:c.1196G>A:p.Ser399Asn,COL6A2:ENST00000357838:missense:MODERATE:exon14/28:c.1196G>A:p.Ser399Asn,COL6A2:ENST00000409416:missense:MODERATE:exon13/27:c.1196G>A:p.Ser399Asn,COL6A2:ENST00000397763:missense:MODERATE:exon13/27:c.1196G>A:p.Ser399Asn		rs2839110	0.7053	0.7734	36591,21934,1479	0.5376,0.9068,0.8737,0.8194,0.5777	0.7845	0.3610	T,T,T,T,T	T	B,B,B	D,D,D,D,D	8.06	120240 [COL6A2 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Myosclerosis,congenital,255600];	RCV000079842.6 [benign]; RCV000323060.1 [benign]; RCV000382221.1 [benign]; 		COSM3758958, COSM3758960, COSM3758959	1319	691					COL6A2 (inh=AR+AD pLI=0.00)
chr21	47542861	47542861	A	G	hom	anno_omim	QUAL=20931;DP=139;AF=0.99;MQM=59;TRIO=HOM,139,0.99,HOM,234,1.00,HOM,315,1.00	COL6A2	splice_region&intron	COL6A2:ENST00000300527:splice_region&intron:LOW:exon21/27:c.1671+10A>G:,COL6A2:ENST00000310645:splice_region&intron:LOW:exon21/27:c.1671+10A>G:,COL6A2:ENST00000357838:splice_region&intron:LOW:exon21/27:c.1671+10A>G:,COL6A2:ENST00000409416:splice_region&intron:LOW:exon20/26:c.1671+10A>G:,COL6A2:ENST00000397763:splice_region&intron:LOW:exon20/26:c.1671+10A>G:		rs915786	0.8474	0.8122	40202,21592,4615	0.9466,0.9186,0.8796,0.8103,0.6364	0.8551							120240 [COL6A2 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Myosclerosis,congenital,255600];	RCV000079853.8 [other]; RCV000284926.1 [benign]; RCV000339110.1 [benign]; 			1341	677					COL6A2 (inh=AR+AD pLI=0.00)
chr21	47545768	47545768	G	A	hom	pred_pathogenic;anno_omim	QUAL=24899;DP=238;AF=1.00;MQM=59;TRIO=HOM,238,1.00,HOM,243,1.00,HOM,361,1.00	COL6A2	missense	COL6A2:ENST00000300527:missense:MODERATE:exon26/28:c.2039G>A:p.Arg680His,COL6A2:ENST00000310645:missense:MODERATE:exon26/28:c.2039G>A:p.Arg680His,COL6A2:ENST00000357838:missense:MODERATE:exon26/28:c.2039G>A:p.Arg680His,COL6A2:ENST00000409416:missense:MODERATE:exon25/27:c.2039G>A:p.Arg680His,COL6A2:ENST00000397763:missense:MODERATE:exon25/27:c.2039G>A:p.Arg680His		rs1042917	0.3940	0.4784	14691,8634,318	0.2432,0.6727,0.4363,0.5100,0.3267	0.4921	4.7640	T,D,T,T,D,T	T	D,P,P	T,T,T,T,T,T	25.80	120240 [COL6A2 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Myosclerosis,congenital,255600];	RCV000079868.6 [benign]; RCV000320471.1 [benign]; RCV000380396.1 [benign]; 		COSM3758963, COSM3758961, COSM3758962	471	1045					COL6A2 (inh=AR+AD pLI=0.00)
chr21	47545823	47545823	G	A	hom	anno_omim	QUAL=28429;DP=235;AF=0.92;MQM=59;TRIO=HOM,235,0.92,HOM,311,0.98,HOM,441,0.99	COL6A2	synonymous	COL6A2:ENST00000300527:synonymous:LOW:exon26/28:c.2094G>A:p.Ala698Ala,COL6A2:ENST00000310645:synonymous:LOW:exon26/28:c.2094G>A:p.Ala698Ala,COL6A2:ENST00000357838:synonymous:LOW:exon26/28:c.2094G>A:p.Ala698Ala,COL6A2:ENST00000409416:synonymous:LOW:exon25/27:c.2094G>A:p.Ala698Ala,COL6A2:ENST00000397763:synonymous:LOW:exon25/27:c.2094G>A:p.Ala698Ala		rs13052956	0.3942	0.4755	14468,8494,320	0.2434,0.6698,0.4322,0.5064,0.3264	0.4912							120240 [COL6A2 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Myosclerosis,congenital,255600];	RCV000079869.6 [benign]; RCV000267217.1 [benign]; RCV000327020.1 [benign]; 		COSM3758965, COSM3758964, COSM3758966	469	1046					COL6A2 (inh=AR+AD pLI=0.00)
chr21	47545826	47545826	C	T	hom	anno_omim	QUAL=28429;DP=235;AF=0.92;MQM=59;TRIO=HOM,235,0.92,HOM,311,0.98,HOM,441,0.99	COL6A2	synonymous	COL6A2:ENST00000300527:synonymous:LOW:exon26/28:c.2097C>T:p.Gly699Gly,COL6A2:ENST00000310645:synonymous:LOW:exon26/28:c.2097C>T:p.Gly699Gly,COL6A2:ENST00000357838:synonymous:LOW:exon26/28:c.2097C>T:p.Gly699Gly,COL6A2:ENST00000409416:synonymous:LOW:exon25/27:c.2097C>T:p.Gly699Gly,COL6A2:ENST00000397763:synonymous:LOW:exon25/27:c.2097C>T:p.Gly699Gly		rs13046639	0.3940	0.4755	14471,8495,317	0.2430,0.6696,0.4324,0.5064,0.3264	0.4912							120240 [COL6A2 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Myosclerosis,congenital,255600];	RCV000079870.6 [benign]; RCV000291715.1 [benign]; RCV000381689.1 [benign]; 		COSM3758968, COSM3758969, COSM3758967	469	1046					COL6A2 (inh=AR+AD pLI=0.00)
chr21	47545913	47545913	G	A	het	anno_omim	QUAL=12986;DP=175;AF=0.47;MQM=59;TRIO=HET,175,0.47,HET,408,0.48,HET,546,0.50	COL6A2	synonymous	COL6A2:ENST00000300527:synonymous:LOW:exon26/28:c.2184G>A:p.Val728Val,COL6A2:ENST00000310645:synonymous:LOW:exon26/28:c.2184G>A:p.Val728Val,COL6A2:ENST00000357838:synonymous:LOW:exon26/28:c.2184G>A:p.Val728Val,COL6A2:ENST00000409416:synonymous:LOW:exon25/27:c.2184G>A:p.Val728Val,COL6A2:ENST00000397763:synonymous:LOW:exon25/27:c.2184G>A:p.Val728Val		rs2839114	0.3221	0.3748	9378,4800,96	0.1306,0.6145,0.4323,0.3786,0.2797	0.3892							120240 [COL6A2 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Myosclerosis,congenital,255600];	RCV000079875.6 [benign]; RCV000264972.1 [benign]; RCV000304018.1 [benign]; 		COSM3758972, COSM3758971, COSM3758970	273	927					COL6A2 (inh=AR+AD pLI=0.00)
chr21	47549629	47549629	T	A	hom	anno_omim	QUAL=19716;DP=217;AF=0.99;MQM=59;TRIO=HOM,217,0.99,HOM,193,0.99,HOM,254,1.00	COL6A2	3'UTR,intron	COL6A2:ENST00000310645:3'UTR:MODIFIER:exon28/28:c.*787T>A:,COL6A2:ENST00000357838:3'UTR:MODIFIER:exon28/28:c.*224T>A:,COL6A2:ENST00000409416:3'UTR:MODIFIER:exon27/27:c.*787T>A:,COL6A2:ENST00000397763:3'UTR:MODIFIER:exon27/27:c.*224T>A:,COL6A2:ENST00000300527:intron:MODIFIER:exon27/27:c.2462-2239T>A:	MLT1C2	rs1044598	0.3868	0.0000	0,0,0	0,0,0,0,0	0.4423							120240 [COL6A2 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Myosclerosis,congenital,255600];				39	122					COL6A2 (inh=AR+AD pLI=0.00)
chr21	47744038	47744038	G	-	hom	anno_omim	QUAL=6744;DP=33;AF=1.00;MQM=59;TRIO=HOM,33,1.00,HOM,102,1.00,HOM,108,1.00	PCNT	5'UTR	PCNT:ENST00000359568:5'UTR:MODIFIER:exon1/47:c.-100delG:		rs397802954	0.7672	0.0000	0,0,0	0,0,0,0,0	0.8363							605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II,210720];	RCV000336290.1 [benign]; 			1083	423					PCNT (inh=AR pLI=0.00)
chr21	47766650	47766650	G	A	hom	anno_omim	QUAL=8877;DP=82;AF=0.99;MQM=59;TRIO=HOM,82,0.99,HOM,173,1.00,HET,164,0.42	PCNT	splice_region&intron	PCNT:ENST00000359568:splice_region&intron:LOW:exon4/46:c.721-7G>A:		rs2839217	0.2999	0.4134	4846,3264,144	0.2659,0.3506,0.4795,0.4538,0.3373	0.3392							605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II,210720];	RCV000147195.2 [benign]; RCV000317940.1 [benign]; 			359	956					PCNT (inh=AR pLI=0.00)
chr21	47773103	47773103	C	A	hom	anno_omim	QUAL=25357;DP=225;AF=1.00;MQM=60;TRIO=HOM,225,1.00,HOM,353,1.00,HET,478,0.54	PCNT	synonymous	PCNT:ENST00000359568:synonymous:LOW:exon10/47:c.1542C>A:p.Ser514Ser		rs2249057	0.2895	0.3201	6428,3931,272	0.2337,0.2218,0.4264,0.3430,0.3003	0.3135							605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II,210720];	RCV000147090.1 [benign]; RCV000402281.1 [benign]; 		COSM1130514	277	961					PCNT (inh=AR pLI=0.00)
chr21	47777063	47777063	G	A	hom	pred_pathogenic;anno_omim	QUAL=20878;DP=197;AF=1.00;MQM=60;TRIO=HOM,197,1.00,HOM,191,0.99,HOM,273,1.00	PCNT	missense	PCNT:ENST00000359568:missense:MODERATE:exon13/47:c.2111G>A:p.Gly704Glu		rs2839223	0.8486	0.8559	44630,25532,4423	0.9243,0.8349,0.8131,0.8741,0.7847	0.8792	3.8370	T,T	T	B,B	T	3.39	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II,210720];	RCV000147093.1 [benign]; RCV000276066.1 [benign]; 		COSM4135102	1528	544					PCNT (inh=AR pLI=0.00)
chr21	47783796	47783796	T	C	hom	anno_omim	QUAL=10135;DP=135;AF=0.99;MQM=60;TRIO=HOM,135,0.99,HOM,91,1.00,HOM,117,0.99	PCNT	synonymous	PCNT:ENST00000359568:synonymous:LOW:exon14/47:c.2556T>C:p.Ala852Ala		rs8131546	0.8470	0.8548	43091,24499,4074	0.9240,0.8349,0.8152,0.8735,0.7828	0.8788							605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II,210720];	RCV000147097.1 [benign]; RCV000327808.1 [benign]; 		COSM444637	1517	543					PCNT (inh=AR pLI=0.00)
chr21	47786494	47786494	C	T	hom	anno_omim	QUAL=2503;DP=57;AF=1.00;MQM=59;TRIO=HOM,57,1.00,HOM,10,1.00,HOM,20,1.00	PCNT	splice_region&intron	PCNT:ENST00000359568:splice_region&intron:LOW:exon14/46:c.2610-5C>T:		rs2839226	0.6577	0.7487	34455,21052,1003	0.4452,0.7845,0.8100,0.7972,0.6939	0.7559							605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II,210720];	RCV000147099.1 [benign]; RCV000345207.1 [benign]; 			1284	725					PCNT (inh=AR pLI=0.00)
chr21	47786817	47786817	C	G	hom	anno_omim	QUAL=32471;DP=158;AF=0.99;MQM=60;TRIO=HOM,158,0.99,HOM,361,1.00,HOM,507,1.00	PCNT	synonymous	PCNT:ENST00000359568:synonymous:LOW:exon15/47:c.2928C>G:p.Leu976Leu		rs2839228	0.8389	0.8528	44245,25455,4136	0.8920,0.8335,0.8139,0.8736,0.7843	0.8707							605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II,210720];	RCV000147104.2 [benign]; RCV000335049.1 [benign]; 		COSM1414625	1518	556					PCNT (inh=AR pLI=0.00)
chr21	47787002	47787002	T	C	hom	anno_omim	QUAL=22537;DP=115;AF=1.00;MQM=60;TRIO=HOM,115,1.00,HOM,251,0.99,HOM,383,0.99	PCNT	missense	PCNT:ENST00000359568:missense:MODERATE:exon15/47:c.3113T>C:p.Val1038Ala		rs6518289	0.8377	0.8530	43999,25340,4085	0.8936,0.8336,0.8144,0.8743,0.7823	0.8716	-0.9870	T	T	B,B	T	0.01	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II,210720];	RCV000147106.2 [benign]; RCV000399320.1 [benign]; 			1518	557					PCNT (inh=AR pLI=0.00)
chr21	47811272	47811272	C	T	hom	anno_omim	QUAL=5639;DP=61;AF=0.98;MQM=59;TRIO=HOM,61,0.98,HOM,98,1.00,HET,114,0.49	PCNT	synonymous	PCNT:ENST00000359568:synonymous:LOW:exon21/47:c.4197C>T:p.Asp1399Asp		rs3737438	0.3015	0.3658	1224,677,52	0.2656,0.3276,0.4716,0.4359,0.3076	0.3372							605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II,210720];	RCV000147122.2 [benign]; RCV000279190.1 [benign]; 		COSM444639	351	955					PCNT (inh=AR pLI=0.00)
chr21	47832836	47832836	A	G	het	pred_pathogenic;anno_omim	QUAL=5968;DP=158;AF=0.47;MQM=59;TRIO=HET,158,0.47,WT,286,0.00,HET,361,0.45	PCNT	missense	PCNT:ENST00000359568:missense:MODERATE:exon29/47:c.6080A>G:p.Gln2027Arg		rs147189224	0.0008	0.0019	0,0,0	0.0004,0.0000,0.0000,0.0030,0.0015	0.0018	4.5150	T	T	D,D	T	21.70	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II,210720];	RCV000192953.1 [uncertain significance]; 			0	8	3	[3] Stephan Waldm?ller 13.08.2014			PCNT (inh=AR pLI=0.00)
chr21	47836653	47836653	C	T	het	anno_omim	QUAL=2792;DP=100;AF=0.46;MQM=59;TRIO=HET,100,0.46,HET,61,0.62,HET,74,0.47	PCNT	missense	PCNT:ENST00000359568:missense:MODERATE:exon30/47:c.6821C>T:p.Pro2274Leu		rs2070425	0.2496	0.2811	4341,2592,126	0.1825,0.2074,0.4011,0.2965,0.2824	0.2687	0.0390	T	T	B,B	T	0.10	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II,210720];	RCV000147179.1 [benign]; RCV000350993.1 [benign]; 		COSM3759001	201	851					PCNT (inh=AR pLI=0.00)
chr21	47850484	47850484	G	C	hom	anno_omim	QUAL=21158;DP=159;AF=0.99;MQM=59;TRIO=HOM,159,0.99,HOM,225,1.00,HOM,311,1.00	PCNT	missense	PCNT:ENST00000359568:missense:MODERATE:exon37/47:c.7977G>C:p.Gln2659His		rs2070426	0.4882	0.5774	5215,3037,211	0.3809,0.5456,0.6855,0.6260,0.5400	0.5255	-3.2770	T	T	B,B	T	18.05	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II,210720];	RCV000147219.2 [benign]; RCV000367854.1 [benign]; 		COSM3759003	770	980					PCNT (inh=AR pLI=0.00)
chr21	47851753	47851753	A	G	hom	anno_omim	QUAL=19184;DP=213;AF=1.00;MQM=59;TRIO=HOM,213,1.00,HOM,174,0.98,HOM,216,1.00	PCNT	missense	PCNT:ENST00000359568:missense:MODERATE:exon38/47:c.8375A>G:p.Gln2792Arg		rs2073376	0.6699	0.6397	25038,14058,3257	0.7955,0.4753,0.6478,0.6503,0.6209	0.6725	0.2460	T	T	B,B	T	0.01	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II,210720];	RCV000147222.4 [benign]; RCV000329338.1 [benign]; 		COSM4135105	949	929					PCNT (inh=AR pLI=0.00)
chr21	47852085	47852085	G	A	het	pred_pathogenic;anno_omim	QUAL=5734;DP=281;AF=0.41;MQM=59;TRIO=HET,281,0.41,HET,264,0.50,WT,357,0.00	PCNT	missense	PCNT:ENST00000359568:missense:MODERATE:exon38/47:c.8707G>A:p.Ala2903Thr		rs35147998	0.0385	0.0635	286,228,0	0.0163,0.0296,0.0161,0.0857,0.0454	0.0612	3.8120	T	T	B	T	16.89	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II,210720];	RCV000147227.1 [likely benign]; RCV000336085.1 [likely benign]; 			15	288					PCNT (inh=AR pLI=0.00)
chr21	47860764	47860764	T	C	het	anno_omim	QUAL=2903;DP=132;AF=0.61;MQM=60;TRIO=HET,132,0.61,HET,33,0.91,WT,73,0.00	PCNT	splice_region&intron	PCNT:ENST00000359568:splice_region&intron:LOW:exon42/46:c.9394-4T>C:		rs2839260	0.1058	0.1277	1151,905,102	0.1461,0.0646,0.0163,0.1644,0.0849	0.1374							605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II,210720];	RCV000147245.1 [benign]; RCV000338053.1 [likely benign]; 			63	540					PCNT (inh=AR pLI=0.00)
chr21	47863757	47863757	A	C	het	anno_omim	QUAL=1975;DP=93;AF=0.44;MQM=59;TRIO=HET,93,0.44,WT,67,0.00,HET,98,0.46	PCNT	missense	PCNT:ENST00000359568:missense:MODERATE:exon45/47:c.9735A>C:p.Arg3245Ser		rs2073380	0.2063	0.2289	3506,1775,23	0.0767,0.1743,0.4492,0.2327,0.2272	0.2248	-0.0160	T	T	B,B	T	13.29	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II,210720];	RCV000147250.1 [benign]; RCV000348673.1 [benign]; 		COSM1751704	123	770					PCNT (inh=AR pLI=0.00)
chr22	17565888	17565888	C	A	hom	anno_omim	QUAL=5776;DP=30;AF=1.00;MQM=60;TRIO=HOM,30,1.00,HET,106,0.58,HOM,111,1.00	IL17RA	5'UTR	IL17RA:ENST00000319363:5'UTR:MODIFIER:exon1/13:c.-94C>A:		rs13053694	0.3195	0.0000	0,0,0	0,0,0,0,0	0.3925							605461 [IL17RA (provisional) Immunodeficiency 51,613953];	RCV000315798.1 [benign]; 			139	221					IL17RA (inh=AR pLI=0.12)
chr22	17565932	17565932	T	C	hom	anno_omim	QUAL=5607;DP=24;AF=1.00;MQM=60;TRIO=HOM,24,1.00,HOM,82,1.00,HOM,85,1.00	IL17RA	5'UTR	IL17RA:ENST00000319363:5'UTR:MODIFIER:exon1/13:c.-50T>C:		rs917864	0.7750	0.0000	11,8,1	0.0000,0.0000,0.0000,0.0000,0.0000	0.8452							605461 [IL17RA (provisional) Immunodeficiency 51,613953];	RCV000372717.1 [benign]; 			1334	532					IL17RA (inh=AR pLI=0.12)
chr22	17565974	17565974	G	C	hom	low_DP;anno_omim	QUAL=3124;DP=9;AF=1.00;MQM=59;TRIO=HOM,9,1.00,HOM,47,1.00,HOM,54,1.00	IL17RA	5'UTR	IL17RA:ENST00000319363:5'UTR:MODIFIER:exon1/13:c.-8G>C:		rs917865	0.7748	0.8066	85,11,4	0.0000,0.0000,0.0000,0.0000,0.8235	0.8453							605461 [IL17RA (provisional) Immunodeficiency 51,613953];	RCV000293416.1 [benign]; 			1410	570					IL17RA (inh=AR pLI=0.12)
chr22	17591089	17591089	G	A	het	anno_omim	QUAL=12189;DP=249;AF=0.44;MQM=59;TRIO=HET,249,0.44,HOM,236,1.00,HET,268,0.44	IL17RA	3'UTR	IL17RA:ENST00000319363:3'UTR:MODIFIER:exon13/13:c.*379G>A:	L2c	rs2895332	0.7310	0.0000	0,0,0	0,0,0,0,0	0.7184							605461 [IL17RA (provisional) Immunodeficiency 51,613953];	RCV000330329.1 [benign]; 			84	71					IL17RA (inh=AR pLI=0.12)
chr22	17591144	17591144	C	T	het	anno_omim	QUAL=6614;DP=187;AF=0.51;MQM=58;TRIO=HET,187,0.51,HOM,149,1.00,WT,166,0.01	IL17RA	3'UTR	IL17RA:ENST00000319363:3'UTR:MODIFIER:exon13/13:c.*434C>T:	AluSz	rs3179921	0.5397	0.0000	0,0,0	0,0,0,0,0	0.5890							605461 [IL17RA (provisional) Immunodeficiency 51,613953];	RCV000295393.1 [benign]; 			56	78					IL17RA (inh=AR pLI=0.12)
chr22	17591697	17591697	G	A	het	anno_omim	QUAL=5070;DP=146;AF=0.45;MQM=59;TRIO=HET,146,0.45,HOM,111,0.99,WT,149,0.01	IL17RA	3'UTR	IL17RA:ENST00000319363:3'UTR:MODIFIER:exon13/13:c.*987G>A:	AluJo	rs882644	0.5555	0.0000	0,0,0	0,0,0,0,0	0.6083							605461 [IL17RA (provisional) Immunodeficiency 51,613953];	RCV000296969.1 [benign]; 			47	81					IL17RA (inh=AR pLI=0.12)
chr22	17591973	17591973	G	T	het	anno_omim	QUAL=3470;DP=45;AF=0.69;MQM=59;TRIO=HET,45,0.69,HOM,66,0.95,HET,82,0.71	IL17RA	3'UTR	IL17RA:ENST00000319363:3'UTR:MODIFIER:exon13/13:c.*1263G>T:	L2c	rs887795	0.0000	0.0000	0,0,0	0,0,0,0,0	0.8523							605461 [IL17RA (provisional) Immunodeficiency 51,613953];				94	52					IL17RA (inh=AR pLI=0.12)
chr22	17593048	17593049	AT	-	het	anno_omim	QUAL=10433;DP=423;AF=0.52;MQM=59;TRIO=HET,423,0.52,HET,433,0.52,WT,582,0.00	IL17RA	3'UTR	IL17RA:ENST00000319363:3'UTR:MODIFIER:exon13/13:c.*2338_*2339delAT:		rs57380532	0.1152	0.0000	0,0,0	0,0,0,0,0	0.1290							605461 [IL17RA (provisional) Immunodeficiency 51,613953];	RCV000397733.1 [likely benign]; 			2	33					IL17RA (inh=AR pLI=0.12)
chr22	17593685	17593685	G	A	het	anno_omim	QUAL=15314;DP=338;AF=0.54;MQM=60;TRIO=HET,338,0.54,HOM,221,1.00,HET,293,0.46	IL17RA	3'UTR	IL17RA:ENST00000319363:3'UTR:MODIFIER:exon13/13:c.*2975G>A:		rs887796	0.8367	0.0000	0,0,0	0,0,0,0,0	0.8347							605461 [IL17RA (provisional) Immunodeficiency 51,613953];	RCV000344523.1 [benign]; 			102	42					IL17RA (inh=AR pLI=0.12)
chr22	17593891	17593891	T	G	het	anno_omim	QUAL=4872;DP=369;AF=0.31;MQM=59;TRIO=HET,369,0.31,HET,192,0.66,WT,172,0.01	IL17RA	3'UTR	IL17RA:ENST00000319363:3'UTR:MODIFIER:exon13/13:c.*3181T>G:	(T)n	rs73876645	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0007							605461 [IL17RA (provisional) Immunodeficiency 51,613953];	RCV000321823.1 [uncertain significance]; 			0	15					IL17RA (inh=AR pLI=0.12)
chr22	17594623	17594623	C	T	het	anno_omim	QUAL=6390;DP=233;AF=0.54;MQM=59;TRIO=HET,233,0.54,HET,232,0.54,WT,352,0.00	IL17RA	3'UTR	IL17RA:ENST00000319363:3'UTR:MODIFIER:exon13/13:c.*3913C>T:		rs11702918	0.1134	0.0000	0,0,0	0,0,0,0,0	0.1291							605461 [IL17RA (provisional) Immunodeficiency 51,613953];	RCV000359024.1 [likely benign]; 			2	33					IL17RA (inh=AR pLI=0.12)
chr22	17594755	17594755	G	A	het	anno_omim	QUAL=5496;DP=226;AF=0.45;MQM=59;TRIO=HET,226,0.45,HET,272,0.46,WT,362,0.00	IL17RA	3'UTR	IL17RA:ENST00000319363:3'UTR:MODIFIER:exon13/13:c.*4045G>A:	MIR	rs11703539	0.0984	0.0000	0,0,0	0,0,0,0,0	0.1125							605461 [IL17RA (provisional) Immunodeficiency 51,613953];	RCV000275875.1 [likely benign]; 			1	32					IL17RA (inh=AR pLI=0.12)
chr22	17594886	17594886	T	C	het	anno_omim	QUAL=16638;DP=420;AF=0.53;MQM=60;TRIO=HET,420,0.53,HOM,341,0.99,WT,454,0.00	IL17RA	3'UTR	IL17RA:ENST00000319363:3'UTR:MODIFIER:exon13/13:c.*4176T>C:		rs738035	0.4874	0.0000	0,0,0	0,0,0,0,0	0.5501							605461 [IL17RA (provisional) Immunodeficiency 51,613953];	RCV000282593.1 [benign]; 			46	83					IL17RA (inh=AR pLI=0.12)
chr22	17594915	17594915	G	A	het	anno_omim	QUAL=18854;DP=433;AF=0.56;MQM=60;TRIO=HET,433,0.56,HOM,374,1.00,WT,471,0.00	IL17RA	3'UTR	IL17RA:ENST00000319363:3'UTR:MODIFIER:exon13/13:c.*4205G>A:		rs738034	0.4864	0.0000	0,0,0	0,0,0,0,0	0.5494							605461 [IL17RA (provisional) Immunodeficiency 51,613953];	RCV000337488.1 [benign]; 			46	83					IL17RA (inh=AR pLI=0.12)
chr22	17595070	17595070	T	G	het	anno_omim	QUAL=16981;DP=472;AF=0.48;MQM=59;TRIO=HET,472,0.48,HOM,348,1.00,WT,380,0.01	IL17RA	3'UTR	IL17RA:ENST00000319363:3'UTR:MODIFIER:exon13/13:c.*4360T>G:		rs5992628	0.4860	0.0000	0,0,0	0,0,0,0,0	0.5495							605461 [IL17RA (provisional) Immunodeficiency 51,613953];	RCV000343453.1 [benign]; 			45	83					IL17RA (inh=AR pLI=0.12)
chr22	17596178	17596178	T	C	het	anno_omim	QUAL=14101;DP=425;AF=0.52;MQM=60;TRIO=HET,425,0.52,HOM,162,1.00,HET,221,0.50	IL17RA	3'UTR	IL17RA:ENST00000319363:3'UTR:MODIFIER:exon13/13:c.*5468T>C:	MIRc	rs4819962	0.6186	0.0000	0,0,0	0,0,0,0,0	0.7166							605461 [IL17RA (provisional) Immunodeficiency 51,613953];	RCV000346293.1 [benign]; 			76	63					IL17RA (inh=AR pLI=0.12)
chr22	17596388	17596388	G	C	het	anno_omim	QUAL=11335;DP=320;AF=0.55;MQM=60;TRIO=HET,320,0.55,HOM,132,1.00,HET,153,0.58	IL17RA	3'UTR	IL17RA:ENST00000319363:3'UTR:MODIFIER:exon13/13:c.*5678G>C:		rs1654	0.8369	0.0000	0,0,0	0,0,0,0,0	0.8383							605461 [IL17RA (provisional) Immunodeficiency 51,613953];	RCV000367325.1 [benign]; 			102	43					IL17RA (inh=AR pLI=0.12)
chr22	18570974	18570974	C	T	het	anno_omim	QUAL=6537;DP=255;AF=0.48;MQM=59;TRIO=HET,255,0.48,WT,212,0.00,HET,286,0.50	PEX26	3'UTR	PEX26:ENST00000329627:3'UTR:MODIFIER:exon6/6:c.*133C>T:,PEX26:ENST00000399744:3'UTR:MODIFIER:exon5/5:c.*133C>T:		rs200243782	0.0010	0.0021	0,0,0	0.0005,0.0000,0.0000,0.0026,0.0025	0.0014							608666 [PEX26 (confirmed) Peroxisome biogenesis disorder 7A (Zellweger),614872|Peroxisome biogenesis disorder 7B,614873];	RCV000274220.1 [uncertain significance]; 			0	9					PEX26 (inh=AR pLI=0.44)
chr22	18571008	18571008	G	A	hom	pred_pathogenic;anno_omim	QUAL=22698;DP=292;AF=0.99;MQM=59;TRIO=HOM,292,0.99,HET,248,0.47,HOM,343,1.00	PEX26	3'UTR	PEX26:ENST00000329627:3'UTR:MODIFIER:exon6/6:c.*167G>A:,PEX26:ENST00000399744:3'UTR:MODIFIER:exon5/5:c.*167G>A:		rs464385	0.4227	0.6133	5812,3358,143	0.4248,0.4936,0.4412,0.6784,0.5486	0.5453	-0.0230	D	T			6.64	608666 [PEX26 (confirmed) Peroxisome biogenesis disorder 7A (Zellweger),614872|Peroxisome biogenesis disorder 7B,614873];	RCV000331781.1 [benign]; 			603	750					PEX26 (inh=AR pLI=0.44)
chr22	18571670	18571670	A	G	hom	anno_omim	QUAL=33052;DP=302;AF=1.00;MQM=59;TRIO=HOM,302,1.00,HOM,321,1.00,HOM,397,1.00	PEX26	3'UTR	PEX26:ENST00000329627:3'UTR:MODIFIER:exon6/6:c.*829A>G:		rs362057	0.9958	0.0000	0,0,0	0,0,0,0,0	0.9912							608666 [PEX26 (confirmed) Peroxisome biogenesis disorder 7A (Zellweger),614872|Peroxisome biogenesis disorder 7B,614873];	RCV000306534.1 [benign]; 			228	4					PEX26 (inh=AR pLI=0.44)
chr22	18571828	18571828	T	C	hom	anno_omim	QUAL=33097;DP=395;AF=0.99;MQM=59;TRIO=HOM,395,0.99,HOM,287,1.00,HOM,379,1.00	PEX26	3'UTR	PEX26:ENST00000329627:3'UTR:MODIFIER:exon6/6:c.*987T>C:		rs361807	0.8734	0.0000	0,0,0	0,0,0,0,0	0.9009							608666 [PEX26 (confirmed) Peroxisome biogenesis disorder 7A (Zellweger),614872|Peroxisome biogenesis disorder 7B,614873];	RCV000260942.1 [benign]; 			184	43					PEX26 (inh=AR pLI=0.44)
chr22	18572106	18572106	T	A	hom	anno_omim	QUAL=13214;DP=204;AF=0.98;MQM=59;TRIO=HOM,204,0.98,HET,171,0.50,HOM,166,0.99	PEX26	3'UTR	PEX26:ENST00000329627:3'UTR:MODIFIER:exon6/6:c.*1265T>A:		rs456551	0.4231	0.0000	0,0,0	0,0,0,0,0	0.5349							608666 [PEX26 (confirmed) Peroxisome biogenesis disorder 7A (Zellweger),614872|Peroxisome biogenesis disorder 7B,614873];	RCV000291367.1 [benign]; 			93	103					PEX26 (inh=AR pLI=0.44)
chr22	18572371	18572371	-	TTGG	hom	anno_omim	QUAL=29834;DP=264;AF=0.93;MQM=59;TRIO=HOM,264,0.93,HOM,333,0.99,HOM,419,1.00	PEX26	3'UTR	PEX26:ENST00000329627:3'UTR:MODIFIER:exon6/6:c.*1532_*1535dupTGGT:		rs361782;rs397708785;rs5844350	0.8680	0.0000	0,0,0	0,0,0,0,0	0.9001							608666 [PEX26 (confirmed) Peroxisome biogenesis disorder 7A (Zellweger),614872|Peroxisome biogenesis disorder 7B,614873];				121	28					PEX26 (inh=AR pLI=0.44)
chr22	18572499	18572499	-	CTCA	hom	anno_omim	QUAL=14678;DP=169;AF=0.97;MQM=54;TRIO=HOM,169,0.97,HOM,181,0.98,HOM,216,1.00	PEX26	3'UTR	PEX26:ENST00000329627:3'UTR:MODIFIER:exon6/6:c.*1661_*1662insACTC:	AluYf1	rs10629935;rs772261665	0.9952	0.0000	0,0,0	0,0,0,0,0	0.9928							608666 [PEX26 (confirmed) Peroxisome biogenesis disorder 7A (Zellweger),614872|Peroxisome biogenesis disorder 7B,614873];				150	2					PEX26 (inh=AR pLI=0.44)
chr22	18572892	18572892	A	G	hom	anno_omim	QUAL=10531;DP=168;AF=1.00;MQM=60;TRIO=HOM,168,1.00,HOM,71,1.00,HOM,83,1.00	PEX26	3'UTR	PEX26:ENST00000329627:3'UTR:MODIFIER:exon6/6:c.*2051A>G:		rs361946	0.8734	0.0000	0,0,0	0,0,0,0,0	0.9010							608666 [PEX26 (confirmed) Peroxisome biogenesis disorder 7A (Zellweger),614872|Peroxisome biogenesis disorder 7B,614873];	RCV000288555.1 [benign]; 			121	28					PEX26 (inh=AR pLI=0.44)
chr22	18573122	18573122	T	C	hom	anno_omim	QUAL=23816;DP=264;AF=1.00;MQM=59;TRIO=HOM,264,1.00,HOM,193,1.00,HOM,284,1.00	PEX26	3'UTR	PEX26:ENST00000329627:3'UTR:MODIFIER:exon6/6:c.*2281T>C:	L2b	rs362209	0.9960	0.0000	0,0,0	0,0,0,0,0	0.9931							608666 [PEX26 (confirmed) Peroxisome biogenesis disorder 7A (Zellweger),614872|Peroxisome biogenesis disorder 7B,614873];	RCV000349159.1 [benign]; 			150	2					PEX26 (inh=AR pLI=0.44)
chr22	21213380	21213380	C	T	hom	anno_omim	QUAL=14514;DP=166;AF=0.99;MQM=59;TRIO=HOM,166,0.99,HOM,130,1.00,HOM,217,0.99	SNAP29,PI4KA	5'UTR_premature_start_codon_gain,5'UTR	SNAP29:ENST00000215730:5'UTR_premature_start_codon_gain:LOW:exon1/5:c.-19C>T:,SNAP29:ENST00000215730:5'UTR:MODIFIER:exon1/5:c.-19C>T:		rs1061063	0.4639	0.5473	12802,7587,536	0.4282,0.4380,0.4213,0.5638,0.6134	0.5270							604202 [SNAP29 (provisional) Cerebral dysgenesis,neuropathy,ichthyosis,and palmoplantar keratoderma syndrome,609528];	RCV000282177.1 [benign]; 			595	992					SNAP29 (inh=AR pLI=0.15), PI4KA (inh=n/a pLI=0.00)
chr22	21213416	21213416	A	G	hom	anno_omim	QUAL=21139;DP=199;AF=1.00;MQM=59;TRIO=HOM,199,1.00,HOM,206,0.99,HOM,303,0.99	SNAP29,PI4KA	synonymous	SNAP29:ENST00000215730:synonymous:LOW:exon1/5:c.18A>G:p.Lys6Lys		rs1061064	0.4036	0.5358	14180,8596,164	0.2269,0.4312,0.4233,0.5685,0.6128	0.5163							604202 [SNAP29 (provisional) Cerebral dysgenesis,neuropathy,ichthyosis,and palmoplantar keratoderma syndrome,609528];	RCV000342922.1 [benign]; 		COSM444738	604	1006					SNAP29 (inh=AR pLI=0.15), PI4KA (inh=n/a pLI=0.00)
chr22	21242600	21242603	CACA	-	hom	anno_omim	QUAL=2069;DP=94;AF=0.55;MQM=59;TRIO=HOM,94,0.55,HOM,89,0.44,WT,118,0.36	SNAP29	3'UTR	SNAP29:ENST00000215730:3'UTR:MODIFIER:exon5/5:c.*517_*520delACAC:	(CA)n	rs575240461;rs760058624	0.0000	0.0000	0,0,0	0,0,0,0,0	0.2583							604202 [SNAP29 (provisional) Cerebral dysgenesis,neuropathy,ichthyosis,and palmoplantar keratoderma syndrome,609528];	RCV000381344.1 [uncertain significance]; 			26	1					SNAP29 (inh=AR pLI=0.15)
chr22	21244940	21244940	A	G	hom	low_DP;low_MQM;anno_omim	QUAL=330;DP=10;AF=1.00;MQM=47;TRIO=HOM,10,1.00,HOM,1,1.00,HET,4,0.75	SNAP29,AC007308.7	3'UTR	SNAP29:ENST00000215730:3'UTR:MODIFIER:exon5/5:c.*2816A>G:	AluYk3	rs165739	0.8321	0.0000	0,0,0	0,0,0,0,0	0.8412							604202 [SNAP29 (provisional) Cerebral dysgenesis,neuropathy,ichthyosis,and palmoplantar keratoderma syndrome,609528];	RCV000306894.1 [benign]; 			103	24					SNAP29 (inh=AR pLI=0.15), AC007308.7 (inh=n/a pLI=n/a)
chr22	23915370	23915370	G	A	het	anno_omim	QUAL=2069;DP=101;AF=0.48;MQM=59;TRIO=HET,101,0.48,HET,73,0.56,WT,83,0.01	IGLL1,AP000345.2	3'UTR	IGLL1:ENST00000330377:3'UTR:MODIFIER:exon3/3:c.*83C>T:,IGLL1:ENST00000249053:3'UTR:MODIFIER:exon2/2:c.*354C>T:		rs8141940	0.1204	0.0000	0,0,0	0,0,0,0,0	0.1095							146770 [IGLL1 (confirmed) Agammaglobulinemia 2,613500];				6	44					IGLL1 (inh=AR pLI=0.02), AP000345.2 (inh=n/a pLI=n/a)
chr22	23915610	23915610	A	T	het	pred_pathogenic;anno_omim	QUAL=4835;DP=193;AF=0.42;MQM=55;TRIO=HET,193,0.42,HET,245,0.53,WT,300,0.00	IGLL1,AP000345.2	missense,3'UTR	IGLL1:ENST00000330377:missense:MODERATE:exon3/3:c.485T>A:p.Met162Lys,IGLL1:ENST00000249053:3'UTR:MODIFIER:exon2/2:c.*114T>A:		rs111903752	0.0383	0.0312	65,41,11	0.0643,0.0148,0.0132,0.0330,0.0182	0.0386	2.2680	D,D	T	B	T,T	0.35	146770 [IGLL1 (confirmed) Agammaglobulinemia 2,613500];			COSM228749	5	128					IGLL1 (inh=AR pLI=0.02), AP000345.2 (inh=n/a pLI=n/a)
chr22	23915652	23915652	G	A	het	anno_omim	QUAL=5837;DP=238;AF=0.45;MQM=56;TRIO=HET,238,0.45,WT,223,0.00,HET,256,0.52	IGLL1,AP000345.2	missense,3'UTR	IGLL1:ENST00000330377:missense:MODERATE:exon3/3:c.443C>T:p.Thr148Ile,IGLL1:ENST00000249053:3'UTR:MODIFIER:exon2/2:c.*72C>T:		rs73157031	0.1388	0.1501	1679,537,8	0.0288,0.2864,0.2029,0.1266,0.1877	0.1585	0.2820	T,T	T	B	T,T	1.71	146770 [IGLL1 (confirmed) Agammaglobulinemia 2,613500];			COSM149263	37	436					IGLL1 (inh=AR pLI=0.02), AP000345.2 (inh=n/a pLI=n/a)
chr22	24891292	24891292	C	G	hom	anno_omim	QUAL=11035;DP=96;AF=1.00;MQM=59;TRIO=HOM,96,1.00,HOM,180,1.00,HET,217,0.56	UPB1	5'UTR	UPB1:ENST00000326010:5'UTR:MODIFIER:exon1/10:c.-80C>G:,UPB1:ENST00000413389:5'UTR:MODIFIER:exon2/10:c.-112C>G:,UPB1:ENST00000382760:5'UTR:MODIFIER:exon1/4:c.-80C>G:		rs2070474	0.5327	0.0000	0,0,0	0,0,0,0,0	0.6031							606673 [UPB1 (provisional) Beta-ureidopropionase deficiency,613161];	RCV000086537.1 [not provided]; RCV000323244.1 [benign]; 			80	123					UPB1 (inh=AR pLI=0.00)
chr22	31003138	31003138	A	G	hom	anno_omim	QUAL=6543;DP=76;AF=1.00;MQM=59;TRIO=HOM,76,1.00,HOM,61,1.00,HOM,92,0.99	TCN2	5'UTR	TCN2:ENST00000215838:5'UTR:MODIFIER:exon1/9:c.-181A>G:		rs2240433	0.5545	0.0000	0,0,0	0,0,0,0,0	0.6337							613441 [TCN2 (confirmed) Transcobalamin II deficiency,275350];	RCV000285374.1 [benign]; 			75	112					TCN2 (inh=AR pLI=0.02)
chr22	31011610	31011610	G	C	hom	anno_omim	QUAL=15750;DP=220;AF=1.00;MQM=59;TRIO=HOM,220,1.00,HET,310,0.50,HET,359,0.51	TCN2	missense	TCN2:ENST00000215838:missense:MODERATE:exon6/9:c.776G>C:p.Arg259Pro,TCN2:ENST00000405742:missense:MODERATE:exon6/9:c.764G>C:p.Arg255Pro,TCN2:ENST00000407817:missense:MODERATE:exon6/9:c.695G>C:p.Arg232Pro		rs1801198	0.5797	0.5673	20120,10854,3008	0.7598,0.6671,0.4310,0.5703,0.4114	0.6174	0.1460	T,T,T	T	B,B,B	T,T,T	4.51	613441 [TCN2 (confirmed) Transcobalamin II deficiency,275350];	RCV000000117.2 [benign]; RCV000374451.1 [benign]; 		COSM4002151	652	1024					TCN2 (inh=AR pLI=0.02)
chr22	31022635	31022635	C	T	hom	anno_omim	QUAL=15920;DP=256;AF=0.99;MQM=59;TRIO=HOM,256,0.99,HET,225,0.59,HET,337,0.53	TCN2	3'UTR	TCN2:ENST00000215838:3'UTR:MODIFIER:exon9/9:c.*127C>T:,TCN2:ENST00000405742:3'UTR:MODIFIER:exon9/9:c.*127C>T:,TCN2:ENST00000407817:3'UTR:MODIFIER:exon9/9:c.*127C>T:		rs12160073	0.0675	0.0000	0,0,0	0,0,0,0,0	0.1339							613441 [TCN2 (confirmed) Transcobalamin II deficiency,275350];	RCV000273895.1 [likely benign]; 			6	60					TCN2 (inh=AR pLI=0.02)
chr22	33669492	33669492	G	C	het	anno_omim	QUAL=8345;DP=398;AF=0.50;MQM=59;TRIO=HET,398,0.50,HET,235,0.50,WT,322,0.00	LARGE	3'UTR	LARGE:ENST00000354992:3'UTR:MODIFIER:exon16/16:c.*921C>G:,LARGE:ENST00000337431:3'UTR:MODIFIER:exon15/15:c.*921C>G:,LARGE:ENST00000397394:3'UTR:MODIFIER:exon15/15:c.*921C>G:,LARGE:ENST00000402320:3'UTR:MODIFIER:exon14/14:c.*921C>G:		rs16992034	0.0543	0.0000	0,0,0	0,0,0,0,0	0.0732							603590 [LARGE (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,6,613154|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,6,608840];	RCV000268769.1 [likely benign]; RCV000365682.1 [likely benign]; 			1	23					LARGE1 (inh=AR pLI=0.96)
chr22	33670584	33670584	G	A	het	anno_omim	QUAL=4251;DP=172;AF=0.49;MQM=60;TRIO=HET,172,0.49,HET,160,0.51,WT,176,0.00	LARGE	synonymous	LARGE:ENST00000354992:synonymous:LOW:exon16/16:c.2100C>T:p.Asn700Asn,LARGE:ENST00000337431:synonymous:LOW:exon15/15:c.1944C>T:p.Asn648Asn,LARGE:ENST00000397394:synonymous:LOW:exon15/15:c.2100C>T:p.Asn700Asn,LARGE:ENST00000402320:synonymous:LOW:exon14/14:c.1944C>T:p.Asn648Asn,LARGE:ENST00000452586:synonymous:LOW:exon11/11:c.1497C>T:p.Asn499Asn,LARGE:ENST00000437602:synonymous:LOW:exon14/14:c.1953C>T:p.Asn651Asn		rs17722172	0.0210	0.0472	178,163,0	0.0124,0.0285,0.0001,0.0697,0.0197	0.0473							603590 [LARGE (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,6,613154|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,6,608840];	RCV000081178.8 [other]; RCV000296322.1 [likely benign]; RCV000351281.1 [likely benign]; 			13	212					LARGE1 (inh=AR pLI=0.96)
chr22	34022284	34022284	G	A	het	anno_omim	QUAL=15377;DP=340;AF=0.49;MQM=60;TRIO=HET,340,0.49,HET,366,0.53,HET,489,0.49	LARGE	synonymous	LARGE:ENST00000354992:synonymous:LOW:exon5/16:c.435C>T:p.Ala145Ala,LARGE:ENST00000337431:synonymous:LOW:exon5/15:c.435C>T:p.Ala145Ala,LARGE:ENST00000397394:synonymous:LOW:exon4/15:c.435C>T:p.Ala145Ala,LARGE:ENST00000402320:synonymous:LOW:exon4/14:c.435C>T:p.Ala145Ala,LARGE:ENST00000437602:synonymous:LOW:exon4/14:c.435C>T:p.Ala145Ala		rs86487	0.4129	0.4771	14434,7968,126	0.1570,0.5497,0.5833,0.4895,0.5013	0.4885							603590 [LARGE (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,6,613154|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,6,608840];	RCV000081181.7 [other]; RCV000333062.1 [benign]; RCV000373679.1 [benign]; 		COSM4156187	575	1017					LARGE1 (inh=AR pLI=0.96)
chr22	37271882	37271882	T	C	hom	pred_pathogenic;anno_omim	QUAL=15839;DP=114;AF=1.00;MQM=59;TRIO=HOM,114,1.00,HOM,184,0.99,HOM,229,1.00	NCF4	missense,intron	NCF4:ENST00000397147:missense:MODERATE:exon8/9:c.815T>C:p.Leu272Pro,NCF4:ENST00000248899:intron:MODIFIER:exon8/9:c.758+57T>C:		rs2075939	0.8281	0.8337	42411,23351,4665	0.9469,0.8606,0.6688,0.8362,0.8185	0.8614	0.2940	D	T	B	T	13.63	601488 [NCF4 (provisional) Granulomatous disease,chronic,autosomal recessive,cytochrome b-positive,type III,613960];	RCV000253146.1 [benign]; RCV000375140.1 [benign]; 		COSM4156206	1490	551					NCF4 (inh=AR pLI=0.00)
chr22	38369027	38369027	C	T	het	anno_omim	QUAL=8649;DP=173;AF=0.48;MQM=60;TRIO=HET,173,0.48,HOM,149,0.99,HET,192,0.44	SOX10,POLR2F	3'UTR,intron	SOX10:ENST00000360880:3'UTR:MODIFIER:exon5/5:c.*475G>A:,SOX10:ENST00000396884:3'UTR:MODIFIER:exon4/4:c.*475G>A:,POLR2F:ENST00000407936:intron:MODIFIER:exon4/5:c.293+5850C>T:,POLR2F:ENST00000405557:intron:MODIFIER:exon4/4:c.293+5850C>T:		rs139883	0.6084	0.0000	0,0,0	0,0,0,0,0	0.5974							602229 [SOX10 (confirmed) Waardenburg syndrome,type 4C,613266|Waardenburg syndrome,type 2E,with or without neurologic involvement,611584|PCWH syndrome,609136];	RCV000296837.1 [benign]; RCV000354094.1 [benign]; 			97	123					SOX10 (inh=AD pLI=0.91), POLR2F (inh=n/a pLI=0.65)
chr22	38369976	38369976	A	G	het	anno_omim	QUAL=3406;DP=95;AF=0.55;MQM=60;TRIO=HET,95,0.55,HOM,46,1.00,HET,72,0.44	SOX10,POLR2F	synonymous,intron	SOX10:ENST00000360880:synonymous:LOW:exon5/5:c.927T>C:p.His309His,SOX10:ENST00000396884:synonymous:LOW:exon4/4:c.927T>C:p.His309His,POLR2F:ENST00000407936:intron:MODIFIER:exon4/5:c.293+6799A>G:,POLR2F:ENST00000405557:intron:MODIFIER:exon4/4:c.293+6799A>G:		rs139884	0.7133	0.6537	26127,13186,3510	0.8221,0.6093,0.7598,0.6289,0.6348	0.6920							602229 [SOX10 (confirmed) Waardenburg syndrome,type 4C,613266|Waardenburg syndrome,type 2E,with or without neurologic involvement,611584|PCWH syndrome,609136];	RCV000218215.2 [benign]; RCV000276693.1 [benign]; RCV000368913.1 [benign]; 		COSM4156245	1091	1280					SOX10 (inh=AD pLI=0.91), POLR2F (inh=n/a pLI=0.65)
chr22	41323897	41323897	G	A	het	low_MQM;anno_omim	QUAL=524;DP=84;AF=0.14;MQM=37;TRIO=HET,84,0.54,WT,19,0.47,WT,19,0.68	XPNPEP3	3'UTR,intron	XPNPEP3:ENST00000357137:3'UTR:MODIFIER:exon10/10:c.*1458G>A:,XPNPEP3:ENST00000544094:intron:MODIFIER:exon10/13:c.*28+1430G>A:	AluYm1		0.0000	0.0000	0,0,0	0,0,0,0,0	0.0056							613553 [XPNPEP3 (confirmed) Nephronophthisis-like nephropathy 1,613159];	RCV000297081.1 [uncertain significance]; 			10	57					XPNPEP3 (inh=AR pLI=0.00)
chr22	41324205	41324205	C	T	hom	anno_omim	QUAL=1473;DP=34;AF=0.41;MQM=56;TRIO=HOM,34,0.41,HOM,21,0.14,HOM,28,0.11	XPNPEP3	3'UTR,intron	XPNPEP3:ENST00000357137:3'UTR:MODIFIER:exon10/10:c.*1766C>T:,XPNPEP3:ENST00000544094:intron:MODIFIER:exon10/13:c.*28+1738C>T:	AluSx3	rs371229000	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							613553 [XPNPEP3 (confirmed) Nephronophthisis-like nephropathy 1,613159];				1	7					XPNPEP3 (inh=AR pLI=0.00)
chr22	41325068	41325068	G	A	hom	anno_omim	QUAL=16964;DP=239;AF=1.00;MQM=60;TRIO=HOM,239,1.00,HOM,227,1.00,HET,268,0.46	XPNPEP3	3'UTR,intron	XPNPEP3:ENST00000357137:3'UTR:MODIFIER:exon10/10:c.*2629G>A:,XPNPEP3:ENST00000544094:intron:MODIFIER:exon10/13:c.*28+2601G>A:		rs2899341	0.5946	0.0000	0,0,0	0,0,0,0,0	0.5744							613553 [XPNPEP3 (confirmed) Nephronophthisis-like nephropathy 1,613159];	RCV000374085.1 [benign]; 			42	69					XPNPEP3 (inh=AR pLI=0.00)
chr22	41325196	41325196	C	T	hom	anno_omim	QUAL=2365;DP=93;AF=0.20;MQM=54;TRIO=HOM,93,0.20,HOM,37,0.22,HOM,58,0.31	XPNPEP3	3'UTR,intron	XPNPEP3:ENST00000357137:3'UTR:MODIFIER:exon10/10:c.*2757C>T:,XPNPEP3:ENST00000544094:intron:MODIFIER:exon10/13:c.*28+2729C>T:	AluSx3	rs201927557	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							613553 [XPNPEP3 (confirmed) Nephronophthisis-like nephropathy 1,613159];				0	9					XPNPEP3 (inh=AR pLI=0.00)
chr22	42454354	42454354	G	A	hom	anno_omim	QUAL=19175;DP=317;AF=1.00;MQM=59;TRIO=HOM,317,1.00,HET,291,0.49,HET,346,0.53	WBP2NL			L1MC5a	rs5758566	0.6476	0.0000	0,0,0	0,0,0,0,0	0.6252							104170 [NAGA (confirmed) Schindler disease,type I,609241|Kanzaki disease,609242|Schindler disease,type III,609241];	RCV000288226.1 [benign]; RCV000382486.1 [benign]; 			106	100					WBP2NL (inh=n/a pLI=0.00)
chr22	42454494	42454494	A	-	hom	anno_omim	QUAL=21013;DP=308;AF=0.92;MQM=59;TRIO=HOM,308,0.92,HOM,205,0.96,HOM,215,0.95	NAGA	3'UTR	NAGA:ENST00000396398:3'UTR:MODIFIER:exon9/9:c.*1789delT:		rs796216027	0.8966	0.0000	0,0,0	0,0,0,0,0	0.8763							104170 [NAGA (confirmed) Schindler disease,type I,609241|Kanzaki disease,609242|Schindler disease,type III,609241];	RCV000313100.1 [uncertain significance]; RCV000349138.1 [uncertain significance]; 			200	29					NAGA (inh=AR pLI=0.00)
chr22	42454950	42454950	A	G	het	anno_omim	QUAL=11053;DP=450;AF=0.47;MQM=60;TRIO=HET,450,0.47,HET,381,0.52,WT,449,0.00	NAGA	3'UTR	NAGA:ENST00000396398:3'UTR:MODIFIER:exon9/9:c.*1333T>C:		rs1063392	0.4595	0.0000	0,0,0	0,0,0,0,0	0.4034							104170 [NAGA (confirmed) Schindler disease,type I,609241|Kanzaki disease,609242|Schindler disease,type III,609241];	RCV000266251.1 [benign]; RCV000323621.1 [benign]; 			55	115					NAGA (inh=AR pLI=0.00)
chr22	42455248	42455248	C	T	het	anno_omim	QUAL=10862;DP=368;AF=0.45;MQM=60;TRIO=HET,368,0.45,WT,344,0.00,HET,470,0.53	NAGA	3'UTR	NAGA:ENST00000396398:3'UTR:MODIFIER:exon9/9:c.*1035G>A:		rs62238588	0.0306	0.0000	0,0,0	0,0,0,0,0	0.0532							104170 [NAGA (confirmed) Schindler disease,type I,609241|Kanzaki disease,609242|Schindler disease,type III,609241];	RCV000295309.1 [likely benign]; RCV000387189.1 [likely benign]; 			0	28					NAGA (inh=AR pLI=0.00)
chr22	42458827	42458827	G	C	het	low_DP;anno_omim	QUAL=53;DP=9;AF=0.44;MQM=60;TRIO=HET,9,0.44,WT,7,0.00,HET,4,0.25	NAGA	splice_region&intron	NAGA:ENST00000396398:splice_region&intron:LOW:exon7/8:c.957+4C>G:,NAGA:ENST00000403363:splice_region&intron:LOW:exon8/9:c.957+4C>G:,NAGA:ENST00000402937:splice_region&intron:LOW:exon8/9:c.957+4C>G:		rs55715427	0.0298	0.0577	280,249,0	0.0137,0.0309,0.0002,0.0846,0.0317	0.0580							104170 [NAGA (confirmed) Schindler disease,type I,609241|Kanzaki disease,609242|Schindler disease,type III,609241];	RCV000338134.1 [likely benign]; RCV000396099.1 [likely benign]; 			10	247					NAGA (inh=AR pLI=0.00)
chr22	42463814	42463814	C	T	hom	anno_omim	QUAL=13517;DP=186;AF=0.99;MQM=59;TRIO=HOM,186,0.99,HET,278,0.47,HET,384,0.51	NAGA	synonymous	NAGA:ENST00000396398:synonymous:LOW:exon3/9:c.279G>A:p.Pro93Pro,NAGA:ENST00000403363:synonymous:LOW:exon4/10:c.279G>A:p.Pro93Pro,NAGA:ENST00000402937:synonymous:LOW:exon4/10:c.279G>A:p.Pro93Pro		rs133369	0.6769	0.6728	27836,14900,1773	0.5864,0.7611,0.8523,0.6666,0.6223	0.6747							104170 [NAGA (confirmed) Schindler disease,type I,609241|Kanzaki disease,609242|Schindler disease,type III,609241];	RCV000177025.1 [benign]; RCV000282713.1 [benign]; RCV000322543.1 [benign]; 		COSM3759227	876	976					NAGA (inh=AR pLI=0.00)
chr22	42466509	42466509	C	G	hom	anno_omim	QUAL=18767;DP=324;AF=0.99;MQM=59;TRIO=HOM,324,0.99,HET,294,0.48,HET,377,0.52	NAGA	5'UTR,intron	NAGA:ENST00000396398:5'UTR:MODIFIER:exon1/9:c.-208G>C:,NAGA:ENST00000403363:intron:MODIFIER:exon1/9:c.-69-139G>C:,NAGA:ENST00000402937:intron:MODIFIER:exon1/9:c.-76-132G>C:		rs133375	0.6424	0.0000	0,0,0	0,0,0,0,0	0.6210							104170 [NAGA (confirmed) Schindler disease,type I,609241|Kanzaki disease,609242|Schindler disease,type III,609241];	RCV000369898.1 [benign]; RCV000399431.1 [benign]; 			106	100					NAGA (inh=AR pLI=0.00)
chr22	42522550	42522550	G	A	het	low_QUAL;low_DP;low_MQM;anno_omim	QUAL=17;DP=7;AF=0.43;MQM=42;TRIO=HET,7,0.43,WT,1,0.00,WT,1,0.00	CYP2D6,NDUFA6-AS1	3'UTR,intron	CYP2D6:ENST00000360608:3'UTR:MODIFIER:exon9/9:c.*26C>T:,CYP2D6:ENST00000389970:3'UTR:MODIFIER:exon10/10:c.*26C>T:,NDUFA6-AS1:ENST00000416037:intron:MODIFIER:exon5/6:n.1718+1138G>A:,NDUFA6-AS1:ENST00000439129:intron:MODIFIER:exon3/3:n.1046+1983G>A:		rs201759814	0.0000	0.0221	0,0,0	0.0062,0.0084,0.0003,0.0304,0.0273	0.0178							124030 [CYP2D6 (confirmed) Debrisoquine sensitivity,608902|Codeine sensitivity,608902];				2	39					CYP2D6 (inh=n/a pLI=0.00), NDUFA6-AS1 (inh=n/a pLI=n/a)
chr22	42523003	42523003	A	G	hom	low_DP;low_MQM;anno_omim	QUAL=286;DP=9;AF=1.00;MQM=31;TRIO=HOM,9,1.00,WT,110,0.01,HET,157,0.21	CYP2D6,NDUFA6-AS1	splice_region&intron,intron	CYP2D6:ENST00000360608:splice_region&intron:LOW:exon7/8:c.1174-9T>C:,CYP2D6:ENST00000389970:splice_region&intron:LOW:exon8/9:c.1174-9T>C:,CYP2D6:ENST00000359033:splice_region&intron:LOW:exon6/7:c.1021-9T>C:,NDUFA6-AS1:ENST00000416037:intron:MODIFIER:exon5/6:n.1718+1591A>G:,NDUFA6-AS1:ENST00000439129:intron:MODIFIER:exon3/3:n.1046+2436A>G:		rs4987144	0.0000	0.0598	1097,562,98	0.0618,0.0372,0.2096,0.0558,0.0640	0.6294							124030 [CYP2D6 (confirmed) Debrisoquine sensitivity,608902|Codeine sensitivity,608902];				906	426					CYP2D6 (inh=n/a pLI=0.00), NDUFA6-AS1 (inh=n/a pLI=n/a)
chr22	42523528	42523528	C	T	het	pred_pathogenic;anno_omim	QUAL=2573;DP=175;AF=0.30;MQM=52;TRIO=HET,175,0.30,WT,137,0.00,HET,465,0.23	CYP2D6,NDUFA6-AS1	missense,intron	CYP2D6:ENST00000360608:missense:MODERATE:exon7/9:c.1094G>A:p.Arg365His,CYP2D6:ENST00000389970:missense:MODERATE:exon8/10:c.1094G>A:p.Arg365His,CYP2D6:ENST00000359033:missense:MODERATE:exon6/8:c.941G>A:p.Arg314His,NDUFA6-AS1:ENST00000416037:intron:MODIFIER:exon5/6:n.1718+2116C>T:,NDUFA6-AS1:ENST00000439129:intron:MODIFIER:exon3/3:n.1046+2961C>T:		rs1058172	0.0000	0.1211	10,6,0	0.0359,0.0881,0.0017,0.1667,0.0859	0.1091	7.6100	D,D,D,D,D	T	D,D,D	D,D,D	35.00	124030 [CYP2D6 (confirmed) Debrisoquine sensitivity,608902|Codeine sensitivity,608902];			COSM445068, COSM445067	0	506					CYP2D6 (inh=n/a pLI=0.00), NDUFA6-AS1 (inh=n/a pLI=n/a)
chr22	42523636	42523636	C	A	het	low_MQM;pred_pathogenic;anno_omim	QUAL=371;DP=116;AF=0.33;MQM=40;TRIO=HET,116,0.33,WT,105,0.04,WT,330,0.07	CYP2D6,NDUFA6-AS1	missense&splice_region,intron	CYP2D6:ENST00000360608:missense&splice_region:MODERATE:exon7/9:c.986G>T:p.Arg329Leu,CYP2D6:ENST00000389970:missense&splice_region:MODERATE:exon8/10:c.986G>T:p.Arg329Leu,CYP2D6:ENST00000359033:missense&splice_region:MODERATE:exon6/8:c.833G>T:p.Arg278Leu,NDUFA6-AS1:ENST00000416037:intron:MODIFIER:exon5/6:n.1718+2224C>A:,NDUFA6-AS1:ENST00000439129:intron:MODIFIER:exon3/3:n.1046+3069C>A:		rs3915951	0.0000	0.0756	1,1,0	0.0546,0.0418,0.0962,0.0870,0.0673	0.0285	0.4480	D,D,D,D,D	T	B,B,B	T,T,T	23.40	124030 [CYP2D6 (confirmed) Debrisoquine sensitivity,608902|Codeine sensitivity,608902];			COSM304740, COSM225813	0	120					CYP2D6 (inh=n/a pLI=0.00), NDUFA6-AS1 (inh=n/a pLI=n/a)
chr22	42523943	42523943	A	G	hom	anno_omim	QUAL=14082;DP=187;AF=0.99;MQM=56;TRIO=HOM,187,0.99,WT,245,0.02,HET,671,0.50	CYP2D6,NDUFA6-AS1	missense,intron	CYP2D6:ENST00000360608:missense:MODERATE:exon6/9:c.886T>C:p.Cys296Arg,CYP2D6:ENST00000389970:missense:MODERATE:exon7/10:c.886T>C:p.Cys296Arg,CYP2D6:ENST00000359033:missense:MODERATE:exon5/8:c.733T>C:p.Cys245Arg,NDUFA6-AS1:ENST00000416037:intron:MODIFIER:exon5/6:n.1718+2531A>G:,NDUFA6-AS1:ENST00000439129:intron:MODIFIER:exon3/3:n.1046+3376A>G:		rs16947	0.6408	0.6567	27465,14944,1310	0.4802,0.7514,0.8515,0.6571,0.6199	0.6602	-1.2000	T,T,T,T,T	T	B,B	T,T,T	0.04	124030 [CYP2D6 (confirmed) Debrisoquine sensitivity,608902|Codeine sensitivity,608902];			COSM1130423, COSM1130422	911	942					CYP2D6 (inh=n/a pLI=0.00), NDUFA6-AS1 (inh=n/a pLI=n/a)
chr22	42524795	42524795	A	G	het	anno_omim	QUAL=1101;DP=110;AF=0.22;MQM=55;TRIO=HET,110,0.22,HET,327,0.21,WT,270,0.00	CYP2D6,NDUFA6-AS1	synonymous,intron	CYP2D6:ENST00000360608:synonymous:LOW:exon4/9:c.657T>C:p.Phe219Phe,CYP2D6:ENST00000389970:synonymous:LOW:exon5/10:c.657T>C:p.Phe219Phe,CYP2D6:ENST00000359033:synonymous:LOW:exon3/8:c.504T>C:p.Phe168Phe,NDUFA6-AS1:ENST00000416037:intron:MODIFIER:exon5/6:n.1718+3383A>G:,NDUFA6-AS1:ENST00000439129:intron:MODIFIER:exon3/3:n.1046+4228A>G:		rs28371713	0.0000	0.3434	35,17,7	0.2308,0.4241,0.2156,0.3525,0.3642	0.2947							124030 [CYP2D6 (confirmed) Debrisoquine sensitivity,608902|Codeine sensitivity,608902];			COSM1632628, COSM1632629	2	1424					CYP2D6 (inh=n/a pLI=0.00), NDUFA6-AS1 (inh=n/a pLI=n/a)
chr22	42524947	42524947	C	T	hom	low_MQM;anno_high_impact;pred_pathogenic;anno_omim	QUAL=4903;DP=68;AF=0.93;MQM=48;TRIO=HOM,68,0.93,WT,145,0.00,HET,303,0.47	CYP2D6,NDUFA6-AS1	splice_acceptor,intron	CYP2D6:ENST00000360608:splice_acceptor:HIGH:exon3/8:c.506-1G>A:,CYP2D6:ENST00000389970:splice_acceptor:HIGH:exon4/9:c.506-1G>A:,CYP2D6:ENST00000359033:splice_acceptor:HIGH:exon2/7:c.353-1G>A:,NDUFA6-AS1:ENST00000416037:intron:MODIFIER:exon5/6:n.1718+3535C>T:,NDUFA6-AS1:ENST00000439129:intron:MODIFIER:exon3/3:n.1046+4380C>T:		rs3892097	0.0931	0.1708	530,393,37	0.1191,0.1566,0.0042,0.2308,0.1160	0.1384	5.1840					23.00	124030 [CYP2D6 (confirmed) Debrisoquine sensitivity,608902|Codeine sensitivity,608902];	RCV000018385.23 [drug response]; RCV000211167.1 [drug response]; RCV000211174.1 [drug response]; RCV000211232.1 [drug response]; RCV000211292.1 [drug response]; RCV000211293.1 [drug response]; RCV000211307.1 [drug response]; RCV000211390.1 [drug response]; RCV000211415.1 [drug response]; RCV000211422.1 [drug response]; RCV000342450.1 [other]; 	CS900241 [CLASS=FP MUT=ALT PHEN="Poor metaboliser" GENE=CYP2D6]; 		70	558	1	[1] auto-classification 16.06.2016  [2] Peter Bauer 05.08.2014			CYP2D6 (inh=n/a pLI=0.00), NDUFA6-AS1 (inh=n/a pLI=n/a)
chr22	42526694	42526694	G	A	hom	pred_pathogenic;anno_omim	QUAL=2290;DP=39;AF=0.95;MQM=59;TRIO=HOM,39,0.95,WT,44,0.00,HET,109,0.54	CYP2D6,NDUFA6-AS1	missense,intron	CYP2D6:ENST00000360608:missense:MODERATE:exon1/9:c.100C>T:p.Pro34Ser,CYP2D6:ENST00000389970:missense:MODERATE:exon1/10:c.100C>T:p.Pro34Ser,CYP2D6:ENST00000359033:missense:MODERATE:exon1/8:c.100C>T:p.Pro34Ser,NDUFA6-AS1:ENST00000416037:intron:MODIFIER:exon5/6:n.1718+5282G>A:,NDUFA6-AS1:ENST00000439129:intron:MODIFIER:exon3/3:n.1046+6127G>A:		rs1065852	0.2380	0.2467	3570,1648,121	0.1513,0.1513,0.5910,0.2493,0.1805	0.2068	7.1060	D,D,D,D	T	D,P	D,D,D	24.90	124030 [CYP2D6 (confirmed) Debrisoquine sensitivity,608902|Codeine sensitivity,608902];	RCV000018389.23 [drug response]; 	CM900081 [CLASS=FP MUT=ALT PHEN="Poor metaboliser" GENE=CYP2D6]; 		106	608	1	[1] auto-classification 16.06.2016  [2] old entry - no details available			CYP2D6 (inh=n/a pLI=0.00), NDUFA6-AS1 (inh=n/a pLI=n/a)
chr22	43014714	43014714	A	-	het	anno_omim	QUAL=61;DP=74;AF=0.26;MQM=58;TRIO=HET,74,0.26,WT,23,0.09,WT,30,0.27	CYB5R3	3'UTR	CYB5R3:ENST00000361740:3'UTR:MODIFIER:exon9/9:c.*1065delT:,CYB5R3:ENST00000396303:3'UTR:MODIFIER:exon9/9:c.*1065delT:	AluSg4	rs36011098;rs796931131	0.0000	0.0000	0,0,0	0,0,0,0,0	0.3995							613213 [CYB5R3 (confirmed) Methemoglobinemia,type I,250800|Methemoglobinemia,type II,250800];				30	13					CYB5R3 (inh=AR pLI=0.21)
chr22	43032742	43032742	C	T	het	anno_omim	QUAL=5138;DP=151;AF=0.50;MQM=60;TRIO=HET,151,0.50,HET,317,0.49,WT,419,0.00	CYB5R3	synonymous	CYB5R3:ENST00000361740:synonymous:LOW:exon2/9:c.231G>A:p.Pro77Pro,CYB5R3:ENST00000396303:synonymous:LOW:exon2/9:c.63G>A:p.Pro21Pro,CYB5R3:ENST00000352397:synonymous:LOW:exon2/9:c.132G>A:p.Pro44Pro,CYB5R3:ENST00000407623:synonymous:LOW:exon2/9:c.63G>A:p.Pro21Pro,CYB5R3:ENST00000407332:synonymous:LOW:exon1/8:c.63G>A:p.Pro21Pro,CYB5R3:ENST00000402438:synonymous:LOW:exon3/10:c.63G>A:p.Pro21Pro		rs5996200	0.0737	0.1179	889,725,59	0.1112,0.0787,0.0012,0.1572,0.0397	0.1289							613213 [CYB5R3 (confirmed) Methemoglobinemia,type I,250800|Methemoglobinemia,type II,250800];	RCV000251674.1 [benign]; 			64	523					CYB5R3 (inh=AR pLI=0.21)
chr22	46239934	46239934	C	T	het	anno_omim	QUAL=8567;DP=408;AF=0.52;MQM=60;TRIO=HET,408,0.52,HET,242,0.43,WT,333,0.00	ATXN10	3'UTR	ATXN10:ENST00000252934:3'UTR:MODIFIER:exon12/12:c.*383C>T:,ATXN10:ENST00000381061:3'UTR:MODIFIER:exon11/11:c.*383C>T:		rs9614791	0.0200	0.0000	0,0,0	0,0,0,0,0	0.0488							611150 [ATXN10 (confirmed) Spinocerebellar ataxia 10,603516];				2	30					ATXN10 (inh=AD pLI=0.75)
chr22	50297591	50297591	G	A	het	anno_omim	QUAL=5676;DP=205;AF=0.44;MQM=59;TRIO=HET,205,0.44,HET,299,0.51,WT,428,0.00	ALG12,CITF22-1A6.3	synonymous	ALG12:ENST00000330817:synonymous:LOW:exon10/10:c.1362C>T:p.Val454Val		rs12163163	0.0012	0.0010	1,0,0	0.0001,0.0004,0.0094,0.0004,0.0004	0.0009	0.0060		T			7.30	607144 [ALG12 (confirmed) Congenital disorder of glycosylation,type Ig,607143];	RCV000405148.1 [uncertain significance]; 			0	5					ALG12 (inh=n/a pLI=0.01), CITF22-1A6.3 (inh=n/a pLI=n/a)
chr22	50498030	50498030	-	C	het	anno_omim	QUAL=2977;DP=166;AF=0.46;MQM=59;TRIO=HET,166,0.46,HET,173,0.46,WT,175,0.00	MLC1	3'UTR	MLC1:ENST00000311597:3'UTR:MODIFIER:exon12/12:c.*1981dupG:,MLC1:ENST00000395876:3'UTR:MODIFIER:exon12/12:c.*1981dupG:		rs145385166	0.1322	0.0000	0,0,0	0,0,0,0,0	0.1078							605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts,604004];	RCV000379634.1 [likely benign]; 			4	56					MLC1 (inh=AR pLI=0.00)
chr22	50498176	50498176	C	T	het	anno_omim	QUAL=4789;DP=151;AF=0.46;MQM=60;TRIO=HET,151,0.46,HET,132,0.58,HET,138,0.45	MLC1	3'UTR	MLC1:ENST00000311597:3'UTR:MODIFIER:exon12/12:c.*1836G>A:,MLC1:ENST00000395876:3'UTR:MODIFIER:exon12/12:c.*1836G>A:		rs11703598	0.0563	0.0000	0,0,0	0,0,0,0,0	0.1005							605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts,604004];	RCV000341072.1 [likely benign]; 			5	55					MLC1 (inh=AR pLI=0.00)
chr22	50498389	50498389	C	A	het	anno_omim	QUAL=4808;DP=156;AF=0.49;MQM=59;TRIO=HET,156,0.49,HET,89,0.49,HET,123,0.59	MLC1	3'UTR	MLC1:ENST00000311597:3'UTR:MODIFIER:exon12/12:c.*1623G>T:,MLC1:ENST00000395876:3'UTR:MODIFIER:exon12/12:c.*1623G>T:		rs35730155	0.1510	0.0000	0,0,0	0,0,0,0,0	0.1519							605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts,604004];	RCV000335142.1 [likely benign]; 			6	57					MLC1 (inh=AR pLI=0.00)
chr22	50499021	50499021	A	C	het	anno_omim	QUAL=7318;DP=195;AF=0.52;MQM=59;TRIO=HET,195,0.52,HET,445,0.47,WT,565,0.00	MLC1	3'UTR	MLC1:ENST00000311597:3'UTR:MODIFIER:exon12/12:c.*991T>G:,MLC1:ENST00000395876:3'UTR:MODIFIER:exon12/12:c.*991T>G:		rs11704648	0.1304	0.0000	0,0,0	0,0,0,0,0	0.1069							605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts,604004];	RCV000325587.1 [likely benign]; 			5	57					MLC1 (inh=AR pLI=0.00)
chr22	50499075	50499075	G	A	het	anno_omim	QUAL=5237;DP=221;AF=0.48;MQM=59;TRIO=HET,221,0.48,HET,338,0.42,WT,457,0.00	MLC1	3'UTR	MLC1:ENST00000311597:3'UTR:MODIFIER:exon12/12:c.*937C>T:,MLC1:ENST00000395876:3'UTR:MODIFIER:exon12/12:c.*937C>T:		rs41283491	0.1306	0.0000	0,0,0	0,0,0,0,0	0.1070							605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts,604004];	RCV000267260.1 [likely benign]; 			5	57					MLC1 (inh=AR pLI=0.00)
chr22	50499239	50499239	C	T	het	anno_omim	QUAL=741;DP=90;AF=0.46;MQM=54;TRIO=HET,90,0.46,WT,92,0.00,WT,168,0.02	MLC1	3'UTR	MLC1:ENST00000311597:3'UTR:MODIFIER:exon12/12:c.*773G>A:,MLC1:ENST00000395876:3'UTR:MODIFIER:exon12/12:c.*773G>A:		rs4838880	0.1793	0.0000	0,0,0	0,0,0,0,0	0.0004							605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts,604004];	RCV000319349.1 [likely benign]; 			5	49					MLC1 (inh=AR pLI=0.00)
chr22	50499634	50499634	-	GACCCCC	het	anno_omim	QUAL=2902;DP=196;AF=0.42;MQM=59;TRIO=HET,196,0.42,HET,183,0.43,WT,286,0.00	MLC1	3'UTR	MLC1:ENST00000311597:3'UTR:MODIFIER:exon12/12:c.*377_*378insGGGGGTC:,MLC1:ENST00000395876:3'UTR:MODIFIER:exon12/12:c.*377_*378insGGGGGTC:,MLC1:ENST00000538737:3'UTR:MODIFIER:exon11/11:c.*377_*378insGGGGGTC:,MLC1:ENST00000431262:3'UTR:MODIFIER:exon11/11:c.*377_*378insGGGGGTC:		rs368794754	0.1304	0.0000	0,0,0	0,0,0,0,0	0.1061							605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts,604004];	RCV000402457.1 [likely benign]; 			3	58					MLC1 (inh=AR pLI=0.00)
chr22	50499964	50499964	T	C	het	anno_omim	QUAL=8616;DP=178;AF=0.46;MQM=60;TRIO=HET,178,0.46,HET,266,0.45,HET,327,0.45	MLC1	3'UTR	MLC1:ENST00000311597:3'UTR:MODIFIER:exon12/12:c.*48A>G:,MLC1:ENST00000395876:3'UTR:MODIFIER:exon12/12:c.*48A>G:,MLC1:ENST00000538737:3'UTR:MODIFIER:exon11/11:c.*48A>G:,MLC1:ENST00000431262:3'UTR:MODIFIER:exon11/11:c.*48A>G:,MLC1:ENST00000535444:3'UTR:MODIFIER:exon11/11:c.*48A>G:,MLC1:ENST00000450140:3'UTR:MODIFIER:exon10/10:c.*48A>G:		rs137919	0.2829	0.2974	5755,2771,78	0.1072,0.3411,0.3342,0.2881,0.4201	0.3000							605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts,604004];	RCV000246160.1 [benign]; RCV000362458.1 [benign]; 			310	1207					MLC1 (inh=AR pLI=0.00)
chr22	50499967	50499967	T	C	het	anno_omim	QUAL=10516;DP=166;AF=0.55;MQM=60;TRIO=HET,166,0.55,HET,258,0.55,HET,327,0.54	MLC1	3'UTR	MLC1:ENST00000311597:3'UTR:MODIFIER:exon12/12:c.*45A>G:,MLC1:ENST00000395876:3'UTR:MODIFIER:exon12/12:c.*45A>G:,MLC1:ENST00000538737:3'UTR:MODIFIER:exon11/11:c.*45A>G:,MLC1:ENST00000431262:3'UTR:MODIFIER:exon11/11:c.*45A>G:,MLC1:ENST00000535444:3'UTR:MODIFIER:exon11/11:c.*45A>G:,MLC1:ENST00000450140:3'UTR:MODIFIER:exon10/10:c.*45A>G:		rs2072873	0.1504	0.1460	1336,617,181	0.1762,0.1629,0.2011,0.1379,0.1394	0.1499							605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts,604004];	RCV000252122.1 [benign]; RCV000394298.1 [likely benign]; 			56	664					MLC1 (inh=AR pLI=0.00)
chr22	50502491	50502491	T	C	het	pred_pathogenic;anno_omim	QUAL=1472;DP=72;AF=0.50;MQM=59;TRIO=HET,72,0.50,HET,90,0.42,WT,122,0.00	MLC1	missense	MLC1:ENST00000311597:missense:MODERATE:exon11/12:c.1031A>G:p.Asn344Ser,MLC1:ENST00000395876:missense:MODERATE:exon11/12:c.1031A>G:p.Asn344Ser,MLC1:ENST00000538737:missense:MODERATE:exon10/11:c.929A>G:p.Asn310Ser,MLC1:ENST00000431262:missense:MODERATE:exon10/11:c.941A>G:p.Asn314Ser,MLC1:ENST00000535444:missense:MODERATE:exon10/11:c.794A>G:p.Asn265Ser,MLC1:ENST00000450140:missense:MODERATE:exon9/10:c.875A>G:p.Asn292Ser		rs11568188	0.1312	0.0907	670,280,17	0.0463,0.0756,0.0567,0.0861,0.1818	0.1127	0.6210	T,T,T,T,T,T	T	B,B,B	D,D,D,D,D,D	0.01	605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts,604004];	RCV000020711.2 [benign]; RCV000117622.3 [other]; RCV000321929.1 [likely benign]; 		COSM1416980	66	652					MLC1 (inh=AR pLI=0.00)
chr22	50502526	50502526	A	G	het	anno_omim	QUAL=2707;DP=133;AF=0.47;MQM=59;TRIO=HET,133,0.47,HET,132,0.47,WT,174,0.00	MLC1	synonymous	MLC1:ENST00000311597:synonymous:LOW:exon11/12:c.996T>C:p.Ser332Ser,MLC1:ENST00000395876:synonymous:LOW:exon11/12:c.996T>C:p.Ser332Ser,MLC1:ENST00000538737:synonymous:LOW:exon10/11:c.894T>C:p.Ser298Ser,MLC1:ENST00000431262:synonymous:LOW:exon10/11:c.906T>C:p.Ser302Ser,MLC1:ENST00000535444:synonymous:LOW:exon10/11:c.759T>C:p.Ser253Ser,MLC1:ENST00000450140:synonymous:LOW:exon9/10:c.840T>C:p.Ser280Ser		rs11568187	0.1312	0.1303	1030,499,31	0.0723,0.1140,0.0924,0.1295,0.2165	0.1269							605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts,604004];	RCV000117629.3 [other]; RCV000355808.1 [likely benign]; 		COSM3722537	65	661					MLC1 (inh=AR pLI=0.00)
chr22	50502544	50502544	G	A	het	anno_omim	QUAL=3549;DP=171;AF=0.49;MQM=59;TRIO=HET,171,0.49,HET,153,0.46,WT,180,0.01	MLC1	synonymous	MLC1:ENST00000311597:synonymous:LOW:exon11/12:c.978C>T:p.Cys326Cys,MLC1:ENST00000395876:synonymous:LOW:exon11/12:c.978C>T:p.Cys326Cys,MLC1:ENST00000538737:synonymous:LOW:exon10/11:c.876C>T:p.Cys292Cys,MLC1:ENST00000431262:synonymous:LOW:exon10/11:c.888C>T:p.Cys296Cys,MLC1:ENST00000535444:synonymous:LOW:exon10/11:c.741C>T:p.Cys247Cys,MLC1:ENST00000450140:synonymous:LOW:exon9/10:c.822C>T:p.Cys274Cys		rs11568186	0.1312	0.1311	1027,493,29	0.0730,0.1145,0.0926,0.1302,0.2171	0.1295							605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts,604004];	RCV000117628.3 [other]; RCV000263376.1 [likely benign]; 			61	658					MLC1 (inh=AR pLI=0.00)
chr22	50502636	50502636	G	A	het	anno_omim	QUAL=1725;DP=58;AF=0.26;MQM=59;TRIO=HET,58,0.26,HET,136,0.51,WT,191,0.01	MLC1	splice_region&intron	MLC1:ENST00000311597:splice_region&intron:LOW:exon10/11:c.895-9C>T:,MLC1:ENST00000395876:splice_region&intron:LOW:exon10/11:c.895-9C>T:,MLC1:ENST00000538737:splice_region&intron:LOW:exon9/10:c.793-9C>T:,MLC1:ENST00000431262:splice_region&intron:LOW:exon9/10:c.805-9C>T:,MLC1:ENST00000535444:splice_region&intron:LOW:exon9/10:c.658-9C>T:,MLC1:ENST00000450140:splice_region&intron:LOW:exon8/9:c.739-9C>T:		rs11568185	0.1316	0.1386	584,234,18	0.0742,0.1145,0.0978,0.1348,0.2182	0.1275							605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts,604004];	RCV000117627.3 [other]; RCV000316264.1 [likely benign]; 			66	792					MLC1 (inh=AR pLI=0.00)
chr22	50515270	50515270	T	C	het	anno_omim	QUAL=8752;DP=241;AF=0.51;MQM=59;TRIO=HET,241,0.51,HET,407,0.53,WT,443,0.00	MLC1	splice_region&synonymous	MLC1:ENST00000311597:splice_region&synonymous:LOW:exon7/12:c.597A>G:p.Ser199Ser,MLC1:ENST00000395876:splice_region&synonymous:LOW:exon7/12:c.597A>G:p.Ser199Ser,MLC1:ENST00000538737:splice_region&synonymous:LOW:exon6/11:c.495A>G:p.Ser165Ser,MLC1:ENST00000431262:splice_region&synonymous:LOW:exon6/11:c.507A>G:p.Ser169Ser,MLC1:ENST00000535444:splice_region&synonymous:LOW:exon6/11:c.360A>G:p.Ser120Ser,MLC1:ENST00000450140:splice_region&synonymous:LOW:exon5/10:c.441A>G:p.Ser147Ser		rs6010164	0.1306	0.1270	1096,468,66	0.1035,0.1164,0.0900,0.1174,0.2248	0.1250							605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts,604004];	RCV000117626.3 [other]; RCV000389139.1 [likely benign]; 		COSM4002217	57	732					MLC1 (inh=AR pLI=0.00)
chr22	50515273	50515273	G	A	het	anno_omim	QUAL=8752;DP=241;AF=0.51;MQM=59;TRIO=HET,241,0.51,HET,407,0.53,WT,443,0.00	MLC1	synonymous	MLC1:ENST00000311597:synonymous:LOW:exon7/12:c.594C>T:p.Tyr198Tyr,MLC1:ENST00000395876:synonymous:LOW:exon7/12:c.594C>T:p.Tyr198Tyr,MLC1:ENST00000538737:synonymous:LOW:exon6/11:c.492C>T:p.Tyr164Tyr,MLC1:ENST00000431262:synonymous:LOW:exon6/11:c.504C>T:p.Tyr168Tyr,MLC1:ENST00000535444:synonymous:LOW:exon6/11:c.357C>T:p.Tyr119Tyr,MLC1:ENST00000450140:synonymous:LOW:exon5/10:c.438C>T:p.Tyr146Tyr		rs6010165	0.1306	0.1270	1096,468,66	0.1036,0.1164,0.0897,0.1174,0.2248	0.1249							605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts,604004];	RCV000117625.3 [other]; RCV000294810.1 [likely benign]; 		COSM4002218	57	732					MLC1 (inh=AR pLI=0.00)
chr22	50515843	50515843	C	A	het	pred_pathogenic;anno_omim	QUAL=2287;DP=99;AF=0.43;MQM=60;TRIO=HET,99,0.43,HET,111,0.50,WT,153,0.00	MLC1	missense	MLC1:ENST00000311597:missense:MODERATE:exon6/12:c.512G>T:p.Cys171Phe,MLC1:ENST00000395876:missense:MODERATE:exon6/12:c.512G>T:p.Cys171Phe,MLC1:ENST00000538737:missense:MODERATE:exon5/11:c.410G>T:p.Cys137Phe,MLC1:ENST00000431262:missense:MODERATE:exon5/11:c.422G>T:p.Cys141Phe,MLC1:ENST00000535444:missense:MODERATE:exon5/11:c.275G>T:p.Cys92Phe,MLC1:ENST00000450140:missense:MODERATE:exon4/10:c.356G>T:p.Cys119Phe		rs6010260	0.1216	0.1243	1025,444,27	0.0675,0.1154,0.0895,0.1176,0.2261	0.1221	2.1120	D,D,D,D,D,D,D	T	B,B,B,B	D,D,D,D,D,D,D	24.40	605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts,604004];	RCV000020714.2 [benign]; RCV000117624.3 [other]; RCV000392609.1 [likely benign]; 			56	730					MLC1 (inh=AR pLI=0.00)
chr22	50524250	50524250	-	C	hom	anno_omim	QUAL=12325;DP=133;AF=0.91;MQM=59;TRIO=HOM,133,0.91,HOM,130,0.98,HOM,187,0.98	MLC1	5'UTR	MLC1:ENST00000311597:5'UTR:MODIFIER:exon1/12:c.-527dupG:		rs137931	0.6719	0.0000	0,0,0	0,0,0,0,0	0.7014							605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts,604004];	RCV000333064.1 [benign]; 			133	89					MLC1 (inh=AR pLI=0.00)
chr22	50524285	50524285	C	T	het	anno_omim	QUAL=3720;DP=162;AF=0.48;MQM=59;TRIO=HET,162,0.48,HET,89,0.37,HET,142,0.44	MLC1	5'UTR	MLC1:ENST00000311597:5'UTR:MODIFIER:exon1/12:c.-561G>A:		rs4838883	0.1494	0.0000	0,0,0	0,0,0,0,0	0.1407							605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts,604004];	RCV000269244.1 [likely benign]; 			6	60					MLC1 (inh=AR pLI=0.00)
chr22	50962208	50962208	T	G	het	anno_omim	QUAL=2899;DP=145;AF=0.48;MQM=60;TRIO=HET,145,0.48,WT,86,0.00,HET,80,0.54	SCO2	synonymous	SCO2:ENST00000252785:synonymous:LOW:exon2/2:c.633A>C:p.Ala211Ala,SCO2:ENST00000395693:synonymous:LOW:exon2/2:c.633A>C:p.Ala211Ala,SCO2:ENST00000535425:synonymous:LOW:exon2/2:c.633A>C:p.Ala211Ala,SCO2:ENST00000543927:synonymous:LOW:exon2/2:c.633A>C:p.Ala211Ala		rs12148	0.6556	0.6384	24848,12588,2265	0.6604,0.6376,0.6977,0.6139,0.6843	0.6403							604272 [SCO2 (confirmed) Cardioencephalomyopathy,fatal infantile,due to cytochrome c oxidase deficiency 1,604377|Myopia 6,608908];	RCV000128016.1 [benign]; RCV000269901.1 [benign]; RCV000300513.1 [benign]; RCV000404245.1 [benign]; 			870	994					SCO2 (inh=AR+AD pLI=0.00)
chr22	50962782	50962782	C	G	het	pred_pathogenic;anno_omim	QUAL=1851;DP=96;AF=0.45;MQM=60;TRIO=HET,96,0.45,WT,45,0.02,HET,75,0.49	SCO2,CTA-384D8.36	missense	SCO2:ENST00000252785:missense:MODERATE:exon2/2:c.59G>C:p.Arg20Pro,SCO2:ENST00000395693:missense:MODERATE:exon2/2:c.59G>C:p.Arg20Pro,SCO2:ENST00000535425:missense:MODERATE:exon2/2:c.59G>C:p.Arg20Pro,SCO2:ENST00000543927:missense:MODERATE:exon2/2:c.59G>C:p.Arg20Pro		rs140523	0.6516	0.6393	23621,11904,1889	0.6513,0.6368,0.6989,0.6160,0.6846	0.6390	-3.5700	T,T,T,T,T,T	T	B	D,D,D,D,T,T	4.15	604272 [SCO2 (confirmed) Cardioencephalomyopathy,fatal infantile,due to cytochrome c oxidase deficiency 1,604377|Myopia 6,608908];	RCV000128012.1 [benign]; RCV000271220.1 [benign]; RCV000338357.1 [benign]; RCV000374348.1 [benign]; 		COSM445183, COSM1484348	867	988					SCO2 (inh=AR+AD pLI=0.00), CTA-384D8.36 (inh=n/a pLI=n/a)
chr22	50963965	50963965	C	G	het	anno_omim	QUAL=1567;DP=53;AF=0.57;MQM=60;TRIO=HET,53,0.57,WT,51,0.00,HET,78,0.54	SCO2	5'UTR,intron	SCO2:ENST00000252785:5'UTR:MODIFIER:exon1/2:c.-108G>C:,SCO2:ENST00000395693:5'UTR:MODIFIER:exon1/2:c.-78G>C:,SCO2:ENST00000535425:intron:MODIFIER:exon1/1:c.-14+465G>C:,SCO2:ENST00000543927:intron:MODIFIER:exon1/1:c.-14+710G>C:		rs131806	0.5339	0.0000	0,0,0	0,0,0,0,0	0.5187							604272 [SCO2 (confirmed) Cardioencephalomyopathy,fatal infantile,due to cytochrome c oxidase deficiency 1,604377|Myopia 6,608908];	RCV000309935.1 [benign]; RCV000364567.1 [benign]; RCV000376198.1 [benign]; 			75	108					SCO2 (inh=AR+AD pLI=0.00)
chr22	50964862	50964862	G	A	hom	low_DP;anno_omim	QUAL=47;DP=4;AF=1.00;MQM=60;TRIO=HOM,4,1.00,WT,8,0.00,WT,3,0.00	TYMP,SCO2	synonymous,5'UTR	TYMP:ENST00000395681:synonymous:LOW:exon8/10:c.972C>T:p.Ala324Ala,TYMP:ENST00000395680:synonymous:LOW:exon8/10:c.972C>T:p.Ala324Ala,TYMP:ENST00000252029:synonymous:LOW:exon8/10:c.972C>T:p.Ala324Ala,TYMP:ENST00000395678:synonymous:LOW:exon8/10:c.972C>T:p.Ala324Ala,SCO2:ENST00000543927:5'UTR:MODIFIER:exon1/2:c.-201C>T:		rs131804	0.5329	0.6721	3624,1538,63	0.4903,0.7336,0.7800,0.6702,0.6641	0.6106							604272 [SCO2 (confirmed) Cardioencephalomyopathy,fatal infantile,due to cytochrome c oxidase deficiency 1,604377|Myopia 6,608908]:131222 [TYMP (confirmed) Mitochondrial DNA depletion syndrome 1 (MNGIE type),603041];	RCV000118808.5 [other]; RCV000278985.1 [benign]; RCV000279726.1 [benign]; RCV000338776.1 [benign]; 			639	964					TYMP (inh=AR pLI=0.00), SCO2 (inh=AR+AD pLI=0.00)
chr22	51062051	51062051	G	T	het	anno_omim	QUAL=3136;DP=170;AF=0.45;MQM=58;TRIO=HET,170,0.45,WT,52,0.00,HOM,53,1.00	ARSA			AluSx	rs6009939	0.3321	0.0000	0,0,0	0,0,0,0,0	0.2563							607574 [ARSA (confirmed) Metachromatic leukodystrophy,250100];	RCV000336859.1 [benign]; 			4	49					ARSA (inh=AR pLI=0.00)
chr22	51062222	51062222	G	C	het	low_DP;anno_omim	QUAL=119;DP=14;AF=0.50;MQM=51;TRIO=HET,14,0.50,WT,1,0.00,WT,53,1.00	ARSA			AluSx	rs131717	0.4762	0.0000	0,0,0	0,0,0,0,0	0.5082							607574 [ARSA (confirmed) Metachromatic leukodystrophy,250100];	RCV000270537.1 [benign]; 			48	42					ARSA (inh=AR pLI=0.00)
chr22	51062654	51062654	T	C	hom	anno_omim	QUAL=5566;DP=79;AF=0.99;MQM=55;TRIO=HOM,79,0.99,HET,57,0.53,HOM,88,1.00	ARSA			AluSp	rs5770805	0.8349	0.0000	0,0,0	0,0,0,0,0	0.7893							607574 [ARSA (confirmed) Metachromatic leukodystrophy,250100];	RCV000281321.1 [benign]; 			86	59					ARSA (inh=AR pLI=0.00)
chr22	51062718	51062718	C	T	het	anno_omim	QUAL=2003;DP=89;AF=0.48;MQM=50;TRIO=HET,89,0.48,HET,105,0.48,WT,144,0.00	ARSA			AluSp	rs7288050	0.3490	0.0000	0,0,0	0,0,0,0,0	0.4203							607574 [ARSA (confirmed) Metachromatic leukodystrophy,250100];	RCV000407866.1 [benign]; 			31	79					ARSA (inh=AR pLI=0.00)
chr22	51062832	51062832	G	A	het	anno_omim	QUAL=8738;DP=305;AF=0.49;MQM=59;TRIO=HET,305,0.49,WT,268,0.00,HET,386,0.50	ARSA			L2	rs8142033	0.1773	0.0000	0,0,0	0,0,0,0,0	0.1230							607574 [ARSA (confirmed) Metachromatic leukodystrophy,250100];	RCV000407824.1 [likely benign]; 			0	32					ARSA (inh=AR pLI=0.00)
chr22	51062891	51062891	C	G	het	anno_omim	QUAL=4813;DP=177;AF=0.55;MQM=60;TRIO=HET,177,0.55,HET,227,0.42,WT,336,0.00	ARSA				rs7288338	0.3510	0.0000	0,0,0	0,0,0,0,0	0.4267							607574 [ARSA (confirmed) Metachromatic leukodystrophy,250100];	RCV000346142.1 [benign]; 			33	79					ARSA (inh=AR pLI=0.00)
chr22	51062938	51062938	C	T	het	anno_omim	QUAL=8993;DP=131;AF=0.46;MQM=59;TRIO=HET,131,0.46,WT,198,0.00,HOM,252,0.98	ARSA				rs5770953	0.3588	0.0000	0,0,0	0,0,0,0,0	0.2835							607574 [ARSA (confirmed) Metachromatic leukodystrophy,250100];	RCV000301794.1 [benign]; 			4	49					ARSA (inh=AR pLI=0.00)
chr22	51063477	51063477	T	C	het	anno_omim;anno_pathogenic_clinvar	QUAL=11488;DP=210;AF=0.49;MQM=59;TRIO=HET,210,0.49,WT,582,0.00,HET,740,0.49	ARSA	3'UTR	ARSA:ENST00000216124:3'UTR:MODIFIER:exon8/8:c.*96A>G:,ARSA:ENST00000356098:3'UTR:MODIFIER:exon9/9:c.*96A>G:,ARSA:ENST00000547307:3'UTR:MODIFIER:exon8/8:c.*96A>G:,ARSA:ENST00000547805:3'UTR:MODIFIER:exon9/9:c.*96A>G:,ARSA:ENST00000395621:3'UTR:MODIFIER:exon9/9:c.*96A>G:,ARSA:ENST00000453344:3'UTR:MODIFIER:exon8/8:c.*96A>G:,ARSA:ENST00000395619:3'UTR:MODIFIER:exon9/9:c.*96A>G:		rs6151429	0.0499	0.0000	0,0,0	0,0,0,0,0	0.0459							607574 [ARSA (confirmed) Metachromatic leukodystrophy,250100];	RCV000003190.2 [pathogenic]; RCV000020309.2 [other]; RCV000180167.2 [other]; RCV000246300.1 [benign]; 	CR890137 [CLASS=DP MUT=ALT PHEN="Arylsulphatase A pseudodeficiency association" GENE=ARSA]; 		1	48	2	[2] old entry - no details available			ARSA (inh=AR pLI=0.00)
chr22	51064039	51064039	G	C	het	pred_pathogenic;anno_omim	QUAL=9971;DP=201;AF=0.56;MQM=59;TRIO=HET,201,0.56,HET,206,0.67,HET,290,0.45	ARSA	missense	ARSA:ENST00000216124:missense:MODERATE:exon7/8:c.1178C>G:p.Thr393Ser,ARSA:ENST00000356098:missense:MODERATE:exon8/9:c.1178C>G:p.Thr393Ser,ARSA:ENST00000547307:missense:MODERATE:exon7/8:c.1172C>G:p.Thr391Ser,ARSA:ENST00000547805:missense:MODERATE:exon8/9:c.1172C>G:p.Thr391Ser,ARSA:ENST00000395621:missense:MODERATE:exon8/9:c.1178C>G:p.Thr393Ser,ARSA:ENST00000453344:missense:MODERATE:exon7/8:c.920C>G:p.Thr307Ser,ARSA:ENST00000395619:missense:MODERATE:exon8/9:c.1178C>G:p.Thr393Ser		rs743616	0.4056	0.4843	14735,9758,824	0.3941,0.4156,0.2984,0.5393,0.4220	0.4955	0.1030	T,T,T,T,T,T,T	T	B	D,D,D,D,D,D,D	7.55	607574 [ARSA (confirmed) Metachromatic leukodystrophy,250100];	RCV000020311.2 [other]; RCV000078937.5 [benign]; 	CM910052 [CLASS=DP MUT=ALT PHEN="Phenotype modifier association with" GENE=ARSA]; 		845	1642	2	[2] old entry - no details available			ARSA (inh=AR pLI=0.00)
chr22	51064416	51064416	T	C	het	pred_pathogenic;anno_omim	QUAL=6149;DP=166;AF=0.49;MQM=59;TRIO=HET,166,0.49,WT,283,0.00,HET,303,0.54	ARSA	missense	ARSA:ENST00000216124:missense:MODERATE:exon6/8:c.1055A>G:p.Asn352Ser,ARSA:ENST00000356098:missense:MODERATE:exon7/9:c.1055A>G:p.Asn352Ser,ARSA:ENST00000547307:missense:MODERATE:exon6/8:c.1049A>G:p.Asn350Ser,ARSA:ENST00000547805:missense:MODERATE:exon7/9:c.1049A>G:p.Asn350Ser,ARSA:ENST00000395621:missense:MODERATE:exon7/9:c.1055A>G:p.Asn352Ser,ARSA:ENST00000453344:missense:MODERATE:exon6/8:c.797A>G:p.Asn266Ser,ARSA:ENST00000395619:missense:MODERATE:exon7/9:c.1055A>G:p.Asn352Ser		rs2071421	0.2248	0.2166	839,252,316	0.3776,0.3948,0.2285,0.1917,0.1687	0.1738	1.7670	T,T,T,T,T,T,T	T	B	D,D,D,D,D,D,D	15.45	607574 [ARSA (confirmed) Metachromatic leukodystrophy,250100];	RCV000003191.2 [benign]; RCV000020310.2 [other]; RCV000078931.5 [other]; RCV000249834.1 [benign]; 	CM890013 [CLASS=DP MUT=ALT PHEN="Arylsulphatase A pseudodeficiency association" GENE=ARSA]; 	COSM4004968	59	796	2	[2] old entry - no details available			ARSA (inh=AR pLI=0.00)
chrX	2856155	2856155	C	T	hom	pred_pathogenic;anno_omim	QUAL=5926;DP=75;AF=1.00;MQM=59;TRIO=HOM,75,1.00,HOM,69,0.99,HOM,58,1.00	ARSE	missense	ARSE:ENST00000545496:missense:MODERATE:exon10/12:c.1345G>A:p.Gly449Ser,ARSE:ENST00000540563:missense:MODERATE:exon8/10:c.1135G>A:p.Gly379Ser,ARSE:ENST00000381134:missense:MODERATE:exon9/11:c.1270G>A:p.Gly424Ser		rs35143646	0.5746	0.6593	11756,6675,93	0.1640,0.6247,0.8920,0.6842,0.8276	0.6592	6.3350	T,T,T	T	P,B,P	D,D,D	24.20	300180 [ARSE (confirmed) Chondrodysplasia punctata,X-linked recessive,302950];	RCV000145026.2 [benign]; RCV000224630.1 [benign]; 			1420	344					ARSE (inh=XLR pLI=0.12)
chrX	5808861	5808861	G	A	hom	anno_omim	QUAL=12150;DP=196;AF=0.99;MQM=60;TRIO=HOM,196,0.99,HET,150,0.55,HOM,113,1.00	NLGN4X	3'UTR	NLGN4X:ENST00000381093:3'UTR:MODIFIER:exon7/7:c.*1997C>T:,NLGN4X:ENST00000381095:3'UTR:MODIFIER:exon6/6:c.*1997C>T:,NLGN4X:ENST00000275857:3'UTR:MODIFIER:exon6/6:c.*1997C>T:		rs1882260	0.7083	0.0000	0,0,0	0,0,0,0,0	0.7095							300427 [NLGN4X (provisional) Autism susceptibility,X-linked 2,300495|Asperger syndrome susceptibility,X-linked 2,300497|Mental retardation,X-linked,300495];				236	45					NLGN4X (inh=n/a pLI=0.93)
chrX	5810090	5810090	A	G	hom	anno_omim	QUAL=3648;DP=98;AF=0.98;MQM=60;TRIO=HOM,98,0.98,HET,58,0.47,WT,27,0.00	NLGN4X	3'UTR	NLGN4X:ENST00000381093:3'UTR:MODIFIER:exon7/7:c.*768T>C:,NLGN4X:ENST00000381095:3'UTR:MODIFIER:exon6/6:c.*768T>C:,NLGN4X:ENST00000275857:3'UTR:MODIFIER:exon6/6:c.*768T>C:	(TA)n	rs3810685	0.3687	0.0000	0,0,0	0,0,0,0,0	0.3040							300427 [NLGN4X (provisional) Autism susceptibility,X-linked 2,300495|Asperger syndrome susceptibility,X-linked 2,300497|Mental retardation,X-linked,300495];				107	83					NLGN4X (inh=n/a pLI=0.93)
chrX	5810574	5810574	C	T	hom	anno_omim	QUAL=9755;DP=209;AF=1.00;MQM=60;TRIO=HOM,209,1.00,HET,252,0.46,WT,176,0.00	NLGN4X	3'UTR	NLGN4X:ENST00000381093:3'UTR:MODIFIER:exon7/7:c.*284G>A:,NLGN4X:ENST00000381095:3'UTR:MODIFIER:exon6/6:c.*284G>A:,NLGN4X:ENST00000275857:3'UTR:MODIFIER:exon6/6:c.*284G>A:,NLGN4X:ENST00000381092:3'UTR:MODIFIER:exon7/7:c.*284G>A:,NLGN4X:ENST00000538097:3'UTR:MODIFIER:exon6/6:c.*284G>A:		rs3810686	0.3674	0.0000	0,0,0	0,0,0,0,0	0.3293							300427 [NLGN4X (provisional) Autism susceptibility,X-linked 2,300495|Asperger syndrome susceptibility,X-linked 2,300497|Mental retardation,X-linked,300495];				132	60					NLGN4X (inh=n/a pLI=0.93)
chrX	10588431	10588431	C	A	hom	anno_omim	QUAL=13531;DP=281;AF=0.97;MQM=59;TRIO=HOM,281,0.97,HET,441,0.51,WT,236,0.00	MID1	5'UTR,intron	MID1:ENST00000317552:5'UTR:MODIFIER:exon1/10:c.-158G>T:,MID1:ENST00000380785:5'UTR:MODIFIER:exon2/11:c.-158G>T:,MID1:ENST00000380782:5'UTR:MODIFIER:exon1/10:c.-158G>T:,MID1:ENST00000453318:intron:MODIFIER:exon1/9:c.-56-52788G>T:,MID1:ENST00000380787:intron:MODIFIER:exon1/9:c.-56-52788G>T:		rs147326498	0.0037	0.0000	0,0,0	0,0,0,0,0	0.0135							300552 [MID1 (confirmed) Opitz GBBB syndrome,type I,300000];				6	1					MID1 (inh=XLR pLI=0.50)
chrX	12725042	12725042	C	T	hom	low_QUAL;low_DP;anno_omim	QUAL=20;DP=11;AF=0.45;MQM=57;TRIO=HOM,11,0.45,WT,16,0.13,WT,13,0.15	FRMPD4	splice_region&intron	FRMPD4:ENST00000380682:splice_region&intron:LOW:exon12/16:c.1287+8C>T:	(T)n	rs201309783	0.0000	0.1156	0,0,0	0.1436,0.1396,0.0920,0.1047,0.1118	0.1625							300838 [FRMPD4 (provisional) Mental retardation,X-linked 104,300983];				9	186					FRMPD4 (inh=XLR pLI=1.00)
chrX	12739294	12739294	A	G	hom	anno_omim	QUAL=8278;DP=167;AF=0.99;MQM=59;TRIO=HOM,167,0.99,HET,284,0.45,WT,188,0.01	FRMPD4	3'UTR	FRMPD4:ENST00000380682:3'UTR:MODIFIER:exon17/17:c.*642A>G:		rs3827468	0.2662	0.0000	0,0,0	0,0,0,0,0	0.3346							300838 [FRMPD4 (provisional) Mental retardation,X-linked 104,300983];				372	305					FRMPD4 (inh=XLR pLI=1.00)
chrX	12739359	12739359	G	C	hom	anno_omim	QUAL=7871;DP=146;AF=0.99;MQM=59;TRIO=HOM,146,0.99,HET,314,0.45,WT,184,0.00	FRMPD4	3'UTR	FRMPD4:ENST00000380682:3'UTR:MODIFIER:exon17/17:c.*707G>C:		rs5979716	0.0885	0.0000	0,0,0	0,0,0,0,0	0.0937							300838 [FRMPD4 (provisional) Mental retardation,X-linked 104,300983];				42	38					FRMPD4 (inh=XLR pLI=1.00)
chrX	12740371	12740371	A	G	hom	anno_omim	QUAL=6742;DP=118;AF=0.99;MQM=60;TRIO=HOM,118,0.99,HOM,93,1.00,WT,55,0.00	FRMPD4	3'UTR	FRMPD4:ENST00000380682:3'UTR:MODIFIER:exon17/17:c.*1719A>G:	GA-rich	rs5978572	0.5089	0.0000	0,0,0	0,0,0,0,0	0.4295							300838 [FRMPD4 (provisional) Mental retardation,X-linked 104,300983];				99	51					FRMPD4 (inh=XLR pLI=1.00)
chrX	12741502	12741502	T	G	hom	anno_omim	QUAL=13505;DP=175;AF=0.99;MQM=59;TRIO=HOM,175,0.99,HOM,249,1.00,WT,184,0.01	FRMPD4	3'UTR	FRMPD4:ENST00000380682:3'UTR:MODIFIER:exon17/17:c.*2850T>G:		rs5979717	0.6310	0.0000	0,0,0	0,0,0,0,0	0.6230							300838 [FRMPD4 (provisional) Mental retardation,X-linked 104,300983];				96	32					FRMPD4 (inh=XLR pLI=1.00)
chrX	13752895	13752895	G	T	hom	anno_omim	QUAL=3278;DP=93;AF=1.00;MQM=59;TRIO=HOM,93,1.00,HET,82,0.40,WT,57,0.02	OFD1	5'UTR	OFD1:ENST00000340096:5'UTR:MODIFIER:exon1/23:c.-296G>T:,OFD1:ENST00000380550:5'UTR:MODIFIER:exon1/22:c.-296G>T:,OFD1:ENST00000398395:5'UTR:MODIFIER:exon1/11:c.-296G>T:,OFD1:ENST00000380567:5'UTR:MODIFIER:exon1/24:c.-841G>T:		rs2285635	0.3767	0.0000	0,0,0	0,0,0,0,0	0.2682							300170 [OFD1 (confirmed) Orofaciodigital syndrome I,311200|Simpson-Golabi-Behmel syndrome,type 2,300209|Joubert syndrome 10,300804|Retinitis pigmentosa 23,300424];	RCV000034056.2 [benign]; 			64	41					OFD1 (inh=XLR+XLD pLI=0.98)
chrX	14868806	14868806	A	G	hom	low_DP;anno_omim	QUAL=75;DP=3;AF=1.00;MQM=60;TRIO=HOM,3,1.00,HET,2,0.50,WT,1,0.00	FANCB	splice_region&intron	FANCB:ENST00000324138:splice_region&intron:LOW:exon5/8:c.1327-10T>C:,FANCB:ENST00000398334:splice_region&intron:LOW:exon6/9:c.1327-10T>C:		rs2905223	0.4336	0.5638	6784,4686,666	0.5197,0.4775,0.2185,0.6487,0.4662	0.5374							300515 [FANCB (confirmed) Fanconi anemia,complementation group B,300514];	RCV000079364.5 [benign]; RCV000348663.1 [benign]; RCV000394031.1 [benign]; 			1070	513					FANCB (inh=XLR pLI=0.99)
chrX	14887147	14887147	C	G	hom	anno_omim	QUAL=8719;DP=175;AF=0.99;MQM=60;TRIO=HOM,175,0.99,HET,236,0.47,WT,164,0.00	FANCB	5'UTR,intron	FANCB:ENST00000398334:5'UTR:MODIFIER:exon2/10:c.-173G>C:,FANCB:ENST00000324138:intron:MODIFIER:exon1/8:c.-70-3445G>C:		rs2188383	0.5256	0.0000	0,0,0	0,0,0,0,0	0.6323							300515 [FANCB (confirmed) Fanconi anemia,complementation group B,300514];	RCV000268796.1 [benign]; RCV000364217.1 [benign]; 			173	48					FANCB (inh=XLR pLI=0.99)
chrX	15337614	15337614	T	C	hom	anno_omim	QUAL=2299;DP=63;AF=1.00;MQM=60;TRIO=HOM,63,1.00,HET,40,0.40,WT,32,0.00	PIGA	3'UTR	PIGA:ENST00000333590:3'UTR:MODIFIER:exon6/6:c.*2014A>G:,PIGA:ENST00000542278:3'UTR:MODIFIER:exon5/5:c.*2014A>G:,PIGA:ENST00000428964:3'UTR:MODIFIER:exon6/6:c.*2014A>G:		rs3434	0.3608	0.0000	0,0,0	0,0,0,0,0	0.3490							311770 [PIGA (provisional) Paroxysmal nocturnal hemoglobinuria,somatic,300818|Multiple congenital anomalies-hypotonia-seizures syndrome 2,300868];				114	48					PIGA (inh=XLR pLI=0.92)
chrX	15337849	15337849	-	A	hom	anno_omim	QUAL=5572;DP=92;AF=0.97;MQM=60;TRIO=HOM,92,0.97,HOM,86,1.00,WT,57,0.00	PIGA	3'UTR	PIGA:ENST00000333590:3'UTR:MODIFIER:exon6/6:c.*1778dupT:,PIGA:ENST00000542278:3'UTR:MODIFIER:exon5/5:c.*1778dupT:,PIGA:ENST00000428964:3'UTR:MODIFIER:exon6/6:c.*1778dupT:		rs397950456	0.5783	0.0000	0,0,0	0,0,0,0,0	0.5419							311770 [PIGA (provisional) Paroxysmal nocturnal hemoglobinuria,somatic,300818|Multiple congenital anomalies-hypotonia-seizures syndrome 2,300868];				141	50					PIGA (inh=XLR pLI=0.92)
chrX	15337882	15337882	A	T	hom	anno_omim	QUAL=5005;DP=124;AF=1.00;MQM=59;TRIO=HOM,124,1.00,HET,81,0.48,WT,54,0.00	PIGA	3'UTR	PIGA:ENST00000333590:3'UTR:MODIFIER:exon6/6:c.*1746T>A:,PIGA:ENST00000542278:3'UTR:MODIFIER:exon5/5:c.*1746T>A:,PIGA:ENST00000428964:3'UTR:MODIFIER:exon6/6:c.*1746T>A:		rs3087965	0.3793	0.0000	0,0,0	0,0,0,0,0	0.3585							311770 [PIGA (provisional) Paroxysmal nocturnal hemoglobinuria,somatic,300818|Multiple congenital anomalies-hypotonia-seizures syndrome 2,300868];				115	46					PIGA (inh=XLR pLI=0.92)
chrX	15338002	15338002	A	G	hom	anno_omim	QUAL=4585;DP=111;AF=0.99;MQM=59;TRIO=HOM,111,0.99,HET,81,0.44,WT,61,0.00	PIGA	3'UTR	PIGA:ENST00000333590:3'UTR:MODIFIER:exon6/6:c.*1626T>C:,PIGA:ENST00000542278:3'UTR:MODIFIER:exon5/5:c.*1626T>C:,PIGA:ENST00000428964:3'UTR:MODIFIER:exon6/6:c.*1626T>C:		rs3661	0.4146	0.0000	0,0,0	0,0,0,0,0	0.3851							311770 [PIGA (provisional) Paroxysmal nocturnal hemoglobinuria,somatic,300818|Multiple congenital anomalies-hypotonia-seizures syndrome 2,300868];				116	46					PIGA (inh=XLR pLI=0.92)
chrX	15844899	15844899	A	-	hom	anno_omim	QUAL=666;DP=48;AF=0.58;MQM=59;TRIO=HOM,48,0.58,HOM,26,0.50,WT,7,0.00	AP1S2	3'UTR	AP1S2:ENST00000329235:3'UTR:MODIFIER:exon5/5:c.*549delT:		rs201939651	0.0000	0.0000	0,0,0	0,0,0,0,0	0.2449							300629 [AP1S2 (confirmed) Mental retardation,X-linked syndromic 5,304340];				62	37					AP1S2 (inh=n/a pLI=0.79)
chrX	17753436	17753436	A	T	hom	anno_omim	QUAL=18798;DP=182;AF=1.00;MQM=60;TRIO=HOM,182,1.00,HOM,225,1.00,HOM,167,1.00	NHS	3'UTR	NHS:ENST00000380060:3'UTR:MODIFIER:exon8/8:c.*2852A>T:,NHS:ENST00000398097:3'UTR:MODIFIER:exon9/9:c.*2852A>T:		rs5909331	1.0000	0.0000	0,0,0	0,0,0,0,0	1.0000							300457 [NHS (confirmed) Nance-Horan syndrome,302350|Cataract 40,X-linked,302200];				337	0					NHS (inh=XLD pLI=1.00)
chrX	21392713	21392715	GCA	-	hom	low_DP	QUAL=3726;DP=4;AF=0.25;MQM=59;TRIO=HOM,4,0.25,HET,192,0.53,HOM,124,0.94	CNKSR2	5'UTR	CNKSR2:ENST00000543067:5'UTR:MODIFIER:exon1/20:c.-268_-266delAGC:,CNKSR2:ENST00000425654:5'UTR:MODIFIER:exon1/21:c.-268_-266delAGC:,CNKSR2:ENST00000279451:5'UTR:MODIFIER:exon1/21:c.-268_-266delAGC:	(GCA)n	rs3217648	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1999											14	6					CNKSR2 (inh=XLR+XLD pLI=1.00)
chrX	21672413	21672413	C	A	het		QUAL=948;DP=104;AF=0.55;MQM=51;TRIO=HET,104,0.55,HET,27,0.37,HET,23,0.17	CNKSR2	3'UTR	CNKSR2:ENST00000379510:3'UTR:MODIFIER:exon22/22:c.*1774C>A:,CNKSR2:ENST00000425654:3'UTR:MODIFIER:exon21/21:c.*1774C>A:	(A)n	rs202179371	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1334										COSN200730	0	91					CNKSR2 (inh=XLR+XLD pLI=1.00)
chrX	21861434	21861434	A	G	hom	anno_omim	QUAL=11502;DP=96;AF=1.00;MQM=60;TRIO=HOM,96,1.00,HET,250,0.50,HOM,167,1.00	MBTPS2	splice_region&synonymous	MBTPS2:ENST00000379484:splice_region&synonymous:LOW:exon2/11:c.222A>G:p.Gln74Gln,MBTPS2:ENST00000365779:splice_region&synonymous:LOW:exon2/7:c.222A>G:p.Gln74Gln		rs3213451	0.4577	0.4214	5335,2120,750	0.4732,0.5460,0.6095,0.3818,0.3175	0.4286							300294 [MBTPS2 (provisional) IFAP syndrome with or without BRESHECK syndrome,308205|Keratosis follicularis spinulosa decalvans,X-linked,308800|Olmsted syndrome,X-linked,300918];	RCV000081783.4 [benign]; 		COSM3759449, COSM3759448	668	431					MBTPS2 (inh=XLR pLI=0.94)
chrX	21901903	21901903	G	A	hom	anno_omim	QUAL=13902;DP=162;AF=0.99;MQM=59;TRIO=HOM,162,0.99,HET,251,0.53,HOM,166,0.99	MBTPS2	3'UTR	MBTPS2:ENST00000379484:3'UTR:MODIFIER:exon11/11:c.*1130G>A:		rs5951476	0.4281	0.0000	0,0,0	0,0,0,0,0	0.4053							300294 [MBTPS2 (provisional) IFAP syndrome with or without BRESHECK syndrome,308205|Keratosis follicularis spinulosa decalvans,X-linked,308800|Olmsted syndrome,X-linked,300918];				116	55					MBTPS2 (inh=XLR pLI=0.94)
chrX	23412685	23412685	T	C	hom	anno_omim	QUAL=8760;DP=119;AF=1.00;MQM=59;TRIO=HOM,119,1.00,HET,121,0.53,HOM,103,1.00	PTCHD1	3'UTR	PTCHD1:ENST00000379361:3'UTR:MODIFIER:exon3/3:c.*383T>C:		rs5926307	0.5513	0.0000	0,0,0	0,0,0,0,0	0.5094							300828 [PTCHD1 (provisional) Autism,susceptibility to,X-linked 4,300830];				96	55					PTCHD1 (inh=XLR pLI=0.95)
chrX	23412936	23412936	T	C	hom	anno_omim	QUAL=17721;DP=213;AF=0.99;MQM=60;TRIO=HOM,213,0.99,HET,310,0.56,HOM,201,0.98	PTCHD1	3'UTR	PTCHD1:ENST00000379361:3'UTR:MODIFIER:exon3/3:c.*634T>C:		rs1317583	0.6302	0.0000	0,0,0	0,0,0,0,0	0.5841							300828 [PTCHD1 (provisional) Autism,susceptibility to,X-linked 4,300830];				98	55					PTCHD1 (inh=XLR pLI=0.95)
chrX	24073761	24073761	C	T	hom	anno_omim	QUAL=14974;DP=181;AF=0.99;MQM=59;TRIO=HOM,181,0.99,HOM,207,1.00,HOM,126,1.00	EIF2S3	synonymous	EIF2S3:ENST00000253039:synonymous:LOW:exon2/12:c.99C>T:p.His33His		rs36018672	0.3632	0.5496	9349,6732,120	0.1692,0.6157,0.4079,0.6770,0.2393	0.5664	0.0700					17.12	300161 [EIF2S3 (provisional) Mental retardation,X-linked,syndromic,Borck type,300987];	RCV000116975.2 [likely benign]; 		COSM3759453, COSM3759454	961	324					EIF2S3 (inh=n/a pLI=0.92)
chrX	24095043	24095043	C	T	hom	anno_omim	QUAL=4759;DP=112;AF=0.79;MQM=57;TRIO=HOM,112,0.79,HOM,56,0.91,HOM,36,0.75	EIF2S3	3'UTR	EIF2S3:ENST00000253039:3'UTR:MODIFIER:exon12/12:c.*141C>T:	(T)n	rs5949273	0.3650	0.0000	0,0,0	0,0,0,0,0	0.6235							300161 [EIF2S3 (provisional) Mental retardation,X-linked,syndromic,Borck type,300987];				150	80					EIF2S3 (inh=n/a pLI=0.92)
chrX	25022104	25022104	T	-	hom	anno_omim	QUAL=405;DP=45;AF=0.58;MQM=59;TRIO=HOM,45,0.58,HOM,72,0.43,WT,51,0.22	ARX	3'UTR	ARX:ENST00000379044:3'UTR:MODIFIER:exon5/5:c.*683delA:	(T)n	rs67950419	0.4731	0.0000	0,0,0	0,0,0,0,0	0.4106							300382 [ARX (confirmed) Epileptic encephalopathy,early infantile,1,308350|Lissencephaly,X-linked 2,300215|Mental retardation,X-linked 29 and others,300419|Proud syndrome,300004|Partington syndrome,309510|Hydranencephaly with abnormal genitalia,300215];				62	49					ARX (inh=XLR pLI=0.75)
chrX	28807442	28807442	G	A	hom	anno_omim	QUAL=7681;DP=86;AF=0.99;MQM=60;TRIO=HOM,86,0.99,HOM,85,1.00,HOM,67,1.00	IL1RAPL1	5'UTR	IL1RAPL1:ENST00000378993:5'UTR:MODIFIER:exon2/11:c.-19G>A:		rs6526806	0.7351	0.6013	10243,3559,2751	0.9143,0.6185,0.8412,0.5143,0.6277	0.6165							300206 [IL1RAPL1 (confirmed) Mental retardation,X-linked 21/34,300143];	RCV000289385.1 [benign]; RCV000382997.1 [benign]; 			1082	372					IL1RAPL1 (inh=XLR pLI=1.00)
chrX	30686141	30686141	G	A	hom	anno_omim	QUAL=5724;DP=131;AF=0.98;MQM=57;TRIO=HOM,131,0.98,HET,113,0.52,WT,94,0.00	GK	synonymous,5'UTR	GK:ENST00000378943:synonymous:LOW:exon3/20:c.165G>A:p.Gln55Gln,GK:ENST00000378946:synonymous:LOW:exon3/20:c.165G>A:p.Gln55Gln,GK:ENST00000378945:synonymous:LOW:exon3/19:c.165G>A:p.Gln55Gln,GK:ENST00000378941:synonymous:LOW:exon3/5:c.165G>A:p.Gln55Gln,GK:ENST00000427190:5'UTR:MODIFIER:exon3/22:c.-616G>A:		rs34795481	0.0313	0.0524	91,78,1	0.0101,0.0293,0.0003,0.0769,0.0228	0.0545							300474 [GK (confirmed) Glycerol kinase deficiency,307030];				96	94					GK (inh=XLR+XLD pLI=0.90)
chrX	30747199	30747199	C	T	hom	low_MQM;anno_omim	QUAL=5585;DP=148;AF=0.99;MQM=37;TRIO=HOM,148,0.99,HET,161,0.44,WT,107,0.00	GK	3'UTR	GK:ENST00000378943:3'UTR:MODIFIER:exon20/20:c.*340C>T:,GK:ENST00000378946:3'UTR:MODIFIER:exon20/20:c.*340C>T:,GK:ENST00000378945:3'UTR:MODIFIER:exon19/19:c.*340C>T:,GK:ENST00000427190:3'UTR:MODIFIER:exon22/22:c.*340C>T:		rs3931219	0.0318	0.0000	0,0,0	0,0,0,0,0	0.0539							300474 [GK (confirmed) Glycerol kinase deficiency,307030];				18	14					GK (inh=XLR+XLD pLI=0.90)
chrX	30749081	30749081	T	C	hom	anno_omim	QUAL=23152;DP=232;AF=1.00;MQM=60;TRIO=HOM,232,1.00,HOM,287,1.00,HOM,187,1.00	GK,TAB3	intergenic_region	TAB3:ENSG00000198814-ENSG00000157625:intergenic_region:MODIFIER::n.30749081T>C:		rs2170611	0.8011	0.0000	0,0,0	0,0,0,0,0	0.7824							300474 [GK (confirmed) Glycerol kinase deficiency,307030];				108	22					GK (inh=XLR+XLD pLI=0.90), TAB3 (inh=n/a pLI=0.92)
chrX	30749142	30749142	T	G	hom	anno_omim	QUAL=21663;DP=175;AF=0.99;MQM=60;TRIO=HOM,175,0.99,HOM,303,1.00,HOM,184,1.00	GK,TAB3	intergenic_region	TAB3:ENSG00000198814-ENSG00000157625:intergenic_region:MODIFIER::n.30749142T>G:		rs5927599	0.7581	0.0000	0,0,0	0,0,0,0,0	0.7471							300474 [GK (confirmed) Glycerol kinase deficiency,307030];				108	22					GK (inh=XLR+XLD pLI=0.90), TAB3 (inh=n/a pLI=0.92)
chrX	31138589	31138589	T	C	hom	anno_omim	QUAL=9228;DP=153;AF=0.99;MQM=60;TRIO=HOM,153,0.99,HET,114,0.58,HOM,75,1.00	DMD	3'UTR	DMD:ENST00000357033:3'UTR:MODIFIER:exon79/79:c.*1447A>G:,DMD:ENST00000378723:3'UTR:MODIFIER:exon17/17:c.*1361A>G:,DMD:ENST00000343523:3'UTR:MODIFIER:exon31/31:c.*1361A>G:,DMD:ENST00000359836:3'UTR:MODIFIER:exon34/34:c.*1361A>G:,DMD:ENST00000378707:3'UTR:MODIFIER:exon36/36:c.*1447A>G:,DMD:ENST00000541735:3'UTR:MODIFIER:exon32/32:c.*1447A>G:,DMD:ENST00000378677:3'UTR:MODIFIER:exon79/79:c.*1447A>G:		rs3361	0.3542	0.0000	0,0,0	0,0,0,0,0	0.3418							300377 [DMD (confirmed) Duchenne muscular dystrophy,310200|Becker muscular dystrophy,300376|Cardiomyopathy,dilated,3B,302045];	RCV000287236.1 [likely benign]; 			54	49					DMD (inh=XLR pLI=1.00)
chrX	31496350	31496350	C	T	hom	anno_omim	QUAL=9207;DP=116;AF=1.00;MQM=60;TRIO=HOM,116,1.00,HOM,96,1.00,HOM,77,1.00	DMD	missense	DMD:ENST00000357033:missense:MODERATE:exon59/79:c.8810G>A:p.Arg2937Gln,DMD:ENST00000343523:missense:MODERATE:exon16/31:c.1430G>A:p.Arg477Gln,DMD:ENST00000359836:missense:MODERATE:exon16/34:c.1430G>A:p.Arg477Gln,DMD:ENST00000378707:missense:MODERATE:exon16/36:c.1430G>A:p.Arg477Gln,DMD:ENST00000541735:missense:MODERATE:exon16/32:c.1430G>A:p.Arg477Gln,DMD:ENST00000378677:missense:MODERATE:exon59/79:c.8798G>A:p.Arg2933Gln,DMD:ENST00000474231:missense:MODERATE:exon16/35:c.1430G>A:p.Arg477Gln		rs1800280	0.8819	0.9045	22571,13029,3238	0.9888,0.7877,0.9234,0.9459,0.7103	0.9524	0.8710	T,T,T,T,T,T,T,T,T,T,T,T,T	T	B,B,B,B,B,B,B,B,B	T,T,T,T,T,T,T,T	17.10	300377 [DMD (confirmed) Duchenne muscular dystrophy,310200|Becker muscular dystrophy,300376|Cardiomyopathy,dilated,3B,302045];	RCV000152765.5 [benign]; 			2153	106	2	[2] old entry - no details available			DMD (inh=XLR pLI=1.00)
chrX	31697636	31697636	A	G	hom	anno_omim	QUAL=9151;DP=87;AF=0.99;MQM=60;TRIO=HOM,87,0.99,HET,172,0.49,HOM,131,0.99	DMD	synonymous	DMD:ENST00000357033:synonymous:LOW:exon53/79:c.7728T>C:p.Asn2576Asn,DMD:ENST00000343523:synonymous:LOW:exon10/31:c.348T>C:p.Asn116Asn,DMD:ENST00000359836:synonymous:LOW:exon10/34:c.348T>C:p.Asn116Asn,DMD:ENST00000378707:synonymous:LOW:exon10/36:c.348T>C:p.Asn116Asn,DMD:ENST00000541735:synonymous:LOW:exon10/32:c.348T>C:p.Asn116Asn,DMD:ENST00000378677:synonymous:LOW:exon53/79:c.7716T>C:p.Asn2572Asn,DMD:ENST00000474231:synonymous:LOW:exon10/35:c.348T>C:p.Asn116Asn		rs1801188	0.1812	0.1713	915,514,34	0.1012,0.0759,0.3561,0.1871,0.1391	0.1693	1.0650					7.02	300377 [DMD (confirmed) Duchenne muscular dystrophy,310200|Becker muscular dystrophy,300376|Cardiomyopathy,dilated,3B,302045];	RCV000080769.8 [benign]; RCV000252250.1 [benign]; RCV000382472.1 [likely benign]; 		COSM3759470, COSM3759467, COSM3759469, COSM3759468, COSM3759471	338	279					DMD (inh=XLR pLI=1.00)
chrX	31893307	31893307	T	G	hom	pred_pathogenic;anno_omim	QUAL=3434;DP=64;AF=0.98;MQM=60;TRIO=HOM,64,0.98,HET,118,0.50,WT,68,0.00	DMD	missense&splice_region,splice_region,5'UTR	DMD:ENST00000357033:missense&splice_region:MODERATE:exon48/79:c.7096A>C:p.Lys2366Gln,DMD:ENST00000378677:missense&splice_region:MODERATE:exon48/79:c.7084A>C:p.Lys2362Gln,DMD:ENST00000343523:splice_region:LOW:exon5/31:c.-285A>C:,DMD:ENST00000359836:splice_region:LOW:exon5/34:c.-285A>C:,DMD:ENST00000378707:splice_region:LOW:exon5/36:c.-285A>C:,DMD:ENST00000541735:splice_region:LOW:exon5/32:c.-285A>C:,DMD:ENST00000474231:splice_region:LOW:exon5/35:c.-285A>C:,DMD:ENST00000343523:5'UTR:MODIFIER:exon5/31:c.-285A>C:,DMD:ENST00000359836:5'UTR:MODIFIER:exon5/34:c.-285A>C:,DMD:ENST00000378707:5'UTR:MODIFIER:exon5/36:c.-285A>C:,DMD:ENST00000541735:5'UTR:MODIFIER:exon5/32:c.-285A>C:,DMD:ENST00000474231:5'UTR:MODIFIER:exon5/35:c.-285A>C:		rs1800275	0.1833	0.2781	1898,640,111	0.2023,0.5924,0.1232,0.2685,0.1754	0.2342	2.4550	T,T,T,T,T,T,T,T,.	T,.	D,D,D,D,D,.	T,T,T,.	15.62	300377 [DMD (confirmed) Duchenne muscular dystrophy,310200|Becker muscular dystrophy,300376|Cardiomyopathy,dilated,3B,302045];	RCV000152810.3 [benign]; 		COSM3759475, COSM3759474, COSM3759473, COSM3759472	338	301	1	[1] auto-classification 16.06.2016  [2] Ute Grasshoff 09.04.2015			DMD (inh=XLR pLI=1.00)
chrX	38547308	38547308	C	A	hom	anno_omim	QUAL=17599;DP=220;AF=0.99;MQM=60;TRIO=HOM,220,0.99,HOM,410,0.99,WT,297,0.00	TSPAN7	3'UTR	TSPAN7:ENST00000422612:3'UTR:MODIFIER:exon10/10:c.*123C>A:,TSPAN7:ENST00000378482:3'UTR:MODIFIER:exon8/8:c.*123C>A:,TSPAN7:ENST00000545599:3'UTR:MODIFIER:exon9/9:c.*123C>A:,TSPAN7:ENST00000286824:3'UTR:MODIFIER:exon9/9:c.*123C>A:		rs15765	0.7115	0.0000	0,0,0	0,0,0,0,0	0.6682							300096 [TSPAN7 (confirmed) Mental retardation,X-linked 58,300210];				197	44					TSPAN7 (inh=n/a pLI=0.87)
chrX	38547862	38547862	G	A	hom	anno_omim	QUAL=13506;DP=176;AF=0.99;MQM=60;TRIO=HOM,176,0.99,HOM,246,1.00,WT,168,0.01	TSPAN7	3'UTR	TSPAN7:ENST00000378482:3'UTR:MODIFIER:exon8/8:c.*677G>A:		rs10333	0.7229	0.0000	0,0,0	0,0,0,0,0	0.6806							300096 [TSPAN7 (confirmed) Mental retardation,X-linked 58,300210];				197	44					TSPAN7 (inh=n/a pLI=0.87)
chrX	38548083	38548083	G	A	hom	anno_omim	QUAL=6009;DP=130;AF=0.97;MQM=60;TRIO=HOM,130,0.97,HOM,58,1.00,WT,48,0.00	TSPAN7	3'UTR	TSPAN7:ENST00000378482:3'UTR:MODIFIER:exon8/8:c.*898G>A:		rs3269	0.7200	0.0000	0,0,0	0,0,0,0,0	0.6782							300096 [TSPAN7 (confirmed) Mental retardation,X-linked 58,300210];				197	44					TSPAN7 (inh=n/a pLI=0.87)
chrX	39911629	39911629	C	T	hom	anno_omim	QUAL=8966;DP=212;AF=0.98;MQM=60;TRIO=HOM,212,0.98,HET,199,0.50,WT,138,0.00	BCOR	synonymous	BCOR:ENST00000378444:synonymous:LOW:exon15/15:c.5001G>A:p.Ser1667Ser,BCOR:ENST00000378463:synonymous:LOW:exon10/11:c.1530G>A:p.Ser510Ser,BCOR:ENST00000397354:synonymous:LOW:exon15/15:c.4899G>A:p.Ser1633Ser,BCOR:ENST00000378455:synonymous:LOW:exon14/14:c.4845G>A:p.Ser1615Ser,BCOR:ENST00000342274:synonymous:LOW:exon15/15:c.4899G>A:p.Ser1633Ser		rs375878497	0.0000	0.0001	0,0,0	0.0000,0.0001,0.0000,0.0001,0.0002	0.0001	-1.5110		T			7.58	300485 [BCOR (confirmed) Microphthalmia,syndromic 2,300166];				1	1					BCOR (inh=XLD pLI=1.00)
chrX	39933339	39933339	A	G	hom	anno_omim	QUAL=15685;DP=115;AF=1.00;MQM=60;TRIO=HOM,115,1.00,HOM,237,1.00,HOM,145,0.98	BCOR	synonymous	BCOR:ENST00000378444:synonymous:LOW:exon4/15:c.1260T>C:p.Asp420Asp,BCOR:ENST00000397354:synonymous:LOW:exon4/15:c.1260T>C:p.Asp420Asp,BCOR:ENST00000378455:synonymous:LOW:exon4/14:c.1260T>C:p.Asp420Asp,BCOR:ENST00000342274:synonymous:LOW:exon4/15:c.1260T>C:p.Asp420Asp		rs5917933	0.9030	0.8953	22091,11549,2805	0.9219,0.9583,0.9744,0.8889,0.7707	0.9153							300485 [BCOR (confirmed) Microphthalmia,syndromic 2,300166];	RCV000081809.8 [other]; 		COSM4156839, COSM4156840	1932	229					BCOR (inh=XLD pLI=1.00)
chrX	43571197	43571197	A	C	hom	anno_omim	QUAL=7055;DP=143;AF=0.99;MQM=60;TRIO=HOM,143,0.99,HET,205,0.50,WT,150,0.00	MAOA	synonymous,5'UTR	MAOA:ENST00000338702:synonymous:LOW:exon4/15:c.385A>C:p.Arg129Arg,MAOA:ENST00000542639:5'UTR:MODIFIER:exon5/16:c.-15A>C:		rs1800464	0.1571	0.0785	843,21,816	0.4951,0.0346,0.0002,0.0421,0.0220	0.1581							309850 [MAOA (confirmed) Brunner syndrome,300615|Antisocial behavior,300615];	RCV000117593.3 [other]; 			86	111					MAOA (inh=n/a pLI=0.99)
chrX	43591036	43591036	G	T	hom	anno_omim	QUAL=20763;DP=194;AF=0.99;MQM=60;TRIO=HOM,194,0.99,HOM,291,1.00,HOM,169,0.99	MAOA	synonymous	MAOA:ENST00000338702:synonymous:LOW:exon8/15:c.891G>T:p.Arg297Arg,MAOA:ENST00000542639:synonymous:LOW:exon9/16:c.492G>T:p.Arg164Arg		rs6323	0.6249	0.6529	12444,7177,2388	0.8504,0.6683,0.4411,0.7008,0.3982	0.7196							309850 [MAOA (confirmed) Brunner syndrome,300615|Antisocial behavior,300615];	RCV000078415.8 [other]; 		COSM4156846	1452	400					MAOA (inh=n/a pLI=0.99)
chrX	43603391	43603391	T	C	hom	anno_omim	QUAL=27885;DP=320;AF=1.00;MQM=59;TRIO=HOM,320,1.00,HOM,293,1.00,HOM,229,1.00	MAOA	synonymous	MAOA:ENST00000338702:synonymous:LOW:exon14/15:c.1410T>C:p.Asp470Asp,MAOA:ENST00000542639:synonymous:LOW:exon15/16:c.1011T>C:p.Asp337Asp		rs1137070	0.5518	0.6260	10989,7170,1286	0.6271,0.5964,0.4413,0.7036,0.3999	0.6522							309850 [MAOA (confirmed) Brunner syndrome,300615|Antisocial behavior,300615];	RCV000078414.8 [other]; 			1443	405					MAOA (inh=n/a pLI=0.99)
chrX	43604841	43604841	A	G	hom	anno_omim	QUAL=6805;DP=126;AF=1.00;MQM=60;TRIO=HOM,126,1.00,HOM,41,1.00,HOM,34,1.00	MAOA	3'UTR	MAOA:ENST00000338702:3'UTR:MODIFIER:exon15/15:c.*1081A>G:		rs3027407	0.5510	0.0000	0,0,0	0,0,0,0,0	0.6553							309850 [MAOA (confirmed) Brunner syndrome,300615|Antisocial behavior,300615];				336	79					MAOA (inh=n/a pLI=0.99)
chrX	43605100	43605100	A	-	hom	anno_omim	QUAL=4913;DP=138;AF=0.99;MQM=59;TRIO=HOM,138,0.99,HET,61,0.46,WT,50,0.00	MAOA	3'UTR	MAOA:ENST00000338702:3'UTR:MODIFIER:exon15/15:c.*1341delA:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							309850 [MAOA (confirmed) Brunner syndrome,300615|Antisocial behavior,300615];				1	1					MAOA (inh=n/a pLI=0.99)
chrX	43818002	43818002	C	A	hom	anno_omim	QUAL=17680;DP=403;AF=0.99;MQM=60;TRIO=HOM,403,0.99,HET,388,0.50,WT,210,0.00	NDP,NDP-AS1	5'UTR,intron	NDP:ENST00000378062:5'UTR:MODIFIER:exon2/3:c.-111G>T:,NDP-AS1:ENST00000435093:intron:MODIFIER:exon3/4:n.467-2029C>A:		rs45501198	0.0132	0.0000	0,0,0	0,0,0,0,0	0.0143							300658 [NDP (confirmed) Norrie disease,310600|Exudative vitreoretinopathy 2,X-linked,305390];				9	7					NDP (inh=XLR pLI=0.64), NDP-AS1 (inh=n/a pLI=n/a)
chrX	44938563	44938563	G	A	hom	pred_pathogenic;anno_omim	QUAL=4296;DP=95;AF=1.00;MQM=60;TRIO=HOM,95,1.00,HET,139,0.41,WT,93,0.00	KDM6A	synonymous	KDM6A:ENST00000382899:synonymous:LOW:exon20/29:c.3132G>A:p.Gln1044Gln,KDM6A:ENST00000377967:synonymous:LOW:exon20/29:c.3111G>A:p.Gln1037Gln,KDM6A:ENST00000536777:synonymous:LOW:exon19/28:c.2976G>A:p.Gln992Gln,KDM6A:ENST00000543216:synonymous:LOW:exon18/27:c.2874G>A:p.Gln958Gln		rs20539	0.2217	0.2384	2158,492,8	0.0319,0.5645,0.3342,0.1938,0.2740	0.2521	1.8190		T			4.68	300128 [KDM6A (provisional) Kabuki syndrome 2,300867];	RCV000146125.7 [benign]; 		COSM1179848	381	290					KDM6A (inh=XLD pLI=1.00)
chrX	47061018	47061018	C	G	hom	anno_omim	QUAL=16955;DP=87;AF=1.00;MQM=60;TRIO=HOM,87,1.00,HOM,279,1.00,HOM,175,1.00	UBA1	splice_region&intron	UBA1:ENST00000335972:splice_region&intron:LOW:exon8/25:c.811+9C>G:,UBA1:ENST00000377351:splice_region&intron:LOW:exon8/25:c.811+9C>G:		rs4239964	0.9711	0.9795	26029,14170,3253	0.9971,0.9938,0.9543,0.9855,0.9314	0.9881							314370 [UBA1 (confirmed) Spinal muscular atrophy,X-linked 2,infantile,301830];	RCV000317636.1 [benign]; 			2160	37					UBA1 (inh=XLR pLI=1.00)
chrX	47466361	47466361	A	G	hom	anno_omim	QUAL=21026;DP=176;AF=0.99;MQM=60;TRIO=HOM,176,0.99,HOM,311,1.00,HOM,180,1.00	SYN1	synonymous	SYN1:ENST00000295987:synonymous:LOW:exon3/13:c.510T>C:p.Asn170Asn,SYN1:ENST00000340666:synonymous:LOW:exon3/13:c.510T>C:p.Asn170Asn		rs1142636	0.3687	0.3808	4055,2291,610	0.4337,0.3990,0.2555,0.3924,0.3348	0.3974							313440 [SYN1 (confirmed) Epilepsy,X-linked,with variable learning disabilities and behavior disorders,300491];	RCV000082513.7 [other]; 			681	383					SYN1 (inh=XLR+XLD pLI=0.88)
chrX	48759204	48759204	C	T	hom	anno_omim	QUAL=9350;DP=56;AF=1.00;MQM=60;TRIO=HOM,56,1.00,HOM,256,0.99,WT,162,0.01	PQBP1	splice_region&intron	PQBP1:ENST00000218224:splice_region&intron:LOW:exon2/5:c.180-3C>T:,PQBP1:ENST00000376563:splice_region&intron:LOW:exon3/6:c.180-3C>T:,PQBP1:ENST00000376566:splice_region&intron:LOW:exon3/5:c.180-3C>T:,PQBP1:ENST00000447146:splice_region&intron:LOW:exon3/6:c.180-3C>T:,PQBP1:ENST00000247140:splice_region&intron:LOW:exon3/5:c.180-3C>T:,PQBP1:ENST00000396763:splice_region&intron:LOW:exon3/6:c.180-3C>T:		rs741932	0.6254	0.6124	10022,5244,980	0.5410,0.5226,0.7553,0.5996,0.7351	0.6059							300463 [PQBP1 (confirmed) Renpenning syndrome,309500];	RCV000081326.7 [other]; RCV000407634.1 [benign]; 			1193	416					PQBP1 (inh=XLR pLI=0.59)
chrX	49646968	49646968	G	A	het	anno_omim	QUAL=164;DP=27;AF=0.41;MQM=57;TRIO=HET,27,0.41,HET,4,0.25,WT,2,0.00	USP27X	3'UTR	USP27X:ENST00000508866:3'UTR:MODIFIER:exon1/1:c.*741G>A:	(A)n	rs199555442	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0623							300975 [USP27X (provisional) Mental retardation 105,300984];				5	22					USP27X (inh=n/a pLI=0.59)
chrX	50334695	50334698	TTTC	-	hom	low_DP;low_MQM;anno_omim	QUAL=255;DP=12;AF=0.75;MQM=46;TRIO=HOM,12,0.75,HOM,1,1.00,WT,2,0.00	SHROOM4	3'UTR	SHROOM4:ENST00000289292:3'UTR:MODIFIER:exon10/10:c.*1444_*1447delGAAA:,SHROOM4:ENST00000376020:3'UTR:MODIFIER:exon9/9:c.*4997_*5000delGAAA:	(TTTC)n	rs782605261	0.0000	0.1568	37,21,1	0.0000,0.0000,0.0000,0.2212,0.1205	0.2177							300579 [SHROOM4 (confirmed) Stocco dos Santos X-linked mental retardation syndrome,300434];				125	47					SHROOM4 (inh=XLD pLI=1.00)
chrX	53220836	53220836	G	T	hom	anno_omim	QUAL=18788;DP=173;AF=1.00;MQM=60;TRIO=HOM,173,1.00,HOM,238,1.00,HOM,157,1.00	KDM5C	3'UTR	KDM5C:ENST00000452825:3'UTR:MODIFIER:exon24/24:c.*1090C>A:		rs1886889	0.8072	0.0000	0,0,0	0,0,0,0,0	0.8918							314690 [KDM5C (confirmed) Mental retardation,X-linked,syndromic,Claes-Jensen type,300534];				321	6					KDM5C (inh=XLR pLI=1.00)
chrX	53221259	53221259	-	G	hom	anno_omim	QUAL=4903;DP=73;AF=0.99;MQM=59;TRIO=HOM,73,0.99,HOM,71,1.00,HOM,23,1.00	KDM5C	3'UTR	KDM5C:ENST00000452825:3'UTR:MODIFIER:exon24/24:c.*666dupC:	MIRb	rs66463350;rs75167298	0.7650	0.0000	0,0,0	0,0,0,0,0	0.8263							314690 [KDM5C (confirmed) Mental retardation,X-linked,syndromic,Claes-Jensen type,300534];				243	5					KDM5C (inh=XLR pLI=1.00)
chrX	53222043	53222043	-	C	het	low_DP;anno_omim	QUAL=121;DP=2;AF=0.50;MQM=60;TRIO=HET,2,0.50,HOM,6,0.33,HET,4,0.75	KDM5C	3'UTR,intron	KDM5C:ENST00000375401:3'UTR:MODIFIER:exon26/26:c.*105dupG:,KDM5C:ENST00000404049:3'UTR:MODIFIER:exon26/26:c.*105dupG:,KDM5C:ENST00000452825:intron:MODIFIER:exon23/23:c.4047-25dupG:		rs146836963;rs150558161	0.7759	0.9040	6720,4012,257	0.5878,0.9027,0.8376,0.9542,0.9736	0.8850							314690 [KDM5C (confirmed) Mental retardation,X-linked,syndromic,Claes-Jensen type,300534];				1991	48					KDM5C (inh=XLR pLI=1.00)
chrX	53449568	53449568	G	A	hom	anno_omim	QUAL=15947;DP=186;AF=0.98;MQM=60;TRIO=HOM,186,0.98,HOM,233,1.00,HOM,140,1.00	SMC1A	5'UTR_premature_start_codon_gain,5'UTR	SMC1A:ENST00000322213:5'UTR_premature_start_codon_gain:LOW:exon1/25:c.-19C>T:,SMC1A:ENST00000375340:5'UTR_premature_start_codon_gain:LOW:exon1/10:c.-19C>T:,SMC1A:ENST00000322213:5'UTR:MODIFIER:exon1/25:c.-19C>T:,SMC1A:ENST00000375340:5'UTR:MODIFIER:exon1/10:c.-19C>T:		rs1264011	0.3984	0.5163	7564,4983,34	0.0854,0.5215,0.5424,0.5895,0.4694	0.5241							300040 [SMC1A (provisional) Cornelia de Lange syndrome 2,300590];	RCV000081383.5 [benign]; RCV000260444.1 [benign]; 			1099	431					SMC1A (inh=XLR pLI=1.00)
chrX	53559668	53559668	C	A	hom	anno_omim	QUAL=9849;DP=118;AF=1.00;MQM=60;TRIO=HOM,118,1.00,HOM,195,1.00,WT,109,0.00	HUWE1	3'UTR	HUWE1:ENST00000262854:3'UTR:MODIFIER:exon84/84:c.*602G>T:,HUWE1:ENST00000342160:3'UTR:MODIFIER:exon83/83:c.*602G>T:		rs12836234	0.0570	0.0000	0,0,0	0,0,0,0,0	0.1035							300697 [HUWE1 (provisional) Mental retardation,X-linked syndromic,Turner type,300706];				15	18					HUWE1 (inh=XLR+XLD pLI=1.00)
chrX	53563589	53563589	A	G	hom	anno_omim	QUAL=19956;DP=160;AF=0.99;MQM=59;TRIO=HOM,160,0.99,HOM,316,1.00,HOM,170,1.00	HUWE1	synonymous	HUWE1:ENST00000262854:synonymous:LOW:exon79/84:c.12177T>C:p.Gly4059Gly,HUWE1:ENST00000342160:synonymous:LOW:exon78/83:c.12177T>C:p.Gly4059Gly		rs426298	0.9950	0.9973	26877,14624,3158	0.9767,0.9971,1.0000,0.9999,1.0000	0.9979	-0.3880		T			11.76	300697 [HUWE1 (provisional) Mental retardation,X-linked syndromic,Turner type,300706];	RCV000082281.7 [other]; 			2320	1	1	[1] Peter Bauer 07.08.2014			HUWE1 (inh=XLR+XLD pLI=1.00)
chrX	53641647	53641647	T	C	hom	anno_omim	QUAL=4778;DP=66;AF=1.00;MQM=60;TRIO=HOM,66,1.00,HOM,91,0.98,WT,70,0.01	HUWE1	synonymous	HUWE1:ENST00000262854:synonymous:LOW:exon23/84:c.2109A>G:p.Ser703Ser,HUWE1:ENST00000342160:synonymous:LOW:exon22/83:c.2109A>G:p.Ser703Ser,HUWE1:ENST00000218328:synonymous:LOW:exon23/41:c.2109A>G:p.Ser703Ser		rs6638360	0.3897	0.4896	6721,4208,32	0.0891,0.5146,0.5232,0.5425,0.4888	0.4966							300697 [HUWE1 (provisional) Mental retardation,X-linked syndromic,Turner type,300706];	RCV000117252.2 [likely benign]; 			1030	433					HUWE1 (inh=XLR+XLD pLI=1.00)
chrX	53713601	53713601	C	T	het	anno_omim	QUAL=39;DP=52;AF=0.25;MQM=60;TRIO=HET,52,0.25,WT,129,0.00,WT,81,0.00	HUWE1	5'UTR	HUWE1:ENST00000262854:5'UTR:MODIFIER:exon1/84:c.-330G>A:,HUWE1:ENST00000218328:5'UTR:MODIFIER:exon1/41:c.-330G>A:		rs5978184	0.1881	0.0000	0,0,0	0,0,0,0,0	0.1990							300697 [HUWE1 (provisional) Mental retardation,X-linked syndromic,Turner type,300706];				9	45					HUWE1 (inh=XLR+XLD pLI=1.00)
chrX	53713640	53713640	G	C	hom	anno_omim	QUAL=8807;DP=76;AF=1.00;MQM=59;TRIO=HOM,76,1.00,HOM,131,1.00,HOM,83,1.00	HUWE1	5'UTR	HUWE1:ENST00000262854:5'UTR:MODIFIER:exon1/84:c.-369C>G:,HUWE1:ENST00000218328:5'UTR:MODIFIER:exon1/41:c.-369C>G:		rs2333864	1.0000	0.0000	0,0,0	0,0,0,0,0	0.9264							300697 [HUWE1 (provisional) Mental retardation,X-linked syndromic,Turner type,300706];				189	22					HUWE1 (inh=XLR+XLD pLI=1.00)
chrX	66944120	66944120	A	-	hom	anno_omim	QUAL=2053;DP=48;AF=0.96;MQM=60;TRIO=HOM,48,0.96,HET,76,0.57,HET,69,0.17	AR	splice_region,3'UTR	AR:ENST00000396043:splice_region:LOW:exon8/8:c.*447delA:,AR:ENST00000374690:3'UTR:MODIFIER:exon8/8:c.*447delA:,AR:ENST00000396043:3'UTR:MODIFIER:exon8/8:c.*447delA:	A-rich	rs11351755	0.6805	0.0000	0,0,0	0,0,0,0,0	0.6844							313700 [AR (confirmed) Androgen insensitivity,300068|Spinal and bulbar muscular atrophy of Kennedy,313200|Androgen insensitivity,partial,with or without breast cancer,312300|Prostate cancer,susceptibility to,176807|Hypospadias 1,X-linked,300633];				221	25					AR (inh=n/a pLI=0.99)
chrX	66945740	66945740	T	C	hom	anno_omim	QUAL=23221;DP=172;AF=1.00;MQM=60;TRIO=HOM,172,1.00,HOM,342,1.00,HOM,194,1.00	AR	3'UTR	AR:ENST00000374690:3'UTR:MODIFIER:exon8/8:c.*2057T>C:		rs5919413	0.8593	0.0000	0,0,0	0,0,0,0,0	0.8724							313700 [AR (confirmed) Androgen insensitivity,300068|Spinal and bulbar muscular atrophy of Kennedy,313200|Androgen insensitivity,partial,with or without breast cancer,312300|Prostate cancer,susceptibility to,176807|Hypospadias 1,X-linked,300633];				152	0					AR (inh=n/a pLI=0.99)
chrX	66946851	66946851	T	C	hom	anno_omim	QUAL=15014;DP=177;AF=1.00;MQM=60;TRIO=HOM,177,1.00,HOM,189,1.00,HOM,110,1.00	AR	3'UTR	AR:ENST00000374690:3'UTR:MODIFIER:exon8/8:c.*3168T>C:		rs1931537	0.8593	0.0000	0,0,0	0,0,0,0,0	0.8704							313700 [AR (confirmed) Androgen insensitivity,300068|Spinal and bulbar muscular atrophy of Kennedy,313200|Androgen insensitivity,partial,with or without breast cancer,312300|Prostate cancer,susceptibility to,176807|Hypospadias 1,X-linked,300633];				152	0					AR (inh=n/a pLI=0.99)
chrX	66948019	66948019	-	T	hom	anno_omim	QUAL=5168;DP=137;AF=0.91;MQM=59;TRIO=HOM,137,0.91,HOM,39,0.90,HOM,23,0.96	AR	3'UTR	AR:ENST00000374690:3'UTR:MODIFIER:exon8/8:c.*4345dupT:		rs397737842	0.8416	0.0000	0,0,0	0,0,0,0,0	0.8490							313700 [AR (confirmed) Androgen insensitivity,300068|Spinal and bulbar muscular atrophy of Kennedy,313200|Androgen insensitivity,partial,with or without breast cancer,312300|Prostate cancer,susceptibility to,176807|Hypospadias 1,X-linked,300633];				146	5					AR (inh=n/a pLI=0.99)
chrX	66949722	66949722	C	T	hom	anno_omim	QUAL=10081;DP=136;AF=0.99;MQM=60;TRIO=HOM,136,0.99,HOM,119,1.00,HOM,75,1.00	AR	3'UTR	AR:ENST00000374690:3'UTR:MODIFIER:exon8/8:c.*6039C>T:		rs7440	0.8585	0.0000	0,0,0	0,0,0,0,0	0.8690							313700 [AR (confirmed) Androgen insensitivity,300068|Spinal and bulbar muscular atrophy of Kennedy,313200|Androgen insensitivity,partial,with or without breast cancer,312300|Prostate cancer,susceptibility to,176807|Hypospadias 1,X-linked,300633];				152	0					AR (inh=n/a pLI=0.99)
chrX	66950023	66950025	AAG	-	hom	anno_omim	QUAL=3735;DP=32;AF=1.00;MQM=60;TRIO=HOM,32,1.00,HOM,58,0.98,HOM,32,1.00	AR	3'UTR	AR:ENST00000374690:3'UTR:MODIFIER:exon8/8:c.*6344_*6346delAGA:	A-rich	rs878967261	0.0000	0.0000	0,0,0	0,0,0,0,0	0.8651							313700 [AR (confirmed) Androgen insensitivity,300068|Spinal and bulbar muscular atrophy of Kennedy,313200|Androgen insensitivity,partial,with or without breast cancer,312300|Prostate cancer,susceptibility to,176807|Hypospadias 1,X-linked,300633];				151	0					AR (inh=n/a pLI=0.99)
chrX	66950105	66950105	C	T	hom	anno_omim	QUAL=9656;DP=123;AF=0.99;MQM=59;TRIO=HOM,123,0.99,HOM,113,1.00,HOM,60,1.00	AR	3'UTR	AR:ENST00000374690:3'UTR:MODIFIER:exon8/8:c.*6422C>T:		rs2362520	0.8583	0.0000	0,0,0	0,0,0,0,0	0.8697							313700 [AR (confirmed) Androgen insensitivity,300068|Spinal and bulbar muscular atrophy of Kennedy,313200|Androgen insensitivity,partial,with or without breast cancer,312300|Prostate cancer,susceptibility to,176807|Hypospadias 1,X-linked,300633];				152	0					AR (inh=n/a pLI=0.99)
chrX	67263222	67263222	G	A	hom	low_DP;low_MQM;anno_omim	QUAL=336;DP=6;AF=1.00;MQM=47;TRIO=HOM,6,1.00,HOM,3,1.00,HOM,4,1.00	OPHN1	3'UTR	OPHN1:ENST00000355520:3'UTR:MODIFIER:exon25/25:c.*3792C>T:	L1HS	rs7883184	0.1195	0.0000	0,0,0	0,0,0,0,0	0.2472							300127 [OPHN1 (provisional) Mental retardation,X-linked,with cerebellar hypoplasia and distinctive facial appearance,300486];				54	51					OPHN1 (inh=XLR pLI=1.00)
chrX	67263229	67263229	A	G	het	low_DP;anno_omim	QUAL=133;DP=6;AF=0.50;MQM=51;TRIO=HET,6,0.50,HOM,2,1.00,HOM,2,1.00	OPHN1	3'UTR	OPHN1:ENST00000355520:3'UTR:MODIFIER:exon25/25:c.*3785T>C:		rs184510922	0.1788	0.0000	0,0,0	0,0,0,0,0	0.1958							300127 [OPHN1 (provisional) Mental retardation,X-linked,with cerebellar hypoplasia and distinctive facial appearance,300486];				16	49					OPHN1 (inh=XLR pLI=1.00)
chrX	67263293	67263293	A	G	hom	low_DP;anno_omim	QUAL=1023;DP=16;AF=1.00;MQM=60;TRIO=HOM,16,1.00,HOM,11,1.00,HOM,5,1.00	OPHN1	3'UTR	OPHN1:ENST00000355520:3'UTR:MODIFIER:exon25/25:c.*3721T>C:	Arthur2	rs7888212	0.5189	0.0000	0,0,0	0,0,0,0,0	0.4624							300127 [OPHN1 (provisional) Mental retardation,X-linked,with cerebellar hypoplasia and distinctive facial appearance,300486];				90	43					OPHN1 (inh=XLR pLI=1.00)
chrX	67263844	67263844	C	T	hom	anno_omim	QUAL=15569;DP=196;AF=1.00;MQM=60;TRIO=HOM,196,1.00,HOM,165,0.99,HOM,122,0.98	OPHN1	3'UTR	OPHN1:ENST00000355520:3'UTR:MODIFIER:exon25/25:c.*3170G>A:		rs492933	0.5094	0.0000	0,0,0	0,0,0,0,0	0.4695							300127 [OPHN1 (provisional) Mental retardation,X-linked,with cerebellar hypoplasia and distinctive facial appearance,300486];				94	47					OPHN1 (inh=XLR pLI=1.00)
chrX	67265417	67265417	G	T	hom	anno_omim	QUAL=11604;DP=105;AF=1.00;MQM=60;TRIO=HOM,105,1.00,HOM,149,1.00,HOM,108,0.98	OPHN1	3'UTR	OPHN1:ENST00000355520:3'UTR:MODIFIER:exon25/25:c.*1597C>A:		rs2254886	0.4297	0.0000	0,0,0	0,0,0,0,0	0.3917							300127 [OPHN1 (provisional) Mental retardation,X-linked,with cerebellar hypoplasia and distinctive facial appearance,300486];				93	47					OPHN1 (inh=XLR pLI=1.00)
chrX	67265915	67265915	-	T	hom	anno_omim	QUAL=5146;DP=79;AF=0.99;MQM=60;TRIO=HOM,79,0.99,HOM,47,1.00,HOM,37,1.00	OPHN1	3'UTR	OPHN1:ENST00000355520:3'UTR:MODIFIER:exon25/25:c.*1098dupA:	Charlie4z	rs397698299	0.1823	0.0000	0,0,0	0,0,0,0,0	0.2323							300127 [OPHN1 (provisional) Mental retardation,X-linked,with cerebellar hypoplasia and distinctive facial appearance,300486];				64	39					OPHN1 (inh=XLR pLI=1.00)
chrX	69080840	69080840	G	A	hom	anno_omim	QUAL=13353;DP=145;AF=1.00;MQM=60;TRIO=HOM,145,1.00,HOM,169,1.00,HOM,102,1.00	EDA	3'UTR,intron	EDA:ENST00000525810:3'UTR:MODIFIER:exon2/2:c.*141G>A:,EDA:ENST00000527388:3'UTR:MODIFIER:exon3/3:c.*186G>A:,EDA:ENST00000374552:intron:MODIFIER:exon1/7:c.397-96037G>A:,EDA:ENST00000374553:intron:MODIFIER:exon1/7:c.397-96037G>A:,EDA:ENST00000524573:intron:MODIFIER:exon1/7:c.397-96037G>A:	L1MEd	rs1203003	1.0000	0.0000	0,0,0	0,0,0,0,0	1.0000							300451 [EDA (confirmed) Ectodermal dysplasia 1,hypohidrotic,X-linked,305100|Tooth agenesis,selective,X-linked 1,313500];				470	0					EDA (inh=XLR+XLD pLI=0.92)
chrX	69258515	69258515	T	G	hom	anno_omim	QUAL=11138;DP=183;AF=1.00;MQM=60;TRIO=HOM,183,1.00,HET,144,0.51,HOM,91,1.00	EDA	3'UTR	EDA:ENST00000374552:3'UTR:MODIFIER:exon8/8:c.*3056T>G:,EDA:ENST00000374553:3'UTR:MODIFIER:exon8/8:c.*3056T>G:		rs3795170	0.3939	0.0000	0,0,0	0,0,0,0,0	0.3271							300451 [EDA (confirmed) Ectodermal dysplasia 1,hypohidrotic,X-linked,305100|Tooth agenesis,selective,X-linked 1,313500];				106	49					EDA (inh=XLR+XLD pLI=0.92)
chrX	69626739	69626739	C	T	hom	anno_omim	QUAL=5022;DP=102;AF=1.00;MQM=59;TRIO=HOM,102,1.00,HET,150,0.48,WT,102,0.00	KIF4A	splice_region&intron	KIF4A:ENST00000374403:splice_region&intron:LOW:exon27/30:c.3073-4C>T:,KIF4A:ENST00000374388:splice_region&intron:LOW:exon27/28:c.3073-4C>T:		rs10482161	0.0601	0.0689	180,118,52	0.1234,0.0324,0.0005,0.0893,0.0103	0.0847							300521 [KIF4A (provisional) Mental retardation,X-linked 100,300923];				82	106					KIF4A (inh=n/a pLI=1.00)
chrX	69640700	69640700	C	T	hom	anno_omim	QUAL=8407;DP=192;AF=0.99;MQM=60;TRIO=HOM,192,0.99,HET,172,0.49,WT,118,0.00	KIF4A,GDPD2	intergenic_region	GDPD2:ENSG00000090889-ENSG00000130055:intergenic_region:MODIFIER::n.69640700C>T:		rs1063088	0.0257	0.0000	0,0,0	0,0,0,0,0	0.0533							300521 [KIF4A (provisional) Mental retardation,X-linked 100,300923];				20	20					KIF4A (inh=n/a pLI=1.00), GDPD2 (inh=n/a pLI=0.12)
chrX	69724731	69724731	G	T	hom	anno_omim	QUAL=12644;DP=265;AF=0.98;MQM=59;TRIO=HOM,265,0.98,HET,363,0.50,WT,253,0.01	DLG3	3'UTR	DLG3:ENST00000194900:3'UTR:MODIFIER:exon21/21:c.*2612G>T:,DLG3:ENST00000374360:3'UTR:MODIFIER:exon19/19:c.*2612G>T:,DLG3:ENST00000374355:3'UTR:MODIFIER:exon14/14:c.*2612G>T:,DLG3:ENST00000542398:3'UTR:MODIFIER:exon12/12:c.*2612G>T:		rs3828017	0.5592	0.0000	0,0,0	0,0,0,0,0	0.5429							300189 [DLG3 (provisional) Mental retardation,X-linked 90,300850];				124	58					DLG3 (inh=XLR pLI=1.00)
chrX	70390007	70390007	-	CACA	hom	anno_omim	QUAL=494;DP=33;AF=0.55;MQM=58;TRIO=HOM,33,0.55,HET,93,0.34,WT,58,0.00	NLGN3	3'UTR	NLGN3:ENST00000358741:3'UTR:MODIFIER:exon8/8:c.*78_*81dupACAC:,NLGN3:ENST00000536169:3'UTR:MODIFIER:exon6/6:c.*78_*81dupACAC:,NLGN3:ENST00000374051:3'UTR:MODIFIER:exon7/7:c.*78_*81dupACAC:		rs112095862;rs35156036	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0322							300336 [NLGN3 (provisional) Autism susceptibility,X-linked 1,300425|Asperger syndrome susceptibility,X-linked 1,300494];				11	14					NLGN3 (inh=n/a pLI=0.90)
chrX	70469182	70469182	G	A	hom		QUAL=18021;DP=171;AF=0.99;MQM=60;TRIO=HOM,171,0.99,HOM,217,1.00,HOM,164,1.00	ZMYM3	3'UTR,intron	ZMYM3:ENST00000373982:3'UTR:MODIFIER:exon7/7:c.*111C>T:,ZMYM3:ENST00000373981:3'UTR:MODIFIER:exon7/7:c.*111C>T:,ZMYM3:ENST00000373978:3'UTR:MODIFIER:exon6/6:c.*260C>T:,ZMYM3:ENST00000373988:intron:MODIFIER:exon7/24:c.1476+129C>T:,ZMYM3:ENST00000314425:intron:MODIFIER:exon7/24:c.1470+129C>T:,ZMYM3:ENST00000353904:intron:MODIFIER:exon7/24:c.1470+129C>T:,ZMYM3:ENST00000373998:intron:MODIFIER:exon7/24:c.1470+129C>T:,ZMYM3:ENST00000373984:intron:MODIFIER:exon7/23:c.1476+129C>T:	L1ME3Cz	rs2341539	0.9992	0.0000	0,0,0	0,0,0,0,0	0.9973											490	2					ZMYM3 (inh=n/a pLI=1.00)
chrX	73956893	73956893	T	G	het	anno_omim	QUAL=428;DP=83;AF=0.57;MQM=60;TRIO=HET,83,0.57,WT,49,0.00,WT,31,0.00	KIAA2022	3'UTR	KIAA2022:ENST00000055682:3'UTR:MODIFIER:exon4/4:c.*2347A>C:		rs199521894	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							300524 [KIAA2022 (provisional) Mental retardation,X-linked 98,300912];				0	165					NEXMIF (inh=XLR pLI=0.95)
chrX	73958629	73958629	G	A	hom	anno_omim	QUAL=9364;DP=115;AF=1.00;MQM=59;TRIO=HOM,115,1.00,HOM,105,1.00,HOM,62,1.00	KIAA2022	3'UTR	KIAA2022:ENST00000055682:3'UTR:MODIFIER:exon4/4:c.*611C>T:		rs2209549	0.4095	0.0000	0,0,0	0,0,0,0,0	0.6680							300524 [KIAA2022 (provisional) Mental retardation,X-linked 98,300912];				266	32					NEXMIF (inh=XLR pLI=0.95)
chrX	74589117	74589117	C	T	hom	anno_omim	QUAL=16413;DP=176;AF=0.99;MQM=59;TRIO=HOM,176,0.99,HOM,205,1.00,HOM,130,1.00	ZDHHC15	3'UTR	ZDHHC15:ENST00000373367:3'UTR:MODIFIER:exon12/12:c.*3696G>A:,ZDHHC15:ENST00000541184:3'UTR:MODIFIER:exon11/11:c.*3696G>A:		rs7052314	0.4199	0.0000	0,0,0	0,0,0,0,0	0.6313							300576 [ZDHHC15 (provisional) Mental retardation,X-linked 91,300577];				166	38					ZDHHC15 (inh=n/a pLI=0.90)
chrX	74589151	74589154	TGTG	-	hom	anno_omim	QUAL=10249;DP=113;AF=0.74;MQM=59;TRIO=HOM,113,0.74,HOM,203,0.85,WT,125,0.94	ZDHHC15	3'UTR	ZDHHC15:ENST00000373367:3'UTR:MODIFIER:exon12/12:c.*3659_*3662delCACA:,ZDHHC15:ENST00000541184:3'UTR:MODIFIER:exon11/11:c.*3659_*3662delCACA:	(TG)n	rs752312995	0.0000	0.0000	0,0,0	0,0,0,0,0	0.5027							300576 [ZDHHC15 (provisional) Mental retardation,X-linked 91,300577];				131	8					ZDHHC15 (inh=n/a pLI=0.90)
chrX	74590136	74590136	G	C	hom	anno_omim	QUAL=13807;DP=124;AF=1.00;MQM=60;TRIO=HOM,124,1.00,HOM,180,1.00,HOM,115,1.00	ZDHHC15	3'UTR	ZDHHC15:ENST00000373367:3'UTR:MODIFIER:exon12/12:c.*2677C>G:,ZDHHC15:ENST00000541184:3'UTR:MODIFIER:exon11/11:c.*2677C>G:		rs1998494	0.8127	0.0000	0,0,0	0,0,0,0,0	0.8474							300576 [ZDHHC15 (provisional) Mental retardation,X-linked 91,300577];				216	11					ZDHHC15 (inh=n/a pLI=0.90)
chrX	74590180	74590180	G	A	hom	anno_omim	QUAL=13482;DP=172;AF=1.00;MQM=60;TRIO=HOM,172,1.00,HOM,150,1.00,HOM,81,1.00	ZDHHC15	3'UTR	ZDHHC15:ENST00000373367:3'UTR:MODIFIER:exon12/12:c.*2633C>T:,ZDHHC15:ENST00000541184:3'UTR:MODIFIER:exon11/11:c.*2633C>T:		rs1998493	0.8127	0.0000	0,0,0	0,0,0,0,0	0.8495							300576 [ZDHHC15 (provisional) Mental retardation,X-linked 91,300577];				216	11					ZDHHC15 (inh=n/a pLI=0.90)
chrX	74590258	74590258	G	T	hom	anno_omim	QUAL=13889;DP=195;AF=0.99;MQM=60;TRIO=HOM,195,0.99,HOM,167,1.00,HOM,83,1.00	ZDHHC15	3'UTR	ZDHHC15:ENST00000373367:3'UTR:MODIFIER:exon12/12:c.*2555C>A:,ZDHHC15:ENST00000541184:3'UTR:MODIFIER:exon11/11:c.*2555C>A:		rs1998492	0.8130	0.0000	0,0,0	0,0,0,0,0	0.8472							300576 [ZDHHC15 (provisional) Mental retardation,X-linked 91,300577];				216	11					ZDHHC15 (inh=n/a pLI=0.90)
chrX	74590359	74590368	TTTTTTTTTT	-	hom	anno_omim	QUAL=3144;DP=63;AF=0.56;MQM=58;TRIO=HOM,63,0.56,HOM,77,0.65,HOM,40,0.75	ZDHHC15	3'UTR	ZDHHC15:ENST00000373367:3'UTR:MODIFIER:exon12/12:c.*2445_*2454delAAAAAAAAAA:,ZDHHC15:ENST00000541184:3'UTR:MODIFIER:exon11/11:c.*2445_*2454delAAAAAAAAAA:	AluSp	rs367924484;rs747471622;rs775337620	0.9065	0.0000	0,0,0	0,0,0,0,0	0.6135							300576 [ZDHHC15 (provisional) Mental retardation,X-linked 91,300577];				155	10					ZDHHC15 (inh=n/a pLI=0.90)
chrX	74591706	74591706	T	C	hom	anno_omim	QUAL=11075;DP=151;AF=1.00;MQM=60;TRIO=HOM,151,1.00,HOM,114,1.00,HOM,68,1.00	ZDHHC15	3'UTR	ZDHHC15:ENST00000373367:3'UTR:MODIFIER:exon12/12:c.*1107A>G:,ZDHHC15:ENST00000541184:3'UTR:MODIFIER:exon11/11:c.*1107A>G:		rs2146770	0.9253	0.0000	0,0,0	0,0,0,0,0	0.9281							300576 [ZDHHC15 (provisional) Mental retardation,X-linked 91,300577];				230	0					ZDHHC15 (inh=n/a pLI=0.90)
chrX	74743194	74743194	C	G	hom	anno_omim	QUAL=6533;DP=71;AF=1.00;MQM=60;TRIO=HOM,71,1.00,HOM,99,1.00,HOM,43,1.00	ZDHHC15	5'UTR	ZDHHC15:ENST00000541184:5'UTR:MODIFIER:exon1/11:c.-335G>C:		rs11796028	0.3846	0.0000	0,0,0	0,0,0,0,0	0.5961							300576 [ZDHHC15 (provisional) Mental retardation,X-linked 91,300577];				163	39					ZDHHC15 (inh=n/a pLI=0.90)
chrX	76762375	76762375	C	T	het	anno_omim	QUAL=84;DP=53;AF=0.25;MQM=53;TRIO=HET,53,0.25,WT,14,0.00,WT,8,0.00	ATRX	3'UTR	ATRX:ENST00000373344:3'UTR:MODIFIER:exon35/35:c.*1454G>A:,ATRX:ENST00000395603:3'UTR:MODIFIER:exon34/34:c.*1454G>A:	(T)n	rs782665097	0.3462	0.0000	0,0,0	0,0,0,0,0	0.0959							300032 [ATRX (confirmed) Alpha-thalassemia/mental retardation syndrome,301040|Alpha-thalassemia myelodysplasia syndrome,somatic,300448|Mental retardation-hypotonic facies syndrome,X-linked,309580];				0	94					ATRX (inh=XLR pLI=1.00)
chrX	77298857	77298857	G	A	hom	pred_pathogenic;anno_omim	QUAL=15672;DP=104;AF=1.00;MQM=60;TRIO=HOM,104,1.00,HOM,237,1.00,HOM,131,1.00	ATP7A	missense	ATP7A:ENST00000341514:missense:MODERATE:exon21/23:c.4048G>A:p.Glu1350Lys,ATP7A:ENST00000343533:missense:MODERATE:exon20/22:c.3814G>A:p.Glu1272Lys,ATP7A:ENST00000350425:missense:MODERATE:exon8/10:c.1057G>A:p.Glu353Lys		rs4826245	1.0000	1.0000	27055,14628,3310	1.0000,1.0000,1.0000,1.0000,1.0000	1.0000	7.0780	T,T,T	T	B	D,D,D	10.98	300011 [ATP7A (confirmed) Menkes disease,309400|Occipital horn syndrome,304150|Spinal muscular atrophy,distal,X-linked 3,300489];	RCV000078036.6 [benign]; 			2306	0					ATP7A (inh=XLR pLI=1.00)
chrX	79925246	79925246	A	G	hom	anno_omim	QUAL=2458;DP=45;AF=1.00;MQM=60;TRIO=HOM,45,1.00,HOM,15,1.00,HOM,14,1.00	HK2P1,BRWD3	intergenic_region	BRWD3:ENSG00000228612-ENSG00000165288:intergenic_region:MODIFIER::n.79925246A>G:		rs2063579	0.5211	0.0000	0,0,0	0,0,0,0,0	0.6372							300553 [BRWD3 (provisional) Mental retardation,X-linked 93,300659];	RCV000341194.1 [benign]; 			91	32					HK2P1 (inh=n/a pLI=n/a), BRWD3 (inh=XLR pLI=1.00)
chrX	79931832	79931835	GTGT	-	hom	anno_omim	QUAL=16579;DP=128;AF=0.98;MQM=59;TRIO=HOM,128,0.98,HOM,257,0.98,HOM,176,1.00	BRWD3	3'UTR	BRWD3:ENST00000373275:3'UTR:MODIFIER:exon41/41:c.*273_*276delACAC:	(GT)n	rs397895620	0.5136	0.0000	0,0,0	0,0,0,0,0	0.6167							300553 [BRWD3 (provisional) Mental retardation,X-linked 93,300659];	RCV000337357.1 [benign]; 			213	48					BRWD3 (inh=XLR pLI=1.00)
chrX	79943569	79943569	T	C	hom	anno_omim	QUAL=14390;DP=116;AF=0.99;MQM=60;TRIO=HOM,116,0.99,HOM,208,1.00,HOM,115,1.00	BRWD3	missense&splice_region	BRWD3:ENST00000373275:missense&splice_region:MODERATE:exon34/41:c.3863A>G:p.Lys1288Arg		rs3122407	0.9897	0.9972	26864,14624,3144	0.9725,0.9992,1.0000,0.9999,0.9999	0.9979	0.1700	T	T	B	T	7.36	300553 [BRWD3 (provisional) Mental retardation,X-linked 93,300659];	RCV000371280.1 [benign]; 			2315	2					BRWD3 (inh=XLR pLI=1.00)
chrX	80065236	80065237	AG	-	hom	low_DP;anno_omim	QUAL=1686;DP=7;AF=0.71;MQM=59;TRIO=HOM,7,0.71,HOM,36,0.94,HOM,33,0.97	BRWD3,ACA64	intergenic_region	ACA64:ENSG00000165288-ENSG00000239008:intergenic_region:MODIFIER::n.80065236_80065237delAG:	GA-rich	rs762475206	0.8167	0.0000	0,0,0	0,0,0,0,0	0.7160							300553 [BRWD3 (provisional) Mental retardation,X-linked 93,300659];	RCV000303458.1 [benign]; 			273	4					BRWD3 (inh=XLR pLI=1.00), SNORA78 (inh=n/a pLI=n/a)
chrX	99550883	99550883	G	A	hom	anno_omim	QUAL=873;DP=26;AF=0.96;MQM=60;TRIO=HOM,26,0.96,HET,15,0.53,WT,12,0.00	PCDH19	3'UTR	PCDH19:ENST00000373034:3'UTR:MODIFIER:exon6/6:c.*392C>T:,PCDH19:ENST00000420881:3'UTR:MODIFIER:exon5/5:c.*392C>T:,PCDH19:ENST00000255531:3'UTR:MODIFIER:exon5/5:c.*392C>T:		rs1335268	0.2299	0.0000	0,0,0	0,0,0,0,0	0.3048							300460 [PCDH19 (confirmed) Epileptic encephalopathy,early infantile,9,300088];				81	43					PCDH19 (inh=AR+AD pLI=0.98)
chrX	99661969	99661969	G	A	hom	anno_omim	QUAL=9210;DP=127;AF=0.99;MQM=59;TRIO=HOM,127,0.99,HET,448,0.50,WT,280,0.00	PCDH19	synonymous	PCDH19:ENST00000373034:synonymous:LOW:exon1/6:c.1627C>T:p.Leu543Leu,PCDH19:ENST00000420881:synonymous:LOW:exon1/5:c.1627C>T:p.Leu543Leu,PCDH19:ENST00000255531:synonymous:LOW:exon1/5:c.1627C>T:p.Leu543Leu		rs1953337	0.0861	0.2067	1550,1211,14	0.0515,0.2334,0.0002,0.2763,0.0789	0.2099							300460 [PCDH19 (confirmed) Epileptic encephalopathy,early infantile,9,300088];	RCV000079603.6 [benign]; 		COSM3759554	344	302					PCDH19 (inh=AR+AD pLI=0.98)
chrX	99926122	99926122	G	A	hom	anno_omim	QUAL=31706;DP=271;AF=1.00;MQM=60;TRIO=HOM,271,1.00,HOM,415,1.00,HOM,291,1.00	SRPX2	3'UTR	SRPX2:ENST00000373004:3'UTR:MODIFIER:exon11/11:c.*138G>A:		rs5967163	0.9656	0.0000	0,0,0	0,0,0,0,0	0.9626							300642 [SRPX2 (provisional) Rolandic epilepsy,mental retardation,and speech dyspraxia,300643];				337	0					SRPX2 (inh=AD pLI=0.96)
chrX	100532621	100532621	T	C	hom	pred_pathogenic	QUAL=6398;DP=188;AF=0.99;MQM=60;TRIO=HOM,188,0.99,HET,91,0.44,WT,70,0.00	TAF7L	missense	TAF7L:ENST00000372907:missense:MODERATE:exon9/13:c.922A>G:p.Ser308Gly,TAF7L:ENST00000372905:missense:MODERATE:exon9/12:c.664A>G:p.Ser222Gly,TAF7L:ENST00000324762:missense:MODERATE:exon8/11:c.664A>G:p.Ser222Gly,TAF7L:ENST00000356784:missense:MODERATE:exon9/13:c.664A>G:p.Ser222Gly		rs35899692	0.1804	0.1482	733,263,194	0.2409,0.1179,0.2800,0.1406,0.0651	0.1550	2.3940	T,T,T,T	T	B,B	T,T,T,T	0.01				COSM3759316	217	229					TAF7L (inh=n/a pLI=0.84)
chrX	100547933	100547933	A	G	hom		QUAL=28125;DP=205;AF=1.00;MQM=60;TRIO=HOM,205,1.00,HOM,424,1.00,HOM,259,1.00	TAF7L	missense,5'UTR_premature_start_codon_gain,5'UTR	TAF7L:ENST00000372907:missense:MODERATE:exon1/13:c.101T>C:p.Leu34Pro,TAF7L:ENST00000372905:5'UTR_premature_start_codon_gain:LOW:exon1/12:c.-158T>C:,TAF7L:ENST00000372905:5'UTR:MODIFIER:exon1/12:c.-158T>C:		rs5951328	0.9950	0.9905	26499,14215,3284	0.9985,0.9965,1.0000,0.9866,0.9939	0.9910	-1.2920	T	T	B	T	0.03					2191	19					TAF7L (inh=n/a pLI=0.84)
chrX	103046527	103046527	G	-	hom	anno_omim	QUAL=17487;DP=213;AF=1.00;MQM=59;TRIO=HOM,213,1.00,HOM,191,1.00,HOM,133,1.00	PLP1	3'UTR	PLP1:ENST00000303958:3'UTR:MODIFIER:exon7/7:c.*1005delG:,PLP1:ENST00000418604:3'UTR:MODIFIER:exon8/8:c.*1005delG:,PLP1:ENST00000361621:3'UTR:MODIFIER:exon7/7:c.*1005delG:		rs796941012	1.0000	0.0000	0,0,0	0,0,0,0,0	1.0000							300401 [PLP1 (confirmed) Pelizaeus-Merzbacher disease,312080|Spastic paraplegia 2,X-linked,312920];				337	0					PLP1 (inh=XLR pLI=0.90)
chrX	110540014	110540014	G	A	hom	anno_omim	QUAL=1469;DP=36;AF=0.08;MQM=59;TRIO=HOM,36,0.08,HOM,33,0.12,HOM,21,0.00	DCX	3'UTR	DCX:ENST00000338081:3'UTR:MODIFIER:exon7/7:c.*4901C>T:,DCX:ENST00000371993:3'UTR:MODIFIER:exon7/7:c.*4901C>T:,DCX:ENST00000356915:3'UTR:MODIFIER:exon7/7:c.*4901C>T:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							300121 [DCX (confirmed) Lissencephaly,X-linked,300067|Subcortical laminal heteropia,X-linked,300067];				0	0					DCX (inh=XLR+XLD pLI=0.86)
chrX	119560599	119560599	T	C	hom	anno_omim	QUAL=9284;DP=154;AF=1.00;MQM=60;TRIO=HOM,154,1.00,HET,111,0.49,HOM,80,1.00	ATP1B4,LAMP2	intergenic_region	LAMP2:ENSG00000101892-ENSG00000005893:intergenic_region:MODIFIER::n.119560599T>C:		rs42885	0.7097	0.0000	0,0,0	0,0,0,0,0	0.6281							309060 [LAMP2 (confirmed) Danon disease,300257];	RCV000369947.1 [likely benign]; RCV000404849.1 [likely benign]; 			161	56					ATP1B4 (inh=n/a pLI=0.00), LAMP2 (inh=XLD pLI=0.95)
chrX	119561929	119561929	A	G	hom	anno_omim	QUAL=6634;DP=135;AF=1.00;MQM=60;TRIO=HOM,135,1.00,HET,160,0.53,WT,82,0.00	LAMP2	3'UTR	LAMP2:ENST00000434600:3'UTR:MODIFIER:exon9/9:c.*410T>C:		rs41300908	0.0032	0.0000	0,0,0	0,0,0,0,0	0.0095							309060 [LAMP2 (confirmed) Danon disease,300257];	RCV000349932.1 [uncertain significance]; RCV000399713.1 [uncertain significance]; 			3	3					LAMP2 (inh=XLD pLI=0.95)
chrX	119571157	119571157	-	AT	hom	anno_omim	QUAL=1946;DP=64;AF=0.89;MQM=59;TRIO=HOM,64,0.89,HET,34,0.41,WT,26,0.00	LAMP2	3'UTR,intron	LAMP2:ENST00000371335:3'UTR:MODIFIER:exon9/9:c.*1850_*1851dupAT:,LAMP2:ENST00000434600:intron:MODIFIER:exon8/8:c.1093+4426_1093+4427dupAT:,LAMP2:ENST00000538785:intron:MODIFIER:exon6/6:c.760+4426_760+4427dupAT:,LAMP2:ENST00000200639:intron:MODIFIER:exon8/8:c.1093+4426_1093+4427dupAT:	(TA)n	rs755523524;rs765735586	0.3033	0.0000	0,0,0	0,0,0,0,0	0.2322							309060 [LAMP2 (confirmed) Danon disease,300257];				31	35					LAMP2 (inh=XLD pLI=0.95)
chrX	119571268	119571268	A	-	hom	anno_omim	QUAL=1185;DP=52;AF=0.67;MQM=59;TRIO=HOM,52,0.67,HOM,24,0.42,WT,20,0.10	LAMP2	3'UTR,intron	LAMP2:ENST00000371335:3'UTR:MODIFIER:exon9/9:c.*1741delT:,LAMP2:ENST00000434600:intron:MODIFIER:exon8/8:c.1093+4317delT:,LAMP2:ENST00000538785:intron:MODIFIER:exon6/6:c.760+4317delT:,LAMP2:ENST00000200639:intron:MODIFIER:exon8/8:c.1093+4317delT:	A-rich	rs10565432;rs879252777	0.0000	0.0000	0,0,0	0,0,0,0,0	0.2561							309060 [LAMP2 (confirmed) Danon disease,300257];				31	33					LAMP2 (inh=XLD pLI=0.95)
chrX	119571541	119571541	T	C	hom	anno_omim	QUAL=8117;DP=94;AF=1.00;MQM=60;TRIO=HOM,94,1.00,HOM,84,1.00,HOM,67,1.00	LAMP2	3'UTR,intron	LAMP2:ENST00000371335:3'UTR:MODIFIER:exon9/9:c.*1468A>G:,LAMP2:ENST00000434600:intron:MODIFIER:exon8/8:c.1093+4044A>G:,LAMP2:ENST00000538785:intron:MODIFIER:exon6/6:c.760+4044A>G:,LAMP2:ENST00000200639:intron:MODIFIER:exon8/8:c.1093+4044A>G:		rs42889	0.7889	0.0000	0,0,0	0,0,0,0,0	0.6901							309060 [LAMP2 (confirmed) Danon disease,300257];				170	52					LAMP2 (inh=XLD pLI=0.95)
chrX	119572548	119572553	CACACA	-	hom	anno_omim	QUAL=2592;DP=41;AF=0.80;MQM=59;TRIO=HOM,41,0.80,HET,74,0.89,WT,19,0.74	LAMP2	3'UTR,intron	LAMP2:ENST00000371335:3'UTR:MODIFIER:exon9/9:c.*456_*461delTGTGTG:,LAMP2:ENST00000434600:intron:MODIFIER:exon8/8:c.1093+3032_1093+3037delTGTGTG:,LAMP2:ENST00000538785:intron:MODIFIER:exon6/6:c.760+3032_760+3037delTGTGTG:,LAMP2:ENST00000200639:intron:MODIFIER:exon8/8:c.1093+3032_1093+3037delTGTGTG:	(CA)n	rs767342235	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1147							309060 [LAMP2 (confirmed) Danon disease,300257];				27	3					LAMP2 (inh=XLD pLI=0.95)
chrX	119590533	119590533	T	A	hom	anno_omim	QUAL=3226;DP=53;AF=1.00;MQM=60;TRIO=HOM,53,1.00,HET,37,0.49,HOM,36,1.00	LAMP2	synonymous,intron	LAMP2:ENST00000434600:synonymous:LOW:exon2/9:c.156A>T:p.Val52Val,LAMP2:ENST00000200639:synonymous:LOW:exon2/9:c.156A>T:p.Val52Val,LAMP2:ENST00000371335:synonymous:LOW:exon2/9:c.156A>T:p.Val52Val,LAMP2:ENST00000540603:synonymous:LOW:exon2/9:c.15A>T:p.Val5Val,LAMP2:ENST00000538785:intron:MODIFIER:exon1/6:c.65-7550A>T:		rs12097	0.3809	0.4280	4103,2443,431	0.3712,0.3301,0.4138,0.4528,0.4478	0.4039							309060 [LAMP2 (confirmed) Danon disease,300257];	RCV000037405.9 [benign]; RCV000253949.1 [benign]; RCV000346704.1 [likely benign]; RCV000399625.1 [likely benign]; 		COSM4156558, COSM4156557, COSM4156559	773	448					LAMP2 (inh=XLD pLI=0.95)
chrX	122318386	122318386	-	G	hom	anno_omim	QUAL=7216;DP=67;AF=0.99;MQM=59;TRIO=HOM,67,0.99,HOM,96,1.00,HOM,78,1.00	GRIA3	5'UTR	GRIA3:ENST00000264357:5'UTR:MODIFIER:exon1/16:c.-2_-1insG:,GRIA3:ENST00000371266:5'UTR:MODIFIER:exon2/5:c.-2_-1insG:,GRIA3:ENST00000371264:5'UTR:MODIFIER:exon1/4:c.-2_-1insG:,GRIA3:ENST00000542149:5'UTR:MODIFIER:exon1/17:c.-2_-1insG:,GRIA3:ENST00000371251:5'UTR:MODIFIER:exon1/15:c.-2_-1insG:,GRIA3:ENST00000371256:5'UTR:MODIFIER:exon1/16:c.-2_-1insG:		rs58044961	1.0000	1.0000	27060,14630,3313	0.9999,1.0000,1.0000,1.0000,1.0000	1.0000							305915 [GRIA3 (confirmed) Mental retardation,X-linked 94,300699];				2306	0					GRIA3 (inh=XLR pLI=1.00)
chrX	122336600	122336600	-	G	hom	anno_high_impact;anno_omim	QUAL=17088;DP=94;AF=0.93;MQM=59;TRIO=HOM,94,0.93,HOM,332,0.98,HOM,192,0.98	GRIA3	frameshift,intron	GRIA3:ENST00000371266:frameshift:HIGH:exon4/5:c.384dupG:p.Pro129fs,GRIA3:ENST00000371264:frameshift:HIGH:exon3/4:c.384dupG:p.Pro129fs,GRIA3:ENST00000264357:intron:MODIFIER:exon2/15:c.268+16761dupG:,GRIA3:ENST00000542149:intron:MODIFIER:exon2/16:c.268+16761dupG:,GRIA3:ENST00000371251:intron:MODIFIER:exon2/14:c.268+16761dupG:,GRIA3:ENST00000371256:intron:MODIFIER:exon2/15:c.268+16761dupG:,GRIA3:ENST00000541091:intron:MODIFIER:exon2/10:c.220+16761dupG:		rs11452643	0.9995	1.0000	3156,1449,286	1.0000,1.0000,1.0000,1.0000,1.0000	1.0000							305915 [GRIA3 (confirmed) Mental retardation,X-linked 94,300699];				2149	33	1	[1] auto-classification 16.06.2016  [2] old entry - no details available		GS130554_01: 14.10.13, UG	GRIA3 (inh=XLR pLI=1.00)
chrX	122622934	122622937	ACAC	-	hom	anno_omim	QUAL=2886;DP=86;AF=0.85;MQM=59;TRIO=HOM,86,0.85,HOM,33,0.94,WT,18,0.78	GRIA3	3'UTR	GRIA3:ENST00000264357:3'UTR:MODIFIER:exon16/16:c.*404_*407delCACA:,GRIA3:ENST00000371256:3'UTR:MODIFIER:exon16/16:c.*404_*407delCACA:	(AC)n	rs201935330	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1360							305915 [GRIA3 (confirmed) Mental retardation,X-linked 94,300699];				25	2					GRIA3 (inh=XLR pLI=1.00)
chrX	123034511	123034511	A	C	hom	pred_pathogenic;anno_omim	QUAL=10416;DP=76;AF=0.99;MQM=60;TRIO=HOM,76,0.99,HOM,145,1.00,HOM,103,0.99	XIAP	missense	XIAP:ENST00000355640:missense:MODERATE:exon6/7:c.1268A>C:p.Gln423Pro,XIAP:ENST00000434753:missense:MODERATE:exon6/7:c.1268A>C:p.Gln423Pro,XIAP:ENST00000371199:missense:MODERATE:exon6/7:c.1268A>C:p.Gln423Pro		rs5956583	0.3036	0.3334	3387,1917,724	0.4659,0.3423,0.0929,0.3631,0.1924	0.3870	2.0790	D,D,D	T	B	T,T,T	6.08	300079 [XIAP (confirmed) Lymphoproliferative syndrome,X-linked,2,300635];	RCV000249776.1 [benign]; RCV000328885.1 [benign]; 		COSM3759346	603	402					XIAP (inh=n/a pLI=0.98)
chrX	123044718	123044718	A	-	het	low_QUAL;anno_omim	QUAL=9;DP=37;AF=0.30;MQM=51;TRIO=HET,37,0.30,WT,12,0.25,HET,12,0.25	XIAP	3'UTR	XIAP:ENST00000355640:3'UTR:MODIFIER:exon7/7:c.*3702delA:,XIAP:ENST00000371199:3'UTR:MODIFIER:exon7/7:c.*3702delA:	AluY	rs762891006	0.0000	0.2248	0,0,0	0.0000,0.0000,0.0000,0.2913,0.1806	0.2681							300079 [XIAP (confirmed) Lymphoproliferative syndrome,X-linked,2,300635];				3	119					XIAP (inh=n/a pLI=0.98)
chrX	123045327	123045327	-	A	hom	low_DP;anno_omim	QUAL=303;DP=7;AF=0.71;MQM=57;TRIO=HOM,7,0.71,HOM,9,0.89,HET,3,0.67	XIAP	3'UTR	XIAP:ENST00000355640:3'UTR:MODIFIER:exon7/7:c.*4309dupA:,XIAP:ENST00000371199:3'UTR:MODIFIER:exon7/7:c.*4309dupA:	AluSp	rs34868593;rs397713705;rs748304435	0.3038	0.2433	7,1,0	0.0000,0.0000,0.0000,0.2692,0.2177	0.4079							300079 [XIAP (confirmed) Lymphoproliferative syndrome,X-linked,2,300635];	RCV000261920.1 [benign]; 			54	174					XIAP (inh=n/a pLI=0.98)
chrX	123045641	123045641	C	T	hom	anno_omim	QUAL=8498;DP=94;AF=0.99;MQM=59;TRIO=HOM,94,0.99,HOM,93,1.00,HOM,76,1.00	XIAP	3'UTR	XIAP:ENST00000355640:3'UTR:MODIFIER:exon7/7:c.*4610C>T:,XIAP:ENST00000371199:3'UTR:MODIFIER:exon7/7:c.*4610C>T:		rs9856	0.5844	0.5800	488,185,19	0.0000,0.0000,0.0000,0.5405,0.5967	0.6030							300079 [XIAP (confirmed) Lymphoproliferative syndrome,X-linked,2,300635];	RCV000279320.1 [benign]; 			280	105					XIAP (inh=n/a pLI=0.98)
chrX	123046272	123046272	A	T	hom	anno_omim	QUAL=10487;DP=169;AF=1.00;MQM=59;TRIO=HOM,169,1.00,HOM,105,0.99,HOM,57,0.96	XIAP	3'UTR	XIAP:ENST00000355640:3'UTR:MODIFIER:exon7/7:c.*5241A>T:,XIAP:ENST00000371199:3'UTR:MODIFIER:exon7/7:c.*5241A>T:	MER2	rs5958343	0.5846	0.5797	487,184,19	0.0000,0.0000,0.0000,0.5396,0.5966	0.5954							300079 [XIAP (confirmed) Lymphoproliferative syndrome,X-linked,2,300635];	RCV000299858.1 [benign]; 			286	107					XIAP (inh=n/a pLI=0.98)
chrX	123046537	123046537	T	-	hom	anno_omim	QUAL=2729;DP=93;AF=0.73;MQM=59;TRIO=HOM,93,0.73,HOM,40,0.70,HOM,25,0.76	XIAP	3'UTR	XIAP:ENST00000355640:3'UTR:MODIFIER:exon7/7:c.*5519delT:,XIAP:ENST00000371199:3'UTR:MODIFIER:exon7/7:c.*5519delT:	AluSz	rs374013599	0.2490	0.3974	4,4,0	0.0000,0.0000,0.0000,0.4481,0.3697	0.3818							300079 [XIAP (confirmed) Lymphoproliferative syndrome,X-linked,2,300635];	RCV000330402.1 [benign]; 			80	224					XIAP (inh=n/a pLI=0.98)
chrX	123046923	123046923	T	G	hom	anno_omim	QUAL=5354;DP=53;AF=1.00;MQM=59;TRIO=HOM,53,1.00,HOM,74,1.00,HOM,47,1.00	XIAP	3'UTR	XIAP:ENST00000355640:3'UTR:MODIFIER:exon7/7:c.*5892T>G:,XIAP:ENST00000371199:3'UTR:MODIFIER:exon7/7:c.*5892T>G:	AluSx	rs6648556	0.6212	0.6683	480,173,24	0.0000,0.0000,0.0000,0.5987,0.6989	0.6412							300079 [XIAP (confirmed) Lymphoproliferative syndrome,X-linked,2,300635];	RCV000381680.1 [benign]; 			276	109					XIAP (inh=n/a pLI=0.98)
chrX	123506104	123506104	T	A	hom	anno_omim	QUAL=6225;DP=102;AF=1.00;MQM=60;TRIO=HOM,102,1.00,HOM,87,1.00,WT,57,0.00	SH2D1A,STAG2	3'UTR	SH2D1A:ENST00000371139:3'UTR:MODIFIER:exon4/4:c.*863T>A:		rs7876065	0.8140	0.0000	0,0,0	0,0,0,0,0	0.8404							300490 [SH2D1A (confirmed) Lymphoproliferative syndrome,X-linked,1,308240];	RCV000398926.1 [benign]; 			268	33					SH2D1A (inh=XLR pLI=0.08), STAG2 (inh=n/a pLI=1.00)
chrX	128938958	128938958	T	C	hom	anno_omim	QUAL=15207;DP=218;AF=1.00;MQM=59;TRIO=HOM,218,1.00,HOM,156,1.00,HOM,106,1.00	ZDHHC9	3'UTR	ZDHHC9:ENST00000357166:3'UTR:MODIFIER:exon11/11:c.*1388A>G:		rs1053486	0.6196	0.0000	0,0,0	0,0,0,0,0	0.7697							300646 [ZDHHC9 (confirmed) Mental retardation,X-linked syndromic,Raymond type,300799];				316	10					ZDHHC9 (inh=n/a pLI=0.89)
chrX	129283520	129283520	A	G	hom	anno_omim	QUAL=16470;DP=180;AF=1.00;MQM=60;TRIO=HOM,180,1.00,HOM,204,1.00,HOM,134,0.99	AIFM1	synonymous,intron	AIFM1:ENST00000287295:synonymous:LOW:exon3/16:c.273T>C:p.Asp91Asp,AIFM1:ENST00000535724:synonymous:LOW:exon2/16:c.12T>C:p.Asp4Asp,AIFM1:ENST00000319908:synonymous:LOW:exon3/16:c.261T>C:p.Asp87Asp,AIFM1:ENST00000346424:intron:MODIFIER:exon1/7:c.107-12360T>C:		rs1139851	0.4911	0.4329	5607,2478,1687	0.7132,0.4312,0.1822,0.4097,0.4697	0.4864							300169 [AIFM1 (confirmed) Combined oxidative phosphorylation deficiency 6,300816|Cowchock syndrome,310490|Deafness,X-linked 5,300614];	RCV000373191.1 [benign]; 		COSM1465605, COSM1465604	780	426					AIFM1 (inh=XLR pLI=0.98)
chrX	132838306	132838306	A	-	het	anno_omim	QUAL=139;DP=71;AF=0.30;MQM=59;TRIO=HET,71,0.30,WT,71,0.18,HET,67,0.15	GPC3	splice_region&intron,intron	GPC3:ENST00000394299:splice_region&intron:LOW:exon3/8:c.1033-5delT:,GPC3:ENST00000370818:intron:MODIFIER:exon3/7:c.1033-4250delT:,GPC3:ENST00000543339:intron:MODIFIER:exon2/6:c.871-4250delT:		rs374169314	0.0000	0.3076	0,0,0	0.2675,0.0000,0.3898,0.3709,0.1926	0.3057							300037 [GPC3 (confirmed) Simpson-Golabi-Behmel syndrome,type 1,312870|Wilms tumor,somatic,194070];			COSM1625536	7	245					GPC3 (inh=XLR pLI=0.99)
chrX	135251679	135251679	-	A	hom	anno_omim	QUAL=4123;DP=104;AF=0.88;MQM=59;TRIO=HOM,104,0.88,HOM,56,0.95,WT,39,0.00	FHL1	5'UTR,intron	FHL1:ENST00000543669:5'UTR:MODIFIER:exon1/6:c.-478dupA:,FHL1:ENST00000394155:intron:MODIFIER:exon1/7:c.-100-378dupA:,FHL1:ENST00000370690:intron:MODIFIER:exon1/6:c.-100-378dupA:,FHL1:ENST00000535737:intron:MODIFIER:exon1/6:c.-100-378dupA:		rs397710404;rs760593394	0.0000	0.0000	0,0,0	0,0,0,0,0	0.6899							300163 [FHL1 (confirmed) Scapuloperoneal myopathy,X-linked dominant,300695|Myopathy,X-linked,with postural muscle atrophy,300696|Reducing body myopathy,X-linked 1a,severe,infantile or early childhood onset,300717|Reducing body myopathy,X-linked 1b,with late childhood or adult onset,300718|Emery-Dreifuss muscular dystrophy 6,X-linked,300696];				203	86					FHL1 (inh=n/a pLI=0.92)
chrX	135292022	135292022	C	T	hom	anno_omim	QUAL=11269;DP=96;AF=0.99;MQM=59;TRIO=HOM,96,0.99,HOM,140,1.00,HOM,133,1.00	FHL1	splice_region&intron	FHL1:ENST00000345434:splice_region&intron:LOW:exon6/6:c.889-8C>T:,FHL1:ENST00000394155:splice_region&intron:LOW:exon7/7:c.889-8C>T:,FHL1:ENST00000370690:splice_region&intron:LOW:exon6/6:c.689-8C>T:,FHL1:ENST00000535737:splice_region&intron:LOW:exon6/6:c.689-8C>T:,FHL1:ENST00000543669:splice_region&intron:LOW:exon5/5:c.689-8C>T:,FHL1:ENST00000394153:splice_region&intron:LOW:exon6/6:c.689-8C>T:,FHL1:ENST00000539015:splice_region&intron:LOW:exon5/5:c.776-8C>T:,FHL1:ENST00000370683:splice_region&intron:LOW:exon5/5:c.737-8C>T:,FHL1:ENST00000370676:splice_region&intron:LOW:exon4/4:c.550-8C>T:	(TTTCT)n	rs2076705	0.5197	0.4945	6087,3308,376	0.3579,0.5150,0.6447,0.4981,0.4380	0.5348							300163 [FHL1 (confirmed) Scapuloperoneal myopathy,X-linked dominant,300695|Myopathy,X-linked,with postural muscle atrophy,300696|Reducing body myopathy,X-linked 1a,severe,infantile or early childhood onset,300717|Reducing body myopathy,X-linked 1b,with late childhood or adult onset,300718|Emery-Dreifuss muscular dystrophy 6,X-linked,300696];	RCV000179824.3 [benign]; 			806	533					FHL1 (inh=n/a pLI=0.92)
chrX	135292164	135292164	G	A	hom	pred_pathogenic;anno_omim	QUAL=8223;DP=187;AF=0.99;MQM=59;TRIO=HOM,187,0.99,HET,205,0.45,WT,149,0.00	FHL1	missense,3'UTR	FHL1:ENST00000370690:missense:MODERATE:exon7/7:c.823G>A:p.Asp275Asn,FHL1:ENST00000535737:missense:MODERATE:exon7/7:c.823G>A:p.Asp275Asn,FHL1:ENST00000543669:missense:MODERATE:exon6/6:c.823G>A:p.Asp275Asn,FHL1:ENST00000394153:missense:MODERATE:exon7/7:c.823G>A:p.Asp275Asn,FHL1:ENST00000539015:missense:MODERATE:exon6/6:c.910G>A:p.Asp304Asn,FHL1:ENST00000370683:missense:MODERATE:exon6/6:c.871G>A:p.Asp291Asn,FHL1:ENST00000345434:3'UTR:MODIFIER:exon7/7:c.*51G>A:,FHL1:ENST00000394155:3'UTR:MODIFIER:exon8/8:c.*51G>A:,FHL1:ENST00000370676:3'UTR:MODIFIER:exon5/5:c.*51G>A:		rs151315725	0.0048	0.0113	10,10,0	0.0028,0.0059,0.0000,0.0175,0.0048	0.0110	6.2260	D,D,D,D,D,D,D,D,D	T	B,B	D,D,D,D,D,D	15.77	300163 [FHL1 (confirmed) Scapuloperoneal myopathy,X-linked dominant,300695|Myopathy,X-linked,with postural muscle atrophy,300696|Reducing body myopathy,X-linked 1a,severe,infantile or early childhood onset,300717|Reducing body myopathy,X-linked 1b,with late childhood or adult onset,300718|Emery-Dreifuss muscular dystrophy 6,X-linked,300696];	RCV000228514.1 [benign]; RCV000296313.1 [benign]; 			18	19					FHL1 (inh=n/a pLI=0.92)
chrX	135293082	135293082	G	A	hom	anno_omim	QUAL=18935;DP=226;AF=0.99;MQM=60;TRIO=HOM,226,0.99,HOM,214,1.00,HOM,141,1.00	FHL1	3'UTR	FHL1:ENST00000345434:3'UTR:MODIFIER:exon7/7:c.*969G>A:,FHL1:ENST00000394155:3'UTR:MODIFIER:exon8/8:c.*969G>A:,FHL1:ENST00000370690:3'UTR:MODIFIER:exon7/7:c.*898G>A:,FHL1:ENST00000535737:3'UTR:MODIFIER:exon7/7:c.*898G>A:,FHL1:ENST00000543669:3'UTR:MODIFIER:exon6/6:c.*898G>A:,FHL1:ENST00000394153:3'UTR:MODIFIER:exon7/7:c.*898G>A:,FHL1:ENST00000539015:3'UTR:MODIFIER:exon6/6:c.*898G>A:,FHL1:ENST00000370683:3'UTR:MODIFIER:exon6/6:c.*898G>A:		rs9018	0.5068	0.4787	353,142,6	0.0000,0.0000,0.0000,0.4691,0.4794	0.5132							300163 [FHL1 (confirmed) Scapuloperoneal myopathy,X-linked dominant,300695|Myopathy,X-linked,with postural muscle atrophy,300696|Reducing body myopathy,X-linked 1a,severe,infantile or early childhood onset,300717|Reducing body myopathy,X-linked 1b,with late childhood or adult onset,300718|Emery-Dreifuss muscular dystrophy 6,X-linked,300696];				304	121					FHL1 (inh=n/a pLI=0.92)
chrX	135742076	135742076	G	C	het	anno_omim;trio_denovo	QUAL=396;DP=50;AF=0.48;MQM=52;TRIO=HET,50,0.48,WT,28,0.00,WT,20,0.00	CD40LG	3'UTR	CD40LG:ENST00000370629:3'UTR:MODIFIER:exon5/5:c.*502G>C:,CD40LG:ENST00000370628:3'UTR:MODIFIER:exon4/4:c.*502G>C:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							300386 [CD40LG (confirmed) Immunodeficiency,X-linked,with hyper-IgM,308230];				0	0					CD40LG (inh=XLR pLI=0.86)
chrX	135742096	135742096	G	C	hom	low_DP;anno_omim	QUAL=362;DP=19;AF=0.68;MQM=52;TRIO=HOM,19,0.68,HOM,10,0.10,HOM,6,0.50	CD40LG	3'UTR	CD40LG:ENST00000370629:3'UTR:MODIFIER:exon5/5:c.*522G>C:,CD40LG:ENST00000370628:3'UTR:MODIFIER:exon4/4:c.*522G>C:	(C)n	rs867476242	0.0000	0.0000	0,0,0	0,0,0,0,0	0.3220							300386 [CD40LG (confirmed) Immunodeficiency,X-linked,with hyper-IgM,308230];				2	1					CD40LG (inh=XLR pLI=0.86)
chrX	135742258	135742258	C	T	hom	anno_omim	QUAL=2129;DP=61;AF=1.00;MQM=58;TRIO=HOM,61,1.00,HET,44,0.45,WT,35,0.00	CD40LG	3'UTR	CD40LG:ENST00000370629:3'UTR:MODIFIER:exon5/5:c.*684C>T:,CD40LG:ENST00000370628:3'UTR:MODIFIER:exon4/4:c.*684C>T:	(TC)n	rs779484195	0.0029	0.0000	0,0,0	0,0,0,0,0	0.0068							300386 [CD40LG (confirmed) Immunodeficiency,X-linked,with hyper-IgM,308230];				1	2					CD40LG (inh=XLR pLI=0.86)
chrX	147031538	147031538	C	T	hom	anno_omim	QUAL=4529;DP=70;AF=1.00;MQM=60;TRIO=HOM,70,1.00,HOM,40,1.00,HOM,30,1.00	FMR1	3'UTR	FMR1:ENST00000370475:3'UTR:MODIFIER:exon17/17:c.*1174C>T:,FMR1:ENST00000218200:3'UTR:MODIFIER:exon16/16:c.*1174C>T:,FMR1:ENST00000370471:3'UTR:MODIFIER:exon16/16:c.*1188C>T:,FMR1:ENST00000370477:3'UTR:MODIFIER:exon16/16:c.*1174C>T:,FMR1:ENST00000439526:3'UTR:MODIFIER:exon16/16:c.*1174C>T:		rs25704	0.4956	0.2834	228,49,73	0.5909,0.0000,0.0000,0.2115,0.2770	0.3757							309550 [FMR1 (confirmed) Fragile X syndrome,300624|Fragile X tremor/ataxia syndrome,300623|Premature ovarian failure 1,311360];		CR114249 [CLASS=DP MUT=ALT PHEN="Epithelial ovarian cancer increased risk association" GENE=FMR1]; 		158	90					FMR1 (inh=XLD pLI=0.13)
chrX	148055144	148055144	A	G	hom	anno_omim	QUAL=15818;DP=88;AF=1.00;MQM=60;TRIO=HOM,88,1.00,HOM,256,1.00,HOM,160,1.00	AFF2	splice_region&intron	AFF2:ENST00000370460:splice_region&intron:LOW:exon16/20:c.3404+7A>G:,AFF2:ENST00000370457:splice_region&intron:LOW:exon15/19:c.3299+7A>G:,AFF2:ENST00000342251:splice_region&intron:LOW:exon15/19:c.3305+7A>G:,AFF2:ENST00000286437:splice_region&intron:LOW:exon13/17:c.2327+7A>G:		rs5980615	0.9542	0.9829	25940,14606,2279	0.8333,0.9934,0.9999,0.9995,0.9998	0.9862							300806 [AFF2 (provisional) Mental retardation,X-linked,FRAXE type,309548];	RCV000079971.10 [other]; 			2288	5					AFF2 (inh=XLR pLI=1.00)
chrX	148079639	148079639	A	C	hom	anno_omim	QUAL=12505;DP=141;AF=0.99;MQM=60;TRIO=HOM,141,0.99,HOM,139,1.00,HOM,98,1.00	AFF2	3'UTR	AFF2:ENST00000370460:3'UTR:MODIFIER:exon21/21:c.*6777A>C:,AFF2:ENST00000370457:3'UTR:MODIFIER:exon20/20:c.*6777A>C:,AFF2:ENST00000286437:3'UTR:MODIFIER:exon18/18:c.*6777A>C:		rs16994920	0.8760	0.0000	0,0,0	0,0,0,0,0	0.9113							300806 [AFF2 (provisional) Mental retardation,X-linked,FRAXE type,309548];				307	13					AFF2 (inh=XLR pLI=1.00)
chrX	148079740	148079740	A	C	hom	anno_omim	QUAL=18890;DP=161;AF=1.00;MQM=60;TRIO=HOM,161,1.00,HOM,265,1.00,HOM,160,1.00	AFF2	3'UTR	AFF2:ENST00000370460:3'UTR:MODIFIER:exon21/21:c.*6878A>C:,AFF2:ENST00000370457:3'UTR:MODIFIER:exon20/20:c.*6878A>C:,AFF2:ENST00000286437:3'UTR:MODIFIER:exon18/18:c.*6878A>C:		rs58901446	0.8707	0.0000	0,0,0	0,0,0,0,0	0.9047							300806 [AFF2 (provisional) Mental retardation,X-linked,FRAXE type,309548];				309	12					AFF2 (inh=XLR pLI=1.00)
chrX	148079877	148079877	T	C	hom	anno_omim	QUAL=18325;DP=163;AF=0.99;MQM=60;TRIO=HOM,163,0.99,HOM,238,1.00,HOM,164,0.99	AFF2	3'UTR	AFF2:ENST00000370460:3'UTR:MODIFIER:exon21/21:c.*7015T>C:,AFF2:ENST00000370457:3'UTR:MODIFIER:exon20/20:c.*7015T>C:,AFF2:ENST00000286437:3'UTR:MODIFIER:exon18/18:c.*7015T>C:		rs16994922	0.8302	0.0000	0,0,0	0,0,0,0,0	0.8671							300806 [AFF2 (provisional) Mental retardation,X-linked,FRAXE type,309548];				310	12					AFF2 (inh=XLR pLI=1.00)
chrX	148081140	148081140	A	G	hom	anno_omim	QUAL=21607;DP=150;AF=1.00;MQM=59;TRIO=HOM,150,1.00,HOM,319,1.00,HOM,215,1.00	AFF2	3'UTR	AFF2:ENST00000370460:3'UTR:MODIFIER:exon21/21:c.*8278A>G:,AFF2:ENST00000370457:3'UTR:MODIFIER:exon20/20:c.*8278A>G:,AFF2:ENST00000286437:3'UTR:MODIFIER:exon18/18:c.*8278A>G:	(GT)n	rs184050542	0.9966	0.0000	0,0,0	0,0,0,0,0	0.9521							300806 [AFF2 (provisional) Mental retardation,X-linked,FRAXE type,309548];				328	1					AFF2 (inh=XLR pLI=1.00)
chrX	148081451	148081451	A	G	hom	anno_omim	QUAL=13091;DP=180;AF=1.00;MQM=60;TRIO=HOM,180,1.00,HOM,139,1.00,HOM,77,0.99	AFF2	3'UTR	AFF2:ENST00000370460:3'UTR:MODIFIER:exon21/21:c.*8589A>G:,AFF2:ENST00000370457:3'UTR:MODIFIER:exon20/20:c.*8589A>G:,AFF2:ENST00000286437:3'UTR:MODIFIER:exon18/18:c.*8589A>G:		rs141776682	1.0000	0.0000	0,0,0	0,0,0,0,0	1.0000							300806 [AFF2 (provisional) Mental retardation,X-linked,FRAXE type,309548];				336	0					AFF2 (inh=XLR pLI=1.00)
chrX	149826503	149826503	G	A	hom	anno_omim	QUAL=3747;DP=64;AF=1.00;MQM=60;TRIO=HOM,64,1.00,HOM,57,1.00,WT,35,0.00	MTM1	splice_region&intron	MTM1:ENST00000370396:splice_region&intron:LOW:exon11/14:c.1260+3G>A:,MTM1:ENST00000542741:splice_region&intron:LOW:exon10/13:c.975+3G>A:,MTM1:ENST00000543350:splice_region&intron:LOW:exon9/12:c.915+3G>A:,MTM1:ENST00000413012:splice_region&intron:LOW:exon10/13:c.1149+3G>A:		rs222410	0.6570	0.5797	8850,3658,2570	0.8923,0.5960,0.3229,0.5297,0.7335	0.5859							300415 [MTM1 (confirmed) Myotubular myopathy,X-linked,310400];	RCV000078428.9 [other]; 			1074	411					MTM1 (inh=XLR pLI=1.00)
chrX	153008675	153008675	G	A	het	low_MQM;anno_omim;trio_denovo	QUAL=369;DP=98;AF=0.39;MQM=34;TRIO=HET,98,0.39,WT,362,0.00,WT,208,0.00	ABCD1,U52111.14	splice_region&synonymous	ABCD1:ENST00000218104:splice_region&synonymous:LOW:exon9/10:c.1866G>A:p.Arg622Arg		rs201197921	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];			COSM1636441	0	5					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153008984	153008984	G	A	het	low_MQM;pred_pathogenic;anno_omim;trio_denovo	QUAL=380;DP=77;AF=0.43;MQM=32;TRIO=HET,77,0.43,WT,288,0.00,WT,180,0.00	ABCD1,U52111.14	missense	ABCD1:ENST00000218104:missense:MODERATE:exon10/10:c.2033G>A:p.Gly678Asp		rs75125350	0.0000	0.0001	0,0,0	0.0000,0.0000,0.0000,0.0001,0.0000	0.0001	9.4050	D	D	D	D	26.90	300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				0	7					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009017	153009017	G	A	het	low_MQM;pred_pathogenic;anno_omim;trio_denovo	QUAL=179;DP=76;AF=0.34;MQM=31;TRIO=HET,76,0.34,WT,260,0.00,WT,168,0.00	ABCD1,U52111.14	missense	ABCD1:ENST00000218104:missense:MODERATE:exon10/10:c.2066G>A:p.Arg689His		rs781952886	0.0000	0.0001	0,0,0	0.0000,0.0000,0.0000,0.0001,0.0000	0.0001	7.5710	D	D	D	D	32.00	300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				0	9					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009140	153009140	C	T	het	low_MQM;pred_pathogenic;anno_omim;trio_denovo	QUAL=42;DP=49;AF=0.27;MQM=39;TRIO=HET,49,0.27,WT,78,0.00,WT,62,0.00	ABCD1,U52111.14	missense	ABCD1:ENST00000218104:missense:MODERATE:exon10/10:c.2189C>T:p.Pro730Leu		rs375489051	0.0000	0.0001	0,0,0	0.0000,0.0014,0.0000,0.0000,0.0000	0.0001	-0.2740	T	D	B	D	8.52	300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				0	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009289	153009289	C	A	het	anno_omim;trio_denovo	QUAL=88;DP=45;AF=0.24;MQM=51;TRIO=HET,45,0.24,WT,39,0.00,WT,31,0.00	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*100C>A:		rs182735515	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				0	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009303	153009303	A	G	het	low_MQM;anno_omim;trio_denovo	QUAL=56;DP=42;AF=0.21;MQM=47;TRIO=HET,42,0.21,WT,43,0.00,WT,38,0.00	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*114A>G:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				0	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009304	153009304	A	G	het	low_MQM;anno_omim;trio_denovo	QUAL=56;DP=42;AF=0.21;MQM=47;TRIO=HET,42,0.21,WT,43,0.00,WT,38,0.00	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*115A>G:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				0	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009314	153009314	C	A	het	low_QUAL;low_MQM;anno_omim;trio_denovo	QUAL=14;DP=56;AF=0.21;MQM=43;TRIO=HET,56,0.21,WT,51,0.00,WT,39,0.00	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*125C>A:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0001							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				0	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009342	153009342	C	T	het	low_MQM;anno_omim;trio_denovo	QUAL=102;DP=73;AF=0.29;MQM=38;TRIO=HET,73,0.29,WT,58,0.00,WT,48,0.00	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*153C>T:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0006							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				1	1					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009350	153009350	G	A	het	low_MQM;anno_omim;trio_denovo	QUAL=186;DP=67;AF=0.28;MQM=38;TRIO=HET,67,0.28,WT,64,0.00,WT,54,0.00	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*161G>A:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0005							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				1	1					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009352	153009352	A	G	het	low_MQM;anno_omim;trio_denovo	QUAL=186;DP=67;AF=0.28;MQM=38;TRIO=HET,67,0.28,WT,64,0.00,WT,54,0.00	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*163A>G:		rs191015436	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0005							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				1	1					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009364	153009364	G	A	het	low_MQM;anno_omim;trio_denovo	QUAL=375;DP=86;AF=0.36;MQM=36;TRIO=HET,86,0.36,WT,64,0.00,WT,53,0.00	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*175G>A:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0006							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				1	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009385	153009385	C	G	het	low_MQM;anno_omim;trio_denovo	QUAL=155;DP=63;AF=0.35;MQM=31;TRIO=HET,63,0.35,WT,73,0.00,WT,55,0.00	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*196C>G:		rs367591611	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0005							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];	RCV000384405.1 [uncertain significance]; 			0	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009386	153009386	G	T	het	low_MQM;anno_omim;trio_denovo	QUAL=155;DP=63;AF=0.35;MQM=31;TRIO=HET,63,0.35,WT,73,0.00,WT,55,0.00	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*197G>T:		rs371380320	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0004							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				0	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009448	153009448	A	G	het	low_MQM;anno_omim;trio_denovo	QUAL=362;DP=54;AF=0.43;MQM=36;TRIO=HET,54,0.43,WT,76,0.00,WT,54,0.00	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*259A>G:		rs374092960	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0003							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];	RCV000290033.1 [uncertain significance]; 			0	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009488	153009488	C	T	het	low_MQM;anno_omim;trio_denovo	QUAL=86;DP=68;AF=0.25;MQM=34;TRIO=HET,68,0.25,WT,77,0.00,WT,55,0.00	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*299C>T:		rs201959080	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				0	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009665	153009665	A	G	het	low_MQM;anno_omim;trio_denovo	QUAL=464;DP=131;AF=0.32;MQM=36;TRIO=HET,131,0.32,WT,165,0.01,WT,91,0.00	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*476A>G:		rs372234126	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0001							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				0	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009670	153009670	G	T	het	low_MQM;anno_omim;trio_denovo	QUAL=1145;DP=154;AF=0.46;MQM=38;TRIO=HET,154,0.46,WT,161,0.01,WT,91,0.00	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*481G>T:		rs199942817	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0002							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];	RCV000296588.1 [uncertain significance]; 			0	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009719	153009719	G	A	het	low_MQM;anno_omim;trio_denovo	QUAL=2164;DP=164;AF=0.69;MQM=40;TRIO=HET,164,0.69,WT,163,0.00,WT,93,0.00	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*530G>A:		rs67211405	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0002							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];	RCV000351429.1 [uncertain significance]; 			0	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009769	153009769	C	G	het	low_MQM;anno_omim;trio_denovo	QUAL=218;DP=83;AF=0.33;MQM=45;TRIO=HET,83,0.33,WT,195,0.00,WT,96,0.00	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*580C>G:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				0	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009770	153009770	A	G	het	low_MQM;anno_omim;trio_denovo	QUAL=218;DP=83;AF=0.33;MQM=45;TRIO=HET,83,0.33,WT,195,0.00,WT,96,0.00	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*581A>G:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				0	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009774	153009774	G	A	het	low_MQM;anno_omim;trio_denovo	QUAL=218;DP=83;AF=0.33;MQM=45;TRIO=HET,83,0.33,WT,195,0.00,WT,96,0.00	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*585G>A:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				0	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009808	153009808	A	T	het	low_MQM;anno_omim	QUAL=56;DP=127;AF=0.21;MQM=38;TRIO=HET,127,0.21,WT,229,0.03,HET,154,0.12	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*619A>T:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0009							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				0	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009810	153009810	C	G	het	low_MQM;anno_omim	QUAL=56;DP=127;AF=0.21;MQM=38;TRIO=HET,127,0.21,WT,229,0.03,HET,154,0.12	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*621C>G:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0013							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				0	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009818	153009818	A	G	het	low_MQM;anno_omim	QUAL=276;DP=138;AF=0.25;MQM=36;TRIO=HET,138,0.25,WT,248,0.06,HET,169,0.15	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*629A>G:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0031							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				0	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009838	153009838	C	A	het	low_MQM;anno_omim	QUAL=667;DP=165;AF=0.27;MQM=35;TRIO=HET,165,0.27,WT,259,0.08,HET,183,0.21	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*649C>A:		rs372449563	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0159							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				0	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009876	153009876	G	C	het	low_MQM;anno_omim	QUAL=960;DP=104;AF=0.30;MQM=34;TRIO=HET,104,0.30,WT,247,0.09,HET,186,0.26	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*687G>C:		rs377207559	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0349							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				0	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009912	153009912	G	C	het	low_MQM;anno_omim	QUAL=443;DP=40;AF=0.25;MQM=35;TRIO=HET,40,0.25,WT,217,0.10,HET,171,0.28	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*723G>C:		rs369704281	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0427							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				0	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153009914	153009914	G	T	het	low_MQM;anno_omim	QUAL=443;DP=40;AF=0.25;MQM=35;TRIO=HET,40,0.25,WT,217,0.10,HET,171,0.28	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*725G>T:		rs202120253	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0416							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				0	0					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153010019	153010019	A	G	het	low_MQM;anno_omim	QUAL=764;DP=37;AF=0.05;MQM=39;TRIO=HET,37,0.05,HET,130,0.17,HET,122,0.39	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*830A>G:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0719							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				1	2					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153010020	153010020	G	T	het	low_MQM;anno_omim	QUAL=764;DP=37;AF=0.05;MQM=39;TRIO=HET,37,0.05,HET,130,0.17,HET,122,0.39	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*831G>T:		rs879964075	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0749							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				1	2					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153010059	153010059	G	T	het	low_MQM;anno_omim	QUAL=3041;DP=104;AF=0.63;MQM=37;TRIO=HET,104,0.63,HET,122,0.30,HET,136,0.52	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*870G>T:		rs72616452	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1805							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];	RCV000353490.1 [uncertain significance]; 			2	5					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153010090	153010090	G	A	het	low_MQM;anno_omim	QUAL=2848;DP=117;AF=0.61;MQM=38;TRIO=HET,117,0.61,HET,138,0.28,HET,144,0.53	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*901G>A:		rs75637470	0.0000	0.0000	0,0,0	0,0,0,0,0	0.2206							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				3	2					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153010092	153010092	G	A	het	low_MQM;anno_omim	QUAL=2848;DP=117;AF=0.61;MQM=38;TRIO=HET,117,0.61,HET,138,0.28,HET,144,0.53	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*903G>A:		rs78155328	0.0000	0.0000	0,0,0	0,0,0,0,0	0.2193							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];	RCV000359653.1 [uncertain significance]; 			3	2					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153010137	153010137	C	T	het	low_MQM;anno_omim	QUAL=889;DP=91;AF=0.16;MQM=38;TRIO=HET,91,0.16,HET,161,0.17,HET,126,0.40	ABCD1,U52111.14	3'UTR	ABCD1:ENST00000218104:3'UTR:MODIFIER:exon10/10:c.*948C>T:		rs112109783	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0691							300371 [ABCD1 (confirmed) Adrenoleukodystrophy,300100|Adrenomyeloneuropathy,adult,300100];				0	1					ABCD1 (inh=XLR pLI=0.98), U52111.14 (inh=n/a pLI=n/a)
chrX	153127735	153127735	G	A	hom	anno_omim	QUAL=1988;DP=32;AF=1.00;MQM=60;TRIO=HOM,32,1.00,HET,133,0.44,WT,96,0.00	L1CAM	3'UTR	L1CAM:ENST00000543994:3'UTR:MODIFIER:exon28/28:c.*383C>T:,L1CAM:ENST00000370060:3'UTR:MODIFIER:exon29/29:c.*383C>T:,L1CAM:ENST00000361981:3'UTR:MODIFIER:exon26/26:c.*383C>T:,L1CAM:ENST00000370057:3'UTR:MODIFIER:exon28/28:c.*383C>T:,L1CAM:ENST00000538883:3'UTR:MODIFIER:exon27/27:c.*383C>T:,L1CAM:ENST00000370055:3'UTR:MODIFIER:exon27/27:c.*383C>T:		rs41311708	0.0207	0.0000	0,0,0	0,0,0,0,0	0.0418							308840 [L1CAM (confirmed) Hydrocephalus due to aqueductal stenosis,307000|MASA syndrome,303350|CRASH syndrome,303350|Hydrocephalus with Hirschsprung disease,307000|Hydrocephalus with congenital idiopathic intestinal pseudoobstruction,307000|Corpus callosum,partial agenesis of,304100];				13	10					L1CAM (inh=XLR pLI=1.00)
chrX	153170980	153170980	T	G	hom	anno_omim	QUAL=2223;DP=38;AF=0.97;MQM=59;TRIO=HOM,38,0.97,HOM,25,1.00,HOM,18,1.00	AVPR2,L1CAM	splice_region&intron	AVPR2:ENST00000337474:splice_region&intron:LOW:exon1/2:c.26-6T>G:,AVPR2:ENST00000358927:splice_region&intron:LOW:exon2/3:c.26-6T>G:,AVPR2:ENST00000370049:splice_region&intron:LOW:exon1/1:c.26-6T>G:		rs56689668	0.9992	0.9993	14332,7851,1445	1.0000,0.9998,0.9922,1.0000,0.9997	0.9997							300538 [AVPR2 (confirmed) Diabetes insipidus,nephrogenic,304800|Nephrogenic syndrome of inappropriate antidiuresis,300539];	RCV000242524.1 [benign]; RCV000325895.1 [benign]; 			2176	2					AVPR2 (inh=XLR pLI=0.12), L1CAM (inh=XLR pLI=1.00)
chrX	153215839	153215839	G	A	hom	anno_omim	QUAL=4672;DP=31;AF=0.97;MQM=59;TRIO=HOM,31,0.97,HOM,77,1.00,HOM,59,1.00	HCFC1	synonymous	HCFC1:ENST00000369984:synonymous:LOW:exon24/26:c.5994C>T:p.Cys1998Cys,HCFC1:ENST00000310441:synonymous:LOW:exon24/26:c.5859C>T:p.Cys1953Cys,HCFC1:ENST00000354233:synonymous:LOW:exon25/27:c.5652C>T:p.Cys1884Cys		rs3027875	0.1913	0.4320	6497,5802,27	0.0801,0.1912,0.0006,0.6395,0.1468	0.4317	-0.6000		T			11.37	300019 [HCFC1 (confirmed) Mental retardation,X-linked 3 (methylmalonic acidemia and homocysteinemia,cblX type ),309541];	RCV000081294.7 [other]; 		COSM457075, COSM457076	817	321					HCFC1 (inh=n/a pLI=1.00)
chrX	153287325	153287325	T	G	het	anno_omim	QUAL=44;DP=39;AF=0.36;MQM=58;TRIO=HET,39,0.36,HET,3,0.33,WT,7,0.00	MECP2	3'UTR	MECP2:ENST00000303391:3'UTR:MODIFIER:exon4/4:c.*8493A>C:		rs868980743	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0012							300005 [MECP2 (confirmed) Rett syndrome,312750|Mental retardation,X-linked,syndromic 13,300055|Rett syndrome,preserved speech variant,312750|Encephalopathy,neonatal severe,300673|Autism susceptibility,X-linked 3,300496|Mental retardation,X-linked syndromic,Lubs type,300260|Rett syndrome,atypical,312750];				0	0					MECP2 (inh=XLR+XLD pLI=0.70)
chrX	153292180	153292180	T	C	hom	anno_omim	QUAL=16671;DP=170;AF=1.00;MQM=60;TRIO=HOM,170,1.00,HOM,223,1.00,HOM,131,1.00	MECP2	3'UTR	MECP2:ENST00000303391:3'UTR:MODIFIER:exon4/4:c.*3638A>G:		rs2734647	0.6262	0.0000	0,0,0	0,0,0,0,0	0.8415							300005 [MECP2 (confirmed) Rett syndrome,312750|Mental retardation,X-linked,syndromic 13,300055|Rett syndrome,preserved speech variant,312750|Encephalopathy,neonatal severe,300673|Autism susceptibility,X-linked 3,300496|Mental retardation,X-linked syndromic,Lubs type,300260|Rett syndrome,atypical,312750];				259	31					MECP2 (inh=XLR+XLD pLI=0.70)
chrX	153294542	153294542	T	C	hom	anno_omim	QUAL=16172;DP=133;AF=0.99;MQM=60;TRIO=HOM,133,0.99,HOM,241,1.00,HOM,154,1.00	MECP2	3'UTR	MECP2:ENST00000303391:3'UTR:MODIFIER:exon4/4:c.*1276A>G:		rs2853337	0.9936	0.0000	0,0,0	0,0,0,0,0	0.9986							300005 [MECP2 (confirmed) Rett syndrome,312750|Mental retardation,X-linked,syndromic 13,300055|Rett syndrome,preserved speech variant,312750|Encephalopathy,neonatal severe,300673|Autism susceptibility,X-linked 3,300496|Mental retardation,X-linked syndromic,Lubs type,300260|Rett syndrome,atypical,312750];				337	0					MECP2 (inh=XLR+XLD pLI=0.70)
chrX	153629155	153629155	A	G	hom	low_MQM;anno_omim	QUAL=12907;DP=185;AF=0.99;MQM=44;TRIO=HOM,185,0.99,HOM,156,1.00,HOM,93,1.00	RPL10	missense	RPL10:ENST00000369817:missense:MODERATE:exon8/8:c.605A>G:p.Asn202Ser,RPL10:ENST00000424325:missense:MODERATE:exon7/7:c.605A>G:p.Asn202Ser,RPL10:ENST00000406022:missense:MODERATE:exon6/6:c.452A>G:p.Asn151Ser		rs12012747	0.6689	0.8261	17974,11413,162	0.2343,0.7922,0.9292,0.9049,0.8439	0.8229	1.2780	T,T,T,T,T	T,T	B,B	.,T,T,T,T	10.99	312173 [RPL10 (confirmed) Autism,susceptibility to,X-linked 5,300847];	RCV000081344.7 [other]; 			1940	206					RPL10 (inh=n/a pLI=0.90)
chrX	153630255	153630255	G	C	hom	anno_omim	QUAL=21658;DP=193;AF=1.00;MQM=59;TRIO=HOM,193,1.00,HOM,301,1.00,HOM,178,1.00	RPL10,DNASE1L1	3'UTR	RPL10:ENST00000424325:3'UTR:MODIFIER:exon7/7:c.*1060G>C:,DNASE1L1:ENST00000369809:3'UTR:MODIFIER:exon10/10:c.*793C>G:,DNASE1L1:ENST00000393638:3'UTR:MODIFIER:exon8/8:c.*793C>G:		rs12877	0.6678	0.0000	0,0,0	0,0,0,0,0	0.6984							312173 [RPL10 (confirmed) Autism,susceptibility to,X-linked 5,300847];				239	19					RPL10 (inh=n/a pLI=0.90), DNASE1L1 (inh=n/a pLI=0.06)
chrX	153630293	153630293	C	T	hom	anno_omim	QUAL=20341;DP=188;AF=1.00;MQM=59;TRIO=HOM,188,1.00,HOM,305,1.00,HOM,161,1.00	RPL10,DNASE1L1	3'UTR	RPL10:ENST00000424325:3'UTR:MODIFIER:exon7/7:c.*1098C>T:,DNASE1L1:ENST00000369809:3'UTR:MODIFIER:exon10/10:c.*755G>A:,DNASE1L1:ENST00000393638:3'UTR:MODIFIER:exon8/8:c.*755G>A:		rs12559	0.6681	0.0000	0,0,0	0,0,0,0,0	0.7002							312173 [RPL10 (confirmed) Autism,susceptibility to,X-linked 5,300847];				240	18					RPL10 (inh=n/a pLI=0.90), DNASE1L1 (inh=n/a pLI=0.06)
chrX	153640061	153640061	T	-	hom	low_DP;anno_omim	QUAL=477;DP=1;AF=1.00;MQM=60;TRIO=HOM,1,1.00,HOM,10,1.00,HOM,6,1.00	TAZ,DNASE1L1	5'UTR,intron	TAZ:ENST00000299328:5'UTR:MODIFIER:exon1/11:c.-120delT:,TAZ:ENST00000369790:5'UTR:MODIFIER:exon1/9:c.-120delT:,TAZ:ENST00000350743:5'UTR:MODIFIER:exon1/10:c.-120delT:,TAZ:ENST00000351413:5'UTR:MODIFIER:exon1/10:c.-120delT:,DNASE1L1:ENST00000369809:intron:MODIFIER:exon1/9:c.-431+167delA:,DNASE1L1:ENST00000393638:intron:MODIFIER:exon1/7:c.-88+167delA:		rs11388353	0.7473	0.8577	1111,550,10	0.0000,0.0000,0.0000,0.9268,0.8378	0.8527							300394 [TAZ (confirmed) Barth syndrome,302060];				533	37					TAZ (inh=XLR pLI=0.97), DNASE1L1 (inh=n/a pLI=0.06)
chrX	153649813	153649813	G	C	hom	anno_omim	QUAL=8103;DP=73;AF=1.00;MQM=60;TRIO=HOM,73,1.00,HOM,109,1.00,HOM,80,1.00	TAZ	3'UTR	TAZ:ENST00000299328:3'UTR:MODIFIER:exon11/11:c.*470G>C:,TAZ:ENST00000369790:3'UTR:MODIFIER:exon9/9:c.*470G>C:,TAZ:ENST00000350743:3'UTR:MODIFIER:exon10/10:c.*470G>C:,TAZ:ENST00000351413:3'UTR:MODIFIER:exon10/10:c.*470G>C:,TAZ:ENST00000369776:3'UTR:MODIFIER:exon7/7:c.*470G>C:		rs743547	0.0000	0.8696	1678,879,168	0.8828,0.0000,0.0000,0.9159,0.8373	0.8711							300394 [TAZ (confirmed) Barth syndrome,302060];	RCV000298181.1 [benign]; RCV000301850.1 [benign]; RCV000360069.1 [benign]; RCV000395030.1 [benign]; 			659	50					TAZ (inh=XLR pLI=0.97)
chrX	153994596	153994596	G	T	hom	anno_omim	QUAL=17951;DP=198;AF=1.00;MQM=60;TRIO=HOM,198,1.00,HOM,228,1.00,HOM,140,1.00	DKC1	synonymous	DKC1:ENST00000369550:synonymous:LOW:exon5/15:c.369G>T:p.Thr123Thr		rs2728532	0.9926	0.9974	26889,14628,3152	0.9749,0.9990,1.0000,1.0000,1.0000	0.9980	-3.5150		T			10.62	300126 [DKC1 (confirmed) Dyskeratosis congenita,X-linked,305000];	RCV000153151.2 [benign]; 			2306	1					DKC1 (inh=XLR pLI=1.00)
chrX	154064200	154064200	C	T	hom	anno_omim	QUAL=11091;DP=174;AF=1.00;MQM=60;TRIO=HOM,174,1.00,HOM,105,1.00,HOM,59,1.00	F8	3'UTR	F8:ENST00000360256:3'UTR:MODIFIER:exon26/26:c.*1672G>A:,F8:ENST00000330287:3'UTR:MODIFIER:exon5/5:c.*1672G>A:	LTR37B	rs1050705	0.5560	0.0000	0,0,0	0,0,0,0,0	0.5828							300841 [F8 (confirmed) Hemophilia A,306700];	RCV000311167.1 [benign]; 			185	42					F8 (inh=XLR pLI=1.00)
chrX	154064580	154064580	T	C	hom	anno_omim	QUAL=10757;DP=114;AF=1.00;MQM=60;TRIO=HOM,114,1.00,HOM,124,0.99,HOM,91,1.00	F8	3'UTR	F8:ENST00000360256:3'UTR:MODIFIER:exon26/26:c.*1292A>G:,F8:ENST00000330287:3'UTR:MODIFIER:exon5/5:c.*1292A>G:		rs1396947	0.9926	0.0000	0,0,0	0,0,0,0,0	0.9949							300841 [F8 (confirmed) Hemophilia A,306700];				337	0					F8 (inh=XLR pLI=1.00)
chrX	154488153	154488153	C	T	hom	anno_omim	QUAL=7494;DP=182;AF=1.00;MQM=60;TRIO=HOM,182,1.00,HET,101,0.52,WT,78,0.00	RAB39B	3'UTR	RAB39B:ENST00000369454:3'UTR:MODIFIER:exon2/2:c.*1935G>A:		rs782447828	0.0005	0.0000	0,0,0	0,0,0,0,0	0.0011							300774 [RAB39B (confirmed) Mental retardation,X-linked 72,300271|Waisman syndrome,311510];	RCV000350071.1 [likely benign]; 			1	1					RAB39B (inh=XLR pLI=0.72)
